data_2kid_residue save_MolProbity _Software.Sf_category software _Software.Sf_framecode MolProbity _Software.Entry_ID ? _Software.ID 1 _Software.Name MolProbity _Software.Version 4.0 _Software.Details . save_ save_CYRANGE _Software.Sf_category software _Software.Sf_framecode CYRANGE _Software.Entry_ID ? _Software.ID 2 _Software.Name CYRANGE _Software.Version 2.0 _Software.Details . save_ save_Structure_validation_residue _Structure_validation_residue.Sf_category structure_validation _Structure_validation_residue.Sf_framecode Structure_validation_residue _Structure_validation_residue.Entry_ID ? _Structure_validation_residue.List_ID 1 _Structure_validation_residue.PDB_accession_code 2kid _Structure_validation_residue.Date_analyzed 2016-10-07 loop_ _Residue_analysis_software.Software_ID _Residue_analysis_software.Software_label _Residue_analysis_software.Method_ID _Residue_analysis_software.Method_label _Residue_analysis_software.Entry_ID _Residue_analysis_software.Structure_validation_oneline_list_ID 1 MolProbity . . ? 1 2 CYRANGE . . ? 1 stop_ loop_ _Residue_analysis.ID _Residue_analysis.PDB_model_num _Residue_analysis.Hydrogen_positions _Residue_analysis.MolProbity_flips _Residue_analysis.Cyrange_core_flag _Residue_analysis.Two_letter_chain_ID _Residue_analysis.PDB_strand_ID _Residue_analysis.PDB_residue_no _Residue_analysis.PDB_ins_code _Residue_analysis.PDB_residue_name _Residue_analysis.Assembly_ID _Residue_analysis.Entity_assembly_ID _Residue_analysis.Entity_ID _Residue_analysis.Comp_ID _Residue_analysis.Comp_index_ID _Residue_analysis.Clash_value _Residue_analysis.Clash_source_PDB_atom_name _Residue_analysis.Clash_destination_PDB_atom_name _Residue_analysis.Clash_destination_PDB_strand_ID _Residue_analysis.Clash_destination_PDB_residue_no _Residue_analysis.Clash_destination_PDB_ins_code _Residue_analysis.Clash_destination_PDB_residue_name _Residue_analysis.Cbeta_deviation_value _Residue_analysis.Rotamer_score _Residue_analysis.Rotamer_name _Residue_analysis.Ramachandran_phi _Residue_analysis.Ramachandran_psi _Residue_analysis.Ramachandran_score _Residue_analysis.Ramachandran_evaluation _Residue_analysis.Ramachandran_type _Residue_analysis.Bond_outlier_count _Residue_analysis.Worst_bond _Residue_analysis.Worst_bond_value _Residue_analysis.Worst_bond_sigma _Residue_analysis.Angle_outlier_count _Residue_analysis.Worst_angle _Residue_analysis.Worst_angle_value _Residue_analysis.Worst_angle_sigma _Residue_analysis.RNA_phosphate_perpendicular_outlier _Residue_analysis.RNA_suitness_score _Residue_analysis.RNA_suite_conformer _Residue_analysis.RNA_suite_triage _Residue_analysis.Max_b_factor _Residue_analysis.Tau_angle _Residue_analysis.Omega_dihedral _Residue_analysis.Disulfide_chi1 _Residue_analysis.Disulfide_chi2 _Residue_analysis.Disulfide_chi3 _Residue_analysis.Disulfide_ss_angle _Residue_analysis.Disulfide_ss _Residue_analysis.Disulfide_ss_angle_prime _Residue_analysis.Disulfide_chi2prime _Residue_analysis.Disulfide_chi1prime _Residue_analysis.Outlier_count_separate_geometry _Residue_analysis.Outlier_count _Residue_analysis.Entry_ID _Residue_analysis.Structure_validation_residue_list_ID . 001 nuclear orig core ' A' A ' 63' ' ' PRO . . . . . . . . . . . . . 6.7 Cg_exo . . . . . 0 N--CA 1.486 1.054 0 CA-C-O 121.228 0.428 . . . . 0.0 111.288 . . . . . . . . . 0 0 . 1 . 001 nuclear orig core ' A' A ' 64' ' ' GLN . . . . . 0.613 ' NE2' ' N ' ' A' ' 64' ' ' GLN . 0.0 OUTLIER -155.75 126.9 7.09 Favored 'General case' 0 C--N 1.3 -1.56 0 O-C-N 121.117 -0.99 . . . . 0.0 109.347 179.316 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 65' ' ' ILE . . . . . 0.426 ' C ' ' O ' ' A' ' 64' ' ' GLN . 2.1 mp -46.27 106.37 0.56 Allowed Pre-proline 0 N--CA 1.489 1.495 0 N-CA-C 107.519 -1.289 . . . . 0.0 107.519 178.935 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 66' ' ' PRO . . . . . . . . . . . . . 89.0 Cg_endo -83.42 -162.84 0.18 Allowed 'Trans proline' 0 C--N 1.315 -1.185 0 C-N-CA 122.462 2.108 . . . . 0.0 112.834 -178.111 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 67' ' ' LYS . . . . . . . . . . . . . 24.8 tttm -87.65 -7.56 57.29 Favored 'General case' 0 N--CA 1.487 1.423 0 O-C-N 121.414 -0.803 . . . . 0.0 109.421 179.965 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 68' ' ' ASP . . . . . 0.654 ' O ' ' N ' ' A' ' 70' ' ' SER . 0.7 OUTLIER -76.23 63.38 1.88 Allowed 'General case' 0 N--CA 1.488 1.461 0 CA-C-O 122.936 1.35 . . . . 0.0 108.822 179.561 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 69' ' ' LYS . . . . . 0.462 ' C ' ' O ' ' A' ' 68' ' ' ASP . 8.2 ptpt -45.45 -14.57 0.02 OUTLIER 'General case' 0 N--CA 1.512 2.67 0 C-N-CA 116.881 -1.928 . . . . 0.0 107.321 178.086 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 70' ' ' SER . . . . . 0.654 ' N ' ' O ' ' A' ' 68' ' ' ASP . 0.6 OUTLIER -86.83 -7.29 58.37 Favored 'General case' 0 N--CA 1.498 1.969 0 CA-C-N 113.856 -1.52 . . . . 0.0 111.661 179.793 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 71' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -97.05 142.47 28.95 Favored 'General case' 0 N--CA 1.505 2.323 0 O-C-N 120.435 -1.416 . . . . 0.0 112.552 -178.838 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 72' ' ' VAL . . . . . 0.495 ' O ' ' CG2' ' A' ' 72' ' ' VAL . 2.6 m -68.0 130.55 33.27 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.418 0 N-CA-C 105.375 -2.083 . . . . 0.0 105.375 174.965 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 73' ' ' ALA . . . . . 0.607 ' N ' ' O ' ' A' ' 87' ' ' VAL . . . -79.02 -13.99 59.45 Favored 'General case' 0 C--N 1.293 -1.855 0 O-C-N 119.999 -1.688 . . . . 0.0 107.398 -179.596 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . 173.5 -157.72 26.5 Favored Glycine 0 N--CA 1.479 1.524 0 N-CA-C 109.48 -1.448 . . . . 0.0 109.48 179.771 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 75' ' ' TYR . . . . . 0.405 ' CD2' ' HA ' ' A' ' 86' ' ' PRO . 69.1 m-85 -142.06 169.72 17.06 Favored 'General case' 0 C--N 1.295 -1.787 0 CA-C-O 121.961 0.886 . . . . 0.0 110.456 -177.591 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 76' ' ' ILE . . . . . . . . . . . . . 0.8 OUTLIER -147.27 142.28 20.03 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.72 0 C-N-CA 119.234 -0.986 . . . . 0.0 109.634 -177.362 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -151.52 162.31 41.19 Favored 'General case' 0 N--CA 1.487 1.409 0 O-C-N 121.193 -0.942 . . . . 0.0 109.759 -179.934 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 78' ' ' ILE . . . . . . . . . . . . . 9.5 mt -145.65 123.76 6.4 Favored Pre-proline 0 C--N 1.303 -1.434 0 N-CA-C 107.821 -1.178 . . . . 0.0 107.821 179.338 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 79' ' ' PRO . . . . . . . . . . . . . 41.5 Cg_endo -71.94 -43.69 1.15 Allowed 'Trans proline' 0 C--N 1.314 -1.255 0 C-N-CA 121.867 1.712 . . . . 0.0 112.949 -178.798 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 1.3 m-20 -66.61 -21.4 66.13 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 120.959 -1.088 . . . . 0.0 110.861 178.339 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 81' ' ' ALA . . . . . 0.497 ' O ' ' ND2' ' A' ' 132' ' ' ASN . . . -105.04 -15.89 14.97 Favored 'General case' 0 N--CA 1.496 1.838 0 O-C-N 121.139 -0.975 . . . . 0.0 109.095 179.672 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 82' ' ' ASP . . . . . . . . . . . . . 20.8 t0 62.84 52.2 2.77 Favored 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.472 -0.768 . . . . 0.0 110.847 179.292 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 83' ' ' ILE . . . . . . . . . . . . . 70.2 mt -127.27 152.85 35.79 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.735 0 O-C-N 121.229 -0.919 . . . . 0.0 109.677 -179.239 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 84' ' ' LYS . . . . . . . . . . . . . 34.6 tttp -158.21 106.49 1.98 Allowed 'General case' 0 N--CA 1.491 1.61 0 N-CA-C 107.778 -1.193 . . . . 0.0 107.778 -179.95 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 85' ' ' GLU . . . . . 0.508 ' OE2' ' O ' ' A' ' 128' ' ' TYR . 0.0 OUTLIER -141.31 165.54 28.2 Favored Pre-proline 0 N--CA 1.495 1.791 0 O-C-N 121.14 -0.975 . . . . 0.0 110.779 -178.366 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 86' ' ' PRO . . . . . 0.405 ' HA ' ' CD2' ' A' ' 75' ' ' TYR . 56.0 Cg_endo -73.57 168.13 25.55 Favored 'Trans proline' 0 N--CA 1.497 1.681 0 C-N-CA 123.335 2.69 . . . . 0.0 113.796 -179.595 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 87' ' ' VAL . . . . . 0.607 ' O ' ' N ' ' A' ' 73' ' ' ALA . 54.8 t -126.35 104.19 12.55 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.841 0 N-CA-C 109.368 -0.605 . . . . 0.0 109.368 179.917 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 88' ' ' TYR . . . . . . . . . . . . . 11.9 m-85 -94.92 156.76 37.66 Favored Pre-proline 0 N--CA 1.504 2.26 0 O-C-N 120.766 -1.209 . . . . 0.0 109.801 179.98 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 89' ' ' PRO . . . . . . . . . . . . . 13.4 Cg_endo -62.84 145.16 94.59 Favored 'Trans proline' 0 N--CA 1.498 1.778 0 C-N-CA 122.637 2.225 . . . . 0.0 113.273 179.591 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . -60.46 169.17 8.4 Favored Glycine 0 N--CA 1.494 2.527 0 N-CA-C 109.383 -1.487 . . . . 0.0 109.383 179.318 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 91' ' ' PRO . . . . . 0.504 ' C ' ' H ' ' A' ' 93' ' ' THR . 57.3 Cg_endo -93.5 169.15 20.47 Favored 'Cis proline' 0 C--N 1.307 -1.622 0 C-N-CA 123.966 -1.264 . . . . 0.0 111.989 0.194 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 92' ' ' ALA . . . . . 0.543 ' O ' ' CD1' ' A' ' 97' ' ' LEU . . . -71.83 32.26 0.05 Allowed 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.214 -0.929 . . . . 0.0 109.988 179.957 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 93' ' ' THR . . . . . 0.504 ' H ' ' C ' ' A' ' 91' ' ' PRO . 5.4 p -72.22 150.48 92.11 Favored Pre-proline 0 C--N 1.303 -1.431 0 O-C-N 120.481 -1.387 . . . . 0.0 108.025 179.761 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 94' ' ' PRO . . . . . . . . . . . . . 74.1 Cg_exo -32.96 -52.8 0.41 Allowed 'Trans proline' 0 C--N 1.306 -1.7 0 C-N-CA 122.893 2.396 . . . . 0.0 112.965 -178.549 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 95' ' ' GLU . . . . . 0.436 ' O ' ' ND2' ' A' ' 98' ' ' ASN . 14.3 mt-10 -49.89 -47.84 51.85 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.079 -1.013 . . . . 0.0 110.061 -179.74 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 96' ' ' GLN . . . . . 0.593 ' C ' ' H ' ' A' ' 98' ' ' ASN . 1.5 mp0 -72.57 -53.99 10.4 Favored 'General case' 0 N--CA 1.489 1.487 0 O-C-N 120.98 -1.075 . . . . 0.0 110.187 -179.68 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 97' ' ' LEU . . . . . 0.543 ' CD1' ' O ' ' A' ' 92' ' ' ALA . 94.0 mt -49.31 -6.56 0.02 OUTLIER 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.145 -0.972 . . . . 0.0 109.684 -179.26 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 98' ' ' ASN . . . . . 0.715 HD22 ' NE ' ' A' ' 99' ' ' ARG . 0.2 OUTLIER -73.88 -20.39 60.43 Favored 'General case' 0 N--CA 1.488 1.447 0 O-C-N 121.252 -0.905 . . . . 0.0 109.2 179.903 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 99' ' ' ARG . . . . . 0.715 ' NE ' HD22 ' A' ' 98' ' ' ASN . 3.0 mtt180 -103.06 -58.16 1.92 Allowed 'General case' 0 N--CA 1.489 1.492 0 O-C-N 121.379 -0.825 . . . . 0.0 110.182 -179.357 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . -173.82 -172.43 39.15 Favored Glycine 0 N--CA 1.492 2.4 0 C-N-CA 119.373 -1.394 . . . . 0.0 110.505 -179.752 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 101' ' ' VAL . . . . . 0.446 ' O ' ' CG2' ' A' ' 101' ' ' VAL . 34.0 m -51.49 103.75 0.05 OUTLIER 'Isoleucine or valine' 0 N--CA 1.493 1.701 0 O-C-N 121.575 -0.956 . . . . 0.0 110.017 -179.817 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 102' ' ' SER . . . . . 0.451 ' H ' ' HG ' ' A' ' 102' ' ' SER . 0.3 OUTLIER -91.55 160.75 15.26 Favored 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.193 -0.942 . . . . 0.0 110.158 179.927 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 103' ' ' PHE . . . . . 0.563 ' O ' ' N ' ' A' ' 105' ' ' GLU . 23.1 m-85 -63.74 121.2 13.4 Favored 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.009 -1.057 . . . . 0.0 108.357 178.769 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 104' ' ' ALA . . . . . . . . . . . . . . . -45.23 -12.45 0.02 OUTLIER 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.464 -0.772 . . . . 0.0 110.516 -179.063 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 105' ' ' GLU . . . . . 0.563 ' N ' ' O ' ' A' ' 103' ' ' PHE . 0.1 OUTLIER -136.6 142.7 43.34 Favored 'General case' 0 N--CA 1.494 1.753 0 O-C-N 120.852 -1.155 . . . . 0.0 110.23 179.958 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 106' ' ' GLU . . . . . 0.467 ' OE1' ' ND2' ' A' ' 107' ' ' ASN . 24.3 tt0 -58.79 -63.41 1.3 Allowed 'General case' 0 N--CA 1.488 1.439 0 CA-C-N 116.173 -0.467 . . . . 0.0 111.438 -178.904 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 107' ' ' ASN . . . . . 0.467 ' ND2' ' OE1' ' A' ' 106' ' ' GLU . 1.7 m120 -79.05 35.45 0.26 Allowed 'General case' 0 N--CA 1.49 1.572 0 O-C-N 120.653 -1.279 . . . . 0.0 113.138 -175.694 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 108' ' ' GLU . . . . . . . . . . . . . 1.5 tp10 -58.92 150.47 24.25 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 120.554 -1.341 . . . . 0.0 107.924 179.858 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 109' ' ' SER . . . . . . . . . . . . . 1.5 t -102.73 146.19 28.59 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.006 -1.059 . . . . 0.0 110.975 -178.192 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 110' ' ' LEU . . . . . . . . . . . . . 4.4 tp -62.4 -20.83 64.86 Favored 'General case' 0 N--CA 1.488 1.46 0 N-CA-C 107.79 -1.189 . . . . 0.0 107.79 178.827 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 111' ' ' ASP . . . . . 0.511 ' CG ' HH22 ' A' ' 151' ' ' ARG . 0.9 OUTLIER -131.46 43.23 3.1 Favored 'General case' 0 C--N 1.302 -1.497 0 N-CA-C 108.573 -0.899 . . . . 0.0 108.573 179.58 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 112' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -70.21 154.12 42.29 Favored 'General case' 0 C--N 1.302 -1.47 0 O-C-N 121.173 -0.954 . . . . 0.0 111.095 -179.812 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 113' ' ' GLN . . . . . 0.533 ' N ' ' CD ' ' A' ' 113' ' ' GLN . 0.0 OUTLIER -67.65 -18.27 64.89 Favored 'General case' 0 C--N 1.3 -1.585 0 N-CA-C 108.255 -1.017 . . . . 0.0 108.255 177.626 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 114' ' ' ASN . . . . . 0.57 ' OD1' ' NE2' ' A' ' 178' ' ' GLN . 11.2 t30 -150.84 105.7 3.3 Favored 'General case' 0 C--N 1.298 -1.654 0 N-CA-C 108.438 -0.949 . . . . 0.0 108.438 178.852 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 115' ' ' ILE . . . . . . . . . . . . . 3.8 mt -95.13 105.34 16.86 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.446 0 O-C-N 120.876 -1.14 . . . . 0.0 108.284 179.806 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 116' ' ' SER . . . . . . . . . . . . . 11.5 m -91.72 153.85 19.37 Favored 'General case' 0 N--CA 1.488 1.454 0 O-C-N 121.286 -0.883 . . . . 0.0 111.23 -178.262 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 117' ' ' ILE . . . . . . . . . . . . . 2.3 mt -148.74 148.18 16.13 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.43 0 N-CA-C 108.124 -1.065 . . . . 0.0 108.124 179.286 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 118' ' ' ALA . . . . . . . . . . . . . . . -142.26 160.37 40.38 Favored 'General case' 0 N--CA 1.492 1.634 0 C-N-CA 118.934 -1.106 . . . . 0.0 111.597 -178.919 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 119' ' ' GLY . . . . . . . . . . . . . . . -171.53 149.77 12.56 Favored Glycine 0 N--CA 1.489 2.205 0 N-CA-C 110.214 -1.155 . . . . 0.0 110.214 -179.947 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 120' ' ' HIS . . . . . . . . . . . . . 14.1 m170 -70.18 168.12 16.38 Favored 'General case' 0 N--CA 1.494 1.74 0 O-C-N 121.728 -0.866 . . . . 0.0 110.128 179.517 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 121' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -115.78 160.34 20.25 Favored 'General case' 0 N--CA 1.496 1.843 0 O-C-N 121.362 -0.836 . . . . 0.0 109.425 179.455 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 122' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -133.48 123.49 25.34 Favored 'General case' 0 N--CA 1.497 1.92 0 O-C-N 121.238 -0.914 . . . . 0.0 109.612 -179.409 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 123' ' ' ILE . . . . . 0.461 ' CG2' ' N ' ' A' ' 124' ' ' ASP . 0.6 OUTLIER -66.0 -42.56 91.94 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.667 0 CA-C-O 121.71 0.767 . . . . 0.0 109.01 179.76 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 124' ' ' ASP . . . . . 0.461 ' N ' ' CG2' ' A' ' 123' ' ' ILE . 5.8 t70 -92.76 24.84 3.38 Favored 'General case' 0 N--CA 1.496 1.867 0 O-C-N 121.616 -0.678 . . . . 0.0 111.956 -177.917 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 125' ' ' ARG . . . . . 0.612 HH11 ' CG ' ' A' ' 125' ' ' ARG . 0.0 OUTLIER -157.92 103.57 1.76 Allowed Pre-proline 0 N--CA 1.492 1.647 0 O-C-N 120.347 -1.47 . . . . 0.0 110.406 -179.432 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 126' ' ' PRO . . . . . . . . . . . . . 60.1 Cg_endo -79.13 -17.0 12.08 Favored 'Trans proline' 0 C--N 1.315 -1.206 0 C-N-CA 122.078 1.852 . . . . 0.0 111.822 179.728 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 127' ' ' ASN . . . . . . . . . . . . . 14.0 m120 -90.89 10.79 24.92 Favored 'General case' 0 N--CA 1.488 1.448 0 O-C-N 121.309 -0.869 . . . . 0.0 109.515 179.75 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 128' ' ' TYR . . . . . 0.508 ' O ' ' OE2' ' A' ' 85' ' ' GLU . 2.7 t80 -68.17 -153.07 0.02 OUTLIER 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.154 -0.966 . . . . 0.0 109.531 -179.924 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 129' ' ' GLN . . . . . 0.548 ' N ' ' OE1' ' A' ' 129' ' ' GLN . 1.1 mp0 -68.13 -67.15 0.48 Allowed 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.451 -0.781 . . . . 0.0 109.85 -179.705 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 130' ' ' PHE . . . . . 0.498 ' O ' ' CE ' ' A' ' 134' ' ' LYS . 57.1 m-85 -135.61 52.6 2.0 Favored 'General case' 0 N--CA 1.493 1.686 0 O-C-N 121.038 -1.039 . . . . 0.0 110.35 179.981 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 131' ' ' THR . . . . . 0.4 ' HA ' ' HZ2' ' A' ' 134' ' ' LYS . 23.4 m -86.43 -41.07 14.73 Favored 'General case' 0 C--N 1.301 -1.523 0 O-C-N 121.075 -1.016 . . . . 0.0 108.764 179.33 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 132' ' ' ASN . . . . . 0.497 ' ND2' ' O ' ' A' ' 81' ' ' ALA . 4.0 t30 -83.47 6.2 21.11 Favored 'General case' 0 N--CA 1.496 1.851 0 O-C-N 121.561 -0.712 . . . . 0.0 111.347 -178.492 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 133' ' ' LEU . . . . . 0.493 ' O ' ' N ' ' A' ' 135' ' ' ALA . 0.1 OUTLIER -69.93 -43.46 71.59 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 120.821 -1.174 . . . . 0.0 109.871 -179.557 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 134' ' ' LYS . . . . . 0.498 ' CE ' ' O ' ' A' ' 130' ' ' PHE . 0.0 OUTLIER -45.37 -17.78 0.03 OUTLIER 'General case' 0 N--CA 1.497 1.921 0 O-C-N 121.172 -0.955 . . . . 0.0 110.154 -179.442 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 135' ' ' ALA . . . . . 0.493 ' N ' ' O ' ' A' ' 133' ' ' LEU . . . -84.66 -32.5 23.59 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 120.949 -1.095 . . . . 0.0 109.38 179.89 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 136' ' ' ALA . . . . . 0.404 ' N ' ' O ' ' A' ' 133' ' ' LEU . . . -80.52 153.23 28.24 Favored 'General case' 0 C--N 1.302 -1.466 0 CA-C-O 122.028 0.918 . . . . 0.0 111.386 -178.808 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 137' ' ' LYS . . . . . 0.551 ' O ' ' O ' ' A' ' 138' ' ' LYS . 51.5 mttp -153.38 -165.57 2.19 Favored 'General case' 0 N--CA 1.49 1.531 0 C-N-CA 118.461 -1.295 . . . . 0.0 110.611 -178.543 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 138' ' ' LYS . . . . . 0.585 ' O ' ' N ' ' A' ' 140' ' ' SER . 0.0 OUTLIER -42.74 177.77 0.0 OUTLIER 'General case' 0 C--N 1.302 -1.462 0 CA-C-O 122.232 1.015 . . . . 0.0 110.961 -178.941 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 139' ' ' GLY . . . . . . . . . . . . . . . 46.75 8.63 0.02 OUTLIER Glycine 0 N--CA 1.489 2.191 0 N-CA-C 110.123 -1.191 . . . . 0.0 110.123 -179.943 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 140' ' ' SER . . . . . 0.585 ' N ' ' O ' ' A' ' 138' ' ' LYS . 11.7 m -80.75 122.42 27.13 Favored 'General case' 0 N--CA 1.492 1.663 0 O-C-N 120.817 -1.402 . . . . 0.0 109.544 179.616 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 141' ' ' MET . . . . . . . . . . . . . 6.5 tpt -77.66 121.89 24.6 Favored 'General case' 0 C--N 1.301 -1.515 0 N-CA-C 108.461 -0.94 . . . . 0.0 108.461 179.252 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 142' ' ' VAL . . . . . . . . . . . . . 2.8 t -112.61 135.9 50.57 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.721 0 O-C-N 121.124 -0.985 . . . . 0.0 109.688 -178.918 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 143' ' ' TYR . . . . . . . . . . . . . 67.8 m-85 -115.14 138.37 50.98 Favored 'General case' 0 N--CA 1.495 1.801 0 O-C-N 121.271 -0.893 . . . . 0.0 110.827 -179.453 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 144' ' ' PHE . . . . . 0.409 ' CD1' ' C ' ' A' ' 144' ' ' PHE . 1.4 t80 -122.26 108.45 13.28 Favored 'General case' 0 N--CA 1.494 1.733 0 O-C-N 121.692 -0.63 . . . . 0.0 109.558 -179.315 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 145' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -97.08 132.43 42.88 Favored 'General case' 0 N--CA 1.494 1.76 0 O-C-N 121.227 -0.921 . . . . 0.0 111.073 -178.791 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 146' ' ' VAL . . . . . 0.453 ' O ' ' C ' ' A' ' 147' ' ' GLY . 4.2 p -143.95 143.75 23.53 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.739 0 N-CA-C 107.854 -1.165 . . . . 0.0 107.854 178.632 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 147' ' ' GLY . . . . . 0.453 ' C ' ' O ' ' A' ' 146' ' ' VAL . . . 42.37 -128.28 4.68 Favored Glycine 0 N--CA 1.491 2.308 0 N-CA-C 108.894 -1.682 . . . . 0.0 108.894 -179.597 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 148' ' ' ASN . . . . . 0.532 ' C ' HD21 ' A' ' 148' ' ' ASN . 0.4 OUTLIER -103.34 18.02 22.74 Favored 'General case' 0 C--N 1.299 -1.594 0 O-C-N 121.49 -1.006 . . . . 0.0 108.348 178.976 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 149' ' ' GLU . . . . . . . . . . . . . 7.6 tt0 -113.84 144.49 42.92 Favored 'General case' 0 N--CA 1.49 1.54 0 CA-C-O 121.917 0.865 . . . . 0.0 111.604 -178.184 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 150' ' ' THR . . . . . . . . . . . . . 52.8 m -125.64 105.08 8.75 Favored 'General case' 0 C--N 1.302 -1.48 0 CA-C-O 121.574 0.702 . . . . 0.0 109.889 179.493 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 151' ' ' ARG . . . . . 0.511 HH22 ' CG ' ' A' ' 111' ' ' ASP . 73.8 mtt180 -86.44 -173.59 4.6 Favored 'General case' 0 N--CA 1.486 1.373 0 N-CA-C 108.709 -0.848 . . . . 0.0 108.709 179.863 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 152' ' ' LYS . . . . . 0.468 ' HZ3' ' CB ' ' A' ' 152' ' ' LYS . 6.8 mtmp? -152.49 148.07 26.98 Favored 'General case' 0 C--N 1.301 -1.52 0 C-N-CA 119.145 -1.022 . . . . 0.0 110.589 -179.489 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 153' ' ' TYR . . . . . . . . . . . . . 47.0 m-85 -144.45 161.55 38.76 Favored 'General case' 0 N--CA 1.489 1.49 0 N-CA-C 108.424 -0.954 . . . . 0.0 108.424 178.739 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 154' ' ' LYS . . . . . . . . . . . . . 17.8 ttmt -137.24 119.7 15.9 Favored 'General case' 0 C--N 1.299 -1.611 0 O-C-N 121.273 -0.892 . . . . 0.0 108.801 179.251 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 155' ' ' MET . . . . . . . . . . . . . 27.1 mtp -45.94 109.04 0.15 Allowed 'General case' 0 N--CA 1.494 1.741 0 CA-C-O 122.443 1.116 . . . . 0.0 111.671 -178.484 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 156' ' ' THR . . . . . 0.539 ' OG1' ' CG2' ' A' ' 203' ' ' THR . 0.2 OUTLIER -103.3 -28.28 11.96 Favored 'General case' 0 C--N 1.296 -1.735 0 CA-C-N 115.168 -0.923 . . . . 0.0 110.22 -178.572 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 157' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -146.95 154.69 41.57 Favored 'General case' 0 N--CA 1.496 1.84 0 C-N-CA 118.337 -1.345 . . . . 0.0 110.569 -179.048 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 158' ' ' ILE . . . . . . . . . . . . . 1.6 mt -148.27 137.31 15.62 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.652 0 CA-C-O 121.322 0.582 . . . . 0.0 109.982 -177.927 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 159' ' ' ARG . . . . . . . . . . . . . 2.2 mtt180 -156.14 -177.62 6.72 Favored 'General case' 0 N--CA 1.494 1.742 0 O-C-N 121.298 -0.877 . . . . 0.0 110.931 -179.521 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 160' ' ' ASP . . . . . 0.409 ' C ' ' CG2' ' A' ' 161' ' ' VAL . 9.3 m-20 -146.8 165.01 30.98 Favored 'General case' 0 N--CA 1.493 1.692 0 N-CA-C 108.48 -0.933 . . . . 0.0 108.48 179.825 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 161' ' ' VAL . . . . . 0.461 ' O ' ' O ' ' A' ' 162' ' ' LYS . 0.0 OUTLIER -162.0 158.78 1.84 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.701 0 O-C-N 120.822 -1.174 . . . . 0.0 111.033 -179.874 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 162' ' ' LYS . . . . . 0.461 ' O ' ' O ' ' A' ' 161' ' ' VAL . 0.0 OUTLIER -44.05 171.23 0.04 OUTLIER Pre-proline 0 N--CA 1.493 1.693 0 O-C-N 121.767 -0.583 . . . . 0.0 110.289 179.326 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 163' ' ' PRO . . . . . . . . . . . . . 71.3 Cg_endo -77.89 32.24 0.44 Allowed 'Trans proline' 0 N--CA 1.495 1.591 0 C-N-CA 122.926 2.417 . . . . 0.0 113.669 -179.839 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 164' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -152.26 -2.84 0.26 Allowed 'General case' 0 N--CA 1.495 1.796 0 O-C-N 120.839 -1.163 . . . . 0.0 111.125 179.686 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 165' ' ' ASP . . . . . 0.42 ' O ' ' C ' ' A' ' 166' ' ' VAL . 1.4 t70 -73.31 61.1 0.63 Allowed 'General case' 0 N--CA 1.491 1.582 0 O-C-N 120.748 -1.22 . . . . 0.0 110.132 -179.245 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 166' ' ' VAL . . . . . 0.582 ' O ' ' N ' ' A' ' 168' ' ' VAL . 2.2 t -45.75 -31.66 1.18 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.604 0 O-C-N 121.048 -1.032 . . . . 0.0 109.614 -178.998 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 167' ' ' GLY . . . . . . . . . . . . . . . -44.8 -10.99 0.01 OUTLIER Glycine 0 N--CA 1.494 2.523 0 O-C-N 120.756 -1.215 . . . . 0.0 111.116 -179.583 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 168' ' ' VAL . . . . . 0.582 ' N ' ' O ' ' A' ' 166' ' ' VAL . 5.8 m -53.8 -29.96 18.53 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.634 0 O-C-N 120.552 -1.557 . . . . 0.0 108.774 179.814 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 169' ' ' LEU . . . . . 0.543 ' O ' ' C ' ' A' ' 170' ' ' ASP . 11.7 mt -49.83 -13.59 0.1 Allowed 'General case' 0 N--CA 1.491 1.62 0 N-CA-C 107.33 -1.359 . . . . 0.0 107.33 -178.994 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 170' ' ' ASP . . . . . 0.576 ' H ' ' C ' ' A' ' 168' ' ' VAL . 40.3 t0 19.46 90.97 0.01 OUTLIER 'General case' 0 N--CA 1.5 2.053 0 CA-C-N 116.355 -0.384 . . . . 0.0 111.587 177.322 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 171' ' ' GLU . . . . . . . . . . . . . 7.8 pt-20 -128.7 72.91 1.47 Allowed 'General case' 0 N--CA 1.496 1.873 0 O-C-N 120.952 -1.092 . . . . 0.0 111.099 -179.615 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 172' ' ' GLN . . . . . . . . . . . . . 6.6 mp0 -128.73 -52.12 1.24 Allowed 'General case' 0 N--CA 1.498 1.965 0 O-C-N 121.335 -0.853 . . . . 0.0 111.519 -178.559 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 173' ' ' LYS . . . . . . . . . . . . . 56.9 mttt -58.51 130.6 47.58 Favored 'General case' 0 N--CA 1.498 1.961 0 O-C-N 120.841 -1.162 . . . . 0.0 109.655 -179.34 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 174' ' ' GLY . . . . . 0.53 ' O ' ' C ' ' A' ' 175' ' ' LYS . . . -122.48 -43.76 0.37 Allowed Glycine 0 N--CA 1.48 1.607 0 N-CA-C 108.657 -1.777 . . . . 0.0 108.657 179.761 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 175' ' ' LYS . . . . . 0.53 ' C ' ' O ' ' A' ' 174' ' ' GLY . 13.6 mptt -37.98 -62.9 0.52 Allowed 'General case' 0 N--CA 1.495 1.776 0 N-CA-C 107.319 -1.363 . . . . 0.0 107.319 179.309 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 176' ' ' ASP . . . . . 0.599 ' O ' ' O ' ' A' ' 177' ' ' LYS . 1.1 m-20 -104.34 91.2 3.81 Favored 'General case' 0 C--N 1.293 -1.885 0 N-CA-C 106.942 -1.503 . . . . 0.0 106.942 176.725 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 177' ' ' LYS . . . . . 0.599 ' O ' ' O ' ' A' ' 176' ' ' ASP . 9.7 mttp -45.07 -176.01 0.0 OUTLIER 'General case' 0 N--CA 1.494 1.764 0 O-C-N 121.344 -0.848 . . . . 0.0 109.683 -179.093 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 178' ' ' GLN . . . . . 0.57 ' NE2' ' OD1' ' A' ' 114' ' ' ASN . 18.6 pt20 -161.0 176.45 11.37 Favored 'General case' 0 N--CA 1.487 1.399 0 C-N-CA 118.043 -1.463 . . . . 0.0 111.399 179.581 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 179' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -130.61 96.27 4.07 Favored 'General case' 0 C--N 1.302 -1.493 0 N-CA-C 107.525 -1.287 . . . . 0.0 107.525 178.187 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 180' ' ' THR . . . . . . . . . . . . . 1.2 m -71.09 114.17 8.87 Favored 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.069 -1.019 . . . . 0.0 109.485 -178.979 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 181' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -90.14 141.15 28.97 Favored 'General case' 0 C--N 1.3 -1.554 0 N-CA-C 108.234 -1.024 . . . . 0.0 108.234 178.453 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 182' ' ' ILE . . . . . . . . . . . . . 73.4 mt -135.07 118.72 24.91 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.594 0 N-CA-C 107.638 -1.245 . . . . 0.0 107.638 178.903 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 183' ' ' THR . . . . . . . . . . . . . 3.8 t -138.62 112.09 8.17 Favored 'General case' 0 C--N 1.289 -2.038 0 N-CA-C 107.894 -1.15 . . . . 0.0 107.894 179.902 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 184' ' ' CYS . . . . . . . . . . . . . 1.9 p -78.58 157.1 28.85 Favored 'General case' 0 C--N 1.292 -1.911 0 C-N-CA 119.326 -0.95 . . . . 0.0 110.911 -177.867 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 185' ' ' ASP . . . . . . . . . . . . . 20.7 t0 -165.68 -152.86 0.16 Allowed 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.456 -0.778 . . . . 0.0 109.518 -179.735 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 186' ' ' ASP . . . . . . . . . . . . . 13.0 m-20 47.69 56.48 7.07 Favored 'General case' 0 N--CA 1.496 1.829 0 O-C-N 121.139 -0.975 . . . . 0.0 109.071 -179.707 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 187' ' ' TYR . . . . . 0.623 ' CE1' ' O ' ' A' ' 188' ' ' ASN . 32.9 t80 -67.91 136.08 53.45 Favored 'General case' 0 N--CA 1.49 1.56 0 CA-C-O 121.799 0.809 . . . . 0.0 111.013 -179.221 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 188' ' ' ASN . . . . . 0.623 ' O ' ' CE1' ' A' ' 187' ' ' TYR . 1.1 t-20 -99.43 147.53 25.17 Favored 'General case' 0 C--N 1.297 -1.705 0 N-CA-C 108.128 -1.064 . . . . 0.0 108.128 178.503 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 189' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -112.52 -13.59 13.32 Favored 'General case' 0 C--N 1.293 -1.878 0 N-CA-C 108.114 -1.069 . . . . 0.0 108.114 -179.718 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 190' ' ' LYS . . . . . . . . . . . . . 88.3 mttt -84.32 -51.26 7.12 Favored 'General case' 0 N--CA 1.488 1.474 0 N-CA-C 108.853 -0.795 . . . . 0.0 108.853 178.791 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 191' ' ' THR . . . . . 0.416 ' HG1' HG13 ' A' ' 193' ' ' VAL . 9.4 p -89.61 -10.82 44.56 Favored 'General case' 0 N--CA 1.489 1.488 0 O-C-N 121.546 -0.721 . . . . 0.0 109.075 179.79 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 192' ' ' GLY . . . . . . . . . . . . . . . 68.69 30.76 72.81 Favored Glycine 0 N--CA 1.492 2.399 0 O-C-N 121.316 -0.865 . . . . 0.0 110.945 178.733 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 193' ' ' VAL . . . . . 0.416 HG13 ' HG1' ' A' ' 191' ' ' THR . 2.2 p -145.9 169.29 6.54 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.621 0 O-C-N 120.791 -1.417 . . . . 0.0 110.201 179.397 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 194' ' ' TRP . . . . . 0.541 ' N ' ' CD1' ' A' ' 194' ' ' TRP . 9.4 m95 -86.47 121.37 28.93 Favored 'General case' 0 C--N 1.294 -1.821 0 N-CA-C 109.104 -0.702 . . . . 0.0 109.104 -179.717 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 195' ' ' GLU . . . . . 0.492 ' CD ' ' ND2' ' A' ' 188' ' ' ASN . 1.3 mt-10 -85.04 -61.17 1.84 Allowed 'General case' 0 N--CA 1.497 1.888 0 O-C-N 121.275 -0.891 . . . . 0.0 111.703 -178.216 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 196' ' ' LYS . . . . . . . . . . . . . 1.8 mtpm? -84.61 151.27 24.62 Favored 'General case' 0 N--CA 1.494 1.74 0 O-C-N 120.814 -1.179 . . . . 0.0 110.488 -178.475 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 197' ' ' ARG . . . . . 0.544 ' NH1' ' O ' ' C' ' 704' ' ' ALA . 24.1 mmt180 -120.37 137.42 54.3 Favored 'General case' 0 N--CA 1.492 1.637 0 N-CA-C 108.942 -0.762 . . . . 0.0 108.942 179.497 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 198' ' ' LYS . . . . . . . . . . . . . 5.0 mptp? -115.1 120.01 38.37 Favored 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.467 -0.771 . . . . 0.0 110.304 -179.007 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 199' ' ' ILE . . . . . 0.419 ' O ' HG13 ' A' ' 199' ' ' ILE . 1.1 pp -141.42 121.01 11.35 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.803 0 CA-C-O 122.618 1.199 . . . . 0.0 110.826 179.201 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 200' ' ' PHE . . . . . 0.526 ' CD1' ' N ' ' A' ' 200' ' ' PHE . 0.7 OUTLIER -105.04 141.42 36.65 Favored 'General case' 0 N--CA 1.494 1.773 0 O-C-N 121.131 -0.981 . . . . 0.0 111.177 -178.133 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 201' ' ' VAL . . . . . . . . . . . . . 96.8 t -102.57 149.02 7.22 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.651 0 N-CA-C 107.726 -1.213 . . . . 0.0 107.726 176.722 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 202' ' ' ALA . . . . . . . . . . . . . . . -132.27 139.89 48.42 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.002 -1.061 . . . . 0.0 109.116 -179.513 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 203' ' ' THR . . . . . 0.539 ' CG2' ' OG1' ' A' ' 156' ' ' THR . 16.8 p -89.86 131.19 35.92 Favored 'General case' 0 N--CA 1.487 1.416 0 CA-C-O 122.556 1.169 . . . . 0.0 111.944 -178.316 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 204' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -61.96 135.43 57.55 Favored 'General case' 0 C--N 1.299 -1.598 0 CA-C-N 114.818 -1.083 . . . . 0.0 108.957 179.016 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 205' ' ' VAL . . . . . 0.504 ' O ' ' C ' ' A' ' 206' ' ' LYS . 37.6 t -122.67 -44.47 1.88 Allowed 'Isoleucine or valine' 0 N--CA 1.494 1.76 0 O-C-N 121.382 -0.824 . . . . 0.0 109.71 -179.703 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 206' ' ' LYS . . . . . 0.504 ' C ' ' O ' ' A' ' 205' ' ' VAL . 0.0 OUTLIER . . . . . 0 N--CA 1.494 1.767 0 CA-C-O 118.093 -0.956 . . . . 0.0 110.456 -179.636 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' C' C ' 702' ' ' LEU . . . . . 0.535 ' H ' ' CD1' ' C' ' 702' ' ' LEU . 0.0 OUTLIER . . . . . 0 N--CA 1.493 1.703 0 N-CA-C 110.009 -0.367 . . . . 0.0 110.009 . . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' C' C ' 703' ' ' PRO . . . . . 0.504 ' O ' ' O ' ' C' ' 702' ' ' LEU . 31.3 Cg_exo -51.34 -160.79 0.0 OUTLIER 'Trans proline' 0 N--CA 1.493 1.476 0 C-N-CA 121.945 1.764 . . . . 0.0 111.718 179.057 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' C' C ' 704' ' ' ALA . . . . . 0.544 ' O ' ' NH1' ' A' ' 197' ' ' ARG . . . . . . . . 0 N--CA 1.489 1.481 0 O-C-N 120.981 -1.075 . . . . 0.0 109.055 179.898 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 63' ' ' PRO . . . . . . . . . . . . . 10.6 Cg_endo . . . . . 0 N--CA 1.481 0.781 0 CA-C-O 121.167 0.403 . . . . 0.0 111.473 . . . . . . . . . 0 0 . 1 . 002 nuclear orig core ' A' A ' 64' ' ' GLN . . . . . 0.682 ' NE2' ' N ' ' A' ' 64' ' ' GLN . 0.0 OUTLIER -153.71 119.93 5.44 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.163 -0.961 . . . . 0.0 109.433 179.732 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 65' ' ' ILE . . . . . 0.463 ' C ' ' O ' ' A' ' 64' ' ' GLN . 0.0 OUTLIER -42.18 103.78 0.32 Allowed Pre-proline 0 N--CA 1.495 1.782 0 N-CA-C 108.405 -0.961 . . . . 0.0 108.405 179.203 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 66' ' ' PRO . . . . . . . . . . . . . 88.3 Cg_endo -87.36 -159.99 0.1 OUTLIER 'Trans proline' 0 C--N 1.315 -1.191 0 C-N-CA 122.272 1.982 . . . . 0.0 112.421 -179.436 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 67' ' ' LYS . . . . . . . . . . . . . 13.5 pttt -79.67 -4.99 54.18 Favored 'General case' 0 C--N 1.302 -1.5 0 N-CA-C 108.739 -0.837 . . . . 0.0 108.739 179.765 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 68' ' ' ASP . . . . . 0.662 ' C ' ' N ' ' A' ' 70' ' ' SER . 1.0 OUTLIER -76.79 48.62 0.58 Allowed 'General case' 0 C--N 1.304 -1.396 0 CA-C-O 121.958 0.885 . . . . 0.0 109.393 179.705 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 69' ' ' LYS . . . . . 0.456 ' C ' ' O ' ' A' ' 68' ' ' ASP . 1.6 ptpt -49.3 -13.25 0.07 Allowed 'General case' 0 N--CA 1.508 2.442 0 C-N-CA 116.684 -2.006 . . . . 0.0 106.283 177.599 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 70' ' ' SER . . . . . 0.662 ' N ' ' C ' ' A' ' 68' ' ' ASP . 0.4 OUTLIER -83.43 -9.66 58.88 Favored 'General case' 0 N--CA 1.496 1.83 0 CA-C-N 113.164 -1.835 . . . . 0.0 110.162 179.221 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 71' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -97.36 142.98 28.57 Favored 'General case' 0 N--CA 1.496 1.838 0 O-C-N 120.991 -1.068 . . . . 0.0 110.753 179.601 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 72' ' ' VAL . . . . . 0.405 HG11 ' CZ ' ' A' ' 88' ' ' TYR . 0.8 OUTLIER -66.16 141.94 17.4 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.527 0 N-CA-C 105.131 -2.174 . . . . 0.0 105.131 174.702 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 73' ' ' ALA . . . . . 0.517 ' N ' ' O ' ' A' ' 87' ' ' VAL . . . -82.8 -15.9 49.88 Favored 'General case' 0 C--N 1.295 -1.762 0 O-C-N 119.928 -1.732 . . . . 0.0 106.704 179.75 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . 175.4 -157.83 24.73 Favored Glycine 0 N--CA 1.479 1.546 0 N-CA-C 109.318 -1.513 . . . . 0.0 109.318 179.584 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 75' ' ' TYR . . . . . 0.445 ' CD2' ' O ' ' A' ' 85' ' ' GLU . 0.6 OUTLIER -143.15 168.35 19.96 Favored 'General case' 0 C--N 1.295 -1.778 0 O-C-N 121.682 -0.893 . . . . 0.0 110.463 -177.234 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 76' ' ' ILE . . . . . . . . . . . . . 2.4 tt -148.75 145.91 17.84 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.601 0 C-N-CA 119.225 -0.99 . . . . 0.0 110.075 -178.04 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -150.65 166.43 30.36 Favored 'General case' 0 N--CA 1.489 1.49 0 O-C-N 121.059 -1.026 . . . . 0.0 109.289 179.371 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 78' ' ' ILE . . . . . 0.4 ' O ' ' N ' ' A' ' 82' ' ' ASP . 13.5 mt -147.75 94.98 4.3 Favored Pre-proline 0 C--N 1.302 -1.474 0 N-CA-C 108.6 -0.889 . . . . 0.0 108.6 -179.57 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 79' ' ' PRO . . . . . . . . . . . . . 75.0 Cg_exo -47.55 -47.56 17.69 Favored 'Trans proline' 0 N--CA 1.494 1.506 0 C-N-CA 122.811 2.34 . . . . 0.0 113.811 -178.645 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -65.86 -18.63 65.46 Favored 'General case' 0 N--CA 1.493 1.718 0 O-C-N 120.868 -1.145 . . . . 0.0 110.439 178.474 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 81' ' ' ALA . . . . . 0.531 ' O ' ' ND2' ' A' ' 132' ' ' ASN . . . -105.01 -14.05 15.55 Favored 'General case' 0 N--CA 1.493 1.679 0 O-C-N 121.238 -0.914 . . . . 0.0 109.035 179.904 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 82' ' ' ASP . . . . . 0.4 ' N ' ' O ' ' A' ' 78' ' ' ILE . 0.3 OUTLIER 64.27 48.34 2.89 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.334 -0.853 . . . . 0.0 110.503 179.246 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 83' ' ' ILE . . . . . . . . . . . . . 64.2 mt -131.1 152.08 36.92 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.796 0 O-C-N 121.127 -0.983 . . . . 0.0 110.647 -178.583 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 84' ' ' LYS . . . . . . . . . . . . . 30.2 tttp -158.83 111.85 2.3 Favored 'General case' 0 N--CA 1.492 1.635 0 N-CA-C 108.315 -0.994 . . . . 0.0 108.315 179.282 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 85' ' ' GLU . . . . . 0.445 ' O ' ' CD2' ' A' ' 75' ' ' TYR . 0.4 OUTLIER -143.16 162.79 41.22 Favored Pre-proline 0 N--CA 1.494 1.729 0 O-C-N 121.279 -0.888 . . . . 0.0 110.225 -179.211 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 86' ' ' PRO . . . . . 0.416 ' N ' ' CE2' ' A' ' 75' ' ' TYR . 57.1 Cg_endo -70.92 167.65 25.33 Favored 'Trans proline' 0 N--CA 1.497 1.698 0 C-N-CA 123.346 2.697 . . . . 0.0 113.506 -179.141 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 87' ' ' VAL . . . . . 0.517 ' O ' ' N ' ' A' ' 73' ' ' ALA . 62.0 t -124.67 99.66 6.47 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.66 0 N-CA-C 108.972 -0.751 . . . . 0.0 108.972 179.717 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 88' ' ' TYR . . . . . 0.405 ' CZ ' HG11 ' A' ' 72' ' ' VAL . 33.0 m-85 -92.87 152.94 42.01 Favored Pre-proline 0 N--CA 1.502 2.164 0 O-C-N 120.832 -1.167 . . . . 0.0 110.029 -179.617 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 89' ' ' PRO . . . . . 0.432 ' O ' ' NE2' ' A' ' 96' ' ' GLN . 6.1 Cg_endo -57.19 144.47 90.47 Favored 'Trans proline' 0 C--N 1.312 -1.392 0 C-N-CA 122.531 2.154 . . . . 0.0 113.606 -179.901 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . -57.22 167.6 4.64 Favored Glycine 0 N--CA 1.49 2.268 0 N-CA-C 109.242 -1.543 . . . . 0.0 109.242 179.038 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 91' ' ' PRO . . . . . 0.465 ' C ' ' H ' ' A' ' 93' ' ' THR . 18.9 Cg_endo -93.44 170.4 19.62 Favored 'Cis proline' 0 C--N 1.307 -1.626 0 C-N-CA 123.968 -1.263 . . . . 0.0 112.054 -0.176 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 92' ' ' ALA . . . . . . . . . . . . . . . -72.78 30.57 0.06 Allowed 'General case' 0 N--CA 1.489 1.504 0 O-C-N 121.216 -0.928 . . . . 0.0 110.635 -179.868 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 93' ' ' THR . . . . . 0.465 ' H ' ' C ' ' A' ' 91' ' ' PRO . 1.0 OUTLIER -75.44 152.84 85.73 Favored Pre-proline 0 N--CA 1.49 1.572 0 O-C-N 120.743 -1.223 . . . . 0.0 109.095 -179.741 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 94' ' ' PRO . . . . . 0.412 ' C ' ' O ' ' A' ' 93' ' ' THR . 53.3 Cg_exo -32.82 -52.6 0.39 Allowed 'Trans proline' 0 C--N 1.309 -1.517 0 C-N-CA 122.933 2.422 . . . . 0.0 112.214 -179.292 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 95' ' ' GLU . . . . . 0.586 ' O ' ' ND2' ' A' ' 98' ' ' ASN . 13.0 mt-10 -45.9 -53.11 10.38 Favored 'General case' 0 N--CA 1.489 1.49 0 O-C-N 121.249 -0.907 . . . . 0.0 109.452 179.942 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 96' ' ' GLN . . . . . 0.556 ' O ' ' N ' ' A' ' 98' ' ' ASN . 29.6 mm100 -71.41 -51.66 22.8 Favored 'General case' 0 C--N 1.305 -1.368 0 O-C-N 120.955 -1.091 . . . . 0.0 109.747 179.956 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 97' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -49.52 -7.82 0.03 OUTLIER 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.209 -0.932 . . . . 0.0 109.675 -179.424 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 98' ' ' ASN . . . . . 0.686 HD22 ' CZ ' ' A' ' 99' ' ' ARG . 0.4 OUTLIER -73.05 -24.37 60.69 Favored 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.167 -0.958 . . . . 0.0 109.615 -179.931 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 99' ' ' ARG . . . . . 0.686 ' CZ ' HD22 ' A' ' 98' ' ' ASN . 0.6 OUTLIER -103.56 -59.42 1.72 Allowed 'General case' 0 N--CA 1.489 1.504 0 O-C-N 121.544 -0.722 . . . . 0.0 110.363 -178.936 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . -164.73 -171.53 31.09 Favored Glycine 0 N--CA 1.494 2.545 0 C-N-CA 119.21 -1.471 . . . . 0.0 110.608 -179.674 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 101' ' ' VAL . . . . . 0.476 ' O ' ' CG2' ' A' ' 101' ' ' VAL . 18.9 m -59.94 108.3 0.38 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.667 0 O-C-N 121.411 -1.053 . . . . 0.0 108.955 179.854 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -93.03 165.28 12.93 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.446 -0.784 . . . . 0.0 111.015 -179.133 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 103' ' ' PHE . . . . . 0.505 ' CE1' ' CG1' ' A' ' 87' ' ' VAL . 24.5 m-85 -66.17 160.5 24.0 Favored 'General case' 0 N--CA 1.486 1.368 0 N-CA-C 107.954 -1.128 . . . . 0.0 107.954 178.031 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 104' ' ' ALA . . . . . . . . . . . . . . . -72.5 -22.58 61.03 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.087 -1.008 . . . . 0.0 111.707 -177.913 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 1.2 pm0 -138.95 150.12 45.53 Favored 'General case' 0 N--CA 1.497 1.876 0 O-C-N 120.696 -1.253 . . . . 0.0 110.644 -179.296 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 106' ' ' GLU . . . . . . . . . . . . . 66.2 tt0 -52.7 -59.52 4.38 Favored 'General case' 0 C--N 1.303 -1.415 0 O-C-N 121.777 -0.577 . . . . 0.0 110.491 -179.928 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 107' ' ' ASN . . . . . 0.579 ' H ' ' ND2' ' A' ' 107' ' ' ASN . 0.2 OUTLIER -77.05 32.84 0.14 Allowed 'General case' 0 N--CA 1.488 1.461 0 O-C-N 120.614 -1.304 . . . . 0.0 112.583 -175.706 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 108' ' ' GLU . . . . . . . . . . . . . 2.8 tp10 -60.2 144.29 50.43 Favored 'General case' 0 N--CA 1.488 1.473 0 N-CA-C 107.029 -1.471 . . . . 0.0 107.029 179.742 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 109' ' ' SER . . . . . 0.571 ' C ' ' H ' ' A' ' 111' ' ' ASP . 0.2 OUTLIER -97.76 122.82 41.31 Favored 'General case' 0 N--CA 1.487 1.416 0 O-C-N 120.83 -1.169 . . . . 0.0 110.858 -177.776 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 110' ' ' LEU . . . . . . . . . . . . . 2.1 pp -59.81 -3.26 0.49 Allowed 'General case' 0 C--N 1.301 -1.521 0 N-CA-C 108.04 -1.096 . . . . 0.0 108.04 179.235 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 111' ' ' ASP . . . . . 0.571 ' H ' ' C ' ' A' ' 109' ' ' SER . 75.7 m-20 -132.83 18.63 4.19 Favored 'General case' 0 N--CA 1.489 1.498 0 O-C-N 121.735 -0.603 . . . . 0.0 109.716 179.668 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 112' ' ' ASP . . . . . 0.456 ' C ' ' H ' ' A' ' 114' ' ' ASN . 0.3 OUTLIER -65.07 135.84 56.04 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 120.887 -1.133 . . . . 0.0 109.684 -179.76 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 113' ' ' GLN . . . . . 0.525 ' NE2' ' O ' ' A' ' 173' ' ' LYS . 0.0 OUTLIER -64.44 -4.64 4.13 Favored 'General case' 0 C--N 1.303 -1.439 0 O-C-N 121.24 -0.913 . . . . 0.0 108.766 179.238 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 114' ' ' ASN . . . . . 0.576 ' C ' HD21 ' A' ' 114' ' ' ASN . 0.2 OUTLIER -144.78 92.49 2.29 Favored 'General case' 0 C--N 1.303 -1.436 0 N-CA-C 107.13 -1.433 . . . . 0.0 107.13 177.967 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 115' ' ' ILE . . . . . . . . . . . . . 2.1 mt -101.88 117.22 46.87 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.457 0 O-C-N 121.592 -0.693 . . . . 0.0 110.959 -178.304 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 116' ' ' SER . . . . . . . . . . . . . 97.0 p -99.04 146.82 25.67 Favored 'General case' 0 N--CA 1.495 1.807 0 O-C-N 121.244 -0.91 . . . . 0.0 111.544 -178.928 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 117' ' ' ILE . . . . . 0.406 HG22 ' N ' ' A' ' 118' ' ' ALA . 2.7 mp -135.16 148.55 28.79 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.842 0 N-CA-C 107.521 -1.289 . . . . 0.0 107.521 178.891 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 118' ' ' ALA . . . . . 0.406 ' N ' HG22 ' A' ' 117' ' ' ILE . . . -144.97 160.73 40.88 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 120.531 -1.356 . . . . 0.0 111.849 -179.251 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 119' ' ' GLY . . . . . . . . . . . . . . . -169.88 156.72 27.76 Favored Glycine 0 N--CA 1.485 1.909 0 N-CA-C 109.456 -1.457 . . . . 0.0 109.456 179.424 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 120' ' ' HIS . . . . . . . . . . . . . 20.0 m-70 -71.36 162.59 29.19 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.51 -0.994 . . . . 0.0 109.849 179.676 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 121' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -117.49 160.02 21.89 Favored 'General case' 0 N--CA 1.492 1.669 0 N-CA-C 107.962 -1.125 . . . . 0.0 107.962 178.586 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 122' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -127.28 133.35 50.17 Favored 'General case' 0 N--CA 1.495 1.805 0 O-C-N 121.144 -0.972 . . . . 0.0 110.273 -178.821 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 123' ' ' ILE . . . . . . . . . . . . . 15.9 tt -90.76 -27.1 5.04 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.624 0 CA-C-O 121.827 0.822 . . . . 0.0 110.097 -179.317 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 124' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -87.4 -2.29 58.52 Favored 'General case' 0 C--N 1.291 -1.938 0 C-N-CA 120.128 -0.629 . . . . 0.0 111.318 -178.663 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 125' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -154.2 124.08 3.29 Favored Pre-proline 0 N--CA 1.494 1.774 0 O-C-N 120.625 -1.297 . . . . 0.0 109.683 -179.702 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 126' ' ' PRO . . . . . . . . . . . . . 86.8 Cg_endo -81.14 -16.67 9.66 Favored 'Trans proline' 0 N--CA 1.494 1.518 0 C-N-CA 122.46 2.106 . . . . 0.0 112.992 179.994 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 127' ' ' ASN . . . . . 0.593 ' C ' HD21 ' A' ' 127' ' ' ASN . 0.1 OUTLIER -90.19 22.37 3.33 Favored 'General case' 0 N--CA 1.493 1.702 0 O-C-N 121.071 -1.018 . . . . 0.0 110.308 -179.342 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 128' ' ' TYR . . . . . . . . . . . . . 13.0 t80 -75.3 -150.52 0.03 OUTLIER 'General case' 0 N--CA 1.492 1.673 0 O-C-N 121.004 -1.06 . . . . 0.0 109.751 -179.73 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 129' ' ' GLN . . . . . . . . . . . . . 27.7 mt-30 -68.1 -89.1 0.01 OUTLIER 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.252 -0.905 . . . . 0.0 109.616 -179.636 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 130' ' ' PHE . . . . . . . . . . . . . 27.7 m-85 -108.14 35.13 3.26 Favored 'General case' 0 N--CA 1.493 1.684 0 O-C-N 121.421 -0.799 . . . . 0.0 110.003 -179.533 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 131' ' ' THR . . . . . . . . . . . . . 55.0 m -75.37 -33.31 61.04 Favored 'General case' 0 N--CA 1.488 1.464 0 O-C-N 121.037 -1.039 . . . . 0.0 108.982 179.562 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 132' ' ' ASN . . . . . 0.531 ' ND2' ' O ' ' A' ' 81' ' ' ALA . 4.6 t30 -81.01 3.98 21.21 Favored 'General case' 0 N--CA 1.494 1.741 0 O-C-N 121.32 -0.863 . . . . 0.0 110.512 -179.014 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 133' ' ' LEU . . . . . 0.593 ' O ' ' N ' ' A' ' 135' ' ' ALA . 0.4 OUTLIER -68.85 -48.96 62.17 Favored 'General case' 0 N--CA 1.488 1.456 0 O-C-N 120.982 -1.074 . . . . 0.0 109.318 -179.943 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 134' ' ' LYS . . . . . 0.589 ' CE ' ' H ' ' A' ' 134' ' ' LYS . 0.0 OUTLIER -43.0 -18.21 0.01 OUTLIER 'General case' 0 N--CA 1.488 1.452 0 O-C-N 121.363 -0.835 . . . . 0.0 109.121 179.869 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 135' ' ' ALA . . . . . 0.593 ' N ' ' O ' ' A' ' 133' ' ' LEU . . . -83.43 -39.02 21.14 Favored 'General case' 0 N--CA 1.488 1.435 0 O-C-N 121.219 -0.926 . . . . 0.0 109.266 179.012 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 136' ' ' ALA . . . . . 0.496 ' N ' ' O ' ' A' ' 133' ' ' LEU . . . -80.46 157.45 26.2 Favored 'General case' 0 N--CA 1.49 1.542 0 CA-C-O 121.996 0.903 . . . . 0.0 111.299 -178.965 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 137' ' ' LYS . . . . . 0.536 ' O ' ' O ' ' A' ' 138' ' ' LYS . 1.0 OUTLIER -154.19 -162.36 1.4 Allowed 'General case' 0 N--CA 1.49 1.575 0 C-N-CA 118.5 -1.28 . . . . 0.0 110.961 -178.161 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 138' ' ' LYS . . . . . 0.574 ' O ' ' N ' ' A' ' 140' ' ' SER . 9.4 mttp -43.17 178.27 0.0 OUTLIER 'General case' 0 N--CA 1.487 1.397 0 CA-C-O 122.438 1.113 . . . . 0.0 111.083 -179.03 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 139' ' ' GLY . . . . . . . . . . . . . . . 46.95 7.72 0.02 OUTLIER Glycine 0 N--CA 1.491 2.302 0 N-CA-C 110.668 -0.973 . . . . 0.0 110.668 179.858 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 140' ' ' SER . . . . . 0.574 ' N ' ' O ' ' A' ' 138' ' ' LYS . 58.4 m -86.87 127.14 35.04 Favored 'General case' 0 N--CA 1.496 1.87 0 O-C-N 120.811 -1.406 . . . . 0.0 109.599 179.349 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 141' ' ' MET . . . . . 0.591 ' SD ' ' N ' ' A' ' 142' ' ' VAL . 6.2 tpp -77.61 129.16 35.26 Favored 'General case' 0 N--CA 1.492 1.65 0 O-C-N 120.975 -1.078 . . . . 0.0 109.33 179.688 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 142' ' ' VAL . . . . . 0.591 ' N ' ' SD ' ' A' ' 141' ' ' MET . 1.4 t -112.09 133.27 58.34 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.617 0 N-CA-C 108.546 -0.909 . . . . 0.0 108.546 -179.982 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 143' ' ' TYR . . . . . . . . . . . . . 5.4 m-85 -108.22 134.36 51.17 Favored 'General case' 0 N--CA 1.497 1.897 0 O-C-N 120.719 -1.238 . . . . 0.0 112.31 -177.835 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 144' ' ' PHE . . . . . . . . . . . . . 36.9 t80 -119.92 99.92 6.92 Favored 'General case' 0 N--CA 1.494 1.726 0 N-CA-C 109.511 -0.551 . . . . 0.0 109.511 179.718 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 145' ' ' LYS . . . . . . . . . . . . . 1.0 OUTLIER -96.02 134.3 39.2 Favored 'General case' 0 N--CA 1.493 1.701 0 O-C-N 121.193 -0.942 . . . . 0.0 110.677 -179.348 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 146' ' ' VAL . . . . . 0.479 ' O ' ' C ' ' A' ' 147' ' ' GLY . 0.0 OUTLIER -144.03 141.14 24.97 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.789 0 N-CA-C 107.443 -1.317 . . . . 0.0 107.443 178.861 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 147' ' ' GLY . . . . . 0.479 ' C ' ' O ' ' A' ' 146' ' ' VAL . . . 38.42 -117.67 0.64 Allowed Glycine 0 N--CA 1.493 2.44 0 N-CA-C 109.67 -1.372 . . . . 0.0 109.67 179.78 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 148' ' ' ASN . . . . . 0.501 ' C ' ' ND2' ' A' ' 148' ' ' ASN . 0.4 OUTLIER -108.74 13.45 25.03 Favored 'General case' 0 C--N 1.303 -1.447 0 O-C-N 121.576 -0.955 . . . . 0.0 108.643 179.166 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 149' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -107.0 142.21 36.98 Favored 'General case' 0 N--CA 1.488 1.464 0 CA-C-O 121.934 0.873 . . . . 0.0 111.329 -178.863 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 150' ' ' THR . . . . . . . . . . . . . 97.3 m -134.64 99.06 4.22 Favored 'General case' 0 C--N 1.3 -1.583 0 CA-C-O 121.581 0.705 . . . . 0.0 109.841 -179.428 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 151' ' ' ARG . . . . . . . . . . . . . 86.6 mtt180 -88.24 -171.26 3.29 Favored 'General case' 0 N--CA 1.487 1.411 0 N-CA-C 108.872 -0.788 . . . . 0.0 108.872 179.973 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 152' ' ' LYS . . . . . 0.512 ' C ' ' CD1' ' A' ' 153' ' ' TYR . 34.8 mttp -151.38 150.85 30.95 Favored 'General case' 0 C--N 1.302 -1.471 0 O-C-N 121.201 -0.937 . . . . 0.0 110.139 179.703 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 153' ' ' TYR . . . . . 0.512 ' CD1' ' C ' ' A' ' 152' ' ' LYS . 22.0 m-85 -145.71 158.07 43.89 Favored 'General case' 0 C--N 1.299 -1.618 0 N-CA-C 107.516 -1.29 . . . . 0.0 107.516 178.183 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 154' ' ' LYS . . . . . . . . . . . . . 13.2 ttpp -130.55 125.43 34.21 Favored 'General case' 0 C--N 1.297 -1.71 0 N-CA-C 108.44 -0.948 . . . . 0.0 108.44 -179.996 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 155' ' ' MET . . . . . . . . . . . . . 74.5 mtp -45.87 107.33 0.1 Allowed 'General case' 0 N--CA 1.489 1.517 0 O-C-N 120.697 -1.252 . . . . 0.0 110.797 -178.954 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 156' ' ' THR . . . . . 0.536 ' HG1' ' N ' ' A' ' 203' ' ' THR . 0.4 OUTLIER -104.47 -27.16 12.08 Favored 'General case' 0 C--N 1.292 -1.933 0 CA-C-N 115.292 -0.867 . . . . 0.0 110.284 -178.385 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 157' ' ' SER . . . . . . . . . . . . . 10.0 t -150.63 150.52 31.26 Favored 'General case' 0 N--CA 1.493 1.702 0 C-N-CA 118.418 -1.313 . . . . 0.0 110.927 -178.812 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 158' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -152.91 140.13 13.21 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.389 0 CA-C-O 121.75 0.786 . . . . 0.0 109.563 -178.476 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 159' ' ' ARG . . . . . . . . . . . . . 26.8 mtm180 -154.73 165.2 37.33 Favored 'General case' 0 C--N 1.294 -1.822 0 CA-C-O 121.672 0.749 . . . . 0.0 109.882 -179.441 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 160' ' ' ASP . . . . . . . . . . . . . 8.0 m-20 -116.18 155.03 28.99 Favored 'General case' 0 C--N 1.298 -1.645 0 N-CA-C 108.069 -1.085 . . . . 0.0 108.069 179.253 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 161' ' ' VAL . . . . . 0.409 ' O ' ' O ' ' A' ' 162' ' ' LYS . 13.1 m -155.01 150.69 11.4 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.7 0 O-C-N 120.893 -1.129 . . . . 0.0 110.527 -178.995 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 162' ' ' LYS . . . . . 0.409 ' O ' ' O ' ' A' ' 161' ' ' VAL . 0.0 OUTLIER -47.36 170.38 0.09 OUTLIER Pre-proline 0 N--CA 1.49 1.571 0 O-C-N 121.295 -0.878 . . . . 0.0 109.495 179.677 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 163' ' ' PRO . . . . . . . . . . . . . 57.4 Cg_endo -78.0 37.32 0.62 Allowed 'Trans proline' 0 C--N 1.309 -1.525 0 C-N-CA 122.738 2.292 . . . . 0.0 112.769 -179.706 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 164' ' ' THR . . . . . . . . . . . . . 17.4 m -152.19 -7.98 0.21 Allowed 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.081 -1.012 . . . . 0.0 110.859 -179.88 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 165' ' ' ASP . . . . . 0.456 ' O ' ' C ' ' A' ' 166' ' ' VAL . 6.9 t70 -72.84 61.41 0.55 Allowed 'General case' 0 N--CA 1.492 1.653 0 O-C-N 120.627 -1.296 . . . . 0.0 110.193 -179.412 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 166' ' ' VAL . . . . . 0.67 ' O ' ' N ' ' A' ' 168' ' ' VAL . 0.7 OUTLIER -39.77 -30.0 0.13 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.637 0 O-C-N 121.411 -0.806 . . . . 0.0 109.789 -178.546 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 167' ' ' GLY . . . . . 0.443 ' N ' ' O ' ' A' ' 165' ' ' ASP . . . -42.55 -9.04 0.01 OUTLIER Glycine 0 N--CA 1.5 2.925 0 O-C-N 121.292 -0.88 . . . . 0.0 111.221 -179.497 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 168' ' ' VAL . . . . . 0.67 ' N ' ' O ' ' A' ' 166' ' ' VAL . 19.6 t -48.35 -40.72 10.47 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.62 0 O-C-N 120.89 -1.359 . . . . 0.0 108.729 179.263 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 169' ' ' LEU . . . . . 0.544 ' O ' ' N ' ' A' ' 171' ' ' GLU . 5.4 mt -47.54 -9.4 0.02 OUTLIER 'General case' 0 N--CA 1.496 1.86 0 N-CA-C 108.715 -0.846 . . . . 0.0 108.715 -178.207 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 170' ' ' ASP . . . . . 0.618 ' H ' ' C ' ' A' ' 168' ' ' VAL . 7.0 t0 35.6 27.86 0.01 OUTLIER 'General case' 0 N--CA 1.493 1.72 0 O-C-N 121.508 -0.745 . . . . 0.0 111.5 178.22 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 171' ' ' GLU . . . . . 0.544 ' N ' ' O ' ' A' ' 169' ' ' LEU . 3.8 pt-20 -69.34 94.56 0.72 Allowed 'General case' 0 C--N 1.301 -1.541 0 N-CA-C 107.157 -1.423 . . . . 0.0 107.157 178.034 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 172' ' ' GLN . . . . . . . . . . . . . 2.4 mt-30 -155.14 -74.06 0.11 Allowed 'General case' 0 N--CA 1.493 1.716 0 O-C-N 121.447 -0.783 . . . . 0.0 109.977 -178.645 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 173' ' ' LYS . . . . . 0.525 ' O ' ' NE2' ' A' ' 113' ' ' GLN . 2.3 mptt -59.65 137.84 57.91 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.335 -0.853 . . . . 0.0 109.119 179.841 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 174' ' ' GLY . . . . . 0.504 ' O ' ' C ' ' A' ' 175' ' ' LYS . . . -123.42 -43.61 0.35 Allowed Glycine 0 C--N 1.299 -1.505 0 N-CA-C 107.771 -2.132 . . . . 0.0 107.771 179.172 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 175' ' ' LYS . . . . . 0.504 ' C ' ' O ' ' A' ' 174' ' ' GLY . 0.1 OUTLIER -36.89 -76.9 0.02 OUTLIER 'General case' 0 N--CA 1.498 1.946 0 N-CA-C 108.943 -0.762 . . . . 0.0 108.943 179.729 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 176' ' ' ASP . . . . . 0.582 ' O ' ' O ' ' A' ' 177' ' ' LYS . 1.2 m-20 -91.38 86.62 6.15 Favored 'General case' 0 C--N 1.297 -1.708 0 N-CA-C 107.087 -1.449 . . . . 0.0 107.087 178.059 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 177' ' ' LYS . . . . . 0.582 ' O ' ' O ' ' A' ' 176' ' ' ASP . 0.9 OUTLIER -40.5 178.01 0.0 OUTLIER 'General case' 0 N--CA 1.493 1.713 0 CA-C-O 121.603 0.716 . . . . 0.0 110.907 -178.919 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 178' ' ' GLN . . . . . 0.492 ' NE2' ' CG ' ' A' ' 114' ' ' ASN . 1.0 OUTLIER -160.91 173.49 15.23 Favored 'General case' 0 C--N 1.307 -1.263 0 C-N-CA 118.637 -1.225 . . . . 0.0 110.692 -179.726 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 179' ' ' LEU . . . . . . . . . . . . . 2.2 tp -128.02 100.2 5.79 Favored 'General case' 0 C--N 1.3 -1.57 0 N-CA-C 106.896 -1.52 . . . . 0.0 106.896 178.127 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 180' ' ' THR . . . . . . . . . . . . . 1.4 m -75.18 118.95 18.67 Favored 'General case' 0 C--N 1.303 -1.417 0 C-N-CA 119.071 -1.052 . . . . 0.0 110.287 -178.101 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 181' ' ' LEU . . . . . 0.417 HD11 ' H ' ' A' ' 182' ' ' ILE . 57.8 tp -94.76 146.95 23.82 Favored 'General case' 0 C--N 1.298 -1.647 0 N-CA-C 108.08 -1.081 . . . . 0.0 108.08 178.171 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 182' ' ' ILE . . . . . 0.417 ' H ' HD11 ' A' ' 181' ' ' LEU . 54.9 mt -140.9 125.43 17.88 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.529 0 O-C-N 120.958 -1.089 . . . . 0.0 109.684 179.552 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 183' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -143.84 112.29 6.44 Favored 'General case' 0 C--N 1.295 -1.802 0 N-CA-C 107.047 -1.464 . . . . 0.0 107.047 178.722 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 184' ' ' CYS . . . . . 0.463 ' CB ' HH11 ' A' ' 197' ' ' ARG . 0.6 OUTLIER -78.48 163.06 25.91 Favored 'General case' 0 N--CA 1.498 1.964 0 C-N-CA 118.786 -1.166 . . . . 0.0 110.954 -177.114 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 185' ' ' ASP . . . . . . . . . . . . . 12.3 t0 -165.87 -153.92 0.19 Allowed 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.45 -0.781 . . . . 0.0 109.817 -179.712 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 186' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER 49.98 53.92 11.98 Favored 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.254 -0.904 . . . . 0.0 108.983 -179.67 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 187' ' ' TYR . . . . . 0.603 ' CE1' ' O ' ' A' ' 188' ' ' ASN . 34.2 t80 -65.93 135.17 54.39 Favored 'General case' 0 C--N 1.301 -1.521 0 O-C-N 121.205 -0.935 . . . . 0.0 110.222 -179.419 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 188' ' ' ASN . . . . . 0.603 ' O ' ' CE1' ' A' ' 187' ' ' TYR . 0.6 OUTLIER -100.93 147.68 25.87 Favored 'General case' 0 C--N 1.296 -1.737 0 N-CA-C 107.954 -1.128 . . . . 0.0 107.954 178.578 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 189' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -112.54 -13.65 13.31 Favored 'General case' 0 C--N 1.295 -1.772 0 N-CA-C 108.268 -1.012 . . . . 0.0 108.268 -179.872 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 190' ' ' LYS . . . . . . . . . . . . . 15.0 mtmt -83.46 -52.34 6.59 Favored 'General case' 0 C--N 1.303 -1.426 0 N-CA-C 108.814 -0.81 . . . . 0.0 108.814 179.118 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 191' ' ' THR . . . . . . . . . . . . . 2.6 p -90.56 -9.63 46.43 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.461 -0.775 . . . . 0.0 109.075 179.58 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 192' ' ' GLY . . . . . . . . . . . . . . . 63.68 39.94 98.04 Favored Glycine 0 N--CA 1.493 2.484 0 N-CA-C 110.836 -0.905 . . . . 0.0 110.836 178.941 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 193' ' ' VAL . . . . . . . . . . . . . 57.8 t -145.98 159.32 11.75 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.563 0 O-C-N 121.01 -1.288 . . . . 0.0 109.34 179.346 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 194' ' ' TRP . . . . . 0.47 ' N ' ' CD1' ' A' ' 194' ' ' TRP . 19.9 m95 -85.31 120.48 26.84 Favored 'General case' 0 C--N 1.3 -1.584 0 N-CA-C 107.644 -1.243 . . . . 0.0 107.644 178.667 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 195' ' ' GLU . . . . . 0.514 ' CD ' ' ND2' ' A' ' 188' ' ' ASN . 1.1 mt-10 -89.27 -60.6 1.91 Allowed 'General case' 0 N--CA 1.493 1.713 0 O-C-N 121.138 -0.976 . . . . 0.0 111.749 -177.453 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 196' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -78.98 144.34 34.85 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 120.823 -1.173 . . . . 0.0 110.405 -178.558 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 197' ' ' ARG . . . . . 0.56 ' NH2' ' O ' ' C' ' 703' ' ' PRO . 0.7 OUTLIER -120.77 137.15 54.66 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.632 -0.668 . . . . 0.0 109.206 179.714 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 198' ' ' LYS . . . . . . . . . . . . . 3.2 mtmm -114.97 122.06 45.09 Favored 'General case' 0 N--CA 1.489 1.491 0 O-C-N 121.722 -0.611 . . . . 0.0 110.323 -178.943 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 199' ' ' ILE . . . . . 0.455 ' CG1' ' O ' ' A' ' 199' ' ' ILE . 0.6 OUTLIER -141.85 118.32 6.85 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.7 0 O-C-N 120.957 -1.09 . . . . 0.0 110.416 179.937 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 200' ' ' PHE . . . . . 0.53 ' CD1' ' N ' ' A' ' 200' ' ' PHE . 6.5 m-85 -99.84 137.96 37.58 Favored 'General case' 0 N--CA 1.499 1.975 0 O-C-N 121.294 -0.879 . . . . 0.0 110.134 -179.371 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 201' ' ' VAL . . . . . . . . . . . . . 33.0 t -105.7 148.28 10.33 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.589 0 N-CA-C 107.981 -1.118 . . . . 0.0 107.981 177.744 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 202' ' ' ALA . . . . . 0.416 ' HA ' ' H ' ' A' ' 156' ' ' THR . . . -133.35 139.43 46.82 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.03 -1.044 . . . . 0.0 109.088 -179.608 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 203' ' ' THR . . . . . 0.536 ' N ' ' HG1' ' A' ' 156' ' ' THR . 1.9 p -90.2 134.26 34.39 Favored 'General case' 0 N--CA 1.487 1.383 0 CA-C-O 122.565 1.174 . . . . 0.0 111.197 -178.827 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 204' ' ' GLU . . . . . 0.414 ' HA ' ' CD2' ' A' ' 153' ' ' TYR . 6.8 tt0 -56.0 134.88 52.69 Favored 'General case' 0 C--N 1.296 -1.76 0 C-N-CA 118.761 -1.176 . . . . 0.0 109.621 179.818 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 205' ' ' VAL . . . . . 0.531 ' O ' ' C ' ' A' ' 206' ' ' LYS . 61.0 t -128.35 -42.4 0.85 Allowed 'Isoleucine or valine' 0 N--CA 1.494 1.766 0 O-C-N 121.304 -0.873 . . . . 0.0 110.24 -178.788 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 206' ' ' LYS . . . . . 0.531 ' C ' ' O ' ' A' ' 205' ' ' VAL . 1.2 pptp? . . . . . 0 N--CA 1.501 2.093 0 CA-C-O 118.157 -0.925 . . . . 0.0 110.596 -179.505 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' C' C ' 702' ' ' LEU . . . . . 0.619 ' CD1' ' N ' ' C' ' 702' ' ' LEU . 0.0 OUTLIER . . . . . 0 N--CA 1.493 1.702 0 N-CA-C 108.676 -0.861 . . . . 0.0 108.676 . . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' C' C ' 703' ' ' PRO . . . . . 0.56 ' O ' ' NH2' ' A' ' 197' ' ' ARG . 42.8 Cg_endo -69.59 -179.19 2.66 Favored 'Trans proline' 0 N--CA 1.496 1.64 0 C-N-CA 122.868 2.379 . . . . 0.0 113.276 -178.935 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' C' C ' 704' ' ' ALA . . . . . 0.484 ' O ' ' O ' ' C' ' 703' ' ' PRO . . . . . . . . 0 N--CA 1.486 1.336 0 O-C-N 121.557 -0.714 . . . . 0.0 109.295 179.934 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 63' ' ' PRO . . . . . . . . . . . . . 3.7 Cg_endo . . . . . 0 N--CA 1.483 0.89 0 CA-C-O 121.096 0.374 . . . . 0.0 111.436 . . . . . . . . . 0 0 . 1 . 003 nuclear orig core ' A' A ' 64' ' ' GLN . . . . . 0.712 ' NE2' ' N ' ' A' ' 64' ' ' GLN . 0.0 OUTLIER -153.0 102.59 2.67 Favored 'General case' 0 N--CA 1.493 1.685 0 O-C-N 121.129 -0.982 . . . . 0.0 109.513 -179.63 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 65' ' ' ILE . . . . . 0.486 ' C ' ' O ' ' A' ' 64' ' ' GLN . 3.0 mp -37.83 99.3 0.18 Allowed Pre-proline 0 N--CA 1.494 1.747 0 N-CA-C 108.677 -0.86 . . . . 0.0 108.677 179.715 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 66' ' ' PRO . . . . . 0.463 ' N ' ' O ' ' A' ' 64' ' ' GLN . 57.8 Cg_endo -85.27 -162.55 0.16 Allowed 'Trans proline' 0 C--N 1.315 -1.203 0 C-N-CA 122.264 1.976 . . . . 0.0 112.505 -178.592 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 67' ' ' LYS . . . . . 0.553 ' C ' ' H ' ' A' ' 69' ' ' LYS . 6.6 ptpt -72.98 -5.73 40.69 Favored 'General case' 0 C--N 1.303 -1.415 0 O-C-N 121.393 -0.817 . . . . 0.0 108.829 179.737 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 68' ' ' ASP . . . . . 0.626 ' C ' ' H ' ' A' ' 70' ' ' SER . 1.0 OUTLIER -74.97 46.53 0.31 Allowed 'General case' 0 N--CA 1.486 1.374 0 CA-C-O 122.85 1.309 . . . . 0.0 107.735 178.876 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 69' ' ' LYS . . . . . 0.553 ' H ' ' C ' ' A' ' 67' ' ' LYS . 13.3 ptpt -48.63 -14.41 0.06 Allowed 'General case' 0 N--CA 1.501 2.123 0 C-N-CA 117.23 -1.788 . . . . 0.0 106.728 178.191 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 70' ' ' SER . . . . . 0.626 ' H ' ' C ' ' A' ' 68' ' ' ASP . 0.3 OUTLIER -85.25 -6.3 59.27 Favored 'General case' 0 N--CA 1.496 1.86 0 CA-C-N 113.53 -1.668 . . . . 0.0 110.764 179.284 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 71' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -97.53 140.96 31.17 Favored 'General case' 0 N--CA 1.497 1.886 0 O-C-N 120.876 -1.14 . . . . 0.0 111.478 -179.598 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 72' ' ' VAL . . . . . 0.553 ' CG2' ' O ' ' A' ' 74' ' ' GLY . 0.2 OUTLIER -65.45 136.57 26.48 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.414 0 N-CA-C 105.334 -2.099 . . . . 0.0 105.334 175.36 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 73' ' ' ALA . . . . . 0.535 ' N ' ' O ' ' A' ' 87' ' ' VAL . . . -83.53 -17.16 42.8 Favored 'General case' 0 C--N 1.296 -1.717 0 O-C-N 120.179 -1.576 . . . . 0.0 108.245 -179.017 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 74' ' ' GLY . . . . . 0.553 ' O ' ' CG2' ' A' ' 72' ' ' VAL . . . 172.44 -157.71 27.5 Favored Glycine 0 C--N 1.294 -1.776 0 N-CA-C 109.5 -1.44 . . . . 0.0 109.5 -179.554 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 75' ' ' TYR . . . . . . . . . . . . . 4.6 m-85 -141.47 170.37 15.86 Favored 'General case' 0 C--N 1.293 -1.866 0 O-C-N 121.363 -1.08 . . . . 0.0 110.362 -177.303 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 76' ' ' ILE . . . . . . . . . . . . . 3.0 tp -144.92 140.02 22.99 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.717 0 C-N-CA 119.359 -0.937 . . . . 0.0 109.446 -177.414 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 77' ' ' GLU . . . . . 0.572 ' N ' ' CD ' ' A' ' 77' ' ' GLU . 0.7 OUTLIER -146.71 159.43 43.48 Favored 'General case' 0 C--N 1.304 -1.388 0 O-C-N 121.015 -1.053 . . . . 0.0 109.148 -179.293 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 78' ' ' ILE . . . . . . . . . . . . . 12.2 mt -147.7 94.34 4.41 Favored Pre-proline 0 N--CA 1.489 1.498 0 N-CA-C 108.622 -0.881 . . . . 0.0 108.622 -179.963 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 79' ' ' PRO . . . . . . . . . . . . . 75.0 Cg_exo -46.83 -45.83 19.65 Favored 'Trans proline' 0 N--CA 1.493 1.488 0 C-N-CA 122.937 2.425 . . . . 0.0 114.212 -178.685 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -64.78 -19.83 66.03 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 120.644 -1.285 . . . . 0.0 110.507 178.704 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 81' ' ' ALA . . . . . 0.604 ' O ' ' ND2' ' A' ' 132' ' ' ASN . . . -104.99 -16.73 14.73 Favored 'General case' 0 N--CA 1.493 1.707 0 N-CA-C 108.448 -0.945 . . . . 0.0 108.448 179.223 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 82' ' ' ASP . . . . . . . . . . . . . 7.8 t0 67.21 50.36 1.0 Allowed 'General case' 0 N--CA 1.488 1.437 0 O-C-N 121.364 -0.835 . . . . 0.0 109.951 179.736 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 83' ' ' ILE . . . . . 0.409 ' CD1' ' OD1' ' A' ' 132' ' ' ASN . 78.4 mt -127.82 152.78 36.32 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.671 0 O-C-N 121.395 -0.815 . . . . 0.0 110.009 -178.914 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 84' ' ' LYS . . . . . . . . . . . . . 1.8 tttt -159.06 108.71 1.94 Allowed 'General case' 0 N--CA 1.49 1.561 0 N-CA-C 107.099 -1.445 . . . . 0.0 107.099 179.036 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 85' ' ' GLU . . . . . 0.503 ' OE1' ' O ' ' A' ' 128' ' ' TYR . 0.0 OUTLIER -141.92 169.56 10.88 Favored Pre-proline 0 N--CA 1.494 1.733 0 O-C-N 121.236 -0.915 . . . . 0.0 110.972 -177.842 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 86' ' ' PRO . . . . . . . . . . . . . 73.4 Cg_endo -79.34 166.45 22.38 Favored 'Trans proline' 0 N--CA 1.492 1.385 0 C-N-CA 123.22 2.613 . . . . 0.0 113.43 -179.631 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 87' ' ' VAL . . . . . 0.535 ' O ' ' N ' ' A' ' 73' ' ' ALA . 60.3 t -126.07 102.08 9.31 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.614 0 N-CA-C 109.056 -0.72 . . . . 0.0 109.056 179.705 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 88' ' ' TYR . . . . . 0.454 ' CB ' HE22 ' A' ' 96' ' ' GLN . 22.7 m-85 -96.33 153.82 38.86 Favored Pre-proline 0 N--CA 1.501 2.088 0 O-C-N 120.952 -1.092 . . . . 0.0 110.336 -179.34 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 89' ' ' PRO . . . . . . . . . . . . . 1.2 Cg_endo -55.72 143.82 78.57 Favored 'Trans proline' 0 C--N 1.309 -1.543 0 C-N-CA 122.715 2.277 . . . . 0.0 113.958 -179.891 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . -57.76 169.35 4.4 Favored Glycine 0 N--CA 1.493 2.44 0 N-CA-C 108.888 -1.685 . . . . 0.0 108.888 178.743 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 91' ' ' PRO . . . . . 0.498 ' C ' ' HG ' ' A' ' 102' ' ' SER . 56.3 Cg_endo -94.75 169.38 17.55 Favored 'Cis proline' 0 C--N 1.308 -1.558 0 C-N-CA 124.183 -1.174 . . . . 0.0 112.079 0.141 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 92' ' ' ALA . . . . . 0.509 ' O ' ' CD1' ' A' ' 97' ' ' LEU . . . -72.99 32.07 0.07 Allowed 'General case' 0 N--CA 1.493 1.718 0 O-C-N 120.948 -1.095 . . . . 0.0 110.927 -179.724 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 93' ' ' THR . . . . . 0.433 ' H ' ' C ' ' A' ' 91' ' ' PRO . 11.1 p -73.15 150.4 89.9 Favored Pre-proline 0 C--N 1.302 -1.47 0 O-C-N 120.278 -1.514 . . . . 0.0 108.228 179.695 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 94' ' ' PRO . . . . . . . . . . . . . 91.1 Cg_exo -34.39 -46.41 0.51 Allowed 'Trans proline' 0 C--N 1.309 -1.527 0 C-N-CA 122.78 2.32 . . . . 0.0 112.44 -179.074 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 95' ' ' GLU . . . . . 0.59 ' O ' ' ND2' ' A' ' 98' ' ' ASN . 6.8 mt-10 -53.69 -51.94 61.61 Favored 'General case' 0 N--CA 1.488 1.465 0 O-C-N 121.111 -0.993 . . . . 0.0 109.702 179.9 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 96' ' ' GLN . . . . . 0.564 ' C ' ' H ' ' A' ' 98' ' ' ASN . 0.0 OUTLIER -71.92 -45.94 59.37 Favored 'General case' 0 C--N 1.303 -1.418 0 O-C-N 121.205 -0.935 . . . . 0.0 109.822 -179.848 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 97' ' ' LEU . . . . . 0.509 ' CD1' ' O ' ' A' ' 92' ' ' ALA . 88.9 mt -55.17 -4.91 0.09 Allowed 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.18 -0.95 . . . . 0.0 108.935 179.902 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 98' ' ' ASN . . . . . 0.59 ' ND2' ' O ' ' A' ' 95' ' ' GLU . 0.0 OUTLIER -71.88 -26.01 62.16 Favored 'General case' 0 N--CA 1.489 1.505 0 O-C-N 121.511 -0.743 . . . . 0.0 109.295 179.708 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 99' ' ' ARG . . . . . 0.669 HH11 ' CG ' ' A' ' 99' ' ' ARG . 0.2 OUTLIER -99.9 -59.06 1.78 Allowed 'General case' 0 N--CA 1.488 1.426 0 C-N-CA 119.71 -0.796 . . . . 0.0 110.483 -178.919 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . -170.84 -169.43 33.87 Favored Glycine 0 N--CA 1.49 2.277 0 C-N-CA 119.013 -1.565 . . . . 0.0 110.518 -179.789 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 101' ' ' VAL . . . . . 0.471 ' CG1' ' CE2' ' A' ' 130' ' ' PHE . 27.0 m -53.95 106.25 0.1 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.525 0 O-C-N 121.662 -0.905 . . . . 0.0 109.561 -179.906 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 102' ' ' SER . . . . . 0.498 ' HG ' ' C ' ' A' ' 91' ' ' PRO . 0.0 OUTLIER -92.91 158.08 16.02 Favored 'General case' 0 N--CA 1.495 1.787 0 O-C-N 121.249 -0.907 . . . . 0.0 110.582 -179.88 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 103' ' ' PHE . . . . . 0.562 ' O ' ' N ' ' A' ' 105' ' ' GLU . 23.6 m-85 -61.06 121.76 13.27 Favored 'General case' 0 N--CA 1.491 1.612 0 N-CA-C 108.083 -1.081 . . . . 0.0 108.083 178.58 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 104' ' ' ALA . . . . . . . . . . . . . . . -40.03 -19.99 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.567 -0.708 . . . . 0.0 111.445 -178.434 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 105' ' ' GLU . . . . . 0.562 ' N ' ' O ' ' A' ' 103' ' ' PHE . 0.2 OUTLIER -139.33 151.2 46.2 Favored 'General case' 0 N--CA 1.494 1.767 0 O-C-N 120.688 -1.257 . . . . 0.0 110.707 -179.563 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 106' ' ' GLU . . . . . . . . . . . . . 30.3 tt0 -57.95 -64.19 0.99 Allowed 'General case' 0 C--N 1.303 -1.442 0 CA-C-N 116.146 -0.479 . . . . 0.0 111.3 -178.94 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 107' ' ' ASN . . . . . 0.462 ' C ' ' ND2' ' A' ' 107' ' ' ASN . 0.0 OUTLIER -77.47 33.0 0.16 Allowed 'General case' 0 N--CA 1.491 1.587 0 O-C-N 120.541 -1.349 . . . . 0.0 113.187 -175.214 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 108' ' ' GLU . . . . . . . . . . . . . 33.2 tp10 -59.55 148.61 32.7 Favored 'General case' 0 C--N 1.301 -1.53 0 N-CA-C 107.474 -1.306 . . . . 0.0 107.474 179.899 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 109' ' ' SER . . . . . 0.529 ' C ' ' H ' ' A' ' 111' ' ' ASP . 0.1 OUTLIER -100.59 124.67 46.48 Favored 'General case' 0 N--CA 1.487 1.409 0 O-C-N 120.9 -1.125 . . . . 0.0 110.486 -178.432 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 110' ' ' LEU . . . . . . . . . . . . . 1.5 pp -60.01 -4.61 0.79 Allowed 'General case' 0 C--N 1.301 -1.536 0 N-CA-C 108.467 -0.938 . . . . 0.0 108.467 179.721 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 111' ' ' ASP . . . . . 0.529 ' H ' ' C ' ' A' ' 109' ' ' SER . 11.8 m-20 -131.93 20.77 4.55 Favored 'General case' 0 C--N 1.303 -1.416 0 N-CA-C 108.825 -0.805 . . . . 0.0 108.825 179.57 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 112' ' ' ASP . . . . . 0.419 ' C ' ' H ' ' A' ' 114' ' ' ASN . 0.8 OUTLIER -66.3 140.02 58.09 Favored 'General case' 0 N--CA 1.489 1.505 0 O-C-N 121.349 -0.844 . . . . 0.0 110.198 -179.937 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 113' ' ' GLN . . . . . 0.477 ' CA ' ' NE2' ' A' ' 113' ' ' GLN . 0.8 OUTLIER -65.11 -6.68 9.61 Favored 'General case' 0 C--N 1.302 -1.488 0 N-CA-C 107.892 -1.151 . . . . 0.0 107.892 178.278 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 114' ' ' ASN . . . . . 0.419 ' H ' ' C ' ' A' ' 112' ' ' ASP . 11.1 p-10 -146.02 95.01 2.56 Favored 'General case' 0 C--N 1.3 -1.545 0 N-CA-C 107.95 -1.13 . . . . 0.0 107.95 179.144 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 115' ' ' ILE . . . . . . . . . . . . . 2.6 mt -98.24 111.67 28.5 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.536 0 O-C-N 121.493 -0.754 . . . . 0.0 109.487 -179.366 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 116' ' ' SER . . . . . . . . . . . . . 66.3 m -97.1 151.19 20.02 Favored 'General case' 0 N--CA 1.489 1.517 0 CA-C-O 121.77 0.795 . . . . 0.0 111.066 -178.804 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 117' ' ' ILE . . . . . . . . . . . . . 1.9 mt -146.59 155.85 11.69 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.588 0 N-CA-C 108.184 -1.043 . . . . 0.0 108.184 179.328 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 118' ' ' ALA . . . . . . . . . . . . . . . -146.04 163.41 35.32 Favored 'General case' 0 N--CA 1.493 1.683 0 O-C-N 120.569 -1.332 . . . . 0.0 111.88 -179.049 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 119' ' ' GLY . . . . . . . . . . . . . . . -169.9 148.57 11.95 Favored Glycine 0 N--CA 1.49 2.295 0 N-CA-C 110.403 -1.079 . . . . 0.0 110.403 -179.889 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 120' ' ' HIS . . . . . . . . . . . . . 34.2 m170 -69.33 167.71 15.87 Favored 'General case' 0 N--CA 1.495 1.799 0 O-C-N 121.768 -0.842 . . . . 0.0 110.498 179.783 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 121' ' ' THR . . . . . 0.585 ' HG1' ' HZ2' ' A' ' 134' ' ' LYS . 0.7 OUTLIER -122.9 155.11 37.35 Favored 'General case' 0 N--CA 1.493 1.715 0 N-CA-C 108.165 -1.05 . . . . 0.0 108.165 178.677 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 122' ' ' PHE . . . . . . . . . . . . . 0.4 OUTLIER -144.15 123.38 12.97 Favored 'General case' 0 N--CA 1.496 1.835 0 O-C-N 120.849 -1.157 . . . . 0.0 109.756 -179.487 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 123' ' ' ILE . . . . . 0.466 ' CG2' ' N ' ' A' ' 124' ' ' ASP . 11.1 tt -55.76 -40.75 62.7 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.462 0 CA-C-O 121.628 0.728 . . . . 0.0 109.065 179.963 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 124' ' ' ASP . . . . . 0.466 ' N ' ' CG2' ' A' ' 123' ' ' ILE . 31.3 t70 -88.75 23.4 2.32 Favored 'General case' 0 N--CA 1.493 1.714 0 O-C-N 121.653 -0.654 . . . . 0.0 111.731 -177.703 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 125' ' ' ARG . . . . . . . . . . . . . 54.1 mtt180 -153.62 98.59 2.66 Favored Pre-proline 0 N--CA 1.493 1.679 0 O-C-N 120.866 -1.146 . . . . 0.0 109.183 179.618 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 126' ' ' PRO . . . . . . . . . . . . . 69.7 Cg_endo -82.3 -28.57 1.85 Allowed 'Trans proline' 0 C--N 1.313 -1.321 0 C-N-CA 122.401 2.068 . . . . 0.0 111.939 179.734 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 127' ' ' ASN . . . . . 0.482 ' O ' ' O ' ' A' ' 128' ' ' TYR . 2.1 m120 -89.86 6.43 41.87 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.372 -0.83 . . . . 0.0 109.186 179.79 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 128' ' ' TYR . . . . . 0.503 ' O ' ' OE1' ' A' ' 85' ' ' GLU . 2.4 t80 -59.47 -148.53 0.0 OUTLIER 'General case' 0 N--CA 1.489 1.486 0 O-C-N 121.318 -0.864 . . . . 0.0 109.465 179.901 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 129' ' ' GLN . . . . . 0.489 ' O ' ' OE1' ' A' ' 85' ' ' GLU . 8.7 mt-30 -65.21 -72.45 0.15 Allowed 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.386 -0.821 . . . . 0.0 110.067 -179.321 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 130' ' ' PHE . . . . . 0.471 ' CE2' ' CG1' ' A' ' 101' ' ' VAL . 53.5 m-85 -135.78 42.0 2.67 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.012 -1.055 . . . . 0.0 109.993 -179.693 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 131' ' ' THR . . . . . . . . . . . . . 38.9 m -77.19 -35.82 55.46 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.129 -0.982 . . . . 0.0 109.531 179.94 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 132' ' ' ASN . . . . . 0.604 ' ND2' ' O ' ' A' ' 81' ' ' ALA . 0.1 OUTLIER -84.15 4.71 29.21 Favored 'General case' 0 N--CA 1.498 1.925 0 O-C-N 121.44 -0.788 . . . . 0.0 110.456 -179.277 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 133' ' ' LEU . . . . . 0.569 ' O ' ' N ' ' A' ' 135' ' ' ALA . 0.2 OUTLIER -68.19 -45.52 73.2 Favored 'General case' 0 C--N 1.296 -1.76 0 O-C-N 120.961 -1.087 . . . . 0.0 110.578 -179.636 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 134' ' ' LYS . . . . . 0.585 ' HZ2' ' HG1' ' A' ' 121' ' ' THR . 0.0 OUTLIER -43.17 -17.85 0.01 OUTLIER 'General case' 0 N--CA 1.496 1.865 0 O-C-N 120.955 -1.09 . . . . 0.0 110.191 -179.331 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 135' ' ' ALA . . . . . 0.569 ' N ' ' O ' ' A' ' 133' ' ' LEU . . . -83.24 -38.28 22.42 Favored 'General case' 0 N--CA 1.488 1.471 0 O-C-N 120.925 -1.109 . . . . 0.0 110.147 -179.566 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 136' ' ' ALA . . . . . . . . . . . . . . . -80.0 157.89 26.69 Favored 'General case' 0 C--N 1.302 -1.476 0 CA-C-O 122.283 1.04 . . . . 0.0 111.82 -178.412 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 137' ' ' LYS . . . . . 0.528 ' O ' ' O ' ' A' ' 138' ' ' LYS . 2.4 tttt -154.49 -162.71 1.45 Allowed 'General case' 0 N--CA 1.491 1.617 0 C-N-CA 119.083 -1.047 . . . . 0.0 110.579 -178.61 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 138' ' ' LYS . . . . . 0.601 ' O ' ' N ' ' A' ' 140' ' ' SER . 16.6 pttm -44.65 -179.19 0.0 OUTLIER 'General case' 0 C--N 1.302 -1.482 0 CA-C-O 122.228 1.013 . . . . 0.0 111.039 -179.13 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 139' ' ' GLY . . . . . . . . . . . . . . . 45.42 7.89 0.01 OUTLIER Glycine 0 N--CA 1.491 2.304 0 N-CA-C 110.646 -0.982 . . . . 0.0 110.646 179.978 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 140' ' ' SER . . . . . 0.601 ' N ' ' O ' ' A' ' 138' ' ' LYS . 58.7 m -85.99 124.39 32.38 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 120.71 -1.465 . . . . 0.0 109.244 179.459 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 141' ' ' MET . . . . . . . . . . . . . 1.1 tpt -72.88 136.08 45.23 Favored 'General case' 0 N--CA 1.489 1.506 0 O-C-N 121.133 -0.979 . . . . 0.0 109.16 179.93 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 142' ' ' VAL . . . . . . . . . . . . . 3.5 t -121.42 129.1 75.9 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.627 0 N-CA-C 108.865 -0.791 . . . . 0.0 108.865 -179.835 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 143' ' ' TYR . . . . . . . . . . . . . 16.6 m-85 -113.14 136.6 52.54 Favored 'General case' 0 N--CA 1.498 1.951 0 O-C-N 121.172 -0.955 . . . . 0.0 111.063 -178.667 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 144' ' ' PHE . . . . . 0.418 ' CE2' ' CG1' ' A' ' 146' ' ' VAL . 10.7 t80 -122.52 104.98 9.73 Favored 'General case' 0 N--CA 1.492 1.667 0 CA-C-O 121.5 0.667 . . . . 0.0 110.245 -178.989 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 145' ' ' LYS . . . . . . . . . . . . . 4.6 mttm -97.7 123.41 41.61 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.426 -0.796 . . . . 0.0 109.719 -179.965 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 146' ' ' VAL . . . . . 0.418 ' CG1' ' CE2' ' A' ' 144' ' ' PHE . 0.5 OUTLIER -143.78 122.62 7.42 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.582 0 O-C-N 121.196 -0.94 . . . . 0.0 108.648 179.402 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 147' ' ' GLY . . . . . . . . . . . . . . . 70.47 -131.01 21.6 Favored Glycine 0 N--CA 1.488 2.163 0 N-CA-C 108.525 -1.83 . . . . 0.0 108.525 -179.103 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 148' ' ' ASN . . . . . 0.513 ' C ' ' ND2' ' A' ' 148' ' ' ASN . 0.4 OUTLIER -106.51 11.72 30.35 Favored 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.407 -1.055 . . . . 0.0 108.665 179.101 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 149' ' ' GLU . . . . . . . . . . . . . 4.8 tt0 -114.2 149.42 35.8 Favored 'General case' 0 N--CA 1.491 1.594 0 CA-C-O 121.844 0.831 . . . . 0.0 111.043 -179.003 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 150' ' ' THR . . . . . . . . . . . . . 20.1 m -129.89 105.55 8.07 Favored 'General case' 0 N--CA 1.492 1.656 0 CA-C-O 121.341 0.591 . . . . 0.0 109.762 -179.986 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 151' ' ' ARG . . . . . . . . . . . . . 4.9 mtp180 -87.82 -175.29 5.08 Favored 'General case' 0 N--CA 1.487 1.403 0 N-CA-C 108.293 -1.003 . . . . 0.0 108.293 179.701 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 152' ' ' LYS . . . . . . . . . . . . . 26.3 mtmt -149.31 146.45 27.55 Favored 'General case' 0 C--N 1.301 -1.502 0 O-C-N 120.914 -1.116 . . . . 0.0 110.619 -179.454 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 153' ' ' TYR . . . . . 0.47 ' CD2' ' HA ' ' A' ' 204' ' ' GLU . 4.1 m-85 -138.6 170.25 16.35 Favored 'General case' 0 N--CA 1.488 1.443 0 N-CA-C 107.471 -1.307 . . . . 0.0 107.471 178.794 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 154' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -144.52 122.7 12.19 Favored 'General case' 0 C--N 1.296 -1.726 0 N-CA-C 108.087 -1.079 . . . . 0.0 108.087 178.581 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 155' ' ' MET . . . . . . . . . . . . . 3.7 mtt -46.75 105.88 0.07 Allowed 'General case' 0 N--CA 1.49 1.54 0 O-C-N 120.594 -1.316 . . . . 0.0 111.702 -178.445 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 156' ' ' THR . . . . . 0.54 ' OG1' ' CG2' ' A' ' 203' ' ' THR . 0.1 OUTLIER -106.28 -25.55 11.9 Favored 'General case' 0 C--N 1.292 -1.918 0 CA-C-N 115.183 -0.917 . . . . 0.0 110.074 -179.137 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 157' ' ' SER . . . . . 0.416 ' O ' ' N ' ' A' ' 201' ' ' VAL . 0.1 OUTLIER -153.72 152.72 31.1 Favored 'General case' 0 N--CA 1.495 1.81 0 C-N-CA 118.24 -1.384 . . . . 0.0 111.592 -178.766 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 158' ' ' ILE . . . . . 0.444 HG13 ' CD2' ' A' ' 200' ' ' PHE . 0.0 OUTLIER -156.17 146.52 12.04 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.527 0 CA-C-O 121.758 0.79 . . . . 0.0 110.376 -179.885 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 159' ' ' ARG . . . . . 0.461 ' CG ' HH11 ' A' ' 159' ' ' ARG . 0.0 OUTLIER -150.85 -175.59 5.19 Favored 'General case' 0 C--N 1.3 -1.574 0 CA-C-O 121.833 0.825 . . . . 0.0 110.821 -179.629 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 160' ' ' ASP . . . . . 0.428 ' O ' ' CG1' ' A' ' 161' ' ' VAL . 1.9 m-20 -143.2 157.34 44.59 Favored 'General case' 0 N--CA 1.49 1.566 0 N-CA-C 108.018 -1.105 . . . . 0.0 108.018 -179.851 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 161' ' ' VAL . . . . . 0.449 ' O ' ' O ' ' A' ' 162' ' ' LYS . 2.3 m -160.08 157.38 2.89 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.833 0 C-N-CA 118.624 -1.231 . . . . 0.0 110.902 -179.256 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 162' ' ' LYS . . . . . 0.449 ' O ' ' O ' ' A' ' 161' ' ' VAL . 0.0 OUTLIER -44.02 169.04 0.06 OUTLIER Pre-proline 0 N--CA 1.493 1.685 0 O-C-N 121.559 -0.713 . . . . 0.0 109.833 -179.996 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 163' ' ' PRO . . . . . . . . . . . . . 57.0 Cg_endo -77.2 34.74 0.46 Allowed 'Trans proline' 0 C--N 1.309 -1.521 0 C-N-CA 122.622 2.215 . . . . 0.0 112.402 179.725 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 164' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -150.76 -6.98 0.28 Allowed 'General case' 0 N--CA 1.495 1.778 0 O-C-N 121.1 -1.0 . . . . 0.0 110.904 -179.567 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 165' ' ' ASP . . . . . 0.422 ' O ' ' C ' ' A' ' 166' ' ' VAL . 13.7 t70 -72.53 61.16 0.49 Allowed 'General case' 0 C--N 1.3 -1.56 0 O-C-N 120.881 -1.137 . . . . 0.0 109.127 -179.831 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 166' ' ' VAL . . . . . 0.643 ' O ' ' N ' ' A' ' 168' ' ' VAL . 0.8 OUTLIER -44.0 -29.47 0.52 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.523 0 O-C-N 121.113 -0.992 . . . . 0.0 109.387 -178.567 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 167' ' ' GLY . . . . . . . . . . . . . . . -45.19 -6.43 0.01 OUTLIER Glycine 0 N--CA 1.498 2.788 0 O-C-N 121.197 -0.94 . . . . 0.0 110.763 179.905 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 168' ' ' VAL . . . . . 0.643 ' N ' ' O ' ' A' ' 166' ' ' VAL . 2.8 t -48.24 -34.56 4.99 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.417 0 O-C-N 120.88 -1.365 . . . . 0.0 108.381 179.188 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 169' ' ' LEU . . . . . 0.419 ' O ' ' C ' ' A' ' 170' ' ' ASP . 1.4 mt -47.23 -11.01 0.02 OUTLIER 'General case' 0 N--CA 1.494 1.767 0 N-CA-C 108.239 -1.022 . . . . 0.0 108.239 -178.313 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 170' ' ' ASP . . . . . 0.619 ' H ' ' C ' ' A' ' 168' ' ' VAL . 6.1 t70 38.49 64.65 0.71 Allowed 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.596 -0.69 . . . . 0.0 111.535 177.615 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 171' ' ' GLU . . . . . . . . . . . . . 1.7 pt-20 -101.09 92.81 5.17 Favored 'General case' 0 C--N 1.299 -1.601 0 N-CA-C 106.965 -1.494 . . . . 0.0 106.965 177.715 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 172' ' ' GLN . . . . . . . . . . . . . 1.1 mt-30 -156.01 -79.16 0.09 Allowed 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.651 -0.656 . . . . 0.0 110.266 -178.361 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 173' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -59.49 128.41 36.91 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.15 -0.969 . . . . 0.0 109.195 -179.549 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 174' ' ' GLY . . . . . 0.526 ' O ' ' C ' ' A' ' 175' ' ' LYS . . . -119.36 -40.92 0.6 Allowed Glycine 0 N--CA 1.48 1.584 0 N-CA-C 108.117 -1.993 . . . . 0.0 108.117 179.321 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 175' ' ' LYS . . . . . 0.526 ' C ' ' O ' ' A' ' 174' ' ' GLY . 2.9 mmtt -35.79 -61.88 0.45 Allowed 'General case' 0 N--CA 1.496 1.829 0 N-CA-C 108.728 -0.841 . . . . 0.0 108.728 -179.877 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 176' ' ' ASP . . . . . 0.604 ' O ' ' O ' ' A' ' 177' ' ' LYS . 0.3 OUTLIER -103.48 88.87 3.2 Favored 'General case' 0 C--N 1.297 -1.676 0 N-CA-C 107.801 -1.185 . . . . 0.0 107.801 177.946 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 177' ' ' LYS . . . . . 0.604 ' O ' ' O ' ' A' ' 176' ' ' ASP . 6.0 mtmp? -39.29 177.82 0.0 OUTLIER 'General case' 0 N--CA 1.494 1.748 0 CA-C-O 121.805 0.812 . . . . 0.0 111.023 -179.09 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 178' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -161.69 171.81 17.29 Favored 'General case' 0 C--N 1.305 -1.331 0 O-C-N 120.837 -1.164 . . . . 0.0 110.508 179.186 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 179' ' ' LEU . . . . . . . . . . . . . 1.3 tp -126.74 95.33 4.3 Favored 'General case' 0 C--N 1.302 -1.485 0 N-CA-C 106.491 -1.67 . . . . 0.0 106.491 177.513 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 180' ' ' THR . . . . . . . . . . . . . 1.2 m -70.12 119.11 13.83 Favored 'General case' 0 C--N 1.304 -1.384 0 C-N-CA 119.134 -1.026 . . . . 0.0 109.41 -178.349 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 181' ' ' LEU . . . . . 0.427 HD11 ' H ' ' A' ' 182' ' ' ILE . 36.8 tp -96.82 146.01 25.32 Favored 'General case' 0 C--N 1.294 -1.806 0 N-CA-C 108.028 -1.101 . . . . 0.0 108.028 178.706 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 182' ' ' ILE . . . . . 0.427 ' H ' HD11 ' A' ' 181' ' ' LEU . 25.3 mt -139.34 119.77 14.58 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.484 0 O-C-N 120.956 -1.09 . . . . 0.0 109.718 179.088 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 183' ' ' THR . . . . . 0.417 ' CG2' ' HZ3' ' A' ' 134' ' ' LYS . 10.3 t -135.76 115.45 12.9 Favored 'General case' 0 C--N 1.291 -1.977 0 N-CA-C 107.447 -1.316 . . . . 0.0 107.447 178.508 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 184' ' ' CYS . . . . . . . . . . . . . 5.1 p -78.15 157.38 29.44 Favored 'General case' 0 C--N 1.287 -2.12 0 C-N-CA 118.93 -1.108 . . . . 0.0 110.655 -177.867 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 185' ' ' ASP . . . . . 0.567 ' CG ' ' H ' ' A' ' 186' ' ' ASP . 37.3 t0 -165.7 -158.09 0.34 Allowed 'General case' 0 N--CA 1.492 1.654 0 N-CA-C 108.944 -0.761 . . . . 0.0 108.944 -179.5 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 186' ' ' ASP . . . . . 0.567 ' H ' ' CG ' ' A' ' 185' ' ' ASP . 1.3 m-20 52.93 53.83 11.44 Favored 'General case' 0 N--CA 1.494 1.73 0 O-C-N 120.902 -1.124 . . . . 0.0 109.444 179.979 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 187' ' ' TYR . . . . . 0.617 ' CE1' ' O ' ' A' ' 188' ' ' ASN . 61.2 t80 -67.9 135.03 51.82 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.171 -0.956 . . . . 0.0 110.719 -179.397 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 188' ' ' ASN . . . . . 0.617 ' O ' ' CE1' ' A' ' 187' ' ' TYR . 1.1 t-20 -101.68 146.16 28.11 Favored 'General case' 0 C--N 1.295 -1.792 0 N-CA-C 108.119 -1.067 . . . . 0.0 108.119 178.441 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 189' ' ' GLU . . . . . . . . . . . . . 1.8 tt0 -110.13 -13.39 14.37 Favored 'General case' 0 C--N 1.293 -1.875 0 N-CA-C 108.151 -1.055 . . . . 0.0 108.151 -179.782 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 190' ' ' LYS . . . . . . . . . . . . . 6.4 mttt -84.27 -55.68 4.05 Favored 'General case' 0 C--N 1.301 -1.522 0 N-CA-C 108.827 -0.805 . . . . 0.0 108.827 178.759 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 191' ' ' THR . . . . . . . . . . . . . 6.2 p -87.48 2.55 50.27 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.444 -0.785 . . . . 0.0 109.89 -179.644 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 192' ' ' GLY . . . . . . . . . . . . . . . 56.27 33.07 60.98 Favored Glycine 0 N--CA 1.495 2.62 0 O-C-N 121.172 -0.955 . . . . 0.0 111.79 178.615 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 193' ' ' VAL . . . . . . . . . . . . . 4.1 p -149.25 167.94 2.97 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.75 0 O-C-N 120.677 -1.484 . . . . 0.0 110.583 179.009 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 194' ' ' TRP . . . . . 0.502 ' N ' ' CD1' ' A' ' 194' ' ' TRP . 9.4 m95 -83.98 120.23 25.87 Favored 'General case' 0 C--N 1.296 -1.724 0 N-CA-C 108.558 -0.904 . . . . 0.0 108.558 179.963 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 195' ' ' GLU . . . . . 0.444 ' CD ' ' ND2' ' A' ' 188' ' ' ASN . 3.7 mt-10 -76.23 -60.82 2.17 Favored 'General case' 0 N--CA 1.495 1.784 0 O-C-N 121.395 -0.816 . . . . 0.0 111.356 -178.323 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 196' ' ' LYS . . . . . . . . . . . . . 8.6 tttt -93.18 153.71 18.47 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 120.935 -1.103 . . . . 0.0 110.817 -178.494 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 197' ' ' ARG . . . . . 0.635 ' CG ' HH11 ' A' ' 197' ' ' ARG . 0.0 OUTLIER -119.66 140.13 51.12 Favored 'General case' 0 N--CA 1.49 1.525 0 N-CA-C 107.995 -1.113 . . . . 0.0 107.995 178.845 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 198' ' ' LYS . . . . . . . . . . . . . 2.4 mttm -114.16 122.02 45.54 Favored 'General case' 0 N--CA 1.493 1.719 0 O-C-N 121.899 -0.501 . . . . 0.0 110.904 -177.982 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 199' ' ' ILE . . . . . 0.466 ' C ' ' CD1' ' A' ' 199' ' ' ILE . 0.5 OUTLIER -142.58 120.02 7.02 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.546 0 CA-C-O 122.393 1.092 . . . . 0.0 110.515 179.925 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 200' ' ' PHE . . . . . 0.509 ' CD1' ' N ' ' A' ' 200' ' ' PHE . 3.5 m-85 -98.42 135.45 39.98 Favored 'General case' 0 N--CA 1.499 2.001 0 O-C-N 121.34 -0.85 . . . . 0.0 109.512 -178.982 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 201' ' ' VAL . . . . . 0.416 ' N ' ' O ' ' A' ' 157' ' ' SER . 72.3 t -100.08 130.75 48.76 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.633 0 O-C-N 120.885 -1.134 . . . . 0.0 108.318 177.671 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 202' ' ' ALA . . . . . . . . . . . . . . . -114.48 131.47 56.61 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.37 -0.831 . . . . 0.0 108.771 179.443 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 203' ' ' THR . . . . . 0.54 ' CG2' ' OG1' ' A' ' 156' ' ' THR . 6.7 p -88.59 130.35 35.28 Favored 'General case' 0 N--CA 1.487 1.399 0 CA-C-O 122.137 0.97 . . . . 0.0 110.768 -179.039 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 204' ' ' GLU . . . . . 0.47 ' HA ' ' CD2' ' A' ' 153' ' ' TYR . 0.8 OUTLIER -51.5 134.28 29.21 Favored 'General case' 0 C--N 1.298 -1.64 0 C-N-CA 119.091 -1.044 . . . . 0.0 109.034 179.305 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 205' ' ' VAL . . . . . 0.484 ' CG1' ' N ' ' A' ' 206' ' ' LYS . 93.3 t -132.22 167.03 27.41 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.358 0 CA-C-O 122.081 0.943 . . . . 0.0 110.144 -178.132 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 206' ' ' LYS . . . . . 0.484 ' N ' ' CG1' ' A' ' 205' ' ' VAL . 0.0 OUTLIER . . . . . 0 C--N 1.295 -1.787 0 CA-C-O 117.933 -1.032 . . . . 0.0 109.509 -179.72 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' C' C ' 702' ' ' LEU . . . . . 0.579 ' O ' ' NH2' ' A' ' 197' ' ' ARG . 0.0 OUTLIER . . . . . 0 N--CA 1.494 1.741 0 N-CA-C 109.235 -0.654 . . . . 0.0 109.235 . . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' C' C ' 703' ' ' PRO . . . . . 0.491 ' O ' ' O ' ' C' ' 702' ' ' LEU . 50.7 Cg_exo -48.6 -164.59 0.0 OUTLIER 'Trans proline' 0 N--CA 1.494 1.504 0 C-N-CA 122.437 2.091 . . . . 0.0 113.216 -179.426 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' C' C ' 704' ' ' ALA . . . . . 0.455 ' O ' ' O ' ' C' ' 703' ' ' PRO . . . . . . . . 0 N--CA 1.489 1.511 0 O-C-N 121.679 -0.638 . . . . 0.0 109.983 -179.924 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 63' ' ' PRO . . . . . 0.47 ' O ' ' CD1' ' A' ' 110' ' ' LEU . 18.2 Cg_endo . . . . . 0 N--CA 1.482 0.828 0 CA-C-O 121.003 0.335 . . . . 0.0 111.231 . . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 64' ' ' GLN . . . . . 0.623 ' NE2' ' O ' ' A' ' 64' ' ' GLN . 0.0 OUTLIER -155.53 139.25 16.11 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.175 -0.953 . . . . 0.0 109.658 -179.967 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 65' ' ' ILE . . . . . 0.412 HG23 HD11 ' A' ' 65' ' ' ILE . 4.7 mm -48.05 107.7 0.79 Allowed Pre-proline 0 N--CA 1.491 1.592 0 O-C-N 121.009 -1.057 . . . . 0.0 108.183 179.345 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 66' ' ' PRO . . . . . . . . . . . . . 93.6 Cg_endo -85.75 -170.16 0.68 Allowed 'Trans proline' 0 C--N 1.315 -1.218 0 C-N-CA 122.15 1.9 . . . . 0.0 112.614 -179.015 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 67' ' ' LYS . . . . . . . . . . . . . 38.7 tttt -90.27 -8.86 49.89 Favored 'General case' 0 N--CA 1.488 1.459 0 O-C-N 121.436 -0.79 . . . . 0.0 109.178 179.567 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 68' ' ' ASP . . . . . 0.678 ' C ' ' H ' ' A' ' 70' ' ' SER . 0.4 OUTLIER -75.86 63.86 1.74 Allowed 'General case' 0 N--CA 1.488 1.431 0 CA-C-O 122.848 1.309 . . . . 0.0 109.033 179.813 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 69' ' ' LYS . . . . . 0.478 ' C ' ' O ' ' A' ' 68' ' ' ASP . 23.8 mtmt -45.76 -13.99 0.02 OUTLIER 'General case' 0 N--CA 1.512 2.653 0 C-N-CA 116.686 -2.005 . . . . 0.0 107.157 177.757 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 70' ' ' SER . . . . . 0.678 ' H ' ' C ' ' A' ' 68' ' ' ASP . 0.1 OUTLIER -86.04 -9.02 57.49 Favored 'General case' 0 N--CA 1.497 1.899 0 CA-C-N 113.701 -1.59 . . . . 0.0 111.656 179.395 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 71' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -95.88 142.18 28.44 Favored 'General case' 0 N--CA 1.505 2.303 0 O-C-N 120.468 -1.395 . . . . 0.0 112.971 -178.704 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 72' ' ' VAL . . . . . 0.408 ' O ' ' CG2' ' A' ' 72' ' ' VAL . 1.3 m -68.67 133.42 31.81 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.368 0 N-CA-C 105.305 -2.109 . . . . 0.0 105.305 174.711 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 73' ' ' ALA . . . . . 0.4 ' N ' ' O ' ' A' ' 87' ' ' VAL . . . -80.87 -13.77 58.63 Favored 'General case' 0 C--N 1.297 -1.714 0 O-C-N 119.905 -1.747 . . . . 0.0 107.183 -179.813 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . 172.99 -156.71 25.24 Favored Glycine 0 N--CA 1.483 1.77 0 N-CA-C 109.299 -1.52 . . . . 0.0 109.299 179.648 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 75' ' ' TYR . . . . . 0.404 ' CD2' ' HA ' ' A' ' 86' ' ' PRO . 88.1 m-85 -141.54 169.99 16.56 Favored 'General case' 0 C--N 1.298 -1.668 0 O-C-N 121.58 -0.953 . . . . 0.0 111.044 -177.241 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 76' ' ' ILE . . . . . . . . . . . . . 3.9 tp -146.5 141.39 20.88 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.577 0 C-N-CA 119.461 -0.895 . . . . 0.0 109.455 -177.377 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -153.09 165.02 36.92 Favored 'General case' 0 C--N 1.304 -1.41 0 O-C-N 121.13 -0.981 . . . . 0.0 109.934 179.852 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 78' ' ' ILE . . . . . . . . . . . . . 5.0 mt -147.39 119.92 4.75 Favored Pre-proline 0 C--N 1.303 -1.455 0 N-CA-C 107.87 -1.159 . . . . 0.0 107.87 179.165 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 79' ' ' PRO . . . . . . . . . . . . . 31.1 Cg_endo -70.46 -42.36 2.74 Favored 'Trans proline' 0 C--N 1.315 -1.218 0 C-N-CA 121.658 1.572 . . . . 0.0 112.992 -178.755 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -66.43 -19.8 65.89 Favored 'General case' 0 N--CA 1.489 1.491 0 O-C-N 120.881 -1.137 . . . . 0.0 110.202 177.977 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 81' ' ' ALA . . . . . 0.435 ' O ' ' ND2' ' A' ' 132' ' ' ASN . . . -106.61 -18.78 13.86 Favored 'General case' 0 N--CA 1.494 1.755 0 O-C-N 121.303 -0.873 . . . . 0.0 109.04 179.913 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 82' ' ' ASP . . . . . . . . . . . . . 2.3 t70 66.01 52.09 1.25 Allowed 'General case' 0 N--CA 1.494 1.732 0 O-C-N 121.43 -0.794 . . . . 0.0 111.493 178.781 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 83' ' ' ILE . . . . . . . . . . . . . 31.4 mt -131.46 153.08 38.3 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.862 0 O-C-N 120.977 -1.077 . . . . 0.0 109.636 -179.322 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 84' ' ' LYS . . . . . . . . . . . . . 23.1 tttt -158.11 110.48 2.33 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.244 -0.91 . . . . 0.0 108.628 179.57 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -141.46 165.75 26.6 Favored Pre-proline 0 N--CA 1.492 1.67 0 O-C-N 121.246 -0.909 . . . . 0.0 109.817 -179.256 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 86' ' ' PRO . . . . . 0.404 ' HA ' ' CD2' ' A' ' 75' ' ' TYR . 61.2 Cg_endo -76.29 168.61 23.58 Favored 'Trans proline' 0 C--N 1.309 -1.5 0 C-N-CA 122.939 2.426 . . . . 0.0 113.312 -179.53 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 87' ' ' VAL . . . . . 0.423 ' CG1' ' CE1' ' A' ' 103' ' ' PHE . 49.6 t -124.43 98.84 5.64 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.63 0 N-CA-C 109.27 -0.641 . . . . 0.0 109.27 -179.884 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 88' ' ' TYR . . . . . 0.403 ' CZ ' HG13 ' A' ' 72' ' ' VAL . 35.0 m-85 -90.42 153.55 46.22 Favored Pre-proline 0 N--CA 1.503 2.209 0 O-C-N 120.954 -1.091 . . . . 0.0 109.944 -179.606 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 89' ' ' PRO . . . . . 0.539 ' O ' ' NE2' ' A' ' 96' ' ' GLN . 10.2 Cg_endo -58.7 146.11 93.36 Favored 'Trans proline' 0 N--CA 1.493 1.469 0 C-N-CA 122.492 2.128 . . . . 0.0 113.135 179.82 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . -58.11 169.59 4.7 Favored Glycine 0 N--CA 1.492 2.398 0 N-CA-C 109.326 -1.51 . . . . 0.0 109.326 179.493 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 91' ' ' PRO . . . . . 0.441 ' C ' ' H ' ' A' ' 93' ' ' THR . 57.3 Cg_endo -95.23 169.21 16.63 Favored 'Cis proline' 0 C--N 1.31 -1.485 0 C-N-CA 124.298 -1.126 . . . . 0.0 112.065 0.103 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 92' ' ' ALA . . . . . 0.406 ' HA ' ' HG ' ' A' ' 102' ' ' SER . . . -71.99 30.07 0.05 Allowed 'General case' 0 N--CA 1.493 1.691 0 O-C-N 121.241 -0.912 . . . . 0.0 111.274 -179.421 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 93' ' ' THR . . . . . 0.441 ' H ' ' C ' ' A' ' 91' ' ' PRO . 1.0 OUTLIER -75.85 151.29 84.35 Favored Pre-proline 0 N--CA 1.492 1.64 0 O-C-N 120.651 -1.281 . . . . 0.0 108.788 179.865 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 94' ' ' PRO . . . . . 0.4 ' C ' ' O ' ' A' ' 93' ' ' THR . 82.9 Cg_exo -35.52 -42.24 0.45 Allowed 'Trans proline' 0 C--N 1.308 -1.573 0 C-N-CA 122.511 2.14 . . . . 0.0 112.067 -179.566 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 5.8 mt-10 -49.95 -56.44 10.62 Favored 'General case' 0 C--N 1.304 -1.41 0 O-C-N 121.292 -0.88 . . . . 0.0 109.112 179.512 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 96' ' ' GLN . . . . . 0.596 ' O ' ' N ' ' A' ' 98' ' ' ASN . 13.0 mm100 -74.49 -47.86 30.64 Favored 'General case' 0 N--CA 1.487 1.424 0 O-C-N 121.323 -0.861 . . . . 0.0 109.995 179.69 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 97' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -45.3 -11.89 0.02 OUTLIER 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.221 -0.925 . . . . 0.0 109.989 -178.949 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 98' ' ' ASN . . . . . 0.697 HD22 ' NH1' ' A' ' 99' ' ' ARG . 0.0 OUTLIER -73.88 -31.44 63.15 Favored 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.176 -0.953 . . . . 0.0 108.854 179.204 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 99' ' ' ARG . . . . . 0.697 ' NH1' HD22 ' A' ' 98' ' ' ASN . 1.1 mtt-85 -85.03 -58.2 2.79 Favored 'General case' 0 C--N 1.302 -1.47 0 O-C-N 121.865 -0.522 . . . . 0.0 109.89 -179.14 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . -179.65 -160.34 25.09 Favored Glycine 0 N--CA 1.493 2.442 0 C-N-CA 119.645 -1.264 . . . . 0.0 110.046 -179.944 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 101' ' ' VAL . . . . . 0.504 ' O ' ' CG2' ' A' ' 101' ' ' VAL . 17.8 m -61.66 107.82 0.46 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.594 0 O-C-N 121.403 -1.057 . . . . 0.0 109.522 -179.813 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 102' ' ' SER . . . . . 0.406 ' HG ' ' HA ' ' A' ' 92' ' ' ALA . 0.2 OUTLIER -92.91 161.57 14.43 Favored 'General case' 0 N--CA 1.493 1.681 0 O-C-N 121.322 -0.861 . . . . 0.0 110.498 -179.84 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 103' ' ' PHE . . . . . 0.601 ' O ' ' N ' ' A' ' 105' ' ' GLU . 25.3 m-85 -64.13 123.32 18.77 Favored 'General case' 0 N--CA 1.488 1.447 0 N-CA-C 108.151 -1.055 . . . . 0.0 108.151 178.655 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 104' ' ' ALA . . . . . 0.427 ' C ' ' O ' ' A' ' 103' ' ' PHE . . . -40.39 -18.63 0.01 OUTLIER 'General case' 0 C--N 1.298 -1.636 0 O-C-N 121.602 -0.686 . . . . 0.0 110.774 -178.939 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 105' ' ' GLU . . . . . 0.601 ' N ' ' O ' ' A' ' 103' ' ' PHE . 0.4 OUTLIER -140.0 147.88 41.06 Favored 'General case' 0 N--CA 1.495 1.808 0 O-C-N 120.698 -1.251 . . . . 0.0 110.315 179.915 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 106' ' ' GLU . . . . . . . . . . . . . 4.3 tt0 -57.86 -63.37 1.27 Allowed 'General case' 0 N--CA 1.487 1.425 0 O-C-N 121.965 -0.459 . . . . 0.0 111.203 -179.058 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 107' ' ' ASN . . . . . . . . . . . . . 5.1 m120 -78.68 33.82 0.21 Allowed 'General case' 0 N--CA 1.49 1.544 0 O-C-N 120.477 -1.39 . . . . 0.0 113.465 -175.231 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 108' ' ' GLU . . . . . . . . . . . . . 30.6 tp10 -60.02 150.14 30.1 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 120.426 -1.421 . . . . 0.0 108.175 -179.614 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 109' ' ' SER . . . . . 0.504 ' C ' ' H ' ' A' ' 111' ' ' ASP . 0.1 OUTLIER -101.35 126.26 48.09 Favored 'General case' 0 N--CA 1.489 1.5 0 O-C-N 121.002 -1.061 . . . . 0.0 110.585 -178.613 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 110' ' ' LEU . . . . . 0.47 ' CD1' ' O ' ' A' ' 63' ' ' PRO . 1.0 OUTLIER -60.22 -2.33 0.44 Allowed 'General case' 0 C--N 1.298 -1.664 0 N-CA-C 108.891 -0.781 . . . . 0.0 108.891 -179.964 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 111' ' ' ASP . . . . . 0.504 ' H ' ' C ' ' A' ' 109' ' ' SER . 53.1 m-20 -133.26 20.47 4.02 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.386 -0.822 . . . . 0.0 109.607 179.831 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 112' ' ' ASP . . . . . 0.434 ' C ' ' H ' ' A' ' 114' ' ' ASN . 0.4 OUTLIER -68.05 140.14 56.29 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.002 -1.061 . . . . 0.0 110.661 -179.674 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 113' ' ' GLN . . . . . 0.531 ' N ' ' CD ' ' A' ' 113' ' ' GLN . 2.1 mm100 -64.92 -7.06 9.94 Favored 'General case' 0 C--N 1.303 -1.445 0 N-CA-C 107.521 -1.289 . . . . 0.0 107.521 177.876 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 114' ' ' ASN . . . . . 0.657 ' ND2' HE21 ' A' ' 178' ' ' GLN . 4.9 t-20 -144.68 92.17 2.26 Favored 'General case' 0 C--N 1.304 -1.403 0 N-CA-C 108.206 -1.035 . . . . 0.0 108.206 -179.954 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 115' ' ' ILE . . . . . . . . . . . . . 2.8 mt -99.11 113.71 34.83 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.536 0 O-C-N 121.531 -0.731 . . . . 0.0 109.328 -179.438 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 116' ' ' SER . . . . . . . . . . . . . 69.3 p -98.02 146.61 25.34 Favored 'General case' 0 N--CA 1.488 1.471 0 CA-C-O 122.093 0.949 . . . . 0.0 111.387 -178.299 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 117' ' ' ILE . . . . . . . . . . . . . 2.7 mt -138.21 154.64 28.24 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.511 0 N-CA-C 107.477 -1.305 . . . . 0.0 107.477 178.996 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 118' ' ' ALA . . . . . . . . . . . . . . . -143.44 159.75 41.82 Favored 'General case' 0 N--CA 1.492 1.66 0 O-C-N 120.836 -1.165 . . . . 0.0 111.336 -179.233 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 119' ' ' GLY . . . . . . . . . . . . . . . -167.66 145.56 9.85 Favored Glycine 0 N--CA 1.489 2.183 0 N-CA-C 110.423 -1.071 . . . . 0.0 110.423 179.624 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 120' ' ' HIS . . . . . . . . . . . . . 3.1 m-70 -70.36 164.64 24.1 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.613 -0.933 . . . . 0.0 109.417 179.236 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 121' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -118.06 155.28 30.62 Favored 'General case' 0 N--CA 1.494 1.733 0 O-C-N 121.318 -0.864 . . . . 0.0 108.855 179.422 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 122' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -112.36 128.07 56.19 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.308 -0.87 . . . . 0.0 109.637 179.761 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 123' ' ' ILE . . . . . 0.438 ' CG2' ' N ' ' A' ' 124' ' ' ASP . 16.3 tt -77.26 -38.52 27.21 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.809 0 N-CA-C 108.167 -1.049 . . . . 0.0 108.167 179.076 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 124' ' ' ASP . . . . . 0.438 ' N ' ' CG2' ' A' ' 123' ' ' ILE . 4.8 t70 -100.29 24.32 8.94 Favored 'General case' 0 N--CA 1.494 1.771 0 CA-C-N 115.771 -0.649 . . . . 0.0 110.82 -179.73 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 125' ' ' ARG . . . . . . . . . . . . . 5.1 ttt180 -157.64 99.77 1.87 Allowed Pre-proline 0 N--CA 1.492 1.671 0 O-C-N 120.664 -1.272 . . . . 0.0 110.541 -179.032 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 126' ' ' PRO . . . . . . . . . . . . . 41.3 Cg_endo -78.88 -18.91 11.33 Favored 'Trans proline' 0 C--N 1.314 -1.243 0 C-N-CA 122.175 1.917 . . . . 0.0 112.465 179.517 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 127' ' ' ASN . . . . . . . . . . . . . 14.8 m120 -90.65 26.69 1.95 Allowed 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.23 -0.919 . . . . 0.0 109.241 179.636 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 128' ' ' TYR . . . . . . . . . . . . . 13.1 t80 -87.04 -149.01 0.15 Allowed 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.306 -0.872 . . . . 0.0 109.774 -179.622 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 129' ' ' GLN . . . . . . . . . . . . . 63.3 mt-30 -67.95 -89.43 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.288 -0.882 . . . . 0.0 110.344 -179.323 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 130' ' ' PHE . . . . . 0.411 ' CE2' ' CG1' ' A' ' 101' ' ' VAL . 41.0 m-85 -110.15 40.07 2.02 Favored 'General case' 0 N--CA 1.494 1.752 0 O-C-N 121.287 -0.883 . . . . 0.0 110.338 -179.22 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 131' ' ' THR . . . . . . . . . . . . . 85.6 m -79.78 -32.95 40.9 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.088 -1.008 . . . . 0.0 109.128 179.38 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 132' ' ' ASN . . . . . 0.435 ' ND2' ' O ' ' A' ' 81' ' ' ALA . 4.6 t30 -84.33 7.54 19.04 Favored 'General case' 0 N--CA 1.495 1.784 0 O-C-N 121.608 -0.682 . . . . 0.0 110.335 -179.588 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 133' ' ' LEU . . . . . 0.6 ' O ' ' N ' ' A' ' 135' ' ' ALA . 0.2 OUTLIER -70.26 -46.37 64.53 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.186 -0.946 . . . . 0.0 110.686 -179.146 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 134' ' ' LYS . . . . . 0.554 ' NZ ' ' HG1' ' A' ' 183' ' ' THR . 0.1 OUTLIER -42.53 -17.54 0.01 OUTLIER 'General case' 0 N--CA 1.493 1.692 0 O-C-N 121.024 -1.048 . . . . 0.0 109.983 -179.012 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 135' ' ' ALA . . . . . 0.6 ' N ' ' O ' ' A' ' 133' ' ' LEU . . . -85.12 -33.89 22.28 Favored 'General case' 0 N--CA 1.489 1.482 0 O-C-N 121.183 -0.948 . . . . 0.0 109.64 179.773 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 136' ' ' ALA . . . . . 0.464 ' N ' ' O ' ' A' ' 133' ' ' LEU . . . -80.43 153.21 28.39 Favored 'General case' 0 N--CA 1.489 1.504 0 CA-C-O 122.095 0.95 . . . . 0.0 111.769 -178.546 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 137' ' ' LYS . . . . . 0.511 ' O ' ' O ' ' A' ' 138' ' ' LYS . 2.8 ttmm -157.42 -163.47 1.37 Allowed 'General case' 0 N--CA 1.491 1.624 0 C-N-CA 119.109 -1.037 . . . . 0.0 110.431 -179.25 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 138' ' ' LYS . . . . . 0.604 ' O ' ' N ' ' A' ' 140' ' ' SER . 10.3 tttt -46.23 -178.39 0.0 OUTLIER 'General case' 0 C--N 1.306 -1.3 0 CA-C-O 121.864 0.84 . . . . 0.0 110.265 -179.818 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 139' ' ' GLY . . . . . . . . . . . . . . . 45.7 8.2 0.02 OUTLIER Glycine 0 N--CA 1.492 2.431 0 N-CA-C 110.713 -0.955 . . . . 0.0 110.713 179.574 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 140' ' ' SER . . . . . 0.604 ' N ' ' O ' ' A' ' 138' ' ' LYS . 37.9 m -96.5 133.74 40.57 Favored 'General case' 0 N--CA 1.493 1.679 0 O-C-N 120.814 -1.404 . . . . 0.0 109.125 179.195 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 141' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -82.52 144.62 30.27 Favored 'General case' 0 N--CA 1.489 1.488 0 O-C-N 121.148 -0.97 . . . . 0.0 109.871 -179.816 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 142' ' ' VAL . . . . . . . . . . . . . 5.8 t -129.21 132.85 66.61 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.705 0 O-C-N 121.284 -0.885 . . . . 0.0 108.771 179.902 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 143' ' ' TYR . . . . . . . . . . . . . 32.3 m-85 -114.66 137.68 51.61 Favored 'General case' 0 N--CA 1.501 2.098 0 O-C-N 121.116 -0.99 . . . . 0.0 111.421 -178.455 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 144' ' ' PHE . . . . . . . . . . . . . 26.9 t80 -122.36 107.1 11.69 Favored 'General case' 0 N--CA 1.495 1.817 0 CA-C-O 121.323 0.583 . . . . 0.0 110.442 -179.178 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 145' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -96.63 128.83 43.95 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.384 -0.823 . . . . 0.0 110.582 -179.752 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 146' ' ' VAL . . . . . 0.41 ' O ' ' C ' ' A' ' 147' ' ' GLY . 3.7 p -143.38 142.8 25.15 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.777 0 N-CA-C 107.522 -1.288 . . . . 0.0 107.522 178.752 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 147' ' ' GLY . . . . . 0.41 ' C ' ' O ' ' A' ' 146' ' ' VAL . . . 46.97 -134.28 11.71 Favored Glycine 0 N--CA 1.489 2.224 0 N-CA-C 108.887 -1.685 . . . . 0.0 108.887 -179.754 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 148' ' ' ASN . . . . . 0.573 ' C ' HD21 ' A' ' 148' ' ' ASN . 0.4 OUTLIER -102.33 17.31 23.8 Favored 'General case' 0 C--N 1.301 -1.533 0 O-C-N 121.284 -1.127 . . . . 0.0 108.451 179.208 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 149' ' ' GLU . . . . . . . . . . . . . 8.7 tt0 -114.56 147.42 39.48 Favored 'General case' 0 N--CA 1.487 1.402 0 CA-C-O 121.919 0.866 . . . . 0.0 111.024 -178.605 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 150' ' ' THR . . . . . . . . . . . . . 88.3 m -129.42 105.97 8.47 Favored 'General case' 0 N--CA 1.491 1.596 0 CA-C-O 121.421 0.629 . . . . 0.0 109.718 179.891 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 151' ' ' ARG . . . . . . . . . . . . . 34.2 mtt180 -87.04 -174.54 4.96 Favored 'General case' 0 C--N 1.306 -1.299 0 N-CA-C 107.987 -1.116 . . . . 0.0 107.987 179.52 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 152' ' ' LYS . . . . . 0.433 ' CE ' ' OXT' ' A' ' 206' ' ' LYS . 18.6 mtmm -148.22 146.33 28.63 Favored 'General case' 0 C--N 1.3 -1.571 0 O-C-N 121.007 -1.058 . . . . 0.0 110.135 -179.799 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 153' ' ' TYR . . . . . 0.486 ' CD2' ' HA ' ' A' ' 204' ' ' GLU . 9.1 m-85 -139.02 166.56 24.17 Favored 'General case' 0 C--N 1.3 -1.546 0 N-CA-C 107.523 -1.288 . . . . 0.0 107.523 179.13 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 154' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -142.96 121.86 12.74 Favored 'General case' 0 C--N 1.296 -1.722 0 O-C-N 121.184 -0.948 . . . . 0.0 108.442 178.748 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 155' ' ' MET . . . . . . . . . . . . . 23.1 mmm -46.99 104.89 0.06 Allowed 'General case' 0 N--CA 1.49 1.526 0 O-C-N 120.758 -1.214 . . . . 0.0 111.445 -178.584 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 156' ' ' THR . . . . . . . . . . . . . 1.4 m -107.88 -23.95 11.84 Favored 'General case' 0 C--N 1.293 -1.885 0 CA-C-N 115.288 -0.869 . . . . 0.0 109.921 -179.291 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 157' ' ' SER . . . . . 0.485 ' O ' ' N ' ' A' ' 201' ' ' VAL . 2.0 m -153.94 150.56 28.45 Favored 'General case' 0 N--CA 1.492 1.669 0 C-N-CA 118.217 -1.393 . . . . 0.0 111.426 -178.362 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 158' ' ' ILE . . . . . 0.441 HG13 ' CD2' ' A' ' 200' ' ' PHE . 0.0 OUTLIER -154.95 146.45 13.29 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.44 0 CA-C-O 121.796 0.807 . . . . 0.0 110.333 -179.491 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 159' ' ' ARG . . . . . 0.434 ' N ' HG12 ' A' ' 158' ' ' ILE . 37.5 mtm180 -149.3 177.18 9.89 Favored 'General case' 0 C--N 1.298 -1.656 0 CA-C-O 121.557 0.694 . . . . 0.0 109.812 -179.732 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 160' ' ' ASP . . . . . 0.435 ' C ' ' CG2' ' A' ' 161' ' ' VAL . 1.0 OUTLIER -144.81 161.22 39.81 Favored 'General case' 0 C--N 1.3 -1.567 0 N-CA-C 108.859 -0.793 . . . . 0.0 108.859 -179.463 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 161' ' ' VAL . . . . . 0.435 ' CG2' ' C ' ' A' ' 160' ' ' ASP . 0.1 OUTLIER -169.47 166.6 0.34 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.612 0 O-C-N 121.294 -0.879 . . . . 0.0 109.768 179.673 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 162' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -55.29 177.36 0.13 Allowed Pre-proline 0 N--CA 1.489 1.482 0 O-C-N 121.528 -0.732 . . . . 0.0 109.189 179.669 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 163' ' ' PRO . . . . . . . . . . . . . 9.8 Cg_endo -84.07 42.8 1.26 Allowed 'Trans proline' 0 C--N 1.315 -1.185 0 C-N-CA 122.466 2.111 . . . . 0.0 112.21 -179.87 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 164' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -151.92 -14.0 0.19 Allowed 'General case' 0 N--CA 1.492 1.674 0 O-C-N 121.103 -0.998 . . . . 0.0 110.443 -179.859 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 165' ' ' ASP . . . . . 0.436 ' O ' ' C ' ' A' ' 166' ' ' VAL . 9.5 t70 -73.03 61.63 0.59 Allowed 'General case' 0 N--CA 1.49 1.527 0 O-C-N 120.955 -1.091 . . . . 0.0 109.544 -179.817 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 166' ' ' VAL . . . . . 0.608 ' O ' ' N ' ' A' ' 168' ' ' VAL . 0.9 OUTLIER -39.6 -32.04 0.17 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.55 0 O-C-N 121.659 -0.65 . . . . 0.0 109.431 -178.416 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 167' ' ' GLY . . . . . 0.425 ' N ' ' O ' ' A' ' 165' ' ' ASP . . . -43.03 -14.96 0.02 OUTLIER Glycine 0 N--CA 1.492 2.375 0 N-CA-C 110.325 -1.11 . . . . 0.0 110.325 179.898 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 168' ' ' VAL . . . . . 0.638 ' C ' ' H ' ' A' ' 170' ' ' ASP . 4.8 m -52.72 -37.06 24.04 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.452 0 O-C-N 120.751 -1.441 . . . . 0.0 108.528 179.692 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 169' ' ' LEU . . . . . 0.508 ' O ' ' N ' ' A' ' 171' ' ' GLU . 16.1 mt -51.75 -5.39 0.03 OUTLIER 'General case' 0 N--CA 1.494 1.756 0 N-CA-C 108.088 -1.078 . . . . 0.0 108.088 -179.431 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 170' ' ' ASP . . . . . 0.638 ' H ' ' C ' ' A' ' 168' ' ' VAL . 22.4 t0 35.52 29.49 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.639 -0.663 . . . . 0.0 111.586 178.047 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 171' ' ' GLU . . . . . 0.508 ' N ' ' O ' ' A' ' 169' ' ' LEU . 11.6 pt-20 -68.31 94.5 0.54 Allowed 'General case' 0 N--CA 1.489 1.5 0 O-C-N 120.609 -1.307 . . . . 0.0 108.26 178.935 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 172' ' ' GLN . . . . . 0.401 ' HG3' ' H ' ' A' ' 173' ' ' LYS . 6.0 pt20 -175.98 -56.9 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.535 0 N-CA-C 108.885 -0.783 . . . . 0.0 108.885 179.969 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 173' ' ' LYS . . . . . 0.401 ' H ' ' HG3' ' A' ' 172' ' ' GLN . 44.5 mtpt -64.13 130.24 43.17 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.021 -1.049 . . . . 0.0 108.64 178.462 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 174' ' ' GLY . . . . . 0.571 ' O ' ' C ' ' A' ' 175' ' ' LYS . . . -134.91 -38.72 0.19 Allowed Glycine 0 N--CA 1.48 1.621 0 N-CA-C 108.621 -1.792 . . . . 0.0 108.621 179.581 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 175' ' ' LYS . . . . . 0.571 ' C ' ' O ' ' A' ' 174' ' ' GLY . 4.3 mmtp -27.02 -64.7 0.08 Allowed 'General case' 0 N--CA 1.503 2.199 0 CA-C-O 121.644 0.735 . . . . 0.0 109.033 179.853 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 176' ' ' ASP . . . . . 0.669 ' O ' ' O ' ' A' ' 177' ' ' LYS . 0.0 OUTLIER -102.6 79.26 1.79 Allowed 'General case' 0 C--N 1.298 -1.669 0 N-CA-C 107.163 -1.421 . . . . 0.0 107.163 177.442 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 177' ' ' LYS . . . . . 0.669 ' O ' ' O ' ' A' ' 176' ' ' ASP . 65.7 mttt -26.56 161.34 0.0 OUTLIER 'General case' 0 N--CA 1.503 2.212 0 CA-C-O 121.821 0.82 . . . . 0.0 111.17 -178.676 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 178' ' ' GLN . . . . . 0.657 HE21 ' ND2' ' A' ' 114' ' ' ASN . 3.3 pp0? -159.94 174.0 15.05 Favored 'General case' 0 C--N 1.302 -1.458 0 C-N-CA 117.265 -1.774 . . . . 0.0 112.029 -179.357 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 179' ' ' LEU . . . . . 0.469 ' N ' ' OE1' ' A' ' 178' ' ' GLN . 0.9 OUTLIER -126.01 99.05 5.75 Favored 'General case' 0 C--N 1.303 -1.446 0 N-CA-C 107.242 -1.392 . . . . 0.0 107.242 178.47 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 180' ' ' THR . . . . . 0.467 ' N ' ' OE1' ' A' ' 178' ' ' GLN . 2.7 m -70.82 122.0 19.09 Favored 'General case' 0 N--CA 1.488 1.447 0 O-C-N 120.953 -1.092 . . . . 0.0 109.939 -178.642 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 181' ' ' LEU . . . . . 0.421 HD13 ' H ' ' A' ' 182' ' ' ILE . 51.1 tp -96.84 145.78 25.54 Favored 'General case' 0 C--N 1.298 -1.67 0 N-CA-C 108.387 -0.968 . . . . 0.0 108.387 178.725 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 182' ' ' ILE . . . . . 0.421 ' H ' HD13 ' A' ' 181' ' ' LEU . 6.3 mt -138.31 110.58 6.39 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.458 0 O-C-N 120.994 -1.066 . . . . 0.0 108.982 178.987 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 183' ' ' THR . . . . . 0.554 ' HG1' ' NZ ' ' A' ' 134' ' ' LYS . 1.9 t -129.11 113.47 15.14 Favored 'General case' 0 C--N 1.291 -1.938 0 N-CA-C 106.767 -1.568 . . . . 0.0 106.767 178.546 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 184' ' ' CYS . . . . . . . . . . . . . 28.2 p -78.38 164.52 24.74 Favored 'General case' 0 N--CA 1.497 1.916 0 C-N-CA 119.028 -1.069 . . . . 0.0 111.103 -177.359 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 185' ' ' ASP . . . . . . . . . . . . . 6.4 t70 -165.72 -151.4 0.14 Allowed 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.584 -0.698 . . . . 0.0 109.347 -179.642 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 186' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER 48.15 56.63 7.08 Favored 'General case' 0 N--CA 1.493 1.724 0 O-C-N 121.175 -0.953 . . . . 0.0 109.03 -179.598 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 187' ' ' TYR . . . . . 0.6 ' CE1' ' O ' ' A' ' 188' ' ' ASN . 44.7 t80 -67.38 133.77 50.22 Favored 'General case' 0 C--N 1.302 -1.485 0 O-C-N 121.418 -0.801 . . . . 0.0 110.411 -179.417 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 188' ' ' ASN . . . . . 0.6 ' O ' ' CE1' ' A' ' 187' ' ' TYR . 0.6 OUTLIER -100.74 147.21 26.29 Favored 'General case' 0 C--N 1.296 -1.749 0 N-CA-C 107.79 -1.189 . . . . 0.0 107.79 178.302 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 189' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -112.3 -11.04 13.76 Favored 'General case' 0 C--N 1.295 -1.797 0 N-CA-C 108.373 -0.973 . . . . 0.0 108.373 -179.635 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 190' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -84.23 -52.47 6.22 Favored 'General case' 0 C--N 1.303 -1.447 0 N-CA-C 108.851 -0.796 . . . . 0.0 108.851 178.838 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 191' ' ' THR . . . . . . . . . . . . . 1.1 p -89.44 -12.63 39.64 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.475 -0.766 . . . . 0.0 109.2 179.663 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 192' ' ' GLY . . . . . . . . . . . . . . . 71.84 33.43 63.02 Favored Glycine 0 N--CA 1.493 2.495 0 O-C-N 121.291 -0.881 . . . . 0.0 111.303 178.706 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 193' ' ' VAL . . . . . . . . . . . . . 3.3 p -147.71 170.85 3.2 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.67 0 O-C-N 120.778 -1.425 . . . . 0.0 110.035 179.216 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 194' ' ' TRP . . . . . 0.522 ' CD1' ' N ' ' A' ' 194' ' ' TRP . 2.5 m95 -84.97 121.63 28.05 Favored 'General case' 0 N--CA 1.494 1.726 0 N-CA-C 109.439 -0.578 . . . . 0.0 109.439 -179.809 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 195' ' ' GLU . . . . . 0.531 ' CD ' ' ND2' ' A' ' 188' ' ' ASN . 2.4 mt-10 -80.05 -60.38 2.36 Favored 'General case' 0 N--CA 1.496 1.87 0 O-C-N 121.348 -0.845 . . . . 0.0 111.037 -178.975 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 196' ' ' LYS . . . . . . . . . . . . . 10.6 tttt -93.44 157.34 16.27 Favored 'General case' 0 N--CA 1.493 1.688 0 O-C-N 120.977 -1.077 . . . . 0.0 110.695 -178.544 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 197' ' ' ARG . . . . . 0.615 ' CG ' HH11 ' A' ' 197' ' ' ARG . 0.1 OUTLIER -126.18 142.2 51.62 Favored 'General case' 0 N--CA 1.489 1.485 0 O-C-N 121.653 -0.654 . . . . 0.0 109.351 179.415 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 198' ' ' LYS . . . . . . . . . . . . . 38.5 mttt -115.56 121.73 43.53 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.794 -0.566 . . . . 0.0 110.101 -179.17 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 199' ' ' ILE . . . . . 0.445 ' C ' ' CD1' ' A' ' 199' ' ' ILE . 0.5 OUTLIER -138.09 118.65 16.19 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.811 0 CA-C-O 122.526 1.155 . . . . 0.0 110.076 179.834 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 200' ' ' PHE . . . . . 0.509 ' CD1' ' N ' ' A' ' 200' ' ' PHE . 7.0 m-85 -99.73 135.35 41.28 Favored 'General case' 0 N--CA 1.499 1.992 0 O-C-N 121.499 -0.751 . . . . 0.0 109.894 -178.358 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 201' ' ' VAL . . . . . 0.485 ' N ' ' O ' ' A' ' 157' ' ' SER . 59.9 t -101.03 131.86 47.88 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.714 0 O-C-N 120.984 -1.073 . . . . 0.0 108.826 177.684 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 202' ' ' ALA . . . . . . . . . . . . . . . -115.9 131.38 56.95 Favored 'General case' 0 N--CA 1.491 1.624 0 N-CA-C 108.525 -0.917 . . . . 0.0 108.525 179.43 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 203' ' ' THR . . . . . . . . . . . . . 5.4 t -87.88 132.09 34.33 Favored 'General case' 0 N--CA 1.488 1.468 0 CA-C-O 122.327 1.061 . . . . 0.0 110.709 -179.332 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 204' ' ' GLU . . . . . 0.486 ' HA ' ' CD2' ' A' ' 153' ' ' TYR . 13.7 tm-20 -52.99 135.42 36.85 Favored 'General case' 0 C--N 1.296 -1.752 0 C-N-CA 118.619 -1.233 . . . . 0.0 108.909 179.205 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 205' ' ' VAL . . . . . 0.488 ' CG1' ' N ' ' A' ' 206' ' ' LYS . 84.1 t -131.99 167.97 25.14 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.345 0 CA-C-O 121.993 0.902 . . . . 0.0 110.141 -178.056 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 206' ' ' LYS . . . . . 0.488 ' N ' ' CG1' ' A' ' 205' ' ' VAL . 25.5 mttt . . . . . 0 C--N 1.297 -1.675 0 CA-C-O 117.978 -1.011 . . . . 0.0 109.555 179.937 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' C' C ' 702' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.49 1.561 0 N-CA-C 108.775 -0.824 . . . . 0.0 108.775 . . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' C' C ' 703' ' ' PRO . . . . . 0.603 ' O ' ' NH2' ' A' ' 197' ' ' ARG . 55.5 Cg_endo -72.58 174.76 11.16 Favored 'Trans proline' 0 N--CA 1.495 1.597 0 C-N-CA 122.48 2.12 . . . . 0.0 112.418 -179.497 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' C' C ' 704' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.487 1.388 0 O-C-N 121.234 -0.916 . . . . 0.0 109.49 179.897 . . . . . . . . 0 0 . 1 . 005 nuclear orig core ' A' A ' 63' ' ' PRO . . . . . . . . . . . . . 53.7 Cg_endo . . . . . 0 N--CA 1.482 0.797 0 N-CA-C 110.929 -0.45 . . . . 0.0 110.929 . . . . . . . . . 0 0 . 1 . 005 nuclear orig core ' A' A ' 64' ' ' GLN . . . . . 0.675 ' NE2' ' N ' ' A' ' 64' ' ' GLN . 0.0 OUTLIER -153.38 111.93 3.68 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 120.986 -1.071 . . . . 0.0 110.19 -179.84 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 65' ' ' ILE . . . . . 0.45 ' C ' ' O ' ' A' ' 64' ' ' GLN . 3.1 mp -43.45 103.76 0.34 Allowed Pre-proline 0 N--CA 1.491 1.596 0 N-CA-C 108.148 -1.056 . . . . 0.0 108.148 178.722 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 66' ' ' PRO . . . . . . . . . . . . . 97.9 Cg_endo -85.98 -155.05 0.05 OUTLIER 'Trans proline' 0 N--CA 1.49 1.282 0 C-N-CA 122.407 2.072 . . . . 0.0 113.002 -178.218 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 67' ' ' LYS . . . . . 0.453 ' C ' ' H ' ' A' ' 69' ' ' LYS . 15.1 tttt -82.16 -6.01 58.88 Favored 'General case' 0 N--CA 1.487 1.395 0 O-C-N 121.311 -0.868 . . . . 0.0 109.037 179.936 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 68' ' ' ASP . . . . . 0.64 ' C ' ' N ' ' A' ' 70' ' ' SER . 0.4 OUTLIER -75.12 51.15 0.51 Allowed 'General case' 0 N--CA 1.487 1.384 0 CA-C-O 122.645 1.212 . . . . 0.0 108.308 179.411 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 69' ' ' LYS . . . . . 0.453 ' H ' ' C ' ' A' ' 67' ' ' LYS . 1.9 ptpp? -49.19 -14.32 0.08 Allowed 'General case' 0 N--CA 1.501 2.121 0 C-N-CA 116.769 -1.972 . . . . 0.0 106.61 178.151 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 70' ' ' SER . . . . . 0.64 ' N ' ' C ' ' A' ' 68' ' ' ASP . 38.4 t -85.27 -7.2 59.13 Favored 'General case' 0 N--CA 1.495 1.824 0 CA-C-N 113.786 -1.552 . . . . 0.0 110.534 179.354 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 71' ' ' LYS . . . . . . . . . . . . . 0.9 OUTLIER -98.04 140.82 31.8 Favored 'General case' 0 N--CA 1.496 1.841 0 O-C-N 120.85 -1.156 . . . . 0.0 111.333 -179.745 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 1.0 OUTLIER -66.03 142.4 16.84 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.455 0 N-CA-C 105.319 -2.104 . . . . 0.0 105.319 174.989 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 73' ' ' ALA . . . . . 0.439 ' N ' ' O ' ' A' ' 87' ' ' VAL . . . -83.0 -15.31 51.68 Favored 'General case' 0 C--N 1.293 -1.854 0 N-CA-C 106.078 -1.823 . . . . 0.0 106.078 178.935 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 74' ' ' GLY . . . . . 0.483 ' C ' ' CD1' ' A' ' 75' ' ' TYR . . . 167.56 -150.6 17.2 Favored Glycine 0 N--CA 1.482 1.706 0 N-CA-C 109.38 -1.488 . . . . 0.0 109.38 179.172 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 75' ' ' TYR . . . . . 0.483 ' CD1' ' C ' ' A' ' 74' ' ' GLY . 25.7 m-85 -144.09 175.97 9.66 Favored 'General case' 0 C--N 1.296 -1.74 0 O-C-N 121.597 -0.943 . . . . 0.0 109.782 -178.839 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 76' ' ' ILE . . . . . . . . . . . . . 2.0 tt -150.37 147.65 15.81 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.797 0 N-CA-C 108.923 -0.769 . . . . 0.0 108.923 -178.261 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 4.6 mt-10 -148.67 162.03 40.55 Favored 'General case' 0 C--N 1.301 -1.541 0 O-C-N 121.044 -1.035 . . . . 0.0 109.322 179.845 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 78' ' ' ILE . . . . . 0.428 ' O ' ' N ' ' A' ' 82' ' ' ASP . 36.4 mt -144.24 93.27 5.98 Favored Pre-proline 0 N--CA 1.489 1.51 0 N-CA-C 108.385 -0.968 . . . . 0.0 108.385 -179.733 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 79' ' ' PRO . . . . . . . . . . . . . 74.0 Cg_exo -47.31 -46.84 18.81 Favored 'Trans proline' 0 N--CA 1.494 1.511 0 C-N-CA 122.855 2.37 . . . . 0.0 114.094 -178.598 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 53.8 t0 -65.3 -19.07 65.79 Favored 'General case' 0 N--CA 1.493 1.695 0 O-C-N 120.716 -1.24 . . . . 0.0 110.839 178.921 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 81' ' ' ALA . . . . . 0.51 ' O ' ' ND2' ' A' ' 132' ' ' ASN . . . -106.9 -17.87 14.08 Favored 'General case' 0 N--CA 1.494 1.745 0 O-C-N 121.114 -0.991 . . . . 0.0 108.792 179.527 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 82' ' ' ASP . . . . . 0.428 ' N ' ' O ' ' A' ' 78' ' ' ILE . 0.8 OUTLIER 69.3 50.69 0.54 Allowed 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.472 -0.768 . . . . 0.0 110.688 178.947 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 83' ' ' ILE . . . . . . . . . . . . . 64.1 mt -128.07 152.38 36.11 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.876 0 O-C-N 121.144 -0.972 . . . . 0.0 110.118 -179.247 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 84' ' ' LYS . . . . . . . . . . . . . 8.0 pttm -159.05 109.27 1.99 Allowed 'General case' 0 N--CA 1.49 1.561 0 N-CA-C 107.893 -1.151 . . . . 0.0 107.893 179.309 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 85' ' ' GLU . . . . . 0.436 ' OE2' ' O ' ' A' ' 129' ' ' GLN . 0.2 OUTLIER -140.48 170.99 8.4 Favored Pre-proline 0 N--CA 1.496 1.873 0 O-C-N 121.334 -0.854 . . . . 0.0 110.412 -178.684 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 86' ' ' PRO . . . . . 0.42 ' HA ' ' CD2' ' A' ' 75' ' ' TYR . 72.2 Cg_endo -81.72 159.66 18.99 Favored 'Trans proline' 0 N--CA 1.492 1.436 0 C-N-CA 123.08 2.52 . . . . 0.0 113.494 -179.594 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 87' ' ' VAL . . . . . 0.439 ' O ' ' N ' ' A' ' 73' ' ' ALA . 72.5 t -115.45 100.61 10.88 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.69 0 O-C-N 121.659 -0.651 . . . . 0.0 109.808 -179.842 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 88' ' ' TYR . . . . . . . . . . . . . 20.2 m-85 -92.42 154.14 42.74 Favored Pre-proline 0 N--CA 1.498 1.95 0 O-C-N 120.879 -1.138 . . . . 0.0 109.483 179.717 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 89' ' ' PRO . . . . . . . . . . . . . 9.7 Cg_endo -61.98 146.15 96.43 Favored 'Trans proline' 0 C--N 1.307 -1.65 0 C-N-CA 122.373 2.049 . . . . 0.0 113.504 -179.907 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . -55.15 165.97 3.15 Favored Glycine 0 N--CA 1.494 2.509 0 N-CA-C 108.826 -1.709 . . . . 0.0 108.826 179.008 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 91' ' ' PRO . . . . . 0.492 ' C ' ' H ' ' A' ' 93' ' ' THR . 65.6 Cg_endo -94.83 168.07 17.8 Favored 'Cis proline' 0 C--N 1.307 -1.627 0 C-N-CA 124.08 -1.216 . . . . 0.0 112.205 0.269 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 92' ' ' ALA . . . . . 0.403 ' CA ' ' HG ' ' A' ' 102' ' ' SER . . . -70.71 28.25 0.04 OUTLIER 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.411 -0.806 . . . . 0.0 110.793 -179.626 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 93' ' ' THR . . . . . 0.492 ' H ' ' C ' ' A' ' 91' ' ' PRO . 1.7 p -73.56 152.66 89.65 Favored Pre-proline 0 N--CA 1.491 1.596 0 O-C-N 120.716 -1.24 . . . . 0.0 109.246 -179.743 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 94' ' ' PRO . . . . . . . . . . . . . 88.9 Cg_exo -36.19 -42.07 0.59 Allowed 'Trans proline' 0 C--N 1.31 -1.497 0 C-N-CA 122.821 2.347 . . . . 0.0 112.335 -179.283 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 95' ' ' GLU . . . . . 0.565 ' H ' ' CD ' ' A' ' 95' ' ' GLU . 0.1 OUTLIER -53.18 -53.98 42.61 Favored 'General case' 0 C--N 1.301 -1.507 0 O-C-N 121.254 -0.904 . . . . 0.0 109.302 179.756 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 96' ' ' GLN . . . . . 0.592 ' O ' ' N ' ' A' ' 98' ' ' ASN . 29.7 mm100 -73.64 -51.87 15.3 Favored 'General case' 0 N--CA 1.487 1.389 0 O-C-N 121.155 -0.966 . . . . 0.0 109.77 179.593 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 97' ' ' LEU . . . . . . . . . . . . . 1.4 mp -46.25 -11.06 0.02 OUTLIER 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.416 -0.802 . . . . 0.0 109.741 -179.336 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 98' ' ' ASN . . . . . 0.61 HD22 ' HE ' ' A' ' 99' ' ' ARG . 0.0 OUTLIER -75.28 -23.42 57.4 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.197 -0.939 . . . . 0.0 110.005 -179.815 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 99' ' ' ARG . . . . . 0.61 ' HE ' HD22 ' A' ' 98' ' ' ASN . 7.7 mtt180 -103.19 -54.01 2.7 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.435 -0.79 . . . . 0.0 110.28 -178.88 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . -169.98 179.15 42.46 Favored Glycine 0 N--CA 1.492 2.41 0 C-N-CA 119.273 -1.442 . . . . 0.0 110.298 -179.834 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 101' ' ' VAL . . . . . 0.452 ' CG1' ' CE2' ' A' ' 130' ' ' PHE . 31.7 m -53.06 111.75 0.29 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.601 0 O-C-N 121.556 -0.967 . . . . 0.0 109.222 179.787 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 102' ' ' SER . . . . . 0.403 ' HG ' ' CA ' ' A' ' 92' ' ' ALA . 0.0 OUTLIER -92.29 168.0 11.63 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.315 -0.866 . . . . 0.0 111.288 -179.155 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 103' ' ' PHE . . . . . 0.602 ' O ' ' N ' ' A' ' 105' ' ' GLU . 25.0 m-85 -69.64 120.79 15.95 Favored 'General case' 0 N--CA 1.488 1.439 0 N-CA-C 108.031 -1.1 . . . . 0.0 108.031 178.263 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 104' ' ' ALA . . . . . . . . . . . . . . . -41.09 -16.2 0.01 OUTLIER 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.686 -0.634 . . . . 0.0 111.066 -178.515 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 105' ' ' GLU . . . . . 0.602 ' N ' ' O ' ' A' ' 103' ' ' PHE . 0.4 OUTLIER -139.3 147.58 41.82 Favored 'General case' 0 N--CA 1.494 1.729 0 O-C-N 120.861 -1.149 . . . . 0.0 110.56 179.852 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 106' ' ' GLU . . . . . . . . . . . . . 16.2 tt0 -58.09 -63.9 1.1 Allowed 'General case' 0 C--N 1.302 -1.487 0 CA-C-N 116.113 -0.494 . . . . 0.0 110.863 -179.178 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 107' ' ' ASN . . . . . . . . . . . . . 11.1 m120 -78.02 33.29 0.18 Allowed 'General case' 0 N--CA 1.491 1.621 0 O-C-N 120.501 -1.374 . . . . 0.0 113.342 -175.318 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 108' ' ' GLU . . . . . 0.48 ' OE1' ' OE2' ' A' ' 105' ' ' GLU . 26.9 tp10 -59.73 150.5 27.69 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 120.426 -1.421 . . . . 0.0 107.856 179.681 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 109' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -101.19 144.21 30.34 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 120.986 -1.072 . . . . 0.0 111.099 -178.169 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 110' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -62.63 -22.86 66.74 Favored 'General case' 0 C--N 1.303 -1.433 0 N-CA-C 108.684 -0.858 . . . . 0.0 108.684 179.214 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 111' ' ' ASP . . . . . . . . . . . . . 64.0 m-20 -132.04 40.36 3.35 Favored 'General case' 0 N--CA 1.487 1.376 0 O-C-N 121.642 -0.662 . . . . 0.0 109.426 -179.687 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 112' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -68.53 152.42 45.41 Favored 'General case' 0 C--N 1.299 -1.591 0 O-C-N 121.266 -0.896 . . . . 0.0 110.439 179.906 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 113' ' ' GLN . . . . . 0.433 ' HA ' ' NE2' ' A' ' 113' ' ' GLN . 1.0 OUTLIER -66.21 -13.78 60.86 Favored 'General case' 0 C--N 1.301 -1.525 0 N-CA-C 108.104 -1.073 . . . . 0.0 108.104 178.153 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 114' ' ' ASN . . . . . 0.492 ' OD1' ' O ' ' A' ' 169' ' ' LEU . 1.3 t-20 -151.58 102.27 2.86 Favored 'General case' 0 N--CA 1.489 1.515 0 N-CA-C 108.171 -1.048 . . . . 0.0 108.171 179.126 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 115' ' ' ILE . . . . . . . . . . . . . 3.1 mt -98.75 112.67 31.45 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.511 0 O-C-N 121.199 -0.938 . . . . 0.0 109.435 -179.772 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 116' ' ' SER . . . . . . . . . . . . . 44.1 m -98.56 143.91 28.45 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.316 -0.865 . . . . 0.0 111.338 -178.569 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 117' ' ' ILE . . . . . . . . . . . . . 1.6 mt -135.87 155.94 36.62 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.625 0 N-CA-C 108.111 -1.07 . . . . 0.0 108.111 178.764 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 118' ' ' ALA . . . . . . . . . . . . . . . -142.03 159.83 41.45 Favored 'General case' 0 N--CA 1.493 1.687 0 O-C-N 120.838 -1.163 . . . . 0.0 111.609 -178.967 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 119' ' ' GLY . . . . . . . . . . . . . . . -167.46 146.51 10.75 Favored Glycine 0 N--CA 1.49 2.235 0 C-N-CA 120.206 -0.997 . . . . 0.0 110.774 179.594 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 120' ' ' HIS . . . . . . . . . . . . . 27.7 m170 -70.96 167.7 18.56 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.638 -0.919 . . . . 0.0 109.251 178.964 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 121' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -122.62 157.26 32.57 Favored 'General case' 0 N--CA 1.495 1.788 0 N-CA-C 108.552 -0.907 . . . . 0.0 108.552 179.105 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 122' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -122.03 124.25 43.53 Favored 'General case' 0 N--CA 1.495 1.798 0 O-C-N 121.205 -0.935 . . . . 0.0 109.923 -179.754 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 123' ' ' ILE . . . . . . . . . . . . . 11.4 tt -72.96 -35.18 48.15 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.713 0 CA-C-O 121.69 0.757 . . . . 0.0 109.718 -179.923 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 124' ' ' ASP . . . . . . . . . . . . . 52.0 m-20 -90.6 8.29 34.91 Favored 'General case' 0 C--N 1.294 -1.814 0 C-N-CA 120.154 -0.618 . . . . 0.0 111.501 -178.928 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 125' ' ' ARG . . . . . . . . . . . . . 6.4 mtp180 -152.6 113.52 2.79 Favored Pre-proline 0 N--CA 1.495 1.823 0 O-C-N 120.474 -1.391 . . . . 0.0 110.531 -179.64 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 126' ' ' PRO . . . . . . . . . . . . . 78.8 Cg_endo -82.61 -16.9 7.65 Favored 'Trans proline' 0 N--CA 1.488 1.199 0 C-N-CA 122.436 2.091 . . . . 0.0 112.303 178.965 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 127' ' ' ASN . . . . . . . . . . . . . 83.8 m-20 -89.76 6.83 39.87 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.098 -1.001 . . . . 0.0 109.675 -179.885 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 128' ' ' TYR . . . . . . . . . . . . . 7.0 t80 -62.36 -148.86 0.0 OUTLIER 'General case' 0 N--CA 1.489 1.477 0 O-C-N 121.258 -0.901 . . . . 0.0 109.686 -179.975 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 129' ' ' GLN . . . . . 0.436 ' O ' ' OE2' ' A' ' 85' ' ' GLU . 17.6 mt-30 -67.88 -88.47 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.303 -0.873 . . . . 0.0 110.355 -179.149 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 130' ' ' PHE . . . . . 0.452 ' CE2' ' CG1' ' A' ' 101' ' ' VAL . 30.4 m-85 -110.88 37.26 2.85 Favored 'General case' 0 N--CA 1.494 1.77 0 O-C-N 121.326 -0.859 . . . . 0.0 110.303 -179.054 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 131' ' ' THR . . . . . . . . . . . . . 37.0 m -77.08 -31.69 56.2 Favored 'General case' 0 N--CA 1.489 1.486 0 O-C-N 121.045 -1.034 . . . . 0.0 109.464 179.701 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 132' ' ' ASN . . . . . 0.51 ' ND2' ' O ' ' A' ' 81' ' ' ALA . 3.9 t30 -83.78 7.01 19.18 Favored 'General case' 0 N--CA 1.498 1.968 0 O-C-N 121.387 -0.821 . . . . 0.0 111.033 -179.223 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 133' ' ' LEU . . . . . 0.597 ' O ' ' N ' ' A' ' 135' ' ' ALA . 0.2 OUTLIER -70.21 -45.25 66.97 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 120.971 -1.081 . . . . 0.0 110.218 -179.274 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 134' ' ' LYS . . . . . 0.72 ' NZ ' ' HG1' ' A' ' 183' ' ' THR . 0.2 OUTLIER -41.49 -18.98 0.01 OUTLIER 'General case' 0 N--CA 1.496 1.83 0 O-C-N 121.053 -1.029 . . . . 0.0 110.227 -179.212 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 135' ' ' ALA . . . . . 0.597 ' N ' ' O ' ' A' ' 133' ' ' LEU . . . -85.21 -31.49 23.15 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.082 -1.011 . . . . 0.0 110.038 179.854 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 136' ' ' ALA . . . . . 0.475 ' N ' ' O ' ' A' ' 133' ' ' LEU . . . -80.46 152.56 28.7 Favored 'General case' 0 N--CA 1.491 1.613 0 CA-C-O 122.055 0.931 . . . . 0.0 111.758 -178.437 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 137' ' ' LYS . . . . . 0.496 ' O ' ' O ' ' A' ' 138' ' ' LYS . 24.4 mtmt -151.63 -166.03 2.4 Favored 'General case' 0 N--CA 1.493 1.695 0 C-N-CA 118.597 -1.241 . . . . 0.0 111.004 -178.247 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 138' ' ' LYS . . . . . 0.598 ' O ' ' N ' ' A' ' 140' ' ' SER . 1.1 ptpt -45.21 178.71 0.0 OUTLIER 'General case' 0 C--N 1.305 -1.359 0 CA-C-O 122.127 0.965 . . . . 0.0 110.73 -179.074 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 139' ' ' GLY . . . . . . . . . . . . . . . 46.22 8.1 0.02 OUTLIER Glycine 0 N--CA 1.489 2.199 0 N-CA-C 110.407 -1.077 . . . . 0.0 110.407 179.98 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 140' ' ' SER . . . . . 0.598 ' N ' ' O ' ' A' ' 138' ' ' LYS . 13.3 t -80.55 146.21 31.4 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 120.845 -1.385 . . . . 0.0 109.514 179.366 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 141' ' ' MET . . . . . . . . . . . . . 4.6 tpt -93.46 121.16 34.57 Favored 'General case' 0 C--N 1.3 -1.561 0 O-C-N 121.343 -0.848 . . . . 0.0 108.849 179.409 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 142' ' ' VAL . . . . . . . . . . . . . 12.8 t -112.13 130.03 66.55 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.626 0 O-C-N 121.34 -0.85 . . . . 0.0 109.016 -179.396 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 143' ' ' TYR . . . . . . . . . . . . . 3.5 m-85 -109.16 135.55 50.1 Favored 'General case' 0 N--CA 1.499 1.976 0 O-C-N 121.141 -0.974 . . . . 0.0 111.859 -178.252 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 144' ' ' PHE . . . . . . . . . . . . . 57.8 t80 -120.61 102.06 8.17 Favored 'General case' 0 N--CA 1.494 1.744 0 CA-C-O 121.302 0.572 . . . . 0.0 110.272 -179.407 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 145' ' ' LYS . . . . . . . . . . . . . 23.1 tttt -93.8 122.4 36.23 Favored 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.331 -0.856 . . . . 0.0 109.602 179.799 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 146' ' ' VAL . . . . . . . . . . . . . 7.1 p -142.39 118.47 5.91 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.671 0 O-C-N 121.185 -0.947 . . . . 0.0 109.18 179.752 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 147' ' ' GLY . . . . . . . . . . . . . . . 75.61 -135.8 18.85 Favored Glycine 0 N--CA 1.488 2.132 0 N-CA-C 108.386 -1.885 . . . . 0.0 108.386 -179.094 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 148' ' ' ASN . . . . . 0.566 ' C ' HD21 ' A' ' 148' ' ' ASN . 0.3 OUTLIER -103.47 14.27 31.7 Favored 'General case' 0 C--N 1.298 -1.659 0 N-CA-C 107.907 -1.146 . . . . 0.0 107.907 178.813 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 149' ' ' GLU . . . . . . . . . . . . . 47.9 tt0 -116.26 153.23 32.27 Favored 'General case' 0 N--CA 1.486 1.361 0 CA-C-O 121.987 0.898 . . . . 0.0 110.639 -179.466 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 150' ' ' THR . . . . . . . . . . . . . 86.5 m -130.44 107.29 9.12 Favored 'General case' 0 N--CA 1.494 1.747 0 CA-C-O 121.336 0.589 . . . . 0.0 109.938 -179.701 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 151' ' ' ARG . . . . . 0.449 HH11 ' CG ' ' A' ' 151' ' ' ARG . 0.4 OUTLIER -87.28 -171.03 3.29 Favored 'General case' 0 N--CA 1.487 1.38 0 N-CA-C 108.641 -0.874 . . . . 0.0 108.641 179.826 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 152' ' ' LYS . . . . . 0.467 ' O ' ' N ' ' A' ' 205' ' ' VAL . 20.4 mtpt -148.21 149.04 31.22 Favored 'General case' 0 C--N 1.299 -1.605 0 O-C-N 121.153 -0.967 . . . . 0.0 109.841 -179.694 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 153' ' ' TYR . . . . . 0.495 ' CD2' ' HA ' ' A' ' 204' ' ' GLU . 23.2 m-85 -139.98 164.57 29.65 Favored 'General case' 0 C--N 1.302 -1.481 0 N-CA-C 108.107 -1.072 . . . . 0.0 108.107 179.86 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 154' ' ' LYS . . . . . . . . . . . . . 26.2 ttpt -142.44 119.27 11.19 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.143 -0.973 . . . . 0.0 109.006 179.517 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 155' ' ' MET . . . . . . . . . . . . . 19.5 mmt -46.01 105.96 0.07 Allowed 'General case' 0 N--CA 1.494 1.737 0 O-C-N 120.846 -1.159 . . . . 0.0 112.198 -178.63 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 156' ' ' THR . . . . . . . . . . . . . 4.4 m -108.6 -22.47 12.25 Favored 'General case' 0 C--N 1.297 -1.71 0 C-N-CA 119.897 -0.721 . . . . 0.0 109.666 179.709 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 157' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -144.56 141.02 29.17 Favored 'General case' 0 N--CA 1.492 1.642 0 C-N-CA 118.781 -1.167 . . . . 0.0 109.835 -178.742 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 158' ' ' ILE . . . . . . . . . . . . . 37.2 mt -148.02 134.25 12.42 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.372 0 CA-C-O 121.602 0.715 . . . . 0.0 109.82 -178.147 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 159' ' ' ARG . . . . . . . . . . . . . 3.9 ptm180 -154.63 -175.68 5.53 Favored 'General case' 0 C--N 1.297 -1.711 0 C-N-CA 119.486 -0.886 . . . . 0.0 110.536 -179.763 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 160' ' ' ASP . . . . . 0.405 ' C ' ' CG2' ' A' ' 161' ' ' VAL . 5.3 m-20 -146.48 165.1 30.42 Favored 'General case' 0 N--CA 1.488 1.452 0 N-CA-C 108.336 -0.987 . . . . 0.0 108.336 179.979 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 161' ' ' VAL . . . . . 0.405 ' CG2' ' C ' ' A' ' 160' ' ' ASP . 0.1 OUTLIER -170.1 163.28 0.45 Allowed 'Isoleucine or valine' 0 N--CA 1.494 1.768 0 O-C-N 120.909 -1.12 . . . . 0.0 110.281 179.842 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 162' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -49.47 171.23 0.12 Allowed Pre-proline 0 N--CA 1.488 1.473 0 O-C-N 121.599 -0.688 . . . . 0.0 109.39 179.271 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 163' ' ' PRO . . . . . . . . . . . . . 60.5 Cg_endo -79.21 38.65 0.74 Allowed 'Trans proline' 0 C--N 1.307 -1.618 0 C-N-CA 122.615 2.21 . . . . 0.0 112.49 -179.909 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 164' ' ' THR . . . . . . . . . . . . . 86.0 m -151.88 -8.82 0.21 Allowed 'General case' 0 N--CA 1.494 1.762 0 O-C-N 121.126 -0.984 . . . . 0.0 110.925 -179.732 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 165' ' ' ASP . . . . . 0.437 ' O ' ' C ' ' A' ' 166' ' ' VAL . 17.8 t70 -72.85 61.86 0.57 Allowed 'General case' 0 N--CA 1.494 1.755 0 O-C-N 120.764 -1.21 . . . . 0.0 110.235 -179.351 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 166' ' ' VAL . . . . . 0.61 ' O ' ' N ' ' A' ' 168' ' ' VAL . 1.5 m -39.91 -33.06 0.23 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.65 0 O-C-N 121.408 -0.808 . . . . 0.0 109.692 -178.587 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 167' ' ' GLY . . . . . 0.404 ' C ' ' O ' ' A' ' 166' ' ' VAL . . . -43.07 -13.84 0.01 OUTLIER Glycine 0 N--CA 1.495 2.579 0 O-C-N 120.918 -1.114 . . . . 0.0 110.823 -179.802 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 168' ' ' VAL . . . . . 0.671 ' C ' ' H ' ' A' ' 170' ' ' ASP . 4.8 m -53.34 -36.27 26.25 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.583 0 O-C-N 120.768 -1.43 . . . . 0.0 108.726 179.709 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 169' ' ' LEU . . . . . 0.544 ' O ' ' N ' ' A' ' 171' ' ' GLU . 34.4 mt -51.08 -4.6 0.02 OUTLIER 'General case' 0 N--CA 1.494 1.772 0 N-CA-C 108.117 -1.068 . . . . 0.0 108.117 -179.602 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 170' ' ' ASP . . . . . 0.671 ' H ' ' C ' ' A' ' 168' ' ' VAL . 4.1 m-20 33.41 28.92 0.0 OUTLIER 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.685 -0.634 . . . . 0.0 112.228 177.185 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 171' ' ' GLU . . . . . 0.544 ' N ' ' O ' ' A' ' 169' ' ' LEU . 11.2 pt-20 -67.31 94.46 0.38 Allowed 'General case' 0 N--CA 1.491 1.589 0 O-C-N 120.598 -1.314 . . . . 0.0 107.703 178.376 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 172' ' ' GLN . . . . . . . . . . . . . 0.7 OUTLIER -159.04 -72.75 0.08 Allowed 'General case' 0 N--CA 1.493 1.716 0 O-C-N 121.637 -0.665 . . . . 0.0 109.538 -179.449 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 173' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -62.15 127.07 29.62 Favored 'General case' 0 N--CA 1.492 1.668 0 O-C-N 121.265 -0.897 . . . . 0.0 109.195 179.627 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 174' ' ' GLY . . . . . 0.564 ' O ' ' C ' ' A' ' 175' ' ' LYS . . . -118.24 -39.06 0.76 Allowed Glycine 0 N--CA 1.482 1.733 0 N-CA-C 108.623 -1.791 . . . . 0.0 108.623 179.368 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 175' ' ' LYS . . . . . 0.564 ' C ' ' O ' ' A' ' 174' ' ' GLY . 0.0 OUTLIER -32.54 -62.97 0.22 Allowed 'General case' 0 N--CA 1.498 1.952 0 N-CA-C 108.492 -0.929 . . . . 0.0 108.492 179.822 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 176' ' ' ASP . . . . . 0.66 ' O ' ' O ' ' A' ' 177' ' ' LYS . 5.5 m-20 -103.09 87.01 2.8 Favored 'General case' 0 C--N 1.297 -1.712 0 N-CA-C 106.759 -1.571 . . . . 0.0 106.759 176.914 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 177' ' ' LYS . . . . . 0.66 ' O ' ' O ' ' A' ' 176' ' ' ASP . 12.9 mttt -37.28 176.04 0.0 OUTLIER 'General case' 0 N--CA 1.498 1.942 0 CA-C-O 121.762 0.791 . . . . 0.0 110.541 -178.703 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 178' ' ' GLN . . . . . 0.429 HE22 ' CB ' ' A' ' 170' ' ' ASP . 17.0 pt20 -159.59 171.07 20.3 Favored 'General case' 0 C--N 1.302 -1.459 0 C-N-CA 118.075 -1.45 . . . . 0.0 111.582 -179.867 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 179' ' ' LEU . . . . . . . . . . . . . 1.2 tp -127.02 95.17 4.23 Favored 'General case' 0 C--N 1.303 -1.443 0 N-CA-C 107.412 -1.329 . . . . 0.0 107.412 178.127 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 180' ' ' THR . . . . . . . . . . . . . 1.3 m -71.7 121.26 18.54 Favored 'General case' 0 N--CA 1.489 1.502 0 C-N-CA 119.217 -0.993 . . . . 0.0 110.213 -178.571 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 181' ' ' LEU . . . . . 0.406 HD13 ' H ' ' A' ' 182' ' ' ILE . 49.7 tp -96.24 147.72 23.48 Favored 'General case' 0 C--N 1.297 -1.693 0 N-CA-C 108.342 -0.984 . . . . 0.0 108.342 178.308 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 182' ' ' ILE . . . . . 0.406 ' H ' HD13 ' A' ' 181' ' ' LEU . 2.0 mt -138.73 115.09 10.19 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.578 0 N-CA-C 108.245 -1.02 . . . . 0.0 108.245 178.732 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 183' ' ' THR . . . . . 0.72 ' HG1' ' NZ ' ' A' ' 134' ' ' LYS . 0.0 OUTLIER -137.02 112.56 9.35 Favored 'General case' 0 C--N 1.293 -1.889 0 N-CA-C 107.265 -1.383 . . . . 0.0 107.265 179.364 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 184' ' ' CYS . . . . . 0.445 ' HB3' HH12 ' A' ' 197' ' ' ARG . 0.8 OUTLIER -78.69 163.71 25.2 Favored 'General case' 0 C--N 1.292 -1.918 0 C-N-CA 119.514 -0.874 . . . . 0.0 111.653 -177.14 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 185' ' ' ASP . . . . . . . . . . . . . 18.9 t0 -166.36 -159.4 0.37 Allowed 'General case' 0 N--CA 1.489 1.509 0 N-CA-C 109.205 -0.665 . . . . 0.0 109.205 -179.944 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 186' ' ' ASP . . . . . . . . . . . . . 1.3 m-20 53.84 59.62 4.17 Favored 'General case' 0 N--CA 1.493 1.724 0 O-C-N 121.121 -0.987 . . . . 0.0 109.546 179.933 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 187' ' ' TYR . . . . . 0.608 ' CE1' ' O ' ' A' ' 188' ' ' ASN . 57.0 t80 -67.67 137.77 55.81 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.319 -0.863 . . . . 0.0 110.398 -179.708 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 188' ' ' ASN . . . . . 0.608 ' O ' ' CE1' ' A' ' 187' ' ' TYR . 0.8 OUTLIER -104.41 145.02 30.86 Favored 'General case' 0 C--N 1.298 -1.672 0 N-CA-C 108.255 -1.017 . . . . 0.0 108.255 178.617 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 189' ' ' GLU . . . . . . . . . . . . . 1.4 tt0 -110.57 -13.17 14.27 Favored 'General case' 0 C--N 1.296 -1.744 0 N-CA-C 108.818 -0.808 . . . . 0.0 108.818 -179.36 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 190' ' ' LYS . . . . . . . . . . . . . 29.1 mttt -82.8 -53.66 5.72 Favored 'General case' 0 C--N 1.302 -1.496 0 N-CA-C 108.714 -0.847 . . . . 0.0 108.714 178.873 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 191' ' ' THR . . . . . . . . . . . . . 1.1 p -90.09 -10.76 43.53 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.517 -0.739 . . . . 0.0 109.194 179.714 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 192' ' ' GLY . . . . . . . . . . . . . . . 65.77 40.75 95.83 Favored Glycine 0 N--CA 1.495 2.59 0 N-CA-C 110.637 -0.985 . . . . 0.0 110.637 178.914 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 193' ' ' VAL . . . . . . . . . . . . . 64.8 t -147.63 161.61 7.55 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.641 0 O-C-N 121.023 -1.281 . . . . 0.0 109.565 179.487 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 194' ' ' TRP . . . . . 0.49 ' N ' ' CD1' ' A' ' 194' ' ' TRP . 19.4 m95 -83.71 118.42 23.87 Favored 'General case' 0 C--N 1.301 -1.537 0 N-CA-C 107.901 -1.148 . . . . 0.0 107.901 179.082 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 195' ' ' GLU . . . . . 0.551 ' CD ' ' ND2' ' A' ' 188' ' ' ASN . 2.3 mt-10 -85.17 -60.86 1.91 Allowed 'General case' 0 N--CA 1.492 1.665 0 O-C-N 121.241 -0.912 . . . . 0.0 111.112 -177.941 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 196' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER -78.63 149.18 32.96 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 120.935 -1.103 . . . . 0.0 109.731 -179.315 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 197' ' ' ARG . . . . . 0.581 ' CG ' HH11 ' A' ' 197' ' ' ARG . 0.0 OUTLIER -128.06 136.92 51.88 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.492 -0.755 . . . . 0.0 109.129 179.84 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 198' ' ' LYS . . . . . . . . . . . . . 2.3 mtmm -115.03 121.87 44.45 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.756 -0.59 . . . . 0.0 110.676 -178.623 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 199' ' ' ILE . . . . . 0.417 ' O ' ' CG1' ' A' ' 199' ' ' ILE . 0.9 OUTLIER -139.57 117.89 11.79 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.586 0 CA-C-O 122.477 1.132 . . . . 0.0 109.842 179.419 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 200' ' ' PHE . . . . . 0.526 ' CD1' ' N ' ' A' ' 200' ' ' PHE . 5.0 m-85 -98.88 136.11 39.35 Favored 'General case' 0 N--CA 1.498 1.948 0 O-C-N 121.322 -0.861 . . . . 0.0 110.262 -177.914 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 201' ' ' VAL . . . . . . . . . . . . . 24.2 t -105.12 141.33 20.72 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.76 0 O-C-N 121.032 -1.043 . . . . 0.0 108.777 178.13 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 202' ' ' ALA . . . . . . . . . . . . . . . -131.17 137.44 48.99 Favored 'General case' 0 C--N 1.3 -1.545 0 N-CA-C 108.429 -0.952 . . . . 0.0 108.429 179.874 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 203' ' ' THR . . . . . . . . . . . . . 2.5 t -88.41 136.06 33.17 Favored 'General case' 0 N--CA 1.489 1.515 0 CA-C-O 122.116 0.96 . . . . 0.0 110.568 -179.177 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 204' ' ' GLU . . . . . 0.495 ' HA ' ' CD2' ' A' ' 153' ' ' TYR . 0.8 OUTLIER -53.66 136.22 39.56 Favored 'General case' 0 C--N 1.295 -1.799 0 C-N-CA 118.133 -1.427 . . . . 0.0 108.706 179.014 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 205' ' ' VAL . . . . . 0.497 ' CG1' ' N ' ' A' ' 206' ' ' LYS . 77.7 t -129.99 166.41 27.66 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.34 0 CA-C-O 121.97 0.89 . . . . 0.0 110.063 -177.893 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 206' ' ' LYS . . . . . 0.497 ' N ' ' CG1' ' A' ' 205' ' ' VAL . 9.1 ptmt . . . . . 0 C--N 1.296 -1.752 0 CA-C-O 118.034 -0.984 . . . . 0.0 109.429 -179.836 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' C' C ' 702' ' ' LEU . . . . . 0.46 ' CD1' ' H ' ' C' ' 702' ' ' LEU . 0.1 OUTLIER . . . . . 0 N--CA 1.49 1.56 0 N-CA-C 108.757 -0.831 . . . . 0.0 108.757 . . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' C' C ' 703' ' ' PRO . . . . . . . . . . . . . 29.4 Cg_endo -66.39 -162.92 0.06 OUTLIER 'Trans proline' 0 N--CA 1.495 1.581 0 C-N-CA 122.59 2.194 . . . . 0.0 112.783 -179.224 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' C' C ' 704' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.488 1.456 0 O-C-N 121.476 -0.765 . . . . 0.0 109.356 -179.865 . . . . . . . . 0 0 . 1 . 006 nuclear orig core ' A' A ' 63' ' ' PRO . . . . . . . . . . . . . 9.9 Cg_endo . . . . . 0 N--CA 1.481 0.792 0 CA-C-O 121.21 0.421 . . . . 0.0 111.15 . . . . . . . . . 0 0 . 1 . 006 nuclear orig core ' A' A ' 64' ' ' GLN . . . . . 0.682 ' NE2' ' N ' ' A' ' 64' ' ' GLN . 0.0 OUTLIER -154.85 118.58 4.58 Favored 'General case' 0 N--CA 1.494 1.728 0 O-C-N 121.231 -0.918 . . . . 0.0 109.553 179.857 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 65' ' ' ILE . . . . . 0.401 HD11 ' H ' ' A' ' 65' ' ' ILE . 3.1 mp -46.58 106.4 0.57 Allowed Pre-proline 0 C--N 1.3 -1.548 0 O-C-N 121.316 -0.865 . . . . 0.0 108.773 179.197 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 66' ' ' PRO . . . . . . . . . . . . . 67.5 Cg_endo -86.51 -157.68 0.08 OUTLIER 'Trans proline' 0 C--N 1.314 -1.285 0 C-N-CA 122.487 2.125 . . . . 0.0 112.401 -179.224 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 67' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -82.88 -4.87 58.65 Favored 'General case' 0 C--N 1.302 -1.473 0 N-CA-C 108.838 -0.801 . . . . 0.0 108.838 179.528 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 68' ' ' ASP . . . . . 0.635 ' C ' ' N ' ' A' ' 70' ' ' SER . 0.3 OUTLIER -74.82 52.45 0.53 Allowed 'General case' 0 N--CA 1.488 1.425 0 CA-C-O 122.726 1.251 . . . . 0.0 108.444 179.492 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 69' ' ' LYS . . . . . 0.445 ' C ' ' O ' ' A' ' 68' ' ' ASP . 21.0 mtmt -49.48 -13.94 0.09 Allowed 'General case' 0 N--CA 1.502 2.173 0 C-N-CA 116.798 -1.961 . . . . 0.0 106.551 177.94 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 70' ' ' SER . . . . . 0.635 ' N ' ' C ' ' A' ' 68' ' ' ASP . 0.1 OUTLIER -85.48 -6.56 59.18 Favored 'General case' 0 N--CA 1.493 1.68 0 CA-C-N 113.508 -1.678 . . . . 0.0 110.601 179.285 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 71' ' ' LYS . . . . . 0.409 ' HZ1' ' HA ' ' A' ' 73' ' ' ALA . 2.0 ptmm? -101.2 144.62 29.84 Favored 'General case' 0 N--CA 1.498 1.942 0 O-C-N 120.863 -1.148 . . . . 0.0 111.888 -179.395 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 72' ' ' VAL . . . . . 0.602 ' CG2' ' O ' ' A' ' 74' ' ' GLY . 0.7 OUTLIER -67.26 132.95 32.16 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.364 0 N-CA-C 105.49 -2.041 . . . . 0.0 105.49 174.363 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 73' ' ' ALA . . . . . 0.409 ' HA ' ' HZ1' ' A' ' 71' ' ' LYS . . . -83.77 -13.78 53.07 Favored 'General case' 0 C--N 1.297 -1.71 0 O-C-N 120.026 -1.671 . . . . 0.0 108.618 -179.183 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 74' ' ' GLY . . . . . 0.602 ' O ' ' CG2' ' A' ' 72' ' ' VAL . . . 173.29 -159.63 29.83 Favored Glycine 0 N--CA 1.487 2.086 0 N-CA-C 109.459 -1.456 . . . . 0.0 109.459 -179.805 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 75' ' ' TYR . . . . . . . . . . . . . 81.1 m-85 -140.12 169.9 16.83 Favored 'General case' 0 C--N 1.297 -1.689 0 O-C-N 121.02 -1.282 . . . . 0.0 111.354 -178.334 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 76' ' ' ILE . . . . . . . . . . . . . 1.3 tp -145.9 138.72 20.63 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.605 0 C-N-CA 119.376 -0.93 . . . . 0.0 109.235 -176.165 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -149.46 162.53 39.94 Favored 'General case' 0 C--N 1.302 -1.474 0 O-C-N 120.899 -1.126 . . . . 0.0 109.804 -179.606 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 78' ' ' ILE . . . . . 0.419 ' O ' ' N ' ' A' ' 82' ' ' ASP . 4.5 mt -147.74 99.54 3.79 Favored Pre-proline 0 N--CA 1.488 1.455 0 N-CA-C 108.421 -0.955 . . . . 0.0 108.421 179.879 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 79' ' ' PRO . . . . . . . . . . . . . 52.6 Cg_exo -49.81 -45.76 30.64 Favored 'Trans proline' 0 N--CA 1.493 1.483 0 C-N-CA 122.57 2.18 . . . . 0.0 113.464 -178.826 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 7.9 m-20 -66.04 -19.65 65.92 Favored 'General case' 0 N--CA 1.492 1.656 0 O-C-N 120.944 -1.098 . . . . 0.0 110.924 178.81 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 81' ' ' ALA . . . . . 0.602 ' O ' ' ND2' ' A' ' 132' ' ' ASN . . . -105.01 -16.55 14.78 Favored 'General case' 0 N--CA 1.494 1.754 0 O-C-N 121.093 -1.005 . . . . 0.0 108.46 179.329 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 82' ' ' ASP . . . . . 0.419 ' N ' ' O ' ' A' ' 78' ' ' ILE . 0.6 OUTLIER 66.22 50.58 1.35 Allowed 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.385 -0.822 . . . . 0.0 110.434 179.191 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 83' ' ' ILE . . . . . 0.506 ' CD1' ' OD1' ' A' ' 132' ' ' ASN . 62.0 mt -129.42 151.97 36.59 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.788 0 O-C-N 121.09 -1.006 . . . . 0.0 110.481 -178.848 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 84' ' ' LYS . . . . . 0.491 ' N ' ' OE2' ' A' ' 85' ' ' GLU . 9.2 tttm -159.15 109.59 1.99 Allowed 'General case' 0 N--CA 1.487 1.38 0 N-CA-C 108.08 -1.081 . . . . 0.0 108.08 179.777 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 85' ' ' GLU . . . . . 0.491 ' OE2' ' N ' ' A' ' 84' ' ' LYS . 0.7 OUTLIER -144.05 171.85 6.26 Favored Pre-proline 0 N--CA 1.495 1.811 0 C-N-CA 119.858 -0.737 . . . . 0.0 109.874 -179.491 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 86' ' ' PRO . . . . . . . . . . . . . 68.7 Cg_endo -91.0 148.95 3.82 Favored 'Trans proline' 0 N--CA 1.488 1.19 0 C-N-CA 123.126 2.551 . . . . 0.0 112.963 -179.751 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 87' ' ' VAL . . . . . 0.428 ' CG2' ' C ' ' A' ' 74' ' ' GLY . 0.0 OUTLIER -104.91 106.03 19.72 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.576 0 N-CA-C 108.619 -0.882 . . . . 0.0 108.619 178.669 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 88' ' ' TYR . . . . . . . . . . . . . 13.7 m-85 -87.55 135.0 34.73 Favored Pre-proline 0 N--CA 1.492 1.648 0 O-C-N 120.95 -1.094 . . . . 0.0 110.37 -178.964 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 89' ' ' PRO . . . . . . . . . . . . . 20.2 Cg_exo -34.34 138.15 0.1 OUTLIER 'Trans proline' 0 N--CA 1.49 1.291 0 C-N-CA 123.253 2.635 . . . . 0.0 113.714 179.982 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . -58.87 167.26 7.04 Favored Glycine 0 N--CA 1.491 2.331 0 N-CA-C 109.546 -1.422 . . . . 0.0 109.546 179.679 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 91' ' ' PRO . . . . . 0.514 ' C ' ' H ' ' A' ' 93' ' ' THR . 57.5 Cg_endo -92.46 170.39 21.96 Favored 'Cis proline' 0 C--N 1.307 -1.625 0 C-N-CA 123.659 -1.392 . . . . 0.0 111.94 0.654 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 92' ' ' ALA . . . . . . . . . . . . . . . -70.32 29.38 0.04 OUTLIER 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.253 -0.904 . . . . 0.0 110.54 -179.327 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 93' ' ' THR . . . . . 0.514 ' H ' ' C ' ' A' ' 91' ' ' PRO . 0.8 OUTLIER -72.8 154.55 91.13 Favored Pre-proline 0 N--CA 1.492 1.644 0 O-C-N 120.764 -1.21 . . . . 0.0 109.131 -179.678 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 94' ' ' PRO . . . . . 0.451 ' O ' ' C ' ' A' ' 95' ' ' GLU . 80.5 Cg_exo -30.82 -61.79 0.13 Allowed 'Trans proline' 0 C--N 1.308 -1.574 0 C-N-CA 123.058 2.505 . . . . 0.0 112.567 -179.144 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 95' ' ' GLU . . . . . 0.451 ' C ' ' O ' ' A' ' 94' ' ' PRO . 0.3 OUTLIER -41.67 -48.23 4.09 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.288 -0.882 . . . . 0.0 109.258 179.882 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 96' ' ' GLN . . . . . 0.685 HE21 ' NH1' ' A' ' 99' ' ' ARG . 0.4 OUTLIER -73.6 -59.54 2.67 Favored 'General case' 0 N--CA 1.487 1.391 0 O-C-N 121.221 -0.924 . . . . 0.0 109.934 179.591 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 97' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -45.07 -13.37 0.02 OUTLIER 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.319 -0.863 . . . . 0.0 109.413 -179.393 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 98' ' ' ASN . . . . . 0.606 ' N ' ' O ' ' A' ' 96' ' ' GLN . 0.0 OUTLIER -73.58 -26.19 60.7 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.329 -0.857 . . . . 0.0 109.841 -179.995 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 99' ' ' ARG . . . . . 0.685 ' NH1' HE21 ' A' ' 96' ' ' GLN . 1.7 mpt_? -95.33 -45.58 7.08 Favored 'General case' 0 N--CA 1.488 1.454 0 O-C-N 121.396 -0.815 . . . . 0.0 110.048 -178.959 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . 169.99 -174.13 44.12 Favored Glycine 0 N--CA 1.494 2.537 0 C-N-CA 119.517 -1.325 . . . . 0.0 110.238 179.737 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 101' ' ' VAL . . . . . 0.497 ' O ' ' CG2' ' A' ' 101' ' ' VAL . 19.5 m -50.17 106.34 0.06 OUTLIER 'Isoleucine or valine' 0 N--CA 1.493 1.711 0 O-C-N 121.401 -1.058 . . . . 0.0 109.218 179.765 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -92.88 169.68 10.26 Favored 'General case' 0 N--CA 1.494 1.729 0 O-C-N 121.213 -0.93 . . . . 0.0 110.885 -179.306 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 103' ' ' PHE . . . . . 0.553 ' O ' ' N ' ' A' ' 105' ' ' GLU . 23.1 m-85 -69.52 120.83 15.9 Favored 'General case' 0 N--CA 1.487 1.404 0 N-CA-C 107.957 -1.127 . . . . 0.0 107.957 178.192 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 104' ' ' ALA . . . . . . . . . . . . . . . -46.85 -9.78 0.02 OUTLIER 'General case' 0 C--N 1.301 -1.529 0 O-C-N 121.335 -0.853 . . . . 0.0 110.852 -178.882 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 105' ' ' GLU . . . . . 0.553 ' N ' ' O ' ' A' ' 103' ' ' PHE . 0.1 OUTLIER -140.28 143.8 36.09 Favored 'General case' 0 N--CA 1.496 1.862 0 O-C-N 120.811 -1.181 . . . . 0.0 110.648 -179.786 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 106' ' ' GLU . . . . . . . . . . . . . 27.6 tt0 -59.42 -64.03 1.09 Allowed 'General case' 0 N--CA 1.489 1.502 0 CA-C-N 116.216 -0.447 . . . . 0.0 111.625 -178.892 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 107' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER -78.66 35.56 0.24 Allowed 'General case' 0 N--CA 1.491 1.604 0 O-C-N 120.661 -1.274 . . . . 0.0 112.672 -175.723 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 108' ' ' GLU . . . . . . . . . . . . . 2.0 tp10 -56.67 149.59 17.48 Favored 'General case' 0 N--CA 1.489 1.513 0 O-C-N 120.323 -1.486 . . . . 0.0 107.741 179.779 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 109' ' ' SER . . . . . 0.572 ' HG ' ' CG ' ' A' ' 112' ' ' ASP . 0.7 OUTLIER -100.95 145.0 29.21 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 120.9 -1.125 . . . . 0.0 110.818 -178.261 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 110' ' ' LEU . . . . . 0.436 ' C ' ' OD1' ' A' ' 111' ' ' ASP . 0.2 OUTLIER -61.03 -24.62 66.32 Favored 'General case' 0 C--N 1.306 -1.317 0 N-CA-C 108.199 -1.037 . . . . 0.0 108.199 179.213 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 111' ' ' ASP . . . . . 0.436 ' OD1' ' C ' ' A' ' 110' ' ' LEU . 2.7 m-20 -132.37 45.1 2.8 Favored 'General case' 0 C--N 1.302 -1.463 0 N-CA-C 109.208 -0.664 . . . . 0.0 109.208 179.63 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 112' ' ' ASP . . . . . 0.572 ' CG ' ' HG ' ' A' ' 109' ' ' SER . 1.3 t0 -68.06 155.32 39.8 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.346 -0.846 . . . . 0.0 111.094 -179.638 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 113' ' ' GLN . . . . . 0.59 HE22 ' N ' ' A' ' 172' ' ' GLN . 0.0 OUTLIER -67.06 -17.15 64.77 Favored 'General case' 0 N--CA 1.488 1.456 0 N-CA-C 108.137 -1.06 . . . . 0.0 108.137 177.613 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 114' ' ' ASN . . . . . 0.55 ' OD1' ' NE2' ' A' ' 178' ' ' GLN . 2.3 t30 -151.48 105.35 3.16 Favored 'General case' 0 C--N 1.295 -1.79 0 N-CA-C 107.654 -1.239 . . . . 0.0 107.654 179.528 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 115' ' ' ILE . . . . . . . . . . . . . 3.1 mt -93.6 104.44 15.75 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.711 0 O-C-N 120.675 -1.265 . . . . 0.0 107.916 179.95 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 116' ' ' SER . . . . . 0.438 ' OG ' ' ND2' ' A' ' 114' ' ' ASN . 18.5 m -87.3 147.32 25.56 Favored 'General case' 0 C--N 1.304 -1.382 0 CA-C-O 121.861 0.838 . . . . 0.0 110.988 -177.962 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 117' ' ' ILE . . . . . . . . . . . . . 2.5 mt -142.05 151.3 18.64 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.438 0 N-CA-C 107.897 -1.149 . . . . 0.0 107.897 179.449 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 118' ' ' ALA . . . . . . . . . . . . . . . -142.81 157.15 44.9 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 120.964 -1.085 . . . . 0.0 111.025 -179.026 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 119' ' ' GLY . . . . . . . . . . . . . . . -163.96 145.01 9.94 Favored Glycine 0 N--CA 1.486 1.997 0 N-CA-C 109.889 -1.285 . . . . 0.0 109.889 179.49 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 120' ' ' HIS . . . . . . . . . . . . . 26.5 m170 -70.49 168.49 16.1 Favored 'General case' 0 N--CA 1.493 1.681 0 O-C-N 121.574 -0.957 . . . . 0.0 109.64 179.357 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 121' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -120.67 149.2 42.86 Favored 'General case' 0 N--CA 1.494 1.735 0 O-C-N 121.234 -0.916 . . . . 0.0 108.728 179.035 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 122' ' ' PHE . . . . . . . . . . . . . 0.5 OUTLIER -112.37 140.13 47.35 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.199 -0.938 . . . . 0.0 109.359 179.805 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 123' ' ' ILE . . . . . 0.459 ' CG2' ' N ' ' A' ' 124' ' ' ASP . 16.0 tt -88.57 -37.88 10.85 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.793 0 N-CA-C 108.509 -0.923 . . . . 0.0 108.509 179.631 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 124' ' ' ASP . . . . . 0.459 ' N ' ' CG2' ' A' ' 123' ' ' ILE . 4.9 p-10 -94.37 19.07 10.04 Favored 'General case' 0 C--N 1.296 -1.735 0 C-N-CA 120.121 -0.632 . . . . 0.0 110.633 -179.548 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 125' ' ' ARG . . . . . 0.653 HH11 ' CG ' ' A' ' 125' ' ' ARG . 0.0 OUTLIER -156.35 108.42 2.05 Favored Pre-proline 0 N--CA 1.49 1.55 0 O-C-N 120.628 -1.295 . . . . 0.0 110.348 -179.049 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 126' ' ' PRO . . . . . . . . . . . . . 90.1 Cg_endo -82.55 -22.19 4.75 Favored 'Trans proline' 0 C--N 1.316 -1.181 0 C-N-CA 122.222 1.948 . . . . 0.0 111.953 179.522 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 127' ' ' ASN . . . . . 0.421 ' OD1' ' NH1' ' A' ' 125' ' ' ARG . 1.1 p30 -89.17 29.04 1.11 Allowed 'General case' 0 N--CA 1.489 1.502 0 O-C-N 121.188 -0.945 . . . . 0.0 109.331 179.97 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 128' ' ' TYR . . . . . . . . . . . . . 9.7 t80 -86.12 -149.18 0.13 Allowed 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.269 -0.894 . . . . 0.0 109.922 -179.64 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 129' ' ' GLN . . . . . . . . . . . . . 32.4 mt-30 -67.72 -69.31 0.32 Allowed 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.371 -0.831 . . . . 0.0 110.746 -178.838 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 130' ' ' PHE . . . . . 0.452 ' CE2' ' CG1' ' A' ' 101' ' ' VAL . 50.0 m-85 -129.83 28.66 5.08 Favored 'General case' 0 N--CA 1.496 1.841 0 O-C-N 121.14 -0.975 . . . . 0.0 110.613 -179.405 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 131' ' ' THR . . . . . 0.453 ' C ' ' HZ1' ' A' ' 134' ' ' LYS . 94.6 m -67.8 -34.5 76.89 Favored 'General case' 0 N--CA 1.493 1.717 0 O-C-N 120.79 -1.194 . . . . 0.0 108.968 179.37 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 132' ' ' ASN . . . . . 0.602 ' ND2' ' O ' ' A' ' 81' ' ' ALA . 2.4 p-10 -91.11 13.59 16.48 Favored 'General case' 0 N--CA 1.494 1.752 0 C-N-CA 119.608 -0.837 . . . . 0.0 111.285 -179.665 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 133' ' ' LEU . . . . . 0.595 ' O ' ' N ' ' A' ' 135' ' ' ALA . 0.2 OUTLIER -71.82 -42.74 66.65 Favored 'General case' 0 N--CA 1.492 1.668 0 O-C-N 120.571 -1.331 . . . . 0.0 110.266 -179.038 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 134' ' ' LYS . . . . . 0.564 ' H ' ' CD ' ' A' ' 134' ' ' LYS . 0.0 OUTLIER -44.44 -12.77 0.02 OUTLIER 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.165 -0.959 . . . . 0.0 110.402 -179.263 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 135' ' ' ALA . . . . . 0.595 ' N ' ' O ' ' A' ' 133' ' ' LEU . . . -82.77 -37.98 23.82 Favored 'General case' 0 N--CA 1.489 1.513 0 O-C-N 120.761 -1.212 . . . . 0.0 109.855 -179.829 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 136' ' ' ALA . . . . . 0.415 ' C ' ' CG ' ' A' ' 137' ' ' LYS . . . -78.55 153.38 31.28 Favored 'General case' 0 C--N 1.302 -1.496 0 O-C-N 121.352 -0.843 . . . . 0.0 111.111 -178.741 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 137' ' ' LYS . . . . . 0.519 ' O ' ' O ' ' A' ' 138' ' ' LYS . 0.4 OUTLIER -151.38 -163.69 1.82 Allowed 'General case' 0 N--CA 1.492 1.661 0 C-N-CA 118.479 -1.288 . . . . 0.0 110.744 -178.07 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 138' ' ' LYS . . . . . 0.585 ' O ' ' N ' ' A' ' 140' ' ' SER . 0.2 OUTLIER -46.3 -179.29 0.0 OUTLIER 'General case' 0 C--N 1.304 -1.4 0 CA-C-O 122.145 0.974 . . . . 0.0 110.508 -179.043 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 139' ' ' GLY . . . . . . . . . . . . . . . 46.87 7.77 0.02 OUTLIER Glycine 0 N--CA 1.49 2.284 0 N-CA-C 110.354 -1.098 . . . . 0.0 110.354 -179.848 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 140' ' ' SER . . . . . 0.585 ' N ' ' O ' ' A' ' 138' ' ' LYS . 39.2 m -84.56 130.53 34.73 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 120.926 -1.338 . . . . 0.0 109.517 179.412 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 141' ' ' MET . . . . . 0.639 ' SD ' ' N ' ' A' ' 142' ' ' VAL . 8.7 tpp -83.9 127.25 33.71 Favored 'General case' 0 N--CA 1.488 1.446 0 O-C-N 121.074 -1.016 . . . . 0.0 108.978 179.523 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 142' ' ' VAL . . . . . 0.639 ' N ' ' SD ' ' A' ' 141' ' ' MET . 2.4 t -111.25 133.38 57.0 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.512 0 N-CA-C 108.586 -0.894 . . . . 0.0 108.586 -179.744 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 143' ' ' TYR . . . . . . . . . . . . . 8.1 m-85 -111.05 135.29 51.79 Favored 'General case' 0 N--CA 1.495 1.802 0 O-C-N 120.822 -1.174 . . . . 0.0 111.124 -178.511 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 144' ' ' PHE . . . . . . . . . . . . . 10.3 t80 -120.17 104.57 10.19 Favored 'General case' 0 N--CA 1.493 1.7 0 C-N-CA 120.081 -0.648 . . . . 0.0 110.139 -179.748 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 145' ' ' LYS . . . . . . . . . . . . . 14.3 ttmm -99.64 128.12 45.74 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.135 -0.978 . . . . 0.0 110.556 -179.487 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 146' ' ' VAL . . . . . 0.432 ' O ' ' C ' ' A' ' 147' ' ' GLY . 0.6 OUTLIER -142.7 146.15 22.36 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.568 0 N-CA-C 107.438 -1.319 . . . . 0.0 107.438 178.695 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 147' ' ' GLY . . . . . 0.432 ' C ' ' O ' ' A' ' 146' ' ' VAL . . . 45.8 -131.82 9.93 Favored Glycine 0 N--CA 1.487 2.046 0 N-CA-C 108.465 -1.854 . . . . 0.0 108.465 -179.222 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 148' ' ' ASN . . . . . 0.516 ' C ' HD21 ' A' ' 148' ' ' ASN . 0.4 OUTLIER -104.2 18.07 22.83 Favored 'General case' 0 C--N 1.301 -1.532 0 O-C-N 121.307 -1.113 . . . . 0.0 108.602 179.077 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 149' ' ' GLU . . . . . . . . . . . . . 14.4 tt0 -112.22 147.03 37.08 Favored 'General case' 0 N--CA 1.49 1.557 0 CA-C-O 121.817 0.818 . . . . 0.0 111.328 -178.263 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 150' ' ' THR . . . . . . . . . . . . . 1.4 m -131.79 103.97 6.63 Favored 'General case' 0 N--CA 1.491 1.586 0 CA-C-O 121.579 0.704 . . . . 0.0 109.832 179.796 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 151' ' ' ARG . . . . . 0.477 ' NH2' ' OH ' ' A' ' 153' ' ' TYR . 21.4 mtm180 -88.2 -170.97 3.18 Favored 'General case' 0 N--CA 1.488 1.439 0 N-CA-C 109.134 -0.691 . . . . 0.0 109.134 -179.877 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 152' ' ' LYS . . . . . 0.405 ' C ' ' CD1' ' A' ' 153' ' ' TYR . 40.4 mtmt -150.86 149.26 29.47 Favored 'General case' 0 N--CA 1.489 1.496 0 O-C-N 120.968 -1.083 . . . . 0.0 110.258 -179.574 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 153' ' ' TYR . . . . . 0.578 ' O ' ' SD ' ' A' ' 141' ' ' MET . 15.9 m-85 -141.18 165.77 26.62 Favored 'General case' 0 N--CA 1.489 1.518 0 N-CA-C 107.715 -1.217 . . . . 0.0 107.715 179.224 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 154' ' ' LYS . . . . . . . . . . . . . 5.3 ttmm -141.32 115.85 9.56 Favored 'General case' 0 C--N 1.297 -1.699 0 O-C-N 120.959 -1.088 . . . . 0.0 108.628 179.29 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 155' ' ' MET . . . . . . . . . . . . . 4.6 mtt -43.65 106.16 0.06 Allowed 'General case' 0 N--CA 1.492 1.649 0 O-C-N 120.741 -1.224 . . . . 0.0 111.548 -178.662 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 156' ' ' THR . . . . . 0.489 ' OG1' ' CG2' ' A' ' 203' ' ' THR . 0.6 OUTLIER -109.08 -23.18 11.79 Favored 'General case' 0 C--N 1.292 -1.896 0 CA-C-N 115.267 -0.879 . . . . 0.0 109.894 -179.514 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 157' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -153.14 151.45 30.16 Favored 'General case' 0 C--N 1.297 -1.713 0 C-N-CA 118.493 -1.283 . . . . 0.0 111.431 -178.598 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 158' ' ' ILE . . . . . 0.436 ' CD1' ' CE2' ' A' ' 200' ' ' PHE . 0.2 OUTLIER -152.43 145.13 15.6 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.295 0 CA-C-O 121.708 0.766 . . . . 0.0 110.132 -179.148 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 159' ' ' ARG . . . . . . . . . . . . . 66.2 ttt180 -152.69 149.22 28.18 Favored 'General case' 0 C--N 1.299 -1.614 0 CA-C-O 121.882 0.848 . . . . 0.0 111.089 -178.866 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 160' ' ' ASP . . . . . 0.414 ' C ' ' CG2' ' A' ' 161' ' ' VAL . 5.9 m-20 -119.1 161.51 20.18 Favored 'General case' 0 N--CA 1.49 1.528 0 N-CA-C 108.567 -0.901 . . . . 0.0 108.567 179.349 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 161' ' ' VAL . . . . . 0.515 ' O ' ' O ' ' A' ' 162' ' ' LYS . 0.1 OUTLIER -173.13 164.55 0.26 Allowed 'Isoleucine or valine' 0 N--CA 1.501 2.096 0 O-C-N 121.097 -1.002 . . . . 0.0 109.82 179.463 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 162' ' ' LYS . . . . . 0.515 ' O ' ' O ' ' A' ' 161' ' ' VAL . 0.1 OUTLIER -42.83 168.1 0.06 OUTLIER Pre-proline 0 N--CA 1.491 1.603 0 O-C-N 121.152 -0.968 . . . . 0.0 109.062 179.121 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 163' ' ' PRO . . . . . 0.567 ' O ' ' CD1' ' C' ' 702' ' ' LEU . 57.4 Cg_endo -74.86 -20.41 17.24 Favored 'Trans proline' 0 C--N 1.306 -1.708 0 C-N-CA 122.697 2.264 . . . . 0.0 112.899 -179.294 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 164' ' ' THR . . . . . . . . . . . . . 1.1 p -90.87 -3.1 57.61 Favored 'General case' 0 C--N 1.297 -1.688 0 O-C-N 120.48 -1.387 . . . . 0.0 109.995 -179.644 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 165' ' ' ASP . . . . . . . . . . . . . 11.4 t70 -71.89 58.47 0.34 Allowed 'General case' 0 N--CA 1.491 1.622 0 O-C-N 120.856 -1.153 . . . . 0.0 109.709 -179.543 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 166' ' ' VAL . . . . . 0.551 ' O ' ' N ' ' A' ' 168' ' ' VAL . 1.5 m -44.25 -32.34 0.77 Allowed 'Isoleucine or valine' 0 C--N 1.297 -1.707 0 O-C-N 121.692 -0.63 . . . . 0.0 109.784 -178.339 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 167' ' ' GLY . . . . . . . . . . . . . . . -43.52 -15.4 0.03 OUTLIER Glycine 0 N--CA 1.496 2.688 0 O-C-N 120.83 -1.169 . . . . 0.0 111.356 -179.517 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 168' ' ' VAL . . . . . 0.551 ' C ' ' H ' ' A' ' 170' ' ' ASP . 2.8 m -54.24 -31.52 22.24 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.605 0 O-C-N 120.581 -1.54 . . . . 0.0 109.082 -179.839 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 169' ' ' LEU . . . . . 0.549 ' O ' ' C ' ' A' ' 170' ' ' ASP . 15.8 mt -48.32 -14.93 0.06 Allowed 'General case' 0 N--CA 1.492 1.64 0 N-CA-C 107.748 -1.204 . . . . 0.0 107.748 -178.713 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 170' ' ' ASP . . . . . 0.551 ' H ' ' C ' ' A' ' 168' ' ' VAL . 9.0 m-20 20.62 91.05 0.01 OUTLIER 'General case' 0 N--CA 1.499 2.002 0 CA-C-N 116.583 -0.28 . . . . 0.0 111.701 177.769 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 171' ' ' GLU . . . . . . . . . . . . . 5.9 pt-20 -137.49 77.21 1.62 Allowed 'General case' 0 N--CA 1.495 1.777 0 O-C-N 120.863 -1.148 . . . . 0.0 110.536 179.782 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 172' ' ' GLN . . . . . 0.59 ' N ' HE22 ' A' ' 113' ' ' GLN . 1.9 pt20 -136.87 -42.32 0.59 Allowed 'General case' 0 N--CA 1.495 1.824 0 O-C-N 121.209 -0.932 . . . . 0.0 110.76 -178.988 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 173' ' ' LYS . . . . . . . . . . . . . 5.8 mttp -63.23 129.29 39.65 Favored 'General case' 0 N--CA 1.497 1.892 0 O-C-N 120.688 -1.258 . . . . 0.0 108.854 179.522 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 174' ' ' GLY . . . . . 0.544 ' O ' ' C ' ' A' ' 175' ' ' LYS . . . -118.78 -41.07 0.62 Allowed Glycine 0 N--CA 1.484 1.896 0 N-CA-C 108.605 -1.798 . . . . 0.0 108.605 179.478 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 175' ' ' LYS . . . . . 0.544 ' C ' ' O ' ' A' ' 174' ' ' GLY . 17.9 mmtp -40.8 -61.85 0.89 Allowed 'General case' 0 N--CA 1.491 1.577 0 N-CA-C 106.503 -1.666 . . . . 0.0 106.503 178.48 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 176' ' ' ASP . . . . . 0.583 ' O ' ' O ' ' A' ' 177' ' ' LYS . 7.0 m-20 -105.07 85.64 2.31 Favored 'General case' 0 C--N 1.296 -1.734 0 N-CA-C 107.332 -1.359 . . . . 0.0 107.332 176.405 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 177' ' ' LYS . . . . . 0.583 ' O ' ' O ' ' A' ' 176' ' ' ASP . 0.0 OUTLIER -46.98 -174.41 0.0 OUTLIER 'General case' 0 N--CA 1.501 2.09 0 O-C-N 121.311 -0.868 . . . . 0.0 109.291 -179.233 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 178' ' ' GLN . . . . . 0.55 ' NE2' ' OD1' ' A' ' 114' ' ' ASN . 20.8 pt20 -162.01 175.13 12.12 Favored 'General case' 0 N--CA 1.488 1.456 0 O-C-N 120.328 -1.483 . . . . 0.0 111.374 -179.884 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 179' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -129.8 93.75 3.58 Favored 'General case' 0 N--CA 1.487 1.403 0 N-CA-C 107.197 -1.408 . . . . 0.0 107.197 177.627 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 180' ' ' THR . . . . . . . . . . . . . 1.8 m -71.28 118.45 14.09 Favored 'General case' 0 N--CA 1.493 1.704 0 O-C-N 121.11 -0.994 . . . . 0.0 110.424 -178.335 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 181' ' ' LEU . . . . . . . . . . . . . 42.4 tp -94.11 150.5 20.27 Favored 'General case' 0 C--N 1.298 -1.648 0 N-CA-C 107.817 -1.179 . . . . 0.0 107.817 177.81 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 182' ' ' ILE . . . . . . . . . . . . . 5.3 mt -141.54 112.89 3.55 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.553 0 O-C-N 121.011 -1.055 . . . . 0.0 108.695 178.717 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 183' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -130.58 111.38 12.18 Favored 'General case' 0 C--N 1.291 -1.953 0 N-CA-C 107.078 -1.453 . . . . 0.0 107.078 178.95 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 184' ' ' CYS . . . . . . . . . . . . . 1.8 p -78.82 159.36 27.88 Favored 'General case' 0 C--N 1.29 -1.98 0 C-N-CA 118.843 -1.143 . . . . 0.0 111.46 -177.345 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 185' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -165.73 -154.88 0.21 Allowed 'General case' 0 N--CA 1.49 1.566 0 N-CA-C 109.102 -0.703 . . . . 0.0 109.102 -179.699 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 186' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER 50.61 52.14 15.47 Favored 'General case' 0 N--CA 1.493 1.695 0 O-C-N 121.124 -0.985 . . . . 0.0 109.12 -179.848 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 187' ' ' TYR . . . . . 0.618 ' CE2' ' O ' ' A' ' 188' ' ' ASN . 54.4 t80 -67.37 136.59 55.01 Favored 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.342 -0.849 . . . . 0.0 110.777 -179.144 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 188' ' ' ASN . . . . . 0.618 ' O ' ' CE2' ' A' ' 187' ' ' TYR . 0.7 OUTLIER -101.56 146.8 27.19 Favored 'General case' 0 C--N 1.298 -1.641 0 N-CA-C 107.777 -1.194 . . . . 0.0 107.777 178.314 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 189' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -113.53 -10.16 13.2 Favored 'General case' 0 C--N 1.297 -1.697 0 N-CA-C 108.496 -0.928 . . . . 0.0 108.496 -179.624 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 190' ' ' LYS . . . . . . . . . . . . . 13.1 mttp -84.03 -53.48 5.52 Favored 'General case' 0 N--CA 1.488 1.459 0 N-CA-C 108.649 -0.871 . . . . 0.0 108.649 178.705 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 191' ' ' THR . . . . . . . . . . . . . 1.1 p -91.26 -8.3 48.75 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.588 -0.695 . . . . 0.0 109.129 179.714 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 192' ' ' GLY . . . . . . . . . . . . . . . 62.58 40.98 99.82 Favored Glycine 0 N--CA 1.492 2.425 0 N-CA-C 110.433 -1.067 . . . . 0.0 110.433 179.219 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 193' ' ' VAL . . . . . . . . . . . . . 67.2 t -145.96 157.95 12.1 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.625 0 O-C-N 121.044 -1.268 . . . . 0.0 109.801 179.56 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 194' ' ' TRP . . . . . 0.481 ' N ' ' CD1' ' A' ' 194' ' ' TRP . 23.0 m95 -83.83 120.79 26.48 Favored 'General case' 0 C--N 1.301 -1.543 0 N-CA-C 108.509 -0.923 . . . . 0.0 108.509 179.627 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 195' ' ' GLU . . . . . . . . . . . . . 2.1 mt-10 -89.73 -60.65 1.88 Allowed 'General case' 0 N--CA 1.495 1.816 0 C-N-CA 119.55 -0.86 . . . . 0.0 111.148 -178.194 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 196' ' ' LYS . . . . . . . . . . . . . 5.1 tttm -80.49 143.23 33.49 Favored 'General case' 0 C--N 1.3 -1.545 0 O-C-N 120.815 -1.178 . . . . 0.0 110.165 -178.901 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 197' ' ' ARG . . . . . 0.565 ' NH1' ' O ' ' C' ' 704' ' ' ALA . 13.5 tpp180 -120.05 138.33 53.59 Favored 'General case' 0 N--CA 1.491 1.617 0 N-CA-C 108.552 -0.907 . . . . 0.0 108.552 179.084 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 198' ' ' LYS . . . . . . . . . . . . . 22.7 mttt -116.97 118.6 32.87 Favored 'General case' 0 C--N 1.302 -1.489 0 O-C-N 121.903 -0.498 . . . . 0.0 109.966 -179.464 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 199' ' ' ILE . . . . . . . . . . . . . 0.6 OUTLIER -139.16 120.32 15.7 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.58 0 CA-C-O 122.505 1.145 . . . . 0.0 109.339 179.532 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 200' ' ' PHE . . . . . 0.504 ' CD1' ' N ' ' A' ' 200' ' ' PHE . 3.3 m-85 -99.43 136.71 38.97 Favored 'General case' 0 N--CA 1.496 1.852 0 O-C-N 121.124 -0.985 . . . . 0.0 109.799 -178.074 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 201' ' ' VAL . . . . . . . . . . . . . 97.7 t -101.58 137.16 30.25 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.555 0 N-CA-C 108.004 -1.11 . . . . 0.0 108.004 177.652 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 202' ' ' ALA . . . . . . . . . . . . . . . -121.56 134.91 55.03 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.376 -0.828 . . . . 0.0 108.821 179.831 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 203' ' ' THR . . . . . 0.489 ' CG2' ' OG1' ' A' ' 156' ' ' THR . 2.1 p -88.1 130.36 35.04 Favored 'General case' 0 C--N 1.306 -1.288 0 CA-C-O 122.198 0.999 . . . . 0.0 110.652 -178.782 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 204' ' ' GLU . . . . . 0.488 ' HA ' ' CD2' ' A' ' 153' ' ' TYR . 0.2 OUTLIER -50.9 134.62 25.46 Favored 'General case' 0 C--N 1.298 -1.67 0 C-N-CA 118.688 -1.205 . . . . 0.0 108.673 178.933 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 205' ' ' VAL . . . . . 0.508 ' CG1' ' N ' ' A' ' 206' ' ' LYS . 54.6 t -129.7 164.29 32.74 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.376 0 CA-C-O 121.93 0.872 . . . . 0.0 110.228 -177.741 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 206' ' ' LYS . . . . . 0.508 ' N ' ' CG1' ' A' ' 205' ' ' VAL . 0.5 OUTLIER . . . . . 0 C--N 1.297 -1.706 0 CA-C-O 118.006 -0.997 . . . . 0.0 109.559 -179.804 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' C' C ' 702' ' ' LEU . . . . . 0.567 ' CD1' ' O ' ' A' ' 163' ' ' PRO . 0.3 OUTLIER . . . . . 0 N--CA 1.493 1.714 0 N-CA-C 109.441 -0.577 . . . . 0.0 109.441 . . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' C' C ' 703' ' ' PRO . . . . . 0.501 ' O ' ' O ' ' C' ' 704' ' ' ALA . 40.5 Cg_endo -70.96 -179.29 3.33 Favored 'Trans proline' 0 C--N 1.31 -1.496 0 C-N-CA 122.796 2.331 . . . . 0.0 112.97 -179.691 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' C' C ' 704' ' ' ALA . . . . . 0.565 ' O ' ' NH1' ' A' ' 197' ' ' ARG . . . . . . . . 0 N--CA 1.49 1.567 0 CA-C-O 121.561 0.696 . . . . 0.0 110.168 179.809 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 63' ' ' PRO . . . . . . . . . . . . . 5.6 Cg_exo . . . . . 0 N--CA 1.489 1.218 0 CA-C-O 121.065 0.36 . . . . 0.0 111.283 . . . . . . . . . 0 0 . 1 . 007 nuclear orig core ' A' A ' 64' ' ' GLN . . . . . 0.631 ' NE2' ' O ' ' A' ' 64' ' ' GLN . 0.0 OUTLIER -155.26 127.44 7.7 Favored 'General case' 0 N--CA 1.494 1.77 0 O-C-N 121.054 -1.029 . . . . 0.0 110.315 179.81 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 65' ' ' ILE . . . . . 0.441 ' C ' ' O ' ' A' ' 64' ' ' GLN . 2.1 mp -45.76 105.94 0.51 Allowed Pre-proline 0 N--CA 1.491 1.598 0 N-CA-C 107.857 -1.164 . . . . 0.0 107.857 178.471 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 66' ' ' PRO . . . . . . . . . . . . . 60.2 Cg_endo -81.94 -162.71 0.19 Allowed 'Trans proline' 0 N--CA 1.49 1.272 0 C-N-CA 122.105 1.87 . . . . 0.0 112.639 -178.785 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 67' ' ' LYS . . . . . . . . . . . . . 53.8 tttt -90.46 -8.04 51.5 Favored 'General case' 0 N--CA 1.487 1.405 0 O-C-N 121.223 -0.923 . . . . 0.0 109.727 -179.722 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 68' ' ' ASP . . . . . 0.646 ' O ' ' N ' ' A' ' 70' ' ' SER . 0.2 OUTLIER -75.86 66.14 2.07 Favored 'General case' 0 N--CA 1.487 1.421 0 CA-C-O 123.003 1.383 . . . . 0.0 108.896 179.839 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 69' ' ' LYS . . . . . 0.468 ' C ' ' O ' ' A' ' 68' ' ' ASP . 0.8 OUTLIER -45.77 -14.71 0.02 OUTLIER 'General case' 0 N--CA 1.511 2.579 0 C-N-CA 117.129 -1.828 . . . . 0.0 107.368 178.06 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 70' ' ' SER . . . . . 0.646 ' N ' ' O ' ' A' ' 68' ' ' ASP . 0.1 OUTLIER -87.58 -5.0 58.95 Favored 'General case' 0 N--CA 1.498 1.93 0 CA-C-N 113.615 -1.63 . . . . 0.0 111.9 179.893 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 71' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -100.56 142.65 31.74 Favored 'General case' 0 N--CA 1.503 2.221 0 O-C-N 120.251 -1.531 . . . . 0.0 112.615 -178.991 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 72' ' ' VAL . . . . . 0.587 ' CG2' ' O ' ' A' ' 74' ' ' GLY . 0.7 OUTLIER -67.72 127.13 28.85 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.336 0 N-CA-C 105.196 -2.149 . . . . 0.0 105.196 174.786 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 73' ' ' ALA . . . . . 0.569 ' N ' ' O ' ' A' ' 87' ' ' VAL . . . -80.33 -12.4 59.6 Favored 'General case' 0 C--N 1.297 -1.712 0 O-C-N 120.195 -1.566 . . . . 0.0 109.126 -178.309 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 74' ' ' GLY . . . . . 0.587 ' O ' ' CG2' ' A' ' 72' ' ' VAL . . . 173.53 -161.12 31.72 Favored Glycine 0 N--CA 1.488 2.13 0 N-CA-C 109.614 -1.394 . . . . 0.0 109.614 -179.849 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 75' ' ' TYR . . . . . . . . . . . . . 76.1 m-85 -142.27 170.16 16.23 Favored 'General case' 0 C--N 1.296 -1.747 0 O-C-N 121.076 -1.249 . . . . 0.0 110.767 -178.136 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 76' ' ' ILE . . . . . 0.468 ' CG2' ' OE1' ' A' ' 85' ' ' GLU . 0.4 OUTLIER -148.97 144.26 18.38 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.57 0 C-N-CA 119.422 -0.911 . . . . 0.0 108.994 -177.464 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -152.04 160.35 43.47 Favored 'General case' 0 N--CA 1.492 1.648 0 O-C-N 120.893 -1.129 . . . . 0.0 109.504 -179.855 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 78' ' ' ILE . . . . . . . . . . . . . 3.0 mp -143.16 99.08 5.47 Favored Pre-proline 0 N--CA 1.493 1.695 0 N-CA-C 107.929 -1.137 . . . . 0.0 107.929 179.303 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 79' ' ' PRO . . . . . . . . . . . . . 47.4 Cg_exo -51.06 -44.62 41.29 Favored 'Trans proline' 0 N--CA 1.492 1.425 0 C-N-CA 122.557 2.171 . . . . 0.0 113.808 -178.81 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -65.62 -18.05 65.04 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 120.691 -1.256 . . . . 0.0 110.752 178.741 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 81' ' ' ALA . . . . . 0.585 ' O ' ' ND2' ' A' ' 132' ' ' ASN . . . -106.41 -19.04 13.81 Favored 'General case' 0 N--CA 1.494 1.774 0 O-C-N 121.136 -0.978 . . . . 0.0 108.886 179.746 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 82' ' ' ASP . . . . . 0.426 ' CB ' ' O ' ' A' ' 81' ' ' ALA . 11.6 t0 70.44 49.02 0.44 Allowed 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.475 -0.765 . . . . 0.0 110.767 179.106 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 83' ' ' ILE . . . . . . . . . . . . . 36.2 mt -131.1 152.74 38.01 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.822 0 O-C-N 121.145 -0.972 . . . . 0.0 110.275 -179.047 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 84' ' ' LYS . . . . . . . . . . . . . 9.3 ptmm? -157.7 110.22 2.4 Favored 'General case' 0 N--CA 1.489 1.491 0 N-CA-C 108.244 -1.021 . . . . 0.0 108.244 179.471 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 85' ' ' GLU . . . . . 0.47 ' CD ' ' N ' ' A' ' 85' ' ' GLU . 0.4 OUTLIER -138.32 167.74 18.68 Favored Pre-proline 0 N--CA 1.498 1.949 0 O-C-N 121.113 -0.992 . . . . 0.0 109.805 -178.973 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 86' ' ' PRO . . . . . . . . . . . . . 97.3 Cg_endo -82.99 158.89 15.64 Favored 'Trans proline' 0 N--CA 1.494 1.54 0 C-N-CA 122.944 2.429 . . . . 0.0 113.568 -179.184 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 87' ' ' VAL . . . . . 0.569 ' O ' ' N ' ' A' ' 73' ' ' ALA . 78.6 t -112.04 106.36 20.61 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.698 0 N-CA-C 109.319 -0.622 . . . . 0.0 109.319 180.0 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 88' ' ' TYR . . . . . . . . . . . . . 10.5 m-85 -97.45 153.94 38.18 Favored Pre-proline 0 N--CA 1.5 2.057 0 O-C-N 120.766 -1.209 . . . . 0.0 109.607 179.582 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 89' ' ' PRO . . . . . . . . . . . . . 11.4 Cg_endo -58.78 141.94 98.35 Favored 'Trans proline' 0 N--CA 1.497 1.705 0 C-N-CA 122.954 2.436 . . . . 0.0 113.424 -179.923 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . -59.17 169.19 6.23 Favored Glycine 0 N--CA 1.496 2.667 0 N-CA-C 109.259 -1.537 . . . . 0.0 109.259 179.209 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 91' ' ' PRO . . . . . 0.502 ' C ' ' H ' ' A' ' 93' ' ' THR . 94.3 Cg_endo -93.09 168.92 21.57 Favored 'Cis proline' 0 C--N 1.31 -1.489 0 C-N-CA 123.861 -1.308 . . . . 0.0 111.994 0.239 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 92' ' ' ALA . . . . . . . . . . . . . . . -70.86 29.76 0.04 OUTLIER 'General case' 0 N--CA 1.492 1.662 0 O-C-N 121.166 -0.959 . . . . 0.0 110.6 -179.489 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 93' ' ' THR . . . . . 0.502 ' H ' ' C ' ' A' ' 91' ' ' PRO . 6.5 p -72.42 150.79 91.74 Favored Pre-proline 0 C--N 1.302 -1.485 0 O-C-N 120.688 -1.257 . . . . 0.0 108.4 179.836 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 94' ' ' PRO . . . . . 0.427 ' C ' ' O ' ' A' ' 93' ' ' THR . 70.2 Cg_exo -30.46 -57.15 0.19 Allowed 'Trans proline' 0 C--N 1.309 -1.506 0 C-N-CA 122.973 2.448 . . . . 0.0 112.743 -179.144 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 16.3 mt-10 -44.56 -49.31 10.16 Favored 'General case' 0 C--N 1.302 -1.466 0 O-C-N 121.175 -0.953 . . . . 0.0 109.863 -179.931 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 96' ' ' GLN . . . . . 0.566 ' O ' ' N ' ' A' ' 98' ' ' ASN . 1.4 mp0 -73.15 -54.15 9.19 Favored 'General case' 0 N--CA 1.488 1.47 0 O-C-N 121.081 -1.012 . . . . 0.0 109.912 179.782 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 97' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -44.11 -14.42 0.02 OUTLIER 'General case' 0 N--CA 1.494 1.732 0 O-C-N 121.453 -0.779 . . . . 0.0 110.29 -179.216 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 98' ' ' ASN . . . . . 0.689 ' ND2' ' NE ' ' A' ' 99' ' ' ARG . 0.0 OUTLIER -71.53 -33.53 69.26 Favored 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.052 -1.03 . . . . 0.0 108.599 179.327 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 99' ' ' ARG . . . . . 0.689 ' NE ' ' ND2' ' A' ' 98' ' ' ASN . 16.4 mmt180 -79.64 -58.39 3.21 Favored 'General case' 0 C--N 1.303 -1.442 0 O-C-N 121.688 -0.633 . . . . 0.0 109.565 -179.725 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . 174.08 -156.17 23.03 Favored Glycine 0 N--CA 1.492 2.422 0 N-CA-C 109.989 -1.245 . . . . 0.0 109.989 179.967 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 101' ' ' VAL . . . . . 0.47 ' CG1' ' CE2' ' A' ' 130' ' ' PHE . 27.3 m -59.44 103.18 0.14 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.674 0 O-C-N 121.256 -1.144 . . . . 0.0 109.754 -179.908 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -91.63 166.19 12.94 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.032 -1.043 . . . . 0.0 109.953 -179.992 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 103' ' ' PHE . . . . . 0.597 ' O ' ' N ' ' A' ' 105' ' ' GLU . 26.0 m-85 -70.22 120.86 16.54 Favored 'General case' 0 N--CA 1.486 1.352 0 N-CA-C 107.969 -1.123 . . . . 0.0 107.969 178.639 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 104' ' ' ALA . . . . . . . . . . . . . . . -42.94 -14.54 0.01 OUTLIER 'General case' 0 C--N 1.3 -1.546 0 O-C-N 121.488 -0.757 . . . . 0.0 110.696 -178.729 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 105' ' ' GLU . . . . . 0.597 ' N ' ' O ' ' A' ' 103' ' ' PHE . 0.1 OUTLIER -138.85 146.61 41.44 Favored 'General case' 0 N--CA 1.496 1.86 0 O-C-N 120.828 -1.17 . . . . 0.0 110.762 -179.797 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 106' ' ' GLU . . . . . 0.414 ' HG2' ' H ' ' A' ' 107' ' ' ASN . 0.0 OUTLIER -59.59 -61.72 2.41 Favored 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.929 -0.482 . . . . 0.0 111.523 -179.178 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 107' ' ' ASN . . . . . 0.414 ' H ' ' HG2' ' A' ' 106' ' ' GLU . 17.1 m120 -77.65 34.35 0.18 Allowed 'General case' 0 N--CA 1.493 1.707 0 O-C-N 120.428 -1.42 . . . . 0.0 112.862 -175.553 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 108' ' ' GLU . . . . . . . . . . . . . 14.6 tp10 -57.43 146.73 28.49 Favored 'General case' 0 C--N 1.301 -1.508 0 O-C-N 120.698 -1.252 . . . . 0.0 107.937 179.622 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 109' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -102.26 146.72 27.6 Favored 'General case' 0 N--CA 1.488 1.453 0 O-C-N 121.124 -0.985 . . . . 0.0 111.133 -178.198 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 110' ' ' LEU . . . . . 0.439 ' C ' ' OD1' ' A' ' 111' ' ' ASP . 3.0 tp -62.81 -18.87 63.43 Favored 'General case' 0 C--N 1.303 -1.421 0 N-CA-C 108.028 -1.101 . . . . 0.0 108.028 178.783 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 111' ' ' ASP . . . . . 0.439 ' OD1' ' C ' ' A' ' 110' ' ' LEU . 4.0 m-20 -132.69 42.45 3.08 Favored 'General case' 0 N--CA 1.487 1.383 0 O-C-N 121.637 -0.664 . . . . 0.0 109.84 -179.849 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 112' ' ' ASP . . . . . . . . . . . . . 4.5 t0 -68.15 157.45 35.32 Favored 'General case' 0 N--CA 1.492 1.668 0 O-C-N 120.858 -1.151 . . . . 0.0 111.386 -179.725 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 113' ' ' GLN . . . . . 0.543 ' N ' ' CD ' ' A' ' 113' ' ' GLN . 0.0 OUTLIER -66.58 -16.07 63.9 Favored 'General case' 0 N--CA 1.494 1.742 0 N-CA-C 108.229 -1.026 . . . . 0.0 108.229 177.934 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 114' ' ' ASN . . . . . 0.614 ' ND2' ' O ' ' A' ' 170' ' ' ASP . 34.6 t-20 -153.0 113.81 4.11 Favored 'General case' 0 C--N 1.295 -1.781 0 N-CA-C 107.58 -1.266 . . . . 0.0 107.58 177.141 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 115' ' ' ILE . . . . . . . . . . . . . 3.8 mt -91.41 98.95 8.96 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.69 0 N-CA-C 107.232 -1.396 . . . . 0.0 107.232 179.588 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 116' ' ' SER . . . . . . . . . . . . . 87.6 p -86.44 149.03 25.28 Favored 'General case' 0 N--CA 1.488 1.437 0 CA-C-O 121.864 0.84 . . . . 0.0 111.22 -177.528 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 117' ' ' ILE . . . . . . . . . . . . . 1.7 mt -149.71 149.54 14.56 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.483 0 N-CA-C 107.813 -1.18 . . . . 0.0 107.813 179.112 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 118' ' ' ALA . . . . . . . . . . . . . . . -136.26 159.35 42.02 Favored 'General case' 0 N--CA 1.493 1.686 0 C-N-CA 119.277 -0.969 . . . . 0.0 110.903 -179.018 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 119' ' ' GLY . . . . . . . . . . . . . . . -172.01 146.76 9.54 Favored Glycine 0 N--CA 1.489 2.179 0 N-CA-C 110.482 -1.047 . . . . 0.0 110.482 179.94 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 120' ' ' HIS . . . . . . . . . . . . . 27.7 m170 -71.89 168.0 18.85 Favored 'General case' 0 N--CA 1.494 1.758 0 O-C-N 121.531 -0.981 . . . . 0.0 110.157 179.291 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 121' ' ' THR . . . . . 0.727 ' HG1' ' NZ ' ' A' ' 134' ' ' LYS . 0.7 OUTLIER -118.5 160.06 22.41 Favored 'General case' 0 N--CA 1.498 1.958 0 N-CA-C 108.357 -0.979 . . . . 0.0 108.357 178.818 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 122' ' ' PHE . . . . . . . . . . . . . 2.7 m-85 -143.59 123.35 13.39 Favored 'General case' 0 N--CA 1.498 1.951 0 O-C-N 120.838 -1.164 . . . . 0.0 109.812 -179.766 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 123' ' ' ILE . . . . . 0.44 ' CG2' ' N ' ' A' ' 124' ' ' ASP . 14.3 tt -59.18 -40.24 80.59 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.478 0 CA-C-O 121.545 0.688 . . . . 0.0 109.516 179.89 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 124' ' ' ASP . . . . . 0.44 ' N ' ' CG2' ' A' ' 123' ' ' ILE . 1.7 m-20 -88.92 22.62 2.64 Favored 'General case' 0 N--CA 1.497 1.912 0 O-C-N 121.492 -0.755 . . . . 0.0 111.942 -177.42 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 125' ' ' ARG . . . . . . . . . . . . . 37.9 mtp180 -154.47 99.75 2.45 Favored Pre-proline 0 N--CA 1.493 1.703 0 O-C-N 120.366 -1.459 . . . . 0.0 110.112 -179.862 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 126' ' ' PRO . . . . . . . . . . . . . 56.1 Cg_endo -80.02 -27.94 3.47 Favored 'Trans proline' 0 C--N 1.313 -1.328 0 C-N-CA 121.98 1.787 . . . . 0.0 111.635 179.266 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 127' ' ' ASN . . . . . . . . . . . . . 2.9 m120 -89.09 11.77 17.54 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.047 -1.033 . . . . 0.0 109.227 179.64 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 128' ' ' TYR . . . . . . . . . . . . . 5.1 t80 -65.58 -149.47 0.01 OUTLIER 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.388 -0.82 . . . . 0.0 109.425 179.908 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 129' ' ' GLN . . . . . . . . . . . . . 69.5 mt-30 -68.05 -70.95 0.23 Allowed 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.315 -0.866 . . . . 0.0 109.857 -179.787 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 130' ' ' PHE . . . . . 0.495 ' O ' ' CE ' ' A' ' 134' ' ' LYS . 47.6 m-85 -134.88 52.62 2.03 Favored 'General case' 0 N--CA 1.493 1.71 0 O-C-N 121.104 -0.998 . . . . 0.0 110.303 -179.857 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 131' ' ' THR . . . . . . . . . . . . . 23.1 m -87.33 -39.69 15.12 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 120.903 -1.123 . . . . 0.0 109.396 179.681 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 132' ' ' ASN . . . . . 0.585 ' ND2' ' O ' ' A' ' 81' ' ' ALA . 1.8 t30 -82.86 6.32 18.79 Favored 'General case' 0 N--CA 1.498 1.938 0 O-C-N 121.505 -0.747 . . . . 0.0 111.701 -178.306 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 133' ' ' LEU . . . . . 0.503 ' O ' ' N ' ' A' ' 135' ' ' ALA . 0.2 OUTLIER -71.17 -45.54 63.28 Favored 'General case' 0 C--N 1.299 -1.616 0 O-C-N 120.739 -1.226 . . . . 0.0 109.999 -179.368 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 134' ' ' LYS . . . . . 0.727 ' NZ ' ' HG1' ' A' ' 121' ' ' THR . 0.0 OUTLIER -46.12 -16.96 0.03 OUTLIER 'General case' 0 N--CA 1.494 1.749 0 O-C-N 120.988 -1.07 . . . . 0.0 109.727 -179.802 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 135' ' ' ALA . . . . . 0.503 ' N ' ' O ' ' A' ' 133' ' ' LEU . . . -84.08 -37.53 21.93 Favored 'General case' 0 N--CA 1.487 1.403 0 O-C-N 121.111 -0.993 . . . . 0.0 109.077 179.471 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 136' ' ' ALA . . . . . 0.419 ' N ' ' O ' ' A' ' 133' ' ' LEU . . . -79.76 157.96 26.99 Favored 'General case' 0 C--N 1.303 -1.454 0 CA-C-O 121.976 0.894 . . . . 0.0 110.984 -179.132 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 137' ' ' LYS . . . . . 0.542 ' O ' ' O ' ' A' ' 138' ' ' LYS . 2.4 mttm -150.84 -163.52 1.79 Allowed 'General case' 0 C--N 1.299 -1.628 0 C-N-CA 118.106 -1.438 . . . . 0.0 110.965 -177.902 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 138' ' ' LYS . . . . . 0.585 ' O ' ' N ' ' A' ' 140' ' ' SER . 28.8 mttp -41.18 174.17 0.0 OUTLIER 'General case' 0 C--N 1.301 -1.523 0 CA-C-O 122.589 1.185 . . . . 0.0 111.171 -178.557 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 139' ' ' GLY . . . . . . . . . . . . . . . 47.13 8.25 0.03 OUTLIER Glycine 0 N--CA 1.488 2.148 0 N-CA-C 110.162 -1.175 . . . . 0.0 110.162 -179.971 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 140' ' ' SER . . . . . 0.585 ' N ' ' O ' ' A' ' 138' ' ' LYS . 5.2 m -75.87 112.98 12.83 Favored 'General case' 0 N--CA 1.493 1.723 0 O-C-N 120.867 -1.372 . . . . 0.0 108.982 179.385 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 141' ' ' MET . . . . . 0.659 ' SD ' ' N ' ' A' ' 142' ' ' VAL . 3.0 tpp -68.26 128.02 35.06 Favored 'General case' 0 C--N 1.301 -1.503 0 O-C-N 121.036 -1.04 . . . . 0.0 109.178 179.854 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 142' ' ' VAL . . . . . 0.659 ' N ' ' SD ' ' A' ' 141' ' ' MET . 1.6 t -113.87 133.29 60.33 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.522 0 N-CA-C 108.456 -0.942 . . . . 0.0 108.456 -179.736 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 143' ' ' TYR . . . . . . . . . . . . . 13.4 m-85 -112.31 135.83 52.51 Favored 'General case' 0 N--CA 1.495 1.798 0 O-C-N 120.869 -1.145 . . . . 0.0 110.703 -178.899 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 144' ' ' PHE . . . . . 0.561 ' CZ ' ' CG1' ' A' ' 146' ' ' VAL . 4.2 t80 -120.96 105.88 11.08 Favored 'General case' 0 N--CA 1.493 1.707 0 C-N-CA 120.143 -0.623 . . . . 0.0 109.985 -179.467 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 145' ' ' LYS . . . . . . . . . . . . . 13.9 mtpp -102.3 122.76 44.86 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.23 -0.919 . . . . 0.0 109.819 -179.863 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 146' ' ' VAL . . . . . 0.561 ' CG1' ' CZ ' ' A' ' 144' ' ' PHE . 0.9 OUTLIER -142.65 125.4 13.74 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.629 0 N-CA-C 108.335 -0.987 . . . . 0.0 108.335 178.874 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 147' ' ' GLY . . . . . . . . . . . . . . . 60.47 -125.6 39.0 Favored Glycine 0 N--CA 1.489 2.225 0 N-CA-C 109.054 -1.618 . . . . 0.0 109.054 -179.426 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 148' ' ' ASN . . . . . 0.592 ' C ' ' ND2' ' A' ' 148' ' ' ASN . 0.0 OUTLIER -104.77 5.97 33.68 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.245 -1.15 . . . . 0.0 108.979 179.623 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 149' ' ' GLU . . . . . . . . . . . . . 1.3 tt0 -105.82 141.65 36.89 Favored 'General case' 0 N--CA 1.488 1.461 0 O-C-N 121.295 -0.878 . . . . 0.0 111.797 -178.32 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 150' ' ' THR . . . . . . . . . . . . . 3.5 m -131.93 98.47 4.46 Favored 'General case' 0 N--CA 1.493 1.709 0 CA-C-O 121.482 0.658 . . . . 0.0 109.271 -179.862 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 151' ' ' ARG . . . . . 0.4 HH12 ' HA ' ' A' ' 111' ' ' ASP . 92.6 mtt180 -85.7 -169.36 2.61 Favored 'General case' 0 N--CA 1.488 1.425 0 O-C-N 121.255 -0.903 . . . . 0.0 108.894 -179.711 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 152' ' ' LYS . . . . . 0.476 ' O ' ' N ' ' A' ' 205' ' ' VAL . 1.9 mtmp? -152.02 149.87 29.35 Favored 'General case' 0 C--N 1.301 -1.537 0 O-C-N 121.261 -0.899 . . . . 0.0 109.982 -179.309 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 153' ' ' TYR . . . . . 0.48 ' CD2' ' HA ' ' A' ' 204' ' ' GLU . 5.7 m-85 -143.86 168.51 19.78 Favored 'General case' 0 C--N 1.303 -1.417 0 N-CA-C 107.939 -1.134 . . . . 0.0 107.939 178.494 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 154' ' ' LYS . . . . . . . . . . . . . 1.4 ttpt -143.36 119.82 10.99 Favored 'General case' 0 C--N 1.295 -1.772 0 N-CA-C 108.403 -0.962 . . . . 0.0 108.403 178.689 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 155' ' ' MET . . . . . . . . . . . . . 46.5 mtp -46.3 107.68 0.11 Allowed 'General case' 0 N--CA 1.495 1.784 0 O-C-N 120.637 -1.289 . . . . 0.0 111.564 -178.602 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 156' ' ' THR . . . . . 0.512 ' OG1' ' OG1' ' A' ' 203' ' ' THR . 0.2 OUTLIER -106.4 -25.44 11.89 Favored 'General case' 0 C--N 1.294 -1.844 0 CA-C-N 115.249 -0.887 . . . . 0.0 110.633 -178.739 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 157' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -153.94 153.72 32.52 Favored 'General case' 0 N--CA 1.495 1.813 0 C-N-CA 118.559 -1.256 . . . . 0.0 111.431 -178.512 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 158' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -153.79 146.83 14.15 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.372 0 CA-C-O 122.067 0.937 . . . . 0.0 110.91 -179.76 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 159' ' ' ARG . . . . . . . . . . . . . 12.9 ttm180 -153.66 153.44 32.3 Favored 'General case' 0 C--N 1.296 -1.718 0 CA-C-O 121.642 0.734 . . . . 0.0 109.681 -179.894 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 160' ' ' ASP . . . . . 0.559 ' N ' ' OD1' ' A' ' 160' ' ' ASP . 0.3 OUTLIER -116.18 160.55 20.23 Favored 'General case' 0 C--N 1.301 -1.513 0 N-CA-C 107.895 -1.15 . . . . 0.0 107.895 179.428 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 161' ' ' VAL . . . . . 0.498 ' CG1' ' O ' ' A' ' 160' ' ' ASP . 1.6 m -165.35 159.34 1.14 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.7 0 O-C-N 120.881 -1.137 . . . . 0.0 110.54 -179.271 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 162' ' ' LYS . . . . . 0.497 ' O ' ' O ' ' A' ' 161' ' ' VAL . 0.0 OUTLIER -43.96 171.5 0.04 OUTLIER Pre-proline 0 N--CA 1.49 1.538 0 O-C-N 121.789 -0.569 . . . . 0.0 109.558 179.568 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 163' ' ' PRO . . . . . . . . . . . . . 74.0 Cg_endo -81.47 37.32 0.67 Allowed 'Trans proline' 0 C--N 1.311 -1.431 0 C-N-CA 122.557 2.171 . . . . 0.0 112.107 179.891 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 164' ' ' THR . . . . . . . . . . . . . 86.7 m -152.12 -5.65 0.23 Allowed 'General case' 0 N--CA 1.494 1.76 0 O-C-N 121.216 -0.927 . . . . 0.0 110.736 -179.446 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 165' ' ' ASP . . . . . . . . . . . . . 31.0 t70 -72.86 62.72 0.61 Allowed 'General case' 0 N--CA 1.496 1.834 0 O-C-N 120.796 -1.19 . . . . 0.0 110.169 -179.435 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 166' ' ' VAL . . . . . 0.608 ' O ' ' N ' ' A' ' 168' ' ' VAL . 2.8 t -45.68 -34.01 1.58 Allowed 'Isoleucine or valine' 0 N--CA 1.494 1.763 0 O-C-N 121.099 -1.001 . . . . 0.0 110.247 -178.534 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 167' ' ' GLY . . . . . 0.402 ' C ' ' O ' ' A' ' 166' ' ' VAL . . . -43.46 -12.81 0.01 OUTLIER Glycine 0 N--CA 1.496 2.672 0 O-C-N 120.785 -1.197 . . . . 0.0 110.994 -179.495 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 168' ' ' VAL . . . . . 0.608 ' N ' ' O ' ' A' ' 166' ' ' VAL . 5.3 m -53.97 -30.94 20.36 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.51 0 O-C-N 120.588 -1.537 . . . . 0.0 109.005 179.802 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 169' ' ' LEU . . . . . 0.545 ' O ' ' ND2' ' A' ' 114' ' ' ASN . 13.1 mt -49.04 -11.51 0.04 OUTLIER 'General case' 0 N--CA 1.489 1.519 0 N-CA-C 107.974 -1.121 . . . . 0.0 107.974 -178.535 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 170' ' ' ASP . . . . . 0.614 ' O ' ' ND2' ' A' ' 114' ' ' ASN . 2.2 m-20 19.88 77.21 0.01 OUTLIER 'General case' 0 N--CA 1.5 2.03 0 N-CA-C 112.21 0.448 . . . . 0.0 112.21 177.517 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 171' ' ' GLU . . . . . 0.572 ' N ' ' OE1' ' A' ' 172' ' ' GLN . 9.9 pt-20 -116.51 66.44 0.71 Allowed 'General case' 0 N--CA 1.498 1.957 0 O-C-N 120.922 -1.111 . . . . 0.0 109.499 179.495 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 172' ' ' GLN . . . . . 0.572 ' OE1' ' N ' ' A' ' 171' ' ' GLU . 2.5 mp0 -121.35 -57.28 1.85 Allowed 'General case' 0 N--CA 1.496 1.846 0 O-C-N 121.532 -0.73 . . . . 0.0 110.7 -178.697 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 173' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -58.92 127.0 30.0 Favored 'General case' 0 N--CA 1.494 1.739 0 O-C-N 121.017 -1.052 . . . . 0.0 109.301 -179.687 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 174' ' ' GLY . . . . . 0.498 ' O ' ' C ' ' A' ' 175' ' ' LYS . . . -118.55 -43.0 0.56 Allowed Glycine 0 N--CA 1.482 1.742 0 N-CA-C 108.625 -1.79 . . . . 0.0 108.625 179.835 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 175' ' ' LYS . . . . . 0.498 ' C ' ' O ' ' A' ' 174' ' ' GLY . 0.0 OUTLIER -40.42 -60.03 1.19 Allowed 'General case' 0 N--CA 1.494 1.742 0 N-CA-C 107.324 -1.361 . . . . 0.0 107.324 179.538 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 176' ' ' ASP . . . . . 0.601 ' O ' ' O ' ' A' ' 177' ' ' LYS . 11.4 m-20 -103.72 90.31 3.61 Favored 'General case' 0 C--N 1.292 -1.912 0 N-CA-C 106.792 -1.558 . . . . 0.0 106.792 176.896 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 177' ' ' LYS . . . . . 0.601 ' O ' ' O ' ' A' ' 176' ' ' ASP . 8.3 mtmt -45.28 -176.31 0.0 OUTLIER 'General case' 0 N--CA 1.492 1.641 0 N-CA-C 109.009 -0.737 . . . . 0.0 109.009 -179.161 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 178' ' ' GLN . . . . . 0.61 HE21 ' ND2' ' A' ' 114' ' ' ASN . 16.5 pt20 -161.77 175.84 11.53 Favored 'General case' 0 C--N 1.3 -1.557 0 O-C-N 120.37 -1.456 . . . . 0.0 110.511 179.322 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 179' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -132.51 98.96 4.5 Favored 'General case' 0 C--N 1.301 -1.503 0 N-CA-C 107.604 -1.258 . . . . 0.0 107.604 178.228 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 180' ' ' THR . . . . . 0.536 ' CB ' HD22 ' A' ' 114' ' ' ASN . 1.3 m -77.26 117.42 18.76 Favored 'General case' 0 N--CA 1.489 1.486 0 O-C-N 121.217 -0.927 . . . . 0.0 110.127 -178.628 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 181' ' ' LEU . . . . . . . . . . . . . 9.4 tt -92.76 147.05 23.18 Favored 'General case' 0 C--N 1.302 -1.463 0 N-CA-C 107.851 -1.166 . . . . 0.0 107.851 177.826 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 182' ' ' ILE . . . . . . . . . . . . . 6.4 mt -138.39 109.05 5.0 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.643 0 N-CA-C 108.262 -1.014 . . . . 0.0 108.262 179.088 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 183' ' ' THR . . . . . . . . . . . . . 7.1 t -132.1 115.65 16.02 Favored 'General case' 0 C--N 1.29 -2.007 0 N-CA-C 107.921 -1.14 . . . . 0.0 107.921 179.509 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 184' ' ' CYS . . . . . . . . . . . . . 1.1 p -78.54 160.46 27.62 Favored 'General case' 0 C--N 1.288 -2.076 0 C-N-CA 119.441 -0.904 . . . . 0.0 110.996 -178.021 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 185' ' ' ASP . . . . . 0.53 ' CG ' ' N ' ' A' ' 186' ' ' ASP . 0.1 OUTLIER -166.93 -163.58 0.56 Allowed 'General case' 0 N--CA 1.49 1.53 0 N-CA-C 109.109 -0.7 . . . . 0.0 109.109 179.816 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 186' ' ' ASP . . . . . 0.53 ' N ' ' CG ' ' A' ' 185' ' ' ASP . 0.6 OUTLIER 55.95 54.3 8.2 Favored 'General case' 0 N--CA 1.496 1.828 0 O-C-N 121.126 -0.984 . . . . 0.0 109.476 -179.965 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 187' ' ' TYR . . . . . 0.596 ' CE1' ' O ' ' A' ' 188' ' ' ASN . 43.0 t80 -67.54 130.73 43.95 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.166 -0.959 . . . . 0.0 110.126 -179.829 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 188' ' ' ASN . . . . . 0.785 HD21 ' H ' ' A' ' 193' ' ' VAL . 0.0 OUTLIER -99.94 150.54 22.3 Favored 'General case' 0 C--N 1.292 -1.907 0 N-CA-C 107.318 -1.364 . . . . 0.0 107.318 177.825 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 189' ' ' GLU . . . . . 0.616 ' H ' ' CD ' ' A' ' 189' ' ' GLU . 0.0 OUTLIER -112.18 -8.09 14.01 Favored 'General case' 0 C--N 1.289 -2.034 0 N-CA-C 107.968 -1.123 . . . . 0.0 107.968 -179.476 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 190' ' ' LYS . . . . . 0.577 ' N ' ' OD1' ' A' ' 188' ' ' ASN . 2.7 mtpm? -82.89 -56.91 3.54 Favored 'General case' 0 C--N 1.299 -1.618 0 C-N-CA 119.894 -0.722 . . . . 0.0 109.381 179.51 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 191' ' ' THR . . . . . 0.566 ' C ' HD22 ' A' ' 188' ' ' ASN . 4.7 p -88.44 6.5 37.29 Favored 'General case' 0 N--CA 1.493 1.682 0 O-C-N 121.399 -0.813 . . . . 0.0 110.04 -179.675 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 192' ' ' GLY . . . . . 0.673 ' N ' HD22 ' A' ' 188' ' ' ASN . . . 53.92 35.82 54.38 Favored Glycine 0 N--CA 1.495 2.568 0 N-CA-C 110.664 -0.974 . . . . 0.0 110.664 179.129 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 193' ' ' VAL . . . . . 0.785 ' H ' HD21 ' A' ' 188' ' ' ASN . 58.8 t -149.5 163.58 4.08 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.588 0 O-C-N 120.95 -1.324 . . . . 0.0 109.962 179.708 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 194' ' ' TRP . . . . . 0.522 ' N ' ' CD1' ' A' ' 194' ' ' TRP . 16.1 m95 -84.97 121.17 27.38 Favored 'General case' 0 N--CA 1.49 1.534 0 N-CA-C 108.085 -1.08 . . . . 0.0 108.085 179.137 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 195' ' ' GLU . . . . . . . . . . . . . 2.6 mt-10 -79.69 -61.23 2.06 Favored 'General case' 0 N--CA 1.497 1.878 0 O-C-N 121.295 -0.878 . . . . 0.0 111.767 -177.667 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 196' ' ' LYS . . . . . . . . . . . . . 8.5 mmtm -93.29 145.38 24.49 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 120.777 -1.202 . . . . 0.0 110.296 -178.608 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 197' ' ' ARG . . . . . 0.585 ' CG ' HH11 ' A' ' 197' ' ' ARG . 0.0 OUTLIER -119.61 146.85 45.16 Favored 'General case' 0 N--CA 1.492 1.625 0 N-CA-C 108.711 -0.848 . . . . 0.0 108.711 179.806 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 198' ' ' LYS . . . . . 0.459 ' HZ1' ' CG ' ' A' ' 185' ' ' ASP . 0.5 OUTLIER -116.81 121.07 40.47 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.582 -0.699 . . . . 0.0 111.197 -178.212 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 199' ' ' ILE . . . . . 0.409 HG13 ' O ' ' A' ' 199' ' ' ILE . 0.8 OUTLIER -139.52 118.21 12.27 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.573 0 CA-C-O 122.515 1.15 . . . . 0.0 109.56 178.796 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 200' ' ' PHE . . . . . . . . . . . . . 0.3 OUTLIER -103.6 140.78 37.09 Favored 'General case' 0 N--CA 1.497 1.88 0 O-C-N 121.127 -0.983 . . . . 0.0 110.455 -178.074 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 201' ' ' VAL . . . . . . . . . . . . . 96.1 t -103.47 146.83 10.6 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.482 0 N-CA-C 108.255 -1.017 . . . . 0.0 108.255 177.352 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 202' ' ' ALA . . . . . . . . . . . . . . . -131.89 138.74 48.53 Favored 'General case' 0 C--N 1.3 -1.579 0 N-CA-C 108.34 -0.985 . . . . 0.0 108.34 -179.88 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 203' ' ' THR . . . . . 0.512 ' OG1' ' OG1' ' A' ' 156' ' ' THR . 3.2 p -89.1 130.77 35.49 Favored 'General case' 0 C--N 1.306 -1.315 0 CA-C-O 122.267 1.032 . . . . 0.0 111.213 -178.141 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 204' ' ' GLU . . . . . 0.48 ' HA ' ' CD2' ' A' ' 153' ' ' TYR . 0.2 OUTLIER -51.01 134.48 26.15 Favored 'General case' 0 C--N 1.297 -1.691 0 C-N-CA 119.076 -1.05 . . . . 0.0 109.043 179.346 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 205' ' ' VAL . . . . . 0.503 ' CG1' ' N ' ' A' ' 206' ' ' LYS . 53.3 t -125.03 164.06 24.55 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.369 0 CA-C-O 121.941 0.877 . . . . 0.0 110.433 -177.79 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 206' ' ' LYS . . . . . 0.503 ' N ' ' CG1' ' A' ' 205' ' ' VAL . 0.1 OUTLIER . . . . . 0 C--N 1.297 -1.693 0 CA-C-O 117.976 -1.011 . . . . 0.0 109.651 179.91 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' C' C ' 702' ' ' LEU . . . . . 0.444 ' CD1' ' N ' ' C' ' 702' ' ' LEU . 0.0 OUTLIER . . . . . 0 N--CA 1.492 1.656 0 N-CA-C 108.941 -0.763 . . . . 0.0 108.941 . . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' C' C ' 703' ' ' PRO . . . . . . . . . . . . . 11.9 Cg_endo -61.7 -174.81 0.14 Allowed 'Trans proline' 0 N--CA 1.494 1.549 0 C-N-CA 122.609 2.206 . . . . 0.0 112.861 -179.083 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' C' C ' 704' ' ' ALA . . . . . 0.561 ' C ' ' NH2' ' A' ' 197' ' ' ARG . . . . . . . . 0 N--CA 1.49 1.539 0 O-C-N 121.395 -0.816 . . . . 0.0 109.364 -179.662 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 63' ' ' PRO . . . . . . . . . . . . . 72.9 Cg_endo . . . . . 0 C--O 1.215 -0.633 0 N-CA-C 110.684 -0.544 . . . . 0.0 110.684 . . . . . . . . . 0 0 . 1 . 008 nuclear orig core ' A' A ' 64' ' ' GLN . . . . . 0.601 ' NE2' ' O ' ' A' ' 64' ' ' GLN . 0.0 OUTLIER -159.83 137.72 10.03 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 120.97 -1.081 . . . . 0.0 109.841 179.115 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 65' ' ' ILE . . . . . . . . . . . . . 3.2 mp -47.95 108.0 0.83 Allowed Pre-proline 0 N--CA 1.489 1.488 0 O-C-N 121.172 -0.955 . . . . 0.0 108.701 179.136 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 66' ' ' PRO . . . . . . . . . . . . . 61.4 Cg_endo -81.52 -158.74 0.1 OUTLIER 'Trans proline' 0 C--N 1.314 -1.246 0 C-N-CA 122.026 1.818 . . . . 0.0 112.445 -179.432 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 67' ' ' LYS . . . . . . . . . . . . . 3.4 pttm -90.18 -13.24 35.99 Favored 'General case' 0 N--CA 1.488 1.457 0 O-C-N 121.323 -0.861 . . . . 0.0 109.366 -179.975 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 68' ' ' ASP . . . . . 0.655 ' C ' ' H ' ' A' ' 70' ' ' SER . 0.5 OUTLIER -76.76 64.27 2.31 Favored 'General case' 0 N--CA 1.488 1.456 0 CA-C-O 122.656 1.217 . . . . 0.0 109.548 -179.885 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 69' ' ' LYS . . . . . 0.457 ' C ' ' O ' ' A' ' 68' ' ' ASP . 12.1 ptpt -47.48 -13.01 0.03 OUTLIER 'General case' 0 N--CA 1.512 2.655 0 C-N-CA 117.039 -1.864 . . . . 0.0 106.66 177.03 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 70' ' ' SER . . . . . 0.655 ' H ' ' C ' ' A' ' 68' ' ' ASP . 1.3 p -85.22 -7.06 59.21 Favored 'General case' 0 N--CA 1.497 1.883 0 CA-C-N 113.259 -1.791 . . . . 0.0 111.151 179.337 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 71' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -98.76 145.66 26.7 Favored 'General case' 0 N--CA 1.501 2.107 0 O-C-N 120.671 -1.268 . . . . 0.0 112.329 -179.141 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 72' ' ' VAL . . . . . 0.49 ' O ' ' CG2' ' A' ' 72' ' ' VAL . 3.0 m -68.02 130.06 32.97 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.384 0 N-CA-C 105.227 -2.138 . . . . 0.0 105.227 175.235 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 73' ' ' ALA . . . . . 0.57 ' N ' ' O ' ' A' ' 87' ' ' VAL . . . -78.92 -15.17 58.67 Favored 'General case' 0 C--N 1.293 -1.858 0 O-C-N 120.16 -1.588 . . . . 0.0 107.623 -179.404 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 74' ' ' GLY . . . . . 0.418 ' O ' ' N ' ' A' ' 87' ' ' VAL . . . 176.04 -159.74 27.3 Favored Glycine 0 N--CA 1.48 1.592 0 N-CA-C 109.712 -1.355 . . . . 0.0 109.712 179.73 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 75' ' ' TYR . . . . . 0.595 ' CD2' ' O ' ' A' ' 85' ' ' GLU . 0.6 OUTLIER -142.97 166.86 23.49 Favored 'General case' 0 C--N 1.295 -1.772 0 O-C-N 121.713 -0.875 . . . . 0.0 110.834 -177.221 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 76' ' ' ILE . . . . . . . . . . . . . 1.5 tt -149.86 146.98 16.58 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.517 0 C-N-CA 119.2 -1.0 . . . . 0.0 109.833 -178.528 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -150.96 164.78 35.55 Favored 'General case' 0 N--CA 1.489 1.495 0 N-CA-C 108.689 -0.856 . . . . 0.0 108.689 179.594 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 78' ' ' ILE . . . . . . . . . . . . . 14.9 mt -146.89 95.87 4.42 Favored Pre-proline 0 C--N 1.3 -1.562 0 N-CA-C 108.392 -0.966 . . . . 0.0 108.392 179.997 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 79' ' ' PRO . . . . . . . . . . . . . 73.5 Cg_exo -46.93 -46.45 18.59 Favored 'Trans proline' 0 N--CA 1.493 1.447 0 C-N-CA 122.865 2.377 . . . . 0.0 113.897 -178.503 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 4.0 t0 -65.38 -20.04 66.21 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 120.749 -1.219 . . . . 0.0 110.423 178.622 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -104.35 -12.58 16.51 Favored 'General case' 0 N--CA 1.493 1.676 0 O-C-N 121.308 -0.87 . . . . 0.0 109.227 179.739 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 82' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER 62.4 48.82 4.43 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.332 -0.855 . . . . 0.0 110.154 179.574 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 83' ' ' ILE . . . . . . . . . . . . . 69.9 mt -129.08 151.84 36.35 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.801 0 O-C-N 121.142 -0.974 . . . . 0.0 110.408 -178.862 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 84' ' ' LYS . . . . . 0.458 ' O ' ' CD ' ' A' ' 85' ' ' GLU . 27.7 tttt -158.86 108.74 1.99 Allowed 'General case' 0 N--CA 1.49 1.545 0 N-CA-C 108.192 -1.04 . . . . 0.0 108.192 179.778 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 85' ' ' GLU . . . . . 0.595 ' O ' ' CD2' ' A' ' 75' ' ' TYR . 7.4 mm-40 -139.64 176.41 2.59 Favored Pre-proline 0 N--CA 1.496 1.859 0 O-C-N 121.457 -0.777 . . . . 0.0 109.899 -178.998 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 86' ' ' PRO . . . . . 0.407 ' HB3' ' CE1' ' A' ' 75' ' ' TYR . 12.3 Cg_endo -85.86 169.68 8.98 Favored 'Trans proline' 0 N--CA 1.491 1.342 0 C-N-CA 123.15 2.566 . . . . 0.0 113.55 -178.75 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 87' ' ' VAL . . . . . 0.57 ' O ' ' N ' ' A' ' 73' ' ' ALA . 45.8 t -124.35 99.38 6.25 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.85 0 O-C-N 121.616 -0.677 . . . . 0.0 109.42 179.497 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 88' ' ' TYR . . . . . . . . . . . . . 26.1 m-85 -90.08 155.52 47.08 Favored Pre-proline 0 N--CA 1.506 2.345 0 O-C-N 120.861 -1.149 . . . . 0.0 109.716 -179.806 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 89' ' ' PRO . . . . . 0.578 ' O ' ' NE2' ' A' ' 96' ' ' GLN . 18.3 Cg_endo -65.62 145.46 81.81 Favored 'Trans proline' 0 N--CA 1.494 1.522 0 C-N-CA 122.486 2.124 . . . . 0.0 113.946 -179.587 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . -53.1 166.5 1.41 Allowed Glycine 0 N--CA 1.49 2.261 0 N-CA-C 109.369 -1.492 . . . . 0.0 109.369 179.167 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 91' ' ' PRO . . . . . 0.478 ' C ' ' H ' ' A' ' 93' ' ' THR . 57.8 Cg_endo -93.72 167.47 20.81 Favored 'Cis proline' 0 C--N 1.308 -1.589 0 C-N-CA 123.756 -1.352 . . . . 0.0 111.583 0.14 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 92' ' ' ALA . . . . . . . . . . . . . . . -73.32 31.07 0.07 Allowed 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.104 -0.997 . . . . 0.0 110.495 -179.781 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 93' ' ' THR . . . . . 0.478 ' H ' ' C ' ' A' ' 91' ' ' PRO . 1.4 p -73.16 153.01 90.57 Favored Pre-proline 0 N--CA 1.49 1.534 0 O-C-N 120.725 -1.234 . . . . 0.0 109.288 -179.65 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 94' ' ' PRO . . . . . . . . . . . . . 89.8 Cg_exo -33.22 -56.83 0.35 Allowed 'Trans proline' 0 C--N 1.311 -1.431 0 C-N-CA 122.982 2.454 . . . . 0.0 112.299 -179.686 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 41.1 mt-10 -46.5 -48.33 19.24 Favored 'General case' 0 N--CA 1.488 1.444 0 O-C-N 121.171 -0.955 . . . . 0.0 108.874 179.813 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 96' ' ' GLN . . . . . 0.578 ' NE2' ' O ' ' A' ' 89' ' ' PRO . 3.4 mm-40 -72.29 -54.95 8.04 Favored 'General case' 0 C--N 1.305 -1.333 0 O-C-N 121.192 -0.942 . . . . 0.0 109.712 179.767 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 97' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -48.33 -8.01 0.02 OUTLIER 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.254 -0.904 . . . . 0.0 109.926 -179.593 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 98' ' ' ASN . . . . . 0.741 HD22 ' HE ' ' A' ' 99' ' ' ARG . 0.1 OUTLIER -74.41 -24.45 59.11 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.163 -0.961 . . . . 0.0 109.162 179.672 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 99' ' ' ARG . . . . . 0.741 ' HE ' HD22 ' A' ' 98' ' ' ASN . 4.2 mtt180 -95.2 -53.65 3.71 Favored 'General case' 0 C--N 1.3 -1.561 0 O-C-N 121.659 -0.651 . . . . 0.0 110.294 -178.813 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . 177.52 -159.7 25.9 Favored Glycine 0 N--CA 1.492 2.402 0 C-N-CA 119.366 -1.397 . . . . 0.0 110.167 179.807 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 101' ' ' VAL . . . . . 0.526 ' O ' ' CG2' ' A' ' 101' ' ' VAL . 25.0 m -62.03 100.07 0.15 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.629 0 O-C-N 121.523 -0.986 . . . . 0.0 109.296 -179.911 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 102' ' ' SER . . . . . 0.558 ' HG ' ' CD ' ' A' ' 96' ' ' GLN . 1.6 m -93.35 159.9 15.06 Favored 'General case' 0 C--N 1.298 -1.644 0 O-C-N 121.2 -0.938 . . . . 0.0 110.156 -179.963 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 103' ' ' PHE . . . . . . . . . . . . . 21.2 m-85 -59.63 160.72 6.88 Favored 'General case' 0 N--CA 1.49 1.57 0 N-CA-C 107.869 -1.16 . . . . 0.0 107.869 178.671 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 104' ' ' ALA . . . . . . . . . . . . . . . -72.33 -28.16 62.88 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.211 -0.93 . . . . 0.0 111.814 -177.932 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -135.25 150.45 50.06 Favored 'General case' 0 N--CA 1.495 1.819 0 O-C-N 120.822 -1.174 . . . . 0.0 111.023 -178.518 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 106' ' ' GLU . . . . . 0.454 ' CG ' ' H ' ' A' ' 107' ' ' ASN . 1.3 pt-20 -54.15 -63.33 1.18 Allowed 'General case' 0 N--CA 1.487 1.402 0 CA-C-N 115.999 -0.546 . . . . 0.0 111.293 -179.256 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 107' ' ' ASN . . . . . 0.454 ' H ' ' CG ' ' A' ' 106' ' ' GLU . 15.8 m120 -75.84 32.46 0.11 Allowed 'General case' 0 N--CA 1.49 1.543 0 O-C-N 120.175 -1.578 . . . . 0.0 112.621 -175.398 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 108' ' ' GLU . . . . . . . . . . . . . 44.6 tp10 -60.48 148.55 37.26 Favored 'General case' 0 C--N 1.299 -1.597 0 C-N-CA 118.865 -1.134 . . . . 0.0 108.008 -179.684 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 109' ' ' SER . . . . . 0.576 ' C ' ' H ' ' A' ' 111' ' ' ASP . 1.3 t -96.57 121.62 38.59 Favored 'General case' 0 C--N 1.302 -1.49 0 O-C-N 121.039 -1.038 . . . . 0.0 109.683 -178.77 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 110' ' ' LEU . . . . . . . . . . . . . 12.7 tp -59.19 -1.57 0.2 Allowed 'General case' 0 C--N 1.302 -1.479 0 N-CA-C 108.54 -0.911 . . . . 0.0 108.54 -179.912 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 111' ' ' ASP . . . . . 0.576 ' H ' ' C ' ' A' ' 109' ' ' SER . 8.7 m-20 -131.77 20.58 4.62 Favored 'General case' 0 N--CA 1.487 1.406 0 N-CA-C 108.927 -0.768 . . . . 0.0 108.927 179.36 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 112' ' ' ASP . . . . . 0.428 ' C ' ' H ' ' A' ' 114' ' ' ASN . 0.3 OUTLIER -65.47 133.82 52.1 Favored 'General case' 0 N--CA 1.49 1.525 0 O-C-N 121.348 -0.845 . . . . 0.0 109.944 -179.958 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 113' ' ' GLN . . . . . 0.594 ' NE2' ' O ' ' A' ' 173' ' ' LYS . 0.0 OUTLIER -65.46 -4.33 5.62 Favored 'General case' 0 C--N 1.303 -1.436 0 O-C-N 121.058 -1.026 . . . . 0.0 108.869 179.032 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 114' ' ' ASN . . . . . 0.685 ' ND2' ' NE2' ' A' ' 178' ' ' GLN . 18.4 t-20 -143.38 91.19 2.24 Favored 'General case' 0 C--N 1.301 -1.517 0 N-CA-C 107.559 -1.274 . . . . 0.0 107.559 178.409 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 115' ' ' ILE . . . . . . . . . . . . . 3.3 mt -100.69 115.14 41.61 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.466 0 O-C-N 121.627 -0.671 . . . . 0.0 109.913 -178.913 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 116' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -101.82 145.53 29.05 Favored 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.345 -0.847 . . . . 0.0 110.93 -179.149 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 117' ' ' ILE . . . . . . . . . . . . . 1.2 mt -135.15 157.38 40.37 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.461 0 N-CA-C 108.101 -1.074 . . . . 0.0 108.101 179.521 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 118' ' ' ALA . . . . . . . . . . . . . . . -142.62 161.82 37.08 Favored 'General case' 0 N--CA 1.492 1.658 0 O-C-N 120.822 -1.174 . . . . 0.0 111.177 -179.611 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 119' ' ' GLY . . . . . . . . . . . . . . . -170.29 143.54 7.87 Favored Glycine 0 N--CA 1.49 2.249 0 C-N-CA 120.191 -1.004 . . . . 0.0 110.755 179.801 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 120' ' ' HIS . . . . . . . . . . . . . 29.9 m170 -71.16 167.86 18.44 Favored 'General case' 0 N--CA 1.493 1.693 0 O-C-N 121.674 -0.898 . . . . 0.0 109.514 179.024 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 121' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -118.29 159.57 23.14 Favored 'General case' 0 N--CA 1.496 1.863 0 O-C-N 121.211 -0.931 . . . . 0.0 108.84 179.449 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 122' ' ' PHE . . . . . . . . . . . . . 0.5 OUTLIER -143.68 127.97 17.77 Favored 'General case' 0 N--CA 1.497 1.918 0 O-C-N 120.935 -1.103 . . . . 0.0 109.705 -179.623 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 123' ' ' ILE . . . . . . . . . . . . . 4.4 tt -64.66 -40.11 87.92 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.55 0 N-CA-C 108.982 -0.748 . . . . 0.0 108.982 179.858 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 124' ' ' ASP . . . . . . . . . . . . . 70.3 m-20 -89.11 26.08 1.69 Allowed 'General case' 0 N--CA 1.496 1.829 0 O-C-N 121.563 -0.711 . . . . 0.0 112.253 -177.358 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 125' ' ' ARG . . . . . 0.671 HH11 ' CG ' ' A' ' 125' ' ' ARG . 1.8 mtt-85 -154.29 100.77 2.45 Favored Pre-proline 0 N--CA 1.496 1.826 0 O-C-N 120.754 -1.216 . . . . 0.0 109.692 179.781 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 126' ' ' PRO . . . . . . . . . . . . . 73.1 Cg_endo -80.69 -28.08 2.9 Favored 'Trans proline' 0 C--N 1.315 -1.195 0 C-N-CA 122.107 1.871 . . . . 0.0 112.546 -179.934 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 127' ' ' ASN . . . . . 0.427 ' O ' ' O ' ' A' ' 128' ' ' TYR . 1.6 m120 -91.61 7.5 41.19 Favored 'General case' 0 N--CA 1.489 1.478 0 O-C-N 121.089 -1.007 . . . . 0.0 109.715 -179.864 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 128' ' ' TYR . . . . . 0.687 ' CE2' ' NE2' ' A' ' 129' ' ' GLN . 4.6 t80 -60.48 -151.25 0.0 OUTLIER 'General case' 0 C--N 1.301 -1.529 0 O-C-N 121.258 -0.901 . . . . 0.0 109.84 -179.733 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 129' ' ' GLN . . . . . 0.687 ' NE2' ' CE2' ' A' ' 128' ' ' TYR . 2.6 mp0 -67.78 -71.57 0.2 Allowed 'General case' 0 N--CA 1.489 1.478 0 O-C-N 121.341 -0.849 . . . . 0.0 110.051 -179.482 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 130' ' ' PHE . . . . . 0.463 ' CE2' ' CG1' ' A' ' 101' ' ' VAL . 55.4 m-85 -135.44 50.82 2.1 Favored 'General case' 0 N--CA 1.492 1.673 0 O-C-N 121.193 -0.942 . . . . 0.0 110.473 -179.371 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 131' ' ' THR . . . . . . . . . . . . . 2.9 m -82.13 -38.77 24.26 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.031 -1.043 . . . . 0.0 108.81 179.067 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 132' ' ' ASN . . . . . . . . . . . . . 4.8 t30 -84.34 6.42 23.12 Favored 'General case' 0 N--CA 1.494 1.731 0 C-N-CA 120.083 -0.647 . . . . 0.0 111.121 -178.91 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 133' ' ' LEU . . . . . 0.598 ' O ' ' N ' ' A' ' 135' ' ' ALA . 0.2 OUTLIER -68.5 -47.75 66.18 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 120.906 -1.121 . . . . 0.0 110.69 -179.04 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 134' ' ' LYS . . . . . 0.552 ' H ' ' CD ' ' A' ' 134' ' ' LYS . 0.1 OUTLIER -42.15 -18.48 0.01 OUTLIER 'General case' 0 N--CA 1.494 1.747 0 O-C-N 121.098 -1.001 . . . . 0.0 109.949 -179.025 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 135' ' ' ALA . . . . . 0.598 ' N ' ' O ' ' A' ' 133' ' ' LEU . . . -83.87 -31.82 25.53 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.063 -1.023 . . . . 0.0 109.94 -179.946 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 136' ' ' ALA . . . . . 0.476 ' N ' ' O ' ' A' ' 133' ' ' LEU . . . -80.78 153.99 27.45 Favored 'General case' 0 N--CA 1.489 1.518 0 CA-C-O 122.163 0.982 . . . . 0.0 112.142 -178.366 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 137' ' ' LYS . . . . . 0.524 ' O ' ' O ' ' A' ' 138' ' ' LYS . 4.8 tttt -150.92 -166.93 2.67 Favored 'General case' 0 N--CA 1.493 1.717 0 C-N-CA 118.926 -1.11 . . . . 0.0 110.879 -178.197 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 138' ' ' LYS . . . . . 0.592 ' O ' ' N ' ' A' ' 140' ' ' SER . 36.3 mttm -44.45 178.72 0.0 OUTLIER 'General case' 0 N--CA 1.487 1.378 0 CA-C-O 122.221 1.01 . . . . 0.0 110.971 -178.755 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 139' ' ' GLY . . . . . . . . . . . . . . . 46.6 7.59 0.02 OUTLIER Glycine 0 N--CA 1.491 2.351 0 N-CA-C 110.545 -1.022 . . . . 0.0 110.545 -179.959 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 140' ' ' SER . . . . . 0.592 ' N ' ' O ' ' A' ' 138' ' ' LYS . 48.7 m -84.77 121.57 27.88 Favored 'General case' 0 N--CA 1.495 1.785 0 O-C-N 120.809 -1.406 . . . . 0.0 109.215 179.244 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 141' ' ' MET . . . . . 0.646 ' SD ' ' N ' ' A' ' 142' ' ' VAL . 10.8 tpp -72.47 131.76 42.98 Favored 'General case' 0 N--CA 1.488 1.462 0 O-C-N 121.125 -0.984 . . . . 0.0 109.223 179.898 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 142' ' ' VAL . . . . . 0.646 ' N ' ' SD ' ' A' ' 141' ' ' MET . 3.2 t -116.02 133.13 63.46 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.702 0 N-CA-C 108.794 -0.817 . . . . 0.0 108.794 -179.593 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 143' ' ' TYR . . . . . . . . . . . . . 17.9 m-85 -109.23 135.28 50.59 Favored 'General case' 0 N--CA 1.497 1.92 0 O-C-N 120.89 -1.132 . . . . 0.0 111.531 -178.434 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 144' ' ' PHE . . . . . . . . . . . . . 49.1 t80 -120.25 101.86 8.1 Favored 'General case' 0 N--CA 1.495 1.793 0 C-N-CA 120.359 -0.536 . . . . 0.0 109.566 -179.432 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 145' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -96.65 132.1 42.64 Favored 'General case' 0 N--CA 1.493 1.708 0 O-C-N 121.205 -0.935 . . . . 0.0 110.878 -178.822 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 146' ' ' VAL . . . . . 0.414 ' O ' ' C ' ' A' ' 147' ' ' GLY . 0.1 OUTLIER -142.96 143.78 24.79 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.738 0 N-CA-C 107.764 -1.199 . . . . 0.0 107.764 178.655 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 147' ' ' GLY . . . . . 0.414 ' C ' ' O ' ' A' ' 146' ' ' VAL . . . 44.37 -130.77 7.25 Favored Glycine 0 N--CA 1.489 2.221 0 O-C-N 120.28 -1.512 . . . . 0.0 109.324 -179.958 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 148' ' ' ASN . . . . . 0.558 ' C ' HD21 ' A' ' 148' ' ' ASN . 0.4 OUTLIER -102.86 18.49 21.4 Favored 'General case' 0 C--N 1.3 -1.572 0 O-C-N 121.374 -1.074 . . . . 0.0 108.588 179.537 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 149' ' ' GLU . . . . . . . . . . . . . 8.4 tt0 -114.38 147.94 38.41 Favored 'General case' 0 N--CA 1.489 1.523 0 CA-C-O 121.862 0.839 . . . . 0.0 111.249 -178.538 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 150' ' ' THR . . . . . . . . . . . . . 1.2 m -129.24 105.68 8.31 Favored 'General case' 0 N--CA 1.492 1.646 0 CA-C-O 121.585 0.707 . . . . 0.0 109.675 179.941 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 151' ' ' ARG . . . . . . . . . . . . . 10.8 mtp180 -87.34 -171.6 3.55 Favored 'General case' 0 N--CA 1.487 1.401 0 N-CA-C 108.624 -0.88 . . . . 0.0 108.624 -179.967 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 152' ' ' LYS . . . . . . . . . . . . . 1.1 ttmt -150.41 147.36 27.46 Favored 'General case' 0 C--N 1.303 -1.442 0 O-C-N 120.918 -1.114 . . . . 0.0 110.787 -179.299 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 153' ' ' TYR . . . . . 0.562 ' O ' ' SD ' ' A' ' 141' ' ' MET . 22.2 m-85 -142.2 165.6 26.98 Favored 'General case' 0 N--CA 1.49 1.574 0 N-CA-C 108.024 -1.102 . . . . 0.0 108.024 179.24 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 154' ' ' LYS . . . . . . . . . . . . . 30.9 ttpt -142.91 121.02 12.15 Favored 'General case' 0 N--CA 1.493 1.684 0 O-C-N 121.061 -1.025 . . . . 0.0 108.666 178.854 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 155' ' ' MET . . . . . . . . . . . . . 4.1 mtt -47.1 105.9 0.08 Allowed 'General case' 0 N--CA 1.493 1.687 0 O-C-N 120.889 -1.132 . . . . 0.0 112.017 -178.419 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 156' ' ' THR . . . . . 0.519 ' OG1' ' CG2' ' A' ' 203' ' ' THR . 0.0 OUTLIER -107.46 -23.38 12.21 Favored 'General case' 0 C--N 1.293 -1.886 0 CA-C-N 115.16 -0.927 . . . . 0.0 110.112 -179.572 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 157' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -153.16 150.43 29.06 Favored 'General case' 0 C--N 1.296 -1.728 0 C-N-CA 118.388 -1.325 . . . . 0.0 111.363 -178.797 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 158' ' ' ILE . . . . . 0.422 HG13 ' CD2' ' A' ' 200' ' ' PHE . 0.0 OUTLIER -154.18 145.12 14.08 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.357 0 CA-C-O 121.872 0.844 . . . . 0.0 110.055 -179.276 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 159' ' ' ARG . . . . . 0.417 ' N ' HG12 ' A' ' 158' ' ' ILE . 0.1 OUTLIER -151.38 156.6 41.04 Favored 'General case' 0 C--N 1.3 -1.568 0 CA-C-O 121.52 0.676 . . . . 0.0 109.747 -179.792 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 160' ' ' ASP . . . . . 0.467 ' N ' ' OD1' ' A' ' 160' ' ' ASP . 2.2 m-20 -117.62 157.08 27.04 Favored 'General case' 0 N--CA 1.49 1.563 0 N-CA-C 108.781 -0.822 . . . . 0.0 108.781 -179.909 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 161' ' ' VAL . . . . . . . . . . . . . 0.1 OUTLIER -163.43 160.24 1.29 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.654 0 O-C-N 121.072 -1.017 . . . . 0.0 110.49 -179.912 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 162' ' ' LYS . . . . . . . . . . . . . 14.1 ptmt -52.13 177.88 0.06 OUTLIER Pre-proline 0 N--CA 1.49 1.562 0 N-CA-C 108.694 -0.854 . . . . 0.0 108.694 179.043 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 163' ' ' PRO . . . . . . . . . . . . . 37.3 Cg_endo -86.63 43.39 1.03 Allowed 'Trans proline' 0 C--N 1.316 -1.18 0 C-N-CA 122.238 1.959 . . . . 0.0 112.502 -179.344 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 164' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -151.93 -11.21 0.2 Allowed 'General case' 0 N--CA 1.494 1.741 0 O-C-N 121.262 -0.899 . . . . 0.0 110.372 -179.972 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 165' ' ' ASP . . . . . 0.449 ' O ' ' C ' ' A' ' 166' ' ' VAL . 1.2 t70 -73.21 61.93 0.65 Allowed 'General case' 0 N--CA 1.49 1.558 0 O-C-N 120.867 -1.146 . . . . 0.0 110.258 -179.301 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 166' ' ' VAL . . . . . 0.623 ' O ' ' N ' ' A' ' 168' ' ' VAL . 0.9 OUTLIER -41.89 -31.42 0.35 Allowed 'Isoleucine or valine' 0 N--CA 1.494 1.73 0 O-C-N 121.399 -0.813 . . . . 0.0 109.023 -178.329 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 167' ' ' GLY . . . . . . . . . . . . . . . -42.65 -13.38 0.01 OUTLIER Glycine 0 N--CA 1.494 2.546 0 O-C-N 121.06 -1.025 . . . . 0.0 110.742 179.892 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 168' ' ' VAL . . . . . 0.636 ' C ' ' H ' ' A' ' 170' ' ' ASP . 6.1 m -53.46 -35.64 25.67 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.468 0 O-C-N 120.708 -1.466 . . . . 0.0 108.738 179.62 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 169' ' ' LEU . . . . . 0.522 ' O ' ' N ' ' A' ' 171' ' ' GLU . 27.8 mt -51.86 -7.19 0.05 OUTLIER 'General case' 0 N--CA 1.495 1.805 0 N-CA-C 108.004 -1.11 . . . . 0.0 108.004 -179.272 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 170' ' ' ASP . . . . . 0.636 ' H ' ' C ' ' A' ' 168' ' ' VAL . 34.4 t0 35.16 28.58 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.525 0 O-C-N 121.764 -0.585 . . . . 0.0 111.87 177.687 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 171' ' ' GLU . . . . . 0.522 ' N ' ' O ' ' A' ' 169' ' ' LEU . 12.7 pt-20 -62.3 94.26 0.06 Allowed 'General case' 0 N--CA 1.494 1.767 0 O-C-N 120.382 -1.449 . . . . 0.0 107.45 178.105 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 172' ' ' GLN . . . . . . . . . . . . . 2.2 mt-30 -152.66 -78.16 0.11 Allowed 'General case' 0 N--CA 1.497 1.877 0 O-C-N 121.434 -0.791 . . . . 0.0 110.548 -178.595 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 173' ' ' LYS . . . . . 0.594 ' O ' ' NE2' ' A' ' 113' ' ' GLN . 1.0 OUTLIER -55.95 136.52 51.77 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.43 -0.794 . . . . 0.0 109.386 -179.432 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 174' ' ' GLY . . . . . 0.477 ' O ' ' C ' ' A' ' 175' ' ' LYS . . . -120.03 -45.78 0.4 Allowed Glycine 0 N--CA 1.479 1.527 0 N-CA-C 107.441 -2.263 . . . . 0.0 107.441 179.239 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 175' ' ' LYS . . . . . 0.477 ' C ' ' O ' ' A' ' 174' ' ' GLY . 0.4 OUTLIER -38.13 -75.44 0.03 OUTLIER 'General case' 0 N--CA 1.493 1.724 0 N-CA-C 108.272 -1.011 . . . . 0.0 108.272 179.562 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 176' ' ' ASP . . . . . 0.547 ' O ' ' O ' ' A' ' 177' ' ' LYS . 66.7 m-20 -89.97 94.7 9.9 Favored 'General case' 0 C--N 1.296 -1.754 0 N-CA-C 106.967 -1.494 . . . . 0.0 106.967 177.943 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 177' ' ' LYS . . . . . 0.547 ' O ' ' O ' ' A' ' 176' ' ' ASP . 19.6 mttp -44.19 -178.4 0.0 OUTLIER 'General case' 0 N--CA 1.493 1.687 0 CA-C-O 121.487 0.66 . . . . 0.0 110.795 -178.311 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 178' ' ' GLN . . . . . 0.685 ' NE2' ' ND2' ' A' ' 114' ' ' ASN . 20.3 pt20 -161.06 161.38 31.29 Favored 'General case' 0 N--CA 1.487 1.386 0 C-N-CA 118.557 -1.257 . . . . 0.0 111.089 179.86 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 179' ' ' LEU . . . . . . . . . . . . . 1.2 tp -123.6 94.34 4.21 Favored 'General case' 0 C--N 1.303 -1.445 0 N-CA-C 106.944 -1.502 . . . . 0.0 106.944 177.398 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 180' ' ' THR . . . . . . . . . . . . . 3.3 m -71.64 120.32 17.06 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.111 -0.993 . . . . 0.0 110.427 -178.097 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 181' ' ' LEU . . . . . 0.423 HD13 ' H ' ' A' ' 182' ' ' ILE . 34.4 tp -95.98 142.6 28.01 Favored 'General case' 0 C--N 1.302 -1.498 0 N-CA-C 108.153 -1.054 . . . . 0.0 108.153 178.338 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 182' ' ' ILE . . . . . 0.423 ' H ' HD13 ' A' ' 181' ' ' LEU . 3.9 mt -136.39 109.69 8.83 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.612 0 O-C-N 121.02 -1.05 . . . . 0.0 108.689 178.9 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 183' ' ' THR . . . . . . . . . . . . . 4.4 t -129.76 113.06 14.25 Favored 'General case' 0 C--N 1.293 -1.881 0 N-CA-C 107.337 -1.357 . . . . 0.0 107.337 179.327 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 184' ' ' CYS . . . . . . . . . . . . . 0.8 OUTLIER -79.23 164.03 24.49 Favored 'General case' 0 C--N 1.289 -2.026 0 C-N-CA 118.994 -1.082 . . . . 0.0 111.145 -177.691 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 185' ' ' ASP . . . . . . . . . . . . . 9.9 t0 -165.2 -154.33 0.21 Allowed 'General case' 0 N--CA 1.493 1.687 0 N-CA-C 108.892 -0.781 . . . . 0.0 108.892 -179.829 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 186' ' ' ASP . . . . . . . . . . . . . 1.5 m-20 49.43 59.28 4.6 Favored 'General case' 0 N--CA 1.495 1.802 0 O-C-N 120.95 -1.094 . . . . 0.0 108.971 -179.666 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 187' ' ' TYR . . . . . 0.607 ' CE2' ' O ' ' A' ' 188' ' ' ASN . 68.2 t80 -67.4 138.76 56.94 Favored 'General case' 0 N--CA 1.491 1.579 0 CA-C-O 121.85 0.833 . . . . 0.0 110.871 -179.184 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 188' ' ' ASN . . . . . 0.607 ' O ' ' CE2' ' A' ' 187' ' ' TYR . 0.7 OUTLIER -104.32 143.72 32.59 Favored 'General case' 0 C--N 1.299 -1.589 0 N-CA-C 108.305 -0.998 . . . . 0.0 108.305 178.391 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 189' ' ' GLU . . . . . . . . . . . . . 2.5 tt0 -108.22 -17.05 14.11 Favored 'General case' 0 C--N 1.293 -1.891 0 N-CA-C 108.879 -0.786 . . . . 0.0 108.879 -179.284 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 190' ' ' LYS . . . . . . . . . . . . . 24.4 mmtm -82.77 -51.64 7.49 Favored 'General case' 0 C--N 1.301 -1.541 0 C-N-CA 119.792 -0.763 . . . . 0.0 108.96 179.154 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 191' ' ' THR . . . . . . . . . . . . . 4.1 p -89.83 -10.91 43.64 Favored 'General case' 0 N--CA 1.489 1.477 0 O-C-N 121.442 -0.786 . . . . 0.0 109.802 -179.608 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 192' ' ' GLY . . . . . . . . . . . . . . . 63.73 39.32 97.36 Favored Glycine 0 N--CA 1.494 2.537 0 O-C-N 120.945 -1.097 . . . . 0.0 110.375 179.25 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 193' ' ' VAL . . . . . 0.516 ' CG1' ' N ' ' A' ' 194' ' ' TRP . 55.4 t -147.99 163.45 6.19 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.571 0 O-C-N 121.114 -1.227 . . . . 0.0 109.679 179.959 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 194' ' ' TRP . . . . . 0.516 ' N ' ' CG1' ' A' ' 193' ' ' VAL . 10.0 m95 -82.29 118.81 23.41 Favored 'General case' 0 C--N 1.301 -1.524 0 N-CA-C 108.356 -0.979 . . . . 0.0 108.356 179.613 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 195' ' ' GLU . . . . . 0.545 ' CD ' ' ND2' ' A' ' 188' ' ' ASN . 2.8 mt-10 -79.2 -60.82 2.22 Favored 'General case' 0 N--CA 1.493 1.692 0 O-C-N 121.32 -0.863 . . . . 0.0 110.946 -178.528 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 196' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -95.29 152.82 18.04 Favored 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.197 -0.939 . . . . 0.0 110.121 -178.789 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 197' ' ' ARG . . . . . 0.621 ' CG ' HH11 ' A' ' 197' ' ' ARG . 0.1 OUTLIER -122.94 143.18 50.07 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.668 -0.645 . . . . 0.0 109.723 179.86 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 198' ' ' LYS . . . . . 0.441 ' NZ ' ' OD2' ' A' ' 160' ' ' ASP . 4.2 mptp? -113.77 120.72 41.75 Favored 'General case' 0 C--N 1.302 -1.487 0 O-C-N 121.7 -0.625 . . . . 0.0 109.56 -179.68 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 199' ' ' ILE . . . . . 0.435 ' C ' ' CD1' ' A' ' 199' ' ' ILE . 0.5 OUTLIER -139.66 118.41 12.13 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.677 0 CA-C-O 122.502 1.144 . . . . 0.0 109.829 179.926 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 200' ' ' PHE . . . . . 0.527 ' CD1' ' N ' ' A' ' 200' ' ' PHE . 6.6 m-85 -100.57 138.5 37.54 Favored 'General case' 0 N--CA 1.494 1.728 0 O-C-N 121.353 -0.842 . . . . 0.0 109.912 -178.626 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 201' ' ' VAL . . . . . . . . . . . . . 44.6 t -101.61 136.34 33.97 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.543 0 N-CA-C 107.795 -1.187 . . . . 0.0 107.795 177.662 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 202' ' ' ALA . . . . . . . . . . . . . . . -121.16 134.59 55.23 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.238 -0.914 . . . . 0.0 109.171 -179.939 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 203' ' ' THR . . . . . 0.519 ' CG2' ' OG1' ' A' ' 156' ' ' THR . 13.7 p -88.76 133.34 34.27 Favored 'General case' 0 C--N 1.306 -1.316 0 CA-C-O 122.158 0.98 . . . . 0.0 110.99 -178.72 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 204' ' ' GLU . . . . . 0.497 ' HA ' ' CD2' ' A' ' 153' ' ' TYR . 3.1 tt0 -51.72 133.84 30.87 Favored 'General case' 0 C--N 1.297 -1.686 0 C-N-CA 118.811 -1.155 . . . . 0.0 109.38 179.394 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 205' ' ' VAL . . . . . 0.477 ' CG1' ' N ' ' A' ' 206' ' ' LYS . 44.3 t -127.53 161.66 34.64 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.295 0 CA-C-O 122.044 0.926 . . . . 0.0 110.242 -177.59 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 206' ' ' LYS . . . . . 0.477 ' N ' ' CG1' ' A' ' 205' ' ' VAL . 70.7 mttt . . . . . 0 C--N 1.296 -1.731 0 CA-C-O 118.047 -0.978 . . . . 0.0 109.294 179.85 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' C' C ' 702' ' ' LEU . . . . . 0.56 ' H ' ' CD1' ' C' ' 702' ' ' LEU . 0.0 OUTLIER . . . . . 0 N--CA 1.492 1.661 0 N-CA-C 109.227 -0.657 . . . . 0.0 109.227 . . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' C' C ' 703' ' ' PRO . . . . . 0.551 ' O ' ' NH2' ' A' ' 197' ' ' ARG . 16.3 Cg_endo -57.99 162.98 10.29 Favored 'Trans proline' 0 N--CA 1.499 1.845 0 C-N-CA 123.633 2.888 . . . . 0.0 113.55 -178.934 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' C' C ' 704' ' ' ALA . . . . . 0.47 ' C ' ' O ' ' C' ' 703' ' ' PRO . . . . . . . . 0 N--CA 1.491 1.622 0 CA-C-O 121.39 0.614 . . . . 0.0 110.277 179.274 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 63' ' ' PRO . . . . . . . . . . . . . 52.1 Cg_endo . . . . . 0 N--CA 1.481 0.762 0 CA-C-O 121.005 0.336 . . . . 0.0 111.467 . . . . . . . . . 0 0 . 1 . 009 nuclear orig core ' A' A ' 64' ' ' GLN . . . . . 0.638 ' NE2' ' N ' ' A' ' 64' ' ' GLN . 0.0 OUTLIER -156.36 127.73 7.1 Favored 'General case' 0 N--CA 1.495 1.793 0 O-C-N 120.955 -1.091 . . . . 0.0 109.62 179.366 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 65' ' ' ILE . . . . . 0.533 ' H ' ' CD1' ' A' ' 65' ' ' ILE . 0.0 OUTLIER -50.79 110.03 1.58 Allowed Pre-proline 0 N--CA 1.49 1.552 0 O-C-N 121.085 -1.009 . . . . 0.0 109.195 178.929 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 66' ' ' PRO . . . . . . . . . . . . . 89.0 Cg_endo -85.64 -154.47 0.05 OUTLIER 'Trans proline' 0 C--N 1.312 -1.392 0 C-N-CA 121.954 1.769 . . . . 0.0 111.712 179.607 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 67' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -83.71 -4.69 58.83 Favored 'General case' 0 N--CA 1.488 1.46 0 O-C-N 121.189 -0.944 . . . . 0.0 109.185 179.553 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 68' ' ' ASP . . . . . 0.634 ' C ' ' N ' ' A' ' 70' ' ' SER . 4.6 t0 -76.14 52.1 0.71 Allowed 'General case' 0 N--CA 1.49 1.574 0 CA-C-O 122.221 1.01 . . . . 0.0 110.099 -179.689 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 69' ' ' LYS . . . . . 0.413 ' C ' ' O ' ' A' ' 68' ' ' ASP . 0.0 OUTLIER -49.38 -13.45 0.08 Allowed 'General case' 0 N--CA 1.507 2.375 0 C-N-CA 116.723 -1.991 . . . . 0.0 106.749 177.593 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 70' ' ' SER . . . . . 0.634 ' N ' ' C ' ' A' ' 68' ' ' ASP . 0.0 OUTLIER -83.31 -8.22 59.47 Favored 'General case' 0 N--CA 1.497 1.896 0 CA-C-N 113.331 -1.759 . . . . 0.0 110.381 179.557 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 71' ' ' LYS . . . . . . . . . . . . . 8.3 ptmt -101.88 142.88 32.49 Favored 'General case' 0 N--CA 1.495 1.793 0 O-C-N 121.021 -1.049 . . . . 0.0 110.643 179.875 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 0.9 OUTLIER -64.92 142.63 16.68 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.434 0 N-CA-C 105.309 -2.108 . . . . 0.0 105.309 175.291 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 73' ' ' ALA . . . . . 0.498 ' N ' ' O ' ' A' ' 87' ' ' VAL . . . -83.16 -14.0 54.39 Favored 'General case' 0 C--N 1.296 -1.757 0 O-C-N 120.101 -1.624 . . . . 0.0 107.134 179.944 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . 173.83 -157.11 25.1 Favored Glycine 0 C--N 1.296 -1.677 0 N-CA-C 108.595 -1.802 . . . . 0.0 108.595 179.472 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 75' ' ' TYR . . . . . 0.55 ' CE1' ' N ' ' A' ' 86' ' ' PRO . 0.3 OUTLIER -142.96 171.09 14.52 Favored 'General case' 0 C--N 1.292 -1.909 0 O-C-N 121.441 -1.034 . . . . 0.0 110.335 -177.624 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 76' ' ' ILE . . . . . . . . . . . . . 0.5 OUTLIER -148.12 143.72 19.19 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.601 0 C-N-CA 119.048 -1.061 . . . . 0.0 109.77 -177.29 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 2.2 mt-10 -151.53 163.35 39.23 Favored 'General case' 0 C--N 1.304 -1.41 0 O-C-N 121.136 -0.977 . . . . 0.0 109.254 179.573 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 78' ' ' ILE . . . . . . . . . . . . . 14.6 mt -144.77 126.51 7.95 Favored Pre-proline 0 N--CA 1.492 1.656 0 N-CA-C 108.538 -0.912 . . . . 0.0 108.538 179.886 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 79' ' ' PRO . . . . . . . . . . . . . 36.0 Cg_endo -71.52 -48.73 0.39 Allowed 'Trans proline' 0 N--CA 1.491 1.362 0 C-N-CA 122.011 1.807 . . . . 0.0 113.501 -179.064 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 50.5 t0 -66.48 -21.24 66.18 Favored 'General case' 0 N--CA 1.493 1.705 0 O-C-N 120.976 -1.077 . . . . 0.0 111.306 178.806 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 81' ' ' ALA . . . . . 0.6 ' O ' ' ND2' ' A' ' 132' ' ' ASN . . . -104.55 -16.44 15.04 Favored 'General case' 0 N--CA 1.493 1.685 0 O-C-N 120.833 -1.167 . . . . 0.0 108.991 179.657 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 82' ' ' ASP . . . . . . . . . . . . . 8.5 t0 61.17 53.57 3.54 Favored 'General case' 0 N--CA 1.494 1.735 0 O-C-N 121.284 -0.885 . . . . 0.0 111.462 178.518 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 83' ' ' ILE . . . . . . . . . . . . . 50.8 mt -128.96 154.45 39.98 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.794 0 O-C-N 121.027 -1.045 . . . . 0.0 109.43 -179.798 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 84' ' ' LYS . . . . . . . . . . . . . 2.1 pttt -157.81 107.72 2.14 Favored 'General case' 0 N--CA 1.487 1.422 0 N-CA-C 107.959 -1.126 . . . . 0.0 107.959 -179.786 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 85' ' ' GLU . . . . . 0.498 ' C ' ' CE1' ' A' ' 75' ' ' TYR . 0.1 OUTLIER -141.17 160.32 58.13 Favored Pre-proline 0 N--CA 1.493 1.682 0 O-C-N 121.336 -0.852 . . . . 0.0 110.126 -179.065 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 86' ' ' PRO . . . . . 0.55 ' N ' ' CE1' ' A' ' 75' ' ' TYR . 36.7 Cg_endo -68.18 168.85 18.08 Favored 'Trans proline' 0 C--N 1.307 -1.611 0 C-N-CA 123.095 2.53 . . . . 0.0 113.081 -179.061 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 87' ' ' VAL . . . . . 0.498 ' O ' ' N ' ' A' ' 73' ' ' ALA . 94.1 t -127.46 99.31 5.2 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.627 0 N-CA-C 109.106 -0.701 . . . . 0.0 109.106 179.69 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 88' ' ' TYR . . . . . . . . . . . . . 20.9 m-85 -92.34 154.18 42.86 Favored Pre-proline 0 N--CA 1.503 2.204 0 O-C-N 120.873 -1.142 . . . . 0.0 109.79 -179.734 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 89' ' ' PRO . . . . . . . . . . . . . 7.3 Cg_endo -59.02 144.6 99.3 Favored 'Trans proline' 0 C--N 1.309 -1.518 0 C-N-CA 122.476 2.117 . . . . 0.0 113.551 -179.663 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . -59.14 169.1 6.23 Favored Glycine 0 N--CA 1.494 2.541 0 N-CA-C 108.899 -1.681 . . . . 0.0 108.899 178.902 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 91' ' ' PRO . . . . . 0.47 ' C ' ' H ' ' A' ' 93' ' ' THR . 59.8 Cg_endo -93.56 168.02 20.96 Favored 'Cis proline' 0 C--N 1.31 -1.452 0 C-N-CA 124.046 -1.231 . . . . 0.0 111.916 0.619 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 92' ' ' ALA . . . . . 0.449 ' O ' ' CD1' ' A' ' 97' ' ' LEU . . . -71.99 32.05 0.06 Allowed 'General case' 0 N--CA 1.493 1.706 0 O-C-N 121.159 -0.963 . . . . 0.0 110.716 -179.664 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 93' ' ' THR . . . . . 0.47 ' H ' ' C ' ' A' ' 91' ' ' PRO . 0.8 OUTLIER -73.46 155.1 89.76 Favored Pre-proline 0 N--CA 1.489 1.523 0 O-C-N 120.692 -1.255 . . . . 0.0 108.751 -179.956 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 94' ' ' PRO . . . . . 0.401 ' C ' ' O ' ' A' ' 93' ' ' THR . 85.2 Cg_exo -34.55 -55.78 0.5 Allowed 'Trans proline' 0 C--N 1.306 -1.668 0 C-N-CA 122.818 2.346 . . . . 0.0 112.387 -179.506 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 95' ' ' GLU . . . . . 0.479 ' OE2' ' OE1' ' A' ' 96' ' ' GLN . 0.1 OUTLIER -47.36 -48.74 25.55 Favored 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.083 -1.011 . . . . 0.0 109.67 -179.812 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 96' ' ' GLN . . . . . 0.594 ' O ' ' N ' ' A' ' 98' ' ' ASN . 5.9 mp0 -71.94 -56.1 6.28 Favored 'General case' 0 N--CA 1.489 1.476 0 O-C-N 121.04 -1.038 . . . . 0.0 110.572 -179.563 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 97' ' ' LEU . . . . . 0.449 ' CD1' ' O ' ' A' ' 92' ' ' ALA . 93.6 mt -48.09 -7.0 0.02 OUTLIER 'General case' 0 N--CA 1.494 1.74 0 O-C-N 121.193 -0.942 . . . . 0.0 110.005 -178.939 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 98' ' ' ASN . . . . . 0.687 HD22 ' NE ' ' A' ' 99' ' ' ARG . 0.2 OUTLIER -73.4 -26.35 60.95 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.201 -0.937 . . . . 0.0 109.042 179.274 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 99' ' ' ARG . . . . . 0.687 ' NE ' HD22 ' A' ' 98' ' ' ASN . 4.3 mtt180 -95.08 -51.15 4.77 Favored 'General case' 0 N--CA 1.488 1.442 0 C-N-CA 119.842 -0.743 . . . . 0.0 109.783 -179.218 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . 176.44 -165.29 35.55 Favored Glycine 0 N--CA 1.491 2.325 0 C-N-CA 119.462 -1.351 . . . . 0.0 110.232 179.776 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 101' ' ' VAL . . . . . 0.477 ' CG1' ' CE2' ' A' ' 130' ' ' PHE . 21.0 m -58.47 105.76 0.19 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.632 0 O-C-N 121.498 -1.001 . . . . 0.0 109.554 -179.676 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -92.68 166.65 12.36 Favored 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.476 -0.765 . . . . 0.0 110.775 -179.519 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 103' ' ' PHE . . . . . 0.479 ' CE1' ' CG1' ' A' ' 87' ' ' VAL . 25.5 m-85 -72.25 131.15 42.34 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 120.987 -1.071 . . . . 0.0 108.176 178.458 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 104' ' ' ALA . . . . . . . . . . . . . . . -51.93 -7.21 0.05 OUTLIER 'General case' 0 C--N 1.295 -1.786 0 O-C-N 121.416 -0.802 . . . . 0.0 111.873 -178.596 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 105' ' ' GLU . . . . . 0.411 ' H ' ' C ' ' A' ' 103' ' ' PHE . 0.2 OUTLIER -141.22 139.54 33.81 Favored 'General case' 0 N--CA 1.499 2.023 0 O-C-N 120.444 -1.41 . . . . 0.0 111.469 -179.682 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 106' ' ' GLU . . . . . 0.427 ' CG ' ' H ' ' A' ' 107' ' ' ASN . 1.9 pt-20 -54.3 -62.0 1.94 Allowed 'General case' 0 N--CA 1.488 1.472 0 O-C-N 121.855 -0.528 . . . . 0.0 109.947 179.51 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 107' ' ' ASN . . . . . 0.427 ' H ' ' CG ' ' A' ' 106' ' ' GLU . 8.1 m120 -76.83 35.32 0.16 Allowed 'General case' 0 N--CA 1.489 1.483 0 O-C-N 120.545 -1.347 . . . . 0.0 111.607 -176.833 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 108' ' ' GLU . . . . . . . . . . . . . 35.1 tp10 -57.19 144.37 35.44 Favored 'General case' 0 C--N 1.303 -1.428 0 O-C-N 120.813 -1.179 . . . . 0.0 107.83 -179.802 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 109' ' ' SER . . . . . 0.578 ' C ' ' H ' ' A' ' 111' ' ' ASP . 1.2 m -101.24 124.85 47.59 Favored 'General case' 0 C--N 1.303 -1.438 0 O-C-N 121.058 -1.026 . . . . 0.0 110.648 -178.455 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 110' ' ' LEU . . . . . . . . . . . . . 3.5 tp -58.99 -3.45 0.35 Allowed 'General case' 0 C--N 1.3 -1.548 0 N-CA-C 107.693 -1.225 . . . . 0.0 107.693 179.066 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 111' ' ' ASP . . . . . 0.578 ' H ' ' C ' ' A' ' 109' ' ' SER . 1.6 m-20 -132.17 21.66 4.46 Favored 'General case' 0 N--CA 1.486 1.363 0 N-CA-C 109.128 -0.693 . . . . 0.0 109.128 179.696 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 112' ' ' ASP . . . . . 0.489 ' OD2' ' OG ' ' A' ' 109' ' ' SER . 0.2 OUTLIER -64.96 138.34 58.3 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 120.985 -1.072 . . . . 0.0 109.543 179.839 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 113' ' ' GLN . . . . . 0.552 HE21 ' C ' ' A' ' 113' ' ' GLN . 0.0 OUTLIER -66.29 -5.86 11.98 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 120.94 -1.1 . . . . 0.0 108.696 179.201 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 114' ' ' ASN . . . . . 0.608 ' OD1' ' NE2' ' A' ' 178' ' ' GLN . 4.1 t30 -145.54 97.34 2.97 Favored 'General case' 0 C--N 1.297 -1.7 0 N-CA-C 107.305 -1.369 . . . . 0.0 107.305 178.16 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 115' ' ' ILE . . . . . . . . . . . . . 1.8 mt -95.64 107.09 19.12 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.599 0 O-C-N 121.13 -0.981 . . . . 0.0 108.694 -179.522 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 116' ' ' SER . . . . . . . . . . . . . 7.5 p -90.22 154.71 19.53 Favored 'General case' 0 C--N 1.305 -1.355 0 CA-C-O 121.728 0.775 . . . . 0.0 110.814 -178.458 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 117' ' ' ILE . . . . . . . . . . . . . 3.2 mt -144.35 153.68 15.18 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.412 0 N-CA-C 108.337 -0.986 . . . . 0.0 108.337 179.135 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 118' ' ' ALA . . . . . . . . . . . . . . . -140.34 153.9 46.57 Favored 'General case' 0 N--CA 1.49 1.562 0 C-N-CA 119.217 -0.993 . . . . 0.0 110.481 -179.586 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 119' ' ' GLY . . . . . . . . . . . . . . . -166.57 148.17 13.07 Favored Glycine 0 N--CA 1.487 2.074 0 C-N-CA 119.912 -1.137 . . . . 0.0 110.715 -179.988 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 120' ' ' HIS . . . . . . . . . . . . . 3.2 m-70 -72.47 161.74 30.41 Favored 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.919 -0.754 . . . . 0.0 110.006 179.337 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 121' ' ' THR . . . . . . . . . . . . . 1.1 t -116.22 158.29 23.55 Favored 'General case' 0 N--CA 1.496 1.85 0 O-C-N 121.338 -0.851 . . . . 0.0 109.079 178.958 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 122' ' ' PHE . . . . . . . . . . . . . 0.3 OUTLIER -124.67 127.03 46.68 Favored 'General case' 0 N--CA 1.498 1.946 0 O-C-N 121.296 -0.877 . . . . 0.0 109.852 -179.637 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 123' ' ' ILE . . . . . 0.429 ' CG2' ' N ' ' A' ' 124' ' ' ASP . 16.3 tt -74.73 -36.74 41.08 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.665 0 CA-C-O 121.922 0.868 . . . . 0.0 109.141 179.712 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 124' ' ' ASP . . . . . 0.429 ' N ' ' CG2' ' A' ' 123' ' ' ILE . 2.0 p30 -95.54 22.49 7.01 Favored 'General case' 0 C--N 1.296 -1.756 0 O-C-N 121.827 -0.546 . . . . 0.0 111.042 -179.224 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 125' ' ' ARG . . . . . . . . . . . . . 9.4 ttt180 -157.06 107.42 1.91 Allowed Pre-proline 0 N--CA 1.492 1.674 0 O-C-N 120.518 -1.364 . . . . 0.0 110.441 -179.08 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 126' ' ' PRO . . . . . . . . . . . . . 56.9 Cg_endo -79.79 -23.27 7.01 Favored 'Trans proline' 0 C--N 1.315 -1.193 0 C-N-CA 122.056 1.837 . . . . 0.0 112.454 179.416 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 127' ' ' ASN . . . . . . . . . . . . . 28.4 m120 -91.5 29.64 1.45 Allowed 'General case' 0 N--CA 1.493 1.681 0 O-C-N 121.186 -0.946 . . . . 0.0 109.573 179.902 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 128' ' ' TYR . . . . . 0.687 ' CZ ' ' NE2' ' A' ' 129' ' ' GLN . 14.8 t80 -81.32 -151.04 0.08 Allowed 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.254 -0.904 . . . . 0.0 109.843 -179.669 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 129' ' ' GLN . . . . . 0.687 ' NE2' ' CZ ' ' A' ' 128' ' ' TYR . 1.7 mp0 -68.3 -71.85 0.2 Allowed 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.265 -0.897 . . . . 0.0 109.906 -179.507 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 130' ' ' PHE . . . . . 0.477 ' CE2' ' CG1' ' A' ' 101' ' ' VAL . 50.5 m-85 -125.88 25.94 6.72 Favored 'General case' 0 N--CA 1.497 1.884 0 O-C-N 121.21 -0.931 . . . . 0.0 110.278 -179.927 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 131' ' ' THR . . . . . . . . . . . . . 36.7 m -63.78 -34.85 78.81 Favored 'General case' 0 N--CA 1.493 1.693 0 O-C-N 120.844 -1.16 . . . . 0.0 109.754 -179.964 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 132' ' ' ASN . . . . . 0.6 ' ND2' ' O ' ' A' ' 81' ' ' ALA . 12.5 t30 -85.24 9.57 14.83 Favored 'General case' 0 N--CA 1.497 1.883 0 C-N-CA 119.913 -0.715 . . . . 0.0 111.788 -178.234 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 133' ' ' LEU . . . . . 0.606 ' O ' ' N ' ' A' ' 135' ' ' ALA . 0.1 OUTLIER -71.94 -44.56 63.4 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 120.565 -1.334 . . . . 0.0 110.328 -179.442 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 134' ' ' LYS . . . . . 0.534 ' H ' ' CD ' ' A' ' 134' ' ' LYS . 0.0 OUTLIER -42.58 -16.36 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.663 0 O-C-N 121.192 -0.942 . . . . 0.0 110.089 -179.132 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 135' ' ' ALA . . . . . 0.606 ' N ' ' O ' ' A' ' 133' ' ' LEU . . . -85.23 -37.06 20.52 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.02 -1.05 . . . . 0.0 109.738 179.708 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 136' ' ' ALA . . . . . 0.438 ' N ' ' O ' ' A' ' 133' ' ' LEU . . . -78.43 153.54 31.42 Favored 'General case' 0 N--CA 1.489 1.519 0 CA-C-O 121.977 0.894 . . . . 0.0 111.317 -178.6 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 137' ' ' LYS . . . . . 0.502 ' O ' ' O ' ' A' ' 138' ' ' LYS . 0.6 OUTLIER -156.15 -163.36 1.46 Allowed 'General case' 0 N--CA 1.494 1.744 0 C-N-CA 118.559 -1.257 . . . . 0.0 111.224 -178.387 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 138' ' ' LYS . . . . . 0.604 ' O ' ' N ' ' A' ' 140' ' ' SER . 24.9 pttt -45.95 179.74 0.0 OUTLIER 'General case' 0 C--N 1.305 -1.364 0 CA-C-O 121.95 0.881 . . . . 0.0 110.296 -179.395 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 139' ' ' GLY . . . . . . . . . . . . . . . 45.58 8.07 0.01 OUTLIER Glycine 0 N--CA 1.491 2.336 0 N-CA-C 110.817 -0.913 . . . . 0.0 110.817 179.705 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 140' ' ' SER . . . . . 0.604 ' N ' ' O ' ' A' ' 138' ' ' LYS . 46.9 m -94.07 136.85 33.91 Favored 'General case' 0 N--CA 1.494 1.734 0 O-C-N 120.823 -1.398 . . . . 0.0 109.333 179.225 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 141' ' ' MET . . . . . . . . . . . . . 0.4 OUTLIER -85.04 147.6 26.58 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.155 -0.965 . . . . 0.0 109.55 -179.96 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 142' ' ' VAL . . . . . . . . . . . . . 2.1 t -132.15 134.93 59.05 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.661 0 N-CA-C 108.368 -0.975 . . . . 0.0 108.368 -179.759 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 143' ' ' TYR . . . . . . . . . . . . . 37.0 m-85 -114.03 137.53 51.59 Favored 'General case' 0 N--CA 1.499 2.008 0 O-C-N 120.792 -1.192 . . . . 0.0 111.391 -178.842 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 144' ' ' PHE . . . . . . . . . . . . . 5.1 t80 -123.15 107.02 11.28 Favored 'General case' 0 N--CA 1.494 1.77 0 CA-C-O 121.476 0.655 . . . . 0.0 109.833 -179.215 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 145' ' ' LYS . . . . . . . . . . . . . 14.7 tttt -95.55 132.83 40.25 Favored 'General case' 0 N--CA 1.495 1.799 0 O-C-N 121.417 -0.802 . . . . 0.0 111.43 -178.725 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 146' ' ' VAL . . . . . 0.458 ' O ' ' C ' ' A' ' 147' ' ' GLY . 0.0 OUTLIER -143.26 141.1 26.48 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.813 0 N-CA-C 107.629 -1.249 . . . . 0.0 107.629 178.589 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 147' ' ' GLY . . . . . 0.458 ' C ' ' O ' ' A' ' 146' ' ' VAL . . . 40.02 -126.3 2.54 Favored Glycine 0 N--CA 1.494 2.533 0 N-CA-C 109.776 -1.33 . . . . 0.0 109.776 179.778 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 148' ' ' ASN . . . . . 0.513 ' C ' ' ND2' ' A' ' 148' ' ' ASN . 0.4 OUTLIER -101.65 14.94 30.46 Favored 'General case' 0 C--N 1.302 -1.476 0 O-C-N 121.426 -1.043 . . . . 0.0 108.339 179.209 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 149' ' ' GLU . . . . . . . . . . . . . 3.2 tt0 -109.92 142.39 41.33 Favored 'General case' 0 N--CA 1.485 1.324 0 CA-C-O 121.946 0.879 . . . . 0.0 111.515 -178.43 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 150' ' ' THR . . . . . . . . . . . . . 54.3 m -129.48 101.83 6.12 Favored 'General case' 0 C--N 1.3 -1.58 0 CA-C-O 121.658 0.742 . . . . 0.0 109.713 179.81 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 151' ' ' ARG . . . . . 0.419 ' HE ' ' HZ1' ' A' ' 206' ' ' LYS . 2.5 mtp180 -87.33 179.3 6.63 Favored 'General case' 0 C--N 1.306 -1.322 0 N-CA-C 108.601 -0.889 . . . . 0.0 108.601 179.951 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 152' ' ' LYS . . . . . 0.408 ' C ' ' CD1' ' A' ' 153' ' ' TYR . 24.6 mtmm -147.53 148.16 30.89 Favored 'General case' 0 C--N 1.302 -1.495 0 O-C-N 121.089 -1.007 . . . . 0.0 109.838 -179.671 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 153' ' ' TYR . . . . . 0.408 ' CD1' ' C ' ' A' ' 152' ' ' LYS . 20.6 m-85 -141.64 167.5 21.99 Favored 'General case' 0 N--CA 1.492 1.629 0 N-CA-C 108.491 -0.929 . . . . 0.0 108.491 179.258 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 154' ' ' LYS . . . . . . . . . . . . . 4.4 ttpm? -137.7 122.41 18.68 Favored 'General case' 0 C--N 1.296 -1.731 0 N-CA-C 108.698 -0.853 . . . . 0.0 108.698 179.155 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 155' ' ' MET . . . . . . . . . . . . . 38.4 mmm -48.98 107.38 0.13 Allowed 'General case' 0 N--CA 1.491 1.604 0 O-C-N 120.785 -1.197 . . . . 0.0 110.904 -178.891 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 156' ' ' THR . . . . . 0.424 ' OG1' ' OG1' ' A' ' 203' ' ' THR . 0.0 OUTLIER -109.49 -22.18 12.12 Favored 'General case' 0 C--N 1.296 -1.748 0 C-N-CA 119.832 -0.747 . . . . 0.0 110.597 -178.959 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 157' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -151.67 146.98 26.19 Favored 'General case' 0 C--N 1.294 -1.838 0 C-N-CA 118.702 -1.199 . . . . 0.0 110.966 -178.411 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 158' ' ' ILE . . . . . 0.436 ' CD1' ' N ' ' A' ' 159' ' ' ARG . 0.1 OUTLIER -155.51 142.57 11.66 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.334 0 CA-C-O 121.778 0.799 . . . . 0.0 110.013 -178.834 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 159' ' ' ARG . . . . . 0.436 ' N ' ' CD1' ' A' ' 158' ' ' ILE . 23.1 ttm180 -155.99 160.3 39.94 Favored 'General case' 0 C--N 1.297 -1.679 0 CA-C-O 121.79 0.805 . . . . 0.0 110.44 -179.618 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 160' ' ' ASP . . . . . . . . . . . . . 35.7 m-20 -116.02 161.44 18.87 Favored 'General case' 0 N--CA 1.49 1.564 0 N-CA-C 108.203 -1.036 . . . . 0.0 108.203 179.185 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 161' ' ' VAL . . . . . 0.438 ' O ' ' O ' ' A' ' 162' ' ' LYS . 3.3 m -156.79 155.01 5.57 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.63 0 O-C-N 121.117 -0.99 . . . . 0.0 110.722 -178.569 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 162' ' ' LYS . . . . . 0.438 ' O ' ' O ' ' A' ' 161' ' ' VAL . 0.0 OUTLIER -45.02 169.9 0.06 OUTLIER Pre-proline 0 N--CA 1.492 1.652 0 O-C-N 121.594 -0.691 . . . . 0.0 109.795 179.527 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 163' ' ' PRO . . . . . . . . . . . . . 65.1 Cg_endo -78.54 34.59 0.51 Allowed 'Trans proline' 0 N--CA 1.493 1.466 0 C-N-CA 123.052 2.501 . . . . 0.0 113.026 -179.975 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 164' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -153.26 -3.86 0.2 Allowed 'General case' 0 N--CA 1.496 1.873 0 O-C-N 121.022 -1.049 . . . . 0.0 110.925 -179.824 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 165' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -77.2 64.44 2.62 Favored 'General case' 0 N--CA 1.496 1.857 0 O-C-N 120.861 -1.149 . . . . 0.0 110.899 -179.078 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 166' ' ' VAL . . . . . 0.593 ' O ' ' N ' ' A' ' 168' ' ' VAL . 1.4 m -46.44 -30.26 1.22 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.702 0 O-C-N 121.13 -0.981 . . . . 0.0 110.563 -178.244 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 167' ' ' GLY . . . . . . . . . . . . . . . -45.22 -9.1 0.01 OUTLIER Glycine 0 N--CA 1.498 2.796 0 O-C-N 120.694 -1.254 . . . . 0.0 111.313 -179.353 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 168' ' ' VAL . . . . . 0.593 ' N ' ' O ' ' A' ' 166' ' ' VAL . 4.2 m -53.88 -31.67 21.02 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.657 0 O-C-N 120.615 -1.521 . . . . 0.0 109.114 -179.988 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 169' ' ' LEU . . . . . 0.552 ' O ' ' C ' ' A' ' 170' ' ' ASP . 10.9 mt -45.57 -17.79 0.03 OUTLIER 'General case' 0 N--CA 1.493 1.677 0 N-CA-C 108.19 -1.041 . . . . 0.0 108.19 -178.41 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 170' ' ' ASP . . . . . 0.552 ' C ' ' O ' ' A' ' 169' ' ' LEU . 2.5 m-20 21.44 90.51 0.01 OUTLIER 'General case' 0 N--CA 1.501 2.086 0 CA-C-O 120.81 0.338 . . . . 0.0 111.797 178.151 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 171' ' ' GLU . . . . . . . . . . . . . 10.1 pt-20 -140.27 78.06 1.64 Allowed 'General case' 0 N--CA 1.494 1.754 0 O-C-N 120.845 -1.16 . . . . 0.0 109.808 179.512 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 172' ' ' GLN . . . . . . . . . . . . . 2.6 mp0 -136.49 -41.43 0.63 Allowed 'General case' 0 N--CA 1.495 1.793 0 O-C-N 121.453 -0.779 . . . . 0.0 110.607 -178.749 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 173' ' ' LYS . . . . . . . . . . . . . 49.7 mttp -58.24 140.41 53.2 Favored 'General case' 0 N--CA 1.493 1.686 0 O-C-N 120.74 -1.225 . . . . 0.0 108.514 179.676 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 174' ' ' GLY . . . . . 0.478 ' O ' ' C ' ' A' ' 175' ' ' LYS . . . -127.29 -46.6 0.2 Allowed Glycine 0 C--N 1.298 -1.534 0 N-CA-C 107.619 -2.192 . . . . 0.0 107.619 179.704 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 175' ' ' LYS . . . . . 0.478 ' C ' ' O ' ' A' ' 174' ' ' GLY . 27.9 mmtt -42.77 -61.42 1.26 Allowed 'General case' 0 N--CA 1.489 1.523 0 N-CA-C 108.023 -1.103 . . . . 0.0 108.023 178.611 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 176' ' ' ASP . . . . . 0.525 ' O ' ' O ' ' A' ' 177' ' ' LYS . 3.6 p30 -104.53 95.23 5.78 Favored 'General case' 0 C--N 1.299 -1.63 0 N-CA-C 108.059 -1.089 . . . . 0.0 108.059 178.086 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 177' ' ' LYS . . . . . 0.525 ' O ' ' O ' ' A' ' 176' ' ' ASP . 0.5 OUTLIER -48.39 -176.37 0.0 OUTLIER 'General case' 0 N--CA 1.494 1.734 0 O-C-N 121.119 -0.988 . . . . 0.0 109.432 -179.694 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 178' ' ' GLN . . . . . 0.608 ' NE2' ' OD1' ' A' ' 114' ' ' ASN . 20.9 pt20 -162.06 174.47 12.96 Favored 'General case' 0 C--N 1.308 -1.227 0 C-N-CA 118.605 -1.238 . . . . 0.0 110.663 179.214 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 179' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -134.62 100.36 4.61 Favored 'General case' 0 C--N 1.301 -1.518 0 N-CA-C 107.756 -1.201 . . . . 0.0 107.756 178.046 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 180' ' ' THR . . . . . . . . . . . . . 1.0 OUTLIER -79.99 116.62 20.23 Favored 'General case' 0 N--CA 1.493 1.707 0 O-C-N 121.095 -1.003 . . . . 0.0 110.186 -178.794 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 181' ' ' LEU . . . . . . . . . . . . . 8.8 tp -99.43 106.13 18.15 Favored 'General case' 0 C--N 1.3 -1.583 0 O-C-N 121.453 -0.779 . . . . 0.0 109.496 179.146 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 182' ' ' ILE . . . . . . . . . . . . . 48.2 mt -93.74 127.83 45.52 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.541 0 O-C-N 120.895 -1.128 . . . . 0.0 108.76 178.909 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 183' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -144.55 111.28 5.73 Favored 'General case' 0 C--N 1.291 -1.948 0 N-CA-C 107.409 -1.33 . . . . 0.0 107.409 179.569 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 184' ' ' CYS . . . . . . . . . . . . . 15.9 p -79.62 161.0 26.16 Favored 'General case' 0 C--N 1.291 -1.975 0 C-N-CA 118.988 -1.085 . . . . 0.0 111.782 -177.334 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 185' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -166.67 -161.71 0.47 Allowed 'General case' 0 N--CA 1.494 1.775 0 O-C-N 121.665 -0.647 . . . . 0.0 109.338 179.759 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 186' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER 55.15 57.03 5.86 Favored 'General case' 0 N--CA 1.496 1.857 0 O-C-N 121.144 -0.973 . . . . 0.0 109.368 -179.838 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 187' ' ' TYR . . . . . 0.619 ' CE1' ' O ' ' A' ' 188' ' ' ASN . 65.7 t80 -67.78 137.23 55.24 Favored 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.342 -0.849 . . . . 0.0 110.703 -179.514 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 188' ' ' ASN . . . . . 0.619 ' O ' ' CE1' ' A' ' 187' ' ' TYR . 1.2 t-20 -101.98 145.66 28.96 Favored 'General case' 0 C--N 1.297 -1.697 0 N-CA-C 108.39 -0.967 . . . . 0.0 108.39 178.376 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 189' ' ' GLU . . . . . . . . . . . . . 1.9 tt0 -110.08 -14.74 14.17 Favored 'General case' 0 C--N 1.294 -1.823 0 N-CA-C 108.984 -0.747 . . . . 0.0 108.984 -179.217 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 190' ' ' LYS . . . . . . . . . . . . . 4.6 mttm -83.53 -52.36 6.54 Favored 'General case' 0 C--N 1.301 -1.506 0 C-N-CA 119.82 -0.752 . . . . 0.0 109.099 179.423 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 191' ' ' THR . . . . . . . . . . . . . 2.1 p -89.16 -9.25 51.62 Favored 'General case' 0 N--CA 1.489 1.525 0 O-C-N 121.52 -0.738 . . . . 0.0 109.235 179.799 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 192' ' ' GLY . . . . . . . . . . . . . . . 68.4 33.31 77.07 Favored Glycine 0 N--CA 1.493 2.496 0 O-C-N 121.298 -0.876 . . . . 0.0 111.119 178.606 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 193' ' ' VAL . . . . . . . . . . . . . 2.4 p -147.54 169.63 3.96 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.582 0 O-C-N 120.806 -1.408 . . . . 0.0 109.891 179.169 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 194' ' ' TRP . . . . . 0.517 ' N ' ' CD1' ' A' ' 194' ' ' TRP . 10.7 m95 -85.74 121.55 28.56 Favored 'General case' 0 C--N 1.294 -1.836 0 O-C-N 121.648 -0.657 . . . . 0.0 109.271 -179.908 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 195' ' ' GLU . . . . . 0.512 ' CD ' ' ND2' ' A' ' 188' ' ' ASN . 7.5 mt-10 -77.31 -60.14 2.49 Favored 'General case' 0 N--CA 1.496 1.862 0 O-C-N 121.385 -0.822 . . . . 0.0 111.575 -178.521 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 196' ' ' LYS . . . . . . . . . . . . . 6.3 mtmt -92.1 158.16 16.35 Favored 'General case' 0 N--CA 1.493 1.72 0 O-C-N 120.86 -1.15 . . . . 0.0 111.397 -177.946 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 197' ' ' ARG . . . . . . . . . . . . . 25.3 mmt180 -124.14 139.17 54.19 Favored 'General case' 0 N--CA 1.488 1.466 0 N-CA-C 108.674 -0.862 . . . . 0.0 108.674 179.001 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 198' ' ' LYS . . . . . . . . . . . . . 14.9 mttt -119.8 120.63 37.07 Favored 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.544 -0.723 . . . . 0.0 110.13 -179.017 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 199' ' ' ILE . . . . . 0.406 ' O ' ' CG1' ' A' ' 199' ' ' ILE . 0.8 OUTLIER -139.81 119.83 13.54 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.66 0 O-C-N 121.192 -0.943 . . . . 0.0 109.562 179.43 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 200' ' ' PHE . . . . . 0.537 ' CD1' ' N ' ' A' ' 200' ' ' PHE . 8.7 m-85 -99.91 139.05 36.15 Favored 'General case' 0 N--CA 1.499 2.012 0 O-C-N 121.468 -0.77 . . . . 0.0 110.76 -178.534 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 201' ' ' VAL . . . . . . . . . . . . . 24.3 t -104.12 149.07 8.11 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.553 0 N-CA-C 107.39 -1.337 . . . . 0.0 107.39 176.489 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 202' ' ' ALA . . . . . . . . . . . . . . . -132.47 139.6 48.04 Favored 'General case' 0 C--N 1.3 -1.585 0 O-C-N 121.047 -1.033 . . . . 0.0 108.249 -179.864 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 203' ' ' THR . . . . . 0.424 ' OG1' ' OG1' ' A' ' 156' ' ' THR . 13.7 p -90.85 132.15 36.07 Favored 'General case' 0 C--N 1.305 -1.343 0 CA-C-O 122.647 1.213 . . . . 0.0 111.608 -178.242 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 204' ' ' GLU . . . . . . . . . . . . . 1.2 tm-20 -60.79 136.24 58.01 Favored 'General case' 0 C--N 1.297 -1.711 0 C-N-CA 118.334 -1.347 . . . . 0.0 108.798 179.159 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 205' ' ' VAL . . . . . 0.473 ' O ' ' C ' ' A' ' 206' ' ' LYS . 36.6 t -130.85 -35.82 0.59 Allowed 'Isoleucine or valine' 0 N--CA 1.495 1.795 0 O-C-N 121.298 -0.877 . . . . 0.0 110.189 -179.437 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 206' ' ' LYS . . . . . 0.473 ' C ' ' O ' ' A' ' 205' ' ' VAL . 0.0 OUTLIER . . . . . 0 N--CA 1.495 1.777 0 CA-C-O 117.945 -1.026 . . . . 0.0 110.259 -179.584 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' C' C ' 702' ' ' LEU . . . . . 0.641 ' H ' ' CD1' ' C' ' 702' ' ' LEU . 0.0 OUTLIER . . . . . 0 N--CA 1.491 1.614 0 N-CA-C 109.074 -0.713 . . . . 0.0 109.074 . . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' C' C ' 703' ' ' PRO . . . . . 0.433 ' O ' ' O ' ' C' ' 702' ' ' LEU . 31.9 Cg_exo -43.31 175.79 0.0 OUTLIER 'Trans proline' 0 N--CA 1.49 1.313 0 C-N-CA 122.593 2.195 . . . . 0.0 112.981 -179.097 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' C' C ' 704' ' ' ALA . . . . . 0.403 ' C ' ' O ' ' C' ' 703' ' ' PRO . . . . . . . . 0 N--CA 1.489 1.519 0 O-C-N 121.502 -0.749 . . . . 0.0 109.769 179.477 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 63' ' ' PRO . . . . . 0.413 ' O ' ' CD1' ' A' ' 110' ' ' LEU . 6.2 Cg_exo . . . . . 0 N--CA 1.487 1.094 0 CA-C-O 121.383 0.493 . . . . 0.0 111.455 . . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 64' ' ' GLN . . . . . 0.617 ' NE2' ' O ' ' A' ' 64' ' ' GLN . 0.0 OUTLIER -158.97 137.07 10.53 Favored 'General case' 0 C--N 1.299 -1.598 0 O-C-N 121.169 -0.957 . . . . 0.0 109.43 179.684 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 65' ' ' ILE . . . . . 0.563 ' N ' ' CD1' ' A' ' 65' ' ' ILE . 0.2 OUTLIER -50.79 110.42 1.73 Allowed Pre-proline 0 N--CA 1.489 1.501 0 O-C-N 120.829 -1.169 . . . . 0.0 108.624 179.253 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 66' ' ' PRO . . . . . . . . . . . . . 87.1 Cg_endo -82.52 -162.77 0.19 Allowed 'Trans proline' 0 C--N 1.314 -1.251 0 C-N-CA 121.998 1.798 . . . . 0.0 111.797 -179.784 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 67' ' ' LYS . . . . . . . . . . . . . 36.4 tttp -90.11 -10.28 45.23 Favored 'General case' 0 C--N 1.302 -1.481 0 O-C-N 121.176 -0.953 . . . . 0.0 109.081 179.534 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 68' ' ' ASP . . . . . 0.651 ' C ' ' H ' ' A' ' 70' ' ' SER . 0.2 OUTLIER -76.61 64.02 2.18 Favored 'General case' 0 N--CA 1.489 1.505 0 CA-C-O 122.763 1.268 . . . . 0.0 108.71 179.194 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 69' ' ' LYS . . . . . 0.459 ' C ' ' O ' ' A' ' 68' ' ' ASP . 6.3 ptpp? -46.99 -14.16 0.03 OUTLIER 'General case' 0 N--CA 1.508 2.472 0 C-N-CA 117.259 -1.776 . . . . 0.0 106.701 177.534 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 70' ' ' SER . . . . . 0.651 ' H ' ' C ' ' A' ' 68' ' ' ASP . 3.4 p -85.93 -6.36 59.08 Favored 'General case' 0 N--CA 1.496 1.839 0 CA-C-N 113.414 -1.721 . . . . 0.0 111.496 179.564 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 71' ' ' LYS . . . . . 0.546 ' CB ' ' HZ3' ' A' ' 71' ' ' LYS . 0.0 OUTLIER -95.35 142.6 27.55 Favored 'General case' 0 N--CA 1.501 2.079 0 O-C-N 120.579 -1.325 . . . . 0.0 112.225 -179.288 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 72' ' ' VAL . . . . . 0.454 ' O ' ' CG2' ' A' ' 72' ' ' VAL . 3.1 m -66.46 134.44 29.95 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.5 0 N-CA-C 104.318 -2.475 . . . . 0.0 104.318 174.65 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 73' ' ' ALA . . . . . 0.495 ' N ' ' O ' ' A' ' 87' ' ' VAL . . . -81.47 -15.65 54.37 Favored 'General case' 0 C--N 1.291 -1.967 0 O-C-N 119.849 -1.782 . . . . 0.0 106.859 179.985 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . 172.16 -155.78 24.23 Favored Glycine 0 C--N 1.298 -1.533 0 N-CA-C 109.817 -1.313 . . . . 0.0 109.817 179.512 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 75' ' ' TYR . . . . . . . . . . . . . 73.0 m-85 -142.56 169.99 16.54 Favored 'General case' 0 C--N 1.297 -1.684 0 CA-C-O 122.06 0.933 . . . . 0.0 110.848 -177.459 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 76' ' ' ILE . . . . . . . . . . . . . 1.0 OUTLIER -150.15 146.9 16.46 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.814 0 C-N-CA 119.58 -0.848 . . . . 0.0 109.179 -178.382 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -151.15 164.8 35.68 Favored 'General case' 0 C--N 1.302 -1.494 0 O-C-N 120.919 -1.113 . . . . 0.0 109.262 -179.734 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 78' ' ' ILE . . . . . . . . . . . . . 10.0 mt -147.91 92.97 4.57 Favored Pre-proline 0 N--CA 1.488 1.425 0 N-CA-C 108.516 -0.92 . . . . 0.0 108.516 179.998 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 79' ' ' PRO . . . . . . . . . . . . . 72.3 Cg_exo -46.77 -43.54 23.41 Favored 'Trans proline' 0 N--CA 1.494 1.536 0 C-N-CA 122.852 2.368 . . . . 0.0 113.954 -178.972 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 37.9 t70 -65.54 -20.62 66.41 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 120.665 -1.272 . . . . 0.0 110.343 178.582 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 81' ' ' ALA . . . . . 0.648 ' O ' ' ND2' ' A' ' 132' ' ' ASN . . . -106.33 -15.05 14.93 Favored 'General case' 0 C--N 1.302 -1.471 0 O-C-N 121.354 -0.841 . . . . 0.0 108.762 179.664 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 82' ' ' ASP . . . . . . . . . . . . . 2.5 t70 66.38 49.51 1.41 Allowed 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.163 -0.961 . . . . 0.0 110.227 179.506 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 83' ' ' ILE . . . . . 0.465 ' CD1' ' OD1' ' A' ' 132' ' ' ASN . 62.7 mt -128.57 151.38 35.28 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.786 0 O-C-N 121.259 -0.901 . . . . 0.0 110.333 -178.988 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 84' ' ' LYS . . . . . . . . . . . . . 17.4 tttt -159.53 106.42 1.7 Allowed 'General case' 0 N--CA 1.493 1.69 0 N-CA-C 108.416 -0.957 . . . . 0.0 108.416 178.964 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 85' ' ' GLU . . . . . 0.54 ' OE2' ' N ' ' A' ' 85' ' ' GLU . 0.0 OUTLIER -140.07 165.77 28.37 Favored Pre-proline 0 N--CA 1.491 1.621 0 O-C-N 121.393 -0.817 . . . . 0.0 109.858 -179.008 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 86' ' ' PRO . . . . . . . . . . . . . 56.9 Cg_endo -74.27 166.53 29.3 Favored 'Trans proline' 0 N--CA 1.496 1.621 0 C-N-CA 123.116 2.544 . . . . 0.0 113.779 -178.548 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 87' ' ' VAL . . . . . 0.495 ' O ' ' N ' ' A' ' 73' ' ' ALA . 61.3 t -122.9 100.07 7.6 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.539 0 N-CA-C 109.093 -0.706 . . . . 0.0 109.093 179.715 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 88' ' ' TYR . . . . . . . . . . . . . 42.1 m-85 -91.87 154.76 43.7 Favored Pre-proline 0 N--CA 1.505 2.298 0 O-C-N 120.944 -1.098 . . . . 0.0 110.086 -179.359 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 89' ' ' PRO . . . . . . . . . . . . . 7.0 Cg_endo -56.84 145.78 81.98 Favored 'Trans proline' 0 N--CA 1.494 1.537 0 C-N-CA 122.467 2.111 . . . . 0.0 113.119 179.157 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . -63.57 169.52 19.56 Favored Glycine 0 N--CA 1.492 2.415 0 N-CA-C 109.159 -1.576 . . . . 0.0 109.159 179.188 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 91' ' ' PRO . . . . . 0.405 ' C ' ' H ' ' A' ' 93' ' ' THR . 73.0 Cg_endo -93.4 170.25 19.82 Favored 'Cis proline' 0 C--N 1.309 -1.519 0 C-N-CA 123.939 -1.275 . . . . 0.0 112.424 0.101 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 92' ' ' ALA . . . . . 0.417 ' O ' ' CD1' ' A' ' 97' ' ' LEU . . . -73.09 33.68 0.07 Allowed 'General case' 0 N--CA 1.494 1.767 0 O-C-N 121.323 -0.861 . . . . 0.0 111.261 -179.399 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 93' ' ' THR . . . . . 0.471 ' OG1' ' OE1' ' A' ' 96' ' ' GLN . 1.0 OUTLIER -73.54 152.5 89.66 Favored Pre-proline 0 C--N 1.3 -1.547 0 O-C-N 120.48 -1.387 . . . . 0.0 108.146 179.729 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 94' ' ' PRO . . . . . 0.414 ' C ' ' O ' ' A' ' 93' ' ' THR . 94.6 Cg_exo -33.29 -57.06 0.35 Allowed 'Trans proline' 0 C--N 1.306 -1.702 0 C-N-CA 122.749 2.299 . . . . 0.0 112.621 -178.463 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 88.0 mt-10 -46.57 -50.29 17.55 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.256 -0.902 . . . . 0.0 110.094 -179.896 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 96' ' ' GLN . . . . . 0.498 ' CD ' ' N ' ' A' ' 96' ' ' GLN . 10.9 mp0 -71.48 -45.41 62.61 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 120.992 -1.067 . . . . 0.0 110.534 -179.231 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 97' ' ' LEU . . . . . 0.417 ' CD1' ' O ' ' A' ' 92' ' ' ALA . 61.5 mt -57.64 -7.29 0.63 Allowed 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.095 -1.003 . . . . 0.0 110.473 -178.585 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 98' ' ' ASN . . . . . 0.625 HD21 ' NH1' ' A' ' 99' ' ' ARG . 0.1 OUTLIER -77.66 -29.09 51.41 Favored 'General case' 0 N--CA 1.494 1.759 0 O-C-N 120.946 -1.097 . . . . 0.0 109.44 179.208 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 99' ' ' ARG . . . . . 0.654 HH11 ' CG ' ' A' ' 99' ' ' ARG . 1.1 mtt-85 -90.17 -44.63 9.64 Favored 'General case' 0 N--CA 1.489 1.495 0 O-C-N 121.667 -0.646 . . . . 0.0 110.322 -178.36 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . 173.71 175.83 41.71 Favored Glycine 0 N--CA 1.491 2.335 0 C-N-CA 119.342 -1.409 . . . . 0.0 110.343 179.938 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 101' ' ' VAL . . . . . 0.443 ' O ' ' CG2' ' A' ' 101' ' ' VAL . 33.5 m -50.05 109.0 0.1 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.543 0 O-C-N 121.564 -0.962 . . . . 0.0 109.029 179.814 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -92.58 159.29 15.55 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.159 -0.963 . . . . 0.0 110.683 -179.321 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 103' ' ' PHE . . . . . 0.58 ' O ' ' N ' ' A' ' 105' ' ' GLU . 26.7 m-85 -61.1 123.79 18.67 Favored 'General case' 0 N--CA 1.491 1.58 0 N-CA-C 107.982 -1.118 . . . . 0.0 107.982 178.662 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 104' ' ' ALA . . . . . . . . . . . . . . . -47.04 -9.75 0.02 OUTLIER 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.061 -1.024 . . . . 0.0 110.249 -179.073 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 105' ' ' GLU . . . . . 0.58 ' N ' ' O ' ' A' ' 103' ' ' PHE . 0.4 OUTLIER -137.89 142.84 40.66 Favored 'General case' 0 N--CA 1.496 1.839 0 O-C-N 120.803 -1.186 . . . . 0.0 110.266 179.643 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 106' ' ' GLU . . . . . . . . . . . . . 33.6 tt0 -58.24 -63.33 1.3 Allowed 'General case' 0 C--N 1.301 -1.516 0 O-C-N 121.951 -0.468 . . . . 0.0 110.661 -179.458 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 107' ' ' ASN . . . . . . . . . . . . . 7.6 m120 -78.67 34.98 0.23 Allowed 'General case' 0 N--CA 1.488 1.449 0 O-C-N 120.874 -1.141 . . . . 0.0 112.969 -175.924 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 108' ' ' GLU . . . . . . . . . . . . . 1.7 tp10 -60.55 148.28 38.57 Favored 'General case' 0 N--CA 1.489 1.486 0 O-C-N 120.685 -1.259 . . . . 0.0 108.327 179.766 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 109' ' ' SER . . . . . . . . . . . . . 2.8 t -98.02 146.91 25.05 Favored 'General case' 0 N--CA 1.489 1.482 0 O-C-N 121.115 -0.991 . . . . 0.0 110.664 -178.675 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 110' ' ' LEU . . . . . 0.413 ' CD1' ' O ' ' A' ' 63' ' ' PRO . 0.6 OUTLIER -63.42 -22.6 66.98 Favored 'General case' 0 C--N 1.301 -1.543 0 N-CA-C 107.974 -1.121 . . . . 0.0 107.974 179.136 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 111' ' ' ASP . . . . . 0.57 ' CG ' HH22 ' A' ' 151' ' ' ARG . 48.5 m-20 -132.81 44.01 2.91 Favored 'General case' 0 N--CA 1.487 1.412 0 O-C-N 121.589 -0.694 . . . . 0.0 110.21 -179.779 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 112' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -67.96 150.16 48.85 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 120.99 -1.069 . . . . 0.0 110.069 179.557 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 113' ' ' GLN . . . . . 0.422 ' HA ' ' NE2' ' A' ' 113' ' ' GLN . 0.9 OUTLIER -65.93 -13.92 60.61 Favored 'General case' 0 N--CA 1.488 1.475 0 N-CA-C 108.008 -1.108 . . . . 0.0 108.008 178.426 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 114' ' ' ASN . . . . . 0.436 ' ND2' ' O ' ' A' ' 170' ' ' ASP . 1.8 t30 -147.87 99.26 3.06 Favored 'General case' 0 C--N 1.301 -1.523 0 N-CA-C 107.206 -1.405 . . . . 0.0 107.206 178.193 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 115' ' ' ILE . . . . . 0.427 HG21 HD13 ' A' ' 115' ' ' ILE . 2.9 mt -98.13 111.41 27.79 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.627 0 O-C-N 120.969 -1.082 . . . . 0.0 109.637 -179.013 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 116' ' ' SER . . . . . . . . . . . . . 87.5 p -101.87 151.42 22.11 Favored 'General case' 0 N--CA 1.491 1.604 0 CA-C-O 122.055 0.931 . . . . 0.0 111.86 -178.329 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 117' ' ' ILE . . . . . . . . . . . . . 2.1 mt -139.66 159.78 27.54 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.599 0 N-CA-C 108.496 -0.927 . . . . 0.0 108.496 179.504 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 118' ' ' ALA . . . . . . . . . . . . . . . -143.3 155.72 44.53 Favored 'General case' 0 N--CA 1.489 1.518 0 C-N-CA 118.758 -1.177 . . . . 0.0 111.326 -179.391 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 119' ' ' GLY . . . . . . . . . . . . . . . -166.32 146.07 10.61 Favored Glycine 0 N--CA 1.485 1.966 0 N-CA-C 110.358 -1.097 . . . . 0.0 110.358 -179.854 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 120' ' ' HIS . . . . . . . . . . . . . 35.1 m170 -71.63 167.28 20.14 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.93 -0.747 . . . . 0.0 109.721 179.202 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 121' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -116.33 147.31 41.7 Favored 'General case' 0 N--CA 1.495 1.779 0 N-CA-C 108.158 -1.053 . . . . 0.0 108.158 178.533 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 122' ' ' PHE . . . . . . . . . . . . . 0.3 OUTLIER -110.61 123.56 50.21 Favored 'General case' 0 N--CA 1.497 1.924 0 O-C-N 120.908 -1.12 . . . . 0.0 109.955 -179.874 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 123' ' ' ILE . . . . . 0.498 ' CG2' ' N ' ' A' ' 124' ' ' ASP . 11.8 tt -69.17 -42.96 81.85 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.824 0 O-C-N 121.367 -0.833 . . . . 0.0 109.4 179.427 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 124' ' ' ASP . . . . . 0.498 ' N ' ' CG2' ' A' ' 123' ' ' ILE . 61.1 t0 -93.24 23.81 4.21 Favored 'General case' 0 N--CA 1.494 1.747 0 O-C-N 121.421 -0.799 . . . . 0.0 111.136 -179.16 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 125' ' ' ARG . . . . . . . . . . . . . 3.3 ttt180 -157.9 107.35 1.76 Allowed Pre-proline 0 N--CA 1.492 1.667 0 O-C-N 120.616 -1.303 . . . . 0.0 110.253 -179.523 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 126' ' ' PRO . . . . . . . . . . . . . 71.9 Cg_endo -83.05 -20.24 5.29 Favored 'Trans proline' 0 C--N 1.314 -1.289 0 C-N-CA 122.368 2.046 . . . . 0.0 112.325 179.482 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 127' ' ' ASN . . . . . . . . . . . . . 4.9 m120 -91.12 23.93 3.06 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.276 -0.89 . . . . 0.0 109.668 179.94 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 128' ' ' TYR . . . . . . . . . . . . . 10.0 t80 -81.09 -149.4 0.07 Allowed 'General case' 0 C--N 1.301 -1.516 0 O-C-N 121.162 -0.961 . . . . 0.0 109.589 -179.692 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 129' ' ' GLN . . . . . . . . . . . . . 69.2 mt-30 -67.12 -69.61 0.3 Allowed 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.246 -0.909 . . . . 0.0 110.684 -178.941 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 130' ' ' PHE . . . . . . . . . . . . . 52.8 m-85 -129.23 36.72 4.13 Favored 'General case' 0 N--CA 1.496 1.827 0 O-C-N 121.249 -0.907 . . . . 0.0 110.524 -179.214 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 131' ' ' THR . . . . . . . . . . . . . 33.8 m -80.86 -33.72 34.27 Favored 'General case' 0 N--CA 1.493 1.687 0 O-C-N 120.815 -1.178 . . . . 0.0 108.965 179.461 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 132' ' ' ASN . . . . . 0.648 ' ND2' ' O ' ' A' ' 81' ' ' ALA . 0.1 OUTLIER -84.62 5.89 26.12 Favored 'General case' 0 N--CA 1.495 1.8 0 CA-C-O 121.876 0.846 . . . . 0.0 109.986 -179.246 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 133' ' ' LEU . . . . . 0.599 ' O ' ' N ' ' A' ' 135' ' ' ALA . 0.2 OUTLIER -68.5 -46.76 68.77 Favored 'General case' 0 C--N 1.299 -1.595 0 O-C-N 121.159 -0.963 . . . . 0.0 110.529 -179.748 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 134' ' ' LYS . . . . . 0.555 ' HZ2' ' HG1' ' A' ' 183' ' ' THR . 0.1 OUTLIER -41.68 -18.18 0.01 OUTLIER 'General case' 0 N--CA 1.496 1.826 0 O-C-N 121.07 -1.019 . . . . 0.0 110.328 -179.133 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 135' ' ' ALA . . . . . 0.599 ' N ' ' O ' ' A' ' 133' ' ' LEU . . . -82.87 -39.48 21.54 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 120.951 -1.093 . . . . 0.0 109.855 -179.773 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 136' ' ' ALA . . . . . 0.404 ' N ' ' O ' ' A' ' 133' ' ' LEU . . . -78.9 156.63 28.52 Favored 'General case' 0 C--N 1.299 -1.59 0 CA-C-O 122.179 0.99 . . . . 0.0 111.698 -178.506 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 137' ' ' LYS . . . . . 0.513 ' O ' ' O ' ' A' ' 138' ' ' LYS . 1.2 ttmt -156.01 -163.21 1.43 Allowed 'General case' 0 N--CA 1.49 1.543 0 C-N-CA 118.832 -1.147 . . . . 0.0 110.455 -178.92 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 138' ' ' LYS . . . . . 0.596 ' O ' ' N ' ' A' ' 140' ' ' SER . 0.1 OUTLIER -46.44 -178.29 0.0 OUTLIER 'General case' 0 C--N 1.302 -1.479 0 CA-C-O 122.043 0.925 . . . . 0.0 110.36 -179.332 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 139' ' ' GLY . . . . . . . . . . . . . . . 45.84 8.1 0.02 OUTLIER Glycine 0 N--CA 1.492 2.411 0 N-CA-C 110.707 -0.957 . . . . 0.0 110.707 179.956 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 140' ' ' SER . . . . . 0.596 ' N ' ' O ' ' A' ' 138' ' ' LYS . 66.1 m -90.54 136.86 32.79 Favored 'General case' 0 N--CA 1.493 1.7 0 O-C-N 120.768 -1.43 . . . . 0.0 109.606 179.412 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 141' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -78.21 142.16 38.11 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.092 -1.005 . . . . 0.0 109.154 179.729 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 142' ' ' VAL . . . . . . . . . . . . . 21.2 t -131.14 127.82 61.2 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.711 0 O-C-N 121.366 -0.834 . . . . 0.0 109.148 -179.845 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 143' ' ' TYR . . . . . . . . . . . . . 6.4 m-85 -105.51 134.22 48.99 Favored 'General case' 0 N--CA 1.498 1.971 0 O-C-N 121.313 -0.867 . . . . 0.0 112.223 -177.913 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 144' ' ' PHE . . . . . . . . . . . . . 57.4 t80 -119.7 98.09 5.95 Favored 'General case' 0 N--CA 1.494 1.741 0 CA-C-O 121.403 0.62 . . . . 0.0 109.406 179.409 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 145' ' ' LYS . . . . . . . . . . . . . 11.8 mttt -93.49 128.44 39.6 Favored 'General case' 0 N--CA 1.492 1.668 0 O-C-N 121.361 -0.837 . . . . 0.0 110.632 -179.217 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 146' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -142.11 137.87 30.23 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.778 0 N-CA-C 107.619 -1.252 . . . . 0.0 107.619 179.098 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 147' ' ' GLY . . . . . . . . . . . . . . . 48.45 -134.06 19.93 Favored Glycine 0 N--CA 1.49 2.241 0 N-CA-C 108.854 -1.698 . . . . 0.0 108.854 -179.493 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 148' ' ' ASN . . . . . 0.56 ' C ' HD21 ' A' ' 148' ' ' ASN . 0.4 OUTLIER -101.17 18.52 19.66 Favored 'General case' 0 C--N 1.301 -1.516 0 O-C-N 121.229 -1.159 . . . . 0.0 107.941 178.959 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 149' ' ' GLU . . . . . . . . . . . . . 26.2 tt0 -112.59 147.46 36.61 Favored 'General case' 0 N--CA 1.484 1.266 0 CA-C-O 121.97 0.89 . . . . 0.0 111.255 -178.957 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 150' ' ' THR . . . . . . . . . . . . . 1.7 m -129.42 103.64 7.02 Favored 'General case' 0 N--CA 1.489 1.509 0 CA-C-O 121.477 0.656 . . . . 0.0 110.052 -179.966 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 151' ' ' ARG . . . . . 0.57 HH22 ' CG ' ' A' ' 111' ' ' ASP . 94.5 mtt180 -93.05 128.75 39.06 Favored 'General case' 0 N--CA 1.487 1.403 0 N-CA-C 107.938 -1.134 . . . . 0.0 107.938 179.008 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 152' ' ' LYS . . . . . 0.432 ' O ' ' N ' ' A' ' 205' ' ' VAL . 14.4 mtmt -91.68 156.01 17.9 Favored 'General case' 0 C--N 1.297 -1.697 0 C-N-CA 119.183 -1.007 . . . . 0.0 110.021 -179.115 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 153' ' ' TYR . . . . . 0.496 ' CD2' ' HA ' ' A' ' 204' ' ' GLU . 30.7 m-85 -143.51 167.1 23.02 Favored 'General case' 0 N--CA 1.49 1.536 0 N-CA-C 107.428 -1.323 . . . . 0.0 107.428 178.953 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 154' ' ' LYS . . . . . . . . . . . . . 17.8 ttpt -143.16 123.0 13.44 Favored 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.071 -1.018 . . . . 0.0 108.286 178.592 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 155' ' ' MET . . . . . . . . . . . . . 3.6 mtt -47.07 109.49 0.21 Allowed 'General case' 0 N--CA 1.492 1.674 0 O-C-N 120.856 -1.153 . . . . 0.0 111.207 -178.595 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 156' ' ' THR . . . . . 0.533 ' CG2' ' HG1' ' A' ' 203' ' ' THR . 0.2 OUTLIER -103.89 -29.78 10.75 Favored 'General case' 0 C--N 1.29 -1.99 0 CA-C-N 115.269 -0.878 . . . . 0.0 110.102 -178.915 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 157' ' ' SER . . . . . 0.419 ' O ' ' N ' ' A' ' 201' ' ' VAL . 0.1 OUTLIER -155.71 157.58 36.83 Favored 'General case' 0 N--CA 1.492 1.641 0 C-N-CA 118.438 -1.305 . . . . 0.0 111.556 -178.816 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 158' ' ' ILE . . . . . 0.451 HG13 ' CD2' ' A' ' 200' ' ' PHE . 0.0 OUTLIER -156.77 148.23 11.14 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.393 0 CA-C-O 121.823 0.82 . . . . 0.0 110.285 179.823 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 159' ' ' ARG . . . . . 0.454 ' O ' ' OD1' ' A' ' 160' ' ' ASP . 6.1 ttm180 -153.59 -173.24 4.5 Favored 'General case' 0 C--N 1.299 -1.622 0 CA-C-O 121.737 0.779 . . . . 0.0 110.502 -179.559 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 160' ' ' ASP . . . . . 0.454 ' OD1' ' O ' ' A' ' 159' ' ' ARG . 2.5 m-20 -145.0 158.78 43.71 Favored 'General case' 0 C--N 1.301 -1.535 0 N-CA-C 108.378 -0.971 . . . . 0.0 108.378 -179.817 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 161' ' ' VAL . . . . . 0.412 ' CG2' ' C ' ' A' ' 160' ' ' ASP . 0.1 OUTLIER -155.57 157.27 4.19 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.99 0 O-C-N 120.994 -1.066 . . . . 0.0 110.686 179.706 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 162' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -46.22 169.19 0.09 OUTLIER Pre-proline 0 N--CA 1.496 1.827 0 O-C-N 121.419 -0.801 . . . . 0.0 110.372 -179.776 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 163' ' ' PRO . . . . . 0.41 ' HA ' ' HE ' ' A' ' 197' ' ' ARG . 73.8 Cg_endo -78.97 28.57 0.49 Allowed 'Trans proline' 0 N--CA 1.493 1.466 0 C-N-CA 123.025 2.483 . . . . 0.0 113.575 -179.778 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 164' ' ' THR . . . . . . . . . . . . . 67.3 m -150.87 -2.66 0.34 Allowed 'General case' 0 N--CA 1.496 1.842 0 O-C-N 120.962 -1.086 . . . . 0.0 110.012 179.792 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 165' ' ' ASP . . . . . 0.446 ' O ' ' C ' ' A' ' 166' ' ' VAL . 2.2 t70 -76.3 64.98 2.15 Favored 'General case' 0 N--CA 1.488 1.471 0 O-C-N 121.203 -0.936 . . . . 0.0 110.112 -179.957 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 166' ' ' VAL . . . . . 0.605 ' O ' ' N ' ' A' ' 168' ' ' VAL . 1.0 OUTLIER -44.4 -32.05 0.78 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.531 0 O-C-N 120.943 -1.098 . . . . 0.0 108.805 -179.099 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 167' ' ' GLY . . . . . 0.446 ' C ' ' O ' ' A' ' 166' ' ' VAL . . . -42.67 -16.76 0.03 OUTLIER Glycine 0 N--CA 1.491 2.316 0 N-CA-C 109.795 -1.322 . . . . 0.0 109.795 179.535 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 168' ' ' VAL . . . . . 0.605 ' N ' ' O ' ' A' ' 166' ' ' VAL . 47.6 t -50.27 -32.6 9.44 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.434 0 O-C-N 121.014 -1.286 . . . . 0.0 108.455 179.728 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 169' ' ' LEU . . . . . 0.518 ' O ' ' C ' ' A' ' 170' ' ' ASP . 98.8 mt -46.91 -14.48 0.03 OUTLIER 'General case' 0 N--CA 1.49 1.566 0 N-CA-C 108.075 -1.083 . . . . 0.0 108.075 -178.816 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 170' ' ' ASP . . . . . 0.567 ' N ' ' O ' ' A' ' 168' ' ' VAL . 9.2 p30 19.94 91.0 0.01 OUTLIER 'General case' 0 N--CA 1.499 2.012 0 N-CA-C 112.651 0.611 . . . . 0.0 112.651 177.669 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 171' ' ' GLU . . . . . . . . . . . . . 16.5 pt-20 -127.02 69.14 1.27 Allowed 'General case' 0 N--CA 1.495 1.809 0 O-C-N 121.099 -1.001 . . . . 0.0 109.493 178.488 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 172' ' ' GLN . . . . . . . . . . . . . 1.6 mp0 -133.69 -47.41 0.81 Allowed 'General case' 0 N--CA 1.495 1.79 0 O-C-N 121.329 -0.857 . . . . 0.0 110.723 -178.387 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 173' ' ' LYS . . . . . . . . . . . . . 9.0 mttp -63.4 125.56 24.58 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 120.835 -1.165 . . . . 0.0 108.992 179.861 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 174' ' ' GLY . . . . . 0.564 ' O ' ' C ' ' A' ' 175' ' ' LYS . . . -133.2 -39.13 0.21 Allowed Glycine 0 C--N 1.298 -1.541 0 N-CA-C 108.543 -1.823 . . . . 0.0 108.543 179.888 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 175' ' ' LYS . . . . . 0.564 ' C ' ' O ' ' A' ' 174' ' ' GLY . 3.8 mptt -32.33 -63.36 0.2 Allowed 'General case' 0 N--CA 1.499 2.015 0 N-CA-C 108.14 -1.059 . . . . 0.0 108.14 179.576 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 176' ' ' ASP . . . . . 0.665 ' O ' ' O ' ' A' ' 177' ' ' LYS . 1.0 OUTLIER -103.01 77.37 1.55 Allowed 'General case' 0 C--N 1.296 -1.72 0 N-CA-C 106.418 -1.697 . . . . 0.0 106.418 176.413 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 177' ' ' LYS . . . . . 0.665 ' O ' ' O ' ' A' ' 176' ' ' ASP . 10.1 mttt -26.74 163.55 0.0 OUTLIER 'General case' 0 N--CA 1.505 2.313 0 CA-C-O 122.091 0.948 . . . . 0.0 112.047 -178.111 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 178' ' ' GLN . . . . . 0.434 ' CD ' ' OD1' ' A' ' 114' ' ' ASN . 0.8 OUTLIER -158.45 168.33 27.23 Favored 'General case' 0 N--CA 1.489 1.499 0 C-N-CA 117.832 -1.547 . . . . 0.0 111.96 -179.792 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 179' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -124.65 101.9 7.34 Favored 'General case' 0 C--N 1.302 -1.47 0 N-CA-C 107.074 -1.454 . . . . 0.0 107.074 178.453 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 180' ' ' THR . . . . . . . . . . . . . 2.1 m -76.12 122.38 24.2 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.202 -0.936 . . . . 0.0 110.595 -177.973 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 181' ' ' LEU . . . . . . . . . . . . . 9.8 tp -98.8 111.79 24.07 Favored 'General case' 0 N--CA 1.493 1.706 0 O-C-N 121.272 -0.893 . . . . 0.0 109.23 178.774 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 182' ' ' ILE . . . . . . . . . . . . . 37.1 mt -100.1 122.99 52.66 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.489 0 O-C-N 120.972 -1.08 . . . . 0.0 109.148 178.357 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 183' ' ' THR . . . . . 0.555 ' HG1' ' HZ2' ' A' ' 134' ' ' LYS . 0.3 OUTLIER -138.9 107.12 5.76 Favored 'General case' 0 C--N 1.296 -1.743 0 N-CA-C 107.882 -1.155 . . . . 0.0 107.882 179.045 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 184' ' ' CYS . . . . . . . . . . . . . 1.9 p -80.88 157.27 25.7 Favored 'General case' 0 N--CA 1.497 1.915 0 C-N-CA 119.275 -0.97 . . . . 0.0 111.597 -177.48 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 185' ' ' ASP . . . . . 0.545 ' OD1' ' N ' ' A' ' 186' ' ' ASP . 20.0 t0 -167.27 177.16 6.27 Favored 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.635 -0.666 . . . . 0.0 109.393 -179.769 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 186' ' ' ASP . . . . . 0.545 ' N ' ' OD1' ' A' ' 185' ' ' ASP . 0.4 OUTLIER 81.05 54.6 0.02 OUTLIER 'General case' 0 N--CA 1.497 1.884 0 O-C-N 121.336 -0.853 . . . . 0.0 109.598 -179.779 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 187' ' ' TYR . . . . . 0.595 ' CE1' ' O ' ' A' ' 188' ' ' ASN . 37.2 t80 -66.07 132.54 48.76 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.124 -0.985 . . . . 0.0 110.204 -179.941 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 188' ' ' ASN . . . . . 0.763 ' ND2' ' H ' ' A' ' 193' ' ' VAL . 0.5 OUTLIER -99.93 149.72 23.14 Favored 'General case' 0 C--N 1.298 -1.632 0 N-CA-C 107.441 -1.318 . . . . 0.0 107.441 178.115 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 189' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -112.11 -2.84 14.88 Favored 'General case' 0 C--N 1.291 -1.938 0 N-CA-C 108.647 -0.872 . . . . 0.0 108.647 -179.179 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 190' ' ' LYS . . . . . . . . . . . . . 32.9 mttt -83.73 -59.8 2.32 Favored 'General case' 0 N--CA 1.488 1.439 0 N-CA-C 108.48 -0.933 . . . . 0.0 108.48 178.581 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 191' ' ' THR . . . . . 0.592 ' OG1' ' ND2' ' A' ' 188' ' ' ASN . 1.3 p -88.25 -12.18 44.42 Favored 'General case' 0 N--CA 1.493 1.687 0 O-C-N 121.338 -0.851 . . . . 0.0 108.954 179.094 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 192' ' ' GLY . . . . . 0.418 ' N ' ' OD1' ' A' ' 188' ' ' ASN . . . 73.29 41.54 45.74 Favored Glycine 0 N--CA 1.493 2.496 0 N-CA-C 110.588 -1.005 . . . . 0.0 110.588 178.902 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 193' ' ' VAL . . . . . 0.763 ' H ' ' ND2' ' A' ' 188' ' ' ASN . 95.9 t -149.14 163.52 4.4 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.612 0 O-C-N 121.043 -1.269 . . . . 0.0 110.542 179.817 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 194' ' ' TRP . . . . . 0.481 ' N ' ' CG1' ' A' ' 193' ' ' VAL . 73.4 m95 -83.07 121.55 27.18 Favored 'General case' 0 N--CA 1.49 1.553 0 N-CA-C 108.572 -0.899 . . . . 0.0 108.572 179.358 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 195' ' ' GLU . . . . . . . . . . . . . 2.3 mt-10 -89.65 -61.05 1.78 Allowed 'General case' 0 N--CA 1.495 1.796 0 O-C-N 121.401 -0.812 . . . . 0.0 112.089 -177.523 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 196' ' ' LYS . . . . . . . . . . . . . 12.5 tttt -75.88 148.36 38.36 Favored 'General case' 0 N--CA 1.494 1.736 0 O-C-N 121.142 -0.974 . . . . 0.0 111.068 -177.876 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 197' ' ' ARG . . . . . 0.41 ' HE ' ' HA ' ' A' ' 163' ' ' PRO . 21.8 mmt180 -124.45 128.56 49.2 Favored 'General case' 0 N--CA 1.494 1.74 0 N-CA-C 108.274 -1.009 . . . . 0.0 108.274 178.361 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 198' ' ' LYS . . . . . . . . . . . . . 11.1 mmtp -116.13 118.42 32.79 Favored 'General case' 0 C--N 1.3 -1.587 0 O-C-N 121.59 -0.694 . . . . 0.0 110.27 -178.916 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 199' ' ' ILE . . . . . 0.447 ' O ' HG13 ' A' ' 199' ' ' ILE . 0.8 OUTLIER -136.95 121.39 24.05 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.768 0 CA-C-O 122.6 1.19 . . . . 0.0 110.877 179.474 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 200' ' ' PHE . . . . . 0.515 ' CD1' ' N ' ' A' ' 200' ' ' PHE . 3.1 m-85 -99.3 135.6 40.48 Favored 'General case' 0 N--CA 1.502 2.171 0 O-C-N 120.941 -1.099 . . . . 0.0 109.979 -178.293 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 201' ' ' VAL . . . . . 0.419 ' N ' ' O ' ' A' ' 157' ' ' SER . 84.4 t -105.33 146.29 12.53 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.849 0 O-C-N 120.94 -1.1 . . . . 0.0 108.968 177.315 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 202' ' ' ALA . . . . . 0.415 ' HA ' ' H ' ' A' ' 156' ' ' THR . . . -134.32 141.46 46.93 Favored 'General case' 0 N--CA 1.493 1.677 0 O-C-N 121.031 -1.043 . . . . 0.0 109.628 -179.749 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 203' ' ' THR . . . . . 0.533 ' HG1' ' CG2' ' A' ' 156' ' ' THR . 0.8 OUTLIER -88.93 130.64 35.4 Favored 'General case' 0 N--CA 1.488 1.426 0 CA-C-O 122.457 1.122 . . . . 0.0 111.27 -178.769 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 204' ' ' GLU . . . . . 0.496 ' HA ' ' CD2' ' A' ' 153' ' ' TYR . 1.3 tm-20 -49.39 134.52 18.78 Favored 'General case' 0 C--N 1.297 -1.713 0 C-N-CA 119.223 -0.991 . . . . 0.0 109.28 179.124 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 205' ' ' VAL . . . . . 0.516 ' CG1' ' N ' ' A' ' 206' ' ' LYS . 28.4 t -122.26 162.32 22.05 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.436 0 CA-C-O 122.055 0.931 . . . . 0.0 110.357 -178.02 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 206' ' ' LYS . . . . . 0.516 ' N ' ' CG1' ' A' ' 205' ' ' VAL . 1.3 ptpp? . . . . . 0 C--N 1.294 -1.838 0 CA-C-O 117.906 -1.045 . . . . 0.0 109.37 179.717 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' C' C ' 702' ' ' LEU . . . . . 0.69 ' CD1' ' N ' ' C' ' 702' ' ' LEU . 0.0 OUTLIER . . . . . 0 N--CA 1.494 1.744 0 N-CA-C 110.231 -0.285 . . . . 0.0 110.231 . . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' C' C ' 703' ' ' PRO . . . . . 0.508 ' O ' ' O ' ' C' ' 702' ' ' LEU . 51.0 Cg_exo -50.87 -157.23 0.0 OUTLIER 'Trans proline' 0 N--CA 1.496 1.646 0 C-N-CA 122.096 1.864 . . . . 0.0 112.6 179.864 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' C' C ' 704' ' ' ALA . . . . . 0.484 ' O ' ' O ' ' C' ' 703' ' ' PRO . . . . . . . . 0 N--CA 1.493 1.692 0 O-C-N 121.125 -0.984 . . . . 0.0 110.212 179.845 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 63' ' ' PRO . . . . . . . . . . . . . 18.9 Cg_endo . . . . . 0 N--CA 1.482 0.795 0 CA-C-O 121.234 0.431 . . . . 0.0 111.513 . . . . . . . . . 0 0 . 1 . 011 nuclear orig core ' A' A ' 64' ' ' GLN . . . . . 0.579 ' N ' ' CD ' ' A' ' 64' ' ' GLN . 0.0 OUTLIER -154.29 133.91 12.84 Favored 'General case' 0 N--CA 1.493 1.701 0 O-C-N 120.996 -1.065 . . . . 0.0 109.452 179.733 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 65' ' ' ILE . . . . . 0.453 ' C ' ' O ' ' A' ' 64' ' ' GLN . 0.0 OUTLIER -45.95 108.35 0.8 Allowed Pre-proline 0 N--CA 1.489 1.494 0 N-CA-C 107.812 -1.181 . . . . 0.0 107.812 179.155 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 66' ' ' PRO . . . . . . . . . . . . . 60.1 Cg_endo -78.1 -162.68 0.18 Allowed 'Trans proline' 0 C--N 1.311 -1.419 0 C-N-CA 121.618 1.545 . . . . 0.0 112.148 -179.024 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 67' ' ' LYS . . . . . . . . . . . . . 15.8 tttp -89.81 -13.92 35.55 Favored 'General case' 0 C--N 1.301 -1.543 0 O-C-N 121.287 -0.883 . . . . 0.0 109.289 -179.874 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 68' ' ' ASP . . . . . 0.679 ' C ' ' H ' ' A' ' 70' ' ' SER . 0.6 OUTLIER -77.07 64.87 2.6 Favored 'General case' 0 N--CA 1.487 1.395 0 CA-C-O 122.654 1.216 . . . . 0.0 109.762 -179.868 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 69' ' ' LYS . . . . . 0.447 ' C ' ' O ' ' A' ' 68' ' ' ASP . 16.6 ptpt -48.2 -12.16 0.04 OUTLIER 'General case' 0 N--CA 1.516 2.827 0 C-N-CA 116.921 -1.912 . . . . 0.0 106.332 176.567 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 70' ' ' SER . . . . . 0.679 ' H ' ' C ' ' A' ' 68' ' ' ASP . 1.9 m -84.83 -6.38 59.35 Favored 'General case' 0 C--N 1.297 -1.688 0 CA-C-N 113.094 -1.866 . . . . 0.0 110.764 179.117 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 71' ' ' LYS . . . . . 0.429 ' N ' ' O ' ' A' ' 68' ' ' ASP . 0.3 OUTLIER -100.42 144.33 29.55 Favored 'General case' 0 N--CA 1.5 2.068 0 O-C-N 120.649 -1.282 . . . . 0.0 111.759 -179.661 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 0.7 OUTLIER -66.4 134.08 30.38 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.369 0 N-CA-C 105.085 -2.191 . . . . 0.0 105.085 175.638 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 73' ' ' ALA . . . . . 0.549 ' N ' ' O ' ' A' ' 87' ' ' VAL . . . -80.5 -13.96 58.66 Favored 'General case' 0 C--N 1.295 -1.776 0 O-C-N 119.587 -1.946 . . . . 0.0 107.161 -179.525 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . 177.16 -159.63 26.06 Favored Glycine 0 N--CA 1.482 1.725 0 N-CA-C 109.835 -1.306 . . . . 0.0 109.835 179.07 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 75' ' ' TYR . . . . . 0.469 ' CD2' ' O ' ' A' ' 85' ' ' GLU . 0.6 OUTLIER -143.83 165.96 26.25 Favored 'General case' 0 C--N 1.295 -1.768 0 C-N-CA 119.468 -0.893 . . . . 0.0 110.75 -177.283 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 76' ' ' ILE . . . . . . . . . . . . . 1.2 tt -148.38 147.4 17.0 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.534 0 C-N-CA 119.346 -0.942 . . . . 0.0 110.072 -178.189 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -150.76 162.48 40.65 Favored 'General case' 0 N--CA 1.486 1.373 0 O-C-N 121.276 -0.89 . . . . 0.0 109.042 179.934 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 78' ' ' ILE . . . . . . . . . . . . . 38.6 mt -147.62 97.08 4.04 Favored Pre-proline 0 N--CA 1.488 1.445 0 O-C-N 121.238 -0.913 . . . . 0.0 108.817 -179.444 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 79' ' ' PRO . . . . . . . . . . . . . 51.0 Cg_exo -49.15 -45.13 30.84 Favored 'Trans proline' 0 N--CA 1.493 1.485 0 C-N-CA 122.795 2.33 . . . . 0.0 114.423 -178.59 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 80' ' ' ASP . . . . . 0.482 ' O ' ' OD1' ' A' ' 80' ' ' ASP . 47.7 t0 -66.09 -20.26 66.11 Favored 'General case' 0 N--CA 1.496 1.843 0 O-C-N 120.48 -1.387 . . . . 0.0 111.024 179.073 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 81' ' ' ALA . . . . . 0.577 ' O ' ' ND2' ' A' ' 132' ' ' ASN . . . -107.09 -10.49 15.88 Favored 'General case' 0 N--CA 1.491 1.582 0 N-CA-C 108.528 -0.916 . . . . 0.0 108.528 179.639 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 82' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER 61.42 50.88 4.41 Favored 'General case' 0 N--CA 1.493 1.697 0 O-C-N 121.541 -0.724 . . . . 0.0 110.719 179.481 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 83' ' ' ILE . . . . . . . . . . . . . 46.6 mt -128.83 152.2 36.67 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.815 0 O-C-N 121.062 -1.024 . . . . 0.0 110.229 -178.975 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 84' ' ' LYS . . . . . . . . . . . . . 27.2 tttp -157.88 108.47 2.19 Favored 'General case' 0 N--CA 1.49 1.566 0 N-CA-C 107.662 -1.236 . . . . 0.0 107.662 179.762 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 85' ' ' GLU . . . . . 0.512 ' OE2' ' O ' ' A' ' 129' ' ' GLN . 0.0 OUTLIER -141.6 163.35 41.61 Favored Pre-proline 0 N--CA 1.494 1.771 0 O-C-N 121.283 -0.886 . . . . 0.0 110.88 -178.361 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 86' ' ' PRO . . . . . 0.41 ' N ' ' CE2' ' A' ' 75' ' ' TYR . 40.9 Cg_endo -72.15 165.36 32.84 Favored 'Trans proline' 0 N--CA 1.495 1.609 0 C-N-CA 123.259 2.639 . . . . 0.0 113.031 -179.882 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 87' ' ' VAL . . . . . 0.549 ' O ' ' N ' ' A' ' 73' ' ' ALA . 66.0 t -124.36 98.96 5.76 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.695 0 N-CA-C 108.903 -0.777 . . . . 0.0 108.903 179.54 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 88' ' ' TYR . . . . . 0.423 ' CE1' ' HB3' ' A' ' 99' ' ' ARG . 15.9 m-85 -91.45 155.58 44.02 Favored Pre-proline 0 N--CA 1.501 2.12 0 O-C-N 120.964 -1.085 . . . . 0.0 110.224 -179.212 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 89' ' ' PRO . . . . . . . . . . . . . 9.6 Cg_endo -61.75 145.25 97.45 Favored 'Trans proline' 0 C--N 1.311 -1.443 0 C-N-CA 122.639 2.226 . . . . 0.0 113.408 179.683 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . -58.82 168.23 6.34 Favored Glycine 0 N--CA 1.494 2.504 0 N-CA-C 109.408 -1.477 . . . . 0.0 109.408 179.305 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 91' ' ' PRO . . . . . 0.459 ' C ' ' H ' ' A' ' 93' ' ' THR . 97.5 Cg_endo -94.13 169.53 18.82 Favored 'Cis proline' 0 C--N 1.307 -1.654 0 C-N-CA 123.873 -1.303 . . . . 0.0 112.021 -0.257 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 92' ' ' ALA . . . . . 0.515 ' O ' ' CD1' ' A' ' 97' ' ' LEU . . . -72.16 31.47 0.06 Allowed 'General case' 0 N--CA 1.489 1.49 0 O-C-N 121.217 -0.927 . . . . 0.0 110.756 -179.786 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 93' ' ' THR . . . . . 0.459 ' H ' ' C ' ' A' ' 91' ' ' PRO . 6.0 p -72.41 151.42 91.88 Favored Pre-proline 0 N--CA 1.492 1.643 0 O-C-N 120.543 -1.348 . . . . 0.0 108.075 179.865 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 94' ' ' PRO . . . . . 0.435 ' C ' ' O ' ' A' ' 93' ' ' THR . 88.7 Cg_exo -31.68 -57.91 0.23 Allowed 'Trans proline' 0 C--N 1.306 -1.692 0 C-N-CA 122.702 2.268 . . . . 0.0 112.636 -178.656 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 95' ' ' GLU . . . . . 0.506 ' O ' ' ND2' ' A' ' 98' ' ' ASN . 29.0 mt-10 -43.87 -49.09 8.39 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.11 -0.994 . . . . 0.0 109.715 179.929 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 96' ' ' GLN . . . . . 0.586 ' O ' ' N ' ' A' ' 98' ' ' ASN . 39.2 mm-40 -71.63 -56.98 4.81 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.195 -0.941 . . . . 0.0 110.981 -179.058 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 97' ' ' LEU . . . . . 0.515 ' CD1' ' O ' ' A' ' 92' ' ' ALA . 91.7 mt -48.95 -5.99 0.02 OUTLIER 'General case' 0 N--CA 1.495 1.783 0 O-C-N 120.989 -1.069 . . . . 0.0 109.878 -179.156 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 98' ' ' ASN . . . . . 0.802 HD22 ' NE ' ' A' ' 99' ' ' ARG . 0.1 OUTLIER -73.2 -28.63 62.3 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.213 -0.929 . . . . 0.0 108.904 179.466 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 99' ' ' ARG . . . . . 0.802 ' NE ' HD22 ' A' ' 98' ' ' ASN . 0.0 OUTLIER -92.34 -54.57 3.75 Favored 'General case' 0 N--CA 1.487 1.406 0 O-C-N 121.692 -0.63 . . . . 0.0 109.552 -179.659 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . -179.89 -160.63 25.71 Favored Glycine 0 N--CA 1.491 2.353 0 C-N-CA 119.554 -1.308 . . . . 0.0 110.188 -179.917 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 101' ' ' VAL . . . . . 0.468 ' O ' ' CG2' ' A' ' 101' ' ' VAL . 20.5 m -61.48 104.93 0.29 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.659 0 O-C-N 121.474 -1.015 . . . . 0.0 109.92 -179.507 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -92.73 157.16 16.59 Favored 'General case' 0 N--CA 1.493 1.715 0 O-C-N 121.495 -0.753 . . . . 0.0 110.67 -179.503 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 103' ' ' PHE . . . . . . . . . . . . . 22.1 m-85 -59.69 130.36 46.43 Favored 'General case' 0 N--CA 1.49 1.568 0 N-CA-C 107.468 -1.308 . . . . 0.0 107.468 178.276 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 104' ' ' ALA . . . . . . . . . . . . . . . -50.95 -16.45 0.43 Allowed 'General case' 0 C--N 1.301 -1.542 0 O-C-N 121.378 -0.826 . . . . 0.0 111.467 -178.337 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -139.49 147.61 41.53 Favored 'General case' 0 N--CA 1.494 1.766 0 O-C-N 120.722 -1.236 . . . . 0.0 110.577 -179.862 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 106' ' ' GLU . . . . . 0.559 ' OE2' ' ND2' ' A' ' 107' ' ' ASN . 3.3 tt0 -54.71 -64.44 0.83 Allowed 'General case' 0 C--N 1.301 -1.527 0 CA-C-N 115.857 -0.611 . . . . 0.0 111.151 -178.986 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 107' ' ' ASN . . . . . 0.559 ' ND2' ' OE2' ' A' ' 106' ' ' GLU . 2.5 m120 -78.28 33.37 0.19 Allowed 'General case' 0 N--CA 1.49 1.566 0 O-C-N 120.522 -1.361 . . . . 0.0 113.059 -175.325 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 108' ' ' GLU . . . . . . . . . . . . . 27.8 tp10 -59.39 148.41 32.66 Favored 'General case' 0 C--N 1.299 -1.597 0 N-CA-C 107.191 -1.411 . . . . 0.0 107.191 179.886 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 109' ' ' SER . . . . . 0.402 ' C ' ' H ' ' A' ' 111' ' ' ASP . 0.3 OUTLIER -99.64 129.82 45.81 Favored 'General case' 0 C--N 1.301 -1.504 0 O-C-N 120.987 -1.071 . . . . 0.0 110.443 -178.019 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 110' ' ' LEU . . . . . . . . . . . . . 3.2 tp -59.03 -11.98 4.16 Favored 'General case' 0 C--N 1.301 -1.505 0 N-CA-C 108.02 -1.104 . . . . 0.0 108.02 179.63 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 111' ' ' ASP . . . . . 0.402 ' H ' ' C ' ' A' ' 109' ' ' SER . 57.7 m-20 -132.57 30.03 4.15 Favored 'General case' 0 N--CA 1.491 1.615 0 N-CA-C 109.0 -0.741 . . . . 0.0 109.0 179.044 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 112' ' ' ASP . . . . . . . . . . . . . 6.2 t0 -67.27 149.1 50.86 Favored 'General case' 0 N--CA 1.493 1.704 0 O-C-N 121.105 -0.997 . . . . 0.0 111.19 -179.056 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 113' ' ' GLN . . . . . 0.713 HE22 ' NZ ' ' A' ' 177' ' ' LYS . 0.4 OUTLIER -66.36 -12.83 59.03 Favored 'General case' 0 N--CA 1.49 1.564 0 N-CA-C 108.319 -0.993 . . . . 0.0 108.319 178.285 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 114' ' ' ASN . . . . . 0.587 ' C ' HD21 ' A' ' 114' ' ' ASN . 0.2 OUTLIER -149.92 99.98 2.89 Favored 'General case' 0 N--CA 1.491 1.601 0 N-CA-C 108.204 -1.035 . . . . 0.0 108.204 179.351 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 115' ' ' ILE . . . . . 0.427 HG23 HD12 ' A' ' 115' ' ' ILE . 3.9 mt -98.79 111.94 29.67 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.621 0 O-C-N 121.111 -0.993 . . . . 0.0 109.497 -179.367 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 116' ' ' SER . . . . . . . . . . . . . 48.9 m -97.84 153.58 18.21 Favored 'General case' 0 N--CA 1.492 1.675 0 O-C-N 121.026 -1.046 . . . . 0.0 110.94 -179.142 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 117' ' ' ILE . . . . . . . . . . . . . 1.5 mt -144.79 159.94 14.24 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.617 0 N-CA-C 108.629 -0.878 . . . . 0.0 108.629 179.586 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 118' ' ' ALA . . . . . . . . . . . . . . . -144.53 160.25 41.44 Favored 'General case' 0 N--CA 1.491 1.606 0 C-N-CA 118.639 -1.224 . . . . 0.0 112.17 -179.441 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 119' ' ' GLY . . . . . . . . . . . . . . . -172.16 146.24 9.16 Favored Glycine 0 N--CA 1.49 2.239 0 N-CA-C 110.622 -0.991 . . . . 0.0 110.622 179.909 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 120' ' ' HIS . . . . . . . . . . . . . 11.5 m170 -71.29 167.63 19.06 Favored 'General case' 0 N--CA 1.496 1.856 0 O-C-N 121.744 -0.857 . . . . 0.0 110.45 179.483 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 121' ' ' THR . . . . . 0.504 ' OG1' ' NZ ' ' A' ' 134' ' ' LYS . 0.7 OUTLIER -119.02 162.29 18.8 Favored 'General case' 0 N--CA 1.5 2.048 0 O-C-N 121.188 -0.945 . . . . 0.0 108.874 179.301 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 122' ' ' PHE . . . . . . . . . . . . . 0.3 OUTLIER -133.25 122.37 23.82 Favored 'General case' 0 N--CA 1.499 1.982 0 O-C-N 120.868 -1.145 . . . . 0.0 110.291 -179.281 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 123' ' ' ILE . . . . . 0.448 ' CG2' ' N ' ' A' ' 124' ' ' ASP . 18.1 tt -65.5 -40.75 89.15 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.582 0 CA-C-O 121.58 0.705 . . . . 0.0 109.217 179.588 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 124' ' ' ASP . . . . . 0.448 ' N ' ' CG2' ' A' ' 123' ' ' ILE . 1.2 t70 -96.69 25.75 4.97 Favored 'General case' 0 N--CA 1.497 1.914 0 C-N-CA 120.154 -0.619 . . . . 0.0 111.452 -178.473 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 125' ' ' ARG . . . . . 0.638 HH11 ' CG ' ' A' ' 125' ' ' ARG . 0.0 OUTLIER -158.67 106.15 1.62 Allowed Pre-proline 0 N--CA 1.493 1.712 0 O-C-N 120.553 -1.342 . . . . 0.0 110.126 -179.209 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 126' ' ' PRO . . . . . . . . . . . . . 74.3 Cg_endo -81.91 -23.61 4.52 Favored 'Trans proline' 0 N--CA 1.489 1.217 0 C-N-CA 122.293 1.995 . . . . 0.0 112.325 179.834 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 127' ' ' ASN . . . . . . . . . . . . . 1.3 m-20 -90.34 28.91 1.35 Allowed 'General case' 0 N--CA 1.489 1.495 0 O-C-N 121.295 -0.878 . . . . 0.0 109.815 -179.685 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 128' ' ' TYR . . . . . . . . . . . . . 7.6 t80 -83.9 -149.27 0.1 Allowed 'General case' 0 N--CA 1.494 1.735 0 O-C-N 121.303 -0.873 . . . . 0.0 109.15 179.61 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 129' ' ' GLN . . . . . 0.512 ' O ' ' OE2' ' A' ' 85' ' ' GLU . 51.3 mt-30 -67.77 -73.05 0.15 Allowed 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.102 -0.999 . . . . 0.0 109.875 -179.698 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 130' ' ' PHE . . . . . 0.422 ' O ' ' CE ' ' A' ' 134' ' ' LYS . 38.7 m-85 -129.63 45.92 2.73 Favored 'General case' 0 N--CA 1.497 1.918 0 O-C-N 121.013 -1.054 . . . . 0.0 110.119 -179.845 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 131' ' ' THR . . . . . . . . . . . . . 25.0 m -82.58 -37.64 24.79 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 120.991 -1.068 . . . . 0.0 110.222 -179.919 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 132' ' ' ASN . . . . . 0.577 ' ND2' ' O ' ' A' ' 81' ' ' ALA . 7.6 t30 -83.39 7.84 15.49 Favored 'General case' 0 N--CA 1.491 1.618 0 C-N-CA 119.389 -0.924 . . . . 0.0 111.145 -178.574 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 133' ' ' LEU . . . . . 0.545 ' O ' ' N ' ' A' ' 135' ' ' ALA . 0.1 OUTLIER -70.29 -46.21 64.76 Favored 'General case' 0 C--N 1.301 -1.523 0 O-C-N 120.793 -1.192 . . . . 0.0 109.237 179.936 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 134' ' ' LYS . . . . . 0.513 ' H ' ' CD ' ' A' ' 134' ' ' LYS . 0.0 OUTLIER -43.75 -18.16 0.02 OUTLIER 'General case' 0 N--CA 1.494 1.747 0 O-C-N 121.368 -0.832 . . . . 0.0 109.861 -179.74 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 135' ' ' ALA . . . . . 0.545 ' N ' ' O ' ' A' ' 133' ' ' LEU . . . -83.8 -37.14 22.93 Favored 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.048 -1.032 . . . . 0.0 109.433 179.943 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 136' ' ' ALA . . . . . 0.43 ' N ' ' O ' ' A' ' 133' ' ' LEU . . . -79.62 157.05 27.39 Favored 'General case' 0 C--N 1.301 -1.541 0 CA-C-O 122.298 1.047 . . . . 0.0 111.517 -178.502 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 137' ' ' LYS . . . . . 0.562 ' O ' ' O ' ' A' ' 138' ' ' LYS . 0.1 OUTLIER -152.04 -163.26 1.69 Allowed 'General case' 0 C--N 1.304 -1.404 0 C-N-CA 119.017 -1.073 . . . . 0.0 110.03 -178.016 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 138' ' ' LYS . . . . . 0.582 ' O ' ' N ' ' A' ' 140' ' ' SER . 51.2 mttm -41.0 177.67 0.0 OUTLIER 'General case' 0 C--N 1.304 -1.381 0 CA-C-O 122.583 1.182 . . . . 0.0 111.716 -179.093 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 139' ' ' GLY . . . . . . . . . . . . . . . 46.32 8.3 0.02 OUTLIER Glycine 0 N--CA 1.492 2.386 0 N-CA-C 110.353 -1.099 . . . . 0.0 110.353 -179.918 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 140' ' ' SER . . . . . 0.582 ' N ' ' O ' ' A' ' 138' ' ' LYS . 6.3 m -79.0 121.52 25.04 Favored 'General case' 0 N--CA 1.493 1.719 0 O-C-N 120.887 -1.36 . . . . 0.0 109.693 179.258 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 141' ' ' MET . . . . . 0.687 ' SD ' ' N ' ' A' ' 142' ' ' VAL . 5.1 tpp -77.99 125.15 28.92 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.192 -0.943 . . . . 0.0 108.971 179.529 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 142' ' ' VAL . . . . . 0.687 ' N ' ' SD ' ' A' ' 141' ' ' MET . 2.5 t -110.48 131.51 61.38 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.446 0 N-CA-C 108.585 -0.894 . . . . 0.0 108.585 -179.594 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 143' ' ' TYR . . . . . . . . . . . . . 9.8 m-85 -109.98 135.54 50.66 Favored 'General case' 0 N--CA 1.497 1.922 0 O-C-N 121.036 -1.04 . . . . 0.0 111.111 -178.321 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 144' ' ' PHE . . . . . . . . . . . . . 46.7 t80 -121.03 102.48 8.36 Favored 'General case' 0 N--CA 1.49 1.534 0 CA-C-O 121.262 0.553 . . . . 0.0 109.829 -178.957 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 145' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -100.93 121.81 42.4 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.202 -0.936 . . . . 0.0 110.117 -179.966 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 146' ' ' VAL . . . . . . . . . . . . . 1.0 OUTLIER -142.53 124.49 12.86 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.581 0 O-C-N 121.126 -0.984 . . . . 0.0 108.424 179.091 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 147' ' ' GLY . . . . . . . . . . . . . . . 66.9 -132.1 31.26 Favored Glycine 0 N--CA 1.49 2.239 0 N-CA-C 108.103 -1.999 . . . . 0.0 108.103 -178.735 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 148' ' ' ASN . . . . . 0.606 ' C ' ' ND2' ' A' ' 148' ' ' ASN . 0.0 OUTLIER -102.43 10.31 39.09 Favored 'General case' 0 C--N 1.301 -1.526 0 O-C-N 121.266 -1.138 . . . . 0.0 108.209 178.955 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 149' ' ' GLU . . . . . 0.402 ' OE1' ' N ' ' A' ' 150' ' ' THR . 1.4 tm-20 -107.91 144.44 35.16 Favored 'General case' 0 N--CA 1.489 1.524 0 CA-C-O 121.941 0.877 . . . . 0.0 111.706 -178.666 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 150' ' ' THR . . . . . 0.402 ' N ' ' OE1' ' A' ' 149' ' ' GLU . 44.2 m -133.8 100.51 4.78 Favored 'General case' 0 N--CA 1.491 1.603 0 CA-C-O 121.517 0.675 . . . . 0.0 109.563 -179.749 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 151' ' ' ARG . . . . . . . . . . . . . 17.4 mtt180 -87.06 -174.16 4.78 Favored 'General case' 0 N--CA 1.488 1.445 0 N-CA-C 108.435 -0.95 . . . . 0.0 108.435 179.994 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 152' ' ' LYS . . . . . 0.496 ' O ' ' N ' ' A' ' 205' ' ' VAL . 35.6 mtmt -148.59 142.95 26.25 Favored 'General case' 0 N--CA 1.488 1.469 0 O-C-N 121.068 -1.02 . . . . 0.0 110.273 -179.335 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 153' ' ' TYR . . . . . 0.57 ' O ' ' SD ' ' A' ' 141' ' ' MET . 2.8 m-85 -136.18 167.77 20.66 Favored 'General case' 0 N--CA 1.492 1.642 0 N-CA-C 107.582 -1.266 . . . . 0.0 107.582 179.029 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 154' ' ' LYS . . . . . . . . . . . . . 1.5 ttpm? -142.26 122.93 14.23 Favored 'General case' 0 N--CA 1.493 1.704 0 O-C-N 121.127 -0.983 . . . . 0.0 108.393 178.387 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 155' ' ' MET . . . . . . . . . . . . . 67.2 mtp -45.57 105.94 0.07 Allowed 'General case' 0 N--CA 1.491 1.608 0 O-C-N 120.586 -1.321 . . . . 0.0 111.351 -178.67 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 156' ' ' THR . . . . . 0.456 ' OG1' ' OG1' ' A' ' 203' ' ' THR . 0.1 OUTLIER -106.41 -24.87 12.12 Favored 'General case' 0 C--N 1.293 -1.888 0 CA-C-N 115.401 -0.818 . . . . 0.0 110.073 -179.077 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 157' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -151.45 151.5 31.76 Favored 'General case' 0 N--CA 1.494 1.765 0 C-N-CA 118.405 -1.318 . . . . 0.0 111.206 -178.299 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 158' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -154.16 144.4 13.98 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.189 0 CA-C-O 122.039 0.923 . . . . 0.0 110.448 -179.538 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 159' ' ' ARG . . . . . . . . . . . . . 31.4 ttp180 -153.98 155.91 36.45 Favored 'General case' 0 C--N 1.297 -1.685 0 CA-C-O 121.934 0.873 . . . . 0.0 110.76 -179.036 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 160' ' ' ASP . . . . . . . . . . . . . 26.5 m-20 -118.65 160.66 21.42 Favored 'General case' 0 N--CA 1.492 1.666 0 N-CA-C 108.957 -0.757 . . . . 0.0 108.957 179.325 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 161' ' ' VAL . . . . . 0.451 ' O ' ' O ' ' A' ' 162' ' ' LYS . 0.0 OUTLIER -164.54 161.65 0.94 Allowed 'Isoleucine or valine' 0 N--CA 1.496 1.826 0 O-C-N 121.003 -1.061 . . . . 0.0 110.213 179.508 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 162' ' ' LYS . . . . . 0.688 ' H ' ' CD ' ' A' ' 162' ' ' LYS . 0.0 OUTLIER -45.99 173.04 0.04 OUTLIER Pre-proline 0 N--CA 1.493 1.723 0 O-C-N 121.591 -0.693 . . . . 0.0 109.815 179.456 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 163' ' ' PRO . . . . . 0.647 ' CA ' HH21 ' A' ' 197' ' ' ARG . 63.1 Cg_endo -81.34 35.06 0.57 Allowed 'Trans proline' 0 C--N 1.313 -1.34 0 C-N-CA 122.532 2.155 . . . . 0.0 112.54 179.815 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 164' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -150.76 -2.66 0.35 Allowed 'General case' 0 N--CA 1.495 1.814 0 O-C-N 121.053 -1.03 . . . . 0.0 110.821 179.961 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 165' ' ' ASP . . . . . 0.432 ' O ' ' C ' ' A' ' 166' ' ' VAL . 9.7 t70 -75.8 62.66 1.56 Allowed 'General case' 0 N--CA 1.495 1.785 0 O-C-N 120.675 -1.266 . . . . 0.0 110.675 -179.58 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 166' ' ' VAL . . . . . 0.621 ' O ' ' N ' ' A' ' 168' ' ' VAL . 2.6 t -42.99 -31.48 0.49 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.659 0 O-C-N 121.236 -0.915 . . . . 0.0 109.096 -178.853 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 167' ' ' GLY . . . . . . . . . . . . . . . -44.08 -9.81 0.01 OUTLIER Glycine 0 N--CA 1.495 2.632 0 O-C-N 121.126 -0.983 . . . . 0.0 111.055 -179.788 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 168' ' ' VAL . . . . . 0.672 ' C ' ' H ' ' A' ' 170' ' ' ASP . 7.4 m -55.47 -32.18 29.38 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.51 0 O-C-N 120.615 -1.521 . . . . 0.0 108.759 179.543 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 169' ' ' LEU . . . . . 0.564 ' O ' ' N ' ' A' ' 171' ' ' GLU . 9.5 mt -52.53 -4.65 0.03 OUTLIER 'General case' 0 N--CA 1.498 1.969 0 N-CA-C 107.957 -1.127 . . . . 0.0 107.957 -179.328 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 170' ' ' ASP . . . . . 0.672 ' H ' ' C ' ' A' ' 168' ' ' VAL . 0.6 OUTLIER 34.12 28.21 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.762 -0.586 . . . . 0.0 111.713 177.838 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 171' ' ' GLU . . . . . 0.564 ' N ' ' O ' ' A' ' 169' ' ' LEU . 11.8 pt-20 -63.91 93.17 0.08 Allowed 'General case' 0 C--N 1.298 -1.647 0 N-CA-C 107.645 -1.242 . . . . 0.0 107.645 178.528 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 172' ' ' GLN . . . . . . . . . . . . . 1.0 OUTLIER -160.84 -71.75 0.06 Allowed 'General case' 0 N--CA 1.491 1.588 0 CA-C-O 121.263 0.554 . . . . 0.0 109.511 -179.371 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 173' ' ' LYS . . . . . 0.601 ' NZ ' HE21 ' A' ' 178' ' ' GLN . 8.9 pttm -62.09 126.6 27.91 Favored 'General case' 0 N--CA 1.488 1.446 0 O-C-N 121.143 -0.973 . . . . 0.0 108.908 179.631 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 174' ' ' GLY . . . . . 0.568 ' O ' ' C ' ' A' ' 175' ' ' LYS . . . -121.18 -39.81 0.57 Allowed Glycine 0 C--N 1.298 -1.565 0 N-CA-C 108.283 -1.927 . . . . 0.0 108.283 179.721 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 175' ' ' LYS . . . . . 0.568 ' C ' ' O ' ' A' ' 174' ' ' GLY . 0.8 OUTLIER -31.59 -62.22 0.2 Allowed 'General case' 0 N--CA 1.498 1.929 0 N-CA-C 108.124 -1.065 . . . . 0.0 108.124 179.783 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 176' ' ' ASP . . . . . 0.631 ' O ' ' O ' ' A' ' 177' ' ' LYS . 69.6 m-20 -104.09 85.72 2.44 Favored 'General case' 0 C--N 1.294 -1.815 0 N-CA-C 107.487 -1.301 . . . . 0.0 107.487 177.092 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 177' ' ' LYS . . . . . 0.713 ' NZ ' HE22 ' A' ' 113' ' ' GLN . 35.8 mttt -37.23 174.08 0.0 OUTLIER 'General case' 0 N--CA 1.497 1.904 0 CA-C-O 121.696 0.76 . . . . 0.0 110.588 -179.113 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 178' ' ' GLN . . . . . 0.601 HE21 ' NZ ' ' A' ' 173' ' ' LYS . 0.6 OUTLIER -161.51 175.42 12.15 Favored 'General case' 0 N--CA 1.489 1.479 0 C-N-CA 118.371 -1.332 . . . . 0.0 111.105 -179.864 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 179' ' ' LEU . . . . . 0.422 ' N ' ' OE1' ' A' ' 178' ' ' GLN . 1.3 tp -128.44 98.0 4.9 Favored 'General case' 0 C--N 1.302 -1.485 0 N-CA-C 107.274 -1.38 . . . . 0.0 107.274 178.103 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 180' ' ' THR . . . . . 0.481 ' N ' ' OE1' ' A' ' 178' ' ' GLN . 1.1 m -71.66 120.74 17.67 Favored 'General case' 0 N--CA 1.486 1.371 0 O-C-N 121.1 -1.0 . . . . 0.0 110.157 -178.341 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 181' ' ' LEU . . . . . . . . . . . . . 6.6 tt -95.69 146.71 24.29 Favored 'General case' 0 C--N 1.299 -1.593 0 N-CA-C 107.915 -1.143 . . . . 0.0 107.915 178.01 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 182' ' ' ILE . . . . . . . . . . . . . 19.8 mt -141.16 117.47 7.17 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.781 0 O-C-N 121.059 -1.026 . . . . 0.0 108.817 179.081 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 183' ' ' THR . . . . . . . . . . . . . 14.3 t -138.07 119.01 14.27 Favored 'General case' 0 C--N 1.29 -1.978 0 N-CA-C 108.002 -1.11 . . . . 0.0 108.002 179.229 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 184' ' ' CYS . . . . . . . . . . . . . 0.8 OUTLIER -79.85 162.5 25.01 Favored 'General case' 0 C--N 1.285 -2.236 0 C-N-CA 119.466 -0.894 . . . . 0.0 111.397 -177.842 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 185' ' ' ASP . . . . . 0.417 ' OD1' ' N ' ' A' ' 186' ' ' ASP . 4.4 t0 -165.51 -152.48 0.16 Allowed 'General case' 0 N--CA 1.492 1.644 0 N-CA-C 108.938 -0.764 . . . . 0.0 108.938 179.745 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 186' ' ' ASP . . . . . 0.417 ' N ' ' OD1' ' A' ' 185' ' ' ASP . 0.5 OUTLIER 47.78 59.34 4.25 Favored 'General case' 0 N--CA 1.495 1.777 0 O-C-N 121.136 -0.977 . . . . 0.0 109.072 -179.678 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 187' ' ' TYR . . . . . 0.591 ' CE1' ' O ' ' A' ' 188' ' ' ASN . 43.4 t80 -68.37 134.58 50.46 Favored 'General case' 0 N--CA 1.489 1.485 0 CA-C-O 121.821 0.819 . . . . 0.0 110.612 -179.585 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 188' ' ' ASN . . . . . 0.591 ' O ' ' CE1' ' A' ' 187' ' ' TYR . 0.8 OUTLIER -99.6 146.02 26.9 Favored 'General case' 0 C--N 1.294 -1.838 0 N-CA-C 107.916 -1.142 . . . . 0.0 107.916 178.224 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 189' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -111.55 -18.32 12.85 Favored 'General case' 0 C--N 1.296 -1.734 0 N-CA-C 108.1 -1.074 . . . . 0.0 108.1 -179.812 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 190' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER -83.68 -49.77 8.82 Favored 'General case' 0 C--N 1.302 -1.472 0 N-CA-C 108.267 -1.012 . . . . 0.0 108.267 178.457 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 191' ' ' THR . . . . . . . . . . . . . 44.4 p -87.41 -6.52 58.41 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.487 -0.758 . . . . 0.0 109.514 -179.971 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 192' ' ' GLY . . . . . . . . . . . . . . . 56.53 36.3 70.18 Favored Glycine 0 N--CA 1.493 2.463 0 O-C-N 121.081 -1.012 . . . . 0.0 110.648 179.025 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 193' ' ' VAL . . . . . . . . . . . . . 3.3 m -147.23 161.85 8.15 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.545 0 O-C-N 121.025 -1.279 . . . . 0.0 109.339 179.709 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 194' ' ' TRP . . . . . 0.472 ' N ' ' CD1' ' A' ' 194' ' ' TRP . 22.7 m95 -84.15 118.88 24.4 Favored 'General case' 0 N--CA 1.489 1.495 0 N-CA-C 107.604 -1.258 . . . . 0.0 107.604 178.654 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 195' ' ' GLU . . . . . 0.522 ' CD ' ' ND2' ' A' ' 188' ' ' ASN . 3.5 mt-10 -82.74 -62.09 1.7 Allowed 'General case' 0 N--CA 1.495 1.809 0 O-C-N 121.14 -0.975 . . . . 0.0 112.319 -177.103 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 196' ' ' LYS . . . . . . . . . . . . . 8.0 tptp -86.63 156.46 20.01 Favored 'General case' 0 N--CA 1.494 1.754 0 O-C-N 120.753 -1.217 . . . . 0.0 110.856 -178.141 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 197' ' ' ARG . . . . . 0.647 HH21 ' CA ' ' A' ' 163' ' ' PRO . 6.4 tpp180 -124.98 139.94 53.36 Favored 'General case' 0 N--CA 1.489 1.489 0 N-CA-C 109.133 -0.691 . . . . 0.0 109.133 179.389 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 198' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -112.46 121.8 45.87 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.626 -0.671 . . . . 0.0 109.863 -179.053 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 199' ' ' ILE . . . . . 0.413 ' O ' ' CG1' ' A' ' 199' ' ' ILE . 0.9 OUTLIER -141.51 119.44 8.88 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.665 0 CA-C-O 122.615 1.198 . . . . 0.0 110.996 179.857 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 200' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -104.7 138.71 40.59 Favored 'General case' 0 N--CA 1.494 1.759 0 O-C-N 121.526 -0.734 . . . . 0.0 110.438 -178.305 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 201' ' ' VAL . . . . . . . . . . . . . 58.0 t -101.93 143.52 14.59 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.729 0 O-C-N 120.971 -1.081 . . . . 0.0 108.447 178.314 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 202' ' ' ALA . . . . . . . . . . . . . . . -124.95 135.23 52.63 Favored 'General case' 0 N--CA 1.489 1.477 0 N-CA-C 108.49 -0.93 . . . . 0.0 108.49 179.687 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 203' ' ' THR . . . . . 0.456 ' OG1' ' OG1' ' A' ' 156' ' ' THR . 1.3 p -89.17 128.4 35.8 Favored 'General case' 0 C--N 1.303 -1.427 0 CA-C-O 122.23 1.014 . . . . 0.0 111.225 -178.61 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 204' ' ' GLU . . . . . 0.47 ' HA ' ' CD2' ' A' ' 153' ' ' TYR . 5.5 tt0 -51.18 134.43 27.22 Favored 'General case' 0 C--N 1.297 -1.684 0 C-N-CA 118.949 -1.101 . . . . 0.0 108.369 178.728 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 205' ' ' VAL . . . . . 0.496 ' N ' ' O ' ' A' ' 152' ' ' LYS . 95.6 t -131.12 166.81 27.68 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.34 0 CA-C-O 121.934 0.873 . . . . 0.0 110.023 -177.859 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 206' ' ' LYS . . . . . 0.47 ' N ' ' CG1' ' A' ' 205' ' ' VAL . 2.0 pttp . . . . . 0 C--N 1.298 -1.658 0 CA-C-O 117.925 -1.036 . . . . 0.0 109.455 -179.672 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' C' C ' 702' ' ' LEU . . . . . 0.594 ' CD1' ' N ' ' C' ' 702' ' ' LEU . 0.0 OUTLIER . . . . . 0 N--CA 1.492 1.67 0 N-CA-C 109.762 -0.458 . . . . 0.0 109.762 . . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' C' C ' 703' ' ' PRO . . . . . 0.524 ' O ' ' O ' ' C' ' 704' ' ' ALA . 52.7 Cg_exo -48.01 -173.39 0.0 OUTLIER 'Trans proline' 0 N--CA 1.489 1.262 0 C-N-CA 121.957 1.771 . . . . 0.0 111.652 178.948 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' C' C ' 704' ' ' ALA . . . . . 0.524 ' O ' ' O ' ' C' ' 703' ' ' PRO . . . . . . . . 0 N--CA 1.492 1.662 0 O-C-N 121.501 -0.749 . . . . 0.0 109.806 179.673 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 63' ' ' PRO . . . . . . . . . . . . . 16.3 Cg_exo . . . . . 0 N--CA 1.49 1.285 0 CA-C-O 121.254 0.439 . . . . 0.0 111.85 . . . . . . . . . 0 0 . 1 . 012 nuclear orig core ' A' A ' 64' ' ' GLN . . . . . 0.589 HE21 ' C ' ' A' ' 64' ' ' GLN . 0.0 OUTLIER -152.75 103.92 2.82 Favored 'General case' 0 N--CA 1.489 1.476 0 O-C-N 121.372 -0.83 . . . . 0.0 109.408 -179.7 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 65' ' ' ILE . . . . . 0.469 ' C ' ' O ' ' A' ' 64' ' ' GLN . 3.5 mp -40.14 102.27 0.26 Allowed Pre-proline 0 N--CA 1.488 1.45 0 N-CA-C 108.43 -0.952 . . . . 0.0 108.43 179.233 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 66' ' ' PRO . . . . . 0.411 ' N ' ' O ' ' A' ' 64' ' ' GLN . 97.9 Cg_endo -84.55 -155.61 0.06 OUTLIER 'Trans proline' 0 N--CA 1.489 1.206 0 C-N-CA 122.751 2.3 . . . . 0.0 112.968 -178.124 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 67' ' ' LYS . . . . . 0.475 ' C ' ' H ' ' A' ' 69' ' ' LYS . 6.5 ptpt -82.81 -5.03 58.76 Favored 'General case' 0 C--N 1.305 -1.362 0 N-CA-C 108.877 -0.786 . . . . 0.0 108.877 179.698 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 68' ' ' ASP . . . . . 0.631 ' C ' ' N ' ' A' ' 70' ' ' SER . 0.3 OUTLIER -75.39 50.18 0.51 Allowed 'General case' 0 N--CA 1.491 1.579 0 CA-C-O 123.005 1.383 . . . . 0.0 108.189 179.013 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 69' ' ' LYS . . . . . 0.475 ' H ' ' C ' ' A' ' 67' ' ' LYS . 1.9 mtpt -48.07 -15.17 0.06 Allowed 'General case' 0 N--CA 1.506 2.359 0 C-N-CA 116.758 -1.977 . . . . 0.0 107.149 178.425 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 70' ' ' SER . . . . . 0.631 ' N ' ' C ' ' A' ' 68' ' ' ASP . 0.2 OUTLIER -86.81 -5.22 59.17 Favored 'General case' 0 C--N 1.293 -1.856 0 CA-C-N 113.701 -1.591 . . . . 0.0 110.613 179.758 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 71' ' ' LYS . . . . . . . . . . . . . 2.4 ptmm? -97.28 138.36 34.87 Favored 'General case' 0 N--CA 1.494 1.736 0 O-C-N 120.899 -1.126 . . . . 0.0 112.007 -179.305 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 72' ' ' VAL . . . . . 0.593 ' CG2' ' O ' ' A' ' 74' ' ' GLY . 0.7 OUTLIER -67.01 132.25 32.38 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.444 0 N-CA-C 104.977 -2.231 . . . . 0.0 104.977 174.554 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 73' ' ' ALA . . . . . 0.452 ' N ' ' O ' ' A' ' 87' ' ' VAL . . . -82.04 -12.87 58.05 Favored 'General case' 0 C--N 1.299 -1.617 0 O-C-N 120.121 -1.612 . . . . 0.0 108.681 -178.671 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 74' ' ' GLY . . . . . 0.593 ' O ' ' CG2' ' A' ' 72' ' ' VAL . . . 170.35 -156.4 26.86 Favored Glycine 0 N--CA 1.483 1.784 0 N-CA-C 109.642 -1.383 . . . . 0.0 109.642 179.974 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 75' ' ' TYR . . . . . 0.55 ' CD1' ' C ' ' A' ' 74' ' ' GLY . 10.8 m-85 -143.71 173.81 11.34 Favored 'General case' 0 C--N 1.293 -1.889 0 O-C-N 121.276 -1.132 . . . . 0.0 109.702 -178.811 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 76' ' ' ILE . . . . . . . . . . . . . 1.4 tt -147.25 144.97 19.52 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.79 0 N-CA-C 108.72 -0.844 . . . . 0.0 108.72 -178.067 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -150.48 157.19 42.74 Favored 'General case' 0 C--N 1.301 -1.536 0 O-C-N 121.043 -1.035 . . . . 0.0 109.849 -179.513 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 78' ' ' ILE . . . . . . . . . . . . . 22.4 mt -142.6 121.28 7.51 Favored Pre-proline 0 C--N 1.301 -1.526 0 N-CA-C 107.291 -1.374 . . . . 0.0 107.291 179.718 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 79' ' ' PRO . . . . . . . . . . . . . 55.6 Cg_endo -73.33 -42.85 0.81 Allowed 'Trans proline' 0 N--CA 1.49 1.321 0 C-N-CA 121.893 1.729 . . . . 0.0 113.569 -177.89 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 19.6 t70 -65.98 -19.4 65.85 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 120.766 -1.209 . . . . 0.0 110.274 178.06 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 81' ' ' ALA . . . . . 0.595 ' O ' ' ND2' ' A' ' 132' ' ' ASN . . . -105.6 -20.99 13.3 Favored 'General case' 0 N--CA 1.495 1.804 0 O-C-N 121.165 -0.959 . . . . 0.0 108.79 179.502 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 82' ' ' ASP . . . . . 0.423 ' OD2' ' C ' ' A' ' 81' ' ' ALA . 0.4 OUTLIER 68.65 51.56 0.61 Allowed 'General case' 0 C--N 1.303 -1.441 0 O-C-N 121.336 -0.853 . . . . 0.0 111.127 178.816 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 83' ' ' ILE . . . . . 0.486 ' CG1' ' OD1' ' A' ' 132' ' ' ASN . 57.6 mt -127.15 152.27 34.98 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.864 0 O-C-N 121.163 -0.96 . . . . 0.0 109.481 -179.777 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 84' ' ' LYS . . . . . . . . . . . . . 0.8 OUTLIER -159.26 108.36 1.87 Allowed 'General case' 0 C--N 1.303 -1.435 0 N-CA-C 107.892 -1.151 . . . . 0.0 107.892 179.727 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 85' ' ' GLU . . . . . 0.493 ' OE1' ' O ' ' A' ' 128' ' ' TYR . 0.0 OUTLIER -142.82 170.53 8.58 Favored Pre-proline 0 N--CA 1.497 1.921 0 O-C-N 121.362 -0.836 . . . . 0.0 111.105 -177.597 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 86' ' ' PRO . . . . . 0.414 ' HA ' ' CD2' ' A' ' 75' ' ' TYR . 90.4 Cg_endo -79.8 161.53 24.34 Favored 'Trans proline' 0 N--CA 1.493 1.474 0 C-N-CA 123.25 2.634 . . . . 0.0 113.247 179.752 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 87' ' ' VAL . . . . . 0.499 ' CG1' ' CE1' ' A' ' 103' ' ' PHE . 92.8 t -118.14 101.97 12.57 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.485 0 N-CA-C 108.99 -0.744 . . . . 0.0 108.99 179.91 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 88' ' ' TYR . . . . . . . . . . . . . 17.5 m-85 -93.35 153.93 41.44 Favored Pre-proline 0 N--CA 1.504 2.236 0 O-C-N 120.865 -1.147 . . . . 0.0 110.664 -179.015 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 89' ' ' PRO . . . . . . . . . . . . . 11.2 Cg_endo -62.44 143.0 92.66 Favored 'Trans proline' 0 C--N 1.312 -1.346 0 C-N-CA 122.571 2.181 . . . . 0.0 113.863 -179.067 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 90' ' ' GLY . . . . . 0.412 ' O ' ' NZ ' ' A' ' 69' ' ' LYS . . . -58.33 168.24 5.71 Favored Glycine 0 N--CA 1.487 2.034 0 N-CA-C 110.167 -1.173 . . . . 0.0 110.167 179.611 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 91' ' ' PRO . . . . . 0.496 ' C ' ' H ' ' A' ' 93' ' ' THR . 38.2 Cg_endo -93.11 169.46 21.09 Favored 'Cis proline' 0 C--N 1.307 -1.606 0 C-N-CA 123.713 -1.37 . . . . 0.0 111.497 0.132 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 92' ' ' ALA . . . . . 0.417 ' O ' ' CD1' ' A' ' 97' ' ' LEU . . . -72.81 33.3 0.07 Allowed 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.02 -1.05 . . . . 0.0 110.237 -179.691 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 93' ' ' THR . . . . . 0.523 ' H ' ' HG1' ' A' ' 93' ' ' THR . 1.6 p -72.21 152.74 92.47 Favored Pre-proline 0 C--N 1.3 -1.559 0 O-C-N 120.86 -1.15 . . . . 0.0 108.008 179.776 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 94' ' ' PRO . . . . . 0.428 ' C ' ' O ' ' A' ' 93' ' ' THR . 92.2 Cg_exo -32.79 -58.73 0.26 Allowed 'Trans proline' 0 C--N 1.305 -1.747 0 C-N-CA 122.575 2.184 . . . . 0.0 112.347 -179.253 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 21.0 mt-10 -44.2 -49.06 9.3 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.249 -0.907 . . . . 0.0 109.971 179.862 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 96' ' ' GLN . . . . . 0.616 ' NE2' HH12 ' A' ' 99' ' ' ARG . 3.8 mp0 -72.33 -55.87 6.41 Favored 'General case' 0 N--CA 1.489 1.491 0 O-C-N 121.203 -0.935 . . . . 0.0 111.014 -178.973 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 97' ' ' LEU . . . . . 0.417 ' CD1' ' O ' ' A' ' 92' ' ' ALA . 80.9 mt -49.21 -6.59 0.02 OUTLIER 'General case' 0 N--CA 1.496 1.845 0 O-C-N 121.067 -1.021 . . . . 0.0 110.279 -178.867 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 98' ' ' ASN . . . . . 0.743 HD22 ' NE ' ' A' ' 99' ' ' ARG . 0.2 OUTLIER -72.77 -25.16 61.07 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.337 -0.852 . . . . 0.0 108.928 179.679 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 99' ' ' ARG . . . . . 0.743 ' NE ' HD22 ' A' ' 98' ' ' ASN . 3.5 mtt180 -92.06 -51.97 4.93 Favored 'General case' 0 C--N 1.302 -1.467 0 O-C-N 121.682 -0.636 . . . . 0.0 110.497 -179.035 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . 172.23 -166.58 39.41 Favored Glycine 0 N--CA 1.493 2.486 0 N-CA-C 109.741 -1.343 . . . . 0.0 109.741 -179.687 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 101' ' ' VAL . . . . . 0.489 ' CG1' ' CE2' ' A' ' 130' ' ' PHE . 34.7 m -54.69 100.41 0.04 OUTLIER 'Isoleucine or valine' 0 N--CA 1.493 1.724 0 O-C-N 121.146 -1.209 . . . . 0.0 109.802 -179.659 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 1.9 m -92.07 171.73 8.91 Favored 'General case' 0 N--CA 1.497 1.875 0 O-C-N 121.417 -0.802 . . . . 0.0 110.324 -179.789 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 103' ' ' PHE . . . . . 0.499 ' CE1' ' CG1' ' A' ' 87' ' ' VAL . 23.6 m-85 -75.08 145.68 42.09 Favored 'General case' 0 N--CA 1.493 1.697 0 N-CA-C 108.069 -1.086 . . . . 0.0 108.069 178.263 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 104' ' ' ALA . . . . . . . . . . . . . . . -66.71 -13.42 61.29 Favored 'General case' 0 N--CA 1.492 1.671 0 O-C-N 121.243 -0.911 . . . . 0.0 111.571 -178.105 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 105' ' ' GLU . . . . . 0.452 ' OE2' ' OE1' ' A' ' 108' ' ' GLU . 0.3 OUTLIER -138.6 144.32 39.72 Favored 'General case' 0 N--CA 1.496 1.838 0 O-C-N 120.762 -1.211 . . . . 0.0 110.592 -179.211 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 106' ' ' GLU . . . . . 0.561 ' CG ' ' H ' ' A' ' 107' ' ' ASN . 6.0 pt-20 -57.12 -59.6 4.85 Favored 'General case' 0 C--N 1.304 -1.402 0 O-C-N 121.732 -0.605 . . . . 0.0 110.224 -179.806 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 107' ' ' ASN . . . . . 0.717 ' N ' HD21 ' A' ' 107' ' ' ASN . 0.0 OUTLIER -78.27 33.96 0.2 Allowed 'General case' 0 N--CA 1.488 1.442 0 O-C-N 120.542 -1.349 . . . . 0.0 112.895 -176.114 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 108' ' ' GLU . . . . . 0.452 ' OE1' ' OE2' ' A' ' 105' ' ' GLU . 32.9 tp10 -60.09 147.45 39.37 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 120.824 -1.173 . . . . 0.0 108.141 -179.568 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 109' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -95.25 147.53 23.38 Favored 'General case' 0 N--CA 1.489 1.497 0 O-C-N 120.797 -1.189 . . . . 0.0 111.03 -178.093 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 110' ' ' LEU . . . . . 0.55 ' H ' ' CD2' ' A' ' 110' ' ' LEU . 0.2 OUTLIER -63.67 -24.61 67.85 Favored 'General case' 0 C--N 1.305 -1.337 0 N-CA-C 107.536 -1.283 . . . . 0.0 107.536 178.548 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 111' ' ' ASP . . . . . 0.48 ' CG ' HH22 ' A' ' 151' ' ' ARG . 55.3 m-20 -132.93 49.19 2.34 Favored 'General case' 0 N--CA 1.487 1.391 0 N-CA-C 109.183 -0.673 . . . . 0.0 109.183 179.513 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 112' ' ' ASP . . . . . . . . . . . . . 1.9 t0 -69.07 159.97 31.9 Favored 'General case' 0 N--CA 1.493 1.72 0 O-C-N 121.257 -0.902 . . . . 0.0 111.287 -179.745 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 113' ' ' GLN . . . . . 0.536 ' N ' ' CD ' ' A' ' 113' ' ' GLN . 0.0 OUTLIER -65.21 -18.52 65.38 Favored 'General case' 0 N--CA 1.491 1.614 0 N-CA-C 107.263 -1.384 . . . . 0.0 107.263 177.675 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 114' ' ' ASN . . . . . 0.608 ' ND2' ' O ' ' A' ' 169' ' ' LEU . 8.5 p-10 -153.11 111.85 3.73 Favored 'General case' 0 C--N 1.299 -1.588 0 N-CA-C 108.026 -1.102 . . . . 0.0 108.026 177.505 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 115' ' ' ILE . . . . . . . . . . . . . 2.5 mt -96.82 105.68 17.44 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.692 0 N-CA-C 107.604 -1.258 . . . . 0.0 107.604 179.507 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 116' ' ' SER . . . . . . . . . . . . . 4.8 m -86.23 151.6 23.49 Favored 'General case' 0 C--N 1.303 -1.422 0 CA-C-O 122.088 0.947 . . . . 0.0 111.421 -177.739 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 117' ' ' ILE . . . . . . . . . . . . . 1.6 mt -147.19 142.26 20.11 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.532 0 N-CA-C 106.998 -1.482 . . . . 0.0 106.998 178.542 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 118' ' ' ALA . . . . . . . . . . . . . . . -137.89 158.37 44.48 Favored 'General case' 0 N--CA 1.493 1.722 0 O-C-N 120.985 -1.072 . . . . 0.0 110.698 -178.284 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 119' ' ' GLY . . . . . . . . . . . . . . . -169.93 145.86 9.54 Favored Glycine 0 N--CA 1.48 1.603 0 N-CA-C 110.055 -1.218 . . . . 0.0 110.055 179.342 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 120' ' ' HIS . . . . . . . . . . . . . 30.0 m170 -70.25 167.48 17.87 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.671 -0.899 . . . . 0.0 109.766 179.589 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 121' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -115.21 157.36 23.79 Favored 'General case' 0 N--CA 1.492 1.644 0 N-CA-C 108.49 -0.93 . . . . 0.0 108.49 179.038 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 122' ' ' PHE . . . . . . . . . . . . . 2.4 m-85 -141.07 122.95 15.39 Favored 'General case' 0 N--CA 1.494 1.769 0 O-C-N 121.152 -0.967 . . . . 0.0 108.873 -179.889 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 123' ' ' ILE . . . . . 0.448 ' CG2' ' N ' ' A' ' 124' ' ' ASP . 19.6 tt -60.32 -40.99 85.55 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.548 0 CA-C-O 121.62 0.724 . . . . 0.0 109.52 -179.608 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 124' ' ' ASP . . . . . 0.448 ' N ' ' CG2' ' A' ' 123' ' ' ILE . 6.0 p-10 -88.96 21.62 3.04 Favored 'General case' 0 C--N 1.295 -1.787 0 O-C-N 121.698 -0.626 . . . . 0.0 111.774 -177.548 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 125' ' ' ARG . . . . . . . . . . . . . 91.6 mtt180 -152.69 101.56 2.71 Favored Pre-proline 0 N--CA 1.492 1.663 0 O-C-N 120.708 -1.245 . . . . 0.0 109.561 179.778 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 126' ' ' PRO . . . . . . . . . . . . . 55.6 Cg_endo -79.32 -30.07 2.77 Favored 'Trans proline' 0 N--CA 1.488 1.177 0 C-N-CA 122.459 2.106 . . . . 0.0 112.903 -179.781 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 127' ' ' ASN . . . . . 0.49 ' O ' ' O ' ' A' ' 128' ' ' TYR . 1.2 m120 -90.07 8.65 31.58 Favored 'General case' 0 N--CA 1.493 1.696 0 O-C-N 121.047 -1.033 . . . . 0.0 109.199 179.594 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 128' ' ' TYR . . . . . 0.493 ' O ' ' OE1' ' A' ' 85' ' ' GLU . 2.1 t80 -59.43 -148.67 0.0 OUTLIER 'General case' 0 C--N 1.302 -1.464 0 O-C-N 121.459 -0.776 . . . . 0.0 109.444 -179.82 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 129' ' ' GLN . . . . . . . . . . . . . 26.7 mt-30 -64.42 -75.6 0.08 Allowed 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.24 -0.913 . . . . 0.0 110.14 -179.252 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 130' ' ' PHE . . . . . 0.523 ' O ' ' CE ' ' A' ' 134' ' ' LYS . 49.4 m-85 -133.87 48.28 2.37 Favored 'General case' 0 N--CA 1.492 1.67 0 O-C-N 121.402 -0.811 . . . . 0.0 109.71 -179.848 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 131' ' ' THR . . . . . . . . . . . . . 23.7 m -83.02 -38.84 22.05 Favored 'General case' 0 C--N 1.298 -1.659 0 O-C-N 121.03 -1.044 . . . . 0.0 109.228 179.864 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 132' ' ' ASN . . . . . 0.595 ' ND2' ' O ' ' A' ' 81' ' ' ALA . 0.2 OUTLIER -83.61 4.19 29.4 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.475 -0.766 . . . . 0.0 110.781 -179.079 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 133' ' ' LEU . . . . . 0.544 ' O ' ' N ' ' A' ' 135' ' ' ALA . 0.1 OUTLIER -66.49 -45.5 79.43 Favored 'General case' 0 N--CA 1.497 1.909 0 O-C-N 120.591 -1.318 . . . . 0.0 110.164 179.874 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 134' ' ' LYS . . . . . 0.652 ' HZ2' ' HG1' ' A' ' 183' ' ' THR . 0.0 OUTLIER -43.07 -17.6 0.01 OUTLIER 'General case' 0 N--CA 1.499 1.995 0 O-C-N 121.142 -0.974 . . . . 0.0 110.814 -178.861 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 135' ' ' ALA . . . . . 0.544 ' N ' ' O ' ' A' ' 133' ' ' LEU . . . -84.09 -31.85 25.08 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 120.976 -1.078 . . . . 0.0 109.725 -179.931 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 136' ' ' ALA . . . . . 0.43 ' N ' ' O ' ' A' ' 133' ' ' LEU . . . -79.6 151.53 30.56 Favored 'General case' 0 C--N 1.3 -1.545 0 CA-C-O 121.874 0.845 . . . . 0.0 111.623 -178.413 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 137' ' ' LYS . . . . . 0.576 ' O ' ' O ' ' A' ' 138' ' ' LYS . 0.0 OUTLIER -153.11 -168.91 3.17 Favored 'General case' 0 N--CA 1.495 1.796 0 C-N-CA 118.474 -1.29 . . . . 0.0 111.313 -177.964 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 138' ' ' LYS . . . . . 0.576 ' O ' ' O ' ' A' ' 137' ' ' LYS . 50.1 mttm -38.55 172.37 0.0 OUTLIER 'General case' 0 N--CA 1.487 1.415 0 CA-C-O 122.488 1.137 . . . . 0.0 110.971 -178.986 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 139' ' ' GLY . . . . . . . . . . . . . . . 49.13 9.12 0.1 Allowed Glycine 0 N--CA 1.488 2.143 0 N-CA-C 109.8 -1.32 . . . . 0.0 109.8 -179.977 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 140' ' ' SER . . . . . 0.54 ' H ' ' C ' ' A' ' 138' ' ' LYS . 4.3 m -80.56 132.26 35.63 Favored 'General case' 0 N--CA 1.496 1.86 0 O-C-N 120.975 -1.309 . . . . 0.0 109.778 179.677 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 141' ' ' MET . . . . . . . . . . . . . 0.1 OUTLIER -83.68 128.81 34.81 Favored 'General case' 0 N--CA 1.49 1.567 0 N-CA-C 108.515 -0.921 . . . . 0.0 108.515 179.195 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 142' ' ' VAL . . . . . . . . . . . . . 2.6 t -117.96 131.68 69.99 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.857 0 O-C-N 121.414 -0.804 . . . . 0.0 109.061 -179.185 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 143' ' ' TYR . . . . . . . . . . . . . 3.1 m-85 -110.58 135.58 51.01 Favored 'General case' 0 N--CA 1.496 1.866 0 O-C-N 120.851 -1.156 . . . . 0.0 111.444 -178.443 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 144' ' ' PHE . . . . . . . . . . . . . 52.6 t80 -122.15 103.11 8.56 Favored 'General case' 0 N--CA 1.493 1.718 0 CA-C-O 121.495 0.664 . . . . 0.0 109.844 -179.428 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 145' ' ' LYS . . . . . . . . . . . . . 46.1 mttt -96.94 128.59 44.05 Favored 'General case' 0 N--CA 1.494 1.764 0 O-C-N 121.458 -0.776 . . . . 0.0 110.992 -179.291 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 146' ' ' VAL . . . . . 0.443 ' O ' ' C ' ' A' ' 147' ' ' GLY . 2.0 p -141.46 142.12 29.4 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.668 0 N-CA-C 107.519 -1.289 . . . . 0.0 107.519 178.52 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 147' ' ' GLY . . . . . 0.443 ' C ' ' O ' ' A' ' 146' ' ' VAL . . . 43.59 -129.38 6.17 Favored Glycine 0 N--CA 1.49 2.276 0 N-CA-C 109.313 -1.515 . . . . 0.0 109.313 -179.827 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 148' ' ' ASN . . . . . 0.444 ' C ' HD21 ' A' ' 148' ' ' ASN . 0.5 OUTLIER -102.29 15.15 30.0 Favored 'General case' 0 N--CA 1.488 1.469 0 O-C-N 121.278 -1.131 . . . . 0.0 108.336 179.15 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 149' ' ' GLU . . . . . . . . . . . . . 2.3 mm-40 -109.07 143.91 37.79 Favored 'General case' 0 N--CA 1.49 1.531 0 CA-C-O 121.771 0.796 . . . . 0.0 111.576 -178.546 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 150' ' ' THR . . . . . . . . . . . . . 3.4 m -130.02 101.16 5.71 Favored 'General case' 0 N--CA 1.495 1.779 0 CA-C-O 121.46 0.647 . . . . 0.0 109.77 179.915 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 151' ' ' ARG . . . . . 0.48 HH22 ' CG ' ' A' ' 111' ' ' ASP . 16.5 mtt180 -86.13 -171.67 3.68 Favored 'General case' 0 N--CA 1.487 1.404 0 O-C-N 121.243 -0.91 . . . . 0.0 108.983 -179.671 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 152' ' ' LYS . . . . . 0.422 ' C ' ' CD1' ' A' ' 153' ' ' TYR . 36.3 mtmt -151.38 148.35 28.02 Favored 'General case' 0 C--N 1.301 -1.532 0 O-C-N 121.111 -0.993 . . . . 0.0 110.423 -178.895 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 153' ' ' TYR . . . . . 0.482 ' CD2' ' HA ' ' A' ' 204' ' ' GLU . 11.1 m-85 -141.76 168.68 19.18 Favored 'General case' 0 C--N 1.302 -1.493 0 N-CA-C 108.157 -1.053 . . . . 0.0 108.157 179.189 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 154' ' ' LYS . . . . . . . . . . . . . 29.1 ttpt -143.17 119.0 10.54 Favored 'General case' 0 C--N 1.297 -1.714 0 N-CA-C 108.038 -1.097 . . . . 0.0 108.038 178.703 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 155' ' ' MET . . . . . . . . . . . . . 18.0 mtp -47.13 108.69 0.16 Allowed 'General case' 0 N--CA 1.492 1.662 0 O-C-N 120.536 -1.353 . . . . 0.0 111.528 -178.381 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 156' ' ' THR . . . . . 0.498 ' OG1' ' OG1' ' A' ' 203' ' ' THR . 0.1 OUTLIER -105.16 -25.15 12.6 Favored 'General case' 0 C--N 1.294 -1.822 0 CA-C-N 115.351 -0.841 . . . . 0.0 110.714 -178.638 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 157' ' ' SER . . . . . . . . . . . . . 49.8 m -145.84 147.44 31.82 Favored 'General case' 0 C--N 1.296 -1.748 0 C-N-CA 118.511 -1.276 . . . . 0.0 110.15 -178.769 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 158' ' ' ILE . . . . . . . . . . . . . 2.3 mt -146.96 136.54 16.67 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.611 0 CA-C-O 121.538 0.685 . . . . 0.0 110.111 -177.781 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 159' ' ' ARG . . . . . 0.669 ' CG ' HH11 ' A' ' 159' ' ' ARG . 0.0 OUTLIER -155.63 -172.83 4.29 Favored 'General case' 0 N--CA 1.491 1.604 0 C-N-CA 119.505 -0.878 . . . . 0.0 110.459 179.733 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 160' ' ' ASP . . . . . . . . . . . . . 10.7 m-20 -149.54 165.47 32.11 Favored 'General case' 0 N--CA 1.489 1.507 0 N-CA-C 108.324 -0.991 . . . . 0.0 108.324 179.554 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 161' ' ' VAL . . . . . 0.484 ' O ' ' O ' ' A' ' 162' ' ' LYS . 0.1 OUTLIER -166.07 161.44 0.81 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.685 0 O-C-N 121.088 -1.008 . . . . 0.0 109.877 179.829 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 162' ' ' LYS . . . . . 0.484 ' O ' ' O ' ' A' ' 161' ' ' VAL . 0.0 OUTLIER -44.62 170.99 0.05 OUTLIER Pre-proline 0 N--CA 1.489 1.503 0 O-C-N 121.366 -0.834 . . . . 0.0 109.653 179.73 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 163' ' ' PRO . . . . . . . . . . . . . 62.1 Cg_endo -80.74 36.16 0.61 Allowed 'Trans proline' 0 C--N 1.31 -1.483 0 C-N-CA 122.672 2.248 . . . . 0.0 113.061 -179.851 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 164' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -151.88 -2.88 0.28 Allowed 'General case' 0 N--CA 1.497 1.896 0 O-C-N 121.047 -1.033 . . . . 0.0 110.214 179.987 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 165' ' ' ASP . . . . . . . . . . . . . 7.2 t70 -74.83 62.98 1.13 Allowed 'General case' 0 N--CA 1.488 1.45 0 O-C-N 120.899 -1.126 . . . . 0.0 109.386 -179.988 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 166' ' ' VAL . . . . . 0.589 ' O ' ' N ' ' A' ' 168' ' ' VAL . 1.8 m -49.68 -33.82 8.37 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.503 0 O-C-N 121.659 -0.65 . . . . 0.0 109.776 -178.392 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 167' ' ' GLY . . . . . 0.405 ' C ' ' O ' ' A' ' 166' ' ' VAL . . . -43.89 -13.35 0.02 OUTLIER Glycine 0 N--CA 1.496 2.65 0 O-C-N 120.865 -1.147 . . . . 0.0 110.725 -179.766 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 168' ' ' VAL . . . . . 0.589 ' N ' ' O ' ' A' ' 166' ' ' VAL . 3.5 m -53.48 -26.77 13.54 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.563 0 O-C-N 120.712 -1.463 . . . . 0.0 108.741 179.688 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 169' ' ' LEU . . . . . 0.608 ' O ' ' ND2' ' A' ' 114' ' ' ASN . 1.2 mm? -44.43 -24.67 0.19 Allowed 'General case' 0 C--N 1.299 -1.61 0 N-CA-C 107.808 -1.182 . . . . 0.0 107.808 -178.658 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 170' ' ' ASP . . . . . 0.474 ' N ' ' C ' ' A' ' 168' ' ' VAL . 14.9 t0 37.29 90.51 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.715 -0.616 . . . . 0.0 110.804 177.944 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 171' ' ' GLU . . . . . . . . . . . . . 14.9 pt-20 -130.13 60.09 1.62 Allowed 'General case' 0 N--CA 1.497 1.922 0 O-C-N 120.904 -1.123 . . . . 0.0 109.735 179.515 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 172' ' ' GLN . . . . . . . . . . . . . 10.7 mt-30 -123.06 -56.87 1.73 Allowed 'General case' 0 N--CA 1.497 1.899 0 O-C-N 121.438 -0.789 . . . . 0.0 110.958 -178.969 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 173' ' ' LYS . . . . . 0.401 ' H ' ' HD2' ' A' ' 173' ' ' LYS . 2.3 mptp? -57.62 123.2 14.79 Favored 'General case' 0 N--CA 1.493 1.696 0 O-C-N 120.817 -1.177 . . . . 0.0 108.909 -179.67 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 174' ' ' GLY . . . . . 0.485 ' O ' ' C ' ' A' ' 175' ' ' LYS . . . -117.29 -43.59 0.59 Allowed Glycine 0 N--CA 1.478 1.483 0 N-CA-C 108.166 -1.974 . . . . 0.0 108.166 179.589 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 175' ' ' LYS . . . . . 0.485 ' C ' ' O ' ' A' ' 174' ' ' GLY . 11.9 mptt -43.52 -58.53 2.57 Favored 'General case' 0 N--CA 1.49 1.545 0 N-CA-C 107.107 -1.442 . . . . 0.0 107.107 179.565 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 176' ' ' ASP . . . . . 0.617 ' O ' ' O ' ' A' ' 177' ' ' LYS . 3.4 m-20 -103.8 85.66 2.47 Favored 'General case' 0 C--N 1.293 -1.866 0 N-CA-C 106.835 -1.543 . . . . 0.0 106.835 176.672 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 177' ' ' LYS . . . . . 0.617 ' O ' ' O ' ' A' ' 176' ' ' ASP . 35.6 mttt -44.23 -175.92 0.0 OUTLIER 'General case' 0 N--CA 1.493 1.691 0 O-C-N 121.632 -0.667 . . . . 0.0 109.663 -179.159 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 178' ' ' GLN . . . . . . . . . . . . . 16.6 pt20 -160.7 173.68 15.07 Favored 'General case' 0 C--N 1.303 -1.439 0 O-C-N 120.307 -1.496 . . . . 0.0 110.949 179.524 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 179' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -129.35 97.74 4.66 Favored 'General case' 0 C--N 1.303 -1.453 0 N-CA-C 107.225 -1.398 . . . . 0.0 107.225 178.459 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 180' ' ' THR . . . . . . . . . . . . . 1.1 m -73.56 115.69 13.25 Favored 'General case' 0 N--CA 1.493 1.72 0 O-C-N 121.162 -0.961 . . . . 0.0 110.662 -178.372 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 181' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -89.55 144.48 25.99 Favored 'General case' 0 C--N 1.301 -1.535 0 N-CA-C 108.11 -1.07 . . . . 0.0 108.11 177.47 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 182' ' ' ILE . . . . . . . . . . . . . 4.7 mt -137.91 113.03 9.85 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.643 0 N-CA-C 107.822 -1.177 . . . . 0.0 107.822 179.102 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 183' ' ' THR . . . . . 0.652 ' HG1' ' HZ2' ' A' ' 134' ' ' LYS . 5.8 t -134.34 119.44 18.65 Favored 'General case' 0 C--N 1.293 -1.88 0 N-CA-C 108.141 -1.059 . . . . 0.0 108.141 179.708 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 184' ' ' CYS . . . . . . . . . . . . . 1.0 OUTLIER -80.21 156.37 26.94 Favored 'General case' 0 C--N 1.289 -2.065 0 C-N-CA 119.514 -0.874 . . . . 0.0 111.183 -178.366 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 185' ' ' ASP . . . . . 0.549 ' O ' ' CB ' ' A' ' 186' ' ' ASP . 0.2 OUTLIER -166.68 170.55 12.44 Favored 'General case' 0 N--CA 1.493 1.698 0 O-C-N 121.538 -0.726 . . . . 0.0 109.058 179.831 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 186' ' ' ASP . . . . . 0.549 ' CB ' ' O ' ' A' ' 185' ' ' ASP . 1.0 OUTLIER 79.28 52.42 0.03 OUTLIER 'General case' 0 N--CA 1.492 1.668 0 O-C-N 121.23 -0.919 . . . . 0.0 109.704 179.863 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 187' ' ' TYR . . . . . 0.581 ' CE1' ' O ' ' A' ' 188' ' ' ASN . 36.9 t80 -65.9 131.42 46.23 Favored 'General case' 0 C--N 1.302 -1.497 0 O-C-N 120.92 -1.113 . . . . 0.0 109.623 179.946 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 188' ' ' ASN . . . . . 0.807 HD22 ' N ' ' A' ' 192' ' ' GLY . 0.0 OUTLIER -100.13 148.71 24.28 Favored 'General case' 0 C--N 1.291 -1.936 0 N-CA-C 107.589 -1.263 . . . . 0.0 107.589 178.68 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 189' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -109.9 -9.57 14.78 Favored 'General case' 0 C--N 1.294 -1.819 0 N-CA-C 108.495 -0.928 . . . . 0.0 108.495 -179.505 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 190' ' ' LYS . . . . . . . . . . . . . 6.4 mmtt -84.49 -56.23 3.73 Favored 'General case' 0 N--CA 1.488 1.432 0 C-N-CA 119.841 -0.744 . . . . 0.0 109.182 178.774 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 191' ' ' THR . . . . . 0.662 ' N ' HD22 ' A' ' 188' ' ' ASN . 7.1 p -86.44 7.93 23.86 Favored 'General case' 0 N--CA 1.493 1.678 0 O-C-N 121.559 -0.713 . . . . 0.0 110.688 -178.823 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 192' ' ' GLY . . . . . 0.807 ' N ' HD22 ' A' ' 188' ' ' ASN . . . 51.69 30.47 28.07 Favored Glycine 0 N--CA 1.494 2.544 0 O-C-N 121.098 -1.001 . . . . 0.0 111.733 178.82 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 193' ' ' VAL . . . . . 0.569 ' H ' HD21 ' A' ' 188' ' ' ASN . 0.4 OUTLIER -149.59 170.58 1.98 Allowed 'Isoleucine or valine' 0 N--CA 1.495 1.798 0 O-C-N 120.463 -1.61 . . . . 0.0 109.909 179.129 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 194' ' ' TRP . . . . . 0.437 ' N ' ' CD1' ' A' ' 194' ' ' TRP . 44.1 m95 -84.93 122.07 28.66 Favored 'General case' 0 C--N 1.295 -1.795 0 CA-C-O 121.577 0.704 . . . . 0.0 109.994 -179.427 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 195' ' ' GLU . . . . . . . . . . . . . 2.0 mt-10 -77.81 -60.96 2.16 Favored 'General case' 0 N--CA 1.496 1.871 0 O-C-N 121.546 -0.721 . . . . 0.0 111.902 -178.326 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 196' ' ' LYS . . . . . . . . . . . . . 5.3 tttm -92.44 150.11 20.99 Favored 'General case' 0 N--CA 1.495 1.797 0 O-C-N 121.003 -1.061 . . . . 0.0 111.761 -177.481 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 197' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -120.7 139.03 53.64 Favored 'General case' 0 N--CA 1.493 1.676 0 N-CA-C 108.319 -0.993 . . . . 0.0 108.319 178.353 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 198' ' ' LYS . . . . . . . . . . . . . 7.9 mttt -116.72 120.46 38.68 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.447 -0.783 . . . . 0.0 110.406 -178.624 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 199' ' ' ILE . . . . . 0.432 ' O ' HG13 ' A' ' 199' ' ' ILE . 0.9 OUTLIER -140.78 121.06 13.09 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.733 0 CA-C-O 122.787 1.279 . . . . 0.0 110.724 179.77 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 200' ' ' PHE . . . . . . . . . . . . . 2.0 m-85 -105.33 141.44 36.83 Favored 'General case' 0 N--CA 1.496 1.841 0 O-C-N 121.218 -0.926 . . . . 0.0 111.012 -177.502 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 201' ' ' VAL . . . . . . . . . . . . . 61.3 t -104.63 148.39 9.32 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.539 0 N-CA-C 108.394 -0.965 . . . . 0.0 108.394 177.247 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 202' ' ' ALA . . . . . . . . . . . . . . . -133.05 139.84 47.39 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.037 -1.039 . . . . 0.0 109.022 -179.899 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 203' ' ' THR . . . . . 0.498 ' OG1' ' OG1' ' A' ' 156' ' ' THR . 1.5 p -90.14 129.19 36.45 Favored 'General case' 0 N--CA 1.489 1.509 0 CA-C-O 122.431 1.11 . . . . 0.0 111.753 -178.525 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 204' ' ' GLU . . . . . 0.482 ' HA ' ' CD2' ' A' ' 153' ' ' TYR . 3.6 tm-20 -50.53 135.36 22.81 Favored 'General case' 0 C--N 1.298 -1.656 0 C-N-CA 118.369 -1.333 . . . . 0.0 109.361 178.951 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 205' ' ' VAL . . . . . 0.501 ' CG1' ' N ' ' A' ' 206' ' ' LYS . 72.1 t -129.57 164.82 31.15 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.359 0 CA-C-O 122.083 0.944 . . . . 0.0 110.273 -177.907 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 206' ' ' LYS . . . . . 0.501 ' N ' ' CG1' ' A' ' 205' ' ' VAL . 0.0 OUTLIER . . . . . 0 C--N 1.295 -1.776 0 CA-C-O 118.025 -0.988 . . . . 0.0 109.482 179.84 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' C' C ' 702' ' ' LEU . . . . . 0.6 ' CD1' ' N ' ' C' ' 702' ' ' LEU . 0.0 OUTLIER . . . . . 0 N--CA 1.488 1.436 0 N-CA-C 109.08 -0.711 . . . . 0.0 109.08 . . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' C' C ' 703' ' ' PRO . . . . . 0.484 ' O ' ' O ' ' C' ' 702' ' ' LEU . 16.2 Cg_exo -51.54 -160.81 0.0 OUTLIER 'Trans proline' 0 N--CA 1.49 1.319 0 C-N-CA 121.805 1.67 . . . . 0.0 112.242 179.911 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' C' C ' 704' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.493 1.681 0 O-C-N 121.383 -0.823 . . . . 0.0 109.544 179.936 . . . . . . . . 0 0 . 1 . 013 nuclear orig core ' A' A ' 63' ' ' PRO . . . . . . . . . . . . . 58.0 Cg_endo . . . . . 0 C--O 1.213 -0.759 0 CA-C-O 120.958 0.316 . . . . 0.0 111.577 . . . . . . . . . 0 0 . 1 . 013 nuclear orig core ' A' A ' 64' ' ' GLN . . . . . 0.489 HE21 ' C ' ' A' ' 64' ' ' GLN . 0.0 OUTLIER -156.0 113.01 3.19 Favored 'General case' 0 C--N 1.302 -1.475 0 O-C-N 121.049 -1.032 . . . . 0.0 109.925 179.544 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 65' ' ' ILE . . . . . 0.459 ' C ' ' O ' ' A' ' 64' ' ' GLN . 0.1 OUTLIER -41.35 99.65 0.21 Allowed Pre-proline 0 N--CA 1.498 1.939 0 N-CA-C 108.174 -1.047 . . . . 0.0 108.174 179.386 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 66' ' ' PRO . . . . . 0.456 ' N ' ' O ' ' A' ' 64' ' ' GLN . 66.5 Cg_endo -89.76 -160.69 0.1 OUTLIER 'Trans proline' 0 C--N 1.317 -1.108 0 C-N-CA 122.222 1.948 . . . . 0.0 112.778 -178.76 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 67' ' ' LYS . . . . . 0.525 ' C ' ' H ' ' A' ' 69' ' ' LYS . 0.0 OUTLIER -71.91 -4.94 31.1 Favored 'General case' 0 N--CA 1.488 1.426 0 O-C-N 121.414 -0.804 . . . . 0.0 109.08 179.926 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 68' ' ' ASP . . . . . 0.586 ' C ' ' N ' ' A' ' 70' ' ' SER . 64.6 m-20 -76.21 42.86 0.28 Allowed 'General case' 0 N--CA 1.49 1.561 0 CA-C-O 122.45 1.119 . . . . 0.0 108.459 179.223 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 69' ' ' LYS . . . . . 0.525 ' H ' ' C ' ' A' ' 67' ' ' LYS . 0.5 OUTLIER -50.11 -16.26 0.29 Allowed 'General case' 0 N--CA 1.496 1.854 0 N-CA-C 105.984 -1.858 . . . . 0.0 105.984 178.102 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 70' ' ' SER . . . . . 0.586 ' N ' ' C ' ' A' ' 68' ' ' ASP . 3.0 p -86.66 50.84 2.08 Favored 'General case' 0 C--N 1.298 -1.643 0 CA-C-N 113.94 -1.482 . . . . 0.0 108.742 178.644 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 71' ' ' LYS . . . . . . . . . . . . . 6.5 ptmt -162.63 143.19 9.79 Favored 'General case' 0 C--N 1.296 -1.731 0 C-N-CA 118.224 -1.391 . . . . 0.0 111.235 -179.657 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 0.8 OUTLIER -64.28 136.14 26.9 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.577 0 N-CA-C 105.644 -1.984 . . . . 0.0 105.644 175.434 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -81.66 -13.85 57.38 Favored 'General case' 0 C--N 1.292 -1.897 0 N-CA-C 105.661 -1.977 . . . . 0.0 105.661 179.371 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . 174.01 -156.88 24.49 Favored Glycine 0 N--CA 1.478 1.448 0 N-CA-C 109.251 -1.54 . . . . 0.0 109.251 179.388 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 75' ' ' TYR . . . . . 0.415 ' CD2' ' HA ' ' A' ' 86' ' ' PRO . 94.4 m-85 -141.32 170.62 15.37 Favored 'General case' 0 C--N 1.296 -1.754 0 CA-C-O 121.875 0.845 . . . . 0.0 109.766 -178.144 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 76' ' ' ILE . . . . . . . . . . . . . 0.7 OUTLIER -147.66 143.74 19.58 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.646 0 C-N-CA 119.366 -0.934 . . . . 0.0 109.258 -178.095 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 77' ' ' GLU . . . . . 0.518 ' N ' ' CD ' ' A' ' 77' ' ' GLU . 2.6 mp0 -146.76 162.66 38.08 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 120.929 -1.107 . . . . 0.0 109.967 -179.837 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 78' ' ' ILE . . . . . . . . . . . . . 4.1 mt -148.16 90.3 5.04 Favored Pre-proline 0 N--CA 1.489 1.48 0 N-CA-C 108.311 -0.996 . . . . 0.0 108.311 179.839 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 79' ' ' PRO . . . . . . . . . . . . . 73.5 Cg_exo -45.29 -44.49 16.06 Favored 'Trans proline' 0 C--N 1.31 -1.457 0 C-N-CA 122.597 2.198 . . . . 0.0 113.63 -178.583 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 4.4 m-20 -67.14 -19.29 65.58 Favored 'General case' 0 N--CA 1.492 1.652 0 O-C-N 120.869 -1.145 . . . . 0.0 110.789 178.418 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 81' ' ' ALA . . . . . 0.558 ' O ' ' ND2' ' A' ' 132' ' ' ASN . . . -106.63 -15.01 14.88 Favored 'General case' 0 N--CA 1.493 1.717 0 O-C-N 121.137 -0.977 . . . . 0.0 109.176 179.976 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 82' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER 68.3 46.72 1.05 Allowed 'General case' 0 N--CA 1.488 1.459 0 O-C-N 121.375 -0.828 . . . . 0.0 110.338 179.22 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 83' ' ' ILE . . . . . 0.456 ' CG1' ' OD1' ' A' ' 132' ' ' ASN . 60.9 mt -120.98 148.36 24.29 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.797 0 O-C-N 121.296 -0.877 . . . . 0.0 110.357 -178.928 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 84' ' ' LYS . . . . . 0.402 ' O ' ' CD ' ' A' ' 85' ' ' GLU . 0.0 OUTLIER -160.44 102.63 1.38 Allowed 'General case' 0 C--N 1.305 -1.367 0 N-CA-C 107.322 -1.362 . . . . 0.0 107.322 179.731 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 85' ' ' GLU . . . . . 0.441 ' CB ' ' CD ' ' A' ' 86' ' ' PRO . 1.3 mm-40 -141.49 178.25 1.61 Allowed Pre-proline 0 N--CA 1.497 1.914 0 O-C-N 121.301 -0.874 . . . . 0.0 110.247 -178.831 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 86' ' ' PRO . . . . . 0.441 ' CD ' ' CB ' ' A' ' 85' ' ' GLU . 69.2 Cg_endo -91.2 158.02 3.81 Favored 'Trans proline' 0 N--CA 1.487 1.112 0 C-N-CA 123.314 2.676 . . . . 0.0 113.661 -178.565 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 87' ' ' VAL . . . . . 0.555 ' CG1' ' CZ ' ' A' ' 103' ' ' PHE . 35.5 t -111.07 100.04 9.93 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.498 0 N-CA-C 109.191 -0.67 . . . . 0.0 109.191 -179.85 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 88' ' ' TYR . . . . . 0.4 ' CE2' ' HD2' ' A' ' 99' ' ' ARG . 8.1 m-85 -91.71 170.31 9.69 Favored Pre-proline 0 N--CA 1.507 2.4 0 O-C-N 120.535 -1.353 . . . . 0.0 110.135 -179.102 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 89' ' ' PRO . . . . . . . . . . . . . 3.0 Cg_exo -71.35 141.71 39.54 Favored 'Trans proline' 0 N--CA 1.5 1.883 0 C-N-CA 122.505 2.137 . . . . 0.0 114.241 -178.394 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . -62.16 167.18 17.9 Favored Glycine 0 N--CA 1.492 2.394 0 N-CA-C 108.8 -1.72 . . . . 0.0 108.8 178.38 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 91' ' ' PRO . . . . . 0.445 ' C ' ' H ' ' A' ' 93' ' ' THR . 45.1 Cg_endo -91.67 172.69 21.43 Favored 'Cis proline' 0 C--N 1.307 -1.648 0 C-N-CA 123.55 -1.437 . . . . 0.0 112.001 0.651 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 92' ' ' ALA . . . . . 0.523 ' O ' ' CD1' ' A' ' 97' ' ' LEU . . . -73.2 33.34 0.07 Allowed 'General case' 0 N--CA 1.493 1.706 0 O-C-N 121.352 -0.843 . . . . 0.0 110.677 -179.418 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 93' ' ' THR . . . . . 0.445 ' H ' ' C ' ' A' ' 91' ' ' PRO . 0.8 OUTLIER -71.8 149.56 92.85 Favored Pre-proline 0 C--N 1.301 -1.519 0 O-C-N 120.59 -1.319 . . . . 0.0 108.45 179.773 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 94' ' ' PRO . . . . . 0.439 ' C ' ' O ' ' A' ' 93' ' ' THR . 80.7 Cg_exo -31.78 -53.18 0.31 Allowed 'Trans proline' 0 C--N 1.308 -1.563 0 C-N-CA 122.723 2.282 . . . . 0.0 112.203 -179.183 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 95' ' ' GLU . . . . . 0.493 ' O ' ' ND2' ' A' ' 98' ' ' ASN . 7.1 tp10 -47.65 -52.64 17.37 Favored 'General case' 0 C--N 1.299 -1.601 0 O-C-N 121.397 -0.814 . . . . 0.0 109.259 179.487 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 96' ' ' GLN . . . . . 0.541 ' C ' ' H ' ' A' ' 98' ' ' ASN . 12.2 mp0 -70.14 -54.66 11.98 Favored 'General case' 0 N--CA 1.489 1.504 0 O-C-N 121.382 -0.824 . . . . 0.0 110.918 -179.349 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 97' ' ' LEU . . . . . 0.523 ' CD1' ' O ' ' A' ' 92' ' ' ALA . 81.5 mt -50.84 -6.28 0.03 OUTLIER 'General case' 0 N--CA 1.494 1.764 0 O-C-N 121.002 -1.061 . . . . 0.0 110.341 -178.671 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 98' ' ' ASN . . . . . 0.541 ' H ' ' C ' ' A' ' 96' ' ' GLN . 0.2 OUTLIER -75.3 -32.61 61.04 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.169 -0.957 . . . . 0.0 109.392 179.24 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 99' ' ' ARG . . . . . 0.4 ' HD2' ' CE2' ' A' ' 88' ' ' TYR . 9.3 mtt180 -85.53 -44.93 12.25 Favored 'General case' 0 N--CA 1.488 1.469 0 O-C-N 121.478 -0.764 . . . . 0.0 109.727 -179.321 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . 169.87 -170.6 42.91 Favored Glycine 0 N--CA 1.495 2.624 0 C-N-CA 119.698 -1.239 . . . . 0.0 110.141 179.653 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 101' ' ' VAL . . . . . . . . . . . . . 26.8 m -55.0 106.74 0.12 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.572 0 O-C-N 121.093 -1.239 . . . . 0.0 109.17 -179.981 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -92.88 164.55 13.28 Favored 'General case' 0 N--CA 1.494 1.737 0 O-C-N 121.433 -0.792 . . . . 0.0 110.664 -179.282 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 103' ' ' PHE . . . . . 0.555 ' CZ ' ' CG1' ' A' ' 87' ' ' VAL . 28.5 m-85 -68.04 123.12 19.76 Favored 'General case' 0 N--CA 1.488 1.452 0 N-CA-C 108.549 -0.908 . . . . 0.0 108.549 178.413 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 104' ' ' ALA . . . . . . . . . . . . . . . -50.58 -7.33 0.03 OUTLIER 'General case' 0 C--N 1.3 -1.571 0 O-C-N 121.453 -0.779 . . . . 0.0 110.634 -179.42 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 105' ' ' GLU . . . . . 0.488 ' H ' ' C ' ' A' ' 103' ' ' PHE . 0.0 OUTLIER -139.83 144.22 37.2 Favored 'General case' 0 N--CA 1.495 1.814 0 O-C-N 120.915 -1.116 . . . . 0.0 110.433 -179.246 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 106' ' ' GLU . . . . . . . . . . . . . 28.2 tt0 -59.91 -64.35 0.98 Allowed 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.784 -0.572 . . . . 0.0 111.245 -178.959 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 107' ' ' ASN . . . . . . . . . . . . . 2.1 m-80 -78.5 35.51 0.23 Allowed 'General case' 0 N--CA 1.49 1.541 0 O-C-N 120.813 -1.179 . . . . 0.0 112.378 -175.981 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 108' ' ' GLU . . . . . 0.429 ' OE2' ' OE2' ' A' ' 105' ' ' GLU . 1.6 tp10 -59.0 149.24 27.97 Favored 'General case' 0 C--N 1.303 -1.415 0 O-C-N 120.703 -1.248 . . . . 0.0 107.725 -179.912 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 109' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -103.98 137.51 41.84 Favored 'General case' 0 C--N 1.304 -1.372 0 O-C-N 121.069 -1.019 . . . . 0.0 110.616 -178.236 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 110' ' ' LEU . . . . . . . . . . . . . 2.2 pp -60.74 -17.79 50.7 Favored 'General case' 0 C--N 1.298 -1.636 0 N-CA-C 108.225 -1.028 . . . . 0.0 108.225 179.138 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 111' ' ' ASP . . . . . . . . . . . . . 41.3 m-20 -132.13 37.77 3.55 Favored 'General case' 0 N--CA 1.489 1.492 0 N-CA-C 108.836 -0.801 . . . . 0.0 108.836 179.237 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 112' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -68.84 156.57 38.16 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.24 -0.913 . . . . 0.0 110.804 -179.786 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 113' ' ' GLN . . . . . 0.587 HE22 ' N ' ' A' ' 172' ' ' GLN . 0.0 OUTLIER -66.75 -15.96 63.91 Favored 'General case' 0 N--CA 1.487 1.402 0 N-CA-C 107.964 -1.125 . . . . 0.0 107.964 177.612 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 114' ' ' ASN . . . . . 0.607 ' OD1' ' NE2' ' A' ' 178' ' ' GLN . 3.0 t30 -151.4 106.11 3.26 Favored 'General case' 0 C--N 1.299 -1.61 0 N-CA-C 108.158 -1.053 . . . . 0.0 108.158 179.655 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 115' ' ' ILE . . . . . . . . . . . . . 2.7 mt -94.92 105.25 16.74 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.604 0 N-CA-C 107.66 -1.237 . . . . 0.0 107.66 179.655 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 116' ' ' SER . . . . . 0.423 ' OG ' ' ND2' ' A' ' 114' ' ' ASN . 36.6 m -89.57 147.42 23.95 Favored 'General case' 0 N--CA 1.487 1.39 0 CA-C-O 121.905 0.859 . . . . 0.0 111.303 -177.596 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 117' ' ' ILE . . . . . . . . . . . . . 1.7 mt -144.48 150.92 16.1 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.394 0 N-CA-C 108.092 -1.077 . . . . 0.0 108.092 179.194 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 118' ' ' ALA . . . . . . . . . . . . . . . -141.41 160.58 39.83 Favored 'General case' 0 N--CA 1.493 1.703 0 O-C-N 120.921 -1.112 . . . . 0.0 111.209 -178.886 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 119' ' ' GLY . . . . . . . . . . . . . . . -168.36 149.01 13.25 Favored Glycine 0 N--CA 1.489 2.221 0 C-N-CA 119.962 -1.113 . . . . 0.0 111.092 -179.98 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 120' ' ' HIS . . . . . . . . . . . . . 12.7 m170 -71.35 168.93 16.36 Favored 'General case' 0 N--CA 1.495 1.781 0 O-C-N 122.13 -0.629 . . . . 0.0 110.232 179.202 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 121' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -123.7 155.62 37.48 Favored 'General case' 0 N--CA 1.495 1.819 0 N-CA-C 108.864 -0.791 . . . . 0.0 108.864 179.233 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 122' ' ' PHE . . . . . . . . . . . . . 0.7 OUTLIER -143.92 123.17 12.99 Favored 'General case' 0 N--CA 1.501 2.091 0 O-C-N 120.913 -1.117 . . . . 0.0 110.228 179.606 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 123' ' ' ILE . . . . . 0.408 ' CG2' ' N ' ' A' ' 124' ' ' ASP . 17.1 tt -57.83 -40.61 76.9 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.43 0 CA-C-O 121.582 0.705 . . . . 0.0 109.291 179.606 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 124' ' ' ASP . . . . . 0.408 ' N ' ' CG2' ' A' ' 123' ' ' ILE . 0.4 OUTLIER -87.19 23.43 1.82 Allowed 'General case' 0 N--CA 1.497 1.898 0 O-C-N 121.648 -0.658 . . . . 0.0 111.461 -177.477 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 125' ' ' ARG . . . . . . . . . . . . . 82.9 mtt180 -153.18 99.83 2.68 Favored Pre-proline 0 N--CA 1.493 1.696 0 O-C-N 120.761 -1.212 . . . . 0.0 109.665 -179.582 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 126' ' ' PRO . . . . . . . . . . . . . 34.0 Cg_endo -77.41 -33.65 2.38 Favored 'Trans proline' 0 N--CA 1.489 1.255 0 C-N-CA 122.263 1.976 . . . . 0.0 112.782 -179.744 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 127' ' ' ASN . . . . . 0.485 ' O ' ' O ' ' A' ' 128' ' ' TYR . 5.1 p30 -90.64 11.14 23.01 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.198 -0.939 . . . . 0.0 109.602 179.911 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 128' ' ' TYR . . . . . 0.485 ' O ' ' O ' ' A' ' 127' ' ' ASN . 2.8 t80 -59.53 -149.67 0.0 OUTLIER 'General case' 0 N--CA 1.489 1.478 0 O-C-N 121.091 -1.006 . . . . 0.0 109.516 179.978 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 129' ' ' GLN . . . . . . . . . . . . . 37.1 mt-30 -66.95 -70.37 0.25 Allowed 'General case' 0 N--CA 1.487 1.413 0 O-C-N 121.337 -0.852 . . . . 0.0 109.605 -179.779 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 130' ' ' PHE . . . . . 0.401 ' CE1' HD13 ' A' ' 181' ' ' LEU . 50.6 m-85 -136.22 42.29 2.57 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.167 -0.958 . . . . 0.0 110.771 -179.39 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 131' ' ' THR . . . . . . . . . . . . . 8.5 m -74.68 -40.16 61.56 Favored 'General case' 0 N--CA 1.495 1.792 0 O-C-N 120.875 -1.141 . . . . 0.0 109.034 179.241 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 132' ' ' ASN . . . . . 0.558 ' ND2' ' O ' ' A' ' 81' ' ' ALA . 0.2 OUTLIER -89.18 11.59 18.27 Favored 'General case' 0 N--CA 1.492 1.673 0 C-N-CA 119.465 -0.894 . . . . 0.0 111.625 -178.678 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 133' ' ' LEU . . . . . 0.546 ' O ' ' N ' ' A' ' 135' ' ' ALA . 0.2 OUTLIER -68.02 -46.9 69.94 Favored 'General case' 0 N--CA 1.492 1.663 0 O-C-N 120.536 -1.353 . . . . 0.0 109.988 -179.16 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 134' ' ' LYS . . . . . 0.571 ' H ' ' CD ' ' A' ' 134' ' ' LYS . 0.0 OUTLIER -46.0 -14.11 0.02 OUTLIER 'General case' 0 N--CA 1.495 1.805 0 O-C-N 121.05 -1.031 . . . . 0.0 110.03 -179.514 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 135' ' ' ALA . . . . . 0.546 ' N ' ' O ' ' A' ' 133' ' ' LEU . . . -82.41 -35.89 27.23 Favored 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.108 -0.995 . . . . 0.0 109.123 179.669 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 136' ' ' ALA . . . . . . . . . . . . . . . -78.88 152.1 31.42 Favored 'General case' 0 C--N 1.302 -1.469 0 CA-C-O 121.858 0.837 . . . . 0.0 110.667 -179.35 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 137' ' ' LYS . . . . . 0.555 ' O ' ' O ' ' A' ' 138' ' ' LYS . 28.0 mtmm -153.06 -168.54 3.06 Favored 'General case' 0 N--CA 1.492 1.631 0 C-N-CA 118.351 -1.34 . . . . 0.0 110.939 -178.332 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 138' ' ' LYS . . . . . 0.555 ' O ' ' O ' ' A' ' 137' ' ' LYS . 0.0 OUTLIER -29.78 159.78 0.0 OUTLIER 'General case' 0 N--CA 1.489 1.509 0 CA-C-O 122.992 1.377 . . . . 0.0 112.681 -178.028 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 139' ' ' GLY . . . . . . . . . . . . . . . 51.9 8.81 0.44 Allowed Glycine 0 N--CA 1.489 2.199 0 N-CA-C 109.824 -1.311 . . . . 0.0 109.824 179.612 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 140' ' ' SER . . . . . 0.511 ' H ' ' C ' ' A' ' 138' ' ' LYS . 1.5 m -68.04 115.19 7.26 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.17 -1.194 . . . . 0.0 108.979 179.493 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 141' ' ' MET . . . . . . . . . . . . . 3.2 tpt -66.94 120.42 13.58 Favored 'General case' 0 C--N 1.301 -1.506 0 O-C-N 121.186 -0.946 . . . . 0.0 109.621 -179.866 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 142' ' ' VAL . . . . . . . . . . . . . 5.1 t -110.56 127.98 67.2 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.651 0 N-CA-C 108.192 -1.04 . . . . 0.0 108.192 179.835 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 143' ' ' TYR . . . . . . . . . . . . . 26.3 m-85 -107.79 135.06 49.84 Favored 'General case' 0 N--CA 1.498 1.963 0 O-C-N 121.022 -1.049 . . . . 0.0 111.348 -178.442 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 144' ' ' PHE . . . . . . . . . . . . . 58.5 t80 -119.19 101.16 7.8 Favored 'General case' 0 N--CA 1.486 1.355 0 N-CA-C 109.214 -0.661 . . . . 0.0 109.214 179.323 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 145' ' ' LYS . . . . . . . . . . . . . 35.8 mttt -95.47 129.33 42.67 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.127 -0.983 . . . . 0.0 109.62 -179.74 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 146' ' ' VAL . . . . . 0.428 ' O ' ' C ' ' A' ' 147' ' ' GLY . 3.3 p -141.67 141.43 29.85 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.636 0 N-CA-C 107.957 -1.127 . . . . 0.0 107.957 179.369 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 147' ' ' GLY . . . . . 0.428 ' C ' ' O ' ' A' ' 146' ' ' VAL . . . 44.43 -128.75 7.14 Favored Glycine 0 N--CA 1.487 2.05 0 N-CA-C 108.885 -1.686 . . . . 0.0 108.885 -179.59 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 148' ' ' ASN . . . . . 0.528 ' C ' ' ND2' ' A' ' 148' ' ' ASN . 0.4 OUTLIER -103.66 16.39 26.53 Favored 'General case' 0 C--N 1.298 -1.649 0 O-C-N 121.424 -1.045 . . . . 0.0 108.298 179.094 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 149' ' ' GLU . . . . . . . . . . . . . 13.9 tt0 -111.75 145.31 39.58 Favored 'General case' 0 N--CA 1.489 1.477 0 CA-C-O 121.896 0.855 . . . . 0.0 111.273 -178.471 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 150' ' ' THR . . . . . . . . . . . . . 2.1 m -127.4 102.69 7.0 Favored 'General case' 0 N--CA 1.491 1.613 0 CA-C-O 121.433 0.635 . . . . 0.0 109.757 -179.737 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 151' ' ' ARG . . . . . . . . . . . . . 50.9 mtt180 -86.22 -175.69 5.62 Favored 'General case' 0 N--CA 1.487 1.386 0 N-CA-C 108.541 -0.911 . . . . 0.0 108.541 -179.878 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 152' ' ' LYS . . . . . 0.44 ' O ' ' N ' ' A' ' 205' ' ' VAL . 1.7 mtmp? -145.0 149.36 35.0 Favored 'General case' 0 C--N 1.303 -1.45 0 C-N-CA 119.216 -0.993 . . . . 0.0 110.048 -179.457 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 153' ' ' TYR . . . . . 0.49 ' CD2' ' HA ' ' A' ' 204' ' ' GLU . 31.2 m-85 -143.71 166.29 25.28 Favored 'General case' 0 C--N 1.303 -1.454 0 N-CA-C 107.822 -1.177 . . . . 0.0 107.822 178.719 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 154' ' ' LYS . . . . . . . . . . . . . 5.9 ttmm -143.99 119.81 10.57 Favored 'General case' 0 C--N 1.296 -1.723 0 N-CA-C 108.125 -1.065 . . . . 0.0 108.125 179.074 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 155' ' ' MET . . . . . . . . . . . . . 14.1 mtp -48.45 107.71 0.14 Allowed 'General case' 0 N--CA 1.493 1.678 0 O-C-N 120.522 -1.361 . . . . 0.0 111.543 -178.623 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 156' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -107.45 -22.36 12.58 Favored 'General case' 0 C--N 1.296 -1.736 0 CA-C-N 115.34 -0.845 . . . . 0.0 110.758 -178.646 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 157' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -151.21 150.43 30.6 Favored 'General case' 0 N--CA 1.494 1.762 0 C-N-CA 118.395 -1.322 . . . . 0.0 111.284 -178.71 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 158' ' ' ILE . . . . . 0.543 ' CD1' ' N ' ' A' ' 159' ' ' ARG . 0.1 OUTLIER -154.53 142.46 12.96 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.3 0 CA-C-O 121.923 0.868 . . . . 0.0 110.3 -178.743 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 159' ' ' ARG . . . . . 0.543 ' N ' ' CD1' ' A' ' 158' ' ' ILE . 27.2 ptt180 -155.21 155.02 33.13 Favored 'General case' 0 C--N 1.296 -1.722 0 CA-C-O 121.663 0.744 . . . . 0.0 109.929 -179.902 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 160' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -115.06 162.28 17.22 Favored 'General case' 0 N--CA 1.492 1.633 0 N-CA-C 108.165 -1.05 . . . . 0.0 108.165 179.218 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 161' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -158.34 160.15 2.11 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.609 0 O-C-N 121.169 -0.957 . . . . 0.0 110.394 -179.539 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 162' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -52.45 176.91 0.07 OUTLIER Pre-proline 0 N--CA 1.488 1.456 0 O-C-N 121.477 -0.764 . . . . 0.0 109.053 179.663 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 163' ' ' PRO . . . . . . . . . . . . . 2.4 Cg_endo -78.67 37.31 0.64 Allowed 'Trans proline' 0 N--CA 1.491 1.333 0 C-N-CA 122.478 2.119 . . . . 0.0 113.086 -179.531 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 164' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -152.65 -6.69 0.2 Allowed 'General case' 0 N--CA 1.495 1.821 0 O-C-N 120.464 -1.397 . . . . 0.0 111.792 -179.4 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 165' ' ' ASP . . . . . . . . . . . . . 6.0 t70 -74.7 62.29 1.05 Allowed 'General case' 0 N--CA 1.493 1.677 0 O-C-N 120.676 -1.265 . . . . 0.0 110.041 -179.581 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 166' ' ' VAL . . . . . 0.613 ' O ' ' N ' ' A' ' 168' ' ' VAL . 1.5 m -47.82 -31.44 2.68 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.594 0 O-C-N 121.144 -0.972 . . . . 0.0 109.968 -178.55 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 167' ' ' GLY . . . . . . . . . . . . . . . -44.26 -10.01 0.01 OUTLIER Glycine 0 N--CA 1.496 2.65 0 O-C-N 120.811 -1.18 . . . . 0.0 111.094 -179.545 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 168' ' ' VAL . . . . . 0.613 ' N ' ' O ' ' A' ' 166' ' ' VAL . 5.5 m -53.51 -29.35 16.82 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.614 0 O-C-N 120.62 -1.518 . . . . 0.0 108.976 179.785 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 169' ' ' LEU . . . . . 0.533 ' O ' ' C ' ' A' ' 170' ' ' ASP . 11.1 mt -49.47 -13.79 0.09 Allowed 'General case' 0 N--CA 1.49 1.564 0 N-CA-C 107.31 -1.367 . . . . 0.0 107.31 -179.14 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 170' ' ' ASP . . . . . 0.568 ' H ' ' C ' ' A' ' 168' ' ' VAL . 3.2 t70 21.84 91.77 0.01 OUTLIER 'General case' 0 N--CA 1.502 2.139 0 CA-C-N 116.281 -0.418 . . . . 0.0 111.649 177.261 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 171' ' ' GLU . . . . . 0.425 ' C ' ' OE1' ' A' ' 113' ' ' GLN . 3.3 pt-20 -136.93 74.41 1.49 Allowed 'General case' 0 N--CA 1.493 1.699 0 O-C-N 120.913 -1.117 . . . . 0.0 110.863 -179.814 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 172' ' ' GLN . . . . . 0.587 ' N ' HE22 ' A' ' 113' ' ' GLN . 1.1 pt20 -132.01 -47.95 0.94 Allowed 'General case' 0 N--CA 1.499 2.021 0 O-C-N 121.284 -0.885 . . . . 0.0 111.661 -178.451 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 173' ' ' LYS . . . . . 0.515 ' NZ ' ' O ' ' A' ' 176' ' ' ASP . 8.4 ptmm? -64.31 129.13 38.73 Favored 'General case' 0 N--CA 1.499 1.989 0 O-C-N 120.576 -1.327 . . . . 0.0 109.324 -179.968 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 174' ' ' GLY . . . . . 0.527 ' O ' ' C ' ' A' ' 175' ' ' LYS . . . -115.37 -40.0 0.9 Allowed Glycine 0 N--CA 1.484 1.89 0 N-CA-C 108.676 -1.769 . . . . 0.0 108.676 179.591 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 175' ' ' LYS . . . . . 0.527 ' C ' ' O ' ' A' ' 174' ' ' GLY . 0.2 OUTLIER -41.44 -62.08 0.93 Allowed 'General case' 0 N--CA 1.491 1.597 0 N-CA-C 107.022 -1.473 . . . . 0.0 107.022 178.864 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 176' ' ' ASP . . . . . 0.567 ' O ' ' O ' ' A' ' 177' ' ' LYS . 81.8 m-20 -104.4 85.36 2.34 Favored 'General case' 0 C--N 1.298 -1.635 0 N-CA-C 107.691 -1.226 . . . . 0.0 107.691 176.781 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 177' ' ' LYS . . . . . 0.567 ' O ' ' O ' ' A' ' 176' ' ' ASP . 2.1 mptp? -47.55 -175.16 0.0 OUTLIER 'General case' 0 N--CA 1.5 2.044 0 O-C-N 121.28 -0.888 . . . . 0.0 108.93 -179.755 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 178' ' ' GLN . . . . . 0.607 ' NE2' ' OD1' ' A' ' 114' ' ' ASN . 0.0 OUTLIER -162.75 178.63 8.31 Favored 'General case' 0 C--N 1.305 -1.355 0 O-C-N 120.264 -1.523 . . . . 0.0 110.936 179.836 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 179' ' ' LEU . . . . . . . . . . . . . 4.6 tt -128.55 97.55 4.74 Favored 'General case' 0 C--N 1.302 -1.474 0 N-CA-C 107.54 -1.281 . . . . 0.0 107.54 178.436 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 180' ' ' THR . . . . . . . . . . . . . 1.2 m -71.29 115.18 10.15 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 120.996 -1.065 . . . . 0.0 109.967 -178.719 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 181' ' ' LEU . . . . . 0.401 HD13 ' CE1' ' A' ' 130' ' ' PHE . 48.5 tp -93.16 142.45 27.28 Favored 'General case' 0 C--N 1.295 -1.794 0 N-CA-C 108.368 -0.975 . . . . 0.0 108.368 178.328 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 182' ' ' ILE . . . . . . . . . . . . . 47.0 mt -136.11 120.58 25.93 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.533 0 N-CA-C 108.197 -1.038 . . . . 0.0 108.197 178.925 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 183' ' ' THR . . . . . . . . . . . . . 2.2 t -140.72 111.84 7.18 Favored 'General case' 0 C--N 1.291 -1.943 0 N-CA-C 107.718 -1.215 . . . . 0.0 107.718 179.117 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 184' ' ' CYS . . . . . . . . . . . . . 1.2 p -78.81 159.55 27.8 Favored 'General case' 0 C--N 1.292 -1.907 0 C-N-CA 118.856 -1.138 . . . . 0.0 110.665 -178.09 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 185' ' ' ASP . . . . . 0.439 ' CB ' ' HZ2' ' A' ' 198' ' ' LYS . 0.4 OUTLIER -164.57 -155.66 0.28 Allowed 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.629 -0.669 . . . . 0.0 109.413 -179.488 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 186' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER 52.32 60.67 3.65 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.128 -0.982 . . . . 0.0 108.597 -179.469 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 187' ' ' TYR . . . . . 0.593 ' CE1' ' O ' ' A' ' 188' ' ' ASN . 35.5 t80 -68.34 134.02 49.64 Favored 'General case' 0 N--CA 1.488 1.459 0 CA-C-O 121.812 0.815 . . . . 0.0 111.142 -178.977 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 188' ' ' ASN . . . . . 0.593 ' O ' ' CE1' ' A' ' 187' ' ' TYR . 0.9 OUTLIER -98.67 145.64 26.67 Favored 'General case' 0 C--N 1.296 -1.721 0 N-CA-C 108.218 -1.03 . . . . 0.0 108.218 178.395 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 189' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -112.01 -19.91 12.16 Favored 'General case' 0 C--N 1.296 -1.749 0 N-CA-C 107.904 -1.147 . . . . 0.0 107.904 -179.86 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 190' ' ' LYS . . . . . . . . . . . . . 33.5 mttt -82.63 -50.06 9.16 Favored 'General case' 0 C--N 1.3 -1.551 0 N-CA-C 108.235 -1.024 . . . . 0.0 108.235 178.62 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 191' ' ' THR . . . . . . . . . . . . . 71.4 p -87.97 -8.97 54.93 Favored 'General case' 0 C--N 1.303 -1.428 0 N-CA-C 109.105 -0.702 . . . . 0.0 109.105 -179.97 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 192' ' ' GLY . . . . . . . . . . . . . . . 57.56 38.73 88.91 Favored Glycine 0 N--CA 1.493 2.466 0 N-CA-C 110.745 -0.942 . . . . 0.0 110.745 178.872 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 193' ' ' VAL . . . . . . . . . . . . . 3.2 m -148.05 162.1 6.63 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.58 0 O-C-N 120.989 -1.3 . . . . 0.0 108.872 179.35 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 194' ' ' TRP . . . . . . . . . . . . . 47.6 m95 -83.58 120.47 26.0 Favored 'General case' 0 N--CA 1.489 1.518 0 N-CA-C 107.802 -1.184 . . . . 0.0 107.802 178.901 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 195' ' ' GLU . . . . . . . . . . . . . 2.0 mt-10 -86.8 -61.05 1.82 Allowed 'General case' 0 N--CA 1.496 1.858 0 O-C-N 121.132 -0.98 . . . . 0.0 112.083 -177.318 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 196' ' ' LYS . . . . . . . . . . . . . 11.1 tttm -76.84 150.51 36.08 Favored 'General case' 0 N--CA 1.493 1.723 0 O-C-N 120.973 -1.079 . . . . 0.0 111.304 -177.663 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 197' ' ' ARG . . . . . 0.431 ' NH1' ' O ' ' C' ' 704' ' ' ALA . 16.9 mmt180 -122.01 129.83 52.78 Favored 'General case' 0 N--CA 1.491 1.584 0 N-CA-C 108.839 -0.8 . . . . 0.0 108.839 179.481 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 198' ' ' LYS . . . . . 0.439 ' HZ2' ' CB ' ' A' ' 185' ' ' ASP . 9.6 mtmt -113.72 120.25 40.18 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.482 -0.761 . . . . 0.0 109.969 -179.399 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 199' ' ' ILE . . . . . 0.415 ' O ' HG13 ' A' ' 199' ' ' ILE . 0.8 OUTLIER -140.04 118.42 11.14 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.723 0 CA-C-O 122.405 1.097 . . . . 0.0 109.929 179.269 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 200' ' ' PHE . . . . . 0.524 ' CD1' ' N ' ' A' ' 200' ' ' PHE . 4.7 m-85 -100.09 139.68 35.41 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.181 -0.949 . . . . 0.0 109.512 -179.082 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 201' ' ' VAL . . . . . . . . . . . . . 40.7 t -102.33 145.79 11.42 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.645 0 N-CA-C 107.31 -1.367 . . . . 0.0 107.31 177.395 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 202' ' ' ALA . . . . . . . . . . . . . . . -129.25 137.42 51.07 Favored 'General case' 0 C--N 1.301 -1.503 0 O-C-N 120.949 -1.095 . . . . 0.0 109.146 -179.4 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 203' ' ' THR . . . . . . . . . . . . . 2.5 p -88.83 129.99 35.47 Favored 'General case' 0 C--N 1.305 -1.352 0 CA-C-O 122.393 1.092 . . . . 0.0 110.705 -178.791 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 204' ' ' GLU . . . . . 0.49 ' HA ' ' CD2' ' A' ' 153' ' ' TYR . 3.9 tm-20 -50.84 133.82 26.06 Favored 'General case' 0 C--N 1.296 -1.734 0 C-N-CA 119.184 -1.007 . . . . 0.0 109.659 179.739 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 205' ' ' VAL . . . . . 0.495 ' CG1' ' N ' ' A' ' 206' ' ' LYS . 73.8 t -126.94 164.52 27.35 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.452 0 CA-C-O 122.109 0.957 . . . . 0.0 110.066 -178.14 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 206' ' ' LYS . . . . . 0.495 ' N ' ' CG1' ' A' ' 205' ' ' VAL . 0.9 OUTLIER . . . . . 0 C--N 1.295 -1.765 0 CA-C-O 117.931 -1.033 . . . . 0.0 109.468 179.929 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' C' C ' 702' ' ' LEU . . . . . 0.65 ' H ' ' CD1' ' C' ' 702' ' ' LEU . 0.0 OUTLIER . . . . . 0 N--CA 1.492 1.632 0 N-CA-C 108.998 -0.741 . . . . 0.0 108.998 . . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' C' C ' 703' ' ' PRO . . . . . 0.486 ' O ' ' O ' ' C' ' 704' ' ' ALA . 28.8 Cg_endo -68.95 -162.03 0.08 OUTLIER 'Trans proline' 0 N--CA 1.491 1.347 0 C-N-CA 122.271 1.981 . . . . 0.0 112.272 179.779 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' C' C ' 704' ' ' ALA . . . . . 0.486 ' O ' ' O ' ' C' ' 703' ' ' PRO . . . . . . . . 0 N--CA 1.489 1.491 0 O-C-N 121.306 -0.871 . . . . 0.0 108.993 -179.928 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 63' ' ' PRO . . . . . . . . . . . . . 21.3 Cg_endo . . . . . 0 C--O 1.212 -0.794 0 CA-C-O 121.412 0.505 . . . . 0.0 111.586 . . . . . . . . . 0 0 . 1 . 014 nuclear orig core ' A' A ' 64' ' ' GLN . . . . . 0.829 ' H ' HE21 ' A' ' 64' ' ' GLN . 0.0 OUTLIER -158.14 113.4 2.67 Favored 'General case' 0 N--CA 1.488 1.453 0 O-C-N 121.249 -0.907 . . . . 0.0 109.528 -179.773 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 65' ' ' ILE . . . . . 0.581 ' H ' ' CD1' ' A' ' 65' ' ' ILE . 0.0 OUTLIER -42.0 103.29 0.3 Allowed Pre-proline 0 N--CA 1.49 1.571 0 N-CA-C 108.757 -0.831 . . . . 0.0 108.757 179.471 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 66' ' ' PRO . . . . . . . . . . . . . 94.3 Cg_endo -87.6 -155.82 0.06 OUTLIER 'Trans proline' 0 C--N 1.313 -1.338 0 C-N-CA 122.372 2.048 . . . . 0.0 112.259 -179.18 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 67' ' ' LYS . . . . . 0.429 ' C ' ' H ' ' A' ' 69' ' ' LYS . 23.1 pttm -79.42 -7.86 58.7 Favored 'General case' 0 C--N 1.302 -1.474 0 O-C-N 121.308 -0.87 . . . . 0.0 108.847 179.673 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 68' ' ' ASP . . . . . 0.603 ' C ' ' H ' ' A' ' 70' ' ' SER . 1.9 t0 -76.7 48.3 0.55 Allowed 'General case' 0 N--CA 1.487 1.423 0 CA-C-O 122.342 1.068 . . . . 0.0 108.931 179.385 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 69' ' ' LYS . . . . . 0.444 ' C ' ' O ' ' A' ' 68' ' ' ASP . 0.0 OUTLIER -49.27 -14.69 0.1 Allowed 'General case' 0 N--CA 1.503 2.217 0 C-N-CA 117.094 -1.842 . . . . 0.0 106.554 178.257 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 70' ' ' SER . . . . . 0.603 ' H ' ' C ' ' A' ' 68' ' ' ASP . 1.1 p -82.28 -8.91 59.64 Favored 'General case' 0 N--CA 1.495 1.804 0 CA-C-N 113.942 -1.481 . . . . 0.0 110.035 179.552 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 71' ' ' LYS . . . . . 0.402 ' O ' ' CG ' ' A' ' 71' ' ' LYS . 0.0 OUTLIER -99.19 144.17 28.62 Favored 'General case' 0 N--CA 1.494 1.73 0 O-C-N 121.034 -1.041 . . . . 0.0 110.312 179.294 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 1.0 OUTLIER -65.26 141.48 18.13 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.575 0 N-CA-C 104.868 -2.271 . . . . 0.0 104.868 174.542 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -80.82 -14.9 57.64 Favored 'General case' 0 C--N 1.294 -1.825 0 O-C-N 119.864 -1.772 . . . . 0.0 106.411 179.66 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . 175.46 -156.58 22.36 Favored Glycine 0 N--CA 1.481 1.645 0 N-CA-C 109.16 -1.576 . . . . 0.0 109.16 179.274 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 75' ' ' TYR . . . . . 0.572 ' CD2' ' O ' ' A' ' 85' ' ' GLU . 0.5 OUTLIER -141.7 167.98 20.86 Favored 'General case' 0 C--N 1.292 -1.893 0 O-C-N 121.664 -0.903 . . . . 0.0 110.655 -176.991 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 76' ' ' ILE . . . . . . . . . . . . . 0.6 OUTLIER -144.75 140.32 23.44 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.597 0 C-N-CA 119.087 -1.045 . . . . 0.0 109.781 -177.432 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -148.57 161.46 41.63 Favored 'General case' 0 C--N 1.303 -1.456 0 O-C-N 121.287 -0.883 . . . . 0.0 109.158 -179.571 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 78' ' ' ILE . . . . . . . . . . . . . 6.6 mt -146.89 94.42 4.64 Favored Pre-proline 0 C--N 1.3 -1.553 0 N-CA-C 108.53 -0.915 . . . . 0.0 108.53 -179.75 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 79' ' ' PRO . . . . . . . . . . . . . 74.4 Cg_exo -47.32 -47.42 17.47 Favored 'Trans proline' 0 N--CA 1.493 1.449 0 C-N-CA 122.805 2.337 . . . . 0.0 113.765 -178.745 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -65.24 -18.17 65.1 Favored 'General case' 0 N--CA 1.492 1.65 0 O-C-N 120.765 -1.209 . . . . 0.0 110.565 178.667 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 81' ' ' ALA . . . . . 0.575 ' O ' ' ND2' ' A' ' 132' ' ' ASN . . . -105.69 -16.74 14.6 Favored 'General case' 0 N--CA 1.493 1.718 0 O-C-N 121.24 -0.912 . . . . 0.0 108.918 179.653 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 82' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER 69.39 47.79 0.67 Allowed 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.432 -0.793 . . . . 0.0 110.53 178.87 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 83' ' ' ILE . . . . . . . . . . . . . 67.2 mt -127.1 149.58 32.31 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.81 0 O-C-N 121.065 -1.022 . . . . 0.0 110.732 -178.87 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 84' ' ' LYS . . . . . . . . . . . . . 6.7 ttpm? -157.38 107.86 2.25 Favored 'General case' 0 N--CA 1.491 1.595 0 N-CA-C 107.544 -1.28 . . . . 0.0 107.544 179.516 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 85' ' ' GLU . . . . . 0.572 ' O ' ' CD2' ' A' ' 75' ' ' TYR . 0.4 OUTLIER -145.31 174.37 3.51 Favored Pre-proline 0 N--CA 1.492 1.65 0 O-C-N 121.503 -0.748 . . . . 0.0 110.409 -178.8 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 86' ' ' PRO . . . . . 0.421 ' HA ' ' CD1' ' A' ' 75' ' ' TYR . 60.3 Cg_endo -82.41 168.85 14.43 Favored 'Trans proline' 0 C--N 1.313 -1.305 0 C-N-CA 122.809 2.339 . . . . 0.0 113.841 -179.347 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 87' ' ' VAL . . . . . 0.531 ' CG1' ' CZ ' ' A' ' 103' ' ' PHE . 3.2 t -128.93 105.84 13.42 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.607 0 N-CA-C 108.448 -0.945 . . . . 0.0 108.448 179.91 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 88' ' ' TYR . . . . . 0.411 ' CD2' ' HD2' ' A' ' 99' ' ' ARG . 34.6 m-85 -99.22 152.76 37.91 Favored Pre-proline 0 N--CA 1.499 2.006 0 O-C-N 120.769 -1.207 . . . . 0.0 110.129 -179.018 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 89' ' ' PRO . . . . . . . . . . . . . 2.7 Cg_exo -50.35 144.42 23.97 Favored 'Trans proline' 0 C--N 1.312 -1.351 0 C-N-CA 122.707 2.271 . . . . 0.0 113.487 179.871 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . -61.41 169.57 10.5 Favored Glycine 0 N--CA 1.493 2.47 0 N-CA-C 108.807 -1.717 . . . . 0.0 108.807 178.894 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 91' ' ' PRO . . . . . 0.522 ' C ' ' H ' ' A' ' 93' ' ' THR . 63.9 Cg_endo -95.7 172.86 13.58 Favored 'Cis proline' 0 C--N 1.311 -1.407 0 C-N-CA 124.227 -1.156 . . . . 0.0 112.226 0.133 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 92' ' ' ALA . . . . . . . . . . . . . . . -70.48 29.03 0.04 OUTLIER 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.229 -0.919 . . . . 0.0 110.378 -179.794 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 93' ' ' THR . . . . . 0.522 ' H ' ' C ' ' A' ' 91' ' ' PRO . 1.8 p -75.19 152.14 86.05 Favored Pre-proline 0 N--CA 1.489 1.524 0 O-C-N 120.626 -1.296 . . . . 0.0 108.833 -179.958 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 94' ' ' PRO . . . . . . . . . . . . . 86.4 Cg_exo -35.03 -42.34 0.35 Allowed 'Trans proline' 0 C--N 1.309 -1.546 0 C-N-CA 122.821 2.348 . . . . 0.0 112.398 -179.362 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 95' ' ' GLU . . . . . 0.485 ' O ' ' OD1' ' A' ' 98' ' ' ASN . 53.2 mt-10 -52.84 -55.18 25.01 Favored 'General case' 0 C--N 1.304 -1.407 0 O-C-N 121.094 -1.004 . . . . 0.0 109.12 179.636 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 96' ' ' GLN . . . . . 0.57 ' C ' ' H ' ' A' ' 98' ' ' ASN . 28.6 mm100 -72.29 -50.99 22.87 Favored 'General case' 0 N--CA 1.488 1.458 0 O-C-N 121.124 -0.985 . . . . 0.0 110.151 179.965 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 97' ' ' LEU . . . . . . . . . . . . . 2.5 mp -48.39 -9.12 0.02 OUTLIER 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.038 -1.039 . . . . 0.0 109.784 -179.306 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 98' ' ' ASN . . . . . 0.699 HD22 ' CZ ' ' A' ' 99' ' ' ARG . 14.4 p-10 -72.38 -30.35 64.6 Favored 'General case' 0 N--CA 1.492 1.625 0 CA-C-O 121.873 0.844 . . . . 0.0 109.48 179.624 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 99' ' ' ARG . . . . . 0.699 ' CZ ' HD22 ' A' ' 98' ' ' ASN . 1.2 mtt-85 -98.66 -47.1 5.47 Favored 'General case' 0 C--N 1.299 -1.591 0 C-N-CA 119.829 -0.749 . . . . 0.0 110.106 -178.479 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . 176.28 -176.58 47.78 Favored Glycine 0 N--CA 1.493 2.485 0 C-N-CA 119.096 -1.526 . . . . 0.0 110.916 179.857 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 101' ' ' VAL . . . . . . . . . . . . . 0.2 OUTLIER -50.46 111.7 0.2 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.597 0 O-C-N 121.697 -0.884 . . . . 0.0 109.892 -179.859 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 102' ' ' SER . . . . . 0.437 ' H ' ' HG ' ' A' ' 102' ' ' SER . 0.7 OUTLIER -93.94 169.7 10.09 Favored 'General case' 0 N--CA 1.496 1.84 0 O-C-N 121.273 -0.892 . . . . 0.0 110.741 -179.888 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 103' ' ' PHE . . . . . 0.603 ' O ' ' N ' ' A' ' 105' ' ' GLU . 27.5 m-85 -71.06 121.02 17.48 Favored 'General case' 0 N--CA 1.485 1.314 0 N-CA-C 107.68 -1.23 . . . . 0.0 107.68 177.609 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 104' ' ' ALA . . . . . 0.412 ' C ' ' O ' ' A' ' 103' ' ' PHE . . . -41.95 -15.65 0.01 OUTLIER 'General case' 0 C--N 1.299 -1.597 0 O-C-N 121.497 -0.752 . . . . 0.0 110.682 -178.821 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 105' ' ' GLU . . . . . 0.603 ' N ' ' O ' ' A' ' 103' ' ' PHE . 0.1 OUTLIER -136.22 145.45 45.67 Favored 'General case' 0 N--CA 1.496 1.86 0 O-C-N 120.811 -1.18 . . . . 0.0 110.243 179.638 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 106' ' ' GLU . . . . . . . . . . . . . 2.0 tt0 -60.02 -63.43 1.3 Allowed 'General case' 0 N--CA 1.489 1.482 0 O-C-N 121.835 -0.54 . . . . 0.0 111.416 -178.904 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 107' ' ' ASN . . . . . 0.712 ' H ' HD21 ' A' ' 107' ' ' ASN . 0.2 OUTLIER -78.11 35.09 0.21 Allowed 'General case' 0 N--CA 1.491 1.609 0 O-C-N 120.649 -1.282 . . . . 0.0 112.76 -175.608 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 108' ' ' GLU . . . . . . . . . . . . . 1.7 tp10 -58.24 148.94 25.51 Favored 'General case' 0 N--CA 1.488 1.451 0 N-CA-C 107.591 -1.263 . . . . 0.0 107.591 179.891 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 109' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -101.6 146.3 27.88 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.139 -0.975 . . . . 0.0 110.709 -178.305 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 110' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -62.1 -24.15 66.95 Favored 'General case' 0 C--N 1.302 -1.477 0 N-CA-C 108.035 -1.098 . . . . 0.0 108.035 179.14 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 111' ' ' ASP . . . . . . . . . . . . . 13.0 m-20 -132.7 43.34 2.99 Favored 'General case' 0 N--CA 1.488 1.448 0 O-C-N 121.688 -0.633 . . . . 0.0 109.762 179.97 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 112' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -69.12 156.04 39.35 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.15 -0.969 . . . . 0.0 110.806 -179.852 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 113' ' ' GLN . . . . . 0.457 ' N ' ' CD ' ' A' ' 113' ' ' GLN . 0.8 OUTLIER -67.14 -18.16 65.17 Favored 'General case' 0 N--CA 1.491 1.622 0 N-CA-C 108.15 -1.055 . . . . 0.0 108.15 178.097 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 114' ' ' ASN . . . . . 0.597 ' ND2' ' NE2' ' A' ' 178' ' ' GLN . 1.9 t-20 -150.37 103.84 3.18 Favored 'General case' 0 C--N 1.299 -1.626 0 N-CA-C 107.871 -1.159 . . . . 0.0 107.871 178.533 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 115' ' ' ILE . . . . . . . . . . . . . 2.9 mt -97.77 109.2 23.09 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.66 0 O-C-N 120.885 -1.134 . . . . 0.0 108.696 -179.955 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 116' ' ' SER . . . . . . . . . . . . . 80.8 p -88.0 152.24 22.18 Favored 'General case' 0 N--CA 1.49 1.538 0 CA-C-O 121.863 0.839 . . . . 0.0 110.842 -178.445 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 117' ' ' ILE . . . . . . . . . . . . . 1.5 mt -146.95 122.29 2.63 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.413 0 N-CA-C 107.876 -1.157 . . . . 0.0 107.876 -179.725 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 118' ' ' ALA . . . . . . . . . . . . . . . -118.58 159.72 23.07 Favored 'General case' 0 N--CA 1.496 1.846 0 C-N-CA 119.516 -0.874 . . . . 0.0 112.074 -177.933 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 119' ' ' GLY . . . . . . . . . . . . . . . -170.7 148.11 11.13 Favored Glycine 0 N--CA 1.49 2.255 0 CA-C-O 122.163 0.868 . . . . 0.0 110.936 179.929 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 120' ' ' HIS . . . . . 0.565 ' N ' ' OE1' ' A' ' 129' ' ' GLN . 6.4 m170 -71.19 168.47 17.17 Favored 'General case' 0 N--CA 1.496 1.831 0 O-C-N 121.889 -0.771 . . . . 0.0 109.909 179.084 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 121' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -122.64 158.07 30.81 Favored 'General case' 0 N--CA 1.496 1.844 0 N-CA-C 108.48 -0.933 . . . . 0.0 108.48 178.786 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 122' ' ' PHE . . . . . . . . . . . . . 1.1 m-85 -144.16 123.61 13.15 Favored 'General case' 0 N--CA 1.498 1.974 0 O-C-N 120.819 -1.175 . . . . 0.0 110.006 -179.926 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 123' ' ' ILE . . . . . 0.467 ' CG2' ' N ' ' A' ' 124' ' ' ASP . 14.4 tt -58.51 -40.92 80.34 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.541 0 CA-C-O 121.619 0.723 . . . . 0.0 109.46 179.714 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 124' ' ' ASP . . . . . 0.467 ' N ' ' CG2' ' A' ' 123' ' ' ILE . 13.1 t70 -90.14 26.21 1.95 Allowed 'General case' 0 N--CA 1.497 1.888 0 O-C-N 121.573 -0.704 . . . . 0.0 112.166 -177.215 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 125' ' ' ARG . . . . . 0.657 HH11 ' CG ' ' A' ' 125' ' ' ARG . 2.2 mtt-85 -155.59 99.69 2.25 Favored Pre-proline 0 N--CA 1.493 1.679 0 O-C-N 120.451 -1.406 . . . . 0.0 109.718 179.989 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 126' ' ' PRO . . . . . . . . . . . . . 53.9 Cg_endo -78.54 -25.15 6.93 Favored 'Trans proline' 0 C--N 1.314 -1.277 0 C-N-CA 122.067 1.845 . . . . 0.0 112.172 179.893 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 127' ' ' ASN . . . . . 0.447 ' O ' ' O ' ' A' ' 128' ' ' TYR . 3.0 t30 -91.77 5.17 50.88 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.264 -0.897 . . . . 0.0 109.43 179.743 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 128' ' ' TYR . . . . . 0.465 ' O ' ' OE2' ' A' ' 85' ' ' GLU . 9.7 t80 -59.22 -150.25 0.0 OUTLIER 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.296 -0.878 . . . . 0.0 109.88 -179.765 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 129' ' ' GLN . . . . . 0.565 ' OE1' ' N ' ' A' ' 120' ' ' HIS . 10.3 mt-30 -68.04 -70.26 0.27 Allowed 'General case' 0 C--N 1.303 -1.422 0 O-C-N 121.549 -0.72 . . . . 0.0 109.483 179.968 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 130' ' ' PHE . . . . . . . . . . . . . 55.6 m-85 -136.59 51.88 1.98 Allowed 'General case' 0 N--CA 1.489 1.501 0 O-C-N 121.29 -0.881 . . . . 0.0 110.289 -179.536 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 131' ' ' THR . . . . . 0.537 ' O ' ' CD ' ' A' ' 134' ' ' LYS . 54.0 m -81.78 -40.06 23.18 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 120.936 -1.102 . . . . 0.0 109.275 179.844 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 132' ' ' ASN . . . . . 0.575 ' ND2' ' O ' ' A' ' 81' ' ' ALA . 32.1 t30 -91.88 13.56 18.11 Favored 'General case' 0 N--CA 1.496 1.854 0 C-N-CA 119.61 -0.836 . . . . 0.0 111.783 -178.781 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 133' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -68.15 -33.51 74.61 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 120.49 -1.381 . . . . 0.0 109.402 -179.696 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 134' ' ' LYS . . . . . 0.603 ' H ' ' CD ' ' A' ' 134' ' ' LYS . 0.0 OUTLIER -44.66 -25.41 0.28 Allowed 'General case' 0 N--CA 1.494 1.734 0 O-C-N 121.35 -0.844 . . . . 0.0 110.625 -179.977 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 135' ' ' ALA . . . . . . . . . . . . . . . -82.31 -29.83 30.87 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.087 -1.008 . . . . 0.0 110.651 -178.623 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 136' ' ' ALA . . . . . . . . . . . . . . . -79.91 145.24 32.77 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.034 -1.041 . . . . 0.0 111.496 -178.639 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 137' ' ' LYS . . . . . 0.586 ' CG ' ' H ' ' A' ' 138' ' ' LYS . 0.5 OUTLIER -153.18 -167.69 2.8 Favored 'General case' 0 N--CA 1.496 1.828 0 C-N-CA 118.676 -1.209 . . . . 0.0 110.698 -177.994 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 138' ' ' LYS . . . . . 0.596 ' O ' ' N ' ' A' ' 140' ' ' SER . 22.1 mtmt -44.09 178.77 0.0 OUTLIER 'General case' 0 N--CA 1.487 1.407 0 CA-C-O 122.335 1.064 . . . . 0.0 110.709 -179.197 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 139' ' ' GLY . . . . . . . . . . . . . . . 46.1 7.88 0.02 OUTLIER Glycine 0 N--CA 1.487 2.057 0 N-CA-C 110.526 -1.03 . . . . 0.0 110.526 179.593 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 140' ' ' SER . . . . . 0.596 ' N ' ' O ' ' A' ' 138' ' ' LYS . 38.2 t -92.57 135.63 33.91 Favored 'General case' 0 N--CA 1.494 1.748 0 O-C-N 120.706 -1.467 . . . . 0.0 109.293 179.318 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 141' ' ' MET . . . . . 0.673 ' SD ' ' N ' ' A' ' 142' ' ' VAL . 9.7 tpp -87.94 132.7 34.13 Favored 'General case' 0 C--N 1.299 -1.608 0 O-C-N 121.246 -0.908 . . . . 0.0 109.621 179.94 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 142' ' ' VAL . . . . . 0.673 ' N ' ' SD ' ' A' ' 141' ' ' MET . 2.3 t -115.51 136.51 52.08 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.457 0 N-CA-C 108.068 -1.086 . . . . 0.0 108.068 179.875 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 143' ' ' TYR . . . . . . . . . . . . . 10.0 m-85 -115.73 137.64 51.89 Favored 'General case' 0 N--CA 1.499 2.016 0 O-C-N 121.021 -1.049 . . . . 0.0 111.758 -178.1 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 144' ' ' PHE . . . . . . . . . . . . . 12.6 t80 -122.16 107.93 12.73 Favored 'General case' 0 N--CA 1.492 1.665 0 CA-C-O 121.322 0.582 . . . . 0.0 109.5 -179.951 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 145' ' ' LYS . . . . . . . . . . . . . 1.6 tttp -95.46 131.78 41.24 Favored 'General case' 0 N--CA 1.493 1.684 0 O-C-N 121.333 -0.854 . . . . 0.0 110.371 -179.291 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 146' ' ' VAL . . . . . 0.45 ' O ' ' C ' ' A' ' 147' ' ' GLY . 0.7 OUTLIER -144.54 141.23 23.94 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.644 0 N-CA-C 107.9 -1.148 . . . . 0.0 107.9 178.667 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 147' ' ' GLY . . . . . 0.45 ' C ' ' O ' ' A' ' 146' ' ' VAL . . . 42.56 -127.57 4.77 Favored Glycine 0 N--CA 1.49 2.28 0 N-CA-C 109.394 -1.482 . . . . 0.0 109.394 -179.821 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 148' ' ' ASN . . . . . 0.511 ' C ' HD21 ' A' ' 148' ' ' ASN . 0.4 OUTLIER -103.01 14.62 31.51 Favored 'General case' 0 C--N 1.3 -1.566 0 O-C-N 121.418 -1.048 . . . . 0.0 108.47 179.365 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 149' ' ' GLU . . . . . . . . . . . . . 3.6 tt0 -110.85 143.77 40.92 Favored 'General case' 0 N--CA 1.488 1.442 0 CA-C-O 122.031 0.919 . . . . 0.0 111.26 -178.589 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 150' ' ' THR . . . . . . . . . . . . . 6.4 m -127.22 102.18 6.82 Favored 'General case' 0 N--CA 1.49 1.544 0 CA-C-O 121.395 0.617 . . . . 0.0 109.452 179.896 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 151' ' ' ARG . . . . . . . . . . . . . 22.1 mtt180 -87.6 -178.33 6.08 Favored 'General case' 0 C--N 1.305 -1.368 0 N-CA-C 108.459 -0.941 . . . . 0.0 108.459 179.789 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 152' ' ' LYS . . . . . 0.447 ' C ' ' CD1' ' A' ' 153' ' ' TYR . 22.6 mtmt -148.8 152.51 36.66 Favored 'General case' 0 C--N 1.3 -1.57 0 C-N-CA 119.303 -0.959 . . . . 0.0 110.024 -179.677 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 153' ' ' TYR . . . . . 0.557 ' O ' ' SD ' ' A' ' 141' ' ' MET . 42.1 m-85 -144.23 157.19 44.42 Favored 'General case' 0 C--N 1.3 -1.565 0 N-CA-C 107.987 -1.116 . . . . 0.0 107.987 179.137 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 154' ' ' LYS . . . . . . . . . . . . . 26.1 ttpt -132.1 118.33 19.48 Favored 'General case' 0 C--N 1.297 -1.684 0 N-CA-C 108.514 -0.921 . . . . 0.0 108.514 179.529 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 155' ' ' MET . . . . . . . . . . . . . 15.0 mtp -45.33 105.64 0.06 Allowed 'General case' 0 N--CA 1.489 1.496 0 CA-C-O 122.284 1.04 . . . . 0.0 111.632 -178.494 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 156' ' ' THR . . . . . 0.424 ' H ' ' HG1' ' A' ' 156' ' ' THR . 0.2 OUTLIER -105.7 -25.25 12.31 Favored 'General case' 0 C--N 1.295 -1.786 0 CA-C-N 115.37 -0.832 . . . . 0.0 110.538 -178.803 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 157' ' ' SER . . . . . 0.484 ' O ' ' N ' ' A' ' 201' ' ' VAL . 0.0 OUTLIER -152.93 155.73 37.56 Favored 'General case' 0 N--CA 1.496 1.835 0 C-N-CA 118.456 -1.298 . . . . 0.0 110.914 -178.684 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 158' ' ' ILE . . . . . 0.423 HG12 ' N ' ' A' ' 159' ' ' ARG . 0.0 OUTLIER -154.52 146.7 13.61 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.561 0 CA-C-O 121.812 0.815 . . . . 0.0 110.857 -178.998 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 159' ' ' ARG . . . . . 0.508 ' O ' ' OD1' ' A' ' 160' ' ' ASP . 1.6 tpt180 -148.83 167.84 24.58 Favored 'General case' 0 N--CA 1.491 1.589 0 CA-C-O 121.448 0.642 . . . . 0.0 109.755 -179.659 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 160' ' ' ASP . . . . . 0.508 ' OD1' ' O ' ' A' ' 159' ' ' ARG . 6.5 m-20 -140.5 163.29 33.22 Favored 'General case' 0 N--CA 1.493 1.71 0 O-C-N 121.488 -0.757 . . . . 0.0 108.976 -179.388 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 161' ' ' VAL . . . . . 0.492 ' CG2' ' N ' ' A' ' 162' ' ' LYS . 11.8 p -165.49 169.05 0.36 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.708 0 O-C-N 120.906 -1.121 . . . . 0.0 111.277 179.894 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 162' ' ' LYS . . . . . 0.581 ' N ' ' CD ' ' A' ' 162' ' ' LYS . 0.0 OUTLIER -60.82 174.0 0.59 Allowed Pre-proline 0 N--CA 1.492 1.643 0 N-CA-C 109.099 -0.704 . . . . 0.0 109.099 178.771 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 163' ' ' PRO . . . . . . . . . . . . . 59.2 Cg_endo -82.2 42.92 1.4 Allowed 'Trans proline' 0 C--N 1.311 -1.416 0 C-N-CA 122.444 2.096 . . . . 0.0 112.855 -179.324 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 164' ' ' THR . . . . . . . . . . . . . 24.0 m -151.74 -11.58 0.2 Allowed 'General case' 0 N--CA 1.494 1.748 0 O-C-N 120.93 -1.106 . . . . 0.0 111.081 179.788 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 165' ' ' ASP . . . . . . . . . . . . . 37.0 t70 -78.82 67.77 4.62 Favored 'General case' 0 N--CA 1.492 1.67 0 O-C-N 120.771 -1.206 . . . . 0.0 110.684 -179.549 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 166' ' ' VAL . . . . . 0.652 ' O ' ' N ' ' A' ' 168' ' ' VAL . 0.9 OUTLIER -47.54 -35.07 3.93 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.479 0 O-C-N 120.828 -1.17 . . . . 0.0 109.44 -179.097 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 167' ' ' GLY . . . . . 0.439 ' C ' ' O ' ' A' ' 166' ' ' VAL . . . -42.37 -13.65 0.01 OUTLIER Glycine 0 N--CA 1.496 2.651 0 C-N-CA 119.937 -1.125 . . . . 0.0 110.389 179.958 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 168' ' ' VAL . . . . . 0.652 ' N ' ' O ' ' A' ' 166' ' ' VAL . 9.3 p -53.79 -28.23 16.4 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.408 0 O-C-N 120.782 -1.422 . . . . 0.0 109.108 179.849 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 169' ' ' LEU . . . . . 0.514 ' O ' ' C ' ' A' ' 170' ' ' ASP . 1.4 mt -45.87 -19.66 0.07 Allowed 'General case' 0 N--CA 1.496 1.857 0 N-CA-C 107.068 -1.456 . . . . 0.0 107.068 -178.298 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 170' ' ' ASP . . . . . 0.581 ' O ' ' ND2' ' A' ' 114' ' ' ASN . 19.4 t0 27.32 91.09 0.01 OUTLIER 'General case' 0 N--CA 1.497 1.892 0 CA-C-N 116.392 -0.367 . . . . 0.0 111.486 177.399 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 171' ' ' GLU . . . . . . . . . . . . . 4.8 pt-20 -136.83 73.98 1.47 Allowed 'General case' 0 N--CA 1.493 1.71 0 O-C-N 120.967 -1.083 . . . . 0.0 110.252 179.663 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 172' ' ' GLN . . . . . . . . . . . . . 16.8 mm-40 -130.94 -48.41 1.02 Allowed 'General case' 0 N--CA 1.495 1.783 0 O-C-N 121.558 -0.714 . . . . 0.0 110.564 -178.745 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 173' ' ' LYS . . . . . . . . . . . . . 7.2 mttp -58.8 133.94 56.43 Favored 'General case' 0 N--CA 1.492 1.669 0 O-C-N 120.926 -1.109 . . . . 0.0 108.988 -179.869 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 174' ' ' GLY . . . . . 0.571 ' O ' ' C ' ' A' ' 175' ' ' LYS . . . -130.45 -43.57 0.19 Allowed Glycine 0 C--N 1.299 -1.486 0 N-CA-C 108.363 -1.895 . . . . 0.0 108.363 179.567 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 175' ' ' LYS . . . . . 0.571 ' C ' ' O ' ' A' ' 174' ' ' GLY . 32.6 mmtt -33.78 -63.34 0.27 Allowed 'General case' 0 N--CA 1.496 1.831 0 N-CA-C 107.843 -1.169 . . . . 0.0 107.843 179.658 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 176' ' ' ASP . . . . . 0.618 ' O ' ' O ' ' A' ' 177' ' ' LYS . 15.8 m-20 -104.54 86.27 2.48 Favored 'General case' 0 C--N 1.294 -1.805 0 N-CA-C 107.406 -1.331 . . . . 0.0 107.406 176.854 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 177' ' ' LYS . . . . . 0.618 ' O ' ' O ' ' A' ' 176' ' ' ASP . 29.3 mtmt -39.25 176.65 0.0 OUTLIER 'General case' 0 N--CA 1.501 2.081 0 O-C-N 121.507 -0.746 . . . . 0.0 110.431 -179.053 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 178' ' ' GLN . . . . . 0.597 ' NE2' ' ND2' ' A' ' 114' ' ' ASN . 0.0 OUTLIER -161.88 176.35 10.93 Favored 'General case' 0 N--CA 1.488 1.434 0 O-C-N 120.431 -1.418 . . . . 0.0 111.365 -179.999 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 179' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -130.28 98.03 4.6 Favored 'General case' 0 N--CA 1.487 1.424 0 N-CA-C 107.105 -1.443 . . . . 0.0 107.105 178.191 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 180' ' ' THR . . . . . . . . . . . . . 1.1 m -71.42 119.89 16.22 Favored 'General case' 0 C--N 1.303 -1.448 0 O-C-N 121.06 -1.025 . . . . 0.0 110.193 -178.381 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 181' ' ' LEU . . . . . 0.429 ' CD1' ' N ' ' A' ' 182' ' ' ILE . 1.1 tm? -89.85 140.55 29.49 Favored 'General case' 0 C--N 1.303 -1.436 0 N-CA-C 106.91 -1.515 . . . . 0.0 106.91 177.456 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 182' ' ' ILE . . . . . 0.429 ' N ' ' CD1' ' A' ' 181' ' ' LEU . 5.3 mt -136.54 117.42 18.13 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.753 0 O-C-N 120.92 -1.112 . . . . 0.0 108.008 178.709 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 183' ' ' THR . . . . . . . . . . . . . 1.4 t -144.7 114.72 7.4 Favored 'General case' 0 C--N 1.287 -2.11 0 N-CA-C 107.84 -1.17 . . . . 0.0 107.84 -179.538 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 184' ' ' CYS . . . . . . . . . . . . . 0.7 OUTLIER -79.41 163.73 24.57 Favored 'General case' 0 C--N 1.288 -2.076 0 C-N-CA 118.762 -1.175 . . . . 0.0 110.649 -178.092 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 185' ' ' ASP . . . . . . . . . . . . . 4.8 t70 -165.18 -154.42 0.22 Allowed 'General case' 0 N--CA 1.492 1.658 0 N-CA-C 109.232 -0.655 . . . . 0.0 109.232 -179.672 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 186' ' ' ASP . . . . . . . . . . . . . 1.1 m-20 51.04 60.91 3.54 Favored 'General case' 0 N--CA 1.494 1.743 0 O-C-N 121.081 -1.012 . . . . 0.0 108.409 -179.246 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 187' ' ' TYR . . . . . 0.595 ' CE1' ' O ' ' A' ' 188' ' ' ASN . 50.7 t80 -67.78 134.37 50.86 Favored 'General case' 0 N--CA 1.49 1.544 0 CA-C-O 122.052 0.929 . . . . 0.0 111.591 -178.679 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 188' ' ' ASN . . . . . 0.595 ' O ' ' CE1' ' A' ' 187' ' ' TYR . 0.8 OUTLIER -100.78 146.15 27.63 Favored 'General case' 0 C--N 1.297 -1.7 0 N-CA-C 107.929 -1.137 . . . . 0.0 107.929 177.923 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 189' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -112.69 -14.78 13.1 Favored 'General case' 0 C--N 1.297 -1.706 0 N-CA-C 108.604 -0.887 . . . . 0.0 108.604 -179.712 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 190' ' ' LYS . . . . . . . . . . . . . 12.8 mttm -83.58 -49.87 8.79 Favored 'General case' 0 C--N 1.301 -1.505 0 N-CA-C 108.595 -0.891 . . . . 0.0 108.595 178.729 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 191' ' ' THR . . . . . . . . . . . . . 6.5 p -88.86 -11.99 43.12 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.432 -0.792 . . . . 0.0 108.916 179.454 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 192' ' ' GLY . . . . . . . . . . . . . . . 67.89 34.6 82.8 Favored Glycine 0 N--CA 1.493 2.438 0 O-C-N 121.309 -0.869 . . . . 0.0 111.059 178.561 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 193' ' ' VAL . . . . . . . . . . . . . 3.5 p -148.12 167.96 4.15 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.543 0 O-C-N 120.789 -1.418 . . . . 0.0 110.216 179.382 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 194' ' ' TRP . . . . . . . . . . . . . 36.7 m95 -84.89 120.85 26.94 Favored 'General case' 0 C--N 1.296 -1.74 0 N-CA-C 109.058 -0.719 . . . . 0.0 109.058 179.991 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 195' ' ' GLU . . . . . 0.546 ' CD ' ' ND2' ' A' ' 188' ' ' ASN . 3.8 mt-10 -84.99 -61.05 1.87 Allowed 'General case' 0 N--CA 1.496 1.865 0 O-C-N 121.268 -0.895 . . . . 0.0 111.089 -178.657 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 196' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -83.98 154.32 23.38 Favored 'General case' 0 N--CA 1.491 1.575 0 O-C-N 120.903 -1.123 . . . . 0.0 110.05 -178.917 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 197' ' ' ARG . . . . . 0.636 ' CG ' HH11 ' A' ' 197' ' ' ARG . 0.0 OUTLIER -126.89 140.17 52.53 Favored 'General case' 0 N--CA 1.489 1.482 0 N-CA-C 109.019 -0.734 . . . . 0.0 109.019 179.583 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 198' ' ' LYS . . . . . . . . . . . . . 23.4 mttt -114.58 121.17 42.61 Favored 'General case' 0 C--N 1.302 -1.478 0 O-C-N 121.793 -0.567 . . . . 0.0 110.2 -178.929 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 199' ' ' ILE . . . . . 0.493 ' O ' HG13 ' A' ' 199' ' ' ILE . 0.8 OUTLIER -139.22 118.21 13.07 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.576 0 CA-C-O 122.809 1.29 . . . . 0.0 110.16 179.553 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 200' ' ' PHE . . . . . 0.501 ' CD1' ' N ' ' A' ' 200' ' ' PHE . 5.7 m-85 -101.0 137.03 39.91 Favored 'General case' 0 N--CA 1.495 1.814 0 O-C-N 120.707 -1.245 . . . . 0.0 110.276 -178.265 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 201' ' ' VAL . . . . . 0.484 ' N ' ' O ' ' A' ' 157' ' ' SER . 70.2 t -102.2 140.5 20.53 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.545 0 N-CA-C 108.09 -1.078 . . . . 0.0 108.09 177.465 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 202' ' ' ALA . . . . . . . . . . . . . . . -130.11 138.08 50.5 Favored 'General case' 0 C--N 1.301 -1.517 0 O-C-N 121.194 -0.941 . . . . 0.0 108.998 -179.66 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 203' ' ' THR . . . . . 0.459 ' H ' ' HG1' ' A' ' 203' ' ' THR . 1.9 p -88.94 136.34 33.06 Favored 'General case' 0 C--N 1.306 -1.3 0 CA-C-O 122.474 1.13 . . . . 0.0 111.213 -178.276 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 204' ' ' GLU . . . . . 0.439 ' HA ' ' CD2' ' A' ' 153' ' ' TYR . 2.5 tt0 -60.22 134.06 56.69 Favored 'General case' 0 C--N 1.297 -1.686 0 CA-C-N 115.039 -0.982 . . . . 0.0 110.642 -179.915 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 205' ' ' VAL . . . . . 0.446 ' O ' ' OXT' ' A' ' 206' ' ' LYS . 42.2 t -121.11 -13.69 8.06 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.55 0 N-CA-C 107.997 -1.112 . . . . 0.0 107.997 179.247 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 206' ' ' LYS . . . . . 0.446 ' OXT' ' O ' ' A' ' 205' ' ' VAL . 0.1 OUTLIER . . . . . 0 N--CA 1.489 1.499 0 CA-C-O 118.029 -0.986 . . . . 0.0 109.674 -179.671 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' C' C ' 702' ' ' LEU . . . . . 0.65 ' CD1' ' N ' ' C' ' 702' ' ' LEU . 0.0 OUTLIER . . . . . 0 N--CA 1.491 1.599 0 N-CA-C 109.016 -0.735 . . . . 0.0 109.016 . . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' C' C ' 703' ' ' PRO . . . . . 0.487 ' O ' ' O ' ' C' ' 702' ' ' LEU . 52.6 Cg_exo -46.41 -176.71 0.0 OUTLIER 'Trans proline' 0 N--CA 1.49 1.287 0 C-N-CA 122.023 1.816 . . . . 0.0 112.239 -179.379 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' C' C ' 704' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.488 1.443 0 O-C-N 121.37 -0.831 . . . . 0.0 109.231 -179.905 . . . . . . . . 0 0 . 1 . 015 nuclear orig core ' A' A ' 63' ' ' PRO . . . . . . . . . . . . . 95.0 Cg_endo . . . . . 0 N--CA 1.482 0.843 0 CA-C-O 121.173 0.405 . . . . 0.0 111.975 . . . . . . . . . 0 0 . 1 . 015 nuclear orig core ' A' A ' 64' ' ' GLN . . . . . 0.651 ' NE2' ' N ' ' A' ' 64' ' ' GLN . 0.0 OUTLIER -153.49 120.16 5.62 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.158 -0.964 . . . . 0.0 109.424 179.537 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 65' ' ' ILE . . . . . 0.444 ' C ' ' O ' ' A' ' 64' ' ' GLN . 2.9 mp -45.32 106.41 0.54 Allowed Pre-proline 0 N--CA 1.489 1.51 0 N-CA-C 107.874 -1.158 . . . . 0.0 107.874 179.079 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 66' ' ' PRO . . . . . . . . . . . . . 61.3 Cg_endo -77.64 -162.82 0.18 Allowed 'Trans proline' 0 N--CA 1.49 1.285 0 C-N-CA 122.113 1.875 . . . . 0.0 113.171 -178.075 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 67' ' ' LYS . . . . . . . . . . . . . 7.0 ttpt -84.75 -7.86 59.05 Favored 'General case' 0 N--CA 1.488 1.447 0 O-C-N 121.603 -0.686 . . . . 0.0 109.388 -179.74 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 68' ' ' ASP . . . . . 0.645 ' C ' ' N ' ' A' ' 70' ' ' SER . 1.0 OUTLIER -76.9 62.75 2.14 Favored 'General case' 0 N--CA 1.489 1.478 0 CA-C-O 122.756 1.265 . . . . 0.0 109.259 179.801 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 69' ' ' LYS . . . . . 0.463 ' C ' ' O ' ' A' ' 68' ' ' ASP . 0.9 OUTLIER -47.61 -13.36 0.04 OUTLIER 'General case' 0 N--CA 1.511 2.584 0 C-N-CA 116.926 -1.91 . . . . 0.0 106.79 177.397 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 70' ' ' SER . . . . . 0.645 ' N ' ' C ' ' A' ' 68' ' ' ASP . 0.0 OUTLIER -87.58 -3.14 58.99 Favored 'General case' 0 N--CA 1.498 1.944 0 CA-C-N 113.592 -1.64 . . . . 0.0 111.805 179.448 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 71' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -99.18 141.79 31.5 Favored 'General case' 0 N--CA 1.504 2.273 0 O-C-N 120.472 -1.393 . . . . 0.0 112.606 -178.941 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 72' ' ' VAL . . . . . 0.53 ' CG2' ' O ' ' A' ' 74' ' ' GLY . 0.2 OUTLIER -66.37 127.67 28.1 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.38 0 N-CA-C 104.551 -2.389 . . . . 0.0 104.551 174.397 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 73' ' ' ALA . . . . . 0.585 ' N ' ' O ' ' A' ' 87' ' ' VAL . . . -80.08 -13.71 59.08 Favored 'General case' 0 C--N 1.295 -1.783 0 O-C-N 120.165 -1.585 . . . . 0.0 108.381 -178.536 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 74' ' ' GLY . . . . . 0.53 ' O ' ' CG2' ' A' ' 72' ' ' VAL . . . 171.55 -155.42 24.11 Favored Glycine 0 N--CA 1.484 1.851 0 C-N-CA 118.759 -1.686 . . . . 0.0 110.819 179.23 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 75' ' ' TYR . . . . . . . . . . . . . 6.2 m-85 -144.29 169.22 18.32 Favored 'General case' 0 C--N 1.298 -1.647 0 O-C-N 121.639 -0.918 . . . . 0.0 110.79 -177.333 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 76' ' ' ILE . . . . . . . . . . . . . 0.8 OUTLIER -149.85 147.67 16.05 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.59 0 C-N-CA 119.902 -0.719 . . . . 0.0 109.414 -178.136 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -149.25 164.76 33.9 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 120.971 -1.081 . . . . 0.0 109.731 179.558 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 78' ' ' ILE . . . . . 0.522 ' O ' ' N ' ' A' ' 82' ' ' ASP . 32.6 mt -146.1 94.76 4.88 Favored Pre-proline 0 N--CA 1.489 1.517 0 N-CA-C 108.482 -0.933 . . . . 0.0 108.482 -179.808 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 79' ' ' PRO . . . . . . . . . . . . . 51.2 Cg_exo -49.02 -46.37 25.57 Favored 'Trans proline' 0 C--N 1.31 -1.451 0 C-N-CA 122.604 2.203 . . . . 0.0 113.622 -178.764 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 80' ' ' ASP . . . . . 0.553 ' OD1' ' N ' ' A' ' 80' ' ' ASP . 0.0 OUTLIER -65.41 -19.79 66.1 Favored 'General case' 0 N--CA 1.493 1.716 0 O-C-N 120.821 -1.174 . . . . 0.0 110.445 178.551 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 81' ' ' ALA . . . . . 0.624 ' O ' ' ND2' ' A' ' 132' ' ' ASN . . . -106.33 -16.95 14.43 Favored 'General case' 0 N--CA 1.491 1.624 0 N-CA-C 108.361 -0.978 . . . . 0.0 108.361 179.33 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 82' ' ' ASP . . . . . 0.522 ' N ' ' O ' ' A' ' 78' ' ' ILE . 3.4 t70 66.52 51.61 1.12 Allowed 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.367 -0.833 . . . . 0.0 110.761 179.07 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 83' ' ' ILE . . . . . 0.479 ' CD1' ' OD1' ' A' ' 132' ' ' ASN . 89.5 mt -129.31 153.9 39.35 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.843 0 O-C-N 121.185 -0.947 . . . . 0.0 110.052 -179.282 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 84' ' ' LYS . . . . . . . . . . . . . 22.9 tttt -158.13 109.0 2.17 Favored 'General case' 0 N--CA 1.491 1.613 0 N-CA-C 107.646 -1.242 . . . . 0.0 107.646 179.372 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 85' ' ' GLU . . . . . 0.504 ' OE1' ' O ' ' A' ' 128' ' ' TYR . 0.0 OUTLIER -141.43 165.17 30.4 Favored Pre-proline 0 N--CA 1.495 1.808 0 O-C-N 121.044 -1.035 . . . . 0.0 110.798 -178.118 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 86' ' ' PRO . . . . . . . . . . . . . 59.3 Cg_endo -74.52 161.58 39.64 Favored 'Trans proline' 0 N--CA 1.495 1.603 0 C-N-CA 123.404 2.736 . . . . 0.0 113.549 -179.362 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 87' ' ' VAL . . . . . 0.585 ' O ' ' N ' ' A' ' 73' ' ' ALA . 58.6 t -120.05 99.97 8.55 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.683 0 N-CA-C 109.294 -0.632 . . . . 0.0 109.294 179.588 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 88' ' ' TYR . . . . . 0.43 ' CD2' ' CD ' ' A' ' 99' ' ' ARG . 19.5 m-85 -92.09 154.9 43.32 Favored Pre-proline 0 N--CA 1.504 2.232 0 O-C-N 120.777 -1.202 . . . . 0.0 110.276 -179.479 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 89' ' ' PRO . . . . . . . . . . . . . 11.4 Cg_endo -60.2 143.65 99.52 Favored 'Trans proline' 0 N--CA 1.495 1.559 0 C-N-CA 122.741 2.294 . . . . 0.0 113.517 -179.902 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . -59.85 168.55 7.88 Favored Glycine 0 N--CA 1.496 2.654 0 N-CA-C 109.444 -1.462 . . . . 0.0 109.444 179.271 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 91' ' ' PRO . . . . . 0.471 ' C ' ' H ' ' A' ' 93' ' ' THR . 55.6 Cg_endo -93.32 169.78 20.36 Favored 'Cis proline' 0 C--N 1.309 -1.53 0 C-N-CA 123.941 -1.274 . . . . 0.0 111.941 0.168 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 92' ' ' ALA . . . . . 0.555 ' O ' ' CD1' ' A' ' 97' ' ' LEU . . . -72.28 32.52 0.06 Allowed 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.081 -1.012 . . . . 0.0 110.398 -179.903 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 93' ' ' THR . . . . . 0.5 ' OG1' ' OE1' ' A' ' 96' ' ' GLN . 3.1 p -74.81 150.67 86.39 Favored Pre-proline 0 C--N 1.3 -1.548 0 O-C-N 120.485 -1.384 . . . . 0.0 108.487 179.993 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 94' ' ' PRO . . . . . 0.403 ' C ' ' O ' ' A' ' 93' ' ' THR . 82.0 Cg_exo -30.69 -52.32 0.23 Allowed 'Trans proline' 0 C--N 1.308 -1.569 0 C-N-CA 123.18 2.587 . . . . 0.0 113.022 -179.034 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 4.9 mm-40 -49.55 -49.3 46.81 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.09 -1.006 . . . . 0.0 109.688 -179.833 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 96' ' ' GLN . . . . . 0.57 ' O ' ' N ' ' A' ' 98' ' ' ASN . 12.5 mp0 -73.53 -54.35 8.42 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 120.96 -1.088 . . . . 0.0 110.452 -179.644 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 97' ' ' LEU . . . . . 0.555 ' CD1' ' O ' ' A' ' 92' ' ' ALA . 95.8 mt -47.2 -9.32 0.02 OUTLIER 'General case' 0 N--CA 1.495 1.818 0 O-C-N 121.185 -0.947 . . . . 0.0 110.279 -178.793 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 98' ' ' ASN . . . . . 0.57 ' N ' ' O ' ' A' ' 96' ' ' GLN . 0.0 OUTLIER -74.86 -26.04 59.4 Favored 'General case' 0 N--CA 1.493 1.686 0 O-C-N 121.115 -0.991 . . . . 0.0 109.126 179.727 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 99' ' ' ARG . . . . . 0.564 HH11 ' CG ' ' A' ' 99' ' ' ARG . 0.3 OUTLIER -91.1 -56.11 3.28 Favored 'General case' 0 C--N 1.301 -1.527 0 O-C-N 121.796 -0.565 . . . . 0.0 109.642 -179.484 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . -179.46 -165.36 33.47 Favored Glycine 0 N--CA 1.49 2.283 0 N-CA-C 109.949 -1.26 . . . . 0.0 109.949 179.89 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 101' ' ' VAL . . . . . . . . . . . . . 28.9 m -59.23 105.95 0.22 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.64 0 O-C-N 121.325 -1.103 . . . . 0.0 109.696 -179.731 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -91.63 169.04 11.06 Favored 'General case' 0 N--CA 1.495 1.777 0 O-C-N 121.224 -0.922 . . . . 0.0 110.864 -179.308 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 103' ' ' PHE . . . . . 0.559 ' O ' ' N ' ' A' ' 105' ' ' GLU . 26.0 m-85 -72.74 122.43 21.49 Favored 'General case' 0 N--CA 1.493 1.721 0 N-CA-C 108.123 -1.065 . . . . 0.0 108.123 178.469 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 104' ' ' ALA . . . . . 0.404 ' C ' ' O ' ' A' ' 103' ' ' PHE . . . -39.67 -20.51 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.526 -0.734 . . . . 0.0 111.716 -178.388 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 105' ' ' GLU . . . . . 0.559 ' N ' ' O ' ' A' ' 103' ' ' PHE . 13.4 pt-20 -139.51 148.71 43.01 Favored 'General case' 0 N--CA 1.498 1.943 0 O-C-N 120.673 -1.267 . . . . 0.0 110.696 -179.479 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 106' ' ' GLU . . . . . . . . . . . . . 8.8 tt0 -56.79 -62.5 1.7 Allowed 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.91 -0.494 . . . . 0.0 111.76 -178.575 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 107' ' ' ASN . . . . . 0.588 ' N ' HD21 ' A' ' 107' ' ' ASN . 1.0 OUTLIER -76.62 33.5 0.14 Allowed 'General case' 0 N--CA 1.492 1.65 0 O-C-N 120.533 -1.354 . . . . 0.0 112.782 -175.247 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 108' ' ' GLU . . . . . 0.499 ' OE1' ' OE2' ' A' ' 105' ' ' GLU . 38.3 tp10 -60.24 146.67 42.88 Favored 'General case' 0 N--CA 1.488 1.466 0 O-C-N 120.776 -1.202 . . . . 0.0 107.906 179.821 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 109' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -97.8 144.31 27.52 Favored 'General case' 0 N--CA 1.488 1.468 0 O-C-N 120.923 -1.111 . . . . 0.0 110.806 -178.243 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 110' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -61.99 -21.05 64.53 Favored 'General case' 0 C--N 1.302 -1.46 0 N-CA-C 107.734 -1.21 . . . . 0.0 107.734 179.037 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 111' ' ' ASP . . . . . . . . . . . . . 75.5 m-20 -132.62 44.79 2.83 Favored 'General case' 0 N--CA 1.488 1.451 0 CA-C-O 121.388 0.613 . . . . 0.0 109.363 179.63 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 112' ' ' ASP . . . . . . . . . . . . . 1.1 t0 -68.64 157.38 36.3 Favored 'General case' 0 N--CA 1.493 1.685 0 O-C-N 121.195 -0.941 . . . . 0.0 111.232 -179.7 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 113' ' ' GLN . . . . . 0.541 ' N ' ' CD ' ' A' ' 113' ' ' GLN . 0.0 OUTLIER -65.92 -15.7 63.2 Favored 'General case' 0 N--CA 1.492 1.653 0 N-CA-C 107.387 -1.338 . . . . 0.0 107.387 177.495 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 114' ' ' ASN . . . . . 0.496 ' O ' ' CG ' ' A' ' 114' ' ' ASN . 11.8 p-10 -150.31 108.29 3.72 Favored 'General case' 0 C--N 1.298 -1.655 0 N-CA-C 107.72 -1.215 . . . . 0.0 107.72 178.054 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 115' ' ' ILE . . . . . 0.444 ' CD1' HH22 ' A' ' 151' ' ' ARG . 2.9 mt -94.38 102.48 13.66 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.63 0 N-CA-C 107.437 -1.32 . . . . 0.0 107.437 179.61 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 116' ' ' SER . . . . . . . . . . . . . 9.0 p -88.87 150.46 22.87 Favored 'General case' 0 C--N 1.303 -1.419 0 CA-C-O 121.997 0.903 . . . . 0.0 111.483 -177.476 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 117' ' ' ILE . . . . . . . . . . . . . 1.4 mt -147.68 145.82 18.6 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.458 0 N-CA-C 107.34 -1.355 . . . . 0.0 107.34 178.762 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 118' ' ' ALA . . . . . . . . . . . . . . . -141.96 159.39 42.32 Favored 'General case' 0 N--CA 1.494 1.726 0 O-C-N 120.789 -1.194 . . . . 0.0 111.348 -178.434 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 119' ' ' GLY . . . . . . . . . . . . . . . -171.02 153.24 20.3 Favored Glycine 0 N--CA 1.487 2.096 0 N-CA-C 110.097 -1.201 . . . . 0.0 110.097 179.873 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 120' ' ' HIS . . . . . . . . . . . . . 12.0 m170 -71.19 167.97 18.25 Favored 'General case' 0 N--CA 1.493 1.713 0 O-C-N 121.724 -0.868 . . . . 0.0 109.944 179.378 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 121' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -117.37 158.3 24.66 Favored 'General case' 0 N--CA 1.496 1.831 0 N-CA-C 108.094 -1.076 . . . . 0.0 108.094 178.76 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 122' ' ' PHE . . . . . . . . . . . . . 3.8 m-85 -141.91 123.21 14.79 Favored 'General case' 0 N--CA 1.497 1.911 0 O-C-N 120.867 -1.145 . . . . 0.0 109.805 -179.39 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 123' ' ' ILE . . . . . 0.483 ' CG2' ' N ' ' A' ' 124' ' ' ASP . 14.0 tt -60.38 -41.41 87.22 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.567 0 CA-C-O 121.6 0.714 . . . . 0.0 109.285 179.622 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 124' ' ' ASP . . . . . 0.483 ' N ' ' CG2' ' A' ' 123' ' ' ILE . 0.3 OUTLIER -87.16 22.23 2.14 Favored 'General case' 0 N--CA 1.495 1.808 0 O-C-N 121.693 -0.629 . . . . 0.0 111.955 -177.13 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 125' ' ' ARG . . . . . . . . . . . . . 46.9 mtp180 -155.29 97.12 2.42 Favored Pre-proline 0 N--CA 1.492 1.673 0 O-C-N 120.546 -1.347 . . . . 0.0 109.757 179.763 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 126' ' ' PRO . . . . . . . . . . . . . 2.9 Cg_endo -73.66 -25.76 14.48 Favored 'Trans proline' 0 C--N 1.314 -1.239 0 C-N-CA 122.113 1.876 . . . . 0.0 111.662 178.634 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 127' ' ' ASN . . . . . 0.473 ' O ' ' O ' ' A' ' 128' ' ' TYR . 0.9 OUTLIER -91.2 5.73 47.92 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.429 -0.794 . . . . 0.0 109.736 -179.843 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 128' ' ' TYR . . . . . 0.504 ' O ' ' OE1' ' A' ' 85' ' ' GLU . 4.5 t80 -59.1 -149.27 0.0 OUTLIER 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.192 -0.943 . . . . 0.0 109.936 -179.751 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 129' ' ' GLN . . . . . 0.487 ' O ' ' OE1' ' A' ' 85' ' ' GLU . 63.4 mt-30 -66.79 -72.08 0.18 Allowed 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.439 -0.788 . . . . 0.0 109.614 -179.686 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 130' ' ' PHE . . . . . 0.504 ' O ' ' CE ' ' A' ' 134' ' ' LYS . 52.6 m-85 -133.78 47.8 2.41 Favored 'General case' 0 N--CA 1.492 1.658 0 O-C-N 121.279 -0.888 . . . . 0.0 110.059 -179.741 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 131' ' ' THR . . . . . . . . . . . . . 23.5 m -81.72 -40.82 22.16 Favored 'General case' 0 N--CA 1.489 1.481 0 O-C-N 121.052 -1.03 . . . . 0.0 109.281 179.783 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 132' ' ' ASN . . . . . 0.624 ' ND2' ' O ' ' A' ' 81' ' ' ALA . 0.2 OUTLIER -83.09 2.7 33.92 Favored 'General case' 0 N--CA 1.495 1.785 0 O-C-N 121.364 -0.835 . . . . 0.0 111.377 -178.283 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 133' ' ' LEU . . . . . 0.563 ' O ' ' N ' ' A' ' 135' ' ' ALA . 0.2 OUTLIER -65.6 -46.07 80.75 Favored 'General case' 0 N--CA 1.493 1.681 0 O-C-N 120.549 -1.344 . . . . 0.0 110.359 -179.568 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 134' ' ' LYS . . . . . 0.505 ' H ' ' CD ' ' A' ' 134' ' ' LYS . 0.0 OUTLIER -42.41 -18.15 0.01 OUTLIER 'General case' 0 N--CA 1.494 1.739 0 O-C-N 121.071 -1.018 . . . . 0.0 110.755 -179.185 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 135' ' ' ALA . . . . . 0.563 ' N ' ' O ' ' A' ' 133' ' ' LEU . . . -83.48 -35.39 24.94 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 120.837 -1.164 . . . . 0.0 110.251 -179.506 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 136' ' ' ALA . . . . . . . . . . . . . . . -79.98 155.76 27.51 Favored 'General case' 0 N--CA 1.489 1.51 0 CA-C-O 122.209 1.004 . . . . 0.0 111.889 -178.479 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 137' ' ' LYS . . . . . 0.505 ' O ' ' O ' ' A' ' 138' ' ' LYS . 0.1 OUTLIER -154.32 -165.91 2.21 Favored 'General case' 0 N--CA 1.493 1.725 0 C-N-CA 118.734 -1.186 . . . . 0.0 110.915 -178.44 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 138' ' ' LYS . . . . . 0.579 ' O ' ' N ' ' A' ' 140' ' ' SER . 17.4 mttp -45.44 179.23 0.0 OUTLIER 'General case' 0 C--N 1.305 -1.365 0 CA-C-O 121.987 0.898 . . . . 0.0 110.509 -179.222 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 139' ' ' GLY . . . . . . . . . . . . . . . 47.0 7.77 0.02 OUTLIER Glycine 0 N--CA 1.491 2.304 0 N-CA-C 110.253 -1.139 . . . . 0.0 110.253 -179.849 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 140' ' ' SER . . . . . 0.579 ' N ' ' O ' ' A' ' 138' ' ' LYS . 40.4 t -89.42 141.3 28.68 Favored 'General case' 0 N--CA 1.493 1.699 0 O-C-N 120.858 -1.378 . . . . 0.0 109.591 179.239 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 141' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -90.88 127.73 36.49 Favored 'General case' 0 C--N 1.301 -1.539 0 O-C-N 121.413 -0.805 . . . . 0.0 109.487 179.732 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 142' ' ' VAL . . . . . . . . . . . . . 3.2 t -114.48 133.6 60.07 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.674 0 O-C-N 121.364 -0.835 . . . . 0.0 108.814 179.928 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 143' ' ' TYR . . . . . 0.413 ' CE1' ' CG ' ' A' ' 152' ' ' LYS . 8.5 m-85 -107.9 135.39 49.36 Favored 'General case' 0 N--CA 1.496 1.851 0 O-C-N 121.177 -0.952 . . . . 0.0 111.521 -178.603 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 144' ' ' PHE . . . . . . . . . . . . . 66.8 t80 -115.36 157.21 24.2 Favored 'General case' 0 N--CA 1.493 1.698 0 CA-C-O 121.807 0.813 . . . . 0.0 110.82 -179.185 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 145' ' ' LYS . . . . . . . . . . . . . 55.0 tttt -152.42 130.59 11.94 Favored 'General case' 0 N--CA 1.492 1.642 0 C-N-CA 118.887 -1.125 . . . . 0.0 111.962 -179.309 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 146' ' ' VAL . . . . . . . . . . . . . 1.9 p -145.04 139.95 22.71 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.485 0 N-CA-C 106.24 -1.763 . . . . 0.0 106.24 177.431 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 147' ' ' GLY . . . . . . . . . . . . . . . 53.88 -134.67 43.61 Favored Glycine 0 N--CA 1.488 2.157 0 N-CA-C 108.726 -1.749 . . . . 0.0 108.726 -179.079 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 148' ' ' ASN . . . . . 0.572 ' C ' HD21 ' A' ' 148' ' ' ASN . 0.4 OUTLIER -103.17 22.67 13.65 Favored 'General case' 0 C--N 1.302 -1.496 0 O-C-N 121.234 -1.156 . . . . 0.0 108.71 179.354 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 149' ' ' GLU . . . . . . . . . . . . . 18.4 tt0 -112.44 152.79 28.29 Favored 'General case' 0 N--CA 1.486 1.362 0 CA-C-O 121.752 0.786 . . . . 0.0 111.095 -179.023 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 150' ' ' THR . . . . . . . . . . . . . 1.3 m -141.78 105.13 4.65 Favored 'General case' 0 N--CA 1.493 1.698 0 CA-C-O 121.666 0.746 . . . . 0.0 109.436 179.996 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 151' ' ' ARG . . . . . 0.444 HH22 ' CD1' ' A' ' 115' ' ' ILE . 2.9 mpp_? -88.69 -161.55 0.76 Allowed 'General case' 0 N--CA 1.488 1.453 0 O-C-N 121.659 -0.651 . . . . 0.0 109.706 -179.149 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 152' ' ' LYS . . . . . 0.429 ' O ' ' N ' ' A' ' 205' ' ' VAL . 15.0 mtmm -149.73 146.06 27.01 Favored 'General case' 0 C--N 1.304 -1.381 0 O-C-N 121.211 -0.93 . . . . 0.0 110.139 -178.814 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 153' ' ' TYR . . . . . 0.494 ' CD2' ' HA ' ' A' ' 204' ' ' GLU . 15.0 m-85 -141.06 166.88 23.57 Favored 'General case' 0 N--CA 1.49 1.559 0 N-CA-C 107.922 -1.14 . . . . 0.0 107.922 179.193 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 154' ' ' LYS . . . . . . . . . . . . . 12.7 ttmt -142.8 120.43 11.8 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.236 -0.915 . . . . 0.0 108.576 178.865 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 155' ' ' MET . . . . . . . . . . . . . 44.4 mmm -47.83 107.26 0.11 Allowed 'General case' 0 N--CA 1.493 1.688 0 O-C-N 120.611 -1.306 . . . . 0.0 111.315 -178.626 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 156' ' ' THR . . . . . 0.492 ' OG1' ' OG1' ' A' ' 203' ' ' THR . 0.2 OUTLIER -105.18 -24.44 12.74 Favored 'General case' 0 C--N 1.294 -1.843 0 CA-C-N 115.259 -0.882 . . . . 0.0 110.836 -178.655 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 157' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -146.8 150.5 35.43 Favored 'General case' 0 C--N 1.296 -1.757 0 C-N-CA 118.51 -1.276 . . . . 0.0 110.367 -178.784 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 158' ' ' ILE . . . . . . . . . . . . . 1.9 mt -147.35 137.59 17.13 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.382 0 CA-C-O 121.324 0.583 . . . . 0.0 109.537 -178.459 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 159' ' ' ARG . . . . . 0.488 ' O ' ' OD1' ' A' ' 160' ' ' ASP . 44.7 mtp180 -155.59 -167.71 2.59 Favored 'General case' 0 N--CA 1.492 1.647 0 CA-C-O 121.907 0.86 . . . . 0.0 110.956 -178.799 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 160' ' ' ASP . . . . . 0.488 ' OD1' ' O ' ' A' ' 159' ' ' ARG . 63.8 m-20 -146.71 153.04 39.8 Favored 'General case' 0 N--CA 1.489 1.48 0 N-CA-C 108.183 -1.043 . . . . 0.0 108.183 179.512 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 161' ' ' VAL . . . . . 0.425 ' O ' ' O ' ' A' ' 162' ' ' LYS . 0.1 OUTLIER -143.11 146.54 21.48 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.627 0 O-C-N 120.899 -1.125 . . . . 0.0 109.884 179.939 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 162' ' ' LYS . . . . . 0.617 ' H ' ' CD ' ' A' ' 162' ' ' LYS . 0.0 OUTLIER -45.44 167.13 0.12 Allowed Pre-proline 0 N--CA 1.49 1.526 0 O-C-N 121.285 -0.884 . . . . 0.0 109.391 -179.787 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 163' ' ' PRO . . . . . . . . . . . . . 57.9 Cg_endo -76.54 30.4 0.4 Allowed 'Trans proline' 0 C--N 1.308 -1.574 0 C-N-CA 122.838 2.359 . . . . 0.0 113.387 -179.488 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 164' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -152.29 -0.58 0.3 Allowed 'General case' 0 N--CA 1.495 1.817 0 O-C-N 120.921 -1.112 . . . . 0.0 110.306 179.612 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 165' ' ' ASP . . . . . 0.414 ' O ' ' C ' ' A' ' 166' ' ' VAL . 7.4 t70 -76.85 64.4 2.38 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.12 -0.987 . . . . 0.0 110.16 -179.866 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 166' ' ' VAL . . . . . 0.616 ' O ' ' N ' ' A' ' 168' ' ' VAL . 1.3 m -47.1 -31.4 1.79 Allowed 'Isoleucine or valine' 0 N--CA 1.487 1.405 0 O-C-N 120.642 -1.286 . . . . 0.0 108.941 -178.837 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 167' ' ' GLY . . . . . . . . . . . . . . . -46.86 -9.49 0.03 OUTLIER Glycine 0 N--CA 1.495 2.571 0 N-CA-C 109.458 -1.457 . . . . 0.0 109.458 179.35 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 168' ' ' VAL . . . . . 0.616 ' N ' ' O ' ' A' ' 166' ' ' VAL . 9.8 p -49.43 -31.54 5.58 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.481 0 N-CA-C 107.775 -1.194 . . . . 0.0 107.775 179.22 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 169' ' ' LEU . . . . . 0.509 ' O ' ' C ' ' A' ' 170' ' ' ASP . 1.7 mm? -45.21 -19.38 0.04 OUTLIER 'General case' 0 C--N 1.293 -1.852 0 N-CA-C 107.694 -1.225 . . . . 0.0 107.694 -178.25 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 170' ' ' ASP . . . . . 0.531 ' N ' ' O ' ' A' ' 168' ' ' VAL . 8.3 t0 27.88 91.38 0.01 OUTLIER 'General case' 0 N--CA 1.501 2.121 0 CA-C-N 116.459 -0.337 . . . . 0.0 111.399 177.268 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 171' ' ' GLU . . . . . 0.433 ' CB ' ' OD1' ' A' ' 114' ' ' ASN . 17.1 pt-20 -130.85 67.27 1.51 Allowed 'General case' 0 N--CA 1.499 1.984 0 O-C-N 121.016 -1.053 . . . . 0.0 110.435 -179.989 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 172' ' ' GLN . . . . . . . . . . . . . 2.1 mt-30 -127.96 -52.6 1.32 Allowed 'General case' 0 N--CA 1.498 1.942 0 O-C-N 121.26 -0.9 . . . . 0.0 110.745 -178.979 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 173' ' ' LYS . . . . . . . . . . . . . 15.4 mttt -58.82 124.93 21.46 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 120.886 -1.134 . . . . 0.0 108.453 179.9 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 174' ' ' GLY . . . . . 0.538 ' O ' ' C ' ' A' ' 175' ' ' LYS . . . -124.74 -43.63 0.3 Allowed Glycine 0 N--CA 1.48 1.602 0 N-CA-C 108.337 -1.905 . . . . 0.0 108.337 -179.838 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 175' ' ' LYS . . . . . 0.538 ' C ' ' O ' ' A' ' 174' ' ' GLY . 2.2 mptm? -37.9 -61.85 0.61 Allowed 'General case' 0 N--CA 1.492 1.655 0 N-CA-C 107.243 -1.392 . . . . 0.0 107.243 179.308 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 176' ' ' ASP . . . . . 0.624 ' O ' ' O ' ' A' ' 177' ' ' LYS . 8.7 m-20 -104.32 85.9 2.44 Favored 'General case' 0 C--N 1.295 -1.787 0 N-CA-C 106.7 -1.592 . . . . 0.0 106.7 176.512 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 177' ' ' LYS . . . . . 0.624 ' O ' ' O ' ' A' ' 176' ' ' ASP . 12.5 mttt -40.97 179.8 0.0 OUTLIER 'General case' 0 N--CA 1.496 1.85 0 O-C-N 121.489 -0.757 . . . . 0.0 110.235 -178.726 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 178' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -161.21 170.08 20.97 Favored 'General case' 0 N--CA 1.487 1.398 0 O-C-N 120.339 -1.476 . . . . 0.0 111.138 179.911 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 179' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -123.49 99.09 6.14 Favored 'General case' 0 C--N 1.304 -1.389 0 N-CA-C 107.406 -1.331 . . . . 0.0 107.406 178.297 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 180' ' ' THR . . . . . . . . . . . . . 1.1 m -70.56 114.08 8.31 Favored 'General case' 0 N--CA 1.487 1.418 0 O-C-N 121.18 -0.95 . . . . 0.0 109.857 -178.774 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 181' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -88.9 142.58 27.53 Favored 'General case' 0 C--N 1.303 -1.456 0 N-CA-C 107.339 -1.356 . . . . 0.0 107.339 177.677 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 182' ' ' ILE . . . . . . . . . . . . . 81.6 mt -137.87 115.72 12.96 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.76 0 N-CA-C 107.824 -1.176 . . . . 0.0 107.824 179.259 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 183' ' ' THR . . . . . . . . . . . . . 3.7 t -139.54 113.49 8.73 Favored 'General case' 0 C--N 1.289 -2.063 0 N-CA-C 108.155 -1.054 . . . . 0.0 108.155 -179.623 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 184' ' ' CYS . . . . . . . . . . . . . 0.8 OUTLIER -78.84 159.75 27.67 Favored 'General case' 0 C--N 1.291 -1.938 0 C-N-CA 119.101 -1.04 . . . . 0.0 111.095 -178.078 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 185' ' ' ASP . . . . . . . . . . . . . 1.2 t70 -165.93 -155.81 0.24 Allowed 'General case' 0 N--CA 1.493 1.683 0 N-CA-C 109.046 -0.724 . . . . 0.0 109.046 -179.613 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 186' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER 54.2 55.22 8.47 Favored 'General case' 0 N--CA 1.496 1.826 0 O-C-N 121.047 -1.033 . . . . 0.0 109.335 179.898 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 187' ' ' TYR . . . . . 0.611 ' CE2' ' O ' ' A' ' 188' ' ' ASN . 71.2 t80 -67.61 132.2 47.07 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 120.975 -1.078 . . . . 0.0 111.402 -179.151 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 188' ' ' ASN . . . . . 0.816 HD22 ' H ' ' A' ' 192' ' ' GLY . 0.0 OUTLIER -100.54 149.36 23.8 Favored 'General case' 0 C--N 1.296 -1.736 0 N-CA-C 107.292 -1.373 . . . . 0.0 107.292 177.364 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 189' ' ' GLU . . . . . . . . . . . . . 1.8 tt0 -111.65 -10.56 14.09 Favored 'General case' 0 C--N 1.293 -1.871 0 N-CA-C 108.833 -0.802 . . . . 0.0 108.833 -179.122 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 190' ' ' LYS . . . . . . . . . . . . . 13.9 mttm -85.88 -50.89 6.76 Favored 'General case' 0 C--N 1.301 -1.5 0 CA-C-O 121.583 0.706 . . . . 0.0 109.447 179.537 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 191' ' ' THR . . . . . 0.671 ' N ' HD22 ' A' ' 188' ' ' ASN . 72.6 p -89.15 -1.09 57.94 Favored 'General case' 0 N--CA 1.493 1.713 0 O-C-N 121.584 -0.698 . . . . 0.0 110.781 -178.879 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 192' ' ' GLY . . . . . 0.816 ' H ' HD22 ' A' ' 188' ' ' ASN . . . 56.38 36.08 68.39 Favored Glycine 0 N--CA 1.492 2.388 0 O-C-N 120.865 -1.147 . . . . 0.0 110.327 179.622 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 193' ' ' VAL . . . . . 0.491 ' H ' HD21 ' A' ' 188' ' ' ASN . 3.1 m -148.63 163.77 5.04 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.738 0 O-C-N 120.885 -1.362 . . . . 0.0 109.449 179.519 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 194' ' ' TRP . . . . . 0.495 ' N ' ' CD1' ' A' ' 194' ' ' TRP . 24.2 m95 -84.46 121.16 27.18 Favored 'General case' 0 C--N 1.303 -1.42 0 N-CA-C 107.97 -1.122 . . . . 0.0 107.97 178.845 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 195' ' ' GLU . . . . . . . . . . . . . 1.7 mt-10 -76.7 -61.27 2.02 Favored 'General case' 0 N--CA 1.496 1.832 0 O-C-N 121.225 -0.922 . . . . 0.0 112.905 -176.831 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 196' ' ' LYS . . . . . . . . . . . . . 2.0 tptm -93.02 159.49 15.28 Favored 'General case' 0 N--CA 1.495 1.809 0 O-C-N 120.762 -1.211 . . . . 0.0 111.51 -177.201 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 197' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -121.75 135.83 54.94 Favored 'General case' 0 N--CA 1.493 1.676 0 N-CA-C 109.179 -0.675 . . . . 0.0 109.179 179.577 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 198' ' ' LYS . . . . . . . . . . . . . 49.3 mttt -117.4 120.38 37.97 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.495 -0.753 . . . . 0.0 110.104 -179.243 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 199' ' ' ILE . . . . . 0.471 ' O ' HG13 ' A' ' 199' ' ' ILE . 1.0 OUTLIER -137.8 122.26 22.97 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.677 0 CA-C-O 122.667 1.222 . . . . 0.0 110.623 179.554 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 200' ' ' PHE . . . . . 0.471 ' CD1' ' N ' ' A' ' 200' ' ' PHE . 1.6 m-85 -103.5 138.83 39.66 Favored 'General case' 0 C--N 1.297 -1.689 0 O-C-N 120.91 -1.119 . . . . 0.0 110.334 -178.22 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 201' ' ' VAL . . . . . . . . . . . . . 59.7 t -102.36 147.04 9.48 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.494 0 N-CA-C 107.678 -1.23 . . . . 0.0 107.678 177.615 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 202' ' ' ALA . . . . . . . . . . . . . . . -130.53 138.63 50.3 Favored 'General case' 0 C--N 1.3 -1.567 0 O-C-N 121.138 -0.976 . . . . 0.0 108.388 -179.874 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 203' ' ' THR . . . . . 0.492 ' OG1' ' OG1' ' A' ' 156' ' ' THR . 6.5 p -89.0 127.78 35.68 Favored 'General case' 0 C--N 1.305 -1.365 0 CA-C-O 122.226 1.012 . . . . 0.0 111.41 -178.167 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 204' ' ' GLU . . . . . 0.494 ' HA ' ' CD2' ' A' ' 153' ' ' TYR . 1.1 tm-20 -50.37 134.9 22.79 Favored 'General case' 0 C--N 1.299 -1.595 0 C-N-CA 118.957 -1.097 . . . . 0.0 108.607 178.766 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 205' ' ' VAL . . . . . 0.486 ' CG1' ' N ' ' A' ' 206' ' ' LYS . 69.8 t -130.54 163.96 34.82 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.338 0 CA-C-O 122.116 0.96 . . . . 0.0 110.606 -177.333 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 206' ' ' LYS . . . . . 0.486 ' N ' ' CG1' ' A' ' 205' ' ' VAL . 0.1 OUTLIER . . . . . 0 C--N 1.299 -1.627 0 CA-C-O 118.032 -0.985 . . . . 0.0 109.366 179.876 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' C' C ' 702' ' ' LEU . . . . . 0.68 ' CD1' ' N ' ' C' ' 702' ' ' LEU . 0.0 OUTLIER . . . . . 0 N--CA 1.501 2.08 0 N-CA-C 109.991 -0.374 . . . . 0.0 109.991 . . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' C' C ' 703' ' ' PRO . . . . . 0.498 ' O ' ' O ' ' C' ' 704' ' ' ALA . 27.7 Cg_exo -55.6 -166.77 0.02 OUTLIER 'Trans proline' 0 N--CA 1.493 1.498 0 C-N-CA 122.195 1.93 . . . . 0.0 112.606 -179.463 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' C' C ' 704' ' ' ALA . . . . . 0.498 ' O ' ' O ' ' C' ' 703' ' ' PRO . . . . . . . . 0 N--CA 1.49 1.563 0 O-C-N 121.493 -0.754 . . . . 0.0 109.207 -179.817 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 63' ' ' PRO . . . . . . . . . . . . . 9.8 Cg_exo . . . . . 0 N--CA 1.491 1.37 0 CA-C-O 121.349 0.479 . . . . 0.0 111.65 . . . . . . . . . 0 0 . 1 . 016 nuclear orig core ' A' A ' 64' ' ' GLN . . . . . 0.677 ' NE2' ' N ' ' A' ' 64' ' ' GLN . 0.0 OUTLIER -156.41 117.75 3.83 Favored 'General case' 0 N--CA 1.494 1.739 0 O-C-N 121.276 -0.89 . . . . 0.0 109.071 179.816 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 65' ' ' ILE . . . . . 0.462 ' C ' ' O ' ' A' ' 64' ' ' GLN . 0.0 OUTLIER -42.72 103.97 0.34 Allowed Pre-proline 0 N--CA 1.497 1.923 0 O-C-N 121.119 -0.988 . . . . 0.0 108.743 179.626 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 66' ' ' PRO . . . . . . . . . . . . . 61.3 Cg_endo -90.15 -154.86 0.05 OUTLIER 'Trans proline' 0 C--N 1.313 -1.339 0 C-N-CA 122.194 1.929 . . . . 0.0 112.043 -179.742 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 67' ' ' LYS . . . . . 0.442 ' C ' ' H ' ' A' ' 69' ' ' LYS . 22.0 tttt -85.32 -4.76 59.26 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.119 -0.988 . . . . 0.0 108.771 179.597 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 68' ' ' ASP . . . . . 0.616 ' C ' ' N ' ' A' ' 70' ' ' SER . 1.1 t0 -75.03 49.58 0.44 Allowed 'General case' 0 N--CA 1.488 1.452 0 CA-C-O 122.533 1.159 . . . . 0.0 108.997 179.87 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 69' ' ' LYS . . . . . 0.467 ' CB ' ' HZ2' ' A' ' 69' ' ' LYS . 4.1 mtmp? -48.7 -14.77 0.07 Allowed 'General case' 0 N--CA 1.503 2.211 0 C-N-CA 117.218 -1.793 . . . . 0.0 106.664 177.99 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 70' ' ' SER . . . . . 0.616 ' N ' ' C ' ' A' ' 68' ' ' ASP . 0.0 OUTLIER -86.15 -4.46 59.17 Favored 'General case' 0 N--CA 1.494 1.766 0 CA-C-N 113.702 -1.59 . . . . 0.0 110.916 179.714 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 71' ' ' LYS . . . . . . . . . . . . . 5.4 ptmt -99.54 140.5 33.63 Favored 'General case' 0 N--CA 1.493 1.72 0 O-C-N 120.896 -1.127 . . . . 0.0 110.957 179.698 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 72' ' ' VAL . . . . . 0.6 ' CG2' ' O ' ' A' ' 74' ' ' GLY . 0.6 OUTLIER -64.82 136.57 26.42 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.476 0 N-CA-C 104.883 -2.265 . . . . 0.0 104.883 174.725 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 73' ' ' ALA . . . . . 0.486 ' N ' ' O ' ' A' ' 87' ' ' VAL . . . -84.68 -14.72 47.62 Favored 'General case' 0 C--N 1.296 -1.745 0 O-C-N 120.211 -1.556 . . . . 0.0 108.386 -179.163 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 74' ' ' GLY . . . . . 0.6 ' O ' ' CG2' ' A' ' 72' ' ' VAL . . . 172.7 -158.51 28.65 Favored Glycine 0 N--CA 1.485 1.93 0 N-CA-C 109.432 -1.467 . . . . 0.0 109.432 -179.692 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 75' ' ' TYR . . . . . 0.59 ' CD2' ' O ' ' A' ' 85' ' ' GLU . 2.0 m-85 -142.81 170.32 15.92 Favored 'General case' 0 C--N 1.299 -1.63 0 O-C-N 121.013 -1.286 . . . . 0.0 111.544 -177.16 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 76' ' ' ILE . . . . . . . . . . . . . 3.0 tp -146.92 143.94 20.16 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.453 0 C-N-CA 119.906 -0.718 . . . . 0.0 109.734 -177.528 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -151.29 159.99 44.04 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 120.999 -1.063 . . . . 0.0 109.129 179.572 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 78' ' ' ILE . . . . . . . . . . . . . 19.0 mt -146.83 103.27 3.89 Favored Pre-proline 0 N--CA 1.491 1.604 0 O-C-N 121.296 -0.877 . . . . 0.0 109.067 -179.703 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 79' ' ' PRO . . . . . . . . . . . . . 46.6 Cg_exo -51.16 -44.02 45.11 Favored 'Trans proline' 0 N--CA 1.494 1.538 0 C-N-CA 122.566 2.177 . . . . 0.0 113.949 -179.149 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 1.1 m-20 -67.28 -22.71 65.64 Favored 'General case' 0 N--CA 1.493 1.676 0 O-C-N 120.69 -1.256 . . . . 0.0 110.991 178.975 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -104.03 -10.85 17.75 Favored 'General case' 0 N--CA 1.493 1.716 0 O-C-N 121.135 -0.978 . . . . 0.0 109.106 179.588 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 82' ' ' ASP . . . . . . . . . . . . . 1.1 t70 59.05 50.24 8.46 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.336 -0.853 . . . . 0.0 110.439 179.322 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 83' ' ' ILE . . . . . . . . . . . . . 70.3 mt -125.97 152.61 33.32 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.854 0 O-C-N 121.298 -0.876 . . . . 0.0 110.285 -179.061 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 84' ' ' LYS . . . . . 0.408 ' C ' ' CD ' ' A' ' 85' ' ' GLU . 0.2 OUTLIER -160.69 105.07 1.4 Allowed 'General case' 0 N--CA 1.492 1.667 0 O-C-N 121.166 -0.959 . . . . 0.0 108.762 179.469 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 85' ' ' GLU . . . . . 0.59 ' O ' ' CD2' ' A' ' 75' ' ' TYR . 1.2 mm-40 -139.72 179.2 1.34 Allowed Pre-proline 0 N--CA 1.499 1.979 0 O-C-N 121.13 -0.981 . . . . 0.0 109.674 -179.373 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 86' ' ' PRO . . . . . 0.47 ' CD ' ' CB ' ' A' ' 85' ' ' GLU . 35.5 Cg_endo -86.15 167.33 9.38 Favored 'Trans proline' 0 C--N 1.314 -1.24 0 C-N-CA 122.707 2.272 . . . . 0.0 113.34 -178.691 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 87' ' ' VAL . . . . . 0.486 ' O ' ' N ' ' A' ' 73' ' ' ALA . 57.5 t -124.43 104.76 14.3 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.469 0 N-CA-C 108.042 -1.096 . . . . 0.0 108.042 178.901 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 88' ' ' TYR . . . . . . . . . . . . . 29.5 m-85 -97.83 154.73 37.72 Favored Pre-proline 0 N--CA 1.496 1.831 0 O-C-N 121.047 -1.033 . . . . 0.0 110.202 -178.731 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 89' ' ' PRO . . . . . . . . . . . . . 8.9 Cg_endo -56.33 144.32 82.93 Favored 'Trans proline' 0 N--CA 1.496 1.62 0 C-N-CA 122.961 2.44 . . . . 0.0 113.949 -179.972 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . -59.87 170.25 6.71 Favored Glycine 0 N--CA 1.489 2.208 0 N-CA-C 109.01 -1.636 . . . . 0.0 109.01 178.553 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 91' ' ' PRO . . . . . 0.465 ' C ' ' H ' ' A' ' 93' ' ' THR . 54.6 Cg_endo -93.94 167.4 20.28 Favored 'Cis proline' 0 C--N 1.307 -1.645 0 C-N-CA 124.016 -1.243 . . . . 0.0 111.275 -0.04 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 92' ' ' ALA . . . . . 0.511 ' O ' ' CD1' ' A' ' 97' ' ' LEU . . . -72.11 32.61 0.06 Allowed 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.125 -0.985 . . . . 0.0 110.532 -179.612 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 93' ' ' THR . . . . . 0.465 ' H ' ' C ' ' A' ' 91' ' ' PRO . 2.0 p -73.3 149.78 89.26 Favored Pre-proline 0 N--CA 1.489 1.52 0 O-C-N 120.566 -1.333 . . . . 0.0 108.653 -179.817 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 94' ' ' PRO . . . . . . . . . . . . . 91.8 Cg_exo -30.53 -50.43 0.22 Allowed 'Trans proline' 0 C--N 1.31 -1.454 0 C-N-CA 123.372 2.715 . . . . 0.0 112.944 -179.125 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 95' ' ' GLU . . . . . 0.434 ' O ' ' NH2' ' A' ' 99' ' ' ARG . 10.6 mt-10 -53.8 -47.65 70.62 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.201 -0.937 . . . . 0.0 109.702 -179.973 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 96' ' ' GLN . . . . . 0.488 ' C ' ' H ' ' A' ' 98' ' ' ASN . 3.3 mp0 -72.08 -49.21 38.3 Favored 'General case' 0 C--N 1.302 -1.478 0 O-C-N 121.263 -0.898 . . . . 0.0 110.416 -179.453 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 97' ' ' LEU . . . . . 0.511 ' CD1' ' O ' ' A' ' 92' ' ' ALA . 96.2 mt -52.8 -8.25 0.09 Allowed 'General case' 0 N--CA 1.493 1.695 0 O-C-N 121.055 -1.028 . . . . 0.0 110.06 -178.936 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 98' ' ' ASN . . . . . 0.628 ' ND2' ' CZ ' ' A' ' 99' ' ' ARG . 0.0 OUTLIER -75.68 -37.73 59.3 Favored 'General case' 0 N--CA 1.488 1.432 0 N-CA-C 107.91 -1.145 . . . . 0.0 107.91 178.269 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 99' ' ' ARG . . . . . 0.628 ' CZ ' ' ND2' ' A' ' 98' ' ' ASN . 1.0 OUTLIER -72.41 -51.28 21.06 Favored 'General case' 0 C--N 1.304 -1.378 0 CA-C-N 115.893 -0.594 . . . . 0.0 109.646 179.677 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . 169.6 -158.43 30.7 Favored Glycine 0 N--CA 1.497 2.762 0 N-CA-C 109.565 -1.414 . . . . 0.0 109.565 -179.834 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 101' ' ' VAL . . . . . 0.526 ' O ' ' CG2' ' A' ' 101' ' ' VAL . 16.2 m -66.2 104.26 0.57 Allowed 'Isoleucine or valine' 0 N--CA 1.496 1.848 0 O-C-N 120.924 -1.339 . . . . 0.0 108.987 179.697 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 102' ' ' SER . . . . . 0.603 ' HG ' ' N ' ' A' ' 103' ' ' PHE . 0.0 OUTLIER -92.4 167.71 11.79 Favored 'General case' 0 N--CA 1.495 1.813 0 O-C-N 121.218 -0.926 . . . . 0.0 111.6 -178.719 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 103' ' ' PHE . . . . . 0.603 ' N ' ' HG ' ' A' ' 102' ' ' SER . 24.3 m-85 -70.97 143.88 50.69 Favored 'General case' 0 N--CA 1.489 1.505 0 N-CA-C 107.876 -1.157 . . . . 0.0 107.876 178.238 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 104' ' ' ALA . . . . . . . . . . . . . . . -61.94 -13.47 25.43 Favored 'General case' 0 C--N 1.297 -1.68 0 O-C-N 121.179 -0.951 . . . . 0.0 111.376 -178.71 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -138.29 143.27 39.92 Favored 'General case' 0 N--CA 1.498 1.964 0 O-C-N 120.618 -1.301 . . . . 0.0 110.998 -179.49 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 106' ' ' GLU . . . . . 0.446 ' CG ' ' H ' ' A' ' 107' ' ' ASN . 6.1 pt-20 -57.09 -58.92 6.06 Favored 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.935 -0.478 . . . . 0.0 111.134 -179.432 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 107' ' ' ASN . . . . . 0.446 ' H ' ' CG ' ' A' ' 106' ' ' GLU . 1.1 m-80 -77.99 35.22 0.2 Allowed 'General case' 0 N--CA 1.489 1.478 0 O-C-N 120.361 -1.462 . . . . 0.0 112.107 -176.24 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 108' ' ' GLU . . . . . . . . . . . . . 40.6 tp10 -59.28 145.46 43.02 Favored 'General case' 0 C--N 1.304 -1.374 0 O-C-N 120.742 -1.224 . . . . 0.0 107.834 -179.96 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 109' ' ' SER . . . . . 0.444 ' OG ' ' OD2' ' A' ' 112' ' ' ASP . 0.7 OUTLIER -96.86 144.22 27.01 Favored 'General case' 0 C--N 1.301 -1.542 0 O-C-N 121.119 -0.988 . . . . 0.0 110.67 -178.324 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 110' ' ' LEU . . . . . . . . . . . . . 5.6 tp -60.9 -21.52 63.43 Favored 'General case' 0 C--N 1.302 -1.465 0 N-CA-C 107.971 -1.122 . . . . 0.0 107.971 179.165 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 111' ' ' ASP . . . . . . . . . . . . . 82.5 m-20 -132.19 43.77 2.98 Favored 'General case' 0 C--N 1.302 -1.482 0 C-N-CA 120.269 -0.572 . . . . 0.0 109.861 -179.616 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 112' ' ' ASP . . . . . 0.444 ' OD2' ' OG ' ' A' ' 109' ' ' SER . 0.6 OUTLIER -67.09 148.79 51.42 Favored 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.153 -0.967 . . . . 0.0 110.059 179.63 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 113' ' ' GLN . . . . . 0.424 ' HA ' ' NE2' ' A' ' 113' ' ' GLN . 1.0 OUTLIER -68.12 -12.4 60.83 Favored 'General case' 0 C--N 1.302 -1.482 0 O-C-N 121.256 -0.902 . . . . 0.0 109.199 179.029 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 114' ' ' ASN . . . . . 0.674 ' ND2' ' NE2' ' A' ' 178' ' ' GLN . 8.0 t-20 -149.97 101.79 3.06 Favored 'General case' 0 C--N 1.301 -1.517 0 N-CA-C 107.167 -1.42 . . . . 0.0 107.167 177.378 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 115' ' ' ILE . . . . . . . . . . . . . 4.0 mt -97.83 110.55 25.74 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.45 0 O-C-N 121.047 -1.033 . . . . 0.0 108.848 -179.253 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 116' ' ' SER . . . . . . . . . . . . . 28.9 m -98.93 138.26 36.31 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.154 -0.966 . . . . 0.0 111.122 -178.485 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 117' ' ' ILE . . . . . 0.426 HG22 ' N ' ' A' ' 118' ' ' ALA . 14.4 mt -123.42 151.52 28.01 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.424 0 N-CA-C 107.229 -1.397 . . . . 0.0 107.229 178.83 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 118' ' ' ALA . . . . . 0.426 ' N ' HG22 ' A' ' 117' ' ' ILE . . . -140.93 154.67 46.2 Favored 'General case' 0 N--CA 1.487 1.409 0 O-C-N 120.95 -1.094 . . . . 0.0 110.609 -179.171 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 119' ' ' GLY . . . . . . . . . . . . . . . -166.57 151.73 20.14 Favored Glycine 0 N--CA 1.484 1.849 0 N-CA-C 110.201 -1.16 . . . . 0.0 110.201 179.984 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 120' ' ' HIS . . . . . . . . . . . . . 10.9 m170 -71.71 165.51 23.87 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.918 -0.754 . . . . 0.0 110.465 179.642 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 121' ' ' THR . . . . . 0.523 ' OG1' ' NZ ' ' A' ' 134' ' ' LYS . 0.7 OUTLIER -121.03 148.32 44.3 Favored 'General case' 0 N--CA 1.495 1.823 0 N-CA-C 107.75 -1.204 . . . . 0.0 107.75 178.293 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 122' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -107.41 138.33 43.81 Favored 'General case' 0 N--CA 1.495 1.782 0 O-C-N 120.882 -1.136 . . . . 0.0 110.192 -179.663 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 123' ' ' ILE . . . . . 0.441 ' CG2' ' N ' ' A' ' 124' ' ' ASP . 15.0 tt -90.26 -36.54 8.5 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.771 0 N-CA-C 108.152 -1.055 . . . . 0.0 108.152 178.277 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 124' ' ' ASP . . . . . 0.441 ' N ' ' CG2' ' A' ' 123' ' ' ILE . 18.3 t0 -96.6 17.18 16.9 Favored 'General case' 0 N--CA 1.496 1.843 0 CA-C-N 115.777 -0.647 . . . . 0.0 111.13 -179.638 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 125' ' ' ARG . . . . . . . . . . . . . 7.7 ttt180 -156.72 107.35 1.97 Allowed Pre-proline 0 N--CA 1.499 1.993 0 O-C-N 120.516 -1.365 . . . . 0.0 110.152 -178.856 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 126' ' ' PRO . . . . . . . . . . . . . 66.0 Cg_endo -81.04 -17.02 9.6 Favored 'Trans proline' 0 C--N 1.314 -1.247 0 C-N-CA 121.886 1.724 . . . . 0.0 112.703 179.885 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 127' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -90.95 31.24 1.1 Allowed 'General case' 0 N--CA 1.494 1.742 0 O-C-N 121.152 -0.968 . . . . 0.0 109.946 -179.933 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 128' ' ' TYR . . . . . . . . . . . . . 8.8 t80 -89.41 -153.16 0.26 Allowed 'General case' 0 N--CA 1.492 1.668 0 O-C-N 120.956 -1.09 . . . . 0.0 110.675 -179.193 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 129' ' ' GLN . . . . . . . . . . . . . 39.8 mt-30 -66.77 -72.71 0.15 Allowed 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.32 -0.863 . . . . 0.0 110.919 -178.308 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 130' ' ' PHE . . . . . 0.438 ' CE2' ' CG1' ' A' ' 101' ' ' VAL . 49.2 m-85 -121.6 28.98 7.4 Favored 'General case' 0 N--CA 1.497 1.876 0 O-C-N 121.289 -0.882 . . . . 0.0 110.126 -179.447 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 131' ' ' THR . . . . . . . . . . . . . 99.0 m -72.55 -30.92 64.86 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 120.781 -1.199 . . . . 0.0 109.146 179.933 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 132' ' ' ASN . . . . . . . . . . . . . 4.6 t30 -85.0 7.99 19.39 Favored 'General case' 0 N--CA 1.496 1.86 0 C-N-CA 119.513 -0.875 . . . . 0.0 109.923 -179.869 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 133' ' ' LEU . . . . . 0.583 ' O ' ' N ' ' A' ' 135' ' ' ALA . 0.2 OUTLIER -70.81 -49.64 44.2 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.353 -0.842 . . . . 0.0 109.827 179.897 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 134' ' ' LYS . . . . . 0.523 ' NZ ' ' OG1' ' A' ' 121' ' ' THR . 0.0 OUTLIER -44.39 -16.14 0.02 OUTLIER 'General case' 0 N--CA 1.495 1.804 0 O-C-N 120.995 -1.066 . . . . 0.0 109.386 -179.311 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 135' ' ' ALA . . . . . 0.583 ' N ' ' O ' ' A' ' 133' ' ' LEU . . . -83.15 -35.87 25.2 Favored 'General case' 0 N--CA 1.494 1.773 0 O-C-N 121.264 -0.898 . . . . 0.0 109.824 179.78 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 136' ' ' ALA . . . . . 0.431 ' N ' ' O ' ' A' ' 133' ' ' LEU . . . -80.43 158.71 25.87 Favored 'General case' 0 N--CA 1.491 1.621 0 CA-C-O 121.778 0.799 . . . . 0.0 111.446 -178.735 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 137' ' ' LYS . . . . . 0.55 ' O ' ' O ' ' A' ' 138' ' ' LYS . 17.1 mtmt -149.64 -168.08 3.01 Favored 'General case' 0 N--CA 1.493 1.7 0 C-N-CA 118.935 -1.106 . . . . 0.0 110.619 -177.888 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 138' ' ' LYS . . . . . 0.581 ' O ' ' N ' ' A' ' 140' ' ' SER . 21.7 mtmm -40.48 176.06 0.0 OUTLIER 'General case' 0 C--N 1.304 -1.407 0 CA-C-O 122.608 1.194 . . . . 0.0 111.502 -178.618 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 139' ' ' GLY . . . . . . . . . . . . . . . 47.83 7.81 0.04 OUTLIER Glycine 0 N--CA 1.487 2.072 0 N-CA-C 109.825 -1.31 . . . . 0.0 109.825 -179.649 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 140' ' ' SER . . . . . 0.581 ' N ' ' O ' ' A' ' 138' ' ' LYS . 2.3 p -75.32 116.67 16.3 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 120.96 -1.318 . . . . 0.0 109.156 179.207 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 141' ' ' MET . . . . . . . . . . . . . 3.3 tpt -70.6 139.3 51.38 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.215 -0.928 . . . . 0.0 109.393 -179.956 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 142' ' ' VAL . . . . . . . . . . . . . 5.0 t -125.35 128.25 72.53 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.719 0 O-C-N 121.491 -0.755 . . . . 0.0 108.998 -179.789 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 143' ' ' TYR . . . . . . . . . . . . . 64.4 m-85 -107.41 135.04 49.57 Favored 'General case' 0 N--CA 1.5 2.056 0 O-C-N 121.236 -0.915 . . . . 0.0 110.69 -179.295 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 144' ' ' PHE . . . . . . . . . . . . . 62.9 t80 -118.78 101.65 8.24 Favored 'General case' 0 N--CA 1.5 2.066 0 O-C-N 121.474 -0.766 . . . . 0.0 110.406 -179.405 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 145' ' ' LYS . . . . . . . . . . . . . 36.5 tttt -96.51 129.98 43.78 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.03 -1.044 . . . . 0.0 110.543 -179.554 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 146' ' ' VAL . . . . . 0.42 ' O ' ' C ' ' A' ' 147' ' ' GLY . 2.6 p -146.16 141.84 21.37 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.574 0 N-CA-C 107.238 -1.393 . . . . 0.0 107.238 178.376 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 147' ' ' GLY . . . . . 0.42 ' C ' ' O ' ' A' ' 146' ' ' VAL . . . 47.85 -133.72 16.87 Favored Glycine 0 N--CA 1.487 2.077 0 N-CA-C 108.857 -1.697 . . . . 0.0 108.857 -179.391 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 148' ' ' ASN . . . . . 0.507 ' C ' ' ND2' ' A' ' 148' ' ' ASN . 0.5 OUTLIER -102.91 17.85 23.0 Favored 'General case' 0 C--N 1.302 -1.495 0 O-C-N 121.314 -1.109 . . . . 0.0 108.418 179.314 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 149' ' ' GLU . . . . . 0.525 ' CD ' ' N ' ' A' ' 150' ' ' THR . 11.5 tp10 -113.03 145.31 41.09 Favored 'General case' 0 N--CA 1.486 1.368 0 CA-C-O 121.714 0.768 . . . . 0.0 110.658 -178.447 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 150' ' ' THR . . . . . 0.525 ' N ' ' CD ' ' A' ' 149' ' ' GLU . 86.0 m -129.72 104.79 7.62 Favored 'General case' 0 N--CA 1.492 1.647 0 CA-C-O 121.487 0.66 . . . . 0.0 109.526 179.815 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 151' ' ' ARG . . . . . . . . . . . . . 84.3 mtt180 -85.92 -168.97 2.43 Favored 'General case' 0 N--CA 1.486 1.363 0 N-CA-C 108.646 -0.872 . . . . 0.0 108.646 -179.759 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 152' ' ' LYS . . . . . 0.589 ' N ' ' OXT' ' A' ' 206' ' ' LYS . 21.7 mtpt -149.9 148.47 29.16 Favored 'General case' 0 C--N 1.3 -1.563 0 O-C-N 120.999 -1.063 . . . . 0.0 110.317 -178.855 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 153' ' ' TYR . . . . . 0.446 ' CD1' ' C ' ' A' ' 152' ' ' LYS . 51.7 m-85 -146.94 151.48 37.08 Favored 'General case' 0 C--N 1.302 -1.475 0 N-CA-C 108.401 -0.963 . . . . 0.0 108.401 178.718 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 154' ' ' LYS . . . . . . . . . . . . . 10.8 ttmt -133.05 117.05 17.11 Favored 'General case' 0 C--N 1.298 -1.648 0 N-CA-C 108.711 -0.848 . . . . 0.0 108.711 179.291 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 155' ' ' MET . . . . . 0.557 ' SD ' ' OG ' ' A' ' 140' ' ' SER . 6.5 mtt -41.66 107.71 0.08 Allowed 'General case' 0 N--CA 1.489 1.483 0 CA-C-O 122.75 1.262 . . . . 0.0 111.858 -178.126 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 156' ' ' THR . . . . . 0.504 ' OG1' ' OG1' ' A' ' 203' ' ' THR . 0.2 OUTLIER -106.07 -26.19 11.73 Favored 'General case' 0 C--N 1.293 -1.865 0 CA-C-N 114.537 -1.211 . . . . 0.0 110.03 -178.842 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 157' ' ' SER . . . . . 0.467 ' O ' ' N ' ' A' ' 201' ' ' VAL . 19.8 t -154.27 150.77 28.37 Favored 'General case' 0 N--CA 1.494 1.748 0 C-N-CA 118.713 -1.195 . . . . 0.0 111.394 -178.678 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 158' ' ' ILE . . . . . 0.434 HG13 ' CD2' ' A' ' 200' ' ' PHE . 0.0 OUTLIER -155.25 146.9 12.98 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.486 0 CA-C-O 121.767 0.794 . . . . 0.0 110.252 -179.884 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 159' ' ' ARG . . . . . 0.588 ' CG ' HH11 ' A' ' 159' ' ' ARG . 0.0 OUTLIER -151.32 -167.46 2.81 Favored 'General case' 0 N--CA 1.491 1.603 0 CA-C-O 121.785 0.802 . . . . 0.0 110.551 -179.147 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 160' ' ' ASP . . . . . . . . . . . . . 5.5 m-20 -145.11 152.91 40.8 Favored 'General case' 0 N--CA 1.491 1.599 0 N-CA-C 108.585 -0.894 . . . . 0.0 108.585 -179.429 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 161' ' ' VAL . . . . . . . . . . . . . 0.1 OUTLIER -153.04 150.83 12.38 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.873 0 O-C-N 120.713 -1.242 . . . . 0.0 111.21 -178.834 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 162' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -49.07 171.3 0.11 Allowed Pre-proline 0 N--CA 1.496 1.866 0 O-C-N 121.652 -0.655 . . . . 0.0 109.961 179.418 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 163' ' ' PRO . . . . . . . . . . . . . 74.2 Cg_endo -81.07 29.37 0.53 Allowed 'Trans proline' 0 N--CA 1.492 1.428 0 C-N-CA 122.792 2.328 . . . . 0.0 113.008 179.83 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 164' ' ' THR . . . . . . . . . . . . . 55.3 m -151.16 -6.01 0.27 Allowed 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.005 -1.059 . . . . 0.0 110.356 -179.949 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 165' ' ' ASP . . . . . 0.485 ' O ' ' C ' ' A' ' 166' ' ' VAL . 12.0 t0 -75.8 63.62 1.68 Allowed 'General case' 0 N--CA 1.487 1.411 0 O-C-N 120.994 -1.066 . . . . 0.0 109.292 179.549 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 166' ' ' VAL . . . . . 0.538 ' O ' ' N ' ' A' ' 168' ' ' VAL . 1.0 OUTLIER -39.54 -31.96 0.17 Allowed 'Isoleucine or valine' 0 N--CA 1.488 1.433 0 O-C-N 121.473 -0.767 . . . . 0.0 109.152 -178.647 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 167' ' ' GLY . . . . . 0.442 ' N ' ' O ' ' A' ' 165' ' ' ASP . . . -45.52 -13.52 0.05 OUTLIER Glycine 0 N--CA 1.494 2.545 0 N-CA-C 110.541 -1.024 . . . . 0.0 110.541 179.929 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 168' ' ' VAL . . . . . 0.589 ' O ' ' N ' ' A' ' 170' ' ' ASP . 16.7 t -52.74 -35.39 21.28 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.607 0 O-C-N 120.818 -1.401 . . . . 0.0 108.115 179.531 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 169' ' ' LEU . . . . . 0.54 ' O ' ' C ' ' A' ' 170' ' ' ASP . 84.3 mt -46.23 -14.05 0.02 OUTLIER 'General case' 0 C--N 1.3 -1.569 0 N-CA-C 108.26 -1.015 . . . . 0.0 108.26 -178.268 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 170' ' ' ASP . . . . . 0.6 ' O ' ' ND2' ' A' ' 114' ' ' ASN . 39.1 t0 19.78 54.36 0.01 OUTLIER 'General case' 0 N--CA 1.501 2.079 0 N-CA-C 111.874 0.324 . . . . 0.0 111.874 177.699 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 171' ' ' GLU . . . . . 0.435 ' N ' ' O ' ' A' ' 169' ' ' LEU . 4.9 pt-20 -100.87 75.6 1.71 Allowed 'General case' 0 N--CA 1.497 1.878 0 O-C-N 120.777 -1.202 . . . . 0.0 110.554 -179.597 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 172' ' ' GLN . . . . . . . . . . . . . 4.3 pt20 -139.69 -39.25 0.46 Allowed 'General case' 0 N--CA 1.492 1.665 0 O-C-N 121.568 -0.708 . . . . 0.0 109.266 -179.843 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 173' ' ' LYS . . . . . . . . . . . . . 9.2 mtpp -63.82 131.05 46.6 Favored 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.06 -1.025 . . . . 0.0 108.743 178.818 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 174' ' ' GLY . . . . . 0.559 ' O ' ' C ' ' A' ' 175' ' ' LYS . . . -137.5 -38.94 0.13 Allowed Glycine 0 C--N 1.294 -1.761 0 N-CA-C 108.514 -1.834 . . . . 0.0 108.514 179.763 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 175' ' ' LYS . . . . . 0.559 ' C ' ' O ' ' A' ' 174' ' ' GLY . 3.4 tptp -33.41 -62.97 0.26 Allowed 'General case' 0 N--CA 1.493 1.717 0 N-CA-C 108.529 -0.915 . . . . 0.0 108.529 179.676 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 176' ' ' ASP . . . . . 0.715 ' O ' ' O ' ' A' ' 177' ' ' LYS . 0.9 OUTLIER -103.6 76.1 1.37 Allowed 'General case' 0 C--N 1.297 -1.697 0 N-CA-C 107.796 -1.187 . . . . 0.0 107.796 177.775 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 177' ' ' LYS . . . . . 0.715 ' O ' ' O ' ' A' ' 176' ' ' ASP . 17.6 mtmt -19.16 158.63 0.0 OUTLIER 'General case' 0 N--CA 1.508 2.458 0 CA-C-O 122.145 0.974 . . . . 0.0 112.719 -178.985 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 178' ' ' GLN . . . . . 0.674 ' NE2' ' ND2' ' A' ' 114' ' ' ASN . 18.0 pt20 -156.08 159.23 38.91 Favored 'General case' 0 N--CA 1.491 1.593 0 C-N-CA 117.061 -1.856 . . . . 0.0 112.483 179.863 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 179' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -121.58 102.88 8.51 Favored 'General case' 0 N--CA 1.486 1.349 0 N-CA-C 107.072 -1.455 . . . . 0.0 107.072 178.418 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 180' ' ' THR . . . . . . . . . . . . . 1.0 OUTLIER -79.92 123.9 28.2 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.148 -0.97 . . . . 0.0 110.438 -178.454 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 181' ' ' LEU . . . . . . . . . . . . . 7.5 tp -99.8 110.9 23.25 Favored 'General case' 0 N--CA 1.492 1.661 0 N-CA-C 108.711 -0.848 . . . . 0.0 108.711 178.386 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 182' ' ' ILE . . . . . . . . . . . . . 18.1 mt -98.94 120.23 47.98 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.549 0 O-C-N 120.85 -1.156 . . . . 0.0 109.768 179.432 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 183' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -135.44 109.06 7.97 Favored 'General case' 0 C--N 1.296 -1.718 0 N-CA-C 107.279 -1.378 . . . . 0.0 107.279 178.548 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 184' ' ' CYS . . . . . . . . . . . . . 0.7 OUTLIER -79.83 156.68 27.28 Favored 'General case' 0 N--CA 1.498 1.933 0 C-N-CA 118.935 -1.106 . . . . 0.0 111.341 -177.306 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 185' ' ' ASP . . . . . 0.642 ' CG ' ' H ' ' A' ' 186' ' ' ASP . 28.9 t0 -166.53 -161.92 0.49 Allowed 'General case' 0 N--CA 1.489 1.523 0 N-CA-C 108.659 -0.867 . . . . 0.0 108.659 -179.943 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 186' ' ' ASP . . . . . 0.642 ' H ' ' CG ' ' A' ' 185' ' ' ASP . 0.6 OUTLIER 58.49 49.12 11.08 Favored 'General case' 0 N--CA 1.497 1.916 0 O-C-N 121.026 -1.046 . . . . 0.0 109.457 -179.656 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 187' ' ' TYR . . . . . 0.587 ' CE1' ' O ' ' A' ' 188' ' ' ASN . 30.1 t80 -67.16 133.09 49.11 Favored 'General case' 0 C--N 1.3 -1.562 0 CA-C-O 121.843 0.83 . . . . 0.0 110.469 -179.858 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 188' ' ' ASN . . . . . 0.789 ' ND2' ' H ' ' A' ' 193' ' ' VAL . 0.1 OUTLIER -102.56 150.66 23.18 Favored 'General case' 0 C--N 1.292 -1.894 0 N-CA-C 107.572 -1.27 . . . . 0.0 107.572 178.033 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 189' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -113.24 -3.08 13.92 Favored 'General case' 0 C--N 1.292 -1.934 0 N-CA-C 108.178 -1.045 . . . . 0.0 108.178 -179.61 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 190' ' ' LYS . . . . . 0.566 ' N ' ' OD1' ' A' ' 188' ' ' ASN . 2.6 mtpm? -83.66 -60.21 2.19 Favored 'General case' 0 N--CA 1.489 1.49 0 N-CA-C 108.714 -0.847 . . . . 0.0 108.714 178.558 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 191' ' ' THR . . . . . 0.623 ' OG1' ' ND2' ' A' ' 188' ' ' ASN . 1.1 p -89.34 4.15 49.86 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.41 -0.806 . . . . 0.0 109.245 179.896 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 192' ' ' GLY . . . . . . . . . . . . . . . 56.73 38.01 80.27 Favored Glycine 0 N--CA 1.494 2.53 0 N-CA-C 110.05 -1.22 . . . . 0.0 110.05 179.4 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 193' ' ' VAL . . . . . 0.789 ' H ' ' ND2' ' A' ' 188' ' ' ASN . 46.0 t -148.35 161.02 6.5 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.493 0 O-C-N 121.162 -1.199 . . . . 0.0 110.042 -179.975 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 194' ' ' TRP . . . . . 0.497 ' N ' ' CG1' ' A' ' 193' ' ' VAL . 11.1 m95 -83.4 120.62 26.11 Favored 'General case' 0 C--N 1.298 -1.656 0 N-CA-C 108.564 -0.902 . . . . 0.0 108.564 179.55 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 195' ' ' GLU . . . . . . . . . . . . . 1.4 mt-10 -79.53 -60.09 2.5 Favored 'General case' 0 N--CA 1.493 1.709 0 O-C-N 121.309 -0.869 . . . . 0.0 111.013 -178.888 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 196' ' ' LYS . . . . . . . . . . . . . 19.0 mttp -95.04 146.37 24.32 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.285 -0.884 . . . . 0.0 110.31 -178.759 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 197' ' ' ARG . . . . . 0.65 ' CG ' HH11 ' A' ' 197' ' ' ARG . 0.0 OUTLIER -118.81 145.42 45.65 Favored 'General case' 0 N--CA 1.492 1.635 0 N-CA-C 108.564 -0.902 . . . . 0.0 108.564 179.035 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 198' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER -116.95 120.75 39.4 Favored 'General case' 0 N--CA 1.492 1.666 0 O-C-N 121.672 -0.643 . . . . 0.0 110.358 -178.704 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 199' ' ' ILE . . . . . 0.436 ' O ' HG13 ' A' ' 199' ' ' ILE . 0.8 OUTLIER -141.67 121.46 11.17 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.527 0 CA-C-O 122.672 1.225 . . . . 0.0 110.551 179.554 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 200' ' ' PHE . . . . . 0.53 ' CD1' ' N ' ' A' ' 200' ' ' PHE . 3.3 m-85 -99.52 134.64 42.1 Favored 'General case' 0 N--CA 1.497 1.915 0 O-C-N 121.163 -0.961 . . . . 0.0 110.125 -177.653 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 201' ' ' VAL . . . . . 0.467 ' N ' ' O ' ' A' ' 157' ' ' SER . 3.4 t -103.95 145.38 12.9 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.456 0 N-CA-C 107.646 -1.242 . . . . 0.0 107.646 176.805 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 202' ' ' ALA . . . . . 0.414 ' HA ' ' H ' ' A' ' 156' ' ' THR . . . -135.01 142.31 46.39 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.042 -1.036 . . . . 0.0 109.465 -179.753 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 203' ' ' THR . . . . . 0.504 ' OG1' ' OG1' ' A' ' 156' ' ' THR . 2.2 p -90.11 127.55 36.11 Favored 'General case' 0 C--N 1.306 -1.322 0 CA-C-O 122.694 1.235 . . . . 0.0 111.693 -178.353 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 204' ' ' GLU . . . . . . . . . . . . . 2.7 tm-20 -53.99 135.84 42.21 Favored 'General case' 0 C--N 1.291 -1.976 0 CA-C-N 114.364 -1.289 . . . . 0.0 108.286 178.594 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 205' ' ' VAL . . . . . . . . . . . . . 62.6 t -121.55 -50.14 3.02 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.898 0 O-C-N 121.177 -0.952 . . . . 0.0 109.436 -179.13 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 206' ' ' LYS . . . . . 0.589 ' OXT' ' N ' ' A' ' 152' ' ' LYS . 4.4 mmtp . . . . . 0 C--N 1.302 -1.469 0 CA-C-O 118.114 -0.946 . . . . 0.0 109.667 179.151 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' C' C ' 702' ' ' LEU . . . . . 0.634 ' CD1' ' N ' ' C' ' 702' ' ' LEU . 0.0 OUTLIER . . . . . 0 N--CA 1.491 1.598 0 N-CA-C 108.316 -0.994 . . . . 0.0 108.316 . . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' C' C ' 703' ' ' PRO . . . . . 0.586 ' O ' ' NH2' ' A' ' 197' ' ' ARG . 64.8 Cg_endo -80.85 164.11 20.5 Favored 'Trans proline' 0 C--N 1.308 -1.584 0 C-N-CA 122.381 2.054 . . . . 0.0 113.119 -179.123 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' C' C ' 704' ' ' ALA . . . . . 0.462 ' O ' ' O ' ' C' ' 703' ' ' PRO . . . . . . . . 0 N--CA 1.488 1.462 0 O-C-N 121.345 -0.847 . . . . 0.0 110.033 179.441 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 63' ' ' PRO . . . . . . . . . . . . . 75.7 Cg_endo . . . . . 0 N--CA 1.487 1.098 0 CA-C-O 121.054 0.356 . . . . 0.0 111.488 . . . . . . . . . 0 0 . 1 . 017 nuclear orig core ' A' A ' 64' ' ' GLN . . . . . 0.602 HE21 ' C ' ' A' ' 64' ' ' GLN . 0.0 OUTLIER -156.31 117.53 3.83 Favored 'General case' 0 N--CA 1.496 1.87 0 O-C-N 121.118 -0.989 . . . . 0.0 109.39 179.664 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 65' ' ' ILE . . . . . 0.408 ' C ' ' O ' ' A' ' 64' ' ' GLN . 3.2 mp -43.86 104.39 0.37 Allowed Pre-proline 0 N--CA 1.494 1.767 0 O-C-N 120.972 -1.08 . . . . 0.0 109.119 179.48 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 66' ' ' PRO . . . . . . . . . . . . . 83.8 Cg_endo -87.34 -158.81 0.09 OUTLIER 'Trans proline' 0 C--N 1.315 -1.23 0 C-N-CA 122.287 1.991 . . . . 0.0 112.651 -179.476 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 67' ' ' LYS . . . . . 0.467 ' CG ' ' O ' ' A' ' 67' ' ' LYS . 19.5 tttm -77.86 -6.87 55.65 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.306 -0.871 . . . . 0.0 108.7 179.516 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 68' ' ' ASP . . . . . 0.611 ' C ' ' H ' ' A' ' 70' ' ' SER . 3.6 t0 -76.5 48.04 0.52 Allowed 'General case' 0 N--CA 1.489 1.488 0 CA-C-O 122.237 1.018 . . . . 0.0 109.05 179.477 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 69' ' ' LYS . . . . . 0.456 ' C ' ' O ' ' A' ' 68' ' ' ASP . 9.5 ptpt -49.11 -14.57 0.08 Allowed 'General case' 0 N--CA 1.503 2.186 0 C-N-CA 116.845 -1.942 . . . . 0.0 106.863 178.234 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 70' ' ' SER . . . . . 0.611 ' H ' ' C ' ' A' ' 68' ' ' ASP . 1.8 t -82.85 -8.49 59.57 Favored 'General case' 0 N--CA 1.494 1.764 0 CA-C-N 113.629 -1.623 . . . . 0.0 110.15 179.958 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 71' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -97.54 145.93 25.76 Favored 'General case' 0 N--CA 1.492 1.665 0 O-C-N 120.981 -1.074 . . . . 0.0 109.929 179.109 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 1.1 m -65.24 140.06 20.33 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.58 0 N-CA-C 105.046 -2.205 . . . . 0.0 105.046 174.853 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 73' ' ' ALA . . . . . 0.543 ' N ' ' O ' ' A' ' 87' ' ' VAL . . . -80.64 -18.61 47.54 Favored 'General case' 0 C--N 1.291 -1.935 0 O-C-N 120.022 -1.674 . . . . 0.0 106.645 179.764 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 74' ' ' GLY . . . . . 0.453 ' O ' ' N ' ' A' ' 87' ' ' VAL . . . 176.16 -159.05 26.08 Favored Glycine 0 N--CA 1.483 1.796 0 N-CA-C 109.721 -1.352 . . . . 0.0 109.721 179.323 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 75' ' ' TYR . . . . . 0.417 ' CD2' ' HA ' ' A' ' 86' ' ' PRO . 92.1 m-85 -140.77 166.66 24.16 Favored 'General case' 0 C--N 1.299 -1.619 0 O-C-N 121.62 -0.929 . . . . 0.0 110.63 -177.268 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 76' ' ' ILE . . . . . . . . . . . . . 1.7 tt -147.71 143.39 19.64 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.551 0 C-N-CA 118.98 -1.088 . . . . 0.0 109.959 -178.189 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 77' ' ' GLU . . . . . 0.56 ' N ' ' CD ' ' A' ' 77' ' ' GLU . 2.3 mp0 -147.31 164.35 33.52 Favored 'General case' 0 N--CA 1.487 1.424 0 O-C-N 121.116 -0.99 . . . . 0.0 108.823 -179.831 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 78' ' ' ILE . . . . . 0.438 ' O ' ' N ' ' A' ' 82' ' ' ASP . 5.1 mt -147.5 93.39 4.62 Favored Pre-proline 0 N--CA 1.49 1.552 0 N-CA-C 108.181 -1.044 . . . . 0.0 108.181 179.674 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 79' ' ' PRO . . . . . . . . . . . . . 80.7 Cg_exo -46.87 -48.49 14.18 Favored 'Trans proline' 0 N--CA 1.494 1.527 0 C-N-CA 122.995 2.464 . . . . 0.0 114.098 -178.428 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -64.8 -18.98 65.58 Favored 'General case' 0 N--CA 1.494 1.73 0 O-C-N 120.868 -1.145 . . . . 0.0 110.749 178.968 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 81' ' ' ALA . . . . . 0.552 ' O ' ' ND2' ' A' ' 132' ' ' ASN . . . -105.5 -17.49 14.4 Favored 'General case' 0 N--CA 1.492 1.663 0 O-C-N 121.176 -0.953 . . . . 0.0 108.488 179.207 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 82' ' ' ASP . . . . . 0.438 ' N ' ' O ' ' A' ' 78' ' ' ILE . 0.7 OUTLIER 67.93 51.12 0.78 Allowed 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.528 -0.732 . . . . 0.0 110.453 179.022 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 83' ' ' ILE . . . . . . . . . . . . . 70.8 mt -128.75 151.57 35.72 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.756 0 O-C-N 121.343 -0.848 . . . . 0.0 110.074 -178.768 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 84' ' ' LYS . . . . . 0.45 ' CG ' ' O ' ' A' ' 84' ' ' LYS . 7.7 pttt -158.37 107.86 2.03 Favored 'General case' 0 N--CA 1.494 1.757 0 N-CA-C 108.345 -0.984 . . . . 0.0 108.345 -179.923 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -142.34 166.12 23.1 Favored Pre-proline 0 N--CA 1.496 1.833 0 O-C-N 121.234 -0.916 . . . . 0.0 110.759 -179.064 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 86' ' ' PRO . . . . . 0.417 ' HA ' ' CD2' ' A' ' 75' ' ' TYR . 73.8 Cg_endo -77.35 166.35 26.25 Favored 'Trans proline' 0 N--CA 1.498 1.761 0 C-N-CA 123.333 2.689 . . . . 0.0 113.652 -179.225 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 87' ' ' VAL . . . . . 0.543 ' O ' ' N ' ' A' ' 73' ' ' ALA . 39.9 t -122.83 100.95 8.82 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.651 0 O-C-N 121.735 -0.603 . . . . 0.0 109.422 179.953 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 88' ' ' TYR . . . . . 0.458 ' CE2' ' CD ' ' A' ' 99' ' ' ARG . 7.5 m-85 -89.73 173.61 5.69 Favored Pre-proline 0 N--CA 1.499 2.005 0 O-C-N 120.946 -1.096 . . . . 0.0 109.468 -179.684 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 89' ' ' PRO . . . . . . . . . . . . . 9.4 Cg_endo -83.84 145.61 11.44 Favored 'Trans proline' 0 N--CA 1.484 0.96 0 C-N-CA 122.064 1.843 . . . . 0.0 113.898 -177.982 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . -55.97 164.41 4.8 Favored Glycine 0 N--CA 1.487 2.069 0 N-CA-C 109.081 -1.608 . . . . 0.0 109.081 179.133 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 91' ' ' PRO . . . . . 0.5 ' C ' ' H ' ' A' ' 93' ' ' THR . 58.0 Cg_endo -91.5 167.27 27.37 Favored 'Cis proline' 0 C--N 1.305 -1.747 0 C-N-CA 123.408 -1.497 . . . . 0.0 112.401 0.69 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 92' ' ' ALA . . . . . . . . . . . . . . . -73.21 30.52 0.07 Allowed 'General case' 0 C--N 1.303 -1.449 0 C-N-CA 119.887 -0.725 . . . . 0.0 110.091 -179.944 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 93' ' ' THR . . . . . 0.5 ' H ' ' C ' ' A' ' 91' ' ' PRO . 6.5 p -71.5 150.6 93.82 Favored Pre-proline 0 N--CA 1.489 1.493 0 O-C-N 121.034 -1.041 . . . . 0.0 108.847 -179.289 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 94' ' ' PRO . . . . . . . . . . . . . 77.8 Cg_exo -33.35 -49.03 0.45 Allowed 'Trans proline' 0 C--N 1.308 -1.562 0 C-N-CA 122.898 2.398 . . . . 0.0 112.385 -178.9 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 95' ' ' GLU . . . . . 0.544 ' O ' ' ND2' ' A' ' 98' ' ' ASN . 5.4 mp0 -49.83 -51.36 40.5 Favored 'General case' 0 C--N 1.3 -1.551 0 O-C-N 121.317 -0.865 . . . . 0.0 109.773 -179.838 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 96' ' ' GLN . . . . . 0.566 ' O ' ' N ' ' A' ' 98' ' ' ASN . 3.3 mp0 -72.32 -50.76 24.45 Favored 'General case' 0 N--CA 1.489 1.493 0 O-C-N 120.99 -1.069 . . . . 0.0 109.954 179.908 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 97' ' ' LEU . . . . . 0.627 ' CD2' ' CE1' ' A' ' 120' ' ' HIS . 1.3 mp -48.5 -8.75 0.02 OUTLIER 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.135 -0.978 . . . . 0.0 109.737 -179.786 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 98' ' ' ASN . . . . . 0.566 ' N ' ' O ' ' A' ' 96' ' ' GLN . 0.4 OUTLIER -72.66 -28.01 62.46 Favored 'General case' 0 N--CA 1.489 1.479 0 O-C-N 121.379 -0.826 . . . . 0.0 109.346 179.868 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 99' ' ' ARG . . . . . 0.627 HH11 ' CG ' ' A' ' 99' ' ' ARG . 0.2 OUTLIER -96.17 -57.61 2.29 Favored 'General case' 0 N--CA 1.488 1.428 0 C-N-CA 119.79 -0.764 . . . . 0.0 110.186 -179.526 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . -170.2 -162.8 23.15 Favored Glycine 0 N--CA 1.493 2.468 0 C-N-CA 119.383 -1.389 . . . . 0.0 110.531 -179.934 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 101' ' ' VAL . . . . . 0.534 ' O ' ' CG2' ' A' ' 101' ' ' VAL . 13.7 m -64.58 106.27 0.57 Allowed 'Isoleucine or valine' 0 N--CA 1.496 1.845 0 O-C-N 121.698 -0.883 . . . . 0.0 109.351 -179.61 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -92.57 161.44 14.59 Favored 'General case' 0 N--CA 1.494 1.731 0 O-C-N 121.23 -0.919 . . . . 0.0 110.679 -179.55 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 103' ' ' PHE . . . . . . . . . . . . . 23.8 m-85 -63.6 150.42 44.14 Favored 'General case' 0 N--CA 1.489 1.48 0 N-CA-C 107.724 -1.213 . . . . 0.0 107.724 178.11 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 104' ' ' ALA . . . . . . . . . . . . . . . -69.71 -13.08 62.11 Favored 'General case' 0 N--CA 1.492 1.652 0 O-C-N 120.998 -1.064 . . . . 0.0 111.309 -178.504 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -136.3 142.01 43.87 Favored 'General case' 0 N--CA 1.498 1.97 0 O-C-N 120.841 -1.162 . . . . 0.0 110.803 -179.307 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 106' ' ' GLU . . . . . . . . . . . . . 2.3 tm-20 -51.89 -61.64 2.13 Favored 'General case' 0 N--CA 1.489 1.495 0 O-C-N 121.883 -0.511 . . . . 0.0 110.675 -179.556 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 107' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER -76.63 34.49 0.14 Allowed 'General case' 0 N--CA 1.489 1.52 0 O-C-N 120.698 -1.251 . . . . 0.0 112.251 -175.832 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 108' ' ' GLU . . . . . . . . . . . . . 29.6 tp10 -55.22 146.74 18.12 Favored 'General case' 0 C--N 1.303 -1.422 0 O-C-N 120.585 -1.322 . . . . 0.0 107.624 179.681 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 109' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -103.59 143.49 32.68 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 120.941 -1.099 . . . . 0.0 110.901 -178.038 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 110' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -64.47 -16.47 62.53 Favored 'General case' 0 C--N 1.303 -1.447 0 N-CA-C 108.884 -0.784 . . . . 0.0 108.884 179.217 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 111' ' ' ASP . . . . . . . . . . . . . 74.0 m-20 -132.97 35.99 3.51 Favored 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.248 -0.907 . . . . 0.0 110.298 -179.539 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 112' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -66.52 153.36 43.15 Favored 'General case' 0 N--CA 1.493 1.7 0 O-C-N 120.825 -1.172 . . . . 0.0 111.203 -179.673 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 113' ' ' GLN . . . . . 0.561 ' NE2' ' O ' ' A' ' 173' ' ' LYS . 0.0 OUTLIER -67.77 -13.78 62.41 Favored 'General case' 0 N--CA 1.494 1.755 0 CA-C-O 121.949 0.88 . . . . 0.0 109.537 178.677 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 114' ' ' ASN . . . . . 0.615 ' O ' ' ND2' ' A' ' 114' ' ' ASN . 0.3 OUTLIER -150.33 106.71 3.48 Favored 'General case' 0 C--N 1.298 -1.669 0 N-CA-C 107.205 -1.405 . . . . 0.0 107.205 179.477 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 115' ' ' ILE . . . . . . . . . . . . . 1.5 mm -94.23 104.52 15.86 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.737 0 O-C-N 120.534 -1.354 . . . . 0.0 108.823 -179.459 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 116' ' ' SER . . . . . 0.581 ' HG ' HD22 ' A' ' 114' ' ' ASN . 42.8 m -82.55 153.12 25.68 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.291 -0.881 . . . . 0.0 110.986 -178.182 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 117' ' ' ILE . . . . . . . . . . . . . 7.9 mt -151.13 147.12 15.8 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.437 0 N-CA-C 108.207 -1.034 . . . . 0.0 108.207 179.736 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 118' ' ' ALA . . . . . . . . . . . . . . . -144.89 160.97 40.45 Favored 'General case' 0 N--CA 1.491 1.582 0 C-N-CA 118.742 -1.183 . . . . 0.0 111.435 -179.948 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 119' ' ' GLY . . . . . . . . . . . . . . . -167.95 151.0 17.71 Favored Glycine 0 N--CA 1.485 1.939 0 N-CA-C 109.65 -1.38 . . . . 0.0 109.65 179.718 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 120' ' ' HIS . . . . . 0.627 ' CE1' ' CD2' ' A' ' 97' ' ' LEU . 3.9 m-70 -70.91 167.73 18.41 Favored 'General case' 0 N--CA 1.493 1.699 0 O-C-N 121.639 -0.918 . . . . 0.0 109.972 179.689 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 121' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -121.39 157.95 29.37 Favored 'General case' 0 N--CA 1.496 1.842 0 N-CA-C 108.363 -0.977 . . . . 0.0 108.363 178.954 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 122' ' ' PHE . . . . . 0.406 ' O ' ' CG2' ' A' ' 131' ' ' THR . 0.1 OUTLIER -140.66 121.97 14.92 Favored 'General case' 0 N--CA 1.498 1.934 0 O-C-N 120.927 -1.108 . . . . 0.0 110.31 -179.234 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 123' ' ' ILE . . . . . 0.417 ' CG2' ' N ' ' A' ' 124' ' ' ASP . 8.6 tt -59.44 -38.54 75.61 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.485 0 O-C-N 121.556 -0.715 . . . . 0.0 110.096 -179.884 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 124' ' ' ASP . . . . . 0.417 ' N ' ' CG2' ' A' ' 123' ' ' ILE . 0.1 OUTLIER -90.97 18.29 6.85 Favored 'General case' 0 N--CA 1.496 1.858 0 C-N-CA 119.659 -0.816 . . . . 0.0 111.988 -177.718 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 125' ' ' ARG . . . . . 0.434 HH11 ' CG ' ' A' ' 125' ' ' ARG . 0.3 OUTLIER -152.08 99.31 2.9 Favored Pre-proline 0 N--CA 1.493 1.706 0 O-C-N 120.521 -1.362 . . . . 0.0 109.719 -179.821 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 126' ' ' PRO . . . . . . . . . . . . . 58.4 Cg_endo -77.55 -19.03 13.31 Favored 'Trans proline' 0 N--CA 1.489 1.236 0 C-N-CA 122.061 1.841 . . . . 0.0 112.143 179.697 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 127' ' ' ASN . . . . . 0.489 ' O ' ' O ' ' A' ' 128' ' ' TYR . 0.7 OUTLIER -91.29 2.59 56.27 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.301 -0.874 . . . . 0.0 109.948 -179.811 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 128' ' ' TYR . . . . . 0.679 ' CE2' ' NE2' ' A' ' 129' ' ' GLN . 2.5 t80 -57.82 -148.83 0.0 OUTLIER 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.182 -0.949 . . . . 0.0 110.025 -179.657 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 129' ' ' GLN . . . . . 0.679 ' NE2' ' CE2' ' A' ' 128' ' ' TYR . 0.5 OUTLIER -65.39 -71.24 0.19 Allowed 'General case' 0 N--CA 1.493 1.703 0 O-C-N 121.316 -0.865 . . . . 0.0 109.871 -179.387 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 130' ' ' PHE . . . . . 0.513 ' CZ ' ' CG1' ' A' ' 101' ' ' VAL . 28.8 m-85 -135.16 39.78 2.91 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.288 -0.883 . . . . 0.0 109.808 -179.633 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 131' ' ' THR . . . . . 0.544 ' O ' ' CD ' ' A' ' 134' ' ' LYS . 60.5 m -74.94 -32.88 61.86 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.246 -0.909 . . . . 0.0 109.354 179.858 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 132' ' ' ASN . . . . . 0.552 ' ND2' ' O ' ' A' ' 81' ' ' ALA . 22.1 t30 -92.83 14.12 18.32 Favored 'General case' 0 N--CA 1.498 1.972 0 C-N-CA 119.698 -0.801 . . . . 0.0 111.63 -178.889 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 133' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -68.5 -26.98 65.73 Favored 'General case' 0 N--CA 1.496 1.875 0 O-C-N 120.582 -1.324 . . . . 0.0 109.429 -179.92 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 134' ' ' LYS . . . . . 0.593 ' H ' ' CD ' ' A' ' 134' ' ' LYS . 0.0 OUTLIER -46.14 -28.71 1.29 Allowed 'General case' 0 N--CA 1.495 1.817 0 O-C-N 121.401 -0.812 . . . . 0.0 110.937 -179.176 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 135' ' ' ALA . . . . . . . . . . . . . . . -83.37 -22.61 32.74 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 120.758 -1.214 . . . . 0.0 109.954 -179.189 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 136' ' ' ALA . . . . . . . . . . . . . . . -79.79 138.02 37.14 Favored 'General case' 0 C--N 1.3 -1.559 0 O-C-N 121.29 -0.881 . . . . 0.0 111.405 -178.897 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 137' ' ' LYS . . . . . 0.554 ' O ' ' O ' ' A' ' 138' ' ' LYS . 6.3 mttt -151.46 -170.26 3.6 Favored 'General case' 0 N--CA 1.494 1.77 0 C-N-CA 118.639 -1.225 . . . . 0.0 111.221 -178.231 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 138' ' ' LYS . . . . . 0.554 ' O ' ' O ' ' A' ' 137' ' ' LYS . 15.4 tttt -32.55 163.96 0.0 OUTLIER 'General case' 0 N--CA 1.492 1.653 0 CA-C-O 122.902 1.334 . . . . 0.0 112.342 -178.204 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 139' ' ' GLY . . . . . . . . . . . . . . . 49.68 8.73 0.14 Allowed Glycine 0 N--CA 1.491 2.317 0 N-CA-C 110.146 -1.182 . . . . 0.0 110.146 179.78 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 140' ' ' SER . . . . . 0.516 ' H ' ' C ' ' A' ' 138' ' ' LYS . 2.0 m -69.33 130.01 41.39 Favored 'General case' 0 N--CA 1.495 1.812 0 O-C-N 120.803 -1.41 . . . . 0.0 109.194 179.539 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 141' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -83.78 123.17 29.6 Favored 'General case' 0 N--CA 1.489 1.498 0 O-C-N 121.224 -0.923 . . . . 0.0 109.214 179.743 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 142' ' ' VAL . . . . . . . . . . . . . 2.4 t -112.99 132.12 62.7 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.576 0 N-CA-C 108.069 -1.086 . . . . 0.0 108.069 179.75 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 143' ' ' TYR . . . . . . . . . . . . . 5.3 m-85 -108.65 134.24 51.65 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.025 -1.047 . . . . 0.0 110.897 -178.42 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 144' ' ' PHE . . . . . . . . . . . . . 44.8 t80 -120.13 102.62 8.64 Favored 'General case' 0 N--CA 1.489 1.524 0 N-CA-C 109.056 -0.72 . . . . 0.0 109.056 179.633 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 145' ' ' LYS . . . . . . . . . . . . . 25.2 tttm -100.21 129.99 46.29 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.319 -0.863 . . . . 0.0 110.868 -179.008 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 146' ' ' VAL . . . . . 0.441 ' O ' ' C ' ' A' ' 147' ' ' GLY . 6.8 p -142.43 146.51 22.2 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.566 0 N-CA-C 107.805 -1.183 . . . . 0.0 107.805 178.415 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 147' ' ' GLY . . . . . 0.441 ' C ' ' O ' ' A' ' 146' ' ' VAL . . . 42.61 -124.08 3.84 Favored Glycine 0 N--CA 1.491 2.355 0 N-CA-C 109.336 -1.506 . . . . 0.0 109.336 -179.795 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 148' ' ' ASN . . . . . 0.513 ' C ' ' ND2' ' A' ' 148' ' ' ASN . 0.4 OUTLIER -108.36 15.62 23.84 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.483 -1.01 . . . . 0.0 109.041 179.393 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 149' ' ' GLU . . . . . . . . . . . . . 8.7 tt0 -112.28 144.02 42.4 Favored 'General case' 0 N--CA 1.489 1.479 0 O-C-N 121.388 -0.82 . . . . 0.0 111.444 -178.288 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 150' ' ' THR . . . . . . . . . . . . . 29.9 m -127.25 104.12 7.78 Favored 'General case' 0 N--CA 1.49 1.541 0 CA-C-O 121.373 0.606 . . . . 0.0 109.6 179.561 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 151' ' ' ARG . . . . . . . . . . . . . 15.4 mtp180 -88.17 -173.1 4.08 Favored 'General case' 0 C--N 1.301 -1.513 0 N-CA-C 107.748 -1.204 . . . . 0.0 107.748 179.357 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 152' ' ' LYS . . . . . 0.472 ' O ' ' N ' ' A' ' 205' ' ' VAL . 15.4 mtmm -149.15 150.74 33.17 Favored 'General case' 0 C--N 1.298 -1.67 0 O-C-N 120.811 -1.181 . . . . 0.0 109.728 -179.678 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 153' ' ' TYR . . . . . 0.504 ' CD2' ' HA ' ' A' ' 204' ' ' GLU . 27.6 m-85 -142.97 164.47 29.99 Favored 'General case' 0 C--N 1.297 -1.697 0 N-CA-C 107.695 -1.224 . . . . 0.0 107.695 178.69 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 154' ' ' LYS . . . . . . . . . . . . . 26.2 ttpp -140.31 118.01 11.64 Favored 'General case' 0 C--N 1.296 -1.745 0 N-CA-C 108.308 -0.997 . . . . 0.0 108.308 179.499 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 155' ' ' MET . . . . . . . . . . . . . 36.8 mtp -44.95 109.09 0.14 Allowed 'General case' 0 N--CA 1.497 1.895 0 O-C-N 120.507 -1.371 . . . . 0.0 111.344 -178.307 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 156' ' ' THR . . . . . 0.54 ' OG1' ' CG2' ' A' ' 203' ' ' THR . 0.2 OUTLIER -107.59 -26.79 10.72 Favored 'General case' 0 C--N 1.298 -1.645 0 CA-C-N 115.452 -0.794 . . . . 0.0 110.893 -178.858 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 157' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -154.03 153.33 31.75 Favored 'General case' 0 N--CA 1.5 2.044 0 C-N-CA 118.171 -1.411 . . . . 0.0 111.903 -178.334 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 158' ' ' ILE . . . . . 0.476 ' CD1' ' CD1' ' A' ' 200' ' ' PHE . 0.2 OUTLIER -154.49 146.91 13.61 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.425 0 CA-C-O 122.068 0.937 . . . . 0.0 111.383 -178.946 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 159' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -153.35 158.48 41.6 Favored 'General case' 0 C--N 1.299 -1.612 0 CA-C-O 121.707 0.765 . . . . 0.0 109.86 179.834 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 160' ' ' ASP . . . . . . . . . . . . . 7.9 m-20 -116.52 156.46 26.87 Favored 'General case' 0 N--CA 1.491 1.597 0 N-CA-C 108.081 -1.081 . . . . 0.0 108.081 179.254 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 161' ' ' VAL . . . . . 0.486 ' O ' ' O ' ' A' ' 162' ' ' LYS . 14.8 m -155.35 154.25 6.93 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.921 0 O-C-N 120.841 -1.162 . . . . 0.0 111.357 -178.507 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 162' ' ' LYS . . . . . 0.486 ' O ' ' O ' ' A' ' 161' ' ' VAL . 0.0 OUTLIER -43.25 170.46 0.04 OUTLIER Pre-proline 0 N--CA 1.495 1.799 0 O-C-N 121.555 -0.716 . . . . 0.0 109.986 179.651 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 163' ' ' PRO . . . . . . . . . . . . . 65.2 Cg_endo -79.56 30.9 0.47 Allowed 'Trans proline' 0 N--CA 1.492 1.408 0 C-N-CA 122.904 2.403 . . . . 0.0 113.071 179.82 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 164' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -151.02 0.31 0.39 Allowed 'General case' 0 N--CA 1.495 1.789 0 O-C-N 121.064 -1.022 . . . . 0.0 110.11 -179.968 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 165' ' ' ASP . . . . . 0.438 ' O ' ' C ' ' A' ' 166' ' ' VAL . 13.0 t70 -75.46 63.9 1.53 Allowed 'General case' 0 N--CA 1.489 1.491 0 O-C-N 121.251 -0.906 . . . . 0.0 110.362 -179.749 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 166' ' ' VAL . . . . . 0.685 ' O ' ' N ' ' A' ' 168' ' ' VAL . 1.0 OUTLIER -39.73 -31.12 0.15 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.517 0 O-C-N 121.14 -0.975 . . . . 0.0 109.79 -178.668 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 167' ' ' GLY . . . . . 0.428 ' N ' ' O ' ' A' ' 165' ' ' ASP . . . -41.48 -12.01 0.01 OUTLIER Glycine 0 N--CA 1.496 2.652 0 N-CA-C 110.288 -1.125 . . . . 0.0 110.288 -179.94 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 168' ' ' VAL . . . . . 0.685 ' N ' ' O ' ' A' ' 166' ' ' VAL . 3.5 t -49.03 -42.52 14.56 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.432 0 O-C-N 121.121 -1.223 . . . . 0.0 108.841 179.235 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 169' ' ' LEU . . . . . 0.551 ' O ' ' C ' ' A' ' 170' ' ' ASP . 10.8 mt -46.84 -14.71 0.03 OUTLIER 'General case' 0 N--CA 1.491 1.601 0 N-CA-C 108.444 -0.947 . . . . 0.0 108.444 -178.274 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 170' ' ' ASP . . . . . 0.555 ' N ' ' O ' ' A' ' 168' ' ' VAL . 32.7 p30 17.78 91.26 0.01 OUTLIER 'General case' 0 N--CA 1.505 2.319 0 N-CA-C 111.927 0.343 . . . . 0.0 111.927 177.206 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 171' ' ' GLU . . . . . 0.619 ' H ' HE21 ' A' ' 172' ' ' GLN . 3.0 pt-20 -141.48 78.79 1.65 Allowed 'General case' 0 N--CA 1.494 1.733 0 O-C-N 120.732 -1.23 . . . . 0.0 110.272 179.965 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 172' ' ' GLN . . . . . 0.619 HE21 ' H ' ' A' ' 171' ' ' GLU . 32.3 mm-40 -130.13 -47.51 1.11 Allowed 'General case' 0 N--CA 1.499 2.002 0 O-C-N 121.282 -0.886 . . . . 0.0 110.967 -178.788 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 173' ' ' LYS . . . . . 0.561 ' O ' ' NE2' ' A' ' 113' ' ' GLN . 0.0 OUTLIER -60.48 137.85 58.1 Favored 'General case' 0 N--CA 1.498 1.967 0 O-C-N 120.894 -1.129 . . . . 0.0 109.064 -179.894 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 174' ' ' GLY . . . . . 0.533 ' O ' ' C ' ' A' ' 175' ' ' LYS . . . -122.93 -44.09 0.34 Allowed Glycine 0 N--CA 1.481 1.648 0 N-CA-C 108.093 -2.003 . . . . 0.0 108.093 179.547 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 175' ' ' LYS . . . . . 0.533 ' C ' ' O ' ' A' ' 174' ' ' GLY . 3.0 mmtt -40.48 -63.87 0.58 Allowed 'General case' 0 N--CA 1.491 1.59 0 N-CA-C 107.072 -1.455 . . . . 0.0 107.072 178.725 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 176' ' ' ASP . . . . . 0.589 ' O ' ' O ' ' A' ' 177' ' ' LYS . 1.2 p-10 -104.7 88.18 2.86 Favored 'General case' 0 C--N 1.299 -1.614 0 N-CA-C 108.207 -1.035 . . . . 0.0 108.207 177.428 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 177' ' ' LYS . . . . . 0.589 ' O ' ' O ' ' A' ' 176' ' ' ASP . 23.6 mttm -47.32 -174.19 0.0 OUTLIER 'General case' 0 N--CA 1.499 1.978 0 N-CA-C 108.793 -0.817 . . . . 0.0 108.793 179.936 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 178' ' ' GLN . . . . . 0.506 ' NE2' ' OD1' ' A' ' 114' ' ' ASN . 0.0 OUTLIER -162.59 167.28 23.53 Favored 'General case' 0 C--N 1.303 -1.419 0 O-C-N 120.267 -1.521 . . . . 0.0 110.862 179.626 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 179' ' ' LEU . . . . . 0.402 ' HB2' ' CD2' ' A' ' 153' ' ' TYR . 0.9 OUTLIER -119.03 98.03 5.98 Favored 'General case' 0 C--N 1.304 -1.408 0 N-CA-C 107.028 -1.471 . . . . 0.0 107.028 177.976 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 180' ' ' THR . . . . . 0.504 ' OG1' ' OD1' ' A' ' 170' ' ' ASP . 1.3 m -76.98 116.13 17.38 Favored 'General case' 0 C--N 1.302 -1.488 0 O-C-N 121.411 -0.806 . . . . 0.0 110.205 -178.449 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 181' ' ' LEU . . . . . 0.4 HD13 ' H ' ' A' ' 182' ' ' ILE . 54.4 tp -93.78 152.08 19.17 Favored 'General case' 0 C--N 1.301 -1.537 0 N-CA-C 107.774 -1.195 . . . . 0.0 107.774 177.715 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 182' ' ' ILE . . . . . 0.4 ' H ' HD13 ' A' ' 181' ' ' LEU . 85.4 mt -141.07 117.88 7.81 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.713 0 O-C-N 121.009 -1.057 . . . . 0.0 108.687 179.247 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 183' ' ' THR . . . . . 0.416 ' O ' ' CG2' ' A' ' 183' ' ' THR . 10.1 t -131.12 111.44 11.98 Favored 'General case' 0 C--N 1.292 -1.908 0 N-CA-C 108.039 -1.097 . . . . 0.0 108.039 179.485 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 184' ' ' CYS . . . . . . . . . . . . . 0.8 OUTLIER -78.46 153.06 31.76 Favored 'General case' 0 C--N 1.289 -2.044 0 C-N-CA 118.882 -1.127 . . . . 0.0 110.583 -177.977 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 185' ' ' ASP . . . . . . . . . . . . . 2.5 t0 -166.1 -159.13 0.37 Allowed 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.616 -0.677 . . . . 0.0 109.504 -179.447 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 186' ' ' ASP . . . . . . . . . . . . . 1.2 m-20 55.79 52.78 10.28 Favored 'General case' 0 N--CA 1.493 1.717 0 O-C-N 121.233 -0.917 . . . . 0.0 109.453 179.977 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 187' ' ' TYR . . . . . 0.628 ' CE2' ' O ' ' A' ' 188' ' ' ASN . 64.5 t80 -67.96 134.18 50.32 Favored 'General case' 0 C--N 1.3 -1.551 0 O-C-N 121.063 -1.023 . . . . 0.0 110.949 -179.508 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 188' ' ' ASN . . . . . 0.628 ' O ' ' CE2' ' A' ' 187' ' ' TYR . 0.7 OUTLIER -101.46 146.46 27.59 Favored 'General case' 0 C--N 1.295 -1.766 0 N-CA-C 108.091 -1.077 . . . . 0.0 108.091 178.201 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 189' ' ' GLU . . . . . . . . . . . . . 3.1 tt0 -109.65 -12.17 14.68 Favored 'General case' 0 C--N 1.292 -1.923 0 N-CA-C 108.458 -0.942 . . . . 0.0 108.458 -179.793 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 190' ' ' LYS . . . . . . . . . . . . . 11.7 mtpt -85.75 -55.03 4.17 Favored 'General case' 0 C--N 1.302 -1.469 0 N-CA-C 109.079 -0.712 . . . . 0.0 109.079 178.908 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 191' ' ' THR . . . . . . . . . . . . . 1.2 p -89.55 1.59 55.74 Favored 'General case' 0 N--CA 1.494 1.729 0 O-C-N 121.236 -0.915 . . . . 0.0 110.073 -179.754 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 192' ' ' GLY . . . . . . . . . . . . . . . 52.78 40.89 57.27 Favored Glycine 0 N--CA 1.496 2.644 0 O-C-N 120.97 -1.081 . . . . 0.0 110.969 179.169 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 193' ' ' VAL . . . . . 0.477 ' CG1' ' N ' ' A' ' 194' ' ' TRP . 52.9 t -149.65 160.5 5.01 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.653 0 O-C-N 120.858 -1.377 . . . . 0.0 109.356 178.999 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 194' ' ' TRP . . . . . 0.477 ' N ' ' CG1' ' A' ' 193' ' ' VAL . 12.7 m95 -82.94 118.98 23.86 Favored 'General case' 0 N--CA 1.491 1.586 0 N-CA-C 107.989 -1.115 . . . . 0.0 107.989 179.308 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 195' ' ' GLU . . . . . . . . . . . . . 2.1 mt-10 -75.88 -60.46 2.31 Favored 'General case' 0 N--CA 1.494 1.769 0 O-C-N 121.336 -0.853 . . . . 0.0 111.538 -177.745 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 196' ' ' LYS . . . . . . . . . . . . . 16.8 mmtp -92.01 153.18 19.6 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 120.901 -1.124 . . . . 0.0 111.262 -178.047 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 197' ' ' ARG . . . . . . . . . . . . . 21.5 mmm180 -119.17 138.97 52.58 Favored 'General case' 0 N--CA 1.488 1.471 0 N-CA-C 107.825 -1.176 . . . . 0.0 107.825 178.659 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 198' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -116.77 116.68 27.95 Favored 'General case' 0 C--N 1.301 -1.519 0 O-C-N 121.61 -0.681 . . . . 0.0 110.192 -178.715 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 199' ' ' ILE . . . . . 0.418 ' C ' ' CD1' ' A' ' 199' ' ' ILE . 0.6 OUTLIER -141.18 122.26 13.4 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.685 0 CA-C-O 122.338 1.066 . . . . 0.0 109.842 179.456 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 200' ' ' PHE . . . . . 0.622 ' CD1' ' N ' ' A' ' 200' ' ' PHE . 0.2 OUTLIER -106.33 142.1 36.56 Favored 'General case' 0 N--CA 1.494 1.769 0 O-C-N 121.438 -0.789 . . . . 0.0 110.318 -178.55 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 201' ' ' VAL . . . . . . . . . . . . . 47.6 t -104.45 150.11 7.66 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.532 0 N-CA-C 108.476 -0.935 . . . . 0.0 108.476 178.555 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 202' ' ' ALA . . . . . . . . . . . . . . . -131.37 139.38 49.47 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.246 -0.909 . . . . 0.0 109.035 -179.802 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 203' ' ' THR . . . . . 0.54 ' CG2' ' OG1' ' A' ' 156' ' ' THR . 25.1 p -88.86 127.46 35.63 Favored 'General case' 0 C--N 1.303 -1.452 0 CA-C-O 122.354 1.073 . . . . 0.0 110.917 -178.57 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 204' ' ' GLU . . . . . 0.504 ' HA ' ' CD2' ' A' ' 153' ' ' TYR . 1.7 tt0 -48.75 134.35 16.34 Favored 'General case' 0 C--N 1.297 -1.713 0 C-N-CA 118.873 -1.131 . . . . 0.0 109.248 179.83 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 205' ' ' VAL . . . . . 0.498 ' CG1' ' N ' ' A' ' 206' ' ' LYS . 72.7 t -126.54 163.6 28.44 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.361 0 CA-C-O 122.141 0.972 . . . . 0.0 110.039 -177.674 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 206' ' ' LYS . . . . . 0.498 ' N ' ' CG1' ' A' ' 205' ' ' VAL . 0.2 OUTLIER . . . . . 0 C--N 1.291 -1.949 0 CA-C-O 118.024 -0.989 . . . . 0.0 109.45 -179.981 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' C' C ' 702' ' ' LEU . . . . . 0.652 ' CD1' ' N ' ' C' ' 702' ' ' LEU . 0.0 OUTLIER . . . . . 0 N--CA 1.489 1.511 0 N-CA-C 109.303 -0.628 . . . . 0.0 109.303 . . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' C' C ' 703' ' ' PRO . . . . . 0.495 ' O ' ' O ' ' C' ' 704' ' ' ALA . 96.9 Cg_endo -79.79 -174.44 2.27 Favored 'Trans proline' 0 N--CA 1.495 1.612 0 C-N-CA 122.94 2.427 . . . . 0.0 113.524 -179.418 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' C' C ' 704' ' ' ALA . . . . . 0.495 ' O ' ' O ' ' C' ' 703' ' ' PRO . . . . . . . . 0 N--CA 1.491 1.579 0 CA-C-O 121.744 0.783 . . . . 0.0 110.544 179.076 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 63' ' ' PRO . . . . . . . . . . . . . 5.3 Cg_exo . . . . . 0 N--CA 1.487 1.146 0 CA-C-O 121.416 0.507 . . . . 0.0 112.269 . . . . . . . . . 0 0 . 1 . 018 nuclear orig core ' A' A ' 64' ' ' GLN . . . . . 0.74 ' N ' HE21 ' A' ' 64' ' ' GLN . 0.0 OUTLIER -150.34 101.75 3.0 Favored 'General case' 0 N--CA 1.494 1.732 0 O-C-N 121.205 -0.935 . . . . 0.0 109.618 -179.891 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 65' ' ' ILE . . . . . 0.471 ' C ' ' O ' ' A' ' 64' ' ' GLN . 2.8 mp -39.79 100.83 0.22 Allowed Pre-proline 0 N--CA 1.491 1.603 0 N-CA-C 108.557 -0.905 . . . . 0.0 108.557 179.523 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 66' ' ' PRO . . . . . 0.423 ' N ' ' O ' ' A' ' 64' ' ' GLN . 71.8 Cg_endo -83.87 -155.32 0.06 OUTLIER 'Trans proline' 0 C--N 1.317 -1.118 0 C-N-CA 122.286 1.991 . . . . 0.0 112.679 -178.311 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 67' ' ' LYS . . . . . 0.414 ' C ' ' H ' ' A' ' 69' ' ' LYS . 8.5 ptmt -83.93 -4.94 59.08 Favored 'General case' 0 C--N 1.304 -1.371 0 O-C-N 121.391 -0.818 . . . . 0.0 109.388 -179.825 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 68' ' ' ASP . . . . . 0.588 ' C ' ' N ' ' A' ' 70' ' ' SER . 0.1 OUTLIER -73.82 51.47 0.38 Allowed 'General case' 0 N--CA 1.491 1.58 0 CA-C-O 122.566 1.174 . . . . 0.0 108.326 179.52 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 69' ' ' LYS . . . . . 0.598 ' O ' ' NH1' ' A' ' 99' ' ' ARG . 12.0 mtmm -49.49 -16.11 0.19 Allowed 'General case' 0 N--CA 1.497 1.888 0 C-N-CA 116.949 -1.9 . . . . 0.0 107.152 178.857 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 70' ' ' SER . . . . . 0.588 ' N ' ' C ' ' A' ' 68' ' ' ASP . 1.2 t -83.94 -7.16 59.49 Favored 'General case' 0 C--N 1.293 -1.89 0 CA-C-N 113.995 -1.457 . . . . 0.0 110.22 179.976 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 71' ' ' LYS . . . . . 0.413 ' O ' ' CG ' ' A' ' 71' ' ' LYS . 1.0 OUTLIER -96.84 141.41 30.07 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.126 -0.984 . . . . 0.0 110.826 179.825 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 2.3 m -65.01 139.62 21.1 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.522 0 N-CA-C 103.988 -2.597 . . . . 0.0 103.988 174.361 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 73' ' ' ALA . . . . . 0.511 ' N ' ' O ' ' A' ' 87' ' ' VAL . . . -81.21 -14.18 57.8 Favored 'General case' 0 C--N 1.292 -1.917 0 C-N-CA 117.11 -1.836 . . . . 0.0 106.203 179.799 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . 169.07 -152.04 19.12 Favored Glycine 0 N--CA 1.481 1.677 0 N-CA-C 109.873 -1.291 . . . . 0.0 109.873 178.868 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 75' ' ' TYR . . . . . 0.468 ' CD2' ' O ' ' A' ' 85' ' ' GLU . 2.3 m-85 -142.59 173.25 11.7 Favored 'General case' 0 C--N 1.298 -1.639 0 CA-C-O 122.085 0.945 . . . . 0.0 110.545 -178.118 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 76' ' ' ILE . . . . . . . . . . . . . 1.6 tp -147.9 141.88 19.3 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.682 0 C-N-CA 119.93 -0.708 . . . . 0.0 109.142 -176.954 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 77' ' ' GLU . . . . . 0.563 ' N ' ' OE1' ' A' ' 77' ' ' GLU . 0.0 OUTLIER -149.96 163.07 39.08 Favored 'General case' 0 C--N 1.304 -1.39 0 O-C-N 121.014 -1.054 . . . . 0.0 109.244 178.913 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 78' ' ' ILE . . . . . 0.495 ' O ' ' N ' ' A' ' 82' ' ' ASP . 7.9 mt -144.35 100.57 4.82 Favored Pre-proline 0 C--N 1.302 -1.496 0 O-C-N 121.338 -0.851 . . . . 0.0 109.022 179.991 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 79' ' ' PRO . . . . . . . . . . . . . 81.9 Cg_exo -48.25 -50.55 11.84 Favored 'Trans proline' 0 N--CA 1.493 1.469 0 C-N-CA 122.794 2.329 . . . . 0.0 113.632 -179.453 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -65.94 -18.93 65.67 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 120.889 -1.132 . . . . 0.0 111.098 178.906 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 81' ' ' ALA . . . . . 0.543 ' O ' ' ND2' ' A' ' 132' ' ' ASN . . . -105.32 -16.93 14.62 Favored 'General case' 0 N--CA 1.494 1.734 0 O-C-N 121.069 -1.019 . . . . 0.0 108.81 179.521 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 82' ' ' ASP . . . . . 0.495 ' N ' ' O ' ' A' ' 78' ' ' ILE . 9.1 t0 65.81 50.47 1.54 Allowed 'General case' 0 N--CA 1.493 1.704 0 O-C-N 121.372 -0.83 . . . . 0.0 111.368 178.157 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 83' ' ' ILE . . . . . . . . . . . . . 45.2 mt -130.66 153.94 39.86 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.92 0 O-C-N 121.14 -0.975 . . . . 0.0 109.668 -179.273 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 84' ' ' LYS . . . . . . . . . . . . . 30.8 ttmt -158.01 110.25 2.33 Favored 'General case' 0 N--CA 1.497 1.88 0 N-CA-C 108.184 -1.043 . . . . 0.0 108.184 179.991 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 85' ' ' GLU . . . . . 0.497 ' OE1' ' O ' ' A' ' 129' ' ' GLN . 0.0 OUTLIER -141.33 167.2 17.92 Favored Pre-proline 0 N--CA 1.499 1.976 0 O-C-N 121.281 -0.887 . . . . 0.0 110.871 -178.45 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 86' ' ' PRO . . . . . . . . . . . . . 55.8 Cg_endo -74.75 161.92 38.53 Favored 'Trans proline' 0 N--CA 1.497 1.722 0 C-N-CA 123.263 2.642 . . . . 0.0 113.108 -179.869 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 87' ' ' VAL . . . . . 0.511 ' O ' ' N ' ' A' ' 73' ' ' ALA . 55.7 t -123.32 99.79 7.09 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.844 0 O-C-N 121.686 -0.634 . . . . 0.0 109.337 179.582 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 88' ' ' TYR . . . . . . . . . . . . . 15.3 m-85 -89.99 155.1 47.56 Favored Pre-proline 0 N--CA 1.496 1.849 0 O-C-N 120.835 -1.166 . . . . 0.0 109.423 179.861 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 89' ' ' PRO . . . . . . . . . . . . . 11.8 Cg_endo -64.39 146.66 90.12 Favored 'Trans proline' 0 N--CA 1.496 1.642 0 C-N-CA 122.529 2.152 . . . . 0.0 113.952 -179.343 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . -59.04 167.59 7.06 Favored Glycine 0 N--CA 1.495 2.609 0 N-CA-C 110.382 -1.087 . . . . 0.0 110.382 179.663 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 91' ' ' PRO . . . . . 0.465 ' C ' ' H ' ' A' ' 93' ' ' THR . 90.2 Cg_endo -93.48 168.68 20.81 Favored 'Cis proline' 0 C--N 1.314 -1.237 0 C-N-CA 123.592 -1.42 . . . . 0.0 111.762 0.569 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 92' ' ' ALA . . . . . . . . . . . . . . . -72.03 33.04 0.06 Allowed 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.032 -1.042 . . . . 0.0 110.713 -179.9 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 93' ' ' THR . . . . . 0.465 ' H ' ' C ' ' A' ' 91' ' ' PRO . 3.3 p -71.18 150.39 94.54 Favored Pre-proline 0 N--CA 1.488 1.472 0 O-C-N 120.668 -1.27 . . . . 0.0 108.157 -179.865 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 94' ' ' PRO . . . . . 0.421 ' C ' ' O ' ' A' ' 93' ' ' THR . 87.3 Cg_exo -30.35 -56.26 0.19 Allowed 'Trans proline' 0 C--N 1.308 -1.6 0 C-N-CA 123.007 2.471 . . . . 0.0 112.672 -179.011 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 98.6 mt-10 -51.06 -46.32 61.67 Favored 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.12 -0.988 . . . . 0.0 109.825 -179.76 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 96' ' ' GLN . . . . . 0.422 ' OE1' ' CZ ' ' A' ' 99' ' ' ARG . 1.1 mp0 -71.92 -36.95 70.1 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.387 -0.821 . . . . 0.0 110.712 -179.375 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 97' ' ' LEU . . . . . . . . . . . . . 89.0 mt -68.4 -5.94 21.85 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 120.833 -1.167 . . . . 0.0 109.248 -179.682 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 98' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER -78.24 -27.05 47.53 Favored 'General case' 0 N--CA 1.492 1.673 0 O-C-N 121.319 -0.863 . . . . 0.0 109.893 179.42 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 99' ' ' ARG . . . . . 0.598 ' NH1' ' O ' ' A' ' 69' ' ' LYS . 63.8 mtt180 -91.07 -43.5 9.88 Favored 'General case' 0 N--CA 1.488 1.47 0 O-C-N 121.531 -0.731 . . . . 0.0 109.956 -178.524 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . 169.81 -171.7 43.43 Favored Glycine 0 N--CA 1.49 2.28 0 N-CA-C 109.898 -1.281 . . . . 0.0 109.898 -179.992 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 101' ' ' VAL . . . . . 0.527 ' O ' ' CG2' ' A' ' 101' ' ' VAL . 13.0 m -57.48 106.63 0.18 Allowed 'Isoleucine or valine' 0 N--CA 1.494 1.758 0 O-C-N 121.401 -1.058 . . . . 0.0 109.152 -179.915 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 102' ' ' SER . . . . . 0.418 ' HG ' ' C ' ' A' ' 91' ' ' PRO . 0.0 OUTLIER -92.52 163.31 13.86 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 120.87 -1.144 . . . . 0.0 111.184 -179.176 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 103' ' ' PHE . . . . . 0.484 ' CZ ' ' CG1' ' A' ' 87' ' ' VAL . 25.0 m-85 -70.46 141.85 52.0 Favored 'General case' 0 N--CA 1.489 1.501 0 N-CA-C 108.145 -1.057 . . . . 0.0 108.145 178.334 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 104' ' ' ALA . . . . . . . . . . . . . . . -58.73 -15.86 14.0 Favored 'General case' 0 C--N 1.3 -1.548 0 O-C-N 121.474 -0.766 . . . . 0.0 111.104 -178.828 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -139.07 144.24 38.68 Favored 'General case' 0 N--CA 1.492 1.65 0 O-C-N 120.906 -1.121 . . . . 0.0 110.082 -179.304 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 106' ' ' GLU . . . . . . . . . . . . . 6.3 tt0 -58.1 -55.43 35.04 Favored 'General case' 0 C--N 1.299 -1.618 0 O-C-N 121.892 -0.505 . . . . 0.0 110.599 -179.363 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 107' ' ' ASN . . . . . 0.498 ' N ' ' ND2' ' A' ' 107' ' ' ASN . 1.8 m120 -77.85 35.15 0.2 Allowed 'General case' 0 N--CA 1.487 1.395 0 O-C-N 120.622 -1.299 . . . . 0.0 112.223 -176.152 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 108' ' ' GLU . . . . . . . . . . . . . 21.7 tp10 -57.81 139.82 53.15 Favored 'General case' 0 N--CA 1.488 1.457 0 N-CA-C 107.605 -1.257 . . . . 0.0 107.605 179.635 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 109' ' ' SER . . . . . 0.404 ' OG ' ' OD2' ' A' ' 112' ' ' ASP . 0.9 OUTLIER -93.08 146.53 23.57 Favored 'General case' 0 C--N 1.302 -1.486 0 O-C-N 120.97 -1.081 . . . . 0.0 110.776 -178.08 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 110' ' ' LEU . . . . . 0.461 ' H ' ' CD2' ' A' ' 110' ' ' LEU . 0.3 OUTLIER -62.66 -24.5 67.65 Favored 'General case' 0 C--N 1.303 -1.424 0 N-CA-C 107.281 -1.377 . . . . 0.0 107.281 178.641 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 111' ' ' ASP . . . . . . . . . . . . . 4.0 m-20 -133.03 48.95 2.35 Favored 'General case' 0 N--CA 1.485 1.298 0 N-CA-C 109.396 -0.594 . . . . 0.0 109.396 179.663 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 112' ' ' ASP . . . . . 0.404 ' OD2' ' OG ' ' A' ' 109' ' ' SER . 1.7 t0 -69.33 159.47 33.06 Favored 'General case' 0 N--CA 1.494 1.731 0 O-C-N 121.127 -0.983 . . . . 0.0 111.333 -179.608 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 113' ' ' GLN . . . . . 0.547 ' N ' ' CD ' ' A' ' 113' ' ' GLN . 0.0 OUTLIER -64.63 -17.98 64.52 Favored 'General case' 0 N--CA 1.491 1.607 0 N-CA-C 107.361 -1.348 . . . . 0.0 107.361 177.668 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 114' ' ' ASN . . . . . 0.682 ' ND2' ' NE2' ' A' ' 178' ' ' GLN . 59.9 t-20 -153.55 111.81 3.62 Favored 'General case' 0 C--N 1.298 -1.662 0 N-CA-C 107.803 -1.184 . . . . 0.0 107.803 177.631 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 115' ' ' ILE . . . . . 0.442 HD12 HG21 ' A' ' 115' ' ' ILE . 2.8 mt -93.6 102.8 14.01 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.557 0 O-C-N 120.988 -1.07 . . . . 0.0 108.128 -179.935 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 116' ' ' SER . . . . . . . . . . . . . 72.3 m -81.76 141.31 33.64 Favored 'General case' 0 N--CA 1.488 1.453 0 CA-C-O 122.088 0.947 . . . . 0.0 112.114 -177.001 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 117' ' ' ILE . . . . . . . . . . . . . 28.2 mt -138.05 140.85 39.78 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.474 0 N-CA-C 107.357 -1.349 . . . . 0.0 107.357 178.609 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 118' ' ' ALA . . . . . . . . . . . . . . . -141.98 155.58 45.45 Favored 'General case' 0 N--CA 1.489 1.492 0 C-N-CA 118.63 -1.228 . . . . 0.0 111.043 -178.967 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 119' ' ' GLY . . . . . . . . . . . . . . . -166.8 152.55 21.55 Favored Glycine 0 N--CA 1.483 1.813 0 N-CA-C 109.967 -1.253 . . . . 0.0 109.967 179.769 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 120' ' ' HIS . . . . . . . . . . . . . 26.4 m170 -71.73 142.1 49.78 Favored 'General case' 0 N--CA 1.493 1.71 0 O-C-N 121.604 -0.939 . . . . 0.0 110.592 179.864 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 121' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -99.06 153.36 18.94 Favored 'General case' 0 N--CA 1.496 1.835 0 N-CA-C 107.896 -1.15 . . . . 0.0 107.896 178.419 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 122' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -116.85 140.69 49.15 Favored 'General case' 0 N--CA 1.496 1.869 0 O-C-N 121.139 -0.976 . . . . 0.0 110.603 -179.676 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 123' ' ' ILE . . . . . . . . . . . . . 15.7 tt -90.28 -33.13 5.76 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.641 0 CA-C-O 121.876 0.846 . . . . 0.0 109.083 179.619 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 124' ' ' ASP . . . . . . . . . . . . . 80.0 m-20 -89.78 3.08 53.95 Favored 'General case' 0 N--CA 1.497 1.888 0 CA-C-N 116.069 -0.514 . . . . 0.0 111.772 -178.706 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 125' ' ' ARG . . . . . 0.651 HH11 ' CG ' ' A' ' 125' ' ' ARG . 1.7 mtt-85 -151.3 120.7 3.53 Favored Pre-proline 0 N--CA 1.499 1.995 0 O-C-N 120.383 -1.448 . . . . 0.0 110.114 -179.193 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 126' ' ' PRO . . . . . . . . . . . . . 88.9 Cg_endo -81.48 -18.99 7.95 Favored 'Trans proline' 0 N--CA 1.489 1.257 0 C-N-CA 122.279 1.986 . . . . 0.0 112.396 179.199 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 127' ' ' ASN . . . . . 0.514 ' O ' ' O ' ' A' ' 128' ' ' TYR . 3.9 m120 -92.65 4.35 53.84 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.274 -0.891 . . . . 0.0 110.109 -179.759 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 128' ' ' TYR . . . . . 0.514 ' O ' ' O ' ' A' ' 127' ' ' ASN . 9.1 t80 -58.7 -147.25 0.0 OUTLIER 'General case' 0 N--CA 1.488 1.447 0 O-C-N 121.283 -0.886 . . . . 0.0 109.337 179.995 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 129' ' ' GLN . . . . . 0.497 ' O ' ' OE1' ' A' ' 85' ' ' GLU . 12.7 mt-30 -64.96 -91.23 0.01 OUTLIER 'General case' 0 N--CA 1.493 1.724 0 O-C-N 120.833 -1.167 . . . . 0.0 110.284 -178.941 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 130' ' ' PHE . . . . . 0.409 ' CZ ' ' OE2' ' A' ' 85' ' ' GLU . 44.2 m-85 -114.28 48.0 1.15 Allowed 'General case' 0 N--CA 1.496 1.835 0 O-C-N 121.159 -0.963 . . . . 0.0 109.355 179.851 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 131' ' ' THR . . . . . 0.526 ' O ' ' CD ' ' A' ' 134' ' ' LYS . 56.9 m -77.83 -26.54 49.51 Favored 'General case' 0 C--N 1.3 -1.558 0 O-C-N 121.213 -0.93 . . . . 0.0 109.563 -179.998 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 132' ' ' ASN . . . . . 0.543 ' ND2' ' O ' ' A' ' 81' ' ' ALA . 12.4 t30 -90.23 13.36 15.46 Favored 'General case' 0 N--CA 1.5 2.042 0 C-N-CA 119.759 -0.776 . . . . 0.0 111.932 -178.855 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 133' ' ' LEU . . . . . 0.448 ' O ' ' N ' ' A' ' 136' ' ' ALA . 0.2 OUTLIER -67.97 -29.81 68.94 Favored 'General case' 0 N--CA 1.495 1.779 0 O-C-N 120.399 -1.438 . . . . 0.0 109.594 -179.749 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 134' ' ' LYS . . . . . 0.656 ' H ' ' CD ' ' A' ' 134' ' ' LYS . 0.0 OUTLIER -44.09 -29.96 0.69 Allowed 'General case' 0 N--CA 1.496 1.862 0 O-C-N 121.43 -0.794 . . . . 0.0 110.455 -179.432 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 135' ' ' ALA . . . . . . . . . . . . . . . -84.76 -21.39 30.03 Favored 'General case' 0 N--CA 1.488 1.466 0 O-C-N 121.045 -1.034 . . . . 0.0 109.937 -179.621 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 136' ' ' ALA . . . . . 0.448 ' N ' ' O ' ' A' ' 133' ' ' LEU . . . -81.74 137.69 35.31 Favored 'General case' 0 C--N 1.301 -1.526 0 CA-C-O 122.039 0.924 . . . . 0.0 111.957 -178.336 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 137' ' ' LYS . . . . . 0.513 ' O ' ' OG ' ' A' ' 140' ' ' SER . 3.9 tttt -156.59 -166.0 2.02 Favored 'General case' 0 C--N 1.299 -1.604 0 C-N-CA 118.824 -1.15 . . . . 0.0 110.857 -179.349 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 138' ' ' LYS . . . . . 0.622 ' O ' ' N ' ' A' ' 140' ' ' SER . 29.0 mttt -46.61 -178.36 0.0 OUTLIER 'General case' 0 C--N 1.3 -1.549 0 CA-C-O 121.873 0.844 . . . . 0.0 110.107 -179.916 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 139' ' ' GLY . . . . . . . . . . . . . . . 44.95 8.41 0.01 OUTLIER Glycine 0 N--CA 1.489 2.198 0 N-CA-C 110.641 -0.984 . . . . 0.0 110.641 179.56 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 140' ' ' SER . . . . . 0.622 ' N ' ' O ' ' A' ' 138' ' ' LYS . 45.8 m -94.55 128.49 41.2 Favored 'General case' 0 N--CA 1.489 1.503 0 O-C-N 120.723 -1.457 . . . . 0.0 109.247 179.47 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 141' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -81.66 127.54 33.01 Favored 'General case' 0 C--N 1.3 -1.545 0 O-C-N 121.288 -0.883 . . . . 0.0 108.792 179.809 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 142' ' ' VAL . . . . . . . . . . . . . 12.8 t -113.72 135.13 54.33 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.553 0 N-CA-C 108.788 -0.819 . . . . 0.0 108.788 -179.529 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 143' ' ' TYR . . . . . 0.539 ' CE1' ' CG ' ' A' ' 152' ' ' LYS . 9.5 m-85 -111.36 136.13 50.93 Favored 'General case' 0 N--CA 1.493 1.7 0 O-C-N 121.012 -1.055 . . . . 0.0 110.316 -178.886 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 144' ' ' PHE . . . . . 0.463 ' CG ' ' N ' ' A' ' 145' ' ' LYS . 44.6 t80 -113.37 160.1 18.75 Favored 'General case' 0 N--CA 1.493 1.696 0 CA-C-O 122.072 0.939 . . . . 0.0 110.806 -178.263 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 145' ' ' LYS . . . . . 0.463 ' N ' ' CG ' ' A' ' 144' ' ' PHE . 36.7 tttm -148.13 125.23 11.41 Favored 'General case' 0 C--N 1.301 -1.525 0 C-N-CA 119.25 -0.98 . . . . 0.0 110.761 -178.546 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 146' ' ' VAL . . . . . . . . . . . . . 11.8 p -145.82 138.94 20.95 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.63 0 N-CA-C 106.827 -1.545 . . . . 0.0 106.827 178.625 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 147' ' ' GLY . . . . . . . . . . . . . . . 58.67 -141.23 46.7 Favored Glycine 0 N--CA 1.486 1.985 0 N-CA-C 108.359 -1.896 . . . . 0.0 108.359 -179.273 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 148' ' ' ASN . . . . . 0.536 ' C ' HD21 ' A' ' 148' ' ' ASN . 0.4 OUTLIER -101.79 24.75 9.44 Favored 'General case' 0 C--N 1.296 -1.741 0 N-CA-C 107.821 -1.177 . . . . 0.0 107.821 178.821 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 149' ' ' GLU . . . . . . . . . . . . . 2.0 tm-20 -116.52 159.24 22.37 Favored 'General case' 0 N--CA 1.49 1.54 0 CA-C-O 121.796 0.808 . . . . 0.0 110.727 -179.086 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 150' ' ' THR . . . . . . . . . . . . . 11.1 m -140.15 109.44 6.17 Favored 'General case' 0 N--CA 1.492 1.666 0 N-CA-C 109.029 -0.73 . . . . 0.0 109.029 179.212 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 151' ' ' ARG . . . . . . . . . . . . . 9.8 mtt180 -89.16 -161.01 0.72 Allowed 'General case' 0 N--CA 1.489 1.495 0 CA-C-O 121.546 0.688 . . . . 0.0 110.433 -178.586 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 152' ' ' LYS . . . . . 0.539 ' CG ' ' CE1' ' A' ' 143' ' ' TYR . 9.3 mtmt -148.26 148.78 30.85 Favored 'General case' 0 N--CA 1.486 1.359 0 O-C-N 121.394 -0.816 . . . . 0.0 110.326 -179.187 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 153' ' ' TYR . . . . . 0.406 ' CD1' ' C ' ' A' ' 152' ' ' LYS . 52.8 m-85 -146.31 158.66 43.91 Favored 'General case' 0 C--N 1.303 -1.433 0 N-CA-C 108.111 -1.07 . . . . 0.0 108.111 179.277 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 154' ' ' LYS . . . . . . . . . . . . . 15.1 ttmm -137.1 121.5 18.21 Favored 'General case' 0 N--CA 1.495 1.824 0 O-C-N 121.186 -0.946 . . . . 0.0 108.538 179.053 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 155' ' ' MET . . . . . . . . . . . . . 5.7 mtt -47.96 107.79 0.14 Allowed 'General case' 0 N--CA 1.493 1.685 0 O-C-N 120.913 -1.117 . . . . 0.0 111.193 -178.588 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 156' ' ' THR . . . . . 0.537 ' HG1' ' HG1' ' A' ' 203' ' ' THR . 0.3 OUTLIER -108.02 -25.51 11.12 Favored 'General case' 0 C--N 1.293 -1.872 0 CA-C-N 115.3 -0.864 . . . . 0.0 109.635 -179.342 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 157' ' ' SER . . . . . . . . . . . . . 60.7 m -149.87 146.3 27.03 Favored 'General case' 0 C--N 1.299 -1.626 0 C-N-CA 118.61 -1.236 . . . . 0.0 110.455 -179.048 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 158' ' ' ILE . . . . . . . . . . . . . 3.8 mp -151.48 141.73 15.71 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.445 0 CA-C-O 121.925 0.869 . . . . 0.0 109.988 -179.274 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 159' ' ' ARG . . . . . 0.419 HH21 HG12 ' A' ' 161' ' ' VAL . 3.0 ttp180 -155.09 -171.98 4.02 Favored 'General case' 0 C--N 1.292 -1.897 0 C-N-CA 119.67 -0.812 . . . . 0.0 110.394 -179.601 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 160' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -145.67 161.17 40.48 Favored 'General case' 0 C--N 1.301 -1.539 0 N-CA-C 108.0 -1.111 . . . . 0.0 108.0 -179.725 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 161' ' ' VAL . . . . . 0.489 ' O ' ' O ' ' A' ' 162' ' ' LYS . 0.0 OUTLIER -154.4 155.62 5.89 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.645 0 O-C-N 120.755 -1.216 . . . . 0.0 110.835 -179.091 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 162' ' ' LYS . . . . . 0.489 ' O ' ' O ' ' A' ' 161' ' ' VAL . 0.2 OUTLIER -51.47 179.47 0.04 OUTLIER Pre-proline 0 C--N 1.305 -1.33 0 N-CA-C 107.153 -1.425 . . . . 0.0 107.153 178.064 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 163' ' ' PRO . . . . . 0.445 ' C ' ' HG1' ' A' ' 164' ' ' THR . 29.5 Cg_endo -87.69 45.79 1.2 Allowed 'Trans proline' 0 C--N 1.307 -1.631 0 C-N-CA 122.103 1.869 . . . . 0.0 111.748 -179.548 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 164' ' ' THR . . . . . 0.445 ' HG1' ' C ' ' A' ' 163' ' ' PRO . 7.5 m -153.28 -16.41 0.15 Allowed 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.268 -0.895 . . . . 0.0 110.671 -179.626 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 165' ' ' ASP . . . . . 0.489 ' O ' ' N ' ' A' ' 167' ' ' GLY . 0.4 OUTLIER -72.36 58.94 0.41 Allowed 'General case' 0 N--CA 1.493 1.699 0 O-C-N 120.791 -1.193 . . . . 0.0 110.397 -179.063 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 166' ' ' VAL . . . . . 0.59 ' O ' ' N ' ' A' ' 168' ' ' VAL . 1.0 OUTLIER -40.64 -27.22 0.09 OUTLIER 'Isoleucine or valine' 0 N--CA 1.489 1.515 0 O-C-N 121.297 -0.877 . . . . 0.0 109.129 -178.797 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 167' ' ' GLY . . . . . 0.489 ' N ' ' O ' ' A' ' 165' ' ' ASP . . . -46.48 -4.64 0.01 OUTLIER Glycine 0 N--CA 1.496 2.658 0 O-C-N 120.799 -1.188 . . . . 0.0 112.006 -179.768 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 168' ' ' VAL . . . . . 0.632 ' C ' ' H ' ' A' ' 170' ' ' ASP . 0.2 OUTLIER -51.76 -36.33 18.82 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.894 0 O-C-N 120.131 -1.805 . . . . 0.0 108.69 179.866 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 169' ' ' LEU . . . . . 0.536 ' O ' ' C ' ' A' ' 170' ' ' ASP . 5.3 mt -52.69 -6.17 0.05 OUTLIER 'General case' 0 N--CA 1.492 1.653 0 N-CA-C 108.7 -0.852 . . . . 0.0 108.7 -177.469 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 170' ' ' ASP . . . . . 0.632 ' H ' ' C ' ' A' ' 168' ' ' VAL . 47.6 t0 18.22 58.87 0.01 OUTLIER 'General case' 0 N--CA 1.496 1.868 0 N-CA-C 112.419 0.525 . . . . 0.0 112.419 176.999 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 171' ' ' GLU . . . . . . . . . . . . . 11.4 pt-20 -94.87 62.13 2.62 Favored 'General case' 0 N--CA 1.499 2.017 0 O-C-N 120.34 -1.475 . . . . 0.0 109.896 179.924 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 172' ' ' GLN . . . . . . . . . . . . . 0.6 OUTLIER -114.88 -63.63 1.43 Allowed 'General case' 0 N--CA 1.496 1.837 0 O-C-N 121.563 -0.71 . . . . 0.0 110.525 -178.711 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 173' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -60.18 127.58 32.54 Favored 'General case' 0 N--CA 1.496 1.831 0 O-C-N 121.216 -0.928 . . . . 0.0 109.751 -179.704 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 174' ' ' GLY . . . . . 0.49 ' O ' ' C ' ' A' ' 175' ' ' LYS . . . -117.1 -41.72 0.68 Allowed Glycine 0 N--CA 1.484 1.873 0 N-CA-C 108.824 -1.71 . . . . 0.0 108.824 179.682 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 175' ' ' LYS . . . . . 0.49 ' C ' ' O ' ' A' ' 174' ' ' GLY . 13.1 mptt -41.05 -59.78 1.38 Allowed 'General case' 0 N--CA 1.495 1.791 0 N-CA-C 107.804 -1.184 . . . . 0.0 107.804 179.573 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 176' ' ' ASP . . . . . 0.598 ' O ' ' O ' ' A' ' 177' ' ' LYS . 4.3 m-20 -103.22 83.04 2.14 Favored 'General case' 0 C--N 1.295 -1.791 0 N-CA-C 107.294 -1.373 . . . . 0.0 107.294 177.461 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 177' ' ' LYS . . . . . 0.598 ' O ' ' O ' ' A' ' 176' ' ' ASP . 2.6 mttt -43.59 -177.99 0.0 OUTLIER 'General case' 0 N--CA 1.494 1.73 0 O-C-N 121.425 -0.797 . . . . 0.0 109.464 -179.144 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 178' ' ' GLN . . . . . 0.682 ' NE2' ' ND2' ' A' ' 114' ' ' ASN . 0.0 OUTLIER -160.44 170.86 20.12 Favored 'General case' 0 C--N 1.302 -1.487 0 O-C-N 120.418 -1.426 . . . . 0.0 110.977 179.03 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 179' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -122.86 91.99 3.61 Favored 'General case' 0 C--N 1.302 -1.484 0 N-CA-C 107.446 -1.316 . . . . 0.0 107.446 178.493 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 180' ' ' THR . . . . . 0.444 ' HG1' HG23 ' A' ' 201' ' ' VAL . 1.3 m -71.74 118.32 14.44 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.172 -0.955 . . . . 0.0 110.457 -178.388 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 181' ' ' LEU . . . . . . . . . . . . . 41.1 tp -97.4 154.04 17.72 Favored 'General case' 0 C--N 1.3 -1.568 0 N-CA-C 107.458 -1.312 . . . . 0.0 107.458 177.57 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 182' ' ' ILE . . . . . . . . . . . . . 11.0 mt -145.77 121.31 3.33 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.554 0 O-C-N 120.613 -1.304 . . . . 0.0 110.489 179.496 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 183' ' ' THR . . . . . 0.517 ' CG2' ' O ' ' A' ' 183' ' ' THR . 5.2 t -134.44 116.8 15.57 Favored 'General case' 0 C--N 1.293 -1.865 0 N-CA-C 107.427 -1.323 . . . . 0.0 107.427 178.627 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 184' ' ' CYS . . . . . . . . . . . . . 5.1 p -78.57 157.15 28.85 Favored 'General case' 0 C--N 1.282 -2.337 0 C-N-CA 118.933 -1.107 . . . . 0.0 110.964 -177.687 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 185' ' ' ASP . . . . . . . . . . . . . 12.3 t0 -164.15 -157.47 0.39 Allowed 'General case' 0 N--CA 1.492 1.658 0 O-C-N 121.514 -0.742 . . . . 0.0 109.376 -179.613 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 186' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER 54.93 52.45 11.9 Favored 'General case' 0 N--CA 1.495 1.807 0 O-C-N 121.002 -1.061 . . . . 0.0 109.567 -179.7 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 187' ' ' TYR . . . . . 0.599 ' CE1' ' O ' ' A' ' 188' ' ' ASN . 63.4 t80 -67.69 134.36 50.96 Favored 'General case' 0 N--CA 1.493 1.675 0 O-C-N 121.122 -0.986 . . . . 0.0 110.582 -179.857 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 188' ' ' ASN . . . . . 0.599 ' O ' ' CE1' ' A' ' 187' ' ' TYR . 0.7 OUTLIER -101.52 145.66 28.71 Favored 'General case' 0 C--N 1.296 -1.749 0 N-CA-C 108.214 -1.032 . . . . 0.0 108.214 178.119 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 189' ' ' GLU . . . . . . . . . . . . . 2.0 tt0 -109.49 -14.31 14.42 Favored 'General case' 0 C--N 1.294 -1.81 0 N-CA-C 108.719 -0.845 . . . . 0.0 108.719 -179.557 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 190' ' ' LYS . . . . . . . . . . . . . 7.7 mttm -82.62 -54.47 5.14 Favored 'General case' 0 C--N 1.302 -1.489 0 N-CA-C 108.879 -0.785 . . . . 0.0 108.879 179.096 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 191' ' ' THR . . . . . . . . . . . . . 1.0 OUTLIER -88.48 -5.36 58.29 Favored 'General case' 0 C--N 1.301 -1.503 0 O-C-N 121.391 -0.818 . . . . 0.0 109.645 -179.756 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 192' ' ' GLY . . . . . . . . . . . . . . . 64.93 35.21 91.63 Favored Glycine 0 N--CA 1.496 2.697 0 O-C-N 120.992 -1.068 . . . . 0.0 111.928 177.988 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 193' ' ' VAL . . . . . . . . . . . . . 3.4 p -149.27 167.87 2.98 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.681 0 O-C-N 120.692 -1.475 . . . . 0.0 110.383 179.178 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 194' ' ' TRP . . . . . 0.53 ' N ' ' CD1' ' A' ' 194' ' ' TRP . 10.1 m95 -84.83 120.86 26.92 Favored 'General case' 0 N--CA 1.493 1.704 0 N-CA-C 108.813 -0.81 . . . . 0.0 108.813 -179.933 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 195' ' ' GLU . . . . . 0.507 ' CD ' ' ND2' ' A' ' 188' ' ' ASN . 6.8 mt-10 -79.35 -61.64 1.94 Allowed 'General case' 0 N--CA 1.493 1.689 0 O-C-N 121.424 -0.798 . . . . 0.0 111.241 -178.29 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 196' ' ' LYS . . . . . . . . . . . . . 0.9 OUTLIER -101.64 151.14 22.37 Favored 'General case' 0 N--CA 1.494 1.73 0 O-C-N 120.906 -1.121 . . . . 0.0 110.262 -179.216 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 197' ' ' ARG . . . . . 0.666 ' CG ' HH11 ' A' ' 197' ' ' ARG . 1.4 mtt-85 -120.5 153.59 36.45 Favored 'General case' 0 N--CA 1.489 1.497 0 N-CA-C 108.432 -0.951 . . . . 0.0 108.432 178.34 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 198' ' ' LYS . . . . . . . . . . . . . 1.1 mptp? -114.97 123.14 48.33 Favored 'General case' 0 C--N 1.3 -1.585 0 O-C-N 121.645 -0.659 . . . . 0.0 110.581 -177.882 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 199' ' ' ILE . . . . . 0.425 ' C ' ' CD1' ' A' ' 199' ' ' ILE . 0.5 OUTLIER -136.79 118.49 19.11 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.757 0 CA-C-O 122.748 1.261 . . . . 0.0 110.655 179.693 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 200' ' ' PHE . . . . . 0.556 ' CD1' ' N ' ' A' ' 200' ' ' PHE . 0.2 OUTLIER -100.15 134.64 42.77 Favored 'General case' 0 N--CA 1.5 2.054 0 CA-C-N 115.604 -0.725 . . . . 0.0 110.481 -178.161 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 201' ' ' VAL . . . . . 0.444 HG23 ' HG1' ' A' ' 180' ' ' THR . 52.9 t -103.48 141.34 19.45 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.992 0 O-C-N 120.721 -1.237 . . . . 0.0 108.554 177.922 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 202' ' ' ALA . . . . . . . . . . . . . . . -125.15 136.66 53.82 Favored 'General case' 0 N--CA 1.495 1.794 0 O-C-N 121.157 -0.964 . . . . 0.0 108.795 179.56 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 203' ' ' THR . . . . . 0.537 ' HG1' ' HG1' ' A' ' 156' ' ' THR . 1.2 p -88.98 134.66 33.9 Favored 'General case' 0 N--CA 1.49 1.529 0 CA-C-O 122.126 0.965 . . . . 0.0 111.383 -178.552 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 204' ' ' GLU . . . . . 0.404 ' HA ' ' CD2' ' A' ' 153' ' ' TYR . 2.6 tm-20 -62.53 135.07 57.23 Favored 'General case' 0 C--N 1.301 -1.541 0 C-N-CA 118.919 -1.113 . . . . 0.0 108.96 179.25 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 205' ' ' VAL . . . . . 0.54 ' O ' ' C ' ' A' ' 206' ' ' LYS . 71.5 t -123.9 -45.39 1.73 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.642 0 O-C-N 121.397 -0.814 . . . . 0.0 109.908 -178.91 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 206' ' ' LYS . . . . . 0.54 ' C ' ' O ' ' A' ' 205' ' ' VAL . 2.3 ttpt . . . . . 0 N--CA 1.496 1.838 0 CA-C-O 118.044 -0.979 . . . . 0.0 110.679 -179.655 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' C' C ' 702' ' ' LEU . . . . . 0.571 ' CD1' ' N ' ' C' ' 702' ' ' LEU . 0.0 OUTLIER . . . . . 0 N--CA 1.491 1.584 0 N-CA-C 108.412 -0.959 . . . . 0.0 108.412 . . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' C' C ' 703' ' ' PRO . . . . . 0.492 ' O ' ' O ' ' C' ' 704' ' ' ALA . 97.2 Cg_endo -77.88 -162.48 0.17 Allowed 'Trans proline' 0 N--CA 1.494 1.55 0 C-N-CA 122.521 2.148 . . . . 0.0 113.081 -179.509 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' C' C ' 704' ' ' ALA . . . . . 0.492 ' O ' ' O ' ' C' ' 703' ' ' PRO . . . . . . . . 0 N--CA 1.49 1.553 0 CA-C-O 121.443 0.64 . . . . 0.0 110.273 179.457 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 63' ' ' PRO . . . . . 0.581 ' O ' ' CD1' ' A' ' 110' ' ' LEU . 29.3 Cg_endo . . . . . 0 C--O 1.21 -0.894 0 N-CA-C 110.156 -0.748 . . . . 0.0 110.156 . . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 64' ' ' GLN . . . . . 0.425 ' O ' ' C ' ' A' ' 65' ' ' ILE . 0.0 OUTLIER -162.47 115.62 1.71 Allowed 'General case' 0 C--N 1.297 -1.686 0 O-C-N 121.165 -0.96 . . . . 0.0 109.976 -179.836 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 65' ' ' ILE . . . . . 0.425 ' C ' ' O ' ' A' ' 64' ' ' GLN . 2.7 mp -42.78 102.41 0.27 Allowed Pre-proline 0 N--CA 1.489 1.511 0 O-C-N 121.518 -0.739 . . . . 0.0 109.262 179.536 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 66' ' ' PRO . . . . . . . . . . . . . 72.7 Cg_endo -89.13 -154.21 0.05 OUTLIER 'Trans proline' 0 N--CA 1.492 1.414 0 C-N-CA 122.697 2.265 . . . . 0.0 113.004 -179.011 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 67' ' ' LYS . . . . . 0.481 ' CG ' ' O ' ' A' ' 67' ' ' LYS . 7.8 ttmm -81.06 -7.45 59.56 Favored 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.239 -0.913 . . . . 0.0 108.766 179.666 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 68' ' ' ASP . . . . . 0.605 ' C ' ' H ' ' A' ' 70' ' ' SER . 0.5 OUTLIER -75.1 52.89 0.59 Allowed 'General case' 0 C--N 1.304 -1.393 0 CA-C-O 122.524 1.154 . . . . 0.0 108.594 179.608 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 69' ' ' LYS . . . . . 0.437 ' C ' ' O ' ' A' ' 68' ' ' ASP . 14.9 ptpt -49.7 -15.07 0.15 Allowed 'General case' 0 N--CA 1.501 2.088 0 C-N-CA 117.26 -1.776 . . . . 0.0 106.469 177.961 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 70' ' ' SER . . . . . 0.605 ' H ' ' C ' ' A' ' 68' ' ' ASP . 3.7 m -85.92 -4.68 59.22 Favored 'General case' 0 N--CA 1.494 1.77 0 CA-C-N 113.516 -1.675 . . . . 0.0 110.739 179.571 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 71' ' ' LYS . . . . . . . . . . . . . 7.9 ptmt -97.73 142.53 29.39 Favored 'General case' 0 N--CA 1.497 1.877 0 O-C-N 120.913 -1.117 . . . . 0.0 111.985 -179.181 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 72' ' ' VAL . . . . . 0.579 ' CG2' ' O ' ' A' ' 74' ' ' GLY . 0.3 OUTLIER -67.52 135.0 29.34 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.507 0 N-CA-C 105.186 -2.153 . . . . 0.0 105.186 174.777 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 73' ' ' ALA . . . . . 0.535 ' N ' ' O ' ' A' ' 87' ' ' VAL . . . -80.93 -16.58 53.14 Favored 'General case' 0 C--N 1.298 -1.635 0 O-C-N 119.988 -1.695 . . . . 0.0 107.219 -179.556 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 74' ' ' GLY . . . . . 0.579 ' O ' ' CG2' ' A' ' 72' ' ' VAL . . . 167.04 -148.9 13.85 Favored Glycine 0 N--CA 1.486 1.98 0 C-N-CA 119.078 -1.534 . . . . 0.0 110.253 178.774 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 75' ' ' TYR . . . . . 0.551 ' CD1' ' C ' ' A' ' 74' ' ' GLY . 13.4 m-85 -144.91 174.79 10.71 Favored 'General case' 0 C--N 1.293 -1.885 0 O-C-N 121.153 -1.204 . . . . 0.0 109.921 -178.342 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 76' ' ' ILE . . . . . . . . . . . . . 0.4 OUTLIER -148.48 147.83 16.56 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.777 0 N-CA-C 108.124 -1.065 . . . . 0.0 108.124 -178.64 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 3.9 mt-10 -149.37 159.82 43.95 Favored 'General case' 0 C--N 1.302 -1.471 0 O-C-N 120.789 -1.194 . . . . 0.0 110.548 -179.353 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 78' ' ' ILE . . . . . 0.443 HG23 ' H ' ' A' ' 81' ' ' ALA . 83.3 mt -145.58 120.15 5.56 Favored Pre-proline 0 N--CA 1.488 1.442 0 N-CA-C 107.233 -1.395 . . . . 0.0 107.233 179.722 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 79' ' ' PRO . . . . . . . . . . . . . 68.9 Cg_endo -76.36 -39.66 0.76 Allowed 'Trans proline' 0 N--CA 1.493 1.468 0 C-N-CA 122.024 1.816 . . . . 0.0 113.613 -178.543 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 4.7 m-20 -65.72 -20.23 66.2 Favored 'General case' 0 N--CA 1.494 1.76 0 O-C-N 121.062 -1.024 . . . . 0.0 110.025 178.344 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 81' ' ' ALA . . . . . 0.575 ' O ' ' ND2' ' A' ' 132' ' ' ASN . . . -108.31 -18.63 13.71 Favored 'General case' 0 C--N 1.301 -1.535 0 N-CA-C 107.857 -1.164 . . . . 0.0 107.857 179.497 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 82' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER 67.41 54.72 0.68 Allowed 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.74 -0.6 . . . . 0.0 110.942 178.921 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 83' ' ' ILE . . . . . . . . . . . . . 61.2 mt -126.66 151.77 33.66 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.924 0 O-C-N 120.935 -1.103 . . . . 0.0 110.68 -179.02 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 84' ' ' LYS . . . . . . . . . . . . . 1.6 pttm -159.19 106.46 1.77 Allowed 'General case' 0 N--CA 1.489 1.512 0 N-CA-C 107.734 -1.21 . . . . 0.0 107.734 179.105 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 85' ' ' GLU . . . . . 0.435 ' OE2' ' O ' ' A' ' 129' ' ' GLN . 0.4 OUTLIER -141.6 174.16 4.09 Favored Pre-proline 0 N--CA 1.493 1.71 0 O-C-N 121.064 -1.023 . . . . 0.0 110.779 -178.344 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 86' ' ' PRO . . . . . 0.403 ' HA ' ' CD2' ' A' ' 75' ' ' TYR . 73.2 Cg_endo -83.96 157.75 13.55 Favored 'Trans proline' 0 N--CA 1.492 1.433 0 C-N-CA 123.147 2.565 . . . . 0.0 114.082 -178.869 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 87' ' ' VAL . . . . . 0.535 ' O ' ' N ' ' A' ' 73' ' ' ALA . 57.3 t -114.6 103.24 15.03 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.89 0 O-C-N 121.73 -0.606 . . . . 0.0 109.706 -179.816 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 88' ' ' TYR . . . . . . . . . . . . . 19.5 m-85 -94.83 153.71 39.97 Favored Pre-proline 0 N--CA 1.502 2.139 0 O-C-N 120.827 -1.17 . . . . 0.0 110.31 -179.916 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 89' ' ' PRO . . . . . . . . . . . . . 8.3 Cg_endo -58.4 145.38 94.24 Favored 'Trans proline' 0 N--CA 1.494 1.537 0 C-N-CA 122.908 2.405 . . . . 0.0 113.452 -179.514 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . -59.84 168.91 7.55 Favored Glycine 0 N--CA 1.492 2.384 0 N-CA-C 109.208 -1.557 . . . . 0.0 109.208 179.211 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 91' ' ' PRO . . . . . 0.484 ' C ' ' H ' ' A' ' 93' ' ' THR . 72.1 Cg_endo -93.24 170.45 19.98 Favored 'Cis proline' 0 C--N 1.306 -1.669 0 C-N-CA 123.765 -1.348 . . . . 0.0 111.903 -0.237 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 92' ' ' ALA . . . . . . . . . . . . . . . -72.44 32.15 0.06 Allowed 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.134 -0.979 . . . . 0.0 110.433 -179.892 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 93' ' ' THR . . . . . 0.484 ' H ' ' C ' ' A' ' 91' ' ' PRO . 1.1 p -73.51 149.9 88.86 Favored Pre-proline 0 C--N 1.302 -1.486 0 O-C-N 120.847 -1.158 . . . . 0.0 108.427 179.723 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 94' ' ' PRO . . . . . 0.412 ' C ' ' O ' ' A' ' 93' ' ' THR . 95.4 Cg_exo -35.54 -45.05 0.71 Allowed 'Trans proline' 0 C--N 1.304 -1.772 0 C-N-CA 122.438 2.092 . . . . 0.0 111.746 -179.615 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 95' ' ' GLU . . . . . 0.628 ' O ' ' ND2' ' A' ' 98' ' ' ASN . 7.1 mt-10 -49.97 -55.13 15.78 Favored 'General case' 0 N--CA 1.489 1.477 0 O-C-N 121.18 -0.95 . . . . 0.0 109.393 179.341 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 96' ' ' GLN . . . . . 0.578 ' C ' ' H ' ' A' ' 98' ' ' ASN . 2.7 mp0 -73.03 -47.77 42.06 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.162 -0.961 . . . . 0.0 110.719 -179.658 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 97' ' ' LEU . . . . . . . . . . . . . 42.2 mt -52.55 -5.34 0.04 OUTLIER 'General case' 0 N--CA 1.493 1.691 0 O-C-N 120.971 -1.08 . . . . 0.0 109.095 -179.046 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 98' ' ' ASN . . . . . 0.709 HD22 ' NE ' ' A' ' 99' ' ' ARG . 0.5 OUTLIER -73.23 -26.35 61.09 Favored 'General case' 0 N--CA 1.494 1.747 0 O-C-N 121.351 -0.843 . . . . 0.0 109.087 179.466 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 99' ' ' ARG . . . . . 0.709 ' NE ' HD22 ' A' ' 98' ' ' ASN . 0.1 OUTLIER -99.03 -50.2 4.25 Favored 'General case' 0 C--N 1.3 -1.544 0 C-N-CA 119.7 -0.8 . . . . 0.0 110.064 -179.016 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . 180.0 -169.17 39.83 Favored Glycine 0 N--CA 1.495 2.578 0 C-N-CA 118.858 -1.639 . . . . 0.0 111.224 179.497 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 101' ' ' VAL . . . . . 0.485 ' O ' ' CG2' ' A' ' 101' ' ' VAL . 18.5 m -55.01 106.16 0.11 Allowed 'Isoleucine or valine' 0 N--CA 1.496 1.84 0 O-C-N 121.883 -0.775 . . . . 0.0 109.289 -179.851 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -92.56 164.17 13.53 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.373 -0.829 . . . . 0.0 111.577 -178.713 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 103' ' ' PHE . . . . . 0.427 ' CE1' ' CG1' ' A' ' 87' ' ' VAL . 23.9 m-85 -68.2 126.58 29.99 Favored 'General case' 0 N--CA 1.485 1.278 0 N-CA-C 106.763 -1.569 . . . . 0.0 106.763 177.309 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 104' ' ' ALA . . . . . . . . . . . . . . . -50.37 -11.26 0.07 Allowed 'General case' 0 C--N 1.293 -1.856 0 O-C-N 121.513 -0.742 . . . . 0.0 111.593 -178.267 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 105' ' ' GLU . . . . . 0.495 ' OE2' ' OE1' ' A' ' 108' ' ' GLU . 0.4 OUTLIER -140.57 145.89 37.34 Favored 'General case' 0 N--CA 1.495 1.795 0 O-C-N 120.751 -1.218 . . . . 0.0 110.565 179.988 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 106' ' ' GLU . . . . . . . . . . . . . 25.0 tt0 -58.84 -63.22 1.37 Allowed 'General case' 0 C--N 1.305 -1.356 0 O-C-N 121.733 -0.604 . . . . 0.0 110.019 -179.993 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 107' ' ' ASN . . . . . . . . . . . . . 15.9 m-80 -76.94 33.2 0.14 Allowed 'General case' 0 N--CA 1.487 1.413 0 O-C-N 120.381 -1.449 . . . . 0.0 112.683 -176.103 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 108' ' ' GLU . . . . . 0.495 ' OE1' ' OE2' ' A' ' 105' ' ' GLU . 35.0 tp10 -60.16 146.9 41.65 Favored 'General case' 0 N--CA 1.493 1.698 0 O-C-N 120.483 -1.386 . . . . 0.0 107.801 179.448 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 109' ' ' SER . . . . . 0.433 ' C ' ' H ' ' A' ' 111' ' ' ASP . 0.1 OUTLIER -101.2 128.59 47.24 Favored 'General case' 0 N--CA 1.489 1.501 0 O-C-N 120.824 -1.172 . . . . 0.0 110.912 -178.285 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 110' ' ' LEU . . . . . 0.581 ' CD1' ' O ' ' A' ' 63' ' ' PRO . 1.2 pt? -59.0 -10.02 2.27 Favored 'General case' 0 C--N 1.303 -1.433 0 N-CA-C 108.45 -0.945 . . . . 0.0 108.45 179.48 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 111' ' ' ASP . . . . . 0.433 ' H ' ' C ' ' A' ' 109' ' ' SER . 44.8 m-20 -131.74 29.62 4.45 Favored 'General case' 0 N--CA 1.491 1.587 0 N-CA-C 108.598 -0.89 . . . . 0.0 108.598 179.32 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 112' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -65.37 149.48 49.92 Favored 'General case' 0 N--CA 1.493 1.686 0 O-C-N 121.273 -0.892 . . . . 0.0 110.479 -179.232 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 113' ' ' GLN . . . . . 0.425 ' HA ' ' NE2' ' A' ' 113' ' ' GLN . 0.8 OUTLIER -66.87 -11.41 55.72 Favored 'General case' 0 C--N 1.303 -1.442 0 N-CA-C 107.709 -1.219 . . . . 0.0 107.709 177.773 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 114' ' ' ASN . . . . . 0.428 HD21 ' NE2' ' A' ' 178' ' ' GLN . 0.1 OUTLIER -149.47 102.59 3.2 Favored 'General case' 0 C--N 1.305 -1.347 0 N-CA-C 107.683 -1.229 . . . . 0.0 107.683 177.838 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 115' ' ' ILE . . . . . . . . . . . . . 3.8 mt -97.74 111.26 27.13 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.528 0 O-C-N 120.961 -1.087 . . . . 0.0 109.437 -179.19 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 116' ' ' SER . . . . . . . . . . . . . 50.5 m -96.97 140.68 31.14 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.24 -0.913 . . . . 0.0 111.707 -178.087 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 117' ' ' ILE . . . . . . . . . . . . . 11.9 mt -130.25 152.49 37.51 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.414 0 N-CA-C 107.284 -1.376 . . . . 0.0 107.284 178.305 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 118' ' ' ALA . . . . . . . . . . . . . . . -142.87 157.54 44.49 Favored 'General case' 0 N--CA 1.493 1.684 0 O-C-N 120.707 -1.246 . . . . 0.0 111.087 -179.836 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 119' ' ' GLY . . . . . . . . . . . . . . . -162.45 145.09 10.28 Favored Glycine 0 N--CA 1.487 2.056 0 N-CA-C 110.085 -1.206 . . . . 0.0 110.085 179.964 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 120' ' ' HIS . . . . . . . . . . . . . 29.4 m170 -71.19 157.98 37.21 Favored 'General case' 0 N--CA 1.493 1.701 0 O-C-N 121.716 -0.873 . . . . 0.0 110.062 179.461 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 121' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -110.98 145.88 37.65 Favored 'General case' 0 N--CA 1.495 1.808 0 O-C-N 121.321 -0.862 . . . . 0.0 108.86 178.916 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 122' ' ' PHE . . . . . . . . . . . . . 0.3 OUTLIER -109.23 125.32 52.13 Favored 'General case' 0 N--CA 1.494 1.734 0 O-C-N 121.058 -1.026 . . . . 0.0 109.277 179.333 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 123' ' ' ILE . . . . . 0.435 ' CG2' ' N ' ' A' ' 124' ' ' ASP . 6.9 tp -74.43 -37.04 43.84 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.785 0 CA-C-O 121.876 0.846 . . . . 0.0 109.195 179.833 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 124' ' ' ASP . . . . . 0.435 ' N ' ' CG2' ' A' ' 123' ' ' ILE . 80.8 m-20 -92.88 15.13 15.49 Favored 'General case' 0 C--N 1.297 -1.715 0 O-C-N 121.897 -0.502 . . . . 0.0 111.281 -179.043 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 125' ' ' ARG . . . . . . . . . . . . . 7.3 ttt180 -153.95 115.17 2.58 Favored Pre-proline 0 N--CA 1.494 1.737 0 O-C-N 120.445 -1.409 . . . . 0.0 110.789 -178.555 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 126' ' ' PRO . . . . . . . . . . . . . 74.0 Cg_endo -83.76 -23.75 3.1 Favored 'Trans proline' 0 N--CA 1.487 1.123 0 C-N-CA 122.11 1.873 . . . . 0.0 112.083 178.81 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 127' ' ' ASN . . . . . 0.48 ' ND2' ' O ' ' A' ' 127' ' ' ASN . 2.3 p-10 -88.82 28.89 1.09 Allowed 'General case' 0 N--CA 1.492 1.654 0 O-C-N 120.898 -1.126 . . . . 0.0 110.051 -179.558 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 128' ' ' TYR . . . . . . . . . . . . . 9.9 t80 -87.71 -148.58 0.15 Allowed 'General case' 0 N--CA 1.49 1.564 0 O-C-N 120.94 -1.1 . . . . 0.0 109.554 179.906 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 129' ' ' GLN . . . . . 0.435 ' O ' ' OE2' ' A' ' 85' ' ' GLU . 80.4 mt-30 -66.95 -69.59 0.3 Allowed 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.29 -0.881 . . . . 0.0 110.802 -178.742 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 130' ' ' PHE . . . . . . . . . . . . . 55.8 m-85 -130.47 31.34 4.59 Favored 'General case' 0 N--CA 1.499 1.99 0 O-C-N 121.056 -1.027 . . . . 0.0 110.841 -179.126 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 131' ' ' THR . . . . . . . . . . . . . 52.4 m -70.77 -32.99 70.3 Favored 'General case' 0 C--N 1.301 -1.522 0 O-C-N 120.344 -1.473 . . . . 0.0 108.205 179.451 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 132' ' ' ASN . . . . . 0.575 ' ND2' ' O ' ' A' ' 81' ' ' ALA . 2.0 p-10 -91.21 15.24 12.27 Favored 'General case' 0 N--CA 1.498 1.97 0 C-N-CA 119.915 -0.714 . . . . 0.0 111.179 -179.565 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 133' ' ' LEU . . . . . 0.599 ' O ' ' N ' ' A' ' 135' ' ' ALA . 0.2 OUTLIER -77.06 -44.17 31.69 Favored 'General case' 0 C--N 1.301 -1.535 0 O-C-N 120.651 -1.281 . . . . 0.0 109.185 -179.801 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 134' ' ' LYS . . . . . 0.653 ' CE ' ' H ' ' A' ' 134' ' ' LYS . 0.0 OUTLIER -46.97 -6.94 0.01 OUTLIER 'General case' 0 C--N 1.299 -1.606 0 O-C-N 121.661 -0.65 . . . . 0.0 110.428 -179.42 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 135' ' ' ALA . . . . . 0.599 ' N ' ' O ' ' A' ' 133' ' ' LEU . . . -84.0 -40.32 18.58 Favored 'General case' 0 N--CA 1.488 1.462 0 O-C-N 120.912 -1.118 . . . . 0.0 108.97 178.962 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 136' ' ' ALA . . . . . . . . . . . . . . . -79.77 162.3 25.21 Favored 'General case' 0 N--CA 1.487 1.402 0 CA-C-O 122.21 1.005 . . . . 0.0 111.357 -178.752 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 137' ' ' LYS . . . . . 0.513 ' O ' ' O ' ' A' ' 138' ' ' LYS . 17.4 pttt -153.04 -164.02 1.83 Allowed 'General case' 0 C--N 1.3 -1.584 0 C-N-CA 118.721 -1.192 . . . . 0.0 111.097 -177.918 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 138' ' ' LYS . . . . . 0.602 ' O ' ' N ' ' A' ' 140' ' ' SER . 1.4 mmmp? -45.92 -179.9 0.0 OUTLIER 'General case' 0 C--N 1.303 -1.445 0 CA-C-O 122.1 0.953 . . . . 0.0 110.356 -179.564 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 139' ' ' GLY . . . . . . . . . . . . . . . 46.14 7.81 0.02 OUTLIER Glycine 0 N--CA 1.49 2.283 0 N-CA-C 110.547 -1.021 . . . . 0.0 110.547 179.735 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 140' ' ' SER . . . . . 0.602 ' N ' ' O ' ' A' ' 138' ' ' LYS . 13.1 t -83.04 143.78 30.37 Favored 'General case' 0 N--CA 1.493 1.679 0 O-C-N 120.849 -1.383 . . . . 0.0 108.922 179.108 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 141' ' ' MET . . . . . . . . . . . . . 0.1 OUTLIER -88.68 133.91 34.06 Favored 'General case' 0 C--N 1.3 -1.552 0 O-C-N 121.091 -1.006 . . . . 0.0 109.316 179.787 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 142' ' ' VAL . . . . . . . . . . . . . 21.4 t -121.81 126.19 74.28 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.631 0 N-CA-C 108.781 -0.822 . . . . 0.0 108.781 179.934 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 143' ' ' TYR . . . . . . . . . . . . . 61.1 m-85 -104.2 134.28 47.71 Favored 'General case' 0 N--CA 1.496 1.857 0 O-C-N 121.26 -0.9 . . . . 0.0 110.975 -178.915 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 144' ' ' PHE . . . . . . . . . . . . . 53.0 t80 -112.0 154.3 25.53 Favored 'General case' 0 N--CA 1.492 1.666 0 CA-C-O 121.773 0.797 . . . . 0.0 110.101 -179.393 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 145' ' ' LYS . . . . . 0.429 ' CG ' ' OG1' ' A' ' 150' ' ' THR . 1.8 mttm -149.07 125.64 11.02 Favored 'General case' 0 N--CA 1.494 1.759 0 C-N-CA 118.866 -1.134 . . . . 0.0 111.707 -177.764 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 146' ' ' VAL . . . . . . . . . . . . . 0.2 OUTLIER -144.81 139.9 23.19 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.559 0 N-CA-C 107.028 -1.471 . . . . 0.0 107.028 178.149 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 147' ' ' GLY . . . . . . . . . . . . . . . 53.89 -138.07 38.95 Favored Glycine 0 N--CA 1.489 2.201 0 N-CA-C 107.878 -2.089 . . . . 0.0 107.878 -178.692 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 148' ' ' ASN . . . . . 0.564 ' C ' HD21 ' A' ' 148' ' ' ASN . 0.4 OUTLIER -101.63 26.65 7.12 Favored 'General case' 0 N--CA 1.489 1.498 0 O-C-N 121.052 -1.263 . . . . 0.0 107.832 178.491 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 149' ' ' GLU . . . . . . . . . . . . . 2.1 tm-20 -112.05 151.97 28.74 Favored 'General case' 0 N--CA 1.486 1.335 0 CA-C-O 121.872 0.844 . . . . 0.0 110.921 -178.805 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 150' ' ' THR . . . . . 0.429 ' OG1' ' CG ' ' A' ' 145' ' ' LYS . 2.9 m -141.02 104.89 4.75 Favored 'General case' 0 N--CA 1.495 1.818 0 CA-C-O 121.559 0.695 . . . . 0.0 109.216 179.828 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 151' ' ' ARG . . . . . . . . . . . . . 73.9 mtt180 -87.57 -164.9 1.17 Allowed 'General case' 0 N--CA 1.487 1.403 0 O-C-N 121.355 -0.841 . . . . 0.0 109.297 -179.52 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 152' ' ' LYS . . . . . 0.519 ' O ' ' N ' ' A' ' 205' ' ' VAL . 7.3 mtmt -147.34 144.24 28.61 Favored 'General case' 0 C--N 1.301 -1.535 0 O-C-N 121.433 -0.792 . . . . 0.0 109.329 -179.671 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 153' ' ' TYR . . . . . 0.513 ' CD2' ' HA ' ' A' ' 204' ' ' GLU . 26.9 m-85 -140.44 169.41 17.72 Favored 'General case' 0 N--CA 1.489 1.51 0 N-CA-C 108.344 -0.984 . . . . 0.0 108.344 179.948 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 154' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -143.38 120.91 11.74 Favored 'General case' 0 C--N 1.299 -1.623 0 O-C-N 121.329 -0.857 . . . . 0.0 108.986 179.175 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 155' ' ' MET . . . . . . . . . . . . . 27.0 mtp -46.61 110.09 0.25 Allowed 'General case' 0 N--CA 1.496 1.855 0 O-C-N 120.576 -1.327 . . . . 0.0 110.954 -179.112 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 156' ' ' THR . . . . . 0.44 ' HG1' ' HG1' ' A' ' 203' ' ' THR . 0.2 OUTLIER -104.24 -30.26 10.28 Favored 'General case' 0 C--N 1.294 -1.846 0 C-N-CA 119.817 -0.753 . . . . 0.0 111.034 -178.286 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 157' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -154.53 157.52 38.45 Favored 'General case' 0 N--CA 1.495 1.801 0 C-N-CA 118.179 -1.408 . . . . 0.0 111.757 -178.136 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 158' ' ' ILE . . . . . 0.41 HG12 ' N ' ' A' ' 159' ' ' ARG . 0.0 OUTLIER -155.26 146.23 12.99 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.562 0 CA-C-O 121.785 0.802 . . . . 0.0 110.748 -178.995 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 159' ' ' ARG . . . . . 0.644 ' CG ' HH11 ' A' ' 159' ' ' ARG . 0.0 OUTLIER -158.13 159.16 35.91 Favored 'General case' 0 C--N 1.303 -1.429 0 CA-C-O 121.757 0.789 . . . . 0.0 110.967 -179.824 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 160' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -117.37 163.92 15.63 Favored 'General case' 0 N--CA 1.488 1.43 0 N-CA-C 108.326 -0.99 . . . . 0.0 108.326 178.829 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 161' ' ' VAL . . . . . 0.487 ' O ' ' O ' ' A' ' 162' ' ' LYS . 0.1 OUTLIER -162.11 156.2 2.64 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.816 0 O-C-N 121.158 -0.964 . . . . 0.0 109.828 -179.425 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 162' ' ' LYS . . . . . 0.508 ' H ' ' CD ' ' A' ' 162' ' ' LYS . 0.0 OUTLIER -44.96 171.68 0.05 OUTLIER Pre-proline 0 N--CA 1.494 1.738 0 O-C-N 121.378 -0.826 . . . . 0.0 109.63 179.723 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 163' ' ' PRO . . . . . . . . . . . . . 73.7 Cg_endo -81.87 36.38 0.62 Allowed 'Trans proline' 0 N--CA 1.493 1.451 0 C-N-CA 122.791 2.328 . . . . 0.0 113.141 -179.521 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 164' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -152.69 -4.8 0.22 Allowed 'General case' 0 N--CA 1.492 1.663 0 O-C-N 120.907 -1.121 . . . . 0.0 110.35 -179.981 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 165' ' ' ASP . . . . . 0.475 ' O ' ' N ' ' A' ' 167' ' ' GLY . 8.8 t0 -74.8 62.6 1.1 Allowed 'General case' 0 N--CA 1.492 1.631 0 O-C-N 120.925 -1.109 . . . . 0.0 110.641 -179.35 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 166' ' ' VAL . . . . . 0.648 ' O ' ' N ' ' A' ' 168' ' ' VAL . 0.9 OUTLIER -39.43 -29.03 0.09 OUTLIER 'Isoleucine or valine' 0 N--CA 1.497 1.89 0 O-C-N 121.284 -0.885 . . . . 0.0 109.563 -178.45 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 167' ' ' GLY . . . . . 0.475 ' N ' ' O ' ' A' ' 165' ' ' ASP . . . -43.07 -13.92 0.01 OUTLIER Glycine 0 N--CA 1.496 2.636 0 N-CA-C 109.515 -1.434 . . . . 0.0 109.515 179.622 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 168' ' ' VAL . . . . . 0.648 ' N ' ' O ' ' A' ' 166' ' ' VAL . 1.3 t -48.26 -44.41 12.73 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.454 0 O-C-N 121.448 -1.031 . . . . 0.0 108.43 178.925 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 169' ' ' LEU . . . . . 0.571 ' O ' ' C ' ' A' ' 170' ' ' ASP . 47.1 mt -49.92 -9.7 0.04 OUTLIER 'General case' 0 N--CA 1.492 1.66 0 N-CA-C 109.001 -0.741 . . . . 0.0 109.001 -178.092 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 170' ' ' ASP . . . . . 0.572 ' H ' ' C ' ' A' ' 168' ' ' VAL . 17.7 p-10 19.46 86.51 0.01 OUTLIER 'General case' 0 N--CA 1.494 1.739 0 CA-C-O 121.051 0.453 . . . . 0.0 110.981 178.578 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 171' ' ' GLU . . . . . . . . . . . . . 6.7 pt-20 -121.29 61.38 0.91 Allowed 'General case' 0 N--CA 1.494 1.725 0 O-C-N 121.175 -0.953 . . . . 0.0 109.938 -179.228 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 172' ' ' GLN . . . . . . . . . . . . . 3.0 pt20 -135.03 -44.93 0.72 Allowed 'General case' 0 N--CA 1.492 1.668 0 O-C-N 121.527 -0.733 . . . . 0.0 109.942 -178.975 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 173' ' ' LYS . . . . . . . . . . . . . 21.5 mttp -62.54 128.93 38.29 Favored 'General case' 0 N--CA 1.489 1.498 0 O-C-N 120.899 -1.126 . . . . 0.0 108.106 178.949 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 174' ' ' GLY . . . . . 0.552 ' O ' ' C ' ' A' ' 175' ' ' LYS . . . -137.63 -40.37 0.11 Allowed Glycine 0 C--N 1.293 -1.807 0 N-CA-C 109.071 -1.612 . . . . 0.0 109.071 -179.722 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 175' ' ' LYS . . . . . 0.552 ' C ' ' O ' ' A' ' 174' ' ' GLY . 4.4 mptp? -30.87 -65.28 0.12 Allowed 'General case' 0 N--CA 1.499 2.011 0 N-CA-C 108.9 -0.778 . . . . 0.0 108.9 -179.751 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 176' ' ' ASP . . . . . 0.696 ' O ' ' O ' ' A' ' 177' ' ' LYS . 58.2 m-20 -101.39 78.7 1.9 Allowed 'General case' 0 C--N 1.296 -1.728 0 N-CA-C 107.79 -1.189 . . . . 0.0 107.79 177.843 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 177' ' ' LYS . . . . . 0.696 ' O ' ' O ' ' A' ' 176' ' ' ASP . 0.7 OUTLIER -20.54 158.02 0.0 OUTLIER 'General case' 0 N--CA 1.507 2.39 0 CA-C-O 122.218 1.009 . . . . 0.0 112.249 -179.075 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 178' ' ' GLN . . . . . 0.428 ' NE2' HD21 ' A' ' 114' ' ' ASN . 0.4 OUTLIER -157.03 164.22 38.2 Favored 'General case' 0 C--N 1.303 -1.414 0 C-N-CA 117.052 -1.859 . . . . 0.0 112.026 179.804 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 179' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -122.23 107.39 12.08 Favored 'General case' 0 C--N 1.303 -1.42 0 N-CA-C 107.345 -1.354 . . . . 0.0 107.345 179.083 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 180' ' ' THR . . . . . 0.487 ' OG1' ' OD2' ' A' ' 170' ' ' ASP . 1.0 OUTLIER -78.66 120.32 23.16 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 120.87 -1.144 . . . . 0.0 110.278 -178.427 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 181' ' ' LEU . . . . . . . . . . . . . 10.2 tp -100.16 105.78 17.42 Favored 'General case' 0 N--CA 1.492 1.671 0 O-C-N 121.536 -0.728 . . . . 0.0 109.099 178.883 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 182' ' ' ILE . . . . . . . . . . . . . 56.3 mt -95.63 125.86 48.29 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.419 0 O-C-N 121.064 -1.022 . . . . 0.0 110.046 179.875 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 183' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -135.75 111.74 9.57 Favored 'General case' 0 C--N 1.294 -1.843 0 N-CA-C 107.367 -1.346 . . . . 0.0 107.367 178.493 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 184' ' ' CYS . . . . . . . . . . . . . 0.8 OUTLIER -79.6 156.14 27.81 Favored 'General case' 0 C--N 1.292 -1.909 0 C-N-CA 118.783 -1.167 . . . . 0.0 110.851 -177.947 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 185' ' ' ASP . . . . . 0.481 ' OD1' ' N ' ' A' ' 186' ' ' ASP . 10.3 t0 -167.24 -154.07 0.16 Allowed 'General case' 0 N--CA 1.495 1.789 0 O-C-N 121.365 -0.834 . . . . 0.0 109.821 -179.656 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 186' ' ' ASP . . . . . 0.481 ' N ' ' OD1' ' A' ' 185' ' ' ASP . 0.9 OUTLIER 52.8 52.63 13.58 Favored 'General case' 0 N--CA 1.496 1.862 0 O-C-N 121.294 -0.879 . . . . 0.0 109.504 -179.858 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 187' ' ' TYR . . . . . 0.577 ' CE1' ' O ' ' A' ' 188' ' ' ASN . 56.9 t80 -68.68 129.25 39.39 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.291 -0.881 . . . . 0.0 110.958 -179.677 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 188' ' ' ASN . . . . . 0.779 HD22 ' N ' ' A' ' 192' ' ' GLY . 0.0 OUTLIER -101.09 151.39 21.87 Favored 'General case' 0 C--N 1.293 -1.86 0 N-CA-C 107.07 -1.456 . . . . 0.0 107.07 177.073 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 189' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -112.82 -7.15 13.79 Favored 'General case' 0 C--N 1.294 -1.816 0 N-CA-C 108.179 -1.045 . . . . 0.0 108.179 -179.526 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 190' ' ' LYS . . . . . 0.585 ' N ' ' OD1' ' A' ' 188' ' ' ASN . 0.6 OUTLIER -82.91 -56.16 3.98 Favored 'General case' 0 N--CA 1.489 1.482 0 C-N-CA 120.062 -0.655 . . . . 0.0 109.424 179.144 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 191' ' ' THR . . . . . 0.684 ' HG1' ' ND2' ' A' ' 188' ' ' ASN . 4.9 p -88.12 -2.86 58.86 Favored 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.305 -0.872 . . . . 0.0 109.453 -179.779 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 192' ' ' GLY . . . . . 0.779 ' N ' HD22 ' A' ' 188' ' ' ASN . . . 62.86 33.18 86.3 Favored Glycine 0 N--CA 1.493 2.483 0 O-C-N 121.345 -0.847 . . . . 0.0 111.657 178.349 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 193' ' ' VAL . . . . . 0.756 ' H ' ' ND2' ' A' ' 188' ' ' ASN . 4.0 p -147.81 167.05 4.97 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.689 0 O-C-N 120.686 -1.479 . . . . 0.0 109.959 178.873 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 194' ' ' TRP . . . . . 0.457 ' CD1' ' N ' ' A' ' 194' ' ' TRP . 17.0 m95 -82.04 120.86 25.81 Favored 'General case' 0 C--N 1.295 -1.764 0 N-CA-C 108.495 -0.928 . . . . 0.0 108.495 179.854 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 195' ' ' GLU . . . . . . . . . . . . . 1.3 mt-10 -83.84 -60.97 1.95 Allowed 'General case' 0 C--N 1.301 -1.513 0 O-C-N 121.471 -0.768 . . . . 0.0 110.864 -178.086 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 196' ' ' LYS . . . . . . . . . . . . . 12.8 tttt -86.39 158.42 19.63 Favored 'General case' 0 C--N 1.301 -1.527 0 O-C-N 120.888 -1.132 . . . . 0.0 110.566 -179.007 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 197' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -126.29 135.73 51.89 Favored 'General case' 0 N--CA 1.489 1.482 0 N-CA-C 108.512 -0.922 . . . . 0.0 108.512 179.116 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 198' ' ' LYS . . . . . . . . . . . . . 14.3 mttt -115.39 120.93 41.23 Favored 'General case' 0 N--CA 1.494 1.727 0 O-C-N 121.553 -0.717 . . . . 0.0 110.422 -179.197 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 199' ' ' ILE . . . . . . . . . . . . . 0.9 OUTLIER -141.51 118.81 8.06 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.646 0 CA-C-O 122.494 1.14 . . . . 0.0 110.043 179.478 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 200' ' ' PHE . . . . . 0.619 ' CD1' ' N ' ' A' ' 200' ' ' PHE . 0.3 OUTLIER -104.24 135.74 45.15 Favored 'General case' 0 N--CA 1.496 1.855 0 O-C-N 121.295 -0.878 . . . . 0.0 109.586 -178.441 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 201' ' ' VAL . . . . . . . . . . . . . 85.2 t -104.36 154.57 6.1 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.611 0 O-C-N 120.979 -1.076 . . . . 0.0 109.07 178.585 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 202' ' ' ALA . . . . . . . . . . . . . . . -136.49 142.37 43.52 Favored 'General case' 0 C--N 1.302 -1.472 0 O-C-N 121.153 -0.967 . . . . 0.0 109.055 179.991 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 203' ' ' THR . . . . . 0.44 ' HG1' ' HG1' ' A' ' 156' ' ' THR . 0.6 OUTLIER -88.59 129.66 35.44 Favored 'General case' 0 N--CA 1.488 1.465 0 CA-C-O 122.281 1.039 . . . . 0.0 111.26 -178.455 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 204' ' ' GLU . . . . . 0.513 ' HA ' ' CD2' ' A' ' 153' ' ' TYR . 12.0 tt0 -49.59 134.74 19.42 Favored 'General case' 0 C--N 1.298 -1.643 0 C-N-CA 119.098 -1.041 . . . . 0.0 108.626 178.38 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 205' ' ' VAL . . . . . 0.519 ' N ' ' O ' ' A' ' 152' ' ' LYS . 39.0 t -125.86 161.13 31.62 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.304 0 CA-C-O 122.263 1.03 . . . . 0.0 110.431 -177.765 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 206' ' ' LYS . . . . . 0.515 ' N ' ' CG1' ' A' ' 205' ' ' VAL . 13.1 mtmt . . . . . 0 C--N 1.293 -1.864 0 CA-C-O 117.931 -1.033 . . . . 0.0 108.983 179.754 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' C' C ' 702' ' ' LEU . . . . . 0.636 ' CD1' ' N ' ' C' ' 702' ' ' LEU . 0.0 OUTLIER . . . . . 0 N--CA 1.488 1.453 0 N-CA-C 108.735 -0.839 . . . . 0.0 108.735 . . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' C' C ' 703' ' ' PRO . . . . . . . . . . . . . 9.4 Cg_endo -64.97 -173.0 0.23 Allowed 'Trans proline' 0 N--CA 1.491 1.341 0 C-N-CA 121.619 1.546 . . . . 0.0 112.099 -179.666 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' C' C ' 704' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.487 1.415 0 O-C-N 121.334 -0.854 . . . . 0.0 109.396 -179.558 . . . . . . . . 0 0 . 1 . 020 nuclear orig core ' A' A ' 63' ' ' PRO . . . . . . . . . . . . . 45.2 Cg_endo . . . . . 0 C--O 1.217 -0.57 0 CA-C-O 121.339 0.474 . . . . 0.0 112.224 . . . . . . . . . 0 0 . 1 . 020 nuclear orig core ' A' A ' 64' ' ' GLN . . . . . 0.672 ' NE2' ' N ' ' A' ' 64' ' ' GLN . 0.0 OUTLIER -153.98 117.49 4.63 Favored 'General case' 0 N--CA 1.498 1.932 0 O-C-N 121.531 -0.73 . . . . 0.0 109.163 179.517 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 65' ' ' ILE . . . . . 0.44 ' C ' ' O ' ' A' ' 64' ' ' GLN . 3.2 mp -45.28 105.75 0.49 Allowed Pre-proline 0 N--CA 1.493 1.682 0 O-C-N 121.027 -1.045 . . . . 0.0 108.758 179.395 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 66' ' ' PRO . . . . . . . . . . . . . 84.5 Cg_endo -86.46 -158.08 0.08 OUTLIER 'Trans proline' 0 N--CA 1.488 1.148 0 C-N-CA 122.048 1.832 . . . . 0.0 112.51 -179.536 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 67' ' ' LYS . . . . . 0.492 ' C ' ' H ' ' A' ' 69' ' ' LYS . 0.0 OUTLIER -82.82 -4.56 58.18 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.396 -0.815 . . . . 0.0 109.584 -179.756 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 68' ' ' ASP . . . . . 0.62 ' C ' ' N ' ' A' ' 70' ' ' SER . 0.3 OUTLIER -74.05 51.1 0.39 Allowed 'General case' 0 N--CA 1.487 1.411 0 CA-C-O 122.913 1.34 . . . . 0.0 107.919 179.28 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 69' ' ' LYS . . . . . 0.492 ' H ' ' C ' ' A' ' 67' ' ' LYS . 0.1 OUTLIER -49.54 -13.13 0.07 Allowed 'General case' 0 C--N 1.29 -1.99 0 C-N-CA 116.889 -1.924 . . . . 0.0 106.976 178.792 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 70' ' ' SER . . . . . 0.62 ' N ' ' C ' ' A' ' 68' ' ' ASP . 3.6 p -84.25 -8.99 58.87 Favored 'General case' 0 N--CA 1.498 1.96 0 CA-C-N 113.631 -1.622 . . . . 0.0 110.056 178.444 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 71' ' ' LYS . . . . . . . . . . . . . 2.6 ptmm? -96.89 140.57 31.24 Favored 'General case' 0 N--CA 1.494 1.737 0 O-C-N 120.905 -1.122 . . . . 0.0 111.003 -179.739 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 1.1 m -63.23 139.78 20.71 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.387 0 N-CA-C 104.331 -2.47 . . . . 0.0 104.331 175.288 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 73' ' ' ALA . . . . . 0.512 ' N ' ' O ' ' A' ' 87' ' ' VAL . . . -82.15 -16.99 47.93 Favored 'General case' 0 C--N 1.287 -2.14 0 C-N-CA 117.405 -1.718 . . . . 0.0 106.806 -179.948 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . 177.7 -158.54 23.8 Favored Glycine 0 C--N 1.298 -1.54 0 N-CA-C 109.383 -1.487 . . . . 0.0 109.383 179.408 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 75' ' ' TYR . . . . . 0.413 ' CD2' ' C ' ' A' ' 85' ' ' GLU . 0.7 OUTLIER -143.47 165.48 27.44 Favored 'General case' 0 C--N 1.296 -1.729 0 O-C-N 121.716 -0.873 . . . . 0.0 110.55 -176.722 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 76' ' ' ILE . . . . . . . . . . . . . 4.4 tt -148.66 146.68 17.42 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.453 0 C-N-CA 119.069 -1.052 . . . . 0.0 110.659 -177.866 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -150.13 167.84 25.66 Favored 'General case' 0 N--CA 1.489 1.482 0 O-C-N 121.181 -0.949 . . . . 0.0 109.195 179.119 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 78' ' ' ILE . . . . . . . . . . . . . 16.9 mt -149.67 98.18 3.43 Favored Pre-proline 0 C--N 1.303 -1.442 0 N-CA-C 108.543 -0.91 . . . . 0.0 108.543 179.474 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 79' ' ' PRO . . . . . . . . . . . . . 54.1 Cg_exo -48.83 -46.57 24.22 Favored 'Trans proline' 0 C--N 1.31 -1.481 0 C-N-CA 122.517 2.145 . . . . 0.0 113.76 -178.95 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -66.02 -19.83 65.99 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 120.892 -1.13 . . . . 0.0 111.244 179.339 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 81' ' ' ALA . . . . . 0.606 ' O ' ' ND2' ' A' ' 132' ' ' ASN . . . -105.42 -19.34 13.82 Favored 'General case' 0 N--CA 1.495 1.806 0 O-C-N 121.052 -1.03 . . . . 0.0 108.861 179.633 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 82' ' ' ASP . . . . . 0.452 ' CB ' ' O ' ' A' ' 81' ' ' ALA . 5.6 t70 71.42 48.01 0.35 Allowed 'General case' 0 N--CA 1.494 1.736 0 O-C-N 120.988 -1.07 . . . . 0.0 110.328 179.33 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 83' ' ' ILE . . . . . . . . . . . . . 82.5 mt -127.42 152.57 35.63 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.696 0 O-C-N 121.265 -0.897 . . . . 0.0 110.021 -179.006 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 84' ' ' LYS . . . . . . . . . . . . . 33.2 tttt -159.46 107.32 1.76 Allowed 'General case' 0 N--CA 1.491 1.617 0 N-CA-C 107.944 -1.132 . . . . 0.0 107.944 179.427 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 85' ' ' GLU . . . . . 0.413 ' C ' ' CD2' ' A' ' 75' ' ' TYR . 0.3 OUTLIER -144.05 164.85 27.03 Favored Pre-proline 0 N--CA 1.491 1.604 0 O-C-N 121.281 -0.887 . . . . 0.0 110.488 -178.741 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 86' ' ' PRO . . . . . . . . . . . . . 55.8 Cg_endo -72.46 170.38 19.47 Favored 'Trans proline' 0 N--CA 1.495 1.578 0 C-N-CA 123.635 2.89 . . . . 0.0 113.633 -179.494 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 87' ' ' VAL . . . . . 0.512 ' O ' ' N ' ' A' ' 73' ' ' ALA . 54.1 t -127.26 98.07 4.41 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.822 0 N-CA-C 109.047 -0.723 . . . . 0.0 109.047 179.828 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 88' ' ' TYR . . . . . 0.407 ' CD2' ' HD3' ' A' ' 99' ' ' ARG . 21.1 m-85 -88.17 154.05 51.74 Favored Pre-proline 0 N--CA 1.505 2.284 0 O-C-N 120.659 -1.276 . . . . 0.0 110.42 -179.443 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 89' ' ' PRO . . . . . . . . . . . . . 9.7 Cg_endo -61.54 145.09 98.12 Favored 'Trans proline' 0 C--N 1.311 -1.429 0 C-N-CA 122.5 2.133 . . . . 0.0 113.76 -179.677 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . -56.58 166.05 4.69 Favored Glycine 0 N--CA 1.491 2.342 0 N-CA-C 109.575 -1.41 . . . . 0.0 109.575 179.255 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 91' ' ' PRO . . . . . 0.475 ' C ' ' H ' ' A' ' 93' ' ' THR . 44.8 Cg_endo -94.29 168.22 19.08 Favored 'Cis proline' 0 C--N 1.312 -1.38 0 C-N-CA 123.864 -1.307 . . . . 0.0 111.949 0.167 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 92' ' ' ALA . . . . . 0.532 ' O ' ' CD1' ' A' ' 97' ' ' LEU . . . -71.91 31.26 0.05 Allowed 'General case' 0 C--N 1.302 -1.463 0 O-C-N 121.281 -0.887 . . . . 0.0 110.396 179.952 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 93' ' ' THR . . . . . 0.475 ' H ' ' C ' ' A' ' 91' ' ' PRO . 1.0 OUTLIER -74.71 151.24 86.85 Favored Pre-proline 0 N--CA 1.491 1.605 0 O-C-N 120.501 -1.374 . . . . 0.0 108.43 179.846 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 94' ' ' PRO . . . . . 0.414 ' C ' ' O ' ' A' ' 93' ' ' THR . 86.5 Cg_exo -29.91 -54.42 0.19 Allowed 'Trans proline' 0 C--N 1.308 -1.565 0 C-N-CA 123.228 2.619 . . . . 0.0 113.207 -178.861 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 83.6 mt-10 -47.24 -49.31 23.58 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 120.796 -1.19 . . . . 0.0 109.706 -179.528 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 96' ' ' GLN . . . . . 0.657 HE21 HH12 ' A' ' 99' ' ' ARG . 6.1 mp0 -71.72 -53.13 14.47 Favored 'General case' 0 C--N 1.303 -1.446 0 O-C-N 121.337 -0.852 . . . . 0.0 110.376 -179.658 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 97' ' ' LEU . . . . . 0.532 ' CD1' ' O ' ' A' ' 92' ' ' ALA . 83.8 mt -50.53 -9.0 0.04 OUTLIER 'General case' 0 N--CA 1.493 1.724 0 O-C-N 121.149 -0.969 . . . . 0.0 110.299 -178.498 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 98' ' ' ASN . . . . . 0.601 HD22 ' NE ' ' A' ' 99' ' ' ARG . 0.2 OUTLIER -72.55 -27.69 62.38 Favored 'General case' 0 N--CA 1.488 1.45 0 O-C-N 121.029 -1.044 . . . . 0.0 108.863 179.534 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 99' ' ' ARG . . . . . 0.657 HH12 HE21 ' A' ' 96' ' ' GLN . 6.1 mtt180 -94.27 -60.17 1.79 Allowed 'General case' 0 N--CA 1.491 1.577 0 C-N-CA 119.973 -0.691 . . . . 0.0 110.529 -179.651 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . -171.66 -166.58 30.61 Favored Glycine 0 N--CA 1.499 2.835 0 C-N-CA 119.424 -1.369 . . . . 0.0 111.003 -179.501 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 101' ' ' VAL . . . . . 0.526 ' O ' ' CG2' ' A' ' 101' ' ' VAL . 16.3 m -57.47 106.46 0.18 Allowed 'Isoleucine or valine' 0 N--CA 1.498 1.928 0 O-C-N 121.554 -0.968 . . . . 0.0 109.455 -179.783 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -93.8 159.71 15.07 Favored 'General case' 0 N--CA 1.493 1.696 0 O-C-N 121.244 -0.91 . . . . 0.0 111.633 -179.068 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 103' ' ' PHE . . . . . 0.412 ' CE1' ' CG1' ' A' ' 87' ' ' VAL . 23.5 m-85 -63.18 130.93 46.71 Favored 'General case' 0 N--CA 1.49 1.531 0 N-CA-C 107.881 -1.155 . . . . 0.0 107.881 178.235 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 104' ' ' ALA . . . . . . . . . . . . . . . -50.95 -18.34 0.75 Allowed 'General case' 0 C--N 1.299 -1.619 0 O-C-N 121.58 -0.7 . . . . 0.0 111.42 -178.532 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -136.91 146.66 45.74 Favored 'General case' 0 N--CA 1.495 1.808 0 O-C-N 120.799 -1.188 . . . . 0.0 111.011 -179.447 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 106' ' ' GLU . . . . . . . . . . . . . 1.7 tt0 -55.26 -62.33 1.74 Allowed 'General case' 0 C--N 1.305 -1.351 0 CA-C-N 116.061 -0.518 . . . . 0.0 110.316 -179.903 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 107' ' ' ASN . . . . . 0.639 ' N ' HD21 ' A' ' 107' ' ' ASN . 0.7 OUTLIER -78.81 33.48 0.21 Allowed 'General case' 0 N--CA 1.491 1.607 0 O-C-N 120.609 -1.307 . . . . 0.0 113.184 -175.638 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 108' ' ' GLU . . . . . . . . . . . . . 29.0 tp10 -58.25 143.32 44.85 Favored 'General case' 0 N--CA 1.495 1.813 0 O-C-N 120.468 -1.395 . . . . 0.0 107.963 179.945 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 109' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -94.95 140.45 29.92 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 120.961 -1.087 . . . . 0.0 110.987 -178.013 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 110' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -63.7 -16.78 61.94 Favored 'General case' 0 C--N 1.302 -1.469 0 N-CA-C 108.754 -0.832 . . . . 0.0 108.754 179.207 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 111' ' ' ASP . . . . . . . . . . . . . 13.0 m-20 -133.1 36.83 3.43 Favored 'General case' 0 N--CA 1.488 1.475 0 O-C-N 121.677 -0.639 . . . . 0.0 109.762 -179.439 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 112' ' ' ASP . . . . . . . . . . . . . 1.7 t0 -65.93 150.07 49.22 Favored 'General case' 0 N--CA 1.494 1.76 0 O-C-N 121.033 -1.042 . . . . 0.0 110.706 -179.58 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 113' ' ' GLN . . . . . 0.452 ' HA ' ' NE2' ' A' ' 113' ' ' GLN . 0.8 OUTLIER -68.11 -13.12 61.97 Favored 'General case' 0 N--CA 1.491 1.598 0 N-CA-C 107.849 -1.167 . . . . 0.0 107.849 177.84 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 114' ' ' ASN . . . . . . . . . . . . . 2.7 t30 -149.38 103.0 3.25 Favored 'General case' 0 C--N 1.302 -1.477 0 N-CA-C 107.818 -1.178 . . . . 0.0 107.818 177.913 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 115' ' ' ILE . . . . . . . . . . . . . 3.0 mt -97.34 110.47 25.26 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.479 0 O-C-N 121.156 -0.965 . . . . 0.0 109.837 -179.135 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 116' ' ' SER . . . . . 0.439 ' H ' ' HG ' ' A' ' 116' ' ' SER . 0.9 OUTLIER -96.38 145.23 25.81 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.075 -1.015 . . . . 0.0 111.265 -178.392 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 117' ' ' ILE . . . . . . . . . . . . . 1.4 mt -139.65 156.55 26.21 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.768 0 N-CA-C 107.887 -1.153 . . . . 0.0 107.887 178.951 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 118' ' ' ALA . . . . . . . . . . . . . . . -142.06 160.38 40.34 Favored 'General case' 0 N--CA 1.491 1.601 0 C-N-CA 118.775 -1.17 . . . . 0.0 111.812 -179.07 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 119' ' ' GLY . . . . . . . . . . . . . . . -164.66 145.49 10.34 Favored Glycine 0 N--CA 1.481 1.688 0 N-CA-C 109.636 -1.386 . . . . 0.0 109.636 179.667 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 120' ' ' HIS . . . . . . . . . . . . . 10.5 m-70 -71.03 166.22 21.82 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.665 -0.903 . . . . 0.0 109.897 179.119 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 121' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -123.69 149.28 45.68 Favored 'General case' 0 N--CA 1.496 1.858 0 N-CA-C 107.637 -1.245 . . . . 0.0 107.637 178.53 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 122' ' ' PHE . . . . . . . . . . . . . 0.4 OUTLIER -114.88 138.02 51.28 Favored 'General case' 0 N--CA 1.492 1.666 0 O-C-N 121.178 -0.951 . . . . 0.0 109.99 -179.227 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 123' ' ' ILE . . . . . . . . . . . . . 17.8 tt -89.39 -31.56 5.41 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.677 0 CA-C-O 121.98 0.895 . . . . 0.0 109.432 -179.782 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 124' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -85.48 -3.67 58.93 Favored 'General case' 0 C--N 1.292 -1.908 0 C-N-CA 120.05 -0.66 . . . . 0.0 112.218 -177.71 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 125' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -157.15 130.97 4.8 Favored Pre-proline 0 N--CA 1.499 1.986 0 O-C-N 120.249 -1.532 . . . . 0.0 110.668 179.443 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 126' ' ' PRO . . . . . . . . . . . . . 88.7 Cg_endo -83.18 -13.23 9.02 Favored 'Trans proline' 0 N--CA 1.497 1.709 0 C-N-CA 122.676 2.251 . . . . 0.0 113.218 178.94 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 127' ' ' ASN . . . . . . . . . . . . . 1.4 t30 -89.32 24.79 2.1 Favored 'General case' 0 N--CA 1.494 1.735 0 O-C-N 121.041 -1.037 . . . . 0.0 110.05 -178.924 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 128' ' ' TYR . . . . . . . . . . . . . 9.6 t80 -83.15 -148.75 0.09 Allowed 'General case' 0 C--N 1.299 -1.621 0 O-C-N 121.237 -0.914 . . . . 0.0 109.322 -179.892 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 129' ' ' GLN . . . . . . . . . . . . . 6.4 mt-30 -65.75 -88.51 0.01 OUTLIER 'General case' 0 C--N 1.299 -1.63 0 O-C-N 121.345 -0.847 . . . . 0.0 110.172 -179.319 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 130' ' ' PHE . . . . . 0.452 ' CE2' ' CG1' ' A' ' 101' ' ' VAL . 35.8 m-85 -111.91 32.27 5.6 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.353 -0.842 . . . . 0.0 109.977 -179.249 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 131' ' ' THR . . . . . . . . . . . . . 89.8 m -71.23 -33.94 70.32 Favored 'General case' 0 N--CA 1.497 1.878 0 O-C-N 121.385 -0.822 . . . . 0.0 109.441 179.514 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 132' ' ' ASN . . . . . 0.606 ' ND2' ' O ' ' A' ' 81' ' ' ALA . 0.1 OUTLIER -84.69 5.82 26.67 Favored 'General case' 0 N--CA 1.498 1.962 0 CA-C-O 121.945 0.879 . . . . 0.0 109.364 -179.624 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 133' ' ' LEU . . . . . 0.592 ' O ' ' N ' ' A' ' 135' ' ' ALA . 0.2 OUTLIER -72.34 -45.25 60.72 Favored 'General case' 0 C--N 1.297 -1.684 0 O-C-N 121.157 -0.964 . . . . 0.0 109.738 179.69 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 134' ' ' LYS . . . . . 0.557 ' CE ' ' H ' ' A' ' 134' ' ' LYS . 0.0 OUTLIER -47.39 -10.39 0.02 OUTLIER 'General case' 0 C--N 1.3 -1.585 0 O-C-N 121.14 -0.975 . . . . 0.0 109.546 -179.634 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 135' ' ' ALA . . . . . 0.592 ' N ' ' O ' ' A' ' 133' ' ' LEU . . . -84.65 -39.72 18.28 Favored 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.081 -1.012 . . . . 0.0 109.165 179.225 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 136' ' ' ALA . . . . . . . . . . . . . . . -78.19 159.58 28.47 Favored 'General case' 0 N--CA 1.489 1.49 0 CA-C-O 122.08 0.943 . . . . 0.0 111.586 -178.472 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 137' ' ' LYS . . . . . 0.559 ' O ' ' O ' ' A' ' 138' ' ' LYS . 7.9 tttt -154.25 -162.76 1.47 Allowed 'General case' 0 N--CA 1.492 1.662 0 C-N-CA 118.801 -1.159 . . . . 0.0 110.467 -178.515 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 138' ' ' LYS . . . . . 0.606 ' O ' ' N ' ' A' ' 140' ' ' SER . 23.0 mttt -44.25 -179.26 0.0 OUTLIER 'General case' 0 C--N 1.302 -1.468 0 CA-C-O 122.334 1.064 . . . . 0.0 110.667 -179.282 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 139' ' ' GLY . . . . . . . . . . . . . . . 46.41 8.25 0.02 OUTLIER Glycine 0 N--CA 1.492 2.408 0 N-CA-C 110.018 -1.233 . . . . 0.0 110.018 -179.676 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 140' ' ' SER . . . . . 0.606 ' N ' ' O ' ' A' ' 138' ' ' LYS . 9.9 m -81.2 144.11 31.85 Favored 'General case' 0 N--CA 1.493 1.705 0 O-C-N 120.864 -1.374 . . . . 0.0 109.224 179.235 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 141' ' ' MET . . . . . . . . . . . . . 2.1 tpt -96.39 125.95 41.25 Favored 'General case' 0 C--N 1.301 -1.535 0 O-C-N 121.127 -0.983 . . . . 0.0 109.403 -179.921 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 142' ' ' VAL . . . . . . . . . . . . . 2.4 t -113.77 128.77 70.52 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.838 0 O-C-N 121.269 -0.894 . . . . 0.0 109.554 -179.438 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 143' ' ' TYR . . . . . 0.409 ' CZ ' ' CD ' ' A' ' 152' ' ' LYS . 3.0 m-85 -107.48 134.39 50.58 Favored 'General case' 0 N--CA 1.497 1.91 0 O-C-N 121.172 -0.955 . . . . 0.0 111.158 -178.838 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 144' ' ' PHE . . . . . . . . . . . . . 24.7 t80 -118.86 99.89 7.04 Favored 'General case' 0 N--CA 1.494 1.726 0 N-CA-C 109.221 -0.659 . . . . 0.0 109.221 179.965 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 145' ' ' LYS . . . . . . . . . . . . . 8.2 mtpm? -98.56 122.47 41.8 Favored 'General case' 0 N--CA 1.488 1.426 0 O-C-N 121.231 -0.918 . . . . 0.0 110.196 -179.353 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 146' ' ' VAL . . . . . . . . . . . . . 1.0 OUTLIER -143.51 122.82 8.25 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.499 0 O-C-N 120.885 -1.134 . . . . 0.0 109.058 179.005 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 147' ' ' GLY . . . . . . . . . . . . . . . 67.23 -132.91 30.7 Favored Glycine 0 N--CA 1.484 1.869 0 N-CA-C 108.186 -1.966 . . . . 0.0 108.186 -179.387 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 148' ' ' ASN . . . . . 0.611 ' C ' ' ND2' ' A' ' 148' ' ' ASN . 0.0 OUTLIER -101.28 11.36 39.44 Favored 'General case' 0 C--N 1.296 -1.727 0 N-CA-C 107.918 -1.141 . . . . 0.0 107.918 178.789 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 149' ' ' GLU . . . . . . . . . . . . . 2.4 tt0 -108.13 143.03 37.45 Favored 'General case' 0 N--CA 1.489 1.484 0 O-C-N 121.311 -0.868 . . . . 0.0 111.35 -178.841 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 150' ' ' THR . . . . . . . . . . . . . 3.7 m -131.03 100.64 5.3 Favored 'General case' 0 N--CA 1.495 1.822 0 CA-C-O 121.413 0.625 . . . . 0.0 109.724 179.923 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 151' ' ' ARG . . . . . 0.566 HH12 ' CD ' ' A' ' 204' ' ' GLU . 0.1 OUTLIER -86.63 -169.99 2.88 Favored 'General case' 0 C--N 1.305 -1.347 0 N-CA-C 108.382 -0.969 . . . . 0.0 108.382 179.466 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 152' ' ' LYS . . . . . 0.42 ' C ' ' CD1' ' A' ' 153' ' ' TYR . 24.8 mtmm -153.22 151.29 29.9 Favored 'General case' 0 C--N 1.3 -1.57 0 O-C-N 121.327 -0.858 . . . . 0.0 109.7 -179.857 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 153' ' ' TYR . . . . . 0.491 ' CD2' ' HA ' ' A' ' 204' ' ' GLU . 6.2 m-85 -142.79 168.81 18.85 Favored 'General case' 0 N--CA 1.493 1.706 0 N-CA-C 107.856 -1.164 . . . . 0.0 107.856 178.759 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 154' ' ' LYS . . . . . . . . . . . . . 20.5 ttpt -142.9 119.38 10.98 Favored 'General case' 0 N--CA 1.493 1.678 0 O-C-N 121.51 -0.744 . . . . 0.0 109.186 178.884 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 155' ' ' MET . . . . . . . . . . . . . 29.2 mtp -47.28 105.62 0.07 Allowed 'General case' 0 N--CA 1.494 1.747 0 O-C-N 120.819 -1.176 . . . . 0.0 112.321 -178.983 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 156' ' ' THR . . . . . . . . . . . . . 1.3 m -105.39 -21.29 13.26 Favored 'General case' 0 N--CA 1.494 1.755 0 CA-C-N 115.445 -0.798 . . . . 0.0 110.168 -179.548 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 157' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -148.38 147.02 28.75 Favored 'General case' 0 N--CA 1.494 1.753 0 C-N-CA 118.336 -1.345 . . . . 0.0 110.814 -178.689 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 158' ' ' ILE . . . . . . . . . . . . . 1.1 mt -148.49 138.24 16.22 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.547 0 CA-C-O 121.577 0.703 . . . . 0.0 109.953 -178.463 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 159' ' ' ARG . . . . . . . . . . . . . 5.7 ttm180 -156.45 -161.96 1.19 Allowed 'General case' 0 N--CA 1.497 1.893 0 O-C-N 121.325 -0.859 . . . . 0.0 110.594 -179.565 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 160' ' ' ASP . . . . . . . . . . . . . 67.4 m-20 -149.09 156.17 41.81 Favored 'General case' 0 N--CA 1.498 1.956 0 N-CA-C 108.954 -0.758 . . . . 0.0 108.954 -179.909 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 161' ' ' VAL . . . . . 0.454 ' O ' ' O ' ' A' ' 162' ' ' LYS . 0.1 OUTLIER -149.15 148.08 16.04 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.807 0 O-C-N 120.699 -1.251 . . . . 0.0 110.359 179.851 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 162' ' ' LYS . . . . . 0.497 ' H ' ' CD ' ' A' ' 162' ' ' LYS . 0.0 OUTLIER -44.33 169.07 0.07 OUTLIER Pre-proline 0 N--CA 1.494 1.756 0 O-C-N 121.409 -0.807 . . . . 0.0 110.191 179.997 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 163' ' ' PRO . . . . . . . . . . . . . 58.0 Cg_endo -78.98 23.7 0.62 Allowed 'Trans proline' 0 C--N 1.31 -1.476 0 C-N-CA 122.917 2.411 . . . . 0.0 112.572 -179.169 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 164' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -151.22 1.69 0.41 Allowed 'General case' 0 C--N 1.299 -1.592 0 O-C-N 121.322 -0.861 . . . . 0.0 109.864 -179.488 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 165' ' ' ASP . . . . . 0.481 ' O ' ' C ' ' A' ' 166' ' ' VAL . 8.3 t70 -77.35 66.44 3.11 Favored 'General case' 0 N--CA 1.493 1.687 0 O-C-N 121.15 -0.969 . . . . 0.0 110.334 -179.877 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 166' ' ' VAL . . . . . 0.639 ' O ' ' N ' ' A' ' 168' ' ' VAL . 0.9 OUTLIER -38.0 -32.54 0.11 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.576 0 O-C-N 121.158 -0.963 . . . . 0.0 109.375 -178.638 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 167' ' ' GLY . . . . . 0.466 ' N ' ' O ' ' A' ' 165' ' ' ASP . . . -43.16 -15.71 0.03 OUTLIER Glycine 0 N--CA 1.491 2.325 0 N-CA-C 108.848 -1.701 . . . . 0.0 108.848 179.428 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 168' ' ' VAL . . . . . 0.639 ' N ' ' O ' ' A' ' 166' ' ' VAL . 3.5 t -49.98 -44.28 21.39 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.735 0 N-CA-C 108.168 -1.049 . . . . 0.0 108.168 178.412 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 169' ' ' LEU . . . . . 0.54 ' O ' ' C ' ' A' ' 170' ' ' ASP . 8.9 mt -50.2 -9.38 0.04 OUTLIER 'General case' 0 C--N 1.299 -1.628 0 N-CA-C 108.425 -0.954 . . . . 0.0 108.425 -177.396 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 170' ' ' ASP . . . . . 0.585 ' H ' ' C ' ' A' ' 168' ' ' VAL . 10.6 p30 18.46 80.87 0.01 OUTLIER 'General case' 0 N--CA 1.5 2.05 0 CA-C-N 116.582 -0.281 . . . . 0.0 111.699 177.793 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 171' ' ' GLU . . . . . . . . . . . . . 3.7 pt-20 -117.33 65.09 0.73 Allowed 'General case' 0 N--CA 1.493 1.692 0 O-C-N 121.152 -0.967 . . . . 0.0 110.069 179.833 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 172' ' ' GLN . . . . . . . . . . . . . 12.2 mt-30 -134.44 -45.91 0.76 Allowed 'General case' 0 N--CA 1.492 1.663 0 O-C-N 121.41 -0.806 . . . . 0.0 110.253 -178.598 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 173' ' ' LYS . . . . . . . . . . . . . 17.9 mttp -62.64 135.15 57.24 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 120.769 -1.207 . . . . 0.0 108.615 179.049 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 174' ' ' GLY . . . . . 0.52 ' O ' ' C ' ' A' ' 175' ' ' LYS . . . -141.21 -40.64 0.08 OUTLIER Glycine 0 C--N 1.295 -1.707 0 N-CA-C 108.138 -1.985 . . . . 0.0 108.138 179.899 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 175' ' ' LYS . . . . . 0.52 ' C ' ' O ' ' A' ' 174' ' ' GLY . 13.0 mptt -31.84 -64.08 0.17 Allowed 'General case' 0 N--CA 1.501 2.075 0 N-CA-C 108.653 -0.869 . . . . 0.0 108.653 179.196 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 176' ' ' ASP . . . . . 0.726 ' O ' ' O ' ' A' ' 177' ' ' LYS . 2.6 m-20 -101.93 73.28 1.39 Allowed 'General case' 0 C--N 1.297 -1.706 0 N-CA-C 107.255 -1.387 . . . . 0.0 107.255 177.627 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 177' ' ' LYS . . . . . 0.726 ' O ' ' O ' ' A' ' 176' ' ' ASP . 28.2 mttt -20.62 157.79 0.0 OUTLIER 'General case' 0 N--CA 1.504 2.233 0 CA-C-O 122.132 0.968 . . . . 0.0 111.851 -178.907 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 178' ' ' GLN . . . . . . . . . . . . . 3.3 pt20 -156.07 170.89 21.14 Favored 'General case' 0 N--CA 1.488 1.467 0 C-N-CA 117.096 -1.842 . . . . 0.0 112.084 -178.727 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 179' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -126.55 97.78 5.15 Favored 'General case' 0 C--N 1.303 -1.433 0 N-CA-C 107.237 -1.394 . . . . 0.0 107.237 178.366 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 180' ' ' THR . . . . . . . . . . . . . 1.1 m -71.23 121.06 17.71 Favored 'General case' 0 C--N 1.302 -1.464 0 C-N-CA 118.726 -1.19 . . . . 0.0 110.004 -178.615 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 181' ' ' LEU . . . . . . . . . . . . . 66.8 tp -94.55 152.25 18.69 Favored 'General case' 0 C--N 1.298 -1.654 0 N-CA-C 107.589 -1.263 . . . . 0.0 107.589 177.632 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 182' ' ' ILE . . . . . . . . . . . . . 36.5 mt -142.12 109.22 1.99 Allowed 'Isoleucine or valine' 0 C--N 1.301 -1.53 0 C-N-CA 119.083 -1.047 . . . . 0.0 109.242 178.941 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 183' ' ' THR . . . . . . . . . . . . . 1.2 t -129.21 109.36 11.08 Favored 'General case' 0 C--N 1.294 -1.836 0 N-CA-C 107.751 -1.203 . . . . 0.0 107.751 179.635 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 184' ' ' CYS . . . . . . . . . . . . . 4.0 p -81.06 157.96 25.24 Favored 'General case' 0 C--N 1.293 -1.879 0 C-N-CA 119.182 -1.007 . . . . 0.0 111.349 -177.609 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 185' ' ' ASP . . . . . 0.575 ' CG ' ' H ' ' A' ' 186' ' ' ASP . 43.9 t0 -164.3 -158.4 0.42 Allowed 'General case' 0 N--CA 1.489 1.509 0 N-CA-C 108.88 -0.785 . . . . 0.0 108.88 -179.536 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 186' ' ' ASP . . . . . 0.575 ' H ' ' CG ' ' A' ' 185' ' ' ASP . 1.3 m-20 56.91 49.35 14.2 Favored 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.161 -0.962 . . . . 0.0 109.675 179.561 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 187' ' ' TYR . . . . . 0.58 ' CE1' ' O ' ' A' ' 188' ' ' ASN . 33.9 t80 -65.43 128.69 36.91 Favored 'General case' 0 C--N 1.297 -1.674 0 O-C-N 121.075 -1.016 . . . . 0.0 109.772 -179.945 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 188' ' ' ASN . . . . . 0.76 ' ND2' ' H ' ' A' ' 193' ' ' VAL . 0.0 OUTLIER -97.85 150.55 21.17 Favored 'General case' 0 C--N 1.294 -1.838 0 N-CA-C 107.886 -1.153 . . . . 0.0 107.886 178.591 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 189' ' ' GLU . . . . . . . . . . . . . 1.7 tt0 -112.58 -5.95 13.97 Favored 'General case' 0 C--N 1.294 -1.831 0 N-CA-C 108.674 -0.862 . . . . 0.0 108.674 -178.683 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 190' ' ' LYS . . . . . 0.613 ' N ' ' OD1' ' A' ' 188' ' ' ASN . 10.2 mmtm -84.06 -57.45 3.18 Favored 'General case' 0 C--N 1.299 -1.618 0 N-CA-C 108.939 -0.763 . . . . 0.0 108.939 179.401 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 191' ' ' THR . . . . . 0.572 ' OG1' ' ND2' ' A' ' 188' ' ' ASN . 1.5 p -89.25 0.14 57.0 Favored 'General case' 0 N--CA 1.494 1.77 0 O-C-N 121.443 -0.785 . . . . 0.0 109.706 179.647 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 192' ' ' GLY . . . . . 0.646 ' N ' HD22 ' A' ' 188' ' ' ASN . . . 60.34 37.2 92.73 Favored Glycine 0 N--CA 1.498 2.783 0 N-CA-C 110.634 -0.986 . . . . 0.0 110.634 179.318 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 193' ' ' VAL . . . . . 0.76 ' H ' ' ND2' ' A' ' 188' ' ' ASN . 73.9 t -148.64 163.84 4.99 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.629 0 O-C-N 120.996 -1.297 . . . . 0.0 110.298 179.879 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 194' ' ' TRP . . . . . 0.514 ' N ' ' CG1' ' A' ' 193' ' ' VAL . 5.5 m95 -82.44 121.36 26.64 Favored 'General case' 0 N--CA 1.489 1.518 0 N-CA-C 108.373 -0.973 . . . . 0.0 108.373 179.257 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 195' ' ' GLU . . . . . . . . . . . . . 2.5 mt-10 -86.16 -57.39 3.04 Favored 'General case' 0 C--N 1.3 -1.566 0 O-C-N 121.15 -0.969 . . . . 0.0 110.463 -178.597 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 196' ' ' LYS . . . . . . . . . . . . . 2.6 mttp -92.33 143.65 26.18 Favored 'General case' 0 N--CA 1.489 1.494 0 O-C-N 120.911 -1.118 . . . . 0.0 110.205 -179.302 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 197' ' ' ARG . . . . . 0.64 ' CG ' HH11 ' A' ' 197' ' ' ARG . 0.2 OUTLIER -122.14 144.42 48.95 Favored 'General case' 0 N--CA 1.488 1.447 0 N-CA-C 108.784 -0.821 . . . . 0.0 108.784 179.108 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 198' ' ' LYS . . . . . . . . . . . . . 13.4 mptt -115.78 119.42 35.96 Favored 'General case' 0 C--N 1.299 -1.606 0 C-N-CA 120.349 -0.54 . . . . 0.0 110.087 -178.91 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 199' ' ' ILE . . . . . . . . . . . . . 1.0 OUTLIER -136.33 118.15 19.94 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.566 0 CA-C-O 122.716 1.246 . . . . 0.0 109.018 178.968 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 200' ' ' PHE . . . . . 0.535 ' CD1' ' N ' ' A' ' 200' ' ' PHE . 1.0 OUTLIER -102.84 138.37 39.82 Favored 'General case' 0 N--CA 1.492 1.671 0 CA-C-N 115.6 -0.727 . . . . 0.0 111.257 -176.918 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 201' ' ' VAL . . . . . . . . . . . . . 47.0 t -105.94 143.22 17.31 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.37 0 O-C-N 121.523 -0.736 . . . . 0.0 109.396 177.799 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 202' ' ' ALA . . . . . . . . . . . . . . . -130.37 137.57 49.96 Favored 'General case' 0 C--N 1.301 -1.502 0 N-CA-C 107.978 -1.119 . . . . 0.0 107.978 179.662 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 203' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -89.89 132.82 35.09 Favored 'General case' 0 C--N 1.303 -1.422 0 CA-C-O 122.576 1.179 . . . . 0.0 111.549 -178.796 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 204' ' ' GLU . . . . . 0.566 ' CD ' HH12 ' A' ' 151' ' ' ARG . 3.9 tt0 -49.45 135.01 18.5 Favored 'General case' 0 C--N 1.293 -1.888 0 C-N-CA 118.459 -1.296 . . . . 0.0 108.796 178.575 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 205' ' ' VAL . . . . . 0.464 ' CG1' ' N ' ' A' ' 206' ' ' LYS . 70.8 t -129.79 162.41 37.5 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.547 0 CA-C-O 122.082 0.944 . . . . 0.0 110.284 -177.739 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 206' ' ' LYS . . . . . 0.464 ' N ' ' CG1' ' A' ' 205' ' ' VAL . 4.6 ptmt . . . . . 0 C--N 1.298 -1.651 0 CA-C-O 118.145 -0.931 . . . . 0.0 109.42 -179.661 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' C' C ' 702' ' ' LEU . . . . . 0.653 ' CD1' ' N ' ' C' ' 702' ' ' LEU . 0.0 OUTLIER . . . . . 0 N--CA 1.485 1.32 0 N-CA-C 108.304 -0.998 . . . . 0.0 108.304 . . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' C' C ' 703' ' ' PRO . . . . . 0.603 ' O ' ' NH2' ' A' ' 197' ' ' ARG . 88.7 Cg_endo -81.1 172.76 12.56 Favored 'Trans proline' 0 C--N 1.303 -1.848 0 C-N-CA 122.632 2.221 . . . . 0.0 112.406 -179.688 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' C' C ' 704' ' ' ALA . . . . . 0.478 ' C ' ' O ' ' C' ' 703' ' ' PRO . . . . . . . . 0 N--CA 1.492 1.643 0 CA-C-O 121.536 0.684 . . . . 0.0 110.422 178.802 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 59' ' ' MET . . . . . . . . . . . . . 11.1 mtp . . . . . 0 N--CA 1.491 1.592 0 CA-C-O 121.212 0.529 . . . . 0.0 109.628 . . . . . . . . . 0 0 . 1 . 001 nuclear orig full ' A' A ' 60' ' ' GLN . . . . . . . . . . . . . 9.6 mm100 -60.03 173.39 0.63 Allowed 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.252 -0.905 . . . . 0.0 109.471 -179.773 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . -64.09 156.88 26.91 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.23 -0.919 . . . . 0.0 109.424 -179.988 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 62' ' ' LYS . . . . . 0.494 ' O ' ' OE1' ' A' ' 64' ' ' GLN . 0.0 OUTLIER -147.61 71.18 11.63 Favored Pre-proline 0 N--CA 1.488 1.446 0 O-C-N 121.293 -0.879 . . . . 0.0 109.022 -179.9 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 63' ' ' PRO . . . . . . . . . . . . . 6.7 Cg_exo -68.37 139.44 45.46 Favored 'Trans proline' 0 C--N 1.302 -1.876 0 C-N-CA 122.725 2.283 . . . . 0.0 111.288 -179.868 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 64' ' ' GLN . . . . . 0.613 ' NE2' ' N ' ' A' ' 64' ' ' GLN . 0.0 OUTLIER -155.75 126.9 7.09 Favored 'General case' 0 C--N 1.3 -1.56 0 O-C-N 121.117 -0.99 . . . . 0.0 109.347 179.316 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 65' ' ' ILE . . . . . 0.426 ' C ' ' O ' ' A' ' 64' ' ' GLN . 2.1 mp -46.27 106.37 0.56 Allowed Pre-proline 0 N--CA 1.489 1.495 0 N-CA-C 107.519 -1.289 . . . . 0.0 107.519 178.935 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 66' ' ' PRO . . . . . . . . . . . . . 89.0 Cg_endo -83.42 -162.84 0.18 Allowed 'Trans proline' 0 C--N 1.315 -1.185 0 C-N-CA 122.462 2.108 . . . . 0.0 112.834 -178.111 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 67' ' ' LYS . . . . . . . . . . . . . 24.8 tttm -87.65 -7.56 57.29 Favored 'General case' 0 N--CA 1.487 1.423 0 O-C-N 121.414 -0.803 . . . . 0.0 109.421 179.965 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 68' ' ' ASP . . . . . 0.654 ' O ' ' N ' ' A' ' 70' ' ' SER . 0.7 OUTLIER -76.23 63.38 1.88 Allowed 'General case' 0 N--CA 1.488 1.461 0 CA-C-O 122.936 1.35 . . . . 0.0 108.822 179.561 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 69' ' ' LYS . . . . . 0.462 ' C ' ' O ' ' A' ' 68' ' ' ASP . 8.2 ptpt -45.45 -14.57 0.02 OUTLIER 'General case' 0 N--CA 1.512 2.67 0 C-N-CA 116.881 -1.928 . . . . 0.0 107.321 178.086 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 70' ' ' SER . . . . . 0.654 ' N ' ' O ' ' A' ' 68' ' ' ASP . 0.6 OUTLIER -86.83 -7.29 58.37 Favored 'General case' 0 N--CA 1.498 1.969 0 CA-C-N 113.856 -1.52 . . . . 0.0 111.661 179.793 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 71' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -97.05 142.47 28.95 Favored 'General case' 0 N--CA 1.505 2.323 0 O-C-N 120.435 -1.416 . . . . 0.0 112.552 -178.838 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 72' ' ' VAL . . . . . 0.495 ' O ' ' CG2' ' A' ' 72' ' ' VAL . 2.6 m -68.0 130.55 33.27 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.418 0 N-CA-C 105.375 -2.083 . . . . 0.0 105.375 174.965 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 73' ' ' ALA . . . . . 0.607 ' N ' ' O ' ' A' ' 87' ' ' VAL . . . -79.02 -13.99 59.45 Favored 'General case' 0 C--N 1.293 -1.855 0 O-C-N 119.999 -1.688 . . . . 0.0 107.398 -179.596 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . 173.5 -157.72 26.5 Favored Glycine 0 N--CA 1.479 1.524 0 N-CA-C 109.48 -1.448 . . . . 0.0 109.48 179.771 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 75' ' ' TYR . . . . . 0.405 ' CD2' ' HA ' ' A' ' 86' ' ' PRO . 69.1 m-85 -142.06 169.72 17.06 Favored 'General case' 0 C--N 1.295 -1.787 0 CA-C-O 121.961 0.886 . . . . 0.0 110.456 -177.591 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 76' ' ' ILE . . . . . . . . . . . . . 0.8 OUTLIER -147.27 142.28 20.03 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.72 0 C-N-CA 119.234 -0.986 . . . . 0.0 109.634 -177.362 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -151.52 162.31 41.19 Favored 'General case' 0 N--CA 1.487 1.409 0 O-C-N 121.193 -0.942 . . . . 0.0 109.759 -179.934 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 78' ' ' ILE . . . . . . . . . . . . . 9.5 mt -145.65 123.76 6.4 Favored Pre-proline 0 C--N 1.303 -1.434 0 N-CA-C 107.821 -1.178 . . . . 0.0 107.821 179.338 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 79' ' ' PRO . . . . . . . . . . . . . 41.5 Cg_endo -71.94 -43.69 1.15 Allowed 'Trans proline' 0 C--N 1.314 -1.255 0 C-N-CA 121.867 1.712 . . . . 0.0 112.949 -178.798 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 1.3 m-20 -66.61 -21.4 66.13 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 120.959 -1.088 . . . . 0.0 110.861 178.339 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 81' ' ' ALA . . . . . 0.497 ' O ' ' ND2' ' A' ' 132' ' ' ASN . . . -105.04 -15.89 14.97 Favored 'General case' 0 N--CA 1.496 1.838 0 O-C-N 121.139 -0.975 . . . . 0.0 109.095 179.672 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 82' ' ' ASP . . . . . . . . . . . . . 20.8 t0 62.84 52.2 2.77 Favored 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.472 -0.768 . . . . 0.0 110.847 179.292 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 83' ' ' ILE . . . . . . . . . . . . . 70.2 mt -127.27 152.85 35.79 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.735 0 O-C-N 121.229 -0.919 . . . . 0.0 109.677 -179.239 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 84' ' ' LYS . . . . . . . . . . . . . 34.6 tttp -158.21 106.49 1.98 Allowed 'General case' 0 N--CA 1.491 1.61 0 N-CA-C 107.778 -1.193 . . . . 0.0 107.778 -179.95 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 85' ' ' GLU . . . . . 0.508 ' OE2' ' O ' ' A' ' 128' ' ' TYR . 0.0 OUTLIER -141.31 165.54 28.2 Favored Pre-proline 0 N--CA 1.495 1.791 0 O-C-N 121.14 -0.975 . . . . 0.0 110.779 -178.366 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 86' ' ' PRO . . . . . 0.405 ' HA ' ' CD2' ' A' ' 75' ' ' TYR . 56.0 Cg_endo -73.57 168.13 25.55 Favored 'Trans proline' 0 N--CA 1.497 1.681 0 C-N-CA 123.335 2.69 . . . . 0.0 113.796 -179.595 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 87' ' ' VAL . . . . . 0.607 ' O ' ' N ' ' A' ' 73' ' ' ALA . 54.8 t -126.35 104.19 12.55 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.841 0 N-CA-C 109.368 -0.605 . . . . 0.0 109.368 179.917 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 88' ' ' TYR . . . . . . . . . . . . . 11.9 m-85 -94.92 156.76 37.66 Favored Pre-proline 0 N--CA 1.504 2.26 0 O-C-N 120.766 -1.209 . . . . 0.0 109.801 179.98 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 89' ' ' PRO . . . . . . . . . . . . . 13.4 Cg_endo -62.84 145.16 94.59 Favored 'Trans proline' 0 N--CA 1.498 1.778 0 C-N-CA 122.637 2.225 . . . . 0.0 113.273 179.591 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . -60.46 169.17 8.4 Favored Glycine 0 N--CA 1.494 2.527 0 N-CA-C 109.383 -1.487 . . . . 0.0 109.383 179.318 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 91' ' ' PRO . . . . . 0.504 ' C ' ' H ' ' A' ' 93' ' ' THR . 57.3 Cg_endo -93.5 169.15 20.47 Favored 'Cis proline' 0 C--N 1.307 -1.622 0 C-N-CA 123.966 -1.264 . . . . 0.0 111.989 0.194 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 92' ' ' ALA . . . . . 0.543 ' O ' ' CD1' ' A' ' 97' ' ' LEU . . . -71.83 32.26 0.05 Allowed 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.214 -0.929 . . . . 0.0 109.988 179.957 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 93' ' ' THR . . . . . 0.504 ' H ' ' C ' ' A' ' 91' ' ' PRO . 5.4 p -72.22 150.48 92.11 Favored Pre-proline 0 C--N 1.303 -1.431 0 O-C-N 120.481 -1.387 . . . . 0.0 108.025 179.761 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 94' ' ' PRO . . . . . . . . . . . . . 74.1 Cg_exo -32.96 -52.8 0.41 Allowed 'Trans proline' 0 C--N 1.306 -1.7 0 C-N-CA 122.893 2.396 . . . . 0.0 112.965 -178.549 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 95' ' ' GLU . . . . . 0.436 ' O ' ' ND2' ' A' ' 98' ' ' ASN . 14.3 mt-10 -49.89 -47.84 51.85 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.079 -1.013 . . . . 0.0 110.061 -179.74 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 96' ' ' GLN . . . . . 0.593 ' C ' ' H ' ' A' ' 98' ' ' ASN . 1.5 mp0 -72.57 -53.99 10.4 Favored 'General case' 0 N--CA 1.489 1.487 0 O-C-N 120.98 -1.075 . . . . 0.0 110.187 -179.68 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 97' ' ' LEU . . . . . 0.543 ' CD1' ' O ' ' A' ' 92' ' ' ALA . 94.0 mt -49.31 -6.56 0.02 OUTLIER 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.145 -0.972 . . . . 0.0 109.684 -179.26 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 98' ' ' ASN . . . . . 0.715 HD22 ' NE ' ' A' ' 99' ' ' ARG . 0.2 OUTLIER -73.88 -20.39 60.43 Favored 'General case' 0 N--CA 1.488 1.447 0 O-C-N 121.252 -0.905 . . . . 0.0 109.2 179.903 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 99' ' ' ARG . . . . . 0.715 ' NE ' HD22 ' A' ' 98' ' ' ASN . 3.0 mtt180 -103.06 -58.16 1.92 Allowed 'General case' 0 N--CA 1.489 1.492 0 O-C-N 121.379 -0.825 . . . . 0.0 110.182 -179.357 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . -173.82 -172.43 39.15 Favored Glycine 0 N--CA 1.492 2.4 0 C-N-CA 119.373 -1.394 . . . . 0.0 110.505 -179.752 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 101' ' ' VAL . . . . . 0.446 ' O ' ' CG2' ' A' ' 101' ' ' VAL . 34.0 m -51.49 103.75 0.05 OUTLIER 'Isoleucine or valine' 0 N--CA 1.493 1.701 0 O-C-N 121.575 -0.956 . . . . 0.0 110.017 -179.817 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 102' ' ' SER . . . . . 0.451 ' H ' ' HG ' ' A' ' 102' ' ' SER . 0.3 OUTLIER -91.55 160.75 15.26 Favored 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.193 -0.942 . . . . 0.0 110.158 179.927 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 103' ' ' PHE . . . . . 0.563 ' O ' ' N ' ' A' ' 105' ' ' GLU . 23.1 m-85 -63.74 121.2 13.4 Favored 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.009 -1.057 . . . . 0.0 108.357 178.769 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 104' ' ' ALA . . . . . . . . . . . . . . . -45.23 -12.45 0.02 OUTLIER 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.464 -0.772 . . . . 0.0 110.516 -179.063 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 105' ' ' GLU . . . . . 0.563 ' N ' ' O ' ' A' ' 103' ' ' PHE . 0.1 OUTLIER -136.6 142.7 43.34 Favored 'General case' 0 N--CA 1.494 1.753 0 O-C-N 120.852 -1.155 . . . . 0.0 110.23 179.958 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 106' ' ' GLU . . . . . 0.467 ' OE1' ' ND2' ' A' ' 107' ' ' ASN . 24.3 tt0 -58.79 -63.41 1.3 Allowed 'General case' 0 N--CA 1.488 1.439 0 CA-C-N 116.173 -0.467 . . . . 0.0 111.438 -178.904 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 107' ' ' ASN . . . . . 0.467 ' ND2' ' OE1' ' A' ' 106' ' ' GLU . 1.7 m120 -79.05 35.45 0.26 Allowed 'General case' 0 N--CA 1.49 1.572 0 O-C-N 120.653 -1.279 . . . . 0.0 113.138 -175.694 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 108' ' ' GLU . . . . . . . . . . . . . 1.5 tp10 -58.92 150.47 24.25 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 120.554 -1.341 . . . . 0.0 107.924 179.858 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 109' ' ' SER . . . . . . . . . . . . . 1.5 t -102.73 146.19 28.59 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.006 -1.059 . . . . 0.0 110.975 -178.192 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 110' ' ' LEU . . . . . . . . . . . . . 4.4 tp -62.4 -20.83 64.86 Favored 'General case' 0 N--CA 1.488 1.46 0 N-CA-C 107.79 -1.189 . . . . 0.0 107.79 178.827 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 111' ' ' ASP . . . . . 0.511 ' CG ' HH22 ' A' ' 151' ' ' ARG . 0.9 OUTLIER -131.46 43.23 3.1 Favored 'General case' 0 C--N 1.302 -1.497 0 N-CA-C 108.573 -0.899 . . . . 0.0 108.573 179.58 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 112' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -70.21 154.12 42.29 Favored 'General case' 0 C--N 1.302 -1.47 0 O-C-N 121.173 -0.954 . . . . 0.0 111.095 -179.812 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 113' ' ' GLN . . . . . 0.533 ' N ' ' CD ' ' A' ' 113' ' ' GLN . 0.0 OUTLIER -67.65 -18.27 64.89 Favored 'General case' 0 C--N 1.3 -1.585 0 N-CA-C 108.255 -1.017 . . . . 0.0 108.255 177.626 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 114' ' ' ASN . . . . . 0.57 ' OD1' ' NE2' ' A' ' 178' ' ' GLN . 11.2 t30 -150.84 105.7 3.3 Favored 'General case' 0 C--N 1.298 -1.654 0 N-CA-C 108.438 -0.949 . . . . 0.0 108.438 178.852 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 115' ' ' ILE . . . . . . . . . . . . . 3.8 mt -95.13 105.34 16.86 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.446 0 O-C-N 120.876 -1.14 . . . . 0.0 108.284 179.806 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 116' ' ' SER . . . . . . . . . . . . . 11.5 m -91.72 153.85 19.37 Favored 'General case' 0 N--CA 1.488 1.454 0 O-C-N 121.286 -0.883 . . . . 0.0 111.23 -178.262 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 117' ' ' ILE . . . . . . . . . . . . . 2.3 mt -148.74 148.18 16.13 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.43 0 N-CA-C 108.124 -1.065 . . . . 0.0 108.124 179.286 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 118' ' ' ALA . . . . . . . . . . . . . . . -142.26 160.37 40.38 Favored 'General case' 0 N--CA 1.492 1.634 0 C-N-CA 118.934 -1.106 . . . . 0.0 111.597 -178.919 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 119' ' ' GLY . . . . . . . . . . . . . . . -171.53 149.77 12.56 Favored Glycine 0 N--CA 1.489 2.205 0 N-CA-C 110.214 -1.155 . . . . 0.0 110.214 -179.947 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 120' ' ' HIS . . . . . . . . . . . . . 14.1 m170 -70.18 168.12 16.38 Favored 'General case' 0 N--CA 1.494 1.74 0 O-C-N 121.728 -0.866 . . . . 0.0 110.128 179.517 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 121' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -115.78 160.34 20.25 Favored 'General case' 0 N--CA 1.496 1.843 0 O-C-N 121.362 -0.836 . . . . 0.0 109.425 179.455 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 122' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -133.48 123.49 25.34 Favored 'General case' 0 N--CA 1.497 1.92 0 O-C-N 121.238 -0.914 . . . . 0.0 109.612 -179.409 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 123' ' ' ILE . . . . . 0.461 ' CG2' ' N ' ' A' ' 124' ' ' ASP . 0.6 OUTLIER -66.0 -42.56 91.94 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.667 0 CA-C-O 121.71 0.767 . . . . 0.0 109.01 179.76 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 124' ' ' ASP . . . . . 0.461 ' N ' ' CG2' ' A' ' 123' ' ' ILE . 5.8 t70 -92.76 24.84 3.38 Favored 'General case' 0 N--CA 1.496 1.867 0 O-C-N 121.616 -0.678 . . . . 0.0 111.956 -177.917 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 125' ' ' ARG . . . . . 0.612 HH11 ' CG ' ' A' ' 125' ' ' ARG . 0.0 OUTLIER -157.92 103.57 1.76 Allowed Pre-proline 0 N--CA 1.492 1.647 0 O-C-N 120.347 -1.47 . . . . 0.0 110.406 -179.432 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 126' ' ' PRO . . . . . . . . . . . . . 60.1 Cg_endo -79.13 -17.0 12.08 Favored 'Trans proline' 0 C--N 1.315 -1.206 0 C-N-CA 122.078 1.852 . . . . 0.0 111.822 179.728 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 127' ' ' ASN . . . . . . . . . . . . . 14.0 m120 -90.89 10.79 24.92 Favored 'General case' 0 N--CA 1.488 1.448 0 O-C-N 121.309 -0.869 . . . . 0.0 109.515 179.75 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 128' ' ' TYR . . . . . 0.508 ' O ' ' OE2' ' A' ' 85' ' ' GLU . 2.7 t80 -68.17 -153.07 0.02 OUTLIER 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.154 -0.966 . . . . 0.0 109.531 -179.924 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 129' ' ' GLN . . . . . 0.548 ' N ' ' OE1' ' A' ' 129' ' ' GLN . 1.1 mp0 -68.13 -67.15 0.48 Allowed 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.451 -0.781 . . . . 0.0 109.85 -179.705 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 130' ' ' PHE . . . . . 0.498 ' O ' ' CE ' ' A' ' 134' ' ' LYS . 57.1 m-85 -135.61 52.6 2.0 Favored 'General case' 0 N--CA 1.493 1.686 0 O-C-N 121.038 -1.039 . . . . 0.0 110.35 179.981 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 131' ' ' THR . . . . . 0.4 ' HA ' ' HZ2' ' A' ' 134' ' ' LYS . 23.4 m -86.43 -41.07 14.73 Favored 'General case' 0 C--N 1.301 -1.523 0 O-C-N 121.075 -1.016 . . . . 0.0 108.764 179.33 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 132' ' ' ASN . . . . . 0.497 ' ND2' ' O ' ' A' ' 81' ' ' ALA . 4.0 t30 -83.47 6.2 21.11 Favored 'General case' 0 N--CA 1.496 1.851 0 O-C-N 121.561 -0.712 . . . . 0.0 111.347 -178.492 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 133' ' ' LEU . . . . . 0.493 ' O ' ' N ' ' A' ' 135' ' ' ALA . 0.1 OUTLIER -69.93 -43.46 71.59 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 120.821 -1.174 . . . . 0.0 109.871 -179.557 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 134' ' ' LYS . . . . . 0.498 ' CE ' ' O ' ' A' ' 130' ' ' PHE . 0.0 OUTLIER -45.37 -17.78 0.03 OUTLIER 'General case' 0 N--CA 1.497 1.921 0 O-C-N 121.172 -0.955 . . . . 0.0 110.154 -179.442 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 135' ' ' ALA . . . . . 0.493 ' N ' ' O ' ' A' ' 133' ' ' LEU . . . -84.66 -32.5 23.59 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 120.949 -1.095 . . . . 0.0 109.38 179.89 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 136' ' ' ALA . . . . . 0.404 ' N ' ' O ' ' A' ' 133' ' ' LEU . . . -80.52 153.23 28.24 Favored 'General case' 0 C--N 1.302 -1.466 0 CA-C-O 122.028 0.918 . . . . 0.0 111.386 -178.808 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 137' ' ' LYS . . . . . 0.551 ' O ' ' O ' ' A' ' 138' ' ' LYS . 51.5 mttp -153.38 -165.57 2.19 Favored 'General case' 0 N--CA 1.49 1.531 0 C-N-CA 118.461 -1.295 . . . . 0.0 110.611 -178.543 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 138' ' ' LYS . . . . . 0.585 ' O ' ' N ' ' A' ' 140' ' ' SER . 0.0 OUTLIER -42.74 177.77 0.0 OUTLIER 'General case' 0 C--N 1.302 -1.462 0 CA-C-O 122.232 1.015 . . . . 0.0 110.961 -178.941 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 139' ' ' GLY . . . . . . . . . . . . . . . 46.75 8.63 0.02 OUTLIER Glycine 0 N--CA 1.489 2.191 0 N-CA-C 110.123 -1.191 . . . . 0.0 110.123 -179.943 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 140' ' ' SER . . . . . 0.585 ' N ' ' O ' ' A' ' 138' ' ' LYS . 11.7 m -80.75 122.42 27.13 Favored 'General case' 0 N--CA 1.492 1.663 0 O-C-N 120.817 -1.402 . . . . 0.0 109.544 179.616 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 141' ' ' MET . . . . . . . . . . . . . 6.5 tpt -77.66 121.89 24.6 Favored 'General case' 0 C--N 1.301 -1.515 0 N-CA-C 108.461 -0.94 . . . . 0.0 108.461 179.252 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 142' ' ' VAL . . . . . . . . . . . . . 2.8 t -112.61 135.9 50.57 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.721 0 O-C-N 121.124 -0.985 . . . . 0.0 109.688 -178.918 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 143' ' ' TYR . . . . . . . . . . . . . 67.8 m-85 -115.14 138.37 50.98 Favored 'General case' 0 N--CA 1.495 1.801 0 O-C-N 121.271 -0.893 . . . . 0.0 110.827 -179.453 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 144' ' ' PHE . . . . . 0.409 ' CD1' ' C ' ' A' ' 144' ' ' PHE . 1.4 t80 -122.26 108.45 13.28 Favored 'General case' 0 N--CA 1.494 1.733 0 O-C-N 121.692 -0.63 . . . . 0.0 109.558 -179.315 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 145' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -97.08 132.43 42.88 Favored 'General case' 0 N--CA 1.494 1.76 0 O-C-N 121.227 -0.921 . . . . 0.0 111.073 -178.791 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 146' ' ' VAL . . . . . 0.453 ' O ' ' C ' ' A' ' 147' ' ' GLY . 4.2 p -143.95 143.75 23.53 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.739 0 N-CA-C 107.854 -1.165 . . . . 0.0 107.854 178.632 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 147' ' ' GLY . . . . . 0.453 ' C ' ' O ' ' A' ' 146' ' ' VAL . . . 42.37 -128.28 4.68 Favored Glycine 0 N--CA 1.491 2.308 0 N-CA-C 108.894 -1.682 . . . . 0.0 108.894 -179.597 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 148' ' ' ASN . . . . . 0.532 ' C ' HD21 ' A' ' 148' ' ' ASN . 0.4 OUTLIER -103.34 18.02 22.74 Favored 'General case' 0 C--N 1.299 -1.594 0 O-C-N 121.49 -1.006 . . . . 0.0 108.348 178.976 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 149' ' ' GLU . . . . . . . . . . . . . 7.6 tt0 -113.84 144.49 42.92 Favored 'General case' 0 N--CA 1.49 1.54 0 CA-C-O 121.917 0.865 . . . . 0.0 111.604 -178.184 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 150' ' ' THR . . . . . . . . . . . . . 52.8 m -125.64 105.08 8.75 Favored 'General case' 0 C--N 1.302 -1.48 0 CA-C-O 121.574 0.702 . . . . 0.0 109.889 179.493 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 151' ' ' ARG . . . . . 0.511 HH22 ' CG ' ' A' ' 111' ' ' ASP . 73.8 mtt180 -86.44 -173.59 4.6 Favored 'General case' 0 N--CA 1.486 1.373 0 N-CA-C 108.709 -0.848 . . . . 0.0 108.709 179.863 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 152' ' ' LYS . . . . . 0.468 ' HZ3' ' CB ' ' A' ' 152' ' ' LYS . 6.8 mtmp? -152.49 148.07 26.98 Favored 'General case' 0 C--N 1.301 -1.52 0 C-N-CA 119.145 -1.022 . . . . 0.0 110.589 -179.489 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 153' ' ' TYR . . . . . . . . . . . . . 47.0 m-85 -144.45 161.55 38.76 Favored 'General case' 0 N--CA 1.489 1.49 0 N-CA-C 108.424 -0.954 . . . . 0.0 108.424 178.739 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 154' ' ' LYS . . . . . . . . . . . . . 17.8 ttmt -137.24 119.7 15.9 Favored 'General case' 0 C--N 1.299 -1.611 0 O-C-N 121.273 -0.892 . . . . 0.0 108.801 179.251 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 155' ' ' MET . . . . . . . . . . . . . 27.1 mtp -45.94 109.04 0.15 Allowed 'General case' 0 N--CA 1.494 1.741 0 CA-C-O 122.443 1.116 . . . . 0.0 111.671 -178.484 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 156' ' ' THR . . . . . 0.539 ' OG1' ' CG2' ' A' ' 203' ' ' THR . 0.2 OUTLIER -103.3 -28.28 11.96 Favored 'General case' 0 C--N 1.296 -1.735 0 CA-C-N 115.168 -0.923 . . . . 0.0 110.22 -178.572 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 157' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -146.95 154.69 41.57 Favored 'General case' 0 N--CA 1.496 1.84 0 C-N-CA 118.337 -1.345 . . . . 0.0 110.569 -179.048 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 158' ' ' ILE . . . . . . . . . . . . . 1.6 mt -148.27 137.31 15.62 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.652 0 CA-C-O 121.322 0.582 . . . . 0.0 109.982 -177.927 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 159' ' ' ARG . . . . . . . . . . . . . 2.2 mtt180 -156.14 -177.62 6.72 Favored 'General case' 0 N--CA 1.494 1.742 0 O-C-N 121.298 -0.877 . . . . 0.0 110.931 -179.521 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 160' ' ' ASP . . . . . 0.409 ' C ' ' CG2' ' A' ' 161' ' ' VAL . 9.3 m-20 -146.8 165.01 30.98 Favored 'General case' 0 N--CA 1.493 1.692 0 N-CA-C 108.48 -0.933 . . . . 0.0 108.48 179.825 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 161' ' ' VAL . . . . . 0.461 ' O ' ' O ' ' A' ' 162' ' ' LYS . 0.0 OUTLIER -162.0 158.78 1.84 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.701 0 O-C-N 120.822 -1.174 . . . . 0.0 111.033 -179.874 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 162' ' ' LYS . . . . . 0.461 ' O ' ' O ' ' A' ' 161' ' ' VAL . 0.0 OUTLIER -44.05 171.23 0.04 OUTLIER Pre-proline 0 N--CA 1.493 1.693 0 O-C-N 121.767 -0.583 . . . . 0.0 110.289 179.326 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 163' ' ' PRO . . . . . . . . . . . . . 71.3 Cg_endo -77.89 32.24 0.44 Allowed 'Trans proline' 0 N--CA 1.495 1.591 0 C-N-CA 122.926 2.417 . . . . 0.0 113.669 -179.839 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 164' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -152.26 -2.84 0.26 Allowed 'General case' 0 N--CA 1.495 1.796 0 O-C-N 120.839 -1.163 . . . . 0.0 111.125 179.686 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 165' ' ' ASP . . . . . 0.42 ' O ' ' C ' ' A' ' 166' ' ' VAL . 1.4 t70 -73.31 61.1 0.63 Allowed 'General case' 0 N--CA 1.491 1.582 0 O-C-N 120.748 -1.22 . . . . 0.0 110.132 -179.245 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 166' ' ' VAL . . . . . 0.582 ' O ' ' N ' ' A' ' 168' ' ' VAL . 2.2 t -45.75 -31.66 1.18 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.604 0 O-C-N 121.048 -1.032 . . . . 0.0 109.614 -178.998 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 167' ' ' GLY . . . . . . . . . . . . . . . -44.8 -10.99 0.01 OUTLIER Glycine 0 N--CA 1.494 2.523 0 O-C-N 120.756 -1.215 . . . . 0.0 111.116 -179.583 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 168' ' ' VAL . . . . . 0.582 ' N ' ' O ' ' A' ' 166' ' ' VAL . 5.8 m -53.8 -29.96 18.53 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.634 0 O-C-N 120.552 -1.557 . . . . 0.0 108.774 179.814 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 169' ' ' LEU . . . . . 0.543 ' O ' ' C ' ' A' ' 170' ' ' ASP . 11.7 mt -49.83 -13.59 0.1 Allowed 'General case' 0 N--CA 1.491 1.62 0 N-CA-C 107.33 -1.359 . . . . 0.0 107.33 -178.994 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 170' ' ' ASP . . . . . 0.576 ' H ' ' C ' ' A' ' 168' ' ' VAL . 40.3 t0 19.46 90.97 0.01 OUTLIER 'General case' 0 N--CA 1.5 2.053 0 CA-C-N 116.355 -0.384 . . . . 0.0 111.587 177.322 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 171' ' ' GLU . . . . . . . . . . . . . 7.8 pt-20 -128.7 72.91 1.47 Allowed 'General case' 0 N--CA 1.496 1.873 0 O-C-N 120.952 -1.092 . . . . 0.0 111.099 -179.615 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 172' ' ' GLN . . . . . . . . . . . . . 6.6 mp0 -128.73 -52.12 1.24 Allowed 'General case' 0 N--CA 1.498 1.965 0 O-C-N 121.335 -0.853 . . . . 0.0 111.519 -178.559 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 173' ' ' LYS . . . . . . . . . . . . . 56.9 mttt -58.51 130.6 47.58 Favored 'General case' 0 N--CA 1.498 1.961 0 O-C-N 120.841 -1.162 . . . . 0.0 109.655 -179.34 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 174' ' ' GLY . . . . . 0.53 ' O ' ' C ' ' A' ' 175' ' ' LYS . . . -122.48 -43.76 0.37 Allowed Glycine 0 N--CA 1.48 1.607 0 N-CA-C 108.657 -1.777 . . . . 0.0 108.657 179.761 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 175' ' ' LYS . . . . . 0.53 ' C ' ' O ' ' A' ' 174' ' ' GLY . 13.6 mptt -37.98 -62.9 0.52 Allowed 'General case' 0 N--CA 1.495 1.776 0 N-CA-C 107.319 -1.363 . . . . 0.0 107.319 179.309 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 176' ' ' ASP . . . . . 0.599 ' O ' ' O ' ' A' ' 177' ' ' LYS . 1.1 m-20 -104.34 91.2 3.81 Favored 'General case' 0 C--N 1.293 -1.885 0 N-CA-C 106.942 -1.503 . . . . 0.0 106.942 176.725 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 177' ' ' LYS . . . . . 0.599 ' O ' ' O ' ' A' ' 176' ' ' ASP . 9.7 mttp -45.07 -176.01 0.0 OUTLIER 'General case' 0 N--CA 1.494 1.764 0 O-C-N 121.344 -0.848 . . . . 0.0 109.683 -179.093 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 178' ' ' GLN . . . . . 0.57 ' NE2' ' OD1' ' A' ' 114' ' ' ASN . 18.6 pt20 -161.0 176.45 11.37 Favored 'General case' 0 N--CA 1.487 1.399 0 C-N-CA 118.043 -1.463 . . . . 0.0 111.399 179.581 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 179' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -130.61 96.27 4.07 Favored 'General case' 0 C--N 1.302 -1.493 0 N-CA-C 107.525 -1.287 . . . . 0.0 107.525 178.187 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 180' ' ' THR . . . . . . . . . . . . . 1.2 m -71.09 114.17 8.87 Favored 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.069 -1.019 . . . . 0.0 109.485 -178.979 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 181' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -90.14 141.15 28.97 Favored 'General case' 0 C--N 1.3 -1.554 0 N-CA-C 108.234 -1.024 . . . . 0.0 108.234 178.453 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 182' ' ' ILE . . . . . . . . . . . . . 73.4 mt -135.07 118.72 24.91 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.594 0 N-CA-C 107.638 -1.245 . . . . 0.0 107.638 178.903 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 183' ' ' THR . . . . . . . . . . . . . 3.8 t -138.62 112.09 8.17 Favored 'General case' 0 C--N 1.289 -2.038 0 N-CA-C 107.894 -1.15 . . . . 0.0 107.894 179.902 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 184' ' ' CYS . . . . . . . . . . . . . 1.9 p -78.58 157.1 28.85 Favored 'General case' 0 C--N 1.292 -1.911 0 C-N-CA 119.326 -0.95 . . . . 0.0 110.911 -177.867 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 185' ' ' ASP . . . . . . . . . . . . . 20.7 t0 -165.68 -152.86 0.16 Allowed 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.456 -0.778 . . . . 0.0 109.518 -179.735 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 186' ' ' ASP . . . . . . . . . . . . . 13.0 m-20 47.69 56.48 7.07 Favored 'General case' 0 N--CA 1.496 1.829 0 O-C-N 121.139 -0.975 . . . . 0.0 109.071 -179.707 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 187' ' ' TYR . . . . . 0.623 ' CE1' ' O ' ' A' ' 188' ' ' ASN . 32.9 t80 -67.91 136.08 53.45 Favored 'General case' 0 N--CA 1.49 1.56 0 CA-C-O 121.799 0.809 . . . . 0.0 111.013 -179.221 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 188' ' ' ASN . . . . . 0.623 ' O ' ' CE1' ' A' ' 187' ' ' TYR . 1.1 t-20 -99.43 147.53 25.17 Favored 'General case' 0 C--N 1.297 -1.705 0 N-CA-C 108.128 -1.064 . . . . 0.0 108.128 178.503 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 189' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -112.52 -13.59 13.32 Favored 'General case' 0 C--N 1.293 -1.878 0 N-CA-C 108.114 -1.069 . . . . 0.0 108.114 -179.718 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 190' ' ' LYS . . . . . . . . . . . . . 88.3 mttt -84.32 -51.26 7.12 Favored 'General case' 0 N--CA 1.488 1.474 0 N-CA-C 108.853 -0.795 . . . . 0.0 108.853 178.791 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 191' ' ' THR . . . . . 0.416 ' HG1' HG13 ' A' ' 193' ' ' VAL . 9.4 p -89.61 -10.82 44.56 Favored 'General case' 0 N--CA 1.489 1.488 0 O-C-N 121.546 -0.721 . . . . 0.0 109.075 179.79 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 192' ' ' GLY . . . . . . . . . . . . . . . 68.69 30.76 72.81 Favored Glycine 0 N--CA 1.492 2.399 0 O-C-N 121.316 -0.865 . . . . 0.0 110.945 178.733 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 193' ' ' VAL . . . . . 0.416 HG13 ' HG1' ' A' ' 191' ' ' THR . 2.2 p -145.9 169.29 6.54 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.621 0 O-C-N 120.791 -1.417 . . . . 0.0 110.201 179.397 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 194' ' ' TRP . . . . . 0.541 ' N ' ' CD1' ' A' ' 194' ' ' TRP . 9.4 m95 -86.47 121.37 28.93 Favored 'General case' 0 C--N 1.294 -1.821 0 N-CA-C 109.104 -0.702 . . . . 0.0 109.104 -179.717 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 195' ' ' GLU . . . . . 0.492 ' CD ' ' ND2' ' A' ' 188' ' ' ASN . 1.3 mt-10 -85.04 -61.17 1.84 Allowed 'General case' 0 N--CA 1.497 1.888 0 O-C-N 121.275 -0.891 . . . . 0.0 111.703 -178.216 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 196' ' ' LYS . . . . . . . . . . . . . 1.8 mtpm? -84.61 151.27 24.62 Favored 'General case' 0 N--CA 1.494 1.74 0 O-C-N 120.814 -1.179 . . . . 0.0 110.488 -178.475 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 197' ' ' ARG . . . . . 0.544 ' NH1' ' O ' ' C' ' 704' ' ' ALA . 24.1 mmt180 -120.37 137.42 54.3 Favored 'General case' 0 N--CA 1.492 1.637 0 N-CA-C 108.942 -0.762 . . . . 0.0 108.942 179.497 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 198' ' ' LYS . . . . . . . . . . . . . 5.0 mptp? -115.1 120.01 38.37 Favored 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.467 -0.771 . . . . 0.0 110.304 -179.007 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 199' ' ' ILE . . . . . 0.419 ' O ' HG13 ' A' ' 199' ' ' ILE . 1.1 pp -141.42 121.01 11.35 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.803 0 CA-C-O 122.618 1.199 . . . . 0.0 110.826 179.201 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 200' ' ' PHE . . . . . 0.526 ' CD1' ' N ' ' A' ' 200' ' ' PHE . 0.7 OUTLIER -105.04 141.42 36.65 Favored 'General case' 0 N--CA 1.494 1.773 0 O-C-N 121.131 -0.981 . . . . 0.0 111.177 -178.133 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 201' ' ' VAL . . . . . . . . . . . . . 96.8 t -102.57 149.02 7.22 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.651 0 N-CA-C 107.726 -1.213 . . . . 0.0 107.726 176.722 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 202' ' ' ALA . . . . . . . . . . . . . . . -132.27 139.89 48.42 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.002 -1.061 . . . . 0.0 109.116 -179.513 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 203' ' ' THR . . . . . 0.539 ' CG2' ' OG1' ' A' ' 156' ' ' THR . 16.8 p -89.86 131.19 35.92 Favored 'General case' 0 N--CA 1.487 1.416 0 CA-C-O 122.556 1.169 . . . . 0.0 111.944 -178.316 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 204' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -61.96 135.43 57.55 Favored 'General case' 0 C--N 1.299 -1.598 0 CA-C-N 114.818 -1.083 . . . . 0.0 108.957 179.016 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 205' ' ' VAL . . . . . 0.504 ' O ' ' C ' ' A' ' 206' ' ' LYS . 37.6 t -122.67 -44.47 1.88 Allowed 'Isoleucine or valine' 0 N--CA 1.494 1.76 0 O-C-N 121.382 -0.824 . . . . 0.0 109.71 -179.703 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 206' ' ' LYS . . . . . 0.504 ' C ' ' O ' ' A' ' 205' ' ' VAL . 0.0 OUTLIER . . . . . 0 N--CA 1.494 1.767 0 CA-C-O 118.093 -0.956 . . . . 0.0 110.456 -179.636 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' C' C ' 701' ' ' PHQ . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 001 nuclear orig full ' C' C ' 702' ' ' LEU . . . . . 0.535 ' H ' ' CD1' ' C' ' 702' ' ' LEU . 0.0 OUTLIER . . . . . 0 N--CA 1.493 1.703 0 N-CA-C 110.009 -0.367 . . . . 0.0 110.009 . . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' C' C ' 703' ' ' PRO . . . . . 0.504 ' O ' ' O ' ' C' ' 702' ' ' LEU . 31.3 Cg_exo -51.34 -160.79 0.0 OUTLIER 'Trans proline' 0 N--CA 1.493 1.476 0 C-N-CA 121.945 1.764 . . . . 0.0 111.718 179.057 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' C' C ' 704' ' ' ALA . . . . . 0.544 ' O ' ' NH1' ' A' ' 197' ' ' ARG . . . 51.03 98.39 0.01 OUTLIER 'General case' 0 N--CA 1.489 1.481 0 O-C-N 120.981 -1.075 . . . . 0.0 109.055 179.898 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' C' C ' 705' ' ' B27 . . . . . 0.442 ' HN ' HOG1 ' C' ' 705' ' ' B27 . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 700' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 002 nuclear orig full ' A' A ' 59' ' ' MET . . . . . . . . . . . . . 5.8 ptp . . . . . 0 N--CA 1.492 1.674 0 N-CA-C 109.468 -0.568 . . . . 0.0 109.468 . . . . . . . . . 0 0 . 1 . 002 nuclear orig full ' A' A ' 60' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -60.17 175.05 0.45 Allowed 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.296 -0.878 . . . . 0.0 109.556 -179.95 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . -65.2 147.34 53.63 Favored 'General case' 0 C--N 1.303 -1.419 0 O-C-N 121.47 -0.769 . . . . 0.0 109.756 179.986 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 62' ' ' LYS . . . . . . . . . . . . . 55.1 mttt -141.6 70.69 25.76 Favored Pre-proline 0 C--N 1.303 -1.453 0 O-C-N 121.363 -0.836 . . . . 0.0 109.103 179.437 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 63' ' ' PRO . . . . . . . . . . . . . 10.6 Cg_endo -87.4 157.46 8.03 Favored 'Trans proline' 0 C--N 1.31 -1.458 0 C-N-CA 123.51 2.807 . . . . 0.0 111.473 179.999 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 64' ' ' GLN . . . . . 0.682 ' NE2' ' N ' ' A' ' 64' ' ' GLN . 0.0 OUTLIER -153.71 119.93 5.44 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.163 -0.961 . . . . 0.0 109.433 179.732 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 65' ' ' ILE . . . . . 0.463 ' C ' ' O ' ' A' ' 64' ' ' GLN . 0.0 OUTLIER -42.18 103.78 0.32 Allowed Pre-proline 0 N--CA 1.495 1.782 0 N-CA-C 108.405 -0.961 . . . . 0.0 108.405 179.203 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 66' ' ' PRO . . . . . . . . . . . . . 88.3 Cg_endo -87.36 -159.99 0.1 OUTLIER 'Trans proline' 0 C--N 1.315 -1.191 0 C-N-CA 122.272 1.982 . . . . 0.0 112.421 -179.436 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 67' ' ' LYS . . . . . . . . . . . . . 13.5 pttt -79.67 -4.99 54.18 Favored 'General case' 0 C--N 1.302 -1.5 0 N-CA-C 108.739 -0.837 . . . . 0.0 108.739 179.765 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 68' ' ' ASP . . . . . 0.662 ' C ' ' N ' ' A' ' 70' ' ' SER . 1.0 OUTLIER -76.79 48.62 0.58 Allowed 'General case' 0 C--N 1.304 -1.396 0 CA-C-O 121.958 0.885 . . . . 0.0 109.393 179.705 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 69' ' ' LYS . . . . . 0.456 ' C ' ' O ' ' A' ' 68' ' ' ASP . 1.6 ptpt -49.3 -13.25 0.07 Allowed 'General case' 0 N--CA 1.508 2.442 0 C-N-CA 116.684 -2.006 . . . . 0.0 106.283 177.599 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 70' ' ' SER . . . . . 0.662 ' N ' ' C ' ' A' ' 68' ' ' ASP . 0.4 OUTLIER -83.43 -9.66 58.88 Favored 'General case' 0 N--CA 1.496 1.83 0 CA-C-N 113.164 -1.835 . . . . 0.0 110.162 179.221 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 71' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -97.36 142.98 28.57 Favored 'General case' 0 N--CA 1.496 1.838 0 O-C-N 120.991 -1.068 . . . . 0.0 110.753 179.601 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 72' ' ' VAL . . . . . 0.405 HG11 ' CZ ' ' A' ' 88' ' ' TYR . 0.8 OUTLIER -66.16 141.94 17.4 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.527 0 N-CA-C 105.131 -2.174 . . . . 0.0 105.131 174.702 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 73' ' ' ALA . . . . . 0.517 ' N ' ' O ' ' A' ' 87' ' ' VAL . . . -82.8 -15.9 49.88 Favored 'General case' 0 C--N 1.295 -1.762 0 O-C-N 119.928 -1.732 . . . . 0.0 106.704 179.75 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . 175.4 -157.83 24.73 Favored Glycine 0 N--CA 1.479 1.546 0 N-CA-C 109.318 -1.513 . . . . 0.0 109.318 179.584 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 75' ' ' TYR . . . . . 0.445 ' CD2' ' O ' ' A' ' 85' ' ' GLU . 0.6 OUTLIER -143.15 168.35 19.96 Favored 'General case' 0 C--N 1.295 -1.778 0 O-C-N 121.682 -0.893 . . . . 0.0 110.463 -177.234 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 76' ' ' ILE . . . . . . . . . . . . . 2.4 tt -148.75 145.91 17.84 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.601 0 C-N-CA 119.225 -0.99 . . . . 0.0 110.075 -178.04 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -150.65 166.43 30.36 Favored 'General case' 0 N--CA 1.489 1.49 0 O-C-N 121.059 -1.026 . . . . 0.0 109.289 179.371 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 78' ' ' ILE . . . . . 0.4 ' O ' ' N ' ' A' ' 82' ' ' ASP . 13.5 mt -147.75 94.98 4.3 Favored Pre-proline 0 C--N 1.302 -1.474 0 N-CA-C 108.6 -0.889 . . . . 0.0 108.6 -179.57 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 79' ' ' PRO . . . . . . . . . . . . . 75.0 Cg_exo -47.55 -47.56 17.69 Favored 'Trans proline' 0 N--CA 1.494 1.506 0 C-N-CA 122.811 2.34 . . . . 0.0 113.811 -178.645 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -65.86 -18.63 65.46 Favored 'General case' 0 N--CA 1.493 1.718 0 O-C-N 120.868 -1.145 . . . . 0.0 110.439 178.474 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 81' ' ' ALA . . . . . 0.531 ' O ' ' ND2' ' A' ' 132' ' ' ASN . . . -105.01 -14.05 15.55 Favored 'General case' 0 N--CA 1.493 1.679 0 O-C-N 121.238 -0.914 . . . . 0.0 109.035 179.904 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 82' ' ' ASP . . . . . 0.4 ' N ' ' O ' ' A' ' 78' ' ' ILE . 0.3 OUTLIER 64.27 48.34 2.89 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.334 -0.853 . . . . 0.0 110.503 179.246 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 83' ' ' ILE . . . . . . . . . . . . . 64.2 mt -131.1 152.08 36.92 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.796 0 O-C-N 121.127 -0.983 . . . . 0.0 110.647 -178.583 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 84' ' ' LYS . . . . . . . . . . . . . 30.2 tttp -158.83 111.85 2.3 Favored 'General case' 0 N--CA 1.492 1.635 0 N-CA-C 108.315 -0.994 . . . . 0.0 108.315 179.282 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 85' ' ' GLU . . . . . 0.445 ' O ' ' CD2' ' A' ' 75' ' ' TYR . 0.4 OUTLIER -143.16 162.79 41.22 Favored Pre-proline 0 N--CA 1.494 1.729 0 O-C-N 121.279 -0.888 . . . . 0.0 110.225 -179.211 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 86' ' ' PRO . . . . . 0.416 ' N ' ' CE2' ' A' ' 75' ' ' TYR . 57.1 Cg_endo -70.92 167.65 25.33 Favored 'Trans proline' 0 N--CA 1.497 1.698 0 C-N-CA 123.346 2.697 . . . . 0.0 113.506 -179.141 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 87' ' ' VAL . . . . . 0.517 ' O ' ' N ' ' A' ' 73' ' ' ALA . 62.0 t -124.67 99.66 6.47 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.66 0 N-CA-C 108.972 -0.751 . . . . 0.0 108.972 179.717 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 88' ' ' TYR . . . . . 0.405 ' CZ ' HG11 ' A' ' 72' ' ' VAL . 33.0 m-85 -92.87 152.94 42.01 Favored Pre-proline 0 N--CA 1.502 2.164 0 O-C-N 120.832 -1.167 . . . . 0.0 110.029 -179.617 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 89' ' ' PRO . . . . . 0.432 ' O ' ' NE2' ' A' ' 96' ' ' GLN . 6.1 Cg_endo -57.19 144.47 90.47 Favored 'Trans proline' 0 C--N 1.312 -1.392 0 C-N-CA 122.531 2.154 . . . . 0.0 113.606 -179.901 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . -57.22 167.6 4.64 Favored Glycine 0 N--CA 1.49 2.268 0 N-CA-C 109.242 -1.543 . . . . 0.0 109.242 179.038 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 91' ' ' PRO . . . . . 0.465 ' C ' ' H ' ' A' ' 93' ' ' THR . 18.9 Cg_endo -93.44 170.4 19.62 Favored 'Cis proline' 0 C--N 1.307 -1.626 0 C-N-CA 123.968 -1.263 . . . . 0.0 112.054 -0.176 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 92' ' ' ALA . . . . . . . . . . . . . . . -72.78 30.57 0.06 Allowed 'General case' 0 N--CA 1.489 1.504 0 O-C-N 121.216 -0.928 . . . . 0.0 110.635 -179.868 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 93' ' ' THR . . . . . 0.465 ' H ' ' C ' ' A' ' 91' ' ' PRO . 1.0 OUTLIER -75.44 152.84 85.73 Favored Pre-proline 0 N--CA 1.49 1.572 0 O-C-N 120.743 -1.223 . . . . 0.0 109.095 -179.741 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 94' ' ' PRO . . . . . 0.412 ' C ' ' O ' ' A' ' 93' ' ' THR . 53.3 Cg_exo -32.82 -52.6 0.39 Allowed 'Trans proline' 0 C--N 1.309 -1.517 0 C-N-CA 122.933 2.422 . . . . 0.0 112.214 -179.292 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 95' ' ' GLU . . . . . 0.586 ' O ' ' ND2' ' A' ' 98' ' ' ASN . 13.0 mt-10 -45.9 -53.11 10.38 Favored 'General case' 0 N--CA 1.489 1.49 0 O-C-N 121.249 -0.907 . . . . 0.0 109.452 179.942 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 96' ' ' GLN . . . . . 0.556 ' O ' ' N ' ' A' ' 98' ' ' ASN . 29.6 mm100 -71.41 -51.66 22.8 Favored 'General case' 0 C--N 1.305 -1.368 0 O-C-N 120.955 -1.091 . . . . 0.0 109.747 179.956 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 97' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -49.52 -7.82 0.03 OUTLIER 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.209 -0.932 . . . . 0.0 109.675 -179.424 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 98' ' ' ASN . . . . . 0.686 HD22 ' CZ ' ' A' ' 99' ' ' ARG . 0.4 OUTLIER -73.05 -24.37 60.69 Favored 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.167 -0.958 . . . . 0.0 109.615 -179.931 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 99' ' ' ARG . . . . . 0.686 ' CZ ' HD22 ' A' ' 98' ' ' ASN . 0.6 OUTLIER -103.56 -59.42 1.72 Allowed 'General case' 0 N--CA 1.489 1.504 0 O-C-N 121.544 -0.722 . . . . 0.0 110.363 -178.936 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . -164.73 -171.53 31.09 Favored Glycine 0 N--CA 1.494 2.545 0 C-N-CA 119.21 -1.471 . . . . 0.0 110.608 -179.674 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 101' ' ' VAL . . . . . 0.476 ' O ' ' CG2' ' A' ' 101' ' ' VAL . 18.9 m -59.94 108.3 0.38 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.667 0 O-C-N 121.411 -1.053 . . . . 0.0 108.955 179.854 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -93.03 165.28 12.93 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.446 -0.784 . . . . 0.0 111.015 -179.133 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 103' ' ' PHE . . . . . 0.505 ' CE1' ' CG1' ' A' ' 87' ' ' VAL . 24.5 m-85 -66.17 160.5 24.0 Favored 'General case' 0 N--CA 1.486 1.368 0 N-CA-C 107.954 -1.128 . . . . 0.0 107.954 178.031 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 104' ' ' ALA . . . . . . . . . . . . . . . -72.5 -22.58 61.03 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.087 -1.008 . . . . 0.0 111.707 -177.913 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 1.2 pm0 -138.95 150.12 45.53 Favored 'General case' 0 N--CA 1.497 1.876 0 O-C-N 120.696 -1.253 . . . . 0.0 110.644 -179.296 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 106' ' ' GLU . . . . . . . . . . . . . 66.2 tt0 -52.7 -59.52 4.38 Favored 'General case' 0 C--N 1.303 -1.415 0 O-C-N 121.777 -0.577 . . . . 0.0 110.491 -179.928 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 107' ' ' ASN . . . . . 0.579 ' H ' ' ND2' ' A' ' 107' ' ' ASN . 0.2 OUTLIER -77.05 32.84 0.14 Allowed 'General case' 0 N--CA 1.488 1.461 0 O-C-N 120.614 -1.304 . . . . 0.0 112.583 -175.706 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 108' ' ' GLU . . . . . . . . . . . . . 2.8 tp10 -60.2 144.29 50.43 Favored 'General case' 0 N--CA 1.488 1.473 0 N-CA-C 107.029 -1.471 . . . . 0.0 107.029 179.742 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 109' ' ' SER . . . . . 0.571 ' C ' ' H ' ' A' ' 111' ' ' ASP . 0.2 OUTLIER -97.76 122.82 41.31 Favored 'General case' 0 N--CA 1.487 1.416 0 O-C-N 120.83 -1.169 . . . . 0.0 110.858 -177.776 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 110' ' ' LEU . . . . . . . . . . . . . 2.1 pp -59.81 -3.26 0.49 Allowed 'General case' 0 C--N 1.301 -1.521 0 N-CA-C 108.04 -1.096 . . . . 0.0 108.04 179.235 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 111' ' ' ASP . . . . . 0.571 ' H ' ' C ' ' A' ' 109' ' ' SER . 75.7 m-20 -132.83 18.63 4.19 Favored 'General case' 0 N--CA 1.489 1.498 0 O-C-N 121.735 -0.603 . . . . 0.0 109.716 179.668 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 112' ' ' ASP . . . . . 0.456 ' C ' ' H ' ' A' ' 114' ' ' ASN . 0.3 OUTLIER -65.07 135.84 56.04 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 120.887 -1.133 . . . . 0.0 109.684 -179.76 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 113' ' ' GLN . . . . . 0.525 ' NE2' ' O ' ' A' ' 173' ' ' LYS . 0.0 OUTLIER -64.44 -4.64 4.13 Favored 'General case' 0 C--N 1.303 -1.439 0 O-C-N 121.24 -0.913 . . . . 0.0 108.766 179.238 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 114' ' ' ASN . . . . . 0.576 ' C ' HD21 ' A' ' 114' ' ' ASN . 0.2 OUTLIER -144.78 92.49 2.29 Favored 'General case' 0 C--N 1.303 -1.436 0 N-CA-C 107.13 -1.433 . . . . 0.0 107.13 177.967 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 115' ' ' ILE . . . . . . . . . . . . . 2.1 mt -101.88 117.22 46.87 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.457 0 O-C-N 121.592 -0.693 . . . . 0.0 110.959 -178.304 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 116' ' ' SER . . . . . . . . . . . . . 97.0 p -99.04 146.82 25.67 Favored 'General case' 0 N--CA 1.495 1.807 0 O-C-N 121.244 -0.91 . . . . 0.0 111.544 -178.928 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 117' ' ' ILE . . . . . 0.406 HG22 ' N ' ' A' ' 118' ' ' ALA . 2.7 mp -135.16 148.55 28.79 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.842 0 N-CA-C 107.521 -1.289 . . . . 0.0 107.521 178.891 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 118' ' ' ALA . . . . . 0.406 ' N ' HG22 ' A' ' 117' ' ' ILE . . . -144.97 160.73 40.88 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 120.531 -1.356 . . . . 0.0 111.849 -179.251 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 119' ' ' GLY . . . . . . . . . . . . . . . -169.88 156.72 27.76 Favored Glycine 0 N--CA 1.485 1.909 0 N-CA-C 109.456 -1.457 . . . . 0.0 109.456 179.424 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 120' ' ' HIS . . . . . . . . . . . . . 20.0 m-70 -71.36 162.59 29.19 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.51 -0.994 . . . . 0.0 109.849 179.676 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 121' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -117.49 160.02 21.89 Favored 'General case' 0 N--CA 1.492 1.669 0 N-CA-C 107.962 -1.125 . . . . 0.0 107.962 178.586 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 122' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -127.28 133.35 50.17 Favored 'General case' 0 N--CA 1.495 1.805 0 O-C-N 121.144 -0.972 . . . . 0.0 110.273 -178.821 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 123' ' ' ILE . . . . . . . . . . . . . 15.9 tt -90.76 -27.1 5.04 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.624 0 CA-C-O 121.827 0.822 . . . . 0.0 110.097 -179.317 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 124' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -87.4 -2.29 58.52 Favored 'General case' 0 C--N 1.291 -1.938 0 C-N-CA 120.128 -0.629 . . . . 0.0 111.318 -178.663 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 125' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -154.2 124.08 3.29 Favored Pre-proline 0 N--CA 1.494 1.774 0 O-C-N 120.625 -1.297 . . . . 0.0 109.683 -179.702 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 126' ' ' PRO . . . . . . . . . . . . . 86.8 Cg_endo -81.14 -16.67 9.66 Favored 'Trans proline' 0 N--CA 1.494 1.518 0 C-N-CA 122.46 2.106 . . . . 0.0 112.992 179.994 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 127' ' ' ASN . . . . . 0.593 ' C ' HD21 ' A' ' 127' ' ' ASN . 0.1 OUTLIER -90.19 22.37 3.33 Favored 'General case' 0 N--CA 1.493 1.702 0 O-C-N 121.071 -1.018 . . . . 0.0 110.308 -179.342 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 128' ' ' TYR . . . . . . . . . . . . . 13.0 t80 -75.3 -150.52 0.03 OUTLIER 'General case' 0 N--CA 1.492 1.673 0 O-C-N 121.004 -1.06 . . . . 0.0 109.751 -179.73 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 129' ' ' GLN . . . . . . . . . . . . . 27.7 mt-30 -68.1 -89.1 0.01 OUTLIER 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.252 -0.905 . . . . 0.0 109.616 -179.636 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 130' ' ' PHE . . . . . . . . . . . . . 27.7 m-85 -108.14 35.13 3.26 Favored 'General case' 0 N--CA 1.493 1.684 0 O-C-N 121.421 -0.799 . . . . 0.0 110.003 -179.533 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 131' ' ' THR . . . . . . . . . . . . . 55.0 m -75.37 -33.31 61.04 Favored 'General case' 0 N--CA 1.488 1.464 0 O-C-N 121.037 -1.039 . . . . 0.0 108.982 179.562 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 132' ' ' ASN . . . . . 0.531 ' ND2' ' O ' ' A' ' 81' ' ' ALA . 4.6 t30 -81.01 3.98 21.21 Favored 'General case' 0 N--CA 1.494 1.741 0 O-C-N 121.32 -0.863 . . . . 0.0 110.512 -179.014 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 133' ' ' LEU . . . . . 0.593 ' O ' ' N ' ' A' ' 135' ' ' ALA . 0.4 OUTLIER -68.85 -48.96 62.17 Favored 'General case' 0 N--CA 1.488 1.456 0 O-C-N 120.982 -1.074 . . . . 0.0 109.318 -179.943 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 134' ' ' LYS . . . . . 0.589 ' CE ' ' H ' ' A' ' 134' ' ' LYS . 0.0 OUTLIER -43.0 -18.21 0.01 OUTLIER 'General case' 0 N--CA 1.488 1.452 0 O-C-N 121.363 -0.835 . . . . 0.0 109.121 179.869 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 135' ' ' ALA . . . . . 0.593 ' N ' ' O ' ' A' ' 133' ' ' LEU . . . -83.43 -39.02 21.14 Favored 'General case' 0 N--CA 1.488 1.435 0 O-C-N 121.219 -0.926 . . . . 0.0 109.266 179.012 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 136' ' ' ALA . . . . . 0.496 ' N ' ' O ' ' A' ' 133' ' ' LEU . . . -80.46 157.45 26.2 Favored 'General case' 0 N--CA 1.49 1.542 0 CA-C-O 121.996 0.903 . . . . 0.0 111.299 -178.965 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 137' ' ' LYS . . . . . 0.536 ' O ' ' O ' ' A' ' 138' ' ' LYS . 1.0 OUTLIER -154.19 -162.36 1.4 Allowed 'General case' 0 N--CA 1.49 1.575 0 C-N-CA 118.5 -1.28 . . . . 0.0 110.961 -178.161 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 138' ' ' LYS . . . . . 0.574 ' O ' ' N ' ' A' ' 140' ' ' SER . 9.4 mttp -43.17 178.27 0.0 OUTLIER 'General case' 0 N--CA 1.487 1.397 0 CA-C-O 122.438 1.113 . . . . 0.0 111.083 -179.03 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 139' ' ' GLY . . . . . . . . . . . . . . . 46.95 7.72 0.02 OUTLIER Glycine 0 N--CA 1.491 2.302 0 N-CA-C 110.668 -0.973 . . . . 0.0 110.668 179.858 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 140' ' ' SER . . . . . 0.574 ' N ' ' O ' ' A' ' 138' ' ' LYS . 58.4 m -86.87 127.14 35.04 Favored 'General case' 0 N--CA 1.496 1.87 0 O-C-N 120.811 -1.406 . . . . 0.0 109.599 179.349 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 141' ' ' MET . . . . . 0.591 ' SD ' ' N ' ' A' ' 142' ' ' VAL . 6.2 tpp -77.61 129.16 35.26 Favored 'General case' 0 N--CA 1.492 1.65 0 O-C-N 120.975 -1.078 . . . . 0.0 109.33 179.688 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 142' ' ' VAL . . . . . 0.591 ' N ' ' SD ' ' A' ' 141' ' ' MET . 1.4 t -112.09 133.27 58.34 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.617 0 N-CA-C 108.546 -0.909 . . . . 0.0 108.546 -179.982 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 143' ' ' TYR . . . . . . . . . . . . . 5.4 m-85 -108.22 134.36 51.17 Favored 'General case' 0 N--CA 1.497 1.897 0 O-C-N 120.719 -1.238 . . . . 0.0 112.31 -177.835 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 144' ' ' PHE . . . . . . . . . . . . . 36.9 t80 -119.92 99.92 6.92 Favored 'General case' 0 N--CA 1.494 1.726 0 N-CA-C 109.511 -0.551 . . . . 0.0 109.511 179.718 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 145' ' ' LYS . . . . . . . . . . . . . 1.0 OUTLIER -96.02 134.3 39.2 Favored 'General case' 0 N--CA 1.493 1.701 0 O-C-N 121.193 -0.942 . . . . 0.0 110.677 -179.348 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 146' ' ' VAL . . . . . 0.479 ' O ' ' C ' ' A' ' 147' ' ' GLY . 0.0 OUTLIER -144.03 141.14 24.97 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.789 0 N-CA-C 107.443 -1.317 . . . . 0.0 107.443 178.861 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 147' ' ' GLY . . . . . 0.479 ' C ' ' O ' ' A' ' 146' ' ' VAL . . . 38.42 -117.67 0.64 Allowed Glycine 0 N--CA 1.493 2.44 0 N-CA-C 109.67 -1.372 . . . . 0.0 109.67 179.78 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 148' ' ' ASN . . . . . 0.501 ' C ' ' ND2' ' A' ' 148' ' ' ASN . 0.4 OUTLIER -108.74 13.45 25.03 Favored 'General case' 0 C--N 1.303 -1.447 0 O-C-N 121.576 -0.955 . . . . 0.0 108.643 179.166 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 149' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -107.0 142.21 36.98 Favored 'General case' 0 N--CA 1.488 1.464 0 CA-C-O 121.934 0.873 . . . . 0.0 111.329 -178.863 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 150' ' ' THR . . . . . . . . . . . . . 97.3 m -134.64 99.06 4.22 Favored 'General case' 0 C--N 1.3 -1.583 0 CA-C-O 121.581 0.705 . . . . 0.0 109.841 -179.428 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 151' ' ' ARG . . . . . . . . . . . . . 86.6 mtt180 -88.24 -171.26 3.29 Favored 'General case' 0 N--CA 1.487 1.411 0 N-CA-C 108.872 -0.788 . . . . 0.0 108.872 179.973 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 152' ' ' LYS . . . . . 0.512 ' C ' ' CD1' ' A' ' 153' ' ' TYR . 34.8 mttp -151.38 150.85 30.95 Favored 'General case' 0 C--N 1.302 -1.471 0 O-C-N 121.201 -0.937 . . . . 0.0 110.139 179.703 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 153' ' ' TYR . . . . . 0.512 ' CD1' ' C ' ' A' ' 152' ' ' LYS . 22.0 m-85 -145.71 158.07 43.89 Favored 'General case' 0 C--N 1.299 -1.618 0 N-CA-C 107.516 -1.29 . . . . 0.0 107.516 178.183 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 154' ' ' LYS . . . . . . . . . . . . . 13.2 ttpp -130.55 125.43 34.21 Favored 'General case' 0 C--N 1.297 -1.71 0 N-CA-C 108.44 -0.948 . . . . 0.0 108.44 -179.996 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 155' ' ' MET . . . . . . . . . . . . . 74.5 mtp -45.87 107.33 0.1 Allowed 'General case' 0 N--CA 1.489 1.517 0 O-C-N 120.697 -1.252 . . . . 0.0 110.797 -178.954 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 156' ' ' THR . . . . . 0.536 ' HG1' ' N ' ' A' ' 203' ' ' THR . 0.4 OUTLIER -104.47 -27.16 12.08 Favored 'General case' 0 C--N 1.292 -1.933 0 CA-C-N 115.292 -0.867 . . . . 0.0 110.284 -178.385 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 157' ' ' SER . . . . . . . . . . . . . 10.0 t -150.63 150.52 31.26 Favored 'General case' 0 N--CA 1.493 1.702 0 C-N-CA 118.418 -1.313 . . . . 0.0 110.927 -178.812 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 158' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -152.91 140.13 13.21 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.389 0 CA-C-O 121.75 0.786 . . . . 0.0 109.563 -178.476 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 159' ' ' ARG . . . . . . . . . . . . . 26.8 mtm180 -154.73 165.2 37.33 Favored 'General case' 0 C--N 1.294 -1.822 0 CA-C-O 121.672 0.749 . . . . 0.0 109.882 -179.441 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 160' ' ' ASP . . . . . . . . . . . . . 8.0 m-20 -116.18 155.03 28.99 Favored 'General case' 0 C--N 1.298 -1.645 0 N-CA-C 108.069 -1.085 . . . . 0.0 108.069 179.253 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 161' ' ' VAL . . . . . 0.409 ' O ' ' O ' ' A' ' 162' ' ' LYS . 13.1 m -155.01 150.69 11.4 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.7 0 O-C-N 120.893 -1.129 . . . . 0.0 110.527 -178.995 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 162' ' ' LYS . . . . . 0.409 ' O ' ' O ' ' A' ' 161' ' ' VAL . 0.0 OUTLIER -47.36 170.38 0.09 OUTLIER Pre-proline 0 N--CA 1.49 1.571 0 O-C-N 121.295 -0.878 . . . . 0.0 109.495 179.677 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 163' ' ' PRO . . . . . . . . . . . . . 57.4 Cg_endo -78.0 37.32 0.62 Allowed 'Trans proline' 0 C--N 1.309 -1.525 0 C-N-CA 122.738 2.292 . . . . 0.0 112.769 -179.706 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 164' ' ' THR . . . . . . . . . . . . . 17.4 m -152.19 -7.98 0.21 Allowed 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.081 -1.012 . . . . 0.0 110.859 -179.88 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 165' ' ' ASP . . . . . 0.456 ' O ' ' C ' ' A' ' 166' ' ' VAL . 6.9 t70 -72.84 61.41 0.55 Allowed 'General case' 0 N--CA 1.492 1.653 0 O-C-N 120.627 -1.296 . . . . 0.0 110.193 -179.412 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 166' ' ' VAL . . . . . 0.67 ' O ' ' N ' ' A' ' 168' ' ' VAL . 0.7 OUTLIER -39.77 -30.0 0.13 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.637 0 O-C-N 121.411 -0.806 . . . . 0.0 109.789 -178.546 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 167' ' ' GLY . . . . . 0.443 ' N ' ' O ' ' A' ' 165' ' ' ASP . . . -42.55 -9.04 0.01 OUTLIER Glycine 0 N--CA 1.5 2.925 0 O-C-N 121.292 -0.88 . . . . 0.0 111.221 -179.497 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 168' ' ' VAL . . . . . 0.67 ' N ' ' O ' ' A' ' 166' ' ' VAL . 19.6 t -48.35 -40.72 10.47 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.62 0 O-C-N 120.89 -1.359 . . . . 0.0 108.729 179.263 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 169' ' ' LEU . . . . . 0.544 ' O ' ' N ' ' A' ' 171' ' ' GLU . 5.4 mt -47.54 -9.4 0.02 OUTLIER 'General case' 0 N--CA 1.496 1.86 0 N-CA-C 108.715 -0.846 . . . . 0.0 108.715 -178.207 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 170' ' ' ASP . . . . . 0.618 ' H ' ' C ' ' A' ' 168' ' ' VAL . 7.0 t0 35.6 27.86 0.01 OUTLIER 'General case' 0 N--CA 1.493 1.72 0 O-C-N 121.508 -0.745 . . . . 0.0 111.5 178.22 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 171' ' ' GLU . . . . . 0.544 ' N ' ' O ' ' A' ' 169' ' ' LEU . 3.8 pt-20 -69.34 94.56 0.72 Allowed 'General case' 0 C--N 1.301 -1.541 0 N-CA-C 107.157 -1.423 . . . . 0.0 107.157 178.034 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 172' ' ' GLN . . . . . . . . . . . . . 2.4 mt-30 -155.14 -74.06 0.11 Allowed 'General case' 0 N--CA 1.493 1.716 0 O-C-N 121.447 -0.783 . . . . 0.0 109.977 -178.645 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 173' ' ' LYS . . . . . 0.525 ' O ' ' NE2' ' A' ' 113' ' ' GLN . 2.3 mptt -59.65 137.84 57.91 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.335 -0.853 . . . . 0.0 109.119 179.841 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 174' ' ' GLY . . . . . 0.504 ' O ' ' C ' ' A' ' 175' ' ' LYS . . . -123.42 -43.61 0.35 Allowed Glycine 0 C--N 1.299 -1.505 0 N-CA-C 107.771 -2.132 . . . . 0.0 107.771 179.172 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 175' ' ' LYS . . . . . 0.504 ' C ' ' O ' ' A' ' 174' ' ' GLY . 0.1 OUTLIER -36.89 -76.9 0.02 OUTLIER 'General case' 0 N--CA 1.498 1.946 0 N-CA-C 108.943 -0.762 . . . . 0.0 108.943 179.729 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 176' ' ' ASP . . . . . 0.582 ' O ' ' O ' ' A' ' 177' ' ' LYS . 1.2 m-20 -91.38 86.62 6.15 Favored 'General case' 0 C--N 1.297 -1.708 0 N-CA-C 107.087 -1.449 . . . . 0.0 107.087 178.059 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 177' ' ' LYS . . . . . 0.582 ' O ' ' O ' ' A' ' 176' ' ' ASP . 0.9 OUTLIER -40.5 178.01 0.0 OUTLIER 'General case' 0 N--CA 1.493 1.713 0 CA-C-O 121.603 0.716 . . . . 0.0 110.907 -178.919 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 178' ' ' GLN . . . . . 0.492 ' NE2' ' CG ' ' A' ' 114' ' ' ASN . 1.0 OUTLIER -160.91 173.49 15.23 Favored 'General case' 0 C--N 1.307 -1.263 0 C-N-CA 118.637 -1.225 . . . . 0.0 110.692 -179.726 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 179' ' ' LEU . . . . . . . . . . . . . 2.2 tp -128.02 100.2 5.79 Favored 'General case' 0 C--N 1.3 -1.57 0 N-CA-C 106.896 -1.52 . . . . 0.0 106.896 178.127 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 180' ' ' THR . . . . . . . . . . . . . 1.4 m -75.18 118.95 18.67 Favored 'General case' 0 C--N 1.303 -1.417 0 C-N-CA 119.071 -1.052 . . . . 0.0 110.287 -178.101 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 181' ' ' LEU . . . . . 0.417 HD11 ' H ' ' A' ' 182' ' ' ILE . 57.8 tp -94.76 146.95 23.82 Favored 'General case' 0 C--N 1.298 -1.647 0 N-CA-C 108.08 -1.081 . . . . 0.0 108.08 178.171 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 182' ' ' ILE . . . . . 0.417 ' H ' HD11 ' A' ' 181' ' ' LEU . 54.9 mt -140.9 125.43 17.88 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.529 0 O-C-N 120.958 -1.089 . . . . 0.0 109.684 179.552 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 183' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -143.84 112.29 6.44 Favored 'General case' 0 C--N 1.295 -1.802 0 N-CA-C 107.047 -1.464 . . . . 0.0 107.047 178.722 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 184' ' ' CYS . . . . . 0.463 ' CB ' HH11 ' A' ' 197' ' ' ARG . 0.6 OUTLIER -78.48 163.06 25.91 Favored 'General case' 0 N--CA 1.498 1.964 0 C-N-CA 118.786 -1.166 . . . . 0.0 110.954 -177.114 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 185' ' ' ASP . . . . . . . . . . . . . 12.3 t0 -165.87 -153.92 0.19 Allowed 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.45 -0.781 . . . . 0.0 109.817 -179.712 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 186' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER 49.98 53.92 11.98 Favored 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.254 -0.904 . . . . 0.0 108.983 -179.67 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 187' ' ' TYR . . . . . 0.603 ' CE1' ' O ' ' A' ' 188' ' ' ASN . 34.2 t80 -65.93 135.17 54.39 Favored 'General case' 0 C--N 1.301 -1.521 0 O-C-N 121.205 -0.935 . . . . 0.0 110.222 -179.419 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 188' ' ' ASN . . . . . 0.603 ' O ' ' CE1' ' A' ' 187' ' ' TYR . 0.6 OUTLIER -100.93 147.68 25.87 Favored 'General case' 0 C--N 1.296 -1.737 0 N-CA-C 107.954 -1.128 . . . . 0.0 107.954 178.578 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 189' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -112.54 -13.65 13.31 Favored 'General case' 0 C--N 1.295 -1.772 0 N-CA-C 108.268 -1.012 . . . . 0.0 108.268 -179.872 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 190' ' ' LYS . . . . . . . . . . . . . 15.0 mtmt -83.46 -52.34 6.59 Favored 'General case' 0 C--N 1.303 -1.426 0 N-CA-C 108.814 -0.81 . . . . 0.0 108.814 179.118 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 191' ' ' THR . . . . . . . . . . . . . 2.6 p -90.56 -9.63 46.43 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.461 -0.775 . . . . 0.0 109.075 179.58 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 192' ' ' GLY . . . . . . . . . . . . . . . 63.68 39.94 98.04 Favored Glycine 0 N--CA 1.493 2.484 0 N-CA-C 110.836 -0.905 . . . . 0.0 110.836 178.941 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 193' ' ' VAL . . . . . . . . . . . . . 57.8 t -145.98 159.32 11.75 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.563 0 O-C-N 121.01 -1.288 . . . . 0.0 109.34 179.346 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 194' ' ' TRP . . . . . 0.47 ' N ' ' CD1' ' A' ' 194' ' ' TRP . 19.9 m95 -85.31 120.48 26.84 Favored 'General case' 0 C--N 1.3 -1.584 0 N-CA-C 107.644 -1.243 . . . . 0.0 107.644 178.667 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 195' ' ' GLU . . . . . 0.514 ' CD ' ' ND2' ' A' ' 188' ' ' ASN . 1.1 mt-10 -89.27 -60.6 1.91 Allowed 'General case' 0 N--CA 1.493 1.713 0 O-C-N 121.138 -0.976 . . . . 0.0 111.749 -177.453 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 196' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -78.98 144.34 34.85 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 120.823 -1.173 . . . . 0.0 110.405 -178.558 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 197' ' ' ARG . . . . . 0.56 ' NH2' ' O ' ' C' ' 703' ' ' PRO . 0.7 OUTLIER -120.77 137.15 54.66 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.632 -0.668 . . . . 0.0 109.206 179.714 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 198' ' ' LYS . . . . . . . . . . . . . 3.2 mtmm -114.97 122.06 45.09 Favored 'General case' 0 N--CA 1.489 1.491 0 O-C-N 121.722 -0.611 . . . . 0.0 110.323 -178.943 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 199' ' ' ILE . . . . . 0.455 ' CG1' ' O ' ' A' ' 199' ' ' ILE . 0.6 OUTLIER -141.85 118.32 6.85 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.7 0 O-C-N 120.957 -1.09 . . . . 0.0 110.416 179.937 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 200' ' ' PHE . . . . . 0.53 ' CD1' ' N ' ' A' ' 200' ' ' PHE . 6.5 m-85 -99.84 137.96 37.58 Favored 'General case' 0 N--CA 1.499 1.975 0 O-C-N 121.294 -0.879 . . . . 0.0 110.134 -179.371 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 201' ' ' VAL . . . . . . . . . . . . . 33.0 t -105.7 148.28 10.33 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.589 0 N-CA-C 107.981 -1.118 . . . . 0.0 107.981 177.744 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 202' ' ' ALA . . . . . 0.416 ' HA ' ' H ' ' A' ' 156' ' ' THR . . . -133.35 139.43 46.82 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.03 -1.044 . . . . 0.0 109.088 -179.608 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 203' ' ' THR . . . . . 0.536 ' N ' ' HG1' ' A' ' 156' ' ' THR . 1.9 p -90.2 134.26 34.39 Favored 'General case' 0 N--CA 1.487 1.383 0 CA-C-O 122.565 1.174 . . . . 0.0 111.197 -178.827 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 204' ' ' GLU . . . . . 0.414 ' HA ' ' CD2' ' A' ' 153' ' ' TYR . 6.8 tt0 -56.0 134.88 52.69 Favored 'General case' 0 C--N 1.296 -1.76 0 C-N-CA 118.761 -1.176 . . . . 0.0 109.621 179.818 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 205' ' ' VAL . . . . . 0.531 ' O ' ' C ' ' A' ' 206' ' ' LYS . 61.0 t -128.35 -42.4 0.85 Allowed 'Isoleucine or valine' 0 N--CA 1.494 1.766 0 O-C-N 121.304 -0.873 . . . . 0.0 110.24 -178.788 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 206' ' ' LYS . . . . . 0.531 ' C ' ' O ' ' A' ' 205' ' ' VAL . 1.2 pptp? . . . . . 0 N--CA 1.501 2.093 0 CA-C-O 118.157 -0.925 . . . . 0.0 110.596 -179.505 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' C' C ' 701' ' ' PHQ . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 002 nuclear orig full ' C' C ' 702' ' ' LEU . . . . . 0.619 ' CD1' ' N ' ' C' ' 702' ' ' LEU . 0.0 OUTLIER . . . . . 0 N--CA 1.493 1.702 0 N-CA-C 108.676 -0.861 . . . . 0.0 108.676 . . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' C' C ' 703' ' ' PRO . . . . . 0.56 ' O ' ' NH2' ' A' ' 197' ' ' ARG . 42.8 Cg_endo -69.59 -179.19 2.66 Favored 'Trans proline' 0 N--CA 1.496 1.64 0 C-N-CA 122.868 2.379 . . . . 0.0 113.276 -178.935 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' C' C ' 704' ' ' ALA . . . . . 0.484 ' O ' ' O ' ' C' ' 703' ' ' PRO . . . 45.05 -171.3 0.01 OUTLIER 'General case' 0 N--CA 1.486 1.336 0 O-C-N 121.557 -0.714 . . . . 0.0 109.295 179.934 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' C' C ' 705' ' ' B27 . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 002 nuclear orig full ' A' A ' 700' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 003 nuclear orig full ' A' A ' 59' ' ' MET . . . . . . . . . . . . . 9.4 ttt . . . . . 0 N--CA 1.491 1.596 0 CA-C-O 121.32 0.581 . . . . 0.0 109.455 . . . . . . . . . 0 0 . 1 . 003 nuclear orig full ' A' A ' 60' ' ' GLN . . . . . . . . . . . . . 2.7 mp0 -61.01 -177.41 0.08 Allowed 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.232 -0.918 . . . . 0.0 110.005 -179.769 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . -64.29 177.39 0.85 Allowed 'General case' 0 N--CA 1.494 1.743 0 O-C-N 121.365 -0.834 . . . . 0.0 109.917 -179.889 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 62' ' ' LYS . . . . . . . . . . . . . 14.3 mtpt -145.42 78.19 12.23 Favored Pre-proline 0 N--CA 1.492 1.636 0 C-N-CA 119.343 -0.943 . . . . 0.0 110.397 -179.438 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 63' ' ' PRO . . . . . . . . . . . . . 3.7 Cg_endo -82.21 147.58 14.6 Favored 'Trans proline' 0 C--N 1.304 -1.809 0 C-N-CA 123.234 2.623 . . . . 0.0 111.436 178.97 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 64' ' ' GLN . . . . . 0.712 ' NE2' ' N ' ' A' ' 64' ' ' GLN . 0.0 OUTLIER -153.0 102.59 2.67 Favored 'General case' 0 N--CA 1.493 1.685 0 O-C-N 121.129 -0.982 . . . . 0.0 109.513 -179.63 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 65' ' ' ILE . . . . . 0.486 ' C ' ' O ' ' A' ' 64' ' ' GLN . 3.0 mp -37.83 99.3 0.18 Allowed Pre-proline 0 N--CA 1.494 1.747 0 N-CA-C 108.677 -0.86 . . . . 0.0 108.677 179.715 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 66' ' ' PRO . . . . . 0.463 ' N ' ' O ' ' A' ' 64' ' ' GLN . 57.8 Cg_endo -85.27 -162.55 0.16 Allowed 'Trans proline' 0 C--N 1.315 -1.203 0 C-N-CA 122.264 1.976 . . . . 0.0 112.505 -178.592 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 67' ' ' LYS . . . . . 0.553 ' C ' ' H ' ' A' ' 69' ' ' LYS . 6.6 ptpt -72.98 -5.73 40.69 Favored 'General case' 0 C--N 1.303 -1.415 0 O-C-N 121.393 -0.817 . . . . 0.0 108.829 179.737 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 68' ' ' ASP . . . . . 0.626 ' C ' ' H ' ' A' ' 70' ' ' SER . 1.0 OUTLIER -74.97 46.53 0.31 Allowed 'General case' 0 N--CA 1.486 1.374 0 CA-C-O 122.85 1.309 . . . . 0.0 107.735 178.876 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 69' ' ' LYS . . . . . 0.553 ' H ' ' C ' ' A' ' 67' ' ' LYS . 13.3 ptpt -48.63 -14.41 0.06 Allowed 'General case' 0 N--CA 1.501 2.123 0 C-N-CA 117.23 -1.788 . . . . 0.0 106.728 178.191 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 70' ' ' SER . . . . . 0.626 ' H ' ' C ' ' A' ' 68' ' ' ASP . 0.3 OUTLIER -85.25 -6.3 59.27 Favored 'General case' 0 N--CA 1.496 1.86 0 CA-C-N 113.53 -1.668 . . . . 0.0 110.764 179.284 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 71' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -97.53 140.96 31.17 Favored 'General case' 0 N--CA 1.497 1.886 0 O-C-N 120.876 -1.14 . . . . 0.0 111.478 -179.598 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 72' ' ' VAL . . . . . 0.553 ' CG2' ' O ' ' A' ' 74' ' ' GLY . 0.2 OUTLIER -65.45 136.57 26.48 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.414 0 N-CA-C 105.334 -2.099 . . . . 0.0 105.334 175.36 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 73' ' ' ALA . . . . . 0.535 ' N ' ' O ' ' A' ' 87' ' ' VAL . . . -83.53 -17.16 42.8 Favored 'General case' 0 C--N 1.296 -1.717 0 O-C-N 120.179 -1.576 . . . . 0.0 108.245 -179.017 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 74' ' ' GLY . . . . . 0.553 ' O ' ' CG2' ' A' ' 72' ' ' VAL . . . 172.44 -157.71 27.5 Favored Glycine 0 C--N 1.294 -1.776 0 N-CA-C 109.5 -1.44 . . . . 0.0 109.5 -179.554 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 75' ' ' TYR . . . . . . . . . . . . . 4.6 m-85 -141.47 170.37 15.86 Favored 'General case' 0 C--N 1.293 -1.866 0 O-C-N 121.363 -1.08 . . . . 0.0 110.362 -177.303 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 76' ' ' ILE . . . . . . . . . . . . . 3.0 tp -144.92 140.02 22.99 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.717 0 C-N-CA 119.359 -0.937 . . . . 0.0 109.446 -177.414 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 77' ' ' GLU . . . . . 0.572 ' N ' ' CD ' ' A' ' 77' ' ' GLU . 0.7 OUTLIER -146.71 159.43 43.48 Favored 'General case' 0 C--N 1.304 -1.388 0 O-C-N 121.015 -1.053 . . . . 0.0 109.148 -179.293 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 78' ' ' ILE . . . . . . . . . . . . . 12.2 mt -147.7 94.34 4.41 Favored Pre-proline 0 N--CA 1.489 1.498 0 N-CA-C 108.622 -0.881 . . . . 0.0 108.622 -179.963 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 79' ' ' PRO . . . . . . . . . . . . . 75.0 Cg_exo -46.83 -45.83 19.65 Favored 'Trans proline' 0 N--CA 1.493 1.488 0 C-N-CA 122.937 2.425 . . . . 0.0 114.212 -178.685 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -64.78 -19.83 66.03 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 120.644 -1.285 . . . . 0.0 110.507 178.704 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 81' ' ' ALA . . . . . 0.604 ' O ' ' ND2' ' A' ' 132' ' ' ASN . . . -104.99 -16.73 14.73 Favored 'General case' 0 N--CA 1.493 1.707 0 N-CA-C 108.448 -0.945 . . . . 0.0 108.448 179.223 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 82' ' ' ASP . . . . . . . . . . . . . 7.8 t0 67.21 50.36 1.0 Allowed 'General case' 0 N--CA 1.488 1.437 0 O-C-N 121.364 -0.835 . . . . 0.0 109.951 179.736 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 83' ' ' ILE . . . . . 0.409 ' CD1' ' OD1' ' A' ' 132' ' ' ASN . 78.4 mt -127.82 152.78 36.32 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.671 0 O-C-N 121.395 -0.815 . . . . 0.0 110.009 -178.914 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 84' ' ' LYS . . . . . . . . . . . . . 1.8 tttt -159.06 108.71 1.94 Allowed 'General case' 0 N--CA 1.49 1.561 0 N-CA-C 107.099 -1.445 . . . . 0.0 107.099 179.036 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 85' ' ' GLU . . . . . 0.503 ' OE1' ' O ' ' A' ' 128' ' ' TYR . 0.0 OUTLIER -141.92 169.56 10.88 Favored Pre-proline 0 N--CA 1.494 1.733 0 O-C-N 121.236 -0.915 . . . . 0.0 110.972 -177.842 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 86' ' ' PRO . . . . . . . . . . . . . 73.4 Cg_endo -79.34 166.45 22.38 Favored 'Trans proline' 0 N--CA 1.492 1.385 0 C-N-CA 123.22 2.613 . . . . 0.0 113.43 -179.631 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 87' ' ' VAL . . . . . 0.535 ' O ' ' N ' ' A' ' 73' ' ' ALA . 60.3 t -126.07 102.08 9.31 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.614 0 N-CA-C 109.056 -0.72 . . . . 0.0 109.056 179.705 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 88' ' ' TYR . . . . . 0.454 ' CB ' HE22 ' A' ' 96' ' ' GLN . 22.7 m-85 -96.33 153.82 38.86 Favored Pre-proline 0 N--CA 1.501 2.088 0 O-C-N 120.952 -1.092 . . . . 0.0 110.336 -179.34 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 89' ' ' PRO . . . . . . . . . . . . . 1.2 Cg_endo -55.72 143.82 78.57 Favored 'Trans proline' 0 C--N 1.309 -1.543 0 C-N-CA 122.715 2.277 . . . . 0.0 113.958 -179.891 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . -57.76 169.35 4.4 Favored Glycine 0 N--CA 1.493 2.44 0 N-CA-C 108.888 -1.685 . . . . 0.0 108.888 178.743 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 91' ' ' PRO . . . . . 0.498 ' C ' ' HG ' ' A' ' 102' ' ' SER . 56.3 Cg_endo -94.75 169.38 17.55 Favored 'Cis proline' 0 C--N 1.308 -1.558 0 C-N-CA 124.183 -1.174 . . . . 0.0 112.079 0.141 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 92' ' ' ALA . . . . . 0.509 ' O ' ' CD1' ' A' ' 97' ' ' LEU . . . -72.99 32.07 0.07 Allowed 'General case' 0 N--CA 1.493 1.718 0 O-C-N 120.948 -1.095 . . . . 0.0 110.927 -179.724 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 93' ' ' THR . . . . . 0.433 ' H ' ' C ' ' A' ' 91' ' ' PRO . 11.1 p -73.15 150.4 89.9 Favored Pre-proline 0 C--N 1.302 -1.47 0 O-C-N 120.278 -1.514 . . . . 0.0 108.228 179.695 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 94' ' ' PRO . . . . . . . . . . . . . 91.1 Cg_exo -34.39 -46.41 0.51 Allowed 'Trans proline' 0 C--N 1.309 -1.527 0 C-N-CA 122.78 2.32 . . . . 0.0 112.44 -179.074 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 95' ' ' GLU . . . . . 0.59 ' O ' ' ND2' ' A' ' 98' ' ' ASN . 6.8 mt-10 -53.69 -51.94 61.61 Favored 'General case' 0 N--CA 1.488 1.465 0 O-C-N 121.111 -0.993 . . . . 0.0 109.702 179.9 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 96' ' ' GLN . . . . . 0.564 ' C ' ' H ' ' A' ' 98' ' ' ASN . 0.0 OUTLIER -71.92 -45.94 59.37 Favored 'General case' 0 C--N 1.303 -1.418 0 O-C-N 121.205 -0.935 . . . . 0.0 109.822 -179.848 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 97' ' ' LEU . . . . . 0.509 ' CD1' ' O ' ' A' ' 92' ' ' ALA . 88.9 mt -55.17 -4.91 0.09 Allowed 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.18 -0.95 . . . . 0.0 108.935 179.902 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 98' ' ' ASN . . . . . 0.59 ' ND2' ' O ' ' A' ' 95' ' ' GLU . 0.0 OUTLIER -71.88 -26.01 62.16 Favored 'General case' 0 N--CA 1.489 1.505 0 O-C-N 121.511 -0.743 . . . . 0.0 109.295 179.708 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 99' ' ' ARG . . . . . 0.669 HH11 ' CG ' ' A' ' 99' ' ' ARG . 0.2 OUTLIER -99.9 -59.06 1.78 Allowed 'General case' 0 N--CA 1.488 1.426 0 C-N-CA 119.71 -0.796 . . . . 0.0 110.483 -178.919 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . -170.84 -169.43 33.87 Favored Glycine 0 N--CA 1.49 2.277 0 C-N-CA 119.013 -1.565 . . . . 0.0 110.518 -179.789 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 101' ' ' VAL . . . . . 0.471 ' CG1' ' CE2' ' A' ' 130' ' ' PHE . 27.0 m -53.95 106.25 0.1 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.525 0 O-C-N 121.662 -0.905 . . . . 0.0 109.561 -179.906 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 102' ' ' SER . . . . . 0.498 ' HG ' ' C ' ' A' ' 91' ' ' PRO . 0.0 OUTLIER -92.91 158.08 16.02 Favored 'General case' 0 N--CA 1.495 1.787 0 O-C-N 121.249 -0.907 . . . . 0.0 110.582 -179.88 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 103' ' ' PHE . . . . . 0.562 ' O ' ' N ' ' A' ' 105' ' ' GLU . 23.6 m-85 -61.06 121.76 13.27 Favored 'General case' 0 N--CA 1.491 1.612 0 N-CA-C 108.083 -1.081 . . . . 0.0 108.083 178.58 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 104' ' ' ALA . . . . . . . . . . . . . . . -40.03 -19.99 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.567 -0.708 . . . . 0.0 111.445 -178.434 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 105' ' ' GLU . . . . . 0.562 ' N ' ' O ' ' A' ' 103' ' ' PHE . 0.2 OUTLIER -139.33 151.2 46.2 Favored 'General case' 0 N--CA 1.494 1.767 0 O-C-N 120.688 -1.257 . . . . 0.0 110.707 -179.563 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 106' ' ' GLU . . . . . . . . . . . . . 30.3 tt0 -57.95 -64.19 0.99 Allowed 'General case' 0 C--N 1.303 -1.442 0 CA-C-N 116.146 -0.479 . . . . 0.0 111.3 -178.94 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 107' ' ' ASN . . . . . 0.462 ' C ' ' ND2' ' A' ' 107' ' ' ASN . 0.0 OUTLIER -77.47 33.0 0.16 Allowed 'General case' 0 N--CA 1.491 1.587 0 O-C-N 120.541 -1.349 . . . . 0.0 113.187 -175.214 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 108' ' ' GLU . . . . . . . . . . . . . 33.2 tp10 -59.55 148.61 32.7 Favored 'General case' 0 C--N 1.301 -1.53 0 N-CA-C 107.474 -1.306 . . . . 0.0 107.474 179.899 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 109' ' ' SER . . . . . 0.529 ' C ' ' H ' ' A' ' 111' ' ' ASP . 0.1 OUTLIER -100.59 124.67 46.48 Favored 'General case' 0 N--CA 1.487 1.409 0 O-C-N 120.9 -1.125 . . . . 0.0 110.486 -178.432 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 110' ' ' LEU . . . . . . . . . . . . . 1.5 pp -60.01 -4.61 0.79 Allowed 'General case' 0 C--N 1.301 -1.536 0 N-CA-C 108.467 -0.938 . . . . 0.0 108.467 179.721 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 111' ' ' ASP . . . . . 0.529 ' H ' ' C ' ' A' ' 109' ' ' SER . 11.8 m-20 -131.93 20.77 4.55 Favored 'General case' 0 C--N 1.303 -1.416 0 N-CA-C 108.825 -0.805 . . . . 0.0 108.825 179.57 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 112' ' ' ASP . . . . . 0.419 ' C ' ' H ' ' A' ' 114' ' ' ASN . 0.8 OUTLIER -66.3 140.02 58.09 Favored 'General case' 0 N--CA 1.489 1.505 0 O-C-N 121.349 -0.844 . . . . 0.0 110.198 -179.937 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 113' ' ' GLN . . . . . 0.477 ' CA ' ' NE2' ' A' ' 113' ' ' GLN . 0.8 OUTLIER -65.11 -6.68 9.61 Favored 'General case' 0 C--N 1.302 -1.488 0 N-CA-C 107.892 -1.151 . . . . 0.0 107.892 178.278 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 114' ' ' ASN . . . . . 0.419 ' H ' ' C ' ' A' ' 112' ' ' ASP . 11.1 p-10 -146.02 95.01 2.56 Favored 'General case' 0 C--N 1.3 -1.545 0 N-CA-C 107.95 -1.13 . . . . 0.0 107.95 179.144 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 115' ' ' ILE . . . . . . . . . . . . . 2.6 mt -98.24 111.67 28.5 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.536 0 O-C-N 121.493 -0.754 . . . . 0.0 109.487 -179.366 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 116' ' ' SER . . . . . . . . . . . . . 66.3 m -97.1 151.19 20.02 Favored 'General case' 0 N--CA 1.489 1.517 0 CA-C-O 121.77 0.795 . . . . 0.0 111.066 -178.804 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 117' ' ' ILE . . . . . . . . . . . . . 1.9 mt -146.59 155.85 11.69 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.588 0 N-CA-C 108.184 -1.043 . . . . 0.0 108.184 179.328 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 118' ' ' ALA . . . . . . . . . . . . . . . -146.04 163.41 35.32 Favored 'General case' 0 N--CA 1.493 1.683 0 O-C-N 120.569 -1.332 . . . . 0.0 111.88 -179.049 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 119' ' ' GLY . . . . . . . . . . . . . . . -169.9 148.57 11.95 Favored Glycine 0 N--CA 1.49 2.295 0 N-CA-C 110.403 -1.079 . . . . 0.0 110.403 -179.889 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 120' ' ' HIS . . . . . . . . . . . . . 34.2 m170 -69.33 167.71 15.87 Favored 'General case' 0 N--CA 1.495 1.799 0 O-C-N 121.768 -0.842 . . . . 0.0 110.498 179.783 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 121' ' ' THR . . . . . 0.585 ' HG1' ' HZ2' ' A' ' 134' ' ' LYS . 0.7 OUTLIER -122.9 155.11 37.35 Favored 'General case' 0 N--CA 1.493 1.715 0 N-CA-C 108.165 -1.05 . . . . 0.0 108.165 178.677 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 122' ' ' PHE . . . . . . . . . . . . . 0.4 OUTLIER -144.15 123.38 12.97 Favored 'General case' 0 N--CA 1.496 1.835 0 O-C-N 120.849 -1.157 . . . . 0.0 109.756 -179.487 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 123' ' ' ILE . . . . . 0.466 ' CG2' ' N ' ' A' ' 124' ' ' ASP . 11.1 tt -55.76 -40.75 62.7 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.462 0 CA-C-O 121.628 0.728 . . . . 0.0 109.065 179.963 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 124' ' ' ASP . . . . . 0.466 ' N ' ' CG2' ' A' ' 123' ' ' ILE . 31.3 t70 -88.75 23.4 2.32 Favored 'General case' 0 N--CA 1.493 1.714 0 O-C-N 121.653 -0.654 . . . . 0.0 111.731 -177.703 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 125' ' ' ARG . . . . . . . . . . . . . 54.1 mtt180 -153.62 98.59 2.66 Favored Pre-proline 0 N--CA 1.493 1.679 0 O-C-N 120.866 -1.146 . . . . 0.0 109.183 179.618 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 126' ' ' PRO . . . . . . . . . . . . . 69.7 Cg_endo -82.3 -28.57 1.85 Allowed 'Trans proline' 0 C--N 1.313 -1.321 0 C-N-CA 122.401 2.068 . . . . 0.0 111.939 179.734 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 127' ' ' ASN . . . . . 0.482 ' O ' ' O ' ' A' ' 128' ' ' TYR . 2.1 m120 -89.86 6.43 41.87 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.372 -0.83 . . . . 0.0 109.186 179.79 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 128' ' ' TYR . . . . . 0.503 ' O ' ' OE1' ' A' ' 85' ' ' GLU . 2.4 t80 -59.47 -148.53 0.0 OUTLIER 'General case' 0 N--CA 1.489 1.486 0 O-C-N 121.318 -0.864 . . . . 0.0 109.465 179.901 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 129' ' ' GLN . . . . . 0.489 ' O ' ' OE1' ' A' ' 85' ' ' GLU . 8.7 mt-30 -65.21 -72.45 0.15 Allowed 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.386 -0.821 . . . . 0.0 110.067 -179.321 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 130' ' ' PHE . . . . . 0.471 ' CE2' ' CG1' ' A' ' 101' ' ' VAL . 53.5 m-85 -135.78 42.0 2.67 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.012 -1.055 . . . . 0.0 109.993 -179.693 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 131' ' ' THR . . . . . . . . . . . . . 38.9 m -77.19 -35.82 55.46 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.129 -0.982 . . . . 0.0 109.531 179.94 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 132' ' ' ASN . . . . . 0.604 ' ND2' ' O ' ' A' ' 81' ' ' ALA . 0.1 OUTLIER -84.15 4.71 29.21 Favored 'General case' 0 N--CA 1.498 1.925 0 O-C-N 121.44 -0.788 . . . . 0.0 110.456 -179.277 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 133' ' ' LEU . . . . . 0.569 ' O ' ' N ' ' A' ' 135' ' ' ALA . 0.2 OUTLIER -68.19 -45.52 73.2 Favored 'General case' 0 C--N 1.296 -1.76 0 O-C-N 120.961 -1.087 . . . . 0.0 110.578 -179.636 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 134' ' ' LYS . . . . . 0.585 ' HZ2' ' HG1' ' A' ' 121' ' ' THR . 0.0 OUTLIER -43.17 -17.85 0.01 OUTLIER 'General case' 0 N--CA 1.496 1.865 0 O-C-N 120.955 -1.09 . . . . 0.0 110.191 -179.331 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 135' ' ' ALA . . . . . 0.569 ' N ' ' O ' ' A' ' 133' ' ' LEU . . . -83.24 -38.28 22.42 Favored 'General case' 0 N--CA 1.488 1.471 0 O-C-N 120.925 -1.109 . . . . 0.0 110.147 -179.566 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 136' ' ' ALA . . . . . . . . . . . . . . . -80.0 157.89 26.69 Favored 'General case' 0 C--N 1.302 -1.476 0 CA-C-O 122.283 1.04 . . . . 0.0 111.82 -178.412 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 137' ' ' LYS . . . . . 0.528 ' O ' ' O ' ' A' ' 138' ' ' LYS . 2.4 tttt -154.49 -162.71 1.45 Allowed 'General case' 0 N--CA 1.491 1.617 0 C-N-CA 119.083 -1.047 . . . . 0.0 110.579 -178.61 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 138' ' ' LYS . . . . . 0.601 ' O ' ' N ' ' A' ' 140' ' ' SER . 16.6 pttm -44.65 -179.19 0.0 OUTLIER 'General case' 0 C--N 1.302 -1.482 0 CA-C-O 122.228 1.013 . . . . 0.0 111.039 -179.13 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 139' ' ' GLY . . . . . . . . . . . . . . . 45.42 7.89 0.01 OUTLIER Glycine 0 N--CA 1.491 2.304 0 N-CA-C 110.646 -0.982 . . . . 0.0 110.646 179.978 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 140' ' ' SER . . . . . 0.601 ' N ' ' O ' ' A' ' 138' ' ' LYS . 58.7 m -85.99 124.39 32.38 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 120.71 -1.465 . . . . 0.0 109.244 179.459 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 141' ' ' MET . . . . . . . . . . . . . 1.1 tpt -72.88 136.08 45.23 Favored 'General case' 0 N--CA 1.489 1.506 0 O-C-N 121.133 -0.979 . . . . 0.0 109.16 179.93 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 142' ' ' VAL . . . . . . . . . . . . . 3.5 t -121.42 129.1 75.9 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.627 0 N-CA-C 108.865 -0.791 . . . . 0.0 108.865 -179.835 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 143' ' ' TYR . . . . . . . . . . . . . 16.6 m-85 -113.14 136.6 52.54 Favored 'General case' 0 N--CA 1.498 1.951 0 O-C-N 121.172 -0.955 . . . . 0.0 111.063 -178.667 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 144' ' ' PHE . . . . . 0.418 ' CE2' ' CG1' ' A' ' 146' ' ' VAL . 10.7 t80 -122.52 104.98 9.73 Favored 'General case' 0 N--CA 1.492 1.667 0 CA-C-O 121.5 0.667 . . . . 0.0 110.245 -178.989 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 145' ' ' LYS . . . . . . . . . . . . . 4.6 mttm -97.7 123.41 41.61 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.426 -0.796 . . . . 0.0 109.719 -179.965 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 146' ' ' VAL . . . . . 0.418 ' CG1' ' CE2' ' A' ' 144' ' ' PHE . 0.5 OUTLIER -143.78 122.62 7.42 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.582 0 O-C-N 121.196 -0.94 . . . . 0.0 108.648 179.402 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 147' ' ' GLY . . . . . . . . . . . . . . . 70.47 -131.01 21.6 Favored Glycine 0 N--CA 1.488 2.163 0 N-CA-C 108.525 -1.83 . . . . 0.0 108.525 -179.103 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 148' ' ' ASN . . . . . 0.513 ' C ' ' ND2' ' A' ' 148' ' ' ASN . 0.4 OUTLIER -106.51 11.72 30.35 Favored 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.407 -1.055 . . . . 0.0 108.665 179.101 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 149' ' ' GLU . . . . . . . . . . . . . 4.8 tt0 -114.2 149.42 35.8 Favored 'General case' 0 N--CA 1.491 1.594 0 CA-C-O 121.844 0.831 . . . . 0.0 111.043 -179.003 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 150' ' ' THR . . . . . . . . . . . . . 20.1 m -129.89 105.55 8.07 Favored 'General case' 0 N--CA 1.492 1.656 0 CA-C-O 121.341 0.591 . . . . 0.0 109.762 -179.986 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 151' ' ' ARG . . . . . . . . . . . . . 4.9 mtp180 -87.82 -175.29 5.08 Favored 'General case' 0 N--CA 1.487 1.403 0 N-CA-C 108.293 -1.003 . . . . 0.0 108.293 179.701 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 152' ' ' LYS . . . . . . . . . . . . . 26.3 mtmt -149.31 146.45 27.55 Favored 'General case' 0 C--N 1.301 -1.502 0 O-C-N 120.914 -1.116 . . . . 0.0 110.619 -179.454 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 153' ' ' TYR . . . . . 0.47 ' CD2' ' HA ' ' A' ' 204' ' ' GLU . 4.1 m-85 -138.6 170.25 16.35 Favored 'General case' 0 N--CA 1.488 1.443 0 N-CA-C 107.471 -1.307 . . . . 0.0 107.471 178.794 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 154' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -144.52 122.7 12.19 Favored 'General case' 0 C--N 1.296 -1.726 0 N-CA-C 108.087 -1.079 . . . . 0.0 108.087 178.581 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 155' ' ' MET . . . . . . . . . . . . . 3.7 mtt -46.75 105.88 0.07 Allowed 'General case' 0 N--CA 1.49 1.54 0 O-C-N 120.594 -1.316 . . . . 0.0 111.702 -178.445 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 156' ' ' THR . . . . . 0.54 ' OG1' ' CG2' ' A' ' 203' ' ' THR . 0.1 OUTLIER -106.28 -25.55 11.9 Favored 'General case' 0 C--N 1.292 -1.918 0 CA-C-N 115.183 -0.917 . . . . 0.0 110.074 -179.137 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 157' ' ' SER . . . . . 0.416 ' O ' ' N ' ' A' ' 201' ' ' VAL . 0.1 OUTLIER -153.72 152.72 31.1 Favored 'General case' 0 N--CA 1.495 1.81 0 C-N-CA 118.24 -1.384 . . . . 0.0 111.592 -178.766 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 158' ' ' ILE . . . . . 0.444 HG13 ' CD2' ' A' ' 200' ' ' PHE . 0.0 OUTLIER -156.17 146.52 12.04 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.527 0 CA-C-O 121.758 0.79 . . . . 0.0 110.376 -179.885 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 159' ' ' ARG . . . . . 0.461 ' CG ' HH11 ' A' ' 159' ' ' ARG . 0.0 OUTLIER -150.85 -175.59 5.19 Favored 'General case' 0 C--N 1.3 -1.574 0 CA-C-O 121.833 0.825 . . . . 0.0 110.821 -179.629 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 160' ' ' ASP . . . . . 0.428 ' O ' ' CG1' ' A' ' 161' ' ' VAL . 1.9 m-20 -143.2 157.34 44.59 Favored 'General case' 0 N--CA 1.49 1.566 0 N-CA-C 108.018 -1.105 . . . . 0.0 108.018 -179.851 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 161' ' ' VAL . . . . . 0.449 ' O ' ' O ' ' A' ' 162' ' ' LYS . 2.3 m -160.08 157.38 2.89 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.833 0 C-N-CA 118.624 -1.231 . . . . 0.0 110.902 -179.256 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 162' ' ' LYS . . . . . 0.449 ' O ' ' O ' ' A' ' 161' ' ' VAL . 0.0 OUTLIER -44.02 169.04 0.06 OUTLIER Pre-proline 0 N--CA 1.493 1.685 0 O-C-N 121.559 -0.713 . . . . 0.0 109.833 -179.996 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 163' ' ' PRO . . . . . . . . . . . . . 57.0 Cg_endo -77.2 34.74 0.46 Allowed 'Trans proline' 0 C--N 1.309 -1.521 0 C-N-CA 122.622 2.215 . . . . 0.0 112.402 179.725 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 164' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -150.76 -6.98 0.28 Allowed 'General case' 0 N--CA 1.495 1.778 0 O-C-N 121.1 -1.0 . . . . 0.0 110.904 -179.567 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 165' ' ' ASP . . . . . 0.422 ' O ' ' C ' ' A' ' 166' ' ' VAL . 13.7 t70 -72.53 61.16 0.49 Allowed 'General case' 0 C--N 1.3 -1.56 0 O-C-N 120.881 -1.137 . . . . 0.0 109.127 -179.831 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 166' ' ' VAL . . . . . 0.643 ' O ' ' N ' ' A' ' 168' ' ' VAL . 0.8 OUTLIER -44.0 -29.47 0.52 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.523 0 O-C-N 121.113 -0.992 . . . . 0.0 109.387 -178.567 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 167' ' ' GLY . . . . . . . . . . . . . . . -45.19 -6.43 0.01 OUTLIER Glycine 0 N--CA 1.498 2.788 0 O-C-N 121.197 -0.94 . . . . 0.0 110.763 179.905 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 168' ' ' VAL . . . . . 0.643 ' N ' ' O ' ' A' ' 166' ' ' VAL . 2.8 t -48.24 -34.56 4.99 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.417 0 O-C-N 120.88 -1.365 . . . . 0.0 108.381 179.188 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 169' ' ' LEU . . . . . 0.419 ' O ' ' C ' ' A' ' 170' ' ' ASP . 1.4 mt -47.23 -11.01 0.02 OUTLIER 'General case' 0 N--CA 1.494 1.767 0 N-CA-C 108.239 -1.022 . . . . 0.0 108.239 -178.313 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 170' ' ' ASP . . . . . 0.619 ' H ' ' C ' ' A' ' 168' ' ' VAL . 6.1 t70 38.49 64.65 0.71 Allowed 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.596 -0.69 . . . . 0.0 111.535 177.615 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 171' ' ' GLU . . . . . . . . . . . . . 1.7 pt-20 -101.09 92.81 5.17 Favored 'General case' 0 C--N 1.299 -1.601 0 N-CA-C 106.965 -1.494 . . . . 0.0 106.965 177.715 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 172' ' ' GLN . . . . . . . . . . . . . 1.1 mt-30 -156.01 -79.16 0.09 Allowed 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.651 -0.656 . . . . 0.0 110.266 -178.361 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 173' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -59.49 128.41 36.91 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.15 -0.969 . . . . 0.0 109.195 -179.549 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 174' ' ' GLY . . . . . 0.526 ' O ' ' C ' ' A' ' 175' ' ' LYS . . . -119.36 -40.92 0.6 Allowed Glycine 0 N--CA 1.48 1.584 0 N-CA-C 108.117 -1.993 . . . . 0.0 108.117 179.321 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 175' ' ' LYS . . . . . 0.526 ' C ' ' O ' ' A' ' 174' ' ' GLY . 2.9 mmtt -35.79 -61.88 0.45 Allowed 'General case' 0 N--CA 1.496 1.829 0 N-CA-C 108.728 -0.841 . . . . 0.0 108.728 -179.877 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 176' ' ' ASP . . . . . 0.604 ' O ' ' O ' ' A' ' 177' ' ' LYS . 0.3 OUTLIER -103.48 88.87 3.2 Favored 'General case' 0 C--N 1.297 -1.676 0 N-CA-C 107.801 -1.185 . . . . 0.0 107.801 177.946 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 177' ' ' LYS . . . . . 0.604 ' O ' ' O ' ' A' ' 176' ' ' ASP . 6.0 mtmp? -39.29 177.82 0.0 OUTLIER 'General case' 0 N--CA 1.494 1.748 0 CA-C-O 121.805 0.812 . . . . 0.0 111.023 -179.09 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 178' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -161.69 171.81 17.29 Favored 'General case' 0 C--N 1.305 -1.331 0 O-C-N 120.837 -1.164 . . . . 0.0 110.508 179.186 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 179' ' ' LEU . . . . . . . . . . . . . 1.3 tp -126.74 95.33 4.3 Favored 'General case' 0 C--N 1.302 -1.485 0 N-CA-C 106.491 -1.67 . . . . 0.0 106.491 177.513 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 180' ' ' THR . . . . . . . . . . . . . 1.2 m -70.12 119.11 13.83 Favored 'General case' 0 C--N 1.304 -1.384 0 C-N-CA 119.134 -1.026 . . . . 0.0 109.41 -178.349 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 181' ' ' LEU . . . . . 0.427 HD11 ' H ' ' A' ' 182' ' ' ILE . 36.8 tp -96.82 146.01 25.32 Favored 'General case' 0 C--N 1.294 -1.806 0 N-CA-C 108.028 -1.101 . . . . 0.0 108.028 178.706 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 182' ' ' ILE . . . . . 0.427 ' H ' HD11 ' A' ' 181' ' ' LEU . 25.3 mt -139.34 119.77 14.58 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.484 0 O-C-N 120.956 -1.09 . . . . 0.0 109.718 179.088 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 183' ' ' THR . . . . . 0.417 ' CG2' ' HZ3' ' A' ' 134' ' ' LYS . 10.3 t -135.76 115.45 12.9 Favored 'General case' 0 C--N 1.291 -1.977 0 N-CA-C 107.447 -1.316 . . . . 0.0 107.447 178.508 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 184' ' ' CYS . . . . . . . . . . . . . 5.1 p -78.15 157.38 29.44 Favored 'General case' 0 C--N 1.287 -2.12 0 C-N-CA 118.93 -1.108 . . . . 0.0 110.655 -177.867 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 185' ' ' ASP . . . . . 0.567 ' CG ' ' H ' ' A' ' 186' ' ' ASP . 37.3 t0 -165.7 -158.09 0.34 Allowed 'General case' 0 N--CA 1.492 1.654 0 N-CA-C 108.944 -0.761 . . . . 0.0 108.944 -179.5 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 186' ' ' ASP . . . . . 0.567 ' H ' ' CG ' ' A' ' 185' ' ' ASP . 1.3 m-20 52.93 53.83 11.44 Favored 'General case' 0 N--CA 1.494 1.73 0 O-C-N 120.902 -1.124 . . . . 0.0 109.444 179.979 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 187' ' ' TYR . . . . . 0.617 ' CE1' ' O ' ' A' ' 188' ' ' ASN . 61.2 t80 -67.9 135.03 51.82 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.171 -0.956 . . . . 0.0 110.719 -179.397 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 188' ' ' ASN . . . . . 0.617 ' O ' ' CE1' ' A' ' 187' ' ' TYR . 1.1 t-20 -101.68 146.16 28.11 Favored 'General case' 0 C--N 1.295 -1.792 0 N-CA-C 108.119 -1.067 . . . . 0.0 108.119 178.441 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 189' ' ' GLU . . . . . . . . . . . . . 1.8 tt0 -110.13 -13.39 14.37 Favored 'General case' 0 C--N 1.293 -1.875 0 N-CA-C 108.151 -1.055 . . . . 0.0 108.151 -179.782 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 190' ' ' LYS . . . . . . . . . . . . . 6.4 mttt -84.27 -55.68 4.05 Favored 'General case' 0 C--N 1.301 -1.522 0 N-CA-C 108.827 -0.805 . . . . 0.0 108.827 178.759 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 191' ' ' THR . . . . . . . . . . . . . 6.2 p -87.48 2.55 50.27 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.444 -0.785 . . . . 0.0 109.89 -179.644 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 192' ' ' GLY . . . . . . . . . . . . . . . 56.27 33.07 60.98 Favored Glycine 0 N--CA 1.495 2.62 0 O-C-N 121.172 -0.955 . . . . 0.0 111.79 178.615 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 193' ' ' VAL . . . . . . . . . . . . . 4.1 p -149.25 167.94 2.97 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.75 0 O-C-N 120.677 -1.484 . . . . 0.0 110.583 179.009 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 194' ' ' TRP . . . . . 0.502 ' N ' ' CD1' ' A' ' 194' ' ' TRP . 9.4 m95 -83.98 120.23 25.87 Favored 'General case' 0 C--N 1.296 -1.724 0 N-CA-C 108.558 -0.904 . . . . 0.0 108.558 179.963 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 195' ' ' GLU . . . . . 0.444 ' CD ' ' ND2' ' A' ' 188' ' ' ASN . 3.7 mt-10 -76.23 -60.82 2.17 Favored 'General case' 0 N--CA 1.495 1.784 0 O-C-N 121.395 -0.816 . . . . 0.0 111.356 -178.323 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 196' ' ' LYS . . . . . . . . . . . . . 8.6 tttt -93.18 153.71 18.47 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 120.935 -1.103 . . . . 0.0 110.817 -178.494 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 197' ' ' ARG . . . . . 0.635 ' CG ' HH11 ' A' ' 197' ' ' ARG . 0.0 OUTLIER -119.66 140.13 51.12 Favored 'General case' 0 N--CA 1.49 1.525 0 N-CA-C 107.995 -1.113 . . . . 0.0 107.995 178.845 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 198' ' ' LYS . . . . . . . . . . . . . 2.4 mttm -114.16 122.02 45.54 Favored 'General case' 0 N--CA 1.493 1.719 0 O-C-N 121.899 -0.501 . . . . 0.0 110.904 -177.982 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 199' ' ' ILE . . . . . 0.466 ' C ' ' CD1' ' A' ' 199' ' ' ILE . 0.5 OUTLIER -142.58 120.02 7.02 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.546 0 CA-C-O 122.393 1.092 . . . . 0.0 110.515 179.925 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 200' ' ' PHE . . . . . 0.509 ' CD1' ' N ' ' A' ' 200' ' ' PHE . 3.5 m-85 -98.42 135.45 39.98 Favored 'General case' 0 N--CA 1.499 2.001 0 O-C-N 121.34 -0.85 . . . . 0.0 109.512 -178.982 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 201' ' ' VAL . . . . . 0.416 ' N ' ' O ' ' A' ' 157' ' ' SER . 72.3 t -100.08 130.75 48.76 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.633 0 O-C-N 120.885 -1.134 . . . . 0.0 108.318 177.671 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 202' ' ' ALA . . . . . . . . . . . . . . . -114.48 131.47 56.61 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.37 -0.831 . . . . 0.0 108.771 179.443 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 203' ' ' THR . . . . . 0.54 ' CG2' ' OG1' ' A' ' 156' ' ' THR . 6.7 p -88.59 130.35 35.28 Favored 'General case' 0 N--CA 1.487 1.399 0 CA-C-O 122.137 0.97 . . . . 0.0 110.768 -179.039 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 204' ' ' GLU . . . . . 0.47 ' HA ' ' CD2' ' A' ' 153' ' ' TYR . 0.8 OUTLIER -51.5 134.28 29.21 Favored 'General case' 0 C--N 1.298 -1.64 0 C-N-CA 119.091 -1.044 . . . . 0.0 109.034 179.305 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 205' ' ' VAL . . . . . 0.484 ' CG1' ' N ' ' A' ' 206' ' ' LYS . 93.3 t -132.22 167.03 27.41 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.358 0 CA-C-O 122.081 0.943 . . . . 0.0 110.144 -178.132 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 206' ' ' LYS . . . . . 0.484 ' N ' ' CG1' ' A' ' 205' ' ' VAL . 0.0 OUTLIER . . . . . 0 C--N 1.295 -1.787 0 CA-C-O 117.933 -1.032 . . . . 0.0 109.509 -179.72 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' C' C ' 701' ' ' PHQ . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 003 nuclear orig full ' C' C ' 702' ' ' LEU . . . . . 0.579 ' O ' ' NH2' ' A' ' 197' ' ' ARG . 0.0 OUTLIER . . . . . 0 N--CA 1.494 1.741 0 N-CA-C 109.235 -0.654 . . . . 0.0 109.235 . . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' C' C ' 703' ' ' PRO . . . . . 0.491 ' O ' ' O ' ' C' ' 702' ' ' LEU . 50.7 Cg_exo -48.6 -164.59 0.0 OUTLIER 'Trans proline' 0 N--CA 1.494 1.504 0 C-N-CA 122.437 2.091 . . . . 0.0 113.216 -179.426 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' C' C ' 704' ' ' ALA . . . . . 0.502 ' C ' ' SG ' ' C' ' 705' ' ' B27 . . . 48.05 99.62 0.01 OUTLIER 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.679 -0.638 . . . . 0.0 109.983 -179.924 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' C' C ' 705' ' ' B27 . . . . . 0.502 ' SG ' ' C ' ' C' ' 704' ' ' ALA . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 700' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 004 nuclear orig full ' A' A ' 59' ' ' MET . . . . . . . . . . . . . 2.2 mtt . . . . . 0 N--CA 1.491 1.581 0 N-CA-C 109.4 -0.592 . . . . 0.0 109.4 . . . . . . . . . 0 0 . 1 . 004 nuclear orig full ' A' A ' 60' ' ' GLN . . . . . . . . . . . . . 7.5 tp-100 -60.62 113.07 2.26 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.295 -0.878 . . . . 0.0 109.588 -179.91 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . -64.0 -169.8 0.03 OUTLIER 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.192 -0.942 . . . . 0.0 109.238 179.804 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 62' ' ' LYS . . . . . . . . . . . . . 27.2 mttp -147.41 83.75 7.54 Favored Pre-proline 0 N--CA 1.489 1.516 0 O-C-N 121.252 -0.905 . . . . 0.0 109.567 -179.682 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 63' ' ' PRO . . . . . 0.47 ' O ' ' CD1' ' A' ' 110' ' ' LEU . 18.2 Cg_endo -81.46 141.2 12.42 Favored 'Trans proline' 0 C--N 1.306 -1.672 0 C-N-CA 122.792 2.328 . . . . 0.0 111.231 179.584 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 64' ' ' GLN . . . . . 0.623 ' NE2' ' O ' ' A' ' 64' ' ' GLN . 0.0 OUTLIER -155.53 139.25 16.11 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.175 -0.953 . . . . 0.0 109.658 -179.967 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 65' ' ' ILE . . . . . 0.412 HG23 HD11 ' A' ' 65' ' ' ILE . 4.7 mm -48.05 107.7 0.79 Allowed Pre-proline 0 N--CA 1.491 1.592 0 O-C-N 121.009 -1.057 . . . . 0.0 108.183 179.345 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 66' ' ' PRO . . . . . . . . . . . . . 93.6 Cg_endo -85.75 -170.16 0.68 Allowed 'Trans proline' 0 C--N 1.315 -1.218 0 C-N-CA 122.15 1.9 . . . . 0.0 112.614 -179.015 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 67' ' ' LYS . . . . . . . . . . . . . 38.7 tttt -90.27 -8.86 49.89 Favored 'General case' 0 N--CA 1.488 1.459 0 O-C-N 121.436 -0.79 . . . . 0.0 109.178 179.567 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 68' ' ' ASP . . . . . 0.678 ' C ' ' H ' ' A' ' 70' ' ' SER . 0.4 OUTLIER -75.86 63.86 1.74 Allowed 'General case' 0 N--CA 1.488 1.431 0 CA-C-O 122.848 1.309 . . . . 0.0 109.033 179.813 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 69' ' ' LYS . . . . . 0.478 ' C ' ' O ' ' A' ' 68' ' ' ASP . 23.8 mtmt -45.76 -13.99 0.02 OUTLIER 'General case' 0 N--CA 1.512 2.653 0 C-N-CA 116.686 -2.005 . . . . 0.0 107.157 177.757 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 70' ' ' SER . . . . . 0.678 ' H ' ' C ' ' A' ' 68' ' ' ASP . 0.1 OUTLIER -86.04 -9.02 57.49 Favored 'General case' 0 N--CA 1.497 1.899 0 CA-C-N 113.701 -1.59 . . . . 0.0 111.656 179.395 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 71' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -95.88 142.18 28.44 Favored 'General case' 0 N--CA 1.505 2.303 0 O-C-N 120.468 -1.395 . . . . 0.0 112.971 -178.704 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 72' ' ' VAL . . . . . 0.408 ' O ' ' CG2' ' A' ' 72' ' ' VAL . 1.3 m -68.67 133.42 31.81 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.368 0 N-CA-C 105.305 -2.109 . . . . 0.0 105.305 174.711 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 73' ' ' ALA . . . . . 0.4 ' N ' ' O ' ' A' ' 87' ' ' VAL . . . -80.87 -13.77 58.63 Favored 'General case' 0 C--N 1.297 -1.714 0 O-C-N 119.905 -1.747 . . . . 0.0 107.183 -179.813 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . 172.99 -156.71 25.24 Favored Glycine 0 N--CA 1.483 1.77 0 N-CA-C 109.299 -1.52 . . . . 0.0 109.299 179.648 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 75' ' ' TYR . . . . . 0.404 ' CD2' ' HA ' ' A' ' 86' ' ' PRO . 88.1 m-85 -141.54 169.99 16.56 Favored 'General case' 0 C--N 1.298 -1.668 0 O-C-N 121.58 -0.953 . . . . 0.0 111.044 -177.241 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 76' ' ' ILE . . . . . . . . . . . . . 3.9 tp -146.5 141.39 20.88 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.577 0 C-N-CA 119.461 -0.895 . . . . 0.0 109.455 -177.377 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -153.09 165.02 36.92 Favored 'General case' 0 C--N 1.304 -1.41 0 O-C-N 121.13 -0.981 . . . . 0.0 109.934 179.852 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 78' ' ' ILE . . . . . . . . . . . . . 5.0 mt -147.39 119.92 4.75 Favored Pre-proline 0 C--N 1.303 -1.455 0 N-CA-C 107.87 -1.159 . . . . 0.0 107.87 179.165 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 79' ' ' PRO . . . . . . . . . . . . . 31.1 Cg_endo -70.46 -42.36 2.74 Favored 'Trans proline' 0 C--N 1.315 -1.218 0 C-N-CA 121.658 1.572 . . . . 0.0 112.992 -178.755 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -66.43 -19.8 65.89 Favored 'General case' 0 N--CA 1.489 1.491 0 O-C-N 120.881 -1.137 . . . . 0.0 110.202 177.977 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 81' ' ' ALA . . . . . 0.435 ' O ' ' ND2' ' A' ' 132' ' ' ASN . . . -106.61 -18.78 13.86 Favored 'General case' 0 N--CA 1.494 1.755 0 O-C-N 121.303 -0.873 . . . . 0.0 109.04 179.913 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 82' ' ' ASP . . . . . . . . . . . . . 2.3 t70 66.01 52.09 1.25 Allowed 'General case' 0 N--CA 1.494 1.732 0 O-C-N 121.43 -0.794 . . . . 0.0 111.493 178.781 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 83' ' ' ILE . . . . . . . . . . . . . 31.4 mt -131.46 153.08 38.3 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.862 0 O-C-N 120.977 -1.077 . . . . 0.0 109.636 -179.322 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 84' ' ' LYS . . . . . . . . . . . . . 23.1 tttt -158.11 110.48 2.33 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.244 -0.91 . . . . 0.0 108.628 179.57 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -141.46 165.75 26.6 Favored Pre-proline 0 N--CA 1.492 1.67 0 O-C-N 121.246 -0.909 . . . . 0.0 109.817 -179.256 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 86' ' ' PRO . . . . . 0.404 ' HA ' ' CD2' ' A' ' 75' ' ' TYR . 61.2 Cg_endo -76.29 168.61 23.58 Favored 'Trans proline' 0 C--N 1.309 -1.5 0 C-N-CA 122.939 2.426 . . . . 0.0 113.312 -179.53 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 87' ' ' VAL . . . . . 0.423 ' CG1' ' CE1' ' A' ' 103' ' ' PHE . 49.6 t -124.43 98.84 5.64 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.63 0 N-CA-C 109.27 -0.641 . . . . 0.0 109.27 -179.884 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 88' ' ' TYR . . . . . 0.403 ' CZ ' HG13 ' A' ' 72' ' ' VAL . 35.0 m-85 -90.42 153.55 46.22 Favored Pre-proline 0 N--CA 1.503 2.209 0 O-C-N 120.954 -1.091 . . . . 0.0 109.944 -179.606 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 89' ' ' PRO . . . . . 0.539 ' O ' ' NE2' ' A' ' 96' ' ' GLN . 10.2 Cg_endo -58.7 146.11 93.36 Favored 'Trans proline' 0 N--CA 1.493 1.469 0 C-N-CA 122.492 2.128 . . . . 0.0 113.135 179.82 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . -58.11 169.59 4.7 Favored Glycine 0 N--CA 1.492 2.398 0 N-CA-C 109.326 -1.51 . . . . 0.0 109.326 179.493 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 91' ' ' PRO . . . . . 0.441 ' C ' ' H ' ' A' ' 93' ' ' THR . 57.3 Cg_endo -95.23 169.21 16.63 Favored 'Cis proline' 0 C--N 1.31 -1.485 0 C-N-CA 124.298 -1.126 . . . . 0.0 112.065 0.103 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 92' ' ' ALA . . . . . 0.406 ' HA ' ' HG ' ' A' ' 102' ' ' SER . . . -71.99 30.07 0.05 Allowed 'General case' 0 N--CA 1.493 1.691 0 O-C-N 121.241 -0.912 . . . . 0.0 111.274 -179.421 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 93' ' ' THR . . . . . 0.441 ' H ' ' C ' ' A' ' 91' ' ' PRO . 1.0 OUTLIER -75.85 151.29 84.35 Favored Pre-proline 0 N--CA 1.492 1.64 0 O-C-N 120.651 -1.281 . . . . 0.0 108.788 179.865 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 94' ' ' PRO . . . . . 0.4 ' C ' ' O ' ' A' ' 93' ' ' THR . 82.9 Cg_exo -35.52 -42.24 0.45 Allowed 'Trans proline' 0 C--N 1.308 -1.573 0 C-N-CA 122.511 2.14 . . . . 0.0 112.067 -179.566 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 5.8 mt-10 -49.95 -56.44 10.62 Favored 'General case' 0 C--N 1.304 -1.41 0 O-C-N 121.292 -0.88 . . . . 0.0 109.112 179.512 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 96' ' ' GLN . . . . . 0.596 ' O ' ' N ' ' A' ' 98' ' ' ASN . 13.0 mm100 -74.49 -47.86 30.64 Favored 'General case' 0 N--CA 1.487 1.424 0 O-C-N 121.323 -0.861 . . . . 0.0 109.995 179.69 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 97' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -45.3 -11.89 0.02 OUTLIER 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.221 -0.925 . . . . 0.0 109.989 -178.949 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 98' ' ' ASN . . . . . 0.697 HD22 ' NH1' ' A' ' 99' ' ' ARG . 0.0 OUTLIER -73.88 -31.44 63.15 Favored 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.176 -0.953 . . . . 0.0 108.854 179.204 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 99' ' ' ARG . . . . . 0.697 ' NH1' HD22 ' A' ' 98' ' ' ASN . 1.1 mtt-85 -85.03 -58.2 2.79 Favored 'General case' 0 C--N 1.302 -1.47 0 O-C-N 121.865 -0.522 . . . . 0.0 109.89 -179.14 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . -179.65 -160.34 25.09 Favored Glycine 0 N--CA 1.493 2.442 0 C-N-CA 119.645 -1.264 . . . . 0.0 110.046 -179.944 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 101' ' ' VAL . . . . . 0.504 ' O ' ' CG2' ' A' ' 101' ' ' VAL . 17.8 m -61.66 107.82 0.46 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.594 0 O-C-N 121.403 -1.057 . . . . 0.0 109.522 -179.813 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 102' ' ' SER . . . . . 0.406 ' HG ' ' HA ' ' A' ' 92' ' ' ALA . 0.2 OUTLIER -92.91 161.57 14.43 Favored 'General case' 0 N--CA 1.493 1.681 0 O-C-N 121.322 -0.861 . . . . 0.0 110.498 -179.84 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 103' ' ' PHE . . . . . 0.601 ' O ' ' N ' ' A' ' 105' ' ' GLU . 25.3 m-85 -64.13 123.32 18.77 Favored 'General case' 0 N--CA 1.488 1.447 0 N-CA-C 108.151 -1.055 . . . . 0.0 108.151 178.655 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 104' ' ' ALA . . . . . 0.427 ' C ' ' O ' ' A' ' 103' ' ' PHE . . . -40.39 -18.63 0.01 OUTLIER 'General case' 0 C--N 1.298 -1.636 0 O-C-N 121.602 -0.686 . . . . 0.0 110.774 -178.939 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 105' ' ' GLU . . . . . 0.601 ' N ' ' O ' ' A' ' 103' ' ' PHE . 0.4 OUTLIER -140.0 147.88 41.06 Favored 'General case' 0 N--CA 1.495 1.808 0 O-C-N 120.698 -1.251 . . . . 0.0 110.315 179.915 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 106' ' ' GLU . . . . . . . . . . . . . 4.3 tt0 -57.86 -63.37 1.27 Allowed 'General case' 0 N--CA 1.487 1.425 0 O-C-N 121.965 -0.459 . . . . 0.0 111.203 -179.058 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 107' ' ' ASN . . . . . . . . . . . . . 5.1 m120 -78.68 33.82 0.21 Allowed 'General case' 0 N--CA 1.49 1.544 0 O-C-N 120.477 -1.39 . . . . 0.0 113.465 -175.231 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 108' ' ' GLU . . . . . . . . . . . . . 30.6 tp10 -60.02 150.14 30.1 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 120.426 -1.421 . . . . 0.0 108.175 -179.614 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 109' ' ' SER . . . . . 0.504 ' C ' ' H ' ' A' ' 111' ' ' ASP . 0.1 OUTLIER -101.35 126.26 48.09 Favored 'General case' 0 N--CA 1.489 1.5 0 O-C-N 121.002 -1.061 . . . . 0.0 110.585 -178.613 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 110' ' ' LEU . . . . . 0.47 ' CD1' ' O ' ' A' ' 63' ' ' PRO . 1.0 OUTLIER -60.22 -2.33 0.44 Allowed 'General case' 0 C--N 1.298 -1.664 0 N-CA-C 108.891 -0.781 . . . . 0.0 108.891 -179.964 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 111' ' ' ASP . . . . . 0.504 ' H ' ' C ' ' A' ' 109' ' ' SER . 53.1 m-20 -133.26 20.47 4.02 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.386 -0.822 . . . . 0.0 109.607 179.831 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 112' ' ' ASP . . . . . 0.434 ' C ' ' H ' ' A' ' 114' ' ' ASN . 0.4 OUTLIER -68.05 140.14 56.29 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.002 -1.061 . . . . 0.0 110.661 -179.674 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 113' ' ' GLN . . . . . 0.531 ' N ' ' CD ' ' A' ' 113' ' ' GLN . 2.1 mm100 -64.92 -7.06 9.94 Favored 'General case' 0 C--N 1.303 -1.445 0 N-CA-C 107.521 -1.289 . . . . 0.0 107.521 177.876 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 114' ' ' ASN . . . . . 0.657 ' ND2' HE21 ' A' ' 178' ' ' GLN . 4.9 t-20 -144.68 92.17 2.26 Favored 'General case' 0 C--N 1.304 -1.403 0 N-CA-C 108.206 -1.035 . . . . 0.0 108.206 -179.954 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 115' ' ' ILE . . . . . . . . . . . . . 2.8 mt -99.11 113.71 34.83 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.536 0 O-C-N 121.531 -0.731 . . . . 0.0 109.328 -179.438 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 116' ' ' SER . . . . . . . . . . . . . 69.3 p -98.02 146.61 25.34 Favored 'General case' 0 N--CA 1.488 1.471 0 CA-C-O 122.093 0.949 . . . . 0.0 111.387 -178.299 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 117' ' ' ILE . . . . . . . . . . . . . 2.7 mt -138.21 154.64 28.24 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.511 0 N-CA-C 107.477 -1.305 . . . . 0.0 107.477 178.996 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 118' ' ' ALA . . . . . . . . . . . . . . . -143.44 159.75 41.82 Favored 'General case' 0 N--CA 1.492 1.66 0 O-C-N 120.836 -1.165 . . . . 0.0 111.336 -179.233 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 119' ' ' GLY . . . . . . . . . . . . . . . -167.66 145.56 9.85 Favored Glycine 0 N--CA 1.489 2.183 0 N-CA-C 110.423 -1.071 . . . . 0.0 110.423 179.624 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 120' ' ' HIS . . . . . 0.403 ' ND1' ' SG ' ' C' ' 705' ' ' B27 . 3.1 m-70 -70.36 164.64 24.1 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.613 -0.933 . . . . 0.0 109.417 179.236 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 121' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -118.06 155.28 30.62 Favored 'General case' 0 N--CA 1.494 1.733 0 O-C-N 121.318 -0.864 . . . . 0.0 108.855 179.422 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 122' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -112.36 128.07 56.19 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.308 -0.87 . . . . 0.0 109.637 179.761 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 123' ' ' ILE . . . . . 0.438 ' CG2' ' N ' ' A' ' 124' ' ' ASP . 16.3 tt -77.26 -38.52 27.21 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.809 0 N-CA-C 108.167 -1.049 . . . . 0.0 108.167 179.076 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 124' ' ' ASP . . . . . 0.438 ' N ' ' CG2' ' A' ' 123' ' ' ILE . 4.8 t70 -100.29 24.32 8.94 Favored 'General case' 0 N--CA 1.494 1.771 0 CA-C-N 115.771 -0.649 . . . . 0.0 110.82 -179.73 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 125' ' ' ARG . . . . . . . . . . . . . 5.1 ttt180 -157.64 99.77 1.87 Allowed Pre-proline 0 N--CA 1.492 1.671 0 O-C-N 120.664 -1.272 . . . . 0.0 110.541 -179.032 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 126' ' ' PRO . . . . . . . . . . . . . 41.3 Cg_endo -78.88 -18.91 11.33 Favored 'Trans proline' 0 C--N 1.314 -1.243 0 C-N-CA 122.175 1.917 . . . . 0.0 112.465 179.517 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 127' ' ' ASN . . . . . . . . . . . . . 14.8 m120 -90.65 26.69 1.95 Allowed 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.23 -0.919 . . . . 0.0 109.241 179.636 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 128' ' ' TYR . . . . . . . . . . . . . 13.1 t80 -87.04 -149.01 0.15 Allowed 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.306 -0.872 . . . . 0.0 109.774 -179.622 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 129' ' ' GLN . . . . . . . . . . . . . 63.3 mt-30 -67.95 -89.43 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.288 -0.882 . . . . 0.0 110.344 -179.323 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 130' ' ' PHE . . . . . 0.411 ' CE2' ' CG1' ' A' ' 101' ' ' VAL . 41.0 m-85 -110.15 40.07 2.02 Favored 'General case' 0 N--CA 1.494 1.752 0 O-C-N 121.287 -0.883 . . . . 0.0 110.338 -179.22 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 131' ' ' THR . . . . . . . . . . . . . 85.6 m -79.78 -32.95 40.9 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.088 -1.008 . . . . 0.0 109.128 179.38 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 132' ' ' ASN . . . . . 0.435 ' ND2' ' O ' ' A' ' 81' ' ' ALA . 4.6 t30 -84.33 7.54 19.04 Favored 'General case' 0 N--CA 1.495 1.784 0 O-C-N 121.608 -0.682 . . . . 0.0 110.335 -179.588 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 133' ' ' LEU . . . . . 0.6 ' O ' ' N ' ' A' ' 135' ' ' ALA . 0.2 OUTLIER -70.26 -46.37 64.53 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.186 -0.946 . . . . 0.0 110.686 -179.146 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 134' ' ' LYS . . . . . 0.554 ' NZ ' ' HG1' ' A' ' 183' ' ' THR . 0.1 OUTLIER -42.53 -17.54 0.01 OUTLIER 'General case' 0 N--CA 1.493 1.692 0 O-C-N 121.024 -1.048 . . . . 0.0 109.983 -179.012 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 135' ' ' ALA . . . . . 0.6 ' N ' ' O ' ' A' ' 133' ' ' LEU . . . -85.12 -33.89 22.28 Favored 'General case' 0 N--CA 1.489 1.482 0 O-C-N 121.183 -0.948 . . . . 0.0 109.64 179.773 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 136' ' ' ALA . . . . . 0.464 ' N ' ' O ' ' A' ' 133' ' ' LEU . . . -80.43 153.21 28.39 Favored 'General case' 0 N--CA 1.489 1.504 0 CA-C-O 122.095 0.95 . . . . 0.0 111.769 -178.546 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 137' ' ' LYS . . . . . 0.511 ' O ' ' O ' ' A' ' 138' ' ' LYS . 2.8 ttmm -157.42 -163.47 1.37 Allowed 'General case' 0 N--CA 1.491 1.624 0 C-N-CA 119.109 -1.037 . . . . 0.0 110.431 -179.25 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 138' ' ' LYS . . . . . 0.604 ' O ' ' N ' ' A' ' 140' ' ' SER . 10.3 tttt -46.23 -178.39 0.0 OUTLIER 'General case' 0 C--N 1.306 -1.3 0 CA-C-O 121.864 0.84 . . . . 0.0 110.265 -179.818 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 139' ' ' GLY . . . . . . . . . . . . . . . 45.7 8.2 0.02 OUTLIER Glycine 0 N--CA 1.492 2.431 0 N-CA-C 110.713 -0.955 . . . . 0.0 110.713 179.574 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 140' ' ' SER . . . . . 0.604 ' N ' ' O ' ' A' ' 138' ' ' LYS . 37.9 m -96.5 133.74 40.57 Favored 'General case' 0 N--CA 1.493 1.679 0 O-C-N 120.814 -1.404 . . . . 0.0 109.125 179.195 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 141' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -82.52 144.62 30.27 Favored 'General case' 0 N--CA 1.489 1.488 0 O-C-N 121.148 -0.97 . . . . 0.0 109.871 -179.816 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 142' ' ' VAL . . . . . . . . . . . . . 5.8 t -129.21 132.85 66.61 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.705 0 O-C-N 121.284 -0.885 . . . . 0.0 108.771 179.902 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 143' ' ' TYR . . . . . . . . . . . . . 32.3 m-85 -114.66 137.68 51.61 Favored 'General case' 0 N--CA 1.501 2.098 0 O-C-N 121.116 -0.99 . . . . 0.0 111.421 -178.455 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 144' ' ' PHE . . . . . . . . . . . . . 26.9 t80 -122.36 107.1 11.69 Favored 'General case' 0 N--CA 1.495 1.817 0 CA-C-O 121.323 0.583 . . . . 0.0 110.442 -179.178 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 145' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -96.63 128.83 43.95 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.384 -0.823 . . . . 0.0 110.582 -179.752 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 146' ' ' VAL . . . . . 0.41 ' O ' ' C ' ' A' ' 147' ' ' GLY . 3.7 p -143.38 142.8 25.15 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.777 0 N-CA-C 107.522 -1.288 . . . . 0.0 107.522 178.752 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 147' ' ' GLY . . . . . 0.41 ' C ' ' O ' ' A' ' 146' ' ' VAL . . . 46.97 -134.28 11.71 Favored Glycine 0 N--CA 1.489 2.224 0 N-CA-C 108.887 -1.685 . . . . 0.0 108.887 -179.754 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 148' ' ' ASN . . . . . 0.573 ' C ' HD21 ' A' ' 148' ' ' ASN . 0.4 OUTLIER -102.33 17.31 23.8 Favored 'General case' 0 C--N 1.301 -1.533 0 O-C-N 121.284 -1.127 . . . . 0.0 108.451 179.208 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 149' ' ' GLU . . . . . . . . . . . . . 8.7 tt0 -114.56 147.42 39.48 Favored 'General case' 0 N--CA 1.487 1.402 0 CA-C-O 121.919 0.866 . . . . 0.0 111.024 -178.605 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 150' ' ' THR . . . . . . . . . . . . . 88.3 m -129.42 105.97 8.47 Favored 'General case' 0 N--CA 1.491 1.596 0 CA-C-O 121.421 0.629 . . . . 0.0 109.718 179.891 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 151' ' ' ARG . . . . . . . . . . . . . 34.2 mtt180 -87.04 -174.54 4.96 Favored 'General case' 0 C--N 1.306 -1.299 0 N-CA-C 107.987 -1.116 . . . . 0.0 107.987 179.52 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 152' ' ' LYS . . . . . 0.433 ' CE ' ' OXT' ' A' ' 206' ' ' LYS . 18.6 mtmm -148.22 146.33 28.63 Favored 'General case' 0 C--N 1.3 -1.571 0 O-C-N 121.007 -1.058 . . . . 0.0 110.135 -179.799 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 153' ' ' TYR . . . . . 0.486 ' CD2' ' HA ' ' A' ' 204' ' ' GLU . 9.1 m-85 -139.02 166.56 24.17 Favored 'General case' 0 C--N 1.3 -1.546 0 N-CA-C 107.523 -1.288 . . . . 0.0 107.523 179.13 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 154' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -142.96 121.86 12.74 Favored 'General case' 0 C--N 1.296 -1.722 0 O-C-N 121.184 -0.948 . . . . 0.0 108.442 178.748 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 155' ' ' MET . . . . . . . . . . . . . 23.1 mmm -46.99 104.89 0.06 Allowed 'General case' 0 N--CA 1.49 1.526 0 O-C-N 120.758 -1.214 . . . . 0.0 111.445 -178.584 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 156' ' ' THR . . . . . . . . . . . . . 1.4 m -107.88 -23.95 11.84 Favored 'General case' 0 C--N 1.293 -1.885 0 CA-C-N 115.288 -0.869 . . . . 0.0 109.921 -179.291 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 157' ' ' SER . . . . . 0.485 ' O ' ' N ' ' A' ' 201' ' ' VAL . 2.0 m -153.94 150.56 28.45 Favored 'General case' 0 N--CA 1.492 1.669 0 C-N-CA 118.217 -1.393 . . . . 0.0 111.426 -178.362 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 158' ' ' ILE . . . . . 0.441 HG13 ' CD2' ' A' ' 200' ' ' PHE . 0.0 OUTLIER -154.95 146.45 13.29 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.44 0 CA-C-O 121.796 0.807 . . . . 0.0 110.333 -179.491 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 159' ' ' ARG . . . . . 0.434 ' N ' HG12 ' A' ' 158' ' ' ILE . 37.5 mtm180 -149.3 177.18 9.89 Favored 'General case' 0 C--N 1.298 -1.656 0 CA-C-O 121.557 0.694 . . . . 0.0 109.812 -179.732 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 160' ' ' ASP . . . . . 0.435 ' C ' ' CG2' ' A' ' 161' ' ' VAL . 1.0 OUTLIER -144.81 161.22 39.81 Favored 'General case' 0 C--N 1.3 -1.567 0 N-CA-C 108.859 -0.793 . . . . 0.0 108.859 -179.463 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 161' ' ' VAL . . . . . 0.435 ' CG2' ' C ' ' A' ' 160' ' ' ASP . 0.1 OUTLIER -169.47 166.6 0.34 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.612 0 O-C-N 121.294 -0.879 . . . . 0.0 109.768 179.673 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 162' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -55.29 177.36 0.13 Allowed Pre-proline 0 N--CA 1.489 1.482 0 O-C-N 121.528 -0.732 . . . . 0.0 109.189 179.669 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 163' ' ' PRO . . . . . . . . . . . . . 9.8 Cg_endo -84.07 42.8 1.26 Allowed 'Trans proline' 0 C--N 1.315 -1.185 0 C-N-CA 122.466 2.111 . . . . 0.0 112.21 -179.87 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 164' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -151.92 -14.0 0.19 Allowed 'General case' 0 N--CA 1.492 1.674 0 O-C-N 121.103 -0.998 . . . . 0.0 110.443 -179.859 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 165' ' ' ASP . . . . . 0.436 ' O ' ' C ' ' A' ' 166' ' ' VAL . 9.5 t70 -73.03 61.63 0.59 Allowed 'General case' 0 N--CA 1.49 1.527 0 O-C-N 120.955 -1.091 . . . . 0.0 109.544 -179.817 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 166' ' ' VAL . . . . . 0.608 ' O ' ' N ' ' A' ' 168' ' ' VAL . 0.9 OUTLIER -39.6 -32.04 0.17 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.55 0 O-C-N 121.659 -0.65 . . . . 0.0 109.431 -178.416 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 167' ' ' GLY . . . . . 0.425 ' N ' ' O ' ' A' ' 165' ' ' ASP . . . -43.03 -14.96 0.02 OUTLIER Glycine 0 N--CA 1.492 2.375 0 N-CA-C 110.325 -1.11 . . . . 0.0 110.325 179.898 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 168' ' ' VAL . . . . . 0.638 ' C ' ' H ' ' A' ' 170' ' ' ASP . 4.8 m -52.72 -37.06 24.04 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.452 0 O-C-N 120.751 -1.441 . . . . 0.0 108.528 179.692 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 169' ' ' LEU . . . . . 0.508 ' O ' ' N ' ' A' ' 171' ' ' GLU . 16.1 mt -51.75 -5.39 0.03 OUTLIER 'General case' 0 N--CA 1.494 1.756 0 N-CA-C 108.088 -1.078 . . . . 0.0 108.088 -179.431 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 170' ' ' ASP . . . . . 0.638 ' H ' ' C ' ' A' ' 168' ' ' VAL . 22.4 t0 35.52 29.49 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.639 -0.663 . . . . 0.0 111.586 178.047 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 171' ' ' GLU . . . . . 0.508 ' N ' ' O ' ' A' ' 169' ' ' LEU . 11.6 pt-20 -68.31 94.5 0.54 Allowed 'General case' 0 N--CA 1.489 1.5 0 O-C-N 120.609 -1.307 . . . . 0.0 108.26 178.935 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 172' ' ' GLN . . . . . 0.401 ' HG3' ' H ' ' A' ' 173' ' ' LYS . 6.0 pt20 -175.98 -56.9 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.535 0 N-CA-C 108.885 -0.783 . . . . 0.0 108.885 179.969 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 173' ' ' LYS . . . . . 0.401 ' H ' ' HG3' ' A' ' 172' ' ' GLN . 44.5 mtpt -64.13 130.24 43.17 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.021 -1.049 . . . . 0.0 108.64 178.462 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 174' ' ' GLY . . . . . 0.571 ' O ' ' C ' ' A' ' 175' ' ' LYS . . . -134.91 -38.72 0.19 Allowed Glycine 0 N--CA 1.48 1.621 0 N-CA-C 108.621 -1.792 . . . . 0.0 108.621 179.581 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 175' ' ' LYS . . . . . 0.571 ' C ' ' O ' ' A' ' 174' ' ' GLY . 4.3 mmtp -27.02 -64.7 0.08 Allowed 'General case' 0 N--CA 1.503 2.199 0 CA-C-O 121.644 0.735 . . . . 0.0 109.033 179.853 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 176' ' ' ASP . . . . . 0.669 ' O ' ' O ' ' A' ' 177' ' ' LYS . 0.0 OUTLIER -102.6 79.26 1.79 Allowed 'General case' 0 C--N 1.298 -1.669 0 N-CA-C 107.163 -1.421 . . . . 0.0 107.163 177.442 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 177' ' ' LYS . . . . . 0.669 ' O ' ' O ' ' A' ' 176' ' ' ASP . 65.7 mttt -26.56 161.34 0.0 OUTLIER 'General case' 0 N--CA 1.503 2.212 0 CA-C-O 121.821 0.82 . . . . 0.0 111.17 -178.676 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 178' ' ' GLN . . . . . 0.657 HE21 ' ND2' ' A' ' 114' ' ' ASN . 3.3 pp0? -159.94 174.0 15.05 Favored 'General case' 0 C--N 1.302 -1.458 0 C-N-CA 117.265 -1.774 . . . . 0.0 112.029 -179.357 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 179' ' ' LEU . . . . . 0.469 ' N ' ' OE1' ' A' ' 178' ' ' GLN . 0.9 OUTLIER -126.01 99.05 5.75 Favored 'General case' 0 C--N 1.303 -1.446 0 N-CA-C 107.242 -1.392 . . . . 0.0 107.242 178.47 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 180' ' ' THR . . . . . 0.467 ' N ' ' OE1' ' A' ' 178' ' ' GLN . 2.7 m -70.82 122.0 19.09 Favored 'General case' 0 N--CA 1.488 1.447 0 O-C-N 120.953 -1.092 . . . . 0.0 109.939 -178.642 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 181' ' ' LEU . . . . . 0.421 HD13 ' H ' ' A' ' 182' ' ' ILE . 51.1 tp -96.84 145.78 25.54 Favored 'General case' 0 C--N 1.298 -1.67 0 N-CA-C 108.387 -0.968 . . . . 0.0 108.387 178.725 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 182' ' ' ILE . . . . . 0.421 ' H ' HD13 ' A' ' 181' ' ' LEU . 6.3 mt -138.31 110.58 6.39 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.458 0 O-C-N 120.994 -1.066 . . . . 0.0 108.982 178.987 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 183' ' ' THR . . . . . 0.554 ' HG1' ' NZ ' ' A' ' 134' ' ' LYS . 1.9 t -129.11 113.47 15.14 Favored 'General case' 0 C--N 1.291 -1.938 0 N-CA-C 106.767 -1.568 . . . . 0.0 106.767 178.546 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 184' ' ' CYS . . . . . . . . . . . . . 28.2 p -78.38 164.52 24.74 Favored 'General case' 0 N--CA 1.497 1.916 0 C-N-CA 119.028 -1.069 . . . . 0.0 111.103 -177.359 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 185' ' ' ASP . . . . . . . . . . . . . 6.4 t70 -165.72 -151.4 0.14 Allowed 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.584 -0.698 . . . . 0.0 109.347 -179.642 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 186' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER 48.15 56.63 7.08 Favored 'General case' 0 N--CA 1.493 1.724 0 O-C-N 121.175 -0.953 . . . . 0.0 109.03 -179.598 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 187' ' ' TYR . . . . . 0.6 ' CE1' ' O ' ' A' ' 188' ' ' ASN . 44.7 t80 -67.38 133.77 50.22 Favored 'General case' 0 C--N 1.302 -1.485 0 O-C-N 121.418 -0.801 . . . . 0.0 110.411 -179.417 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 188' ' ' ASN . . . . . 0.6 ' O ' ' CE1' ' A' ' 187' ' ' TYR . 0.6 OUTLIER -100.74 147.21 26.29 Favored 'General case' 0 C--N 1.296 -1.749 0 N-CA-C 107.79 -1.189 . . . . 0.0 107.79 178.302 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 189' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -112.3 -11.04 13.76 Favored 'General case' 0 C--N 1.295 -1.797 0 N-CA-C 108.373 -0.973 . . . . 0.0 108.373 -179.635 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 190' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -84.23 -52.47 6.22 Favored 'General case' 0 C--N 1.303 -1.447 0 N-CA-C 108.851 -0.796 . . . . 0.0 108.851 178.838 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 191' ' ' THR . . . . . . . . . . . . . 1.1 p -89.44 -12.63 39.64 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.475 -0.766 . . . . 0.0 109.2 179.663 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 192' ' ' GLY . . . . . . . . . . . . . . . 71.84 33.43 63.02 Favored Glycine 0 N--CA 1.493 2.495 0 O-C-N 121.291 -0.881 . . . . 0.0 111.303 178.706 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 193' ' ' VAL . . . . . . . . . . . . . 3.3 p -147.71 170.85 3.2 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.67 0 O-C-N 120.778 -1.425 . . . . 0.0 110.035 179.216 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 194' ' ' TRP . . . . . 0.522 ' CD1' ' N ' ' A' ' 194' ' ' TRP . 2.5 m95 -84.97 121.63 28.05 Favored 'General case' 0 N--CA 1.494 1.726 0 N-CA-C 109.439 -0.578 . . . . 0.0 109.439 -179.809 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 195' ' ' GLU . . . . . 0.531 ' CD ' ' ND2' ' A' ' 188' ' ' ASN . 2.4 mt-10 -80.05 -60.38 2.36 Favored 'General case' 0 N--CA 1.496 1.87 0 O-C-N 121.348 -0.845 . . . . 0.0 111.037 -178.975 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 196' ' ' LYS . . . . . . . . . . . . . 10.6 tttt -93.44 157.34 16.27 Favored 'General case' 0 N--CA 1.493 1.688 0 O-C-N 120.977 -1.077 . . . . 0.0 110.695 -178.544 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 197' ' ' ARG . . . . . 0.615 ' CG ' HH11 ' A' ' 197' ' ' ARG . 0.1 OUTLIER -126.18 142.2 51.62 Favored 'General case' 0 N--CA 1.489 1.485 0 O-C-N 121.653 -0.654 . . . . 0.0 109.351 179.415 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 198' ' ' LYS . . . . . . . . . . . . . 38.5 mttt -115.56 121.73 43.53 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.794 -0.566 . . . . 0.0 110.101 -179.17 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 199' ' ' ILE . . . . . 0.445 ' C ' ' CD1' ' A' ' 199' ' ' ILE . 0.5 OUTLIER -138.09 118.65 16.19 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.811 0 CA-C-O 122.526 1.155 . . . . 0.0 110.076 179.834 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 200' ' ' PHE . . . . . 0.509 ' CD1' ' N ' ' A' ' 200' ' ' PHE . 7.0 m-85 -99.73 135.35 41.28 Favored 'General case' 0 N--CA 1.499 1.992 0 O-C-N 121.499 -0.751 . . . . 0.0 109.894 -178.358 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 201' ' ' VAL . . . . . 0.485 ' N ' ' O ' ' A' ' 157' ' ' SER . 59.9 t -101.03 131.86 47.88 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.714 0 O-C-N 120.984 -1.073 . . . . 0.0 108.826 177.684 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 202' ' ' ALA . . . . . . . . . . . . . . . -115.9 131.38 56.95 Favored 'General case' 0 N--CA 1.491 1.624 0 N-CA-C 108.525 -0.917 . . . . 0.0 108.525 179.43 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 203' ' ' THR . . . . . . . . . . . . . 5.4 t -87.88 132.09 34.33 Favored 'General case' 0 N--CA 1.488 1.468 0 CA-C-O 122.327 1.061 . . . . 0.0 110.709 -179.332 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 204' ' ' GLU . . . . . 0.486 ' HA ' ' CD2' ' A' ' 153' ' ' TYR . 13.7 tm-20 -52.99 135.42 36.85 Favored 'General case' 0 C--N 1.296 -1.752 0 C-N-CA 118.619 -1.233 . . . . 0.0 108.909 179.205 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 205' ' ' VAL . . . . . 0.488 ' CG1' ' N ' ' A' ' 206' ' ' LYS . 84.1 t -131.99 167.97 25.14 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.345 0 CA-C-O 121.993 0.902 . . . . 0.0 110.141 -178.056 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 206' ' ' LYS . . . . . 0.488 ' N ' ' CG1' ' A' ' 205' ' ' VAL . 25.5 mttt . . . . . 0 C--N 1.297 -1.675 0 CA-C-O 117.978 -1.011 . . . . 0.0 109.555 179.937 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' C' C ' 701' ' ' PHQ . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 004 nuclear orig full ' C' C ' 702' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.49 1.561 0 N-CA-C 108.775 -0.824 . . . . 0.0 108.775 . . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' C' C ' 703' ' ' PRO . . . . . 0.603 ' O ' ' NH2' ' A' ' 197' ' ' ARG . 55.5 Cg_endo -72.58 174.76 11.16 Favored 'Trans proline' 0 N--CA 1.495 1.597 0 C-N-CA 122.48 2.12 . . . . 0.0 112.418 -179.497 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' C' C ' 704' ' ' ALA . . . . . . . . . . . . . . . 54.77 -173.81 0.04 OUTLIER 'General case' 0 N--CA 1.487 1.388 0 O-C-N 121.234 -0.916 . . . . 0.0 109.49 179.897 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' C' C ' 705' ' ' B27 . . . . . 0.49 ' OG1' ' CD1' ' A' ' 194' ' ' TRP . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 700' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 005 nuclear orig full ' A' A ' 59' ' ' MET . . . . . . . . . . . . . 0.3 OUTLIER . . . . . 0 N--CA 1.49 1.534 0 N-CA-C 109.474 -0.565 . . . . 0.0 109.474 . . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 60' ' ' GLN . . . . . 0.534 ' H ' ' CD ' ' A' ' 60' ' ' GLN . 1.4 mp0 -59.65 -179.73 0.1 Allowed 'General case' 0 N--CA 1.489 1.49 0 O-C-N 121.174 -0.954 . . . . 0.0 109.109 179.862 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . -63.49 157.11 24.34 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.099 -1.001 . . . . 0.0 109.262 -179.908 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 62' ' ' LYS . . . . . . . . . . . . . 40.0 mtpt -142.26 71.9 22.14 Favored Pre-proline 0 N--CA 1.489 1.491 0 O-C-N 121.152 -0.967 . . . . 0.0 109.693 -179.64 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 63' ' ' PRO . . . . . . . . . . . . . 53.7 Cg_endo -84.92 153.61 11.31 Favored 'Trans proline' 0 C--N 1.305 -1.737 0 C-N-CA 123.247 2.631 . . . . 0.0 110.929 179.271 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 64' ' ' GLN . . . . . 0.675 ' NE2' ' N ' ' A' ' 64' ' ' GLN . 0.0 OUTLIER -153.38 111.93 3.68 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 120.986 -1.071 . . . . 0.0 110.19 -179.84 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 65' ' ' ILE . . . . . 0.45 ' C ' ' O ' ' A' ' 64' ' ' GLN . 3.1 mp -43.45 103.76 0.34 Allowed Pre-proline 0 N--CA 1.491 1.596 0 N-CA-C 108.148 -1.056 . . . . 0.0 108.148 178.722 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 66' ' ' PRO . . . . . . . . . . . . . 97.9 Cg_endo -85.98 -155.05 0.05 OUTLIER 'Trans proline' 0 N--CA 1.49 1.282 0 C-N-CA 122.407 2.072 . . . . 0.0 113.002 -178.218 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 67' ' ' LYS . . . . . 0.453 ' C ' ' H ' ' A' ' 69' ' ' LYS . 15.1 tttt -82.16 -6.01 58.88 Favored 'General case' 0 N--CA 1.487 1.395 0 O-C-N 121.311 -0.868 . . . . 0.0 109.037 179.936 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 68' ' ' ASP . . . . . 0.64 ' C ' ' N ' ' A' ' 70' ' ' SER . 0.4 OUTLIER -75.12 51.15 0.51 Allowed 'General case' 0 N--CA 1.487 1.384 0 CA-C-O 122.645 1.212 . . . . 0.0 108.308 179.411 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 69' ' ' LYS . . . . . 0.453 ' H ' ' C ' ' A' ' 67' ' ' LYS . 1.9 ptpp? -49.19 -14.32 0.08 Allowed 'General case' 0 N--CA 1.501 2.121 0 C-N-CA 116.769 -1.972 . . . . 0.0 106.61 178.151 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 70' ' ' SER . . . . . 0.64 ' N ' ' C ' ' A' ' 68' ' ' ASP . 38.4 t -85.27 -7.2 59.13 Favored 'General case' 0 N--CA 1.495 1.824 0 CA-C-N 113.786 -1.552 . . . . 0.0 110.534 179.354 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 71' ' ' LYS . . . . . . . . . . . . . 0.9 OUTLIER -98.04 140.82 31.8 Favored 'General case' 0 N--CA 1.496 1.841 0 O-C-N 120.85 -1.156 . . . . 0.0 111.333 -179.745 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 1.0 OUTLIER -66.03 142.4 16.84 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.455 0 N-CA-C 105.319 -2.104 . . . . 0.0 105.319 174.989 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 73' ' ' ALA . . . . . 0.439 ' N ' ' O ' ' A' ' 87' ' ' VAL . . . -83.0 -15.31 51.68 Favored 'General case' 0 C--N 1.293 -1.854 0 N-CA-C 106.078 -1.823 . . . . 0.0 106.078 178.935 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 74' ' ' GLY . . . . . 0.483 ' C ' ' CD1' ' A' ' 75' ' ' TYR . . . 167.56 -150.6 17.2 Favored Glycine 0 N--CA 1.482 1.706 0 N-CA-C 109.38 -1.488 . . . . 0.0 109.38 179.172 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 75' ' ' TYR . . . . . 0.483 ' CD1' ' C ' ' A' ' 74' ' ' GLY . 25.7 m-85 -144.09 175.97 9.66 Favored 'General case' 0 C--N 1.296 -1.74 0 O-C-N 121.597 -0.943 . . . . 0.0 109.782 -178.839 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 76' ' ' ILE . . . . . . . . . . . . . 2.0 tt -150.37 147.65 15.81 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.797 0 N-CA-C 108.923 -0.769 . . . . 0.0 108.923 -178.261 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 4.6 mt-10 -148.67 162.03 40.55 Favored 'General case' 0 C--N 1.301 -1.541 0 O-C-N 121.044 -1.035 . . . . 0.0 109.322 179.845 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 78' ' ' ILE . . . . . 0.428 ' O ' ' N ' ' A' ' 82' ' ' ASP . 36.4 mt -144.24 93.27 5.98 Favored Pre-proline 0 N--CA 1.489 1.51 0 N-CA-C 108.385 -0.968 . . . . 0.0 108.385 -179.733 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 79' ' ' PRO . . . . . . . . . . . . . 74.0 Cg_exo -47.31 -46.84 18.81 Favored 'Trans proline' 0 N--CA 1.494 1.511 0 C-N-CA 122.855 2.37 . . . . 0.0 114.094 -178.598 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 53.8 t0 -65.3 -19.07 65.79 Favored 'General case' 0 N--CA 1.493 1.695 0 O-C-N 120.716 -1.24 . . . . 0.0 110.839 178.921 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 81' ' ' ALA . . . . . 0.51 ' O ' ' ND2' ' A' ' 132' ' ' ASN . . . -106.9 -17.87 14.08 Favored 'General case' 0 N--CA 1.494 1.745 0 O-C-N 121.114 -0.991 . . . . 0.0 108.792 179.527 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 82' ' ' ASP . . . . . 0.428 ' N ' ' O ' ' A' ' 78' ' ' ILE . 0.8 OUTLIER 69.3 50.69 0.54 Allowed 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.472 -0.768 . . . . 0.0 110.688 178.947 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 83' ' ' ILE . . . . . . . . . . . . . 64.1 mt -128.07 152.38 36.11 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.876 0 O-C-N 121.144 -0.972 . . . . 0.0 110.118 -179.247 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 84' ' ' LYS . . . . . . . . . . . . . 8.0 pttm -159.05 109.27 1.99 Allowed 'General case' 0 N--CA 1.49 1.561 0 N-CA-C 107.893 -1.151 . . . . 0.0 107.893 179.309 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 85' ' ' GLU . . . . . 0.436 ' OE2' ' O ' ' A' ' 129' ' ' GLN . 0.2 OUTLIER -140.48 170.99 8.4 Favored Pre-proline 0 N--CA 1.496 1.873 0 O-C-N 121.334 -0.854 . . . . 0.0 110.412 -178.684 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 86' ' ' PRO . . . . . 0.42 ' HA ' ' CD2' ' A' ' 75' ' ' TYR . 72.2 Cg_endo -81.72 159.66 18.99 Favored 'Trans proline' 0 N--CA 1.492 1.436 0 C-N-CA 123.08 2.52 . . . . 0.0 113.494 -179.594 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 87' ' ' VAL . . . . . 0.439 ' O ' ' N ' ' A' ' 73' ' ' ALA . 72.5 t -115.45 100.61 10.88 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.69 0 O-C-N 121.659 -0.651 . . . . 0.0 109.808 -179.842 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 88' ' ' TYR . . . . . . . . . . . . . 20.2 m-85 -92.42 154.14 42.74 Favored Pre-proline 0 N--CA 1.498 1.95 0 O-C-N 120.879 -1.138 . . . . 0.0 109.483 179.717 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 89' ' ' PRO . . . . . . . . . . . . . 9.7 Cg_endo -61.98 146.15 96.43 Favored 'Trans proline' 0 C--N 1.307 -1.65 0 C-N-CA 122.373 2.049 . . . . 0.0 113.504 -179.907 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . -55.15 165.97 3.15 Favored Glycine 0 N--CA 1.494 2.509 0 N-CA-C 108.826 -1.709 . . . . 0.0 108.826 179.008 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 91' ' ' PRO . . . . . 0.492 ' C ' ' H ' ' A' ' 93' ' ' THR . 65.6 Cg_endo -94.83 168.07 17.8 Favored 'Cis proline' 0 C--N 1.307 -1.627 0 C-N-CA 124.08 -1.216 . . . . 0.0 112.205 0.269 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 92' ' ' ALA . . . . . 0.403 ' CA ' ' HG ' ' A' ' 102' ' ' SER . . . -70.71 28.25 0.04 OUTLIER 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.411 -0.806 . . . . 0.0 110.793 -179.626 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 93' ' ' THR . . . . . 0.492 ' H ' ' C ' ' A' ' 91' ' ' PRO . 1.7 p -73.56 152.66 89.65 Favored Pre-proline 0 N--CA 1.491 1.596 0 O-C-N 120.716 -1.24 . . . . 0.0 109.246 -179.743 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 94' ' ' PRO . . . . . . . . . . . . . 88.9 Cg_exo -36.19 -42.07 0.59 Allowed 'Trans proline' 0 C--N 1.31 -1.497 0 C-N-CA 122.821 2.347 . . . . 0.0 112.335 -179.283 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 95' ' ' GLU . . . . . 0.565 ' H ' ' CD ' ' A' ' 95' ' ' GLU . 0.1 OUTLIER -53.18 -53.98 42.61 Favored 'General case' 0 C--N 1.301 -1.507 0 O-C-N 121.254 -0.904 . . . . 0.0 109.302 179.756 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 96' ' ' GLN . . . . . 0.592 ' O ' ' N ' ' A' ' 98' ' ' ASN . 29.7 mm100 -73.64 -51.87 15.3 Favored 'General case' 0 N--CA 1.487 1.389 0 O-C-N 121.155 -0.966 . . . . 0.0 109.77 179.593 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 97' ' ' LEU . . . . . . . . . . . . . 1.4 mp -46.25 -11.06 0.02 OUTLIER 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.416 -0.802 . . . . 0.0 109.741 -179.336 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 98' ' ' ASN . . . . . 0.61 HD22 ' HE ' ' A' ' 99' ' ' ARG . 0.0 OUTLIER -75.28 -23.42 57.4 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.197 -0.939 . . . . 0.0 110.005 -179.815 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 99' ' ' ARG . . . . . 0.61 ' HE ' HD22 ' A' ' 98' ' ' ASN . 7.7 mtt180 -103.19 -54.01 2.7 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.435 -0.79 . . . . 0.0 110.28 -178.88 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . -169.98 179.15 42.46 Favored Glycine 0 N--CA 1.492 2.41 0 C-N-CA 119.273 -1.442 . . . . 0.0 110.298 -179.834 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 101' ' ' VAL . . . . . 0.452 ' CG1' ' CE2' ' A' ' 130' ' ' PHE . 31.7 m -53.06 111.75 0.29 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.601 0 O-C-N 121.556 -0.967 . . . . 0.0 109.222 179.787 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 102' ' ' SER . . . . . 0.403 ' HG ' ' CA ' ' A' ' 92' ' ' ALA . 0.0 OUTLIER -92.29 168.0 11.63 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.315 -0.866 . . . . 0.0 111.288 -179.155 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 103' ' ' PHE . . . . . 0.602 ' O ' ' N ' ' A' ' 105' ' ' GLU . 25.0 m-85 -69.64 120.79 15.95 Favored 'General case' 0 N--CA 1.488 1.439 0 N-CA-C 108.031 -1.1 . . . . 0.0 108.031 178.263 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 104' ' ' ALA . . . . . . . . . . . . . . . -41.09 -16.2 0.01 OUTLIER 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.686 -0.634 . . . . 0.0 111.066 -178.515 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 105' ' ' GLU . . . . . 0.602 ' N ' ' O ' ' A' ' 103' ' ' PHE . 0.4 OUTLIER -139.3 147.58 41.82 Favored 'General case' 0 N--CA 1.494 1.729 0 O-C-N 120.861 -1.149 . . . . 0.0 110.56 179.852 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 106' ' ' GLU . . . . . . . . . . . . . 16.2 tt0 -58.09 -63.9 1.1 Allowed 'General case' 0 C--N 1.302 -1.487 0 CA-C-N 116.113 -0.494 . . . . 0.0 110.863 -179.178 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 107' ' ' ASN . . . . . . . . . . . . . 11.1 m120 -78.02 33.29 0.18 Allowed 'General case' 0 N--CA 1.491 1.621 0 O-C-N 120.501 -1.374 . . . . 0.0 113.342 -175.318 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 108' ' ' GLU . . . . . 0.48 ' OE1' ' OE2' ' A' ' 105' ' ' GLU . 26.9 tp10 -59.73 150.5 27.69 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 120.426 -1.421 . . . . 0.0 107.856 179.681 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 109' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -101.19 144.21 30.34 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 120.986 -1.072 . . . . 0.0 111.099 -178.169 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 110' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -62.63 -22.86 66.74 Favored 'General case' 0 C--N 1.303 -1.433 0 N-CA-C 108.684 -0.858 . . . . 0.0 108.684 179.214 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 111' ' ' ASP . . . . . . . . . . . . . 64.0 m-20 -132.04 40.36 3.35 Favored 'General case' 0 N--CA 1.487 1.376 0 O-C-N 121.642 -0.662 . . . . 0.0 109.426 -179.687 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 112' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -68.53 152.42 45.41 Favored 'General case' 0 C--N 1.299 -1.591 0 O-C-N 121.266 -0.896 . . . . 0.0 110.439 179.906 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 113' ' ' GLN . . . . . 0.433 ' HA ' ' NE2' ' A' ' 113' ' ' GLN . 1.0 OUTLIER -66.21 -13.78 60.86 Favored 'General case' 0 C--N 1.301 -1.525 0 N-CA-C 108.104 -1.073 . . . . 0.0 108.104 178.153 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 114' ' ' ASN . . . . . 0.492 ' OD1' ' O ' ' A' ' 169' ' ' LEU . 1.3 t-20 -151.58 102.27 2.86 Favored 'General case' 0 N--CA 1.489 1.515 0 N-CA-C 108.171 -1.048 . . . . 0.0 108.171 179.126 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 115' ' ' ILE . . . . . . . . . . . . . 3.1 mt -98.75 112.67 31.45 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.511 0 O-C-N 121.199 -0.938 . . . . 0.0 109.435 -179.772 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 116' ' ' SER . . . . . . . . . . . . . 44.1 m -98.56 143.91 28.45 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.316 -0.865 . . . . 0.0 111.338 -178.569 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 117' ' ' ILE . . . . . . . . . . . . . 1.6 mt -135.87 155.94 36.62 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.625 0 N-CA-C 108.111 -1.07 . . . . 0.0 108.111 178.764 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 118' ' ' ALA . . . . . . . . . . . . . . . -142.03 159.83 41.45 Favored 'General case' 0 N--CA 1.493 1.687 0 O-C-N 120.838 -1.163 . . . . 0.0 111.609 -178.967 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 119' ' ' GLY . . . . . . . . . . . . . . . -167.46 146.51 10.75 Favored Glycine 0 N--CA 1.49 2.235 0 C-N-CA 120.206 -0.997 . . . . 0.0 110.774 179.594 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 120' ' ' HIS . . . . . 0.551 ' CD2' ' SG ' ' C' ' 705' ' ' B27 . 27.7 m170 -70.96 167.7 18.56 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.638 -0.919 . . . . 0.0 109.251 178.964 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 121' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -122.62 157.26 32.57 Favored 'General case' 0 N--CA 1.495 1.788 0 N-CA-C 108.552 -0.907 . . . . 0.0 108.552 179.105 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 122' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -122.03 124.25 43.53 Favored 'General case' 0 N--CA 1.495 1.798 0 O-C-N 121.205 -0.935 . . . . 0.0 109.923 -179.754 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 123' ' ' ILE . . . . . . . . . . . . . 11.4 tt -72.96 -35.18 48.15 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.713 0 CA-C-O 121.69 0.757 . . . . 0.0 109.718 -179.923 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 124' ' ' ASP . . . . . . . . . . . . . 52.0 m-20 -90.6 8.29 34.91 Favored 'General case' 0 C--N 1.294 -1.814 0 C-N-CA 120.154 -0.618 . . . . 0.0 111.501 -178.928 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 125' ' ' ARG . . . . . . . . . . . . . 6.4 mtp180 -152.6 113.52 2.79 Favored Pre-proline 0 N--CA 1.495 1.823 0 O-C-N 120.474 -1.391 . . . . 0.0 110.531 -179.64 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 126' ' ' PRO . . . . . . . . . . . . . 78.8 Cg_endo -82.61 -16.9 7.65 Favored 'Trans proline' 0 N--CA 1.488 1.199 0 C-N-CA 122.436 2.091 . . . . 0.0 112.303 178.965 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 127' ' ' ASN . . . . . . . . . . . . . 83.8 m-20 -89.76 6.83 39.87 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.098 -1.001 . . . . 0.0 109.675 -179.885 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 128' ' ' TYR . . . . . . . . . . . . . 7.0 t80 -62.36 -148.86 0.0 OUTLIER 'General case' 0 N--CA 1.489 1.477 0 O-C-N 121.258 -0.901 . . . . 0.0 109.686 -179.975 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 129' ' ' GLN . . . . . 0.436 ' O ' ' OE2' ' A' ' 85' ' ' GLU . 17.6 mt-30 -67.88 -88.47 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.303 -0.873 . . . . 0.0 110.355 -179.149 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 130' ' ' PHE . . . . . 0.452 ' CE2' ' CG1' ' A' ' 101' ' ' VAL . 30.4 m-85 -110.88 37.26 2.85 Favored 'General case' 0 N--CA 1.494 1.77 0 O-C-N 121.326 -0.859 . . . . 0.0 110.303 -179.054 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 131' ' ' THR . . . . . . . . . . . . . 37.0 m -77.08 -31.69 56.2 Favored 'General case' 0 N--CA 1.489 1.486 0 O-C-N 121.045 -1.034 . . . . 0.0 109.464 179.701 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 132' ' ' ASN . . . . . 0.51 ' ND2' ' O ' ' A' ' 81' ' ' ALA . 3.9 t30 -83.78 7.01 19.18 Favored 'General case' 0 N--CA 1.498 1.968 0 O-C-N 121.387 -0.821 . . . . 0.0 111.033 -179.223 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 133' ' ' LEU . . . . . 0.597 ' O ' ' N ' ' A' ' 135' ' ' ALA . 0.2 OUTLIER -70.21 -45.25 66.97 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 120.971 -1.081 . . . . 0.0 110.218 -179.274 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 134' ' ' LYS . . . . . 0.72 ' NZ ' ' HG1' ' A' ' 183' ' ' THR . 0.2 OUTLIER -41.49 -18.98 0.01 OUTLIER 'General case' 0 N--CA 1.496 1.83 0 O-C-N 121.053 -1.029 . . . . 0.0 110.227 -179.212 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 135' ' ' ALA . . . . . 0.597 ' N ' ' O ' ' A' ' 133' ' ' LEU . . . -85.21 -31.49 23.15 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.082 -1.011 . . . . 0.0 110.038 179.854 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 136' ' ' ALA . . . . . 0.475 ' N ' ' O ' ' A' ' 133' ' ' LEU . . . -80.46 152.56 28.7 Favored 'General case' 0 N--CA 1.491 1.613 0 CA-C-O 122.055 0.931 . . . . 0.0 111.758 -178.437 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 137' ' ' LYS . . . . . 0.496 ' O ' ' O ' ' A' ' 138' ' ' LYS . 24.4 mtmt -151.63 -166.03 2.4 Favored 'General case' 0 N--CA 1.493 1.695 0 C-N-CA 118.597 -1.241 . . . . 0.0 111.004 -178.247 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 138' ' ' LYS . . . . . 0.598 ' O ' ' N ' ' A' ' 140' ' ' SER . 1.1 ptpt -45.21 178.71 0.0 OUTLIER 'General case' 0 C--N 1.305 -1.359 0 CA-C-O 122.127 0.965 . . . . 0.0 110.73 -179.074 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 139' ' ' GLY . . . . . . . . . . . . . . . 46.22 8.1 0.02 OUTLIER Glycine 0 N--CA 1.489 2.199 0 N-CA-C 110.407 -1.077 . . . . 0.0 110.407 179.98 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 140' ' ' SER . . . . . 0.598 ' N ' ' O ' ' A' ' 138' ' ' LYS . 13.3 t -80.55 146.21 31.4 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 120.845 -1.385 . . . . 0.0 109.514 179.366 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 141' ' ' MET . . . . . . . . . . . . . 4.6 tpt -93.46 121.16 34.57 Favored 'General case' 0 C--N 1.3 -1.561 0 O-C-N 121.343 -0.848 . . . . 0.0 108.849 179.409 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 142' ' ' VAL . . . . . . . . . . . . . 12.8 t -112.13 130.03 66.55 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.626 0 O-C-N 121.34 -0.85 . . . . 0.0 109.016 -179.396 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 143' ' ' TYR . . . . . . . . . . . . . 3.5 m-85 -109.16 135.55 50.1 Favored 'General case' 0 N--CA 1.499 1.976 0 O-C-N 121.141 -0.974 . . . . 0.0 111.859 -178.252 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 144' ' ' PHE . . . . . . . . . . . . . 57.8 t80 -120.61 102.06 8.17 Favored 'General case' 0 N--CA 1.494 1.744 0 CA-C-O 121.302 0.572 . . . . 0.0 110.272 -179.407 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 145' ' ' LYS . . . . . . . . . . . . . 23.1 tttt -93.8 122.4 36.23 Favored 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.331 -0.856 . . . . 0.0 109.602 179.799 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 146' ' ' VAL . . . . . . . . . . . . . 7.1 p -142.39 118.47 5.91 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.671 0 O-C-N 121.185 -0.947 . . . . 0.0 109.18 179.752 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 147' ' ' GLY . . . . . . . . . . . . . . . 75.61 -135.8 18.85 Favored Glycine 0 N--CA 1.488 2.132 0 N-CA-C 108.386 -1.885 . . . . 0.0 108.386 -179.094 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 148' ' ' ASN . . . . . 0.566 ' C ' HD21 ' A' ' 148' ' ' ASN . 0.3 OUTLIER -103.47 14.27 31.7 Favored 'General case' 0 C--N 1.298 -1.659 0 N-CA-C 107.907 -1.146 . . . . 0.0 107.907 178.813 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 149' ' ' GLU . . . . . . . . . . . . . 47.9 tt0 -116.26 153.23 32.27 Favored 'General case' 0 N--CA 1.486 1.361 0 CA-C-O 121.987 0.898 . . . . 0.0 110.639 -179.466 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 150' ' ' THR . . . . . . . . . . . . . 86.5 m -130.44 107.29 9.12 Favored 'General case' 0 N--CA 1.494 1.747 0 CA-C-O 121.336 0.589 . . . . 0.0 109.938 -179.701 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 151' ' ' ARG . . . . . 0.449 HH11 ' CG ' ' A' ' 151' ' ' ARG . 0.4 OUTLIER -87.28 -171.03 3.29 Favored 'General case' 0 N--CA 1.487 1.38 0 N-CA-C 108.641 -0.874 . . . . 0.0 108.641 179.826 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 152' ' ' LYS . . . . . 0.467 ' O ' ' N ' ' A' ' 205' ' ' VAL . 20.4 mtpt -148.21 149.04 31.22 Favored 'General case' 0 C--N 1.299 -1.605 0 O-C-N 121.153 -0.967 . . . . 0.0 109.841 -179.694 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 153' ' ' TYR . . . . . 0.495 ' CD2' ' HA ' ' A' ' 204' ' ' GLU . 23.2 m-85 -139.98 164.57 29.65 Favored 'General case' 0 C--N 1.302 -1.481 0 N-CA-C 108.107 -1.072 . . . . 0.0 108.107 179.86 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 154' ' ' LYS . . . . . . . . . . . . . 26.2 ttpt -142.44 119.27 11.19 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.143 -0.973 . . . . 0.0 109.006 179.517 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 155' ' ' MET . . . . . . . . . . . . . 19.5 mmt -46.01 105.96 0.07 Allowed 'General case' 0 N--CA 1.494 1.737 0 O-C-N 120.846 -1.159 . . . . 0.0 112.198 -178.63 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 156' ' ' THR . . . . . . . . . . . . . 4.4 m -108.6 -22.47 12.25 Favored 'General case' 0 C--N 1.297 -1.71 0 C-N-CA 119.897 -0.721 . . . . 0.0 109.666 179.709 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 157' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -144.56 141.02 29.17 Favored 'General case' 0 N--CA 1.492 1.642 0 C-N-CA 118.781 -1.167 . . . . 0.0 109.835 -178.742 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 158' ' ' ILE . . . . . . . . . . . . . 37.2 mt -148.02 134.25 12.42 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.372 0 CA-C-O 121.602 0.715 . . . . 0.0 109.82 -178.147 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 159' ' ' ARG . . . . . . . . . . . . . 3.9 ptm180 -154.63 -175.68 5.53 Favored 'General case' 0 C--N 1.297 -1.711 0 C-N-CA 119.486 -0.886 . . . . 0.0 110.536 -179.763 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 160' ' ' ASP . . . . . 0.405 ' C ' ' CG2' ' A' ' 161' ' ' VAL . 5.3 m-20 -146.48 165.1 30.42 Favored 'General case' 0 N--CA 1.488 1.452 0 N-CA-C 108.336 -0.987 . . . . 0.0 108.336 179.979 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 161' ' ' VAL . . . . . 0.405 ' CG2' ' C ' ' A' ' 160' ' ' ASP . 0.1 OUTLIER -170.1 163.28 0.45 Allowed 'Isoleucine or valine' 0 N--CA 1.494 1.768 0 O-C-N 120.909 -1.12 . . . . 0.0 110.281 179.842 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 162' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -49.47 171.23 0.12 Allowed Pre-proline 0 N--CA 1.488 1.473 0 O-C-N 121.599 -0.688 . . . . 0.0 109.39 179.271 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 163' ' ' PRO . . . . . . . . . . . . . 60.5 Cg_endo -79.21 38.65 0.74 Allowed 'Trans proline' 0 C--N 1.307 -1.618 0 C-N-CA 122.615 2.21 . . . . 0.0 112.49 -179.909 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 164' ' ' THR . . . . . . . . . . . . . 86.0 m -151.88 -8.82 0.21 Allowed 'General case' 0 N--CA 1.494 1.762 0 O-C-N 121.126 -0.984 . . . . 0.0 110.925 -179.732 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 165' ' ' ASP . . . . . 0.437 ' O ' ' C ' ' A' ' 166' ' ' VAL . 17.8 t70 -72.85 61.86 0.57 Allowed 'General case' 0 N--CA 1.494 1.755 0 O-C-N 120.764 -1.21 . . . . 0.0 110.235 -179.351 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 166' ' ' VAL . . . . . 0.61 ' O ' ' N ' ' A' ' 168' ' ' VAL . 1.5 m -39.91 -33.06 0.23 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.65 0 O-C-N 121.408 -0.808 . . . . 0.0 109.692 -178.587 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 167' ' ' GLY . . . . . 0.404 ' C ' ' O ' ' A' ' 166' ' ' VAL . . . -43.07 -13.84 0.01 OUTLIER Glycine 0 N--CA 1.495 2.579 0 O-C-N 120.918 -1.114 . . . . 0.0 110.823 -179.802 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 168' ' ' VAL . . . . . 0.671 ' C ' ' H ' ' A' ' 170' ' ' ASP . 4.8 m -53.34 -36.27 26.25 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.583 0 O-C-N 120.768 -1.43 . . . . 0.0 108.726 179.709 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 169' ' ' LEU . . . . . 0.544 ' O ' ' N ' ' A' ' 171' ' ' GLU . 34.4 mt -51.08 -4.6 0.02 OUTLIER 'General case' 0 N--CA 1.494 1.772 0 N-CA-C 108.117 -1.068 . . . . 0.0 108.117 -179.602 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 170' ' ' ASP . . . . . 0.671 ' H ' ' C ' ' A' ' 168' ' ' VAL . 4.1 m-20 33.41 28.92 0.0 OUTLIER 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.685 -0.634 . . . . 0.0 112.228 177.185 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 171' ' ' GLU . . . . . 0.544 ' N ' ' O ' ' A' ' 169' ' ' LEU . 11.2 pt-20 -67.31 94.46 0.38 Allowed 'General case' 0 N--CA 1.491 1.589 0 O-C-N 120.598 -1.314 . . . . 0.0 107.703 178.376 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 172' ' ' GLN . . . . . . . . . . . . . 0.7 OUTLIER -159.04 -72.75 0.08 Allowed 'General case' 0 N--CA 1.493 1.716 0 O-C-N 121.637 -0.665 . . . . 0.0 109.538 -179.449 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 173' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -62.15 127.07 29.62 Favored 'General case' 0 N--CA 1.492 1.668 0 O-C-N 121.265 -0.897 . . . . 0.0 109.195 179.627 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 174' ' ' GLY . . . . . 0.564 ' O ' ' C ' ' A' ' 175' ' ' LYS . . . -118.24 -39.06 0.76 Allowed Glycine 0 N--CA 1.482 1.733 0 N-CA-C 108.623 -1.791 . . . . 0.0 108.623 179.368 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 175' ' ' LYS . . . . . 0.564 ' C ' ' O ' ' A' ' 174' ' ' GLY . 0.0 OUTLIER -32.54 -62.97 0.22 Allowed 'General case' 0 N--CA 1.498 1.952 0 N-CA-C 108.492 -0.929 . . . . 0.0 108.492 179.822 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 176' ' ' ASP . . . . . 0.66 ' O ' ' O ' ' A' ' 177' ' ' LYS . 5.5 m-20 -103.09 87.01 2.8 Favored 'General case' 0 C--N 1.297 -1.712 0 N-CA-C 106.759 -1.571 . . . . 0.0 106.759 176.914 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 177' ' ' LYS . . . . . 0.66 ' O ' ' O ' ' A' ' 176' ' ' ASP . 12.9 mttt -37.28 176.04 0.0 OUTLIER 'General case' 0 N--CA 1.498 1.942 0 CA-C-O 121.762 0.791 . . . . 0.0 110.541 -178.703 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 178' ' ' GLN . . . . . 0.429 HE22 ' CB ' ' A' ' 170' ' ' ASP . 17.0 pt20 -159.59 171.07 20.3 Favored 'General case' 0 C--N 1.302 -1.459 0 C-N-CA 118.075 -1.45 . . . . 0.0 111.582 -179.867 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 179' ' ' LEU . . . . . . . . . . . . . 1.2 tp -127.02 95.17 4.23 Favored 'General case' 0 C--N 1.303 -1.443 0 N-CA-C 107.412 -1.329 . . . . 0.0 107.412 178.127 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 180' ' ' THR . . . . . . . . . . . . . 1.3 m -71.7 121.26 18.54 Favored 'General case' 0 N--CA 1.489 1.502 0 C-N-CA 119.217 -0.993 . . . . 0.0 110.213 -178.571 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 181' ' ' LEU . . . . . 0.406 HD13 ' H ' ' A' ' 182' ' ' ILE . 49.7 tp -96.24 147.72 23.48 Favored 'General case' 0 C--N 1.297 -1.693 0 N-CA-C 108.342 -0.984 . . . . 0.0 108.342 178.308 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 182' ' ' ILE . . . . . 0.406 ' H ' HD13 ' A' ' 181' ' ' LEU . 2.0 mt -138.73 115.09 10.19 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.578 0 N-CA-C 108.245 -1.02 . . . . 0.0 108.245 178.732 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 183' ' ' THR . . . . . 0.72 ' HG1' ' NZ ' ' A' ' 134' ' ' LYS . 0.0 OUTLIER -137.02 112.56 9.35 Favored 'General case' 0 C--N 1.293 -1.889 0 N-CA-C 107.265 -1.383 . . . . 0.0 107.265 179.364 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 184' ' ' CYS . . . . . 0.445 ' HB3' HH12 ' A' ' 197' ' ' ARG . 0.8 OUTLIER -78.69 163.71 25.2 Favored 'General case' 0 C--N 1.292 -1.918 0 C-N-CA 119.514 -0.874 . . . . 0.0 111.653 -177.14 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 185' ' ' ASP . . . . . . . . . . . . . 18.9 t0 -166.36 -159.4 0.37 Allowed 'General case' 0 N--CA 1.489 1.509 0 N-CA-C 109.205 -0.665 . . . . 0.0 109.205 -179.944 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 186' ' ' ASP . . . . . . . . . . . . . 1.3 m-20 53.84 59.62 4.17 Favored 'General case' 0 N--CA 1.493 1.724 0 O-C-N 121.121 -0.987 . . . . 0.0 109.546 179.933 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 187' ' ' TYR . . . . . 0.608 ' CE1' ' O ' ' A' ' 188' ' ' ASN . 57.0 t80 -67.67 137.77 55.81 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.319 -0.863 . . . . 0.0 110.398 -179.708 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 188' ' ' ASN . . . . . 0.608 ' O ' ' CE1' ' A' ' 187' ' ' TYR . 0.8 OUTLIER -104.41 145.02 30.86 Favored 'General case' 0 C--N 1.298 -1.672 0 N-CA-C 108.255 -1.017 . . . . 0.0 108.255 178.617 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 189' ' ' GLU . . . . . . . . . . . . . 1.4 tt0 -110.57 -13.17 14.27 Favored 'General case' 0 C--N 1.296 -1.744 0 N-CA-C 108.818 -0.808 . . . . 0.0 108.818 -179.36 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 190' ' ' LYS . . . . . . . . . . . . . 29.1 mttt -82.8 -53.66 5.72 Favored 'General case' 0 C--N 1.302 -1.496 0 N-CA-C 108.714 -0.847 . . . . 0.0 108.714 178.873 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 191' ' ' THR . . . . . . . . . . . . . 1.1 p -90.09 -10.76 43.53 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.517 -0.739 . . . . 0.0 109.194 179.714 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 192' ' ' GLY . . . . . . . . . . . . . . . 65.77 40.75 95.83 Favored Glycine 0 N--CA 1.495 2.59 0 N-CA-C 110.637 -0.985 . . . . 0.0 110.637 178.914 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 193' ' ' VAL . . . . . . . . . . . . . 64.8 t -147.63 161.61 7.55 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.641 0 O-C-N 121.023 -1.281 . . . . 0.0 109.565 179.487 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 194' ' ' TRP . . . . . 0.49 ' N ' ' CD1' ' A' ' 194' ' ' TRP . 19.4 m95 -83.71 118.42 23.87 Favored 'General case' 0 C--N 1.301 -1.537 0 N-CA-C 107.901 -1.148 . . . . 0.0 107.901 179.082 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 195' ' ' GLU . . . . . 0.551 ' CD ' ' ND2' ' A' ' 188' ' ' ASN . 2.3 mt-10 -85.17 -60.86 1.91 Allowed 'General case' 0 N--CA 1.492 1.665 0 O-C-N 121.241 -0.912 . . . . 0.0 111.112 -177.941 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 196' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER -78.63 149.18 32.96 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 120.935 -1.103 . . . . 0.0 109.731 -179.315 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 197' ' ' ARG . . . . . 0.581 ' CG ' HH11 ' A' ' 197' ' ' ARG . 0.0 OUTLIER -128.06 136.92 51.88 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.492 -0.755 . . . . 0.0 109.129 179.84 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 198' ' ' LYS . . . . . . . . . . . . . 2.3 mtmm -115.03 121.87 44.45 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.756 -0.59 . . . . 0.0 110.676 -178.623 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 199' ' ' ILE . . . . . 0.417 ' O ' ' CG1' ' A' ' 199' ' ' ILE . 0.9 OUTLIER -139.57 117.89 11.79 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.586 0 CA-C-O 122.477 1.132 . . . . 0.0 109.842 179.419 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 200' ' ' PHE . . . . . 0.526 ' CD1' ' N ' ' A' ' 200' ' ' PHE . 5.0 m-85 -98.88 136.11 39.35 Favored 'General case' 0 N--CA 1.498 1.948 0 O-C-N 121.322 -0.861 . . . . 0.0 110.262 -177.914 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 201' ' ' VAL . . . . . . . . . . . . . 24.2 t -105.12 141.33 20.72 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.76 0 O-C-N 121.032 -1.043 . . . . 0.0 108.777 178.13 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 202' ' ' ALA . . . . . . . . . . . . . . . -131.17 137.44 48.99 Favored 'General case' 0 C--N 1.3 -1.545 0 N-CA-C 108.429 -0.952 . . . . 0.0 108.429 179.874 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 203' ' ' THR . . . . . . . . . . . . . 2.5 t -88.41 136.06 33.17 Favored 'General case' 0 N--CA 1.489 1.515 0 CA-C-O 122.116 0.96 . . . . 0.0 110.568 -179.177 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 204' ' ' GLU . . . . . 0.495 ' HA ' ' CD2' ' A' ' 153' ' ' TYR . 0.8 OUTLIER -53.66 136.22 39.56 Favored 'General case' 0 C--N 1.295 -1.799 0 C-N-CA 118.133 -1.427 . . . . 0.0 108.706 179.014 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 205' ' ' VAL . . . . . 0.497 ' CG1' ' N ' ' A' ' 206' ' ' LYS . 77.7 t -129.99 166.41 27.66 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.34 0 CA-C-O 121.97 0.89 . . . . 0.0 110.063 -177.893 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 206' ' ' LYS . . . . . 0.497 ' N ' ' CG1' ' A' ' 205' ' ' VAL . 9.1 ptmt . . . . . 0 C--N 1.296 -1.752 0 CA-C-O 118.034 -0.984 . . . . 0.0 109.429 -179.836 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' C' C ' 701' ' ' PHQ . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 005 nuclear orig full ' C' C ' 702' ' ' LEU . . . . . 0.46 ' CD1' ' H ' ' C' ' 702' ' ' LEU . 0.1 OUTLIER . . . . . 0 N--CA 1.49 1.56 0 N-CA-C 108.757 -0.831 . . . . 0.0 108.757 . . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' C' C ' 703' ' ' PRO . . . . . . . . . . . . . 29.4 Cg_endo -66.39 -162.92 0.06 OUTLIER 'Trans proline' 0 N--CA 1.495 1.581 0 C-N-CA 122.59 2.194 . . . . 0.0 112.783 -179.224 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' C' C ' 704' ' ' ALA . . . . . . . . . . . . . . . 60.25 161.04 0.05 OUTLIER 'General case' 0 N--CA 1.488 1.456 0 O-C-N 121.476 -0.765 . . . . 0.0 109.356 -179.865 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' C' C ' 705' ' ' B27 . . . . . 0.551 ' SG ' ' CD2' ' A' ' 120' ' ' HIS . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 700' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 006 nuclear orig full ' A' A ' 59' ' ' MET . . . . . 0.547 ' N ' ' SD ' ' A' ' 59' ' ' MET . 1.9 mpt? . . . . . 0 N--CA 1.49 1.558 0 N-CA-C 109.444 -0.576 . . . . 0.0 109.444 . . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 60' ' ' GLN . . . . . . . . . . . . . 1.9 tp60 -60.37 148.34 37.5 Favored 'General case' 0 N--CA 1.488 1.452 0 O-C-N 121.227 -0.92 . . . . 0.0 109.265 -179.978 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . -64.15 179.06 0.59 Allowed 'General case' 0 N--CA 1.488 1.457 0 O-C-N 121.238 -0.913 . . . . 0.0 109.679 -179.907 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 62' ' ' LYS . . . . . . . . . . . . . 2.7 pttm -150.64 83.14 5.92 Favored Pre-proline 0 N--CA 1.489 1.522 0 O-C-N 121.339 -0.851 . . . . 0.0 109.757 -179.843 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 63' ' ' PRO . . . . . . . . . . . . . 9.9 Cg_endo -80.0 144.18 16.71 Favored 'Trans proline' 0 C--N 1.304 -1.802 0 C-N-CA 122.556 2.171 . . . . 0.0 111.15 179.501 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 64' ' ' GLN . . . . . 0.682 ' NE2' ' N ' ' A' ' 64' ' ' GLN . 0.0 OUTLIER -154.85 118.58 4.58 Favored 'General case' 0 N--CA 1.494 1.728 0 O-C-N 121.231 -0.918 . . . . 0.0 109.553 179.857 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 65' ' ' ILE . . . . . 0.401 HD11 ' H ' ' A' ' 65' ' ' ILE . 3.1 mp -46.58 106.4 0.57 Allowed Pre-proline 0 C--N 1.3 -1.548 0 O-C-N 121.316 -0.865 . . . . 0.0 108.773 179.197 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 66' ' ' PRO . . . . . . . . . . . . . 67.5 Cg_endo -86.51 -157.68 0.08 OUTLIER 'Trans proline' 0 C--N 1.314 -1.285 0 C-N-CA 122.487 2.125 . . . . 0.0 112.401 -179.224 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 67' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -82.88 -4.87 58.65 Favored 'General case' 0 C--N 1.302 -1.473 0 N-CA-C 108.838 -0.801 . . . . 0.0 108.838 179.528 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 68' ' ' ASP . . . . . 0.635 ' C ' ' N ' ' A' ' 70' ' ' SER . 0.3 OUTLIER -74.82 52.45 0.53 Allowed 'General case' 0 N--CA 1.488 1.425 0 CA-C-O 122.726 1.251 . . . . 0.0 108.444 179.492 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 69' ' ' LYS . . . . . 0.445 ' C ' ' O ' ' A' ' 68' ' ' ASP . 21.0 mtmt -49.48 -13.94 0.09 Allowed 'General case' 0 N--CA 1.502 2.173 0 C-N-CA 116.798 -1.961 . . . . 0.0 106.551 177.94 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 70' ' ' SER . . . . . 0.635 ' N ' ' C ' ' A' ' 68' ' ' ASP . 0.1 OUTLIER -85.48 -6.56 59.18 Favored 'General case' 0 N--CA 1.493 1.68 0 CA-C-N 113.508 -1.678 . . . . 0.0 110.601 179.285 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 71' ' ' LYS . . . . . 0.409 ' HZ1' ' HA ' ' A' ' 73' ' ' ALA . 2.0 ptmm? -101.2 144.62 29.84 Favored 'General case' 0 N--CA 1.498 1.942 0 O-C-N 120.863 -1.148 . . . . 0.0 111.888 -179.395 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 72' ' ' VAL . . . . . 0.602 ' CG2' ' O ' ' A' ' 74' ' ' GLY . 0.7 OUTLIER -67.26 132.95 32.16 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.364 0 N-CA-C 105.49 -2.041 . . . . 0.0 105.49 174.363 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 73' ' ' ALA . . . . . 0.409 ' HA ' ' HZ1' ' A' ' 71' ' ' LYS . . . -83.77 -13.78 53.07 Favored 'General case' 0 C--N 1.297 -1.71 0 O-C-N 120.026 -1.671 . . . . 0.0 108.618 -179.183 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 74' ' ' GLY . . . . . 0.602 ' O ' ' CG2' ' A' ' 72' ' ' VAL . . . 173.29 -159.63 29.83 Favored Glycine 0 N--CA 1.487 2.086 0 N-CA-C 109.459 -1.456 . . . . 0.0 109.459 -179.805 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 75' ' ' TYR . . . . . . . . . . . . . 81.1 m-85 -140.12 169.9 16.83 Favored 'General case' 0 C--N 1.297 -1.689 0 O-C-N 121.02 -1.282 . . . . 0.0 111.354 -178.334 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 76' ' ' ILE . . . . . . . . . . . . . 1.3 tp -145.9 138.72 20.63 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.605 0 C-N-CA 119.376 -0.93 . . . . 0.0 109.235 -176.165 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -149.46 162.53 39.94 Favored 'General case' 0 C--N 1.302 -1.474 0 O-C-N 120.899 -1.126 . . . . 0.0 109.804 -179.606 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 78' ' ' ILE . . . . . 0.419 ' O ' ' N ' ' A' ' 82' ' ' ASP . 4.5 mt -147.74 99.54 3.79 Favored Pre-proline 0 N--CA 1.488 1.455 0 N-CA-C 108.421 -0.955 . . . . 0.0 108.421 179.879 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 79' ' ' PRO . . . . . . . . . . . . . 52.6 Cg_exo -49.81 -45.76 30.64 Favored 'Trans proline' 0 N--CA 1.493 1.483 0 C-N-CA 122.57 2.18 . . . . 0.0 113.464 -178.826 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 7.9 m-20 -66.04 -19.65 65.92 Favored 'General case' 0 N--CA 1.492 1.656 0 O-C-N 120.944 -1.098 . . . . 0.0 110.924 178.81 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 81' ' ' ALA . . . . . 0.602 ' O ' ' ND2' ' A' ' 132' ' ' ASN . . . -105.01 -16.55 14.78 Favored 'General case' 0 N--CA 1.494 1.754 0 O-C-N 121.093 -1.005 . . . . 0.0 108.46 179.329 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 82' ' ' ASP . . . . . 0.419 ' N ' ' O ' ' A' ' 78' ' ' ILE . 0.6 OUTLIER 66.22 50.58 1.35 Allowed 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.385 -0.822 . . . . 0.0 110.434 179.191 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 83' ' ' ILE . . . . . 0.506 ' CD1' ' OD1' ' A' ' 132' ' ' ASN . 62.0 mt -129.42 151.97 36.59 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.788 0 O-C-N 121.09 -1.006 . . . . 0.0 110.481 -178.848 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 84' ' ' LYS . . . . . 0.491 ' N ' ' OE2' ' A' ' 85' ' ' GLU . 9.2 tttm -159.15 109.59 1.99 Allowed 'General case' 0 N--CA 1.487 1.38 0 N-CA-C 108.08 -1.081 . . . . 0.0 108.08 179.777 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 85' ' ' GLU . . . . . 0.491 ' OE2' ' N ' ' A' ' 84' ' ' LYS . 0.7 OUTLIER -144.05 171.85 6.26 Favored Pre-proline 0 N--CA 1.495 1.811 0 C-N-CA 119.858 -0.737 . . . . 0.0 109.874 -179.491 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 86' ' ' PRO . . . . . . . . . . . . . 68.7 Cg_endo -91.0 148.95 3.82 Favored 'Trans proline' 0 N--CA 1.488 1.19 0 C-N-CA 123.126 2.551 . . . . 0.0 112.963 -179.751 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 87' ' ' VAL . . . . . 0.428 ' CG2' ' C ' ' A' ' 74' ' ' GLY . 0.0 OUTLIER -104.91 106.03 19.72 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.576 0 N-CA-C 108.619 -0.882 . . . . 0.0 108.619 178.669 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 88' ' ' TYR . . . . . . . . . . . . . 13.7 m-85 -87.55 135.0 34.73 Favored Pre-proline 0 N--CA 1.492 1.648 0 O-C-N 120.95 -1.094 . . . . 0.0 110.37 -178.964 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 89' ' ' PRO . . . . . . . . . . . . . 20.2 Cg_exo -34.34 138.15 0.1 OUTLIER 'Trans proline' 0 N--CA 1.49 1.291 0 C-N-CA 123.253 2.635 . . . . 0.0 113.714 179.982 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . -58.87 167.26 7.04 Favored Glycine 0 N--CA 1.491 2.331 0 N-CA-C 109.546 -1.422 . . . . 0.0 109.546 179.679 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 91' ' ' PRO . . . . . 0.514 ' C ' ' H ' ' A' ' 93' ' ' THR . 57.5 Cg_endo -92.46 170.39 21.96 Favored 'Cis proline' 0 C--N 1.307 -1.625 0 C-N-CA 123.659 -1.392 . . . . 0.0 111.94 0.654 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 92' ' ' ALA . . . . . . . . . . . . . . . -70.32 29.38 0.04 OUTLIER 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.253 -0.904 . . . . 0.0 110.54 -179.327 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 93' ' ' THR . . . . . 0.514 ' H ' ' C ' ' A' ' 91' ' ' PRO . 0.8 OUTLIER -72.8 154.55 91.13 Favored Pre-proline 0 N--CA 1.492 1.644 0 O-C-N 120.764 -1.21 . . . . 0.0 109.131 -179.678 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 94' ' ' PRO . . . . . 0.451 ' O ' ' C ' ' A' ' 95' ' ' GLU . 80.5 Cg_exo -30.82 -61.79 0.13 Allowed 'Trans proline' 0 C--N 1.308 -1.574 0 C-N-CA 123.058 2.505 . . . . 0.0 112.567 -179.144 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 95' ' ' GLU . . . . . 0.451 ' C ' ' O ' ' A' ' 94' ' ' PRO . 0.3 OUTLIER -41.67 -48.23 4.09 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.288 -0.882 . . . . 0.0 109.258 179.882 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 96' ' ' GLN . . . . . 0.685 HE21 ' NH1' ' A' ' 99' ' ' ARG . 0.4 OUTLIER -73.6 -59.54 2.67 Favored 'General case' 0 N--CA 1.487 1.391 0 O-C-N 121.221 -0.924 . . . . 0.0 109.934 179.591 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 97' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -45.07 -13.37 0.02 OUTLIER 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.319 -0.863 . . . . 0.0 109.413 -179.393 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 98' ' ' ASN . . . . . 0.606 ' N ' ' O ' ' A' ' 96' ' ' GLN . 0.0 OUTLIER -73.58 -26.19 60.7 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.329 -0.857 . . . . 0.0 109.841 -179.995 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 99' ' ' ARG . . . . . 0.685 ' NH1' HE21 ' A' ' 96' ' ' GLN . 1.7 mpt_? -95.33 -45.58 7.08 Favored 'General case' 0 N--CA 1.488 1.454 0 O-C-N 121.396 -0.815 . . . . 0.0 110.048 -178.959 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . 169.99 -174.13 44.12 Favored Glycine 0 N--CA 1.494 2.537 0 C-N-CA 119.517 -1.325 . . . . 0.0 110.238 179.737 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 101' ' ' VAL . . . . . 0.497 ' O ' ' CG2' ' A' ' 101' ' ' VAL . 19.5 m -50.17 106.34 0.06 OUTLIER 'Isoleucine or valine' 0 N--CA 1.493 1.711 0 O-C-N 121.401 -1.058 . . . . 0.0 109.218 179.765 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -92.88 169.68 10.26 Favored 'General case' 0 N--CA 1.494 1.729 0 O-C-N 121.213 -0.93 . . . . 0.0 110.885 -179.306 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 103' ' ' PHE . . . . . 0.553 ' O ' ' N ' ' A' ' 105' ' ' GLU . 23.1 m-85 -69.52 120.83 15.9 Favored 'General case' 0 N--CA 1.487 1.404 0 N-CA-C 107.957 -1.127 . . . . 0.0 107.957 178.192 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 104' ' ' ALA . . . . . . . . . . . . . . . -46.85 -9.78 0.02 OUTLIER 'General case' 0 C--N 1.301 -1.529 0 O-C-N 121.335 -0.853 . . . . 0.0 110.852 -178.882 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 105' ' ' GLU . . . . . 0.553 ' N ' ' O ' ' A' ' 103' ' ' PHE . 0.1 OUTLIER -140.28 143.8 36.09 Favored 'General case' 0 N--CA 1.496 1.862 0 O-C-N 120.811 -1.181 . . . . 0.0 110.648 -179.786 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 106' ' ' GLU . . . . . . . . . . . . . 27.6 tt0 -59.42 -64.03 1.09 Allowed 'General case' 0 N--CA 1.489 1.502 0 CA-C-N 116.216 -0.447 . . . . 0.0 111.625 -178.892 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 107' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER -78.66 35.56 0.24 Allowed 'General case' 0 N--CA 1.491 1.604 0 O-C-N 120.661 -1.274 . . . . 0.0 112.672 -175.723 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 108' ' ' GLU . . . . . . . . . . . . . 2.0 tp10 -56.67 149.59 17.48 Favored 'General case' 0 N--CA 1.489 1.513 0 O-C-N 120.323 -1.486 . . . . 0.0 107.741 179.779 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 109' ' ' SER . . . . . 0.572 ' HG ' ' CG ' ' A' ' 112' ' ' ASP . 0.7 OUTLIER -100.95 145.0 29.21 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 120.9 -1.125 . . . . 0.0 110.818 -178.261 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 110' ' ' LEU . . . . . 0.436 ' C ' ' OD1' ' A' ' 111' ' ' ASP . 0.2 OUTLIER -61.03 -24.62 66.32 Favored 'General case' 0 C--N 1.306 -1.317 0 N-CA-C 108.199 -1.037 . . . . 0.0 108.199 179.213 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 111' ' ' ASP . . . . . 0.436 ' OD1' ' C ' ' A' ' 110' ' ' LEU . 2.7 m-20 -132.37 45.1 2.8 Favored 'General case' 0 C--N 1.302 -1.463 0 N-CA-C 109.208 -0.664 . . . . 0.0 109.208 179.63 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 112' ' ' ASP . . . . . 0.572 ' CG ' ' HG ' ' A' ' 109' ' ' SER . 1.3 t0 -68.06 155.32 39.8 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.346 -0.846 . . . . 0.0 111.094 -179.638 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 113' ' ' GLN . . . . . 0.59 HE22 ' N ' ' A' ' 172' ' ' GLN . 0.0 OUTLIER -67.06 -17.15 64.77 Favored 'General case' 0 N--CA 1.488 1.456 0 N-CA-C 108.137 -1.06 . . . . 0.0 108.137 177.613 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 114' ' ' ASN . . . . . 0.55 ' OD1' ' NE2' ' A' ' 178' ' ' GLN . 2.3 t30 -151.48 105.35 3.16 Favored 'General case' 0 C--N 1.295 -1.79 0 N-CA-C 107.654 -1.239 . . . . 0.0 107.654 179.528 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 115' ' ' ILE . . . . . . . . . . . . . 3.1 mt -93.6 104.44 15.75 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.711 0 O-C-N 120.675 -1.265 . . . . 0.0 107.916 179.95 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 116' ' ' SER . . . . . 0.438 ' OG ' ' ND2' ' A' ' 114' ' ' ASN . 18.5 m -87.3 147.32 25.56 Favored 'General case' 0 C--N 1.304 -1.382 0 CA-C-O 121.861 0.838 . . . . 0.0 110.988 -177.962 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 117' ' ' ILE . . . . . . . . . . . . . 2.5 mt -142.05 151.3 18.64 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.438 0 N-CA-C 107.897 -1.149 . . . . 0.0 107.897 179.449 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 118' ' ' ALA . . . . . . . . . . . . . . . -142.81 157.15 44.9 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 120.964 -1.085 . . . . 0.0 111.025 -179.026 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 119' ' ' GLY . . . . . . . . . . . . . . . -163.96 145.01 9.94 Favored Glycine 0 N--CA 1.486 1.997 0 N-CA-C 109.889 -1.285 . . . . 0.0 109.889 179.49 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 120' ' ' HIS . . . . . . . . . . . . . 26.5 m170 -70.49 168.49 16.1 Favored 'General case' 0 N--CA 1.493 1.681 0 O-C-N 121.574 -0.957 . . . . 0.0 109.64 179.357 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 121' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -120.67 149.2 42.86 Favored 'General case' 0 N--CA 1.494 1.735 0 O-C-N 121.234 -0.916 . . . . 0.0 108.728 179.035 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 122' ' ' PHE . . . . . . . . . . . . . 0.5 OUTLIER -112.37 140.13 47.35 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.199 -0.938 . . . . 0.0 109.359 179.805 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 123' ' ' ILE . . . . . 0.459 ' CG2' ' N ' ' A' ' 124' ' ' ASP . 16.0 tt -88.57 -37.88 10.85 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.793 0 N-CA-C 108.509 -0.923 . . . . 0.0 108.509 179.631 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 124' ' ' ASP . . . . . 0.459 ' N ' ' CG2' ' A' ' 123' ' ' ILE . 4.9 p-10 -94.37 19.07 10.04 Favored 'General case' 0 C--N 1.296 -1.735 0 C-N-CA 120.121 -0.632 . . . . 0.0 110.633 -179.548 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 125' ' ' ARG . . . . . 0.653 HH11 ' CG ' ' A' ' 125' ' ' ARG . 0.0 OUTLIER -156.35 108.42 2.05 Favored Pre-proline 0 N--CA 1.49 1.55 0 O-C-N 120.628 -1.295 . . . . 0.0 110.348 -179.049 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 126' ' ' PRO . . . . . . . . . . . . . 90.1 Cg_endo -82.55 -22.19 4.75 Favored 'Trans proline' 0 C--N 1.316 -1.181 0 C-N-CA 122.222 1.948 . . . . 0.0 111.953 179.522 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 127' ' ' ASN . . . . . 0.421 ' OD1' ' NH1' ' A' ' 125' ' ' ARG . 1.1 p30 -89.17 29.04 1.11 Allowed 'General case' 0 N--CA 1.489 1.502 0 O-C-N 121.188 -0.945 . . . . 0.0 109.331 179.97 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 128' ' ' TYR . . . . . . . . . . . . . 9.7 t80 -86.12 -149.18 0.13 Allowed 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.269 -0.894 . . . . 0.0 109.922 -179.64 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 129' ' ' GLN . . . . . . . . . . . . . 32.4 mt-30 -67.72 -69.31 0.32 Allowed 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.371 -0.831 . . . . 0.0 110.746 -178.838 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 130' ' ' PHE . . . . . 0.452 ' CE2' ' CG1' ' A' ' 101' ' ' VAL . 50.0 m-85 -129.83 28.66 5.08 Favored 'General case' 0 N--CA 1.496 1.841 0 O-C-N 121.14 -0.975 . . . . 0.0 110.613 -179.405 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 131' ' ' THR . . . . . 0.453 ' C ' ' HZ1' ' A' ' 134' ' ' LYS . 94.6 m -67.8 -34.5 76.89 Favored 'General case' 0 N--CA 1.493 1.717 0 O-C-N 120.79 -1.194 . . . . 0.0 108.968 179.37 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 132' ' ' ASN . . . . . 0.602 ' ND2' ' O ' ' A' ' 81' ' ' ALA . 2.4 p-10 -91.11 13.59 16.48 Favored 'General case' 0 N--CA 1.494 1.752 0 C-N-CA 119.608 -0.837 . . . . 0.0 111.285 -179.665 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 133' ' ' LEU . . . . . 0.595 ' O ' ' N ' ' A' ' 135' ' ' ALA . 0.2 OUTLIER -71.82 -42.74 66.65 Favored 'General case' 0 N--CA 1.492 1.668 0 O-C-N 120.571 -1.331 . . . . 0.0 110.266 -179.038 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 134' ' ' LYS . . . . . 0.564 ' H ' ' CD ' ' A' ' 134' ' ' LYS . 0.0 OUTLIER -44.44 -12.77 0.02 OUTLIER 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.165 -0.959 . . . . 0.0 110.402 -179.263 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 135' ' ' ALA . . . . . 0.595 ' N ' ' O ' ' A' ' 133' ' ' LEU . . . -82.77 -37.98 23.82 Favored 'General case' 0 N--CA 1.489 1.513 0 O-C-N 120.761 -1.212 . . . . 0.0 109.855 -179.829 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 136' ' ' ALA . . . . . 0.415 ' C ' ' CG ' ' A' ' 137' ' ' LYS . . . -78.55 153.38 31.28 Favored 'General case' 0 C--N 1.302 -1.496 0 O-C-N 121.352 -0.843 . . . . 0.0 111.111 -178.741 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 137' ' ' LYS . . . . . 0.519 ' O ' ' O ' ' A' ' 138' ' ' LYS . 0.4 OUTLIER -151.38 -163.69 1.82 Allowed 'General case' 0 N--CA 1.492 1.661 0 C-N-CA 118.479 -1.288 . . . . 0.0 110.744 -178.07 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 138' ' ' LYS . . . . . 0.585 ' O ' ' N ' ' A' ' 140' ' ' SER . 0.2 OUTLIER -46.3 -179.29 0.0 OUTLIER 'General case' 0 C--N 1.304 -1.4 0 CA-C-O 122.145 0.974 . . . . 0.0 110.508 -179.043 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 139' ' ' GLY . . . . . . . . . . . . . . . 46.87 7.77 0.02 OUTLIER Glycine 0 N--CA 1.49 2.284 0 N-CA-C 110.354 -1.098 . . . . 0.0 110.354 -179.848 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 140' ' ' SER . . . . . 0.585 ' N ' ' O ' ' A' ' 138' ' ' LYS . 39.2 m -84.56 130.53 34.73 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 120.926 -1.338 . . . . 0.0 109.517 179.412 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 141' ' ' MET . . . . . 0.639 ' SD ' ' N ' ' A' ' 142' ' ' VAL . 8.7 tpp -83.9 127.25 33.71 Favored 'General case' 0 N--CA 1.488 1.446 0 O-C-N 121.074 -1.016 . . . . 0.0 108.978 179.523 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 142' ' ' VAL . . . . . 0.639 ' N ' ' SD ' ' A' ' 141' ' ' MET . 2.4 t -111.25 133.38 57.0 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.512 0 N-CA-C 108.586 -0.894 . . . . 0.0 108.586 -179.744 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 143' ' ' TYR . . . . . . . . . . . . . 8.1 m-85 -111.05 135.29 51.79 Favored 'General case' 0 N--CA 1.495 1.802 0 O-C-N 120.822 -1.174 . . . . 0.0 111.124 -178.511 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 144' ' ' PHE . . . . . . . . . . . . . 10.3 t80 -120.17 104.57 10.19 Favored 'General case' 0 N--CA 1.493 1.7 0 C-N-CA 120.081 -0.648 . . . . 0.0 110.139 -179.748 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 145' ' ' LYS . . . . . . . . . . . . . 14.3 ttmm -99.64 128.12 45.74 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.135 -0.978 . . . . 0.0 110.556 -179.487 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 146' ' ' VAL . . . . . 0.432 ' O ' ' C ' ' A' ' 147' ' ' GLY . 0.6 OUTLIER -142.7 146.15 22.36 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.568 0 N-CA-C 107.438 -1.319 . . . . 0.0 107.438 178.695 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 147' ' ' GLY . . . . . 0.432 ' C ' ' O ' ' A' ' 146' ' ' VAL . . . 45.8 -131.82 9.93 Favored Glycine 0 N--CA 1.487 2.046 0 N-CA-C 108.465 -1.854 . . . . 0.0 108.465 -179.222 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 148' ' ' ASN . . . . . 0.516 ' C ' HD21 ' A' ' 148' ' ' ASN . 0.4 OUTLIER -104.2 18.07 22.83 Favored 'General case' 0 C--N 1.301 -1.532 0 O-C-N 121.307 -1.113 . . . . 0.0 108.602 179.077 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 149' ' ' GLU . . . . . . . . . . . . . 14.4 tt0 -112.22 147.03 37.08 Favored 'General case' 0 N--CA 1.49 1.557 0 CA-C-O 121.817 0.818 . . . . 0.0 111.328 -178.263 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 150' ' ' THR . . . . . . . . . . . . . 1.4 m -131.79 103.97 6.63 Favored 'General case' 0 N--CA 1.491 1.586 0 CA-C-O 121.579 0.704 . . . . 0.0 109.832 179.796 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 151' ' ' ARG . . . . . 0.477 ' NH2' ' OH ' ' A' ' 153' ' ' TYR . 21.4 mtm180 -88.2 -170.97 3.18 Favored 'General case' 0 N--CA 1.488 1.439 0 N-CA-C 109.134 -0.691 . . . . 0.0 109.134 -179.877 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 152' ' ' LYS . . . . . 0.405 ' C ' ' CD1' ' A' ' 153' ' ' TYR . 40.4 mtmt -150.86 149.26 29.47 Favored 'General case' 0 N--CA 1.489 1.496 0 O-C-N 120.968 -1.083 . . . . 0.0 110.258 -179.574 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 153' ' ' TYR . . . . . 0.578 ' O ' ' SD ' ' A' ' 141' ' ' MET . 15.9 m-85 -141.18 165.77 26.62 Favored 'General case' 0 N--CA 1.489 1.518 0 N-CA-C 107.715 -1.217 . . . . 0.0 107.715 179.224 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 154' ' ' LYS . . . . . . . . . . . . . 5.3 ttmm -141.32 115.85 9.56 Favored 'General case' 0 C--N 1.297 -1.699 0 O-C-N 120.959 -1.088 . . . . 0.0 108.628 179.29 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 155' ' ' MET . . . . . . . . . . . . . 4.6 mtt -43.65 106.16 0.06 Allowed 'General case' 0 N--CA 1.492 1.649 0 O-C-N 120.741 -1.224 . . . . 0.0 111.548 -178.662 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 156' ' ' THR . . . . . 0.489 ' OG1' ' CG2' ' A' ' 203' ' ' THR . 0.6 OUTLIER -109.08 -23.18 11.79 Favored 'General case' 0 C--N 1.292 -1.896 0 CA-C-N 115.267 -0.879 . . . . 0.0 109.894 -179.514 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 157' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -153.14 151.45 30.16 Favored 'General case' 0 C--N 1.297 -1.713 0 C-N-CA 118.493 -1.283 . . . . 0.0 111.431 -178.598 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 158' ' ' ILE . . . . . 0.436 ' CD1' ' CE2' ' A' ' 200' ' ' PHE . 0.2 OUTLIER -152.43 145.13 15.6 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.295 0 CA-C-O 121.708 0.766 . . . . 0.0 110.132 -179.148 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 159' ' ' ARG . . . . . . . . . . . . . 66.2 ttt180 -152.69 149.22 28.18 Favored 'General case' 0 C--N 1.299 -1.614 0 CA-C-O 121.882 0.848 . . . . 0.0 111.089 -178.866 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 160' ' ' ASP . . . . . 0.414 ' C ' ' CG2' ' A' ' 161' ' ' VAL . 5.9 m-20 -119.1 161.51 20.18 Favored 'General case' 0 N--CA 1.49 1.528 0 N-CA-C 108.567 -0.901 . . . . 0.0 108.567 179.349 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 161' ' ' VAL . . . . . 0.515 ' O ' ' O ' ' A' ' 162' ' ' LYS . 0.1 OUTLIER -173.13 164.55 0.26 Allowed 'Isoleucine or valine' 0 N--CA 1.501 2.096 0 O-C-N 121.097 -1.002 . . . . 0.0 109.82 179.463 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 162' ' ' LYS . . . . . 0.515 ' O ' ' O ' ' A' ' 161' ' ' VAL . 0.1 OUTLIER -42.83 168.1 0.06 OUTLIER Pre-proline 0 N--CA 1.491 1.603 0 O-C-N 121.152 -0.968 . . . . 0.0 109.062 179.121 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 163' ' ' PRO . . . . . 0.567 ' O ' ' CD1' ' C' ' 702' ' ' LEU . 57.4 Cg_endo -74.86 -20.41 17.24 Favored 'Trans proline' 0 C--N 1.306 -1.708 0 C-N-CA 122.697 2.264 . . . . 0.0 112.899 -179.294 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 164' ' ' THR . . . . . . . . . . . . . 1.1 p -90.87 -3.1 57.61 Favored 'General case' 0 C--N 1.297 -1.688 0 O-C-N 120.48 -1.387 . . . . 0.0 109.995 -179.644 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 165' ' ' ASP . . . . . . . . . . . . . 11.4 t70 -71.89 58.47 0.34 Allowed 'General case' 0 N--CA 1.491 1.622 0 O-C-N 120.856 -1.153 . . . . 0.0 109.709 -179.543 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 166' ' ' VAL . . . . . 0.551 ' O ' ' N ' ' A' ' 168' ' ' VAL . 1.5 m -44.25 -32.34 0.77 Allowed 'Isoleucine or valine' 0 C--N 1.297 -1.707 0 O-C-N 121.692 -0.63 . . . . 0.0 109.784 -178.339 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 167' ' ' GLY . . . . . . . . . . . . . . . -43.52 -15.4 0.03 OUTLIER Glycine 0 N--CA 1.496 2.688 0 O-C-N 120.83 -1.169 . . . . 0.0 111.356 -179.517 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 168' ' ' VAL . . . . . 0.551 ' C ' ' H ' ' A' ' 170' ' ' ASP . 2.8 m -54.24 -31.52 22.24 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.605 0 O-C-N 120.581 -1.54 . . . . 0.0 109.082 -179.839 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 169' ' ' LEU . . . . . 0.549 ' O ' ' C ' ' A' ' 170' ' ' ASP . 15.8 mt -48.32 -14.93 0.06 Allowed 'General case' 0 N--CA 1.492 1.64 0 N-CA-C 107.748 -1.204 . . . . 0.0 107.748 -178.713 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 170' ' ' ASP . . . . . 0.551 ' H ' ' C ' ' A' ' 168' ' ' VAL . 9.0 m-20 20.62 91.05 0.01 OUTLIER 'General case' 0 N--CA 1.499 2.002 0 CA-C-N 116.583 -0.28 . . . . 0.0 111.701 177.769 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 171' ' ' GLU . . . . . . . . . . . . . 5.9 pt-20 -137.49 77.21 1.62 Allowed 'General case' 0 N--CA 1.495 1.777 0 O-C-N 120.863 -1.148 . . . . 0.0 110.536 179.782 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 172' ' ' GLN . . . . . 0.59 ' N ' HE22 ' A' ' 113' ' ' GLN . 1.9 pt20 -136.87 -42.32 0.59 Allowed 'General case' 0 N--CA 1.495 1.824 0 O-C-N 121.209 -0.932 . . . . 0.0 110.76 -178.988 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 173' ' ' LYS . . . . . . . . . . . . . 5.8 mttp -63.23 129.29 39.65 Favored 'General case' 0 N--CA 1.497 1.892 0 O-C-N 120.688 -1.258 . . . . 0.0 108.854 179.522 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 174' ' ' GLY . . . . . 0.544 ' O ' ' C ' ' A' ' 175' ' ' LYS . . . -118.78 -41.07 0.62 Allowed Glycine 0 N--CA 1.484 1.896 0 N-CA-C 108.605 -1.798 . . . . 0.0 108.605 179.478 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 175' ' ' LYS . . . . . 0.544 ' C ' ' O ' ' A' ' 174' ' ' GLY . 17.9 mmtp -40.8 -61.85 0.89 Allowed 'General case' 0 N--CA 1.491 1.577 0 N-CA-C 106.503 -1.666 . . . . 0.0 106.503 178.48 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 176' ' ' ASP . . . . . 0.583 ' O ' ' O ' ' A' ' 177' ' ' LYS . 7.0 m-20 -105.07 85.64 2.31 Favored 'General case' 0 C--N 1.296 -1.734 0 N-CA-C 107.332 -1.359 . . . . 0.0 107.332 176.405 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 177' ' ' LYS . . . . . 0.583 ' O ' ' O ' ' A' ' 176' ' ' ASP . 0.0 OUTLIER -46.98 -174.41 0.0 OUTLIER 'General case' 0 N--CA 1.501 2.09 0 O-C-N 121.311 -0.868 . . . . 0.0 109.291 -179.233 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 178' ' ' GLN . . . . . 0.55 ' NE2' ' OD1' ' A' ' 114' ' ' ASN . 20.8 pt20 -162.01 175.13 12.12 Favored 'General case' 0 N--CA 1.488 1.456 0 O-C-N 120.328 -1.483 . . . . 0.0 111.374 -179.884 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 179' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -129.8 93.75 3.58 Favored 'General case' 0 N--CA 1.487 1.403 0 N-CA-C 107.197 -1.408 . . . . 0.0 107.197 177.627 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 180' ' ' THR . . . . . . . . . . . . . 1.8 m -71.28 118.45 14.09 Favored 'General case' 0 N--CA 1.493 1.704 0 O-C-N 121.11 -0.994 . . . . 0.0 110.424 -178.335 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 181' ' ' LEU . . . . . . . . . . . . . 42.4 tp -94.11 150.5 20.27 Favored 'General case' 0 C--N 1.298 -1.648 0 N-CA-C 107.817 -1.179 . . . . 0.0 107.817 177.81 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 182' ' ' ILE . . . . . . . . . . . . . 5.3 mt -141.54 112.89 3.55 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.553 0 O-C-N 121.011 -1.055 . . . . 0.0 108.695 178.717 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 183' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -130.58 111.38 12.18 Favored 'General case' 0 C--N 1.291 -1.953 0 N-CA-C 107.078 -1.453 . . . . 0.0 107.078 178.95 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 184' ' ' CYS . . . . . . . . . . . . . 1.8 p -78.82 159.36 27.88 Favored 'General case' 0 C--N 1.29 -1.98 0 C-N-CA 118.843 -1.143 . . . . 0.0 111.46 -177.345 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 185' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -165.73 -154.88 0.21 Allowed 'General case' 0 N--CA 1.49 1.566 0 N-CA-C 109.102 -0.703 . . . . 0.0 109.102 -179.699 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 186' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER 50.61 52.14 15.47 Favored 'General case' 0 N--CA 1.493 1.695 0 O-C-N 121.124 -0.985 . . . . 0.0 109.12 -179.848 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 187' ' ' TYR . . . . . 0.618 ' CE2' ' O ' ' A' ' 188' ' ' ASN . 54.4 t80 -67.37 136.59 55.01 Favored 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.342 -0.849 . . . . 0.0 110.777 -179.144 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 188' ' ' ASN . . . . . 0.618 ' O ' ' CE2' ' A' ' 187' ' ' TYR . 0.7 OUTLIER -101.56 146.8 27.19 Favored 'General case' 0 C--N 1.298 -1.641 0 N-CA-C 107.777 -1.194 . . . . 0.0 107.777 178.314 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 189' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -113.53 -10.16 13.2 Favored 'General case' 0 C--N 1.297 -1.697 0 N-CA-C 108.496 -0.928 . . . . 0.0 108.496 -179.624 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 190' ' ' LYS . . . . . . . . . . . . . 13.1 mttp -84.03 -53.48 5.52 Favored 'General case' 0 N--CA 1.488 1.459 0 N-CA-C 108.649 -0.871 . . . . 0.0 108.649 178.705 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 191' ' ' THR . . . . . . . . . . . . . 1.1 p -91.26 -8.3 48.75 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.588 -0.695 . . . . 0.0 109.129 179.714 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 192' ' ' GLY . . . . . . . . . . . . . . . 62.58 40.98 99.82 Favored Glycine 0 N--CA 1.492 2.425 0 N-CA-C 110.433 -1.067 . . . . 0.0 110.433 179.219 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 193' ' ' VAL . . . . . . . . . . . . . 67.2 t -145.96 157.95 12.1 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.625 0 O-C-N 121.044 -1.268 . . . . 0.0 109.801 179.56 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 194' ' ' TRP . . . . . 0.481 ' N ' ' CD1' ' A' ' 194' ' ' TRP . 23.0 m95 -83.83 120.79 26.48 Favored 'General case' 0 C--N 1.301 -1.543 0 N-CA-C 108.509 -0.923 . . . . 0.0 108.509 179.627 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 195' ' ' GLU . . . . . . . . . . . . . 2.1 mt-10 -89.73 -60.65 1.88 Allowed 'General case' 0 N--CA 1.495 1.816 0 C-N-CA 119.55 -0.86 . . . . 0.0 111.148 -178.194 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 196' ' ' LYS . . . . . . . . . . . . . 5.1 tttm -80.49 143.23 33.49 Favored 'General case' 0 C--N 1.3 -1.545 0 O-C-N 120.815 -1.178 . . . . 0.0 110.165 -178.901 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 197' ' ' ARG . . . . . 0.565 ' NH1' ' O ' ' C' ' 704' ' ' ALA . 13.5 tpp180 -120.05 138.33 53.59 Favored 'General case' 0 N--CA 1.491 1.617 0 N-CA-C 108.552 -0.907 . . . . 0.0 108.552 179.084 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 198' ' ' LYS . . . . . . . . . . . . . 22.7 mttt -116.97 118.6 32.87 Favored 'General case' 0 C--N 1.302 -1.489 0 O-C-N 121.903 -0.498 . . . . 0.0 109.966 -179.464 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 199' ' ' ILE . . . . . . . . . . . . . 0.6 OUTLIER -139.16 120.32 15.7 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.58 0 CA-C-O 122.505 1.145 . . . . 0.0 109.339 179.532 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 200' ' ' PHE . . . . . 0.504 ' CD1' ' N ' ' A' ' 200' ' ' PHE . 3.3 m-85 -99.43 136.71 38.97 Favored 'General case' 0 N--CA 1.496 1.852 0 O-C-N 121.124 -0.985 . . . . 0.0 109.799 -178.074 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 201' ' ' VAL . . . . . . . . . . . . . 97.7 t -101.58 137.16 30.25 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.555 0 N-CA-C 108.004 -1.11 . . . . 0.0 108.004 177.652 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 202' ' ' ALA . . . . . . . . . . . . . . . -121.56 134.91 55.03 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.376 -0.828 . . . . 0.0 108.821 179.831 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 203' ' ' THR . . . . . 0.489 ' CG2' ' OG1' ' A' ' 156' ' ' THR . 2.1 p -88.1 130.36 35.04 Favored 'General case' 0 C--N 1.306 -1.288 0 CA-C-O 122.198 0.999 . . . . 0.0 110.652 -178.782 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 204' ' ' GLU . . . . . 0.488 ' HA ' ' CD2' ' A' ' 153' ' ' TYR . 0.2 OUTLIER -50.9 134.62 25.46 Favored 'General case' 0 C--N 1.298 -1.67 0 C-N-CA 118.688 -1.205 . . . . 0.0 108.673 178.933 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 205' ' ' VAL . . . . . 0.508 ' CG1' ' N ' ' A' ' 206' ' ' LYS . 54.6 t -129.7 164.29 32.74 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.376 0 CA-C-O 121.93 0.872 . . . . 0.0 110.228 -177.741 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 206' ' ' LYS . . . . . 0.508 ' N ' ' CG1' ' A' ' 205' ' ' VAL . 0.5 OUTLIER . . . . . 0 C--N 1.297 -1.706 0 CA-C-O 118.006 -0.997 . . . . 0.0 109.559 -179.804 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' C' C ' 701' ' ' PHQ . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 006 nuclear orig full ' C' C ' 702' ' ' LEU . . . . . 0.567 ' CD1' ' O ' ' A' ' 163' ' ' PRO . 0.3 OUTLIER . . . . . 0 N--CA 1.493 1.714 0 N-CA-C 109.441 -0.577 . . . . 0.0 109.441 . . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' C' C ' 703' ' ' PRO . . . . . 0.501 ' O ' ' O ' ' C' ' 704' ' ' ALA . 40.5 Cg_endo -70.96 -179.29 3.33 Favored 'Trans proline' 0 C--N 1.31 -1.496 0 C-N-CA 122.796 2.331 . . . . 0.0 112.97 -179.691 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' C' C ' 704' ' ' ALA . . . . . 0.565 ' O ' ' NH1' ' A' ' 197' ' ' ARG . . . 56.44 122.02 0.0 OUTLIER 'General case' 0 N--CA 1.49 1.567 0 CA-C-O 121.561 0.696 . . . . 0.0 110.168 179.809 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' C' C ' 705' ' ' B27 . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 006 nuclear orig full ' A' A ' 700' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 007 nuclear orig full ' A' A ' 59' ' ' MET . . . . . . . . . . . . . 1.3 mpt? . . . . . 0 N--CA 1.49 1.561 0 N-CA-C 109.256 -0.646 . . . . 0.0 109.256 . . . . . . . . . 0 0 . 1 . 007 nuclear orig full ' A' A ' 60' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -60.74 153.45 24.21 Favored 'General case' 0 N--CA 1.489 1.496 0 O-C-N 121.376 -0.827 . . . . 0.0 109.861 -179.704 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . -65.3 -172.11 0.09 Allowed 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.376 -0.827 . . . . 0.0 109.801 -179.991 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 62' ' ' LYS . . . . . 0.483 ' O ' ' OE1' ' A' ' 64' ' ' GLN . 24.4 ttpt -147.5 79.06 9.77 Favored Pre-proline 0 N--CA 1.49 1.528 0 O-C-N 121.398 -0.814 . . . . 0.0 109.557 179.764 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 63' ' ' PRO . . . . . . . . . . . . . 5.6 Cg_exo -71.53 137.45 30.49 Favored 'Trans proline' 0 C--N 1.306 -1.707 0 C-N-CA 122.915 2.41 . . . . 0.0 111.283 179.585 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 64' ' ' GLN . . . . . 0.631 ' NE2' ' O ' ' A' ' 64' ' ' GLN . 0.0 OUTLIER -155.26 127.44 7.7 Favored 'General case' 0 N--CA 1.494 1.77 0 O-C-N 121.054 -1.029 . . . . 0.0 110.315 179.81 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 65' ' ' ILE . . . . . 0.441 ' C ' ' O ' ' A' ' 64' ' ' GLN . 2.1 mp -45.76 105.94 0.51 Allowed Pre-proline 0 N--CA 1.491 1.598 0 N-CA-C 107.857 -1.164 . . . . 0.0 107.857 178.471 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 66' ' ' PRO . . . . . . . . . . . . . 60.2 Cg_endo -81.94 -162.71 0.19 Allowed 'Trans proline' 0 N--CA 1.49 1.272 0 C-N-CA 122.105 1.87 . . . . 0.0 112.639 -178.785 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 67' ' ' LYS . . . . . . . . . . . . . 53.8 tttt -90.46 -8.04 51.5 Favored 'General case' 0 N--CA 1.487 1.405 0 O-C-N 121.223 -0.923 . . . . 0.0 109.727 -179.722 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 68' ' ' ASP . . . . . 0.646 ' O ' ' N ' ' A' ' 70' ' ' SER . 0.2 OUTLIER -75.86 66.14 2.07 Favored 'General case' 0 N--CA 1.487 1.421 0 CA-C-O 123.003 1.383 . . . . 0.0 108.896 179.839 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 69' ' ' LYS . . . . . 0.468 ' C ' ' O ' ' A' ' 68' ' ' ASP . 0.8 OUTLIER -45.77 -14.71 0.02 OUTLIER 'General case' 0 N--CA 1.511 2.579 0 C-N-CA 117.129 -1.828 . . . . 0.0 107.368 178.06 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 70' ' ' SER . . . . . 0.646 ' N ' ' O ' ' A' ' 68' ' ' ASP . 0.1 OUTLIER -87.58 -5.0 58.95 Favored 'General case' 0 N--CA 1.498 1.93 0 CA-C-N 113.615 -1.63 . . . . 0.0 111.9 179.893 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 71' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -100.56 142.65 31.74 Favored 'General case' 0 N--CA 1.503 2.221 0 O-C-N 120.251 -1.531 . . . . 0.0 112.615 -178.991 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 72' ' ' VAL . . . . . 0.587 ' CG2' ' O ' ' A' ' 74' ' ' GLY . 0.7 OUTLIER -67.72 127.13 28.85 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.336 0 N-CA-C 105.196 -2.149 . . . . 0.0 105.196 174.786 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 73' ' ' ALA . . . . . 0.569 ' N ' ' O ' ' A' ' 87' ' ' VAL . . . -80.33 -12.4 59.6 Favored 'General case' 0 C--N 1.297 -1.712 0 O-C-N 120.195 -1.566 . . . . 0.0 109.126 -178.309 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 74' ' ' GLY . . . . . 0.587 ' O ' ' CG2' ' A' ' 72' ' ' VAL . . . 173.53 -161.12 31.72 Favored Glycine 0 N--CA 1.488 2.13 0 N-CA-C 109.614 -1.394 . . . . 0.0 109.614 -179.849 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 75' ' ' TYR . . . . . . . . . . . . . 76.1 m-85 -142.27 170.16 16.23 Favored 'General case' 0 C--N 1.296 -1.747 0 O-C-N 121.076 -1.249 . . . . 0.0 110.767 -178.136 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 76' ' ' ILE . . . . . 0.468 ' CG2' ' OE1' ' A' ' 85' ' ' GLU . 0.4 OUTLIER -148.97 144.26 18.38 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.57 0 C-N-CA 119.422 -0.911 . . . . 0.0 108.994 -177.464 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -152.04 160.35 43.47 Favored 'General case' 0 N--CA 1.492 1.648 0 O-C-N 120.893 -1.129 . . . . 0.0 109.504 -179.855 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 78' ' ' ILE . . . . . . . . . . . . . 3.0 mp -143.16 99.08 5.47 Favored Pre-proline 0 N--CA 1.493 1.695 0 N-CA-C 107.929 -1.137 . . . . 0.0 107.929 179.303 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 79' ' ' PRO . . . . . . . . . . . . . 47.4 Cg_exo -51.06 -44.62 41.29 Favored 'Trans proline' 0 N--CA 1.492 1.425 0 C-N-CA 122.557 2.171 . . . . 0.0 113.808 -178.81 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -65.62 -18.05 65.04 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 120.691 -1.256 . . . . 0.0 110.752 178.741 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 81' ' ' ALA . . . . . 0.585 ' O ' ' ND2' ' A' ' 132' ' ' ASN . . . -106.41 -19.04 13.81 Favored 'General case' 0 N--CA 1.494 1.774 0 O-C-N 121.136 -0.978 . . . . 0.0 108.886 179.746 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 82' ' ' ASP . . . . . 0.426 ' CB ' ' O ' ' A' ' 81' ' ' ALA . 11.6 t0 70.44 49.02 0.44 Allowed 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.475 -0.765 . . . . 0.0 110.767 179.106 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 83' ' ' ILE . . . . . . . . . . . . . 36.2 mt -131.1 152.74 38.01 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.822 0 O-C-N 121.145 -0.972 . . . . 0.0 110.275 -179.047 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 84' ' ' LYS . . . . . . . . . . . . . 9.3 ptmm? -157.7 110.22 2.4 Favored 'General case' 0 N--CA 1.489 1.491 0 N-CA-C 108.244 -1.021 . . . . 0.0 108.244 179.471 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 85' ' ' GLU . . . . . 0.47 ' CD ' ' N ' ' A' ' 85' ' ' GLU . 0.4 OUTLIER -138.32 167.74 18.68 Favored Pre-proline 0 N--CA 1.498 1.949 0 O-C-N 121.113 -0.992 . . . . 0.0 109.805 -178.973 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 86' ' ' PRO . . . . . . . . . . . . . 97.3 Cg_endo -82.99 158.89 15.64 Favored 'Trans proline' 0 N--CA 1.494 1.54 0 C-N-CA 122.944 2.429 . . . . 0.0 113.568 -179.184 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 87' ' ' VAL . . . . . 0.569 ' O ' ' N ' ' A' ' 73' ' ' ALA . 78.6 t -112.04 106.36 20.61 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.698 0 N-CA-C 109.319 -0.622 . . . . 0.0 109.319 180.0 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 88' ' ' TYR . . . . . . . . . . . . . 10.5 m-85 -97.45 153.94 38.18 Favored Pre-proline 0 N--CA 1.5 2.057 0 O-C-N 120.766 -1.209 . . . . 0.0 109.607 179.582 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 89' ' ' PRO . . . . . . . . . . . . . 11.4 Cg_endo -58.78 141.94 98.35 Favored 'Trans proline' 0 N--CA 1.497 1.705 0 C-N-CA 122.954 2.436 . . . . 0.0 113.424 -179.923 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . -59.17 169.19 6.23 Favored Glycine 0 N--CA 1.496 2.667 0 N-CA-C 109.259 -1.537 . . . . 0.0 109.259 179.209 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 91' ' ' PRO . . . . . 0.502 ' C ' ' H ' ' A' ' 93' ' ' THR . 94.3 Cg_endo -93.09 168.92 21.57 Favored 'Cis proline' 0 C--N 1.31 -1.489 0 C-N-CA 123.861 -1.308 . . . . 0.0 111.994 0.239 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 92' ' ' ALA . . . . . . . . . . . . . . . -70.86 29.76 0.04 OUTLIER 'General case' 0 N--CA 1.492 1.662 0 O-C-N 121.166 -0.959 . . . . 0.0 110.6 -179.489 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 93' ' ' THR . . . . . 0.502 ' H ' ' C ' ' A' ' 91' ' ' PRO . 6.5 p -72.42 150.79 91.74 Favored Pre-proline 0 C--N 1.302 -1.485 0 O-C-N 120.688 -1.257 . . . . 0.0 108.4 179.836 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 94' ' ' PRO . . . . . 0.427 ' C ' ' O ' ' A' ' 93' ' ' THR . 70.2 Cg_exo -30.46 -57.15 0.19 Allowed 'Trans proline' 0 C--N 1.309 -1.506 0 C-N-CA 122.973 2.448 . . . . 0.0 112.743 -179.144 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 16.3 mt-10 -44.56 -49.31 10.16 Favored 'General case' 0 C--N 1.302 -1.466 0 O-C-N 121.175 -0.953 . . . . 0.0 109.863 -179.931 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 96' ' ' GLN . . . . . 0.566 ' O ' ' N ' ' A' ' 98' ' ' ASN . 1.4 mp0 -73.15 -54.15 9.19 Favored 'General case' 0 N--CA 1.488 1.47 0 O-C-N 121.081 -1.012 . . . . 0.0 109.912 179.782 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 97' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -44.11 -14.42 0.02 OUTLIER 'General case' 0 N--CA 1.494 1.732 0 O-C-N 121.453 -0.779 . . . . 0.0 110.29 -179.216 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 98' ' ' ASN . . . . . 0.689 ' ND2' ' NE ' ' A' ' 99' ' ' ARG . 0.0 OUTLIER -71.53 -33.53 69.26 Favored 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.052 -1.03 . . . . 0.0 108.599 179.327 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 99' ' ' ARG . . . . . 0.689 ' NE ' ' ND2' ' A' ' 98' ' ' ASN . 16.4 mmt180 -79.64 -58.39 3.21 Favored 'General case' 0 C--N 1.303 -1.442 0 O-C-N 121.688 -0.633 . . . . 0.0 109.565 -179.725 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . 174.08 -156.17 23.03 Favored Glycine 0 N--CA 1.492 2.422 0 N-CA-C 109.989 -1.245 . . . . 0.0 109.989 179.967 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 101' ' ' VAL . . . . . 0.47 ' CG1' ' CE2' ' A' ' 130' ' ' PHE . 27.3 m -59.44 103.18 0.14 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.674 0 O-C-N 121.256 -1.144 . . . . 0.0 109.754 -179.908 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -91.63 166.19 12.94 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.032 -1.043 . . . . 0.0 109.953 -179.992 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 103' ' ' PHE . . . . . 0.597 ' O ' ' N ' ' A' ' 105' ' ' GLU . 26.0 m-85 -70.22 120.86 16.54 Favored 'General case' 0 N--CA 1.486 1.352 0 N-CA-C 107.969 -1.123 . . . . 0.0 107.969 178.639 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 104' ' ' ALA . . . . . . . . . . . . . . . -42.94 -14.54 0.01 OUTLIER 'General case' 0 C--N 1.3 -1.546 0 O-C-N 121.488 -0.757 . . . . 0.0 110.696 -178.729 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 105' ' ' GLU . . . . . 0.597 ' N ' ' O ' ' A' ' 103' ' ' PHE . 0.1 OUTLIER -138.85 146.61 41.44 Favored 'General case' 0 N--CA 1.496 1.86 0 O-C-N 120.828 -1.17 . . . . 0.0 110.762 -179.797 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 106' ' ' GLU . . . . . 0.414 ' HG2' ' H ' ' A' ' 107' ' ' ASN . 0.0 OUTLIER -59.59 -61.72 2.41 Favored 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.929 -0.482 . . . . 0.0 111.523 -179.178 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 107' ' ' ASN . . . . . 0.414 ' H ' ' HG2' ' A' ' 106' ' ' GLU . 17.1 m120 -77.65 34.35 0.18 Allowed 'General case' 0 N--CA 1.493 1.707 0 O-C-N 120.428 -1.42 . . . . 0.0 112.862 -175.553 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 108' ' ' GLU . . . . . . . . . . . . . 14.6 tp10 -57.43 146.73 28.49 Favored 'General case' 0 C--N 1.301 -1.508 0 O-C-N 120.698 -1.252 . . . . 0.0 107.937 179.622 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 109' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -102.26 146.72 27.6 Favored 'General case' 0 N--CA 1.488 1.453 0 O-C-N 121.124 -0.985 . . . . 0.0 111.133 -178.198 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 110' ' ' LEU . . . . . 0.439 ' C ' ' OD1' ' A' ' 111' ' ' ASP . 3.0 tp -62.81 -18.87 63.43 Favored 'General case' 0 C--N 1.303 -1.421 0 N-CA-C 108.028 -1.101 . . . . 0.0 108.028 178.783 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 111' ' ' ASP . . . . . 0.439 ' OD1' ' C ' ' A' ' 110' ' ' LEU . 4.0 m-20 -132.69 42.45 3.08 Favored 'General case' 0 N--CA 1.487 1.383 0 O-C-N 121.637 -0.664 . . . . 0.0 109.84 -179.849 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 112' ' ' ASP . . . . . . . . . . . . . 4.5 t0 -68.15 157.45 35.32 Favored 'General case' 0 N--CA 1.492 1.668 0 O-C-N 120.858 -1.151 . . . . 0.0 111.386 -179.725 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 113' ' ' GLN . . . . . 0.543 ' N ' ' CD ' ' A' ' 113' ' ' GLN . 0.0 OUTLIER -66.58 -16.07 63.9 Favored 'General case' 0 N--CA 1.494 1.742 0 N-CA-C 108.229 -1.026 . . . . 0.0 108.229 177.934 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 114' ' ' ASN . . . . . 0.614 ' ND2' ' O ' ' A' ' 170' ' ' ASP . 34.6 t-20 -153.0 113.81 4.11 Favored 'General case' 0 C--N 1.295 -1.781 0 N-CA-C 107.58 -1.266 . . . . 0.0 107.58 177.141 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 115' ' ' ILE . . . . . . . . . . . . . 3.8 mt -91.41 98.95 8.96 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.69 0 N-CA-C 107.232 -1.396 . . . . 0.0 107.232 179.588 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 116' ' ' SER . . . . . . . . . . . . . 87.6 p -86.44 149.03 25.28 Favored 'General case' 0 N--CA 1.488 1.437 0 CA-C-O 121.864 0.84 . . . . 0.0 111.22 -177.528 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 117' ' ' ILE . . . . . . . . . . . . . 1.7 mt -149.71 149.54 14.56 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.483 0 N-CA-C 107.813 -1.18 . . . . 0.0 107.813 179.112 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 118' ' ' ALA . . . . . . . . . . . . . . . -136.26 159.35 42.02 Favored 'General case' 0 N--CA 1.493 1.686 0 C-N-CA 119.277 -0.969 . . . . 0.0 110.903 -179.018 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 119' ' ' GLY . . . . . . . . . . . . . . . -172.01 146.76 9.54 Favored Glycine 0 N--CA 1.489 2.179 0 N-CA-C 110.482 -1.047 . . . . 0.0 110.482 179.94 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 120' ' ' HIS . . . . . 0.527 ' CD2' ' SG ' ' C' ' 705' ' ' B27 . 27.7 m170 -71.89 168.0 18.85 Favored 'General case' 0 N--CA 1.494 1.758 0 O-C-N 121.531 -0.981 . . . . 0.0 110.157 179.291 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 121' ' ' THR . . . . . 0.727 ' HG1' ' NZ ' ' A' ' 134' ' ' LYS . 0.7 OUTLIER -118.5 160.06 22.41 Favored 'General case' 0 N--CA 1.498 1.958 0 N-CA-C 108.357 -0.979 . . . . 0.0 108.357 178.818 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 122' ' ' PHE . . . . . . . . . . . . . 2.7 m-85 -143.59 123.35 13.39 Favored 'General case' 0 N--CA 1.498 1.951 0 O-C-N 120.838 -1.164 . . . . 0.0 109.812 -179.766 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 123' ' ' ILE . . . . . 0.44 ' CG2' ' N ' ' A' ' 124' ' ' ASP . 14.3 tt -59.18 -40.24 80.59 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.478 0 CA-C-O 121.545 0.688 . . . . 0.0 109.516 179.89 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 124' ' ' ASP . . . . . 0.44 ' N ' ' CG2' ' A' ' 123' ' ' ILE . 1.7 m-20 -88.92 22.62 2.64 Favored 'General case' 0 N--CA 1.497 1.912 0 O-C-N 121.492 -0.755 . . . . 0.0 111.942 -177.42 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 125' ' ' ARG . . . . . . . . . . . . . 37.9 mtp180 -154.47 99.75 2.45 Favored Pre-proline 0 N--CA 1.493 1.703 0 O-C-N 120.366 -1.459 . . . . 0.0 110.112 -179.862 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 126' ' ' PRO . . . . . . . . . . . . . 56.1 Cg_endo -80.02 -27.94 3.47 Favored 'Trans proline' 0 C--N 1.313 -1.328 0 C-N-CA 121.98 1.787 . . . . 0.0 111.635 179.266 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 127' ' ' ASN . . . . . . . . . . . . . 2.9 m120 -89.09 11.77 17.54 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.047 -1.033 . . . . 0.0 109.227 179.64 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 128' ' ' TYR . . . . . . . . . . . . . 5.1 t80 -65.58 -149.47 0.01 OUTLIER 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.388 -0.82 . . . . 0.0 109.425 179.908 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 129' ' ' GLN . . . . . . . . . . . . . 69.5 mt-30 -68.05 -70.95 0.23 Allowed 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.315 -0.866 . . . . 0.0 109.857 -179.787 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 130' ' ' PHE . . . . . 0.495 ' O ' ' CE ' ' A' ' 134' ' ' LYS . 47.6 m-85 -134.88 52.62 2.03 Favored 'General case' 0 N--CA 1.493 1.71 0 O-C-N 121.104 -0.998 . . . . 0.0 110.303 -179.857 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 131' ' ' THR . . . . . . . . . . . . . 23.1 m -87.33 -39.69 15.12 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 120.903 -1.123 . . . . 0.0 109.396 179.681 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 132' ' ' ASN . . . . . 0.585 ' ND2' ' O ' ' A' ' 81' ' ' ALA . 1.8 t30 -82.86 6.32 18.79 Favored 'General case' 0 N--CA 1.498 1.938 0 O-C-N 121.505 -0.747 . . . . 0.0 111.701 -178.306 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 133' ' ' LEU . . . . . 0.503 ' O ' ' N ' ' A' ' 135' ' ' ALA . 0.2 OUTLIER -71.17 -45.54 63.28 Favored 'General case' 0 C--N 1.299 -1.616 0 O-C-N 120.739 -1.226 . . . . 0.0 109.999 -179.368 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 134' ' ' LYS . . . . . 0.727 ' NZ ' ' HG1' ' A' ' 121' ' ' THR . 0.0 OUTLIER -46.12 -16.96 0.03 OUTLIER 'General case' 0 N--CA 1.494 1.749 0 O-C-N 120.988 -1.07 . . . . 0.0 109.727 -179.802 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 135' ' ' ALA . . . . . 0.503 ' N ' ' O ' ' A' ' 133' ' ' LEU . . . -84.08 -37.53 21.93 Favored 'General case' 0 N--CA 1.487 1.403 0 O-C-N 121.111 -0.993 . . . . 0.0 109.077 179.471 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 136' ' ' ALA . . . . . 0.419 ' N ' ' O ' ' A' ' 133' ' ' LEU . . . -79.76 157.96 26.99 Favored 'General case' 0 C--N 1.303 -1.454 0 CA-C-O 121.976 0.894 . . . . 0.0 110.984 -179.132 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 137' ' ' LYS . . . . . 0.542 ' O ' ' O ' ' A' ' 138' ' ' LYS . 2.4 mttm -150.84 -163.52 1.79 Allowed 'General case' 0 C--N 1.299 -1.628 0 C-N-CA 118.106 -1.438 . . . . 0.0 110.965 -177.902 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 138' ' ' LYS . . . . . 0.585 ' O ' ' N ' ' A' ' 140' ' ' SER . 28.8 mttp -41.18 174.17 0.0 OUTLIER 'General case' 0 C--N 1.301 -1.523 0 CA-C-O 122.589 1.185 . . . . 0.0 111.171 -178.557 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 139' ' ' GLY . . . . . . . . . . . . . . . 47.13 8.25 0.03 OUTLIER Glycine 0 N--CA 1.488 2.148 0 N-CA-C 110.162 -1.175 . . . . 0.0 110.162 -179.971 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 140' ' ' SER . . . . . 0.585 ' N ' ' O ' ' A' ' 138' ' ' LYS . 5.2 m -75.87 112.98 12.83 Favored 'General case' 0 N--CA 1.493 1.723 0 O-C-N 120.867 -1.372 . . . . 0.0 108.982 179.385 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 141' ' ' MET . . . . . 0.659 ' SD ' ' N ' ' A' ' 142' ' ' VAL . 3.0 tpp -68.26 128.02 35.06 Favored 'General case' 0 C--N 1.301 -1.503 0 O-C-N 121.036 -1.04 . . . . 0.0 109.178 179.854 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 142' ' ' VAL . . . . . 0.659 ' N ' ' SD ' ' A' ' 141' ' ' MET . 1.6 t -113.87 133.29 60.33 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.522 0 N-CA-C 108.456 -0.942 . . . . 0.0 108.456 -179.736 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 143' ' ' TYR . . . . . . . . . . . . . 13.4 m-85 -112.31 135.83 52.51 Favored 'General case' 0 N--CA 1.495 1.798 0 O-C-N 120.869 -1.145 . . . . 0.0 110.703 -178.899 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 144' ' ' PHE . . . . . 0.561 ' CZ ' ' CG1' ' A' ' 146' ' ' VAL . 4.2 t80 -120.96 105.88 11.08 Favored 'General case' 0 N--CA 1.493 1.707 0 C-N-CA 120.143 -0.623 . . . . 0.0 109.985 -179.467 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 145' ' ' LYS . . . . . . . . . . . . . 13.9 mtpp -102.3 122.76 44.86 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.23 -0.919 . . . . 0.0 109.819 -179.863 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 146' ' ' VAL . . . . . 0.561 ' CG1' ' CZ ' ' A' ' 144' ' ' PHE . 0.9 OUTLIER -142.65 125.4 13.74 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.629 0 N-CA-C 108.335 -0.987 . . . . 0.0 108.335 178.874 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 147' ' ' GLY . . . . . . . . . . . . . . . 60.47 -125.6 39.0 Favored Glycine 0 N--CA 1.489 2.225 0 N-CA-C 109.054 -1.618 . . . . 0.0 109.054 -179.426 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 148' ' ' ASN . . . . . 0.592 ' C ' ' ND2' ' A' ' 148' ' ' ASN . 0.0 OUTLIER -104.77 5.97 33.68 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.245 -1.15 . . . . 0.0 108.979 179.623 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 149' ' ' GLU . . . . . . . . . . . . . 1.3 tt0 -105.82 141.65 36.89 Favored 'General case' 0 N--CA 1.488 1.461 0 O-C-N 121.295 -0.878 . . . . 0.0 111.797 -178.32 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 150' ' ' THR . . . . . . . . . . . . . 3.5 m -131.93 98.47 4.46 Favored 'General case' 0 N--CA 1.493 1.709 0 CA-C-O 121.482 0.658 . . . . 0.0 109.271 -179.862 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 151' ' ' ARG . . . . . 0.4 HH12 ' HA ' ' A' ' 111' ' ' ASP . 92.6 mtt180 -85.7 -169.36 2.61 Favored 'General case' 0 N--CA 1.488 1.425 0 O-C-N 121.255 -0.903 . . . . 0.0 108.894 -179.711 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 152' ' ' LYS . . . . . 0.476 ' O ' ' N ' ' A' ' 205' ' ' VAL . 1.9 mtmp? -152.02 149.87 29.35 Favored 'General case' 0 C--N 1.301 -1.537 0 O-C-N 121.261 -0.899 . . . . 0.0 109.982 -179.309 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 153' ' ' TYR . . . . . 0.48 ' CD2' ' HA ' ' A' ' 204' ' ' GLU . 5.7 m-85 -143.86 168.51 19.78 Favored 'General case' 0 C--N 1.303 -1.417 0 N-CA-C 107.939 -1.134 . . . . 0.0 107.939 178.494 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 154' ' ' LYS . . . . . . . . . . . . . 1.4 ttpt -143.36 119.82 10.99 Favored 'General case' 0 C--N 1.295 -1.772 0 N-CA-C 108.403 -0.962 . . . . 0.0 108.403 178.689 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 155' ' ' MET . . . . . . . . . . . . . 46.5 mtp -46.3 107.68 0.11 Allowed 'General case' 0 N--CA 1.495 1.784 0 O-C-N 120.637 -1.289 . . . . 0.0 111.564 -178.602 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 156' ' ' THR . . . . . 0.512 ' OG1' ' OG1' ' A' ' 203' ' ' THR . 0.2 OUTLIER -106.4 -25.44 11.89 Favored 'General case' 0 C--N 1.294 -1.844 0 CA-C-N 115.249 -0.887 . . . . 0.0 110.633 -178.739 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 157' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -153.94 153.72 32.52 Favored 'General case' 0 N--CA 1.495 1.813 0 C-N-CA 118.559 -1.256 . . . . 0.0 111.431 -178.512 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 158' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -153.79 146.83 14.15 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.372 0 CA-C-O 122.067 0.937 . . . . 0.0 110.91 -179.76 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 159' ' ' ARG . . . . . . . . . . . . . 12.9 ttm180 -153.66 153.44 32.3 Favored 'General case' 0 C--N 1.296 -1.718 0 CA-C-O 121.642 0.734 . . . . 0.0 109.681 -179.894 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 160' ' ' ASP . . . . . 0.559 ' N ' ' OD1' ' A' ' 160' ' ' ASP . 0.3 OUTLIER -116.18 160.55 20.23 Favored 'General case' 0 C--N 1.301 -1.513 0 N-CA-C 107.895 -1.15 . . . . 0.0 107.895 179.428 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 161' ' ' VAL . . . . . 0.498 ' CG1' ' O ' ' A' ' 160' ' ' ASP . 1.6 m -165.35 159.34 1.14 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.7 0 O-C-N 120.881 -1.137 . . . . 0.0 110.54 -179.271 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 162' ' ' LYS . . . . . 0.497 ' O ' ' O ' ' A' ' 161' ' ' VAL . 0.0 OUTLIER -43.96 171.5 0.04 OUTLIER Pre-proline 0 N--CA 1.49 1.538 0 O-C-N 121.789 -0.569 . . . . 0.0 109.558 179.568 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 163' ' ' PRO . . . . . . . . . . . . . 74.0 Cg_endo -81.47 37.32 0.67 Allowed 'Trans proline' 0 C--N 1.311 -1.431 0 C-N-CA 122.557 2.171 . . . . 0.0 112.107 179.891 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 164' ' ' THR . . . . . . . . . . . . . 86.7 m -152.12 -5.65 0.23 Allowed 'General case' 0 N--CA 1.494 1.76 0 O-C-N 121.216 -0.927 . . . . 0.0 110.736 -179.446 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 165' ' ' ASP . . . . . . . . . . . . . 31.0 t70 -72.86 62.72 0.61 Allowed 'General case' 0 N--CA 1.496 1.834 0 O-C-N 120.796 -1.19 . . . . 0.0 110.169 -179.435 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 166' ' ' VAL . . . . . 0.608 ' O ' ' N ' ' A' ' 168' ' ' VAL . 2.8 t -45.68 -34.01 1.58 Allowed 'Isoleucine or valine' 0 N--CA 1.494 1.763 0 O-C-N 121.099 -1.001 . . . . 0.0 110.247 -178.534 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 167' ' ' GLY . . . . . 0.402 ' C ' ' O ' ' A' ' 166' ' ' VAL . . . -43.46 -12.81 0.01 OUTLIER Glycine 0 N--CA 1.496 2.672 0 O-C-N 120.785 -1.197 . . . . 0.0 110.994 -179.495 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 168' ' ' VAL . . . . . 0.608 ' N ' ' O ' ' A' ' 166' ' ' VAL . 5.3 m -53.97 -30.94 20.36 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.51 0 O-C-N 120.588 -1.537 . . . . 0.0 109.005 179.802 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 169' ' ' LEU . . . . . 0.545 ' O ' ' ND2' ' A' ' 114' ' ' ASN . 13.1 mt -49.04 -11.51 0.04 OUTLIER 'General case' 0 N--CA 1.489 1.519 0 N-CA-C 107.974 -1.121 . . . . 0.0 107.974 -178.535 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 170' ' ' ASP . . . . . 0.614 ' O ' ' ND2' ' A' ' 114' ' ' ASN . 2.2 m-20 19.88 77.21 0.01 OUTLIER 'General case' 0 N--CA 1.5 2.03 0 N-CA-C 112.21 0.448 . . . . 0.0 112.21 177.517 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 171' ' ' GLU . . . . . 0.572 ' N ' ' OE1' ' A' ' 172' ' ' GLN . 9.9 pt-20 -116.51 66.44 0.71 Allowed 'General case' 0 N--CA 1.498 1.957 0 O-C-N 120.922 -1.111 . . . . 0.0 109.499 179.495 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 172' ' ' GLN . . . . . 0.572 ' OE1' ' N ' ' A' ' 171' ' ' GLU . 2.5 mp0 -121.35 -57.28 1.85 Allowed 'General case' 0 N--CA 1.496 1.846 0 O-C-N 121.532 -0.73 . . . . 0.0 110.7 -178.697 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 173' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -58.92 127.0 30.0 Favored 'General case' 0 N--CA 1.494 1.739 0 O-C-N 121.017 -1.052 . . . . 0.0 109.301 -179.687 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 174' ' ' GLY . . . . . 0.498 ' O ' ' C ' ' A' ' 175' ' ' LYS . . . -118.55 -43.0 0.56 Allowed Glycine 0 N--CA 1.482 1.742 0 N-CA-C 108.625 -1.79 . . . . 0.0 108.625 179.835 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 175' ' ' LYS . . . . . 0.498 ' C ' ' O ' ' A' ' 174' ' ' GLY . 0.0 OUTLIER -40.42 -60.03 1.19 Allowed 'General case' 0 N--CA 1.494 1.742 0 N-CA-C 107.324 -1.361 . . . . 0.0 107.324 179.538 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 176' ' ' ASP . . . . . 0.601 ' O ' ' O ' ' A' ' 177' ' ' LYS . 11.4 m-20 -103.72 90.31 3.61 Favored 'General case' 0 C--N 1.292 -1.912 0 N-CA-C 106.792 -1.558 . . . . 0.0 106.792 176.896 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 177' ' ' LYS . . . . . 0.601 ' O ' ' O ' ' A' ' 176' ' ' ASP . 8.3 mtmt -45.28 -176.31 0.0 OUTLIER 'General case' 0 N--CA 1.492 1.641 0 N-CA-C 109.009 -0.737 . . . . 0.0 109.009 -179.161 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 178' ' ' GLN . . . . . 0.61 HE21 ' ND2' ' A' ' 114' ' ' ASN . 16.5 pt20 -161.77 175.84 11.53 Favored 'General case' 0 C--N 1.3 -1.557 0 O-C-N 120.37 -1.456 . . . . 0.0 110.511 179.322 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 179' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -132.51 98.96 4.5 Favored 'General case' 0 C--N 1.301 -1.503 0 N-CA-C 107.604 -1.258 . . . . 0.0 107.604 178.228 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 180' ' ' THR . . . . . 0.536 ' CB ' HD22 ' A' ' 114' ' ' ASN . 1.3 m -77.26 117.42 18.76 Favored 'General case' 0 N--CA 1.489 1.486 0 O-C-N 121.217 -0.927 . . . . 0.0 110.127 -178.628 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 181' ' ' LEU . . . . . . . . . . . . . 9.4 tt -92.76 147.05 23.18 Favored 'General case' 0 C--N 1.302 -1.463 0 N-CA-C 107.851 -1.166 . . . . 0.0 107.851 177.826 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 182' ' ' ILE . . . . . . . . . . . . . 6.4 mt -138.39 109.05 5.0 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.643 0 N-CA-C 108.262 -1.014 . . . . 0.0 108.262 179.088 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 183' ' ' THR . . . . . . . . . . . . . 7.1 t -132.1 115.65 16.02 Favored 'General case' 0 C--N 1.29 -2.007 0 N-CA-C 107.921 -1.14 . . . . 0.0 107.921 179.509 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 184' ' ' CYS . . . . . . . . . . . . . 1.1 p -78.54 160.46 27.62 Favored 'General case' 0 C--N 1.288 -2.076 0 C-N-CA 119.441 -0.904 . . . . 0.0 110.996 -178.021 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 185' ' ' ASP . . . . . 0.53 ' CG ' ' N ' ' A' ' 186' ' ' ASP . 0.1 OUTLIER -166.93 -163.58 0.56 Allowed 'General case' 0 N--CA 1.49 1.53 0 N-CA-C 109.109 -0.7 . . . . 0.0 109.109 179.816 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 186' ' ' ASP . . . . . 0.53 ' N ' ' CG ' ' A' ' 185' ' ' ASP . 0.6 OUTLIER 55.95 54.3 8.2 Favored 'General case' 0 N--CA 1.496 1.828 0 O-C-N 121.126 -0.984 . . . . 0.0 109.476 -179.965 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 187' ' ' TYR . . . . . 0.596 ' CE1' ' O ' ' A' ' 188' ' ' ASN . 43.0 t80 -67.54 130.73 43.95 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.166 -0.959 . . . . 0.0 110.126 -179.829 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 188' ' ' ASN . . . . . 0.785 HD21 ' H ' ' A' ' 193' ' ' VAL . 0.0 OUTLIER -99.94 150.54 22.3 Favored 'General case' 0 C--N 1.292 -1.907 0 N-CA-C 107.318 -1.364 . . . . 0.0 107.318 177.825 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 189' ' ' GLU . . . . . 0.616 ' H ' ' CD ' ' A' ' 189' ' ' GLU . 0.0 OUTLIER -112.18 -8.09 14.01 Favored 'General case' 0 C--N 1.289 -2.034 0 N-CA-C 107.968 -1.123 . . . . 0.0 107.968 -179.476 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 190' ' ' LYS . . . . . 0.577 ' N ' ' OD1' ' A' ' 188' ' ' ASN . 2.7 mtpm? -82.89 -56.91 3.54 Favored 'General case' 0 C--N 1.299 -1.618 0 C-N-CA 119.894 -0.722 . . . . 0.0 109.381 179.51 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 191' ' ' THR . . . . . 0.566 ' C ' HD22 ' A' ' 188' ' ' ASN . 4.7 p -88.44 6.5 37.29 Favored 'General case' 0 N--CA 1.493 1.682 0 O-C-N 121.399 -0.813 . . . . 0.0 110.04 -179.675 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 192' ' ' GLY . . . . . 0.673 ' N ' HD22 ' A' ' 188' ' ' ASN . . . 53.92 35.82 54.38 Favored Glycine 0 N--CA 1.495 2.568 0 N-CA-C 110.664 -0.974 . . . . 0.0 110.664 179.129 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 193' ' ' VAL . . . . . 0.785 ' H ' HD21 ' A' ' 188' ' ' ASN . 58.8 t -149.5 163.58 4.08 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.588 0 O-C-N 120.95 -1.324 . . . . 0.0 109.962 179.708 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 194' ' ' TRP . . . . . 0.522 ' N ' ' CD1' ' A' ' 194' ' ' TRP . 16.1 m95 -84.97 121.17 27.38 Favored 'General case' 0 N--CA 1.49 1.534 0 N-CA-C 108.085 -1.08 . . . . 0.0 108.085 179.137 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 195' ' ' GLU . . . . . . . . . . . . . 2.6 mt-10 -79.69 -61.23 2.06 Favored 'General case' 0 N--CA 1.497 1.878 0 O-C-N 121.295 -0.878 . . . . 0.0 111.767 -177.667 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 196' ' ' LYS . . . . . . . . . . . . . 8.5 mmtm -93.29 145.38 24.49 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 120.777 -1.202 . . . . 0.0 110.296 -178.608 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 197' ' ' ARG . . . . . 0.585 ' CG ' HH11 ' A' ' 197' ' ' ARG . 0.0 OUTLIER -119.61 146.85 45.16 Favored 'General case' 0 N--CA 1.492 1.625 0 N-CA-C 108.711 -0.848 . . . . 0.0 108.711 179.806 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 198' ' ' LYS . . . . . 0.459 ' HZ1' ' CG ' ' A' ' 185' ' ' ASP . 0.5 OUTLIER -116.81 121.07 40.47 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.582 -0.699 . . . . 0.0 111.197 -178.212 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 199' ' ' ILE . . . . . 0.409 HG13 ' O ' ' A' ' 199' ' ' ILE . 0.8 OUTLIER -139.52 118.21 12.27 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.573 0 CA-C-O 122.515 1.15 . . . . 0.0 109.56 178.796 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 200' ' ' PHE . . . . . . . . . . . . . 0.3 OUTLIER -103.6 140.78 37.09 Favored 'General case' 0 N--CA 1.497 1.88 0 O-C-N 121.127 -0.983 . . . . 0.0 110.455 -178.074 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 201' ' ' VAL . . . . . . . . . . . . . 96.1 t -103.47 146.83 10.6 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.482 0 N-CA-C 108.255 -1.017 . . . . 0.0 108.255 177.352 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 202' ' ' ALA . . . . . . . . . . . . . . . -131.89 138.74 48.53 Favored 'General case' 0 C--N 1.3 -1.579 0 N-CA-C 108.34 -0.985 . . . . 0.0 108.34 -179.88 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 203' ' ' THR . . . . . 0.512 ' OG1' ' OG1' ' A' ' 156' ' ' THR . 3.2 p -89.1 130.77 35.49 Favored 'General case' 0 C--N 1.306 -1.315 0 CA-C-O 122.267 1.032 . . . . 0.0 111.213 -178.141 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 204' ' ' GLU . . . . . 0.48 ' HA ' ' CD2' ' A' ' 153' ' ' TYR . 0.2 OUTLIER -51.01 134.48 26.15 Favored 'General case' 0 C--N 1.297 -1.691 0 C-N-CA 119.076 -1.05 . . . . 0.0 109.043 179.346 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 205' ' ' VAL . . . . . 0.503 ' CG1' ' N ' ' A' ' 206' ' ' LYS . 53.3 t -125.03 164.06 24.55 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.369 0 CA-C-O 121.941 0.877 . . . . 0.0 110.433 -177.79 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 206' ' ' LYS . . . . . 0.503 ' N ' ' CG1' ' A' ' 205' ' ' VAL . 0.1 OUTLIER . . . . . 0 C--N 1.297 -1.693 0 CA-C-O 117.976 -1.011 . . . . 0.0 109.651 179.91 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' C' C ' 701' ' ' PHQ . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 007 nuclear orig full ' C' C ' 702' ' ' LEU . . . . . 0.444 ' CD1' ' N ' ' C' ' 702' ' ' LEU . 0.0 OUTLIER . . . . . 0 N--CA 1.492 1.656 0 N-CA-C 108.941 -0.763 . . . . 0.0 108.941 . . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' C' C ' 703' ' ' PRO . . . . . . . . . . . . . 11.9 Cg_endo -61.7 -174.81 0.14 Allowed 'Trans proline' 0 N--CA 1.494 1.549 0 C-N-CA 122.609 2.206 . . . . 0.0 112.861 -179.083 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' C' C ' 704' ' ' ALA . . . . . 0.561 ' C ' ' NH2' ' A' ' 197' ' ' ARG . . . 54.23 175.3 0.02 OUTLIER 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.395 -0.816 . . . . 0.0 109.364 -179.662 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' C' C ' 705' ' ' B27 . . . . . 0.527 ' SG ' ' CD2' ' A' ' 120' ' ' HIS . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 700' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 008 nuclear orig full ' A' A ' 59' ' ' MET . . . . . . . . . . . . . 1.5 mpt? . . . . . 0 N--CA 1.491 1.58 0 CA-C-O 121.385 0.612 . . . . 0.0 109.501 . . . . . . . . . 0 0 . 1 . 008 nuclear orig full ' A' A ' 60' ' ' GLN . . . . . . . . . . . . . 1.1 tt0 -60.95 149.9 35.05 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.393 -0.817 . . . . 0.0 109.929 -179.856 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . -65.04 157.6 27.96 Favored 'General case' 0 N--CA 1.489 1.5 0 O-C-N 121.245 -0.91 . . . . 0.0 109.117 179.533 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 62' ' ' LYS . . . . . . . . . . . . . 3.5 tptm -139.0 75.19 35.67 Favored Pre-proline 0 N--CA 1.491 1.583 0 C-N-CA 119.533 -0.867 . . . . 0.0 109.651 -179.696 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 63' ' ' PRO . . . . . . . . . . . . . 72.9 Cg_endo -93.0 151.63 2.63 Favored 'Trans proline' 0 C--N 1.301 -1.921 0 C-N-CA 124.011 3.141 . . . . 0.0 110.684 179.386 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 64' ' ' GLN . . . . . 0.601 ' NE2' ' O ' ' A' ' 64' ' ' GLN . 0.0 OUTLIER -159.83 137.72 10.03 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 120.97 -1.081 . . . . 0.0 109.841 179.115 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 65' ' ' ILE . . . . . . . . . . . . . 3.2 mp -47.95 108.0 0.83 Allowed Pre-proline 0 N--CA 1.489 1.488 0 O-C-N 121.172 -0.955 . . . . 0.0 108.701 179.136 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 66' ' ' PRO . . . . . . . . . . . . . 61.4 Cg_endo -81.52 -158.74 0.1 OUTLIER 'Trans proline' 0 C--N 1.314 -1.246 0 C-N-CA 122.026 1.818 . . . . 0.0 112.445 -179.432 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 67' ' ' LYS . . . . . . . . . . . . . 3.4 pttm -90.18 -13.24 35.99 Favored 'General case' 0 N--CA 1.488 1.457 0 O-C-N 121.323 -0.861 . . . . 0.0 109.366 -179.975 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 68' ' ' ASP . . . . . 0.655 ' C ' ' H ' ' A' ' 70' ' ' SER . 0.5 OUTLIER -76.76 64.27 2.31 Favored 'General case' 0 N--CA 1.488 1.456 0 CA-C-O 122.656 1.217 . . . . 0.0 109.548 -179.885 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 69' ' ' LYS . . . . . 0.457 ' C ' ' O ' ' A' ' 68' ' ' ASP . 12.1 ptpt -47.48 -13.01 0.03 OUTLIER 'General case' 0 N--CA 1.512 2.655 0 C-N-CA 117.039 -1.864 . . . . 0.0 106.66 177.03 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 70' ' ' SER . . . . . 0.655 ' H ' ' C ' ' A' ' 68' ' ' ASP . 1.3 p -85.22 -7.06 59.21 Favored 'General case' 0 N--CA 1.497 1.883 0 CA-C-N 113.259 -1.791 . . . . 0.0 111.151 179.337 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 71' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -98.76 145.66 26.7 Favored 'General case' 0 N--CA 1.501 2.107 0 O-C-N 120.671 -1.268 . . . . 0.0 112.329 -179.141 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 72' ' ' VAL . . . . . 0.49 ' O ' ' CG2' ' A' ' 72' ' ' VAL . 3.0 m -68.02 130.06 32.97 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.384 0 N-CA-C 105.227 -2.138 . . . . 0.0 105.227 175.235 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 73' ' ' ALA . . . . . 0.57 ' N ' ' O ' ' A' ' 87' ' ' VAL . . . -78.92 -15.17 58.67 Favored 'General case' 0 C--N 1.293 -1.858 0 O-C-N 120.16 -1.588 . . . . 0.0 107.623 -179.404 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 74' ' ' GLY . . . . . 0.418 ' O ' ' N ' ' A' ' 87' ' ' VAL . . . 176.04 -159.74 27.3 Favored Glycine 0 N--CA 1.48 1.592 0 N-CA-C 109.712 -1.355 . . . . 0.0 109.712 179.73 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 75' ' ' TYR . . . . . 0.595 ' CD2' ' O ' ' A' ' 85' ' ' GLU . 0.6 OUTLIER -142.97 166.86 23.49 Favored 'General case' 0 C--N 1.295 -1.772 0 O-C-N 121.713 -0.875 . . . . 0.0 110.834 -177.221 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 76' ' ' ILE . . . . . . . . . . . . . 1.5 tt -149.86 146.98 16.58 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.517 0 C-N-CA 119.2 -1.0 . . . . 0.0 109.833 -178.528 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -150.96 164.78 35.55 Favored 'General case' 0 N--CA 1.489 1.495 0 N-CA-C 108.689 -0.856 . . . . 0.0 108.689 179.594 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 78' ' ' ILE . . . . . . . . . . . . . 14.9 mt -146.89 95.87 4.42 Favored Pre-proline 0 C--N 1.3 -1.562 0 N-CA-C 108.392 -0.966 . . . . 0.0 108.392 179.997 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 79' ' ' PRO . . . . . . . . . . . . . 73.5 Cg_exo -46.93 -46.45 18.59 Favored 'Trans proline' 0 N--CA 1.493 1.447 0 C-N-CA 122.865 2.377 . . . . 0.0 113.897 -178.503 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 4.0 t0 -65.38 -20.04 66.21 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 120.749 -1.219 . . . . 0.0 110.423 178.622 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -104.35 -12.58 16.51 Favored 'General case' 0 N--CA 1.493 1.676 0 O-C-N 121.308 -0.87 . . . . 0.0 109.227 179.739 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 82' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER 62.4 48.82 4.43 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.332 -0.855 . . . . 0.0 110.154 179.574 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 83' ' ' ILE . . . . . . . . . . . . . 69.9 mt -129.08 151.84 36.35 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.801 0 O-C-N 121.142 -0.974 . . . . 0.0 110.408 -178.862 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 84' ' ' LYS . . . . . 0.458 ' O ' ' CD ' ' A' ' 85' ' ' GLU . 27.7 tttt -158.86 108.74 1.99 Allowed 'General case' 0 N--CA 1.49 1.545 0 N-CA-C 108.192 -1.04 . . . . 0.0 108.192 179.778 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 85' ' ' GLU . . . . . 0.595 ' O ' ' CD2' ' A' ' 75' ' ' TYR . 7.4 mm-40 -139.64 176.41 2.59 Favored Pre-proline 0 N--CA 1.496 1.859 0 O-C-N 121.457 -0.777 . . . . 0.0 109.899 -178.998 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 86' ' ' PRO . . . . . 0.407 ' HB3' ' CE1' ' A' ' 75' ' ' TYR . 12.3 Cg_endo -85.86 169.68 8.98 Favored 'Trans proline' 0 N--CA 1.491 1.342 0 C-N-CA 123.15 2.566 . . . . 0.0 113.55 -178.75 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 87' ' ' VAL . . . . . 0.57 ' O ' ' N ' ' A' ' 73' ' ' ALA . 45.8 t -124.35 99.38 6.25 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.85 0 O-C-N 121.616 -0.677 . . . . 0.0 109.42 179.497 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 88' ' ' TYR . . . . . . . . . . . . . 26.1 m-85 -90.08 155.52 47.08 Favored Pre-proline 0 N--CA 1.506 2.345 0 O-C-N 120.861 -1.149 . . . . 0.0 109.716 -179.806 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 89' ' ' PRO . . . . . 0.578 ' O ' ' NE2' ' A' ' 96' ' ' GLN . 18.3 Cg_endo -65.62 145.46 81.81 Favored 'Trans proline' 0 N--CA 1.494 1.522 0 C-N-CA 122.486 2.124 . . . . 0.0 113.946 -179.587 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . -53.1 166.5 1.41 Allowed Glycine 0 N--CA 1.49 2.261 0 N-CA-C 109.369 -1.492 . . . . 0.0 109.369 179.167 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 91' ' ' PRO . . . . . 0.478 ' C ' ' H ' ' A' ' 93' ' ' THR . 57.8 Cg_endo -93.72 167.47 20.81 Favored 'Cis proline' 0 C--N 1.308 -1.589 0 C-N-CA 123.756 -1.352 . . . . 0.0 111.583 0.14 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 92' ' ' ALA . . . . . . . . . . . . . . . -73.32 31.07 0.07 Allowed 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.104 -0.997 . . . . 0.0 110.495 -179.781 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 93' ' ' THR . . . . . 0.478 ' H ' ' C ' ' A' ' 91' ' ' PRO . 1.4 p -73.16 153.01 90.57 Favored Pre-proline 0 N--CA 1.49 1.534 0 O-C-N 120.725 -1.234 . . . . 0.0 109.288 -179.65 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 94' ' ' PRO . . . . . . . . . . . . . 89.8 Cg_exo -33.22 -56.83 0.35 Allowed 'Trans proline' 0 C--N 1.311 -1.431 0 C-N-CA 122.982 2.454 . . . . 0.0 112.299 -179.686 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 41.1 mt-10 -46.5 -48.33 19.24 Favored 'General case' 0 N--CA 1.488 1.444 0 O-C-N 121.171 -0.955 . . . . 0.0 108.874 179.813 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 96' ' ' GLN . . . . . 0.578 ' NE2' ' O ' ' A' ' 89' ' ' PRO . 3.4 mm-40 -72.29 -54.95 8.04 Favored 'General case' 0 C--N 1.305 -1.333 0 O-C-N 121.192 -0.942 . . . . 0.0 109.712 179.767 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 97' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -48.33 -8.01 0.02 OUTLIER 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.254 -0.904 . . . . 0.0 109.926 -179.593 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 98' ' ' ASN . . . . . 0.741 HD22 ' HE ' ' A' ' 99' ' ' ARG . 0.1 OUTLIER -74.41 -24.45 59.11 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.163 -0.961 . . . . 0.0 109.162 179.672 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 99' ' ' ARG . . . . . 0.741 ' HE ' HD22 ' A' ' 98' ' ' ASN . 4.2 mtt180 -95.2 -53.65 3.71 Favored 'General case' 0 C--N 1.3 -1.561 0 O-C-N 121.659 -0.651 . . . . 0.0 110.294 -178.813 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . 177.52 -159.7 25.9 Favored Glycine 0 N--CA 1.492 2.402 0 C-N-CA 119.366 -1.397 . . . . 0.0 110.167 179.807 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 101' ' ' VAL . . . . . 0.526 ' O ' ' CG2' ' A' ' 101' ' ' VAL . 25.0 m -62.03 100.07 0.15 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.629 0 O-C-N 121.523 -0.986 . . . . 0.0 109.296 -179.911 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 102' ' ' SER . . . . . 0.558 ' HG ' ' CD ' ' A' ' 96' ' ' GLN . 1.6 m -93.35 159.9 15.06 Favored 'General case' 0 C--N 1.298 -1.644 0 O-C-N 121.2 -0.938 . . . . 0.0 110.156 -179.963 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 103' ' ' PHE . . . . . . . . . . . . . 21.2 m-85 -59.63 160.72 6.88 Favored 'General case' 0 N--CA 1.49 1.57 0 N-CA-C 107.869 -1.16 . . . . 0.0 107.869 178.671 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 104' ' ' ALA . . . . . . . . . . . . . . . -72.33 -28.16 62.88 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.211 -0.93 . . . . 0.0 111.814 -177.932 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -135.25 150.45 50.06 Favored 'General case' 0 N--CA 1.495 1.819 0 O-C-N 120.822 -1.174 . . . . 0.0 111.023 -178.518 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 106' ' ' GLU . . . . . 0.454 ' CG ' ' H ' ' A' ' 107' ' ' ASN . 1.3 pt-20 -54.15 -63.33 1.18 Allowed 'General case' 0 N--CA 1.487 1.402 0 CA-C-N 115.999 -0.546 . . . . 0.0 111.293 -179.256 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 107' ' ' ASN . . . . . 0.454 ' H ' ' CG ' ' A' ' 106' ' ' GLU . 15.8 m120 -75.84 32.46 0.11 Allowed 'General case' 0 N--CA 1.49 1.543 0 O-C-N 120.175 -1.578 . . . . 0.0 112.621 -175.398 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 108' ' ' GLU . . . . . . . . . . . . . 44.6 tp10 -60.48 148.55 37.26 Favored 'General case' 0 C--N 1.299 -1.597 0 C-N-CA 118.865 -1.134 . . . . 0.0 108.008 -179.684 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 109' ' ' SER . . . . . 0.576 ' C ' ' H ' ' A' ' 111' ' ' ASP . 1.3 t -96.57 121.62 38.59 Favored 'General case' 0 C--N 1.302 -1.49 0 O-C-N 121.039 -1.038 . . . . 0.0 109.683 -178.77 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 110' ' ' LEU . . . . . . . . . . . . . 12.7 tp -59.19 -1.57 0.2 Allowed 'General case' 0 C--N 1.302 -1.479 0 N-CA-C 108.54 -0.911 . . . . 0.0 108.54 -179.912 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 111' ' ' ASP . . . . . 0.576 ' H ' ' C ' ' A' ' 109' ' ' SER . 8.7 m-20 -131.77 20.58 4.62 Favored 'General case' 0 N--CA 1.487 1.406 0 N-CA-C 108.927 -0.768 . . . . 0.0 108.927 179.36 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 112' ' ' ASP . . . . . 0.428 ' C ' ' H ' ' A' ' 114' ' ' ASN . 0.3 OUTLIER -65.47 133.82 52.1 Favored 'General case' 0 N--CA 1.49 1.525 0 O-C-N 121.348 -0.845 . . . . 0.0 109.944 -179.958 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 113' ' ' GLN . . . . . 0.594 ' NE2' ' O ' ' A' ' 173' ' ' LYS . 0.0 OUTLIER -65.46 -4.33 5.62 Favored 'General case' 0 C--N 1.303 -1.436 0 O-C-N 121.058 -1.026 . . . . 0.0 108.869 179.032 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 114' ' ' ASN . . . . . 0.685 ' ND2' ' NE2' ' A' ' 178' ' ' GLN . 18.4 t-20 -143.38 91.19 2.24 Favored 'General case' 0 C--N 1.301 -1.517 0 N-CA-C 107.559 -1.274 . . . . 0.0 107.559 178.409 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 115' ' ' ILE . . . . . . . . . . . . . 3.3 mt -100.69 115.14 41.61 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.466 0 O-C-N 121.627 -0.671 . . . . 0.0 109.913 -178.913 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 116' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -101.82 145.53 29.05 Favored 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.345 -0.847 . . . . 0.0 110.93 -179.149 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 117' ' ' ILE . . . . . . . . . . . . . 1.2 mt -135.15 157.38 40.37 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.461 0 N-CA-C 108.101 -1.074 . . . . 0.0 108.101 179.521 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 118' ' ' ALA . . . . . . . . . . . . . . . -142.62 161.82 37.08 Favored 'General case' 0 N--CA 1.492 1.658 0 O-C-N 120.822 -1.174 . . . . 0.0 111.177 -179.611 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 119' ' ' GLY . . . . . . . . . . . . . . . -170.29 143.54 7.87 Favored Glycine 0 N--CA 1.49 2.249 0 C-N-CA 120.191 -1.004 . . . . 0.0 110.755 179.801 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 120' ' ' HIS . . . . . . . . . . . . . 29.9 m170 -71.16 167.86 18.44 Favored 'General case' 0 N--CA 1.493 1.693 0 O-C-N 121.674 -0.898 . . . . 0.0 109.514 179.024 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 121' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -118.29 159.57 23.14 Favored 'General case' 0 N--CA 1.496 1.863 0 O-C-N 121.211 -0.931 . . . . 0.0 108.84 179.449 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 122' ' ' PHE . . . . . . . . . . . . . 0.5 OUTLIER -143.68 127.97 17.77 Favored 'General case' 0 N--CA 1.497 1.918 0 O-C-N 120.935 -1.103 . . . . 0.0 109.705 -179.623 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 123' ' ' ILE . . . . . . . . . . . . . 4.4 tt -64.66 -40.11 87.92 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.55 0 N-CA-C 108.982 -0.748 . . . . 0.0 108.982 179.858 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 124' ' ' ASP . . . . . . . . . . . . . 70.3 m-20 -89.11 26.08 1.69 Allowed 'General case' 0 N--CA 1.496 1.829 0 O-C-N 121.563 -0.711 . . . . 0.0 112.253 -177.358 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 125' ' ' ARG . . . . . 0.671 HH11 ' CG ' ' A' ' 125' ' ' ARG . 1.8 mtt-85 -154.29 100.77 2.45 Favored Pre-proline 0 N--CA 1.496 1.826 0 O-C-N 120.754 -1.216 . . . . 0.0 109.692 179.781 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 126' ' ' PRO . . . . . . . . . . . . . 73.1 Cg_endo -80.69 -28.08 2.9 Favored 'Trans proline' 0 C--N 1.315 -1.195 0 C-N-CA 122.107 1.871 . . . . 0.0 112.546 -179.934 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 127' ' ' ASN . . . . . 0.427 ' O ' ' O ' ' A' ' 128' ' ' TYR . 1.6 m120 -91.61 7.5 41.19 Favored 'General case' 0 N--CA 1.489 1.478 0 O-C-N 121.089 -1.007 . . . . 0.0 109.715 -179.864 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 128' ' ' TYR . . . . . 0.687 ' CE2' ' NE2' ' A' ' 129' ' ' GLN . 4.6 t80 -60.48 -151.25 0.0 OUTLIER 'General case' 0 C--N 1.301 -1.529 0 O-C-N 121.258 -0.901 . . . . 0.0 109.84 -179.733 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 129' ' ' GLN . . . . . 0.687 ' NE2' ' CE2' ' A' ' 128' ' ' TYR . 2.6 mp0 -67.78 -71.57 0.2 Allowed 'General case' 0 N--CA 1.489 1.478 0 O-C-N 121.341 -0.849 . . . . 0.0 110.051 -179.482 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 130' ' ' PHE . . . . . 0.463 ' CE2' ' CG1' ' A' ' 101' ' ' VAL . 55.4 m-85 -135.44 50.82 2.1 Favored 'General case' 0 N--CA 1.492 1.673 0 O-C-N 121.193 -0.942 . . . . 0.0 110.473 -179.371 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 131' ' ' THR . . . . . . . . . . . . . 2.9 m -82.13 -38.77 24.26 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.031 -1.043 . . . . 0.0 108.81 179.067 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 132' ' ' ASN . . . . . . . . . . . . . 4.8 t30 -84.34 6.42 23.12 Favored 'General case' 0 N--CA 1.494 1.731 0 C-N-CA 120.083 -0.647 . . . . 0.0 111.121 -178.91 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 133' ' ' LEU . . . . . 0.598 ' O ' ' N ' ' A' ' 135' ' ' ALA . 0.2 OUTLIER -68.5 -47.75 66.18 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 120.906 -1.121 . . . . 0.0 110.69 -179.04 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 134' ' ' LYS . . . . . 0.552 ' H ' ' CD ' ' A' ' 134' ' ' LYS . 0.1 OUTLIER -42.15 -18.48 0.01 OUTLIER 'General case' 0 N--CA 1.494 1.747 0 O-C-N 121.098 -1.001 . . . . 0.0 109.949 -179.025 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 135' ' ' ALA . . . . . 0.598 ' N ' ' O ' ' A' ' 133' ' ' LEU . . . -83.87 -31.82 25.53 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.063 -1.023 . . . . 0.0 109.94 -179.946 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 136' ' ' ALA . . . . . 0.476 ' N ' ' O ' ' A' ' 133' ' ' LEU . . . -80.78 153.99 27.45 Favored 'General case' 0 N--CA 1.489 1.518 0 CA-C-O 122.163 0.982 . . . . 0.0 112.142 -178.366 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 137' ' ' LYS . . . . . 0.524 ' O ' ' O ' ' A' ' 138' ' ' LYS . 4.8 tttt -150.92 -166.93 2.67 Favored 'General case' 0 N--CA 1.493 1.717 0 C-N-CA 118.926 -1.11 . . . . 0.0 110.879 -178.197 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 138' ' ' LYS . . . . . 0.592 ' O ' ' N ' ' A' ' 140' ' ' SER . 36.3 mttm -44.45 178.72 0.0 OUTLIER 'General case' 0 N--CA 1.487 1.378 0 CA-C-O 122.221 1.01 . . . . 0.0 110.971 -178.755 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 139' ' ' GLY . . . . . . . . . . . . . . . 46.6 7.59 0.02 OUTLIER Glycine 0 N--CA 1.491 2.351 0 N-CA-C 110.545 -1.022 . . . . 0.0 110.545 -179.959 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 140' ' ' SER . . . . . 0.592 ' N ' ' O ' ' A' ' 138' ' ' LYS . 48.7 m -84.77 121.57 27.88 Favored 'General case' 0 N--CA 1.495 1.785 0 O-C-N 120.809 -1.406 . . . . 0.0 109.215 179.244 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 141' ' ' MET . . . . . 0.646 ' SD ' ' N ' ' A' ' 142' ' ' VAL . 10.8 tpp -72.47 131.76 42.98 Favored 'General case' 0 N--CA 1.488 1.462 0 O-C-N 121.125 -0.984 . . . . 0.0 109.223 179.898 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 142' ' ' VAL . . . . . 0.646 ' N ' ' SD ' ' A' ' 141' ' ' MET . 3.2 t -116.02 133.13 63.46 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.702 0 N-CA-C 108.794 -0.817 . . . . 0.0 108.794 -179.593 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 143' ' ' TYR . . . . . . . . . . . . . 17.9 m-85 -109.23 135.28 50.59 Favored 'General case' 0 N--CA 1.497 1.92 0 O-C-N 120.89 -1.132 . . . . 0.0 111.531 -178.434 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 144' ' ' PHE . . . . . . . . . . . . . 49.1 t80 -120.25 101.86 8.1 Favored 'General case' 0 N--CA 1.495 1.793 0 C-N-CA 120.359 -0.536 . . . . 0.0 109.566 -179.432 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 145' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -96.65 132.1 42.64 Favored 'General case' 0 N--CA 1.493 1.708 0 O-C-N 121.205 -0.935 . . . . 0.0 110.878 -178.822 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 146' ' ' VAL . . . . . 0.414 ' O ' ' C ' ' A' ' 147' ' ' GLY . 0.1 OUTLIER -142.96 143.78 24.79 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.738 0 N-CA-C 107.764 -1.199 . . . . 0.0 107.764 178.655 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 147' ' ' GLY . . . . . 0.414 ' C ' ' O ' ' A' ' 146' ' ' VAL . . . 44.37 -130.77 7.25 Favored Glycine 0 N--CA 1.489 2.221 0 O-C-N 120.28 -1.512 . . . . 0.0 109.324 -179.958 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 148' ' ' ASN . . . . . 0.558 ' C ' HD21 ' A' ' 148' ' ' ASN . 0.4 OUTLIER -102.86 18.49 21.4 Favored 'General case' 0 C--N 1.3 -1.572 0 O-C-N 121.374 -1.074 . . . . 0.0 108.588 179.537 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 149' ' ' GLU . . . . . . . . . . . . . 8.4 tt0 -114.38 147.94 38.41 Favored 'General case' 0 N--CA 1.489 1.523 0 CA-C-O 121.862 0.839 . . . . 0.0 111.249 -178.538 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 150' ' ' THR . . . . . . . . . . . . . 1.2 m -129.24 105.68 8.31 Favored 'General case' 0 N--CA 1.492 1.646 0 CA-C-O 121.585 0.707 . . . . 0.0 109.675 179.941 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 151' ' ' ARG . . . . . . . . . . . . . 10.8 mtp180 -87.34 -171.6 3.55 Favored 'General case' 0 N--CA 1.487 1.401 0 N-CA-C 108.624 -0.88 . . . . 0.0 108.624 -179.967 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 152' ' ' LYS . . . . . . . . . . . . . 1.1 ttmt -150.41 147.36 27.46 Favored 'General case' 0 C--N 1.303 -1.442 0 O-C-N 120.918 -1.114 . . . . 0.0 110.787 -179.299 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 153' ' ' TYR . . . . . 0.562 ' O ' ' SD ' ' A' ' 141' ' ' MET . 22.2 m-85 -142.2 165.6 26.98 Favored 'General case' 0 N--CA 1.49 1.574 0 N-CA-C 108.024 -1.102 . . . . 0.0 108.024 179.24 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 154' ' ' LYS . . . . . . . . . . . . . 30.9 ttpt -142.91 121.02 12.15 Favored 'General case' 0 N--CA 1.493 1.684 0 O-C-N 121.061 -1.025 . . . . 0.0 108.666 178.854 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 155' ' ' MET . . . . . . . . . . . . . 4.1 mtt -47.1 105.9 0.08 Allowed 'General case' 0 N--CA 1.493 1.687 0 O-C-N 120.889 -1.132 . . . . 0.0 112.017 -178.419 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 156' ' ' THR . . . . . 0.519 ' OG1' ' CG2' ' A' ' 203' ' ' THR . 0.0 OUTLIER -107.46 -23.38 12.21 Favored 'General case' 0 C--N 1.293 -1.886 0 CA-C-N 115.16 -0.927 . . . . 0.0 110.112 -179.572 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 157' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -153.16 150.43 29.06 Favored 'General case' 0 C--N 1.296 -1.728 0 C-N-CA 118.388 -1.325 . . . . 0.0 111.363 -178.797 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 158' ' ' ILE . . . . . 0.422 HG13 ' CD2' ' A' ' 200' ' ' PHE . 0.0 OUTLIER -154.18 145.12 14.08 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.357 0 CA-C-O 121.872 0.844 . . . . 0.0 110.055 -179.276 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 159' ' ' ARG . . . . . 0.417 ' N ' HG12 ' A' ' 158' ' ' ILE . 0.1 OUTLIER -151.38 156.6 41.04 Favored 'General case' 0 C--N 1.3 -1.568 0 CA-C-O 121.52 0.676 . . . . 0.0 109.747 -179.792 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 160' ' ' ASP . . . . . 0.467 ' N ' ' OD1' ' A' ' 160' ' ' ASP . 2.2 m-20 -117.62 157.08 27.04 Favored 'General case' 0 N--CA 1.49 1.563 0 N-CA-C 108.781 -0.822 . . . . 0.0 108.781 -179.909 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 161' ' ' VAL . . . . . . . . . . . . . 0.1 OUTLIER -163.43 160.24 1.29 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.654 0 O-C-N 121.072 -1.017 . . . . 0.0 110.49 -179.912 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 162' ' ' LYS . . . . . . . . . . . . . 14.1 ptmt -52.13 177.88 0.06 OUTLIER Pre-proline 0 N--CA 1.49 1.562 0 N-CA-C 108.694 -0.854 . . . . 0.0 108.694 179.043 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 163' ' ' PRO . . . . . . . . . . . . . 37.3 Cg_endo -86.63 43.39 1.03 Allowed 'Trans proline' 0 C--N 1.316 -1.18 0 C-N-CA 122.238 1.959 . . . . 0.0 112.502 -179.344 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 164' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -151.93 -11.21 0.2 Allowed 'General case' 0 N--CA 1.494 1.741 0 O-C-N 121.262 -0.899 . . . . 0.0 110.372 -179.972 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 165' ' ' ASP . . . . . 0.449 ' O ' ' C ' ' A' ' 166' ' ' VAL . 1.2 t70 -73.21 61.93 0.65 Allowed 'General case' 0 N--CA 1.49 1.558 0 O-C-N 120.867 -1.146 . . . . 0.0 110.258 -179.301 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 166' ' ' VAL . . . . . 0.623 ' O ' ' N ' ' A' ' 168' ' ' VAL . 0.9 OUTLIER -41.89 -31.42 0.35 Allowed 'Isoleucine or valine' 0 N--CA 1.494 1.73 0 O-C-N 121.399 -0.813 . . . . 0.0 109.023 -178.329 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 167' ' ' GLY . . . . . . . . . . . . . . . -42.65 -13.38 0.01 OUTLIER Glycine 0 N--CA 1.494 2.546 0 O-C-N 121.06 -1.025 . . . . 0.0 110.742 179.892 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 168' ' ' VAL . . . . . 0.636 ' C ' ' H ' ' A' ' 170' ' ' ASP . 6.1 m -53.46 -35.64 25.67 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.468 0 O-C-N 120.708 -1.466 . . . . 0.0 108.738 179.62 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 169' ' ' LEU . . . . . 0.522 ' O ' ' N ' ' A' ' 171' ' ' GLU . 27.8 mt -51.86 -7.19 0.05 OUTLIER 'General case' 0 N--CA 1.495 1.805 0 N-CA-C 108.004 -1.11 . . . . 0.0 108.004 -179.272 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 170' ' ' ASP . . . . . 0.636 ' H ' ' C ' ' A' ' 168' ' ' VAL . 34.4 t0 35.16 28.58 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.525 0 O-C-N 121.764 -0.585 . . . . 0.0 111.87 177.687 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 171' ' ' GLU . . . . . 0.522 ' N ' ' O ' ' A' ' 169' ' ' LEU . 12.7 pt-20 -62.3 94.26 0.06 Allowed 'General case' 0 N--CA 1.494 1.767 0 O-C-N 120.382 -1.449 . . . . 0.0 107.45 178.105 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 172' ' ' GLN . . . . . . . . . . . . . 2.2 mt-30 -152.66 -78.16 0.11 Allowed 'General case' 0 N--CA 1.497 1.877 0 O-C-N 121.434 -0.791 . . . . 0.0 110.548 -178.595 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 173' ' ' LYS . . . . . 0.594 ' O ' ' NE2' ' A' ' 113' ' ' GLN . 1.0 OUTLIER -55.95 136.52 51.77 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.43 -0.794 . . . . 0.0 109.386 -179.432 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 174' ' ' GLY . . . . . 0.477 ' O ' ' C ' ' A' ' 175' ' ' LYS . . . -120.03 -45.78 0.4 Allowed Glycine 0 N--CA 1.479 1.527 0 N-CA-C 107.441 -2.263 . . . . 0.0 107.441 179.239 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 175' ' ' LYS . . . . . 0.477 ' C ' ' O ' ' A' ' 174' ' ' GLY . 0.4 OUTLIER -38.13 -75.44 0.03 OUTLIER 'General case' 0 N--CA 1.493 1.724 0 N-CA-C 108.272 -1.011 . . . . 0.0 108.272 179.562 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 176' ' ' ASP . . . . . 0.547 ' O ' ' O ' ' A' ' 177' ' ' LYS . 66.7 m-20 -89.97 94.7 9.9 Favored 'General case' 0 C--N 1.296 -1.754 0 N-CA-C 106.967 -1.494 . . . . 0.0 106.967 177.943 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 177' ' ' LYS . . . . . 0.547 ' O ' ' O ' ' A' ' 176' ' ' ASP . 19.6 mttp -44.19 -178.4 0.0 OUTLIER 'General case' 0 N--CA 1.493 1.687 0 CA-C-O 121.487 0.66 . . . . 0.0 110.795 -178.311 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 178' ' ' GLN . . . . . 0.685 ' NE2' ' ND2' ' A' ' 114' ' ' ASN . 20.3 pt20 -161.06 161.38 31.29 Favored 'General case' 0 N--CA 1.487 1.386 0 C-N-CA 118.557 -1.257 . . . . 0.0 111.089 179.86 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 179' ' ' LEU . . . . . . . . . . . . . 1.2 tp -123.6 94.34 4.21 Favored 'General case' 0 C--N 1.303 -1.445 0 N-CA-C 106.944 -1.502 . . . . 0.0 106.944 177.398 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 180' ' ' THR . . . . . . . . . . . . . 3.3 m -71.64 120.32 17.06 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.111 -0.993 . . . . 0.0 110.427 -178.097 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 181' ' ' LEU . . . . . 0.423 HD13 ' H ' ' A' ' 182' ' ' ILE . 34.4 tp -95.98 142.6 28.01 Favored 'General case' 0 C--N 1.302 -1.498 0 N-CA-C 108.153 -1.054 . . . . 0.0 108.153 178.338 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 182' ' ' ILE . . . . . 0.423 ' H ' HD13 ' A' ' 181' ' ' LEU . 3.9 mt -136.39 109.69 8.83 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.612 0 O-C-N 121.02 -1.05 . . . . 0.0 108.689 178.9 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 183' ' ' THR . . . . . . . . . . . . . 4.4 t -129.76 113.06 14.25 Favored 'General case' 0 C--N 1.293 -1.881 0 N-CA-C 107.337 -1.357 . . . . 0.0 107.337 179.327 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 184' ' ' CYS . . . . . . . . . . . . . 0.8 OUTLIER -79.23 164.03 24.49 Favored 'General case' 0 C--N 1.289 -2.026 0 C-N-CA 118.994 -1.082 . . . . 0.0 111.145 -177.691 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 185' ' ' ASP . . . . . . . . . . . . . 9.9 t0 -165.2 -154.33 0.21 Allowed 'General case' 0 N--CA 1.493 1.687 0 N-CA-C 108.892 -0.781 . . . . 0.0 108.892 -179.829 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 186' ' ' ASP . . . . . . . . . . . . . 1.5 m-20 49.43 59.28 4.6 Favored 'General case' 0 N--CA 1.495 1.802 0 O-C-N 120.95 -1.094 . . . . 0.0 108.971 -179.666 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 187' ' ' TYR . . . . . 0.607 ' CE2' ' O ' ' A' ' 188' ' ' ASN . 68.2 t80 -67.4 138.76 56.94 Favored 'General case' 0 N--CA 1.491 1.579 0 CA-C-O 121.85 0.833 . . . . 0.0 110.871 -179.184 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 188' ' ' ASN . . . . . 0.607 ' O ' ' CE2' ' A' ' 187' ' ' TYR . 0.7 OUTLIER -104.32 143.72 32.59 Favored 'General case' 0 C--N 1.299 -1.589 0 N-CA-C 108.305 -0.998 . . . . 0.0 108.305 178.391 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 189' ' ' GLU . . . . . . . . . . . . . 2.5 tt0 -108.22 -17.05 14.11 Favored 'General case' 0 C--N 1.293 -1.891 0 N-CA-C 108.879 -0.786 . . . . 0.0 108.879 -179.284 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 190' ' ' LYS . . . . . . . . . . . . . 24.4 mmtm -82.77 -51.64 7.49 Favored 'General case' 0 C--N 1.301 -1.541 0 C-N-CA 119.792 -0.763 . . . . 0.0 108.96 179.154 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 191' ' ' THR . . . . . . . . . . . . . 4.1 p -89.83 -10.91 43.64 Favored 'General case' 0 N--CA 1.489 1.477 0 O-C-N 121.442 -0.786 . . . . 0.0 109.802 -179.608 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 192' ' ' GLY . . . . . . . . . . . . . . . 63.73 39.32 97.36 Favored Glycine 0 N--CA 1.494 2.537 0 O-C-N 120.945 -1.097 . . . . 0.0 110.375 179.25 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 193' ' ' VAL . . . . . 0.516 ' CG1' ' N ' ' A' ' 194' ' ' TRP . 55.4 t -147.99 163.45 6.19 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.571 0 O-C-N 121.114 -1.227 . . . . 0.0 109.679 179.959 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 194' ' ' TRP . . . . . 0.516 ' N ' ' CG1' ' A' ' 193' ' ' VAL . 10.0 m95 -82.29 118.81 23.41 Favored 'General case' 0 C--N 1.301 -1.524 0 N-CA-C 108.356 -0.979 . . . . 0.0 108.356 179.613 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 195' ' ' GLU . . . . . 0.545 ' CD ' ' ND2' ' A' ' 188' ' ' ASN . 2.8 mt-10 -79.2 -60.82 2.22 Favored 'General case' 0 N--CA 1.493 1.692 0 O-C-N 121.32 -0.863 . . . . 0.0 110.946 -178.528 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 196' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -95.29 152.82 18.04 Favored 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.197 -0.939 . . . . 0.0 110.121 -178.789 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 197' ' ' ARG . . . . . 0.621 ' CG ' HH11 ' A' ' 197' ' ' ARG . 0.1 OUTLIER -122.94 143.18 50.07 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.668 -0.645 . . . . 0.0 109.723 179.86 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 198' ' ' LYS . . . . . 0.441 ' NZ ' ' OD2' ' A' ' 160' ' ' ASP . 4.2 mptp? -113.77 120.72 41.75 Favored 'General case' 0 C--N 1.302 -1.487 0 O-C-N 121.7 -0.625 . . . . 0.0 109.56 -179.68 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 199' ' ' ILE . . . . . 0.435 ' C ' ' CD1' ' A' ' 199' ' ' ILE . 0.5 OUTLIER -139.66 118.41 12.13 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.677 0 CA-C-O 122.502 1.144 . . . . 0.0 109.829 179.926 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 200' ' ' PHE . . . . . 0.527 ' CD1' ' N ' ' A' ' 200' ' ' PHE . 6.6 m-85 -100.57 138.5 37.54 Favored 'General case' 0 N--CA 1.494 1.728 0 O-C-N 121.353 -0.842 . . . . 0.0 109.912 -178.626 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 201' ' ' VAL . . . . . . . . . . . . . 44.6 t -101.61 136.34 33.97 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.543 0 N-CA-C 107.795 -1.187 . . . . 0.0 107.795 177.662 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 202' ' ' ALA . . . . . . . . . . . . . . . -121.16 134.59 55.23 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.238 -0.914 . . . . 0.0 109.171 -179.939 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 203' ' ' THR . . . . . 0.519 ' CG2' ' OG1' ' A' ' 156' ' ' THR . 13.7 p -88.76 133.34 34.27 Favored 'General case' 0 C--N 1.306 -1.316 0 CA-C-O 122.158 0.98 . . . . 0.0 110.99 -178.72 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 204' ' ' GLU . . . . . 0.497 ' HA ' ' CD2' ' A' ' 153' ' ' TYR . 3.1 tt0 -51.72 133.84 30.87 Favored 'General case' 0 C--N 1.297 -1.686 0 C-N-CA 118.811 -1.155 . . . . 0.0 109.38 179.394 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 205' ' ' VAL . . . . . 0.477 ' CG1' ' N ' ' A' ' 206' ' ' LYS . 44.3 t -127.53 161.66 34.64 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.295 0 CA-C-O 122.044 0.926 . . . . 0.0 110.242 -177.59 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 206' ' ' LYS . . . . . 0.477 ' N ' ' CG1' ' A' ' 205' ' ' VAL . 70.7 mttt . . . . . 0 C--N 1.296 -1.731 0 CA-C-O 118.047 -0.978 . . . . 0.0 109.294 179.85 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' C' C ' 701' ' ' PHQ . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 008 nuclear orig full ' C' C ' 702' ' ' LEU . . . . . 0.56 ' H ' ' CD1' ' C' ' 702' ' ' LEU . 0.0 OUTLIER . . . . . 0 N--CA 1.492 1.661 0 N-CA-C 109.227 -0.657 . . . . 0.0 109.227 . . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' C' C ' 703' ' ' PRO . . . . . 0.551 ' O ' ' NH2' ' A' ' 197' ' ' ARG . 16.3 Cg_endo -57.99 162.98 10.29 Favored 'Trans proline' 0 N--CA 1.499 1.845 0 C-N-CA 123.633 2.888 . . . . 0.0 113.55 -178.934 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' C' C ' 704' ' ' ALA . . . . . 0.47 ' C ' ' O ' ' C' ' 703' ' ' PRO . . . 34.97 -151.38 0.0 OUTLIER 'General case' 0 N--CA 1.491 1.622 0 CA-C-O 121.39 0.614 . . . . 0.0 110.277 179.274 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' C' C ' 705' ' ' B27 . . . . . 0.46 ' OG1' ' NE1' ' A' ' 194' ' ' TRP . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 700' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 009 nuclear orig full ' A' A ' 59' ' ' MET . . . . . . . . . . . . . 1.1 ttp . . . . . 0 N--CA 1.49 1.555 0 CA-C-O 121.31 0.576 . . . . 0.0 109.491 . . . . . . . . . 0 0 . 1 . 009 nuclear orig full ' A' A ' 60' ' ' GLN . . . . . . . . . . . . . 1.5 tt0 -60.89 145.24 50.9 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.298 -0.876 . . . . 0.0 109.702 -179.936 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 61' ' ' ALA . . . . . 0.41 ' HB2' HD22 ' A' ' 148' ' ' ASN . . . -64.71 172.24 2.87 Favored 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.156 -0.965 . . . . 0.0 109.479 179.908 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 62' ' ' LYS . . . . . . . . . . . . . 6.8 tttt -143.77 72.12 17.11 Favored Pre-proline 0 N--CA 1.489 1.478 0 O-C-N 121.156 -0.965 . . . . 0.0 109.59 179.848 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 63' ' ' PRO . . . . . . . . . . . . . 52.1 Cg_endo -88.4 156.54 6.64 Favored 'Trans proline' 0 C--N 1.305 -1.763 0 C-N-CA 123.6 2.867 . . . . 0.0 111.467 179.536 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 64' ' ' GLN . . . . . 0.638 ' NE2' ' N ' ' A' ' 64' ' ' GLN . 0.0 OUTLIER -156.36 127.73 7.1 Favored 'General case' 0 N--CA 1.495 1.793 0 O-C-N 120.955 -1.091 . . . . 0.0 109.62 179.366 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 65' ' ' ILE . . . . . 0.533 ' H ' ' CD1' ' A' ' 65' ' ' ILE . 0.0 OUTLIER -50.79 110.03 1.58 Allowed Pre-proline 0 N--CA 1.49 1.552 0 O-C-N 121.085 -1.009 . . . . 0.0 109.195 178.929 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 66' ' ' PRO . . . . . . . . . . . . . 89.0 Cg_endo -85.64 -154.47 0.05 OUTLIER 'Trans proline' 0 C--N 1.312 -1.392 0 C-N-CA 121.954 1.769 . . . . 0.0 111.712 179.607 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 67' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -83.71 -4.69 58.83 Favored 'General case' 0 N--CA 1.488 1.46 0 O-C-N 121.189 -0.944 . . . . 0.0 109.185 179.553 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 68' ' ' ASP . . . . . 0.634 ' C ' ' N ' ' A' ' 70' ' ' SER . 4.6 t0 -76.14 52.1 0.71 Allowed 'General case' 0 N--CA 1.49 1.574 0 CA-C-O 122.221 1.01 . . . . 0.0 110.099 -179.689 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 69' ' ' LYS . . . . . 0.413 ' C ' ' O ' ' A' ' 68' ' ' ASP . 0.0 OUTLIER -49.38 -13.45 0.08 Allowed 'General case' 0 N--CA 1.507 2.375 0 C-N-CA 116.723 -1.991 . . . . 0.0 106.749 177.593 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 70' ' ' SER . . . . . 0.634 ' N ' ' C ' ' A' ' 68' ' ' ASP . 0.0 OUTLIER -83.31 -8.22 59.47 Favored 'General case' 0 N--CA 1.497 1.896 0 CA-C-N 113.331 -1.759 . . . . 0.0 110.381 179.557 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 71' ' ' LYS . . . . . . . . . . . . . 8.3 ptmt -101.88 142.88 32.49 Favored 'General case' 0 N--CA 1.495 1.793 0 O-C-N 121.021 -1.049 . . . . 0.0 110.643 179.875 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 0.9 OUTLIER -64.92 142.63 16.68 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.434 0 N-CA-C 105.309 -2.108 . . . . 0.0 105.309 175.291 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 73' ' ' ALA . . . . . 0.498 ' N ' ' O ' ' A' ' 87' ' ' VAL . . . -83.16 -14.0 54.39 Favored 'General case' 0 C--N 1.296 -1.757 0 O-C-N 120.101 -1.624 . . . . 0.0 107.134 179.944 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . 173.83 -157.11 25.1 Favored Glycine 0 C--N 1.296 -1.677 0 N-CA-C 108.595 -1.802 . . . . 0.0 108.595 179.472 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 75' ' ' TYR . . . . . 0.55 ' CE1' ' N ' ' A' ' 86' ' ' PRO . 0.3 OUTLIER -142.96 171.09 14.52 Favored 'General case' 0 C--N 1.292 -1.909 0 O-C-N 121.441 -1.034 . . . . 0.0 110.335 -177.624 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 76' ' ' ILE . . . . . . . . . . . . . 0.5 OUTLIER -148.12 143.72 19.19 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.601 0 C-N-CA 119.048 -1.061 . . . . 0.0 109.77 -177.29 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 2.2 mt-10 -151.53 163.35 39.23 Favored 'General case' 0 C--N 1.304 -1.41 0 O-C-N 121.136 -0.977 . . . . 0.0 109.254 179.573 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 78' ' ' ILE . . . . . . . . . . . . . 14.6 mt -144.77 126.51 7.95 Favored Pre-proline 0 N--CA 1.492 1.656 0 N-CA-C 108.538 -0.912 . . . . 0.0 108.538 179.886 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 79' ' ' PRO . . . . . . . . . . . . . 36.0 Cg_endo -71.52 -48.73 0.39 Allowed 'Trans proline' 0 N--CA 1.491 1.362 0 C-N-CA 122.011 1.807 . . . . 0.0 113.501 -179.064 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 50.5 t0 -66.48 -21.24 66.18 Favored 'General case' 0 N--CA 1.493 1.705 0 O-C-N 120.976 -1.077 . . . . 0.0 111.306 178.806 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 81' ' ' ALA . . . . . 0.6 ' O ' ' ND2' ' A' ' 132' ' ' ASN . . . -104.55 -16.44 15.04 Favored 'General case' 0 N--CA 1.493 1.685 0 O-C-N 120.833 -1.167 . . . . 0.0 108.991 179.657 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 82' ' ' ASP . . . . . . . . . . . . . 8.5 t0 61.17 53.57 3.54 Favored 'General case' 0 N--CA 1.494 1.735 0 O-C-N 121.284 -0.885 . . . . 0.0 111.462 178.518 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 83' ' ' ILE . . . . . . . . . . . . . 50.8 mt -128.96 154.45 39.98 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.794 0 O-C-N 121.027 -1.045 . . . . 0.0 109.43 -179.798 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 84' ' ' LYS . . . . . . . . . . . . . 2.1 pttt -157.81 107.72 2.14 Favored 'General case' 0 N--CA 1.487 1.422 0 N-CA-C 107.959 -1.126 . . . . 0.0 107.959 -179.786 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 85' ' ' GLU . . . . . 0.498 ' C ' ' CE1' ' A' ' 75' ' ' TYR . 0.1 OUTLIER -141.17 160.32 58.13 Favored Pre-proline 0 N--CA 1.493 1.682 0 O-C-N 121.336 -0.852 . . . . 0.0 110.126 -179.065 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 86' ' ' PRO . . . . . 0.55 ' N ' ' CE1' ' A' ' 75' ' ' TYR . 36.7 Cg_endo -68.18 168.85 18.08 Favored 'Trans proline' 0 C--N 1.307 -1.611 0 C-N-CA 123.095 2.53 . . . . 0.0 113.081 -179.061 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 87' ' ' VAL . . . . . 0.498 ' O ' ' N ' ' A' ' 73' ' ' ALA . 94.1 t -127.46 99.31 5.2 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.627 0 N-CA-C 109.106 -0.701 . . . . 0.0 109.106 179.69 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 88' ' ' TYR . . . . . . . . . . . . . 20.9 m-85 -92.34 154.18 42.86 Favored Pre-proline 0 N--CA 1.503 2.204 0 O-C-N 120.873 -1.142 . . . . 0.0 109.79 -179.734 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 89' ' ' PRO . . . . . . . . . . . . . 7.3 Cg_endo -59.02 144.6 99.3 Favored 'Trans proline' 0 C--N 1.309 -1.518 0 C-N-CA 122.476 2.117 . . . . 0.0 113.551 -179.663 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . -59.14 169.1 6.23 Favored Glycine 0 N--CA 1.494 2.541 0 N-CA-C 108.899 -1.681 . . . . 0.0 108.899 178.902 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 91' ' ' PRO . . . . . 0.47 ' C ' ' H ' ' A' ' 93' ' ' THR . 59.8 Cg_endo -93.56 168.02 20.96 Favored 'Cis proline' 0 C--N 1.31 -1.452 0 C-N-CA 124.046 -1.231 . . . . 0.0 111.916 0.619 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 92' ' ' ALA . . . . . 0.449 ' O ' ' CD1' ' A' ' 97' ' ' LEU . . . -71.99 32.05 0.06 Allowed 'General case' 0 N--CA 1.493 1.706 0 O-C-N 121.159 -0.963 . . . . 0.0 110.716 -179.664 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 93' ' ' THR . . . . . 0.47 ' H ' ' C ' ' A' ' 91' ' ' PRO . 0.8 OUTLIER -73.46 155.1 89.76 Favored Pre-proline 0 N--CA 1.489 1.523 0 O-C-N 120.692 -1.255 . . . . 0.0 108.751 -179.956 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 94' ' ' PRO . . . . . 0.401 ' C ' ' O ' ' A' ' 93' ' ' THR . 85.2 Cg_exo -34.55 -55.78 0.5 Allowed 'Trans proline' 0 C--N 1.306 -1.668 0 C-N-CA 122.818 2.346 . . . . 0.0 112.387 -179.506 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 95' ' ' GLU . . . . . 0.479 ' OE2' ' OE1' ' A' ' 96' ' ' GLN . 0.1 OUTLIER -47.36 -48.74 25.55 Favored 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.083 -1.011 . . . . 0.0 109.67 -179.812 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 96' ' ' GLN . . . . . 0.594 ' O ' ' N ' ' A' ' 98' ' ' ASN . 5.9 mp0 -71.94 -56.1 6.28 Favored 'General case' 0 N--CA 1.489 1.476 0 O-C-N 121.04 -1.038 . . . . 0.0 110.572 -179.563 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 97' ' ' LEU . . . . . 0.449 ' CD1' ' O ' ' A' ' 92' ' ' ALA . 93.6 mt -48.09 -7.0 0.02 OUTLIER 'General case' 0 N--CA 1.494 1.74 0 O-C-N 121.193 -0.942 . . . . 0.0 110.005 -178.939 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 98' ' ' ASN . . . . . 0.687 HD22 ' NE ' ' A' ' 99' ' ' ARG . 0.2 OUTLIER -73.4 -26.35 60.95 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.201 -0.937 . . . . 0.0 109.042 179.274 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 99' ' ' ARG . . . . . 0.687 ' NE ' HD22 ' A' ' 98' ' ' ASN . 4.3 mtt180 -95.08 -51.15 4.77 Favored 'General case' 0 N--CA 1.488 1.442 0 C-N-CA 119.842 -0.743 . . . . 0.0 109.783 -179.218 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . 176.44 -165.29 35.55 Favored Glycine 0 N--CA 1.491 2.325 0 C-N-CA 119.462 -1.351 . . . . 0.0 110.232 179.776 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 101' ' ' VAL . . . . . 0.477 ' CG1' ' CE2' ' A' ' 130' ' ' PHE . 21.0 m -58.47 105.76 0.19 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.632 0 O-C-N 121.498 -1.001 . . . . 0.0 109.554 -179.676 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -92.68 166.65 12.36 Favored 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.476 -0.765 . . . . 0.0 110.775 -179.519 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 103' ' ' PHE . . . . . 0.479 ' CE1' ' CG1' ' A' ' 87' ' ' VAL . 25.5 m-85 -72.25 131.15 42.34 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 120.987 -1.071 . . . . 0.0 108.176 178.458 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 104' ' ' ALA . . . . . . . . . . . . . . . -51.93 -7.21 0.05 OUTLIER 'General case' 0 C--N 1.295 -1.786 0 O-C-N 121.416 -0.802 . . . . 0.0 111.873 -178.596 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 105' ' ' GLU . . . . . 0.411 ' H ' ' C ' ' A' ' 103' ' ' PHE . 0.2 OUTLIER -141.22 139.54 33.81 Favored 'General case' 0 N--CA 1.499 2.023 0 O-C-N 120.444 -1.41 . . . . 0.0 111.469 -179.682 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 106' ' ' GLU . . . . . 0.427 ' CG ' ' H ' ' A' ' 107' ' ' ASN . 1.9 pt-20 -54.3 -62.0 1.94 Allowed 'General case' 0 N--CA 1.488 1.472 0 O-C-N 121.855 -0.528 . . . . 0.0 109.947 179.51 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 107' ' ' ASN . . . . . 0.427 ' H ' ' CG ' ' A' ' 106' ' ' GLU . 8.1 m120 -76.83 35.32 0.16 Allowed 'General case' 0 N--CA 1.489 1.483 0 O-C-N 120.545 -1.347 . . . . 0.0 111.607 -176.833 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 108' ' ' GLU . . . . . . . . . . . . . 35.1 tp10 -57.19 144.37 35.44 Favored 'General case' 0 C--N 1.303 -1.428 0 O-C-N 120.813 -1.179 . . . . 0.0 107.83 -179.802 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 109' ' ' SER . . . . . 0.578 ' C ' ' H ' ' A' ' 111' ' ' ASP . 1.2 m -101.24 124.85 47.59 Favored 'General case' 0 C--N 1.303 -1.438 0 O-C-N 121.058 -1.026 . . . . 0.0 110.648 -178.455 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 110' ' ' LEU . . . . . . . . . . . . . 3.5 tp -58.99 -3.45 0.35 Allowed 'General case' 0 C--N 1.3 -1.548 0 N-CA-C 107.693 -1.225 . . . . 0.0 107.693 179.066 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 111' ' ' ASP . . . . . 0.578 ' H ' ' C ' ' A' ' 109' ' ' SER . 1.6 m-20 -132.17 21.66 4.46 Favored 'General case' 0 N--CA 1.486 1.363 0 N-CA-C 109.128 -0.693 . . . . 0.0 109.128 179.696 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 112' ' ' ASP . . . . . 0.489 ' OD2' ' OG ' ' A' ' 109' ' ' SER . 0.2 OUTLIER -64.96 138.34 58.3 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 120.985 -1.072 . . . . 0.0 109.543 179.839 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 113' ' ' GLN . . . . . 0.552 HE21 ' C ' ' A' ' 113' ' ' GLN . 0.0 OUTLIER -66.29 -5.86 11.98 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 120.94 -1.1 . . . . 0.0 108.696 179.201 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 114' ' ' ASN . . . . . 0.608 ' OD1' ' NE2' ' A' ' 178' ' ' GLN . 4.1 t30 -145.54 97.34 2.97 Favored 'General case' 0 C--N 1.297 -1.7 0 N-CA-C 107.305 -1.369 . . . . 0.0 107.305 178.16 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 115' ' ' ILE . . . . . . . . . . . . . 1.8 mt -95.64 107.09 19.12 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.599 0 O-C-N 121.13 -0.981 . . . . 0.0 108.694 -179.522 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 116' ' ' SER . . . . . . . . . . . . . 7.5 p -90.22 154.71 19.53 Favored 'General case' 0 C--N 1.305 -1.355 0 CA-C-O 121.728 0.775 . . . . 0.0 110.814 -178.458 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 117' ' ' ILE . . . . . . . . . . . . . 3.2 mt -144.35 153.68 15.18 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.412 0 N-CA-C 108.337 -0.986 . . . . 0.0 108.337 179.135 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 118' ' ' ALA . . . . . . . . . . . . . . . -140.34 153.9 46.57 Favored 'General case' 0 N--CA 1.49 1.562 0 C-N-CA 119.217 -0.993 . . . . 0.0 110.481 -179.586 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 119' ' ' GLY . . . . . . . . . . . . . . . -166.57 148.17 13.07 Favored Glycine 0 N--CA 1.487 2.074 0 C-N-CA 119.912 -1.137 . . . . 0.0 110.715 -179.988 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 120' ' ' HIS . . . . . 0.501 ' ND1' ' SG ' ' C' ' 705' ' ' B27 . 3.2 m-70 -72.47 161.74 30.41 Favored 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.919 -0.754 . . . . 0.0 110.006 179.337 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 121' ' ' THR . . . . . . . . . . . . . 1.1 t -116.22 158.29 23.55 Favored 'General case' 0 N--CA 1.496 1.85 0 O-C-N 121.338 -0.851 . . . . 0.0 109.079 178.958 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 122' ' ' PHE . . . . . . . . . . . . . 0.3 OUTLIER -124.67 127.03 46.68 Favored 'General case' 0 N--CA 1.498 1.946 0 O-C-N 121.296 -0.877 . . . . 0.0 109.852 -179.637 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 123' ' ' ILE . . . . . 0.429 ' CG2' ' N ' ' A' ' 124' ' ' ASP . 16.3 tt -74.73 -36.74 41.08 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.665 0 CA-C-O 121.922 0.868 . . . . 0.0 109.141 179.712 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 124' ' ' ASP . . . . . 0.429 ' N ' ' CG2' ' A' ' 123' ' ' ILE . 2.0 p30 -95.54 22.49 7.01 Favored 'General case' 0 C--N 1.296 -1.756 0 O-C-N 121.827 -0.546 . . . . 0.0 111.042 -179.224 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 125' ' ' ARG . . . . . . . . . . . . . 9.4 ttt180 -157.06 107.42 1.91 Allowed Pre-proline 0 N--CA 1.492 1.674 0 O-C-N 120.518 -1.364 . . . . 0.0 110.441 -179.08 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 126' ' ' PRO . . . . . . . . . . . . . 56.9 Cg_endo -79.79 -23.27 7.01 Favored 'Trans proline' 0 C--N 1.315 -1.193 0 C-N-CA 122.056 1.837 . . . . 0.0 112.454 179.416 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 127' ' ' ASN . . . . . . . . . . . . . 28.4 m120 -91.5 29.64 1.45 Allowed 'General case' 0 N--CA 1.493 1.681 0 O-C-N 121.186 -0.946 . . . . 0.0 109.573 179.902 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 128' ' ' TYR . . . . . 0.687 ' CZ ' ' NE2' ' A' ' 129' ' ' GLN . 14.8 t80 -81.32 -151.04 0.08 Allowed 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.254 -0.904 . . . . 0.0 109.843 -179.669 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 129' ' ' GLN . . . . . 0.687 ' NE2' ' CZ ' ' A' ' 128' ' ' TYR . 1.7 mp0 -68.3 -71.85 0.2 Allowed 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.265 -0.897 . . . . 0.0 109.906 -179.507 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 130' ' ' PHE . . . . . 0.477 ' CE2' ' CG1' ' A' ' 101' ' ' VAL . 50.5 m-85 -125.88 25.94 6.72 Favored 'General case' 0 N--CA 1.497 1.884 0 O-C-N 121.21 -0.931 . . . . 0.0 110.278 -179.927 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 131' ' ' THR . . . . . . . . . . . . . 36.7 m -63.78 -34.85 78.81 Favored 'General case' 0 N--CA 1.493 1.693 0 O-C-N 120.844 -1.16 . . . . 0.0 109.754 -179.964 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 132' ' ' ASN . . . . . 0.6 ' ND2' ' O ' ' A' ' 81' ' ' ALA . 12.5 t30 -85.24 9.57 14.83 Favored 'General case' 0 N--CA 1.497 1.883 0 C-N-CA 119.913 -0.715 . . . . 0.0 111.788 -178.234 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 133' ' ' LEU . . . . . 0.606 ' O ' ' N ' ' A' ' 135' ' ' ALA . 0.1 OUTLIER -71.94 -44.56 63.4 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 120.565 -1.334 . . . . 0.0 110.328 -179.442 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 134' ' ' LYS . . . . . 0.534 ' H ' ' CD ' ' A' ' 134' ' ' LYS . 0.0 OUTLIER -42.58 -16.36 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.663 0 O-C-N 121.192 -0.942 . . . . 0.0 110.089 -179.132 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 135' ' ' ALA . . . . . 0.606 ' N ' ' O ' ' A' ' 133' ' ' LEU . . . -85.23 -37.06 20.52 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.02 -1.05 . . . . 0.0 109.738 179.708 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 136' ' ' ALA . . . . . 0.438 ' N ' ' O ' ' A' ' 133' ' ' LEU . . . -78.43 153.54 31.42 Favored 'General case' 0 N--CA 1.489 1.519 0 CA-C-O 121.977 0.894 . . . . 0.0 111.317 -178.6 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 137' ' ' LYS . . . . . 0.502 ' O ' ' O ' ' A' ' 138' ' ' LYS . 0.6 OUTLIER -156.15 -163.36 1.46 Allowed 'General case' 0 N--CA 1.494 1.744 0 C-N-CA 118.559 -1.257 . . . . 0.0 111.224 -178.387 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 138' ' ' LYS . . . . . 0.604 ' O ' ' N ' ' A' ' 140' ' ' SER . 24.9 pttt -45.95 179.74 0.0 OUTLIER 'General case' 0 C--N 1.305 -1.364 0 CA-C-O 121.95 0.881 . . . . 0.0 110.296 -179.395 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 139' ' ' GLY . . . . . . . . . . . . . . . 45.58 8.07 0.01 OUTLIER Glycine 0 N--CA 1.491 2.336 0 N-CA-C 110.817 -0.913 . . . . 0.0 110.817 179.705 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 140' ' ' SER . . . . . 0.604 ' N ' ' O ' ' A' ' 138' ' ' LYS . 46.9 m -94.07 136.85 33.91 Favored 'General case' 0 N--CA 1.494 1.734 0 O-C-N 120.823 -1.398 . . . . 0.0 109.333 179.225 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 141' ' ' MET . . . . . . . . . . . . . 0.4 OUTLIER -85.04 147.6 26.58 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.155 -0.965 . . . . 0.0 109.55 -179.96 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 142' ' ' VAL . . . . . . . . . . . . . 2.1 t -132.15 134.93 59.05 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.661 0 N-CA-C 108.368 -0.975 . . . . 0.0 108.368 -179.759 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 143' ' ' TYR . . . . . . . . . . . . . 37.0 m-85 -114.03 137.53 51.59 Favored 'General case' 0 N--CA 1.499 2.008 0 O-C-N 120.792 -1.192 . . . . 0.0 111.391 -178.842 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 144' ' ' PHE . . . . . . . . . . . . . 5.1 t80 -123.15 107.02 11.28 Favored 'General case' 0 N--CA 1.494 1.77 0 CA-C-O 121.476 0.655 . . . . 0.0 109.833 -179.215 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 145' ' ' LYS . . . . . . . . . . . . . 14.7 tttt -95.55 132.83 40.25 Favored 'General case' 0 N--CA 1.495 1.799 0 O-C-N 121.417 -0.802 . . . . 0.0 111.43 -178.725 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 146' ' ' VAL . . . . . 0.458 ' O ' ' C ' ' A' ' 147' ' ' GLY . 0.0 OUTLIER -143.26 141.1 26.48 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.813 0 N-CA-C 107.629 -1.249 . . . . 0.0 107.629 178.589 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 147' ' ' GLY . . . . . 0.458 ' C ' ' O ' ' A' ' 146' ' ' VAL . . . 40.02 -126.3 2.54 Favored Glycine 0 N--CA 1.494 2.533 0 N-CA-C 109.776 -1.33 . . . . 0.0 109.776 179.778 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 148' ' ' ASN . . . . . 0.513 ' C ' ' ND2' ' A' ' 148' ' ' ASN . 0.4 OUTLIER -101.65 14.94 30.46 Favored 'General case' 0 C--N 1.302 -1.476 0 O-C-N 121.426 -1.043 . . . . 0.0 108.339 179.209 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 149' ' ' GLU . . . . . . . . . . . . . 3.2 tt0 -109.92 142.39 41.33 Favored 'General case' 0 N--CA 1.485 1.324 0 CA-C-O 121.946 0.879 . . . . 0.0 111.515 -178.43 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 150' ' ' THR . . . . . . . . . . . . . 54.3 m -129.48 101.83 6.12 Favored 'General case' 0 C--N 1.3 -1.58 0 CA-C-O 121.658 0.742 . . . . 0.0 109.713 179.81 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 151' ' ' ARG . . . . . 0.419 ' HE ' ' HZ1' ' A' ' 206' ' ' LYS . 2.5 mtp180 -87.33 179.3 6.63 Favored 'General case' 0 C--N 1.306 -1.322 0 N-CA-C 108.601 -0.889 . . . . 0.0 108.601 179.951 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 152' ' ' LYS . . . . . 0.408 ' C ' ' CD1' ' A' ' 153' ' ' TYR . 24.6 mtmm -147.53 148.16 30.89 Favored 'General case' 0 C--N 1.302 -1.495 0 O-C-N 121.089 -1.007 . . . . 0.0 109.838 -179.671 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 153' ' ' TYR . . . . . 0.408 ' CD1' ' C ' ' A' ' 152' ' ' LYS . 20.6 m-85 -141.64 167.5 21.99 Favored 'General case' 0 N--CA 1.492 1.629 0 N-CA-C 108.491 -0.929 . . . . 0.0 108.491 179.258 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 154' ' ' LYS . . . . . . . . . . . . . 4.4 ttpm? -137.7 122.41 18.68 Favored 'General case' 0 C--N 1.296 -1.731 0 N-CA-C 108.698 -0.853 . . . . 0.0 108.698 179.155 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 155' ' ' MET . . . . . . . . . . . . . 38.4 mmm -48.98 107.38 0.13 Allowed 'General case' 0 N--CA 1.491 1.604 0 O-C-N 120.785 -1.197 . . . . 0.0 110.904 -178.891 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 156' ' ' THR . . . . . 0.424 ' OG1' ' OG1' ' A' ' 203' ' ' THR . 0.0 OUTLIER -109.49 -22.18 12.12 Favored 'General case' 0 C--N 1.296 -1.748 0 C-N-CA 119.832 -0.747 . . . . 0.0 110.597 -178.959 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 157' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -151.67 146.98 26.19 Favored 'General case' 0 C--N 1.294 -1.838 0 C-N-CA 118.702 -1.199 . . . . 0.0 110.966 -178.411 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 158' ' ' ILE . . . . . 0.436 ' CD1' ' N ' ' A' ' 159' ' ' ARG . 0.1 OUTLIER -155.51 142.57 11.66 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.334 0 CA-C-O 121.778 0.799 . . . . 0.0 110.013 -178.834 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 159' ' ' ARG . . . . . 0.436 ' N ' ' CD1' ' A' ' 158' ' ' ILE . 23.1 ttm180 -155.99 160.3 39.94 Favored 'General case' 0 C--N 1.297 -1.679 0 CA-C-O 121.79 0.805 . . . . 0.0 110.44 -179.618 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 160' ' ' ASP . . . . . . . . . . . . . 35.7 m-20 -116.02 161.44 18.87 Favored 'General case' 0 N--CA 1.49 1.564 0 N-CA-C 108.203 -1.036 . . . . 0.0 108.203 179.185 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 161' ' ' VAL . . . . . 0.438 ' O ' ' O ' ' A' ' 162' ' ' LYS . 3.3 m -156.79 155.01 5.57 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.63 0 O-C-N 121.117 -0.99 . . . . 0.0 110.722 -178.569 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 162' ' ' LYS . . . . . 0.438 ' O ' ' O ' ' A' ' 161' ' ' VAL . 0.0 OUTLIER -45.02 169.9 0.06 OUTLIER Pre-proline 0 N--CA 1.492 1.652 0 O-C-N 121.594 -0.691 . . . . 0.0 109.795 179.527 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 163' ' ' PRO . . . . . . . . . . . . . 65.1 Cg_endo -78.54 34.59 0.51 Allowed 'Trans proline' 0 N--CA 1.493 1.466 0 C-N-CA 123.052 2.501 . . . . 0.0 113.026 -179.975 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 164' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -153.26 -3.86 0.2 Allowed 'General case' 0 N--CA 1.496 1.873 0 O-C-N 121.022 -1.049 . . . . 0.0 110.925 -179.824 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 165' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -77.2 64.44 2.62 Favored 'General case' 0 N--CA 1.496 1.857 0 O-C-N 120.861 -1.149 . . . . 0.0 110.899 -179.078 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 166' ' ' VAL . . . . . 0.593 ' O ' ' N ' ' A' ' 168' ' ' VAL . 1.4 m -46.44 -30.26 1.22 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.702 0 O-C-N 121.13 -0.981 . . . . 0.0 110.563 -178.244 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 167' ' ' GLY . . . . . . . . . . . . . . . -45.22 -9.1 0.01 OUTLIER Glycine 0 N--CA 1.498 2.796 0 O-C-N 120.694 -1.254 . . . . 0.0 111.313 -179.353 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 168' ' ' VAL . . . . . 0.593 ' N ' ' O ' ' A' ' 166' ' ' VAL . 4.2 m -53.88 -31.67 21.02 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.657 0 O-C-N 120.615 -1.521 . . . . 0.0 109.114 -179.988 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 169' ' ' LEU . . . . . 0.552 ' O ' ' C ' ' A' ' 170' ' ' ASP . 10.9 mt -45.57 -17.79 0.03 OUTLIER 'General case' 0 N--CA 1.493 1.677 0 N-CA-C 108.19 -1.041 . . . . 0.0 108.19 -178.41 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 170' ' ' ASP . . . . . 0.552 ' C ' ' O ' ' A' ' 169' ' ' LEU . 2.5 m-20 21.44 90.51 0.01 OUTLIER 'General case' 0 N--CA 1.501 2.086 0 CA-C-O 120.81 0.338 . . . . 0.0 111.797 178.151 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 171' ' ' GLU . . . . . . . . . . . . . 10.1 pt-20 -140.27 78.06 1.64 Allowed 'General case' 0 N--CA 1.494 1.754 0 O-C-N 120.845 -1.16 . . . . 0.0 109.808 179.512 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 172' ' ' GLN . . . . . . . . . . . . . 2.6 mp0 -136.49 -41.43 0.63 Allowed 'General case' 0 N--CA 1.495 1.793 0 O-C-N 121.453 -0.779 . . . . 0.0 110.607 -178.749 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 173' ' ' LYS . . . . . . . . . . . . . 49.7 mttp -58.24 140.41 53.2 Favored 'General case' 0 N--CA 1.493 1.686 0 O-C-N 120.74 -1.225 . . . . 0.0 108.514 179.676 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 174' ' ' GLY . . . . . 0.478 ' O ' ' C ' ' A' ' 175' ' ' LYS . . . -127.29 -46.6 0.2 Allowed Glycine 0 C--N 1.298 -1.534 0 N-CA-C 107.619 -2.192 . . . . 0.0 107.619 179.704 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 175' ' ' LYS . . . . . 0.478 ' C ' ' O ' ' A' ' 174' ' ' GLY . 27.9 mmtt -42.77 -61.42 1.26 Allowed 'General case' 0 N--CA 1.489 1.523 0 N-CA-C 108.023 -1.103 . . . . 0.0 108.023 178.611 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 176' ' ' ASP . . . . . 0.525 ' O ' ' O ' ' A' ' 177' ' ' LYS . 3.6 p30 -104.53 95.23 5.78 Favored 'General case' 0 C--N 1.299 -1.63 0 N-CA-C 108.059 -1.089 . . . . 0.0 108.059 178.086 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 177' ' ' LYS . . . . . 0.525 ' O ' ' O ' ' A' ' 176' ' ' ASP . 0.5 OUTLIER -48.39 -176.37 0.0 OUTLIER 'General case' 0 N--CA 1.494 1.734 0 O-C-N 121.119 -0.988 . . . . 0.0 109.432 -179.694 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 178' ' ' GLN . . . . . 0.608 ' NE2' ' OD1' ' A' ' 114' ' ' ASN . 20.9 pt20 -162.06 174.47 12.96 Favored 'General case' 0 C--N 1.308 -1.227 0 C-N-CA 118.605 -1.238 . . . . 0.0 110.663 179.214 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 179' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -134.62 100.36 4.61 Favored 'General case' 0 C--N 1.301 -1.518 0 N-CA-C 107.756 -1.201 . . . . 0.0 107.756 178.046 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 180' ' ' THR . . . . . . . . . . . . . 1.0 OUTLIER -79.99 116.62 20.23 Favored 'General case' 0 N--CA 1.493 1.707 0 O-C-N 121.095 -1.003 . . . . 0.0 110.186 -178.794 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 181' ' ' LEU . . . . . . . . . . . . . 8.8 tp -99.43 106.13 18.15 Favored 'General case' 0 C--N 1.3 -1.583 0 O-C-N 121.453 -0.779 . . . . 0.0 109.496 179.146 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 182' ' ' ILE . . . . . . . . . . . . . 48.2 mt -93.74 127.83 45.52 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.541 0 O-C-N 120.895 -1.128 . . . . 0.0 108.76 178.909 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 183' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -144.55 111.28 5.73 Favored 'General case' 0 C--N 1.291 -1.948 0 N-CA-C 107.409 -1.33 . . . . 0.0 107.409 179.569 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 184' ' ' CYS . . . . . . . . . . . . . 15.9 p -79.62 161.0 26.16 Favored 'General case' 0 C--N 1.291 -1.975 0 C-N-CA 118.988 -1.085 . . . . 0.0 111.782 -177.334 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 185' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -166.67 -161.71 0.47 Allowed 'General case' 0 N--CA 1.494 1.775 0 O-C-N 121.665 -0.647 . . . . 0.0 109.338 179.759 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 186' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER 55.15 57.03 5.86 Favored 'General case' 0 N--CA 1.496 1.857 0 O-C-N 121.144 -0.973 . . . . 0.0 109.368 -179.838 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 187' ' ' TYR . . . . . 0.619 ' CE1' ' O ' ' A' ' 188' ' ' ASN . 65.7 t80 -67.78 137.23 55.24 Favored 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.342 -0.849 . . . . 0.0 110.703 -179.514 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 188' ' ' ASN . . . . . 0.619 ' O ' ' CE1' ' A' ' 187' ' ' TYR . 1.2 t-20 -101.98 145.66 28.96 Favored 'General case' 0 C--N 1.297 -1.697 0 N-CA-C 108.39 -0.967 . . . . 0.0 108.39 178.376 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 189' ' ' GLU . . . . . . . . . . . . . 1.9 tt0 -110.08 -14.74 14.17 Favored 'General case' 0 C--N 1.294 -1.823 0 N-CA-C 108.984 -0.747 . . . . 0.0 108.984 -179.217 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 190' ' ' LYS . . . . . . . . . . . . . 4.6 mttm -83.53 -52.36 6.54 Favored 'General case' 0 C--N 1.301 -1.506 0 C-N-CA 119.82 -0.752 . . . . 0.0 109.099 179.423 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 191' ' ' THR . . . . . . . . . . . . . 2.1 p -89.16 -9.25 51.62 Favored 'General case' 0 N--CA 1.489 1.525 0 O-C-N 121.52 -0.738 . . . . 0.0 109.235 179.799 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 192' ' ' GLY . . . . . . . . . . . . . . . 68.4 33.31 77.07 Favored Glycine 0 N--CA 1.493 2.496 0 O-C-N 121.298 -0.876 . . . . 0.0 111.119 178.606 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 193' ' ' VAL . . . . . . . . . . . . . 2.4 p -147.54 169.63 3.96 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.582 0 O-C-N 120.806 -1.408 . . . . 0.0 109.891 179.169 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 194' ' ' TRP . . . . . 0.517 ' N ' ' CD1' ' A' ' 194' ' ' TRP . 10.7 m95 -85.74 121.55 28.56 Favored 'General case' 0 C--N 1.294 -1.836 0 O-C-N 121.648 -0.657 . . . . 0.0 109.271 -179.908 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 195' ' ' GLU . . . . . 0.512 ' CD ' ' ND2' ' A' ' 188' ' ' ASN . 7.5 mt-10 -77.31 -60.14 2.49 Favored 'General case' 0 N--CA 1.496 1.862 0 O-C-N 121.385 -0.822 . . . . 0.0 111.575 -178.521 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 196' ' ' LYS . . . . . . . . . . . . . 6.3 mtmt -92.1 158.16 16.35 Favored 'General case' 0 N--CA 1.493 1.72 0 O-C-N 120.86 -1.15 . . . . 0.0 111.397 -177.946 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 197' ' ' ARG . . . . . . . . . . . . . 25.3 mmt180 -124.14 139.17 54.19 Favored 'General case' 0 N--CA 1.488 1.466 0 N-CA-C 108.674 -0.862 . . . . 0.0 108.674 179.001 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 198' ' ' LYS . . . . . . . . . . . . . 14.9 mttt -119.8 120.63 37.07 Favored 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.544 -0.723 . . . . 0.0 110.13 -179.017 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 199' ' ' ILE . . . . . 0.406 ' O ' ' CG1' ' A' ' 199' ' ' ILE . 0.8 OUTLIER -139.81 119.83 13.54 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.66 0 O-C-N 121.192 -0.943 . . . . 0.0 109.562 179.43 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 200' ' ' PHE . . . . . 0.537 ' CD1' ' N ' ' A' ' 200' ' ' PHE . 8.7 m-85 -99.91 139.05 36.15 Favored 'General case' 0 N--CA 1.499 2.012 0 O-C-N 121.468 -0.77 . . . . 0.0 110.76 -178.534 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 201' ' ' VAL . . . . . . . . . . . . . 24.3 t -104.12 149.07 8.11 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.553 0 N-CA-C 107.39 -1.337 . . . . 0.0 107.39 176.489 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 202' ' ' ALA . . . . . . . . . . . . . . . -132.47 139.6 48.04 Favored 'General case' 0 C--N 1.3 -1.585 0 O-C-N 121.047 -1.033 . . . . 0.0 108.249 -179.864 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 203' ' ' THR . . . . . 0.424 ' OG1' ' OG1' ' A' ' 156' ' ' THR . 13.7 p -90.85 132.15 36.07 Favored 'General case' 0 C--N 1.305 -1.343 0 CA-C-O 122.647 1.213 . . . . 0.0 111.608 -178.242 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 204' ' ' GLU . . . . . . . . . . . . . 1.2 tm-20 -60.79 136.24 58.01 Favored 'General case' 0 C--N 1.297 -1.711 0 C-N-CA 118.334 -1.347 . . . . 0.0 108.798 179.159 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 205' ' ' VAL . . . . . 0.473 ' O ' ' C ' ' A' ' 206' ' ' LYS . 36.6 t -130.85 -35.82 0.59 Allowed 'Isoleucine or valine' 0 N--CA 1.495 1.795 0 O-C-N 121.298 -0.877 . . . . 0.0 110.189 -179.437 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 206' ' ' LYS . . . . . 0.473 ' C ' ' O ' ' A' ' 205' ' ' VAL . 0.0 OUTLIER . . . . . 0 N--CA 1.495 1.777 0 CA-C-O 117.945 -1.026 . . . . 0.0 110.259 -179.584 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' C' C ' 701' ' ' PHQ . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 009 nuclear orig full ' C' C ' 702' ' ' LEU . . . . . 0.641 ' H ' ' CD1' ' C' ' 702' ' ' LEU . 0.0 OUTLIER . . . . . 0 N--CA 1.491 1.614 0 N-CA-C 109.074 -0.713 . . . . 0.0 109.074 . . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' C' C ' 703' ' ' PRO . . . . . 0.433 ' O ' ' O ' ' C' ' 702' ' ' LEU . 31.9 Cg_exo -43.31 175.79 0.0 OUTLIER 'Trans proline' 0 N--CA 1.49 1.313 0 C-N-CA 122.593 2.195 . . . . 0.0 112.981 -179.097 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' C' C ' 704' ' ' ALA . . . . . 0.403 ' C ' ' O ' ' C' ' 703' ' ' PRO . . . 43.19 -158.29 0.02 OUTLIER 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.502 -0.749 . . . . 0.0 109.769 179.477 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' C' C ' 705' ' ' B27 . . . . . 0.501 ' SG ' ' ND1' ' A' ' 120' ' ' HIS . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 700' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 010 nuclear orig full ' A' A ' 59' ' ' MET . . . . . . . . . . . . . 28.4 mtt . . . . . 0 N--CA 1.49 1.559 0 N-CA-C 109.664 -0.495 . . . . 0.0 109.664 . . . . . . . . . 0 0 . 1 . 010 nuclear orig full ' A' A ' 60' ' ' GLN . . . . . . . . . . . . . 74.9 mt-30 -61.31 -97.99 0.0 OUTLIER 'General case' 0 N--CA 1.492 1.669 0 O-C-N 121.083 -1.011 . . . . 0.0 109.549 -179.993 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . -64.91 -163.7 0.02 OUTLIER 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.076 -1.015 . . . . 0.0 109.17 179.734 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 62' ' ' LYS . . . . . . . . . . . . . 15.8 tttm -146.93 79.21 10.16 Favored Pre-proline 0 N--CA 1.491 1.601 0 O-C-N 121.222 -0.924 . . . . 0.0 109.454 179.993 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 63' ' ' PRO . . . . . 0.413 ' O ' ' CD1' ' A' ' 110' ' ' LEU . 6.2 Cg_exo -74.54 138.6 24.49 Favored 'Trans proline' 0 C--N 1.302 -1.869 0 C-N-CA 123.004 2.469 . . . . 0.0 111.455 179.781 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 64' ' ' GLN . . . . . 0.617 ' NE2' ' O ' ' A' ' 64' ' ' GLN . 0.0 OUTLIER -158.97 137.07 10.53 Favored 'General case' 0 C--N 1.299 -1.598 0 O-C-N 121.169 -0.957 . . . . 0.0 109.43 179.684 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 65' ' ' ILE . . . . . 0.563 ' N ' ' CD1' ' A' ' 65' ' ' ILE . 0.2 OUTLIER -50.79 110.42 1.73 Allowed Pre-proline 0 N--CA 1.489 1.501 0 O-C-N 120.829 -1.169 . . . . 0.0 108.624 179.253 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 66' ' ' PRO . . . . . . . . . . . . . 87.1 Cg_endo -82.52 -162.77 0.19 Allowed 'Trans proline' 0 C--N 1.314 -1.251 0 C-N-CA 121.998 1.798 . . . . 0.0 111.797 -179.784 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 67' ' ' LYS . . . . . . . . . . . . . 36.4 tttp -90.11 -10.28 45.23 Favored 'General case' 0 C--N 1.302 -1.481 0 O-C-N 121.176 -0.953 . . . . 0.0 109.081 179.534 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 68' ' ' ASP . . . . . 0.651 ' C ' ' H ' ' A' ' 70' ' ' SER . 0.2 OUTLIER -76.61 64.02 2.18 Favored 'General case' 0 N--CA 1.489 1.505 0 CA-C-O 122.763 1.268 . . . . 0.0 108.71 179.194 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 69' ' ' LYS . . . . . 0.459 ' C ' ' O ' ' A' ' 68' ' ' ASP . 6.3 ptpp? -46.99 -14.16 0.03 OUTLIER 'General case' 0 N--CA 1.508 2.472 0 C-N-CA 117.259 -1.776 . . . . 0.0 106.701 177.534 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 70' ' ' SER . . . . . 0.651 ' H ' ' C ' ' A' ' 68' ' ' ASP . 3.4 p -85.93 -6.36 59.08 Favored 'General case' 0 N--CA 1.496 1.839 0 CA-C-N 113.414 -1.721 . . . . 0.0 111.496 179.564 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 71' ' ' LYS . . . . . 0.546 ' CB ' ' HZ3' ' A' ' 71' ' ' LYS . 0.0 OUTLIER -95.35 142.6 27.55 Favored 'General case' 0 N--CA 1.501 2.079 0 O-C-N 120.579 -1.325 . . . . 0.0 112.225 -179.288 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 72' ' ' VAL . . . . . 0.454 ' O ' ' CG2' ' A' ' 72' ' ' VAL . 3.1 m -66.46 134.44 29.95 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.5 0 N-CA-C 104.318 -2.475 . . . . 0.0 104.318 174.65 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 73' ' ' ALA . . . . . 0.495 ' N ' ' O ' ' A' ' 87' ' ' VAL . . . -81.47 -15.65 54.37 Favored 'General case' 0 C--N 1.291 -1.967 0 O-C-N 119.849 -1.782 . . . . 0.0 106.859 179.985 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . 172.16 -155.78 24.23 Favored Glycine 0 C--N 1.298 -1.533 0 N-CA-C 109.817 -1.313 . . . . 0.0 109.817 179.512 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 75' ' ' TYR . . . . . . . . . . . . . 73.0 m-85 -142.56 169.99 16.54 Favored 'General case' 0 C--N 1.297 -1.684 0 CA-C-O 122.06 0.933 . . . . 0.0 110.848 -177.459 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 76' ' ' ILE . . . . . . . . . . . . . 1.0 OUTLIER -150.15 146.9 16.46 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.814 0 C-N-CA 119.58 -0.848 . . . . 0.0 109.179 -178.382 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -151.15 164.8 35.68 Favored 'General case' 0 C--N 1.302 -1.494 0 O-C-N 120.919 -1.113 . . . . 0.0 109.262 -179.734 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 78' ' ' ILE . . . . . . . . . . . . . 10.0 mt -147.91 92.97 4.57 Favored Pre-proline 0 N--CA 1.488 1.425 0 N-CA-C 108.516 -0.92 . . . . 0.0 108.516 179.998 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 79' ' ' PRO . . . . . . . . . . . . . 72.3 Cg_exo -46.77 -43.54 23.41 Favored 'Trans proline' 0 N--CA 1.494 1.536 0 C-N-CA 122.852 2.368 . . . . 0.0 113.954 -178.972 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 37.9 t70 -65.54 -20.62 66.41 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 120.665 -1.272 . . . . 0.0 110.343 178.582 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 81' ' ' ALA . . . . . 0.648 ' O ' ' ND2' ' A' ' 132' ' ' ASN . . . -106.33 -15.05 14.93 Favored 'General case' 0 C--N 1.302 -1.471 0 O-C-N 121.354 -0.841 . . . . 0.0 108.762 179.664 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 82' ' ' ASP . . . . . . . . . . . . . 2.5 t70 66.38 49.51 1.41 Allowed 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.163 -0.961 . . . . 0.0 110.227 179.506 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 83' ' ' ILE . . . . . 0.465 ' CD1' ' OD1' ' A' ' 132' ' ' ASN . 62.7 mt -128.57 151.38 35.28 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.786 0 O-C-N 121.259 -0.901 . . . . 0.0 110.333 -178.988 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 84' ' ' LYS . . . . . . . . . . . . . 17.4 tttt -159.53 106.42 1.7 Allowed 'General case' 0 N--CA 1.493 1.69 0 N-CA-C 108.416 -0.957 . . . . 0.0 108.416 178.964 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 85' ' ' GLU . . . . . 0.54 ' OE2' ' N ' ' A' ' 85' ' ' GLU . 0.0 OUTLIER -140.07 165.77 28.37 Favored Pre-proline 0 N--CA 1.491 1.621 0 O-C-N 121.393 -0.817 . . . . 0.0 109.858 -179.008 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 86' ' ' PRO . . . . . . . . . . . . . 56.9 Cg_endo -74.27 166.53 29.3 Favored 'Trans proline' 0 N--CA 1.496 1.621 0 C-N-CA 123.116 2.544 . . . . 0.0 113.779 -178.548 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 87' ' ' VAL . . . . . 0.495 ' O ' ' N ' ' A' ' 73' ' ' ALA . 61.3 t -122.9 100.07 7.6 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.539 0 N-CA-C 109.093 -0.706 . . . . 0.0 109.093 179.715 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 88' ' ' TYR . . . . . . . . . . . . . 42.1 m-85 -91.87 154.76 43.7 Favored Pre-proline 0 N--CA 1.505 2.298 0 O-C-N 120.944 -1.098 . . . . 0.0 110.086 -179.359 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 89' ' ' PRO . . . . . . . . . . . . . 7.0 Cg_endo -56.84 145.78 81.98 Favored 'Trans proline' 0 N--CA 1.494 1.537 0 C-N-CA 122.467 2.111 . . . . 0.0 113.119 179.157 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . -63.57 169.52 19.56 Favored Glycine 0 N--CA 1.492 2.415 0 N-CA-C 109.159 -1.576 . . . . 0.0 109.159 179.188 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 91' ' ' PRO . . . . . 0.405 ' C ' ' H ' ' A' ' 93' ' ' THR . 73.0 Cg_endo -93.4 170.25 19.82 Favored 'Cis proline' 0 C--N 1.309 -1.519 0 C-N-CA 123.939 -1.275 . . . . 0.0 112.424 0.101 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 92' ' ' ALA . . . . . 0.417 ' O ' ' CD1' ' A' ' 97' ' ' LEU . . . -73.09 33.68 0.07 Allowed 'General case' 0 N--CA 1.494 1.767 0 O-C-N 121.323 -0.861 . . . . 0.0 111.261 -179.399 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 93' ' ' THR . . . . . 0.471 ' OG1' ' OE1' ' A' ' 96' ' ' GLN . 1.0 OUTLIER -73.54 152.5 89.66 Favored Pre-proline 0 C--N 1.3 -1.547 0 O-C-N 120.48 -1.387 . . . . 0.0 108.146 179.729 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 94' ' ' PRO . . . . . 0.414 ' C ' ' O ' ' A' ' 93' ' ' THR . 94.6 Cg_exo -33.29 -57.06 0.35 Allowed 'Trans proline' 0 C--N 1.306 -1.702 0 C-N-CA 122.749 2.299 . . . . 0.0 112.621 -178.463 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 88.0 mt-10 -46.57 -50.29 17.55 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.256 -0.902 . . . . 0.0 110.094 -179.896 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 96' ' ' GLN . . . . . 0.498 ' CD ' ' N ' ' A' ' 96' ' ' GLN . 10.9 mp0 -71.48 -45.41 62.61 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 120.992 -1.067 . . . . 0.0 110.534 -179.231 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 97' ' ' LEU . . . . . 0.417 ' CD1' ' O ' ' A' ' 92' ' ' ALA . 61.5 mt -57.64 -7.29 0.63 Allowed 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.095 -1.003 . . . . 0.0 110.473 -178.585 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 98' ' ' ASN . . . . . 0.625 HD21 ' NH1' ' A' ' 99' ' ' ARG . 0.1 OUTLIER -77.66 -29.09 51.41 Favored 'General case' 0 N--CA 1.494 1.759 0 O-C-N 120.946 -1.097 . . . . 0.0 109.44 179.208 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 99' ' ' ARG . . . . . 0.654 HH11 ' CG ' ' A' ' 99' ' ' ARG . 1.1 mtt-85 -90.17 -44.63 9.64 Favored 'General case' 0 N--CA 1.489 1.495 0 O-C-N 121.667 -0.646 . . . . 0.0 110.322 -178.36 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . 173.71 175.83 41.71 Favored Glycine 0 N--CA 1.491 2.335 0 C-N-CA 119.342 -1.409 . . . . 0.0 110.343 179.938 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 101' ' ' VAL . . . . . 0.443 ' O ' ' CG2' ' A' ' 101' ' ' VAL . 33.5 m -50.05 109.0 0.1 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.543 0 O-C-N 121.564 -0.962 . . . . 0.0 109.029 179.814 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -92.58 159.29 15.55 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.159 -0.963 . . . . 0.0 110.683 -179.321 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 103' ' ' PHE . . . . . 0.58 ' O ' ' N ' ' A' ' 105' ' ' GLU . 26.7 m-85 -61.1 123.79 18.67 Favored 'General case' 0 N--CA 1.491 1.58 0 N-CA-C 107.982 -1.118 . . . . 0.0 107.982 178.662 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 104' ' ' ALA . . . . . . . . . . . . . . . -47.04 -9.75 0.02 OUTLIER 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.061 -1.024 . . . . 0.0 110.249 -179.073 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 105' ' ' GLU . . . . . 0.58 ' N ' ' O ' ' A' ' 103' ' ' PHE . 0.4 OUTLIER -137.89 142.84 40.66 Favored 'General case' 0 N--CA 1.496 1.839 0 O-C-N 120.803 -1.186 . . . . 0.0 110.266 179.643 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 106' ' ' GLU . . . . . . . . . . . . . 33.6 tt0 -58.24 -63.33 1.3 Allowed 'General case' 0 C--N 1.301 -1.516 0 O-C-N 121.951 -0.468 . . . . 0.0 110.661 -179.458 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 107' ' ' ASN . . . . . . . . . . . . . 7.6 m120 -78.67 34.98 0.23 Allowed 'General case' 0 N--CA 1.488 1.449 0 O-C-N 120.874 -1.141 . . . . 0.0 112.969 -175.924 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 108' ' ' GLU . . . . . . . . . . . . . 1.7 tp10 -60.55 148.28 38.57 Favored 'General case' 0 N--CA 1.489 1.486 0 O-C-N 120.685 -1.259 . . . . 0.0 108.327 179.766 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 109' ' ' SER . . . . . . . . . . . . . 2.8 t -98.02 146.91 25.05 Favored 'General case' 0 N--CA 1.489 1.482 0 O-C-N 121.115 -0.991 . . . . 0.0 110.664 -178.675 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 110' ' ' LEU . . . . . 0.413 ' CD1' ' O ' ' A' ' 63' ' ' PRO . 0.6 OUTLIER -63.42 -22.6 66.98 Favored 'General case' 0 C--N 1.301 -1.543 0 N-CA-C 107.974 -1.121 . . . . 0.0 107.974 179.136 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 111' ' ' ASP . . . . . 0.57 ' CG ' HH22 ' A' ' 151' ' ' ARG . 48.5 m-20 -132.81 44.01 2.91 Favored 'General case' 0 N--CA 1.487 1.412 0 O-C-N 121.589 -0.694 . . . . 0.0 110.21 -179.779 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 112' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -67.96 150.16 48.85 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 120.99 -1.069 . . . . 0.0 110.069 179.557 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 113' ' ' GLN . . . . . 0.422 ' HA ' ' NE2' ' A' ' 113' ' ' GLN . 0.9 OUTLIER -65.93 -13.92 60.61 Favored 'General case' 0 N--CA 1.488 1.475 0 N-CA-C 108.008 -1.108 . . . . 0.0 108.008 178.426 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 114' ' ' ASN . . . . . 0.436 ' ND2' ' O ' ' A' ' 170' ' ' ASP . 1.8 t30 -147.87 99.26 3.06 Favored 'General case' 0 C--N 1.301 -1.523 0 N-CA-C 107.206 -1.405 . . . . 0.0 107.206 178.193 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 115' ' ' ILE . . . . . 0.427 HG21 HD13 ' A' ' 115' ' ' ILE . 2.9 mt -98.13 111.41 27.79 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.627 0 O-C-N 120.969 -1.082 . . . . 0.0 109.637 -179.013 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 116' ' ' SER . . . . . . . . . . . . . 87.5 p -101.87 151.42 22.11 Favored 'General case' 0 N--CA 1.491 1.604 0 CA-C-O 122.055 0.931 . . . . 0.0 111.86 -178.329 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 117' ' ' ILE . . . . . . . . . . . . . 2.1 mt -139.66 159.78 27.54 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.599 0 N-CA-C 108.496 -0.927 . . . . 0.0 108.496 179.504 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 118' ' ' ALA . . . . . . . . . . . . . . . -143.3 155.72 44.53 Favored 'General case' 0 N--CA 1.489 1.518 0 C-N-CA 118.758 -1.177 . . . . 0.0 111.326 -179.391 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 119' ' ' GLY . . . . . . . . . . . . . . . -166.32 146.07 10.61 Favored Glycine 0 N--CA 1.485 1.966 0 N-CA-C 110.358 -1.097 . . . . 0.0 110.358 -179.854 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 120' ' ' HIS . . . . . 0.62 ' NE2' ' N ' ' C' ' 705' ' ' B27 . 35.1 m170 -71.63 167.28 20.14 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.93 -0.747 . . . . 0.0 109.721 179.202 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 121' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -116.33 147.31 41.7 Favored 'General case' 0 N--CA 1.495 1.779 0 N-CA-C 108.158 -1.053 . . . . 0.0 108.158 178.533 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 122' ' ' PHE . . . . . . . . . . . . . 0.3 OUTLIER -110.61 123.56 50.21 Favored 'General case' 0 N--CA 1.497 1.924 0 O-C-N 120.908 -1.12 . . . . 0.0 109.955 -179.874 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 123' ' ' ILE . . . . . 0.498 ' CG2' ' N ' ' A' ' 124' ' ' ASP . 11.8 tt -69.17 -42.96 81.85 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.824 0 O-C-N 121.367 -0.833 . . . . 0.0 109.4 179.427 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 124' ' ' ASP . . . . . 0.498 ' N ' ' CG2' ' A' ' 123' ' ' ILE . 61.1 t0 -93.24 23.81 4.21 Favored 'General case' 0 N--CA 1.494 1.747 0 O-C-N 121.421 -0.799 . . . . 0.0 111.136 -179.16 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 125' ' ' ARG . . . . . . . . . . . . . 3.3 ttt180 -157.9 107.35 1.76 Allowed Pre-proline 0 N--CA 1.492 1.667 0 O-C-N 120.616 -1.303 . . . . 0.0 110.253 -179.523 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 126' ' ' PRO . . . . . . . . . . . . . 71.9 Cg_endo -83.05 -20.24 5.29 Favored 'Trans proline' 0 C--N 1.314 -1.289 0 C-N-CA 122.368 2.046 . . . . 0.0 112.325 179.482 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 127' ' ' ASN . . . . . . . . . . . . . 4.9 m120 -91.12 23.93 3.06 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.276 -0.89 . . . . 0.0 109.668 179.94 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 128' ' ' TYR . . . . . . . . . . . . . 10.0 t80 -81.09 -149.4 0.07 Allowed 'General case' 0 C--N 1.301 -1.516 0 O-C-N 121.162 -0.961 . . . . 0.0 109.589 -179.692 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 129' ' ' GLN . . . . . . . . . . . . . 69.2 mt-30 -67.12 -69.61 0.3 Allowed 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.246 -0.909 . . . . 0.0 110.684 -178.941 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 130' ' ' PHE . . . . . . . . . . . . . 52.8 m-85 -129.23 36.72 4.13 Favored 'General case' 0 N--CA 1.496 1.827 0 O-C-N 121.249 -0.907 . . . . 0.0 110.524 -179.214 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 131' ' ' THR . . . . . . . . . . . . . 33.8 m -80.86 -33.72 34.27 Favored 'General case' 0 N--CA 1.493 1.687 0 O-C-N 120.815 -1.178 . . . . 0.0 108.965 179.461 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 132' ' ' ASN . . . . . 0.648 ' ND2' ' O ' ' A' ' 81' ' ' ALA . 0.1 OUTLIER -84.62 5.89 26.12 Favored 'General case' 0 N--CA 1.495 1.8 0 CA-C-O 121.876 0.846 . . . . 0.0 109.986 -179.246 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 133' ' ' LEU . . . . . 0.599 ' O ' ' N ' ' A' ' 135' ' ' ALA . 0.2 OUTLIER -68.5 -46.76 68.77 Favored 'General case' 0 C--N 1.299 -1.595 0 O-C-N 121.159 -0.963 . . . . 0.0 110.529 -179.748 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 134' ' ' LYS . . . . . 0.555 ' HZ2' ' HG1' ' A' ' 183' ' ' THR . 0.1 OUTLIER -41.68 -18.18 0.01 OUTLIER 'General case' 0 N--CA 1.496 1.826 0 O-C-N 121.07 -1.019 . . . . 0.0 110.328 -179.133 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 135' ' ' ALA . . . . . 0.599 ' N ' ' O ' ' A' ' 133' ' ' LEU . . . -82.87 -39.48 21.54 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 120.951 -1.093 . . . . 0.0 109.855 -179.773 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 136' ' ' ALA . . . . . 0.404 ' N ' ' O ' ' A' ' 133' ' ' LEU . . . -78.9 156.63 28.52 Favored 'General case' 0 C--N 1.299 -1.59 0 CA-C-O 122.179 0.99 . . . . 0.0 111.698 -178.506 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 137' ' ' LYS . . . . . 0.513 ' O ' ' O ' ' A' ' 138' ' ' LYS . 1.2 ttmt -156.01 -163.21 1.43 Allowed 'General case' 0 N--CA 1.49 1.543 0 C-N-CA 118.832 -1.147 . . . . 0.0 110.455 -178.92 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 138' ' ' LYS . . . . . 0.596 ' O ' ' N ' ' A' ' 140' ' ' SER . 0.1 OUTLIER -46.44 -178.29 0.0 OUTLIER 'General case' 0 C--N 1.302 -1.479 0 CA-C-O 122.043 0.925 . . . . 0.0 110.36 -179.332 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 139' ' ' GLY . . . . . . . . . . . . . . . 45.84 8.1 0.02 OUTLIER Glycine 0 N--CA 1.492 2.411 0 N-CA-C 110.707 -0.957 . . . . 0.0 110.707 179.956 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 140' ' ' SER . . . . . 0.596 ' N ' ' O ' ' A' ' 138' ' ' LYS . 66.1 m -90.54 136.86 32.79 Favored 'General case' 0 N--CA 1.493 1.7 0 O-C-N 120.768 -1.43 . . . . 0.0 109.606 179.412 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 141' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -78.21 142.16 38.11 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.092 -1.005 . . . . 0.0 109.154 179.729 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 142' ' ' VAL . . . . . . . . . . . . . 21.2 t -131.14 127.82 61.2 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.711 0 O-C-N 121.366 -0.834 . . . . 0.0 109.148 -179.845 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 143' ' ' TYR . . . . . . . . . . . . . 6.4 m-85 -105.51 134.22 48.99 Favored 'General case' 0 N--CA 1.498 1.971 0 O-C-N 121.313 -0.867 . . . . 0.0 112.223 -177.913 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 144' ' ' PHE . . . . . . . . . . . . . 57.4 t80 -119.7 98.09 5.95 Favored 'General case' 0 N--CA 1.494 1.741 0 CA-C-O 121.403 0.62 . . . . 0.0 109.406 179.409 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 145' ' ' LYS . . . . . . . . . . . . . 11.8 mttt -93.49 128.44 39.6 Favored 'General case' 0 N--CA 1.492 1.668 0 O-C-N 121.361 -0.837 . . . . 0.0 110.632 -179.217 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 146' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -142.11 137.87 30.23 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.778 0 N-CA-C 107.619 -1.252 . . . . 0.0 107.619 179.098 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 147' ' ' GLY . . . . . . . . . . . . . . . 48.45 -134.06 19.93 Favored Glycine 0 N--CA 1.49 2.241 0 N-CA-C 108.854 -1.698 . . . . 0.0 108.854 -179.493 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 148' ' ' ASN . . . . . 0.56 ' C ' HD21 ' A' ' 148' ' ' ASN . 0.4 OUTLIER -101.17 18.52 19.66 Favored 'General case' 0 C--N 1.301 -1.516 0 O-C-N 121.229 -1.159 . . . . 0.0 107.941 178.959 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 149' ' ' GLU . . . . . . . . . . . . . 26.2 tt0 -112.59 147.46 36.61 Favored 'General case' 0 N--CA 1.484 1.266 0 CA-C-O 121.97 0.89 . . . . 0.0 111.255 -178.957 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 150' ' ' THR . . . . . . . . . . . . . 1.7 m -129.42 103.64 7.02 Favored 'General case' 0 N--CA 1.489 1.509 0 CA-C-O 121.477 0.656 . . . . 0.0 110.052 -179.966 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 151' ' ' ARG . . . . . 0.57 HH22 ' CG ' ' A' ' 111' ' ' ASP . 94.5 mtt180 -93.05 128.75 39.06 Favored 'General case' 0 N--CA 1.487 1.403 0 N-CA-C 107.938 -1.134 . . . . 0.0 107.938 179.008 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 152' ' ' LYS . . . . . 0.432 ' O ' ' N ' ' A' ' 205' ' ' VAL . 14.4 mtmt -91.68 156.01 17.9 Favored 'General case' 0 C--N 1.297 -1.697 0 C-N-CA 119.183 -1.007 . . . . 0.0 110.021 -179.115 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 153' ' ' TYR . . . . . 0.496 ' CD2' ' HA ' ' A' ' 204' ' ' GLU . 30.7 m-85 -143.51 167.1 23.02 Favored 'General case' 0 N--CA 1.49 1.536 0 N-CA-C 107.428 -1.323 . . . . 0.0 107.428 178.953 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 154' ' ' LYS . . . . . . . . . . . . . 17.8 ttpt -143.16 123.0 13.44 Favored 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.071 -1.018 . . . . 0.0 108.286 178.592 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 155' ' ' MET . . . . . . . . . . . . . 3.6 mtt -47.07 109.49 0.21 Allowed 'General case' 0 N--CA 1.492 1.674 0 O-C-N 120.856 -1.153 . . . . 0.0 111.207 -178.595 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 156' ' ' THR . . . . . 0.533 ' CG2' ' HG1' ' A' ' 203' ' ' THR . 0.2 OUTLIER -103.89 -29.78 10.75 Favored 'General case' 0 C--N 1.29 -1.99 0 CA-C-N 115.269 -0.878 . . . . 0.0 110.102 -178.915 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 157' ' ' SER . . . . . 0.419 ' O ' ' N ' ' A' ' 201' ' ' VAL . 0.1 OUTLIER -155.71 157.58 36.83 Favored 'General case' 0 N--CA 1.492 1.641 0 C-N-CA 118.438 -1.305 . . . . 0.0 111.556 -178.816 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 158' ' ' ILE . . . . . 0.451 HG13 ' CD2' ' A' ' 200' ' ' PHE . 0.0 OUTLIER -156.77 148.23 11.14 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.393 0 CA-C-O 121.823 0.82 . . . . 0.0 110.285 179.823 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 159' ' ' ARG . . . . . 0.454 ' O ' ' OD1' ' A' ' 160' ' ' ASP . 6.1 ttm180 -153.59 -173.24 4.5 Favored 'General case' 0 C--N 1.299 -1.622 0 CA-C-O 121.737 0.779 . . . . 0.0 110.502 -179.559 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 160' ' ' ASP . . . . . 0.454 ' OD1' ' O ' ' A' ' 159' ' ' ARG . 2.5 m-20 -145.0 158.78 43.71 Favored 'General case' 0 C--N 1.301 -1.535 0 N-CA-C 108.378 -0.971 . . . . 0.0 108.378 -179.817 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 161' ' ' VAL . . . . . 0.412 ' CG2' ' C ' ' A' ' 160' ' ' ASP . 0.1 OUTLIER -155.57 157.27 4.19 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.99 0 O-C-N 120.994 -1.066 . . . . 0.0 110.686 179.706 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 162' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -46.22 169.19 0.09 OUTLIER Pre-proline 0 N--CA 1.496 1.827 0 O-C-N 121.419 -0.801 . . . . 0.0 110.372 -179.776 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 163' ' ' PRO . . . . . 0.41 ' HA ' ' HE ' ' A' ' 197' ' ' ARG . 73.8 Cg_endo -78.97 28.57 0.49 Allowed 'Trans proline' 0 N--CA 1.493 1.466 0 C-N-CA 123.025 2.483 . . . . 0.0 113.575 -179.778 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 164' ' ' THR . . . . . . . . . . . . . 67.3 m -150.87 -2.66 0.34 Allowed 'General case' 0 N--CA 1.496 1.842 0 O-C-N 120.962 -1.086 . . . . 0.0 110.012 179.792 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 165' ' ' ASP . . . . . 0.446 ' O ' ' C ' ' A' ' 166' ' ' VAL . 2.2 t70 -76.3 64.98 2.15 Favored 'General case' 0 N--CA 1.488 1.471 0 O-C-N 121.203 -0.936 . . . . 0.0 110.112 -179.957 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 166' ' ' VAL . . . . . 0.605 ' O ' ' N ' ' A' ' 168' ' ' VAL . 1.0 OUTLIER -44.4 -32.05 0.78 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.531 0 O-C-N 120.943 -1.098 . . . . 0.0 108.805 -179.099 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 167' ' ' GLY . . . . . 0.446 ' C ' ' O ' ' A' ' 166' ' ' VAL . . . -42.67 -16.76 0.03 OUTLIER Glycine 0 N--CA 1.491 2.316 0 N-CA-C 109.795 -1.322 . . . . 0.0 109.795 179.535 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 168' ' ' VAL . . . . . 0.605 ' N ' ' O ' ' A' ' 166' ' ' VAL . 47.6 t -50.27 -32.6 9.44 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.434 0 O-C-N 121.014 -1.286 . . . . 0.0 108.455 179.728 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 169' ' ' LEU . . . . . 0.518 ' O ' ' C ' ' A' ' 170' ' ' ASP . 98.8 mt -46.91 -14.48 0.03 OUTLIER 'General case' 0 N--CA 1.49 1.566 0 N-CA-C 108.075 -1.083 . . . . 0.0 108.075 -178.816 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 170' ' ' ASP . . . . . 0.567 ' N ' ' O ' ' A' ' 168' ' ' VAL . 9.2 p30 19.94 91.0 0.01 OUTLIER 'General case' 0 N--CA 1.499 2.012 0 N-CA-C 112.651 0.611 . . . . 0.0 112.651 177.669 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 171' ' ' GLU . . . . . . . . . . . . . 16.5 pt-20 -127.02 69.14 1.27 Allowed 'General case' 0 N--CA 1.495 1.809 0 O-C-N 121.099 -1.001 . . . . 0.0 109.493 178.488 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 172' ' ' GLN . . . . . . . . . . . . . 1.6 mp0 -133.69 -47.41 0.81 Allowed 'General case' 0 N--CA 1.495 1.79 0 O-C-N 121.329 -0.857 . . . . 0.0 110.723 -178.387 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 173' ' ' LYS . . . . . . . . . . . . . 9.0 mttp -63.4 125.56 24.58 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 120.835 -1.165 . . . . 0.0 108.992 179.861 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 174' ' ' GLY . . . . . 0.564 ' O ' ' C ' ' A' ' 175' ' ' LYS . . . -133.2 -39.13 0.21 Allowed Glycine 0 C--N 1.298 -1.541 0 N-CA-C 108.543 -1.823 . . . . 0.0 108.543 179.888 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 175' ' ' LYS . . . . . 0.564 ' C ' ' O ' ' A' ' 174' ' ' GLY . 3.8 mptt -32.33 -63.36 0.2 Allowed 'General case' 0 N--CA 1.499 2.015 0 N-CA-C 108.14 -1.059 . . . . 0.0 108.14 179.576 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 176' ' ' ASP . . . . . 0.665 ' O ' ' O ' ' A' ' 177' ' ' LYS . 1.0 OUTLIER -103.01 77.37 1.55 Allowed 'General case' 0 C--N 1.296 -1.72 0 N-CA-C 106.418 -1.697 . . . . 0.0 106.418 176.413 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 177' ' ' LYS . . . . . 0.665 ' O ' ' O ' ' A' ' 176' ' ' ASP . 10.1 mttt -26.74 163.55 0.0 OUTLIER 'General case' 0 N--CA 1.505 2.313 0 CA-C-O 122.091 0.948 . . . . 0.0 112.047 -178.111 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 178' ' ' GLN . . . . . 0.434 ' CD ' ' OD1' ' A' ' 114' ' ' ASN . 0.8 OUTLIER -158.45 168.33 27.23 Favored 'General case' 0 N--CA 1.489 1.499 0 C-N-CA 117.832 -1.547 . . . . 0.0 111.96 -179.792 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 179' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -124.65 101.9 7.34 Favored 'General case' 0 C--N 1.302 -1.47 0 N-CA-C 107.074 -1.454 . . . . 0.0 107.074 178.453 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 180' ' ' THR . . . . . . . . . . . . . 2.1 m -76.12 122.38 24.2 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.202 -0.936 . . . . 0.0 110.595 -177.973 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 181' ' ' LEU . . . . . . . . . . . . . 9.8 tp -98.8 111.79 24.07 Favored 'General case' 0 N--CA 1.493 1.706 0 O-C-N 121.272 -0.893 . . . . 0.0 109.23 178.774 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 182' ' ' ILE . . . . . . . . . . . . . 37.1 mt -100.1 122.99 52.66 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.489 0 O-C-N 120.972 -1.08 . . . . 0.0 109.148 178.357 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 183' ' ' THR . . . . . 0.555 ' HG1' ' HZ2' ' A' ' 134' ' ' LYS . 0.3 OUTLIER -138.9 107.12 5.76 Favored 'General case' 0 C--N 1.296 -1.743 0 N-CA-C 107.882 -1.155 . . . . 0.0 107.882 179.045 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 184' ' ' CYS . . . . . . . . . . . . . 1.9 p -80.88 157.27 25.7 Favored 'General case' 0 N--CA 1.497 1.915 0 C-N-CA 119.275 -0.97 . . . . 0.0 111.597 -177.48 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 185' ' ' ASP . . . . . 0.545 ' OD1' ' N ' ' A' ' 186' ' ' ASP . 20.0 t0 -167.27 177.16 6.27 Favored 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.635 -0.666 . . . . 0.0 109.393 -179.769 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 186' ' ' ASP . . . . . 0.545 ' N ' ' OD1' ' A' ' 185' ' ' ASP . 0.4 OUTLIER 81.05 54.6 0.02 OUTLIER 'General case' 0 N--CA 1.497 1.884 0 O-C-N 121.336 -0.853 . . . . 0.0 109.598 -179.779 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 187' ' ' TYR . . . . . 0.595 ' CE1' ' O ' ' A' ' 188' ' ' ASN . 37.2 t80 -66.07 132.54 48.76 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.124 -0.985 . . . . 0.0 110.204 -179.941 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 188' ' ' ASN . . . . . 0.763 ' ND2' ' H ' ' A' ' 193' ' ' VAL . 0.5 OUTLIER -99.93 149.72 23.14 Favored 'General case' 0 C--N 1.298 -1.632 0 N-CA-C 107.441 -1.318 . . . . 0.0 107.441 178.115 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 189' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -112.11 -2.84 14.88 Favored 'General case' 0 C--N 1.291 -1.938 0 N-CA-C 108.647 -0.872 . . . . 0.0 108.647 -179.179 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 190' ' ' LYS . . . . . . . . . . . . . 32.9 mttt -83.73 -59.8 2.32 Favored 'General case' 0 N--CA 1.488 1.439 0 N-CA-C 108.48 -0.933 . . . . 0.0 108.48 178.581 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 191' ' ' THR . . . . . 0.592 ' OG1' ' ND2' ' A' ' 188' ' ' ASN . 1.3 p -88.25 -12.18 44.42 Favored 'General case' 0 N--CA 1.493 1.687 0 O-C-N 121.338 -0.851 . . . . 0.0 108.954 179.094 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 192' ' ' GLY . . . . . 0.418 ' N ' ' OD1' ' A' ' 188' ' ' ASN . . . 73.29 41.54 45.74 Favored Glycine 0 N--CA 1.493 2.496 0 N-CA-C 110.588 -1.005 . . . . 0.0 110.588 178.902 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 193' ' ' VAL . . . . . 0.763 ' H ' ' ND2' ' A' ' 188' ' ' ASN . 95.9 t -149.14 163.52 4.4 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.612 0 O-C-N 121.043 -1.269 . . . . 0.0 110.542 179.817 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 194' ' ' TRP . . . . . 0.675 ' CG ' ' SG ' ' C' ' 705' ' ' B27 . 73.4 m95 -83.07 121.55 27.18 Favored 'General case' 0 N--CA 1.49 1.553 0 N-CA-C 108.572 -0.899 . . . . 0.0 108.572 179.358 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 195' ' ' GLU . . . . . . . . . . . . . 2.3 mt-10 -89.65 -61.05 1.78 Allowed 'General case' 0 N--CA 1.495 1.796 0 O-C-N 121.401 -0.812 . . . . 0.0 112.089 -177.523 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 196' ' ' LYS . . . . . . . . . . . . . 12.5 tttt -75.88 148.36 38.36 Favored 'General case' 0 N--CA 1.494 1.736 0 O-C-N 121.142 -0.974 . . . . 0.0 111.068 -177.876 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 197' ' ' ARG . . . . . 0.41 ' HE ' ' HA ' ' A' ' 163' ' ' PRO . 21.8 mmt180 -124.45 128.56 49.2 Favored 'General case' 0 N--CA 1.494 1.74 0 N-CA-C 108.274 -1.009 . . . . 0.0 108.274 178.361 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 198' ' ' LYS . . . . . . . . . . . . . 11.1 mmtp -116.13 118.42 32.79 Favored 'General case' 0 C--N 1.3 -1.587 0 O-C-N 121.59 -0.694 . . . . 0.0 110.27 -178.916 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 199' ' ' ILE . . . . . 0.447 ' O ' HG13 ' A' ' 199' ' ' ILE . 0.8 OUTLIER -136.95 121.39 24.05 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.768 0 CA-C-O 122.6 1.19 . . . . 0.0 110.877 179.474 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 200' ' ' PHE . . . . . 0.515 ' CD1' ' N ' ' A' ' 200' ' ' PHE . 3.1 m-85 -99.3 135.6 40.48 Favored 'General case' 0 N--CA 1.502 2.171 0 O-C-N 120.941 -1.099 . . . . 0.0 109.979 -178.293 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 201' ' ' VAL . . . . . 0.419 ' N ' ' O ' ' A' ' 157' ' ' SER . 84.4 t -105.33 146.29 12.53 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.849 0 O-C-N 120.94 -1.1 . . . . 0.0 108.968 177.315 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 202' ' ' ALA . . . . . 0.415 ' HA ' ' H ' ' A' ' 156' ' ' THR . . . -134.32 141.46 46.93 Favored 'General case' 0 N--CA 1.493 1.677 0 O-C-N 121.031 -1.043 . . . . 0.0 109.628 -179.749 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 203' ' ' THR . . . . . 0.533 ' HG1' ' CG2' ' A' ' 156' ' ' THR . 0.8 OUTLIER -88.93 130.64 35.4 Favored 'General case' 0 N--CA 1.488 1.426 0 CA-C-O 122.457 1.122 . . . . 0.0 111.27 -178.769 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 204' ' ' GLU . . . . . 0.496 ' HA ' ' CD2' ' A' ' 153' ' ' TYR . 1.3 tm-20 -49.39 134.52 18.78 Favored 'General case' 0 C--N 1.297 -1.713 0 C-N-CA 119.223 -0.991 . . . . 0.0 109.28 179.124 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 205' ' ' VAL . . . . . 0.516 ' CG1' ' N ' ' A' ' 206' ' ' LYS . 28.4 t -122.26 162.32 22.05 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.436 0 CA-C-O 122.055 0.931 . . . . 0.0 110.357 -178.02 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 206' ' ' LYS . . . . . 0.516 ' N ' ' CG1' ' A' ' 205' ' ' VAL . 1.3 ptpp? . . . . . 0 C--N 1.294 -1.838 0 CA-C-O 117.906 -1.045 . . . . 0.0 109.37 179.717 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' C' C ' 701' ' ' PHQ . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 010 nuclear orig full ' C' C ' 702' ' ' LEU . . . . . 0.69 ' CD1' ' N ' ' C' ' 702' ' ' LEU . 0.0 OUTLIER . . . . . 0 N--CA 1.494 1.744 0 N-CA-C 110.231 -0.285 . . . . 0.0 110.231 . . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' C' C ' 703' ' ' PRO . . . . . 0.508 ' O ' ' O ' ' C' ' 702' ' ' LEU . 51.0 Cg_exo -50.87 -157.23 0.0 OUTLIER 'Trans proline' 0 N--CA 1.496 1.646 0 C-N-CA 122.096 1.864 . . . . 0.0 112.6 179.864 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' C' C ' 704' ' ' ALA . . . . . 0.484 ' O ' ' O ' ' C' ' 703' ' ' PRO . . . 51.25 106.75 0.01 OUTLIER 'General case' 0 N--CA 1.493 1.692 0 O-C-N 121.125 -0.984 . . . . 0.0 110.212 179.845 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' C' C ' 705' ' ' B27 . . . . . 0.675 ' SG ' ' CG ' ' A' ' 194' ' ' TRP . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 700' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 011 nuclear orig full ' A' A ' 59' ' ' MET . . . . . . . . . . . . . 1.7 mpt? . . . . . 0 N--CA 1.491 1.596 0 N-CA-C 109.591 -0.522 . . . . 0.0 109.591 . . . . . . . . . 0 0 . 1 . 011 nuclear orig full ' A' A ' 60' ' ' GLN . . . . . . . . . . . . . 2.4 mt-30 -59.57 -86.47 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.092 -1.005 . . . . 0.0 109.439 -179.879 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . -65.23 169.6 5.5 Favored 'General case' 0 N--CA 1.493 1.714 0 O-C-N 121.308 -0.87 . . . . 0.0 110.194 -179.779 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 62' ' ' LYS . . . . . . . . . . . . . 61.4 tttm -142.17 72.61 22.31 Favored Pre-proline 0 N--CA 1.491 1.614 0 O-C-N 121.285 -0.884 . . . . 0.0 109.716 -179.614 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 63' ' ' PRO . . . . . . . . . . . . . 18.9 Cg_endo -89.32 156.37 5.52 Favored 'Trans proline' 0 C--N 1.307 -1.61 0 C-N-CA 123.576 2.85 . . . . 0.0 111.513 179.64 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 64' ' ' GLN . . . . . 0.579 ' N ' ' CD ' ' A' ' 64' ' ' GLN . 0.0 OUTLIER -154.29 133.91 12.84 Favored 'General case' 0 N--CA 1.493 1.701 0 O-C-N 120.996 -1.065 . . . . 0.0 109.452 179.733 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 65' ' ' ILE . . . . . 0.453 ' C ' ' O ' ' A' ' 64' ' ' GLN . 0.0 OUTLIER -45.95 108.35 0.8 Allowed Pre-proline 0 N--CA 1.489 1.494 0 N-CA-C 107.812 -1.181 . . . . 0.0 107.812 179.155 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 66' ' ' PRO . . . . . . . . . . . . . 60.1 Cg_endo -78.1 -162.68 0.18 Allowed 'Trans proline' 0 C--N 1.311 -1.419 0 C-N-CA 121.618 1.545 . . . . 0.0 112.148 -179.024 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 67' ' ' LYS . . . . . . . . . . . . . 15.8 tttp -89.81 -13.92 35.55 Favored 'General case' 0 C--N 1.301 -1.543 0 O-C-N 121.287 -0.883 . . . . 0.0 109.289 -179.874 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 68' ' ' ASP . . . . . 0.679 ' C ' ' H ' ' A' ' 70' ' ' SER . 0.6 OUTLIER -77.07 64.87 2.6 Favored 'General case' 0 N--CA 1.487 1.395 0 CA-C-O 122.654 1.216 . . . . 0.0 109.762 -179.868 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 69' ' ' LYS . . . . . 0.447 ' C ' ' O ' ' A' ' 68' ' ' ASP . 16.6 ptpt -48.2 -12.16 0.04 OUTLIER 'General case' 0 N--CA 1.516 2.827 0 C-N-CA 116.921 -1.912 . . . . 0.0 106.332 176.567 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 70' ' ' SER . . . . . 0.679 ' H ' ' C ' ' A' ' 68' ' ' ASP . 1.9 m -84.83 -6.38 59.35 Favored 'General case' 0 C--N 1.297 -1.688 0 CA-C-N 113.094 -1.866 . . . . 0.0 110.764 179.117 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 71' ' ' LYS . . . . . 0.429 ' N ' ' O ' ' A' ' 68' ' ' ASP . 0.3 OUTLIER -100.42 144.33 29.55 Favored 'General case' 0 N--CA 1.5 2.068 0 O-C-N 120.649 -1.282 . . . . 0.0 111.759 -179.661 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 0.7 OUTLIER -66.4 134.08 30.38 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.369 0 N-CA-C 105.085 -2.191 . . . . 0.0 105.085 175.638 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 73' ' ' ALA . . . . . 0.549 ' N ' ' O ' ' A' ' 87' ' ' VAL . . . -80.5 -13.96 58.66 Favored 'General case' 0 C--N 1.295 -1.776 0 O-C-N 119.587 -1.946 . . . . 0.0 107.161 -179.525 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . 177.16 -159.63 26.06 Favored Glycine 0 N--CA 1.482 1.725 0 N-CA-C 109.835 -1.306 . . . . 0.0 109.835 179.07 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 75' ' ' TYR . . . . . 0.469 ' CD2' ' O ' ' A' ' 85' ' ' GLU . 0.6 OUTLIER -143.83 165.96 26.25 Favored 'General case' 0 C--N 1.295 -1.768 0 C-N-CA 119.468 -0.893 . . . . 0.0 110.75 -177.283 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 76' ' ' ILE . . . . . . . . . . . . . 1.2 tt -148.38 147.4 17.0 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.534 0 C-N-CA 119.346 -0.942 . . . . 0.0 110.072 -178.189 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -150.76 162.48 40.65 Favored 'General case' 0 N--CA 1.486 1.373 0 O-C-N 121.276 -0.89 . . . . 0.0 109.042 179.934 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 78' ' ' ILE . . . . . . . . . . . . . 38.6 mt -147.62 97.08 4.04 Favored Pre-proline 0 N--CA 1.488 1.445 0 O-C-N 121.238 -0.913 . . . . 0.0 108.817 -179.444 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 79' ' ' PRO . . . . . . . . . . . . . 51.0 Cg_exo -49.15 -45.13 30.84 Favored 'Trans proline' 0 N--CA 1.493 1.485 0 C-N-CA 122.795 2.33 . . . . 0.0 114.423 -178.59 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 80' ' ' ASP . . . . . 0.482 ' O ' ' OD1' ' A' ' 80' ' ' ASP . 47.7 t0 -66.09 -20.26 66.11 Favored 'General case' 0 N--CA 1.496 1.843 0 O-C-N 120.48 -1.387 . . . . 0.0 111.024 179.073 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 81' ' ' ALA . . . . . 0.577 ' O ' ' ND2' ' A' ' 132' ' ' ASN . . . -107.09 -10.49 15.88 Favored 'General case' 0 N--CA 1.491 1.582 0 N-CA-C 108.528 -0.916 . . . . 0.0 108.528 179.639 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 82' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER 61.42 50.88 4.41 Favored 'General case' 0 N--CA 1.493 1.697 0 O-C-N 121.541 -0.724 . . . . 0.0 110.719 179.481 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 83' ' ' ILE . . . . . . . . . . . . . 46.6 mt -128.83 152.2 36.67 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.815 0 O-C-N 121.062 -1.024 . . . . 0.0 110.229 -178.975 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 84' ' ' LYS . . . . . . . . . . . . . 27.2 tttp -157.88 108.47 2.19 Favored 'General case' 0 N--CA 1.49 1.566 0 N-CA-C 107.662 -1.236 . . . . 0.0 107.662 179.762 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 85' ' ' GLU . . . . . 0.512 ' OE2' ' O ' ' A' ' 129' ' ' GLN . 0.0 OUTLIER -141.6 163.35 41.61 Favored Pre-proline 0 N--CA 1.494 1.771 0 O-C-N 121.283 -0.886 . . . . 0.0 110.88 -178.361 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 86' ' ' PRO . . . . . 0.41 ' N ' ' CE2' ' A' ' 75' ' ' TYR . 40.9 Cg_endo -72.15 165.36 32.84 Favored 'Trans proline' 0 N--CA 1.495 1.609 0 C-N-CA 123.259 2.639 . . . . 0.0 113.031 -179.882 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 87' ' ' VAL . . . . . 0.549 ' O ' ' N ' ' A' ' 73' ' ' ALA . 66.0 t -124.36 98.96 5.76 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.695 0 N-CA-C 108.903 -0.777 . . . . 0.0 108.903 179.54 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 88' ' ' TYR . . . . . 0.423 ' CE1' ' HB3' ' A' ' 99' ' ' ARG . 15.9 m-85 -91.45 155.58 44.02 Favored Pre-proline 0 N--CA 1.501 2.12 0 O-C-N 120.964 -1.085 . . . . 0.0 110.224 -179.212 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 89' ' ' PRO . . . . . . . . . . . . . 9.6 Cg_endo -61.75 145.25 97.45 Favored 'Trans proline' 0 C--N 1.311 -1.443 0 C-N-CA 122.639 2.226 . . . . 0.0 113.408 179.683 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . -58.82 168.23 6.34 Favored Glycine 0 N--CA 1.494 2.504 0 N-CA-C 109.408 -1.477 . . . . 0.0 109.408 179.305 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 91' ' ' PRO . . . . . 0.459 ' C ' ' H ' ' A' ' 93' ' ' THR . 97.5 Cg_endo -94.13 169.53 18.82 Favored 'Cis proline' 0 C--N 1.307 -1.654 0 C-N-CA 123.873 -1.303 . . . . 0.0 112.021 -0.257 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 92' ' ' ALA . . . . . 0.515 ' O ' ' CD1' ' A' ' 97' ' ' LEU . . . -72.16 31.47 0.06 Allowed 'General case' 0 N--CA 1.489 1.49 0 O-C-N 121.217 -0.927 . . . . 0.0 110.756 -179.786 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 93' ' ' THR . . . . . 0.459 ' H ' ' C ' ' A' ' 91' ' ' PRO . 6.0 p -72.41 151.42 91.88 Favored Pre-proline 0 N--CA 1.492 1.643 0 O-C-N 120.543 -1.348 . . . . 0.0 108.075 179.865 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 94' ' ' PRO . . . . . 0.435 ' C ' ' O ' ' A' ' 93' ' ' THR . 88.7 Cg_exo -31.68 -57.91 0.23 Allowed 'Trans proline' 0 C--N 1.306 -1.692 0 C-N-CA 122.702 2.268 . . . . 0.0 112.636 -178.656 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 95' ' ' GLU . . . . . 0.506 ' O ' ' ND2' ' A' ' 98' ' ' ASN . 29.0 mt-10 -43.87 -49.09 8.39 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.11 -0.994 . . . . 0.0 109.715 179.929 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 96' ' ' GLN . . . . . 0.586 ' O ' ' N ' ' A' ' 98' ' ' ASN . 39.2 mm-40 -71.63 -56.98 4.81 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.195 -0.941 . . . . 0.0 110.981 -179.058 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 97' ' ' LEU . . . . . 0.515 ' CD1' ' O ' ' A' ' 92' ' ' ALA . 91.7 mt -48.95 -5.99 0.02 OUTLIER 'General case' 0 N--CA 1.495 1.783 0 O-C-N 120.989 -1.069 . . . . 0.0 109.878 -179.156 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 98' ' ' ASN . . . . . 0.802 HD22 ' NE ' ' A' ' 99' ' ' ARG . 0.1 OUTLIER -73.2 -28.63 62.3 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.213 -0.929 . . . . 0.0 108.904 179.466 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 99' ' ' ARG . . . . . 0.802 ' NE ' HD22 ' A' ' 98' ' ' ASN . 0.0 OUTLIER -92.34 -54.57 3.75 Favored 'General case' 0 N--CA 1.487 1.406 0 O-C-N 121.692 -0.63 . . . . 0.0 109.552 -179.659 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . -179.89 -160.63 25.71 Favored Glycine 0 N--CA 1.491 2.353 0 C-N-CA 119.554 -1.308 . . . . 0.0 110.188 -179.917 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 101' ' ' VAL . . . . . 0.468 ' O ' ' CG2' ' A' ' 101' ' ' VAL . 20.5 m -61.48 104.93 0.29 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.659 0 O-C-N 121.474 -1.015 . . . . 0.0 109.92 -179.507 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -92.73 157.16 16.59 Favored 'General case' 0 N--CA 1.493 1.715 0 O-C-N 121.495 -0.753 . . . . 0.0 110.67 -179.503 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 103' ' ' PHE . . . . . . . . . . . . . 22.1 m-85 -59.69 130.36 46.43 Favored 'General case' 0 N--CA 1.49 1.568 0 N-CA-C 107.468 -1.308 . . . . 0.0 107.468 178.276 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 104' ' ' ALA . . . . . . . . . . . . . . . -50.95 -16.45 0.43 Allowed 'General case' 0 C--N 1.301 -1.542 0 O-C-N 121.378 -0.826 . . . . 0.0 111.467 -178.337 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -139.49 147.61 41.53 Favored 'General case' 0 N--CA 1.494 1.766 0 O-C-N 120.722 -1.236 . . . . 0.0 110.577 -179.862 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 106' ' ' GLU . . . . . 0.559 ' OE2' ' ND2' ' A' ' 107' ' ' ASN . 3.3 tt0 -54.71 -64.44 0.83 Allowed 'General case' 0 C--N 1.301 -1.527 0 CA-C-N 115.857 -0.611 . . . . 0.0 111.151 -178.986 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 107' ' ' ASN . . . . . 0.559 ' ND2' ' OE2' ' A' ' 106' ' ' GLU . 2.5 m120 -78.28 33.37 0.19 Allowed 'General case' 0 N--CA 1.49 1.566 0 O-C-N 120.522 -1.361 . . . . 0.0 113.059 -175.325 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 108' ' ' GLU . . . . . . . . . . . . . 27.8 tp10 -59.39 148.41 32.66 Favored 'General case' 0 C--N 1.299 -1.597 0 N-CA-C 107.191 -1.411 . . . . 0.0 107.191 179.886 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 109' ' ' SER . . . . . 0.402 ' C ' ' H ' ' A' ' 111' ' ' ASP . 0.3 OUTLIER -99.64 129.82 45.81 Favored 'General case' 0 C--N 1.301 -1.504 0 O-C-N 120.987 -1.071 . . . . 0.0 110.443 -178.019 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 110' ' ' LEU . . . . . . . . . . . . . 3.2 tp -59.03 -11.98 4.16 Favored 'General case' 0 C--N 1.301 -1.505 0 N-CA-C 108.02 -1.104 . . . . 0.0 108.02 179.63 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 111' ' ' ASP . . . . . 0.402 ' H ' ' C ' ' A' ' 109' ' ' SER . 57.7 m-20 -132.57 30.03 4.15 Favored 'General case' 0 N--CA 1.491 1.615 0 N-CA-C 109.0 -0.741 . . . . 0.0 109.0 179.044 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 112' ' ' ASP . . . . . . . . . . . . . 6.2 t0 -67.27 149.1 50.86 Favored 'General case' 0 N--CA 1.493 1.704 0 O-C-N 121.105 -0.997 . . . . 0.0 111.19 -179.056 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 113' ' ' GLN . . . . . 0.713 HE22 ' NZ ' ' A' ' 177' ' ' LYS . 0.4 OUTLIER -66.36 -12.83 59.03 Favored 'General case' 0 N--CA 1.49 1.564 0 N-CA-C 108.319 -0.993 . . . . 0.0 108.319 178.285 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 114' ' ' ASN . . . . . 0.587 ' C ' HD21 ' A' ' 114' ' ' ASN . 0.2 OUTLIER -149.92 99.98 2.89 Favored 'General case' 0 N--CA 1.491 1.601 0 N-CA-C 108.204 -1.035 . . . . 0.0 108.204 179.351 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 115' ' ' ILE . . . . . 0.427 HG23 HD12 ' A' ' 115' ' ' ILE . 3.9 mt -98.79 111.94 29.67 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.621 0 O-C-N 121.111 -0.993 . . . . 0.0 109.497 -179.367 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 116' ' ' SER . . . . . . . . . . . . . 48.9 m -97.84 153.58 18.21 Favored 'General case' 0 N--CA 1.492 1.675 0 O-C-N 121.026 -1.046 . . . . 0.0 110.94 -179.142 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 117' ' ' ILE . . . . . . . . . . . . . 1.5 mt -144.79 159.94 14.24 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.617 0 N-CA-C 108.629 -0.878 . . . . 0.0 108.629 179.586 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 118' ' ' ALA . . . . . . . . . . . . . . . -144.53 160.25 41.44 Favored 'General case' 0 N--CA 1.491 1.606 0 C-N-CA 118.639 -1.224 . . . . 0.0 112.17 -179.441 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 119' ' ' GLY . . . . . . . . . . . . . . . -172.16 146.24 9.16 Favored Glycine 0 N--CA 1.49 2.239 0 N-CA-C 110.622 -0.991 . . . . 0.0 110.622 179.909 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 120' ' ' HIS . . . . . 0.654 ' CD2' ' SG ' ' C' ' 705' ' ' B27 . 11.5 m170 -71.29 167.63 19.06 Favored 'General case' 0 N--CA 1.496 1.856 0 O-C-N 121.744 -0.857 . . . . 0.0 110.45 179.483 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 121' ' ' THR . . . . . 0.504 ' OG1' ' NZ ' ' A' ' 134' ' ' LYS . 0.7 OUTLIER -119.02 162.29 18.8 Favored 'General case' 0 N--CA 1.5 2.048 0 O-C-N 121.188 -0.945 . . . . 0.0 108.874 179.301 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 122' ' ' PHE . . . . . . . . . . . . . 0.3 OUTLIER -133.25 122.37 23.82 Favored 'General case' 0 N--CA 1.499 1.982 0 O-C-N 120.868 -1.145 . . . . 0.0 110.291 -179.281 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 123' ' ' ILE . . . . . 0.448 ' CG2' ' N ' ' A' ' 124' ' ' ASP . 18.1 tt -65.5 -40.75 89.15 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.582 0 CA-C-O 121.58 0.705 . . . . 0.0 109.217 179.588 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 124' ' ' ASP . . . . . 0.448 ' N ' ' CG2' ' A' ' 123' ' ' ILE . 1.2 t70 -96.69 25.75 4.97 Favored 'General case' 0 N--CA 1.497 1.914 0 C-N-CA 120.154 -0.619 . . . . 0.0 111.452 -178.473 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 125' ' ' ARG . . . . . 0.638 HH11 ' CG ' ' A' ' 125' ' ' ARG . 0.0 OUTLIER -158.67 106.15 1.62 Allowed Pre-proline 0 N--CA 1.493 1.712 0 O-C-N 120.553 -1.342 . . . . 0.0 110.126 -179.209 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 126' ' ' PRO . . . . . . . . . . . . . 74.3 Cg_endo -81.91 -23.61 4.52 Favored 'Trans proline' 0 N--CA 1.489 1.217 0 C-N-CA 122.293 1.995 . . . . 0.0 112.325 179.834 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 127' ' ' ASN . . . . . . . . . . . . . 1.3 m-20 -90.34 28.91 1.35 Allowed 'General case' 0 N--CA 1.489 1.495 0 O-C-N 121.295 -0.878 . . . . 0.0 109.815 -179.685 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 128' ' ' TYR . . . . . . . . . . . . . 7.6 t80 -83.9 -149.27 0.1 Allowed 'General case' 0 N--CA 1.494 1.735 0 O-C-N 121.303 -0.873 . . . . 0.0 109.15 179.61 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 129' ' ' GLN . . . . . 0.512 ' O ' ' OE2' ' A' ' 85' ' ' GLU . 51.3 mt-30 -67.77 -73.05 0.15 Allowed 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.102 -0.999 . . . . 0.0 109.875 -179.698 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 130' ' ' PHE . . . . . 0.422 ' O ' ' CE ' ' A' ' 134' ' ' LYS . 38.7 m-85 -129.63 45.92 2.73 Favored 'General case' 0 N--CA 1.497 1.918 0 O-C-N 121.013 -1.054 . . . . 0.0 110.119 -179.845 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 131' ' ' THR . . . . . . . . . . . . . 25.0 m -82.58 -37.64 24.79 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 120.991 -1.068 . . . . 0.0 110.222 -179.919 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 132' ' ' ASN . . . . . 0.577 ' ND2' ' O ' ' A' ' 81' ' ' ALA . 7.6 t30 -83.39 7.84 15.49 Favored 'General case' 0 N--CA 1.491 1.618 0 C-N-CA 119.389 -0.924 . . . . 0.0 111.145 -178.574 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 133' ' ' LEU . . . . . 0.545 ' O ' ' N ' ' A' ' 135' ' ' ALA . 0.1 OUTLIER -70.29 -46.21 64.76 Favored 'General case' 0 C--N 1.301 -1.523 0 O-C-N 120.793 -1.192 . . . . 0.0 109.237 179.936 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 134' ' ' LYS . . . . . 0.513 ' H ' ' CD ' ' A' ' 134' ' ' LYS . 0.0 OUTLIER -43.75 -18.16 0.02 OUTLIER 'General case' 0 N--CA 1.494 1.747 0 O-C-N 121.368 -0.832 . . . . 0.0 109.861 -179.74 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 135' ' ' ALA . . . . . 0.545 ' N ' ' O ' ' A' ' 133' ' ' LEU . . . -83.8 -37.14 22.93 Favored 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.048 -1.032 . . . . 0.0 109.433 179.943 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 136' ' ' ALA . . . . . 0.43 ' N ' ' O ' ' A' ' 133' ' ' LEU . . . -79.62 157.05 27.39 Favored 'General case' 0 C--N 1.301 -1.541 0 CA-C-O 122.298 1.047 . . . . 0.0 111.517 -178.502 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 137' ' ' LYS . . . . . 0.562 ' O ' ' O ' ' A' ' 138' ' ' LYS . 0.1 OUTLIER -152.04 -163.26 1.69 Allowed 'General case' 0 C--N 1.304 -1.404 0 C-N-CA 119.017 -1.073 . . . . 0.0 110.03 -178.016 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 138' ' ' LYS . . . . . 0.582 ' O ' ' N ' ' A' ' 140' ' ' SER . 51.2 mttm -41.0 177.67 0.0 OUTLIER 'General case' 0 C--N 1.304 -1.381 0 CA-C-O 122.583 1.182 . . . . 0.0 111.716 -179.093 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 139' ' ' GLY . . . . . . . . . . . . . . . 46.32 8.3 0.02 OUTLIER Glycine 0 N--CA 1.492 2.386 0 N-CA-C 110.353 -1.099 . . . . 0.0 110.353 -179.918 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 140' ' ' SER . . . . . 0.582 ' N ' ' O ' ' A' ' 138' ' ' LYS . 6.3 m -79.0 121.52 25.04 Favored 'General case' 0 N--CA 1.493 1.719 0 O-C-N 120.887 -1.36 . . . . 0.0 109.693 179.258 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 141' ' ' MET . . . . . 0.687 ' SD ' ' N ' ' A' ' 142' ' ' VAL . 5.1 tpp -77.99 125.15 28.92 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.192 -0.943 . . . . 0.0 108.971 179.529 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 142' ' ' VAL . . . . . 0.687 ' N ' ' SD ' ' A' ' 141' ' ' MET . 2.5 t -110.48 131.51 61.38 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.446 0 N-CA-C 108.585 -0.894 . . . . 0.0 108.585 -179.594 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 143' ' ' TYR . . . . . . . . . . . . . 9.8 m-85 -109.98 135.54 50.66 Favored 'General case' 0 N--CA 1.497 1.922 0 O-C-N 121.036 -1.04 . . . . 0.0 111.111 -178.321 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 144' ' ' PHE . . . . . . . . . . . . . 46.7 t80 -121.03 102.48 8.36 Favored 'General case' 0 N--CA 1.49 1.534 0 CA-C-O 121.262 0.553 . . . . 0.0 109.829 -178.957 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 145' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -100.93 121.81 42.4 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.202 -0.936 . . . . 0.0 110.117 -179.966 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 146' ' ' VAL . . . . . . . . . . . . . 1.0 OUTLIER -142.53 124.49 12.86 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.581 0 O-C-N 121.126 -0.984 . . . . 0.0 108.424 179.091 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 147' ' ' GLY . . . . . . . . . . . . . . . 66.9 -132.1 31.26 Favored Glycine 0 N--CA 1.49 2.239 0 N-CA-C 108.103 -1.999 . . . . 0.0 108.103 -178.735 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 148' ' ' ASN . . . . . 0.606 ' C ' ' ND2' ' A' ' 148' ' ' ASN . 0.0 OUTLIER -102.43 10.31 39.09 Favored 'General case' 0 C--N 1.301 -1.526 0 O-C-N 121.266 -1.138 . . . . 0.0 108.209 178.955 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 149' ' ' GLU . . . . . 0.402 ' OE1' ' N ' ' A' ' 150' ' ' THR . 1.4 tm-20 -107.91 144.44 35.16 Favored 'General case' 0 N--CA 1.489 1.524 0 CA-C-O 121.941 0.877 . . . . 0.0 111.706 -178.666 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 150' ' ' THR . . . . . 0.402 ' N ' ' OE1' ' A' ' 149' ' ' GLU . 44.2 m -133.8 100.51 4.78 Favored 'General case' 0 N--CA 1.491 1.603 0 CA-C-O 121.517 0.675 . . . . 0.0 109.563 -179.749 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 151' ' ' ARG . . . . . . . . . . . . . 17.4 mtt180 -87.06 -174.16 4.78 Favored 'General case' 0 N--CA 1.488 1.445 0 N-CA-C 108.435 -0.95 . . . . 0.0 108.435 179.994 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 152' ' ' LYS . . . . . 0.496 ' O ' ' N ' ' A' ' 205' ' ' VAL . 35.6 mtmt -148.59 142.95 26.25 Favored 'General case' 0 N--CA 1.488 1.469 0 O-C-N 121.068 -1.02 . . . . 0.0 110.273 -179.335 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 153' ' ' TYR . . . . . 0.57 ' O ' ' SD ' ' A' ' 141' ' ' MET . 2.8 m-85 -136.18 167.77 20.66 Favored 'General case' 0 N--CA 1.492 1.642 0 N-CA-C 107.582 -1.266 . . . . 0.0 107.582 179.029 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 154' ' ' LYS . . . . . . . . . . . . . 1.5 ttpm? -142.26 122.93 14.23 Favored 'General case' 0 N--CA 1.493 1.704 0 O-C-N 121.127 -0.983 . . . . 0.0 108.393 178.387 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 155' ' ' MET . . . . . . . . . . . . . 67.2 mtp -45.57 105.94 0.07 Allowed 'General case' 0 N--CA 1.491 1.608 0 O-C-N 120.586 -1.321 . . . . 0.0 111.351 -178.67 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 156' ' ' THR . . . . . 0.456 ' OG1' ' OG1' ' A' ' 203' ' ' THR . 0.1 OUTLIER -106.41 -24.87 12.12 Favored 'General case' 0 C--N 1.293 -1.888 0 CA-C-N 115.401 -0.818 . . . . 0.0 110.073 -179.077 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 157' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -151.45 151.5 31.76 Favored 'General case' 0 N--CA 1.494 1.765 0 C-N-CA 118.405 -1.318 . . . . 0.0 111.206 -178.299 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 158' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -154.16 144.4 13.98 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.189 0 CA-C-O 122.039 0.923 . . . . 0.0 110.448 -179.538 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 159' ' ' ARG . . . . . . . . . . . . . 31.4 ttp180 -153.98 155.91 36.45 Favored 'General case' 0 C--N 1.297 -1.685 0 CA-C-O 121.934 0.873 . . . . 0.0 110.76 -179.036 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 160' ' ' ASP . . . . . . . . . . . . . 26.5 m-20 -118.65 160.66 21.42 Favored 'General case' 0 N--CA 1.492 1.666 0 N-CA-C 108.957 -0.757 . . . . 0.0 108.957 179.325 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 161' ' ' VAL . . . . . 0.451 ' O ' ' O ' ' A' ' 162' ' ' LYS . 0.0 OUTLIER -164.54 161.65 0.94 Allowed 'Isoleucine or valine' 0 N--CA 1.496 1.826 0 O-C-N 121.003 -1.061 . . . . 0.0 110.213 179.508 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 162' ' ' LYS . . . . . 0.688 ' H ' ' CD ' ' A' ' 162' ' ' LYS . 0.0 OUTLIER -45.99 173.04 0.04 OUTLIER Pre-proline 0 N--CA 1.493 1.723 0 O-C-N 121.591 -0.693 . . . . 0.0 109.815 179.456 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 163' ' ' PRO . . . . . 0.647 ' CA ' HH21 ' A' ' 197' ' ' ARG . 63.1 Cg_endo -81.34 35.06 0.57 Allowed 'Trans proline' 0 C--N 1.313 -1.34 0 C-N-CA 122.532 2.155 . . . . 0.0 112.54 179.815 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 164' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -150.76 -2.66 0.35 Allowed 'General case' 0 N--CA 1.495 1.814 0 O-C-N 121.053 -1.03 . . . . 0.0 110.821 179.961 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 165' ' ' ASP . . . . . 0.432 ' O ' ' C ' ' A' ' 166' ' ' VAL . 9.7 t70 -75.8 62.66 1.56 Allowed 'General case' 0 N--CA 1.495 1.785 0 O-C-N 120.675 -1.266 . . . . 0.0 110.675 -179.58 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 166' ' ' VAL . . . . . 0.621 ' O ' ' N ' ' A' ' 168' ' ' VAL . 2.6 t -42.99 -31.48 0.49 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.659 0 O-C-N 121.236 -0.915 . . . . 0.0 109.096 -178.853 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 167' ' ' GLY . . . . . . . . . . . . . . . -44.08 -9.81 0.01 OUTLIER Glycine 0 N--CA 1.495 2.632 0 O-C-N 121.126 -0.983 . . . . 0.0 111.055 -179.788 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 168' ' ' VAL . . . . . 0.672 ' C ' ' H ' ' A' ' 170' ' ' ASP . 7.4 m -55.47 -32.18 29.38 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.51 0 O-C-N 120.615 -1.521 . . . . 0.0 108.759 179.543 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 169' ' ' LEU . . . . . 0.564 ' O ' ' N ' ' A' ' 171' ' ' GLU . 9.5 mt -52.53 -4.65 0.03 OUTLIER 'General case' 0 N--CA 1.498 1.969 0 N-CA-C 107.957 -1.127 . . . . 0.0 107.957 -179.328 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 170' ' ' ASP . . . . . 0.672 ' H ' ' C ' ' A' ' 168' ' ' VAL . 0.6 OUTLIER 34.12 28.21 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.762 -0.586 . . . . 0.0 111.713 177.838 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 171' ' ' GLU . . . . . 0.564 ' N ' ' O ' ' A' ' 169' ' ' LEU . 11.8 pt-20 -63.91 93.17 0.08 Allowed 'General case' 0 C--N 1.298 -1.647 0 N-CA-C 107.645 -1.242 . . . . 0.0 107.645 178.528 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 172' ' ' GLN . . . . . . . . . . . . . 1.0 OUTLIER -160.84 -71.75 0.06 Allowed 'General case' 0 N--CA 1.491 1.588 0 CA-C-O 121.263 0.554 . . . . 0.0 109.511 -179.371 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 173' ' ' LYS . . . . . 0.601 ' NZ ' HE21 ' A' ' 178' ' ' GLN . 8.9 pttm -62.09 126.6 27.91 Favored 'General case' 0 N--CA 1.488 1.446 0 O-C-N 121.143 -0.973 . . . . 0.0 108.908 179.631 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 174' ' ' GLY . . . . . 0.568 ' O ' ' C ' ' A' ' 175' ' ' LYS . . . -121.18 -39.81 0.57 Allowed Glycine 0 C--N 1.298 -1.565 0 N-CA-C 108.283 -1.927 . . . . 0.0 108.283 179.721 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 175' ' ' LYS . . . . . 0.568 ' C ' ' O ' ' A' ' 174' ' ' GLY . 0.8 OUTLIER -31.59 -62.22 0.2 Allowed 'General case' 0 N--CA 1.498 1.929 0 N-CA-C 108.124 -1.065 . . . . 0.0 108.124 179.783 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 176' ' ' ASP . . . . . 0.631 ' O ' ' O ' ' A' ' 177' ' ' LYS . 69.6 m-20 -104.09 85.72 2.44 Favored 'General case' 0 C--N 1.294 -1.815 0 N-CA-C 107.487 -1.301 . . . . 0.0 107.487 177.092 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 177' ' ' LYS . . . . . 0.713 ' NZ ' HE22 ' A' ' 113' ' ' GLN . 35.8 mttt -37.23 174.08 0.0 OUTLIER 'General case' 0 N--CA 1.497 1.904 0 CA-C-O 121.696 0.76 . . . . 0.0 110.588 -179.113 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 178' ' ' GLN . . . . . 0.601 HE21 ' NZ ' ' A' ' 173' ' ' LYS . 0.6 OUTLIER -161.51 175.42 12.15 Favored 'General case' 0 N--CA 1.489 1.479 0 C-N-CA 118.371 -1.332 . . . . 0.0 111.105 -179.864 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 179' ' ' LEU . . . . . 0.422 ' N ' ' OE1' ' A' ' 178' ' ' GLN . 1.3 tp -128.44 98.0 4.9 Favored 'General case' 0 C--N 1.302 -1.485 0 N-CA-C 107.274 -1.38 . . . . 0.0 107.274 178.103 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 180' ' ' THR . . . . . 0.481 ' N ' ' OE1' ' A' ' 178' ' ' GLN . 1.1 m -71.66 120.74 17.67 Favored 'General case' 0 N--CA 1.486 1.371 0 O-C-N 121.1 -1.0 . . . . 0.0 110.157 -178.341 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 181' ' ' LEU . . . . . . . . . . . . . 6.6 tt -95.69 146.71 24.29 Favored 'General case' 0 C--N 1.299 -1.593 0 N-CA-C 107.915 -1.143 . . . . 0.0 107.915 178.01 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 182' ' ' ILE . . . . . . . . . . . . . 19.8 mt -141.16 117.47 7.17 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.781 0 O-C-N 121.059 -1.026 . . . . 0.0 108.817 179.081 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 183' ' ' THR . . . . . . . . . . . . . 14.3 t -138.07 119.01 14.27 Favored 'General case' 0 C--N 1.29 -1.978 0 N-CA-C 108.002 -1.11 . . . . 0.0 108.002 179.229 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 184' ' ' CYS . . . . . . . . . . . . . 0.8 OUTLIER -79.85 162.5 25.01 Favored 'General case' 0 C--N 1.285 -2.236 0 C-N-CA 119.466 -0.894 . . . . 0.0 111.397 -177.842 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 185' ' ' ASP . . . . . 0.417 ' OD1' ' N ' ' A' ' 186' ' ' ASP . 4.4 t0 -165.51 -152.48 0.16 Allowed 'General case' 0 N--CA 1.492 1.644 0 N-CA-C 108.938 -0.764 . . . . 0.0 108.938 179.745 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 186' ' ' ASP . . . . . 0.417 ' N ' ' OD1' ' A' ' 185' ' ' ASP . 0.5 OUTLIER 47.78 59.34 4.25 Favored 'General case' 0 N--CA 1.495 1.777 0 O-C-N 121.136 -0.977 . . . . 0.0 109.072 -179.678 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 187' ' ' TYR . . . . . 0.591 ' CE1' ' O ' ' A' ' 188' ' ' ASN . 43.4 t80 -68.37 134.58 50.46 Favored 'General case' 0 N--CA 1.489 1.485 0 CA-C-O 121.821 0.819 . . . . 0.0 110.612 -179.585 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 188' ' ' ASN . . . . . 0.591 ' O ' ' CE1' ' A' ' 187' ' ' TYR . 0.8 OUTLIER -99.6 146.02 26.9 Favored 'General case' 0 C--N 1.294 -1.838 0 N-CA-C 107.916 -1.142 . . . . 0.0 107.916 178.224 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 189' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -111.55 -18.32 12.85 Favored 'General case' 0 C--N 1.296 -1.734 0 N-CA-C 108.1 -1.074 . . . . 0.0 108.1 -179.812 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 190' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER -83.68 -49.77 8.82 Favored 'General case' 0 C--N 1.302 -1.472 0 N-CA-C 108.267 -1.012 . . . . 0.0 108.267 178.457 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 191' ' ' THR . . . . . . . . . . . . . 44.4 p -87.41 -6.52 58.41 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.487 -0.758 . . . . 0.0 109.514 -179.971 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 192' ' ' GLY . . . . . . . . . . . . . . . 56.53 36.3 70.18 Favored Glycine 0 N--CA 1.493 2.463 0 O-C-N 121.081 -1.012 . . . . 0.0 110.648 179.025 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 193' ' ' VAL . . . . . . . . . . . . . 3.3 m -147.23 161.85 8.15 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.545 0 O-C-N 121.025 -1.279 . . . . 0.0 109.339 179.709 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 194' ' ' TRP . . . . . 0.472 ' N ' ' CD1' ' A' ' 194' ' ' TRP . 22.7 m95 -84.15 118.88 24.4 Favored 'General case' 0 N--CA 1.489 1.495 0 N-CA-C 107.604 -1.258 . . . . 0.0 107.604 178.654 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 195' ' ' GLU . . . . . 0.522 ' CD ' ' ND2' ' A' ' 188' ' ' ASN . 3.5 mt-10 -82.74 -62.09 1.7 Allowed 'General case' 0 N--CA 1.495 1.809 0 O-C-N 121.14 -0.975 . . . . 0.0 112.319 -177.103 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 196' ' ' LYS . . . . . . . . . . . . . 8.0 tptp -86.63 156.46 20.01 Favored 'General case' 0 N--CA 1.494 1.754 0 O-C-N 120.753 -1.217 . . . . 0.0 110.856 -178.141 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 197' ' ' ARG . . . . . 0.647 HH21 ' CA ' ' A' ' 163' ' ' PRO . 6.4 tpp180 -124.98 139.94 53.36 Favored 'General case' 0 N--CA 1.489 1.489 0 N-CA-C 109.133 -0.691 . . . . 0.0 109.133 179.389 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 198' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -112.46 121.8 45.87 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.626 -0.671 . . . . 0.0 109.863 -179.053 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 199' ' ' ILE . . . . . 0.413 ' O ' ' CG1' ' A' ' 199' ' ' ILE . 0.9 OUTLIER -141.51 119.44 8.88 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.665 0 CA-C-O 122.615 1.198 . . . . 0.0 110.996 179.857 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 200' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -104.7 138.71 40.59 Favored 'General case' 0 N--CA 1.494 1.759 0 O-C-N 121.526 -0.734 . . . . 0.0 110.438 -178.305 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 201' ' ' VAL . . . . . . . . . . . . . 58.0 t -101.93 143.52 14.59 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.729 0 O-C-N 120.971 -1.081 . . . . 0.0 108.447 178.314 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 202' ' ' ALA . . . . . . . . . . . . . . . -124.95 135.23 52.63 Favored 'General case' 0 N--CA 1.489 1.477 0 N-CA-C 108.49 -0.93 . . . . 0.0 108.49 179.687 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 203' ' ' THR . . . . . 0.456 ' OG1' ' OG1' ' A' ' 156' ' ' THR . 1.3 p -89.17 128.4 35.8 Favored 'General case' 0 C--N 1.303 -1.427 0 CA-C-O 122.23 1.014 . . . . 0.0 111.225 -178.61 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 204' ' ' GLU . . . . . 0.47 ' HA ' ' CD2' ' A' ' 153' ' ' TYR . 5.5 tt0 -51.18 134.43 27.22 Favored 'General case' 0 C--N 1.297 -1.684 0 C-N-CA 118.949 -1.101 . . . . 0.0 108.369 178.728 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 205' ' ' VAL . . . . . 0.496 ' N ' ' O ' ' A' ' 152' ' ' LYS . 95.6 t -131.12 166.81 27.68 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.34 0 CA-C-O 121.934 0.873 . . . . 0.0 110.023 -177.859 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 206' ' ' LYS . . . . . 0.47 ' N ' ' CG1' ' A' ' 205' ' ' VAL . 2.0 pttp . . . . . 0 C--N 1.298 -1.658 0 CA-C-O 117.925 -1.036 . . . . 0.0 109.455 -179.672 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' C' C ' 701' ' ' PHQ . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 011 nuclear orig full ' C' C ' 702' ' ' LEU . . . . . 0.594 ' CD1' ' N ' ' C' ' 702' ' ' LEU . 0.0 OUTLIER . . . . . 0 N--CA 1.492 1.67 0 N-CA-C 109.762 -0.458 . . . . 0.0 109.762 . . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' C' C ' 703' ' ' PRO . . . . . 0.524 ' O ' ' O ' ' C' ' 704' ' ' ALA . 52.7 Cg_exo -48.01 -173.39 0.0 OUTLIER 'Trans proline' 0 N--CA 1.489 1.262 0 C-N-CA 121.957 1.771 . . . . 0.0 111.652 178.948 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' C' C ' 704' ' ' ALA . . . . . 0.524 ' O ' ' O ' ' C' ' 703' ' ' PRO . . . 56.76 123.12 0.0 OUTLIER 'General case' 0 N--CA 1.492 1.662 0 O-C-N 121.501 -0.749 . . . . 0.0 109.806 179.673 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' C' C ' 705' ' ' B27 . . . . . 0.654 ' SG ' ' CD2' ' A' ' 120' ' ' HIS . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 700' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 012 nuclear orig full ' A' A ' 59' ' ' MET . . . . . . . . . . . . . 2.4 mpt? . . . . . 0 N--CA 1.488 1.444 0 CA-C-O 121.519 0.676 . . . . 0.0 109.553 . . . . . . . . . 0 0 . 1 . 012 nuclear orig full ' A' A ' 60' ' ' GLN . . . . . . . . . . . . . 27.2 mt-30 -60.71 164.53 4.59 Favored 'General case' 0 C--N 1.299 -1.621 0 N-CA-C 108.576 -0.898 . . . . 0.0 108.576 179.205 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . -65.08 -174.42 0.15 Allowed 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.228 -0.92 . . . . 0.0 109.936 -179.673 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 62' ' ' LYS . . . . . 0.499 ' O ' ' OE1' ' A' ' 64' ' ' GLN . 28.2 tttm -148.12 80.36 8.69 Favored Pre-proline 0 N--CA 1.493 1.696 0 O-C-N 121.47 -0.769 . . . . 0.0 109.249 179.448 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 63' ' ' PRO . . . . . . . . . . . . . 16.3 Cg_exo -66.94 134.41 34.37 Favored 'Trans proline' 0 C--N 1.305 -1.753 0 C-N-CA 122.741 2.294 . . . . 0.0 111.85 -179.863 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 64' ' ' GLN . . . . . 0.589 HE21 ' C ' ' A' ' 64' ' ' GLN . 0.0 OUTLIER -152.75 103.92 2.82 Favored 'General case' 0 N--CA 1.489 1.476 0 O-C-N 121.372 -0.83 . . . . 0.0 109.408 -179.7 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 65' ' ' ILE . . . . . 0.469 ' C ' ' O ' ' A' ' 64' ' ' GLN . 3.5 mp -40.14 102.27 0.26 Allowed Pre-proline 0 N--CA 1.488 1.45 0 N-CA-C 108.43 -0.952 . . . . 0.0 108.43 179.233 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 66' ' ' PRO . . . . . 0.411 ' N ' ' O ' ' A' ' 64' ' ' GLN . 97.9 Cg_endo -84.55 -155.61 0.06 OUTLIER 'Trans proline' 0 N--CA 1.489 1.206 0 C-N-CA 122.751 2.3 . . . . 0.0 112.968 -178.124 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 67' ' ' LYS . . . . . 0.475 ' C ' ' H ' ' A' ' 69' ' ' LYS . 6.5 ptpt -82.81 -5.03 58.76 Favored 'General case' 0 C--N 1.305 -1.362 0 N-CA-C 108.877 -0.786 . . . . 0.0 108.877 179.698 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 68' ' ' ASP . . . . . 0.631 ' C ' ' N ' ' A' ' 70' ' ' SER . 0.3 OUTLIER -75.39 50.18 0.51 Allowed 'General case' 0 N--CA 1.491 1.579 0 CA-C-O 123.005 1.383 . . . . 0.0 108.189 179.013 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 69' ' ' LYS . . . . . 0.475 ' H ' ' C ' ' A' ' 67' ' ' LYS . 1.9 mtpt -48.07 -15.17 0.06 Allowed 'General case' 0 N--CA 1.506 2.359 0 C-N-CA 116.758 -1.977 . . . . 0.0 107.149 178.425 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 70' ' ' SER . . . . . 0.631 ' N ' ' C ' ' A' ' 68' ' ' ASP . 0.2 OUTLIER -86.81 -5.22 59.17 Favored 'General case' 0 C--N 1.293 -1.856 0 CA-C-N 113.701 -1.591 . . . . 0.0 110.613 179.758 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 71' ' ' LYS . . . . . . . . . . . . . 2.4 ptmm? -97.28 138.36 34.87 Favored 'General case' 0 N--CA 1.494 1.736 0 O-C-N 120.899 -1.126 . . . . 0.0 112.007 -179.305 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 72' ' ' VAL . . . . . 0.593 ' CG2' ' O ' ' A' ' 74' ' ' GLY . 0.7 OUTLIER -67.01 132.25 32.38 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.444 0 N-CA-C 104.977 -2.231 . . . . 0.0 104.977 174.554 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 73' ' ' ALA . . . . . 0.452 ' N ' ' O ' ' A' ' 87' ' ' VAL . . . -82.04 -12.87 58.05 Favored 'General case' 0 C--N 1.299 -1.617 0 O-C-N 120.121 -1.612 . . . . 0.0 108.681 -178.671 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 74' ' ' GLY . . . . . 0.593 ' O ' ' CG2' ' A' ' 72' ' ' VAL . . . 170.35 -156.4 26.86 Favored Glycine 0 N--CA 1.483 1.784 0 N-CA-C 109.642 -1.383 . . . . 0.0 109.642 179.974 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 75' ' ' TYR . . . . . 0.55 ' CD1' ' C ' ' A' ' 74' ' ' GLY . 10.8 m-85 -143.71 173.81 11.34 Favored 'General case' 0 C--N 1.293 -1.889 0 O-C-N 121.276 -1.132 . . . . 0.0 109.702 -178.811 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 76' ' ' ILE . . . . . . . . . . . . . 1.4 tt -147.25 144.97 19.52 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.79 0 N-CA-C 108.72 -0.844 . . . . 0.0 108.72 -178.067 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -150.48 157.19 42.74 Favored 'General case' 0 C--N 1.301 -1.536 0 O-C-N 121.043 -1.035 . . . . 0.0 109.849 -179.513 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 78' ' ' ILE . . . . . . . . . . . . . 22.4 mt -142.6 121.28 7.51 Favored Pre-proline 0 C--N 1.301 -1.526 0 N-CA-C 107.291 -1.374 . . . . 0.0 107.291 179.718 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 79' ' ' PRO . . . . . . . . . . . . . 55.6 Cg_endo -73.33 -42.85 0.81 Allowed 'Trans proline' 0 N--CA 1.49 1.321 0 C-N-CA 121.893 1.729 . . . . 0.0 113.569 -177.89 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 19.6 t70 -65.98 -19.4 65.85 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 120.766 -1.209 . . . . 0.0 110.274 178.06 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 81' ' ' ALA . . . . . 0.595 ' O ' ' ND2' ' A' ' 132' ' ' ASN . . . -105.6 -20.99 13.3 Favored 'General case' 0 N--CA 1.495 1.804 0 O-C-N 121.165 -0.959 . . . . 0.0 108.79 179.502 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 82' ' ' ASP . . . . . 0.423 ' OD2' ' C ' ' A' ' 81' ' ' ALA . 0.4 OUTLIER 68.65 51.56 0.61 Allowed 'General case' 0 C--N 1.303 -1.441 0 O-C-N 121.336 -0.853 . . . . 0.0 111.127 178.816 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 83' ' ' ILE . . . . . 0.486 ' CG1' ' OD1' ' A' ' 132' ' ' ASN . 57.6 mt -127.15 152.27 34.98 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.864 0 O-C-N 121.163 -0.96 . . . . 0.0 109.481 -179.777 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 84' ' ' LYS . . . . . . . . . . . . . 0.8 OUTLIER -159.26 108.36 1.87 Allowed 'General case' 0 C--N 1.303 -1.435 0 N-CA-C 107.892 -1.151 . . . . 0.0 107.892 179.727 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 85' ' ' GLU . . . . . 0.493 ' OE1' ' O ' ' A' ' 128' ' ' TYR . 0.0 OUTLIER -142.82 170.53 8.58 Favored Pre-proline 0 N--CA 1.497 1.921 0 O-C-N 121.362 -0.836 . . . . 0.0 111.105 -177.597 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 86' ' ' PRO . . . . . 0.414 ' HA ' ' CD2' ' A' ' 75' ' ' TYR . 90.4 Cg_endo -79.8 161.53 24.34 Favored 'Trans proline' 0 N--CA 1.493 1.474 0 C-N-CA 123.25 2.634 . . . . 0.0 113.247 179.752 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 87' ' ' VAL . . . . . 0.499 ' CG1' ' CE1' ' A' ' 103' ' ' PHE . 92.8 t -118.14 101.97 12.57 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.485 0 N-CA-C 108.99 -0.744 . . . . 0.0 108.99 179.91 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 88' ' ' TYR . . . . . . . . . . . . . 17.5 m-85 -93.35 153.93 41.44 Favored Pre-proline 0 N--CA 1.504 2.236 0 O-C-N 120.865 -1.147 . . . . 0.0 110.664 -179.015 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 89' ' ' PRO . . . . . . . . . . . . . 11.2 Cg_endo -62.44 143.0 92.66 Favored 'Trans proline' 0 C--N 1.312 -1.346 0 C-N-CA 122.571 2.181 . . . . 0.0 113.863 -179.067 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 90' ' ' GLY . . . . . 0.412 ' O ' ' NZ ' ' A' ' 69' ' ' LYS . . . -58.33 168.24 5.71 Favored Glycine 0 N--CA 1.487 2.034 0 N-CA-C 110.167 -1.173 . . . . 0.0 110.167 179.611 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 91' ' ' PRO . . . . . 0.496 ' C ' ' H ' ' A' ' 93' ' ' THR . 38.2 Cg_endo -93.11 169.46 21.09 Favored 'Cis proline' 0 C--N 1.307 -1.606 0 C-N-CA 123.713 -1.37 . . . . 0.0 111.497 0.132 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 92' ' ' ALA . . . . . 0.417 ' O ' ' CD1' ' A' ' 97' ' ' LEU . . . -72.81 33.3 0.07 Allowed 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.02 -1.05 . . . . 0.0 110.237 -179.691 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 93' ' ' THR . . . . . 0.523 ' H ' ' HG1' ' A' ' 93' ' ' THR . 1.6 p -72.21 152.74 92.47 Favored Pre-proline 0 C--N 1.3 -1.559 0 O-C-N 120.86 -1.15 . . . . 0.0 108.008 179.776 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 94' ' ' PRO . . . . . 0.428 ' C ' ' O ' ' A' ' 93' ' ' THR . 92.2 Cg_exo -32.79 -58.73 0.26 Allowed 'Trans proline' 0 C--N 1.305 -1.747 0 C-N-CA 122.575 2.184 . . . . 0.0 112.347 -179.253 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 21.0 mt-10 -44.2 -49.06 9.3 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.249 -0.907 . . . . 0.0 109.971 179.862 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 96' ' ' GLN . . . . . 0.616 ' NE2' HH12 ' A' ' 99' ' ' ARG . 3.8 mp0 -72.33 -55.87 6.41 Favored 'General case' 0 N--CA 1.489 1.491 0 O-C-N 121.203 -0.935 . . . . 0.0 111.014 -178.973 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 97' ' ' LEU . . . . . 0.417 ' CD1' ' O ' ' A' ' 92' ' ' ALA . 80.9 mt -49.21 -6.59 0.02 OUTLIER 'General case' 0 N--CA 1.496 1.845 0 O-C-N 121.067 -1.021 . . . . 0.0 110.279 -178.867 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 98' ' ' ASN . . . . . 0.743 HD22 ' NE ' ' A' ' 99' ' ' ARG . 0.2 OUTLIER -72.77 -25.16 61.07 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.337 -0.852 . . . . 0.0 108.928 179.679 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 99' ' ' ARG . . . . . 0.743 ' NE ' HD22 ' A' ' 98' ' ' ASN . 3.5 mtt180 -92.06 -51.97 4.93 Favored 'General case' 0 C--N 1.302 -1.467 0 O-C-N 121.682 -0.636 . . . . 0.0 110.497 -179.035 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . 172.23 -166.58 39.41 Favored Glycine 0 N--CA 1.493 2.486 0 N-CA-C 109.741 -1.343 . . . . 0.0 109.741 -179.687 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 101' ' ' VAL . . . . . 0.489 ' CG1' ' CE2' ' A' ' 130' ' ' PHE . 34.7 m -54.69 100.41 0.04 OUTLIER 'Isoleucine or valine' 0 N--CA 1.493 1.724 0 O-C-N 121.146 -1.209 . . . . 0.0 109.802 -179.659 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 1.9 m -92.07 171.73 8.91 Favored 'General case' 0 N--CA 1.497 1.875 0 O-C-N 121.417 -0.802 . . . . 0.0 110.324 -179.789 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 103' ' ' PHE . . . . . 0.499 ' CE1' ' CG1' ' A' ' 87' ' ' VAL . 23.6 m-85 -75.08 145.68 42.09 Favored 'General case' 0 N--CA 1.493 1.697 0 N-CA-C 108.069 -1.086 . . . . 0.0 108.069 178.263 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 104' ' ' ALA . . . . . . . . . . . . . . . -66.71 -13.42 61.29 Favored 'General case' 0 N--CA 1.492 1.671 0 O-C-N 121.243 -0.911 . . . . 0.0 111.571 -178.105 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 105' ' ' GLU . . . . . 0.452 ' OE2' ' OE1' ' A' ' 108' ' ' GLU . 0.3 OUTLIER -138.6 144.32 39.72 Favored 'General case' 0 N--CA 1.496 1.838 0 O-C-N 120.762 -1.211 . . . . 0.0 110.592 -179.211 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 106' ' ' GLU . . . . . 0.561 ' CG ' ' H ' ' A' ' 107' ' ' ASN . 6.0 pt-20 -57.12 -59.6 4.85 Favored 'General case' 0 C--N 1.304 -1.402 0 O-C-N 121.732 -0.605 . . . . 0.0 110.224 -179.806 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 107' ' ' ASN . . . . . 0.717 ' N ' HD21 ' A' ' 107' ' ' ASN . 0.0 OUTLIER -78.27 33.96 0.2 Allowed 'General case' 0 N--CA 1.488 1.442 0 O-C-N 120.542 -1.349 . . . . 0.0 112.895 -176.114 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 108' ' ' GLU . . . . . 0.452 ' OE1' ' OE2' ' A' ' 105' ' ' GLU . 32.9 tp10 -60.09 147.45 39.37 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 120.824 -1.173 . . . . 0.0 108.141 -179.568 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 109' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -95.25 147.53 23.38 Favored 'General case' 0 N--CA 1.489 1.497 0 O-C-N 120.797 -1.189 . . . . 0.0 111.03 -178.093 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 110' ' ' LEU . . . . . 0.55 ' H ' ' CD2' ' A' ' 110' ' ' LEU . 0.2 OUTLIER -63.67 -24.61 67.85 Favored 'General case' 0 C--N 1.305 -1.337 0 N-CA-C 107.536 -1.283 . . . . 0.0 107.536 178.548 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 111' ' ' ASP . . . . . 0.48 ' CG ' HH22 ' A' ' 151' ' ' ARG . 55.3 m-20 -132.93 49.19 2.34 Favored 'General case' 0 N--CA 1.487 1.391 0 N-CA-C 109.183 -0.673 . . . . 0.0 109.183 179.513 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 112' ' ' ASP . . . . . . . . . . . . . 1.9 t0 -69.07 159.97 31.9 Favored 'General case' 0 N--CA 1.493 1.72 0 O-C-N 121.257 -0.902 . . . . 0.0 111.287 -179.745 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 113' ' ' GLN . . . . . 0.536 ' N ' ' CD ' ' A' ' 113' ' ' GLN . 0.0 OUTLIER -65.21 -18.52 65.38 Favored 'General case' 0 N--CA 1.491 1.614 0 N-CA-C 107.263 -1.384 . . . . 0.0 107.263 177.675 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 114' ' ' ASN . . . . . 0.608 ' ND2' ' O ' ' A' ' 169' ' ' LEU . 8.5 p-10 -153.11 111.85 3.73 Favored 'General case' 0 C--N 1.299 -1.588 0 N-CA-C 108.026 -1.102 . . . . 0.0 108.026 177.505 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 115' ' ' ILE . . . . . . . . . . . . . 2.5 mt -96.82 105.68 17.44 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.692 0 N-CA-C 107.604 -1.258 . . . . 0.0 107.604 179.507 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 116' ' ' SER . . . . . . . . . . . . . 4.8 m -86.23 151.6 23.49 Favored 'General case' 0 C--N 1.303 -1.422 0 CA-C-O 122.088 0.947 . . . . 0.0 111.421 -177.739 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 117' ' ' ILE . . . . . . . . . . . . . 1.6 mt -147.19 142.26 20.11 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.532 0 N-CA-C 106.998 -1.482 . . . . 0.0 106.998 178.542 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 118' ' ' ALA . . . . . . . . . . . . . . . -137.89 158.37 44.48 Favored 'General case' 0 N--CA 1.493 1.722 0 O-C-N 120.985 -1.072 . . . . 0.0 110.698 -178.284 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 119' ' ' GLY . . . . . . . . . . . . . . . -169.93 145.86 9.54 Favored Glycine 0 N--CA 1.48 1.603 0 N-CA-C 110.055 -1.218 . . . . 0.0 110.055 179.342 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 120' ' ' HIS . . . . . 0.712 ' CD2' ' HN ' ' C' ' 705' ' ' B27 . 30.0 m170 -70.25 167.48 17.87 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.671 -0.899 . . . . 0.0 109.766 179.589 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 121' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -115.21 157.36 23.79 Favored 'General case' 0 N--CA 1.492 1.644 0 N-CA-C 108.49 -0.93 . . . . 0.0 108.49 179.038 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 122' ' ' PHE . . . . . . . . . . . . . 2.4 m-85 -141.07 122.95 15.39 Favored 'General case' 0 N--CA 1.494 1.769 0 O-C-N 121.152 -0.967 . . . . 0.0 108.873 -179.889 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 123' ' ' ILE . . . . . 0.448 ' CG2' ' N ' ' A' ' 124' ' ' ASP . 19.6 tt -60.32 -40.99 85.55 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.548 0 CA-C-O 121.62 0.724 . . . . 0.0 109.52 -179.608 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 124' ' ' ASP . . . . . 0.448 ' N ' ' CG2' ' A' ' 123' ' ' ILE . 6.0 p-10 -88.96 21.62 3.04 Favored 'General case' 0 C--N 1.295 -1.787 0 O-C-N 121.698 -0.626 . . . . 0.0 111.774 -177.548 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 125' ' ' ARG . . . . . . . . . . . . . 91.6 mtt180 -152.69 101.56 2.71 Favored Pre-proline 0 N--CA 1.492 1.663 0 O-C-N 120.708 -1.245 . . . . 0.0 109.561 179.778 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 126' ' ' PRO . . . . . . . . . . . . . 55.6 Cg_endo -79.32 -30.07 2.77 Favored 'Trans proline' 0 N--CA 1.488 1.177 0 C-N-CA 122.459 2.106 . . . . 0.0 112.903 -179.781 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 127' ' ' ASN . . . . . 0.49 ' O ' ' O ' ' A' ' 128' ' ' TYR . 1.2 m120 -90.07 8.65 31.58 Favored 'General case' 0 N--CA 1.493 1.696 0 O-C-N 121.047 -1.033 . . . . 0.0 109.199 179.594 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 128' ' ' TYR . . . . . 0.493 ' O ' ' OE1' ' A' ' 85' ' ' GLU . 2.1 t80 -59.43 -148.67 0.0 OUTLIER 'General case' 0 C--N 1.302 -1.464 0 O-C-N 121.459 -0.776 . . . . 0.0 109.444 -179.82 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 129' ' ' GLN . . . . . . . . . . . . . 26.7 mt-30 -64.42 -75.6 0.08 Allowed 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.24 -0.913 . . . . 0.0 110.14 -179.252 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 130' ' ' PHE . . . . . 0.523 ' O ' ' CE ' ' A' ' 134' ' ' LYS . 49.4 m-85 -133.87 48.28 2.37 Favored 'General case' 0 N--CA 1.492 1.67 0 O-C-N 121.402 -0.811 . . . . 0.0 109.71 -179.848 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 131' ' ' THR . . . . . . . . . . . . . 23.7 m -83.02 -38.84 22.05 Favored 'General case' 0 C--N 1.298 -1.659 0 O-C-N 121.03 -1.044 . . . . 0.0 109.228 179.864 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 132' ' ' ASN . . . . . 0.595 ' ND2' ' O ' ' A' ' 81' ' ' ALA . 0.2 OUTLIER -83.61 4.19 29.4 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.475 -0.766 . . . . 0.0 110.781 -179.079 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 133' ' ' LEU . . . . . 0.544 ' O ' ' N ' ' A' ' 135' ' ' ALA . 0.1 OUTLIER -66.49 -45.5 79.43 Favored 'General case' 0 N--CA 1.497 1.909 0 O-C-N 120.591 -1.318 . . . . 0.0 110.164 179.874 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 134' ' ' LYS . . . . . 0.652 ' HZ2' ' HG1' ' A' ' 183' ' ' THR . 0.0 OUTLIER -43.07 -17.6 0.01 OUTLIER 'General case' 0 N--CA 1.499 1.995 0 O-C-N 121.142 -0.974 . . . . 0.0 110.814 -178.861 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 135' ' ' ALA . . . . . 0.544 ' N ' ' O ' ' A' ' 133' ' ' LEU . . . -84.09 -31.85 25.08 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 120.976 -1.078 . . . . 0.0 109.725 -179.931 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 136' ' ' ALA . . . . . 0.43 ' N ' ' O ' ' A' ' 133' ' ' LEU . . . -79.6 151.53 30.56 Favored 'General case' 0 C--N 1.3 -1.545 0 CA-C-O 121.874 0.845 . . . . 0.0 111.623 -178.413 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 137' ' ' LYS . . . . . 0.576 ' O ' ' O ' ' A' ' 138' ' ' LYS . 0.0 OUTLIER -153.11 -168.91 3.17 Favored 'General case' 0 N--CA 1.495 1.796 0 C-N-CA 118.474 -1.29 . . . . 0.0 111.313 -177.964 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 138' ' ' LYS . . . . . 0.576 ' O ' ' O ' ' A' ' 137' ' ' LYS . 50.1 mttm -38.55 172.37 0.0 OUTLIER 'General case' 0 N--CA 1.487 1.415 0 CA-C-O 122.488 1.137 . . . . 0.0 110.971 -178.986 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 139' ' ' GLY . . . . . . . . . . . . . . . 49.13 9.12 0.1 Allowed Glycine 0 N--CA 1.488 2.143 0 N-CA-C 109.8 -1.32 . . . . 0.0 109.8 -179.977 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 140' ' ' SER . . . . . 0.54 ' H ' ' C ' ' A' ' 138' ' ' LYS . 4.3 m -80.56 132.26 35.63 Favored 'General case' 0 N--CA 1.496 1.86 0 O-C-N 120.975 -1.309 . . . . 0.0 109.778 179.677 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 141' ' ' MET . . . . . . . . . . . . . 0.1 OUTLIER -83.68 128.81 34.81 Favored 'General case' 0 N--CA 1.49 1.567 0 N-CA-C 108.515 -0.921 . . . . 0.0 108.515 179.195 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 142' ' ' VAL . . . . . . . . . . . . . 2.6 t -117.96 131.68 69.99 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.857 0 O-C-N 121.414 -0.804 . . . . 0.0 109.061 -179.185 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 143' ' ' TYR . . . . . . . . . . . . . 3.1 m-85 -110.58 135.58 51.01 Favored 'General case' 0 N--CA 1.496 1.866 0 O-C-N 120.851 -1.156 . . . . 0.0 111.444 -178.443 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 144' ' ' PHE . . . . . . . . . . . . . 52.6 t80 -122.15 103.11 8.56 Favored 'General case' 0 N--CA 1.493 1.718 0 CA-C-O 121.495 0.664 . . . . 0.0 109.844 -179.428 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 145' ' ' LYS . . . . . . . . . . . . . 46.1 mttt -96.94 128.59 44.05 Favored 'General case' 0 N--CA 1.494 1.764 0 O-C-N 121.458 -0.776 . . . . 0.0 110.992 -179.291 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 146' ' ' VAL . . . . . 0.443 ' O ' ' C ' ' A' ' 147' ' ' GLY . 2.0 p -141.46 142.12 29.4 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.668 0 N-CA-C 107.519 -1.289 . . . . 0.0 107.519 178.52 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 147' ' ' GLY . . . . . 0.443 ' C ' ' O ' ' A' ' 146' ' ' VAL . . . 43.59 -129.38 6.17 Favored Glycine 0 N--CA 1.49 2.276 0 N-CA-C 109.313 -1.515 . . . . 0.0 109.313 -179.827 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 148' ' ' ASN . . . . . 0.444 ' C ' HD21 ' A' ' 148' ' ' ASN . 0.5 OUTLIER -102.29 15.15 30.0 Favored 'General case' 0 N--CA 1.488 1.469 0 O-C-N 121.278 -1.131 . . . . 0.0 108.336 179.15 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 149' ' ' GLU . . . . . . . . . . . . . 2.3 mm-40 -109.07 143.91 37.79 Favored 'General case' 0 N--CA 1.49 1.531 0 CA-C-O 121.771 0.796 . . . . 0.0 111.576 -178.546 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 150' ' ' THR . . . . . . . . . . . . . 3.4 m -130.02 101.16 5.71 Favored 'General case' 0 N--CA 1.495 1.779 0 CA-C-O 121.46 0.647 . . . . 0.0 109.77 179.915 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 151' ' ' ARG . . . . . 0.48 HH22 ' CG ' ' A' ' 111' ' ' ASP . 16.5 mtt180 -86.13 -171.67 3.68 Favored 'General case' 0 N--CA 1.487 1.404 0 O-C-N 121.243 -0.91 . . . . 0.0 108.983 -179.671 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 152' ' ' LYS . . . . . 0.422 ' C ' ' CD1' ' A' ' 153' ' ' TYR . 36.3 mtmt -151.38 148.35 28.02 Favored 'General case' 0 C--N 1.301 -1.532 0 O-C-N 121.111 -0.993 . . . . 0.0 110.423 -178.895 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 153' ' ' TYR . . . . . 0.482 ' CD2' ' HA ' ' A' ' 204' ' ' GLU . 11.1 m-85 -141.76 168.68 19.18 Favored 'General case' 0 C--N 1.302 -1.493 0 N-CA-C 108.157 -1.053 . . . . 0.0 108.157 179.189 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 154' ' ' LYS . . . . . . . . . . . . . 29.1 ttpt -143.17 119.0 10.54 Favored 'General case' 0 C--N 1.297 -1.714 0 N-CA-C 108.038 -1.097 . . . . 0.0 108.038 178.703 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 155' ' ' MET . . . . . . . . . . . . . 18.0 mtp -47.13 108.69 0.16 Allowed 'General case' 0 N--CA 1.492 1.662 0 O-C-N 120.536 -1.353 . . . . 0.0 111.528 -178.381 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 156' ' ' THR . . . . . 0.498 ' OG1' ' OG1' ' A' ' 203' ' ' THR . 0.1 OUTLIER -105.16 -25.15 12.6 Favored 'General case' 0 C--N 1.294 -1.822 0 CA-C-N 115.351 -0.841 . . . . 0.0 110.714 -178.638 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 157' ' ' SER . . . . . . . . . . . . . 49.8 m -145.84 147.44 31.82 Favored 'General case' 0 C--N 1.296 -1.748 0 C-N-CA 118.511 -1.276 . . . . 0.0 110.15 -178.769 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 158' ' ' ILE . . . . . . . . . . . . . 2.3 mt -146.96 136.54 16.67 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.611 0 CA-C-O 121.538 0.685 . . . . 0.0 110.111 -177.781 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 159' ' ' ARG . . . . . 0.669 ' CG ' HH11 ' A' ' 159' ' ' ARG . 0.0 OUTLIER -155.63 -172.83 4.29 Favored 'General case' 0 N--CA 1.491 1.604 0 C-N-CA 119.505 -0.878 . . . . 0.0 110.459 179.733 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 160' ' ' ASP . . . . . . . . . . . . . 10.7 m-20 -149.54 165.47 32.11 Favored 'General case' 0 N--CA 1.489 1.507 0 N-CA-C 108.324 -0.991 . . . . 0.0 108.324 179.554 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 161' ' ' VAL . . . . . 0.484 ' O ' ' O ' ' A' ' 162' ' ' LYS . 0.1 OUTLIER -166.07 161.44 0.81 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.685 0 O-C-N 121.088 -1.008 . . . . 0.0 109.877 179.829 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 162' ' ' LYS . . . . . 0.484 ' O ' ' O ' ' A' ' 161' ' ' VAL . 0.0 OUTLIER -44.62 170.99 0.05 OUTLIER Pre-proline 0 N--CA 1.489 1.503 0 O-C-N 121.366 -0.834 . . . . 0.0 109.653 179.73 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 163' ' ' PRO . . . . . . . . . . . . . 62.1 Cg_endo -80.74 36.16 0.61 Allowed 'Trans proline' 0 C--N 1.31 -1.483 0 C-N-CA 122.672 2.248 . . . . 0.0 113.061 -179.851 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 164' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -151.88 -2.88 0.28 Allowed 'General case' 0 N--CA 1.497 1.896 0 O-C-N 121.047 -1.033 . . . . 0.0 110.214 179.987 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 165' ' ' ASP . . . . . . . . . . . . . 7.2 t70 -74.83 62.98 1.13 Allowed 'General case' 0 N--CA 1.488 1.45 0 O-C-N 120.899 -1.126 . . . . 0.0 109.386 -179.988 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 166' ' ' VAL . . . . . 0.589 ' O ' ' N ' ' A' ' 168' ' ' VAL . 1.8 m -49.68 -33.82 8.37 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.503 0 O-C-N 121.659 -0.65 . . . . 0.0 109.776 -178.392 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 167' ' ' GLY . . . . . 0.405 ' C ' ' O ' ' A' ' 166' ' ' VAL . . . -43.89 -13.35 0.02 OUTLIER Glycine 0 N--CA 1.496 2.65 0 O-C-N 120.865 -1.147 . . . . 0.0 110.725 -179.766 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 168' ' ' VAL . . . . . 0.589 ' N ' ' O ' ' A' ' 166' ' ' VAL . 3.5 m -53.48 -26.77 13.54 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.563 0 O-C-N 120.712 -1.463 . . . . 0.0 108.741 179.688 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 169' ' ' LEU . . . . . 0.608 ' O ' ' ND2' ' A' ' 114' ' ' ASN . 1.2 mm? -44.43 -24.67 0.19 Allowed 'General case' 0 C--N 1.299 -1.61 0 N-CA-C 107.808 -1.182 . . . . 0.0 107.808 -178.658 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 170' ' ' ASP . . . . . 0.474 ' N ' ' C ' ' A' ' 168' ' ' VAL . 14.9 t0 37.29 90.51 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.715 -0.616 . . . . 0.0 110.804 177.944 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 171' ' ' GLU . . . . . . . . . . . . . 14.9 pt-20 -130.13 60.09 1.62 Allowed 'General case' 0 N--CA 1.497 1.922 0 O-C-N 120.904 -1.123 . . . . 0.0 109.735 179.515 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 172' ' ' GLN . . . . . . . . . . . . . 10.7 mt-30 -123.06 -56.87 1.73 Allowed 'General case' 0 N--CA 1.497 1.899 0 O-C-N 121.438 -0.789 . . . . 0.0 110.958 -178.969 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 173' ' ' LYS . . . . . 0.401 ' H ' ' HD2' ' A' ' 173' ' ' LYS . 2.3 mptp? -57.62 123.2 14.79 Favored 'General case' 0 N--CA 1.493 1.696 0 O-C-N 120.817 -1.177 . . . . 0.0 108.909 -179.67 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 174' ' ' GLY . . . . . 0.485 ' O ' ' C ' ' A' ' 175' ' ' LYS . . . -117.29 -43.59 0.59 Allowed Glycine 0 N--CA 1.478 1.483 0 N-CA-C 108.166 -1.974 . . . . 0.0 108.166 179.589 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 175' ' ' LYS . . . . . 0.485 ' C ' ' O ' ' A' ' 174' ' ' GLY . 11.9 mptt -43.52 -58.53 2.57 Favored 'General case' 0 N--CA 1.49 1.545 0 N-CA-C 107.107 -1.442 . . . . 0.0 107.107 179.565 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 176' ' ' ASP . . . . . 0.617 ' O ' ' O ' ' A' ' 177' ' ' LYS . 3.4 m-20 -103.8 85.66 2.47 Favored 'General case' 0 C--N 1.293 -1.866 0 N-CA-C 106.835 -1.543 . . . . 0.0 106.835 176.672 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 177' ' ' LYS . . . . . 0.617 ' O ' ' O ' ' A' ' 176' ' ' ASP . 35.6 mttt -44.23 -175.92 0.0 OUTLIER 'General case' 0 N--CA 1.493 1.691 0 O-C-N 121.632 -0.667 . . . . 0.0 109.663 -179.159 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 178' ' ' GLN . . . . . . . . . . . . . 16.6 pt20 -160.7 173.68 15.07 Favored 'General case' 0 C--N 1.303 -1.439 0 O-C-N 120.307 -1.496 . . . . 0.0 110.949 179.524 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 179' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -129.35 97.74 4.66 Favored 'General case' 0 C--N 1.303 -1.453 0 N-CA-C 107.225 -1.398 . . . . 0.0 107.225 178.459 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 180' ' ' THR . . . . . . . . . . . . . 1.1 m -73.56 115.69 13.25 Favored 'General case' 0 N--CA 1.493 1.72 0 O-C-N 121.162 -0.961 . . . . 0.0 110.662 -178.372 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 181' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -89.55 144.48 25.99 Favored 'General case' 0 C--N 1.301 -1.535 0 N-CA-C 108.11 -1.07 . . . . 0.0 108.11 177.47 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 182' ' ' ILE . . . . . . . . . . . . . 4.7 mt -137.91 113.03 9.85 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.643 0 N-CA-C 107.822 -1.177 . . . . 0.0 107.822 179.102 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 183' ' ' THR . . . . . 0.652 ' HG1' ' HZ2' ' A' ' 134' ' ' LYS . 5.8 t -134.34 119.44 18.65 Favored 'General case' 0 C--N 1.293 -1.88 0 N-CA-C 108.141 -1.059 . . . . 0.0 108.141 179.708 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 184' ' ' CYS . . . . . . . . . . . . . 1.0 OUTLIER -80.21 156.37 26.94 Favored 'General case' 0 C--N 1.289 -2.065 0 C-N-CA 119.514 -0.874 . . . . 0.0 111.183 -178.366 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 185' ' ' ASP . . . . . 0.549 ' O ' ' CB ' ' A' ' 186' ' ' ASP . 0.2 OUTLIER -166.68 170.55 12.44 Favored 'General case' 0 N--CA 1.493 1.698 0 O-C-N 121.538 -0.726 . . . . 0.0 109.058 179.831 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 186' ' ' ASP . . . . . 0.549 ' CB ' ' O ' ' A' ' 185' ' ' ASP . 1.0 OUTLIER 79.28 52.42 0.03 OUTLIER 'General case' 0 N--CA 1.492 1.668 0 O-C-N 121.23 -0.919 . . . . 0.0 109.704 179.863 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 187' ' ' TYR . . . . . 0.581 ' CE1' ' O ' ' A' ' 188' ' ' ASN . 36.9 t80 -65.9 131.42 46.23 Favored 'General case' 0 C--N 1.302 -1.497 0 O-C-N 120.92 -1.113 . . . . 0.0 109.623 179.946 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 188' ' ' ASN . . . . . 0.807 HD22 ' N ' ' A' ' 192' ' ' GLY . 0.0 OUTLIER -100.13 148.71 24.28 Favored 'General case' 0 C--N 1.291 -1.936 0 N-CA-C 107.589 -1.263 . . . . 0.0 107.589 178.68 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 189' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -109.9 -9.57 14.78 Favored 'General case' 0 C--N 1.294 -1.819 0 N-CA-C 108.495 -0.928 . . . . 0.0 108.495 -179.505 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 190' ' ' LYS . . . . . . . . . . . . . 6.4 mmtt -84.49 -56.23 3.73 Favored 'General case' 0 N--CA 1.488 1.432 0 C-N-CA 119.841 -0.744 . . . . 0.0 109.182 178.774 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 191' ' ' THR . . . . . 0.662 ' N ' HD22 ' A' ' 188' ' ' ASN . 7.1 p -86.44 7.93 23.86 Favored 'General case' 0 N--CA 1.493 1.678 0 O-C-N 121.559 -0.713 . . . . 0.0 110.688 -178.823 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 192' ' ' GLY . . . . . 0.807 ' N ' HD22 ' A' ' 188' ' ' ASN . . . 51.69 30.47 28.07 Favored Glycine 0 N--CA 1.494 2.544 0 O-C-N 121.098 -1.001 . . . . 0.0 111.733 178.82 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 193' ' ' VAL . . . . . 0.569 ' H ' HD21 ' A' ' 188' ' ' ASN . 0.4 OUTLIER -149.59 170.58 1.98 Allowed 'Isoleucine or valine' 0 N--CA 1.495 1.798 0 O-C-N 120.463 -1.61 . . . . 0.0 109.909 179.129 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 194' ' ' TRP . . . . . 0.437 ' N ' ' CD1' ' A' ' 194' ' ' TRP . 44.1 m95 -84.93 122.07 28.66 Favored 'General case' 0 C--N 1.295 -1.795 0 CA-C-O 121.577 0.704 . . . . 0.0 109.994 -179.427 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 195' ' ' GLU . . . . . . . . . . . . . 2.0 mt-10 -77.81 -60.96 2.16 Favored 'General case' 0 N--CA 1.496 1.871 0 O-C-N 121.546 -0.721 . . . . 0.0 111.902 -178.326 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 196' ' ' LYS . . . . . . . . . . . . . 5.3 tttm -92.44 150.11 20.99 Favored 'General case' 0 N--CA 1.495 1.797 0 O-C-N 121.003 -1.061 . . . . 0.0 111.761 -177.481 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 197' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -120.7 139.03 53.64 Favored 'General case' 0 N--CA 1.493 1.676 0 N-CA-C 108.319 -0.993 . . . . 0.0 108.319 178.353 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 198' ' ' LYS . . . . . . . . . . . . . 7.9 mttt -116.72 120.46 38.68 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.447 -0.783 . . . . 0.0 110.406 -178.624 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 199' ' ' ILE . . . . . 0.432 ' O ' HG13 ' A' ' 199' ' ' ILE . 0.9 OUTLIER -140.78 121.06 13.09 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.733 0 CA-C-O 122.787 1.279 . . . . 0.0 110.724 179.77 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 200' ' ' PHE . . . . . . . . . . . . . 2.0 m-85 -105.33 141.44 36.83 Favored 'General case' 0 N--CA 1.496 1.841 0 O-C-N 121.218 -0.926 . . . . 0.0 111.012 -177.502 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 201' ' ' VAL . . . . . . . . . . . . . 61.3 t -104.63 148.39 9.32 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.539 0 N-CA-C 108.394 -0.965 . . . . 0.0 108.394 177.247 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 202' ' ' ALA . . . . . . . . . . . . . . . -133.05 139.84 47.39 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.037 -1.039 . . . . 0.0 109.022 -179.899 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 203' ' ' THR . . . . . 0.498 ' OG1' ' OG1' ' A' ' 156' ' ' THR . 1.5 p -90.14 129.19 36.45 Favored 'General case' 0 N--CA 1.489 1.509 0 CA-C-O 122.431 1.11 . . . . 0.0 111.753 -178.525 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 204' ' ' GLU . . . . . 0.482 ' HA ' ' CD2' ' A' ' 153' ' ' TYR . 3.6 tm-20 -50.53 135.36 22.81 Favored 'General case' 0 C--N 1.298 -1.656 0 C-N-CA 118.369 -1.333 . . . . 0.0 109.361 178.951 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 205' ' ' VAL . . . . . 0.501 ' CG1' ' N ' ' A' ' 206' ' ' LYS . 72.1 t -129.57 164.82 31.15 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.359 0 CA-C-O 122.083 0.944 . . . . 0.0 110.273 -177.907 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 206' ' ' LYS . . . . . 0.501 ' N ' ' CG1' ' A' ' 205' ' ' VAL . 0.0 OUTLIER . . . . . 0 C--N 1.295 -1.776 0 CA-C-O 118.025 -0.988 . . . . 0.0 109.482 179.84 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' C' C ' 701' ' ' PHQ . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 012 nuclear orig full ' C' C ' 702' ' ' LEU . . . . . 0.6 ' CD1' ' N ' ' C' ' 702' ' ' LEU . 0.0 OUTLIER . . . . . 0 N--CA 1.488 1.436 0 N-CA-C 109.08 -0.711 . . . . 0.0 109.08 . . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' C' C ' 703' ' ' PRO . . . . . 0.484 ' O ' ' O ' ' C' ' 702' ' ' LEU . 16.2 Cg_exo -51.54 -160.81 0.0 OUTLIER 'Trans proline' 0 N--CA 1.49 1.319 0 C-N-CA 121.805 1.67 . . . . 0.0 112.242 179.911 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' C' C ' 704' ' ' ALA . . . . . . . . . . . . . . . 53.46 175.11 0.02 OUTLIER 'General case' 0 N--CA 1.493 1.681 0 O-C-N 121.383 -0.823 . . . . 0.0 109.544 179.936 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' C' C ' 705' ' ' B27 . . . . . 0.712 ' HN ' ' CD2' ' A' ' 120' ' ' HIS . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 700' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 013 nuclear orig full ' A' A ' 59' ' ' MET . . . . . . . . . . . . . 39.9 mtt . . . . . 0 N--CA 1.491 1.588 0 CA-C-O 121.245 0.545 . . . . 0.0 109.776 . . . . . . . . . 0 0 . 1 . 013 nuclear orig full ' A' A ' 60' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -59.95 -109.13 0.0 OUTLIER 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.253 -0.904 . . . . 0.0 109.779 -179.699 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . -63.11 159.85 16.53 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.205 -0.935 . . . . 0.0 109.212 -179.89 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 62' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -142.15 71.47 22.8 Favored Pre-proline 0 N--CA 1.49 1.568 0 O-C-N 121.262 -0.899 . . . . 0.0 109.178 -179.377 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 63' ' ' PRO . . . . . . . . . . . . . 58.0 Cg_endo -91.86 160.25 3.38 Favored 'Trans proline' 0 C--N 1.304 -1.795 0 C-N-CA 123.794 2.996 . . . . 0.0 111.577 -179.883 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 64' ' ' GLN . . . . . 0.489 HE21 ' C ' ' A' ' 64' ' ' GLN . 0.0 OUTLIER -156.0 113.01 3.19 Favored 'General case' 0 C--N 1.302 -1.475 0 O-C-N 121.049 -1.032 . . . . 0.0 109.925 179.544 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 65' ' ' ILE . . . . . 0.459 ' C ' ' O ' ' A' ' 64' ' ' GLN . 0.1 OUTLIER -41.35 99.65 0.21 Allowed Pre-proline 0 N--CA 1.498 1.939 0 N-CA-C 108.174 -1.047 . . . . 0.0 108.174 179.386 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 66' ' ' PRO . . . . . 0.456 ' N ' ' O ' ' A' ' 64' ' ' GLN . 66.5 Cg_endo -89.76 -160.69 0.1 OUTLIER 'Trans proline' 0 C--N 1.317 -1.108 0 C-N-CA 122.222 1.948 . . . . 0.0 112.778 -178.76 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 67' ' ' LYS . . . . . 0.525 ' C ' ' H ' ' A' ' 69' ' ' LYS . 0.0 OUTLIER -71.91 -4.94 31.1 Favored 'General case' 0 N--CA 1.488 1.426 0 O-C-N 121.414 -0.804 . . . . 0.0 109.08 179.926 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 68' ' ' ASP . . . . . 0.586 ' C ' ' N ' ' A' ' 70' ' ' SER . 64.6 m-20 -76.21 42.86 0.28 Allowed 'General case' 0 N--CA 1.49 1.561 0 CA-C-O 122.45 1.119 . . . . 0.0 108.459 179.223 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 69' ' ' LYS . . . . . 0.525 ' H ' ' C ' ' A' ' 67' ' ' LYS . 0.5 OUTLIER -50.11 -16.26 0.29 Allowed 'General case' 0 N--CA 1.496 1.854 0 N-CA-C 105.984 -1.858 . . . . 0.0 105.984 178.102 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 70' ' ' SER . . . . . 0.586 ' N ' ' C ' ' A' ' 68' ' ' ASP . 3.0 p -86.66 50.84 2.08 Favored 'General case' 0 C--N 1.298 -1.643 0 CA-C-N 113.94 -1.482 . . . . 0.0 108.742 178.644 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 71' ' ' LYS . . . . . . . . . . . . . 6.5 ptmt -162.63 143.19 9.79 Favored 'General case' 0 C--N 1.296 -1.731 0 C-N-CA 118.224 -1.391 . . . . 0.0 111.235 -179.657 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 0.8 OUTLIER -64.28 136.14 26.9 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.577 0 N-CA-C 105.644 -1.984 . . . . 0.0 105.644 175.434 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -81.66 -13.85 57.38 Favored 'General case' 0 C--N 1.292 -1.897 0 N-CA-C 105.661 -1.977 . . . . 0.0 105.661 179.371 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . 174.01 -156.88 24.49 Favored Glycine 0 N--CA 1.478 1.448 0 N-CA-C 109.251 -1.54 . . . . 0.0 109.251 179.388 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 75' ' ' TYR . . . . . 0.415 ' CD2' ' HA ' ' A' ' 86' ' ' PRO . 94.4 m-85 -141.32 170.62 15.37 Favored 'General case' 0 C--N 1.296 -1.754 0 CA-C-O 121.875 0.845 . . . . 0.0 109.766 -178.144 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 76' ' ' ILE . . . . . . . . . . . . . 0.7 OUTLIER -147.66 143.74 19.58 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.646 0 C-N-CA 119.366 -0.934 . . . . 0.0 109.258 -178.095 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 77' ' ' GLU . . . . . 0.518 ' N ' ' CD ' ' A' ' 77' ' ' GLU . 2.6 mp0 -146.76 162.66 38.08 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 120.929 -1.107 . . . . 0.0 109.967 -179.837 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 78' ' ' ILE . . . . . . . . . . . . . 4.1 mt -148.16 90.3 5.04 Favored Pre-proline 0 N--CA 1.489 1.48 0 N-CA-C 108.311 -0.996 . . . . 0.0 108.311 179.839 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 79' ' ' PRO . . . . . . . . . . . . . 73.5 Cg_exo -45.29 -44.49 16.06 Favored 'Trans proline' 0 C--N 1.31 -1.457 0 C-N-CA 122.597 2.198 . . . . 0.0 113.63 -178.583 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 4.4 m-20 -67.14 -19.29 65.58 Favored 'General case' 0 N--CA 1.492 1.652 0 O-C-N 120.869 -1.145 . . . . 0.0 110.789 178.418 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 81' ' ' ALA . . . . . 0.558 ' O ' ' ND2' ' A' ' 132' ' ' ASN . . . -106.63 -15.01 14.88 Favored 'General case' 0 N--CA 1.493 1.717 0 O-C-N 121.137 -0.977 . . . . 0.0 109.176 179.976 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 82' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER 68.3 46.72 1.05 Allowed 'General case' 0 N--CA 1.488 1.459 0 O-C-N 121.375 -0.828 . . . . 0.0 110.338 179.22 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 83' ' ' ILE . . . . . 0.456 ' CG1' ' OD1' ' A' ' 132' ' ' ASN . 60.9 mt -120.98 148.36 24.29 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.797 0 O-C-N 121.296 -0.877 . . . . 0.0 110.357 -178.928 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 84' ' ' LYS . . . . . 0.402 ' O ' ' CD ' ' A' ' 85' ' ' GLU . 0.0 OUTLIER -160.44 102.63 1.38 Allowed 'General case' 0 C--N 1.305 -1.367 0 N-CA-C 107.322 -1.362 . . . . 0.0 107.322 179.731 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 85' ' ' GLU . . . . . 0.441 ' CB ' ' CD ' ' A' ' 86' ' ' PRO . 1.3 mm-40 -141.49 178.25 1.61 Allowed Pre-proline 0 N--CA 1.497 1.914 0 O-C-N 121.301 -0.874 . . . . 0.0 110.247 -178.831 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 86' ' ' PRO . . . . . 0.441 ' CD ' ' CB ' ' A' ' 85' ' ' GLU . 69.2 Cg_endo -91.2 158.02 3.81 Favored 'Trans proline' 0 N--CA 1.487 1.112 0 C-N-CA 123.314 2.676 . . . . 0.0 113.661 -178.565 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 87' ' ' VAL . . . . . 0.555 ' CG1' ' CZ ' ' A' ' 103' ' ' PHE . 35.5 t -111.07 100.04 9.93 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.498 0 N-CA-C 109.191 -0.67 . . . . 0.0 109.191 -179.85 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 88' ' ' TYR . . . . . 0.4 ' CE2' ' HD2' ' A' ' 99' ' ' ARG . 8.1 m-85 -91.71 170.31 9.69 Favored Pre-proline 0 N--CA 1.507 2.4 0 O-C-N 120.535 -1.353 . . . . 0.0 110.135 -179.102 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 89' ' ' PRO . . . . . . . . . . . . . 3.0 Cg_exo -71.35 141.71 39.54 Favored 'Trans proline' 0 N--CA 1.5 1.883 0 C-N-CA 122.505 2.137 . . . . 0.0 114.241 -178.394 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . -62.16 167.18 17.9 Favored Glycine 0 N--CA 1.492 2.394 0 N-CA-C 108.8 -1.72 . . . . 0.0 108.8 178.38 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 91' ' ' PRO . . . . . 0.445 ' C ' ' H ' ' A' ' 93' ' ' THR . 45.1 Cg_endo -91.67 172.69 21.43 Favored 'Cis proline' 0 C--N 1.307 -1.648 0 C-N-CA 123.55 -1.437 . . . . 0.0 112.001 0.651 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 92' ' ' ALA . . . . . 0.523 ' O ' ' CD1' ' A' ' 97' ' ' LEU . . . -73.2 33.34 0.07 Allowed 'General case' 0 N--CA 1.493 1.706 0 O-C-N 121.352 -0.843 . . . . 0.0 110.677 -179.418 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 93' ' ' THR . . . . . 0.445 ' H ' ' C ' ' A' ' 91' ' ' PRO . 0.8 OUTLIER -71.8 149.56 92.85 Favored Pre-proline 0 C--N 1.301 -1.519 0 O-C-N 120.59 -1.319 . . . . 0.0 108.45 179.773 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 94' ' ' PRO . . . . . 0.439 ' C ' ' O ' ' A' ' 93' ' ' THR . 80.7 Cg_exo -31.78 -53.18 0.31 Allowed 'Trans proline' 0 C--N 1.308 -1.563 0 C-N-CA 122.723 2.282 . . . . 0.0 112.203 -179.183 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 95' ' ' GLU . . . . . 0.493 ' O ' ' ND2' ' A' ' 98' ' ' ASN . 7.1 tp10 -47.65 -52.64 17.37 Favored 'General case' 0 C--N 1.299 -1.601 0 O-C-N 121.397 -0.814 . . . . 0.0 109.259 179.487 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 96' ' ' GLN . . . . . 0.541 ' C ' ' H ' ' A' ' 98' ' ' ASN . 12.2 mp0 -70.14 -54.66 11.98 Favored 'General case' 0 N--CA 1.489 1.504 0 O-C-N 121.382 -0.824 . . . . 0.0 110.918 -179.349 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 97' ' ' LEU . . . . . 0.523 ' CD1' ' O ' ' A' ' 92' ' ' ALA . 81.5 mt -50.84 -6.28 0.03 OUTLIER 'General case' 0 N--CA 1.494 1.764 0 O-C-N 121.002 -1.061 . . . . 0.0 110.341 -178.671 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 98' ' ' ASN . . . . . 0.541 ' H ' ' C ' ' A' ' 96' ' ' GLN . 0.2 OUTLIER -75.3 -32.61 61.04 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.169 -0.957 . . . . 0.0 109.392 179.24 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 99' ' ' ARG . . . . . 0.4 ' HD2' ' CE2' ' A' ' 88' ' ' TYR . 9.3 mtt180 -85.53 -44.93 12.25 Favored 'General case' 0 N--CA 1.488 1.469 0 O-C-N 121.478 -0.764 . . . . 0.0 109.727 -179.321 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . 169.87 -170.6 42.91 Favored Glycine 0 N--CA 1.495 2.624 0 C-N-CA 119.698 -1.239 . . . . 0.0 110.141 179.653 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 101' ' ' VAL . . . . . . . . . . . . . 26.8 m -55.0 106.74 0.12 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.572 0 O-C-N 121.093 -1.239 . . . . 0.0 109.17 -179.981 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -92.88 164.55 13.28 Favored 'General case' 0 N--CA 1.494 1.737 0 O-C-N 121.433 -0.792 . . . . 0.0 110.664 -179.282 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 103' ' ' PHE . . . . . 0.555 ' CZ ' ' CG1' ' A' ' 87' ' ' VAL . 28.5 m-85 -68.04 123.12 19.76 Favored 'General case' 0 N--CA 1.488 1.452 0 N-CA-C 108.549 -0.908 . . . . 0.0 108.549 178.413 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 104' ' ' ALA . . . . . . . . . . . . . . . -50.58 -7.33 0.03 OUTLIER 'General case' 0 C--N 1.3 -1.571 0 O-C-N 121.453 -0.779 . . . . 0.0 110.634 -179.42 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 105' ' ' GLU . . . . . 0.488 ' H ' ' C ' ' A' ' 103' ' ' PHE . 0.0 OUTLIER -139.83 144.22 37.2 Favored 'General case' 0 N--CA 1.495 1.814 0 O-C-N 120.915 -1.116 . . . . 0.0 110.433 -179.246 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 106' ' ' GLU . . . . . . . . . . . . . 28.2 tt0 -59.91 -64.35 0.98 Allowed 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.784 -0.572 . . . . 0.0 111.245 -178.959 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 107' ' ' ASN . . . . . . . . . . . . . 2.1 m-80 -78.5 35.51 0.23 Allowed 'General case' 0 N--CA 1.49 1.541 0 O-C-N 120.813 -1.179 . . . . 0.0 112.378 -175.981 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 108' ' ' GLU . . . . . 0.429 ' OE2' ' OE2' ' A' ' 105' ' ' GLU . 1.6 tp10 -59.0 149.24 27.97 Favored 'General case' 0 C--N 1.303 -1.415 0 O-C-N 120.703 -1.248 . . . . 0.0 107.725 -179.912 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 109' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -103.98 137.51 41.84 Favored 'General case' 0 C--N 1.304 -1.372 0 O-C-N 121.069 -1.019 . . . . 0.0 110.616 -178.236 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 110' ' ' LEU . . . . . . . . . . . . . 2.2 pp -60.74 -17.79 50.7 Favored 'General case' 0 C--N 1.298 -1.636 0 N-CA-C 108.225 -1.028 . . . . 0.0 108.225 179.138 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 111' ' ' ASP . . . . . . . . . . . . . 41.3 m-20 -132.13 37.77 3.55 Favored 'General case' 0 N--CA 1.489 1.492 0 N-CA-C 108.836 -0.801 . . . . 0.0 108.836 179.237 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 112' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -68.84 156.57 38.16 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.24 -0.913 . . . . 0.0 110.804 -179.786 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 113' ' ' GLN . . . . . 0.587 HE22 ' N ' ' A' ' 172' ' ' GLN . 0.0 OUTLIER -66.75 -15.96 63.91 Favored 'General case' 0 N--CA 1.487 1.402 0 N-CA-C 107.964 -1.125 . . . . 0.0 107.964 177.612 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 114' ' ' ASN . . . . . 0.607 ' OD1' ' NE2' ' A' ' 178' ' ' GLN . 3.0 t30 -151.4 106.11 3.26 Favored 'General case' 0 C--N 1.299 -1.61 0 N-CA-C 108.158 -1.053 . . . . 0.0 108.158 179.655 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 115' ' ' ILE . . . . . . . . . . . . . 2.7 mt -94.92 105.25 16.74 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.604 0 N-CA-C 107.66 -1.237 . . . . 0.0 107.66 179.655 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 116' ' ' SER . . . . . 0.423 ' OG ' ' ND2' ' A' ' 114' ' ' ASN . 36.6 m -89.57 147.42 23.95 Favored 'General case' 0 N--CA 1.487 1.39 0 CA-C-O 121.905 0.859 . . . . 0.0 111.303 -177.596 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 117' ' ' ILE . . . . . . . . . . . . . 1.7 mt -144.48 150.92 16.1 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.394 0 N-CA-C 108.092 -1.077 . . . . 0.0 108.092 179.194 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 118' ' ' ALA . . . . . . . . . . . . . . . -141.41 160.58 39.83 Favored 'General case' 0 N--CA 1.493 1.703 0 O-C-N 120.921 -1.112 . . . . 0.0 111.209 -178.886 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 119' ' ' GLY . . . . . . . . . . . . . . . -168.36 149.01 13.25 Favored Glycine 0 N--CA 1.489 2.221 0 C-N-CA 119.962 -1.113 . . . . 0.0 111.092 -179.98 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 120' ' ' HIS . . . . . . . . . . . . . 12.7 m170 -71.35 168.93 16.36 Favored 'General case' 0 N--CA 1.495 1.781 0 O-C-N 122.13 -0.629 . . . . 0.0 110.232 179.202 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 121' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -123.7 155.62 37.48 Favored 'General case' 0 N--CA 1.495 1.819 0 N-CA-C 108.864 -0.791 . . . . 0.0 108.864 179.233 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 122' ' ' PHE . . . . . . . . . . . . . 0.7 OUTLIER -143.92 123.17 12.99 Favored 'General case' 0 N--CA 1.501 2.091 0 O-C-N 120.913 -1.117 . . . . 0.0 110.228 179.606 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 123' ' ' ILE . . . . . 0.408 ' CG2' ' N ' ' A' ' 124' ' ' ASP . 17.1 tt -57.83 -40.61 76.9 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.43 0 CA-C-O 121.582 0.705 . . . . 0.0 109.291 179.606 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 124' ' ' ASP . . . . . 0.408 ' N ' ' CG2' ' A' ' 123' ' ' ILE . 0.4 OUTLIER -87.19 23.43 1.82 Allowed 'General case' 0 N--CA 1.497 1.898 0 O-C-N 121.648 -0.658 . . . . 0.0 111.461 -177.477 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 125' ' ' ARG . . . . . . . . . . . . . 82.9 mtt180 -153.18 99.83 2.68 Favored Pre-proline 0 N--CA 1.493 1.696 0 O-C-N 120.761 -1.212 . . . . 0.0 109.665 -179.582 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 126' ' ' PRO . . . . . . . . . . . . . 34.0 Cg_endo -77.41 -33.65 2.38 Favored 'Trans proline' 0 N--CA 1.489 1.255 0 C-N-CA 122.263 1.976 . . . . 0.0 112.782 -179.744 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 127' ' ' ASN . . . . . 0.485 ' O ' ' O ' ' A' ' 128' ' ' TYR . 5.1 p30 -90.64 11.14 23.01 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.198 -0.939 . . . . 0.0 109.602 179.911 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 128' ' ' TYR . . . . . 0.485 ' O ' ' O ' ' A' ' 127' ' ' ASN . 2.8 t80 -59.53 -149.67 0.0 OUTLIER 'General case' 0 N--CA 1.489 1.478 0 O-C-N 121.091 -1.006 . . . . 0.0 109.516 179.978 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 129' ' ' GLN . . . . . . . . . . . . . 37.1 mt-30 -66.95 -70.37 0.25 Allowed 'General case' 0 N--CA 1.487 1.413 0 O-C-N 121.337 -0.852 . . . . 0.0 109.605 -179.779 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 130' ' ' PHE . . . . . 0.401 ' CE1' HD13 ' A' ' 181' ' ' LEU . 50.6 m-85 -136.22 42.29 2.57 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.167 -0.958 . . . . 0.0 110.771 -179.39 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 131' ' ' THR . . . . . . . . . . . . . 8.5 m -74.68 -40.16 61.56 Favored 'General case' 0 N--CA 1.495 1.792 0 O-C-N 120.875 -1.141 . . . . 0.0 109.034 179.241 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 132' ' ' ASN . . . . . 0.558 ' ND2' ' O ' ' A' ' 81' ' ' ALA . 0.2 OUTLIER -89.18 11.59 18.27 Favored 'General case' 0 N--CA 1.492 1.673 0 C-N-CA 119.465 -0.894 . . . . 0.0 111.625 -178.678 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 133' ' ' LEU . . . . . 0.546 ' O ' ' N ' ' A' ' 135' ' ' ALA . 0.2 OUTLIER -68.02 -46.9 69.94 Favored 'General case' 0 N--CA 1.492 1.663 0 O-C-N 120.536 -1.353 . . . . 0.0 109.988 -179.16 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 134' ' ' LYS . . . . . 0.571 ' H ' ' CD ' ' A' ' 134' ' ' LYS . 0.0 OUTLIER -46.0 -14.11 0.02 OUTLIER 'General case' 0 N--CA 1.495 1.805 0 O-C-N 121.05 -1.031 . . . . 0.0 110.03 -179.514 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 135' ' ' ALA . . . . . 0.546 ' N ' ' O ' ' A' ' 133' ' ' LEU . . . -82.41 -35.89 27.23 Favored 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.108 -0.995 . . . . 0.0 109.123 179.669 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 136' ' ' ALA . . . . . . . . . . . . . . . -78.88 152.1 31.42 Favored 'General case' 0 C--N 1.302 -1.469 0 CA-C-O 121.858 0.837 . . . . 0.0 110.667 -179.35 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 137' ' ' LYS . . . . . 0.555 ' O ' ' O ' ' A' ' 138' ' ' LYS . 28.0 mtmm -153.06 -168.54 3.06 Favored 'General case' 0 N--CA 1.492 1.631 0 C-N-CA 118.351 -1.34 . . . . 0.0 110.939 -178.332 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 138' ' ' LYS . . . . . 0.555 ' O ' ' O ' ' A' ' 137' ' ' LYS . 0.0 OUTLIER -29.78 159.78 0.0 OUTLIER 'General case' 0 N--CA 1.489 1.509 0 CA-C-O 122.992 1.377 . . . . 0.0 112.681 -178.028 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 139' ' ' GLY . . . . . . . . . . . . . . . 51.9 8.81 0.44 Allowed Glycine 0 N--CA 1.489 2.199 0 N-CA-C 109.824 -1.311 . . . . 0.0 109.824 179.612 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 140' ' ' SER . . . . . 0.511 ' H ' ' C ' ' A' ' 138' ' ' LYS . 1.5 m -68.04 115.19 7.26 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.17 -1.194 . . . . 0.0 108.979 179.493 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 141' ' ' MET . . . . . . . . . . . . . 3.2 tpt -66.94 120.42 13.58 Favored 'General case' 0 C--N 1.301 -1.506 0 O-C-N 121.186 -0.946 . . . . 0.0 109.621 -179.866 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 142' ' ' VAL . . . . . . . . . . . . . 5.1 t -110.56 127.98 67.2 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.651 0 N-CA-C 108.192 -1.04 . . . . 0.0 108.192 179.835 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 143' ' ' TYR . . . . . . . . . . . . . 26.3 m-85 -107.79 135.06 49.84 Favored 'General case' 0 N--CA 1.498 1.963 0 O-C-N 121.022 -1.049 . . . . 0.0 111.348 -178.442 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 144' ' ' PHE . . . . . . . . . . . . . 58.5 t80 -119.19 101.16 7.8 Favored 'General case' 0 N--CA 1.486 1.355 0 N-CA-C 109.214 -0.661 . . . . 0.0 109.214 179.323 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 145' ' ' LYS . . . . . . . . . . . . . 35.8 mttt -95.47 129.33 42.67 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.127 -0.983 . . . . 0.0 109.62 -179.74 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 146' ' ' VAL . . . . . 0.428 ' O ' ' C ' ' A' ' 147' ' ' GLY . 3.3 p -141.67 141.43 29.85 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.636 0 N-CA-C 107.957 -1.127 . . . . 0.0 107.957 179.369 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 147' ' ' GLY . . . . . 0.428 ' C ' ' O ' ' A' ' 146' ' ' VAL . . . 44.43 -128.75 7.14 Favored Glycine 0 N--CA 1.487 2.05 0 N-CA-C 108.885 -1.686 . . . . 0.0 108.885 -179.59 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 148' ' ' ASN . . . . . 0.528 ' C ' ' ND2' ' A' ' 148' ' ' ASN . 0.4 OUTLIER -103.66 16.39 26.53 Favored 'General case' 0 C--N 1.298 -1.649 0 O-C-N 121.424 -1.045 . . . . 0.0 108.298 179.094 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 149' ' ' GLU . . . . . . . . . . . . . 13.9 tt0 -111.75 145.31 39.58 Favored 'General case' 0 N--CA 1.489 1.477 0 CA-C-O 121.896 0.855 . . . . 0.0 111.273 -178.471 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 150' ' ' THR . . . . . . . . . . . . . 2.1 m -127.4 102.69 7.0 Favored 'General case' 0 N--CA 1.491 1.613 0 CA-C-O 121.433 0.635 . . . . 0.0 109.757 -179.737 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 151' ' ' ARG . . . . . . . . . . . . . 50.9 mtt180 -86.22 -175.69 5.62 Favored 'General case' 0 N--CA 1.487 1.386 0 N-CA-C 108.541 -0.911 . . . . 0.0 108.541 -179.878 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 152' ' ' LYS . . . . . 0.44 ' O ' ' N ' ' A' ' 205' ' ' VAL . 1.7 mtmp? -145.0 149.36 35.0 Favored 'General case' 0 C--N 1.303 -1.45 0 C-N-CA 119.216 -0.993 . . . . 0.0 110.048 -179.457 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 153' ' ' TYR . . . . . 0.49 ' CD2' ' HA ' ' A' ' 204' ' ' GLU . 31.2 m-85 -143.71 166.29 25.28 Favored 'General case' 0 C--N 1.303 -1.454 0 N-CA-C 107.822 -1.177 . . . . 0.0 107.822 178.719 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 154' ' ' LYS . . . . . . . . . . . . . 5.9 ttmm -143.99 119.81 10.57 Favored 'General case' 0 C--N 1.296 -1.723 0 N-CA-C 108.125 -1.065 . . . . 0.0 108.125 179.074 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 155' ' ' MET . . . . . . . . . . . . . 14.1 mtp -48.45 107.71 0.14 Allowed 'General case' 0 N--CA 1.493 1.678 0 O-C-N 120.522 -1.361 . . . . 0.0 111.543 -178.623 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 156' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -107.45 -22.36 12.58 Favored 'General case' 0 C--N 1.296 -1.736 0 CA-C-N 115.34 -0.845 . . . . 0.0 110.758 -178.646 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 157' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -151.21 150.43 30.6 Favored 'General case' 0 N--CA 1.494 1.762 0 C-N-CA 118.395 -1.322 . . . . 0.0 111.284 -178.71 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 158' ' ' ILE . . . . . 0.543 ' CD1' ' N ' ' A' ' 159' ' ' ARG . 0.1 OUTLIER -154.53 142.46 12.96 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.3 0 CA-C-O 121.923 0.868 . . . . 0.0 110.3 -178.743 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 159' ' ' ARG . . . . . 0.543 ' N ' ' CD1' ' A' ' 158' ' ' ILE . 27.2 ptt180 -155.21 155.02 33.13 Favored 'General case' 0 C--N 1.296 -1.722 0 CA-C-O 121.663 0.744 . . . . 0.0 109.929 -179.902 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 160' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -115.06 162.28 17.22 Favored 'General case' 0 N--CA 1.492 1.633 0 N-CA-C 108.165 -1.05 . . . . 0.0 108.165 179.218 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 161' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -158.34 160.15 2.11 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.609 0 O-C-N 121.169 -0.957 . . . . 0.0 110.394 -179.539 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 162' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -52.45 176.91 0.07 OUTLIER Pre-proline 0 N--CA 1.488 1.456 0 O-C-N 121.477 -0.764 . . . . 0.0 109.053 179.663 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 163' ' ' PRO . . . . . . . . . . . . . 2.4 Cg_endo -78.67 37.31 0.64 Allowed 'Trans proline' 0 N--CA 1.491 1.333 0 C-N-CA 122.478 2.119 . . . . 0.0 113.086 -179.531 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 164' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -152.65 -6.69 0.2 Allowed 'General case' 0 N--CA 1.495 1.821 0 O-C-N 120.464 -1.397 . . . . 0.0 111.792 -179.4 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 165' ' ' ASP . . . . . . . . . . . . . 6.0 t70 -74.7 62.29 1.05 Allowed 'General case' 0 N--CA 1.493 1.677 0 O-C-N 120.676 -1.265 . . . . 0.0 110.041 -179.581 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 166' ' ' VAL . . . . . 0.613 ' O ' ' N ' ' A' ' 168' ' ' VAL . 1.5 m -47.82 -31.44 2.68 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.594 0 O-C-N 121.144 -0.972 . . . . 0.0 109.968 -178.55 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 167' ' ' GLY . . . . . . . . . . . . . . . -44.26 -10.01 0.01 OUTLIER Glycine 0 N--CA 1.496 2.65 0 O-C-N 120.811 -1.18 . . . . 0.0 111.094 -179.545 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 168' ' ' VAL . . . . . 0.613 ' N ' ' O ' ' A' ' 166' ' ' VAL . 5.5 m -53.51 -29.35 16.82 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.614 0 O-C-N 120.62 -1.518 . . . . 0.0 108.976 179.785 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 169' ' ' LEU . . . . . 0.533 ' O ' ' C ' ' A' ' 170' ' ' ASP . 11.1 mt -49.47 -13.79 0.09 Allowed 'General case' 0 N--CA 1.49 1.564 0 N-CA-C 107.31 -1.367 . . . . 0.0 107.31 -179.14 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 170' ' ' ASP . . . . . 0.568 ' H ' ' C ' ' A' ' 168' ' ' VAL . 3.2 t70 21.84 91.77 0.01 OUTLIER 'General case' 0 N--CA 1.502 2.139 0 CA-C-N 116.281 -0.418 . . . . 0.0 111.649 177.261 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 171' ' ' GLU . . . . . 0.425 ' C ' ' OE1' ' A' ' 113' ' ' GLN . 3.3 pt-20 -136.93 74.41 1.49 Allowed 'General case' 0 N--CA 1.493 1.699 0 O-C-N 120.913 -1.117 . . . . 0.0 110.863 -179.814 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 172' ' ' GLN . . . . . 0.587 ' N ' HE22 ' A' ' 113' ' ' GLN . 1.1 pt20 -132.01 -47.95 0.94 Allowed 'General case' 0 N--CA 1.499 2.021 0 O-C-N 121.284 -0.885 . . . . 0.0 111.661 -178.451 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 173' ' ' LYS . . . . . 0.515 ' NZ ' ' O ' ' A' ' 176' ' ' ASP . 8.4 ptmm? -64.31 129.13 38.73 Favored 'General case' 0 N--CA 1.499 1.989 0 O-C-N 120.576 -1.327 . . . . 0.0 109.324 -179.968 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 174' ' ' GLY . . . . . 0.527 ' O ' ' C ' ' A' ' 175' ' ' LYS . . . -115.37 -40.0 0.9 Allowed Glycine 0 N--CA 1.484 1.89 0 N-CA-C 108.676 -1.769 . . . . 0.0 108.676 179.591 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 175' ' ' LYS . . . . . 0.527 ' C ' ' O ' ' A' ' 174' ' ' GLY . 0.2 OUTLIER -41.44 -62.08 0.93 Allowed 'General case' 0 N--CA 1.491 1.597 0 N-CA-C 107.022 -1.473 . . . . 0.0 107.022 178.864 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 176' ' ' ASP . . . . . 0.567 ' O ' ' O ' ' A' ' 177' ' ' LYS . 81.8 m-20 -104.4 85.36 2.34 Favored 'General case' 0 C--N 1.298 -1.635 0 N-CA-C 107.691 -1.226 . . . . 0.0 107.691 176.781 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 177' ' ' LYS . . . . . 0.567 ' O ' ' O ' ' A' ' 176' ' ' ASP . 2.1 mptp? -47.55 -175.16 0.0 OUTLIER 'General case' 0 N--CA 1.5 2.044 0 O-C-N 121.28 -0.888 . . . . 0.0 108.93 -179.755 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 178' ' ' GLN . . . . . 0.607 ' NE2' ' OD1' ' A' ' 114' ' ' ASN . 0.0 OUTLIER -162.75 178.63 8.31 Favored 'General case' 0 C--N 1.305 -1.355 0 O-C-N 120.264 -1.523 . . . . 0.0 110.936 179.836 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 179' ' ' LEU . . . . . . . . . . . . . 4.6 tt -128.55 97.55 4.74 Favored 'General case' 0 C--N 1.302 -1.474 0 N-CA-C 107.54 -1.281 . . . . 0.0 107.54 178.436 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 180' ' ' THR . . . . . . . . . . . . . 1.2 m -71.29 115.18 10.15 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 120.996 -1.065 . . . . 0.0 109.967 -178.719 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 181' ' ' LEU . . . . . 0.401 HD13 ' CE1' ' A' ' 130' ' ' PHE . 48.5 tp -93.16 142.45 27.28 Favored 'General case' 0 C--N 1.295 -1.794 0 N-CA-C 108.368 -0.975 . . . . 0.0 108.368 178.328 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 182' ' ' ILE . . . . . . . . . . . . . 47.0 mt -136.11 120.58 25.93 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.533 0 N-CA-C 108.197 -1.038 . . . . 0.0 108.197 178.925 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 183' ' ' THR . . . . . . . . . . . . . 2.2 t -140.72 111.84 7.18 Favored 'General case' 0 C--N 1.291 -1.943 0 N-CA-C 107.718 -1.215 . . . . 0.0 107.718 179.117 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 184' ' ' CYS . . . . . . . . . . . . . 1.2 p -78.81 159.55 27.8 Favored 'General case' 0 C--N 1.292 -1.907 0 C-N-CA 118.856 -1.138 . . . . 0.0 110.665 -178.09 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 185' ' ' ASP . . . . . 0.439 ' CB ' ' HZ2' ' A' ' 198' ' ' LYS . 0.4 OUTLIER -164.57 -155.66 0.28 Allowed 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.629 -0.669 . . . . 0.0 109.413 -179.488 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 186' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER 52.32 60.67 3.65 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.128 -0.982 . . . . 0.0 108.597 -179.469 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 187' ' ' TYR . . . . . 0.593 ' CE1' ' O ' ' A' ' 188' ' ' ASN . 35.5 t80 -68.34 134.02 49.64 Favored 'General case' 0 N--CA 1.488 1.459 0 CA-C-O 121.812 0.815 . . . . 0.0 111.142 -178.977 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 188' ' ' ASN . . . . . 0.593 ' O ' ' CE1' ' A' ' 187' ' ' TYR . 0.9 OUTLIER -98.67 145.64 26.67 Favored 'General case' 0 C--N 1.296 -1.721 0 N-CA-C 108.218 -1.03 . . . . 0.0 108.218 178.395 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 189' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -112.01 -19.91 12.16 Favored 'General case' 0 C--N 1.296 -1.749 0 N-CA-C 107.904 -1.147 . . . . 0.0 107.904 -179.86 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 190' ' ' LYS . . . . . . . . . . . . . 33.5 mttt -82.63 -50.06 9.16 Favored 'General case' 0 C--N 1.3 -1.551 0 N-CA-C 108.235 -1.024 . . . . 0.0 108.235 178.62 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 191' ' ' THR . . . . . . . . . . . . . 71.4 p -87.97 -8.97 54.93 Favored 'General case' 0 C--N 1.303 -1.428 0 N-CA-C 109.105 -0.702 . . . . 0.0 109.105 -179.97 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 192' ' ' GLY . . . . . . . . . . . . . . . 57.56 38.73 88.91 Favored Glycine 0 N--CA 1.493 2.466 0 N-CA-C 110.745 -0.942 . . . . 0.0 110.745 178.872 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 193' ' ' VAL . . . . . . . . . . . . . 3.2 m -148.05 162.1 6.63 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.58 0 O-C-N 120.989 -1.3 . . . . 0.0 108.872 179.35 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 194' ' ' TRP . . . . . . . . . . . . . 47.6 m95 -83.58 120.47 26.0 Favored 'General case' 0 N--CA 1.489 1.518 0 N-CA-C 107.802 -1.184 . . . . 0.0 107.802 178.901 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 195' ' ' GLU . . . . . . . . . . . . . 2.0 mt-10 -86.8 -61.05 1.82 Allowed 'General case' 0 N--CA 1.496 1.858 0 O-C-N 121.132 -0.98 . . . . 0.0 112.083 -177.318 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 196' ' ' LYS . . . . . . . . . . . . . 11.1 tttm -76.84 150.51 36.08 Favored 'General case' 0 N--CA 1.493 1.723 0 O-C-N 120.973 -1.079 . . . . 0.0 111.304 -177.663 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 197' ' ' ARG . . . . . 0.431 ' NH1' ' O ' ' C' ' 704' ' ' ALA . 16.9 mmt180 -122.01 129.83 52.78 Favored 'General case' 0 N--CA 1.491 1.584 0 N-CA-C 108.839 -0.8 . . . . 0.0 108.839 179.481 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 198' ' ' LYS . . . . . 0.439 ' HZ2' ' CB ' ' A' ' 185' ' ' ASP . 9.6 mtmt -113.72 120.25 40.18 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.482 -0.761 . . . . 0.0 109.969 -179.399 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 199' ' ' ILE . . . . . 0.415 ' O ' HG13 ' A' ' 199' ' ' ILE . 0.8 OUTLIER -140.04 118.42 11.14 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.723 0 CA-C-O 122.405 1.097 . . . . 0.0 109.929 179.269 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 200' ' ' PHE . . . . . 0.524 ' CD1' ' N ' ' A' ' 200' ' ' PHE . 4.7 m-85 -100.09 139.68 35.41 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.181 -0.949 . . . . 0.0 109.512 -179.082 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 201' ' ' VAL . . . . . . . . . . . . . 40.7 t -102.33 145.79 11.42 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.645 0 N-CA-C 107.31 -1.367 . . . . 0.0 107.31 177.395 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 202' ' ' ALA . . . . . . . . . . . . . . . -129.25 137.42 51.07 Favored 'General case' 0 C--N 1.301 -1.503 0 O-C-N 120.949 -1.095 . . . . 0.0 109.146 -179.4 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 203' ' ' THR . . . . . . . . . . . . . 2.5 p -88.83 129.99 35.47 Favored 'General case' 0 C--N 1.305 -1.352 0 CA-C-O 122.393 1.092 . . . . 0.0 110.705 -178.791 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 204' ' ' GLU . . . . . 0.49 ' HA ' ' CD2' ' A' ' 153' ' ' TYR . 3.9 tm-20 -50.84 133.82 26.06 Favored 'General case' 0 C--N 1.296 -1.734 0 C-N-CA 119.184 -1.007 . . . . 0.0 109.659 179.739 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 205' ' ' VAL . . . . . 0.495 ' CG1' ' N ' ' A' ' 206' ' ' LYS . 73.8 t -126.94 164.52 27.35 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.452 0 CA-C-O 122.109 0.957 . . . . 0.0 110.066 -178.14 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 206' ' ' LYS . . . . . 0.495 ' N ' ' CG1' ' A' ' 205' ' ' VAL . 0.9 OUTLIER . . . . . 0 C--N 1.295 -1.765 0 CA-C-O 117.931 -1.033 . . . . 0.0 109.468 179.929 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' C' C ' 701' ' ' PHQ . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 013 nuclear orig full ' C' C ' 702' ' ' LEU . . . . . 0.65 ' H ' ' CD1' ' C' ' 702' ' ' LEU . 0.0 OUTLIER . . . . . 0 N--CA 1.492 1.632 0 N-CA-C 108.998 -0.741 . . . . 0.0 108.998 . . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' C' C ' 703' ' ' PRO . . . . . 0.486 ' O ' ' O ' ' C' ' 704' ' ' ALA . 28.8 Cg_endo -68.95 -162.03 0.08 OUTLIER 'Trans proline' 0 N--CA 1.491 1.347 0 C-N-CA 122.271 1.981 . . . . 0.0 112.272 179.779 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' C' C ' 704' ' ' ALA . . . . . 0.54 ' C ' ' SG ' ' C' ' 705' ' ' B27 . . . 48.38 97.48 0.01 OUTLIER 'General case' 0 N--CA 1.489 1.491 0 O-C-N 121.306 -0.871 . . . . 0.0 108.993 -179.928 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' C' C ' 705' ' ' B27 . . . . . 0.54 ' SG ' ' C ' ' C' ' 704' ' ' ALA . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 700' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 014 nuclear orig full ' A' A ' 59' ' ' MET . . . . . . . . . . . . . 11.4 mtt . . . . . 0 N--CA 1.489 1.522 0 N-CA-C 109.456 -0.572 . . . . 0.0 109.456 . . . . . . . . . 0 0 . 1 . 014 nuclear orig full ' A' A ' 60' ' ' GLN . . . . . . . . . . . . . 13.3 mt-30 -60.54 179.08 0.17 Allowed 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.38 -0.825 . . . . 0.0 109.437 -179.992 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . -64.1 -164.26 0.02 OUTLIER 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.27 -0.894 . . . . 0.0 109.508 -179.921 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 62' ' ' LYS . . . . . . . . . . . . . 24.8 tttt -147.88 89.63 5.27 Favored Pre-proline 0 N--CA 1.491 1.596 0 O-C-N 121.347 -0.846 . . . . 0.0 109.653 -179.645 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 63' ' ' PRO . . . . . . . . . . . . . 21.3 Cg_endo -83.57 138.86 8.66 Favored 'Trans proline' 0 C--N 1.31 -1.474 0 C-N-CA 122.598 2.199 . . . . 0.0 111.586 179.722 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 64' ' ' GLN . . . . . 0.829 ' H ' HE21 ' A' ' 64' ' ' GLN . 0.0 OUTLIER -158.14 113.4 2.67 Favored 'General case' 0 N--CA 1.488 1.453 0 O-C-N 121.249 -0.907 . . . . 0.0 109.528 -179.773 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 65' ' ' ILE . . . . . 0.581 ' H ' ' CD1' ' A' ' 65' ' ' ILE . 0.0 OUTLIER -42.0 103.29 0.3 Allowed Pre-proline 0 N--CA 1.49 1.571 0 N-CA-C 108.757 -0.831 . . . . 0.0 108.757 179.471 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 66' ' ' PRO . . . . . . . . . . . . . 94.3 Cg_endo -87.6 -155.82 0.06 OUTLIER 'Trans proline' 0 C--N 1.313 -1.338 0 C-N-CA 122.372 2.048 . . . . 0.0 112.259 -179.18 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 67' ' ' LYS . . . . . 0.429 ' C ' ' H ' ' A' ' 69' ' ' LYS . 23.1 pttm -79.42 -7.86 58.7 Favored 'General case' 0 C--N 1.302 -1.474 0 O-C-N 121.308 -0.87 . . . . 0.0 108.847 179.673 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 68' ' ' ASP . . . . . 0.603 ' C ' ' H ' ' A' ' 70' ' ' SER . 1.9 t0 -76.7 48.3 0.55 Allowed 'General case' 0 N--CA 1.487 1.423 0 CA-C-O 122.342 1.068 . . . . 0.0 108.931 179.385 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 69' ' ' LYS . . . . . 0.444 ' C ' ' O ' ' A' ' 68' ' ' ASP . 0.0 OUTLIER -49.27 -14.69 0.1 Allowed 'General case' 0 N--CA 1.503 2.217 0 C-N-CA 117.094 -1.842 . . . . 0.0 106.554 178.257 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 70' ' ' SER . . . . . 0.603 ' H ' ' C ' ' A' ' 68' ' ' ASP . 1.1 p -82.28 -8.91 59.64 Favored 'General case' 0 N--CA 1.495 1.804 0 CA-C-N 113.942 -1.481 . . . . 0.0 110.035 179.552 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 71' ' ' LYS . . . . . 0.402 ' O ' ' CG ' ' A' ' 71' ' ' LYS . 0.0 OUTLIER -99.19 144.17 28.62 Favored 'General case' 0 N--CA 1.494 1.73 0 O-C-N 121.034 -1.041 . . . . 0.0 110.312 179.294 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 1.0 OUTLIER -65.26 141.48 18.13 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.575 0 N-CA-C 104.868 -2.271 . . . . 0.0 104.868 174.542 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -80.82 -14.9 57.64 Favored 'General case' 0 C--N 1.294 -1.825 0 O-C-N 119.864 -1.772 . . . . 0.0 106.411 179.66 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . 175.46 -156.58 22.36 Favored Glycine 0 N--CA 1.481 1.645 0 N-CA-C 109.16 -1.576 . . . . 0.0 109.16 179.274 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 75' ' ' TYR . . . . . 0.572 ' CD2' ' O ' ' A' ' 85' ' ' GLU . 0.5 OUTLIER -141.7 167.98 20.86 Favored 'General case' 0 C--N 1.292 -1.893 0 O-C-N 121.664 -0.903 . . . . 0.0 110.655 -176.991 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 76' ' ' ILE . . . . . . . . . . . . . 0.6 OUTLIER -144.75 140.32 23.44 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.597 0 C-N-CA 119.087 -1.045 . . . . 0.0 109.781 -177.432 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -148.57 161.46 41.63 Favored 'General case' 0 C--N 1.303 -1.456 0 O-C-N 121.287 -0.883 . . . . 0.0 109.158 -179.571 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 78' ' ' ILE . . . . . . . . . . . . . 6.6 mt -146.89 94.42 4.64 Favored Pre-proline 0 C--N 1.3 -1.553 0 N-CA-C 108.53 -0.915 . . . . 0.0 108.53 -179.75 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 79' ' ' PRO . . . . . . . . . . . . . 74.4 Cg_exo -47.32 -47.42 17.47 Favored 'Trans proline' 0 N--CA 1.493 1.449 0 C-N-CA 122.805 2.337 . . . . 0.0 113.765 -178.745 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -65.24 -18.17 65.1 Favored 'General case' 0 N--CA 1.492 1.65 0 O-C-N 120.765 -1.209 . . . . 0.0 110.565 178.667 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 81' ' ' ALA . . . . . 0.575 ' O ' ' ND2' ' A' ' 132' ' ' ASN . . . -105.69 -16.74 14.6 Favored 'General case' 0 N--CA 1.493 1.718 0 O-C-N 121.24 -0.912 . . . . 0.0 108.918 179.653 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 82' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER 69.39 47.79 0.67 Allowed 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.432 -0.793 . . . . 0.0 110.53 178.87 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 83' ' ' ILE . . . . . . . . . . . . . 67.2 mt -127.1 149.58 32.31 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.81 0 O-C-N 121.065 -1.022 . . . . 0.0 110.732 -178.87 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 84' ' ' LYS . . . . . . . . . . . . . 6.7 ttpm? -157.38 107.86 2.25 Favored 'General case' 0 N--CA 1.491 1.595 0 N-CA-C 107.544 -1.28 . . . . 0.0 107.544 179.516 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 85' ' ' GLU . . . . . 0.572 ' O ' ' CD2' ' A' ' 75' ' ' TYR . 0.4 OUTLIER -145.31 174.37 3.51 Favored Pre-proline 0 N--CA 1.492 1.65 0 O-C-N 121.503 -0.748 . . . . 0.0 110.409 -178.8 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 86' ' ' PRO . . . . . 0.421 ' HA ' ' CD1' ' A' ' 75' ' ' TYR . 60.3 Cg_endo -82.41 168.85 14.43 Favored 'Trans proline' 0 C--N 1.313 -1.305 0 C-N-CA 122.809 2.339 . . . . 0.0 113.841 -179.347 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 87' ' ' VAL . . . . . 0.531 ' CG1' ' CZ ' ' A' ' 103' ' ' PHE . 3.2 t -128.93 105.84 13.42 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.607 0 N-CA-C 108.448 -0.945 . . . . 0.0 108.448 179.91 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 88' ' ' TYR . . . . . 0.411 ' CD2' ' HD2' ' A' ' 99' ' ' ARG . 34.6 m-85 -99.22 152.76 37.91 Favored Pre-proline 0 N--CA 1.499 2.006 0 O-C-N 120.769 -1.207 . . . . 0.0 110.129 -179.018 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 89' ' ' PRO . . . . . . . . . . . . . 2.7 Cg_exo -50.35 144.42 23.97 Favored 'Trans proline' 0 C--N 1.312 -1.351 0 C-N-CA 122.707 2.271 . . . . 0.0 113.487 179.871 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . -61.41 169.57 10.5 Favored Glycine 0 N--CA 1.493 2.47 0 N-CA-C 108.807 -1.717 . . . . 0.0 108.807 178.894 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 91' ' ' PRO . . . . . 0.522 ' C ' ' H ' ' A' ' 93' ' ' THR . 63.9 Cg_endo -95.7 172.86 13.58 Favored 'Cis proline' 0 C--N 1.311 -1.407 0 C-N-CA 124.227 -1.156 . . . . 0.0 112.226 0.133 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 92' ' ' ALA . . . . . . . . . . . . . . . -70.48 29.03 0.04 OUTLIER 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.229 -0.919 . . . . 0.0 110.378 -179.794 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 93' ' ' THR . . . . . 0.522 ' H ' ' C ' ' A' ' 91' ' ' PRO . 1.8 p -75.19 152.14 86.05 Favored Pre-proline 0 N--CA 1.489 1.524 0 O-C-N 120.626 -1.296 . . . . 0.0 108.833 -179.958 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 94' ' ' PRO . . . . . . . . . . . . . 86.4 Cg_exo -35.03 -42.34 0.35 Allowed 'Trans proline' 0 C--N 1.309 -1.546 0 C-N-CA 122.821 2.348 . . . . 0.0 112.398 -179.362 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 95' ' ' GLU . . . . . 0.485 ' O ' ' OD1' ' A' ' 98' ' ' ASN . 53.2 mt-10 -52.84 -55.18 25.01 Favored 'General case' 0 C--N 1.304 -1.407 0 O-C-N 121.094 -1.004 . . . . 0.0 109.12 179.636 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 96' ' ' GLN . . . . . 0.57 ' C ' ' H ' ' A' ' 98' ' ' ASN . 28.6 mm100 -72.29 -50.99 22.87 Favored 'General case' 0 N--CA 1.488 1.458 0 O-C-N 121.124 -0.985 . . . . 0.0 110.151 179.965 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 97' ' ' LEU . . . . . . . . . . . . . 2.5 mp -48.39 -9.12 0.02 OUTLIER 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.038 -1.039 . . . . 0.0 109.784 -179.306 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 98' ' ' ASN . . . . . 0.699 HD22 ' CZ ' ' A' ' 99' ' ' ARG . 14.4 p-10 -72.38 -30.35 64.6 Favored 'General case' 0 N--CA 1.492 1.625 0 CA-C-O 121.873 0.844 . . . . 0.0 109.48 179.624 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 99' ' ' ARG . . . . . 0.699 ' CZ ' HD22 ' A' ' 98' ' ' ASN . 1.2 mtt-85 -98.66 -47.1 5.47 Favored 'General case' 0 C--N 1.299 -1.591 0 C-N-CA 119.829 -0.749 . . . . 0.0 110.106 -178.479 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . 176.28 -176.58 47.78 Favored Glycine 0 N--CA 1.493 2.485 0 C-N-CA 119.096 -1.526 . . . . 0.0 110.916 179.857 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 101' ' ' VAL . . . . . . . . . . . . . 0.2 OUTLIER -50.46 111.7 0.2 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.597 0 O-C-N 121.697 -0.884 . . . . 0.0 109.892 -179.859 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 102' ' ' SER . . . . . 0.437 ' H ' ' HG ' ' A' ' 102' ' ' SER . 0.7 OUTLIER -93.94 169.7 10.09 Favored 'General case' 0 N--CA 1.496 1.84 0 O-C-N 121.273 -0.892 . . . . 0.0 110.741 -179.888 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 103' ' ' PHE . . . . . 0.603 ' O ' ' N ' ' A' ' 105' ' ' GLU . 27.5 m-85 -71.06 121.02 17.48 Favored 'General case' 0 N--CA 1.485 1.314 0 N-CA-C 107.68 -1.23 . . . . 0.0 107.68 177.609 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 104' ' ' ALA . . . . . 0.412 ' C ' ' O ' ' A' ' 103' ' ' PHE . . . -41.95 -15.65 0.01 OUTLIER 'General case' 0 C--N 1.299 -1.597 0 O-C-N 121.497 -0.752 . . . . 0.0 110.682 -178.821 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 105' ' ' GLU . . . . . 0.603 ' N ' ' O ' ' A' ' 103' ' ' PHE . 0.1 OUTLIER -136.22 145.45 45.67 Favored 'General case' 0 N--CA 1.496 1.86 0 O-C-N 120.811 -1.18 . . . . 0.0 110.243 179.638 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 106' ' ' GLU . . . . . . . . . . . . . 2.0 tt0 -60.02 -63.43 1.3 Allowed 'General case' 0 N--CA 1.489 1.482 0 O-C-N 121.835 -0.54 . . . . 0.0 111.416 -178.904 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 107' ' ' ASN . . . . . 0.712 ' H ' HD21 ' A' ' 107' ' ' ASN . 0.2 OUTLIER -78.11 35.09 0.21 Allowed 'General case' 0 N--CA 1.491 1.609 0 O-C-N 120.649 -1.282 . . . . 0.0 112.76 -175.608 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 108' ' ' GLU . . . . . . . . . . . . . 1.7 tp10 -58.24 148.94 25.51 Favored 'General case' 0 N--CA 1.488 1.451 0 N-CA-C 107.591 -1.263 . . . . 0.0 107.591 179.891 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 109' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -101.6 146.3 27.88 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.139 -0.975 . . . . 0.0 110.709 -178.305 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 110' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -62.1 -24.15 66.95 Favored 'General case' 0 C--N 1.302 -1.477 0 N-CA-C 108.035 -1.098 . . . . 0.0 108.035 179.14 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 111' ' ' ASP . . . . . . . . . . . . . 13.0 m-20 -132.7 43.34 2.99 Favored 'General case' 0 N--CA 1.488 1.448 0 O-C-N 121.688 -0.633 . . . . 0.0 109.762 179.97 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 112' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -69.12 156.04 39.35 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.15 -0.969 . . . . 0.0 110.806 -179.852 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 113' ' ' GLN . . . . . 0.457 ' N ' ' CD ' ' A' ' 113' ' ' GLN . 0.8 OUTLIER -67.14 -18.16 65.17 Favored 'General case' 0 N--CA 1.491 1.622 0 N-CA-C 108.15 -1.055 . . . . 0.0 108.15 178.097 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 114' ' ' ASN . . . . . 0.597 ' ND2' ' NE2' ' A' ' 178' ' ' GLN . 1.9 t-20 -150.37 103.84 3.18 Favored 'General case' 0 C--N 1.299 -1.626 0 N-CA-C 107.871 -1.159 . . . . 0.0 107.871 178.533 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 115' ' ' ILE . . . . . . . . . . . . . 2.9 mt -97.77 109.2 23.09 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.66 0 O-C-N 120.885 -1.134 . . . . 0.0 108.696 -179.955 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 116' ' ' SER . . . . . . . . . . . . . 80.8 p -88.0 152.24 22.18 Favored 'General case' 0 N--CA 1.49 1.538 0 CA-C-O 121.863 0.839 . . . . 0.0 110.842 -178.445 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 117' ' ' ILE . . . . . . . . . . . . . 1.5 mt -146.95 122.29 2.63 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.413 0 N-CA-C 107.876 -1.157 . . . . 0.0 107.876 -179.725 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 118' ' ' ALA . . . . . . . . . . . . . . . -118.58 159.72 23.07 Favored 'General case' 0 N--CA 1.496 1.846 0 C-N-CA 119.516 -0.874 . . . . 0.0 112.074 -177.933 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 119' ' ' GLY . . . . . . . . . . . . . . . -170.7 148.11 11.13 Favored Glycine 0 N--CA 1.49 2.255 0 CA-C-O 122.163 0.868 . . . . 0.0 110.936 179.929 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 120' ' ' HIS . . . . . 0.565 ' N ' ' OE1' ' A' ' 129' ' ' GLN . 6.4 m170 -71.19 168.47 17.17 Favored 'General case' 0 N--CA 1.496 1.831 0 O-C-N 121.889 -0.771 . . . . 0.0 109.909 179.084 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 121' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -122.64 158.07 30.81 Favored 'General case' 0 N--CA 1.496 1.844 0 N-CA-C 108.48 -0.933 . . . . 0.0 108.48 178.786 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 122' ' ' PHE . . . . . . . . . . . . . 1.1 m-85 -144.16 123.61 13.15 Favored 'General case' 0 N--CA 1.498 1.974 0 O-C-N 120.819 -1.175 . . . . 0.0 110.006 -179.926 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 123' ' ' ILE . . . . . 0.467 ' CG2' ' N ' ' A' ' 124' ' ' ASP . 14.4 tt -58.51 -40.92 80.34 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.541 0 CA-C-O 121.619 0.723 . . . . 0.0 109.46 179.714 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 124' ' ' ASP . . . . . 0.467 ' N ' ' CG2' ' A' ' 123' ' ' ILE . 13.1 t70 -90.14 26.21 1.95 Allowed 'General case' 0 N--CA 1.497 1.888 0 O-C-N 121.573 -0.704 . . . . 0.0 112.166 -177.215 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 125' ' ' ARG . . . . . 0.657 HH11 ' CG ' ' A' ' 125' ' ' ARG . 2.2 mtt-85 -155.59 99.69 2.25 Favored Pre-proline 0 N--CA 1.493 1.679 0 O-C-N 120.451 -1.406 . . . . 0.0 109.718 179.989 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 126' ' ' PRO . . . . . . . . . . . . . 53.9 Cg_endo -78.54 -25.15 6.93 Favored 'Trans proline' 0 C--N 1.314 -1.277 0 C-N-CA 122.067 1.845 . . . . 0.0 112.172 179.893 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 127' ' ' ASN . . . . . 0.447 ' O ' ' O ' ' A' ' 128' ' ' TYR . 3.0 t30 -91.77 5.17 50.88 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.264 -0.897 . . . . 0.0 109.43 179.743 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 128' ' ' TYR . . . . . 0.465 ' O ' ' OE2' ' A' ' 85' ' ' GLU . 9.7 t80 -59.22 -150.25 0.0 OUTLIER 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.296 -0.878 . . . . 0.0 109.88 -179.765 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 129' ' ' GLN . . . . . 0.565 ' OE1' ' N ' ' A' ' 120' ' ' HIS . 10.3 mt-30 -68.04 -70.26 0.27 Allowed 'General case' 0 C--N 1.303 -1.422 0 O-C-N 121.549 -0.72 . . . . 0.0 109.483 179.968 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 130' ' ' PHE . . . . . . . . . . . . . 55.6 m-85 -136.59 51.88 1.98 Allowed 'General case' 0 N--CA 1.489 1.501 0 O-C-N 121.29 -0.881 . . . . 0.0 110.289 -179.536 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 131' ' ' THR . . . . . 0.537 ' O ' ' CD ' ' A' ' 134' ' ' LYS . 54.0 m -81.78 -40.06 23.18 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 120.936 -1.102 . . . . 0.0 109.275 179.844 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 132' ' ' ASN . . . . . 0.575 ' ND2' ' O ' ' A' ' 81' ' ' ALA . 32.1 t30 -91.88 13.56 18.11 Favored 'General case' 0 N--CA 1.496 1.854 0 C-N-CA 119.61 -0.836 . . . . 0.0 111.783 -178.781 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 133' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -68.15 -33.51 74.61 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 120.49 -1.381 . . . . 0.0 109.402 -179.696 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 134' ' ' LYS . . . . . 0.603 ' H ' ' CD ' ' A' ' 134' ' ' LYS . 0.0 OUTLIER -44.66 -25.41 0.28 Allowed 'General case' 0 N--CA 1.494 1.734 0 O-C-N 121.35 -0.844 . . . . 0.0 110.625 -179.977 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 135' ' ' ALA . . . . . . . . . . . . . . . -82.31 -29.83 30.87 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.087 -1.008 . . . . 0.0 110.651 -178.623 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 136' ' ' ALA . . . . . . . . . . . . . . . -79.91 145.24 32.77 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.034 -1.041 . . . . 0.0 111.496 -178.639 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 137' ' ' LYS . . . . . 0.586 ' CG ' ' H ' ' A' ' 138' ' ' LYS . 0.5 OUTLIER -153.18 -167.69 2.8 Favored 'General case' 0 N--CA 1.496 1.828 0 C-N-CA 118.676 -1.209 . . . . 0.0 110.698 -177.994 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 138' ' ' LYS . . . . . 0.596 ' O ' ' N ' ' A' ' 140' ' ' SER . 22.1 mtmt -44.09 178.77 0.0 OUTLIER 'General case' 0 N--CA 1.487 1.407 0 CA-C-O 122.335 1.064 . . . . 0.0 110.709 -179.197 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 139' ' ' GLY . . . . . . . . . . . . . . . 46.1 7.88 0.02 OUTLIER Glycine 0 N--CA 1.487 2.057 0 N-CA-C 110.526 -1.03 . . . . 0.0 110.526 179.593 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 140' ' ' SER . . . . . 0.596 ' N ' ' O ' ' A' ' 138' ' ' LYS . 38.2 t -92.57 135.63 33.91 Favored 'General case' 0 N--CA 1.494 1.748 0 O-C-N 120.706 -1.467 . . . . 0.0 109.293 179.318 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 141' ' ' MET . . . . . 0.673 ' SD ' ' N ' ' A' ' 142' ' ' VAL . 9.7 tpp -87.94 132.7 34.13 Favored 'General case' 0 C--N 1.299 -1.608 0 O-C-N 121.246 -0.908 . . . . 0.0 109.621 179.94 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 142' ' ' VAL . . . . . 0.673 ' N ' ' SD ' ' A' ' 141' ' ' MET . 2.3 t -115.51 136.51 52.08 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.457 0 N-CA-C 108.068 -1.086 . . . . 0.0 108.068 179.875 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 143' ' ' TYR . . . . . . . . . . . . . 10.0 m-85 -115.73 137.64 51.89 Favored 'General case' 0 N--CA 1.499 2.016 0 O-C-N 121.021 -1.049 . . . . 0.0 111.758 -178.1 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 144' ' ' PHE . . . . . . . . . . . . . 12.6 t80 -122.16 107.93 12.73 Favored 'General case' 0 N--CA 1.492 1.665 0 CA-C-O 121.322 0.582 . . . . 0.0 109.5 -179.951 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 145' ' ' LYS . . . . . . . . . . . . . 1.6 tttp -95.46 131.78 41.24 Favored 'General case' 0 N--CA 1.493 1.684 0 O-C-N 121.333 -0.854 . . . . 0.0 110.371 -179.291 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 146' ' ' VAL . . . . . 0.45 ' O ' ' C ' ' A' ' 147' ' ' GLY . 0.7 OUTLIER -144.54 141.23 23.94 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.644 0 N-CA-C 107.9 -1.148 . . . . 0.0 107.9 178.667 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 147' ' ' GLY . . . . . 0.45 ' C ' ' O ' ' A' ' 146' ' ' VAL . . . 42.56 -127.57 4.77 Favored Glycine 0 N--CA 1.49 2.28 0 N-CA-C 109.394 -1.482 . . . . 0.0 109.394 -179.821 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 148' ' ' ASN . . . . . 0.511 ' C ' HD21 ' A' ' 148' ' ' ASN . 0.4 OUTLIER -103.01 14.62 31.51 Favored 'General case' 0 C--N 1.3 -1.566 0 O-C-N 121.418 -1.048 . . . . 0.0 108.47 179.365 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 149' ' ' GLU . . . . . . . . . . . . . 3.6 tt0 -110.85 143.77 40.92 Favored 'General case' 0 N--CA 1.488 1.442 0 CA-C-O 122.031 0.919 . . . . 0.0 111.26 -178.589 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 150' ' ' THR . . . . . . . . . . . . . 6.4 m -127.22 102.18 6.82 Favored 'General case' 0 N--CA 1.49 1.544 0 CA-C-O 121.395 0.617 . . . . 0.0 109.452 179.896 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 151' ' ' ARG . . . . . . . . . . . . . 22.1 mtt180 -87.6 -178.33 6.08 Favored 'General case' 0 C--N 1.305 -1.368 0 N-CA-C 108.459 -0.941 . . . . 0.0 108.459 179.789 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 152' ' ' LYS . . . . . 0.447 ' C ' ' CD1' ' A' ' 153' ' ' TYR . 22.6 mtmt -148.8 152.51 36.66 Favored 'General case' 0 C--N 1.3 -1.57 0 C-N-CA 119.303 -0.959 . . . . 0.0 110.024 -179.677 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 153' ' ' TYR . . . . . 0.557 ' O ' ' SD ' ' A' ' 141' ' ' MET . 42.1 m-85 -144.23 157.19 44.42 Favored 'General case' 0 C--N 1.3 -1.565 0 N-CA-C 107.987 -1.116 . . . . 0.0 107.987 179.137 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 154' ' ' LYS . . . . . . . . . . . . . 26.1 ttpt -132.1 118.33 19.48 Favored 'General case' 0 C--N 1.297 -1.684 0 N-CA-C 108.514 -0.921 . . . . 0.0 108.514 179.529 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 155' ' ' MET . . . . . . . . . . . . . 15.0 mtp -45.33 105.64 0.06 Allowed 'General case' 0 N--CA 1.489 1.496 0 CA-C-O 122.284 1.04 . . . . 0.0 111.632 -178.494 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 156' ' ' THR . . . . . 0.424 ' H ' ' HG1' ' A' ' 156' ' ' THR . 0.2 OUTLIER -105.7 -25.25 12.31 Favored 'General case' 0 C--N 1.295 -1.786 0 CA-C-N 115.37 -0.832 . . . . 0.0 110.538 -178.803 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 157' ' ' SER . . . . . 0.484 ' O ' ' N ' ' A' ' 201' ' ' VAL . 0.0 OUTLIER -152.93 155.73 37.56 Favored 'General case' 0 N--CA 1.496 1.835 0 C-N-CA 118.456 -1.298 . . . . 0.0 110.914 -178.684 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 158' ' ' ILE . . . . . 0.423 HG12 ' N ' ' A' ' 159' ' ' ARG . 0.0 OUTLIER -154.52 146.7 13.61 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.561 0 CA-C-O 121.812 0.815 . . . . 0.0 110.857 -178.998 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 159' ' ' ARG . . . . . 0.508 ' O ' ' OD1' ' A' ' 160' ' ' ASP . 1.6 tpt180 -148.83 167.84 24.58 Favored 'General case' 0 N--CA 1.491 1.589 0 CA-C-O 121.448 0.642 . . . . 0.0 109.755 -179.659 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 160' ' ' ASP . . . . . 0.508 ' OD1' ' O ' ' A' ' 159' ' ' ARG . 6.5 m-20 -140.5 163.29 33.22 Favored 'General case' 0 N--CA 1.493 1.71 0 O-C-N 121.488 -0.757 . . . . 0.0 108.976 -179.388 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 161' ' ' VAL . . . . . 0.492 ' CG2' ' N ' ' A' ' 162' ' ' LYS . 11.8 p -165.49 169.05 0.36 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.708 0 O-C-N 120.906 -1.121 . . . . 0.0 111.277 179.894 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 162' ' ' LYS . . . . . 0.581 ' N ' ' CD ' ' A' ' 162' ' ' LYS . 0.0 OUTLIER -60.82 174.0 0.59 Allowed Pre-proline 0 N--CA 1.492 1.643 0 N-CA-C 109.099 -0.704 . . . . 0.0 109.099 178.771 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 163' ' ' PRO . . . . . . . . . . . . . 59.2 Cg_endo -82.2 42.92 1.4 Allowed 'Trans proline' 0 C--N 1.311 -1.416 0 C-N-CA 122.444 2.096 . . . . 0.0 112.855 -179.324 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 164' ' ' THR . . . . . . . . . . . . . 24.0 m -151.74 -11.58 0.2 Allowed 'General case' 0 N--CA 1.494 1.748 0 O-C-N 120.93 -1.106 . . . . 0.0 111.081 179.788 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 165' ' ' ASP . . . . . . . . . . . . . 37.0 t70 -78.82 67.77 4.62 Favored 'General case' 0 N--CA 1.492 1.67 0 O-C-N 120.771 -1.206 . . . . 0.0 110.684 -179.549 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 166' ' ' VAL . . . . . 0.652 ' O ' ' N ' ' A' ' 168' ' ' VAL . 0.9 OUTLIER -47.54 -35.07 3.93 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.479 0 O-C-N 120.828 -1.17 . . . . 0.0 109.44 -179.097 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 167' ' ' GLY . . . . . 0.439 ' C ' ' O ' ' A' ' 166' ' ' VAL . . . -42.37 -13.65 0.01 OUTLIER Glycine 0 N--CA 1.496 2.651 0 C-N-CA 119.937 -1.125 . . . . 0.0 110.389 179.958 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 168' ' ' VAL . . . . . 0.652 ' N ' ' O ' ' A' ' 166' ' ' VAL . 9.3 p -53.79 -28.23 16.4 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.408 0 O-C-N 120.782 -1.422 . . . . 0.0 109.108 179.849 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 169' ' ' LEU . . . . . 0.514 ' O ' ' C ' ' A' ' 170' ' ' ASP . 1.4 mt -45.87 -19.66 0.07 Allowed 'General case' 0 N--CA 1.496 1.857 0 N-CA-C 107.068 -1.456 . . . . 0.0 107.068 -178.298 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 170' ' ' ASP . . . . . 0.581 ' O ' ' ND2' ' A' ' 114' ' ' ASN . 19.4 t0 27.32 91.09 0.01 OUTLIER 'General case' 0 N--CA 1.497 1.892 0 CA-C-N 116.392 -0.367 . . . . 0.0 111.486 177.399 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 171' ' ' GLU . . . . . . . . . . . . . 4.8 pt-20 -136.83 73.98 1.47 Allowed 'General case' 0 N--CA 1.493 1.71 0 O-C-N 120.967 -1.083 . . . . 0.0 110.252 179.663 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 172' ' ' GLN . . . . . . . . . . . . . 16.8 mm-40 -130.94 -48.41 1.02 Allowed 'General case' 0 N--CA 1.495 1.783 0 O-C-N 121.558 -0.714 . . . . 0.0 110.564 -178.745 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 173' ' ' LYS . . . . . . . . . . . . . 7.2 mttp -58.8 133.94 56.43 Favored 'General case' 0 N--CA 1.492 1.669 0 O-C-N 120.926 -1.109 . . . . 0.0 108.988 -179.869 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 174' ' ' GLY . . . . . 0.571 ' O ' ' C ' ' A' ' 175' ' ' LYS . . . -130.45 -43.57 0.19 Allowed Glycine 0 C--N 1.299 -1.486 0 N-CA-C 108.363 -1.895 . . . . 0.0 108.363 179.567 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 175' ' ' LYS . . . . . 0.571 ' C ' ' O ' ' A' ' 174' ' ' GLY . 32.6 mmtt -33.78 -63.34 0.27 Allowed 'General case' 0 N--CA 1.496 1.831 0 N-CA-C 107.843 -1.169 . . . . 0.0 107.843 179.658 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 176' ' ' ASP . . . . . 0.618 ' O ' ' O ' ' A' ' 177' ' ' LYS . 15.8 m-20 -104.54 86.27 2.48 Favored 'General case' 0 C--N 1.294 -1.805 0 N-CA-C 107.406 -1.331 . . . . 0.0 107.406 176.854 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 177' ' ' LYS . . . . . 0.618 ' O ' ' O ' ' A' ' 176' ' ' ASP . 29.3 mtmt -39.25 176.65 0.0 OUTLIER 'General case' 0 N--CA 1.501 2.081 0 O-C-N 121.507 -0.746 . . . . 0.0 110.431 -179.053 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 178' ' ' GLN . . . . . 0.597 ' NE2' ' ND2' ' A' ' 114' ' ' ASN . 0.0 OUTLIER -161.88 176.35 10.93 Favored 'General case' 0 N--CA 1.488 1.434 0 O-C-N 120.431 -1.418 . . . . 0.0 111.365 -179.999 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 179' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -130.28 98.03 4.6 Favored 'General case' 0 N--CA 1.487 1.424 0 N-CA-C 107.105 -1.443 . . . . 0.0 107.105 178.191 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 180' ' ' THR . . . . . . . . . . . . . 1.1 m -71.42 119.89 16.22 Favored 'General case' 0 C--N 1.303 -1.448 0 O-C-N 121.06 -1.025 . . . . 0.0 110.193 -178.381 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 181' ' ' LEU . . . . . 0.429 ' CD1' ' N ' ' A' ' 182' ' ' ILE . 1.1 tm? -89.85 140.55 29.49 Favored 'General case' 0 C--N 1.303 -1.436 0 N-CA-C 106.91 -1.515 . . . . 0.0 106.91 177.456 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 182' ' ' ILE . . . . . 0.429 ' N ' ' CD1' ' A' ' 181' ' ' LEU . 5.3 mt -136.54 117.42 18.13 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.753 0 O-C-N 120.92 -1.112 . . . . 0.0 108.008 178.709 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 183' ' ' THR . . . . . . . . . . . . . 1.4 t -144.7 114.72 7.4 Favored 'General case' 0 C--N 1.287 -2.11 0 N-CA-C 107.84 -1.17 . . . . 0.0 107.84 -179.538 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 184' ' ' CYS . . . . . . . . . . . . . 0.7 OUTLIER -79.41 163.73 24.57 Favored 'General case' 0 C--N 1.288 -2.076 0 C-N-CA 118.762 -1.175 . . . . 0.0 110.649 -178.092 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 185' ' ' ASP . . . . . . . . . . . . . 4.8 t70 -165.18 -154.42 0.22 Allowed 'General case' 0 N--CA 1.492 1.658 0 N-CA-C 109.232 -0.655 . . . . 0.0 109.232 -179.672 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 186' ' ' ASP . . . . . . . . . . . . . 1.1 m-20 51.04 60.91 3.54 Favored 'General case' 0 N--CA 1.494 1.743 0 O-C-N 121.081 -1.012 . . . . 0.0 108.409 -179.246 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 187' ' ' TYR . . . . . 0.595 ' CE1' ' O ' ' A' ' 188' ' ' ASN . 50.7 t80 -67.78 134.37 50.86 Favored 'General case' 0 N--CA 1.49 1.544 0 CA-C-O 122.052 0.929 . . . . 0.0 111.591 -178.679 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 188' ' ' ASN . . . . . 0.595 ' O ' ' CE1' ' A' ' 187' ' ' TYR . 0.8 OUTLIER -100.78 146.15 27.63 Favored 'General case' 0 C--N 1.297 -1.7 0 N-CA-C 107.929 -1.137 . . . . 0.0 107.929 177.923 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 189' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -112.69 -14.78 13.1 Favored 'General case' 0 C--N 1.297 -1.706 0 N-CA-C 108.604 -0.887 . . . . 0.0 108.604 -179.712 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 190' ' ' LYS . . . . . . . . . . . . . 12.8 mttm -83.58 -49.87 8.79 Favored 'General case' 0 C--N 1.301 -1.505 0 N-CA-C 108.595 -0.891 . . . . 0.0 108.595 178.729 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 191' ' ' THR . . . . . . . . . . . . . 6.5 p -88.86 -11.99 43.12 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.432 -0.792 . . . . 0.0 108.916 179.454 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 192' ' ' GLY . . . . . . . . . . . . . . . 67.89 34.6 82.8 Favored Glycine 0 N--CA 1.493 2.438 0 O-C-N 121.309 -0.869 . . . . 0.0 111.059 178.561 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 193' ' ' VAL . . . . . . . . . . . . . 3.5 p -148.12 167.96 4.15 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.543 0 O-C-N 120.789 -1.418 . . . . 0.0 110.216 179.382 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 194' ' ' TRP . . . . . . . . . . . . . 36.7 m95 -84.89 120.85 26.94 Favored 'General case' 0 C--N 1.296 -1.74 0 N-CA-C 109.058 -0.719 . . . . 0.0 109.058 179.991 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 195' ' ' GLU . . . . . 0.546 ' CD ' ' ND2' ' A' ' 188' ' ' ASN . 3.8 mt-10 -84.99 -61.05 1.87 Allowed 'General case' 0 N--CA 1.496 1.865 0 O-C-N 121.268 -0.895 . . . . 0.0 111.089 -178.657 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 196' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -83.98 154.32 23.38 Favored 'General case' 0 N--CA 1.491 1.575 0 O-C-N 120.903 -1.123 . . . . 0.0 110.05 -178.917 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 197' ' ' ARG . . . . . 0.636 ' CG ' HH11 ' A' ' 197' ' ' ARG . 0.0 OUTLIER -126.89 140.17 52.53 Favored 'General case' 0 N--CA 1.489 1.482 0 N-CA-C 109.019 -0.734 . . . . 0.0 109.019 179.583 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 198' ' ' LYS . . . . . . . . . . . . . 23.4 mttt -114.58 121.17 42.61 Favored 'General case' 0 C--N 1.302 -1.478 0 O-C-N 121.793 -0.567 . . . . 0.0 110.2 -178.929 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 199' ' ' ILE . . . . . 0.493 ' O ' HG13 ' A' ' 199' ' ' ILE . 0.8 OUTLIER -139.22 118.21 13.07 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.576 0 CA-C-O 122.809 1.29 . . . . 0.0 110.16 179.553 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 200' ' ' PHE . . . . . 0.501 ' CD1' ' N ' ' A' ' 200' ' ' PHE . 5.7 m-85 -101.0 137.03 39.91 Favored 'General case' 0 N--CA 1.495 1.814 0 O-C-N 120.707 -1.245 . . . . 0.0 110.276 -178.265 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 201' ' ' VAL . . . . . 0.484 ' N ' ' O ' ' A' ' 157' ' ' SER . 70.2 t -102.2 140.5 20.53 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.545 0 N-CA-C 108.09 -1.078 . . . . 0.0 108.09 177.465 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 202' ' ' ALA . . . . . . . . . . . . . . . -130.11 138.08 50.5 Favored 'General case' 0 C--N 1.301 -1.517 0 O-C-N 121.194 -0.941 . . . . 0.0 108.998 -179.66 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 203' ' ' THR . . . . . 0.459 ' H ' ' HG1' ' A' ' 203' ' ' THR . 1.9 p -88.94 136.34 33.06 Favored 'General case' 0 C--N 1.306 -1.3 0 CA-C-O 122.474 1.13 . . . . 0.0 111.213 -178.276 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 204' ' ' GLU . . . . . 0.439 ' HA ' ' CD2' ' A' ' 153' ' ' TYR . 2.5 tt0 -60.22 134.06 56.69 Favored 'General case' 0 C--N 1.297 -1.686 0 CA-C-N 115.039 -0.982 . . . . 0.0 110.642 -179.915 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 205' ' ' VAL . . . . . 0.446 ' O ' ' OXT' ' A' ' 206' ' ' LYS . 42.2 t -121.11 -13.69 8.06 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.55 0 N-CA-C 107.997 -1.112 . . . . 0.0 107.997 179.247 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 206' ' ' LYS . . . . . 0.446 ' OXT' ' O ' ' A' ' 205' ' ' VAL . 0.1 OUTLIER . . . . . 0 N--CA 1.489 1.499 0 CA-C-O 118.029 -0.986 . . . . 0.0 109.674 -179.671 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' C' C ' 701' ' ' PHQ . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 014 nuclear orig full ' C' C ' 702' ' ' LEU . . . . . 0.65 ' CD1' ' N ' ' C' ' 702' ' ' LEU . 0.0 OUTLIER . . . . . 0 N--CA 1.491 1.599 0 N-CA-C 109.016 -0.735 . . . . 0.0 109.016 . . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' C' C ' 703' ' ' PRO . . . . . 0.487 ' O ' ' O ' ' C' ' 702' ' ' LEU . 52.6 Cg_exo -46.41 -176.71 0.0 OUTLIER 'Trans proline' 0 N--CA 1.49 1.287 0 C-N-CA 122.023 1.816 . . . . 0.0 112.239 -179.379 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' C' C ' 704' ' ' ALA . . . . . . . . . . . . . . . 49.87 -164.06 0.04 OUTLIER 'General case' 0 N--CA 1.488 1.443 0 O-C-N 121.37 -0.831 . . . . 0.0 109.231 -179.905 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' C' C ' 705' ' ' B27 . . . . . 0.412 ' OG1' ' NE2' ' A' ' 120' ' ' HIS . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 700' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 015 nuclear orig full ' A' A ' 59' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.491 1.578 0 N-CA-C 109.432 -0.581 . . . . 0.0 109.432 . . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 60' ' ' GLN . . . . . . . . . . . . . 14.6 mm100 -60.48 -159.36 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.315 -0.866 . . . . 0.0 109.569 -179.916 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . -64.48 152.04 42.76 Favored 'General case' 0 N--CA 1.488 1.473 0 O-C-N 121.29 -0.881 . . . . 0.0 109.381 179.914 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 62' ' ' LYS . . . . . . . . . . . . . 5.4 tptt -138.66 72.04 43.05 Favored Pre-proline 0 N--CA 1.49 1.549 0 O-C-N 121.314 -0.866 . . . . 0.0 109.248 -179.72 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 63' ' ' PRO . . . . . . . . . . . . . 95.0 Cg_endo -88.95 153.81 5.87 Favored 'Trans proline' 0 C--N 1.306 -1.692 0 C-N-CA 123.703 2.936 . . . . 0.0 111.975 -179.89 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 64' ' ' GLN . . . . . 0.651 ' NE2' ' N ' ' A' ' 64' ' ' GLN . 0.0 OUTLIER -153.49 120.16 5.62 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.158 -0.964 . . . . 0.0 109.424 179.537 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 65' ' ' ILE . . . . . 0.444 ' C ' ' O ' ' A' ' 64' ' ' GLN . 2.9 mp -45.32 106.41 0.54 Allowed Pre-proline 0 N--CA 1.489 1.51 0 N-CA-C 107.874 -1.158 . . . . 0.0 107.874 179.079 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 66' ' ' PRO . . . . . . . . . . . . . 61.3 Cg_endo -77.64 -162.82 0.18 Allowed 'Trans proline' 0 N--CA 1.49 1.285 0 C-N-CA 122.113 1.875 . . . . 0.0 113.171 -178.075 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 67' ' ' LYS . . . . . . . . . . . . . 7.0 ttpt -84.75 -7.86 59.05 Favored 'General case' 0 N--CA 1.488 1.447 0 O-C-N 121.603 -0.686 . . . . 0.0 109.388 -179.74 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 68' ' ' ASP . . . . . 0.645 ' C ' ' N ' ' A' ' 70' ' ' SER . 1.0 OUTLIER -76.9 62.75 2.14 Favored 'General case' 0 N--CA 1.489 1.478 0 CA-C-O 122.756 1.265 . . . . 0.0 109.259 179.801 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 69' ' ' LYS . . . . . 0.463 ' C ' ' O ' ' A' ' 68' ' ' ASP . 0.9 OUTLIER -47.61 -13.36 0.04 OUTLIER 'General case' 0 N--CA 1.511 2.584 0 C-N-CA 116.926 -1.91 . . . . 0.0 106.79 177.397 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 70' ' ' SER . . . . . 0.645 ' N ' ' C ' ' A' ' 68' ' ' ASP . 0.0 OUTLIER -87.58 -3.14 58.99 Favored 'General case' 0 N--CA 1.498 1.944 0 CA-C-N 113.592 -1.64 . . . . 0.0 111.805 179.448 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 71' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -99.18 141.79 31.5 Favored 'General case' 0 N--CA 1.504 2.273 0 O-C-N 120.472 -1.393 . . . . 0.0 112.606 -178.941 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 72' ' ' VAL . . . . . 0.53 ' CG2' ' O ' ' A' ' 74' ' ' GLY . 0.2 OUTLIER -66.37 127.67 28.1 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.38 0 N-CA-C 104.551 -2.389 . . . . 0.0 104.551 174.397 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 73' ' ' ALA . . . . . 0.585 ' N ' ' O ' ' A' ' 87' ' ' VAL . . . -80.08 -13.71 59.08 Favored 'General case' 0 C--N 1.295 -1.783 0 O-C-N 120.165 -1.585 . . . . 0.0 108.381 -178.536 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 74' ' ' GLY . . . . . 0.53 ' O ' ' CG2' ' A' ' 72' ' ' VAL . . . 171.55 -155.42 24.11 Favored Glycine 0 N--CA 1.484 1.851 0 C-N-CA 118.759 -1.686 . . . . 0.0 110.819 179.23 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 75' ' ' TYR . . . . . . . . . . . . . 6.2 m-85 -144.29 169.22 18.32 Favored 'General case' 0 C--N 1.298 -1.647 0 O-C-N 121.639 -0.918 . . . . 0.0 110.79 -177.333 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 76' ' ' ILE . . . . . . . . . . . . . 0.8 OUTLIER -149.85 147.67 16.05 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.59 0 C-N-CA 119.902 -0.719 . . . . 0.0 109.414 -178.136 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -149.25 164.76 33.9 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 120.971 -1.081 . . . . 0.0 109.731 179.558 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 78' ' ' ILE . . . . . 0.522 ' O ' ' N ' ' A' ' 82' ' ' ASP . 32.6 mt -146.1 94.76 4.88 Favored Pre-proline 0 N--CA 1.489 1.517 0 N-CA-C 108.482 -0.933 . . . . 0.0 108.482 -179.808 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 79' ' ' PRO . . . . . . . . . . . . . 51.2 Cg_exo -49.02 -46.37 25.57 Favored 'Trans proline' 0 C--N 1.31 -1.451 0 C-N-CA 122.604 2.203 . . . . 0.0 113.622 -178.764 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 80' ' ' ASP . . . . . 0.553 ' OD1' ' N ' ' A' ' 80' ' ' ASP . 0.0 OUTLIER -65.41 -19.79 66.1 Favored 'General case' 0 N--CA 1.493 1.716 0 O-C-N 120.821 -1.174 . . . . 0.0 110.445 178.551 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 81' ' ' ALA . . . . . 0.624 ' O ' ' ND2' ' A' ' 132' ' ' ASN . . . -106.33 -16.95 14.43 Favored 'General case' 0 N--CA 1.491 1.624 0 N-CA-C 108.361 -0.978 . . . . 0.0 108.361 179.33 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 82' ' ' ASP . . . . . 0.522 ' N ' ' O ' ' A' ' 78' ' ' ILE . 3.4 t70 66.52 51.61 1.12 Allowed 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.367 -0.833 . . . . 0.0 110.761 179.07 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 83' ' ' ILE . . . . . 0.479 ' CD1' ' OD1' ' A' ' 132' ' ' ASN . 89.5 mt -129.31 153.9 39.35 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.843 0 O-C-N 121.185 -0.947 . . . . 0.0 110.052 -179.282 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 84' ' ' LYS . . . . . . . . . . . . . 22.9 tttt -158.13 109.0 2.17 Favored 'General case' 0 N--CA 1.491 1.613 0 N-CA-C 107.646 -1.242 . . . . 0.0 107.646 179.372 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 85' ' ' GLU . . . . . 0.504 ' OE1' ' O ' ' A' ' 128' ' ' TYR . 0.0 OUTLIER -141.43 165.17 30.4 Favored Pre-proline 0 N--CA 1.495 1.808 0 O-C-N 121.044 -1.035 . . . . 0.0 110.798 -178.118 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 86' ' ' PRO . . . . . . . . . . . . . 59.3 Cg_endo -74.52 161.58 39.64 Favored 'Trans proline' 0 N--CA 1.495 1.603 0 C-N-CA 123.404 2.736 . . . . 0.0 113.549 -179.362 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 87' ' ' VAL . . . . . 0.585 ' O ' ' N ' ' A' ' 73' ' ' ALA . 58.6 t -120.05 99.97 8.55 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.683 0 N-CA-C 109.294 -0.632 . . . . 0.0 109.294 179.588 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 88' ' ' TYR . . . . . 0.43 ' CD2' ' CD ' ' A' ' 99' ' ' ARG . 19.5 m-85 -92.09 154.9 43.32 Favored Pre-proline 0 N--CA 1.504 2.232 0 O-C-N 120.777 -1.202 . . . . 0.0 110.276 -179.479 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 89' ' ' PRO . . . . . . . . . . . . . 11.4 Cg_endo -60.2 143.65 99.52 Favored 'Trans proline' 0 N--CA 1.495 1.559 0 C-N-CA 122.741 2.294 . . . . 0.0 113.517 -179.902 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . -59.85 168.55 7.88 Favored Glycine 0 N--CA 1.496 2.654 0 N-CA-C 109.444 -1.462 . . . . 0.0 109.444 179.271 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 91' ' ' PRO . . . . . 0.471 ' C ' ' H ' ' A' ' 93' ' ' THR . 55.6 Cg_endo -93.32 169.78 20.36 Favored 'Cis proline' 0 C--N 1.309 -1.53 0 C-N-CA 123.941 -1.274 . . . . 0.0 111.941 0.168 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 92' ' ' ALA . . . . . 0.555 ' O ' ' CD1' ' A' ' 97' ' ' LEU . . . -72.28 32.52 0.06 Allowed 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.081 -1.012 . . . . 0.0 110.398 -179.903 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 93' ' ' THR . . . . . 0.5 ' OG1' ' OE1' ' A' ' 96' ' ' GLN . 3.1 p -74.81 150.67 86.39 Favored Pre-proline 0 C--N 1.3 -1.548 0 O-C-N 120.485 -1.384 . . . . 0.0 108.487 179.993 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 94' ' ' PRO . . . . . 0.403 ' C ' ' O ' ' A' ' 93' ' ' THR . 82.0 Cg_exo -30.69 -52.32 0.23 Allowed 'Trans proline' 0 C--N 1.308 -1.569 0 C-N-CA 123.18 2.587 . . . . 0.0 113.022 -179.034 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 4.9 mm-40 -49.55 -49.3 46.81 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.09 -1.006 . . . . 0.0 109.688 -179.833 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 96' ' ' GLN . . . . . 0.57 ' O ' ' N ' ' A' ' 98' ' ' ASN . 12.5 mp0 -73.53 -54.35 8.42 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 120.96 -1.088 . . . . 0.0 110.452 -179.644 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 97' ' ' LEU . . . . . 0.555 ' CD1' ' O ' ' A' ' 92' ' ' ALA . 95.8 mt -47.2 -9.32 0.02 OUTLIER 'General case' 0 N--CA 1.495 1.818 0 O-C-N 121.185 -0.947 . . . . 0.0 110.279 -178.793 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 98' ' ' ASN . . . . . 0.57 ' N ' ' O ' ' A' ' 96' ' ' GLN . 0.0 OUTLIER -74.86 -26.04 59.4 Favored 'General case' 0 N--CA 1.493 1.686 0 O-C-N 121.115 -0.991 . . . . 0.0 109.126 179.727 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 99' ' ' ARG . . . . . 0.564 HH11 ' CG ' ' A' ' 99' ' ' ARG . 0.3 OUTLIER -91.1 -56.11 3.28 Favored 'General case' 0 C--N 1.301 -1.527 0 O-C-N 121.796 -0.565 . . . . 0.0 109.642 -179.484 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . -179.46 -165.36 33.47 Favored Glycine 0 N--CA 1.49 2.283 0 N-CA-C 109.949 -1.26 . . . . 0.0 109.949 179.89 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 101' ' ' VAL . . . . . . . . . . . . . 28.9 m -59.23 105.95 0.22 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.64 0 O-C-N 121.325 -1.103 . . . . 0.0 109.696 -179.731 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -91.63 169.04 11.06 Favored 'General case' 0 N--CA 1.495 1.777 0 O-C-N 121.224 -0.922 . . . . 0.0 110.864 -179.308 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 103' ' ' PHE . . . . . 0.559 ' O ' ' N ' ' A' ' 105' ' ' GLU . 26.0 m-85 -72.74 122.43 21.49 Favored 'General case' 0 N--CA 1.493 1.721 0 N-CA-C 108.123 -1.065 . . . . 0.0 108.123 178.469 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 104' ' ' ALA . . . . . 0.404 ' C ' ' O ' ' A' ' 103' ' ' PHE . . . -39.67 -20.51 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.526 -0.734 . . . . 0.0 111.716 -178.388 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 105' ' ' GLU . . . . . 0.559 ' N ' ' O ' ' A' ' 103' ' ' PHE . 13.4 pt-20 -139.51 148.71 43.01 Favored 'General case' 0 N--CA 1.498 1.943 0 O-C-N 120.673 -1.267 . . . . 0.0 110.696 -179.479 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 106' ' ' GLU . . . . . . . . . . . . . 8.8 tt0 -56.79 -62.5 1.7 Allowed 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.91 -0.494 . . . . 0.0 111.76 -178.575 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 107' ' ' ASN . . . . . 0.588 ' N ' HD21 ' A' ' 107' ' ' ASN . 1.0 OUTLIER -76.62 33.5 0.14 Allowed 'General case' 0 N--CA 1.492 1.65 0 O-C-N 120.533 -1.354 . . . . 0.0 112.782 -175.247 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 108' ' ' GLU . . . . . 0.499 ' OE1' ' OE2' ' A' ' 105' ' ' GLU . 38.3 tp10 -60.24 146.67 42.88 Favored 'General case' 0 N--CA 1.488 1.466 0 O-C-N 120.776 -1.202 . . . . 0.0 107.906 179.821 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 109' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -97.8 144.31 27.52 Favored 'General case' 0 N--CA 1.488 1.468 0 O-C-N 120.923 -1.111 . . . . 0.0 110.806 -178.243 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 110' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -61.99 -21.05 64.53 Favored 'General case' 0 C--N 1.302 -1.46 0 N-CA-C 107.734 -1.21 . . . . 0.0 107.734 179.037 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 111' ' ' ASP . . . . . . . . . . . . . 75.5 m-20 -132.62 44.79 2.83 Favored 'General case' 0 N--CA 1.488 1.451 0 CA-C-O 121.388 0.613 . . . . 0.0 109.363 179.63 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 112' ' ' ASP . . . . . . . . . . . . . 1.1 t0 -68.64 157.38 36.3 Favored 'General case' 0 N--CA 1.493 1.685 0 O-C-N 121.195 -0.941 . . . . 0.0 111.232 -179.7 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 113' ' ' GLN . . . . . 0.541 ' N ' ' CD ' ' A' ' 113' ' ' GLN . 0.0 OUTLIER -65.92 -15.7 63.2 Favored 'General case' 0 N--CA 1.492 1.653 0 N-CA-C 107.387 -1.338 . . . . 0.0 107.387 177.495 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 114' ' ' ASN . . . . . 0.496 ' O ' ' CG ' ' A' ' 114' ' ' ASN . 11.8 p-10 -150.31 108.29 3.72 Favored 'General case' 0 C--N 1.298 -1.655 0 N-CA-C 107.72 -1.215 . . . . 0.0 107.72 178.054 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 115' ' ' ILE . . . . . 0.444 ' CD1' HH22 ' A' ' 151' ' ' ARG . 2.9 mt -94.38 102.48 13.66 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.63 0 N-CA-C 107.437 -1.32 . . . . 0.0 107.437 179.61 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 116' ' ' SER . . . . . . . . . . . . . 9.0 p -88.87 150.46 22.87 Favored 'General case' 0 C--N 1.303 -1.419 0 CA-C-O 121.997 0.903 . . . . 0.0 111.483 -177.476 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 117' ' ' ILE . . . . . . . . . . . . . 1.4 mt -147.68 145.82 18.6 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.458 0 N-CA-C 107.34 -1.355 . . . . 0.0 107.34 178.762 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 118' ' ' ALA . . . . . . . . . . . . . . . -141.96 159.39 42.32 Favored 'General case' 0 N--CA 1.494 1.726 0 O-C-N 120.789 -1.194 . . . . 0.0 111.348 -178.434 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 119' ' ' GLY . . . . . . . . . . . . . . . -171.02 153.24 20.3 Favored Glycine 0 N--CA 1.487 2.096 0 N-CA-C 110.097 -1.201 . . . . 0.0 110.097 179.873 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 120' ' ' HIS . . . . . . . . . . . . . 12.0 m170 -71.19 167.97 18.25 Favored 'General case' 0 N--CA 1.493 1.713 0 O-C-N 121.724 -0.868 . . . . 0.0 109.944 179.378 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 121' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -117.37 158.3 24.66 Favored 'General case' 0 N--CA 1.496 1.831 0 N-CA-C 108.094 -1.076 . . . . 0.0 108.094 178.76 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 122' ' ' PHE . . . . . . . . . . . . . 3.8 m-85 -141.91 123.21 14.79 Favored 'General case' 0 N--CA 1.497 1.911 0 O-C-N 120.867 -1.145 . . . . 0.0 109.805 -179.39 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 123' ' ' ILE . . . . . 0.483 ' CG2' ' N ' ' A' ' 124' ' ' ASP . 14.0 tt -60.38 -41.41 87.22 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.567 0 CA-C-O 121.6 0.714 . . . . 0.0 109.285 179.622 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 124' ' ' ASP . . . . . 0.483 ' N ' ' CG2' ' A' ' 123' ' ' ILE . 0.3 OUTLIER -87.16 22.23 2.14 Favored 'General case' 0 N--CA 1.495 1.808 0 O-C-N 121.693 -0.629 . . . . 0.0 111.955 -177.13 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 125' ' ' ARG . . . . . . . . . . . . . 46.9 mtp180 -155.29 97.12 2.42 Favored Pre-proline 0 N--CA 1.492 1.673 0 O-C-N 120.546 -1.347 . . . . 0.0 109.757 179.763 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 126' ' ' PRO . . . . . . . . . . . . . 2.9 Cg_endo -73.66 -25.76 14.48 Favored 'Trans proline' 0 C--N 1.314 -1.239 0 C-N-CA 122.113 1.876 . . . . 0.0 111.662 178.634 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 127' ' ' ASN . . . . . 0.473 ' O ' ' O ' ' A' ' 128' ' ' TYR . 0.9 OUTLIER -91.2 5.73 47.92 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.429 -0.794 . . . . 0.0 109.736 -179.843 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 128' ' ' TYR . . . . . 0.504 ' O ' ' OE1' ' A' ' 85' ' ' GLU . 4.5 t80 -59.1 -149.27 0.0 OUTLIER 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.192 -0.943 . . . . 0.0 109.936 -179.751 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 129' ' ' GLN . . . . . 0.487 ' O ' ' OE1' ' A' ' 85' ' ' GLU . 63.4 mt-30 -66.79 -72.08 0.18 Allowed 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.439 -0.788 . . . . 0.0 109.614 -179.686 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 130' ' ' PHE . . . . . 0.504 ' O ' ' CE ' ' A' ' 134' ' ' LYS . 52.6 m-85 -133.78 47.8 2.41 Favored 'General case' 0 N--CA 1.492 1.658 0 O-C-N 121.279 -0.888 . . . . 0.0 110.059 -179.741 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 131' ' ' THR . . . . . . . . . . . . . 23.5 m -81.72 -40.82 22.16 Favored 'General case' 0 N--CA 1.489 1.481 0 O-C-N 121.052 -1.03 . . . . 0.0 109.281 179.783 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 132' ' ' ASN . . . . . 0.624 ' ND2' ' O ' ' A' ' 81' ' ' ALA . 0.2 OUTLIER -83.09 2.7 33.92 Favored 'General case' 0 N--CA 1.495 1.785 0 O-C-N 121.364 -0.835 . . . . 0.0 111.377 -178.283 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 133' ' ' LEU . . . . . 0.563 ' O ' ' N ' ' A' ' 135' ' ' ALA . 0.2 OUTLIER -65.6 -46.07 80.75 Favored 'General case' 0 N--CA 1.493 1.681 0 O-C-N 120.549 -1.344 . . . . 0.0 110.359 -179.568 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 134' ' ' LYS . . . . . 0.505 ' H ' ' CD ' ' A' ' 134' ' ' LYS . 0.0 OUTLIER -42.41 -18.15 0.01 OUTLIER 'General case' 0 N--CA 1.494 1.739 0 O-C-N 121.071 -1.018 . . . . 0.0 110.755 -179.185 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 135' ' ' ALA . . . . . 0.563 ' N ' ' O ' ' A' ' 133' ' ' LEU . . . -83.48 -35.39 24.94 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 120.837 -1.164 . . . . 0.0 110.251 -179.506 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 136' ' ' ALA . . . . . . . . . . . . . . . -79.98 155.76 27.51 Favored 'General case' 0 N--CA 1.489 1.51 0 CA-C-O 122.209 1.004 . . . . 0.0 111.889 -178.479 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 137' ' ' LYS . . . . . 0.505 ' O ' ' O ' ' A' ' 138' ' ' LYS . 0.1 OUTLIER -154.32 -165.91 2.21 Favored 'General case' 0 N--CA 1.493 1.725 0 C-N-CA 118.734 -1.186 . . . . 0.0 110.915 -178.44 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 138' ' ' LYS . . . . . 0.579 ' O ' ' N ' ' A' ' 140' ' ' SER . 17.4 mttp -45.44 179.23 0.0 OUTLIER 'General case' 0 C--N 1.305 -1.365 0 CA-C-O 121.987 0.898 . . . . 0.0 110.509 -179.222 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 139' ' ' GLY . . . . . . . . . . . . . . . 47.0 7.77 0.02 OUTLIER Glycine 0 N--CA 1.491 2.304 0 N-CA-C 110.253 -1.139 . . . . 0.0 110.253 -179.849 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 140' ' ' SER . . . . . 0.579 ' N ' ' O ' ' A' ' 138' ' ' LYS . 40.4 t -89.42 141.3 28.68 Favored 'General case' 0 N--CA 1.493 1.699 0 O-C-N 120.858 -1.378 . . . . 0.0 109.591 179.239 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 141' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -90.88 127.73 36.49 Favored 'General case' 0 C--N 1.301 -1.539 0 O-C-N 121.413 -0.805 . . . . 0.0 109.487 179.732 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 142' ' ' VAL . . . . . . . . . . . . . 3.2 t -114.48 133.6 60.07 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.674 0 O-C-N 121.364 -0.835 . . . . 0.0 108.814 179.928 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 143' ' ' TYR . . . . . 0.413 ' CE1' ' CG ' ' A' ' 152' ' ' LYS . 8.5 m-85 -107.9 135.39 49.36 Favored 'General case' 0 N--CA 1.496 1.851 0 O-C-N 121.177 -0.952 . . . . 0.0 111.521 -178.603 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 144' ' ' PHE . . . . . . . . . . . . . 66.8 t80 -115.36 157.21 24.2 Favored 'General case' 0 N--CA 1.493 1.698 0 CA-C-O 121.807 0.813 . . . . 0.0 110.82 -179.185 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 145' ' ' LYS . . . . . . . . . . . . . 55.0 tttt -152.42 130.59 11.94 Favored 'General case' 0 N--CA 1.492 1.642 0 C-N-CA 118.887 -1.125 . . . . 0.0 111.962 -179.309 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 146' ' ' VAL . . . . . . . . . . . . . 1.9 p -145.04 139.95 22.71 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.485 0 N-CA-C 106.24 -1.763 . . . . 0.0 106.24 177.431 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 147' ' ' GLY . . . . . . . . . . . . . . . 53.88 -134.67 43.61 Favored Glycine 0 N--CA 1.488 2.157 0 N-CA-C 108.726 -1.749 . . . . 0.0 108.726 -179.079 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 148' ' ' ASN . . . . . 0.572 ' C ' HD21 ' A' ' 148' ' ' ASN . 0.4 OUTLIER -103.17 22.67 13.65 Favored 'General case' 0 C--N 1.302 -1.496 0 O-C-N 121.234 -1.156 . . . . 0.0 108.71 179.354 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 149' ' ' GLU . . . . . . . . . . . . . 18.4 tt0 -112.44 152.79 28.29 Favored 'General case' 0 N--CA 1.486 1.362 0 CA-C-O 121.752 0.786 . . . . 0.0 111.095 -179.023 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 150' ' ' THR . . . . . . . . . . . . . 1.3 m -141.78 105.13 4.65 Favored 'General case' 0 N--CA 1.493 1.698 0 CA-C-O 121.666 0.746 . . . . 0.0 109.436 179.996 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 151' ' ' ARG . . . . . 0.444 HH22 ' CD1' ' A' ' 115' ' ' ILE . 2.9 mpp_? -88.69 -161.55 0.76 Allowed 'General case' 0 N--CA 1.488 1.453 0 O-C-N 121.659 -0.651 . . . . 0.0 109.706 -179.149 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 152' ' ' LYS . . . . . 0.429 ' O ' ' N ' ' A' ' 205' ' ' VAL . 15.0 mtmm -149.73 146.06 27.01 Favored 'General case' 0 C--N 1.304 -1.381 0 O-C-N 121.211 -0.93 . . . . 0.0 110.139 -178.814 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 153' ' ' TYR . . . . . 0.494 ' CD2' ' HA ' ' A' ' 204' ' ' GLU . 15.0 m-85 -141.06 166.88 23.57 Favored 'General case' 0 N--CA 1.49 1.559 0 N-CA-C 107.922 -1.14 . . . . 0.0 107.922 179.193 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 154' ' ' LYS . . . . . . . . . . . . . 12.7 ttmt -142.8 120.43 11.8 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.236 -0.915 . . . . 0.0 108.576 178.865 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 155' ' ' MET . . . . . . . . . . . . . 44.4 mmm -47.83 107.26 0.11 Allowed 'General case' 0 N--CA 1.493 1.688 0 O-C-N 120.611 -1.306 . . . . 0.0 111.315 -178.626 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 156' ' ' THR . . . . . 0.492 ' OG1' ' OG1' ' A' ' 203' ' ' THR . 0.2 OUTLIER -105.18 -24.44 12.74 Favored 'General case' 0 C--N 1.294 -1.843 0 CA-C-N 115.259 -0.882 . . . . 0.0 110.836 -178.655 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 157' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -146.8 150.5 35.43 Favored 'General case' 0 C--N 1.296 -1.757 0 C-N-CA 118.51 -1.276 . . . . 0.0 110.367 -178.784 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 158' ' ' ILE . . . . . . . . . . . . . 1.9 mt -147.35 137.59 17.13 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.382 0 CA-C-O 121.324 0.583 . . . . 0.0 109.537 -178.459 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 159' ' ' ARG . . . . . 0.488 ' O ' ' OD1' ' A' ' 160' ' ' ASP . 44.7 mtp180 -155.59 -167.71 2.59 Favored 'General case' 0 N--CA 1.492 1.647 0 CA-C-O 121.907 0.86 . . . . 0.0 110.956 -178.799 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 160' ' ' ASP . . . . . 0.488 ' OD1' ' O ' ' A' ' 159' ' ' ARG . 63.8 m-20 -146.71 153.04 39.8 Favored 'General case' 0 N--CA 1.489 1.48 0 N-CA-C 108.183 -1.043 . . . . 0.0 108.183 179.512 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 161' ' ' VAL . . . . . 0.425 ' O ' ' O ' ' A' ' 162' ' ' LYS . 0.1 OUTLIER -143.11 146.54 21.48 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.627 0 O-C-N 120.899 -1.125 . . . . 0.0 109.884 179.939 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 162' ' ' LYS . . . . . 0.617 ' H ' ' CD ' ' A' ' 162' ' ' LYS . 0.0 OUTLIER -45.44 167.13 0.12 Allowed Pre-proline 0 N--CA 1.49 1.526 0 O-C-N 121.285 -0.884 . . . . 0.0 109.391 -179.787 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 163' ' ' PRO . . . . . . . . . . . . . 57.9 Cg_endo -76.54 30.4 0.4 Allowed 'Trans proline' 0 C--N 1.308 -1.574 0 C-N-CA 122.838 2.359 . . . . 0.0 113.387 -179.488 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 164' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -152.29 -0.58 0.3 Allowed 'General case' 0 N--CA 1.495 1.817 0 O-C-N 120.921 -1.112 . . . . 0.0 110.306 179.612 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 165' ' ' ASP . . . . . 0.414 ' O ' ' C ' ' A' ' 166' ' ' VAL . 7.4 t70 -76.85 64.4 2.38 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.12 -0.987 . . . . 0.0 110.16 -179.866 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 166' ' ' VAL . . . . . 0.616 ' O ' ' N ' ' A' ' 168' ' ' VAL . 1.3 m -47.1 -31.4 1.79 Allowed 'Isoleucine or valine' 0 N--CA 1.487 1.405 0 O-C-N 120.642 -1.286 . . . . 0.0 108.941 -178.837 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 167' ' ' GLY . . . . . . . . . . . . . . . -46.86 -9.49 0.03 OUTLIER Glycine 0 N--CA 1.495 2.571 0 N-CA-C 109.458 -1.457 . . . . 0.0 109.458 179.35 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 168' ' ' VAL . . . . . 0.616 ' N ' ' O ' ' A' ' 166' ' ' VAL . 9.8 p -49.43 -31.54 5.58 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.481 0 N-CA-C 107.775 -1.194 . . . . 0.0 107.775 179.22 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 169' ' ' LEU . . . . . 0.509 ' O ' ' C ' ' A' ' 170' ' ' ASP . 1.7 mm? -45.21 -19.38 0.04 OUTLIER 'General case' 0 C--N 1.293 -1.852 0 N-CA-C 107.694 -1.225 . . . . 0.0 107.694 -178.25 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 170' ' ' ASP . . . . . 0.531 ' N ' ' O ' ' A' ' 168' ' ' VAL . 8.3 t0 27.88 91.38 0.01 OUTLIER 'General case' 0 N--CA 1.501 2.121 0 CA-C-N 116.459 -0.337 . . . . 0.0 111.399 177.268 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 171' ' ' GLU . . . . . 0.433 ' CB ' ' OD1' ' A' ' 114' ' ' ASN . 17.1 pt-20 -130.85 67.27 1.51 Allowed 'General case' 0 N--CA 1.499 1.984 0 O-C-N 121.016 -1.053 . . . . 0.0 110.435 -179.989 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 172' ' ' GLN . . . . . . . . . . . . . 2.1 mt-30 -127.96 -52.6 1.32 Allowed 'General case' 0 N--CA 1.498 1.942 0 O-C-N 121.26 -0.9 . . . . 0.0 110.745 -178.979 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 173' ' ' LYS . . . . . . . . . . . . . 15.4 mttt -58.82 124.93 21.46 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 120.886 -1.134 . . . . 0.0 108.453 179.9 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 174' ' ' GLY . . . . . 0.538 ' O ' ' C ' ' A' ' 175' ' ' LYS . . . -124.74 -43.63 0.3 Allowed Glycine 0 N--CA 1.48 1.602 0 N-CA-C 108.337 -1.905 . . . . 0.0 108.337 -179.838 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 175' ' ' LYS . . . . . 0.538 ' C ' ' O ' ' A' ' 174' ' ' GLY . 2.2 mptm? -37.9 -61.85 0.61 Allowed 'General case' 0 N--CA 1.492 1.655 0 N-CA-C 107.243 -1.392 . . . . 0.0 107.243 179.308 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 176' ' ' ASP . . . . . 0.624 ' O ' ' O ' ' A' ' 177' ' ' LYS . 8.7 m-20 -104.32 85.9 2.44 Favored 'General case' 0 C--N 1.295 -1.787 0 N-CA-C 106.7 -1.592 . . . . 0.0 106.7 176.512 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 177' ' ' LYS . . . . . 0.624 ' O ' ' O ' ' A' ' 176' ' ' ASP . 12.5 mttt -40.97 179.8 0.0 OUTLIER 'General case' 0 N--CA 1.496 1.85 0 O-C-N 121.489 -0.757 . . . . 0.0 110.235 -178.726 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 178' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -161.21 170.08 20.97 Favored 'General case' 0 N--CA 1.487 1.398 0 O-C-N 120.339 -1.476 . . . . 0.0 111.138 179.911 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 179' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -123.49 99.09 6.14 Favored 'General case' 0 C--N 1.304 -1.389 0 N-CA-C 107.406 -1.331 . . . . 0.0 107.406 178.297 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 180' ' ' THR . . . . . . . . . . . . . 1.1 m -70.56 114.08 8.31 Favored 'General case' 0 N--CA 1.487 1.418 0 O-C-N 121.18 -0.95 . . . . 0.0 109.857 -178.774 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 181' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -88.9 142.58 27.53 Favored 'General case' 0 C--N 1.303 -1.456 0 N-CA-C 107.339 -1.356 . . . . 0.0 107.339 177.677 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 182' ' ' ILE . . . . . . . . . . . . . 81.6 mt -137.87 115.72 12.96 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.76 0 N-CA-C 107.824 -1.176 . . . . 0.0 107.824 179.259 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 183' ' ' THR . . . . . . . . . . . . . 3.7 t -139.54 113.49 8.73 Favored 'General case' 0 C--N 1.289 -2.063 0 N-CA-C 108.155 -1.054 . . . . 0.0 108.155 -179.623 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 184' ' ' CYS . . . . . . . . . . . . . 0.8 OUTLIER -78.84 159.75 27.67 Favored 'General case' 0 C--N 1.291 -1.938 0 C-N-CA 119.101 -1.04 . . . . 0.0 111.095 -178.078 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 185' ' ' ASP . . . . . . . . . . . . . 1.2 t70 -165.93 -155.81 0.24 Allowed 'General case' 0 N--CA 1.493 1.683 0 N-CA-C 109.046 -0.724 . . . . 0.0 109.046 -179.613 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 186' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER 54.2 55.22 8.47 Favored 'General case' 0 N--CA 1.496 1.826 0 O-C-N 121.047 -1.033 . . . . 0.0 109.335 179.898 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 187' ' ' TYR . . . . . 0.611 ' CE2' ' O ' ' A' ' 188' ' ' ASN . 71.2 t80 -67.61 132.2 47.07 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 120.975 -1.078 . . . . 0.0 111.402 -179.151 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 188' ' ' ASN . . . . . 0.816 HD22 ' H ' ' A' ' 192' ' ' GLY . 0.0 OUTLIER -100.54 149.36 23.8 Favored 'General case' 0 C--N 1.296 -1.736 0 N-CA-C 107.292 -1.373 . . . . 0.0 107.292 177.364 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 189' ' ' GLU . . . . . . . . . . . . . 1.8 tt0 -111.65 -10.56 14.09 Favored 'General case' 0 C--N 1.293 -1.871 0 N-CA-C 108.833 -0.802 . . . . 0.0 108.833 -179.122 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 190' ' ' LYS . . . . . . . . . . . . . 13.9 mttm -85.88 -50.89 6.76 Favored 'General case' 0 C--N 1.301 -1.5 0 CA-C-O 121.583 0.706 . . . . 0.0 109.447 179.537 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 191' ' ' THR . . . . . 0.671 ' N ' HD22 ' A' ' 188' ' ' ASN . 72.6 p -89.15 -1.09 57.94 Favored 'General case' 0 N--CA 1.493 1.713 0 O-C-N 121.584 -0.698 . . . . 0.0 110.781 -178.879 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 192' ' ' GLY . . . . . 0.816 ' H ' HD22 ' A' ' 188' ' ' ASN . . . 56.38 36.08 68.39 Favored Glycine 0 N--CA 1.492 2.388 0 O-C-N 120.865 -1.147 . . . . 0.0 110.327 179.622 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 193' ' ' VAL . . . . . 0.491 ' H ' HD21 ' A' ' 188' ' ' ASN . 3.1 m -148.63 163.77 5.04 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.738 0 O-C-N 120.885 -1.362 . . . . 0.0 109.449 179.519 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 194' ' ' TRP . . . . . 0.495 ' N ' ' CD1' ' A' ' 194' ' ' TRP . 24.2 m95 -84.46 121.16 27.18 Favored 'General case' 0 C--N 1.303 -1.42 0 N-CA-C 107.97 -1.122 . . . . 0.0 107.97 178.845 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 195' ' ' GLU . . . . . . . . . . . . . 1.7 mt-10 -76.7 -61.27 2.02 Favored 'General case' 0 N--CA 1.496 1.832 0 O-C-N 121.225 -0.922 . . . . 0.0 112.905 -176.831 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 196' ' ' LYS . . . . . . . . . . . . . 2.0 tptm -93.02 159.49 15.28 Favored 'General case' 0 N--CA 1.495 1.809 0 O-C-N 120.762 -1.211 . . . . 0.0 111.51 -177.201 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 197' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -121.75 135.83 54.94 Favored 'General case' 0 N--CA 1.493 1.676 0 N-CA-C 109.179 -0.675 . . . . 0.0 109.179 179.577 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 198' ' ' LYS . . . . . . . . . . . . . 49.3 mttt -117.4 120.38 37.97 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.495 -0.753 . . . . 0.0 110.104 -179.243 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 199' ' ' ILE . . . . . 0.471 ' O ' HG13 ' A' ' 199' ' ' ILE . 1.0 OUTLIER -137.8 122.26 22.97 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.677 0 CA-C-O 122.667 1.222 . . . . 0.0 110.623 179.554 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 200' ' ' PHE . . . . . 0.471 ' CD1' ' N ' ' A' ' 200' ' ' PHE . 1.6 m-85 -103.5 138.83 39.66 Favored 'General case' 0 C--N 1.297 -1.689 0 O-C-N 120.91 -1.119 . . . . 0.0 110.334 -178.22 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 201' ' ' VAL . . . . . . . . . . . . . 59.7 t -102.36 147.04 9.48 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.494 0 N-CA-C 107.678 -1.23 . . . . 0.0 107.678 177.615 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 202' ' ' ALA . . . . . . . . . . . . . . . -130.53 138.63 50.3 Favored 'General case' 0 C--N 1.3 -1.567 0 O-C-N 121.138 -0.976 . . . . 0.0 108.388 -179.874 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 203' ' ' THR . . . . . 0.492 ' OG1' ' OG1' ' A' ' 156' ' ' THR . 6.5 p -89.0 127.78 35.68 Favored 'General case' 0 C--N 1.305 -1.365 0 CA-C-O 122.226 1.012 . . . . 0.0 111.41 -178.167 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 204' ' ' GLU . . . . . 0.494 ' HA ' ' CD2' ' A' ' 153' ' ' TYR . 1.1 tm-20 -50.37 134.9 22.79 Favored 'General case' 0 C--N 1.299 -1.595 0 C-N-CA 118.957 -1.097 . . . . 0.0 108.607 178.766 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 205' ' ' VAL . . . . . 0.486 ' CG1' ' N ' ' A' ' 206' ' ' LYS . 69.8 t -130.54 163.96 34.82 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.338 0 CA-C-O 122.116 0.96 . . . . 0.0 110.606 -177.333 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 206' ' ' LYS . . . . . 0.486 ' N ' ' CG1' ' A' ' 205' ' ' VAL . 0.1 OUTLIER . . . . . 0 C--N 1.299 -1.627 0 CA-C-O 118.032 -0.985 . . . . 0.0 109.366 179.876 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' C' C ' 701' ' ' PHQ . . . . . 0.422 ' O1 ' ' C ' ' C' ' 702' ' ' LEU . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' C' C ' 702' ' ' LEU . . . . . 0.68 ' CD1' ' N ' ' C' ' 702' ' ' LEU . 0.0 OUTLIER . . . . . 0 N--CA 1.501 2.08 0 N-CA-C 109.991 -0.374 . . . . 0.0 109.991 . . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' C' C ' 703' ' ' PRO . . . . . 0.498 ' O ' ' O ' ' C' ' 704' ' ' ALA . 27.7 Cg_exo -55.6 -166.77 0.02 OUTLIER 'Trans proline' 0 N--CA 1.493 1.498 0 C-N-CA 122.195 1.93 . . . . 0.0 112.606 -179.463 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' C' C ' 704' ' ' ALA . . . . . 0.498 ' O ' ' O ' ' C' ' 703' ' ' PRO . . . 48.48 99.45 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.493 -0.754 . . . . 0.0 109.207 -179.817 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' C' C ' 705' ' ' B27 . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 015 nuclear orig full ' A' A ' 700' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 016 nuclear orig full ' A' A ' 59' ' ' MET . . . . . . . . . . . . . 9.4 mmt . . . . . 0 N--CA 1.492 1.634 0 CA-C-O 121.383 0.611 . . . . 0.0 109.414 . . . . . . . . . 0 0 . 1 . 016 nuclear orig full ' A' A ' 60' ' ' GLN . . . . . . . . . . . . . 1.2 pt20 -60.91 170.56 1.49 Allowed 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.58 -0.7 . . . . 0.0 110.111 -179.406 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . -63.86 -178.17 0.3 Allowed 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.301 -0.874 . . . . 0.0 109.883 -179.607 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 62' ' ' LYS . . . . . 0.488 ' O ' ' OE1' ' A' ' 64' ' ' GLN . 19.2 tttp -149.69 74.26 9.53 Favored Pre-proline 0 N--CA 1.491 1.586 0 O-C-N 121.208 -0.933 . . . . 0.0 110.126 -179.525 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 63' ' ' PRO . . . . . . . . . . . . . 9.8 Cg_exo -70.52 141.07 41.26 Favored 'Trans proline' 0 C--N 1.305 -1.754 0 C-N-CA 122.879 2.386 . . . . 0.0 111.65 179.753 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 64' ' ' GLN . . . . . 0.677 ' NE2' ' N ' ' A' ' 64' ' ' GLN . 0.0 OUTLIER -156.41 117.75 3.83 Favored 'General case' 0 N--CA 1.494 1.739 0 O-C-N 121.276 -0.89 . . . . 0.0 109.071 179.816 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 65' ' ' ILE . . . . . 0.462 ' C ' ' O ' ' A' ' 64' ' ' GLN . 0.0 OUTLIER -42.72 103.97 0.34 Allowed Pre-proline 0 N--CA 1.497 1.923 0 O-C-N 121.119 -0.988 . . . . 0.0 108.743 179.626 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 66' ' ' PRO . . . . . . . . . . . . . 61.3 Cg_endo -90.15 -154.86 0.05 OUTLIER 'Trans proline' 0 C--N 1.313 -1.339 0 C-N-CA 122.194 1.929 . . . . 0.0 112.043 -179.742 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 67' ' ' LYS . . . . . 0.442 ' C ' ' H ' ' A' ' 69' ' ' LYS . 22.0 tttt -85.32 -4.76 59.26 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.119 -0.988 . . . . 0.0 108.771 179.597 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 68' ' ' ASP . . . . . 0.616 ' C ' ' N ' ' A' ' 70' ' ' SER . 1.1 t0 -75.03 49.58 0.44 Allowed 'General case' 0 N--CA 1.488 1.452 0 CA-C-O 122.533 1.159 . . . . 0.0 108.997 179.87 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 69' ' ' LYS . . . . . 0.467 ' CB ' ' HZ2' ' A' ' 69' ' ' LYS . 4.1 mtmp? -48.7 -14.77 0.07 Allowed 'General case' 0 N--CA 1.503 2.211 0 C-N-CA 117.218 -1.793 . . . . 0.0 106.664 177.99 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 70' ' ' SER . . . . . 0.616 ' N ' ' C ' ' A' ' 68' ' ' ASP . 0.0 OUTLIER -86.15 -4.46 59.17 Favored 'General case' 0 N--CA 1.494 1.766 0 CA-C-N 113.702 -1.59 . . . . 0.0 110.916 179.714 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 71' ' ' LYS . . . . . . . . . . . . . 5.4 ptmt -99.54 140.5 33.63 Favored 'General case' 0 N--CA 1.493 1.72 0 O-C-N 120.896 -1.127 . . . . 0.0 110.957 179.698 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 72' ' ' VAL . . . . . 0.6 ' CG2' ' O ' ' A' ' 74' ' ' GLY . 0.6 OUTLIER -64.82 136.57 26.42 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.476 0 N-CA-C 104.883 -2.265 . . . . 0.0 104.883 174.725 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 73' ' ' ALA . . . . . 0.486 ' N ' ' O ' ' A' ' 87' ' ' VAL . . . -84.68 -14.72 47.62 Favored 'General case' 0 C--N 1.296 -1.745 0 O-C-N 120.211 -1.556 . . . . 0.0 108.386 -179.163 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 74' ' ' GLY . . . . . 0.6 ' O ' ' CG2' ' A' ' 72' ' ' VAL . . . 172.7 -158.51 28.65 Favored Glycine 0 N--CA 1.485 1.93 0 N-CA-C 109.432 -1.467 . . . . 0.0 109.432 -179.692 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 75' ' ' TYR . . . . . 0.59 ' CD2' ' O ' ' A' ' 85' ' ' GLU . 2.0 m-85 -142.81 170.32 15.92 Favored 'General case' 0 C--N 1.299 -1.63 0 O-C-N 121.013 -1.286 . . . . 0.0 111.544 -177.16 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 76' ' ' ILE . . . . . . . . . . . . . 3.0 tp -146.92 143.94 20.16 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.453 0 C-N-CA 119.906 -0.718 . . . . 0.0 109.734 -177.528 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -151.29 159.99 44.04 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 120.999 -1.063 . . . . 0.0 109.129 179.572 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 78' ' ' ILE . . . . . . . . . . . . . 19.0 mt -146.83 103.27 3.89 Favored Pre-proline 0 N--CA 1.491 1.604 0 O-C-N 121.296 -0.877 . . . . 0.0 109.067 -179.703 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 79' ' ' PRO . . . . . . . . . . . . . 46.6 Cg_exo -51.16 -44.02 45.11 Favored 'Trans proline' 0 N--CA 1.494 1.538 0 C-N-CA 122.566 2.177 . . . . 0.0 113.949 -179.149 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 1.1 m-20 -67.28 -22.71 65.64 Favored 'General case' 0 N--CA 1.493 1.676 0 O-C-N 120.69 -1.256 . . . . 0.0 110.991 178.975 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -104.03 -10.85 17.75 Favored 'General case' 0 N--CA 1.493 1.716 0 O-C-N 121.135 -0.978 . . . . 0.0 109.106 179.588 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 82' ' ' ASP . . . . . . . . . . . . . 1.1 t70 59.05 50.24 8.46 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.336 -0.853 . . . . 0.0 110.439 179.322 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 83' ' ' ILE . . . . . . . . . . . . . 70.3 mt -125.97 152.61 33.32 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.854 0 O-C-N 121.298 -0.876 . . . . 0.0 110.285 -179.061 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 84' ' ' LYS . . . . . 0.408 ' C ' ' CD ' ' A' ' 85' ' ' GLU . 0.2 OUTLIER -160.69 105.07 1.4 Allowed 'General case' 0 N--CA 1.492 1.667 0 O-C-N 121.166 -0.959 . . . . 0.0 108.762 179.469 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 85' ' ' GLU . . . . . 0.59 ' O ' ' CD2' ' A' ' 75' ' ' TYR . 1.2 mm-40 -139.72 179.2 1.34 Allowed Pre-proline 0 N--CA 1.499 1.979 0 O-C-N 121.13 -0.981 . . . . 0.0 109.674 -179.373 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 86' ' ' PRO . . . . . 0.47 ' CD ' ' CB ' ' A' ' 85' ' ' GLU . 35.5 Cg_endo -86.15 167.33 9.38 Favored 'Trans proline' 0 C--N 1.314 -1.24 0 C-N-CA 122.707 2.272 . . . . 0.0 113.34 -178.691 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 87' ' ' VAL . . . . . 0.486 ' O ' ' N ' ' A' ' 73' ' ' ALA . 57.5 t -124.43 104.76 14.3 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.469 0 N-CA-C 108.042 -1.096 . . . . 0.0 108.042 178.901 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 88' ' ' TYR . . . . . . . . . . . . . 29.5 m-85 -97.83 154.73 37.72 Favored Pre-proline 0 N--CA 1.496 1.831 0 O-C-N 121.047 -1.033 . . . . 0.0 110.202 -178.731 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 89' ' ' PRO . . . . . . . . . . . . . 8.9 Cg_endo -56.33 144.32 82.93 Favored 'Trans proline' 0 N--CA 1.496 1.62 0 C-N-CA 122.961 2.44 . . . . 0.0 113.949 -179.972 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . -59.87 170.25 6.71 Favored Glycine 0 N--CA 1.489 2.208 0 N-CA-C 109.01 -1.636 . . . . 0.0 109.01 178.553 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 91' ' ' PRO . . . . . 0.465 ' C ' ' H ' ' A' ' 93' ' ' THR . 54.6 Cg_endo -93.94 167.4 20.28 Favored 'Cis proline' 0 C--N 1.307 -1.645 0 C-N-CA 124.016 -1.243 . . . . 0.0 111.275 -0.04 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 92' ' ' ALA . . . . . 0.511 ' O ' ' CD1' ' A' ' 97' ' ' LEU . . . -72.11 32.61 0.06 Allowed 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.125 -0.985 . . . . 0.0 110.532 -179.612 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 93' ' ' THR . . . . . 0.465 ' H ' ' C ' ' A' ' 91' ' ' PRO . 2.0 p -73.3 149.78 89.26 Favored Pre-proline 0 N--CA 1.489 1.52 0 O-C-N 120.566 -1.333 . . . . 0.0 108.653 -179.817 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 94' ' ' PRO . . . . . . . . . . . . . 91.8 Cg_exo -30.53 -50.43 0.22 Allowed 'Trans proline' 0 C--N 1.31 -1.454 0 C-N-CA 123.372 2.715 . . . . 0.0 112.944 -179.125 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 95' ' ' GLU . . . . . 0.434 ' O ' ' NH2' ' A' ' 99' ' ' ARG . 10.6 mt-10 -53.8 -47.65 70.62 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.201 -0.937 . . . . 0.0 109.702 -179.973 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 96' ' ' GLN . . . . . 0.488 ' C ' ' H ' ' A' ' 98' ' ' ASN . 3.3 mp0 -72.08 -49.21 38.3 Favored 'General case' 0 C--N 1.302 -1.478 0 O-C-N 121.263 -0.898 . . . . 0.0 110.416 -179.453 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 97' ' ' LEU . . . . . 0.511 ' CD1' ' O ' ' A' ' 92' ' ' ALA . 96.2 mt -52.8 -8.25 0.09 Allowed 'General case' 0 N--CA 1.493 1.695 0 O-C-N 121.055 -1.028 . . . . 0.0 110.06 -178.936 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 98' ' ' ASN . . . . . 0.628 ' ND2' ' CZ ' ' A' ' 99' ' ' ARG . 0.0 OUTLIER -75.68 -37.73 59.3 Favored 'General case' 0 N--CA 1.488 1.432 0 N-CA-C 107.91 -1.145 . . . . 0.0 107.91 178.269 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 99' ' ' ARG . . . . . 0.628 ' CZ ' ' ND2' ' A' ' 98' ' ' ASN . 1.0 OUTLIER -72.41 -51.28 21.06 Favored 'General case' 0 C--N 1.304 -1.378 0 CA-C-N 115.893 -0.594 . . . . 0.0 109.646 179.677 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . 169.6 -158.43 30.7 Favored Glycine 0 N--CA 1.497 2.762 0 N-CA-C 109.565 -1.414 . . . . 0.0 109.565 -179.834 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 101' ' ' VAL . . . . . 0.526 ' O ' ' CG2' ' A' ' 101' ' ' VAL . 16.2 m -66.2 104.26 0.57 Allowed 'Isoleucine or valine' 0 N--CA 1.496 1.848 0 O-C-N 120.924 -1.339 . . . . 0.0 108.987 179.697 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 102' ' ' SER . . . . . 0.603 ' HG ' ' N ' ' A' ' 103' ' ' PHE . 0.0 OUTLIER -92.4 167.71 11.79 Favored 'General case' 0 N--CA 1.495 1.813 0 O-C-N 121.218 -0.926 . . . . 0.0 111.6 -178.719 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 103' ' ' PHE . . . . . 0.603 ' N ' ' HG ' ' A' ' 102' ' ' SER . 24.3 m-85 -70.97 143.88 50.69 Favored 'General case' 0 N--CA 1.489 1.505 0 N-CA-C 107.876 -1.157 . . . . 0.0 107.876 178.238 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 104' ' ' ALA . . . . . . . . . . . . . . . -61.94 -13.47 25.43 Favored 'General case' 0 C--N 1.297 -1.68 0 O-C-N 121.179 -0.951 . . . . 0.0 111.376 -178.71 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -138.29 143.27 39.92 Favored 'General case' 0 N--CA 1.498 1.964 0 O-C-N 120.618 -1.301 . . . . 0.0 110.998 -179.49 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 106' ' ' GLU . . . . . 0.446 ' CG ' ' H ' ' A' ' 107' ' ' ASN . 6.1 pt-20 -57.09 -58.92 6.06 Favored 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.935 -0.478 . . . . 0.0 111.134 -179.432 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 107' ' ' ASN . . . . . 0.446 ' H ' ' CG ' ' A' ' 106' ' ' GLU . 1.1 m-80 -77.99 35.22 0.2 Allowed 'General case' 0 N--CA 1.489 1.478 0 O-C-N 120.361 -1.462 . . . . 0.0 112.107 -176.24 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 108' ' ' GLU . . . . . . . . . . . . . 40.6 tp10 -59.28 145.46 43.02 Favored 'General case' 0 C--N 1.304 -1.374 0 O-C-N 120.742 -1.224 . . . . 0.0 107.834 -179.96 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 109' ' ' SER . . . . . 0.444 ' OG ' ' OD2' ' A' ' 112' ' ' ASP . 0.7 OUTLIER -96.86 144.22 27.01 Favored 'General case' 0 C--N 1.301 -1.542 0 O-C-N 121.119 -0.988 . . . . 0.0 110.67 -178.324 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 110' ' ' LEU . . . . . . . . . . . . . 5.6 tp -60.9 -21.52 63.43 Favored 'General case' 0 C--N 1.302 -1.465 0 N-CA-C 107.971 -1.122 . . . . 0.0 107.971 179.165 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 111' ' ' ASP . . . . . . . . . . . . . 82.5 m-20 -132.19 43.77 2.98 Favored 'General case' 0 C--N 1.302 -1.482 0 C-N-CA 120.269 -0.572 . . . . 0.0 109.861 -179.616 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 112' ' ' ASP . . . . . 0.444 ' OD2' ' OG ' ' A' ' 109' ' ' SER . 0.6 OUTLIER -67.09 148.79 51.42 Favored 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.153 -0.967 . . . . 0.0 110.059 179.63 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 113' ' ' GLN . . . . . 0.424 ' HA ' ' NE2' ' A' ' 113' ' ' GLN . 1.0 OUTLIER -68.12 -12.4 60.83 Favored 'General case' 0 C--N 1.302 -1.482 0 O-C-N 121.256 -0.902 . . . . 0.0 109.199 179.029 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 114' ' ' ASN . . . . . 0.674 ' ND2' ' NE2' ' A' ' 178' ' ' GLN . 8.0 t-20 -149.97 101.79 3.06 Favored 'General case' 0 C--N 1.301 -1.517 0 N-CA-C 107.167 -1.42 . . . . 0.0 107.167 177.378 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 115' ' ' ILE . . . . . . . . . . . . . 4.0 mt -97.83 110.55 25.74 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.45 0 O-C-N 121.047 -1.033 . . . . 0.0 108.848 -179.253 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 116' ' ' SER . . . . . . . . . . . . . 28.9 m -98.93 138.26 36.31 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.154 -0.966 . . . . 0.0 111.122 -178.485 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 117' ' ' ILE . . . . . 0.426 HG22 ' N ' ' A' ' 118' ' ' ALA . 14.4 mt -123.42 151.52 28.01 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.424 0 N-CA-C 107.229 -1.397 . . . . 0.0 107.229 178.83 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 118' ' ' ALA . . . . . 0.426 ' N ' HG22 ' A' ' 117' ' ' ILE . . . -140.93 154.67 46.2 Favored 'General case' 0 N--CA 1.487 1.409 0 O-C-N 120.95 -1.094 . . . . 0.0 110.609 -179.171 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 119' ' ' GLY . . . . . . . . . . . . . . . -166.57 151.73 20.14 Favored Glycine 0 N--CA 1.484 1.849 0 N-CA-C 110.201 -1.16 . . . . 0.0 110.201 179.984 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 120' ' ' HIS . . . . . . . . . . . . . 10.9 m170 -71.71 165.51 23.87 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.918 -0.754 . . . . 0.0 110.465 179.642 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 121' ' ' THR . . . . . 0.523 ' OG1' ' NZ ' ' A' ' 134' ' ' LYS . 0.7 OUTLIER -121.03 148.32 44.3 Favored 'General case' 0 N--CA 1.495 1.823 0 N-CA-C 107.75 -1.204 . . . . 0.0 107.75 178.293 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 122' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -107.41 138.33 43.81 Favored 'General case' 0 N--CA 1.495 1.782 0 O-C-N 120.882 -1.136 . . . . 0.0 110.192 -179.663 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 123' ' ' ILE . . . . . 0.441 ' CG2' ' N ' ' A' ' 124' ' ' ASP . 15.0 tt -90.26 -36.54 8.5 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.771 0 N-CA-C 108.152 -1.055 . . . . 0.0 108.152 178.277 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 124' ' ' ASP . . . . . 0.441 ' N ' ' CG2' ' A' ' 123' ' ' ILE . 18.3 t0 -96.6 17.18 16.9 Favored 'General case' 0 N--CA 1.496 1.843 0 CA-C-N 115.777 -0.647 . . . . 0.0 111.13 -179.638 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 125' ' ' ARG . . . . . . . . . . . . . 7.7 ttt180 -156.72 107.35 1.97 Allowed Pre-proline 0 N--CA 1.499 1.993 0 O-C-N 120.516 -1.365 . . . . 0.0 110.152 -178.856 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 126' ' ' PRO . . . . . . . . . . . . . 66.0 Cg_endo -81.04 -17.02 9.6 Favored 'Trans proline' 0 C--N 1.314 -1.247 0 C-N-CA 121.886 1.724 . . . . 0.0 112.703 179.885 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 127' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -90.95 31.24 1.1 Allowed 'General case' 0 N--CA 1.494 1.742 0 O-C-N 121.152 -0.968 . . . . 0.0 109.946 -179.933 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 128' ' ' TYR . . . . . . . . . . . . . 8.8 t80 -89.41 -153.16 0.26 Allowed 'General case' 0 N--CA 1.492 1.668 0 O-C-N 120.956 -1.09 . . . . 0.0 110.675 -179.193 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 129' ' ' GLN . . . . . . . . . . . . . 39.8 mt-30 -66.77 -72.71 0.15 Allowed 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.32 -0.863 . . . . 0.0 110.919 -178.308 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 130' ' ' PHE . . . . . 0.438 ' CE2' ' CG1' ' A' ' 101' ' ' VAL . 49.2 m-85 -121.6 28.98 7.4 Favored 'General case' 0 N--CA 1.497 1.876 0 O-C-N 121.289 -0.882 . . . . 0.0 110.126 -179.447 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 131' ' ' THR . . . . . . . . . . . . . 99.0 m -72.55 -30.92 64.86 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 120.781 -1.199 . . . . 0.0 109.146 179.933 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 132' ' ' ASN . . . . . . . . . . . . . 4.6 t30 -85.0 7.99 19.39 Favored 'General case' 0 N--CA 1.496 1.86 0 C-N-CA 119.513 -0.875 . . . . 0.0 109.923 -179.869 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 133' ' ' LEU . . . . . 0.583 ' O ' ' N ' ' A' ' 135' ' ' ALA . 0.2 OUTLIER -70.81 -49.64 44.2 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.353 -0.842 . . . . 0.0 109.827 179.897 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 134' ' ' LYS . . . . . 0.523 ' NZ ' ' OG1' ' A' ' 121' ' ' THR . 0.0 OUTLIER -44.39 -16.14 0.02 OUTLIER 'General case' 0 N--CA 1.495 1.804 0 O-C-N 120.995 -1.066 . . . . 0.0 109.386 -179.311 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 135' ' ' ALA . . . . . 0.583 ' N ' ' O ' ' A' ' 133' ' ' LEU . . . -83.15 -35.87 25.2 Favored 'General case' 0 N--CA 1.494 1.773 0 O-C-N 121.264 -0.898 . . . . 0.0 109.824 179.78 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 136' ' ' ALA . . . . . 0.431 ' N ' ' O ' ' A' ' 133' ' ' LEU . . . -80.43 158.71 25.87 Favored 'General case' 0 N--CA 1.491 1.621 0 CA-C-O 121.778 0.799 . . . . 0.0 111.446 -178.735 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 137' ' ' LYS . . . . . 0.55 ' O ' ' O ' ' A' ' 138' ' ' LYS . 17.1 mtmt -149.64 -168.08 3.01 Favored 'General case' 0 N--CA 1.493 1.7 0 C-N-CA 118.935 -1.106 . . . . 0.0 110.619 -177.888 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 138' ' ' LYS . . . . . 0.581 ' O ' ' N ' ' A' ' 140' ' ' SER . 21.7 mtmm -40.48 176.06 0.0 OUTLIER 'General case' 0 C--N 1.304 -1.407 0 CA-C-O 122.608 1.194 . . . . 0.0 111.502 -178.618 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 139' ' ' GLY . . . . . . . . . . . . . . . 47.83 7.81 0.04 OUTLIER Glycine 0 N--CA 1.487 2.072 0 N-CA-C 109.825 -1.31 . . . . 0.0 109.825 -179.649 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 140' ' ' SER . . . . . 0.581 ' N ' ' O ' ' A' ' 138' ' ' LYS . 2.3 p -75.32 116.67 16.3 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 120.96 -1.318 . . . . 0.0 109.156 179.207 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 141' ' ' MET . . . . . . . . . . . . . 3.3 tpt -70.6 139.3 51.38 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.215 -0.928 . . . . 0.0 109.393 -179.956 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 142' ' ' VAL . . . . . . . . . . . . . 5.0 t -125.35 128.25 72.53 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.719 0 O-C-N 121.491 -0.755 . . . . 0.0 108.998 -179.789 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 143' ' ' TYR . . . . . . . . . . . . . 64.4 m-85 -107.41 135.04 49.57 Favored 'General case' 0 N--CA 1.5 2.056 0 O-C-N 121.236 -0.915 . . . . 0.0 110.69 -179.295 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 144' ' ' PHE . . . . . . . . . . . . . 62.9 t80 -118.78 101.65 8.24 Favored 'General case' 0 N--CA 1.5 2.066 0 O-C-N 121.474 -0.766 . . . . 0.0 110.406 -179.405 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 145' ' ' LYS . . . . . . . . . . . . . 36.5 tttt -96.51 129.98 43.78 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.03 -1.044 . . . . 0.0 110.543 -179.554 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 146' ' ' VAL . . . . . 0.42 ' O ' ' C ' ' A' ' 147' ' ' GLY . 2.6 p -146.16 141.84 21.37 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.574 0 N-CA-C 107.238 -1.393 . . . . 0.0 107.238 178.376 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 147' ' ' GLY . . . . . 0.42 ' C ' ' O ' ' A' ' 146' ' ' VAL . . . 47.85 -133.72 16.87 Favored Glycine 0 N--CA 1.487 2.077 0 N-CA-C 108.857 -1.697 . . . . 0.0 108.857 -179.391 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 148' ' ' ASN . . . . . 0.507 ' C ' ' ND2' ' A' ' 148' ' ' ASN . 0.5 OUTLIER -102.91 17.85 23.0 Favored 'General case' 0 C--N 1.302 -1.495 0 O-C-N 121.314 -1.109 . . . . 0.0 108.418 179.314 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 149' ' ' GLU . . . . . 0.525 ' CD ' ' N ' ' A' ' 150' ' ' THR . 11.5 tp10 -113.03 145.31 41.09 Favored 'General case' 0 N--CA 1.486 1.368 0 CA-C-O 121.714 0.768 . . . . 0.0 110.658 -178.447 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 150' ' ' THR . . . . . 0.525 ' N ' ' CD ' ' A' ' 149' ' ' GLU . 86.0 m -129.72 104.79 7.62 Favored 'General case' 0 N--CA 1.492 1.647 0 CA-C-O 121.487 0.66 . . . . 0.0 109.526 179.815 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 151' ' ' ARG . . . . . . . . . . . . . 84.3 mtt180 -85.92 -168.97 2.43 Favored 'General case' 0 N--CA 1.486 1.363 0 N-CA-C 108.646 -0.872 . . . . 0.0 108.646 -179.759 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 152' ' ' LYS . . . . . 0.589 ' N ' ' OXT' ' A' ' 206' ' ' LYS . 21.7 mtpt -149.9 148.47 29.16 Favored 'General case' 0 C--N 1.3 -1.563 0 O-C-N 120.999 -1.063 . . . . 0.0 110.317 -178.855 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 153' ' ' TYR . . . . . 0.446 ' CD1' ' C ' ' A' ' 152' ' ' LYS . 51.7 m-85 -146.94 151.48 37.08 Favored 'General case' 0 C--N 1.302 -1.475 0 N-CA-C 108.401 -0.963 . . . . 0.0 108.401 178.718 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 154' ' ' LYS . . . . . . . . . . . . . 10.8 ttmt -133.05 117.05 17.11 Favored 'General case' 0 C--N 1.298 -1.648 0 N-CA-C 108.711 -0.848 . . . . 0.0 108.711 179.291 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 155' ' ' MET . . . . . 0.557 ' SD ' ' OG ' ' A' ' 140' ' ' SER . 6.5 mtt -41.66 107.71 0.08 Allowed 'General case' 0 N--CA 1.489 1.483 0 CA-C-O 122.75 1.262 . . . . 0.0 111.858 -178.126 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 156' ' ' THR . . . . . 0.504 ' OG1' ' OG1' ' A' ' 203' ' ' THR . 0.2 OUTLIER -106.07 -26.19 11.73 Favored 'General case' 0 C--N 1.293 -1.865 0 CA-C-N 114.537 -1.211 . . . . 0.0 110.03 -178.842 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 157' ' ' SER . . . . . 0.467 ' O ' ' N ' ' A' ' 201' ' ' VAL . 19.8 t -154.27 150.77 28.37 Favored 'General case' 0 N--CA 1.494 1.748 0 C-N-CA 118.713 -1.195 . . . . 0.0 111.394 -178.678 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 158' ' ' ILE . . . . . 0.434 HG13 ' CD2' ' A' ' 200' ' ' PHE . 0.0 OUTLIER -155.25 146.9 12.98 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.486 0 CA-C-O 121.767 0.794 . . . . 0.0 110.252 -179.884 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 159' ' ' ARG . . . . . 0.588 ' CG ' HH11 ' A' ' 159' ' ' ARG . 0.0 OUTLIER -151.32 -167.46 2.81 Favored 'General case' 0 N--CA 1.491 1.603 0 CA-C-O 121.785 0.802 . . . . 0.0 110.551 -179.147 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 160' ' ' ASP . . . . . . . . . . . . . 5.5 m-20 -145.11 152.91 40.8 Favored 'General case' 0 N--CA 1.491 1.599 0 N-CA-C 108.585 -0.894 . . . . 0.0 108.585 -179.429 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 161' ' ' VAL . . . . . . . . . . . . . 0.1 OUTLIER -153.04 150.83 12.38 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.873 0 O-C-N 120.713 -1.242 . . . . 0.0 111.21 -178.834 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 162' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -49.07 171.3 0.11 Allowed Pre-proline 0 N--CA 1.496 1.866 0 O-C-N 121.652 -0.655 . . . . 0.0 109.961 179.418 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 163' ' ' PRO . . . . . . . . . . . . . 74.2 Cg_endo -81.07 29.37 0.53 Allowed 'Trans proline' 0 N--CA 1.492 1.428 0 C-N-CA 122.792 2.328 . . . . 0.0 113.008 179.83 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 164' ' ' THR . . . . . . . . . . . . . 55.3 m -151.16 -6.01 0.27 Allowed 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.005 -1.059 . . . . 0.0 110.356 -179.949 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 165' ' ' ASP . . . . . 0.485 ' O ' ' C ' ' A' ' 166' ' ' VAL . 12.0 t0 -75.8 63.62 1.68 Allowed 'General case' 0 N--CA 1.487 1.411 0 O-C-N 120.994 -1.066 . . . . 0.0 109.292 179.549 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 166' ' ' VAL . . . . . 0.538 ' O ' ' N ' ' A' ' 168' ' ' VAL . 1.0 OUTLIER -39.54 -31.96 0.17 Allowed 'Isoleucine or valine' 0 N--CA 1.488 1.433 0 O-C-N 121.473 -0.767 . . . . 0.0 109.152 -178.647 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 167' ' ' GLY . . . . . 0.442 ' N ' ' O ' ' A' ' 165' ' ' ASP . . . -45.52 -13.52 0.05 OUTLIER Glycine 0 N--CA 1.494 2.545 0 N-CA-C 110.541 -1.024 . . . . 0.0 110.541 179.929 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 168' ' ' VAL . . . . . 0.589 ' O ' ' N ' ' A' ' 170' ' ' ASP . 16.7 t -52.74 -35.39 21.28 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.607 0 O-C-N 120.818 -1.401 . . . . 0.0 108.115 179.531 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 169' ' ' LEU . . . . . 0.54 ' O ' ' C ' ' A' ' 170' ' ' ASP . 84.3 mt -46.23 -14.05 0.02 OUTLIER 'General case' 0 C--N 1.3 -1.569 0 N-CA-C 108.26 -1.015 . . . . 0.0 108.26 -178.268 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 170' ' ' ASP . . . . . 0.6 ' O ' ' ND2' ' A' ' 114' ' ' ASN . 39.1 t0 19.78 54.36 0.01 OUTLIER 'General case' 0 N--CA 1.501 2.079 0 N-CA-C 111.874 0.324 . . . . 0.0 111.874 177.699 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 171' ' ' GLU . . . . . 0.435 ' N ' ' O ' ' A' ' 169' ' ' LEU . 4.9 pt-20 -100.87 75.6 1.71 Allowed 'General case' 0 N--CA 1.497 1.878 0 O-C-N 120.777 -1.202 . . . . 0.0 110.554 -179.597 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 172' ' ' GLN . . . . . . . . . . . . . 4.3 pt20 -139.69 -39.25 0.46 Allowed 'General case' 0 N--CA 1.492 1.665 0 O-C-N 121.568 -0.708 . . . . 0.0 109.266 -179.843 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 173' ' ' LYS . . . . . . . . . . . . . 9.2 mtpp -63.82 131.05 46.6 Favored 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.06 -1.025 . . . . 0.0 108.743 178.818 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 174' ' ' GLY . . . . . 0.559 ' O ' ' C ' ' A' ' 175' ' ' LYS . . . -137.5 -38.94 0.13 Allowed Glycine 0 C--N 1.294 -1.761 0 N-CA-C 108.514 -1.834 . . . . 0.0 108.514 179.763 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 175' ' ' LYS . . . . . 0.559 ' C ' ' O ' ' A' ' 174' ' ' GLY . 3.4 tptp -33.41 -62.97 0.26 Allowed 'General case' 0 N--CA 1.493 1.717 0 N-CA-C 108.529 -0.915 . . . . 0.0 108.529 179.676 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 176' ' ' ASP . . . . . 0.715 ' O ' ' O ' ' A' ' 177' ' ' LYS . 0.9 OUTLIER -103.6 76.1 1.37 Allowed 'General case' 0 C--N 1.297 -1.697 0 N-CA-C 107.796 -1.187 . . . . 0.0 107.796 177.775 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 177' ' ' LYS . . . . . 0.715 ' O ' ' O ' ' A' ' 176' ' ' ASP . 17.6 mtmt -19.16 158.63 0.0 OUTLIER 'General case' 0 N--CA 1.508 2.458 0 CA-C-O 122.145 0.974 . . . . 0.0 112.719 -178.985 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 178' ' ' GLN . . . . . 0.674 ' NE2' ' ND2' ' A' ' 114' ' ' ASN . 18.0 pt20 -156.08 159.23 38.91 Favored 'General case' 0 N--CA 1.491 1.593 0 C-N-CA 117.061 -1.856 . . . . 0.0 112.483 179.863 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 179' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -121.58 102.88 8.51 Favored 'General case' 0 N--CA 1.486 1.349 0 N-CA-C 107.072 -1.455 . . . . 0.0 107.072 178.418 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 180' ' ' THR . . . . . . . . . . . . . 1.0 OUTLIER -79.92 123.9 28.2 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.148 -0.97 . . . . 0.0 110.438 -178.454 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 181' ' ' LEU . . . . . . . . . . . . . 7.5 tp -99.8 110.9 23.25 Favored 'General case' 0 N--CA 1.492 1.661 0 N-CA-C 108.711 -0.848 . . . . 0.0 108.711 178.386 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 182' ' ' ILE . . . . . . . . . . . . . 18.1 mt -98.94 120.23 47.98 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.549 0 O-C-N 120.85 -1.156 . . . . 0.0 109.768 179.432 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 183' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -135.44 109.06 7.97 Favored 'General case' 0 C--N 1.296 -1.718 0 N-CA-C 107.279 -1.378 . . . . 0.0 107.279 178.548 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 184' ' ' CYS . . . . . . . . . . . . . 0.7 OUTLIER -79.83 156.68 27.28 Favored 'General case' 0 N--CA 1.498 1.933 0 C-N-CA 118.935 -1.106 . . . . 0.0 111.341 -177.306 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 185' ' ' ASP . . . . . 0.642 ' CG ' ' H ' ' A' ' 186' ' ' ASP . 28.9 t0 -166.53 -161.92 0.49 Allowed 'General case' 0 N--CA 1.489 1.523 0 N-CA-C 108.659 -0.867 . . . . 0.0 108.659 -179.943 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 186' ' ' ASP . . . . . 0.642 ' H ' ' CG ' ' A' ' 185' ' ' ASP . 0.6 OUTLIER 58.49 49.12 11.08 Favored 'General case' 0 N--CA 1.497 1.916 0 O-C-N 121.026 -1.046 . . . . 0.0 109.457 -179.656 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 187' ' ' TYR . . . . . 0.587 ' CE1' ' O ' ' A' ' 188' ' ' ASN . 30.1 t80 -67.16 133.09 49.11 Favored 'General case' 0 C--N 1.3 -1.562 0 CA-C-O 121.843 0.83 . . . . 0.0 110.469 -179.858 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 188' ' ' ASN . . . . . 0.789 ' ND2' ' H ' ' A' ' 193' ' ' VAL . 0.1 OUTLIER -102.56 150.66 23.18 Favored 'General case' 0 C--N 1.292 -1.894 0 N-CA-C 107.572 -1.27 . . . . 0.0 107.572 178.033 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 189' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -113.24 -3.08 13.92 Favored 'General case' 0 C--N 1.292 -1.934 0 N-CA-C 108.178 -1.045 . . . . 0.0 108.178 -179.61 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 190' ' ' LYS . . . . . 0.566 ' N ' ' OD1' ' A' ' 188' ' ' ASN . 2.6 mtpm? -83.66 -60.21 2.19 Favored 'General case' 0 N--CA 1.489 1.49 0 N-CA-C 108.714 -0.847 . . . . 0.0 108.714 178.558 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 191' ' ' THR . . . . . 0.623 ' OG1' ' ND2' ' A' ' 188' ' ' ASN . 1.1 p -89.34 4.15 49.86 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.41 -0.806 . . . . 0.0 109.245 179.896 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 192' ' ' GLY . . . . . . . . . . . . . . . 56.73 38.01 80.27 Favored Glycine 0 N--CA 1.494 2.53 0 N-CA-C 110.05 -1.22 . . . . 0.0 110.05 179.4 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 193' ' ' VAL . . . . . 0.789 ' H ' ' ND2' ' A' ' 188' ' ' ASN . 46.0 t -148.35 161.02 6.5 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.493 0 O-C-N 121.162 -1.199 . . . . 0.0 110.042 -179.975 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 194' ' ' TRP . . . . . 0.563 ' NE1' ' OG1' ' C' ' 705' ' ' B27 . 11.1 m95 -83.4 120.62 26.11 Favored 'General case' 0 C--N 1.298 -1.656 0 N-CA-C 108.564 -0.902 . . . . 0.0 108.564 179.55 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 195' ' ' GLU . . . . . . . . . . . . . 1.4 mt-10 -79.53 -60.09 2.5 Favored 'General case' 0 N--CA 1.493 1.709 0 O-C-N 121.309 -0.869 . . . . 0.0 111.013 -178.888 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 196' ' ' LYS . . . . . . . . . . . . . 19.0 mttp -95.04 146.37 24.32 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.285 -0.884 . . . . 0.0 110.31 -178.759 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 197' ' ' ARG . . . . . 0.65 ' CG ' HH11 ' A' ' 197' ' ' ARG . 0.0 OUTLIER -118.81 145.42 45.65 Favored 'General case' 0 N--CA 1.492 1.635 0 N-CA-C 108.564 -0.902 . . . . 0.0 108.564 179.035 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 198' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER -116.95 120.75 39.4 Favored 'General case' 0 N--CA 1.492 1.666 0 O-C-N 121.672 -0.643 . . . . 0.0 110.358 -178.704 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 199' ' ' ILE . . . . . 0.436 ' O ' HG13 ' A' ' 199' ' ' ILE . 0.8 OUTLIER -141.67 121.46 11.17 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.527 0 CA-C-O 122.672 1.225 . . . . 0.0 110.551 179.554 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 200' ' ' PHE . . . . . 0.53 ' CD1' ' N ' ' A' ' 200' ' ' PHE . 3.3 m-85 -99.52 134.64 42.1 Favored 'General case' 0 N--CA 1.497 1.915 0 O-C-N 121.163 -0.961 . . . . 0.0 110.125 -177.653 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 201' ' ' VAL . . . . . 0.467 ' N ' ' O ' ' A' ' 157' ' ' SER . 3.4 t -103.95 145.38 12.9 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.456 0 N-CA-C 107.646 -1.242 . . . . 0.0 107.646 176.805 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 202' ' ' ALA . . . . . 0.414 ' HA ' ' H ' ' A' ' 156' ' ' THR . . . -135.01 142.31 46.39 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.042 -1.036 . . . . 0.0 109.465 -179.753 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 203' ' ' THR . . . . . 0.504 ' OG1' ' OG1' ' A' ' 156' ' ' THR . 2.2 p -90.11 127.55 36.11 Favored 'General case' 0 C--N 1.306 -1.322 0 CA-C-O 122.694 1.235 . . . . 0.0 111.693 -178.353 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 204' ' ' GLU . . . . . . . . . . . . . 2.7 tm-20 -53.99 135.84 42.21 Favored 'General case' 0 C--N 1.291 -1.976 0 CA-C-N 114.364 -1.289 . . . . 0.0 108.286 178.594 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 205' ' ' VAL . . . . . . . . . . . . . 62.6 t -121.55 -50.14 3.02 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.898 0 O-C-N 121.177 -0.952 . . . . 0.0 109.436 -179.13 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 206' ' ' LYS . . . . . 0.589 ' OXT' ' N ' ' A' ' 152' ' ' LYS . 4.4 mmtp . . . . . 0 C--N 1.302 -1.469 0 CA-C-O 118.114 -0.946 . . . . 0.0 109.667 179.151 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' C' C ' 701' ' ' PHQ . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 016 nuclear orig full ' C' C ' 702' ' ' LEU . . . . . 0.634 ' CD1' ' N ' ' C' ' 702' ' ' LEU . 0.0 OUTLIER . . . . . 0 N--CA 1.491 1.598 0 N-CA-C 108.316 -0.994 . . . . 0.0 108.316 . . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' C' C ' 703' ' ' PRO . . . . . 0.586 ' O ' ' NH2' ' A' ' 197' ' ' ARG . 64.8 Cg_endo -80.85 164.11 20.5 Favored 'Trans proline' 0 C--N 1.308 -1.584 0 C-N-CA 122.381 2.054 . . . . 0.0 113.119 -179.123 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' C' C ' 704' ' ' ALA . . . . . 0.462 ' O ' ' O ' ' C' ' 703' ' ' PRO . . . 51.9 173.73 0.01 OUTLIER 'General case' 0 N--CA 1.488 1.462 0 O-C-N 121.345 -0.847 . . . . 0.0 110.033 179.441 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' C' C ' 705' ' ' B27 . . . . . 0.563 ' OG1' ' NE1' ' A' ' 194' ' ' TRP . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 700' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 017 nuclear orig full ' A' A ' 59' ' ' MET . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 N--CA 1.491 1.597 0 N-CA-C 109.335 -0.617 . . . . 0.0 109.335 . . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 60' ' ' GLN . . . . . . . . . . . . . 1.8 mp0 -60.32 -170.23 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.044 -1.035 . . . . 0.0 109.922 -179.846 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . -62.2 154.07 28.51 Favored 'General case' 0 N--CA 1.488 1.443 0 O-C-N 121.351 -0.843 . . . . 0.0 109.265 179.87 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 62' ' ' LYS . . . . . . . . . . . . . 10.3 tttm -139.9 69.22 36.24 Favored Pre-proline 0 N--CA 1.491 1.583 0 C-N-CA 119.578 -0.849 . . . . 0.0 109.548 -179.547 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 63' ' ' PRO . . . . . . . . . . . . . 75.7 Cg_endo -81.23 148.63 16.81 Favored 'Trans proline' 0 C--N 1.303 -1.824 0 C-N-CA 123.455 2.77 . . . . 0.0 111.488 179.571 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 64' ' ' GLN . . . . . 0.602 HE21 ' C ' ' A' ' 64' ' ' GLN . 0.0 OUTLIER -156.31 117.53 3.83 Favored 'General case' 0 N--CA 1.496 1.87 0 O-C-N 121.118 -0.989 . . . . 0.0 109.39 179.664 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 65' ' ' ILE . . . . . 0.408 ' C ' ' O ' ' A' ' 64' ' ' GLN . 3.2 mp -43.86 104.39 0.37 Allowed Pre-proline 0 N--CA 1.494 1.767 0 O-C-N 120.972 -1.08 . . . . 0.0 109.119 179.48 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 66' ' ' PRO . . . . . . . . . . . . . 83.8 Cg_endo -87.34 -158.81 0.09 OUTLIER 'Trans proline' 0 C--N 1.315 -1.23 0 C-N-CA 122.287 1.991 . . . . 0.0 112.651 -179.476 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 67' ' ' LYS . . . . . 0.467 ' CG ' ' O ' ' A' ' 67' ' ' LYS . 19.5 tttm -77.86 -6.87 55.65 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.306 -0.871 . . . . 0.0 108.7 179.516 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 68' ' ' ASP . . . . . 0.611 ' C ' ' H ' ' A' ' 70' ' ' SER . 3.6 t0 -76.5 48.04 0.52 Allowed 'General case' 0 N--CA 1.489 1.488 0 CA-C-O 122.237 1.018 . . . . 0.0 109.05 179.477 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 69' ' ' LYS . . . . . 0.456 ' C ' ' O ' ' A' ' 68' ' ' ASP . 9.5 ptpt -49.11 -14.57 0.08 Allowed 'General case' 0 N--CA 1.503 2.186 0 C-N-CA 116.845 -1.942 . . . . 0.0 106.863 178.234 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 70' ' ' SER . . . . . 0.611 ' H ' ' C ' ' A' ' 68' ' ' ASP . 1.8 t -82.85 -8.49 59.57 Favored 'General case' 0 N--CA 1.494 1.764 0 CA-C-N 113.629 -1.623 . . . . 0.0 110.15 179.958 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 71' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -97.54 145.93 25.76 Favored 'General case' 0 N--CA 1.492 1.665 0 O-C-N 120.981 -1.074 . . . . 0.0 109.929 179.109 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 1.1 m -65.24 140.06 20.33 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.58 0 N-CA-C 105.046 -2.205 . . . . 0.0 105.046 174.853 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 73' ' ' ALA . . . . . 0.543 ' N ' ' O ' ' A' ' 87' ' ' VAL . . . -80.64 -18.61 47.54 Favored 'General case' 0 C--N 1.291 -1.935 0 O-C-N 120.022 -1.674 . . . . 0.0 106.645 179.764 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 74' ' ' GLY . . . . . 0.453 ' O ' ' N ' ' A' ' 87' ' ' VAL . . . 176.16 -159.05 26.08 Favored Glycine 0 N--CA 1.483 1.796 0 N-CA-C 109.721 -1.352 . . . . 0.0 109.721 179.323 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 75' ' ' TYR . . . . . 0.417 ' CD2' ' HA ' ' A' ' 86' ' ' PRO . 92.1 m-85 -140.77 166.66 24.16 Favored 'General case' 0 C--N 1.299 -1.619 0 O-C-N 121.62 -0.929 . . . . 0.0 110.63 -177.268 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 76' ' ' ILE . . . . . . . . . . . . . 1.7 tt -147.71 143.39 19.64 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.551 0 C-N-CA 118.98 -1.088 . . . . 0.0 109.959 -178.189 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 77' ' ' GLU . . . . . 0.56 ' N ' ' CD ' ' A' ' 77' ' ' GLU . 2.3 mp0 -147.31 164.35 33.52 Favored 'General case' 0 N--CA 1.487 1.424 0 O-C-N 121.116 -0.99 . . . . 0.0 108.823 -179.831 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 78' ' ' ILE . . . . . 0.438 ' O ' ' N ' ' A' ' 82' ' ' ASP . 5.1 mt -147.5 93.39 4.62 Favored Pre-proline 0 N--CA 1.49 1.552 0 N-CA-C 108.181 -1.044 . . . . 0.0 108.181 179.674 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 79' ' ' PRO . . . . . . . . . . . . . 80.7 Cg_exo -46.87 -48.49 14.18 Favored 'Trans proline' 0 N--CA 1.494 1.527 0 C-N-CA 122.995 2.464 . . . . 0.0 114.098 -178.428 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -64.8 -18.98 65.58 Favored 'General case' 0 N--CA 1.494 1.73 0 O-C-N 120.868 -1.145 . . . . 0.0 110.749 178.968 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 81' ' ' ALA . . . . . 0.552 ' O ' ' ND2' ' A' ' 132' ' ' ASN . . . -105.5 -17.49 14.4 Favored 'General case' 0 N--CA 1.492 1.663 0 O-C-N 121.176 -0.953 . . . . 0.0 108.488 179.207 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 82' ' ' ASP . . . . . 0.438 ' N ' ' O ' ' A' ' 78' ' ' ILE . 0.7 OUTLIER 67.93 51.12 0.78 Allowed 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.528 -0.732 . . . . 0.0 110.453 179.022 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 83' ' ' ILE . . . . . . . . . . . . . 70.8 mt -128.75 151.57 35.72 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.756 0 O-C-N 121.343 -0.848 . . . . 0.0 110.074 -178.768 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 84' ' ' LYS . . . . . 0.45 ' CG ' ' O ' ' A' ' 84' ' ' LYS . 7.7 pttt -158.37 107.86 2.03 Favored 'General case' 0 N--CA 1.494 1.757 0 N-CA-C 108.345 -0.984 . . . . 0.0 108.345 -179.923 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -142.34 166.12 23.1 Favored Pre-proline 0 N--CA 1.496 1.833 0 O-C-N 121.234 -0.916 . . . . 0.0 110.759 -179.064 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 86' ' ' PRO . . . . . 0.417 ' HA ' ' CD2' ' A' ' 75' ' ' TYR . 73.8 Cg_endo -77.35 166.35 26.25 Favored 'Trans proline' 0 N--CA 1.498 1.761 0 C-N-CA 123.333 2.689 . . . . 0.0 113.652 -179.225 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 87' ' ' VAL . . . . . 0.543 ' O ' ' N ' ' A' ' 73' ' ' ALA . 39.9 t -122.83 100.95 8.82 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.651 0 O-C-N 121.735 -0.603 . . . . 0.0 109.422 179.953 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 88' ' ' TYR . . . . . 0.458 ' CE2' ' CD ' ' A' ' 99' ' ' ARG . 7.5 m-85 -89.73 173.61 5.69 Favored Pre-proline 0 N--CA 1.499 2.005 0 O-C-N 120.946 -1.096 . . . . 0.0 109.468 -179.684 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 89' ' ' PRO . . . . . . . . . . . . . 9.4 Cg_endo -83.84 145.61 11.44 Favored 'Trans proline' 0 N--CA 1.484 0.96 0 C-N-CA 122.064 1.843 . . . . 0.0 113.898 -177.982 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . -55.97 164.41 4.8 Favored Glycine 0 N--CA 1.487 2.069 0 N-CA-C 109.081 -1.608 . . . . 0.0 109.081 179.133 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 91' ' ' PRO . . . . . 0.5 ' C ' ' H ' ' A' ' 93' ' ' THR . 58.0 Cg_endo -91.5 167.27 27.37 Favored 'Cis proline' 0 C--N 1.305 -1.747 0 C-N-CA 123.408 -1.497 . . . . 0.0 112.401 0.69 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 92' ' ' ALA . . . . . . . . . . . . . . . -73.21 30.52 0.07 Allowed 'General case' 0 C--N 1.303 -1.449 0 C-N-CA 119.887 -0.725 . . . . 0.0 110.091 -179.944 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 93' ' ' THR . . . . . 0.5 ' H ' ' C ' ' A' ' 91' ' ' PRO . 6.5 p -71.5 150.6 93.82 Favored Pre-proline 0 N--CA 1.489 1.493 0 O-C-N 121.034 -1.041 . . . . 0.0 108.847 -179.289 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 94' ' ' PRO . . . . . . . . . . . . . 77.8 Cg_exo -33.35 -49.03 0.45 Allowed 'Trans proline' 0 C--N 1.308 -1.562 0 C-N-CA 122.898 2.398 . . . . 0.0 112.385 -178.9 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 95' ' ' GLU . . . . . 0.544 ' O ' ' ND2' ' A' ' 98' ' ' ASN . 5.4 mp0 -49.83 -51.36 40.5 Favored 'General case' 0 C--N 1.3 -1.551 0 O-C-N 121.317 -0.865 . . . . 0.0 109.773 -179.838 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 96' ' ' GLN . . . . . 0.566 ' O ' ' N ' ' A' ' 98' ' ' ASN . 3.3 mp0 -72.32 -50.76 24.45 Favored 'General case' 0 N--CA 1.489 1.493 0 O-C-N 120.99 -1.069 . . . . 0.0 109.954 179.908 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 97' ' ' LEU . . . . . 0.627 ' CD2' ' CE1' ' A' ' 120' ' ' HIS . 1.3 mp -48.5 -8.75 0.02 OUTLIER 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.135 -0.978 . . . . 0.0 109.737 -179.786 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 98' ' ' ASN . . . . . 0.566 ' N ' ' O ' ' A' ' 96' ' ' GLN . 0.4 OUTLIER -72.66 -28.01 62.46 Favored 'General case' 0 N--CA 1.489 1.479 0 O-C-N 121.379 -0.826 . . . . 0.0 109.346 179.868 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 99' ' ' ARG . . . . . 0.627 HH11 ' CG ' ' A' ' 99' ' ' ARG . 0.2 OUTLIER -96.17 -57.61 2.29 Favored 'General case' 0 N--CA 1.488 1.428 0 C-N-CA 119.79 -0.764 . . . . 0.0 110.186 -179.526 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . -170.2 -162.8 23.15 Favored Glycine 0 N--CA 1.493 2.468 0 C-N-CA 119.383 -1.389 . . . . 0.0 110.531 -179.934 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 101' ' ' VAL . . . . . 0.534 ' O ' ' CG2' ' A' ' 101' ' ' VAL . 13.7 m -64.58 106.27 0.57 Allowed 'Isoleucine or valine' 0 N--CA 1.496 1.845 0 O-C-N 121.698 -0.883 . . . . 0.0 109.351 -179.61 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -92.57 161.44 14.59 Favored 'General case' 0 N--CA 1.494 1.731 0 O-C-N 121.23 -0.919 . . . . 0.0 110.679 -179.55 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 103' ' ' PHE . . . . . . . . . . . . . 23.8 m-85 -63.6 150.42 44.14 Favored 'General case' 0 N--CA 1.489 1.48 0 N-CA-C 107.724 -1.213 . . . . 0.0 107.724 178.11 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 104' ' ' ALA . . . . . . . . . . . . . . . -69.71 -13.08 62.11 Favored 'General case' 0 N--CA 1.492 1.652 0 O-C-N 120.998 -1.064 . . . . 0.0 111.309 -178.504 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -136.3 142.01 43.87 Favored 'General case' 0 N--CA 1.498 1.97 0 O-C-N 120.841 -1.162 . . . . 0.0 110.803 -179.307 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 106' ' ' GLU . . . . . . . . . . . . . 2.3 tm-20 -51.89 -61.64 2.13 Favored 'General case' 0 N--CA 1.489 1.495 0 O-C-N 121.883 -0.511 . . . . 0.0 110.675 -179.556 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 107' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER -76.63 34.49 0.14 Allowed 'General case' 0 N--CA 1.489 1.52 0 O-C-N 120.698 -1.251 . . . . 0.0 112.251 -175.832 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 108' ' ' GLU . . . . . . . . . . . . . 29.6 tp10 -55.22 146.74 18.12 Favored 'General case' 0 C--N 1.303 -1.422 0 O-C-N 120.585 -1.322 . . . . 0.0 107.624 179.681 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 109' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -103.59 143.49 32.68 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 120.941 -1.099 . . . . 0.0 110.901 -178.038 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 110' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -64.47 -16.47 62.53 Favored 'General case' 0 C--N 1.303 -1.447 0 N-CA-C 108.884 -0.784 . . . . 0.0 108.884 179.217 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 111' ' ' ASP . . . . . . . . . . . . . 74.0 m-20 -132.97 35.99 3.51 Favored 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.248 -0.907 . . . . 0.0 110.298 -179.539 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 112' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -66.52 153.36 43.15 Favored 'General case' 0 N--CA 1.493 1.7 0 O-C-N 120.825 -1.172 . . . . 0.0 111.203 -179.673 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 113' ' ' GLN . . . . . 0.561 ' NE2' ' O ' ' A' ' 173' ' ' LYS . 0.0 OUTLIER -67.77 -13.78 62.41 Favored 'General case' 0 N--CA 1.494 1.755 0 CA-C-O 121.949 0.88 . . . . 0.0 109.537 178.677 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 114' ' ' ASN . . . . . 0.615 ' O ' ' ND2' ' A' ' 114' ' ' ASN . 0.3 OUTLIER -150.33 106.71 3.48 Favored 'General case' 0 C--N 1.298 -1.669 0 N-CA-C 107.205 -1.405 . . . . 0.0 107.205 179.477 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 115' ' ' ILE . . . . . . . . . . . . . 1.5 mm -94.23 104.52 15.86 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.737 0 O-C-N 120.534 -1.354 . . . . 0.0 108.823 -179.459 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 116' ' ' SER . . . . . 0.581 ' HG ' HD22 ' A' ' 114' ' ' ASN . 42.8 m -82.55 153.12 25.68 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.291 -0.881 . . . . 0.0 110.986 -178.182 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 117' ' ' ILE . . . . . . . . . . . . . 7.9 mt -151.13 147.12 15.8 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.437 0 N-CA-C 108.207 -1.034 . . . . 0.0 108.207 179.736 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 118' ' ' ALA . . . . . . . . . . . . . . . -144.89 160.97 40.45 Favored 'General case' 0 N--CA 1.491 1.582 0 C-N-CA 118.742 -1.183 . . . . 0.0 111.435 -179.948 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 119' ' ' GLY . . . . . . . . . . . . . . . -167.95 151.0 17.71 Favored Glycine 0 N--CA 1.485 1.939 0 N-CA-C 109.65 -1.38 . . . . 0.0 109.65 179.718 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 120' ' ' HIS . . . . . 0.627 ' CE1' ' CD2' ' A' ' 97' ' ' LEU . 3.9 m-70 -70.91 167.73 18.41 Favored 'General case' 0 N--CA 1.493 1.699 0 O-C-N 121.639 -0.918 . . . . 0.0 109.972 179.689 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 121' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -121.39 157.95 29.37 Favored 'General case' 0 N--CA 1.496 1.842 0 N-CA-C 108.363 -0.977 . . . . 0.0 108.363 178.954 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 122' ' ' PHE . . . . . 0.406 ' O ' ' CG2' ' A' ' 131' ' ' THR . 0.1 OUTLIER -140.66 121.97 14.92 Favored 'General case' 0 N--CA 1.498 1.934 0 O-C-N 120.927 -1.108 . . . . 0.0 110.31 -179.234 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 123' ' ' ILE . . . . . 0.417 ' CG2' ' N ' ' A' ' 124' ' ' ASP . 8.6 tt -59.44 -38.54 75.61 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.485 0 O-C-N 121.556 -0.715 . . . . 0.0 110.096 -179.884 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 124' ' ' ASP . . . . . 0.417 ' N ' ' CG2' ' A' ' 123' ' ' ILE . 0.1 OUTLIER -90.97 18.29 6.85 Favored 'General case' 0 N--CA 1.496 1.858 0 C-N-CA 119.659 -0.816 . . . . 0.0 111.988 -177.718 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 125' ' ' ARG . . . . . 0.434 HH11 ' CG ' ' A' ' 125' ' ' ARG . 0.3 OUTLIER -152.08 99.31 2.9 Favored Pre-proline 0 N--CA 1.493 1.706 0 O-C-N 120.521 -1.362 . . . . 0.0 109.719 -179.821 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 126' ' ' PRO . . . . . . . . . . . . . 58.4 Cg_endo -77.55 -19.03 13.31 Favored 'Trans proline' 0 N--CA 1.489 1.236 0 C-N-CA 122.061 1.841 . . . . 0.0 112.143 179.697 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 127' ' ' ASN . . . . . 0.489 ' O ' ' O ' ' A' ' 128' ' ' TYR . 0.7 OUTLIER -91.29 2.59 56.27 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.301 -0.874 . . . . 0.0 109.948 -179.811 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 128' ' ' TYR . . . . . 0.679 ' CE2' ' NE2' ' A' ' 129' ' ' GLN . 2.5 t80 -57.82 -148.83 0.0 OUTLIER 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.182 -0.949 . . . . 0.0 110.025 -179.657 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 129' ' ' GLN . . . . . 0.679 ' NE2' ' CE2' ' A' ' 128' ' ' TYR . 0.5 OUTLIER -65.39 -71.24 0.19 Allowed 'General case' 0 N--CA 1.493 1.703 0 O-C-N 121.316 -0.865 . . . . 0.0 109.871 -179.387 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 130' ' ' PHE . . . . . 0.513 ' CZ ' ' CG1' ' A' ' 101' ' ' VAL . 28.8 m-85 -135.16 39.78 2.91 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.288 -0.883 . . . . 0.0 109.808 -179.633 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 131' ' ' THR . . . . . 0.544 ' O ' ' CD ' ' A' ' 134' ' ' LYS . 60.5 m -74.94 -32.88 61.86 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.246 -0.909 . . . . 0.0 109.354 179.858 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 132' ' ' ASN . . . . . 0.552 ' ND2' ' O ' ' A' ' 81' ' ' ALA . 22.1 t30 -92.83 14.12 18.32 Favored 'General case' 0 N--CA 1.498 1.972 0 C-N-CA 119.698 -0.801 . . . . 0.0 111.63 -178.889 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 133' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -68.5 -26.98 65.73 Favored 'General case' 0 N--CA 1.496 1.875 0 O-C-N 120.582 -1.324 . . . . 0.0 109.429 -179.92 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 134' ' ' LYS . . . . . 0.593 ' H ' ' CD ' ' A' ' 134' ' ' LYS . 0.0 OUTLIER -46.14 -28.71 1.29 Allowed 'General case' 0 N--CA 1.495 1.817 0 O-C-N 121.401 -0.812 . . . . 0.0 110.937 -179.176 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 135' ' ' ALA . . . . . . . . . . . . . . . -83.37 -22.61 32.74 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 120.758 -1.214 . . . . 0.0 109.954 -179.189 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 136' ' ' ALA . . . . . . . . . . . . . . . -79.79 138.02 37.14 Favored 'General case' 0 C--N 1.3 -1.559 0 O-C-N 121.29 -0.881 . . . . 0.0 111.405 -178.897 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 137' ' ' LYS . . . . . 0.554 ' O ' ' O ' ' A' ' 138' ' ' LYS . 6.3 mttt -151.46 -170.26 3.6 Favored 'General case' 0 N--CA 1.494 1.77 0 C-N-CA 118.639 -1.225 . . . . 0.0 111.221 -178.231 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 138' ' ' LYS . . . . . 0.554 ' O ' ' O ' ' A' ' 137' ' ' LYS . 15.4 tttt -32.55 163.96 0.0 OUTLIER 'General case' 0 N--CA 1.492 1.653 0 CA-C-O 122.902 1.334 . . . . 0.0 112.342 -178.204 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 139' ' ' GLY . . . . . . . . . . . . . . . 49.68 8.73 0.14 Allowed Glycine 0 N--CA 1.491 2.317 0 N-CA-C 110.146 -1.182 . . . . 0.0 110.146 179.78 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 140' ' ' SER . . . . . 0.516 ' H ' ' C ' ' A' ' 138' ' ' LYS . 2.0 m -69.33 130.01 41.39 Favored 'General case' 0 N--CA 1.495 1.812 0 O-C-N 120.803 -1.41 . . . . 0.0 109.194 179.539 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 141' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -83.78 123.17 29.6 Favored 'General case' 0 N--CA 1.489 1.498 0 O-C-N 121.224 -0.923 . . . . 0.0 109.214 179.743 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 142' ' ' VAL . . . . . . . . . . . . . 2.4 t -112.99 132.12 62.7 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.576 0 N-CA-C 108.069 -1.086 . . . . 0.0 108.069 179.75 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 143' ' ' TYR . . . . . . . . . . . . . 5.3 m-85 -108.65 134.24 51.65 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.025 -1.047 . . . . 0.0 110.897 -178.42 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 144' ' ' PHE . . . . . . . . . . . . . 44.8 t80 -120.13 102.62 8.64 Favored 'General case' 0 N--CA 1.489 1.524 0 N-CA-C 109.056 -0.72 . . . . 0.0 109.056 179.633 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 145' ' ' LYS . . . . . . . . . . . . . 25.2 tttm -100.21 129.99 46.29 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.319 -0.863 . . . . 0.0 110.868 -179.008 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 146' ' ' VAL . . . . . 0.441 ' O ' ' C ' ' A' ' 147' ' ' GLY . 6.8 p -142.43 146.51 22.2 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.566 0 N-CA-C 107.805 -1.183 . . . . 0.0 107.805 178.415 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 147' ' ' GLY . . . . . 0.441 ' C ' ' O ' ' A' ' 146' ' ' VAL . . . 42.61 -124.08 3.84 Favored Glycine 0 N--CA 1.491 2.355 0 N-CA-C 109.336 -1.506 . . . . 0.0 109.336 -179.795 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 148' ' ' ASN . . . . . 0.513 ' C ' ' ND2' ' A' ' 148' ' ' ASN . 0.4 OUTLIER -108.36 15.62 23.84 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.483 -1.01 . . . . 0.0 109.041 179.393 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 149' ' ' GLU . . . . . . . . . . . . . 8.7 tt0 -112.28 144.02 42.4 Favored 'General case' 0 N--CA 1.489 1.479 0 O-C-N 121.388 -0.82 . . . . 0.0 111.444 -178.288 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 150' ' ' THR . . . . . . . . . . . . . 29.9 m -127.25 104.12 7.78 Favored 'General case' 0 N--CA 1.49 1.541 0 CA-C-O 121.373 0.606 . . . . 0.0 109.6 179.561 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 151' ' ' ARG . . . . . . . . . . . . . 15.4 mtp180 -88.17 -173.1 4.08 Favored 'General case' 0 C--N 1.301 -1.513 0 N-CA-C 107.748 -1.204 . . . . 0.0 107.748 179.357 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 152' ' ' LYS . . . . . 0.472 ' O ' ' N ' ' A' ' 205' ' ' VAL . 15.4 mtmm -149.15 150.74 33.17 Favored 'General case' 0 C--N 1.298 -1.67 0 O-C-N 120.811 -1.181 . . . . 0.0 109.728 -179.678 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 153' ' ' TYR . . . . . 0.504 ' CD2' ' HA ' ' A' ' 204' ' ' GLU . 27.6 m-85 -142.97 164.47 29.99 Favored 'General case' 0 C--N 1.297 -1.697 0 N-CA-C 107.695 -1.224 . . . . 0.0 107.695 178.69 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 154' ' ' LYS . . . . . . . . . . . . . 26.2 ttpp -140.31 118.01 11.64 Favored 'General case' 0 C--N 1.296 -1.745 0 N-CA-C 108.308 -0.997 . . . . 0.0 108.308 179.499 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 155' ' ' MET . . . . . . . . . . . . . 36.8 mtp -44.95 109.09 0.14 Allowed 'General case' 0 N--CA 1.497 1.895 0 O-C-N 120.507 -1.371 . . . . 0.0 111.344 -178.307 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 156' ' ' THR . . . . . 0.54 ' OG1' ' CG2' ' A' ' 203' ' ' THR . 0.2 OUTLIER -107.59 -26.79 10.72 Favored 'General case' 0 C--N 1.298 -1.645 0 CA-C-N 115.452 -0.794 . . . . 0.0 110.893 -178.858 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 157' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -154.03 153.33 31.75 Favored 'General case' 0 N--CA 1.5 2.044 0 C-N-CA 118.171 -1.411 . . . . 0.0 111.903 -178.334 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 158' ' ' ILE . . . . . 0.476 ' CD1' ' CD1' ' A' ' 200' ' ' PHE . 0.2 OUTLIER -154.49 146.91 13.61 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.425 0 CA-C-O 122.068 0.937 . . . . 0.0 111.383 -178.946 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 159' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -153.35 158.48 41.6 Favored 'General case' 0 C--N 1.299 -1.612 0 CA-C-O 121.707 0.765 . . . . 0.0 109.86 179.834 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 160' ' ' ASP . . . . . . . . . . . . . 7.9 m-20 -116.52 156.46 26.87 Favored 'General case' 0 N--CA 1.491 1.597 0 N-CA-C 108.081 -1.081 . . . . 0.0 108.081 179.254 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 161' ' ' VAL . . . . . 0.486 ' O ' ' O ' ' A' ' 162' ' ' LYS . 14.8 m -155.35 154.25 6.93 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.921 0 O-C-N 120.841 -1.162 . . . . 0.0 111.357 -178.507 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 162' ' ' LYS . . . . . 0.486 ' O ' ' O ' ' A' ' 161' ' ' VAL . 0.0 OUTLIER -43.25 170.46 0.04 OUTLIER Pre-proline 0 N--CA 1.495 1.799 0 O-C-N 121.555 -0.716 . . . . 0.0 109.986 179.651 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 163' ' ' PRO . . . . . . . . . . . . . 65.2 Cg_endo -79.56 30.9 0.47 Allowed 'Trans proline' 0 N--CA 1.492 1.408 0 C-N-CA 122.904 2.403 . . . . 0.0 113.071 179.82 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 164' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -151.02 0.31 0.39 Allowed 'General case' 0 N--CA 1.495 1.789 0 O-C-N 121.064 -1.022 . . . . 0.0 110.11 -179.968 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 165' ' ' ASP . . . . . 0.438 ' O ' ' C ' ' A' ' 166' ' ' VAL . 13.0 t70 -75.46 63.9 1.53 Allowed 'General case' 0 N--CA 1.489 1.491 0 O-C-N 121.251 -0.906 . . . . 0.0 110.362 -179.749 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 166' ' ' VAL . . . . . 0.685 ' O ' ' N ' ' A' ' 168' ' ' VAL . 1.0 OUTLIER -39.73 -31.12 0.15 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.517 0 O-C-N 121.14 -0.975 . . . . 0.0 109.79 -178.668 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 167' ' ' GLY . . . . . 0.428 ' N ' ' O ' ' A' ' 165' ' ' ASP . . . -41.48 -12.01 0.01 OUTLIER Glycine 0 N--CA 1.496 2.652 0 N-CA-C 110.288 -1.125 . . . . 0.0 110.288 -179.94 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 168' ' ' VAL . . . . . 0.685 ' N ' ' O ' ' A' ' 166' ' ' VAL . 3.5 t -49.03 -42.52 14.56 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.432 0 O-C-N 121.121 -1.223 . . . . 0.0 108.841 179.235 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 169' ' ' LEU . . . . . 0.551 ' O ' ' C ' ' A' ' 170' ' ' ASP . 10.8 mt -46.84 -14.71 0.03 OUTLIER 'General case' 0 N--CA 1.491 1.601 0 N-CA-C 108.444 -0.947 . . . . 0.0 108.444 -178.274 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 170' ' ' ASP . . . . . 0.555 ' N ' ' O ' ' A' ' 168' ' ' VAL . 32.7 p30 17.78 91.26 0.01 OUTLIER 'General case' 0 N--CA 1.505 2.319 0 N-CA-C 111.927 0.343 . . . . 0.0 111.927 177.206 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 171' ' ' GLU . . . . . 0.619 ' H ' HE21 ' A' ' 172' ' ' GLN . 3.0 pt-20 -141.48 78.79 1.65 Allowed 'General case' 0 N--CA 1.494 1.733 0 O-C-N 120.732 -1.23 . . . . 0.0 110.272 179.965 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 172' ' ' GLN . . . . . 0.619 HE21 ' H ' ' A' ' 171' ' ' GLU . 32.3 mm-40 -130.13 -47.51 1.11 Allowed 'General case' 0 N--CA 1.499 2.002 0 O-C-N 121.282 -0.886 . . . . 0.0 110.967 -178.788 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 173' ' ' LYS . . . . . 0.561 ' O ' ' NE2' ' A' ' 113' ' ' GLN . 0.0 OUTLIER -60.48 137.85 58.1 Favored 'General case' 0 N--CA 1.498 1.967 0 O-C-N 120.894 -1.129 . . . . 0.0 109.064 -179.894 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 174' ' ' GLY . . . . . 0.533 ' O ' ' C ' ' A' ' 175' ' ' LYS . . . -122.93 -44.09 0.34 Allowed Glycine 0 N--CA 1.481 1.648 0 N-CA-C 108.093 -2.003 . . . . 0.0 108.093 179.547 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 175' ' ' LYS . . . . . 0.533 ' C ' ' O ' ' A' ' 174' ' ' GLY . 3.0 mmtt -40.48 -63.87 0.58 Allowed 'General case' 0 N--CA 1.491 1.59 0 N-CA-C 107.072 -1.455 . . . . 0.0 107.072 178.725 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 176' ' ' ASP . . . . . 0.589 ' O ' ' O ' ' A' ' 177' ' ' LYS . 1.2 p-10 -104.7 88.18 2.86 Favored 'General case' 0 C--N 1.299 -1.614 0 N-CA-C 108.207 -1.035 . . . . 0.0 108.207 177.428 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 177' ' ' LYS . . . . . 0.589 ' O ' ' O ' ' A' ' 176' ' ' ASP . 23.6 mttm -47.32 -174.19 0.0 OUTLIER 'General case' 0 N--CA 1.499 1.978 0 N-CA-C 108.793 -0.817 . . . . 0.0 108.793 179.936 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 178' ' ' GLN . . . . . 0.506 ' NE2' ' OD1' ' A' ' 114' ' ' ASN . 0.0 OUTLIER -162.59 167.28 23.53 Favored 'General case' 0 C--N 1.303 -1.419 0 O-C-N 120.267 -1.521 . . . . 0.0 110.862 179.626 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 179' ' ' LEU . . . . . 0.402 ' HB2' ' CD2' ' A' ' 153' ' ' TYR . 0.9 OUTLIER -119.03 98.03 5.98 Favored 'General case' 0 C--N 1.304 -1.408 0 N-CA-C 107.028 -1.471 . . . . 0.0 107.028 177.976 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 180' ' ' THR . . . . . 0.504 ' OG1' ' OD1' ' A' ' 170' ' ' ASP . 1.3 m -76.98 116.13 17.38 Favored 'General case' 0 C--N 1.302 -1.488 0 O-C-N 121.411 -0.806 . . . . 0.0 110.205 -178.449 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 181' ' ' LEU . . . . . 0.4 HD13 ' H ' ' A' ' 182' ' ' ILE . 54.4 tp -93.78 152.08 19.17 Favored 'General case' 0 C--N 1.301 -1.537 0 N-CA-C 107.774 -1.195 . . . . 0.0 107.774 177.715 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 182' ' ' ILE . . . . . 0.4 ' H ' HD13 ' A' ' 181' ' ' LEU . 85.4 mt -141.07 117.88 7.81 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.713 0 O-C-N 121.009 -1.057 . . . . 0.0 108.687 179.247 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 183' ' ' THR . . . . . 0.416 ' O ' ' CG2' ' A' ' 183' ' ' THR . 10.1 t -131.12 111.44 11.98 Favored 'General case' 0 C--N 1.292 -1.908 0 N-CA-C 108.039 -1.097 . . . . 0.0 108.039 179.485 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 184' ' ' CYS . . . . . . . . . . . . . 0.8 OUTLIER -78.46 153.06 31.76 Favored 'General case' 0 C--N 1.289 -2.044 0 C-N-CA 118.882 -1.127 . . . . 0.0 110.583 -177.977 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 185' ' ' ASP . . . . . . . . . . . . . 2.5 t0 -166.1 -159.13 0.37 Allowed 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.616 -0.677 . . . . 0.0 109.504 -179.447 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 186' ' ' ASP . . . . . . . . . . . . . 1.2 m-20 55.79 52.78 10.28 Favored 'General case' 0 N--CA 1.493 1.717 0 O-C-N 121.233 -0.917 . . . . 0.0 109.453 179.977 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 187' ' ' TYR . . . . . 0.628 ' CE2' ' O ' ' A' ' 188' ' ' ASN . 64.5 t80 -67.96 134.18 50.32 Favored 'General case' 0 C--N 1.3 -1.551 0 O-C-N 121.063 -1.023 . . . . 0.0 110.949 -179.508 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 188' ' ' ASN . . . . . 0.628 ' O ' ' CE2' ' A' ' 187' ' ' TYR . 0.7 OUTLIER -101.46 146.46 27.59 Favored 'General case' 0 C--N 1.295 -1.766 0 N-CA-C 108.091 -1.077 . . . . 0.0 108.091 178.201 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 189' ' ' GLU . . . . . . . . . . . . . 3.1 tt0 -109.65 -12.17 14.68 Favored 'General case' 0 C--N 1.292 -1.923 0 N-CA-C 108.458 -0.942 . . . . 0.0 108.458 -179.793 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 190' ' ' LYS . . . . . . . . . . . . . 11.7 mtpt -85.75 -55.03 4.17 Favored 'General case' 0 C--N 1.302 -1.469 0 N-CA-C 109.079 -0.712 . . . . 0.0 109.079 178.908 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 191' ' ' THR . . . . . . . . . . . . . 1.2 p -89.55 1.59 55.74 Favored 'General case' 0 N--CA 1.494 1.729 0 O-C-N 121.236 -0.915 . . . . 0.0 110.073 -179.754 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 192' ' ' GLY . . . . . . . . . . . . . . . 52.78 40.89 57.27 Favored Glycine 0 N--CA 1.496 2.644 0 O-C-N 120.97 -1.081 . . . . 0.0 110.969 179.169 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 193' ' ' VAL . . . . . 0.477 ' CG1' ' N ' ' A' ' 194' ' ' TRP . 52.9 t -149.65 160.5 5.01 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.653 0 O-C-N 120.858 -1.377 . . . . 0.0 109.356 178.999 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 194' ' ' TRP . . . . . 0.477 ' N ' ' CG1' ' A' ' 193' ' ' VAL . 12.7 m95 -82.94 118.98 23.86 Favored 'General case' 0 N--CA 1.491 1.586 0 N-CA-C 107.989 -1.115 . . . . 0.0 107.989 179.308 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 195' ' ' GLU . . . . . . . . . . . . . 2.1 mt-10 -75.88 -60.46 2.31 Favored 'General case' 0 N--CA 1.494 1.769 0 O-C-N 121.336 -0.853 . . . . 0.0 111.538 -177.745 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 196' ' ' LYS . . . . . . . . . . . . . 16.8 mmtp -92.01 153.18 19.6 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 120.901 -1.124 . . . . 0.0 111.262 -178.047 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 197' ' ' ARG . . . . . . . . . . . . . 21.5 mmm180 -119.17 138.97 52.58 Favored 'General case' 0 N--CA 1.488 1.471 0 N-CA-C 107.825 -1.176 . . . . 0.0 107.825 178.659 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 198' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -116.77 116.68 27.95 Favored 'General case' 0 C--N 1.301 -1.519 0 O-C-N 121.61 -0.681 . . . . 0.0 110.192 -178.715 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 199' ' ' ILE . . . . . 0.418 ' C ' ' CD1' ' A' ' 199' ' ' ILE . 0.6 OUTLIER -141.18 122.26 13.4 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.685 0 CA-C-O 122.338 1.066 . . . . 0.0 109.842 179.456 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 200' ' ' PHE . . . . . 0.622 ' CD1' ' N ' ' A' ' 200' ' ' PHE . 0.2 OUTLIER -106.33 142.1 36.56 Favored 'General case' 0 N--CA 1.494 1.769 0 O-C-N 121.438 -0.789 . . . . 0.0 110.318 -178.55 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 201' ' ' VAL . . . . . . . . . . . . . 47.6 t -104.45 150.11 7.66 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.532 0 N-CA-C 108.476 -0.935 . . . . 0.0 108.476 178.555 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 202' ' ' ALA . . . . . . . . . . . . . . . -131.37 139.38 49.47 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.246 -0.909 . . . . 0.0 109.035 -179.802 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 203' ' ' THR . . . . . 0.54 ' CG2' ' OG1' ' A' ' 156' ' ' THR . 25.1 p -88.86 127.46 35.63 Favored 'General case' 0 C--N 1.303 -1.452 0 CA-C-O 122.354 1.073 . . . . 0.0 110.917 -178.57 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 204' ' ' GLU . . . . . 0.504 ' HA ' ' CD2' ' A' ' 153' ' ' TYR . 1.7 tt0 -48.75 134.35 16.34 Favored 'General case' 0 C--N 1.297 -1.713 0 C-N-CA 118.873 -1.131 . . . . 0.0 109.248 179.83 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 205' ' ' VAL . . . . . 0.498 ' CG1' ' N ' ' A' ' 206' ' ' LYS . 72.7 t -126.54 163.6 28.44 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.361 0 CA-C-O 122.141 0.972 . . . . 0.0 110.039 -177.674 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 206' ' ' LYS . . . . . 0.498 ' N ' ' CG1' ' A' ' 205' ' ' VAL . 0.2 OUTLIER . . . . . 0 C--N 1.291 -1.949 0 CA-C-O 118.024 -0.989 . . . . 0.0 109.45 -179.981 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' C' C ' 701' ' ' PHQ . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 017 nuclear orig full ' C' C ' 702' ' ' LEU . . . . . 0.652 ' CD1' ' N ' ' C' ' 702' ' ' LEU . 0.0 OUTLIER . . . . . 0 N--CA 1.489 1.511 0 N-CA-C 109.303 -0.628 . . . . 0.0 109.303 . . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' C' C ' 703' ' ' PRO . . . . . 0.495 ' O ' ' O ' ' C' ' 704' ' ' ALA . 96.9 Cg_endo -79.79 -174.44 2.27 Favored 'Trans proline' 0 N--CA 1.495 1.612 0 C-N-CA 122.94 2.427 . . . . 0.0 113.524 -179.418 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' C' C ' 704' ' ' ALA . . . . . 0.495 ' O ' ' O ' ' C' ' 703' ' ' PRO . . . 39.4 -165.39 0.0 OUTLIER 'General case' 0 N--CA 1.491 1.579 0 CA-C-O 121.744 0.783 . . . . 0.0 110.544 179.076 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' C' C ' 705' ' ' B27 . . . . . 0.521 ' SG ' ' ND1' ' A' ' 120' ' ' HIS . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 700' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 018 nuclear orig full ' A' A ' 59' ' ' MET . . . . . 0.425 ' H1 ' ' H ' ' A' ' 60' ' ' GLN . 8.9 mmt . . . . . 0 N--CA 1.49 1.529 0 N-CA-C 109.406 -0.59 . . . . 0.0 109.406 . . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 60' ' ' GLN . . . . . 0.723 ' NE2' ' H ' ' A' ' 61' ' ' ALA . 0.1 OUTLIER -61.34 160.19 11.18 Favored 'General case' 0 N--CA 1.493 1.693 0 O-C-N 121.367 -0.833 . . . . 0.0 109.644 179.92 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 61' ' ' ALA . . . . . 0.723 ' H ' ' NE2' ' A' ' 60' ' ' GLN . . . -65.18 169.61 5.41 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.057 -1.027 . . . . 0.0 109.143 179.522 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 62' ' ' LYS . . . . . . . . . . . . . 64.9 tttt -147.24 86.1 6.59 Favored Pre-proline 0 C--N 1.303 -1.417 0 O-C-N 121.184 -0.947 . . . . 0.0 109.535 -179.677 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 63' ' ' PRO . . . . . . . . . . . . . 5.3 Cg_exo -71.95 130.1 16.23 Favored 'Trans proline' 0 C--N 1.307 -1.626 0 C-N-CA 122.483 2.122 . . . . 0.0 112.269 -179.891 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 64' ' ' GLN . . . . . 0.74 ' N ' HE21 ' A' ' 64' ' ' GLN . 0.0 OUTLIER -150.34 101.75 3.0 Favored 'General case' 0 N--CA 1.494 1.732 0 O-C-N 121.205 -0.935 . . . . 0.0 109.618 -179.891 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 65' ' ' ILE . . . . . 0.471 ' C ' ' O ' ' A' ' 64' ' ' GLN . 2.8 mp -39.79 100.83 0.22 Allowed Pre-proline 0 N--CA 1.491 1.603 0 N-CA-C 108.557 -0.905 . . . . 0.0 108.557 179.523 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 66' ' ' PRO . . . . . 0.423 ' N ' ' O ' ' A' ' 64' ' ' GLN . 71.8 Cg_endo -83.87 -155.32 0.06 OUTLIER 'Trans proline' 0 C--N 1.317 -1.118 0 C-N-CA 122.286 1.991 . . . . 0.0 112.679 -178.311 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 67' ' ' LYS . . . . . 0.414 ' C ' ' H ' ' A' ' 69' ' ' LYS . 8.5 ptmt -83.93 -4.94 59.08 Favored 'General case' 0 C--N 1.304 -1.371 0 O-C-N 121.391 -0.818 . . . . 0.0 109.388 -179.825 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 68' ' ' ASP . . . . . 0.588 ' C ' ' N ' ' A' ' 70' ' ' SER . 0.1 OUTLIER -73.82 51.47 0.38 Allowed 'General case' 0 N--CA 1.491 1.58 0 CA-C-O 122.566 1.174 . . . . 0.0 108.326 179.52 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 69' ' ' LYS . . . . . 0.598 ' O ' ' NH1' ' A' ' 99' ' ' ARG . 12.0 mtmm -49.49 -16.11 0.19 Allowed 'General case' 0 N--CA 1.497 1.888 0 C-N-CA 116.949 -1.9 . . . . 0.0 107.152 178.857 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 70' ' ' SER . . . . . 0.588 ' N ' ' C ' ' A' ' 68' ' ' ASP . 1.2 t -83.94 -7.16 59.49 Favored 'General case' 0 C--N 1.293 -1.89 0 CA-C-N 113.995 -1.457 . . . . 0.0 110.22 179.976 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 71' ' ' LYS . . . . . 0.413 ' O ' ' CG ' ' A' ' 71' ' ' LYS . 1.0 OUTLIER -96.84 141.41 30.07 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.126 -0.984 . . . . 0.0 110.826 179.825 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 2.3 m -65.01 139.62 21.1 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.522 0 N-CA-C 103.988 -2.597 . . . . 0.0 103.988 174.361 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 73' ' ' ALA . . . . . 0.511 ' N ' ' O ' ' A' ' 87' ' ' VAL . . . -81.21 -14.18 57.8 Favored 'General case' 0 C--N 1.292 -1.917 0 C-N-CA 117.11 -1.836 . . . . 0.0 106.203 179.799 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . 169.07 -152.04 19.12 Favored Glycine 0 N--CA 1.481 1.677 0 N-CA-C 109.873 -1.291 . . . . 0.0 109.873 178.868 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 75' ' ' TYR . . . . . 0.468 ' CD2' ' O ' ' A' ' 85' ' ' GLU . 2.3 m-85 -142.59 173.25 11.7 Favored 'General case' 0 C--N 1.298 -1.639 0 CA-C-O 122.085 0.945 . . . . 0.0 110.545 -178.118 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 76' ' ' ILE . . . . . . . . . . . . . 1.6 tp -147.9 141.88 19.3 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.682 0 C-N-CA 119.93 -0.708 . . . . 0.0 109.142 -176.954 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 77' ' ' GLU . . . . . 0.563 ' N ' ' OE1' ' A' ' 77' ' ' GLU . 0.0 OUTLIER -149.96 163.07 39.08 Favored 'General case' 0 C--N 1.304 -1.39 0 O-C-N 121.014 -1.054 . . . . 0.0 109.244 178.913 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 78' ' ' ILE . . . . . 0.495 ' O ' ' N ' ' A' ' 82' ' ' ASP . 7.9 mt -144.35 100.57 4.82 Favored Pre-proline 0 C--N 1.302 -1.496 0 O-C-N 121.338 -0.851 . . . . 0.0 109.022 179.991 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 79' ' ' PRO . . . . . . . . . . . . . 81.9 Cg_exo -48.25 -50.55 11.84 Favored 'Trans proline' 0 N--CA 1.493 1.469 0 C-N-CA 122.794 2.329 . . . . 0.0 113.632 -179.453 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -65.94 -18.93 65.67 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 120.889 -1.132 . . . . 0.0 111.098 178.906 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 81' ' ' ALA . . . . . 0.543 ' O ' ' ND2' ' A' ' 132' ' ' ASN . . . -105.32 -16.93 14.62 Favored 'General case' 0 N--CA 1.494 1.734 0 O-C-N 121.069 -1.019 . . . . 0.0 108.81 179.521 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 82' ' ' ASP . . . . . 0.495 ' N ' ' O ' ' A' ' 78' ' ' ILE . 9.1 t0 65.81 50.47 1.54 Allowed 'General case' 0 N--CA 1.493 1.704 0 O-C-N 121.372 -0.83 . . . . 0.0 111.368 178.157 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 83' ' ' ILE . . . . . . . . . . . . . 45.2 mt -130.66 153.94 39.86 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.92 0 O-C-N 121.14 -0.975 . . . . 0.0 109.668 -179.273 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 84' ' ' LYS . . . . . . . . . . . . . 30.8 ttmt -158.01 110.25 2.33 Favored 'General case' 0 N--CA 1.497 1.88 0 N-CA-C 108.184 -1.043 . . . . 0.0 108.184 179.991 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 85' ' ' GLU . . . . . 0.497 ' OE1' ' O ' ' A' ' 129' ' ' GLN . 0.0 OUTLIER -141.33 167.2 17.92 Favored Pre-proline 0 N--CA 1.499 1.976 0 O-C-N 121.281 -0.887 . . . . 0.0 110.871 -178.45 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 86' ' ' PRO . . . . . . . . . . . . . 55.8 Cg_endo -74.75 161.92 38.53 Favored 'Trans proline' 0 N--CA 1.497 1.722 0 C-N-CA 123.263 2.642 . . . . 0.0 113.108 -179.869 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 87' ' ' VAL . . . . . 0.511 ' O ' ' N ' ' A' ' 73' ' ' ALA . 55.7 t -123.32 99.79 7.09 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.844 0 O-C-N 121.686 -0.634 . . . . 0.0 109.337 179.582 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 88' ' ' TYR . . . . . . . . . . . . . 15.3 m-85 -89.99 155.1 47.56 Favored Pre-proline 0 N--CA 1.496 1.849 0 O-C-N 120.835 -1.166 . . . . 0.0 109.423 179.861 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 89' ' ' PRO . . . . . . . . . . . . . 11.8 Cg_endo -64.39 146.66 90.12 Favored 'Trans proline' 0 N--CA 1.496 1.642 0 C-N-CA 122.529 2.152 . . . . 0.0 113.952 -179.343 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . -59.04 167.59 7.06 Favored Glycine 0 N--CA 1.495 2.609 0 N-CA-C 110.382 -1.087 . . . . 0.0 110.382 179.663 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 91' ' ' PRO . . . . . 0.465 ' C ' ' H ' ' A' ' 93' ' ' THR . 90.2 Cg_endo -93.48 168.68 20.81 Favored 'Cis proline' 0 C--N 1.314 -1.237 0 C-N-CA 123.592 -1.42 . . . . 0.0 111.762 0.569 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 92' ' ' ALA . . . . . . . . . . . . . . . -72.03 33.04 0.06 Allowed 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.032 -1.042 . . . . 0.0 110.713 -179.9 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 93' ' ' THR . . . . . 0.465 ' H ' ' C ' ' A' ' 91' ' ' PRO . 3.3 p -71.18 150.39 94.54 Favored Pre-proline 0 N--CA 1.488 1.472 0 O-C-N 120.668 -1.27 . . . . 0.0 108.157 -179.865 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 94' ' ' PRO . . . . . 0.421 ' C ' ' O ' ' A' ' 93' ' ' THR . 87.3 Cg_exo -30.35 -56.26 0.19 Allowed 'Trans proline' 0 C--N 1.308 -1.6 0 C-N-CA 123.007 2.471 . . . . 0.0 112.672 -179.011 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 98.6 mt-10 -51.06 -46.32 61.67 Favored 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.12 -0.988 . . . . 0.0 109.825 -179.76 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 96' ' ' GLN . . . . . 0.422 ' OE1' ' CZ ' ' A' ' 99' ' ' ARG . 1.1 mp0 -71.92 -36.95 70.1 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.387 -0.821 . . . . 0.0 110.712 -179.375 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 97' ' ' LEU . . . . . . . . . . . . . 89.0 mt -68.4 -5.94 21.85 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 120.833 -1.167 . . . . 0.0 109.248 -179.682 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 98' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER -78.24 -27.05 47.53 Favored 'General case' 0 N--CA 1.492 1.673 0 O-C-N 121.319 -0.863 . . . . 0.0 109.893 179.42 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 99' ' ' ARG . . . . . 0.598 ' NH1' ' O ' ' A' ' 69' ' ' LYS . 63.8 mtt180 -91.07 -43.5 9.88 Favored 'General case' 0 N--CA 1.488 1.47 0 O-C-N 121.531 -0.731 . . . . 0.0 109.956 -178.524 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . 169.81 -171.7 43.43 Favored Glycine 0 N--CA 1.49 2.28 0 N-CA-C 109.898 -1.281 . . . . 0.0 109.898 -179.992 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 101' ' ' VAL . . . . . 0.527 ' O ' ' CG2' ' A' ' 101' ' ' VAL . 13.0 m -57.48 106.63 0.18 Allowed 'Isoleucine or valine' 0 N--CA 1.494 1.758 0 O-C-N 121.401 -1.058 . . . . 0.0 109.152 -179.915 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 102' ' ' SER . . . . . 0.418 ' HG ' ' C ' ' A' ' 91' ' ' PRO . 0.0 OUTLIER -92.52 163.31 13.86 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 120.87 -1.144 . . . . 0.0 111.184 -179.176 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 103' ' ' PHE . . . . . 0.484 ' CZ ' ' CG1' ' A' ' 87' ' ' VAL . 25.0 m-85 -70.46 141.85 52.0 Favored 'General case' 0 N--CA 1.489 1.501 0 N-CA-C 108.145 -1.057 . . . . 0.0 108.145 178.334 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 104' ' ' ALA . . . . . . . . . . . . . . . -58.73 -15.86 14.0 Favored 'General case' 0 C--N 1.3 -1.548 0 O-C-N 121.474 -0.766 . . . . 0.0 111.104 -178.828 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -139.07 144.24 38.68 Favored 'General case' 0 N--CA 1.492 1.65 0 O-C-N 120.906 -1.121 . . . . 0.0 110.082 -179.304 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 106' ' ' GLU . . . . . . . . . . . . . 6.3 tt0 -58.1 -55.43 35.04 Favored 'General case' 0 C--N 1.299 -1.618 0 O-C-N 121.892 -0.505 . . . . 0.0 110.599 -179.363 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 107' ' ' ASN . . . . . 0.498 ' N ' ' ND2' ' A' ' 107' ' ' ASN . 1.8 m120 -77.85 35.15 0.2 Allowed 'General case' 0 N--CA 1.487 1.395 0 O-C-N 120.622 -1.299 . . . . 0.0 112.223 -176.152 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 108' ' ' GLU . . . . . . . . . . . . . 21.7 tp10 -57.81 139.82 53.15 Favored 'General case' 0 N--CA 1.488 1.457 0 N-CA-C 107.605 -1.257 . . . . 0.0 107.605 179.635 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 109' ' ' SER . . . . . 0.404 ' OG ' ' OD2' ' A' ' 112' ' ' ASP . 0.9 OUTLIER -93.08 146.53 23.57 Favored 'General case' 0 C--N 1.302 -1.486 0 O-C-N 120.97 -1.081 . . . . 0.0 110.776 -178.08 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 110' ' ' LEU . . . . . 0.461 ' H ' ' CD2' ' A' ' 110' ' ' LEU . 0.3 OUTLIER -62.66 -24.5 67.65 Favored 'General case' 0 C--N 1.303 -1.424 0 N-CA-C 107.281 -1.377 . . . . 0.0 107.281 178.641 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 111' ' ' ASP . . . . . . . . . . . . . 4.0 m-20 -133.03 48.95 2.35 Favored 'General case' 0 N--CA 1.485 1.298 0 N-CA-C 109.396 -0.594 . . . . 0.0 109.396 179.663 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 112' ' ' ASP . . . . . 0.404 ' OD2' ' OG ' ' A' ' 109' ' ' SER . 1.7 t0 -69.33 159.47 33.06 Favored 'General case' 0 N--CA 1.494 1.731 0 O-C-N 121.127 -0.983 . . . . 0.0 111.333 -179.608 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 113' ' ' GLN . . . . . 0.547 ' N ' ' CD ' ' A' ' 113' ' ' GLN . 0.0 OUTLIER -64.63 -17.98 64.52 Favored 'General case' 0 N--CA 1.491 1.607 0 N-CA-C 107.361 -1.348 . . . . 0.0 107.361 177.668 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 114' ' ' ASN . . . . . 0.682 ' ND2' ' NE2' ' A' ' 178' ' ' GLN . 59.9 t-20 -153.55 111.81 3.62 Favored 'General case' 0 C--N 1.298 -1.662 0 N-CA-C 107.803 -1.184 . . . . 0.0 107.803 177.631 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 115' ' ' ILE . . . . . 0.442 HD12 HG21 ' A' ' 115' ' ' ILE . 2.8 mt -93.6 102.8 14.01 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.557 0 O-C-N 120.988 -1.07 . . . . 0.0 108.128 -179.935 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 116' ' ' SER . . . . . . . . . . . . . 72.3 m -81.76 141.31 33.64 Favored 'General case' 0 N--CA 1.488 1.453 0 CA-C-O 122.088 0.947 . . . . 0.0 112.114 -177.001 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 117' ' ' ILE . . . . . . . . . . . . . 28.2 mt -138.05 140.85 39.78 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.474 0 N-CA-C 107.357 -1.349 . . . . 0.0 107.357 178.609 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 118' ' ' ALA . . . . . . . . . . . . . . . -141.98 155.58 45.45 Favored 'General case' 0 N--CA 1.489 1.492 0 C-N-CA 118.63 -1.228 . . . . 0.0 111.043 -178.967 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 119' ' ' GLY . . . . . . . . . . . . . . . -166.8 152.55 21.55 Favored Glycine 0 N--CA 1.483 1.813 0 N-CA-C 109.967 -1.253 . . . . 0.0 109.967 179.769 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 120' ' ' HIS . . . . . 0.575 ' CD2' ' SG ' ' C' ' 705' ' ' B27 . 26.4 m170 -71.73 142.1 49.78 Favored 'General case' 0 N--CA 1.493 1.71 0 O-C-N 121.604 -0.939 . . . . 0.0 110.592 179.864 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 121' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -99.06 153.36 18.94 Favored 'General case' 0 N--CA 1.496 1.835 0 N-CA-C 107.896 -1.15 . . . . 0.0 107.896 178.419 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 122' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -116.85 140.69 49.15 Favored 'General case' 0 N--CA 1.496 1.869 0 O-C-N 121.139 -0.976 . . . . 0.0 110.603 -179.676 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 123' ' ' ILE . . . . . . . . . . . . . 15.7 tt -90.28 -33.13 5.76 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.641 0 CA-C-O 121.876 0.846 . . . . 0.0 109.083 179.619 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 124' ' ' ASP . . . . . . . . . . . . . 80.0 m-20 -89.78 3.08 53.95 Favored 'General case' 0 N--CA 1.497 1.888 0 CA-C-N 116.069 -0.514 . . . . 0.0 111.772 -178.706 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 125' ' ' ARG . . . . . 0.651 HH11 ' CG ' ' A' ' 125' ' ' ARG . 1.7 mtt-85 -151.3 120.7 3.53 Favored Pre-proline 0 N--CA 1.499 1.995 0 O-C-N 120.383 -1.448 . . . . 0.0 110.114 -179.193 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 126' ' ' PRO . . . . . . . . . . . . . 88.9 Cg_endo -81.48 -18.99 7.95 Favored 'Trans proline' 0 N--CA 1.489 1.257 0 C-N-CA 122.279 1.986 . . . . 0.0 112.396 179.199 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 127' ' ' ASN . . . . . 0.514 ' O ' ' O ' ' A' ' 128' ' ' TYR . 3.9 m120 -92.65 4.35 53.84 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.274 -0.891 . . . . 0.0 110.109 -179.759 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 128' ' ' TYR . . . . . 0.514 ' O ' ' O ' ' A' ' 127' ' ' ASN . 9.1 t80 -58.7 -147.25 0.0 OUTLIER 'General case' 0 N--CA 1.488 1.447 0 O-C-N 121.283 -0.886 . . . . 0.0 109.337 179.995 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 129' ' ' GLN . . . . . 0.497 ' O ' ' OE1' ' A' ' 85' ' ' GLU . 12.7 mt-30 -64.96 -91.23 0.01 OUTLIER 'General case' 0 N--CA 1.493 1.724 0 O-C-N 120.833 -1.167 . . . . 0.0 110.284 -178.941 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 130' ' ' PHE . . . . . 0.409 ' CZ ' ' OE2' ' A' ' 85' ' ' GLU . 44.2 m-85 -114.28 48.0 1.15 Allowed 'General case' 0 N--CA 1.496 1.835 0 O-C-N 121.159 -0.963 . . . . 0.0 109.355 179.851 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 131' ' ' THR . . . . . 0.526 ' O ' ' CD ' ' A' ' 134' ' ' LYS . 56.9 m -77.83 -26.54 49.51 Favored 'General case' 0 C--N 1.3 -1.558 0 O-C-N 121.213 -0.93 . . . . 0.0 109.563 -179.998 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 132' ' ' ASN . . . . . 0.543 ' ND2' ' O ' ' A' ' 81' ' ' ALA . 12.4 t30 -90.23 13.36 15.46 Favored 'General case' 0 N--CA 1.5 2.042 0 C-N-CA 119.759 -0.776 . . . . 0.0 111.932 -178.855 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 133' ' ' LEU . . . . . 0.448 ' O ' ' N ' ' A' ' 136' ' ' ALA . 0.2 OUTLIER -67.97 -29.81 68.94 Favored 'General case' 0 N--CA 1.495 1.779 0 O-C-N 120.399 -1.438 . . . . 0.0 109.594 -179.749 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 134' ' ' LYS . . . . . 0.656 ' H ' ' CD ' ' A' ' 134' ' ' LYS . 0.0 OUTLIER -44.09 -29.96 0.69 Allowed 'General case' 0 N--CA 1.496 1.862 0 O-C-N 121.43 -0.794 . . . . 0.0 110.455 -179.432 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 135' ' ' ALA . . . . . . . . . . . . . . . -84.76 -21.39 30.03 Favored 'General case' 0 N--CA 1.488 1.466 0 O-C-N 121.045 -1.034 . . . . 0.0 109.937 -179.621 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 136' ' ' ALA . . . . . 0.448 ' N ' ' O ' ' A' ' 133' ' ' LEU . . . -81.74 137.69 35.31 Favored 'General case' 0 C--N 1.301 -1.526 0 CA-C-O 122.039 0.924 . . . . 0.0 111.957 -178.336 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 137' ' ' LYS . . . . . 0.513 ' O ' ' OG ' ' A' ' 140' ' ' SER . 3.9 tttt -156.59 -166.0 2.02 Favored 'General case' 0 C--N 1.299 -1.604 0 C-N-CA 118.824 -1.15 . . . . 0.0 110.857 -179.349 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 138' ' ' LYS . . . . . 0.622 ' O ' ' N ' ' A' ' 140' ' ' SER . 29.0 mttt -46.61 -178.36 0.0 OUTLIER 'General case' 0 C--N 1.3 -1.549 0 CA-C-O 121.873 0.844 . . . . 0.0 110.107 -179.916 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 139' ' ' GLY . . . . . . . . . . . . . . . 44.95 8.41 0.01 OUTLIER Glycine 0 N--CA 1.489 2.198 0 N-CA-C 110.641 -0.984 . . . . 0.0 110.641 179.56 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 140' ' ' SER . . . . . 0.622 ' N ' ' O ' ' A' ' 138' ' ' LYS . 45.8 m -94.55 128.49 41.2 Favored 'General case' 0 N--CA 1.489 1.503 0 O-C-N 120.723 -1.457 . . . . 0.0 109.247 179.47 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 141' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -81.66 127.54 33.01 Favored 'General case' 0 C--N 1.3 -1.545 0 O-C-N 121.288 -0.883 . . . . 0.0 108.792 179.809 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 142' ' ' VAL . . . . . . . . . . . . . 12.8 t -113.72 135.13 54.33 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.553 0 N-CA-C 108.788 -0.819 . . . . 0.0 108.788 -179.529 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 143' ' ' TYR . . . . . 0.539 ' CE1' ' CG ' ' A' ' 152' ' ' LYS . 9.5 m-85 -111.36 136.13 50.93 Favored 'General case' 0 N--CA 1.493 1.7 0 O-C-N 121.012 -1.055 . . . . 0.0 110.316 -178.886 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 144' ' ' PHE . . . . . 0.463 ' CG ' ' N ' ' A' ' 145' ' ' LYS . 44.6 t80 -113.37 160.1 18.75 Favored 'General case' 0 N--CA 1.493 1.696 0 CA-C-O 122.072 0.939 . . . . 0.0 110.806 -178.263 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 145' ' ' LYS . . . . . 0.463 ' N ' ' CG ' ' A' ' 144' ' ' PHE . 36.7 tttm -148.13 125.23 11.41 Favored 'General case' 0 C--N 1.301 -1.525 0 C-N-CA 119.25 -0.98 . . . . 0.0 110.761 -178.546 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 146' ' ' VAL . . . . . . . . . . . . . 11.8 p -145.82 138.94 20.95 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.63 0 N-CA-C 106.827 -1.545 . . . . 0.0 106.827 178.625 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 147' ' ' GLY . . . . . . . . . . . . . . . 58.67 -141.23 46.7 Favored Glycine 0 N--CA 1.486 1.985 0 N-CA-C 108.359 -1.896 . . . . 0.0 108.359 -179.273 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 148' ' ' ASN . . . . . 0.536 ' C ' HD21 ' A' ' 148' ' ' ASN . 0.4 OUTLIER -101.79 24.75 9.44 Favored 'General case' 0 C--N 1.296 -1.741 0 N-CA-C 107.821 -1.177 . . . . 0.0 107.821 178.821 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 149' ' ' GLU . . . . . . . . . . . . . 2.0 tm-20 -116.52 159.24 22.37 Favored 'General case' 0 N--CA 1.49 1.54 0 CA-C-O 121.796 0.808 . . . . 0.0 110.727 -179.086 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 150' ' ' THR . . . . . . . . . . . . . 11.1 m -140.15 109.44 6.17 Favored 'General case' 0 N--CA 1.492 1.666 0 N-CA-C 109.029 -0.73 . . . . 0.0 109.029 179.212 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 151' ' ' ARG . . . . . . . . . . . . . 9.8 mtt180 -89.16 -161.01 0.72 Allowed 'General case' 0 N--CA 1.489 1.495 0 CA-C-O 121.546 0.688 . . . . 0.0 110.433 -178.586 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 152' ' ' LYS . . . . . 0.539 ' CG ' ' CE1' ' A' ' 143' ' ' TYR . 9.3 mtmt -148.26 148.78 30.85 Favored 'General case' 0 N--CA 1.486 1.359 0 O-C-N 121.394 -0.816 . . . . 0.0 110.326 -179.187 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 153' ' ' TYR . . . . . 0.406 ' CD1' ' C ' ' A' ' 152' ' ' LYS . 52.8 m-85 -146.31 158.66 43.91 Favored 'General case' 0 C--N 1.303 -1.433 0 N-CA-C 108.111 -1.07 . . . . 0.0 108.111 179.277 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 154' ' ' LYS . . . . . . . . . . . . . 15.1 ttmm -137.1 121.5 18.21 Favored 'General case' 0 N--CA 1.495 1.824 0 O-C-N 121.186 -0.946 . . . . 0.0 108.538 179.053 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 155' ' ' MET . . . . . . . . . . . . . 5.7 mtt -47.96 107.79 0.14 Allowed 'General case' 0 N--CA 1.493 1.685 0 O-C-N 120.913 -1.117 . . . . 0.0 111.193 -178.588 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 156' ' ' THR . . . . . 0.537 ' HG1' ' HG1' ' A' ' 203' ' ' THR . 0.3 OUTLIER -108.02 -25.51 11.12 Favored 'General case' 0 C--N 1.293 -1.872 0 CA-C-N 115.3 -0.864 . . . . 0.0 109.635 -179.342 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 157' ' ' SER . . . . . . . . . . . . . 60.7 m -149.87 146.3 27.03 Favored 'General case' 0 C--N 1.299 -1.626 0 C-N-CA 118.61 -1.236 . . . . 0.0 110.455 -179.048 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 158' ' ' ILE . . . . . . . . . . . . . 3.8 mp -151.48 141.73 15.71 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.445 0 CA-C-O 121.925 0.869 . . . . 0.0 109.988 -179.274 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 159' ' ' ARG . . . . . 0.419 HH21 HG12 ' A' ' 161' ' ' VAL . 3.0 ttp180 -155.09 -171.98 4.02 Favored 'General case' 0 C--N 1.292 -1.897 0 C-N-CA 119.67 -0.812 . . . . 0.0 110.394 -179.601 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 160' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -145.67 161.17 40.48 Favored 'General case' 0 C--N 1.301 -1.539 0 N-CA-C 108.0 -1.111 . . . . 0.0 108.0 -179.725 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 161' ' ' VAL . . . . . 0.489 ' O ' ' O ' ' A' ' 162' ' ' LYS . 0.0 OUTLIER -154.4 155.62 5.89 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.645 0 O-C-N 120.755 -1.216 . . . . 0.0 110.835 -179.091 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 162' ' ' LYS . . . . . 0.489 ' O ' ' O ' ' A' ' 161' ' ' VAL . 0.2 OUTLIER -51.47 179.47 0.04 OUTLIER Pre-proline 0 C--N 1.305 -1.33 0 N-CA-C 107.153 -1.425 . . . . 0.0 107.153 178.064 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 163' ' ' PRO . . . . . 0.445 ' C ' ' HG1' ' A' ' 164' ' ' THR . 29.5 Cg_endo -87.69 45.79 1.2 Allowed 'Trans proline' 0 C--N 1.307 -1.631 0 C-N-CA 122.103 1.869 . . . . 0.0 111.748 -179.548 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 164' ' ' THR . . . . . 0.445 ' HG1' ' C ' ' A' ' 163' ' ' PRO . 7.5 m -153.28 -16.41 0.15 Allowed 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.268 -0.895 . . . . 0.0 110.671 -179.626 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 165' ' ' ASP . . . . . 0.489 ' O ' ' N ' ' A' ' 167' ' ' GLY . 0.4 OUTLIER -72.36 58.94 0.41 Allowed 'General case' 0 N--CA 1.493 1.699 0 O-C-N 120.791 -1.193 . . . . 0.0 110.397 -179.063 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 166' ' ' VAL . . . . . 0.59 ' O ' ' N ' ' A' ' 168' ' ' VAL . 1.0 OUTLIER -40.64 -27.22 0.09 OUTLIER 'Isoleucine or valine' 0 N--CA 1.489 1.515 0 O-C-N 121.297 -0.877 . . . . 0.0 109.129 -178.797 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 167' ' ' GLY . . . . . 0.489 ' N ' ' O ' ' A' ' 165' ' ' ASP . . . -46.48 -4.64 0.01 OUTLIER Glycine 0 N--CA 1.496 2.658 0 O-C-N 120.799 -1.188 . . . . 0.0 112.006 -179.768 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 168' ' ' VAL . . . . . 0.632 ' C ' ' H ' ' A' ' 170' ' ' ASP . 0.2 OUTLIER -51.76 -36.33 18.82 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.894 0 O-C-N 120.131 -1.805 . . . . 0.0 108.69 179.866 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 169' ' ' LEU . . . . . 0.536 ' O ' ' C ' ' A' ' 170' ' ' ASP . 5.3 mt -52.69 -6.17 0.05 OUTLIER 'General case' 0 N--CA 1.492 1.653 0 N-CA-C 108.7 -0.852 . . . . 0.0 108.7 -177.469 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 170' ' ' ASP . . . . . 0.632 ' H ' ' C ' ' A' ' 168' ' ' VAL . 47.6 t0 18.22 58.87 0.01 OUTLIER 'General case' 0 N--CA 1.496 1.868 0 N-CA-C 112.419 0.525 . . . . 0.0 112.419 176.999 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 171' ' ' GLU . . . . . . . . . . . . . 11.4 pt-20 -94.87 62.13 2.62 Favored 'General case' 0 N--CA 1.499 2.017 0 O-C-N 120.34 -1.475 . . . . 0.0 109.896 179.924 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 172' ' ' GLN . . . . . . . . . . . . . 0.6 OUTLIER -114.88 -63.63 1.43 Allowed 'General case' 0 N--CA 1.496 1.837 0 O-C-N 121.563 -0.71 . . . . 0.0 110.525 -178.711 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 173' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -60.18 127.58 32.54 Favored 'General case' 0 N--CA 1.496 1.831 0 O-C-N 121.216 -0.928 . . . . 0.0 109.751 -179.704 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 174' ' ' GLY . . . . . 0.49 ' O ' ' C ' ' A' ' 175' ' ' LYS . . . -117.1 -41.72 0.68 Allowed Glycine 0 N--CA 1.484 1.873 0 N-CA-C 108.824 -1.71 . . . . 0.0 108.824 179.682 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 175' ' ' LYS . . . . . 0.49 ' C ' ' O ' ' A' ' 174' ' ' GLY . 13.1 mptt -41.05 -59.78 1.38 Allowed 'General case' 0 N--CA 1.495 1.791 0 N-CA-C 107.804 -1.184 . . . . 0.0 107.804 179.573 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 176' ' ' ASP . . . . . 0.598 ' O ' ' O ' ' A' ' 177' ' ' LYS . 4.3 m-20 -103.22 83.04 2.14 Favored 'General case' 0 C--N 1.295 -1.791 0 N-CA-C 107.294 -1.373 . . . . 0.0 107.294 177.461 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 177' ' ' LYS . . . . . 0.598 ' O ' ' O ' ' A' ' 176' ' ' ASP . 2.6 mttt -43.59 -177.99 0.0 OUTLIER 'General case' 0 N--CA 1.494 1.73 0 O-C-N 121.425 -0.797 . . . . 0.0 109.464 -179.144 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 178' ' ' GLN . . . . . 0.682 ' NE2' ' ND2' ' A' ' 114' ' ' ASN . 0.0 OUTLIER -160.44 170.86 20.12 Favored 'General case' 0 C--N 1.302 -1.487 0 O-C-N 120.418 -1.426 . . . . 0.0 110.977 179.03 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 179' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -122.86 91.99 3.61 Favored 'General case' 0 C--N 1.302 -1.484 0 N-CA-C 107.446 -1.316 . . . . 0.0 107.446 178.493 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 180' ' ' THR . . . . . 0.444 ' HG1' HG23 ' A' ' 201' ' ' VAL . 1.3 m -71.74 118.32 14.44 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.172 -0.955 . . . . 0.0 110.457 -178.388 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 181' ' ' LEU . . . . . . . . . . . . . 41.1 tp -97.4 154.04 17.72 Favored 'General case' 0 C--N 1.3 -1.568 0 N-CA-C 107.458 -1.312 . . . . 0.0 107.458 177.57 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 182' ' ' ILE . . . . . . . . . . . . . 11.0 mt -145.77 121.31 3.33 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.554 0 O-C-N 120.613 -1.304 . . . . 0.0 110.489 179.496 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 183' ' ' THR . . . . . 0.517 ' CG2' ' O ' ' A' ' 183' ' ' THR . 5.2 t -134.44 116.8 15.57 Favored 'General case' 0 C--N 1.293 -1.865 0 N-CA-C 107.427 -1.323 . . . . 0.0 107.427 178.627 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 184' ' ' CYS . . . . . . . . . . . . . 5.1 p -78.57 157.15 28.85 Favored 'General case' 0 C--N 1.282 -2.337 0 C-N-CA 118.933 -1.107 . . . . 0.0 110.964 -177.687 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 185' ' ' ASP . . . . . . . . . . . . . 12.3 t0 -164.15 -157.47 0.39 Allowed 'General case' 0 N--CA 1.492 1.658 0 O-C-N 121.514 -0.742 . . . . 0.0 109.376 -179.613 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 186' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER 54.93 52.45 11.9 Favored 'General case' 0 N--CA 1.495 1.807 0 O-C-N 121.002 -1.061 . . . . 0.0 109.567 -179.7 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 187' ' ' TYR . . . . . 0.599 ' CE1' ' O ' ' A' ' 188' ' ' ASN . 63.4 t80 -67.69 134.36 50.96 Favored 'General case' 0 N--CA 1.493 1.675 0 O-C-N 121.122 -0.986 . . . . 0.0 110.582 -179.857 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 188' ' ' ASN . . . . . 0.599 ' O ' ' CE1' ' A' ' 187' ' ' TYR . 0.7 OUTLIER -101.52 145.66 28.71 Favored 'General case' 0 C--N 1.296 -1.749 0 N-CA-C 108.214 -1.032 . . . . 0.0 108.214 178.119 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 189' ' ' GLU . . . . . . . . . . . . . 2.0 tt0 -109.49 -14.31 14.42 Favored 'General case' 0 C--N 1.294 -1.81 0 N-CA-C 108.719 -0.845 . . . . 0.0 108.719 -179.557 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 190' ' ' LYS . . . . . . . . . . . . . 7.7 mttm -82.62 -54.47 5.14 Favored 'General case' 0 C--N 1.302 -1.489 0 N-CA-C 108.879 -0.785 . . . . 0.0 108.879 179.096 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 191' ' ' THR . . . . . . . . . . . . . 1.0 OUTLIER -88.48 -5.36 58.29 Favored 'General case' 0 C--N 1.301 -1.503 0 O-C-N 121.391 -0.818 . . . . 0.0 109.645 -179.756 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 192' ' ' GLY . . . . . . . . . . . . . . . 64.93 35.21 91.63 Favored Glycine 0 N--CA 1.496 2.697 0 O-C-N 120.992 -1.068 . . . . 0.0 111.928 177.988 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 193' ' ' VAL . . . . . . . . . . . . . 3.4 p -149.27 167.87 2.98 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.681 0 O-C-N 120.692 -1.475 . . . . 0.0 110.383 179.178 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 194' ' ' TRP . . . . . 0.53 ' N ' ' CD1' ' A' ' 194' ' ' TRP . 10.1 m95 -84.83 120.86 26.92 Favored 'General case' 0 N--CA 1.493 1.704 0 N-CA-C 108.813 -0.81 . . . . 0.0 108.813 -179.933 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 195' ' ' GLU . . . . . 0.507 ' CD ' ' ND2' ' A' ' 188' ' ' ASN . 6.8 mt-10 -79.35 -61.64 1.94 Allowed 'General case' 0 N--CA 1.493 1.689 0 O-C-N 121.424 -0.798 . . . . 0.0 111.241 -178.29 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 196' ' ' LYS . . . . . . . . . . . . . 0.9 OUTLIER -101.64 151.14 22.37 Favored 'General case' 0 N--CA 1.494 1.73 0 O-C-N 120.906 -1.121 . . . . 0.0 110.262 -179.216 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 197' ' ' ARG . . . . . 0.666 ' CG ' HH11 ' A' ' 197' ' ' ARG . 1.4 mtt-85 -120.5 153.59 36.45 Favored 'General case' 0 N--CA 1.489 1.497 0 N-CA-C 108.432 -0.951 . . . . 0.0 108.432 178.34 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 198' ' ' LYS . . . . . . . . . . . . . 1.1 mptp? -114.97 123.14 48.33 Favored 'General case' 0 C--N 1.3 -1.585 0 O-C-N 121.645 -0.659 . . . . 0.0 110.581 -177.882 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 199' ' ' ILE . . . . . 0.425 ' C ' ' CD1' ' A' ' 199' ' ' ILE . 0.5 OUTLIER -136.79 118.49 19.11 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.757 0 CA-C-O 122.748 1.261 . . . . 0.0 110.655 179.693 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 200' ' ' PHE . . . . . 0.556 ' CD1' ' N ' ' A' ' 200' ' ' PHE . 0.2 OUTLIER -100.15 134.64 42.77 Favored 'General case' 0 N--CA 1.5 2.054 0 CA-C-N 115.604 -0.725 . . . . 0.0 110.481 -178.161 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 201' ' ' VAL . . . . . 0.444 HG23 ' HG1' ' A' ' 180' ' ' THR . 52.9 t -103.48 141.34 19.45 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.992 0 O-C-N 120.721 -1.237 . . . . 0.0 108.554 177.922 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 202' ' ' ALA . . . . . . . . . . . . . . . -125.15 136.66 53.82 Favored 'General case' 0 N--CA 1.495 1.794 0 O-C-N 121.157 -0.964 . . . . 0.0 108.795 179.56 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 203' ' ' THR . . . . . 0.537 ' HG1' ' HG1' ' A' ' 156' ' ' THR . 1.2 p -88.98 134.66 33.9 Favored 'General case' 0 N--CA 1.49 1.529 0 CA-C-O 122.126 0.965 . . . . 0.0 111.383 -178.552 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 204' ' ' GLU . . . . . 0.404 ' HA ' ' CD2' ' A' ' 153' ' ' TYR . 2.6 tm-20 -62.53 135.07 57.23 Favored 'General case' 0 C--N 1.301 -1.541 0 C-N-CA 118.919 -1.113 . . . . 0.0 108.96 179.25 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 205' ' ' VAL . . . . . 0.54 ' O ' ' C ' ' A' ' 206' ' ' LYS . 71.5 t -123.9 -45.39 1.73 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.642 0 O-C-N 121.397 -0.814 . . . . 0.0 109.908 -178.91 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 206' ' ' LYS . . . . . 0.54 ' C ' ' O ' ' A' ' 205' ' ' VAL . 2.3 ttpt . . . . . 0 N--CA 1.496 1.838 0 CA-C-O 118.044 -0.979 . . . . 0.0 110.679 -179.655 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' C' C ' 701' ' ' PHQ . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 018 nuclear orig full ' C' C ' 702' ' ' LEU . . . . . 0.571 ' CD1' ' N ' ' C' ' 702' ' ' LEU . 0.0 OUTLIER . . . . . 0 N--CA 1.491 1.584 0 N-CA-C 108.412 -0.959 . . . . 0.0 108.412 . . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' C' C ' 703' ' ' PRO . . . . . 0.492 ' O ' ' O ' ' C' ' 704' ' ' ALA . 97.2 Cg_endo -77.88 -162.48 0.17 Allowed 'Trans proline' 0 N--CA 1.494 1.55 0 C-N-CA 122.521 2.148 . . . . 0.0 113.081 -179.509 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' C' C ' 704' ' ' ALA . . . . . 0.493 ' C ' ' SG ' ' C' ' 705' ' ' B27 . . . 41.41 98.84 0.0 OUTLIER 'General case' 0 N--CA 1.49 1.553 0 CA-C-O 121.443 0.64 . . . . 0.0 110.273 179.457 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' C' C ' 705' ' ' B27 . . . . . 0.575 ' SG ' ' CD2' ' A' ' 120' ' ' HIS . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 700' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 019 nuclear orig full ' A' A ' 59' ' ' MET . . . . . . . . . . . . . 5.0 mmt . . . . . 0 N--CA 1.49 1.549 0 N-CA-C 109.44 -0.578 . . . . 0.0 109.44 . . . . . . . . . 0 0 . 1 . 019 nuclear orig full ' A' A ' 60' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -59.74 -161.91 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.673 0 O-C-N 121.079 -1.013 . . . . 0.0 109.198 179.804 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . -64.35 -168.02 0.03 OUTLIER 'General case' 0 N--CA 1.488 1.445 0 O-C-N 121.245 -0.91 . . . . 0.0 109.276 179.83 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 62' ' ' LYS . . . . . . . . . . . . . 6.1 pttm -138.5 90.08 13.26 Favored Pre-proline 0 N--CA 1.487 1.391 0 O-C-N 121.207 -0.933 . . . . 0.0 109.403 -179.276 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 63' ' ' PRO . . . . . 0.581 ' O ' ' CD1' ' A' ' 110' ' ' LEU . 29.3 Cg_endo -86.51 131.28 3.42 Favored 'Trans proline' 0 C--N 1.309 -1.541 0 C-N-CA 122.965 2.443 . . . . 0.0 110.156 179.414 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 64' ' ' GLN . . . . . 0.425 ' O ' ' C ' ' A' ' 65' ' ' ILE . 0.0 OUTLIER -162.47 115.62 1.71 Allowed 'General case' 0 C--N 1.297 -1.686 0 O-C-N 121.165 -0.96 . . . . 0.0 109.976 -179.836 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 65' ' ' ILE . . . . . 0.425 ' C ' ' O ' ' A' ' 64' ' ' GLN . 2.7 mp -42.78 102.41 0.27 Allowed Pre-proline 0 N--CA 1.489 1.511 0 O-C-N 121.518 -0.739 . . . . 0.0 109.262 179.536 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 66' ' ' PRO . . . . . . . . . . . . . 72.7 Cg_endo -89.13 -154.21 0.05 OUTLIER 'Trans proline' 0 N--CA 1.492 1.414 0 C-N-CA 122.697 2.265 . . . . 0.0 113.004 -179.011 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 67' ' ' LYS . . . . . 0.481 ' CG ' ' O ' ' A' ' 67' ' ' LYS . 7.8 ttmm -81.06 -7.45 59.56 Favored 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.239 -0.913 . . . . 0.0 108.766 179.666 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 68' ' ' ASP . . . . . 0.605 ' C ' ' H ' ' A' ' 70' ' ' SER . 0.5 OUTLIER -75.1 52.89 0.59 Allowed 'General case' 0 C--N 1.304 -1.393 0 CA-C-O 122.524 1.154 . . . . 0.0 108.594 179.608 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 69' ' ' LYS . . . . . 0.437 ' C ' ' O ' ' A' ' 68' ' ' ASP . 14.9 ptpt -49.7 -15.07 0.15 Allowed 'General case' 0 N--CA 1.501 2.088 0 C-N-CA 117.26 -1.776 . . . . 0.0 106.469 177.961 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 70' ' ' SER . . . . . 0.605 ' H ' ' C ' ' A' ' 68' ' ' ASP . 3.7 m -85.92 -4.68 59.22 Favored 'General case' 0 N--CA 1.494 1.77 0 CA-C-N 113.516 -1.675 . . . . 0.0 110.739 179.571 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 71' ' ' LYS . . . . . . . . . . . . . 7.9 ptmt -97.73 142.53 29.39 Favored 'General case' 0 N--CA 1.497 1.877 0 O-C-N 120.913 -1.117 . . . . 0.0 111.985 -179.181 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 72' ' ' VAL . . . . . 0.579 ' CG2' ' O ' ' A' ' 74' ' ' GLY . 0.3 OUTLIER -67.52 135.0 29.34 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.507 0 N-CA-C 105.186 -2.153 . . . . 0.0 105.186 174.777 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 73' ' ' ALA . . . . . 0.535 ' N ' ' O ' ' A' ' 87' ' ' VAL . . . -80.93 -16.58 53.14 Favored 'General case' 0 C--N 1.298 -1.635 0 O-C-N 119.988 -1.695 . . . . 0.0 107.219 -179.556 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 74' ' ' GLY . . . . . 0.579 ' O ' ' CG2' ' A' ' 72' ' ' VAL . . . 167.04 -148.9 13.85 Favored Glycine 0 N--CA 1.486 1.98 0 C-N-CA 119.078 -1.534 . . . . 0.0 110.253 178.774 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 75' ' ' TYR . . . . . 0.551 ' CD1' ' C ' ' A' ' 74' ' ' GLY . 13.4 m-85 -144.91 174.79 10.71 Favored 'General case' 0 C--N 1.293 -1.885 0 O-C-N 121.153 -1.204 . . . . 0.0 109.921 -178.342 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 76' ' ' ILE . . . . . . . . . . . . . 0.4 OUTLIER -148.48 147.83 16.56 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.777 0 N-CA-C 108.124 -1.065 . . . . 0.0 108.124 -178.64 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 3.9 mt-10 -149.37 159.82 43.95 Favored 'General case' 0 C--N 1.302 -1.471 0 O-C-N 120.789 -1.194 . . . . 0.0 110.548 -179.353 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 78' ' ' ILE . . . . . 0.443 HG23 ' H ' ' A' ' 81' ' ' ALA . 83.3 mt -145.58 120.15 5.56 Favored Pre-proline 0 N--CA 1.488 1.442 0 N-CA-C 107.233 -1.395 . . . . 0.0 107.233 179.722 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 79' ' ' PRO . . . . . . . . . . . . . 68.9 Cg_endo -76.36 -39.66 0.76 Allowed 'Trans proline' 0 N--CA 1.493 1.468 0 C-N-CA 122.024 1.816 . . . . 0.0 113.613 -178.543 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 4.7 m-20 -65.72 -20.23 66.2 Favored 'General case' 0 N--CA 1.494 1.76 0 O-C-N 121.062 -1.024 . . . . 0.0 110.025 178.344 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 81' ' ' ALA . . . . . 0.575 ' O ' ' ND2' ' A' ' 132' ' ' ASN . . . -108.31 -18.63 13.71 Favored 'General case' 0 C--N 1.301 -1.535 0 N-CA-C 107.857 -1.164 . . . . 0.0 107.857 179.497 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 82' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER 67.41 54.72 0.68 Allowed 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.74 -0.6 . . . . 0.0 110.942 178.921 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 83' ' ' ILE . . . . . . . . . . . . . 61.2 mt -126.66 151.77 33.66 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.924 0 O-C-N 120.935 -1.103 . . . . 0.0 110.68 -179.02 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 84' ' ' LYS . . . . . . . . . . . . . 1.6 pttm -159.19 106.46 1.77 Allowed 'General case' 0 N--CA 1.489 1.512 0 N-CA-C 107.734 -1.21 . . . . 0.0 107.734 179.105 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 85' ' ' GLU . . . . . 0.435 ' OE2' ' O ' ' A' ' 129' ' ' GLN . 0.4 OUTLIER -141.6 174.16 4.09 Favored Pre-proline 0 N--CA 1.493 1.71 0 O-C-N 121.064 -1.023 . . . . 0.0 110.779 -178.344 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 86' ' ' PRO . . . . . 0.403 ' HA ' ' CD2' ' A' ' 75' ' ' TYR . 73.2 Cg_endo -83.96 157.75 13.55 Favored 'Trans proline' 0 N--CA 1.492 1.433 0 C-N-CA 123.147 2.565 . . . . 0.0 114.082 -178.869 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 87' ' ' VAL . . . . . 0.535 ' O ' ' N ' ' A' ' 73' ' ' ALA . 57.3 t -114.6 103.24 15.03 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.89 0 O-C-N 121.73 -0.606 . . . . 0.0 109.706 -179.816 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 88' ' ' TYR . . . . . . . . . . . . . 19.5 m-85 -94.83 153.71 39.97 Favored Pre-proline 0 N--CA 1.502 2.139 0 O-C-N 120.827 -1.17 . . . . 0.0 110.31 -179.916 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 89' ' ' PRO . . . . . . . . . . . . . 8.3 Cg_endo -58.4 145.38 94.24 Favored 'Trans proline' 0 N--CA 1.494 1.537 0 C-N-CA 122.908 2.405 . . . . 0.0 113.452 -179.514 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . -59.84 168.91 7.55 Favored Glycine 0 N--CA 1.492 2.384 0 N-CA-C 109.208 -1.557 . . . . 0.0 109.208 179.211 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 91' ' ' PRO . . . . . 0.484 ' C ' ' H ' ' A' ' 93' ' ' THR . 72.1 Cg_endo -93.24 170.45 19.98 Favored 'Cis proline' 0 C--N 1.306 -1.669 0 C-N-CA 123.765 -1.348 . . . . 0.0 111.903 -0.237 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 92' ' ' ALA . . . . . . . . . . . . . . . -72.44 32.15 0.06 Allowed 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.134 -0.979 . . . . 0.0 110.433 -179.892 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 93' ' ' THR . . . . . 0.484 ' H ' ' C ' ' A' ' 91' ' ' PRO . 1.1 p -73.51 149.9 88.86 Favored Pre-proline 0 C--N 1.302 -1.486 0 O-C-N 120.847 -1.158 . . . . 0.0 108.427 179.723 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 94' ' ' PRO . . . . . 0.412 ' C ' ' O ' ' A' ' 93' ' ' THR . 95.4 Cg_exo -35.54 -45.05 0.71 Allowed 'Trans proline' 0 C--N 1.304 -1.772 0 C-N-CA 122.438 2.092 . . . . 0.0 111.746 -179.615 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 95' ' ' GLU . . . . . 0.628 ' O ' ' ND2' ' A' ' 98' ' ' ASN . 7.1 mt-10 -49.97 -55.13 15.78 Favored 'General case' 0 N--CA 1.489 1.477 0 O-C-N 121.18 -0.95 . . . . 0.0 109.393 179.341 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 96' ' ' GLN . . . . . 0.578 ' C ' ' H ' ' A' ' 98' ' ' ASN . 2.7 mp0 -73.03 -47.77 42.06 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.162 -0.961 . . . . 0.0 110.719 -179.658 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 97' ' ' LEU . . . . . . . . . . . . . 42.2 mt -52.55 -5.34 0.04 OUTLIER 'General case' 0 N--CA 1.493 1.691 0 O-C-N 120.971 -1.08 . . . . 0.0 109.095 -179.046 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 98' ' ' ASN . . . . . 0.709 HD22 ' NE ' ' A' ' 99' ' ' ARG . 0.5 OUTLIER -73.23 -26.35 61.09 Favored 'General case' 0 N--CA 1.494 1.747 0 O-C-N 121.351 -0.843 . . . . 0.0 109.087 179.466 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 99' ' ' ARG . . . . . 0.709 ' NE ' HD22 ' A' ' 98' ' ' ASN . 0.1 OUTLIER -99.03 -50.2 4.25 Favored 'General case' 0 C--N 1.3 -1.544 0 C-N-CA 119.7 -0.8 . . . . 0.0 110.064 -179.016 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . 180.0 -169.17 39.83 Favored Glycine 0 N--CA 1.495 2.578 0 C-N-CA 118.858 -1.639 . . . . 0.0 111.224 179.497 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 101' ' ' VAL . . . . . 0.485 ' O ' ' CG2' ' A' ' 101' ' ' VAL . 18.5 m -55.01 106.16 0.11 Allowed 'Isoleucine or valine' 0 N--CA 1.496 1.84 0 O-C-N 121.883 -0.775 . . . . 0.0 109.289 -179.851 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -92.56 164.17 13.53 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.373 -0.829 . . . . 0.0 111.577 -178.713 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 103' ' ' PHE . . . . . 0.427 ' CE1' ' CG1' ' A' ' 87' ' ' VAL . 23.9 m-85 -68.2 126.58 29.99 Favored 'General case' 0 N--CA 1.485 1.278 0 N-CA-C 106.763 -1.569 . . . . 0.0 106.763 177.309 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 104' ' ' ALA . . . . . . . . . . . . . . . -50.37 -11.26 0.07 Allowed 'General case' 0 C--N 1.293 -1.856 0 O-C-N 121.513 -0.742 . . . . 0.0 111.593 -178.267 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 105' ' ' GLU . . . . . 0.495 ' OE2' ' OE1' ' A' ' 108' ' ' GLU . 0.4 OUTLIER -140.57 145.89 37.34 Favored 'General case' 0 N--CA 1.495 1.795 0 O-C-N 120.751 -1.218 . . . . 0.0 110.565 179.988 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 106' ' ' GLU . . . . . . . . . . . . . 25.0 tt0 -58.84 -63.22 1.37 Allowed 'General case' 0 C--N 1.305 -1.356 0 O-C-N 121.733 -0.604 . . . . 0.0 110.019 -179.993 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 107' ' ' ASN . . . . . . . . . . . . . 15.9 m-80 -76.94 33.2 0.14 Allowed 'General case' 0 N--CA 1.487 1.413 0 O-C-N 120.381 -1.449 . . . . 0.0 112.683 -176.103 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 108' ' ' GLU . . . . . 0.495 ' OE1' ' OE2' ' A' ' 105' ' ' GLU . 35.0 tp10 -60.16 146.9 41.65 Favored 'General case' 0 N--CA 1.493 1.698 0 O-C-N 120.483 -1.386 . . . . 0.0 107.801 179.448 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 109' ' ' SER . . . . . 0.433 ' C ' ' H ' ' A' ' 111' ' ' ASP . 0.1 OUTLIER -101.2 128.59 47.24 Favored 'General case' 0 N--CA 1.489 1.501 0 O-C-N 120.824 -1.172 . . . . 0.0 110.912 -178.285 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 110' ' ' LEU . . . . . 0.581 ' CD1' ' O ' ' A' ' 63' ' ' PRO . 1.2 pt? -59.0 -10.02 2.27 Favored 'General case' 0 C--N 1.303 -1.433 0 N-CA-C 108.45 -0.945 . . . . 0.0 108.45 179.48 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 111' ' ' ASP . . . . . 0.433 ' H ' ' C ' ' A' ' 109' ' ' SER . 44.8 m-20 -131.74 29.62 4.45 Favored 'General case' 0 N--CA 1.491 1.587 0 N-CA-C 108.598 -0.89 . . . . 0.0 108.598 179.32 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 112' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -65.37 149.48 49.92 Favored 'General case' 0 N--CA 1.493 1.686 0 O-C-N 121.273 -0.892 . . . . 0.0 110.479 -179.232 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 113' ' ' GLN . . . . . 0.425 ' HA ' ' NE2' ' A' ' 113' ' ' GLN . 0.8 OUTLIER -66.87 -11.41 55.72 Favored 'General case' 0 C--N 1.303 -1.442 0 N-CA-C 107.709 -1.219 . . . . 0.0 107.709 177.773 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 114' ' ' ASN . . . . . 0.428 HD21 ' NE2' ' A' ' 178' ' ' GLN . 0.1 OUTLIER -149.47 102.59 3.2 Favored 'General case' 0 C--N 1.305 -1.347 0 N-CA-C 107.683 -1.229 . . . . 0.0 107.683 177.838 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 115' ' ' ILE . . . . . . . . . . . . . 3.8 mt -97.74 111.26 27.13 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.528 0 O-C-N 120.961 -1.087 . . . . 0.0 109.437 -179.19 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 116' ' ' SER . . . . . . . . . . . . . 50.5 m -96.97 140.68 31.14 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.24 -0.913 . . . . 0.0 111.707 -178.087 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 117' ' ' ILE . . . . . . . . . . . . . 11.9 mt -130.25 152.49 37.51 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.414 0 N-CA-C 107.284 -1.376 . . . . 0.0 107.284 178.305 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 118' ' ' ALA . . . . . . . . . . . . . . . -142.87 157.54 44.49 Favored 'General case' 0 N--CA 1.493 1.684 0 O-C-N 120.707 -1.246 . . . . 0.0 111.087 -179.836 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 119' ' ' GLY . . . . . . . . . . . . . . . -162.45 145.09 10.28 Favored Glycine 0 N--CA 1.487 2.056 0 N-CA-C 110.085 -1.206 . . . . 0.0 110.085 179.964 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 120' ' ' HIS . . . . . 0.632 ' CD2' ' SG ' ' C' ' 705' ' ' B27 . 29.4 m170 -71.19 157.98 37.21 Favored 'General case' 0 N--CA 1.493 1.701 0 O-C-N 121.716 -0.873 . . . . 0.0 110.062 179.461 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 121' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -110.98 145.88 37.65 Favored 'General case' 0 N--CA 1.495 1.808 0 O-C-N 121.321 -0.862 . . . . 0.0 108.86 178.916 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 122' ' ' PHE . . . . . . . . . . . . . 0.3 OUTLIER -109.23 125.32 52.13 Favored 'General case' 0 N--CA 1.494 1.734 0 O-C-N 121.058 -1.026 . . . . 0.0 109.277 179.333 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 123' ' ' ILE . . . . . 0.435 ' CG2' ' N ' ' A' ' 124' ' ' ASP . 6.9 tp -74.43 -37.04 43.84 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.785 0 CA-C-O 121.876 0.846 . . . . 0.0 109.195 179.833 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 124' ' ' ASP . . . . . 0.435 ' N ' ' CG2' ' A' ' 123' ' ' ILE . 80.8 m-20 -92.88 15.13 15.49 Favored 'General case' 0 C--N 1.297 -1.715 0 O-C-N 121.897 -0.502 . . . . 0.0 111.281 -179.043 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 125' ' ' ARG . . . . . . . . . . . . . 7.3 ttt180 -153.95 115.17 2.58 Favored Pre-proline 0 N--CA 1.494 1.737 0 O-C-N 120.445 -1.409 . . . . 0.0 110.789 -178.555 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 126' ' ' PRO . . . . . . . . . . . . . 74.0 Cg_endo -83.76 -23.75 3.1 Favored 'Trans proline' 0 N--CA 1.487 1.123 0 C-N-CA 122.11 1.873 . . . . 0.0 112.083 178.81 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 127' ' ' ASN . . . . . 0.48 ' ND2' ' O ' ' A' ' 127' ' ' ASN . 2.3 p-10 -88.82 28.89 1.09 Allowed 'General case' 0 N--CA 1.492 1.654 0 O-C-N 120.898 -1.126 . . . . 0.0 110.051 -179.558 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 128' ' ' TYR . . . . . . . . . . . . . 9.9 t80 -87.71 -148.58 0.15 Allowed 'General case' 0 N--CA 1.49 1.564 0 O-C-N 120.94 -1.1 . . . . 0.0 109.554 179.906 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 129' ' ' GLN . . . . . 0.435 ' O ' ' OE2' ' A' ' 85' ' ' GLU . 80.4 mt-30 -66.95 -69.59 0.3 Allowed 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.29 -0.881 . . . . 0.0 110.802 -178.742 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 130' ' ' PHE . . . . . . . . . . . . . 55.8 m-85 -130.47 31.34 4.59 Favored 'General case' 0 N--CA 1.499 1.99 0 O-C-N 121.056 -1.027 . . . . 0.0 110.841 -179.126 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 131' ' ' THR . . . . . . . . . . . . . 52.4 m -70.77 -32.99 70.3 Favored 'General case' 0 C--N 1.301 -1.522 0 O-C-N 120.344 -1.473 . . . . 0.0 108.205 179.451 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 132' ' ' ASN . . . . . 0.575 ' ND2' ' O ' ' A' ' 81' ' ' ALA . 2.0 p-10 -91.21 15.24 12.27 Favored 'General case' 0 N--CA 1.498 1.97 0 C-N-CA 119.915 -0.714 . . . . 0.0 111.179 -179.565 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 133' ' ' LEU . . . . . 0.599 ' O ' ' N ' ' A' ' 135' ' ' ALA . 0.2 OUTLIER -77.06 -44.17 31.69 Favored 'General case' 0 C--N 1.301 -1.535 0 O-C-N 120.651 -1.281 . . . . 0.0 109.185 -179.801 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 134' ' ' LYS . . . . . 0.653 ' CE ' ' H ' ' A' ' 134' ' ' LYS . 0.0 OUTLIER -46.97 -6.94 0.01 OUTLIER 'General case' 0 C--N 1.299 -1.606 0 O-C-N 121.661 -0.65 . . . . 0.0 110.428 -179.42 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 135' ' ' ALA . . . . . 0.599 ' N ' ' O ' ' A' ' 133' ' ' LEU . . . -84.0 -40.32 18.58 Favored 'General case' 0 N--CA 1.488 1.462 0 O-C-N 120.912 -1.118 . . . . 0.0 108.97 178.962 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 136' ' ' ALA . . . . . . . . . . . . . . . -79.77 162.3 25.21 Favored 'General case' 0 N--CA 1.487 1.402 0 CA-C-O 122.21 1.005 . . . . 0.0 111.357 -178.752 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 137' ' ' LYS . . . . . 0.513 ' O ' ' O ' ' A' ' 138' ' ' LYS . 17.4 pttt -153.04 -164.02 1.83 Allowed 'General case' 0 C--N 1.3 -1.584 0 C-N-CA 118.721 -1.192 . . . . 0.0 111.097 -177.918 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 138' ' ' LYS . . . . . 0.602 ' O ' ' N ' ' A' ' 140' ' ' SER . 1.4 mmmp? -45.92 -179.9 0.0 OUTLIER 'General case' 0 C--N 1.303 -1.445 0 CA-C-O 122.1 0.953 . . . . 0.0 110.356 -179.564 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 139' ' ' GLY . . . . . . . . . . . . . . . 46.14 7.81 0.02 OUTLIER Glycine 0 N--CA 1.49 2.283 0 N-CA-C 110.547 -1.021 . . . . 0.0 110.547 179.735 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 140' ' ' SER . . . . . 0.602 ' N ' ' O ' ' A' ' 138' ' ' LYS . 13.1 t -83.04 143.78 30.37 Favored 'General case' 0 N--CA 1.493 1.679 0 O-C-N 120.849 -1.383 . . . . 0.0 108.922 179.108 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 141' ' ' MET . . . . . . . . . . . . . 0.1 OUTLIER -88.68 133.91 34.06 Favored 'General case' 0 C--N 1.3 -1.552 0 O-C-N 121.091 -1.006 . . . . 0.0 109.316 179.787 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 142' ' ' VAL . . . . . . . . . . . . . 21.4 t -121.81 126.19 74.28 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.631 0 N-CA-C 108.781 -0.822 . . . . 0.0 108.781 179.934 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 143' ' ' TYR . . . . . . . . . . . . . 61.1 m-85 -104.2 134.28 47.71 Favored 'General case' 0 N--CA 1.496 1.857 0 O-C-N 121.26 -0.9 . . . . 0.0 110.975 -178.915 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 144' ' ' PHE . . . . . . . . . . . . . 53.0 t80 -112.0 154.3 25.53 Favored 'General case' 0 N--CA 1.492 1.666 0 CA-C-O 121.773 0.797 . . . . 0.0 110.101 -179.393 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 145' ' ' LYS . . . . . 0.429 ' CG ' ' OG1' ' A' ' 150' ' ' THR . 1.8 mttm -149.07 125.64 11.02 Favored 'General case' 0 N--CA 1.494 1.759 0 C-N-CA 118.866 -1.134 . . . . 0.0 111.707 -177.764 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 146' ' ' VAL . . . . . . . . . . . . . 0.2 OUTLIER -144.81 139.9 23.19 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.559 0 N-CA-C 107.028 -1.471 . . . . 0.0 107.028 178.149 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 147' ' ' GLY . . . . . . . . . . . . . . . 53.89 -138.07 38.95 Favored Glycine 0 N--CA 1.489 2.201 0 N-CA-C 107.878 -2.089 . . . . 0.0 107.878 -178.692 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 148' ' ' ASN . . . . . 0.564 ' C ' HD21 ' A' ' 148' ' ' ASN . 0.4 OUTLIER -101.63 26.65 7.12 Favored 'General case' 0 N--CA 1.489 1.498 0 O-C-N 121.052 -1.263 . . . . 0.0 107.832 178.491 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 149' ' ' GLU . . . . . . . . . . . . . 2.1 tm-20 -112.05 151.97 28.74 Favored 'General case' 0 N--CA 1.486 1.335 0 CA-C-O 121.872 0.844 . . . . 0.0 110.921 -178.805 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 150' ' ' THR . . . . . 0.429 ' OG1' ' CG ' ' A' ' 145' ' ' LYS . 2.9 m -141.02 104.89 4.75 Favored 'General case' 0 N--CA 1.495 1.818 0 CA-C-O 121.559 0.695 . . . . 0.0 109.216 179.828 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 151' ' ' ARG . . . . . . . . . . . . . 73.9 mtt180 -87.57 -164.9 1.17 Allowed 'General case' 0 N--CA 1.487 1.403 0 O-C-N 121.355 -0.841 . . . . 0.0 109.297 -179.52 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 152' ' ' LYS . . . . . 0.519 ' O ' ' N ' ' A' ' 205' ' ' VAL . 7.3 mtmt -147.34 144.24 28.61 Favored 'General case' 0 C--N 1.301 -1.535 0 O-C-N 121.433 -0.792 . . . . 0.0 109.329 -179.671 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 153' ' ' TYR . . . . . 0.513 ' CD2' ' HA ' ' A' ' 204' ' ' GLU . 26.9 m-85 -140.44 169.41 17.72 Favored 'General case' 0 N--CA 1.489 1.51 0 N-CA-C 108.344 -0.984 . . . . 0.0 108.344 179.948 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 154' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -143.38 120.91 11.74 Favored 'General case' 0 C--N 1.299 -1.623 0 O-C-N 121.329 -0.857 . . . . 0.0 108.986 179.175 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 155' ' ' MET . . . . . . . . . . . . . 27.0 mtp -46.61 110.09 0.25 Allowed 'General case' 0 N--CA 1.496 1.855 0 O-C-N 120.576 -1.327 . . . . 0.0 110.954 -179.112 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 156' ' ' THR . . . . . 0.44 ' HG1' ' HG1' ' A' ' 203' ' ' THR . 0.2 OUTLIER -104.24 -30.26 10.28 Favored 'General case' 0 C--N 1.294 -1.846 0 C-N-CA 119.817 -0.753 . . . . 0.0 111.034 -178.286 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 157' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -154.53 157.52 38.45 Favored 'General case' 0 N--CA 1.495 1.801 0 C-N-CA 118.179 -1.408 . . . . 0.0 111.757 -178.136 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 158' ' ' ILE . . . . . 0.41 HG12 ' N ' ' A' ' 159' ' ' ARG . 0.0 OUTLIER -155.26 146.23 12.99 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.562 0 CA-C-O 121.785 0.802 . . . . 0.0 110.748 -178.995 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 159' ' ' ARG . . . . . 0.644 ' CG ' HH11 ' A' ' 159' ' ' ARG . 0.0 OUTLIER -158.13 159.16 35.91 Favored 'General case' 0 C--N 1.303 -1.429 0 CA-C-O 121.757 0.789 . . . . 0.0 110.967 -179.824 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 160' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -117.37 163.92 15.63 Favored 'General case' 0 N--CA 1.488 1.43 0 N-CA-C 108.326 -0.99 . . . . 0.0 108.326 178.829 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 161' ' ' VAL . . . . . 0.487 ' O ' ' O ' ' A' ' 162' ' ' LYS . 0.1 OUTLIER -162.11 156.2 2.64 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.816 0 O-C-N 121.158 -0.964 . . . . 0.0 109.828 -179.425 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 162' ' ' LYS . . . . . 0.508 ' H ' ' CD ' ' A' ' 162' ' ' LYS . 0.0 OUTLIER -44.96 171.68 0.05 OUTLIER Pre-proline 0 N--CA 1.494 1.738 0 O-C-N 121.378 -0.826 . . . . 0.0 109.63 179.723 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 163' ' ' PRO . . . . . . . . . . . . . 73.7 Cg_endo -81.87 36.38 0.62 Allowed 'Trans proline' 0 N--CA 1.493 1.451 0 C-N-CA 122.791 2.328 . . . . 0.0 113.141 -179.521 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 164' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -152.69 -4.8 0.22 Allowed 'General case' 0 N--CA 1.492 1.663 0 O-C-N 120.907 -1.121 . . . . 0.0 110.35 -179.981 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 165' ' ' ASP . . . . . 0.475 ' O ' ' N ' ' A' ' 167' ' ' GLY . 8.8 t0 -74.8 62.6 1.1 Allowed 'General case' 0 N--CA 1.492 1.631 0 O-C-N 120.925 -1.109 . . . . 0.0 110.641 -179.35 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 166' ' ' VAL . . . . . 0.648 ' O ' ' N ' ' A' ' 168' ' ' VAL . 0.9 OUTLIER -39.43 -29.03 0.09 OUTLIER 'Isoleucine or valine' 0 N--CA 1.497 1.89 0 O-C-N 121.284 -0.885 . . . . 0.0 109.563 -178.45 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 167' ' ' GLY . . . . . 0.475 ' N ' ' O ' ' A' ' 165' ' ' ASP . . . -43.07 -13.92 0.01 OUTLIER Glycine 0 N--CA 1.496 2.636 0 N-CA-C 109.515 -1.434 . . . . 0.0 109.515 179.622 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 168' ' ' VAL . . . . . 0.648 ' N ' ' O ' ' A' ' 166' ' ' VAL . 1.3 t -48.26 -44.41 12.73 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.454 0 O-C-N 121.448 -1.031 . . . . 0.0 108.43 178.925 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 169' ' ' LEU . . . . . 0.571 ' O ' ' C ' ' A' ' 170' ' ' ASP . 47.1 mt -49.92 -9.7 0.04 OUTLIER 'General case' 0 N--CA 1.492 1.66 0 N-CA-C 109.001 -0.741 . . . . 0.0 109.001 -178.092 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 170' ' ' ASP . . . . . 0.572 ' H ' ' C ' ' A' ' 168' ' ' VAL . 17.7 p-10 19.46 86.51 0.01 OUTLIER 'General case' 0 N--CA 1.494 1.739 0 CA-C-O 121.051 0.453 . . . . 0.0 110.981 178.578 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 171' ' ' GLU . . . . . . . . . . . . . 6.7 pt-20 -121.29 61.38 0.91 Allowed 'General case' 0 N--CA 1.494 1.725 0 O-C-N 121.175 -0.953 . . . . 0.0 109.938 -179.228 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 172' ' ' GLN . . . . . . . . . . . . . 3.0 pt20 -135.03 -44.93 0.72 Allowed 'General case' 0 N--CA 1.492 1.668 0 O-C-N 121.527 -0.733 . . . . 0.0 109.942 -178.975 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 173' ' ' LYS . . . . . . . . . . . . . 21.5 mttp -62.54 128.93 38.29 Favored 'General case' 0 N--CA 1.489 1.498 0 O-C-N 120.899 -1.126 . . . . 0.0 108.106 178.949 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 174' ' ' GLY . . . . . 0.552 ' O ' ' C ' ' A' ' 175' ' ' LYS . . . -137.63 -40.37 0.11 Allowed Glycine 0 C--N 1.293 -1.807 0 N-CA-C 109.071 -1.612 . . . . 0.0 109.071 -179.722 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 175' ' ' LYS . . . . . 0.552 ' C ' ' O ' ' A' ' 174' ' ' GLY . 4.4 mptp? -30.87 -65.28 0.12 Allowed 'General case' 0 N--CA 1.499 2.011 0 N-CA-C 108.9 -0.778 . . . . 0.0 108.9 -179.751 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 176' ' ' ASP . . . . . 0.696 ' O ' ' O ' ' A' ' 177' ' ' LYS . 58.2 m-20 -101.39 78.7 1.9 Allowed 'General case' 0 C--N 1.296 -1.728 0 N-CA-C 107.79 -1.189 . . . . 0.0 107.79 177.843 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 177' ' ' LYS . . . . . 0.696 ' O ' ' O ' ' A' ' 176' ' ' ASP . 0.7 OUTLIER -20.54 158.02 0.0 OUTLIER 'General case' 0 N--CA 1.507 2.39 0 CA-C-O 122.218 1.009 . . . . 0.0 112.249 -179.075 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 178' ' ' GLN . . . . . 0.428 ' NE2' HD21 ' A' ' 114' ' ' ASN . 0.4 OUTLIER -157.03 164.22 38.2 Favored 'General case' 0 C--N 1.303 -1.414 0 C-N-CA 117.052 -1.859 . . . . 0.0 112.026 179.804 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 179' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -122.23 107.39 12.08 Favored 'General case' 0 C--N 1.303 -1.42 0 N-CA-C 107.345 -1.354 . . . . 0.0 107.345 179.083 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 180' ' ' THR . . . . . 0.487 ' OG1' ' OD2' ' A' ' 170' ' ' ASP . 1.0 OUTLIER -78.66 120.32 23.16 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 120.87 -1.144 . . . . 0.0 110.278 -178.427 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 181' ' ' LEU . . . . . . . . . . . . . 10.2 tp -100.16 105.78 17.42 Favored 'General case' 0 N--CA 1.492 1.671 0 O-C-N 121.536 -0.728 . . . . 0.0 109.099 178.883 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 182' ' ' ILE . . . . . . . . . . . . . 56.3 mt -95.63 125.86 48.29 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.419 0 O-C-N 121.064 -1.022 . . . . 0.0 110.046 179.875 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 183' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -135.75 111.74 9.57 Favored 'General case' 0 C--N 1.294 -1.843 0 N-CA-C 107.367 -1.346 . . . . 0.0 107.367 178.493 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 184' ' ' CYS . . . . . . . . . . . . . 0.8 OUTLIER -79.6 156.14 27.81 Favored 'General case' 0 C--N 1.292 -1.909 0 C-N-CA 118.783 -1.167 . . . . 0.0 110.851 -177.947 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 185' ' ' ASP . . . . . 0.481 ' OD1' ' N ' ' A' ' 186' ' ' ASP . 10.3 t0 -167.24 -154.07 0.16 Allowed 'General case' 0 N--CA 1.495 1.789 0 O-C-N 121.365 -0.834 . . . . 0.0 109.821 -179.656 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 186' ' ' ASP . . . . . 0.481 ' N ' ' OD1' ' A' ' 185' ' ' ASP . 0.9 OUTLIER 52.8 52.63 13.58 Favored 'General case' 0 N--CA 1.496 1.862 0 O-C-N 121.294 -0.879 . . . . 0.0 109.504 -179.858 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 187' ' ' TYR . . . . . 0.577 ' CE1' ' O ' ' A' ' 188' ' ' ASN . 56.9 t80 -68.68 129.25 39.39 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.291 -0.881 . . . . 0.0 110.958 -179.677 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 188' ' ' ASN . . . . . 0.779 HD22 ' N ' ' A' ' 192' ' ' GLY . 0.0 OUTLIER -101.09 151.39 21.87 Favored 'General case' 0 C--N 1.293 -1.86 0 N-CA-C 107.07 -1.456 . . . . 0.0 107.07 177.073 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 189' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -112.82 -7.15 13.79 Favored 'General case' 0 C--N 1.294 -1.816 0 N-CA-C 108.179 -1.045 . . . . 0.0 108.179 -179.526 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 190' ' ' LYS . . . . . 0.585 ' N ' ' OD1' ' A' ' 188' ' ' ASN . 0.6 OUTLIER -82.91 -56.16 3.98 Favored 'General case' 0 N--CA 1.489 1.482 0 C-N-CA 120.062 -0.655 . . . . 0.0 109.424 179.144 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 191' ' ' THR . . . . . 0.684 ' HG1' ' ND2' ' A' ' 188' ' ' ASN . 4.9 p -88.12 -2.86 58.86 Favored 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.305 -0.872 . . . . 0.0 109.453 -179.779 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 192' ' ' GLY . . . . . 0.779 ' N ' HD22 ' A' ' 188' ' ' ASN . . . 62.86 33.18 86.3 Favored Glycine 0 N--CA 1.493 2.483 0 O-C-N 121.345 -0.847 . . . . 0.0 111.657 178.349 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 193' ' ' VAL . . . . . 0.756 ' H ' ' ND2' ' A' ' 188' ' ' ASN . 4.0 p -147.81 167.05 4.97 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.689 0 O-C-N 120.686 -1.479 . . . . 0.0 109.959 178.873 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 194' ' ' TRP . . . . . 0.581 ' CD1' ' OG1' ' C' ' 705' ' ' B27 . 17.0 m95 -82.04 120.86 25.81 Favored 'General case' 0 C--N 1.295 -1.764 0 N-CA-C 108.495 -0.928 . . . . 0.0 108.495 179.854 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 195' ' ' GLU . . . . . . . . . . . . . 1.3 mt-10 -83.84 -60.97 1.95 Allowed 'General case' 0 C--N 1.301 -1.513 0 O-C-N 121.471 -0.768 . . . . 0.0 110.864 -178.086 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 196' ' ' LYS . . . . . . . . . . . . . 12.8 tttt -86.39 158.42 19.63 Favored 'General case' 0 C--N 1.301 -1.527 0 O-C-N 120.888 -1.132 . . . . 0.0 110.566 -179.007 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 197' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -126.29 135.73 51.89 Favored 'General case' 0 N--CA 1.489 1.482 0 N-CA-C 108.512 -0.922 . . . . 0.0 108.512 179.116 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 198' ' ' LYS . . . . . . . . . . . . . 14.3 mttt -115.39 120.93 41.23 Favored 'General case' 0 N--CA 1.494 1.727 0 O-C-N 121.553 -0.717 . . . . 0.0 110.422 -179.197 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 199' ' ' ILE . . . . . . . . . . . . . 0.9 OUTLIER -141.51 118.81 8.06 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.646 0 CA-C-O 122.494 1.14 . . . . 0.0 110.043 179.478 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 200' ' ' PHE . . . . . 0.619 ' CD1' ' N ' ' A' ' 200' ' ' PHE . 0.3 OUTLIER -104.24 135.74 45.15 Favored 'General case' 0 N--CA 1.496 1.855 0 O-C-N 121.295 -0.878 . . . . 0.0 109.586 -178.441 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 201' ' ' VAL . . . . . . . . . . . . . 85.2 t -104.36 154.57 6.1 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.611 0 O-C-N 120.979 -1.076 . . . . 0.0 109.07 178.585 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 202' ' ' ALA . . . . . . . . . . . . . . . -136.49 142.37 43.52 Favored 'General case' 0 C--N 1.302 -1.472 0 O-C-N 121.153 -0.967 . . . . 0.0 109.055 179.991 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 203' ' ' THR . . . . . 0.44 ' HG1' ' HG1' ' A' ' 156' ' ' THR . 0.6 OUTLIER -88.59 129.66 35.44 Favored 'General case' 0 N--CA 1.488 1.465 0 CA-C-O 122.281 1.039 . . . . 0.0 111.26 -178.455 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 204' ' ' GLU . . . . . 0.513 ' HA ' ' CD2' ' A' ' 153' ' ' TYR . 12.0 tt0 -49.59 134.74 19.42 Favored 'General case' 0 C--N 1.298 -1.643 0 C-N-CA 119.098 -1.041 . . . . 0.0 108.626 178.38 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 205' ' ' VAL . . . . . 0.519 ' N ' ' O ' ' A' ' 152' ' ' LYS . 39.0 t -125.86 161.13 31.62 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.304 0 CA-C-O 122.263 1.03 . . . . 0.0 110.431 -177.765 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 206' ' ' LYS . . . . . 0.515 ' N ' ' CG1' ' A' ' 205' ' ' VAL . 13.1 mtmt . . . . . 0 C--N 1.293 -1.864 0 CA-C-O 117.931 -1.033 . . . . 0.0 108.983 179.754 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' C' C ' 701' ' ' PHQ . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 019 nuclear orig full ' C' C ' 702' ' ' LEU . . . . . 0.636 ' CD1' ' N ' ' C' ' 702' ' ' LEU . 0.0 OUTLIER . . . . . 0 N--CA 1.488 1.453 0 N-CA-C 108.735 -0.839 . . . . 0.0 108.735 . . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' C' C ' 703' ' ' PRO . . . . . . . . . . . . . 9.4 Cg_endo -64.97 -173.0 0.23 Allowed 'Trans proline' 0 N--CA 1.491 1.341 0 C-N-CA 121.619 1.546 . . . . 0.0 112.099 -179.666 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' C' C ' 704' ' ' ALA . . . . . 0.456 ' C ' ' SG ' ' C' ' 705' ' ' B27 . . . 56.99 97.51 0.02 OUTLIER 'General case' 0 N--CA 1.487 1.415 0 O-C-N 121.334 -0.854 . . . . 0.0 109.396 -179.558 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' C' C ' 705' ' ' B27 . . . . . 0.632 ' SG ' ' CD2' ' A' ' 120' ' ' HIS . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 700' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 020 nuclear orig full ' A' A ' 59' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.491 1.575 0 N-CA-C 109.391 -0.596 . . . . 0.0 109.391 . . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 60' ' ' GLN . . . . . . . . . . . . . 0.4 OUTLIER -60.33 -176.54 0.05 Allowed 'General case' 0 N--CA 1.491 1.615 0 N-CA-C 108.794 -0.817 . . . . 0.0 108.794 179.665 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . -65.05 154.19 38.54 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 120.878 -1.139 . . . . 0.0 109.467 179.981 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 62' ' ' LYS . . . . . . . . . . . . . 5.4 tmtm? -141.46 74.64 23.56 Favored Pre-proline 0 N--CA 1.491 1.618 0 C-N-CA 119.397 -0.921 . . . . 0.0 109.896 179.932 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 63' ' ' PRO . . . . . . . . . . . . . 45.2 Cg_endo -91.71 156.74 3.49 Favored 'Trans proline' 0 C--N 1.307 -1.62 0 C-N-CA 123.378 2.718 . . . . 0.0 112.224 179.712 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 64' ' ' GLN . . . . . 0.672 ' NE2' ' N ' ' A' ' 64' ' ' GLN . 0.0 OUTLIER -153.98 117.49 4.63 Favored 'General case' 0 N--CA 1.498 1.932 0 O-C-N 121.531 -0.73 . . . . 0.0 109.163 179.517 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 65' ' ' ILE . . . . . 0.44 ' C ' ' O ' ' A' ' 64' ' ' GLN . 3.2 mp -45.28 105.75 0.49 Allowed Pre-proline 0 N--CA 1.493 1.682 0 O-C-N 121.027 -1.045 . . . . 0.0 108.758 179.395 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 66' ' ' PRO . . . . . . . . . . . . . 84.5 Cg_endo -86.46 -158.08 0.08 OUTLIER 'Trans proline' 0 N--CA 1.488 1.148 0 C-N-CA 122.048 1.832 . . . . 0.0 112.51 -179.536 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 67' ' ' LYS . . . . . 0.492 ' C ' ' H ' ' A' ' 69' ' ' LYS . 0.0 OUTLIER -82.82 -4.56 58.18 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.396 -0.815 . . . . 0.0 109.584 -179.756 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 68' ' ' ASP . . . . . 0.62 ' C ' ' N ' ' A' ' 70' ' ' SER . 0.3 OUTLIER -74.05 51.1 0.39 Allowed 'General case' 0 N--CA 1.487 1.411 0 CA-C-O 122.913 1.34 . . . . 0.0 107.919 179.28 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 69' ' ' LYS . . . . . 0.492 ' H ' ' C ' ' A' ' 67' ' ' LYS . 0.1 OUTLIER -49.54 -13.13 0.07 Allowed 'General case' 0 C--N 1.29 -1.99 0 C-N-CA 116.889 -1.924 . . . . 0.0 106.976 178.792 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 70' ' ' SER . . . . . 0.62 ' N ' ' C ' ' A' ' 68' ' ' ASP . 3.6 p -84.25 -8.99 58.87 Favored 'General case' 0 N--CA 1.498 1.96 0 CA-C-N 113.631 -1.622 . . . . 0.0 110.056 178.444 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 71' ' ' LYS . . . . . . . . . . . . . 2.6 ptmm? -96.89 140.57 31.24 Favored 'General case' 0 N--CA 1.494 1.737 0 O-C-N 120.905 -1.122 . . . . 0.0 111.003 -179.739 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 1.1 m -63.23 139.78 20.71 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.387 0 N-CA-C 104.331 -2.47 . . . . 0.0 104.331 175.288 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 73' ' ' ALA . . . . . 0.512 ' N ' ' O ' ' A' ' 87' ' ' VAL . . . -82.15 -16.99 47.93 Favored 'General case' 0 C--N 1.287 -2.14 0 C-N-CA 117.405 -1.718 . . . . 0.0 106.806 -179.948 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . 177.7 -158.54 23.8 Favored Glycine 0 C--N 1.298 -1.54 0 N-CA-C 109.383 -1.487 . . . . 0.0 109.383 179.408 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 75' ' ' TYR . . . . . 0.413 ' CD2' ' C ' ' A' ' 85' ' ' GLU . 0.7 OUTLIER -143.47 165.48 27.44 Favored 'General case' 0 C--N 1.296 -1.729 0 O-C-N 121.716 -0.873 . . . . 0.0 110.55 -176.722 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 76' ' ' ILE . . . . . . . . . . . . . 4.4 tt -148.66 146.68 17.42 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.453 0 C-N-CA 119.069 -1.052 . . . . 0.0 110.659 -177.866 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -150.13 167.84 25.66 Favored 'General case' 0 N--CA 1.489 1.482 0 O-C-N 121.181 -0.949 . . . . 0.0 109.195 179.119 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 78' ' ' ILE . . . . . . . . . . . . . 16.9 mt -149.67 98.18 3.43 Favored Pre-proline 0 C--N 1.303 -1.442 0 N-CA-C 108.543 -0.91 . . . . 0.0 108.543 179.474 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 79' ' ' PRO . . . . . . . . . . . . . 54.1 Cg_exo -48.83 -46.57 24.22 Favored 'Trans proline' 0 C--N 1.31 -1.481 0 C-N-CA 122.517 2.145 . . . . 0.0 113.76 -178.95 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -66.02 -19.83 65.99 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 120.892 -1.13 . . . . 0.0 111.244 179.339 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 81' ' ' ALA . . . . . 0.606 ' O ' ' ND2' ' A' ' 132' ' ' ASN . . . -105.42 -19.34 13.82 Favored 'General case' 0 N--CA 1.495 1.806 0 O-C-N 121.052 -1.03 . . . . 0.0 108.861 179.633 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 82' ' ' ASP . . . . . 0.452 ' CB ' ' O ' ' A' ' 81' ' ' ALA . 5.6 t70 71.42 48.01 0.35 Allowed 'General case' 0 N--CA 1.494 1.736 0 O-C-N 120.988 -1.07 . . . . 0.0 110.328 179.33 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 83' ' ' ILE . . . . . . . . . . . . . 82.5 mt -127.42 152.57 35.63 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.696 0 O-C-N 121.265 -0.897 . . . . 0.0 110.021 -179.006 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 84' ' ' LYS . . . . . . . . . . . . . 33.2 tttt -159.46 107.32 1.76 Allowed 'General case' 0 N--CA 1.491 1.617 0 N-CA-C 107.944 -1.132 . . . . 0.0 107.944 179.427 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 85' ' ' GLU . . . . . 0.413 ' C ' ' CD2' ' A' ' 75' ' ' TYR . 0.3 OUTLIER -144.05 164.85 27.03 Favored Pre-proline 0 N--CA 1.491 1.604 0 O-C-N 121.281 -0.887 . . . . 0.0 110.488 -178.741 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 86' ' ' PRO . . . . . . . . . . . . . 55.8 Cg_endo -72.46 170.38 19.47 Favored 'Trans proline' 0 N--CA 1.495 1.578 0 C-N-CA 123.635 2.89 . . . . 0.0 113.633 -179.494 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 87' ' ' VAL . . . . . 0.512 ' O ' ' N ' ' A' ' 73' ' ' ALA . 54.1 t -127.26 98.07 4.41 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.822 0 N-CA-C 109.047 -0.723 . . . . 0.0 109.047 179.828 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 88' ' ' TYR . . . . . 0.407 ' CD2' ' HD3' ' A' ' 99' ' ' ARG . 21.1 m-85 -88.17 154.05 51.74 Favored Pre-proline 0 N--CA 1.505 2.284 0 O-C-N 120.659 -1.276 . . . . 0.0 110.42 -179.443 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 89' ' ' PRO . . . . . . . . . . . . . 9.7 Cg_endo -61.54 145.09 98.12 Favored 'Trans proline' 0 C--N 1.311 -1.429 0 C-N-CA 122.5 2.133 . . . . 0.0 113.76 -179.677 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . -56.58 166.05 4.69 Favored Glycine 0 N--CA 1.491 2.342 0 N-CA-C 109.575 -1.41 . . . . 0.0 109.575 179.255 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 91' ' ' PRO . . . . . 0.475 ' C ' ' H ' ' A' ' 93' ' ' THR . 44.8 Cg_endo -94.29 168.22 19.08 Favored 'Cis proline' 0 C--N 1.312 -1.38 0 C-N-CA 123.864 -1.307 . . . . 0.0 111.949 0.167 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 92' ' ' ALA . . . . . 0.532 ' O ' ' CD1' ' A' ' 97' ' ' LEU . . . -71.91 31.26 0.05 Allowed 'General case' 0 C--N 1.302 -1.463 0 O-C-N 121.281 -0.887 . . . . 0.0 110.396 179.952 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 93' ' ' THR . . . . . 0.475 ' H ' ' C ' ' A' ' 91' ' ' PRO . 1.0 OUTLIER -74.71 151.24 86.85 Favored Pre-proline 0 N--CA 1.491 1.605 0 O-C-N 120.501 -1.374 . . . . 0.0 108.43 179.846 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 94' ' ' PRO . . . . . 0.414 ' C ' ' O ' ' A' ' 93' ' ' THR . 86.5 Cg_exo -29.91 -54.42 0.19 Allowed 'Trans proline' 0 C--N 1.308 -1.565 0 C-N-CA 123.228 2.619 . . . . 0.0 113.207 -178.861 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 83.6 mt-10 -47.24 -49.31 23.58 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 120.796 -1.19 . . . . 0.0 109.706 -179.528 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 96' ' ' GLN . . . . . 0.657 HE21 HH12 ' A' ' 99' ' ' ARG . 6.1 mp0 -71.72 -53.13 14.47 Favored 'General case' 0 C--N 1.303 -1.446 0 O-C-N 121.337 -0.852 . . . . 0.0 110.376 -179.658 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 97' ' ' LEU . . . . . 0.532 ' CD1' ' O ' ' A' ' 92' ' ' ALA . 83.8 mt -50.53 -9.0 0.04 OUTLIER 'General case' 0 N--CA 1.493 1.724 0 O-C-N 121.149 -0.969 . . . . 0.0 110.299 -178.498 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 98' ' ' ASN . . . . . 0.601 HD22 ' NE ' ' A' ' 99' ' ' ARG . 0.2 OUTLIER -72.55 -27.69 62.38 Favored 'General case' 0 N--CA 1.488 1.45 0 O-C-N 121.029 -1.044 . . . . 0.0 108.863 179.534 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 99' ' ' ARG . . . . . 0.657 HH12 HE21 ' A' ' 96' ' ' GLN . 6.1 mtt180 -94.27 -60.17 1.79 Allowed 'General case' 0 N--CA 1.491 1.577 0 C-N-CA 119.973 -0.691 . . . . 0.0 110.529 -179.651 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . -171.66 -166.58 30.61 Favored Glycine 0 N--CA 1.499 2.835 0 C-N-CA 119.424 -1.369 . . . . 0.0 111.003 -179.501 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 101' ' ' VAL . . . . . 0.526 ' O ' ' CG2' ' A' ' 101' ' ' VAL . 16.3 m -57.47 106.46 0.18 Allowed 'Isoleucine or valine' 0 N--CA 1.498 1.928 0 O-C-N 121.554 -0.968 . . . . 0.0 109.455 -179.783 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -93.8 159.71 15.07 Favored 'General case' 0 N--CA 1.493 1.696 0 O-C-N 121.244 -0.91 . . . . 0.0 111.633 -179.068 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 103' ' ' PHE . . . . . 0.412 ' CE1' ' CG1' ' A' ' 87' ' ' VAL . 23.5 m-85 -63.18 130.93 46.71 Favored 'General case' 0 N--CA 1.49 1.531 0 N-CA-C 107.881 -1.155 . . . . 0.0 107.881 178.235 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 104' ' ' ALA . . . . . . . . . . . . . . . -50.95 -18.34 0.75 Allowed 'General case' 0 C--N 1.299 -1.619 0 O-C-N 121.58 -0.7 . . . . 0.0 111.42 -178.532 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -136.91 146.66 45.74 Favored 'General case' 0 N--CA 1.495 1.808 0 O-C-N 120.799 -1.188 . . . . 0.0 111.011 -179.447 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 106' ' ' GLU . . . . . . . . . . . . . 1.7 tt0 -55.26 -62.33 1.74 Allowed 'General case' 0 C--N 1.305 -1.351 0 CA-C-N 116.061 -0.518 . . . . 0.0 110.316 -179.903 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 107' ' ' ASN . . . . . 0.639 ' N ' HD21 ' A' ' 107' ' ' ASN . 0.7 OUTLIER -78.81 33.48 0.21 Allowed 'General case' 0 N--CA 1.491 1.607 0 O-C-N 120.609 -1.307 . . . . 0.0 113.184 -175.638 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 108' ' ' GLU . . . . . . . . . . . . . 29.0 tp10 -58.25 143.32 44.85 Favored 'General case' 0 N--CA 1.495 1.813 0 O-C-N 120.468 -1.395 . . . . 0.0 107.963 179.945 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 109' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -94.95 140.45 29.92 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 120.961 -1.087 . . . . 0.0 110.987 -178.013 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 110' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -63.7 -16.78 61.94 Favored 'General case' 0 C--N 1.302 -1.469 0 N-CA-C 108.754 -0.832 . . . . 0.0 108.754 179.207 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 111' ' ' ASP . . . . . . . . . . . . . 13.0 m-20 -133.1 36.83 3.43 Favored 'General case' 0 N--CA 1.488 1.475 0 O-C-N 121.677 -0.639 . . . . 0.0 109.762 -179.439 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 112' ' ' ASP . . . . . . . . . . . . . 1.7 t0 -65.93 150.07 49.22 Favored 'General case' 0 N--CA 1.494 1.76 0 O-C-N 121.033 -1.042 . . . . 0.0 110.706 -179.58 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 113' ' ' GLN . . . . . 0.452 ' HA ' ' NE2' ' A' ' 113' ' ' GLN . 0.8 OUTLIER -68.11 -13.12 61.97 Favored 'General case' 0 N--CA 1.491 1.598 0 N-CA-C 107.849 -1.167 . . . . 0.0 107.849 177.84 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 114' ' ' ASN . . . . . . . . . . . . . 2.7 t30 -149.38 103.0 3.25 Favored 'General case' 0 C--N 1.302 -1.477 0 N-CA-C 107.818 -1.178 . . . . 0.0 107.818 177.913 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 115' ' ' ILE . . . . . . . . . . . . . 3.0 mt -97.34 110.47 25.26 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.479 0 O-C-N 121.156 -0.965 . . . . 0.0 109.837 -179.135 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 116' ' ' SER . . . . . 0.439 ' H ' ' HG ' ' A' ' 116' ' ' SER . 0.9 OUTLIER -96.38 145.23 25.81 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.075 -1.015 . . . . 0.0 111.265 -178.392 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 117' ' ' ILE . . . . . . . . . . . . . 1.4 mt -139.65 156.55 26.21 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.768 0 N-CA-C 107.887 -1.153 . . . . 0.0 107.887 178.951 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 118' ' ' ALA . . . . . . . . . . . . . . . -142.06 160.38 40.34 Favored 'General case' 0 N--CA 1.491 1.601 0 C-N-CA 118.775 -1.17 . . . . 0.0 111.812 -179.07 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 119' ' ' GLY . . . . . . . . . . . . . . . -164.66 145.49 10.34 Favored Glycine 0 N--CA 1.481 1.688 0 N-CA-C 109.636 -1.386 . . . . 0.0 109.636 179.667 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 120' ' ' HIS . . . . . . . . . . . . . 10.5 m-70 -71.03 166.22 21.82 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.665 -0.903 . . . . 0.0 109.897 179.119 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 121' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -123.69 149.28 45.68 Favored 'General case' 0 N--CA 1.496 1.858 0 N-CA-C 107.637 -1.245 . . . . 0.0 107.637 178.53 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 122' ' ' PHE . . . . . . . . . . . . . 0.4 OUTLIER -114.88 138.02 51.28 Favored 'General case' 0 N--CA 1.492 1.666 0 O-C-N 121.178 -0.951 . . . . 0.0 109.99 -179.227 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 123' ' ' ILE . . . . . . . . . . . . . 17.8 tt -89.39 -31.56 5.41 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.677 0 CA-C-O 121.98 0.895 . . . . 0.0 109.432 -179.782 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 124' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -85.48 -3.67 58.93 Favored 'General case' 0 C--N 1.292 -1.908 0 C-N-CA 120.05 -0.66 . . . . 0.0 112.218 -177.71 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 125' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -157.15 130.97 4.8 Favored Pre-proline 0 N--CA 1.499 1.986 0 O-C-N 120.249 -1.532 . . . . 0.0 110.668 179.443 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 126' ' ' PRO . . . . . . . . . . . . . 88.7 Cg_endo -83.18 -13.23 9.02 Favored 'Trans proline' 0 N--CA 1.497 1.709 0 C-N-CA 122.676 2.251 . . . . 0.0 113.218 178.94 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 127' ' ' ASN . . . . . . . . . . . . . 1.4 t30 -89.32 24.79 2.1 Favored 'General case' 0 N--CA 1.494 1.735 0 O-C-N 121.041 -1.037 . . . . 0.0 110.05 -178.924 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 128' ' ' TYR . . . . . . . . . . . . . 9.6 t80 -83.15 -148.75 0.09 Allowed 'General case' 0 C--N 1.299 -1.621 0 O-C-N 121.237 -0.914 . . . . 0.0 109.322 -179.892 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 129' ' ' GLN . . . . . . . . . . . . . 6.4 mt-30 -65.75 -88.51 0.01 OUTLIER 'General case' 0 C--N 1.299 -1.63 0 O-C-N 121.345 -0.847 . . . . 0.0 110.172 -179.319 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 130' ' ' PHE . . . . . 0.452 ' CE2' ' CG1' ' A' ' 101' ' ' VAL . 35.8 m-85 -111.91 32.27 5.6 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.353 -0.842 . . . . 0.0 109.977 -179.249 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 131' ' ' THR . . . . . . . . . . . . . 89.8 m -71.23 -33.94 70.32 Favored 'General case' 0 N--CA 1.497 1.878 0 O-C-N 121.385 -0.822 . . . . 0.0 109.441 179.514 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 132' ' ' ASN . . . . . 0.606 ' ND2' ' O ' ' A' ' 81' ' ' ALA . 0.1 OUTLIER -84.69 5.82 26.67 Favored 'General case' 0 N--CA 1.498 1.962 0 CA-C-O 121.945 0.879 . . . . 0.0 109.364 -179.624 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 133' ' ' LEU . . . . . 0.592 ' O ' ' N ' ' A' ' 135' ' ' ALA . 0.2 OUTLIER -72.34 -45.25 60.72 Favored 'General case' 0 C--N 1.297 -1.684 0 O-C-N 121.157 -0.964 . . . . 0.0 109.738 179.69 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 134' ' ' LYS . . . . . 0.557 ' CE ' ' H ' ' A' ' 134' ' ' LYS . 0.0 OUTLIER -47.39 -10.39 0.02 OUTLIER 'General case' 0 C--N 1.3 -1.585 0 O-C-N 121.14 -0.975 . . . . 0.0 109.546 -179.634 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 135' ' ' ALA . . . . . 0.592 ' N ' ' O ' ' A' ' 133' ' ' LEU . . . -84.65 -39.72 18.28 Favored 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.081 -1.012 . . . . 0.0 109.165 179.225 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 136' ' ' ALA . . . . . . . . . . . . . . . -78.19 159.58 28.47 Favored 'General case' 0 N--CA 1.489 1.49 0 CA-C-O 122.08 0.943 . . . . 0.0 111.586 -178.472 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 137' ' ' LYS . . . . . 0.559 ' O ' ' O ' ' A' ' 138' ' ' LYS . 7.9 tttt -154.25 -162.76 1.47 Allowed 'General case' 0 N--CA 1.492 1.662 0 C-N-CA 118.801 -1.159 . . . . 0.0 110.467 -178.515 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 138' ' ' LYS . . . . . 0.606 ' O ' ' N ' ' A' ' 140' ' ' SER . 23.0 mttt -44.25 -179.26 0.0 OUTLIER 'General case' 0 C--N 1.302 -1.468 0 CA-C-O 122.334 1.064 . . . . 0.0 110.667 -179.282 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 139' ' ' GLY . . . . . . . . . . . . . . . 46.41 8.25 0.02 OUTLIER Glycine 0 N--CA 1.492 2.408 0 N-CA-C 110.018 -1.233 . . . . 0.0 110.018 -179.676 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 140' ' ' SER . . . . . 0.606 ' N ' ' O ' ' A' ' 138' ' ' LYS . 9.9 m -81.2 144.11 31.85 Favored 'General case' 0 N--CA 1.493 1.705 0 O-C-N 120.864 -1.374 . . . . 0.0 109.224 179.235 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 141' ' ' MET . . . . . . . . . . . . . 2.1 tpt -96.39 125.95 41.25 Favored 'General case' 0 C--N 1.301 -1.535 0 O-C-N 121.127 -0.983 . . . . 0.0 109.403 -179.921 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 142' ' ' VAL . . . . . . . . . . . . . 2.4 t -113.77 128.77 70.52 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.838 0 O-C-N 121.269 -0.894 . . . . 0.0 109.554 -179.438 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 143' ' ' TYR . . . . . 0.409 ' CZ ' ' CD ' ' A' ' 152' ' ' LYS . 3.0 m-85 -107.48 134.39 50.58 Favored 'General case' 0 N--CA 1.497 1.91 0 O-C-N 121.172 -0.955 . . . . 0.0 111.158 -178.838 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 144' ' ' PHE . . . . . . . . . . . . . 24.7 t80 -118.86 99.89 7.04 Favored 'General case' 0 N--CA 1.494 1.726 0 N-CA-C 109.221 -0.659 . . . . 0.0 109.221 179.965 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 145' ' ' LYS . . . . . . . . . . . . . 8.2 mtpm? -98.56 122.47 41.8 Favored 'General case' 0 N--CA 1.488 1.426 0 O-C-N 121.231 -0.918 . . . . 0.0 110.196 -179.353 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 146' ' ' VAL . . . . . . . . . . . . . 1.0 OUTLIER -143.51 122.82 8.25 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.499 0 O-C-N 120.885 -1.134 . . . . 0.0 109.058 179.005 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 147' ' ' GLY . . . . . . . . . . . . . . . 67.23 -132.91 30.7 Favored Glycine 0 N--CA 1.484 1.869 0 N-CA-C 108.186 -1.966 . . . . 0.0 108.186 -179.387 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 148' ' ' ASN . . . . . 0.611 ' C ' ' ND2' ' A' ' 148' ' ' ASN . 0.0 OUTLIER -101.28 11.36 39.44 Favored 'General case' 0 C--N 1.296 -1.727 0 N-CA-C 107.918 -1.141 . . . . 0.0 107.918 178.789 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 149' ' ' GLU . . . . . . . . . . . . . 2.4 tt0 -108.13 143.03 37.45 Favored 'General case' 0 N--CA 1.489 1.484 0 O-C-N 121.311 -0.868 . . . . 0.0 111.35 -178.841 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 150' ' ' THR . . . . . . . . . . . . . 3.7 m -131.03 100.64 5.3 Favored 'General case' 0 N--CA 1.495 1.822 0 CA-C-O 121.413 0.625 . . . . 0.0 109.724 179.923 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 151' ' ' ARG . . . . . 0.566 HH12 ' CD ' ' A' ' 204' ' ' GLU . 0.1 OUTLIER -86.63 -169.99 2.88 Favored 'General case' 0 C--N 1.305 -1.347 0 N-CA-C 108.382 -0.969 . . . . 0.0 108.382 179.466 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 152' ' ' LYS . . . . . 0.42 ' C ' ' CD1' ' A' ' 153' ' ' TYR . 24.8 mtmm -153.22 151.29 29.9 Favored 'General case' 0 C--N 1.3 -1.57 0 O-C-N 121.327 -0.858 . . . . 0.0 109.7 -179.857 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 153' ' ' TYR . . . . . 0.491 ' CD2' ' HA ' ' A' ' 204' ' ' GLU . 6.2 m-85 -142.79 168.81 18.85 Favored 'General case' 0 N--CA 1.493 1.706 0 N-CA-C 107.856 -1.164 . . . . 0.0 107.856 178.759 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 154' ' ' LYS . . . . . . . . . . . . . 20.5 ttpt -142.9 119.38 10.98 Favored 'General case' 0 N--CA 1.493 1.678 0 O-C-N 121.51 -0.744 . . . . 0.0 109.186 178.884 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 155' ' ' MET . . . . . . . . . . . . . 29.2 mtp -47.28 105.62 0.07 Allowed 'General case' 0 N--CA 1.494 1.747 0 O-C-N 120.819 -1.176 . . . . 0.0 112.321 -178.983 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 156' ' ' THR . . . . . . . . . . . . . 1.3 m -105.39 -21.29 13.26 Favored 'General case' 0 N--CA 1.494 1.755 0 CA-C-N 115.445 -0.798 . . . . 0.0 110.168 -179.548 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 157' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -148.38 147.02 28.75 Favored 'General case' 0 N--CA 1.494 1.753 0 C-N-CA 118.336 -1.345 . . . . 0.0 110.814 -178.689 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 158' ' ' ILE . . . . . . . . . . . . . 1.1 mt -148.49 138.24 16.22 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.547 0 CA-C-O 121.577 0.703 . . . . 0.0 109.953 -178.463 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 159' ' ' ARG . . . . . . . . . . . . . 5.7 ttm180 -156.45 -161.96 1.19 Allowed 'General case' 0 N--CA 1.497 1.893 0 O-C-N 121.325 -0.859 . . . . 0.0 110.594 -179.565 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 160' ' ' ASP . . . . . . . . . . . . . 67.4 m-20 -149.09 156.17 41.81 Favored 'General case' 0 N--CA 1.498 1.956 0 N-CA-C 108.954 -0.758 . . . . 0.0 108.954 -179.909 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 161' ' ' VAL . . . . . 0.454 ' O ' ' O ' ' A' ' 162' ' ' LYS . 0.1 OUTLIER -149.15 148.08 16.04 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.807 0 O-C-N 120.699 -1.251 . . . . 0.0 110.359 179.851 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 162' ' ' LYS . . . . . 0.497 ' H ' ' CD ' ' A' ' 162' ' ' LYS . 0.0 OUTLIER -44.33 169.07 0.07 OUTLIER Pre-proline 0 N--CA 1.494 1.756 0 O-C-N 121.409 -0.807 . . . . 0.0 110.191 179.997 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 163' ' ' PRO . . . . . . . . . . . . . 58.0 Cg_endo -78.98 23.7 0.62 Allowed 'Trans proline' 0 C--N 1.31 -1.476 0 C-N-CA 122.917 2.411 . . . . 0.0 112.572 -179.169 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 164' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -151.22 1.69 0.41 Allowed 'General case' 0 C--N 1.299 -1.592 0 O-C-N 121.322 -0.861 . . . . 0.0 109.864 -179.488 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 165' ' ' ASP . . . . . 0.481 ' O ' ' C ' ' A' ' 166' ' ' VAL . 8.3 t70 -77.35 66.44 3.11 Favored 'General case' 0 N--CA 1.493 1.687 0 O-C-N 121.15 -0.969 . . . . 0.0 110.334 -179.877 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 166' ' ' VAL . . . . . 0.639 ' O ' ' N ' ' A' ' 168' ' ' VAL . 0.9 OUTLIER -38.0 -32.54 0.11 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.576 0 O-C-N 121.158 -0.963 . . . . 0.0 109.375 -178.638 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 167' ' ' GLY . . . . . 0.466 ' N ' ' O ' ' A' ' 165' ' ' ASP . . . -43.16 -15.71 0.03 OUTLIER Glycine 0 N--CA 1.491 2.325 0 N-CA-C 108.848 -1.701 . . . . 0.0 108.848 179.428 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 168' ' ' VAL . . . . . 0.639 ' N ' ' O ' ' A' ' 166' ' ' VAL . 3.5 t -49.98 -44.28 21.39 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.735 0 N-CA-C 108.168 -1.049 . . . . 0.0 108.168 178.412 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 169' ' ' LEU . . . . . 0.54 ' O ' ' C ' ' A' ' 170' ' ' ASP . 8.9 mt -50.2 -9.38 0.04 OUTLIER 'General case' 0 C--N 1.299 -1.628 0 N-CA-C 108.425 -0.954 . . . . 0.0 108.425 -177.396 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 170' ' ' ASP . . . . . 0.585 ' H ' ' C ' ' A' ' 168' ' ' VAL . 10.6 p30 18.46 80.87 0.01 OUTLIER 'General case' 0 N--CA 1.5 2.05 0 CA-C-N 116.582 -0.281 . . . . 0.0 111.699 177.793 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 171' ' ' GLU . . . . . . . . . . . . . 3.7 pt-20 -117.33 65.09 0.73 Allowed 'General case' 0 N--CA 1.493 1.692 0 O-C-N 121.152 -0.967 . . . . 0.0 110.069 179.833 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 172' ' ' GLN . . . . . . . . . . . . . 12.2 mt-30 -134.44 -45.91 0.76 Allowed 'General case' 0 N--CA 1.492 1.663 0 O-C-N 121.41 -0.806 . . . . 0.0 110.253 -178.598 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 173' ' ' LYS . . . . . . . . . . . . . 17.9 mttp -62.64 135.15 57.24 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 120.769 -1.207 . . . . 0.0 108.615 179.049 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 174' ' ' GLY . . . . . 0.52 ' O ' ' C ' ' A' ' 175' ' ' LYS . . . -141.21 -40.64 0.08 OUTLIER Glycine 0 C--N 1.295 -1.707 0 N-CA-C 108.138 -1.985 . . . . 0.0 108.138 179.899 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 175' ' ' LYS . . . . . 0.52 ' C ' ' O ' ' A' ' 174' ' ' GLY . 13.0 mptt -31.84 -64.08 0.17 Allowed 'General case' 0 N--CA 1.501 2.075 0 N-CA-C 108.653 -0.869 . . . . 0.0 108.653 179.196 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 176' ' ' ASP . . . . . 0.726 ' O ' ' O ' ' A' ' 177' ' ' LYS . 2.6 m-20 -101.93 73.28 1.39 Allowed 'General case' 0 C--N 1.297 -1.706 0 N-CA-C 107.255 -1.387 . . . . 0.0 107.255 177.627 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 177' ' ' LYS . . . . . 0.726 ' O ' ' O ' ' A' ' 176' ' ' ASP . 28.2 mttt -20.62 157.79 0.0 OUTLIER 'General case' 0 N--CA 1.504 2.233 0 CA-C-O 122.132 0.968 . . . . 0.0 111.851 -178.907 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 178' ' ' GLN . . . . . . . . . . . . . 3.3 pt20 -156.07 170.89 21.14 Favored 'General case' 0 N--CA 1.488 1.467 0 C-N-CA 117.096 -1.842 . . . . 0.0 112.084 -178.727 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 179' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -126.55 97.78 5.15 Favored 'General case' 0 C--N 1.303 -1.433 0 N-CA-C 107.237 -1.394 . . . . 0.0 107.237 178.366 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 180' ' ' THR . . . . . . . . . . . . . 1.1 m -71.23 121.06 17.71 Favored 'General case' 0 C--N 1.302 -1.464 0 C-N-CA 118.726 -1.19 . . . . 0.0 110.004 -178.615 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 181' ' ' LEU . . . . . . . . . . . . . 66.8 tp -94.55 152.25 18.69 Favored 'General case' 0 C--N 1.298 -1.654 0 N-CA-C 107.589 -1.263 . . . . 0.0 107.589 177.632 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 182' ' ' ILE . . . . . . . . . . . . . 36.5 mt -142.12 109.22 1.99 Allowed 'Isoleucine or valine' 0 C--N 1.301 -1.53 0 C-N-CA 119.083 -1.047 . . . . 0.0 109.242 178.941 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 183' ' ' THR . . . . . . . . . . . . . 1.2 t -129.21 109.36 11.08 Favored 'General case' 0 C--N 1.294 -1.836 0 N-CA-C 107.751 -1.203 . . . . 0.0 107.751 179.635 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 184' ' ' CYS . . . . . . . . . . . . . 4.0 p -81.06 157.96 25.24 Favored 'General case' 0 C--N 1.293 -1.879 0 C-N-CA 119.182 -1.007 . . . . 0.0 111.349 -177.609 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 185' ' ' ASP . . . . . 0.575 ' CG ' ' H ' ' A' ' 186' ' ' ASP . 43.9 t0 -164.3 -158.4 0.42 Allowed 'General case' 0 N--CA 1.489 1.509 0 N-CA-C 108.88 -0.785 . . . . 0.0 108.88 -179.536 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 186' ' ' ASP . . . . . 0.575 ' H ' ' CG ' ' A' ' 185' ' ' ASP . 1.3 m-20 56.91 49.35 14.2 Favored 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.161 -0.962 . . . . 0.0 109.675 179.561 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 187' ' ' TYR . . . . . 0.58 ' CE1' ' O ' ' A' ' 188' ' ' ASN . 33.9 t80 -65.43 128.69 36.91 Favored 'General case' 0 C--N 1.297 -1.674 0 O-C-N 121.075 -1.016 . . . . 0.0 109.772 -179.945 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 188' ' ' ASN . . . . . 0.76 ' ND2' ' H ' ' A' ' 193' ' ' VAL . 0.0 OUTLIER -97.85 150.55 21.17 Favored 'General case' 0 C--N 1.294 -1.838 0 N-CA-C 107.886 -1.153 . . . . 0.0 107.886 178.591 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 189' ' ' GLU . . . . . . . . . . . . . 1.7 tt0 -112.58 -5.95 13.97 Favored 'General case' 0 C--N 1.294 -1.831 0 N-CA-C 108.674 -0.862 . . . . 0.0 108.674 -178.683 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 190' ' ' LYS . . . . . 0.613 ' N ' ' OD1' ' A' ' 188' ' ' ASN . 10.2 mmtm -84.06 -57.45 3.18 Favored 'General case' 0 C--N 1.299 -1.618 0 N-CA-C 108.939 -0.763 . . . . 0.0 108.939 179.401 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 191' ' ' THR . . . . . 0.572 ' OG1' ' ND2' ' A' ' 188' ' ' ASN . 1.5 p -89.25 0.14 57.0 Favored 'General case' 0 N--CA 1.494 1.77 0 O-C-N 121.443 -0.785 . . . . 0.0 109.706 179.647 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 192' ' ' GLY . . . . . 0.646 ' N ' HD22 ' A' ' 188' ' ' ASN . . . 60.34 37.2 92.73 Favored Glycine 0 N--CA 1.498 2.783 0 N-CA-C 110.634 -0.986 . . . . 0.0 110.634 179.318 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 193' ' ' VAL . . . . . 0.76 ' H ' ' ND2' ' A' ' 188' ' ' ASN . 73.9 t -148.64 163.84 4.99 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.629 0 O-C-N 120.996 -1.297 . . . . 0.0 110.298 179.879 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 194' ' ' TRP . . . . . 0.586 ' CD1' ' OG1' ' C' ' 705' ' ' B27 . 5.5 m95 -82.44 121.36 26.64 Favored 'General case' 0 N--CA 1.489 1.518 0 N-CA-C 108.373 -0.973 . . . . 0.0 108.373 179.257 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 195' ' ' GLU . . . . . . . . . . . . . 2.5 mt-10 -86.16 -57.39 3.04 Favored 'General case' 0 C--N 1.3 -1.566 0 O-C-N 121.15 -0.969 . . . . 0.0 110.463 -178.597 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 196' ' ' LYS . . . . . . . . . . . . . 2.6 mttp -92.33 143.65 26.18 Favored 'General case' 0 N--CA 1.489 1.494 0 O-C-N 120.911 -1.118 . . . . 0.0 110.205 -179.302 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 197' ' ' ARG . . . . . 0.64 ' CG ' HH11 ' A' ' 197' ' ' ARG . 0.2 OUTLIER -122.14 144.42 48.95 Favored 'General case' 0 N--CA 1.488 1.447 0 N-CA-C 108.784 -0.821 . . . . 0.0 108.784 179.108 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 198' ' ' LYS . . . . . . . . . . . . . 13.4 mptt -115.78 119.42 35.96 Favored 'General case' 0 C--N 1.299 -1.606 0 C-N-CA 120.349 -0.54 . . . . 0.0 110.087 -178.91 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 199' ' ' ILE . . . . . . . . . . . . . 1.0 OUTLIER -136.33 118.15 19.94 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.566 0 CA-C-O 122.716 1.246 . . . . 0.0 109.018 178.968 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 200' ' ' PHE . . . . . 0.535 ' CD1' ' N ' ' A' ' 200' ' ' PHE . 1.0 OUTLIER -102.84 138.37 39.82 Favored 'General case' 0 N--CA 1.492 1.671 0 CA-C-N 115.6 -0.727 . . . . 0.0 111.257 -176.918 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 201' ' ' VAL . . . . . . . . . . . . . 47.0 t -105.94 143.22 17.31 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.37 0 O-C-N 121.523 -0.736 . . . . 0.0 109.396 177.799 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 202' ' ' ALA . . . . . . . . . . . . . . . -130.37 137.57 49.96 Favored 'General case' 0 C--N 1.301 -1.502 0 N-CA-C 107.978 -1.119 . . . . 0.0 107.978 179.662 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 203' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -89.89 132.82 35.09 Favored 'General case' 0 C--N 1.303 -1.422 0 CA-C-O 122.576 1.179 . . . . 0.0 111.549 -178.796 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 204' ' ' GLU . . . . . 0.566 ' CD ' HH12 ' A' ' 151' ' ' ARG . 3.9 tt0 -49.45 135.01 18.5 Favored 'General case' 0 C--N 1.293 -1.888 0 C-N-CA 118.459 -1.296 . . . . 0.0 108.796 178.575 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 205' ' ' VAL . . . . . 0.464 ' CG1' ' N ' ' A' ' 206' ' ' LYS . 70.8 t -129.79 162.41 37.5 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.547 0 CA-C-O 122.082 0.944 . . . . 0.0 110.284 -177.739 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 206' ' ' LYS . . . . . 0.464 ' N ' ' CG1' ' A' ' 205' ' ' VAL . 4.6 ptmt . . . . . 0 C--N 1.298 -1.651 0 CA-C-O 118.145 -0.931 . . . . 0.0 109.42 -179.661 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' C' C ' 701' ' ' PHQ . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 020 nuclear orig full ' C' C ' 702' ' ' LEU . . . . . 0.653 ' CD1' ' N ' ' C' ' 702' ' ' LEU . 0.0 OUTLIER . . . . . 0 N--CA 1.485 1.32 0 N-CA-C 108.304 -0.998 . . . . 0.0 108.304 . . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' C' C ' 703' ' ' PRO . . . . . 0.603 ' O ' ' NH2' ' A' ' 197' ' ' ARG . 88.7 Cg_endo -81.1 172.76 12.56 Favored 'Trans proline' 0 C--N 1.303 -1.848 0 C-N-CA 122.632 2.221 . . . . 0.0 112.406 -179.688 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' C' C ' 704' ' ' ALA . . . . . 0.478 ' C ' ' O ' ' C' ' 703' ' ' PRO . . . 36.02 -156.04 0.0 OUTLIER 'General case' 0 N--CA 1.492 1.643 0 CA-C-O 121.536 0.684 . . . . 0.0 110.422 178.802 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' C' C ' 705' ' ' B27 . . . . . 0.586 ' OG1' ' CD1' ' A' ' 194' ' ' TRP . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 700' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 001 nuclear build core ' A' A ' 63' ' ' PRO . . . . . 0.458 ' O ' HD22 ' A' ' 110' ' ' LEU . 6.7 Cg_exo . . . . . 0 N--CA 1.486 1.054 0 CA-C-O 121.228 0.428 . . . . 0.0 111.288 . . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 64' ' ' GLN . . . . . 0.554 ' N ' ' CD ' ' A' ' 64' ' ' GLN . 0.0 OUTLIER -155.75 126.9 7.09 Favored 'General case' 0 C--N 1.3 -1.56 0 O-C-N 121.117 -0.99 . . . . 0.0 109.347 179.316 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 65' ' ' ILE . . . . . 0.582 ' H ' HD12 ' A' ' 65' ' ' ILE . 2.1 mp -46.27 106.37 0.56 Allowed Pre-proline 0 N--CA 1.489 1.495 0 N-CA-C 107.519 -1.289 . . . . 0.0 107.519 178.935 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 66' ' ' PRO . . . . . . . . . . . . . 89.0 Cg_endo -83.42 -162.84 0.18 Allowed 'Trans proline' 0 C--N 1.315 -1.185 0 C-N-CA 122.462 2.108 . . . . 0.0 112.834 -178.111 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 67' ' ' LYS . . . . . . . . . . . . . 24.8 tttm -87.65 -7.56 57.29 Favored 'General case' 0 N--CA 1.487 1.423 0 O-C-N 121.414 -0.803 . . . . 0.0 109.421 179.965 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 68' ' ' ASP . . . . . 0.654 ' O ' ' N ' ' A' ' 70' ' ' SER . 0.7 OUTLIER -76.23 63.38 1.88 Allowed 'General case' 0 N--CA 1.488 1.461 0 CA-C-O 122.936 1.35 . . . . 0.0 108.822 179.561 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 69' ' ' LYS . . . . . 0.462 ' C ' ' O ' ' A' ' 68' ' ' ASP . 8.2 ptpt -45.45 -14.57 0.02 OUTLIER 'General case' 0 N--CA 1.512 2.67 0 C-N-CA 116.881 -1.928 . . . . 0.0 107.321 178.086 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 70' ' ' SER . . . . . 0.654 ' N ' ' O ' ' A' ' 68' ' ' ASP . 0.6 OUTLIER -86.83 -7.29 58.37 Favored 'General case' 0 N--CA 1.498 1.969 0 CA-C-N 113.856 -1.52 . . . . 0.0 111.661 179.793 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 71' ' ' LYS . . . . . 0.47 ' N ' ' O ' ' A' ' 68' ' ' ASP . 0.0 OUTLIER -97.05 142.47 28.95 Favored 'General case' 0 N--CA 1.505 2.323 0 O-C-N 120.435 -1.416 . . . . 0.0 112.552 -178.838 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 72' ' ' VAL . . . . . 0.844 HG12 ' CE1' ' A' ' 88' ' ' TYR . 2.6 m -68.0 130.55 33.27 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.418 0 N-CA-C 105.375 -2.083 . . . . 0.0 105.375 174.965 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 73' ' ' ALA . . . . . 0.607 ' N ' ' O ' ' A' ' 87' ' ' VAL . . . -79.02 -13.99 59.45 Favored 'General case' 0 C--N 1.293 -1.855 0 O-C-N 119.999 -1.688 . . . . 0.0 107.398 -179.596 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . 173.5 -157.72 26.5 Favored Glycine 0 N--CA 1.479 1.524 0 N-CA-C 109.48 -1.448 . . . . 0.0 109.48 179.771 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 75' ' ' TYR . . . . . 0.606 ' HA ' HG23 ' A' ' 87' ' ' VAL . 69.1 m-85 -142.06 169.72 17.06 Favored 'General case' 0 C--N 1.295 -1.787 0 CA-C-O 121.961 0.886 . . . . 0.0 110.456 -177.591 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 76' ' ' ILE . . . . . . . . . . . . . 0.8 OUTLIER -147.27 142.28 20.03 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.72 0 C-N-CA 119.234 -0.986 . . . . 0.0 109.634 -177.362 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -151.52 162.31 41.19 Favored 'General case' 0 N--CA 1.487 1.409 0 O-C-N 121.193 -0.942 . . . . 0.0 109.759 -179.934 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 78' ' ' ILE . . . . . 0.544 ' HB ' ' HB3' ' A' ' 81' ' ' ALA . 9.5 mt -145.65 123.76 6.4 Favored Pre-proline 0 C--N 1.303 -1.434 0 N-CA-C 107.821 -1.178 . . . . 0.0 107.821 179.338 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 79' ' ' PRO . . . . . . . . . . . . . 41.5 Cg_endo -71.94 -43.69 1.15 Allowed 'Trans proline' 0 C--N 1.314 -1.255 0 C-N-CA 121.867 1.712 . . . . 0.0 112.949 -178.798 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 1.3 m-20 -66.61 -21.4 66.13 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 120.959 -1.088 . . . . 0.0 110.861 178.339 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 81' ' ' ALA . . . . . 0.847 ' HB2' ' HB2' ' A' ' 136' ' ' ALA . . . -105.04 -15.89 14.97 Favored 'General case' 0 N--CA 1.496 1.838 0 O-C-N 121.139 -0.975 . . . . 0.0 109.095 179.672 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 82' ' ' ASP . . . . . . . . . . . . . 20.8 t0 62.84 52.2 2.77 Favored 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.472 -0.768 . . . . 0.0 110.847 179.292 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 83' ' ' ILE . . . . . . . . . . . . . 70.2 mt -127.27 152.85 35.79 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.735 0 O-C-N 121.229 -0.919 . . . . 0.0 109.677 -179.239 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 84' ' ' LYS . . . . . . . . . . . . . 34.6 tttp -158.21 106.49 1.98 Allowed 'General case' 0 N--CA 1.491 1.61 0 N-CA-C 107.778 -1.193 . . . . 0.0 107.778 -179.95 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 85' ' ' GLU . . . . . 0.508 ' OE2' ' O ' ' A' ' 128' ' ' TYR . 0.0 OUTLIER -141.31 165.54 28.2 Favored Pre-proline 0 N--CA 1.495 1.791 0 O-C-N 121.14 -0.975 . . . . 0.0 110.779 -178.366 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 86' ' ' PRO . . . . . . . . . . . . . 56.0 Cg_endo -73.57 168.13 25.55 Favored 'Trans proline' 0 N--CA 1.497 1.681 0 C-N-CA 123.335 2.69 . . . . 0.0 113.796 -179.595 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 87' ' ' VAL . . . . . 0.607 ' O ' ' N ' ' A' ' 73' ' ' ALA . 54.8 t -126.35 104.19 12.55 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.841 0 N-CA-C 109.368 -0.605 . . . . 0.0 109.368 179.917 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 88' ' ' TYR . . . . . 0.844 ' CE1' HG12 ' A' ' 72' ' ' VAL . 11.9 m-85 -94.92 156.76 37.66 Favored Pre-proline 0 N--CA 1.504 2.26 0 O-C-N 120.766 -1.209 . . . . 0.0 109.801 179.98 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 89' ' ' PRO . . . . . . . . . . . . . 13.4 Cg_endo -62.84 145.16 94.59 Favored 'Trans proline' 0 N--CA 1.498 1.778 0 C-N-CA 122.637 2.225 . . . . 0.0 113.273 179.591 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . -60.46 169.17 8.4 Favored Glycine 0 N--CA 1.494 2.527 0 N-CA-C 109.383 -1.487 . . . . 0.0 109.383 179.318 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 91' ' ' PRO . . . . . 0.525 ' HD2' HE21 ' A' ' 96' ' ' GLN . 57.3 Cg_endo -93.5 169.15 20.47 Favored 'Cis proline' 0 C--N 1.307 -1.622 0 C-N-CA 123.966 -1.264 . . . . 0.0 111.989 0.194 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 92' ' ' ALA . . . . . 0.7 ' HB1' HD21 ' A' ' 97' ' ' LEU . . . -71.83 32.26 0.05 Allowed 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.214 -0.929 . . . . 0.0 109.988 179.957 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 93' ' ' THR . . . . . 0.494 ' OG1' ' NE2' ' A' ' 96' ' ' GLN . 5.4 p -72.22 150.48 92.11 Favored Pre-proline 0 C--N 1.303 -1.431 0 O-C-N 120.481 -1.387 . . . . 0.0 108.025 179.761 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 94' ' ' PRO . . . . . . . . . . . . . 74.1 Cg_exo -32.96 -52.8 0.41 Allowed 'Trans proline' 0 C--N 1.306 -1.7 0 C-N-CA 122.893 2.396 . . . . 0.0 112.965 -178.549 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 95' ' ' GLU . . . . . 0.403 ' O ' ' OD1' ' A' ' 98' ' ' ASN . 14.3 mt-10 -49.89 -47.84 51.85 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.079 -1.013 . . . . 0.0 110.061 -179.74 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 96' ' ' GLN . . . . . 0.579 ' O ' ' N ' ' A' ' 98' ' ' ASN . 2.5 mp0 -72.57 -53.99 10.4 Favored 'General case' 0 N--CA 1.489 1.487 0 O-C-N 120.98 -1.075 . . . . 0.0 110.187 -179.68 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 97' ' ' LEU . . . . . 0.7 HD21 ' HB1' ' A' ' 92' ' ' ALA . 94.0 mt -49.31 -6.56 0.02 OUTLIER 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.145 -0.972 . . . . 0.0 109.684 -179.26 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 98' ' ' ASN . . . . . 0.579 ' N ' ' O ' ' A' ' 96' ' ' GLN . 0.0 OUTLIER -73.88 -20.39 60.43 Favored 'General case' 0 N--CA 1.488 1.447 0 O-C-N 121.252 -0.905 . . . . 0.0 109.2 179.903 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 99' ' ' ARG . . . . . 0.41 ' HG3' ' ND2' ' A' ' 98' ' ' ASN . 3.0 mtt180 -103.06 -58.16 1.92 Allowed 'General case' 0 N--CA 1.489 1.492 0 O-C-N 121.379 -0.825 . . . . 0.0 110.182 -179.357 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . -173.82 -172.43 39.15 Favored Glycine 0 N--CA 1.492 2.4 0 C-N-CA 119.373 -1.394 . . . . 0.0 110.505 -179.752 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 101' ' ' VAL . . . . . 0.695 HG23 ' O ' ' A' ' 101' ' ' VAL . 34.0 m -51.49 103.75 0.05 OUTLIER 'Isoleucine or valine' 0 N--CA 1.493 1.701 0 O-C-N 121.575 -0.956 . . . . 0.0 110.017 -179.817 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -91.55 160.75 15.26 Favored 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.193 -0.942 . . . . 0.0 110.158 179.927 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 103' ' ' PHE . . . . . 0.563 ' O ' ' N ' ' A' ' 105' ' ' GLU . 23.1 m-85 -63.74 121.2 13.4 Favored 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.009 -1.057 . . . . 0.0 108.357 178.769 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 104' ' ' ALA . . . . . 0.615 ' HB3' ' HB2' ' A' ' 116' ' ' SER . . . -45.23 -12.45 0.02 OUTLIER 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.464 -0.772 . . . . 0.0 110.516 -179.063 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 105' ' ' GLU . . . . . 0.563 ' N ' ' O ' ' A' ' 103' ' ' PHE . 0.1 OUTLIER -136.6 142.7 43.34 Favored 'General case' 0 N--CA 1.494 1.753 0 O-C-N 120.852 -1.155 . . . . 0.0 110.23 179.958 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 106' ' ' GLU . . . . . 0.467 ' OE1' ' ND2' ' A' ' 107' ' ' ASN . 24.3 tt0 -58.79 -63.41 1.3 Allowed 'General case' 0 N--CA 1.488 1.439 0 CA-C-N 116.173 -0.467 . . . . 0.0 111.438 -178.904 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 107' ' ' ASN . . . . . 0.467 ' ND2' ' OE1' ' A' ' 106' ' ' GLU . 1.7 m120 -79.05 35.45 0.26 Allowed 'General case' 0 N--CA 1.49 1.572 0 O-C-N 120.653 -1.279 . . . . 0.0 113.138 -175.694 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 108' ' ' GLU . . . . . . . . . . . . . 1.5 tp10 -58.92 150.47 24.25 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 120.554 -1.341 . . . . 0.0 107.924 179.858 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 109' ' ' SER . . . . . . . . . . . . . 1.5 t -102.73 146.19 28.59 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.006 -1.059 . . . . 0.0 110.975 -178.192 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 110' ' ' LEU . . . . . 0.491 HD11 HG21 ' A' ' 146' ' ' VAL . 4.4 tp -62.4 -20.83 64.86 Favored 'General case' 0 N--CA 1.488 1.46 0 N-CA-C 107.79 -1.189 . . . . 0.0 107.79 178.827 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 111' ' ' ASP . . . . . 0.523 ' CG ' HH22 ' A' ' 151' ' ' ARG . 0.9 OUTLIER -131.46 43.23 3.1 Favored 'General case' 0 C--N 1.302 -1.497 0 N-CA-C 108.573 -0.899 . . . . 0.0 108.573 179.58 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 112' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -70.21 154.12 42.29 Favored 'General case' 0 C--N 1.302 -1.47 0 O-C-N 121.173 -0.954 . . . . 0.0 111.095 -179.812 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 113' ' ' GLN . . . . . 0.533 ' N ' ' CD ' ' A' ' 113' ' ' GLN . 0.0 OUTLIER -67.65 -18.27 64.89 Favored 'General case' 0 C--N 1.3 -1.585 0 N-CA-C 108.255 -1.017 . . . . 0.0 108.255 177.626 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 114' ' ' ASN . . . . . 0.57 ' OD1' ' NE2' ' A' ' 178' ' ' GLN . 11.2 t30 -150.84 105.7 3.3 Favored 'General case' 0 C--N 1.298 -1.654 0 N-CA-C 108.438 -0.949 . . . . 0.0 108.438 178.852 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 115' ' ' ILE . . . . . 0.532 HG22 ' O ' ' A' ' 115' ' ' ILE . 3.8 mt -95.13 105.34 16.86 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.446 0 O-C-N 120.876 -1.14 . . . . 0.0 108.284 179.806 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 116' ' ' SER . . . . . 0.615 ' HB2' ' HB3' ' A' ' 104' ' ' ALA . 11.5 m -91.72 153.85 19.37 Favored 'General case' 0 N--CA 1.488 1.454 0 O-C-N 121.286 -0.883 . . . . 0.0 111.23 -178.262 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 117' ' ' ILE . . . . . 0.411 HD13 HG21 ' A' ' 117' ' ' ILE . 2.3 mt -148.74 148.18 16.13 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.43 0 N-CA-C 108.124 -1.065 . . . . 0.0 108.124 179.286 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 118' ' ' ALA . . . . . 1.019 ' HB1' ' HB2' ' C' ' 704' ' ' ALA . . . -142.26 160.37 40.38 Favored 'General case' 0 N--CA 1.492 1.634 0 C-N-CA 118.934 -1.106 . . . . 0.0 111.597 -178.919 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 119' ' ' GLY . . . . . . . . . . . . . . . -171.53 149.77 12.56 Favored Glycine 0 N--CA 1.489 2.205 0 N-CA-C 110.214 -1.155 . . . . 0.0 110.214 -179.947 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 120' ' ' HIS . . . . . . . . . . . . . 14.1 m170 -70.18 168.12 16.38 Favored 'General case' 0 N--CA 1.494 1.74 0 O-C-N 121.728 -0.866 . . . . 0.0 110.128 179.517 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 121' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -115.78 160.34 20.25 Favored 'General case' 0 N--CA 1.496 1.843 0 O-C-N 121.362 -0.836 . . . . 0.0 109.425 179.455 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 122' ' ' PHE . . . . . 0.413 ' O ' HG21 ' A' ' 131' ' ' THR . 0.2 OUTLIER -133.48 123.49 25.34 Favored 'General case' 0 N--CA 1.497 1.92 0 O-C-N 121.238 -0.914 . . . . 0.0 109.612 -179.409 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 123' ' ' ILE . . . . . 0.608 HG23 ' N ' ' A' ' 124' ' ' ASP . 0.6 OUTLIER -66.0 -42.56 91.94 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.667 0 CA-C-O 121.71 0.767 . . . . 0.0 109.01 179.76 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 124' ' ' ASP . . . . . 0.608 ' N ' HG23 ' A' ' 123' ' ' ILE . 5.8 t70 -92.76 24.84 3.38 Favored 'General case' 0 N--CA 1.496 1.867 0 O-C-N 121.616 -0.678 . . . . 0.0 111.956 -177.917 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 125' ' ' ARG . . . . . 0.622 HH11 ' CG ' ' A' ' 125' ' ' ARG . 0.0 OUTLIER -157.92 103.57 1.76 Allowed Pre-proline 0 N--CA 1.492 1.647 0 O-C-N 120.347 -1.47 . . . . 0.0 110.406 -179.432 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 126' ' ' PRO . . . . . . . . . . . . . 60.1 Cg_endo -79.13 -17.0 12.08 Favored 'Trans proline' 0 C--N 1.315 -1.206 0 C-N-CA 122.078 1.852 . . . . 0.0 111.822 179.728 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 127' ' ' ASN . . . . . . . . . . . . . 14.0 m120 -90.89 10.79 24.92 Favored 'General case' 0 N--CA 1.488 1.448 0 O-C-N 121.309 -0.869 . . . . 0.0 109.515 179.75 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 128' ' ' TYR . . . . . 0.508 ' O ' ' OE2' ' A' ' 85' ' ' GLU . 2.7 t80 -68.17 -153.07 0.02 OUTLIER 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.154 -0.966 . . . . 0.0 109.531 -179.924 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 129' ' ' GLN . . . . . 0.548 ' N ' ' OE1' ' A' ' 129' ' ' GLN . 1.1 mp0 -68.13 -67.15 0.48 Allowed 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.451 -0.781 . . . . 0.0 109.85 -179.705 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 130' ' ' PHE . . . . . 0.498 ' O ' ' CE ' ' A' ' 134' ' ' LYS . 57.1 m-85 -135.61 52.6 2.0 Favored 'General case' 0 N--CA 1.493 1.686 0 O-C-N 121.038 -1.039 . . . . 0.0 110.35 179.981 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 131' ' ' THR . . . . . 0.413 HG21 ' O ' ' A' ' 122' ' ' PHE . 23.4 m -86.43 -41.07 14.73 Favored 'General case' 0 C--N 1.301 -1.523 0 O-C-N 121.075 -1.016 . . . . 0.0 108.764 179.33 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 132' ' ' ASN . . . . . 0.497 ' ND2' ' O ' ' A' ' 81' ' ' ALA . 4.0 t30 -83.47 6.2 21.11 Favored 'General case' 0 N--CA 1.496 1.851 0 O-C-N 121.561 -0.712 . . . . 0.0 111.347 -178.492 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 133' ' ' LEU . . . . . 0.568 HD13 ' HB3' ' A' ' 136' ' ' ALA . 0.1 OUTLIER -69.93 -43.46 71.59 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 120.821 -1.174 . . . . 0.0 109.871 -179.557 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 134' ' ' LYS . . . . . 0.521 ' CD ' ' H ' ' A' ' 134' ' ' LYS . 0.0 OUTLIER -45.37 -17.78 0.03 OUTLIER 'General case' 0 N--CA 1.497 1.921 0 O-C-N 121.172 -0.955 . . . . 0.0 110.154 -179.442 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 135' ' ' ALA . . . . . 0.493 ' N ' ' O ' ' A' ' 133' ' ' LEU . . . -84.66 -32.5 23.59 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 120.949 -1.095 . . . . 0.0 109.38 179.89 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 136' ' ' ALA . . . . . 0.847 ' HB2' ' HB2' ' A' ' 81' ' ' ALA . . . -80.52 153.23 28.24 Favored 'General case' 0 C--N 1.302 -1.466 0 CA-C-O 122.028 0.918 . . . . 0.0 111.386 -178.808 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 137' ' ' LYS . . . . . 0.551 ' O ' ' O ' ' A' ' 138' ' ' LYS . 51.5 mttp -153.38 -165.57 2.19 Favored 'General case' 0 N--CA 1.49 1.531 0 C-N-CA 118.461 -1.295 . . . . 0.0 110.611 -178.543 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 138' ' ' LYS . . . . . 0.585 ' O ' ' N ' ' A' ' 140' ' ' SER . 0.0 OUTLIER -42.74 177.77 0.0 OUTLIER 'General case' 0 C--N 1.302 -1.462 0 CA-C-O 122.232 1.015 . . . . 0.0 110.961 -178.941 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 139' ' ' GLY . . . . . . . . . . . . . . . 46.75 8.63 0.02 OUTLIER Glycine 0 N--CA 1.489 2.191 0 N-CA-C 110.123 -1.191 . . . . 0.0 110.123 -179.943 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 140' ' ' SER . . . . . 0.585 ' N ' ' O ' ' A' ' 138' ' ' LYS . 11.7 m -80.75 122.42 27.13 Favored 'General case' 0 N--CA 1.492 1.663 0 O-C-N 120.817 -1.402 . . . . 0.0 109.544 179.616 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 141' ' ' MET . . . . . . . . . . . . . 6.5 tpt -77.66 121.89 24.6 Favored 'General case' 0 C--N 1.301 -1.515 0 N-CA-C 108.461 -0.94 . . . . 0.0 108.461 179.252 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 142' ' ' VAL . . . . . . . . . . . . . 2.8 t -112.61 135.9 50.57 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.721 0 O-C-N 121.124 -0.985 . . . . 0.0 109.688 -178.918 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 143' ' ' TYR . . . . . . . . . . . . . 67.8 m-85 -115.14 138.37 50.98 Favored 'General case' 0 N--CA 1.495 1.801 0 O-C-N 121.271 -0.893 . . . . 0.0 110.827 -179.453 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 144' ' ' PHE . . . . . 0.409 ' CD1' ' C ' ' A' ' 144' ' ' PHE . 1.4 t80 -122.26 108.45 13.28 Favored 'General case' 0 N--CA 1.494 1.733 0 O-C-N 121.692 -0.63 . . . . 0.0 109.558 -179.315 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 145' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -97.08 132.43 42.88 Favored 'General case' 0 N--CA 1.494 1.76 0 O-C-N 121.227 -0.921 . . . . 0.0 111.073 -178.791 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 146' ' ' VAL . . . . . 0.518 HG23 ' O ' ' A' ' 73' ' ' ALA . 4.2 p -143.95 143.75 23.53 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.739 0 N-CA-C 107.854 -1.165 . . . . 0.0 107.854 178.632 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 147' ' ' GLY . . . . . 0.453 ' C ' ' O ' ' A' ' 146' ' ' VAL . . . 42.37 -128.28 4.68 Favored Glycine 0 N--CA 1.491 2.308 0 N-CA-C 108.894 -1.682 . . . . 0.0 108.894 -179.597 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 148' ' ' ASN . . . . . . . . . . . . . 21.5 p30 -103.34 18.02 22.74 Favored 'General case' 0 C--N 1.299 -1.594 0 O-C-N 121.49 -1.006 . . . . 0.0 108.348 178.976 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 149' ' ' GLU . . . . . . . . . . . . . 7.6 tt0 -113.84 144.49 42.92 Favored 'General case' 0 N--CA 1.49 1.54 0 CA-C-O 121.917 0.865 . . . . 0.0 111.604 -178.184 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 150' ' ' THR . . . . . . . . . . . . . 52.8 m -125.64 105.08 8.75 Favored 'General case' 0 C--N 1.302 -1.48 0 CA-C-O 121.574 0.702 . . . . 0.0 109.889 179.493 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 151' ' ' ARG . . . . . 0.523 HH22 ' CG ' ' A' ' 111' ' ' ASP . 73.8 mtt180 -86.44 -173.59 4.6 Favored 'General case' 0 N--CA 1.486 1.373 0 N-CA-C 108.709 -0.848 . . . . 0.0 108.709 179.863 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 152' ' ' LYS . . . . . . . . . . . . . 6.8 mtmp? -152.49 148.07 26.98 Favored 'General case' 0 C--N 1.301 -1.52 0 C-N-CA 119.145 -1.022 . . . . 0.0 110.589 -179.489 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 153' ' ' TYR . . . . . 0.412 ' CD2' ' HA ' ' A' ' 204' ' ' GLU . 47.0 m-85 -144.45 161.55 38.76 Favored 'General case' 0 N--CA 1.489 1.49 0 N-CA-C 108.424 -0.954 . . . . 0.0 108.424 178.739 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 154' ' ' LYS . . . . . . . . . . . . . 17.8 ttmt -137.24 119.7 15.9 Favored 'General case' 0 C--N 1.299 -1.611 0 O-C-N 121.273 -0.892 . . . . 0.0 108.801 179.251 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 155' ' ' MET . . . . . . . . . . . . . 27.1 mtp -45.94 109.04 0.15 Allowed 'General case' 0 N--CA 1.494 1.741 0 CA-C-O 122.443 1.116 . . . . 0.0 111.671 -178.484 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 156' ' ' THR . . . . . 0.691 ' OG1' HG23 ' A' ' 203' ' ' THR . 0.2 OUTLIER -103.3 -28.28 11.96 Favored 'General case' 0 C--N 1.296 -1.735 0 CA-C-N 115.168 -0.923 . . . . 0.0 110.22 -178.572 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 157' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -146.95 154.69 41.57 Favored 'General case' 0 N--CA 1.496 1.84 0 C-N-CA 118.337 -1.345 . . . . 0.0 110.569 -179.048 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 158' ' ' ILE . . . . . 0.405 HG12 ' CD1' ' A' ' 200' ' ' PHE . 1.6 mt -148.27 137.31 15.62 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.652 0 CA-C-O 121.322 0.582 . . . . 0.0 109.982 -177.927 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 159' ' ' ARG . . . . . . . . . . . . . 2.2 mtt180 -156.14 -177.62 6.72 Favored 'General case' 0 N--CA 1.494 1.742 0 O-C-N 121.298 -0.877 . . . . 0.0 110.931 -179.521 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 160' ' ' ASP . . . . . 0.494 ' C ' HG22 ' A' ' 161' ' ' VAL . 9.3 m-20 -146.8 165.01 30.98 Favored 'General case' 0 N--CA 1.493 1.692 0 N-CA-C 108.48 -0.933 . . . . 0.0 108.48 179.825 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 161' ' ' VAL . . . . . 0.494 HG22 ' C ' ' A' ' 160' ' ' ASP . 0.0 OUTLIER -162.0 158.78 1.84 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.701 0 O-C-N 120.822 -1.174 . . . . 0.0 111.033 -179.874 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 162' ' ' LYS . . . . . 0.461 ' O ' ' O ' ' A' ' 161' ' ' VAL . 0.0 OUTLIER -44.05 171.23 0.04 OUTLIER Pre-proline 0 N--CA 1.493 1.693 0 O-C-N 121.767 -0.583 . . . . 0.0 110.289 179.326 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 163' ' ' PRO . . . . . 0.483 ' C ' HD11 ' C' ' 702' ' ' LEU . 71.3 Cg_endo -77.89 32.24 0.44 Allowed 'Trans proline' 0 N--CA 1.495 1.591 0 C-N-CA 122.926 2.417 . . . . 0.0 113.669 -179.839 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 164' ' ' THR . . . . . 0.517 ' N ' HD11 ' C' ' 702' ' ' LEU . 0.0 OUTLIER -152.26 -2.84 0.26 Allowed 'General case' 0 N--CA 1.495 1.796 0 O-C-N 120.839 -1.163 . . . . 0.0 111.125 179.686 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 165' ' ' ASP . . . . . 0.42 ' O ' ' C ' ' A' ' 166' ' ' VAL . 1.4 t70 -73.31 61.1 0.63 Allowed 'General case' 0 N--CA 1.491 1.582 0 O-C-N 120.748 -1.22 . . . . 0.0 110.132 -179.245 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 166' ' ' VAL . . . . . 0.582 ' O ' ' N ' ' A' ' 168' ' ' VAL . 2.2 t -45.75 -31.66 1.18 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.604 0 O-C-N 121.048 -1.032 . . . . 0.0 109.614 -178.998 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 167' ' ' GLY . . . . . . . . . . . . . . . -44.8 -10.99 0.01 OUTLIER Glycine 0 N--CA 1.494 2.523 0 O-C-N 120.756 -1.215 . . . . 0.0 111.116 -179.583 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 168' ' ' VAL . . . . . 0.582 ' N ' ' O ' ' A' ' 166' ' ' VAL . 5.8 m -53.8 -29.96 18.53 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.634 0 O-C-N 120.552 -1.557 . . . . 0.0 108.774 179.814 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 169' ' ' LEU . . . . . 0.543 ' O ' ' C ' ' A' ' 170' ' ' ASP . 11.7 mt -49.83 -13.59 0.1 Allowed 'General case' 0 N--CA 1.491 1.62 0 N-CA-C 107.33 -1.359 . . . . 0.0 107.33 -178.994 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 170' ' ' ASP . . . . . 0.556 ' N ' ' C ' ' A' ' 168' ' ' VAL . 40.3 t0 19.46 90.97 0.01 OUTLIER 'General case' 0 N--CA 1.5 2.053 0 CA-C-N 116.355 -0.384 . . . . 0.0 111.587 177.322 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 171' ' ' GLU . . . . . . . . . . . . . 7.8 pt-20 -128.7 72.91 1.47 Allowed 'General case' 0 N--CA 1.496 1.873 0 O-C-N 120.952 -1.092 . . . . 0.0 111.099 -179.615 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 172' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -128.73 -52.12 1.24 Allowed 'General case' 0 N--CA 1.498 1.965 0 O-C-N 121.335 -0.853 . . . . 0.0 111.519 -178.559 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 173' ' ' LYS . . . . . . . . . . . . . 56.9 mttt -58.51 130.6 47.58 Favored 'General case' 0 N--CA 1.498 1.961 0 O-C-N 120.841 -1.162 . . . . 0.0 109.655 -179.34 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 174' ' ' GLY . . . . . 0.53 ' O ' ' C ' ' A' ' 175' ' ' LYS . . . -122.48 -43.76 0.37 Allowed Glycine 0 N--CA 1.48 1.607 0 N-CA-C 108.657 -1.777 . . . . 0.0 108.657 179.761 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 175' ' ' LYS . . . . . 0.53 ' C ' ' O ' ' A' ' 174' ' ' GLY . 13.6 mptt -37.98 -62.9 0.52 Allowed 'General case' 0 N--CA 1.495 1.776 0 N-CA-C 107.319 -1.363 . . . . 0.0 107.319 179.309 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 176' ' ' ASP . . . . . 0.599 ' O ' ' O ' ' A' ' 177' ' ' LYS . 1.1 m-20 -104.34 91.2 3.81 Favored 'General case' 0 C--N 1.293 -1.885 0 N-CA-C 106.942 -1.503 . . . . 0.0 106.942 176.725 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 177' ' ' LYS . . . . . 0.599 ' O ' ' O ' ' A' ' 176' ' ' ASP . 9.7 mttp -45.07 -176.01 0.0 OUTLIER 'General case' 0 N--CA 1.494 1.764 0 O-C-N 121.344 -0.848 . . . . 0.0 109.683 -179.093 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 178' ' ' GLN . . . . . 0.57 ' NE2' ' OD1' ' A' ' 114' ' ' ASN . 18.6 pt20 -161.0 176.45 11.37 Favored 'General case' 0 N--CA 1.487 1.399 0 C-N-CA 118.043 -1.463 . . . . 0.0 111.399 179.581 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 179' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -130.61 96.27 4.07 Favored 'General case' 0 C--N 1.302 -1.493 0 N-CA-C 107.525 -1.287 . . . . 0.0 107.525 178.187 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 180' ' ' THR . . . . . 0.404 ' O ' HG22 ' A' ' 180' ' ' THR . 1.2 m -71.09 114.17 8.87 Favored 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.069 -1.019 . . . . 0.0 109.485 -178.979 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 181' ' ' LEU . . . . . 0.729 HD13 ' N ' ' A' ' 182' ' ' ILE . 0.3 OUTLIER -90.14 141.15 28.97 Favored 'General case' 0 C--N 1.3 -1.554 0 N-CA-C 108.234 -1.024 . . . . 0.0 108.234 178.453 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 182' ' ' ILE . . . . . 0.729 ' N ' HD13 ' A' ' 181' ' ' LEU . 73.4 mt -135.07 118.72 24.91 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.594 0 N-CA-C 107.638 -1.245 . . . . 0.0 107.638 178.903 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 183' ' ' THR . . . . . 0.482 ' O ' HG23 ' A' ' 183' ' ' THR . 3.8 t -138.62 112.09 8.17 Favored 'General case' 0 C--N 1.289 -2.038 0 N-CA-C 107.894 -1.15 . . . . 0.0 107.894 179.902 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 184' ' ' CYS . . . . . . . . . . . . . 1.9 p -78.58 157.1 28.85 Favored 'General case' 0 C--N 1.292 -1.911 0 C-N-CA 119.326 -0.95 . . . . 0.0 110.911 -177.867 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 185' ' ' ASP . . . . . . . . . . . . . 20.7 t0 -165.68 -152.86 0.16 Allowed 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.456 -0.778 . . . . 0.0 109.518 -179.735 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 186' ' ' ASP . . . . . . . . . . . . . 13.0 m-20 47.69 56.48 7.07 Favored 'General case' 0 N--CA 1.496 1.829 0 O-C-N 121.139 -0.975 . . . . 0.0 109.071 -179.707 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 187' ' ' TYR . . . . . 0.623 ' CE1' ' O ' ' A' ' 188' ' ' ASN . 32.9 t80 -67.91 136.08 53.45 Favored 'General case' 0 N--CA 1.49 1.56 0 CA-C-O 121.799 0.809 . . . . 0.0 111.013 -179.221 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 188' ' ' ASN . . . . . 0.623 ' O ' ' CE1' ' A' ' 187' ' ' TYR . 1.1 t-20 -99.43 147.53 25.17 Favored 'General case' 0 C--N 1.297 -1.705 0 N-CA-C 108.128 -1.064 . . . . 0.0 108.128 178.503 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 189' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -112.52 -13.59 13.32 Favored 'General case' 0 C--N 1.293 -1.878 0 N-CA-C 108.114 -1.069 . . . . 0.0 108.114 -179.718 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 190' ' ' LYS . . . . . . . . . . . . . 88.3 mttt -84.32 -51.26 7.12 Favored 'General case' 0 N--CA 1.488 1.474 0 N-CA-C 108.853 -0.795 . . . . 0.0 108.853 178.791 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 191' ' ' THR . . . . . 0.473 ' OG1' HG12 ' A' ' 193' ' ' VAL . 9.4 p -89.61 -10.82 44.56 Favored 'General case' 0 N--CA 1.489 1.488 0 O-C-N 121.546 -0.721 . . . . 0.0 109.075 179.79 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 192' ' ' GLY . . . . . . . . . . . . . . . 68.69 30.76 72.81 Favored Glycine 0 N--CA 1.492 2.399 0 O-C-N 121.316 -0.865 . . . . 0.0 110.945 178.733 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 193' ' ' VAL . . . . . 0.514 HG22 ' H ' ' A' ' 194' ' ' TRP . 2.2 p -145.9 169.29 6.54 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.621 0 O-C-N 120.791 -1.417 . . . . 0.0 110.201 179.397 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 194' ' ' TRP . . . . . 0.541 ' N ' ' CD1' ' A' ' 194' ' ' TRP . 9.4 m95 -86.47 121.37 28.93 Favored 'General case' 0 C--N 1.294 -1.821 0 N-CA-C 109.104 -0.702 . . . . 0.0 109.104 -179.717 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 195' ' ' GLU . . . . . 0.492 ' CD ' ' ND2' ' A' ' 188' ' ' ASN . 1.3 mt-10 -85.04 -61.17 1.84 Allowed 'General case' 0 N--CA 1.497 1.888 0 O-C-N 121.275 -0.891 . . . . 0.0 111.703 -178.216 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 196' ' ' LYS . . . . . . . . . . . . . 1.8 mtpm? -84.61 151.27 24.62 Favored 'General case' 0 N--CA 1.494 1.74 0 O-C-N 120.814 -1.179 . . . . 0.0 110.488 -178.475 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 197' ' ' ARG . . . . . 0.544 ' NH1' ' O ' ' C' ' 704' ' ' ALA . 24.1 mmt180 -120.37 137.42 54.3 Favored 'General case' 0 N--CA 1.492 1.637 0 N-CA-C 108.942 -0.762 . . . . 0.0 108.942 179.497 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 198' ' ' LYS . . . . . . . . . . . . . 5.0 mptp? -115.1 120.01 38.37 Favored 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.467 -0.771 . . . . 0.0 110.304 -179.007 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 199' ' ' ILE . . . . . 0.423 ' O ' HG13 ' A' ' 199' ' ' ILE . 1.1 pp -141.42 121.01 11.35 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.803 0 CA-C-O 122.618 1.199 . . . . 0.0 110.826 179.201 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 200' ' ' PHE . . . . . 0.526 ' CD1' ' N ' ' A' ' 200' ' ' PHE . 0.7 OUTLIER -105.04 141.42 36.65 Favored 'General case' 0 N--CA 1.494 1.773 0 O-C-N 121.131 -0.981 . . . . 0.0 111.177 -178.133 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 201' ' ' VAL . . . . . . . . . . . . . 96.8 t -102.57 149.02 7.22 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.651 0 N-CA-C 107.726 -1.213 . . . . 0.0 107.726 176.722 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 202' ' ' ALA . . . . . . . . . . . . . . . -132.27 139.89 48.42 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.002 -1.061 . . . . 0.0 109.116 -179.513 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 203' ' ' THR . . . . . 0.691 HG23 ' OG1' ' A' ' 156' ' ' THR . 16.8 p -89.86 131.19 35.92 Favored 'General case' 0 N--CA 1.487 1.416 0 CA-C-O 122.556 1.169 . . . . 0.0 111.944 -178.316 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 204' ' ' GLU . . . . . 0.412 ' HA ' ' CD2' ' A' ' 153' ' ' TYR . 1.0 OUTLIER -61.96 135.43 57.55 Favored 'General case' 0 C--N 1.299 -1.598 0 CA-C-N 114.818 -1.083 . . . . 0.0 108.957 179.016 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 205' ' ' VAL . . . . . 0.504 ' O ' ' C ' ' A' ' 206' ' ' LYS . 37.6 t -122.67 -44.47 1.88 Allowed 'Isoleucine or valine' 0 N--CA 1.494 1.76 0 O-C-N 121.382 -0.824 . . . . 0.0 109.71 -179.703 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 206' ' ' LYS . . . . . 0.504 ' C ' ' O ' ' A' ' 205' ' ' VAL . 0.0 OUTLIER . . . . . 0 N--CA 1.494 1.767 0 CA-C-O 118.093 -0.956 . . . . 0.0 110.456 -179.636 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' C' C ' 702' ' ' LEU . . . . . 0.657 ' N ' HD12 ' C' ' 702' ' ' LEU . 0.0 OUTLIER . . . . . 0 N--CA 1.493 1.703 0 N-CA-C 110.009 -0.367 . . . . 0.0 110.009 . . . . . . . . . 2 2 . 1 . 001 nuclear build core ' C' C ' 703' ' ' PRO . . . . . 0.545 ' HB3' ' HB3' ' A' ' 92' ' ' ALA . 31.3 Cg_exo -51.34 -160.79 0.0 OUTLIER 'Trans proline' 0 N--CA 1.493 1.476 0 C-N-CA 121.945 1.764 . . . . 0.0 111.718 179.057 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' C' C ' 704' ' ' ALA . . . . . 1.019 ' HB2' ' HB1' ' A' ' 118' ' ' ALA . . . . . . . . 0 N--CA 1.489 1.481 0 O-C-N 120.981 -1.075 . . . . 0.0 109.055 179.898 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 63' ' ' PRO . . . . . . . . . . . . . 10.6 Cg_endo . . . . . 0 N--CA 1.481 0.781 0 CA-C-O 121.167 0.403 . . . . 0.0 111.473 . . . . . . . . . 0 0 . 1 . 002 nuclear build core ' A' A ' 64' ' ' GLN . . . . . 0.573 ' N ' ' CD ' ' A' ' 64' ' ' GLN . 0.0 OUTLIER -153.71 119.93 5.44 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.163 -0.961 . . . . 0.0 109.433 179.732 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 65' ' ' ILE . . . . . 0.463 ' C ' ' O ' ' A' ' 64' ' ' GLN . 0.0 OUTLIER -42.18 103.78 0.32 Allowed Pre-proline 0 N--CA 1.495 1.782 0 N-CA-C 108.405 -0.961 . . . . 0.0 108.405 179.203 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 66' ' ' PRO . . . . . . . . . . . . . 88.3 Cg_endo -87.36 -159.99 0.1 OUTLIER 'Trans proline' 0 C--N 1.315 -1.191 0 C-N-CA 122.272 1.982 . . . . 0.0 112.421 -179.436 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 67' ' ' LYS . . . . . . . . . . . . . 13.5 pttt -79.67 -4.99 54.18 Favored 'General case' 0 C--N 1.302 -1.5 0 N-CA-C 108.739 -0.837 . . . . 0.0 108.739 179.765 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 68' ' ' ASP . . . . . 0.662 ' C ' ' N ' ' A' ' 70' ' ' SER . 1.0 OUTLIER -76.79 48.62 0.58 Allowed 'General case' 0 C--N 1.304 -1.396 0 CA-C-O 121.958 0.885 . . . . 0.0 109.393 179.705 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 69' ' ' LYS . . . . . 0.456 ' C ' ' O ' ' A' ' 68' ' ' ASP . 1.6 ptpt -49.3 -13.25 0.07 Allowed 'General case' 0 N--CA 1.508 2.442 0 C-N-CA 116.684 -2.006 . . . . 0.0 106.283 177.599 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 70' ' ' SER . . . . . 0.662 ' N ' ' C ' ' A' ' 68' ' ' ASP . 0.4 OUTLIER -83.43 -9.66 58.88 Favored 'General case' 0 N--CA 1.496 1.83 0 CA-C-N 113.164 -1.835 . . . . 0.0 110.162 179.221 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 71' ' ' LYS . . . . . 0.442 ' N ' ' O ' ' A' ' 68' ' ' ASP . 0.0 OUTLIER -97.36 142.98 28.57 Favored 'General case' 0 N--CA 1.496 1.838 0 O-C-N 120.991 -1.068 . . . . 0.0 110.753 179.601 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 72' ' ' VAL . . . . . 0.549 HG12 ' CZ ' ' A' ' 88' ' ' TYR . 0.8 OUTLIER -66.16 141.94 17.4 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.527 0 N-CA-C 105.131 -2.174 . . . . 0.0 105.131 174.702 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 73' ' ' ALA . . . . . 0.517 ' N ' ' O ' ' A' ' 87' ' ' VAL . . . -82.8 -15.9 49.88 Favored 'General case' 0 C--N 1.295 -1.762 0 O-C-N 119.928 -1.732 . . . . 0.0 106.704 179.75 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 74' ' ' GLY . . . . . 0.415 ' N ' HG23 ' A' ' 72' ' ' VAL . . . 175.4 -157.83 24.73 Favored Glycine 0 N--CA 1.479 1.546 0 N-CA-C 109.318 -1.513 . . . . 0.0 109.318 179.584 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 75' ' ' TYR . . . . . 0.605 ' HA ' HG23 ' A' ' 87' ' ' VAL . 0.6 OUTLIER -143.15 168.35 19.96 Favored 'General case' 0 C--N 1.295 -1.778 0 O-C-N 121.682 -0.893 . . . . 0.0 110.463 -177.234 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 76' ' ' ILE . . . . . . . . . . . . . 2.4 tt -148.75 145.91 17.84 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.601 0 C-N-CA 119.225 -0.99 . . . . 0.0 110.075 -178.04 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -150.65 166.43 30.36 Favored 'General case' 0 N--CA 1.489 1.49 0 O-C-N 121.059 -1.026 . . . . 0.0 109.289 179.371 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 78' ' ' ILE . . . . . 0.664 ' HB ' ' HB3' ' A' ' 81' ' ' ALA . 13.5 mt -147.75 94.98 4.3 Favored Pre-proline 0 C--N 1.302 -1.474 0 N-CA-C 108.6 -0.889 . . . . 0.0 108.6 -179.57 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 79' ' ' PRO . . . . . . . . . . . . . 75.0 Cg_exo -47.55 -47.56 17.69 Favored 'Trans proline' 0 N--CA 1.494 1.506 0 C-N-CA 122.811 2.34 . . . . 0.0 113.811 -178.645 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -65.86 -18.63 65.46 Favored 'General case' 0 N--CA 1.493 1.718 0 O-C-N 120.868 -1.145 . . . . 0.0 110.439 178.474 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 81' ' ' ALA . . . . . 0.743 ' HB2' ' HB2' ' A' ' 136' ' ' ALA . . . -105.01 -14.05 15.55 Favored 'General case' 0 N--CA 1.493 1.679 0 O-C-N 121.238 -0.914 . . . . 0.0 109.035 179.904 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 82' ' ' ASP . . . . . 0.4 ' N ' ' O ' ' A' ' 78' ' ' ILE . 0.3 OUTLIER 64.27 48.34 2.89 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.334 -0.853 . . . . 0.0 110.503 179.246 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 83' ' ' ILE . . . . . 0.487 HD11 ' HB3' ' A' ' 132' ' ' ASN . 64.2 mt -131.1 152.08 36.92 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.796 0 O-C-N 121.127 -0.983 . . . . 0.0 110.647 -178.583 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 84' ' ' LYS . . . . . . . . . . . . . 30.2 tttp -158.83 111.85 2.3 Favored 'General case' 0 N--CA 1.492 1.635 0 N-CA-C 108.315 -0.994 . . . . 0.0 108.315 179.282 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 85' ' ' GLU . . . . . 0.445 ' O ' ' CD2' ' A' ' 75' ' ' TYR . 0.4 OUTLIER -143.16 162.79 41.22 Favored Pre-proline 0 N--CA 1.494 1.729 0 O-C-N 121.279 -0.888 . . . . 0.0 110.225 -179.211 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 86' ' ' PRO . . . . . 0.416 ' N ' ' CE2' ' A' ' 75' ' ' TYR . 57.1 Cg_endo -70.92 167.65 25.33 Favored 'Trans proline' 0 N--CA 1.497 1.698 0 C-N-CA 123.346 2.697 . . . . 0.0 113.506 -179.141 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 87' ' ' VAL . . . . . 0.605 HG23 ' HA ' ' A' ' 75' ' ' TYR . 62.0 t -124.67 99.66 6.47 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.66 0 N-CA-C 108.972 -0.751 . . . . 0.0 108.972 179.717 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 88' ' ' TYR . . . . . 0.549 ' CZ ' HG12 ' A' ' 72' ' ' VAL . 33.0 m-85 -92.87 152.94 42.01 Favored Pre-proline 0 N--CA 1.502 2.164 0 O-C-N 120.832 -1.167 . . . . 0.0 110.029 -179.617 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 89' ' ' PRO . . . . . . . . . . . . . 6.1 Cg_endo -57.19 144.47 90.47 Favored 'Trans proline' 0 C--N 1.312 -1.392 0 C-N-CA 122.531 2.154 . . . . 0.0 113.606 -179.901 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . -57.22 167.6 4.64 Favored Glycine 0 N--CA 1.49 2.268 0 N-CA-C 109.242 -1.543 . . . . 0.0 109.242 179.038 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 91' ' ' PRO . . . . . 0.423 ' C ' ' H ' ' A' ' 93' ' ' THR . 18.9 Cg_endo -93.44 170.4 19.62 Favored 'Cis proline' 0 C--N 1.307 -1.626 0 C-N-CA 123.968 -1.263 . . . . 0.0 112.054 -0.176 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 92' ' ' ALA . . . . . . . . . . . . . . . -72.78 30.57 0.06 Allowed 'General case' 0 N--CA 1.489 1.504 0 O-C-N 121.216 -0.928 . . . . 0.0 110.635 -179.868 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 93' ' ' THR . . . . . 0.423 ' H ' ' C ' ' A' ' 91' ' ' PRO . 1.0 OUTLIER -75.44 152.84 85.73 Favored Pre-proline 0 N--CA 1.49 1.572 0 O-C-N 120.743 -1.223 . . . . 0.0 109.095 -179.741 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 94' ' ' PRO . . . . . 0.412 ' C ' ' O ' ' A' ' 93' ' ' THR . 53.3 Cg_exo -32.82 -52.6 0.39 Allowed 'Trans proline' 0 C--N 1.309 -1.517 0 C-N-CA 122.933 2.422 . . . . 0.0 112.214 -179.292 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 95' ' ' GLU . . . . . 0.586 ' O ' ' ND2' ' A' ' 98' ' ' ASN . 13.0 mt-10 -45.9 -53.11 10.38 Favored 'General case' 0 N--CA 1.489 1.49 0 O-C-N 121.249 -0.907 . . . . 0.0 109.452 179.942 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 96' ' ' GLN . . . . . 0.556 ' O ' ' N ' ' A' ' 98' ' ' ASN . 94.4 mm-40 -71.41 -51.66 22.8 Favored 'General case' 0 C--N 1.305 -1.368 0 O-C-N 120.955 -1.091 . . . . 0.0 109.747 179.956 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 97' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -49.52 -7.82 0.03 OUTLIER 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.209 -0.932 . . . . 0.0 109.675 -179.424 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 98' ' ' ASN . . . . . 0.722 HD21 ' CZ ' ' A' ' 99' ' ' ARG . 0.4 OUTLIER -73.05 -24.37 60.69 Favored 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.167 -0.958 . . . . 0.0 109.615 -179.931 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 99' ' ' ARG . . . . . 0.722 ' CZ ' HD21 ' A' ' 98' ' ' ASN . 0.6 OUTLIER -103.56 -59.42 1.72 Allowed 'General case' 0 N--CA 1.489 1.504 0 O-C-N 121.544 -0.722 . . . . 0.0 110.363 -178.936 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . -164.73 -171.53 31.09 Favored Glycine 0 N--CA 1.494 2.545 0 C-N-CA 119.21 -1.471 . . . . 0.0 110.608 -179.674 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 101' ' ' VAL . . . . . 0.687 HG23 ' O ' ' A' ' 101' ' ' VAL . 18.9 m -59.94 108.3 0.38 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.667 0 O-C-N 121.411 -1.053 . . . . 0.0 108.955 179.854 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -93.03 165.28 12.93 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.446 -0.784 . . . . 0.0 111.015 -179.133 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 103' ' ' PHE . . . . . 0.505 ' CE1' ' CG1' ' A' ' 87' ' ' VAL . 24.5 m-85 -66.17 160.5 24.0 Favored 'General case' 0 N--CA 1.486 1.368 0 N-CA-C 107.954 -1.128 . . . . 0.0 107.954 178.031 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 104' ' ' ALA . . . . . . . . . . . . . . . -72.5 -22.58 61.03 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.087 -1.008 . . . . 0.0 111.707 -177.913 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 1.2 pm0 -138.95 150.12 45.53 Favored 'General case' 0 N--CA 1.497 1.876 0 O-C-N 120.696 -1.253 . . . . 0.0 110.644 -179.296 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 106' ' ' GLU . . . . . . . . . . . . . 66.2 tt0 -52.7 -59.52 4.38 Favored 'General case' 0 C--N 1.303 -1.415 0 O-C-N 121.777 -0.577 . . . . 0.0 110.491 -179.928 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 107' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER -77.05 32.84 0.14 Allowed 'General case' 0 N--CA 1.488 1.461 0 O-C-N 120.614 -1.304 . . . . 0.0 112.583 -175.706 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 108' ' ' GLU . . . . . . . . . . . . . 2.8 tp10 -60.2 144.29 50.43 Favored 'General case' 0 N--CA 1.488 1.473 0 N-CA-C 107.029 -1.471 . . . . 0.0 107.029 179.742 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 109' ' ' SER . . . . . 0.524 ' C ' ' H ' ' A' ' 111' ' ' ASP . 0.2 OUTLIER -97.76 122.82 41.31 Favored 'General case' 0 N--CA 1.487 1.416 0 O-C-N 120.83 -1.169 . . . . 0.0 110.858 -177.776 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 110' ' ' LEU . . . . . . . . . . . . . 2.1 pp -59.81 -3.26 0.49 Allowed 'General case' 0 C--N 1.301 -1.521 0 N-CA-C 108.04 -1.096 . . . . 0.0 108.04 179.235 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 111' ' ' ASP . . . . . 0.524 ' H ' ' C ' ' A' ' 109' ' ' SER . 75.7 m-20 -132.83 18.63 4.19 Favored 'General case' 0 N--CA 1.489 1.498 0 O-C-N 121.735 -0.603 . . . . 0.0 109.716 179.668 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 112' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -65.07 135.84 56.04 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 120.887 -1.133 . . . . 0.0 109.684 -179.76 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 113' ' ' GLN . . . . . 0.525 ' NE2' ' O ' ' A' ' 173' ' ' LYS . 0.0 OUTLIER -64.44 -4.64 4.13 Favored 'General case' 0 C--N 1.303 -1.439 0 O-C-N 121.24 -0.913 . . . . 0.0 108.766 179.238 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 114' ' ' ASN . . . . . 0.592 HD22 ' C ' ' A' ' 114' ' ' ASN . 0.2 OUTLIER -144.78 92.49 2.29 Favored 'General case' 0 C--N 1.303 -1.436 0 N-CA-C 107.13 -1.433 . . . . 0.0 107.13 177.967 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 115' ' ' ILE . . . . . 0.445 HD11 ' O ' ' A' ' 109' ' ' SER . 2.1 mt -101.88 117.22 46.87 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.457 0 O-C-N 121.592 -0.693 . . . . 0.0 110.959 -178.304 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 116' ' ' SER . . . . . . . . . . . . . 97.0 p -99.04 146.82 25.67 Favored 'General case' 0 N--CA 1.495 1.807 0 O-C-N 121.244 -0.91 . . . . 0.0 111.544 -178.928 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 117' ' ' ILE . . . . . . . . . . . . . 2.7 mp -135.16 148.55 28.79 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.842 0 N-CA-C 107.521 -1.289 . . . . 0.0 107.521 178.891 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 118' ' ' ALA . . . . . . . . . . . . . . . -144.97 160.73 40.88 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 120.531 -1.356 . . . . 0.0 111.849 -179.251 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 119' ' ' GLY . . . . . . . . . . . . . . . -169.88 156.72 27.76 Favored Glycine 0 N--CA 1.485 1.909 0 N-CA-C 109.456 -1.457 . . . . 0.0 109.456 179.424 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 120' ' ' HIS . . . . . . . . . . . . . 20.0 m-70 -71.36 162.59 29.19 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.51 -0.994 . . . . 0.0 109.849 179.676 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 121' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -117.49 160.02 21.89 Favored 'General case' 0 N--CA 1.492 1.669 0 N-CA-C 107.962 -1.125 . . . . 0.0 107.962 178.586 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 122' ' ' PHE . . . . . 0.41 ' O ' HG21 ' A' ' 131' ' ' THR . 0.2 OUTLIER -127.28 133.35 50.17 Favored 'General case' 0 N--CA 1.495 1.805 0 O-C-N 121.144 -0.972 . . . . 0.0 110.273 -178.821 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 123' ' ' ILE . . . . . . . . . . . . . 15.9 tt -90.76 -27.1 5.04 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.624 0 CA-C-O 121.827 0.822 . . . . 0.0 110.097 -179.317 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 124' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -87.4 -2.29 58.52 Favored 'General case' 0 C--N 1.291 -1.938 0 C-N-CA 120.128 -0.629 . . . . 0.0 111.318 -178.663 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 125' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -154.2 124.08 3.29 Favored Pre-proline 0 N--CA 1.494 1.774 0 O-C-N 120.625 -1.297 . . . . 0.0 109.683 -179.702 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 126' ' ' PRO . . . . . . . . . . . . . 86.8 Cg_endo -81.14 -16.67 9.66 Favored 'Trans proline' 0 N--CA 1.494 1.518 0 C-N-CA 122.46 2.106 . . . . 0.0 112.992 179.994 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 127' ' ' ASN . . . . . . . . . . . . . 33.7 p30 -90.19 22.37 3.33 Favored 'General case' 0 N--CA 1.493 1.702 0 O-C-N 121.071 -1.018 . . . . 0.0 110.308 -179.342 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 128' ' ' TYR . . . . . . . . . . . . . 13.0 t80 -75.3 -150.52 0.03 OUTLIER 'General case' 0 N--CA 1.492 1.673 0 O-C-N 121.004 -1.06 . . . . 0.0 109.751 -179.73 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 129' ' ' GLN . . . . . . . . . . . . . 69.0 mt-30 -68.1 -89.1 0.01 OUTLIER 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.252 -0.905 . . . . 0.0 109.616 -179.636 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 130' ' ' PHE . . . . . 0.684 ' CE2' HG11 ' A' ' 101' ' ' VAL . 27.7 m-85 -108.14 35.13 3.26 Favored 'General case' 0 N--CA 1.493 1.684 0 O-C-N 121.421 -0.799 . . . . 0.0 110.003 -179.533 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 131' ' ' THR . . . . . 0.41 HG21 ' O ' ' A' ' 122' ' ' PHE . 55.0 m -75.37 -33.31 61.04 Favored 'General case' 0 N--CA 1.488 1.464 0 O-C-N 121.037 -1.039 . . . . 0.0 108.982 179.562 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 132' ' ' ASN . . . . . 0.531 ' ND2' ' O ' ' A' ' 81' ' ' ALA . 4.6 t30 -81.01 3.98 21.21 Favored 'General case' 0 N--CA 1.494 1.741 0 O-C-N 121.32 -0.863 . . . . 0.0 110.512 -179.014 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 133' ' ' LEU . . . . . 0.601 HD13 ' O ' ' A' ' 133' ' ' LEU . 0.4 OUTLIER -68.85 -48.96 62.17 Favored 'General case' 0 N--CA 1.488 1.456 0 O-C-N 120.982 -1.074 . . . . 0.0 109.318 -179.943 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 134' ' ' LYS . . . . . 0.664 ' CE ' ' H ' ' A' ' 134' ' ' LYS . 0.0 OUTLIER -43.0 -18.21 0.01 OUTLIER 'General case' 0 N--CA 1.488 1.452 0 O-C-N 121.363 -0.835 . . . . 0.0 109.121 179.869 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 135' ' ' ALA . . . . . 0.593 ' N ' ' O ' ' A' ' 133' ' ' LEU . . . -83.43 -39.02 21.14 Favored 'General case' 0 N--CA 1.488 1.435 0 O-C-N 121.219 -0.926 . . . . 0.0 109.266 179.012 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 136' ' ' ALA . . . . . 0.743 ' HB2' ' HB2' ' A' ' 81' ' ' ALA . . . -80.46 157.45 26.2 Favored 'General case' 0 N--CA 1.49 1.542 0 CA-C-O 121.996 0.903 . . . . 0.0 111.299 -178.965 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 137' ' ' LYS . . . . . 0.536 ' O ' ' O ' ' A' ' 138' ' ' LYS . 1.0 OUTLIER -154.19 -162.36 1.4 Allowed 'General case' 0 N--CA 1.49 1.575 0 C-N-CA 118.5 -1.28 . . . . 0.0 110.961 -178.161 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 138' ' ' LYS . . . . . 0.574 ' O ' ' N ' ' A' ' 140' ' ' SER . 9.4 mttp -43.17 178.27 0.0 OUTLIER 'General case' 0 N--CA 1.487 1.397 0 CA-C-O 122.438 1.113 . . . . 0.0 111.083 -179.03 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 139' ' ' GLY . . . . . . . . . . . . . . . 46.95 7.72 0.02 OUTLIER Glycine 0 N--CA 1.491 2.302 0 N-CA-C 110.668 -0.973 . . . . 0.0 110.668 179.858 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 140' ' ' SER . . . . . 0.574 ' N ' ' O ' ' A' ' 138' ' ' LYS . 58.4 m -86.87 127.14 35.04 Favored 'General case' 0 N--CA 1.496 1.87 0 O-C-N 120.811 -1.406 . . . . 0.0 109.599 179.349 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 141' ' ' MET . . . . . 0.591 ' SD ' ' N ' ' A' ' 142' ' ' VAL . 6.2 tpp -77.61 129.16 35.26 Favored 'General case' 0 N--CA 1.492 1.65 0 O-C-N 120.975 -1.078 . . . . 0.0 109.33 179.688 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 142' ' ' VAL . . . . . 0.591 ' N ' ' SD ' ' A' ' 141' ' ' MET . 1.4 t -112.09 133.27 58.34 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.617 0 N-CA-C 108.546 -0.909 . . . . 0.0 108.546 -179.982 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 143' ' ' TYR . . . . . . . . . . . . . 5.4 m-85 -108.22 134.36 51.17 Favored 'General case' 0 N--CA 1.497 1.897 0 O-C-N 120.719 -1.238 . . . . 0.0 112.31 -177.835 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 144' ' ' PHE . . . . . . . . . . . . . 36.9 t80 -119.92 99.92 6.92 Favored 'General case' 0 N--CA 1.494 1.726 0 N-CA-C 109.511 -0.551 . . . . 0.0 109.511 179.718 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 145' ' ' LYS . . . . . . . . . . . . . 1.0 OUTLIER -96.02 134.3 39.2 Favored 'General case' 0 N--CA 1.493 1.701 0 O-C-N 121.193 -0.942 . . . . 0.0 110.677 -179.348 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 146' ' ' VAL . . . . . 0.479 ' O ' ' C ' ' A' ' 147' ' ' GLY . 0.0 OUTLIER -144.03 141.14 24.97 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.789 0 N-CA-C 107.443 -1.317 . . . . 0.0 107.443 178.861 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 147' ' ' GLY . . . . . 0.479 ' C ' ' O ' ' A' ' 146' ' ' VAL . . . 38.42 -117.67 0.64 Allowed Glycine 0 N--CA 1.493 2.44 0 N-CA-C 109.67 -1.372 . . . . 0.0 109.67 179.78 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 148' ' ' ASN . . . . . 0.501 ' C ' ' ND2' ' A' ' 148' ' ' ASN . 0.4 OUTLIER -108.74 13.45 25.03 Favored 'General case' 0 C--N 1.303 -1.447 0 O-C-N 121.576 -0.955 . . . . 0.0 108.643 179.166 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 149' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -107.0 142.21 36.98 Favored 'General case' 0 N--CA 1.488 1.464 0 CA-C-O 121.934 0.873 . . . . 0.0 111.329 -178.863 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 150' ' ' THR . . . . . . . . . . . . . 97.3 m -134.64 99.06 4.22 Favored 'General case' 0 C--N 1.3 -1.583 0 CA-C-O 121.581 0.705 . . . . 0.0 109.841 -179.428 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 151' ' ' ARG . . . . . . . . . . . . . 86.6 mtt180 -88.24 -171.26 3.29 Favored 'General case' 0 N--CA 1.487 1.411 0 N-CA-C 108.872 -0.788 . . . . 0.0 108.872 179.973 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 152' ' ' LYS . . . . . 0.512 ' C ' ' CD1' ' A' ' 153' ' ' TYR . 34.8 mttp -151.38 150.85 30.95 Favored 'General case' 0 C--N 1.302 -1.471 0 O-C-N 121.201 -0.937 . . . . 0.0 110.139 179.703 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 153' ' ' TYR . . . . . 0.512 ' CD1' ' C ' ' A' ' 152' ' ' LYS . 22.0 m-85 -145.71 158.07 43.89 Favored 'General case' 0 C--N 1.299 -1.618 0 N-CA-C 107.516 -1.29 . . . . 0.0 107.516 178.183 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 154' ' ' LYS . . . . . . . . . . . . . 13.2 ttpp -130.55 125.43 34.21 Favored 'General case' 0 C--N 1.297 -1.71 0 N-CA-C 108.44 -0.948 . . . . 0.0 108.44 -179.996 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 155' ' ' MET . . . . . . . . . . . . . 74.5 mtp -45.87 107.33 0.1 Allowed 'General case' 0 N--CA 1.489 1.517 0 O-C-N 120.697 -1.252 . . . . 0.0 110.797 -178.954 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 156' ' ' THR . . . . . . . . . . . . . 0.4 OUTLIER -104.47 -27.16 12.08 Favored 'General case' 0 C--N 1.292 -1.933 0 CA-C-N 115.292 -0.867 . . . . 0.0 110.284 -178.385 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 157' ' ' SER . . . . . . . . . . . . . 10.0 t -150.63 150.52 31.26 Favored 'General case' 0 N--CA 1.493 1.702 0 C-N-CA 118.418 -1.313 . . . . 0.0 110.927 -178.812 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 158' ' ' ILE . . . . . 0.696 HD12 ' N ' ' A' ' 159' ' ' ARG . 0.1 OUTLIER -152.91 140.13 13.21 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.389 0 CA-C-O 121.75 0.786 . . . . 0.0 109.563 -178.476 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 159' ' ' ARG . . . . . 0.696 ' N ' HD12 ' A' ' 158' ' ' ILE . 26.8 mtm180 -154.73 165.2 37.33 Favored 'General case' 0 C--N 1.294 -1.822 0 CA-C-O 121.672 0.749 . . . . 0.0 109.882 -179.441 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 160' ' ' ASP . . . . . 0.49 ' O ' HG13 ' A' ' 161' ' ' VAL . 8.0 m-20 -116.18 155.03 28.99 Favored 'General case' 0 C--N 1.298 -1.645 0 N-CA-C 108.069 -1.085 . . . . 0.0 108.069 179.253 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 161' ' ' VAL . . . . . 0.49 HG13 ' O ' ' A' ' 160' ' ' ASP . 13.1 m -155.01 150.69 11.4 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.7 0 O-C-N 120.893 -1.129 . . . . 0.0 110.527 -178.995 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 162' ' ' LYS . . . . . 0.409 ' O ' ' O ' ' A' ' 161' ' ' VAL . 0.0 OUTLIER -47.36 170.38 0.09 OUTLIER Pre-proline 0 N--CA 1.49 1.571 0 O-C-N 121.295 -0.878 . . . . 0.0 109.495 179.677 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 163' ' ' PRO . . . . . . . . . . . . . 57.4 Cg_endo -78.0 37.32 0.62 Allowed 'Trans proline' 0 C--N 1.309 -1.525 0 C-N-CA 122.738 2.292 . . . . 0.0 112.769 -179.706 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 164' ' ' THR . . . . . . . . . . . . . 17.4 m -152.19 -7.98 0.21 Allowed 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.081 -1.012 . . . . 0.0 110.859 -179.88 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 165' ' ' ASP . . . . . 0.456 ' O ' ' C ' ' A' ' 166' ' ' VAL . 6.9 t70 -72.84 61.41 0.55 Allowed 'General case' 0 N--CA 1.492 1.653 0 O-C-N 120.627 -1.296 . . . . 0.0 110.193 -179.412 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 166' ' ' VAL . . . . . 0.67 ' O ' ' N ' ' A' ' 168' ' ' VAL . 0.7 OUTLIER -39.77 -30.0 0.13 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.637 0 O-C-N 121.411 -0.806 . . . . 0.0 109.789 -178.546 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 167' ' ' GLY . . . . . 0.443 ' N ' ' O ' ' A' ' 165' ' ' ASP . . . -42.55 -9.04 0.01 OUTLIER Glycine 0 N--CA 1.5 2.925 0 O-C-N 121.292 -0.88 . . . . 0.0 111.221 -179.497 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 168' ' ' VAL . . . . . 0.67 ' N ' ' O ' ' A' ' 166' ' ' VAL . 19.6 t -48.35 -40.72 10.47 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.62 0 O-C-N 120.89 -1.359 . . . . 0.0 108.729 179.263 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 169' ' ' LEU . . . . . 0.544 ' O ' ' N ' ' A' ' 171' ' ' GLU . 5.4 mt -47.54 -9.4 0.02 OUTLIER 'General case' 0 N--CA 1.496 1.86 0 N-CA-C 108.715 -0.846 . . . . 0.0 108.715 -178.207 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 170' ' ' ASP . . . . . 0.599 ' N ' ' O ' ' A' ' 168' ' ' VAL . 7.0 t0 35.6 27.86 0.01 OUTLIER 'General case' 0 N--CA 1.493 1.72 0 O-C-N 121.508 -0.745 . . . . 0.0 111.5 178.22 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 171' ' ' GLU . . . . . 0.544 ' N ' ' O ' ' A' ' 169' ' ' LEU . 3.8 pt-20 -69.34 94.56 0.72 Allowed 'General case' 0 C--N 1.301 -1.541 0 N-CA-C 107.157 -1.423 . . . . 0.0 107.157 178.034 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 172' ' ' GLN . . . . . . . . . . . . . 2.4 mt-30 -155.14 -74.06 0.11 Allowed 'General case' 0 N--CA 1.493 1.716 0 O-C-N 121.447 -0.783 . . . . 0.0 109.977 -178.645 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 173' ' ' LYS . . . . . 0.525 ' O ' ' NE2' ' A' ' 113' ' ' GLN . 2.3 mptt -59.65 137.84 57.91 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.335 -0.853 . . . . 0.0 109.119 179.841 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 174' ' ' GLY . . . . . 0.504 ' O ' ' C ' ' A' ' 175' ' ' LYS . . . -123.42 -43.61 0.35 Allowed Glycine 0 C--N 1.299 -1.505 0 N-CA-C 107.771 -2.132 . . . . 0.0 107.771 179.172 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 175' ' ' LYS . . . . . 0.504 ' C ' ' O ' ' A' ' 174' ' ' GLY . 0.1 OUTLIER -36.89 -76.9 0.02 OUTLIER 'General case' 0 N--CA 1.498 1.946 0 N-CA-C 108.943 -0.762 . . . . 0.0 108.943 179.729 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 176' ' ' ASP . . . . . 0.582 ' O ' ' O ' ' A' ' 177' ' ' LYS . 1.2 m-20 -91.38 86.62 6.15 Favored 'General case' 0 C--N 1.297 -1.708 0 N-CA-C 107.087 -1.449 . . . . 0.0 107.087 178.059 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 177' ' ' LYS . . . . . 0.582 ' O ' ' O ' ' A' ' 176' ' ' ASP . 0.9 OUTLIER -40.5 178.01 0.0 OUTLIER 'General case' 0 N--CA 1.493 1.713 0 CA-C-O 121.603 0.716 . . . . 0.0 110.907 -178.919 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 178' ' ' GLN . . . . . 0.534 ' NE2' HG13 ' A' ' 201' ' ' VAL . 0.0 OUTLIER -160.91 173.49 15.23 Favored 'General case' 0 C--N 1.307 -1.263 0 C-N-CA 118.637 -1.225 . . . . 0.0 110.692 -179.726 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 179' ' ' LEU . . . . . . . . . . . . . 2.2 tp -128.02 100.2 5.79 Favored 'General case' 0 C--N 1.3 -1.57 0 N-CA-C 106.896 -1.52 . . . . 0.0 106.896 178.127 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 180' ' ' THR . . . . . . . . . . . . . 1.4 m -75.18 118.95 18.67 Favored 'General case' 0 C--N 1.303 -1.417 0 C-N-CA 119.071 -1.052 . . . . 0.0 110.287 -178.101 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 181' ' ' LEU . . . . . . . . . . . . . 57.8 tp -94.76 146.95 23.82 Favored 'General case' 0 C--N 1.298 -1.647 0 N-CA-C 108.08 -1.081 . . . . 0.0 108.08 178.171 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 182' ' ' ILE . . . . . . . . . . . . . 54.9 mt -140.9 125.43 17.88 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.529 0 O-C-N 120.958 -1.089 . . . . 0.0 109.684 179.552 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 183' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -143.84 112.29 6.44 Favored 'General case' 0 C--N 1.295 -1.802 0 N-CA-C 107.047 -1.464 . . . . 0.0 107.047 178.722 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 184' ' ' CYS . . . . . 0.477 ' CB ' HH11 ' A' ' 197' ' ' ARG . 0.6 OUTLIER -78.48 163.06 25.91 Favored 'General case' 0 N--CA 1.498 1.964 0 C-N-CA 118.786 -1.166 . . . . 0.0 110.954 -177.114 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 185' ' ' ASP . . . . . . . . . . . . . 12.3 t0 -165.87 -153.92 0.19 Allowed 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.45 -0.781 . . . . 0.0 109.817 -179.712 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 186' ' ' ASP . . . . . 0.444 ' HB3' ' H ' ' A' ' 196' ' ' LYS . 0.4 OUTLIER 49.98 53.92 11.98 Favored 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.254 -0.904 . . . . 0.0 108.983 -179.67 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 187' ' ' TYR . . . . . 0.603 ' CE1' ' O ' ' A' ' 188' ' ' ASN . 34.2 t80 -65.93 135.17 54.39 Favored 'General case' 0 C--N 1.301 -1.521 0 O-C-N 121.205 -0.935 . . . . 0.0 110.222 -179.419 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 188' ' ' ASN . . . . . 0.603 ' O ' ' CE1' ' A' ' 187' ' ' TYR . 0.6 OUTLIER -100.93 147.68 25.87 Favored 'General case' 0 C--N 1.296 -1.737 0 N-CA-C 107.954 -1.128 . . . . 0.0 107.954 178.578 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 189' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -112.54 -13.65 13.31 Favored 'General case' 0 C--N 1.295 -1.772 0 N-CA-C 108.268 -1.012 . . . . 0.0 108.268 -179.872 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 190' ' ' LYS . . . . . . . . . . . . . 15.0 mtmt -83.46 -52.34 6.59 Favored 'General case' 0 C--N 1.303 -1.426 0 N-CA-C 108.814 -0.81 . . . . 0.0 108.814 179.118 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 191' ' ' THR . . . . . . . . . . . . . 2.6 p -90.56 -9.63 46.43 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.461 -0.775 . . . . 0.0 109.075 179.58 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 192' ' ' GLY . . . . . . . . . . . . . . . 63.68 39.94 98.04 Favored Glycine 0 N--CA 1.493 2.484 0 N-CA-C 110.836 -0.905 . . . . 0.0 110.836 178.941 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 193' ' ' VAL . . . . . 0.495 HG12 ' N ' ' A' ' 194' ' ' TRP . 57.8 t -145.98 159.32 11.75 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.563 0 O-C-N 121.01 -1.288 . . . . 0.0 109.34 179.346 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 194' ' ' TRP . . . . . 0.495 ' N ' HG12 ' A' ' 193' ' ' VAL . 19.9 m95 -85.31 120.48 26.84 Favored 'General case' 0 C--N 1.3 -1.584 0 N-CA-C 107.644 -1.243 . . . . 0.0 107.644 178.667 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 195' ' ' GLU . . . . . 0.514 ' CD ' ' ND2' ' A' ' 188' ' ' ASN . 1.1 mt-10 -89.27 -60.6 1.91 Allowed 'General case' 0 N--CA 1.493 1.713 0 O-C-N 121.138 -0.976 . . . . 0.0 111.749 -177.453 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 196' ' ' LYS . . . . . 0.444 ' H ' ' HB3' ' A' ' 186' ' ' ASP . 0.0 OUTLIER -78.98 144.34 34.85 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 120.823 -1.173 . . . . 0.0 110.405 -178.558 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 197' ' ' ARG . . . . . 0.56 ' NH2' ' O ' ' C' ' 703' ' ' PRO . 0.7 OUTLIER -120.77 137.15 54.66 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.632 -0.668 . . . . 0.0 109.206 179.714 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 198' ' ' LYS . . . . . . . . . . . . . 3.2 mtmm -114.97 122.06 45.09 Favored 'General case' 0 N--CA 1.489 1.491 0 O-C-N 121.722 -0.611 . . . . 0.0 110.323 -178.943 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 199' ' ' ILE . . . . . 0.648 ' C ' HD12 ' A' ' 199' ' ' ILE . 0.6 OUTLIER -141.85 118.32 6.85 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.7 0 O-C-N 120.957 -1.09 . . . . 0.0 110.416 179.937 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 200' ' ' PHE . . . . . 0.53 ' CD1' ' N ' ' A' ' 200' ' ' PHE . 6.5 m-85 -99.84 137.96 37.58 Favored 'General case' 0 N--CA 1.499 1.975 0 O-C-N 121.294 -0.879 . . . . 0.0 110.134 -179.371 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 201' ' ' VAL . . . . . 0.534 HG13 ' NE2' ' A' ' 178' ' ' GLN . 33.0 t -105.7 148.28 10.33 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.589 0 N-CA-C 107.981 -1.118 . . . . 0.0 107.981 177.744 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 202' ' ' ALA . . . . . . . . . . . . . . . -133.35 139.43 46.82 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.03 -1.044 . . . . 0.0 109.088 -179.608 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 203' ' ' THR . . . . . 0.403 ' O ' HG23 ' A' ' 205' ' ' VAL . 1.9 p -90.2 134.26 34.39 Favored 'General case' 0 N--CA 1.487 1.383 0 CA-C-O 122.565 1.174 . . . . 0.0 111.197 -178.827 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 204' ' ' GLU . . . . . 0.43 ' HA ' ' CD2' ' A' ' 153' ' ' TYR . 6.8 tt0 -56.0 134.88 52.69 Favored 'General case' 0 C--N 1.296 -1.76 0 C-N-CA 118.761 -1.176 . . . . 0.0 109.621 179.818 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 205' ' ' VAL . . . . . 0.531 ' O ' ' C ' ' A' ' 206' ' ' LYS . 61.0 t -128.35 -42.4 0.85 Allowed 'Isoleucine or valine' 0 N--CA 1.494 1.766 0 O-C-N 121.304 -0.873 . . . . 0.0 110.24 -178.788 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 206' ' ' LYS . . . . . 0.531 ' C ' ' O ' ' A' ' 205' ' ' VAL . 1.2 pptp? . . . . . 0 N--CA 1.501 2.093 0 CA-C-O 118.157 -0.925 . . . . 0.0 110.596 -179.505 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' C' C ' 702' ' ' LEU . . . . . 0.821 ' N ' HD12 ' C' ' 702' ' ' LEU . 0.0 OUTLIER . . . . . 0 N--CA 1.493 1.702 0 N-CA-C 108.676 -0.861 . . . . 0.0 108.676 . . . . . . . . . 2 2 . 1 . 002 nuclear build core ' C' C ' 703' ' ' PRO . . . . . 0.56 ' O ' ' NH2' ' A' ' 197' ' ' ARG . 42.8 Cg_endo -69.59 -179.19 2.66 Favored 'Trans proline' 0 N--CA 1.496 1.64 0 C-N-CA 122.868 2.379 . . . . 0.0 113.276 -178.935 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' C' C ' 704' ' ' ALA . . . . . 0.484 ' O ' ' O ' ' C' ' 703' ' ' PRO . . . . . . . . 0 N--CA 1.486 1.336 0 O-C-N 121.557 -0.714 . . . . 0.0 109.295 179.934 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 63' ' ' PRO . . . . . . . . . . . . . 3.7 Cg_endo . . . . . 0 N--CA 1.483 0.89 0 CA-C-O 121.096 0.374 . . . . 0.0 111.436 . . . . . . . . . 0 0 . 1 . 003 nuclear build core ' A' A ' 64' ' ' GLN . . . . . 0.562 ' N ' ' OE1' ' A' ' 64' ' ' GLN . 0.0 OUTLIER -153.0 102.59 2.67 Favored 'General case' 0 N--CA 1.493 1.685 0 O-C-N 121.129 -0.982 . . . . 0.0 109.513 -179.63 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 65' ' ' ILE . . . . . 0.486 ' C ' ' O ' ' A' ' 64' ' ' GLN . 3.0 mp -37.83 99.3 0.18 Allowed Pre-proline 0 N--CA 1.494 1.747 0 N-CA-C 108.677 -0.86 . . . . 0.0 108.677 179.715 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 66' ' ' PRO . . . . . 0.463 ' N ' ' O ' ' A' ' 64' ' ' GLN . 57.8 Cg_endo -85.27 -162.55 0.16 Allowed 'Trans proline' 0 C--N 1.315 -1.203 0 C-N-CA 122.264 1.976 . . . . 0.0 112.505 -178.592 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 67' ' ' LYS . . . . . 0.515 ' C ' ' H ' ' A' ' 69' ' ' LYS . 6.6 ptpt -72.98 -5.73 40.69 Favored 'General case' 0 C--N 1.303 -1.415 0 O-C-N 121.393 -0.817 . . . . 0.0 108.829 179.737 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 68' ' ' ASP . . . . . 0.594 ' O ' ' N ' ' A' ' 70' ' ' SER . 1.0 OUTLIER -74.97 46.53 0.31 Allowed 'General case' 0 N--CA 1.486 1.374 0 CA-C-O 122.85 1.309 . . . . 0.0 107.735 178.876 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 69' ' ' LYS . . . . . 0.515 ' H ' ' C ' ' A' ' 67' ' ' LYS . 13.3 ptpt -48.63 -14.41 0.06 Allowed 'General case' 0 N--CA 1.501 2.123 0 C-N-CA 117.23 -1.788 . . . . 0.0 106.728 178.191 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 70' ' ' SER . . . . . 0.594 ' N ' ' O ' ' A' ' 68' ' ' ASP . 0.3 OUTLIER -85.25 -6.3 59.27 Favored 'General case' 0 N--CA 1.496 1.86 0 CA-C-N 113.53 -1.668 . . . . 0.0 110.764 179.284 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 71' ' ' LYS . . . . . 0.433 ' N ' ' O ' ' A' ' 68' ' ' ASP . 0.0 OUTLIER -97.53 140.96 31.17 Favored 'General case' 0 N--CA 1.497 1.886 0 O-C-N 120.876 -1.14 . . . . 0.0 111.478 -179.598 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 72' ' ' VAL . . . . . 0.574 HG23 ' H ' ' A' ' 87' ' ' VAL . 0.2 OUTLIER -65.45 136.57 26.48 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.414 0 N-CA-C 105.334 -2.099 . . . . 0.0 105.334 175.36 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 73' ' ' ALA . . . . . 0.535 ' N ' ' O ' ' A' ' 87' ' ' VAL . . . -83.53 -17.16 42.8 Favored 'General case' 0 C--N 1.296 -1.717 0 O-C-N 120.179 -1.576 . . . . 0.0 108.245 -179.017 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 74' ' ' GLY . . . . . 0.553 ' O ' ' CG2' ' A' ' 72' ' ' VAL . . . 172.44 -157.71 27.5 Favored Glycine 0 C--N 1.294 -1.776 0 N-CA-C 109.5 -1.44 . . . . 0.0 109.5 -179.554 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 75' ' ' TYR . . . . . 0.57 ' HA ' HG23 ' A' ' 87' ' ' VAL . 4.6 m-85 -141.47 170.37 15.86 Favored 'General case' 0 C--N 1.293 -1.866 0 O-C-N 121.363 -1.08 . . . . 0.0 110.362 -177.303 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 76' ' ' ILE . . . . . . . . . . . . . 3.0 tp -144.92 140.02 22.99 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.717 0 C-N-CA 119.359 -0.937 . . . . 0.0 109.446 -177.414 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 77' ' ' GLU . . . . . 0.572 ' N ' ' CD ' ' A' ' 77' ' ' GLU . 0.7 OUTLIER -146.71 159.43 43.48 Favored 'General case' 0 C--N 1.304 -1.388 0 O-C-N 121.015 -1.053 . . . . 0.0 109.148 -179.293 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 78' ' ' ILE . . . . . 0.505 ' HB ' ' HB3' ' A' ' 81' ' ' ALA . 12.2 mt -147.7 94.34 4.41 Favored Pre-proline 0 N--CA 1.489 1.498 0 N-CA-C 108.622 -0.881 . . . . 0.0 108.622 -179.963 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 79' ' ' PRO . . . . . . . . . . . . . 75.0 Cg_exo -46.83 -45.83 19.65 Favored 'Trans proline' 0 N--CA 1.493 1.488 0 C-N-CA 122.937 2.425 . . . . 0.0 114.212 -178.685 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -64.78 -19.83 66.03 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 120.644 -1.285 . . . . 0.0 110.507 178.704 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 81' ' ' ALA . . . . . 0.81 ' HB2' ' HB2' ' A' ' 136' ' ' ALA . . . -104.99 -16.73 14.73 Favored 'General case' 0 N--CA 1.493 1.707 0 N-CA-C 108.448 -0.945 . . . . 0.0 108.448 179.223 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 82' ' ' ASP . . . . . . . . . . . . . 7.8 t0 67.21 50.36 1.0 Allowed 'General case' 0 N--CA 1.488 1.437 0 O-C-N 121.364 -0.835 . . . . 0.0 109.951 179.736 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 83' ' ' ILE . . . . . 0.59 HD11 ' OD1' ' A' ' 132' ' ' ASN . 78.4 mt -127.82 152.78 36.32 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.671 0 O-C-N 121.395 -0.815 . . . . 0.0 110.009 -178.914 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 84' ' ' LYS . . . . . . . . . . . . . 1.8 tttt -159.06 108.71 1.94 Allowed 'General case' 0 N--CA 1.49 1.561 0 N-CA-C 107.099 -1.445 . . . . 0.0 107.099 179.036 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 85' ' ' GLU . . . . . 0.503 ' OE1' ' O ' ' A' ' 128' ' ' TYR . 0.0 OUTLIER -141.92 169.56 10.88 Favored Pre-proline 0 N--CA 1.494 1.733 0 O-C-N 121.236 -0.915 . . . . 0.0 110.972 -177.842 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 86' ' ' PRO . . . . . . . . . . . . . 73.4 Cg_endo -79.34 166.45 22.38 Favored 'Trans proline' 0 N--CA 1.492 1.385 0 C-N-CA 123.22 2.613 . . . . 0.0 113.43 -179.631 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 87' ' ' VAL . . . . . 0.574 ' H ' HG23 ' A' ' 72' ' ' VAL . 60.3 t -126.07 102.08 9.31 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.614 0 N-CA-C 109.056 -0.72 . . . . 0.0 109.056 179.705 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 88' ' ' TYR . . . . . 0.736 ' HB3' HE22 ' A' ' 96' ' ' GLN . 22.7 m-85 -96.33 153.82 38.86 Favored Pre-proline 0 N--CA 1.501 2.088 0 O-C-N 120.952 -1.092 . . . . 0.0 110.336 -179.34 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 89' ' ' PRO . . . . . 0.457 ' O ' ' NE2' ' A' ' 96' ' ' GLN . 1.2 Cg_endo -55.72 143.82 78.57 Favored 'Trans proline' 0 C--N 1.309 -1.543 0 C-N-CA 122.715 2.277 . . . . 0.0 113.958 -179.891 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . -57.76 169.35 4.4 Favored Glycine 0 N--CA 1.493 2.44 0 N-CA-C 108.888 -1.685 . . . . 0.0 108.888 178.743 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 91' ' ' PRO . . . . . . . . . . . . . 56.3 Cg_endo -94.75 169.38 17.55 Favored 'Cis proline' 0 C--N 1.308 -1.558 0 C-N-CA 124.183 -1.174 . . . . 0.0 112.079 0.141 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 92' ' ' ALA . . . . . 0.637 ' HB3' ' HB3' ' C' ' 703' ' ' PRO . . . -72.99 32.07 0.07 Allowed 'General case' 0 N--CA 1.493 1.718 0 O-C-N 120.948 -1.095 . . . . 0.0 110.927 -179.724 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 93' ' ' THR . . . . . . . . . . . . . 11.1 p -73.15 150.4 89.9 Favored Pre-proline 0 C--N 1.302 -1.47 0 O-C-N 120.278 -1.514 . . . . 0.0 108.228 179.695 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 94' ' ' PRO . . . . . . . . . . . . . 91.1 Cg_exo -34.39 -46.41 0.51 Allowed 'Trans proline' 0 C--N 1.309 -1.527 0 C-N-CA 122.78 2.32 . . . . 0.0 112.44 -179.074 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 95' ' ' GLU . . . . . 0.59 ' O ' ' ND2' ' A' ' 98' ' ' ASN . 6.8 mt-10 -53.69 -51.94 61.61 Favored 'General case' 0 N--CA 1.488 1.465 0 O-C-N 121.111 -0.993 . . . . 0.0 109.702 179.9 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 96' ' ' GLN . . . . . 0.736 HE22 ' HB3' ' A' ' 88' ' ' TYR . 2.5 mm-40 -71.92 -45.94 59.37 Favored 'General case' 0 C--N 1.303 -1.418 0 O-C-N 121.205 -0.935 . . . . 0.0 109.822 -179.848 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 97' ' ' LEU . . . . . 0.509 ' CD1' ' O ' ' A' ' 92' ' ' ALA . 88.9 mt -55.17 -4.91 0.09 Allowed 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.18 -0.95 . . . . 0.0 108.935 179.902 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 98' ' ' ASN . . . . . 0.59 ' ND2' ' O ' ' A' ' 95' ' ' GLU . 0.0 OUTLIER -71.88 -26.01 62.16 Favored 'General case' 0 N--CA 1.489 1.505 0 O-C-N 121.511 -0.743 . . . . 0.0 109.295 179.708 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 99' ' ' ARG . . . . . 0.681 HH11 ' CG ' ' A' ' 99' ' ' ARG . 0.2 OUTLIER -99.9 -59.06 1.78 Allowed 'General case' 0 N--CA 1.488 1.426 0 C-N-CA 119.71 -0.796 . . . . 0.0 110.483 -178.919 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . -170.84 -169.43 33.87 Favored Glycine 0 N--CA 1.49 2.277 0 C-N-CA 119.013 -1.565 . . . . 0.0 110.518 -179.789 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 101' ' ' VAL . . . . . 0.711 HG23 ' O ' ' A' ' 101' ' ' VAL . 27.0 m -53.95 106.25 0.1 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.525 0 O-C-N 121.662 -0.905 . . . . 0.0 109.561 -179.906 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -92.91 158.08 16.02 Favored 'General case' 0 N--CA 1.495 1.787 0 O-C-N 121.249 -0.907 . . . . 0.0 110.582 -179.88 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 103' ' ' PHE . . . . . 0.562 ' O ' ' N ' ' A' ' 105' ' ' GLU . 23.6 m-85 -61.06 121.76 13.27 Favored 'General case' 0 N--CA 1.491 1.612 0 N-CA-C 108.083 -1.081 . . . . 0.0 108.083 178.58 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 104' ' ' ALA . . . . . 0.43 ' HB1' ' HG2' ' C' ' 703' ' ' PRO . . . -40.03 -19.99 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.567 -0.708 . . . . 0.0 111.445 -178.434 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 105' ' ' GLU . . . . . 0.64 ' OE1' HD13 ' A' ' 169' ' ' LEU . 0.2 OUTLIER -139.33 151.2 46.2 Favored 'General case' 0 N--CA 1.494 1.767 0 O-C-N 120.688 -1.257 . . . . 0.0 110.707 -179.563 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 106' ' ' GLU . . . . . . . . . . . . . 30.3 tt0 -57.95 -64.19 0.99 Allowed 'General case' 0 C--N 1.303 -1.442 0 CA-C-N 116.146 -0.479 . . . . 0.0 111.3 -178.94 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 107' ' ' ASN . . . . . . . . . . . . . 39.2 p-10 -77.47 33.0 0.16 Allowed 'General case' 0 N--CA 1.491 1.587 0 O-C-N 120.541 -1.349 . . . . 0.0 113.187 -175.214 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 108' ' ' GLU . . . . . . . . . . . . . 33.2 tp10 -59.55 148.61 32.7 Favored 'General case' 0 C--N 1.301 -1.53 0 N-CA-C 107.474 -1.306 . . . . 0.0 107.474 179.899 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 109' ' ' SER . . . . . 0.479 ' C ' ' H ' ' A' ' 111' ' ' ASP . 0.1 OUTLIER -100.59 124.67 46.48 Favored 'General case' 0 N--CA 1.487 1.409 0 O-C-N 120.9 -1.125 . . . . 0.0 110.486 -178.432 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 110' ' ' LEU . . . . . 0.451 HD12 ' OD1' ' A' ' 111' ' ' ASP . 1.5 pp -60.01 -4.61 0.79 Allowed 'General case' 0 C--N 1.301 -1.536 0 N-CA-C 108.467 -0.938 . . . . 0.0 108.467 179.721 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 111' ' ' ASP . . . . . 0.479 ' H ' ' C ' ' A' ' 109' ' ' SER . 11.8 m-20 -131.93 20.77 4.55 Favored 'General case' 0 C--N 1.303 -1.416 0 N-CA-C 108.825 -0.805 . . . . 0.0 108.825 179.57 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 112' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -66.3 140.02 58.09 Favored 'General case' 0 N--CA 1.489 1.505 0 O-C-N 121.349 -0.844 . . . . 0.0 110.198 -179.937 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 113' ' ' GLN . . . . . 0.459 ' N ' ' CD ' ' A' ' 113' ' ' GLN . 3.9 mm-40 -65.11 -6.68 9.61 Favored 'General case' 0 C--N 1.302 -1.488 0 N-CA-C 107.892 -1.151 . . . . 0.0 107.892 178.278 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 114' ' ' ASN . . . . . 0.417 ' O ' ' CG ' ' A' ' 114' ' ' ASN . 11.1 p-10 -146.02 95.01 2.56 Favored 'General case' 0 C--N 1.3 -1.545 0 N-CA-C 107.95 -1.13 . . . . 0.0 107.95 179.144 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 115' ' ' ILE . . . . . 0.479 ' O ' HG22 ' A' ' 115' ' ' ILE . 2.6 mt -98.24 111.67 28.5 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.536 0 O-C-N 121.493 -0.754 . . . . 0.0 109.487 -179.366 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 116' ' ' SER . . . . . . . . . . . . . 66.3 m -97.1 151.19 20.02 Favored 'General case' 0 N--CA 1.489 1.517 0 CA-C-O 121.77 0.795 . . . . 0.0 111.066 -178.804 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 117' ' ' ILE . . . . . . . . . . . . . 1.9 mt -146.59 155.85 11.69 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.588 0 N-CA-C 108.184 -1.043 . . . . 0.0 108.184 179.328 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 118' ' ' ALA . . . . . 0.748 ' HB1' ' HB2' ' C' ' 704' ' ' ALA . . . -146.04 163.41 35.32 Favored 'General case' 0 N--CA 1.493 1.683 0 O-C-N 120.569 -1.332 . . . . 0.0 111.88 -179.049 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 119' ' ' GLY . . . . . . . . . . . . . . . -169.9 148.57 11.95 Favored Glycine 0 N--CA 1.49 2.295 0 N-CA-C 110.403 -1.079 . . . . 0.0 110.403 -179.889 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 120' ' ' HIS . . . . . . . . . . . . . 34.2 m170 -69.33 167.71 15.87 Favored 'General case' 0 N--CA 1.495 1.799 0 O-C-N 121.768 -0.842 . . . . 0.0 110.498 179.783 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 121' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -122.9 155.11 37.35 Favored 'General case' 0 N--CA 1.493 1.715 0 N-CA-C 108.165 -1.05 . . . . 0.0 108.165 178.677 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 122' ' ' PHE . . . . . 0.7 ' O ' HG21 ' A' ' 131' ' ' THR . 0.4 OUTLIER -144.15 123.38 12.97 Favored 'General case' 0 N--CA 1.496 1.835 0 O-C-N 120.849 -1.157 . . . . 0.0 109.756 -179.487 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 123' ' ' ILE . . . . . 0.573 HG23 ' N ' ' A' ' 124' ' ' ASP . 11.1 tt -55.76 -40.75 62.7 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.462 0 CA-C-O 121.628 0.728 . . . . 0.0 109.065 179.963 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 124' ' ' ASP . . . . . 0.573 ' N ' HG23 ' A' ' 123' ' ' ILE . 31.3 t70 -88.75 23.4 2.32 Favored 'General case' 0 N--CA 1.493 1.714 0 O-C-N 121.653 -0.654 . . . . 0.0 111.731 -177.703 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 125' ' ' ARG . . . . . . . . . . . . . 54.1 mtt180 -153.62 98.59 2.66 Favored Pre-proline 0 N--CA 1.493 1.679 0 O-C-N 120.866 -1.146 . . . . 0.0 109.183 179.618 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 126' ' ' PRO . . . . . . . . . . . . . 69.7 Cg_endo -82.3 -28.57 1.85 Allowed 'Trans proline' 0 C--N 1.313 -1.321 0 C-N-CA 122.401 2.068 . . . . 0.0 111.939 179.734 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 127' ' ' ASN . . . . . 0.482 ' O ' ' O ' ' A' ' 128' ' ' TYR . 32.6 m-20 -89.86 6.43 41.87 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.372 -0.83 . . . . 0.0 109.186 179.79 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 128' ' ' TYR . . . . . 0.503 ' O ' ' OE1' ' A' ' 85' ' ' GLU . 2.4 t80 -59.47 -148.53 0.0 OUTLIER 'General case' 0 N--CA 1.489 1.486 0 O-C-N 121.318 -0.864 . . . . 0.0 109.465 179.901 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 129' ' ' GLN . . . . . 0.489 ' O ' ' OE1' ' A' ' 85' ' ' GLU . 8.7 mt-30 -65.21 -72.45 0.15 Allowed 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.386 -0.821 . . . . 0.0 110.067 -179.321 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 130' ' ' PHE . . . . . 0.567 ' CE2' HG11 ' A' ' 101' ' ' VAL . 53.5 m-85 -135.78 42.0 2.67 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.012 -1.055 . . . . 0.0 109.993 -179.693 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 131' ' ' THR . . . . . 0.7 HG21 ' O ' ' A' ' 122' ' ' PHE . 38.9 m -77.19 -35.82 55.46 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.129 -0.982 . . . . 0.0 109.531 179.94 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 132' ' ' ASN . . . . . 0.604 ' ND2' ' O ' ' A' ' 81' ' ' ALA . 0.1 OUTLIER -84.15 4.71 29.21 Favored 'General case' 0 N--CA 1.498 1.925 0 O-C-N 121.44 -0.788 . . . . 0.0 110.456 -179.277 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 133' ' ' LEU . . . . . 0.569 ' O ' ' N ' ' A' ' 135' ' ' ALA . 0.2 OUTLIER -68.19 -45.52 73.2 Favored 'General case' 0 C--N 1.296 -1.76 0 O-C-N 120.961 -1.087 . . . . 0.0 110.578 -179.636 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 134' ' ' LYS . . . . . 0.52 ' CD ' ' H ' ' A' ' 134' ' ' LYS . 0.0 OUTLIER -43.17 -17.85 0.01 OUTLIER 'General case' 0 N--CA 1.496 1.865 0 O-C-N 120.955 -1.09 . . . . 0.0 110.191 -179.331 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 135' ' ' ALA . . . . . 0.569 ' N ' ' O ' ' A' ' 133' ' ' LEU . . . -83.24 -38.28 22.42 Favored 'General case' 0 N--CA 1.488 1.471 0 O-C-N 120.925 -1.109 . . . . 0.0 110.147 -179.566 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 136' ' ' ALA . . . . . 0.81 ' HB2' ' HB2' ' A' ' 81' ' ' ALA . . . -80.0 157.89 26.69 Favored 'General case' 0 C--N 1.302 -1.476 0 CA-C-O 122.283 1.04 . . . . 0.0 111.82 -178.412 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 137' ' ' LYS . . . . . 0.528 ' O ' ' O ' ' A' ' 138' ' ' LYS . 2.4 tttt -154.49 -162.71 1.45 Allowed 'General case' 0 N--CA 1.491 1.617 0 C-N-CA 119.083 -1.047 . . . . 0.0 110.579 -178.61 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 138' ' ' LYS . . . . . 0.601 ' O ' ' N ' ' A' ' 140' ' ' SER . 16.6 pttm -44.65 -179.19 0.0 OUTLIER 'General case' 0 C--N 1.302 -1.482 0 CA-C-O 122.228 1.013 . . . . 0.0 111.039 -179.13 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 139' ' ' GLY . . . . . . . . . . . . . . . 45.42 7.89 0.01 OUTLIER Glycine 0 N--CA 1.491 2.304 0 N-CA-C 110.646 -0.982 . . . . 0.0 110.646 179.978 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 140' ' ' SER . . . . . 0.601 ' N ' ' O ' ' A' ' 138' ' ' LYS . 58.7 m -85.99 124.39 32.38 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 120.71 -1.465 . . . . 0.0 109.244 179.459 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 141' ' ' MET . . . . . . . . . . . . . 1.1 tpt -72.88 136.08 45.23 Favored 'General case' 0 N--CA 1.489 1.506 0 O-C-N 121.133 -0.979 . . . . 0.0 109.16 179.93 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 142' ' ' VAL . . . . . . . . . . . . . 3.5 t -121.42 129.1 75.9 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.627 0 N-CA-C 108.865 -0.791 . . . . 0.0 108.865 -179.835 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 143' ' ' TYR . . . . . . . . . . . . . 16.6 m-85 -113.14 136.6 52.54 Favored 'General case' 0 N--CA 1.498 1.951 0 O-C-N 121.172 -0.955 . . . . 0.0 111.063 -178.667 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 144' ' ' PHE . . . . . 0.565 ' CE2' HG11 ' A' ' 146' ' ' VAL . 10.7 t80 -122.52 104.98 9.73 Favored 'General case' 0 N--CA 1.492 1.667 0 CA-C-O 121.5 0.667 . . . . 0.0 110.245 -178.989 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 145' ' ' LYS . . . . . . . . . . . . . 4.6 mttm -97.7 123.41 41.61 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.426 -0.796 . . . . 0.0 109.719 -179.965 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 146' ' ' VAL . . . . . 0.565 HG11 ' CE2' ' A' ' 144' ' ' PHE . 0.5 OUTLIER -143.78 122.62 7.42 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.582 0 O-C-N 121.196 -0.94 . . . . 0.0 108.648 179.402 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 147' ' ' GLY . . . . . . . . . . . . . . . 70.47 -131.01 21.6 Favored Glycine 0 N--CA 1.488 2.163 0 N-CA-C 108.525 -1.83 . . . . 0.0 108.525 -179.103 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 148' ' ' ASN . . . . . . . . . . . . . 18.7 p30 -106.51 11.72 30.35 Favored 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.407 -1.055 . . . . 0.0 108.665 179.101 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 149' ' ' GLU . . . . . . . . . . . . . 4.8 tt0 -114.2 149.42 35.8 Favored 'General case' 0 N--CA 1.491 1.594 0 CA-C-O 121.844 0.831 . . . . 0.0 111.043 -179.003 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 150' ' ' THR . . . . . . . . . . . . . 20.1 m -129.89 105.55 8.07 Favored 'General case' 0 N--CA 1.492 1.656 0 CA-C-O 121.341 0.591 . . . . 0.0 109.762 -179.986 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 151' ' ' ARG . . . . . . . . . . . . . 4.9 mtp180 -87.82 -175.29 5.08 Favored 'General case' 0 N--CA 1.487 1.403 0 N-CA-C 108.293 -1.003 . . . . 0.0 108.293 179.701 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 152' ' ' LYS . . . . . . . . . . . . . 26.3 mtmt -149.31 146.45 27.55 Favored 'General case' 0 C--N 1.301 -1.502 0 O-C-N 120.914 -1.116 . . . . 0.0 110.619 -179.454 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 153' ' ' TYR . . . . . 0.491 ' CD2' ' HA ' ' A' ' 204' ' ' GLU . 4.1 m-85 -138.6 170.25 16.35 Favored 'General case' 0 N--CA 1.488 1.443 0 N-CA-C 107.471 -1.307 . . . . 0.0 107.471 178.794 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 154' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -144.52 122.7 12.19 Favored 'General case' 0 C--N 1.296 -1.726 0 N-CA-C 108.087 -1.079 . . . . 0.0 108.087 178.581 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 155' ' ' MET . . . . . . . . . . . . . 3.7 mtt -46.75 105.88 0.07 Allowed 'General case' 0 N--CA 1.49 1.54 0 O-C-N 120.594 -1.316 . . . . 0.0 111.702 -178.445 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 156' ' ' THR . . . . . 0.724 ' OG1' HG23 ' A' ' 203' ' ' THR . 0.1 OUTLIER -106.28 -25.55 11.9 Favored 'General case' 0 C--N 1.292 -1.918 0 CA-C-N 115.183 -0.917 . . . . 0.0 110.074 -179.137 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 157' ' ' SER . . . . . 0.416 ' O ' ' N ' ' A' ' 201' ' ' VAL . 0.1 OUTLIER -153.72 152.72 31.1 Favored 'General case' 0 N--CA 1.495 1.81 0 C-N-CA 118.24 -1.384 . . . . 0.0 111.592 -178.766 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 158' ' ' ILE . . . . . 0.454 HG13 ' CD2' ' A' ' 200' ' ' PHE . 0.0 OUTLIER -156.17 146.52 12.04 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.527 0 CA-C-O 121.758 0.79 . . . . 0.0 110.376 -179.885 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 159' ' ' ARG . . . . . 0.471 ' CG ' HH11 ' A' ' 159' ' ' ARG . 0.0 OUTLIER -150.85 -175.59 5.19 Favored 'General case' 0 C--N 1.3 -1.574 0 CA-C-O 121.833 0.825 . . . . 0.0 110.821 -179.629 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 160' ' ' ASP . . . . . 0.648 ' O ' HG13 ' A' ' 161' ' ' VAL . 1.9 m-20 -143.2 157.34 44.59 Favored 'General case' 0 N--CA 1.49 1.566 0 N-CA-C 108.018 -1.105 . . . . 0.0 108.018 -179.851 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 161' ' ' VAL . . . . . 0.648 HG13 ' O ' ' A' ' 160' ' ' ASP . 2.3 m -160.08 157.38 2.89 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.833 0 C-N-CA 118.624 -1.231 . . . . 0.0 110.902 -179.256 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 162' ' ' LYS . . . . . 0.449 ' O ' ' O ' ' A' ' 161' ' ' VAL . 0.0 OUTLIER -44.02 169.04 0.06 OUTLIER Pre-proline 0 N--CA 1.493 1.685 0 O-C-N 121.559 -0.713 . . . . 0.0 109.833 -179.996 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 163' ' ' PRO . . . . . 0.463 ' C ' HD11 ' C' ' 702' ' ' LEU . 57.0 Cg_endo -77.2 34.74 0.46 Allowed 'Trans proline' 0 C--N 1.309 -1.521 0 C-N-CA 122.622 2.215 . . . . 0.0 112.402 179.725 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 164' ' ' THR . . . . . 0.478 ' N ' HD11 ' C' ' 702' ' ' LEU . 0.0 OUTLIER -150.76 -6.98 0.28 Allowed 'General case' 0 N--CA 1.495 1.778 0 O-C-N 121.1 -1.0 . . . . 0.0 110.904 -179.567 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 165' ' ' ASP . . . . . 0.422 ' O ' ' C ' ' A' ' 166' ' ' VAL . 13.7 t70 -72.53 61.16 0.49 Allowed 'General case' 0 C--N 1.3 -1.56 0 O-C-N 120.881 -1.137 . . . . 0.0 109.127 -179.831 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 166' ' ' VAL . . . . . 0.643 ' O ' ' N ' ' A' ' 168' ' ' VAL . 0.8 OUTLIER -44.0 -29.47 0.52 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.523 0 O-C-N 121.113 -0.992 . . . . 0.0 109.387 -178.567 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 167' ' ' GLY . . . . . . . . . . . . . . . -45.19 -6.43 0.01 OUTLIER Glycine 0 N--CA 1.498 2.788 0 O-C-N 121.197 -0.94 . . . . 0.0 110.763 179.905 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 168' ' ' VAL . . . . . 0.643 ' N ' ' O ' ' A' ' 166' ' ' VAL . 2.8 t -48.24 -34.56 4.99 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.417 0 O-C-N 120.88 -1.365 . . . . 0.0 108.381 179.188 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 169' ' ' LEU . . . . . 0.64 HD13 ' OE1' ' A' ' 105' ' ' GLU . 1.4 mt -47.23 -11.01 0.02 OUTLIER 'General case' 0 N--CA 1.494 1.767 0 N-CA-C 108.239 -1.022 . . . . 0.0 108.239 -178.313 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 170' ' ' ASP . . . . . 0.603 ' N ' ' O ' ' A' ' 168' ' ' VAL . 6.1 t70 38.49 64.65 0.71 Allowed 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.596 -0.69 . . . . 0.0 111.535 177.615 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 171' ' ' GLU . . . . . 0.426 ' H ' ' HG2' ' A' ' 171' ' ' GLU . 1.7 pt-20 -101.09 92.81 5.17 Favored 'General case' 0 C--N 1.299 -1.601 0 N-CA-C 106.965 -1.494 . . . . 0.0 106.965 177.715 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 172' ' ' GLN . . . . . . . . . . . . . 1.1 mt-30 -156.01 -79.16 0.09 Allowed 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.651 -0.656 . . . . 0.0 110.266 -178.361 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 173' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -59.49 128.41 36.91 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.15 -0.969 . . . . 0.0 109.195 -179.549 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 174' ' ' GLY . . . . . 0.526 ' O ' ' C ' ' A' ' 175' ' ' LYS . . . -119.36 -40.92 0.6 Allowed Glycine 0 N--CA 1.48 1.584 0 N-CA-C 108.117 -1.993 . . . . 0.0 108.117 179.321 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 175' ' ' LYS . . . . . 0.526 ' C ' ' O ' ' A' ' 174' ' ' GLY . 2.9 mmtt -35.79 -61.88 0.45 Allowed 'General case' 0 N--CA 1.496 1.829 0 N-CA-C 108.728 -0.841 . . . . 0.0 108.728 -179.877 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 176' ' ' ASP . . . . . 0.604 ' O ' ' O ' ' A' ' 177' ' ' LYS . 0.3 OUTLIER -103.48 88.87 3.2 Favored 'General case' 0 C--N 1.297 -1.676 0 N-CA-C 107.801 -1.185 . . . . 0.0 107.801 177.946 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 177' ' ' LYS . . . . . 0.604 ' O ' ' O ' ' A' ' 176' ' ' ASP . 6.0 mtmp? -39.29 177.82 0.0 OUTLIER 'General case' 0 N--CA 1.494 1.748 0 CA-C-O 121.805 0.812 . . . . 0.0 111.023 -179.09 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 178' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -161.69 171.81 17.29 Favored 'General case' 0 C--N 1.305 -1.331 0 O-C-N 120.837 -1.164 . . . . 0.0 110.508 179.186 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 179' ' ' LEU . . . . . . . . . . . . . 1.3 tp -126.74 95.33 4.3 Favored 'General case' 0 C--N 1.302 -1.485 0 N-CA-C 106.491 -1.67 . . . . 0.0 106.491 177.513 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 180' ' ' THR . . . . . . . . . . . . . 1.2 m -70.12 119.11 13.83 Favored 'General case' 0 C--N 1.304 -1.384 0 C-N-CA 119.134 -1.026 . . . . 0.0 109.41 -178.349 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 181' ' ' LEU . . . . . 0.467 HD21 ' HG ' ' A' ' 133' ' ' LEU . 36.8 tp -96.82 146.01 25.32 Favored 'General case' 0 C--N 1.294 -1.806 0 N-CA-C 108.028 -1.101 . . . . 0.0 108.028 178.706 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 182' ' ' ILE . . . . . . . . . . . . . 25.3 mt -139.34 119.77 14.58 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.484 0 O-C-N 120.956 -1.09 . . . . 0.0 109.718 179.088 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 183' ' ' THR . . . . . 0.592 ' O ' HG23 ' A' ' 183' ' ' THR . 10.3 t -135.76 115.45 12.9 Favored 'General case' 0 C--N 1.291 -1.977 0 N-CA-C 107.447 -1.316 . . . . 0.0 107.447 178.508 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 184' ' ' CYS . . . . . . . . . . . . . 5.1 p -78.15 157.38 29.44 Favored 'General case' 0 C--N 1.287 -2.12 0 C-N-CA 118.93 -1.108 . . . . 0.0 110.655 -177.867 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 185' ' ' ASP . . . . . 0.522 ' CG ' ' H ' ' A' ' 186' ' ' ASP . 37.3 t0 -165.7 -158.09 0.34 Allowed 'General case' 0 N--CA 1.492 1.654 0 N-CA-C 108.944 -0.761 . . . . 0.0 108.944 -179.5 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 186' ' ' ASP . . . . . 0.522 ' H ' ' CG ' ' A' ' 185' ' ' ASP . 1.3 m-20 52.93 53.83 11.44 Favored 'General case' 0 N--CA 1.494 1.73 0 O-C-N 120.902 -1.124 . . . . 0.0 109.444 179.979 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 187' ' ' TYR . . . . . 0.617 ' CE1' ' O ' ' A' ' 188' ' ' ASN . 61.2 t80 -67.9 135.03 51.82 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.171 -0.956 . . . . 0.0 110.719 -179.397 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 188' ' ' ASN . . . . . 0.617 ' O ' ' CE1' ' A' ' 187' ' ' TYR . 1.1 t-20 -101.68 146.16 28.11 Favored 'General case' 0 C--N 1.295 -1.792 0 N-CA-C 108.119 -1.067 . . . . 0.0 108.119 178.441 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 189' ' ' GLU . . . . . . . . . . . . . 1.8 tt0 -110.13 -13.39 14.37 Favored 'General case' 0 C--N 1.293 -1.875 0 N-CA-C 108.151 -1.055 . . . . 0.0 108.151 -179.782 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 190' ' ' LYS . . . . . . . . . . . . . 6.4 mttt -84.27 -55.68 4.05 Favored 'General case' 0 C--N 1.301 -1.522 0 N-CA-C 108.827 -0.805 . . . . 0.0 108.827 178.759 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 191' ' ' THR . . . . . 0.583 ' OG1' HG12 ' A' ' 193' ' ' VAL . 6.2 p -87.48 2.55 50.27 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.444 -0.785 . . . . 0.0 109.89 -179.644 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 192' ' ' GLY . . . . . . . . . . . . . . . 56.27 33.07 60.98 Favored Glycine 0 N--CA 1.495 2.62 0 O-C-N 121.172 -0.955 . . . . 0.0 111.79 178.615 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 193' ' ' VAL . . . . . 0.583 HG12 ' OG1' ' A' ' 191' ' ' THR . 4.1 p -149.25 167.94 2.97 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.75 0 O-C-N 120.677 -1.484 . . . . 0.0 110.583 179.009 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 194' ' ' TRP . . . . . 0.524 ' H ' HG22 ' A' ' 193' ' ' VAL . 9.4 m95 -83.98 120.23 25.87 Favored 'General case' 0 C--N 1.296 -1.724 0 N-CA-C 108.558 -0.904 . . . . 0.0 108.558 179.963 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 195' ' ' GLU . . . . . 0.444 ' CD ' ' ND2' ' A' ' 188' ' ' ASN . 3.7 mt-10 -76.23 -60.82 2.17 Favored 'General case' 0 N--CA 1.495 1.784 0 O-C-N 121.395 -0.816 . . . . 0.0 111.356 -178.323 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 196' ' ' LYS . . . . . . . . . . . . . 8.6 tttt -93.18 153.71 18.47 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 120.935 -1.103 . . . . 0.0 110.817 -178.494 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 197' ' ' ARG . . . . . 0.647 ' CG ' HH11 ' A' ' 197' ' ' ARG . 0.0 OUTLIER -119.66 140.13 51.12 Favored 'General case' 0 N--CA 1.49 1.525 0 N-CA-C 107.995 -1.113 . . . . 0.0 107.995 178.845 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 198' ' ' LYS . . . . . . . . . . . . . 2.4 mttm -114.16 122.02 45.54 Favored 'General case' 0 N--CA 1.493 1.719 0 O-C-N 121.899 -0.501 . . . . 0.0 110.904 -177.982 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 199' ' ' ILE . . . . . 0.694 ' C ' HD12 ' A' ' 199' ' ' ILE . 0.5 OUTLIER -142.58 120.02 7.02 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.546 0 CA-C-O 122.393 1.092 . . . . 0.0 110.515 179.925 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 200' ' ' PHE . . . . . 0.509 ' CD1' ' N ' ' A' ' 200' ' ' PHE . 3.5 m-85 -98.42 135.45 39.98 Favored 'General case' 0 N--CA 1.499 2.001 0 O-C-N 121.34 -0.85 . . . . 0.0 109.512 -178.982 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 201' ' ' VAL . . . . . 0.416 ' N ' ' O ' ' A' ' 157' ' ' SER . 72.3 t -100.08 130.75 48.76 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.633 0 O-C-N 120.885 -1.134 . . . . 0.0 108.318 177.671 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 202' ' ' ALA . . . . . . . . . . . . . . . -114.48 131.47 56.61 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.37 -0.831 . . . . 0.0 108.771 179.443 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 203' ' ' THR . . . . . 0.724 HG23 ' OG1' ' A' ' 156' ' ' THR . 6.7 p -88.59 130.35 35.28 Favored 'General case' 0 N--CA 1.487 1.399 0 CA-C-O 122.137 0.97 . . . . 0.0 110.768 -179.039 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 204' ' ' GLU . . . . . 0.491 ' HA ' ' CD2' ' A' ' 153' ' ' TYR . 0.8 OUTLIER -51.5 134.28 29.21 Favored 'General case' 0 C--N 1.298 -1.64 0 C-N-CA 119.091 -1.044 . . . . 0.0 109.034 179.305 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 205' ' ' VAL . . . . . 0.721 HG23 ' O ' ' A' ' 203' ' ' THR . 93.3 t -132.22 167.03 27.41 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.358 0 CA-C-O 122.081 0.943 . . . . 0.0 110.144 -178.132 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 206' ' ' LYS . . . . . 0.603 ' N ' HG12 ' A' ' 205' ' ' VAL . 0.0 OUTLIER . . . . . 0 C--N 1.295 -1.787 0 CA-C-O 117.933 -1.032 . . . . 0.0 109.509 -179.72 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' C' C ' 702' ' ' LEU . . . . . 0.784 ' N ' HD12 ' C' ' 702' ' ' LEU . 0.0 OUTLIER . . . . . 0 N--CA 1.494 1.741 0 N-CA-C 109.235 -0.654 . . . . 0.0 109.235 . . . . . . . . . 2 2 . 1 . 003 nuclear build core ' C' C ' 703' ' ' PRO . . . . . 0.637 ' HB3' ' HB3' ' A' ' 92' ' ' ALA . 50.7 Cg_exo -48.6 -164.59 0.0 OUTLIER 'Trans proline' 0 N--CA 1.494 1.504 0 C-N-CA 122.437 2.091 . . . . 0.0 113.216 -179.426 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' C' C ' 704' ' ' ALA . . . . . 0.748 ' HB2' ' HB1' ' A' ' 118' ' ' ALA . . . . . . . . 0 N--CA 1.489 1.511 0 O-C-N 121.679 -0.638 . . . . 0.0 109.983 -179.924 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 63' ' ' PRO . . . . . 0.47 ' O ' ' CD1' ' A' ' 110' ' ' LEU . 18.2 Cg_endo . . . . . 0 N--CA 1.482 0.828 0 CA-C-O 121.003 0.335 . . . . 0.0 111.231 . . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 64' ' ' GLN . . . . . 0.48 ' O ' ' OE1' ' A' ' 64' ' ' GLN . 0.0 OUTLIER -155.53 139.25 16.11 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.175 -0.953 . . . . 0.0 109.658 -179.967 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 65' ' ' ILE . . . . . . . . . . . . . 4.7 mm -48.05 107.7 0.79 Allowed Pre-proline 0 N--CA 1.491 1.592 0 O-C-N 121.009 -1.057 . . . . 0.0 108.183 179.345 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 66' ' ' PRO . . . . . . . . . . . . . 93.6 Cg_endo -85.75 -170.16 0.68 Allowed 'Trans proline' 0 C--N 1.315 -1.218 0 C-N-CA 122.15 1.9 . . . . 0.0 112.614 -179.015 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 67' ' ' LYS . . . . . . . . . . . . . 38.7 tttt -90.27 -8.86 49.89 Favored 'General case' 0 N--CA 1.488 1.459 0 O-C-N 121.436 -0.79 . . . . 0.0 109.178 179.567 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 68' ' ' ASP . . . . . 0.664 ' O ' ' N ' ' A' ' 70' ' ' SER . 0.4 OUTLIER -75.86 63.86 1.74 Allowed 'General case' 0 N--CA 1.488 1.431 0 CA-C-O 122.848 1.309 . . . . 0.0 109.033 179.813 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 69' ' ' LYS . . . . . 0.478 ' C ' ' O ' ' A' ' 68' ' ' ASP . 23.8 mtmt -45.76 -13.99 0.02 OUTLIER 'General case' 0 N--CA 1.512 2.653 0 C-N-CA 116.686 -2.005 . . . . 0.0 107.157 177.757 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 70' ' ' SER . . . . . 0.664 ' N ' ' O ' ' A' ' 68' ' ' ASP . 0.1 OUTLIER -86.04 -9.02 57.49 Favored 'General case' 0 N--CA 1.497 1.899 0 CA-C-N 113.701 -1.59 . . . . 0.0 111.656 179.395 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 71' ' ' LYS . . . . . 0.464 ' N ' ' O ' ' A' ' 68' ' ' ASP . 0.0 OUTLIER -95.88 142.18 28.44 Favored 'General case' 0 N--CA 1.505 2.303 0 O-C-N 120.468 -1.395 . . . . 0.0 112.971 -178.704 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 72' ' ' VAL . . . . . 0.633 HG12 ' CZ ' ' A' ' 88' ' ' TYR . 1.3 m -68.67 133.42 31.81 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.368 0 N-CA-C 105.305 -2.109 . . . . 0.0 105.305 174.711 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 73' ' ' ALA . . . . . 0.7 ' O ' HG23 ' A' ' 146' ' ' VAL . . . -80.87 -13.77 58.63 Favored 'General case' 0 C--N 1.297 -1.714 0 O-C-N 119.905 -1.747 . . . . 0.0 107.183 -179.813 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . 172.99 -156.71 25.24 Favored Glycine 0 N--CA 1.483 1.77 0 N-CA-C 109.299 -1.52 . . . . 0.0 109.299 179.648 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 75' ' ' TYR . . . . . 0.547 ' HA ' HG23 ' A' ' 87' ' ' VAL . 88.1 m-85 -141.54 169.99 16.56 Favored 'General case' 0 C--N 1.298 -1.668 0 O-C-N 121.58 -0.953 . . . . 0.0 111.044 -177.241 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 76' ' ' ILE . . . . . . . . . . . . . 3.9 tp -146.5 141.39 20.88 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.577 0 C-N-CA 119.461 -0.895 . . . . 0.0 109.455 -177.377 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -153.09 165.02 36.92 Favored 'General case' 0 C--N 1.304 -1.41 0 O-C-N 121.13 -0.981 . . . . 0.0 109.934 179.852 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 78' ' ' ILE . . . . . 0.639 ' HB ' ' HB3' ' A' ' 81' ' ' ALA . 5.0 mt -147.39 119.92 4.75 Favored Pre-proline 0 C--N 1.303 -1.455 0 N-CA-C 107.87 -1.159 . . . . 0.0 107.87 179.165 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 79' ' ' PRO . . . . . . . . . . . . . 31.1 Cg_endo -70.46 -42.36 2.74 Favored 'Trans proline' 0 C--N 1.315 -1.218 0 C-N-CA 121.658 1.572 . . . . 0.0 112.992 -178.755 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -66.43 -19.8 65.89 Favored 'General case' 0 N--CA 1.489 1.491 0 O-C-N 120.881 -1.137 . . . . 0.0 110.202 177.977 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 81' ' ' ALA . . . . . 0.931 ' HB2' ' HB2' ' A' ' 136' ' ' ALA . . . -106.61 -18.78 13.86 Favored 'General case' 0 N--CA 1.494 1.755 0 O-C-N 121.303 -0.873 . . . . 0.0 109.04 179.913 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 82' ' ' ASP . . . . . . . . . . . . . 2.3 t70 66.01 52.09 1.25 Allowed 'General case' 0 N--CA 1.494 1.732 0 O-C-N 121.43 -0.794 . . . . 0.0 111.493 178.781 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 83' ' ' ILE . . . . . . . . . . . . . 31.4 mt -131.46 153.08 38.3 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.862 0 O-C-N 120.977 -1.077 . . . . 0.0 109.636 -179.322 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 84' ' ' LYS . . . . . . . . . . . . . 23.1 tttt -158.11 110.48 2.33 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.244 -0.91 . . . . 0.0 108.628 179.57 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -141.46 165.75 26.6 Favored Pre-proline 0 N--CA 1.492 1.67 0 O-C-N 121.246 -0.909 . . . . 0.0 109.817 -179.256 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 86' ' ' PRO . . . . . . . . . . . . . 61.2 Cg_endo -76.29 168.61 23.58 Favored 'Trans proline' 0 C--N 1.309 -1.5 0 C-N-CA 122.939 2.426 . . . . 0.0 113.312 -179.53 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 87' ' ' VAL . . . . . 0.547 HG23 ' HA ' ' A' ' 75' ' ' TYR . 49.6 t -124.43 98.84 5.64 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.63 0 N-CA-C 109.27 -0.641 . . . . 0.0 109.27 -179.884 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 88' ' ' TYR . . . . . 0.633 ' CZ ' HG12 ' A' ' 72' ' ' VAL . 35.0 m-85 -90.42 153.55 46.22 Favored Pre-proline 0 N--CA 1.503 2.209 0 O-C-N 120.954 -1.091 . . . . 0.0 109.944 -179.606 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 89' ' ' PRO . . . . . 0.539 ' O ' ' NE2' ' A' ' 96' ' ' GLN . 10.2 Cg_endo -58.7 146.11 93.36 Favored 'Trans proline' 0 N--CA 1.493 1.469 0 C-N-CA 122.492 2.128 . . . . 0.0 113.135 179.82 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . -58.11 169.59 4.7 Favored Glycine 0 N--CA 1.492 2.398 0 N-CA-C 109.326 -1.51 . . . . 0.0 109.326 179.493 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 91' ' ' PRO . . . . . 0.4 ' C ' ' H ' ' A' ' 93' ' ' THR . 57.3 Cg_endo -95.23 169.21 16.63 Favored 'Cis proline' 0 C--N 1.31 -1.485 0 C-N-CA 124.298 -1.126 . . . . 0.0 112.065 0.103 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 92' ' ' ALA . . . . . 0.676 ' HB3' ' HB2' ' C' ' 703' ' ' PRO . . . -71.99 30.07 0.05 Allowed 'General case' 0 N--CA 1.493 1.691 0 O-C-N 121.241 -0.912 . . . . 0.0 111.274 -179.421 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 93' ' ' THR . . . . . 0.4 ' H ' ' C ' ' A' ' 91' ' ' PRO . 1.0 OUTLIER -75.85 151.29 84.35 Favored Pre-proline 0 N--CA 1.492 1.64 0 O-C-N 120.651 -1.281 . . . . 0.0 108.788 179.865 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 94' ' ' PRO . . . . . 0.4 ' C ' ' O ' ' A' ' 93' ' ' THR . 82.9 Cg_exo -35.52 -42.24 0.45 Allowed 'Trans proline' 0 C--N 1.308 -1.573 0 C-N-CA 122.511 2.14 . . . . 0.0 112.067 -179.566 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 5.8 mt-10 -49.95 -56.44 10.62 Favored 'General case' 0 C--N 1.304 -1.41 0 O-C-N 121.292 -0.88 . . . . 0.0 109.112 179.512 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 96' ' ' GLN . . . . . 0.596 ' O ' ' N ' ' A' ' 98' ' ' ASN . 13.0 mm100 -74.49 -47.86 30.64 Favored 'General case' 0 N--CA 1.487 1.424 0 O-C-N 121.323 -0.861 . . . . 0.0 109.995 179.69 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 97' ' ' LEU . . . . . 0.595 HD23 ' O ' ' A' ' 92' ' ' ALA . 0.4 OUTLIER -45.3 -11.89 0.02 OUTLIER 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.221 -0.925 . . . . 0.0 109.989 -178.949 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 98' ' ' ASN . . . . . 0.596 ' N ' ' O ' ' A' ' 96' ' ' GLN . 0.0 OUTLIER -73.88 -31.44 63.15 Favored 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.176 -0.953 . . . . 0.0 108.854 179.204 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 99' ' ' ARG . . . . . 0.62 HH11 ' CG ' ' A' ' 99' ' ' ARG . 1.1 mtt-85 -85.03 -58.2 2.79 Favored 'General case' 0 C--N 1.302 -1.47 0 O-C-N 121.865 -0.522 . . . . 0.0 109.89 -179.14 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . -179.65 -160.34 25.09 Favored Glycine 0 N--CA 1.493 2.442 0 C-N-CA 119.645 -1.264 . . . . 0.0 110.046 -179.944 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 101' ' ' VAL . . . . . 0.736 HG23 ' O ' ' A' ' 101' ' ' VAL . 17.8 m -61.66 107.82 0.46 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.594 0 O-C-N 121.403 -1.057 . . . . 0.0 109.522 -179.813 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -92.91 161.57 14.43 Favored 'General case' 0 N--CA 1.493 1.681 0 O-C-N 121.322 -0.861 . . . . 0.0 110.498 -179.84 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 103' ' ' PHE . . . . . 0.601 ' O ' ' N ' ' A' ' 105' ' ' GLU . 25.3 m-85 -64.13 123.32 18.77 Favored 'General case' 0 N--CA 1.488 1.447 0 N-CA-C 108.151 -1.055 . . . . 0.0 108.151 178.655 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 104' ' ' ALA . . . . . 0.702 ' HB1' ' HG3' ' C' ' 703' ' ' PRO . . . -40.39 -18.63 0.01 OUTLIER 'General case' 0 C--N 1.298 -1.636 0 O-C-N 121.602 -0.686 . . . . 0.0 110.774 -178.939 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 105' ' ' GLU . . . . . 0.601 ' N ' ' O ' ' A' ' 103' ' ' PHE . 0.4 OUTLIER -140.0 147.88 41.06 Favored 'General case' 0 N--CA 1.495 1.808 0 O-C-N 120.698 -1.251 . . . . 0.0 110.315 179.915 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 106' ' ' GLU . . . . . . . . . . . . . 4.3 tt0 -57.86 -63.37 1.27 Allowed 'General case' 0 N--CA 1.487 1.425 0 O-C-N 121.965 -0.459 . . . . 0.0 111.203 -179.058 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 107' ' ' ASN . . . . . . . . . . . . . 5.1 m120 -78.68 33.82 0.21 Allowed 'General case' 0 N--CA 1.49 1.544 0 O-C-N 120.477 -1.39 . . . . 0.0 113.465 -175.231 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 108' ' ' GLU . . . . . . . . . . . . . 30.6 tp10 -60.02 150.14 30.1 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 120.426 -1.421 . . . . 0.0 108.175 -179.614 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 109' ' ' SER . . . . . 0.489 ' C ' ' H ' ' A' ' 111' ' ' ASP . 0.1 OUTLIER -101.35 126.26 48.09 Favored 'General case' 0 N--CA 1.489 1.5 0 O-C-N 121.002 -1.061 . . . . 0.0 110.585 -178.613 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 110' ' ' LEU . . . . . 0.534 HD23 ' N ' ' A' ' 110' ' ' LEU . 1.0 OUTLIER -60.22 -2.33 0.44 Allowed 'General case' 0 C--N 1.298 -1.664 0 N-CA-C 108.891 -0.781 . . . . 0.0 108.891 -179.964 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 111' ' ' ASP . . . . . 0.489 ' H ' ' C ' ' A' ' 109' ' ' SER . 53.1 m-20 -133.26 20.47 4.02 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.386 -0.822 . . . . 0.0 109.607 179.831 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 112' ' ' ASP . . . . . 0.41 ' N ' ' OG ' ' A' ' 109' ' ' SER . 0.4 OUTLIER -68.05 140.14 56.29 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.002 -1.061 . . . . 0.0 110.661 -179.674 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 113' ' ' GLN . . . . . 0.531 ' N ' ' CD ' ' A' ' 113' ' ' GLN . 7.6 mm-40 -64.92 -7.06 9.94 Favored 'General case' 0 C--N 1.303 -1.445 0 N-CA-C 107.521 -1.289 . . . . 0.0 107.521 177.876 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 114' ' ' ASN . . . . . 0.667 HD21 ' C ' ' A' ' 114' ' ' ASN . 0.2 OUTLIER -144.68 92.17 2.26 Favored 'General case' 0 C--N 1.304 -1.403 0 N-CA-C 108.206 -1.035 . . . . 0.0 108.206 -179.954 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 115' ' ' ILE . . . . . 0.448 ' O ' HG22 ' A' ' 115' ' ' ILE . 2.8 mt -99.11 113.71 34.83 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.536 0 O-C-N 121.531 -0.731 . . . . 0.0 109.328 -179.438 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 116' ' ' SER . . . . . 0.572 ' OG ' ' HB3' ' A' ' 104' ' ' ALA . 69.3 p -98.02 146.61 25.34 Favored 'General case' 0 N--CA 1.488 1.471 0 CA-C-O 122.093 0.949 . . . . 0.0 111.387 -178.299 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 117' ' ' ILE . . . . . . . . . . . . . 2.7 mt -138.21 154.64 28.24 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.511 0 N-CA-C 107.477 -1.305 . . . . 0.0 107.477 178.996 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 118' ' ' ALA . . . . . . . . . . . . . . . -143.44 159.75 41.82 Favored 'General case' 0 N--CA 1.492 1.66 0 O-C-N 120.836 -1.165 . . . . 0.0 111.336 -179.233 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 119' ' ' GLY . . . . . . . . . . . . . . . -167.66 145.56 9.85 Favored Glycine 0 N--CA 1.489 2.183 0 N-CA-C 110.423 -1.071 . . . . 0.0 110.423 179.624 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 120' ' ' HIS . . . . . . . . . . . . . 3.1 m-70 -70.36 164.64 24.1 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.613 -0.933 . . . . 0.0 109.417 179.236 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 121' ' ' THR . . . . . 0.423 HG21 ' OD2' ' A' ' 185' ' ' ASP . 0.7 OUTLIER -118.06 155.28 30.62 Favored 'General case' 0 N--CA 1.494 1.733 0 O-C-N 121.318 -0.864 . . . . 0.0 108.855 179.422 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 122' ' ' PHE . . . . . 0.401 ' CD1' ' HB2' ' A' ' 125' ' ' ARG . 0.2 OUTLIER -112.36 128.07 56.19 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.308 -0.87 . . . . 0.0 109.637 179.761 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 123' ' ' ILE . . . . . 0.567 HG23 ' N ' ' A' ' 124' ' ' ASP . 16.3 tt -77.26 -38.52 27.21 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.809 0 N-CA-C 108.167 -1.049 . . . . 0.0 108.167 179.076 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 124' ' ' ASP . . . . . 0.567 ' N ' HG23 ' A' ' 123' ' ' ILE . 4.8 t70 -100.29 24.32 8.94 Favored 'General case' 0 N--CA 1.494 1.771 0 CA-C-N 115.771 -0.649 . . . . 0.0 110.82 -179.73 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 125' ' ' ARG . . . . . 0.401 ' HB2' ' CD1' ' A' ' 122' ' ' PHE . 5.1 ttt180 -157.64 99.77 1.87 Allowed Pre-proline 0 N--CA 1.492 1.671 0 O-C-N 120.664 -1.272 . . . . 0.0 110.541 -179.032 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 126' ' ' PRO . . . . . . . . . . . . . 41.3 Cg_endo -78.88 -18.91 11.33 Favored 'Trans proline' 0 C--N 1.314 -1.243 0 C-N-CA 122.175 1.917 . . . . 0.0 112.465 179.517 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 127' ' ' ASN . . . . . . . . . . . . . 14.8 m120 -90.65 26.69 1.95 Allowed 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.23 -0.919 . . . . 0.0 109.241 179.636 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 128' ' ' TYR . . . . . . . . . . . . . 13.1 t80 -87.04 -149.01 0.15 Allowed 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.306 -0.872 . . . . 0.0 109.774 -179.622 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 129' ' ' GLN . . . . . . . . . . . . . 63.3 mt-30 -67.95 -89.43 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.288 -0.882 . . . . 0.0 110.344 -179.323 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 130' ' ' PHE . . . . . 0.704 ' CE2' HG11 ' A' ' 101' ' ' VAL . 41.0 m-85 -110.15 40.07 2.02 Favored 'General case' 0 N--CA 1.494 1.752 0 O-C-N 121.287 -0.883 . . . . 0.0 110.338 -179.22 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 131' ' ' THR . . . . . . . . . . . . . 85.6 m -79.78 -32.95 40.9 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.088 -1.008 . . . . 0.0 109.128 179.38 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 132' ' ' ASN . . . . . 0.435 ' ND2' ' O ' ' A' ' 81' ' ' ALA . 4.6 t30 -84.33 7.54 19.04 Favored 'General case' 0 N--CA 1.495 1.784 0 O-C-N 121.608 -0.682 . . . . 0.0 110.335 -179.588 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 133' ' ' LEU . . . . . 0.6 ' O ' ' N ' ' A' ' 135' ' ' ALA . 0.2 OUTLIER -70.26 -46.37 64.53 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.186 -0.946 . . . . 0.0 110.686 -179.146 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 134' ' ' LYS . . . . . 0.597 ' H ' ' CD ' ' A' ' 134' ' ' LYS . 0.1 OUTLIER -42.53 -17.54 0.01 OUTLIER 'General case' 0 N--CA 1.493 1.692 0 O-C-N 121.024 -1.048 . . . . 0.0 109.983 -179.012 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 135' ' ' ALA . . . . . 0.6 ' N ' ' O ' ' A' ' 133' ' ' LEU . . . -85.12 -33.89 22.28 Favored 'General case' 0 N--CA 1.489 1.482 0 O-C-N 121.183 -0.948 . . . . 0.0 109.64 179.773 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 136' ' ' ALA . . . . . 0.931 ' HB2' ' HB2' ' A' ' 81' ' ' ALA . . . -80.43 153.21 28.39 Favored 'General case' 0 N--CA 1.489 1.504 0 CA-C-O 122.095 0.95 . . . . 0.0 111.769 -178.546 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 137' ' ' LYS . . . . . 0.511 ' O ' ' O ' ' A' ' 138' ' ' LYS . 2.8 ttmm -157.42 -163.47 1.37 Allowed 'General case' 0 N--CA 1.491 1.624 0 C-N-CA 119.109 -1.037 . . . . 0.0 110.431 -179.25 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 138' ' ' LYS . . . . . 0.604 ' O ' ' N ' ' A' ' 140' ' ' SER . 10.3 tttt -46.23 -178.39 0.0 OUTLIER 'General case' 0 C--N 1.306 -1.3 0 CA-C-O 121.864 0.84 . . . . 0.0 110.265 -179.818 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 139' ' ' GLY . . . . . . . . . . . . . . . 45.7 8.2 0.02 OUTLIER Glycine 0 N--CA 1.492 2.431 0 N-CA-C 110.713 -0.955 . . . . 0.0 110.713 179.574 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 140' ' ' SER . . . . . 0.604 ' N ' ' O ' ' A' ' 138' ' ' LYS . 37.9 m -96.5 133.74 40.57 Favored 'General case' 0 N--CA 1.493 1.679 0 O-C-N 120.814 -1.404 . . . . 0.0 109.125 179.195 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 141' ' ' MET . . . . . 0.409 ' HG2' ' CE2' ' A' ' 143' ' ' TYR . 0.0 OUTLIER -82.52 144.62 30.27 Favored 'General case' 0 N--CA 1.489 1.488 0 O-C-N 121.148 -0.97 . . . . 0.0 109.871 -179.816 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 142' ' ' VAL . . . . . . . . . . . . . 5.8 t -129.21 132.85 66.61 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.705 0 O-C-N 121.284 -0.885 . . . . 0.0 108.771 179.902 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 143' ' ' TYR . . . . . 0.409 ' CE2' ' HG2' ' A' ' 141' ' ' MET . 32.3 m-85 -114.66 137.68 51.61 Favored 'General case' 0 N--CA 1.501 2.098 0 O-C-N 121.116 -0.99 . . . . 0.0 111.421 -178.455 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 144' ' ' PHE . . . . . . . . . . . . . 26.9 t80 -122.36 107.1 11.69 Favored 'General case' 0 N--CA 1.495 1.817 0 CA-C-O 121.323 0.583 . . . . 0.0 110.442 -179.178 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 145' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -96.63 128.83 43.95 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.384 -0.823 . . . . 0.0 110.582 -179.752 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 146' ' ' VAL . . . . . 0.7 HG23 ' O ' ' A' ' 73' ' ' ALA . 3.7 p -143.38 142.8 25.15 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.777 0 N-CA-C 107.522 -1.288 . . . . 0.0 107.522 178.752 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 147' ' ' GLY . . . . . 0.41 ' C ' ' O ' ' A' ' 146' ' ' VAL . . . 46.97 -134.28 11.71 Favored Glycine 0 N--CA 1.489 2.224 0 N-CA-C 108.887 -1.685 . . . . 0.0 108.887 -179.754 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 148' ' ' ASN . . . . . . . . . . . . . 25.0 p30 -102.33 17.31 23.8 Favored 'General case' 0 C--N 1.301 -1.533 0 O-C-N 121.284 -1.127 . . . . 0.0 108.451 179.208 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 149' ' ' GLU . . . . . . . . . . . . . 8.7 tt0 -114.56 147.42 39.48 Favored 'General case' 0 N--CA 1.487 1.402 0 CA-C-O 121.919 0.866 . . . . 0.0 111.024 -178.605 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 150' ' ' THR . . . . . . . . . . . . . 88.3 m -129.42 105.97 8.47 Favored 'General case' 0 N--CA 1.491 1.596 0 CA-C-O 121.421 0.629 . . . . 0.0 109.718 179.891 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 151' ' ' ARG . . . . . . . . . . . . . 34.2 mtt180 -87.04 -174.54 4.96 Favored 'General case' 0 C--N 1.306 -1.299 0 N-CA-C 107.987 -1.116 . . . . 0.0 107.987 179.52 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 152' ' ' LYS . . . . . 0.433 ' CE ' ' OXT' ' A' ' 206' ' ' LYS . 18.6 mtmm -148.22 146.33 28.63 Favored 'General case' 0 C--N 1.3 -1.571 0 O-C-N 121.007 -1.058 . . . . 0.0 110.135 -179.799 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 153' ' ' TYR . . . . . 0.507 ' CD2' ' HA ' ' A' ' 204' ' ' GLU . 9.1 m-85 -139.02 166.56 24.17 Favored 'General case' 0 C--N 1.3 -1.546 0 N-CA-C 107.523 -1.288 . . . . 0.0 107.523 179.13 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 154' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -142.96 121.86 12.74 Favored 'General case' 0 C--N 1.296 -1.722 0 O-C-N 121.184 -0.948 . . . . 0.0 108.442 178.748 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 155' ' ' MET . . . . . . . . . . . . . 23.1 mmm -46.99 104.89 0.06 Allowed 'General case' 0 N--CA 1.49 1.526 0 O-C-N 120.758 -1.214 . . . . 0.0 111.445 -178.584 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 156' ' ' THR . . . . . . . . . . . . . 1.4 m -107.88 -23.95 11.84 Favored 'General case' 0 C--N 1.293 -1.885 0 CA-C-N 115.288 -0.869 . . . . 0.0 109.921 -179.291 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 157' ' ' SER . . . . . 0.485 ' O ' ' N ' ' A' ' 201' ' ' VAL . 2.0 m -153.94 150.56 28.45 Favored 'General case' 0 N--CA 1.492 1.669 0 C-N-CA 118.217 -1.393 . . . . 0.0 111.426 -178.362 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 158' ' ' ILE . . . . . 0.453 HG13 ' CD2' ' A' ' 200' ' ' PHE . 0.0 OUTLIER -154.95 146.45 13.29 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.44 0 CA-C-O 121.796 0.807 . . . . 0.0 110.333 -179.491 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 159' ' ' ARG . . . . . 0.434 ' N ' HG12 ' A' ' 158' ' ' ILE . 37.5 mtm180 -149.3 177.18 9.89 Favored 'General case' 0 C--N 1.298 -1.656 0 CA-C-O 121.557 0.694 . . . . 0.0 109.812 -179.732 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 160' ' ' ASP . . . . . 0.571 ' C ' HG22 ' A' ' 161' ' ' VAL . 1.0 OUTLIER -144.81 161.22 39.81 Favored 'General case' 0 C--N 1.3 -1.567 0 N-CA-C 108.859 -0.793 . . . . 0.0 108.859 -179.463 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 161' ' ' VAL . . . . . 0.571 HG22 ' C ' ' A' ' 160' ' ' ASP . 0.1 OUTLIER -169.47 166.6 0.34 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.612 0 O-C-N 121.294 -0.879 . . . . 0.0 109.768 179.673 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 162' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -55.29 177.36 0.13 Allowed Pre-proline 0 N--CA 1.489 1.482 0 O-C-N 121.528 -0.732 . . . . 0.0 109.189 179.669 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 163' ' ' PRO . . . . . 0.739 ' C ' HD11 ' C' ' 702' ' ' LEU . 9.8 Cg_endo -84.07 42.8 1.26 Allowed 'Trans proline' 0 C--N 1.315 -1.185 0 C-N-CA 122.466 2.111 . . . . 0.0 112.21 -179.87 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 164' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -151.92 -14.0 0.19 Allowed 'General case' 0 N--CA 1.492 1.674 0 O-C-N 121.103 -0.998 . . . . 0.0 110.443 -179.859 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 165' ' ' ASP . . . . . 0.436 ' O ' ' C ' ' A' ' 166' ' ' VAL . 9.5 t70 -73.03 61.63 0.59 Allowed 'General case' 0 N--CA 1.49 1.527 0 O-C-N 120.955 -1.091 . . . . 0.0 109.544 -179.817 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 166' ' ' VAL . . . . . 0.608 ' O ' ' N ' ' A' ' 168' ' ' VAL . 0.9 OUTLIER -39.6 -32.04 0.17 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.55 0 O-C-N 121.659 -0.65 . . . . 0.0 109.431 -178.416 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 167' ' ' GLY . . . . . 0.425 ' N ' ' O ' ' A' ' 165' ' ' ASP . . . -43.03 -14.96 0.02 OUTLIER Glycine 0 N--CA 1.492 2.375 0 N-CA-C 110.325 -1.11 . . . . 0.0 110.325 179.898 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 168' ' ' VAL . . . . . 0.616 ' C ' ' H ' ' A' ' 170' ' ' ASP . 4.8 m -52.72 -37.06 24.04 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.452 0 O-C-N 120.751 -1.441 . . . . 0.0 108.528 179.692 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 169' ' ' LEU . . . . . 0.508 ' O ' ' N ' ' A' ' 171' ' ' GLU . 16.1 mt -51.75 -5.39 0.03 OUTLIER 'General case' 0 N--CA 1.494 1.756 0 N-CA-C 108.088 -1.078 . . . . 0.0 108.088 -179.431 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 170' ' ' ASP . . . . . 0.616 ' H ' ' C ' ' A' ' 168' ' ' VAL . 22.4 t0 35.52 29.49 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.639 -0.663 . . . . 0.0 111.586 178.047 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 171' ' ' GLU . . . . . 0.508 ' N ' ' O ' ' A' ' 169' ' ' LEU . 11.6 pt-20 -68.31 94.5 0.54 Allowed 'General case' 0 N--CA 1.489 1.5 0 O-C-N 120.609 -1.307 . . . . 0.0 108.26 178.935 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 172' ' ' GLN . . . . . 0.427 ' HG3' ' H ' ' A' ' 173' ' ' LYS . 6.0 pt20 -175.98 -56.9 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.535 0 N-CA-C 108.885 -0.783 . . . . 0.0 108.885 179.969 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 173' ' ' LYS . . . . . 0.427 ' H ' ' HG3' ' A' ' 172' ' ' GLN . 44.5 mtpt -64.13 130.24 43.17 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.021 -1.049 . . . . 0.0 108.64 178.462 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 174' ' ' GLY . . . . . 0.571 ' O ' ' C ' ' A' ' 175' ' ' LYS . . . -134.91 -38.72 0.19 Allowed Glycine 0 N--CA 1.48 1.621 0 N-CA-C 108.621 -1.792 . . . . 0.0 108.621 179.581 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 175' ' ' LYS . . . . . 0.571 ' C ' ' O ' ' A' ' 174' ' ' GLY . 4.3 mmtp -27.02 -64.7 0.08 Allowed 'General case' 0 N--CA 1.503 2.199 0 CA-C-O 121.644 0.735 . . . . 0.0 109.033 179.853 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 176' ' ' ASP . . . . . 0.669 ' O ' ' O ' ' A' ' 177' ' ' LYS . 0.0 OUTLIER -102.6 79.26 1.79 Allowed 'General case' 0 C--N 1.298 -1.669 0 N-CA-C 107.163 -1.421 . . . . 0.0 107.163 177.442 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 177' ' ' LYS . . . . . 0.669 ' O ' ' O ' ' A' ' 176' ' ' ASP . 65.7 mttt -26.56 161.34 0.0 OUTLIER 'General case' 0 N--CA 1.503 2.212 0 CA-C-O 121.821 0.82 . . . . 0.0 111.17 -178.676 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 178' ' ' GLN . . . . . 0.601 HE21 ' CG ' ' A' ' 114' ' ' ASN . 3.3 pp0? -159.94 174.0 15.05 Favored 'General case' 0 C--N 1.302 -1.458 0 C-N-CA 117.265 -1.774 . . . . 0.0 112.029 -179.357 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 179' ' ' LEU . . . . . 0.469 ' N ' ' OE1' ' A' ' 178' ' ' GLN . 0.9 OUTLIER -126.01 99.05 5.75 Favored 'General case' 0 C--N 1.303 -1.446 0 N-CA-C 107.242 -1.392 . . . . 0.0 107.242 178.47 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 180' ' ' THR . . . . . 0.487 HG23 HD13 ' A' ' 199' ' ' ILE . 2.7 m -70.82 122.0 19.09 Favored 'General case' 0 N--CA 1.488 1.447 0 O-C-N 120.953 -1.092 . . . . 0.0 109.939 -178.642 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 181' ' ' LEU . . . . . . . . . . . . . 51.1 tp -96.84 145.78 25.54 Favored 'General case' 0 C--N 1.298 -1.67 0 N-CA-C 108.387 -0.968 . . . . 0.0 108.387 178.725 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 182' ' ' ILE . . . . . 0.486 HG22 ' O ' ' A' ' 182' ' ' ILE . 6.3 mt -138.31 110.58 6.39 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.458 0 O-C-N 120.994 -1.066 . . . . 0.0 108.982 178.987 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 183' ' ' THR . . . . . 0.445 ' O ' HG23 ' A' ' 183' ' ' THR . 1.9 t -129.11 113.47 15.14 Favored 'General case' 0 C--N 1.291 -1.938 0 N-CA-C 106.767 -1.568 . . . . 0.0 106.767 178.546 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 184' ' ' CYS . . . . . . . . . . . . . 28.2 p -78.38 164.52 24.74 Favored 'General case' 0 N--CA 1.497 1.916 0 C-N-CA 119.028 -1.069 . . . . 0.0 111.103 -177.359 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 185' ' ' ASP . . . . . 0.423 ' OD2' HG21 ' A' ' 121' ' ' THR . 6.4 t70 -165.72 -151.4 0.14 Allowed 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.584 -0.698 . . . . 0.0 109.347 -179.642 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 186' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER 48.15 56.63 7.08 Favored 'General case' 0 N--CA 1.493 1.724 0 O-C-N 121.175 -0.953 . . . . 0.0 109.03 -179.598 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 187' ' ' TYR . . . . . 0.6 ' CE1' ' O ' ' A' ' 188' ' ' ASN . 44.7 t80 -67.38 133.77 50.22 Favored 'General case' 0 C--N 1.302 -1.485 0 O-C-N 121.418 -0.801 . . . . 0.0 110.411 -179.417 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 188' ' ' ASN . . . . . 0.6 ' O ' ' CE1' ' A' ' 187' ' ' TYR . 0.6 OUTLIER -100.74 147.21 26.29 Favored 'General case' 0 C--N 1.296 -1.749 0 N-CA-C 107.79 -1.189 . . . . 0.0 107.79 178.302 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 189' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -112.3 -11.04 13.76 Favored 'General case' 0 C--N 1.295 -1.797 0 N-CA-C 108.373 -0.973 . . . . 0.0 108.373 -179.635 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 190' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -84.23 -52.47 6.22 Favored 'General case' 0 C--N 1.303 -1.447 0 N-CA-C 108.851 -0.796 . . . . 0.0 108.851 178.838 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 191' ' ' THR . . . . . 0.591 ' OG1' HG12 ' A' ' 193' ' ' VAL . 1.1 p -89.44 -12.63 39.64 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.475 -0.766 . . . . 0.0 109.2 179.663 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 192' ' ' GLY . . . . . . . . . . . . . . . 71.84 33.43 63.02 Favored Glycine 0 N--CA 1.493 2.495 0 O-C-N 121.291 -0.881 . . . . 0.0 111.303 178.706 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 193' ' ' VAL . . . . . 0.591 HG12 ' OG1' ' A' ' 191' ' ' THR . 3.3 p -147.71 170.85 3.2 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.67 0 O-C-N 120.778 -1.425 . . . . 0.0 110.035 179.216 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 194' ' ' TRP . . . . . 0.556 ' H ' HG22 ' A' ' 193' ' ' VAL . 2.5 m95 -84.97 121.63 28.05 Favored 'General case' 0 N--CA 1.494 1.726 0 N-CA-C 109.439 -0.578 . . . . 0.0 109.439 -179.809 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 195' ' ' GLU . . . . . 0.531 ' CD ' ' ND2' ' A' ' 188' ' ' ASN . 2.4 mt-10 -80.05 -60.38 2.36 Favored 'General case' 0 N--CA 1.496 1.87 0 O-C-N 121.348 -0.845 . . . . 0.0 111.037 -178.975 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 196' ' ' LYS . . . . . . . . . . . . . 10.6 tttt -93.44 157.34 16.27 Favored 'General case' 0 N--CA 1.493 1.688 0 O-C-N 120.977 -1.077 . . . . 0.0 110.695 -178.544 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 197' ' ' ARG . . . . . 0.636 ' CG ' HH11 ' A' ' 197' ' ' ARG . 0.1 OUTLIER -126.18 142.2 51.62 Favored 'General case' 0 N--CA 1.489 1.485 0 O-C-N 121.653 -0.654 . . . . 0.0 109.351 179.415 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 198' ' ' LYS . . . . . . . . . . . . . 38.5 mttt -115.56 121.73 43.53 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.794 -0.566 . . . . 0.0 110.101 -179.17 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 199' ' ' ILE . . . . . 0.667 ' C ' HD12 ' A' ' 199' ' ' ILE . 0.5 OUTLIER -138.09 118.65 16.19 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.811 0 CA-C-O 122.526 1.155 . . . . 0.0 110.076 179.834 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 200' ' ' PHE . . . . . 0.586 ' CZ ' HD12 ' A' ' 133' ' ' LEU . 7.0 m-85 -99.73 135.35 41.28 Favored 'General case' 0 N--CA 1.499 1.992 0 O-C-N 121.499 -0.751 . . . . 0.0 109.894 -178.358 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 201' ' ' VAL . . . . . 0.485 ' N ' ' O ' ' A' ' 157' ' ' SER . 59.9 t -101.03 131.86 47.88 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.714 0 O-C-N 120.984 -1.073 . . . . 0.0 108.826 177.684 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 202' ' ' ALA . . . . . . . . . . . . . . . -115.9 131.38 56.95 Favored 'General case' 0 N--CA 1.491 1.624 0 N-CA-C 108.525 -0.917 . . . . 0.0 108.525 179.43 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 203' ' ' THR . . . . . 0.683 ' O ' HG23 ' A' ' 205' ' ' VAL . 5.4 t -87.88 132.09 34.33 Favored 'General case' 0 N--CA 1.488 1.468 0 CA-C-O 122.327 1.061 . . . . 0.0 110.709 -179.332 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 204' ' ' GLU . . . . . 0.507 ' HA ' ' CD2' ' A' ' 153' ' ' TYR . 13.7 tm-20 -52.99 135.42 36.85 Favored 'General case' 0 C--N 1.296 -1.752 0 C-N-CA 118.619 -1.233 . . . . 0.0 108.909 179.205 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 205' ' ' VAL . . . . . 0.683 HG23 ' O ' ' A' ' 203' ' ' THR . 84.1 t -131.99 167.97 25.14 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.345 0 CA-C-O 121.993 0.902 . . . . 0.0 110.141 -178.056 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 206' ' ' LYS . . . . . 0.61 ' N ' HG12 ' A' ' 205' ' ' VAL . 25.5 mttt . . . . . 0 C--N 1.297 -1.675 0 CA-C-O 117.978 -1.011 . . . . 0.0 109.555 179.937 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' C' C ' 702' ' ' LEU . . . . . 0.739 HD11 ' C ' ' A' ' 163' ' ' PRO . 0.0 OUTLIER . . . . . 0 N--CA 1.49 1.561 0 N-CA-C 108.775 -0.824 . . . . 0.0 108.775 . . . . . . . . . 2 2 . 1 . 004 nuclear build core ' C' C ' 703' ' ' PRO . . . . . 0.702 ' HG3' ' HB1' ' A' ' 104' ' ' ALA . 55.5 Cg_endo -72.58 174.76 11.16 Favored 'Trans proline' 0 N--CA 1.495 1.597 0 C-N-CA 122.48 2.12 . . . . 0.0 112.418 -179.497 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' C' C ' 704' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.487 1.388 0 O-C-N 121.234 -0.916 . . . . 0.0 109.49 179.897 . . . . . . . . 0 0 . 1 . 005 nuclear build core ' A' A ' 63' ' ' PRO . . . . . . . . . . . . . 53.7 Cg_endo . . . . . 0 N--CA 1.482 0.797 0 N-CA-C 110.929 -0.45 . . . . 0.0 110.929 . . . . . . . . . 0 0 . 1 . 005 nuclear build core ' A' A ' 64' ' ' GLN . . . . . 0.574 ' N ' ' CD ' ' A' ' 64' ' ' GLN . 0.0 OUTLIER -153.38 111.93 3.68 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 120.986 -1.071 . . . . 0.0 110.19 -179.84 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 65' ' ' ILE . . . . . 0.482 ' H ' HD12 ' A' ' 65' ' ' ILE . 3.1 mp -43.45 103.76 0.34 Allowed Pre-proline 0 N--CA 1.491 1.596 0 N-CA-C 108.148 -1.056 . . . . 0.0 108.148 178.722 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 66' ' ' PRO . . . . . . . . . . . . . 97.9 Cg_endo -85.98 -155.05 0.05 OUTLIER 'Trans proline' 0 N--CA 1.49 1.282 0 C-N-CA 122.407 2.072 . . . . 0.0 113.002 -178.218 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 67' ' ' LYS . . . . . 0.434 ' O ' ' CG ' ' A' ' 67' ' ' LYS . 15.1 tttt -82.16 -6.01 58.88 Favored 'General case' 0 N--CA 1.487 1.395 0 O-C-N 121.311 -0.868 . . . . 0.0 109.037 179.936 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 68' ' ' ASP . . . . . 0.64 ' C ' ' N ' ' A' ' 70' ' ' SER . 0.4 OUTLIER -75.12 51.15 0.51 Allowed 'General case' 0 N--CA 1.487 1.384 0 CA-C-O 122.645 1.212 . . . . 0.0 108.308 179.411 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 69' ' ' LYS . . . . . 0.452 ' C ' ' O ' ' A' ' 68' ' ' ASP . 1.9 ptpp? -49.19 -14.32 0.08 Allowed 'General case' 0 N--CA 1.501 2.121 0 C-N-CA 116.769 -1.972 . . . . 0.0 106.61 178.151 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 70' ' ' SER . . . . . 0.64 ' N ' ' C ' ' A' ' 68' ' ' ASP . 38.4 t -85.27 -7.2 59.13 Favored 'General case' 0 N--CA 1.495 1.824 0 CA-C-N 113.786 -1.552 . . . . 0.0 110.534 179.354 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 71' ' ' LYS . . . . . 0.416 ' CD ' ' HB2' ' A' ' 68' ' ' ASP . 0.9 OUTLIER -98.04 140.82 31.8 Favored 'General case' 0 N--CA 1.496 1.841 0 O-C-N 120.85 -1.156 . . . . 0.0 111.333 -179.745 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 72' ' ' VAL . . . . . 0.621 HG12 ' CE1' ' A' ' 88' ' ' TYR . 1.0 OUTLIER -66.03 142.4 16.84 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.455 0 N-CA-C 105.319 -2.104 . . . . 0.0 105.319 174.989 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 73' ' ' ALA . . . . . 0.439 ' N ' ' O ' ' A' ' 87' ' ' VAL . . . -83.0 -15.31 51.68 Favored 'General case' 0 C--N 1.293 -1.854 0 N-CA-C 106.078 -1.823 . . . . 0.0 106.078 178.935 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 74' ' ' GLY . . . . . 0.483 ' C ' ' CD1' ' A' ' 75' ' ' TYR . . . 167.56 -150.6 17.2 Favored Glycine 0 N--CA 1.482 1.706 0 N-CA-C 109.38 -1.488 . . . . 0.0 109.38 179.172 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 75' ' ' TYR . . . . . 0.483 ' CD1' ' C ' ' A' ' 74' ' ' GLY . 25.7 m-85 -144.09 175.97 9.66 Favored 'General case' 0 C--N 1.296 -1.74 0 O-C-N 121.597 -0.943 . . . . 0.0 109.782 -178.839 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 76' ' ' ILE . . . . . . . . . . . . . 2.0 tt -150.37 147.65 15.81 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.797 0 N-CA-C 108.923 -0.769 . . . . 0.0 108.923 -178.261 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 4.6 mt-10 -148.67 162.03 40.55 Favored 'General case' 0 C--N 1.301 -1.541 0 O-C-N 121.044 -1.035 . . . . 0.0 109.322 179.845 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 78' ' ' ILE . . . . . 0.468 ' HB ' ' HB3' ' A' ' 81' ' ' ALA . 36.4 mt -144.24 93.27 5.98 Favored Pre-proline 0 N--CA 1.489 1.51 0 N-CA-C 108.385 -0.968 . . . . 0.0 108.385 -179.733 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 79' ' ' PRO . . . . . . . . . . . . . 74.0 Cg_exo -47.31 -46.84 18.81 Favored 'Trans proline' 0 N--CA 1.494 1.511 0 C-N-CA 122.855 2.37 . . . . 0.0 114.094 -178.598 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 53.8 t0 -65.3 -19.07 65.79 Favored 'General case' 0 N--CA 1.493 1.695 0 O-C-N 120.716 -1.24 . . . . 0.0 110.839 178.921 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 81' ' ' ALA . . . . . 0.91 ' HB2' ' HB2' ' A' ' 136' ' ' ALA . . . -106.9 -17.87 14.08 Favored 'General case' 0 N--CA 1.494 1.745 0 O-C-N 121.114 -0.991 . . . . 0.0 108.792 179.527 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 82' ' ' ASP . . . . . 0.428 ' N ' ' O ' ' A' ' 78' ' ' ILE . 0.8 OUTLIER 69.3 50.69 0.54 Allowed 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.472 -0.768 . . . . 0.0 110.688 178.947 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 83' ' ' ILE . . . . . . . . . . . . . 64.1 mt -128.07 152.38 36.11 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.876 0 O-C-N 121.144 -0.972 . . . . 0.0 110.118 -179.247 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 84' ' ' LYS . . . . . . . . . . . . . 8.0 pttm -159.05 109.27 1.99 Allowed 'General case' 0 N--CA 1.49 1.561 0 N-CA-C 107.893 -1.151 . . . . 0.0 107.893 179.309 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 85' ' ' GLU . . . . . 0.436 ' OE2' ' O ' ' A' ' 129' ' ' GLN . 0.2 OUTLIER -140.48 170.99 8.4 Favored Pre-proline 0 N--CA 1.496 1.873 0 O-C-N 121.334 -0.854 . . . . 0.0 110.412 -178.684 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 86' ' ' PRO . . . . . . . . . . . . . 72.2 Cg_endo -81.72 159.66 18.99 Favored 'Trans proline' 0 N--CA 1.492 1.436 0 C-N-CA 123.08 2.52 . . . . 0.0 113.494 -179.594 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 87' ' ' VAL . . . . . 0.439 ' O ' ' N ' ' A' ' 73' ' ' ALA . 72.5 t -115.45 100.61 10.88 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.69 0 O-C-N 121.659 -0.651 . . . . 0.0 109.808 -179.842 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 88' ' ' TYR . . . . . 0.621 ' CE1' HG12 ' A' ' 72' ' ' VAL . 20.2 m-85 -92.42 154.14 42.74 Favored Pre-proline 0 N--CA 1.498 1.95 0 O-C-N 120.879 -1.138 . . . . 0.0 109.483 179.717 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 89' ' ' PRO . . . . . 0.425 ' HA ' ' CD2' ' A' ' 103' ' ' PHE . 9.7 Cg_endo -61.98 146.15 96.43 Favored 'Trans proline' 0 C--N 1.307 -1.65 0 C-N-CA 122.373 2.049 . . . . 0.0 113.504 -179.907 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . -55.15 165.97 3.15 Favored Glycine 0 N--CA 1.494 2.509 0 N-CA-C 108.826 -1.709 . . . . 0.0 108.826 179.008 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 91' ' ' PRO . . . . . 0.447 ' C ' ' H ' ' A' ' 93' ' ' THR . 65.6 Cg_endo -94.83 168.07 17.8 Favored 'Cis proline' 0 C--N 1.307 -1.627 0 C-N-CA 124.08 -1.216 . . . . 0.0 112.205 0.269 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 92' ' ' ALA . . . . . 0.599 ' O ' HD13 ' A' ' 97' ' ' LEU . . . -70.71 28.25 0.04 OUTLIER 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.411 -0.806 . . . . 0.0 110.793 -179.626 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 93' ' ' THR . . . . . 0.447 ' H ' ' C ' ' A' ' 91' ' ' PRO . 1.7 p -73.56 152.66 89.65 Favored Pre-proline 0 N--CA 1.491 1.596 0 O-C-N 120.716 -1.24 . . . . 0.0 109.246 -179.743 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 94' ' ' PRO . . . . . . . . . . . . . 88.9 Cg_exo -36.19 -42.07 0.59 Allowed 'Trans proline' 0 C--N 1.31 -1.497 0 C-N-CA 122.821 2.347 . . . . 0.0 112.335 -179.283 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 95' ' ' GLU . . . . . 0.637 ' H ' ' CD ' ' A' ' 95' ' ' GLU . 0.1 OUTLIER -53.18 -53.98 42.61 Favored 'General case' 0 C--N 1.301 -1.507 0 O-C-N 121.254 -0.904 . . . . 0.0 109.302 179.756 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 96' ' ' GLN . . . . . 0.592 ' O ' ' N ' ' A' ' 98' ' ' ASN . 29.7 mm100 -73.64 -51.87 15.3 Favored 'General case' 0 N--CA 1.487 1.389 0 O-C-N 121.155 -0.966 . . . . 0.0 109.77 179.593 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 97' ' ' LEU . . . . . 0.599 HD13 ' O ' ' A' ' 92' ' ' ALA . 1.4 mp -46.25 -11.06 0.02 OUTLIER 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.416 -0.802 . . . . 0.0 109.741 -179.336 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 98' ' ' ASN . . . . . 0.592 ' N ' ' O ' ' A' ' 96' ' ' GLN . 0.0 OUTLIER -75.28 -23.42 57.4 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.197 -0.939 . . . . 0.0 110.005 -179.815 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 99' ' ' ARG . . . . . 0.425 ' HD2' ' CE2' ' A' ' 88' ' ' TYR . 7.7 mtt180 -103.19 -54.01 2.7 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.435 -0.79 . . . . 0.0 110.28 -178.88 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . -169.98 179.15 42.46 Favored Glycine 0 N--CA 1.492 2.41 0 C-N-CA 119.273 -1.442 . . . . 0.0 110.298 -179.834 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 101' ' ' VAL . . . . . 0.806 HG11 ' CE2' ' A' ' 130' ' ' PHE . 31.7 m -53.06 111.75 0.29 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.601 0 O-C-N 121.556 -0.967 . . . . 0.0 109.222 179.787 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -92.29 168.0 11.63 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.315 -0.866 . . . . 0.0 111.288 -179.155 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 103' ' ' PHE . . . . . 0.602 ' O ' ' N ' ' A' ' 105' ' ' GLU . 25.0 m-85 -69.64 120.79 15.95 Favored 'General case' 0 N--CA 1.488 1.439 0 N-CA-C 108.031 -1.1 . . . . 0.0 108.031 178.263 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 104' ' ' ALA . . . . . 0.572 ' HB1' ' HG3' ' C' ' 703' ' ' PRO . . . -41.09 -16.2 0.01 OUTLIER 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.686 -0.634 . . . . 0.0 111.066 -178.515 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 105' ' ' GLU . . . . . 0.602 ' N ' ' O ' ' A' ' 103' ' ' PHE . 0.4 OUTLIER -139.3 147.58 41.82 Favored 'General case' 0 N--CA 1.494 1.729 0 O-C-N 120.861 -1.149 . . . . 0.0 110.56 179.852 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 106' ' ' GLU . . . . . . . . . . . . . 16.2 tt0 -58.09 -63.9 1.1 Allowed 'General case' 0 C--N 1.302 -1.487 0 CA-C-N 116.113 -0.494 . . . . 0.0 110.863 -179.178 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 107' ' ' ASN . . . . . . . . . . . . . 43.9 m-20 -78.02 33.29 0.18 Allowed 'General case' 0 N--CA 1.491 1.621 0 O-C-N 120.501 -1.374 . . . . 0.0 113.342 -175.318 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 108' ' ' GLU . . . . . 0.48 ' OE1' ' OE2' ' A' ' 105' ' ' GLU . 26.9 tp10 -59.73 150.5 27.69 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 120.426 -1.421 . . . . 0.0 107.856 179.681 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 109' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -101.19 144.21 30.34 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 120.986 -1.072 . . . . 0.0 111.099 -178.169 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 110' ' ' LEU . . . . . 0.55 HD23 ' H ' ' A' ' 110' ' ' LEU . 0.4 OUTLIER -62.63 -22.86 66.74 Favored 'General case' 0 C--N 1.303 -1.433 0 N-CA-C 108.684 -0.858 . . . . 0.0 108.684 179.214 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 111' ' ' ASP . . . . . . . . . . . . . 64.0 m-20 -132.04 40.36 3.35 Favored 'General case' 0 N--CA 1.487 1.376 0 O-C-N 121.642 -0.662 . . . . 0.0 109.426 -179.687 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 112' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -68.53 152.42 45.41 Favored 'General case' 0 C--N 1.299 -1.591 0 O-C-N 121.266 -0.896 . . . . 0.0 110.439 179.906 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 113' ' ' GLN . . . . . . . . . . . . . 2.6 mp0 -66.21 -13.78 60.86 Favored 'General case' 0 C--N 1.301 -1.525 0 N-CA-C 108.104 -1.073 . . . . 0.0 108.104 178.153 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 114' ' ' ASN . . . . . 0.492 ' OD1' ' O ' ' A' ' 169' ' ' LEU . 1.3 t-20 -151.58 102.27 2.86 Favored 'General case' 0 N--CA 1.489 1.515 0 N-CA-C 108.171 -1.048 . . . . 0.0 108.171 179.126 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 115' ' ' ILE . . . . . 0.45 ' O ' HG22 ' A' ' 115' ' ' ILE . 3.1 mt -98.75 112.67 31.45 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.511 0 O-C-N 121.199 -0.938 . . . . 0.0 109.435 -179.772 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 116' ' ' SER . . . . . . . . . . . . . 44.1 m -98.56 143.91 28.45 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.316 -0.865 . . . . 0.0 111.338 -178.569 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 117' ' ' ILE . . . . . . . . . . . . . 1.6 mt -135.87 155.94 36.62 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.625 0 N-CA-C 108.111 -1.07 . . . . 0.0 108.111 178.764 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 118' ' ' ALA . . . . . 0.691 ' HB1' ' HB2' ' C' ' 704' ' ' ALA . . . -142.03 159.83 41.45 Favored 'General case' 0 N--CA 1.493 1.687 0 O-C-N 120.838 -1.163 . . . . 0.0 111.609 -178.967 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 119' ' ' GLY . . . . . . . . . . . . . . . -167.46 146.51 10.75 Favored Glycine 0 N--CA 1.49 2.235 0 C-N-CA 120.206 -0.997 . . . . 0.0 110.774 179.594 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 120' ' ' HIS . . . . . . . . . . . . . 27.7 m170 -70.96 167.7 18.56 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.638 -0.919 . . . . 0.0 109.251 178.964 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 121' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -122.62 157.26 32.57 Favored 'General case' 0 N--CA 1.495 1.788 0 N-CA-C 108.552 -0.907 . . . . 0.0 108.552 179.105 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 122' ' ' PHE . . . . . 0.568 ' O ' HG21 ' A' ' 131' ' ' THR . 0.2 OUTLIER -122.03 124.25 43.53 Favored 'General case' 0 N--CA 1.495 1.798 0 O-C-N 121.205 -0.935 . . . . 0.0 109.923 -179.754 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 123' ' ' ILE . . . . . 0.513 HG23 ' N ' ' A' ' 124' ' ' ASP . 11.4 tt -72.96 -35.18 48.15 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.713 0 CA-C-O 121.69 0.757 . . . . 0.0 109.718 -179.923 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 124' ' ' ASP . . . . . 0.513 ' N ' HG23 ' A' ' 123' ' ' ILE . 52.0 m-20 -90.6 8.29 34.91 Favored 'General case' 0 C--N 1.294 -1.814 0 C-N-CA 120.154 -0.618 . . . . 0.0 111.501 -178.928 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 125' ' ' ARG . . . . . . . . . . . . . 6.4 mtp180 -152.6 113.52 2.79 Favored Pre-proline 0 N--CA 1.495 1.823 0 O-C-N 120.474 -1.391 . . . . 0.0 110.531 -179.64 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 126' ' ' PRO . . . . . . . . . . . . . 78.8 Cg_endo -82.61 -16.9 7.65 Favored 'Trans proline' 0 N--CA 1.488 1.199 0 C-N-CA 122.436 2.091 . . . . 0.0 112.303 178.965 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 127' ' ' ASN . . . . . . . . . . . . . 83.8 m-20 -89.76 6.83 39.87 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.098 -1.001 . . . . 0.0 109.675 -179.885 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 128' ' ' TYR . . . . . . . . . . . . . 7.0 t80 -62.36 -148.86 0.0 OUTLIER 'General case' 0 N--CA 1.489 1.477 0 O-C-N 121.258 -0.901 . . . . 0.0 109.686 -179.975 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 129' ' ' GLN . . . . . 0.436 ' O ' ' OE2' ' A' ' 85' ' ' GLU . 17.6 mt-30 -67.88 -88.47 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.303 -0.873 . . . . 0.0 110.355 -179.149 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 130' ' ' PHE . . . . . 0.806 ' CE2' HG11 ' A' ' 101' ' ' VAL . 30.4 m-85 -110.88 37.26 2.85 Favored 'General case' 0 N--CA 1.494 1.77 0 O-C-N 121.326 -0.859 . . . . 0.0 110.303 -179.054 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 131' ' ' THR . . . . . 0.568 HG21 ' O ' ' A' ' 122' ' ' PHE . 37.0 m -77.08 -31.69 56.2 Favored 'General case' 0 N--CA 1.489 1.486 0 O-C-N 121.045 -1.034 . . . . 0.0 109.464 179.701 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 132' ' ' ASN . . . . . 0.51 ' ND2' ' O ' ' A' ' 81' ' ' ALA . 3.9 t30 -83.78 7.01 19.18 Favored 'General case' 0 N--CA 1.498 1.968 0 O-C-N 121.387 -0.821 . . . . 0.0 111.033 -179.223 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 133' ' ' LEU . . . . . 0.609 HD13 ' O ' ' A' ' 133' ' ' LEU . 0.2 OUTLIER -70.21 -45.25 66.97 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 120.971 -1.081 . . . . 0.0 110.218 -179.274 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 134' ' ' LYS . . . . . 0.551 ' H ' ' CD ' ' A' ' 134' ' ' LYS . 0.2 OUTLIER -41.49 -18.98 0.01 OUTLIER 'General case' 0 N--CA 1.496 1.83 0 O-C-N 121.053 -1.029 . . . . 0.0 110.227 -179.212 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 135' ' ' ALA . . . . . 0.597 ' N ' ' O ' ' A' ' 133' ' ' LEU . . . -85.21 -31.49 23.15 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.082 -1.011 . . . . 0.0 110.038 179.854 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 136' ' ' ALA . . . . . 0.91 ' HB2' ' HB2' ' A' ' 81' ' ' ALA . . . -80.46 152.56 28.7 Favored 'General case' 0 N--CA 1.491 1.613 0 CA-C-O 122.055 0.931 . . . . 0.0 111.758 -178.437 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 137' ' ' LYS . . . . . 0.496 ' O ' ' O ' ' A' ' 138' ' ' LYS . 24.4 mtmt -151.63 -166.03 2.4 Favored 'General case' 0 N--CA 1.493 1.695 0 C-N-CA 118.597 -1.241 . . . . 0.0 111.004 -178.247 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 138' ' ' LYS . . . . . 0.598 ' O ' ' N ' ' A' ' 140' ' ' SER . 1.1 ptpt -45.21 178.71 0.0 OUTLIER 'General case' 0 C--N 1.305 -1.359 0 CA-C-O 122.127 0.965 . . . . 0.0 110.73 -179.074 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 139' ' ' GLY . . . . . . . . . . . . . . . 46.22 8.1 0.02 OUTLIER Glycine 0 N--CA 1.489 2.199 0 N-CA-C 110.407 -1.077 . . . . 0.0 110.407 179.98 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 140' ' ' SER . . . . . 0.598 ' N ' ' O ' ' A' ' 138' ' ' LYS . 13.3 t -80.55 146.21 31.4 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 120.845 -1.385 . . . . 0.0 109.514 179.366 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 141' ' ' MET . . . . . . . . . . . . . 4.6 tpt -93.46 121.16 34.57 Favored 'General case' 0 C--N 1.3 -1.561 0 O-C-N 121.343 -0.848 . . . . 0.0 108.849 179.409 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 142' ' ' VAL . . . . . . . . . . . . . 12.8 t -112.13 130.03 66.55 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.626 0 O-C-N 121.34 -0.85 . . . . 0.0 109.016 -179.396 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 143' ' ' TYR . . . . . . . . . . . . . 3.5 m-85 -109.16 135.55 50.1 Favored 'General case' 0 N--CA 1.499 1.976 0 O-C-N 121.141 -0.974 . . . . 0.0 111.859 -178.252 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 144' ' ' PHE . . . . . . . . . . . . . 57.8 t80 -120.61 102.06 8.17 Favored 'General case' 0 N--CA 1.494 1.744 0 CA-C-O 121.302 0.572 . . . . 0.0 110.272 -179.407 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 145' ' ' LYS . . . . . . . . . . . . . 23.1 tttt -93.8 122.4 36.23 Favored 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.331 -0.856 . . . . 0.0 109.602 179.799 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 146' ' ' VAL . . . . . 0.598 HG13 ' O ' ' A' ' 146' ' ' VAL . 7.1 p -142.39 118.47 5.91 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.671 0 O-C-N 121.185 -0.947 . . . . 0.0 109.18 179.752 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 147' ' ' GLY . . . . . . . . . . . . . . . 75.61 -135.8 18.85 Favored Glycine 0 N--CA 1.488 2.132 0 N-CA-C 108.386 -1.885 . . . . 0.0 108.386 -179.094 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 148' ' ' ASN . . . . . . . . . . . . . 20.6 p30 -103.47 14.27 31.7 Favored 'General case' 0 C--N 1.298 -1.659 0 N-CA-C 107.907 -1.146 . . . . 0.0 107.907 178.813 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 149' ' ' GLU . . . . . . . . . . . . . 47.9 tt0 -116.26 153.23 32.27 Favored 'General case' 0 N--CA 1.486 1.361 0 CA-C-O 121.987 0.898 . . . . 0.0 110.639 -179.466 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 150' ' ' THR . . . . . . . . . . . . . 86.5 m -130.44 107.29 9.12 Favored 'General case' 0 N--CA 1.494 1.747 0 CA-C-O 121.336 0.589 . . . . 0.0 109.938 -179.701 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 151' ' ' ARG . . . . . 0.459 HH11 ' CG ' ' A' ' 151' ' ' ARG . 0.4 OUTLIER -87.28 -171.03 3.29 Favored 'General case' 0 N--CA 1.487 1.38 0 N-CA-C 108.641 -0.874 . . . . 0.0 108.641 179.826 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 152' ' ' LYS . . . . . 0.497 ' O ' ' N ' ' A' ' 205' ' ' VAL . 20.4 mtpt -148.21 149.04 31.22 Favored 'General case' 0 C--N 1.299 -1.605 0 O-C-N 121.153 -0.967 . . . . 0.0 109.841 -179.694 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 153' ' ' TYR . . . . . 0.513 ' CD2' ' HA ' ' A' ' 204' ' ' GLU . 23.2 m-85 -139.98 164.57 29.65 Favored 'General case' 0 C--N 1.302 -1.481 0 N-CA-C 108.107 -1.072 . . . . 0.0 108.107 179.86 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 154' ' ' LYS . . . . . . . . . . . . . 26.2 ttpt -142.44 119.27 11.19 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.143 -0.973 . . . . 0.0 109.006 179.517 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 155' ' ' MET . . . . . . . . . . . . . 19.5 mmt -46.01 105.96 0.07 Allowed 'General case' 0 N--CA 1.494 1.737 0 O-C-N 120.846 -1.159 . . . . 0.0 112.198 -178.63 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 156' ' ' THR . . . . . . . . . . . . . 4.4 m -108.6 -22.47 12.25 Favored 'General case' 0 C--N 1.297 -1.71 0 C-N-CA 119.897 -0.721 . . . . 0.0 109.666 179.709 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 157' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -144.56 141.02 29.17 Favored 'General case' 0 N--CA 1.492 1.642 0 C-N-CA 118.781 -1.167 . . . . 0.0 109.835 -178.742 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 158' ' ' ILE . . . . . . . . . . . . . 37.2 mt -148.02 134.25 12.42 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.372 0 CA-C-O 121.602 0.715 . . . . 0.0 109.82 -178.147 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 159' ' ' ARG . . . . . . . . . . . . . 3.9 ptm180 -154.63 -175.68 5.53 Favored 'General case' 0 C--N 1.297 -1.711 0 C-N-CA 119.486 -0.886 . . . . 0.0 110.536 -179.763 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 160' ' ' ASP . . . . . 0.584 ' C ' HG22 ' A' ' 161' ' ' VAL . 5.3 m-20 -146.48 165.1 30.42 Favored 'General case' 0 N--CA 1.488 1.452 0 N-CA-C 108.336 -0.987 . . . . 0.0 108.336 179.979 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 161' ' ' VAL . . . . . 0.584 HG22 ' C ' ' A' ' 160' ' ' ASP . 0.1 OUTLIER -170.1 163.28 0.45 Allowed 'Isoleucine or valine' 0 N--CA 1.494 1.768 0 O-C-N 120.909 -1.12 . . . . 0.0 110.281 179.842 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 162' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -49.47 171.23 0.12 Allowed Pre-proline 0 N--CA 1.488 1.473 0 O-C-N 121.599 -0.688 . . . . 0.0 109.39 179.271 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 163' ' ' PRO . . . . . 0.666 ' C ' HD11 ' C' ' 702' ' ' LEU . 60.5 Cg_endo -79.21 38.65 0.74 Allowed 'Trans proline' 0 C--N 1.307 -1.618 0 C-N-CA 122.615 2.21 . . . . 0.0 112.49 -179.909 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 164' ' ' THR . . . . . 0.465 ' O ' HG22 ' A' ' 164' ' ' THR . 86.0 m -151.88 -8.82 0.21 Allowed 'General case' 0 N--CA 1.494 1.762 0 O-C-N 121.126 -0.984 . . . . 0.0 110.925 -179.732 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 165' ' ' ASP . . . . . 0.437 ' O ' ' C ' ' A' ' 166' ' ' VAL . 17.8 t70 -72.85 61.86 0.57 Allowed 'General case' 0 N--CA 1.494 1.755 0 O-C-N 120.764 -1.21 . . . . 0.0 110.235 -179.351 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 166' ' ' VAL . . . . . 0.61 ' O ' ' N ' ' A' ' 168' ' ' VAL . 1.5 m -39.91 -33.06 0.23 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.65 0 O-C-N 121.408 -0.808 . . . . 0.0 109.692 -178.587 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 167' ' ' GLY . . . . . 0.404 ' C ' ' O ' ' A' ' 166' ' ' VAL . . . -43.07 -13.84 0.01 OUTLIER Glycine 0 N--CA 1.495 2.579 0 O-C-N 120.918 -1.114 . . . . 0.0 110.823 -179.802 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 168' ' ' VAL . . . . . 0.641 ' C ' ' H ' ' A' ' 170' ' ' ASP . 4.8 m -53.34 -36.27 26.25 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.583 0 O-C-N 120.768 -1.43 . . . . 0.0 108.726 179.709 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 169' ' ' LEU . . . . . 0.544 ' O ' ' N ' ' A' ' 171' ' ' GLU . 34.4 mt -51.08 -4.6 0.02 OUTLIER 'General case' 0 N--CA 1.494 1.772 0 N-CA-C 108.117 -1.068 . . . . 0.0 108.117 -179.602 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 170' ' ' ASP . . . . . 0.641 ' H ' ' C ' ' A' ' 168' ' ' VAL . 4.1 m-20 33.41 28.92 0.0 OUTLIER 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.685 -0.634 . . . . 0.0 112.228 177.185 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 171' ' ' GLU . . . . . 0.544 ' N ' ' O ' ' A' ' 169' ' ' LEU . 11.2 pt-20 -67.31 94.46 0.38 Allowed 'General case' 0 N--CA 1.491 1.589 0 O-C-N 120.598 -1.314 . . . . 0.0 107.703 178.376 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 172' ' ' GLN . . . . . . . . . . . . . 0.7 OUTLIER -159.04 -72.75 0.08 Allowed 'General case' 0 N--CA 1.493 1.716 0 O-C-N 121.637 -0.665 . . . . 0.0 109.538 -179.449 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 173' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -62.15 127.07 29.62 Favored 'General case' 0 N--CA 1.492 1.668 0 O-C-N 121.265 -0.897 . . . . 0.0 109.195 179.627 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 174' ' ' GLY . . . . . 0.564 ' O ' ' C ' ' A' ' 175' ' ' LYS . . . -118.24 -39.06 0.76 Allowed Glycine 0 N--CA 1.482 1.733 0 N-CA-C 108.623 -1.791 . . . . 0.0 108.623 179.368 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 175' ' ' LYS . . . . . 0.564 ' C ' ' O ' ' A' ' 174' ' ' GLY . 0.0 OUTLIER -32.54 -62.97 0.22 Allowed 'General case' 0 N--CA 1.498 1.952 0 N-CA-C 108.492 -0.929 . . . . 0.0 108.492 179.822 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 176' ' ' ASP . . . . . 0.66 ' O ' ' O ' ' A' ' 177' ' ' LYS . 5.5 m-20 -103.09 87.01 2.8 Favored 'General case' 0 C--N 1.297 -1.712 0 N-CA-C 106.759 -1.571 . . . . 0.0 106.759 176.914 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 177' ' ' LYS . . . . . 0.66 ' O ' ' O ' ' A' ' 176' ' ' ASP . 12.9 mttt -37.28 176.04 0.0 OUTLIER 'General case' 0 N--CA 1.498 1.942 0 CA-C-O 121.762 0.791 . . . . 0.0 110.541 -178.703 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 178' ' ' GLN . . . . . 0.425 ' HG3' HD22 ' A' ' 114' ' ' ASN . 5.2 pt20 -159.59 171.07 20.3 Favored 'General case' 0 C--N 1.302 -1.459 0 C-N-CA 118.075 -1.45 . . . . 0.0 111.582 -179.867 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 179' ' ' LEU . . . . . . . . . . . . . 1.2 tp -127.02 95.17 4.23 Favored 'General case' 0 C--N 1.303 -1.443 0 N-CA-C 107.412 -1.329 . . . . 0.0 107.412 178.127 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 180' ' ' THR . . . . . . . . . . . . . 1.3 m -71.7 121.26 18.54 Favored 'General case' 0 N--CA 1.489 1.502 0 C-N-CA 119.217 -0.993 . . . . 0.0 110.213 -178.571 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 181' ' ' LEU . . . . . 0.419 HD11 ' CE2' ' A' ' 130' ' ' PHE . 49.7 tp -96.24 147.72 23.48 Favored 'General case' 0 C--N 1.297 -1.693 0 N-CA-C 108.342 -0.984 . . . . 0.0 108.342 178.308 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 182' ' ' ILE . . . . . 0.46 ' O ' HG22 ' A' ' 182' ' ' ILE . 2.0 mt -138.73 115.09 10.19 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.578 0 N-CA-C 108.245 -1.02 . . . . 0.0 108.245 178.732 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 183' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -137.02 112.56 9.35 Favored 'General case' 0 C--N 1.293 -1.889 0 N-CA-C 107.265 -1.383 . . . . 0.0 107.265 179.364 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 184' ' ' CYS . . . . . 0.491 ' HB3' HH12 ' A' ' 197' ' ' ARG . 0.8 OUTLIER -78.69 163.71 25.2 Favored 'General case' 0 C--N 1.292 -1.918 0 C-N-CA 119.514 -0.874 . . . . 0.0 111.653 -177.14 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 185' ' ' ASP . . . . . . . . . . . . . 18.9 t0 -166.36 -159.4 0.37 Allowed 'General case' 0 N--CA 1.489 1.509 0 N-CA-C 109.205 -0.665 . . . . 0.0 109.205 -179.944 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 186' ' ' ASP . . . . . . . . . . . . . 1.3 m-20 53.84 59.62 4.17 Favored 'General case' 0 N--CA 1.493 1.724 0 O-C-N 121.121 -0.987 . . . . 0.0 109.546 179.933 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 187' ' ' TYR . . . . . 0.608 ' CE1' ' O ' ' A' ' 188' ' ' ASN . 57.0 t80 -67.67 137.77 55.81 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.319 -0.863 . . . . 0.0 110.398 -179.708 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 188' ' ' ASN . . . . . 0.608 ' O ' ' CE1' ' A' ' 187' ' ' TYR . 0.8 OUTLIER -104.41 145.02 30.86 Favored 'General case' 0 C--N 1.298 -1.672 0 N-CA-C 108.255 -1.017 . . . . 0.0 108.255 178.617 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 189' ' ' GLU . . . . . . . . . . . . . 1.4 tt0 -110.57 -13.17 14.27 Favored 'General case' 0 C--N 1.296 -1.744 0 N-CA-C 108.818 -0.808 . . . . 0.0 108.818 -179.36 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 190' ' ' LYS . . . . . . . . . . . . . 29.1 mttt -82.8 -53.66 5.72 Favored 'General case' 0 C--N 1.302 -1.496 0 N-CA-C 108.714 -0.847 . . . . 0.0 108.714 178.873 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 191' ' ' THR . . . . . . . . . . . . . 1.1 p -90.09 -10.76 43.53 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.517 -0.739 . . . . 0.0 109.194 179.714 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 192' ' ' GLY . . . . . . . . . . . . . . . 65.77 40.75 95.83 Favored Glycine 0 N--CA 1.495 2.59 0 N-CA-C 110.637 -0.985 . . . . 0.0 110.637 178.914 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 193' ' ' VAL . . . . . 0.541 HG12 ' N ' ' A' ' 194' ' ' TRP . 64.8 t -147.63 161.61 7.55 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.641 0 O-C-N 121.023 -1.281 . . . . 0.0 109.565 179.487 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 194' ' ' TRP . . . . . 0.541 ' N ' HG12 ' A' ' 193' ' ' VAL . 19.4 m95 -83.71 118.42 23.87 Favored 'General case' 0 C--N 1.301 -1.537 0 N-CA-C 107.901 -1.148 . . . . 0.0 107.901 179.082 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 195' ' ' GLU . . . . . 0.551 ' CD ' ' ND2' ' A' ' 188' ' ' ASN . 2.3 mt-10 -85.17 -60.86 1.91 Allowed 'General case' 0 N--CA 1.492 1.665 0 O-C-N 121.241 -0.912 . . . . 0.0 111.112 -177.941 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 196' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER -78.63 149.18 32.96 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 120.935 -1.103 . . . . 0.0 109.731 -179.315 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 197' ' ' ARG . . . . . 0.669 ' NE ' HD13 ' C' ' 702' ' ' LEU . 0.0 OUTLIER -128.06 136.92 51.88 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.492 -0.755 . . . . 0.0 109.129 179.84 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 198' ' ' LYS . . . . . . . . . . . . . 2.3 mtmm -115.03 121.87 44.45 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.756 -0.59 . . . . 0.0 110.676 -178.623 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 199' ' ' ILE . . . . . 0.563 ' C ' HD12 ' A' ' 199' ' ' ILE . 0.9 OUTLIER -139.57 117.89 11.79 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.586 0 CA-C-O 122.477 1.132 . . . . 0.0 109.842 179.419 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 200' ' ' PHE . . . . . 0.551 ' CZ ' HD12 ' A' ' 133' ' ' LEU . 5.0 m-85 -98.88 136.11 39.35 Favored 'General case' 0 N--CA 1.498 1.948 0 O-C-N 121.322 -0.861 . . . . 0.0 110.262 -177.914 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 201' ' ' VAL . . . . . . . . . . . . . 24.2 t -105.12 141.33 20.72 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.76 0 O-C-N 121.032 -1.043 . . . . 0.0 108.777 178.13 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 202' ' ' ALA . . . . . . . . . . . . . . . -131.17 137.44 48.99 Favored 'General case' 0 C--N 1.3 -1.545 0 N-CA-C 108.429 -0.952 . . . . 0.0 108.429 179.874 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 203' ' ' THR . . . . . 0.615 ' O ' HG23 ' A' ' 205' ' ' VAL . 2.5 t -88.41 136.06 33.17 Favored 'General case' 0 N--CA 1.489 1.515 0 CA-C-O 122.116 0.96 . . . . 0.0 110.568 -179.177 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 204' ' ' GLU . . . . . 0.513 ' HA ' ' CD2' ' A' ' 153' ' ' TYR . 0.8 OUTLIER -53.66 136.22 39.56 Favored 'General case' 0 C--N 1.295 -1.799 0 C-N-CA 118.133 -1.427 . . . . 0.0 108.706 179.014 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 205' ' ' VAL . . . . . 0.615 HG23 ' O ' ' A' ' 203' ' ' THR . 77.7 t -129.99 166.41 27.66 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.34 0 CA-C-O 121.97 0.89 . . . . 0.0 110.063 -177.893 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 206' ' ' LYS . . . . . 0.611 ' N ' HG12 ' A' ' 205' ' ' VAL . 9.1 ptmt . . . . . 0 C--N 1.296 -1.752 0 CA-C-O 118.034 -0.984 . . . . 0.0 109.429 -179.836 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' C' C ' 702' ' ' LEU . . . . . 0.669 HD13 ' NE ' ' A' ' 197' ' ' ARG . 0.1 OUTLIER . . . . . 0 N--CA 1.49 1.56 0 N-CA-C 108.757 -0.831 . . . . 0.0 108.757 . . . . . . . . . 2 2 . 1 . 005 nuclear build core ' C' C ' 703' ' ' PRO . . . . . 0.577 ' HB2' ' HB3' ' A' ' 92' ' ' ALA . 29.4 Cg_endo -66.39 -162.92 0.06 OUTLIER 'Trans proline' 0 N--CA 1.495 1.581 0 C-N-CA 122.59 2.194 . . . . 0.0 112.783 -179.224 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' C' C ' 704' ' ' ALA . . . . . 0.691 ' HB2' ' HB1' ' A' ' 118' ' ' ALA . . . . . . . . 0 N--CA 1.488 1.456 0 O-C-N 121.476 -0.765 . . . . 0.0 109.356 -179.865 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 63' ' ' PRO . . . . . . . . . . . . . 9.9 Cg_endo . . . . . 0 N--CA 1.481 0.792 0 CA-C-O 121.21 0.421 . . . . 0.0 111.15 . . . . . . . . . 0 0 . 1 . 006 nuclear build core ' A' A ' 64' ' ' GLN . . . . . 0.557 ' N ' ' CD ' ' A' ' 64' ' ' GLN . 0.0 OUTLIER -154.85 118.58 4.58 Favored 'General case' 0 N--CA 1.494 1.728 0 O-C-N 121.231 -0.918 . . . . 0.0 109.553 179.857 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 65' ' ' ILE . . . . . 0.501 ' H ' HD12 ' A' ' 65' ' ' ILE . 3.1 mp -46.58 106.4 0.57 Allowed Pre-proline 0 C--N 1.3 -1.548 0 O-C-N 121.316 -0.865 . . . . 0.0 108.773 179.197 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 66' ' ' PRO . . . . . . . . . . . . . 67.5 Cg_endo -86.51 -157.68 0.08 OUTLIER 'Trans proline' 0 C--N 1.314 -1.285 0 C-N-CA 122.487 2.125 . . . . 0.0 112.401 -179.224 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 67' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -82.88 -4.87 58.65 Favored 'General case' 0 C--N 1.302 -1.473 0 N-CA-C 108.838 -0.801 . . . . 0.0 108.838 179.528 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 68' ' ' ASP . . . . . 0.635 ' C ' ' N ' ' A' ' 70' ' ' SER . 0.3 OUTLIER -74.82 52.45 0.53 Allowed 'General case' 0 N--CA 1.488 1.425 0 CA-C-O 122.726 1.251 . . . . 0.0 108.444 179.492 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 69' ' ' LYS . . . . . 0.445 ' C ' ' O ' ' A' ' 68' ' ' ASP . 21.0 mtmt -49.48 -13.94 0.09 Allowed 'General case' 0 N--CA 1.502 2.173 0 C-N-CA 116.798 -1.961 . . . . 0.0 106.551 177.94 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 70' ' ' SER . . . . . 0.635 ' N ' ' C ' ' A' ' 68' ' ' ASP . 0.1 OUTLIER -85.48 -6.56 59.18 Favored 'General case' 0 N--CA 1.493 1.68 0 CA-C-N 113.508 -1.678 . . . . 0.0 110.601 179.285 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 71' ' ' LYS . . . . . . . . . . . . . 2.0 ptmm? -101.2 144.62 29.84 Favored 'General case' 0 N--CA 1.498 1.942 0 O-C-N 120.863 -1.148 . . . . 0.0 111.888 -179.395 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 72' ' ' VAL . . . . . 0.602 ' CG2' ' O ' ' A' ' 74' ' ' GLY . 0.7 OUTLIER -67.26 132.95 32.16 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.364 0 N-CA-C 105.49 -2.041 . . . . 0.0 105.49 174.363 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -83.77 -13.78 53.07 Favored 'General case' 0 C--N 1.297 -1.71 0 O-C-N 120.026 -1.671 . . . . 0.0 108.618 -179.183 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 74' ' ' GLY . . . . . 0.602 ' O ' ' CG2' ' A' ' 72' ' ' VAL . . . 173.29 -159.63 29.83 Favored Glycine 0 N--CA 1.487 2.086 0 N-CA-C 109.459 -1.456 . . . . 0.0 109.459 -179.805 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 75' ' ' TYR . . . . . . . . . . . . . 81.1 m-85 -140.12 169.9 16.83 Favored 'General case' 0 C--N 1.297 -1.689 0 O-C-N 121.02 -1.282 . . . . 0.0 111.354 -178.334 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 76' ' ' ILE . . . . . . . . . . . . . 1.3 tp -145.9 138.72 20.63 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.605 0 C-N-CA 119.376 -0.93 . . . . 0.0 109.235 -176.165 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -149.46 162.53 39.94 Favored 'General case' 0 C--N 1.302 -1.474 0 O-C-N 120.899 -1.126 . . . . 0.0 109.804 -179.606 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 78' ' ' ILE . . . . . 0.637 ' HB ' ' HB3' ' A' ' 81' ' ' ALA . 4.5 mt -147.74 99.54 3.79 Favored Pre-proline 0 N--CA 1.488 1.455 0 N-CA-C 108.421 -0.955 . . . . 0.0 108.421 179.879 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 79' ' ' PRO . . . . . . . . . . . . . 52.6 Cg_exo -49.81 -45.76 30.64 Favored 'Trans proline' 0 N--CA 1.493 1.483 0 C-N-CA 122.57 2.18 . . . . 0.0 113.464 -178.826 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 7.9 m-20 -66.04 -19.65 65.92 Favored 'General case' 0 N--CA 1.492 1.656 0 O-C-N 120.944 -1.098 . . . . 0.0 110.924 178.81 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 81' ' ' ALA . . . . . 0.772 ' HB2' ' HB2' ' A' ' 136' ' ' ALA . . . -105.01 -16.55 14.78 Favored 'General case' 0 N--CA 1.494 1.754 0 O-C-N 121.093 -1.005 . . . . 0.0 108.46 179.329 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 82' ' ' ASP . . . . . 0.419 ' N ' ' O ' ' A' ' 78' ' ' ILE . 0.6 OUTLIER 66.22 50.58 1.35 Allowed 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.385 -0.822 . . . . 0.0 110.434 179.191 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 83' ' ' ILE . . . . . 0.528 HD11 ' OD1' ' A' ' 132' ' ' ASN . 62.0 mt -129.42 151.97 36.59 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.788 0 O-C-N 121.09 -1.006 . . . . 0.0 110.481 -178.848 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 84' ' ' LYS . . . . . 0.491 ' N ' ' OE2' ' A' ' 85' ' ' GLU . 9.2 tttm -159.15 109.59 1.99 Allowed 'General case' 0 N--CA 1.487 1.38 0 N-CA-C 108.08 -1.081 . . . . 0.0 108.08 179.777 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 85' ' ' GLU . . . . . 0.491 ' OE2' ' N ' ' A' ' 84' ' ' LYS . 0.7 OUTLIER -144.05 171.85 6.26 Favored Pre-proline 0 N--CA 1.495 1.811 0 C-N-CA 119.858 -0.737 . . . . 0.0 109.874 -179.491 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 86' ' ' PRO . . . . . . . . . . . . . 68.7 Cg_endo -91.0 148.95 3.82 Favored 'Trans proline' 0 N--CA 1.488 1.19 0 C-N-CA 123.126 2.551 . . . . 0.0 112.963 -179.751 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 87' ' ' VAL . . . . . 0.428 ' CG2' ' C ' ' A' ' 74' ' ' GLY . 0.0 OUTLIER -104.91 106.03 19.72 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.576 0 N-CA-C 108.619 -0.882 . . . . 0.0 108.619 178.669 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 88' ' ' TYR . . . . . 0.405 ' CE1' ' HB3' ' A' ' 99' ' ' ARG . 13.7 m-85 -87.55 135.0 34.73 Favored Pre-proline 0 N--CA 1.492 1.648 0 O-C-N 120.95 -1.094 . . . . 0.0 110.37 -178.964 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 89' ' ' PRO . . . . . . . . . . . . . 20.2 Cg_exo -34.34 138.15 0.1 OUTLIER 'Trans proline' 0 N--CA 1.49 1.291 0 C-N-CA 123.253 2.635 . . . . 0.0 113.714 179.982 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . -58.87 167.26 7.04 Favored Glycine 0 N--CA 1.491 2.331 0 N-CA-C 109.546 -1.422 . . . . 0.0 109.546 179.679 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 91' ' ' PRO . . . . . 0.711 ' HD2' HE21 ' A' ' 96' ' ' GLN . 57.5 Cg_endo -92.46 170.39 21.96 Favored 'Cis proline' 0 C--N 1.307 -1.625 0 C-N-CA 123.659 -1.392 . . . . 0.0 111.94 0.654 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 92' ' ' ALA . . . . . 0.639 ' O ' HD23 ' A' ' 97' ' ' LEU . . . -70.32 29.38 0.04 OUTLIER 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.253 -0.904 . . . . 0.0 110.54 -179.327 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 93' ' ' THR . . . . . 0.482 ' H ' ' C ' ' A' ' 91' ' ' PRO . 0.8 OUTLIER -72.8 154.55 91.13 Favored Pre-proline 0 N--CA 1.492 1.644 0 O-C-N 120.764 -1.21 . . . . 0.0 109.131 -179.678 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 94' ' ' PRO . . . . . 0.451 ' O ' ' C ' ' A' ' 95' ' ' GLU . 80.5 Cg_exo -30.82 -61.79 0.13 Allowed 'Trans proline' 0 C--N 1.308 -1.574 0 C-N-CA 123.058 2.505 . . . . 0.0 112.567 -179.144 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 95' ' ' GLU . . . . . 0.451 ' C ' ' O ' ' A' ' 94' ' ' PRO . 0.3 OUTLIER -41.67 -48.23 4.09 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.288 -0.882 . . . . 0.0 109.258 179.882 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 96' ' ' GLN . . . . . 0.711 HE21 ' HD2' ' A' ' 91' ' ' PRO . 1.9 mp0 -73.6 -59.54 2.67 Favored 'General case' 0 N--CA 1.487 1.391 0 O-C-N 121.221 -0.924 . . . . 0.0 109.934 179.591 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 97' ' ' LEU . . . . . 0.639 HD23 ' O ' ' A' ' 92' ' ' ALA . 0.5 OUTLIER -45.07 -13.37 0.02 OUTLIER 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.319 -0.863 . . . . 0.0 109.413 -179.393 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 98' ' ' ASN . . . . . 0.606 ' N ' ' O ' ' A' ' 96' ' ' GLN . 0.0 OUTLIER -73.58 -26.19 60.7 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.329 -0.857 . . . . 0.0 109.841 -179.995 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 99' ' ' ARG . . . . . 0.444 ' NH1' ' O ' ' A' ' 95' ' ' GLU . 1.7 mpt_? -95.33 -45.58 7.08 Favored 'General case' 0 N--CA 1.488 1.454 0 O-C-N 121.396 -0.815 . . . . 0.0 110.048 -178.959 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . 169.99 -174.13 44.12 Favored Glycine 0 N--CA 1.494 2.537 0 C-N-CA 119.517 -1.325 . . . . 0.0 110.238 179.737 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 101' ' ' VAL . . . . . 0.737 HG23 ' O ' ' A' ' 101' ' ' VAL . 19.5 m -50.17 106.34 0.06 OUTLIER 'Isoleucine or valine' 0 N--CA 1.493 1.711 0 O-C-N 121.401 -1.058 . . . . 0.0 109.218 179.765 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -92.88 169.68 10.26 Favored 'General case' 0 N--CA 1.494 1.729 0 O-C-N 121.213 -0.93 . . . . 0.0 110.885 -179.306 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 103' ' ' PHE . . . . . 0.553 ' O ' ' N ' ' A' ' 105' ' ' GLU . 23.1 m-85 -69.52 120.83 15.9 Favored 'General case' 0 N--CA 1.487 1.404 0 N-CA-C 107.957 -1.127 . . . . 0.0 107.957 178.192 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 104' ' ' ALA . . . . . 0.597 ' HB1' ' HG3' ' C' ' 703' ' ' PRO . . . -46.85 -9.78 0.02 OUTLIER 'General case' 0 C--N 1.301 -1.529 0 O-C-N 121.335 -0.853 . . . . 0.0 110.852 -178.882 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 105' ' ' GLU . . . . . 0.553 ' N ' ' O ' ' A' ' 103' ' ' PHE . 0.1 OUTLIER -140.28 143.8 36.09 Favored 'General case' 0 N--CA 1.496 1.862 0 O-C-N 120.811 -1.181 . . . . 0.0 110.648 -179.786 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 106' ' ' GLU . . . . . . . . . . . . . 27.6 tt0 -59.42 -64.03 1.09 Allowed 'General case' 0 N--CA 1.489 1.502 0 CA-C-N 116.216 -0.447 . . . . 0.0 111.625 -178.892 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 107' ' ' ASN . . . . . . . . . . . . . 6.8 m-20 -78.66 35.56 0.24 Allowed 'General case' 0 N--CA 1.491 1.604 0 O-C-N 120.661 -1.274 . . . . 0.0 112.672 -175.723 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 108' ' ' GLU . . . . . . . . . . . . . 2.0 tp10 -56.67 149.59 17.48 Favored 'General case' 0 N--CA 1.489 1.513 0 O-C-N 120.323 -1.486 . . . . 0.0 107.741 179.779 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 109' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -100.95 145.0 29.21 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 120.9 -1.125 . . . . 0.0 110.818 -178.261 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 110' ' ' LEU . . . . . 0.495 HD13 ' O ' ' A' ' 110' ' ' LEU . 0.2 OUTLIER -61.03 -24.62 66.32 Favored 'General case' 0 C--N 1.306 -1.317 0 N-CA-C 108.199 -1.037 . . . . 0.0 108.199 179.213 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 111' ' ' ASP . . . . . 0.436 ' OD1' ' C ' ' A' ' 110' ' ' LEU . 2.7 m-20 -132.37 45.1 2.8 Favored 'General case' 0 C--N 1.302 -1.463 0 N-CA-C 109.208 -0.664 . . . . 0.0 109.208 179.63 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 112' ' ' ASP . . . . . . . . . . . . . 1.3 t0 -68.06 155.32 39.8 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.346 -0.846 . . . . 0.0 111.094 -179.638 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 113' ' ' GLN . . . . . 0.623 HE22 ' N ' ' A' ' 172' ' ' GLN . 0.0 OUTLIER -67.06 -17.15 64.77 Favored 'General case' 0 N--CA 1.488 1.456 0 N-CA-C 108.137 -1.06 . . . . 0.0 108.137 177.613 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 114' ' ' ASN . . . . . 0.55 ' OD1' ' NE2' ' A' ' 178' ' ' GLN . 2.3 t30 -151.48 105.35 3.16 Favored 'General case' 0 C--N 1.295 -1.79 0 N-CA-C 107.654 -1.239 . . . . 0.0 107.654 179.528 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 115' ' ' ILE . . . . . 0.538 HG22 ' O ' ' A' ' 115' ' ' ILE . 3.1 mt -93.6 104.44 15.75 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.711 0 O-C-N 120.675 -1.265 . . . . 0.0 107.916 179.95 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 116' ' ' SER . . . . . 0.438 ' OG ' ' ND2' ' A' ' 114' ' ' ASN . 18.5 m -87.3 147.32 25.56 Favored 'General case' 0 C--N 1.304 -1.382 0 CA-C-O 121.861 0.838 . . . . 0.0 110.988 -177.962 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 117' ' ' ILE . . . . . . . . . . . . . 2.5 mt -142.05 151.3 18.64 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.438 0 N-CA-C 107.897 -1.149 . . . . 0.0 107.897 179.449 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 118' ' ' ALA . . . . . 0.401 ' HB1' ' HB2' ' C' ' 704' ' ' ALA . . . -142.81 157.15 44.9 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 120.964 -1.085 . . . . 0.0 111.025 -179.026 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 119' ' ' GLY . . . . . . . . . . . . . . . -163.96 145.01 9.94 Favored Glycine 0 N--CA 1.486 1.997 0 N-CA-C 109.889 -1.285 . . . . 0.0 109.889 179.49 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 120' ' ' HIS . . . . . . . . . . . . . 26.5 m170 -70.49 168.49 16.1 Favored 'General case' 0 N--CA 1.493 1.681 0 O-C-N 121.574 -0.957 . . . . 0.0 109.64 179.357 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 121' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -120.67 149.2 42.86 Favored 'General case' 0 N--CA 1.494 1.735 0 O-C-N 121.234 -0.916 . . . . 0.0 108.728 179.035 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 122' ' ' PHE . . . . . . . . . . . . . 0.5 OUTLIER -112.37 140.13 47.35 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.199 -0.938 . . . . 0.0 109.359 179.805 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 123' ' ' ILE . . . . . 0.577 HG23 ' N ' ' A' ' 124' ' ' ASP . 16.0 tt -88.57 -37.88 10.85 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.793 0 N-CA-C 108.509 -0.923 . . . . 0.0 108.509 179.631 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 124' ' ' ASP . . . . . 0.577 ' N ' HG23 ' A' ' 123' ' ' ILE . 4.9 p-10 -94.37 19.07 10.04 Favored 'General case' 0 C--N 1.296 -1.735 0 C-N-CA 120.121 -0.632 . . . . 0.0 110.633 -179.548 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 125' ' ' ARG . . . . . 0.664 HH11 ' CG ' ' A' ' 125' ' ' ARG . 0.0 OUTLIER -156.35 108.42 2.05 Favored Pre-proline 0 N--CA 1.49 1.55 0 O-C-N 120.628 -1.295 . . . . 0.0 110.348 -179.049 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 126' ' ' PRO . . . . . . . . . . . . . 90.1 Cg_endo -82.55 -22.19 4.75 Favored 'Trans proline' 0 C--N 1.316 -1.181 0 C-N-CA 122.222 1.948 . . . . 0.0 111.953 179.522 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 127' ' ' ASN . . . . . 0.421 ' OD1' ' NH1' ' A' ' 125' ' ' ARG . 1.1 p30 -89.17 29.04 1.11 Allowed 'General case' 0 N--CA 1.489 1.502 0 O-C-N 121.188 -0.945 . . . . 0.0 109.331 179.97 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 128' ' ' TYR . . . . . . . . . . . . . 9.7 t80 -86.12 -149.18 0.13 Allowed 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.269 -0.894 . . . . 0.0 109.922 -179.64 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 129' ' ' GLN . . . . . . . . . . . . . 32.4 mt-30 -67.72 -69.31 0.32 Allowed 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.371 -0.831 . . . . 0.0 110.746 -178.838 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 130' ' ' PHE . . . . . 0.512 ' CE2' HG11 ' A' ' 101' ' ' VAL . 50.0 m-85 -129.83 28.66 5.08 Favored 'General case' 0 N--CA 1.496 1.841 0 O-C-N 121.14 -0.975 . . . . 0.0 110.613 -179.405 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 131' ' ' THR . . . . . . . . . . . . . 94.6 m -67.8 -34.5 76.89 Favored 'General case' 0 N--CA 1.493 1.717 0 O-C-N 120.79 -1.194 . . . . 0.0 108.968 179.37 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 132' ' ' ASN . . . . . 0.602 ' ND2' ' O ' ' A' ' 81' ' ' ALA . 2.4 p-10 -91.11 13.59 16.48 Favored 'General case' 0 N--CA 1.494 1.752 0 C-N-CA 119.608 -0.837 . . . . 0.0 111.285 -179.665 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 133' ' ' LEU . . . . . 0.619 HD13 ' O ' ' A' ' 133' ' ' LEU . 0.2 OUTLIER -71.82 -42.74 66.65 Favored 'General case' 0 N--CA 1.492 1.668 0 O-C-N 120.571 -1.331 . . . . 0.0 110.266 -179.038 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 134' ' ' LYS . . . . . 0.627 ' H ' ' CD ' ' A' ' 134' ' ' LYS . 0.0 OUTLIER -44.44 -12.77 0.02 OUTLIER 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.165 -0.959 . . . . 0.0 110.402 -179.263 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 135' ' ' ALA . . . . . 0.595 ' N ' ' O ' ' A' ' 133' ' ' LEU . . . -82.77 -37.98 23.82 Favored 'General case' 0 N--CA 1.489 1.513 0 O-C-N 120.761 -1.212 . . . . 0.0 109.855 -179.829 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 136' ' ' ALA . . . . . 0.772 ' HB2' ' HB2' ' A' ' 81' ' ' ALA . . . -78.55 153.38 31.28 Favored 'General case' 0 C--N 1.302 -1.496 0 O-C-N 121.352 -0.843 . . . . 0.0 111.111 -178.741 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 137' ' ' LYS . . . . . 0.519 ' O ' ' O ' ' A' ' 138' ' ' LYS . 0.4 OUTLIER -151.38 -163.69 1.82 Allowed 'General case' 0 N--CA 1.492 1.661 0 C-N-CA 118.479 -1.288 . . . . 0.0 110.744 -178.07 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 138' ' ' LYS . . . . . 0.585 ' O ' ' N ' ' A' ' 140' ' ' SER . 0.2 OUTLIER -46.3 -179.29 0.0 OUTLIER 'General case' 0 C--N 1.304 -1.4 0 CA-C-O 122.145 0.974 . . . . 0.0 110.508 -179.043 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 139' ' ' GLY . . . . . . . . . . . . . . . 46.87 7.77 0.02 OUTLIER Glycine 0 N--CA 1.49 2.284 0 N-CA-C 110.354 -1.098 . . . . 0.0 110.354 -179.848 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 140' ' ' SER . . . . . 0.585 ' N ' ' O ' ' A' ' 138' ' ' LYS . 39.2 m -84.56 130.53 34.73 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 120.926 -1.338 . . . . 0.0 109.517 179.412 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 141' ' ' MET . . . . . 0.639 ' SD ' ' N ' ' A' ' 142' ' ' VAL . 8.7 tpp -83.9 127.25 33.71 Favored 'General case' 0 N--CA 1.488 1.446 0 O-C-N 121.074 -1.016 . . . . 0.0 108.978 179.523 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 142' ' ' VAL . . . . . 0.639 ' N ' ' SD ' ' A' ' 141' ' ' MET . 2.4 t -111.25 133.38 57.0 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.512 0 N-CA-C 108.586 -0.894 . . . . 0.0 108.586 -179.744 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 143' ' ' TYR . . . . . . . . . . . . . 8.1 m-85 -111.05 135.29 51.79 Favored 'General case' 0 N--CA 1.495 1.802 0 O-C-N 120.822 -1.174 . . . . 0.0 111.124 -178.511 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 144' ' ' PHE . . . . . . . . . . . . . 10.3 t80 -120.17 104.57 10.19 Favored 'General case' 0 N--CA 1.493 1.7 0 C-N-CA 120.081 -0.648 . . . . 0.0 110.139 -179.748 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 145' ' ' LYS . . . . . . . . . . . . . 14.3 ttmm -99.64 128.12 45.74 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.135 -0.978 . . . . 0.0 110.556 -179.487 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 146' ' ' VAL . . . . . 0.462 HG21 HD11 ' A' ' 110' ' ' LEU . 0.6 OUTLIER -142.7 146.15 22.36 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.568 0 N-CA-C 107.438 -1.319 . . . . 0.0 107.438 178.695 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 147' ' ' GLY . . . . . 0.432 ' C ' ' O ' ' A' ' 146' ' ' VAL . . . 45.8 -131.82 9.93 Favored Glycine 0 N--CA 1.487 2.046 0 N-CA-C 108.465 -1.854 . . . . 0.0 108.465 -179.222 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 148' ' ' ASN . . . . . . . . . . . . . 21.4 p30 -104.2 18.07 22.83 Favored 'General case' 0 C--N 1.301 -1.532 0 O-C-N 121.307 -1.113 . . . . 0.0 108.602 179.077 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 149' ' ' GLU . . . . . . . . . . . . . 14.4 tt0 -112.22 147.03 37.08 Favored 'General case' 0 N--CA 1.49 1.557 0 CA-C-O 121.817 0.818 . . . . 0.0 111.328 -178.263 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 150' ' ' THR . . . . . 0.479 ' O ' HG22 ' A' ' 150' ' ' THR . 1.4 m -131.79 103.97 6.63 Favored 'General case' 0 N--CA 1.491 1.586 0 CA-C-O 121.579 0.704 . . . . 0.0 109.832 179.796 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 151' ' ' ARG . . . . . 0.477 ' NH2' ' OH ' ' A' ' 153' ' ' TYR . 21.4 mtm180 -88.2 -170.97 3.18 Favored 'General case' 0 N--CA 1.488 1.439 0 N-CA-C 109.134 -0.691 . . . . 0.0 109.134 -179.877 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 152' ' ' LYS . . . . . 0.405 ' C ' ' CD1' ' A' ' 153' ' ' TYR . 40.4 mtmt -150.86 149.26 29.47 Favored 'General case' 0 N--CA 1.489 1.496 0 O-C-N 120.968 -1.083 . . . . 0.0 110.258 -179.574 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 153' ' ' TYR . . . . . 0.578 ' O ' ' SD ' ' A' ' 141' ' ' MET . 15.9 m-85 -141.18 165.77 26.62 Favored 'General case' 0 N--CA 1.489 1.518 0 N-CA-C 107.715 -1.217 . . . . 0.0 107.715 179.224 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 154' ' ' LYS . . . . . 0.454 ' HB2' HG21 ' A' ' 205' ' ' VAL . 5.3 ttmm -141.32 115.85 9.56 Favored 'General case' 0 C--N 1.297 -1.699 0 O-C-N 120.959 -1.088 . . . . 0.0 108.628 179.29 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 155' ' ' MET . . . . . . . . . . . . . 4.6 mtt -43.65 106.16 0.06 Allowed 'General case' 0 N--CA 1.492 1.649 0 O-C-N 120.741 -1.224 . . . . 0.0 111.548 -178.662 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 156' ' ' THR . . . . . 0.748 ' OG1' HG23 ' A' ' 203' ' ' THR . 0.6 OUTLIER -109.08 -23.18 11.79 Favored 'General case' 0 C--N 1.292 -1.896 0 CA-C-N 115.267 -0.879 . . . . 0.0 109.894 -179.514 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 157' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -153.14 151.45 30.16 Favored 'General case' 0 C--N 1.297 -1.713 0 C-N-CA 118.493 -1.283 . . . . 0.0 111.431 -178.598 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 158' ' ' ILE . . . . . 0.884 HD12 ' CD2' ' A' ' 200' ' ' PHE . 0.2 OUTLIER -152.43 145.13 15.6 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.295 0 CA-C-O 121.708 0.766 . . . . 0.0 110.132 -179.148 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 159' ' ' ARG . . . . . . . . . . . . . 66.2 ttt180 -152.69 149.22 28.18 Favored 'General case' 0 C--N 1.299 -1.614 0 CA-C-O 121.882 0.848 . . . . 0.0 111.089 -178.866 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 160' ' ' ASP . . . . . 0.592 ' C ' HG22 ' A' ' 161' ' ' VAL . 5.9 m-20 -119.1 161.51 20.18 Favored 'General case' 0 N--CA 1.49 1.528 0 N-CA-C 108.567 -0.901 . . . . 0.0 108.567 179.349 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 161' ' ' VAL . . . . . 0.592 HG22 ' C ' ' A' ' 160' ' ' ASP . 0.1 OUTLIER -173.13 164.55 0.26 Allowed 'Isoleucine or valine' 0 N--CA 1.501 2.096 0 O-C-N 121.097 -1.002 . . . . 0.0 109.82 179.463 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 162' ' ' LYS . . . . . 0.515 ' O ' ' O ' ' A' ' 161' ' ' VAL . 0.1 OUTLIER -42.83 168.1 0.06 OUTLIER Pre-proline 0 N--CA 1.491 1.603 0 O-C-N 121.152 -0.968 . . . . 0.0 109.062 179.121 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 163' ' ' PRO . . . . . 0.754 ' O ' HD11 ' C' ' 702' ' ' LEU . 57.4 Cg_endo -74.86 -20.41 17.24 Favored 'Trans proline' 0 C--N 1.306 -1.708 0 C-N-CA 122.697 2.264 . . . . 0.0 112.899 -179.294 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 164' ' ' THR . . . . . 0.416 ' O ' HG13 ' A' ' 166' ' ' VAL . 1.1 p -90.87 -3.1 57.61 Favored 'General case' 0 C--N 1.297 -1.688 0 O-C-N 120.48 -1.387 . . . . 0.0 109.995 -179.644 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 165' ' ' ASP . . . . . . . . . . . . . 11.4 t70 -71.89 58.47 0.34 Allowed 'General case' 0 N--CA 1.491 1.622 0 O-C-N 120.856 -1.153 . . . . 0.0 109.709 -179.543 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 166' ' ' VAL . . . . . 0.551 ' O ' ' N ' ' A' ' 168' ' ' VAL . 1.5 m -44.25 -32.34 0.77 Allowed 'Isoleucine or valine' 0 C--N 1.297 -1.707 0 O-C-N 121.692 -0.63 . . . . 0.0 109.784 -178.339 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 167' ' ' GLY . . . . . . . . . . . . . . . -43.52 -15.4 0.03 OUTLIER Glycine 0 N--CA 1.496 2.688 0 O-C-N 120.83 -1.169 . . . . 0.0 111.356 -179.517 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 168' ' ' VAL . . . . . 0.551 ' N ' ' O ' ' A' ' 166' ' ' VAL . 2.8 m -54.24 -31.52 22.24 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.605 0 O-C-N 120.581 -1.54 . . . . 0.0 109.082 -179.839 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 169' ' ' LEU . . . . . 0.549 ' O ' ' C ' ' A' ' 170' ' ' ASP . 15.8 mt -48.32 -14.93 0.06 Allowed 'General case' 0 N--CA 1.492 1.64 0 N-CA-C 107.748 -1.204 . . . . 0.0 107.748 -178.713 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 170' ' ' ASP . . . . . 0.549 ' C ' ' O ' ' A' ' 169' ' ' LEU . 9.0 m-20 20.62 91.05 0.01 OUTLIER 'General case' 0 N--CA 1.499 2.002 0 CA-C-N 116.583 -0.28 . . . . 0.0 111.701 177.769 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 171' ' ' GLU . . . . . . . . . . . . . 5.9 pt-20 -137.49 77.21 1.62 Allowed 'General case' 0 N--CA 1.495 1.777 0 O-C-N 120.863 -1.148 . . . . 0.0 110.536 179.782 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 172' ' ' GLN . . . . . 0.623 ' N ' HE22 ' A' ' 113' ' ' GLN . 1.9 pt20 -136.87 -42.32 0.59 Allowed 'General case' 0 N--CA 1.495 1.824 0 O-C-N 121.209 -0.932 . . . . 0.0 110.76 -178.988 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 173' ' ' LYS . . . . . . . . . . . . . 5.8 mttp -63.23 129.29 39.65 Favored 'General case' 0 N--CA 1.497 1.892 0 O-C-N 120.688 -1.258 . . . . 0.0 108.854 179.522 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 174' ' ' GLY . . . . . 0.544 ' O ' ' C ' ' A' ' 175' ' ' LYS . . . -118.78 -41.07 0.62 Allowed Glycine 0 N--CA 1.484 1.896 0 N-CA-C 108.605 -1.798 . . . . 0.0 108.605 179.478 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 175' ' ' LYS . . . . . 0.544 ' C ' ' O ' ' A' ' 174' ' ' GLY . 17.9 mmtp -40.8 -61.85 0.89 Allowed 'General case' 0 N--CA 1.491 1.577 0 N-CA-C 106.503 -1.666 . . . . 0.0 106.503 178.48 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 176' ' ' ASP . . . . . 0.583 ' O ' ' O ' ' A' ' 177' ' ' LYS . 7.0 m-20 -105.07 85.64 2.31 Favored 'General case' 0 C--N 1.296 -1.734 0 N-CA-C 107.332 -1.359 . . . . 0.0 107.332 176.405 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 177' ' ' LYS . . . . . 0.583 ' O ' ' O ' ' A' ' 176' ' ' ASP . 0.0 OUTLIER -46.98 -174.41 0.0 OUTLIER 'General case' 0 N--CA 1.501 2.09 0 O-C-N 121.311 -0.868 . . . . 0.0 109.291 -179.233 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 178' ' ' GLN . . . . . 0.55 ' NE2' ' OD1' ' A' ' 114' ' ' ASN . 20.8 pt20 -162.01 175.13 12.12 Favored 'General case' 0 N--CA 1.488 1.456 0 O-C-N 120.328 -1.483 . . . . 0.0 111.374 -179.884 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 179' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -129.8 93.75 3.58 Favored 'General case' 0 N--CA 1.487 1.403 0 N-CA-C 107.197 -1.408 . . . . 0.0 107.197 177.627 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 180' ' ' THR . . . . . 0.5 HG23 HD13 ' A' ' 199' ' ' ILE . 1.8 m -71.28 118.45 14.09 Favored 'General case' 0 N--CA 1.493 1.704 0 O-C-N 121.11 -0.994 . . . . 0.0 110.424 -178.335 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 181' ' ' LEU . . . . . . . . . . . . . 42.4 tp -94.11 150.5 20.27 Favored 'General case' 0 C--N 1.298 -1.648 0 N-CA-C 107.817 -1.179 . . . . 0.0 107.817 177.81 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 182' ' ' ILE . . . . . 0.422 ' O ' HG22 ' A' ' 182' ' ' ILE . 5.3 mt -141.54 112.89 3.55 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.553 0 O-C-N 121.011 -1.055 . . . . 0.0 108.695 178.717 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 183' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -130.58 111.38 12.18 Favored 'General case' 0 C--N 1.291 -1.953 0 N-CA-C 107.078 -1.453 . . . . 0.0 107.078 178.95 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 184' ' ' CYS . . . . . . . . . . . . . 1.8 p -78.82 159.36 27.88 Favored 'General case' 0 C--N 1.29 -1.98 0 C-N-CA 118.843 -1.143 . . . . 0.0 111.46 -177.345 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 185' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -165.73 -154.88 0.21 Allowed 'General case' 0 N--CA 1.49 1.566 0 N-CA-C 109.102 -0.703 . . . . 0.0 109.102 -179.699 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 186' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER 50.61 52.14 15.47 Favored 'General case' 0 N--CA 1.493 1.695 0 O-C-N 121.124 -0.985 . . . . 0.0 109.12 -179.848 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 187' ' ' TYR . . . . . 0.618 ' CE2' ' O ' ' A' ' 188' ' ' ASN . 54.4 t80 -67.37 136.59 55.01 Favored 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.342 -0.849 . . . . 0.0 110.777 -179.144 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 188' ' ' ASN . . . . . 0.618 ' O ' ' CE2' ' A' ' 187' ' ' TYR . 0.7 OUTLIER -101.56 146.8 27.19 Favored 'General case' 0 C--N 1.298 -1.641 0 N-CA-C 107.777 -1.194 . . . . 0.0 107.777 178.314 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 189' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -113.53 -10.16 13.2 Favored 'General case' 0 C--N 1.297 -1.697 0 N-CA-C 108.496 -0.928 . . . . 0.0 108.496 -179.624 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 190' ' ' LYS . . . . . . . . . . . . . 13.1 mttp -84.03 -53.48 5.52 Favored 'General case' 0 N--CA 1.488 1.459 0 N-CA-C 108.649 -0.871 . . . . 0.0 108.649 178.705 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 191' ' ' THR . . . . . . . . . . . . . 1.1 p -91.26 -8.3 48.75 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.588 -0.695 . . . . 0.0 109.129 179.714 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 192' ' ' GLY . . . . . . . . . . . . . . . 62.58 40.98 99.82 Favored Glycine 0 N--CA 1.492 2.425 0 N-CA-C 110.433 -1.067 . . . . 0.0 110.433 179.219 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 193' ' ' VAL . . . . . 0.489 HG12 ' N ' ' A' ' 194' ' ' TRP . 67.2 t -145.96 157.95 12.1 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.625 0 O-C-N 121.044 -1.268 . . . . 0.0 109.801 179.56 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 194' ' ' TRP . . . . . 0.489 ' N ' HG12 ' A' ' 193' ' ' VAL . 23.0 m95 -83.83 120.79 26.48 Favored 'General case' 0 C--N 1.301 -1.543 0 N-CA-C 108.509 -0.923 . . . . 0.0 108.509 179.627 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 195' ' ' GLU . . . . . . . . . . . . . 2.1 mt-10 -89.73 -60.65 1.88 Allowed 'General case' 0 N--CA 1.495 1.816 0 C-N-CA 119.55 -0.86 . . . . 0.0 111.148 -178.194 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 196' ' ' LYS . . . . . . . . . . . . . 5.1 tttm -80.49 143.23 33.49 Favored 'General case' 0 C--N 1.3 -1.545 0 O-C-N 120.815 -1.178 . . . . 0.0 110.165 -178.901 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 197' ' ' ARG . . . . . 0.565 ' NH1' ' O ' ' C' ' 704' ' ' ALA . 13.5 tpp180 -120.05 138.33 53.59 Favored 'General case' 0 N--CA 1.491 1.617 0 N-CA-C 108.552 -0.907 . . . . 0.0 108.552 179.084 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 198' ' ' LYS . . . . . . . . . . . . . 22.7 mttt -116.97 118.6 32.87 Favored 'General case' 0 C--N 1.302 -1.489 0 O-C-N 121.903 -0.498 . . . . 0.0 109.966 -179.464 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 199' ' ' ILE . . . . . 0.5 HD13 HG23 ' A' ' 180' ' ' THR . 0.6 OUTLIER -139.16 120.32 15.7 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.58 0 CA-C-O 122.505 1.145 . . . . 0.0 109.339 179.532 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 200' ' ' PHE . . . . . 0.884 ' CD2' HD12 ' A' ' 158' ' ' ILE . 3.3 m-85 -99.43 136.71 38.97 Favored 'General case' 0 N--CA 1.496 1.852 0 O-C-N 121.124 -0.985 . . . . 0.0 109.799 -178.074 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 201' ' ' VAL . . . . . . . . . . . . . 97.7 t -101.58 137.16 30.25 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.555 0 N-CA-C 108.004 -1.11 . . . . 0.0 108.004 177.652 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 202' ' ' ALA . . . . . 0.417 ' HB1' ' HB3' ' A' ' 153' ' ' TYR . . . -121.56 134.91 55.03 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.376 -0.828 . . . . 0.0 108.821 179.831 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 203' ' ' THR . . . . . 0.748 HG23 ' OG1' ' A' ' 156' ' ' THR . 2.1 p -88.1 130.36 35.04 Favored 'General case' 0 C--N 1.306 -1.288 0 CA-C-O 122.198 0.999 . . . . 0.0 110.652 -178.782 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 204' ' ' GLU . . . . . 0.507 ' HA ' ' CD2' ' A' ' 153' ' ' TYR . 0.2 OUTLIER -50.9 134.62 25.46 Favored 'General case' 0 C--N 1.298 -1.67 0 C-N-CA 118.688 -1.205 . . . . 0.0 108.673 178.933 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 205' ' ' VAL . . . . . 0.646 HG23 ' O ' ' A' ' 203' ' ' THR . 54.6 t -129.7 164.29 32.74 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.376 0 CA-C-O 121.93 0.872 . . . . 0.0 110.228 -177.741 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 206' ' ' LYS . . . . . 0.57 ' N ' HG12 ' A' ' 205' ' ' VAL . 0.5 OUTLIER . . . . . 0 C--N 1.297 -1.706 0 CA-C-O 118.006 -0.997 . . . . 0.0 109.559 -179.804 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' C' C ' 702' ' ' LEU . . . . . 0.754 HD11 ' O ' ' A' ' 163' ' ' PRO . 0.3 OUTLIER . . . . . 0 N--CA 1.493 1.714 0 N-CA-C 109.441 -0.577 . . . . 0.0 109.441 . . . . . . . . . 2 2 . 1 . 006 nuclear build core ' C' C ' 703' ' ' PRO . . . . . 0.597 ' HG3' ' HB1' ' A' ' 104' ' ' ALA . 40.5 Cg_endo -70.96 -179.29 3.33 Favored 'Trans proline' 0 C--N 1.31 -1.496 0 C-N-CA 122.796 2.331 . . . . 0.0 112.97 -179.691 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' C' C ' 704' ' ' ALA . . . . . 0.565 ' O ' ' NH1' ' A' ' 197' ' ' ARG . . . . . . . . 0 N--CA 1.49 1.567 0 CA-C-O 121.561 0.696 . . . . 0.0 110.168 179.809 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 63' ' ' PRO . . . . . 0.453 ' O ' HD22 ' A' ' 110' ' ' LEU . 5.6 Cg_exo . . . . . 0 N--CA 1.489 1.218 0 CA-C-O 121.065 0.36 . . . . 0.0 111.283 . . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 64' ' ' GLN . . . . . 0.554 ' N ' ' CD ' ' A' ' 64' ' ' GLN . 0.0 OUTLIER -155.26 127.44 7.7 Favored 'General case' 0 N--CA 1.494 1.77 0 O-C-N 121.054 -1.029 . . . . 0.0 110.315 179.81 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 65' ' ' ILE . . . . . 0.564 ' H ' HD12 ' A' ' 65' ' ' ILE . 2.1 mp -45.76 105.94 0.51 Allowed Pre-proline 0 N--CA 1.491 1.598 0 N-CA-C 107.857 -1.164 . . . . 0.0 107.857 178.471 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 66' ' ' PRO . . . . . . . . . . . . . 60.2 Cg_endo -81.94 -162.71 0.19 Allowed 'Trans proline' 0 N--CA 1.49 1.272 0 C-N-CA 122.105 1.87 . . . . 0.0 112.639 -178.785 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 67' ' ' LYS . . . . . . . . . . . . . 53.8 tttt -90.46 -8.04 51.5 Favored 'General case' 0 N--CA 1.487 1.405 0 O-C-N 121.223 -0.923 . . . . 0.0 109.727 -179.722 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 68' ' ' ASP . . . . . 0.646 ' O ' ' N ' ' A' ' 70' ' ' SER . 0.2 OUTLIER -75.86 66.14 2.07 Favored 'General case' 0 N--CA 1.487 1.421 0 CA-C-O 123.003 1.383 . . . . 0.0 108.896 179.839 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 69' ' ' LYS . . . . . 0.468 ' C ' ' O ' ' A' ' 68' ' ' ASP . 0.8 OUTLIER -45.77 -14.71 0.02 OUTLIER 'General case' 0 N--CA 1.511 2.579 0 C-N-CA 117.129 -1.828 . . . . 0.0 107.368 178.06 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 70' ' ' SER . . . . . 0.646 ' N ' ' O ' ' A' ' 68' ' ' ASP . 0.1 OUTLIER -87.58 -5.0 58.95 Favored 'General case' 0 N--CA 1.498 1.93 0 CA-C-N 113.615 -1.63 . . . . 0.0 111.9 179.893 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 71' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -100.56 142.65 31.74 Favored 'General case' 0 N--CA 1.503 2.221 0 O-C-N 120.251 -1.531 . . . . 0.0 112.615 -178.991 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 72' ' ' VAL . . . . . 0.587 ' CG2' ' O ' ' A' ' 74' ' ' GLY . 0.7 OUTLIER -67.72 127.13 28.85 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.336 0 N-CA-C 105.196 -2.149 . . . . 0.0 105.196 174.786 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 73' ' ' ALA . . . . . 0.569 ' N ' ' O ' ' A' ' 87' ' ' VAL . . . -80.33 -12.4 59.6 Favored 'General case' 0 C--N 1.297 -1.712 0 O-C-N 120.195 -1.566 . . . . 0.0 109.126 -178.309 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 74' ' ' GLY . . . . . 0.587 ' O ' ' CG2' ' A' ' 72' ' ' VAL . . . 173.53 -161.12 31.72 Favored Glycine 0 N--CA 1.488 2.13 0 N-CA-C 109.614 -1.394 . . . . 0.0 109.614 -179.849 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 75' ' ' TYR . . . . . . . . . . . . . 76.1 m-85 -142.27 170.16 16.23 Favored 'General case' 0 C--N 1.296 -1.747 0 O-C-N 121.076 -1.249 . . . . 0.0 110.767 -178.136 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 76' ' ' ILE . . . . . 0.468 ' CG2' ' OE1' ' A' ' 85' ' ' GLU . 0.4 OUTLIER -148.97 144.26 18.38 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.57 0 C-N-CA 119.422 -0.911 . . . . 0.0 108.994 -177.464 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -152.04 160.35 43.47 Favored 'General case' 0 N--CA 1.492 1.648 0 O-C-N 120.893 -1.129 . . . . 0.0 109.504 -179.855 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 78' ' ' ILE . . . . . 0.495 ' CG1' HG22 ' A' ' 142' ' ' VAL . 3.0 mp -143.16 99.08 5.47 Favored Pre-proline 0 N--CA 1.493 1.695 0 N-CA-C 107.929 -1.137 . . . . 0.0 107.929 179.303 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 79' ' ' PRO . . . . . . . . . . . . . 47.4 Cg_exo -51.06 -44.62 41.29 Favored 'Trans proline' 0 N--CA 1.492 1.425 0 C-N-CA 122.557 2.171 . . . . 0.0 113.808 -178.81 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -65.62 -18.05 65.04 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 120.691 -1.256 . . . . 0.0 110.752 178.741 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 81' ' ' ALA . . . . . 0.804 ' HB2' ' HB2' ' A' ' 136' ' ' ALA . . . -106.41 -19.04 13.81 Favored 'General case' 0 N--CA 1.494 1.774 0 O-C-N 121.136 -0.978 . . . . 0.0 108.886 179.746 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 82' ' ' ASP . . . . . 0.426 ' CB ' ' O ' ' A' ' 81' ' ' ALA . 11.6 t0 70.44 49.02 0.44 Allowed 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.475 -0.765 . . . . 0.0 110.767 179.106 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 83' ' ' ILE . . . . . 0.546 HD11 ' HB3' ' A' ' 132' ' ' ASN . 36.2 mt -131.1 152.74 38.01 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.822 0 O-C-N 121.145 -0.972 . . . . 0.0 110.275 -179.047 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 84' ' ' LYS . . . . . . . . . . . . . 9.3 ptmm? -157.7 110.22 2.4 Favored 'General case' 0 N--CA 1.489 1.491 0 N-CA-C 108.244 -1.021 . . . . 0.0 108.244 179.471 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 85' ' ' GLU . . . . . 0.47 ' CD ' ' N ' ' A' ' 85' ' ' GLU . 0.4 OUTLIER -138.32 167.74 18.68 Favored Pre-proline 0 N--CA 1.498 1.949 0 O-C-N 121.113 -0.992 . . . . 0.0 109.805 -178.973 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 86' ' ' PRO . . . . . . . . . . . . . 97.3 Cg_endo -82.99 158.89 15.64 Favored 'Trans proline' 0 N--CA 1.494 1.54 0 C-N-CA 122.944 2.429 . . . . 0.0 113.568 -179.184 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 87' ' ' VAL . . . . . 0.569 ' O ' ' N ' ' A' ' 73' ' ' ALA . 78.6 t -112.04 106.36 20.61 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.698 0 N-CA-C 109.319 -0.622 . . . . 0.0 109.319 180.0 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 88' ' ' TYR . . . . . 0.404 ' CZ ' ' HB3' ' A' ' 99' ' ' ARG . 10.5 m-85 -97.45 153.94 38.18 Favored Pre-proline 0 N--CA 1.5 2.057 0 O-C-N 120.766 -1.209 . . . . 0.0 109.607 179.582 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 89' ' ' PRO . . . . . . . . . . . . . 11.4 Cg_endo -58.78 141.94 98.35 Favored 'Trans proline' 0 N--CA 1.497 1.705 0 C-N-CA 122.954 2.436 . . . . 0.0 113.424 -179.923 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . -59.17 169.19 6.23 Favored Glycine 0 N--CA 1.496 2.667 0 N-CA-C 109.259 -1.537 . . . . 0.0 109.259 179.209 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 91' ' ' PRO . . . . . 0.469 ' C ' ' H ' ' A' ' 93' ' ' THR . 94.3 Cg_endo -93.09 168.92 21.57 Favored 'Cis proline' 0 C--N 1.31 -1.489 0 C-N-CA 123.861 -1.308 . . . . 0.0 111.994 0.239 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 92' ' ' ALA . . . . . 0.645 ' O ' HD23 ' A' ' 97' ' ' LEU . . . -70.86 29.76 0.04 OUTLIER 'General case' 0 N--CA 1.492 1.662 0 O-C-N 121.166 -0.959 . . . . 0.0 110.6 -179.489 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 93' ' ' THR . . . . . 0.469 ' H ' ' C ' ' A' ' 91' ' ' PRO . 6.5 p -72.42 150.79 91.74 Favored Pre-proline 0 C--N 1.302 -1.485 0 O-C-N 120.688 -1.257 . . . . 0.0 108.4 179.836 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 94' ' ' PRO . . . . . 0.427 ' C ' ' O ' ' A' ' 93' ' ' THR . 70.2 Cg_exo -30.46 -57.15 0.19 Allowed 'Trans proline' 0 C--N 1.309 -1.506 0 C-N-CA 122.973 2.448 . . . . 0.0 112.743 -179.144 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 16.3 mt-10 -44.56 -49.31 10.16 Favored 'General case' 0 C--N 1.302 -1.466 0 O-C-N 121.175 -0.953 . . . . 0.0 109.863 -179.931 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 96' ' ' GLN . . . . . 0.566 ' O ' ' N ' ' A' ' 98' ' ' ASN . 1.4 mp0 -73.15 -54.15 9.19 Favored 'General case' 0 N--CA 1.488 1.47 0 O-C-N 121.081 -1.012 . . . . 0.0 109.912 179.782 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 97' ' ' LEU . . . . . 0.645 HD23 ' O ' ' A' ' 92' ' ' ALA . 0.7 OUTLIER -44.11 -14.42 0.02 OUTLIER 'General case' 0 N--CA 1.494 1.732 0 O-C-N 121.453 -0.779 . . . . 0.0 110.29 -179.216 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 98' ' ' ASN . . . . . 0.566 ' N ' ' O ' ' A' ' 96' ' ' GLN . 0.0 OUTLIER -71.53 -33.53 69.26 Favored 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.052 -1.03 . . . . 0.0 108.599 179.327 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 99' ' ' ARG . . . . . 0.539 ' NE ' ' OD1' ' A' ' 98' ' ' ASN . 16.4 mmt180 -79.64 -58.39 3.21 Favored 'General case' 0 C--N 1.303 -1.442 0 O-C-N 121.688 -0.633 . . . . 0.0 109.565 -179.725 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . 174.08 -156.17 23.03 Favored Glycine 0 N--CA 1.492 2.422 0 N-CA-C 109.989 -1.245 . . . . 0.0 109.989 179.967 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 101' ' ' VAL . . . . . 0.639 HG23 ' O ' ' A' ' 101' ' ' VAL . 27.3 m -59.44 103.18 0.14 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.674 0 O-C-N 121.256 -1.144 . . . . 0.0 109.754 -179.908 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -91.63 166.19 12.94 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.032 -1.043 . . . . 0.0 109.953 -179.992 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 103' ' ' PHE . . . . . 0.597 ' O ' ' N ' ' A' ' 105' ' ' GLU . 26.0 m-85 -70.22 120.86 16.54 Favored 'General case' 0 N--CA 1.486 1.352 0 N-CA-C 107.969 -1.123 . . . . 0.0 107.969 178.639 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 104' ' ' ALA . . . . . 0.576 ' HB1' ' HG3' ' C' ' 703' ' ' PRO . . . -42.94 -14.54 0.01 OUTLIER 'General case' 0 C--N 1.3 -1.546 0 O-C-N 121.488 -0.757 . . . . 0.0 110.696 -178.729 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 105' ' ' GLU . . . . . 0.597 ' N ' ' O ' ' A' ' 103' ' ' PHE . 0.1 OUTLIER -138.85 146.61 41.44 Favored 'General case' 0 N--CA 1.496 1.86 0 O-C-N 120.828 -1.17 . . . . 0.0 110.762 -179.797 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 106' ' ' GLU . . . . . 0.412 ' HG2' ' H ' ' A' ' 107' ' ' ASN . 0.0 OUTLIER -59.59 -61.72 2.41 Favored 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.929 -0.482 . . . . 0.0 111.523 -179.178 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 107' ' ' ASN . . . . . 0.412 ' H ' ' HG2' ' A' ' 106' ' ' GLU . 91.8 m-20 -77.65 34.35 0.18 Allowed 'General case' 0 N--CA 1.493 1.707 0 O-C-N 120.428 -1.42 . . . . 0.0 112.862 -175.553 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 108' ' ' GLU . . . . . . . . . . . . . 14.6 tp10 -57.43 146.73 28.49 Favored 'General case' 0 C--N 1.301 -1.508 0 O-C-N 120.698 -1.252 . . . . 0.0 107.937 179.622 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 109' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -102.26 146.72 27.6 Favored 'General case' 0 N--CA 1.488 1.453 0 O-C-N 121.124 -0.985 . . . . 0.0 111.133 -178.198 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 110' ' ' LEU . . . . . 0.453 HD22 ' O ' ' A' ' 63' ' ' PRO . 3.0 tp -62.81 -18.87 63.43 Favored 'General case' 0 C--N 1.303 -1.421 0 N-CA-C 108.028 -1.101 . . . . 0.0 108.028 178.783 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 111' ' ' ASP . . . . . 0.439 ' OD1' ' C ' ' A' ' 110' ' ' LEU . 4.0 m-20 -132.69 42.45 3.08 Favored 'General case' 0 N--CA 1.487 1.383 0 O-C-N 121.637 -0.664 . . . . 0.0 109.84 -179.849 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 112' ' ' ASP . . . . . . . . . . . . . 4.5 t0 -68.15 157.45 35.32 Favored 'General case' 0 N--CA 1.492 1.668 0 O-C-N 120.858 -1.151 . . . . 0.0 111.386 -179.725 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 113' ' ' GLN . . . . . 0.543 ' N ' ' CD ' ' A' ' 113' ' ' GLN . 0.0 OUTLIER -66.58 -16.07 63.9 Favored 'General case' 0 N--CA 1.494 1.742 0 N-CA-C 108.229 -1.026 . . . . 0.0 108.229 177.934 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 114' ' ' ASN . . . . . 0.614 ' ND2' ' O ' ' A' ' 170' ' ' ASP . 34.6 t-20 -153.0 113.81 4.11 Favored 'General case' 0 C--N 1.295 -1.781 0 N-CA-C 107.58 -1.266 . . . . 0.0 107.58 177.141 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 115' ' ' ILE . . . . . 0.555 HG22 ' O ' ' A' ' 115' ' ' ILE . 3.8 mt -91.41 98.95 8.96 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.69 0 N-CA-C 107.232 -1.396 . . . . 0.0 107.232 179.588 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 116' ' ' SER . . . . . 0.43 ' OG ' ' HB3' ' A' ' 104' ' ' ALA . 87.6 p -86.44 149.03 25.28 Favored 'General case' 0 N--CA 1.488 1.437 0 CA-C-O 121.864 0.84 . . . . 0.0 111.22 -177.528 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 117' ' ' ILE . . . . . . . . . . . . . 1.7 mt -149.71 149.54 14.56 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.483 0 N-CA-C 107.813 -1.18 . . . . 0.0 107.813 179.112 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 118' ' ' ALA . . . . . . . . . . . . . . . -136.26 159.35 42.02 Favored 'General case' 0 N--CA 1.493 1.686 0 C-N-CA 119.277 -0.969 . . . . 0.0 110.903 -179.018 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 119' ' ' GLY . . . . . 0.516 ' HA2' HD11 ' A' ' 97' ' ' LEU . . . -172.01 146.76 9.54 Favored Glycine 0 N--CA 1.489 2.179 0 N-CA-C 110.482 -1.047 . . . . 0.0 110.482 179.94 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 120' ' ' HIS . . . . . . . . . . . . . 27.7 m170 -71.89 168.0 18.85 Favored 'General case' 0 N--CA 1.494 1.758 0 O-C-N 121.531 -0.981 . . . . 0.0 110.157 179.291 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 121' ' ' THR . . . . . 0.457 ' OG1' ' NZ ' ' A' ' 134' ' ' LYS . 0.7 OUTLIER -118.5 160.06 22.41 Favored 'General case' 0 N--CA 1.498 1.958 0 N-CA-C 108.357 -0.979 . . . . 0.0 108.357 178.818 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 122' ' ' PHE . . . . . . . . . . . . . 2.7 m-85 -143.59 123.35 13.39 Favored 'General case' 0 N--CA 1.498 1.951 0 O-C-N 120.838 -1.164 . . . . 0.0 109.812 -179.766 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 123' ' ' ILE . . . . . 0.563 HG23 ' N ' ' A' ' 124' ' ' ASP . 14.3 tt -59.18 -40.24 80.59 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.478 0 CA-C-O 121.545 0.688 . . . . 0.0 109.516 179.89 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 124' ' ' ASP . . . . . 0.563 ' N ' HG23 ' A' ' 123' ' ' ILE . 1.7 m-20 -88.92 22.62 2.64 Favored 'General case' 0 N--CA 1.497 1.912 0 O-C-N 121.492 -0.755 . . . . 0.0 111.942 -177.42 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 125' ' ' ARG . . . . . . . . . . . . . 37.9 mtp180 -154.47 99.75 2.45 Favored Pre-proline 0 N--CA 1.493 1.703 0 O-C-N 120.366 -1.459 . . . . 0.0 110.112 -179.862 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 126' ' ' PRO . . . . . . . . . . . . . 56.1 Cg_endo -80.02 -27.94 3.47 Favored 'Trans proline' 0 C--N 1.313 -1.328 0 C-N-CA 121.98 1.787 . . . . 0.0 111.635 179.266 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 127' ' ' ASN . . . . . . . . . . . . . 2.9 m120 -89.09 11.77 17.54 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.047 -1.033 . . . . 0.0 109.227 179.64 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 128' ' ' TYR . . . . . . . . . . . . . 5.1 t80 -65.58 -149.47 0.01 OUTLIER 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.388 -0.82 . . . . 0.0 109.425 179.908 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 129' ' ' GLN . . . . . 0.433 HE22 ' CD1' ' A' ' 97' ' ' LEU . 69.5 mt-30 -68.05 -70.95 0.23 Allowed 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.315 -0.866 . . . . 0.0 109.857 -179.787 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 130' ' ' PHE . . . . . 0.701 ' CE1' HD11 ' A' ' 181' ' ' LEU . 47.6 m-85 -134.88 52.62 2.03 Favored 'General case' 0 N--CA 1.493 1.71 0 O-C-N 121.104 -0.998 . . . . 0.0 110.303 -179.857 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 131' ' ' THR . . . . . . . . . . . . . 23.1 m -87.33 -39.69 15.12 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 120.903 -1.123 . . . . 0.0 109.396 179.681 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 132' ' ' ASN . . . . . 0.585 ' ND2' ' O ' ' A' ' 81' ' ' ALA . 1.8 t30 -82.86 6.32 18.79 Favored 'General case' 0 N--CA 1.498 1.938 0 O-C-N 121.505 -0.747 . . . . 0.0 111.701 -178.306 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 133' ' ' LEU . . . . . 0.503 ' O ' ' N ' ' A' ' 135' ' ' ALA . 0.2 OUTLIER -71.17 -45.54 63.28 Favored 'General case' 0 C--N 1.299 -1.616 0 O-C-N 120.739 -1.226 . . . . 0.0 109.999 -179.368 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 134' ' ' LYS . . . . . 0.652 ' H ' ' CD ' ' A' ' 134' ' ' LYS . 0.0 OUTLIER -46.12 -16.96 0.03 OUTLIER 'General case' 0 N--CA 1.494 1.749 0 O-C-N 120.988 -1.07 . . . . 0.0 109.727 -179.802 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 135' ' ' ALA . . . . . 0.503 ' N ' ' O ' ' A' ' 133' ' ' LEU . . . -84.08 -37.53 21.93 Favored 'General case' 0 N--CA 1.487 1.403 0 O-C-N 121.111 -0.993 . . . . 0.0 109.077 179.471 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 136' ' ' ALA . . . . . 0.804 ' HB2' ' HB2' ' A' ' 81' ' ' ALA . . . -79.76 157.96 26.99 Favored 'General case' 0 C--N 1.303 -1.454 0 CA-C-O 121.976 0.894 . . . . 0.0 110.984 -179.132 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 137' ' ' LYS . . . . . 0.542 ' O ' ' O ' ' A' ' 138' ' ' LYS . 2.4 mttm -150.84 -163.52 1.79 Allowed 'General case' 0 C--N 1.299 -1.628 0 C-N-CA 118.106 -1.438 . . . . 0.0 110.965 -177.902 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 138' ' ' LYS . . . . . 0.585 ' O ' ' N ' ' A' ' 140' ' ' SER . 28.8 mttp -41.18 174.17 0.0 OUTLIER 'General case' 0 C--N 1.301 -1.523 0 CA-C-O 122.589 1.185 . . . . 0.0 111.171 -178.557 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 139' ' ' GLY . . . . . . . . . . . . . . . 47.13 8.25 0.03 OUTLIER Glycine 0 N--CA 1.488 2.148 0 N-CA-C 110.162 -1.175 . . . . 0.0 110.162 -179.971 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 140' ' ' SER . . . . . 0.585 ' N ' ' O ' ' A' ' 138' ' ' LYS . 5.2 m -75.87 112.98 12.83 Favored 'General case' 0 N--CA 1.493 1.723 0 O-C-N 120.867 -1.372 . . . . 0.0 108.982 179.385 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 141' ' ' MET . . . . . 0.659 ' SD ' ' N ' ' A' ' 142' ' ' VAL . 3.0 tpp -68.26 128.02 35.06 Favored 'General case' 0 C--N 1.301 -1.503 0 O-C-N 121.036 -1.04 . . . . 0.0 109.178 179.854 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 142' ' ' VAL . . . . . 0.659 ' N ' ' SD ' ' A' ' 141' ' ' MET . 1.6 t -113.87 133.29 60.33 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.522 0 N-CA-C 108.456 -0.942 . . . . 0.0 108.456 -179.736 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 143' ' ' TYR . . . . . . . . . . . . . 13.4 m-85 -112.31 135.83 52.51 Favored 'General case' 0 N--CA 1.495 1.798 0 O-C-N 120.869 -1.145 . . . . 0.0 110.703 -178.899 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 144' ' ' PHE . . . . . 0.561 ' CZ ' ' CG1' ' A' ' 146' ' ' VAL . 4.2 t80 -120.96 105.88 11.08 Favored 'General case' 0 N--CA 1.493 1.707 0 C-N-CA 120.143 -0.623 . . . . 0.0 109.985 -179.467 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 145' ' ' LYS . . . . . . . . . . . . . 13.9 mtpp -102.3 122.76 44.86 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.23 -0.919 . . . . 0.0 109.819 -179.863 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 146' ' ' VAL . . . . . 0.561 ' CG1' ' CZ ' ' A' ' 144' ' ' PHE . 0.9 OUTLIER -142.65 125.4 13.74 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.629 0 N-CA-C 108.335 -0.987 . . . . 0.0 108.335 178.874 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 147' ' ' GLY . . . . . . . . . . . . . . . 60.47 -125.6 39.0 Favored Glycine 0 N--CA 1.489 2.225 0 N-CA-C 109.054 -1.618 . . . . 0.0 109.054 -179.426 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 148' ' ' ASN . . . . . 0.445 ' O ' ' CG ' ' A' ' 148' ' ' ASN . 0.1 OUTLIER -104.77 5.97 33.68 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.245 -1.15 . . . . 0.0 108.979 179.623 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 149' ' ' GLU . . . . . . . . . . . . . 1.3 tt0 -105.82 141.65 36.89 Favored 'General case' 0 N--CA 1.488 1.461 0 O-C-N 121.295 -0.878 . . . . 0.0 111.797 -178.32 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 150' ' ' THR . . . . . . . . . . . . . 3.5 m -131.93 98.47 4.46 Favored 'General case' 0 N--CA 1.493 1.709 0 CA-C-O 121.482 0.658 . . . . 0.0 109.271 -179.862 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 151' ' ' ARG . . . . . 0.427 HH12 ' HA ' ' A' ' 111' ' ' ASP . 92.6 mtt180 -85.7 -169.36 2.61 Favored 'General case' 0 N--CA 1.488 1.425 0 O-C-N 121.255 -0.903 . . . . 0.0 108.894 -179.711 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 152' ' ' LYS . . . . . 0.476 ' O ' ' N ' ' A' ' 205' ' ' VAL . 1.9 mtmp? -152.02 149.87 29.35 Favored 'General case' 0 C--N 1.301 -1.537 0 O-C-N 121.261 -0.899 . . . . 0.0 109.982 -179.309 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 153' ' ' TYR . . . . . 0.499 ' CD2' ' HA ' ' A' ' 204' ' ' GLU . 5.7 m-85 -143.86 168.51 19.78 Favored 'General case' 0 C--N 1.303 -1.417 0 N-CA-C 107.939 -1.134 . . . . 0.0 107.939 178.494 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 154' ' ' LYS . . . . . . . . . . . . . 1.4 ttpt -143.36 119.82 10.99 Favored 'General case' 0 C--N 1.295 -1.772 0 N-CA-C 108.403 -0.962 . . . . 0.0 108.403 178.689 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 155' ' ' MET . . . . . . . . . . . . . 46.5 mtp -46.3 107.68 0.11 Allowed 'General case' 0 N--CA 1.495 1.784 0 O-C-N 120.637 -1.289 . . . . 0.0 111.564 -178.602 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 156' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -106.4 -25.44 11.89 Favored 'General case' 0 C--N 1.294 -1.844 0 CA-C-N 115.249 -0.887 . . . . 0.0 110.633 -178.739 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 157' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -153.94 153.72 32.52 Favored 'General case' 0 N--CA 1.495 1.813 0 C-N-CA 118.559 -1.256 . . . . 0.0 111.431 -178.512 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 158' ' ' ILE . . . . . 0.633 HD12 ' CD1' ' A' ' 200' ' ' PHE . 0.2 OUTLIER -153.79 146.83 14.15 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.372 0 CA-C-O 122.067 0.937 . . . . 0.0 110.91 -179.76 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 159' ' ' ARG . . . . . . . . . . . . . 12.9 ttm180 -153.66 153.44 32.3 Favored 'General case' 0 C--N 1.296 -1.718 0 CA-C-O 121.642 0.734 . . . . 0.0 109.681 -179.894 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 160' ' ' ASP . . . . . 0.773 ' O ' HG13 ' A' ' 161' ' ' VAL . 0.3 OUTLIER -116.18 160.55 20.23 Favored 'General case' 0 C--N 1.301 -1.513 0 N-CA-C 107.895 -1.15 . . . . 0.0 107.895 179.428 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 161' ' ' VAL . . . . . 0.773 HG13 ' O ' ' A' ' 160' ' ' ASP . 1.6 m -165.35 159.34 1.14 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.7 0 O-C-N 120.881 -1.137 . . . . 0.0 110.54 -179.271 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 162' ' ' LYS . . . . . 0.497 ' O ' ' O ' ' A' ' 161' ' ' VAL . 0.0 OUTLIER -43.96 171.5 0.04 OUTLIER Pre-proline 0 N--CA 1.49 1.538 0 O-C-N 121.789 -0.569 . . . . 0.0 109.558 179.568 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 163' ' ' PRO . . . . . 0.503 ' C ' HD11 ' C' ' 702' ' ' LEU . 74.0 Cg_endo -81.47 37.32 0.67 Allowed 'Trans proline' 0 C--N 1.311 -1.431 0 C-N-CA 122.557 2.171 . . . . 0.0 112.107 179.891 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 164' ' ' THR . . . . . 0.607 ' N ' HD11 ' C' ' 702' ' ' LEU . 86.7 m -152.12 -5.65 0.23 Allowed 'General case' 0 N--CA 1.494 1.76 0 O-C-N 121.216 -0.927 . . . . 0.0 110.736 -179.446 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 165' ' ' ASP . . . . . . . . . . . . . 31.0 t70 -72.86 62.72 0.61 Allowed 'General case' 0 N--CA 1.496 1.834 0 O-C-N 120.796 -1.19 . . . . 0.0 110.169 -179.435 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 166' ' ' VAL . . . . . 0.608 ' O ' ' N ' ' A' ' 168' ' ' VAL . 2.8 t -45.68 -34.01 1.58 Allowed 'Isoleucine or valine' 0 N--CA 1.494 1.763 0 O-C-N 121.099 -1.001 . . . . 0.0 110.247 -178.534 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 167' ' ' GLY . . . . . 0.402 ' C ' ' O ' ' A' ' 166' ' ' VAL . . . -43.46 -12.81 0.01 OUTLIER Glycine 0 N--CA 1.496 2.672 0 O-C-N 120.785 -1.197 . . . . 0.0 110.994 -179.495 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 168' ' ' VAL . . . . . 0.608 ' N ' ' O ' ' A' ' 166' ' ' VAL . 5.3 m -53.97 -30.94 20.36 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.51 0 O-C-N 120.588 -1.537 . . . . 0.0 109.005 179.802 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 169' ' ' LEU . . . . . 0.545 ' O ' ' ND2' ' A' ' 114' ' ' ASN . 13.1 mt -49.04 -11.51 0.04 OUTLIER 'General case' 0 N--CA 1.489 1.519 0 N-CA-C 107.974 -1.121 . . . . 0.0 107.974 -178.535 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 170' ' ' ASP . . . . . 0.614 ' O ' ' ND2' ' A' ' 114' ' ' ASN . 2.2 m-20 19.88 77.21 0.01 OUTLIER 'General case' 0 N--CA 1.5 2.03 0 N-CA-C 112.21 0.448 . . . . 0.0 112.21 177.517 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 171' ' ' GLU . . . . . 0.572 ' N ' ' OE1' ' A' ' 172' ' ' GLN . 9.9 pt-20 -116.51 66.44 0.71 Allowed 'General case' 0 N--CA 1.498 1.957 0 O-C-N 120.922 -1.111 . . . . 0.0 109.499 179.495 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 172' ' ' GLN . . . . . 0.572 ' OE1' ' N ' ' A' ' 171' ' ' GLU . 2.5 mp0 -121.35 -57.28 1.85 Allowed 'General case' 0 N--CA 1.496 1.846 0 O-C-N 121.532 -0.73 . . . . 0.0 110.7 -178.697 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 173' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -58.92 127.0 30.0 Favored 'General case' 0 N--CA 1.494 1.739 0 O-C-N 121.017 -1.052 . . . . 0.0 109.301 -179.687 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 174' ' ' GLY . . . . . 0.498 ' O ' ' C ' ' A' ' 175' ' ' LYS . . . -118.55 -43.0 0.56 Allowed Glycine 0 N--CA 1.482 1.742 0 N-CA-C 108.625 -1.79 . . . . 0.0 108.625 179.835 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 175' ' ' LYS . . . . . 0.498 ' C ' ' O ' ' A' ' 174' ' ' GLY . 0.0 OUTLIER -40.42 -60.03 1.19 Allowed 'General case' 0 N--CA 1.494 1.742 0 N-CA-C 107.324 -1.361 . . . . 0.0 107.324 179.538 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 176' ' ' ASP . . . . . 0.601 ' O ' ' O ' ' A' ' 177' ' ' LYS . 11.4 m-20 -103.72 90.31 3.61 Favored 'General case' 0 C--N 1.292 -1.912 0 N-CA-C 106.792 -1.558 . . . . 0.0 106.792 176.896 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 177' ' ' LYS . . . . . 0.601 ' O ' ' O ' ' A' ' 176' ' ' ASP . 8.3 mtmt -45.28 -176.31 0.0 OUTLIER 'General case' 0 N--CA 1.492 1.641 0 N-CA-C 109.009 -0.737 . . . . 0.0 109.009 -179.161 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 178' ' ' GLN . . . . . . . . . . . . . 4.1 pt20 -161.77 175.84 11.53 Favored 'General case' 0 C--N 1.3 -1.557 0 O-C-N 120.37 -1.456 . . . . 0.0 110.511 179.322 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 179' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -132.51 98.96 4.5 Favored 'General case' 0 C--N 1.301 -1.503 0 N-CA-C 107.604 -1.258 . . . . 0.0 107.604 178.228 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 180' ' ' THR . . . . . 0.571 ' CB ' HD21 ' A' ' 114' ' ' ASN . 1.3 m -77.26 117.42 18.76 Favored 'General case' 0 N--CA 1.489 1.486 0 O-C-N 121.217 -0.927 . . . . 0.0 110.127 -178.628 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 181' ' ' LEU . . . . . 0.763 HD22 ' CE2' ' A' ' 200' ' ' PHE . 9.4 tt -92.76 147.05 23.18 Favored 'General case' 0 C--N 1.302 -1.463 0 N-CA-C 107.851 -1.166 . . . . 0.0 107.851 177.826 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 182' ' ' ILE . . . . . 0.614 ' N ' HD23 ' A' ' 181' ' ' LEU . 6.4 mt -138.39 109.05 5.0 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.643 0 N-CA-C 108.262 -1.014 . . . . 0.0 108.262 179.088 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 183' ' ' THR . . . . . 0.541 ' O ' HG23 ' A' ' 183' ' ' THR . 7.1 t -132.1 115.65 16.02 Favored 'General case' 0 C--N 1.29 -2.007 0 N-CA-C 107.921 -1.14 . . . . 0.0 107.921 179.509 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 184' ' ' CYS . . . . . . . . . . . . . 1.1 p -78.54 160.46 27.62 Favored 'General case' 0 C--N 1.288 -2.076 0 C-N-CA 119.441 -0.904 . . . . 0.0 110.996 -178.021 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 185' ' ' ASP . . . . . 0.53 ' CG ' ' N ' ' A' ' 186' ' ' ASP . 0.1 OUTLIER -166.93 -163.58 0.56 Allowed 'General case' 0 N--CA 1.49 1.53 0 N-CA-C 109.109 -0.7 . . . . 0.0 109.109 179.816 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 186' ' ' ASP . . . . . 0.53 ' N ' ' CG ' ' A' ' 185' ' ' ASP . 0.6 OUTLIER 55.95 54.3 8.2 Favored 'General case' 0 N--CA 1.496 1.828 0 O-C-N 121.126 -0.984 . . . . 0.0 109.476 -179.965 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 187' ' ' TYR . . . . . 0.596 ' CE1' ' O ' ' A' ' 188' ' ' ASN . 43.0 t80 -67.54 130.73 43.95 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.166 -0.959 . . . . 0.0 110.126 -179.829 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 188' ' ' ASN . . . . . 0.989 HD22 ' N ' ' A' ' 191' ' ' THR . 0.1 OUTLIER -99.94 150.54 22.3 Favored 'General case' 0 C--N 1.292 -1.907 0 N-CA-C 107.318 -1.364 . . . . 0.0 107.318 177.825 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 189' ' ' GLU . . . . . 0.706 ' H ' ' CD ' ' A' ' 189' ' ' GLU . 0.0 OUTLIER -112.18 -8.09 14.01 Favored 'General case' 0 C--N 1.289 -2.034 0 N-CA-C 107.968 -1.123 . . . . 0.0 107.968 -179.476 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 190' ' ' LYS . . . . . 0.877 ' H ' ' ND2' ' A' ' 188' ' ' ASN . 2.7 mtpm? -82.89 -56.91 3.54 Favored 'General case' 0 C--N 1.299 -1.618 0 C-N-CA 119.894 -0.722 . . . . 0.0 109.381 179.51 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 191' ' ' THR . . . . . 0.989 ' N ' HD22 ' A' ' 188' ' ' ASN . 4.7 p -88.44 6.5 37.29 Favored 'General case' 0 N--CA 1.493 1.682 0 O-C-N 121.399 -0.813 . . . . 0.0 110.04 -179.675 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 192' ' ' GLY . . . . . . . . . . . . . . . 53.92 35.82 54.38 Favored Glycine 0 N--CA 1.495 2.568 0 N-CA-C 110.664 -0.974 . . . . 0.0 110.664 179.129 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 193' ' ' VAL . . . . . 0.582 HG12 ' N ' ' A' ' 194' ' ' TRP . 58.8 t -149.5 163.58 4.08 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.588 0 O-C-N 120.95 -1.324 . . . . 0.0 109.962 179.708 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 194' ' ' TRP . . . . . 0.582 ' N ' HG12 ' A' ' 193' ' ' VAL . 16.1 m95 -84.97 121.17 27.38 Favored 'General case' 0 N--CA 1.49 1.534 0 N-CA-C 108.085 -1.08 . . . . 0.0 108.085 179.137 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 195' ' ' GLU . . . . . . . . . . . . . 2.6 mt-10 -79.69 -61.23 2.06 Favored 'General case' 0 N--CA 1.497 1.878 0 O-C-N 121.295 -0.878 . . . . 0.0 111.767 -177.667 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 196' ' ' LYS . . . . . . . . . . . . . 8.5 mmtm -93.29 145.38 24.49 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 120.777 -1.202 . . . . 0.0 110.296 -178.608 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 197' ' ' ARG . . . . . 0.599 ' CG ' HH11 ' A' ' 197' ' ' ARG . 0.0 OUTLIER -119.61 146.85 45.16 Favored 'General case' 0 N--CA 1.492 1.625 0 N-CA-C 108.711 -0.848 . . . . 0.0 108.711 179.806 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 198' ' ' LYS . . . . . 0.505 ' HZ1' ' CG ' ' A' ' 185' ' ' ASP . 0.5 OUTLIER -116.81 121.07 40.47 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.582 -0.699 . . . . 0.0 111.197 -178.212 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 199' ' ' ILE . . . . . 0.49 ' C ' HD12 ' A' ' 199' ' ' ILE . 0.8 OUTLIER -139.52 118.21 12.27 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.573 0 CA-C-O 122.515 1.15 . . . . 0.0 109.56 178.796 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 200' ' ' PHE . . . . . 0.763 ' CE2' HD22 ' A' ' 181' ' ' LEU . 0.3 OUTLIER -103.6 140.78 37.09 Favored 'General case' 0 N--CA 1.497 1.88 0 O-C-N 121.127 -0.983 . . . . 0.0 110.455 -178.074 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 201' ' ' VAL . . . . . . . . . . . . . 96.1 t -103.47 146.83 10.6 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.482 0 N-CA-C 108.255 -1.017 . . . . 0.0 108.255 177.352 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 202' ' ' ALA . . . . . . . . . . . . . . . -131.89 138.74 48.53 Favored 'General case' 0 C--N 1.3 -1.579 0 N-CA-C 108.34 -0.985 . . . . 0.0 108.34 -179.88 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 203' ' ' THR . . . . . 0.533 ' O ' HG23 ' A' ' 205' ' ' VAL . 3.2 p -89.1 130.77 35.49 Favored 'General case' 0 C--N 1.306 -1.315 0 CA-C-O 122.267 1.032 . . . . 0.0 111.213 -178.141 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 204' ' ' GLU . . . . . 0.499 ' HA ' ' CD2' ' A' ' 153' ' ' TYR . 0.2 OUTLIER -51.01 134.48 26.15 Favored 'General case' 0 C--N 1.297 -1.691 0 C-N-CA 119.076 -1.05 . . . . 0.0 109.043 179.346 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 205' ' ' VAL . . . . . 0.556 HG12 ' N ' ' A' ' 206' ' ' LYS . 53.3 t -125.03 164.06 24.55 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.369 0 CA-C-O 121.941 0.877 . . . . 0.0 110.433 -177.79 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 206' ' ' LYS . . . . . 0.556 ' N ' HG12 ' A' ' 205' ' ' VAL . 0.1 OUTLIER . . . . . 0 C--N 1.297 -1.693 0 CA-C-O 117.976 -1.011 . . . . 0.0 109.651 179.91 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' C' C ' 702' ' ' LEU . . . . . 0.607 HD11 ' N ' ' A' ' 164' ' ' THR . 0.0 OUTLIER . . . . . 0 N--CA 1.492 1.656 0 N-CA-C 108.941 -0.763 . . . . 0.0 108.941 . . . . . . . . . 2 2 . 1 . 007 nuclear build core ' C' C ' 703' ' ' PRO . . . . . 0.576 ' HG3' ' HB1' ' A' ' 104' ' ' ALA . 11.9 Cg_endo -61.7 -174.81 0.14 Allowed 'Trans proline' 0 N--CA 1.494 1.549 0 C-N-CA 122.609 2.206 . . . . 0.0 112.861 -179.083 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' C' C ' 704' ' ' ALA . . . . . 0.561 ' C ' ' NH2' ' A' ' 197' ' ' ARG . . . . . . . . 0 N--CA 1.49 1.539 0 O-C-N 121.395 -0.816 . . . . 0.0 109.364 -179.662 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 63' ' ' PRO . . . . . . . . . . . . . 72.9 Cg_endo . . . . . 0 C--O 1.215 -0.633 0 N-CA-C 110.684 -0.544 . . . . 0.0 110.684 . . . . . . . . . 0 0 . 1 . 008 nuclear build core ' A' A ' 64' ' ' GLN . . . . . 0.451 ' O ' ' OE1' ' A' ' 64' ' ' GLN . 0.0 OUTLIER -159.83 137.72 10.03 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 120.97 -1.081 . . . . 0.0 109.841 179.115 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 65' ' ' ILE . . . . . 0.46 HG23 ' HB3' ' A' ' 89' ' ' PRO . 3.2 mp -47.95 108.0 0.83 Allowed Pre-proline 0 N--CA 1.489 1.488 0 O-C-N 121.172 -0.955 . . . . 0.0 108.701 179.136 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 66' ' ' PRO . . . . . 0.4 ' HG3' ' NZ ' ' A' ' 71' ' ' LYS . 61.4 Cg_endo -81.52 -158.74 0.1 OUTLIER 'Trans proline' 0 C--N 1.314 -1.246 0 C-N-CA 122.026 1.818 . . . . 0.0 112.445 -179.432 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 67' ' ' LYS . . . . . . . . . . . . . 3.4 pttm -90.18 -13.24 35.99 Favored 'General case' 0 N--CA 1.488 1.457 0 O-C-N 121.323 -0.861 . . . . 0.0 109.366 -179.975 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 68' ' ' ASP . . . . . 0.653 ' C ' ' N ' ' A' ' 70' ' ' SER . 0.5 OUTLIER -76.76 64.27 2.31 Favored 'General case' 0 N--CA 1.488 1.456 0 CA-C-O 122.656 1.217 . . . . 0.0 109.548 -179.885 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 69' ' ' LYS . . . . . 0.457 ' C ' ' O ' ' A' ' 68' ' ' ASP . 12.1 ptpt -47.48 -13.01 0.03 OUTLIER 'General case' 0 N--CA 1.512 2.655 0 C-N-CA 117.039 -1.864 . . . . 0.0 106.66 177.03 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 70' ' ' SER . . . . . 0.653 ' N ' ' C ' ' A' ' 68' ' ' ASP . 1.3 p -85.22 -7.06 59.21 Favored 'General case' 0 N--CA 1.497 1.883 0 CA-C-N 113.259 -1.791 . . . . 0.0 111.151 179.337 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 71' ' ' LYS . . . . . 0.519 ' N ' ' O ' ' A' ' 68' ' ' ASP . 0.0 OUTLIER -98.76 145.66 26.7 Favored 'General case' 0 N--CA 1.501 2.107 0 O-C-N 120.671 -1.268 . . . . 0.0 112.329 -179.141 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 72' ' ' VAL . . . . . 0.716 HG12 ' CE1' ' A' ' 88' ' ' TYR . 3.0 m -68.02 130.06 32.97 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.384 0 N-CA-C 105.227 -2.138 . . . . 0.0 105.227 175.235 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 73' ' ' ALA . . . . . 0.57 ' N ' ' O ' ' A' ' 87' ' ' VAL . . . -78.92 -15.17 58.67 Favored 'General case' 0 C--N 1.293 -1.858 0 O-C-N 120.16 -1.588 . . . . 0.0 107.623 -179.404 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 74' ' ' GLY . . . . . 0.418 ' O ' ' N ' ' A' ' 87' ' ' VAL . . . 176.04 -159.74 27.3 Favored Glycine 0 N--CA 1.48 1.592 0 N-CA-C 109.712 -1.355 . . . . 0.0 109.712 179.73 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 75' ' ' TYR . . . . . 0.624 ' HA ' HG23 ' A' ' 87' ' ' VAL . 0.6 OUTLIER -142.97 166.86 23.49 Favored 'General case' 0 C--N 1.295 -1.772 0 O-C-N 121.713 -0.875 . . . . 0.0 110.834 -177.221 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 76' ' ' ILE . . . . . . . . . . . . . 1.5 tt -149.86 146.98 16.58 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.517 0 C-N-CA 119.2 -1.0 . . . . 0.0 109.833 -178.528 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -150.96 164.78 35.55 Favored 'General case' 0 N--CA 1.489 1.495 0 N-CA-C 108.689 -0.856 . . . . 0.0 108.689 179.594 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 78' ' ' ILE . . . . . 0.607 ' HB ' ' HB3' ' A' ' 81' ' ' ALA . 14.9 mt -146.89 95.87 4.42 Favored Pre-proline 0 C--N 1.3 -1.562 0 N-CA-C 108.392 -0.966 . . . . 0.0 108.392 179.997 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 79' ' ' PRO . . . . . . . . . . . . . 73.5 Cg_exo -46.93 -46.45 18.59 Favored 'Trans proline' 0 N--CA 1.493 1.447 0 C-N-CA 122.865 2.377 . . . . 0.0 113.897 -178.503 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 4.0 t0 -65.38 -20.04 66.21 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 120.749 -1.219 . . . . 0.0 110.423 178.622 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 81' ' ' ALA . . . . . 0.817 ' HB2' ' HB2' ' A' ' 136' ' ' ALA . . . -104.35 -12.58 16.51 Favored 'General case' 0 N--CA 1.493 1.676 0 O-C-N 121.308 -0.87 . . . . 0.0 109.227 179.739 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 82' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER 62.4 48.82 4.43 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.332 -0.855 . . . . 0.0 110.154 179.574 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 83' ' ' ILE . . . . . . . . . . . . . 69.9 mt -129.08 151.84 36.35 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.801 0 O-C-N 121.142 -0.974 . . . . 0.0 110.408 -178.862 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 84' ' ' LYS . . . . . 0.458 ' O ' ' CD ' ' A' ' 85' ' ' GLU . 27.7 tttt -158.86 108.74 1.99 Allowed 'General case' 0 N--CA 1.49 1.545 0 N-CA-C 108.192 -1.04 . . . . 0.0 108.192 179.778 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 85' ' ' GLU . . . . . 0.595 ' O ' ' CD2' ' A' ' 75' ' ' TYR . 7.4 mm-40 -139.64 176.41 2.59 Favored Pre-proline 0 N--CA 1.496 1.859 0 O-C-N 121.457 -0.777 . . . . 0.0 109.899 -178.998 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 86' ' ' PRO . . . . . 0.419 ' O ' HG22 ' A' ' 101' ' ' VAL . 12.3 Cg_endo -85.86 169.68 8.98 Favored 'Trans proline' 0 N--CA 1.491 1.342 0 C-N-CA 123.15 2.566 . . . . 0.0 113.55 -178.75 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 87' ' ' VAL . . . . . 0.624 HG23 ' HA ' ' A' ' 75' ' ' TYR . 45.8 t -124.35 99.38 6.25 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.85 0 O-C-N 121.616 -0.677 . . . . 0.0 109.42 179.497 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 88' ' ' TYR . . . . . 0.716 ' CE1' HG12 ' A' ' 72' ' ' VAL . 26.1 m-85 -90.08 155.52 47.08 Favored Pre-proline 0 N--CA 1.506 2.345 0 O-C-N 120.861 -1.149 . . . . 0.0 109.716 -179.806 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 89' ' ' PRO . . . . . 0.578 ' O ' ' NE2' ' A' ' 96' ' ' GLN . 18.3 Cg_endo -65.62 145.46 81.81 Favored 'Trans proline' 0 N--CA 1.494 1.522 0 C-N-CA 122.486 2.124 . . . . 0.0 113.946 -179.587 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . -53.1 166.5 1.41 Allowed Glycine 0 N--CA 1.49 2.261 0 N-CA-C 109.369 -1.492 . . . . 0.0 109.369 179.167 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 91' ' ' PRO . . . . . 0.432 ' C ' ' H ' ' A' ' 93' ' ' THR . 57.8 Cg_endo -93.72 167.47 20.81 Favored 'Cis proline' 0 C--N 1.308 -1.589 0 C-N-CA 123.756 -1.352 . . . . 0.0 111.583 0.14 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 92' ' ' ALA . . . . . 0.473 ' O ' HD23 ' A' ' 97' ' ' LEU . . . -73.32 31.07 0.07 Allowed 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.104 -0.997 . . . . 0.0 110.495 -179.781 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 93' ' ' THR . . . . . 0.432 ' H ' ' C ' ' A' ' 91' ' ' PRO . 1.4 p -73.16 153.01 90.57 Favored Pre-proline 0 N--CA 1.49 1.534 0 O-C-N 120.725 -1.234 . . . . 0.0 109.288 -179.65 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 94' ' ' PRO . . . . . . . . . . . . . 89.8 Cg_exo -33.22 -56.83 0.35 Allowed 'Trans proline' 0 C--N 1.311 -1.431 0 C-N-CA 122.982 2.454 . . . . 0.0 112.299 -179.686 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 41.1 mt-10 -46.5 -48.33 19.24 Favored 'General case' 0 N--CA 1.488 1.444 0 O-C-N 121.171 -0.955 . . . . 0.0 108.874 179.813 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 96' ' ' GLN . . . . . 0.578 ' NE2' ' O ' ' A' ' 89' ' ' PRO . 3.4 mm-40 -72.29 -54.95 8.04 Favored 'General case' 0 C--N 1.305 -1.333 0 O-C-N 121.192 -0.942 . . . . 0.0 109.712 179.767 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 97' ' ' LEU . . . . . 0.703 HD11 ' HA2' ' A' ' 119' ' ' GLY . 0.5 OUTLIER -48.33 -8.01 0.02 OUTLIER 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.254 -0.904 . . . . 0.0 109.926 -179.593 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 98' ' ' ASN . . . . . 0.585 ' C ' ' ND2' ' A' ' 98' ' ' ASN . 0.0 OUTLIER -74.41 -24.45 59.11 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.163 -0.961 . . . . 0.0 109.162 179.672 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 99' ' ' ARG . . . . . 0.416 ' HD2' ' CD2' ' A' ' 88' ' ' TYR . 4.2 mtt180 -95.2 -53.65 3.71 Favored 'General case' 0 C--N 1.3 -1.561 0 O-C-N 121.659 -0.651 . . . . 0.0 110.294 -178.813 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . 177.52 -159.7 25.9 Favored Glycine 0 N--CA 1.492 2.402 0 C-N-CA 119.366 -1.397 . . . . 0.0 110.167 179.807 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 101' ' ' VAL . . . . . 0.785 HG23 ' O ' ' A' ' 101' ' ' VAL . 25.0 m -62.03 100.07 0.15 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.629 0 O-C-N 121.523 -0.986 . . . . 0.0 109.296 -179.911 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 102' ' ' SER . . . . . 0.458 ' OG ' ' OE1' ' A' ' 96' ' ' GLN . 1.6 m -93.35 159.9 15.06 Favored 'General case' 0 C--N 1.298 -1.644 0 O-C-N 121.2 -0.938 . . . . 0.0 110.156 -179.963 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 103' ' ' PHE . . . . . . . . . . . . . 21.2 m-85 -59.63 160.72 6.88 Favored 'General case' 0 N--CA 1.49 1.57 0 N-CA-C 107.869 -1.16 . . . . 0.0 107.869 178.671 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 104' ' ' ALA . . . . . . . . . . . . . . . -72.33 -28.16 62.88 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.211 -0.93 . . . . 0.0 111.814 -177.932 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -135.25 150.45 50.06 Favored 'General case' 0 N--CA 1.495 1.819 0 O-C-N 120.822 -1.174 . . . . 0.0 111.023 -178.518 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 106' ' ' GLU . . . . . . . . . . . . . 1.3 pt-20 -54.15 -63.33 1.18 Allowed 'General case' 0 N--CA 1.487 1.402 0 CA-C-N 115.999 -0.546 . . . . 0.0 111.293 -179.256 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 107' ' ' ASN . . . . . . . . . . . . . 15.8 m120 -75.84 32.46 0.11 Allowed 'General case' 0 N--CA 1.49 1.543 0 O-C-N 120.175 -1.578 . . . . 0.0 112.621 -175.398 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 108' ' ' GLU . . . . . . . . . . . . . 44.6 tp10 -60.48 148.55 37.26 Favored 'General case' 0 C--N 1.299 -1.597 0 C-N-CA 118.865 -1.134 . . . . 0.0 108.008 -179.684 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 109' ' ' SER . . . . . 0.536 ' C ' ' H ' ' A' ' 111' ' ' ASP . 1.3 t -96.57 121.62 38.59 Favored 'General case' 0 C--N 1.302 -1.49 0 O-C-N 121.039 -1.038 . . . . 0.0 109.683 -178.77 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 110' ' ' LEU . . . . . . . . . . . . . 12.7 tp -59.19 -1.57 0.2 Allowed 'General case' 0 C--N 1.302 -1.479 0 N-CA-C 108.54 -0.911 . . . . 0.0 108.54 -179.912 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 111' ' ' ASP . . . . . 0.536 ' H ' ' C ' ' A' ' 109' ' ' SER . 8.7 m-20 -131.77 20.58 4.62 Favored 'General case' 0 N--CA 1.487 1.406 0 N-CA-C 108.927 -0.768 . . . . 0.0 108.927 179.36 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 112' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -65.47 133.82 52.1 Favored 'General case' 0 N--CA 1.49 1.525 0 O-C-N 121.348 -0.845 . . . . 0.0 109.944 -179.958 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 113' ' ' GLN . . . . . 0.594 ' NE2' ' O ' ' A' ' 173' ' ' LYS . 0.0 OUTLIER -65.46 -4.33 5.62 Favored 'General case' 0 C--N 1.303 -1.436 0 O-C-N 121.058 -1.026 . . . . 0.0 108.869 179.032 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 114' ' ' ASN . . . . . 0.647 ' C ' HD21 ' A' ' 114' ' ' ASN . 0.2 OUTLIER -143.38 91.19 2.24 Favored 'General case' 0 C--N 1.301 -1.517 0 N-CA-C 107.559 -1.274 . . . . 0.0 107.559 178.409 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 115' ' ' ILE . . . . . 0.439 ' O ' HG22 ' A' ' 115' ' ' ILE . 3.3 mt -100.69 115.14 41.61 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.466 0 O-C-N 121.627 -0.671 . . . . 0.0 109.913 -178.913 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 116' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -101.82 145.53 29.05 Favored 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.345 -0.847 . . . . 0.0 110.93 -179.149 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 117' ' ' ILE . . . . . . . . . . . . . 1.2 mt -135.15 157.38 40.37 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.461 0 N-CA-C 108.101 -1.074 . . . . 0.0 108.101 179.521 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 118' ' ' ALA . . . . . . . . . . . . . . . -142.62 161.82 37.08 Favored 'General case' 0 N--CA 1.492 1.658 0 O-C-N 120.822 -1.174 . . . . 0.0 111.177 -179.611 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 119' ' ' GLY . . . . . 0.703 ' HA2' HD11 ' A' ' 97' ' ' LEU . . . -170.29 143.54 7.87 Favored Glycine 0 N--CA 1.49 2.249 0 C-N-CA 120.191 -1.004 . . . . 0.0 110.755 179.801 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 120' ' ' HIS . . . . . . . . . . . . . 29.9 m170 -71.16 167.86 18.44 Favored 'General case' 0 N--CA 1.493 1.693 0 O-C-N 121.674 -0.898 . . . . 0.0 109.514 179.024 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 121' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -118.29 159.57 23.14 Favored 'General case' 0 N--CA 1.496 1.863 0 O-C-N 121.211 -0.931 . . . . 0.0 108.84 179.449 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 122' ' ' PHE . . . . . . . . . . . . . 0.5 OUTLIER -143.68 127.97 17.77 Favored 'General case' 0 N--CA 1.497 1.918 0 O-C-N 120.935 -1.103 . . . . 0.0 109.705 -179.623 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 123' ' ' ILE . . . . . 0.511 HG23 ' N ' ' A' ' 124' ' ' ASP . 4.4 tt -64.66 -40.11 87.92 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.55 0 N-CA-C 108.982 -0.748 . . . . 0.0 108.982 179.858 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 124' ' ' ASP . . . . . 0.511 ' N ' HG23 ' A' ' 123' ' ' ILE . 70.3 m-20 -89.11 26.08 1.69 Allowed 'General case' 0 N--CA 1.496 1.829 0 O-C-N 121.563 -0.711 . . . . 0.0 112.253 -177.358 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 125' ' ' ARG . . . . . 0.684 HH11 ' CG ' ' A' ' 125' ' ' ARG . 1.8 mtt-85 -154.29 100.77 2.45 Favored Pre-proline 0 N--CA 1.496 1.826 0 O-C-N 120.754 -1.216 . . . . 0.0 109.692 179.781 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 126' ' ' PRO . . . . . . . . . . . . . 73.1 Cg_endo -80.69 -28.08 2.9 Favored 'Trans proline' 0 C--N 1.315 -1.195 0 C-N-CA 122.107 1.871 . . . . 0.0 112.546 -179.934 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 127' ' ' ASN . . . . . 0.427 ' O ' ' O ' ' A' ' 128' ' ' TYR . 1.6 m120 -91.61 7.5 41.19 Favored 'General case' 0 N--CA 1.489 1.478 0 O-C-N 121.089 -1.007 . . . . 0.0 109.715 -179.864 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 128' ' ' TYR . . . . . 0.687 ' CE2' ' NE2' ' A' ' 129' ' ' GLN . 4.6 t80 -60.48 -151.25 0.0 OUTLIER 'General case' 0 C--N 1.301 -1.529 0 O-C-N 121.258 -0.901 . . . . 0.0 109.84 -179.733 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 129' ' ' GLN . . . . . 0.687 ' NE2' ' CE2' ' A' ' 128' ' ' TYR . 2.6 mp0 -67.78 -71.57 0.2 Allowed 'General case' 0 N--CA 1.489 1.478 0 O-C-N 121.341 -0.849 . . . . 0.0 110.051 -179.482 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 130' ' ' PHE . . . . . 0.503 ' CE2' HG11 ' A' ' 101' ' ' VAL . 55.4 m-85 -135.44 50.82 2.1 Favored 'General case' 0 N--CA 1.492 1.673 0 O-C-N 121.193 -0.942 . . . . 0.0 110.473 -179.371 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 131' ' ' THR . . . . . . . . . . . . . 2.9 m -82.13 -38.77 24.26 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.031 -1.043 . . . . 0.0 108.81 179.067 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 132' ' ' ASN . . . . . . . . . . . . . 4.8 t30 -84.34 6.42 23.12 Favored 'General case' 0 N--CA 1.494 1.731 0 C-N-CA 120.083 -0.647 . . . . 0.0 111.121 -178.91 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 133' ' ' LEU . . . . . 0.598 ' O ' ' N ' ' A' ' 135' ' ' ALA . 0.2 OUTLIER -68.5 -47.75 66.18 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 120.906 -1.121 . . . . 0.0 110.69 -179.04 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 134' ' ' LYS . . . . . 0.625 ' H ' ' CD ' ' A' ' 134' ' ' LYS . 0.1 OUTLIER -42.15 -18.48 0.01 OUTLIER 'General case' 0 N--CA 1.494 1.747 0 O-C-N 121.098 -1.001 . . . . 0.0 109.949 -179.025 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 135' ' ' ALA . . . . . 0.598 ' N ' ' O ' ' A' ' 133' ' ' LEU . . . -83.87 -31.82 25.53 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.063 -1.023 . . . . 0.0 109.94 -179.946 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 136' ' ' ALA . . . . . 0.817 ' HB2' ' HB2' ' A' ' 81' ' ' ALA . . . -80.78 153.99 27.45 Favored 'General case' 0 N--CA 1.489 1.518 0 CA-C-O 122.163 0.982 . . . . 0.0 112.142 -178.366 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 137' ' ' LYS . . . . . 0.524 ' O ' ' O ' ' A' ' 138' ' ' LYS . 4.8 tttt -150.92 -166.93 2.67 Favored 'General case' 0 N--CA 1.493 1.717 0 C-N-CA 118.926 -1.11 . . . . 0.0 110.879 -178.197 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 138' ' ' LYS . . . . . 0.592 ' O ' ' N ' ' A' ' 140' ' ' SER . 36.3 mttm -44.45 178.72 0.0 OUTLIER 'General case' 0 N--CA 1.487 1.378 0 CA-C-O 122.221 1.01 . . . . 0.0 110.971 -178.755 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 139' ' ' GLY . . . . . . . . . . . . . . . 46.6 7.59 0.02 OUTLIER Glycine 0 N--CA 1.491 2.351 0 N-CA-C 110.545 -1.022 . . . . 0.0 110.545 -179.959 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 140' ' ' SER . . . . . 0.592 ' N ' ' O ' ' A' ' 138' ' ' LYS . 48.7 m -84.77 121.57 27.88 Favored 'General case' 0 N--CA 1.495 1.785 0 O-C-N 120.809 -1.406 . . . . 0.0 109.215 179.244 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 141' ' ' MET . . . . . 0.646 ' SD ' ' N ' ' A' ' 142' ' ' VAL . 10.8 tpp -72.47 131.76 42.98 Favored 'General case' 0 N--CA 1.488 1.462 0 O-C-N 121.125 -0.984 . . . . 0.0 109.223 179.898 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 142' ' ' VAL . . . . . 0.646 ' N ' ' SD ' ' A' ' 141' ' ' MET . 3.2 t -116.02 133.13 63.46 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.702 0 N-CA-C 108.794 -0.817 . . . . 0.0 108.794 -179.593 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 143' ' ' TYR . . . . . . . . . . . . . 17.9 m-85 -109.23 135.28 50.59 Favored 'General case' 0 N--CA 1.497 1.92 0 O-C-N 120.89 -1.132 . . . . 0.0 111.531 -178.434 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 144' ' ' PHE . . . . . . . . . . . . . 49.1 t80 -120.25 101.86 8.1 Favored 'General case' 0 N--CA 1.495 1.793 0 C-N-CA 120.359 -0.536 . . . . 0.0 109.566 -179.432 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 145' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -96.65 132.1 42.64 Favored 'General case' 0 N--CA 1.493 1.708 0 O-C-N 121.205 -0.935 . . . . 0.0 110.878 -178.822 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 146' ' ' VAL . . . . . 0.414 ' O ' ' C ' ' A' ' 147' ' ' GLY . 0.1 OUTLIER -142.96 143.78 24.79 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.738 0 N-CA-C 107.764 -1.199 . . . . 0.0 107.764 178.655 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 147' ' ' GLY . . . . . 0.414 ' C ' ' O ' ' A' ' 146' ' ' VAL . . . 44.37 -130.77 7.25 Favored Glycine 0 N--CA 1.489 2.221 0 O-C-N 120.28 -1.512 . . . . 0.0 109.324 -179.958 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 148' ' ' ASN . . . . . . . . . . . . . 24.4 p30 -102.86 18.49 21.4 Favored 'General case' 0 C--N 1.3 -1.572 0 O-C-N 121.374 -1.074 . . . . 0.0 108.588 179.537 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 149' ' ' GLU . . . . . . . . . . . . . 8.4 tt0 -114.38 147.94 38.41 Favored 'General case' 0 N--CA 1.489 1.523 0 CA-C-O 121.862 0.839 . . . . 0.0 111.249 -178.538 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 150' ' ' THR . . . . . 0.487 ' O ' HG22 ' A' ' 150' ' ' THR . 1.2 m -129.24 105.68 8.31 Favored 'General case' 0 N--CA 1.492 1.646 0 CA-C-O 121.585 0.707 . . . . 0.0 109.675 179.941 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 151' ' ' ARG . . . . . . . . . . . . . 10.8 mtp180 -87.34 -171.6 3.55 Favored 'General case' 0 N--CA 1.487 1.401 0 N-CA-C 108.624 -0.88 . . . . 0.0 108.624 -179.967 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 152' ' ' LYS . . . . . . . . . . . . . 1.1 ttmt -150.41 147.36 27.46 Favored 'General case' 0 C--N 1.303 -1.442 0 O-C-N 120.918 -1.114 . . . . 0.0 110.787 -179.299 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 153' ' ' TYR . . . . . 0.562 ' O ' ' SD ' ' A' ' 141' ' ' MET . 22.2 m-85 -142.2 165.6 26.98 Favored 'General case' 0 N--CA 1.49 1.574 0 N-CA-C 108.024 -1.102 . . . . 0.0 108.024 179.24 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 154' ' ' LYS . . . . . . . . . . . . . 30.9 ttpt -142.91 121.02 12.15 Favored 'General case' 0 N--CA 1.493 1.684 0 O-C-N 121.061 -1.025 . . . . 0.0 108.666 178.854 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 155' ' ' MET . . . . . . . . . . . . . 4.1 mtt -47.1 105.9 0.08 Allowed 'General case' 0 N--CA 1.493 1.687 0 O-C-N 120.889 -1.132 . . . . 0.0 112.017 -178.419 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 156' ' ' THR . . . . . 0.657 ' OG1' HG23 ' A' ' 203' ' ' THR . 0.0 OUTLIER -107.46 -23.38 12.21 Favored 'General case' 0 C--N 1.293 -1.886 0 CA-C-N 115.16 -0.927 . . . . 0.0 110.112 -179.572 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 157' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -153.16 150.43 29.06 Favored 'General case' 0 C--N 1.296 -1.728 0 C-N-CA 118.388 -1.325 . . . . 0.0 111.363 -178.797 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 158' ' ' ILE . . . . . 0.432 HG13 ' CD2' ' A' ' 200' ' ' PHE . 0.0 OUTLIER -154.18 145.12 14.08 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.357 0 CA-C-O 121.872 0.844 . . . . 0.0 110.055 -179.276 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 159' ' ' ARG . . . . . 0.424 ' N ' HG12 ' A' ' 158' ' ' ILE . 0.1 OUTLIER -151.38 156.6 41.04 Favored 'General case' 0 C--N 1.3 -1.568 0 CA-C-O 121.52 0.676 . . . . 0.0 109.747 -179.792 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 160' ' ' ASP . . . . . 0.5 ' C ' HG22 ' A' ' 161' ' ' VAL . 2.2 m-20 -117.62 157.08 27.04 Favored 'General case' 0 N--CA 1.49 1.563 0 N-CA-C 108.781 -0.822 . . . . 0.0 108.781 -179.909 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 161' ' ' VAL . . . . . 0.5 HG22 ' C ' ' A' ' 160' ' ' ASP . 0.1 OUTLIER -163.43 160.24 1.29 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.654 0 O-C-N 121.072 -1.017 . . . . 0.0 110.49 -179.912 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 162' ' ' LYS . . . . . . . . . . . . . 14.1 ptmt -52.13 177.88 0.06 OUTLIER Pre-proline 0 N--CA 1.49 1.562 0 N-CA-C 108.694 -0.854 . . . . 0.0 108.694 179.043 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 163' ' ' PRO . . . . . 0.721 ' C ' HD11 ' C' ' 702' ' ' LEU . 37.3 Cg_endo -86.63 43.39 1.03 Allowed 'Trans proline' 0 C--N 1.316 -1.18 0 C-N-CA 122.238 1.959 . . . . 0.0 112.502 -179.344 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 164' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -151.93 -11.21 0.2 Allowed 'General case' 0 N--CA 1.494 1.741 0 O-C-N 121.262 -0.899 . . . . 0.0 110.372 -179.972 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 165' ' ' ASP . . . . . 0.449 ' O ' ' C ' ' A' ' 166' ' ' VAL . 1.2 t70 -73.21 61.93 0.65 Allowed 'General case' 0 N--CA 1.49 1.558 0 O-C-N 120.867 -1.146 . . . . 0.0 110.258 -179.301 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 166' ' ' VAL . . . . . 0.623 ' O ' ' N ' ' A' ' 168' ' ' VAL . 0.9 OUTLIER -41.89 -31.42 0.35 Allowed 'Isoleucine or valine' 0 N--CA 1.494 1.73 0 O-C-N 121.399 -0.813 . . . . 0.0 109.023 -178.329 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 167' ' ' GLY . . . . . . . . . . . . . . . -42.65 -13.38 0.01 OUTLIER Glycine 0 N--CA 1.494 2.546 0 O-C-N 121.06 -1.025 . . . . 0.0 110.742 179.892 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 168' ' ' VAL . . . . . 0.623 ' N ' ' O ' ' A' ' 166' ' ' VAL . 6.1 m -53.46 -35.64 25.67 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.468 0 O-C-N 120.708 -1.466 . . . . 0.0 108.738 179.62 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 169' ' ' LEU . . . . . 0.522 ' O ' ' N ' ' A' ' 171' ' ' GLU . 27.8 mt -51.86 -7.19 0.05 OUTLIER 'General case' 0 N--CA 1.495 1.805 0 N-CA-C 108.004 -1.11 . . . . 0.0 108.004 -179.272 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 170' ' ' ASP . . . . . 0.593 ' H ' ' C ' ' A' ' 168' ' ' VAL . 34.4 t0 35.16 28.58 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.525 0 O-C-N 121.764 -0.585 . . . . 0.0 111.87 177.687 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 171' ' ' GLU . . . . . 0.522 ' N ' ' O ' ' A' ' 169' ' ' LEU . 12.7 pt-20 -62.3 94.26 0.06 Allowed 'General case' 0 N--CA 1.494 1.767 0 O-C-N 120.382 -1.449 . . . . 0.0 107.45 178.105 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 172' ' ' GLN . . . . . . . . . . . . . 2.2 mt-30 -152.66 -78.16 0.11 Allowed 'General case' 0 N--CA 1.497 1.877 0 O-C-N 121.434 -0.791 . . . . 0.0 110.548 -178.595 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 173' ' ' LYS . . . . . 0.594 ' O ' ' NE2' ' A' ' 113' ' ' GLN . 1.0 OUTLIER -55.95 136.52 51.77 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.43 -0.794 . . . . 0.0 109.386 -179.432 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 174' ' ' GLY . . . . . 0.477 ' O ' ' C ' ' A' ' 175' ' ' LYS . . . -120.03 -45.78 0.4 Allowed Glycine 0 N--CA 1.479 1.527 0 N-CA-C 107.441 -2.263 . . . . 0.0 107.441 179.239 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 175' ' ' LYS . . . . . 0.477 ' C ' ' O ' ' A' ' 174' ' ' GLY . 0.4 OUTLIER -38.13 -75.44 0.03 OUTLIER 'General case' 0 N--CA 1.493 1.724 0 N-CA-C 108.272 -1.011 . . . . 0.0 108.272 179.562 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 176' ' ' ASP . . . . . 0.547 ' O ' ' O ' ' A' ' 177' ' ' LYS . 66.7 m-20 -89.97 94.7 9.9 Favored 'General case' 0 C--N 1.296 -1.754 0 N-CA-C 106.967 -1.494 . . . . 0.0 106.967 177.943 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 177' ' ' LYS . . . . . 0.547 ' O ' ' O ' ' A' ' 176' ' ' ASP . 19.6 mttp -44.19 -178.4 0.0 OUTLIER 'General case' 0 N--CA 1.493 1.687 0 CA-C-O 121.487 0.66 . . . . 0.0 110.795 -178.311 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 178' ' ' GLN . . . . . 0.456 HE22 ' HD2' ' A' ' 173' ' ' LYS . 6.8 pt20 -161.06 161.38 31.29 Favored 'General case' 0 N--CA 1.487 1.386 0 C-N-CA 118.557 -1.257 . . . . 0.0 111.089 179.86 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 179' ' ' LEU . . . . . . . . . . . . . 1.2 tp -123.6 94.34 4.21 Favored 'General case' 0 C--N 1.303 -1.445 0 N-CA-C 106.944 -1.502 . . . . 0.0 106.944 177.398 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 180' ' ' THR . . . . . . . . . . . . . 3.3 m -71.64 120.32 17.06 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.111 -0.993 . . . . 0.0 110.427 -178.097 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 181' ' ' LEU . . . . . 0.466 HD21 ' HG ' ' A' ' 133' ' ' LEU . 34.4 tp -95.98 142.6 28.01 Favored 'General case' 0 C--N 1.302 -1.498 0 N-CA-C 108.153 -1.054 . . . . 0.0 108.153 178.338 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 182' ' ' ILE . . . . . 0.487 HG22 ' O ' ' A' ' 182' ' ' ILE . 3.9 mt -136.39 109.69 8.83 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.612 0 O-C-N 121.02 -1.05 . . . . 0.0 108.689 178.9 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 183' ' ' THR . . . . . 0.548 ' O ' HG23 ' A' ' 183' ' ' THR . 4.4 t -129.76 113.06 14.25 Favored 'General case' 0 C--N 1.293 -1.881 0 N-CA-C 107.337 -1.357 . . . . 0.0 107.337 179.327 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 184' ' ' CYS . . . . . . . . . . . . . 0.8 OUTLIER -79.23 164.03 24.49 Favored 'General case' 0 C--N 1.289 -2.026 0 C-N-CA 118.994 -1.082 . . . . 0.0 111.145 -177.691 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 185' ' ' ASP . . . . . . . . . . . . . 9.9 t0 -165.2 -154.33 0.21 Allowed 'General case' 0 N--CA 1.493 1.687 0 N-CA-C 108.892 -0.781 . . . . 0.0 108.892 -179.829 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 186' ' ' ASP . . . . . . . . . . . . . 1.5 m-20 49.43 59.28 4.6 Favored 'General case' 0 N--CA 1.495 1.802 0 O-C-N 120.95 -1.094 . . . . 0.0 108.971 -179.666 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 187' ' ' TYR . . . . . 0.607 ' CE2' ' O ' ' A' ' 188' ' ' ASN . 68.2 t80 -67.4 138.76 56.94 Favored 'General case' 0 N--CA 1.491 1.579 0 CA-C-O 121.85 0.833 . . . . 0.0 110.871 -179.184 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 188' ' ' ASN . . . . . 0.607 ' O ' ' CE2' ' A' ' 187' ' ' TYR . 0.7 OUTLIER -104.32 143.72 32.59 Favored 'General case' 0 C--N 1.299 -1.589 0 N-CA-C 108.305 -0.998 . . . . 0.0 108.305 178.391 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 189' ' ' GLU . . . . . . . . . . . . . 2.5 tt0 -108.22 -17.05 14.11 Favored 'General case' 0 C--N 1.293 -1.891 0 N-CA-C 108.879 -0.786 . . . . 0.0 108.879 -179.284 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 190' ' ' LYS . . . . . . . . . . . . . 24.4 mmtm -82.77 -51.64 7.49 Favored 'General case' 0 C--N 1.301 -1.541 0 C-N-CA 119.792 -0.763 . . . . 0.0 108.96 179.154 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 191' ' ' THR . . . . . . . . . . . . . 4.1 p -89.83 -10.91 43.64 Favored 'General case' 0 N--CA 1.489 1.477 0 O-C-N 121.442 -0.786 . . . . 0.0 109.802 -179.608 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 192' ' ' GLY . . . . . . . . . . . . . . . 63.73 39.32 97.36 Favored Glycine 0 N--CA 1.494 2.537 0 O-C-N 120.945 -1.097 . . . . 0.0 110.375 179.25 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 193' ' ' VAL . . . . . 0.591 HG12 ' N ' ' A' ' 194' ' ' TRP . 55.4 t -147.99 163.45 6.19 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.571 0 O-C-N 121.114 -1.227 . . . . 0.0 109.679 179.959 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 194' ' ' TRP . . . . . 0.591 ' N ' HG12 ' A' ' 193' ' ' VAL . 10.0 m95 -82.29 118.81 23.41 Favored 'General case' 0 C--N 1.301 -1.524 0 N-CA-C 108.356 -0.979 . . . . 0.0 108.356 179.613 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 195' ' ' GLU . . . . . 0.545 ' CD ' ' ND2' ' A' ' 188' ' ' ASN . 2.8 mt-10 -79.2 -60.82 2.22 Favored 'General case' 0 N--CA 1.493 1.692 0 O-C-N 121.32 -0.863 . . . . 0.0 110.946 -178.528 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 196' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -95.29 152.82 18.04 Favored 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.197 -0.939 . . . . 0.0 110.121 -178.789 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 197' ' ' ARG . . . . . 0.672 ' HE ' HD22 ' C' ' 702' ' ' LEU . 0.1 OUTLIER -122.94 143.18 50.07 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.668 -0.645 . . . . 0.0 109.723 179.86 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 198' ' ' LYS . . . . . . . . . . . . . 4.2 mptp? -113.77 120.72 41.75 Favored 'General case' 0 C--N 1.302 -1.487 0 O-C-N 121.7 -0.625 . . . . 0.0 109.56 -179.68 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 199' ' ' ILE . . . . . 0.662 ' C ' HD12 ' A' ' 199' ' ' ILE . 0.5 OUTLIER -139.66 118.41 12.13 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.677 0 CA-C-O 122.502 1.144 . . . . 0.0 109.829 179.926 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 200' ' ' PHE . . . . . 0.527 ' CD1' ' N ' ' A' ' 200' ' ' PHE . 6.6 m-85 -100.57 138.5 37.54 Favored 'General case' 0 N--CA 1.494 1.728 0 O-C-N 121.353 -0.842 . . . . 0.0 109.912 -178.626 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 201' ' ' VAL . . . . . . . . . . . . . 44.6 t -101.61 136.34 33.97 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.543 0 N-CA-C 107.795 -1.187 . . . . 0.0 107.795 177.662 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 202' ' ' ALA . . . . . . . . . . . . . . . -121.16 134.59 55.23 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.238 -0.914 . . . . 0.0 109.171 -179.939 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 203' ' ' THR . . . . . 0.657 HG23 ' OG1' ' A' ' 156' ' ' THR . 13.7 p -88.76 133.34 34.27 Favored 'General case' 0 C--N 1.306 -1.316 0 CA-C-O 122.158 0.98 . . . . 0.0 110.99 -178.72 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 204' ' ' GLU . . . . . 0.523 ' HA ' ' CD2' ' A' ' 153' ' ' TYR . 3.1 tt0 -51.72 133.84 30.87 Favored 'General case' 0 C--N 1.297 -1.686 0 C-N-CA 118.811 -1.155 . . . . 0.0 109.38 179.394 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 205' ' ' VAL . . . . . 0.545 HG23 ' O ' ' A' ' 203' ' ' THR . 44.3 t -127.53 161.66 34.64 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.295 0 CA-C-O 122.044 0.926 . . . . 0.0 110.242 -177.59 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 206' ' ' LYS . . . . . 0.497 ' N ' HG12 ' A' ' 205' ' ' VAL . 70.7 mttt . . . . . 0 C--N 1.296 -1.731 0 CA-C-O 118.047 -0.978 . . . . 0.0 109.294 179.85 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' C' C ' 702' ' ' LEU . . . . . 0.721 HD11 ' C ' ' A' ' 163' ' ' PRO . 0.0 OUTLIER . . . . . 0 N--CA 1.492 1.661 0 N-CA-C 109.227 -0.657 . . . . 0.0 109.227 . . . . . . . . . 2 2 . 1 . 008 nuclear build core ' C' C ' 703' ' ' PRO . . . . . 0.551 ' O ' ' NH2' ' A' ' 197' ' ' ARG . 16.3 Cg_endo -57.99 162.98 10.29 Favored 'Trans proline' 0 N--CA 1.499 1.845 0 C-N-CA 123.633 2.888 . . . . 0.0 113.55 -178.934 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' C' C ' 704' ' ' ALA . . . . . 0.47 ' C ' ' O ' ' C' ' 703' ' ' PRO . . . . . . . . 0 N--CA 1.491 1.622 0 CA-C-O 121.39 0.614 . . . . 0.0 110.277 179.274 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 63' ' ' PRO . . . . . 0.602 ' HG2' HD23 ' A' ' 110' ' ' LEU . 52.1 Cg_endo . . . . . 0 N--CA 1.481 0.762 0 CA-C-O 121.005 0.336 . . . . 0.0 111.467 . . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 64' ' ' GLN . . . . . 0.578 ' N ' ' CD ' ' A' ' 64' ' ' GLN . 0.0 OUTLIER -156.36 127.73 7.1 Favored 'General case' 0 N--CA 1.495 1.793 0 O-C-N 120.955 -1.091 . . . . 0.0 109.62 179.366 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 65' ' ' ILE . . . . . 0.639 ' H ' HD13 ' A' ' 65' ' ' ILE . 0.0 OUTLIER -50.79 110.03 1.58 Allowed Pre-proline 0 N--CA 1.49 1.552 0 O-C-N 121.085 -1.009 . . . . 0.0 109.195 178.929 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 66' ' ' PRO . . . . . . . . . . . . . 89.0 Cg_endo -85.64 -154.47 0.05 OUTLIER 'Trans proline' 0 C--N 1.312 -1.392 0 C-N-CA 121.954 1.769 . . . . 0.0 111.712 179.607 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 67' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -83.71 -4.69 58.83 Favored 'General case' 0 N--CA 1.488 1.46 0 O-C-N 121.189 -0.944 . . . . 0.0 109.185 179.553 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 68' ' ' ASP . . . . . 0.634 ' C ' ' N ' ' A' ' 70' ' ' SER . 4.6 t0 -76.14 52.1 0.71 Allowed 'General case' 0 N--CA 1.49 1.574 0 CA-C-O 122.221 1.01 . . . . 0.0 110.099 -179.689 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 69' ' ' LYS . . . . . 0.413 ' C ' ' O ' ' A' ' 68' ' ' ASP . 0.0 OUTLIER -49.38 -13.45 0.08 Allowed 'General case' 0 N--CA 1.507 2.375 0 C-N-CA 116.723 -1.991 . . . . 0.0 106.749 177.593 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 70' ' ' SER . . . . . 0.634 ' N ' ' C ' ' A' ' 68' ' ' ASP . 0.0 OUTLIER -83.31 -8.22 59.47 Favored 'General case' 0 N--CA 1.497 1.896 0 CA-C-N 113.331 -1.759 . . . . 0.0 110.381 179.557 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 71' ' ' LYS . . . . . . . . . . . . . 8.3 ptmt -101.88 142.88 32.49 Favored 'General case' 0 N--CA 1.495 1.793 0 O-C-N 121.021 -1.049 . . . . 0.0 110.643 179.875 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 72' ' ' VAL . . . . . 0.719 HG12 ' CE1' ' A' ' 88' ' ' TYR . 0.9 OUTLIER -64.92 142.63 16.68 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.434 0 N-CA-C 105.309 -2.108 . . . . 0.0 105.309 175.291 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 73' ' ' ALA . . . . . 0.498 ' N ' ' O ' ' A' ' 87' ' ' VAL . . . -83.16 -14.0 54.39 Favored 'General case' 0 C--N 1.296 -1.757 0 O-C-N 120.101 -1.624 . . . . 0.0 107.134 179.944 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 74' ' ' GLY . . . . . 0.409 ' N ' HG23 ' A' ' 72' ' ' VAL . . . 173.83 -157.11 25.1 Favored Glycine 0 C--N 1.296 -1.677 0 N-CA-C 108.595 -1.802 . . . . 0.0 108.595 179.472 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 75' ' ' TYR . . . . . 0.55 ' CE1' ' N ' ' A' ' 86' ' ' PRO . 0.3 OUTLIER -142.96 171.09 14.52 Favored 'General case' 0 C--N 1.292 -1.909 0 O-C-N 121.441 -1.034 . . . . 0.0 110.335 -177.624 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 76' ' ' ILE . . . . . . . . . . . . . 0.5 OUTLIER -148.12 143.72 19.19 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.601 0 C-N-CA 119.048 -1.061 . . . . 0.0 109.77 -177.29 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 2.2 mt-10 -151.53 163.35 39.23 Favored 'General case' 0 C--N 1.304 -1.41 0 O-C-N 121.136 -0.977 . . . . 0.0 109.254 179.573 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 78' ' ' ILE . . . . . 0.493 ' HB ' ' HB3' ' A' ' 81' ' ' ALA . 14.6 mt -144.77 126.51 7.95 Favored Pre-proline 0 N--CA 1.492 1.656 0 N-CA-C 108.538 -0.912 . . . . 0.0 108.538 179.886 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 79' ' ' PRO . . . . . . . . . . . . . 36.0 Cg_endo -71.52 -48.73 0.39 Allowed 'Trans proline' 0 N--CA 1.491 1.362 0 C-N-CA 122.011 1.807 . . . . 0.0 113.501 -179.064 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 50.5 t0 -66.48 -21.24 66.18 Favored 'General case' 0 N--CA 1.493 1.705 0 O-C-N 120.976 -1.077 . . . . 0.0 111.306 178.806 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 81' ' ' ALA . . . . . 0.87 ' HB2' ' HB2' ' A' ' 136' ' ' ALA . . . -104.55 -16.44 15.04 Favored 'General case' 0 N--CA 1.493 1.685 0 O-C-N 120.833 -1.167 . . . . 0.0 108.991 179.657 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 82' ' ' ASP . . . . . . . . . . . . . 8.5 t0 61.17 53.57 3.54 Favored 'General case' 0 N--CA 1.494 1.735 0 O-C-N 121.284 -0.885 . . . . 0.0 111.462 178.518 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 83' ' ' ILE . . . . . . . . . . . . . 50.8 mt -128.96 154.45 39.98 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.794 0 O-C-N 121.027 -1.045 . . . . 0.0 109.43 -179.798 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 84' ' ' LYS . . . . . . . . . . . . . 2.1 pttt -157.81 107.72 2.14 Favored 'General case' 0 N--CA 1.487 1.422 0 N-CA-C 107.959 -1.126 . . . . 0.0 107.959 -179.786 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 85' ' ' GLU . . . . . 0.498 ' C ' ' CE1' ' A' ' 75' ' ' TYR . 0.1 OUTLIER -141.17 160.32 58.13 Favored Pre-proline 0 N--CA 1.493 1.682 0 O-C-N 121.336 -0.852 . . . . 0.0 110.126 -179.065 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 86' ' ' PRO . . . . . 0.55 ' N ' ' CE1' ' A' ' 75' ' ' TYR . 36.7 Cg_endo -68.18 168.85 18.08 Favored 'Trans proline' 0 C--N 1.307 -1.611 0 C-N-CA 123.095 2.53 . . . . 0.0 113.081 -179.061 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 87' ' ' VAL . . . . . 0.502 HG23 ' HA ' ' A' ' 75' ' ' TYR . 94.1 t -127.46 99.31 5.2 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.627 0 N-CA-C 109.106 -0.701 . . . . 0.0 109.106 179.69 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 88' ' ' TYR . . . . . 0.719 ' CE1' HG12 ' A' ' 72' ' ' VAL . 20.9 m-85 -92.34 154.18 42.86 Favored Pre-proline 0 N--CA 1.503 2.204 0 O-C-N 120.873 -1.142 . . . . 0.0 109.79 -179.734 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 89' ' ' PRO . . . . . . . . . . . . . 7.3 Cg_endo -59.02 144.6 99.3 Favored 'Trans proline' 0 C--N 1.309 -1.518 0 C-N-CA 122.476 2.117 . . . . 0.0 113.551 -179.663 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . -59.14 169.1 6.23 Favored Glycine 0 N--CA 1.494 2.541 0 N-CA-C 108.899 -1.681 . . . . 0.0 108.899 178.902 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 91' ' ' PRO . . . . . 0.435 ' C ' ' H ' ' A' ' 93' ' ' THR . 59.8 Cg_endo -93.56 168.02 20.96 Favored 'Cis proline' 0 C--N 1.31 -1.452 0 C-N-CA 124.046 -1.231 . . . . 0.0 111.916 0.619 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 92' ' ' ALA . . . . . 0.473 ' HB1' HD21 ' A' ' 97' ' ' LEU . . . -71.99 32.05 0.06 Allowed 'General case' 0 N--CA 1.493 1.706 0 O-C-N 121.159 -0.963 . . . . 0.0 110.716 -179.664 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 93' ' ' THR . . . . . 0.435 ' H ' ' C ' ' A' ' 91' ' ' PRO . 0.8 OUTLIER -73.46 155.1 89.76 Favored Pre-proline 0 N--CA 1.489 1.523 0 O-C-N 120.692 -1.255 . . . . 0.0 108.751 -179.956 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 94' ' ' PRO . . . . . 0.401 ' C ' ' O ' ' A' ' 93' ' ' THR . 85.2 Cg_exo -34.55 -55.78 0.5 Allowed 'Trans proline' 0 C--N 1.306 -1.668 0 C-N-CA 122.818 2.346 . . . . 0.0 112.387 -179.506 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 95' ' ' GLU . . . . . 0.479 ' OE2' ' OE1' ' A' ' 96' ' ' GLN . 0.1 OUTLIER -47.36 -48.74 25.55 Favored 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.083 -1.011 . . . . 0.0 109.67 -179.812 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 96' ' ' GLN . . . . . 0.594 ' O ' ' N ' ' A' ' 98' ' ' ASN . 5.9 mp0 -71.94 -56.1 6.28 Favored 'General case' 0 N--CA 1.489 1.476 0 O-C-N 121.04 -1.038 . . . . 0.0 110.572 -179.563 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 97' ' ' LEU . . . . . 0.473 HD21 ' HB1' ' A' ' 92' ' ' ALA . 93.6 mt -48.09 -7.0 0.02 OUTLIER 'General case' 0 N--CA 1.494 1.74 0 O-C-N 121.193 -0.942 . . . . 0.0 110.005 -178.939 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 98' ' ' ASN . . . . . 0.594 ' N ' ' O ' ' A' ' 96' ' ' GLN . 0.0 OUTLIER -73.4 -26.35 60.95 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.201 -0.937 . . . . 0.0 109.042 179.274 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 99' ' ' ARG . . . . . 0.492 HH12 ' NE2' ' A' ' 96' ' ' GLN . 4.3 mtt180 -95.08 -51.15 4.77 Favored 'General case' 0 N--CA 1.488 1.442 0 C-N-CA 119.842 -0.743 . . . . 0.0 109.783 -179.218 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . 176.44 -165.29 35.55 Favored Glycine 0 N--CA 1.491 2.325 0 C-N-CA 119.462 -1.351 . . . . 0.0 110.232 179.776 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 101' ' ' VAL . . . . . 0.723 HG23 ' O ' ' A' ' 101' ' ' VAL . 21.0 m -58.47 105.76 0.19 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.632 0 O-C-N 121.498 -1.001 . . . . 0.0 109.554 -179.676 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -92.68 166.65 12.36 Favored 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.476 -0.765 . . . . 0.0 110.775 -179.519 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 103' ' ' PHE . . . . . 0.479 ' CE1' ' CG1' ' A' ' 87' ' ' VAL . 25.5 m-85 -72.25 131.15 42.34 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 120.987 -1.071 . . . . 0.0 108.176 178.458 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 104' ' ' ALA . . . . . 0.476 ' HB1' ' HG2' ' C' ' 703' ' ' PRO . . . -51.93 -7.21 0.05 OUTLIER 'General case' 0 C--N 1.295 -1.786 0 O-C-N 121.416 -0.802 . . . . 0.0 111.873 -178.596 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -141.22 139.54 33.81 Favored 'General case' 0 N--CA 1.499 2.023 0 O-C-N 120.444 -1.41 . . . . 0.0 111.469 -179.682 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 106' ' ' GLU . . . . . . . . . . . . . 1.9 pt-20 -54.3 -62.0 1.94 Allowed 'General case' 0 N--CA 1.488 1.472 0 O-C-N 121.855 -0.528 . . . . 0.0 109.947 179.51 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 107' ' ' ASN . . . . . . . . . . . . . 8.1 m120 -76.83 35.32 0.16 Allowed 'General case' 0 N--CA 1.489 1.483 0 O-C-N 120.545 -1.347 . . . . 0.0 111.607 -176.833 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 108' ' ' GLU . . . . . . . . . . . . . 35.1 tp10 -57.19 144.37 35.44 Favored 'General case' 0 C--N 1.303 -1.428 0 O-C-N 120.813 -1.179 . . . . 0.0 107.83 -179.802 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 109' ' ' SER . . . . . 0.557 ' C ' ' H ' ' A' ' 111' ' ' ASP . 1.2 m -101.24 124.85 47.59 Favored 'General case' 0 C--N 1.303 -1.438 0 O-C-N 121.058 -1.026 . . . . 0.0 110.648 -178.455 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 110' ' ' LEU . . . . . 0.602 HD23 ' HG2' ' A' ' 63' ' ' PRO . 3.5 tp -58.99 -3.45 0.35 Allowed 'General case' 0 C--N 1.3 -1.548 0 N-CA-C 107.693 -1.225 . . . . 0.0 107.693 179.066 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 111' ' ' ASP . . . . . 0.557 ' H ' ' C ' ' A' ' 109' ' ' SER . 1.6 m-20 -132.17 21.66 4.46 Favored 'General case' 0 N--CA 1.486 1.363 0 N-CA-C 109.128 -0.693 . . . . 0.0 109.128 179.696 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 112' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -64.96 138.34 58.3 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 120.985 -1.072 . . . . 0.0 109.543 179.839 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 113' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -66.29 -5.86 11.98 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 120.94 -1.1 . . . . 0.0 108.696 179.201 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 114' ' ' ASN . . . . . 0.493 ' OD1' ' O ' ' A' ' 170' ' ' ASP . 4.1 t30 -145.54 97.34 2.97 Favored 'General case' 0 C--N 1.297 -1.7 0 N-CA-C 107.305 -1.369 . . . . 0.0 107.305 178.16 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 115' ' ' ILE . . . . . 0.509 HG22 ' O ' ' A' ' 115' ' ' ILE . 1.8 mt -95.64 107.09 19.12 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.599 0 O-C-N 121.13 -0.981 . . . . 0.0 108.694 -179.522 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 116' ' ' SER . . . . . . . . . . . . . 7.5 p -90.22 154.71 19.53 Favored 'General case' 0 C--N 1.305 -1.355 0 CA-C-O 121.728 0.775 . . . . 0.0 110.814 -178.458 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 117' ' ' ILE . . . . . 0.419 HG21 HD13 ' A' ' 117' ' ' ILE . 3.2 mt -144.35 153.68 15.18 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.412 0 N-CA-C 108.337 -0.986 . . . . 0.0 108.337 179.135 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 118' ' ' ALA . . . . . 0.417 ' HB3' ' HB2' ' A' ' 92' ' ' ALA . . . -140.34 153.9 46.57 Favored 'General case' 0 N--CA 1.49 1.562 0 C-N-CA 119.217 -0.993 . . . . 0.0 110.481 -179.586 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 119' ' ' GLY . . . . . . . . . . . . . . . -166.57 148.17 13.07 Favored Glycine 0 N--CA 1.487 2.074 0 C-N-CA 119.912 -1.137 . . . . 0.0 110.715 -179.988 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 120' ' ' HIS . . . . . . . . . . . . . 3.2 m-70 -72.47 161.74 30.41 Favored 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.919 -0.754 . . . . 0.0 110.006 179.337 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 121' ' ' THR . . . . . . . . . . . . . 1.1 t -116.22 158.29 23.55 Favored 'General case' 0 N--CA 1.496 1.85 0 O-C-N 121.338 -0.851 . . . . 0.0 109.079 178.958 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 122' ' ' PHE . . . . . . . . . . . . . 0.3 OUTLIER -124.67 127.03 46.68 Favored 'General case' 0 N--CA 1.498 1.946 0 O-C-N 121.296 -0.877 . . . . 0.0 109.852 -179.637 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 123' ' ' ILE . . . . . 0.534 HG23 ' N ' ' A' ' 124' ' ' ASP . 16.3 tt -74.73 -36.74 41.08 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.665 0 CA-C-O 121.922 0.868 . . . . 0.0 109.141 179.712 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 124' ' ' ASP . . . . . 0.534 ' N ' HG23 ' A' ' 123' ' ' ILE . 2.0 p30 -95.54 22.49 7.01 Favored 'General case' 0 C--N 1.296 -1.756 0 O-C-N 121.827 -0.546 . . . . 0.0 111.042 -179.224 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 125' ' ' ARG . . . . . . . . . . . . . 9.4 ttt180 -157.06 107.42 1.91 Allowed Pre-proline 0 N--CA 1.492 1.674 0 O-C-N 120.518 -1.364 . . . . 0.0 110.441 -179.08 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 126' ' ' PRO . . . . . . . . . . . . . 56.9 Cg_endo -79.79 -23.27 7.01 Favored 'Trans proline' 0 C--N 1.315 -1.193 0 C-N-CA 122.056 1.837 . . . . 0.0 112.454 179.416 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 127' ' ' ASN . . . . . . . . . . . . . 28.4 m120 -91.5 29.64 1.45 Allowed 'General case' 0 N--CA 1.493 1.681 0 O-C-N 121.186 -0.946 . . . . 0.0 109.573 179.902 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 128' ' ' TYR . . . . . 0.687 ' CZ ' ' NE2' ' A' ' 129' ' ' GLN . 14.8 t80 -81.32 -151.04 0.08 Allowed 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.254 -0.904 . . . . 0.0 109.843 -179.669 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 129' ' ' GLN . . . . . 0.687 ' NE2' ' CZ ' ' A' ' 128' ' ' TYR . 1.7 mp0 -68.3 -71.85 0.2 Allowed 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.265 -0.897 . . . . 0.0 109.906 -179.507 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 130' ' ' PHE . . . . . 0.55 ' CE2' HG11 ' A' ' 101' ' ' VAL . 50.5 m-85 -125.88 25.94 6.72 Favored 'General case' 0 N--CA 1.497 1.884 0 O-C-N 121.21 -0.931 . . . . 0.0 110.278 -179.927 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 131' ' ' THR . . . . . . . . . . . . . 36.7 m -63.78 -34.85 78.81 Favored 'General case' 0 N--CA 1.493 1.693 0 O-C-N 120.844 -1.16 . . . . 0.0 109.754 -179.964 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 132' ' ' ASN . . . . . 0.6 ' ND2' ' O ' ' A' ' 81' ' ' ALA . 12.5 t30 -85.24 9.57 14.83 Favored 'General case' 0 N--CA 1.497 1.883 0 C-N-CA 119.913 -0.715 . . . . 0.0 111.788 -178.234 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 133' ' ' LEU . . . . . 0.606 ' O ' ' N ' ' A' ' 135' ' ' ALA . 0.1 OUTLIER -71.94 -44.56 63.4 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 120.565 -1.334 . . . . 0.0 110.328 -179.442 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 134' ' ' LYS . . . . . 0.62 ' H ' ' CD ' ' A' ' 134' ' ' LYS . 0.0 OUTLIER -42.58 -16.36 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.663 0 O-C-N 121.192 -0.942 . . . . 0.0 110.089 -179.132 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 135' ' ' ALA . . . . . 0.606 ' N ' ' O ' ' A' ' 133' ' ' LEU . . . -85.23 -37.06 20.52 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.02 -1.05 . . . . 0.0 109.738 179.708 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 136' ' ' ALA . . . . . 0.87 ' HB2' ' HB2' ' A' ' 81' ' ' ALA . . . -78.43 153.54 31.42 Favored 'General case' 0 N--CA 1.489 1.519 0 CA-C-O 121.977 0.894 . . . . 0.0 111.317 -178.6 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 137' ' ' LYS . . . . . 0.508 ' O ' ' OG ' ' A' ' 140' ' ' SER . 0.6 OUTLIER -156.15 -163.36 1.46 Allowed 'General case' 0 N--CA 1.494 1.744 0 C-N-CA 118.559 -1.257 . . . . 0.0 111.224 -178.387 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 138' ' ' LYS . . . . . 0.604 ' O ' ' N ' ' A' ' 140' ' ' SER . 24.9 pttt -45.95 179.74 0.0 OUTLIER 'General case' 0 C--N 1.305 -1.364 0 CA-C-O 121.95 0.881 . . . . 0.0 110.296 -179.395 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 139' ' ' GLY . . . . . . . . . . . . . . . 45.58 8.07 0.01 OUTLIER Glycine 0 N--CA 1.491 2.336 0 N-CA-C 110.817 -0.913 . . . . 0.0 110.817 179.705 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 140' ' ' SER . . . . . 0.604 ' N ' ' O ' ' A' ' 138' ' ' LYS . 46.9 m -94.07 136.85 33.91 Favored 'General case' 0 N--CA 1.494 1.734 0 O-C-N 120.823 -1.398 . . . . 0.0 109.333 179.225 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 141' ' ' MET . . . . . 0.407 ' HG2' ' CE1' ' A' ' 143' ' ' TYR . 0.4 OUTLIER -85.04 147.6 26.58 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.155 -0.965 . . . . 0.0 109.55 -179.96 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 142' ' ' VAL . . . . . . . . . . . . . 2.1 t -132.15 134.93 59.05 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.661 0 N-CA-C 108.368 -0.975 . . . . 0.0 108.368 -179.759 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 143' ' ' TYR . . . . . 0.407 ' CE1' ' HG2' ' A' ' 141' ' ' MET . 37.0 m-85 -114.03 137.53 51.59 Favored 'General case' 0 N--CA 1.499 2.008 0 O-C-N 120.792 -1.192 . . . . 0.0 111.391 -178.842 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 144' ' ' PHE . . . . . . . . . . . . . 5.1 t80 -123.15 107.02 11.28 Favored 'General case' 0 N--CA 1.494 1.77 0 CA-C-O 121.476 0.655 . . . . 0.0 109.833 -179.215 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 145' ' ' LYS . . . . . . . . . . . . . 14.7 tttt -95.55 132.83 40.25 Favored 'General case' 0 N--CA 1.495 1.799 0 O-C-N 121.417 -0.802 . . . . 0.0 111.43 -178.725 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 146' ' ' VAL . . . . . 0.458 ' O ' ' C ' ' A' ' 147' ' ' GLY . 0.0 OUTLIER -143.26 141.1 26.48 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.813 0 N-CA-C 107.629 -1.249 . . . . 0.0 107.629 178.589 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 147' ' ' GLY . . . . . 0.458 ' C ' ' O ' ' A' ' 146' ' ' VAL . . . 40.02 -126.3 2.54 Favored Glycine 0 N--CA 1.494 2.533 0 N-CA-C 109.776 -1.33 . . . . 0.0 109.776 179.778 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 148' ' ' ASN . . . . . . . . . . . . . 19.8 p30 -101.65 14.94 30.46 Favored 'General case' 0 C--N 1.302 -1.476 0 O-C-N 121.426 -1.043 . . . . 0.0 108.339 179.209 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 149' ' ' GLU . . . . . . . . . . . . . 3.2 tt0 -109.92 142.39 41.33 Favored 'General case' 0 N--CA 1.485 1.324 0 CA-C-O 121.946 0.879 . . . . 0.0 111.515 -178.43 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 150' ' ' THR . . . . . . . . . . . . . 54.3 m -129.48 101.83 6.12 Favored 'General case' 0 C--N 1.3 -1.58 0 CA-C-O 121.658 0.742 . . . . 0.0 109.713 179.81 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 151' ' ' ARG . . . . . . . . . . . . . 2.5 mtp180 -87.33 179.3 6.63 Favored 'General case' 0 C--N 1.306 -1.322 0 N-CA-C 108.601 -0.889 . . . . 0.0 108.601 179.951 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 152' ' ' LYS . . . . . 0.408 ' C ' ' CD1' ' A' ' 153' ' ' TYR . 24.6 mtmm -147.53 148.16 30.89 Favored 'General case' 0 C--N 1.302 -1.495 0 O-C-N 121.089 -1.007 . . . . 0.0 109.838 -179.671 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 153' ' ' TYR . . . . . 0.408 ' CD1' ' C ' ' A' ' 152' ' ' LYS . 20.6 m-85 -141.64 167.5 21.99 Favored 'General case' 0 N--CA 1.492 1.629 0 N-CA-C 108.491 -0.929 . . . . 0.0 108.491 179.258 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 154' ' ' LYS . . . . . 0.461 ' HZ3' HG21 ' A' ' 205' ' ' VAL . 4.4 ttpm? -137.7 122.41 18.68 Favored 'General case' 0 C--N 1.296 -1.731 0 N-CA-C 108.698 -0.853 . . . . 0.0 108.698 179.155 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 155' ' ' MET . . . . . . . . . . . . . 38.4 mmm -48.98 107.38 0.13 Allowed 'General case' 0 N--CA 1.491 1.604 0 O-C-N 120.785 -1.197 . . . . 0.0 110.904 -178.891 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 156' ' ' THR . . . . . 0.609 ' OG1' HG23 ' A' ' 203' ' ' THR . 0.0 OUTLIER -109.49 -22.18 12.12 Favored 'General case' 0 C--N 1.296 -1.748 0 C-N-CA 119.832 -0.747 . . . . 0.0 110.597 -178.959 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 157' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -151.67 146.98 26.19 Favored 'General case' 0 C--N 1.294 -1.838 0 C-N-CA 118.702 -1.199 . . . . 0.0 110.966 -178.411 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 158' ' ' ILE . . . . . 0.841 HD12 ' N ' ' A' ' 159' ' ' ARG . 0.1 OUTLIER -155.51 142.57 11.66 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.334 0 CA-C-O 121.778 0.799 . . . . 0.0 110.013 -178.834 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 159' ' ' ARG . . . . . 0.841 ' N ' HD12 ' A' ' 158' ' ' ILE . 23.1 ttm180 -155.99 160.3 39.94 Favored 'General case' 0 C--N 1.297 -1.679 0 CA-C-O 121.79 0.805 . . . . 0.0 110.44 -179.618 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 160' ' ' ASP . . . . . 0.547 ' O ' HG13 ' A' ' 161' ' ' VAL . 35.7 m-20 -116.02 161.44 18.87 Favored 'General case' 0 N--CA 1.49 1.564 0 N-CA-C 108.203 -1.036 . . . . 0.0 108.203 179.185 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 161' ' ' VAL . . . . . 0.577 HG21 ' CG1' ' A' ' 168' ' ' VAL . 3.3 m -156.79 155.01 5.57 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.63 0 O-C-N 121.117 -0.99 . . . . 0.0 110.722 -178.569 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 162' ' ' LYS . . . . . 0.438 ' O ' ' O ' ' A' ' 161' ' ' VAL . 0.0 OUTLIER -45.02 169.9 0.06 OUTLIER Pre-proline 0 N--CA 1.492 1.652 0 O-C-N 121.594 -0.691 . . . . 0.0 109.795 179.527 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 163' ' ' PRO . . . . . 0.467 ' C ' HD11 ' C' ' 702' ' ' LEU . 65.1 Cg_endo -78.54 34.59 0.51 Allowed 'Trans proline' 0 N--CA 1.493 1.466 0 C-N-CA 123.052 2.501 . . . . 0.0 113.026 -179.975 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 164' ' ' THR . . . . . 0.441 ' N ' HD11 ' C' ' 702' ' ' LEU . 0.3 OUTLIER -153.26 -3.86 0.2 Allowed 'General case' 0 N--CA 1.496 1.873 0 O-C-N 121.022 -1.049 . . . . 0.0 110.925 -179.824 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 165' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -77.2 64.44 2.62 Favored 'General case' 0 N--CA 1.496 1.857 0 O-C-N 120.861 -1.149 . . . . 0.0 110.899 -179.078 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 166' ' ' VAL . . . . . 0.593 ' O ' ' N ' ' A' ' 168' ' ' VAL . 1.4 m -46.44 -30.26 1.22 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.702 0 O-C-N 121.13 -0.981 . . . . 0.0 110.563 -178.244 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 167' ' ' GLY . . . . . . . . . . . . . . . -45.22 -9.1 0.01 OUTLIER Glycine 0 N--CA 1.498 2.796 0 O-C-N 120.694 -1.254 . . . . 0.0 111.313 -179.353 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 168' ' ' VAL . . . . . 0.593 ' N ' ' O ' ' A' ' 166' ' ' VAL . 4.2 m -53.88 -31.67 21.02 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.657 0 O-C-N 120.615 -1.521 . . . . 0.0 109.114 -179.988 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 169' ' ' LEU . . . . . 0.552 ' O ' ' C ' ' A' ' 170' ' ' ASP . 10.9 mt -45.57 -17.79 0.03 OUTLIER 'General case' 0 N--CA 1.493 1.677 0 N-CA-C 108.19 -1.041 . . . . 0.0 108.19 -178.41 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 170' ' ' ASP . . . . . 0.552 ' C ' ' O ' ' A' ' 169' ' ' LEU . 2.5 m-20 21.44 90.51 0.01 OUTLIER 'General case' 0 N--CA 1.501 2.086 0 CA-C-O 120.81 0.338 . . . . 0.0 111.797 178.151 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 171' ' ' GLU . . . . . 0.408 ' HB3' ' ND2' ' A' ' 114' ' ' ASN . 10.1 pt-20 -140.27 78.06 1.64 Allowed 'General case' 0 N--CA 1.494 1.754 0 O-C-N 120.845 -1.16 . . . . 0.0 109.808 179.512 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 172' ' ' GLN . . . . . . . . . . . . . 2.6 mp0 -136.49 -41.43 0.63 Allowed 'General case' 0 N--CA 1.495 1.793 0 O-C-N 121.453 -0.779 . . . . 0.0 110.607 -178.749 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 173' ' ' LYS . . . . . . . . . . . . . 49.7 mttp -58.24 140.41 53.2 Favored 'General case' 0 N--CA 1.493 1.686 0 O-C-N 120.74 -1.225 . . . . 0.0 108.514 179.676 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 174' ' ' GLY . . . . . 0.478 ' O ' ' C ' ' A' ' 175' ' ' LYS . . . -127.29 -46.6 0.2 Allowed Glycine 0 C--N 1.298 -1.534 0 N-CA-C 107.619 -2.192 . . . . 0.0 107.619 179.704 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 175' ' ' LYS . . . . . 0.478 ' C ' ' O ' ' A' ' 174' ' ' GLY . 27.9 mmtt -42.77 -61.42 1.26 Allowed 'General case' 0 N--CA 1.489 1.523 0 N-CA-C 108.023 -1.103 . . . . 0.0 108.023 178.611 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 176' ' ' ASP . . . . . 0.525 ' O ' ' O ' ' A' ' 177' ' ' LYS . 3.6 p30 -104.53 95.23 5.78 Favored 'General case' 0 C--N 1.299 -1.63 0 N-CA-C 108.059 -1.089 . . . . 0.0 108.059 178.086 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 177' ' ' LYS . . . . . 0.525 ' O ' ' O ' ' A' ' 176' ' ' ASP . 0.5 OUTLIER -48.39 -176.37 0.0 OUTLIER 'General case' 0 N--CA 1.494 1.734 0 O-C-N 121.119 -0.988 . . . . 0.0 109.432 -179.694 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 178' ' ' GLN . . . . . 0.456 ' OE1' ' OD1' ' A' ' 114' ' ' ASN . 9.3 pt20 -162.06 174.47 12.96 Favored 'General case' 0 C--N 1.308 -1.227 0 C-N-CA 118.605 -1.238 . . . . 0.0 110.663 179.214 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 179' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -134.62 100.36 4.61 Favored 'General case' 0 C--N 1.301 -1.518 0 N-CA-C 107.756 -1.201 . . . . 0.0 107.756 178.046 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 180' ' ' THR . . . . . 0.423 ' O ' HG22 ' A' ' 180' ' ' THR . 1.0 OUTLIER -79.99 116.62 20.23 Favored 'General case' 0 N--CA 1.493 1.707 0 O-C-N 121.095 -1.003 . . . . 0.0 110.186 -178.794 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 181' ' ' LEU . . . . . . . . . . . . . 8.8 tp -99.43 106.13 18.15 Favored 'General case' 0 C--N 1.3 -1.583 0 O-C-N 121.453 -0.779 . . . . 0.0 109.496 179.146 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 182' ' ' ILE . . . . . 0.4 ' O ' ' HA ' ' A' ' 118' ' ' ALA . 48.2 mt -93.74 127.83 45.52 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.541 0 O-C-N 120.895 -1.128 . . . . 0.0 108.76 178.909 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 183' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -144.55 111.28 5.73 Favored 'General case' 0 C--N 1.291 -1.948 0 N-CA-C 107.409 -1.33 . . . . 0.0 107.409 179.569 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 184' ' ' CYS . . . . . . . . . . . . . 15.9 p -79.62 161.0 26.16 Favored 'General case' 0 C--N 1.291 -1.975 0 C-N-CA 118.988 -1.085 . . . . 0.0 111.782 -177.334 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 185' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -166.67 -161.71 0.47 Allowed 'General case' 0 N--CA 1.494 1.775 0 O-C-N 121.665 -0.647 . . . . 0.0 109.338 179.759 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 186' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER 55.15 57.03 5.86 Favored 'General case' 0 N--CA 1.496 1.857 0 O-C-N 121.144 -0.973 . . . . 0.0 109.368 -179.838 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 187' ' ' TYR . . . . . 0.619 ' CE1' ' O ' ' A' ' 188' ' ' ASN . 65.7 t80 -67.78 137.23 55.24 Favored 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.342 -0.849 . . . . 0.0 110.703 -179.514 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 188' ' ' ASN . . . . . 0.619 ' O ' ' CE1' ' A' ' 187' ' ' TYR . 1.2 t-20 -101.98 145.66 28.96 Favored 'General case' 0 C--N 1.297 -1.697 0 N-CA-C 108.39 -0.967 . . . . 0.0 108.39 178.376 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 189' ' ' GLU . . . . . . . . . . . . . 1.9 tt0 -110.08 -14.74 14.17 Favored 'General case' 0 C--N 1.294 -1.823 0 N-CA-C 108.984 -0.747 . . . . 0.0 108.984 -179.217 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 190' ' ' LYS . . . . . . . . . . . . . 4.6 mttm -83.53 -52.36 6.54 Favored 'General case' 0 C--N 1.301 -1.506 0 C-N-CA 119.82 -0.752 . . . . 0.0 109.099 179.423 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 191' ' ' THR . . . . . 0.541 ' OG1' HG12 ' A' ' 193' ' ' VAL . 2.1 p -89.16 -9.25 51.62 Favored 'General case' 0 N--CA 1.489 1.525 0 O-C-N 121.52 -0.738 . . . . 0.0 109.235 179.799 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 192' ' ' GLY . . . . . . . . . . . . . . . 68.4 33.31 77.07 Favored Glycine 0 N--CA 1.493 2.496 0 O-C-N 121.298 -0.876 . . . . 0.0 111.119 178.606 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 193' ' ' VAL . . . . . 0.541 HG12 ' OG1' ' A' ' 191' ' ' THR . 2.4 p -147.54 169.63 3.96 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.582 0 O-C-N 120.806 -1.408 . . . . 0.0 109.891 179.169 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 194' ' ' TRP . . . . . 0.521 ' H ' HG22 ' A' ' 193' ' ' VAL . 10.7 m95 -85.74 121.55 28.56 Favored 'General case' 0 C--N 1.294 -1.836 0 O-C-N 121.648 -0.657 . . . . 0.0 109.271 -179.908 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 195' ' ' GLU . . . . . 0.512 ' CD ' ' ND2' ' A' ' 188' ' ' ASN . 7.5 mt-10 -77.31 -60.14 2.49 Favored 'General case' 0 N--CA 1.496 1.862 0 O-C-N 121.385 -0.822 . . . . 0.0 111.575 -178.521 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 196' ' ' LYS . . . . . . . . . . . . . 6.3 mtmt -92.1 158.16 16.35 Favored 'General case' 0 N--CA 1.493 1.72 0 O-C-N 120.86 -1.15 . . . . 0.0 111.397 -177.946 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 197' ' ' ARG . . . . . . . . . . . . . 25.3 mmt180 -124.14 139.17 54.19 Favored 'General case' 0 N--CA 1.488 1.466 0 N-CA-C 108.674 -0.862 . . . . 0.0 108.674 179.001 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 198' ' ' LYS . . . . . . . . . . . . . 14.9 mttt -119.8 120.63 37.07 Favored 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.544 -0.723 . . . . 0.0 110.13 -179.017 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 199' ' ' ILE . . . . . 0.566 ' C ' HD12 ' A' ' 199' ' ' ILE . 0.8 OUTLIER -139.81 119.83 13.54 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.66 0 O-C-N 121.192 -0.943 . . . . 0.0 109.562 179.43 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 200' ' ' PHE . . . . . 0.537 ' CD1' ' N ' ' A' ' 200' ' ' PHE . 8.7 m-85 -99.91 139.05 36.15 Favored 'General case' 0 N--CA 1.499 2.012 0 O-C-N 121.468 -0.77 . . . . 0.0 110.76 -178.534 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 201' ' ' VAL . . . . . . . . . . . . . 24.3 t -104.12 149.07 8.11 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.553 0 N-CA-C 107.39 -1.337 . . . . 0.0 107.39 176.489 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 202' ' ' ALA . . . . . . . . . . . . . . . -132.47 139.6 48.04 Favored 'General case' 0 C--N 1.3 -1.585 0 O-C-N 121.047 -1.033 . . . . 0.0 108.249 -179.864 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 203' ' ' THR . . . . . 0.609 HG23 ' OG1' ' A' ' 156' ' ' THR . 13.7 p -90.85 132.15 36.07 Favored 'General case' 0 C--N 1.305 -1.343 0 CA-C-O 122.647 1.213 . . . . 0.0 111.608 -178.242 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 204' ' ' GLU . . . . . 0.403 ' HA ' ' CD2' ' A' ' 153' ' ' TYR . 1.2 tm-20 -60.79 136.24 58.01 Favored 'General case' 0 C--N 1.297 -1.711 0 C-N-CA 118.334 -1.347 . . . . 0.0 108.798 179.159 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 205' ' ' VAL . . . . . 0.473 ' O ' ' C ' ' A' ' 206' ' ' LYS . 36.6 t -130.85 -35.82 0.59 Allowed 'Isoleucine or valine' 0 N--CA 1.495 1.795 0 O-C-N 121.298 -0.877 . . . . 0.0 110.189 -179.437 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 206' ' ' LYS . . . . . 0.473 ' C ' ' O ' ' A' ' 205' ' ' VAL . 0.0 OUTLIER . . . . . 0 N--CA 1.495 1.777 0 CA-C-O 117.945 -1.026 . . . . 0.0 110.259 -179.584 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' C' C ' 702' ' ' LEU . . . . . 0.632 ' N ' HD12 ' C' ' 702' ' ' LEU . 0.0 OUTLIER . . . . . 0 N--CA 1.491 1.614 0 N-CA-C 109.074 -0.713 . . . . 0.0 109.074 . . . . . . . . . 2 2 . 1 . 009 nuclear build core ' C' C ' 703' ' ' PRO . . . . . 0.476 ' HG2' ' HB1' ' A' ' 104' ' ' ALA . 31.9 Cg_exo -43.31 175.79 0.0 OUTLIER 'Trans proline' 0 N--CA 1.49 1.313 0 C-N-CA 122.593 2.195 . . . . 0.0 112.981 -179.097 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' C' C ' 704' ' ' ALA . . . . . 0.403 ' C ' ' O ' ' C' ' 703' ' ' PRO . . . . . . . . 0 N--CA 1.489 1.519 0 O-C-N 121.502 -0.749 . . . . 0.0 109.769 179.477 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 63' ' ' PRO . . . . . 0.843 ' O ' HD13 ' A' ' 110' ' ' LEU . 6.2 Cg_exo . . . . . 0 N--CA 1.487 1.094 0 CA-C-O 121.383 0.493 . . . . 0.0 111.455 . . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 64' ' ' GLN . . . . . 0.617 ' NE2' ' O ' ' A' ' 64' ' ' GLN . 0.0 OUTLIER -158.97 137.07 10.53 Favored 'General case' 0 C--N 1.299 -1.598 0 O-C-N 121.169 -0.957 . . . . 0.0 109.43 179.684 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 65' ' ' ILE . . . . . 0.75 ' N ' HD13 ' A' ' 65' ' ' ILE . 0.2 OUTLIER -50.79 110.42 1.73 Allowed Pre-proline 0 N--CA 1.489 1.501 0 O-C-N 120.829 -1.169 . . . . 0.0 108.624 179.253 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 66' ' ' PRO . . . . . . . . . . . . . 87.1 Cg_endo -82.52 -162.77 0.19 Allowed 'Trans proline' 0 C--N 1.314 -1.251 0 C-N-CA 121.998 1.798 . . . . 0.0 111.797 -179.784 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 67' ' ' LYS . . . . . . . . . . . . . 36.4 tttp -90.11 -10.28 45.23 Favored 'General case' 0 C--N 1.302 -1.481 0 O-C-N 121.176 -0.953 . . . . 0.0 109.081 179.534 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 68' ' ' ASP . . . . . 0.644 ' C ' ' H ' ' A' ' 70' ' ' SER . 0.2 OUTLIER -76.61 64.02 2.18 Favored 'General case' 0 N--CA 1.489 1.505 0 CA-C-O 122.763 1.268 . . . . 0.0 108.71 179.194 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 69' ' ' LYS . . . . . 0.459 ' C ' ' O ' ' A' ' 68' ' ' ASP . 6.3 ptpp? -46.99 -14.16 0.03 OUTLIER 'General case' 0 N--CA 1.508 2.472 0 C-N-CA 117.259 -1.776 . . . . 0.0 106.701 177.534 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 70' ' ' SER . . . . . 0.644 ' H ' ' C ' ' A' ' 68' ' ' ASP . 3.4 p -85.93 -6.36 59.08 Favored 'General case' 0 N--CA 1.496 1.839 0 CA-C-N 113.414 -1.721 . . . . 0.0 111.496 179.564 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 71' ' ' LYS . . . . . 0.496 ' N ' ' O ' ' A' ' 68' ' ' ASP . 0.0 OUTLIER -95.35 142.6 27.55 Favored 'General case' 0 N--CA 1.501 2.079 0 O-C-N 120.579 -1.325 . . . . 0.0 112.225 -179.288 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 72' ' ' VAL . . . . . 0.691 HG12 ' CZ ' ' A' ' 88' ' ' TYR . 3.1 m -66.46 134.44 29.95 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.5 0 N-CA-C 104.318 -2.475 . . . . 0.0 104.318 174.65 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 73' ' ' ALA . . . . . 0.517 ' N ' ' O ' ' A' ' 87' ' ' VAL . . . -81.47 -15.65 54.37 Favored 'General case' 0 C--N 1.291 -1.967 0 O-C-N 119.849 -1.782 . . . . 0.0 106.859 179.985 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . 172.16 -155.78 24.23 Favored Glycine 0 C--N 1.298 -1.533 0 N-CA-C 109.817 -1.313 . . . . 0.0 109.817 179.512 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 75' ' ' TYR . . . . . 0.527 ' HA ' HG23 ' A' ' 87' ' ' VAL . 73.0 m-85 -142.56 169.99 16.54 Favored 'General case' 0 C--N 1.297 -1.684 0 CA-C-O 122.06 0.933 . . . . 0.0 110.848 -177.459 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 76' ' ' ILE . . . . . . . . . . . . . 1.0 OUTLIER -150.15 146.9 16.46 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.814 0 C-N-CA 119.58 -0.848 . . . . 0.0 109.179 -178.382 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -151.15 164.8 35.68 Favored 'General case' 0 C--N 1.302 -1.494 0 O-C-N 120.919 -1.113 . . . . 0.0 109.262 -179.734 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 78' ' ' ILE . . . . . 0.512 ' HB ' ' HB3' ' A' ' 81' ' ' ALA . 10.0 mt -147.91 92.97 4.57 Favored Pre-proline 0 N--CA 1.488 1.425 0 N-CA-C 108.516 -0.92 . . . . 0.0 108.516 179.998 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 79' ' ' PRO . . . . . . . . . . . . . 72.3 Cg_exo -46.77 -43.54 23.41 Favored 'Trans proline' 0 N--CA 1.494 1.536 0 C-N-CA 122.852 2.368 . . . . 0.0 113.954 -178.972 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 37.9 t70 -65.54 -20.62 66.41 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 120.665 -1.272 . . . . 0.0 110.343 178.582 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 81' ' ' ALA . . . . . 0.788 ' HB2' ' HB2' ' A' ' 136' ' ' ALA . . . -106.33 -15.05 14.93 Favored 'General case' 0 C--N 1.302 -1.471 0 O-C-N 121.354 -0.841 . . . . 0.0 108.762 179.664 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 82' ' ' ASP . . . . . . . . . . . . . 2.5 t70 66.38 49.51 1.41 Allowed 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.163 -0.961 . . . . 0.0 110.227 179.506 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 83' ' ' ILE . . . . . 0.685 HD11 ' OD1' ' A' ' 132' ' ' ASN . 62.7 mt -128.57 151.38 35.28 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.786 0 O-C-N 121.259 -0.901 . . . . 0.0 110.333 -178.988 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 84' ' ' LYS . . . . . . . . . . . . . 17.4 tttt -159.53 106.42 1.7 Allowed 'General case' 0 N--CA 1.493 1.69 0 N-CA-C 108.416 -0.957 . . . . 0.0 108.416 178.964 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 85' ' ' GLU . . . . . 0.54 ' OE2' ' N ' ' A' ' 85' ' ' GLU . 0.0 OUTLIER -140.07 165.77 28.37 Favored Pre-proline 0 N--CA 1.491 1.621 0 O-C-N 121.393 -0.817 . . . . 0.0 109.858 -179.008 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 86' ' ' PRO . . . . . . . . . . . . . 56.9 Cg_endo -74.27 166.53 29.3 Favored 'Trans proline' 0 N--CA 1.496 1.621 0 C-N-CA 123.116 2.544 . . . . 0.0 113.779 -178.548 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 87' ' ' VAL . . . . . 0.527 HG23 ' HA ' ' A' ' 75' ' ' TYR . 61.3 t -122.9 100.07 7.6 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.539 0 N-CA-C 109.093 -0.706 . . . . 0.0 109.093 179.715 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 88' ' ' TYR . . . . . 0.691 ' CZ ' HG12 ' A' ' 72' ' ' VAL . 42.1 m-85 -91.87 154.76 43.7 Favored Pre-proline 0 N--CA 1.505 2.298 0 O-C-N 120.944 -1.098 . . . . 0.0 110.086 -179.359 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 89' ' ' PRO . . . . . . . . . . . . . 7.0 Cg_endo -56.84 145.78 81.98 Favored 'Trans proline' 0 N--CA 1.494 1.537 0 C-N-CA 122.467 2.111 . . . . 0.0 113.119 179.157 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . -63.57 169.52 19.56 Favored Glycine 0 N--CA 1.492 2.415 0 N-CA-C 109.159 -1.576 . . . . 0.0 109.159 179.188 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 91' ' ' PRO . . . . . . . . . . . . . 73.0 Cg_endo -93.4 170.25 19.82 Favored 'Cis proline' 0 C--N 1.309 -1.519 0 C-N-CA 123.939 -1.275 . . . . 0.0 112.424 0.101 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 92' ' ' ALA . . . . . 0.437 ' HB3' ' HB3' ' C' ' 703' ' ' PRO . . . -73.09 33.68 0.07 Allowed 'General case' 0 N--CA 1.494 1.767 0 O-C-N 121.323 -0.861 . . . . 0.0 111.261 -179.399 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 93' ' ' THR . . . . . 0.414 ' O ' ' C ' ' A' ' 94' ' ' PRO . 1.0 OUTLIER -73.54 152.5 89.66 Favored Pre-proline 0 C--N 1.3 -1.547 0 O-C-N 120.48 -1.387 . . . . 0.0 108.146 179.729 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 94' ' ' PRO . . . . . 0.414 ' C ' ' O ' ' A' ' 93' ' ' THR . 94.6 Cg_exo -33.29 -57.06 0.35 Allowed 'Trans proline' 0 C--N 1.306 -1.702 0 C-N-CA 122.749 2.299 . . . . 0.0 112.621 -178.463 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 88.0 mt-10 -46.57 -50.29 17.55 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.256 -0.902 . . . . 0.0 110.094 -179.896 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 96' ' ' GLN . . . . . 0.498 ' CD ' ' N ' ' A' ' 96' ' ' GLN . 10.9 mp0 -71.48 -45.41 62.61 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 120.992 -1.067 . . . . 0.0 110.534 -179.231 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 97' ' ' LEU . . . . . 0.422 HD23 ' HA ' ' A' ' 97' ' ' LEU . 61.5 mt -57.64 -7.29 0.63 Allowed 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.095 -1.003 . . . . 0.0 110.473 -178.585 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 98' ' ' ASN . . . . . 0.474 ' ND2' ' O ' ' A' ' 98' ' ' ASN . 0.0 OUTLIER -77.66 -29.09 51.41 Favored 'General case' 0 N--CA 1.494 1.759 0 O-C-N 120.946 -1.097 . . . . 0.0 109.44 179.208 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 99' ' ' ARG . . . . . 0.667 HH11 ' CG ' ' A' ' 99' ' ' ARG . 1.1 mtt-85 -90.17 -44.63 9.64 Favored 'General case' 0 N--CA 1.489 1.495 0 O-C-N 121.667 -0.646 . . . . 0.0 110.322 -178.36 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . 173.71 175.83 41.71 Favored Glycine 0 N--CA 1.491 2.335 0 C-N-CA 119.342 -1.409 . . . . 0.0 110.343 179.938 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 101' ' ' VAL . . . . . 0.692 HG23 ' O ' ' A' ' 101' ' ' VAL . 33.5 m -50.05 109.0 0.1 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.543 0 O-C-N 121.564 -0.962 . . . . 0.0 109.029 179.814 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -92.58 159.29 15.55 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.159 -0.963 . . . . 0.0 110.683 -179.321 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 103' ' ' PHE . . . . . 0.58 ' O ' ' N ' ' A' ' 105' ' ' GLU . 26.7 m-85 -61.1 123.79 18.67 Favored 'General case' 0 N--CA 1.491 1.58 0 N-CA-C 107.982 -1.118 . . . . 0.0 107.982 178.662 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 104' ' ' ALA . . . . . 0.562 ' HB1' ' HG2' ' C' ' 703' ' ' PRO . . . -47.04 -9.75 0.02 OUTLIER 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.061 -1.024 . . . . 0.0 110.249 -179.073 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 105' ' ' GLU . . . . . 0.58 ' N ' ' O ' ' A' ' 103' ' ' PHE . 0.4 OUTLIER -137.89 142.84 40.66 Favored 'General case' 0 N--CA 1.496 1.839 0 O-C-N 120.803 -1.186 . . . . 0.0 110.266 179.643 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 106' ' ' GLU . . . . . . . . . . . . . 33.6 tt0 -58.24 -63.33 1.3 Allowed 'General case' 0 C--N 1.301 -1.516 0 O-C-N 121.951 -0.468 . . . . 0.0 110.661 -179.458 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 107' ' ' ASN . . . . . . . . . . . . . 7.6 m120 -78.67 34.98 0.23 Allowed 'General case' 0 N--CA 1.488 1.449 0 O-C-N 120.874 -1.141 . . . . 0.0 112.969 -175.924 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 108' ' ' GLU . . . . . . . . . . . . . 1.7 tp10 -60.55 148.28 38.57 Favored 'General case' 0 N--CA 1.489 1.486 0 O-C-N 120.685 -1.259 . . . . 0.0 108.327 179.766 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 109' ' ' SER . . . . . . . . . . . . . 2.8 t -98.02 146.91 25.05 Favored 'General case' 0 N--CA 1.489 1.482 0 O-C-N 121.115 -0.991 . . . . 0.0 110.664 -178.675 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 110' ' ' LEU . . . . . 0.843 HD13 ' O ' ' A' ' 63' ' ' PRO . 0.6 OUTLIER -63.42 -22.6 66.98 Favored 'General case' 0 C--N 1.301 -1.543 0 N-CA-C 107.974 -1.121 . . . . 0.0 107.974 179.136 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 111' ' ' ASP . . . . . 0.579 ' CG ' HH22 ' A' ' 151' ' ' ARG . 48.5 m-20 -132.81 44.01 2.91 Favored 'General case' 0 N--CA 1.487 1.412 0 O-C-N 121.589 -0.694 . . . . 0.0 110.21 -179.779 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 112' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -67.96 150.16 48.85 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 120.99 -1.069 . . . . 0.0 110.069 179.557 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 113' ' ' GLN . . . . . . . . . . . . . 2.3 mp0 -65.93 -13.92 60.61 Favored 'General case' 0 N--CA 1.488 1.475 0 N-CA-C 108.008 -1.108 . . . . 0.0 108.008 178.426 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 114' ' ' ASN . . . . . 0.436 ' ND2' ' O ' ' A' ' 170' ' ' ASP . 1.8 t30 -147.87 99.26 3.06 Favored 'General case' 0 C--N 1.301 -1.523 0 N-CA-C 107.206 -1.405 . . . . 0.0 107.206 178.193 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 115' ' ' ILE . . . . . 0.474 ' O ' HG22 ' A' ' 115' ' ' ILE . 2.9 mt -98.13 111.41 27.79 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.627 0 O-C-N 120.969 -1.082 . . . . 0.0 109.637 -179.013 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 116' ' ' SER . . . . . . . . . . . . . 87.5 p -101.87 151.42 22.11 Favored 'General case' 0 N--CA 1.491 1.604 0 CA-C-O 122.055 0.931 . . . . 0.0 111.86 -178.329 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 117' ' ' ILE . . . . . . . . . . . . . 2.1 mt -139.66 159.78 27.54 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.599 0 N-CA-C 108.496 -0.927 . . . . 0.0 108.496 179.504 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 118' ' ' ALA . . . . . 0.867 ' HB1' ' HB2' ' C' ' 704' ' ' ALA . . . -143.3 155.72 44.53 Favored 'General case' 0 N--CA 1.489 1.518 0 C-N-CA 118.758 -1.177 . . . . 0.0 111.326 -179.391 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 119' ' ' GLY . . . . . . . . . . . . . . . -166.32 146.07 10.61 Favored Glycine 0 N--CA 1.485 1.966 0 N-CA-C 110.358 -1.097 . . . . 0.0 110.358 -179.854 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 120' ' ' HIS . . . . . . . . . . . . . 35.1 m170 -71.63 167.28 20.14 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.93 -0.747 . . . . 0.0 109.721 179.202 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 121' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -116.33 147.31 41.7 Favored 'General case' 0 N--CA 1.495 1.779 0 N-CA-C 108.158 -1.053 . . . . 0.0 108.158 178.533 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 122' ' ' PHE . . . . . 0.642 ' O ' HG21 ' A' ' 131' ' ' THR . 0.3 OUTLIER -110.61 123.56 50.21 Favored 'General case' 0 N--CA 1.497 1.924 0 O-C-N 120.908 -1.12 . . . . 0.0 109.955 -179.874 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 123' ' ' ILE . . . . . 0.615 HG23 ' N ' ' A' ' 124' ' ' ASP . 11.8 tt -69.17 -42.96 81.85 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.824 0 O-C-N 121.367 -0.833 . . . . 0.0 109.4 179.427 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 124' ' ' ASP . . . . . 0.615 ' N ' HG23 ' A' ' 123' ' ' ILE . 61.1 t0 -93.24 23.81 4.21 Favored 'General case' 0 N--CA 1.494 1.747 0 O-C-N 121.421 -0.799 . . . . 0.0 111.136 -179.16 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 125' ' ' ARG . . . . . . . . . . . . . 3.3 ttt180 -157.9 107.35 1.76 Allowed Pre-proline 0 N--CA 1.492 1.667 0 O-C-N 120.616 -1.303 . . . . 0.0 110.253 -179.523 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 126' ' ' PRO . . . . . . . . . . . . . 71.9 Cg_endo -83.05 -20.24 5.29 Favored 'Trans proline' 0 C--N 1.314 -1.289 0 C-N-CA 122.368 2.046 . . . . 0.0 112.325 179.482 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 127' ' ' ASN . . . . . . . . . . . . . 19.1 m-20 -91.12 23.93 3.06 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.276 -0.89 . . . . 0.0 109.668 179.94 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 128' ' ' TYR . . . . . . . . . . . . . 10.0 t80 -81.09 -149.4 0.07 Allowed 'General case' 0 C--N 1.301 -1.516 0 O-C-N 121.162 -0.961 . . . . 0.0 109.589 -179.692 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 129' ' ' GLN . . . . . . . . . . . . . 69.2 mt-30 -67.12 -69.61 0.3 Allowed 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.246 -0.909 . . . . 0.0 110.684 -178.941 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 130' ' ' PHE . . . . . 0.492 ' CE2' HG11 ' A' ' 101' ' ' VAL . 52.8 m-85 -129.23 36.72 4.13 Favored 'General case' 0 N--CA 1.496 1.827 0 O-C-N 121.249 -0.907 . . . . 0.0 110.524 -179.214 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 131' ' ' THR . . . . . 0.642 HG21 ' O ' ' A' ' 122' ' ' PHE . 33.8 m -80.86 -33.72 34.27 Favored 'General case' 0 N--CA 1.493 1.687 0 O-C-N 120.815 -1.178 . . . . 0.0 108.965 179.461 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 132' ' ' ASN . . . . . 0.685 ' OD1' HD11 ' A' ' 83' ' ' ILE . 0.1 OUTLIER -84.62 5.89 26.12 Favored 'General case' 0 N--CA 1.495 1.8 0 CA-C-O 121.876 0.846 . . . . 0.0 109.986 -179.246 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 133' ' ' LEU . . . . . 0.599 ' O ' ' N ' ' A' ' 135' ' ' ALA . 0.2 OUTLIER -68.5 -46.76 68.77 Favored 'General case' 0 C--N 1.299 -1.595 0 O-C-N 121.159 -0.963 . . . . 0.0 110.529 -179.748 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 134' ' ' LYS . . . . . 0.543 ' H ' ' CD ' ' A' ' 134' ' ' LYS . 0.1 OUTLIER -41.68 -18.18 0.01 OUTLIER 'General case' 0 N--CA 1.496 1.826 0 O-C-N 121.07 -1.019 . . . . 0.0 110.328 -179.133 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 135' ' ' ALA . . . . . 0.599 ' N ' ' O ' ' A' ' 133' ' ' LEU . . . -82.87 -39.48 21.54 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 120.951 -1.093 . . . . 0.0 109.855 -179.773 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 136' ' ' ALA . . . . . 0.788 ' HB2' ' HB2' ' A' ' 81' ' ' ALA . . . -78.9 156.63 28.52 Favored 'General case' 0 C--N 1.299 -1.59 0 CA-C-O 122.179 0.99 . . . . 0.0 111.698 -178.506 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 137' ' ' LYS . . . . . 0.513 ' O ' ' O ' ' A' ' 138' ' ' LYS . 1.2 ttmt -156.01 -163.21 1.43 Allowed 'General case' 0 N--CA 1.49 1.543 0 C-N-CA 118.832 -1.147 . . . . 0.0 110.455 -178.92 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 138' ' ' LYS . . . . . 0.596 ' O ' ' N ' ' A' ' 140' ' ' SER . 0.1 OUTLIER -46.44 -178.29 0.0 OUTLIER 'General case' 0 C--N 1.302 -1.479 0 CA-C-O 122.043 0.925 . . . . 0.0 110.36 -179.332 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 139' ' ' GLY . . . . . . . . . . . . . . . 45.84 8.1 0.02 OUTLIER Glycine 0 N--CA 1.492 2.411 0 N-CA-C 110.707 -0.957 . . . . 0.0 110.707 179.956 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 140' ' ' SER . . . . . 0.596 ' N ' ' O ' ' A' ' 138' ' ' LYS . 66.1 m -90.54 136.86 32.79 Favored 'General case' 0 N--CA 1.493 1.7 0 O-C-N 120.768 -1.43 . . . . 0.0 109.606 179.412 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 141' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -78.21 142.16 38.11 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.092 -1.005 . . . . 0.0 109.154 179.729 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 142' ' ' VAL . . . . . . . . . . . . . 21.2 t -131.14 127.82 61.2 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.711 0 O-C-N 121.366 -0.834 . . . . 0.0 109.148 -179.845 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 143' ' ' TYR . . . . . . . . . . . . . 6.4 m-85 -105.51 134.22 48.99 Favored 'General case' 0 N--CA 1.498 1.971 0 O-C-N 121.313 -0.867 . . . . 0.0 112.223 -177.913 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 144' ' ' PHE . . . . . . . . . . . . . 57.4 t80 -119.7 98.09 5.95 Favored 'General case' 0 N--CA 1.494 1.741 0 CA-C-O 121.403 0.62 . . . . 0.0 109.406 179.409 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 145' ' ' LYS . . . . . . . . . . . . . 11.8 mttt -93.49 128.44 39.6 Favored 'General case' 0 N--CA 1.492 1.668 0 O-C-N 121.361 -0.837 . . . . 0.0 110.632 -179.217 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 146' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -142.11 137.87 30.23 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.778 0 N-CA-C 107.619 -1.252 . . . . 0.0 107.619 179.098 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 147' ' ' GLY . . . . . . . . . . . . . . . 48.45 -134.06 19.93 Favored Glycine 0 N--CA 1.49 2.241 0 N-CA-C 108.854 -1.698 . . . . 0.0 108.854 -179.493 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 148' ' ' ASN . . . . . . . . . . . . . 21.4 p30 -101.17 18.52 19.66 Favored 'General case' 0 C--N 1.301 -1.516 0 O-C-N 121.229 -1.159 . . . . 0.0 107.941 178.959 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 149' ' ' GLU . . . . . . . . . . . . . 26.2 tt0 -112.59 147.46 36.61 Favored 'General case' 0 N--CA 1.484 1.266 0 CA-C-O 121.97 0.89 . . . . 0.0 111.255 -178.957 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 150' ' ' THR . . . . . 0.468 ' O ' HG22 ' A' ' 150' ' ' THR . 1.7 m -129.42 103.64 7.02 Favored 'General case' 0 N--CA 1.489 1.509 0 CA-C-O 121.477 0.656 . . . . 0.0 110.052 -179.966 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 151' ' ' ARG . . . . . 0.579 HH22 ' CG ' ' A' ' 111' ' ' ASP . 94.5 mtt180 -93.05 128.75 39.06 Favored 'General case' 0 N--CA 1.487 1.403 0 N-CA-C 107.938 -1.134 . . . . 0.0 107.938 179.008 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 152' ' ' LYS . . . . . 0.432 ' O ' ' N ' ' A' ' 205' ' ' VAL . 14.4 mtmt -91.68 156.01 17.9 Favored 'General case' 0 C--N 1.297 -1.697 0 C-N-CA 119.183 -1.007 . . . . 0.0 110.021 -179.115 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 153' ' ' TYR . . . . . 0.516 ' CD2' ' HA ' ' A' ' 204' ' ' GLU . 30.7 m-85 -143.51 167.1 23.02 Favored 'General case' 0 N--CA 1.49 1.536 0 N-CA-C 107.428 -1.323 . . . . 0.0 107.428 178.953 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 154' ' ' LYS . . . . . . . . . . . . . 17.8 ttpt -143.16 123.0 13.44 Favored 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.071 -1.018 . . . . 0.0 108.286 178.592 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 155' ' ' MET . . . . . . . . . . . . . 3.6 mtt -47.07 109.49 0.21 Allowed 'General case' 0 N--CA 1.492 1.674 0 O-C-N 120.856 -1.153 . . . . 0.0 111.207 -178.595 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 156' ' ' THR . . . . . 0.458 ' OG1' ' N ' ' A' ' 203' ' ' THR . 0.2 OUTLIER -103.89 -29.78 10.75 Favored 'General case' 0 C--N 1.29 -1.99 0 CA-C-N 115.269 -0.878 . . . . 0.0 110.102 -178.915 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 157' ' ' SER . . . . . 0.409 ' O ' ' N ' ' A' ' 201' ' ' VAL . 0.1 OUTLIER -155.71 157.58 36.83 Favored 'General case' 0 N--CA 1.492 1.641 0 C-N-CA 118.438 -1.305 . . . . 0.0 111.556 -178.816 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 158' ' ' ILE . . . . . 0.465 HG13 ' CD2' ' A' ' 200' ' ' PHE . 0.0 OUTLIER -156.77 148.23 11.14 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.393 0 CA-C-O 121.823 0.82 . . . . 0.0 110.285 179.823 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 159' ' ' ARG . . . . . 0.454 ' O ' ' OD1' ' A' ' 160' ' ' ASP . 6.1 ttm180 -153.59 -173.24 4.5 Favored 'General case' 0 C--N 1.299 -1.622 0 CA-C-O 121.737 0.779 . . . . 0.0 110.502 -179.559 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 160' ' ' ASP . . . . . 0.454 ' OD1' ' O ' ' A' ' 159' ' ' ARG . 2.5 m-20 -145.0 158.78 43.71 Favored 'General case' 0 C--N 1.301 -1.535 0 N-CA-C 108.378 -0.971 . . . . 0.0 108.378 -179.817 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 161' ' ' VAL . . . . . 0.451 HG21 HG22 ' A' ' 168' ' ' VAL . 0.1 OUTLIER -155.57 157.27 4.19 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.99 0 O-C-N 120.994 -1.066 . . . . 0.0 110.686 179.706 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 162' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -46.22 169.19 0.09 OUTLIER Pre-proline 0 N--CA 1.496 1.827 0 O-C-N 121.419 -0.801 . . . . 0.0 110.372 -179.776 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 163' ' ' PRO . . . . . . . . . . . . . 73.8 Cg_endo -78.97 28.57 0.49 Allowed 'Trans proline' 0 N--CA 1.493 1.466 0 C-N-CA 123.025 2.483 . . . . 0.0 113.575 -179.778 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 164' ' ' THR . . . . . 0.585 ' O ' HG22 ' A' ' 164' ' ' THR . 67.3 m -150.87 -2.66 0.34 Allowed 'General case' 0 N--CA 1.496 1.842 0 O-C-N 120.962 -1.086 . . . . 0.0 110.012 179.792 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 165' ' ' ASP . . . . . 0.927 ' O ' HG23 ' A' ' 168' ' ' VAL . 2.2 t70 -76.3 64.98 2.15 Favored 'General case' 0 N--CA 1.488 1.471 0 O-C-N 121.203 -0.936 . . . . 0.0 110.112 -179.957 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 166' ' ' VAL . . . . . 0.605 ' O ' ' N ' ' A' ' 168' ' ' VAL . 1.0 OUTLIER -44.4 -32.05 0.78 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.531 0 O-C-N 120.943 -1.098 . . . . 0.0 108.805 -179.099 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 167' ' ' GLY . . . . . 0.446 ' C ' ' O ' ' A' ' 166' ' ' VAL . . . -42.67 -16.76 0.03 OUTLIER Glycine 0 N--CA 1.491 2.316 0 N-CA-C 109.795 -1.322 . . . . 0.0 109.795 179.535 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 168' ' ' VAL . . . . . 0.927 HG23 ' O ' ' A' ' 165' ' ' ASP . 47.6 t -50.27 -32.6 9.44 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.434 0 O-C-N 121.014 -1.286 . . . . 0.0 108.455 179.728 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 169' ' ' LEU . . . . . 0.518 ' O ' ' C ' ' A' ' 170' ' ' ASP . 98.8 mt -46.91 -14.48 0.03 OUTLIER 'General case' 0 N--CA 1.49 1.566 0 N-CA-C 108.075 -1.083 . . . . 0.0 108.075 -178.816 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 170' ' ' ASP . . . . . 0.567 ' N ' ' O ' ' A' ' 168' ' ' VAL . 9.2 p30 19.94 91.0 0.01 OUTLIER 'General case' 0 N--CA 1.499 2.012 0 N-CA-C 112.651 0.611 . . . . 0.0 112.651 177.669 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 171' ' ' GLU . . . . . . . . . . . . . 16.5 pt-20 -127.02 69.14 1.27 Allowed 'General case' 0 N--CA 1.495 1.809 0 O-C-N 121.099 -1.001 . . . . 0.0 109.493 178.488 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 172' ' ' GLN . . . . . . . . . . . . . 1.6 mp0 -133.69 -47.41 0.81 Allowed 'General case' 0 N--CA 1.495 1.79 0 O-C-N 121.329 -0.857 . . . . 0.0 110.723 -178.387 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 173' ' ' LYS . . . . . . . . . . . . . 9.0 mttp -63.4 125.56 24.58 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 120.835 -1.165 . . . . 0.0 108.992 179.861 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 174' ' ' GLY . . . . . 0.564 ' O ' ' C ' ' A' ' 175' ' ' LYS . . . -133.2 -39.13 0.21 Allowed Glycine 0 C--N 1.298 -1.541 0 N-CA-C 108.543 -1.823 . . . . 0.0 108.543 179.888 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 175' ' ' LYS . . . . . 0.564 ' C ' ' O ' ' A' ' 174' ' ' GLY . 3.8 mptt -32.33 -63.36 0.2 Allowed 'General case' 0 N--CA 1.499 2.015 0 N-CA-C 108.14 -1.059 . . . . 0.0 108.14 179.576 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 176' ' ' ASP . . . . . 0.665 ' O ' ' O ' ' A' ' 177' ' ' LYS . 1.0 OUTLIER -103.01 77.37 1.55 Allowed 'General case' 0 C--N 1.296 -1.72 0 N-CA-C 106.418 -1.697 . . . . 0.0 106.418 176.413 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 177' ' ' LYS . . . . . 0.665 ' O ' ' O ' ' A' ' 176' ' ' ASP . 10.1 mttt -26.74 163.55 0.0 OUTLIER 'General case' 0 N--CA 1.505 2.313 0 CA-C-O 122.091 0.948 . . . . 0.0 112.047 -178.111 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 178' ' ' GLN . . . . . 0.676 ' NE2' HG13 ' A' ' 201' ' ' VAL . 0.0 OUTLIER -158.45 168.33 27.23 Favored 'General case' 0 N--CA 1.489 1.499 0 C-N-CA 117.832 -1.547 . . . . 0.0 111.96 -179.792 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 179' ' ' LEU . . . . . 0.408 ' HB2' ' CE2' ' A' ' 153' ' ' TYR . 0.6 OUTLIER -124.65 101.9 7.34 Favored 'General case' 0 C--N 1.302 -1.47 0 N-CA-C 107.074 -1.454 . . . . 0.0 107.074 178.453 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 180' ' ' THR . . . . . . . . . . . . . 2.1 m -76.12 122.38 24.2 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.202 -0.936 . . . . 0.0 110.595 -177.973 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 181' ' ' LEU . . . . . . . . . . . . . 9.8 tp -98.8 111.79 24.07 Favored 'General case' 0 N--CA 1.493 1.706 0 O-C-N 121.272 -0.893 . . . . 0.0 109.23 178.774 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 182' ' ' ILE . . . . . 0.563 HG23 HG22 ' A' ' 199' ' ' ILE . 37.1 mt -100.1 122.99 52.66 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.489 0 O-C-N 120.972 -1.08 . . . . 0.0 109.148 178.357 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 183' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -138.9 107.12 5.76 Favored 'General case' 0 C--N 1.296 -1.743 0 N-CA-C 107.882 -1.155 . . . . 0.0 107.882 179.045 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 184' ' ' CYS . . . . . . . . . . . . . 1.9 p -80.88 157.27 25.7 Favored 'General case' 0 N--CA 1.497 1.915 0 C-N-CA 119.275 -0.97 . . . . 0.0 111.597 -177.48 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 185' ' ' ASP . . . . . 0.586 ' OD1' ' N ' ' A' ' 186' ' ' ASP . 20.0 t0 -167.27 177.16 6.27 Favored 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.635 -0.666 . . . . 0.0 109.393 -179.769 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 186' ' ' ASP . . . . . 0.586 ' N ' ' OD1' ' A' ' 185' ' ' ASP . 0.4 OUTLIER 81.05 54.6 0.02 OUTLIER 'General case' 0 N--CA 1.497 1.884 0 O-C-N 121.336 -0.853 . . . . 0.0 109.598 -179.779 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 187' ' ' TYR . . . . . 0.595 ' CE1' ' O ' ' A' ' 188' ' ' ASN . 37.2 t80 -66.07 132.54 48.76 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.124 -0.985 . . . . 0.0 110.204 -179.941 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 188' ' ' ASN . . . . . 0.834 ' ND2' ' H ' ' A' ' 193' ' ' VAL . 0.5 OUTLIER -99.93 149.72 23.14 Favored 'General case' 0 C--N 1.298 -1.632 0 N-CA-C 107.441 -1.318 . . . . 0.0 107.441 178.115 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 189' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -112.11 -2.84 14.88 Favored 'General case' 0 C--N 1.291 -1.938 0 N-CA-C 108.647 -0.872 . . . . 0.0 108.647 -179.179 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 190' ' ' LYS . . . . . . . . . . . . . 32.9 mttt -83.73 -59.8 2.32 Favored 'General case' 0 N--CA 1.488 1.439 0 N-CA-C 108.48 -0.933 . . . . 0.0 108.48 178.581 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 191' ' ' THR . . . . . 0.592 ' OG1' ' ND2' ' A' ' 188' ' ' ASN . 1.3 p -88.25 -12.18 44.42 Favored 'General case' 0 N--CA 1.493 1.687 0 O-C-N 121.338 -0.851 . . . . 0.0 108.954 179.094 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 192' ' ' GLY . . . . . 0.418 ' N ' ' OD1' ' A' ' 188' ' ' ASN . . . 73.29 41.54 45.74 Favored Glycine 0 N--CA 1.493 2.496 0 N-CA-C 110.588 -1.005 . . . . 0.0 110.588 178.902 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 193' ' ' VAL . . . . . 0.834 ' H ' ' ND2' ' A' ' 188' ' ' ASN . 95.9 t -149.14 163.52 4.4 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.612 0 O-C-N 121.043 -1.269 . . . . 0.0 110.542 179.817 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 194' ' ' TRP . . . . . 0.606 ' N ' HG12 ' A' ' 193' ' ' VAL . 73.4 m95 -83.07 121.55 27.18 Favored 'General case' 0 N--CA 1.49 1.553 0 N-CA-C 108.572 -0.899 . . . . 0.0 108.572 179.358 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 195' ' ' GLU . . . . . . . . . . . . . 2.3 mt-10 -89.65 -61.05 1.78 Allowed 'General case' 0 N--CA 1.495 1.796 0 O-C-N 121.401 -0.812 . . . . 0.0 112.089 -177.523 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 196' ' ' LYS . . . . . . . . . . . . . 12.5 tttt -75.88 148.36 38.36 Favored 'General case' 0 N--CA 1.494 1.736 0 O-C-N 121.142 -0.974 . . . . 0.0 111.068 -177.876 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 197' ' ' ARG . . . . . 0.567 ' CD ' HD22 ' C' ' 702' ' ' LEU . 21.8 mmt180 -124.45 128.56 49.2 Favored 'General case' 0 N--CA 1.494 1.74 0 N-CA-C 108.274 -1.009 . . . . 0.0 108.274 178.361 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 198' ' ' LYS . . . . . . . . . . . . . 11.1 mmtp -116.13 118.42 32.79 Favored 'General case' 0 C--N 1.3 -1.587 0 O-C-N 121.59 -0.694 . . . . 0.0 110.27 -178.916 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 199' ' ' ILE . . . . . 0.693 HG21 HG11 ' A' ' 168' ' ' VAL . 0.8 OUTLIER -136.95 121.39 24.05 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.768 0 CA-C-O 122.6 1.19 . . . . 0.0 110.877 179.474 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 200' ' ' PHE . . . . . 0.515 ' CD1' ' N ' ' A' ' 200' ' ' PHE . 3.1 m-85 -99.3 135.6 40.48 Favored 'General case' 0 N--CA 1.502 2.171 0 O-C-N 120.941 -1.099 . . . . 0.0 109.979 -178.293 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 201' ' ' VAL . . . . . 0.676 HG13 ' NE2' ' A' ' 178' ' ' GLN . 84.4 t -105.33 146.29 12.53 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.849 0 O-C-N 120.94 -1.1 . . . . 0.0 108.968 177.315 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 202' ' ' ALA . . . . . 0.402 ' HA ' ' H ' ' A' ' 156' ' ' THR . . . -134.32 141.46 46.93 Favored 'General case' 0 N--CA 1.493 1.677 0 O-C-N 121.031 -1.043 . . . . 0.0 109.628 -179.749 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 203' ' ' THR . . . . . 0.458 ' N ' ' OG1' ' A' ' 156' ' ' THR . 0.8 OUTLIER -88.93 130.64 35.4 Favored 'General case' 0 N--CA 1.488 1.426 0 CA-C-O 122.457 1.122 . . . . 0.0 111.27 -178.769 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 204' ' ' GLU . . . . . 0.516 ' HA ' ' CD2' ' A' ' 153' ' ' TYR . 1.3 tm-20 -49.39 134.52 18.78 Favored 'General case' 0 C--N 1.297 -1.713 0 C-N-CA 119.223 -0.991 . . . . 0.0 109.28 179.124 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 205' ' ' VAL . . . . . 0.516 ' CG1' ' N ' ' A' ' 206' ' ' LYS . 28.4 t -122.26 162.32 22.05 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.436 0 CA-C-O 122.055 0.931 . . . . 0.0 110.357 -178.02 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 206' ' ' LYS . . . . . 0.516 ' N ' ' CG1' ' A' ' 205' ' ' VAL . 1.3 ptpp? . . . . . 0 C--N 1.294 -1.838 0 CA-C-O 117.906 -1.045 . . . . 0.0 109.37 179.717 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' C' C ' 702' ' ' LEU . . . . . 0.911 ' N ' HD12 ' C' ' 702' ' ' LEU . 0.0 OUTLIER . . . . . 0 N--CA 1.494 1.744 0 N-CA-C 110.231 -0.285 . . . . 0.0 110.231 . . . . . . . . . 2 2 . 1 . 010 nuclear build core ' C' C ' 703' ' ' PRO . . . . . 0.562 ' HG2' ' HB1' ' A' ' 104' ' ' ALA . 51.0 Cg_exo -50.87 -157.23 0.0 OUTLIER 'Trans proline' 0 N--CA 1.496 1.646 0 C-N-CA 122.096 1.864 . . . . 0.0 112.6 179.864 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' C' C ' 704' ' ' ALA . . . . . 0.867 ' HB2' ' HB1' ' A' ' 118' ' ' ALA . . . . . . . . 0 N--CA 1.493 1.692 0 O-C-N 121.125 -0.984 . . . . 0.0 110.212 179.845 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 63' ' ' PRO . . . . . . . . . . . . . 18.9 Cg_endo . . . . . 0 N--CA 1.482 0.795 0 CA-C-O 121.234 0.431 . . . . 0.0 111.513 . . . . . . . . . 0 0 . 1 . 011 nuclear build core ' A' A ' 64' ' ' GLN . . . . . 0.579 ' N ' ' CD ' ' A' ' 64' ' ' GLN . 0.0 OUTLIER -154.29 133.91 12.84 Favored 'General case' 0 N--CA 1.493 1.701 0 O-C-N 120.996 -1.065 . . . . 0.0 109.452 179.733 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 65' ' ' ILE . . . . . 0.532 ' CD1' HD13 ' A' ' 110' ' ' LEU . 0.0 OUTLIER -45.95 108.35 0.8 Allowed Pre-proline 0 N--CA 1.489 1.494 0 N-CA-C 107.812 -1.181 . . . . 0.0 107.812 179.155 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 66' ' ' PRO . . . . . . . . . . . . . 60.1 Cg_endo -78.1 -162.68 0.18 Allowed 'Trans proline' 0 C--N 1.311 -1.419 0 C-N-CA 121.618 1.545 . . . . 0.0 112.148 -179.024 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 67' ' ' LYS . . . . . . . . . . . . . 15.8 tttp -89.81 -13.92 35.55 Favored 'General case' 0 C--N 1.301 -1.543 0 O-C-N 121.287 -0.883 . . . . 0.0 109.289 -179.874 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 68' ' ' ASP . . . . . 0.659 ' C ' ' N ' ' A' ' 70' ' ' SER . 0.6 OUTLIER -77.07 64.87 2.6 Favored 'General case' 0 N--CA 1.487 1.395 0 CA-C-O 122.654 1.216 . . . . 0.0 109.762 -179.868 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 69' ' ' LYS . . . . . 0.447 ' C ' ' O ' ' A' ' 68' ' ' ASP . 16.6 ptpt -48.2 -12.16 0.04 OUTLIER 'General case' 0 N--CA 1.516 2.827 0 C-N-CA 116.921 -1.912 . . . . 0.0 106.332 176.567 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 70' ' ' SER . . . . . 0.659 ' N ' ' C ' ' A' ' 68' ' ' ASP . 1.9 m -84.83 -6.38 59.35 Favored 'General case' 0 C--N 1.297 -1.688 0 CA-C-N 113.094 -1.866 . . . . 0.0 110.764 179.117 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 71' ' ' LYS . . . . . 0.546 ' N ' ' O ' ' A' ' 68' ' ' ASP . 0.3 OUTLIER -100.42 144.33 29.55 Favored 'General case' 0 N--CA 1.5 2.068 0 O-C-N 120.649 -1.282 . . . . 0.0 111.759 -179.661 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 72' ' ' VAL . . . . . 0.525 HG12 ' CE1' ' A' ' 88' ' ' TYR . 0.7 OUTLIER -66.4 134.08 30.38 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.369 0 N-CA-C 105.085 -2.191 . . . . 0.0 105.085 175.638 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 73' ' ' ALA . . . . . 0.549 ' N ' ' O ' ' A' ' 87' ' ' VAL . . . -80.5 -13.96 58.66 Favored 'General case' 0 C--N 1.295 -1.776 0 O-C-N 119.587 -1.946 . . . . 0.0 107.161 -179.525 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 74' ' ' GLY . . . . . 0.417 ' N ' HG23 ' A' ' 72' ' ' VAL . . . 177.16 -159.63 26.06 Favored Glycine 0 N--CA 1.482 1.725 0 N-CA-C 109.835 -1.306 . . . . 0.0 109.835 179.07 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 75' ' ' TYR . . . . . 0.529 ' HA ' HG23 ' A' ' 87' ' ' VAL . 0.6 OUTLIER -143.83 165.96 26.25 Favored 'General case' 0 C--N 1.295 -1.768 0 C-N-CA 119.468 -0.893 . . . . 0.0 110.75 -177.283 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 76' ' ' ILE . . . . . . . . . . . . . 1.2 tt -148.38 147.4 17.0 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.534 0 C-N-CA 119.346 -0.942 . . . . 0.0 110.072 -178.189 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -150.76 162.48 40.65 Favored 'General case' 0 N--CA 1.486 1.373 0 O-C-N 121.276 -0.89 . . . . 0.0 109.042 179.934 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 78' ' ' ILE . . . . . 0.415 HD12 HD21 ' A' ' 133' ' ' LEU . 38.6 mt -147.62 97.08 4.04 Favored Pre-proline 0 N--CA 1.488 1.445 0 O-C-N 121.238 -0.913 . . . . 0.0 108.817 -179.444 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 79' ' ' PRO . . . . . . . . . . . . . 51.0 Cg_exo -49.15 -45.13 30.84 Favored 'Trans proline' 0 N--CA 1.493 1.485 0 C-N-CA 122.795 2.33 . . . . 0.0 114.423 -178.59 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 80' ' ' ASP . . . . . 0.482 ' O ' ' OD1' ' A' ' 80' ' ' ASP . 47.7 t0 -66.09 -20.26 66.11 Favored 'General case' 0 N--CA 1.496 1.843 0 O-C-N 120.48 -1.387 . . . . 0.0 111.024 179.073 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 81' ' ' ALA . . . . . 0.756 ' HB2' ' HB2' ' A' ' 136' ' ' ALA . . . -107.09 -10.49 15.88 Favored 'General case' 0 N--CA 1.491 1.582 0 N-CA-C 108.528 -0.916 . . . . 0.0 108.528 179.639 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 82' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER 61.42 50.88 4.41 Favored 'General case' 0 N--CA 1.493 1.697 0 O-C-N 121.541 -0.724 . . . . 0.0 110.719 179.481 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 83' ' ' ILE . . . . . . . . . . . . . 46.6 mt -128.83 152.2 36.67 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.815 0 O-C-N 121.062 -1.024 . . . . 0.0 110.229 -178.975 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 84' ' ' LYS . . . . . . . . . . . . . 27.2 tttp -157.88 108.47 2.19 Favored 'General case' 0 N--CA 1.49 1.566 0 N-CA-C 107.662 -1.236 . . . . 0.0 107.662 179.762 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 85' ' ' GLU . . . . . 0.512 ' OE2' ' O ' ' A' ' 129' ' ' GLN . 0.0 OUTLIER -141.6 163.35 41.61 Favored Pre-proline 0 N--CA 1.494 1.771 0 O-C-N 121.283 -0.886 . . . . 0.0 110.88 -178.361 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 86' ' ' PRO . . . . . 0.41 ' N ' ' CE2' ' A' ' 75' ' ' TYR . 40.9 Cg_endo -72.15 165.36 32.84 Favored 'Trans proline' 0 N--CA 1.495 1.609 0 C-N-CA 123.259 2.639 . . . . 0.0 113.031 -179.882 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 87' ' ' VAL . . . . . 0.549 ' O ' ' N ' ' A' ' 73' ' ' ALA . 66.0 t -124.36 98.96 5.76 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.695 0 N-CA-C 108.903 -0.777 . . . . 0.0 108.903 179.54 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 88' ' ' TYR . . . . . 0.525 ' CE1' HG12 ' A' ' 72' ' ' VAL . 15.9 m-85 -91.45 155.58 44.02 Favored Pre-proline 0 N--CA 1.501 2.12 0 O-C-N 120.964 -1.085 . . . . 0.0 110.224 -179.212 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 89' ' ' PRO . . . . . 0.411 ' HA ' ' CD2' ' A' ' 103' ' ' PHE . 9.6 Cg_endo -61.75 145.25 97.45 Favored 'Trans proline' 0 C--N 1.311 -1.443 0 C-N-CA 122.639 2.226 . . . . 0.0 113.408 179.683 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . -58.82 168.23 6.34 Favored Glycine 0 N--CA 1.494 2.504 0 N-CA-C 109.408 -1.477 . . . . 0.0 109.408 179.305 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 91' ' ' PRO . . . . . 0.426 ' C ' ' H ' ' A' ' 93' ' ' THR . 97.5 Cg_endo -94.13 169.53 18.82 Favored 'Cis proline' 0 C--N 1.307 -1.654 0 C-N-CA 123.873 -1.303 . . . . 0.0 112.021 -0.257 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 92' ' ' ALA . . . . . 0.631 ' HB1' HD21 ' A' ' 97' ' ' LEU . . . -72.16 31.47 0.06 Allowed 'General case' 0 N--CA 1.489 1.49 0 O-C-N 121.217 -0.927 . . . . 0.0 110.756 -179.786 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 93' ' ' THR . . . . . 0.435 ' O ' ' C ' ' A' ' 94' ' ' PRO . 6.0 p -72.41 151.42 91.88 Favored Pre-proline 0 N--CA 1.492 1.643 0 O-C-N 120.543 -1.348 . . . . 0.0 108.075 179.865 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 94' ' ' PRO . . . . . 0.435 ' C ' ' O ' ' A' ' 93' ' ' THR . 88.7 Cg_exo -31.68 -57.91 0.23 Allowed 'Trans proline' 0 C--N 1.306 -1.692 0 C-N-CA 122.702 2.268 . . . . 0.0 112.636 -178.656 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 95' ' ' GLU . . . . . 0.431 ' O ' ' OD1' ' A' ' 98' ' ' ASN . 29.0 mt-10 -43.87 -49.09 8.39 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.11 -0.994 . . . . 0.0 109.715 179.929 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 96' ' ' GLN . . . . . 0.586 ' O ' ' N ' ' A' ' 98' ' ' ASN . 39.2 mm-40 -71.63 -56.98 4.81 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.195 -0.941 . . . . 0.0 110.981 -179.058 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 97' ' ' LEU . . . . . 0.631 HD21 ' HB1' ' A' ' 92' ' ' ALA . 91.7 mt -48.95 -5.99 0.02 OUTLIER 'General case' 0 N--CA 1.495 1.783 0 O-C-N 120.989 -1.069 . . . . 0.0 109.878 -179.156 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 98' ' ' ASN . . . . . 0.586 ' C ' ' ND2' ' A' ' 98' ' ' ASN . 0.0 OUTLIER -73.2 -28.63 62.3 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.213 -0.929 . . . . 0.0 108.904 179.466 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 99' ' ' ARG . . . . . 0.494 ' HG2' HH11 ' A' ' 99' ' ' ARG . 0.0 OUTLIER -92.34 -54.57 3.75 Favored 'General case' 0 N--CA 1.487 1.406 0 O-C-N 121.692 -0.63 . . . . 0.0 109.552 -179.659 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . -179.89 -160.63 25.71 Favored Glycine 0 N--CA 1.491 2.353 0 C-N-CA 119.554 -1.308 . . . . 0.0 110.188 -179.917 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 101' ' ' VAL . . . . . 0.718 HG23 ' O ' ' A' ' 101' ' ' VAL . 20.5 m -61.48 104.93 0.29 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.659 0 O-C-N 121.474 -1.015 . . . . 0.0 109.92 -179.507 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -92.73 157.16 16.59 Favored 'General case' 0 N--CA 1.493 1.715 0 O-C-N 121.495 -0.753 . . . . 0.0 110.67 -179.503 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 103' ' ' PHE . . . . . 0.411 ' CD2' ' HA ' ' A' ' 89' ' ' PRO . 22.1 m-85 -59.69 130.36 46.43 Favored 'General case' 0 N--CA 1.49 1.568 0 N-CA-C 107.468 -1.308 . . . . 0.0 107.468 178.276 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 104' ' ' ALA . . . . . . . . . . . . . . . -50.95 -16.45 0.43 Allowed 'General case' 0 C--N 1.301 -1.542 0 O-C-N 121.378 -0.826 . . . . 0.0 111.467 -178.337 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 105' ' ' GLU . . . . . 0.452 ' CD ' HD13 ' A' ' 169' ' ' LEU . 0.5 OUTLIER -139.49 147.61 41.53 Favored 'General case' 0 N--CA 1.494 1.766 0 O-C-N 120.722 -1.236 . . . . 0.0 110.577 -179.862 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 106' ' ' GLU . . . . . 0.409 ' OE2' ' OD1' ' A' ' 107' ' ' ASN . 3.3 tt0 -54.71 -64.44 0.83 Allowed 'General case' 0 C--N 1.301 -1.527 0 CA-C-N 115.857 -0.611 . . . . 0.0 111.151 -178.986 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 107' ' ' ASN . . . . . 0.409 ' OD1' ' OE2' ' A' ' 106' ' ' GLU . 8.1 m-20 -78.28 33.37 0.19 Allowed 'General case' 0 N--CA 1.49 1.566 0 O-C-N 120.522 -1.361 . . . . 0.0 113.059 -175.325 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 108' ' ' GLU . . . . . . . . . . . . . 27.8 tp10 -59.39 148.41 32.66 Favored 'General case' 0 C--N 1.299 -1.597 0 N-CA-C 107.191 -1.411 . . . . 0.0 107.191 179.886 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 109' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -99.64 129.82 45.81 Favored 'General case' 0 C--N 1.301 -1.504 0 O-C-N 120.987 -1.071 . . . . 0.0 110.443 -178.019 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 110' ' ' LEU . . . . . 0.532 HD13 ' CD1' ' A' ' 65' ' ' ILE . 3.2 tp -59.03 -11.98 4.16 Favored 'General case' 0 C--N 1.301 -1.505 0 N-CA-C 108.02 -1.104 . . . . 0.0 108.02 179.63 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 111' ' ' ASP . . . . . . . . . . . . . 57.7 m-20 -132.57 30.03 4.15 Favored 'General case' 0 N--CA 1.491 1.615 0 N-CA-C 109.0 -0.741 . . . . 0.0 109.0 179.044 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 112' ' ' ASP . . . . . . . . . . . . . 6.2 t0 -67.27 149.1 50.86 Favored 'General case' 0 N--CA 1.493 1.704 0 O-C-N 121.105 -0.997 . . . . 0.0 111.19 -179.056 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 113' ' ' GLN . . . . . 0.423 ' OE1' ' CE ' ' A' ' 177' ' ' LYS . 2.2 mp0 -66.36 -12.83 59.03 Favored 'General case' 0 N--CA 1.49 1.564 0 N-CA-C 108.319 -0.993 . . . . 0.0 108.319 178.285 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 114' ' ' ASN . . . . . 0.618 HD22 ' C ' ' A' ' 114' ' ' ASN . 0.2 OUTLIER -149.92 99.98 2.89 Favored 'General case' 0 N--CA 1.491 1.601 0 N-CA-C 108.204 -1.035 . . . . 0.0 108.204 179.351 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 115' ' ' ILE . . . . . 0.484 ' O ' HG22 ' A' ' 115' ' ' ILE . 3.9 mt -98.79 111.94 29.67 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.621 0 O-C-N 121.111 -0.993 . . . . 0.0 109.497 -179.367 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 116' ' ' SER . . . . . . . . . . . . . 48.9 m -97.84 153.58 18.21 Favored 'General case' 0 N--CA 1.492 1.675 0 O-C-N 121.026 -1.046 . . . . 0.0 110.94 -179.142 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 117' ' ' ILE . . . . . 0.402 HG21 HD13 ' A' ' 117' ' ' ILE . 1.5 mt -144.79 159.94 14.24 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.617 0 N-CA-C 108.629 -0.878 . . . . 0.0 108.629 179.586 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 118' ' ' ALA . . . . . 0.752 ' HB1' ' HB2' ' C' ' 704' ' ' ALA . . . -144.53 160.25 41.44 Favored 'General case' 0 N--CA 1.491 1.606 0 C-N-CA 118.639 -1.224 . . . . 0.0 112.17 -179.441 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 119' ' ' GLY . . . . . . . . . . . . . . . -172.16 146.24 9.16 Favored Glycine 0 N--CA 1.49 2.239 0 N-CA-C 110.622 -0.991 . . . . 0.0 110.622 179.909 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 120' ' ' HIS . . . . . . . . . . . . . 11.5 m170 -71.29 167.63 19.06 Favored 'General case' 0 N--CA 1.496 1.856 0 O-C-N 121.744 -0.857 . . . . 0.0 110.45 179.483 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 121' ' ' THR . . . . . 0.504 ' OG1' ' NZ ' ' A' ' 134' ' ' LYS . 0.7 OUTLIER -119.02 162.29 18.8 Favored 'General case' 0 N--CA 1.5 2.048 0 O-C-N 121.188 -0.945 . . . . 0.0 108.874 179.301 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 122' ' ' PHE . . . . . 0.648 ' O ' HG21 ' A' ' 131' ' ' THR . 0.3 OUTLIER -133.25 122.37 23.82 Favored 'General case' 0 N--CA 1.499 1.982 0 O-C-N 120.868 -1.145 . . . . 0.0 110.291 -179.281 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 123' ' ' ILE . . . . . 0.563 HG23 ' N ' ' A' ' 124' ' ' ASP . 18.1 tt -65.5 -40.75 89.15 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.582 0 CA-C-O 121.58 0.705 . . . . 0.0 109.217 179.588 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 124' ' ' ASP . . . . . 0.563 ' N ' HG23 ' A' ' 123' ' ' ILE . 1.2 t70 -96.69 25.75 4.97 Favored 'General case' 0 N--CA 1.497 1.914 0 C-N-CA 120.154 -0.619 . . . . 0.0 111.452 -178.473 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 125' ' ' ARG . . . . . 0.655 HH11 ' CG ' ' A' ' 125' ' ' ARG . 0.0 OUTLIER -158.67 106.15 1.62 Allowed Pre-proline 0 N--CA 1.493 1.712 0 O-C-N 120.553 -1.342 . . . . 0.0 110.126 -179.209 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 126' ' ' PRO . . . . . . . . . . . . . 74.3 Cg_endo -81.91 -23.61 4.52 Favored 'Trans proline' 0 N--CA 1.489 1.217 0 C-N-CA 122.293 1.995 . . . . 0.0 112.325 179.834 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 127' ' ' ASN . . . . . . . . . . . . . 1.3 m-20 -90.34 28.91 1.35 Allowed 'General case' 0 N--CA 1.489 1.495 0 O-C-N 121.295 -0.878 . . . . 0.0 109.815 -179.685 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 128' ' ' TYR . . . . . . . . . . . . . 7.6 t80 -83.9 -149.27 0.1 Allowed 'General case' 0 N--CA 1.494 1.735 0 O-C-N 121.303 -0.873 . . . . 0.0 109.15 179.61 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 129' ' ' GLN . . . . . 0.512 ' O ' ' OE2' ' A' ' 85' ' ' GLU . 51.3 mt-30 -67.77 -73.05 0.15 Allowed 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.102 -0.999 . . . . 0.0 109.875 -179.698 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 130' ' ' PHE . . . . . 0.736 ' CE1' HD11 ' A' ' 181' ' ' LEU . 38.7 m-85 -129.63 45.92 2.73 Favored 'General case' 0 N--CA 1.497 1.918 0 O-C-N 121.013 -1.054 . . . . 0.0 110.119 -179.845 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 131' ' ' THR . . . . . 0.648 HG21 ' O ' ' A' ' 122' ' ' PHE . 25.0 m -82.58 -37.64 24.79 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 120.991 -1.068 . . . . 0.0 110.222 -179.919 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 132' ' ' ASN . . . . . 0.577 ' ND2' ' O ' ' A' ' 81' ' ' ALA . 7.6 t30 -83.39 7.84 15.49 Favored 'General case' 0 N--CA 1.491 1.618 0 C-N-CA 119.389 -0.924 . . . . 0.0 111.145 -178.574 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 133' ' ' LEU . . . . . 0.545 ' O ' ' N ' ' A' ' 135' ' ' ALA . 0.1 OUTLIER -70.29 -46.21 64.76 Favored 'General case' 0 C--N 1.301 -1.523 0 O-C-N 120.793 -1.192 . . . . 0.0 109.237 179.936 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 134' ' ' LYS . . . . . 0.599 ' H ' ' CD ' ' A' ' 134' ' ' LYS . 0.0 OUTLIER -43.75 -18.16 0.02 OUTLIER 'General case' 0 N--CA 1.494 1.747 0 O-C-N 121.368 -0.832 . . . . 0.0 109.861 -179.74 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 135' ' ' ALA . . . . . 0.545 ' N ' ' O ' ' A' ' 133' ' ' LEU . . . -83.8 -37.14 22.93 Favored 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.048 -1.032 . . . . 0.0 109.433 179.943 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 136' ' ' ALA . . . . . 0.756 ' HB2' ' HB2' ' A' ' 81' ' ' ALA . . . -79.62 157.05 27.39 Favored 'General case' 0 C--N 1.301 -1.541 0 CA-C-O 122.298 1.047 . . . . 0.0 111.517 -178.502 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 137' ' ' LYS . . . . . 0.562 ' O ' ' O ' ' A' ' 138' ' ' LYS . 0.1 OUTLIER -152.04 -163.26 1.69 Allowed 'General case' 0 C--N 1.304 -1.404 0 C-N-CA 119.017 -1.073 . . . . 0.0 110.03 -178.016 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 138' ' ' LYS . . . . . 0.582 ' O ' ' N ' ' A' ' 140' ' ' SER . 51.2 mttm -41.0 177.67 0.0 OUTLIER 'General case' 0 C--N 1.304 -1.381 0 CA-C-O 122.583 1.182 . . . . 0.0 111.716 -179.093 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 139' ' ' GLY . . . . . . . . . . . . . . . 46.32 8.3 0.02 OUTLIER Glycine 0 N--CA 1.492 2.386 0 N-CA-C 110.353 -1.099 . . . . 0.0 110.353 -179.918 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 140' ' ' SER . . . . . 0.582 ' N ' ' O ' ' A' ' 138' ' ' LYS . 6.3 m -79.0 121.52 25.04 Favored 'General case' 0 N--CA 1.493 1.719 0 O-C-N 120.887 -1.36 . . . . 0.0 109.693 179.258 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 141' ' ' MET . . . . . 0.687 ' SD ' ' N ' ' A' ' 142' ' ' VAL . 5.1 tpp -77.99 125.15 28.92 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.192 -0.943 . . . . 0.0 108.971 179.529 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 142' ' ' VAL . . . . . 0.687 ' N ' ' SD ' ' A' ' 141' ' ' MET . 2.5 t -110.48 131.51 61.38 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.446 0 N-CA-C 108.585 -0.894 . . . . 0.0 108.585 -179.594 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 143' ' ' TYR . . . . . . . . . . . . . 9.8 m-85 -109.98 135.54 50.66 Favored 'General case' 0 N--CA 1.497 1.922 0 O-C-N 121.036 -1.04 . . . . 0.0 111.111 -178.321 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 144' ' ' PHE . . . . . . . . . . . . . 46.7 t80 -121.03 102.48 8.36 Favored 'General case' 0 N--CA 1.49 1.534 0 CA-C-O 121.262 0.553 . . . . 0.0 109.829 -178.957 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 145' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -100.93 121.81 42.4 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.202 -0.936 . . . . 0.0 110.117 -179.966 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 146' ' ' VAL . . . . . 0.537 HG23 ' O ' ' A' ' 73' ' ' ALA . 1.0 OUTLIER -142.53 124.49 12.86 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.581 0 O-C-N 121.126 -0.984 . . . . 0.0 108.424 179.091 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 147' ' ' GLY . . . . . . . . . . . . . . . 66.9 -132.1 31.26 Favored Glycine 0 N--CA 1.49 2.239 0 N-CA-C 108.103 -1.999 . . . . 0.0 108.103 -178.735 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 148' ' ' ASN . . . . . 0.497 ' CG ' ' O ' ' A' ' 148' ' ' ASN . 0.1 OUTLIER -102.43 10.31 39.09 Favored 'General case' 0 C--N 1.301 -1.526 0 O-C-N 121.266 -1.138 . . . . 0.0 108.209 178.955 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 149' ' ' GLU . . . . . 0.402 ' OE1' ' N ' ' A' ' 150' ' ' THR . 1.4 tm-20 -107.91 144.44 35.16 Favored 'General case' 0 N--CA 1.489 1.524 0 CA-C-O 121.941 0.877 . . . . 0.0 111.706 -178.666 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 150' ' ' THR . . . . . 0.402 ' N ' ' OE1' ' A' ' 149' ' ' GLU . 44.2 m -133.8 100.51 4.78 Favored 'General case' 0 N--CA 1.491 1.603 0 CA-C-O 121.517 0.675 . . . . 0.0 109.563 -179.749 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 151' ' ' ARG . . . . . . . . . . . . . 17.4 mtt180 -87.06 -174.16 4.78 Favored 'General case' 0 N--CA 1.488 1.445 0 N-CA-C 108.435 -0.95 . . . . 0.0 108.435 179.994 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 152' ' ' LYS . . . . . 0.477 ' O ' ' N ' ' A' ' 205' ' ' VAL . 35.6 mtmt -148.59 142.95 26.25 Favored 'General case' 0 N--CA 1.488 1.469 0 O-C-N 121.068 -1.02 . . . . 0.0 110.273 -179.335 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 153' ' ' TYR . . . . . 0.57 ' O ' ' SD ' ' A' ' 141' ' ' MET . 2.8 m-85 -136.18 167.77 20.66 Favored 'General case' 0 N--CA 1.492 1.642 0 N-CA-C 107.582 -1.266 . . . . 0.0 107.582 179.029 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 154' ' ' LYS . . . . . . . . . . . . . 1.5 ttpm? -142.26 122.93 14.23 Favored 'General case' 0 N--CA 1.493 1.704 0 O-C-N 121.127 -0.983 . . . . 0.0 108.393 178.387 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 155' ' ' MET . . . . . . . . . . . . . 67.2 mtp -45.57 105.94 0.07 Allowed 'General case' 0 N--CA 1.491 1.608 0 O-C-N 120.586 -1.321 . . . . 0.0 111.351 -178.67 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 156' ' ' THR . . . . . 0.554 ' OG1' HG23 ' A' ' 203' ' ' THR . 0.1 OUTLIER -106.41 -24.87 12.12 Favored 'General case' 0 C--N 1.293 -1.888 0 CA-C-N 115.401 -0.818 . . . . 0.0 110.073 -179.077 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 157' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -151.45 151.5 31.76 Favored 'General case' 0 N--CA 1.494 1.765 0 C-N-CA 118.405 -1.318 . . . . 0.0 111.206 -178.299 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 158' ' ' ILE . . . . . 0.433 HD12 ' CD1' ' A' ' 200' ' ' PHE . 0.1 OUTLIER -154.16 144.4 13.98 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.189 0 CA-C-O 122.039 0.923 . . . . 0.0 110.448 -179.538 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 159' ' ' ARG . . . . . . . . . . . . . 31.4 ttp180 -153.98 155.91 36.45 Favored 'General case' 0 C--N 1.297 -1.685 0 CA-C-O 121.934 0.873 . . . . 0.0 110.76 -179.036 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 160' ' ' ASP . . . . . 0.446 ' C ' HG22 ' A' ' 161' ' ' VAL . 26.5 m-20 -118.65 160.66 21.42 Favored 'General case' 0 N--CA 1.492 1.666 0 N-CA-C 108.957 -0.757 . . . . 0.0 108.957 179.325 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 161' ' ' VAL . . . . . 0.451 ' O ' ' O ' ' A' ' 162' ' ' LYS . 0.0 OUTLIER -164.54 161.65 0.94 Allowed 'Isoleucine or valine' 0 N--CA 1.496 1.826 0 O-C-N 121.003 -1.061 . . . . 0.0 110.213 179.508 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 162' ' ' LYS . . . . . 0.758 ' H ' ' CD ' ' A' ' 162' ' ' LYS . 0.0 OUTLIER -45.99 173.04 0.04 OUTLIER Pre-proline 0 N--CA 1.493 1.723 0 O-C-N 121.591 -0.693 . . . . 0.0 109.815 179.456 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 163' ' ' PRO . . . . . 0.659 ' CA ' HH21 ' A' ' 197' ' ' ARG . 63.1 Cg_endo -81.34 35.06 0.57 Allowed 'Trans proline' 0 C--N 1.313 -1.34 0 C-N-CA 122.532 2.155 . . . . 0.0 112.54 179.815 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 164' ' ' THR . . . . . 0.423 ' N ' HD11 ' C' ' 702' ' ' LEU . 0.2 OUTLIER -150.76 -2.66 0.35 Allowed 'General case' 0 N--CA 1.495 1.814 0 O-C-N 121.053 -1.03 . . . . 0.0 110.821 179.961 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 165' ' ' ASP . . . . . 0.432 ' O ' ' C ' ' A' ' 166' ' ' VAL . 9.7 t70 -75.8 62.66 1.56 Allowed 'General case' 0 N--CA 1.495 1.785 0 O-C-N 120.675 -1.266 . . . . 0.0 110.675 -179.58 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 166' ' ' VAL . . . . . 0.621 ' O ' ' N ' ' A' ' 168' ' ' VAL . 2.6 t -42.99 -31.48 0.49 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.659 0 O-C-N 121.236 -0.915 . . . . 0.0 109.096 -178.853 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 167' ' ' GLY . . . . . . . . . . . . . . . -44.08 -9.81 0.01 OUTLIER Glycine 0 N--CA 1.495 2.632 0 O-C-N 121.126 -0.983 . . . . 0.0 111.055 -179.788 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 168' ' ' VAL . . . . . 0.629 ' C ' ' H ' ' A' ' 170' ' ' ASP . 7.4 m -55.47 -32.18 29.38 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.51 0 O-C-N 120.615 -1.521 . . . . 0.0 108.759 179.543 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 169' ' ' LEU . . . . . 0.564 ' O ' ' N ' ' A' ' 171' ' ' GLU . 9.5 mt -52.53 -4.65 0.03 OUTLIER 'General case' 0 N--CA 1.498 1.969 0 N-CA-C 107.957 -1.127 . . . . 0.0 107.957 -179.328 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 170' ' ' ASP . . . . . 0.629 ' H ' ' C ' ' A' ' 168' ' ' VAL . 0.6 OUTLIER 34.12 28.21 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.762 -0.586 . . . . 0.0 111.713 177.838 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 171' ' ' GLU . . . . . 0.564 ' N ' ' O ' ' A' ' 169' ' ' LEU . 11.8 pt-20 -63.91 93.17 0.08 Allowed 'General case' 0 C--N 1.298 -1.647 0 N-CA-C 107.645 -1.242 . . . . 0.0 107.645 178.528 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 172' ' ' GLN . . . . . . . . . . . . . 1.0 OUTLIER -160.84 -71.75 0.06 Allowed 'General case' 0 N--CA 1.491 1.588 0 CA-C-O 121.263 0.554 . . . . 0.0 109.511 -179.371 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 173' ' ' LYS . . . . . 0.63 ' NZ ' HE21 ' A' ' 178' ' ' GLN . 8.9 pttm -62.09 126.6 27.91 Favored 'General case' 0 N--CA 1.488 1.446 0 O-C-N 121.143 -0.973 . . . . 0.0 108.908 179.631 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 174' ' ' GLY . . . . . 0.568 ' O ' ' C ' ' A' ' 175' ' ' LYS . . . -121.18 -39.81 0.57 Allowed Glycine 0 C--N 1.298 -1.565 0 N-CA-C 108.283 -1.927 . . . . 0.0 108.283 179.721 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 175' ' ' LYS . . . . . 0.568 ' C ' ' O ' ' A' ' 174' ' ' GLY . 0.8 OUTLIER -31.59 -62.22 0.2 Allowed 'General case' 0 N--CA 1.498 1.929 0 N-CA-C 108.124 -1.065 . . . . 0.0 108.124 179.783 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 176' ' ' ASP . . . . . 0.631 ' O ' ' O ' ' A' ' 177' ' ' LYS . 69.6 m-20 -104.09 85.72 2.44 Favored 'General case' 0 C--N 1.294 -1.815 0 N-CA-C 107.487 -1.301 . . . . 0.0 107.487 177.092 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 177' ' ' LYS . . . . . 0.631 ' O ' ' O ' ' A' ' 176' ' ' ASP . 35.8 mttt -37.23 174.08 0.0 OUTLIER 'General case' 0 N--CA 1.497 1.904 0 CA-C-O 121.696 0.76 . . . . 0.0 110.588 -179.113 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 178' ' ' GLN . . . . . 0.63 HE21 ' NZ ' ' A' ' 173' ' ' LYS . 0.6 OUTLIER -161.51 175.42 12.15 Favored 'General case' 0 N--CA 1.489 1.479 0 C-N-CA 118.371 -1.332 . . . . 0.0 111.105 -179.864 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 179' ' ' LEU . . . . . 0.422 ' N ' ' OE1' ' A' ' 178' ' ' GLN . 1.3 tp -128.44 98.0 4.9 Favored 'General case' 0 C--N 1.302 -1.485 0 N-CA-C 107.274 -1.38 . . . . 0.0 107.274 178.103 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 180' ' ' THR . . . . . 0.481 ' N ' ' OE1' ' A' ' 178' ' ' GLN . 1.1 m -71.66 120.74 17.67 Favored 'General case' 0 N--CA 1.486 1.371 0 O-C-N 121.1 -1.0 . . . . 0.0 110.157 -178.341 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 181' ' ' LEU . . . . . 0.854 HD23 ' N ' ' A' ' 182' ' ' ILE . 6.6 tt -95.69 146.71 24.29 Favored 'General case' 0 C--N 1.299 -1.593 0 N-CA-C 107.915 -1.143 . . . . 0.0 107.915 178.01 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 182' ' ' ILE . . . . . 0.854 ' N ' HD23 ' A' ' 181' ' ' LEU . 19.8 mt -141.16 117.47 7.17 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.781 0 O-C-N 121.059 -1.026 . . . . 0.0 108.817 179.081 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 183' ' ' THR . . . . . 0.516 ' O ' HG23 ' A' ' 183' ' ' THR . 14.3 t -138.07 119.01 14.27 Favored 'General case' 0 C--N 1.29 -1.978 0 N-CA-C 108.002 -1.11 . . . . 0.0 108.002 179.229 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 184' ' ' CYS . . . . . . . . . . . . . 0.8 OUTLIER -79.85 162.5 25.01 Favored 'General case' 0 C--N 1.285 -2.236 0 C-N-CA 119.466 -0.894 . . . . 0.0 111.397 -177.842 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 185' ' ' ASP . . . . . 0.417 ' OD1' ' N ' ' A' ' 186' ' ' ASP . 4.4 t0 -165.51 -152.48 0.16 Allowed 'General case' 0 N--CA 1.492 1.644 0 N-CA-C 108.938 -0.764 . . . . 0.0 108.938 179.745 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 186' ' ' ASP . . . . . 0.417 ' N ' ' OD1' ' A' ' 185' ' ' ASP . 0.5 OUTLIER 47.78 59.34 4.25 Favored 'General case' 0 N--CA 1.495 1.777 0 O-C-N 121.136 -0.977 . . . . 0.0 109.072 -179.678 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 187' ' ' TYR . . . . . 0.591 ' CE1' ' O ' ' A' ' 188' ' ' ASN . 43.4 t80 -68.37 134.58 50.46 Favored 'General case' 0 N--CA 1.489 1.485 0 CA-C-O 121.821 0.819 . . . . 0.0 110.612 -179.585 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 188' ' ' ASN . . . . . 0.591 ' O ' ' CE1' ' A' ' 187' ' ' TYR . 0.8 OUTLIER -99.6 146.02 26.9 Favored 'General case' 0 C--N 1.294 -1.838 0 N-CA-C 107.916 -1.142 . . . . 0.0 107.916 178.224 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 189' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -111.55 -18.32 12.85 Favored 'General case' 0 C--N 1.296 -1.734 0 N-CA-C 108.1 -1.074 . . . . 0.0 108.1 -179.812 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 190' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER -83.68 -49.77 8.82 Favored 'General case' 0 C--N 1.302 -1.472 0 N-CA-C 108.267 -1.012 . . . . 0.0 108.267 178.457 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 191' ' ' THR . . . . . . . . . . . . . 44.4 p -87.41 -6.52 58.41 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.487 -0.758 . . . . 0.0 109.514 -179.971 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 192' ' ' GLY . . . . . . . . . . . . . . . 56.53 36.3 70.18 Favored Glycine 0 N--CA 1.493 2.463 0 O-C-N 121.081 -1.012 . . . . 0.0 110.648 179.025 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 193' ' ' VAL . . . . . . . . . . . . . 3.3 m -147.23 161.85 8.15 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.545 0 O-C-N 121.025 -1.279 . . . . 0.0 109.339 179.709 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 194' ' ' TRP . . . . . 0.472 ' N ' ' CD1' ' A' ' 194' ' ' TRP . 22.7 m95 -84.15 118.88 24.4 Favored 'General case' 0 N--CA 1.489 1.495 0 N-CA-C 107.604 -1.258 . . . . 0.0 107.604 178.654 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 195' ' ' GLU . . . . . 0.522 ' CD ' ' ND2' ' A' ' 188' ' ' ASN . 3.5 mt-10 -82.74 -62.09 1.7 Allowed 'General case' 0 N--CA 1.495 1.809 0 O-C-N 121.14 -0.975 . . . . 0.0 112.319 -177.103 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 196' ' ' LYS . . . . . . . . . . . . . 8.0 tptp -86.63 156.46 20.01 Favored 'General case' 0 N--CA 1.494 1.754 0 O-C-N 120.753 -1.217 . . . . 0.0 110.856 -178.141 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 197' ' ' ARG . . . . . 0.659 HH21 ' CA ' ' A' ' 163' ' ' PRO . 6.4 tpp180 -124.98 139.94 53.36 Favored 'General case' 0 N--CA 1.489 1.489 0 N-CA-C 109.133 -0.691 . . . . 0.0 109.133 179.389 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 198' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -112.46 121.8 45.87 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.626 -0.671 . . . . 0.0 109.863 -179.053 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 199' ' ' ILE . . . . . 0.66 HG22 HG23 ' A' ' 182' ' ' ILE . 0.9 OUTLIER -141.51 119.44 8.88 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.665 0 CA-C-O 122.615 1.198 . . . . 0.0 110.996 179.857 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 200' ' ' PHE . . . . . 0.564 ' CE2' HD22 ' A' ' 181' ' ' LEU . 0.2 OUTLIER -104.7 138.71 40.59 Favored 'General case' 0 N--CA 1.494 1.759 0 O-C-N 121.526 -0.734 . . . . 0.0 110.438 -178.305 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 201' ' ' VAL . . . . . . . . . . . . . 58.0 t -101.93 143.52 14.59 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.729 0 O-C-N 120.971 -1.081 . . . . 0.0 108.447 178.314 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 202' ' ' ALA . . . . . . . . . . . . . . . -124.95 135.23 52.63 Favored 'General case' 0 N--CA 1.489 1.477 0 N-CA-C 108.49 -0.93 . . . . 0.0 108.49 179.687 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 203' ' ' THR . . . . . 0.736 ' O ' HG23 ' A' ' 205' ' ' VAL . 1.3 p -89.17 128.4 35.8 Favored 'General case' 0 C--N 1.303 -1.427 0 CA-C-O 122.23 1.014 . . . . 0.0 111.225 -178.61 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 204' ' ' GLU . . . . . 0.484 ' HA ' ' CD2' ' A' ' 153' ' ' TYR . 5.5 tt0 -51.18 134.43 27.22 Favored 'General case' 0 C--N 1.297 -1.684 0 C-N-CA 118.949 -1.101 . . . . 0.0 108.369 178.728 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 205' ' ' VAL . . . . . 0.736 HG23 ' O ' ' A' ' 203' ' ' THR . 95.6 t -131.12 166.81 27.68 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.34 0 CA-C-O 121.934 0.873 . . . . 0.0 110.023 -177.859 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 206' ' ' LYS . . . . . 0.595 ' N ' HG12 ' A' ' 205' ' ' VAL . 2.0 pttp . . . . . 0 C--N 1.298 -1.658 0 CA-C-O 117.925 -1.036 . . . . 0.0 109.455 -179.672 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' C' C ' 702' ' ' LEU . . . . . 0.805 ' N ' HD12 ' C' ' 702' ' ' LEU . 0.0 OUTLIER . . . . . 0 N--CA 1.492 1.67 0 N-CA-C 109.762 -0.458 . . . . 0.0 109.762 . . . . . . . . . 2 2 . 1 . 011 nuclear build core ' C' C ' 703' ' ' PRO . . . . . 0.546 ' HB3' ' HB3' ' A' ' 92' ' ' ALA . 52.7 Cg_exo -48.01 -173.39 0.0 OUTLIER 'Trans proline' 0 N--CA 1.489 1.262 0 C-N-CA 121.957 1.771 . . . . 0.0 111.652 178.948 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' C' C ' 704' ' ' ALA . . . . . 0.752 ' HB2' ' HB1' ' A' ' 118' ' ' ALA . . . . . . . . 0 N--CA 1.492 1.662 0 O-C-N 121.501 -0.749 . . . . 0.0 109.806 179.673 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 63' ' ' PRO . . . . . 0.788 ' O ' HD13 ' A' ' 110' ' ' LEU . 16.3 Cg_exo . . . . . 0 N--CA 1.49 1.285 0 CA-C-O 121.254 0.439 . . . . 0.0 111.85 . . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 64' ' ' GLN . . . . . 0.571 ' N ' ' CD ' ' A' ' 64' ' ' GLN . 0.0 OUTLIER -152.75 103.92 2.82 Favored 'General case' 0 N--CA 1.489 1.476 0 O-C-N 121.372 -0.83 . . . . 0.0 109.408 -179.7 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 65' ' ' ILE . . . . . 0.58 ' H ' HD12 ' A' ' 65' ' ' ILE . 3.5 mp -40.14 102.27 0.26 Allowed Pre-proline 0 N--CA 1.488 1.45 0 N-CA-C 108.43 -0.952 . . . . 0.0 108.43 179.233 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 66' ' ' PRO . . . . . 0.411 ' N ' ' O ' ' A' ' 64' ' ' GLN . 97.9 Cg_endo -84.55 -155.61 0.06 OUTLIER 'Trans proline' 0 N--CA 1.489 1.206 0 C-N-CA 122.751 2.3 . . . . 0.0 112.968 -178.124 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 67' ' ' LYS . . . . . 0.44 ' C ' ' H ' ' A' ' 69' ' ' LYS . 6.5 ptpt -82.81 -5.03 58.76 Favored 'General case' 0 C--N 1.305 -1.362 0 N-CA-C 108.877 -0.786 . . . . 0.0 108.877 179.698 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 68' ' ' ASP . . . . . 0.631 ' C ' ' N ' ' A' ' 70' ' ' SER . 0.3 OUTLIER -75.39 50.18 0.51 Allowed 'General case' 0 N--CA 1.491 1.579 0 CA-C-O 123.005 1.383 . . . . 0.0 108.189 179.013 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 69' ' ' LYS . . . . . 0.455 ' C ' ' O ' ' A' ' 68' ' ' ASP . 1.9 mtpt -48.07 -15.17 0.06 Allowed 'General case' 0 N--CA 1.506 2.359 0 C-N-CA 116.758 -1.977 . . . . 0.0 107.149 178.425 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 70' ' ' SER . . . . . 0.631 ' N ' ' C ' ' A' ' 68' ' ' ASP . 0.2 OUTLIER -86.81 -5.22 59.17 Favored 'General case' 0 C--N 1.293 -1.856 0 CA-C-N 113.701 -1.591 . . . . 0.0 110.613 179.758 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 71' ' ' LYS . . . . . 0.446 ' N ' ' O ' ' A' ' 68' ' ' ASP . 2.4 ptmm? -97.28 138.36 34.87 Favored 'General case' 0 N--CA 1.494 1.736 0 O-C-N 120.899 -1.126 . . . . 0.0 112.007 -179.305 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 72' ' ' VAL . . . . . 0.593 ' CG2' ' O ' ' A' ' 74' ' ' GLY . 0.7 OUTLIER -67.01 132.25 32.38 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.444 0 N-CA-C 104.977 -2.231 . . . . 0.0 104.977 174.554 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 73' ' ' ALA . . . . . 0.452 ' N ' ' O ' ' A' ' 87' ' ' VAL . . . -82.04 -12.87 58.05 Favored 'General case' 0 C--N 1.299 -1.617 0 O-C-N 120.121 -1.612 . . . . 0.0 108.681 -178.671 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 74' ' ' GLY . . . . . 0.593 ' O ' ' CG2' ' A' ' 72' ' ' VAL . . . 170.35 -156.4 26.86 Favored Glycine 0 N--CA 1.483 1.784 0 N-CA-C 109.642 -1.383 . . . . 0.0 109.642 179.974 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 75' ' ' TYR . . . . . 0.55 ' CD1' ' C ' ' A' ' 74' ' ' GLY . 10.8 m-85 -143.71 173.81 11.34 Favored 'General case' 0 C--N 1.293 -1.889 0 O-C-N 121.276 -1.132 . . . . 0.0 109.702 -178.811 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 76' ' ' ILE . . . . . . . . . . . . . 1.4 tt -147.25 144.97 19.52 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.79 0 N-CA-C 108.72 -0.844 . . . . 0.0 108.72 -178.067 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -150.48 157.19 42.74 Favored 'General case' 0 C--N 1.301 -1.536 0 O-C-N 121.043 -1.035 . . . . 0.0 109.849 -179.513 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 78' ' ' ILE . . . . . 0.451 HG23 ' O ' ' A' ' 141' ' ' MET . 22.4 mt -142.6 121.28 7.51 Favored Pre-proline 0 C--N 1.301 -1.526 0 N-CA-C 107.291 -1.374 . . . . 0.0 107.291 179.718 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 79' ' ' PRO . . . . . . . . . . . . . 55.6 Cg_endo -73.33 -42.85 0.81 Allowed 'Trans proline' 0 N--CA 1.49 1.321 0 C-N-CA 121.893 1.729 . . . . 0.0 113.569 -177.89 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 19.6 t70 -65.98 -19.4 65.85 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 120.766 -1.209 . . . . 0.0 110.274 178.06 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 81' ' ' ALA . . . . . 0.95 ' HB2' ' HB2' ' A' ' 136' ' ' ALA . . . -105.6 -20.99 13.3 Favored 'General case' 0 N--CA 1.495 1.804 0 O-C-N 121.165 -0.959 . . . . 0.0 108.79 179.502 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 82' ' ' ASP . . . . . 0.423 ' OD2' ' C ' ' A' ' 81' ' ' ALA . 0.4 OUTLIER 68.65 51.56 0.61 Allowed 'General case' 0 C--N 1.303 -1.441 0 O-C-N 121.336 -0.853 . . . . 0.0 111.127 178.816 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 83' ' ' ILE . . . . . 0.6 HD11 ' OD1' ' A' ' 132' ' ' ASN . 57.6 mt -127.15 152.27 34.98 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.864 0 O-C-N 121.163 -0.96 . . . . 0.0 109.481 -179.777 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 84' ' ' LYS . . . . . . . . . . . . . 0.8 OUTLIER -159.26 108.36 1.87 Allowed 'General case' 0 C--N 1.303 -1.435 0 N-CA-C 107.892 -1.151 . . . . 0.0 107.892 179.727 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 85' ' ' GLU . . . . . 0.493 ' OE1' ' O ' ' A' ' 128' ' ' TYR . 0.0 OUTLIER -142.82 170.53 8.58 Favored Pre-proline 0 N--CA 1.497 1.921 0 O-C-N 121.362 -0.836 . . . . 0.0 111.105 -177.597 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 86' ' ' PRO . . . . . . . . . . . . . 90.4 Cg_endo -79.8 161.53 24.34 Favored 'Trans proline' 0 N--CA 1.493 1.474 0 C-N-CA 123.25 2.634 . . . . 0.0 113.247 179.752 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 87' ' ' VAL . . . . . 0.57 ' H ' HG23 ' A' ' 72' ' ' VAL . 92.8 t -118.14 101.97 12.57 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.485 0 N-CA-C 108.99 -0.744 . . . . 0.0 108.99 179.91 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 88' ' ' TYR . . . . . 0.402 ' CE1' ' HB3' ' A' ' 99' ' ' ARG . 17.5 m-85 -93.35 153.93 41.44 Favored Pre-proline 0 N--CA 1.504 2.236 0 O-C-N 120.865 -1.147 . . . . 0.0 110.664 -179.015 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 89' ' ' PRO . . . . . . . . . . . . . 11.2 Cg_endo -62.44 143.0 92.66 Favored 'Trans proline' 0 C--N 1.312 -1.346 0 C-N-CA 122.571 2.181 . . . . 0.0 113.863 -179.067 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 90' ' ' GLY . . . . . 0.412 ' O ' ' NZ ' ' A' ' 69' ' ' LYS . . . -58.33 168.24 5.71 Favored Glycine 0 N--CA 1.487 2.034 0 N-CA-C 110.167 -1.173 . . . . 0.0 110.167 179.611 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 91' ' ' PRO . . . . . 0.465 ' C ' ' H ' ' A' ' 93' ' ' THR . 38.2 Cg_endo -93.11 169.46 21.09 Favored 'Cis proline' 0 C--N 1.307 -1.606 0 C-N-CA 123.713 -1.37 . . . . 0.0 111.497 0.132 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 92' ' ' ALA . . . . . 0.605 ' HB3' ' CB ' ' C' ' 703' ' ' PRO . . . -72.81 33.3 0.07 Allowed 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.02 -1.05 . . . . 0.0 110.237 -179.691 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 93' ' ' THR . . . . . 0.465 ' H ' ' C ' ' A' ' 91' ' ' PRO . 1.6 p -72.21 152.74 92.47 Favored Pre-proline 0 C--N 1.3 -1.559 0 O-C-N 120.86 -1.15 . . . . 0.0 108.008 179.776 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 94' ' ' PRO . . . . . 0.428 ' C ' ' O ' ' A' ' 93' ' ' THR . 92.2 Cg_exo -32.79 -58.73 0.26 Allowed 'Trans proline' 0 C--N 1.305 -1.747 0 C-N-CA 122.575 2.184 . . . . 0.0 112.347 -179.253 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 21.0 mt-10 -44.2 -49.06 9.3 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.249 -0.907 . . . . 0.0 109.971 179.862 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 96' ' ' GLN . . . . . 0.563 ' O ' ' N ' ' A' ' 98' ' ' ASN . 2.5 mp0 -72.33 -55.87 6.41 Favored 'General case' 0 N--CA 1.489 1.491 0 O-C-N 121.203 -0.935 . . . . 0.0 111.014 -178.973 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 97' ' ' LEU . . . . . 0.417 ' CD1' ' O ' ' A' ' 92' ' ' ALA . 80.9 mt -49.21 -6.59 0.02 OUTLIER 'General case' 0 N--CA 1.496 1.845 0 O-C-N 121.067 -1.021 . . . . 0.0 110.279 -178.867 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 98' ' ' ASN . . . . . 0.563 ' N ' ' O ' ' A' ' 96' ' ' GLN . 0.0 OUTLIER -72.77 -25.16 61.07 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.337 -0.852 . . . . 0.0 108.928 179.679 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 99' ' ' ARG . . . . . 0.402 ' HB3' ' CE1' ' A' ' 88' ' ' TYR . 3.5 mtt180 -92.06 -51.97 4.93 Favored 'General case' 0 C--N 1.302 -1.467 0 O-C-N 121.682 -0.636 . . . . 0.0 110.497 -179.035 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . 172.23 -166.58 39.41 Favored Glycine 0 N--CA 1.493 2.486 0 N-CA-C 109.741 -1.343 . . . . 0.0 109.741 -179.687 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 101' ' ' VAL . . . . . 0.623 HG23 ' O ' ' A' ' 101' ' ' VAL . 34.7 m -54.69 100.41 0.04 OUTLIER 'Isoleucine or valine' 0 N--CA 1.493 1.724 0 O-C-N 121.146 -1.209 . . . . 0.0 109.802 -179.659 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 1.9 m -92.07 171.73 8.91 Favored 'General case' 0 N--CA 1.497 1.875 0 O-C-N 121.417 -0.802 . . . . 0.0 110.324 -179.789 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 103' ' ' PHE . . . . . 0.499 ' CE1' ' CG1' ' A' ' 87' ' ' VAL . 23.6 m-85 -75.08 145.68 42.09 Favored 'General case' 0 N--CA 1.493 1.697 0 N-CA-C 108.069 -1.086 . . . . 0.0 108.069 178.263 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 104' ' ' ALA . . . . . . . . . . . . . . . -66.71 -13.42 61.29 Favored 'General case' 0 N--CA 1.492 1.671 0 O-C-N 121.243 -0.911 . . . . 0.0 111.571 -178.105 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 105' ' ' GLU . . . . . 0.452 ' OE2' ' OE1' ' A' ' 108' ' ' GLU . 0.3 OUTLIER -138.6 144.32 39.72 Favored 'General case' 0 N--CA 1.496 1.838 0 O-C-N 120.762 -1.211 . . . . 0.0 110.592 -179.211 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 106' ' ' GLU . . . . . 0.505 ' CG ' ' N ' ' A' ' 107' ' ' ASN . 6.0 pt-20 -57.12 -59.6 4.85 Favored 'General case' 0 C--N 1.304 -1.402 0 O-C-N 121.732 -0.605 . . . . 0.0 110.224 -179.806 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 107' ' ' ASN . . . . . 0.505 ' N ' ' CG ' ' A' ' 106' ' ' GLU . 35.9 p-10 -78.27 33.96 0.2 Allowed 'General case' 0 N--CA 1.488 1.442 0 O-C-N 120.542 -1.349 . . . . 0.0 112.895 -176.114 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 108' ' ' GLU . . . . . 0.452 ' OE1' ' OE2' ' A' ' 105' ' ' GLU . 32.9 tp10 -60.09 147.45 39.37 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 120.824 -1.173 . . . . 0.0 108.141 -179.568 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 109' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -95.25 147.53 23.38 Favored 'General case' 0 N--CA 1.489 1.497 0 O-C-N 120.797 -1.189 . . . . 0.0 111.03 -178.093 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 110' ' ' LEU . . . . . 0.899 HD23 ' H ' ' A' ' 110' ' ' LEU . 0.2 OUTLIER -63.67 -24.61 67.85 Favored 'General case' 0 C--N 1.305 -1.337 0 N-CA-C 107.536 -1.283 . . . . 0.0 107.536 178.548 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 111' ' ' ASP . . . . . 0.491 ' CG ' HH22 ' A' ' 151' ' ' ARG . 55.3 m-20 -132.93 49.19 2.34 Favored 'General case' 0 N--CA 1.487 1.391 0 N-CA-C 109.183 -0.673 . . . . 0.0 109.183 179.513 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 112' ' ' ASP . . . . . . . . . . . . . 1.9 t0 -69.07 159.97 31.9 Favored 'General case' 0 N--CA 1.493 1.72 0 O-C-N 121.257 -0.902 . . . . 0.0 111.287 -179.745 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 113' ' ' GLN . . . . . 0.536 ' N ' ' CD ' ' A' ' 113' ' ' GLN . 0.0 OUTLIER -65.21 -18.52 65.38 Favored 'General case' 0 N--CA 1.491 1.614 0 N-CA-C 107.263 -1.384 . . . . 0.0 107.263 177.675 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 114' ' ' ASN . . . . . 0.608 ' ND2' ' O ' ' A' ' 169' ' ' LEU . 8.5 p-10 -153.11 111.85 3.73 Favored 'General case' 0 C--N 1.299 -1.588 0 N-CA-C 108.026 -1.102 . . . . 0.0 108.026 177.505 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 115' ' ' ILE . . . . . 0.485 HG22 ' O ' ' A' ' 115' ' ' ILE . 2.5 mt -96.82 105.68 17.44 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.692 0 N-CA-C 107.604 -1.258 . . . . 0.0 107.604 179.507 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 116' ' ' SER . . . . . . . . . . . . . 4.8 m -86.23 151.6 23.49 Favored 'General case' 0 C--N 1.303 -1.422 0 CA-C-O 122.088 0.947 . . . . 0.0 111.421 -177.739 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 117' ' ' ILE . . . . . . . . . . . . . 1.6 mt -147.19 142.26 20.11 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.532 0 N-CA-C 106.998 -1.482 . . . . 0.0 106.998 178.542 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 118' ' ' ALA . . . . . 0.54 ' HB1' ' HB2' ' C' ' 704' ' ' ALA . . . -137.89 158.37 44.48 Favored 'General case' 0 N--CA 1.493 1.722 0 O-C-N 120.985 -1.072 . . . . 0.0 110.698 -178.284 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 119' ' ' GLY . . . . . . . . . . . . . . . -169.93 145.86 9.54 Favored Glycine 0 N--CA 1.48 1.603 0 N-CA-C 110.055 -1.218 . . . . 0.0 110.055 179.342 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 120' ' ' HIS . . . . . . . . . . . . . 30.0 m170 -70.25 167.48 17.87 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.671 -0.899 . . . . 0.0 109.766 179.589 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 121' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -115.21 157.36 23.79 Favored 'General case' 0 N--CA 1.492 1.644 0 N-CA-C 108.49 -0.93 . . . . 0.0 108.49 179.038 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 122' ' ' PHE . . . . . 0.716 ' O ' HG21 ' A' ' 131' ' ' THR . 2.4 m-85 -141.07 122.95 15.39 Favored 'General case' 0 N--CA 1.494 1.769 0 O-C-N 121.152 -0.967 . . . . 0.0 108.873 -179.889 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 123' ' ' ILE . . . . . 0.555 HG23 ' N ' ' A' ' 124' ' ' ASP . 19.6 tt -60.32 -40.99 85.55 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.548 0 CA-C-O 121.62 0.724 . . . . 0.0 109.52 -179.608 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 124' ' ' ASP . . . . . 0.555 ' N ' HG23 ' A' ' 123' ' ' ILE . 6.0 p-10 -88.96 21.62 3.04 Favored 'General case' 0 C--N 1.295 -1.787 0 O-C-N 121.698 -0.626 . . . . 0.0 111.774 -177.548 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 125' ' ' ARG . . . . . . . . . . . . . 91.6 mtt180 -152.69 101.56 2.71 Favored Pre-proline 0 N--CA 1.492 1.663 0 O-C-N 120.708 -1.245 . . . . 0.0 109.561 179.778 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 126' ' ' PRO . . . . . . . . . . . . . 55.6 Cg_endo -79.32 -30.07 2.77 Favored 'Trans proline' 0 N--CA 1.488 1.177 0 C-N-CA 122.459 2.106 . . . . 0.0 112.903 -179.781 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 127' ' ' ASN . . . . . 0.49 ' O ' ' O ' ' A' ' 128' ' ' TYR . 1.2 m120 -90.07 8.65 31.58 Favored 'General case' 0 N--CA 1.493 1.696 0 O-C-N 121.047 -1.033 . . . . 0.0 109.199 179.594 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 128' ' ' TYR . . . . . 0.493 ' O ' ' OE1' ' A' ' 85' ' ' GLU . 2.1 t80 -59.43 -148.67 0.0 OUTLIER 'General case' 0 C--N 1.302 -1.464 0 O-C-N 121.459 -0.776 . . . . 0.0 109.444 -179.82 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 129' ' ' GLN . . . . . . . . . . . . . 26.7 mt-30 -64.42 -75.6 0.08 Allowed 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.24 -0.913 . . . . 0.0 110.14 -179.252 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 130' ' ' PHE . . . . . 0.523 ' O ' ' CE ' ' A' ' 134' ' ' LYS . 49.4 m-85 -133.87 48.28 2.37 Favored 'General case' 0 N--CA 1.492 1.67 0 O-C-N 121.402 -0.811 . . . . 0.0 109.71 -179.848 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 131' ' ' THR . . . . . 0.716 HG21 ' O ' ' A' ' 122' ' ' PHE . 23.7 m -83.02 -38.84 22.05 Favored 'General case' 0 C--N 1.298 -1.659 0 O-C-N 121.03 -1.044 . . . . 0.0 109.228 179.864 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 132' ' ' ASN . . . . . 0.6 ' OD1' HD11 ' A' ' 83' ' ' ILE . 0.2 OUTLIER -83.61 4.19 29.4 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.475 -0.766 . . . . 0.0 110.781 -179.079 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 133' ' ' LEU . . . . . 0.544 ' O ' ' N ' ' A' ' 135' ' ' ALA . 0.1 OUTLIER -66.49 -45.5 79.43 Favored 'General case' 0 N--CA 1.497 1.909 0 O-C-N 120.591 -1.318 . . . . 0.0 110.164 179.874 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 134' ' ' LYS . . . . . 0.541 ' H ' ' CD ' ' A' ' 134' ' ' LYS . 0.0 OUTLIER -43.07 -17.6 0.01 OUTLIER 'General case' 0 N--CA 1.499 1.995 0 O-C-N 121.142 -0.974 . . . . 0.0 110.814 -178.861 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 135' ' ' ALA . . . . . 0.544 ' N ' ' O ' ' A' ' 133' ' ' LEU . . . -84.09 -31.85 25.08 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 120.976 -1.078 . . . . 0.0 109.725 -179.931 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 136' ' ' ALA . . . . . 0.95 ' HB2' ' HB2' ' A' ' 81' ' ' ALA . . . -79.6 151.53 30.56 Favored 'General case' 0 C--N 1.3 -1.545 0 CA-C-O 121.874 0.845 . . . . 0.0 111.623 -178.413 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 137' ' ' LYS . . . . . 0.576 ' O ' ' O ' ' A' ' 138' ' ' LYS . 0.0 OUTLIER -153.11 -168.91 3.17 Favored 'General case' 0 N--CA 1.495 1.796 0 C-N-CA 118.474 -1.29 . . . . 0.0 111.313 -177.964 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 138' ' ' LYS . . . . . 0.576 ' O ' ' O ' ' A' ' 137' ' ' LYS . 50.1 mttm -38.55 172.37 0.0 OUTLIER 'General case' 0 N--CA 1.487 1.415 0 CA-C-O 122.488 1.137 . . . . 0.0 110.971 -178.986 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 139' ' ' GLY . . . . . . . . . . . . . . . 49.13 9.12 0.1 Allowed Glycine 0 N--CA 1.488 2.143 0 N-CA-C 109.8 -1.32 . . . . 0.0 109.8 -179.977 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 140' ' ' SER . . . . . 0.519 ' N ' ' O ' ' A' ' 138' ' ' LYS . 4.3 m -80.56 132.26 35.63 Favored 'General case' 0 N--CA 1.496 1.86 0 O-C-N 120.975 -1.309 . . . . 0.0 109.778 179.677 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 141' ' ' MET . . . . . 0.451 ' O ' HG23 ' A' ' 78' ' ' ILE . 0.1 OUTLIER -83.68 128.81 34.81 Favored 'General case' 0 N--CA 1.49 1.567 0 N-CA-C 108.515 -0.921 . . . . 0.0 108.515 179.195 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 142' ' ' VAL . . . . . . . . . . . . . 2.6 t -117.96 131.68 69.99 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.857 0 O-C-N 121.414 -0.804 . . . . 0.0 109.061 -179.185 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 143' ' ' TYR . . . . . . . . . . . . . 3.1 m-85 -110.58 135.58 51.01 Favored 'General case' 0 N--CA 1.496 1.866 0 O-C-N 120.851 -1.156 . . . . 0.0 111.444 -178.443 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 144' ' ' PHE . . . . . . . . . . . . . 52.6 t80 -122.15 103.11 8.56 Favored 'General case' 0 N--CA 1.493 1.718 0 CA-C-O 121.495 0.664 . . . . 0.0 109.844 -179.428 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 145' ' ' LYS . . . . . . . . . . . . . 46.1 mttt -96.94 128.59 44.05 Favored 'General case' 0 N--CA 1.494 1.764 0 O-C-N 121.458 -0.776 . . . . 0.0 110.992 -179.291 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 146' ' ' VAL . . . . . 0.443 ' O ' ' C ' ' A' ' 147' ' ' GLY . 2.0 p -141.46 142.12 29.4 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.668 0 N-CA-C 107.519 -1.289 . . . . 0.0 107.519 178.52 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 147' ' ' GLY . . . . . 0.443 ' C ' ' O ' ' A' ' 146' ' ' VAL . . . 43.59 -129.38 6.17 Favored Glycine 0 N--CA 1.49 2.276 0 N-CA-C 109.313 -1.515 . . . . 0.0 109.313 -179.827 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 148' ' ' ASN . . . . . . . . . . . . . 21.3 p30 -102.29 15.15 30.0 Favored 'General case' 0 N--CA 1.488 1.469 0 O-C-N 121.278 -1.131 . . . . 0.0 108.336 179.15 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 149' ' ' GLU . . . . . . . . . . . . . 2.3 mm-40 -109.07 143.91 37.79 Favored 'General case' 0 N--CA 1.49 1.531 0 CA-C-O 121.771 0.796 . . . . 0.0 111.576 -178.546 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 150' ' ' THR . . . . . . . . . . . . . 3.4 m -130.02 101.16 5.71 Favored 'General case' 0 N--CA 1.495 1.779 0 CA-C-O 121.46 0.647 . . . . 0.0 109.77 179.915 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 151' ' ' ARG . . . . . 0.491 HH22 ' CG ' ' A' ' 111' ' ' ASP . 16.5 mtt180 -86.13 -171.67 3.68 Favored 'General case' 0 N--CA 1.487 1.404 0 O-C-N 121.243 -0.91 . . . . 0.0 108.983 -179.671 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 152' ' ' LYS . . . . . 0.465 ' O ' ' N ' ' A' ' 205' ' ' VAL . 36.3 mtmt -151.38 148.35 28.02 Favored 'General case' 0 C--N 1.301 -1.532 0 O-C-N 121.111 -0.993 . . . . 0.0 110.423 -178.895 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 153' ' ' TYR . . . . . 0.503 ' CD2' ' HA ' ' A' ' 204' ' ' GLU . 11.1 m-85 -141.76 168.68 19.18 Favored 'General case' 0 C--N 1.302 -1.493 0 N-CA-C 108.157 -1.053 . . . . 0.0 108.157 179.189 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 154' ' ' LYS . . . . . . . . . . . . . 29.1 ttpt -143.17 119.0 10.54 Favored 'General case' 0 C--N 1.297 -1.714 0 N-CA-C 108.038 -1.097 . . . . 0.0 108.038 178.703 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 155' ' ' MET . . . . . . . . . . . . . 18.0 mtp -47.13 108.69 0.16 Allowed 'General case' 0 N--CA 1.492 1.662 0 O-C-N 120.536 -1.353 . . . . 0.0 111.528 -178.381 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 156' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -105.16 -25.15 12.6 Favored 'General case' 0 C--N 1.294 -1.822 0 CA-C-N 115.351 -0.841 . . . . 0.0 110.714 -178.638 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 157' ' ' SER . . . . . . . . . . . . . 49.8 m -145.84 147.44 31.82 Favored 'General case' 0 C--N 1.296 -1.748 0 C-N-CA 118.511 -1.276 . . . . 0.0 110.15 -178.769 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 158' ' ' ILE . . . . . . . . . . . . . 2.3 mt -146.96 136.54 16.67 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.611 0 CA-C-O 121.538 0.685 . . . . 0.0 110.111 -177.781 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 159' ' ' ARG . . . . . 0.684 ' CG ' HH11 ' A' ' 159' ' ' ARG . 0.0 OUTLIER -155.63 -172.83 4.29 Favored 'General case' 0 N--CA 1.491 1.604 0 C-N-CA 119.505 -0.878 . . . . 0.0 110.459 179.733 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 160' ' ' ASP . . . . . 0.514 ' C ' HG22 ' A' ' 161' ' ' VAL . 10.7 m-20 -149.54 165.47 32.11 Favored 'General case' 0 N--CA 1.489 1.507 0 N-CA-C 108.324 -0.991 . . . . 0.0 108.324 179.554 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 161' ' ' VAL . . . . . 0.514 HG22 ' C ' ' A' ' 160' ' ' ASP . 0.1 OUTLIER -166.07 161.44 0.81 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.685 0 O-C-N 121.088 -1.008 . . . . 0.0 109.877 179.829 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 162' ' ' LYS . . . . . 0.484 ' O ' ' O ' ' A' ' 161' ' ' VAL . 0.0 OUTLIER -44.62 170.99 0.05 OUTLIER Pre-proline 0 N--CA 1.489 1.503 0 O-C-N 121.366 -0.834 . . . . 0.0 109.653 179.73 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 163' ' ' PRO . . . . . 0.485 ' C ' HD11 ' C' ' 702' ' ' LEU . 62.1 Cg_endo -80.74 36.16 0.61 Allowed 'Trans proline' 0 C--N 1.31 -1.483 0 C-N-CA 122.672 2.248 . . . . 0.0 113.061 -179.851 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 164' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -151.88 -2.88 0.28 Allowed 'General case' 0 N--CA 1.497 1.896 0 O-C-N 121.047 -1.033 . . . . 0.0 110.214 179.987 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 165' ' ' ASP . . . . . . . . . . . . . 7.2 t70 -74.83 62.98 1.13 Allowed 'General case' 0 N--CA 1.488 1.45 0 O-C-N 120.899 -1.126 . . . . 0.0 109.386 -179.988 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 166' ' ' VAL . . . . . 0.589 ' O ' ' N ' ' A' ' 168' ' ' VAL . 1.8 m -49.68 -33.82 8.37 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.503 0 O-C-N 121.659 -0.65 . . . . 0.0 109.776 -178.392 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 167' ' ' GLY . . . . . 0.405 ' C ' ' O ' ' A' ' 166' ' ' VAL . . . -43.89 -13.35 0.02 OUTLIER Glycine 0 N--CA 1.496 2.65 0 O-C-N 120.865 -1.147 . . . . 0.0 110.725 -179.766 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 168' ' ' VAL . . . . . 0.589 ' N ' ' O ' ' A' ' 166' ' ' VAL . 3.5 m -53.48 -26.77 13.54 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.563 0 O-C-N 120.712 -1.463 . . . . 0.0 108.741 179.688 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 169' ' ' LEU . . . . . 0.608 ' O ' ' ND2' ' A' ' 114' ' ' ASN . 1.2 mm? -44.43 -24.67 0.19 Allowed 'General case' 0 C--N 1.299 -1.61 0 N-CA-C 107.808 -1.182 . . . . 0.0 107.808 -178.658 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 170' ' ' ASP . . . . . 0.474 ' N ' ' C ' ' A' ' 168' ' ' VAL . 14.9 t0 37.29 90.51 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.715 -0.616 . . . . 0.0 110.804 177.944 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 171' ' ' GLU . . . . . . . . . . . . . 14.9 pt-20 -130.13 60.09 1.62 Allowed 'General case' 0 N--CA 1.497 1.922 0 O-C-N 120.904 -1.123 . . . . 0.0 109.735 179.515 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 172' ' ' GLN . . . . . . . . . . . . . 10.7 mt-30 -123.06 -56.87 1.73 Allowed 'General case' 0 N--CA 1.497 1.899 0 O-C-N 121.438 -0.789 . . . . 0.0 110.958 -178.969 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 173' ' ' LYS . . . . . 0.467 ' H ' ' HD2' ' A' ' 173' ' ' LYS . 2.3 mptp? -57.62 123.2 14.79 Favored 'General case' 0 N--CA 1.493 1.696 0 O-C-N 120.817 -1.177 . . . . 0.0 108.909 -179.67 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 174' ' ' GLY . . . . . 0.485 ' O ' ' C ' ' A' ' 175' ' ' LYS . . . -117.29 -43.59 0.59 Allowed Glycine 0 N--CA 1.478 1.483 0 N-CA-C 108.166 -1.974 . . . . 0.0 108.166 179.589 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 175' ' ' LYS . . . . . 0.485 ' C ' ' O ' ' A' ' 174' ' ' GLY . 11.9 mptt -43.52 -58.53 2.57 Favored 'General case' 0 N--CA 1.49 1.545 0 N-CA-C 107.107 -1.442 . . . . 0.0 107.107 179.565 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 176' ' ' ASP . . . . . 0.617 ' O ' ' O ' ' A' ' 177' ' ' LYS . 3.4 m-20 -103.8 85.66 2.47 Favored 'General case' 0 C--N 1.293 -1.866 0 N-CA-C 106.835 -1.543 . . . . 0.0 106.835 176.672 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 177' ' ' LYS . . . . . 0.617 ' O ' ' O ' ' A' ' 176' ' ' ASP . 35.6 mttt -44.23 -175.92 0.0 OUTLIER 'General case' 0 N--CA 1.493 1.691 0 O-C-N 121.632 -0.667 . . . . 0.0 109.663 -179.159 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 178' ' ' GLN . . . . . . . . . . . . . 4.1 pt20 -160.7 173.68 15.07 Favored 'General case' 0 C--N 1.303 -1.439 0 O-C-N 120.307 -1.496 . . . . 0.0 110.949 179.524 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 179' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -129.35 97.74 4.66 Favored 'General case' 0 C--N 1.303 -1.453 0 N-CA-C 107.225 -1.398 . . . . 0.0 107.225 178.459 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 180' ' ' THR . . . . . 0.467 ' O ' HG22 ' A' ' 180' ' ' THR . 1.1 m -73.56 115.69 13.25 Favored 'General case' 0 N--CA 1.493 1.72 0 O-C-N 121.162 -0.961 . . . . 0.0 110.662 -178.372 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 181' ' ' LEU . . . . . 0.688 HD13 ' H ' ' A' ' 182' ' ' ILE . 0.2 OUTLIER -89.55 144.48 25.99 Favored 'General case' 0 C--N 1.301 -1.535 0 N-CA-C 108.11 -1.07 . . . . 0.0 108.11 177.47 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 182' ' ' ILE . . . . . 0.688 ' H ' HD13 ' A' ' 181' ' ' LEU . 4.7 mt -137.91 113.03 9.85 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.643 0 N-CA-C 107.822 -1.177 . . . . 0.0 107.822 179.102 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 183' ' ' THR . . . . . 0.479 ' O ' HG23 ' A' ' 183' ' ' THR . 5.8 t -134.34 119.44 18.65 Favored 'General case' 0 C--N 1.293 -1.88 0 N-CA-C 108.141 -1.059 . . . . 0.0 108.141 179.708 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 184' ' ' CYS . . . . . . . . . . . . . 1.0 OUTLIER -80.21 156.37 26.94 Favored 'General case' 0 C--N 1.289 -2.065 0 C-N-CA 119.514 -0.874 . . . . 0.0 111.183 -178.366 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 185' ' ' ASP . . . . . 0.549 ' O ' ' CB ' ' A' ' 186' ' ' ASP . 0.2 OUTLIER -166.68 170.55 12.44 Favored 'General case' 0 N--CA 1.493 1.698 0 O-C-N 121.538 -0.726 . . . . 0.0 109.058 179.831 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 186' ' ' ASP . . . . . 0.549 ' CB ' ' O ' ' A' ' 185' ' ' ASP . 1.0 OUTLIER 79.28 52.42 0.03 OUTLIER 'General case' 0 N--CA 1.492 1.668 0 O-C-N 121.23 -0.919 . . . . 0.0 109.704 179.863 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 187' ' ' TYR . . . . . 0.581 ' CE1' ' O ' ' A' ' 188' ' ' ASN . 36.9 t80 -65.9 131.42 46.23 Favored 'General case' 0 C--N 1.302 -1.497 0 O-C-N 120.92 -1.113 . . . . 0.0 109.623 179.946 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 188' ' ' ASN . . . . . 1.062 ' ND2' ' H ' ' A' ' 191' ' ' THR . 0.1 OUTLIER -100.13 148.71 24.28 Favored 'General case' 0 C--N 1.291 -1.936 0 N-CA-C 107.589 -1.263 . . . . 0.0 107.589 178.68 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 189' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -109.9 -9.57 14.78 Favored 'General case' 0 C--N 1.294 -1.819 0 N-CA-C 108.495 -0.928 . . . . 0.0 108.495 -179.505 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 190' ' ' LYS . . . . . 0.493 ' H ' ' ND2' ' A' ' 188' ' ' ASN . 6.4 mmtt -84.49 -56.23 3.73 Favored 'General case' 0 N--CA 1.488 1.432 0 C-N-CA 119.841 -0.744 . . . . 0.0 109.182 178.774 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 191' ' ' THR . . . . . 1.062 ' H ' ' ND2' ' A' ' 188' ' ' ASN . 7.1 p -86.44 7.93 23.86 Favored 'General case' 0 N--CA 1.493 1.678 0 O-C-N 121.559 -0.713 . . . . 0.0 110.688 -178.823 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 192' ' ' GLY . . . . . 0.447 ' N ' ' OD1' ' A' ' 188' ' ' ASN . . . 51.69 30.47 28.07 Favored Glycine 0 N--CA 1.494 2.544 0 O-C-N 121.098 -1.001 . . . . 0.0 111.733 178.82 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 193' ' ' VAL . . . . . 0.403 HG22 ' H ' ' A' ' 194' ' ' TRP . 0.4 OUTLIER -149.59 170.58 1.98 Allowed 'Isoleucine or valine' 0 N--CA 1.495 1.798 0 O-C-N 120.463 -1.61 . . . . 0.0 109.909 179.129 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 194' ' ' TRP . . . . . 0.437 ' N ' ' CD1' ' A' ' 194' ' ' TRP . 44.1 m95 -84.93 122.07 28.66 Favored 'General case' 0 C--N 1.295 -1.795 0 CA-C-O 121.577 0.704 . . . . 0.0 109.994 -179.427 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 195' ' ' GLU . . . . . 0.402 ' HG3' ' H ' ' A' ' 195' ' ' GLU . 2.0 mt-10 -77.81 -60.96 2.16 Favored 'General case' 0 N--CA 1.496 1.871 0 O-C-N 121.546 -0.721 . . . . 0.0 111.902 -178.326 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 196' ' ' LYS . . . . . . . . . . . . . 5.3 tttm -92.44 150.11 20.99 Favored 'General case' 0 N--CA 1.495 1.797 0 O-C-N 121.003 -1.061 . . . . 0.0 111.761 -177.481 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 197' ' ' ARG . . . . . 0.699 ' HE ' HD13 ' C' ' 702' ' ' LEU . 0.0 OUTLIER -120.7 139.03 53.64 Favored 'General case' 0 N--CA 1.493 1.676 0 N-CA-C 108.319 -0.993 . . . . 0.0 108.319 178.353 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 198' ' ' LYS . . . . . . . . . . . . . 7.9 mttt -116.72 120.46 38.68 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.447 -0.783 . . . . 0.0 110.406 -178.624 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 199' ' ' ILE . . . . . 0.441 ' O ' HG13 ' A' ' 199' ' ' ILE . 0.9 OUTLIER -140.78 121.06 13.09 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.733 0 CA-C-O 122.787 1.279 . . . . 0.0 110.724 179.77 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 200' ' ' PHE . . . . . . . . . . . . . 2.0 m-85 -105.33 141.44 36.83 Favored 'General case' 0 N--CA 1.496 1.841 0 O-C-N 121.218 -0.926 . . . . 0.0 111.012 -177.502 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 201' ' ' VAL . . . . . . . . . . . . . 61.3 t -104.63 148.39 9.32 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.539 0 N-CA-C 108.394 -0.965 . . . . 0.0 108.394 177.247 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 202' ' ' ALA . . . . . . . . . . . . . . . -133.05 139.84 47.39 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.037 -1.039 . . . . 0.0 109.022 -179.899 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 203' ' ' THR . . . . . 0.628 ' O ' HG23 ' A' ' 205' ' ' VAL . 1.5 p -90.14 129.19 36.45 Favored 'General case' 0 N--CA 1.489 1.509 0 CA-C-O 122.431 1.11 . . . . 0.0 111.753 -178.525 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 204' ' ' GLU . . . . . 0.503 ' HA ' ' CD2' ' A' ' 153' ' ' TYR . 3.6 tm-20 -50.53 135.36 22.81 Favored 'General case' 0 C--N 1.298 -1.656 0 C-N-CA 118.369 -1.333 . . . . 0.0 109.361 178.951 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 205' ' ' VAL . . . . . 0.628 HG23 ' O ' ' A' ' 203' ' ' THR . 72.1 t -129.57 164.82 31.15 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.359 0 CA-C-O 122.083 0.944 . . . . 0.0 110.273 -177.907 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 206' ' ' LYS . . . . . 0.599 ' N ' HG12 ' A' ' 205' ' ' VAL . 0.0 OUTLIER . . . . . 0 C--N 1.295 -1.776 0 CA-C-O 118.025 -0.988 . . . . 0.0 109.482 179.84 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' C' C ' 702' ' ' LEU . . . . . 0.798 ' N ' HD12 ' C' ' 702' ' ' LEU . 0.0 OUTLIER . . . . . 0 N--CA 1.488 1.436 0 N-CA-C 109.08 -0.711 . . . . 0.0 109.08 . . . . . . . . . 2 2 . 1 . 012 nuclear build core ' C' C ' 703' ' ' PRO . . . . . 0.605 ' CB ' ' HB3' ' A' ' 92' ' ' ALA . 16.2 Cg_exo -51.54 -160.81 0.0 OUTLIER 'Trans proline' 0 N--CA 1.49 1.319 0 C-N-CA 121.805 1.67 . . . . 0.0 112.242 179.911 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' C' C ' 704' ' ' ALA . . . . . 0.54 ' HB2' ' HB1' ' A' ' 118' ' ' ALA . . . . . . . . 0 N--CA 1.493 1.681 0 O-C-N 121.383 -0.823 . . . . 0.0 109.544 179.936 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 63' ' ' PRO . . . . . . . . . . . . . 58.0 Cg_endo . . . . . 0 C--O 1.213 -0.759 0 CA-C-O 120.958 0.316 . . . . 0.0 111.577 . . . . . . . . . 0 0 . 1 . 013 nuclear build core ' A' A ' 64' ' ' GLN . . . . . 0.459 ' O ' ' C ' ' A' ' 65' ' ' ILE . 2.6 mm-40 -156.0 113.01 3.19 Favored 'General case' 0 C--N 1.302 -1.475 0 O-C-N 121.049 -1.032 . . . . 0.0 109.925 179.544 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 65' ' ' ILE . . . . . 0.459 ' C ' ' O ' ' A' ' 64' ' ' GLN . 0.1 OUTLIER -41.35 99.65 0.21 Allowed Pre-proline 0 N--CA 1.498 1.939 0 N-CA-C 108.174 -1.047 . . . . 0.0 108.174 179.386 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 66' ' ' PRO . . . . . 0.456 ' N ' ' O ' ' A' ' 64' ' ' GLN . 66.5 Cg_endo -89.76 -160.69 0.1 OUTLIER 'Trans proline' 0 C--N 1.317 -1.108 0 C-N-CA 122.222 1.948 . . . . 0.0 112.778 -178.76 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 67' ' ' LYS . . . . . 0.479 ' C ' ' H ' ' A' ' 69' ' ' LYS . 0.0 OUTLIER -71.91 -4.94 31.1 Favored 'General case' 0 N--CA 1.488 1.426 0 O-C-N 121.414 -0.804 . . . . 0.0 109.08 179.926 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 68' ' ' ASP . . . . . 0.586 ' C ' ' N ' ' A' ' 70' ' ' SER . 64.6 m-20 -76.21 42.86 0.28 Allowed 'General case' 0 N--CA 1.49 1.561 0 CA-C-O 122.45 1.119 . . . . 0.0 108.459 179.223 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 69' ' ' LYS . . . . . 0.479 ' H ' ' C ' ' A' ' 67' ' ' LYS . 0.5 OUTLIER -50.11 -16.26 0.29 Allowed 'General case' 0 N--CA 1.496 1.854 0 N-CA-C 105.984 -1.858 . . . . 0.0 105.984 178.102 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 70' ' ' SER . . . . . 0.586 ' N ' ' C ' ' A' ' 68' ' ' ASP . 3.0 p -86.66 50.84 2.08 Favored 'General case' 0 C--N 1.298 -1.643 0 CA-C-N 113.94 -1.482 . . . . 0.0 108.742 178.644 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 71' ' ' LYS . . . . . . . . . . . . . 6.5 ptmt -162.63 143.19 9.79 Favored 'General case' 0 C--N 1.296 -1.731 0 C-N-CA 118.224 -1.391 . . . . 0.0 111.235 -179.657 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 72' ' ' VAL . . . . . 0.582 HG12 ' CE1' ' A' ' 88' ' ' TYR . 0.8 OUTLIER -64.28 136.14 26.9 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.577 0 N-CA-C 105.644 -1.984 . . . . 0.0 105.644 175.434 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -81.66 -13.85 57.38 Favored 'General case' 0 C--N 1.292 -1.897 0 N-CA-C 105.661 -1.977 . . . . 0.0 105.661 179.371 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . 174.01 -156.88 24.49 Favored Glycine 0 N--CA 1.478 1.448 0 N-CA-C 109.251 -1.54 . . . . 0.0 109.251 179.388 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 75' ' ' TYR . . . . . . . . . . . . . 94.4 m-85 -141.32 170.62 15.37 Favored 'General case' 0 C--N 1.296 -1.754 0 CA-C-O 121.875 0.845 . . . . 0.0 109.766 -178.144 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 76' ' ' ILE . . . . . . . . . . . . . 0.7 OUTLIER -147.66 143.74 19.58 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.646 0 C-N-CA 119.366 -0.934 . . . . 0.0 109.258 -178.095 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 77' ' ' GLU . . . . . 0.518 ' N ' ' CD ' ' A' ' 77' ' ' GLU . 2.6 mp0 -146.76 162.66 38.08 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 120.929 -1.107 . . . . 0.0 109.967 -179.837 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 78' ' ' ILE . . . . . 0.661 ' HB ' ' HB3' ' A' ' 81' ' ' ALA . 4.1 mt -148.16 90.3 5.04 Favored Pre-proline 0 N--CA 1.489 1.48 0 N-CA-C 108.311 -0.996 . . . . 0.0 108.311 179.839 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 79' ' ' PRO . . . . . . . . . . . . . 73.5 Cg_exo -45.29 -44.49 16.06 Favored 'Trans proline' 0 C--N 1.31 -1.457 0 C-N-CA 122.597 2.198 . . . . 0.0 113.63 -178.583 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 4.4 m-20 -67.14 -19.29 65.58 Favored 'General case' 0 N--CA 1.492 1.652 0 O-C-N 120.869 -1.145 . . . . 0.0 110.789 178.418 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 81' ' ' ALA . . . . . 0.882 ' HB2' ' HB2' ' A' ' 136' ' ' ALA . . . -106.63 -15.01 14.88 Favored 'General case' 0 N--CA 1.493 1.717 0 O-C-N 121.137 -0.977 . . . . 0.0 109.176 179.976 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 82' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER 68.3 46.72 1.05 Allowed 'General case' 0 N--CA 1.488 1.459 0 O-C-N 121.375 -0.828 . . . . 0.0 110.338 179.22 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 83' ' ' ILE . . . . . 0.456 ' CG1' ' OD1' ' A' ' 132' ' ' ASN . 60.9 mt -120.98 148.36 24.29 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.797 0 O-C-N 121.296 -0.877 . . . . 0.0 110.357 -178.928 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 84' ' ' LYS . . . . . 0.402 ' O ' ' CD ' ' A' ' 85' ' ' GLU . 0.0 OUTLIER -160.44 102.63 1.38 Allowed 'General case' 0 C--N 1.305 -1.367 0 N-CA-C 107.322 -1.362 . . . . 0.0 107.322 179.731 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 85' ' ' GLU . . . . . 0.441 ' CB ' ' CD ' ' A' ' 86' ' ' PRO . 1.3 mm-40 -141.49 178.25 1.61 Allowed Pre-proline 0 N--CA 1.497 1.914 0 O-C-N 121.301 -0.874 . . . . 0.0 110.247 -178.831 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 86' ' ' PRO . . . . . 0.441 ' CD ' ' CB ' ' A' ' 85' ' ' GLU . 69.2 Cg_endo -91.2 158.02 3.81 Favored 'Trans proline' 0 N--CA 1.487 1.112 0 C-N-CA 123.314 2.676 . . . . 0.0 113.661 -178.565 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 87' ' ' VAL . . . . . 0.555 ' CG1' ' CZ ' ' A' ' 103' ' ' PHE . 35.5 t -111.07 100.04 9.93 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.498 0 N-CA-C 109.191 -0.67 . . . . 0.0 109.191 -179.85 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 88' ' ' TYR . . . . . 0.582 ' CE1' HG12 ' A' ' 72' ' ' VAL . 8.1 m-85 -91.71 170.31 9.69 Favored Pre-proline 0 N--CA 1.507 2.4 0 O-C-N 120.535 -1.353 . . . . 0.0 110.135 -179.102 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 89' ' ' PRO . . . . . . . . . . . . . 3.0 Cg_exo -71.35 141.71 39.54 Favored 'Trans proline' 0 N--CA 1.5 1.883 0 C-N-CA 122.505 2.137 . . . . 0.0 114.241 -178.394 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . -62.16 167.18 17.9 Favored Glycine 0 N--CA 1.492 2.394 0 N-CA-C 108.8 -1.72 . . . . 0.0 108.8 178.38 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 91' ' ' PRO . . . . . 0.41 ' C ' ' H ' ' A' ' 93' ' ' THR . 45.1 Cg_endo -91.67 172.69 21.43 Favored 'Cis proline' 0 C--N 1.307 -1.648 0 C-N-CA 123.55 -1.437 . . . . 0.0 112.001 0.651 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 92' ' ' ALA . . . . . 0.556 ' HB3' ' HB2' ' C' ' 703' ' ' PRO . . . -73.2 33.34 0.07 Allowed 'General case' 0 N--CA 1.493 1.706 0 O-C-N 121.352 -0.843 . . . . 0.0 110.677 -179.418 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 93' ' ' THR . . . . . 0.439 ' O ' ' C ' ' A' ' 94' ' ' PRO . 0.8 OUTLIER -71.8 149.56 92.85 Favored Pre-proline 0 C--N 1.301 -1.519 0 O-C-N 120.59 -1.319 . . . . 0.0 108.45 179.773 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 94' ' ' PRO . . . . . 0.439 ' C ' ' O ' ' A' ' 93' ' ' THR . 80.7 Cg_exo -31.78 -53.18 0.31 Allowed 'Trans proline' 0 C--N 1.308 -1.563 0 C-N-CA 122.723 2.282 . . . . 0.0 112.203 -179.183 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 95' ' ' GLU . . . . . 0.493 ' O ' ' ND2' ' A' ' 98' ' ' ASN . 7.1 tp10 -47.65 -52.64 17.37 Favored 'General case' 0 C--N 1.299 -1.601 0 O-C-N 121.397 -0.814 . . . . 0.0 109.259 179.487 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 96' ' ' GLN . . . . . 0.517 ' C ' ' H ' ' A' ' 98' ' ' ASN . 12.2 mp0 -70.14 -54.66 11.98 Favored 'General case' 0 N--CA 1.489 1.504 0 O-C-N 121.382 -0.824 . . . . 0.0 110.918 -179.349 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 97' ' ' LEU . . . . . 0.523 ' CD1' ' O ' ' A' ' 92' ' ' ALA . 81.5 mt -50.84 -6.28 0.03 OUTLIER 'General case' 0 N--CA 1.494 1.764 0 O-C-N 121.002 -1.061 . . . . 0.0 110.341 -178.671 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 98' ' ' ASN . . . . . 0.517 ' H ' ' C ' ' A' ' 96' ' ' GLN . 0.2 OUTLIER -75.3 -32.61 61.04 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.169 -0.957 . . . . 0.0 109.392 179.24 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 99' ' ' ARG . . . . . 0.44 ' HD2' ' CE2' ' A' ' 88' ' ' TYR . 9.3 mtt180 -85.53 -44.93 12.25 Favored 'General case' 0 N--CA 1.488 1.469 0 O-C-N 121.478 -0.764 . . . . 0.0 109.727 -179.321 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . 169.87 -170.6 42.91 Favored Glycine 0 N--CA 1.495 2.624 0 C-N-CA 119.698 -1.239 . . . . 0.0 110.141 179.653 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 101' ' ' VAL . . . . . 0.589 HG23 ' O ' ' A' ' 101' ' ' VAL . 26.8 m -55.0 106.74 0.12 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.572 0 O-C-N 121.093 -1.239 . . . . 0.0 109.17 -179.981 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -92.88 164.55 13.28 Favored 'General case' 0 N--CA 1.494 1.737 0 O-C-N 121.433 -0.792 . . . . 0.0 110.664 -179.282 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 103' ' ' PHE . . . . . 0.555 ' CZ ' ' CG1' ' A' ' 87' ' ' VAL . 28.5 m-85 -68.04 123.12 19.76 Favored 'General case' 0 N--CA 1.488 1.452 0 N-CA-C 108.549 -0.908 . . . . 0.0 108.549 178.413 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 104' ' ' ALA . . . . . 0.586 ' HB1' ' HG3' ' C' ' 703' ' ' PRO . . . -50.58 -7.33 0.03 OUTLIER 'General case' 0 C--N 1.3 -1.571 0 O-C-N 121.453 -0.779 . . . . 0.0 110.634 -179.42 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 105' ' ' GLU . . . . . 0.486 ' N ' ' O ' ' A' ' 103' ' ' PHE . 0.0 OUTLIER -139.83 144.22 37.2 Favored 'General case' 0 N--CA 1.495 1.814 0 O-C-N 120.915 -1.116 . . . . 0.0 110.433 -179.246 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 106' ' ' GLU . . . . . . . . . . . . . 28.2 tt0 -59.91 -64.35 0.98 Allowed 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.784 -0.572 . . . . 0.0 111.245 -178.959 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 107' ' ' ASN . . . . . . . . . . . . . 4.6 m120 -78.5 35.51 0.23 Allowed 'General case' 0 N--CA 1.49 1.541 0 O-C-N 120.813 -1.179 . . . . 0.0 112.378 -175.981 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 108' ' ' GLU . . . . . 0.429 ' OE2' ' OE2' ' A' ' 105' ' ' GLU . 1.6 tp10 -59.0 149.24 27.97 Favored 'General case' 0 C--N 1.303 -1.415 0 O-C-N 120.703 -1.248 . . . . 0.0 107.725 -179.912 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 109' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -103.98 137.51 41.84 Favored 'General case' 0 C--N 1.304 -1.372 0 O-C-N 121.069 -1.019 . . . . 0.0 110.616 -178.236 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 110' ' ' LEU . . . . . . . . . . . . . 2.2 pp -60.74 -17.79 50.7 Favored 'General case' 0 C--N 1.298 -1.636 0 N-CA-C 108.225 -1.028 . . . . 0.0 108.225 179.138 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 111' ' ' ASP . . . . . . . . . . . . . 41.3 m-20 -132.13 37.77 3.55 Favored 'General case' 0 N--CA 1.489 1.492 0 N-CA-C 108.836 -0.801 . . . . 0.0 108.836 179.237 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 112' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -68.84 156.57 38.16 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.24 -0.913 . . . . 0.0 110.804 -179.786 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 113' ' ' GLN . . . . . 0.617 HE22 ' N ' ' A' ' 172' ' ' GLN . 0.0 OUTLIER -66.75 -15.96 63.91 Favored 'General case' 0 N--CA 1.487 1.402 0 N-CA-C 107.964 -1.125 . . . . 0.0 107.964 177.612 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 114' ' ' ASN . . . . . 0.457 ' OD1' ' OE1' ' A' ' 178' ' ' GLN . 3.0 t30 -151.4 106.11 3.26 Favored 'General case' 0 C--N 1.299 -1.61 0 N-CA-C 108.158 -1.053 . . . . 0.0 108.158 179.655 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 115' ' ' ILE . . . . . 0.511 HG22 ' O ' ' A' ' 115' ' ' ILE . 2.7 mt -94.92 105.25 16.74 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.604 0 N-CA-C 107.66 -1.237 . . . . 0.0 107.66 179.655 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 116' ' ' SER . . . . . 0.423 ' OG ' ' ND2' ' A' ' 114' ' ' ASN . 36.6 m -89.57 147.42 23.95 Favored 'General case' 0 N--CA 1.487 1.39 0 CA-C-O 121.905 0.859 . . . . 0.0 111.303 -177.596 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 117' ' ' ILE . . . . . . . . . . . . . 1.7 mt -144.48 150.92 16.1 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.394 0 N-CA-C 108.092 -1.077 . . . . 0.0 108.092 179.194 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 118' ' ' ALA . . . . . 0.942 ' HB1' ' HB2' ' C' ' 704' ' ' ALA . . . -141.41 160.58 39.83 Favored 'General case' 0 N--CA 1.493 1.703 0 O-C-N 120.921 -1.112 . . . . 0.0 111.209 -178.886 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 119' ' ' GLY . . . . . . . . . . . . . . . -168.36 149.01 13.25 Favored Glycine 0 N--CA 1.489 2.221 0 C-N-CA 119.962 -1.113 . . . . 0.0 111.092 -179.98 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 120' ' ' HIS . . . . . . . . . . . . . 12.7 m170 -71.35 168.93 16.36 Favored 'General case' 0 N--CA 1.495 1.781 0 O-C-N 122.13 -0.629 . . . . 0.0 110.232 179.202 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 121' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -123.7 155.62 37.48 Favored 'General case' 0 N--CA 1.495 1.819 0 N-CA-C 108.864 -0.791 . . . . 0.0 108.864 179.233 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 122' ' ' PHE . . . . . . . . . . . . . 0.7 OUTLIER -143.92 123.17 12.99 Favored 'General case' 0 N--CA 1.501 2.091 0 O-C-N 120.913 -1.117 . . . . 0.0 110.228 179.606 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 123' ' ' ILE . . . . . 0.538 HG23 ' N ' ' A' ' 124' ' ' ASP . 17.1 tt -57.83 -40.61 76.9 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.43 0 CA-C-O 121.582 0.705 . . . . 0.0 109.291 179.606 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 124' ' ' ASP . . . . . 0.538 ' N ' HG23 ' A' ' 123' ' ' ILE . 0.4 OUTLIER -87.19 23.43 1.82 Allowed 'General case' 0 N--CA 1.497 1.898 0 O-C-N 121.648 -0.658 . . . . 0.0 111.461 -177.477 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 125' ' ' ARG . . . . . . . . . . . . . 82.9 mtt180 -153.18 99.83 2.68 Favored Pre-proline 0 N--CA 1.493 1.696 0 O-C-N 120.761 -1.212 . . . . 0.0 109.665 -179.582 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 126' ' ' PRO . . . . . . . . . . . . . 34.0 Cg_endo -77.41 -33.65 2.38 Favored 'Trans proline' 0 N--CA 1.489 1.255 0 C-N-CA 122.263 1.976 . . . . 0.0 112.782 -179.744 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 127' ' ' ASN . . . . . 0.485 ' O ' ' O ' ' A' ' 128' ' ' TYR . 5.1 p30 -90.64 11.14 23.01 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.198 -0.939 . . . . 0.0 109.602 179.911 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 128' ' ' TYR . . . . . 0.485 ' O ' ' O ' ' A' ' 127' ' ' ASN . 2.8 t80 -59.53 -149.67 0.0 OUTLIER 'General case' 0 N--CA 1.489 1.478 0 O-C-N 121.091 -1.006 . . . . 0.0 109.516 179.978 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 129' ' ' GLN . . . . . . . . . . . . . 37.1 mt-30 -66.95 -70.37 0.25 Allowed 'General case' 0 N--CA 1.487 1.413 0 O-C-N 121.337 -0.852 . . . . 0.0 109.605 -179.779 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 130' ' ' PHE . . . . . 0.505 ' CZ ' HG11 ' A' ' 101' ' ' VAL . 50.6 m-85 -136.22 42.29 2.57 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.167 -0.958 . . . . 0.0 110.771 -179.39 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 131' ' ' THR . . . . . . . . . . . . . 8.5 m -74.68 -40.16 61.56 Favored 'General case' 0 N--CA 1.495 1.792 0 O-C-N 120.875 -1.141 . . . . 0.0 109.034 179.241 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 132' ' ' ASN . . . . . 0.558 ' ND2' ' O ' ' A' ' 81' ' ' ALA . 0.2 OUTLIER -89.18 11.59 18.27 Favored 'General case' 0 N--CA 1.492 1.673 0 C-N-CA 119.465 -0.894 . . . . 0.0 111.625 -178.678 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 133' ' ' LEU . . . . . 0.546 ' O ' ' N ' ' A' ' 135' ' ' ALA . 0.2 OUTLIER -68.02 -46.9 69.94 Favored 'General case' 0 N--CA 1.492 1.663 0 O-C-N 120.536 -1.353 . . . . 0.0 109.988 -179.16 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 134' ' ' LYS . . . . . 0.651 ' H ' ' CD ' ' A' ' 134' ' ' LYS . 0.0 OUTLIER -46.0 -14.11 0.02 OUTLIER 'General case' 0 N--CA 1.495 1.805 0 O-C-N 121.05 -1.031 . . . . 0.0 110.03 -179.514 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 135' ' ' ALA . . . . . 0.546 ' N ' ' O ' ' A' ' 133' ' ' LEU . . . -82.41 -35.89 27.23 Favored 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.108 -0.995 . . . . 0.0 109.123 179.669 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 136' ' ' ALA . . . . . 0.882 ' HB2' ' HB2' ' A' ' 81' ' ' ALA . . . -78.88 152.1 31.42 Favored 'General case' 0 C--N 1.302 -1.469 0 CA-C-O 121.858 0.837 . . . . 0.0 110.667 -179.35 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 137' ' ' LYS . . . . . 0.555 ' O ' ' O ' ' A' ' 138' ' ' LYS . 28.0 mtmm -153.06 -168.54 3.06 Favored 'General case' 0 N--CA 1.492 1.631 0 C-N-CA 118.351 -1.34 . . . . 0.0 110.939 -178.332 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 138' ' ' LYS . . . . . 0.555 ' O ' ' O ' ' A' ' 137' ' ' LYS . 0.0 OUTLIER -29.78 159.78 0.0 OUTLIER 'General case' 0 N--CA 1.489 1.509 0 CA-C-O 122.992 1.377 . . . . 0.0 112.681 -178.028 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 139' ' ' GLY . . . . . . . . . . . . . . . 51.9 8.81 0.44 Allowed Glycine 0 N--CA 1.489 2.199 0 N-CA-C 109.824 -1.311 . . . . 0.0 109.824 179.612 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 140' ' ' SER . . . . . 0.471 ' H ' ' C ' ' A' ' 138' ' ' LYS . 1.5 m -68.04 115.19 7.26 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.17 -1.194 . . . . 0.0 108.979 179.493 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 141' ' ' MET . . . . . . . . . . . . . 3.2 tpt -66.94 120.42 13.58 Favored 'General case' 0 C--N 1.301 -1.506 0 O-C-N 121.186 -0.946 . . . . 0.0 109.621 -179.866 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 142' ' ' VAL . . . . . . . . . . . . . 5.1 t -110.56 127.98 67.2 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.651 0 N-CA-C 108.192 -1.04 . . . . 0.0 108.192 179.835 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 143' ' ' TYR . . . . . . . . . . . . . 26.3 m-85 -107.79 135.06 49.84 Favored 'General case' 0 N--CA 1.498 1.963 0 O-C-N 121.022 -1.049 . . . . 0.0 111.348 -178.442 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 144' ' ' PHE . . . . . . . . . . . . . 58.5 t80 -119.19 101.16 7.8 Favored 'General case' 0 N--CA 1.486 1.355 0 N-CA-C 109.214 -0.661 . . . . 0.0 109.214 179.323 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 145' ' ' LYS . . . . . . . . . . . . . 35.8 mttt -95.47 129.33 42.67 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.127 -0.983 . . . . 0.0 109.62 -179.74 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 146' ' ' VAL . . . . . 0.428 ' O ' ' C ' ' A' ' 147' ' ' GLY . 3.3 p -141.67 141.43 29.85 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.636 0 N-CA-C 107.957 -1.127 . . . . 0.0 107.957 179.369 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 147' ' ' GLY . . . . . 0.428 ' C ' ' O ' ' A' ' 146' ' ' VAL . . . 44.43 -128.75 7.14 Favored Glycine 0 N--CA 1.487 2.05 0 N-CA-C 108.885 -1.686 . . . . 0.0 108.885 -179.59 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 148' ' ' ASN . . . . . 0.537 HD22 ' C ' ' A' ' 148' ' ' ASN . 0.4 OUTLIER -103.66 16.39 26.53 Favored 'General case' 0 C--N 1.298 -1.649 0 O-C-N 121.424 -1.045 . . . . 0.0 108.298 179.094 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 149' ' ' GLU . . . . . . . . . . . . . 13.9 tt0 -111.75 145.31 39.58 Favored 'General case' 0 N--CA 1.489 1.477 0 CA-C-O 121.896 0.855 . . . . 0.0 111.273 -178.471 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 150' ' ' THR . . . . . 0.429 ' O ' HG22 ' A' ' 150' ' ' THR . 2.1 m -127.4 102.69 7.0 Favored 'General case' 0 N--CA 1.491 1.613 0 CA-C-O 121.433 0.635 . . . . 0.0 109.757 -179.737 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 151' ' ' ARG . . . . . . . . . . . . . 50.9 mtt180 -86.22 -175.69 5.62 Favored 'General case' 0 N--CA 1.487 1.386 0 N-CA-C 108.541 -0.911 . . . . 0.0 108.541 -179.878 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 152' ' ' LYS . . . . . . . . . . . . . 1.7 mtmp? -145.0 149.36 35.0 Favored 'General case' 0 C--N 1.303 -1.45 0 C-N-CA 119.216 -0.993 . . . . 0.0 110.048 -179.457 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 153' ' ' TYR . . . . . 0.504 ' CD2' ' HA ' ' A' ' 204' ' ' GLU . 31.2 m-85 -143.71 166.29 25.28 Favored 'General case' 0 C--N 1.303 -1.454 0 N-CA-C 107.822 -1.177 . . . . 0.0 107.822 178.719 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 154' ' ' LYS . . . . . 0.587 ' HB2' HG21 ' A' ' 205' ' ' VAL . 5.9 ttmm -143.99 119.81 10.57 Favored 'General case' 0 C--N 1.296 -1.723 0 N-CA-C 108.125 -1.065 . . . . 0.0 108.125 179.074 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 155' ' ' MET . . . . . . . . . . . . . 14.1 mtp -48.45 107.71 0.14 Allowed 'General case' 0 N--CA 1.493 1.678 0 O-C-N 120.522 -1.361 . . . . 0.0 111.543 -178.623 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 156' ' ' THR . . . . . 0.515 ' OG1' HG23 ' A' ' 203' ' ' THR . 0.0 OUTLIER -107.45 -22.36 12.58 Favored 'General case' 0 C--N 1.296 -1.736 0 CA-C-N 115.34 -0.845 . . . . 0.0 110.758 -178.646 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 157' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -151.21 150.43 30.6 Favored 'General case' 0 N--CA 1.494 1.762 0 C-N-CA 118.395 -1.322 . . . . 0.0 111.284 -178.71 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 158' ' ' ILE . . . . . 0.994 HD12 ' N ' ' A' ' 159' ' ' ARG . 0.1 OUTLIER -154.53 142.46 12.96 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.3 0 CA-C-O 121.923 0.868 . . . . 0.0 110.3 -178.743 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 159' ' ' ARG . . . . . 0.994 ' N ' HD12 ' A' ' 158' ' ' ILE . 27.2 ptt180 -155.21 155.02 33.13 Favored 'General case' 0 C--N 1.296 -1.722 0 CA-C-O 121.663 0.744 . . . . 0.0 109.929 -179.902 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 160' ' ' ASP . . . . . 0.416 ' C ' HG22 ' A' ' 161' ' ' VAL . 0.2 OUTLIER -115.06 162.28 17.22 Favored 'General case' 0 N--CA 1.492 1.633 0 N-CA-C 108.165 -1.05 . . . . 0.0 108.165 179.218 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 161' ' ' VAL . . . . . 0.416 HG22 ' C ' ' A' ' 160' ' ' ASP . 0.0 OUTLIER -158.34 160.15 2.11 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.609 0 O-C-N 121.169 -0.957 . . . . 0.0 110.394 -179.539 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 162' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -52.45 176.91 0.07 OUTLIER Pre-proline 0 N--CA 1.488 1.456 0 O-C-N 121.477 -0.764 . . . . 0.0 109.053 179.663 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 163' ' ' PRO . . . . . 0.457 ' C ' HD11 ' C' ' 702' ' ' LEU . 2.4 Cg_endo -78.67 37.31 0.64 Allowed 'Trans proline' 0 N--CA 1.491 1.333 0 C-N-CA 122.478 2.119 . . . . 0.0 113.086 -179.531 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 164' ' ' THR . . . . . 0.423 ' N ' HD11 ' C' ' 702' ' ' LEU . 0.2 OUTLIER -152.65 -6.69 0.2 Allowed 'General case' 0 N--CA 1.495 1.821 0 O-C-N 120.464 -1.397 . . . . 0.0 111.792 -179.4 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 165' ' ' ASP . . . . . . . . . . . . . 6.0 t70 -74.7 62.29 1.05 Allowed 'General case' 0 N--CA 1.493 1.677 0 O-C-N 120.676 -1.265 . . . . 0.0 110.041 -179.581 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 166' ' ' VAL . . . . . 0.613 ' O ' ' N ' ' A' ' 168' ' ' VAL . 1.5 m -47.82 -31.44 2.68 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.594 0 O-C-N 121.144 -0.972 . . . . 0.0 109.968 -178.55 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 167' ' ' GLY . . . . . . . . . . . . . . . -44.26 -10.01 0.01 OUTLIER Glycine 0 N--CA 1.496 2.65 0 O-C-N 120.811 -1.18 . . . . 0.0 111.094 -179.545 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 168' ' ' VAL . . . . . 0.613 ' N ' ' O ' ' A' ' 166' ' ' VAL . 5.5 m -53.51 -29.35 16.82 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.614 0 O-C-N 120.62 -1.518 . . . . 0.0 108.976 179.785 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 169' ' ' LEU . . . . . 0.533 ' O ' ' C ' ' A' ' 170' ' ' ASP . 11.1 mt -49.47 -13.79 0.09 Allowed 'General case' 0 N--CA 1.49 1.564 0 N-CA-C 107.31 -1.367 . . . . 0.0 107.31 -179.14 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 170' ' ' ASP . . . . . 0.551 ' N ' ' C ' ' A' ' 168' ' ' VAL . 3.2 t70 21.84 91.77 0.01 OUTLIER 'General case' 0 N--CA 1.502 2.139 0 CA-C-N 116.281 -0.418 . . . . 0.0 111.649 177.261 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 171' ' ' GLU . . . . . 0.425 ' C ' ' OE1' ' A' ' 113' ' ' GLN . 3.3 pt-20 -136.93 74.41 1.49 Allowed 'General case' 0 N--CA 1.493 1.699 0 O-C-N 120.913 -1.117 . . . . 0.0 110.863 -179.814 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 172' ' ' GLN . . . . . 0.617 ' N ' HE22 ' A' ' 113' ' ' GLN . 1.1 pt20 -132.01 -47.95 0.94 Allowed 'General case' 0 N--CA 1.499 2.021 0 O-C-N 121.284 -0.885 . . . . 0.0 111.661 -178.451 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 173' ' ' LYS . . . . . 0.515 ' NZ ' ' O ' ' A' ' 176' ' ' ASP . 8.4 ptmm? -64.31 129.13 38.73 Favored 'General case' 0 N--CA 1.499 1.989 0 O-C-N 120.576 -1.327 . . . . 0.0 109.324 -179.968 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 174' ' ' GLY . . . . . 0.527 ' O ' ' C ' ' A' ' 175' ' ' LYS . . . -115.37 -40.0 0.9 Allowed Glycine 0 N--CA 1.484 1.89 0 N-CA-C 108.676 -1.769 . . . . 0.0 108.676 179.591 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 175' ' ' LYS . . . . . 0.527 ' C ' ' O ' ' A' ' 174' ' ' GLY . 0.2 OUTLIER -41.44 -62.08 0.93 Allowed 'General case' 0 N--CA 1.491 1.597 0 N-CA-C 107.022 -1.473 . . . . 0.0 107.022 178.864 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 176' ' ' ASP . . . . . 0.567 ' O ' ' O ' ' A' ' 177' ' ' LYS . 81.8 m-20 -104.4 85.36 2.34 Favored 'General case' 0 C--N 1.298 -1.635 0 N-CA-C 107.691 -1.226 . . . . 0.0 107.691 176.781 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 177' ' ' LYS . . . . . 0.567 ' O ' ' O ' ' A' ' 176' ' ' ASP . 2.1 mptp? -47.55 -175.16 0.0 OUTLIER 'General case' 0 N--CA 1.5 2.044 0 O-C-N 121.28 -0.888 . . . . 0.0 108.93 -179.755 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 178' ' ' GLN . . . . . 0.457 ' OE1' ' OD1' ' A' ' 114' ' ' ASN . 0.3 OUTLIER -162.75 178.63 8.31 Favored 'General case' 0 C--N 1.305 -1.355 0 O-C-N 120.264 -1.523 . . . . 0.0 110.936 179.836 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 179' ' ' LEU . . . . . 0.453 HD23 ' C ' ' A' ' 179' ' ' LEU . 4.6 tt -128.55 97.55 4.74 Favored 'General case' 0 C--N 1.302 -1.474 0 N-CA-C 107.54 -1.281 . . . . 0.0 107.54 178.436 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 180' ' ' THR . . . . . 0.441 ' O ' HG22 ' A' ' 180' ' ' THR . 1.2 m -71.29 115.18 10.15 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 120.996 -1.065 . . . . 0.0 109.967 -178.719 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 181' ' ' LEU . . . . . 0.475 HD21 ' HG ' ' A' ' 133' ' ' LEU . 48.5 tp -93.16 142.45 27.28 Favored 'General case' 0 C--N 1.295 -1.794 0 N-CA-C 108.368 -0.975 . . . . 0.0 108.368 178.328 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 182' ' ' ILE . . . . . . . . . . . . . 47.0 mt -136.11 120.58 25.93 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.533 0 N-CA-C 108.197 -1.038 . . . . 0.0 108.197 178.925 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 183' ' ' THR . . . . . 0.487 ' O ' HG23 ' A' ' 183' ' ' THR . 2.2 t -140.72 111.84 7.18 Favored 'General case' 0 C--N 1.291 -1.943 0 N-CA-C 107.718 -1.215 . . . . 0.0 107.718 179.117 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 184' ' ' CYS . . . . . . . . . . . . . 1.2 p -78.81 159.55 27.8 Favored 'General case' 0 C--N 1.292 -1.907 0 C-N-CA 118.856 -1.138 . . . . 0.0 110.665 -178.09 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 185' ' ' ASP . . . . . 0.438 ' HB3' ' HZ1' ' A' ' 198' ' ' LYS . 0.4 OUTLIER -164.57 -155.66 0.28 Allowed 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.629 -0.669 . . . . 0.0 109.413 -179.488 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 186' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER 52.32 60.67 3.65 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.128 -0.982 . . . . 0.0 108.597 -179.469 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 187' ' ' TYR . . . . . 0.593 ' CE1' ' O ' ' A' ' 188' ' ' ASN . 35.5 t80 -68.34 134.02 49.64 Favored 'General case' 0 N--CA 1.488 1.459 0 CA-C-O 121.812 0.815 . . . . 0.0 111.142 -178.977 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 188' ' ' ASN . . . . . 0.593 ' O ' ' CE1' ' A' ' 187' ' ' TYR . 0.9 OUTLIER -98.67 145.64 26.67 Favored 'General case' 0 C--N 1.296 -1.721 0 N-CA-C 108.218 -1.03 . . . . 0.0 108.218 178.395 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 189' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -112.01 -19.91 12.16 Favored 'General case' 0 C--N 1.296 -1.749 0 N-CA-C 107.904 -1.147 . . . . 0.0 107.904 -179.86 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 190' ' ' LYS . . . . . . . . . . . . . 33.5 mttt -82.63 -50.06 9.16 Favored 'General case' 0 C--N 1.3 -1.551 0 N-CA-C 108.235 -1.024 . . . . 0.0 108.235 178.62 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 191' ' ' THR . . . . . . . . . . . . . 71.4 p -87.97 -8.97 54.93 Favored 'General case' 0 C--N 1.303 -1.428 0 N-CA-C 109.105 -0.702 . . . . 0.0 109.105 -179.97 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 192' ' ' GLY . . . . . . . . . . . . . . . 57.56 38.73 88.91 Favored Glycine 0 N--CA 1.493 2.466 0 N-CA-C 110.745 -0.942 . . . . 0.0 110.745 178.872 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 193' ' ' VAL . . . . . . . . . . . . . 3.2 m -148.05 162.1 6.63 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.58 0 O-C-N 120.989 -1.3 . . . . 0.0 108.872 179.35 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 194' ' ' TRP . . . . . . . . . . . . . 47.6 m95 -83.58 120.47 26.0 Favored 'General case' 0 N--CA 1.489 1.518 0 N-CA-C 107.802 -1.184 . . . . 0.0 107.802 178.901 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 195' ' ' GLU . . . . . . . . . . . . . 2.0 mt-10 -86.8 -61.05 1.82 Allowed 'General case' 0 N--CA 1.496 1.858 0 O-C-N 121.132 -0.98 . . . . 0.0 112.083 -177.318 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 196' ' ' LYS . . . . . . . . . . . . . 11.1 tttm -76.84 150.51 36.08 Favored 'General case' 0 N--CA 1.493 1.723 0 O-C-N 120.973 -1.079 . . . . 0.0 111.304 -177.663 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 197' ' ' ARG . . . . . 0.431 ' NH1' ' O ' ' C' ' 704' ' ' ALA . 16.9 mmt180 -122.01 129.83 52.78 Favored 'General case' 0 N--CA 1.491 1.584 0 N-CA-C 108.839 -0.8 . . . . 0.0 108.839 179.481 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 198' ' ' LYS . . . . . 0.438 ' HZ1' ' HB3' ' A' ' 185' ' ' ASP . 9.6 mtmt -113.72 120.25 40.18 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.482 -0.761 . . . . 0.0 109.969 -179.399 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 199' ' ' ILE . . . . . 0.508 ' C ' HD12 ' A' ' 199' ' ' ILE . 0.8 OUTLIER -140.04 118.42 11.14 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.723 0 CA-C-O 122.405 1.097 . . . . 0.0 109.929 179.269 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 200' ' ' PHE . . . . . 0.524 ' CD1' ' N ' ' A' ' 200' ' ' PHE . 4.7 m-85 -100.09 139.68 35.41 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.181 -0.949 . . . . 0.0 109.512 -179.082 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 201' ' ' VAL . . . . . . . . . . . . . 40.7 t -102.33 145.79 11.42 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.645 0 N-CA-C 107.31 -1.367 . . . . 0.0 107.31 177.395 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 202' ' ' ALA . . . . . . . . . . . . . . . -129.25 137.42 51.07 Favored 'General case' 0 C--N 1.301 -1.503 0 O-C-N 120.949 -1.095 . . . . 0.0 109.146 -179.4 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 203' ' ' THR . . . . . 0.559 ' O ' HG23 ' A' ' 205' ' ' VAL . 2.5 p -88.83 129.99 35.47 Favored 'General case' 0 C--N 1.305 -1.352 0 CA-C-O 122.393 1.092 . . . . 0.0 110.705 -178.791 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 204' ' ' GLU . . . . . 0.504 ' HA ' ' CD2' ' A' ' 153' ' ' TYR . 3.9 tm-20 -50.84 133.82 26.06 Favored 'General case' 0 C--N 1.296 -1.734 0 C-N-CA 119.184 -1.007 . . . . 0.0 109.659 179.739 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 205' ' ' VAL . . . . . 0.597 HG12 ' N ' ' A' ' 206' ' ' LYS . 73.8 t -126.94 164.52 27.35 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.452 0 CA-C-O 122.109 0.957 . . . . 0.0 110.066 -178.14 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 206' ' ' LYS . . . . . 0.597 ' N ' HG12 ' A' ' 205' ' ' VAL . 0.9 OUTLIER . . . . . 0 C--N 1.295 -1.765 0 CA-C-O 117.931 -1.033 . . . . 0.0 109.468 179.929 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' C' C ' 702' ' ' LEU . . . . . 0.772 ' N ' HD12 ' C' ' 702' ' ' LEU . 0.0 OUTLIER . . . . . 0 N--CA 1.492 1.632 0 N-CA-C 108.998 -0.741 . . . . 0.0 108.998 . . . . . . . . . 2 2 . 1 . 013 nuclear build core ' C' C ' 703' ' ' PRO . . . . . 0.586 ' HG3' ' HB1' ' A' ' 104' ' ' ALA . 28.8 Cg_endo -68.95 -162.03 0.08 OUTLIER 'Trans proline' 0 N--CA 1.491 1.347 0 C-N-CA 122.271 1.981 . . . . 0.0 112.272 179.779 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' C' C ' 704' ' ' ALA . . . . . 0.942 ' HB2' ' HB1' ' A' ' 118' ' ' ALA . . . . . . . . 0 N--CA 1.489 1.491 0 O-C-N 121.306 -0.871 . . . . 0.0 108.993 -179.928 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 63' ' ' PRO . . . . . 0.644 ' O ' HD13 ' A' ' 110' ' ' LEU . 21.3 Cg_endo . . . . . 0 C--O 1.212 -0.794 0 CA-C-O 121.412 0.505 . . . . 0.0 111.586 . . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 64' ' ' GLN . . . . . 0.442 ' N ' ' OE1' ' A' ' 64' ' ' GLN . 0.0 OUTLIER -158.14 113.4 2.67 Favored 'General case' 0 N--CA 1.488 1.453 0 O-C-N 121.249 -0.907 . . . . 0.0 109.528 -179.773 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 65' ' ' ILE . . . . . 0.722 ' H ' HD13 ' A' ' 65' ' ' ILE . 0.0 OUTLIER -42.0 103.29 0.3 Allowed Pre-proline 0 N--CA 1.49 1.571 0 N-CA-C 108.757 -0.831 . . . . 0.0 108.757 179.471 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 66' ' ' PRO . . . . . . . . . . . . . 94.3 Cg_endo -87.6 -155.82 0.06 OUTLIER 'Trans proline' 0 C--N 1.313 -1.338 0 C-N-CA 122.372 2.048 . . . . 0.0 112.259 -179.18 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 67' ' ' LYS . . . . . . . . . . . . . 23.1 pttm -79.42 -7.86 58.7 Favored 'General case' 0 C--N 1.302 -1.474 0 O-C-N 121.308 -0.87 . . . . 0.0 108.847 179.673 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 68' ' ' ASP . . . . . 0.579 ' O ' ' N ' ' A' ' 70' ' ' SER . 1.9 t0 -76.7 48.3 0.55 Allowed 'General case' 0 N--CA 1.487 1.423 0 CA-C-O 122.342 1.068 . . . . 0.0 108.931 179.385 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 69' ' ' LYS . . . . . 0.444 ' C ' ' O ' ' A' ' 68' ' ' ASP . 0.0 OUTLIER -49.27 -14.69 0.1 Allowed 'General case' 0 N--CA 1.503 2.217 0 C-N-CA 117.094 -1.842 . . . . 0.0 106.554 178.257 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 70' ' ' SER . . . . . 0.579 ' N ' ' O ' ' A' ' 68' ' ' ASP . 1.1 p -82.28 -8.91 59.64 Favored 'General case' 0 N--CA 1.495 1.804 0 CA-C-N 113.942 -1.481 . . . . 0.0 110.035 179.552 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 71' ' ' LYS . . . . . 0.416 ' CD ' ' HB3' ' A' ' 68' ' ' ASP . 0.0 OUTLIER -99.19 144.17 28.62 Favored 'General case' 0 N--CA 1.494 1.73 0 O-C-N 121.034 -1.041 . . . . 0.0 110.312 179.294 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 72' ' ' VAL . . . . . 0.517 HG12 ' CZ ' ' A' ' 88' ' ' TYR . 1.0 OUTLIER -65.26 141.48 18.13 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.575 0 N-CA-C 104.868 -2.271 . . . . 0.0 104.868 174.542 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -80.82 -14.9 57.64 Favored 'General case' 0 C--N 1.294 -1.825 0 O-C-N 119.864 -1.772 . . . . 0.0 106.411 179.66 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . 175.46 -156.58 22.36 Favored Glycine 0 N--CA 1.481 1.645 0 N-CA-C 109.16 -1.576 . . . . 0.0 109.16 179.274 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 75' ' ' TYR . . . . . 0.572 ' CD2' ' O ' ' A' ' 85' ' ' GLU . 0.5 OUTLIER -141.7 167.98 20.86 Favored 'General case' 0 C--N 1.292 -1.893 0 O-C-N 121.664 -0.903 . . . . 0.0 110.655 -176.991 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 76' ' ' ILE . . . . . . . . . . . . . 0.6 OUTLIER -144.75 140.32 23.44 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.597 0 C-N-CA 119.087 -1.045 . . . . 0.0 109.781 -177.432 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -148.57 161.46 41.63 Favored 'General case' 0 C--N 1.303 -1.456 0 O-C-N 121.287 -0.883 . . . . 0.0 109.158 -179.571 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 78' ' ' ILE . . . . . 0.654 ' HB ' ' HB3' ' A' ' 81' ' ' ALA . 6.6 mt -146.89 94.42 4.64 Favored Pre-proline 0 C--N 1.3 -1.553 0 N-CA-C 108.53 -0.915 . . . . 0.0 108.53 -179.75 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 79' ' ' PRO . . . . . . . . . . . . . 74.4 Cg_exo -47.32 -47.42 17.47 Favored 'Trans proline' 0 N--CA 1.493 1.449 0 C-N-CA 122.805 2.337 . . . . 0.0 113.765 -178.745 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -65.24 -18.17 65.1 Favored 'General case' 0 N--CA 1.492 1.65 0 O-C-N 120.765 -1.209 . . . . 0.0 110.565 178.667 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 81' ' ' ALA . . . . . 0.893 ' HB2' ' HB2' ' A' ' 136' ' ' ALA . . . -105.69 -16.74 14.6 Favored 'General case' 0 N--CA 1.493 1.718 0 O-C-N 121.24 -0.912 . . . . 0.0 108.918 179.653 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 82' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER 69.39 47.79 0.67 Allowed 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.432 -0.793 . . . . 0.0 110.53 178.87 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 83' ' ' ILE . . . . . . . . . . . . . 67.2 mt -127.1 149.58 32.31 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.81 0 O-C-N 121.065 -1.022 . . . . 0.0 110.732 -178.87 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 84' ' ' LYS . . . . . . . . . . . . . 6.7 ttpm? -157.38 107.86 2.25 Favored 'General case' 0 N--CA 1.491 1.595 0 N-CA-C 107.544 -1.28 . . . . 0.0 107.544 179.516 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 85' ' ' GLU . . . . . 0.572 ' O ' ' CD2' ' A' ' 75' ' ' TYR . 0.4 OUTLIER -145.31 174.37 3.51 Favored Pre-proline 0 N--CA 1.492 1.65 0 O-C-N 121.503 -0.748 . . . . 0.0 110.409 -178.8 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 86' ' ' PRO . . . . . . . . . . . . . 60.3 Cg_endo -82.41 168.85 14.43 Favored 'Trans proline' 0 C--N 1.313 -1.305 0 C-N-CA 122.809 2.339 . . . . 0.0 113.841 -179.347 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 87' ' ' VAL . . . . . 0.531 ' CG1' ' CZ ' ' A' ' 103' ' ' PHE . 3.2 t -128.93 105.84 13.42 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.607 0 N-CA-C 108.448 -0.945 . . . . 0.0 108.448 179.91 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 88' ' ' TYR . . . . . 0.517 ' CZ ' HG12 ' A' ' 72' ' ' VAL . 34.6 m-85 -99.22 152.76 37.91 Favored Pre-proline 0 N--CA 1.499 2.006 0 O-C-N 120.769 -1.207 . . . . 0.0 110.129 -179.018 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 89' ' ' PRO . . . . . . . . . . . . . 2.7 Cg_exo -50.35 144.42 23.97 Favored 'Trans proline' 0 C--N 1.312 -1.351 0 C-N-CA 122.707 2.271 . . . . 0.0 113.487 179.871 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . -61.41 169.57 10.5 Favored Glycine 0 N--CA 1.493 2.47 0 N-CA-C 108.807 -1.717 . . . . 0.0 108.807 178.894 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 91' ' ' PRO . . . . . 0.487 ' C ' ' H ' ' A' ' 93' ' ' THR . 63.9 Cg_endo -95.7 172.86 13.58 Favored 'Cis proline' 0 C--N 1.311 -1.407 0 C-N-CA 124.227 -1.156 . . . . 0.0 112.226 0.133 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 92' ' ' ALA . . . . . 0.553 ' O ' HD13 ' A' ' 97' ' ' LEU . . . -70.48 29.03 0.04 OUTLIER 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.229 -0.919 . . . . 0.0 110.378 -179.794 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 93' ' ' THR . . . . . 0.487 ' H ' ' C ' ' A' ' 91' ' ' PRO . 1.8 p -75.19 152.14 86.05 Favored Pre-proline 0 N--CA 1.489 1.524 0 O-C-N 120.626 -1.296 . . . . 0.0 108.833 -179.958 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 94' ' ' PRO . . . . . . . . . . . . . 86.4 Cg_exo -35.03 -42.34 0.35 Allowed 'Trans proline' 0 C--N 1.309 -1.546 0 C-N-CA 122.821 2.348 . . . . 0.0 112.398 -179.362 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 95' ' ' GLU . . . . . 0.485 ' O ' ' OD1' ' A' ' 98' ' ' ASN . 53.2 mt-10 -52.84 -55.18 25.01 Favored 'General case' 0 C--N 1.304 -1.407 0 O-C-N 121.094 -1.004 . . . . 0.0 109.12 179.636 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 96' ' ' GLN . . . . . 0.569 ' O ' ' N ' ' A' ' 98' ' ' ASN . 28.6 mm100 -72.29 -50.99 22.87 Favored 'General case' 0 N--CA 1.488 1.458 0 O-C-N 121.124 -0.985 . . . . 0.0 110.151 179.965 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 97' ' ' LEU . . . . . 0.553 HD13 ' O ' ' A' ' 92' ' ' ALA . 2.5 mp -48.39 -9.12 0.02 OUTLIER 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.038 -1.039 . . . . 0.0 109.784 -179.306 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 98' ' ' ASN . . . . . 0.737 HD21 ' CZ ' ' A' ' 99' ' ' ARG . 14.4 p-10 -72.38 -30.35 64.6 Favored 'General case' 0 N--CA 1.492 1.625 0 CA-C-O 121.873 0.844 . . . . 0.0 109.48 179.624 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 99' ' ' ARG . . . . . 0.737 ' CZ ' HD21 ' A' ' 98' ' ' ASN . 1.2 mtt-85 -98.66 -47.1 5.47 Favored 'General case' 0 C--N 1.299 -1.591 0 C-N-CA 119.829 -0.749 . . . . 0.0 110.106 -178.479 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . 176.28 -176.58 47.78 Favored Glycine 0 N--CA 1.493 2.485 0 C-N-CA 119.096 -1.526 . . . . 0.0 110.916 179.857 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 101' ' ' VAL . . . . . 0.739 ' CG2' HG22 ' A' ' 117' ' ' ILE . 0.2 OUTLIER -50.46 111.7 0.2 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.597 0 O-C-N 121.697 -0.884 . . . . 0.0 109.892 -179.859 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -93.94 169.7 10.09 Favored 'General case' 0 N--CA 1.496 1.84 0 O-C-N 121.273 -0.892 . . . . 0.0 110.741 -179.888 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 103' ' ' PHE . . . . . 0.603 ' O ' ' N ' ' A' ' 105' ' ' GLU . 27.5 m-85 -71.06 121.02 17.48 Favored 'General case' 0 N--CA 1.485 1.314 0 N-CA-C 107.68 -1.23 . . . . 0.0 107.68 177.609 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 104' ' ' ALA . . . . . 0.806 ' HB3' ' OG ' ' A' ' 116' ' ' SER . . . -41.95 -15.65 0.01 OUTLIER 'General case' 0 C--N 1.299 -1.597 0 O-C-N 121.497 -0.752 . . . . 0.0 110.682 -178.821 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 105' ' ' GLU . . . . . 0.603 ' N ' ' O ' ' A' ' 103' ' ' PHE . 0.1 OUTLIER -136.22 145.45 45.67 Favored 'General case' 0 N--CA 1.496 1.86 0 O-C-N 120.811 -1.18 . . . . 0.0 110.243 179.638 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 106' ' ' GLU . . . . . . . . . . . . . 2.0 tt0 -60.02 -63.43 1.3 Allowed 'General case' 0 N--CA 1.489 1.482 0 O-C-N 121.835 -0.54 . . . . 0.0 111.416 -178.904 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 107' ' ' ASN . . . . . . . . . . . . . 6.2 p-10 -78.11 35.09 0.21 Allowed 'General case' 0 N--CA 1.491 1.609 0 O-C-N 120.649 -1.282 . . . . 0.0 112.76 -175.608 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 108' ' ' GLU . . . . . . . . . . . . . 1.7 tp10 -58.24 148.94 25.51 Favored 'General case' 0 N--CA 1.488 1.451 0 N-CA-C 107.591 -1.263 . . . . 0.0 107.591 179.891 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 109' ' ' SER . . . . . 0.483 ' O ' HD11 ' A' ' 115' ' ' ILE . 0.2 OUTLIER -101.6 146.3 27.88 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.139 -0.975 . . . . 0.0 110.709 -178.305 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 110' ' ' LEU . . . . . 0.683 HD23 ' H ' ' A' ' 110' ' ' LEU . 0.3 OUTLIER -62.1 -24.15 66.95 Favored 'General case' 0 C--N 1.302 -1.477 0 N-CA-C 108.035 -1.098 . . . . 0.0 108.035 179.14 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 111' ' ' ASP . . . . . 0.405 ' CG ' HH12 ' A' ' 151' ' ' ARG . 13.0 m-20 -132.7 43.34 2.99 Favored 'General case' 0 N--CA 1.488 1.448 0 O-C-N 121.688 -0.633 . . . . 0.0 109.762 179.97 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 112' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -69.12 156.04 39.35 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.15 -0.969 . . . . 0.0 110.806 -179.852 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 113' ' ' GLN . . . . . 0.457 ' N ' ' CD ' ' A' ' 113' ' ' GLN . 1.9 mp0 -67.14 -18.16 65.17 Favored 'General case' 0 N--CA 1.491 1.622 0 N-CA-C 108.15 -1.055 . . . . 0.0 108.15 178.097 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 114' ' ' ASN . . . . . 0.498 ' O ' ' ND2' ' A' ' 114' ' ' ASN . 1.1 t30 -150.37 103.84 3.18 Favored 'General case' 0 C--N 1.299 -1.626 0 N-CA-C 107.871 -1.159 . . . . 0.0 107.871 178.533 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 115' ' ' ILE . . . . . 0.489 ' O ' HG22 ' A' ' 115' ' ' ILE . 2.9 mt -97.77 109.2 23.09 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.66 0 O-C-N 120.885 -1.134 . . . . 0.0 108.696 -179.955 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 116' ' ' SER . . . . . 0.806 ' OG ' ' HB3' ' A' ' 104' ' ' ALA . 80.8 p -88.0 152.24 22.18 Favored 'General case' 0 N--CA 1.49 1.538 0 CA-C-O 121.863 0.839 . . . . 0.0 110.842 -178.445 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 117' ' ' ILE . . . . . 0.739 HG22 ' CG2' ' A' ' 101' ' ' VAL . 1.5 mt -146.95 122.29 2.63 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.413 0 N-CA-C 107.876 -1.157 . . . . 0.0 107.876 -179.725 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 118' ' ' ALA . . . . . . . . . . . . . . . -118.58 159.72 23.07 Favored 'General case' 0 N--CA 1.496 1.846 0 C-N-CA 119.516 -0.874 . . . . 0.0 112.074 -177.933 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 119' ' ' GLY . . . . . . . . . . . . . . . -170.7 148.11 11.13 Favored Glycine 0 N--CA 1.49 2.255 0 CA-C-O 122.163 0.868 . . . . 0.0 110.936 179.929 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 120' ' ' HIS . . . . . 0.565 ' N ' ' OE1' ' A' ' 129' ' ' GLN . 0.3 OUTLIER -71.19 168.47 17.17 Favored 'General case' 0 N--CA 1.496 1.831 0 O-C-N 121.889 -0.771 . . . . 0.0 109.909 179.084 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 121' ' ' THR . . . . . 0.503 HG22 ' CZ3' ' A' ' 194' ' ' TRP . 0.7 OUTLIER -122.64 158.07 30.81 Favored 'General case' 0 N--CA 1.496 1.844 0 N-CA-C 108.48 -0.933 . . . . 0.0 108.48 178.786 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 122' ' ' PHE . . . . . 0.438 ' O ' HG21 ' A' ' 131' ' ' THR . 1.1 m-85 -144.16 123.61 13.15 Favored 'General case' 0 N--CA 1.498 1.974 0 O-C-N 120.819 -1.175 . . . . 0.0 110.006 -179.926 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 123' ' ' ILE . . . . . 0.585 HG23 ' N ' ' A' ' 124' ' ' ASP . 14.4 tt -58.51 -40.92 80.34 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.541 0 CA-C-O 121.619 0.723 . . . . 0.0 109.46 179.714 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 124' ' ' ASP . . . . . 0.585 ' N ' HG23 ' A' ' 123' ' ' ILE . 13.1 t70 -90.14 26.21 1.95 Allowed 'General case' 0 N--CA 1.497 1.888 0 O-C-N 121.573 -0.704 . . . . 0.0 112.166 -177.215 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 125' ' ' ARG . . . . . 0.67 HH11 ' CG ' ' A' ' 125' ' ' ARG . 2.2 mtt-85 -155.59 99.69 2.25 Favored Pre-proline 0 N--CA 1.493 1.679 0 O-C-N 120.451 -1.406 . . . . 0.0 109.718 179.989 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 126' ' ' PRO . . . . . . . . . . . . . 53.9 Cg_endo -78.54 -25.15 6.93 Favored 'Trans proline' 0 C--N 1.314 -1.277 0 C-N-CA 122.067 1.845 . . . . 0.0 112.172 179.893 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 127' ' ' ASN . . . . . 0.447 ' O ' ' O ' ' A' ' 128' ' ' TYR . 3.0 t30 -91.77 5.17 50.88 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.264 -0.897 . . . . 0.0 109.43 179.743 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 128' ' ' TYR . . . . . 0.465 ' O ' ' OE2' ' A' ' 85' ' ' GLU . 9.7 t80 -59.22 -150.25 0.0 OUTLIER 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.296 -0.878 . . . . 0.0 109.88 -179.765 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 129' ' ' GLN . . . . . 0.565 ' OE1' ' N ' ' A' ' 120' ' ' HIS . 10.3 mt-30 -68.04 -70.26 0.27 Allowed 'General case' 0 C--N 1.303 -1.422 0 O-C-N 121.549 -0.72 . . . . 0.0 109.483 179.968 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 130' ' ' PHE . . . . . 0.641 ' CE1' HD21 ' A' ' 181' ' ' LEU . 55.6 m-85 -136.59 51.88 1.98 Allowed 'General case' 0 N--CA 1.489 1.501 0 O-C-N 121.29 -0.881 . . . . 0.0 110.289 -179.536 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 131' ' ' THR . . . . . 0.537 ' O ' ' CD ' ' A' ' 134' ' ' LYS . 54.0 m -81.78 -40.06 23.18 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 120.936 -1.102 . . . . 0.0 109.275 179.844 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 132' ' ' ASN . . . . . 0.575 ' ND2' ' O ' ' A' ' 81' ' ' ALA . 32.1 t30 -91.88 13.56 18.11 Favored 'General case' 0 N--CA 1.496 1.854 0 C-N-CA 119.61 -0.836 . . . . 0.0 111.783 -178.781 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 133' ' ' LEU . . . . . 0.598 HD13 ' O ' ' A' ' 133' ' ' LEU . 0.2 OUTLIER -68.15 -33.51 74.61 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 120.49 -1.381 . . . . 0.0 109.402 -179.696 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 134' ' ' LYS . . . . . 0.697 ' H ' ' CD ' ' A' ' 134' ' ' LYS . 0.0 OUTLIER -44.66 -25.41 0.28 Allowed 'General case' 0 N--CA 1.494 1.734 0 O-C-N 121.35 -0.844 . . . . 0.0 110.625 -179.977 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 135' ' ' ALA . . . . . . . . . . . . . . . -82.31 -29.83 30.87 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.087 -1.008 . . . . 0.0 110.651 -178.623 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 136' ' ' ALA . . . . . 0.893 ' HB2' ' HB2' ' A' ' 81' ' ' ALA . . . -79.91 145.24 32.77 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.034 -1.041 . . . . 0.0 111.496 -178.639 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 137' ' ' LYS . . . . . 0.565 ' CG ' ' H ' ' A' ' 138' ' ' LYS . 0.5 OUTLIER -153.18 -167.69 2.8 Favored 'General case' 0 N--CA 1.496 1.828 0 C-N-CA 118.676 -1.209 . . . . 0.0 110.698 -177.994 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 138' ' ' LYS . . . . . 0.596 ' O ' ' N ' ' A' ' 140' ' ' SER . 22.1 mtmt -44.09 178.77 0.0 OUTLIER 'General case' 0 N--CA 1.487 1.407 0 CA-C-O 122.335 1.064 . . . . 0.0 110.709 -179.197 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 139' ' ' GLY . . . . . . . . . . . . . . . 46.1 7.88 0.02 OUTLIER Glycine 0 N--CA 1.487 2.057 0 N-CA-C 110.526 -1.03 . . . . 0.0 110.526 179.593 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 140' ' ' SER . . . . . 0.596 ' N ' ' O ' ' A' ' 138' ' ' LYS . 38.2 t -92.57 135.63 33.91 Favored 'General case' 0 N--CA 1.494 1.748 0 O-C-N 120.706 -1.467 . . . . 0.0 109.293 179.318 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 141' ' ' MET . . . . . 0.673 ' SD ' ' N ' ' A' ' 142' ' ' VAL . 9.7 tpp -87.94 132.7 34.13 Favored 'General case' 0 C--N 1.299 -1.608 0 O-C-N 121.246 -0.908 . . . . 0.0 109.621 179.94 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 142' ' ' VAL . . . . . 0.673 ' N ' ' SD ' ' A' ' 141' ' ' MET . 2.3 t -115.51 136.51 52.08 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.457 0 N-CA-C 108.068 -1.086 . . . . 0.0 108.068 179.875 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 143' ' ' TYR . . . . . . . . . . . . . 10.0 m-85 -115.73 137.64 51.89 Favored 'General case' 0 N--CA 1.499 2.016 0 O-C-N 121.021 -1.049 . . . . 0.0 111.758 -178.1 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 144' ' ' PHE . . . . . . . . . . . . . 12.6 t80 -122.16 107.93 12.73 Favored 'General case' 0 N--CA 1.492 1.665 0 CA-C-O 121.322 0.582 . . . . 0.0 109.5 -179.951 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 145' ' ' LYS . . . . . 0.453 ' O ' ' N ' ' A' ' 75' ' ' TYR . 1.6 tttp -95.46 131.78 41.24 Favored 'General case' 0 N--CA 1.493 1.684 0 O-C-N 121.333 -0.854 . . . . 0.0 110.371 -179.291 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 146' ' ' VAL . . . . . 0.45 ' O ' ' C ' ' A' ' 147' ' ' GLY . 0.7 OUTLIER -144.54 141.23 23.94 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.644 0 N-CA-C 107.9 -1.148 . . . . 0.0 107.9 178.667 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 147' ' ' GLY . . . . . 0.45 ' C ' ' O ' ' A' ' 146' ' ' VAL . . . 42.56 -127.57 4.77 Favored Glycine 0 N--CA 1.49 2.28 0 N-CA-C 109.394 -1.482 . . . . 0.0 109.394 -179.821 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 148' ' ' ASN . . . . . . . . . . . . . 22.0 p30 -103.01 14.62 31.51 Favored 'General case' 0 C--N 1.3 -1.566 0 O-C-N 121.418 -1.048 . . . . 0.0 108.47 179.365 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 149' ' ' GLU . . . . . . . . . . . . . 3.6 tt0 -110.85 143.77 40.92 Favored 'General case' 0 N--CA 1.488 1.442 0 CA-C-O 122.031 0.919 . . . . 0.0 111.26 -178.589 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 150' ' ' THR . . . . . . . . . . . . . 6.4 m -127.22 102.18 6.82 Favored 'General case' 0 N--CA 1.49 1.544 0 CA-C-O 121.395 0.617 . . . . 0.0 109.452 179.896 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 151' ' ' ARG . . . . . 0.405 HH12 ' CG ' ' A' ' 111' ' ' ASP . 22.1 mtt180 -87.6 -178.33 6.08 Favored 'General case' 0 C--N 1.305 -1.368 0 N-CA-C 108.459 -0.941 . . . . 0.0 108.459 179.789 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 152' ' ' LYS . . . . . 0.447 ' C ' ' CD1' ' A' ' 153' ' ' TYR . 22.6 mtmt -148.8 152.51 36.66 Favored 'General case' 0 C--N 1.3 -1.57 0 C-N-CA 119.303 -0.959 . . . . 0.0 110.024 -179.677 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 153' ' ' TYR . . . . . 0.557 ' O ' ' SD ' ' A' ' 141' ' ' MET . 42.1 m-85 -144.23 157.19 44.42 Favored 'General case' 0 C--N 1.3 -1.565 0 N-CA-C 107.987 -1.116 . . . . 0.0 107.987 179.137 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 154' ' ' LYS . . . . . . . . . . . . . 26.1 ttpt -132.1 118.33 19.48 Favored 'General case' 0 C--N 1.297 -1.684 0 N-CA-C 108.514 -0.921 . . . . 0.0 108.514 179.529 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 155' ' ' MET . . . . . . . . . . . . . 15.0 mtp -45.33 105.64 0.06 Allowed 'General case' 0 N--CA 1.489 1.496 0 CA-C-O 122.284 1.04 . . . . 0.0 111.632 -178.494 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 156' ' ' THR . . . . . 0.528 ' OG1' HG23 ' A' ' 203' ' ' THR . 0.2 OUTLIER -105.7 -25.25 12.31 Favored 'General case' 0 C--N 1.295 -1.786 0 CA-C-N 115.37 -0.832 . . . . 0.0 110.538 -178.803 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 157' ' ' SER . . . . . 0.484 ' O ' ' N ' ' A' ' 201' ' ' VAL . 0.0 OUTLIER -152.93 155.73 37.56 Favored 'General case' 0 N--CA 1.496 1.835 0 C-N-CA 118.456 -1.298 . . . . 0.0 110.914 -178.684 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 158' ' ' ILE . . . . . 0.42 HG12 ' N ' ' A' ' 159' ' ' ARG . 0.0 OUTLIER -154.52 146.7 13.61 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.561 0 CA-C-O 121.812 0.815 . . . . 0.0 110.857 -178.998 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 159' ' ' ARG . . . . . 0.508 ' O ' ' OD1' ' A' ' 160' ' ' ASP . 1.6 tpt180 -148.83 167.84 24.58 Favored 'General case' 0 N--CA 1.491 1.589 0 CA-C-O 121.448 0.642 . . . . 0.0 109.755 -179.659 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 160' ' ' ASP . . . . . 0.508 ' OD1' ' O ' ' A' ' 159' ' ' ARG . 6.5 m-20 -140.5 163.29 33.22 Favored 'General case' 0 N--CA 1.493 1.71 0 O-C-N 121.488 -0.757 . . . . 0.0 108.976 -179.388 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 161' ' ' VAL . . . . . 0.713 HG22 ' N ' ' A' ' 162' ' ' LYS . 11.8 p -165.49 169.05 0.36 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.708 0 O-C-N 120.906 -1.121 . . . . 0.0 111.277 179.894 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 162' ' ' LYS . . . . . 0.713 ' N ' HG22 ' A' ' 161' ' ' VAL . 0.0 OUTLIER -60.82 174.0 0.59 Allowed Pre-proline 0 N--CA 1.492 1.643 0 N-CA-C 109.099 -0.704 . . . . 0.0 109.099 178.771 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 163' ' ' PRO . . . . . . . . . . . . . 59.2 Cg_endo -82.2 42.92 1.4 Allowed 'Trans proline' 0 C--N 1.311 -1.416 0 C-N-CA 122.444 2.096 . . . . 0.0 112.855 -179.324 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 164' ' ' THR . . . . . 0.412 ' N ' HD21 ' C' ' 702' ' ' LEU . 24.0 m -151.74 -11.58 0.2 Allowed 'General case' 0 N--CA 1.494 1.748 0 O-C-N 120.93 -1.106 . . . . 0.0 111.081 179.788 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 165' ' ' ASP . . . . . 0.699 ' CB ' HG21 ' A' ' 161' ' ' VAL . 37.0 t70 -78.82 67.77 4.62 Favored 'General case' 0 N--CA 1.492 1.67 0 O-C-N 120.771 -1.206 . . . . 0.0 110.684 -179.549 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 166' ' ' VAL . . . . . 0.652 ' O ' ' N ' ' A' ' 168' ' ' VAL . 0.9 OUTLIER -47.54 -35.07 3.93 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.479 0 O-C-N 120.828 -1.17 . . . . 0.0 109.44 -179.097 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 167' ' ' GLY . . . . . 0.439 ' C ' ' O ' ' A' ' 166' ' ' VAL . . . -42.37 -13.65 0.01 OUTLIER Glycine 0 N--CA 1.496 2.651 0 C-N-CA 119.937 -1.125 . . . . 0.0 110.389 179.958 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 168' ' ' VAL . . . . . 0.652 ' N ' ' O ' ' A' ' 166' ' ' VAL . 9.3 p -53.79 -28.23 16.4 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.408 0 O-C-N 120.782 -1.422 . . . . 0.0 109.108 179.849 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 169' ' ' LEU . . . . . 0.615 HD23 ' N ' ' A' ' 169' ' ' LEU . 1.4 mt -45.87 -19.66 0.07 Allowed 'General case' 0 N--CA 1.496 1.857 0 N-CA-C 107.068 -1.456 . . . . 0.0 107.068 -178.298 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 170' ' ' ASP . . . . . 0.539 ' N ' ' O ' ' A' ' 168' ' ' VAL . 19.4 t0 27.32 91.09 0.01 OUTLIER 'General case' 0 N--CA 1.497 1.892 0 CA-C-N 116.392 -0.367 . . . . 0.0 111.486 177.399 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 171' ' ' GLU . . . . . 0.402 ' HA ' ' CB ' ' A' ' 114' ' ' ASN . 4.8 pt-20 -136.83 73.98 1.47 Allowed 'General case' 0 N--CA 1.493 1.71 0 O-C-N 120.967 -1.083 . . . . 0.0 110.252 179.663 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 172' ' ' GLN . . . . . . . . . . . . . 16.8 mm-40 -130.94 -48.41 1.02 Allowed 'General case' 0 N--CA 1.495 1.783 0 O-C-N 121.558 -0.714 . . . . 0.0 110.564 -178.745 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 173' ' ' LYS . . . . . 0.403 ' H ' ' HG3' ' A' ' 173' ' ' LYS . 7.2 mttp -58.8 133.94 56.43 Favored 'General case' 0 N--CA 1.492 1.669 0 O-C-N 120.926 -1.109 . . . . 0.0 108.988 -179.869 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 174' ' ' GLY . . . . . 0.571 ' O ' ' C ' ' A' ' 175' ' ' LYS . . . -130.45 -43.57 0.19 Allowed Glycine 0 C--N 1.299 -1.486 0 N-CA-C 108.363 -1.895 . . . . 0.0 108.363 179.567 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 175' ' ' LYS . . . . . 0.571 ' C ' ' O ' ' A' ' 174' ' ' GLY . 32.6 mmtt -33.78 -63.34 0.27 Allowed 'General case' 0 N--CA 1.496 1.831 0 N-CA-C 107.843 -1.169 . . . . 0.0 107.843 179.658 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 176' ' ' ASP . . . . . 0.618 ' O ' ' O ' ' A' ' 177' ' ' LYS . 15.8 m-20 -104.54 86.27 2.48 Favored 'General case' 0 C--N 1.294 -1.805 0 N-CA-C 107.406 -1.331 . . . . 0.0 107.406 176.854 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 177' ' ' LYS . . . . . 0.618 ' O ' ' O ' ' A' ' 176' ' ' ASP . 29.3 mtmt -39.25 176.65 0.0 OUTLIER 'General case' 0 N--CA 1.501 2.081 0 O-C-N 121.507 -0.746 . . . . 0.0 110.431 -179.053 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 178' ' ' GLN . . . . . 0.458 ' NE2' HG13 ' A' ' 201' ' ' VAL . 0.0 OUTLIER -161.88 176.35 10.93 Favored 'General case' 0 N--CA 1.488 1.434 0 O-C-N 120.431 -1.418 . . . . 0.0 111.365 -179.999 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 179' ' ' LEU . . . . . 0.408 ' HB2' ' CD2' ' A' ' 153' ' ' TYR . 1.0 OUTLIER -130.28 98.03 4.6 Favored 'General case' 0 N--CA 1.487 1.424 0 N-CA-C 107.105 -1.443 . . . . 0.0 107.105 178.191 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 180' ' ' THR . . . . . . . . . . . . . 1.1 m -71.42 119.89 16.22 Favored 'General case' 0 C--N 1.303 -1.448 0 O-C-N 121.06 -1.025 . . . . 0.0 110.193 -178.381 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 181' ' ' LEU . . . . . 0.856 HD13 ' N ' ' A' ' 182' ' ' ILE . 1.1 tm? -89.85 140.55 29.49 Favored 'General case' 0 C--N 1.303 -1.436 0 N-CA-C 106.91 -1.515 . . . . 0.0 106.91 177.456 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 182' ' ' ILE . . . . . 0.856 ' N ' HD13 ' A' ' 181' ' ' LEU . 5.3 mt -136.54 117.42 18.13 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.753 0 O-C-N 120.92 -1.112 . . . . 0.0 108.008 178.709 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 183' ' ' THR . . . . . . . . . . . . . 1.4 t -144.7 114.72 7.4 Favored 'General case' 0 C--N 1.287 -2.11 0 N-CA-C 107.84 -1.17 . . . . 0.0 107.84 -179.538 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 184' ' ' CYS . . . . . . . . . . . . . 0.7 OUTLIER -79.41 163.73 24.57 Favored 'General case' 0 C--N 1.288 -2.076 0 C-N-CA 118.762 -1.175 . . . . 0.0 110.649 -178.092 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 185' ' ' ASP . . . . . 0.438 ' OD1' ' N ' ' A' ' 186' ' ' ASP . 4.8 t70 -165.18 -154.42 0.22 Allowed 'General case' 0 N--CA 1.492 1.658 0 N-CA-C 109.232 -0.655 . . . . 0.0 109.232 -179.672 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 186' ' ' ASP . . . . . 0.438 ' N ' ' OD1' ' A' ' 185' ' ' ASP . 1.1 m-20 51.04 60.91 3.54 Favored 'General case' 0 N--CA 1.494 1.743 0 O-C-N 121.081 -1.012 . . . . 0.0 108.409 -179.246 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 187' ' ' TYR . . . . . 0.595 ' CE1' ' O ' ' A' ' 188' ' ' ASN . 50.7 t80 -67.78 134.37 50.86 Favored 'General case' 0 N--CA 1.49 1.544 0 CA-C-O 122.052 0.929 . . . . 0.0 111.591 -178.679 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 188' ' ' ASN . . . . . 0.595 ' O ' ' CE1' ' A' ' 187' ' ' TYR . 0.8 OUTLIER -100.78 146.15 27.63 Favored 'General case' 0 C--N 1.297 -1.7 0 N-CA-C 107.929 -1.137 . . . . 0.0 107.929 177.923 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 189' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -112.69 -14.78 13.1 Favored 'General case' 0 C--N 1.297 -1.706 0 N-CA-C 108.604 -0.887 . . . . 0.0 108.604 -179.712 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 190' ' ' LYS . . . . . . . . . . . . . 12.8 mttm -83.58 -49.87 8.79 Favored 'General case' 0 C--N 1.301 -1.505 0 N-CA-C 108.595 -0.891 . . . . 0.0 108.595 178.729 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 191' ' ' THR . . . . . 0.545 ' OG1' HG12 ' A' ' 193' ' ' VAL . 6.5 p -88.86 -11.99 43.12 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.432 -0.792 . . . . 0.0 108.916 179.454 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 192' ' ' GLY . . . . . . . . . . . . . . . 67.89 34.6 82.8 Favored Glycine 0 N--CA 1.493 2.438 0 O-C-N 121.309 -0.869 . . . . 0.0 111.059 178.561 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 193' ' ' VAL . . . . . 0.545 HG12 ' OG1' ' A' ' 191' ' ' THR . 3.5 p -148.12 167.96 4.15 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.543 0 O-C-N 120.789 -1.418 . . . . 0.0 110.216 179.382 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 194' ' ' TRP . . . . . 0.518 ' H ' HG22 ' A' ' 193' ' ' VAL . 36.7 m95 -84.89 120.85 26.94 Favored 'General case' 0 C--N 1.296 -1.74 0 N-CA-C 109.058 -0.719 . . . . 0.0 109.058 179.991 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 195' ' ' GLU . . . . . 0.546 ' CD ' ' ND2' ' A' ' 188' ' ' ASN . 3.8 mt-10 -84.99 -61.05 1.87 Allowed 'General case' 0 N--CA 1.496 1.865 0 O-C-N 121.268 -0.895 . . . . 0.0 111.089 -178.657 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 196' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -83.98 154.32 23.38 Favored 'General case' 0 N--CA 1.491 1.575 0 O-C-N 120.903 -1.123 . . . . 0.0 110.05 -178.917 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 197' ' ' ARG . . . . . 0.647 ' CG ' HH11 ' A' ' 197' ' ' ARG . 0.0 OUTLIER -126.89 140.17 52.53 Favored 'General case' 0 N--CA 1.489 1.482 0 N-CA-C 109.019 -0.734 . . . . 0.0 109.019 179.583 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 198' ' ' LYS . . . . . . . . . . . . . 23.4 mttt -114.58 121.17 42.61 Favored 'General case' 0 C--N 1.302 -1.478 0 O-C-N 121.793 -0.567 . . . . 0.0 110.2 -178.929 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 199' ' ' ILE . . . . . 0.539 HG21 HG21 ' A' ' 168' ' ' VAL . 0.8 OUTLIER -139.22 118.21 13.07 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.576 0 CA-C-O 122.809 1.29 . . . . 0.0 110.16 179.553 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 200' ' ' PHE . . . . . 0.501 ' CD1' ' N ' ' A' ' 200' ' ' PHE . 5.7 m-85 -101.0 137.03 39.91 Favored 'General case' 0 N--CA 1.495 1.814 0 O-C-N 120.707 -1.245 . . . . 0.0 110.276 -178.265 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 201' ' ' VAL . . . . . 0.484 ' N ' ' O ' ' A' ' 157' ' ' SER . 70.2 t -102.2 140.5 20.53 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.545 0 N-CA-C 108.09 -1.078 . . . . 0.0 108.09 177.465 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 202' ' ' ALA . . . . . . . . . . . . . . . -130.11 138.08 50.5 Favored 'General case' 0 C--N 1.301 -1.517 0 O-C-N 121.194 -0.941 . . . . 0.0 108.998 -179.66 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 203' ' ' THR . . . . . 0.528 HG23 ' OG1' ' A' ' 156' ' ' THR . 1.9 p -88.94 136.34 33.06 Favored 'General case' 0 C--N 1.306 -1.3 0 CA-C-O 122.474 1.13 . . . . 0.0 111.213 -178.276 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 204' ' ' GLU . . . . . 0.45 ' HA ' ' CD2' ' A' ' 153' ' ' TYR . 2.5 tt0 -60.22 134.06 56.69 Favored 'General case' 0 C--N 1.297 -1.686 0 CA-C-N 115.039 -0.982 . . . . 0.0 110.642 -179.915 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 205' ' ' VAL . . . . . 0.446 ' O ' ' OXT' ' A' ' 206' ' ' LYS . 42.2 t -121.11 -13.69 8.06 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.55 0 N-CA-C 107.997 -1.112 . . . . 0.0 107.997 179.247 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 206' ' ' LYS . . . . . 0.446 ' OXT' ' O ' ' A' ' 205' ' ' VAL . 0.1 OUTLIER . . . . . 0 N--CA 1.489 1.499 0 CA-C-O 118.029 -0.986 . . . . 0.0 109.674 -179.671 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' C' C ' 702' ' ' LEU . . . . . 0.871 ' N ' HD12 ' C' ' 702' ' ' LEU . 0.0 OUTLIER . . . . . 0 N--CA 1.491 1.599 0 N-CA-C 109.016 -0.735 . . . . 0.0 109.016 . . . . . . . . . 2 2 . 1 . 014 nuclear build core ' C' C ' 703' ' ' PRO . . . . . 0.65 ' HG2' ' HB1' ' A' ' 104' ' ' ALA . 52.6 Cg_exo -46.41 -176.71 0.0 OUTLIER 'Trans proline' 0 N--CA 1.49 1.287 0 C-N-CA 122.023 1.816 . . . . 0.0 112.239 -179.379 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' C' C ' 704' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.488 1.443 0 O-C-N 121.37 -0.831 . . . . 0.0 109.231 -179.905 . . . . . . . . 0 0 . 1 . 015 nuclear build core ' A' A ' 63' ' ' PRO . . . . . . . . . . . . . 95.0 Cg_endo . . . . . 0 N--CA 1.482 0.843 0 CA-C-O 121.173 0.405 . . . . 0.0 111.975 . . . . . . . . . 0 0 . 1 . 015 nuclear build core ' A' A ' 64' ' ' GLN . . . . . 0.578 ' N ' ' CD ' ' A' ' 64' ' ' GLN . 0.0 OUTLIER -153.49 120.16 5.62 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.158 -0.964 . . . . 0.0 109.424 179.537 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 65' ' ' ILE . . . . . 0.495 ' H ' HD12 ' A' ' 65' ' ' ILE . 2.9 mp -45.32 106.41 0.54 Allowed Pre-proline 0 N--CA 1.489 1.51 0 N-CA-C 107.874 -1.158 . . . . 0.0 107.874 179.079 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 66' ' ' PRO . . . . . . . . . . . . . 61.3 Cg_endo -77.64 -162.82 0.18 Allowed 'Trans proline' 0 N--CA 1.49 1.285 0 C-N-CA 122.113 1.875 . . . . 0.0 113.171 -178.075 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 67' ' ' LYS . . . . . . . . . . . . . 7.0 ttpt -84.75 -7.86 59.05 Favored 'General case' 0 N--CA 1.488 1.447 0 O-C-N 121.603 -0.686 . . . . 0.0 109.388 -179.74 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 68' ' ' ASP . . . . . 0.645 ' C ' ' N ' ' A' ' 70' ' ' SER . 1.0 OUTLIER -76.9 62.75 2.14 Favored 'General case' 0 N--CA 1.489 1.478 0 CA-C-O 122.756 1.265 . . . . 0.0 109.259 179.801 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 69' ' ' LYS . . . . . 0.463 ' C ' ' O ' ' A' ' 68' ' ' ASP . 0.9 OUTLIER -47.61 -13.36 0.04 OUTLIER 'General case' 0 N--CA 1.511 2.584 0 C-N-CA 116.926 -1.91 . . . . 0.0 106.79 177.397 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 70' ' ' SER . . . . . 0.645 ' N ' ' C ' ' A' ' 68' ' ' ASP . 0.0 OUTLIER -87.58 -3.14 58.99 Favored 'General case' 0 N--CA 1.498 1.944 0 CA-C-N 113.592 -1.64 . . . . 0.0 111.805 179.448 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 71' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -99.18 141.79 31.5 Favored 'General case' 0 N--CA 1.504 2.273 0 O-C-N 120.472 -1.393 . . . . 0.0 112.606 -178.941 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 72' ' ' VAL . . . . . 0.537 HG23 ' H ' ' A' ' 87' ' ' VAL . 0.2 OUTLIER -66.37 127.67 28.1 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.38 0 N-CA-C 104.551 -2.389 . . . . 0.0 104.551 174.397 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 73' ' ' ALA . . . . . 0.578 ' N ' ' O ' ' A' ' 87' ' ' VAL . . . -80.08 -13.71 59.08 Favored 'General case' 0 C--N 1.295 -1.783 0 O-C-N 120.165 -1.585 . . . . 0.0 108.381 -178.536 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 74' ' ' GLY . . . . . 0.53 ' O ' ' CG2' ' A' ' 72' ' ' VAL . . . 171.55 -155.42 24.11 Favored Glycine 0 N--CA 1.484 1.851 0 C-N-CA 118.759 -1.686 . . . . 0.0 110.819 179.23 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 75' ' ' TYR . . . . . 0.495 ' CA ' HG23 ' A' ' 87' ' ' VAL . 6.2 m-85 -144.29 169.22 18.32 Favored 'General case' 0 C--N 1.298 -1.647 0 O-C-N 121.639 -0.918 . . . . 0.0 110.79 -177.333 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 76' ' ' ILE . . . . . . . . . . . . . 0.8 OUTLIER -149.85 147.67 16.05 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.59 0 C-N-CA 119.902 -0.719 . . . . 0.0 109.414 -178.136 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -149.25 164.76 33.9 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 120.971 -1.081 . . . . 0.0 109.731 179.558 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 78' ' ' ILE . . . . . 0.604 ' HB ' ' HB3' ' A' ' 81' ' ' ALA . 32.6 mt -146.1 94.76 4.88 Favored Pre-proline 0 N--CA 1.489 1.517 0 N-CA-C 108.482 -0.933 . . . . 0.0 108.482 -179.808 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 79' ' ' PRO . . . . . . . . . . . . . 51.2 Cg_exo -49.02 -46.37 25.57 Favored 'Trans proline' 0 C--N 1.31 -1.451 0 C-N-CA 122.604 2.203 . . . . 0.0 113.622 -178.764 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 80' ' ' ASP . . . . . 0.553 ' OD1' ' N ' ' A' ' 80' ' ' ASP . 0.0 OUTLIER -65.41 -19.79 66.1 Favored 'General case' 0 N--CA 1.493 1.716 0 O-C-N 120.821 -1.174 . . . . 0.0 110.445 178.551 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 81' ' ' ALA . . . . . 0.857 ' HB2' ' HB2' ' A' ' 136' ' ' ALA . . . -106.33 -16.95 14.43 Favored 'General case' 0 N--CA 1.491 1.624 0 N-CA-C 108.361 -0.978 . . . . 0.0 108.361 179.33 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 82' ' ' ASP . . . . . 0.522 ' N ' ' O ' ' A' ' 78' ' ' ILE . 3.4 t70 66.52 51.61 1.12 Allowed 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.367 -0.833 . . . . 0.0 110.761 179.07 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 83' ' ' ILE . . . . . 0.658 HD11 ' OD1' ' A' ' 132' ' ' ASN . 89.5 mt -129.31 153.9 39.35 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.843 0 O-C-N 121.185 -0.947 . . . . 0.0 110.052 -179.282 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 84' ' ' LYS . . . . . 0.426 ' N ' HG22 ' A' ' 83' ' ' ILE . 22.9 tttt -158.13 109.0 2.17 Favored 'General case' 0 N--CA 1.491 1.613 0 N-CA-C 107.646 -1.242 . . . . 0.0 107.646 179.372 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 85' ' ' GLU . . . . . 0.504 ' OE1' ' O ' ' A' ' 128' ' ' TYR . 0.0 OUTLIER -141.43 165.17 30.4 Favored Pre-proline 0 N--CA 1.495 1.808 0 O-C-N 121.044 -1.035 . . . . 0.0 110.798 -178.118 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 86' ' ' PRO . . . . . . . . . . . . . 59.3 Cg_endo -74.52 161.58 39.64 Favored 'Trans proline' 0 N--CA 1.495 1.603 0 C-N-CA 123.404 2.736 . . . . 0.0 113.549 -179.362 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 87' ' ' VAL . . . . . 0.578 ' O ' ' N ' ' A' ' 73' ' ' ALA . 58.6 t -120.05 99.97 8.55 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.683 0 N-CA-C 109.294 -0.632 . . . . 0.0 109.294 179.588 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 88' ' ' TYR . . . . . 0.43 ' CD2' ' CD ' ' A' ' 99' ' ' ARG . 19.5 m-85 -92.09 154.9 43.32 Favored Pre-proline 0 N--CA 1.504 2.232 0 O-C-N 120.777 -1.202 . . . . 0.0 110.276 -179.479 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 89' ' ' PRO . . . . . . . . . . . . . 11.4 Cg_endo -60.2 143.65 99.52 Favored 'Trans proline' 0 N--CA 1.495 1.559 0 C-N-CA 122.741 2.294 . . . . 0.0 113.517 -179.902 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . -59.85 168.55 7.88 Favored Glycine 0 N--CA 1.496 2.654 0 N-CA-C 109.444 -1.462 . . . . 0.0 109.444 179.271 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 91' ' ' PRO . . . . . 0.438 ' C ' ' H ' ' A' ' 93' ' ' THR . 55.6 Cg_endo -93.32 169.78 20.36 Favored 'Cis proline' 0 C--N 1.309 -1.53 0 C-N-CA 123.941 -1.274 . . . . 0.0 111.941 0.168 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 92' ' ' ALA . . . . . 0.663 ' HB1' HD21 ' A' ' 97' ' ' LEU . . . -72.28 32.52 0.06 Allowed 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.081 -1.012 . . . . 0.0 110.398 -179.903 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 93' ' ' THR . . . . . 0.5 ' OG1' ' OE1' ' A' ' 96' ' ' GLN . 3.1 p -74.81 150.67 86.39 Favored Pre-proline 0 C--N 1.3 -1.548 0 O-C-N 120.485 -1.384 . . . . 0.0 108.487 179.993 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 94' ' ' PRO . . . . . 0.403 ' C ' ' O ' ' A' ' 93' ' ' THR . 82.0 Cg_exo -30.69 -52.32 0.23 Allowed 'Trans proline' 0 C--N 1.308 -1.569 0 C-N-CA 123.18 2.587 . . . . 0.0 113.022 -179.034 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 4.9 mm-40 -49.55 -49.3 46.81 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.09 -1.006 . . . . 0.0 109.688 -179.833 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 96' ' ' GLN . . . . . 0.57 ' O ' ' N ' ' A' ' 98' ' ' ASN . 12.5 mp0 -73.53 -54.35 8.42 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 120.96 -1.088 . . . . 0.0 110.452 -179.644 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 97' ' ' LEU . . . . . 0.663 HD21 ' HB1' ' A' ' 92' ' ' ALA . 95.8 mt -47.2 -9.32 0.02 OUTLIER 'General case' 0 N--CA 1.495 1.818 0 O-C-N 121.185 -0.947 . . . . 0.0 110.279 -178.793 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 98' ' ' ASN . . . . . 0.57 ' N ' ' O ' ' A' ' 96' ' ' GLN . 0.0 OUTLIER -74.86 -26.04 59.4 Favored 'General case' 0 N--CA 1.493 1.686 0 O-C-N 121.115 -0.991 . . . . 0.0 109.126 179.727 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 99' ' ' ARG . . . . . 0.581 HH11 ' CG ' ' A' ' 99' ' ' ARG . 0.3 OUTLIER -91.1 -56.11 3.28 Favored 'General case' 0 C--N 1.301 -1.527 0 O-C-N 121.796 -0.565 . . . . 0.0 109.642 -179.484 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . -179.46 -165.36 33.47 Favored Glycine 0 N--CA 1.49 2.283 0 N-CA-C 109.949 -1.26 . . . . 0.0 109.949 179.89 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 101' ' ' VAL . . . . . 0.551 HG23 ' O ' ' A' ' 101' ' ' VAL . 28.9 m -59.23 105.95 0.22 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.64 0 O-C-N 121.325 -1.103 . . . . 0.0 109.696 -179.731 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -91.63 169.04 11.06 Favored 'General case' 0 N--CA 1.495 1.777 0 O-C-N 121.224 -0.922 . . . . 0.0 110.864 -179.308 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 103' ' ' PHE . . . . . 0.559 ' O ' ' N ' ' A' ' 105' ' ' GLU . 26.0 m-85 -72.74 122.43 21.49 Favored 'General case' 0 N--CA 1.493 1.721 0 N-CA-C 108.123 -1.065 . . . . 0.0 108.123 178.469 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 104' ' ' ALA . . . . . 0.404 ' C ' ' O ' ' A' ' 103' ' ' PHE . . . -39.67 -20.51 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.526 -0.734 . . . . 0.0 111.716 -178.388 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 105' ' ' GLU . . . . . 0.559 ' N ' ' O ' ' A' ' 103' ' ' PHE . 13.4 pt-20 -139.51 148.71 43.01 Favored 'General case' 0 N--CA 1.498 1.943 0 O-C-N 120.673 -1.267 . . . . 0.0 110.696 -179.479 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 106' ' ' GLU . . . . . . . . . . . . . 8.8 tt0 -56.79 -62.5 1.7 Allowed 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.91 -0.494 . . . . 0.0 111.76 -178.575 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 107' ' ' ASN . . . . . . . . . . . . . 2.6 m120 -76.62 33.5 0.14 Allowed 'General case' 0 N--CA 1.492 1.65 0 O-C-N 120.533 -1.354 . . . . 0.0 112.782 -175.247 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 108' ' ' GLU . . . . . 0.499 ' OE1' ' OE2' ' A' ' 105' ' ' GLU . 38.3 tp10 -60.24 146.67 42.88 Favored 'General case' 0 N--CA 1.488 1.466 0 O-C-N 120.776 -1.202 . . . . 0.0 107.906 179.821 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 109' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -97.8 144.31 27.52 Favored 'General case' 0 N--CA 1.488 1.468 0 O-C-N 120.923 -1.111 . . . . 0.0 110.806 -178.243 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 110' ' ' LEU . . . . . 0.558 HD23 ' H ' ' A' ' 110' ' ' LEU . 0.4 OUTLIER -61.99 -21.05 64.53 Favored 'General case' 0 C--N 1.302 -1.46 0 N-CA-C 107.734 -1.21 . . . . 0.0 107.734 179.037 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 111' ' ' ASP . . . . . . . . . . . . . 75.5 m-20 -132.62 44.79 2.83 Favored 'General case' 0 N--CA 1.488 1.451 0 CA-C-O 121.388 0.613 . . . . 0.0 109.363 179.63 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 112' ' ' ASP . . . . . . . . . . . . . 1.1 t0 -68.64 157.38 36.3 Favored 'General case' 0 N--CA 1.493 1.685 0 O-C-N 121.195 -0.941 . . . . 0.0 111.232 -179.7 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 113' ' ' GLN . . . . . 0.541 ' N ' ' CD ' ' A' ' 113' ' ' GLN . 0.2 OUTLIER -65.92 -15.7 63.2 Favored 'General case' 0 N--CA 1.492 1.653 0 N-CA-C 107.387 -1.338 . . . . 0.0 107.387 177.495 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 114' ' ' ASN . . . . . 0.496 ' O ' ' CG ' ' A' ' 114' ' ' ASN . 11.8 p-10 -150.31 108.29 3.72 Favored 'General case' 0 C--N 1.298 -1.655 0 N-CA-C 107.72 -1.215 . . . . 0.0 107.72 178.054 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 115' ' ' ILE . . . . . 0.535 HG22 ' O ' ' A' ' 115' ' ' ILE . 2.9 mt -94.38 102.48 13.66 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.63 0 N-CA-C 107.437 -1.32 . . . . 0.0 107.437 179.61 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 116' ' ' SER . . . . . . . . . . . . . 9.0 p -88.87 150.46 22.87 Favored 'General case' 0 C--N 1.303 -1.419 0 CA-C-O 121.997 0.903 . . . . 0.0 111.483 -177.476 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 117' ' ' ILE . . . . . . . . . . . . . 1.4 mt -147.68 145.82 18.6 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.458 0 N-CA-C 107.34 -1.355 . . . . 0.0 107.34 178.762 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 118' ' ' ALA . . . . . 0.615 ' HB1' ' HB2' ' C' ' 704' ' ' ALA . . . -141.96 159.39 42.32 Favored 'General case' 0 N--CA 1.494 1.726 0 O-C-N 120.789 -1.194 . . . . 0.0 111.348 -178.434 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 119' ' ' GLY . . . . . . . . . . . . . . . -171.02 153.24 20.3 Favored Glycine 0 N--CA 1.487 2.096 0 N-CA-C 110.097 -1.201 . . . . 0.0 110.097 179.873 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 120' ' ' HIS . . . . . . . . . . . . . 12.0 m170 -71.19 167.97 18.25 Favored 'General case' 0 N--CA 1.493 1.713 0 O-C-N 121.724 -0.868 . . . . 0.0 109.944 179.378 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 121' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -117.37 158.3 24.66 Favored 'General case' 0 N--CA 1.496 1.831 0 N-CA-C 108.094 -1.076 . . . . 0.0 108.094 178.76 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 122' ' ' PHE . . . . . . . . . . . . . 3.8 m-85 -141.91 123.21 14.79 Favored 'General case' 0 N--CA 1.497 1.911 0 O-C-N 120.867 -1.145 . . . . 0.0 109.805 -179.39 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 123' ' ' ILE . . . . . 0.598 HG23 ' N ' ' A' ' 124' ' ' ASP . 14.0 tt -60.38 -41.41 87.22 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.567 0 CA-C-O 121.6 0.714 . . . . 0.0 109.285 179.622 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 124' ' ' ASP . . . . . 0.598 ' N ' HG23 ' A' ' 123' ' ' ILE . 0.3 OUTLIER -87.16 22.23 2.14 Favored 'General case' 0 N--CA 1.495 1.808 0 O-C-N 121.693 -0.629 . . . . 0.0 111.955 -177.13 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 125' ' ' ARG . . . . . . . . . . . . . 46.9 mtp180 -155.29 97.12 2.42 Favored Pre-proline 0 N--CA 1.492 1.673 0 O-C-N 120.546 -1.347 . . . . 0.0 109.757 179.763 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 126' ' ' PRO . . . . . . . . . . . . . 2.9 Cg_endo -73.66 -25.76 14.48 Favored 'Trans proline' 0 C--N 1.314 -1.239 0 C-N-CA 122.113 1.876 . . . . 0.0 111.662 178.634 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 127' ' ' ASN . . . . . 0.473 ' O ' ' O ' ' A' ' 128' ' ' TYR . 0.9 OUTLIER -91.2 5.73 47.92 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.429 -0.794 . . . . 0.0 109.736 -179.843 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 128' ' ' TYR . . . . . 0.504 ' O ' ' OE1' ' A' ' 85' ' ' GLU . 4.5 t80 -59.1 -149.27 0.0 OUTLIER 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.192 -0.943 . . . . 0.0 109.936 -179.751 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 129' ' ' GLN . . . . . 0.487 ' O ' ' OE1' ' A' ' 85' ' ' GLU . 63.4 mt-30 -66.79 -72.08 0.18 Allowed 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.439 -0.788 . . . . 0.0 109.614 -179.686 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 130' ' ' PHE . . . . . 0.504 ' O ' ' CE ' ' A' ' 134' ' ' LYS . 52.6 m-85 -133.78 47.8 2.41 Favored 'General case' 0 N--CA 1.492 1.658 0 O-C-N 121.279 -0.888 . . . . 0.0 110.059 -179.741 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 131' ' ' THR . . . . . . . . . . . . . 23.5 m -81.72 -40.82 22.16 Favored 'General case' 0 N--CA 1.489 1.481 0 O-C-N 121.052 -1.03 . . . . 0.0 109.281 179.783 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 132' ' ' ASN . . . . . 0.658 ' OD1' HD11 ' A' ' 83' ' ' ILE . 0.2 OUTLIER -83.09 2.7 33.92 Favored 'General case' 0 N--CA 1.495 1.785 0 O-C-N 121.364 -0.835 . . . . 0.0 111.377 -178.283 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 133' ' ' LEU . . . . . 0.568 HD13 ' O ' ' A' ' 133' ' ' LEU . 0.2 OUTLIER -65.6 -46.07 80.75 Favored 'General case' 0 N--CA 1.493 1.681 0 O-C-N 120.549 -1.344 . . . . 0.0 110.359 -179.568 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 134' ' ' LYS . . . . . 0.57 ' H ' ' CD ' ' A' ' 134' ' ' LYS . 0.0 OUTLIER -42.41 -18.15 0.01 OUTLIER 'General case' 0 N--CA 1.494 1.739 0 O-C-N 121.071 -1.018 . . . . 0.0 110.755 -179.185 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 135' ' ' ALA . . . . . 0.563 ' N ' ' O ' ' A' ' 133' ' ' LEU . . . -83.48 -35.39 24.94 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 120.837 -1.164 . . . . 0.0 110.251 -179.506 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 136' ' ' ALA . . . . . 0.857 ' HB2' ' HB2' ' A' ' 81' ' ' ALA . . . -79.98 155.76 27.51 Favored 'General case' 0 N--CA 1.489 1.51 0 CA-C-O 122.209 1.004 . . . . 0.0 111.889 -178.479 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 137' ' ' LYS . . . . . 0.505 ' O ' ' O ' ' A' ' 138' ' ' LYS . 0.1 OUTLIER -154.32 -165.91 2.21 Favored 'General case' 0 N--CA 1.493 1.725 0 C-N-CA 118.734 -1.186 . . . . 0.0 110.915 -178.44 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 138' ' ' LYS . . . . . 0.579 ' O ' ' N ' ' A' ' 140' ' ' SER . 17.4 mttp -45.44 179.23 0.0 OUTLIER 'General case' 0 C--N 1.305 -1.365 0 CA-C-O 121.987 0.898 . . . . 0.0 110.509 -179.222 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 139' ' ' GLY . . . . . . . . . . . . . . . 47.0 7.77 0.02 OUTLIER Glycine 0 N--CA 1.491 2.304 0 N-CA-C 110.253 -1.139 . . . . 0.0 110.253 -179.849 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 140' ' ' SER . . . . . 0.579 ' N ' ' O ' ' A' ' 138' ' ' LYS . 40.4 t -89.42 141.3 28.68 Favored 'General case' 0 N--CA 1.493 1.699 0 O-C-N 120.858 -1.378 . . . . 0.0 109.591 179.239 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 141' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -90.88 127.73 36.49 Favored 'General case' 0 C--N 1.301 -1.539 0 O-C-N 121.413 -0.805 . . . . 0.0 109.487 179.732 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 142' ' ' VAL . . . . . . . . . . . . . 3.2 t -114.48 133.6 60.07 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.674 0 O-C-N 121.364 -0.835 . . . . 0.0 108.814 179.928 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 143' ' ' TYR . . . . . 0.413 ' CE1' ' CG ' ' A' ' 152' ' ' LYS . 8.5 m-85 -107.9 135.39 49.36 Favored 'General case' 0 N--CA 1.496 1.851 0 O-C-N 121.177 -0.952 . . . . 0.0 111.521 -178.603 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 144' ' ' PHE . . . . . . . . . . . . . 66.8 t80 -115.36 157.21 24.2 Favored 'General case' 0 N--CA 1.493 1.698 0 CA-C-O 121.807 0.813 . . . . 0.0 110.82 -179.185 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 145' ' ' LYS . . . . . 0.418 ' HB3' ' H ' ' A' ' 75' ' ' TYR . 55.0 tttt -152.42 130.59 11.94 Favored 'General case' 0 N--CA 1.492 1.642 0 C-N-CA 118.887 -1.125 . . . . 0.0 111.962 -179.309 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 146' ' ' VAL . . . . . . . . . . . . . 1.9 p -145.04 139.95 22.71 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.485 0 N-CA-C 106.24 -1.763 . . . . 0.0 106.24 177.431 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 147' ' ' GLY . . . . . . . . . . . . . . . 53.88 -134.67 43.61 Favored Glycine 0 N--CA 1.488 2.157 0 N-CA-C 108.726 -1.749 . . . . 0.0 108.726 -179.079 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 148' ' ' ASN . . . . . . . . . . . . . 21.9 p30 -103.17 22.67 13.65 Favored 'General case' 0 C--N 1.302 -1.496 0 O-C-N 121.234 -1.156 . . . . 0.0 108.71 179.354 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 149' ' ' GLU . . . . . . . . . . . . . 18.4 tt0 -112.44 152.79 28.29 Favored 'General case' 0 N--CA 1.486 1.362 0 CA-C-O 121.752 0.786 . . . . 0.0 111.095 -179.023 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 150' ' ' THR . . . . . 0.437 ' O ' HG22 ' A' ' 150' ' ' THR . 1.3 m -141.78 105.13 4.65 Favored 'General case' 0 N--CA 1.493 1.698 0 CA-C-O 121.666 0.746 . . . . 0.0 109.436 179.996 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 151' ' ' ARG . . . . . 0.46 HH22 ' CD1' ' A' ' 115' ' ' ILE . 2.9 mpp_? -88.69 -161.55 0.76 Allowed 'General case' 0 N--CA 1.488 1.453 0 O-C-N 121.659 -0.651 . . . . 0.0 109.706 -179.149 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 152' ' ' LYS . . . . . 0.429 ' O ' ' N ' ' A' ' 205' ' ' VAL . 15.0 mtmm -149.73 146.06 27.01 Favored 'General case' 0 C--N 1.304 -1.381 0 O-C-N 121.211 -0.93 . . . . 0.0 110.139 -178.814 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 153' ' ' TYR . . . . . 0.513 ' CD2' ' HA ' ' A' ' 204' ' ' GLU . 15.0 m-85 -141.06 166.88 23.57 Favored 'General case' 0 N--CA 1.49 1.559 0 N-CA-C 107.922 -1.14 . . . . 0.0 107.922 179.193 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 154' ' ' LYS . . . . . 0.484 ' HB2' HG21 ' A' ' 205' ' ' VAL . 12.7 ttmt -142.8 120.43 11.8 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.236 -0.915 . . . . 0.0 108.576 178.865 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 155' ' ' MET . . . . . 0.409 ' H ' ' HG2' ' A' ' 155' ' ' MET . 44.4 mmm -47.83 107.26 0.11 Allowed 'General case' 0 N--CA 1.493 1.688 0 O-C-N 120.611 -1.306 . . . . 0.0 111.315 -178.626 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 156' ' ' THR . . . . . 0.488 ' OG1' HG23 ' A' ' 203' ' ' THR . 0.2 OUTLIER -105.18 -24.44 12.74 Favored 'General case' 0 C--N 1.294 -1.843 0 CA-C-N 115.259 -0.882 . . . . 0.0 110.836 -178.655 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 157' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -146.8 150.5 35.43 Favored 'General case' 0 C--N 1.296 -1.757 0 C-N-CA 118.51 -1.276 . . . . 0.0 110.367 -178.784 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 158' ' ' ILE . . . . . . . . . . . . . 1.9 mt -147.35 137.59 17.13 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.382 0 CA-C-O 121.324 0.583 . . . . 0.0 109.537 -178.459 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 159' ' ' ARG . . . . . 0.488 ' O ' ' OD1' ' A' ' 160' ' ' ASP . 44.7 mtp180 -155.59 -167.71 2.59 Favored 'General case' 0 N--CA 1.492 1.647 0 CA-C-O 121.907 0.86 . . . . 0.0 110.956 -178.799 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 160' ' ' ASP . . . . . 0.488 ' OD1' ' O ' ' A' ' 159' ' ' ARG . 63.8 m-20 -146.71 153.04 39.8 Favored 'General case' 0 N--CA 1.489 1.48 0 N-CA-C 108.183 -1.043 . . . . 0.0 108.183 179.512 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 161' ' ' VAL . . . . . 0.425 ' O ' ' O ' ' A' ' 162' ' ' LYS . 0.1 OUTLIER -143.11 146.54 21.48 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.627 0 O-C-N 120.899 -1.125 . . . . 0.0 109.884 179.939 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 162' ' ' LYS . . . . . 0.697 ' H ' ' CD ' ' A' ' 162' ' ' LYS . 0.0 OUTLIER -45.44 167.13 0.12 Allowed Pre-proline 0 N--CA 1.49 1.526 0 O-C-N 121.285 -0.884 . . . . 0.0 109.391 -179.787 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 163' ' ' PRO . . . . . . . . . . . . . 57.9 Cg_endo -76.54 30.4 0.4 Allowed 'Trans proline' 0 C--N 1.308 -1.574 0 C-N-CA 122.838 2.359 . . . . 0.0 113.387 -179.488 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 164' ' ' THR . . . . . 0.623 ' HA ' HD11 ' C' ' 702' ' ' LEU . 0.2 OUTLIER -152.29 -0.58 0.3 Allowed 'General case' 0 N--CA 1.495 1.817 0 O-C-N 120.921 -1.112 . . . . 0.0 110.306 179.612 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 165' ' ' ASP . . . . . 0.414 ' O ' ' C ' ' A' ' 166' ' ' VAL . 7.4 t70 -76.85 64.4 2.38 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.12 -0.987 . . . . 0.0 110.16 -179.866 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 166' ' ' VAL . . . . . 0.616 ' O ' ' N ' ' A' ' 168' ' ' VAL . 1.3 m -47.1 -31.4 1.79 Allowed 'Isoleucine or valine' 0 N--CA 1.487 1.405 0 O-C-N 120.642 -1.286 . . . . 0.0 108.941 -178.837 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 167' ' ' GLY . . . . . . . . . . . . . . . -46.86 -9.49 0.03 OUTLIER Glycine 0 N--CA 1.495 2.571 0 N-CA-C 109.458 -1.457 . . . . 0.0 109.458 179.35 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 168' ' ' VAL . . . . . 0.708 HG21 HG21 ' A' ' 199' ' ' ILE . 9.8 p -49.43 -31.54 5.58 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.481 0 N-CA-C 107.775 -1.194 . . . . 0.0 107.775 179.22 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 169' ' ' LEU . . . . . 0.509 ' O ' ' C ' ' A' ' 170' ' ' ASP . 1.7 mm? -45.21 -19.38 0.04 OUTLIER 'General case' 0 C--N 1.293 -1.852 0 N-CA-C 107.694 -1.225 . . . . 0.0 107.694 -178.25 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 170' ' ' ASP . . . . . 0.531 ' N ' ' O ' ' A' ' 168' ' ' VAL . 8.3 t0 27.88 91.38 0.01 OUTLIER 'General case' 0 N--CA 1.501 2.121 0 CA-C-N 116.459 -0.337 . . . . 0.0 111.399 177.268 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 171' ' ' GLU . . . . . 0.433 ' CB ' ' OD1' ' A' ' 114' ' ' ASN . 17.1 pt-20 -130.85 67.27 1.51 Allowed 'General case' 0 N--CA 1.499 1.984 0 O-C-N 121.016 -1.053 . . . . 0.0 110.435 -179.989 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 172' ' ' GLN . . . . . . . . . . . . . 2.1 mt-30 -127.96 -52.6 1.32 Allowed 'General case' 0 N--CA 1.498 1.942 0 O-C-N 121.26 -0.9 . . . . 0.0 110.745 -178.979 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 173' ' ' LYS . . . . . . . . . . . . . 15.4 mttt -58.82 124.93 21.46 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 120.886 -1.134 . . . . 0.0 108.453 179.9 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 174' ' ' GLY . . . . . 0.538 ' O ' ' C ' ' A' ' 175' ' ' LYS . . . -124.74 -43.63 0.3 Allowed Glycine 0 N--CA 1.48 1.602 0 N-CA-C 108.337 -1.905 . . . . 0.0 108.337 -179.838 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 175' ' ' LYS . . . . . 0.538 ' C ' ' O ' ' A' ' 174' ' ' GLY . 2.2 mptm? -37.9 -61.85 0.61 Allowed 'General case' 0 N--CA 1.492 1.655 0 N-CA-C 107.243 -1.392 . . . . 0.0 107.243 179.308 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 176' ' ' ASP . . . . . 0.624 ' O ' ' O ' ' A' ' 177' ' ' LYS . 8.7 m-20 -104.32 85.9 2.44 Favored 'General case' 0 C--N 1.295 -1.787 0 N-CA-C 106.7 -1.592 . . . . 0.0 106.7 176.512 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 177' ' ' LYS . . . . . 0.624 ' O ' ' O ' ' A' ' 176' ' ' ASP . 12.5 mttt -40.97 179.8 0.0 OUTLIER 'General case' 0 N--CA 1.496 1.85 0 O-C-N 121.489 -0.757 . . . . 0.0 110.235 -178.726 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 178' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -161.21 170.08 20.97 Favored 'General case' 0 N--CA 1.487 1.398 0 O-C-N 120.339 -1.476 . . . . 0.0 111.138 179.911 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 179' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -123.49 99.09 6.14 Favored 'General case' 0 C--N 1.304 -1.389 0 N-CA-C 107.406 -1.331 . . . . 0.0 107.406 178.297 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 180' ' ' THR . . . . . 0.462 HG22 ' O ' ' A' ' 180' ' ' THR . 1.1 m -70.56 114.08 8.31 Favored 'General case' 0 N--CA 1.487 1.418 0 O-C-N 121.18 -0.95 . . . . 0.0 109.857 -178.774 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 181' ' ' LEU . . . . . 0.725 HD13 ' N ' ' A' ' 182' ' ' ILE . 0.3 OUTLIER -88.9 142.58 27.53 Favored 'General case' 0 C--N 1.303 -1.456 0 N-CA-C 107.339 -1.356 . . . . 0.0 107.339 177.677 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 182' ' ' ILE . . . . . 0.725 ' N ' HD13 ' A' ' 181' ' ' LEU . 81.6 mt -137.87 115.72 12.96 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.76 0 N-CA-C 107.824 -1.176 . . . . 0.0 107.824 179.259 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 183' ' ' THR . . . . . 0.464 ' O ' HG23 ' A' ' 183' ' ' THR . 3.7 t -139.54 113.49 8.73 Favored 'General case' 0 C--N 1.289 -2.063 0 N-CA-C 108.155 -1.054 . . . . 0.0 108.155 -179.623 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 184' ' ' CYS . . . . . . . . . . . . . 0.8 OUTLIER -78.84 159.75 27.67 Favored 'General case' 0 C--N 1.291 -1.938 0 C-N-CA 119.101 -1.04 . . . . 0.0 111.095 -178.078 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 185' ' ' ASP . . . . . . . . . . . . . 1.2 t70 -165.93 -155.81 0.24 Allowed 'General case' 0 N--CA 1.493 1.683 0 N-CA-C 109.046 -0.724 . . . . 0.0 109.046 -179.613 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 186' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER 54.2 55.22 8.47 Favored 'General case' 0 N--CA 1.496 1.826 0 O-C-N 121.047 -1.033 . . . . 0.0 109.335 179.898 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 187' ' ' TYR . . . . . 0.611 ' CE2' ' O ' ' A' ' 188' ' ' ASN . 71.2 t80 -67.61 132.2 47.07 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 120.975 -1.078 . . . . 0.0 111.402 -179.151 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 188' ' ' ASN . . . . . 1.055 ' ND2' ' H ' ' A' ' 191' ' ' THR . 0.1 OUTLIER -100.54 149.36 23.8 Favored 'General case' 0 C--N 1.296 -1.736 0 N-CA-C 107.292 -1.373 . . . . 0.0 107.292 177.364 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 189' ' ' GLU . . . . . . . . . . . . . 1.8 tt0 -111.65 -10.56 14.09 Favored 'General case' 0 C--N 1.293 -1.871 0 N-CA-C 108.833 -0.802 . . . . 0.0 108.833 -179.122 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 190' ' ' LYS . . . . . 0.438 ' H ' ' ND2' ' A' ' 188' ' ' ASN . 13.9 mttm -85.88 -50.89 6.76 Favored 'General case' 0 C--N 1.301 -1.5 0 CA-C-O 121.583 0.706 . . . . 0.0 109.447 179.537 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 191' ' ' THR . . . . . 1.055 ' H ' ' ND2' ' A' ' 188' ' ' ASN . 72.6 p -89.15 -1.09 57.94 Favored 'General case' 0 N--CA 1.493 1.713 0 O-C-N 121.584 -0.698 . . . . 0.0 110.781 -178.879 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 192' ' ' GLY . . . . . 0.527 ' N ' ' OD1' ' A' ' 188' ' ' ASN . . . 56.38 36.08 68.39 Favored Glycine 0 N--CA 1.492 2.388 0 O-C-N 120.865 -1.147 . . . . 0.0 110.327 179.622 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 193' ' ' VAL . . . . . . . . . . . . . 3.1 m -148.63 163.77 5.04 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.738 0 O-C-N 120.885 -1.362 . . . . 0.0 109.449 179.519 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 194' ' ' TRP . . . . . 0.495 ' N ' ' CD1' ' A' ' 194' ' ' TRP . 24.2 m95 -84.46 121.16 27.18 Favored 'General case' 0 C--N 1.303 -1.42 0 N-CA-C 107.97 -1.122 . . . . 0.0 107.97 178.845 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 195' ' ' GLU . . . . . . . . . . . . . 1.7 mt-10 -76.7 -61.27 2.02 Favored 'General case' 0 N--CA 1.496 1.832 0 O-C-N 121.225 -0.922 . . . . 0.0 112.905 -176.831 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 196' ' ' LYS . . . . . . . . . . . . . 2.0 tptm -93.02 159.49 15.28 Favored 'General case' 0 N--CA 1.495 1.809 0 O-C-N 120.762 -1.211 . . . . 0.0 111.51 -177.201 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 197' ' ' ARG . . . . . 0.423 ' NH1' ' HB2' ' A' ' 194' ' ' TRP . 0.0 OUTLIER -121.75 135.83 54.94 Favored 'General case' 0 N--CA 1.493 1.676 0 N-CA-C 109.179 -0.675 . . . . 0.0 109.179 179.577 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 198' ' ' LYS . . . . . . . . . . . . . 49.3 mttt -117.4 120.38 37.97 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.495 -0.753 . . . . 0.0 110.104 -179.243 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 199' ' ' ILE . . . . . 0.708 HG21 HG21 ' A' ' 168' ' ' VAL . 1.0 OUTLIER -137.8 122.26 22.97 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.677 0 CA-C-O 122.667 1.222 . . . . 0.0 110.623 179.554 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 200' ' ' PHE . . . . . 0.471 ' CD1' ' N ' ' A' ' 200' ' ' PHE . 1.6 m-85 -103.5 138.83 39.66 Favored 'General case' 0 C--N 1.297 -1.689 0 O-C-N 120.91 -1.119 . . . . 0.0 110.334 -178.22 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 201' ' ' VAL . . . . . . . . . . . . . 59.7 t -102.36 147.04 9.48 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.494 0 N-CA-C 107.678 -1.23 . . . . 0.0 107.678 177.615 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 202' ' ' ALA . . . . . . . . . . . . . . . -130.53 138.63 50.3 Favored 'General case' 0 C--N 1.3 -1.567 0 O-C-N 121.138 -0.976 . . . . 0.0 108.388 -179.874 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 203' ' ' THR . . . . . 0.714 ' O ' HG23 ' A' ' 205' ' ' VAL . 6.5 p -89.0 127.78 35.68 Favored 'General case' 0 C--N 1.305 -1.365 0 CA-C-O 122.226 1.012 . . . . 0.0 111.41 -178.167 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 204' ' ' GLU . . . . . 0.513 ' HA ' ' CD2' ' A' ' 153' ' ' TYR . 1.1 tm-20 -50.37 134.9 22.79 Favored 'General case' 0 C--N 1.299 -1.595 0 C-N-CA 118.957 -1.097 . . . . 0.0 108.607 178.766 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 205' ' ' VAL . . . . . 0.714 HG23 ' O ' ' A' ' 203' ' ' THR . 69.8 t -130.54 163.96 34.82 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.338 0 CA-C-O 122.116 0.96 . . . . 0.0 110.606 -177.333 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 206' ' ' LYS . . . . . 0.578 ' N ' HG12 ' A' ' 205' ' ' VAL . 0.1 OUTLIER . . . . . 0 C--N 1.299 -1.627 0 CA-C-O 118.032 -0.985 . . . . 0.0 109.366 179.876 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' C' C ' 702' ' ' LEU . . . . . 0.899 ' N ' HD12 ' C' ' 702' ' ' LEU . 0.0 OUTLIER . . . . . 0 N--CA 1.501 2.08 0 N-CA-C 109.991 -0.374 . . . . 0.0 109.991 . . . . . . . . . 2 2 . 1 . 015 nuclear build core ' C' C ' 703' ' ' PRO . . . . . 0.623 ' CB ' ' HB3' ' A' ' 92' ' ' ALA . 27.7 Cg_exo -55.6 -166.77 0.02 OUTLIER 'Trans proline' 0 N--CA 1.493 1.498 0 C-N-CA 122.195 1.93 . . . . 0.0 112.606 -179.463 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' C' C ' 704' ' ' ALA . . . . . 0.615 ' HB2' ' HB1' ' A' ' 118' ' ' ALA . . . . . . . . 0 N--CA 1.49 1.563 0 O-C-N 121.493 -0.754 . . . . 0.0 109.207 -179.817 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 63' ' ' PRO . . . . . . . . . . . . . 9.8 Cg_exo . . . . . 0 N--CA 1.491 1.37 0 CA-C-O 121.349 0.479 . . . . 0.0 111.65 . . . . . . . . . 0 0 . 1 . 016 nuclear build core ' A' A ' 64' ' ' GLN . . . . . 0.58 ' N ' ' CD ' ' A' ' 64' ' ' GLN . 0.0 OUTLIER -156.41 117.75 3.83 Favored 'General case' 0 N--CA 1.494 1.739 0 O-C-N 121.276 -0.89 . . . . 0.0 109.071 179.816 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 65' ' ' ILE . . . . . 0.492 ' H ' ' CD1' ' A' ' 65' ' ' ILE . 0.0 OUTLIER -42.72 103.97 0.34 Allowed Pre-proline 0 N--CA 1.497 1.923 0 O-C-N 121.119 -0.988 . . . . 0.0 108.743 179.626 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 66' ' ' PRO . . . . . . . . . . . . . 61.3 Cg_endo -90.15 -154.86 0.05 OUTLIER 'Trans proline' 0 C--N 1.313 -1.339 0 C-N-CA 122.194 1.929 . . . . 0.0 112.043 -179.742 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 67' ' ' LYS . . . . . 0.409 ' C ' ' H ' ' A' ' 69' ' ' LYS . 22.0 tttt -85.32 -4.76 59.26 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.119 -0.988 . . . . 0.0 108.771 179.597 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 68' ' ' ASP . . . . . 0.616 ' C ' ' N ' ' A' ' 70' ' ' SER . 1.1 t0 -75.03 49.58 0.44 Allowed 'General case' 0 N--CA 1.488 1.452 0 CA-C-O 122.533 1.159 . . . . 0.0 108.997 179.87 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 69' ' ' LYS . . . . . 0.418 ' C ' ' O ' ' A' ' 68' ' ' ASP . 4.1 mtmp? -48.7 -14.77 0.07 Allowed 'General case' 0 N--CA 1.503 2.211 0 C-N-CA 117.218 -1.793 . . . . 0.0 106.664 177.99 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 70' ' ' SER . . . . . 0.616 ' N ' ' C ' ' A' ' 68' ' ' ASP . 0.0 OUTLIER -86.15 -4.46 59.17 Favored 'General case' 0 N--CA 1.494 1.766 0 CA-C-N 113.702 -1.59 . . . . 0.0 110.916 179.714 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 71' ' ' LYS . . . . . 0.402 ' CD ' ' HB3' ' A' ' 68' ' ' ASP . 5.4 ptmt -99.54 140.5 33.63 Favored 'General case' 0 N--CA 1.493 1.72 0 O-C-N 120.896 -1.127 . . . . 0.0 110.957 179.698 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 72' ' ' VAL . . . . . 0.6 ' CG2' ' O ' ' A' ' 74' ' ' GLY . 0.6 OUTLIER -64.82 136.57 26.42 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.476 0 N-CA-C 104.883 -2.265 . . . . 0.0 104.883 174.725 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 73' ' ' ALA . . . . . 0.651 ' O ' HG23 ' A' ' 146' ' ' VAL . . . -84.68 -14.72 47.62 Favored 'General case' 0 C--N 1.296 -1.745 0 O-C-N 120.211 -1.556 . . . . 0.0 108.386 -179.163 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 74' ' ' GLY . . . . . 0.6 ' O ' ' CG2' ' A' ' 72' ' ' VAL . . . 172.7 -158.51 28.65 Favored Glycine 0 N--CA 1.485 1.93 0 N-CA-C 109.432 -1.467 . . . . 0.0 109.432 -179.692 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 75' ' ' TYR . . . . . 0.59 ' CD2' ' O ' ' A' ' 85' ' ' GLU . 2.0 m-85 -142.81 170.32 15.92 Favored 'General case' 0 C--N 1.299 -1.63 0 O-C-N 121.013 -1.286 . . . . 0.0 111.544 -177.16 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 76' ' ' ILE . . . . . . . . . . . . . 3.0 tp -146.92 143.94 20.16 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.453 0 C-N-CA 119.906 -0.718 . . . . 0.0 109.734 -177.528 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -151.29 159.99 44.04 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 120.999 -1.063 . . . . 0.0 109.129 179.572 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 78' ' ' ILE . . . . . 0.488 ' HB ' ' HB3' ' A' ' 81' ' ' ALA . 19.0 mt -146.83 103.27 3.89 Favored Pre-proline 0 N--CA 1.491 1.604 0 O-C-N 121.296 -0.877 . . . . 0.0 109.067 -179.703 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 79' ' ' PRO . . . . . . . . . . . . . 46.6 Cg_exo -51.16 -44.02 45.11 Favored 'Trans proline' 0 N--CA 1.494 1.538 0 C-N-CA 122.566 2.177 . . . . 0.0 113.949 -179.149 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 1.1 m-20 -67.28 -22.71 65.64 Favored 'General case' 0 N--CA 1.493 1.676 0 O-C-N 120.69 -1.256 . . . . 0.0 110.991 178.975 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 81' ' ' ALA . . . . . 0.77 ' HB2' ' HB2' ' A' ' 136' ' ' ALA . . . -104.03 -10.85 17.75 Favored 'General case' 0 N--CA 1.493 1.716 0 O-C-N 121.135 -0.978 . . . . 0.0 109.106 179.588 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 82' ' ' ASP . . . . . . . . . . . . . 1.1 t70 59.05 50.24 8.46 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.336 -0.853 . . . . 0.0 110.439 179.322 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 83' ' ' ILE . . . . . . . . . . . . . 70.3 mt -125.97 152.61 33.32 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.854 0 O-C-N 121.298 -0.876 . . . . 0.0 110.285 -179.061 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 84' ' ' LYS . . . . . 0.408 ' C ' ' CD ' ' A' ' 85' ' ' GLU . 0.2 OUTLIER -160.69 105.07 1.4 Allowed 'General case' 0 N--CA 1.492 1.667 0 O-C-N 121.166 -0.959 . . . . 0.0 108.762 179.469 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 85' ' ' GLU . . . . . 0.59 ' O ' ' CD2' ' A' ' 75' ' ' TYR . 1.2 mm-40 -139.72 179.2 1.34 Allowed Pre-proline 0 N--CA 1.499 1.979 0 O-C-N 121.13 -0.981 . . . . 0.0 109.674 -179.373 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 86' ' ' PRO . . . . . 0.47 ' CD ' ' CB ' ' A' ' 85' ' ' GLU . 35.5 Cg_endo -86.15 167.33 9.38 Favored 'Trans proline' 0 C--N 1.314 -1.24 0 C-N-CA 122.707 2.272 . . . . 0.0 113.34 -178.691 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 87' ' ' VAL . . . . . 0.563 ' H ' HG23 ' A' ' 72' ' ' VAL . 57.5 t -124.43 104.76 14.3 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.469 0 N-CA-C 108.042 -1.096 . . . . 0.0 108.042 178.901 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 88' ' ' TYR . . . . . 0.409 ' CD2' ' HG2' ' A' ' 99' ' ' ARG . 29.5 m-85 -97.83 154.73 37.72 Favored Pre-proline 0 N--CA 1.496 1.831 0 O-C-N 121.047 -1.033 . . . . 0.0 110.202 -178.731 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 89' ' ' PRO . . . . . . . . . . . . . 8.9 Cg_endo -56.33 144.32 82.93 Favored 'Trans proline' 0 N--CA 1.496 1.62 0 C-N-CA 122.961 2.44 . . . . 0.0 113.949 -179.972 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . -59.87 170.25 6.71 Favored Glycine 0 N--CA 1.489 2.208 0 N-CA-C 109.01 -1.636 . . . . 0.0 109.01 178.553 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 91' ' ' PRO . . . . . 0.429 ' C ' ' H ' ' A' ' 93' ' ' THR . 54.6 Cg_endo -93.94 167.4 20.28 Favored 'Cis proline' 0 C--N 1.307 -1.645 0 C-N-CA 124.016 -1.243 . . . . 0.0 111.275 -0.04 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 92' ' ' ALA . . . . . 0.659 ' HB1' HD21 ' A' ' 97' ' ' LEU . . . -72.11 32.61 0.06 Allowed 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.125 -0.985 . . . . 0.0 110.532 -179.612 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 93' ' ' THR . . . . . 0.429 ' H ' ' C ' ' A' ' 91' ' ' PRO . 2.0 p -73.3 149.78 89.26 Favored Pre-proline 0 N--CA 1.489 1.52 0 O-C-N 120.566 -1.333 . . . . 0.0 108.653 -179.817 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 94' ' ' PRO . . . . . . . . . . . . . 91.8 Cg_exo -30.53 -50.43 0.22 Allowed 'Trans proline' 0 C--N 1.31 -1.454 0 C-N-CA 123.372 2.715 . . . . 0.0 112.944 -179.125 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 95' ' ' GLU . . . . . 0.434 ' O ' ' NH2' ' A' ' 99' ' ' ARG . 10.6 mt-10 -53.8 -47.65 70.62 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.201 -0.937 . . . . 0.0 109.702 -179.973 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 96' ' ' GLN . . . . . 0.452 ' C ' ' H ' ' A' ' 98' ' ' ASN . 3.3 mp0 -72.08 -49.21 38.3 Favored 'General case' 0 C--N 1.302 -1.478 0 O-C-N 121.263 -0.898 . . . . 0.0 110.416 -179.453 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 97' ' ' LEU . . . . . 0.659 HD21 ' HB1' ' A' ' 92' ' ' ALA . 96.2 mt -52.8 -8.25 0.09 Allowed 'General case' 0 N--CA 1.493 1.695 0 O-C-N 121.055 -1.028 . . . . 0.0 110.06 -178.936 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 98' ' ' ASN . . . . . 0.547 ' C ' ' ND2' ' A' ' 98' ' ' ASN . 0.0 OUTLIER -75.68 -37.73 59.3 Favored 'General case' 0 N--CA 1.488 1.432 0 N-CA-C 107.91 -1.145 . . . . 0.0 107.91 178.269 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 99' ' ' ARG . . . . . 0.477 ' CZ ' ' OD1' ' A' ' 98' ' ' ASN . 1.0 OUTLIER -72.41 -51.28 21.06 Favored 'General case' 0 C--N 1.304 -1.378 0 CA-C-N 115.893 -0.594 . . . . 0.0 109.646 179.677 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . 169.6 -158.43 30.7 Favored Glycine 0 N--CA 1.497 2.762 0 N-CA-C 109.565 -1.414 . . . . 0.0 109.565 -179.834 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 101' ' ' VAL . . . . . 0.763 HG23 ' O ' ' A' ' 101' ' ' VAL . 16.2 m -66.2 104.26 0.57 Allowed 'Isoleucine or valine' 0 N--CA 1.496 1.848 0 O-C-N 120.924 -1.339 . . . . 0.0 108.987 179.697 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -92.4 167.71 11.79 Favored 'General case' 0 N--CA 1.495 1.813 0 O-C-N 121.218 -0.926 . . . . 0.0 111.6 -178.719 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 103' ' ' PHE . . . . . 0.425 ' CE1' ' CG1' ' A' ' 87' ' ' VAL . 24.3 m-85 -70.97 143.88 50.69 Favored 'General case' 0 N--CA 1.489 1.505 0 N-CA-C 107.876 -1.157 . . . . 0.0 107.876 178.238 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 104' ' ' ALA . . . . . . . . . . . . . . . -61.94 -13.47 25.43 Favored 'General case' 0 C--N 1.297 -1.68 0 O-C-N 121.179 -0.951 . . . . 0.0 111.376 -178.71 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -138.29 143.27 39.92 Favored 'General case' 0 N--CA 1.498 1.964 0 O-C-N 120.618 -1.301 . . . . 0.0 110.998 -179.49 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 106' ' ' GLU . . . . . . . . . . . . . 6.1 pt-20 -57.09 -58.92 6.06 Favored 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.935 -0.478 . . . . 0.0 111.134 -179.432 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 107' ' ' ASN . . . . . . . . . . . . . 10.5 m-20 -77.99 35.22 0.2 Allowed 'General case' 0 N--CA 1.489 1.478 0 O-C-N 120.361 -1.462 . . . . 0.0 112.107 -176.24 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 108' ' ' GLU . . . . . . . . . . . . . 40.6 tp10 -59.28 145.46 43.02 Favored 'General case' 0 C--N 1.304 -1.374 0 O-C-N 120.742 -1.224 . . . . 0.0 107.834 -179.96 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 109' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -96.86 144.22 27.01 Favored 'General case' 0 C--N 1.301 -1.542 0 O-C-N 121.119 -0.988 . . . . 0.0 110.67 -178.324 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 110' ' ' LEU . . . . . 0.513 HD11 HG21 ' A' ' 146' ' ' VAL . 5.6 tp -60.9 -21.52 63.43 Favored 'General case' 0 C--N 1.302 -1.465 0 N-CA-C 107.971 -1.122 . . . . 0.0 107.971 179.165 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 111' ' ' ASP . . . . . . . . . . . . . 82.5 m-20 -132.19 43.77 2.98 Favored 'General case' 0 C--N 1.302 -1.482 0 C-N-CA 120.269 -0.572 . . . . 0.0 109.861 -179.616 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 112' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -67.09 148.79 51.42 Favored 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.153 -0.967 . . . . 0.0 110.059 179.63 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 113' ' ' GLN . . . . . . . . . . . . . 2.4 mp0 -68.12 -12.4 60.83 Favored 'General case' 0 C--N 1.302 -1.482 0 O-C-N 121.256 -0.902 . . . . 0.0 109.199 179.029 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 114' ' ' ASN . . . . . 0.694 ' C ' HD21 ' A' ' 114' ' ' ASN . 0.2 OUTLIER -149.97 101.79 3.06 Favored 'General case' 0 C--N 1.301 -1.517 0 N-CA-C 107.167 -1.42 . . . . 0.0 107.167 177.378 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 115' ' ' ILE . . . . . 0.432 ' O ' HG22 ' A' ' 115' ' ' ILE . 4.0 mt -97.83 110.55 25.74 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.45 0 O-C-N 121.047 -1.033 . . . . 0.0 108.848 -179.253 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 116' ' ' SER . . . . . . . . . . . . . 28.9 m -98.93 138.26 36.31 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.154 -0.966 . . . . 0.0 111.122 -178.485 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 117' ' ' ILE . . . . . 0.459 ' CD1' HD21 ' A' ' 179' ' ' LEU . 14.4 mt -123.42 151.52 28.01 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.424 0 N-CA-C 107.229 -1.397 . . . . 0.0 107.229 178.83 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 118' ' ' ALA . . . . . 0.405 ' HA ' ' O ' ' A' ' 182' ' ' ILE . . . -140.93 154.67 46.2 Favored 'General case' 0 N--CA 1.487 1.409 0 O-C-N 120.95 -1.094 . . . . 0.0 110.609 -179.171 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 119' ' ' GLY . . . . . . . . . . . . . . . -166.57 151.73 20.14 Favored Glycine 0 N--CA 1.484 1.849 0 N-CA-C 110.201 -1.16 . . . . 0.0 110.201 179.984 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 120' ' ' HIS . . . . . . . . . . . . . 10.9 m170 -71.71 165.51 23.87 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.918 -0.754 . . . . 0.0 110.465 179.642 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 121' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -121.03 148.32 44.3 Favored 'General case' 0 N--CA 1.495 1.823 0 N-CA-C 107.75 -1.204 . . . . 0.0 107.75 178.293 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 122' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -107.41 138.33 43.81 Favored 'General case' 0 N--CA 1.495 1.782 0 O-C-N 120.882 -1.136 . . . . 0.0 110.192 -179.663 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 123' ' ' ILE . . . . . 0.536 HG23 ' N ' ' A' ' 124' ' ' ASP . 15.0 tt -90.26 -36.54 8.5 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.771 0 N-CA-C 108.152 -1.055 . . . . 0.0 108.152 178.277 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 124' ' ' ASP . . . . . 0.536 ' N ' HG23 ' A' ' 123' ' ' ILE . 18.3 t0 -96.6 17.18 16.9 Favored 'General case' 0 N--CA 1.496 1.843 0 CA-C-N 115.777 -0.647 . . . . 0.0 111.13 -179.638 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 125' ' ' ARG . . . . . . . . . . . . . 7.7 ttt180 -156.72 107.35 1.97 Allowed Pre-proline 0 N--CA 1.499 1.993 0 O-C-N 120.516 -1.365 . . . . 0.0 110.152 -178.856 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 126' ' ' PRO . . . . . . . . . . . . . 66.0 Cg_endo -81.04 -17.02 9.6 Favored 'Trans proline' 0 C--N 1.314 -1.247 0 C-N-CA 121.886 1.724 . . . . 0.0 112.703 179.885 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 127' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -90.95 31.24 1.1 Allowed 'General case' 0 N--CA 1.494 1.742 0 O-C-N 121.152 -0.968 . . . . 0.0 109.946 -179.933 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 128' ' ' TYR . . . . . . . . . . . . . 8.8 t80 -89.41 -153.16 0.26 Allowed 'General case' 0 N--CA 1.492 1.668 0 O-C-N 120.956 -1.09 . . . . 0.0 110.675 -179.193 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 129' ' ' GLN . . . . . . . . . . . . . 39.8 mt-30 -66.77 -72.71 0.15 Allowed 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.32 -0.863 . . . . 0.0 110.919 -178.308 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 130' ' ' PHE . . . . . 0.573 ' CE2' HG11 ' A' ' 101' ' ' VAL . 49.2 m-85 -121.6 28.98 7.4 Favored 'General case' 0 N--CA 1.497 1.876 0 O-C-N 121.289 -0.882 . . . . 0.0 110.126 -179.447 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 131' ' ' THR . . . . . . . . . . . . . 99.0 m -72.55 -30.92 64.86 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 120.781 -1.199 . . . . 0.0 109.146 179.933 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 132' ' ' ASN . . . . . . . . . . . . . 4.6 t30 -85.0 7.99 19.39 Favored 'General case' 0 N--CA 1.496 1.86 0 C-N-CA 119.513 -0.875 . . . . 0.0 109.923 -179.869 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 133' ' ' LEU . . . . . 0.583 ' O ' ' N ' ' A' ' 135' ' ' ALA . 0.2 OUTLIER -70.81 -49.64 44.2 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.353 -0.842 . . . . 0.0 109.827 179.897 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 134' ' ' LYS . . . . . 0.599 ' H ' ' CD ' ' A' ' 134' ' ' LYS . 0.0 OUTLIER -44.39 -16.14 0.02 OUTLIER 'General case' 0 N--CA 1.495 1.804 0 O-C-N 120.995 -1.066 . . . . 0.0 109.386 -179.311 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 135' ' ' ALA . . . . . 0.583 ' N ' ' O ' ' A' ' 133' ' ' LEU . . . -83.15 -35.87 25.2 Favored 'General case' 0 N--CA 1.494 1.773 0 O-C-N 121.264 -0.898 . . . . 0.0 109.824 179.78 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 136' ' ' ALA . . . . . 0.77 ' HB2' ' HB2' ' A' ' 81' ' ' ALA . . . -80.43 158.71 25.87 Favored 'General case' 0 N--CA 1.491 1.621 0 CA-C-O 121.778 0.799 . . . . 0.0 111.446 -178.735 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 137' ' ' LYS . . . . . 0.55 ' O ' ' O ' ' A' ' 138' ' ' LYS . 17.1 mtmt -149.64 -168.08 3.01 Favored 'General case' 0 N--CA 1.493 1.7 0 C-N-CA 118.935 -1.106 . . . . 0.0 110.619 -177.888 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 138' ' ' LYS . . . . . 0.581 ' O ' ' N ' ' A' ' 140' ' ' SER . 21.7 mtmm -40.48 176.06 0.0 OUTLIER 'General case' 0 C--N 1.304 -1.407 0 CA-C-O 122.608 1.194 . . . . 0.0 111.502 -178.618 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 139' ' ' GLY . . . . . . . . . . . . . . . 47.83 7.81 0.04 OUTLIER Glycine 0 N--CA 1.487 2.072 0 N-CA-C 109.825 -1.31 . . . . 0.0 109.825 -179.649 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 140' ' ' SER . . . . . 0.581 ' N ' ' O ' ' A' ' 138' ' ' LYS . 2.3 p -75.32 116.67 16.3 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 120.96 -1.318 . . . . 0.0 109.156 179.207 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 141' ' ' MET . . . . . . . . . . . . . 3.3 tpt -70.6 139.3 51.38 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.215 -0.928 . . . . 0.0 109.393 -179.956 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 142' ' ' VAL . . . . . . . . . . . . . 5.0 t -125.35 128.25 72.53 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.719 0 O-C-N 121.491 -0.755 . . . . 0.0 108.998 -179.789 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 143' ' ' TYR . . . . . . . . . . . . . 64.4 m-85 -107.41 135.04 49.57 Favored 'General case' 0 N--CA 1.5 2.056 0 O-C-N 121.236 -0.915 . . . . 0.0 110.69 -179.295 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 144' ' ' PHE . . . . . . . . . . . . . 62.9 t80 -118.78 101.65 8.24 Favored 'General case' 0 N--CA 1.5 2.066 0 O-C-N 121.474 -0.766 . . . . 0.0 110.406 -179.405 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 145' ' ' LYS . . . . . 0.405 ' O ' ' N ' ' A' ' 75' ' ' TYR . 36.5 tttt -96.51 129.98 43.78 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.03 -1.044 . . . . 0.0 110.543 -179.554 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 146' ' ' VAL . . . . . 0.651 HG23 ' O ' ' A' ' 73' ' ' ALA . 2.6 p -146.16 141.84 21.37 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.574 0 N-CA-C 107.238 -1.393 . . . . 0.0 107.238 178.376 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 147' ' ' GLY . . . . . 0.42 ' C ' ' O ' ' A' ' 146' ' ' VAL . . . 47.85 -133.72 16.87 Favored Glycine 0 N--CA 1.487 2.077 0 N-CA-C 108.857 -1.697 . . . . 0.0 108.857 -179.391 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 148' ' ' ASN . . . . . 0.507 ' C ' ' ND2' ' A' ' 148' ' ' ASN . 0.5 OUTLIER -102.91 17.85 23.0 Favored 'General case' 0 C--N 1.302 -1.495 0 O-C-N 121.314 -1.109 . . . . 0.0 108.418 179.314 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 149' ' ' GLU . . . . . 0.525 ' CD ' ' N ' ' A' ' 150' ' ' THR . 11.5 tp10 -113.03 145.31 41.09 Favored 'General case' 0 N--CA 1.486 1.368 0 CA-C-O 121.714 0.768 . . . . 0.0 110.658 -178.447 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 150' ' ' THR . . . . . 0.525 ' N ' ' CD ' ' A' ' 149' ' ' GLU . 86.0 m -129.72 104.79 7.62 Favored 'General case' 0 N--CA 1.492 1.647 0 CA-C-O 121.487 0.66 . . . . 0.0 109.526 179.815 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 151' ' ' ARG . . . . . . . . . . . . . 84.3 mtt180 -85.92 -168.97 2.43 Favored 'General case' 0 N--CA 1.486 1.363 0 N-CA-C 108.646 -0.872 . . . . 0.0 108.646 -179.759 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 152' ' ' LYS . . . . . 0.589 ' N ' ' OXT' ' A' ' 206' ' ' LYS . 21.7 mtpt -149.9 148.47 29.16 Favored 'General case' 0 C--N 1.3 -1.563 0 O-C-N 120.999 -1.063 . . . . 0.0 110.317 -178.855 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 153' ' ' TYR . . . . . 0.446 ' CD1' ' C ' ' A' ' 152' ' ' LYS . 51.7 m-85 -146.94 151.48 37.08 Favored 'General case' 0 C--N 1.302 -1.475 0 N-CA-C 108.401 -0.963 . . . . 0.0 108.401 178.718 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 154' ' ' LYS . . . . . . . . . . . . . 10.8 ttmt -133.05 117.05 17.11 Favored 'General case' 0 C--N 1.298 -1.648 0 N-CA-C 108.711 -0.848 . . . . 0.0 108.711 179.291 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 155' ' ' MET . . . . . 0.557 ' SD ' ' OG ' ' A' ' 140' ' ' SER . 6.5 mtt -41.66 107.71 0.08 Allowed 'General case' 0 N--CA 1.489 1.483 0 CA-C-O 122.75 1.262 . . . . 0.0 111.858 -178.126 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 156' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -106.07 -26.19 11.73 Favored 'General case' 0 C--N 1.293 -1.865 0 CA-C-N 114.537 -1.211 . . . . 0.0 110.03 -178.842 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 157' ' ' SER . . . . . 0.488 ' O ' ' N ' ' A' ' 201' ' ' VAL . 19.8 t -154.27 150.77 28.37 Favored 'General case' 0 N--CA 1.494 1.748 0 C-N-CA 118.713 -1.195 . . . . 0.0 111.394 -178.678 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 158' ' ' ILE . . . . . 0.444 HG13 ' CD2' ' A' ' 200' ' ' PHE . 0.0 OUTLIER -155.25 146.9 12.98 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.486 0 CA-C-O 121.767 0.794 . . . . 0.0 110.252 -179.884 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 159' ' ' ARG . . . . . 0.599 ' CG ' HH11 ' A' ' 159' ' ' ARG . 0.0 OUTLIER -151.32 -167.46 2.81 Favored 'General case' 0 N--CA 1.491 1.603 0 CA-C-O 121.785 0.802 . . . . 0.0 110.551 -179.147 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 160' ' ' ASP . . . . . . . . . . . . . 5.5 m-20 -145.11 152.91 40.8 Favored 'General case' 0 N--CA 1.491 1.599 0 N-CA-C 108.585 -0.894 . . . . 0.0 108.585 -179.429 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 161' ' ' VAL . . . . . 0.653 HG21 HG22 ' A' ' 168' ' ' VAL . 0.1 OUTLIER -153.04 150.83 12.38 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.873 0 O-C-N 120.713 -1.242 . . . . 0.0 111.21 -178.834 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 162' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -49.07 171.3 0.11 Allowed Pre-proline 0 N--CA 1.496 1.866 0 O-C-N 121.652 -0.655 . . . . 0.0 109.961 179.418 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 163' ' ' PRO . . . . . . . . . . . . . 74.2 Cg_endo -81.07 29.37 0.53 Allowed 'Trans proline' 0 N--CA 1.492 1.428 0 C-N-CA 122.792 2.328 . . . . 0.0 113.008 179.83 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 164' ' ' THR . . . . . 0.506 ' O ' HG22 ' A' ' 164' ' ' THR . 55.3 m -151.16 -6.01 0.27 Allowed 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.005 -1.059 . . . . 0.0 110.356 -179.949 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 165' ' ' ASP . . . . . 0.86 ' O ' HG23 ' A' ' 168' ' ' VAL . 12.0 t0 -75.8 63.62 1.68 Allowed 'General case' 0 N--CA 1.487 1.411 0 O-C-N 120.994 -1.066 . . . . 0.0 109.292 179.549 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 166' ' ' VAL . . . . . 0.538 ' O ' ' N ' ' A' ' 168' ' ' VAL . 1.0 OUTLIER -39.54 -31.96 0.17 Allowed 'Isoleucine or valine' 0 N--CA 1.488 1.433 0 O-C-N 121.473 -0.767 . . . . 0.0 109.152 -178.647 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 167' ' ' GLY . . . . . 0.442 ' N ' ' O ' ' A' ' 165' ' ' ASP . . . -45.52 -13.52 0.05 OUTLIER Glycine 0 N--CA 1.494 2.545 0 N-CA-C 110.541 -1.024 . . . . 0.0 110.541 179.929 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 168' ' ' VAL . . . . . 0.86 HG23 ' O ' ' A' ' 165' ' ' ASP . 16.7 t -52.74 -35.39 21.28 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.607 0 O-C-N 120.818 -1.401 . . . . 0.0 108.115 179.531 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 169' ' ' LEU . . . . . 0.54 ' O ' ' C ' ' A' ' 170' ' ' ASP . 84.3 mt -46.23 -14.05 0.02 OUTLIER 'General case' 0 C--N 1.3 -1.569 0 N-CA-C 108.26 -1.015 . . . . 0.0 108.26 -178.268 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 170' ' ' ASP . . . . . 0.589 ' N ' ' O ' ' A' ' 168' ' ' VAL . 39.1 t0 19.78 54.36 0.01 OUTLIER 'General case' 0 N--CA 1.501 2.079 0 N-CA-C 111.874 0.324 . . . . 0.0 111.874 177.699 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 171' ' ' GLU . . . . . 0.435 ' N ' ' O ' ' A' ' 169' ' ' LEU . 4.9 pt-20 -100.87 75.6 1.71 Allowed 'General case' 0 N--CA 1.497 1.878 0 O-C-N 120.777 -1.202 . . . . 0.0 110.554 -179.597 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 172' ' ' GLN . . . . . . . . . . . . . 4.3 pt20 -139.69 -39.25 0.46 Allowed 'General case' 0 N--CA 1.492 1.665 0 O-C-N 121.568 -0.708 . . . . 0.0 109.266 -179.843 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 173' ' ' LYS . . . . . . . . . . . . . 9.2 mtpp -63.82 131.05 46.6 Favored 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.06 -1.025 . . . . 0.0 108.743 178.818 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 174' ' ' GLY . . . . . 0.559 ' O ' ' C ' ' A' ' 175' ' ' LYS . . . -137.5 -38.94 0.13 Allowed Glycine 0 C--N 1.294 -1.761 0 N-CA-C 108.514 -1.834 . . . . 0.0 108.514 179.763 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 175' ' ' LYS . . . . . 0.559 ' C ' ' O ' ' A' ' 174' ' ' GLY . 3.4 tptp -33.41 -62.97 0.26 Allowed 'General case' 0 N--CA 1.493 1.717 0 N-CA-C 108.529 -0.915 . . . . 0.0 108.529 179.676 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 176' ' ' ASP . . . . . 0.715 ' O ' ' O ' ' A' ' 177' ' ' LYS . 0.9 OUTLIER -103.6 76.1 1.37 Allowed 'General case' 0 C--N 1.297 -1.697 0 N-CA-C 107.796 -1.187 . . . . 0.0 107.796 177.775 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 177' ' ' LYS . . . . . 0.715 ' O ' ' O ' ' A' ' 176' ' ' ASP . 17.6 mtmt -19.16 158.63 0.0 OUTLIER 'General case' 0 N--CA 1.508 2.458 0 CA-C-O 122.145 0.974 . . . . 0.0 112.719 -178.985 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 178' ' ' GLN . . . . . 0.535 ' NE2' ' OD1' ' A' ' 114' ' ' ASN . 18.0 pt20 -156.08 159.23 38.91 Favored 'General case' 0 N--CA 1.491 1.593 0 C-N-CA 117.061 -1.856 . . . . 0.0 112.483 179.863 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 179' ' ' LEU . . . . . 0.459 HD21 ' CD1' ' A' ' 117' ' ' ILE . 0.8 OUTLIER -121.58 102.88 8.51 Favored 'General case' 0 N--CA 1.486 1.349 0 N-CA-C 107.072 -1.455 . . . . 0.0 107.072 178.418 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 180' ' ' THR . . . . . 0.45 ' OG1' HG22 ' A' ' 201' ' ' VAL . 1.0 OUTLIER -79.92 123.9 28.2 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.148 -0.97 . . . . 0.0 110.438 -178.454 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 181' ' ' LEU . . . . . . . . . . . . . 7.5 tp -99.8 110.9 23.25 Favored 'General case' 0 N--CA 1.492 1.661 0 N-CA-C 108.711 -0.848 . . . . 0.0 108.711 178.386 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 182' ' ' ILE . . . . . 0.405 ' O ' ' HA ' ' A' ' 118' ' ' ALA . 18.1 mt -98.94 120.23 47.98 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.549 0 O-C-N 120.85 -1.156 . . . . 0.0 109.768 179.432 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 183' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -135.44 109.06 7.97 Favored 'General case' 0 C--N 1.296 -1.718 0 N-CA-C 107.279 -1.378 . . . . 0.0 107.279 178.548 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 184' ' ' CYS . . . . . 0.408 ' HB3' HH12 ' A' ' 197' ' ' ARG . 0.7 OUTLIER -79.83 156.68 27.28 Favored 'General case' 0 N--CA 1.498 1.933 0 C-N-CA 118.935 -1.106 . . . . 0.0 111.341 -177.306 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 185' ' ' ASP . . . . . 0.613 ' CG ' ' H ' ' A' ' 186' ' ' ASP . 28.9 t0 -166.53 -161.92 0.49 Allowed 'General case' 0 N--CA 1.489 1.523 0 N-CA-C 108.659 -0.867 . . . . 0.0 108.659 -179.943 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 186' ' ' ASP . . . . . 0.613 ' H ' ' CG ' ' A' ' 185' ' ' ASP . 0.6 OUTLIER 58.49 49.12 11.08 Favored 'General case' 0 N--CA 1.497 1.916 0 O-C-N 121.026 -1.046 . . . . 0.0 109.457 -179.656 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 187' ' ' TYR . . . . . 0.587 ' CE1' ' O ' ' A' ' 188' ' ' ASN . 30.1 t80 -67.16 133.09 49.11 Favored 'General case' 0 C--N 1.3 -1.562 0 CA-C-O 121.843 0.83 . . . . 0.0 110.469 -179.858 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 188' ' ' ASN . . . . . 0.86 ' ND2' ' H ' ' A' ' 193' ' ' VAL . 0.1 OUTLIER -102.56 150.66 23.18 Favored 'General case' 0 C--N 1.292 -1.894 0 N-CA-C 107.572 -1.27 . . . . 0.0 107.572 178.033 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 189' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -113.24 -3.08 13.92 Favored 'General case' 0 C--N 1.292 -1.934 0 N-CA-C 108.178 -1.045 . . . . 0.0 108.178 -179.61 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 190' ' ' LYS . . . . . 0.566 ' N ' ' OD1' ' A' ' 188' ' ' ASN . 2.6 mtpm? -83.66 -60.21 2.19 Favored 'General case' 0 N--CA 1.489 1.49 0 N-CA-C 108.714 -0.847 . . . . 0.0 108.714 178.558 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 191' ' ' THR . . . . . 0.623 ' OG1' ' ND2' ' A' ' 188' ' ' ASN . 1.1 p -89.34 4.15 49.86 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.41 -0.806 . . . . 0.0 109.245 179.896 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 192' ' ' GLY . . . . . . . . . . . . . . . 56.73 38.01 80.27 Favored Glycine 0 N--CA 1.494 2.53 0 N-CA-C 110.05 -1.22 . . . . 0.0 110.05 179.4 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 193' ' ' VAL . . . . . 0.86 ' H ' ' ND2' ' A' ' 188' ' ' ASN . 46.0 t -148.35 161.02 6.5 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.493 0 O-C-N 121.162 -1.199 . . . . 0.0 110.042 -179.975 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 194' ' ' TRP . . . . . 0.537 ' N ' HG12 ' A' ' 193' ' ' VAL . 11.1 m95 -83.4 120.62 26.11 Favored 'General case' 0 C--N 1.298 -1.656 0 N-CA-C 108.564 -0.902 . . . . 0.0 108.564 179.55 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 195' ' ' GLU . . . . . . . . . . . . . 1.4 mt-10 -79.53 -60.09 2.5 Favored 'General case' 0 N--CA 1.493 1.709 0 O-C-N 121.309 -0.869 . . . . 0.0 111.013 -178.888 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 196' ' ' LYS . . . . . . . . . . . . . 19.0 mttp -95.04 146.37 24.32 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.285 -0.884 . . . . 0.0 110.31 -178.759 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 197' ' ' ARG . . . . . 0.657 ' CG ' HH11 ' A' ' 197' ' ' ARG . 0.0 OUTLIER -118.81 145.42 45.65 Favored 'General case' 0 N--CA 1.492 1.635 0 N-CA-C 108.564 -0.902 . . . . 0.0 108.564 179.035 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 198' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER -116.95 120.75 39.4 Favored 'General case' 0 N--CA 1.492 1.666 0 O-C-N 121.672 -0.643 . . . . 0.0 110.358 -178.704 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 199' ' ' ILE . . . . . 0.514 HG21 HG11 ' A' ' 168' ' ' VAL . 0.8 OUTLIER -141.67 121.46 11.17 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.527 0 CA-C-O 122.672 1.225 . . . . 0.0 110.551 179.554 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 200' ' ' PHE . . . . . 0.53 ' CD1' ' N ' ' A' ' 200' ' ' PHE . 3.3 m-85 -99.52 134.64 42.1 Favored 'General case' 0 N--CA 1.497 1.915 0 O-C-N 121.163 -0.961 . . . . 0.0 110.125 -177.653 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 201' ' ' VAL . . . . . 0.488 ' N ' ' O ' ' A' ' 157' ' ' SER . 3.4 t -103.95 145.38 12.9 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.456 0 N-CA-C 107.646 -1.242 . . . . 0.0 107.646 176.805 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 202' ' ' ALA . . . . . . . . . . . . . . . -135.01 142.31 46.39 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.042 -1.036 . . . . 0.0 109.465 -179.753 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 203' ' ' THR . . . . . . . . . . . . . 2.2 p -90.11 127.55 36.11 Favored 'General case' 0 C--N 1.306 -1.322 0 CA-C-O 122.694 1.235 . . . . 0.0 111.693 -178.353 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 204' ' ' GLU . . . . . . . . . . . . . 2.7 tm-20 -53.99 135.84 42.21 Favored 'General case' 0 C--N 1.291 -1.976 0 CA-C-N 114.364 -1.289 . . . . 0.0 108.286 178.594 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 205' ' ' VAL . . . . . . . . . . . . . 62.6 t -121.55 -50.14 3.02 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.898 0 O-C-N 121.177 -0.952 . . . . 0.0 109.436 -179.13 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 206' ' ' LYS . . . . . 0.589 ' OXT' ' N ' ' A' ' 152' ' ' LYS . 4.4 mmtp . . . . . 0 C--N 1.302 -1.469 0 CA-C-O 118.114 -0.946 . . . . 0.0 109.667 179.151 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' C' C ' 702' ' ' LEU . . . . . 0.827 ' N ' HD12 ' C' ' 702' ' ' LEU . 0.0 OUTLIER . . . . . 0 N--CA 1.491 1.598 0 N-CA-C 108.316 -0.994 . . . . 0.0 108.316 . . . . . . . . . 2 2 . 1 . 016 nuclear build core ' C' C ' 703' ' ' PRO . . . . . 0.586 ' O ' ' NH2' ' A' ' 197' ' ' ARG . 64.8 Cg_endo -80.85 164.11 20.5 Favored 'Trans proline' 0 C--N 1.308 -1.584 0 C-N-CA 122.381 2.054 . . . . 0.0 113.119 -179.123 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' C' C ' 704' ' ' ALA . . . . . 0.462 ' O ' ' O ' ' C' ' 703' ' ' PRO . . . . . . . . 0 N--CA 1.488 1.462 0 O-C-N 121.345 -0.847 . . . . 0.0 110.033 179.441 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 63' ' ' PRO . . . . . . . . . . . . . 75.7 Cg_endo . . . . . 0 N--CA 1.487 1.098 0 CA-C-O 121.054 0.356 . . . . 0.0 111.488 . . . . . . . . . 0 0 . 1 . 017 nuclear build core ' A' A ' 64' ' ' GLN . . . . . 0.568 ' N ' ' CD ' ' A' ' 64' ' ' GLN . 0.0 OUTLIER -156.31 117.53 3.83 Favored 'General case' 0 N--CA 1.496 1.87 0 O-C-N 121.118 -0.989 . . . . 0.0 109.39 179.664 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 65' ' ' ILE . . . . . 0.45 ' H ' HD12 ' A' ' 65' ' ' ILE . 3.2 mp -43.86 104.39 0.37 Allowed Pre-proline 0 N--CA 1.494 1.767 0 O-C-N 120.972 -1.08 . . . . 0.0 109.119 179.48 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 66' ' ' PRO . . . . . . . . . . . . . 83.8 Cg_endo -87.34 -158.81 0.09 OUTLIER 'Trans proline' 0 C--N 1.315 -1.23 0 C-N-CA 122.287 1.991 . . . . 0.0 112.651 -179.476 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 67' ' ' LYS . . . . . 0.467 ' CG ' ' O ' ' A' ' 67' ' ' LYS . 19.5 tttm -77.86 -6.87 55.65 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.306 -0.871 . . . . 0.0 108.7 179.516 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 68' ' ' ASP . . . . . 0.589 ' O ' ' N ' ' A' ' 70' ' ' SER . 3.6 t0 -76.5 48.04 0.52 Allowed 'General case' 0 N--CA 1.489 1.488 0 CA-C-O 122.237 1.018 . . . . 0.0 109.05 179.477 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 69' ' ' LYS . . . . . 0.456 ' C ' ' O ' ' A' ' 68' ' ' ASP . 9.5 ptpt -49.11 -14.57 0.08 Allowed 'General case' 0 N--CA 1.503 2.186 0 C-N-CA 116.845 -1.942 . . . . 0.0 106.863 178.234 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 70' ' ' SER . . . . . 0.589 ' N ' ' O ' ' A' ' 68' ' ' ASP . 1.8 t -82.85 -8.49 59.57 Favored 'General case' 0 N--CA 1.494 1.764 0 CA-C-N 113.629 -1.623 . . . . 0.0 110.15 179.958 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 71' ' ' LYS . . . . . 0.408 ' CD ' ' HB3' ' A' ' 68' ' ' ASP . 0.0 OUTLIER -97.54 145.93 25.76 Favored 'General case' 0 N--CA 1.492 1.665 0 O-C-N 120.981 -1.074 . . . . 0.0 109.929 179.109 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 72' ' ' VAL . . . . . 0.703 HG12 ' CE1' ' A' ' 88' ' ' TYR . 1.1 m -65.24 140.06 20.33 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.58 0 N-CA-C 105.046 -2.205 . . . . 0.0 105.046 174.853 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 73' ' ' ALA . . . . . 0.636 ' O ' HG23 ' A' ' 146' ' ' VAL . . . -80.64 -18.61 47.54 Favored 'General case' 0 C--N 1.291 -1.935 0 O-C-N 120.022 -1.674 . . . . 0.0 106.645 179.764 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 74' ' ' GLY . . . . . 0.453 ' O ' ' N ' ' A' ' 87' ' ' VAL . . . 176.16 -159.05 26.08 Favored Glycine 0 N--CA 1.483 1.796 0 N-CA-C 109.721 -1.352 . . . . 0.0 109.721 179.323 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 75' ' ' TYR . . . . . 0.551 ' HA ' HG23 ' A' ' 87' ' ' VAL . 92.1 m-85 -140.77 166.66 24.16 Favored 'General case' 0 C--N 1.299 -1.619 0 O-C-N 121.62 -0.929 . . . . 0.0 110.63 -177.268 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 76' ' ' ILE . . . . . . . . . . . . . 1.7 tt -147.71 143.39 19.64 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.551 0 C-N-CA 118.98 -1.088 . . . . 0.0 109.959 -178.189 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 77' ' ' GLU . . . . . 0.56 ' N ' ' CD ' ' A' ' 77' ' ' GLU . 2.3 mp0 -147.31 164.35 33.52 Favored 'General case' 0 N--CA 1.487 1.424 0 O-C-N 121.116 -0.99 . . . . 0.0 108.823 -179.831 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 78' ' ' ILE . . . . . 0.608 ' HB ' ' HB3' ' A' ' 81' ' ' ALA . 5.1 mt -147.5 93.39 4.62 Favored Pre-proline 0 N--CA 1.49 1.552 0 N-CA-C 108.181 -1.044 . . . . 0.0 108.181 179.674 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 79' ' ' PRO . . . . . . . . . . . . . 80.7 Cg_exo -46.87 -48.49 14.18 Favored 'Trans proline' 0 N--CA 1.494 1.527 0 C-N-CA 122.995 2.464 . . . . 0.0 114.098 -178.428 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -64.8 -18.98 65.58 Favored 'General case' 0 N--CA 1.494 1.73 0 O-C-N 120.868 -1.145 . . . . 0.0 110.749 178.968 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 81' ' ' ALA . . . . . 0.786 ' HB2' ' HB2' ' A' ' 136' ' ' ALA . . . -105.5 -17.49 14.4 Favored 'General case' 0 N--CA 1.492 1.663 0 O-C-N 121.176 -0.953 . . . . 0.0 108.488 179.207 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 82' ' ' ASP . . . . . 0.438 ' N ' ' O ' ' A' ' 78' ' ' ILE . 0.7 OUTLIER 67.93 51.12 0.78 Allowed 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.528 -0.732 . . . . 0.0 110.453 179.022 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 83' ' ' ILE . . . . . . . . . . . . . 70.8 mt -128.75 151.57 35.72 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.756 0 O-C-N 121.343 -0.848 . . . . 0.0 110.074 -178.768 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 84' ' ' LYS . . . . . 0.45 ' CG ' ' O ' ' A' ' 84' ' ' LYS . 7.7 pttt -158.37 107.86 2.03 Favored 'General case' 0 N--CA 1.494 1.757 0 N-CA-C 108.345 -0.984 . . . . 0.0 108.345 -179.923 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -142.34 166.12 23.1 Favored Pre-proline 0 N--CA 1.496 1.833 0 O-C-N 121.234 -0.916 . . . . 0.0 110.759 -179.064 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 86' ' ' PRO . . . . . . . . . . . . . 73.8 Cg_endo -77.35 166.35 26.25 Favored 'Trans proline' 0 N--CA 1.498 1.761 0 C-N-CA 123.333 2.689 . . . . 0.0 113.652 -179.225 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 87' ' ' VAL . . . . . 0.551 HG23 ' HA ' ' A' ' 75' ' ' TYR . 39.9 t -122.83 100.95 8.82 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.651 0 O-C-N 121.735 -0.603 . . . . 0.0 109.422 179.953 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 88' ' ' TYR . . . . . 0.703 ' CE1' HG12 ' A' ' 72' ' ' VAL . 7.5 m-85 -89.73 173.61 5.69 Favored Pre-proline 0 N--CA 1.499 2.005 0 O-C-N 120.946 -1.096 . . . . 0.0 109.468 -179.684 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 89' ' ' PRO . . . . . 0.434 ' HA ' ' CD2' ' A' ' 103' ' ' PHE . 9.4 Cg_endo -83.84 145.61 11.44 Favored 'Trans proline' 0 N--CA 1.484 0.96 0 C-N-CA 122.064 1.843 . . . . 0.0 113.898 -177.982 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . -55.97 164.41 4.8 Favored Glycine 0 N--CA 1.487 2.069 0 N-CA-C 109.081 -1.608 . . . . 0.0 109.081 179.133 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 91' ' ' PRO . . . . . 0.453 ' C ' ' H ' ' A' ' 93' ' ' THR . 58.0 Cg_endo -91.5 167.27 27.37 Favored 'Cis proline' 0 C--N 1.305 -1.747 0 C-N-CA 123.408 -1.497 . . . . 0.0 112.401 0.69 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 92' ' ' ALA . . . . . 0.551 ' HB3' ' HB2' ' C' ' 703' ' ' PRO . . . -73.21 30.52 0.07 Allowed 'General case' 0 C--N 1.303 -1.449 0 C-N-CA 119.887 -0.725 . . . . 0.0 110.091 -179.944 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 93' ' ' THR . . . . . 0.453 ' H ' ' C ' ' A' ' 91' ' ' PRO . 6.5 p -71.5 150.6 93.82 Favored Pre-proline 0 N--CA 1.489 1.493 0 O-C-N 121.034 -1.041 . . . . 0.0 108.847 -179.289 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 94' ' ' PRO . . . . . . . . . . . . . 77.8 Cg_exo -33.35 -49.03 0.45 Allowed 'Trans proline' 0 C--N 1.308 -1.562 0 C-N-CA 122.898 2.398 . . . . 0.0 112.385 -178.9 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 95' ' ' GLU . . . . . 0.596 ' O ' ' ND2' ' A' ' 98' ' ' ASN . 5.4 mp0 -49.83 -51.36 40.5 Favored 'General case' 0 C--N 1.3 -1.551 0 O-C-N 121.317 -0.865 . . . . 0.0 109.773 -179.838 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 96' ' ' GLN . . . . . 0.566 ' O ' ' N ' ' A' ' 98' ' ' ASN . 3.3 mp0 -72.32 -50.76 24.45 Favored 'General case' 0 N--CA 1.489 1.493 0 O-C-N 120.99 -1.069 . . . . 0.0 109.954 179.908 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 97' ' ' LEU . . . . . 0.627 ' CD2' ' CE1' ' A' ' 120' ' ' HIS . 1.3 mp -48.5 -8.75 0.02 OUTLIER 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.135 -0.978 . . . . 0.0 109.737 -179.786 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 98' ' ' ASN . . . . . 0.596 ' ND2' ' O ' ' A' ' 95' ' ' GLU . 0.4 OUTLIER -72.66 -28.01 62.46 Favored 'General case' 0 N--CA 1.489 1.479 0 O-C-N 121.379 -0.826 . . . . 0.0 109.346 179.868 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 99' ' ' ARG . . . . . 0.646 HH11 ' CG ' ' A' ' 99' ' ' ARG . 0.2 OUTLIER -96.17 -57.61 2.29 Favored 'General case' 0 N--CA 1.488 1.428 0 C-N-CA 119.79 -0.764 . . . . 0.0 110.186 -179.526 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . -170.2 -162.8 23.15 Favored Glycine 0 N--CA 1.493 2.468 0 C-N-CA 119.383 -1.389 . . . . 0.0 110.531 -179.934 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 101' ' ' VAL . . . . . 0.75 HG11 ' CZ ' ' A' ' 130' ' ' PHE . 13.7 m -64.58 106.27 0.57 Allowed 'Isoleucine or valine' 0 N--CA 1.496 1.845 0 O-C-N 121.698 -0.883 . . . . 0.0 109.351 -179.61 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -92.57 161.44 14.59 Favored 'General case' 0 N--CA 1.494 1.731 0 O-C-N 121.23 -0.919 . . . . 0.0 110.679 -179.55 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 103' ' ' PHE . . . . . 0.434 ' CD2' ' HA ' ' A' ' 89' ' ' PRO . 23.8 m-85 -63.6 150.42 44.14 Favored 'General case' 0 N--CA 1.489 1.48 0 N-CA-C 107.724 -1.213 . . . . 0.0 107.724 178.11 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 104' ' ' ALA . . . . . . . . . . . . . . . -69.71 -13.08 62.11 Favored 'General case' 0 N--CA 1.492 1.652 0 O-C-N 120.998 -1.064 . . . . 0.0 111.309 -178.504 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -136.3 142.01 43.87 Favored 'General case' 0 N--CA 1.498 1.97 0 O-C-N 120.841 -1.162 . . . . 0.0 110.803 -179.307 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 106' ' ' GLU . . . . . . . . . . . . . 2.3 tm-20 -51.89 -61.64 2.13 Favored 'General case' 0 N--CA 1.489 1.495 0 O-C-N 121.883 -0.511 . . . . 0.0 110.675 -179.556 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 107' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER -76.63 34.49 0.14 Allowed 'General case' 0 N--CA 1.489 1.52 0 O-C-N 120.698 -1.251 . . . . 0.0 112.251 -175.832 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 108' ' ' GLU . . . . . 0.488 ' OE2' HD13 ' A' ' 115' ' ' ILE . 29.6 tp10 -55.22 146.74 18.12 Favored 'General case' 0 C--N 1.303 -1.422 0 O-C-N 120.585 -1.322 . . . . 0.0 107.624 179.681 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 109' ' ' SER . . . . . 0.752 ' O ' HD11 ' A' ' 115' ' ' ILE . 0.3 OUTLIER -103.59 143.49 32.68 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 120.941 -1.099 . . . . 0.0 110.901 -178.038 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 110' ' ' LEU . . . . . 0.645 HD11 HG21 ' A' ' 146' ' ' VAL . 0.2 OUTLIER -64.47 -16.47 62.53 Favored 'General case' 0 C--N 1.303 -1.447 0 N-CA-C 108.884 -0.784 . . . . 0.0 108.884 179.217 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 111' ' ' ASP . . . . . . . . . . . . . 74.0 m-20 -132.97 35.99 3.51 Favored 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.248 -0.907 . . . . 0.0 110.298 -179.539 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 112' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -66.52 153.36 43.15 Favored 'General case' 0 N--CA 1.493 1.7 0 O-C-N 120.825 -1.172 . . . . 0.0 111.203 -179.673 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 113' ' ' GLN . . . . . 0.561 ' NE2' ' O ' ' A' ' 173' ' ' LYS . 0.0 OUTLIER -67.77 -13.78 62.41 Favored 'General case' 0 N--CA 1.494 1.755 0 CA-C-O 121.949 0.88 . . . . 0.0 109.537 178.677 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 114' ' ' ASN . . . . . 0.615 ' O ' ' ND2' ' A' ' 114' ' ' ASN . 0.3 OUTLIER -150.33 106.71 3.48 Favored 'General case' 0 C--N 1.298 -1.669 0 N-CA-C 107.205 -1.405 . . . . 0.0 107.205 179.477 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 115' ' ' ILE . . . . . 0.752 HD11 ' O ' ' A' ' 109' ' ' SER . 1.5 mm -94.23 104.52 15.86 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.737 0 O-C-N 120.534 -1.354 . . . . 0.0 108.823 -179.459 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 116' ' ' SER . . . . . . . . . . . . . 42.8 m -82.55 153.12 25.68 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.291 -0.881 . . . . 0.0 110.986 -178.182 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 117' ' ' ILE . . . . . 0.453 HG22 ' HB ' ' A' ' 101' ' ' VAL . 7.9 mt -151.13 147.12 15.8 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.437 0 N-CA-C 108.207 -1.034 . . . . 0.0 108.207 179.736 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 118' ' ' ALA . . . . . . . . . . . . . . . -144.89 160.97 40.45 Favored 'General case' 0 N--CA 1.491 1.582 0 C-N-CA 118.742 -1.183 . . . . 0.0 111.435 -179.948 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 119' ' ' GLY . . . . . . . . . . . . . . . -167.95 151.0 17.71 Favored Glycine 0 N--CA 1.485 1.939 0 N-CA-C 109.65 -1.38 . . . . 0.0 109.65 179.718 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 120' ' ' HIS . . . . . 0.627 ' CE1' ' CD2' ' A' ' 97' ' ' LEU . 3.9 m-70 -70.91 167.73 18.41 Favored 'General case' 0 N--CA 1.493 1.699 0 O-C-N 121.639 -0.918 . . . . 0.0 109.972 179.689 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 121' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -121.39 157.95 29.37 Favored 'General case' 0 N--CA 1.496 1.842 0 N-CA-C 108.363 -0.977 . . . . 0.0 108.363 178.954 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 122' ' ' PHE . . . . . 0.73 ' O ' HG21 ' A' ' 131' ' ' THR . 0.1 OUTLIER -140.66 121.97 14.92 Favored 'General case' 0 N--CA 1.498 1.934 0 O-C-N 120.927 -1.108 . . . . 0.0 110.31 -179.234 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 123' ' ' ILE . . . . . 0.502 HG23 ' N ' ' A' ' 124' ' ' ASP . 8.6 tt -59.44 -38.54 75.61 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.485 0 O-C-N 121.556 -0.715 . . . . 0.0 110.096 -179.884 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 124' ' ' ASP . . . . . 0.502 ' N ' HG23 ' A' ' 123' ' ' ILE . 0.1 OUTLIER -90.97 18.29 6.85 Favored 'General case' 0 N--CA 1.496 1.858 0 C-N-CA 119.659 -0.816 . . . . 0.0 111.988 -177.718 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 125' ' ' ARG . . . . . 0.443 HH11 ' CG ' ' A' ' 125' ' ' ARG . 0.3 OUTLIER -152.08 99.31 2.9 Favored Pre-proline 0 N--CA 1.493 1.706 0 O-C-N 120.521 -1.362 . . . . 0.0 109.719 -179.821 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 126' ' ' PRO . . . . . . . . . . . . . 58.4 Cg_endo -77.55 -19.03 13.31 Favored 'Trans proline' 0 N--CA 1.489 1.236 0 C-N-CA 122.061 1.841 . . . . 0.0 112.143 179.697 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 127' ' ' ASN . . . . . 0.489 ' O ' ' O ' ' A' ' 128' ' ' TYR . 0.7 OUTLIER -91.29 2.59 56.27 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.301 -0.874 . . . . 0.0 109.948 -179.811 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 128' ' ' TYR . . . . . 0.679 ' CE2' ' NE2' ' A' ' 129' ' ' GLN . 2.5 t80 -57.82 -148.83 0.0 OUTLIER 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.182 -0.949 . . . . 0.0 110.025 -179.657 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 129' ' ' GLN . . . . . 0.679 ' NE2' ' CE2' ' A' ' 128' ' ' TYR . 0.5 OUTLIER -65.39 -71.24 0.19 Allowed 'General case' 0 N--CA 1.493 1.703 0 O-C-N 121.316 -0.865 . . . . 0.0 109.871 -179.387 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 130' ' ' PHE . . . . . 0.75 ' CZ ' HG11 ' A' ' 101' ' ' VAL . 28.8 m-85 -135.16 39.78 2.91 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.288 -0.883 . . . . 0.0 109.808 -179.633 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 131' ' ' THR . . . . . 0.73 HG21 ' O ' ' A' ' 122' ' ' PHE . 60.5 m -74.94 -32.88 61.86 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.246 -0.909 . . . . 0.0 109.354 179.858 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 132' ' ' ASN . . . . . 0.471 ' CG ' ' O ' ' A' ' 132' ' ' ASN . 5.7 t-20 -92.83 14.12 18.32 Favored 'General case' 0 N--CA 1.498 1.972 0 C-N-CA 119.698 -0.801 . . . . 0.0 111.63 -178.889 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 133' ' ' LEU . . . . . 0.774 HD13 ' HB3' ' A' ' 136' ' ' ALA . 0.2 OUTLIER -68.5 -26.98 65.73 Favored 'General case' 0 N--CA 1.496 1.875 0 O-C-N 120.582 -1.324 . . . . 0.0 109.429 -179.92 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 134' ' ' LYS . . . . . 0.68 ' H ' ' CD ' ' A' ' 134' ' ' LYS . 0.0 OUTLIER -46.14 -28.71 1.29 Allowed 'General case' 0 N--CA 1.495 1.817 0 O-C-N 121.401 -0.812 . . . . 0.0 110.937 -179.176 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 135' ' ' ALA . . . . . . . . . . . . . . . -83.37 -22.61 32.74 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 120.758 -1.214 . . . . 0.0 109.954 -179.189 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 136' ' ' ALA . . . . . 0.786 ' HB2' ' HB2' ' A' ' 81' ' ' ALA . . . -79.79 138.02 37.14 Favored 'General case' 0 C--N 1.3 -1.559 0 O-C-N 121.29 -0.881 . . . . 0.0 111.405 -178.897 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 137' ' ' LYS . . . . . 0.554 ' O ' ' O ' ' A' ' 138' ' ' LYS . 6.3 mttt -151.46 -170.26 3.6 Favored 'General case' 0 N--CA 1.494 1.77 0 C-N-CA 118.639 -1.225 . . . . 0.0 111.221 -178.231 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 138' ' ' LYS . . . . . 0.554 ' O ' ' O ' ' A' ' 137' ' ' LYS . 15.4 tttt -32.55 163.96 0.0 OUTLIER 'General case' 0 N--CA 1.492 1.653 0 CA-C-O 122.902 1.334 . . . . 0.0 112.342 -178.204 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 139' ' ' GLY . . . . . . . . . . . . . . . 49.68 8.73 0.14 Allowed Glycine 0 N--CA 1.491 2.317 0 N-CA-C 110.146 -1.182 . . . . 0.0 110.146 179.78 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 140' ' ' SER . . . . . 0.491 ' N ' ' O ' ' A' ' 138' ' ' LYS . 2.0 m -69.33 130.01 41.39 Favored 'General case' 0 N--CA 1.495 1.812 0 O-C-N 120.803 -1.41 . . . . 0.0 109.194 179.539 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 141' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -83.78 123.17 29.6 Favored 'General case' 0 N--CA 1.489 1.498 0 O-C-N 121.224 -0.923 . . . . 0.0 109.214 179.743 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 142' ' ' VAL . . . . . . . . . . . . . 2.4 t -112.99 132.12 62.7 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.576 0 N-CA-C 108.069 -1.086 . . . . 0.0 108.069 179.75 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 143' ' ' TYR . . . . . . . . . . . . . 5.3 m-85 -108.65 134.24 51.65 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.025 -1.047 . . . . 0.0 110.897 -178.42 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 144' ' ' PHE . . . . . . . . . . . . . 44.8 t80 -120.13 102.62 8.64 Favored 'General case' 0 N--CA 1.489 1.524 0 N-CA-C 109.056 -0.72 . . . . 0.0 109.056 179.633 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 145' ' ' LYS . . . . . . . . . . . . . 25.2 tttm -100.21 129.99 46.29 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.319 -0.863 . . . . 0.0 110.868 -179.008 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 146' ' ' VAL . . . . . 0.645 HG21 HD11 ' A' ' 110' ' ' LEU . 6.8 p -142.43 146.51 22.2 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.566 0 N-CA-C 107.805 -1.183 . . . . 0.0 107.805 178.415 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 147' ' ' GLY . . . . . 0.441 ' C ' ' O ' ' A' ' 146' ' ' VAL . . . 42.61 -124.08 3.84 Favored Glycine 0 N--CA 1.491 2.355 0 N-CA-C 109.336 -1.506 . . . . 0.0 109.336 -179.795 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 148' ' ' ASN . . . . . 0.513 ' C ' ' ND2' ' A' ' 148' ' ' ASN . 0.4 OUTLIER -108.36 15.62 23.84 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.483 -1.01 . . . . 0.0 109.041 179.393 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 149' ' ' GLU . . . . . . . . . . . . . 8.7 tt0 -112.28 144.02 42.4 Favored 'General case' 0 N--CA 1.489 1.479 0 O-C-N 121.388 -0.82 . . . . 0.0 111.444 -178.288 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 150' ' ' THR . . . . . . . . . . . . . 29.9 m -127.25 104.12 7.78 Favored 'General case' 0 N--CA 1.49 1.541 0 CA-C-O 121.373 0.606 . . . . 0.0 109.6 179.561 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 151' ' ' ARG . . . . . . . . . . . . . 15.4 mtp180 -88.17 -173.1 4.08 Favored 'General case' 0 C--N 1.301 -1.513 0 N-CA-C 107.748 -1.204 . . . . 0.0 107.748 179.357 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 152' ' ' LYS . . . . . 0.491 ' O ' ' N ' ' A' ' 205' ' ' VAL . 15.4 mtmm -149.15 150.74 33.17 Favored 'General case' 0 C--N 1.298 -1.67 0 O-C-N 120.811 -1.181 . . . . 0.0 109.728 -179.678 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 153' ' ' TYR . . . . . 0.527 ' CD2' ' HA ' ' A' ' 204' ' ' GLU . 27.6 m-85 -142.97 164.47 29.99 Favored 'General case' 0 C--N 1.297 -1.697 0 N-CA-C 107.695 -1.224 . . . . 0.0 107.695 178.69 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 154' ' ' LYS . . . . . 0.525 ' HB2' HG21 ' A' ' 205' ' ' VAL . 26.2 ttpp -140.31 118.01 11.64 Favored 'General case' 0 C--N 1.296 -1.745 0 N-CA-C 108.308 -0.997 . . . . 0.0 108.308 179.499 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 155' ' ' MET . . . . . . . . . . . . . 36.8 mtp -44.95 109.09 0.14 Allowed 'General case' 0 N--CA 1.497 1.895 0 O-C-N 120.507 -1.371 . . . . 0.0 111.344 -178.307 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 156' ' ' THR . . . . . 0.677 ' OG1' HG23 ' A' ' 203' ' ' THR . 0.2 OUTLIER -107.59 -26.79 10.72 Favored 'General case' 0 C--N 1.298 -1.645 0 CA-C-N 115.452 -0.794 . . . . 0.0 110.893 -178.858 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 157' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -154.03 153.33 31.75 Favored 'General case' 0 N--CA 1.5 2.044 0 C-N-CA 118.171 -1.411 . . . . 0.0 111.903 -178.334 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 158' ' ' ILE . . . . . 0.867 HD12 ' CD1' ' A' ' 200' ' ' PHE . 0.2 OUTLIER -154.49 146.91 13.61 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.425 0 CA-C-O 122.068 0.937 . . . . 0.0 111.383 -178.946 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 159' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -153.35 158.48 41.6 Favored 'General case' 0 C--N 1.299 -1.612 0 CA-C-O 121.707 0.765 . . . . 0.0 109.86 179.834 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 160' ' ' ASP . . . . . 0.478 ' O ' HG13 ' A' ' 161' ' ' VAL . 7.9 m-20 -116.52 156.46 26.87 Favored 'General case' 0 N--CA 1.491 1.597 0 N-CA-C 108.081 -1.081 . . . . 0.0 108.081 179.254 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 161' ' ' VAL . . . . . 0.486 ' O ' ' O ' ' A' ' 162' ' ' LYS . 14.8 m -155.35 154.25 6.93 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.921 0 O-C-N 120.841 -1.162 . . . . 0.0 111.357 -178.507 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 162' ' ' LYS . . . . . 0.486 ' O ' ' O ' ' A' ' 161' ' ' VAL . 0.0 OUTLIER -43.25 170.46 0.04 OUTLIER Pre-proline 0 N--CA 1.495 1.799 0 O-C-N 121.555 -0.716 . . . . 0.0 109.986 179.651 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 163' ' ' PRO . . . . . . . . . . . . . 65.2 Cg_endo -79.56 30.9 0.47 Allowed 'Trans proline' 0 N--CA 1.492 1.408 0 C-N-CA 122.904 2.403 . . . . 0.0 113.071 179.82 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 164' ' ' THR . . . . . 0.586 ' HA ' HD11 ' C' ' 702' ' ' LEU . 0.2 OUTLIER -151.02 0.31 0.39 Allowed 'General case' 0 N--CA 1.495 1.789 0 O-C-N 121.064 -1.022 . . . . 0.0 110.11 -179.968 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 165' ' ' ASP . . . . . 0.438 ' O ' ' C ' ' A' ' 166' ' ' VAL . 13.0 t70 -75.46 63.9 1.53 Allowed 'General case' 0 N--CA 1.489 1.491 0 O-C-N 121.251 -0.906 . . . . 0.0 110.362 -179.749 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 166' ' ' VAL . . . . . 0.685 ' O ' ' N ' ' A' ' 168' ' ' VAL . 1.0 OUTLIER -39.73 -31.12 0.15 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.517 0 O-C-N 121.14 -0.975 . . . . 0.0 109.79 -178.668 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 167' ' ' GLY . . . . . 0.428 ' N ' ' O ' ' A' ' 165' ' ' ASP . . . -41.48 -12.01 0.01 OUTLIER Glycine 0 N--CA 1.496 2.652 0 N-CA-C 110.288 -1.125 . . . . 0.0 110.288 -179.94 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 168' ' ' VAL . . . . . 0.685 ' N ' ' O ' ' A' ' 166' ' ' VAL . 3.5 t -49.03 -42.52 14.56 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.432 0 O-C-N 121.121 -1.223 . . . . 0.0 108.841 179.235 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 169' ' ' LEU . . . . . 0.551 ' O ' ' C ' ' A' ' 170' ' ' ASP . 10.8 mt -46.84 -14.71 0.03 OUTLIER 'General case' 0 N--CA 1.491 1.601 0 N-CA-C 108.444 -0.947 . . . . 0.0 108.444 -178.274 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 170' ' ' ASP . . . . . 0.555 ' N ' ' O ' ' A' ' 168' ' ' VAL . 32.7 p30 17.78 91.26 0.01 OUTLIER 'General case' 0 N--CA 1.505 2.319 0 N-CA-C 111.927 0.343 . . . . 0.0 111.927 177.206 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 171' ' ' GLU . . . . . . . . . . . . . 3.0 pt-20 -141.48 78.79 1.65 Allowed 'General case' 0 N--CA 1.494 1.733 0 O-C-N 120.732 -1.23 . . . . 0.0 110.272 179.965 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 172' ' ' GLN . . . . . . . . . . . . . 8.4 mm100 -130.13 -47.51 1.11 Allowed 'General case' 0 N--CA 1.499 2.002 0 O-C-N 121.282 -0.886 . . . . 0.0 110.967 -178.788 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 173' ' ' LYS . . . . . 0.561 ' O ' ' NE2' ' A' ' 113' ' ' GLN . 0.0 OUTLIER -60.48 137.85 58.1 Favored 'General case' 0 N--CA 1.498 1.967 0 O-C-N 120.894 -1.129 . . . . 0.0 109.064 -179.894 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 174' ' ' GLY . . . . . 0.533 ' O ' ' C ' ' A' ' 175' ' ' LYS . . . -122.93 -44.09 0.34 Allowed Glycine 0 N--CA 1.481 1.648 0 N-CA-C 108.093 -2.003 . . . . 0.0 108.093 179.547 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 175' ' ' LYS . . . . . 0.533 ' C ' ' O ' ' A' ' 174' ' ' GLY . 3.0 mmtt -40.48 -63.87 0.58 Allowed 'General case' 0 N--CA 1.491 1.59 0 N-CA-C 107.072 -1.455 . . . . 0.0 107.072 178.725 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 176' ' ' ASP . . . . . 0.589 ' O ' ' O ' ' A' ' 177' ' ' LYS . 1.2 p-10 -104.7 88.18 2.86 Favored 'General case' 0 C--N 1.299 -1.614 0 N-CA-C 108.207 -1.035 . . . . 0.0 108.207 177.428 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 177' ' ' LYS . . . . . 0.589 ' O ' ' O ' ' A' ' 176' ' ' ASP . 23.6 mttm -47.32 -174.19 0.0 OUTLIER 'General case' 0 N--CA 1.499 1.978 0 N-CA-C 108.793 -0.817 . . . . 0.0 108.793 179.936 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 178' ' ' GLN . . . . . 0.55 HE22 ' HG1' ' A' ' 180' ' ' THR . 0.0 OUTLIER -162.59 167.28 23.53 Favored 'General case' 0 C--N 1.303 -1.419 0 O-C-N 120.267 -1.521 . . . . 0.0 110.862 179.626 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 179' ' ' LEU . . . . . 0.419 ' HB2' ' CD2' ' A' ' 153' ' ' TYR . 0.9 OUTLIER -119.03 98.03 5.98 Favored 'General case' 0 C--N 1.304 -1.408 0 N-CA-C 107.028 -1.471 . . . . 0.0 107.028 177.976 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 180' ' ' THR . . . . . 0.55 ' HG1' HE22 ' A' ' 178' ' ' GLN . 1.3 m -76.98 116.13 17.38 Favored 'General case' 0 C--N 1.302 -1.488 0 O-C-N 121.411 -0.806 . . . . 0.0 110.205 -178.449 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 181' ' ' LEU . . . . . 0.525 HD23 ' CD2' ' A' ' 200' ' ' PHE . 54.4 tp -93.78 152.08 19.17 Favored 'General case' 0 C--N 1.301 -1.537 0 N-CA-C 107.774 -1.195 . . . . 0.0 107.774 177.715 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 182' ' ' ILE . . . . . . . . . . . . . 85.4 mt -141.07 117.88 7.81 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.713 0 O-C-N 121.009 -1.057 . . . . 0.0 108.687 179.247 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 183' ' ' THR . . . . . 0.604 ' O ' HG23 ' A' ' 183' ' ' THR . 10.1 t -131.12 111.44 11.98 Favored 'General case' 0 C--N 1.292 -1.908 0 N-CA-C 108.039 -1.097 . . . . 0.0 108.039 179.485 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 184' ' ' CYS . . . . . . . . . . . . . 0.8 OUTLIER -78.46 153.06 31.76 Favored 'General case' 0 C--N 1.289 -2.044 0 C-N-CA 118.882 -1.127 . . . . 0.0 110.583 -177.977 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 185' ' ' ASP . . . . . . . . . . . . . 2.5 t0 -166.1 -159.13 0.37 Allowed 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.616 -0.677 . . . . 0.0 109.504 -179.447 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 186' ' ' ASP . . . . . . . . . . . . . 1.2 m-20 55.79 52.78 10.28 Favored 'General case' 0 N--CA 1.493 1.717 0 O-C-N 121.233 -0.917 . . . . 0.0 109.453 179.977 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 187' ' ' TYR . . . . . 0.628 ' CE2' ' O ' ' A' ' 188' ' ' ASN . 64.5 t80 -67.96 134.18 50.32 Favored 'General case' 0 C--N 1.3 -1.551 0 O-C-N 121.063 -1.023 . . . . 0.0 110.949 -179.508 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 188' ' ' ASN . . . . . 0.628 ' O ' ' CE2' ' A' ' 187' ' ' TYR . 0.7 OUTLIER -101.46 146.46 27.59 Favored 'General case' 0 C--N 1.295 -1.766 0 N-CA-C 108.091 -1.077 . . . . 0.0 108.091 178.201 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 189' ' ' GLU . . . . . . . . . . . . . 3.1 tt0 -109.65 -12.17 14.68 Favored 'General case' 0 C--N 1.292 -1.923 0 N-CA-C 108.458 -0.942 . . . . 0.0 108.458 -179.793 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 190' ' ' LYS . . . . . . . . . . . . . 11.7 mtpt -85.75 -55.03 4.17 Favored 'General case' 0 C--N 1.302 -1.469 0 N-CA-C 109.079 -0.712 . . . . 0.0 109.079 178.908 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 191' ' ' THR . . . . . . . . . . . . . 1.2 p -89.55 1.59 55.74 Favored 'General case' 0 N--CA 1.494 1.729 0 O-C-N 121.236 -0.915 . . . . 0.0 110.073 -179.754 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 192' ' ' GLY . . . . . . . . . . . . . . . 52.78 40.89 57.27 Favored Glycine 0 N--CA 1.496 2.644 0 O-C-N 120.97 -1.081 . . . . 0.0 110.969 179.169 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 193' ' ' VAL . . . . . 0.537 HG12 ' N ' ' A' ' 194' ' ' TRP . 52.9 t -149.65 160.5 5.01 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.653 0 O-C-N 120.858 -1.377 . . . . 0.0 109.356 178.999 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 194' ' ' TRP . . . . . 0.537 ' N ' HG12 ' A' ' 193' ' ' VAL . 12.7 m95 -82.94 118.98 23.86 Favored 'General case' 0 N--CA 1.491 1.586 0 N-CA-C 107.989 -1.115 . . . . 0.0 107.989 179.308 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 195' ' ' GLU . . . . . . . . . . . . . 2.1 mt-10 -75.88 -60.46 2.31 Favored 'General case' 0 N--CA 1.494 1.769 0 O-C-N 121.336 -0.853 . . . . 0.0 111.538 -177.745 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 196' ' ' LYS . . . . . . . . . . . . . 16.8 mmtp -92.01 153.18 19.6 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 120.901 -1.124 . . . . 0.0 111.262 -178.047 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 197' ' ' ARG . . . . . 0.47 ' NE ' HD22 ' C' ' 702' ' ' LEU . 21.5 mmm180 -119.17 138.97 52.58 Favored 'General case' 0 N--CA 1.488 1.471 0 N-CA-C 107.825 -1.176 . . . . 0.0 107.825 178.659 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 198' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -116.77 116.68 27.95 Favored 'General case' 0 C--N 1.301 -1.519 0 O-C-N 121.61 -0.681 . . . . 0.0 110.192 -178.715 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 199' ' ' ILE . . . . . 0.632 ' C ' HD12 ' A' ' 199' ' ' ILE . 0.6 OUTLIER -141.18 122.26 13.4 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.685 0 CA-C-O 122.338 1.066 . . . . 0.0 109.842 179.456 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 200' ' ' PHE . . . . . 0.867 ' CD1' HD12 ' A' ' 158' ' ' ILE . 0.2 OUTLIER -106.33 142.1 36.56 Favored 'General case' 0 N--CA 1.494 1.769 0 O-C-N 121.438 -0.789 . . . . 0.0 110.318 -178.55 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 201' ' ' VAL . . . . . . . . . . . . . 47.6 t -104.45 150.11 7.66 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.532 0 N-CA-C 108.476 -0.935 . . . . 0.0 108.476 178.555 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 202' ' ' ALA . . . . . . . . . . . . . . . -131.37 139.38 49.47 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.246 -0.909 . . . . 0.0 109.035 -179.802 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 203' ' ' THR . . . . . 0.677 HG23 ' OG1' ' A' ' 156' ' ' THR . 25.1 p -88.86 127.46 35.63 Favored 'General case' 0 C--N 1.303 -1.452 0 CA-C-O 122.354 1.073 . . . . 0.0 110.917 -178.57 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 204' ' ' GLU . . . . . 0.527 ' HA ' ' CD2' ' A' ' 153' ' ' TYR . 1.7 tt0 -48.75 134.35 16.34 Favored 'General case' 0 C--N 1.297 -1.713 0 C-N-CA 118.873 -1.131 . . . . 0.0 109.248 179.83 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 205' ' ' VAL . . . . . 0.603 HG23 ' O ' ' A' ' 203' ' ' THR . 72.7 t -126.54 163.6 28.44 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.361 0 CA-C-O 122.141 0.972 . . . . 0.0 110.039 -177.674 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 206' ' ' LYS . . . . . 0.558 ' N ' HG12 ' A' ' 205' ' ' VAL . 0.2 OUTLIER . . . . . 0 C--N 1.291 -1.949 0 CA-C-O 118.024 -0.989 . . . . 0.0 109.45 -179.981 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' C' C ' 702' ' ' LEU . . . . . 0.852 ' N ' HD12 ' C' ' 702' ' ' LEU . 0.0 OUTLIER . . . . . 0 N--CA 1.489 1.511 0 N-CA-C 109.303 -0.628 . . . . 0.0 109.303 . . . . . . . . . 2 2 . 1 . 017 nuclear build core ' C' C ' 703' ' ' PRO . . . . . 0.551 ' HB2' ' HB3' ' A' ' 92' ' ' ALA . 96.9 Cg_endo -79.79 -174.44 2.27 Favored 'Trans proline' 0 N--CA 1.495 1.612 0 C-N-CA 122.94 2.427 . . . . 0.0 113.524 -179.418 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' C' C ' 704' ' ' ALA . . . . . 0.495 ' O ' ' O ' ' C' ' 703' ' ' PRO . . . . . . . . 0 N--CA 1.491 1.579 0 CA-C-O 121.744 0.783 . . . . 0.0 110.544 179.076 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 63' ' ' PRO . . . . . 0.629 ' O ' HD13 ' A' ' 110' ' ' LEU . 5.3 Cg_exo . . . . . 0 N--CA 1.487 1.146 0 CA-C-O 121.416 0.507 . . . . 0.0 112.269 . . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 64' ' ' GLN . . . . . 0.518 ' N ' ' OE1' ' A' ' 64' ' ' GLN . 0.0 OUTLIER -150.34 101.75 3.0 Favored 'General case' 0 N--CA 1.494 1.732 0 O-C-N 121.205 -0.935 . . . . 0.0 109.618 -179.891 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 65' ' ' ILE . . . . . 0.471 ' C ' ' O ' ' A' ' 64' ' ' GLN . 2.8 mp -39.79 100.83 0.22 Allowed Pre-proline 0 N--CA 1.491 1.603 0 N-CA-C 108.557 -0.905 . . . . 0.0 108.557 179.523 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 66' ' ' PRO . . . . . 0.423 ' N ' ' O ' ' A' ' 64' ' ' GLN . 71.8 Cg_endo -83.87 -155.32 0.06 OUTLIER 'Trans proline' 0 C--N 1.317 -1.118 0 C-N-CA 122.286 1.991 . . . . 0.0 112.679 -178.311 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 67' ' ' LYS . . . . . 0.404 ' O ' ' N ' ' A' ' 69' ' ' LYS . 8.5 ptmt -83.93 -4.94 59.08 Favored 'General case' 0 C--N 1.304 -1.371 0 O-C-N 121.391 -0.818 . . . . 0.0 109.388 -179.825 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 68' ' ' ASP . . . . . 0.588 ' C ' ' N ' ' A' ' 70' ' ' SER . 0.1 OUTLIER -73.82 51.47 0.38 Allowed 'General case' 0 N--CA 1.491 1.58 0 CA-C-O 122.566 1.174 . . . . 0.0 108.326 179.52 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 69' ' ' LYS . . . . . 0.598 ' O ' ' NH1' ' A' ' 99' ' ' ARG . 12.0 mtmm -49.49 -16.11 0.19 Allowed 'General case' 0 N--CA 1.497 1.888 0 C-N-CA 116.949 -1.9 . . . . 0.0 107.152 178.857 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 70' ' ' SER . . . . . 0.588 ' N ' ' C ' ' A' ' 68' ' ' ASP . 1.2 t -83.94 -7.16 59.49 Favored 'General case' 0 C--N 1.293 -1.89 0 CA-C-N 113.995 -1.457 . . . . 0.0 110.22 179.976 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 71' ' ' LYS . . . . . 0.413 ' CD ' ' HB2' ' A' ' 68' ' ' ASP . 1.0 OUTLIER -96.84 141.41 30.07 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.126 -0.984 . . . . 0.0 110.826 179.825 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 72' ' ' VAL . . . . . 0.825 HG12 ' CE1' ' A' ' 88' ' ' TYR . 2.3 m -65.01 139.62 21.1 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.522 0 N-CA-C 103.988 -2.597 . . . . 0.0 103.988 174.361 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 73' ' ' ALA . . . . . 0.511 ' N ' ' O ' ' A' ' 87' ' ' VAL . . . -81.21 -14.18 57.8 Favored 'General case' 0 C--N 1.292 -1.917 0 C-N-CA 117.11 -1.836 . . . . 0.0 106.203 179.799 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . 169.07 -152.04 19.12 Favored Glycine 0 N--CA 1.481 1.677 0 N-CA-C 109.873 -1.291 . . . . 0.0 109.873 178.868 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 75' ' ' TYR . . . . . 0.468 ' CD2' ' O ' ' A' ' 85' ' ' GLU . 2.3 m-85 -142.59 173.25 11.7 Favored 'General case' 0 C--N 1.298 -1.639 0 CA-C-O 122.085 0.945 . . . . 0.0 110.545 -178.118 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 76' ' ' ILE . . . . . . . . . . . . . 1.6 tp -147.9 141.88 19.3 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.682 0 C-N-CA 119.93 -0.708 . . . . 0.0 109.142 -176.954 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 77' ' ' GLU . . . . . 0.563 ' N ' ' OE1' ' A' ' 77' ' ' GLU . 0.0 OUTLIER -149.96 163.07 39.08 Favored 'General case' 0 C--N 1.304 -1.39 0 O-C-N 121.014 -1.054 . . . . 0.0 109.244 178.913 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 78' ' ' ILE . . . . . 0.694 ' HB ' ' HB3' ' A' ' 81' ' ' ALA . 7.9 mt -144.35 100.57 4.82 Favored Pre-proline 0 C--N 1.302 -1.496 0 O-C-N 121.338 -0.851 . . . . 0.0 109.022 179.991 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 79' ' ' PRO . . . . . . . . . . . . . 81.9 Cg_exo -48.25 -50.55 11.84 Favored 'Trans proline' 0 N--CA 1.493 1.469 0 C-N-CA 122.794 2.329 . . . . 0.0 113.632 -179.453 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -65.94 -18.93 65.67 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 120.889 -1.132 . . . . 0.0 111.098 178.906 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 81' ' ' ALA . . . . . 0.813 ' HB2' ' HB2' ' A' ' 136' ' ' ALA . . . -105.32 -16.93 14.62 Favored 'General case' 0 N--CA 1.494 1.734 0 O-C-N 121.069 -1.019 . . . . 0.0 108.81 179.521 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 82' ' ' ASP . . . . . 0.495 ' N ' ' O ' ' A' ' 78' ' ' ILE . 9.1 t0 65.81 50.47 1.54 Allowed 'General case' 0 N--CA 1.493 1.704 0 O-C-N 121.372 -0.83 . . . . 0.0 111.368 178.157 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 83' ' ' ILE . . . . . . . . . . . . . 45.2 mt -130.66 153.94 39.86 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.92 0 O-C-N 121.14 -0.975 . . . . 0.0 109.668 -179.273 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 84' ' ' LYS . . . . . . . . . . . . . 30.8 ttmt -158.01 110.25 2.33 Favored 'General case' 0 N--CA 1.497 1.88 0 N-CA-C 108.184 -1.043 . . . . 0.0 108.184 179.991 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 85' ' ' GLU . . . . . 0.497 ' OE1' ' O ' ' A' ' 129' ' ' GLN . 0.0 OUTLIER -141.33 167.2 17.92 Favored Pre-proline 0 N--CA 1.499 1.976 0 O-C-N 121.281 -0.887 . . . . 0.0 110.871 -178.45 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 86' ' ' PRO . . . . . 0.485 ' O ' HG22 ' A' ' 101' ' ' VAL . 55.8 Cg_endo -74.75 161.92 38.53 Favored 'Trans proline' 0 N--CA 1.497 1.722 0 C-N-CA 123.263 2.642 . . . . 0.0 113.108 -179.869 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 87' ' ' VAL . . . . . 0.511 ' O ' ' N ' ' A' ' 73' ' ' ALA . 55.7 t -123.32 99.79 7.09 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.844 0 O-C-N 121.686 -0.634 . . . . 0.0 109.337 179.582 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 88' ' ' TYR . . . . . 0.825 ' CE1' HG12 ' A' ' 72' ' ' VAL . 15.3 m-85 -89.99 155.1 47.56 Favored Pre-proline 0 N--CA 1.496 1.849 0 O-C-N 120.835 -1.166 . . . . 0.0 109.423 179.861 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 89' ' ' PRO . . . . . . . . . . . . . 11.8 Cg_endo -64.39 146.66 90.12 Favored 'Trans proline' 0 N--CA 1.496 1.642 0 C-N-CA 122.529 2.152 . . . . 0.0 113.952 -179.343 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . -59.04 167.59 7.06 Favored Glycine 0 N--CA 1.495 2.609 0 N-CA-C 110.382 -1.087 . . . . 0.0 110.382 179.663 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 91' ' ' PRO . . . . . 0.428 ' C ' ' H ' ' A' ' 93' ' ' THR . 90.2 Cg_endo -93.48 168.68 20.81 Favored 'Cis proline' 0 C--N 1.314 -1.237 0 C-N-CA 123.592 -1.42 . . . . 0.0 111.762 0.569 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 92' ' ' ALA . . . . . 0.543 ' HB1' HD21 ' A' ' 97' ' ' LEU . . . -72.03 33.04 0.06 Allowed 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.032 -1.042 . . . . 0.0 110.713 -179.9 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 93' ' ' THR . . . . . 0.428 ' H ' ' C ' ' A' ' 91' ' ' PRO . 3.3 p -71.18 150.39 94.54 Favored Pre-proline 0 N--CA 1.488 1.472 0 O-C-N 120.668 -1.27 . . . . 0.0 108.157 -179.865 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 94' ' ' PRO . . . . . 0.421 ' C ' ' O ' ' A' ' 93' ' ' THR . 87.3 Cg_exo -30.35 -56.26 0.19 Allowed 'Trans proline' 0 C--N 1.308 -1.6 0 C-N-CA 123.007 2.471 . . . . 0.0 112.672 -179.011 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 98.6 mt-10 -51.06 -46.32 61.67 Favored 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.12 -0.988 . . . . 0.0 109.825 -179.76 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 96' ' ' GLN . . . . . 0.422 ' OE1' ' CZ ' ' A' ' 99' ' ' ARG . 1.1 mp0 -71.92 -36.95 70.1 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.387 -0.821 . . . . 0.0 110.712 -179.375 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 97' ' ' LEU . . . . . 0.543 HD21 ' HB1' ' A' ' 92' ' ' ALA . 89.0 mt -68.4 -5.94 21.85 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 120.833 -1.167 . . . . 0.0 109.248 -179.682 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 98' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER -78.24 -27.05 47.53 Favored 'General case' 0 N--CA 1.492 1.673 0 O-C-N 121.319 -0.863 . . . . 0.0 109.893 179.42 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 99' ' ' ARG . . . . . 0.598 ' NH1' ' O ' ' A' ' 69' ' ' LYS . 63.8 mtt180 -91.07 -43.5 9.88 Favored 'General case' 0 N--CA 1.488 1.47 0 O-C-N 121.531 -0.731 . . . . 0.0 109.956 -178.524 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . 169.81 -171.7 43.43 Favored Glycine 0 N--CA 1.49 2.28 0 N-CA-C 109.898 -1.281 . . . . 0.0 109.898 -179.992 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 101' ' ' VAL . . . . . 0.742 HG23 ' O ' ' A' ' 101' ' ' VAL . 13.0 m -57.48 106.63 0.18 Allowed 'Isoleucine or valine' 0 N--CA 1.494 1.758 0 O-C-N 121.401 -1.058 . . . . 0.0 109.152 -179.915 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -92.52 163.31 13.86 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 120.87 -1.144 . . . . 0.0 111.184 -179.176 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 103' ' ' PHE . . . . . 0.484 ' CZ ' ' CG1' ' A' ' 87' ' ' VAL . 25.0 m-85 -70.46 141.85 52.0 Favored 'General case' 0 N--CA 1.489 1.501 0 N-CA-C 108.145 -1.057 . . . . 0.0 108.145 178.334 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 104' ' ' ALA . . . . . . . . . . . . . . . -58.73 -15.86 14.0 Favored 'General case' 0 C--N 1.3 -1.548 0 O-C-N 121.474 -0.766 . . . . 0.0 111.104 -178.828 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -139.07 144.24 38.68 Favored 'General case' 0 N--CA 1.492 1.65 0 O-C-N 120.906 -1.121 . . . . 0.0 110.082 -179.304 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 106' ' ' GLU . . . . . . . . . . . . . 6.3 tt0 -58.1 -55.43 35.04 Favored 'General case' 0 C--N 1.299 -1.618 0 O-C-N 121.892 -0.505 . . . . 0.0 110.599 -179.363 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 107' ' ' ASN . . . . . . . . . . . . . 6.1 m-20 -77.85 35.15 0.2 Allowed 'General case' 0 N--CA 1.487 1.395 0 O-C-N 120.622 -1.299 . . . . 0.0 112.223 -176.152 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 108' ' ' GLU . . . . . . . . . . . . . 21.7 tp10 -57.81 139.82 53.15 Favored 'General case' 0 N--CA 1.488 1.457 0 N-CA-C 107.605 -1.257 . . . . 0.0 107.605 179.635 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 109' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -93.08 146.53 23.57 Favored 'General case' 0 C--N 1.302 -1.486 0 O-C-N 120.97 -1.081 . . . . 0.0 110.776 -178.08 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 110' ' ' LEU . . . . . 0.828 HD23 ' H ' ' A' ' 110' ' ' LEU . 0.3 OUTLIER -62.66 -24.5 67.65 Favored 'General case' 0 C--N 1.303 -1.424 0 N-CA-C 107.281 -1.377 . . . . 0.0 107.281 178.641 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 111' ' ' ASP . . . . . . . . . . . . . 4.0 m-20 -133.03 48.95 2.35 Favored 'General case' 0 N--CA 1.485 1.298 0 N-CA-C 109.396 -0.594 . . . . 0.0 109.396 179.663 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 112' ' ' ASP . . . . . . . . . . . . . 1.7 t0 -69.33 159.47 33.06 Favored 'General case' 0 N--CA 1.494 1.731 0 O-C-N 121.127 -0.983 . . . . 0.0 111.333 -179.608 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 113' ' ' GLN . . . . . 0.547 ' N ' ' CD ' ' A' ' 113' ' ' GLN . 0.0 OUTLIER -64.63 -17.98 64.52 Favored 'General case' 0 N--CA 1.491 1.607 0 N-CA-C 107.361 -1.348 . . . . 0.0 107.361 177.668 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 114' ' ' ASN . . . . . 0.532 ' ND2' ' OE1' ' A' ' 178' ' ' GLN . 59.9 t-20 -153.55 111.81 3.62 Favored 'General case' 0 C--N 1.298 -1.662 0 N-CA-C 107.803 -1.184 . . . . 0.0 107.803 177.631 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 115' ' ' ILE . . . . . 0.505 HG22 ' O ' ' A' ' 115' ' ' ILE . 2.8 mt -93.6 102.8 14.01 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.557 0 O-C-N 120.988 -1.07 . . . . 0.0 108.128 -179.935 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 116' ' ' SER . . . . . . . . . . . . . 72.3 m -81.76 141.31 33.64 Favored 'General case' 0 N--CA 1.488 1.453 0 CA-C-O 122.088 0.947 . . . . 0.0 112.114 -177.001 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 117' ' ' ILE . . . . . . . . . . . . . 28.2 mt -138.05 140.85 39.78 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.474 0 N-CA-C 107.357 -1.349 . . . . 0.0 107.357 178.609 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 118' ' ' ALA . . . . . . . . . . . . . . . -141.98 155.58 45.45 Favored 'General case' 0 N--CA 1.489 1.492 0 C-N-CA 118.63 -1.228 . . . . 0.0 111.043 -178.967 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 119' ' ' GLY . . . . . . . . . . . . . . . -166.8 152.55 21.55 Favored Glycine 0 N--CA 1.483 1.813 0 N-CA-C 109.967 -1.253 . . . . 0.0 109.967 179.769 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 120' ' ' HIS . . . . . . . . . . . . . 26.4 m170 -71.73 142.1 49.78 Favored 'General case' 0 N--CA 1.493 1.71 0 O-C-N 121.604 -0.939 . . . . 0.0 110.592 179.864 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 121' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -99.06 153.36 18.94 Favored 'General case' 0 N--CA 1.496 1.835 0 N-CA-C 107.896 -1.15 . . . . 0.0 107.896 178.419 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 122' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -116.85 140.69 49.15 Favored 'General case' 0 N--CA 1.496 1.869 0 O-C-N 121.139 -0.976 . . . . 0.0 110.603 -179.676 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 123' ' ' ILE . . . . . 0.505 HG23 ' N ' ' A' ' 124' ' ' ASP . 15.7 tt -90.28 -33.13 5.76 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.641 0 CA-C-O 121.876 0.846 . . . . 0.0 109.083 179.619 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 124' ' ' ASP . . . . . 0.505 ' N ' HG23 ' A' ' 123' ' ' ILE . 80.0 m-20 -89.78 3.08 53.95 Favored 'General case' 0 N--CA 1.497 1.888 0 CA-C-N 116.069 -0.514 . . . . 0.0 111.772 -178.706 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 125' ' ' ARG . . . . . 0.665 HH11 ' CG ' ' A' ' 125' ' ' ARG . 1.7 mtt-85 -151.3 120.7 3.53 Favored Pre-proline 0 N--CA 1.499 1.995 0 O-C-N 120.383 -1.448 . . . . 0.0 110.114 -179.193 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 126' ' ' PRO . . . . . . . . . . . . . 88.9 Cg_endo -81.48 -18.99 7.95 Favored 'Trans proline' 0 N--CA 1.489 1.257 0 C-N-CA 122.279 1.986 . . . . 0.0 112.396 179.199 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 127' ' ' ASN . . . . . 0.514 ' O ' ' O ' ' A' ' 128' ' ' TYR . 56.9 m-20 -92.65 4.35 53.84 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.274 -0.891 . . . . 0.0 110.109 -179.759 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 128' ' ' TYR . . . . . 0.514 ' O ' ' O ' ' A' ' 127' ' ' ASN . 9.1 t80 -58.7 -147.25 0.0 OUTLIER 'General case' 0 N--CA 1.488 1.447 0 O-C-N 121.283 -0.886 . . . . 0.0 109.337 179.995 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 129' ' ' GLN . . . . . 0.497 ' O ' ' OE1' ' A' ' 85' ' ' GLU . 12.7 mt-30 -64.96 -91.23 0.01 OUTLIER 'General case' 0 N--CA 1.493 1.724 0 O-C-N 120.833 -1.167 . . . . 0.0 110.284 -178.941 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 130' ' ' PHE . . . . . 0.711 ' CE2' HG11 ' A' ' 101' ' ' VAL . 44.2 m-85 -114.28 48.0 1.15 Allowed 'General case' 0 N--CA 1.496 1.835 0 O-C-N 121.159 -0.963 . . . . 0.0 109.355 179.851 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 131' ' ' THR . . . . . 0.526 ' O ' ' CD ' ' A' ' 134' ' ' LYS . 56.9 m -77.83 -26.54 49.51 Favored 'General case' 0 C--N 1.3 -1.558 0 O-C-N 121.213 -0.93 . . . . 0.0 109.563 -179.998 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 132' ' ' ASN . . . . . . . . . . . . . 28.8 t-20 -90.23 13.36 15.46 Favored 'General case' 0 N--CA 1.5 2.042 0 C-N-CA 119.759 -0.776 . . . . 0.0 111.932 -178.855 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 133' ' ' LEU . . . . . 0.993 HD13 ' HB3' ' A' ' 136' ' ' ALA . 0.2 OUTLIER -67.97 -29.81 68.94 Favored 'General case' 0 N--CA 1.495 1.779 0 O-C-N 120.399 -1.438 . . . . 0.0 109.594 -179.749 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 134' ' ' LYS . . . . . 0.746 ' H ' ' CD ' ' A' ' 134' ' ' LYS . 0.0 OUTLIER -44.09 -29.96 0.69 Allowed 'General case' 0 N--CA 1.496 1.862 0 O-C-N 121.43 -0.794 . . . . 0.0 110.455 -179.432 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 135' ' ' ALA . . . . . . . . . . . . . . . -84.76 -21.39 30.03 Favored 'General case' 0 N--CA 1.488 1.466 0 O-C-N 121.045 -1.034 . . . . 0.0 109.937 -179.621 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 136' ' ' ALA . . . . . 0.993 ' HB3' HD13 ' A' ' 133' ' ' LEU . . . -81.74 137.69 35.31 Favored 'General case' 0 C--N 1.301 -1.526 0 CA-C-O 122.039 0.924 . . . . 0.0 111.957 -178.336 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 137' ' ' LYS . . . . . 0.512 ' O ' ' OG ' ' A' ' 140' ' ' SER . 3.9 tttt -156.59 -166.0 2.02 Favored 'General case' 0 C--N 1.299 -1.604 0 C-N-CA 118.824 -1.15 . . . . 0.0 110.857 -179.349 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 138' ' ' LYS . . . . . 0.622 ' O ' ' N ' ' A' ' 140' ' ' SER . 29.0 mttt -46.61 -178.36 0.0 OUTLIER 'General case' 0 C--N 1.3 -1.549 0 CA-C-O 121.873 0.844 . . . . 0.0 110.107 -179.916 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 139' ' ' GLY . . . . . . . . . . . . . . . 44.95 8.41 0.01 OUTLIER Glycine 0 N--CA 1.489 2.198 0 N-CA-C 110.641 -0.984 . . . . 0.0 110.641 179.56 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 140' ' ' SER . . . . . 0.622 ' N ' ' O ' ' A' ' 138' ' ' LYS . 45.8 m -94.55 128.49 41.2 Favored 'General case' 0 N--CA 1.489 1.503 0 O-C-N 120.723 -1.457 . . . . 0.0 109.247 179.47 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 141' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -81.66 127.54 33.01 Favored 'General case' 0 C--N 1.3 -1.545 0 O-C-N 121.288 -0.883 . . . . 0.0 108.792 179.809 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 142' ' ' VAL . . . . . 0.481 HG22 HG23 ' A' ' 78' ' ' ILE . 12.8 t -113.72 135.13 54.33 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.553 0 N-CA-C 108.788 -0.819 . . . . 0.0 108.788 -179.529 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 143' ' ' TYR . . . . . 0.539 ' CE1' ' CG ' ' A' ' 152' ' ' LYS . 9.5 m-85 -111.36 136.13 50.93 Favored 'General case' 0 N--CA 1.493 1.7 0 O-C-N 121.012 -1.055 . . . . 0.0 110.316 -178.886 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 144' ' ' PHE . . . . . 0.528 ' O ' HG23 ' A' ' 150' ' ' THR . 44.6 t80 -113.37 160.1 18.75 Favored 'General case' 0 N--CA 1.493 1.696 0 CA-C-O 122.072 0.939 . . . . 0.0 110.806 -178.263 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 145' ' ' LYS . . . . . 0.463 ' N ' ' CG ' ' A' ' 144' ' ' PHE . 36.7 tttm -148.13 125.23 11.41 Favored 'General case' 0 C--N 1.301 -1.525 0 C-N-CA 119.25 -0.98 . . . . 0.0 110.761 -178.546 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 146' ' ' VAL . . . . . . . . . . . . . 11.8 p -145.82 138.94 20.95 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.63 0 N-CA-C 106.827 -1.545 . . . . 0.0 106.827 178.625 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 147' ' ' GLY . . . . . . . . . . . . . . . 58.67 -141.23 46.7 Favored Glycine 0 N--CA 1.486 1.985 0 N-CA-C 108.359 -1.896 . . . . 0.0 108.359 -179.273 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 148' ' ' ASN . . . . . . . . . . . . . 24.1 p30 -101.79 24.75 9.44 Favored 'General case' 0 C--N 1.296 -1.741 0 N-CA-C 107.821 -1.177 . . . . 0.0 107.821 178.821 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 149' ' ' GLU . . . . . . . . . . . . . 2.0 tm-20 -116.52 159.24 22.37 Favored 'General case' 0 N--CA 1.49 1.54 0 CA-C-O 121.796 0.808 . . . . 0.0 110.727 -179.086 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 150' ' ' THR . . . . . 0.528 HG23 ' O ' ' A' ' 144' ' ' PHE . 11.1 m -140.15 109.44 6.17 Favored 'General case' 0 N--CA 1.492 1.666 0 N-CA-C 109.029 -0.73 . . . . 0.0 109.029 179.212 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 151' ' ' ARG . . . . . . . . . . . . . 9.8 mtt180 -89.16 -161.01 0.72 Allowed 'General case' 0 N--CA 1.489 1.495 0 CA-C-O 121.546 0.688 . . . . 0.0 110.433 -178.586 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 152' ' ' LYS . . . . . 0.539 ' CG ' ' CE1' ' A' ' 143' ' ' TYR . 9.3 mtmt -148.26 148.78 30.85 Favored 'General case' 0 N--CA 1.486 1.359 0 O-C-N 121.394 -0.816 . . . . 0.0 110.326 -179.187 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 153' ' ' TYR . . . . . 0.449 ' HB3' ' HB1' ' A' ' 202' ' ' ALA . 52.8 m-85 -146.31 158.66 43.91 Favored 'General case' 0 C--N 1.303 -1.433 0 N-CA-C 108.111 -1.07 . . . . 0.0 108.111 179.277 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 154' ' ' LYS . . . . . . . . . . . . . 15.1 ttmm -137.1 121.5 18.21 Favored 'General case' 0 N--CA 1.495 1.824 0 O-C-N 121.186 -0.946 . . . . 0.0 108.538 179.053 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 155' ' ' MET . . . . . 0.467 ' HB3' HD11 ' A' ' 158' ' ' ILE . 5.7 mtt -47.96 107.79 0.14 Allowed 'General case' 0 N--CA 1.493 1.685 0 O-C-N 120.913 -1.117 . . . . 0.0 111.193 -178.588 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 156' ' ' THR . . . . . 0.679 ' OG1' HG23 ' A' ' 203' ' ' THR . 0.3 OUTLIER -108.02 -25.51 11.12 Favored 'General case' 0 C--N 1.293 -1.872 0 CA-C-N 115.3 -0.864 . . . . 0.0 109.635 -179.342 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 157' ' ' SER . . . . . 0.702 ' C ' HD12 ' A' ' 158' ' ' ILE . 60.7 m -149.87 146.3 27.03 Favored 'General case' 0 C--N 1.299 -1.626 0 C-N-CA 118.61 -1.236 . . . . 0.0 110.455 -179.048 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 158' ' ' ILE . . . . . 0.702 HD12 ' C ' ' A' ' 157' ' ' SER . 3.8 mp -151.48 141.73 15.71 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.445 0 CA-C-O 121.925 0.869 . . . . 0.0 109.988 -179.274 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 159' ' ' ARG . . . . . 0.496 HH21 HG13 ' A' ' 161' ' ' VAL . 3.0 ttp180 -155.09 -171.98 4.02 Favored 'General case' 0 C--N 1.292 -1.897 0 C-N-CA 119.67 -0.812 . . . . 0.0 110.394 -179.601 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 160' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -145.67 161.17 40.48 Favored 'General case' 0 C--N 1.301 -1.539 0 N-CA-C 108.0 -1.111 . . . . 0.0 108.0 -179.725 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 161' ' ' VAL . . . . . 0.496 HG13 HH21 ' A' ' 159' ' ' ARG . 0.0 OUTLIER -154.4 155.62 5.89 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.645 0 O-C-N 120.755 -1.216 . . . . 0.0 110.835 -179.091 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 162' ' ' LYS . . . . . 0.489 ' O ' ' O ' ' A' ' 161' ' ' VAL . 0.2 OUTLIER -51.47 179.47 0.04 OUTLIER Pre-proline 0 C--N 1.305 -1.33 0 N-CA-C 107.153 -1.425 . . . . 0.0 107.153 178.064 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 163' ' ' PRO . . . . . 0.453 ' C ' HD11 ' C' ' 702' ' ' LEU . 29.5 Cg_endo -87.69 45.79 1.2 Allowed 'Trans proline' 0 C--N 1.307 -1.631 0 C-N-CA 122.103 1.869 . . . . 0.0 111.748 -179.548 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 164' ' ' THR . . . . . . . . . . . . . 7.5 m -153.28 -16.41 0.15 Allowed 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.268 -0.895 . . . . 0.0 110.671 -179.626 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 165' ' ' ASP . . . . . 0.489 ' O ' ' N ' ' A' ' 167' ' ' GLY . 0.4 OUTLIER -72.36 58.94 0.41 Allowed 'General case' 0 N--CA 1.493 1.699 0 O-C-N 120.791 -1.193 . . . . 0.0 110.397 -179.063 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 166' ' ' VAL . . . . . 0.59 ' O ' ' N ' ' A' ' 168' ' ' VAL . 1.0 OUTLIER -40.64 -27.22 0.09 OUTLIER 'Isoleucine or valine' 0 N--CA 1.489 1.515 0 O-C-N 121.297 -0.877 . . . . 0.0 109.129 -178.797 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 167' ' ' GLY . . . . . 0.489 ' N ' ' O ' ' A' ' 165' ' ' ASP . . . -46.48 -4.64 0.01 OUTLIER Glycine 0 N--CA 1.496 2.658 0 O-C-N 120.799 -1.188 . . . . 0.0 112.006 -179.768 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 168' ' ' VAL . . . . . 0.59 ' N ' ' O ' ' A' ' 166' ' ' VAL . 0.2 OUTLIER -51.76 -36.33 18.82 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.894 0 O-C-N 120.131 -1.805 . . . . 0.0 108.69 179.866 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 169' ' ' LEU . . . . . 0.536 ' O ' ' C ' ' A' ' 170' ' ' ASP . 5.3 mt -52.69 -6.17 0.05 OUTLIER 'General case' 0 N--CA 1.492 1.653 0 N-CA-C 108.7 -0.852 . . . . 0.0 108.7 -177.469 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 170' ' ' ASP . . . . . 0.569 ' H ' ' C ' ' A' ' 168' ' ' VAL . 47.6 t0 18.22 58.87 0.01 OUTLIER 'General case' 0 N--CA 1.496 1.868 0 N-CA-C 112.419 0.525 . . . . 0.0 112.419 176.999 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 171' ' ' GLU . . . . . . . . . . . . . 11.4 pt-20 -94.87 62.13 2.62 Favored 'General case' 0 N--CA 1.499 2.017 0 O-C-N 120.34 -1.475 . . . . 0.0 109.896 179.924 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 172' ' ' GLN . . . . . . . . . . . . . 4.1 mt-30 -114.88 -63.63 1.43 Allowed 'General case' 0 N--CA 1.496 1.837 0 O-C-N 121.563 -0.71 . . . . 0.0 110.525 -178.711 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 173' ' ' LYS . . . . . 0.52 ' HD2' HE21 ' A' ' 178' ' ' GLN . 0.0 OUTLIER -60.18 127.58 32.54 Favored 'General case' 0 N--CA 1.496 1.831 0 O-C-N 121.216 -0.928 . . . . 0.0 109.751 -179.704 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 174' ' ' GLY . . . . . 0.49 ' O ' ' C ' ' A' ' 175' ' ' LYS . . . -117.1 -41.72 0.68 Allowed Glycine 0 N--CA 1.484 1.873 0 N-CA-C 108.824 -1.71 . . . . 0.0 108.824 179.682 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 175' ' ' LYS . . . . . 0.49 ' C ' ' O ' ' A' ' 174' ' ' GLY . 13.1 mptt -41.05 -59.78 1.38 Allowed 'General case' 0 N--CA 1.495 1.791 0 N-CA-C 107.804 -1.184 . . . . 0.0 107.804 179.573 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 176' ' ' ASP . . . . . 0.598 ' O ' ' O ' ' A' ' 177' ' ' LYS . 4.3 m-20 -103.22 83.04 2.14 Favored 'General case' 0 C--N 1.295 -1.791 0 N-CA-C 107.294 -1.373 . . . . 0.0 107.294 177.461 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 177' ' ' LYS . . . . . 0.598 ' O ' ' O ' ' A' ' 176' ' ' ASP . 2.6 mttt -43.59 -177.99 0.0 OUTLIER 'General case' 0 N--CA 1.494 1.73 0 O-C-N 121.425 -0.797 . . . . 0.0 109.464 -179.144 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 178' ' ' GLN . . . . . 0.532 ' OE1' ' ND2' ' A' ' 114' ' ' ASN . 0.0 OUTLIER -160.44 170.86 20.12 Favored 'General case' 0 C--N 1.302 -1.487 0 O-C-N 120.418 -1.426 . . . . 0.0 110.977 179.03 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 179' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -122.86 91.99 3.61 Favored 'General case' 0 C--N 1.302 -1.484 0 N-CA-C 107.446 -1.316 . . . . 0.0 107.446 178.493 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 180' ' ' THR . . . . . 0.444 ' OG1' ' ND2' ' A' ' 114' ' ' ASN . 1.3 m -71.74 118.32 14.44 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.172 -0.955 . . . . 0.0 110.457 -178.388 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 181' ' ' LEU . . . . . 0.506 HD11 ' CE2' ' A' ' 130' ' ' PHE . 41.1 tp -97.4 154.04 17.72 Favored 'General case' 0 C--N 1.3 -1.568 0 N-CA-C 107.458 -1.312 . . . . 0.0 107.458 177.57 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 182' ' ' ILE . . . . . 0.572 HG23 HG22 ' A' ' 199' ' ' ILE . 11.0 mt -145.77 121.31 3.33 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.554 0 O-C-N 120.613 -1.304 . . . . 0.0 110.489 179.496 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 183' ' ' THR . . . . . 0.569 ' O ' HG23 ' A' ' 183' ' ' THR . 5.2 t -134.44 116.8 15.57 Favored 'General case' 0 C--N 1.293 -1.865 0 N-CA-C 107.427 -1.323 . . . . 0.0 107.427 178.627 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 184' ' ' CYS . . . . . . . . . . . . . 5.1 p -78.57 157.15 28.85 Favored 'General case' 0 C--N 1.282 -2.337 0 C-N-CA 118.933 -1.107 . . . . 0.0 110.964 -177.687 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 185' ' ' ASP . . . . . . . . . . . . . 12.3 t0 -164.15 -157.47 0.39 Allowed 'General case' 0 N--CA 1.492 1.658 0 O-C-N 121.514 -0.742 . . . . 0.0 109.376 -179.613 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 186' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER 54.93 52.45 11.9 Favored 'General case' 0 N--CA 1.495 1.807 0 O-C-N 121.002 -1.061 . . . . 0.0 109.567 -179.7 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 187' ' ' TYR . . . . . 0.599 ' CE1' ' O ' ' A' ' 188' ' ' ASN . 63.4 t80 -67.69 134.36 50.96 Favored 'General case' 0 N--CA 1.493 1.675 0 O-C-N 121.122 -0.986 . . . . 0.0 110.582 -179.857 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 188' ' ' ASN . . . . . 0.599 ' O ' ' CE1' ' A' ' 187' ' ' TYR . 0.7 OUTLIER -101.52 145.66 28.71 Favored 'General case' 0 C--N 1.296 -1.749 0 N-CA-C 108.214 -1.032 . . . . 0.0 108.214 178.119 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 189' ' ' GLU . . . . . . . . . . . . . 2.0 tt0 -109.49 -14.31 14.42 Favored 'General case' 0 C--N 1.294 -1.81 0 N-CA-C 108.719 -0.845 . . . . 0.0 108.719 -179.557 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 190' ' ' LYS . . . . . . . . . . . . . 7.7 mttm -82.62 -54.47 5.14 Favored 'General case' 0 C--N 1.302 -1.489 0 N-CA-C 108.879 -0.785 . . . . 0.0 108.879 179.096 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 191' ' ' THR . . . . . 0.572 ' OG1' HG12 ' A' ' 193' ' ' VAL . 1.0 OUTLIER -88.48 -5.36 58.29 Favored 'General case' 0 C--N 1.301 -1.503 0 O-C-N 121.391 -0.818 . . . . 0.0 109.645 -179.756 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 192' ' ' GLY . . . . . . . . . . . . . . . 64.93 35.21 91.63 Favored Glycine 0 N--CA 1.496 2.697 0 O-C-N 120.992 -1.068 . . . . 0.0 111.928 177.988 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 193' ' ' VAL . . . . . 0.572 HG12 ' OG1' ' A' ' 191' ' ' THR . 3.4 p -149.27 167.87 2.98 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.681 0 O-C-N 120.692 -1.475 . . . . 0.0 110.383 179.178 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 194' ' ' TRP . . . . . 0.53 ' N ' ' CD1' ' A' ' 194' ' ' TRP . 10.1 m95 -84.83 120.86 26.92 Favored 'General case' 0 N--CA 1.493 1.704 0 N-CA-C 108.813 -0.81 . . . . 0.0 108.813 -179.933 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 195' ' ' GLU . . . . . 0.507 ' CD ' ' ND2' ' A' ' 188' ' ' ASN . 6.8 mt-10 -79.35 -61.64 1.94 Allowed 'General case' 0 N--CA 1.493 1.689 0 O-C-N 121.424 -0.798 . . . . 0.0 111.241 -178.29 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 196' ' ' LYS . . . . . . . . . . . . . 0.9 OUTLIER -101.64 151.14 22.37 Favored 'General case' 0 N--CA 1.494 1.73 0 O-C-N 120.906 -1.121 . . . . 0.0 110.262 -179.216 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 197' ' ' ARG . . . . . 0.883 ' HE ' HD13 ' C' ' 702' ' ' LEU . 1.4 mtt-85 -120.5 153.59 36.45 Favored 'General case' 0 N--CA 1.489 1.497 0 N-CA-C 108.432 -0.951 . . . . 0.0 108.432 178.34 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 198' ' ' LYS . . . . . . . . . . . . . 1.1 mptp? -114.97 123.14 48.33 Favored 'General case' 0 C--N 1.3 -1.585 0 O-C-N 121.645 -0.659 . . . . 0.0 110.581 -177.882 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 199' ' ' ILE . . . . . 0.63 ' C ' HD12 ' A' ' 199' ' ' ILE . 0.5 OUTLIER -136.79 118.49 19.11 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.757 0 CA-C-O 122.748 1.261 . . . . 0.0 110.655 179.693 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 200' ' ' PHE . . . . . 0.556 ' CD1' ' N ' ' A' ' 200' ' ' PHE . 0.2 OUTLIER -100.15 134.64 42.77 Favored 'General case' 0 N--CA 1.5 2.054 0 CA-C-N 115.604 -0.725 . . . . 0.0 110.481 -178.161 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 201' ' ' VAL . . . . . . . . . . . . . 52.9 t -103.48 141.34 19.45 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.992 0 O-C-N 120.721 -1.237 . . . . 0.0 108.554 177.922 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 202' ' ' ALA . . . . . 0.449 ' HB1' ' HB3' ' A' ' 153' ' ' TYR . . . -125.15 136.66 53.82 Favored 'General case' 0 N--CA 1.495 1.794 0 O-C-N 121.157 -0.964 . . . . 0.0 108.795 179.56 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 203' ' ' THR . . . . . 0.679 HG23 ' OG1' ' A' ' 156' ' ' THR . 1.2 p -88.98 134.66 33.9 Favored 'General case' 0 N--CA 1.49 1.529 0 CA-C-O 122.126 0.965 . . . . 0.0 111.383 -178.552 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 204' ' ' GLU . . . . . 0.418 ' HA ' ' CD2' ' A' ' 153' ' ' TYR . 2.6 tm-20 -62.53 135.07 57.23 Favored 'General case' 0 C--N 1.301 -1.541 0 C-N-CA 118.919 -1.113 . . . . 0.0 108.96 179.25 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 205' ' ' VAL . . . . . 0.54 ' O ' ' C ' ' A' ' 206' ' ' LYS . 71.5 t -123.9 -45.39 1.73 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.642 0 O-C-N 121.397 -0.814 . . . . 0.0 109.908 -178.91 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 206' ' ' LYS . . . . . 0.54 ' C ' ' O ' ' A' ' 205' ' ' VAL . 2.3 ttpt . . . . . 0 N--CA 1.496 1.838 0 CA-C-O 118.044 -0.979 . . . . 0.0 110.679 -179.655 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' C' C ' 702' ' ' LEU . . . . . 0.883 HD13 ' HE ' ' A' ' 197' ' ' ARG . 0.0 OUTLIER . . . . . 0 N--CA 1.491 1.584 0 N-CA-C 108.412 -0.959 . . . . 0.0 108.412 . . . . . . . . . 2 2 . 1 . 018 nuclear build core ' C' C ' 703' ' ' PRO . . . . . 0.492 ' O ' ' O ' ' C' ' 704' ' ' ALA . 97.2 Cg_endo -77.88 -162.48 0.17 Allowed 'Trans proline' 0 N--CA 1.494 1.55 0 C-N-CA 122.521 2.148 . . . . 0.0 113.081 -179.509 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' C' C ' 704' ' ' ALA . . . . . 0.492 ' O ' ' O ' ' C' ' 703' ' ' PRO . . . . . . . . 0 N--CA 1.49 1.553 0 CA-C-O 121.443 0.64 . . . . 0.0 110.273 179.457 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 63' ' ' PRO . . . . . 0.581 ' O ' ' CD1' ' A' ' 110' ' ' LEU . 29.3 Cg_endo . . . . . 0 C--O 1.21 -0.894 0 N-CA-C 110.156 -0.748 . . . . 0.0 110.156 . . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 64' ' ' GLN . . . . . 0.425 ' O ' ' C ' ' A' ' 65' ' ' ILE . 0.9 OUTLIER -162.47 115.62 1.71 Allowed 'General case' 0 C--N 1.297 -1.686 0 O-C-N 121.165 -0.96 . . . . 0.0 109.976 -179.836 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 65' ' ' ILE . . . . . 0.425 ' C ' ' O ' ' A' ' 64' ' ' GLN . 2.7 mp -42.78 102.41 0.27 Allowed Pre-proline 0 N--CA 1.489 1.511 0 O-C-N 121.518 -0.739 . . . . 0.0 109.262 179.536 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 66' ' ' PRO . . . . . . . . . . . . . 72.7 Cg_endo -89.13 -154.21 0.05 OUTLIER 'Trans proline' 0 N--CA 1.492 1.414 0 C-N-CA 122.697 2.265 . . . . 0.0 113.004 -179.011 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 67' ' ' LYS . . . . . 0.481 ' CG ' ' O ' ' A' ' 67' ' ' LYS . 7.8 ttmm -81.06 -7.45 59.56 Favored 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.239 -0.913 . . . . 0.0 108.766 179.666 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 68' ' ' ASP . . . . . 0.584 ' C ' ' N ' ' A' ' 70' ' ' SER . 0.5 OUTLIER -75.1 52.89 0.59 Allowed 'General case' 0 C--N 1.304 -1.393 0 CA-C-O 122.524 1.154 . . . . 0.0 108.594 179.608 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 69' ' ' LYS . . . . . 0.437 ' C ' ' O ' ' A' ' 68' ' ' ASP . 14.9 ptpt -49.7 -15.07 0.15 Allowed 'General case' 0 N--CA 1.501 2.088 0 C-N-CA 117.26 -1.776 . . . . 0.0 106.469 177.961 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 70' ' ' SER . . . . . 0.584 ' N ' ' C ' ' A' ' 68' ' ' ASP . 3.7 m -85.92 -4.68 59.22 Favored 'General case' 0 N--CA 1.494 1.77 0 CA-C-N 113.516 -1.675 . . . . 0.0 110.739 179.571 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 71' ' ' LYS . . . . . . . . . . . . . 7.9 ptmt -97.73 142.53 29.39 Favored 'General case' 0 N--CA 1.497 1.877 0 O-C-N 120.913 -1.117 . . . . 0.0 111.985 -179.181 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 72' ' ' VAL . . . . . 0.579 ' CG2' ' O ' ' A' ' 74' ' ' GLY . 0.3 OUTLIER -67.52 135.0 29.34 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.507 0 N-CA-C 105.186 -2.153 . . . . 0.0 105.186 174.777 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 73' ' ' ALA . . . . . 0.535 ' N ' ' O ' ' A' ' 87' ' ' VAL . . . -80.93 -16.58 53.14 Favored 'General case' 0 C--N 1.298 -1.635 0 O-C-N 119.988 -1.695 . . . . 0.0 107.219 -179.556 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 74' ' ' GLY . . . . . 0.579 ' O ' ' CG2' ' A' ' 72' ' ' VAL . . . 167.04 -148.9 13.85 Favored Glycine 0 N--CA 1.486 1.98 0 C-N-CA 119.078 -1.534 . . . . 0.0 110.253 178.774 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 75' ' ' TYR . . . . . 0.558 ' HA ' HG23 ' A' ' 87' ' ' VAL . 13.4 m-85 -144.91 174.79 10.71 Favored 'General case' 0 C--N 1.293 -1.885 0 O-C-N 121.153 -1.204 . . . . 0.0 109.921 -178.342 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 76' ' ' ILE . . . . . . . . . . . . . 0.4 OUTLIER -148.48 147.83 16.56 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.777 0 N-CA-C 108.124 -1.065 . . . . 0.0 108.124 -178.64 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 3.9 mt-10 -149.37 159.82 43.95 Favored 'General case' 0 C--N 1.302 -1.471 0 O-C-N 120.789 -1.194 . . . . 0.0 110.548 -179.353 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 78' ' ' ILE . . . . . 0.562 HG22 ' H ' ' A' ' 81' ' ' ALA . 83.3 mt -145.58 120.15 5.56 Favored Pre-proline 0 N--CA 1.488 1.442 0 N-CA-C 107.233 -1.395 . . . . 0.0 107.233 179.722 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 79' ' ' PRO . . . . . . . . . . . . . 68.9 Cg_endo -76.36 -39.66 0.76 Allowed 'Trans proline' 0 N--CA 1.493 1.468 0 C-N-CA 122.024 1.816 . . . . 0.0 113.613 -178.543 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 4.7 m-20 -65.72 -20.23 66.2 Favored 'General case' 0 N--CA 1.494 1.76 0 O-C-N 121.062 -1.024 . . . . 0.0 110.025 178.344 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 81' ' ' ALA . . . . . 0.575 ' O ' ' ND2' ' A' ' 132' ' ' ASN . . . -108.31 -18.63 13.71 Favored 'General case' 0 C--N 1.301 -1.535 0 N-CA-C 107.857 -1.164 . . . . 0.0 107.857 179.497 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 82' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER 67.41 54.72 0.68 Allowed 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.74 -0.6 . . . . 0.0 110.942 178.921 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 83' ' ' ILE . . . . . 0.409 ' CG1' HD21 ' A' ' 132' ' ' ASN . 61.2 mt -126.66 151.77 33.66 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.924 0 O-C-N 120.935 -1.103 . . . . 0.0 110.68 -179.02 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 84' ' ' LYS . . . . . . . . . . . . . 1.6 pttm -159.19 106.46 1.77 Allowed 'General case' 0 N--CA 1.489 1.512 0 N-CA-C 107.734 -1.21 . . . . 0.0 107.734 179.105 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 85' ' ' GLU . . . . . 0.435 ' OE2' ' O ' ' A' ' 129' ' ' GLN . 0.4 OUTLIER -141.6 174.16 4.09 Favored Pre-proline 0 N--CA 1.493 1.71 0 O-C-N 121.064 -1.023 . . . . 0.0 110.779 -178.344 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 86' ' ' PRO . . . . . . . . . . . . . 73.2 Cg_endo -83.96 157.75 13.55 Favored 'Trans proline' 0 N--CA 1.492 1.433 0 C-N-CA 123.147 2.565 . . . . 0.0 114.082 -178.869 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 87' ' ' VAL . . . . . 0.558 HG23 ' HA ' ' A' ' 75' ' ' TYR . 57.3 t -114.6 103.24 15.03 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.89 0 O-C-N 121.73 -0.606 . . . . 0.0 109.706 -179.816 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 88' ' ' TYR . . . . . 0.412 ' CD2' ' HD2' ' A' ' 99' ' ' ARG . 19.5 m-85 -94.83 153.71 39.97 Favored Pre-proline 0 N--CA 1.502 2.139 0 O-C-N 120.827 -1.17 . . . . 0.0 110.31 -179.916 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 89' ' ' PRO . . . . . 0.425 ' HA ' ' CD2' ' A' ' 103' ' ' PHE . 8.3 Cg_endo -58.4 145.38 94.24 Favored 'Trans proline' 0 N--CA 1.494 1.537 0 C-N-CA 122.908 2.405 . . . . 0.0 113.452 -179.514 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . -59.84 168.91 7.55 Favored Glycine 0 N--CA 1.492 2.384 0 N-CA-C 109.208 -1.557 . . . . 0.0 109.208 179.211 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 91' ' ' PRO . . . . . 0.444 ' C ' ' H ' ' A' ' 93' ' ' THR . 72.1 Cg_endo -93.24 170.45 19.98 Favored 'Cis proline' 0 C--N 1.306 -1.669 0 C-N-CA 123.765 -1.348 . . . . 0.0 111.903 -0.237 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 92' ' ' ALA . . . . . 0.47 ' HB3' ' HB2' ' C' ' 703' ' ' PRO . . . -72.44 32.15 0.06 Allowed 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.134 -0.979 . . . . 0.0 110.433 -179.892 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 93' ' ' THR . . . . . 0.444 ' H ' ' C ' ' A' ' 91' ' ' PRO . 1.1 p -73.51 149.9 88.86 Favored Pre-proline 0 C--N 1.302 -1.486 0 O-C-N 120.847 -1.158 . . . . 0.0 108.427 179.723 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 94' ' ' PRO . . . . . 0.412 ' C ' ' O ' ' A' ' 93' ' ' THR . 95.4 Cg_exo -35.54 -45.05 0.71 Allowed 'Trans proline' 0 C--N 1.304 -1.772 0 C-N-CA 122.438 2.092 . . . . 0.0 111.746 -179.615 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 95' ' ' GLU . . . . . 0.628 ' O ' ' ND2' ' A' ' 98' ' ' ASN . 7.1 mt-10 -49.97 -55.13 15.78 Favored 'General case' 0 N--CA 1.489 1.477 0 O-C-N 121.18 -0.95 . . . . 0.0 109.393 179.341 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 96' ' ' GLN . . . . . 0.563 ' C ' ' H ' ' A' ' 98' ' ' ASN . 2.7 mp0 -73.03 -47.77 42.06 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.162 -0.961 . . . . 0.0 110.719 -179.658 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 97' ' ' LEU . . . . . 0.448 HD23 ' HA ' ' A' ' 97' ' ' LEU . 42.2 mt -52.55 -5.34 0.04 OUTLIER 'General case' 0 N--CA 1.493 1.691 0 O-C-N 120.971 -1.08 . . . . 0.0 109.095 -179.046 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 98' ' ' ASN . . . . . 0.75 HD21 ' NE ' ' A' ' 99' ' ' ARG . 0.5 OUTLIER -73.23 -26.35 61.09 Favored 'General case' 0 N--CA 1.494 1.747 0 O-C-N 121.351 -0.843 . . . . 0.0 109.087 179.466 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 99' ' ' ARG . . . . . 0.75 ' NE ' HD21 ' A' ' 98' ' ' ASN . 0.1 OUTLIER -99.03 -50.2 4.25 Favored 'General case' 0 C--N 1.3 -1.544 0 C-N-CA 119.7 -0.8 . . . . 0.0 110.064 -179.016 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . 180.0 -169.17 39.83 Favored Glycine 0 N--CA 1.495 2.578 0 C-N-CA 118.858 -1.639 . . . . 0.0 111.224 179.497 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 101' ' ' VAL . . . . . 0.73 HG23 ' O ' ' A' ' 101' ' ' VAL . 18.5 m -55.01 106.16 0.11 Allowed 'Isoleucine or valine' 0 N--CA 1.496 1.84 0 O-C-N 121.883 -0.775 . . . . 0.0 109.289 -179.851 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -92.56 164.17 13.53 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.373 -0.829 . . . . 0.0 111.577 -178.713 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 103' ' ' PHE . . . . . 0.427 ' CE1' ' CG1' ' A' ' 87' ' ' VAL . 23.9 m-85 -68.2 126.58 29.99 Favored 'General case' 0 N--CA 1.485 1.278 0 N-CA-C 106.763 -1.569 . . . . 0.0 106.763 177.309 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 104' ' ' ALA . . . . . 0.453 ' HB1' ' CG ' ' C' ' 703' ' ' PRO . . . -50.37 -11.26 0.07 Allowed 'General case' 0 C--N 1.293 -1.856 0 O-C-N 121.513 -0.742 . . . . 0.0 111.593 -178.267 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 105' ' ' GLU . . . . . 0.495 ' OE2' ' OE1' ' A' ' 108' ' ' GLU . 0.4 OUTLIER -140.57 145.89 37.34 Favored 'General case' 0 N--CA 1.495 1.795 0 O-C-N 120.751 -1.218 . . . . 0.0 110.565 179.988 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 106' ' ' GLU . . . . . . . . . . . . . 25.0 tt0 -58.84 -63.22 1.37 Allowed 'General case' 0 C--N 1.305 -1.356 0 O-C-N 121.733 -0.604 . . . . 0.0 110.019 -179.993 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 107' ' ' ASN . . . . . . . . . . . . . 15.9 m-80 -76.94 33.2 0.14 Allowed 'General case' 0 N--CA 1.487 1.413 0 O-C-N 120.381 -1.449 . . . . 0.0 112.683 -176.103 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 108' ' ' GLU . . . . . 0.495 ' OE1' ' OE2' ' A' ' 105' ' ' GLU . 35.0 tp10 -60.16 146.9 41.65 Favored 'General case' 0 N--CA 1.493 1.698 0 O-C-N 120.483 -1.386 . . . . 0.0 107.801 179.448 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 109' ' ' SER . . . . . 0.401 ' C ' ' N ' ' A' ' 111' ' ' ASP . 0.1 OUTLIER -101.2 128.59 47.24 Favored 'General case' 0 N--CA 1.489 1.501 0 O-C-N 120.824 -1.172 . . . . 0.0 110.912 -178.285 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 110' ' ' LEU . . . . . 0.626 HD23 ' N ' ' A' ' 110' ' ' LEU . 1.2 pt? -59.0 -10.02 2.27 Favored 'General case' 0 C--N 1.303 -1.433 0 N-CA-C 108.45 -0.945 . . . . 0.0 108.45 179.48 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 111' ' ' ASP . . . . . 0.401 ' N ' ' C ' ' A' ' 109' ' ' SER . 44.8 m-20 -131.74 29.62 4.45 Favored 'General case' 0 N--CA 1.491 1.587 0 N-CA-C 108.598 -0.89 . . . . 0.0 108.598 179.32 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 112' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -65.37 149.48 49.92 Favored 'General case' 0 N--CA 1.493 1.686 0 O-C-N 121.273 -0.892 . . . . 0.0 110.479 -179.232 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 113' ' ' GLN . . . . . . . . . . . . . 2.3 mp0 -66.87 -11.41 55.72 Favored 'General case' 0 C--N 1.303 -1.442 0 N-CA-C 107.709 -1.219 . . . . 0.0 107.709 177.773 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 114' ' ' ASN . . . . . 0.49 HD21 ' HB3' ' A' ' 171' ' ' GLU . 0.3 OUTLIER -149.47 102.59 3.2 Favored 'General case' 0 C--N 1.305 -1.347 0 N-CA-C 107.683 -1.229 . . . . 0.0 107.683 177.838 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 115' ' ' ILE . . . . . 0.461 ' O ' HG22 ' A' ' 115' ' ' ILE . 3.8 mt -97.74 111.26 27.13 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.528 0 O-C-N 120.961 -1.087 . . . . 0.0 109.437 -179.19 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 116' ' ' SER . . . . . . . . . . . . . 50.5 m -96.97 140.68 31.14 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.24 -0.913 . . . . 0.0 111.707 -178.087 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 117' ' ' ILE . . . . . . . . . . . . . 11.9 mt -130.25 152.49 37.51 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.414 0 N-CA-C 107.284 -1.376 . . . . 0.0 107.284 178.305 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 118' ' ' ALA . . . . . 0.663 ' HB1' ' HB2' ' C' ' 704' ' ' ALA . . . -142.87 157.54 44.49 Favored 'General case' 0 N--CA 1.493 1.684 0 O-C-N 120.707 -1.246 . . . . 0.0 111.087 -179.836 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 119' ' ' GLY . . . . . . . . . . . . . . . -162.45 145.09 10.28 Favored Glycine 0 N--CA 1.487 2.056 0 N-CA-C 110.085 -1.206 . . . . 0.0 110.085 179.964 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 120' ' ' HIS . . . . . . . . . . . . . 29.4 m170 -71.19 157.98 37.21 Favored 'General case' 0 N--CA 1.493 1.701 0 O-C-N 121.716 -0.873 . . . . 0.0 110.062 179.461 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 121' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -110.98 145.88 37.65 Favored 'General case' 0 N--CA 1.495 1.808 0 O-C-N 121.321 -0.862 . . . . 0.0 108.86 178.916 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 122' ' ' PHE . . . . . 0.489 ' O ' HG21 ' A' ' 131' ' ' THR . 0.3 OUTLIER -109.23 125.32 52.13 Favored 'General case' 0 N--CA 1.494 1.734 0 O-C-N 121.058 -1.026 . . . . 0.0 109.277 179.333 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 123' ' ' ILE . . . . . 0.559 HG23 ' N ' ' A' ' 124' ' ' ASP . 6.9 tp -74.43 -37.04 43.84 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.785 0 CA-C-O 121.876 0.846 . . . . 0.0 109.195 179.833 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 124' ' ' ASP . . . . . 0.559 ' N ' HG23 ' A' ' 123' ' ' ILE . 80.8 m-20 -92.88 15.13 15.49 Favored 'General case' 0 C--N 1.297 -1.715 0 O-C-N 121.897 -0.502 . . . . 0.0 111.281 -179.043 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 125' ' ' ARG . . . . . . . . . . . . . 7.3 ttt180 -153.95 115.17 2.58 Favored Pre-proline 0 N--CA 1.494 1.737 0 O-C-N 120.445 -1.409 . . . . 0.0 110.789 -178.555 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 126' ' ' PRO . . . . . . . . . . . . . 74.0 Cg_endo -83.76 -23.75 3.1 Favored 'Trans proline' 0 N--CA 1.487 1.123 0 C-N-CA 122.11 1.873 . . . . 0.0 112.083 178.81 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 127' ' ' ASN . . . . . 0.48 ' ND2' ' O ' ' A' ' 127' ' ' ASN . 2.3 p-10 -88.82 28.89 1.09 Allowed 'General case' 0 N--CA 1.492 1.654 0 O-C-N 120.898 -1.126 . . . . 0.0 110.051 -179.558 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 128' ' ' TYR . . . . . . . . . . . . . 9.9 t80 -87.71 -148.58 0.15 Allowed 'General case' 0 N--CA 1.49 1.564 0 O-C-N 120.94 -1.1 . . . . 0.0 109.554 179.906 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 129' ' ' GLN . . . . . 0.435 ' O ' ' OE2' ' A' ' 85' ' ' GLU . 80.4 mt-30 -66.95 -69.59 0.3 Allowed 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.29 -0.881 . . . . 0.0 110.802 -178.742 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 130' ' ' PHE . . . . . . . . . . . . . 55.8 m-85 -130.47 31.34 4.59 Favored 'General case' 0 N--CA 1.499 1.99 0 O-C-N 121.056 -1.027 . . . . 0.0 110.841 -179.126 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 131' ' ' THR . . . . . 0.489 HG21 ' O ' ' A' ' 122' ' ' PHE . 52.4 m -70.77 -32.99 70.3 Favored 'General case' 0 C--N 1.301 -1.522 0 O-C-N 120.344 -1.473 . . . . 0.0 108.205 179.451 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 132' ' ' ASN . . . . . 0.575 ' ND2' ' O ' ' A' ' 81' ' ' ALA . 2.0 p-10 -91.21 15.24 12.27 Favored 'General case' 0 N--CA 1.498 1.97 0 C-N-CA 119.915 -0.714 . . . . 0.0 111.179 -179.565 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 133' ' ' LEU . . . . . 0.599 ' O ' ' N ' ' A' ' 135' ' ' ALA . 0.2 OUTLIER -77.06 -44.17 31.69 Favored 'General case' 0 C--N 1.301 -1.535 0 O-C-N 120.651 -1.281 . . . . 0.0 109.185 -179.801 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 134' ' ' LYS . . . . . 0.71 ' CE ' ' H ' ' A' ' 134' ' ' LYS . 0.0 OUTLIER -46.97 -6.94 0.01 OUTLIER 'General case' 0 C--N 1.299 -1.606 0 O-C-N 121.661 -0.65 . . . . 0.0 110.428 -179.42 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 135' ' ' ALA . . . . . 0.599 ' N ' ' O ' ' A' ' 133' ' ' LEU . . . -84.0 -40.32 18.58 Favored 'General case' 0 N--CA 1.488 1.462 0 O-C-N 120.912 -1.118 . . . . 0.0 108.97 178.962 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 136' ' ' ALA . . . . . 0.555 ' HB2' ' HB2' ' A' ' 81' ' ' ALA . . . -79.77 162.3 25.21 Favored 'General case' 0 N--CA 1.487 1.402 0 CA-C-O 122.21 1.005 . . . . 0.0 111.357 -178.752 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 137' ' ' LYS . . . . . 0.513 ' O ' ' O ' ' A' ' 138' ' ' LYS . 17.4 pttt -153.04 -164.02 1.83 Allowed 'General case' 0 C--N 1.3 -1.584 0 C-N-CA 118.721 -1.192 . . . . 0.0 111.097 -177.918 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 138' ' ' LYS . . . . . 0.602 ' O ' ' N ' ' A' ' 140' ' ' SER . 1.4 mmmp? -45.92 -179.9 0.0 OUTLIER 'General case' 0 C--N 1.303 -1.445 0 CA-C-O 122.1 0.953 . . . . 0.0 110.356 -179.564 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 139' ' ' GLY . . . . . . . . . . . . . . . 46.14 7.81 0.02 OUTLIER Glycine 0 N--CA 1.49 2.283 0 N-CA-C 110.547 -1.021 . . . . 0.0 110.547 179.735 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 140' ' ' SER . . . . . 0.602 ' N ' ' O ' ' A' ' 138' ' ' LYS . 13.1 t -83.04 143.78 30.37 Favored 'General case' 0 N--CA 1.493 1.679 0 O-C-N 120.849 -1.383 . . . . 0.0 108.922 179.108 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 141' ' ' MET . . . . . . . . . . . . . 0.1 OUTLIER -88.68 133.91 34.06 Favored 'General case' 0 C--N 1.3 -1.552 0 O-C-N 121.091 -1.006 . . . . 0.0 109.316 179.787 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 142' ' ' VAL . . . . . 0.429 HG22 HG12 ' A' ' 78' ' ' ILE . 21.4 t -121.81 126.19 74.28 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.631 0 N-CA-C 108.781 -0.822 . . . . 0.0 108.781 179.934 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 143' ' ' TYR . . . . . . . . . . . . . 61.1 m-85 -104.2 134.28 47.71 Favored 'General case' 0 N--CA 1.496 1.857 0 O-C-N 121.26 -0.9 . . . . 0.0 110.975 -178.915 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 144' ' ' PHE . . . . . . . . . . . . . 53.0 t80 -112.0 154.3 25.53 Favored 'General case' 0 N--CA 1.492 1.666 0 CA-C-O 121.773 0.797 . . . . 0.0 110.101 -179.393 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 145' ' ' LYS . . . . . 0.429 ' CG ' ' OG1' ' A' ' 150' ' ' THR . 1.8 mttm -149.07 125.64 11.02 Favored 'General case' 0 N--CA 1.494 1.759 0 C-N-CA 118.866 -1.134 . . . . 0.0 111.707 -177.764 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 146' ' ' VAL . . . . . . . . . . . . . 0.2 OUTLIER -144.81 139.9 23.19 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.559 0 N-CA-C 107.028 -1.471 . . . . 0.0 107.028 178.149 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 147' ' ' GLY . . . . . . . . . . . . . . . 53.89 -138.07 38.95 Favored Glycine 0 N--CA 1.489 2.201 0 N-CA-C 107.878 -2.089 . . . . 0.0 107.878 -178.692 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 148' ' ' ASN . . . . . . . . . . . . . 25.0 p30 -101.63 26.65 7.12 Favored 'General case' 0 N--CA 1.489 1.498 0 O-C-N 121.052 -1.263 . . . . 0.0 107.832 178.491 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 149' ' ' GLU . . . . . . . . . . . . . 2.1 tm-20 -112.05 151.97 28.74 Favored 'General case' 0 N--CA 1.486 1.335 0 CA-C-O 121.872 0.844 . . . . 0.0 110.921 -178.805 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 150' ' ' THR . . . . . 0.429 ' OG1' ' CG ' ' A' ' 145' ' ' LYS . 2.9 m -141.02 104.89 4.75 Favored 'General case' 0 N--CA 1.495 1.818 0 CA-C-O 121.559 0.695 . . . . 0.0 109.216 179.828 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 151' ' ' ARG . . . . . . . . . . . . . 73.9 mtt180 -87.57 -164.9 1.17 Allowed 'General case' 0 N--CA 1.487 1.403 0 O-C-N 121.355 -0.841 . . . . 0.0 109.297 -179.52 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 152' ' ' LYS . . . . . 0.528 ' O ' ' N ' ' A' ' 205' ' ' VAL . 7.3 mtmt -147.34 144.24 28.61 Favored 'General case' 0 C--N 1.301 -1.535 0 O-C-N 121.433 -0.792 . . . . 0.0 109.329 -179.671 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 153' ' ' TYR . . . . . 0.536 ' CD2' ' HA ' ' A' ' 204' ' ' GLU . 26.9 m-85 -140.44 169.41 17.72 Favored 'General case' 0 N--CA 1.489 1.51 0 N-CA-C 108.344 -0.984 . . . . 0.0 108.344 179.948 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 154' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -143.38 120.91 11.74 Favored 'General case' 0 C--N 1.299 -1.623 0 O-C-N 121.329 -0.857 . . . . 0.0 108.986 179.175 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 155' ' ' MET . . . . . . . . . . . . . 27.0 mtp -46.61 110.09 0.25 Allowed 'General case' 0 N--CA 1.496 1.855 0 O-C-N 120.576 -1.327 . . . . 0.0 110.954 -179.112 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 156' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -104.24 -30.26 10.28 Favored 'General case' 0 C--N 1.294 -1.846 0 C-N-CA 119.817 -0.753 . . . . 0.0 111.034 -178.286 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 157' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -154.53 157.52 38.45 Favored 'General case' 0 N--CA 1.495 1.801 0 C-N-CA 118.179 -1.408 . . . . 0.0 111.757 -178.136 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 158' ' ' ILE . . . . . 0.423 HG12 ' N ' ' A' ' 159' ' ' ARG . 0.0 OUTLIER -155.26 146.23 12.99 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.562 0 CA-C-O 121.785 0.802 . . . . 0.0 110.748 -178.995 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 159' ' ' ARG . . . . . 0.65 ' CG ' HH11 ' A' ' 159' ' ' ARG . 0.0 OUTLIER -158.13 159.16 35.91 Favored 'General case' 0 C--N 1.303 -1.429 0 CA-C-O 121.757 0.789 . . . . 0.0 110.967 -179.824 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 160' ' ' ASP . . . . . 0.469 ' C ' HG22 ' A' ' 161' ' ' VAL . 0.3 OUTLIER -117.37 163.92 15.63 Favored 'General case' 0 N--CA 1.488 1.43 0 N-CA-C 108.326 -0.99 . . . . 0.0 108.326 178.829 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 161' ' ' VAL . . . . . 0.487 ' O ' ' O ' ' A' ' 162' ' ' LYS . 0.1 OUTLIER -162.11 156.2 2.64 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.816 0 O-C-N 121.158 -0.964 . . . . 0.0 109.828 -179.425 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 162' ' ' LYS . . . . . 0.584 ' H ' ' CD ' ' A' ' 162' ' ' LYS . 0.0 OUTLIER -44.96 171.68 0.05 OUTLIER Pre-proline 0 N--CA 1.494 1.738 0 O-C-N 121.378 -0.826 . . . . 0.0 109.63 179.723 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 163' ' ' PRO . . . . . . . . . . . . . 73.7 Cg_endo -81.87 36.38 0.62 Allowed 'Trans proline' 0 N--CA 1.493 1.451 0 C-N-CA 122.791 2.328 . . . . 0.0 113.141 -179.521 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 164' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -152.69 -4.8 0.22 Allowed 'General case' 0 N--CA 1.492 1.663 0 O-C-N 120.907 -1.121 . . . . 0.0 110.35 -179.981 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 165' ' ' ASP . . . . . 0.475 ' O ' ' N ' ' A' ' 167' ' ' GLY . 8.8 t0 -74.8 62.6 1.1 Allowed 'General case' 0 N--CA 1.492 1.631 0 O-C-N 120.925 -1.109 . . . . 0.0 110.641 -179.35 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 166' ' ' VAL . . . . . 0.648 ' O ' ' N ' ' A' ' 168' ' ' VAL . 0.9 OUTLIER -39.43 -29.03 0.09 OUTLIER 'Isoleucine or valine' 0 N--CA 1.497 1.89 0 O-C-N 121.284 -0.885 . . . . 0.0 109.563 -178.45 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 167' ' ' GLY . . . . . 0.475 ' N ' ' O ' ' A' ' 165' ' ' ASP . . . -43.07 -13.92 0.01 OUTLIER Glycine 0 N--CA 1.496 2.636 0 N-CA-C 109.515 -1.434 . . . . 0.0 109.515 179.622 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 168' ' ' VAL . . . . . 0.648 ' N ' ' O ' ' A' ' 166' ' ' VAL . 1.3 t -48.26 -44.41 12.73 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.454 0 O-C-N 121.448 -1.031 . . . . 0.0 108.43 178.925 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 169' ' ' LEU . . . . . 0.571 ' O ' ' C ' ' A' ' 170' ' ' ASP . 47.1 mt -49.92 -9.7 0.04 OUTLIER 'General case' 0 N--CA 1.492 1.66 0 N-CA-C 109.001 -0.741 . . . . 0.0 109.001 -178.092 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 170' ' ' ASP . . . . . 0.617 ' CG ' ' HG1' ' A' ' 180' ' ' THR . 17.7 p-10 19.46 86.51 0.01 OUTLIER 'General case' 0 N--CA 1.494 1.739 0 CA-C-O 121.051 0.453 . . . . 0.0 110.981 178.578 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 171' ' ' GLU . . . . . 0.49 ' HB3' HD21 ' A' ' 114' ' ' ASN . 6.7 pt-20 -121.29 61.38 0.91 Allowed 'General case' 0 N--CA 1.494 1.725 0 O-C-N 121.175 -0.953 . . . . 0.0 109.938 -179.228 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 172' ' ' GLN . . . . . . . . . . . . . 3.0 pt20 -135.03 -44.93 0.72 Allowed 'General case' 0 N--CA 1.492 1.668 0 O-C-N 121.527 -0.733 . . . . 0.0 109.942 -178.975 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 173' ' ' LYS . . . . . . . . . . . . . 21.5 mttp -62.54 128.93 38.29 Favored 'General case' 0 N--CA 1.489 1.498 0 O-C-N 120.899 -1.126 . . . . 0.0 108.106 178.949 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 174' ' ' GLY . . . . . 0.552 ' O ' ' C ' ' A' ' 175' ' ' LYS . . . -137.63 -40.37 0.11 Allowed Glycine 0 C--N 1.293 -1.807 0 N-CA-C 109.071 -1.612 . . . . 0.0 109.071 -179.722 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 175' ' ' LYS . . . . . 0.552 ' C ' ' O ' ' A' ' 174' ' ' GLY . 4.4 mptp? -30.87 -65.28 0.12 Allowed 'General case' 0 N--CA 1.499 2.011 0 N-CA-C 108.9 -0.778 . . . . 0.0 108.9 -179.751 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 176' ' ' ASP . . . . . 0.696 ' O ' ' O ' ' A' ' 177' ' ' LYS . 58.2 m-20 -101.39 78.7 1.9 Allowed 'General case' 0 C--N 1.296 -1.728 0 N-CA-C 107.79 -1.189 . . . . 0.0 107.79 177.843 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 177' ' ' LYS . . . . . 0.696 ' O ' ' O ' ' A' ' 176' ' ' ASP . 0.7 OUTLIER -20.54 158.02 0.0 OUTLIER 'General case' 0 N--CA 1.507 2.39 0 CA-C-O 122.218 1.009 . . . . 0.0 112.249 -179.075 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 178' ' ' GLN . . . . . . . . . . . . . 0.4 OUTLIER -157.03 164.22 38.2 Favored 'General case' 0 C--N 1.303 -1.414 0 C-N-CA 117.052 -1.859 . . . . 0.0 112.026 179.804 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 179' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -122.23 107.39 12.08 Favored 'General case' 0 C--N 1.303 -1.42 0 N-CA-C 107.345 -1.354 . . . . 0.0 107.345 179.083 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 180' ' ' THR . . . . . 0.617 ' HG1' ' CG ' ' A' ' 170' ' ' ASP . 1.0 OUTLIER -78.66 120.32 23.16 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 120.87 -1.144 . . . . 0.0 110.278 -178.427 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 181' ' ' LEU . . . . . . . . . . . . . 10.2 tp -100.16 105.78 17.42 Favored 'General case' 0 N--CA 1.492 1.671 0 O-C-N 121.536 -0.728 . . . . 0.0 109.099 178.883 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 182' ' ' ILE . . . . . . . . . . . . . 56.3 mt -95.63 125.86 48.29 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.419 0 O-C-N 121.064 -1.022 . . . . 0.0 110.046 179.875 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 183' ' ' THR . . . . . 0.434 HG21 ' CE2' ' A' ' 200' ' ' PHE . 0.0 OUTLIER -135.75 111.74 9.57 Favored 'General case' 0 C--N 1.294 -1.843 0 N-CA-C 107.367 -1.346 . . . . 0.0 107.367 178.493 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 184' ' ' CYS . . . . . . . . . . . . . 0.8 OUTLIER -79.6 156.14 27.81 Favored 'General case' 0 C--N 1.292 -1.909 0 C-N-CA 118.783 -1.167 . . . . 0.0 110.851 -177.947 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 185' ' ' ASP . . . . . 0.481 ' OD1' ' N ' ' A' ' 186' ' ' ASP . 10.3 t0 -167.24 -154.07 0.16 Allowed 'General case' 0 N--CA 1.495 1.789 0 O-C-N 121.365 -0.834 . . . . 0.0 109.821 -179.656 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 186' ' ' ASP . . . . . 0.481 ' N ' ' OD1' ' A' ' 185' ' ' ASP . 0.9 OUTLIER 52.8 52.63 13.58 Favored 'General case' 0 N--CA 1.496 1.862 0 O-C-N 121.294 -0.879 . . . . 0.0 109.504 -179.858 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 187' ' ' TYR . . . . . 0.577 ' CE1' ' O ' ' A' ' 188' ' ' ASN . 56.9 t80 -68.68 129.25 39.39 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.291 -0.881 . . . . 0.0 110.958 -179.677 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 188' ' ' ASN . . . . . 1.044 HD22 ' N ' ' A' ' 191' ' ' THR . 0.0 OUTLIER -101.09 151.39 21.87 Favored 'General case' 0 C--N 1.293 -1.86 0 N-CA-C 107.07 -1.456 . . . . 0.0 107.07 177.073 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 189' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -112.82 -7.15 13.79 Favored 'General case' 0 C--N 1.294 -1.816 0 N-CA-C 108.179 -1.045 . . . . 0.0 108.179 -179.526 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 190' ' ' LYS . . . . . 0.844 ' H ' ' ND2' ' A' ' 188' ' ' ASN . 0.6 OUTLIER -82.91 -56.16 3.98 Favored 'General case' 0 N--CA 1.489 1.482 0 C-N-CA 120.062 -0.655 . . . . 0.0 109.424 179.144 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 191' ' ' THR . . . . . 1.044 ' N ' HD22 ' A' ' 188' ' ' ASN . 4.9 p -88.12 -2.86 58.86 Favored 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.305 -0.872 . . . . 0.0 109.453 -179.779 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 192' ' ' GLY . . . . . . . . . . . . . . . 62.86 33.18 86.3 Favored Glycine 0 N--CA 1.493 2.483 0 O-C-N 121.345 -0.847 . . . . 0.0 111.657 178.349 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 193' ' ' VAL . . . . . 0.545 HG12 ' OG1' ' A' ' 191' ' ' THR . 4.0 p -147.81 167.05 4.97 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.689 0 O-C-N 120.686 -1.479 . . . . 0.0 109.959 178.873 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 194' ' ' TRP . . . . . 0.491 ' H ' HG22 ' A' ' 193' ' ' VAL . 17.0 m95 -82.04 120.86 25.81 Favored 'General case' 0 C--N 1.295 -1.764 0 N-CA-C 108.495 -0.928 . . . . 0.0 108.495 179.854 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 195' ' ' GLU . . . . . . . . . . . . . 1.3 mt-10 -83.84 -60.97 1.95 Allowed 'General case' 0 C--N 1.301 -1.513 0 O-C-N 121.471 -0.768 . . . . 0.0 110.864 -178.086 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 196' ' ' LYS . . . . . . . . . . . . . 12.8 tttt -86.39 158.42 19.63 Favored 'General case' 0 C--N 1.301 -1.527 0 O-C-N 120.888 -1.132 . . . . 0.0 110.566 -179.007 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 197' ' ' ARG . . . . . 0.404 ' HE ' ' HB2' ' C' ' 702' ' ' LEU . 0.0 OUTLIER -126.29 135.73 51.89 Favored 'General case' 0 N--CA 1.489 1.482 0 N-CA-C 108.512 -0.922 . . . . 0.0 108.512 179.116 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 198' ' ' LYS . . . . . . . . . . . . . 14.3 mttt -115.39 120.93 41.23 Favored 'General case' 0 N--CA 1.494 1.727 0 O-C-N 121.553 -0.717 . . . . 0.0 110.422 -179.197 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 199' ' ' ILE . . . . . 0.462 ' C ' HD12 ' A' ' 199' ' ' ILE . 0.9 OUTLIER -141.51 118.81 8.06 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.646 0 CA-C-O 122.494 1.14 . . . . 0.0 110.043 179.478 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 200' ' ' PHE . . . . . 0.619 ' CD1' ' N ' ' A' ' 200' ' ' PHE . 0.3 OUTLIER -104.24 135.74 45.15 Favored 'General case' 0 N--CA 1.496 1.855 0 O-C-N 121.295 -0.878 . . . . 0.0 109.586 -178.441 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 201' ' ' VAL . . . . . 0.444 HG12 ' N ' ' A' ' 202' ' ' ALA . 85.2 t -104.36 154.57 6.1 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.611 0 O-C-N 120.979 -1.076 . . . . 0.0 109.07 178.585 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 202' ' ' ALA . . . . . 0.444 ' N ' HG12 ' A' ' 201' ' ' VAL . . . -136.49 142.37 43.52 Favored 'General case' 0 C--N 1.302 -1.472 0 O-C-N 121.153 -0.967 . . . . 0.0 109.055 179.991 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 203' ' ' THR . . . . . 0.507 ' O ' HG23 ' A' ' 205' ' ' VAL . 0.6 OUTLIER -88.59 129.66 35.44 Favored 'General case' 0 N--CA 1.488 1.465 0 CA-C-O 122.281 1.039 . . . . 0.0 111.26 -178.455 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 204' ' ' GLU . . . . . 0.536 ' HA ' ' CD2' ' A' ' 153' ' ' TYR . 12.0 tt0 -49.59 134.74 19.42 Favored 'General case' 0 C--N 1.298 -1.643 0 C-N-CA 119.098 -1.041 . . . . 0.0 108.626 178.38 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 205' ' ' VAL . . . . . 0.539 HG12 ' N ' ' A' ' 206' ' ' LYS . 39.0 t -125.86 161.13 31.62 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.304 0 CA-C-O 122.263 1.03 . . . . 0.0 110.431 -177.765 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 206' ' ' LYS . . . . . 0.539 ' N ' HG12 ' A' ' 205' ' ' VAL . 13.1 mtmt . . . . . 0 C--N 1.293 -1.864 0 CA-C-O 117.931 -1.033 . . . . 0.0 108.983 179.754 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' C' C ' 702' ' ' LEU . . . . . 0.858 ' N ' HD12 ' C' ' 702' ' ' LEU . 0.0 OUTLIER . . . . . 0 N--CA 1.488 1.453 0 N-CA-C 108.735 -0.839 . . . . 0.0 108.735 . . . . . . . . . 2 2 . 1 . 019 nuclear build core ' C' C ' 703' ' ' PRO . . . . . 0.47 ' HB2' ' HB3' ' A' ' 92' ' ' ALA . 9.4 Cg_endo -64.97 -173.0 0.23 Allowed 'Trans proline' 0 N--CA 1.491 1.341 0 C-N-CA 121.619 1.546 . . . . 0.0 112.099 -179.666 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' C' C ' 704' ' ' ALA . . . . . 0.663 ' HB2' ' HB1' ' A' ' 118' ' ' ALA . . . . . . . . 0 N--CA 1.487 1.415 0 O-C-N 121.334 -0.854 . . . . 0.0 109.396 -179.558 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 63' ' ' PRO . . . . . . . . . . . . . 45.2 Cg_endo . . . . . 0 C--O 1.217 -0.57 0 CA-C-O 121.339 0.474 . . . . 0.0 112.224 . . . . . . . . . 0 0 . 1 . 020 nuclear build core ' A' A ' 64' ' ' GLN . . . . . 0.591 ' N ' ' CD ' ' A' ' 64' ' ' GLN . 0.0 OUTLIER -153.98 117.49 4.63 Favored 'General case' 0 N--CA 1.498 1.932 0 O-C-N 121.531 -0.73 . . . . 0.0 109.163 179.517 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 65' ' ' ILE . . . . . 0.44 ' C ' ' O ' ' A' ' 64' ' ' GLN . 3.2 mp -45.28 105.75 0.49 Allowed Pre-proline 0 N--CA 1.493 1.682 0 O-C-N 121.027 -1.045 . . . . 0.0 108.758 179.395 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 66' ' ' PRO . . . . . . . . . . . . . 84.5 Cg_endo -86.46 -158.08 0.08 OUTLIER 'Trans proline' 0 N--CA 1.488 1.148 0 C-N-CA 122.048 1.832 . . . . 0.0 112.51 -179.536 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 67' ' ' LYS . . . . . 0.435 ' O ' ' N ' ' A' ' 69' ' ' LYS . 0.0 OUTLIER -82.82 -4.56 58.18 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.396 -0.815 . . . . 0.0 109.584 -179.756 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 68' ' ' ASP . . . . . 0.62 ' C ' ' N ' ' A' ' 70' ' ' SER . 0.3 OUTLIER -74.05 51.1 0.39 Allowed 'General case' 0 N--CA 1.487 1.411 0 CA-C-O 122.913 1.34 . . . . 0.0 107.919 179.28 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 69' ' ' LYS . . . . . 0.435 ' N ' ' O ' ' A' ' 67' ' ' LYS . 0.1 OUTLIER -49.54 -13.13 0.07 Allowed 'General case' 0 C--N 1.29 -1.99 0 C-N-CA 116.889 -1.924 . . . . 0.0 106.976 178.792 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 70' ' ' SER . . . . . 0.62 ' N ' ' C ' ' A' ' 68' ' ' ASP . 3.6 p -84.25 -8.99 58.87 Favored 'General case' 0 N--CA 1.498 1.96 0 CA-C-N 113.631 -1.622 . . . . 0.0 110.056 178.444 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 71' ' ' LYS . . . . . . . . . . . . . 2.6 ptmm? -96.89 140.57 31.24 Favored 'General case' 0 N--CA 1.494 1.737 0 O-C-N 120.905 -1.122 . . . . 0.0 111.003 -179.739 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 72' ' ' VAL . . . . . 0.674 HG12 ' CE1' ' A' ' 88' ' ' TYR . 1.1 m -63.23 139.78 20.71 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.387 0 N-CA-C 104.331 -2.47 . . . . 0.0 104.331 175.288 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 73' ' ' ALA . . . . . 0.512 ' N ' ' O ' ' A' ' 87' ' ' VAL . . . -82.15 -16.99 47.93 Favored 'General case' 0 C--N 1.287 -2.14 0 C-N-CA 117.405 -1.718 . . . . 0.0 106.806 -179.948 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . 177.7 -158.54 23.8 Favored Glycine 0 C--N 1.298 -1.54 0 N-CA-C 109.383 -1.487 . . . . 0.0 109.383 179.408 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 75' ' ' TYR . . . . . 0.499 ' HA ' HG23 ' A' ' 87' ' ' VAL . 0.7 OUTLIER -143.47 165.48 27.44 Favored 'General case' 0 C--N 1.296 -1.729 0 O-C-N 121.716 -0.873 . . . . 0.0 110.55 -176.722 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 76' ' ' ILE . . . . . . . . . . . . . 4.4 tt -148.66 146.68 17.42 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.453 0 C-N-CA 119.069 -1.052 . . . . 0.0 110.659 -177.866 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -150.13 167.84 25.66 Favored 'General case' 0 N--CA 1.489 1.482 0 O-C-N 121.181 -0.949 . . . . 0.0 109.195 179.119 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 78' ' ' ILE . . . . . 0.472 ' HB ' ' HB3' ' A' ' 81' ' ' ALA . 16.9 mt -149.67 98.18 3.43 Favored Pre-proline 0 C--N 1.303 -1.442 0 N-CA-C 108.543 -0.91 . . . . 0.0 108.543 179.474 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 79' ' ' PRO . . . . . . . . . . . . . 54.1 Cg_exo -48.83 -46.57 24.22 Favored 'Trans proline' 0 C--N 1.31 -1.481 0 C-N-CA 122.517 2.145 . . . . 0.0 113.76 -178.95 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -66.02 -19.83 65.99 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 120.892 -1.13 . . . . 0.0 111.244 179.339 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 81' ' ' ALA . . . . . 0.711 ' HB2' ' HB2' ' A' ' 136' ' ' ALA . . . -105.42 -19.34 13.82 Favored 'General case' 0 N--CA 1.495 1.806 0 O-C-N 121.052 -1.03 . . . . 0.0 108.861 179.633 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 82' ' ' ASP . . . . . 0.452 ' CB ' ' O ' ' A' ' 81' ' ' ALA . 5.6 t70 71.42 48.01 0.35 Allowed 'General case' 0 N--CA 1.494 1.736 0 O-C-N 120.988 -1.07 . . . . 0.0 110.328 179.33 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 83' ' ' ILE . . . . . 0.508 HD11 ' OD1' ' A' ' 132' ' ' ASN . 82.5 mt -127.42 152.57 35.63 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.696 0 O-C-N 121.265 -0.897 . . . . 0.0 110.021 -179.006 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 84' ' ' LYS . . . . . . . . . . . . . 33.2 tttt -159.46 107.32 1.76 Allowed 'General case' 0 N--CA 1.491 1.617 0 N-CA-C 107.944 -1.132 . . . . 0.0 107.944 179.427 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 85' ' ' GLU . . . . . 0.413 ' C ' ' CD2' ' A' ' 75' ' ' TYR . 0.3 OUTLIER -144.05 164.85 27.03 Favored Pre-proline 0 N--CA 1.491 1.604 0 O-C-N 121.281 -0.887 . . . . 0.0 110.488 -178.741 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 86' ' ' PRO . . . . . 0.409 ' O ' HG22 ' A' ' 101' ' ' VAL . 55.8 Cg_endo -72.46 170.38 19.47 Favored 'Trans proline' 0 N--CA 1.495 1.578 0 C-N-CA 123.635 2.89 . . . . 0.0 113.633 -179.494 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 87' ' ' VAL . . . . . 0.512 ' O ' ' N ' ' A' ' 73' ' ' ALA . 54.1 t -127.26 98.07 4.41 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.822 0 N-CA-C 109.047 -0.723 . . . . 0.0 109.047 179.828 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 88' ' ' TYR . . . . . 0.674 ' CE1' HG12 ' A' ' 72' ' ' VAL . 21.1 m-85 -88.17 154.05 51.74 Favored Pre-proline 0 N--CA 1.505 2.284 0 O-C-N 120.659 -1.276 . . . . 0.0 110.42 -179.443 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 89' ' ' PRO . . . . . 0.422 ' HA ' ' CD2' ' A' ' 103' ' ' PHE . 9.7 Cg_endo -61.54 145.09 98.12 Favored 'Trans proline' 0 C--N 1.311 -1.429 0 C-N-CA 122.5 2.133 . . . . 0.0 113.76 -179.677 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . -56.58 166.05 4.69 Favored Glycine 0 N--CA 1.491 2.342 0 N-CA-C 109.575 -1.41 . . . . 0.0 109.575 179.255 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 91' ' ' PRO . . . . . 0.439 ' C ' ' H ' ' A' ' 93' ' ' THR . 44.8 Cg_endo -94.29 168.22 19.08 Favored 'Cis proline' 0 C--N 1.312 -1.38 0 C-N-CA 123.864 -1.307 . . . . 0.0 111.949 0.167 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 92' ' ' ALA . . . . . 0.727 ' HB1' HD21 ' A' ' 97' ' ' LEU . . . -71.91 31.26 0.05 Allowed 'General case' 0 C--N 1.302 -1.463 0 O-C-N 121.281 -0.887 . . . . 0.0 110.396 179.952 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 93' ' ' THR . . . . . 0.439 ' H ' ' C ' ' A' ' 91' ' ' PRO . 1.0 OUTLIER -74.71 151.24 86.85 Favored Pre-proline 0 N--CA 1.491 1.605 0 O-C-N 120.501 -1.374 . . . . 0.0 108.43 179.846 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 94' ' ' PRO . . . . . 0.414 ' C ' ' O ' ' A' ' 93' ' ' THR . 86.5 Cg_exo -29.91 -54.42 0.19 Allowed 'Trans proline' 0 C--N 1.308 -1.565 0 C-N-CA 123.228 2.619 . . . . 0.0 113.207 -178.861 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 95' ' ' GLU . . . . . 0.413 ' HB2' HE22 ' A' ' 96' ' ' GLN . 83.6 mt-10 -47.24 -49.31 23.58 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 120.796 -1.19 . . . . 0.0 109.706 -179.528 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 96' ' ' GLN . . . . . 0.481 ' O ' ' N ' ' A' ' 98' ' ' ASN . 3.3 mp0 -71.72 -53.13 14.47 Favored 'General case' 0 C--N 1.303 -1.446 0 O-C-N 121.337 -0.852 . . . . 0.0 110.376 -179.658 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 97' ' ' LEU . . . . . 0.727 HD21 ' HB1' ' A' ' 92' ' ' ALA . 83.8 mt -50.53 -9.0 0.04 OUTLIER 'General case' 0 N--CA 1.493 1.724 0 O-C-N 121.149 -0.969 . . . . 0.0 110.299 -178.498 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 98' ' ' ASN . . . . . 0.628 HD21 ' NE ' ' A' ' 99' ' ' ARG . 0.2 OUTLIER -72.55 -27.69 62.38 Favored 'General case' 0 N--CA 1.488 1.45 0 O-C-N 121.029 -1.044 . . . . 0.0 108.863 179.534 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 99' ' ' ARG . . . . . 0.628 ' NE ' HD21 ' A' ' 98' ' ' ASN . 6.1 mtt180 -94.27 -60.17 1.79 Allowed 'General case' 0 N--CA 1.491 1.577 0 C-N-CA 119.973 -0.691 . . . . 0.0 110.529 -179.651 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . -171.66 -166.58 30.61 Favored Glycine 0 N--CA 1.499 2.835 0 C-N-CA 119.424 -1.369 . . . . 0.0 111.003 -179.501 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 101' ' ' VAL . . . . . 0.748 HG23 ' O ' ' A' ' 101' ' ' VAL . 16.3 m -57.47 106.46 0.18 Allowed 'Isoleucine or valine' 0 N--CA 1.498 1.928 0 O-C-N 121.554 -0.968 . . . . 0.0 109.455 -179.783 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -93.8 159.71 15.07 Favored 'General case' 0 N--CA 1.493 1.696 0 O-C-N 121.244 -0.91 . . . . 0.0 111.633 -179.068 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 103' ' ' PHE . . . . . 0.422 ' CD2' ' HA ' ' A' ' 89' ' ' PRO . 23.5 m-85 -63.18 130.93 46.71 Favored 'General case' 0 N--CA 1.49 1.531 0 N-CA-C 107.881 -1.155 . . . . 0.0 107.881 178.235 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 104' ' ' ALA . . . . . . . . . . . . . . . -50.95 -18.34 0.75 Allowed 'General case' 0 C--N 1.299 -1.619 0 O-C-N 121.58 -0.7 . . . . 0.0 111.42 -178.532 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -136.91 146.66 45.74 Favored 'General case' 0 N--CA 1.495 1.808 0 O-C-N 120.799 -1.188 . . . . 0.0 111.011 -179.447 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 106' ' ' GLU . . . . . . . . . . . . . 1.7 tt0 -55.26 -62.33 1.74 Allowed 'General case' 0 C--N 1.305 -1.351 0 CA-C-N 116.061 -0.518 . . . . 0.0 110.316 -179.903 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 107' ' ' ASN . . . . . 0.435 ' N ' ' OD1' ' A' ' 107' ' ' ASN . 1.9 m-20 -78.81 33.48 0.21 Allowed 'General case' 0 N--CA 1.491 1.607 0 O-C-N 120.609 -1.307 . . . . 0.0 113.184 -175.638 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 108' ' ' GLU . . . . . . . . . . . . . 29.0 tp10 -58.25 143.32 44.85 Favored 'General case' 0 N--CA 1.495 1.813 0 O-C-N 120.468 -1.395 . . . . 0.0 107.963 179.945 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 109' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -94.95 140.45 29.92 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 120.961 -1.087 . . . . 0.0 110.987 -178.013 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 110' ' ' LEU . . . . . 0.484 HD11 HG21 ' A' ' 146' ' ' VAL . 0.7 OUTLIER -63.7 -16.78 61.94 Favored 'General case' 0 C--N 1.302 -1.469 0 N-CA-C 108.754 -0.832 . . . . 0.0 108.754 179.207 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 111' ' ' ASP . . . . . . . . . . . . . 13.0 m-20 -133.1 36.83 3.43 Favored 'General case' 0 N--CA 1.488 1.475 0 O-C-N 121.677 -0.639 . . . . 0.0 109.762 -179.439 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 112' ' ' ASP . . . . . . . . . . . . . 1.7 t0 -65.93 150.07 49.22 Favored 'General case' 0 N--CA 1.494 1.76 0 O-C-N 121.033 -1.042 . . . . 0.0 110.706 -179.58 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 113' ' ' GLN . . . . . . . . . . . . . 2.4 mp0 -68.11 -13.12 61.97 Favored 'General case' 0 N--CA 1.491 1.598 0 N-CA-C 107.849 -1.167 . . . . 0.0 107.849 177.84 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 114' ' ' ASN . . . . . . . . . . . . . 2.7 t30 -149.38 103.0 3.25 Favored 'General case' 0 C--N 1.302 -1.477 0 N-CA-C 107.818 -1.178 . . . . 0.0 107.818 177.913 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 115' ' ' ILE . . . . . 0.492 ' O ' HG22 ' A' ' 115' ' ' ILE . 3.0 mt -97.34 110.47 25.26 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.479 0 O-C-N 121.156 -0.965 . . . . 0.0 109.837 -179.135 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 116' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -96.38 145.23 25.81 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.075 -1.015 . . . . 0.0 111.265 -178.392 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 117' ' ' ILE . . . . . . . . . . . . . 1.4 mt -139.65 156.55 26.21 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.768 0 N-CA-C 107.887 -1.153 . . . . 0.0 107.887 178.951 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 118' ' ' ALA . . . . . . . . . . . . . . . -142.06 160.38 40.34 Favored 'General case' 0 N--CA 1.491 1.601 0 C-N-CA 118.775 -1.17 . . . . 0.0 111.812 -179.07 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 119' ' ' GLY . . . . . . . . . . . . . . . -164.66 145.49 10.34 Favored Glycine 0 N--CA 1.481 1.688 0 N-CA-C 109.636 -1.386 . . . . 0.0 109.636 179.667 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 120' ' ' HIS . . . . . 0.449 ' CD2' HD13 ' A' ' 97' ' ' LEU . 10.5 m-70 -71.03 166.22 21.82 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.665 -0.903 . . . . 0.0 109.897 179.119 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 121' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -123.69 149.28 45.68 Favored 'General case' 0 N--CA 1.496 1.858 0 N-CA-C 107.637 -1.245 . . . . 0.0 107.637 178.53 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 122' ' ' PHE . . . . . 0.442 ' H ' ' HG1' ' A' ' 131' ' ' THR . 0.4 OUTLIER -114.88 138.02 51.28 Favored 'General case' 0 N--CA 1.492 1.666 0 O-C-N 121.178 -0.951 . . . . 0.0 109.99 -179.227 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 123' ' ' ILE . . . . . 0.487 HG23 ' N ' ' A' ' 124' ' ' ASP . 17.8 tt -89.39 -31.56 5.41 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.677 0 CA-C-O 121.98 0.895 . . . . 0.0 109.432 -179.782 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 124' ' ' ASP . . . . . 0.487 ' N ' HG23 ' A' ' 123' ' ' ILE . 0.2 OUTLIER -85.48 -3.67 58.93 Favored 'General case' 0 C--N 1.292 -1.908 0 C-N-CA 120.05 -0.66 . . . . 0.0 112.218 -177.71 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 125' ' ' ARG . . . . . 0.411 ' HG3' ' CD1' ' A' ' 122' ' ' PHE . 0.0 OUTLIER -157.15 130.97 4.8 Favored Pre-proline 0 N--CA 1.499 1.986 0 O-C-N 120.249 -1.532 . . . . 0.0 110.668 179.443 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 126' ' ' PRO . . . . . . . . . . . . . 88.7 Cg_endo -83.18 -13.23 9.02 Favored 'Trans proline' 0 N--CA 1.497 1.709 0 C-N-CA 122.676 2.251 . . . . 0.0 113.218 178.94 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 127' ' ' ASN . . . . . . . . . . . . . 1.4 t30 -89.32 24.79 2.1 Favored 'General case' 0 N--CA 1.494 1.735 0 O-C-N 121.041 -1.037 . . . . 0.0 110.05 -178.924 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 128' ' ' TYR . . . . . . . . . . . . . 9.6 t80 -83.15 -148.75 0.09 Allowed 'General case' 0 C--N 1.299 -1.621 0 O-C-N 121.237 -0.914 . . . . 0.0 109.322 -179.892 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 129' ' ' GLN . . . . . . . . . . . . . 6.9 mt-30 -65.75 -88.51 0.01 OUTLIER 'General case' 0 C--N 1.299 -1.63 0 O-C-N 121.345 -0.847 . . . . 0.0 110.172 -179.319 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 130' ' ' PHE . . . . . 0.576 ' CE2' HG11 ' A' ' 101' ' ' VAL . 35.8 m-85 -111.91 32.27 5.6 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.353 -0.842 . . . . 0.0 109.977 -179.249 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 131' ' ' THR . . . . . 0.442 ' HG1' ' H ' ' A' ' 122' ' ' PHE . 89.8 m -71.23 -33.94 70.32 Favored 'General case' 0 N--CA 1.497 1.878 0 O-C-N 121.385 -0.822 . . . . 0.0 109.441 179.514 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 132' ' ' ASN . . . . . 0.606 ' ND2' ' O ' ' A' ' 81' ' ' ALA . 0.1 OUTLIER -84.69 5.82 26.67 Favored 'General case' 0 N--CA 1.498 1.962 0 CA-C-O 121.945 0.879 . . . . 0.0 109.364 -179.624 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 133' ' ' LEU . . . . . 0.592 ' O ' ' N ' ' A' ' 135' ' ' ALA . 0.2 OUTLIER -72.34 -45.25 60.72 Favored 'General case' 0 C--N 1.297 -1.684 0 O-C-N 121.157 -0.964 . . . . 0.0 109.738 179.69 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 134' ' ' LYS . . . . . 0.624 ' CE ' ' H ' ' A' ' 134' ' ' LYS . 0.0 OUTLIER -47.39 -10.39 0.02 OUTLIER 'General case' 0 C--N 1.3 -1.585 0 O-C-N 121.14 -0.975 . . . . 0.0 109.546 -179.634 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 135' ' ' ALA . . . . . 0.592 ' N ' ' O ' ' A' ' 133' ' ' LEU . . . -84.65 -39.72 18.28 Favored 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.081 -1.012 . . . . 0.0 109.165 179.225 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 136' ' ' ALA . . . . . 0.711 ' HB2' ' HB2' ' A' ' 81' ' ' ALA . . . -78.19 159.58 28.47 Favored 'General case' 0 N--CA 1.489 1.49 0 CA-C-O 122.08 0.943 . . . . 0.0 111.586 -178.472 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 137' ' ' LYS . . . . . 0.559 ' O ' ' O ' ' A' ' 138' ' ' LYS . 7.9 tttt -154.25 -162.76 1.47 Allowed 'General case' 0 N--CA 1.492 1.662 0 C-N-CA 118.801 -1.159 . . . . 0.0 110.467 -178.515 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 138' ' ' LYS . . . . . 0.606 ' O ' ' N ' ' A' ' 140' ' ' SER . 23.0 mttt -44.25 -179.26 0.0 OUTLIER 'General case' 0 C--N 1.302 -1.468 0 CA-C-O 122.334 1.064 . . . . 0.0 110.667 -179.282 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 139' ' ' GLY . . . . . . . . . . . . . . . 46.41 8.25 0.02 OUTLIER Glycine 0 N--CA 1.492 2.408 0 N-CA-C 110.018 -1.233 . . . . 0.0 110.018 -179.676 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 140' ' ' SER . . . . . 0.606 ' N ' ' O ' ' A' ' 138' ' ' LYS . 9.9 m -81.2 144.11 31.85 Favored 'General case' 0 N--CA 1.493 1.705 0 O-C-N 120.864 -1.374 . . . . 0.0 109.224 179.235 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 141' ' ' MET . . . . . . . . . . . . . 2.1 tpt -96.39 125.95 41.25 Favored 'General case' 0 C--N 1.301 -1.535 0 O-C-N 121.127 -0.983 . . . . 0.0 109.403 -179.921 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 142' ' ' VAL . . . . . . . . . . . . . 2.4 t -113.77 128.77 70.52 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.838 0 O-C-N 121.269 -0.894 . . . . 0.0 109.554 -179.438 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 143' ' ' TYR . . . . . 0.409 ' CZ ' ' CD ' ' A' ' 152' ' ' LYS . 3.0 m-85 -107.48 134.39 50.58 Favored 'General case' 0 N--CA 1.497 1.91 0 O-C-N 121.172 -0.955 . . . . 0.0 111.158 -178.838 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 144' ' ' PHE . . . . . . . . . . . . . 24.7 t80 -118.86 99.89 7.04 Favored 'General case' 0 N--CA 1.494 1.726 0 N-CA-C 109.221 -0.659 . . . . 0.0 109.221 179.965 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 145' ' ' LYS . . . . . . . . . . . . . 8.2 mtpm? -98.56 122.47 41.8 Favored 'General case' 0 N--CA 1.488 1.426 0 O-C-N 121.231 -0.918 . . . . 0.0 110.196 -179.353 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 146' ' ' VAL . . . . . 0.498 HG23 ' O ' ' A' ' 73' ' ' ALA . 1.0 OUTLIER -143.51 122.82 8.25 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.499 0 O-C-N 120.885 -1.134 . . . . 0.0 109.058 179.005 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 147' ' ' GLY . . . . . . . . . . . . . . . 67.23 -132.91 30.7 Favored Glycine 0 N--CA 1.484 1.869 0 N-CA-C 108.186 -1.966 . . . . 0.0 108.186 -179.387 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 148' ' ' ASN . . . . . 0.514 ' CG ' ' O ' ' A' ' 148' ' ' ASN . 0.1 OUTLIER -101.28 11.36 39.44 Favored 'General case' 0 C--N 1.296 -1.727 0 N-CA-C 107.918 -1.141 . . . . 0.0 107.918 178.789 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 149' ' ' GLU . . . . . . . . . . . . . 2.4 tt0 -108.13 143.03 37.45 Favored 'General case' 0 N--CA 1.489 1.484 0 O-C-N 121.311 -0.868 . . . . 0.0 111.35 -178.841 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 150' ' ' THR . . . . . 0.405 ' O ' HG22 ' A' ' 150' ' ' THR . 3.7 m -131.03 100.64 5.3 Favored 'General case' 0 N--CA 1.495 1.822 0 CA-C-O 121.413 0.625 . . . . 0.0 109.724 179.923 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 151' ' ' ARG . . . . . 0.58 HH12 ' CD ' ' A' ' 204' ' ' GLU . 0.1 OUTLIER -86.63 -169.99 2.88 Favored 'General case' 0 C--N 1.305 -1.347 0 N-CA-C 108.382 -0.969 . . . . 0.0 108.382 179.466 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 152' ' ' LYS . . . . . 0.42 ' C ' ' CD1' ' A' ' 153' ' ' TYR . 24.8 mtmm -153.22 151.29 29.9 Favored 'General case' 0 C--N 1.3 -1.57 0 O-C-N 121.327 -0.858 . . . . 0.0 109.7 -179.857 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 153' ' ' TYR . . . . . 0.508 ' CD2' ' HA ' ' A' ' 204' ' ' GLU . 6.2 m-85 -142.79 168.81 18.85 Favored 'General case' 0 N--CA 1.493 1.706 0 N-CA-C 107.856 -1.164 . . . . 0.0 107.856 178.759 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 154' ' ' LYS . . . . . . . . . . . . . 20.5 ttpt -142.9 119.38 10.98 Favored 'General case' 0 N--CA 1.493 1.678 0 O-C-N 121.51 -0.744 . . . . 0.0 109.186 178.884 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 155' ' ' MET . . . . . . . . . . . . . 29.2 mtp -47.28 105.62 0.07 Allowed 'General case' 0 N--CA 1.494 1.747 0 O-C-N 120.819 -1.176 . . . . 0.0 112.321 -178.983 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 156' ' ' THR . . . . . . . . . . . . . 1.3 m -105.39 -21.29 13.26 Favored 'General case' 0 N--CA 1.494 1.755 0 CA-C-N 115.445 -0.798 . . . . 0.0 110.168 -179.548 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 157' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -148.38 147.02 28.75 Favored 'General case' 0 N--CA 1.494 1.753 0 C-N-CA 118.336 -1.345 . . . . 0.0 110.814 -178.689 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 158' ' ' ILE . . . . . . . . . . . . . 1.1 mt -148.49 138.24 16.22 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.547 0 CA-C-O 121.577 0.703 . . . . 0.0 109.953 -178.463 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 159' ' ' ARG . . . . . . . . . . . . . 5.7 ttm180 -156.45 -161.96 1.19 Allowed 'General case' 0 N--CA 1.497 1.893 0 O-C-N 121.325 -0.859 . . . . 0.0 110.594 -179.565 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 160' ' ' ASP . . . . . . . . . . . . . 67.4 m-20 -149.09 156.17 41.81 Favored 'General case' 0 N--CA 1.498 1.956 0 N-CA-C 108.954 -0.758 . . . . 0.0 108.954 -179.909 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 161' ' ' VAL . . . . . 0.454 ' O ' ' O ' ' A' ' 162' ' ' LYS . 0.1 OUTLIER -149.15 148.08 16.04 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.807 0 O-C-N 120.699 -1.251 . . . . 0.0 110.359 179.851 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 162' ' ' LYS . . . . . 0.578 ' H ' ' CD ' ' A' ' 162' ' ' LYS . 0.0 OUTLIER -44.33 169.07 0.07 OUTLIER Pre-proline 0 N--CA 1.494 1.756 0 O-C-N 121.409 -0.807 . . . . 0.0 110.191 179.997 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 163' ' ' PRO . . . . . 0.418 ' C ' HD21 ' C' ' 702' ' ' LEU . 58.0 Cg_endo -78.98 23.7 0.62 Allowed 'Trans proline' 0 C--N 1.31 -1.476 0 C-N-CA 122.917 2.411 . . . . 0.0 112.572 -179.169 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 164' ' ' THR . . . . . 0.704 ' HA ' HD11 ' C' ' 702' ' ' LEU . 0.2 OUTLIER -151.22 1.69 0.41 Allowed 'General case' 0 C--N 1.299 -1.592 0 O-C-N 121.322 -0.861 . . . . 0.0 109.864 -179.488 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 165' ' ' ASP . . . . . 0.481 ' O ' ' C ' ' A' ' 166' ' ' VAL . 8.3 t70 -77.35 66.44 3.11 Favored 'General case' 0 N--CA 1.493 1.687 0 O-C-N 121.15 -0.969 . . . . 0.0 110.334 -179.877 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 166' ' ' VAL . . . . . 0.639 ' O ' ' N ' ' A' ' 168' ' ' VAL . 0.9 OUTLIER -38.0 -32.54 0.11 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.576 0 O-C-N 121.158 -0.963 . . . . 0.0 109.375 -178.638 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 167' ' ' GLY . . . . . 0.466 ' N ' ' O ' ' A' ' 165' ' ' ASP . . . -43.16 -15.71 0.03 OUTLIER Glycine 0 N--CA 1.491 2.325 0 N-CA-C 108.848 -1.701 . . . . 0.0 108.848 179.428 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 168' ' ' VAL . . . . . 0.639 ' N ' ' O ' ' A' ' 166' ' ' VAL . 3.5 t -49.98 -44.28 21.39 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.735 0 N-CA-C 108.168 -1.049 . . . . 0.0 108.168 178.412 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 169' ' ' LEU . . . . . 0.54 ' O ' ' C ' ' A' ' 170' ' ' ASP . 8.9 mt -50.2 -9.38 0.04 OUTLIER 'General case' 0 C--N 1.299 -1.628 0 N-CA-C 108.425 -0.954 . . . . 0.0 108.425 -177.396 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 170' ' ' ASP . . . . . 0.553 ' H ' ' C ' ' A' ' 168' ' ' VAL . 10.6 p30 18.46 80.87 0.01 OUTLIER 'General case' 0 N--CA 1.5 2.05 0 CA-C-N 116.582 -0.281 . . . . 0.0 111.699 177.793 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 171' ' ' GLU . . . . . . . . . . . . . 3.7 pt-20 -117.33 65.09 0.73 Allowed 'General case' 0 N--CA 1.493 1.692 0 O-C-N 121.152 -0.967 . . . . 0.0 110.069 179.833 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 172' ' ' GLN . . . . . . . . . . . . . 12.2 mt-30 -134.44 -45.91 0.76 Allowed 'General case' 0 N--CA 1.492 1.663 0 O-C-N 121.41 -0.806 . . . . 0.0 110.253 -178.598 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 173' ' ' LYS . . . . . . . . . . . . . 17.9 mttp -62.64 135.15 57.24 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 120.769 -1.207 . . . . 0.0 108.615 179.049 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 174' ' ' GLY . . . . . 0.52 ' O ' ' C ' ' A' ' 175' ' ' LYS . . . -141.21 -40.64 0.08 OUTLIER Glycine 0 C--N 1.295 -1.707 0 N-CA-C 108.138 -1.985 . . . . 0.0 108.138 179.899 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 175' ' ' LYS . . . . . 0.52 ' C ' ' O ' ' A' ' 174' ' ' GLY . 13.0 mptt -31.84 -64.08 0.17 Allowed 'General case' 0 N--CA 1.501 2.075 0 N-CA-C 108.653 -0.869 . . . . 0.0 108.653 179.196 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 176' ' ' ASP . . . . . 0.726 ' O ' ' O ' ' A' ' 177' ' ' LYS . 2.6 m-20 -101.93 73.28 1.39 Allowed 'General case' 0 C--N 1.297 -1.706 0 N-CA-C 107.255 -1.387 . . . . 0.0 107.255 177.627 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 177' ' ' LYS . . . . . 0.726 ' O ' ' O ' ' A' ' 176' ' ' ASP . 28.2 mttt -20.62 157.79 0.0 OUTLIER 'General case' 0 N--CA 1.504 2.233 0 CA-C-O 122.132 0.968 . . . . 0.0 111.851 -178.907 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 178' ' ' GLN . . . . . . . . . . . . . 3.3 pt20 -156.07 170.89 21.14 Favored 'General case' 0 N--CA 1.488 1.467 0 C-N-CA 117.096 -1.842 . . . . 0.0 112.084 -178.727 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 179' ' ' LEU . . . . . 0.41 ' HB2' ' CE2' ' A' ' 153' ' ' TYR . 0.7 OUTLIER -126.55 97.78 5.15 Favored 'General case' 0 C--N 1.303 -1.433 0 N-CA-C 107.237 -1.394 . . . . 0.0 107.237 178.366 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 180' ' ' THR . . . . . . . . . . . . . 1.1 m -71.23 121.06 17.71 Favored 'General case' 0 C--N 1.302 -1.464 0 C-N-CA 118.726 -1.19 . . . . 0.0 110.004 -178.615 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 181' ' ' LEU . . . . . 0.526 HD11 ' CE2' ' A' ' 130' ' ' PHE . 66.8 tp -94.55 152.25 18.69 Favored 'General case' 0 C--N 1.298 -1.654 0 N-CA-C 107.589 -1.263 . . . . 0.0 107.589 177.632 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 182' ' ' ILE . . . . . 0.404 HG21 ' HG2' ' C' ' 703' ' ' PRO . 36.5 mt -142.12 109.22 1.99 Allowed 'Isoleucine or valine' 0 C--N 1.301 -1.53 0 C-N-CA 119.083 -1.047 . . . . 0.0 109.242 178.941 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 183' ' ' THR . . . . . . . . . . . . . 1.2 t -129.21 109.36 11.08 Favored 'General case' 0 C--N 1.294 -1.836 0 N-CA-C 107.751 -1.203 . . . . 0.0 107.751 179.635 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 184' ' ' CYS . . . . . . . . . . . . . 4.0 p -81.06 157.96 25.24 Favored 'General case' 0 C--N 1.293 -1.879 0 C-N-CA 119.182 -1.007 . . . . 0.0 111.349 -177.609 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 185' ' ' ASP . . . . . 0.534 ' CG ' ' H ' ' A' ' 186' ' ' ASP . 43.9 t0 -164.3 -158.4 0.42 Allowed 'General case' 0 N--CA 1.489 1.509 0 N-CA-C 108.88 -0.785 . . . . 0.0 108.88 -179.536 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 186' ' ' ASP . . . . . 0.534 ' H ' ' CG ' ' A' ' 185' ' ' ASP . 1.3 m-20 56.91 49.35 14.2 Favored 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.161 -0.962 . . . . 0.0 109.675 179.561 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 187' ' ' TYR . . . . . 0.58 ' CE1' ' O ' ' A' ' 188' ' ' ASN . 33.9 t80 -65.43 128.69 36.91 Favored 'General case' 0 C--N 1.297 -1.674 0 O-C-N 121.075 -1.016 . . . . 0.0 109.772 -179.945 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 188' ' ' ASN . . . . . 0.948 ' ND2' ' H ' ' A' ' 190' ' ' LYS . 0.0 OUTLIER -97.85 150.55 21.17 Favored 'General case' 0 C--N 1.294 -1.838 0 N-CA-C 107.886 -1.153 . . . . 0.0 107.886 178.591 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 189' ' ' GLU . . . . . . . . . . . . . 1.7 tt0 -112.58 -5.95 13.97 Favored 'General case' 0 C--N 1.294 -1.831 0 N-CA-C 108.674 -0.862 . . . . 0.0 108.674 -178.683 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 190' ' ' LYS . . . . . 0.948 ' H ' ' ND2' ' A' ' 188' ' ' ASN . 10.2 mmtm -84.06 -57.45 3.18 Favored 'General case' 0 C--N 1.299 -1.618 0 N-CA-C 108.939 -0.763 . . . . 0.0 108.939 179.401 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 191' ' ' THR . . . . . 0.92 ' N ' HD22 ' A' ' 188' ' ' ASN . 1.5 p -89.25 0.14 57.0 Favored 'General case' 0 N--CA 1.494 1.77 0 O-C-N 121.443 -0.785 . . . . 0.0 109.706 179.647 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 192' ' ' GLY . . . . . . . . . . . . . . . 60.34 37.2 92.73 Favored Glycine 0 N--CA 1.498 2.783 0 N-CA-C 110.634 -0.986 . . . . 0.0 110.634 179.318 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 193' ' ' VAL . . . . . 0.609 HG12 ' N ' ' A' ' 194' ' ' TRP . 73.9 t -148.64 163.84 4.99 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.629 0 O-C-N 120.996 -1.297 . . . . 0.0 110.298 179.879 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 194' ' ' TRP . . . . . 0.609 ' N ' HG12 ' A' ' 193' ' ' VAL . 5.5 m95 -82.44 121.36 26.64 Favored 'General case' 0 N--CA 1.489 1.518 0 N-CA-C 108.373 -0.973 . . . . 0.0 108.373 179.257 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 195' ' ' GLU . . . . . . . . . . . . . 2.5 mt-10 -86.16 -57.39 3.04 Favored 'General case' 0 C--N 1.3 -1.566 0 O-C-N 121.15 -0.969 . . . . 0.0 110.463 -178.597 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 196' ' ' LYS . . . . . . . . . . . . . 2.6 mttp -92.33 143.65 26.18 Favored 'General case' 0 N--CA 1.489 1.494 0 O-C-N 120.911 -1.118 . . . . 0.0 110.205 -179.302 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 197' ' ' ARG . . . . . 0.653 ' CG ' HH11 ' A' ' 197' ' ' ARG . 0.2 OUTLIER -122.14 144.42 48.95 Favored 'General case' 0 N--CA 1.488 1.447 0 N-CA-C 108.784 -0.821 . . . . 0.0 108.784 179.108 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 198' ' ' LYS . . . . . . . . . . . . . 13.4 mptt -115.78 119.42 35.96 Favored 'General case' 0 C--N 1.299 -1.606 0 C-N-CA 120.349 -0.54 . . . . 0.0 110.087 -178.91 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 199' ' ' ILE . . . . . 0.456 ' C ' HD12 ' A' ' 199' ' ' ILE . 1.0 OUTLIER -136.33 118.15 19.94 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.566 0 CA-C-O 122.716 1.246 . . . . 0.0 109.018 178.968 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 200' ' ' PHE . . . . . 0.535 ' CD1' ' N ' ' A' ' 200' ' ' PHE . 1.0 OUTLIER -102.84 138.37 39.82 Favored 'General case' 0 N--CA 1.492 1.671 0 CA-C-N 115.6 -0.727 . . . . 0.0 111.257 -176.918 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 201' ' ' VAL . . . . . . . . . . . . . 47.0 t -105.94 143.22 17.31 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.37 0 O-C-N 121.523 -0.736 . . . . 0.0 109.396 177.799 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 202' ' ' ALA . . . . . . . . . . . . . . . -130.37 137.57 49.96 Favored 'General case' 0 C--N 1.301 -1.502 0 N-CA-C 107.978 -1.119 . . . . 0.0 107.978 179.662 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 203' ' ' THR . . . . . 0.679 ' O ' HG23 ' A' ' 205' ' ' VAL . 0.2 OUTLIER -89.89 132.82 35.09 Favored 'General case' 0 C--N 1.303 -1.422 0 CA-C-O 122.576 1.179 . . . . 0.0 111.549 -178.796 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 204' ' ' GLU . . . . . 0.58 ' CD ' HH12 ' A' ' 151' ' ' ARG . 3.9 tt0 -49.45 135.01 18.5 Favored 'General case' 0 C--N 1.293 -1.888 0 C-N-CA 118.459 -1.296 . . . . 0.0 108.796 178.575 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 205' ' ' VAL . . . . . 0.679 HG23 ' O ' ' A' ' 203' ' ' THR . 70.8 t -129.79 162.41 37.5 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.547 0 CA-C-O 122.082 0.944 . . . . 0.0 110.284 -177.739 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 206' ' ' LYS . . . . . 0.55 ' N ' HG12 ' A' ' 205' ' ' VAL . 4.6 ptmt . . . . . 0 C--N 1.298 -1.651 0 CA-C-O 118.145 -0.931 . . . . 0.0 109.42 -179.661 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' C' C ' 702' ' ' LEU . . . . . 0.884 ' N ' HD12 ' C' ' 702' ' ' LEU . 0.0 OUTLIER . . . . . 0 N--CA 1.485 1.32 0 N-CA-C 108.304 -0.998 . . . . 0.0 108.304 . . . . . . . . . 2 2 . 1 . 020 nuclear build core ' C' C ' 703' ' ' PRO . . . . . 0.603 ' O ' ' NH2' ' A' ' 197' ' ' ARG . 88.7 Cg_endo -81.1 172.76 12.56 Favored 'Trans proline' 0 C--N 1.303 -1.848 0 C-N-CA 122.632 2.221 . . . . 0.0 112.406 -179.688 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' C' C ' 704' ' ' ALA . . . . . 0.478 ' C ' ' O ' ' C' ' 703' ' ' PRO . . . . . . . . 0 N--CA 1.492 1.643 0 CA-C-O 121.536 0.684 . . . . 0.0 110.422 178.802 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 59' ' ' MET . . . . . . . . . . . . . 11.1 mtp . . . . . 0 N--CA 1.491 1.592 0 CA-C-O 121.212 0.529 . . . . 0.0 109.628 . . . . . . . . . 0 0 . 1 . 001 nuclear build full ' A' A ' 60' ' ' GLN . . . . . . . . . . . . . 9.6 mm100 -60.03 173.39 0.63 Allowed 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.252 -0.905 . . . . 0.0 109.471 -179.773 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 61' ' ' ALA . . . . . 0.411 ' HB2' ' OD1' ' A' ' 148' ' ' ASN . . . -64.09 156.88 26.91 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.23 -0.919 . . . . 0.0 109.424 -179.988 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 62' ' ' LYS . . . . . 0.644 ' O ' ' NE2' ' A' ' 64' ' ' GLN . 0.0 OUTLIER -147.61 71.18 11.63 Favored Pre-proline 0 N--CA 1.488 1.446 0 O-C-N 121.293 -0.879 . . . . 0.0 109.022 -179.9 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 63' ' ' PRO . . . . . 0.458 ' O ' HD22 ' A' ' 110' ' ' LEU . 6.7 Cg_exo -68.37 139.44 45.46 Favored 'Trans proline' 0 C--N 1.302 -1.876 0 C-N-CA 122.725 2.283 . . . . 0.0 111.288 -179.868 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 64' ' ' GLN . . . . . 0.644 ' NE2' ' O ' ' A' ' 62' ' ' LYS . 0.0 OUTLIER -155.75 126.9 7.09 Favored 'General case' 0 C--N 1.3 -1.56 0 O-C-N 121.117 -0.99 . . . . 0.0 109.347 179.316 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 65' ' ' ILE . . . . . 0.582 ' H ' HD12 ' A' ' 65' ' ' ILE . 2.1 mp -46.27 106.37 0.56 Allowed Pre-proline 0 N--CA 1.489 1.495 0 N-CA-C 107.519 -1.289 . . . . 0.0 107.519 178.935 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 66' ' ' PRO . . . . . . . . . . . . . 89.0 Cg_endo -83.42 -162.84 0.18 Allowed 'Trans proline' 0 C--N 1.315 -1.185 0 C-N-CA 122.462 2.108 . . . . 0.0 112.834 -178.111 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 67' ' ' LYS . . . . . . . . . . . . . 24.8 tttm -87.65 -7.56 57.29 Favored 'General case' 0 N--CA 1.487 1.423 0 O-C-N 121.414 -0.803 . . . . 0.0 109.421 179.965 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 68' ' ' ASP . . . . . 0.654 ' O ' ' N ' ' A' ' 70' ' ' SER . 0.7 OUTLIER -76.23 63.38 1.88 Allowed 'General case' 0 N--CA 1.488 1.461 0 CA-C-O 122.936 1.35 . . . . 0.0 108.822 179.561 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 69' ' ' LYS . . . . . 0.462 ' C ' ' O ' ' A' ' 68' ' ' ASP . 8.2 ptpt -45.45 -14.57 0.02 OUTLIER 'General case' 0 N--CA 1.512 2.67 0 C-N-CA 116.881 -1.928 . . . . 0.0 107.321 178.086 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 70' ' ' SER . . . . . 0.654 ' N ' ' O ' ' A' ' 68' ' ' ASP . 0.6 OUTLIER -86.83 -7.29 58.37 Favored 'General case' 0 N--CA 1.498 1.969 0 CA-C-N 113.856 -1.52 . . . . 0.0 111.661 179.793 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 71' ' ' LYS . . . . . 0.47 ' N ' ' O ' ' A' ' 68' ' ' ASP . 0.0 OUTLIER -97.05 142.47 28.95 Favored 'General case' 0 N--CA 1.505 2.323 0 O-C-N 120.435 -1.416 . . . . 0.0 112.552 -178.838 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 72' ' ' VAL . . . . . 0.844 HG12 ' CE1' ' A' ' 88' ' ' TYR . 2.6 m -68.0 130.55 33.27 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.418 0 N-CA-C 105.375 -2.083 . . . . 0.0 105.375 174.965 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 73' ' ' ALA . . . . . 0.607 ' N ' ' O ' ' A' ' 87' ' ' VAL . . . -79.02 -13.99 59.45 Favored 'General case' 0 C--N 1.293 -1.855 0 O-C-N 119.999 -1.688 . . . . 0.0 107.398 -179.596 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . 173.5 -157.72 26.5 Favored Glycine 0 N--CA 1.479 1.524 0 N-CA-C 109.48 -1.448 . . . . 0.0 109.48 179.771 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 75' ' ' TYR . . . . . 0.606 ' HA ' HG23 ' A' ' 87' ' ' VAL . 69.1 m-85 -142.06 169.72 17.06 Favored 'General case' 0 C--N 1.295 -1.787 0 CA-C-O 121.961 0.886 . . . . 0.0 110.456 -177.591 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 76' ' ' ILE . . . . . . . . . . . . . 0.8 OUTLIER -147.27 142.28 20.03 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.72 0 C-N-CA 119.234 -0.986 . . . . 0.0 109.634 -177.362 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -151.52 162.31 41.19 Favored 'General case' 0 N--CA 1.487 1.409 0 O-C-N 121.193 -0.942 . . . . 0.0 109.759 -179.934 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 78' ' ' ILE . . . . . 0.544 ' HB ' ' HB3' ' A' ' 81' ' ' ALA . 9.5 mt -145.65 123.76 6.4 Favored Pre-proline 0 C--N 1.303 -1.434 0 N-CA-C 107.821 -1.178 . . . . 0.0 107.821 179.338 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 79' ' ' PRO . . . . . . . . . . . . . 41.5 Cg_endo -71.94 -43.69 1.15 Allowed 'Trans proline' 0 C--N 1.314 -1.255 0 C-N-CA 121.867 1.712 . . . . 0.0 112.949 -178.798 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 1.3 m-20 -66.61 -21.4 66.13 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 120.959 -1.088 . . . . 0.0 110.861 178.339 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 81' ' ' ALA . . . . . 0.847 ' HB2' ' HB2' ' A' ' 136' ' ' ALA . . . -105.04 -15.89 14.97 Favored 'General case' 0 N--CA 1.496 1.838 0 O-C-N 121.139 -0.975 . . . . 0.0 109.095 179.672 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 82' ' ' ASP . . . . . . . . . . . . . 20.8 t0 62.84 52.2 2.77 Favored 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.472 -0.768 . . . . 0.0 110.847 179.292 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 83' ' ' ILE . . . . . . . . . . . . . 70.2 mt -127.27 152.85 35.79 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.735 0 O-C-N 121.229 -0.919 . . . . 0.0 109.677 -179.239 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 84' ' ' LYS . . . . . . . . . . . . . 34.6 tttp -158.21 106.49 1.98 Allowed 'General case' 0 N--CA 1.491 1.61 0 N-CA-C 107.778 -1.193 . . . . 0.0 107.778 -179.95 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 85' ' ' GLU . . . . . 0.508 ' OE2' ' O ' ' A' ' 128' ' ' TYR . 0.0 OUTLIER -141.31 165.54 28.2 Favored Pre-proline 0 N--CA 1.495 1.791 0 O-C-N 121.14 -0.975 . . . . 0.0 110.779 -178.366 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 86' ' ' PRO . . . . . . . . . . . . . 56.0 Cg_endo -73.57 168.13 25.55 Favored 'Trans proline' 0 N--CA 1.497 1.681 0 C-N-CA 123.335 2.69 . . . . 0.0 113.796 -179.595 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 87' ' ' VAL . . . . . 0.607 ' O ' ' N ' ' A' ' 73' ' ' ALA . 54.8 t -126.35 104.19 12.55 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.841 0 N-CA-C 109.368 -0.605 . . . . 0.0 109.368 179.917 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 88' ' ' TYR . . . . . 0.844 ' CE1' HG12 ' A' ' 72' ' ' VAL . 11.9 m-85 -94.92 156.76 37.66 Favored Pre-proline 0 N--CA 1.504 2.26 0 O-C-N 120.766 -1.209 . . . . 0.0 109.801 179.98 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 89' ' ' PRO . . . . . . . . . . . . . 13.4 Cg_endo -62.84 145.16 94.59 Favored 'Trans proline' 0 N--CA 1.498 1.778 0 C-N-CA 122.637 2.225 . . . . 0.0 113.273 179.591 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . -60.46 169.17 8.4 Favored Glycine 0 N--CA 1.494 2.527 0 N-CA-C 109.383 -1.487 . . . . 0.0 109.383 179.318 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 91' ' ' PRO . . . . . 0.525 ' HD2' HE21 ' A' ' 96' ' ' GLN . 57.3 Cg_endo -93.5 169.15 20.47 Favored 'Cis proline' 0 C--N 1.307 -1.622 0 C-N-CA 123.966 -1.264 . . . . 0.0 111.989 0.194 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 92' ' ' ALA . . . . . 0.7 ' HB1' HD21 ' A' ' 97' ' ' LEU . . . -71.83 32.26 0.05 Allowed 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.214 -0.929 . . . . 0.0 109.988 179.957 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 93' ' ' THR . . . . . 0.494 ' OG1' ' NE2' ' A' ' 96' ' ' GLN . 5.4 p -72.22 150.48 92.11 Favored Pre-proline 0 C--N 1.303 -1.431 0 O-C-N 120.481 -1.387 . . . . 0.0 108.025 179.761 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 94' ' ' PRO . . . . . . . . . . . . . 74.1 Cg_exo -32.96 -52.8 0.41 Allowed 'Trans proline' 0 C--N 1.306 -1.7 0 C-N-CA 122.893 2.396 . . . . 0.0 112.965 -178.549 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 95' ' ' GLU . . . . . 0.403 ' O ' ' OD1' ' A' ' 98' ' ' ASN . 14.3 mt-10 -49.89 -47.84 51.85 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.079 -1.013 . . . . 0.0 110.061 -179.74 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 96' ' ' GLN . . . . . 0.579 ' O ' ' N ' ' A' ' 98' ' ' ASN . 2.5 mp0 -72.57 -53.99 10.4 Favored 'General case' 0 N--CA 1.489 1.487 0 O-C-N 120.98 -1.075 . . . . 0.0 110.187 -179.68 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 97' ' ' LEU . . . . . 0.7 HD21 ' HB1' ' A' ' 92' ' ' ALA . 94.0 mt -49.31 -6.56 0.02 OUTLIER 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.145 -0.972 . . . . 0.0 109.684 -179.26 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 98' ' ' ASN . . . . . 0.579 ' N ' ' O ' ' A' ' 96' ' ' GLN . 0.0 OUTLIER -73.88 -20.39 60.43 Favored 'General case' 0 N--CA 1.488 1.447 0 O-C-N 121.252 -0.905 . . . . 0.0 109.2 179.903 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 99' ' ' ARG . . . . . 0.41 ' HG3' ' ND2' ' A' ' 98' ' ' ASN . 3.0 mtt180 -103.06 -58.16 1.92 Allowed 'General case' 0 N--CA 1.489 1.492 0 O-C-N 121.379 -0.825 . . . . 0.0 110.182 -179.357 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . -173.82 -172.43 39.15 Favored Glycine 0 N--CA 1.492 2.4 0 C-N-CA 119.373 -1.394 . . . . 0.0 110.505 -179.752 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 101' ' ' VAL . . . . . 0.695 HG23 ' O ' ' A' ' 101' ' ' VAL . 34.0 m -51.49 103.75 0.05 OUTLIER 'Isoleucine or valine' 0 N--CA 1.493 1.701 0 O-C-N 121.575 -0.956 . . . . 0.0 110.017 -179.817 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -91.55 160.75 15.26 Favored 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.193 -0.942 . . . . 0.0 110.158 179.927 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 103' ' ' PHE . . . . . 0.563 ' O ' ' N ' ' A' ' 105' ' ' GLU . 23.1 m-85 -63.74 121.2 13.4 Favored 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.009 -1.057 . . . . 0.0 108.357 178.769 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 104' ' ' ALA . . . . . 0.615 ' HB3' ' HB2' ' A' ' 116' ' ' SER . . . -45.23 -12.45 0.02 OUTLIER 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.464 -0.772 . . . . 0.0 110.516 -179.063 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 105' ' ' GLU . . . . . 0.563 ' N ' ' O ' ' A' ' 103' ' ' PHE . 0.1 OUTLIER -136.6 142.7 43.34 Favored 'General case' 0 N--CA 1.494 1.753 0 O-C-N 120.852 -1.155 . . . . 0.0 110.23 179.958 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 106' ' ' GLU . . . . . 0.467 ' OE1' ' ND2' ' A' ' 107' ' ' ASN . 24.3 tt0 -58.79 -63.41 1.3 Allowed 'General case' 0 N--CA 1.488 1.439 0 CA-C-N 116.173 -0.467 . . . . 0.0 111.438 -178.904 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 107' ' ' ASN . . . . . 0.467 ' ND2' ' OE1' ' A' ' 106' ' ' GLU . 1.7 m120 -79.05 35.45 0.26 Allowed 'General case' 0 N--CA 1.49 1.572 0 O-C-N 120.653 -1.279 . . . . 0.0 113.138 -175.694 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 108' ' ' GLU . . . . . . . . . . . . . 1.5 tp10 -58.92 150.47 24.25 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 120.554 -1.341 . . . . 0.0 107.924 179.858 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 109' ' ' SER . . . . . . . . . . . . . 1.5 t -102.73 146.19 28.59 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.006 -1.059 . . . . 0.0 110.975 -178.192 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 110' ' ' LEU . . . . . 0.491 HD11 HG21 ' A' ' 146' ' ' VAL . 4.4 tp -62.4 -20.83 64.86 Favored 'General case' 0 N--CA 1.488 1.46 0 N-CA-C 107.79 -1.189 . . . . 0.0 107.79 178.827 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 111' ' ' ASP . . . . . 0.523 ' CG ' HH22 ' A' ' 151' ' ' ARG . 0.9 OUTLIER -131.46 43.23 3.1 Favored 'General case' 0 C--N 1.302 -1.497 0 N-CA-C 108.573 -0.899 . . . . 0.0 108.573 179.58 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 112' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -70.21 154.12 42.29 Favored 'General case' 0 C--N 1.302 -1.47 0 O-C-N 121.173 -0.954 . . . . 0.0 111.095 -179.812 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 113' ' ' GLN . . . . . 0.533 ' N ' ' CD ' ' A' ' 113' ' ' GLN . 0.0 OUTLIER -67.65 -18.27 64.89 Favored 'General case' 0 C--N 1.3 -1.585 0 N-CA-C 108.255 -1.017 . . . . 0.0 108.255 177.626 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 114' ' ' ASN . . . . . 0.57 ' OD1' ' NE2' ' A' ' 178' ' ' GLN . 11.2 t30 -150.84 105.7 3.3 Favored 'General case' 0 C--N 1.298 -1.654 0 N-CA-C 108.438 -0.949 . . . . 0.0 108.438 178.852 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 115' ' ' ILE . . . . . 0.532 HG22 ' O ' ' A' ' 115' ' ' ILE . 3.8 mt -95.13 105.34 16.86 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.446 0 O-C-N 120.876 -1.14 . . . . 0.0 108.284 179.806 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 116' ' ' SER . . . . . 0.615 ' HB2' ' HB3' ' A' ' 104' ' ' ALA . 11.5 m -91.72 153.85 19.37 Favored 'General case' 0 N--CA 1.488 1.454 0 O-C-N 121.286 -0.883 . . . . 0.0 111.23 -178.262 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 117' ' ' ILE . . . . . 0.411 HD13 HG21 ' A' ' 117' ' ' ILE . 2.3 mt -148.74 148.18 16.13 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.43 0 N-CA-C 108.124 -1.065 . . . . 0.0 108.124 179.286 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 118' ' ' ALA . . . . . 1.019 ' HB1' ' HB2' ' C' ' 704' ' ' ALA . . . -142.26 160.37 40.38 Favored 'General case' 0 N--CA 1.492 1.634 0 C-N-CA 118.934 -1.106 . . . . 0.0 111.597 -178.919 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 119' ' ' GLY . . . . . . . . . . . . . . . -171.53 149.77 12.56 Favored Glycine 0 N--CA 1.489 2.205 0 N-CA-C 110.214 -1.155 . . . . 0.0 110.214 -179.947 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 120' ' ' HIS . . . . . . . . . . . . . 14.1 m170 -70.18 168.12 16.38 Favored 'General case' 0 N--CA 1.494 1.74 0 O-C-N 121.728 -0.866 . . . . 0.0 110.128 179.517 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 121' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -115.78 160.34 20.25 Favored 'General case' 0 N--CA 1.496 1.843 0 O-C-N 121.362 -0.836 . . . . 0.0 109.425 179.455 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 122' ' ' PHE . . . . . 0.413 ' O ' HG21 ' A' ' 131' ' ' THR . 0.2 OUTLIER -133.48 123.49 25.34 Favored 'General case' 0 N--CA 1.497 1.92 0 O-C-N 121.238 -0.914 . . . . 0.0 109.612 -179.409 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 123' ' ' ILE . . . . . 0.608 HG23 ' N ' ' A' ' 124' ' ' ASP . 0.6 OUTLIER -66.0 -42.56 91.94 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.667 0 CA-C-O 121.71 0.767 . . . . 0.0 109.01 179.76 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 124' ' ' ASP . . . . . 0.608 ' N ' HG23 ' A' ' 123' ' ' ILE . 5.8 t70 -92.76 24.84 3.38 Favored 'General case' 0 N--CA 1.496 1.867 0 O-C-N 121.616 -0.678 . . . . 0.0 111.956 -177.917 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 125' ' ' ARG . . . . . 0.622 HH11 ' CG ' ' A' ' 125' ' ' ARG . 0.0 OUTLIER -157.92 103.57 1.76 Allowed Pre-proline 0 N--CA 1.492 1.647 0 O-C-N 120.347 -1.47 . . . . 0.0 110.406 -179.432 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 126' ' ' PRO . . . . . . . . . . . . . 60.1 Cg_endo -79.13 -17.0 12.08 Favored 'Trans proline' 0 C--N 1.315 -1.206 0 C-N-CA 122.078 1.852 . . . . 0.0 111.822 179.728 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 127' ' ' ASN . . . . . . . . . . . . . 14.0 m120 -90.89 10.79 24.92 Favored 'General case' 0 N--CA 1.488 1.448 0 O-C-N 121.309 -0.869 . . . . 0.0 109.515 179.75 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 128' ' ' TYR . . . . . 0.508 ' O ' ' OE2' ' A' ' 85' ' ' GLU . 2.7 t80 -68.17 -153.07 0.02 OUTLIER 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.154 -0.966 . . . . 0.0 109.531 -179.924 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 129' ' ' GLN . . . . . 0.548 ' N ' ' OE1' ' A' ' 129' ' ' GLN . 1.1 mp0 -68.13 -67.15 0.48 Allowed 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.451 -0.781 . . . . 0.0 109.85 -179.705 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 130' ' ' PHE . . . . . 0.498 ' O ' ' CE ' ' A' ' 134' ' ' LYS . 57.1 m-85 -135.61 52.6 2.0 Favored 'General case' 0 N--CA 1.493 1.686 0 O-C-N 121.038 -1.039 . . . . 0.0 110.35 179.981 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 131' ' ' THR . . . . . 0.413 HG21 ' O ' ' A' ' 122' ' ' PHE . 23.4 m -86.43 -41.07 14.73 Favored 'General case' 0 C--N 1.301 -1.523 0 O-C-N 121.075 -1.016 . . . . 0.0 108.764 179.33 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 132' ' ' ASN . . . . . 0.497 ' ND2' ' O ' ' A' ' 81' ' ' ALA . 4.0 t30 -83.47 6.2 21.11 Favored 'General case' 0 N--CA 1.496 1.851 0 O-C-N 121.561 -0.712 . . . . 0.0 111.347 -178.492 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 133' ' ' LEU . . . . . 0.568 HD13 ' HB3' ' A' ' 136' ' ' ALA . 0.1 OUTLIER -69.93 -43.46 71.59 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 120.821 -1.174 . . . . 0.0 109.871 -179.557 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 134' ' ' LYS . . . . . 0.521 ' CD ' ' H ' ' A' ' 134' ' ' LYS . 0.0 OUTLIER -45.37 -17.78 0.03 OUTLIER 'General case' 0 N--CA 1.497 1.921 0 O-C-N 121.172 -0.955 . . . . 0.0 110.154 -179.442 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 135' ' ' ALA . . . . . 0.493 ' N ' ' O ' ' A' ' 133' ' ' LEU . . . -84.66 -32.5 23.59 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 120.949 -1.095 . . . . 0.0 109.38 179.89 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 136' ' ' ALA . . . . . 0.847 ' HB2' ' HB2' ' A' ' 81' ' ' ALA . . . -80.52 153.23 28.24 Favored 'General case' 0 C--N 1.302 -1.466 0 CA-C-O 122.028 0.918 . . . . 0.0 111.386 -178.808 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 137' ' ' LYS . . . . . 0.551 ' O ' ' O ' ' A' ' 138' ' ' LYS . 51.5 mttp -153.38 -165.57 2.19 Favored 'General case' 0 N--CA 1.49 1.531 0 C-N-CA 118.461 -1.295 . . . . 0.0 110.611 -178.543 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 138' ' ' LYS . . . . . 0.585 ' O ' ' N ' ' A' ' 140' ' ' SER . 0.0 OUTLIER -42.74 177.77 0.0 OUTLIER 'General case' 0 C--N 1.302 -1.462 0 CA-C-O 122.232 1.015 . . . . 0.0 110.961 -178.941 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 139' ' ' GLY . . . . . . . . . . . . . . . 46.75 8.63 0.02 OUTLIER Glycine 0 N--CA 1.489 2.191 0 N-CA-C 110.123 -1.191 . . . . 0.0 110.123 -179.943 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 140' ' ' SER . . . . . 0.585 ' N ' ' O ' ' A' ' 138' ' ' LYS . 11.7 m -80.75 122.42 27.13 Favored 'General case' 0 N--CA 1.492 1.663 0 O-C-N 120.817 -1.402 . . . . 0.0 109.544 179.616 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 141' ' ' MET . . . . . . . . . . . . . 6.5 tpt -77.66 121.89 24.6 Favored 'General case' 0 C--N 1.301 -1.515 0 N-CA-C 108.461 -0.94 . . . . 0.0 108.461 179.252 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 142' ' ' VAL . . . . . . . . . . . . . 2.8 t -112.61 135.9 50.57 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.721 0 O-C-N 121.124 -0.985 . . . . 0.0 109.688 -178.918 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 143' ' ' TYR . . . . . . . . . . . . . 67.8 m-85 -115.14 138.37 50.98 Favored 'General case' 0 N--CA 1.495 1.801 0 O-C-N 121.271 -0.893 . . . . 0.0 110.827 -179.453 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 144' ' ' PHE . . . . . 0.409 ' CD1' ' C ' ' A' ' 144' ' ' PHE . 1.4 t80 -122.26 108.45 13.28 Favored 'General case' 0 N--CA 1.494 1.733 0 O-C-N 121.692 -0.63 . . . . 0.0 109.558 -179.315 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 145' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -97.08 132.43 42.88 Favored 'General case' 0 N--CA 1.494 1.76 0 O-C-N 121.227 -0.921 . . . . 0.0 111.073 -178.791 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 146' ' ' VAL . . . . . 0.518 HG23 ' O ' ' A' ' 73' ' ' ALA . 4.2 p -143.95 143.75 23.53 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.739 0 N-CA-C 107.854 -1.165 . . . . 0.0 107.854 178.632 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 147' ' ' GLY . . . . . 0.453 ' C ' ' O ' ' A' ' 146' ' ' VAL . . . 42.37 -128.28 4.68 Favored Glycine 0 N--CA 1.491 2.308 0 N-CA-C 108.894 -1.682 . . . . 0.0 108.894 -179.597 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 148' ' ' ASN . . . . . 0.552 ' C ' HD22 ' A' ' 148' ' ' ASN . 0.4 OUTLIER -103.34 18.02 22.74 Favored 'General case' 0 C--N 1.299 -1.594 0 O-C-N 121.49 -1.006 . . . . 0.0 108.348 178.976 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 149' ' ' GLU . . . . . . . . . . . . . 7.6 tt0 -113.84 144.49 42.92 Favored 'General case' 0 N--CA 1.49 1.54 0 CA-C-O 121.917 0.865 . . . . 0.0 111.604 -178.184 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 150' ' ' THR . . . . . . . . . . . . . 52.8 m -125.64 105.08 8.75 Favored 'General case' 0 C--N 1.302 -1.48 0 CA-C-O 121.574 0.702 . . . . 0.0 109.889 179.493 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 151' ' ' ARG . . . . . 0.523 HH22 ' CG ' ' A' ' 111' ' ' ASP . 73.8 mtt180 -86.44 -173.59 4.6 Favored 'General case' 0 N--CA 1.486 1.373 0 N-CA-C 108.709 -0.848 . . . . 0.0 108.709 179.863 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 152' ' ' LYS . . . . . . . . . . . . . 6.8 mtmp? -152.49 148.07 26.98 Favored 'General case' 0 C--N 1.301 -1.52 0 C-N-CA 119.145 -1.022 . . . . 0.0 110.589 -179.489 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 153' ' ' TYR . . . . . 0.412 ' CD2' ' HA ' ' A' ' 204' ' ' GLU . 47.0 m-85 -144.45 161.55 38.76 Favored 'General case' 0 N--CA 1.489 1.49 0 N-CA-C 108.424 -0.954 . . . . 0.0 108.424 178.739 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 154' ' ' LYS . . . . . . . . . . . . . 17.8 ttmt -137.24 119.7 15.9 Favored 'General case' 0 C--N 1.299 -1.611 0 O-C-N 121.273 -0.892 . . . . 0.0 108.801 179.251 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 155' ' ' MET . . . . . . . . . . . . . 27.1 mtp -45.94 109.04 0.15 Allowed 'General case' 0 N--CA 1.494 1.741 0 CA-C-O 122.443 1.116 . . . . 0.0 111.671 -178.484 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 156' ' ' THR . . . . . 0.691 ' OG1' HG23 ' A' ' 203' ' ' THR . 0.2 OUTLIER -103.3 -28.28 11.96 Favored 'General case' 0 C--N 1.296 -1.735 0 CA-C-N 115.168 -0.923 . . . . 0.0 110.22 -178.572 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 157' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -146.95 154.69 41.57 Favored 'General case' 0 N--CA 1.496 1.84 0 C-N-CA 118.337 -1.345 . . . . 0.0 110.569 -179.048 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 158' ' ' ILE . . . . . 0.405 HG12 ' CD1' ' A' ' 200' ' ' PHE . 1.6 mt -148.27 137.31 15.62 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.652 0 CA-C-O 121.322 0.582 . . . . 0.0 109.982 -177.927 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 159' ' ' ARG . . . . . . . . . . . . . 2.2 mtt180 -156.14 -177.62 6.72 Favored 'General case' 0 N--CA 1.494 1.742 0 O-C-N 121.298 -0.877 . . . . 0.0 110.931 -179.521 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 160' ' ' ASP . . . . . 0.494 ' C ' HG22 ' A' ' 161' ' ' VAL . 9.3 m-20 -146.8 165.01 30.98 Favored 'General case' 0 N--CA 1.493 1.692 0 N-CA-C 108.48 -0.933 . . . . 0.0 108.48 179.825 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 161' ' ' VAL . . . . . 0.494 HG22 ' C ' ' A' ' 160' ' ' ASP . 0.0 OUTLIER -162.0 158.78 1.84 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.701 0 O-C-N 120.822 -1.174 . . . . 0.0 111.033 -179.874 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 162' ' ' LYS . . . . . 0.461 ' O ' ' O ' ' A' ' 161' ' ' VAL . 0.0 OUTLIER -44.05 171.23 0.04 OUTLIER Pre-proline 0 N--CA 1.493 1.693 0 O-C-N 121.767 -0.583 . . . . 0.0 110.289 179.326 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 163' ' ' PRO . . . . . 0.483 ' C ' HD11 ' C' ' 702' ' ' LEU . 71.3 Cg_endo -77.89 32.24 0.44 Allowed 'Trans proline' 0 N--CA 1.495 1.591 0 C-N-CA 122.926 2.417 . . . . 0.0 113.669 -179.839 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 164' ' ' THR . . . . . 0.517 ' N ' HD11 ' C' ' 702' ' ' LEU . 0.0 OUTLIER -152.26 -2.84 0.26 Allowed 'General case' 0 N--CA 1.495 1.796 0 O-C-N 120.839 -1.163 . . . . 0.0 111.125 179.686 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 165' ' ' ASP . . . . . 0.42 ' O ' ' C ' ' A' ' 166' ' ' VAL . 1.4 t70 -73.31 61.1 0.63 Allowed 'General case' 0 N--CA 1.491 1.582 0 O-C-N 120.748 -1.22 . . . . 0.0 110.132 -179.245 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 166' ' ' VAL . . . . . 0.596 HG22 ' O2 ' ' C' ' 701' ' ' PHQ . 2.2 t -45.75 -31.66 1.18 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.604 0 O-C-N 121.048 -1.032 . . . . 0.0 109.614 -178.998 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 167' ' ' GLY . . . . . . . . . . . . . . . -44.8 -10.99 0.01 OUTLIER Glycine 0 N--CA 1.494 2.523 0 O-C-N 120.756 -1.215 . . . . 0.0 111.116 -179.583 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 168' ' ' VAL . . . . . 0.582 ' N ' ' O ' ' A' ' 166' ' ' VAL . 5.8 m -53.8 -29.96 18.53 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.634 0 O-C-N 120.552 -1.557 . . . . 0.0 108.774 179.814 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 169' ' ' LEU . . . . . 0.543 ' O ' ' C ' ' A' ' 170' ' ' ASP . 11.7 mt -49.83 -13.59 0.1 Allowed 'General case' 0 N--CA 1.491 1.62 0 N-CA-C 107.33 -1.359 . . . . 0.0 107.33 -178.994 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 170' ' ' ASP . . . . . 0.556 ' N ' ' C ' ' A' ' 168' ' ' VAL . 40.3 t0 19.46 90.97 0.01 OUTLIER 'General case' 0 N--CA 1.5 2.053 0 CA-C-N 116.355 -0.384 . . . . 0.0 111.587 177.322 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 171' ' ' GLU . . . . . . . . . . . . . 7.8 pt-20 -128.7 72.91 1.47 Allowed 'General case' 0 N--CA 1.496 1.873 0 O-C-N 120.952 -1.092 . . . . 0.0 111.099 -179.615 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 172' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -128.73 -52.12 1.24 Allowed 'General case' 0 N--CA 1.498 1.965 0 O-C-N 121.335 -0.853 . . . . 0.0 111.519 -178.559 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 173' ' ' LYS . . . . . . . . . . . . . 56.9 mttt -58.51 130.6 47.58 Favored 'General case' 0 N--CA 1.498 1.961 0 O-C-N 120.841 -1.162 . . . . 0.0 109.655 -179.34 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 174' ' ' GLY . . . . . 0.53 ' O ' ' C ' ' A' ' 175' ' ' LYS . . . -122.48 -43.76 0.37 Allowed Glycine 0 N--CA 1.48 1.607 0 N-CA-C 108.657 -1.777 . . . . 0.0 108.657 179.761 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 175' ' ' LYS . . . . . 0.53 ' C ' ' O ' ' A' ' 174' ' ' GLY . 13.6 mptt -37.98 -62.9 0.52 Allowed 'General case' 0 N--CA 1.495 1.776 0 N-CA-C 107.319 -1.363 . . . . 0.0 107.319 179.309 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 176' ' ' ASP . . . . . 0.599 ' O ' ' O ' ' A' ' 177' ' ' LYS . 1.1 m-20 -104.34 91.2 3.81 Favored 'General case' 0 C--N 1.293 -1.885 0 N-CA-C 106.942 -1.503 . . . . 0.0 106.942 176.725 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 177' ' ' LYS . . . . . 0.599 ' O ' ' O ' ' A' ' 176' ' ' ASP . 9.7 mttp -45.07 -176.01 0.0 OUTLIER 'General case' 0 N--CA 1.494 1.764 0 O-C-N 121.344 -0.848 . . . . 0.0 109.683 -179.093 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 178' ' ' GLN . . . . . 0.57 ' NE2' ' OD1' ' A' ' 114' ' ' ASN . 18.6 pt20 -161.0 176.45 11.37 Favored 'General case' 0 N--CA 1.487 1.399 0 C-N-CA 118.043 -1.463 . . . . 0.0 111.399 179.581 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 179' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -130.61 96.27 4.07 Favored 'General case' 0 C--N 1.302 -1.493 0 N-CA-C 107.525 -1.287 . . . . 0.0 107.525 178.187 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 180' ' ' THR . . . . . 0.404 ' O ' HG22 ' A' ' 180' ' ' THR . 1.2 m -71.09 114.17 8.87 Favored 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.069 -1.019 . . . . 0.0 109.485 -178.979 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 181' ' ' LEU . . . . . 0.729 HD13 ' N ' ' A' ' 182' ' ' ILE . 0.3 OUTLIER -90.14 141.15 28.97 Favored 'General case' 0 C--N 1.3 -1.554 0 N-CA-C 108.234 -1.024 . . . . 0.0 108.234 178.453 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 182' ' ' ILE . . . . . 0.729 ' N ' HD13 ' A' ' 181' ' ' LEU . 73.4 mt -135.07 118.72 24.91 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.594 0 N-CA-C 107.638 -1.245 . . . . 0.0 107.638 178.903 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 183' ' ' THR . . . . . 0.482 ' O ' HG23 ' A' ' 183' ' ' THR . 3.8 t -138.62 112.09 8.17 Favored 'General case' 0 C--N 1.289 -2.038 0 N-CA-C 107.894 -1.15 . . . . 0.0 107.894 179.902 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 184' ' ' CYS . . . . . . . . . . . . . 1.9 p -78.58 157.1 28.85 Favored 'General case' 0 C--N 1.292 -1.911 0 C-N-CA 119.326 -0.95 . . . . 0.0 110.911 -177.867 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 185' ' ' ASP . . . . . . . . . . . . . 20.7 t0 -165.68 -152.86 0.16 Allowed 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.456 -0.778 . . . . 0.0 109.518 -179.735 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 186' ' ' ASP . . . . . . . . . . . . . 13.0 m-20 47.69 56.48 7.07 Favored 'General case' 0 N--CA 1.496 1.829 0 O-C-N 121.139 -0.975 . . . . 0.0 109.071 -179.707 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 187' ' ' TYR . . . . . 0.623 ' CE1' ' O ' ' A' ' 188' ' ' ASN . 32.9 t80 -67.91 136.08 53.45 Favored 'General case' 0 N--CA 1.49 1.56 0 CA-C-O 121.799 0.809 . . . . 0.0 111.013 -179.221 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 188' ' ' ASN . . . . . 0.623 ' O ' ' CE1' ' A' ' 187' ' ' TYR . 1.1 t-20 -99.43 147.53 25.17 Favored 'General case' 0 C--N 1.297 -1.705 0 N-CA-C 108.128 -1.064 . . . . 0.0 108.128 178.503 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 189' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -112.52 -13.59 13.32 Favored 'General case' 0 C--N 1.293 -1.878 0 N-CA-C 108.114 -1.069 . . . . 0.0 108.114 -179.718 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 190' ' ' LYS . . . . . . . . . . . . . 88.3 mttt -84.32 -51.26 7.12 Favored 'General case' 0 N--CA 1.488 1.474 0 N-CA-C 108.853 -0.795 . . . . 0.0 108.853 178.791 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 191' ' ' THR . . . . . 0.473 ' OG1' HG12 ' A' ' 193' ' ' VAL . 9.4 p -89.61 -10.82 44.56 Favored 'General case' 0 N--CA 1.489 1.488 0 O-C-N 121.546 -0.721 . . . . 0.0 109.075 179.79 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 192' ' ' GLY . . . . . . . . . . . . . . . 68.69 30.76 72.81 Favored Glycine 0 N--CA 1.492 2.399 0 O-C-N 121.316 -0.865 . . . . 0.0 110.945 178.733 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 193' ' ' VAL . . . . . 0.514 HG22 ' H ' ' A' ' 194' ' ' TRP . 2.2 p -145.9 169.29 6.54 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.621 0 O-C-N 120.791 -1.417 . . . . 0.0 110.201 179.397 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 194' ' ' TRP . . . . . 0.541 ' N ' ' CD1' ' A' ' 194' ' ' TRP . 9.4 m95 -86.47 121.37 28.93 Favored 'General case' 0 C--N 1.294 -1.821 0 N-CA-C 109.104 -0.702 . . . . 0.0 109.104 -179.717 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 195' ' ' GLU . . . . . 0.492 ' CD ' ' ND2' ' A' ' 188' ' ' ASN . 1.3 mt-10 -85.04 -61.17 1.84 Allowed 'General case' 0 N--CA 1.497 1.888 0 O-C-N 121.275 -0.891 . . . . 0.0 111.703 -178.216 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 196' ' ' LYS . . . . . . . . . . . . . 1.8 mtpm? -84.61 151.27 24.62 Favored 'General case' 0 N--CA 1.494 1.74 0 O-C-N 120.814 -1.179 . . . . 0.0 110.488 -178.475 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 197' ' ' ARG . . . . . 0.544 ' NH1' ' O ' ' C' ' 704' ' ' ALA . 24.1 mmt180 -120.37 137.42 54.3 Favored 'General case' 0 N--CA 1.492 1.637 0 N-CA-C 108.942 -0.762 . . . . 0.0 108.942 179.497 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 198' ' ' LYS . . . . . . . . . . . . . 5.0 mptp? -115.1 120.01 38.37 Favored 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.467 -0.771 . . . . 0.0 110.304 -179.007 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 199' ' ' ILE . . . . . 0.423 ' O ' HG13 ' A' ' 199' ' ' ILE . 1.1 pp -141.42 121.01 11.35 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.803 0 CA-C-O 122.618 1.199 . . . . 0.0 110.826 179.201 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 200' ' ' PHE . . . . . 0.526 ' CD1' ' N ' ' A' ' 200' ' ' PHE . 0.7 OUTLIER -105.04 141.42 36.65 Favored 'General case' 0 N--CA 1.494 1.773 0 O-C-N 121.131 -0.981 . . . . 0.0 111.177 -178.133 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 201' ' ' VAL . . . . . . . . . . . . . 96.8 t -102.57 149.02 7.22 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.651 0 N-CA-C 107.726 -1.213 . . . . 0.0 107.726 176.722 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 202' ' ' ALA . . . . . . . . . . . . . . . -132.27 139.89 48.42 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.002 -1.061 . . . . 0.0 109.116 -179.513 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 203' ' ' THR . . . . . 0.691 HG23 ' OG1' ' A' ' 156' ' ' THR . 16.8 p -89.86 131.19 35.92 Favored 'General case' 0 N--CA 1.487 1.416 0 CA-C-O 122.556 1.169 . . . . 0.0 111.944 -178.316 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 204' ' ' GLU . . . . . 0.412 ' HA ' ' CD2' ' A' ' 153' ' ' TYR . 1.0 OUTLIER -61.96 135.43 57.55 Favored 'General case' 0 C--N 1.299 -1.598 0 CA-C-N 114.818 -1.083 . . . . 0.0 108.957 179.016 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 205' ' ' VAL . . . . . 0.504 ' O ' ' C ' ' A' ' 206' ' ' LYS . 37.6 t -122.67 -44.47 1.88 Allowed 'Isoleucine or valine' 0 N--CA 1.494 1.76 0 O-C-N 121.382 -0.824 . . . . 0.0 109.71 -179.703 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 206' ' ' LYS . . . . . 0.504 ' C ' ' O ' ' A' ' 205' ' ' VAL . 0.0 OUTLIER . . . . . 0 N--CA 1.494 1.767 0 CA-C-O 118.093 -0.956 . . . . 0.0 110.456 -179.636 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' C' C ' 701' ' ' PHQ . . . . . 0.596 ' O2 ' HG22 ' A' ' 166' ' ' VAL . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 001 nuclear build full ' C' C ' 702' ' ' LEU . . . . . 0.657 ' N ' HD12 ' C' ' 702' ' ' LEU . 0.0 OUTLIER . . . . . 0 N--CA 1.493 1.703 0 N-CA-C 110.009 -0.367 . . . . 0.0 110.009 . . . . . . . . . 2 2 . 1 . 001 nuclear build full ' C' C ' 703' ' ' PRO . . . . . 0.545 ' HB3' ' HB3' ' A' ' 92' ' ' ALA . 31.3 Cg_exo -51.34 -160.79 0.0 OUTLIER 'Trans proline' 0 N--CA 1.493 1.476 0 C-N-CA 121.945 1.764 . . . . 0.0 111.718 179.057 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' C' C ' 704' ' ' ALA . . . . . 1.019 ' HB2' ' HB1' ' A' ' 118' ' ' ALA . . . 51.03 98.39 0.01 OUTLIER 'General case' 0 N--CA 1.489 1.481 0 O-C-N 120.981 -1.075 . . . . 0.0 109.055 179.898 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' C' C ' 705' ' ' B27 . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 001 nuclear build full ' A' A ' 700' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 002 nuclear build full ' A' A ' 59' ' ' MET . . . . . . . . . . . . . 5.8 ptp . . . . . 0 N--CA 1.492 1.674 0 N-CA-C 109.468 -0.568 . . . . 0.0 109.468 . . . . . . . . . 0 0 . 1 . 002 nuclear build full ' A' A ' 60' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -60.17 175.05 0.45 Allowed 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.296 -0.878 . . . . 0.0 109.556 -179.95 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . -65.2 147.34 53.63 Favored 'General case' 0 C--N 1.303 -1.419 0 O-C-N 121.47 -0.769 . . . . 0.0 109.756 179.986 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 62' ' ' LYS . . . . . . . . . . . . . 55.1 mttt -141.6 70.69 25.76 Favored Pre-proline 0 C--N 1.303 -1.453 0 O-C-N 121.363 -0.836 . . . . 0.0 109.103 179.437 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 63' ' ' PRO . . . . . . . . . . . . . 10.6 Cg_endo -87.4 157.46 8.03 Favored 'Trans proline' 0 C--N 1.31 -1.458 0 C-N-CA 123.51 2.807 . . . . 0.0 111.473 179.999 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 64' ' ' GLN . . . . . 0.573 ' N ' ' CD ' ' A' ' 64' ' ' GLN . 0.0 OUTLIER -153.71 119.93 5.44 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.163 -0.961 . . . . 0.0 109.433 179.732 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 65' ' ' ILE . . . . . 0.463 ' C ' ' O ' ' A' ' 64' ' ' GLN . 0.0 OUTLIER -42.18 103.78 0.32 Allowed Pre-proline 0 N--CA 1.495 1.782 0 N-CA-C 108.405 -0.961 . . . . 0.0 108.405 179.203 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 66' ' ' PRO . . . . . . . . . . . . . 88.3 Cg_endo -87.36 -159.99 0.1 OUTLIER 'Trans proline' 0 C--N 1.315 -1.191 0 C-N-CA 122.272 1.982 . . . . 0.0 112.421 -179.436 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 67' ' ' LYS . . . . . . . . . . . . . 13.5 pttt -79.67 -4.99 54.18 Favored 'General case' 0 C--N 1.302 -1.5 0 N-CA-C 108.739 -0.837 . . . . 0.0 108.739 179.765 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 68' ' ' ASP . . . . . 0.662 ' C ' ' N ' ' A' ' 70' ' ' SER . 1.0 OUTLIER -76.79 48.62 0.58 Allowed 'General case' 0 C--N 1.304 -1.396 0 CA-C-O 121.958 0.885 . . . . 0.0 109.393 179.705 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 69' ' ' LYS . . . . . 0.456 ' C ' ' O ' ' A' ' 68' ' ' ASP . 1.6 ptpt -49.3 -13.25 0.07 Allowed 'General case' 0 N--CA 1.508 2.442 0 C-N-CA 116.684 -2.006 . . . . 0.0 106.283 177.599 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 70' ' ' SER . . . . . 0.662 ' N ' ' C ' ' A' ' 68' ' ' ASP . 0.4 OUTLIER -83.43 -9.66 58.88 Favored 'General case' 0 N--CA 1.496 1.83 0 CA-C-N 113.164 -1.835 . . . . 0.0 110.162 179.221 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 71' ' ' LYS . . . . . 0.442 ' N ' ' O ' ' A' ' 68' ' ' ASP . 0.0 OUTLIER -97.36 142.98 28.57 Favored 'General case' 0 N--CA 1.496 1.838 0 O-C-N 120.991 -1.068 . . . . 0.0 110.753 179.601 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 72' ' ' VAL . . . . . 0.549 HG12 ' CZ ' ' A' ' 88' ' ' TYR . 0.8 OUTLIER -66.16 141.94 17.4 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.527 0 N-CA-C 105.131 -2.174 . . . . 0.0 105.131 174.702 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 73' ' ' ALA . . . . . 0.517 ' N ' ' O ' ' A' ' 87' ' ' VAL . . . -82.8 -15.9 49.88 Favored 'General case' 0 C--N 1.295 -1.762 0 O-C-N 119.928 -1.732 . . . . 0.0 106.704 179.75 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 74' ' ' GLY . . . . . 0.415 ' N ' HG23 ' A' ' 72' ' ' VAL . . . 175.4 -157.83 24.73 Favored Glycine 0 N--CA 1.479 1.546 0 N-CA-C 109.318 -1.513 . . . . 0.0 109.318 179.584 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 75' ' ' TYR . . . . . 0.605 ' HA ' HG23 ' A' ' 87' ' ' VAL . 0.6 OUTLIER -143.15 168.35 19.96 Favored 'General case' 0 C--N 1.295 -1.778 0 O-C-N 121.682 -0.893 . . . . 0.0 110.463 -177.234 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 76' ' ' ILE . . . . . . . . . . . . . 2.4 tt -148.75 145.91 17.84 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.601 0 C-N-CA 119.225 -0.99 . . . . 0.0 110.075 -178.04 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -150.65 166.43 30.36 Favored 'General case' 0 N--CA 1.489 1.49 0 O-C-N 121.059 -1.026 . . . . 0.0 109.289 179.371 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 78' ' ' ILE . . . . . 0.664 ' HB ' ' HB3' ' A' ' 81' ' ' ALA . 13.5 mt -147.75 94.98 4.3 Favored Pre-proline 0 C--N 1.302 -1.474 0 N-CA-C 108.6 -0.889 . . . . 0.0 108.6 -179.57 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 79' ' ' PRO . . . . . . . . . . . . . 75.0 Cg_exo -47.55 -47.56 17.69 Favored 'Trans proline' 0 N--CA 1.494 1.506 0 C-N-CA 122.811 2.34 . . . . 0.0 113.811 -178.645 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -65.86 -18.63 65.46 Favored 'General case' 0 N--CA 1.493 1.718 0 O-C-N 120.868 -1.145 . . . . 0.0 110.439 178.474 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 81' ' ' ALA . . . . . 0.743 ' HB2' ' HB2' ' A' ' 136' ' ' ALA . . . -105.01 -14.05 15.55 Favored 'General case' 0 N--CA 1.493 1.679 0 O-C-N 121.238 -0.914 . . . . 0.0 109.035 179.904 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 82' ' ' ASP . . . . . 0.4 ' N ' ' O ' ' A' ' 78' ' ' ILE . 0.3 OUTLIER 64.27 48.34 2.89 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.334 -0.853 . . . . 0.0 110.503 179.246 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 83' ' ' ILE . . . . . 0.487 HD11 ' HB3' ' A' ' 132' ' ' ASN . 64.2 mt -131.1 152.08 36.92 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.796 0 O-C-N 121.127 -0.983 . . . . 0.0 110.647 -178.583 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 84' ' ' LYS . . . . . . . . . . . . . 30.2 tttp -158.83 111.85 2.3 Favored 'General case' 0 N--CA 1.492 1.635 0 N-CA-C 108.315 -0.994 . . . . 0.0 108.315 179.282 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 85' ' ' GLU . . . . . 0.445 ' O ' ' CD2' ' A' ' 75' ' ' TYR . 0.4 OUTLIER -143.16 162.79 41.22 Favored Pre-proline 0 N--CA 1.494 1.729 0 O-C-N 121.279 -0.888 . . . . 0.0 110.225 -179.211 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 86' ' ' PRO . . . . . 0.416 ' N ' ' CE2' ' A' ' 75' ' ' TYR . 57.1 Cg_endo -70.92 167.65 25.33 Favored 'Trans proline' 0 N--CA 1.497 1.698 0 C-N-CA 123.346 2.697 . . . . 0.0 113.506 -179.141 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 87' ' ' VAL . . . . . 0.605 HG23 ' HA ' ' A' ' 75' ' ' TYR . 62.0 t -124.67 99.66 6.47 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.66 0 N-CA-C 108.972 -0.751 . . . . 0.0 108.972 179.717 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 88' ' ' TYR . . . . . 0.549 ' CZ ' HG12 ' A' ' 72' ' ' VAL . 33.0 m-85 -92.87 152.94 42.01 Favored Pre-proline 0 N--CA 1.502 2.164 0 O-C-N 120.832 -1.167 . . . . 0.0 110.029 -179.617 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 89' ' ' PRO . . . . . . . . . . . . . 6.1 Cg_endo -57.19 144.47 90.47 Favored 'Trans proline' 0 C--N 1.312 -1.392 0 C-N-CA 122.531 2.154 . . . . 0.0 113.606 -179.901 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . -57.22 167.6 4.64 Favored Glycine 0 N--CA 1.49 2.268 0 N-CA-C 109.242 -1.543 . . . . 0.0 109.242 179.038 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 91' ' ' PRO . . . . . 0.423 ' C ' ' H ' ' A' ' 93' ' ' THR . 18.9 Cg_endo -93.44 170.4 19.62 Favored 'Cis proline' 0 C--N 1.307 -1.626 0 C-N-CA 123.968 -1.263 . . . . 0.0 112.054 -0.176 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 92' ' ' ALA . . . . . . . . . . . . . . . -72.78 30.57 0.06 Allowed 'General case' 0 N--CA 1.489 1.504 0 O-C-N 121.216 -0.928 . . . . 0.0 110.635 -179.868 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 93' ' ' THR . . . . . 0.423 ' H ' ' C ' ' A' ' 91' ' ' PRO . 1.0 OUTLIER -75.44 152.84 85.73 Favored Pre-proline 0 N--CA 1.49 1.572 0 O-C-N 120.743 -1.223 . . . . 0.0 109.095 -179.741 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 94' ' ' PRO . . . . . 0.412 ' C ' ' O ' ' A' ' 93' ' ' THR . 53.3 Cg_exo -32.82 -52.6 0.39 Allowed 'Trans proline' 0 C--N 1.309 -1.517 0 C-N-CA 122.933 2.422 . . . . 0.0 112.214 -179.292 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 95' ' ' GLU . . . . . 0.586 ' O ' ' ND2' ' A' ' 98' ' ' ASN . 13.0 mt-10 -45.9 -53.11 10.38 Favored 'General case' 0 N--CA 1.489 1.49 0 O-C-N 121.249 -0.907 . . . . 0.0 109.452 179.942 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 96' ' ' GLN . . . . . 0.556 ' O ' ' N ' ' A' ' 98' ' ' ASN . 94.4 mm-40 -71.41 -51.66 22.8 Favored 'General case' 0 C--N 1.305 -1.368 0 O-C-N 120.955 -1.091 . . . . 0.0 109.747 179.956 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 97' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -49.52 -7.82 0.03 OUTLIER 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.209 -0.932 . . . . 0.0 109.675 -179.424 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 98' ' ' ASN . . . . . 0.722 HD21 ' CZ ' ' A' ' 99' ' ' ARG . 0.4 OUTLIER -73.05 -24.37 60.69 Favored 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.167 -0.958 . . . . 0.0 109.615 -179.931 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 99' ' ' ARG . . . . . 0.722 ' CZ ' HD21 ' A' ' 98' ' ' ASN . 0.6 OUTLIER -103.56 -59.42 1.72 Allowed 'General case' 0 N--CA 1.489 1.504 0 O-C-N 121.544 -0.722 . . . . 0.0 110.363 -178.936 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . -164.73 -171.53 31.09 Favored Glycine 0 N--CA 1.494 2.545 0 C-N-CA 119.21 -1.471 . . . . 0.0 110.608 -179.674 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 101' ' ' VAL . . . . . 0.687 HG23 ' O ' ' A' ' 101' ' ' VAL . 18.9 m -59.94 108.3 0.38 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.667 0 O-C-N 121.411 -1.053 . . . . 0.0 108.955 179.854 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -93.03 165.28 12.93 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.446 -0.784 . . . . 0.0 111.015 -179.133 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 103' ' ' PHE . . . . . 0.505 ' CE1' ' CG1' ' A' ' 87' ' ' VAL . 24.5 m-85 -66.17 160.5 24.0 Favored 'General case' 0 N--CA 1.486 1.368 0 N-CA-C 107.954 -1.128 . . . . 0.0 107.954 178.031 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 104' ' ' ALA . . . . . . . . . . . . . . . -72.5 -22.58 61.03 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.087 -1.008 . . . . 0.0 111.707 -177.913 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 1.2 pm0 -138.95 150.12 45.53 Favored 'General case' 0 N--CA 1.497 1.876 0 O-C-N 120.696 -1.253 . . . . 0.0 110.644 -179.296 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 106' ' ' GLU . . . . . . . . . . . . . 66.2 tt0 -52.7 -59.52 4.38 Favored 'General case' 0 C--N 1.303 -1.415 0 O-C-N 121.777 -0.577 . . . . 0.0 110.491 -179.928 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 107' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER -77.05 32.84 0.14 Allowed 'General case' 0 N--CA 1.488 1.461 0 O-C-N 120.614 -1.304 . . . . 0.0 112.583 -175.706 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 108' ' ' GLU . . . . . . . . . . . . . 2.8 tp10 -60.2 144.29 50.43 Favored 'General case' 0 N--CA 1.488 1.473 0 N-CA-C 107.029 -1.471 . . . . 0.0 107.029 179.742 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 109' ' ' SER . . . . . 0.524 ' C ' ' H ' ' A' ' 111' ' ' ASP . 0.2 OUTLIER -97.76 122.82 41.31 Favored 'General case' 0 N--CA 1.487 1.416 0 O-C-N 120.83 -1.169 . . . . 0.0 110.858 -177.776 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 110' ' ' LEU . . . . . . . . . . . . . 2.1 pp -59.81 -3.26 0.49 Allowed 'General case' 0 C--N 1.301 -1.521 0 N-CA-C 108.04 -1.096 . . . . 0.0 108.04 179.235 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 111' ' ' ASP . . . . . 0.524 ' H ' ' C ' ' A' ' 109' ' ' SER . 75.7 m-20 -132.83 18.63 4.19 Favored 'General case' 0 N--CA 1.489 1.498 0 O-C-N 121.735 -0.603 . . . . 0.0 109.716 179.668 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 112' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -65.07 135.84 56.04 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 120.887 -1.133 . . . . 0.0 109.684 -179.76 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 113' ' ' GLN . . . . . 0.525 ' NE2' ' O ' ' A' ' 173' ' ' LYS . 0.0 OUTLIER -64.44 -4.64 4.13 Favored 'General case' 0 C--N 1.303 -1.439 0 O-C-N 121.24 -0.913 . . . . 0.0 108.766 179.238 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 114' ' ' ASN . . . . . 0.592 HD22 ' C ' ' A' ' 114' ' ' ASN . 0.2 OUTLIER -144.78 92.49 2.29 Favored 'General case' 0 C--N 1.303 -1.436 0 N-CA-C 107.13 -1.433 . . . . 0.0 107.13 177.967 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 115' ' ' ILE . . . . . 0.445 HD11 ' O ' ' A' ' 109' ' ' SER . 2.1 mt -101.88 117.22 46.87 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.457 0 O-C-N 121.592 -0.693 . . . . 0.0 110.959 -178.304 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 116' ' ' SER . . . . . . . . . . . . . 97.0 p -99.04 146.82 25.67 Favored 'General case' 0 N--CA 1.495 1.807 0 O-C-N 121.244 -0.91 . . . . 0.0 111.544 -178.928 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 117' ' ' ILE . . . . . . . . . . . . . 2.7 mp -135.16 148.55 28.79 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.842 0 N-CA-C 107.521 -1.289 . . . . 0.0 107.521 178.891 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 118' ' ' ALA . . . . . . . . . . . . . . . -144.97 160.73 40.88 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 120.531 -1.356 . . . . 0.0 111.849 -179.251 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 119' ' ' GLY . . . . . . . . . . . . . . . -169.88 156.72 27.76 Favored Glycine 0 N--CA 1.485 1.909 0 N-CA-C 109.456 -1.457 . . . . 0.0 109.456 179.424 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 120' ' ' HIS . . . . . . . . . . . . . 20.0 m-70 -71.36 162.59 29.19 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.51 -0.994 . . . . 0.0 109.849 179.676 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 121' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -117.49 160.02 21.89 Favored 'General case' 0 N--CA 1.492 1.669 0 N-CA-C 107.962 -1.125 . . . . 0.0 107.962 178.586 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 122' ' ' PHE . . . . . 0.41 ' O ' HG21 ' A' ' 131' ' ' THR . 0.2 OUTLIER -127.28 133.35 50.17 Favored 'General case' 0 N--CA 1.495 1.805 0 O-C-N 121.144 -0.972 . . . . 0.0 110.273 -178.821 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 123' ' ' ILE . . . . . . . . . . . . . 15.9 tt -90.76 -27.1 5.04 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.624 0 CA-C-O 121.827 0.822 . . . . 0.0 110.097 -179.317 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 124' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -87.4 -2.29 58.52 Favored 'General case' 0 C--N 1.291 -1.938 0 C-N-CA 120.128 -0.629 . . . . 0.0 111.318 -178.663 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 125' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -154.2 124.08 3.29 Favored Pre-proline 0 N--CA 1.494 1.774 0 O-C-N 120.625 -1.297 . . . . 0.0 109.683 -179.702 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 126' ' ' PRO . . . . . . . . . . . . . 86.8 Cg_endo -81.14 -16.67 9.66 Favored 'Trans proline' 0 N--CA 1.494 1.518 0 C-N-CA 122.46 2.106 . . . . 0.0 112.992 179.994 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 127' ' ' ASN . . . . . . . . . . . . . 33.7 p30 -90.19 22.37 3.33 Favored 'General case' 0 N--CA 1.493 1.702 0 O-C-N 121.071 -1.018 . . . . 0.0 110.308 -179.342 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 128' ' ' TYR . . . . . . . . . . . . . 13.0 t80 -75.3 -150.52 0.03 OUTLIER 'General case' 0 N--CA 1.492 1.673 0 O-C-N 121.004 -1.06 . . . . 0.0 109.751 -179.73 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 129' ' ' GLN . . . . . . . . . . . . . 69.0 mt-30 -68.1 -89.1 0.01 OUTLIER 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.252 -0.905 . . . . 0.0 109.616 -179.636 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 130' ' ' PHE . . . . . 0.684 ' CE2' HG11 ' A' ' 101' ' ' VAL . 27.7 m-85 -108.14 35.13 3.26 Favored 'General case' 0 N--CA 1.493 1.684 0 O-C-N 121.421 -0.799 . . . . 0.0 110.003 -179.533 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 131' ' ' THR . . . . . 0.41 HG21 ' O ' ' A' ' 122' ' ' PHE . 55.0 m -75.37 -33.31 61.04 Favored 'General case' 0 N--CA 1.488 1.464 0 O-C-N 121.037 -1.039 . . . . 0.0 108.982 179.562 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 132' ' ' ASN . . . . . 0.531 ' ND2' ' O ' ' A' ' 81' ' ' ALA . 4.6 t30 -81.01 3.98 21.21 Favored 'General case' 0 N--CA 1.494 1.741 0 O-C-N 121.32 -0.863 . . . . 0.0 110.512 -179.014 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 133' ' ' LEU . . . . . 0.601 HD13 ' O ' ' A' ' 133' ' ' LEU . 0.4 OUTLIER -68.85 -48.96 62.17 Favored 'General case' 0 N--CA 1.488 1.456 0 O-C-N 120.982 -1.074 . . . . 0.0 109.318 -179.943 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 134' ' ' LYS . . . . . 0.664 ' CE ' ' H ' ' A' ' 134' ' ' LYS . 0.0 OUTLIER -43.0 -18.21 0.01 OUTLIER 'General case' 0 N--CA 1.488 1.452 0 O-C-N 121.363 -0.835 . . . . 0.0 109.121 179.869 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 135' ' ' ALA . . . . . 0.593 ' N ' ' O ' ' A' ' 133' ' ' LEU . . . -83.43 -39.02 21.14 Favored 'General case' 0 N--CA 1.488 1.435 0 O-C-N 121.219 -0.926 . . . . 0.0 109.266 179.012 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 136' ' ' ALA . . . . . 0.743 ' HB2' ' HB2' ' A' ' 81' ' ' ALA . . . -80.46 157.45 26.2 Favored 'General case' 0 N--CA 1.49 1.542 0 CA-C-O 121.996 0.903 . . . . 0.0 111.299 -178.965 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 137' ' ' LYS . . . . . 0.536 ' O ' ' O ' ' A' ' 138' ' ' LYS . 1.0 OUTLIER -154.19 -162.36 1.4 Allowed 'General case' 0 N--CA 1.49 1.575 0 C-N-CA 118.5 -1.28 . . . . 0.0 110.961 -178.161 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 138' ' ' LYS . . . . . 0.574 ' O ' ' N ' ' A' ' 140' ' ' SER . 9.4 mttp -43.17 178.27 0.0 OUTLIER 'General case' 0 N--CA 1.487 1.397 0 CA-C-O 122.438 1.113 . . . . 0.0 111.083 -179.03 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 139' ' ' GLY . . . . . . . . . . . . . . . 46.95 7.72 0.02 OUTLIER Glycine 0 N--CA 1.491 2.302 0 N-CA-C 110.668 -0.973 . . . . 0.0 110.668 179.858 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 140' ' ' SER . . . . . 0.574 ' N ' ' O ' ' A' ' 138' ' ' LYS . 58.4 m -86.87 127.14 35.04 Favored 'General case' 0 N--CA 1.496 1.87 0 O-C-N 120.811 -1.406 . . . . 0.0 109.599 179.349 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 141' ' ' MET . . . . . 0.591 ' SD ' ' N ' ' A' ' 142' ' ' VAL . 6.2 tpp -77.61 129.16 35.26 Favored 'General case' 0 N--CA 1.492 1.65 0 O-C-N 120.975 -1.078 . . . . 0.0 109.33 179.688 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 142' ' ' VAL . . . . . 0.591 ' N ' ' SD ' ' A' ' 141' ' ' MET . 1.4 t -112.09 133.27 58.34 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.617 0 N-CA-C 108.546 -0.909 . . . . 0.0 108.546 -179.982 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 143' ' ' TYR . . . . . . . . . . . . . 5.4 m-85 -108.22 134.36 51.17 Favored 'General case' 0 N--CA 1.497 1.897 0 O-C-N 120.719 -1.238 . . . . 0.0 112.31 -177.835 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 144' ' ' PHE . . . . . . . . . . . . . 36.9 t80 -119.92 99.92 6.92 Favored 'General case' 0 N--CA 1.494 1.726 0 N-CA-C 109.511 -0.551 . . . . 0.0 109.511 179.718 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 145' ' ' LYS . . . . . . . . . . . . . 1.0 OUTLIER -96.02 134.3 39.2 Favored 'General case' 0 N--CA 1.493 1.701 0 O-C-N 121.193 -0.942 . . . . 0.0 110.677 -179.348 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 146' ' ' VAL . . . . . 0.479 ' O ' ' C ' ' A' ' 147' ' ' GLY . 0.0 OUTLIER -144.03 141.14 24.97 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.789 0 N-CA-C 107.443 -1.317 . . . . 0.0 107.443 178.861 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 147' ' ' GLY . . . . . 0.479 ' C ' ' O ' ' A' ' 146' ' ' VAL . . . 38.42 -117.67 0.64 Allowed Glycine 0 N--CA 1.493 2.44 0 N-CA-C 109.67 -1.372 . . . . 0.0 109.67 179.78 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 148' ' ' ASN . . . . . . . . . . . . . 15.6 p30 -108.74 13.45 25.03 Favored 'General case' 0 C--N 1.303 -1.447 0 O-C-N 121.576 -0.955 . . . . 0.0 108.643 179.166 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 149' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -107.0 142.21 36.98 Favored 'General case' 0 N--CA 1.488 1.464 0 CA-C-O 121.934 0.873 . . . . 0.0 111.329 -178.863 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 150' ' ' THR . . . . . . . . . . . . . 97.3 m -134.64 99.06 4.22 Favored 'General case' 0 C--N 1.3 -1.583 0 CA-C-O 121.581 0.705 . . . . 0.0 109.841 -179.428 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 151' ' ' ARG . . . . . . . . . . . . . 86.6 mtt180 -88.24 -171.26 3.29 Favored 'General case' 0 N--CA 1.487 1.411 0 N-CA-C 108.872 -0.788 . . . . 0.0 108.872 179.973 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 152' ' ' LYS . . . . . 0.512 ' C ' ' CD1' ' A' ' 153' ' ' TYR . 34.8 mttp -151.38 150.85 30.95 Favored 'General case' 0 C--N 1.302 -1.471 0 O-C-N 121.201 -0.937 . . . . 0.0 110.139 179.703 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 153' ' ' TYR . . . . . 0.512 ' CD1' ' C ' ' A' ' 152' ' ' LYS . 22.0 m-85 -145.71 158.07 43.89 Favored 'General case' 0 C--N 1.299 -1.618 0 N-CA-C 107.516 -1.29 . . . . 0.0 107.516 178.183 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 154' ' ' LYS . . . . . . . . . . . . . 13.2 ttpp -130.55 125.43 34.21 Favored 'General case' 0 C--N 1.297 -1.71 0 N-CA-C 108.44 -0.948 . . . . 0.0 108.44 -179.996 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 155' ' ' MET . . . . . . . . . . . . . 74.5 mtp -45.87 107.33 0.1 Allowed 'General case' 0 N--CA 1.489 1.517 0 O-C-N 120.697 -1.252 . . . . 0.0 110.797 -178.954 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 156' ' ' THR . . . . . . . . . . . . . 0.4 OUTLIER -104.47 -27.16 12.08 Favored 'General case' 0 C--N 1.292 -1.933 0 CA-C-N 115.292 -0.867 . . . . 0.0 110.284 -178.385 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 157' ' ' SER . . . . . . . . . . . . . 10.0 t -150.63 150.52 31.26 Favored 'General case' 0 N--CA 1.493 1.702 0 C-N-CA 118.418 -1.313 . . . . 0.0 110.927 -178.812 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 158' ' ' ILE . . . . . 0.696 HD12 ' N ' ' A' ' 159' ' ' ARG . 0.1 OUTLIER -152.91 140.13 13.21 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.389 0 CA-C-O 121.75 0.786 . . . . 0.0 109.563 -178.476 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 159' ' ' ARG . . . . . 0.696 ' N ' HD12 ' A' ' 158' ' ' ILE . 26.8 mtm180 -154.73 165.2 37.33 Favored 'General case' 0 C--N 1.294 -1.822 0 CA-C-O 121.672 0.749 . . . . 0.0 109.882 -179.441 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 160' ' ' ASP . . . . . 0.49 ' O ' HG13 ' A' ' 161' ' ' VAL . 8.0 m-20 -116.18 155.03 28.99 Favored 'General case' 0 C--N 1.298 -1.645 0 N-CA-C 108.069 -1.085 . . . . 0.0 108.069 179.253 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 161' ' ' VAL . . . . . 0.49 HG13 ' O ' ' A' ' 160' ' ' ASP . 13.1 m -155.01 150.69 11.4 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.7 0 O-C-N 120.893 -1.129 . . . . 0.0 110.527 -178.995 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 162' ' ' LYS . . . . . 0.409 ' O ' ' O ' ' A' ' 161' ' ' VAL . 0.0 OUTLIER -47.36 170.38 0.09 OUTLIER Pre-proline 0 N--CA 1.49 1.571 0 O-C-N 121.295 -0.878 . . . . 0.0 109.495 179.677 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 163' ' ' PRO . . . . . . . . . . . . . 57.4 Cg_endo -78.0 37.32 0.62 Allowed 'Trans proline' 0 C--N 1.309 -1.525 0 C-N-CA 122.738 2.292 . . . . 0.0 112.769 -179.706 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 164' ' ' THR . . . . . . . . . . . . . 17.4 m -152.19 -7.98 0.21 Allowed 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.081 -1.012 . . . . 0.0 110.859 -179.88 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 165' ' ' ASP . . . . . 0.456 ' O ' ' C ' ' A' ' 166' ' ' VAL . 6.9 t70 -72.84 61.41 0.55 Allowed 'General case' 0 N--CA 1.492 1.653 0 O-C-N 120.627 -1.296 . . . . 0.0 110.193 -179.412 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 166' ' ' VAL . . . . . 0.67 ' O ' ' N ' ' A' ' 168' ' ' VAL . 0.7 OUTLIER -39.77 -30.0 0.13 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.637 0 O-C-N 121.411 -0.806 . . . . 0.0 109.789 -178.546 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 167' ' ' GLY . . . . . 0.443 ' N ' ' O ' ' A' ' 165' ' ' ASP . . . -42.55 -9.04 0.01 OUTLIER Glycine 0 N--CA 1.5 2.925 0 O-C-N 121.292 -0.88 . . . . 0.0 111.221 -179.497 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 168' ' ' VAL . . . . . 0.67 ' N ' ' O ' ' A' ' 166' ' ' VAL . 19.6 t -48.35 -40.72 10.47 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.62 0 O-C-N 120.89 -1.359 . . . . 0.0 108.729 179.263 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 169' ' ' LEU . . . . . 0.544 ' O ' ' N ' ' A' ' 171' ' ' GLU . 5.4 mt -47.54 -9.4 0.02 OUTLIER 'General case' 0 N--CA 1.496 1.86 0 N-CA-C 108.715 -0.846 . . . . 0.0 108.715 -178.207 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 170' ' ' ASP . . . . . 0.599 ' N ' ' O ' ' A' ' 168' ' ' VAL . 7.0 t0 35.6 27.86 0.01 OUTLIER 'General case' 0 N--CA 1.493 1.72 0 O-C-N 121.508 -0.745 . . . . 0.0 111.5 178.22 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 171' ' ' GLU . . . . . 0.544 ' N ' ' O ' ' A' ' 169' ' ' LEU . 3.8 pt-20 -69.34 94.56 0.72 Allowed 'General case' 0 C--N 1.301 -1.541 0 N-CA-C 107.157 -1.423 . . . . 0.0 107.157 178.034 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 172' ' ' GLN . . . . . . . . . . . . . 2.4 mt-30 -155.14 -74.06 0.11 Allowed 'General case' 0 N--CA 1.493 1.716 0 O-C-N 121.447 -0.783 . . . . 0.0 109.977 -178.645 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 173' ' ' LYS . . . . . 0.525 ' O ' ' NE2' ' A' ' 113' ' ' GLN . 2.3 mptt -59.65 137.84 57.91 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.335 -0.853 . . . . 0.0 109.119 179.841 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 174' ' ' GLY . . . . . 0.504 ' O ' ' C ' ' A' ' 175' ' ' LYS . . . -123.42 -43.61 0.35 Allowed Glycine 0 C--N 1.299 -1.505 0 N-CA-C 107.771 -2.132 . . . . 0.0 107.771 179.172 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 175' ' ' LYS . . . . . 0.504 ' C ' ' O ' ' A' ' 174' ' ' GLY . 0.1 OUTLIER -36.89 -76.9 0.02 OUTLIER 'General case' 0 N--CA 1.498 1.946 0 N-CA-C 108.943 -0.762 . . . . 0.0 108.943 179.729 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 176' ' ' ASP . . . . . 0.582 ' O ' ' O ' ' A' ' 177' ' ' LYS . 1.2 m-20 -91.38 86.62 6.15 Favored 'General case' 0 C--N 1.297 -1.708 0 N-CA-C 107.087 -1.449 . . . . 0.0 107.087 178.059 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 177' ' ' LYS . . . . . 0.582 ' O ' ' O ' ' A' ' 176' ' ' ASP . 0.9 OUTLIER -40.5 178.01 0.0 OUTLIER 'General case' 0 N--CA 1.493 1.713 0 CA-C-O 121.603 0.716 . . . . 0.0 110.907 -178.919 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 178' ' ' GLN . . . . . 0.534 ' NE2' HG13 ' A' ' 201' ' ' VAL . 0.0 OUTLIER -160.91 173.49 15.23 Favored 'General case' 0 C--N 1.307 -1.263 0 C-N-CA 118.637 -1.225 . . . . 0.0 110.692 -179.726 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 179' ' ' LEU . . . . . . . . . . . . . 2.2 tp -128.02 100.2 5.79 Favored 'General case' 0 C--N 1.3 -1.57 0 N-CA-C 106.896 -1.52 . . . . 0.0 106.896 178.127 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 180' ' ' THR . . . . . . . . . . . . . 1.4 m -75.18 118.95 18.67 Favored 'General case' 0 C--N 1.303 -1.417 0 C-N-CA 119.071 -1.052 . . . . 0.0 110.287 -178.101 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 181' ' ' LEU . . . . . . . . . . . . . 57.8 tp -94.76 146.95 23.82 Favored 'General case' 0 C--N 1.298 -1.647 0 N-CA-C 108.08 -1.081 . . . . 0.0 108.08 178.171 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 182' ' ' ILE . . . . . . . . . . . . . 54.9 mt -140.9 125.43 17.88 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.529 0 O-C-N 120.958 -1.089 . . . . 0.0 109.684 179.552 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 183' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -143.84 112.29 6.44 Favored 'General case' 0 C--N 1.295 -1.802 0 N-CA-C 107.047 -1.464 . . . . 0.0 107.047 178.722 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 184' ' ' CYS . . . . . 0.477 ' CB ' HH11 ' A' ' 197' ' ' ARG . 0.6 OUTLIER -78.48 163.06 25.91 Favored 'General case' 0 N--CA 1.498 1.964 0 C-N-CA 118.786 -1.166 . . . . 0.0 110.954 -177.114 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 185' ' ' ASP . . . . . . . . . . . . . 12.3 t0 -165.87 -153.92 0.19 Allowed 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.45 -0.781 . . . . 0.0 109.817 -179.712 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 186' ' ' ASP . . . . . 0.444 ' HB3' ' H ' ' A' ' 196' ' ' LYS . 0.4 OUTLIER 49.98 53.92 11.98 Favored 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.254 -0.904 . . . . 0.0 108.983 -179.67 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 187' ' ' TYR . . . . . 0.603 ' CE1' ' O ' ' A' ' 188' ' ' ASN . 34.2 t80 -65.93 135.17 54.39 Favored 'General case' 0 C--N 1.301 -1.521 0 O-C-N 121.205 -0.935 . . . . 0.0 110.222 -179.419 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 188' ' ' ASN . . . . . 0.603 ' O ' ' CE1' ' A' ' 187' ' ' TYR . 0.6 OUTLIER -100.93 147.68 25.87 Favored 'General case' 0 C--N 1.296 -1.737 0 N-CA-C 107.954 -1.128 . . . . 0.0 107.954 178.578 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 189' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -112.54 -13.65 13.31 Favored 'General case' 0 C--N 1.295 -1.772 0 N-CA-C 108.268 -1.012 . . . . 0.0 108.268 -179.872 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 190' ' ' LYS . . . . . . . . . . . . . 15.0 mtmt -83.46 -52.34 6.59 Favored 'General case' 0 C--N 1.303 -1.426 0 N-CA-C 108.814 -0.81 . . . . 0.0 108.814 179.118 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 191' ' ' THR . . . . . . . . . . . . . 2.6 p -90.56 -9.63 46.43 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.461 -0.775 . . . . 0.0 109.075 179.58 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 192' ' ' GLY . . . . . . . . . . . . . . . 63.68 39.94 98.04 Favored Glycine 0 N--CA 1.493 2.484 0 N-CA-C 110.836 -0.905 . . . . 0.0 110.836 178.941 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 193' ' ' VAL . . . . . 0.495 HG12 ' N ' ' A' ' 194' ' ' TRP . 57.8 t -145.98 159.32 11.75 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.563 0 O-C-N 121.01 -1.288 . . . . 0.0 109.34 179.346 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 194' ' ' TRP . . . . . 0.495 ' N ' HG12 ' A' ' 193' ' ' VAL . 19.9 m95 -85.31 120.48 26.84 Favored 'General case' 0 C--N 1.3 -1.584 0 N-CA-C 107.644 -1.243 . . . . 0.0 107.644 178.667 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 195' ' ' GLU . . . . . 0.514 ' CD ' ' ND2' ' A' ' 188' ' ' ASN . 1.1 mt-10 -89.27 -60.6 1.91 Allowed 'General case' 0 N--CA 1.493 1.713 0 O-C-N 121.138 -0.976 . . . . 0.0 111.749 -177.453 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 196' ' ' LYS . . . . . 0.444 ' H ' ' HB3' ' A' ' 186' ' ' ASP . 0.0 OUTLIER -78.98 144.34 34.85 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 120.823 -1.173 . . . . 0.0 110.405 -178.558 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 197' ' ' ARG . . . . . 0.56 ' NH2' ' O ' ' C' ' 703' ' ' PRO . 0.7 OUTLIER -120.77 137.15 54.66 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.632 -0.668 . . . . 0.0 109.206 179.714 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 198' ' ' LYS . . . . . . . . . . . . . 3.2 mtmm -114.97 122.06 45.09 Favored 'General case' 0 N--CA 1.489 1.491 0 O-C-N 121.722 -0.611 . . . . 0.0 110.323 -178.943 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 199' ' ' ILE . . . . . 0.648 ' C ' HD12 ' A' ' 199' ' ' ILE . 0.6 OUTLIER -141.85 118.32 6.85 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.7 0 O-C-N 120.957 -1.09 . . . . 0.0 110.416 179.937 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 200' ' ' PHE . . . . . 0.53 ' CD1' ' N ' ' A' ' 200' ' ' PHE . 6.5 m-85 -99.84 137.96 37.58 Favored 'General case' 0 N--CA 1.499 1.975 0 O-C-N 121.294 -0.879 . . . . 0.0 110.134 -179.371 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 201' ' ' VAL . . . . . 0.534 HG13 ' NE2' ' A' ' 178' ' ' GLN . 33.0 t -105.7 148.28 10.33 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.589 0 N-CA-C 107.981 -1.118 . . . . 0.0 107.981 177.744 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 202' ' ' ALA . . . . . . . . . . . . . . . -133.35 139.43 46.82 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.03 -1.044 . . . . 0.0 109.088 -179.608 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 203' ' ' THR . . . . . 0.403 ' O ' HG23 ' A' ' 205' ' ' VAL . 1.9 p -90.2 134.26 34.39 Favored 'General case' 0 N--CA 1.487 1.383 0 CA-C-O 122.565 1.174 . . . . 0.0 111.197 -178.827 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 204' ' ' GLU . . . . . 0.43 ' HA ' ' CD2' ' A' ' 153' ' ' TYR . 6.8 tt0 -56.0 134.88 52.69 Favored 'General case' 0 C--N 1.296 -1.76 0 C-N-CA 118.761 -1.176 . . . . 0.0 109.621 179.818 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 205' ' ' VAL . . . . . 0.531 ' O ' ' C ' ' A' ' 206' ' ' LYS . 61.0 t -128.35 -42.4 0.85 Allowed 'Isoleucine or valine' 0 N--CA 1.494 1.766 0 O-C-N 121.304 -0.873 . . . . 0.0 110.24 -178.788 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 206' ' ' LYS . . . . . 0.531 ' C ' ' O ' ' A' ' 205' ' ' VAL . 1.2 pptp? . . . . . 0 N--CA 1.501 2.093 0 CA-C-O 118.157 -0.925 . . . . 0.0 110.596 -179.505 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' C' C ' 701' ' ' PHQ . . . . . 0.409 ' O2 ' HG12 ' A' ' 166' ' ' VAL . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 002 nuclear build full ' C' C ' 702' ' ' LEU . . . . . 0.821 ' N ' HD12 ' C' ' 702' ' ' LEU . 0.0 OUTLIER . . . . . 0 N--CA 1.493 1.702 0 N-CA-C 108.676 -0.861 . . . . 0.0 108.676 . . . . . . . . . 2 2 . 1 . 002 nuclear build full ' C' C ' 703' ' ' PRO . . . . . 0.56 ' O ' ' NH2' ' A' ' 197' ' ' ARG . 42.8 Cg_endo -69.59 -179.19 2.66 Favored 'Trans proline' 0 N--CA 1.496 1.64 0 C-N-CA 122.868 2.379 . . . . 0.0 113.276 -178.935 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' C' C ' 704' ' ' ALA . . . . . 0.484 ' O ' ' O ' ' C' ' 703' ' ' PRO . . . 45.05 -171.3 0.01 OUTLIER 'General case' 0 N--CA 1.486 1.336 0 O-C-N 121.557 -0.714 . . . . 0.0 109.295 179.934 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' C' C ' 705' ' ' B27 . . . . . 0.41 ' HX ' ' CG ' ' A' ' 194' ' ' TRP . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 700' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 003 nuclear build full ' A' A ' 59' ' ' MET . . . . . . . . . . . . . 9.4 ttt . . . . . 0 N--CA 1.491 1.596 0 CA-C-O 121.32 0.581 . . . . 0.0 109.455 . . . . . . . . . 0 0 . 1 . 003 nuclear build full ' A' A ' 60' ' ' GLN . . . . . . . . . . . . . 2.7 mp0 -61.01 -177.41 0.08 Allowed 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.232 -0.918 . . . . 0.0 110.005 -179.769 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . -64.29 177.39 0.85 Allowed 'General case' 0 N--CA 1.494 1.743 0 O-C-N 121.365 -0.834 . . . . 0.0 109.917 -179.889 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 62' ' ' LYS . . . . . . . . . . . . . 14.3 mtpt -145.42 78.19 12.23 Favored Pre-proline 0 N--CA 1.492 1.636 0 C-N-CA 119.343 -0.943 . . . . 0.0 110.397 -179.438 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 63' ' ' PRO . . . . . . . . . . . . . 3.7 Cg_endo -82.21 147.58 14.6 Favored 'Trans proline' 0 C--N 1.304 -1.809 0 C-N-CA 123.234 2.623 . . . . 0.0 111.436 178.97 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 64' ' ' GLN . . . . . 0.562 ' N ' ' OE1' ' A' ' 64' ' ' GLN . 0.0 OUTLIER -153.0 102.59 2.67 Favored 'General case' 0 N--CA 1.493 1.685 0 O-C-N 121.129 -0.982 . . . . 0.0 109.513 -179.63 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 65' ' ' ILE . . . . . 0.486 ' C ' ' O ' ' A' ' 64' ' ' GLN . 3.0 mp -37.83 99.3 0.18 Allowed Pre-proline 0 N--CA 1.494 1.747 0 N-CA-C 108.677 -0.86 . . . . 0.0 108.677 179.715 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 66' ' ' PRO . . . . . 0.463 ' N ' ' O ' ' A' ' 64' ' ' GLN . 57.8 Cg_endo -85.27 -162.55 0.16 Allowed 'Trans proline' 0 C--N 1.315 -1.203 0 C-N-CA 122.264 1.976 . . . . 0.0 112.505 -178.592 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 67' ' ' LYS . . . . . 0.515 ' C ' ' H ' ' A' ' 69' ' ' LYS . 6.6 ptpt -72.98 -5.73 40.69 Favored 'General case' 0 C--N 1.303 -1.415 0 O-C-N 121.393 -0.817 . . . . 0.0 108.829 179.737 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 68' ' ' ASP . . . . . 0.594 ' O ' ' N ' ' A' ' 70' ' ' SER . 1.0 OUTLIER -74.97 46.53 0.31 Allowed 'General case' 0 N--CA 1.486 1.374 0 CA-C-O 122.85 1.309 . . . . 0.0 107.735 178.876 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 69' ' ' LYS . . . . . 0.515 ' H ' ' C ' ' A' ' 67' ' ' LYS . 13.3 ptpt -48.63 -14.41 0.06 Allowed 'General case' 0 N--CA 1.501 2.123 0 C-N-CA 117.23 -1.788 . . . . 0.0 106.728 178.191 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 70' ' ' SER . . . . . 0.594 ' N ' ' O ' ' A' ' 68' ' ' ASP . 0.3 OUTLIER -85.25 -6.3 59.27 Favored 'General case' 0 N--CA 1.496 1.86 0 CA-C-N 113.53 -1.668 . . . . 0.0 110.764 179.284 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 71' ' ' LYS . . . . . 0.433 ' N ' ' O ' ' A' ' 68' ' ' ASP . 0.0 OUTLIER -97.53 140.96 31.17 Favored 'General case' 0 N--CA 1.497 1.886 0 O-C-N 120.876 -1.14 . . . . 0.0 111.478 -179.598 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 72' ' ' VAL . . . . . 0.574 HG23 ' H ' ' A' ' 87' ' ' VAL . 0.2 OUTLIER -65.45 136.57 26.48 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.414 0 N-CA-C 105.334 -2.099 . . . . 0.0 105.334 175.36 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 73' ' ' ALA . . . . . 0.535 ' N ' ' O ' ' A' ' 87' ' ' VAL . . . -83.53 -17.16 42.8 Favored 'General case' 0 C--N 1.296 -1.717 0 O-C-N 120.179 -1.576 . . . . 0.0 108.245 -179.017 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 74' ' ' GLY . . . . . 0.553 ' O ' ' CG2' ' A' ' 72' ' ' VAL . . . 172.44 -157.71 27.5 Favored Glycine 0 C--N 1.294 -1.776 0 N-CA-C 109.5 -1.44 . . . . 0.0 109.5 -179.554 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 75' ' ' TYR . . . . . 0.57 ' HA ' HG23 ' A' ' 87' ' ' VAL . 4.6 m-85 -141.47 170.37 15.86 Favored 'General case' 0 C--N 1.293 -1.866 0 O-C-N 121.363 -1.08 . . . . 0.0 110.362 -177.303 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 76' ' ' ILE . . . . . . . . . . . . . 3.0 tp -144.92 140.02 22.99 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.717 0 C-N-CA 119.359 -0.937 . . . . 0.0 109.446 -177.414 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 77' ' ' GLU . . . . . 0.572 ' N ' ' CD ' ' A' ' 77' ' ' GLU . 0.7 OUTLIER -146.71 159.43 43.48 Favored 'General case' 0 C--N 1.304 -1.388 0 O-C-N 121.015 -1.053 . . . . 0.0 109.148 -179.293 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 78' ' ' ILE . . . . . 0.505 ' HB ' ' HB3' ' A' ' 81' ' ' ALA . 12.2 mt -147.7 94.34 4.41 Favored Pre-proline 0 N--CA 1.489 1.498 0 N-CA-C 108.622 -0.881 . . . . 0.0 108.622 -179.963 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 79' ' ' PRO . . . . . . . . . . . . . 75.0 Cg_exo -46.83 -45.83 19.65 Favored 'Trans proline' 0 N--CA 1.493 1.488 0 C-N-CA 122.937 2.425 . . . . 0.0 114.212 -178.685 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -64.78 -19.83 66.03 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 120.644 -1.285 . . . . 0.0 110.507 178.704 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 81' ' ' ALA . . . . . 0.81 ' HB2' ' HB2' ' A' ' 136' ' ' ALA . . . -104.99 -16.73 14.73 Favored 'General case' 0 N--CA 1.493 1.707 0 N-CA-C 108.448 -0.945 . . . . 0.0 108.448 179.223 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 82' ' ' ASP . . . . . . . . . . . . . 7.8 t0 67.21 50.36 1.0 Allowed 'General case' 0 N--CA 1.488 1.437 0 O-C-N 121.364 -0.835 . . . . 0.0 109.951 179.736 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 83' ' ' ILE . . . . . 0.59 HD11 ' OD1' ' A' ' 132' ' ' ASN . 78.4 mt -127.82 152.78 36.32 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.671 0 O-C-N 121.395 -0.815 . . . . 0.0 110.009 -178.914 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 84' ' ' LYS . . . . . . . . . . . . . 1.8 tttt -159.06 108.71 1.94 Allowed 'General case' 0 N--CA 1.49 1.561 0 N-CA-C 107.099 -1.445 . . . . 0.0 107.099 179.036 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 85' ' ' GLU . . . . . 0.503 ' OE1' ' O ' ' A' ' 128' ' ' TYR . 0.0 OUTLIER -141.92 169.56 10.88 Favored Pre-proline 0 N--CA 1.494 1.733 0 O-C-N 121.236 -0.915 . . . . 0.0 110.972 -177.842 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 86' ' ' PRO . . . . . . . . . . . . . 73.4 Cg_endo -79.34 166.45 22.38 Favored 'Trans proline' 0 N--CA 1.492 1.385 0 C-N-CA 123.22 2.613 . . . . 0.0 113.43 -179.631 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 87' ' ' VAL . . . . . 0.574 ' H ' HG23 ' A' ' 72' ' ' VAL . 60.3 t -126.07 102.08 9.31 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.614 0 N-CA-C 109.056 -0.72 . . . . 0.0 109.056 179.705 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 88' ' ' TYR . . . . . 0.736 ' HB3' HE22 ' A' ' 96' ' ' GLN . 22.7 m-85 -96.33 153.82 38.86 Favored Pre-proline 0 N--CA 1.501 2.088 0 O-C-N 120.952 -1.092 . . . . 0.0 110.336 -179.34 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 89' ' ' PRO . . . . . 0.457 ' O ' ' NE2' ' A' ' 96' ' ' GLN . 1.2 Cg_endo -55.72 143.82 78.57 Favored 'Trans proline' 0 C--N 1.309 -1.543 0 C-N-CA 122.715 2.277 . . . . 0.0 113.958 -179.891 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . -57.76 169.35 4.4 Favored Glycine 0 N--CA 1.493 2.44 0 N-CA-C 108.888 -1.685 . . . . 0.0 108.888 178.743 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 91' ' ' PRO . . . . . . . . . . . . . 56.3 Cg_endo -94.75 169.38 17.55 Favored 'Cis proline' 0 C--N 1.308 -1.558 0 C-N-CA 124.183 -1.174 . . . . 0.0 112.079 0.141 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 92' ' ' ALA . . . . . 0.637 ' HB3' ' HB3' ' C' ' 703' ' ' PRO . . . -72.99 32.07 0.07 Allowed 'General case' 0 N--CA 1.493 1.718 0 O-C-N 120.948 -1.095 . . . . 0.0 110.927 -179.724 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 93' ' ' THR . . . . . . . . . . . . . 11.1 p -73.15 150.4 89.9 Favored Pre-proline 0 C--N 1.302 -1.47 0 O-C-N 120.278 -1.514 . . . . 0.0 108.228 179.695 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 94' ' ' PRO . . . . . . . . . . . . . 91.1 Cg_exo -34.39 -46.41 0.51 Allowed 'Trans proline' 0 C--N 1.309 -1.527 0 C-N-CA 122.78 2.32 . . . . 0.0 112.44 -179.074 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 95' ' ' GLU . . . . . 0.59 ' O ' ' ND2' ' A' ' 98' ' ' ASN . 6.8 mt-10 -53.69 -51.94 61.61 Favored 'General case' 0 N--CA 1.488 1.465 0 O-C-N 121.111 -0.993 . . . . 0.0 109.702 179.9 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 96' ' ' GLN . . . . . 0.736 HE22 ' HB3' ' A' ' 88' ' ' TYR . 2.5 mm-40 -71.92 -45.94 59.37 Favored 'General case' 0 C--N 1.303 -1.418 0 O-C-N 121.205 -0.935 . . . . 0.0 109.822 -179.848 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 97' ' ' LEU . . . . . 0.509 ' CD1' ' O ' ' A' ' 92' ' ' ALA . 88.9 mt -55.17 -4.91 0.09 Allowed 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.18 -0.95 . . . . 0.0 108.935 179.902 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 98' ' ' ASN . . . . . 0.59 ' ND2' ' O ' ' A' ' 95' ' ' GLU . 0.0 OUTLIER -71.88 -26.01 62.16 Favored 'General case' 0 N--CA 1.489 1.505 0 O-C-N 121.511 -0.743 . . . . 0.0 109.295 179.708 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 99' ' ' ARG . . . . . 0.681 HH11 ' CG ' ' A' ' 99' ' ' ARG . 0.2 OUTLIER -99.9 -59.06 1.78 Allowed 'General case' 0 N--CA 1.488 1.426 0 C-N-CA 119.71 -0.796 . . . . 0.0 110.483 -178.919 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . -170.84 -169.43 33.87 Favored Glycine 0 N--CA 1.49 2.277 0 C-N-CA 119.013 -1.565 . . . . 0.0 110.518 -179.789 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 101' ' ' VAL . . . . . 0.711 HG23 ' O ' ' A' ' 101' ' ' VAL . 27.0 m -53.95 106.25 0.1 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.525 0 O-C-N 121.662 -0.905 . . . . 0.0 109.561 -179.906 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -92.91 158.08 16.02 Favored 'General case' 0 N--CA 1.495 1.787 0 O-C-N 121.249 -0.907 . . . . 0.0 110.582 -179.88 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 103' ' ' PHE . . . . . 0.562 ' O ' ' N ' ' A' ' 105' ' ' GLU . 23.6 m-85 -61.06 121.76 13.27 Favored 'General case' 0 N--CA 1.491 1.612 0 N-CA-C 108.083 -1.081 . . . . 0.0 108.083 178.58 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 104' ' ' ALA . . . . . 0.43 ' HB1' ' HG2' ' C' ' 703' ' ' PRO . . . -40.03 -19.99 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.567 -0.708 . . . . 0.0 111.445 -178.434 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 105' ' ' GLU . . . . . 0.64 ' OE1' HD13 ' A' ' 169' ' ' LEU . 0.2 OUTLIER -139.33 151.2 46.2 Favored 'General case' 0 N--CA 1.494 1.767 0 O-C-N 120.688 -1.257 . . . . 0.0 110.707 -179.563 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 106' ' ' GLU . . . . . . . . . . . . . 30.3 tt0 -57.95 -64.19 0.99 Allowed 'General case' 0 C--N 1.303 -1.442 0 CA-C-N 116.146 -0.479 . . . . 0.0 111.3 -178.94 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 107' ' ' ASN . . . . . . . . . . . . . 39.2 p-10 -77.47 33.0 0.16 Allowed 'General case' 0 N--CA 1.491 1.587 0 O-C-N 120.541 -1.349 . . . . 0.0 113.187 -175.214 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 108' ' ' GLU . . . . . . . . . . . . . 33.2 tp10 -59.55 148.61 32.7 Favored 'General case' 0 C--N 1.301 -1.53 0 N-CA-C 107.474 -1.306 . . . . 0.0 107.474 179.899 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 109' ' ' SER . . . . . 0.479 ' C ' ' H ' ' A' ' 111' ' ' ASP . 0.1 OUTLIER -100.59 124.67 46.48 Favored 'General case' 0 N--CA 1.487 1.409 0 O-C-N 120.9 -1.125 . . . . 0.0 110.486 -178.432 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 110' ' ' LEU . . . . . 0.451 HD12 ' OD1' ' A' ' 111' ' ' ASP . 1.5 pp -60.01 -4.61 0.79 Allowed 'General case' 0 C--N 1.301 -1.536 0 N-CA-C 108.467 -0.938 . . . . 0.0 108.467 179.721 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 111' ' ' ASP . . . . . 0.479 ' H ' ' C ' ' A' ' 109' ' ' SER . 11.8 m-20 -131.93 20.77 4.55 Favored 'General case' 0 C--N 1.303 -1.416 0 N-CA-C 108.825 -0.805 . . . . 0.0 108.825 179.57 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 112' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -66.3 140.02 58.09 Favored 'General case' 0 N--CA 1.489 1.505 0 O-C-N 121.349 -0.844 . . . . 0.0 110.198 -179.937 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 113' ' ' GLN . . . . . 0.459 ' N ' ' CD ' ' A' ' 113' ' ' GLN . 3.9 mm-40 -65.11 -6.68 9.61 Favored 'General case' 0 C--N 1.302 -1.488 0 N-CA-C 107.892 -1.151 . . . . 0.0 107.892 178.278 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 114' ' ' ASN . . . . . 0.417 ' O ' ' CG ' ' A' ' 114' ' ' ASN . 11.1 p-10 -146.02 95.01 2.56 Favored 'General case' 0 C--N 1.3 -1.545 0 N-CA-C 107.95 -1.13 . . . . 0.0 107.95 179.144 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 115' ' ' ILE . . . . . 0.479 ' O ' HG22 ' A' ' 115' ' ' ILE . 2.6 mt -98.24 111.67 28.5 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.536 0 O-C-N 121.493 -0.754 . . . . 0.0 109.487 -179.366 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 116' ' ' SER . . . . . . . . . . . . . 66.3 m -97.1 151.19 20.02 Favored 'General case' 0 N--CA 1.489 1.517 0 CA-C-O 121.77 0.795 . . . . 0.0 111.066 -178.804 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 117' ' ' ILE . . . . . . . . . . . . . 1.9 mt -146.59 155.85 11.69 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.588 0 N-CA-C 108.184 -1.043 . . . . 0.0 108.184 179.328 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 118' ' ' ALA . . . . . 0.748 ' HB1' ' HB2' ' C' ' 704' ' ' ALA . . . -146.04 163.41 35.32 Favored 'General case' 0 N--CA 1.493 1.683 0 O-C-N 120.569 -1.332 . . . . 0.0 111.88 -179.049 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 119' ' ' GLY . . . . . . . . . . . . . . . -169.9 148.57 11.95 Favored Glycine 0 N--CA 1.49 2.295 0 N-CA-C 110.403 -1.079 . . . . 0.0 110.403 -179.889 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 120' ' ' HIS . . . . . . . . . . . . . 34.2 m170 -69.33 167.71 15.87 Favored 'General case' 0 N--CA 1.495 1.799 0 O-C-N 121.768 -0.842 . . . . 0.0 110.498 179.783 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 121' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -122.9 155.11 37.35 Favored 'General case' 0 N--CA 1.493 1.715 0 N-CA-C 108.165 -1.05 . . . . 0.0 108.165 178.677 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 122' ' ' PHE . . . . . 0.7 ' O ' HG21 ' A' ' 131' ' ' THR . 0.4 OUTLIER -144.15 123.38 12.97 Favored 'General case' 0 N--CA 1.496 1.835 0 O-C-N 120.849 -1.157 . . . . 0.0 109.756 -179.487 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 123' ' ' ILE . . . . . 0.573 HG23 ' N ' ' A' ' 124' ' ' ASP . 11.1 tt -55.76 -40.75 62.7 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.462 0 CA-C-O 121.628 0.728 . . . . 0.0 109.065 179.963 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 124' ' ' ASP . . . . . 0.573 ' N ' HG23 ' A' ' 123' ' ' ILE . 31.3 t70 -88.75 23.4 2.32 Favored 'General case' 0 N--CA 1.493 1.714 0 O-C-N 121.653 -0.654 . . . . 0.0 111.731 -177.703 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 125' ' ' ARG . . . . . . . . . . . . . 54.1 mtt180 -153.62 98.59 2.66 Favored Pre-proline 0 N--CA 1.493 1.679 0 O-C-N 120.866 -1.146 . . . . 0.0 109.183 179.618 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 126' ' ' PRO . . . . . . . . . . . . . 69.7 Cg_endo -82.3 -28.57 1.85 Allowed 'Trans proline' 0 C--N 1.313 -1.321 0 C-N-CA 122.401 2.068 . . . . 0.0 111.939 179.734 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 127' ' ' ASN . . . . . 0.482 ' O ' ' O ' ' A' ' 128' ' ' TYR . 32.6 m-20 -89.86 6.43 41.87 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.372 -0.83 . . . . 0.0 109.186 179.79 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 128' ' ' TYR . . . . . 0.503 ' O ' ' OE1' ' A' ' 85' ' ' GLU . 2.4 t80 -59.47 -148.53 0.0 OUTLIER 'General case' 0 N--CA 1.489 1.486 0 O-C-N 121.318 -0.864 . . . . 0.0 109.465 179.901 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 129' ' ' GLN . . . . . 0.489 ' O ' ' OE1' ' A' ' 85' ' ' GLU . 8.7 mt-30 -65.21 -72.45 0.15 Allowed 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.386 -0.821 . . . . 0.0 110.067 -179.321 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 130' ' ' PHE . . . . . 0.567 ' CE2' HG11 ' A' ' 101' ' ' VAL . 53.5 m-85 -135.78 42.0 2.67 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.012 -1.055 . . . . 0.0 109.993 -179.693 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 131' ' ' THR . . . . . 0.7 HG21 ' O ' ' A' ' 122' ' ' PHE . 38.9 m -77.19 -35.82 55.46 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.129 -0.982 . . . . 0.0 109.531 179.94 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 132' ' ' ASN . . . . . 0.604 ' ND2' ' O ' ' A' ' 81' ' ' ALA . 0.1 OUTLIER -84.15 4.71 29.21 Favored 'General case' 0 N--CA 1.498 1.925 0 O-C-N 121.44 -0.788 . . . . 0.0 110.456 -179.277 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 133' ' ' LEU . . . . . 0.569 ' O ' ' N ' ' A' ' 135' ' ' ALA . 0.2 OUTLIER -68.19 -45.52 73.2 Favored 'General case' 0 C--N 1.296 -1.76 0 O-C-N 120.961 -1.087 . . . . 0.0 110.578 -179.636 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 134' ' ' LYS . . . . . 0.52 ' CD ' ' H ' ' A' ' 134' ' ' LYS . 0.0 OUTLIER -43.17 -17.85 0.01 OUTLIER 'General case' 0 N--CA 1.496 1.865 0 O-C-N 120.955 -1.09 . . . . 0.0 110.191 -179.331 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 135' ' ' ALA . . . . . 0.569 ' N ' ' O ' ' A' ' 133' ' ' LEU . . . -83.24 -38.28 22.42 Favored 'General case' 0 N--CA 1.488 1.471 0 O-C-N 120.925 -1.109 . . . . 0.0 110.147 -179.566 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 136' ' ' ALA . . . . . 0.81 ' HB2' ' HB2' ' A' ' 81' ' ' ALA . . . -80.0 157.89 26.69 Favored 'General case' 0 C--N 1.302 -1.476 0 CA-C-O 122.283 1.04 . . . . 0.0 111.82 -178.412 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 137' ' ' LYS . . . . . 0.528 ' O ' ' O ' ' A' ' 138' ' ' LYS . 2.4 tttt -154.49 -162.71 1.45 Allowed 'General case' 0 N--CA 1.491 1.617 0 C-N-CA 119.083 -1.047 . . . . 0.0 110.579 -178.61 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 138' ' ' LYS . . . . . 0.601 ' O ' ' N ' ' A' ' 140' ' ' SER . 16.6 pttm -44.65 -179.19 0.0 OUTLIER 'General case' 0 C--N 1.302 -1.482 0 CA-C-O 122.228 1.013 . . . . 0.0 111.039 -179.13 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 139' ' ' GLY . . . . . . . . . . . . . . . 45.42 7.89 0.01 OUTLIER Glycine 0 N--CA 1.491 2.304 0 N-CA-C 110.646 -0.982 . . . . 0.0 110.646 179.978 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 140' ' ' SER . . . . . 0.601 ' N ' ' O ' ' A' ' 138' ' ' LYS . 58.7 m -85.99 124.39 32.38 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 120.71 -1.465 . . . . 0.0 109.244 179.459 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 141' ' ' MET . . . . . . . . . . . . . 1.1 tpt -72.88 136.08 45.23 Favored 'General case' 0 N--CA 1.489 1.506 0 O-C-N 121.133 -0.979 . . . . 0.0 109.16 179.93 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 142' ' ' VAL . . . . . . . . . . . . . 3.5 t -121.42 129.1 75.9 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.627 0 N-CA-C 108.865 -0.791 . . . . 0.0 108.865 -179.835 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 143' ' ' TYR . . . . . . . . . . . . . 16.6 m-85 -113.14 136.6 52.54 Favored 'General case' 0 N--CA 1.498 1.951 0 O-C-N 121.172 -0.955 . . . . 0.0 111.063 -178.667 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 144' ' ' PHE . . . . . 0.565 ' CE2' HG11 ' A' ' 146' ' ' VAL . 10.7 t80 -122.52 104.98 9.73 Favored 'General case' 0 N--CA 1.492 1.667 0 CA-C-O 121.5 0.667 . . . . 0.0 110.245 -178.989 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 145' ' ' LYS . . . . . . . . . . . . . 4.6 mttm -97.7 123.41 41.61 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.426 -0.796 . . . . 0.0 109.719 -179.965 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 146' ' ' VAL . . . . . 0.565 HG11 ' CE2' ' A' ' 144' ' ' PHE . 0.5 OUTLIER -143.78 122.62 7.42 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.582 0 O-C-N 121.196 -0.94 . . . . 0.0 108.648 179.402 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 147' ' ' GLY . . . . . . . . . . . . . . . 70.47 -131.01 21.6 Favored Glycine 0 N--CA 1.488 2.163 0 N-CA-C 108.525 -1.83 . . . . 0.0 108.525 -179.103 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 148' ' ' ASN . . . . . . . . . . . . . 18.7 p30 -106.51 11.72 30.35 Favored 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.407 -1.055 . . . . 0.0 108.665 179.101 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 149' ' ' GLU . . . . . . . . . . . . . 4.8 tt0 -114.2 149.42 35.8 Favored 'General case' 0 N--CA 1.491 1.594 0 CA-C-O 121.844 0.831 . . . . 0.0 111.043 -179.003 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 150' ' ' THR . . . . . . . . . . . . . 20.1 m -129.89 105.55 8.07 Favored 'General case' 0 N--CA 1.492 1.656 0 CA-C-O 121.341 0.591 . . . . 0.0 109.762 -179.986 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 151' ' ' ARG . . . . . . . . . . . . . 4.9 mtp180 -87.82 -175.29 5.08 Favored 'General case' 0 N--CA 1.487 1.403 0 N-CA-C 108.293 -1.003 . . . . 0.0 108.293 179.701 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 152' ' ' LYS . . . . . . . . . . . . . 26.3 mtmt -149.31 146.45 27.55 Favored 'General case' 0 C--N 1.301 -1.502 0 O-C-N 120.914 -1.116 . . . . 0.0 110.619 -179.454 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 153' ' ' TYR . . . . . 0.491 ' CD2' ' HA ' ' A' ' 204' ' ' GLU . 4.1 m-85 -138.6 170.25 16.35 Favored 'General case' 0 N--CA 1.488 1.443 0 N-CA-C 107.471 -1.307 . . . . 0.0 107.471 178.794 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 154' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -144.52 122.7 12.19 Favored 'General case' 0 C--N 1.296 -1.726 0 N-CA-C 108.087 -1.079 . . . . 0.0 108.087 178.581 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 155' ' ' MET . . . . . . . . . . . . . 3.7 mtt -46.75 105.88 0.07 Allowed 'General case' 0 N--CA 1.49 1.54 0 O-C-N 120.594 -1.316 . . . . 0.0 111.702 -178.445 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 156' ' ' THR . . . . . 0.724 ' OG1' HG23 ' A' ' 203' ' ' THR . 0.1 OUTLIER -106.28 -25.55 11.9 Favored 'General case' 0 C--N 1.292 -1.918 0 CA-C-N 115.183 -0.917 . . . . 0.0 110.074 -179.137 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 157' ' ' SER . . . . . 0.416 ' O ' ' N ' ' A' ' 201' ' ' VAL . 0.1 OUTLIER -153.72 152.72 31.1 Favored 'General case' 0 N--CA 1.495 1.81 0 C-N-CA 118.24 -1.384 . . . . 0.0 111.592 -178.766 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 158' ' ' ILE . . . . . 0.454 HG13 ' CD2' ' A' ' 200' ' ' PHE . 0.0 OUTLIER -156.17 146.52 12.04 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.527 0 CA-C-O 121.758 0.79 . . . . 0.0 110.376 -179.885 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 159' ' ' ARG . . . . . 0.471 ' CG ' HH11 ' A' ' 159' ' ' ARG . 0.0 OUTLIER -150.85 -175.59 5.19 Favored 'General case' 0 C--N 1.3 -1.574 0 CA-C-O 121.833 0.825 . . . . 0.0 110.821 -179.629 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 160' ' ' ASP . . . . . 0.648 ' O ' HG13 ' A' ' 161' ' ' VAL . 1.9 m-20 -143.2 157.34 44.59 Favored 'General case' 0 N--CA 1.49 1.566 0 N-CA-C 108.018 -1.105 . . . . 0.0 108.018 -179.851 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 161' ' ' VAL . . . . . 0.648 HG13 ' O ' ' A' ' 160' ' ' ASP . 2.3 m -160.08 157.38 2.89 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.833 0 C-N-CA 118.624 -1.231 . . . . 0.0 110.902 -179.256 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 162' ' ' LYS . . . . . 0.449 ' O ' ' O ' ' A' ' 161' ' ' VAL . 0.0 OUTLIER -44.02 169.04 0.06 OUTLIER Pre-proline 0 N--CA 1.493 1.685 0 O-C-N 121.559 -0.713 . . . . 0.0 109.833 -179.996 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 163' ' ' PRO . . . . . 0.463 ' C ' HD11 ' C' ' 702' ' ' LEU . 57.0 Cg_endo -77.2 34.74 0.46 Allowed 'Trans proline' 0 C--N 1.309 -1.521 0 C-N-CA 122.622 2.215 . . . . 0.0 112.402 179.725 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 164' ' ' THR . . . . . 0.478 ' N ' HD11 ' C' ' 702' ' ' LEU . 0.0 OUTLIER -150.76 -6.98 0.28 Allowed 'General case' 0 N--CA 1.495 1.778 0 O-C-N 121.1 -1.0 . . . . 0.0 110.904 -179.567 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 165' ' ' ASP . . . . . 0.422 ' O ' ' C ' ' A' ' 166' ' ' VAL . 13.7 t70 -72.53 61.16 0.49 Allowed 'General case' 0 C--N 1.3 -1.56 0 O-C-N 120.881 -1.137 . . . . 0.0 109.127 -179.831 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 166' ' ' VAL . . . . . 0.643 ' O ' ' N ' ' A' ' 168' ' ' VAL . 0.8 OUTLIER -44.0 -29.47 0.52 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.523 0 O-C-N 121.113 -0.992 . . . . 0.0 109.387 -178.567 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 167' ' ' GLY . . . . . . . . . . . . . . . -45.19 -6.43 0.01 OUTLIER Glycine 0 N--CA 1.498 2.788 0 O-C-N 121.197 -0.94 . . . . 0.0 110.763 179.905 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 168' ' ' VAL . . . . . 0.643 ' N ' ' O ' ' A' ' 166' ' ' VAL . 2.8 t -48.24 -34.56 4.99 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.417 0 O-C-N 120.88 -1.365 . . . . 0.0 108.381 179.188 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 169' ' ' LEU . . . . . 0.64 HD13 ' OE1' ' A' ' 105' ' ' GLU . 1.4 mt -47.23 -11.01 0.02 OUTLIER 'General case' 0 N--CA 1.494 1.767 0 N-CA-C 108.239 -1.022 . . . . 0.0 108.239 -178.313 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 170' ' ' ASP . . . . . 0.603 ' N ' ' O ' ' A' ' 168' ' ' VAL . 6.1 t70 38.49 64.65 0.71 Allowed 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.596 -0.69 . . . . 0.0 111.535 177.615 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 171' ' ' GLU . . . . . 0.426 ' H ' ' HG2' ' A' ' 171' ' ' GLU . 1.7 pt-20 -101.09 92.81 5.17 Favored 'General case' 0 C--N 1.299 -1.601 0 N-CA-C 106.965 -1.494 . . . . 0.0 106.965 177.715 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 172' ' ' GLN . . . . . . . . . . . . . 1.1 mt-30 -156.01 -79.16 0.09 Allowed 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.651 -0.656 . . . . 0.0 110.266 -178.361 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 173' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -59.49 128.41 36.91 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.15 -0.969 . . . . 0.0 109.195 -179.549 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 174' ' ' GLY . . . . . 0.526 ' O ' ' C ' ' A' ' 175' ' ' LYS . . . -119.36 -40.92 0.6 Allowed Glycine 0 N--CA 1.48 1.584 0 N-CA-C 108.117 -1.993 . . . . 0.0 108.117 179.321 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 175' ' ' LYS . . . . . 0.526 ' C ' ' O ' ' A' ' 174' ' ' GLY . 2.9 mmtt -35.79 -61.88 0.45 Allowed 'General case' 0 N--CA 1.496 1.829 0 N-CA-C 108.728 -0.841 . . . . 0.0 108.728 -179.877 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 176' ' ' ASP . . . . . 0.604 ' O ' ' O ' ' A' ' 177' ' ' LYS . 0.3 OUTLIER -103.48 88.87 3.2 Favored 'General case' 0 C--N 1.297 -1.676 0 N-CA-C 107.801 -1.185 . . . . 0.0 107.801 177.946 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 177' ' ' LYS . . . . . 0.604 ' O ' ' O ' ' A' ' 176' ' ' ASP . 6.0 mtmp? -39.29 177.82 0.0 OUTLIER 'General case' 0 N--CA 1.494 1.748 0 CA-C-O 121.805 0.812 . . . . 0.0 111.023 -179.09 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 178' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -161.69 171.81 17.29 Favored 'General case' 0 C--N 1.305 -1.331 0 O-C-N 120.837 -1.164 . . . . 0.0 110.508 179.186 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 179' ' ' LEU . . . . . . . . . . . . . 1.3 tp -126.74 95.33 4.3 Favored 'General case' 0 C--N 1.302 -1.485 0 N-CA-C 106.491 -1.67 . . . . 0.0 106.491 177.513 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 180' ' ' THR . . . . . . . . . . . . . 1.2 m -70.12 119.11 13.83 Favored 'General case' 0 C--N 1.304 -1.384 0 C-N-CA 119.134 -1.026 . . . . 0.0 109.41 -178.349 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 181' ' ' LEU . . . . . 0.467 HD21 ' HG ' ' A' ' 133' ' ' LEU . 36.8 tp -96.82 146.01 25.32 Favored 'General case' 0 C--N 1.294 -1.806 0 N-CA-C 108.028 -1.101 . . . . 0.0 108.028 178.706 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 182' ' ' ILE . . . . . . . . . . . . . 25.3 mt -139.34 119.77 14.58 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.484 0 O-C-N 120.956 -1.09 . . . . 0.0 109.718 179.088 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 183' ' ' THR . . . . . 0.592 ' O ' HG23 ' A' ' 183' ' ' THR . 10.3 t -135.76 115.45 12.9 Favored 'General case' 0 C--N 1.291 -1.977 0 N-CA-C 107.447 -1.316 . . . . 0.0 107.447 178.508 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 184' ' ' CYS . . . . . . . . . . . . . 5.1 p -78.15 157.38 29.44 Favored 'General case' 0 C--N 1.287 -2.12 0 C-N-CA 118.93 -1.108 . . . . 0.0 110.655 -177.867 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 185' ' ' ASP . . . . . 0.522 ' CG ' ' H ' ' A' ' 186' ' ' ASP . 37.3 t0 -165.7 -158.09 0.34 Allowed 'General case' 0 N--CA 1.492 1.654 0 N-CA-C 108.944 -0.761 . . . . 0.0 108.944 -179.5 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 186' ' ' ASP . . . . . 0.522 ' H ' ' CG ' ' A' ' 185' ' ' ASP . 1.3 m-20 52.93 53.83 11.44 Favored 'General case' 0 N--CA 1.494 1.73 0 O-C-N 120.902 -1.124 . . . . 0.0 109.444 179.979 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 187' ' ' TYR . . . . . 0.617 ' CE1' ' O ' ' A' ' 188' ' ' ASN . 61.2 t80 -67.9 135.03 51.82 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.171 -0.956 . . . . 0.0 110.719 -179.397 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 188' ' ' ASN . . . . . 0.617 ' O ' ' CE1' ' A' ' 187' ' ' TYR . 1.1 t-20 -101.68 146.16 28.11 Favored 'General case' 0 C--N 1.295 -1.792 0 N-CA-C 108.119 -1.067 . . . . 0.0 108.119 178.441 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 189' ' ' GLU . . . . . . . . . . . . . 1.8 tt0 -110.13 -13.39 14.37 Favored 'General case' 0 C--N 1.293 -1.875 0 N-CA-C 108.151 -1.055 . . . . 0.0 108.151 -179.782 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 190' ' ' LYS . . . . . . . . . . . . . 6.4 mttt -84.27 -55.68 4.05 Favored 'General case' 0 C--N 1.301 -1.522 0 N-CA-C 108.827 -0.805 . . . . 0.0 108.827 178.759 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 191' ' ' THR . . . . . 0.583 ' OG1' HG12 ' A' ' 193' ' ' VAL . 6.2 p -87.48 2.55 50.27 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.444 -0.785 . . . . 0.0 109.89 -179.644 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 192' ' ' GLY . . . . . . . . . . . . . . . 56.27 33.07 60.98 Favored Glycine 0 N--CA 1.495 2.62 0 O-C-N 121.172 -0.955 . . . . 0.0 111.79 178.615 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 193' ' ' VAL . . . . . 0.583 HG12 ' OG1' ' A' ' 191' ' ' THR . 4.1 p -149.25 167.94 2.97 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.75 0 O-C-N 120.677 -1.484 . . . . 0.0 110.583 179.009 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 194' ' ' TRP . . . . . 0.524 ' H ' HG22 ' A' ' 193' ' ' VAL . 9.4 m95 -83.98 120.23 25.87 Favored 'General case' 0 C--N 1.296 -1.724 0 N-CA-C 108.558 -0.904 . . . . 0.0 108.558 179.963 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 195' ' ' GLU . . . . . 0.444 ' CD ' ' ND2' ' A' ' 188' ' ' ASN . 3.7 mt-10 -76.23 -60.82 2.17 Favored 'General case' 0 N--CA 1.495 1.784 0 O-C-N 121.395 -0.816 . . . . 0.0 111.356 -178.323 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 196' ' ' LYS . . . . . . . . . . . . . 8.6 tttt -93.18 153.71 18.47 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 120.935 -1.103 . . . . 0.0 110.817 -178.494 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 197' ' ' ARG . . . . . 0.647 ' CG ' HH11 ' A' ' 197' ' ' ARG . 0.0 OUTLIER -119.66 140.13 51.12 Favored 'General case' 0 N--CA 1.49 1.525 0 N-CA-C 107.995 -1.113 . . . . 0.0 107.995 178.845 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 198' ' ' LYS . . . . . . . . . . . . . 2.4 mttm -114.16 122.02 45.54 Favored 'General case' 0 N--CA 1.493 1.719 0 O-C-N 121.899 -0.501 . . . . 0.0 110.904 -177.982 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 199' ' ' ILE . . . . . 0.694 ' C ' HD12 ' A' ' 199' ' ' ILE . 0.5 OUTLIER -142.58 120.02 7.02 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.546 0 CA-C-O 122.393 1.092 . . . . 0.0 110.515 179.925 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 200' ' ' PHE . . . . . 0.509 ' CD1' ' N ' ' A' ' 200' ' ' PHE . 3.5 m-85 -98.42 135.45 39.98 Favored 'General case' 0 N--CA 1.499 2.001 0 O-C-N 121.34 -0.85 . . . . 0.0 109.512 -178.982 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 201' ' ' VAL . . . . . 0.416 ' N ' ' O ' ' A' ' 157' ' ' SER . 72.3 t -100.08 130.75 48.76 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.633 0 O-C-N 120.885 -1.134 . . . . 0.0 108.318 177.671 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 202' ' ' ALA . . . . . . . . . . . . . . . -114.48 131.47 56.61 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.37 -0.831 . . . . 0.0 108.771 179.443 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 203' ' ' THR . . . . . 0.724 HG23 ' OG1' ' A' ' 156' ' ' THR . 6.7 p -88.59 130.35 35.28 Favored 'General case' 0 N--CA 1.487 1.399 0 CA-C-O 122.137 0.97 . . . . 0.0 110.768 -179.039 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 204' ' ' GLU . . . . . 0.491 ' HA ' ' CD2' ' A' ' 153' ' ' TYR . 0.8 OUTLIER -51.5 134.28 29.21 Favored 'General case' 0 C--N 1.298 -1.64 0 C-N-CA 119.091 -1.044 . . . . 0.0 109.034 179.305 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 205' ' ' VAL . . . . . 0.721 HG23 ' O ' ' A' ' 203' ' ' THR . 93.3 t -132.22 167.03 27.41 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.358 0 CA-C-O 122.081 0.943 . . . . 0.0 110.144 -178.132 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 206' ' ' LYS . . . . . 0.603 ' N ' HG12 ' A' ' 205' ' ' VAL . 0.0 OUTLIER . . . . . 0 C--N 1.295 -1.787 0 CA-C-O 117.933 -1.032 . . . . 0.0 109.509 -179.72 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' C' C ' 701' ' ' PHQ . . . . . 0.613 ' O2 ' HG12 ' A' ' 166' ' ' VAL . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 003 nuclear build full ' C' C ' 702' ' ' LEU . . . . . 0.784 ' N ' HD12 ' C' ' 702' ' ' LEU . 0.0 OUTLIER . . . . . 0 N--CA 1.494 1.741 0 N-CA-C 109.235 -0.654 . . . . 0.0 109.235 . . . . . . . . . 2 2 . 1 . 003 nuclear build full ' C' C ' 703' ' ' PRO . . . . . 0.637 ' HB3' ' HB3' ' A' ' 92' ' ' ALA . 50.7 Cg_exo -48.6 -164.59 0.0 OUTLIER 'Trans proline' 0 N--CA 1.494 1.504 0 C-N-CA 122.437 2.091 . . . . 0.0 113.216 -179.426 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' C' C ' 704' ' ' ALA . . . . . 0.748 ' HB2' ' HB1' ' A' ' 118' ' ' ALA . . . 48.05 99.62 0.01 OUTLIER 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.679 -0.638 . . . . 0.0 109.983 -179.924 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' C' C ' 705' ' ' B27 . . . . . 0.502 ' SG ' ' C ' ' C' ' 704' ' ' ALA . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 700' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 004 nuclear build full ' A' A ' 59' ' ' MET . . . . . . . . . . . . . 2.2 mtt . . . . . 0 N--CA 1.491 1.581 0 N-CA-C 109.4 -0.592 . . . . 0.0 109.4 . . . . . . . . . 0 0 . 1 . 004 nuclear build full ' A' A ' 60' ' ' GLN . . . . . . . . . . . . . 7.5 tp-100 -60.62 113.07 2.26 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.295 -0.878 . . . . 0.0 109.588 -179.91 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . -64.0 -169.8 0.03 OUTLIER 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.192 -0.942 . . . . 0.0 109.238 179.804 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 62' ' ' LYS . . . . . . . . . . . . . 27.2 mttp -147.41 83.75 7.54 Favored Pre-proline 0 N--CA 1.489 1.516 0 O-C-N 121.252 -0.905 . . . . 0.0 109.567 -179.682 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 63' ' ' PRO . . . . . 0.47 ' O ' ' CD1' ' A' ' 110' ' ' LEU . 18.2 Cg_endo -81.46 141.2 12.42 Favored 'Trans proline' 0 C--N 1.306 -1.672 0 C-N-CA 122.792 2.328 . . . . 0.0 111.231 179.584 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 64' ' ' GLN . . . . . 0.48 ' O ' ' OE1' ' A' ' 64' ' ' GLN . 0.0 OUTLIER -155.53 139.25 16.11 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.175 -0.953 . . . . 0.0 109.658 -179.967 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 65' ' ' ILE . . . . . . . . . . . . . 4.7 mm -48.05 107.7 0.79 Allowed Pre-proline 0 N--CA 1.491 1.592 0 O-C-N 121.009 -1.057 . . . . 0.0 108.183 179.345 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 66' ' ' PRO . . . . . . . . . . . . . 93.6 Cg_endo -85.75 -170.16 0.68 Allowed 'Trans proline' 0 C--N 1.315 -1.218 0 C-N-CA 122.15 1.9 . . . . 0.0 112.614 -179.015 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 67' ' ' LYS . . . . . . . . . . . . . 38.7 tttt -90.27 -8.86 49.89 Favored 'General case' 0 N--CA 1.488 1.459 0 O-C-N 121.436 -0.79 . . . . 0.0 109.178 179.567 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 68' ' ' ASP . . . . . 0.664 ' O ' ' N ' ' A' ' 70' ' ' SER . 0.4 OUTLIER -75.86 63.86 1.74 Allowed 'General case' 0 N--CA 1.488 1.431 0 CA-C-O 122.848 1.309 . . . . 0.0 109.033 179.813 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 69' ' ' LYS . . . . . 0.478 ' C ' ' O ' ' A' ' 68' ' ' ASP . 23.8 mtmt -45.76 -13.99 0.02 OUTLIER 'General case' 0 N--CA 1.512 2.653 0 C-N-CA 116.686 -2.005 . . . . 0.0 107.157 177.757 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 70' ' ' SER . . . . . 0.664 ' N ' ' O ' ' A' ' 68' ' ' ASP . 0.1 OUTLIER -86.04 -9.02 57.49 Favored 'General case' 0 N--CA 1.497 1.899 0 CA-C-N 113.701 -1.59 . . . . 0.0 111.656 179.395 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 71' ' ' LYS . . . . . 0.464 ' N ' ' O ' ' A' ' 68' ' ' ASP . 0.0 OUTLIER -95.88 142.18 28.44 Favored 'General case' 0 N--CA 1.505 2.303 0 O-C-N 120.468 -1.395 . . . . 0.0 112.971 -178.704 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 72' ' ' VAL . . . . . 0.633 HG12 ' CZ ' ' A' ' 88' ' ' TYR . 1.3 m -68.67 133.42 31.81 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.368 0 N-CA-C 105.305 -2.109 . . . . 0.0 105.305 174.711 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 73' ' ' ALA . . . . . 0.7 ' O ' HG23 ' A' ' 146' ' ' VAL . . . -80.87 -13.77 58.63 Favored 'General case' 0 C--N 1.297 -1.714 0 O-C-N 119.905 -1.747 . . . . 0.0 107.183 -179.813 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . 172.99 -156.71 25.24 Favored Glycine 0 N--CA 1.483 1.77 0 N-CA-C 109.299 -1.52 . . . . 0.0 109.299 179.648 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 75' ' ' TYR . . . . . 0.547 ' HA ' HG23 ' A' ' 87' ' ' VAL . 88.1 m-85 -141.54 169.99 16.56 Favored 'General case' 0 C--N 1.298 -1.668 0 O-C-N 121.58 -0.953 . . . . 0.0 111.044 -177.241 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 76' ' ' ILE . . . . . . . . . . . . . 3.9 tp -146.5 141.39 20.88 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.577 0 C-N-CA 119.461 -0.895 . . . . 0.0 109.455 -177.377 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -153.09 165.02 36.92 Favored 'General case' 0 C--N 1.304 -1.41 0 O-C-N 121.13 -0.981 . . . . 0.0 109.934 179.852 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 78' ' ' ILE . . . . . 0.639 ' HB ' ' HB3' ' A' ' 81' ' ' ALA . 5.0 mt -147.39 119.92 4.75 Favored Pre-proline 0 C--N 1.303 -1.455 0 N-CA-C 107.87 -1.159 . . . . 0.0 107.87 179.165 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 79' ' ' PRO . . . . . . . . . . . . . 31.1 Cg_endo -70.46 -42.36 2.74 Favored 'Trans proline' 0 C--N 1.315 -1.218 0 C-N-CA 121.658 1.572 . . . . 0.0 112.992 -178.755 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -66.43 -19.8 65.89 Favored 'General case' 0 N--CA 1.489 1.491 0 O-C-N 120.881 -1.137 . . . . 0.0 110.202 177.977 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 81' ' ' ALA . . . . . 0.931 ' HB2' ' HB2' ' A' ' 136' ' ' ALA . . . -106.61 -18.78 13.86 Favored 'General case' 0 N--CA 1.494 1.755 0 O-C-N 121.303 -0.873 . . . . 0.0 109.04 179.913 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 82' ' ' ASP . . . . . . . . . . . . . 2.3 t70 66.01 52.09 1.25 Allowed 'General case' 0 N--CA 1.494 1.732 0 O-C-N 121.43 -0.794 . . . . 0.0 111.493 178.781 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 83' ' ' ILE . . . . . . . . . . . . . 31.4 mt -131.46 153.08 38.3 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.862 0 O-C-N 120.977 -1.077 . . . . 0.0 109.636 -179.322 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 84' ' ' LYS . . . . . . . . . . . . . 23.1 tttt -158.11 110.48 2.33 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.244 -0.91 . . . . 0.0 108.628 179.57 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -141.46 165.75 26.6 Favored Pre-proline 0 N--CA 1.492 1.67 0 O-C-N 121.246 -0.909 . . . . 0.0 109.817 -179.256 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 86' ' ' PRO . . . . . . . . . . . . . 61.2 Cg_endo -76.29 168.61 23.58 Favored 'Trans proline' 0 C--N 1.309 -1.5 0 C-N-CA 122.939 2.426 . . . . 0.0 113.312 -179.53 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 87' ' ' VAL . . . . . 0.547 HG23 ' HA ' ' A' ' 75' ' ' TYR . 49.6 t -124.43 98.84 5.64 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.63 0 N-CA-C 109.27 -0.641 . . . . 0.0 109.27 -179.884 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 88' ' ' TYR . . . . . 0.633 ' CZ ' HG12 ' A' ' 72' ' ' VAL . 35.0 m-85 -90.42 153.55 46.22 Favored Pre-proline 0 N--CA 1.503 2.209 0 O-C-N 120.954 -1.091 . . . . 0.0 109.944 -179.606 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 89' ' ' PRO . . . . . 0.539 ' O ' ' NE2' ' A' ' 96' ' ' GLN . 10.2 Cg_endo -58.7 146.11 93.36 Favored 'Trans proline' 0 N--CA 1.493 1.469 0 C-N-CA 122.492 2.128 . . . . 0.0 113.135 179.82 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . -58.11 169.59 4.7 Favored Glycine 0 N--CA 1.492 2.398 0 N-CA-C 109.326 -1.51 . . . . 0.0 109.326 179.493 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 91' ' ' PRO . . . . . 0.4 ' C ' ' H ' ' A' ' 93' ' ' THR . 57.3 Cg_endo -95.23 169.21 16.63 Favored 'Cis proline' 0 C--N 1.31 -1.485 0 C-N-CA 124.298 -1.126 . . . . 0.0 112.065 0.103 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 92' ' ' ALA . . . . . 0.676 ' HB3' ' HB2' ' C' ' 703' ' ' PRO . . . -71.99 30.07 0.05 Allowed 'General case' 0 N--CA 1.493 1.691 0 O-C-N 121.241 -0.912 . . . . 0.0 111.274 -179.421 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 93' ' ' THR . . . . . 0.4 ' H ' ' C ' ' A' ' 91' ' ' PRO . 1.0 OUTLIER -75.85 151.29 84.35 Favored Pre-proline 0 N--CA 1.492 1.64 0 O-C-N 120.651 -1.281 . . . . 0.0 108.788 179.865 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 94' ' ' PRO . . . . . 0.4 ' C ' ' O ' ' A' ' 93' ' ' THR . 82.9 Cg_exo -35.52 -42.24 0.45 Allowed 'Trans proline' 0 C--N 1.308 -1.573 0 C-N-CA 122.511 2.14 . . . . 0.0 112.067 -179.566 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 5.8 mt-10 -49.95 -56.44 10.62 Favored 'General case' 0 C--N 1.304 -1.41 0 O-C-N 121.292 -0.88 . . . . 0.0 109.112 179.512 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 96' ' ' GLN . . . . . 0.596 ' O ' ' N ' ' A' ' 98' ' ' ASN . 13.0 mm100 -74.49 -47.86 30.64 Favored 'General case' 0 N--CA 1.487 1.424 0 O-C-N 121.323 -0.861 . . . . 0.0 109.995 179.69 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 97' ' ' LEU . . . . . 0.595 HD23 ' O ' ' A' ' 92' ' ' ALA . 0.4 OUTLIER -45.3 -11.89 0.02 OUTLIER 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.221 -0.925 . . . . 0.0 109.989 -178.949 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 98' ' ' ASN . . . . . 0.596 ' N ' ' O ' ' A' ' 96' ' ' GLN . 0.0 OUTLIER -73.88 -31.44 63.15 Favored 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.176 -0.953 . . . . 0.0 108.854 179.204 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 99' ' ' ARG . . . . . 0.62 HH11 ' CG ' ' A' ' 99' ' ' ARG . 1.1 mtt-85 -85.03 -58.2 2.79 Favored 'General case' 0 C--N 1.302 -1.47 0 O-C-N 121.865 -0.522 . . . . 0.0 109.89 -179.14 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . -179.65 -160.34 25.09 Favored Glycine 0 N--CA 1.493 2.442 0 C-N-CA 119.645 -1.264 . . . . 0.0 110.046 -179.944 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 101' ' ' VAL . . . . . 0.736 HG23 ' O ' ' A' ' 101' ' ' VAL . 17.8 m -61.66 107.82 0.46 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.594 0 O-C-N 121.403 -1.057 . . . . 0.0 109.522 -179.813 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -92.91 161.57 14.43 Favored 'General case' 0 N--CA 1.493 1.681 0 O-C-N 121.322 -0.861 . . . . 0.0 110.498 -179.84 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 103' ' ' PHE . . . . . 0.601 ' O ' ' N ' ' A' ' 105' ' ' GLU . 25.3 m-85 -64.13 123.32 18.77 Favored 'General case' 0 N--CA 1.488 1.447 0 N-CA-C 108.151 -1.055 . . . . 0.0 108.151 178.655 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 104' ' ' ALA . . . . . 0.702 ' HB1' ' HG3' ' C' ' 703' ' ' PRO . . . -40.39 -18.63 0.01 OUTLIER 'General case' 0 C--N 1.298 -1.636 0 O-C-N 121.602 -0.686 . . . . 0.0 110.774 -178.939 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 105' ' ' GLU . . . . . 0.601 ' N ' ' O ' ' A' ' 103' ' ' PHE . 0.4 OUTLIER -140.0 147.88 41.06 Favored 'General case' 0 N--CA 1.495 1.808 0 O-C-N 120.698 -1.251 . . . . 0.0 110.315 179.915 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 106' ' ' GLU . . . . . . . . . . . . . 4.3 tt0 -57.86 -63.37 1.27 Allowed 'General case' 0 N--CA 1.487 1.425 0 O-C-N 121.965 -0.459 . . . . 0.0 111.203 -179.058 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 107' ' ' ASN . . . . . . . . . . . . . 5.1 m120 -78.68 33.82 0.21 Allowed 'General case' 0 N--CA 1.49 1.544 0 O-C-N 120.477 -1.39 . . . . 0.0 113.465 -175.231 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 108' ' ' GLU . . . . . . . . . . . . . 30.6 tp10 -60.02 150.14 30.1 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 120.426 -1.421 . . . . 0.0 108.175 -179.614 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 109' ' ' SER . . . . . 0.489 ' C ' ' H ' ' A' ' 111' ' ' ASP . 0.1 OUTLIER -101.35 126.26 48.09 Favored 'General case' 0 N--CA 1.489 1.5 0 O-C-N 121.002 -1.061 . . . . 0.0 110.585 -178.613 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 110' ' ' LEU . . . . . 0.534 HD23 ' N ' ' A' ' 110' ' ' LEU . 1.0 OUTLIER -60.22 -2.33 0.44 Allowed 'General case' 0 C--N 1.298 -1.664 0 N-CA-C 108.891 -0.781 . . . . 0.0 108.891 -179.964 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 111' ' ' ASP . . . . . 0.489 ' H ' ' C ' ' A' ' 109' ' ' SER . 53.1 m-20 -133.26 20.47 4.02 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.386 -0.822 . . . . 0.0 109.607 179.831 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 112' ' ' ASP . . . . . 0.41 ' N ' ' OG ' ' A' ' 109' ' ' SER . 0.4 OUTLIER -68.05 140.14 56.29 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.002 -1.061 . . . . 0.0 110.661 -179.674 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 113' ' ' GLN . . . . . 0.531 ' N ' ' CD ' ' A' ' 113' ' ' GLN . 7.6 mm-40 -64.92 -7.06 9.94 Favored 'General case' 0 C--N 1.303 -1.445 0 N-CA-C 107.521 -1.289 . . . . 0.0 107.521 177.876 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 114' ' ' ASN . . . . . 0.667 HD21 ' C ' ' A' ' 114' ' ' ASN . 0.2 OUTLIER -144.68 92.17 2.26 Favored 'General case' 0 C--N 1.304 -1.403 0 N-CA-C 108.206 -1.035 . . . . 0.0 108.206 -179.954 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 115' ' ' ILE . . . . . 0.448 ' O ' HG22 ' A' ' 115' ' ' ILE . 2.8 mt -99.11 113.71 34.83 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.536 0 O-C-N 121.531 -0.731 . . . . 0.0 109.328 -179.438 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 116' ' ' SER . . . . . 0.572 ' OG ' ' HB3' ' A' ' 104' ' ' ALA . 69.3 p -98.02 146.61 25.34 Favored 'General case' 0 N--CA 1.488 1.471 0 CA-C-O 122.093 0.949 . . . . 0.0 111.387 -178.299 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 117' ' ' ILE . . . . . . . . . . . . . 2.7 mt -138.21 154.64 28.24 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.511 0 N-CA-C 107.477 -1.305 . . . . 0.0 107.477 178.996 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 118' ' ' ALA . . . . . . . . . . . . . . . -143.44 159.75 41.82 Favored 'General case' 0 N--CA 1.492 1.66 0 O-C-N 120.836 -1.165 . . . . 0.0 111.336 -179.233 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 119' ' ' GLY . . . . . . . . . . . . . . . -167.66 145.56 9.85 Favored Glycine 0 N--CA 1.489 2.183 0 N-CA-C 110.423 -1.071 . . . . 0.0 110.423 179.624 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 120' ' ' HIS . . . . . 0.403 ' ND1' ' SG ' ' C' ' 705' ' ' B27 . 3.1 m-70 -70.36 164.64 24.1 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.613 -0.933 . . . . 0.0 109.417 179.236 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 121' ' ' THR . . . . . 0.423 HG21 ' OD2' ' A' ' 185' ' ' ASP . 0.7 OUTLIER -118.06 155.28 30.62 Favored 'General case' 0 N--CA 1.494 1.733 0 O-C-N 121.318 -0.864 . . . . 0.0 108.855 179.422 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 122' ' ' PHE . . . . . 0.401 ' CD1' ' HB2' ' A' ' 125' ' ' ARG . 0.2 OUTLIER -112.36 128.07 56.19 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.308 -0.87 . . . . 0.0 109.637 179.761 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 123' ' ' ILE . . . . . 0.567 HG23 ' N ' ' A' ' 124' ' ' ASP . 16.3 tt -77.26 -38.52 27.21 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.809 0 N-CA-C 108.167 -1.049 . . . . 0.0 108.167 179.076 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 124' ' ' ASP . . . . . 0.567 ' N ' HG23 ' A' ' 123' ' ' ILE . 4.8 t70 -100.29 24.32 8.94 Favored 'General case' 0 N--CA 1.494 1.771 0 CA-C-N 115.771 -0.649 . . . . 0.0 110.82 -179.73 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 125' ' ' ARG . . . . . 0.401 ' HB2' ' CD1' ' A' ' 122' ' ' PHE . 5.1 ttt180 -157.64 99.77 1.87 Allowed Pre-proline 0 N--CA 1.492 1.671 0 O-C-N 120.664 -1.272 . . . . 0.0 110.541 -179.032 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 126' ' ' PRO . . . . . . . . . . . . . 41.3 Cg_endo -78.88 -18.91 11.33 Favored 'Trans proline' 0 C--N 1.314 -1.243 0 C-N-CA 122.175 1.917 . . . . 0.0 112.465 179.517 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 127' ' ' ASN . . . . . . . . . . . . . 14.8 m120 -90.65 26.69 1.95 Allowed 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.23 -0.919 . . . . 0.0 109.241 179.636 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 128' ' ' TYR . . . . . . . . . . . . . 13.1 t80 -87.04 -149.01 0.15 Allowed 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.306 -0.872 . . . . 0.0 109.774 -179.622 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 129' ' ' GLN . . . . . . . . . . . . . 63.3 mt-30 -67.95 -89.43 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.288 -0.882 . . . . 0.0 110.344 -179.323 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 130' ' ' PHE . . . . . 0.704 ' CE2' HG11 ' A' ' 101' ' ' VAL . 41.0 m-85 -110.15 40.07 2.02 Favored 'General case' 0 N--CA 1.494 1.752 0 O-C-N 121.287 -0.883 . . . . 0.0 110.338 -179.22 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 131' ' ' THR . . . . . . . . . . . . . 85.6 m -79.78 -32.95 40.9 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.088 -1.008 . . . . 0.0 109.128 179.38 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 132' ' ' ASN . . . . . 0.435 ' ND2' ' O ' ' A' ' 81' ' ' ALA . 4.6 t30 -84.33 7.54 19.04 Favored 'General case' 0 N--CA 1.495 1.784 0 O-C-N 121.608 -0.682 . . . . 0.0 110.335 -179.588 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 133' ' ' LEU . . . . . 0.6 ' O ' ' N ' ' A' ' 135' ' ' ALA . 0.2 OUTLIER -70.26 -46.37 64.53 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.186 -0.946 . . . . 0.0 110.686 -179.146 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 134' ' ' LYS . . . . . 0.597 ' H ' ' CD ' ' A' ' 134' ' ' LYS . 0.1 OUTLIER -42.53 -17.54 0.01 OUTLIER 'General case' 0 N--CA 1.493 1.692 0 O-C-N 121.024 -1.048 . . . . 0.0 109.983 -179.012 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 135' ' ' ALA . . . . . 0.6 ' N ' ' O ' ' A' ' 133' ' ' LEU . . . -85.12 -33.89 22.28 Favored 'General case' 0 N--CA 1.489 1.482 0 O-C-N 121.183 -0.948 . . . . 0.0 109.64 179.773 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 136' ' ' ALA . . . . . 0.931 ' HB2' ' HB2' ' A' ' 81' ' ' ALA . . . -80.43 153.21 28.39 Favored 'General case' 0 N--CA 1.489 1.504 0 CA-C-O 122.095 0.95 . . . . 0.0 111.769 -178.546 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 137' ' ' LYS . . . . . 0.511 ' O ' ' O ' ' A' ' 138' ' ' LYS . 2.8 ttmm -157.42 -163.47 1.37 Allowed 'General case' 0 N--CA 1.491 1.624 0 C-N-CA 119.109 -1.037 . . . . 0.0 110.431 -179.25 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 138' ' ' LYS . . . . . 0.604 ' O ' ' N ' ' A' ' 140' ' ' SER . 10.3 tttt -46.23 -178.39 0.0 OUTLIER 'General case' 0 C--N 1.306 -1.3 0 CA-C-O 121.864 0.84 . . . . 0.0 110.265 -179.818 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 139' ' ' GLY . . . . . . . . . . . . . . . 45.7 8.2 0.02 OUTLIER Glycine 0 N--CA 1.492 2.431 0 N-CA-C 110.713 -0.955 . . . . 0.0 110.713 179.574 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 140' ' ' SER . . . . . 0.604 ' N ' ' O ' ' A' ' 138' ' ' LYS . 37.9 m -96.5 133.74 40.57 Favored 'General case' 0 N--CA 1.493 1.679 0 O-C-N 120.814 -1.404 . . . . 0.0 109.125 179.195 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 141' ' ' MET . . . . . 0.409 ' HG2' ' CE2' ' A' ' 143' ' ' TYR . 0.0 OUTLIER -82.52 144.62 30.27 Favored 'General case' 0 N--CA 1.489 1.488 0 O-C-N 121.148 -0.97 . . . . 0.0 109.871 -179.816 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 142' ' ' VAL . . . . . . . . . . . . . 5.8 t -129.21 132.85 66.61 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.705 0 O-C-N 121.284 -0.885 . . . . 0.0 108.771 179.902 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 143' ' ' TYR . . . . . 0.409 ' CE2' ' HG2' ' A' ' 141' ' ' MET . 32.3 m-85 -114.66 137.68 51.61 Favored 'General case' 0 N--CA 1.501 2.098 0 O-C-N 121.116 -0.99 . . . . 0.0 111.421 -178.455 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 144' ' ' PHE . . . . . . . . . . . . . 26.9 t80 -122.36 107.1 11.69 Favored 'General case' 0 N--CA 1.495 1.817 0 CA-C-O 121.323 0.583 . . . . 0.0 110.442 -179.178 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 145' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -96.63 128.83 43.95 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.384 -0.823 . . . . 0.0 110.582 -179.752 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 146' ' ' VAL . . . . . 0.7 HG23 ' O ' ' A' ' 73' ' ' ALA . 3.7 p -143.38 142.8 25.15 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.777 0 N-CA-C 107.522 -1.288 . . . . 0.0 107.522 178.752 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 147' ' ' GLY . . . . . 0.41 ' C ' ' O ' ' A' ' 146' ' ' VAL . . . 46.97 -134.28 11.71 Favored Glycine 0 N--CA 1.489 2.224 0 N-CA-C 108.887 -1.685 . . . . 0.0 108.887 -179.754 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 148' ' ' ASN . . . . . 0.596 ' C ' HD22 ' A' ' 148' ' ' ASN . 0.4 OUTLIER -102.33 17.31 23.8 Favored 'General case' 0 C--N 1.301 -1.533 0 O-C-N 121.284 -1.127 . . . . 0.0 108.451 179.208 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 149' ' ' GLU . . . . . . . . . . . . . 8.7 tt0 -114.56 147.42 39.48 Favored 'General case' 0 N--CA 1.487 1.402 0 CA-C-O 121.919 0.866 . . . . 0.0 111.024 -178.605 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 150' ' ' THR . . . . . . . . . . . . . 88.3 m -129.42 105.97 8.47 Favored 'General case' 0 N--CA 1.491 1.596 0 CA-C-O 121.421 0.629 . . . . 0.0 109.718 179.891 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 151' ' ' ARG . . . . . . . . . . . . . 34.2 mtt180 -87.04 -174.54 4.96 Favored 'General case' 0 C--N 1.306 -1.299 0 N-CA-C 107.987 -1.116 . . . . 0.0 107.987 179.52 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 152' ' ' LYS . . . . . 0.433 ' CE ' ' OXT' ' A' ' 206' ' ' LYS . 18.6 mtmm -148.22 146.33 28.63 Favored 'General case' 0 C--N 1.3 -1.571 0 O-C-N 121.007 -1.058 . . . . 0.0 110.135 -179.799 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 153' ' ' TYR . . . . . 0.507 ' CD2' ' HA ' ' A' ' 204' ' ' GLU . 9.1 m-85 -139.02 166.56 24.17 Favored 'General case' 0 C--N 1.3 -1.546 0 N-CA-C 107.523 -1.288 . . . . 0.0 107.523 179.13 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 154' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -142.96 121.86 12.74 Favored 'General case' 0 C--N 1.296 -1.722 0 O-C-N 121.184 -0.948 . . . . 0.0 108.442 178.748 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 155' ' ' MET . . . . . . . . . . . . . 23.1 mmm -46.99 104.89 0.06 Allowed 'General case' 0 N--CA 1.49 1.526 0 O-C-N 120.758 -1.214 . . . . 0.0 111.445 -178.584 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 156' ' ' THR . . . . . . . . . . . . . 1.4 m -107.88 -23.95 11.84 Favored 'General case' 0 C--N 1.293 -1.885 0 CA-C-N 115.288 -0.869 . . . . 0.0 109.921 -179.291 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 157' ' ' SER . . . . . 0.485 ' O ' ' N ' ' A' ' 201' ' ' VAL . 2.0 m -153.94 150.56 28.45 Favored 'General case' 0 N--CA 1.492 1.669 0 C-N-CA 118.217 -1.393 . . . . 0.0 111.426 -178.362 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 158' ' ' ILE . . . . . 0.453 HG13 ' CD2' ' A' ' 200' ' ' PHE . 0.0 OUTLIER -154.95 146.45 13.29 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.44 0 CA-C-O 121.796 0.807 . . . . 0.0 110.333 -179.491 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 159' ' ' ARG . . . . . 0.434 ' N ' HG12 ' A' ' 158' ' ' ILE . 37.5 mtm180 -149.3 177.18 9.89 Favored 'General case' 0 C--N 1.298 -1.656 0 CA-C-O 121.557 0.694 . . . . 0.0 109.812 -179.732 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 160' ' ' ASP . . . . . 0.571 ' C ' HG22 ' A' ' 161' ' ' VAL . 1.0 OUTLIER -144.81 161.22 39.81 Favored 'General case' 0 C--N 1.3 -1.567 0 N-CA-C 108.859 -0.793 . . . . 0.0 108.859 -179.463 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 161' ' ' VAL . . . . . 0.571 HG22 ' C ' ' A' ' 160' ' ' ASP . 0.1 OUTLIER -169.47 166.6 0.34 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.612 0 O-C-N 121.294 -0.879 . . . . 0.0 109.768 179.673 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 162' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -55.29 177.36 0.13 Allowed Pre-proline 0 N--CA 1.489 1.482 0 O-C-N 121.528 -0.732 . . . . 0.0 109.189 179.669 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 163' ' ' PRO . . . . . 0.739 ' C ' HD11 ' C' ' 702' ' ' LEU . 9.8 Cg_endo -84.07 42.8 1.26 Allowed 'Trans proline' 0 C--N 1.315 -1.185 0 C-N-CA 122.466 2.111 . . . . 0.0 112.21 -179.87 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 164' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -151.92 -14.0 0.19 Allowed 'General case' 0 N--CA 1.492 1.674 0 O-C-N 121.103 -0.998 . . . . 0.0 110.443 -179.859 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 165' ' ' ASP . . . . . 0.436 ' O ' ' C ' ' A' ' 166' ' ' VAL . 9.5 t70 -73.03 61.63 0.59 Allowed 'General case' 0 N--CA 1.49 1.527 0 O-C-N 120.955 -1.091 . . . . 0.0 109.544 -179.817 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 166' ' ' VAL . . . . . 0.608 ' O ' ' N ' ' A' ' 168' ' ' VAL . 0.9 OUTLIER -39.6 -32.04 0.17 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.55 0 O-C-N 121.659 -0.65 . . . . 0.0 109.431 -178.416 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 167' ' ' GLY . . . . . 0.425 ' N ' ' O ' ' A' ' 165' ' ' ASP . . . -43.03 -14.96 0.02 OUTLIER Glycine 0 N--CA 1.492 2.375 0 N-CA-C 110.325 -1.11 . . . . 0.0 110.325 179.898 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 168' ' ' VAL . . . . . 0.616 ' C ' ' H ' ' A' ' 170' ' ' ASP . 4.8 m -52.72 -37.06 24.04 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.452 0 O-C-N 120.751 -1.441 . . . . 0.0 108.528 179.692 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 169' ' ' LEU . . . . . 0.508 ' O ' ' N ' ' A' ' 171' ' ' GLU . 16.1 mt -51.75 -5.39 0.03 OUTLIER 'General case' 0 N--CA 1.494 1.756 0 N-CA-C 108.088 -1.078 . . . . 0.0 108.088 -179.431 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 170' ' ' ASP . . . . . 0.616 ' H ' ' C ' ' A' ' 168' ' ' VAL . 22.4 t0 35.52 29.49 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.639 -0.663 . . . . 0.0 111.586 178.047 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 171' ' ' GLU . . . . . 0.508 ' N ' ' O ' ' A' ' 169' ' ' LEU . 11.6 pt-20 -68.31 94.5 0.54 Allowed 'General case' 0 N--CA 1.489 1.5 0 O-C-N 120.609 -1.307 . . . . 0.0 108.26 178.935 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 172' ' ' GLN . . . . . 0.427 ' HG3' ' H ' ' A' ' 173' ' ' LYS . 6.0 pt20 -175.98 -56.9 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.535 0 N-CA-C 108.885 -0.783 . . . . 0.0 108.885 179.969 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 173' ' ' LYS . . . . . 0.427 ' H ' ' HG3' ' A' ' 172' ' ' GLN . 44.5 mtpt -64.13 130.24 43.17 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.021 -1.049 . . . . 0.0 108.64 178.462 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 174' ' ' GLY . . . . . 0.571 ' O ' ' C ' ' A' ' 175' ' ' LYS . . . -134.91 -38.72 0.19 Allowed Glycine 0 N--CA 1.48 1.621 0 N-CA-C 108.621 -1.792 . . . . 0.0 108.621 179.581 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 175' ' ' LYS . . . . . 0.571 ' C ' ' O ' ' A' ' 174' ' ' GLY . 4.3 mmtp -27.02 -64.7 0.08 Allowed 'General case' 0 N--CA 1.503 2.199 0 CA-C-O 121.644 0.735 . . . . 0.0 109.033 179.853 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 176' ' ' ASP . . . . . 0.669 ' O ' ' O ' ' A' ' 177' ' ' LYS . 0.0 OUTLIER -102.6 79.26 1.79 Allowed 'General case' 0 C--N 1.298 -1.669 0 N-CA-C 107.163 -1.421 . . . . 0.0 107.163 177.442 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 177' ' ' LYS . . . . . 0.669 ' O ' ' O ' ' A' ' 176' ' ' ASP . 65.7 mttt -26.56 161.34 0.0 OUTLIER 'General case' 0 N--CA 1.503 2.212 0 CA-C-O 121.821 0.82 . . . . 0.0 111.17 -178.676 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 178' ' ' GLN . . . . . 0.601 HE21 ' CG ' ' A' ' 114' ' ' ASN . 3.3 pp0? -159.94 174.0 15.05 Favored 'General case' 0 C--N 1.302 -1.458 0 C-N-CA 117.265 -1.774 . . . . 0.0 112.029 -179.357 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 179' ' ' LEU . . . . . 0.469 ' N ' ' OE1' ' A' ' 178' ' ' GLN . 0.9 OUTLIER -126.01 99.05 5.75 Favored 'General case' 0 C--N 1.303 -1.446 0 N-CA-C 107.242 -1.392 . . . . 0.0 107.242 178.47 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 180' ' ' THR . . . . . 0.487 HG23 HD13 ' A' ' 199' ' ' ILE . 2.7 m -70.82 122.0 19.09 Favored 'General case' 0 N--CA 1.488 1.447 0 O-C-N 120.953 -1.092 . . . . 0.0 109.939 -178.642 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 181' ' ' LEU . . . . . . . . . . . . . 51.1 tp -96.84 145.78 25.54 Favored 'General case' 0 C--N 1.298 -1.67 0 N-CA-C 108.387 -0.968 . . . . 0.0 108.387 178.725 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 182' ' ' ILE . . . . . 0.486 HG22 ' O ' ' A' ' 182' ' ' ILE . 6.3 mt -138.31 110.58 6.39 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.458 0 O-C-N 120.994 -1.066 . . . . 0.0 108.982 178.987 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 183' ' ' THR . . . . . 0.445 ' O ' HG23 ' A' ' 183' ' ' THR . 1.9 t -129.11 113.47 15.14 Favored 'General case' 0 C--N 1.291 -1.938 0 N-CA-C 106.767 -1.568 . . . . 0.0 106.767 178.546 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 184' ' ' CYS . . . . . . . . . . . . . 28.2 p -78.38 164.52 24.74 Favored 'General case' 0 N--CA 1.497 1.916 0 C-N-CA 119.028 -1.069 . . . . 0.0 111.103 -177.359 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 185' ' ' ASP . . . . . 0.423 ' OD2' HG21 ' A' ' 121' ' ' THR . 6.4 t70 -165.72 -151.4 0.14 Allowed 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.584 -0.698 . . . . 0.0 109.347 -179.642 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 186' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER 48.15 56.63 7.08 Favored 'General case' 0 N--CA 1.493 1.724 0 O-C-N 121.175 -0.953 . . . . 0.0 109.03 -179.598 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 187' ' ' TYR . . . . . 0.6 ' CE1' ' O ' ' A' ' 188' ' ' ASN . 44.7 t80 -67.38 133.77 50.22 Favored 'General case' 0 C--N 1.302 -1.485 0 O-C-N 121.418 -0.801 . . . . 0.0 110.411 -179.417 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 188' ' ' ASN . . . . . 0.6 ' O ' ' CE1' ' A' ' 187' ' ' TYR . 0.6 OUTLIER -100.74 147.21 26.29 Favored 'General case' 0 C--N 1.296 -1.749 0 N-CA-C 107.79 -1.189 . . . . 0.0 107.79 178.302 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 189' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -112.3 -11.04 13.76 Favored 'General case' 0 C--N 1.295 -1.797 0 N-CA-C 108.373 -0.973 . . . . 0.0 108.373 -179.635 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 190' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -84.23 -52.47 6.22 Favored 'General case' 0 C--N 1.303 -1.447 0 N-CA-C 108.851 -0.796 . . . . 0.0 108.851 178.838 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 191' ' ' THR . . . . . 0.591 ' OG1' HG12 ' A' ' 193' ' ' VAL . 1.1 p -89.44 -12.63 39.64 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.475 -0.766 . . . . 0.0 109.2 179.663 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 192' ' ' GLY . . . . . . . . . . . . . . . 71.84 33.43 63.02 Favored Glycine 0 N--CA 1.493 2.495 0 O-C-N 121.291 -0.881 . . . . 0.0 111.303 178.706 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 193' ' ' VAL . . . . . 0.591 HG12 ' OG1' ' A' ' 191' ' ' THR . 3.3 p -147.71 170.85 3.2 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.67 0 O-C-N 120.778 -1.425 . . . . 0.0 110.035 179.216 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 194' ' ' TRP . . . . . 0.556 ' H ' HG22 ' A' ' 193' ' ' VAL . 2.5 m95 -84.97 121.63 28.05 Favored 'General case' 0 N--CA 1.494 1.726 0 N-CA-C 109.439 -0.578 . . . . 0.0 109.439 -179.809 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 195' ' ' GLU . . . . . 0.531 ' CD ' ' ND2' ' A' ' 188' ' ' ASN . 2.4 mt-10 -80.05 -60.38 2.36 Favored 'General case' 0 N--CA 1.496 1.87 0 O-C-N 121.348 -0.845 . . . . 0.0 111.037 -178.975 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 196' ' ' LYS . . . . . . . . . . . . . 10.6 tttt -93.44 157.34 16.27 Favored 'General case' 0 N--CA 1.493 1.688 0 O-C-N 120.977 -1.077 . . . . 0.0 110.695 -178.544 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 197' ' ' ARG . . . . . 0.636 ' CG ' HH11 ' A' ' 197' ' ' ARG . 0.1 OUTLIER -126.18 142.2 51.62 Favored 'General case' 0 N--CA 1.489 1.485 0 O-C-N 121.653 -0.654 . . . . 0.0 109.351 179.415 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 198' ' ' LYS . . . . . . . . . . . . . 38.5 mttt -115.56 121.73 43.53 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.794 -0.566 . . . . 0.0 110.101 -179.17 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 199' ' ' ILE . . . . . 0.667 ' C ' HD12 ' A' ' 199' ' ' ILE . 0.5 OUTLIER -138.09 118.65 16.19 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.811 0 CA-C-O 122.526 1.155 . . . . 0.0 110.076 179.834 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 200' ' ' PHE . . . . . 0.586 ' CZ ' HD12 ' A' ' 133' ' ' LEU . 7.0 m-85 -99.73 135.35 41.28 Favored 'General case' 0 N--CA 1.499 1.992 0 O-C-N 121.499 -0.751 . . . . 0.0 109.894 -178.358 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 201' ' ' VAL . . . . . 0.485 ' N ' ' O ' ' A' ' 157' ' ' SER . 59.9 t -101.03 131.86 47.88 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.714 0 O-C-N 120.984 -1.073 . . . . 0.0 108.826 177.684 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 202' ' ' ALA . . . . . . . . . . . . . . . -115.9 131.38 56.95 Favored 'General case' 0 N--CA 1.491 1.624 0 N-CA-C 108.525 -0.917 . . . . 0.0 108.525 179.43 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 203' ' ' THR . . . . . 0.683 ' O ' HG23 ' A' ' 205' ' ' VAL . 5.4 t -87.88 132.09 34.33 Favored 'General case' 0 N--CA 1.488 1.468 0 CA-C-O 122.327 1.061 . . . . 0.0 110.709 -179.332 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 204' ' ' GLU . . . . . 0.507 ' HA ' ' CD2' ' A' ' 153' ' ' TYR . 13.7 tm-20 -52.99 135.42 36.85 Favored 'General case' 0 C--N 1.296 -1.752 0 C-N-CA 118.619 -1.233 . . . . 0.0 108.909 179.205 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 205' ' ' VAL . . . . . 0.683 HG23 ' O ' ' A' ' 203' ' ' THR . 84.1 t -131.99 167.97 25.14 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.345 0 CA-C-O 121.993 0.902 . . . . 0.0 110.141 -178.056 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 206' ' ' LYS . . . . . 0.61 ' N ' HG12 ' A' ' 205' ' ' VAL . 25.5 mttt . . . . . 0 C--N 1.297 -1.675 0 CA-C-O 117.978 -1.011 . . . . 0.0 109.555 179.937 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' C' C ' 701' ' ' PHQ . . . . . 0.504 ' C1 ' HG12 ' A' ' 166' ' ' VAL . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 004 nuclear build full ' C' C ' 702' ' ' LEU . . . . . 0.739 HD11 ' C ' ' A' ' 163' ' ' PRO . 0.0 OUTLIER . . . . . 0 N--CA 1.49 1.561 0 N-CA-C 108.775 -0.824 . . . . 0.0 108.775 . . . . . . . . . 2 2 . 1 . 004 nuclear build full ' C' C ' 703' ' ' PRO . . . . . 0.702 ' HG3' ' HB1' ' A' ' 104' ' ' ALA . 55.5 Cg_endo -72.58 174.76 11.16 Favored 'Trans proline' 0 N--CA 1.495 1.597 0 C-N-CA 122.48 2.12 . . . . 0.0 112.418 -179.497 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' C' C ' 704' ' ' ALA . . . . . . . . . . . . . . . 54.77 -173.81 0.04 OUTLIER 'General case' 0 N--CA 1.487 1.388 0 O-C-N 121.234 -0.916 . . . . 0.0 109.49 179.897 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' C' C ' 705' ' ' B27 . . . . . 0.486 ' OG1' ' CD1' ' A' ' 194' ' ' TRP . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 700' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 005 nuclear build full ' A' A ' 59' ' ' MET . . . . . . . . . . . . . 0.3 OUTLIER . . . . . 0 N--CA 1.49 1.534 0 N-CA-C 109.474 -0.565 . . . . 0.0 109.474 . . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 60' ' ' GLN . . . . . 0.615 ' H ' ' CD ' ' A' ' 60' ' ' GLN . 1.4 mp0 -59.65 -179.73 0.1 Allowed 'General case' 0 N--CA 1.489 1.49 0 O-C-N 121.174 -0.954 . . . . 0.0 109.109 179.862 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . -63.49 157.11 24.34 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.099 -1.001 . . . . 0.0 109.262 -179.908 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 62' ' ' LYS . . . . . . . . . . . . . 40.0 mtpt -142.26 71.9 22.14 Favored Pre-proline 0 N--CA 1.489 1.491 0 O-C-N 121.152 -0.967 . . . . 0.0 109.693 -179.64 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 63' ' ' PRO . . . . . . . . . . . . . 53.7 Cg_endo -84.92 153.61 11.31 Favored 'Trans proline' 0 C--N 1.305 -1.737 0 C-N-CA 123.247 2.631 . . . . 0.0 110.929 179.271 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 64' ' ' GLN . . . . . 0.574 ' N ' ' CD ' ' A' ' 64' ' ' GLN . 0.0 OUTLIER -153.38 111.93 3.68 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 120.986 -1.071 . . . . 0.0 110.19 -179.84 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 65' ' ' ILE . . . . . 0.482 ' H ' HD12 ' A' ' 65' ' ' ILE . 3.1 mp -43.45 103.76 0.34 Allowed Pre-proline 0 N--CA 1.491 1.596 0 N-CA-C 108.148 -1.056 . . . . 0.0 108.148 178.722 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 66' ' ' PRO . . . . . . . . . . . . . 97.9 Cg_endo -85.98 -155.05 0.05 OUTLIER 'Trans proline' 0 N--CA 1.49 1.282 0 C-N-CA 122.407 2.072 . . . . 0.0 113.002 -178.218 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 67' ' ' LYS . . . . . 0.434 ' O ' ' CG ' ' A' ' 67' ' ' LYS . 15.1 tttt -82.16 -6.01 58.88 Favored 'General case' 0 N--CA 1.487 1.395 0 O-C-N 121.311 -0.868 . . . . 0.0 109.037 179.936 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 68' ' ' ASP . . . . . 0.64 ' C ' ' N ' ' A' ' 70' ' ' SER . 0.4 OUTLIER -75.12 51.15 0.51 Allowed 'General case' 0 N--CA 1.487 1.384 0 CA-C-O 122.645 1.212 . . . . 0.0 108.308 179.411 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 69' ' ' LYS . . . . . 0.452 ' C ' ' O ' ' A' ' 68' ' ' ASP . 1.9 ptpp? -49.19 -14.32 0.08 Allowed 'General case' 0 N--CA 1.501 2.121 0 C-N-CA 116.769 -1.972 . . . . 0.0 106.61 178.151 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 70' ' ' SER . . . . . 0.64 ' N ' ' C ' ' A' ' 68' ' ' ASP . 38.4 t -85.27 -7.2 59.13 Favored 'General case' 0 N--CA 1.495 1.824 0 CA-C-N 113.786 -1.552 . . . . 0.0 110.534 179.354 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 71' ' ' LYS . . . . . 0.416 ' CD ' ' HB2' ' A' ' 68' ' ' ASP . 0.9 OUTLIER -98.04 140.82 31.8 Favored 'General case' 0 N--CA 1.496 1.841 0 O-C-N 120.85 -1.156 . . . . 0.0 111.333 -179.745 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 72' ' ' VAL . . . . . 0.621 HG12 ' CE1' ' A' ' 88' ' ' TYR . 1.0 OUTLIER -66.03 142.4 16.84 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.455 0 N-CA-C 105.319 -2.104 . . . . 0.0 105.319 174.989 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 73' ' ' ALA . . . . . 0.439 ' N ' ' O ' ' A' ' 87' ' ' VAL . . . -83.0 -15.31 51.68 Favored 'General case' 0 C--N 1.293 -1.854 0 N-CA-C 106.078 -1.823 . . . . 0.0 106.078 178.935 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 74' ' ' GLY . . . . . 0.483 ' C ' ' CD1' ' A' ' 75' ' ' TYR . . . 167.56 -150.6 17.2 Favored Glycine 0 N--CA 1.482 1.706 0 N-CA-C 109.38 -1.488 . . . . 0.0 109.38 179.172 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 75' ' ' TYR . . . . . 0.483 ' CD1' ' C ' ' A' ' 74' ' ' GLY . 25.7 m-85 -144.09 175.97 9.66 Favored 'General case' 0 C--N 1.296 -1.74 0 O-C-N 121.597 -0.943 . . . . 0.0 109.782 -178.839 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 76' ' ' ILE . . . . . . . . . . . . . 2.0 tt -150.37 147.65 15.81 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.797 0 N-CA-C 108.923 -0.769 . . . . 0.0 108.923 -178.261 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 4.6 mt-10 -148.67 162.03 40.55 Favored 'General case' 0 C--N 1.301 -1.541 0 O-C-N 121.044 -1.035 . . . . 0.0 109.322 179.845 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 78' ' ' ILE . . . . . 0.468 ' HB ' ' HB3' ' A' ' 81' ' ' ALA . 36.4 mt -144.24 93.27 5.98 Favored Pre-proline 0 N--CA 1.489 1.51 0 N-CA-C 108.385 -0.968 . . . . 0.0 108.385 -179.733 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 79' ' ' PRO . . . . . . . . . . . . . 74.0 Cg_exo -47.31 -46.84 18.81 Favored 'Trans proline' 0 N--CA 1.494 1.511 0 C-N-CA 122.855 2.37 . . . . 0.0 114.094 -178.598 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 53.8 t0 -65.3 -19.07 65.79 Favored 'General case' 0 N--CA 1.493 1.695 0 O-C-N 120.716 -1.24 . . . . 0.0 110.839 178.921 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 81' ' ' ALA . . . . . 0.91 ' HB2' ' HB2' ' A' ' 136' ' ' ALA . . . -106.9 -17.87 14.08 Favored 'General case' 0 N--CA 1.494 1.745 0 O-C-N 121.114 -0.991 . . . . 0.0 108.792 179.527 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 82' ' ' ASP . . . . . 0.428 ' N ' ' O ' ' A' ' 78' ' ' ILE . 0.8 OUTLIER 69.3 50.69 0.54 Allowed 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.472 -0.768 . . . . 0.0 110.688 178.947 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 83' ' ' ILE . . . . . . . . . . . . . 64.1 mt -128.07 152.38 36.11 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.876 0 O-C-N 121.144 -0.972 . . . . 0.0 110.118 -179.247 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 84' ' ' LYS . . . . . . . . . . . . . 8.0 pttm -159.05 109.27 1.99 Allowed 'General case' 0 N--CA 1.49 1.561 0 N-CA-C 107.893 -1.151 . . . . 0.0 107.893 179.309 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 85' ' ' GLU . . . . . 0.436 ' OE2' ' O ' ' A' ' 129' ' ' GLN . 0.2 OUTLIER -140.48 170.99 8.4 Favored Pre-proline 0 N--CA 1.496 1.873 0 O-C-N 121.334 -0.854 . . . . 0.0 110.412 -178.684 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 86' ' ' PRO . . . . . . . . . . . . . 72.2 Cg_endo -81.72 159.66 18.99 Favored 'Trans proline' 0 N--CA 1.492 1.436 0 C-N-CA 123.08 2.52 . . . . 0.0 113.494 -179.594 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 87' ' ' VAL . . . . . 0.439 ' O ' ' N ' ' A' ' 73' ' ' ALA . 72.5 t -115.45 100.61 10.88 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.69 0 O-C-N 121.659 -0.651 . . . . 0.0 109.808 -179.842 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 88' ' ' TYR . . . . . 0.621 ' CE1' HG12 ' A' ' 72' ' ' VAL . 20.2 m-85 -92.42 154.14 42.74 Favored Pre-proline 0 N--CA 1.498 1.95 0 O-C-N 120.879 -1.138 . . . . 0.0 109.483 179.717 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 89' ' ' PRO . . . . . 0.425 ' HA ' ' CD2' ' A' ' 103' ' ' PHE . 9.7 Cg_endo -61.98 146.15 96.43 Favored 'Trans proline' 0 C--N 1.307 -1.65 0 C-N-CA 122.373 2.049 . . . . 0.0 113.504 -179.907 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . -55.15 165.97 3.15 Favored Glycine 0 N--CA 1.494 2.509 0 N-CA-C 108.826 -1.709 . . . . 0.0 108.826 179.008 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 91' ' ' PRO . . . . . 0.447 ' C ' ' H ' ' A' ' 93' ' ' THR . 65.6 Cg_endo -94.83 168.07 17.8 Favored 'Cis proline' 0 C--N 1.307 -1.627 0 C-N-CA 124.08 -1.216 . . . . 0.0 112.205 0.269 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 92' ' ' ALA . . . . . 0.599 ' O ' HD13 ' A' ' 97' ' ' LEU . . . -70.71 28.25 0.04 OUTLIER 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.411 -0.806 . . . . 0.0 110.793 -179.626 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 93' ' ' THR . . . . . 0.447 ' H ' ' C ' ' A' ' 91' ' ' PRO . 1.7 p -73.56 152.66 89.65 Favored Pre-proline 0 N--CA 1.491 1.596 0 O-C-N 120.716 -1.24 . . . . 0.0 109.246 -179.743 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 94' ' ' PRO . . . . . . . . . . . . . 88.9 Cg_exo -36.19 -42.07 0.59 Allowed 'Trans proline' 0 C--N 1.31 -1.497 0 C-N-CA 122.821 2.347 . . . . 0.0 112.335 -179.283 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 95' ' ' GLU . . . . . 0.637 ' H ' ' CD ' ' A' ' 95' ' ' GLU . 0.1 OUTLIER -53.18 -53.98 42.61 Favored 'General case' 0 C--N 1.301 -1.507 0 O-C-N 121.254 -0.904 . . . . 0.0 109.302 179.756 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 96' ' ' GLN . . . . . 0.592 ' O ' ' N ' ' A' ' 98' ' ' ASN . 29.7 mm100 -73.64 -51.87 15.3 Favored 'General case' 0 N--CA 1.487 1.389 0 O-C-N 121.155 -0.966 . . . . 0.0 109.77 179.593 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 97' ' ' LEU . . . . . 0.599 HD13 ' O ' ' A' ' 92' ' ' ALA . 1.4 mp -46.25 -11.06 0.02 OUTLIER 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.416 -0.802 . . . . 0.0 109.741 -179.336 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 98' ' ' ASN . . . . . 0.592 ' N ' ' O ' ' A' ' 96' ' ' GLN . 0.0 OUTLIER -75.28 -23.42 57.4 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.197 -0.939 . . . . 0.0 110.005 -179.815 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 99' ' ' ARG . . . . . 0.425 ' HD2' ' CE2' ' A' ' 88' ' ' TYR . 7.7 mtt180 -103.19 -54.01 2.7 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.435 -0.79 . . . . 0.0 110.28 -178.88 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . -169.98 179.15 42.46 Favored Glycine 0 N--CA 1.492 2.41 0 C-N-CA 119.273 -1.442 . . . . 0.0 110.298 -179.834 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 101' ' ' VAL . . . . . 0.806 HG11 ' CE2' ' A' ' 130' ' ' PHE . 31.7 m -53.06 111.75 0.29 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.601 0 O-C-N 121.556 -0.967 . . . . 0.0 109.222 179.787 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -92.29 168.0 11.63 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.315 -0.866 . . . . 0.0 111.288 -179.155 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 103' ' ' PHE . . . . . 0.602 ' O ' ' N ' ' A' ' 105' ' ' GLU . 25.0 m-85 -69.64 120.79 15.95 Favored 'General case' 0 N--CA 1.488 1.439 0 N-CA-C 108.031 -1.1 . . . . 0.0 108.031 178.263 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 104' ' ' ALA . . . . . 0.572 ' HB1' ' HG3' ' C' ' 703' ' ' PRO . . . -41.09 -16.2 0.01 OUTLIER 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.686 -0.634 . . . . 0.0 111.066 -178.515 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 105' ' ' GLU . . . . . 0.602 ' N ' ' O ' ' A' ' 103' ' ' PHE . 0.4 OUTLIER -139.3 147.58 41.82 Favored 'General case' 0 N--CA 1.494 1.729 0 O-C-N 120.861 -1.149 . . . . 0.0 110.56 179.852 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 106' ' ' GLU . . . . . . . . . . . . . 16.2 tt0 -58.09 -63.9 1.1 Allowed 'General case' 0 C--N 1.302 -1.487 0 CA-C-N 116.113 -0.494 . . . . 0.0 110.863 -179.178 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 107' ' ' ASN . . . . . . . . . . . . . 43.9 m-20 -78.02 33.29 0.18 Allowed 'General case' 0 N--CA 1.491 1.621 0 O-C-N 120.501 -1.374 . . . . 0.0 113.342 -175.318 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 108' ' ' GLU . . . . . 0.48 ' OE1' ' OE2' ' A' ' 105' ' ' GLU . 26.9 tp10 -59.73 150.5 27.69 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 120.426 -1.421 . . . . 0.0 107.856 179.681 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 109' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -101.19 144.21 30.34 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 120.986 -1.072 . . . . 0.0 111.099 -178.169 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 110' ' ' LEU . . . . . 0.55 HD23 ' H ' ' A' ' 110' ' ' LEU . 0.4 OUTLIER -62.63 -22.86 66.74 Favored 'General case' 0 C--N 1.303 -1.433 0 N-CA-C 108.684 -0.858 . . . . 0.0 108.684 179.214 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 111' ' ' ASP . . . . . . . . . . . . . 64.0 m-20 -132.04 40.36 3.35 Favored 'General case' 0 N--CA 1.487 1.376 0 O-C-N 121.642 -0.662 . . . . 0.0 109.426 -179.687 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 112' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -68.53 152.42 45.41 Favored 'General case' 0 C--N 1.299 -1.591 0 O-C-N 121.266 -0.896 . . . . 0.0 110.439 179.906 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 113' ' ' GLN . . . . . . . . . . . . . 2.6 mp0 -66.21 -13.78 60.86 Favored 'General case' 0 C--N 1.301 -1.525 0 N-CA-C 108.104 -1.073 . . . . 0.0 108.104 178.153 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 114' ' ' ASN . . . . . 0.492 ' OD1' ' O ' ' A' ' 169' ' ' LEU . 1.3 t-20 -151.58 102.27 2.86 Favored 'General case' 0 N--CA 1.489 1.515 0 N-CA-C 108.171 -1.048 . . . . 0.0 108.171 179.126 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 115' ' ' ILE . . . . . 0.45 ' O ' HG22 ' A' ' 115' ' ' ILE . 3.1 mt -98.75 112.67 31.45 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.511 0 O-C-N 121.199 -0.938 . . . . 0.0 109.435 -179.772 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 116' ' ' SER . . . . . . . . . . . . . 44.1 m -98.56 143.91 28.45 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.316 -0.865 . . . . 0.0 111.338 -178.569 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 117' ' ' ILE . . . . . . . . . . . . . 1.6 mt -135.87 155.94 36.62 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.625 0 N-CA-C 108.111 -1.07 . . . . 0.0 108.111 178.764 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 118' ' ' ALA . . . . . 0.691 ' HB1' ' HB2' ' C' ' 704' ' ' ALA . . . -142.03 159.83 41.45 Favored 'General case' 0 N--CA 1.493 1.687 0 O-C-N 120.838 -1.163 . . . . 0.0 111.609 -178.967 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 119' ' ' GLY . . . . . . . . . . . . . . . -167.46 146.51 10.75 Favored Glycine 0 N--CA 1.49 2.235 0 C-N-CA 120.206 -0.997 . . . . 0.0 110.774 179.594 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 120' ' ' HIS . . . . . . . . . . . . . 1.1 m-70 -70.96 167.7 18.56 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.638 -0.919 . . . . 0.0 109.251 178.964 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 121' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -122.62 157.26 32.57 Favored 'General case' 0 N--CA 1.495 1.788 0 N-CA-C 108.552 -0.907 . . . . 0.0 108.552 179.105 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 122' ' ' PHE . . . . . 0.568 ' O ' HG21 ' A' ' 131' ' ' THR . 0.2 OUTLIER -122.03 124.25 43.53 Favored 'General case' 0 N--CA 1.495 1.798 0 O-C-N 121.205 -0.935 . . . . 0.0 109.923 -179.754 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 123' ' ' ILE . . . . . 0.513 HG23 ' N ' ' A' ' 124' ' ' ASP . 11.4 tt -72.96 -35.18 48.15 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.713 0 CA-C-O 121.69 0.757 . . . . 0.0 109.718 -179.923 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 124' ' ' ASP . . . . . 0.513 ' N ' HG23 ' A' ' 123' ' ' ILE . 52.0 m-20 -90.6 8.29 34.91 Favored 'General case' 0 C--N 1.294 -1.814 0 C-N-CA 120.154 -0.618 . . . . 0.0 111.501 -178.928 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 125' ' ' ARG . . . . . . . . . . . . . 6.4 mtp180 -152.6 113.52 2.79 Favored Pre-proline 0 N--CA 1.495 1.823 0 O-C-N 120.474 -1.391 . . . . 0.0 110.531 -179.64 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 126' ' ' PRO . . . . . . . . . . . . . 78.8 Cg_endo -82.61 -16.9 7.65 Favored 'Trans proline' 0 N--CA 1.488 1.199 0 C-N-CA 122.436 2.091 . . . . 0.0 112.303 178.965 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 127' ' ' ASN . . . . . . . . . . . . . 83.8 m-20 -89.76 6.83 39.87 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.098 -1.001 . . . . 0.0 109.675 -179.885 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 128' ' ' TYR . . . . . . . . . . . . . 7.0 t80 -62.36 -148.86 0.0 OUTLIER 'General case' 0 N--CA 1.489 1.477 0 O-C-N 121.258 -0.901 . . . . 0.0 109.686 -179.975 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 129' ' ' GLN . . . . . 0.436 ' O ' ' OE2' ' A' ' 85' ' ' GLU . 17.6 mt-30 -67.88 -88.47 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.303 -0.873 . . . . 0.0 110.355 -179.149 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 130' ' ' PHE . . . . . 0.806 ' CE2' HG11 ' A' ' 101' ' ' VAL . 30.4 m-85 -110.88 37.26 2.85 Favored 'General case' 0 N--CA 1.494 1.77 0 O-C-N 121.326 -0.859 . . . . 0.0 110.303 -179.054 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 131' ' ' THR . . . . . 0.568 HG21 ' O ' ' A' ' 122' ' ' PHE . 37.0 m -77.08 -31.69 56.2 Favored 'General case' 0 N--CA 1.489 1.486 0 O-C-N 121.045 -1.034 . . . . 0.0 109.464 179.701 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 132' ' ' ASN . . . . . 0.51 ' ND2' ' O ' ' A' ' 81' ' ' ALA . 3.9 t30 -83.78 7.01 19.18 Favored 'General case' 0 N--CA 1.498 1.968 0 O-C-N 121.387 -0.821 . . . . 0.0 111.033 -179.223 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 133' ' ' LEU . . . . . 0.609 HD13 ' O ' ' A' ' 133' ' ' LEU . 0.2 OUTLIER -70.21 -45.25 66.97 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 120.971 -1.081 . . . . 0.0 110.218 -179.274 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 134' ' ' LYS . . . . . 0.551 ' H ' ' CD ' ' A' ' 134' ' ' LYS . 0.2 OUTLIER -41.49 -18.98 0.01 OUTLIER 'General case' 0 N--CA 1.496 1.83 0 O-C-N 121.053 -1.029 . . . . 0.0 110.227 -179.212 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 135' ' ' ALA . . . . . 0.597 ' N ' ' O ' ' A' ' 133' ' ' LEU . . . -85.21 -31.49 23.15 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.082 -1.011 . . . . 0.0 110.038 179.854 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 136' ' ' ALA . . . . . 0.91 ' HB2' ' HB2' ' A' ' 81' ' ' ALA . . . -80.46 152.56 28.7 Favored 'General case' 0 N--CA 1.491 1.613 0 CA-C-O 122.055 0.931 . . . . 0.0 111.758 -178.437 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 137' ' ' LYS . . . . . 0.496 ' O ' ' O ' ' A' ' 138' ' ' LYS . 24.4 mtmt -151.63 -166.03 2.4 Favored 'General case' 0 N--CA 1.493 1.695 0 C-N-CA 118.597 -1.241 . . . . 0.0 111.004 -178.247 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 138' ' ' LYS . . . . . 0.598 ' O ' ' N ' ' A' ' 140' ' ' SER . 1.1 ptpt -45.21 178.71 0.0 OUTLIER 'General case' 0 C--N 1.305 -1.359 0 CA-C-O 122.127 0.965 . . . . 0.0 110.73 -179.074 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 139' ' ' GLY . . . . . . . . . . . . . . . 46.22 8.1 0.02 OUTLIER Glycine 0 N--CA 1.489 2.199 0 N-CA-C 110.407 -1.077 . . . . 0.0 110.407 179.98 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 140' ' ' SER . . . . . 0.598 ' N ' ' O ' ' A' ' 138' ' ' LYS . 13.3 t -80.55 146.21 31.4 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 120.845 -1.385 . . . . 0.0 109.514 179.366 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 141' ' ' MET . . . . . . . . . . . . . 4.6 tpt -93.46 121.16 34.57 Favored 'General case' 0 C--N 1.3 -1.561 0 O-C-N 121.343 -0.848 . . . . 0.0 108.849 179.409 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 142' ' ' VAL . . . . . . . . . . . . . 12.8 t -112.13 130.03 66.55 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.626 0 O-C-N 121.34 -0.85 . . . . 0.0 109.016 -179.396 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 143' ' ' TYR . . . . . . . . . . . . . 3.5 m-85 -109.16 135.55 50.1 Favored 'General case' 0 N--CA 1.499 1.976 0 O-C-N 121.141 -0.974 . . . . 0.0 111.859 -178.252 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 144' ' ' PHE . . . . . . . . . . . . . 57.8 t80 -120.61 102.06 8.17 Favored 'General case' 0 N--CA 1.494 1.744 0 CA-C-O 121.302 0.572 . . . . 0.0 110.272 -179.407 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 145' ' ' LYS . . . . . . . . . . . . . 23.1 tttt -93.8 122.4 36.23 Favored 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.331 -0.856 . . . . 0.0 109.602 179.799 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 146' ' ' VAL . . . . . 0.598 HG13 ' O ' ' A' ' 146' ' ' VAL . 7.1 p -142.39 118.47 5.91 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.671 0 O-C-N 121.185 -0.947 . . . . 0.0 109.18 179.752 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 147' ' ' GLY . . . . . . . . . . . . . . . 75.61 -135.8 18.85 Favored Glycine 0 N--CA 1.488 2.132 0 N-CA-C 108.386 -1.885 . . . . 0.0 108.386 -179.094 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 148' ' ' ASN . . . . . . . . . . . . . 20.6 p30 -103.47 14.27 31.7 Favored 'General case' 0 C--N 1.298 -1.659 0 N-CA-C 107.907 -1.146 . . . . 0.0 107.907 178.813 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 149' ' ' GLU . . . . . . . . . . . . . 47.9 tt0 -116.26 153.23 32.27 Favored 'General case' 0 N--CA 1.486 1.361 0 CA-C-O 121.987 0.898 . . . . 0.0 110.639 -179.466 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 150' ' ' THR . . . . . . . . . . . . . 86.5 m -130.44 107.29 9.12 Favored 'General case' 0 N--CA 1.494 1.747 0 CA-C-O 121.336 0.589 . . . . 0.0 109.938 -179.701 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 151' ' ' ARG . . . . . 0.459 HH11 ' CG ' ' A' ' 151' ' ' ARG . 0.4 OUTLIER -87.28 -171.03 3.29 Favored 'General case' 0 N--CA 1.487 1.38 0 N-CA-C 108.641 -0.874 . . . . 0.0 108.641 179.826 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 152' ' ' LYS . . . . . 0.497 ' O ' ' N ' ' A' ' 205' ' ' VAL . 20.4 mtpt -148.21 149.04 31.22 Favored 'General case' 0 C--N 1.299 -1.605 0 O-C-N 121.153 -0.967 . . . . 0.0 109.841 -179.694 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 153' ' ' TYR . . . . . 0.513 ' CD2' ' HA ' ' A' ' 204' ' ' GLU . 23.2 m-85 -139.98 164.57 29.65 Favored 'General case' 0 C--N 1.302 -1.481 0 N-CA-C 108.107 -1.072 . . . . 0.0 108.107 179.86 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 154' ' ' LYS . . . . . . . . . . . . . 26.2 ttpt -142.44 119.27 11.19 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.143 -0.973 . . . . 0.0 109.006 179.517 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 155' ' ' MET . . . . . . . . . . . . . 19.5 mmt -46.01 105.96 0.07 Allowed 'General case' 0 N--CA 1.494 1.737 0 O-C-N 120.846 -1.159 . . . . 0.0 112.198 -178.63 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 156' ' ' THR . . . . . . . . . . . . . 4.4 m -108.6 -22.47 12.25 Favored 'General case' 0 C--N 1.297 -1.71 0 C-N-CA 119.897 -0.721 . . . . 0.0 109.666 179.709 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 157' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -144.56 141.02 29.17 Favored 'General case' 0 N--CA 1.492 1.642 0 C-N-CA 118.781 -1.167 . . . . 0.0 109.835 -178.742 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 158' ' ' ILE . . . . . . . . . . . . . 37.2 mt -148.02 134.25 12.42 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.372 0 CA-C-O 121.602 0.715 . . . . 0.0 109.82 -178.147 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 159' ' ' ARG . . . . . . . . . . . . . 3.9 ptm180 -154.63 -175.68 5.53 Favored 'General case' 0 C--N 1.297 -1.711 0 C-N-CA 119.486 -0.886 . . . . 0.0 110.536 -179.763 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 160' ' ' ASP . . . . . 0.584 ' C ' HG22 ' A' ' 161' ' ' VAL . 5.3 m-20 -146.48 165.1 30.42 Favored 'General case' 0 N--CA 1.488 1.452 0 N-CA-C 108.336 -0.987 . . . . 0.0 108.336 179.979 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 161' ' ' VAL . . . . . 0.584 HG22 ' C ' ' A' ' 160' ' ' ASP . 0.1 OUTLIER -170.1 163.28 0.45 Allowed 'Isoleucine or valine' 0 N--CA 1.494 1.768 0 O-C-N 120.909 -1.12 . . . . 0.0 110.281 179.842 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 162' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -49.47 171.23 0.12 Allowed Pre-proline 0 N--CA 1.488 1.473 0 O-C-N 121.599 -0.688 . . . . 0.0 109.39 179.271 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 163' ' ' PRO . . . . . 0.666 ' C ' HD11 ' C' ' 702' ' ' LEU . 60.5 Cg_endo -79.21 38.65 0.74 Allowed 'Trans proline' 0 C--N 1.307 -1.618 0 C-N-CA 122.615 2.21 . . . . 0.0 112.49 -179.909 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 164' ' ' THR . . . . . 0.465 ' O ' HG22 ' A' ' 164' ' ' THR . 86.0 m -151.88 -8.82 0.21 Allowed 'General case' 0 N--CA 1.494 1.762 0 O-C-N 121.126 -0.984 . . . . 0.0 110.925 -179.732 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 165' ' ' ASP . . . . . 0.437 ' O ' ' C ' ' A' ' 166' ' ' VAL . 17.8 t70 -72.85 61.86 0.57 Allowed 'General case' 0 N--CA 1.494 1.755 0 O-C-N 120.764 -1.21 . . . . 0.0 110.235 -179.351 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 166' ' ' VAL . . . . . 0.61 ' O ' ' N ' ' A' ' 168' ' ' VAL . 1.5 m -39.91 -33.06 0.23 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.65 0 O-C-N 121.408 -0.808 . . . . 0.0 109.692 -178.587 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 167' ' ' GLY . . . . . 0.404 ' C ' ' O ' ' A' ' 166' ' ' VAL . . . -43.07 -13.84 0.01 OUTLIER Glycine 0 N--CA 1.495 2.579 0 O-C-N 120.918 -1.114 . . . . 0.0 110.823 -179.802 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 168' ' ' VAL . . . . . 0.641 ' C ' ' H ' ' A' ' 170' ' ' ASP . 4.8 m -53.34 -36.27 26.25 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.583 0 O-C-N 120.768 -1.43 . . . . 0.0 108.726 179.709 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 169' ' ' LEU . . . . . 0.544 ' O ' ' N ' ' A' ' 171' ' ' GLU . 34.4 mt -51.08 -4.6 0.02 OUTLIER 'General case' 0 N--CA 1.494 1.772 0 N-CA-C 108.117 -1.068 . . . . 0.0 108.117 -179.602 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 170' ' ' ASP . . . . . 0.641 ' H ' ' C ' ' A' ' 168' ' ' VAL . 4.1 m-20 33.41 28.92 0.0 OUTLIER 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.685 -0.634 . . . . 0.0 112.228 177.185 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 171' ' ' GLU . . . . . 0.544 ' N ' ' O ' ' A' ' 169' ' ' LEU . 11.2 pt-20 -67.31 94.46 0.38 Allowed 'General case' 0 N--CA 1.491 1.589 0 O-C-N 120.598 -1.314 . . . . 0.0 107.703 178.376 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 172' ' ' GLN . . . . . . . . . . . . . 0.7 OUTLIER -159.04 -72.75 0.08 Allowed 'General case' 0 N--CA 1.493 1.716 0 O-C-N 121.637 -0.665 . . . . 0.0 109.538 -179.449 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 173' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -62.15 127.07 29.62 Favored 'General case' 0 N--CA 1.492 1.668 0 O-C-N 121.265 -0.897 . . . . 0.0 109.195 179.627 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 174' ' ' GLY . . . . . 0.564 ' O ' ' C ' ' A' ' 175' ' ' LYS . . . -118.24 -39.06 0.76 Allowed Glycine 0 N--CA 1.482 1.733 0 N-CA-C 108.623 -1.791 . . . . 0.0 108.623 179.368 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 175' ' ' LYS . . . . . 0.564 ' C ' ' O ' ' A' ' 174' ' ' GLY . 0.0 OUTLIER -32.54 -62.97 0.22 Allowed 'General case' 0 N--CA 1.498 1.952 0 N-CA-C 108.492 -0.929 . . . . 0.0 108.492 179.822 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 176' ' ' ASP . . . . . 0.66 ' O ' ' O ' ' A' ' 177' ' ' LYS . 5.5 m-20 -103.09 87.01 2.8 Favored 'General case' 0 C--N 1.297 -1.712 0 N-CA-C 106.759 -1.571 . . . . 0.0 106.759 176.914 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 177' ' ' LYS . . . . . 0.66 ' O ' ' O ' ' A' ' 176' ' ' ASP . 12.9 mttt -37.28 176.04 0.0 OUTLIER 'General case' 0 N--CA 1.498 1.942 0 CA-C-O 121.762 0.791 . . . . 0.0 110.541 -178.703 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 178' ' ' GLN . . . . . 0.425 ' HG3' HD22 ' A' ' 114' ' ' ASN . 5.2 pt20 -159.59 171.07 20.3 Favored 'General case' 0 C--N 1.302 -1.459 0 C-N-CA 118.075 -1.45 . . . . 0.0 111.582 -179.867 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 179' ' ' LEU . . . . . . . . . . . . . 1.2 tp -127.02 95.17 4.23 Favored 'General case' 0 C--N 1.303 -1.443 0 N-CA-C 107.412 -1.329 . . . . 0.0 107.412 178.127 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 180' ' ' THR . . . . . . . . . . . . . 1.3 m -71.7 121.26 18.54 Favored 'General case' 0 N--CA 1.489 1.502 0 C-N-CA 119.217 -0.993 . . . . 0.0 110.213 -178.571 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 181' ' ' LEU . . . . . 0.419 HD11 ' CE2' ' A' ' 130' ' ' PHE . 49.7 tp -96.24 147.72 23.48 Favored 'General case' 0 C--N 1.297 -1.693 0 N-CA-C 108.342 -0.984 . . . . 0.0 108.342 178.308 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 182' ' ' ILE . . . . . 0.46 ' O ' HG22 ' A' ' 182' ' ' ILE . 2.0 mt -138.73 115.09 10.19 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.578 0 N-CA-C 108.245 -1.02 . . . . 0.0 108.245 178.732 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 183' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -137.02 112.56 9.35 Favored 'General case' 0 C--N 1.293 -1.889 0 N-CA-C 107.265 -1.383 . . . . 0.0 107.265 179.364 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 184' ' ' CYS . . . . . 0.491 ' HB3' HH12 ' A' ' 197' ' ' ARG . 0.8 OUTLIER -78.69 163.71 25.2 Favored 'General case' 0 C--N 1.292 -1.918 0 C-N-CA 119.514 -0.874 . . . . 0.0 111.653 -177.14 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 185' ' ' ASP . . . . . . . . . . . . . 18.9 t0 -166.36 -159.4 0.37 Allowed 'General case' 0 N--CA 1.489 1.509 0 N-CA-C 109.205 -0.665 . . . . 0.0 109.205 -179.944 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 186' ' ' ASP . . . . . . . . . . . . . 1.3 m-20 53.84 59.62 4.17 Favored 'General case' 0 N--CA 1.493 1.724 0 O-C-N 121.121 -0.987 . . . . 0.0 109.546 179.933 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 187' ' ' TYR . . . . . 0.608 ' CE1' ' O ' ' A' ' 188' ' ' ASN . 57.0 t80 -67.67 137.77 55.81 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.319 -0.863 . . . . 0.0 110.398 -179.708 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 188' ' ' ASN . . . . . 0.608 ' O ' ' CE1' ' A' ' 187' ' ' TYR . 0.8 OUTLIER -104.41 145.02 30.86 Favored 'General case' 0 C--N 1.298 -1.672 0 N-CA-C 108.255 -1.017 . . . . 0.0 108.255 178.617 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 189' ' ' GLU . . . . . . . . . . . . . 1.4 tt0 -110.57 -13.17 14.27 Favored 'General case' 0 C--N 1.296 -1.744 0 N-CA-C 108.818 -0.808 . . . . 0.0 108.818 -179.36 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 190' ' ' LYS . . . . . . . . . . . . . 29.1 mttt -82.8 -53.66 5.72 Favored 'General case' 0 C--N 1.302 -1.496 0 N-CA-C 108.714 -0.847 . . . . 0.0 108.714 178.873 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 191' ' ' THR . . . . . . . . . . . . . 1.1 p -90.09 -10.76 43.53 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.517 -0.739 . . . . 0.0 109.194 179.714 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 192' ' ' GLY . . . . . . . . . . . . . . . 65.77 40.75 95.83 Favored Glycine 0 N--CA 1.495 2.59 0 N-CA-C 110.637 -0.985 . . . . 0.0 110.637 178.914 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 193' ' ' VAL . . . . . 0.541 HG12 ' N ' ' A' ' 194' ' ' TRP . 64.8 t -147.63 161.61 7.55 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.641 0 O-C-N 121.023 -1.281 . . . . 0.0 109.565 179.487 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 194' ' ' TRP . . . . . 0.541 ' N ' HG12 ' A' ' 193' ' ' VAL . 19.4 m95 -83.71 118.42 23.87 Favored 'General case' 0 C--N 1.301 -1.537 0 N-CA-C 107.901 -1.148 . . . . 0.0 107.901 179.082 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 195' ' ' GLU . . . . . 0.551 ' CD ' ' ND2' ' A' ' 188' ' ' ASN . 2.3 mt-10 -85.17 -60.86 1.91 Allowed 'General case' 0 N--CA 1.492 1.665 0 O-C-N 121.241 -0.912 . . . . 0.0 111.112 -177.941 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 196' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER -78.63 149.18 32.96 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 120.935 -1.103 . . . . 0.0 109.731 -179.315 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 197' ' ' ARG . . . . . 0.669 ' NE ' HD13 ' C' ' 702' ' ' LEU . 0.0 OUTLIER -128.06 136.92 51.88 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.492 -0.755 . . . . 0.0 109.129 179.84 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 198' ' ' LYS . . . . . . . . . . . . . 2.3 mtmm -115.03 121.87 44.45 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.756 -0.59 . . . . 0.0 110.676 -178.623 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 199' ' ' ILE . . . . . 0.563 ' C ' HD12 ' A' ' 199' ' ' ILE . 0.9 OUTLIER -139.57 117.89 11.79 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.586 0 CA-C-O 122.477 1.132 . . . . 0.0 109.842 179.419 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 200' ' ' PHE . . . . . 0.551 ' CZ ' HD12 ' A' ' 133' ' ' LEU . 5.0 m-85 -98.88 136.11 39.35 Favored 'General case' 0 N--CA 1.498 1.948 0 O-C-N 121.322 -0.861 . . . . 0.0 110.262 -177.914 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 201' ' ' VAL . . . . . . . . . . . . . 24.2 t -105.12 141.33 20.72 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.76 0 O-C-N 121.032 -1.043 . . . . 0.0 108.777 178.13 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 202' ' ' ALA . . . . . . . . . . . . . . . -131.17 137.44 48.99 Favored 'General case' 0 C--N 1.3 -1.545 0 N-CA-C 108.429 -0.952 . . . . 0.0 108.429 179.874 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 203' ' ' THR . . . . . 0.615 ' O ' HG23 ' A' ' 205' ' ' VAL . 2.5 t -88.41 136.06 33.17 Favored 'General case' 0 N--CA 1.489 1.515 0 CA-C-O 122.116 0.96 . . . . 0.0 110.568 -179.177 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 204' ' ' GLU . . . . . 0.513 ' HA ' ' CD2' ' A' ' 153' ' ' TYR . 0.8 OUTLIER -53.66 136.22 39.56 Favored 'General case' 0 C--N 1.295 -1.799 0 C-N-CA 118.133 -1.427 . . . . 0.0 108.706 179.014 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 205' ' ' VAL . . . . . 0.615 HG23 ' O ' ' A' ' 203' ' ' THR . 77.7 t -129.99 166.41 27.66 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.34 0 CA-C-O 121.97 0.89 . . . . 0.0 110.063 -177.893 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 206' ' ' LYS . . . . . 0.611 ' N ' HG12 ' A' ' 205' ' ' VAL . 9.1 ptmt . . . . . 0 C--N 1.296 -1.752 0 CA-C-O 118.034 -0.984 . . . . 0.0 109.429 -179.836 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' C' C ' 701' ' ' PHQ . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 005 nuclear build full ' C' C ' 702' ' ' LEU . . . . . 0.669 HD13 ' NE ' ' A' ' 197' ' ' ARG . 0.1 OUTLIER . . . . . 0 N--CA 1.49 1.56 0 N-CA-C 108.757 -0.831 . . . . 0.0 108.757 . . . . . . . . . 2 2 . 1 . 005 nuclear build full ' C' C ' 703' ' ' PRO . . . . . 0.577 ' HB2' ' HB3' ' A' ' 92' ' ' ALA . 29.4 Cg_endo -66.39 -162.92 0.06 OUTLIER 'Trans proline' 0 N--CA 1.495 1.581 0 C-N-CA 122.59 2.194 . . . . 0.0 112.783 -179.224 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' C' C ' 704' ' ' ALA . . . . . 0.691 ' HB2' ' HB1' ' A' ' 118' ' ' ALA . . . 60.25 161.04 0.05 OUTLIER 'General case' 0 N--CA 1.488 1.456 0 O-C-N 121.476 -0.765 . . . . 0.0 109.356 -179.865 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' C' C ' 705' ' ' B27 . . . . . 0.427 ' HA ' HH22 ' A' ' 197' ' ' ARG . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 700' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 006 nuclear build full ' A' A ' 59' ' ' MET . . . . . 0.547 ' N ' ' SD ' ' A' ' 59' ' ' MET . 1.9 mpt? . . . . . 0 N--CA 1.49 1.558 0 N-CA-C 109.444 -0.576 . . . . 0.0 109.444 . . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 60' ' ' GLN . . . . . . . . . . . . . 1.9 tp60 -60.37 148.34 37.5 Favored 'General case' 0 N--CA 1.488 1.452 0 O-C-N 121.227 -0.92 . . . . 0.0 109.265 -179.978 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 61' ' ' ALA . . . . . 0.468 ' HB2' ' OD1' ' A' ' 148' ' ' ASN . . . -64.15 179.06 0.59 Allowed 'General case' 0 N--CA 1.488 1.457 0 O-C-N 121.238 -0.913 . . . . 0.0 109.679 -179.907 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 62' ' ' LYS . . . . . . . . . . . . . 2.7 pttm -150.64 83.14 5.92 Favored Pre-proline 0 N--CA 1.489 1.522 0 O-C-N 121.339 -0.851 . . . . 0.0 109.757 -179.843 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 63' ' ' PRO . . . . . . . . . . . . . 9.9 Cg_endo -80.0 144.18 16.71 Favored 'Trans proline' 0 C--N 1.304 -1.802 0 C-N-CA 122.556 2.171 . . . . 0.0 111.15 179.501 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 64' ' ' GLN . . . . . 0.557 ' N ' ' CD ' ' A' ' 64' ' ' GLN . 0.0 OUTLIER -154.85 118.58 4.58 Favored 'General case' 0 N--CA 1.494 1.728 0 O-C-N 121.231 -0.918 . . . . 0.0 109.553 179.857 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 65' ' ' ILE . . . . . 0.501 ' H ' HD12 ' A' ' 65' ' ' ILE . 3.1 mp -46.58 106.4 0.57 Allowed Pre-proline 0 C--N 1.3 -1.548 0 O-C-N 121.316 -0.865 . . . . 0.0 108.773 179.197 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 66' ' ' PRO . . . . . . . . . . . . . 67.5 Cg_endo -86.51 -157.68 0.08 OUTLIER 'Trans proline' 0 C--N 1.314 -1.285 0 C-N-CA 122.487 2.125 . . . . 0.0 112.401 -179.224 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 67' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -82.88 -4.87 58.65 Favored 'General case' 0 C--N 1.302 -1.473 0 N-CA-C 108.838 -0.801 . . . . 0.0 108.838 179.528 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 68' ' ' ASP . . . . . 0.635 ' C ' ' N ' ' A' ' 70' ' ' SER . 0.3 OUTLIER -74.82 52.45 0.53 Allowed 'General case' 0 N--CA 1.488 1.425 0 CA-C-O 122.726 1.251 . . . . 0.0 108.444 179.492 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 69' ' ' LYS . . . . . 0.445 ' C ' ' O ' ' A' ' 68' ' ' ASP . 21.0 mtmt -49.48 -13.94 0.09 Allowed 'General case' 0 N--CA 1.502 2.173 0 C-N-CA 116.798 -1.961 . . . . 0.0 106.551 177.94 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 70' ' ' SER . . . . . 0.635 ' N ' ' C ' ' A' ' 68' ' ' ASP . 0.1 OUTLIER -85.48 -6.56 59.18 Favored 'General case' 0 N--CA 1.493 1.68 0 CA-C-N 113.508 -1.678 . . . . 0.0 110.601 179.285 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 71' ' ' LYS . . . . . . . . . . . . . 2.0 ptmm? -101.2 144.62 29.84 Favored 'General case' 0 N--CA 1.498 1.942 0 O-C-N 120.863 -1.148 . . . . 0.0 111.888 -179.395 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 72' ' ' VAL . . . . . 0.602 ' CG2' ' O ' ' A' ' 74' ' ' GLY . 0.7 OUTLIER -67.26 132.95 32.16 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.364 0 N-CA-C 105.49 -2.041 . . . . 0.0 105.49 174.363 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -83.77 -13.78 53.07 Favored 'General case' 0 C--N 1.297 -1.71 0 O-C-N 120.026 -1.671 . . . . 0.0 108.618 -179.183 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 74' ' ' GLY . . . . . 0.602 ' O ' ' CG2' ' A' ' 72' ' ' VAL . . . 173.29 -159.63 29.83 Favored Glycine 0 N--CA 1.487 2.086 0 N-CA-C 109.459 -1.456 . . . . 0.0 109.459 -179.805 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 75' ' ' TYR . . . . . . . . . . . . . 81.1 m-85 -140.12 169.9 16.83 Favored 'General case' 0 C--N 1.297 -1.689 0 O-C-N 121.02 -1.282 . . . . 0.0 111.354 -178.334 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 76' ' ' ILE . . . . . . . . . . . . . 1.3 tp -145.9 138.72 20.63 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.605 0 C-N-CA 119.376 -0.93 . . . . 0.0 109.235 -176.165 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -149.46 162.53 39.94 Favored 'General case' 0 C--N 1.302 -1.474 0 O-C-N 120.899 -1.126 . . . . 0.0 109.804 -179.606 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 78' ' ' ILE . . . . . 0.637 ' HB ' ' HB3' ' A' ' 81' ' ' ALA . 4.5 mt -147.74 99.54 3.79 Favored Pre-proline 0 N--CA 1.488 1.455 0 N-CA-C 108.421 -0.955 . . . . 0.0 108.421 179.879 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 79' ' ' PRO . . . . . . . . . . . . . 52.6 Cg_exo -49.81 -45.76 30.64 Favored 'Trans proline' 0 N--CA 1.493 1.483 0 C-N-CA 122.57 2.18 . . . . 0.0 113.464 -178.826 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 7.9 m-20 -66.04 -19.65 65.92 Favored 'General case' 0 N--CA 1.492 1.656 0 O-C-N 120.944 -1.098 . . . . 0.0 110.924 178.81 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 81' ' ' ALA . . . . . 0.772 ' HB2' ' HB2' ' A' ' 136' ' ' ALA . . . -105.01 -16.55 14.78 Favored 'General case' 0 N--CA 1.494 1.754 0 O-C-N 121.093 -1.005 . . . . 0.0 108.46 179.329 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 82' ' ' ASP . . . . . 0.419 ' N ' ' O ' ' A' ' 78' ' ' ILE . 0.6 OUTLIER 66.22 50.58 1.35 Allowed 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.385 -0.822 . . . . 0.0 110.434 179.191 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 83' ' ' ILE . . . . . 0.528 HD11 ' OD1' ' A' ' 132' ' ' ASN . 62.0 mt -129.42 151.97 36.59 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.788 0 O-C-N 121.09 -1.006 . . . . 0.0 110.481 -178.848 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 84' ' ' LYS . . . . . 0.491 ' N ' ' OE2' ' A' ' 85' ' ' GLU . 9.2 tttm -159.15 109.59 1.99 Allowed 'General case' 0 N--CA 1.487 1.38 0 N-CA-C 108.08 -1.081 . . . . 0.0 108.08 179.777 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 85' ' ' GLU . . . . . 0.491 ' OE2' ' N ' ' A' ' 84' ' ' LYS . 0.7 OUTLIER -144.05 171.85 6.26 Favored Pre-proline 0 N--CA 1.495 1.811 0 C-N-CA 119.858 -0.737 . . . . 0.0 109.874 -179.491 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 86' ' ' PRO . . . . . . . . . . . . . 68.7 Cg_endo -91.0 148.95 3.82 Favored 'Trans proline' 0 N--CA 1.488 1.19 0 C-N-CA 123.126 2.551 . . . . 0.0 112.963 -179.751 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 87' ' ' VAL . . . . . 0.428 ' CG2' ' C ' ' A' ' 74' ' ' GLY . 0.0 OUTLIER -104.91 106.03 19.72 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.576 0 N-CA-C 108.619 -0.882 . . . . 0.0 108.619 178.669 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 88' ' ' TYR . . . . . 0.405 ' CE1' ' HB3' ' A' ' 99' ' ' ARG . 13.7 m-85 -87.55 135.0 34.73 Favored Pre-proline 0 N--CA 1.492 1.648 0 O-C-N 120.95 -1.094 . . . . 0.0 110.37 -178.964 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 89' ' ' PRO . . . . . . . . . . . . . 20.2 Cg_exo -34.34 138.15 0.1 OUTLIER 'Trans proline' 0 N--CA 1.49 1.291 0 C-N-CA 123.253 2.635 . . . . 0.0 113.714 179.982 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . -58.87 167.26 7.04 Favored Glycine 0 N--CA 1.491 2.331 0 N-CA-C 109.546 -1.422 . . . . 0.0 109.546 179.679 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 91' ' ' PRO . . . . . 0.711 ' HD2' HE21 ' A' ' 96' ' ' GLN . 57.5 Cg_endo -92.46 170.39 21.96 Favored 'Cis proline' 0 C--N 1.307 -1.625 0 C-N-CA 123.659 -1.392 . . . . 0.0 111.94 0.654 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 92' ' ' ALA . . . . . 0.639 ' O ' HD23 ' A' ' 97' ' ' LEU . . . -70.32 29.38 0.04 OUTLIER 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.253 -0.904 . . . . 0.0 110.54 -179.327 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 93' ' ' THR . . . . . 0.482 ' H ' ' C ' ' A' ' 91' ' ' PRO . 0.8 OUTLIER -72.8 154.55 91.13 Favored Pre-proline 0 N--CA 1.492 1.644 0 O-C-N 120.764 -1.21 . . . . 0.0 109.131 -179.678 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 94' ' ' PRO . . . . . 0.451 ' O ' ' C ' ' A' ' 95' ' ' GLU . 80.5 Cg_exo -30.82 -61.79 0.13 Allowed 'Trans proline' 0 C--N 1.308 -1.574 0 C-N-CA 123.058 2.505 . . . . 0.0 112.567 -179.144 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 95' ' ' GLU . . . . . 0.451 ' C ' ' O ' ' A' ' 94' ' ' PRO . 0.3 OUTLIER -41.67 -48.23 4.09 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.288 -0.882 . . . . 0.0 109.258 179.882 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 96' ' ' GLN . . . . . 0.711 HE21 ' HD2' ' A' ' 91' ' ' PRO . 1.9 mp0 -73.6 -59.54 2.67 Favored 'General case' 0 N--CA 1.487 1.391 0 O-C-N 121.221 -0.924 . . . . 0.0 109.934 179.591 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 97' ' ' LEU . . . . . 0.639 HD23 ' O ' ' A' ' 92' ' ' ALA . 0.5 OUTLIER -45.07 -13.37 0.02 OUTLIER 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.319 -0.863 . . . . 0.0 109.413 -179.393 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 98' ' ' ASN . . . . . 0.606 ' N ' ' O ' ' A' ' 96' ' ' GLN . 0.0 OUTLIER -73.58 -26.19 60.7 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.329 -0.857 . . . . 0.0 109.841 -179.995 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 99' ' ' ARG . . . . . 0.444 ' NH1' ' O ' ' A' ' 95' ' ' GLU . 1.7 mpt_? -95.33 -45.58 7.08 Favored 'General case' 0 N--CA 1.488 1.454 0 O-C-N 121.396 -0.815 . . . . 0.0 110.048 -178.959 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . 169.99 -174.13 44.12 Favored Glycine 0 N--CA 1.494 2.537 0 C-N-CA 119.517 -1.325 . . . . 0.0 110.238 179.737 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 101' ' ' VAL . . . . . 0.737 HG23 ' O ' ' A' ' 101' ' ' VAL . 19.5 m -50.17 106.34 0.06 OUTLIER 'Isoleucine or valine' 0 N--CA 1.493 1.711 0 O-C-N 121.401 -1.058 . . . . 0.0 109.218 179.765 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -92.88 169.68 10.26 Favored 'General case' 0 N--CA 1.494 1.729 0 O-C-N 121.213 -0.93 . . . . 0.0 110.885 -179.306 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 103' ' ' PHE . . . . . 0.553 ' O ' ' N ' ' A' ' 105' ' ' GLU . 23.1 m-85 -69.52 120.83 15.9 Favored 'General case' 0 N--CA 1.487 1.404 0 N-CA-C 107.957 -1.127 . . . . 0.0 107.957 178.192 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 104' ' ' ALA . . . . . 0.597 ' HB1' ' HG3' ' C' ' 703' ' ' PRO . . . -46.85 -9.78 0.02 OUTLIER 'General case' 0 C--N 1.301 -1.529 0 O-C-N 121.335 -0.853 . . . . 0.0 110.852 -178.882 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 105' ' ' GLU . . . . . 0.553 ' N ' ' O ' ' A' ' 103' ' ' PHE . 0.1 OUTLIER -140.28 143.8 36.09 Favored 'General case' 0 N--CA 1.496 1.862 0 O-C-N 120.811 -1.181 . . . . 0.0 110.648 -179.786 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 106' ' ' GLU . . . . . . . . . . . . . 27.6 tt0 -59.42 -64.03 1.09 Allowed 'General case' 0 N--CA 1.489 1.502 0 CA-C-N 116.216 -0.447 . . . . 0.0 111.625 -178.892 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 107' ' ' ASN . . . . . . . . . . . . . 6.8 m-20 -78.66 35.56 0.24 Allowed 'General case' 0 N--CA 1.491 1.604 0 O-C-N 120.661 -1.274 . . . . 0.0 112.672 -175.723 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 108' ' ' GLU . . . . . . . . . . . . . 2.0 tp10 -56.67 149.59 17.48 Favored 'General case' 0 N--CA 1.489 1.513 0 O-C-N 120.323 -1.486 . . . . 0.0 107.741 179.779 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 109' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -100.95 145.0 29.21 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 120.9 -1.125 . . . . 0.0 110.818 -178.261 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 110' ' ' LEU . . . . . 0.495 HD13 ' O ' ' A' ' 110' ' ' LEU . 0.2 OUTLIER -61.03 -24.62 66.32 Favored 'General case' 0 C--N 1.306 -1.317 0 N-CA-C 108.199 -1.037 . . . . 0.0 108.199 179.213 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 111' ' ' ASP . . . . . 0.436 ' OD1' ' C ' ' A' ' 110' ' ' LEU . 2.7 m-20 -132.37 45.1 2.8 Favored 'General case' 0 C--N 1.302 -1.463 0 N-CA-C 109.208 -0.664 . . . . 0.0 109.208 179.63 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 112' ' ' ASP . . . . . . . . . . . . . 1.3 t0 -68.06 155.32 39.8 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.346 -0.846 . . . . 0.0 111.094 -179.638 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 113' ' ' GLN . . . . . 0.623 HE22 ' N ' ' A' ' 172' ' ' GLN . 0.0 OUTLIER -67.06 -17.15 64.77 Favored 'General case' 0 N--CA 1.488 1.456 0 N-CA-C 108.137 -1.06 . . . . 0.0 108.137 177.613 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 114' ' ' ASN . . . . . 0.55 ' OD1' ' NE2' ' A' ' 178' ' ' GLN . 2.3 t30 -151.48 105.35 3.16 Favored 'General case' 0 C--N 1.295 -1.79 0 N-CA-C 107.654 -1.239 . . . . 0.0 107.654 179.528 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 115' ' ' ILE . . . . . 0.538 HG22 ' O ' ' A' ' 115' ' ' ILE . 3.1 mt -93.6 104.44 15.75 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.711 0 O-C-N 120.675 -1.265 . . . . 0.0 107.916 179.95 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 116' ' ' SER . . . . . 0.438 ' OG ' ' ND2' ' A' ' 114' ' ' ASN . 18.5 m -87.3 147.32 25.56 Favored 'General case' 0 C--N 1.304 -1.382 0 CA-C-O 121.861 0.838 . . . . 0.0 110.988 -177.962 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 117' ' ' ILE . . . . . . . . . . . . . 2.5 mt -142.05 151.3 18.64 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.438 0 N-CA-C 107.897 -1.149 . . . . 0.0 107.897 179.449 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 118' ' ' ALA . . . . . 0.401 ' HB1' ' HB2' ' C' ' 704' ' ' ALA . . . -142.81 157.15 44.9 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 120.964 -1.085 . . . . 0.0 111.025 -179.026 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 119' ' ' GLY . . . . . . . . . . . . . . . -163.96 145.01 9.94 Favored Glycine 0 N--CA 1.486 1.997 0 N-CA-C 109.889 -1.285 . . . . 0.0 109.889 179.49 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 120' ' ' HIS . . . . . . . . . . . . . 26.5 m170 -70.49 168.49 16.1 Favored 'General case' 0 N--CA 1.493 1.681 0 O-C-N 121.574 -0.957 . . . . 0.0 109.64 179.357 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 121' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -120.67 149.2 42.86 Favored 'General case' 0 N--CA 1.494 1.735 0 O-C-N 121.234 -0.916 . . . . 0.0 108.728 179.035 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 122' ' ' PHE . . . . . . . . . . . . . 0.5 OUTLIER -112.37 140.13 47.35 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.199 -0.938 . . . . 0.0 109.359 179.805 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 123' ' ' ILE . . . . . 0.577 HG23 ' N ' ' A' ' 124' ' ' ASP . 16.0 tt -88.57 -37.88 10.85 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.793 0 N-CA-C 108.509 -0.923 . . . . 0.0 108.509 179.631 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 124' ' ' ASP . . . . . 0.577 ' N ' HG23 ' A' ' 123' ' ' ILE . 4.9 p-10 -94.37 19.07 10.04 Favored 'General case' 0 C--N 1.296 -1.735 0 C-N-CA 120.121 -0.632 . . . . 0.0 110.633 -179.548 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 125' ' ' ARG . . . . . 0.664 HH11 ' CG ' ' A' ' 125' ' ' ARG . 0.0 OUTLIER -156.35 108.42 2.05 Favored Pre-proline 0 N--CA 1.49 1.55 0 O-C-N 120.628 -1.295 . . . . 0.0 110.348 -179.049 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 126' ' ' PRO . . . . . . . . . . . . . 90.1 Cg_endo -82.55 -22.19 4.75 Favored 'Trans proline' 0 C--N 1.316 -1.181 0 C-N-CA 122.222 1.948 . . . . 0.0 111.953 179.522 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 127' ' ' ASN . . . . . 0.421 ' OD1' ' NH1' ' A' ' 125' ' ' ARG . 1.1 p30 -89.17 29.04 1.11 Allowed 'General case' 0 N--CA 1.489 1.502 0 O-C-N 121.188 -0.945 . . . . 0.0 109.331 179.97 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 128' ' ' TYR . . . . . . . . . . . . . 9.7 t80 -86.12 -149.18 0.13 Allowed 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.269 -0.894 . . . . 0.0 109.922 -179.64 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 129' ' ' GLN . . . . . . . . . . . . . 32.4 mt-30 -67.72 -69.31 0.32 Allowed 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.371 -0.831 . . . . 0.0 110.746 -178.838 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 130' ' ' PHE . . . . . 0.512 ' CE2' HG11 ' A' ' 101' ' ' VAL . 50.0 m-85 -129.83 28.66 5.08 Favored 'General case' 0 N--CA 1.496 1.841 0 O-C-N 121.14 -0.975 . . . . 0.0 110.613 -179.405 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 131' ' ' THR . . . . . . . . . . . . . 94.6 m -67.8 -34.5 76.89 Favored 'General case' 0 N--CA 1.493 1.717 0 O-C-N 120.79 -1.194 . . . . 0.0 108.968 179.37 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 132' ' ' ASN . . . . . 0.602 ' ND2' ' O ' ' A' ' 81' ' ' ALA . 2.4 p-10 -91.11 13.59 16.48 Favored 'General case' 0 N--CA 1.494 1.752 0 C-N-CA 119.608 -0.837 . . . . 0.0 111.285 -179.665 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 133' ' ' LEU . . . . . 0.619 HD13 ' O ' ' A' ' 133' ' ' LEU . 0.2 OUTLIER -71.82 -42.74 66.65 Favored 'General case' 0 N--CA 1.492 1.668 0 O-C-N 120.571 -1.331 . . . . 0.0 110.266 -179.038 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 134' ' ' LYS . . . . . 0.627 ' H ' ' CD ' ' A' ' 134' ' ' LYS . 0.0 OUTLIER -44.44 -12.77 0.02 OUTLIER 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.165 -0.959 . . . . 0.0 110.402 -179.263 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 135' ' ' ALA . . . . . 0.595 ' N ' ' O ' ' A' ' 133' ' ' LEU . . . -82.77 -37.98 23.82 Favored 'General case' 0 N--CA 1.489 1.513 0 O-C-N 120.761 -1.212 . . . . 0.0 109.855 -179.829 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 136' ' ' ALA . . . . . 0.772 ' HB2' ' HB2' ' A' ' 81' ' ' ALA . . . -78.55 153.38 31.28 Favored 'General case' 0 C--N 1.302 -1.496 0 O-C-N 121.352 -0.843 . . . . 0.0 111.111 -178.741 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 137' ' ' LYS . . . . . 0.519 ' O ' ' O ' ' A' ' 138' ' ' LYS . 0.4 OUTLIER -151.38 -163.69 1.82 Allowed 'General case' 0 N--CA 1.492 1.661 0 C-N-CA 118.479 -1.288 . . . . 0.0 110.744 -178.07 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 138' ' ' LYS . . . . . 0.585 ' O ' ' N ' ' A' ' 140' ' ' SER . 0.2 OUTLIER -46.3 -179.29 0.0 OUTLIER 'General case' 0 C--N 1.304 -1.4 0 CA-C-O 122.145 0.974 . . . . 0.0 110.508 -179.043 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 139' ' ' GLY . . . . . . . . . . . . . . . 46.87 7.77 0.02 OUTLIER Glycine 0 N--CA 1.49 2.284 0 N-CA-C 110.354 -1.098 . . . . 0.0 110.354 -179.848 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 140' ' ' SER . . . . . 0.585 ' N ' ' O ' ' A' ' 138' ' ' LYS . 39.2 m -84.56 130.53 34.73 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 120.926 -1.338 . . . . 0.0 109.517 179.412 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 141' ' ' MET . . . . . 0.639 ' SD ' ' N ' ' A' ' 142' ' ' VAL . 8.7 tpp -83.9 127.25 33.71 Favored 'General case' 0 N--CA 1.488 1.446 0 O-C-N 121.074 -1.016 . . . . 0.0 108.978 179.523 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 142' ' ' VAL . . . . . 0.639 ' N ' ' SD ' ' A' ' 141' ' ' MET . 2.4 t -111.25 133.38 57.0 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.512 0 N-CA-C 108.586 -0.894 . . . . 0.0 108.586 -179.744 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 143' ' ' TYR . . . . . . . . . . . . . 8.1 m-85 -111.05 135.29 51.79 Favored 'General case' 0 N--CA 1.495 1.802 0 O-C-N 120.822 -1.174 . . . . 0.0 111.124 -178.511 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 144' ' ' PHE . . . . . . . . . . . . . 10.3 t80 -120.17 104.57 10.19 Favored 'General case' 0 N--CA 1.493 1.7 0 C-N-CA 120.081 -0.648 . . . . 0.0 110.139 -179.748 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 145' ' ' LYS . . . . . . . . . . . . . 14.3 ttmm -99.64 128.12 45.74 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.135 -0.978 . . . . 0.0 110.556 -179.487 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 146' ' ' VAL . . . . . 0.462 HG21 HD11 ' A' ' 110' ' ' LEU . 0.6 OUTLIER -142.7 146.15 22.36 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.568 0 N-CA-C 107.438 -1.319 . . . . 0.0 107.438 178.695 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 147' ' ' GLY . . . . . 0.432 ' C ' ' O ' ' A' ' 146' ' ' VAL . . . 45.8 -131.82 9.93 Favored Glycine 0 N--CA 1.487 2.046 0 N-CA-C 108.465 -1.854 . . . . 0.0 108.465 -179.222 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 148' ' ' ASN . . . . . 0.536 ' C ' HD22 ' A' ' 148' ' ' ASN . 0.4 OUTLIER -104.2 18.07 22.83 Favored 'General case' 0 C--N 1.301 -1.532 0 O-C-N 121.307 -1.113 . . . . 0.0 108.602 179.077 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 149' ' ' GLU . . . . . . . . . . . . . 14.4 tt0 -112.22 147.03 37.08 Favored 'General case' 0 N--CA 1.49 1.557 0 CA-C-O 121.817 0.818 . . . . 0.0 111.328 -178.263 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 150' ' ' THR . . . . . 0.479 ' O ' HG22 ' A' ' 150' ' ' THR . 1.4 m -131.79 103.97 6.63 Favored 'General case' 0 N--CA 1.491 1.586 0 CA-C-O 121.579 0.704 . . . . 0.0 109.832 179.796 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 151' ' ' ARG . . . . . 0.477 ' NH2' ' OH ' ' A' ' 153' ' ' TYR . 21.4 mtm180 -88.2 -170.97 3.18 Favored 'General case' 0 N--CA 1.488 1.439 0 N-CA-C 109.134 -0.691 . . . . 0.0 109.134 -179.877 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 152' ' ' LYS . . . . . 0.405 ' C ' ' CD1' ' A' ' 153' ' ' TYR . 40.4 mtmt -150.86 149.26 29.47 Favored 'General case' 0 N--CA 1.489 1.496 0 O-C-N 120.968 -1.083 . . . . 0.0 110.258 -179.574 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 153' ' ' TYR . . . . . 0.578 ' O ' ' SD ' ' A' ' 141' ' ' MET . 15.9 m-85 -141.18 165.77 26.62 Favored 'General case' 0 N--CA 1.489 1.518 0 N-CA-C 107.715 -1.217 . . . . 0.0 107.715 179.224 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 154' ' ' LYS . . . . . 0.454 ' HB2' HG21 ' A' ' 205' ' ' VAL . 5.3 ttmm -141.32 115.85 9.56 Favored 'General case' 0 C--N 1.297 -1.699 0 O-C-N 120.959 -1.088 . . . . 0.0 108.628 179.29 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 155' ' ' MET . . . . . . . . . . . . . 4.6 mtt -43.65 106.16 0.06 Allowed 'General case' 0 N--CA 1.492 1.649 0 O-C-N 120.741 -1.224 . . . . 0.0 111.548 -178.662 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 156' ' ' THR . . . . . 0.748 ' OG1' HG23 ' A' ' 203' ' ' THR . 0.6 OUTLIER -109.08 -23.18 11.79 Favored 'General case' 0 C--N 1.292 -1.896 0 CA-C-N 115.267 -0.879 . . . . 0.0 109.894 -179.514 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 157' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -153.14 151.45 30.16 Favored 'General case' 0 C--N 1.297 -1.713 0 C-N-CA 118.493 -1.283 . . . . 0.0 111.431 -178.598 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 158' ' ' ILE . . . . . 0.884 HD12 ' CD2' ' A' ' 200' ' ' PHE . 0.2 OUTLIER -152.43 145.13 15.6 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.295 0 CA-C-O 121.708 0.766 . . . . 0.0 110.132 -179.148 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 159' ' ' ARG . . . . . . . . . . . . . 66.2 ttt180 -152.69 149.22 28.18 Favored 'General case' 0 C--N 1.299 -1.614 0 CA-C-O 121.882 0.848 . . . . 0.0 111.089 -178.866 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 160' ' ' ASP . . . . . 0.592 ' C ' HG22 ' A' ' 161' ' ' VAL . 5.9 m-20 -119.1 161.51 20.18 Favored 'General case' 0 N--CA 1.49 1.528 0 N-CA-C 108.567 -0.901 . . . . 0.0 108.567 179.349 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 161' ' ' VAL . . . . . 0.592 HG22 ' C ' ' A' ' 160' ' ' ASP . 0.1 OUTLIER -173.13 164.55 0.26 Allowed 'Isoleucine or valine' 0 N--CA 1.501 2.096 0 O-C-N 121.097 -1.002 . . . . 0.0 109.82 179.463 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 162' ' ' LYS . . . . . 0.515 ' O ' ' O ' ' A' ' 161' ' ' VAL . 0.1 OUTLIER -42.83 168.1 0.06 OUTLIER Pre-proline 0 N--CA 1.491 1.603 0 O-C-N 121.152 -0.968 . . . . 0.0 109.062 179.121 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 163' ' ' PRO . . . . . 0.754 ' O ' HD11 ' C' ' 702' ' ' LEU . 57.4 Cg_endo -74.86 -20.41 17.24 Favored 'Trans proline' 0 C--N 1.306 -1.708 0 C-N-CA 122.697 2.264 . . . . 0.0 112.899 -179.294 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 164' ' ' THR . . . . . 0.416 ' O ' HG13 ' A' ' 166' ' ' VAL . 1.1 p -90.87 -3.1 57.61 Favored 'General case' 0 C--N 1.297 -1.688 0 O-C-N 120.48 -1.387 . . . . 0.0 109.995 -179.644 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 165' ' ' ASP . . . . . . . . . . . . . 11.4 t70 -71.89 58.47 0.34 Allowed 'General case' 0 N--CA 1.491 1.622 0 O-C-N 120.856 -1.153 . . . . 0.0 109.709 -179.543 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 166' ' ' VAL . . . . . 0.551 ' O ' ' N ' ' A' ' 168' ' ' VAL . 1.5 m -44.25 -32.34 0.77 Allowed 'Isoleucine or valine' 0 C--N 1.297 -1.707 0 O-C-N 121.692 -0.63 . . . . 0.0 109.784 -178.339 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 167' ' ' GLY . . . . . . . . . . . . . . . -43.52 -15.4 0.03 OUTLIER Glycine 0 N--CA 1.496 2.688 0 O-C-N 120.83 -1.169 . . . . 0.0 111.356 -179.517 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 168' ' ' VAL . . . . . 0.551 ' N ' ' O ' ' A' ' 166' ' ' VAL . 2.8 m -54.24 -31.52 22.24 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.605 0 O-C-N 120.581 -1.54 . . . . 0.0 109.082 -179.839 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 169' ' ' LEU . . . . . 0.549 ' O ' ' C ' ' A' ' 170' ' ' ASP . 15.8 mt -48.32 -14.93 0.06 Allowed 'General case' 0 N--CA 1.492 1.64 0 N-CA-C 107.748 -1.204 . . . . 0.0 107.748 -178.713 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 170' ' ' ASP . . . . . 0.549 ' C ' ' O ' ' A' ' 169' ' ' LEU . 9.0 m-20 20.62 91.05 0.01 OUTLIER 'General case' 0 N--CA 1.499 2.002 0 CA-C-N 116.583 -0.28 . . . . 0.0 111.701 177.769 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 171' ' ' GLU . . . . . . . . . . . . . 5.9 pt-20 -137.49 77.21 1.62 Allowed 'General case' 0 N--CA 1.495 1.777 0 O-C-N 120.863 -1.148 . . . . 0.0 110.536 179.782 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 172' ' ' GLN . . . . . 0.623 ' N ' HE22 ' A' ' 113' ' ' GLN . 1.9 pt20 -136.87 -42.32 0.59 Allowed 'General case' 0 N--CA 1.495 1.824 0 O-C-N 121.209 -0.932 . . . . 0.0 110.76 -178.988 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 173' ' ' LYS . . . . . . . . . . . . . 5.8 mttp -63.23 129.29 39.65 Favored 'General case' 0 N--CA 1.497 1.892 0 O-C-N 120.688 -1.258 . . . . 0.0 108.854 179.522 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 174' ' ' GLY . . . . . 0.544 ' O ' ' C ' ' A' ' 175' ' ' LYS . . . -118.78 -41.07 0.62 Allowed Glycine 0 N--CA 1.484 1.896 0 N-CA-C 108.605 -1.798 . . . . 0.0 108.605 179.478 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 175' ' ' LYS . . . . . 0.544 ' C ' ' O ' ' A' ' 174' ' ' GLY . 17.9 mmtp -40.8 -61.85 0.89 Allowed 'General case' 0 N--CA 1.491 1.577 0 N-CA-C 106.503 -1.666 . . . . 0.0 106.503 178.48 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 176' ' ' ASP . . . . . 0.583 ' O ' ' O ' ' A' ' 177' ' ' LYS . 7.0 m-20 -105.07 85.64 2.31 Favored 'General case' 0 C--N 1.296 -1.734 0 N-CA-C 107.332 -1.359 . . . . 0.0 107.332 176.405 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 177' ' ' LYS . . . . . 0.583 ' O ' ' O ' ' A' ' 176' ' ' ASP . 0.0 OUTLIER -46.98 -174.41 0.0 OUTLIER 'General case' 0 N--CA 1.501 2.09 0 O-C-N 121.311 -0.868 . . . . 0.0 109.291 -179.233 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 178' ' ' GLN . . . . . 0.55 ' NE2' ' OD1' ' A' ' 114' ' ' ASN . 20.8 pt20 -162.01 175.13 12.12 Favored 'General case' 0 N--CA 1.488 1.456 0 O-C-N 120.328 -1.483 . . . . 0.0 111.374 -179.884 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 179' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -129.8 93.75 3.58 Favored 'General case' 0 N--CA 1.487 1.403 0 N-CA-C 107.197 -1.408 . . . . 0.0 107.197 177.627 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 180' ' ' THR . . . . . 0.5 HG23 HD13 ' A' ' 199' ' ' ILE . 1.8 m -71.28 118.45 14.09 Favored 'General case' 0 N--CA 1.493 1.704 0 O-C-N 121.11 -0.994 . . . . 0.0 110.424 -178.335 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 181' ' ' LEU . . . . . . . . . . . . . 42.4 tp -94.11 150.5 20.27 Favored 'General case' 0 C--N 1.298 -1.648 0 N-CA-C 107.817 -1.179 . . . . 0.0 107.817 177.81 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 182' ' ' ILE . . . . . 0.422 ' O ' HG22 ' A' ' 182' ' ' ILE . 5.3 mt -141.54 112.89 3.55 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.553 0 O-C-N 121.011 -1.055 . . . . 0.0 108.695 178.717 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 183' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -130.58 111.38 12.18 Favored 'General case' 0 C--N 1.291 -1.953 0 N-CA-C 107.078 -1.453 . . . . 0.0 107.078 178.95 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 184' ' ' CYS . . . . . . . . . . . . . 1.8 p -78.82 159.36 27.88 Favored 'General case' 0 C--N 1.29 -1.98 0 C-N-CA 118.843 -1.143 . . . . 0.0 111.46 -177.345 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 185' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -165.73 -154.88 0.21 Allowed 'General case' 0 N--CA 1.49 1.566 0 N-CA-C 109.102 -0.703 . . . . 0.0 109.102 -179.699 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 186' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER 50.61 52.14 15.47 Favored 'General case' 0 N--CA 1.493 1.695 0 O-C-N 121.124 -0.985 . . . . 0.0 109.12 -179.848 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 187' ' ' TYR . . . . . 0.618 ' CE2' ' O ' ' A' ' 188' ' ' ASN . 54.4 t80 -67.37 136.59 55.01 Favored 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.342 -0.849 . . . . 0.0 110.777 -179.144 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 188' ' ' ASN . . . . . 0.618 ' O ' ' CE2' ' A' ' 187' ' ' TYR . 0.7 OUTLIER -101.56 146.8 27.19 Favored 'General case' 0 C--N 1.298 -1.641 0 N-CA-C 107.777 -1.194 . . . . 0.0 107.777 178.314 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 189' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -113.53 -10.16 13.2 Favored 'General case' 0 C--N 1.297 -1.697 0 N-CA-C 108.496 -0.928 . . . . 0.0 108.496 -179.624 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 190' ' ' LYS . . . . . . . . . . . . . 13.1 mttp -84.03 -53.48 5.52 Favored 'General case' 0 N--CA 1.488 1.459 0 N-CA-C 108.649 -0.871 . . . . 0.0 108.649 178.705 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 191' ' ' THR . . . . . . . . . . . . . 1.1 p -91.26 -8.3 48.75 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.588 -0.695 . . . . 0.0 109.129 179.714 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 192' ' ' GLY . . . . . . . . . . . . . . . 62.58 40.98 99.82 Favored Glycine 0 N--CA 1.492 2.425 0 N-CA-C 110.433 -1.067 . . . . 0.0 110.433 179.219 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 193' ' ' VAL . . . . . 0.489 HG12 ' N ' ' A' ' 194' ' ' TRP . 67.2 t -145.96 157.95 12.1 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.625 0 O-C-N 121.044 -1.268 . . . . 0.0 109.801 179.56 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 194' ' ' TRP . . . . . 0.489 ' N ' HG12 ' A' ' 193' ' ' VAL . 23.0 m95 -83.83 120.79 26.48 Favored 'General case' 0 C--N 1.301 -1.543 0 N-CA-C 108.509 -0.923 . . . . 0.0 108.509 179.627 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 195' ' ' GLU . . . . . . . . . . . . . 2.1 mt-10 -89.73 -60.65 1.88 Allowed 'General case' 0 N--CA 1.495 1.816 0 C-N-CA 119.55 -0.86 . . . . 0.0 111.148 -178.194 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 196' ' ' LYS . . . . . . . . . . . . . 5.1 tttm -80.49 143.23 33.49 Favored 'General case' 0 C--N 1.3 -1.545 0 O-C-N 120.815 -1.178 . . . . 0.0 110.165 -178.901 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 197' ' ' ARG . . . . . 0.565 ' NH1' ' O ' ' C' ' 704' ' ' ALA . 13.5 tpp180 -120.05 138.33 53.59 Favored 'General case' 0 N--CA 1.491 1.617 0 N-CA-C 108.552 -0.907 . . . . 0.0 108.552 179.084 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 198' ' ' LYS . . . . . . . . . . . . . 22.7 mttt -116.97 118.6 32.87 Favored 'General case' 0 C--N 1.302 -1.489 0 O-C-N 121.903 -0.498 . . . . 0.0 109.966 -179.464 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 199' ' ' ILE . . . . . 0.5 HD13 HG23 ' A' ' 180' ' ' THR . 0.6 OUTLIER -139.16 120.32 15.7 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.58 0 CA-C-O 122.505 1.145 . . . . 0.0 109.339 179.532 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 200' ' ' PHE . . . . . 0.884 ' CD2' HD12 ' A' ' 158' ' ' ILE . 3.3 m-85 -99.43 136.71 38.97 Favored 'General case' 0 N--CA 1.496 1.852 0 O-C-N 121.124 -0.985 . . . . 0.0 109.799 -178.074 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 201' ' ' VAL . . . . . . . . . . . . . 97.7 t -101.58 137.16 30.25 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.555 0 N-CA-C 108.004 -1.11 . . . . 0.0 108.004 177.652 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 202' ' ' ALA . . . . . 0.417 ' HB1' ' HB3' ' A' ' 153' ' ' TYR . . . -121.56 134.91 55.03 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.376 -0.828 . . . . 0.0 108.821 179.831 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 203' ' ' THR . . . . . 0.748 HG23 ' OG1' ' A' ' 156' ' ' THR . 2.1 p -88.1 130.36 35.04 Favored 'General case' 0 C--N 1.306 -1.288 0 CA-C-O 122.198 0.999 . . . . 0.0 110.652 -178.782 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 204' ' ' GLU . . . . . 0.507 ' HA ' ' CD2' ' A' ' 153' ' ' TYR . 0.2 OUTLIER -50.9 134.62 25.46 Favored 'General case' 0 C--N 1.298 -1.67 0 C-N-CA 118.688 -1.205 . . . . 0.0 108.673 178.933 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 205' ' ' VAL . . . . . 0.646 HG23 ' O ' ' A' ' 203' ' ' THR . 54.6 t -129.7 164.29 32.74 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.376 0 CA-C-O 121.93 0.872 . . . . 0.0 110.228 -177.741 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 206' ' ' LYS . . . . . 0.57 ' N ' HG12 ' A' ' 205' ' ' VAL . 0.5 OUTLIER . . . . . 0 C--N 1.297 -1.706 0 CA-C-O 118.006 -0.997 . . . . 0.0 109.559 -179.804 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' C' C ' 701' ' ' PHQ . . . . . 0.48 ' C1 ' HG12 ' A' ' 166' ' ' VAL . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 006 nuclear build full ' C' C ' 702' ' ' LEU . . . . . 0.754 HD11 ' O ' ' A' ' 163' ' ' PRO . 0.3 OUTLIER . . . . . 0 N--CA 1.493 1.714 0 N-CA-C 109.441 -0.577 . . . . 0.0 109.441 . . . . . . . . . 2 2 . 1 . 006 nuclear build full ' C' C ' 703' ' ' PRO . . . . . 0.597 ' HG3' ' HB1' ' A' ' 104' ' ' ALA . 40.5 Cg_endo -70.96 -179.29 3.33 Favored 'Trans proline' 0 C--N 1.31 -1.496 0 C-N-CA 122.796 2.331 . . . . 0.0 112.97 -179.691 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' C' C ' 704' ' ' ALA . . . . . 0.565 ' O ' ' NH1' ' A' ' 197' ' ' ARG . . . 56.44 122.02 0.0 OUTLIER 'General case' 0 N--CA 1.49 1.567 0 CA-C-O 121.561 0.696 . . . . 0.0 110.168 179.809 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' C' C ' 705' ' ' B27 . . . . . 0.413 ' HX ' ' NE1' ' A' ' 194' ' ' TRP . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 700' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 007 nuclear build full ' A' A ' 59' ' ' MET . . . . . . . . . . . . . 1.3 mpt? . . . . . 0 N--CA 1.49 1.561 0 N-CA-C 109.256 -0.646 . . . . 0.0 109.256 . . . . . . . . . 0 0 . 1 . 007 nuclear build full ' A' A ' 60' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -60.74 153.45 24.21 Favored 'General case' 0 N--CA 1.489 1.496 0 O-C-N 121.376 -0.827 . . . . 0.0 109.861 -179.704 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . -65.3 -172.11 0.09 Allowed 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.376 -0.827 . . . . 0.0 109.801 -179.991 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 62' ' ' LYS . . . . . 0.633 ' O ' ' NE2' ' A' ' 64' ' ' GLN . 24.4 ttpt -147.5 79.06 9.77 Favored Pre-proline 0 N--CA 1.49 1.528 0 O-C-N 121.398 -0.814 . . . . 0.0 109.557 179.764 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 63' ' ' PRO . . . . . 0.453 ' O ' HD22 ' A' ' 110' ' ' LEU . 5.6 Cg_exo -71.53 137.45 30.49 Favored 'Trans proline' 0 C--N 1.306 -1.707 0 C-N-CA 122.915 2.41 . . . . 0.0 111.283 179.585 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 64' ' ' GLN . . . . . 0.633 ' NE2' ' O ' ' A' ' 62' ' ' LYS . 0.0 OUTLIER -155.26 127.44 7.7 Favored 'General case' 0 N--CA 1.494 1.77 0 O-C-N 121.054 -1.029 . . . . 0.0 110.315 179.81 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 65' ' ' ILE . . . . . 0.564 ' H ' HD12 ' A' ' 65' ' ' ILE . 2.1 mp -45.76 105.94 0.51 Allowed Pre-proline 0 N--CA 1.491 1.598 0 N-CA-C 107.857 -1.164 . . . . 0.0 107.857 178.471 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 66' ' ' PRO . . . . . . . . . . . . . 60.2 Cg_endo -81.94 -162.71 0.19 Allowed 'Trans proline' 0 N--CA 1.49 1.272 0 C-N-CA 122.105 1.87 . . . . 0.0 112.639 -178.785 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 67' ' ' LYS . . . . . . . . . . . . . 53.8 tttt -90.46 -8.04 51.5 Favored 'General case' 0 N--CA 1.487 1.405 0 O-C-N 121.223 -0.923 . . . . 0.0 109.727 -179.722 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 68' ' ' ASP . . . . . 0.646 ' O ' ' N ' ' A' ' 70' ' ' SER . 0.2 OUTLIER -75.86 66.14 2.07 Favored 'General case' 0 N--CA 1.487 1.421 0 CA-C-O 123.003 1.383 . . . . 0.0 108.896 179.839 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 69' ' ' LYS . . . . . 0.468 ' C ' ' O ' ' A' ' 68' ' ' ASP . 0.8 OUTLIER -45.77 -14.71 0.02 OUTLIER 'General case' 0 N--CA 1.511 2.579 0 C-N-CA 117.129 -1.828 . . . . 0.0 107.368 178.06 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 70' ' ' SER . . . . . 0.646 ' N ' ' O ' ' A' ' 68' ' ' ASP . 0.1 OUTLIER -87.58 -5.0 58.95 Favored 'General case' 0 N--CA 1.498 1.93 0 CA-C-N 113.615 -1.63 . . . . 0.0 111.9 179.893 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 71' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -100.56 142.65 31.74 Favored 'General case' 0 N--CA 1.503 2.221 0 O-C-N 120.251 -1.531 . . . . 0.0 112.615 -178.991 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 72' ' ' VAL . . . . . 0.587 ' CG2' ' O ' ' A' ' 74' ' ' GLY . 0.7 OUTLIER -67.72 127.13 28.85 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.336 0 N-CA-C 105.196 -2.149 . . . . 0.0 105.196 174.786 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 73' ' ' ALA . . . . . 0.569 ' N ' ' O ' ' A' ' 87' ' ' VAL . . . -80.33 -12.4 59.6 Favored 'General case' 0 C--N 1.297 -1.712 0 O-C-N 120.195 -1.566 . . . . 0.0 109.126 -178.309 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 74' ' ' GLY . . . . . 0.587 ' O ' ' CG2' ' A' ' 72' ' ' VAL . . . 173.53 -161.12 31.72 Favored Glycine 0 N--CA 1.488 2.13 0 N-CA-C 109.614 -1.394 . . . . 0.0 109.614 -179.849 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 75' ' ' TYR . . . . . . . . . . . . . 76.1 m-85 -142.27 170.16 16.23 Favored 'General case' 0 C--N 1.296 -1.747 0 O-C-N 121.076 -1.249 . . . . 0.0 110.767 -178.136 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 76' ' ' ILE . . . . . 0.468 ' CG2' ' OE1' ' A' ' 85' ' ' GLU . 0.4 OUTLIER -148.97 144.26 18.38 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.57 0 C-N-CA 119.422 -0.911 . . . . 0.0 108.994 -177.464 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -152.04 160.35 43.47 Favored 'General case' 0 N--CA 1.492 1.648 0 O-C-N 120.893 -1.129 . . . . 0.0 109.504 -179.855 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 78' ' ' ILE . . . . . 0.495 ' CG1' HG22 ' A' ' 142' ' ' VAL . 3.0 mp -143.16 99.08 5.47 Favored Pre-proline 0 N--CA 1.493 1.695 0 N-CA-C 107.929 -1.137 . . . . 0.0 107.929 179.303 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 79' ' ' PRO . . . . . . . . . . . . . 47.4 Cg_exo -51.06 -44.62 41.29 Favored 'Trans proline' 0 N--CA 1.492 1.425 0 C-N-CA 122.557 2.171 . . . . 0.0 113.808 -178.81 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -65.62 -18.05 65.04 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 120.691 -1.256 . . . . 0.0 110.752 178.741 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 81' ' ' ALA . . . . . 0.804 ' HB2' ' HB2' ' A' ' 136' ' ' ALA . . . -106.41 -19.04 13.81 Favored 'General case' 0 N--CA 1.494 1.774 0 O-C-N 121.136 -0.978 . . . . 0.0 108.886 179.746 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 82' ' ' ASP . . . . . 0.426 ' CB ' ' O ' ' A' ' 81' ' ' ALA . 11.6 t0 70.44 49.02 0.44 Allowed 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.475 -0.765 . . . . 0.0 110.767 179.106 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 83' ' ' ILE . . . . . 0.546 HD11 ' HB3' ' A' ' 132' ' ' ASN . 36.2 mt -131.1 152.74 38.01 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.822 0 O-C-N 121.145 -0.972 . . . . 0.0 110.275 -179.047 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 84' ' ' LYS . . . . . . . . . . . . . 9.3 ptmm? -157.7 110.22 2.4 Favored 'General case' 0 N--CA 1.489 1.491 0 N-CA-C 108.244 -1.021 . . . . 0.0 108.244 179.471 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 85' ' ' GLU . . . . . 0.47 ' CD ' ' N ' ' A' ' 85' ' ' GLU . 0.4 OUTLIER -138.32 167.74 18.68 Favored Pre-proline 0 N--CA 1.498 1.949 0 O-C-N 121.113 -0.992 . . . . 0.0 109.805 -178.973 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 86' ' ' PRO . . . . . . . . . . . . . 97.3 Cg_endo -82.99 158.89 15.64 Favored 'Trans proline' 0 N--CA 1.494 1.54 0 C-N-CA 122.944 2.429 . . . . 0.0 113.568 -179.184 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 87' ' ' VAL . . . . . 0.569 ' O ' ' N ' ' A' ' 73' ' ' ALA . 78.6 t -112.04 106.36 20.61 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.698 0 N-CA-C 109.319 -0.622 . . . . 0.0 109.319 180.0 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 88' ' ' TYR . . . . . 0.404 ' CZ ' ' HB3' ' A' ' 99' ' ' ARG . 10.5 m-85 -97.45 153.94 38.18 Favored Pre-proline 0 N--CA 1.5 2.057 0 O-C-N 120.766 -1.209 . . . . 0.0 109.607 179.582 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 89' ' ' PRO . . . . . . . . . . . . . 11.4 Cg_endo -58.78 141.94 98.35 Favored 'Trans proline' 0 N--CA 1.497 1.705 0 C-N-CA 122.954 2.436 . . . . 0.0 113.424 -179.923 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . -59.17 169.19 6.23 Favored Glycine 0 N--CA 1.496 2.667 0 N-CA-C 109.259 -1.537 . . . . 0.0 109.259 179.209 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 91' ' ' PRO . . . . . 0.469 ' C ' ' H ' ' A' ' 93' ' ' THR . 94.3 Cg_endo -93.09 168.92 21.57 Favored 'Cis proline' 0 C--N 1.31 -1.489 0 C-N-CA 123.861 -1.308 . . . . 0.0 111.994 0.239 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 92' ' ' ALA . . . . . 0.645 ' O ' HD23 ' A' ' 97' ' ' LEU . . . -70.86 29.76 0.04 OUTLIER 'General case' 0 N--CA 1.492 1.662 0 O-C-N 121.166 -0.959 . . . . 0.0 110.6 -179.489 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 93' ' ' THR . . . . . 0.469 ' H ' ' C ' ' A' ' 91' ' ' PRO . 6.5 p -72.42 150.79 91.74 Favored Pre-proline 0 C--N 1.302 -1.485 0 O-C-N 120.688 -1.257 . . . . 0.0 108.4 179.836 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 94' ' ' PRO . . . . . 0.427 ' C ' ' O ' ' A' ' 93' ' ' THR . 70.2 Cg_exo -30.46 -57.15 0.19 Allowed 'Trans proline' 0 C--N 1.309 -1.506 0 C-N-CA 122.973 2.448 . . . . 0.0 112.743 -179.144 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 16.3 mt-10 -44.56 -49.31 10.16 Favored 'General case' 0 C--N 1.302 -1.466 0 O-C-N 121.175 -0.953 . . . . 0.0 109.863 -179.931 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 96' ' ' GLN . . . . . 0.566 ' O ' ' N ' ' A' ' 98' ' ' ASN . 1.4 mp0 -73.15 -54.15 9.19 Favored 'General case' 0 N--CA 1.488 1.47 0 O-C-N 121.081 -1.012 . . . . 0.0 109.912 179.782 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 97' ' ' LEU . . . . . 0.645 HD23 ' O ' ' A' ' 92' ' ' ALA . 0.7 OUTLIER -44.11 -14.42 0.02 OUTLIER 'General case' 0 N--CA 1.494 1.732 0 O-C-N 121.453 -0.779 . . . . 0.0 110.29 -179.216 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 98' ' ' ASN . . . . . 0.566 ' N ' ' O ' ' A' ' 96' ' ' GLN . 0.0 OUTLIER -71.53 -33.53 69.26 Favored 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.052 -1.03 . . . . 0.0 108.599 179.327 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 99' ' ' ARG . . . . . 0.539 ' NE ' ' OD1' ' A' ' 98' ' ' ASN . 16.4 mmt180 -79.64 -58.39 3.21 Favored 'General case' 0 C--N 1.303 -1.442 0 O-C-N 121.688 -0.633 . . . . 0.0 109.565 -179.725 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . 174.08 -156.17 23.03 Favored Glycine 0 N--CA 1.492 2.422 0 N-CA-C 109.989 -1.245 . . . . 0.0 109.989 179.967 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 101' ' ' VAL . . . . . 0.639 HG23 ' O ' ' A' ' 101' ' ' VAL . 27.3 m -59.44 103.18 0.14 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.674 0 O-C-N 121.256 -1.144 . . . . 0.0 109.754 -179.908 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -91.63 166.19 12.94 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.032 -1.043 . . . . 0.0 109.953 -179.992 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 103' ' ' PHE . . . . . 0.597 ' O ' ' N ' ' A' ' 105' ' ' GLU . 26.0 m-85 -70.22 120.86 16.54 Favored 'General case' 0 N--CA 1.486 1.352 0 N-CA-C 107.969 -1.123 . . . . 0.0 107.969 178.639 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 104' ' ' ALA . . . . . 0.576 ' HB1' ' HG3' ' C' ' 703' ' ' PRO . . . -42.94 -14.54 0.01 OUTLIER 'General case' 0 C--N 1.3 -1.546 0 O-C-N 121.488 -0.757 . . . . 0.0 110.696 -178.729 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 105' ' ' GLU . . . . . 0.597 ' N ' ' O ' ' A' ' 103' ' ' PHE . 0.1 OUTLIER -138.85 146.61 41.44 Favored 'General case' 0 N--CA 1.496 1.86 0 O-C-N 120.828 -1.17 . . . . 0.0 110.762 -179.797 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 106' ' ' GLU . . . . . 0.412 ' HG2' ' H ' ' A' ' 107' ' ' ASN . 0.0 OUTLIER -59.59 -61.72 2.41 Favored 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.929 -0.482 . . . . 0.0 111.523 -179.178 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 107' ' ' ASN . . . . . 0.412 ' H ' ' HG2' ' A' ' 106' ' ' GLU . 91.8 m-20 -77.65 34.35 0.18 Allowed 'General case' 0 N--CA 1.493 1.707 0 O-C-N 120.428 -1.42 . . . . 0.0 112.862 -175.553 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 108' ' ' GLU . . . . . . . . . . . . . 14.6 tp10 -57.43 146.73 28.49 Favored 'General case' 0 C--N 1.301 -1.508 0 O-C-N 120.698 -1.252 . . . . 0.0 107.937 179.622 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 109' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -102.26 146.72 27.6 Favored 'General case' 0 N--CA 1.488 1.453 0 O-C-N 121.124 -0.985 . . . . 0.0 111.133 -178.198 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 110' ' ' LEU . . . . . 0.453 HD22 ' O ' ' A' ' 63' ' ' PRO . 3.0 tp -62.81 -18.87 63.43 Favored 'General case' 0 C--N 1.303 -1.421 0 N-CA-C 108.028 -1.101 . . . . 0.0 108.028 178.783 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 111' ' ' ASP . . . . . 0.439 ' OD1' ' C ' ' A' ' 110' ' ' LEU . 4.0 m-20 -132.69 42.45 3.08 Favored 'General case' 0 N--CA 1.487 1.383 0 O-C-N 121.637 -0.664 . . . . 0.0 109.84 -179.849 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 112' ' ' ASP . . . . . . . . . . . . . 4.5 t0 -68.15 157.45 35.32 Favored 'General case' 0 N--CA 1.492 1.668 0 O-C-N 120.858 -1.151 . . . . 0.0 111.386 -179.725 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 113' ' ' GLN . . . . . 0.543 ' N ' ' CD ' ' A' ' 113' ' ' GLN . 0.0 OUTLIER -66.58 -16.07 63.9 Favored 'General case' 0 N--CA 1.494 1.742 0 N-CA-C 108.229 -1.026 . . . . 0.0 108.229 177.934 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 114' ' ' ASN . . . . . 0.614 ' ND2' ' O ' ' A' ' 170' ' ' ASP . 34.6 t-20 -153.0 113.81 4.11 Favored 'General case' 0 C--N 1.295 -1.781 0 N-CA-C 107.58 -1.266 . . . . 0.0 107.58 177.141 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 115' ' ' ILE . . . . . 0.555 HG22 ' O ' ' A' ' 115' ' ' ILE . 3.8 mt -91.41 98.95 8.96 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.69 0 N-CA-C 107.232 -1.396 . . . . 0.0 107.232 179.588 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 116' ' ' SER . . . . . 0.43 ' OG ' ' HB3' ' A' ' 104' ' ' ALA . 87.6 p -86.44 149.03 25.28 Favored 'General case' 0 N--CA 1.488 1.437 0 CA-C-O 121.864 0.84 . . . . 0.0 111.22 -177.528 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 117' ' ' ILE . . . . . . . . . . . . . 1.7 mt -149.71 149.54 14.56 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.483 0 N-CA-C 107.813 -1.18 . . . . 0.0 107.813 179.112 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 118' ' ' ALA . . . . . . . . . . . . . . . -136.26 159.35 42.02 Favored 'General case' 0 N--CA 1.493 1.686 0 C-N-CA 119.277 -0.969 . . . . 0.0 110.903 -179.018 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 119' ' ' GLY . . . . . 0.516 ' HA2' HD11 ' A' ' 97' ' ' LEU . . . -172.01 146.76 9.54 Favored Glycine 0 N--CA 1.489 2.179 0 N-CA-C 110.482 -1.047 . . . . 0.0 110.482 179.94 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 120' ' ' HIS . . . . . 0.527 ' CD2' ' SG ' ' C' ' 705' ' ' B27 . 27.7 m170 -71.89 168.0 18.85 Favored 'General case' 0 N--CA 1.494 1.758 0 O-C-N 121.531 -0.981 . . . . 0.0 110.157 179.291 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 121' ' ' THR . . . . . 0.457 ' OG1' ' NZ ' ' A' ' 134' ' ' LYS . 0.7 OUTLIER -118.5 160.06 22.41 Favored 'General case' 0 N--CA 1.498 1.958 0 N-CA-C 108.357 -0.979 . . . . 0.0 108.357 178.818 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 122' ' ' PHE . . . . . . . . . . . . . 2.7 m-85 -143.59 123.35 13.39 Favored 'General case' 0 N--CA 1.498 1.951 0 O-C-N 120.838 -1.164 . . . . 0.0 109.812 -179.766 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 123' ' ' ILE . . . . . 0.563 HG23 ' N ' ' A' ' 124' ' ' ASP . 14.3 tt -59.18 -40.24 80.59 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.478 0 CA-C-O 121.545 0.688 . . . . 0.0 109.516 179.89 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 124' ' ' ASP . . . . . 0.563 ' N ' HG23 ' A' ' 123' ' ' ILE . 1.7 m-20 -88.92 22.62 2.64 Favored 'General case' 0 N--CA 1.497 1.912 0 O-C-N 121.492 -0.755 . . . . 0.0 111.942 -177.42 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 125' ' ' ARG . . . . . . . . . . . . . 37.9 mtp180 -154.47 99.75 2.45 Favored Pre-proline 0 N--CA 1.493 1.703 0 O-C-N 120.366 -1.459 . . . . 0.0 110.112 -179.862 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 126' ' ' PRO . . . . . . . . . . . . . 56.1 Cg_endo -80.02 -27.94 3.47 Favored 'Trans proline' 0 C--N 1.313 -1.328 0 C-N-CA 121.98 1.787 . . . . 0.0 111.635 179.266 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 127' ' ' ASN . . . . . . . . . . . . . 2.9 m120 -89.09 11.77 17.54 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.047 -1.033 . . . . 0.0 109.227 179.64 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 128' ' ' TYR . . . . . . . . . . . . . 5.1 t80 -65.58 -149.47 0.01 OUTLIER 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.388 -0.82 . . . . 0.0 109.425 179.908 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 129' ' ' GLN . . . . . 0.433 HE22 ' CD1' ' A' ' 97' ' ' LEU . 69.5 mt-30 -68.05 -70.95 0.23 Allowed 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.315 -0.866 . . . . 0.0 109.857 -179.787 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 130' ' ' PHE . . . . . 0.701 ' CE1' HD11 ' A' ' 181' ' ' LEU . 47.6 m-85 -134.88 52.62 2.03 Favored 'General case' 0 N--CA 1.493 1.71 0 O-C-N 121.104 -0.998 . . . . 0.0 110.303 -179.857 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 131' ' ' THR . . . . . . . . . . . . . 23.1 m -87.33 -39.69 15.12 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 120.903 -1.123 . . . . 0.0 109.396 179.681 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 132' ' ' ASN . . . . . 0.585 ' ND2' ' O ' ' A' ' 81' ' ' ALA . 1.8 t30 -82.86 6.32 18.79 Favored 'General case' 0 N--CA 1.498 1.938 0 O-C-N 121.505 -0.747 . . . . 0.0 111.701 -178.306 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 133' ' ' LEU . . . . . 0.503 ' O ' ' N ' ' A' ' 135' ' ' ALA . 0.2 OUTLIER -71.17 -45.54 63.28 Favored 'General case' 0 C--N 1.299 -1.616 0 O-C-N 120.739 -1.226 . . . . 0.0 109.999 -179.368 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 134' ' ' LYS . . . . . 0.652 ' H ' ' CD ' ' A' ' 134' ' ' LYS . 0.0 OUTLIER -46.12 -16.96 0.03 OUTLIER 'General case' 0 N--CA 1.494 1.749 0 O-C-N 120.988 -1.07 . . . . 0.0 109.727 -179.802 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 135' ' ' ALA . . . . . 0.503 ' N ' ' O ' ' A' ' 133' ' ' LEU . . . -84.08 -37.53 21.93 Favored 'General case' 0 N--CA 1.487 1.403 0 O-C-N 121.111 -0.993 . . . . 0.0 109.077 179.471 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 136' ' ' ALA . . . . . 0.804 ' HB2' ' HB2' ' A' ' 81' ' ' ALA . . . -79.76 157.96 26.99 Favored 'General case' 0 C--N 1.303 -1.454 0 CA-C-O 121.976 0.894 . . . . 0.0 110.984 -179.132 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 137' ' ' LYS . . . . . 0.542 ' O ' ' O ' ' A' ' 138' ' ' LYS . 2.4 mttm -150.84 -163.52 1.79 Allowed 'General case' 0 C--N 1.299 -1.628 0 C-N-CA 118.106 -1.438 . . . . 0.0 110.965 -177.902 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 138' ' ' LYS . . . . . 0.585 ' O ' ' N ' ' A' ' 140' ' ' SER . 28.8 mttp -41.18 174.17 0.0 OUTLIER 'General case' 0 C--N 1.301 -1.523 0 CA-C-O 122.589 1.185 . . . . 0.0 111.171 -178.557 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 139' ' ' GLY . . . . . . . . . . . . . . . 47.13 8.25 0.03 OUTLIER Glycine 0 N--CA 1.488 2.148 0 N-CA-C 110.162 -1.175 . . . . 0.0 110.162 -179.971 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 140' ' ' SER . . . . . 0.585 ' N ' ' O ' ' A' ' 138' ' ' LYS . 5.2 m -75.87 112.98 12.83 Favored 'General case' 0 N--CA 1.493 1.723 0 O-C-N 120.867 -1.372 . . . . 0.0 108.982 179.385 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 141' ' ' MET . . . . . 0.659 ' SD ' ' N ' ' A' ' 142' ' ' VAL . 3.0 tpp -68.26 128.02 35.06 Favored 'General case' 0 C--N 1.301 -1.503 0 O-C-N 121.036 -1.04 . . . . 0.0 109.178 179.854 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 142' ' ' VAL . . . . . 0.659 ' N ' ' SD ' ' A' ' 141' ' ' MET . 1.6 t -113.87 133.29 60.33 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.522 0 N-CA-C 108.456 -0.942 . . . . 0.0 108.456 -179.736 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 143' ' ' TYR . . . . . . . . . . . . . 13.4 m-85 -112.31 135.83 52.51 Favored 'General case' 0 N--CA 1.495 1.798 0 O-C-N 120.869 -1.145 . . . . 0.0 110.703 -178.899 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 144' ' ' PHE . . . . . 0.561 ' CZ ' ' CG1' ' A' ' 146' ' ' VAL . 4.2 t80 -120.96 105.88 11.08 Favored 'General case' 0 N--CA 1.493 1.707 0 C-N-CA 120.143 -0.623 . . . . 0.0 109.985 -179.467 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 145' ' ' LYS . . . . . . . . . . . . . 13.9 mtpp -102.3 122.76 44.86 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.23 -0.919 . . . . 0.0 109.819 -179.863 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 146' ' ' VAL . . . . . 0.561 ' CG1' ' CZ ' ' A' ' 144' ' ' PHE . 0.9 OUTLIER -142.65 125.4 13.74 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.629 0 N-CA-C 108.335 -0.987 . . . . 0.0 108.335 178.874 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 147' ' ' GLY . . . . . . . . . . . . . . . 60.47 -125.6 39.0 Favored Glycine 0 N--CA 1.489 2.225 0 N-CA-C 109.054 -1.618 . . . . 0.0 109.054 -179.426 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 148' ' ' ASN . . . . . 0.445 ' O ' ' CG ' ' A' ' 148' ' ' ASN . 0.1 OUTLIER -104.77 5.97 33.68 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.245 -1.15 . . . . 0.0 108.979 179.623 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 149' ' ' GLU . . . . . . . . . . . . . 1.3 tt0 -105.82 141.65 36.89 Favored 'General case' 0 N--CA 1.488 1.461 0 O-C-N 121.295 -0.878 . . . . 0.0 111.797 -178.32 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 150' ' ' THR . . . . . . . . . . . . . 3.5 m -131.93 98.47 4.46 Favored 'General case' 0 N--CA 1.493 1.709 0 CA-C-O 121.482 0.658 . . . . 0.0 109.271 -179.862 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 151' ' ' ARG . . . . . 0.427 HH12 ' HA ' ' A' ' 111' ' ' ASP . 92.6 mtt180 -85.7 -169.36 2.61 Favored 'General case' 0 N--CA 1.488 1.425 0 O-C-N 121.255 -0.903 . . . . 0.0 108.894 -179.711 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 152' ' ' LYS . . . . . 0.476 ' O ' ' N ' ' A' ' 205' ' ' VAL . 1.9 mtmp? -152.02 149.87 29.35 Favored 'General case' 0 C--N 1.301 -1.537 0 O-C-N 121.261 -0.899 . . . . 0.0 109.982 -179.309 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 153' ' ' TYR . . . . . 0.499 ' CD2' ' HA ' ' A' ' 204' ' ' GLU . 5.7 m-85 -143.86 168.51 19.78 Favored 'General case' 0 C--N 1.303 -1.417 0 N-CA-C 107.939 -1.134 . . . . 0.0 107.939 178.494 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 154' ' ' LYS . . . . . . . . . . . . . 1.4 ttpt -143.36 119.82 10.99 Favored 'General case' 0 C--N 1.295 -1.772 0 N-CA-C 108.403 -0.962 . . . . 0.0 108.403 178.689 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 155' ' ' MET . . . . . . . . . . . . . 46.5 mtp -46.3 107.68 0.11 Allowed 'General case' 0 N--CA 1.495 1.784 0 O-C-N 120.637 -1.289 . . . . 0.0 111.564 -178.602 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 156' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -106.4 -25.44 11.89 Favored 'General case' 0 C--N 1.294 -1.844 0 CA-C-N 115.249 -0.887 . . . . 0.0 110.633 -178.739 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 157' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -153.94 153.72 32.52 Favored 'General case' 0 N--CA 1.495 1.813 0 C-N-CA 118.559 -1.256 . . . . 0.0 111.431 -178.512 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 158' ' ' ILE . . . . . 0.633 HD12 ' CD1' ' A' ' 200' ' ' PHE . 0.2 OUTLIER -153.79 146.83 14.15 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.372 0 CA-C-O 122.067 0.937 . . . . 0.0 110.91 -179.76 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 159' ' ' ARG . . . . . . . . . . . . . 12.9 ttm180 -153.66 153.44 32.3 Favored 'General case' 0 C--N 1.296 -1.718 0 CA-C-O 121.642 0.734 . . . . 0.0 109.681 -179.894 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 160' ' ' ASP . . . . . 0.773 ' O ' HG13 ' A' ' 161' ' ' VAL . 0.3 OUTLIER -116.18 160.55 20.23 Favored 'General case' 0 C--N 1.301 -1.513 0 N-CA-C 107.895 -1.15 . . . . 0.0 107.895 179.428 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 161' ' ' VAL . . . . . 0.773 HG13 ' O ' ' A' ' 160' ' ' ASP . 1.6 m -165.35 159.34 1.14 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.7 0 O-C-N 120.881 -1.137 . . . . 0.0 110.54 -179.271 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 162' ' ' LYS . . . . . 0.497 ' O ' ' O ' ' A' ' 161' ' ' VAL . 0.0 OUTLIER -43.96 171.5 0.04 OUTLIER Pre-proline 0 N--CA 1.49 1.538 0 O-C-N 121.789 -0.569 . . . . 0.0 109.558 179.568 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 163' ' ' PRO . . . . . 0.503 ' C ' HD11 ' C' ' 702' ' ' LEU . 74.0 Cg_endo -81.47 37.32 0.67 Allowed 'Trans proline' 0 C--N 1.311 -1.431 0 C-N-CA 122.557 2.171 . . . . 0.0 112.107 179.891 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 164' ' ' THR . . . . . 0.607 ' N ' HD11 ' C' ' 702' ' ' LEU . 86.7 m -152.12 -5.65 0.23 Allowed 'General case' 0 N--CA 1.494 1.76 0 O-C-N 121.216 -0.927 . . . . 0.0 110.736 -179.446 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 165' ' ' ASP . . . . . . . . . . . . . 31.0 t70 -72.86 62.72 0.61 Allowed 'General case' 0 N--CA 1.496 1.834 0 O-C-N 120.796 -1.19 . . . . 0.0 110.169 -179.435 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 166' ' ' VAL . . . . . 0.668 HG22 ' C1 ' ' C' ' 701' ' ' PHQ . 2.8 t -45.68 -34.01 1.58 Allowed 'Isoleucine or valine' 0 N--CA 1.494 1.763 0 O-C-N 121.099 -1.001 . . . . 0.0 110.247 -178.534 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 167' ' ' GLY . . . . . 0.402 ' C ' ' O ' ' A' ' 166' ' ' VAL . . . -43.46 -12.81 0.01 OUTLIER Glycine 0 N--CA 1.496 2.672 0 O-C-N 120.785 -1.197 . . . . 0.0 110.994 -179.495 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 168' ' ' VAL . . . . . 0.608 ' N ' ' O ' ' A' ' 166' ' ' VAL . 5.3 m -53.97 -30.94 20.36 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.51 0 O-C-N 120.588 -1.537 . . . . 0.0 109.005 179.802 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 169' ' ' LEU . . . . . 0.545 ' O ' ' ND2' ' A' ' 114' ' ' ASN . 13.1 mt -49.04 -11.51 0.04 OUTLIER 'General case' 0 N--CA 1.489 1.519 0 N-CA-C 107.974 -1.121 . . . . 0.0 107.974 -178.535 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 170' ' ' ASP . . . . . 0.614 ' O ' ' ND2' ' A' ' 114' ' ' ASN . 2.2 m-20 19.88 77.21 0.01 OUTLIER 'General case' 0 N--CA 1.5 2.03 0 N-CA-C 112.21 0.448 . . . . 0.0 112.21 177.517 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 171' ' ' GLU . . . . . 0.572 ' N ' ' OE1' ' A' ' 172' ' ' GLN . 9.9 pt-20 -116.51 66.44 0.71 Allowed 'General case' 0 N--CA 1.498 1.957 0 O-C-N 120.922 -1.111 . . . . 0.0 109.499 179.495 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 172' ' ' GLN . . . . . 0.572 ' OE1' ' N ' ' A' ' 171' ' ' GLU . 2.5 mp0 -121.35 -57.28 1.85 Allowed 'General case' 0 N--CA 1.496 1.846 0 O-C-N 121.532 -0.73 . . . . 0.0 110.7 -178.697 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 173' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -58.92 127.0 30.0 Favored 'General case' 0 N--CA 1.494 1.739 0 O-C-N 121.017 -1.052 . . . . 0.0 109.301 -179.687 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 174' ' ' GLY . . . . . 0.498 ' O ' ' C ' ' A' ' 175' ' ' LYS . . . -118.55 -43.0 0.56 Allowed Glycine 0 N--CA 1.482 1.742 0 N-CA-C 108.625 -1.79 . . . . 0.0 108.625 179.835 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 175' ' ' LYS . . . . . 0.498 ' C ' ' O ' ' A' ' 174' ' ' GLY . 0.0 OUTLIER -40.42 -60.03 1.19 Allowed 'General case' 0 N--CA 1.494 1.742 0 N-CA-C 107.324 -1.361 . . . . 0.0 107.324 179.538 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 176' ' ' ASP . . . . . 0.601 ' O ' ' O ' ' A' ' 177' ' ' LYS . 11.4 m-20 -103.72 90.31 3.61 Favored 'General case' 0 C--N 1.292 -1.912 0 N-CA-C 106.792 -1.558 . . . . 0.0 106.792 176.896 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 177' ' ' LYS . . . . . 0.601 ' O ' ' O ' ' A' ' 176' ' ' ASP . 8.3 mtmt -45.28 -176.31 0.0 OUTLIER 'General case' 0 N--CA 1.492 1.641 0 N-CA-C 109.009 -0.737 . . . . 0.0 109.009 -179.161 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 178' ' ' GLN . . . . . . . . . . . . . 4.1 pt20 -161.77 175.84 11.53 Favored 'General case' 0 C--N 1.3 -1.557 0 O-C-N 120.37 -1.456 . . . . 0.0 110.511 179.322 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 179' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -132.51 98.96 4.5 Favored 'General case' 0 C--N 1.301 -1.503 0 N-CA-C 107.604 -1.258 . . . . 0.0 107.604 178.228 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 180' ' ' THR . . . . . 0.571 ' CB ' HD21 ' A' ' 114' ' ' ASN . 1.3 m -77.26 117.42 18.76 Favored 'General case' 0 N--CA 1.489 1.486 0 O-C-N 121.217 -0.927 . . . . 0.0 110.127 -178.628 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 181' ' ' LEU . . . . . 0.763 HD22 ' CE2' ' A' ' 200' ' ' PHE . 9.4 tt -92.76 147.05 23.18 Favored 'General case' 0 C--N 1.302 -1.463 0 N-CA-C 107.851 -1.166 . . . . 0.0 107.851 177.826 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 182' ' ' ILE . . . . . 0.614 ' N ' HD23 ' A' ' 181' ' ' LEU . 6.4 mt -138.39 109.05 5.0 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.643 0 N-CA-C 108.262 -1.014 . . . . 0.0 108.262 179.088 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 183' ' ' THR . . . . . 0.541 ' O ' HG23 ' A' ' 183' ' ' THR . 7.1 t -132.1 115.65 16.02 Favored 'General case' 0 C--N 1.29 -2.007 0 N-CA-C 107.921 -1.14 . . . . 0.0 107.921 179.509 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 184' ' ' CYS . . . . . . . . . . . . . 1.1 p -78.54 160.46 27.62 Favored 'General case' 0 C--N 1.288 -2.076 0 C-N-CA 119.441 -0.904 . . . . 0.0 110.996 -178.021 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 185' ' ' ASP . . . . . 0.53 ' CG ' ' N ' ' A' ' 186' ' ' ASP . 0.1 OUTLIER -166.93 -163.58 0.56 Allowed 'General case' 0 N--CA 1.49 1.53 0 N-CA-C 109.109 -0.7 . . . . 0.0 109.109 179.816 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 186' ' ' ASP . . . . . 0.53 ' N ' ' CG ' ' A' ' 185' ' ' ASP . 0.6 OUTLIER 55.95 54.3 8.2 Favored 'General case' 0 N--CA 1.496 1.828 0 O-C-N 121.126 -0.984 . . . . 0.0 109.476 -179.965 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 187' ' ' TYR . . . . . 0.596 ' CE1' ' O ' ' A' ' 188' ' ' ASN . 43.0 t80 -67.54 130.73 43.95 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.166 -0.959 . . . . 0.0 110.126 -179.829 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 188' ' ' ASN . . . . . 0.989 HD22 ' N ' ' A' ' 191' ' ' THR . 0.1 OUTLIER -99.94 150.54 22.3 Favored 'General case' 0 C--N 1.292 -1.907 0 N-CA-C 107.318 -1.364 . . . . 0.0 107.318 177.825 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 189' ' ' GLU . . . . . 0.706 ' H ' ' CD ' ' A' ' 189' ' ' GLU . 0.0 OUTLIER -112.18 -8.09 14.01 Favored 'General case' 0 C--N 1.289 -2.034 0 N-CA-C 107.968 -1.123 . . . . 0.0 107.968 -179.476 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 190' ' ' LYS . . . . . 0.877 ' H ' ' ND2' ' A' ' 188' ' ' ASN . 2.7 mtpm? -82.89 -56.91 3.54 Favored 'General case' 0 C--N 1.299 -1.618 0 C-N-CA 119.894 -0.722 . . . . 0.0 109.381 179.51 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 191' ' ' THR . . . . . 0.989 ' N ' HD22 ' A' ' 188' ' ' ASN . 4.7 p -88.44 6.5 37.29 Favored 'General case' 0 N--CA 1.493 1.682 0 O-C-N 121.399 -0.813 . . . . 0.0 110.04 -179.675 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 192' ' ' GLY . . . . . . . . . . . . . . . 53.92 35.82 54.38 Favored Glycine 0 N--CA 1.495 2.568 0 N-CA-C 110.664 -0.974 . . . . 0.0 110.664 179.129 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 193' ' ' VAL . . . . . 0.582 HG12 ' N ' ' A' ' 194' ' ' TRP . 58.8 t -149.5 163.58 4.08 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.588 0 O-C-N 120.95 -1.324 . . . . 0.0 109.962 179.708 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 194' ' ' TRP . . . . . 0.582 ' N ' HG12 ' A' ' 193' ' ' VAL . 16.1 m95 -84.97 121.17 27.38 Favored 'General case' 0 N--CA 1.49 1.534 0 N-CA-C 108.085 -1.08 . . . . 0.0 108.085 179.137 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 195' ' ' GLU . . . . . . . . . . . . . 2.6 mt-10 -79.69 -61.23 2.06 Favored 'General case' 0 N--CA 1.497 1.878 0 O-C-N 121.295 -0.878 . . . . 0.0 111.767 -177.667 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 196' ' ' LYS . . . . . . . . . . . . . 8.5 mmtm -93.29 145.38 24.49 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 120.777 -1.202 . . . . 0.0 110.296 -178.608 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 197' ' ' ARG . . . . . 0.599 ' CG ' HH11 ' A' ' 197' ' ' ARG . 0.0 OUTLIER -119.61 146.85 45.16 Favored 'General case' 0 N--CA 1.492 1.625 0 N-CA-C 108.711 -0.848 . . . . 0.0 108.711 179.806 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 198' ' ' LYS . . . . . 0.505 ' HZ1' ' CG ' ' A' ' 185' ' ' ASP . 0.5 OUTLIER -116.81 121.07 40.47 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.582 -0.699 . . . . 0.0 111.197 -178.212 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 199' ' ' ILE . . . . . 0.49 ' C ' HD12 ' A' ' 199' ' ' ILE . 0.8 OUTLIER -139.52 118.21 12.27 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.573 0 CA-C-O 122.515 1.15 . . . . 0.0 109.56 178.796 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 200' ' ' PHE . . . . . 0.763 ' CE2' HD22 ' A' ' 181' ' ' LEU . 0.3 OUTLIER -103.6 140.78 37.09 Favored 'General case' 0 N--CA 1.497 1.88 0 O-C-N 121.127 -0.983 . . . . 0.0 110.455 -178.074 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 201' ' ' VAL . . . . . . . . . . . . . 96.1 t -103.47 146.83 10.6 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.482 0 N-CA-C 108.255 -1.017 . . . . 0.0 108.255 177.352 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 202' ' ' ALA . . . . . . . . . . . . . . . -131.89 138.74 48.53 Favored 'General case' 0 C--N 1.3 -1.579 0 N-CA-C 108.34 -0.985 . . . . 0.0 108.34 -179.88 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 203' ' ' THR . . . . . 0.533 ' O ' HG23 ' A' ' 205' ' ' VAL . 3.2 p -89.1 130.77 35.49 Favored 'General case' 0 C--N 1.306 -1.315 0 CA-C-O 122.267 1.032 . . . . 0.0 111.213 -178.141 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 204' ' ' GLU . . . . . 0.499 ' HA ' ' CD2' ' A' ' 153' ' ' TYR . 0.2 OUTLIER -51.01 134.48 26.15 Favored 'General case' 0 C--N 1.297 -1.691 0 C-N-CA 119.076 -1.05 . . . . 0.0 109.043 179.346 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 205' ' ' VAL . . . . . 0.556 HG12 ' N ' ' A' ' 206' ' ' LYS . 53.3 t -125.03 164.06 24.55 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.369 0 CA-C-O 121.941 0.877 . . . . 0.0 110.433 -177.79 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 206' ' ' LYS . . . . . 0.556 ' N ' HG12 ' A' ' 205' ' ' VAL . 0.1 OUTLIER . . . . . 0 C--N 1.297 -1.693 0 CA-C-O 117.976 -1.011 . . . . 0.0 109.651 179.91 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' C' C ' 701' ' ' PHQ . . . . . 0.668 ' C1 ' HG22 ' A' ' 166' ' ' VAL . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 007 nuclear build full ' C' C ' 702' ' ' LEU . . . . . 0.607 HD11 ' N ' ' A' ' 164' ' ' THR . 0.0 OUTLIER . . . . . 0 N--CA 1.492 1.656 0 N-CA-C 108.941 -0.763 . . . . 0.0 108.941 . . . . . . . . . 2 2 . 1 . 007 nuclear build full ' C' C ' 703' ' ' PRO . . . . . 0.576 ' HG3' ' HB1' ' A' ' 104' ' ' ALA . 11.9 Cg_endo -61.7 -174.81 0.14 Allowed 'Trans proline' 0 N--CA 1.494 1.549 0 C-N-CA 122.609 2.206 . . . . 0.0 112.861 -179.083 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' C' C ' 704' ' ' ALA . . . . . 0.561 ' C ' ' NH2' ' A' ' 197' ' ' ARG . . . 54.23 175.3 0.02 OUTLIER 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.395 -0.816 . . . . 0.0 109.364 -179.662 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' C' C ' 705' ' ' B27 . . . . . 0.527 ' SG ' ' CD2' ' A' ' 120' ' ' HIS . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 700' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 008 nuclear build full ' A' A ' 59' ' ' MET . . . . . . . . . . . . . 1.5 mpt? . . . . . 0 N--CA 1.491 1.58 0 CA-C-O 121.385 0.612 . . . . 0.0 109.501 . . . . . . . . . 0 0 . 1 . 008 nuclear build full ' A' A ' 60' ' ' GLN . . . . . . . . . . . . . 4.4 tt0 -60.95 149.9 35.05 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.393 -0.817 . . . . 0.0 109.929 -179.856 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . -65.04 157.6 27.96 Favored 'General case' 0 N--CA 1.489 1.5 0 O-C-N 121.245 -0.91 . . . . 0.0 109.117 179.533 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 62' ' ' LYS . . . . . . . . . . . . . 3.5 tptm -139.0 75.19 35.67 Favored Pre-proline 0 N--CA 1.491 1.583 0 C-N-CA 119.533 -0.867 . . . . 0.0 109.651 -179.696 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 63' ' ' PRO . . . . . . . . . . . . . 72.9 Cg_endo -93.0 151.63 2.63 Favored 'Trans proline' 0 C--N 1.301 -1.921 0 C-N-CA 124.011 3.141 . . . . 0.0 110.684 179.386 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 64' ' ' GLN . . . . . 0.451 ' O ' ' OE1' ' A' ' 64' ' ' GLN . 0.0 OUTLIER -159.83 137.72 10.03 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 120.97 -1.081 . . . . 0.0 109.841 179.115 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 65' ' ' ILE . . . . . 0.46 HG23 ' HB3' ' A' ' 89' ' ' PRO . 3.2 mp -47.95 108.0 0.83 Allowed Pre-proline 0 N--CA 1.489 1.488 0 O-C-N 121.172 -0.955 . . . . 0.0 108.701 179.136 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 66' ' ' PRO . . . . . 0.4 ' HG3' ' NZ ' ' A' ' 71' ' ' LYS . 61.4 Cg_endo -81.52 -158.74 0.1 OUTLIER 'Trans proline' 0 C--N 1.314 -1.246 0 C-N-CA 122.026 1.818 . . . . 0.0 112.445 -179.432 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 67' ' ' LYS . . . . . . . . . . . . . 3.4 pttm -90.18 -13.24 35.99 Favored 'General case' 0 N--CA 1.488 1.457 0 O-C-N 121.323 -0.861 . . . . 0.0 109.366 -179.975 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 68' ' ' ASP . . . . . 0.653 ' C ' ' N ' ' A' ' 70' ' ' SER . 0.5 OUTLIER -76.76 64.27 2.31 Favored 'General case' 0 N--CA 1.488 1.456 0 CA-C-O 122.656 1.217 . . . . 0.0 109.548 -179.885 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 69' ' ' LYS . . . . . 0.457 ' C ' ' O ' ' A' ' 68' ' ' ASP . 12.1 ptpt -47.48 -13.01 0.03 OUTLIER 'General case' 0 N--CA 1.512 2.655 0 C-N-CA 117.039 -1.864 . . . . 0.0 106.66 177.03 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 70' ' ' SER . . . . . 0.653 ' N ' ' C ' ' A' ' 68' ' ' ASP . 1.3 p -85.22 -7.06 59.21 Favored 'General case' 0 N--CA 1.497 1.883 0 CA-C-N 113.259 -1.791 . . . . 0.0 111.151 179.337 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 71' ' ' LYS . . . . . 0.519 ' N ' ' O ' ' A' ' 68' ' ' ASP . 0.0 OUTLIER -98.76 145.66 26.7 Favored 'General case' 0 N--CA 1.501 2.107 0 O-C-N 120.671 -1.268 . . . . 0.0 112.329 -179.141 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 72' ' ' VAL . . . . . 0.716 HG12 ' CE1' ' A' ' 88' ' ' TYR . 3.0 m -68.02 130.06 32.97 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.384 0 N-CA-C 105.227 -2.138 . . . . 0.0 105.227 175.235 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 73' ' ' ALA . . . . . 0.57 ' N ' ' O ' ' A' ' 87' ' ' VAL . . . -78.92 -15.17 58.67 Favored 'General case' 0 C--N 1.293 -1.858 0 O-C-N 120.16 -1.588 . . . . 0.0 107.623 -179.404 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 74' ' ' GLY . . . . . 0.418 ' O ' ' N ' ' A' ' 87' ' ' VAL . . . 176.04 -159.74 27.3 Favored Glycine 0 N--CA 1.48 1.592 0 N-CA-C 109.712 -1.355 . . . . 0.0 109.712 179.73 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 75' ' ' TYR . . . . . 0.624 ' HA ' HG23 ' A' ' 87' ' ' VAL . 0.6 OUTLIER -142.97 166.86 23.49 Favored 'General case' 0 C--N 1.295 -1.772 0 O-C-N 121.713 -0.875 . . . . 0.0 110.834 -177.221 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 76' ' ' ILE . . . . . . . . . . . . . 1.5 tt -149.86 146.98 16.58 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.517 0 C-N-CA 119.2 -1.0 . . . . 0.0 109.833 -178.528 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -150.96 164.78 35.55 Favored 'General case' 0 N--CA 1.489 1.495 0 N-CA-C 108.689 -0.856 . . . . 0.0 108.689 179.594 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 78' ' ' ILE . . . . . 0.607 ' HB ' ' HB3' ' A' ' 81' ' ' ALA . 14.9 mt -146.89 95.87 4.42 Favored Pre-proline 0 C--N 1.3 -1.562 0 N-CA-C 108.392 -0.966 . . . . 0.0 108.392 179.997 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 79' ' ' PRO . . . . . . . . . . . . . 73.5 Cg_exo -46.93 -46.45 18.59 Favored 'Trans proline' 0 N--CA 1.493 1.447 0 C-N-CA 122.865 2.377 . . . . 0.0 113.897 -178.503 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 4.0 t0 -65.38 -20.04 66.21 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 120.749 -1.219 . . . . 0.0 110.423 178.622 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 81' ' ' ALA . . . . . 0.817 ' HB2' ' HB2' ' A' ' 136' ' ' ALA . . . -104.35 -12.58 16.51 Favored 'General case' 0 N--CA 1.493 1.676 0 O-C-N 121.308 -0.87 . . . . 0.0 109.227 179.739 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 82' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER 62.4 48.82 4.43 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.332 -0.855 . . . . 0.0 110.154 179.574 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 83' ' ' ILE . . . . . . . . . . . . . 69.9 mt -129.08 151.84 36.35 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.801 0 O-C-N 121.142 -0.974 . . . . 0.0 110.408 -178.862 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 84' ' ' LYS . . . . . 0.458 ' O ' ' CD ' ' A' ' 85' ' ' GLU . 27.7 tttt -158.86 108.74 1.99 Allowed 'General case' 0 N--CA 1.49 1.545 0 N-CA-C 108.192 -1.04 . . . . 0.0 108.192 179.778 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 85' ' ' GLU . . . . . 0.595 ' O ' ' CD2' ' A' ' 75' ' ' TYR . 7.4 mm-40 -139.64 176.41 2.59 Favored Pre-proline 0 N--CA 1.496 1.859 0 O-C-N 121.457 -0.777 . . . . 0.0 109.899 -178.998 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 86' ' ' PRO . . . . . 0.419 ' O ' HG22 ' A' ' 101' ' ' VAL . 12.3 Cg_endo -85.86 169.68 8.98 Favored 'Trans proline' 0 N--CA 1.491 1.342 0 C-N-CA 123.15 2.566 . . . . 0.0 113.55 -178.75 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 87' ' ' VAL . . . . . 0.624 HG23 ' HA ' ' A' ' 75' ' ' TYR . 45.8 t -124.35 99.38 6.25 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.85 0 O-C-N 121.616 -0.677 . . . . 0.0 109.42 179.497 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 88' ' ' TYR . . . . . 0.716 ' CE1' HG12 ' A' ' 72' ' ' VAL . 26.1 m-85 -90.08 155.52 47.08 Favored Pre-proline 0 N--CA 1.506 2.345 0 O-C-N 120.861 -1.149 . . . . 0.0 109.716 -179.806 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 89' ' ' PRO . . . . . 0.578 ' O ' ' NE2' ' A' ' 96' ' ' GLN . 18.3 Cg_endo -65.62 145.46 81.81 Favored 'Trans proline' 0 N--CA 1.494 1.522 0 C-N-CA 122.486 2.124 . . . . 0.0 113.946 -179.587 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . -53.1 166.5 1.41 Allowed Glycine 0 N--CA 1.49 2.261 0 N-CA-C 109.369 -1.492 . . . . 0.0 109.369 179.167 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 91' ' ' PRO . . . . . 0.432 ' C ' ' H ' ' A' ' 93' ' ' THR . 57.8 Cg_endo -93.72 167.47 20.81 Favored 'Cis proline' 0 C--N 1.308 -1.589 0 C-N-CA 123.756 -1.352 . . . . 0.0 111.583 0.14 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 92' ' ' ALA . . . . . 0.473 ' O ' HD23 ' A' ' 97' ' ' LEU . . . -73.32 31.07 0.07 Allowed 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.104 -0.997 . . . . 0.0 110.495 -179.781 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 93' ' ' THR . . . . . 0.432 ' H ' ' C ' ' A' ' 91' ' ' PRO . 1.4 p -73.16 153.01 90.57 Favored Pre-proline 0 N--CA 1.49 1.534 0 O-C-N 120.725 -1.234 . . . . 0.0 109.288 -179.65 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 94' ' ' PRO . . . . . . . . . . . . . 89.8 Cg_exo -33.22 -56.83 0.35 Allowed 'Trans proline' 0 C--N 1.311 -1.431 0 C-N-CA 122.982 2.454 . . . . 0.0 112.299 -179.686 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 41.1 mt-10 -46.5 -48.33 19.24 Favored 'General case' 0 N--CA 1.488 1.444 0 O-C-N 121.171 -0.955 . . . . 0.0 108.874 179.813 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 96' ' ' GLN . . . . . 0.578 ' NE2' ' O ' ' A' ' 89' ' ' PRO . 3.4 mm-40 -72.29 -54.95 8.04 Favored 'General case' 0 C--N 1.305 -1.333 0 O-C-N 121.192 -0.942 . . . . 0.0 109.712 179.767 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 97' ' ' LEU . . . . . 0.703 HD11 ' HA2' ' A' ' 119' ' ' GLY . 0.5 OUTLIER -48.33 -8.01 0.02 OUTLIER 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.254 -0.904 . . . . 0.0 109.926 -179.593 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 98' ' ' ASN . . . . . 0.585 ' C ' ' ND2' ' A' ' 98' ' ' ASN . 0.0 OUTLIER -74.41 -24.45 59.11 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.163 -0.961 . . . . 0.0 109.162 179.672 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 99' ' ' ARG . . . . . 0.416 ' HD2' ' CD2' ' A' ' 88' ' ' TYR . 4.2 mtt180 -95.2 -53.65 3.71 Favored 'General case' 0 C--N 1.3 -1.561 0 O-C-N 121.659 -0.651 . . . . 0.0 110.294 -178.813 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . 177.52 -159.7 25.9 Favored Glycine 0 N--CA 1.492 2.402 0 C-N-CA 119.366 -1.397 . . . . 0.0 110.167 179.807 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 101' ' ' VAL . . . . . 0.785 HG23 ' O ' ' A' ' 101' ' ' VAL . 25.0 m -62.03 100.07 0.15 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.629 0 O-C-N 121.523 -0.986 . . . . 0.0 109.296 -179.911 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 102' ' ' SER . . . . . 0.458 ' OG ' ' OE1' ' A' ' 96' ' ' GLN . 1.6 m -93.35 159.9 15.06 Favored 'General case' 0 C--N 1.298 -1.644 0 O-C-N 121.2 -0.938 . . . . 0.0 110.156 -179.963 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 103' ' ' PHE . . . . . . . . . . . . . 21.2 m-85 -59.63 160.72 6.88 Favored 'General case' 0 N--CA 1.49 1.57 0 N-CA-C 107.869 -1.16 . . . . 0.0 107.869 178.671 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 104' ' ' ALA . . . . . . . . . . . . . . . -72.33 -28.16 62.88 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.211 -0.93 . . . . 0.0 111.814 -177.932 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -135.25 150.45 50.06 Favored 'General case' 0 N--CA 1.495 1.819 0 O-C-N 120.822 -1.174 . . . . 0.0 111.023 -178.518 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 106' ' ' GLU . . . . . . . . . . . . . 1.3 pt-20 -54.15 -63.33 1.18 Allowed 'General case' 0 N--CA 1.487 1.402 0 CA-C-N 115.999 -0.546 . . . . 0.0 111.293 -179.256 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 107' ' ' ASN . . . . . . . . . . . . . 15.8 m120 -75.84 32.46 0.11 Allowed 'General case' 0 N--CA 1.49 1.543 0 O-C-N 120.175 -1.578 . . . . 0.0 112.621 -175.398 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 108' ' ' GLU . . . . . . . . . . . . . 44.6 tp10 -60.48 148.55 37.26 Favored 'General case' 0 C--N 1.299 -1.597 0 C-N-CA 118.865 -1.134 . . . . 0.0 108.008 -179.684 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 109' ' ' SER . . . . . 0.536 ' C ' ' H ' ' A' ' 111' ' ' ASP . 1.3 t -96.57 121.62 38.59 Favored 'General case' 0 C--N 1.302 -1.49 0 O-C-N 121.039 -1.038 . . . . 0.0 109.683 -178.77 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 110' ' ' LEU . . . . . . . . . . . . . 12.7 tp -59.19 -1.57 0.2 Allowed 'General case' 0 C--N 1.302 -1.479 0 N-CA-C 108.54 -0.911 . . . . 0.0 108.54 -179.912 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 111' ' ' ASP . . . . . 0.536 ' H ' ' C ' ' A' ' 109' ' ' SER . 8.7 m-20 -131.77 20.58 4.62 Favored 'General case' 0 N--CA 1.487 1.406 0 N-CA-C 108.927 -0.768 . . . . 0.0 108.927 179.36 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 112' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -65.47 133.82 52.1 Favored 'General case' 0 N--CA 1.49 1.525 0 O-C-N 121.348 -0.845 . . . . 0.0 109.944 -179.958 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 113' ' ' GLN . . . . . 0.594 ' NE2' ' O ' ' A' ' 173' ' ' LYS . 0.0 OUTLIER -65.46 -4.33 5.62 Favored 'General case' 0 C--N 1.303 -1.436 0 O-C-N 121.058 -1.026 . . . . 0.0 108.869 179.032 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 114' ' ' ASN . . . . . 0.647 ' C ' HD21 ' A' ' 114' ' ' ASN . 0.2 OUTLIER -143.38 91.19 2.24 Favored 'General case' 0 C--N 1.301 -1.517 0 N-CA-C 107.559 -1.274 . . . . 0.0 107.559 178.409 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 115' ' ' ILE . . . . . 0.439 ' O ' HG22 ' A' ' 115' ' ' ILE . 3.3 mt -100.69 115.14 41.61 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.466 0 O-C-N 121.627 -0.671 . . . . 0.0 109.913 -178.913 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 116' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -101.82 145.53 29.05 Favored 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.345 -0.847 . . . . 0.0 110.93 -179.149 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 117' ' ' ILE . . . . . . . . . . . . . 1.2 mt -135.15 157.38 40.37 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.461 0 N-CA-C 108.101 -1.074 . . . . 0.0 108.101 179.521 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 118' ' ' ALA . . . . . . . . . . . . . . . -142.62 161.82 37.08 Favored 'General case' 0 N--CA 1.492 1.658 0 O-C-N 120.822 -1.174 . . . . 0.0 111.177 -179.611 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 119' ' ' GLY . . . . . 0.703 ' HA2' HD11 ' A' ' 97' ' ' LEU . . . -170.29 143.54 7.87 Favored Glycine 0 N--CA 1.49 2.249 0 C-N-CA 120.191 -1.004 . . . . 0.0 110.755 179.801 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 120' ' ' HIS . . . . . . . . . . . . . 29.9 m170 -71.16 167.86 18.44 Favored 'General case' 0 N--CA 1.493 1.693 0 O-C-N 121.674 -0.898 . . . . 0.0 109.514 179.024 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 121' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -118.29 159.57 23.14 Favored 'General case' 0 N--CA 1.496 1.863 0 O-C-N 121.211 -0.931 . . . . 0.0 108.84 179.449 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 122' ' ' PHE . . . . . . . . . . . . . 0.5 OUTLIER -143.68 127.97 17.77 Favored 'General case' 0 N--CA 1.497 1.918 0 O-C-N 120.935 -1.103 . . . . 0.0 109.705 -179.623 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 123' ' ' ILE . . . . . 0.511 HG23 ' N ' ' A' ' 124' ' ' ASP . 4.4 tt -64.66 -40.11 87.92 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.55 0 N-CA-C 108.982 -0.748 . . . . 0.0 108.982 179.858 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 124' ' ' ASP . . . . . 0.511 ' N ' HG23 ' A' ' 123' ' ' ILE . 70.3 m-20 -89.11 26.08 1.69 Allowed 'General case' 0 N--CA 1.496 1.829 0 O-C-N 121.563 -0.711 . . . . 0.0 112.253 -177.358 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 125' ' ' ARG . . . . . 0.684 HH11 ' CG ' ' A' ' 125' ' ' ARG . 1.8 mtt-85 -154.29 100.77 2.45 Favored Pre-proline 0 N--CA 1.496 1.826 0 O-C-N 120.754 -1.216 . . . . 0.0 109.692 179.781 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 126' ' ' PRO . . . . . . . . . . . . . 73.1 Cg_endo -80.69 -28.08 2.9 Favored 'Trans proline' 0 C--N 1.315 -1.195 0 C-N-CA 122.107 1.871 . . . . 0.0 112.546 -179.934 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 127' ' ' ASN . . . . . 0.427 ' O ' ' O ' ' A' ' 128' ' ' TYR . 1.6 m120 -91.61 7.5 41.19 Favored 'General case' 0 N--CA 1.489 1.478 0 O-C-N 121.089 -1.007 . . . . 0.0 109.715 -179.864 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 128' ' ' TYR . . . . . 0.687 ' CE2' ' NE2' ' A' ' 129' ' ' GLN . 4.6 t80 -60.48 -151.25 0.0 OUTLIER 'General case' 0 C--N 1.301 -1.529 0 O-C-N 121.258 -0.901 . . . . 0.0 109.84 -179.733 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 129' ' ' GLN . . . . . 0.687 ' NE2' ' CE2' ' A' ' 128' ' ' TYR . 2.6 mp0 -67.78 -71.57 0.2 Allowed 'General case' 0 N--CA 1.489 1.478 0 O-C-N 121.341 -0.849 . . . . 0.0 110.051 -179.482 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 130' ' ' PHE . . . . . 0.503 ' CE2' HG11 ' A' ' 101' ' ' VAL . 55.4 m-85 -135.44 50.82 2.1 Favored 'General case' 0 N--CA 1.492 1.673 0 O-C-N 121.193 -0.942 . . . . 0.0 110.473 -179.371 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 131' ' ' THR . . . . . . . . . . . . . 2.9 m -82.13 -38.77 24.26 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.031 -1.043 . . . . 0.0 108.81 179.067 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 132' ' ' ASN . . . . . . . . . . . . . 4.8 t30 -84.34 6.42 23.12 Favored 'General case' 0 N--CA 1.494 1.731 0 C-N-CA 120.083 -0.647 . . . . 0.0 111.121 -178.91 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 133' ' ' LEU . . . . . 0.598 ' O ' ' N ' ' A' ' 135' ' ' ALA . 0.2 OUTLIER -68.5 -47.75 66.18 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 120.906 -1.121 . . . . 0.0 110.69 -179.04 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 134' ' ' LYS . . . . . 0.625 ' H ' ' CD ' ' A' ' 134' ' ' LYS . 0.1 OUTLIER -42.15 -18.48 0.01 OUTLIER 'General case' 0 N--CA 1.494 1.747 0 O-C-N 121.098 -1.001 . . . . 0.0 109.949 -179.025 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 135' ' ' ALA . . . . . 0.598 ' N ' ' O ' ' A' ' 133' ' ' LEU . . . -83.87 -31.82 25.53 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.063 -1.023 . . . . 0.0 109.94 -179.946 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 136' ' ' ALA . . . . . 0.817 ' HB2' ' HB2' ' A' ' 81' ' ' ALA . . . -80.78 153.99 27.45 Favored 'General case' 0 N--CA 1.489 1.518 0 CA-C-O 122.163 0.982 . . . . 0.0 112.142 -178.366 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 137' ' ' LYS . . . . . 0.524 ' O ' ' O ' ' A' ' 138' ' ' LYS . 4.8 tttt -150.92 -166.93 2.67 Favored 'General case' 0 N--CA 1.493 1.717 0 C-N-CA 118.926 -1.11 . . . . 0.0 110.879 -178.197 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 138' ' ' LYS . . . . . 0.592 ' O ' ' N ' ' A' ' 140' ' ' SER . 36.3 mttm -44.45 178.72 0.0 OUTLIER 'General case' 0 N--CA 1.487 1.378 0 CA-C-O 122.221 1.01 . . . . 0.0 110.971 -178.755 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 139' ' ' GLY . . . . . . . . . . . . . . . 46.6 7.59 0.02 OUTLIER Glycine 0 N--CA 1.491 2.351 0 N-CA-C 110.545 -1.022 . . . . 0.0 110.545 -179.959 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 140' ' ' SER . . . . . 0.592 ' N ' ' O ' ' A' ' 138' ' ' LYS . 48.7 m -84.77 121.57 27.88 Favored 'General case' 0 N--CA 1.495 1.785 0 O-C-N 120.809 -1.406 . . . . 0.0 109.215 179.244 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 141' ' ' MET . . . . . 0.646 ' SD ' ' N ' ' A' ' 142' ' ' VAL . 10.8 tpp -72.47 131.76 42.98 Favored 'General case' 0 N--CA 1.488 1.462 0 O-C-N 121.125 -0.984 . . . . 0.0 109.223 179.898 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 142' ' ' VAL . . . . . 0.646 ' N ' ' SD ' ' A' ' 141' ' ' MET . 3.2 t -116.02 133.13 63.46 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.702 0 N-CA-C 108.794 -0.817 . . . . 0.0 108.794 -179.593 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 143' ' ' TYR . . . . . . . . . . . . . 17.9 m-85 -109.23 135.28 50.59 Favored 'General case' 0 N--CA 1.497 1.92 0 O-C-N 120.89 -1.132 . . . . 0.0 111.531 -178.434 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 144' ' ' PHE . . . . . . . . . . . . . 49.1 t80 -120.25 101.86 8.1 Favored 'General case' 0 N--CA 1.495 1.793 0 C-N-CA 120.359 -0.536 . . . . 0.0 109.566 -179.432 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 145' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -96.65 132.1 42.64 Favored 'General case' 0 N--CA 1.493 1.708 0 O-C-N 121.205 -0.935 . . . . 0.0 110.878 -178.822 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 146' ' ' VAL . . . . . 0.414 ' O ' ' C ' ' A' ' 147' ' ' GLY . 0.1 OUTLIER -142.96 143.78 24.79 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.738 0 N-CA-C 107.764 -1.199 . . . . 0.0 107.764 178.655 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 147' ' ' GLY . . . . . 0.414 ' C ' ' O ' ' A' ' 146' ' ' VAL . . . 44.37 -130.77 7.25 Favored Glycine 0 N--CA 1.489 2.221 0 O-C-N 120.28 -1.512 . . . . 0.0 109.324 -179.958 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 148' ' ' ASN . . . . . . . . . . . . . 24.4 p30 -102.86 18.49 21.4 Favored 'General case' 0 C--N 1.3 -1.572 0 O-C-N 121.374 -1.074 . . . . 0.0 108.588 179.537 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 149' ' ' GLU . . . . . . . . . . . . . 8.4 tt0 -114.38 147.94 38.41 Favored 'General case' 0 N--CA 1.489 1.523 0 CA-C-O 121.862 0.839 . . . . 0.0 111.249 -178.538 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 150' ' ' THR . . . . . 0.487 ' O ' HG22 ' A' ' 150' ' ' THR . 1.2 m -129.24 105.68 8.31 Favored 'General case' 0 N--CA 1.492 1.646 0 CA-C-O 121.585 0.707 . . . . 0.0 109.675 179.941 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 151' ' ' ARG . . . . . . . . . . . . . 10.8 mtp180 -87.34 -171.6 3.55 Favored 'General case' 0 N--CA 1.487 1.401 0 N-CA-C 108.624 -0.88 . . . . 0.0 108.624 -179.967 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 152' ' ' LYS . . . . . . . . . . . . . 1.1 ttmt -150.41 147.36 27.46 Favored 'General case' 0 C--N 1.303 -1.442 0 O-C-N 120.918 -1.114 . . . . 0.0 110.787 -179.299 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 153' ' ' TYR . . . . . 0.562 ' O ' ' SD ' ' A' ' 141' ' ' MET . 22.2 m-85 -142.2 165.6 26.98 Favored 'General case' 0 N--CA 1.49 1.574 0 N-CA-C 108.024 -1.102 . . . . 0.0 108.024 179.24 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 154' ' ' LYS . . . . . . . . . . . . . 30.9 ttpt -142.91 121.02 12.15 Favored 'General case' 0 N--CA 1.493 1.684 0 O-C-N 121.061 -1.025 . . . . 0.0 108.666 178.854 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 155' ' ' MET . . . . . . . . . . . . . 4.1 mtt -47.1 105.9 0.08 Allowed 'General case' 0 N--CA 1.493 1.687 0 O-C-N 120.889 -1.132 . . . . 0.0 112.017 -178.419 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 156' ' ' THR . . . . . 0.657 ' OG1' HG23 ' A' ' 203' ' ' THR . 0.0 OUTLIER -107.46 -23.38 12.21 Favored 'General case' 0 C--N 1.293 -1.886 0 CA-C-N 115.16 -0.927 . . . . 0.0 110.112 -179.572 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 157' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -153.16 150.43 29.06 Favored 'General case' 0 C--N 1.296 -1.728 0 C-N-CA 118.388 -1.325 . . . . 0.0 111.363 -178.797 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 158' ' ' ILE . . . . . 0.432 HG13 ' CD2' ' A' ' 200' ' ' PHE . 0.0 OUTLIER -154.18 145.12 14.08 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.357 0 CA-C-O 121.872 0.844 . . . . 0.0 110.055 -179.276 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 159' ' ' ARG . . . . . 0.424 ' N ' HG12 ' A' ' 158' ' ' ILE . 0.1 OUTLIER -151.38 156.6 41.04 Favored 'General case' 0 C--N 1.3 -1.568 0 CA-C-O 121.52 0.676 . . . . 0.0 109.747 -179.792 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 160' ' ' ASP . . . . . 0.5 ' C ' HG22 ' A' ' 161' ' ' VAL . 2.2 m-20 -117.62 157.08 27.04 Favored 'General case' 0 N--CA 1.49 1.563 0 N-CA-C 108.781 -0.822 . . . . 0.0 108.781 -179.909 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 161' ' ' VAL . . . . . 0.5 HG22 ' C ' ' A' ' 160' ' ' ASP . 0.1 OUTLIER -163.43 160.24 1.29 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.654 0 O-C-N 121.072 -1.017 . . . . 0.0 110.49 -179.912 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 162' ' ' LYS . . . . . . . . . . . . . 14.1 ptmt -52.13 177.88 0.06 OUTLIER Pre-proline 0 N--CA 1.49 1.562 0 N-CA-C 108.694 -0.854 . . . . 0.0 108.694 179.043 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 163' ' ' PRO . . . . . 0.721 ' C ' HD11 ' C' ' 702' ' ' LEU . 37.3 Cg_endo -86.63 43.39 1.03 Allowed 'Trans proline' 0 C--N 1.316 -1.18 0 C-N-CA 122.238 1.959 . . . . 0.0 112.502 -179.344 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 164' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -151.93 -11.21 0.2 Allowed 'General case' 0 N--CA 1.494 1.741 0 O-C-N 121.262 -0.899 . . . . 0.0 110.372 -179.972 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 165' ' ' ASP . . . . . 0.449 ' O ' ' C ' ' A' ' 166' ' ' VAL . 1.2 t70 -73.21 61.93 0.65 Allowed 'General case' 0 N--CA 1.49 1.558 0 O-C-N 120.867 -1.146 . . . . 0.0 110.258 -179.301 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 166' ' ' VAL . . . . . 0.623 ' O ' ' N ' ' A' ' 168' ' ' VAL . 0.9 OUTLIER -41.89 -31.42 0.35 Allowed 'Isoleucine or valine' 0 N--CA 1.494 1.73 0 O-C-N 121.399 -0.813 . . . . 0.0 109.023 -178.329 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 167' ' ' GLY . . . . . . . . . . . . . . . -42.65 -13.38 0.01 OUTLIER Glycine 0 N--CA 1.494 2.546 0 O-C-N 121.06 -1.025 . . . . 0.0 110.742 179.892 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 168' ' ' VAL . . . . . 0.623 ' N ' ' O ' ' A' ' 166' ' ' VAL . 6.1 m -53.46 -35.64 25.67 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.468 0 O-C-N 120.708 -1.466 . . . . 0.0 108.738 179.62 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 169' ' ' LEU . . . . . 0.522 ' O ' ' N ' ' A' ' 171' ' ' GLU . 27.8 mt -51.86 -7.19 0.05 OUTLIER 'General case' 0 N--CA 1.495 1.805 0 N-CA-C 108.004 -1.11 . . . . 0.0 108.004 -179.272 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 170' ' ' ASP . . . . . 0.593 ' H ' ' C ' ' A' ' 168' ' ' VAL . 34.4 t0 35.16 28.58 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.525 0 O-C-N 121.764 -0.585 . . . . 0.0 111.87 177.687 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 171' ' ' GLU . . . . . 0.522 ' N ' ' O ' ' A' ' 169' ' ' LEU . 12.7 pt-20 -62.3 94.26 0.06 Allowed 'General case' 0 N--CA 1.494 1.767 0 O-C-N 120.382 -1.449 . . . . 0.0 107.45 178.105 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 172' ' ' GLN . . . . . . . . . . . . . 2.2 mt-30 -152.66 -78.16 0.11 Allowed 'General case' 0 N--CA 1.497 1.877 0 O-C-N 121.434 -0.791 . . . . 0.0 110.548 -178.595 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 173' ' ' LYS . . . . . 0.594 ' O ' ' NE2' ' A' ' 113' ' ' GLN . 1.0 OUTLIER -55.95 136.52 51.77 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.43 -0.794 . . . . 0.0 109.386 -179.432 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 174' ' ' GLY . . . . . 0.477 ' O ' ' C ' ' A' ' 175' ' ' LYS . . . -120.03 -45.78 0.4 Allowed Glycine 0 N--CA 1.479 1.527 0 N-CA-C 107.441 -2.263 . . . . 0.0 107.441 179.239 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 175' ' ' LYS . . . . . 0.477 ' C ' ' O ' ' A' ' 174' ' ' GLY . 0.4 OUTLIER -38.13 -75.44 0.03 OUTLIER 'General case' 0 N--CA 1.493 1.724 0 N-CA-C 108.272 -1.011 . . . . 0.0 108.272 179.562 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 176' ' ' ASP . . . . . 0.547 ' O ' ' O ' ' A' ' 177' ' ' LYS . 66.7 m-20 -89.97 94.7 9.9 Favored 'General case' 0 C--N 1.296 -1.754 0 N-CA-C 106.967 -1.494 . . . . 0.0 106.967 177.943 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 177' ' ' LYS . . . . . 0.547 ' O ' ' O ' ' A' ' 176' ' ' ASP . 19.6 mttp -44.19 -178.4 0.0 OUTLIER 'General case' 0 N--CA 1.493 1.687 0 CA-C-O 121.487 0.66 . . . . 0.0 110.795 -178.311 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 178' ' ' GLN . . . . . 0.456 HE22 ' HD2' ' A' ' 173' ' ' LYS . 6.8 pt20 -161.06 161.38 31.29 Favored 'General case' 0 N--CA 1.487 1.386 0 C-N-CA 118.557 -1.257 . . . . 0.0 111.089 179.86 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 179' ' ' LEU . . . . . . . . . . . . . 1.2 tp -123.6 94.34 4.21 Favored 'General case' 0 C--N 1.303 -1.445 0 N-CA-C 106.944 -1.502 . . . . 0.0 106.944 177.398 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 180' ' ' THR . . . . . . . . . . . . . 3.3 m -71.64 120.32 17.06 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.111 -0.993 . . . . 0.0 110.427 -178.097 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 181' ' ' LEU . . . . . 0.466 HD21 ' HG ' ' A' ' 133' ' ' LEU . 34.4 tp -95.98 142.6 28.01 Favored 'General case' 0 C--N 1.302 -1.498 0 N-CA-C 108.153 -1.054 . . . . 0.0 108.153 178.338 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 182' ' ' ILE . . . . . 0.487 HG22 ' O ' ' A' ' 182' ' ' ILE . 3.9 mt -136.39 109.69 8.83 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.612 0 O-C-N 121.02 -1.05 . . . . 0.0 108.689 178.9 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 183' ' ' THR . . . . . 0.548 ' O ' HG23 ' A' ' 183' ' ' THR . 4.4 t -129.76 113.06 14.25 Favored 'General case' 0 C--N 1.293 -1.881 0 N-CA-C 107.337 -1.357 . . . . 0.0 107.337 179.327 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 184' ' ' CYS . . . . . . . . . . . . . 0.8 OUTLIER -79.23 164.03 24.49 Favored 'General case' 0 C--N 1.289 -2.026 0 C-N-CA 118.994 -1.082 . . . . 0.0 111.145 -177.691 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 185' ' ' ASP . . . . . . . . . . . . . 9.9 t0 -165.2 -154.33 0.21 Allowed 'General case' 0 N--CA 1.493 1.687 0 N-CA-C 108.892 -0.781 . . . . 0.0 108.892 -179.829 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 186' ' ' ASP . . . . . . . . . . . . . 1.5 m-20 49.43 59.28 4.6 Favored 'General case' 0 N--CA 1.495 1.802 0 O-C-N 120.95 -1.094 . . . . 0.0 108.971 -179.666 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 187' ' ' TYR . . . . . 0.607 ' CE2' ' O ' ' A' ' 188' ' ' ASN . 68.2 t80 -67.4 138.76 56.94 Favored 'General case' 0 N--CA 1.491 1.579 0 CA-C-O 121.85 0.833 . . . . 0.0 110.871 -179.184 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 188' ' ' ASN . . . . . 0.607 ' O ' ' CE2' ' A' ' 187' ' ' TYR . 0.7 OUTLIER -104.32 143.72 32.59 Favored 'General case' 0 C--N 1.299 -1.589 0 N-CA-C 108.305 -0.998 . . . . 0.0 108.305 178.391 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 189' ' ' GLU . . . . . . . . . . . . . 2.5 tt0 -108.22 -17.05 14.11 Favored 'General case' 0 C--N 1.293 -1.891 0 N-CA-C 108.879 -0.786 . . . . 0.0 108.879 -179.284 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 190' ' ' LYS . . . . . . . . . . . . . 24.4 mmtm -82.77 -51.64 7.49 Favored 'General case' 0 C--N 1.301 -1.541 0 C-N-CA 119.792 -0.763 . . . . 0.0 108.96 179.154 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 191' ' ' THR . . . . . . . . . . . . . 4.1 p -89.83 -10.91 43.64 Favored 'General case' 0 N--CA 1.489 1.477 0 O-C-N 121.442 -0.786 . . . . 0.0 109.802 -179.608 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 192' ' ' GLY . . . . . . . . . . . . . . . 63.73 39.32 97.36 Favored Glycine 0 N--CA 1.494 2.537 0 O-C-N 120.945 -1.097 . . . . 0.0 110.375 179.25 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 193' ' ' VAL . . . . . 0.591 HG12 ' N ' ' A' ' 194' ' ' TRP . 55.4 t -147.99 163.45 6.19 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.571 0 O-C-N 121.114 -1.227 . . . . 0.0 109.679 179.959 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 194' ' ' TRP . . . . . 0.591 ' N ' HG12 ' A' ' 193' ' ' VAL . 10.0 m95 -82.29 118.81 23.41 Favored 'General case' 0 C--N 1.301 -1.524 0 N-CA-C 108.356 -0.979 . . . . 0.0 108.356 179.613 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 195' ' ' GLU . . . . . 0.545 ' CD ' ' ND2' ' A' ' 188' ' ' ASN . 2.8 mt-10 -79.2 -60.82 2.22 Favored 'General case' 0 N--CA 1.493 1.692 0 O-C-N 121.32 -0.863 . . . . 0.0 110.946 -178.528 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 196' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -95.29 152.82 18.04 Favored 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.197 -0.939 . . . . 0.0 110.121 -178.789 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 197' ' ' ARG . . . . . 0.672 ' HE ' HD22 ' C' ' 702' ' ' LEU . 0.1 OUTLIER -122.94 143.18 50.07 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.668 -0.645 . . . . 0.0 109.723 179.86 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 198' ' ' LYS . . . . . . . . . . . . . 4.2 mptp? -113.77 120.72 41.75 Favored 'General case' 0 C--N 1.302 -1.487 0 O-C-N 121.7 -0.625 . . . . 0.0 109.56 -179.68 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 199' ' ' ILE . . . . . 0.662 ' C ' HD12 ' A' ' 199' ' ' ILE . 0.5 OUTLIER -139.66 118.41 12.13 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.677 0 CA-C-O 122.502 1.144 . . . . 0.0 109.829 179.926 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 200' ' ' PHE . . . . . 0.527 ' CD1' ' N ' ' A' ' 200' ' ' PHE . 6.6 m-85 -100.57 138.5 37.54 Favored 'General case' 0 N--CA 1.494 1.728 0 O-C-N 121.353 -0.842 . . . . 0.0 109.912 -178.626 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 201' ' ' VAL . . . . . . . . . . . . . 44.6 t -101.61 136.34 33.97 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.543 0 N-CA-C 107.795 -1.187 . . . . 0.0 107.795 177.662 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 202' ' ' ALA . . . . . . . . . . . . . . . -121.16 134.59 55.23 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.238 -0.914 . . . . 0.0 109.171 -179.939 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 203' ' ' THR . . . . . 0.657 HG23 ' OG1' ' A' ' 156' ' ' THR . 13.7 p -88.76 133.34 34.27 Favored 'General case' 0 C--N 1.306 -1.316 0 CA-C-O 122.158 0.98 . . . . 0.0 110.99 -178.72 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 204' ' ' GLU . . . . . 0.523 ' HA ' ' CD2' ' A' ' 153' ' ' TYR . 3.1 tt0 -51.72 133.84 30.87 Favored 'General case' 0 C--N 1.297 -1.686 0 C-N-CA 118.811 -1.155 . . . . 0.0 109.38 179.394 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 205' ' ' VAL . . . . . 0.545 HG23 ' O ' ' A' ' 203' ' ' THR . 44.3 t -127.53 161.66 34.64 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.295 0 CA-C-O 122.044 0.926 . . . . 0.0 110.242 -177.59 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 206' ' ' LYS . . . . . 0.497 ' N ' HG12 ' A' ' 205' ' ' VAL . 70.7 mttt . . . . . 0 C--N 1.296 -1.731 0 CA-C-O 118.047 -0.978 . . . . 0.0 109.294 179.85 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' C' C ' 701' ' ' PHQ . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 008 nuclear build full ' C' C ' 702' ' ' LEU . . . . . 0.721 HD11 ' C ' ' A' ' 163' ' ' PRO . 0.0 OUTLIER . . . . . 0 N--CA 1.492 1.661 0 N-CA-C 109.227 -0.657 . . . . 0.0 109.227 . . . . . . . . . 2 2 . 1 . 008 nuclear build full ' C' C ' 703' ' ' PRO . . . . . 0.551 ' O ' ' NH2' ' A' ' 197' ' ' ARG . 16.3 Cg_endo -57.99 162.98 10.29 Favored 'Trans proline' 0 N--CA 1.499 1.845 0 C-N-CA 123.633 2.888 . . . . 0.0 113.55 -178.934 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' C' C ' 704' ' ' ALA . . . . . 0.47 ' C ' ' O ' ' C' ' 703' ' ' PRO . . . 34.97 -151.38 0.0 OUTLIER 'General case' 0 N--CA 1.491 1.622 0 CA-C-O 121.39 0.614 . . . . 0.0 110.277 179.274 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' C' C ' 705' ' ' B27 . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 008 nuclear build full ' A' A ' 700' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 009 nuclear build full ' A' A ' 59' ' ' MET . . . . . . . . . . . . . 1.1 ttp . . . . . 0 N--CA 1.49 1.555 0 CA-C-O 121.31 0.576 . . . . 0.0 109.491 . . . . . . . . . 0 0 . 1 . 009 nuclear build full ' A' A ' 60' ' ' GLN . . . . . . . . . . . . . 1.5 tt0 -60.89 145.24 50.9 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.298 -0.876 . . . . 0.0 109.702 -179.936 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . -64.71 172.24 2.87 Favored 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.156 -0.965 . . . . 0.0 109.479 179.908 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 62' ' ' LYS . . . . . . . . . . . . . 6.8 tttt -143.77 72.12 17.11 Favored Pre-proline 0 N--CA 1.489 1.478 0 O-C-N 121.156 -0.965 . . . . 0.0 109.59 179.848 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 63' ' ' PRO . . . . . 0.602 ' HG2' HD23 ' A' ' 110' ' ' LEU . 52.1 Cg_endo -88.4 156.54 6.64 Favored 'Trans proline' 0 C--N 1.305 -1.763 0 C-N-CA 123.6 2.867 . . . . 0.0 111.467 179.536 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 64' ' ' GLN . . . . . 0.578 ' N ' ' CD ' ' A' ' 64' ' ' GLN . 0.0 OUTLIER -156.36 127.73 7.1 Favored 'General case' 0 N--CA 1.495 1.793 0 O-C-N 120.955 -1.091 . . . . 0.0 109.62 179.366 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 65' ' ' ILE . . . . . 0.639 ' H ' HD13 ' A' ' 65' ' ' ILE . 0.0 OUTLIER -50.79 110.03 1.58 Allowed Pre-proline 0 N--CA 1.49 1.552 0 O-C-N 121.085 -1.009 . . . . 0.0 109.195 178.929 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 66' ' ' PRO . . . . . . . . . . . . . 89.0 Cg_endo -85.64 -154.47 0.05 OUTLIER 'Trans proline' 0 C--N 1.312 -1.392 0 C-N-CA 121.954 1.769 . . . . 0.0 111.712 179.607 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 67' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -83.71 -4.69 58.83 Favored 'General case' 0 N--CA 1.488 1.46 0 O-C-N 121.189 -0.944 . . . . 0.0 109.185 179.553 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 68' ' ' ASP . . . . . 0.634 ' C ' ' N ' ' A' ' 70' ' ' SER . 4.6 t0 -76.14 52.1 0.71 Allowed 'General case' 0 N--CA 1.49 1.574 0 CA-C-O 122.221 1.01 . . . . 0.0 110.099 -179.689 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 69' ' ' LYS . . . . . 0.413 ' C ' ' O ' ' A' ' 68' ' ' ASP . 0.0 OUTLIER -49.38 -13.45 0.08 Allowed 'General case' 0 N--CA 1.507 2.375 0 C-N-CA 116.723 -1.991 . . . . 0.0 106.749 177.593 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 70' ' ' SER . . . . . 0.634 ' N ' ' C ' ' A' ' 68' ' ' ASP . 0.0 OUTLIER -83.31 -8.22 59.47 Favored 'General case' 0 N--CA 1.497 1.896 0 CA-C-N 113.331 -1.759 . . . . 0.0 110.381 179.557 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 71' ' ' LYS . . . . . . . . . . . . . 8.3 ptmt -101.88 142.88 32.49 Favored 'General case' 0 N--CA 1.495 1.793 0 O-C-N 121.021 -1.049 . . . . 0.0 110.643 179.875 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 72' ' ' VAL . . . . . 0.719 HG12 ' CE1' ' A' ' 88' ' ' TYR . 0.9 OUTLIER -64.92 142.63 16.68 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.434 0 N-CA-C 105.309 -2.108 . . . . 0.0 105.309 175.291 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 73' ' ' ALA . . . . . 0.498 ' N ' ' O ' ' A' ' 87' ' ' VAL . . . -83.16 -14.0 54.39 Favored 'General case' 0 C--N 1.296 -1.757 0 O-C-N 120.101 -1.624 . . . . 0.0 107.134 179.944 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 74' ' ' GLY . . . . . 0.409 ' N ' HG23 ' A' ' 72' ' ' VAL . . . 173.83 -157.11 25.1 Favored Glycine 0 C--N 1.296 -1.677 0 N-CA-C 108.595 -1.802 . . . . 0.0 108.595 179.472 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 75' ' ' TYR . . . . . 0.55 ' CE1' ' N ' ' A' ' 86' ' ' PRO . 0.3 OUTLIER -142.96 171.09 14.52 Favored 'General case' 0 C--N 1.292 -1.909 0 O-C-N 121.441 -1.034 . . . . 0.0 110.335 -177.624 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 76' ' ' ILE . . . . . . . . . . . . . 0.5 OUTLIER -148.12 143.72 19.19 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.601 0 C-N-CA 119.048 -1.061 . . . . 0.0 109.77 -177.29 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 2.2 mt-10 -151.53 163.35 39.23 Favored 'General case' 0 C--N 1.304 -1.41 0 O-C-N 121.136 -0.977 . . . . 0.0 109.254 179.573 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 78' ' ' ILE . . . . . 0.493 ' HB ' ' HB3' ' A' ' 81' ' ' ALA . 14.6 mt -144.77 126.51 7.95 Favored Pre-proline 0 N--CA 1.492 1.656 0 N-CA-C 108.538 -0.912 . . . . 0.0 108.538 179.886 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 79' ' ' PRO . . . . . . . . . . . . . 36.0 Cg_endo -71.52 -48.73 0.39 Allowed 'Trans proline' 0 N--CA 1.491 1.362 0 C-N-CA 122.011 1.807 . . . . 0.0 113.501 -179.064 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 50.5 t0 -66.48 -21.24 66.18 Favored 'General case' 0 N--CA 1.493 1.705 0 O-C-N 120.976 -1.077 . . . . 0.0 111.306 178.806 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 81' ' ' ALA . . . . . 0.87 ' HB2' ' HB2' ' A' ' 136' ' ' ALA . . . -104.55 -16.44 15.04 Favored 'General case' 0 N--CA 1.493 1.685 0 O-C-N 120.833 -1.167 . . . . 0.0 108.991 179.657 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 82' ' ' ASP . . . . . . . . . . . . . 8.5 t0 61.17 53.57 3.54 Favored 'General case' 0 N--CA 1.494 1.735 0 O-C-N 121.284 -0.885 . . . . 0.0 111.462 178.518 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 83' ' ' ILE . . . . . . . . . . . . . 50.8 mt -128.96 154.45 39.98 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.794 0 O-C-N 121.027 -1.045 . . . . 0.0 109.43 -179.798 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 84' ' ' LYS . . . . . . . . . . . . . 2.1 pttt -157.81 107.72 2.14 Favored 'General case' 0 N--CA 1.487 1.422 0 N-CA-C 107.959 -1.126 . . . . 0.0 107.959 -179.786 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 85' ' ' GLU . . . . . 0.498 ' C ' ' CE1' ' A' ' 75' ' ' TYR . 0.1 OUTLIER -141.17 160.32 58.13 Favored Pre-proline 0 N--CA 1.493 1.682 0 O-C-N 121.336 -0.852 . . . . 0.0 110.126 -179.065 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 86' ' ' PRO . . . . . 0.55 ' N ' ' CE1' ' A' ' 75' ' ' TYR . 36.7 Cg_endo -68.18 168.85 18.08 Favored 'Trans proline' 0 C--N 1.307 -1.611 0 C-N-CA 123.095 2.53 . . . . 0.0 113.081 -179.061 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 87' ' ' VAL . . . . . 0.502 HG23 ' HA ' ' A' ' 75' ' ' TYR . 94.1 t -127.46 99.31 5.2 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.627 0 N-CA-C 109.106 -0.701 . . . . 0.0 109.106 179.69 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 88' ' ' TYR . . . . . 0.719 ' CE1' HG12 ' A' ' 72' ' ' VAL . 20.9 m-85 -92.34 154.18 42.86 Favored Pre-proline 0 N--CA 1.503 2.204 0 O-C-N 120.873 -1.142 . . . . 0.0 109.79 -179.734 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 89' ' ' PRO . . . . . . . . . . . . . 7.3 Cg_endo -59.02 144.6 99.3 Favored 'Trans proline' 0 C--N 1.309 -1.518 0 C-N-CA 122.476 2.117 . . . . 0.0 113.551 -179.663 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . -59.14 169.1 6.23 Favored Glycine 0 N--CA 1.494 2.541 0 N-CA-C 108.899 -1.681 . . . . 0.0 108.899 178.902 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 91' ' ' PRO . . . . . 0.435 ' C ' ' H ' ' A' ' 93' ' ' THR . 59.8 Cg_endo -93.56 168.02 20.96 Favored 'Cis proline' 0 C--N 1.31 -1.452 0 C-N-CA 124.046 -1.231 . . . . 0.0 111.916 0.619 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 92' ' ' ALA . . . . . 0.473 ' HB1' HD21 ' A' ' 97' ' ' LEU . . . -71.99 32.05 0.06 Allowed 'General case' 0 N--CA 1.493 1.706 0 O-C-N 121.159 -0.963 . . . . 0.0 110.716 -179.664 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 93' ' ' THR . . . . . 0.435 ' H ' ' C ' ' A' ' 91' ' ' PRO . 0.8 OUTLIER -73.46 155.1 89.76 Favored Pre-proline 0 N--CA 1.489 1.523 0 O-C-N 120.692 -1.255 . . . . 0.0 108.751 -179.956 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 94' ' ' PRO . . . . . 0.401 ' C ' ' O ' ' A' ' 93' ' ' THR . 85.2 Cg_exo -34.55 -55.78 0.5 Allowed 'Trans proline' 0 C--N 1.306 -1.668 0 C-N-CA 122.818 2.346 . . . . 0.0 112.387 -179.506 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 95' ' ' GLU . . . . . 0.479 ' OE2' ' OE1' ' A' ' 96' ' ' GLN . 0.1 OUTLIER -47.36 -48.74 25.55 Favored 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.083 -1.011 . . . . 0.0 109.67 -179.812 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 96' ' ' GLN . . . . . 0.594 ' O ' ' N ' ' A' ' 98' ' ' ASN . 5.9 mp0 -71.94 -56.1 6.28 Favored 'General case' 0 N--CA 1.489 1.476 0 O-C-N 121.04 -1.038 . . . . 0.0 110.572 -179.563 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 97' ' ' LEU . . . . . 0.473 HD21 ' HB1' ' A' ' 92' ' ' ALA . 93.6 mt -48.09 -7.0 0.02 OUTLIER 'General case' 0 N--CA 1.494 1.74 0 O-C-N 121.193 -0.942 . . . . 0.0 110.005 -178.939 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 98' ' ' ASN . . . . . 0.594 ' N ' ' O ' ' A' ' 96' ' ' GLN . 0.0 OUTLIER -73.4 -26.35 60.95 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.201 -0.937 . . . . 0.0 109.042 179.274 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 99' ' ' ARG . . . . . 0.492 HH12 ' NE2' ' A' ' 96' ' ' GLN . 4.3 mtt180 -95.08 -51.15 4.77 Favored 'General case' 0 N--CA 1.488 1.442 0 C-N-CA 119.842 -0.743 . . . . 0.0 109.783 -179.218 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . 176.44 -165.29 35.55 Favored Glycine 0 N--CA 1.491 2.325 0 C-N-CA 119.462 -1.351 . . . . 0.0 110.232 179.776 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 101' ' ' VAL . . . . . 0.723 HG23 ' O ' ' A' ' 101' ' ' VAL . 21.0 m -58.47 105.76 0.19 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.632 0 O-C-N 121.498 -1.001 . . . . 0.0 109.554 -179.676 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -92.68 166.65 12.36 Favored 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.476 -0.765 . . . . 0.0 110.775 -179.519 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 103' ' ' PHE . . . . . 0.479 ' CE1' ' CG1' ' A' ' 87' ' ' VAL . 25.5 m-85 -72.25 131.15 42.34 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 120.987 -1.071 . . . . 0.0 108.176 178.458 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 104' ' ' ALA . . . . . 0.476 ' HB1' ' HG2' ' C' ' 703' ' ' PRO . . . -51.93 -7.21 0.05 OUTLIER 'General case' 0 C--N 1.295 -1.786 0 O-C-N 121.416 -0.802 . . . . 0.0 111.873 -178.596 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -141.22 139.54 33.81 Favored 'General case' 0 N--CA 1.499 2.023 0 O-C-N 120.444 -1.41 . . . . 0.0 111.469 -179.682 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 106' ' ' GLU . . . . . . . . . . . . . 1.9 pt-20 -54.3 -62.0 1.94 Allowed 'General case' 0 N--CA 1.488 1.472 0 O-C-N 121.855 -0.528 . . . . 0.0 109.947 179.51 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 107' ' ' ASN . . . . . . . . . . . . . 8.1 m120 -76.83 35.32 0.16 Allowed 'General case' 0 N--CA 1.489 1.483 0 O-C-N 120.545 -1.347 . . . . 0.0 111.607 -176.833 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 108' ' ' GLU . . . . . . . . . . . . . 35.1 tp10 -57.19 144.37 35.44 Favored 'General case' 0 C--N 1.303 -1.428 0 O-C-N 120.813 -1.179 . . . . 0.0 107.83 -179.802 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 109' ' ' SER . . . . . 0.557 ' C ' ' H ' ' A' ' 111' ' ' ASP . 1.2 m -101.24 124.85 47.59 Favored 'General case' 0 C--N 1.303 -1.438 0 O-C-N 121.058 -1.026 . . . . 0.0 110.648 -178.455 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 110' ' ' LEU . . . . . 0.602 HD23 ' HG2' ' A' ' 63' ' ' PRO . 3.5 tp -58.99 -3.45 0.35 Allowed 'General case' 0 C--N 1.3 -1.548 0 N-CA-C 107.693 -1.225 . . . . 0.0 107.693 179.066 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 111' ' ' ASP . . . . . 0.557 ' H ' ' C ' ' A' ' 109' ' ' SER . 1.6 m-20 -132.17 21.66 4.46 Favored 'General case' 0 N--CA 1.486 1.363 0 N-CA-C 109.128 -0.693 . . . . 0.0 109.128 179.696 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 112' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -64.96 138.34 58.3 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 120.985 -1.072 . . . . 0.0 109.543 179.839 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 113' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -66.29 -5.86 11.98 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 120.94 -1.1 . . . . 0.0 108.696 179.201 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 114' ' ' ASN . . . . . 0.493 ' OD1' ' O ' ' A' ' 170' ' ' ASP . 4.1 t30 -145.54 97.34 2.97 Favored 'General case' 0 C--N 1.297 -1.7 0 N-CA-C 107.305 -1.369 . . . . 0.0 107.305 178.16 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 115' ' ' ILE . . . . . 0.509 HG22 ' O ' ' A' ' 115' ' ' ILE . 1.8 mt -95.64 107.09 19.12 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.599 0 O-C-N 121.13 -0.981 . . . . 0.0 108.694 -179.522 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 116' ' ' SER . . . . . . . . . . . . . 7.5 p -90.22 154.71 19.53 Favored 'General case' 0 C--N 1.305 -1.355 0 CA-C-O 121.728 0.775 . . . . 0.0 110.814 -178.458 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 117' ' ' ILE . . . . . 0.419 HG21 HD13 ' A' ' 117' ' ' ILE . 3.2 mt -144.35 153.68 15.18 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.412 0 N-CA-C 108.337 -0.986 . . . . 0.0 108.337 179.135 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 118' ' ' ALA . . . . . 0.417 ' HB3' ' HB2' ' A' ' 92' ' ' ALA . . . -140.34 153.9 46.57 Favored 'General case' 0 N--CA 1.49 1.562 0 C-N-CA 119.217 -0.993 . . . . 0.0 110.481 -179.586 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 119' ' ' GLY . . . . . . . . . . . . . . . -166.57 148.17 13.07 Favored Glycine 0 N--CA 1.487 2.074 0 C-N-CA 119.912 -1.137 . . . . 0.0 110.715 -179.988 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 120' ' ' HIS . . . . . 0.501 ' ND1' ' SG ' ' C' ' 705' ' ' B27 . 3.2 m-70 -72.47 161.74 30.41 Favored 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.919 -0.754 . . . . 0.0 110.006 179.337 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 121' ' ' THR . . . . . . . . . . . . . 1.1 t -116.22 158.29 23.55 Favored 'General case' 0 N--CA 1.496 1.85 0 O-C-N 121.338 -0.851 . . . . 0.0 109.079 178.958 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 122' ' ' PHE . . . . . . . . . . . . . 0.3 OUTLIER -124.67 127.03 46.68 Favored 'General case' 0 N--CA 1.498 1.946 0 O-C-N 121.296 -0.877 . . . . 0.0 109.852 -179.637 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 123' ' ' ILE . . . . . 0.534 HG23 ' N ' ' A' ' 124' ' ' ASP . 16.3 tt -74.73 -36.74 41.08 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.665 0 CA-C-O 121.922 0.868 . . . . 0.0 109.141 179.712 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 124' ' ' ASP . . . . . 0.534 ' N ' HG23 ' A' ' 123' ' ' ILE . 2.0 p30 -95.54 22.49 7.01 Favored 'General case' 0 C--N 1.296 -1.756 0 O-C-N 121.827 -0.546 . . . . 0.0 111.042 -179.224 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 125' ' ' ARG . . . . . . . . . . . . . 9.4 ttt180 -157.06 107.42 1.91 Allowed Pre-proline 0 N--CA 1.492 1.674 0 O-C-N 120.518 -1.364 . . . . 0.0 110.441 -179.08 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 126' ' ' PRO . . . . . . . . . . . . . 56.9 Cg_endo -79.79 -23.27 7.01 Favored 'Trans proline' 0 C--N 1.315 -1.193 0 C-N-CA 122.056 1.837 . . . . 0.0 112.454 179.416 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 127' ' ' ASN . . . . . . . . . . . . . 28.4 m120 -91.5 29.64 1.45 Allowed 'General case' 0 N--CA 1.493 1.681 0 O-C-N 121.186 -0.946 . . . . 0.0 109.573 179.902 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 128' ' ' TYR . . . . . 0.687 ' CZ ' ' NE2' ' A' ' 129' ' ' GLN . 14.8 t80 -81.32 -151.04 0.08 Allowed 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.254 -0.904 . . . . 0.0 109.843 -179.669 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 129' ' ' GLN . . . . . 0.687 ' NE2' ' CZ ' ' A' ' 128' ' ' TYR . 1.7 mp0 -68.3 -71.85 0.2 Allowed 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.265 -0.897 . . . . 0.0 109.906 -179.507 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 130' ' ' PHE . . . . . 0.55 ' CE2' HG11 ' A' ' 101' ' ' VAL . 50.5 m-85 -125.88 25.94 6.72 Favored 'General case' 0 N--CA 1.497 1.884 0 O-C-N 121.21 -0.931 . . . . 0.0 110.278 -179.927 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 131' ' ' THR . . . . . . . . . . . . . 36.7 m -63.78 -34.85 78.81 Favored 'General case' 0 N--CA 1.493 1.693 0 O-C-N 120.844 -1.16 . . . . 0.0 109.754 -179.964 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 132' ' ' ASN . . . . . 0.6 ' ND2' ' O ' ' A' ' 81' ' ' ALA . 12.5 t30 -85.24 9.57 14.83 Favored 'General case' 0 N--CA 1.497 1.883 0 C-N-CA 119.913 -0.715 . . . . 0.0 111.788 -178.234 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 133' ' ' LEU . . . . . 0.606 ' O ' ' N ' ' A' ' 135' ' ' ALA . 0.1 OUTLIER -71.94 -44.56 63.4 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 120.565 -1.334 . . . . 0.0 110.328 -179.442 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 134' ' ' LYS . . . . . 0.62 ' H ' ' CD ' ' A' ' 134' ' ' LYS . 0.0 OUTLIER -42.58 -16.36 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.663 0 O-C-N 121.192 -0.942 . . . . 0.0 110.089 -179.132 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 135' ' ' ALA . . . . . 0.606 ' N ' ' O ' ' A' ' 133' ' ' LEU . . . -85.23 -37.06 20.52 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.02 -1.05 . . . . 0.0 109.738 179.708 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 136' ' ' ALA . . . . . 0.87 ' HB2' ' HB2' ' A' ' 81' ' ' ALA . . . -78.43 153.54 31.42 Favored 'General case' 0 N--CA 1.489 1.519 0 CA-C-O 121.977 0.894 . . . . 0.0 111.317 -178.6 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 137' ' ' LYS . . . . . 0.508 ' O ' ' OG ' ' A' ' 140' ' ' SER . 0.6 OUTLIER -156.15 -163.36 1.46 Allowed 'General case' 0 N--CA 1.494 1.744 0 C-N-CA 118.559 -1.257 . . . . 0.0 111.224 -178.387 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 138' ' ' LYS . . . . . 0.604 ' O ' ' N ' ' A' ' 140' ' ' SER . 24.9 pttt -45.95 179.74 0.0 OUTLIER 'General case' 0 C--N 1.305 -1.364 0 CA-C-O 121.95 0.881 . . . . 0.0 110.296 -179.395 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 139' ' ' GLY . . . . . . . . . . . . . . . 45.58 8.07 0.01 OUTLIER Glycine 0 N--CA 1.491 2.336 0 N-CA-C 110.817 -0.913 . . . . 0.0 110.817 179.705 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 140' ' ' SER . . . . . 0.604 ' N ' ' O ' ' A' ' 138' ' ' LYS . 46.9 m -94.07 136.85 33.91 Favored 'General case' 0 N--CA 1.494 1.734 0 O-C-N 120.823 -1.398 . . . . 0.0 109.333 179.225 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 141' ' ' MET . . . . . 0.407 ' HG2' ' CE1' ' A' ' 143' ' ' TYR . 0.4 OUTLIER -85.04 147.6 26.58 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.155 -0.965 . . . . 0.0 109.55 -179.96 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 142' ' ' VAL . . . . . . . . . . . . . 2.1 t -132.15 134.93 59.05 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.661 0 N-CA-C 108.368 -0.975 . . . . 0.0 108.368 -179.759 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 143' ' ' TYR . . . . . 0.407 ' CE1' ' HG2' ' A' ' 141' ' ' MET . 37.0 m-85 -114.03 137.53 51.59 Favored 'General case' 0 N--CA 1.499 2.008 0 O-C-N 120.792 -1.192 . . . . 0.0 111.391 -178.842 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 144' ' ' PHE . . . . . . . . . . . . . 5.1 t80 -123.15 107.02 11.28 Favored 'General case' 0 N--CA 1.494 1.77 0 CA-C-O 121.476 0.655 . . . . 0.0 109.833 -179.215 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 145' ' ' LYS . . . . . . . . . . . . . 14.7 tttt -95.55 132.83 40.25 Favored 'General case' 0 N--CA 1.495 1.799 0 O-C-N 121.417 -0.802 . . . . 0.0 111.43 -178.725 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 146' ' ' VAL . . . . . 0.458 ' O ' ' C ' ' A' ' 147' ' ' GLY . 0.0 OUTLIER -143.26 141.1 26.48 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.813 0 N-CA-C 107.629 -1.249 . . . . 0.0 107.629 178.589 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 147' ' ' GLY . . . . . 0.458 ' C ' ' O ' ' A' ' 146' ' ' VAL . . . 40.02 -126.3 2.54 Favored Glycine 0 N--CA 1.494 2.533 0 N-CA-C 109.776 -1.33 . . . . 0.0 109.776 179.778 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 148' ' ' ASN . . . . . . . . . . . . . 19.8 p30 -101.65 14.94 30.46 Favored 'General case' 0 C--N 1.302 -1.476 0 O-C-N 121.426 -1.043 . . . . 0.0 108.339 179.209 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 149' ' ' GLU . . . . . . . . . . . . . 3.2 tt0 -109.92 142.39 41.33 Favored 'General case' 0 N--CA 1.485 1.324 0 CA-C-O 121.946 0.879 . . . . 0.0 111.515 -178.43 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 150' ' ' THR . . . . . . . . . . . . . 54.3 m -129.48 101.83 6.12 Favored 'General case' 0 C--N 1.3 -1.58 0 CA-C-O 121.658 0.742 . . . . 0.0 109.713 179.81 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 151' ' ' ARG . . . . . . . . . . . . . 2.5 mtp180 -87.33 179.3 6.63 Favored 'General case' 0 C--N 1.306 -1.322 0 N-CA-C 108.601 -0.889 . . . . 0.0 108.601 179.951 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 152' ' ' LYS . . . . . 0.408 ' C ' ' CD1' ' A' ' 153' ' ' TYR . 24.6 mtmm -147.53 148.16 30.89 Favored 'General case' 0 C--N 1.302 -1.495 0 O-C-N 121.089 -1.007 . . . . 0.0 109.838 -179.671 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 153' ' ' TYR . . . . . 0.408 ' CD1' ' C ' ' A' ' 152' ' ' LYS . 20.6 m-85 -141.64 167.5 21.99 Favored 'General case' 0 N--CA 1.492 1.629 0 N-CA-C 108.491 -0.929 . . . . 0.0 108.491 179.258 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 154' ' ' LYS . . . . . 0.461 ' HZ3' HG21 ' A' ' 205' ' ' VAL . 4.4 ttpm? -137.7 122.41 18.68 Favored 'General case' 0 C--N 1.296 -1.731 0 N-CA-C 108.698 -0.853 . . . . 0.0 108.698 179.155 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 155' ' ' MET . . . . . . . . . . . . . 38.4 mmm -48.98 107.38 0.13 Allowed 'General case' 0 N--CA 1.491 1.604 0 O-C-N 120.785 -1.197 . . . . 0.0 110.904 -178.891 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 156' ' ' THR . . . . . 0.609 ' OG1' HG23 ' A' ' 203' ' ' THR . 0.0 OUTLIER -109.49 -22.18 12.12 Favored 'General case' 0 C--N 1.296 -1.748 0 C-N-CA 119.832 -0.747 . . . . 0.0 110.597 -178.959 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 157' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -151.67 146.98 26.19 Favored 'General case' 0 C--N 1.294 -1.838 0 C-N-CA 118.702 -1.199 . . . . 0.0 110.966 -178.411 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 158' ' ' ILE . . . . . 0.841 HD12 ' N ' ' A' ' 159' ' ' ARG . 0.1 OUTLIER -155.51 142.57 11.66 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.334 0 CA-C-O 121.778 0.799 . . . . 0.0 110.013 -178.834 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 159' ' ' ARG . . . . . 0.841 ' N ' HD12 ' A' ' 158' ' ' ILE . 23.1 ttm180 -155.99 160.3 39.94 Favored 'General case' 0 C--N 1.297 -1.679 0 CA-C-O 121.79 0.805 . . . . 0.0 110.44 -179.618 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 160' ' ' ASP . . . . . 0.547 ' O ' HG13 ' A' ' 161' ' ' VAL . 35.7 m-20 -116.02 161.44 18.87 Favored 'General case' 0 N--CA 1.49 1.564 0 N-CA-C 108.203 -1.036 . . . . 0.0 108.203 179.185 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 161' ' ' VAL . . . . . 0.577 HG21 ' CG1' ' A' ' 168' ' ' VAL . 3.3 m -156.79 155.01 5.57 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.63 0 O-C-N 121.117 -0.99 . . . . 0.0 110.722 -178.569 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 162' ' ' LYS . . . . . 0.438 ' O ' ' O ' ' A' ' 161' ' ' VAL . 0.0 OUTLIER -45.02 169.9 0.06 OUTLIER Pre-proline 0 N--CA 1.492 1.652 0 O-C-N 121.594 -0.691 . . . . 0.0 109.795 179.527 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 163' ' ' PRO . . . . . 0.467 ' C ' HD11 ' C' ' 702' ' ' LEU . 65.1 Cg_endo -78.54 34.59 0.51 Allowed 'Trans proline' 0 N--CA 1.493 1.466 0 C-N-CA 123.052 2.501 . . . . 0.0 113.026 -179.975 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 164' ' ' THR . . . . . 0.441 ' N ' HD11 ' C' ' 702' ' ' LEU . 0.3 OUTLIER -153.26 -3.86 0.2 Allowed 'General case' 0 N--CA 1.496 1.873 0 O-C-N 121.022 -1.049 . . . . 0.0 110.925 -179.824 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 165' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -77.2 64.44 2.62 Favored 'General case' 0 N--CA 1.496 1.857 0 O-C-N 120.861 -1.149 . . . . 0.0 110.899 -179.078 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 166' ' ' VAL . . . . . 0.593 ' O ' ' N ' ' A' ' 168' ' ' VAL . 1.4 m -46.44 -30.26 1.22 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.702 0 O-C-N 121.13 -0.981 . . . . 0.0 110.563 -178.244 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 167' ' ' GLY . . . . . . . . . . . . . . . -45.22 -9.1 0.01 OUTLIER Glycine 0 N--CA 1.498 2.796 0 O-C-N 120.694 -1.254 . . . . 0.0 111.313 -179.353 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 168' ' ' VAL . . . . . 0.593 ' N ' ' O ' ' A' ' 166' ' ' VAL . 4.2 m -53.88 -31.67 21.02 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.657 0 O-C-N 120.615 -1.521 . . . . 0.0 109.114 -179.988 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 169' ' ' LEU . . . . . 0.552 ' O ' ' C ' ' A' ' 170' ' ' ASP . 10.9 mt -45.57 -17.79 0.03 OUTLIER 'General case' 0 N--CA 1.493 1.677 0 N-CA-C 108.19 -1.041 . . . . 0.0 108.19 -178.41 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 170' ' ' ASP . . . . . 0.552 ' C ' ' O ' ' A' ' 169' ' ' LEU . 2.5 m-20 21.44 90.51 0.01 OUTLIER 'General case' 0 N--CA 1.501 2.086 0 CA-C-O 120.81 0.338 . . . . 0.0 111.797 178.151 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 171' ' ' GLU . . . . . 0.408 ' HB3' ' ND2' ' A' ' 114' ' ' ASN . 10.1 pt-20 -140.27 78.06 1.64 Allowed 'General case' 0 N--CA 1.494 1.754 0 O-C-N 120.845 -1.16 . . . . 0.0 109.808 179.512 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 172' ' ' GLN . . . . . . . . . . . . . 2.6 mp0 -136.49 -41.43 0.63 Allowed 'General case' 0 N--CA 1.495 1.793 0 O-C-N 121.453 -0.779 . . . . 0.0 110.607 -178.749 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 173' ' ' LYS . . . . . . . . . . . . . 49.7 mttp -58.24 140.41 53.2 Favored 'General case' 0 N--CA 1.493 1.686 0 O-C-N 120.74 -1.225 . . . . 0.0 108.514 179.676 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 174' ' ' GLY . . . . . 0.478 ' O ' ' C ' ' A' ' 175' ' ' LYS . . . -127.29 -46.6 0.2 Allowed Glycine 0 C--N 1.298 -1.534 0 N-CA-C 107.619 -2.192 . . . . 0.0 107.619 179.704 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 175' ' ' LYS . . . . . 0.478 ' C ' ' O ' ' A' ' 174' ' ' GLY . 27.9 mmtt -42.77 -61.42 1.26 Allowed 'General case' 0 N--CA 1.489 1.523 0 N-CA-C 108.023 -1.103 . . . . 0.0 108.023 178.611 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 176' ' ' ASP . . . . . 0.525 ' O ' ' O ' ' A' ' 177' ' ' LYS . 3.6 p30 -104.53 95.23 5.78 Favored 'General case' 0 C--N 1.299 -1.63 0 N-CA-C 108.059 -1.089 . . . . 0.0 108.059 178.086 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 177' ' ' LYS . . . . . 0.525 ' O ' ' O ' ' A' ' 176' ' ' ASP . 0.5 OUTLIER -48.39 -176.37 0.0 OUTLIER 'General case' 0 N--CA 1.494 1.734 0 O-C-N 121.119 -0.988 . . . . 0.0 109.432 -179.694 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 178' ' ' GLN . . . . . 0.456 ' OE1' ' OD1' ' A' ' 114' ' ' ASN . 9.3 pt20 -162.06 174.47 12.96 Favored 'General case' 0 C--N 1.308 -1.227 0 C-N-CA 118.605 -1.238 . . . . 0.0 110.663 179.214 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 179' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -134.62 100.36 4.61 Favored 'General case' 0 C--N 1.301 -1.518 0 N-CA-C 107.756 -1.201 . . . . 0.0 107.756 178.046 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 180' ' ' THR . . . . . 0.423 ' O ' HG22 ' A' ' 180' ' ' THR . 1.0 OUTLIER -79.99 116.62 20.23 Favored 'General case' 0 N--CA 1.493 1.707 0 O-C-N 121.095 -1.003 . . . . 0.0 110.186 -178.794 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 181' ' ' LEU . . . . . . . . . . . . . 8.8 tp -99.43 106.13 18.15 Favored 'General case' 0 C--N 1.3 -1.583 0 O-C-N 121.453 -0.779 . . . . 0.0 109.496 179.146 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 182' ' ' ILE . . . . . 0.4 ' O ' ' HA ' ' A' ' 118' ' ' ALA . 48.2 mt -93.74 127.83 45.52 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.541 0 O-C-N 120.895 -1.128 . . . . 0.0 108.76 178.909 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 183' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -144.55 111.28 5.73 Favored 'General case' 0 C--N 1.291 -1.948 0 N-CA-C 107.409 -1.33 . . . . 0.0 107.409 179.569 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 184' ' ' CYS . . . . . . . . . . . . . 15.9 p -79.62 161.0 26.16 Favored 'General case' 0 C--N 1.291 -1.975 0 C-N-CA 118.988 -1.085 . . . . 0.0 111.782 -177.334 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 185' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -166.67 -161.71 0.47 Allowed 'General case' 0 N--CA 1.494 1.775 0 O-C-N 121.665 -0.647 . . . . 0.0 109.338 179.759 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 186' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER 55.15 57.03 5.86 Favored 'General case' 0 N--CA 1.496 1.857 0 O-C-N 121.144 -0.973 . . . . 0.0 109.368 -179.838 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 187' ' ' TYR . . . . . 0.619 ' CE1' ' O ' ' A' ' 188' ' ' ASN . 65.7 t80 -67.78 137.23 55.24 Favored 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.342 -0.849 . . . . 0.0 110.703 -179.514 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 188' ' ' ASN . . . . . 0.619 ' O ' ' CE1' ' A' ' 187' ' ' TYR . 1.2 t-20 -101.98 145.66 28.96 Favored 'General case' 0 C--N 1.297 -1.697 0 N-CA-C 108.39 -0.967 . . . . 0.0 108.39 178.376 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 189' ' ' GLU . . . . . . . . . . . . . 1.9 tt0 -110.08 -14.74 14.17 Favored 'General case' 0 C--N 1.294 -1.823 0 N-CA-C 108.984 -0.747 . . . . 0.0 108.984 -179.217 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 190' ' ' LYS . . . . . . . . . . . . . 4.6 mttm -83.53 -52.36 6.54 Favored 'General case' 0 C--N 1.301 -1.506 0 C-N-CA 119.82 -0.752 . . . . 0.0 109.099 179.423 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 191' ' ' THR . . . . . 0.541 ' OG1' HG12 ' A' ' 193' ' ' VAL . 2.1 p -89.16 -9.25 51.62 Favored 'General case' 0 N--CA 1.489 1.525 0 O-C-N 121.52 -0.738 . . . . 0.0 109.235 179.799 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 192' ' ' GLY . . . . . . . . . . . . . . . 68.4 33.31 77.07 Favored Glycine 0 N--CA 1.493 2.496 0 O-C-N 121.298 -0.876 . . . . 0.0 111.119 178.606 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 193' ' ' VAL . . . . . 0.541 HG12 ' OG1' ' A' ' 191' ' ' THR . 2.4 p -147.54 169.63 3.96 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.582 0 O-C-N 120.806 -1.408 . . . . 0.0 109.891 179.169 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 194' ' ' TRP . . . . . 0.594 ' CD1' HG2B ' C' ' 705' ' ' B27 . 10.7 m95 -85.74 121.55 28.56 Favored 'General case' 0 C--N 1.294 -1.836 0 O-C-N 121.648 -0.657 . . . . 0.0 109.271 -179.908 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 195' ' ' GLU . . . . . 0.512 ' CD ' ' ND2' ' A' ' 188' ' ' ASN . 7.5 mt-10 -77.31 -60.14 2.49 Favored 'General case' 0 N--CA 1.496 1.862 0 O-C-N 121.385 -0.822 . . . . 0.0 111.575 -178.521 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 196' ' ' LYS . . . . . . . . . . . . . 6.3 mtmt -92.1 158.16 16.35 Favored 'General case' 0 N--CA 1.493 1.72 0 O-C-N 120.86 -1.15 . . . . 0.0 111.397 -177.946 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 197' ' ' ARG . . . . . . . . . . . . . 25.3 mmt180 -124.14 139.17 54.19 Favored 'General case' 0 N--CA 1.488 1.466 0 N-CA-C 108.674 -0.862 . . . . 0.0 108.674 179.001 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 198' ' ' LYS . . . . . . . . . . . . . 14.9 mttt -119.8 120.63 37.07 Favored 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.544 -0.723 . . . . 0.0 110.13 -179.017 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 199' ' ' ILE . . . . . 0.566 ' C ' HD12 ' A' ' 199' ' ' ILE . 0.8 OUTLIER -139.81 119.83 13.54 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.66 0 O-C-N 121.192 -0.943 . . . . 0.0 109.562 179.43 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 200' ' ' PHE . . . . . 0.537 ' CD1' ' N ' ' A' ' 200' ' ' PHE . 8.7 m-85 -99.91 139.05 36.15 Favored 'General case' 0 N--CA 1.499 2.012 0 O-C-N 121.468 -0.77 . . . . 0.0 110.76 -178.534 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 201' ' ' VAL . . . . . . . . . . . . . 24.3 t -104.12 149.07 8.11 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.553 0 N-CA-C 107.39 -1.337 . . . . 0.0 107.39 176.489 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 202' ' ' ALA . . . . . . . . . . . . . . . -132.47 139.6 48.04 Favored 'General case' 0 C--N 1.3 -1.585 0 O-C-N 121.047 -1.033 . . . . 0.0 108.249 -179.864 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 203' ' ' THR . . . . . 0.609 HG23 ' OG1' ' A' ' 156' ' ' THR . 13.7 p -90.85 132.15 36.07 Favored 'General case' 0 C--N 1.305 -1.343 0 CA-C-O 122.647 1.213 . . . . 0.0 111.608 -178.242 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 204' ' ' GLU . . . . . 0.403 ' HA ' ' CD2' ' A' ' 153' ' ' TYR . 1.2 tm-20 -60.79 136.24 58.01 Favored 'General case' 0 C--N 1.297 -1.711 0 C-N-CA 118.334 -1.347 . . . . 0.0 108.798 179.159 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 205' ' ' VAL . . . . . 0.473 ' O ' ' C ' ' A' ' 206' ' ' LYS . 36.6 t -130.85 -35.82 0.59 Allowed 'Isoleucine or valine' 0 N--CA 1.495 1.795 0 O-C-N 121.298 -0.877 . . . . 0.0 110.189 -179.437 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 206' ' ' LYS . . . . . 0.473 ' C ' ' O ' ' A' ' 205' ' ' VAL . 0.0 OUTLIER . . . . . 0 N--CA 1.495 1.777 0 CA-C-O 117.945 -1.026 . . . . 0.0 110.259 -179.584 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' C' C ' 701' ' ' PHQ . . . . . 0.583 ' C1 ' HG12 ' A' ' 166' ' ' VAL . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 009 nuclear build full ' C' C ' 702' ' ' LEU . . . . . 0.632 ' N ' HD12 ' C' ' 702' ' ' LEU . 0.0 OUTLIER . . . . . 0 N--CA 1.491 1.614 0 N-CA-C 109.074 -0.713 . . . . 0.0 109.074 . . . . . . . . . 2 2 . 1 . 009 nuclear build full ' C' C ' 703' ' ' PRO . . . . . 0.476 ' HG2' ' HB1' ' A' ' 104' ' ' ALA . 31.9 Cg_exo -43.31 175.79 0.0 OUTLIER 'Trans proline' 0 N--CA 1.49 1.313 0 C-N-CA 122.593 2.195 . . . . 0.0 112.981 -179.097 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' C' C ' 704' ' ' ALA . . . . . 0.403 ' C ' ' O ' ' C' ' 703' ' ' PRO . . . 43.19 -158.29 0.02 OUTLIER 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.502 -0.749 . . . . 0.0 109.769 179.477 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' C' C ' 705' ' ' B27 . . . . . 0.594 HG2B ' CD1' ' A' ' 194' ' ' TRP . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 700' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 010 nuclear build full ' A' A ' 59' ' ' MET . . . . . . . . . . . . . 28.4 mtt . . . . . 0 N--CA 1.49 1.559 0 N-CA-C 109.664 -0.495 . . . . 0.0 109.664 . . . . . . . . . 0 0 . 1 . 010 nuclear build full ' A' A ' 60' ' ' GLN . . . . . . . . . . . . . 74.9 mt-30 -61.31 -97.99 0.0 OUTLIER 'General case' 0 N--CA 1.492 1.669 0 O-C-N 121.083 -1.011 . . . . 0.0 109.549 -179.993 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . -64.91 -163.7 0.02 OUTLIER 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.076 -1.015 . . . . 0.0 109.17 179.734 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 62' ' ' LYS . . . . . . . . . . . . . 15.8 tttm -146.93 79.21 10.16 Favored Pre-proline 0 N--CA 1.491 1.601 0 O-C-N 121.222 -0.924 . . . . 0.0 109.454 179.993 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 63' ' ' PRO . . . . . 0.843 ' O ' HD13 ' A' ' 110' ' ' LEU . 6.2 Cg_exo -74.54 138.6 24.49 Favored 'Trans proline' 0 C--N 1.302 -1.869 0 C-N-CA 123.004 2.469 . . . . 0.0 111.455 179.781 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 64' ' ' GLN . . . . . 0.559 ' N ' ' CD ' ' A' ' 64' ' ' GLN . 0.0 OUTLIER -158.97 137.07 10.53 Favored 'General case' 0 C--N 1.299 -1.598 0 O-C-N 121.169 -0.957 . . . . 0.0 109.43 179.684 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 65' ' ' ILE . . . . . 0.75 ' N ' HD13 ' A' ' 65' ' ' ILE . 0.2 OUTLIER -50.79 110.42 1.73 Allowed Pre-proline 0 N--CA 1.489 1.501 0 O-C-N 120.829 -1.169 . . . . 0.0 108.624 179.253 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 66' ' ' PRO . . . . . . . . . . . . . 87.1 Cg_endo -82.52 -162.77 0.19 Allowed 'Trans proline' 0 C--N 1.314 -1.251 0 C-N-CA 121.998 1.798 . . . . 0.0 111.797 -179.784 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 67' ' ' LYS . . . . . . . . . . . . . 36.4 tttp -90.11 -10.28 45.23 Favored 'General case' 0 C--N 1.302 -1.481 0 O-C-N 121.176 -0.953 . . . . 0.0 109.081 179.534 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 68' ' ' ASP . . . . . 0.644 ' C ' ' H ' ' A' ' 70' ' ' SER . 0.2 OUTLIER -76.61 64.02 2.18 Favored 'General case' 0 N--CA 1.489 1.505 0 CA-C-O 122.763 1.268 . . . . 0.0 108.71 179.194 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 69' ' ' LYS . . . . . 0.459 ' C ' ' O ' ' A' ' 68' ' ' ASP . 6.3 ptpp? -46.99 -14.16 0.03 OUTLIER 'General case' 0 N--CA 1.508 2.472 0 C-N-CA 117.259 -1.776 . . . . 0.0 106.701 177.534 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 70' ' ' SER . . . . . 0.644 ' H ' ' C ' ' A' ' 68' ' ' ASP . 3.4 p -85.93 -6.36 59.08 Favored 'General case' 0 N--CA 1.496 1.839 0 CA-C-N 113.414 -1.721 . . . . 0.0 111.496 179.564 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 71' ' ' LYS . . . . . 0.496 ' N ' ' O ' ' A' ' 68' ' ' ASP . 0.0 OUTLIER -95.35 142.6 27.55 Favored 'General case' 0 N--CA 1.501 2.079 0 O-C-N 120.579 -1.325 . . . . 0.0 112.225 -179.288 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 72' ' ' VAL . . . . . 0.691 HG12 ' CZ ' ' A' ' 88' ' ' TYR . 3.1 m -66.46 134.44 29.95 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.5 0 N-CA-C 104.318 -2.475 . . . . 0.0 104.318 174.65 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 73' ' ' ALA . . . . . 0.517 ' N ' ' O ' ' A' ' 87' ' ' VAL . . . -81.47 -15.65 54.37 Favored 'General case' 0 C--N 1.291 -1.967 0 O-C-N 119.849 -1.782 . . . . 0.0 106.859 179.985 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . 172.16 -155.78 24.23 Favored Glycine 0 C--N 1.298 -1.533 0 N-CA-C 109.817 -1.313 . . . . 0.0 109.817 179.512 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 75' ' ' TYR . . . . . 0.527 ' HA ' HG23 ' A' ' 87' ' ' VAL . 73.0 m-85 -142.56 169.99 16.54 Favored 'General case' 0 C--N 1.297 -1.684 0 CA-C-O 122.06 0.933 . . . . 0.0 110.848 -177.459 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 76' ' ' ILE . . . . . . . . . . . . . 1.0 OUTLIER -150.15 146.9 16.46 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.814 0 C-N-CA 119.58 -0.848 . . . . 0.0 109.179 -178.382 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -151.15 164.8 35.68 Favored 'General case' 0 C--N 1.302 -1.494 0 O-C-N 120.919 -1.113 . . . . 0.0 109.262 -179.734 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 78' ' ' ILE . . . . . 0.512 ' HB ' ' HB3' ' A' ' 81' ' ' ALA . 10.0 mt -147.91 92.97 4.57 Favored Pre-proline 0 N--CA 1.488 1.425 0 N-CA-C 108.516 -0.92 . . . . 0.0 108.516 179.998 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 79' ' ' PRO . . . . . . . . . . . . . 72.3 Cg_exo -46.77 -43.54 23.41 Favored 'Trans proline' 0 N--CA 1.494 1.536 0 C-N-CA 122.852 2.368 . . . . 0.0 113.954 -178.972 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 37.9 t70 -65.54 -20.62 66.41 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 120.665 -1.272 . . . . 0.0 110.343 178.582 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 81' ' ' ALA . . . . . 0.788 ' HB2' ' HB2' ' A' ' 136' ' ' ALA . . . -106.33 -15.05 14.93 Favored 'General case' 0 C--N 1.302 -1.471 0 O-C-N 121.354 -0.841 . . . . 0.0 108.762 179.664 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 82' ' ' ASP . . . . . . . . . . . . . 2.5 t70 66.38 49.51 1.41 Allowed 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.163 -0.961 . . . . 0.0 110.227 179.506 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 83' ' ' ILE . . . . . 0.685 HD11 ' OD1' ' A' ' 132' ' ' ASN . 62.7 mt -128.57 151.38 35.28 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.786 0 O-C-N 121.259 -0.901 . . . . 0.0 110.333 -178.988 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 84' ' ' LYS . . . . . . . . . . . . . 17.4 tttt -159.53 106.42 1.7 Allowed 'General case' 0 N--CA 1.493 1.69 0 N-CA-C 108.416 -0.957 . . . . 0.0 108.416 178.964 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 85' ' ' GLU . . . . . 0.54 ' OE2' ' N ' ' A' ' 85' ' ' GLU . 0.0 OUTLIER -140.07 165.77 28.37 Favored Pre-proline 0 N--CA 1.491 1.621 0 O-C-N 121.393 -0.817 . . . . 0.0 109.858 -179.008 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 86' ' ' PRO . . . . . . . . . . . . . 56.9 Cg_endo -74.27 166.53 29.3 Favored 'Trans proline' 0 N--CA 1.496 1.621 0 C-N-CA 123.116 2.544 . . . . 0.0 113.779 -178.548 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 87' ' ' VAL . . . . . 0.527 HG23 ' HA ' ' A' ' 75' ' ' TYR . 61.3 t -122.9 100.07 7.6 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.539 0 N-CA-C 109.093 -0.706 . . . . 0.0 109.093 179.715 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 88' ' ' TYR . . . . . 0.691 ' CZ ' HG12 ' A' ' 72' ' ' VAL . 42.1 m-85 -91.87 154.76 43.7 Favored Pre-proline 0 N--CA 1.505 2.298 0 O-C-N 120.944 -1.098 . . . . 0.0 110.086 -179.359 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 89' ' ' PRO . . . . . . . . . . . . . 7.0 Cg_endo -56.84 145.78 81.98 Favored 'Trans proline' 0 N--CA 1.494 1.537 0 C-N-CA 122.467 2.111 . . . . 0.0 113.119 179.157 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . -63.57 169.52 19.56 Favored Glycine 0 N--CA 1.492 2.415 0 N-CA-C 109.159 -1.576 . . . . 0.0 109.159 179.188 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 91' ' ' PRO . . . . . . . . . . . . . 73.0 Cg_endo -93.4 170.25 19.82 Favored 'Cis proline' 0 C--N 1.309 -1.519 0 C-N-CA 123.939 -1.275 . . . . 0.0 112.424 0.101 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 92' ' ' ALA . . . . . 0.437 ' HB3' ' HB3' ' C' ' 703' ' ' PRO . . . -73.09 33.68 0.07 Allowed 'General case' 0 N--CA 1.494 1.767 0 O-C-N 121.323 -0.861 . . . . 0.0 111.261 -179.399 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 93' ' ' THR . . . . . 0.414 ' O ' ' C ' ' A' ' 94' ' ' PRO . 1.0 OUTLIER -73.54 152.5 89.66 Favored Pre-proline 0 C--N 1.3 -1.547 0 O-C-N 120.48 -1.387 . . . . 0.0 108.146 179.729 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 94' ' ' PRO . . . . . 0.414 ' C ' ' O ' ' A' ' 93' ' ' THR . 94.6 Cg_exo -33.29 -57.06 0.35 Allowed 'Trans proline' 0 C--N 1.306 -1.702 0 C-N-CA 122.749 2.299 . . . . 0.0 112.621 -178.463 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 88.0 mt-10 -46.57 -50.29 17.55 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.256 -0.902 . . . . 0.0 110.094 -179.896 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 96' ' ' GLN . . . . . 0.498 ' CD ' ' N ' ' A' ' 96' ' ' GLN . 10.9 mp0 -71.48 -45.41 62.61 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 120.992 -1.067 . . . . 0.0 110.534 -179.231 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 97' ' ' LEU . . . . . 0.422 HD23 ' HA ' ' A' ' 97' ' ' LEU . 61.5 mt -57.64 -7.29 0.63 Allowed 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.095 -1.003 . . . . 0.0 110.473 -178.585 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 98' ' ' ASN . . . . . 0.474 ' ND2' ' O ' ' A' ' 98' ' ' ASN . 0.0 OUTLIER -77.66 -29.09 51.41 Favored 'General case' 0 N--CA 1.494 1.759 0 O-C-N 120.946 -1.097 . . . . 0.0 109.44 179.208 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 99' ' ' ARG . . . . . 0.667 HH11 ' CG ' ' A' ' 99' ' ' ARG . 1.1 mtt-85 -90.17 -44.63 9.64 Favored 'General case' 0 N--CA 1.489 1.495 0 O-C-N 121.667 -0.646 . . . . 0.0 110.322 -178.36 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . 173.71 175.83 41.71 Favored Glycine 0 N--CA 1.491 2.335 0 C-N-CA 119.342 -1.409 . . . . 0.0 110.343 179.938 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 101' ' ' VAL . . . . . 0.692 HG23 ' O ' ' A' ' 101' ' ' VAL . 33.5 m -50.05 109.0 0.1 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.543 0 O-C-N 121.564 -0.962 . . . . 0.0 109.029 179.814 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -92.58 159.29 15.55 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.159 -0.963 . . . . 0.0 110.683 -179.321 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 103' ' ' PHE . . . . . 0.58 ' O ' ' N ' ' A' ' 105' ' ' GLU . 26.7 m-85 -61.1 123.79 18.67 Favored 'General case' 0 N--CA 1.491 1.58 0 N-CA-C 107.982 -1.118 . . . . 0.0 107.982 178.662 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 104' ' ' ALA . . . . . 0.562 ' HB1' ' HG2' ' C' ' 703' ' ' PRO . . . -47.04 -9.75 0.02 OUTLIER 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.061 -1.024 . . . . 0.0 110.249 -179.073 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 105' ' ' GLU . . . . . 0.58 ' N ' ' O ' ' A' ' 103' ' ' PHE . 0.4 OUTLIER -137.89 142.84 40.66 Favored 'General case' 0 N--CA 1.496 1.839 0 O-C-N 120.803 -1.186 . . . . 0.0 110.266 179.643 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 106' ' ' GLU . . . . . . . . . . . . . 33.6 tt0 -58.24 -63.33 1.3 Allowed 'General case' 0 C--N 1.301 -1.516 0 O-C-N 121.951 -0.468 . . . . 0.0 110.661 -179.458 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 107' ' ' ASN . . . . . . . . . . . . . 7.6 m120 -78.67 34.98 0.23 Allowed 'General case' 0 N--CA 1.488 1.449 0 O-C-N 120.874 -1.141 . . . . 0.0 112.969 -175.924 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 108' ' ' GLU . . . . . . . . . . . . . 1.7 tp10 -60.55 148.28 38.57 Favored 'General case' 0 N--CA 1.489 1.486 0 O-C-N 120.685 -1.259 . . . . 0.0 108.327 179.766 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 109' ' ' SER . . . . . . . . . . . . . 2.8 t -98.02 146.91 25.05 Favored 'General case' 0 N--CA 1.489 1.482 0 O-C-N 121.115 -0.991 . . . . 0.0 110.664 -178.675 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 110' ' ' LEU . . . . . 0.843 HD13 ' O ' ' A' ' 63' ' ' PRO . 0.6 OUTLIER -63.42 -22.6 66.98 Favored 'General case' 0 C--N 1.301 -1.543 0 N-CA-C 107.974 -1.121 . . . . 0.0 107.974 179.136 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 111' ' ' ASP . . . . . 0.579 ' CG ' HH22 ' A' ' 151' ' ' ARG . 48.5 m-20 -132.81 44.01 2.91 Favored 'General case' 0 N--CA 1.487 1.412 0 O-C-N 121.589 -0.694 . . . . 0.0 110.21 -179.779 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 112' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -67.96 150.16 48.85 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 120.99 -1.069 . . . . 0.0 110.069 179.557 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 113' ' ' GLN . . . . . . . . . . . . . 2.3 mp0 -65.93 -13.92 60.61 Favored 'General case' 0 N--CA 1.488 1.475 0 N-CA-C 108.008 -1.108 . . . . 0.0 108.008 178.426 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 114' ' ' ASN . . . . . 0.436 ' ND2' ' O ' ' A' ' 170' ' ' ASP . 1.8 t30 -147.87 99.26 3.06 Favored 'General case' 0 C--N 1.301 -1.523 0 N-CA-C 107.206 -1.405 . . . . 0.0 107.206 178.193 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 115' ' ' ILE . . . . . 0.474 ' O ' HG22 ' A' ' 115' ' ' ILE . 2.9 mt -98.13 111.41 27.79 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.627 0 O-C-N 120.969 -1.082 . . . . 0.0 109.637 -179.013 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 116' ' ' SER . . . . . . . . . . . . . 87.5 p -101.87 151.42 22.11 Favored 'General case' 0 N--CA 1.491 1.604 0 CA-C-O 122.055 0.931 . . . . 0.0 111.86 -178.329 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 117' ' ' ILE . . . . . . . . . . . . . 2.1 mt -139.66 159.78 27.54 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.599 0 N-CA-C 108.496 -0.927 . . . . 0.0 108.496 179.504 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 118' ' ' ALA . . . . . 0.867 ' HB1' ' HB2' ' C' ' 704' ' ' ALA . . . -143.3 155.72 44.53 Favored 'General case' 0 N--CA 1.489 1.518 0 C-N-CA 118.758 -1.177 . . . . 0.0 111.326 -179.391 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 119' ' ' GLY . . . . . . . . . . . . . . . -166.32 146.07 10.61 Favored Glycine 0 N--CA 1.485 1.966 0 N-CA-C 110.358 -1.097 . . . . 0.0 110.358 -179.854 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 120' ' ' HIS . . . . . 0.633 ' NE2' ' N ' ' C' ' 705' ' ' B27 . 35.1 m170 -71.63 167.28 20.14 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.93 -0.747 . . . . 0.0 109.721 179.202 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 121' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -116.33 147.31 41.7 Favored 'General case' 0 N--CA 1.495 1.779 0 N-CA-C 108.158 -1.053 . . . . 0.0 108.158 178.533 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 122' ' ' PHE . . . . . 0.642 ' O ' HG21 ' A' ' 131' ' ' THR . 0.3 OUTLIER -110.61 123.56 50.21 Favored 'General case' 0 N--CA 1.497 1.924 0 O-C-N 120.908 -1.12 . . . . 0.0 109.955 -179.874 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 123' ' ' ILE . . . . . 0.615 HG23 ' N ' ' A' ' 124' ' ' ASP . 11.8 tt -69.17 -42.96 81.85 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.824 0 O-C-N 121.367 -0.833 . . . . 0.0 109.4 179.427 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 124' ' ' ASP . . . . . 0.615 ' N ' HG23 ' A' ' 123' ' ' ILE . 61.1 t0 -93.24 23.81 4.21 Favored 'General case' 0 N--CA 1.494 1.747 0 O-C-N 121.421 -0.799 . . . . 0.0 111.136 -179.16 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 125' ' ' ARG . . . . . . . . . . . . . 3.3 ttt180 -157.9 107.35 1.76 Allowed Pre-proline 0 N--CA 1.492 1.667 0 O-C-N 120.616 -1.303 . . . . 0.0 110.253 -179.523 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 126' ' ' PRO . . . . . . . . . . . . . 71.9 Cg_endo -83.05 -20.24 5.29 Favored 'Trans proline' 0 C--N 1.314 -1.289 0 C-N-CA 122.368 2.046 . . . . 0.0 112.325 179.482 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 127' ' ' ASN . . . . . . . . . . . . . 19.1 m-20 -91.12 23.93 3.06 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.276 -0.89 . . . . 0.0 109.668 179.94 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 128' ' ' TYR . . . . . . . . . . . . . 10.0 t80 -81.09 -149.4 0.07 Allowed 'General case' 0 C--N 1.301 -1.516 0 O-C-N 121.162 -0.961 . . . . 0.0 109.589 -179.692 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 129' ' ' GLN . . . . . . . . . . . . . 69.2 mt-30 -67.12 -69.61 0.3 Allowed 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.246 -0.909 . . . . 0.0 110.684 -178.941 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 130' ' ' PHE . . . . . 0.492 ' CE2' HG11 ' A' ' 101' ' ' VAL . 52.8 m-85 -129.23 36.72 4.13 Favored 'General case' 0 N--CA 1.496 1.827 0 O-C-N 121.249 -0.907 . . . . 0.0 110.524 -179.214 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 131' ' ' THR . . . . . 0.642 HG21 ' O ' ' A' ' 122' ' ' PHE . 33.8 m -80.86 -33.72 34.27 Favored 'General case' 0 N--CA 1.493 1.687 0 O-C-N 120.815 -1.178 . . . . 0.0 108.965 179.461 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 132' ' ' ASN . . . . . 0.685 ' OD1' HD11 ' A' ' 83' ' ' ILE . 0.1 OUTLIER -84.62 5.89 26.12 Favored 'General case' 0 N--CA 1.495 1.8 0 CA-C-O 121.876 0.846 . . . . 0.0 109.986 -179.246 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 133' ' ' LEU . . . . . 0.599 ' O ' ' N ' ' A' ' 135' ' ' ALA . 0.2 OUTLIER -68.5 -46.76 68.77 Favored 'General case' 0 C--N 1.299 -1.595 0 O-C-N 121.159 -0.963 . . . . 0.0 110.529 -179.748 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 134' ' ' LYS . . . . . 0.543 ' H ' ' CD ' ' A' ' 134' ' ' LYS . 0.1 OUTLIER -41.68 -18.18 0.01 OUTLIER 'General case' 0 N--CA 1.496 1.826 0 O-C-N 121.07 -1.019 . . . . 0.0 110.328 -179.133 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 135' ' ' ALA . . . . . 0.599 ' N ' ' O ' ' A' ' 133' ' ' LEU . . . -82.87 -39.48 21.54 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 120.951 -1.093 . . . . 0.0 109.855 -179.773 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 136' ' ' ALA . . . . . 0.788 ' HB2' ' HB2' ' A' ' 81' ' ' ALA . . . -78.9 156.63 28.52 Favored 'General case' 0 C--N 1.299 -1.59 0 CA-C-O 122.179 0.99 . . . . 0.0 111.698 -178.506 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 137' ' ' LYS . . . . . 0.513 ' O ' ' O ' ' A' ' 138' ' ' LYS . 1.2 ttmt -156.01 -163.21 1.43 Allowed 'General case' 0 N--CA 1.49 1.543 0 C-N-CA 118.832 -1.147 . . . . 0.0 110.455 -178.92 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 138' ' ' LYS . . . . . 0.596 ' O ' ' N ' ' A' ' 140' ' ' SER . 0.1 OUTLIER -46.44 -178.29 0.0 OUTLIER 'General case' 0 C--N 1.302 -1.479 0 CA-C-O 122.043 0.925 . . . . 0.0 110.36 -179.332 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 139' ' ' GLY . . . . . . . . . . . . . . . 45.84 8.1 0.02 OUTLIER Glycine 0 N--CA 1.492 2.411 0 N-CA-C 110.707 -0.957 . . . . 0.0 110.707 179.956 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 140' ' ' SER . . . . . 0.596 ' N ' ' O ' ' A' ' 138' ' ' LYS . 66.1 m -90.54 136.86 32.79 Favored 'General case' 0 N--CA 1.493 1.7 0 O-C-N 120.768 -1.43 . . . . 0.0 109.606 179.412 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 141' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -78.21 142.16 38.11 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.092 -1.005 . . . . 0.0 109.154 179.729 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 142' ' ' VAL . . . . . . . . . . . . . 21.2 t -131.14 127.82 61.2 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.711 0 O-C-N 121.366 -0.834 . . . . 0.0 109.148 -179.845 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 143' ' ' TYR . . . . . . . . . . . . . 6.4 m-85 -105.51 134.22 48.99 Favored 'General case' 0 N--CA 1.498 1.971 0 O-C-N 121.313 -0.867 . . . . 0.0 112.223 -177.913 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 144' ' ' PHE . . . . . . . . . . . . . 57.4 t80 -119.7 98.09 5.95 Favored 'General case' 0 N--CA 1.494 1.741 0 CA-C-O 121.403 0.62 . . . . 0.0 109.406 179.409 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 145' ' ' LYS . . . . . . . . . . . . . 11.8 mttt -93.49 128.44 39.6 Favored 'General case' 0 N--CA 1.492 1.668 0 O-C-N 121.361 -0.837 . . . . 0.0 110.632 -179.217 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 146' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -142.11 137.87 30.23 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.778 0 N-CA-C 107.619 -1.252 . . . . 0.0 107.619 179.098 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 147' ' ' GLY . . . . . . . . . . . . . . . 48.45 -134.06 19.93 Favored Glycine 0 N--CA 1.49 2.241 0 N-CA-C 108.854 -1.698 . . . . 0.0 108.854 -179.493 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 148' ' ' ASN . . . . . 0.578 ' C ' HD22 ' A' ' 148' ' ' ASN . 0.4 OUTLIER -101.17 18.52 19.66 Favored 'General case' 0 C--N 1.301 -1.516 0 O-C-N 121.229 -1.159 . . . . 0.0 107.941 178.959 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 149' ' ' GLU . . . . . . . . . . . . . 26.2 tt0 -112.59 147.46 36.61 Favored 'General case' 0 N--CA 1.484 1.266 0 CA-C-O 121.97 0.89 . . . . 0.0 111.255 -178.957 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 150' ' ' THR . . . . . 0.468 ' O ' HG22 ' A' ' 150' ' ' THR . 1.7 m -129.42 103.64 7.02 Favored 'General case' 0 N--CA 1.489 1.509 0 CA-C-O 121.477 0.656 . . . . 0.0 110.052 -179.966 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 151' ' ' ARG . . . . . 0.579 HH22 ' CG ' ' A' ' 111' ' ' ASP . 94.5 mtt180 -93.05 128.75 39.06 Favored 'General case' 0 N--CA 1.487 1.403 0 N-CA-C 107.938 -1.134 . . . . 0.0 107.938 179.008 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 152' ' ' LYS . . . . . 0.432 ' O ' ' N ' ' A' ' 205' ' ' VAL . 14.4 mtmt -91.68 156.01 17.9 Favored 'General case' 0 C--N 1.297 -1.697 0 C-N-CA 119.183 -1.007 . . . . 0.0 110.021 -179.115 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 153' ' ' TYR . . . . . 0.516 ' CD2' ' HA ' ' A' ' 204' ' ' GLU . 30.7 m-85 -143.51 167.1 23.02 Favored 'General case' 0 N--CA 1.49 1.536 0 N-CA-C 107.428 -1.323 . . . . 0.0 107.428 178.953 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 154' ' ' LYS . . . . . . . . . . . . . 17.8 ttpt -143.16 123.0 13.44 Favored 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.071 -1.018 . . . . 0.0 108.286 178.592 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 155' ' ' MET . . . . . . . . . . . . . 3.6 mtt -47.07 109.49 0.21 Allowed 'General case' 0 N--CA 1.492 1.674 0 O-C-N 120.856 -1.153 . . . . 0.0 111.207 -178.595 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 156' ' ' THR . . . . . 0.458 ' OG1' ' N ' ' A' ' 203' ' ' THR . 0.2 OUTLIER -103.89 -29.78 10.75 Favored 'General case' 0 C--N 1.29 -1.99 0 CA-C-N 115.269 -0.878 . . . . 0.0 110.102 -178.915 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 157' ' ' SER . . . . . 0.409 ' O ' ' N ' ' A' ' 201' ' ' VAL . 0.1 OUTLIER -155.71 157.58 36.83 Favored 'General case' 0 N--CA 1.492 1.641 0 C-N-CA 118.438 -1.305 . . . . 0.0 111.556 -178.816 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 158' ' ' ILE . . . . . 0.465 HG13 ' CD2' ' A' ' 200' ' ' PHE . 0.0 OUTLIER -156.77 148.23 11.14 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.393 0 CA-C-O 121.823 0.82 . . . . 0.0 110.285 179.823 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 159' ' ' ARG . . . . . 0.454 ' O ' ' OD1' ' A' ' 160' ' ' ASP . 6.1 ttm180 -153.59 -173.24 4.5 Favored 'General case' 0 C--N 1.299 -1.622 0 CA-C-O 121.737 0.779 . . . . 0.0 110.502 -179.559 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 160' ' ' ASP . . . . . 0.454 ' OD1' ' O ' ' A' ' 159' ' ' ARG . 2.5 m-20 -145.0 158.78 43.71 Favored 'General case' 0 C--N 1.301 -1.535 0 N-CA-C 108.378 -0.971 . . . . 0.0 108.378 -179.817 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 161' ' ' VAL . . . . . 0.451 HG21 HG22 ' A' ' 168' ' ' VAL . 0.1 OUTLIER -155.57 157.27 4.19 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.99 0 O-C-N 120.994 -1.066 . . . . 0.0 110.686 179.706 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 162' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -46.22 169.19 0.09 OUTLIER Pre-proline 0 N--CA 1.496 1.827 0 O-C-N 121.419 -0.801 . . . . 0.0 110.372 -179.776 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 163' ' ' PRO . . . . . . . . . . . . . 73.8 Cg_endo -78.97 28.57 0.49 Allowed 'Trans proline' 0 N--CA 1.493 1.466 0 C-N-CA 123.025 2.483 . . . . 0.0 113.575 -179.778 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 164' ' ' THR . . . . . 0.585 ' O ' HG22 ' A' ' 164' ' ' THR . 67.3 m -150.87 -2.66 0.34 Allowed 'General case' 0 N--CA 1.496 1.842 0 O-C-N 120.962 -1.086 . . . . 0.0 110.012 179.792 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 165' ' ' ASP . . . . . 0.927 ' O ' HG23 ' A' ' 168' ' ' VAL . 2.2 t70 -76.3 64.98 2.15 Favored 'General case' 0 N--CA 1.488 1.471 0 O-C-N 121.203 -0.936 . . . . 0.0 110.112 -179.957 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 166' ' ' VAL . . . . . 0.605 ' O ' ' N ' ' A' ' 168' ' ' VAL . 1.0 OUTLIER -44.4 -32.05 0.78 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.531 0 O-C-N 120.943 -1.098 . . . . 0.0 108.805 -179.099 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 167' ' ' GLY . . . . . 0.446 ' C ' ' O ' ' A' ' 166' ' ' VAL . . . -42.67 -16.76 0.03 OUTLIER Glycine 0 N--CA 1.491 2.316 0 N-CA-C 109.795 -1.322 . . . . 0.0 109.795 179.535 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 168' ' ' VAL . . . . . 0.927 HG23 ' O ' ' A' ' 165' ' ' ASP . 47.6 t -50.27 -32.6 9.44 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.434 0 O-C-N 121.014 -1.286 . . . . 0.0 108.455 179.728 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 169' ' ' LEU . . . . . 0.518 ' O ' ' C ' ' A' ' 170' ' ' ASP . 98.8 mt -46.91 -14.48 0.03 OUTLIER 'General case' 0 N--CA 1.49 1.566 0 N-CA-C 108.075 -1.083 . . . . 0.0 108.075 -178.816 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 170' ' ' ASP . . . . . 0.567 ' N ' ' O ' ' A' ' 168' ' ' VAL . 9.2 p30 19.94 91.0 0.01 OUTLIER 'General case' 0 N--CA 1.499 2.012 0 N-CA-C 112.651 0.611 . . . . 0.0 112.651 177.669 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 171' ' ' GLU . . . . . . . . . . . . . 16.5 pt-20 -127.02 69.14 1.27 Allowed 'General case' 0 N--CA 1.495 1.809 0 O-C-N 121.099 -1.001 . . . . 0.0 109.493 178.488 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 172' ' ' GLN . . . . . . . . . . . . . 1.6 mp0 -133.69 -47.41 0.81 Allowed 'General case' 0 N--CA 1.495 1.79 0 O-C-N 121.329 -0.857 . . . . 0.0 110.723 -178.387 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 173' ' ' LYS . . . . . . . . . . . . . 9.0 mttp -63.4 125.56 24.58 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 120.835 -1.165 . . . . 0.0 108.992 179.861 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 174' ' ' GLY . . . . . 0.564 ' O ' ' C ' ' A' ' 175' ' ' LYS . . . -133.2 -39.13 0.21 Allowed Glycine 0 C--N 1.298 -1.541 0 N-CA-C 108.543 -1.823 . . . . 0.0 108.543 179.888 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 175' ' ' LYS . . . . . 0.564 ' C ' ' O ' ' A' ' 174' ' ' GLY . 3.8 mptt -32.33 -63.36 0.2 Allowed 'General case' 0 N--CA 1.499 2.015 0 N-CA-C 108.14 -1.059 . . . . 0.0 108.14 179.576 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 176' ' ' ASP . . . . . 0.665 ' O ' ' O ' ' A' ' 177' ' ' LYS . 1.0 OUTLIER -103.01 77.37 1.55 Allowed 'General case' 0 C--N 1.296 -1.72 0 N-CA-C 106.418 -1.697 . . . . 0.0 106.418 176.413 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 177' ' ' LYS . . . . . 0.665 ' O ' ' O ' ' A' ' 176' ' ' ASP . 10.1 mttt -26.74 163.55 0.0 OUTLIER 'General case' 0 N--CA 1.505 2.313 0 CA-C-O 122.091 0.948 . . . . 0.0 112.047 -178.111 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 178' ' ' GLN . . . . . 0.676 ' NE2' HG13 ' A' ' 201' ' ' VAL . 0.0 OUTLIER -158.45 168.33 27.23 Favored 'General case' 0 N--CA 1.489 1.499 0 C-N-CA 117.832 -1.547 . . . . 0.0 111.96 -179.792 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 179' ' ' LEU . . . . . 0.408 ' HB2' ' CE2' ' A' ' 153' ' ' TYR . 0.6 OUTLIER -124.65 101.9 7.34 Favored 'General case' 0 C--N 1.302 -1.47 0 N-CA-C 107.074 -1.454 . . . . 0.0 107.074 178.453 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 180' ' ' THR . . . . . . . . . . . . . 2.1 m -76.12 122.38 24.2 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.202 -0.936 . . . . 0.0 110.595 -177.973 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 181' ' ' LEU . . . . . . . . . . . . . 9.8 tp -98.8 111.79 24.07 Favored 'General case' 0 N--CA 1.493 1.706 0 O-C-N 121.272 -0.893 . . . . 0.0 109.23 178.774 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 182' ' ' ILE . . . . . 0.563 HG23 HG22 ' A' ' 199' ' ' ILE . 37.1 mt -100.1 122.99 52.66 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.489 0 O-C-N 120.972 -1.08 . . . . 0.0 109.148 178.357 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 183' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -138.9 107.12 5.76 Favored 'General case' 0 C--N 1.296 -1.743 0 N-CA-C 107.882 -1.155 . . . . 0.0 107.882 179.045 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 184' ' ' CYS . . . . . . . . . . . . . 1.9 p -80.88 157.27 25.7 Favored 'General case' 0 N--CA 1.497 1.915 0 C-N-CA 119.275 -0.97 . . . . 0.0 111.597 -177.48 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 185' ' ' ASP . . . . . 0.586 ' OD1' ' N ' ' A' ' 186' ' ' ASP . 20.0 t0 -167.27 177.16 6.27 Favored 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.635 -0.666 . . . . 0.0 109.393 -179.769 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 186' ' ' ASP . . . . . 0.586 ' N ' ' OD1' ' A' ' 185' ' ' ASP . 0.4 OUTLIER 81.05 54.6 0.02 OUTLIER 'General case' 0 N--CA 1.497 1.884 0 O-C-N 121.336 -0.853 . . . . 0.0 109.598 -179.779 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 187' ' ' TYR . . . . . 0.595 ' CE1' ' O ' ' A' ' 188' ' ' ASN . 37.2 t80 -66.07 132.54 48.76 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.124 -0.985 . . . . 0.0 110.204 -179.941 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 188' ' ' ASN . . . . . 0.834 ' ND2' ' H ' ' A' ' 193' ' ' VAL . 0.5 OUTLIER -99.93 149.72 23.14 Favored 'General case' 0 C--N 1.298 -1.632 0 N-CA-C 107.441 -1.318 . . . . 0.0 107.441 178.115 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 189' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -112.11 -2.84 14.88 Favored 'General case' 0 C--N 1.291 -1.938 0 N-CA-C 108.647 -0.872 . . . . 0.0 108.647 -179.179 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 190' ' ' LYS . . . . . . . . . . . . . 32.9 mttt -83.73 -59.8 2.32 Favored 'General case' 0 N--CA 1.488 1.439 0 N-CA-C 108.48 -0.933 . . . . 0.0 108.48 178.581 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 191' ' ' THR . . . . . 0.592 ' OG1' ' ND2' ' A' ' 188' ' ' ASN . 1.3 p -88.25 -12.18 44.42 Favored 'General case' 0 N--CA 1.493 1.687 0 O-C-N 121.338 -0.851 . . . . 0.0 108.954 179.094 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 192' ' ' GLY . . . . . 0.418 ' N ' ' OD1' ' A' ' 188' ' ' ASN . . . 73.29 41.54 45.74 Favored Glycine 0 N--CA 1.493 2.496 0 N-CA-C 110.588 -1.005 . . . . 0.0 110.588 178.902 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 193' ' ' VAL . . . . . 0.834 ' H ' ' ND2' ' A' ' 188' ' ' ASN . 95.9 t -149.14 163.52 4.4 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.612 0 O-C-N 121.043 -1.269 . . . . 0.0 110.542 179.817 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 194' ' ' TRP . . . . . 0.675 ' CG ' ' SG ' ' C' ' 705' ' ' B27 . 73.4 m95 -83.07 121.55 27.18 Favored 'General case' 0 N--CA 1.49 1.553 0 N-CA-C 108.572 -0.899 . . . . 0.0 108.572 179.358 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 195' ' ' GLU . . . . . . . . . . . . . 2.3 mt-10 -89.65 -61.05 1.78 Allowed 'General case' 0 N--CA 1.495 1.796 0 O-C-N 121.401 -0.812 . . . . 0.0 112.089 -177.523 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 196' ' ' LYS . . . . . . . . . . . . . 12.5 tttt -75.88 148.36 38.36 Favored 'General case' 0 N--CA 1.494 1.736 0 O-C-N 121.142 -0.974 . . . . 0.0 111.068 -177.876 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 197' ' ' ARG . . . . . 0.567 ' CD ' HD22 ' C' ' 702' ' ' LEU . 21.8 mmt180 -124.45 128.56 49.2 Favored 'General case' 0 N--CA 1.494 1.74 0 N-CA-C 108.274 -1.009 . . . . 0.0 108.274 178.361 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 198' ' ' LYS . . . . . . . . . . . . . 11.1 mmtp -116.13 118.42 32.79 Favored 'General case' 0 C--N 1.3 -1.587 0 O-C-N 121.59 -0.694 . . . . 0.0 110.27 -178.916 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 199' ' ' ILE . . . . . 0.693 HG21 HG11 ' A' ' 168' ' ' VAL . 0.8 OUTLIER -136.95 121.39 24.05 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.768 0 CA-C-O 122.6 1.19 . . . . 0.0 110.877 179.474 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 200' ' ' PHE . . . . . 0.515 ' CD1' ' N ' ' A' ' 200' ' ' PHE . 3.1 m-85 -99.3 135.6 40.48 Favored 'General case' 0 N--CA 1.502 2.171 0 O-C-N 120.941 -1.099 . . . . 0.0 109.979 -178.293 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 201' ' ' VAL . . . . . 0.676 HG13 ' NE2' ' A' ' 178' ' ' GLN . 84.4 t -105.33 146.29 12.53 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.849 0 O-C-N 120.94 -1.1 . . . . 0.0 108.968 177.315 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 202' ' ' ALA . . . . . 0.402 ' HA ' ' H ' ' A' ' 156' ' ' THR . . . -134.32 141.46 46.93 Favored 'General case' 0 N--CA 1.493 1.677 0 O-C-N 121.031 -1.043 . . . . 0.0 109.628 -179.749 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 203' ' ' THR . . . . . 0.458 ' N ' ' OG1' ' A' ' 156' ' ' THR . 0.8 OUTLIER -88.93 130.64 35.4 Favored 'General case' 0 N--CA 1.488 1.426 0 CA-C-O 122.457 1.122 . . . . 0.0 111.27 -178.769 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 204' ' ' GLU . . . . . 0.516 ' HA ' ' CD2' ' A' ' 153' ' ' TYR . 1.3 tm-20 -49.39 134.52 18.78 Favored 'General case' 0 C--N 1.297 -1.713 0 C-N-CA 119.223 -0.991 . . . . 0.0 109.28 179.124 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 205' ' ' VAL . . . . . 0.516 ' CG1' ' N ' ' A' ' 206' ' ' LYS . 28.4 t -122.26 162.32 22.05 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.436 0 CA-C-O 122.055 0.931 . . . . 0.0 110.357 -178.02 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 206' ' ' LYS . . . . . 0.516 ' N ' ' CG1' ' A' ' 205' ' ' VAL . 1.3 ptpp? . . . . . 0 C--N 1.294 -1.838 0 CA-C-O 117.906 -1.045 . . . . 0.0 109.37 179.717 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' C' C ' 701' ' ' PHQ . . . . . 0.539 ' O2 ' HG12 ' A' ' 166' ' ' VAL . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 010 nuclear build full ' C' C ' 702' ' ' LEU . . . . . 0.911 ' N ' HD12 ' C' ' 702' ' ' LEU . 0.0 OUTLIER . . . . . 0 N--CA 1.494 1.744 0 N-CA-C 110.231 -0.285 . . . . 0.0 110.231 . . . . . . . . . 2 2 . 1 . 010 nuclear build full ' C' C ' 703' ' ' PRO . . . . . 0.562 ' HG2' ' HB1' ' A' ' 104' ' ' ALA . 51.0 Cg_exo -50.87 -157.23 0.0 OUTLIER 'Trans proline' 0 N--CA 1.496 1.646 0 C-N-CA 122.096 1.864 . . . . 0.0 112.6 179.864 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' C' C ' 704' ' ' ALA . . . . . 0.867 ' HB2' ' HB1' ' A' ' 118' ' ' ALA . . . 51.25 106.75 0.01 OUTLIER 'General case' 0 N--CA 1.493 1.692 0 O-C-N 121.125 -0.984 . . . . 0.0 110.212 179.845 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' C' C ' 705' ' ' B27 . . . . . 0.675 ' SG ' ' CG ' ' A' ' 194' ' ' TRP . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 700' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 011 nuclear build full ' A' A ' 59' ' ' MET . . . . . . . . . . . . . 1.7 mpt? . . . . . 0 N--CA 1.491 1.596 0 N-CA-C 109.591 -0.522 . . . . 0.0 109.591 . . . . . . . . . 0 0 . 1 . 011 nuclear build full ' A' A ' 60' ' ' GLN . . . . . . . . . . . . . 2.4 mt-30 -59.57 -86.47 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.092 -1.005 . . . . 0.0 109.439 -179.879 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . -65.23 169.6 5.5 Favored 'General case' 0 N--CA 1.493 1.714 0 O-C-N 121.308 -0.87 . . . . 0.0 110.194 -179.779 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 62' ' ' LYS . . . . . . . . . . . . . 61.4 tttm -142.17 72.61 22.31 Favored Pre-proline 0 N--CA 1.491 1.614 0 O-C-N 121.285 -0.884 . . . . 0.0 109.716 -179.614 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 63' ' ' PRO . . . . . . . . . . . . . 18.9 Cg_endo -89.32 156.37 5.52 Favored 'Trans proline' 0 C--N 1.307 -1.61 0 C-N-CA 123.576 2.85 . . . . 0.0 111.513 179.64 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 64' ' ' GLN . . . . . 0.579 ' N ' ' CD ' ' A' ' 64' ' ' GLN . 0.0 OUTLIER -154.29 133.91 12.84 Favored 'General case' 0 N--CA 1.493 1.701 0 O-C-N 120.996 -1.065 . . . . 0.0 109.452 179.733 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 65' ' ' ILE . . . . . 0.532 ' CD1' HD13 ' A' ' 110' ' ' LEU . 0.0 OUTLIER -45.95 108.35 0.8 Allowed Pre-proline 0 N--CA 1.489 1.494 0 N-CA-C 107.812 -1.181 . . . . 0.0 107.812 179.155 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 66' ' ' PRO . . . . . . . . . . . . . 60.1 Cg_endo -78.1 -162.68 0.18 Allowed 'Trans proline' 0 C--N 1.311 -1.419 0 C-N-CA 121.618 1.545 . . . . 0.0 112.148 -179.024 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 67' ' ' LYS . . . . . . . . . . . . . 15.8 tttp -89.81 -13.92 35.55 Favored 'General case' 0 C--N 1.301 -1.543 0 O-C-N 121.287 -0.883 . . . . 0.0 109.289 -179.874 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 68' ' ' ASP . . . . . 0.659 ' C ' ' N ' ' A' ' 70' ' ' SER . 0.6 OUTLIER -77.07 64.87 2.6 Favored 'General case' 0 N--CA 1.487 1.395 0 CA-C-O 122.654 1.216 . . . . 0.0 109.762 -179.868 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 69' ' ' LYS . . . . . 0.447 ' C ' ' O ' ' A' ' 68' ' ' ASP . 16.6 ptpt -48.2 -12.16 0.04 OUTLIER 'General case' 0 N--CA 1.516 2.827 0 C-N-CA 116.921 -1.912 . . . . 0.0 106.332 176.567 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 70' ' ' SER . . . . . 0.659 ' N ' ' C ' ' A' ' 68' ' ' ASP . 1.9 m -84.83 -6.38 59.35 Favored 'General case' 0 C--N 1.297 -1.688 0 CA-C-N 113.094 -1.866 . . . . 0.0 110.764 179.117 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 71' ' ' LYS . . . . . 0.546 ' N ' ' O ' ' A' ' 68' ' ' ASP . 0.3 OUTLIER -100.42 144.33 29.55 Favored 'General case' 0 N--CA 1.5 2.068 0 O-C-N 120.649 -1.282 . . . . 0.0 111.759 -179.661 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 72' ' ' VAL . . . . . 0.525 HG12 ' CE1' ' A' ' 88' ' ' TYR . 0.7 OUTLIER -66.4 134.08 30.38 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.369 0 N-CA-C 105.085 -2.191 . . . . 0.0 105.085 175.638 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 73' ' ' ALA . . . . . 0.549 ' N ' ' O ' ' A' ' 87' ' ' VAL . . . -80.5 -13.96 58.66 Favored 'General case' 0 C--N 1.295 -1.776 0 O-C-N 119.587 -1.946 . . . . 0.0 107.161 -179.525 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 74' ' ' GLY . . . . . 0.417 ' N ' HG23 ' A' ' 72' ' ' VAL . . . 177.16 -159.63 26.06 Favored Glycine 0 N--CA 1.482 1.725 0 N-CA-C 109.835 -1.306 . . . . 0.0 109.835 179.07 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 75' ' ' TYR . . . . . 0.529 ' HA ' HG23 ' A' ' 87' ' ' VAL . 0.6 OUTLIER -143.83 165.96 26.25 Favored 'General case' 0 C--N 1.295 -1.768 0 C-N-CA 119.468 -0.893 . . . . 0.0 110.75 -177.283 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 76' ' ' ILE . . . . . . . . . . . . . 1.2 tt -148.38 147.4 17.0 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.534 0 C-N-CA 119.346 -0.942 . . . . 0.0 110.072 -178.189 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -150.76 162.48 40.65 Favored 'General case' 0 N--CA 1.486 1.373 0 O-C-N 121.276 -0.89 . . . . 0.0 109.042 179.934 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 78' ' ' ILE . . . . . 0.415 HD12 HD21 ' A' ' 133' ' ' LEU . 38.6 mt -147.62 97.08 4.04 Favored Pre-proline 0 N--CA 1.488 1.445 0 O-C-N 121.238 -0.913 . . . . 0.0 108.817 -179.444 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 79' ' ' PRO . . . . . . . . . . . . . 51.0 Cg_exo -49.15 -45.13 30.84 Favored 'Trans proline' 0 N--CA 1.493 1.485 0 C-N-CA 122.795 2.33 . . . . 0.0 114.423 -178.59 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 80' ' ' ASP . . . . . 0.482 ' O ' ' OD1' ' A' ' 80' ' ' ASP . 47.7 t0 -66.09 -20.26 66.11 Favored 'General case' 0 N--CA 1.496 1.843 0 O-C-N 120.48 -1.387 . . . . 0.0 111.024 179.073 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 81' ' ' ALA . . . . . 0.756 ' HB2' ' HB2' ' A' ' 136' ' ' ALA . . . -107.09 -10.49 15.88 Favored 'General case' 0 N--CA 1.491 1.582 0 N-CA-C 108.528 -0.916 . . . . 0.0 108.528 179.639 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 82' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER 61.42 50.88 4.41 Favored 'General case' 0 N--CA 1.493 1.697 0 O-C-N 121.541 -0.724 . . . . 0.0 110.719 179.481 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 83' ' ' ILE . . . . . . . . . . . . . 46.6 mt -128.83 152.2 36.67 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.815 0 O-C-N 121.062 -1.024 . . . . 0.0 110.229 -178.975 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 84' ' ' LYS . . . . . . . . . . . . . 27.2 tttp -157.88 108.47 2.19 Favored 'General case' 0 N--CA 1.49 1.566 0 N-CA-C 107.662 -1.236 . . . . 0.0 107.662 179.762 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 85' ' ' GLU . . . . . 0.512 ' OE2' ' O ' ' A' ' 129' ' ' GLN . 0.0 OUTLIER -141.6 163.35 41.61 Favored Pre-proline 0 N--CA 1.494 1.771 0 O-C-N 121.283 -0.886 . . . . 0.0 110.88 -178.361 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 86' ' ' PRO . . . . . 0.41 ' N ' ' CE2' ' A' ' 75' ' ' TYR . 40.9 Cg_endo -72.15 165.36 32.84 Favored 'Trans proline' 0 N--CA 1.495 1.609 0 C-N-CA 123.259 2.639 . . . . 0.0 113.031 -179.882 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 87' ' ' VAL . . . . . 0.549 ' O ' ' N ' ' A' ' 73' ' ' ALA . 66.0 t -124.36 98.96 5.76 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.695 0 N-CA-C 108.903 -0.777 . . . . 0.0 108.903 179.54 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 88' ' ' TYR . . . . . 0.525 ' CE1' HG12 ' A' ' 72' ' ' VAL . 15.9 m-85 -91.45 155.58 44.02 Favored Pre-proline 0 N--CA 1.501 2.12 0 O-C-N 120.964 -1.085 . . . . 0.0 110.224 -179.212 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 89' ' ' PRO . . . . . 0.411 ' HA ' ' CD2' ' A' ' 103' ' ' PHE . 9.6 Cg_endo -61.75 145.25 97.45 Favored 'Trans proline' 0 C--N 1.311 -1.443 0 C-N-CA 122.639 2.226 . . . . 0.0 113.408 179.683 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . -58.82 168.23 6.34 Favored Glycine 0 N--CA 1.494 2.504 0 N-CA-C 109.408 -1.477 . . . . 0.0 109.408 179.305 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 91' ' ' PRO . . . . . 0.426 ' C ' ' H ' ' A' ' 93' ' ' THR . 97.5 Cg_endo -94.13 169.53 18.82 Favored 'Cis proline' 0 C--N 1.307 -1.654 0 C-N-CA 123.873 -1.303 . . . . 0.0 112.021 -0.257 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 92' ' ' ALA . . . . . 0.631 ' HB1' HD21 ' A' ' 97' ' ' LEU . . . -72.16 31.47 0.06 Allowed 'General case' 0 N--CA 1.489 1.49 0 O-C-N 121.217 -0.927 . . . . 0.0 110.756 -179.786 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 93' ' ' THR . . . . . 0.435 ' O ' ' C ' ' A' ' 94' ' ' PRO . 6.0 p -72.41 151.42 91.88 Favored Pre-proline 0 N--CA 1.492 1.643 0 O-C-N 120.543 -1.348 . . . . 0.0 108.075 179.865 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 94' ' ' PRO . . . . . 0.435 ' C ' ' O ' ' A' ' 93' ' ' THR . 88.7 Cg_exo -31.68 -57.91 0.23 Allowed 'Trans proline' 0 C--N 1.306 -1.692 0 C-N-CA 122.702 2.268 . . . . 0.0 112.636 -178.656 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 95' ' ' GLU . . . . . 0.431 ' O ' ' OD1' ' A' ' 98' ' ' ASN . 29.0 mt-10 -43.87 -49.09 8.39 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.11 -0.994 . . . . 0.0 109.715 179.929 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 96' ' ' GLN . . . . . 0.586 ' O ' ' N ' ' A' ' 98' ' ' ASN . 39.2 mm-40 -71.63 -56.98 4.81 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.195 -0.941 . . . . 0.0 110.981 -179.058 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 97' ' ' LEU . . . . . 0.631 HD21 ' HB1' ' A' ' 92' ' ' ALA . 91.7 mt -48.95 -5.99 0.02 OUTLIER 'General case' 0 N--CA 1.495 1.783 0 O-C-N 120.989 -1.069 . . . . 0.0 109.878 -179.156 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 98' ' ' ASN . . . . . 0.586 ' C ' ' ND2' ' A' ' 98' ' ' ASN . 0.0 OUTLIER -73.2 -28.63 62.3 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.213 -0.929 . . . . 0.0 108.904 179.466 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 99' ' ' ARG . . . . . 0.494 ' HG2' HH11 ' A' ' 99' ' ' ARG . 0.0 OUTLIER -92.34 -54.57 3.75 Favored 'General case' 0 N--CA 1.487 1.406 0 O-C-N 121.692 -0.63 . . . . 0.0 109.552 -179.659 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . -179.89 -160.63 25.71 Favored Glycine 0 N--CA 1.491 2.353 0 C-N-CA 119.554 -1.308 . . . . 0.0 110.188 -179.917 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 101' ' ' VAL . . . . . 0.718 HG23 ' O ' ' A' ' 101' ' ' VAL . 20.5 m -61.48 104.93 0.29 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.659 0 O-C-N 121.474 -1.015 . . . . 0.0 109.92 -179.507 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -92.73 157.16 16.59 Favored 'General case' 0 N--CA 1.493 1.715 0 O-C-N 121.495 -0.753 . . . . 0.0 110.67 -179.503 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 103' ' ' PHE . . . . . 0.411 ' CD2' ' HA ' ' A' ' 89' ' ' PRO . 22.1 m-85 -59.69 130.36 46.43 Favored 'General case' 0 N--CA 1.49 1.568 0 N-CA-C 107.468 -1.308 . . . . 0.0 107.468 178.276 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 104' ' ' ALA . . . . . . . . . . . . . . . -50.95 -16.45 0.43 Allowed 'General case' 0 C--N 1.301 -1.542 0 O-C-N 121.378 -0.826 . . . . 0.0 111.467 -178.337 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 105' ' ' GLU . . . . . 0.452 ' CD ' HD13 ' A' ' 169' ' ' LEU . 0.5 OUTLIER -139.49 147.61 41.53 Favored 'General case' 0 N--CA 1.494 1.766 0 O-C-N 120.722 -1.236 . . . . 0.0 110.577 -179.862 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 106' ' ' GLU . . . . . 0.409 ' OE2' ' OD1' ' A' ' 107' ' ' ASN . 3.3 tt0 -54.71 -64.44 0.83 Allowed 'General case' 0 C--N 1.301 -1.527 0 CA-C-N 115.857 -0.611 . . . . 0.0 111.151 -178.986 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 107' ' ' ASN . . . . . 0.409 ' OD1' ' OE2' ' A' ' 106' ' ' GLU . 8.1 m-20 -78.28 33.37 0.19 Allowed 'General case' 0 N--CA 1.49 1.566 0 O-C-N 120.522 -1.361 . . . . 0.0 113.059 -175.325 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 108' ' ' GLU . . . . . . . . . . . . . 27.8 tp10 -59.39 148.41 32.66 Favored 'General case' 0 C--N 1.299 -1.597 0 N-CA-C 107.191 -1.411 . . . . 0.0 107.191 179.886 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 109' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -99.64 129.82 45.81 Favored 'General case' 0 C--N 1.301 -1.504 0 O-C-N 120.987 -1.071 . . . . 0.0 110.443 -178.019 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 110' ' ' LEU . . . . . 0.532 HD13 ' CD1' ' A' ' 65' ' ' ILE . 3.2 tp -59.03 -11.98 4.16 Favored 'General case' 0 C--N 1.301 -1.505 0 N-CA-C 108.02 -1.104 . . . . 0.0 108.02 179.63 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 111' ' ' ASP . . . . . . . . . . . . . 57.7 m-20 -132.57 30.03 4.15 Favored 'General case' 0 N--CA 1.491 1.615 0 N-CA-C 109.0 -0.741 . . . . 0.0 109.0 179.044 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 112' ' ' ASP . . . . . . . . . . . . . 6.2 t0 -67.27 149.1 50.86 Favored 'General case' 0 N--CA 1.493 1.704 0 O-C-N 121.105 -0.997 . . . . 0.0 111.19 -179.056 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 113' ' ' GLN . . . . . 0.423 ' OE1' ' CE ' ' A' ' 177' ' ' LYS . 2.2 mp0 -66.36 -12.83 59.03 Favored 'General case' 0 N--CA 1.49 1.564 0 N-CA-C 108.319 -0.993 . . . . 0.0 108.319 178.285 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 114' ' ' ASN . . . . . 0.618 HD22 ' C ' ' A' ' 114' ' ' ASN . 0.2 OUTLIER -149.92 99.98 2.89 Favored 'General case' 0 N--CA 1.491 1.601 0 N-CA-C 108.204 -1.035 . . . . 0.0 108.204 179.351 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 115' ' ' ILE . . . . . 0.484 ' O ' HG22 ' A' ' 115' ' ' ILE . 3.9 mt -98.79 111.94 29.67 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.621 0 O-C-N 121.111 -0.993 . . . . 0.0 109.497 -179.367 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 116' ' ' SER . . . . . . . . . . . . . 48.9 m -97.84 153.58 18.21 Favored 'General case' 0 N--CA 1.492 1.675 0 O-C-N 121.026 -1.046 . . . . 0.0 110.94 -179.142 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 117' ' ' ILE . . . . . 0.402 HG21 HD13 ' A' ' 117' ' ' ILE . 1.5 mt -144.79 159.94 14.24 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.617 0 N-CA-C 108.629 -0.878 . . . . 0.0 108.629 179.586 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 118' ' ' ALA . . . . . 0.752 ' HB1' ' HB2' ' C' ' 704' ' ' ALA . . . -144.53 160.25 41.44 Favored 'General case' 0 N--CA 1.491 1.606 0 C-N-CA 118.639 -1.224 . . . . 0.0 112.17 -179.441 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 119' ' ' GLY . . . . . . . . . . . . . . . -172.16 146.24 9.16 Favored Glycine 0 N--CA 1.49 2.239 0 N-CA-C 110.622 -0.991 . . . . 0.0 110.622 179.909 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 120' ' ' HIS . . . . . 0.694 ' CE1' HOG1 ' C' ' 705' ' ' B27 . 11.5 m170 -71.29 167.63 19.06 Favored 'General case' 0 N--CA 1.496 1.856 0 O-C-N 121.744 -0.857 . . . . 0.0 110.45 179.483 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 121' ' ' THR . . . . . 0.504 ' OG1' ' NZ ' ' A' ' 134' ' ' LYS . 0.7 OUTLIER -119.02 162.29 18.8 Favored 'General case' 0 N--CA 1.5 2.048 0 O-C-N 121.188 -0.945 . . . . 0.0 108.874 179.301 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 122' ' ' PHE . . . . . 0.648 ' O ' HG21 ' A' ' 131' ' ' THR . 0.3 OUTLIER -133.25 122.37 23.82 Favored 'General case' 0 N--CA 1.499 1.982 0 O-C-N 120.868 -1.145 . . . . 0.0 110.291 -179.281 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 123' ' ' ILE . . . . . 0.563 HG23 ' N ' ' A' ' 124' ' ' ASP . 18.1 tt -65.5 -40.75 89.15 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.582 0 CA-C-O 121.58 0.705 . . . . 0.0 109.217 179.588 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 124' ' ' ASP . . . . . 0.563 ' N ' HG23 ' A' ' 123' ' ' ILE . 1.2 t70 -96.69 25.75 4.97 Favored 'General case' 0 N--CA 1.497 1.914 0 C-N-CA 120.154 -0.619 . . . . 0.0 111.452 -178.473 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 125' ' ' ARG . . . . . 0.655 HH11 ' CG ' ' A' ' 125' ' ' ARG . 0.0 OUTLIER -158.67 106.15 1.62 Allowed Pre-proline 0 N--CA 1.493 1.712 0 O-C-N 120.553 -1.342 . . . . 0.0 110.126 -179.209 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 126' ' ' PRO . . . . . . . . . . . . . 74.3 Cg_endo -81.91 -23.61 4.52 Favored 'Trans proline' 0 N--CA 1.489 1.217 0 C-N-CA 122.293 1.995 . . . . 0.0 112.325 179.834 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 127' ' ' ASN . . . . . . . . . . . . . 1.3 m-20 -90.34 28.91 1.35 Allowed 'General case' 0 N--CA 1.489 1.495 0 O-C-N 121.295 -0.878 . . . . 0.0 109.815 -179.685 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 128' ' ' TYR . . . . . . . . . . . . . 7.6 t80 -83.9 -149.27 0.1 Allowed 'General case' 0 N--CA 1.494 1.735 0 O-C-N 121.303 -0.873 . . . . 0.0 109.15 179.61 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 129' ' ' GLN . . . . . 0.512 ' O ' ' OE2' ' A' ' 85' ' ' GLU . 51.3 mt-30 -67.77 -73.05 0.15 Allowed 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.102 -0.999 . . . . 0.0 109.875 -179.698 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 130' ' ' PHE . . . . . 0.736 ' CE1' HD11 ' A' ' 181' ' ' LEU . 38.7 m-85 -129.63 45.92 2.73 Favored 'General case' 0 N--CA 1.497 1.918 0 O-C-N 121.013 -1.054 . . . . 0.0 110.119 -179.845 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 131' ' ' THR . . . . . 0.648 HG21 ' O ' ' A' ' 122' ' ' PHE . 25.0 m -82.58 -37.64 24.79 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 120.991 -1.068 . . . . 0.0 110.222 -179.919 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 132' ' ' ASN . . . . . 0.577 ' ND2' ' O ' ' A' ' 81' ' ' ALA . 7.6 t30 -83.39 7.84 15.49 Favored 'General case' 0 N--CA 1.491 1.618 0 C-N-CA 119.389 -0.924 . . . . 0.0 111.145 -178.574 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 133' ' ' LEU . . . . . 0.545 ' O ' ' N ' ' A' ' 135' ' ' ALA . 0.1 OUTLIER -70.29 -46.21 64.76 Favored 'General case' 0 C--N 1.301 -1.523 0 O-C-N 120.793 -1.192 . . . . 0.0 109.237 179.936 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 134' ' ' LYS . . . . . 0.599 ' H ' ' CD ' ' A' ' 134' ' ' LYS . 0.0 OUTLIER -43.75 -18.16 0.02 OUTLIER 'General case' 0 N--CA 1.494 1.747 0 O-C-N 121.368 -0.832 . . . . 0.0 109.861 -179.74 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 135' ' ' ALA . . . . . 0.545 ' N ' ' O ' ' A' ' 133' ' ' LEU . . . -83.8 -37.14 22.93 Favored 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.048 -1.032 . . . . 0.0 109.433 179.943 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 136' ' ' ALA . . . . . 0.756 ' HB2' ' HB2' ' A' ' 81' ' ' ALA . . . -79.62 157.05 27.39 Favored 'General case' 0 C--N 1.301 -1.541 0 CA-C-O 122.298 1.047 . . . . 0.0 111.517 -178.502 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 137' ' ' LYS . . . . . 0.562 ' O ' ' O ' ' A' ' 138' ' ' LYS . 0.1 OUTLIER -152.04 -163.26 1.69 Allowed 'General case' 0 C--N 1.304 -1.404 0 C-N-CA 119.017 -1.073 . . . . 0.0 110.03 -178.016 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 138' ' ' LYS . . . . . 0.582 ' O ' ' N ' ' A' ' 140' ' ' SER . 51.2 mttm -41.0 177.67 0.0 OUTLIER 'General case' 0 C--N 1.304 -1.381 0 CA-C-O 122.583 1.182 . . . . 0.0 111.716 -179.093 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 139' ' ' GLY . . . . . . . . . . . . . . . 46.32 8.3 0.02 OUTLIER Glycine 0 N--CA 1.492 2.386 0 N-CA-C 110.353 -1.099 . . . . 0.0 110.353 -179.918 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 140' ' ' SER . . . . . 0.582 ' N ' ' O ' ' A' ' 138' ' ' LYS . 6.3 m -79.0 121.52 25.04 Favored 'General case' 0 N--CA 1.493 1.719 0 O-C-N 120.887 -1.36 . . . . 0.0 109.693 179.258 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 141' ' ' MET . . . . . 0.687 ' SD ' ' N ' ' A' ' 142' ' ' VAL . 5.1 tpp -77.99 125.15 28.92 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.192 -0.943 . . . . 0.0 108.971 179.529 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 142' ' ' VAL . . . . . 0.687 ' N ' ' SD ' ' A' ' 141' ' ' MET . 2.5 t -110.48 131.51 61.38 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.446 0 N-CA-C 108.585 -0.894 . . . . 0.0 108.585 -179.594 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 143' ' ' TYR . . . . . . . . . . . . . 9.8 m-85 -109.98 135.54 50.66 Favored 'General case' 0 N--CA 1.497 1.922 0 O-C-N 121.036 -1.04 . . . . 0.0 111.111 -178.321 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 144' ' ' PHE . . . . . . . . . . . . . 46.7 t80 -121.03 102.48 8.36 Favored 'General case' 0 N--CA 1.49 1.534 0 CA-C-O 121.262 0.553 . . . . 0.0 109.829 -178.957 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 145' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -100.93 121.81 42.4 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.202 -0.936 . . . . 0.0 110.117 -179.966 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 146' ' ' VAL . . . . . 0.537 HG23 ' O ' ' A' ' 73' ' ' ALA . 1.0 OUTLIER -142.53 124.49 12.86 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.581 0 O-C-N 121.126 -0.984 . . . . 0.0 108.424 179.091 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 147' ' ' GLY . . . . . . . . . . . . . . . 66.9 -132.1 31.26 Favored Glycine 0 N--CA 1.49 2.239 0 N-CA-C 108.103 -1.999 . . . . 0.0 108.103 -178.735 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 148' ' ' ASN . . . . . 0.497 ' CG ' ' O ' ' A' ' 148' ' ' ASN . 0.1 OUTLIER -102.43 10.31 39.09 Favored 'General case' 0 C--N 1.301 -1.526 0 O-C-N 121.266 -1.138 . . . . 0.0 108.209 178.955 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 149' ' ' GLU . . . . . 0.402 ' OE1' ' N ' ' A' ' 150' ' ' THR . 1.4 tm-20 -107.91 144.44 35.16 Favored 'General case' 0 N--CA 1.489 1.524 0 CA-C-O 121.941 0.877 . . . . 0.0 111.706 -178.666 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 150' ' ' THR . . . . . 0.402 ' N ' ' OE1' ' A' ' 149' ' ' GLU . 44.2 m -133.8 100.51 4.78 Favored 'General case' 0 N--CA 1.491 1.603 0 CA-C-O 121.517 0.675 . . . . 0.0 109.563 -179.749 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 151' ' ' ARG . . . . . . . . . . . . . 17.4 mtt180 -87.06 -174.16 4.78 Favored 'General case' 0 N--CA 1.488 1.445 0 N-CA-C 108.435 -0.95 . . . . 0.0 108.435 179.994 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 152' ' ' LYS . . . . . 0.477 ' O ' ' N ' ' A' ' 205' ' ' VAL . 35.6 mtmt -148.59 142.95 26.25 Favored 'General case' 0 N--CA 1.488 1.469 0 O-C-N 121.068 -1.02 . . . . 0.0 110.273 -179.335 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 153' ' ' TYR . . . . . 0.57 ' O ' ' SD ' ' A' ' 141' ' ' MET . 2.8 m-85 -136.18 167.77 20.66 Favored 'General case' 0 N--CA 1.492 1.642 0 N-CA-C 107.582 -1.266 . . . . 0.0 107.582 179.029 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 154' ' ' LYS . . . . . . . . . . . . . 1.5 ttpm? -142.26 122.93 14.23 Favored 'General case' 0 N--CA 1.493 1.704 0 O-C-N 121.127 -0.983 . . . . 0.0 108.393 178.387 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 155' ' ' MET . . . . . . . . . . . . . 67.2 mtp -45.57 105.94 0.07 Allowed 'General case' 0 N--CA 1.491 1.608 0 O-C-N 120.586 -1.321 . . . . 0.0 111.351 -178.67 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 156' ' ' THR . . . . . 0.554 ' OG1' HG23 ' A' ' 203' ' ' THR . 0.1 OUTLIER -106.41 -24.87 12.12 Favored 'General case' 0 C--N 1.293 -1.888 0 CA-C-N 115.401 -0.818 . . . . 0.0 110.073 -179.077 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 157' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -151.45 151.5 31.76 Favored 'General case' 0 N--CA 1.494 1.765 0 C-N-CA 118.405 -1.318 . . . . 0.0 111.206 -178.299 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 158' ' ' ILE . . . . . 0.433 HD12 ' CD1' ' A' ' 200' ' ' PHE . 0.1 OUTLIER -154.16 144.4 13.98 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.189 0 CA-C-O 122.039 0.923 . . . . 0.0 110.448 -179.538 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 159' ' ' ARG . . . . . . . . . . . . . 31.4 ttp180 -153.98 155.91 36.45 Favored 'General case' 0 C--N 1.297 -1.685 0 CA-C-O 121.934 0.873 . . . . 0.0 110.76 -179.036 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 160' ' ' ASP . . . . . 0.446 ' C ' HG22 ' A' ' 161' ' ' VAL . 26.5 m-20 -118.65 160.66 21.42 Favored 'General case' 0 N--CA 1.492 1.666 0 N-CA-C 108.957 -0.757 . . . . 0.0 108.957 179.325 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 161' ' ' VAL . . . . . 0.451 ' O ' ' O ' ' A' ' 162' ' ' LYS . 0.0 OUTLIER -164.54 161.65 0.94 Allowed 'Isoleucine or valine' 0 N--CA 1.496 1.826 0 O-C-N 121.003 -1.061 . . . . 0.0 110.213 179.508 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 162' ' ' LYS . . . . . 0.758 ' H ' ' CD ' ' A' ' 162' ' ' LYS . 0.0 OUTLIER -45.99 173.04 0.04 OUTLIER Pre-proline 0 N--CA 1.493 1.723 0 O-C-N 121.591 -0.693 . . . . 0.0 109.815 179.456 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 163' ' ' PRO . . . . . 0.659 ' CA ' HH21 ' A' ' 197' ' ' ARG . 63.1 Cg_endo -81.34 35.06 0.57 Allowed 'Trans proline' 0 C--N 1.313 -1.34 0 C-N-CA 122.532 2.155 . . . . 0.0 112.54 179.815 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 164' ' ' THR . . . . . 0.423 ' N ' HD11 ' C' ' 702' ' ' LEU . 0.2 OUTLIER -150.76 -2.66 0.35 Allowed 'General case' 0 N--CA 1.495 1.814 0 O-C-N 121.053 -1.03 . . . . 0.0 110.821 179.961 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 165' ' ' ASP . . . . . 0.432 ' O ' ' C ' ' A' ' 166' ' ' VAL . 9.7 t70 -75.8 62.66 1.56 Allowed 'General case' 0 N--CA 1.495 1.785 0 O-C-N 120.675 -1.266 . . . . 0.0 110.675 -179.58 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 166' ' ' VAL . . . . . 0.621 ' O ' ' N ' ' A' ' 168' ' ' VAL . 2.6 t -42.99 -31.48 0.49 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.659 0 O-C-N 121.236 -0.915 . . . . 0.0 109.096 -178.853 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 167' ' ' GLY . . . . . . . . . . . . . . . -44.08 -9.81 0.01 OUTLIER Glycine 0 N--CA 1.495 2.632 0 O-C-N 121.126 -0.983 . . . . 0.0 111.055 -179.788 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 168' ' ' VAL . . . . . 0.629 ' C ' ' H ' ' A' ' 170' ' ' ASP . 7.4 m -55.47 -32.18 29.38 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.51 0 O-C-N 120.615 -1.521 . . . . 0.0 108.759 179.543 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 169' ' ' LEU . . . . . 0.564 ' O ' ' N ' ' A' ' 171' ' ' GLU . 9.5 mt -52.53 -4.65 0.03 OUTLIER 'General case' 0 N--CA 1.498 1.969 0 N-CA-C 107.957 -1.127 . . . . 0.0 107.957 -179.328 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 170' ' ' ASP . . . . . 0.629 ' H ' ' C ' ' A' ' 168' ' ' VAL . 0.6 OUTLIER 34.12 28.21 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.762 -0.586 . . . . 0.0 111.713 177.838 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 171' ' ' GLU . . . . . 0.564 ' N ' ' O ' ' A' ' 169' ' ' LEU . 11.8 pt-20 -63.91 93.17 0.08 Allowed 'General case' 0 C--N 1.298 -1.647 0 N-CA-C 107.645 -1.242 . . . . 0.0 107.645 178.528 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 172' ' ' GLN . . . . . . . . . . . . . 1.0 OUTLIER -160.84 -71.75 0.06 Allowed 'General case' 0 N--CA 1.491 1.588 0 CA-C-O 121.263 0.554 . . . . 0.0 109.511 -179.371 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 173' ' ' LYS . . . . . 0.63 ' NZ ' HE21 ' A' ' 178' ' ' GLN . 8.9 pttm -62.09 126.6 27.91 Favored 'General case' 0 N--CA 1.488 1.446 0 O-C-N 121.143 -0.973 . . . . 0.0 108.908 179.631 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 174' ' ' GLY . . . . . 0.568 ' O ' ' C ' ' A' ' 175' ' ' LYS . . . -121.18 -39.81 0.57 Allowed Glycine 0 C--N 1.298 -1.565 0 N-CA-C 108.283 -1.927 . . . . 0.0 108.283 179.721 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 175' ' ' LYS . . . . . 0.568 ' C ' ' O ' ' A' ' 174' ' ' GLY . 0.8 OUTLIER -31.59 -62.22 0.2 Allowed 'General case' 0 N--CA 1.498 1.929 0 N-CA-C 108.124 -1.065 . . . . 0.0 108.124 179.783 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 176' ' ' ASP . . . . . 0.631 ' O ' ' O ' ' A' ' 177' ' ' LYS . 69.6 m-20 -104.09 85.72 2.44 Favored 'General case' 0 C--N 1.294 -1.815 0 N-CA-C 107.487 -1.301 . . . . 0.0 107.487 177.092 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 177' ' ' LYS . . . . . 0.631 ' O ' ' O ' ' A' ' 176' ' ' ASP . 35.8 mttt -37.23 174.08 0.0 OUTLIER 'General case' 0 N--CA 1.497 1.904 0 CA-C-O 121.696 0.76 . . . . 0.0 110.588 -179.113 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 178' ' ' GLN . . . . . 0.63 HE21 ' NZ ' ' A' ' 173' ' ' LYS . 0.6 OUTLIER -161.51 175.42 12.15 Favored 'General case' 0 N--CA 1.489 1.479 0 C-N-CA 118.371 -1.332 . . . . 0.0 111.105 -179.864 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 179' ' ' LEU . . . . . 0.422 ' N ' ' OE1' ' A' ' 178' ' ' GLN . 1.3 tp -128.44 98.0 4.9 Favored 'General case' 0 C--N 1.302 -1.485 0 N-CA-C 107.274 -1.38 . . . . 0.0 107.274 178.103 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 180' ' ' THR . . . . . 0.481 ' N ' ' OE1' ' A' ' 178' ' ' GLN . 1.1 m -71.66 120.74 17.67 Favored 'General case' 0 N--CA 1.486 1.371 0 O-C-N 121.1 -1.0 . . . . 0.0 110.157 -178.341 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 181' ' ' LEU . . . . . 0.854 HD23 ' N ' ' A' ' 182' ' ' ILE . 6.6 tt -95.69 146.71 24.29 Favored 'General case' 0 C--N 1.299 -1.593 0 N-CA-C 107.915 -1.143 . . . . 0.0 107.915 178.01 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 182' ' ' ILE . . . . . 0.854 ' N ' HD23 ' A' ' 181' ' ' LEU . 19.8 mt -141.16 117.47 7.17 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.781 0 O-C-N 121.059 -1.026 . . . . 0.0 108.817 179.081 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 183' ' ' THR . . . . . 0.516 ' O ' HG23 ' A' ' 183' ' ' THR . 14.3 t -138.07 119.01 14.27 Favored 'General case' 0 C--N 1.29 -1.978 0 N-CA-C 108.002 -1.11 . . . . 0.0 108.002 179.229 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 184' ' ' CYS . . . . . . . . . . . . . 0.8 OUTLIER -79.85 162.5 25.01 Favored 'General case' 0 C--N 1.285 -2.236 0 C-N-CA 119.466 -0.894 . . . . 0.0 111.397 -177.842 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 185' ' ' ASP . . . . . 0.417 ' OD1' ' N ' ' A' ' 186' ' ' ASP . 4.4 t0 -165.51 -152.48 0.16 Allowed 'General case' 0 N--CA 1.492 1.644 0 N-CA-C 108.938 -0.764 . . . . 0.0 108.938 179.745 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 186' ' ' ASP . . . . . 0.417 ' N ' ' OD1' ' A' ' 185' ' ' ASP . 0.5 OUTLIER 47.78 59.34 4.25 Favored 'General case' 0 N--CA 1.495 1.777 0 O-C-N 121.136 -0.977 . . . . 0.0 109.072 -179.678 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 187' ' ' TYR . . . . . 0.591 ' CE1' ' O ' ' A' ' 188' ' ' ASN . 43.4 t80 -68.37 134.58 50.46 Favored 'General case' 0 N--CA 1.489 1.485 0 CA-C-O 121.821 0.819 . . . . 0.0 110.612 -179.585 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 188' ' ' ASN . . . . . 0.591 ' O ' ' CE1' ' A' ' 187' ' ' TYR . 0.8 OUTLIER -99.6 146.02 26.9 Favored 'General case' 0 C--N 1.294 -1.838 0 N-CA-C 107.916 -1.142 . . . . 0.0 107.916 178.224 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 189' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -111.55 -18.32 12.85 Favored 'General case' 0 C--N 1.296 -1.734 0 N-CA-C 108.1 -1.074 . . . . 0.0 108.1 -179.812 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 190' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER -83.68 -49.77 8.82 Favored 'General case' 0 C--N 1.302 -1.472 0 N-CA-C 108.267 -1.012 . . . . 0.0 108.267 178.457 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 191' ' ' THR . . . . . . . . . . . . . 44.4 p -87.41 -6.52 58.41 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.487 -0.758 . . . . 0.0 109.514 -179.971 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 192' ' ' GLY . . . . . . . . . . . . . . . 56.53 36.3 70.18 Favored Glycine 0 N--CA 1.493 2.463 0 O-C-N 121.081 -1.012 . . . . 0.0 110.648 179.025 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 193' ' ' VAL . . . . . . . . . . . . . 3.3 m -147.23 161.85 8.15 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.545 0 O-C-N 121.025 -1.279 . . . . 0.0 109.339 179.709 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 194' ' ' TRP . . . . . 0.472 ' N ' ' CD1' ' A' ' 194' ' ' TRP . 22.7 m95 -84.15 118.88 24.4 Favored 'General case' 0 N--CA 1.489 1.495 0 N-CA-C 107.604 -1.258 . . . . 0.0 107.604 178.654 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 195' ' ' GLU . . . . . 0.522 ' CD ' ' ND2' ' A' ' 188' ' ' ASN . 3.5 mt-10 -82.74 -62.09 1.7 Allowed 'General case' 0 N--CA 1.495 1.809 0 O-C-N 121.14 -0.975 . . . . 0.0 112.319 -177.103 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 196' ' ' LYS . . . . . . . . . . . . . 8.0 tptp -86.63 156.46 20.01 Favored 'General case' 0 N--CA 1.494 1.754 0 O-C-N 120.753 -1.217 . . . . 0.0 110.856 -178.141 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 197' ' ' ARG . . . . . 0.659 HH21 ' CA ' ' A' ' 163' ' ' PRO . 6.4 tpp180 -124.98 139.94 53.36 Favored 'General case' 0 N--CA 1.489 1.489 0 N-CA-C 109.133 -0.691 . . . . 0.0 109.133 179.389 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 198' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -112.46 121.8 45.87 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.626 -0.671 . . . . 0.0 109.863 -179.053 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 199' ' ' ILE . . . . . 0.66 HG22 HG23 ' A' ' 182' ' ' ILE . 0.9 OUTLIER -141.51 119.44 8.88 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.665 0 CA-C-O 122.615 1.198 . . . . 0.0 110.996 179.857 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 200' ' ' PHE . . . . . 0.564 ' CE2' HD22 ' A' ' 181' ' ' LEU . 0.2 OUTLIER -104.7 138.71 40.59 Favored 'General case' 0 N--CA 1.494 1.759 0 O-C-N 121.526 -0.734 . . . . 0.0 110.438 -178.305 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 201' ' ' VAL . . . . . . . . . . . . . 58.0 t -101.93 143.52 14.59 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.729 0 O-C-N 120.971 -1.081 . . . . 0.0 108.447 178.314 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 202' ' ' ALA . . . . . . . . . . . . . . . -124.95 135.23 52.63 Favored 'General case' 0 N--CA 1.489 1.477 0 N-CA-C 108.49 -0.93 . . . . 0.0 108.49 179.687 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 203' ' ' THR . . . . . 0.736 ' O ' HG23 ' A' ' 205' ' ' VAL . 1.3 p -89.17 128.4 35.8 Favored 'General case' 0 C--N 1.303 -1.427 0 CA-C-O 122.23 1.014 . . . . 0.0 111.225 -178.61 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 204' ' ' GLU . . . . . 0.484 ' HA ' ' CD2' ' A' ' 153' ' ' TYR . 5.5 tt0 -51.18 134.43 27.22 Favored 'General case' 0 C--N 1.297 -1.684 0 C-N-CA 118.949 -1.101 . . . . 0.0 108.369 178.728 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 205' ' ' VAL . . . . . 0.736 HG23 ' O ' ' A' ' 203' ' ' THR . 95.6 t -131.12 166.81 27.68 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.34 0 CA-C-O 121.934 0.873 . . . . 0.0 110.023 -177.859 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 206' ' ' LYS . . . . . 0.595 ' N ' HG12 ' A' ' 205' ' ' VAL . 2.0 pttp . . . . . 0 C--N 1.298 -1.658 0 CA-C-O 117.925 -1.036 . . . . 0.0 109.455 -179.672 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' C' C ' 701' ' ' PHQ . . . . . 0.471 ' C1 ' HG22 ' A' ' 166' ' ' VAL . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 011 nuclear build full ' C' C ' 702' ' ' LEU . . . . . 0.805 ' N ' HD12 ' C' ' 702' ' ' LEU . 0.0 OUTLIER . . . . . 0 N--CA 1.492 1.67 0 N-CA-C 109.762 -0.458 . . . . 0.0 109.762 . . . . . . . . . 2 2 . 1 . 011 nuclear build full ' C' C ' 703' ' ' PRO . . . . . 0.546 ' HB3' ' HB3' ' A' ' 92' ' ' ALA . 52.7 Cg_exo -48.01 -173.39 0.0 OUTLIER 'Trans proline' 0 N--CA 1.489 1.262 0 C-N-CA 121.957 1.771 . . . . 0.0 111.652 178.948 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' C' C ' 704' ' ' ALA . . . . . 0.752 ' HB2' ' HB1' ' A' ' 118' ' ' ALA . . . 56.76 123.12 0.0 OUTLIER 'General case' 0 N--CA 1.492 1.662 0 O-C-N 121.501 -0.749 . . . . 0.0 109.806 179.673 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' C' C ' 705' ' ' B27 . . . . . 0.694 HOG1 ' CE1' ' A' ' 120' ' ' HIS . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 700' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 012 nuclear build full ' A' A ' 59' ' ' MET . . . . . . . . . . . . . 2.4 mpt? . . . . . 0 N--CA 1.488 1.444 0 CA-C-O 121.519 0.676 . . . . 0.0 109.553 . . . . . . . . . 0 0 . 1 . 012 nuclear build full ' A' A ' 60' ' ' GLN . . . . . . . . . . . . . 27.2 mt-30 -60.71 164.53 4.59 Favored 'General case' 0 C--N 1.299 -1.621 0 N-CA-C 108.576 -0.898 . . . . 0.0 108.576 179.205 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 61' ' ' ALA . . . . . 0.444 ' HB2' ' OD1' ' A' ' 148' ' ' ASN . . . -65.08 -174.42 0.15 Allowed 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.228 -0.92 . . . . 0.0 109.936 -179.673 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 62' ' ' LYS . . . . . 0.648 ' O ' ' NE2' ' A' ' 64' ' ' GLN . 28.2 tttm -148.12 80.36 8.69 Favored Pre-proline 0 N--CA 1.493 1.696 0 O-C-N 121.47 -0.769 . . . . 0.0 109.249 179.448 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 63' ' ' PRO . . . . . 0.788 ' O ' HD13 ' A' ' 110' ' ' LEU . 16.3 Cg_exo -66.94 134.41 34.37 Favored 'Trans proline' 0 C--N 1.305 -1.753 0 C-N-CA 122.741 2.294 . . . . 0.0 111.85 -179.863 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 64' ' ' GLN . . . . . 0.648 ' NE2' ' O ' ' A' ' 62' ' ' LYS . 0.0 OUTLIER -152.75 103.92 2.82 Favored 'General case' 0 N--CA 1.489 1.476 0 O-C-N 121.372 -0.83 . . . . 0.0 109.408 -179.7 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 65' ' ' ILE . . . . . 0.58 ' H ' HD12 ' A' ' 65' ' ' ILE . 3.5 mp -40.14 102.27 0.26 Allowed Pre-proline 0 N--CA 1.488 1.45 0 N-CA-C 108.43 -0.952 . . . . 0.0 108.43 179.233 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 66' ' ' PRO . . . . . 0.411 ' N ' ' O ' ' A' ' 64' ' ' GLN . 97.9 Cg_endo -84.55 -155.61 0.06 OUTLIER 'Trans proline' 0 N--CA 1.489 1.206 0 C-N-CA 122.751 2.3 . . . . 0.0 112.968 -178.124 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 67' ' ' LYS . . . . . 0.44 ' C ' ' H ' ' A' ' 69' ' ' LYS . 6.5 ptpt -82.81 -5.03 58.76 Favored 'General case' 0 C--N 1.305 -1.362 0 N-CA-C 108.877 -0.786 . . . . 0.0 108.877 179.698 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 68' ' ' ASP . . . . . 0.631 ' C ' ' N ' ' A' ' 70' ' ' SER . 0.3 OUTLIER -75.39 50.18 0.51 Allowed 'General case' 0 N--CA 1.491 1.579 0 CA-C-O 123.005 1.383 . . . . 0.0 108.189 179.013 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 69' ' ' LYS . . . . . 0.455 ' C ' ' O ' ' A' ' 68' ' ' ASP . 1.9 mtpt -48.07 -15.17 0.06 Allowed 'General case' 0 N--CA 1.506 2.359 0 C-N-CA 116.758 -1.977 . . . . 0.0 107.149 178.425 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 70' ' ' SER . . . . . 0.631 ' N ' ' C ' ' A' ' 68' ' ' ASP . 0.2 OUTLIER -86.81 -5.22 59.17 Favored 'General case' 0 C--N 1.293 -1.856 0 CA-C-N 113.701 -1.591 . . . . 0.0 110.613 179.758 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 71' ' ' LYS . . . . . 0.446 ' N ' ' O ' ' A' ' 68' ' ' ASP . 2.4 ptmm? -97.28 138.36 34.87 Favored 'General case' 0 N--CA 1.494 1.736 0 O-C-N 120.899 -1.126 . . . . 0.0 112.007 -179.305 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 72' ' ' VAL . . . . . 0.593 ' CG2' ' O ' ' A' ' 74' ' ' GLY . 0.7 OUTLIER -67.01 132.25 32.38 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.444 0 N-CA-C 104.977 -2.231 . . . . 0.0 104.977 174.554 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 73' ' ' ALA . . . . . 0.452 ' N ' ' O ' ' A' ' 87' ' ' VAL . . . -82.04 -12.87 58.05 Favored 'General case' 0 C--N 1.299 -1.617 0 O-C-N 120.121 -1.612 . . . . 0.0 108.681 -178.671 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 74' ' ' GLY . . . . . 0.593 ' O ' ' CG2' ' A' ' 72' ' ' VAL . . . 170.35 -156.4 26.86 Favored Glycine 0 N--CA 1.483 1.784 0 N-CA-C 109.642 -1.383 . . . . 0.0 109.642 179.974 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 75' ' ' TYR . . . . . 0.55 ' CD1' ' C ' ' A' ' 74' ' ' GLY . 10.8 m-85 -143.71 173.81 11.34 Favored 'General case' 0 C--N 1.293 -1.889 0 O-C-N 121.276 -1.132 . . . . 0.0 109.702 -178.811 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 76' ' ' ILE . . . . . . . . . . . . . 1.4 tt -147.25 144.97 19.52 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.79 0 N-CA-C 108.72 -0.844 . . . . 0.0 108.72 -178.067 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -150.48 157.19 42.74 Favored 'General case' 0 C--N 1.301 -1.536 0 O-C-N 121.043 -1.035 . . . . 0.0 109.849 -179.513 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 78' ' ' ILE . . . . . 0.451 HG23 ' O ' ' A' ' 141' ' ' MET . 22.4 mt -142.6 121.28 7.51 Favored Pre-proline 0 C--N 1.301 -1.526 0 N-CA-C 107.291 -1.374 . . . . 0.0 107.291 179.718 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 79' ' ' PRO . . . . . . . . . . . . . 55.6 Cg_endo -73.33 -42.85 0.81 Allowed 'Trans proline' 0 N--CA 1.49 1.321 0 C-N-CA 121.893 1.729 . . . . 0.0 113.569 -177.89 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 19.6 t70 -65.98 -19.4 65.85 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 120.766 -1.209 . . . . 0.0 110.274 178.06 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 81' ' ' ALA . . . . . 0.95 ' HB2' ' HB2' ' A' ' 136' ' ' ALA . . . -105.6 -20.99 13.3 Favored 'General case' 0 N--CA 1.495 1.804 0 O-C-N 121.165 -0.959 . . . . 0.0 108.79 179.502 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 82' ' ' ASP . . . . . 0.423 ' OD2' ' C ' ' A' ' 81' ' ' ALA . 0.4 OUTLIER 68.65 51.56 0.61 Allowed 'General case' 0 C--N 1.303 -1.441 0 O-C-N 121.336 -0.853 . . . . 0.0 111.127 178.816 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 83' ' ' ILE . . . . . 0.6 HD11 ' OD1' ' A' ' 132' ' ' ASN . 57.6 mt -127.15 152.27 34.98 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.864 0 O-C-N 121.163 -0.96 . . . . 0.0 109.481 -179.777 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 84' ' ' LYS . . . . . . . . . . . . . 0.8 OUTLIER -159.26 108.36 1.87 Allowed 'General case' 0 C--N 1.303 -1.435 0 N-CA-C 107.892 -1.151 . . . . 0.0 107.892 179.727 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 85' ' ' GLU . . . . . 0.493 ' OE1' ' O ' ' A' ' 128' ' ' TYR . 0.0 OUTLIER -142.82 170.53 8.58 Favored Pre-proline 0 N--CA 1.497 1.921 0 O-C-N 121.362 -0.836 . . . . 0.0 111.105 -177.597 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 86' ' ' PRO . . . . . . . . . . . . . 90.4 Cg_endo -79.8 161.53 24.34 Favored 'Trans proline' 0 N--CA 1.493 1.474 0 C-N-CA 123.25 2.634 . . . . 0.0 113.247 179.752 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 87' ' ' VAL . . . . . 0.57 ' H ' HG23 ' A' ' 72' ' ' VAL . 92.8 t -118.14 101.97 12.57 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.485 0 N-CA-C 108.99 -0.744 . . . . 0.0 108.99 179.91 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 88' ' ' TYR . . . . . 0.402 ' CE1' ' HB3' ' A' ' 99' ' ' ARG . 17.5 m-85 -93.35 153.93 41.44 Favored Pre-proline 0 N--CA 1.504 2.236 0 O-C-N 120.865 -1.147 . . . . 0.0 110.664 -179.015 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 89' ' ' PRO . . . . . . . . . . . . . 11.2 Cg_endo -62.44 143.0 92.66 Favored 'Trans proline' 0 C--N 1.312 -1.346 0 C-N-CA 122.571 2.181 . . . . 0.0 113.863 -179.067 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 90' ' ' GLY . . . . . 0.412 ' O ' ' NZ ' ' A' ' 69' ' ' LYS . . . -58.33 168.24 5.71 Favored Glycine 0 N--CA 1.487 2.034 0 N-CA-C 110.167 -1.173 . . . . 0.0 110.167 179.611 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 91' ' ' PRO . . . . . 0.465 ' C ' ' H ' ' A' ' 93' ' ' THR . 38.2 Cg_endo -93.11 169.46 21.09 Favored 'Cis proline' 0 C--N 1.307 -1.606 0 C-N-CA 123.713 -1.37 . . . . 0.0 111.497 0.132 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 92' ' ' ALA . . . . . 0.605 ' HB3' ' CB ' ' C' ' 703' ' ' PRO . . . -72.81 33.3 0.07 Allowed 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.02 -1.05 . . . . 0.0 110.237 -179.691 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 93' ' ' THR . . . . . 0.465 ' H ' ' C ' ' A' ' 91' ' ' PRO . 1.6 p -72.21 152.74 92.47 Favored Pre-proline 0 C--N 1.3 -1.559 0 O-C-N 120.86 -1.15 . . . . 0.0 108.008 179.776 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 94' ' ' PRO . . . . . 0.428 ' C ' ' O ' ' A' ' 93' ' ' THR . 92.2 Cg_exo -32.79 -58.73 0.26 Allowed 'Trans proline' 0 C--N 1.305 -1.747 0 C-N-CA 122.575 2.184 . . . . 0.0 112.347 -179.253 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 21.0 mt-10 -44.2 -49.06 9.3 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.249 -0.907 . . . . 0.0 109.971 179.862 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 96' ' ' GLN . . . . . 0.563 ' O ' ' N ' ' A' ' 98' ' ' ASN . 2.5 mp0 -72.33 -55.87 6.41 Favored 'General case' 0 N--CA 1.489 1.491 0 O-C-N 121.203 -0.935 . . . . 0.0 111.014 -178.973 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 97' ' ' LEU . . . . . 0.417 ' CD1' ' O ' ' A' ' 92' ' ' ALA . 80.9 mt -49.21 -6.59 0.02 OUTLIER 'General case' 0 N--CA 1.496 1.845 0 O-C-N 121.067 -1.021 . . . . 0.0 110.279 -178.867 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 98' ' ' ASN . . . . . 0.563 ' N ' ' O ' ' A' ' 96' ' ' GLN . 0.0 OUTLIER -72.77 -25.16 61.07 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.337 -0.852 . . . . 0.0 108.928 179.679 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 99' ' ' ARG . . . . . 0.402 ' HB3' ' CE1' ' A' ' 88' ' ' TYR . 3.5 mtt180 -92.06 -51.97 4.93 Favored 'General case' 0 C--N 1.302 -1.467 0 O-C-N 121.682 -0.636 . . . . 0.0 110.497 -179.035 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . 172.23 -166.58 39.41 Favored Glycine 0 N--CA 1.493 2.486 0 N-CA-C 109.741 -1.343 . . . . 0.0 109.741 -179.687 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 101' ' ' VAL . . . . . 0.623 HG23 ' O ' ' A' ' 101' ' ' VAL . 34.7 m -54.69 100.41 0.04 OUTLIER 'Isoleucine or valine' 0 N--CA 1.493 1.724 0 O-C-N 121.146 -1.209 . . . . 0.0 109.802 -179.659 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 1.9 m -92.07 171.73 8.91 Favored 'General case' 0 N--CA 1.497 1.875 0 O-C-N 121.417 -0.802 . . . . 0.0 110.324 -179.789 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 103' ' ' PHE . . . . . 0.499 ' CE1' ' CG1' ' A' ' 87' ' ' VAL . 23.6 m-85 -75.08 145.68 42.09 Favored 'General case' 0 N--CA 1.493 1.697 0 N-CA-C 108.069 -1.086 . . . . 0.0 108.069 178.263 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 104' ' ' ALA . . . . . . . . . . . . . . . -66.71 -13.42 61.29 Favored 'General case' 0 N--CA 1.492 1.671 0 O-C-N 121.243 -0.911 . . . . 0.0 111.571 -178.105 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 105' ' ' GLU . . . . . 0.452 ' OE2' ' OE1' ' A' ' 108' ' ' GLU . 0.3 OUTLIER -138.6 144.32 39.72 Favored 'General case' 0 N--CA 1.496 1.838 0 O-C-N 120.762 -1.211 . . . . 0.0 110.592 -179.211 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 106' ' ' GLU . . . . . 0.505 ' CG ' ' N ' ' A' ' 107' ' ' ASN . 6.0 pt-20 -57.12 -59.6 4.85 Favored 'General case' 0 C--N 1.304 -1.402 0 O-C-N 121.732 -0.605 . . . . 0.0 110.224 -179.806 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 107' ' ' ASN . . . . . 0.505 ' N ' ' CG ' ' A' ' 106' ' ' GLU . 35.9 p-10 -78.27 33.96 0.2 Allowed 'General case' 0 N--CA 1.488 1.442 0 O-C-N 120.542 -1.349 . . . . 0.0 112.895 -176.114 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 108' ' ' GLU . . . . . 0.452 ' OE1' ' OE2' ' A' ' 105' ' ' GLU . 32.9 tp10 -60.09 147.45 39.37 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 120.824 -1.173 . . . . 0.0 108.141 -179.568 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 109' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -95.25 147.53 23.38 Favored 'General case' 0 N--CA 1.489 1.497 0 O-C-N 120.797 -1.189 . . . . 0.0 111.03 -178.093 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 110' ' ' LEU . . . . . 0.899 HD23 ' H ' ' A' ' 110' ' ' LEU . 0.2 OUTLIER -63.67 -24.61 67.85 Favored 'General case' 0 C--N 1.305 -1.337 0 N-CA-C 107.536 -1.283 . . . . 0.0 107.536 178.548 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 111' ' ' ASP . . . . . 0.491 ' CG ' HH22 ' A' ' 151' ' ' ARG . 55.3 m-20 -132.93 49.19 2.34 Favored 'General case' 0 N--CA 1.487 1.391 0 N-CA-C 109.183 -0.673 . . . . 0.0 109.183 179.513 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 112' ' ' ASP . . . . . . . . . . . . . 1.9 t0 -69.07 159.97 31.9 Favored 'General case' 0 N--CA 1.493 1.72 0 O-C-N 121.257 -0.902 . . . . 0.0 111.287 -179.745 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 113' ' ' GLN . . . . . 0.536 ' N ' ' CD ' ' A' ' 113' ' ' GLN . 0.0 OUTLIER -65.21 -18.52 65.38 Favored 'General case' 0 N--CA 1.491 1.614 0 N-CA-C 107.263 -1.384 . . . . 0.0 107.263 177.675 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 114' ' ' ASN . . . . . 0.608 ' ND2' ' O ' ' A' ' 169' ' ' LEU . 8.5 p-10 -153.11 111.85 3.73 Favored 'General case' 0 C--N 1.299 -1.588 0 N-CA-C 108.026 -1.102 . . . . 0.0 108.026 177.505 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 115' ' ' ILE . . . . . 0.485 HG22 ' O ' ' A' ' 115' ' ' ILE . 2.5 mt -96.82 105.68 17.44 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.692 0 N-CA-C 107.604 -1.258 . . . . 0.0 107.604 179.507 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 116' ' ' SER . . . . . . . . . . . . . 4.8 m -86.23 151.6 23.49 Favored 'General case' 0 C--N 1.303 -1.422 0 CA-C-O 122.088 0.947 . . . . 0.0 111.421 -177.739 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 117' ' ' ILE . . . . . . . . . . . . . 1.6 mt -147.19 142.26 20.11 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.532 0 N-CA-C 106.998 -1.482 . . . . 0.0 106.998 178.542 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 118' ' ' ALA . . . . . 0.54 ' HB1' ' HB2' ' C' ' 704' ' ' ALA . . . -137.89 158.37 44.48 Favored 'General case' 0 N--CA 1.493 1.722 0 O-C-N 120.985 -1.072 . . . . 0.0 110.698 -178.284 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 119' ' ' GLY . . . . . . . . . . . . . . . -169.93 145.86 9.54 Favored Glycine 0 N--CA 1.48 1.603 0 N-CA-C 110.055 -1.218 . . . . 0.0 110.055 179.342 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 120' ' ' HIS . . . . . 0.65 ' CD2' ' SG ' ' C' ' 705' ' ' B27 . 30.0 m170 -70.25 167.48 17.87 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.671 -0.899 . . . . 0.0 109.766 179.589 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 121' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -115.21 157.36 23.79 Favored 'General case' 0 N--CA 1.492 1.644 0 N-CA-C 108.49 -0.93 . . . . 0.0 108.49 179.038 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 122' ' ' PHE . . . . . 0.716 ' O ' HG21 ' A' ' 131' ' ' THR . 2.4 m-85 -141.07 122.95 15.39 Favored 'General case' 0 N--CA 1.494 1.769 0 O-C-N 121.152 -0.967 . . . . 0.0 108.873 -179.889 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 123' ' ' ILE . . . . . 0.555 HG23 ' N ' ' A' ' 124' ' ' ASP . 19.6 tt -60.32 -40.99 85.55 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.548 0 CA-C-O 121.62 0.724 . . . . 0.0 109.52 -179.608 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 124' ' ' ASP . . . . . 0.555 ' N ' HG23 ' A' ' 123' ' ' ILE . 6.0 p-10 -88.96 21.62 3.04 Favored 'General case' 0 C--N 1.295 -1.787 0 O-C-N 121.698 -0.626 . . . . 0.0 111.774 -177.548 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 125' ' ' ARG . . . . . . . . . . . . . 91.6 mtt180 -152.69 101.56 2.71 Favored Pre-proline 0 N--CA 1.492 1.663 0 O-C-N 120.708 -1.245 . . . . 0.0 109.561 179.778 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 126' ' ' PRO . . . . . . . . . . . . . 55.6 Cg_endo -79.32 -30.07 2.77 Favored 'Trans proline' 0 N--CA 1.488 1.177 0 C-N-CA 122.459 2.106 . . . . 0.0 112.903 -179.781 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 127' ' ' ASN . . . . . 0.49 ' O ' ' O ' ' A' ' 128' ' ' TYR . 1.2 m120 -90.07 8.65 31.58 Favored 'General case' 0 N--CA 1.493 1.696 0 O-C-N 121.047 -1.033 . . . . 0.0 109.199 179.594 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 128' ' ' TYR . . . . . 0.493 ' O ' ' OE1' ' A' ' 85' ' ' GLU . 2.1 t80 -59.43 -148.67 0.0 OUTLIER 'General case' 0 C--N 1.302 -1.464 0 O-C-N 121.459 -0.776 . . . . 0.0 109.444 -179.82 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 129' ' ' GLN . . . . . . . . . . . . . 26.7 mt-30 -64.42 -75.6 0.08 Allowed 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.24 -0.913 . . . . 0.0 110.14 -179.252 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 130' ' ' PHE . . . . . 0.523 ' O ' ' CE ' ' A' ' 134' ' ' LYS . 49.4 m-85 -133.87 48.28 2.37 Favored 'General case' 0 N--CA 1.492 1.67 0 O-C-N 121.402 -0.811 . . . . 0.0 109.71 -179.848 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 131' ' ' THR . . . . . 0.716 HG21 ' O ' ' A' ' 122' ' ' PHE . 23.7 m -83.02 -38.84 22.05 Favored 'General case' 0 C--N 1.298 -1.659 0 O-C-N 121.03 -1.044 . . . . 0.0 109.228 179.864 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 132' ' ' ASN . . . . . 0.6 ' OD1' HD11 ' A' ' 83' ' ' ILE . 0.2 OUTLIER -83.61 4.19 29.4 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.475 -0.766 . . . . 0.0 110.781 -179.079 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 133' ' ' LEU . . . . . 0.544 ' O ' ' N ' ' A' ' 135' ' ' ALA . 0.1 OUTLIER -66.49 -45.5 79.43 Favored 'General case' 0 N--CA 1.497 1.909 0 O-C-N 120.591 -1.318 . . . . 0.0 110.164 179.874 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 134' ' ' LYS . . . . . 0.541 ' H ' ' CD ' ' A' ' 134' ' ' LYS . 0.0 OUTLIER -43.07 -17.6 0.01 OUTLIER 'General case' 0 N--CA 1.499 1.995 0 O-C-N 121.142 -0.974 . . . . 0.0 110.814 -178.861 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 135' ' ' ALA . . . . . 0.544 ' N ' ' O ' ' A' ' 133' ' ' LEU . . . -84.09 -31.85 25.08 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 120.976 -1.078 . . . . 0.0 109.725 -179.931 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 136' ' ' ALA . . . . . 0.95 ' HB2' ' HB2' ' A' ' 81' ' ' ALA . . . -79.6 151.53 30.56 Favored 'General case' 0 C--N 1.3 -1.545 0 CA-C-O 121.874 0.845 . . . . 0.0 111.623 -178.413 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 137' ' ' LYS . . . . . 0.576 ' O ' ' O ' ' A' ' 138' ' ' LYS . 0.0 OUTLIER -153.11 -168.91 3.17 Favored 'General case' 0 N--CA 1.495 1.796 0 C-N-CA 118.474 -1.29 . . . . 0.0 111.313 -177.964 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 138' ' ' LYS . . . . . 0.576 ' O ' ' O ' ' A' ' 137' ' ' LYS . 50.1 mttm -38.55 172.37 0.0 OUTLIER 'General case' 0 N--CA 1.487 1.415 0 CA-C-O 122.488 1.137 . . . . 0.0 110.971 -178.986 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 139' ' ' GLY . . . . . . . . . . . . . . . 49.13 9.12 0.1 Allowed Glycine 0 N--CA 1.488 2.143 0 N-CA-C 109.8 -1.32 . . . . 0.0 109.8 -179.977 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 140' ' ' SER . . . . . 0.519 ' N ' ' O ' ' A' ' 138' ' ' LYS . 4.3 m -80.56 132.26 35.63 Favored 'General case' 0 N--CA 1.496 1.86 0 O-C-N 120.975 -1.309 . . . . 0.0 109.778 179.677 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 141' ' ' MET . . . . . 0.451 ' O ' HG23 ' A' ' 78' ' ' ILE . 0.1 OUTLIER -83.68 128.81 34.81 Favored 'General case' 0 N--CA 1.49 1.567 0 N-CA-C 108.515 -0.921 . . . . 0.0 108.515 179.195 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 142' ' ' VAL . . . . . . . . . . . . . 2.6 t -117.96 131.68 69.99 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.857 0 O-C-N 121.414 -0.804 . . . . 0.0 109.061 -179.185 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 143' ' ' TYR . . . . . . . . . . . . . 3.1 m-85 -110.58 135.58 51.01 Favored 'General case' 0 N--CA 1.496 1.866 0 O-C-N 120.851 -1.156 . . . . 0.0 111.444 -178.443 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 144' ' ' PHE . . . . . . . . . . . . . 52.6 t80 -122.15 103.11 8.56 Favored 'General case' 0 N--CA 1.493 1.718 0 CA-C-O 121.495 0.664 . . . . 0.0 109.844 -179.428 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 145' ' ' LYS . . . . . . . . . . . . . 46.1 mttt -96.94 128.59 44.05 Favored 'General case' 0 N--CA 1.494 1.764 0 O-C-N 121.458 -0.776 . . . . 0.0 110.992 -179.291 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 146' ' ' VAL . . . . . 0.443 ' O ' ' C ' ' A' ' 147' ' ' GLY . 2.0 p -141.46 142.12 29.4 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.668 0 N-CA-C 107.519 -1.289 . . . . 0.0 107.519 178.52 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 147' ' ' GLY . . . . . 0.443 ' C ' ' O ' ' A' ' 146' ' ' VAL . . . 43.59 -129.38 6.17 Favored Glycine 0 N--CA 1.49 2.276 0 N-CA-C 109.313 -1.515 . . . . 0.0 109.313 -179.827 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 148' ' ' ASN . . . . . 0.463 ' C ' HD22 ' A' ' 148' ' ' ASN . 0.5 OUTLIER -102.29 15.15 30.0 Favored 'General case' 0 N--CA 1.488 1.469 0 O-C-N 121.278 -1.131 . . . . 0.0 108.336 179.15 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 149' ' ' GLU . . . . . . . . . . . . . 2.3 mm-40 -109.07 143.91 37.79 Favored 'General case' 0 N--CA 1.49 1.531 0 CA-C-O 121.771 0.796 . . . . 0.0 111.576 -178.546 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 150' ' ' THR . . . . . . . . . . . . . 3.4 m -130.02 101.16 5.71 Favored 'General case' 0 N--CA 1.495 1.779 0 CA-C-O 121.46 0.647 . . . . 0.0 109.77 179.915 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 151' ' ' ARG . . . . . 0.491 HH22 ' CG ' ' A' ' 111' ' ' ASP . 16.5 mtt180 -86.13 -171.67 3.68 Favored 'General case' 0 N--CA 1.487 1.404 0 O-C-N 121.243 -0.91 . . . . 0.0 108.983 -179.671 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 152' ' ' LYS . . . . . 0.465 ' O ' ' N ' ' A' ' 205' ' ' VAL . 36.3 mtmt -151.38 148.35 28.02 Favored 'General case' 0 C--N 1.301 -1.532 0 O-C-N 121.111 -0.993 . . . . 0.0 110.423 -178.895 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 153' ' ' TYR . . . . . 0.503 ' CD2' ' HA ' ' A' ' 204' ' ' GLU . 11.1 m-85 -141.76 168.68 19.18 Favored 'General case' 0 C--N 1.302 -1.493 0 N-CA-C 108.157 -1.053 . . . . 0.0 108.157 179.189 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 154' ' ' LYS . . . . . . . . . . . . . 29.1 ttpt -143.17 119.0 10.54 Favored 'General case' 0 C--N 1.297 -1.714 0 N-CA-C 108.038 -1.097 . . . . 0.0 108.038 178.703 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 155' ' ' MET . . . . . . . . . . . . . 18.0 mtp -47.13 108.69 0.16 Allowed 'General case' 0 N--CA 1.492 1.662 0 O-C-N 120.536 -1.353 . . . . 0.0 111.528 -178.381 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 156' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -105.16 -25.15 12.6 Favored 'General case' 0 C--N 1.294 -1.822 0 CA-C-N 115.351 -0.841 . . . . 0.0 110.714 -178.638 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 157' ' ' SER . . . . . . . . . . . . . 49.8 m -145.84 147.44 31.82 Favored 'General case' 0 C--N 1.296 -1.748 0 C-N-CA 118.511 -1.276 . . . . 0.0 110.15 -178.769 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 158' ' ' ILE . . . . . . . . . . . . . 2.3 mt -146.96 136.54 16.67 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.611 0 CA-C-O 121.538 0.685 . . . . 0.0 110.111 -177.781 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 159' ' ' ARG . . . . . 0.684 ' CG ' HH11 ' A' ' 159' ' ' ARG . 0.0 OUTLIER -155.63 -172.83 4.29 Favored 'General case' 0 N--CA 1.491 1.604 0 C-N-CA 119.505 -0.878 . . . . 0.0 110.459 179.733 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 160' ' ' ASP . . . . . 0.514 ' C ' HG22 ' A' ' 161' ' ' VAL . 10.7 m-20 -149.54 165.47 32.11 Favored 'General case' 0 N--CA 1.489 1.507 0 N-CA-C 108.324 -0.991 . . . . 0.0 108.324 179.554 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 161' ' ' VAL . . . . . 0.514 HG22 ' C ' ' A' ' 160' ' ' ASP . 0.1 OUTLIER -166.07 161.44 0.81 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.685 0 O-C-N 121.088 -1.008 . . . . 0.0 109.877 179.829 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 162' ' ' LYS . . . . . 0.484 ' O ' ' O ' ' A' ' 161' ' ' VAL . 0.0 OUTLIER -44.62 170.99 0.05 OUTLIER Pre-proline 0 N--CA 1.489 1.503 0 O-C-N 121.366 -0.834 . . . . 0.0 109.653 179.73 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 163' ' ' PRO . . . . . 0.485 ' C ' HD11 ' C' ' 702' ' ' LEU . 62.1 Cg_endo -80.74 36.16 0.61 Allowed 'Trans proline' 0 C--N 1.31 -1.483 0 C-N-CA 122.672 2.248 . . . . 0.0 113.061 -179.851 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 164' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -151.88 -2.88 0.28 Allowed 'General case' 0 N--CA 1.497 1.896 0 O-C-N 121.047 -1.033 . . . . 0.0 110.214 179.987 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 165' ' ' ASP . . . . . . . . . . . . . 7.2 t70 -74.83 62.98 1.13 Allowed 'General case' 0 N--CA 1.488 1.45 0 O-C-N 120.899 -1.126 . . . . 0.0 109.386 -179.988 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 166' ' ' VAL . . . . . 0.589 ' O ' ' N ' ' A' ' 168' ' ' VAL . 1.8 m -49.68 -33.82 8.37 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.503 0 O-C-N 121.659 -0.65 . . . . 0.0 109.776 -178.392 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 167' ' ' GLY . . . . . 0.405 ' C ' ' O ' ' A' ' 166' ' ' VAL . . . -43.89 -13.35 0.02 OUTLIER Glycine 0 N--CA 1.496 2.65 0 O-C-N 120.865 -1.147 . . . . 0.0 110.725 -179.766 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 168' ' ' VAL . . . . . 0.589 ' N ' ' O ' ' A' ' 166' ' ' VAL . 3.5 m -53.48 -26.77 13.54 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.563 0 O-C-N 120.712 -1.463 . . . . 0.0 108.741 179.688 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 169' ' ' LEU . . . . . 0.608 ' O ' ' ND2' ' A' ' 114' ' ' ASN . 1.2 mm? -44.43 -24.67 0.19 Allowed 'General case' 0 C--N 1.299 -1.61 0 N-CA-C 107.808 -1.182 . . . . 0.0 107.808 -178.658 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 170' ' ' ASP . . . . . 0.474 ' N ' ' C ' ' A' ' 168' ' ' VAL . 14.9 t0 37.29 90.51 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.715 -0.616 . . . . 0.0 110.804 177.944 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 171' ' ' GLU . . . . . . . . . . . . . 14.9 pt-20 -130.13 60.09 1.62 Allowed 'General case' 0 N--CA 1.497 1.922 0 O-C-N 120.904 -1.123 . . . . 0.0 109.735 179.515 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 172' ' ' GLN . . . . . . . . . . . . . 10.7 mt-30 -123.06 -56.87 1.73 Allowed 'General case' 0 N--CA 1.497 1.899 0 O-C-N 121.438 -0.789 . . . . 0.0 110.958 -178.969 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 173' ' ' LYS . . . . . 0.467 ' H ' ' HD2' ' A' ' 173' ' ' LYS . 2.3 mptp? -57.62 123.2 14.79 Favored 'General case' 0 N--CA 1.493 1.696 0 O-C-N 120.817 -1.177 . . . . 0.0 108.909 -179.67 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 174' ' ' GLY . . . . . 0.485 ' O ' ' C ' ' A' ' 175' ' ' LYS . . . -117.29 -43.59 0.59 Allowed Glycine 0 N--CA 1.478 1.483 0 N-CA-C 108.166 -1.974 . . . . 0.0 108.166 179.589 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 175' ' ' LYS . . . . . 0.485 ' C ' ' O ' ' A' ' 174' ' ' GLY . 11.9 mptt -43.52 -58.53 2.57 Favored 'General case' 0 N--CA 1.49 1.545 0 N-CA-C 107.107 -1.442 . . . . 0.0 107.107 179.565 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 176' ' ' ASP . . . . . 0.617 ' O ' ' O ' ' A' ' 177' ' ' LYS . 3.4 m-20 -103.8 85.66 2.47 Favored 'General case' 0 C--N 1.293 -1.866 0 N-CA-C 106.835 -1.543 . . . . 0.0 106.835 176.672 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 177' ' ' LYS . . . . . 0.617 ' O ' ' O ' ' A' ' 176' ' ' ASP . 35.6 mttt -44.23 -175.92 0.0 OUTLIER 'General case' 0 N--CA 1.493 1.691 0 O-C-N 121.632 -0.667 . . . . 0.0 109.663 -179.159 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 178' ' ' GLN . . . . . . . . . . . . . 4.1 pt20 -160.7 173.68 15.07 Favored 'General case' 0 C--N 1.303 -1.439 0 O-C-N 120.307 -1.496 . . . . 0.0 110.949 179.524 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 179' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -129.35 97.74 4.66 Favored 'General case' 0 C--N 1.303 -1.453 0 N-CA-C 107.225 -1.398 . . . . 0.0 107.225 178.459 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 180' ' ' THR . . . . . 0.467 ' O ' HG22 ' A' ' 180' ' ' THR . 1.1 m -73.56 115.69 13.25 Favored 'General case' 0 N--CA 1.493 1.72 0 O-C-N 121.162 -0.961 . . . . 0.0 110.662 -178.372 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 181' ' ' LEU . . . . . 0.688 HD13 ' H ' ' A' ' 182' ' ' ILE . 0.2 OUTLIER -89.55 144.48 25.99 Favored 'General case' 0 C--N 1.301 -1.535 0 N-CA-C 108.11 -1.07 . . . . 0.0 108.11 177.47 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 182' ' ' ILE . . . . . 0.688 ' H ' HD13 ' A' ' 181' ' ' LEU . 4.7 mt -137.91 113.03 9.85 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.643 0 N-CA-C 107.822 -1.177 . . . . 0.0 107.822 179.102 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 183' ' ' THR . . . . . 0.479 ' O ' HG23 ' A' ' 183' ' ' THR . 5.8 t -134.34 119.44 18.65 Favored 'General case' 0 C--N 1.293 -1.88 0 N-CA-C 108.141 -1.059 . . . . 0.0 108.141 179.708 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 184' ' ' CYS . . . . . . . . . . . . . 1.0 OUTLIER -80.21 156.37 26.94 Favored 'General case' 0 C--N 1.289 -2.065 0 C-N-CA 119.514 -0.874 . . . . 0.0 111.183 -178.366 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 185' ' ' ASP . . . . . 0.549 ' O ' ' CB ' ' A' ' 186' ' ' ASP . 0.2 OUTLIER -166.68 170.55 12.44 Favored 'General case' 0 N--CA 1.493 1.698 0 O-C-N 121.538 -0.726 . . . . 0.0 109.058 179.831 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 186' ' ' ASP . . . . . 0.549 ' CB ' ' O ' ' A' ' 185' ' ' ASP . 1.0 OUTLIER 79.28 52.42 0.03 OUTLIER 'General case' 0 N--CA 1.492 1.668 0 O-C-N 121.23 -0.919 . . . . 0.0 109.704 179.863 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 187' ' ' TYR . . . . . 0.581 ' CE1' ' O ' ' A' ' 188' ' ' ASN . 36.9 t80 -65.9 131.42 46.23 Favored 'General case' 0 C--N 1.302 -1.497 0 O-C-N 120.92 -1.113 . . . . 0.0 109.623 179.946 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 188' ' ' ASN . . . . . 1.062 ' ND2' ' H ' ' A' ' 191' ' ' THR . 0.1 OUTLIER -100.13 148.71 24.28 Favored 'General case' 0 C--N 1.291 -1.936 0 N-CA-C 107.589 -1.263 . . . . 0.0 107.589 178.68 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 189' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -109.9 -9.57 14.78 Favored 'General case' 0 C--N 1.294 -1.819 0 N-CA-C 108.495 -0.928 . . . . 0.0 108.495 -179.505 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 190' ' ' LYS . . . . . 0.493 ' H ' ' ND2' ' A' ' 188' ' ' ASN . 6.4 mmtt -84.49 -56.23 3.73 Favored 'General case' 0 N--CA 1.488 1.432 0 C-N-CA 119.841 -0.744 . . . . 0.0 109.182 178.774 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 191' ' ' THR . . . . . 1.062 ' H ' ' ND2' ' A' ' 188' ' ' ASN . 7.1 p -86.44 7.93 23.86 Favored 'General case' 0 N--CA 1.493 1.678 0 O-C-N 121.559 -0.713 . . . . 0.0 110.688 -178.823 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 192' ' ' GLY . . . . . 0.447 ' N ' ' OD1' ' A' ' 188' ' ' ASN . . . 51.69 30.47 28.07 Favored Glycine 0 N--CA 1.494 2.544 0 O-C-N 121.098 -1.001 . . . . 0.0 111.733 178.82 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 193' ' ' VAL . . . . . 0.403 HG22 ' H ' ' A' ' 194' ' ' TRP . 0.4 OUTLIER -149.59 170.58 1.98 Allowed 'Isoleucine or valine' 0 N--CA 1.495 1.798 0 O-C-N 120.463 -1.61 . . . . 0.0 109.909 179.129 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 194' ' ' TRP . . . . . 0.479 ' CD1' HG2B ' C' ' 705' ' ' B27 . 44.1 m95 -84.93 122.07 28.66 Favored 'General case' 0 C--N 1.295 -1.795 0 CA-C-O 121.577 0.704 . . . . 0.0 109.994 -179.427 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 195' ' ' GLU . . . . . 0.402 ' HG3' ' H ' ' A' ' 195' ' ' GLU . 2.0 mt-10 -77.81 -60.96 2.16 Favored 'General case' 0 N--CA 1.496 1.871 0 O-C-N 121.546 -0.721 . . . . 0.0 111.902 -178.326 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 196' ' ' LYS . . . . . . . . . . . . . 5.3 tttm -92.44 150.11 20.99 Favored 'General case' 0 N--CA 1.495 1.797 0 O-C-N 121.003 -1.061 . . . . 0.0 111.761 -177.481 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 197' ' ' ARG . . . . . 0.699 ' HE ' HD13 ' C' ' 702' ' ' LEU . 0.0 OUTLIER -120.7 139.03 53.64 Favored 'General case' 0 N--CA 1.493 1.676 0 N-CA-C 108.319 -0.993 . . . . 0.0 108.319 178.353 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 198' ' ' LYS . . . . . . . . . . . . . 7.9 mttt -116.72 120.46 38.68 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.447 -0.783 . . . . 0.0 110.406 -178.624 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 199' ' ' ILE . . . . . 0.441 ' O ' HG13 ' A' ' 199' ' ' ILE . 0.9 OUTLIER -140.78 121.06 13.09 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.733 0 CA-C-O 122.787 1.279 . . . . 0.0 110.724 179.77 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 200' ' ' PHE . . . . . . . . . . . . . 2.0 m-85 -105.33 141.44 36.83 Favored 'General case' 0 N--CA 1.496 1.841 0 O-C-N 121.218 -0.926 . . . . 0.0 111.012 -177.502 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 201' ' ' VAL . . . . . . . . . . . . . 61.3 t -104.63 148.39 9.32 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.539 0 N-CA-C 108.394 -0.965 . . . . 0.0 108.394 177.247 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 202' ' ' ALA . . . . . . . . . . . . . . . -133.05 139.84 47.39 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.037 -1.039 . . . . 0.0 109.022 -179.899 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 203' ' ' THR . . . . . 0.628 ' O ' HG23 ' A' ' 205' ' ' VAL . 1.5 p -90.14 129.19 36.45 Favored 'General case' 0 N--CA 1.489 1.509 0 CA-C-O 122.431 1.11 . . . . 0.0 111.753 -178.525 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 204' ' ' GLU . . . . . 0.503 ' HA ' ' CD2' ' A' ' 153' ' ' TYR . 3.6 tm-20 -50.53 135.36 22.81 Favored 'General case' 0 C--N 1.298 -1.656 0 C-N-CA 118.369 -1.333 . . . . 0.0 109.361 178.951 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 205' ' ' VAL . . . . . 0.628 HG23 ' O ' ' A' ' 203' ' ' THR . 72.1 t -129.57 164.82 31.15 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.359 0 CA-C-O 122.083 0.944 . . . . 0.0 110.273 -177.907 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 206' ' ' LYS . . . . . 0.599 ' N ' HG12 ' A' ' 205' ' ' VAL . 0.0 OUTLIER . . . . . 0 C--N 1.295 -1.776 0 CA-C-O 118.025 -0.988 . . . . 0.0 109.482 179.84 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' C' C ' 701' ' ' PHQ . . . . . 0.55 ' C1 ' HG12 ' A' ' 166' ' ' VAL . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 012 nuclear build full ' C' C ' 702' ' ' LEU . . . . . 0.798 ' N ' HD12 ' C' ' 702' ' ' LEU . 0.0 OUTLIER . . . . . 0 N--CA 1.488 1.436 0 N-CA-C 109.08 -0.711 . . . . 0.0 109.08 . . . . . . . . . 2 2 . 1 . 012 nuclear build full ' C' C ' 703' ' ' PRO . . . . . 0.605 ' CB ' ' HB3' ' A' ' 92' ' ' ALA . 16.2 Cg_exo -51.54 -160.81 0.0 OUTLIER 'Trans proline' 0 N--CA 1.49 1.319 0 C-N-CA 121.805 1.67 . . . . 0.0 112.242 179.911 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' C' C ' 704' ' ' ALA . . . . . 0.54 ' HB2' ' HB1' ' A' ' 118' ' ' ALA . . . 53.46 175.11 0.02 OUTLIER 'General case' 0 N--CA 1.493 1.681 0 O-C-N 121.383 -0.823 . . . . 0.0 109.544 179.936 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' C' C ' 705' ' ' B27 . . . . . 0.65 ' SG ' ' CD2' ' A' ' 120' ' ' HIS . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 700' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 013 nuclear build full ' A' A ' 59' ' ' MET . . . . . . . . . . . . . 39.9 mtt . . . . . 0 N--CA 1.491 1.588 0 CA-C-O 121.245 0.545 . . . . 0.0 109.776 . . . . . . . . . 0 0 . 1 . 013 nuclear build full ' A' A ' 60' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -59.95 -109.13 0.0 OUTLIER 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.253 -0.904 . . . . 0.0 109.779 -179.699 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . -63.11 159.85 16.53 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.205 -0.935 . . . . 0.0 109.212 -179.89 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 62' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -142.15 71.47 22.8 Favored Pre-proline 0 N--CA 1.49 1.568 0 O-C-N 121.262 -0.899 . . . . 0.0 109.178 -179.377 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 63' ' ' PRO . . . . . . . . . . . . . 58.0 Cg_endo -91.86 160.25 3.38 Favored 'Trans proline' 0 C--N 1.304 -1.795 0 C-N-CA 123.794 2.996 . . . . 0.0 111.577 -179.883 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 64' ' ' GLN . . . . . 0.459 ' O ' ' C ' ' A' ' 65' ' ' ILE . 2.6 mm-40 -156.0 113.01 3.19 Favored 'General case' 0 C--N 1.302 -1.475 0 O-C-N 121.049 -1.032 . . . . 0.0 109.925 179.544 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 65' ' ' ILE . . . . . 0.459 ' C ' ' O ' ' A' ' 64' ' ' GLN . 0.1 OUTLIER -41.35 99.65 0.21 Allowed Pre-proline 0 N--CA 1.498 1.939 0 N-CA-C 108.174 -1.047 . . . . 0.0 108.174 179.386 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 66' ' ' PRO . . . . . 0.456 ' N ' ' O ' ' A' ' 64' ' ' GLN . 66.5 Cg_endo -89.76 -160.69 0.1 OUTLIER 'Trans proline' 0 C--N 1.317 -1.108 0 C-N-CA 122.222 1.948 . . . . 0.0 112.778 -178.76 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 67' ' ' LYS . . . . . 0.479 ' C ' ' H ' ' A' ' 69' ' ' LYS . 0.0 OUTLIER -71.91 -4.94 31.1 Favored 'General case' 0 N--CA 1.488 1.426 0 O-C-N 121.414 -0.804 . . . . 0.0 109.08 179.926 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 68' ' ' ASP . . . . . 0.586 ' C ' ' N ' ' A' ' 70' ' ' SER . 64.6 m-20 -76.21 42.86 0.28 Allowed 'General case' 0 N--CA 1.49 1.561 0 CA-C-O 122.45 1.119 . . . . 0.0 108.459 179.223 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 69' ' ' LYS . . . . . 0.479 ' H ' ' C ' ' A' ' 67' ' ' LYS . 0.5 OUTLIER -50.11 -16.26 0.29 Allowed 'General case' 0 N--CA 1.496 1.854 0 N-CA-C 105.984 -1.858 . . . . 0.0 105.984 178.102 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 70' ' ' SER . . . . . 0.586 ' N ' ' C ' ' A' ' 68' ' ' ASP . 3.0 p -86.66 50.84 2.08 Favored 'General case' 0 C--N 1.298 -1.643 0 CA-C-N 113.94 -1.482 . . . . 0.0 108.742 178.644 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 71' ' ' LYS . . . . . . . . . . . . . 6.5 ptmt -162.63 143.19 9.79 Favored 'General case' 0 C--N 1.296 -1.731 0 C-N-CA 118.224 -1.391 . . . . 0.0 111.235 -179.657 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 72' ' ' VAL . . . . . 0.582 HG12 ' CE1' ' A' ' 88' ' ' TYR . 0.8 OUTLIER -64.28 136.14 26.9 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.577 0 N-CA-C 105.644 -1.984 . . . . 0.0 105.644 175.434 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -81.66 -13.85 57.38 Favored 'General case' 0 C--N 1.292 -1.897 0 N-CA-C 105.661 -1.977 . . . . 0.0 105.661 179.371 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . 174.01 -156.88 24.49 Favored Glycine 0 N--CA 1.478 1.448 0 N-CA-C 109.251 -1.54 . . . . 0.0 109.251 179.388 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 75' ' ' TYR . . . . . . . . . . . . . 94.4 m-85 -141.32 170.62 15.37 Favored 'General case' 0 C--N 1.296 -1.754 0 CA-C-O 121.875 0.845 . . . . 0.0 109.766 -178.144 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 76' ' ' ILE . . . . . . . . . . . . . 0.7 OUTLIER -147.66 143.74 19.58 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.646 0 C-N-CA 119.366 -0.934 . . . . 0.0 109.258 -178.095 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 77' ' ' GLU . . . . . 0.518 ' N ' ' CD ' ' A' ' 77' ' ' GLU . 2.6 mp0 -146.76 162.66 38.08 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 120.929 -1.107 . . . . 0.0 109.967 -179.837 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 78' ' ' ILE . . . . . 0.661 ' HB ' ' HB3' ' A' ' 81' ' ' ALA . 4.1 mt -148.16 90.3 5.04 Favored Pre-proline 0 N--CA 1.489 1.48 0 N-CA-C 108.311 -0.996 . . . . 0.0 108.311 179.839 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 79' ' ' PRO . . . . . . . . . . . . . 73.5 Cg_exo -45.29 -44.49 16.06 Favored 'Trans proline' 0 C--N 1.31 -1.457 0 C-N-CA 122.597 2.198 . . . . 0.0 113.63 -178.583 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 4.4 m-20 -67.14 -19.29 65.58 Favored 'General case' 0 N--CA 1.492 1.652 0 O-C-N 120.869 -1.145 . . . . 0.0 110.789 178.418 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 81' ' ' ALA . . . . . 0.882 ' HB2' ' HB2' ' A' ' 136' ' ' ALA . . . -106.63 -15.01 14.88 Favored 'General case' 0 N--CA 1.493 1.717 0 O-C-N 121.137 -0.977 . . . . 0.0 109.176 179.976 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 82' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER 68.3 46.72 1.05 Allowed 'General case' 0 N--CA 1.488 1.459 0 O-C-N 121.375 -0.828 . . . . 0.0 110.338 179.22 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 83' ' ' ILE . . . . . 0.456 ' CG1' ' OD1' ' A' ' 132' ' ' ASN . 60.9 mt -120.98 148.36 24.29 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.797 0 O-C-N 121.296 -0.877 . . . . 0.0 110.357 -178.928 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 84' ' ' LYS . . . . . 0.402 ' O ' ' CD ' ' A' ' 85' ' ' GLU . 0.0 OUTLIER -160.44 102.63 1.38 Allowed 'General case' 0 C--N 1.305 -1.367 0 N-CA-C 107.322 -1.362 . . . . 0.0 107.322 179.731 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 85' ' ' GLU . . . . . 0.441 ' CB ' ' CD ' ' A' ' 86' ' ' PRO . 1.3 mm-40 -141.49 178.25 1.61 Allowed Pre-proline 0 N--CA 1.497 1.914 0 O-C-N 121.301 -0.874 . . . . 0.0 110.247 -178.831 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 86' ' ' PRO . . . . . 0.441 ' CD ' ' CB ' ' A' ' 85' ' ' GLU . 69.2 Cg_endo -91.2 158.02 3.81 Favored 'Trans proline' 0 N--CA 1.487 1.112 0 C-N-CA 123.314 2.676 . . . . 0.0 113.661 -178.565 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 87' ' ' VAL . . . . . 0.555 ' CG1' ' CZ ' ' A' ' 103' ' ' PHE . 35.5 t -111.07 100.04 9.93 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.498 0 N-CA-C 109.191 -0.67 . . . . 0.0 109.191 -179.85 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 88' ' ' TYR . . . . . 0.582 ' CE1' HG12 ' A' ' 72' ' ' VAL . 8.1 m-85 -91.71 170.31 9.69 Favored Pre-proline 0 N--CA 1.507 2.4 0 O-C-N 120.535 -1.353 . . . . 0.0 110.135 -179.102 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 89' ' ' PRO . . . . . . . . . . . . . 3.0 Cg_exo -71.35 141.71 39.54 Favored 'Trans proline' 0 N--CA 1.5 1.883 0 C-N-CA 122.505 2.137 . . . . 0.0 114.241 -178.394 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . -62.16 167.18 17.9 Favored Glycine 0 N--CA 1.492 2.394 0 N-CA-C 108.8 -1.72 . . . . 0.0 108.8 178.38 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 91' ' ' PRO . . . . . 0.41 ' C ' ' H ' ' A' ' 93' ' ' THR . 45.1 Cg_endo -91.67 172.69 21.43 Favored 'Cis proline' 0 C--N 1.307 -1.648 0 C-N-CA 123.55 -1.437 . . . . 0.0 112.001 0.651 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 92' ' ' ALA . . . . . 0.556 ' HB3' ' HB2' ' C' ' 703' ' ' PRO . . . -73.2 33.34 0.07 Allowed 'General case' 0 N--CA 1.493 1.706 0 O-C-N 121.352 -0.843 . . . . 0.0 110.677 -179.418 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 93' ' ' THR . . . . . 0.439 ' O ' ' C ' ' A' ' 94' ' ' PRO . 0.8 OUTLIER -71.8 149.56 92.85 Favored Pre-proline 0 C--N 1.301 -1.519 0 O-C-N 120.59 -1.319 . . . . 0.0 108.45 179.773 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 94' ' ' PRO . . . . . 0.439 ' C ' ' O ' ' A' ' 93' ' ' THR . 80.7 Cg_exo -31.78 -53.18 0.31 Allowed 'Trans proline' 0 C--N 1.308 -1.563 0 C-N-CA 122.723 2.282 . . . . 0.0 112.203 -179.183 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 95' ' ' GLU . . . . . 0.493 ' O ' ' ND2' ' A' ' 98' ' ' ASN . 7.1 tp10 -47.65 -52.64 17.37 Favored 'General case' 0 C--N 1.299 -1.601 0 O-C-N 121.397 -0.814 . . . . 0.0 109.259 179.487 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 96' ' ' GLN . . . . . 0.517 ' C ' ' H ' ' A' ' 98' ' ' ASN . 12.2 mp0 -70.14 -54.66 11.98 Favored 'General case' 0 N--CA 1.489 1.504 0 O-C-N 121.382 -0.824 . . . . 0.0 110.918 -179.349 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 97' ' ' LEU . . . . . 0.523 ' CD1' ' O ' ' A' ' 92' ' ' ALA . 81.5 mt -50.84 -6.28 0.03 OUTLIER 'General case' 0 N--CA 1.494 1.764 0 O-C-N 121.002 -1.061 . . . . 0.0 110.341 -178.671 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 98' ' ' ASN . . . . . 0.517 ' H ' ' C ' ' A' ' 96' ' ' GLN . 0.2 OUTLIER -75.3 -32.61 61.04 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.169 -0.957 . . . . 0.0 109.392 179.24 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 99' ' ' ARG . . . . . 0.44 ' HD2' ' CE2' ' A' ' 88' ' ' TYR . 9.3 mtt180 -85.53 -44.93 12.25 Favored 'General case' 0 N--CA 1.488 1.469 0 O-C-N 121.478 -0.764 . . . . 0.0 109.727 -179.321 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . 169.87 -170.6 42.91 Favored Glycine 0 N--CA 1.495 2.624 0 C-N-CA 119.698 -1.239 . . . . 0.0 110.141 179.653 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 101' ' ' VAL . . . . . 0.589 HG23 ' O ' ' A' ' 101' ' ' VAL . 26.8 m -55.0 106.74 0.12 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.572 0 O-C-N 121.093 -1.239 . . . . 0.0 109.17 -179.981 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -92.88 164.55 13.28 Favored 'General case' 0 N--CA 1.494 1.737 0 O-C-N 121.433 -0.792 . . . . 0.0 110.664 -179.282 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 103' ' ' PHE . . . . . 0.555 ' CZ ' ' CG1' ' A' ' 87' ' ' VAL . 28.5 m-85 -68.04 123.12 19.76 Favored 'General case' 0 N--CA 1.488 1.452 0 N-CA-C 108.549 -0.908 . . . . 0.0 108.549 178.413 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 104' ' ' ALA . . . . . 0.586 ' HB1' ' HG3' ' C' ' 703' ' ' PRO . . . -50.58 -7.33 0.03 OUTLIER 'General case' 0 C--N 1.3 -1.571 0 O-C-N 121.453 -0.779 . . . . 0.0 110.634 -179.42 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 105' ' ' GLU . . . . . 0.486 ' N ' ' O ' ' A' ' 103' ' ' PHE . 0.0 OUTLIER -139.83 144.22 37.2 Favored 'General case' 0 N--CA 1.495 1.814 0 O-C-N 120.915 -1.116 . . . . 0.0 110.433 -179.246 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 106' ' ' GLU . . . . . . . . . . . . . 28.2 tt0 -59.91 -64.35 0.98 Allowed 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.784 -0.572 . . . . 0.0 111.245 -178.959 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 107' ' ' ASN . . . . . . . . . . . . . 4.6 m120 -78.5 35.51 0.23 Allowed 'General case' 0 N--CA 1.49 1.541 0 O-C-N 120.813 -1.179 . . . . 0.0 112.378 -175.981 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 108' ' ' GLU . . . . . 0.429 ' OE2' ' OE2' ' A' ' 105' ' ' GLU . 1.6 tp10 -59.0 149.24 27.97 Favored 'General case' 0 C--N 1.303 -1.415 0 O-C-N 120.703 -1.248 . . . . 0.0 107.725 -179.912 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 109' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -103.98 137.51 41.84 Favored 'General case' 0 C--N 1.304 -1.372 0 O-C-N 121.069 -1.019 . . . . 0.0 110.616 -178.236 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 110' ' ' LEU . . . . . . . . . . . . . 2.2 pp -60.74 -17.79 50.7 Favored 'General case' 0 C--N 1.298 -1.636 0 N-CA-C 108.225 -1.028 . . . . 0.0 108.225 179.138 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 111' ' ' ASP . . . . . . . . . . . . . 41.3 m-20 -132.13 37.77 3.55 Favored 'General case' 0 N--CA 1.489 1.492 0 N-CA-C 108.836 -0.801 . . . . 0.0 108.836 179.237 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 112' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -68.84 156.57 38.16 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.24 -0.913 . . . . 0.0 110.804 -179.786 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 113' ' ' GLN . . . . . 0.617 HE22 ' N ' ' A' ' 172' ' ' GLN . 0.0 OUTLIER -66.75 -15.96 63.91 Favored 'General case' 0 N--CA 1.487 1.402 0 N-CA-C 107.964 -1.125 . . . . 0.0 107.964 177.612 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 114' ' ' ASN . . . . . 0.457 ' OD1' ' OE1' ' A' ' 178' ' ' GLN . 3.0 t30 -151.4 106.11 3.26 Favored 'General case' 0 C--N 1.299 -1.61 0 N-CA-C 108.158 -1.053 . . . . 0.0 108.158 179.655 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 115' ' ' ILE . . . . . 0.511 HG22 ' O ' ' A' ' 115' ' ' ILE . 2.7 mt -94.92 105.25 16.74 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.604 0 N-CA-C 107.66 -1.237 . . . . 0.0 107.66 179.655 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 116' ' ' SER . . . . . 0.423 ' OG ' ' ND2' ' A' ' 114' ' ' ASN . 36.6 m -89.57 147.42 23.95 Favored 'General case' 0 N--CA 1.487 1.39 0 CA-C-O 121.905 0.859 . . . . 0.0 111.303 -177.596 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 117' ' ' ILE . . . . . . . . . . . . . 1.7 mt -144.48 150.92 16.1 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.394 0 N-CA-C 108.092 -1.077 . . . . 0.0 108.092 179.194 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 118' ' ' ALA . . . . . 0.942 ' HB1' ' HB2' ' C' ' 704' ' ' ALA . . . -141.41 160.58 39.83 Favored 'General case' 0 N--CA 1.493 1.703 0 O-C-N 120.921 -1.112 . . . . 0.0 111.209 -178.886 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 119' ' ' GLY . . . . . . . . . . . . . . . -168.36 149.01 13.25 Favored Glycine 0 N--CA 1.489 2.221 0 C-N-CA 119.962 -1.113 . . . . 0.0 111.092 -179.98 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 120' ' ' HIS . . . . . . . . . . . . . 12.7 m170 -71.35 168.93 16.36 Favored 'General case' 0 N--CA 1.495 1.781 0 O-C-N 122.13 -0.629 . . . . 0.0 110.232 179.202 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 121' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -123.7 155.62 37.48 Favored 'General case' 0 N--CA 1.495 1.819 0 N-CA-C 108.864 -0.791 . . . . 0.0 108.864 179.233 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 122' ' ' PHE . . . . . . . . . . . . . 0.7 OUTLIER -143.92 123.17 12.99 Favored 'General case' 0 N--CA 1.501 2.091 0 O-C-N 120.913 -1.117 . . . . 0.0 110.228 179.606 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 123' ' ' ILE . . . . . 0.538 HG23 ' N ' ' A' ' 124' ' ' ASP . 17.1 tt -57.83 -40.61 76.9 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.43 0 CA-C-O 121.582 0.705 . . . . 0.0 109.291 179.606 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 124' ' ' ASP . . . . . 0.538 ' N ' HG23 ' A' ' 123' ' ' ILE . 0.4 OUTLIER -87.19 23.43 1.82 Allowed 'General case' 0 N--CA 1.497 1.898 0 O-C-N 121.648 -0.658 . . . . 0.0 111.461 -177.477 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 125' ' ' ARG . . . . . . . . . . . . . 82.9 mtt180 -153.18 99.83 2.68 Favored Pre-proline 0 N--CA 1.493 1.696 0 O-C-N 120.761 -1.212 . . . . 0.0 109.665 -179.582 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 126' ' ' PRO . . . . . . . . . . . . . 34.0 Cg_endo -77.41 -33.65 2.38 Favored 'Trans proline' 0 N--CA 1.489 1.255 0 C-N-CA 122.263 1.976 . . . . 0.0 112.782 -179.744 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 127' ' ' ASN . . . . . 0.485 ' O ' ' O ' ' A' ' 128' ' ' TYR . 5.1 p30 -90.64 11.14 23.01 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.198 -0.939 . . . . 0.0 109.602 179.911 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 128' ' ' TYR . . . . . 0.485 ' O ' ' O ' ' A' ' 127' ' ' ASN . 2.8 t80 -59.53 -149.67 0.0 OUTLIER 'General case' 0 N--CA 1.489 1.478 0 O-C-N 121.091 -1.006 . . . . 0.0 109.516 179.978 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 129' ' ' GLN . . . . . . . . . . . . . 37.1 mt-30 -66.95 -70.37 0.25 Allowed 'General case' 0 N--CA 1.487 1.413 0 O-C-N 121.337 -0.852 . . . . 0.0 109.605 -179.779 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 130' ' ' PHE . . . . . 0.505 ' CZ ' HG11 ' A' ' 101' ' ' VAL . 50.6 m-85 -136.22 42.29 2.57 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.167 -0.958 . . . . 0.0 110.771 -179.39 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 131' ' ' THR . . . . . . . . . . . . . 8.5 m -74.68 -40.16 61.56 Favored 'General case' 0 N--CA 1.495 1.792 0 O-C-N 120.875 -1.141 . . . . 0.0 109.034 179.241 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 132' ' ' ASN . . . . . 0.558 ' ND2' ' O ' ' A' ' 81' ' ' ALA . 0.2 OUTLIER -89.18 11.59 18.27 Favored 'General case' 0 N--CA 1.492 1.673 0 C-N-CA 119.465 -0.894 . . . . 0.0 111.625 -178.678 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 133' ' ' LEU . . . . . 0.546 ' O ' ' N ' ' A' ' 135' ' ' ALA . 0.2 OUTLIER -68.02 -46.9 69.94 Favored 'General case' 0 N--CA 1.492 1.663 0 O-C-N 120.536 -1.353 . . . . 0.0 109.988 -179.16 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 134' ' ' LYS . . . . . 0.651 ' H ' ' CD ' ' A' ' 134' ' ' LYS . 0.0 OUTLIER -46.0 -14.11 0.02 OUTLIER 'General case' 0 N--CA 1.495 1.805 0 O-C-N 121.05 -1.031 . . . . 0.0 110.03 -179.514 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 135' ' ' ALA . . . . . 0.546 ' N ' ' O ' ' A' ' 133' ' ' LEU . . . -82.41 -35.89 27.23 Favored 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.108 -0.995 . . . . 0.0 109.123 179.669 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 136' ' ' ALA . . . . . 0.882 ' HB2' ' HB2' ' A' ' 81' ' ' ALA . . . -78.88 152.1 31.42 Favored 'General case' 0 C--N 1.302 -1.469 0 CA-C-O 121.858 0.837 . . . . 0.0 110.667 -179.35 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 137' ' ' LYS . . . . . 0.555 ' O ' ' O ' ' A' ' 138' ' ' LYS . 28.0 mtmm -153.06 -168.54 3.06 Favored 'General case' 0 N--CA 1.492 1.631 0 C-N-CA 118.351 -1.34 . . . . 0.0 110.939 -178.332 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 138' ' ' LYS . . . . . 0.555 ' O ' ' O ' ' A' ' 137' ' ' LYS . 0.0 OUTLIER -29.78 159.78 0.0 OUTLIER 'General case' 0 N--CA 1.489 1.509 0 CA-C-O 122.992 1.377 . . . . 0.0 112.681 -178.028 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 139' ' ' GLY . . . . . . . . . . . . . . . 51.9 8.81 0.44 Allowed Glycine 0 N--CA 1.489 2.199 0 N-CA-C 109.824 -1.311 . . . . 0.0 109.824 179.612 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 140' ' ' SER . . . . . 0.471 ' H ' ' C ' ' A' ' 138' ' ' LYS . 1.5 m -68.04 115.19 7.26 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.17 -1.194 . . . . 0.0 108.979 179.493 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 141' ' ' MET . . . . . . . . . . . . . 3.2 tpt -66.94 120.42 13.58 Favored 'General case' 0 C--N 1.301 -1.506 0 O-C-N 121.186 -0.946 . . . . 0.0 109.621 -179.866 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 142' ' ' VAL . . . . . . . . . . . . . 5.1 t -110.56 127.98 67.2 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.651 0 N-CA-C 108.192 -1.04 . . . . 0.0 108.192 179.835 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 143' ' ' TYR . . . . . . . . . . . . . 26.3 m-85 -107.79 135.06 49.84 Favored 'General case' 0 N--CA 1.498 1.963 0 O-C-N 121.022 -1.049 . . . . 0.0 111.348 -178.442 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 144' ' ' PHE . . . . . . . . . . . . . 58.5 t80 -119.19 101.16 7.8 Favored 'General case' 0 N--CA 1.486 1.355 0 N-CA-C 109.214 -0.661 . . . . 0.0 109.214 179.323 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 145' ' ' LYS . . . . . . . . . . . . . 35.8 mttt -95.47 129.33 42.67 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.127 -0.983 . . . . 0.0 109.62 -179.74 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 146' ' ' VAL . . . . . 0.428 ' O ' ' C ' ' A' ' 147' ' ' GLY . 3.3 p -141.67 141.43 29.85 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.636 0 N-CA-C 107.957 -1.127 . . . . 0.0 107.957 179.369 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 147' ' ' GLY . . . . . 0.428 ' C ' ' O ' ' A' ' 146' ' ' VAL . . . 44.43 -128.75 7.14 Favored Glycine 0 N--CA 1.487 2.05 0 N-CA-C 108.885 -1.686 . . . . 0.0 108.885 -179.59 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 148' ' ' ASN . . . . . 0.537 HD22 ' C ' ' A' ' 148' ' ' ASN . 0.4 OUTLIER -103.66 16.39 26.53 Favored 'General case' 0 C--N 1.298 -1.649 0 O-C-N 121.424 -1.045 . . . . 0.0 108.298 179.094 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 149' ' ' GLU . . . . . . . . . . . . . 13.9 tt0 -111.75 145.31 39.58 Favored 'General case' 0 N--CA 1.489 1.477 0 CA-C-O 121.896 0.855 . . . . 0.0 111.273 -178.471 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 150' ' ' THR . . . . . 0.429 ' O ' HG22 ' A' ' 150' ' ' THR . 2.1 m -127.4 102.69 7.0 Favored 'General case' 0 N--CA 1.491 1.613 0 CA-C-O 121.433 0.635 . . . . 0.0 109.757 -179.737 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 151' ' ' ARG . . . . . . . . . . . . . 50.9 mtt180 -86.22 -175.69 5.62 Favored 'General case' 0 N--CA 1.487 1.386 0 N-CA-C 108.541 -0.911 . . . . 0.0 108.541 -179.878 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 152' ' ' LYS . . . . . . . . . . . . . 1.7 mtmp? -145.0 149.36 35.0 Favored 'General case' 0 C--N 1.303 -1.45 0 C-N-CA 119.216 -0.993 . . . . 0.0 110.048 -179.457 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 153' ' ' TYR . . . . . 0.504 ' CD2' ' HA ' ' A' ' 204' ' ' GLU . 31.2 m-85 -143.71 166.29 25.28 Favored 'General case' 0 C--N 1.303 -1.454 0 N-CA-C 107.822 -1.177 . . . . 0.0 107.822 178.719 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 154' ' ' LYS . . . . . 0.587 ' HB2' HG21 ' A' ' 205' ' ' VAL . 5.9 ttmm -143.99 119.81 10.57 Favored 'General case' 0 C--N 1.296 -1.723 0 N-CA-C 108.125 -1.065 . . . . 0.0 108.125 179.074 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 155' ' ' MET . . . . . . . . . . . . . 14.1 mtp -48.45 107.71 0.14 Allowed 'General case' 0 N--CA 1.493 1.678 0 O-C-N 120.522 -1.361 . . . . 0.0 111.543 -178.623 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 156' ' ' THR . . . . . 0.515 ' OG1' HG23 ' A' ' 203' ' ' THR . 0.0 OUTLIER -107.45 -22.36 12.58 Favored 'General case' 0 C--N 1.296 -1.736 0 CA-C-N 115.34 -0.845 . . . . 0.0 110.758 -178.646 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 157' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -151.21 150.43 30.6 Favored 'General case' 0 N--CA 1.494 1.762 0 C-N-CA 118.395 -1.322 . . . . 0.0 111.284 -178.71 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 158' ' ' ILE . . . . . 0.994 HD12 ' N ' ' A' ' 159' ' ' ARG . 0.1 OUTLIER -154.53 142.46 12.96 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.3 0 CA-C-O 121.923 0.868 . . . . 0.0 110.3 -178.743 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 159' ' ' ARG . . . . . 0.994 ' N ' HD12 ' A' ' 158' ' ' ILE . 27.2 ptt180 -155.21 155.02 33.13 Favored 'General case' 0 C--N 1.296 -1.722 0 CA-C-O 121.663 0.744 . . . . 0.0 109.929 -179.902 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 160' ' ' ASP . . . . . 0.416 ' C ' HG22 ' A' ' 161' ' ' VAL . 0.2 OUTLIER -115.06 162.28 17.22 Favored 'General case' 0 N--CA 1.492 1.633 0 N-CA-C 108.165 -1.05 . . . . 0.0 108.165 179.218 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 161' ' ' VAL . . . . . 0.416 HG22 ' C ' ' A' ' 160' ' ' ASP . 0.0 OUTLIER -158.34 160.15 2.11 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.609 0 O-C-N 121.169 -0.957 . . . . 0.0 110.394 -179.539 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 162' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -52.45 176.91 0.07 OUTLIER Pre-proline 0 N--CA 1.488 1.456 0 O-C-N 121.477 -0.764 . . . . 0.0 109.053 179.663 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 163' ' ' PRO . . . . . 0.457 ' C ' HD11 ' C' ' 702' ' ' LEU . 2.4 Cg_endo -78.67 37.31 0.64 Allowed 'Trans proline' 0 N--CA 1.491 1.333 0 C-N-CA 122.478 2.119 . . . . 0.0 113.086 -179.531 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 164' ' ' THR . . . . . 0.423 ' N ' HD11 ' C' ' 702' ' ' LEU . 0.2 OUTLIER -152.65 -6.69 0.2 Allowed 'General case' 0 N--CA 1.495 1.821 0 O-C-N 120.464 -1.397 . . . . 0.0 111.792 -179.4 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 165' ' ' ASP . . . . . . . . . . . . . 6.0 t70 -74.7 62.29 1.05 Allowed 'General case' 0 N--CA 1.493 1.677 0 O-C-N 120.676 -1.265 . . . . 0.0 110.041 -179.581 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 166' ' ' VAL . . . . . 0.613 ' O ' ' N ' ' A' ' 168' ' ' VAL . 1.5 m -47.82 -31.44 2.68 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.594 0 O-C-N 121.144 -0.972 . . . . 0.0 109.968 -178.55 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 167' ' ' GLY . . . . . . . . . . . . . . . -44.26 -10.01 0.01 OUTLIER Glycine 0 N--CA 1.496 2.65 0 O-C-N 120.811 -1.18 . . . . 0.0 111.094 -179.545 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 168' ' ' VAL . . . . . 0.613 ' N ' ' O ' ' A' ' 166' ' ' VAL . 5.5 m -53.51 -29.35 16.82 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.614 0 O-C-N 120.62 -1.518 . . . . 0.0 108.976 179.785 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 169' ' ' LEU . . . . . 0.533 ' O ' ' C ' ' A' ' 170' ' ' ASP . 11.1 mt -49.47 -13.79 0.09 Allowed 'General case' 0 N--CA 1.49 1.564 0 N-CA-C 107.31 -1.367 . . . . 0.0 107.31 -179.14 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 170' ' ' ASP . . . . . 0.551 ' N ' ' C ' ' A' ' 168' ' ' VAL . 3.2 t70 21.84 91.77 0.01 OUTLIER 'General case' 0 N--CA 1.502 2.139 0 CA-C-N 116.281 -0.418 . . . . 0.0 111.649 177.261 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 171' ' ' GLU . . . . . 0.425 ' C ' ' OE1' ' A' ' 113' ' ' GLN . 3.3 pt-20 -136.93 74.41 1.49 Allowed 'General case' 0 N--CA 1.493 1.699 0 O-C-N 120.913 -1.117 . . . . 0.0 110.863 -179.814 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 172' ' ' GLN . . . . . 0.617 ' N ' HE22 ' A' ' 113' ' ' GLN . 1.1 pt20 -132.01 -47.95 0.94 Allowed 'General case' 0 N--CA 1.499 2.021 0 O-C-N 121.284 -0.885 . . . . 0.0 111.661 -178.451 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 173' ' ' LYS . . . . . 0.515 ' NZ ' ' O ' ' A' ' 176' ' ' ASP . 8.4 ptmm? -64.31 129.13 38.73 Favored 'General case' 0 N--CA 1.499 1.989 0 O-C-N 120.576 -1.327 . . . . 0.0 109.324 -179.968 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 174' ' ' GLY . . . . . 0.527 ' O ' ' C ' ' A' ' 175' ' ' LYS . . . -115.37 -40.0 0.9 Allowed Glycine 0 N--CA 1.484 1.89 0 N-CA-C 108.676 -1.769 . . . . 0.0 108.676 179.591 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 175' ' ' LYS . . . . . 0.527 ' C ' ' O ' ' A' ' 174' ' ' GLY . 0.2 OUTLIER -41.44 -62.08 0.93 Allowed 'General case' 0 N--CA 1.491 1.597 0 N-CA-C 107.022 -1.473 . . . . 0.0 107.022 178.864 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 176' ' ' ASP . . . . . 0.567 ' O ' ' O ' ' A' ' 177' ' ' LYS . 81.8 m-20 -104.4 85.36 2.34 Favored 'General case' 0 C--N 1.298 -1.635 0 N-CA-C 107.691 -1.226 . . . . 0.0 107.691 176.781 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 177' ' ' LYS . . . . . 0.567 ' O ' ' O ' ' A' ' 176' ' ' ASP . 2.1 mptp? -47.55 -175.16 0.0 OUTLIER 'General case' 0 N--CA 1.5 2.044 0 O-C-N 121.28 -0.888 . . . . 0.0 108.93 -179.755 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 178' ' ' GLN . . . . . 0.457 ' OE1' ' OD1' ' A' ' 114' ' ' ASN . 0.3 OUTLIER -162.75 178.63 8.31 Favored 'General case' 0 C--N 1.305 -1.355 0 O-C-N 120.264 -1.523 . . . . 0.0 110.936 179.836 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 179' ' ' LEU . . . . . 0.453 HD23 ' C ' ' A' ' 179' ' ' LEU . 4.6 tt -128.55 97.55 4.74 Favored 'General case' 0 C--N 1.302 -1.474 0 N-CA-C 107.54 -1.281 . . . . 0.0 107.54 178.436 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 180' ' ' THR . . . . . 0.441 ' O ' HG22 ' A' ' 180' ' ' THR . 1.2 m -71.29 115.18 10.15 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 120.996 -1.065 . . . . 0.0 109.967 -178.719 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 181' ' ' LEU . . . . . 0.475 HD21 ' HG ' ' A' ' 133' ' ' LEU . 48.5 tp -93.16 142.45 27.28 Favored 'General case' 0 C--N 1.295 -1.794 0 N-CA-C 108.368 -0.975 . . . . 0.0 108.368 178.328 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 182' ' ' ILE . . . . . . . . . . . . . 47.0 mt -136.11 120.58 25.93 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.533 0 N-CA-C 108.197 -1.038 . . . . 0.0 108.197 178.925 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 183' ' ' THR . . . . . 0.487 ' O ' HG23 ' A' ' 183' ' ' THR . 2.2 t -140.72 111.84 7.18 Favored 'General case' 0 C--N 1.291 -1.943 0 N-CA-C 107.718 -1.215 . . . . 0.0 107.718 179.117 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 184' ' ' CYS . . . . . . . . . . . . . 1.2 p -78.81 159.55 27.8 Favored 'General case' 0 C--N 1.292 -1.907 0 C-N-CA 118.856 -1.138 . . . . 0.0 110.665 -178.09 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 185' ' ' ASP . . . . . 0.438 ' HB3' ' HZ1' ' A' ' 198' ' ' LYS . 0.4 OUTLIER -164.57 -155.66 0.28 Allowed 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.629 -0.669 . . . . 0.0 109.413 -179.488 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 186' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER 52.32 60.67 3.65 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.128 -0.982 . . . . 0.0 108.597 -179.469 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 187' ' ' TYR . . . . . 0.593 ' CE1' ' O ' ' A' ' 188' ' ' ASN . 35.5 t80 -68.34 134.02 49.64 Favored 'General case' 0 N--CA 1.488 1.459 0 CA-C-O 121.812 0.815 . . . . 0.0 111.142 -178.977 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 188' ' ' ASN . . . . . 0.593 ' O ' ' CE1' ' A' ' 187' ' ' TYR . 0.9 OUTLIER -98.67 145.64 26.67 Favored 'General case' 0 C--N 1.296 -1.721 0 N-CA-C 108.218 -1.03 . . . . 0.0 108.218 178.395 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 189' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -112.01 -19.91 12.16 Favored 'General case' 0 C--N 1.296 -1.749 0 N-CA-C 107.904 -1.147 . . . . 0.0 107.904 -179.86 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 190' ' ' LYS . . . . . . . . . . . . . 33.5 mttt -82.63 -50.06 9.16 Favored 'General case' 0 C--N 1.3 -1.551 0 N-CA-C 108.235 -1.024 . . . . 0.0 108.235 178.62 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 191' ' ' THR . . . . . . . . . . . . . 71.4 p -87.97 -8.97 54.93 Favored 'General case' 0 C--N 1.303 -1.428 0 N-CA-C 109.105 -0.702 . . . . 0.0 109.105 -179.97 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 192' ' ' GLY . . . . . . . . . . . . . . . 57.56 38.73 88.91 Favored Glycine 0 N--CA 1.493 2.466 0 N-CA-C 110.745 -0.942 . . . . 0.0 110.745 178.872 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 193' ' ' VAL . . . . . . . . . . . . . 3.2 m -148.05 162.1 6.63 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.58 0 O-C-N 120.989 -1.3 . . . . 0.0 108.872 179.35 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 194' ' ' TRP . . . . . 0.497 ' CD1' HG2B ' C' ' 705' ' ' B27 . 47.6 m95 -83.58 120.47 26.0 Favored 'General case' 0 N--CA 1.489 1.518 0 N-CA-C 107.802 -1.184 . . . . 0.0 107.802 178.901 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 195' ' ' GLU . . . . . . . . . . . . . 2.0 mt-10 -86.8 -61.05 1.82 Allowed 'General case' 0 N--CA 1.496 1.858 0 O-C-N 121.132 -0.98 . . . . 0.0 112.083 -177.318 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 196' ' ' LYS . . . . . . . . . . . . . 11.1 tttm -76.84 150.51 36.08 Favored 'General case' 0 N--CA 1.493 1.723 0 O-C-N 120.973 -1.079 . . . . 0.0 111.304 -177.663 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 197' ' ' ARG . . . . . 0.431 ' NH1' ' O ' ' C' ' 704' ' ' ALA . 16.9 mmt180 -122.01 129.83 52.78 Favored 'General case' 0 N--CA 1.491 1.584 0 N-CA-C 108.839 -0.8 . . . . 0.0 108.839 179.481 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 198' ' ' LYS . . . . . 0.438 ' HZ1' ' HB3' ' A' ' 185' ' ' ASP . 9.6 mtmt -113.72 120.25 40.18 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.482 -0.761 . . . . 0.0 109.969 -179.399 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 199' ' ' ILE . . . . . 0.508 ' C ' HD12 ' A' ' 199' ' ' ILE . 0.8 OUTLIER -140.04 118.42 11.14 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.723 0 CA-C-O 122.405 1.097 . . . . 0.0 109.929 179.269 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 200' ' ' PHE . . . . . 0.524 ' CD1' ' N ' ' A' ' 200' ' ' PHE . 4.7 m-85 -100.09 139.68 35.41 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.181 -0.949 . . . . 0.0 109.512 -179.082 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 201' ' ' VAL . . . . . . . . . . . . . 40.7 t -102.33 145.79 11.42 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.645 0 N-CA-C 107.31 -1.367 . . . . 0.0 107.31 177.395 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 202' ' ' ALA . . . . . . . . . . . . . . . -129.25 137.42 51.07 Favored 'General case' 0 C--N 1.301 -1.503 0 O-C-N 120.949 -1.095 . . . . 0.0 109.146 -179.4 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 203' ' ' THR . . . . . 0.559 ' O ' HG23 ' A' ' 205' ' ' VAL . 2.5 p -88.83 129.99 35.47 Favored 'General case' 0 C--N 1.305 -1.352 0 CA-C-O 122.393 1.092 . . . . 0.0 110.705 -178.791 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 204' ' ' GLU . . . . . 0.504 ' HA ' ' CD2' ' A' ' 153' ' ' TYR . 3.9 tm-20 -50.84 133.82 26.06 Favored 'General case' 0 C--N 1.296 -1.734 0 C-N-CA 119.184 -1.007 . . . . 0.0 109.659 179.739 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 205' ' ' VAL . . . . . 0.597 HG12 ' N ' ' A' ' 206' ' ' LYS . 73.8 t -126.94 164.52 27.35 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.452 0 CA-C-O 122.109 0.957 . . . . 0.0 110.066 -178.14 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 206' ' ' LYS . . . . . 0.597 ' N ' HG12 ' A' ' 205' ' ' VAL . 0.9 OUTLIER . . . . . 0 C--N 1.295 -1.765 0 CA-C-O 117.931 -1.033 . . . . 0.0 109.468 179.929 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' C' C ' 701' ' ' PHQ . . . . . 0.517 ' C1 ' HG12 ' A' ' 166' ' ' VAL . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 013 nuclear build full ' C' C ' 702' ' ' LEU . . . . . 0.772 ' N ' HD12 ' C' ' 702' ' ' LEU . 0.0 OUTLIER . . . . . 0 N--CA 1.492 1.632 0 N-CA-C 108.998 -0.741 . . . . 0.0 108.998 . . . . . . . . . 2 2 . 1 . 013 nuclear build full ' C' C ' 703' ' ' PRO . . . . . 0.586 ' HG3' ' HB1' ' A' ' 104' ' ' ALA . 28.8 Cg_endo -68.95 -162.03 0.08 OUTLIER 'Trans proline' 0 N--CA 1.491 1.347 0 C-N-CA 122.271 1.981 . . . . 0.0 112.272 179.779 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' C' C ' 704' ' ' ALA . . . . . 0.942 ' HB2' ' HB1' ' A' ' 118' ' ' ALA . . . 48.38 97.48 0.01 OUTLIER 'General case' 0 N--CA 1.489 1.491 0 O-C-N 121.306 -0.871 . . . . 0.0 108.993 -179.928 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' C' C ' 705' ' ' B27 . . . . . 0.54 ' SG ' ' C ' ' C' ' 704' ' ' ALA . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 700' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 014 nuclear build full ' A' A ' 59' ' ' MET . . . . . . . . . . . . . 11.4 mtt . . . . . 0 N--CA 1.489 1.522 0 N-CA-C 109.456 -0.572 . . . . 0.0 109.456 . . . . . . . . . 0 0 . 1 . 014 nuclear build full ' A' A ' 60' ' ' GLN . . . . . . . . . . . . . 13.3 mt-30 -60.54 179.08 0.17 Allowed 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.38 -0.825 . . . . 0.0 109.437 -179.992 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 61' ' ' ALA . . . . . 0.449 ' HB2' ' OD1' ' A' ' 148' ' ' ASN . . . -64.1 -164.26 0.02 OUTLIER 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.27 -0.894 . . . . 0.0 109.508 -179.921 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 62' ' ' LYS . . . . . . . . . . . . . 24.8 tttt -147.88 89.63 5.27 Favored Pre-proline 0 N--CA 1.491 1.596 0 O-C-N 121.347 -0.846 . . . . 0.0 109.653 -179.645 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 63' ' ' PRO . . . . . 0.644 ' O ' HD13 ' A' ' 110' ' ' LEU . 21.3 Cg_endo -83.57 138.86 8.66 Favored 'Trans proline' 0 C--N 1.31 -1.474 0 C-N-CA 122.598 2.199 . . . . 0.0 111.586 179.722 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 64' ' ' GLN . . . . . 0.442 ' N ' ' OE1' ' A' ' 64' ' ' GLN . 0.0 OUTLIER -158.14 113.4 2.67 Favored 'General case' 0 N--CA 1.488 1.453 0 O-C-N 121.249 -0.907 . . . . 0.0 109.528 -179.773 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 65' ' ' ILE . . . . . 0.722 ' H ' HD13 ' A' ' 65' ' ' ILE . 0.0 OUTLIER -42.0 103.29 0.3 Allowed Pre-proline 0 N--CA 1.49 1.571 0 N-CA-C 108.757 -0.831 . . . . 0.0 108.757 179.471 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 66' ' ' PRO . . . . . . . . . . . . . 94.3 Cg_endo -87.6 -155.82 0.06 OUTLIER 'Trans proline' 0 C--N 1.313 -1.338 0 C-N-CA 122.372 2.048 . . . . 0.0 112.259 -179.18 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 67' ' ' LYS . . . . . . . . . . . . . 23.1 pttm -79.42 -7.86 58.7 Favored 'General case' 0 C--N 1.302 -1.474 0 O-C-N 121.308 -0.87 . . . . 0.0 108.847 179.673 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 68' ' ' ASP . . . . . 0.579 ' O ' ' N ' ' A' ' 70' ' ' SER . 1.9 t0 -76.7 48.3 0.55 Allowed 'General case' 0 N--CA 1.487 1.423 0 CA-C-O 122.342 1.068 . . . . 0.0 108.931 179.385 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 69' ' ' LYS . . . . . 0.444 ' C ' ' O ' ' A' ' 68' ' ' ASP . 0.0 OUTLIER -49.27 -14.69 0.1 Allowed 'General case' 0 N--CA 1.503 2.217 0 C-N-CA 117.094 -1.842 . . . . 0.0 106.554 178.257 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 70' ' ' SER . . . . . 0.579 ' N ' ' O ' ' A' ' 68' ' ' ASP . 1.1 p -82.28 -8.91 59.64 Favored 'General case' 0 N--CA 1.495 1.804 0 CA-C-N 113.942 -1.481 . . . . 0.0 110.035 179.552 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 71' ' ' LYS . . . . . 0.416 ' CD ' ' HB3' ' A' ' 68' ' ' ASP . 0.0 OUTLIER -99.19 144.17 28.62 Favored 'General case' 0 N--CA 1.494 1.73 0 O-C-N 121.034 -1.041 . . . . 0.0 110.312 179.294 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 72' ' ' VAL . . . . . 0.517 HG12 ' CZ ' ' A' ' 88' ' ' TYR . 1.0 OUTLIER -65.26 141.48 18.13 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.575 0 N-CA-C 104.868 -2.271 . . . . 0.0 104.868 174.542 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -80.82 -14.9 57.64 Favored 'General case' 0 C--N 1.294 -1.825 0 O-C-N 119.864 -1.772 . . . . 0.0 106.411 179.66 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . 175.46 -156.58 22.36 Favored Glycine 0 N--CA 1.481 1.645 0 N-CA-C 109.16 -1.576 . . . . 0.0 109.16 179.274 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 75' ' ' TYR . . . . . 0.572 ' CD2' ' O ' ' A' ' 85' ' ' GLU . 0.5 OUTLIER -141.7 167.98 20.86 Favored 'General case' 0 C--N 1.292 -1.893 0 O-C-N 121.664 -0.903 . . . . 0.0 110.655 -176.991 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 76' ' ' ILE . . . . . . . . . . . . . 0.6 OUTLIER -144.75 140.32 23.44 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.597 0 C-N-CA 119.087 -1.045 . . . . 0.0 109.781 -177.432 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -148.57 161.46 41.63 Favored 'General case' 0 C--N 1.303 -1.456 0 O-C-N 121.287 -0.883 . . . . 0.0 109.158 -179.571 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 78' ' ' ILE . . . . . 0.654 ' HB ' ' HB3' ' A' ' 81' ' ' ALA . 6.6 mt -146.89 94.42 4.64 Favored Pre-proline 0 C--N 1.3 -1.553 0 N-CA-C 108.53 -0.915 . . . . 0.0 108.53 -179.75 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 79' ' ' PRO . . . . . . . . . . . . . 74.4 Cg_exo -47.32 -47.42 17.47 Favored 'Trans proline' 0 N--CA 1.493 1.449 0 C-N-CA 122.805 2.337 . . . . 0.0 113.765 -178.745 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -65.24 -18.17 65.1 Favored 'General case' 0 N--CA 1.492 1.65 0 O-C-N 120.765 -1.209 . . . . 0.0 110.565 178.667 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 81' ' ' ALA . . . . . 0.893 ' HB2' ' HB2' ' A' ' 136' ' ' ALA . . . -105.69 -16.74 14.6 Favored 'General case' 0 N--CA 1.493 1.718 0 O-C-N 121.24 -0.912 . . . . 0.0 108.918 179.653 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 82' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER 69.39 47.79 0.67 Allowed 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.432 -0.793 . . . . 0.0 110.53 178.87 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 83' ' ' ILE . . . . . . . . . . . . . 67.2 mt -127.1 149.58 32.31 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.81 0 O-C-N 121.065 -1.022 . . . . 0.0 110.732 -178.87 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 84' ' ' LYS . . . . . . . . . . . . . 6.7 ttpm? -157.38 107.86 2.25 Favored 'General case' 0 N--CA 1.491 1.595 0 N-CA-C 107.544 -1.28 . . . . 0.0 107.544 179.516 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 85' ' ' GLU . . . . . 0.572 ' O ' ' CD2' ' A' ' 75' ' ' TYR . 0.4 OUTLIER -145.31 174.37 3.51 Favored Pre-proline 0 N--CA 1.492 1.65 0 O-C-N 121.503 -0.748 . . . . 0.0 110.409 -178.8 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 86' ' ' PRO . . . . . . . . . . . . . 60.3 Cg_endo -82.41 168.85 14.43 Favored 'Trans proline' 0 C--N 1.313 -1.305 0 C-N-CA 122.809 2.339 . . . . 0.0 113.841 -179.347 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 87' ' ' VAL . . . . . 0.531 ' CG1' ' CZ ' ' A' ' 103' ' ' PHE . 3.2 t -128.93 105.84 13.42 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.607 0 N-CA-C 108.448 -0.945 . . . . 0.0 108.448 179.91 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 88' ' ' TYR . . . . . 0.517 ' CZ ' HG12 ' A' ' 72' ' ' VAL . 34.6 m-85 -99.22 152.76 37.91 Favored Pre-proline 0 N--CA 1.499 2.006 0 O-C-N 120.769 -1.207 . . . . 0.0 110.129 -179.018 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 89' ' ' PRO . . . . . . . . . . . . . 2.7 Cg_exo -50.35 144.42 23.97 Favored 'Trans proline' 0 C--N 1.312 -1.351 0 C-N-CA 122.707 2.271 . . . . 0.0 113.487 179.871 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . -61.41 169.57 10.5 Favored Glycine 0 N--CA 1.493 2.47 0 N-CA-C 108.807 -1.717 . . . . 0.0 108.807 178.894 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 91' ' ' PRO . . . . . 0.487 ' C ' ' H ' ' A' ' 93' ' ' THR . 63.9 Cg_endo -95.7 172.86 13.58 Favored 'Cis proline' 0 C--N 1.311 -1.407 0 C-N-CA 124.227 -1.156 . . . . 0.0 112.226 0.133 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 92' ' ' ALA . . . . . 0.553 ' O ' HD13 ' A' ' 97' ' ' LEU . . . -70.48 29.03 0.04 OUTLIER 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.229 -0.919 . . . . 0.0 110.378 -179.794 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 93' ' ' THR . . . . . 0.487 ' H ' ' C ' ' A' ' 91' ' ' PRO . 1.8 p -75.19 152.14 86.05 Favored Pre-proline 0 N--CA 1.489 1.524 0 O-C-N 120.626 -1.296 . . . . 0.0 108.833 -179.958 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 94' ' ' PRO . . . . . . . . . . . . . 86.4 Cg_exo -35.03 -42.34 0.35 Allowed 'Trans proline' 0 C--N 1.309 -1.546 0 C-N-CA 122.821 2.348 . . . . 0.0 112.398 -179.362 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 95' ' ' GLU . . . . . 0.485 ' O ' ' OD1' ' A' ' 98' ' ' ASN . 53.2 mt-10 -52.84 -55.18 25.01 Favored 'General case' 0 C--N 1.304 -1.407 0 O-C-N 121.094 -1.004 . . . . 0.0 109.12 179.636 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 96' ' ' GLN . . . . . 0.569 ' O ' ' N ' ' A' ' 98' ' ' ASN . 28.6 mm100 -72.29 -50.99 22.87 Favored 'General case' 0 N--CA 1.488 1.458 0 O-C-N 121.124 -0.985 . . . . 0.0 110.151 179.965 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 97' ' ' LEU . . . . . 0.553 HD13 ' O ' ' A' ' 92' ' ' ALA . 2.5 mp -48.39 -9.12 0.02 OUTLIER 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.038 -1.039 . . . . 0.0 109.784 -179.306 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 98' ' ' ASN . . . . . 0.737 HD21 ' CZ ' ' A' ' 99' ' ' ARG . 14.4 p-10 -72.38 -30.35 64.6 Favored 'General case' 0 N--CA 1.492 1.625 0 CA-C-O 121.873 0.844 . . . . 0.0 109.48 179.624 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 99' ' ' ARG . . . . . 0.737 ' CZ ' HD21 ' A' ' 98' ' ' ASN . 1.2 mtt-85 -98.66 -47.1 5.47 Favored 'General case' 0 C--N 1.299 -1.591 0 C-N-CA 119.829 -0.749 . . . . 0.0 110.106 -178.479 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . 176.28 -176.58 47.78 Favored Glycine 0 N--CA 1.493 2.485 0 C-N-CA 119.096 -1.526 . . . . 0.0 110.916 179.857 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 101' ' ' VAL . . . . . 0.739 ' CG2' HG22 ' A' ' 117' ' ' ILE . 0.2 OUTLIER -50.46 111.7 0.2 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.597 0 O-C-N 121.697 -0.884 . . . . 0.0 109.892 -179.859 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -93.94 169.7 10.09 Favored 'General case' 0 N--CA 1.496 1.84 0 O-C-N 121.273 -0.892 . . . . 0.0 110.741 -179.888 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 103' ' ' PHE . . . . . 0.603 ' O ' ' N ' ' A' ' 105' ' ' GLU . 27.5 m-85 -71.06 121.02 17.48 Favored 'General case' 0 N--CA 1.485 1.314 0 N-CA-C 107.68 -1.23 . . . . 0.0 107.68 177.609 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 104' ' ' ALA . . . . . 0.806 ' HB3' ' OG ' ' A' ' 116' ' ' SER . . . -41.95 -15.65 0.01 OUTLIER 'General case' 0 C--N 1.299 -1.597 0 O-C-N 121.497 -0.752 . . . . 0.0 110.682 -178.821 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 105' ' ' GLU . . . . . 0.603 ' N ' ' O ' ' A' ' 103' ' ' PHE . 0.1 OUTLIER -136.22 145.45 45.67 Favored 'General case' 0 N--CA 1.496 1.86 0 O-C-N 120.811 -1.18 . . . . 0.0 110.243 179.638 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 106' ' ' GLU . . . . . . . . . . . . . 2.0 tt0 -60.02 -63.43 1.3 Allowed 'General case' 0 N--CA 1.489 1.482 0 O-C-N 121.835 -0.54 . . . . 0.0 111.416 -178.904 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 107' ' ' ASN . . . . . . . . . . . . . 6.2 p-10 -78.11 35.09 0.21 Allowed 'General case' 0 N--CA 1.491 1.609 0 O-C-N 120.649 -1.282 . . . . 0.0 112.76 -175.608 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 108' ' ' GLU . . . . . . . . . . . . . 1.7 tp10 -58.24 148.94 25.51 Favored 'General case' 0 N--CA 1.488 1.451 0 N-CA-C 107.591 -1.263 . . . . 0.0 107.591 179.891 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 109' ' ' SER . . . . . 0.483 ' O ' HD11 ' A' ' 115' ' ' ILE . 0.2 OUTLIER -101.6 146.3 27.88 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.139 -0.975 . . . . 0.0 110.709 -178.305 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 110' ' ' LEU . . . . . 0.683 HD23 ' H ' ' A' ' 110' ' ' LEU . 0.3 OUTLIER -62.1 -24.15 66.95 Favored 'General case' 0 C--N 1.302 -1.477 0 N-CA-C 108.035 -1.098 . . . . 0.0 108.035 179.14 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 111' ' ' ASP . . . . . 0.405 ' CG ' HH12 ' A' ' 151' ' ' ARG . 13.0 m-20 -132.7 43.34 2.99 Favored 'General case' 0 N--CA 1.488 1.448 0 O-C-N 121.688 -0.633 . . . . 0.0 109.762 179.97 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 112' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -69.12 156.04 39.35 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.15 -0.969 . . . . 0.0 110.806 -179.852 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 113' ' ' GLN . . . . . 0.457 ' N ' ' CD ' ' A' ' 113' ' ' GLN . 1.9 mp0 -67.14 -18.16 65.17 Favored 'General case' 0 N--CA 1.491 1.622 0 N-CA-C 108.15 -1.055 . . . . 0.0 108.15 178.097 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 114' ' ' ASN . . . . . 0.498 ' O ' ' ND2' ' A' ' 114' ' ' ASN . 1.1 t30 -150.37 103.84 3.18 Favored 'General case' 0 C--N 1.299 -1.626 0 N-CA-C 107.871 -1.159 . . . . 0.0 107.871 178.533 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 115' ' ' ILE . . . . . 0.489 ' O ' HG22 ' A' ' 115' ' ' ILE . 2.9 mt -97.77 109.2 23.09 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.66 0 O-C-N 120.885 -1.134 . . . . 0.0 108.696 -179.955 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 116' ' ' SER . . . . . 0.806 ' OG ' ' HB3' ' A' ' 104' ' ' ALA . 80.8 p -88.0 152.24 22.18 Favored 'General case' 0 N--CA 1.49 1.538 0 CA-C-O 121.863 0.839 . . . . 0.0 110.842 -178.445 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 117' ' ' ILE . . . . . 0.739 HG22 ' CG2' ' A' ' 101' ' ' VAL . 1.5 mt -146.95 122.29 2.63 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.413 0 N-CA-C 107.876 -1.157 . . . . 0.0 107.876 -179.725 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 118' ' ' ALA . . . . . . . . . . . . . . . -118.58 159.72 23.07 Favored 'General case' 0 N--CA 1.496 1.846 0 C-N-CA 119.516 -0.874 . . . . 0.0 112.074 -177.933 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 119' ' ' GLY . . . . . . . . . . . . . . . -170.7 148.11 11.13 Favored Glycine 0 N--CA 1.49 2.255 0 CA-C-O 122.163 0.868 . . . . 0.0 110.936 179.929 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 120' ' ' HIS . . . . . 0.565 ' N ' ' OE1' ' A' ' 129' ' ' GLN . 6.4 m170 -71.19 168.47 17.17 Favored 'General case' 0 N--CA 1.496 1.831 0 O-C-N 121.889 -0.771 . . . . 0.0 109.909 179.084 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 121' ' ' THR . . . . . 0.503 HG22 ' CZ3' ' A' ' 194' ' ' TRP . 0.7 OUTLIER -122.64 158.07 30.81 Favored 'General case' 0 N--CA 1.496 1.844 0 N-CA-C 108.48 -0.933 . . . . 0.0 108.48 178.786 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 122' ' ' PHE . . . . . 0.438 ' O ' HG21 ' A' ' 131' ' ' THR . 1.1 m-85 -144.16 123.61 13.15 Favored 'General case' 0 N--CA 1.498 1.974 0 O-C-N 120.819 -1.175 . . . . 0.0 110.006 -179.926 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 123' ' ' ILE . . . . . 0.585 HG23 ' N ' ' A' ' 124' ' ' ASP . 14.4 tt -58.51 -40.92 80.34 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.541 0 CA-C-O 121.619 0.723 . . . . 0.0 109.46 179.714 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 124' ' ' ASP . . . . . 0.585 ' N ' HG23 ' A' ' 123' ' ' ILE . 13.1 t70 -90.14 26.21 1.95 Allowed 'General case' 0 N--CA 1.497 1.888 0 O-C-N 121.573 -0.704 . . . . 0.0 112.166 -177.215 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 125' ' ' ARG . . . . . 0.67 HH11 ' CG ' ' A' ' 125' ' ' ARG . 2.2 mtt-85 -155.59 99.69 2.25 Favored Pre-proline 0 N--CA 1.493 1.679 0 O-C-N 120.451 -1.406 . . . . 0.0 109.718 179.989 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 126' ' ' PRO . . . . . . . . . . . . . 53.9 Cg_endo -78.54 -25.15 6.93 Favored 'Trans proline' 0 C--N 1.314 -1.277 0 C-N-CA 122.067 1.845 . . . . 0.0 112.172 179.893 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 127' ' ' ASN . . . . . 0.447 ' O ' ' O ' ' A' ' 128' ' ' TYR . 3.0 t30 -91.77 5.17 50.88 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.264 -0.897 . . . . 0.0 109.43 179.743 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 128' ' ' TYR . . . . . 0.465 ' O ' ' OE2' ' A' ' 85' ' ' GLU . 9.7 t80 -59.22 -150.25 0.0 OUTLIER 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.296 -0.878 . . . . 0.0 109.88 -179.765 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 129' ' ' GLN . . . . . 0.565 ' OE1' ' N ' ' A' ' 120' ' ' HIS . 10.3 mt-30 -68.04 -70.26 0.27 Allowed 'General case' 0 C--N 1.303 -1.422 0 O-C-N 121.549 -0.72 . . . . 0.0 109.483 179.968 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 130' ' ' PHE . . . . . 0.641 ' CE1' HD21 ' A' ' 181' ' ' LEU . 55.6 m-85 -136.59 51.88 1.98 Allowed 'General case' 0 N--CA 1.489 1.501 0 O-C-N 121.29 -0.881 . . . . 0.0 110.289 -179.536 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 131' ' ' THR . . . . . 0.537 ' O ' ' CD ' ' A' ' 134' ' ' LYS . 54.0 m -81.78 -40.06 23.18 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 120.936 -1.102 . . . . 0.0 109.275 179.844 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 132' ' ' ASN . . . . . 0.575 ' ND2' ' O ' ' A' ' 81' ' ' ALA . 32.1 t30 -91.88 13.56 18.11 Favored 'General case' 0 N--CA 1.496 1.854 0 C-N-CA 119.61 -0.836 . . . . 0.0 111.783 -178.781 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 133' ' ' LEU . . . . . 0.598 HD13 ' O ' ' A' ' 133' ' ' LEU . 0.2 OUTLIER -68.15 -33.51 74.61 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 120.49 -1.381 . . . . 0.0 109.402 -179.696 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 134' ' ' LYS . . . . . 0.697 ' H ' ' CD ' ' A' ' 134' ' ' LYS . 0.0 OUTLIER -44.66 -25.41 0.28 Allowed 'General case' 0 N--CA 1.494 1.734 0 O-C-N 121.35 -0.844 . . . . 0.0 110.625 -179.977 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 135' ' ' ALA . . . . . . . . . . . . . . . -82.31 -29.83 30.87 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.087 -1.008 . . . . 0.0 110.651 -178.623 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 136' ' ' ALA . . . . . 0.893 ' HB2' ' HB2' ' A' ' 81' ' ' ALA . . . -79.91 145.24 32.77 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.034 -1.041 . . . . 0.0 111.496 -178.639 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 137' ' ' LYS . . . . . 0.565 ' CG ' ' H ' ' A' ' 138' ' ' LYS . 0.5 OUTLIER -153.18 -167.69 2.8 Favored 'General case' 0 N--CA 1.496 1.828 0 C-N-CA 118.676 -1.209 . . . . 0.0 110.698 -177.994 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 138' ' ' LYS . . . . . 0.596 ' O ' ' N ' ' A' ' 140' ' ' SER . 22.1 mtmt -44.09 178.77 0.0 OUTLIER 'General case' 0 N--CA 1.487 1.407 0 CA-C-O 122.335 1.064 . . . . 0.0 110.709 -179.197 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 139' ' ' GLY . . . . . . . . . . . . . . . 46.1 7.88 0.02 OUTLIER Glycine 0 N--CA 1.487 2.057 0 N-CA-C 110.526 -1.03 . . . . 0.0 110.526 179.593 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 140' ' ' SER . . . . . 0.596 ' N ' ' O ' ' A' ' 138' ' ' LYS . 38.2 t -92.57 135.63 33.91 Favored 'General case' 0 N--CA 1.494 1.748 0 O-C-N 120.706 -1.467 . . . . 0.0 109.293 179.318 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 141' ' ' MET . . . . . 0.673 ' SD ' ' N ' ' A' ' 142' ' ' VAL . 9.7 tpp -87.94 132.7 34.13 Favored 'General case' 0 C--N 1.299 -1.608 0 O-C-N 121.246 -0.908 . . . . 0.0 109.621 179.94 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 142' ' ' VAL . . . . . 0.673 ' N ' ' SD ' ' A' ' 141' ' ' MET . 2.3 t -115.51 136.51 52.08 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.457 0 N-CA-C 108.068 -1.086 . . . . 0.0 108.068 179.875 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 143' ' ' TYR . . . . . . . . . . . . . 10.0 m-85 -115.73 137.64 51.89 Favored 'General case' 0 N--CA 1.499 2.016 0 O-C-N 121.021 -1.049 . . . . 0.0 111.758 -178.1 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 144' ' ' PHE . . . . . . . . . . . . . 12.6 t80 -122.16 107.93 12.73 Favored 'General case' 0 N--CA 1.492 1.665 0 CA-C-O 121.322 0.582 . . . . 0.0 109.5 -179.951 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 145' ' ' LYS . . . . . 0.453 ' O ' ' N ' ' A' ' 75' ' ' TYR . 1.6 tttp -95.46 131.78 41.24 Favored 'General case' 0 N--CA 1.493 1.684 0 O-C-N 121.333 -0.854 . . . . 0.0 110.371 -179.291 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 146' ' ' VAL . . . . . 0.45 ' O ' ' C ' ' A' ' 147' ' ' GLY . 0.7 OUTLIER -144.54 141.23 23.94 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.644 0 N-CA-C 107.9 -1.148 . . . . 0.0 107.9 178.667 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 147' ' ' GLY . . . . . 0.45 ' C ' ' O ' ' A' ' 146' ' ' VAL . . . 42.56 -127.57 4.77 Favored Glycine 0 N--CA 1.49 2.28 0 N-CA-C 109.394 -1.482 . . . . 0.0 109.394 -179.821 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 148' ' ' ASN . . . . . 0.524 ' C ' HD22 ' A' ' 148' ' ' ASN . 0.4 OUTLIER -103.01 14.62 31.51 Favored 'General case' 0 C--N 1.3 -1.566 0 O-C-N 121.418 -1.048 . . . . 0.0 108.47 179.365 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 149' ' ' GLU . . . . . . . . . . . . . 3.6 tt0 -110.85 143.77 40.92 Favored 'General case' 0 N--CA 1.488 1.442 0 CA-C-O 122.031 0.919 . . . . 0.0 111.26 -178.589 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 150' ' ' THR . . . . . . . . . . . . . 6.4 m -127.22 102.18 6.82 Favored 'General case' 0 N--CA 1.49 1.544 0 CA-C-O 121.395 0.617 . . . . 0.0 109.452 179.896 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 151' ' ' ARG . . . . . 0.405 HH12 ' CG ' ' A' ' 111' ' ' ASP . 22.1 mtt180 -87.6 -178.33 6.08 Favored 'General case' 0 C--N 1.305 -1.368 0 N-CA-C 108.459 -0.941 . . . . 0.0 108.459 179.789 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 152' ' ' LYS . . . . . 0.447 ' C ' ' CD1' ' A' ' 153' ' ' TYR . 22.6 mtmt -148.8 152.51 36.66 Favored 'General case' 0 C--N 1.3 -1.57 0 C-N-CA 119.303 -0.959 . . . . 0.0 110.024 -179.677 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 153' ' ' TYR . . . . . 0.557 ' O ' ' SD ' ' A' ' 141' ' ' MET . 42.1 m-85 -144.23 157.19 44.42 Favored 'General case' 0 C--N 1.3 -1.565 0 N-CA-C 107.987 -1.116 . . . . 0.0 107.987 179.137 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 154' ' ' LYS . . . . . . . . . . . . . 26.1 ttpt -132.1 118.33 19.48 Favored 'General case' 0 C--N 1.297 -1.684 0 N-CA-C 108.514 -0.921 . . . . 0.0 108.514 179.529 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 155' ' ' MET . . . . . . . . . . . . . 15.0 mtp -45.33 105.64 0.06 Allowed 'General case' 0 N--CA 1.489 1.496 0 CA-C-O 122.284 1.04 . . . . 0.0 111.632 -178.494 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 156' ' ' THR . . . . . 0.528 ' OG1' HG23 ' A' ' 203' ' ' THR . 0.2 OUTLIER -105.7 -25.25 12.31 Favored 'General case' 0 C--N 1.295 -1.786 0 CA-C-N 115.37 -0.832 . . . . 0.0 110.538 -178.803 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 157' ' ' SER . . . . . 0.484 ' O ' ' N ' ' A' ' 201' ' ' VAL . 0.0 OUTLIER -152.93 155.73 37.56 Favored 'General case' 0 N--CA 1.496 1.835 0 C-N-CA 118.456 -1.298 . . . . 0.0 110.914 -178.684 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 158' ' ' ILE . . . . . 0.42 HG12 ' N ' ' A' ' 159' ' ' ARG . 0.0 OUTLIER -154.52 146.7 13.61 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.561 0 CA-C-O 121.812 0.815 . . . . 0.0 110.857 -178.998 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 159' ' ' ARG . . . . . 0.508 ' O ' ' OD1' ' A' ' 160' ' ' ASP . 1.6 tpt180 -148.83 167.84 24.58 Favored 'General case' 0 N--CA 1.491 1.589 0 CA-C-O 121.448 0.642 . . . . 0.0 109.755 -179.659 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 160' ' ' ASP . . . . . 0.508 ' OD1' ' O ' ' A' ' 159' ' ' ARG . 6.5 m-20 -140.5 163.29 33.22 Favored 'General case' 0 N--CA 1.493 1.71 0 O-C-N 121.488 -0.757 . . . . 0.0 108.976 -179.388 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 161' ' ' VAL . . . . . 0.713 HG22 ' N ' ' A' ' 162' ' ' LYS . 11.8 p -165.49 169.05 0.36 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.708 0 O-C-N 120.906 -1.121 . . . . 0.0 111.277 179.894 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 162' ' ' LYS . . . . . 0.713 ' N ' HG22 ' A' ' 161' ' ' VAL . 0.0 OUTLIER -60.82 174.0 0.59 Allowed Pre-proline 0 N--CA 1.492 1.643 0 N-CA-C 109.099 -0.704 . . . . 0.0 109.099 178.771 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 163' ' ' PRO . . . . . . . . . . . . . 59.2 Cg_endo -82.2 42.92 1.4 Allowed 'Trans proline' 0 C--N 1.311 -1.416 0 C-N-CA 122.444 2.096 . . . . 0.0 112.855 -179.324 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 164' ' ' THR . . . . . 0.412 ' N ' HD21 ' C' ' 702' ' ' LEU . 24.0 m -151.74 -11.58 0.2 Allowed 'General case' 0 N--CA 1.494 1.748 0 O-C-N 120.93 -1.106 . . . . 0.0 111.081 179.788 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 165' ' ' ASP . . . . . 0.699 ' CB ' HG21 ' A' ' 161' ' ' VAL . 37.0 t70 -78.82 67.77 4.62 Favored 'General case' 0 N--CA 1.492 1.67 0 O-C-N 120.771 -1.206 . . . . 0.0 110.684 -179.549 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 166' ' ' VAL . . . . . 0.652 ' O ' ' N ' ' A' ' 168' ' ' VAL . 0.9 OUTLIER -47.54 -35.07 3.93 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.479 0 O-C-N 120.828 -1.17 . . . . 0.0 109.44 -179.097 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 167' ' ' GLY . . . . . 0.439 ' C ' ' O ' ' A' ' 166' ' ' VAL . . . -42.37 -13.65 0.01 OUTLIER Glycine 0 N--CA 1.496 2.651 0 C-N-CA 119.937 -1.125 . . . . 0.0 110.389 179.958 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 168' ' ' VAL . . . . . 0.652 ' N ' ' O ' ' A' ' 166' ' ' VAL . 9.3 p -53.79 -28.23 16.4 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.408 0 O-C-N 120.782 -1.422 . . . . 0.0 109.108 179.849 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 169' ' ' LEU . . . . . 0.615 HD23 ' N ' ' A' ' 169' ' ' LEU . 1.4 mt -45.87 -19.66 0.07 Allowed 'General case' 0 N--CA 1.496 1.857 0 N-CA-C 107.068 -1.456 . . . . 0.0 107.068 -178.298 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 170' ' ' ASP . . . . . 0.539 ' N ' ' O ' ' A' ' 168' ' ' VAL . 19.4 t0 27.32 91.09 0.01 OUTLIER 'General case' 0 N--CA 1.497 1.892 0 CA-C-N 116.392 -0.367 . . . . 0.0 111.486 177.399 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 171' ' ' GLU . . . . . 0.402 ' HA ' ' CB ' ' A' ' 114' ' ' ASN . 4.8 pt-20 -136.83 73.98 1.47 Allowed 'General case' 0 N--CA 1.493 1.71 0 O-C-N 120.967 -1.083 . . . . 0.0 110.252 179.663 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 172' ' ' GLN . . . . . . . . . . . . . 16.8 mm-40 -130.94 -48.41 1.02 Allowed 'General case' 0 N--CA 1.495 1.783 0 O-C-N 121.558 -0.714 . . . . 0.0 110.564 -178.745 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 173' ' ' LYS . . . . . 0.403 ' H ' ' HG3' ' A' ' 173' ' ' LYS . 7.2 mttp -58.8 133.94 56.43 Favored 'General case' 0 N--CA 1.492 1.669 0 O-C-N 120.926 -1.109 . . . . 0.0 108.988 -179.869 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 174' ' ' GLY . . . . . 0.571 ' O ' ' C ' ' A' ' 175' ' ' LYS . . . -130.45 -43.57 0.19 Allowed Glycine 0 C--N 1.299 -1.486 0 N-CA-C 108.363 -1.895 . . . . 0.0 108.363 179.567 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 175' ' ' LYS . . . . . 0.571 ' C ' ' O ' ' A' ' 174' ' ' GLY . 32.6 mmtt -33.78 -63.34 0.27 Allowed 'General case' 0 N--CA 1.496 1.831 0 N-CA-C 107.843 -1.169 . . . . 0.0 107.843 179.658 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 176' ' ' ASP . . . . . 0.618 ' O ' ' O ' ' A' ' 177' ' ' LYS . 15.8 m-20 -104.54 86.27 2.48 Favored 'General case' 0 C--N 1.294 -1.805 0 N-CA-C 107.406 -1.331 . . . . 0.0 107.406 176.854 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 177' ' ' LYS . . . . . 0.618 ' O ' ' O ' ' A' ' 176' ' ' ASP . 29.3 mtmt -39.25 176.65 0.0 OUTLIER 'General case' 0 N--CA 1.501 2.081 0 O-C-N 121.507 -0.746 . . . . 0.0 110.431 -179.053 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 178' ' ' GLN . . . . . 0.458 ' NE2' HG13 ' A' ' 201' ' ' VAL . 0.0 OUTLIER -161.88 176.35 10.93 Favored 'General case' 0 N--CA 1.488 1.434 0 O-C-N 120.431 -1.418 . . . . 0.0 111.365 -179.999 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 179' ' ' LEU . . . . . 0.408 ' HB2' ' CD2' ' A' ' 153' ' ' TYR . 1.0 OUTLIER -130.28 98.03 4.6 Favored 'General case' 0 N--CA 1.487 1.424 0 N-CA-C 107.105 -1.443 . . . . 0.0 107.105 178.191 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 180' ' ' THR . . . . . . . . . . . . . 1.1 m -71.42 119.89 16.22 Favored 'General case' 0 C--N 1.303 -1.448 0 O-C-N 121.06 -1.025 . . . . 0.0 110.193 -178.381 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 181' ' ' LEU . . . . . 0.856 HD13 ' N ' ' A' ' 182' ' ' ILE . 1.1 tm? -89.85 140.55 29.49 Favored 'General case' 0 C--N 1.303 -1.436 0 N-CA-C 106.91 -1.515 . . . . 0.0 106.91 177.456 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 182' ' ' ILE . . . . . 0.856 ' N ' HD13 ' A' ' 181' ' ' LEU . 5.3 mt -136.54 117.42 18.13 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.753 0 O-C-N 120.92 -1.112 . . . . 0.0 108.008 178.709 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 183' ' ' THR . . . . . . . . . . . . . 1.4 t -144.7 114.72 7.4 Favored 'General case' 0 C--N 1.287 -2.11 0 N-CA-C 107.84 -1.17 . . . . 0.0 107.84 -179.538 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 184' ' ' CYS . . . . . . . . . . . . . 0.7 OUTLIER -79.41 163.73 24.57 Favored 'General case' 0 C--N 1.288 -2.076 0 C-N-CA 118.762 -1.175 . . . . 0.0 110.649 -178.092 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 185' ' ' ASP . . . . . 0.438 ' OD1' ' N ' ' A' ' 186' ' ' ASP . 4.8 t70 -165.18 -154.42 0.22 Allowed 'General case' 0 N--CA 1.492 1.658 0 N-CA-C 109.232 -0.655 . . . . 0.0 109.232 -179.672 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 186' ' ' ASP . . . . . 0.438 ' N ' ' OD1' ' A' ' 185' ' ' ASP . 1.1 m-20 51.04 60.91 3.54 Favored 'General case' 0 N--CA 1.494 1.743 0 O-C-N 121.081 -1.012 . . . . 0.0 108.409 -179.246 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 187' ' ' TYR . . . . . 0.595 ' CE1' ' O ' ' A' ' 188' ' ' ASN . 50.7 t80 -67.78 134.37 50.86 Favored 'General case' 0 N--CA 1.49 1.544 0 CA-C-O 122.052 0.929 . . . . 0.0 111.591 -178.679 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 188' ' ' ASN . . . . . 0.595 ' O ' ' CE1' ' A' ' 187' ' ' TYR . 0.8 OUTLIER -100.78 146.15 27.63 Favored 'General case' 0 C--N 1.297 -1.7 0 N-CA-C 107.929 -1.137 . . . . 0.0 107.929 177.923 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 189' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -112.69 -14.78 13.1 Favored 'General case' 0 C--N 1.297 -1.706 0 N-CA-C 108.604 -0.887 . . . . 0.0 108.604 -179.712 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 190' ' ' LYS . . . . . . . . . . . . . 12.8 mttm -83.58 -49.87 8.79 Favored 'General case' 0 C--N 1.301 -1.505 0 N-CA-C 108.595 -0.891 . . . . 0.0 108.595 178.729 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 191' ' ' THR . . . . . 0.545 ' OG1' HG12 ' A' ' 193' ' ' VAL . 6.5 p -88.86 -11.99 43.12 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.432 -0.792 . . . . 0.0 108.916 179.454 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 192' ' ' GLY . . . . . . . . . . . . . . . 67.89 34.6 82.8 Favored Glycine 0 N--CA 1.493 2.438 0 O-C-N 121.309 -0.869 . . . . 0.0 111.059 178.561 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 193' ' ' VAL . . . . . 0.545 HG12 ' OG1' ' A' ' 191' ' ' THR . 3.5 p -148.12 167.96 4.15 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.543 0 O-C-N 120.789 -1.418 . . . . 0.0 110.216 179.382 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 194' ' ' TRP . . . . . 0.518 ' H ' HG22 ' A' ' 193' ' ' VAL . 36.7 m95 -84.89 120.85 26.94 Favored 'General case' 0 C--N 1.296 -1.74 0 N-CA-C 109.058 -0.719 . . . . 0.0 109.058 179.991 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 195' ' ' GLU . . . . . 0.546 ' CD ' ' ND2' ' A' ' 188' ' ' ASN . 3.8 mt-10 -84.99 -61.05 1.87 Allowed 'General case' 0 N--CA 1.496 1.865 0 O-C-N 121.268 -0.895 . . . . 0.0 111.089 -178.657 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 196' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -83.98 154.32 23.38 Favored 'General case' 0 N--CA 1.491 1.575 0 O-C-N 120.903 -1.123 . . . . 0.0 110.05 -178.917 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 197' ' ' ARG . . . . . 0.647 ' CG ' HH11 ' A' ' 197' ' ' ARG . 0.0 OUTLIER -126.89 140.17 52.53 Favored 'General case' 0 N--CA 1.489 1.482 0 N-CA-C 109.019 -0.734 . . . . 0.0 109.019 179.583 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 198' ' ' LYS . . . . . . . . . . . . . 23.4 mttt -114.58 121.17 42.61 Favored 'General case' 0 C--N 1.302 -1.478 0 O-C-N 121.793 -0.567 . . . . 0.0 110.2 -178.929 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 199' ' ' ILE . . . . . 0.539 HG21 HG21 ' A' ' 168' ' ' VAL . 0.8 OUTLIER -139.22 118.21 13.07 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.576 0 CA-C-O 122.809 1.29 . . . . 0.0 110.16 179.553 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 200' ' ' PHE . . . . . 0.501 ' CD1' ' N ' ' A' ' 200' ' ' PHE . 5.7 m-85 -101.0 137.03 39.91 Favored 'General case' 0 N--CA 1.495 1.814 0 O-C-N 120.707 -1.245 . . . . 0.0 110.276 -178.265 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 201' ' ' VAL . . . . . 0.484 ' N ' ' O ' ' A' ' 157' ' ' SER . 70.2 t -102.2 140.5 20.53 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.545 0 N-CA-C 108.09 -1.078 . . . . 0.0 108.09 177.465 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 202' ' ' ALA . . . . . . . . . . . . . . . -130.11 138.08 50.5 Favored 'General case' 0 C--N 1.301 -1.517 0 O-C-N 121.194 -0.941 . . . . 0.0 108.998 -179.66 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 203' ' ' THR . . . . . 0.528 HG23 ' OG1' ' A' ' 156' ' ' THR . 1.9 p -88.94 136.34 33.06 Favored 'General case' 0 C--N 1.306 -1.3 0 CA-C-O 122.474 1.13 . . . . 0.0 111.213 -178.276 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 204' ' ' GLU . . . . . 0.45 ' HA ' ' CD2' ' A' ' 153' ' ' TYR . 2.5 tt0 -60.22 134.06 56.69 Favored 'General case' 0 C--N 1.297 -1.686 0 CA-C-N 115.039 -0.982 . . . . 0.0 110.642 -179.915 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 205' ' ' VAL . . . . . 0.446 ' O ' ' OXT' ' A' ' 206' ' ' LYS . 42.2 t -121.11 -13.69 8.06 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.55 0 N-CA-C 107.997 -1.112 . . . . 0.0 107.997 179.247 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 206' ' ' LYS . . . . . 0.446 ' OXT' ' O ' ' A' ' 205' ' ' VAL . 0.1 OUTLIER . . . . . 0 N--CA 1.489 1.499 0 CA-C-O 118.029 -0.986 . . . . 0.0 109.674 -179.671 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' C' C ' 701' ' ' PHQ . . . . . 0.419 ' O2 ' HG12 ' A' ' 166' ' ' VAL . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 014 nuclear build full ' C' C ' 702' ' ' LEU . . . . . 0.871 ' N ' HD12 ' C' ' 702' ' ' LEU . 0.0 OUTLIER . . . . . 0 N--CA 1.491 1.599 0 N-CA-C 109.016 -0.735 . . . . 0.0 109.016 . . . . . . . . . 2 2 . 1 . 014 nuclear build full ' C' C ' 703' ' ' PRO . . . . . 0.65 ' HG2' ' HB1' ' A' ' 104' ' ' ALA . 52.6 Cg_exo -46.41 -176.71 0.0 OUTLIER 'Trans proline' 0 N--CA 1.49 1.287 0 C-N-CA 122.023 1.816 . . . . 0.0 112.239 -179.379 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' C' C ' 704' ' ' ALA . . . . . . . . . . . . . . . 49.87 -164.06 0.04 OUTLIER 'General case' 0 N--CA 1.488 1.443 0 O-C-N 121.37 -0.831 . . . . 0.0 109.231 -179.905 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' C' C ' 705' ' ' B27 . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 014 nuclear build full ' A' A ' 700' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 015 nuclear build full ' A' A ' 59' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.491 1.578 0 N-CA-C 109.432 -0.581 . . . . 0.0 109.432 . . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 60' ' ' GLN . . . . . . . . . . . . . 14.6 mm100 -60.48 -159.36 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.315 -0.866 . . . . 0.0 109.569 -179.916 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . -64.48 152.04 42.76 Favored 'General case' 0 N--CA 1.488 1.473 0 O-C-N 121.29 -0.881 . . . . 0.0 109.381 179.914 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 62' ' ' LYS . . . . . . . . . . . . . 5.4 tptt -138.66 72.04 43.05 Favored Pre-proline 0 N--CA 1.49 1.549 0 O-C-N 121.314 -0.866 . . . . 0.0 109.248 -179.72 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 63' ' ' PRO . . . . . . . . . . . . . 95.0 Cg_endo -88.95 153.81 5.87 Favored 'Trans proline' 0 C--N 1.306 -1.692 0 C-N-CA 123.703 2.936 . . . . 0.0 111.975 -179.89 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 64' ' ' GLN . . . . . 0.578 ' N ' ' CD ' ' A' ' 64' ' ' GLN . 0.0 OUTLIER -153.49 120.16 5.62 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.158 -0.964 . . . . 0.0 109.424 179.537 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 65' ' ' ILE . . . . . 0.495 ' H ' HD12 ' A' ' 65' ' ' ILE . 2.9 mp -45.32 106.41 0.54 Allowed Pre-proline 0 N--CA 1.489 1.51 0 N-CA-C 107.874 -1.158 . . . . 0.0 107.874 179.079 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 66' ' ' PRO . . . . . . . . . . . . . 61.3 Cg_endo -77.64 -162.82 0.18 Allowed 'Trans proline' 0 N--CA 1.49 1.285 0 C-N-CA 122.113 1.875 . . . . 0.0 113.171 -178.075 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 67' ' ' LYS . . . . . . . . . . . . . 7.0 ttpt -84.75 -7.86 59.05 Favored 'General case' 0 N--CA 1.488 1.447 0 O-C-N 121.603 -0.686 . . . . 0.0 109.388 -179.74 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 68' ' ' ASP . . . . . 0.645 ' C ' ' N ' ' A' ' 70' ' ' SER . 1.0 OUTLIER -76.9 62.75 2.14 Favored 'General case' 0 N--CA 1.489 1.478 0 CA-C-O 122.756 1.265 . . . . 0.0 109.259 179.801 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 69' ' ' LYS . . . . . 0.463 ' C ' ' O ' ' A' ' 68' ' ' ASP . 0.9 OUTLIER -47.61 -13.36 0.04 OUTLIER 'General case' 0 N--CA 1.511 2.584 0 C-N-CA 116.926 -1.91 . . . . 0.0 106.79 177.397 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 70' ' ' SER . . . . . 0.645 ' N ' ' C ' ' A' ' 68' ' ' ASP . 0.0 OUTLIER -87.58 -3.14 58.99 Favored 'General case' 0 N--CA 1.498 1.944 0 CA-C-N 113.592 -1.64 . . . . 0.0 111.805 179.448 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 71' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -99.18 141.79 31.5 Favored 'General case' 0 N--CA 1.504 2.273 0 O-C-N 120.472 -1.393 . . . . 0.0 112.606 -178.941 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 72' ' ' VAL . . . . . 0.537 HG23 ' H ' ' A' ' 87' ' ' VAL . 0.2 OUTLIER -66.37 127.67 28.1 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.38 0 N-CA-C 104.551 -2.389 . . . . 0.0 104.551 174.397 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 73' ' ' ALA . . . . . 0.578 ' N ' ' O ' ' A' ' 87' ' ' VAL . . . -80.08 -13.71 59.08 Favored 'General case' 0 C--N 1.295 -1.783 0 O-C-N 120.165 -1.585 . . . . 0.0 108.381 -178.536 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 74' ' ' GLY . . . . . 0.53 ' O ' ' CG2' ' A' ' 72' ' ' VAL . . . 171.55 -155.42 24.11 Favored Glycine 0 N--CA 1.484 1.851 0 C-N-CA 118.759 -1.686 . . . . 0.0 110.819 179.23 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 75' ' ' TYR . . . . . 0.495 ' CA ' HG23 ' A' ' 87' ' ' VAL . 6.2 m-85 -144.29 169.22 18.32 Favored 'General case' 0 C--N 1.298 -1.647 0 O-C-N 121.639 -0.918 . . . . 0.0 110.79 -177.333 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 76' ' ' ILE . . . . . . . . . . . . . 0.8 OUTLIER -149.85 147.67 16.05 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.59 0 C-N-CA 119.902 -0.719 . . . . 0.0 109.414 -178.136 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -149.25 164.76 33.9 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 120.971 -1.081 . . . . 0.0 109.731 179.558 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 78' ' ' ILE . . . . . 0.604 ' HB ' ' HB3' ' A' ' 81' ' ' ALA . 32.6 mt -146.1 94.76 4.88 Favored Pre-proline 0 N--CA 1.489 1.517 0 N-CA-C 108.482 -0.933 . . . . 0.0 108.482 -179.808 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 79' ' ' PRO . . . . . . . . . . . . . 51.2 Cg_exo -49.02 -46.37 25.57 Favored 'Trans proline' 0 C--N 1.31 -1.451 0 C-N-CA 122.604 2.203 . . . . 0.0 113.622 -178.764 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 80' ' ' ASP . . . . . 0.553 ' OD1' ' N ' ' A' ' 80' ' ' ASP . 0.0 OUTLIER -65.41 -19.79 66.1 Favored 'General case' 0 N--CA 1.493 1.716 0 O-C-N 120.821 -1.174 . . . . 0.0 110.445 178.551 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 81' ' ' ALA . . . . . 0.857 ' HB2' ' HB2' ' A' ' 136' ' ' ALA . . . -106.33 -16.95 14.43 Favored 'General case' 0 N--CA 1.491 1.624 0 N-CA-C 108.361 -0.978 . . . . 0.0 108.361 179.33 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 82' ' ' ASP . . . . . 0.522 ' N ' ' O ' ' A' ' 78' ' ' ILE . 3.4 t70 66.52 51.61 1.12 Allowed 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.367 -0.833 . . . . 0.0 110.761 179.07 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 83' ' ' ILE . . . . . 0.658 HD11 ' OD1' ' A' ' 132' ' ' ASN . 89.5 mt -129.31 153.9 39.35 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.843 0 O-C-N 121.185 -0.947 . . . . 0.0 110.052 -179.282 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 84' ' ' LYS . . . . . 0.426 ' N ' HG22 ' A' ' 83' ' ' ILE . 22.9 tttt -158.13 109.0 2.17 Favored 'General case' 0 N--CA 1.491 1.613 0 N-CA-C 107.646 -1.242 . . . . 0.0 107.646 179.372 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 85' ' ' GLU . . . . . 0.504 ' OE1' ' O ' ' A' ' 128' ' ' TYR . 0.0 OUTLIER -141.43 165.17 30.4 Favored Pre-proline 0 N--CA 1.495 1.808 0 O-C-N 121.044 -1.035 . . . . 0.0 110.798 -178.118 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 86' ' ' PRO . . . . . . . . . . . . . 59.3 Cg_endo -74.52 161.58 39.64 Favored 'Trans proline' 0 N--CA 1.495 1.603 0 C-N-CA 123.404 2.736 . . . . 0.0 113.549 -179.362 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 87' ' ' VAL . . . . . 0.578 ' O ' ' N ' ' A' ' 73' ' ' ALA . 58.6 t -120.05 99.97 8.55 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.683 0 N-CA-C 109.294 -0.632 . . . . 0.0 109.294 179.588 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 88' ' ' TYR . . . . . 0.43 ' CD2' ' CD ' ' A' ' 99' ' ' ARG . 19.5 m-85 -92.09 154.9 43.32 Favored Pre-proline 0 N--CA 1.504 2.232 0 O-C-N 120.777 -1.202 . . . . 0.0 110.276 -179.479 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 89' ' ' PRO . . . . . . . . . . . . . 11.4 Cg_endo -60.2 143.65 99.52 Favored 'Trans proline' 0 N--CA 1.495 1.559 0 C-N-CA 122.741 2.294 . . . . 0.0 113.517 -179.902 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . -59.85 168.55 7.88 Favored Glycine 0 N--CA 1.496 2.654 0 N-CA-C 109.444 -1.462 . . . . 0.0 109.444 179.271 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 91' ' ' PRO . . . . . 0.438 ' C ' ' H ' ' A' ' 93' ' ' THR . 55.6 Cg_endo -93.32 169.78 20.36 Favored 'Cis proline' 0 C--N 1.309 -1.53 0 C-N-CA 123.941 -1.274 . . . . 0.0 111.941 0.168 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 92' ' ' ALA . . . . . 0.663 ' HB1' HD21 ' A' ' 97' ' ' LEU . . . -72.28 32.52 0.06 Allowed 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.081 -1.012 . . . . 0.0 110.398 -179.903 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 93' ' ' THR . . . . . 0.5 ' OG1' ' OE1' ' A' ' 96' ' ' GLN . 3.1 p -74.81 150.67 86.39 Favored Pre-proline 0 C--N 1.3 -1.548 0 O-C-N 120.485 -1.384 . . . . 0.0 108.487 179.993 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 94' ' ' PRO . . . . . 0.403 ' C ' ' O ' ' A' ' 93' ' ' THR . 82.0 Cg_exo -30.69 -52.32 0.23 Allowed 'Trans proline' 0 C--N 1.308 -1.569 0 C-N-CA 123.18 2.587 . . . . 0.0 113.022 -179.034 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 4.9 mm-40 -49.55 -49.3 46.81 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.09 -1.006 . . . . 0.0 109.688 -179.833 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 96' ' ' GLN . . . . . 0.57 ' O ' ' N ' ' A' ' 98' ' ' ASN . 12.5 mp0 -73.53 -54.35 8.42 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 120.96 -1.088 . . . . 0.0 110.452 -179.644 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 97' ' ' LEU . . . . . 0.663 HD21 ' HB1' ' A' ' 92' ' ' ALA . 95.8 mt -47.2 -9.32 0.02 OUTLIER 'General case' 0 N--CA 1.495 1.818 0 O-C-N 121.185 -0.947 . . . . 0.0 110.279 -178.793 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 98' ' ' ASN . . . . . 0.57 ' N ' ' O ' ' A' ' 96' ' ' GLN . 0.0 OUTLIER -74.86 -26.04 59.4 Favored 'General case' 0 N--CA 1.493 1.686 0 O-C-N 121.115 -0.991 . . . . 0.0 109.126 179.727 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 99' ' ' ARG . . . . . 0.581 HH11 ' CG ' ' A' ' 99' ' ' ARG . 0.3 OUTLIER -91.1 -56.11 3.28 Favored 'General case' 0 C--N 1.301 -1.527 0 O-C-N 121.796 -0.565 . . . . 0.0 109.642 -179.484 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . -179.46 -165.36 33.47 Favored Glycine 0 N--CA 1.49 2.283 0 N-CA-C 109.949 -1.26 . . . . 0.0 109.949 179.89 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 101' ' ' VAL . . . . . 0.551 HG23 ' O ' ' A' ' 101' ' ' VAL . 28.9 m -59.23 105.95 0.22 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.64 0 O-C-N 121.325 -1.103 . . . . 0.0 109.696 -179.731 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -91.63 169.04 11.06 Favored 'General case' 0 N--CA 1.495 1.777 0 O-C-N 121.224 -0.922 . . . . 0.0 110.864 -179.308 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 103' ' ' PHE . . . . . 0.559 ' O ' ' N ' ' A' ' 105' ' ' GLU . 26.0 m-85 -72.74 122.43 21.49 Favored 'General case' 0 N--CA 1.493 1.721 0 N-CA-C 108.123 -1.065 . . . . 0.0 108.123 178.469 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 104' ' ' ALA . . . . . 0.404 ' C ' ' O ' ' A' ' 103' ' ' PHE . . . -39.67 -20.51 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.526 -0.734 . . . . 0.0 111.716 -178.388 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 105' ' ' GLU . . . . . 0.559 ' N ' ' O ' ' A' ' 103' ' ' PHE . 13.4 pt-20 -139.51 148.71 43.01 Favored 'General case' 0 N--CA 1.498 1.943 0 O-C-N 120.673 -1.267 . . . . 0.0 110.696 -179.479 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 106' ' ' GLU . . . . . . . . . . . . . 8.8 tt0 -56.79 -62.5 1.7 Allowed 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.91 -0.494 . . . . 0.0 111.76 -178.575 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 107' ' ' ASN . . . . . . . . . . . . . 2.6 m120 -76.62 33.5 0.14 Allowed 'General case' 0 N--CA 1.492 1.65 0 O-C-N 120.533 -1.354 . . . . 0.0 112.782 -175.247 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 108' ' ' GLU . . . . . 0.499 ' OE1' ' OE2' ' A' ' 105' ' ' GLU . 38.3 tp10 -60.24 146.67 42.88 Favored 'General case' 0 N--CA 1.488 1.466 0 O-C-N 120.776 -1.202 . . . . 0.0 107.906 179.821 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 109' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -97.8 144.31 27.52 Favored 'General case' 0 N--CA 1.488 1.468 0 O-C-N 120.923 -1.111 . . . . 0.0 110.806 -178.243 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 110' ' ' LEU . . . . . 0.558 HD23 ' H ' ' A' ' 110' ' ' LEU . 0.4 OUTLIER -61.99 -21.05 64.53 Favored 'General case' 0 C--N 1.302 -1.46 0 N-CA-C 107.734 -1.21 . . . . 0.0 107.734 179.037 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 111' ' ' ASP . . . . . . . . . . . . . 75.5 m-20 -132.62 44.79 2.83 Favored 'General case' 0 N--CA 1.488 1.451 0 CA-C-O 121.388 0.613 . . . . 0.0 109.363 179.63 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 112' ' ' ASP . . . . . . . . . . . . . 1.1 t0 -68.64 157.38 36.3 Favored 'General case' 0 N--CA 1.493 1.685 0 O-C-N 121.195 -0.941 . . . . 0.0 111.232 -179.7 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 113' ' ' GLN . . . . . 0.541 ' N ' ' CD ' ' A' ' 113' ' ' GLN . 0.2 OUTLIER -65.92 -15.7 63.2 Favored 'General case' 0 N--CA 1.492 1.653 0 N-CA-C 107.387 -1.338 . . . . 0.0 107.387 177.495 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 114' ' ' ASN . . . . . 0.496 ' O ' ' CG ' ' A' ' 114' ' ' ASN . 11.8 p-10 -150.31 108.29 3.72 Favored 'General case' 0 C--N 1.298 -1.655 0 N-CA-C 107.72 -1.215 . . . . 0.0 107.72 178.054 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 115' ' ' ILE . . . . . 0.535 HG22 ' O ' ' A' ' 115' ' ' ILE . 2.9 mt -94.38 102.48 13.66 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.63 0 N-CA-C 107.437 -1.32 . . . . 0.0 107.437 179.61 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 116' ' ' SER . . . . . . . . . . . . . 9.0 p -88.87 150.46 22.87 Favored 'General case' 0 C--N 1.303 -1.419 0 CA-C-O 121.997 0.903 . . . . 0.0 111.483 -177.476 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 117' ' ' ILE . . . . . . . . . . . . . 1.4 mt -147.68 145.82 18.6 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.458 0 N-CA-C 107.34 -1.355 . . . . 0.0 107.34 178.762 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 118' ' ' ALA . . . . . 0.615 ' HB1' ' HB2' ' C' ' 704' ' ' ALA . . . -141.96 159.39 42.32 Favored 'General case' 0 N--CA 1.494 1.726 0 O-C-N 120.789 -1.194 . . . . 0.0 111.348 -178.434 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 119' ' ' GLY . . . . . . . . . . . . . . . -171.02 153.24 20.3 Favored Glycine 0 N--CA 1.487 2.096 0 N-CA-C 110.097 -1.201 . . . . 0.0 110.097 179.873 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 120' ' ' HIS . . . . . 0.42 ' CE1' ' HN ' ' C' ' 705' ' ' B27 . 2.0 m80 -71.19 167.97 18.25 Favored 'General case' 0 N--CA 1.493 1.713 0 O-C-N 121.724 -0.868 . . . . 0.0 109.944 179.378 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 121' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -117.37 158.3 24.66 Favored 'General case' 0 N--CA 1.496 1.831 0 N-CA-C 108.094 -1.076 . . . . 0.0 108.094 178.76 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 122' ' ' PHE . . . . . . . . . . . . . 3.8 m-85 -141.91 123.21 14.79 Favored 'General case' 0 N--CA 1.497 1.911 0 O-C-N 120.867 -1.145 . . . . 0.0 109.805 -179.39 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 123' ' ' ILE . . . . . 0.598 HG23 ' N ' ' A' ' 124' ' ' ASP . 14.0 tt -60.38 -41.41 87.22 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.567 0 CA-C-O 121.6 0.714 . . . . 0.0 109.285 179.622 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 124' ' ' ASP . . . . . 0.598 ' N ' HG23 ' A' ' 123' ' ' ILE . 0.3 OUTLIER -87.16 22.23 2.14 Favored 'General case' 0 N--CA 1.495 1.808 0 O-C-N 121.693 -0.629 . . . . 0.0 111.955 -177.13 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 125' ' ' ARG . . . . . . . . . . . . . 46.9 mtp180 -155.29 97.12 2.42 Favored Pre-proline 0 N--CA 1.492 1.673 0 O-C-N 120.546 -1.347 . . . . 0.0 109.757 179.763 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 126' ' ' PRO . . . . . . . . . . . . . 2.9 Cg_endo -73.66 -25.76 14.48 Favored 'Trans proline' 0 C--N 1.314 -1.239 0 C-N-CA 122.113 1.876 . . . . 0.0 111.662 178.634 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 127' ' ' ASN . . . . . 0.473 ' O ' ' O ' ' A' ' 128' ' ' TYR . 0.9 OUTLIER -91.2 5.73 47.92 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.429 -0.794 . . . . 0.0 109.736 -179.843 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 128' ' ' TYR . . . . . 0.504 ' O ' ' OE1' ' A' ' 85' ' ' GLU . 4.5 t80 -59.1 -149.27 0.0 OUTLIER 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.192 -0.943 . . . . 0.0 109.936 -179.751 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 129' ' ' GLN . . . . . 0.487 ' O ' ' OE1' ' A' ' 85' ' ' GLU . 63.4 mt-30 -66.79 -72.08 0.18 Allowed 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.439 -0.788 . . . . 0.0 109.614 -179.686 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 130' ' ' PHE . . . . . 0.504 ' O ' ' CE ' ' A' ' 134' ' ' LYS . 52.6 m-85 -133.78 47.8 2.41 Favored 'General case' 0 N--CA 1.492 1.658 0 O-C-N 121.279 -0.888 . . . . 0.0 110.059 -179.741 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 131' ' ' THR . . . . . . . . . . . . . 23.5 m -81.72 -40.82 22.16 Favored 'General case' 0 N--CA 1.489 1.481 0 O-C-N 121.052 -1.03 . . . . 0.0 109.281 179.783 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 132' ' ' ASN . . . . . 0.658 ' OD1' HD11 ' A' ' 83' ' ' ILE . 0.2 OUTLIER -83.09 2.7 33.92 Favored 'General case' 0 N--CA 1.495 1.785 0 O-C-N 121.364 -0.835 . . . . 0.0 111.377 -178.283 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 133' ' ' LEU . . . . . 0.568 HD13 ' O ' ' A' ' 133' ' ' LEU . 0.2 OUTLIER -65.6 -46.07 80.75 Favored 'General case' 0 N--CA 1.493 1.681 0 O-C-N 120.549 -1.344 . . . . 0.0 110.359 -179.568 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 134' ' ' LYS . . . . . 0.57 ' H ' ' CD ' ' A' ' 134' ' ' LYS . 0.0 OUTLIER -42.41 -18.15 0.01 OUTLIER 'General case' 0 N--CA 1.494 1.739 0 O-C-N 121.071 -1.018 . . . . 0.0 110.755 -179.185 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 135' ' ' ALA . . . . . 0.563 ' N ' ' O ' ' A' ' 133' ' ' LEU . . . -83.48 -35.39 24.94 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 120.837 -1.164 . . . . 0.0 110.251 -179.506 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 136' ' ' ALA . . . . . 0.857 ' HB2' ' HB2' ' A' ' 81' ' ' ALA . . . -79.98 155.76 27.51 Favored 'General case' 0 N--CA 1.489 1.51 0 CA-C-O 122.209 1.004 . . . . 0.0 111.889 -178.479 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 137' ' ' LYS . . . . . 0.505 ' O ' ' O ' ' A' ' 138' ' ' LYS . 0.1 OUTLIER -154.32 -165.91 2.21 Favored 'General case' 0 N--CA 1.493 1.725 0 C-N-CA 118.734 -1.186 . . . . 0.0 110.915 -178.44 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 138' ' ' LYS . . . . . 0.579 ' O ' ' N ' ' A' ' 140' ' ' SER . 17.4 mttp -45.44 179.23 0.0 OUTLIER 'General case' 0 C--N 1.305 -1.365 0 CA-C-O 121.987 0.898 . . . . 0.0 110.509 -179.222 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 139' ' ' GLY . . . . . . . . . . . . . . . 47.0 7.77 0.02 OUTLIER Glycine 0 N--CA 1.491 2.304 0 N-CA-C 110.253 -1.139 . . . . 0.0 110.253 -179.849 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 140' ' ' SER . . . . . 0.579 ' N ' ' O ' ' A' ' 138' ' ' LYS . 40.4 t -89.42 141.3 28.68 Favored 'General case' 0 N--CA 1.493 1.699 0 O-C-N 120.858 -1.378 . . . . 0.0 109.591 179.239 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 141' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -90.88 127.73 36.49 Favored 'General case' 0 C--N 1.301 -1.539 0 O-C-N 121.413 -0.805 . . . . 0.0 109.487 179.732 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 142' ' ' VAL . . . . . . . . . . . . . 3.2 t -114.48 133.6 60.07 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.674 0 O-C-N 121.364 -0.835 . . . . 0.0 108.814 179.928 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 143' ' ' TYR . . . . . 0.413 ' CE1' ' CG ' ' A' ' 152' ' ' LYS . 8.5 m-85 -107.9 135.39 49.36 Favored 'General case' 0 N--CA 1.496 1.851 0 O-C-N 121.177 -0.952 . . . . 0.0 111.521 -178.603 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 144' ' ' PHE . . . . . . . . . . . . . 66.8 t80 -115.36 157.21 24.2 Favored 'General case' 0 N--CA 1.493 1.698 0 CA-C-O 121.807 0.813 . . . . 0.0 110.82 -179.185 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 145' ' ' LYS . . . . . 0.418 ' HB3' ' H ' ' A' ' 75' ' ' TYR . 55.0 tttt -152.42 130.59 11.94 Favored 'General case' 0 N--CA 1.492 1.642 0 C-N-CA 118.887 -1.125 . . . . 0.0 111.962 -179.309 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 146' ' ' VAL . . . . . . . . . . . . . 1.9 p -145.04 139.95 22.71 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.485 0 N-CA-C 106.24 -1.763 . . . . 0.0 106.24 177.431 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 147' ' ' GLY . . . . . . . . . . . . . . . 53.88 -134.67 43.61 Favored Glycine 0 N--CA 1.488 2.157 0 N-CA-C 108.726 -1.749 . . . . 0.0 108.726 -179.079 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 148' ' ' ASN . . . . . . . . . . . . . 21.9 p30 -103.17 22.67 13.65 Favored 'General case' 0 C--N 1.302 -1.496 0 O-C-N 121.234 -1.156 . . . . 0.0 108.71 179.354 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 149' ' ' GLU . . . . . . . . . . . . . 18.4 tt0 -112.44 152.79 28.29 Favored 'General case' 0 N--CA 1.486 1.362 0 CA-C-O 121.752 0.786 . . . . 0.0 111.095 -179.023 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 150' ' ' THR . . . . . 0.437 ' O ' HG22 ' A' ' 150' ' ' THR . 1.3 m -141.78 105.13 4.65 Favored 'General case' 0 N--CA 1.493 1.698 0 CA-C-O 121.666 0.746 . . . . 0.0 109.436 179.996 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 151' ' ' ARG . . . . . 0.46 HH22 ' CD1' ' A' ' 115' ' ' ILE . 2.9 mpp_? -88.69 -161.55 0.76 Allowed 'General case' 0 N--CA 1.488 1.453 0 O-C-N 121.659 -0.651 . . . . 0.0 109.706 -179.149 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 152' ' ' LYS . . . . . 0.429 ' O ' ' N ' ' A' ' 205' ' ' VAL . 15.0 mtmm -149.73 146.06 27.01 Favored 'General case' 0 C--N 1.304 -1.381 0 O-C-N 121.211 -0.93 . . . . 0.0 110.139 -178.814 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 153' ' ' TYR . . . . . 0.513 ' CD2' ' HA ' ' A' ' 204' ' ' GLU . 15.0 m-85 -141.06 166.88 23.57 Favored 'General case' 0 N--CA 1.49 1.559 0 N-CA-C 107.922 -1.14 . . . . 0.0 107.922 179.193 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 154' ' ' LYS . . . . . 0.484 ' HB2' HG21 ' A' ' 205' ' ' VAL . 12.7 ttmt -142.8 120.43 11.8 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.236 -0.915 . . . . 0.0 108.576 178.865 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 155' ' ' MET . . . . . 0.409 ' H ' ' HG2' ' A' ' 155' ' ' MET . 44.4 mmm -47.83 107.26 0.11 Allowed 'General case' 0 N--CA 1.493 1.688 0 O-C-N 120.611 -1.306 . . . . 0.0 111.315 -178.626 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 156' ' ' THR . . . . . 0.488 ' OG1' HG23 ' A' ' 203' ' ' THR . 0.2 OUTLIER -105.18 -24.44 12.74 Favored 'General case' 0 C--N 1.294 -1.843 0 CA-C-N 115.259 -0.882 . . . . 0.0 110.836 -178.655 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 157' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -146.8 150.5 35.43 Favored 'General case' 0 C--N 1.296 -1.757 0 C-N-CA 118.51 -1.276 . . . . 0.0 110.367 -178.784 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 158' ' ' ILE . . . . . . . . . . . . . 1.9 mt -147.35 137.59 17.13 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.382 0 CA-C-O 121.324 0.583 . . . . 0.0 109.537 -178.459 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 159' ' ' ARG . . . . . 0.488 ' O ' ' OD1' ' A' ' 160' ' ' ASP . 44.7 mtp180 -155.59 -167.71 2.59 Favored 'General case' 0 N--CA 1.492 1.647 0 CA-C-O 121.907 0.86 . . . . 0.0 110.956 -178.799 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 160' ' ' ASP . . . . . 0.488 ' OD1' ' O ' ' A' ' 159' ' ' ARG . 63.8 m-20 -146.71 153.04 39.8 Favored 'General case' 0 N--CA 1.489 1.48 0 N-CA-C 108.183 -1.043 . . . . 0.0 108.183 179.512 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 161' ' ' VAL . . . . . 0.425 ' O ' ' O ' ' A' ' 162' ' ' LYS . 0.1 OUTLIER -143.11 146.54 21.48 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.627 0 O-C-N 120.899 -1.125 . . . . 0.0 109.884 179.939 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 162' ' ' LYS . . . . . 0.697 ' H ' ' CD ' ' A' ' 162' ' ' LYS . 0.0 OUTLIER -45.44 167.13 0.12 Allowed Pre-proline 0 N--CA 1.49 1.526 0 O-C-N 121.285 -0.884 . . . . 0.0 109.391 -179.787 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 163' ' ' PRO . . . . . . . . . . . . . 57.9 Cg_endo -76.54 30.4 0.4 Allowed 'Trans proline' 0 C--N 1.308 -1.574 0 C-N-CA 122.838 2.359 . . . . 0.0 113.387 -179.488 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 164' ' ' THR . . . . . 0.623 ' HA ' HD11 ' C' ' 702' ' ' LEU . 0.2 OUTLIER -152.29 -0.58 0.3 Allowed 'General case' 0 N--CA 1.495 1.817 0 O-C-N 120.921 -1.112 . . . . 0.0 110.306 179.612 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 165' ' ' ASP . . . . . 0.414 ' O ' ' C ' ' A' ' 166' ' ' VAL . 7.4 t70 -76.85 64.4 2.38 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.12 -0.987 . . . . 0.0 110.16 -179.866 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 166' ' ' VAL . . . . . 0.616 ' O ' ' N ' ' A' ' 168' ' ' VAL . 1.3 m -47.1 -31.4 1.79 Allowed 'Isoleucine or valine' 0 N--CA 1.487 1.405 0 O-C-N 120.642 -1.286 . . . . 0.0 108.941 -178.837 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 167' ' ' GLY . . . . . . . . . . . . . . . -46.86 -9.49 0.03 OUTLIER Glycine 0 N--CA 1.495 2.571 0 N-CA-C 109.458 -1.457 . . . . 0.0 109.458 179.35 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 168' ' ' VAL . . . . . 0.708 HG21 HG21 ' A' ' 199' ' ' ILE . 9.8 p -49.43 -31.54 5.58 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.481 0 N-CA-C 107.775 -1.194 . . . . 0.0 107.775 179.22 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 169' ' ' LEU . . . . . 0.509 ' O ' ' C ' ' A' ' 170' ' ' ASP . 1.7 mm? -45.21 -19.38 0.04 OUTLIER 'General case' 0 C--N 1.293 -1.852 0 N-CA-C 107.694 -1.225 . . . . 0.0 107.694 -178.25 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 170' ' ' ASP . . . . . 0.531 ' N ' ' O ' ' A' ' 168' ' ' VAL . 8.3 t0 27.88 91.38 0.01 OUTLIER 'General case' 0 N--CA 1.501 2.121 0 CA-C-N 116.459 -0.337 . . . . 0.0 111.399 177.268 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 171' ' ' GLU . . . . . 0.433 ' CB ' ' OD1' ' A' ' 114' ' ' ASN . 17.1 pt-20 -130.85 67.27 1.51 Allowed 'General case' 0 N--CA 1.499 1.984 0 O-C-N 121.016 -1.053 . . . . 0.0 110.435 -179.989 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 172' ' ' GLN . . . . . . . . . . . . . 2.1 mt-30 -127.96 -52.6 1.32 Allowed 'General case' 0 N--CA 1.498 1.942 0 O-C-N 121.26 -0.9 . . . . 0.0 110.745 -178.979 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 173' ' ' LYS . . . . . . . . . . . . . 15.4 mttt -58.82 124.93 21.46 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 120.886 -1.134 . . . . 0.0 108.453 179.9 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 174' ' ' GLY . . . . . 0.538 ' O ' ' C ' ' A' ' 175' ' ' LYS . . . -124.74 -43.63 0.3 Allowed Glycine 0 N--CA 1.48 1.602 0 N-CA-C 108.337 -1.905 . . . . 0.0 108.337 -179.838 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 175' ' ' LYS . . . . . 0.538 ' C ' ' O ' ' A' ' 174' ' ' GLY . 2.2 mptm? -37.9 -61.85 0.61 Allowed 'General case' 0 N--CA 1.492 1.655 0 N-CA-C 107.243 -1.392 . . . . 0.0 107.243 179.308 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 176' ' ' ASP . . . . . 0.624 ' O ' ' O ' ' A' ' 177' ' ' LYS . 8.7 m-20 -104.32 85.9 2.44 Favored 'General case' 0 C--N 1.295 -1.787 0 N-CA-C 106.7 -1.592 . . . . 0.0 106.7 176.512 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 177' ' ' LYS . . . . . 0.624 ' O ' ' O ' ' A' ' 176' ' ' ASP . 12.5 mttt -40.97 179.8 0.0 OUTLIER 'General case' 0 N--CA 1.496 1.85 0 O-C-N 121.489 -0.757 . . . . 0.0 110.235 -178.726 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 178' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -161.21 170.08 20.97 Favored 'General case' 0 N--CA 1.487 1.398 0 O-C-N 120.339 -1.476 . . . . 0.0 111.138 179.911 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 179' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -123.49 99.09 6.14 Favored 'General case' 0 C--N 1.304 -1.389 0 N-CA-C 107.406 -1.331 . . . . 0.0 107.406 178.297 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 180' ' ' THR . . . . . 0.462 HG22 ' O ' ' A' ' 180' ' ' THR . 1.1 m -70.56 114.08 8.31 Favored 'General case' 0 N--CA 1.487 1.418 0 O-C-N 121.18 -0.95 . . . . 0.0 109.857 -178.774 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 181' ' ' LEU . . . . . 0.725 HD13 ' N ' ' A' ' 182' ' ' ILE . 0.3 OUTLIER -88.9 142.58 27.53 Favored 'General case' 0 C--N 1.303 -1.456 0 N-CA-C 107.339 -1.356 . . . . 0.0 107.339 177.677 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 182' ' ' ILE . . . . . 0.725 ' N ' HD13 ' A' ' 181' ' ' LEU . 81.6 mt -137.87 115.72 12.96 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.76 0 N-CA-C 107.824 -1.176 . . . . 0.0 107.824 179.259 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 183' ' ' THR . . . . . 0.464 ' O ' HG23 ' A' ' 183' ' ' THR . 3.7 t -139.54 113.49 8.73 Favored 'General case' 0 C--N 1.289 -2.063 0 N-CA-C 108.155 -1.054 . . . . 0.0 108.155 -179.623 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 184' ' ' CYS . . . . . . . . . . . . . 0.8 OUTLIER -78.84 159.75 27.67 Favored 'General case' 0 C--N 1.291 -1.938 0 C-N-CA 119.101 -1.04 . . . . 0.0 111.095 -178.078 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 185' ' ' ASP . . . . . . . . . . . . . 1.2 t70 -165.93 -155.81 0.24 Allowed 'General case' 0 N--CA 1.493 1.683 0 N-CA-C 109.046 -0.724 . . . . 0.0 109.046 -179.613 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 186' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER 54.2 55.22 8.47 Favored 'General case' 0 N--CA 1.496 1.826 0 O-C-N 121.047 -1.033 . . . . 0.0 109.335 179.898 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 187' ' ' TYR . . . . . 0.611 ' CE2' ' O ' ' A' ' 188' ' ' ASN . 71.2 t80 -67.61 132.2 47.07 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 120.975 -1.078 . . . . 0.0 111.402 -179.151 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 188' ' ' ASN . . . . . 1.055 ' ND2' ' H ' ' A' ' 191' ' ' THR . 0.1 OUTLIER -100.54 149.36 23.8 Favored 'General case' 0 C--N 1.296 -1.736 0 N-CA-C 107.292 -1.373 . . . . 0.0 107.292 177.364 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 189' ' ' GLU . . . . . . . . . . . . . 1.8 tt0 -111.65 -10.56 14.09 Favored 'General case' 0 C--N 1.293 -1.871 0 N-CA-C 108.833 -0.802 . . . . 0.0 108.833 -179.122 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 190' ' ' LYS . . . . . 0.438 ' H ' ' ND2' ' A' ' 188' ' ' ASN . 13.9 mttm -85.88 -50.89 6.76 Favored 'General case' 0 C--N 1.301 -1.5 0 CA-C-O 121.583 0.706 . . . . 0.0 109.447 179.537 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 191' ' ' THR . . . . . 1.055 ' H ' ' ND2' ' A' ' 188' ' ' ASN . 72.6 p -89.15 -1.09 57.94 Favored 'General case' 0 N--CA 1.493 1.713 0 O-C-N 121.584 -0.698 . . . . 0.0 110.781 -178.879 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 192' ' ' GLY . . . . . 0.527 ' N ' ' OD1' ' A' ' 188' ' ' ASN . . . 56.38 36.08 68.39 Favored Glycine 0 N--CA 1.492 2.388 0 O-C-N 120.865 -1.147 . . . . 0.0 110.327 179.622 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 193' ' ' VAL . . . . . . . . . . . . . 3.1 m -148.63 163.77 5.04 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.738 0 O-C-N 120.885 -1.362 . . . . 0.0 109.449 179.519 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 194' ' ' TRP . . . . . 0.495 ' N ' ' CD1' ' A' ' 194' ' ' TRP . 24.2 m95 -84.46 121.16 27.18 Favored 'General case' 0 C--N 1.303 -1.42 0 N-CA-C 107.97 -1.122 . . . . 0.0 107.97 178.845 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 195' ' ' GLU . . . . . . . . . . . . . 1.7 mt-10 -76.7 -61.27 2.02 Favored 'General case' 0 N--CA 1.496 1.832 0 O-C-N 121.225 -0.922 . . . . 0.0 112.905 -176.831 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 196' ' ' LYS . . . . . . . . . . . . . 2.0 tptm -93.02 159.49 15.28 Favored 'General case' 0 N--CA 1.495 1.809 0 O-C-N 120.762 -1.211 . . . . 0.0 111.51 -177.201 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 197' ' ' ARG . . . . . 0.423 ' NH1' ' HB2' ' A' ' 194' ' ' TRP . 0.0 OUTLIER -121.75 135.83 54.94 Favored 'General case' 0 N--CA 1.493 1.676 0 N-CA-C 109.179 -0.675 . . . . 0.0 109.179 179.577 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 198' ' ' LYS . . . . . . . . . . . . . 49.3 mttt -117.4 120.38 37.97 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.495 -0.753 . . . . 0.0 110.104 -179.243 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 199' ' ' ILE . . . . . 0.708 HG21 HG21 ' A' ' 168' ' ' VAL . 1.0 OUTLIER -137.8 122.26 22.97 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.677 0 CA-C-O 122.667 1.222 . . . . 0.0 110.623 179.554 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 200' ' ' PHE . . . . . 0.471 ' CD1' ' N ' ' A' ' 200' ' ' PHE . 1.6 m-85 -103.5 138.83 39.66 Favored 'General case' 0 C--N 1.297 -1.689 0 O-C-N 120.91 -1.119 . . . . 0.0 110.334 -178.22 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 201' ' ' VAL . . . . . . . . . . . . . 59.7 t -102.36 147.04 9.48 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.494 0 N-CA-C 107.678 -1.23 . . . . 0.0 107.678 177.615 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 202' ' ' ALA . . . . . . . . . . . . . . . -130.53 138.63 50.3 Favored 'General case' 0 C--N 1.3 -1.567 0 O-C-N 121.138 -0.976 . . . . 0.0 108.388 -179.874 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 203' ' ' THR . . . . . 0.714 ' O ' HG23 ' A' ' 205' ' ' VAL . 6.5 p -89.0 127.78 35.68 Favored 'General case' 0 C--N 1.305 -1.365 0 CA-C-O 122.226 1.012 . . . . 0.0 111.41 -178.167 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 204' ' ' GLU . . . . . 0.513 ' HA ' ' CD2' ' A' ' 153' ' ' TYR . 1.1 tm-20 -50.37 134.9 22.79 Favored 'General case' 0 C--N 1.299 -1.595 0 C-N-CA 118.957 -1.097 . . . . 0.0 108.607 178.766 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 205' ' ' VAL . . . . . 0.714 HG23 ' O ' ' A' ' 203' ' ' THR . 69.8 t -130.54 163.96 34.82 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.338 0 CA-C-O 122.116 0.96 . . . . 0.0 110.606 -177.333 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 206' ' ' LYS . . . . . 0.578 ' N ' HG12 ' A' ' 205' ' ' VAL . 0.1 OUTLIER . . . . . 0 C--N 1.299 -1.627 0 CA-C-O 118.032 -0.985 . . . . 0.0 109.366 179.876 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' C' C ' 701' ' ' PHQ . . . . . 0.428 ' O2 ' HG12 ' A' ' 166' ' ' VAL . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 015 nuclear build full ' C' C ' 702' ' ' LEU . . . . . 0.899 ' N ' HD12 ' C' ' 702' ' ' LEU . 0.0 OUTLIER . . . . . 0 N--CA 1.501 2.08 0 N-CA-C 109.991 -0.374 . . . . 0.0 109.991 . . . . . . . . . 2 2 . 1 . 015 nuclear build full ' C' C ' 703' ' ' PRO . . . . . 0.623 ' CB ' ' HB3' ' A' ' 92' ' ' ALA . 27.7 Cg_exo -55.6 -166.77 0.02 OUTLIER 'Trans proline' 0 N--CA 1.493 1.498 0 C-N-CA 122.195 1.93 . . . . 0.0 112.606 -179.463 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' C' C ' 704' ' ' ALA . . . . . 0.615 ' HB2' ' HB1' ' A' ' 118' ' ' ALA . . . 48.48 99.45 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.493 -0.754 . . . . 0.0 109.207 -179.817 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' C' C ' 705' ' ' B27 . . . . . 0.42 ' HN ' ' CE1' ' A' ' 120' ' ' HIS . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 700' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 016 nuclear build full ' A' A ' 59' ' ' MET . . . . . . . . . . . . . 9.4 mmt . . . . . 0 N--CA 1.492 1.634 0 CA-C-O 121.383 0.611 . . . . 0.0 109.414 . . . . . . . . . 0 0 . 1 . 016 nuclear build full ' A' A ' 60' ' ' GLN . . . . . . . . . . . . . 1.2 pt20 -60.91 170.56 1.49 Allowed 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.58 -0.7 . . . . 0.0 110.111 -179.406 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 61' ' ' ALA . . . . . 0.574 ' HB2' ' OD1' ' A' ' 148' ' ' ASN . . . -63.86 -178.17 0.3 Allowed 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.301 -0.874 . . . . 0.0 109.883 -179.607 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 62' ' ' LYS . . . . . 0.637 ' O ' ' NE2' ' A' ' 64' ' ' GLN . 19.2 tttp -149.69 74.26 9.53 Favored Pre-proline 0 N--CA 1.491 1.586 0 O-C-N 121.208 -0.933 . . . . 0.0 110.126 -179.525 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 63' ' ' PRO . . . . . . . . . . . . . 9.8 Cg_exo -70.52 141.07 41.26 Favored 'Trans proline' 0 C--N 1.305 -1.754 0 C-N-CA 122.879 2.386 . . . . 0.0 111.65 179.753 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 64' ' ' GLN . . . . . 0.637 ' NE2' ' O ' ' A' ' 62' ' ' LYS . 0.0 OUTLIER -156.41 117.75 3.83 Favored 'General case' 0 N--CA 1.494 1.739 0 O-C-N 121.276 -0.89 . . . . 0.0 109.071 179.816 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 65' ' ' ILE . . . . . 0.492 ' H ' ' CD1' ' A' ' 65' ' ' ILE . 0.0 OUTLIER -42.72 103.97 0.34 Allowed Pre-proline 0 N--CA 1.497 1.923 0 O-C-N 121.119 -0.988 . . . . 0.0 108.743 179.626 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 66' ' ' PRO . . . . . . . . . . . . . 61.3 Cg_endo -90.15 -154.86 0.05 OUTLIER 'Trans proline' 0 C--N 1.313 -1.339 0 C-N-CA 122.194 1.929 . . . . 0.0 112.043 -179.742 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 67' ' ' LYS . . . . . 0.409 ' C ' ' H ' ' A' ' 69' ' ' LYS . 22.0 tttt -85.32 -4.76 59.26 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.119 -0.988 . . . . 0.0 108.771 179.597 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 68' ' ' ASP . . . . . 0.616 ' C ' ' N ' ' A' ' 70' ' ' SER . 1.1 t0 -75.03 49.58 0.44 Allowed 'General case' 0 N--CA 1.488 1.452 0 CA-C-O 122.533 1.159 . . . . 0.0 108.997 179.87 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 69' ' ' LYS . . . . . 0.418 ' C ' ' O ' ' A' ' 68' ' ' ASP . 4.1 mtmp? -48.7 -14.77 0.07 Allowed 'General case' 0 N--CA 1.503 2.211 0 C-N-CA 117.218 -1.793 . . . . 0.0 106.664 177.99 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 70' ' ' SER . . . . . 0.616 ' N ' ' C ' ' A' ' 68' ' ' ASP . 0.0 OUTLIER -86.15 -4.46 59.17 Favored 'General case' 0 N--CA 1.494 1.766 0 CA-C-N 113.702 -1.59 . . . . 0.0 110.916 179.714 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 71' ' ' LYS . . . . . 0.402 ' CD ' ' HB3' ' A' ' 68' ' ' ASP . 5.4 ptmt -99.54 140.5 33.63 Favored 'General case' 0 N--CA 1.493 1.72 0 O-C-N 120.896 -1.127 . . . . 0.0 110.957 179.698 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 72' ' ' VAL . . . . . 0.6 ' CG2' ' O ' ' A' ' 74' ' ' GLY . 0.6 OUTLIER -64.82 136.57 26.42 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.476 0 N-CA-C 104.883 -2.265 . . . . 0.0 104.883 174.725 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 73' ' ' ALA . . . . . 0.651 ' O ' HG23 ' A' ' 146' ' ' VAL . . . -84.68 -14.72 47.62 Favored 'General case' 0 C--N 1.296 -1.745 0 O-C-N 120.211 -1.556 . . . . 0.0 108.386 -179.163 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 74' ' ' GLY . . . . . 0.6 ' O ' ' CG2' ' A' ' 72' ' ' VAL . . . 172.7 -158.51 28.65 Favored Glycine 0 N--CA 1.485 1.93 0 N-CA-C 109.432 -1.467 . . . . 0.0 109.432 -179.692 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 75' ' ' TYR . . . . . 0.59 ' CD2' ' O ' ' A' ' 85' ' ' GLU . 2.0 m-85 -142.81 170.32 15.92 Favored 'General case' 0 C--N 1.299 -1.63 0 O-C-N 121.013 -1.286 . . . . 0.0 111.544 -177.16 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 76' ' ' ILE . . . . . . . . . . . . . 3.0 tp -146.92 143.94 20.16 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.453 0 C-N-CA 119.906 -0.718 . . . . 0.0 109.734 -177.528 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -151.29 159.99 44.04 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 120.999 -1.063 . . . . 0.0 109.129 179.572 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 78' ' ' ILE . . . . . 0.488 ' HB ' ' HB3' ' A' ' 81' ' ' ALA . 19.0 mt -146.83 103.27 3.89 Favored Pre-proline 0 N--CA 1.491 1.604 0 O-C-N 121.296 -0.877 . . . . 0.0 109.067 -179.703 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 79' ' ' PRO . . . . . . . . . . . . . 46.6 Cg_exo -51.16 -44.02 45.11 Favored 'Trans proline' 0 N--CA 1.494 1.538 0 C-N-CA 122.566 2.177 . . . . 0.0 113.949 -179.149 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 1.1 m-20 -67.28 -22.71 65.64 Favored 'General case' 0 N--CA 1.493 1.676 0 O-C-N 120.69 -1.256 . . . . 0.0 110.991 178.975 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 81' ' ' ALA . . . . . 0.77 ' HB2' ' HB2' ' A' ' 136' ' ' ALA . . . -104.03 -10.85 17.75 Favored 'General case' 0 N--CA 1.493 1.716 0 O-C-N 121.135 -0.978 . . . . 0.0 109.106 179.588 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 82' ' ' ASP . . . . . . . . . . . . . 1.1 t70 59.05 50.24 8.46 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.336 -0.853 . . . . 0.0 110.439 179.322 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 83' ' ' ILE . . . . . . . . . . . . . 70.3 mt -125.97 152.61 33.32 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.854 0 O-C-N 121.298 -0.876 . . . . 0.0 110.285 -179.061 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 84' ' ' LYS . . . . . 0.408 ' C ' ' CD ' ' A' ' 85' ' ' GLU . 0.2 OUTLIER -160.69 105.07 1.4 Allowed 'General case' 0 N--CA 1.492 1.667 0 O-C-N 121.166 -0.959 . . . . 0.0 108.762 179.469 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 85' ' ' GLU . . . . . 0.59 ' O ' ' CD2' ' A' ' 75' ' ' TYR . 1.2 mm-40 -139.72 179.2 1.34 Allowed Pre-proline 0 N--CA 1.499 1.979 0 O-C-N 121.13 -0.981 . . . . 0.0 109.674 -179.373 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 86' ' ' PRO . . . . . 0.47 ' CD ' ' CB ' ' A' ' 85' ' ' GLU . 35.5 Cg_endo -86.15 167.33 9.38 Favored 'Trans proline' 0 C--N 1.314 -1.24 0 C-N-CA 122.707 2.272 . . . . 0.0 113.34 -178.691 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 87' ' ' VAL . . . . . 0.563 ' H ' HG23 ' A' ' 72' ' ' VAL . 57.5 t -124.43 104.76 14.3 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.469 0 N-CA-C 108.042 -1.096 . . . . 0.0 108.042 178.901 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 88' ' ' TYR . . . . . 0.409 ' CD2' ' HG2' ' A' ' 99' ' ' ARG . 29.5 m-85 -97.83 154.73 37.72 Favored Pre-proline 0 N--CA 1.496 1.831 0 O-C-N 121.047 -1.033 . . . . 0.0 110.202 -178.731 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 89' ' ' PRO . . . . . . . . . . . . . 8.9 Cg_endo -56.33 144.32 82.93 Favored 'Trans proline' 0 N--CA 1.496 1.62 0 C-N-CA 122.961 2.44 . . . . 0.0 113.949 -179.972 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . -59.87 170.25 6.71 Favored Glycine 0 N--CA 1.489 2.208 0 N-CA-C 109.01 -1.636 . . . . 0.0 109.01 178.553 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 91' ' ' PRO . . . . . 0.429 ' C ' ' H ' ' A' ' 93' ' ' THR . 54.6 Cg_endo -93.94 167.4 20.28 Favored 'Cis proline' 0 C--N 1.307 -1.645 0 C-N-CA 124.016 -1.243 . . . . 0.0 111.275 -0.04 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 92' ' ' ALA . . . . . 0.659 ' HB1' HD21 ' A' ' 97' ' ' LEU . . . -72.11 32.61 0.06 Allowed 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.125 -0.985 . . . . 0.0 110.532 -179.612 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 93' ' ' THR . . . . . 0.429 ' H ' ' C ' ' A' ' 91' ' ' PRO . 2.0 p -73.3 149.78 89.26 Favored Pre-proline 0 N--CA 1.489 1.52 0 O-C-N 120.566 -1.333 . . . . 0.0 108.653 -179.817 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 94' ' ' PRO . . . . . . . . . . . . . 91.8 Cg_exo -30.53 -50.43 0.22 Allowed 'Trans proline' 0 C--N 1.31 -1.454 0 C-N-CA 123.372 2.715 . . . . 0.0 112.944 -179.125 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 95' ' ' GLU . . . . . 0.434 ' O ' ' NH2' ' A' ' 99' ' ' ARG . 10.6 mt-10 -53.8 -47.65 70.62 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.201 -0.937 . . . . 0.0 109.702 -179.973 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 96' ' ' GLN . . . . . 0.452 ' C ' ' H ' ' A' ' 98' ' ' ASN . 3.3 mp0 -72.08 -49.21 38.3 Favored 'General case' 0 C--N 1.302 -1.478 0 O-C-N 121.263 -0.898 . . . . 0.0 110.416 -179.453 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 97' ' ' LEU . . . . . 0.659 HD21 ' HB1' ' A' ' 92' ' ' ALA . 96.2 mt -52.8 -8.25 0.09 Allowed 'General case' 0 N--CA 1.493 1.695 0 O-C-N 121.055 -1.028 . . . . 0.0 110.06 -178.936 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 98' ' ' ASN . . . . . 0.547 ' C ' ' ND2' ' A' ' 98' ' ' ASN . 0.0 OUTLIER -75.68 -37.73 59.3 Favored 'General case' 0 N--CA 1.488 1.432 0 N-CA-C 107.91 -1.145 . . . . 0.0 107.91 178.269 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 99' ' ' ARG . . . . . 0.477 ' CZ ' ' OD1' ' A' ' 98' ' ' ASN . 1.0 OUTLIER -72.41 -51.28 21.06 Favored 'General case' 0 C--N 1.304 -1.378 0 CA-C-N 115.893 -0.594 . . . . 0.0 109.646 179.677 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . 169.6 -158.43 30.7 Favored Glycine 0 N--CA 1.497 2.762 0 N-CA-C 109.565 -1.414 . . . . 0.0 109.565 -179.834 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 101' ' ' VAL . . . . . 0.763 HG23 ' O ' ' A' ' 101' ' ' VAL . 16.2 m -66.2 104.26 0.57 Allowed 'Isoleucine or valine' 0 N--CA 1.496 1.848 0 O-C-N 120.924 -1.339 . . . . 0.0 108.987 179.697 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -92.4 167.71 11.79 Favored 'General case' 0 N--CA 1.495 1.813 0 O-C-N 121.218 -0.926 . . . . 0.0 111.6 -178.719 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 103' ' ' PHE . . . . . 0.425 ' CE1' ' CG1' ' A' ' 87' ' ' VAL . 24.3 m-85 -70.97 143.88 50.69 Favored 'General case' 0 N--CA 1.489 1.505 0 N-CA-C 107.876 -1.157 . . . . 0.0 107.876 178.238 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 104' ' ' ALA . . . . . . . . . . . . . . . -61.94 -13.47 25.43 Favored 'General case' 0 C--N 1.297 -1.68 0 O-C-N 121.179 -0.951 . . . . 0.0 111.376 -178.71 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -138.29 143.27 39.92 Favored 'General case' 0 N--CA 1.498 1.964 0 O-C-N 120.618 -1.301 . . . . 0.0 110.998 -179.49 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 106' ' ' GLU . . . . . . . . . . . . . 6.1 pt-20 -57.09 -58.92 6.06 Favored 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.935 -0.478 . . . . 0.0 111.134 -179.432 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 107' ' ' ASN . . . . . . . . . . . . . 10.5 m-20 -77.99 35.22 0.2 Allowed 'General case' 0 N--CA 1.489 1.478 0 O-C-N 120.361 -1.462 . . . . 0.0 112.107 -176.24 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 108' ' ' GLU . . . . . . . . . . . . . 40.6 tp10 -59.28 145.46 43.02 Favored 'General case' 0 C--N 1.304 -1.374 0 O-C-N 120.742 -1.224 . . . . 0.0 107.834 -179.96 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 109' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -96.86 144.22 27.01 Favored 'General case' 0 C--N 1.301 -1.542 0 O-C-N 121.119 -0.988 . . . . 0.0 110.67 -178.324 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 110' ' ' LEU . . . . . 0.513 HD11 HG21 ' A' ' 146' ' ' VAL . 5.6 tp -60.9 -21.52 63.43 Favored 'General case' 0 C--N 1.302 -1.465 0 N-CA-C 107.971 -1.122 . . . . 0.0 107.971 179.165 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 111' ' ' ASP . . . . . . . . . . . . . 82.5 m-20 -132.19 43.77 2.98 Favored 'General case' 0 C--N 1.302 -1.482 0 C-N-CA 120.269 -0.572 . . . . 0.0 109.861 -179.616 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 112' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -67.09 148.79 51.42 Favored 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.153 -0.967 . . . . 0.0 110.059 179.63 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 113' ' ' GLN . . . . . . . . . . . . . 2.4 mp0 -68.12 -12.4 60.83 Favored 'General case' 0 C--N 1.302 -1.482 0 O-C-N 121.256 -0.902 . . . . 0.0 109.199 179.029 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 114' ' ' ASN . . . . . 0.694 ' C ' HD21 ' A' ' 114' ' ' ASN . 0.2 OUTLIER -149.97 101.79 3.06 Favored 'General case' 0 C--N 1.301 -1.517 0 N-CA-C 107.167 -1.42 . . . . 0.0 107.167 177.378 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 115' ' ' ILE . . . . . 0.432 ' O ' HG22 ' A' ' 115' ' ' ILE . 4.0 mt -97.83 110.55 25.74 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.45 0 O-C-N 121.047 -1.033 . . . . 0.0 108.848 -179.253 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 116' ' ' SER . . . . . . . . . . . . . 28.9 m -98.93 138.26 36.31 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.154 -0.966 . . . . 0.0 111.122 -178.485 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 117' ' ' ILE . . . . . 0.459 ' CD1' HD21 ' A' ' 179' ' ' LEU . 14.4 mt -123.42 151.52 28.01 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.424 0 N-CA-C 107.229 -1.397 . . . . 0.0 107.229 178.83 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 118' ' ' ALA . . . . . 0.405 ' HA ' ' O ' ' A' ' 182' ' ' ILE . . . -140.93 154.67 46.2 Favored 'General case' 0 N--CA 1.487 1.409 0 O-C-N 120.95 -1.094 . . . . 0.0 110.609 -179.171 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 119' ' ' GLY . . . . . . . . . . . . . . . -166.57 151.73 20.14 Favored Glycine 0 N--CA 1.484 1.849 0 N-CA-C 110.201 -1.16 . . . . 0.0 110.201 179.984 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 120' ' ' HIS . . . . . . . . . . . . . 10.9 m170 -71.71 165.51 23.87 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.918 -0.754 . . . . 0.0 110.465 179.642 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 121' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -121.03 148.32 44.3 Favored 'General case' 0 N--CA 1.495 1.823 0 N-CA-C 107.75 -1.204 . . . . 0.0 107.75 178.293 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 122' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -107.41 138.33 43.81 Favored 'General case' 0 N--CA 1.495 1.782 0 O-C-N 120.882 -1.136 . . . . 0.0 110.192 -179.663 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 123' ' ' ILE . . . . . 0.536 HG23 ' N ' ' A' ' 124' ' ' ASP . 15.0 tt -90.26 -36.54 8.5 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.771 0 N-CA-C 108.152 -1.055 . . . . 0.0 108.152 178.277 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 124' ' ' ASP . . . . . 0.536 ' N ' HG23 ' A' ' 123' ' ' ILE . 18.3 t0 -96.6 17.18 16.9 Favored 'General case' 0 N--CA 1.496 1.843 0 CA-C-N 115.777 -0.647 . . . . 0.0 111.13 -179.638 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 125' ' ' ARG . . . . . . . . . . . . . 7.7 ttt180 -156.72 107.35 1.97 Allowed Pre-proline 0 N--CA 1.499 1.993 0 O-C-N 120.516 -1.365 . . . . 0.0 110.152 -178.856 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 126' ' ' PRO . . . . . . . . . . . . . 66.0 Cg_endo -81.04 -17.02 9.6 Favored 'Trans proline' 0 C--N 1.314 -1.247 0 C-N-CA 121.886 1.724 . . . . 0.0 112.703 179.885 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 127' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -90.95 31.24 1.1 Allowed 'General case' 0 N--CA 1.494 1.742 0 O-C-N 121.152 -0.968 . . . . 0.0 109.946 -179.933 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 128' ' ' TYR . . . . . . . . . . . . . 8.8 t80 -89.41 -153.16 0.26 Allowed 'General case' 0 N--CA 1.492 1.668 0 O-C-N 120.956 -1.09 . . . . 0.0 110.675 -179.193 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 129' ' ' GLN . . . . . . . . . . . . . 39.8 mt-30 -66.77 -72.71 0.15 Allowed 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.32 -0.863 . . . . 0.0 110.919 -178.308 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 130' ' ' PHE . . . . . 0.573 ' CE2' HG11 ' A' ' 101' ' ' VAL . 49.2 m-85 -121.6 28.98 7.4 Favored 'General case' 0 N--CA 1.497 1.876 0 O-C-N 121.289 -0.882 . . . . 0.0 110.126 -179.447 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 131' ' ' THR . . . . . . . . . . . . . 99.0 m -72.55 -30.92 64.86 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 120.781 -1.199 . . . . 0.0 109.146 179.933 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 132' ' ' ASN . . . . . . . . . . . . . 4.6 t30 -85.0 7.99 19.39 Favored 'General case' 0 N--CA 1.496 1.86 0 C-N-CA 119.513 -0.875 . . . . 0.0 109.923 -179.869 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 133' ' ' LEU . . . . . 0.583 ' O ' ' N ' ' A' ' 135' ' ' ALA . 0.2 OUTLIER -70.81 -49.64 44.2 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.353 -0.842 . . . . 0.0 109.827 179.897 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 134' ' ' LYS . . . . . 0.599 ' H ' ' CD ' ' A' ' 134' ' ' LYS . 0.0 OUTLIER -44.39 -16.14 0.02 OUTLIER 'General case' 0 N--CA 1.495 1.804 0 O-C-N 120.995 -1.066 . . . . 0.0 109.386 -179.311 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 135' ' ' ALA . . . . . 0.583 ' N ' ' O ' ' A' ' 133' ' ' LEU . . . -83.15 -35.87 25.2 Favored 'General case' 0 N--CA 1.494 1.773 0 O-C-N 121.264 -0.898 . . . . 0.0 109.824 179.78 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 136' ' ' ALA . . . . . 0.77 ' HB2' ' HB2' ' A' ' 81' ' ' ALA . . . -80.43 158.71 25.87 Favored 'General case' 0 N--CA 1.491 1.621 0 CA-C-O 121.778 0.799 . . . . 0.0 111.446 -178.735 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 137' ' ' LYS . . . . . 0.55 ' O ' ' O ' ' A' ' 138' ' ' LYS . 17.1 mtmt -149.64 -168.08 3.01 Favored 'General case' 0 N--CA 1.493 1.7 0 C-N-CA 118.935 -1.106 . . . . 0.0 110.619 -177.888 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 138' ' ' LYS . . . . . 0.581 ' O ' ' N ' ' A' ' 140' ' ' SER . 21.7 mtmm -40.48 176.06 0.0 OUTLIER 'General case' 0 C--N 1.304 -1.407 0 CA-C-O 122.608 1.194 . . . . 0.0 111.502 -178.618 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 139' ' ' GLY . . . . . . . . . . . . . . . 47.83 7.81 0.04 OUTLIER Glycine 0 N--CA 1.487 2.072 0 N-CA-C 109.825 -1.31 . . . . 0.0 109.825 -179.649 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 140' ' ' SER . . . . . 0.581 ' N ' ' O ' ' A' ' 138' ' ' LYS . 2.3 p -75.32 116.67 16.3 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 120.96 -1.318 . . . . 0.0 109.156 179.207 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 141' ' ' MET . . . . . . . . . . . . . 3.3 tpt -70.6 139.3 51.38 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.215 -0.928 . . . . 0.0 109.393 -179.956 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 142' ' ' VAL . . . . . . . . . . . . . 5.0 t -125.35 128.25 72.53 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.719 0 O-C-N 121.491 -0.755 . . . . 0.0 108.998 -179.789 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 143' ' ' TYR . . . . . . . . . . . . . 64.4 m-85 -107.41 135.04 49.57 Favored 'General case' 0 N--CA 1.5 2.056 0 O-C-N 121.236 -0.915 . . . . 0.0 110.69 -179.295 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 144' ' ' PHE . . . . . . . . . . . . . 62.9 t80 -118.78 101.65 8.24 Favored 'General case' 0 N--CA 1.5 2.066 0 O-C-N 121.474 -0.766 . . . . 0.0 110.406 -179.405 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 145' ' ' LYS . . . . . 0.405 ' O ' ' N ' ' A' ' 75' ' ' TYR . 36.5 tttt -96.51 129.98 43.78 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.03 -1.044 . . . . 0.0 110.543 -179.554 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 146' ' ' VAL . . . . . 0.651 HG23 ' O ' ' A' ' 73' ' ' ALA . 2.6 p -146.16 141.84 21.37 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.574 0 N-CA-C 107.238 -1.393 . . . . 0.0 107.238 178.376 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 147' ' ' GLY . . . . . 0.42 ' C ' ' O ' ' A' ' 146' ' ' VAL . . . 47.85 -133.72 16.87 Favored Glycine 0 N--CA 1.487 2.077 0 N-CA-C 108.857 -1.697 . . . . 0.0 108.857 -179.391 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 148' ' ' ASN . . . . . 0.574 ' OD1' ' HB2' ' A' ' 61' ' ' ALA . 0.5 OUTLIER -102.91 17.85 23.0 Favored 'General case' 0 C--N 1.302 -1.495 0 O-C-N 121.314 -1.109 . . . . 0.0 108.418 179.314 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 149' ' ' GLU . . . . . 0.525 ' CD ' ' N ' ' A' ' 150' ' ' THR . 11.5 tp10 -113.03 145.31 41.09 Favored 'General case' 0 N--CA 1.486 1.368 0 CA-C-O 121.714 0.768 . . . . 0.0 110.658 -178.447 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 150' ' ' THR . . . . . 0.525 ' N ' ' CD ' ' A' ' 149' ' ' GLU . 86.0 m -129.72 104.79 7.62 Favored 'General case' 0 N--CA 1.492 1.647 0 CA-C-O 121.487 0.66 . . . . 0.0 109.526 179.815 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 151' ' ' ARG . . . . . . . . . . . . . 84.3 mtt180 -85.92 -168.97 2.43 Favored 'General case' 0 N--CA 1.486 1.363 0 N-CA-C 108.646 -0.872 . . . . 0.0 108.646 -179.759 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 152' ' ' LYS . . . . . 0.589 ' N ' ' OXT' ' A' ' 206' ' ' LYS . 21.7 mtpt -149.9 148.47 29.16 Favored 'General case' 0 C--N 1.3 -1.563 0 O-C-N 120.999 -1.063 . . . . 0.0 110.317 -178.855 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 153' ' ' TYR . . . . . 0.446 ' CD1' ' C ' ' A' ' 152' ' ' LYS . 51.7 m-85 -146.94 151.48 37.08 Favored 'General case' 0 C--N 1.302 -1.475 0 N-CA-C 108.401 -0.963 . . . . 0.0 108.401 178.718 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 154' ' ' LYS . . . . . . . . . . . . . 10.8 ttmt -133.05 117.05 17.11 Favored 'General case' 0 C--N 1.298 -1.648 0 N-CA-C 108.711 -0.848 . . . . 0.0 108.711 179.291 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 155' ' ' MET . . . . . 0.557 ' SD ' ' OG ' ' A' ' 140' ' ' SER . 6.5 mtt -41.66 107.71 0.08 Allowed 'General case' 0 N--CA 1.489 1.483 0 CA-C-O 122.75 1.262 . . . . 0.0 111.858 -178.126 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 156' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -106.07 -26.19 11.73 Favored 'General case' 0 C--N 1.293 -1.865 0 CA-C-N 114.537 -1.211 . . . . 0.0 110.03 -178.842 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 157' ' ' SER . . . . . 0.488 ' O ' ' N ' ' A' ' 201' ' ' VAL . 19.8 t -154.27 150.77 28.37 Favored 'General case' 0 N--CA 1.494 1.748 0 C-N-CA 118.713 -1.195 . . . . 0.0 111.394 -178.678 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 158' ' ' ILE . . . . . 0.444 HG13 ' CD2' ' A' ' 200' ' ' PHE . 0.0 OUTLIER -155.25 146.9 12.98 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.486 0 CA-C-O 121.767 0.794 . . . . 0.0 110.252 -179.884 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 159' ' ' ARG . . . . . 0.599 ' CG ' HH11 ' A' ' 159' ' ' ARG . 0.0 OUTLIER -151.32 -167.46 2.81 Favored 'General case' 0 N--CA 1.491 1.603 0 CA-C-O 121.785 0.802 . . . . 0.0 110.551 -179.147 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 160' ' ' ASP . . . . . . . . . . . . . 5.5 m-20 -145.11 152.91 40.8 Favored 'General case' 0 N--CA 1.491 1.599 0 N-CA-C 108.585 -0.894 . . . . 0.0 108.585 -179.429 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 161' ' ' VAL . . . . . 0.653 HG21 HG22 ' A' ' 168' ' ' VAL . 0.1 OUTLIER -153.04 150.83 12.38 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.873 0 O-C-N 120.713 -1.242 . . . . 0.0 111.21 -178.834 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 162' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -49.07 171.3 0.11 Allowed Pre-proline 0 N--CA 1.496 1.866 0 O-C-N 121.652 -0.655 . . . . 0.0 109.961 179.418 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 163' ' ' PRO . . . . . . . . . . . . . 74.2 Cg_endo -81.07 29.37 0.53 Allowed 'Trans proline' 0 N--CA 1.492 1.428 0 C-N-CA 122.792 2.328 . . . . 0.0 113.008 179.83 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 164' ' ' THR . . . . . 0.506 ' O ' HG22 ' A' ' 164' ' ' THR . 55.3 m -151.16 -6.01 0.27 Allowed 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.005 -1.059 . . . . 0.0 110.356 -179.949 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 165' ' ' ASP . . . . . 0.86 ' O ' HG23 ' A' ' 168' ' ' VAL . 12.0 t0 -75.8 63.62 1.68 Allowed 'General case' 0 N--CA 1.487 1.411 0 O-C-N 120.994 -1.066 . . . . 0.0 109.292 179.549 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 166' ' ' VAL . . . . . 0.538 ' O ' ' N ' ' A' ' 168' ' ' VAL . 1.0 OUTLIER -39.54 -31.96 0.17 Allowed 'Isoleucine or valine' 0 N--CA 1.488 1.433 0 O-C-N 121.473 -0.767 . . . . 0.0 109.152 -178.647 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 167' ' ' GLY . . . . . 0.442 ' N ' ' O ' ' A' ' 165' ' ' ASP . . . -45.52 -13.52 0.05 OUTLIER Glycine 0 N--CA 1.494 2.545 0 N-CA-C 110.541 -1.024 . . . . 0.0 110.541 179.929 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 168' ' ' VAL . . . . . 0.86 HG23 ' O ' ' A' ' 165' ' ' ASP . 16.7 t -52.74 -35.39 21.28 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.607 0 O-C-N 120.818 -1.401 . . . . 0.0 108.115 179.531 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 169' ' ' LEU . . . . . 0.54 ' O ' ' C ' ' A' ' 170' ' ' ASP . 84.3 mt -46.23 -14.05 0.02 OUTLIER 'General case' 0 C--N 1.3 -1.569 0 N-CA-C 108.26 -1.015 . . . . 0.0 108.26 -178.268 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 170' ' ' ASP . . . . . 0.589 ' N ' ' O ' ' A' ' 168' ' ' VAL . 39.1 t0 19.78 54.36 0.01 OUTLIER 'General case' 0 N--CA 1.501 2.079 0 N-CA-C 111.874 0.324 . . . . 0.0 111.874 177.699 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 171' ' ' GLU . . . . . 0.435 ' N ' ' O ' ' A' ' 169' ' ' LEU . 4.9 pt-20 -100.87 75.6 1.71 Allowed 'General case' 0 N--CA 1.497 1.878 0 O-C-N 120.777 -1.202 . . . . 0.0 110.554 -179.597 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 172' ' ' GLN . . . . . . . . . . . . . 4.3 pt20 -139.69 -39.25 0.46 Allowed 'General case' 0 N--CA 1.492 1.665 0 O-C-N 121.568 -0.708 . . . . 0.0 109.266 -179.843 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 173' ' ' LYS . . . . . . . . . . . . . 9.2 mtpp -63.82 131.05 46.6 Favored 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.06 -1.025 . . . . 0.0 108.743 178.818 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 174' ' ' GLY . . . . . 0.559 ' O ' ' C ' ' A' ' 175' ' ' LYS . . . -137.5 -38.94 0.13 Allowed Glycine 0 C--N 1.294 -1.761 0 N-CA-C 108.514 -1.834 . . . . 0.0 108.514 179.763 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 175' ' ' LYS . . . . . 0.559 ' C ' ' O ' ' A' ' 174' ' ' GLY . 3.4 tptp -33.41 -62.97 0.26 Allowed 'General case' 0 N--CA 1.493 1.717 0 N-CA-C 108.529 -0.915 . . . . 0.0 108.529 179.676 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 176' ' ' ASP . . . . . 0.715 ' O ' ' O ' ' A' ' 177' ' ' LYS . 0.9 OUTLIER -103.6 76.1 1.37 Allowed 'General case' 0 C--N 1.297 -1.697 0 N-CA-C 107.796 -1.187 . . . . 0.0 107.796 177.775 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 177' ' ' LYS . . . . . 0.715 ' O ' ' O ' ' A' ' 176' ' ' ASP . 17.6 mtmt -19.16 158.63 0.0 OUTLIER 'General case' 0 N--CA 1.508 2.458 0 CA-C-O 122.145 0.974 . . . . 0.0 112.719 -178.985 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 178' ' ' GLN . . . . . 0.535 ' NE2' ' OD1' ' A' ' 114' ' ' ASN . 18.0 pt20 -156.08 159.23 38.91 Favored 'General case' 0 N--CA 1.491 1.593 0 C-N-CA 117.061 -1.856 . . . . 0.0 112.483 179.863 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 179' ' ' LEU . . . . . 0.459 HD21 ' CD1' ' A' ' 117' ' ' ILE . 0.8 OUTLIER -121.58 102.88 8.51 Favored 'General case' 0 N--CA 1.486 1.349 0 N-CA-C 107.072 -1.455 . . . . 0.0 107.072 178.418 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 180' ' ' THR . . . . . 0.45 ' OG1' HG22 ' A' ' 201' ' ' VAL . 1.0 OUTLIER -79.92 123.9 28.2 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.148 -0.97 . . . . 0.0 110.438 -178.454 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 181' ' ' LEU . . . . . . . . . . . . . 7.5 tp -99.8 110.9 23.25 Favored 'General case' 0 N--CA 1.492 1.661 0 N-CA-C 108.711 -0.848 . . . . 0.0 108.711 178.386 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 182' ' ' ILE . . . . . 0.405 ' O ' ' HA ' ' A' ' 118' ' ' ALA . 18.1 mt -98.94 120.23 47.98 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.549 0 O-C-N 120.85 -1.156 . . . . 0.0 109.768 179.432 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 183' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -135.44 109.06 7.97 Favored 'General case' 0 C--N 1.296 -1.718 0 N-CA-C 107.279 -1.378 . . . . 0.0 107.279 178.548 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 184' ' ' CYS . . . . . 0.408 ' HB3' HH12 ' A' ' 197' ' ' ARG . 0.7 OUTLIER -79.83 156.68 27.28 Favored 'General case' 0 N--CA 1.498 1.933 0 C-N-CA 118.935 -1.106 . . . . 0.0 111.341 -177.306 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 185' ' ' ASP . . . . . 0.613 ' CG ' ' H ' ' A' ' 186' ' ' ASP . 28.9 t0 -166.53 -161.92 0.49 Allowed 'General case' 0 N--CA 1.489 1.523 0 N-CA-C 108.659 -0.867 . . . . 0.0 108.659 -179.943 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 186' ' ' ASP . . . . . 0.613 ' H ' ' CG ' ' A' ' 185' ' ' ASP . 0.6 OUTLIER 58.49 49.12 11.08 Favored 'General case' 0 N--CA 1.497 1.916 0 O-C-N 121.026 -1.046 . . . . 0.0 109.457 -179.656 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 187' ' ' TYR . . . . . 0.587 ' CE1' ' O ' ' A' ' 188' ' ' ASN . 30.1 t80 -67.16 133.09 49.11 Favored 'General case' 0 C--N 1.3 -1.562 0 CA-C-O 121.843 0.83 . . . . 0.0 110.469 -179.858 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 188' ' ' ASN . . . . . 0.86 ' ND2' ' H ' ' A' ' 193' ' ' VAL . 0.1 OUTLIER -102.56 150.66 23.18 Favored 'General case' 0 C--N 1.292 -1.894 0 N-CA-C 107.572 -1.27 . . . . 0.0 107.572 178.033 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 189' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -113.24 -3.08 13.92 Favored 'General case' 0 C--N 1.292 -1.934 0 N-CA-C 108.178 -1.045 . . . . 0.0 108.178 -179.61 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 190' ' ' LYS . . . . . 0.566 ' N ' ' OD1' ' A' ' 188' ' ' ASN . 2.6 mtpm? -83.66 -60.21 2.19 Favored 'General case' 0 N--CA 1.489 1.49 0 N-CA-C 108.714 -0.847 . . . . 0.0 108.714 178.558 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 191' ' ' THR . . . . . 0.623 ' OG1' ' ND2' ' A' ' 188' ' ' ASN . 1.1 p -89.34 4.15 49.86 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.41 -0.806 . . . . 0.0 109.245 179.896 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 192' ' ' GLY . . . . . . . . . . . . . . . 56.73 38.01 80.27 Favored Glycine 0 N--CA 1.494 2.53 0 N-CA-C 110.05 -1.22 . . . . 0.0 110.05 179.4 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 193' ' ' VAL . . . . . 0.86 ' H ' ' ND2' ' A' ' 188' ' ' ASN . 46.0 t -148.35 161.02 6.5 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.493 0 O-C-N 121.162 -1.199 . . . . 0.0 110.042 -179.975 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 194' ' ' TRP . . . . . 0.563 ' NE1' ' OG1' ' C' ' 705' ' ' B27 . 11.1 m95 -83.4 120.62 26.11 Favored 'General case' 0 C--N 1.298 -1.656 0 N-CA-C 108.564 -0.902 . . . . 0.0 108.564 179.55 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 195' ' ' GLU . . . . . . . . . . . . . 1.4 mt-10 -79.53 -60.09 2.5 Favored 'General case' 0 N--CA 1.493 1.709 0 O-C-N 121.309 -0.869 . . . . 0.0 111.013 -178.888 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 196' ' ' LYS . . . . . . . . . . . . . 19.0 mttp -95.04 146.37 24.32 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.285 -0.884 . . . . 0.0 110.31 -178.759 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 197' ' ' ARG . . . . . 0.657 ' CG ' HH11 ' A' ' 197' ' ' ARG . 0.0 OUTLIER -118.81 145.42 45.65 Favored 'General case' 0 N--CA 1.492 1.635 0 N-CA-C 108.564 -0.902 . . . . 0.0 108.564 179.035 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 198' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER -116.95 120.75 39.4 Favored 'General case' 0 N--CA 1.492 1.666 0 O-C-N 121.672 -0.643 . . . . 0.0 110.358 -178.704 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 199' ' ' ILE . . . . . 0.514 HG21 HG11 ' A' ' 168' ' ' VAL . 0.8 OUTLIER -141.67 121.46 11.17 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.527 0 CA-C-O 122.672 1.225 . . . . 0.0 110.551 179.554 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 200' ' ' PHE . . . . . 0.53 ' CD1' ' N ' ' A' ' 200' ' ' PHE . 3.3 m-85 -99.52 134.64 42.1 Favored 'General case' 0 N--CA 1.497 1.915 0 O-C-N 121.163 -0.961 . . . . 0.0 110.125 -177.653 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 201' ' ' VAL . . . . . 0.488 ' N ' ' O ' ' A' ' 157' ' ' SER . 3.4 t -103.95 145.38 12.9 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.456 0 N-CA-C 107.646 -1.242 . . . . 0.0 107.646 176.805 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 202' ' ' ALA . . . . . . . . . . . . . . . -135.01 142.31 46.39 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.042 -1.036 . . . . 0.0 109.465 -179.753 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 203' ' ' THR . . . . . . . . . . . . . 2.2 p -90.11 127.55 36.11 Favored 'General case' 0 C--N 1.306 -1.322 0 CA-C-O 122.694 1.235 . . . . 0.0 111.693 -178.353 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 204' ' ' GLU . . . . . . . . . . . . . 2.7 tm-20 -53.99 135.84 42.21 Favored 'General case' 0 C--N 1.291 -1.976 0 CA-C-N 114.364 -1.289 . . . . 0.0 108.286 178.594 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 205' ' ' VAL . . . . . . . . . . . . . 62.6 t -121.55 -50.14 3.02 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.898 0 O-C-N 121.177 -0.952 . . . . 0.0 109.436 -179.13 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 206' ' ' LYS . . . . . 0.589 ' OXT' ' N ' ' A' ' 152' ' ' LYS . 4.4 mmtp . . . . . 0 C--N 1.302 -1.469 0 CA-C-O 118.114 -0.946 . . . . 0.0 109.667 179.151 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' C' C ' 701' ' ' PHQ . . . . . 0.46 ' O2 ' HG12 ' A' ' 166' ' ' VAL . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 016 nuclear build full ' C' C ' 702' ' ' LEU . . . . . 0.827 ' N ' HD12 ' C' ' 702' ' ' LEU . 0.0 OUTLIER . . . . . 0 N--CA 1.491 1.598 0 N-CA-C 108.316 -0.994 . . . . 0.0 108.316 . . . . . . . . . 2 2 . 1 . 016 nuclear build full ' C' C ' 703' ' ' PRO . . . . . 0.586 ' O ' ' NH2' ' A' ' 197' ' ' ARG . 64.8 Cg_endo -80.85 164.11 20.5 Favored 'Trans proline' 0 C--N 1.308 -1.584 0 C-N-CA 122.381 2.054 . . . . 0.0 113.119 -179.123 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' C' C ' 704' ' ' ALA . . . . . 0.462 ' O ' ' O ' ' C' ' 703' ' ' PRO . . . 51.9 173.73 0.01 OUTLIER 'General case' 0 N--CA 1.488 1.462 0 O-C-N 121.345 -0.847 . . . . 0.0 110.033 179.441 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' C' C ' 705' ' ' B27 . . . . . 0.563 ' OG1' ' NE1' ' A' ' 194' ' ' TRP . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 700' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 017 nuclear build full ' A' A ' 59' ' ' MET . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 N--CA 1.491 1.597 0 N-CA-C 109.335 -0.617 . . . . 0.0 109.335 . . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 60' ' ' GLN . . . . . . . . . . . . . 1.8 mp0 -60.32 -170.23 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.044 -1.035 . . . . 0.0 109.922 -179.846 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . -62.2 154.07 28.51 Favored 'General case' 0 N--CA 1.488 1.443 0 O-C-N 121.351 -0.843 . . . . 0.0 109.265 179.87 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 62' ' ' LYS . . . . . . . . . . . . . 10.3 tttm -139.9 69.22 36.24 Favored Pre-proline 0 N--CA 1.491 1.583 0 C-N-CA 119.578 -0.849 . . . . 0.0 109.548 -179.547 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 63' ' ' PRO . . . . . . . . . . . . . 75.7 Cg_endo -81.23 148.63 16.81 Favored 'Trans proline' 0 C--N 1.303 -1.824 0 C-N-CA 123.455 2.77 . . . . 0.0 111.488 179.571 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 64' ' ' GLN . . . . . 0.568 ' N ' ' CD ' ' A' ' 64' ' ' GLN . 0.0 OUTLIER -156.31 117.53 3.83 Favored 'General case' 0 N--CA 1.496 1.87 0 O-C-N 121.118 -0.989 . . . . 0.0 109.39 179.664 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 65' ' ' ILE . . . . . 0.45 ' H ' HD12 ' A' ' 65' ' ' ILE . 3.2 mp -43.86 104.39 0.37 Allowed Pre-proline 0 N--CA 1.494 1.767 0 O-C-N 120.972 -1.08 . . . . 0.0 109.119 179.48 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 66' ' ' PRO . . . . . . . . . . . . . 83.8 Cg_endo -87.34 -158.81 0.09 OUTLIER 'Trans proline' 0 C--N 1.315 -1.23 0 C-N-CA 122.287 1.991 . . . . 0.0 112.651 -179.476 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 67' ' ' LYS . . . . . 0.467 ' CG ' ' O ' ' A' ' 67' ' ' LYS . 19.5 tttm -77.86 -6.87 55.65 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.306 -0.871 . . . . 0.0 108.7 179.516 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 68' ' ' ASP . . . . . 0.589 ' O ' ' N ' ' A' ' 70' ' ' SER . 3.6 t0 -76.5 48.04 0.52 Allowed 'General case' 0 N--CA 1.489 1.488 0 CA-C-O 122.237 1.018 . . . . 0.0 109.05 179.477 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 69' ' ' LYS . . . . . 0.456 ' C ' ' O ' ' A' ' 68' ' ' ASP . 9.5 ptpt -49.11 -14.57 0.08 Allowed 'General case' 0 N--CA 1.503 2.186 0 C-N-CA 116.845 -1.942 . . . . 0.0 106.863 178.234 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 70' ' ' SER . . . . . 0.589 ' N ' ' O ' ' A' ' 68' ' ' ASP . 1.8 t -82.85 -8.49 59.57 Favored 'General case' 0 N--CA 1.494 1.764 0 CA-C-N 113.629 -1.623 . . . . 0.0 110.15 179.958 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 71' ' ' LYS . . . . . 0.408 ' CD ' ' HB3' ' A' ' 68' ' ' ASP . 0.0 OUTLIER -97.54 145.93 25.76 Favored 'General case' 0 N--CA 1.492 1.665 0 O-C-N 120.981 -1.074 . . . . 0.0 109.929 179.109 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 72' ' ' VAL . . . . . 0.703 HG12 ' CE1' ' A' ' 88' ' ' TYR . 1.1 m -65.24 140.06 20.33 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.58 0 N-CA-C 105.046 -2.205 . . . . 0.0 105.046 174.853 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 73' ' ' ALA . . . . . 0.636 ' O ' HG23 ' A' ' 146' ' ' VAL . . . -80.64 -18.61 47.54 Favored 'General case' 0 C--N 1.291 -1.935 0 O-C-N 120.022 -1.674 . . . . 0.0 106.645 179.764 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 74' ' ' GLY . . . . . 0.453 ' O ' ' N ' ' A' ' 87' ' ' VAL . . . 176.16 -159.05 26.08 Favored Glycine 0 N--CA 1.483 1.796 0 N-CA-C 109.721 -1.352 . . . . 0.0 109.721 179.323 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 75' ' ' TYR . . . . . 0.551 ' HA ' HG23 ' A' ' 87' ' ' VAL . 92.1 m-85 -140.77 166.66 24.16 Favored 'General case' 0 C--N 1.299 -1.619 0 O-C-N 121.62 -0.929 . . . . 0.0 110.63 -177.268 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 76' ' ' ILE . . . . . . . . . . . . . 1.7 tt -147.71 143.39 19.64 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.551 0 C-N-CA 118.98 -1.088 . . . . 0.0 109.959 -178.189 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 77' ' ' GLU . . . . . 0.56 ' N ' ' CD ' ' A' ' 77' ' ' GLU . 2.3 mp0 -147.31 164.35 33.52 Favored 'General case' 0 N--CA 1.487 1.424 0 O-C-N 121.116 -0.99 . . . . 0.0 108.823 -179.831 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 78' ' ' ILE . . . . . 0.608 ' HB ' ' HB3' ' A' ' 81' ' ' ALA . 5.1 mt -147.5 93.39 4.62 Favored Pre-proline 0 N--CA 1.49 1.552 0 N-CA-C 108.181 -1.044 . . . . 0.0 108.181 179.674 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 79' ' ' PRO . . . . . . . . . . . . . 80.7 Cg_exo -46.87 -48.49 14.18 Favored 'Trans proline' 0 N--CA 1.494 1.527 0 C-N-CA 122.995 2.464 . . . . 0.0 114.098 -178.428 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -64.8 -18.98 65.58 Favored 'General case' 0 N--CA 1.494 1.73 0 O-C-N 120.868 -1.145 . . . . 0.0 110.749 178.968 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 81' ' ' ALA . . . . . 0.786 ' HB2' ' HB2' ' A' ' 136' ' ' ALA . . . -105.5 -17.49 14.4 Favored 'General case' 0 N--CA 1.492 1.663 0 O-C-N 121.176 -0.953 . . . . 0.0 108.488 179.207 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 82' ' ' ASP . . . . . 0.438 ' N ' ' O ' ' A' ' 78' ' ' ILE . 0.7 OUTLIER 67.93 51.12 0.78 Allowed 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.528 -0.732 . . . . 0.0 110.453 179.022 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 83' ' ' ILE . . . . . . . . . . . . . 70.8 mt -128.75 151.57 35.72 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.756 0 O-C-N 121.343 -0.848 . . . . 0.0 110.074 -178.768 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 84' ' ' LYS . . . . . 0.45 ' CG ' ' O ' ' A' ' 84' ' ' LYS . 7.7 pttt -158.37 107.86 2.03 Favored 'General case' 0 N--CA 1.494 1.757 0 N-CA-C 108.345 -0.984 . . . . 0.0 108.345 -179.923 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -142.34 166.12 23.1 Favored Pre-proline 0 N--CA 1.496 1.833 0 O-C-N 121.234 -0.916 . . . . 0.0 110.759 -179.064 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 86' ' ' PRO . . . . . . . . . . . . . 73.8 Cg_endo -77.35 166.35 26.25 Favored 'Trans proline' 0 N--CA 1.498 1.761 0 C-N-CA 123.333 2.689 . . . . 0.0 113.652 -179.225 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 87' ' ' VAL . . . . . 0.551 HG23 ' HA ' ' A' ' 75' ' ' TYR . 39.9 t -122.83 100.95 8.82 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.651 0 O-C-N 121.735 -0.603 . . . . 0.0 109.422 179.953 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 88' ' ' TYR . . . . . 0.703 ' CE1' HG12 ' A' ' 72' ' ' VAL . 7.5 m-85 -89.73 173.61 5.69 Favored Pre-proline 0 N--CA 1.499 2.005 0 O-C-N 120.946 -1.096 . . . . 0.0 109.468 -179.684 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 89' ' ' PRO . . . . . 0.434 ' HA ' ' CD2' ' A' ' 103' ' ' PHE . 9.4 Cg_endo -83.84 145.61 11.44 Favored 'Trans proline' 0 N--CA 1.484 0.96 0 C-N-CA 122.064 1.843 . . . . 0.0 113.898 -177.982 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . -55.97 164.41 4.8 Favored Glycine 0 N--CA 1.487 2.069 0 N-CA-C 109.081 -1.608 . . . . 0.0 109.081 179.133 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 91' ' ' PRO . . . . . 0.453 ' C ' ' H ' ' A' ' 93' ' ' THR . 58.0 Cg_endo -91.5 167.27 27.37 Favored 'Cis proline' 0 C--N 1.305 -1.747 0 C-N-CA 123.408 -1.497 . . . . 0.0 112.401 0.69 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 92' ' ' ALA . . . . . 0.551 ' HB3' ' HB2' ' C' ' 703' ' ' PRO . . . -73.21 30.52 0.07 Allowed 'General case' 0 C--N 1.303 -1.449 0 C-N-CA 119.887 -0.725 . . . . 0.0 110.091 -179.944 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 93' ' ' THR . . . . . 0.453 ' H ' ' C ' ' A' ' 91' ' ' PRO . 6.5 p -71.5 150.6 93.82 Favored Pre-proline 0 N--CA 1.489 1.493 0 O-C-N 121.034 -1.041 . . . . 0.0 108.847 -179.289 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 94' ' ' PRO . . . . . . . . . . . . . 77.8 Cg_exo -33.35 -49.03 0.45 Allowed 'Trans proline' 0 C--N 1.308 -1.562 0 C-N-CA 122.898 2.398 . . . . 0.0 112.385 -178.9 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 95' ' ' GLU . . . . . 0.596 ' O ' ' ND2' ' A' ' 98' ' ' ASN . 5.4 mp0 -49.83 -51.36 40.5 Favored 'General case' 0 C--N 1.3 -1.551 0 O-C-N 121.317 -0.865 . . . . 0.0 109.773 -179.838 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 96' ' ' GLN . . . . . 0.566 ' O ' ' N ' ' A' ' 98' ' ' ASN . 3.3 mp0 -72.32 -50.76 24.45 Favored 'General case' 0 N--CA 1.489 1.493 0 O-C-N 120.99 -1.069 . . . . 0.0 109.954 179.908 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 97' ' ' LEU . . . . . 0.627 ' CD2' ' CE1' ' A' ' 120' ' ' HIS . 1.3 mp -48.5 -8.75 0.02 OUTLIER 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.135 -0.978 . . . . 0.0 109.737 -179.786 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 98' ' ' ASN . . . . . 0.596 ' ND2' ' O ' ' A' ' 95' ' ' GLU . 0.4 OUTLIER -72.66 -28.01 62.46 Favored 'General case' 0 N--CA 1.489 1.479 0 O-C-N 121.379 -0.826 . . . . 0.0 109.346 179.868 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 99' ' ' ARG . . . . . 0.646 HH11 ' CG ' ' A' ' 99' ' ' ARG . 0.2 OUTLIER -96.17 -57.61 2.29 Favored 'General case' 0 N--CA 1.488 1.428 0 C-N-CA 119.79 -0.764 . . . . 0.0 110.186 -179.526 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . -170.2 -162.8 23.15 Favored Glycine 0 N--CA 1.493 2.468 0 C-N-CA 119.383 -1.389 . . . . 0.0 110.531 -179.934 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 101' ' ' VAL . . . . . 0.75 HG11 ' CZ ' ' A' ' 130' ' ' PHE . 13.7 m -64.58 106.27 0.57 Allowed 'Isoleucine or valine' 0 N--CA 1.496 1.845 0 O-C-N 121.698 -0.883 . . . . 0.0 109.351 -179.61 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -92.57 161.44 14.59 Favored 'General case' 0 N--CA 1.494 1.731 0 O-C-N 121.23 -0.919 . . . . 0.0 110.679 -179.55 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 103' ' ' PHE . . . . . 0.434 ' CD2' ' HA ' ' A' ' 89' ' ' PRO . 23.8 m-85 -63.6 150.42 44.14 Favored 'General case' 0 N--CA 1.489 1.48 0 N-CA-C 107.724 -1.213 . . . . 0.0 107.724 178.11 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 104' ' ' ALA . . . . . . . . . . . . . . . -69.71 -13.08 62.11 Favored 'General case' 0 N--CA 1.492 1.652 0 O-C-N 120.998 -1.064 . . . . 0.0 111.309 -178.504 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -136.3 142.01 43.87 Favored 'General case' 0 N--CA 1.498 1.97 0 O-C-N 120.841 -1.162 . . . . 0.0 110.803 -179.307 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 106' ' ' GLU . . . . . . . . . . . . . 2.3 tm-20 -51.89 -61.64 2.13 Favored 'General case' 0 N--CA 1.489 1.495 0 O-C-N 121.883 -0.511 . . . . 0.0 110.675 -179.556 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 107' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER -76.63 34.49 0.14 Allowed 'General case' 0 N--CA 1.489 1.52 0 O-C-N 120.698 -1.251 . . . . 0.0 112.251 -175.832 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 108' ' ' GLU . . . . . 0.488 ' OE2' HD13 ' A' ' 115' ' ' ILE . 29.6 tp10 -55.22 146.74 18.12 Favored 'General case' 0 C--N 1.303 -1.422 0 O-C-N 120.585 -1.322 . . . . 0.0 107.624 179.681 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 109' ' ' SER . . . . . 0.752 ' O ' HD11 ' A' ' 115' ' ' ILE . 0.3 OUTLIER -103.59 143.49 32.68 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 120.941 -1.099 . . . . 0.0 110.901 -178.038 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 110' ' ' LEU . . . . . 0.645 HD11 HG21 ' A' ' 146' ' ' VAL . 0.2 OUTLIER -64.47 -16.47 62.53 Favored 'General case' 0 C--N 1.303 -1.447 0 N-CA-C 108.884 -0.784 . . . . 0.0 108.884 179.217 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 111' ' ' ASP . . . . . . . . . . . . . 74.0 m-20 -132.97 35.99 3.51 Favored 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.248 -0.907 . . . . 0.0 110.298 -179.539 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 112' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -66.52 153.36 43.15 Favored 'General case' 0 N--CA 1.493 1.7 0 O-C-N 120.825 -1.172 . . . . 0.0 111.203 -179.673 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 113' ' ' GLN . . . . . 0.561 ' NE2' ' O ' ' A' ' 173' ' ' LYS . 0.0 OUTLIER -67.77 -13.78 62.41 Favored 'General case' 0 N--CA 1.494 1.755 0 CA-C-O 121.949 0.88 . . . . 0.0 109.537 178.677 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 114' ' ' ASN . . . . . 0.615 ' O ' ' ND2' ' A' ' 114' ' ' ASN . 0.3 OUTLIER -150.33 106.71 3.48 Favored 'General case' 0 C--N 1.298 -1.669 0 N-CA-C 107.205 -1.405 . . . . 0.0 107.205 179.477 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 115' ' ' ILE . . . . . 0.752 HD11 ' O ' ' A' ' 109' ' ' SER . 1.5 mm -94.23 104.52 15.86 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.737 0 O-C-N 120.534 -1.354 . . . . 0.0 108.823 -179.459 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 116' ' ' SER . . . . . . . . . . . . . 42.8 m -82.55 153.12 25.68 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.291 -0.881 . . . . 0.0 110.986 -178.182 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 117' ' ' ILE . . . . . 0.453 HG22 ' HB ' ' A' ' 101' ' ' VAL . 7.9 mt -151.13 147.12 15.8 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.437 0 N-CA-C 108.207 -1.034 . . . . 0.0 108.207 179.736 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 118' ' ' ALA . . . . . . . . . . . . . . . -144.89 160.97 40.45 Favored 'General case' 0 N--CA 1.491 1.582 0 C-N-CA 118.742 -1.183 . . . . 0.0 111.435 -179.948 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 119' ' ' GLY . . . . . . . . . . . . . . . -167.95 151.0 17.71 Favored Glycine 0 N--CA 1.485 1.939 0 N-CA-C 109.65 -1.38 . . . . 0.0 109.65 179.718 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 120' ' ' HIS . . . . . 0.627 ' CE1' ' CD2' ' A' ' 97' ' ' LEU . 3.9 m-70 -70.91 167.73 18.41 Favored 'General case' 0 N--CA 1.493 1.699 0 O-C-N 121.639 -0.918 . . . . 0.0 109.972 179.689 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 121' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -121.39 157.95 29.37 Favored 'General case' 0 N--CA 1.496 1.842 0 N-CA-C 108.363 -0.977 . . . . 0.0 108.363 178.954 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 122' ' ' PHE . . . . . 0.73 ' O ' HG21 ' A' ' 131' ' ' THR . 0.1 OUTLIER -140.66 121.97 14.92 Favored 'General case' 0 N--CA 1.498 1.934 0 O-C-N 120.927 -1.108 . . . . 0.0 110.31 -179.234 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 123' ' ' ILE . . . . . 0.502 HG23 ' N ' ' A' ' 124' ' ' ASP . 8.6 tt -59.44 -38.54 75.61 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.485 0 O-C-N 121.556 -0.715 . . . . 0.0 110.096 -179.884 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 124' ' ' ASP . . . . . 0.502 ' N ' HG23 ' A' ' 123' ' ' ILE . 0.1 OUTLIER -90.97 18.29 6.85 Favored 'General case' 0 N--CA 1.496 1.858 0 C-N-CA 119.659 -0.816 . . . . 0.0 111.988 -177.718 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 125' ' ' ARG . . . . . 0.443 HH11 ' CG ' ' A' ' 125' ' ' ARG . 0.3 OUTLIER -152.08 99.31 2.9 Favored Pre-proline 0 N--CA 1.493 1.706 0 O-C-N 120.521 -1.362 . . . . 0.0 109.719 -179.821 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 126' ' ' PRO . . . . . . . . . . . . . 58.4 Cg_endo -77.55 -19.03 13.31 Favored 'Trans proline' 0 N--CA 1.489 1.236 0 C-N-CA 122.061 1.841 . . . . 0.0 112.143 179.697 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 127' ' ' ASN . . . . . 0.489 ' O ' ' O ' ' A' ' 128' ' ' TYR . 0.7 OUTLIER -91.29 2.59 56.27 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.301 -0.874 . . . . 0.0 109.948 -179.811 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 128' ' ' TYR . . . . . 0.679 ' CE2' ' NE2' ' A' ' 129' ' ' GLN . 2.5 t80 -57.82 -148.83 0.0 OUTLIER 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.182 -0.949 . . . . 0.0 110.025 -179.657 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 129' ' ' GLN . . . . . 0.679 ' NE2' ' CE2' ' A' ' 128' ' ' TYR . 0.5 OUTLIER -65.39 -71.24 0.19 Allowed 'General case' 0 N--CA 1.493 1.703 0 O-C-N 121.316 -0.865 . . . . 0.0 109.871 -179.387 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 130' ' ' PHE . . . . . 0.75 ' CZ ' HG11 ' A' ' 101' ' ' VAL . 28.8 m-85 -135.16 39.78 2.91 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.288 -0.883 . . . . 0.0 109.808 -179.633 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 131' ' ' THR . . . . . 0.73 HG21 ' O ' ' A' ' 122' ' ' PHE . 60.5 m -74.94 -32.88 61.86 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.246 -0.909 . . . . 0.0 109.354 179.858 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 132' ' ' ASN . . . . . 0.471 ' CG ' ' O ' ' A' ' 132' ' ' ASN . 5.7 t-20 -92.83 14.12 18.32 Favored 'General case' 0 N--CA 1.498 1.972 0 C-N-CA 119.698 -0.801 . . . . 0.0 111.63 -178.889 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 133' ' ' LEU . . . . . 0.774 HD13 ' HB3' ' A' ' 136' ' ' ALA . 0.2 OUTLIER -68.5 -26.98 65.73 Favored 'General case' 0 N--CA 1.496 1.875 0 O-C-N 120.582 -1.324 . . . . 0.0 109.429 -179.92 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 134' ' ' LYS . . . . . 0.68 ' H ' ' CD ' ' A' ' 134' ' ' LYS . 0.0 OUTLIER -46.14 -28.71 1.29 Allowed 'General case' 0 N--CA 1.495 1.817 0 O-C-N 121.401 -0.812 . . . . 0.0 110.937 -179.176 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 135' ' ' ALA . . . . . . . . . . . . . . . -83.37 -22.61 32.74 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 120.758 -1.214 . . . . 0.0 109.954 -179.189 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 136' ' ' ALA . . . . . 0.786 ' HB2' ' HB2' ' A' ' 81' ' ' ALA . . . -79.79 138.02 37.14 Favored 'General case' 0 C--N 1.3 -1.559 0 O-C-N 121.29 -0.881 . . . . 0.0 111.405 -178.897 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 137' ' ' LYS . . . . . 0.554 ' O ' ' O ' ' A' ' 138' ' ' LYS . 6.3 mttt -151.46 -170.26 3.6 Favored 'General case' 0 N--CA 1.494 1.77 0 C-N-CA 118.639 -1.225 . . . . 0.0 111.221 -178.231 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 138' ' ' LYS . . . . . 0.554 ' O ' ' O ' ' A' ' 137' ' ' LYS . 15.4 tttt -32.55 163.96 0.0 OUTLIER 'General case' 0 N--CA 1.492 1.653 0 CA-C-O 122.902 1.334 . . . . 0.0 112.342 -178.204 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 139' ' ' GLY . . . . . . . . . . . . . . . 49.68 8.73 0.14 Allowed Glycine 0 N--CA 1.491 2.317 0 N-CA-C 110.146 -1.182 . . . . 0.0 110.146 179.78 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 140' ' ' SER . . . . . 0.491 ' N ' ' O ' ' A' ' 138' ' ' LYS . 2.0 m -69.33 130.01 41.39 Favored 'General case' 0 N--CA 1.495 1.812 0 O-C-N 120.803 -1.41 . . . . 0.0 109.194 179.539 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 141' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -83.78 123.17 29.6 Favored 'General case' 0 N--CA 1.489 1.498 0 O-C-N 121.224 -0.923 . . . . 0.0 109.214 179.743 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 142' ' ' VAL . . . . . . . . . . . . . 2.4 t -112.99 132.12 62.7 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.576 0 N-CA-C 108.069 -1.086 . . . . 0.0 108.069 179.75 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 143' ' ' TYR . . . . . . . . . . . . . 5.3 m-85 -108.65 134.24 51.65 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.025 -1.047 . . . . 0.0 110.897 -178.42 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 144' ' ' PHE . . . . . . . . . . . . . 44.8 t80 -120.13 102.62 8.64 Favored 'General case' 0 N--CA 1.489 1.524 0 N-CA-C 109.056 -0.72 . . . . 0.0 109.056 179.633 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 145' ' ' LYS . . . . . . . . . . . . . 25.2 tttm -100.21 129.99 46.29 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.319 -0.863 . . . . 0.0 110.868 -179.008 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 146' ' ' VAL . . . . . 0.645 HG21 HD11 ' A' ' 110' ' ' LEU . 6.8 p -142.43 146.51 22.2 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.566 0 N-CA-C 107.805 -1.183 . . . . 0.0 107.805 178.415 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 147' ' ' GLY . . . . . 0.441 ' C ' ' O ' ' A' ' 146' ' ' VAL . . . 42.61 -124.08 3.84 Favored Glycine 0 N--CA 1.491 2.355 0 N-CA-C 109.336 -1.506 . . . . 0.0 109.336 -179.795 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 148' ' ' ASN . . . . . . . . . . . . . 17.0 p30 -108.36 15.62 23.84 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.483 -1.01 . . . . 0.0 109.041 179.393 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 149' ' ' GLU . . . . . . . . . . . . . 8.7 tt0 -112.28 144.02 42.4 Favored 'General case' 0 N--CA 1.489 1.479 0 O-C-N 121.388 -0.82 . . . . 0.0 111.444 -178.288 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 150' ' ' THR . . . . . . . . . . . . . 29.9 m -127.25 104.12 7.78 Favored 'General case' 0 N--CA 1.49 1.541 0 CA-C-O 121.373 0.606 . . . . 0.0 109.6 179.561 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 151' ' ' ARG . . . . . . . . . . . . . 15.4 mtp180 -88.17 -173.1 4.08 Favored 'General case' 0 C--N 1.301 -1.513 0 N-CA-C 107.748 -1.204 . . . . 0.0 107.748 179.357 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 152' ' ' LYS . . . . . 0.491 ' O ' ' N ' ' A' ' 205' ' ' VAL . 15.4 mtmm -149.15 150.74 33.17 Favored 'General case' 0 C--N 1.298 -1.67 0 O-C-N 120.811 -1.181 . . . . 0.0 109.728 -179.678 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 153' ' ' TYR . . . . . 0.527 ' CD2' ' HA ' ' A' ' 204' ' ' GLU . 27.6 m-85 -142.97 164.47 29.99 Favored 'General case' 0 C--N 1.297 -1.697 0 N-CA-C 107.695 -1.224 . . . . 0.0 107.695 178.69 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 154' ' ' LYS . . . . . 0.525 ' HB2' HG21 ' A' ' 205' ' ' VAL . 26.2 ttpp -140.31 118.01 11.64 Favored 'General case' 0 C--N 1.296 -1.745 0 N-CA-C 108.308 -0.997 . . . . 0.0 108.308 179.499 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 155' ' ' MET . . . . . . . . . . . . . 36.8 mtp -44.95 109.09 0.14 Allowed 'General case' 0 N--CA 1.497 1.895 0 O-C-N 120.507 -1.371 . . . . 0.0 111.344 -178.307 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 156' ' ' THR . . . . . 0.677 ' OG1' HG23 ' A' ' 203' ' ' THR . 0.2 OUTLIER -107.59 -26.79 10.72 Favored 'General case' 0 C--N 1.298 -1.645 0 CA-C-N 115.452 -0.794 . . . . 0.0 110.893 -178.858 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 157' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -154.03 153.33 31.75 Favored 'General case' 0 N--CA 1.5 2.044 0 C-N-CA 118.171 -1.411 . . . . 0.0 111.903 -178.334 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 158' ' ' ILE . . . . . 0.867 HD12 ' CD1' ' A' ' 200' ' ' PHE . 0.2 OUTLIER -154.49 146.91 13.61 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.425 0 CA-C-O 122.068 0.937 . . . . 0.0 111.383 -178.946 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 159' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -153.35 158.48 41.6 Favored 'General case' 0 C--N 1.299 -1.612 0 CA-C-O 121.707 0.765 . . . . 0.0 109.86 179.834 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 160' ' ' ASP . . . . . 0.478 ' O ' HG13 ' A' ' 161' ' ' VAL . 7.9 m-20 -116.52 156.46 26.87 Favored 'General case' 0 N--CA 1.491 1.597 0 N-CA-C 108.081 -1.081 . . . . 0.0 108.081 179.254 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 161' ' ' VAL . . . . . 0.486 ' O ' ' O ' ' A' ' 162' ' ' LYS . 14.8 m -155.35 154.25 6.93 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.921 0 O-C-N 120.841 -1.162 . . . . 0.0 111.357 -178.507 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 162' ' ' LYS . . . . . 0.486 ' O ' ' O ' ' A' ' 161' ' ' VAL . 0.0 OUTLIER -43.25 170.46 0.04 OUTLIER Pre-proline 0 N--CA 1.495 1.799 0 O-C-N 121.555 -0.716 . . . . 0.0 109.986 179.651 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 163' ' ' PRO . . . . . . . . . . . . . 65.2 Cg_endo -79.56 30.9 0.47 Allowed 'Trans proline' 0 N--CA 1.492 1.408 0 C-N-CA 122.904 2.403 . . . . 0.0 113.071 179.82 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 164' ' ' THR . . . . . 0.586 ' HA ' HD11 ' C' ' 702' ' ' LEU . 0.2 OUTLIER -151.02 0.31 0.39 Allowed 'General case' 0 N--CA 1.495 1.789 0 O-C-N 121.064 -1.022 . . . . 0.0 110.11 -179.968 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 165' ' ' ASP . . . . . 0.438 ' O ' ' C ' ' A' ' 166' ' ' VAL . 13.0 t70 -75.46 63.9 1.53 Allowed 'General case' 0 N--CA 1.489 1.491 0 O-C-N 121.251 -0.906 . . . . 0.0 110.362 -179.749 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 166' ' ' VAL . . . . . 0.685 ' O ' ' N ' ' A' ' 168' ' ' VAL . 1.0 OUTLIER -39.73 -31.12 0.15 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.517 0 O-C-N 121.14 -0.975 . . . . 0.0 109.79 -178.668 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 167' ' ' GLY . . . . . 0.428 ' N ' ' O ' ' A' ' 165' ' ' ASP . . . -41.48 -12.01 0.01 OUTLIER Glycine 0 N--CA 1.496 2.652 0 N-CA-C 110.288 -1.125 . . . . 0.0 110.288 -179.94 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 168' ' ' VAL . . . . . 0.685 ' N ' ' O ' ' A' ' 166' ' ' VAL . 3.5 t -49.03 -42.52 14.56 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.432 0 O-C-N 121.121 -1.223 . . . . 0.0 108.841 179.235 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 169' ' ' LEU . . . . . 0.551 ' O ' ' C ' ' A' ' 170' ' ' ASP . 10.8 mt -46.84 -14.71 0.03 OUTLIER 'General case' 0 N--CA 1.491 1.601 0 N-CA-C 108.444 -0.947 . . . . 0.0 108.444 -178.274 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 170' ' ' ASP . . . . . 0.555 ' N ' ' O ' ' A' ' 168' ' ' VAL . 32.7 p30 17.78 91.26 0.01 OUTLIER 'General case' 0 N--CA 1.505 2.319 0 N-CA-C 111.927 0.343 . . . . 0.0 111.927 177.206 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 171' ' ' GLU . . . . . . . . . . . . . 3.0 pt-20 -141.48 78.79 1.65 Allowed 'General case' 0 N--CA 1.494 1.733 0 O-C-N 120.732 -1.23 . . . . 0.0 110.272 179.965 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 172' ' ' GLN . . . . . . . . . . . . . 8.4 mm100 -130.13 -47.51 1.11 Allowed 'General case' 0 N--CA 1.499 2.002 0 O-C-N 121.282 -0.886 . . . . 0.0 110.967 -178.788 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 173' ' ' LYS . . . . . 0.561 ' O ' ' NE2' ' A' ' 113' ' ' GLN . 0.0 OUTLIER -60.48 137.85 58.1 Favored 'General case' 0 N--CA 1.498 1.967 0 O-C-N 120.894 -1.129 . . . . 0.0 109.064 -179.894 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 174' ' ' GLY . . . . . 0.533 ' O ' ' C ' ' A' ' 175' ' ' LYS . . . -122.93 -44.09 0.34 Allowed Glycine 0 N--CA 1.481 1.648 0 N-CA-C 108.093 -2.003 . . . . 0.0 108.093 179.547 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 175' ' ' LYS . . . . . 0.533 ' C ' ' O ' ' A' ' 174' ' ' GLY . 3.0 mmtt -40.48 -63.87 0.58 Allowed 'General case' 0 N--CA 1.491 1.59 0 N-CA-C 107.072 -1.455 . . . . 0.0 107.072 178.725 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 176' ' ' ASP . . . . . 0.589 ' O ' ' O ' ' A' ' 177' ' ' LYS . 1.2 p-10 -104.7 88.18 2.86 Favored 'General case' 0 C--N 1.299 -1.614 0 N-CA-C 108.207 -1.035 . . . . 0.0 108.207 177.428 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 177' ' ' LYS . . . . . 0.589 ' O ' ' O ' ' A' ' 176' ' ' ASP . 23.6 mttm -47.32 -174.19 0.0 OUTLIER 'General case' 0 N--CA 1.499 1.978 0 N-CA-C 108.793 -0.817 . . . . 0.0 108.793 179.936 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 178' ' ' GLN . . . . . 0.55 HE22 ' HG1' ' A' ' 180' ' ' THR . 0.0 OUTLIER -162.59 167.28 23.53 Favored 'General case' 0 C--N 1.303 -1.419 0 O-C-N 120.267 -1.521 . . . . 0.0 110.862 179.626 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 179' ' ' LEU . . . . . 0.419 ' HB2' ' CD2' ' A' ' 153' ' ' TYR . 0.9 OUTLIER -119.03 98.03 5.98 Favored 'General case' 0 C--N 1.304 -1.408 0 N-CA-C 107.028 -1.471 . . . . 0.0 107.028 177.976 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 180' ' ' THR . . . . . 0.55 ' HG1' HE22 ' A' ' 178' ' ' GLN . 1.3 m -76.98 116.13 17.38 Favored 'General case' 0 C--N 1.302 -1.488 0 O-C-N 121.411 -0.806 . . . . 0.0 110.205 -178.449 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 181' ' ' LEU . . . . . 0.525 HD23 ' CD2' ' A' ' 200' ' ' PHE . 54.4 tp -93.78 152.08 19.17 Favored 'General case' 0 C--N 1.301 -1.537 0 N-CA-C 107.774 -1.195 . . . . 0.0 107.774 177.715 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 182' ' ' ILE . . . . . . . . . . . . . 85.4 mt -141.07 117.88 7.81 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.713 0 O-C-N 121.009 -1.057 . . . . 0.0 108.687 179.247 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 183' ' ' THR . . . . . 0.604 ' O ' HG23 ' A' ' 183' ' ' THR . 10.1 t -131.12 111.44 11.98 Favored 'General case' 0 C--N 1.292 -1.908 0 N-CA-C 108.039 -1.097 . . . . 0.0 108.039 179.485 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 184' ' ' CYS . . . . . . . . . . . . . 0.8 OUTLIER -78.46 153.06 31.76 Favored 'General case' 0 C--N 1.289 -2.044 0 C-N-CA 118.882 -1.127 . . . . 0.0 110.583 -177.977 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 185' ' ' ASP . . . . . . . . . . . . . 2.5 t0 -166.1 -159.13 0.37 Allowed 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.616 -0.677 . . . . 0.0 109.504 -179.447 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 186' ' ' ASP . . . . . . . . . . . . . 1.2 m-20 55.79 52.78 10.28 Favored 'General case' 0 N--CA 1.493 1.717 0 O-C-N 121.233 -0.917 . . . . 0.0 109.453 179.977 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 187' ' ' TYR . . . . . 0.628 ' CE2' ' O ' ' A' ' 188' ' ' ASN . 64.5 t80 -67.96 134.18 50.32 Favored 'General case' 0 C--N 1.3 -1.551 0 O-C-N 121.063 -1.023 . . . . 0.0 110.949 -179.508 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 188' ' ' ASN . . . . . 0.628 ' O ' ' CE2' ' A' ' 187' ' ' TYR . 0.7 OUTLIER -101.46 146.46 27.59 Favored 'General case' 0 C--N 1.295 -1.766 0 N-CA-C 108.091 -1.077 . . . . 0.0 108.091 178.201 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 189' ' ' GLU . . . . . . . . . . . . . 3.1 tt0 -109.65 -12.17 14.68 Favored 'General case' 0 C--N 1.292 -1.923 0 N-CA-C 108.458 -0.942 . . . . 0.0 108.458 -179.793 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 190' ' ' LYS . . . . . . . . . . . . . 11.7 mtpt -85.75 -55.03 4.17 Favored 'General case' 0 C--N 1.302 -1.469 0 N-CA-C 109.079 -0.712 . . . . 0.0 109.079 178.908 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 191' ' ' THR . . . . . . . . . . . . . 1.2 p -89.55 1.59 55.74 Favored 'General case' 0 N--CA 1.494 1.729 0 O-C-N 121.236 -0.915 . . . . 0.0 110.073 -179.754 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 192' ' ' GLY . . . . . . . . . . . . . . . 52.78 40.89 57.27 Favored Glycine 0 N--CA 1.496 2.644 0 O-C-N 120.97 -1.081 . . . . 0.0 110.969 179.169 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 193' ' ' VAL . . . . . 0.537 HG12 ' N ' ' A' ' 194' ' ' TRP . 52.9 t -149.65 160.5 5.01 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.653 0 O-C-N 120.858 -1.377 . . . . 0.0 109.356 178.999 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 194' ' ' TRP . . . . . 0.537 ' N ' HG12 ' A' ' 193' ' ' VAL . 12.7 m95 -82.94 118.98 23.86 Favored 'General case' 0 N--CA 1.491 1.586 0 N-CA-C 107.989 -1.115 . . . . 0.0 107.989 179.308 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 195' ' ' GLU . . . . . . . . . . . . . 2.1 mt-10 -75.88 -60.46 2.31 Favored 'General case' 0 N--CA 1.494 1.769 0 O-C-N 121.336 -0.853 . . . . 0.0 111.538 -177.745 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 196' ' ' LYS . . . . . . . . . . . . . 16.8 mmtp -92.01 153.18 19.6 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 120.901 -1.124 . . . . 0.0 111.262 -178.047 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 197' ' ' ARG . . . . . 0.47 ' NE ' HD22 ' C' ' 702' ' ' LEU . 21.5 mmm180 -119.17 138.97 52.58 Favored 'General case' 0 N--CA 1.488 1.471 0 N-CA-C 107.825 -1.176 . . . . 0.0 107.825 178.659 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 198' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -116.77 116.68 27.95 Favored 'General case' 0 C--N 1.301 -1.519 0 O-C-N 121.61 -0.681 . . . . 0.0 110.192 -178.715 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 199' ' ' ILE . . . . . 0.632 ' C ' HD12 ' A' ' 199' ' ' ILE . 0.6 OUTLIER -141.18 122.26 13.4 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.685 0 CA-C-O 122.338 1.066 . . . . 0.0 109.842 179.456 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 200' ' ' PHE . . . . . 0.867 ' CD1' HD12 ' A' ' 158' ' ' ILE . 0.2 OUTLIER -106.33 142.1 36.56 Favored 'General case' 0 N--CA 1.494 1.769 0 O-C-N 121.438 -0.789 . . . . 0.0 110.318 -178.55 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 201' ' ' VAL . . . . . . . . . . . . . 47.6 t -104.45 150.11 7.66 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.532 0 N-CA-C 108.476 -0.935 . . . . 0.0 108.476 178.555 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 202' ' ' ALA . . . . . . . . . . . . . . . -131.37 139.38 49.47 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.246 -0.909 . . . . 0.0 109.035 -179.802 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 203' ' ' THR . . . . . 0.677 HG23 ' OG1' ' A' ' 156' ' ' THR . 25.1 p -88.86 127.46 35.63 Favored 'General case' 0 C--N 1.303 -1.452 0 CA-C-O 122.354 1.073 . . . . 0.0 110.917 -178.57 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 204' ' ' GLU . . . . . 0.527 ' HA ' ' CD2' ' A' ' 153' ' ' TYR . 1.7 tt0 -48.75 134.35 16.34 Favored 'General case' 0 C--N 1.297 -1.713 0 C-N-CA 118.873 -1.131 . . . . 0.0 109.248 179.83 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 205' ' ' VAL . . . . . 0.603 HG23 ' O ' ' A' ' 203' ' ' THR . 72.7 t -126.54 163.6 28.44 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.361 0 CA-C-O 122.141 0.972 . . . . 0.0 110.039 -177.674 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 206' ' ' LYS . . . . . 0.558 ' N ' HG12 ' A' ' 205' ' ' VAL . 0.2 OUTLIER . . . . . 0 C--N 1.291 -1.949 0 CA-C-O 118.024 -0.989 . . . . 0.0 109.45 -179.981 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' C' C ' 701' ' ' PHQ . . . . . 0.568 ' O2 ' HG12 ' A' ' 166' ' ' VAL . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 017 nuclear build full ' C' C ' 702' ' ' LEU . . . . . 0.852 ' N ' HD12 ' C' ' 702' ' ' LEU . 0.0 OUTLIER . . . . . 0 N--CA 1.489 1.511 0 N-CA-C 109.303 -0.628 . . . . 0.0 109.303 . . . . . . . . . 2 2 . 1 . 017 nuclear build full ' C' C ' 703' ' ' PRO . . . . . 0.551 ' HB2' ' HB3' ' A' ' 92' ' ' ALA . 96.9 Cg_endo -79.79 -174.44 2.27 Favored 'Trans proline' 0 N--CA 1.495 1.612 0 C-N-CA 122.94 2.427 . . . . 0.0 113.524 -179.418 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' C' C ' 704' ' ' ALA . . . . . 0.495 ' O ' ' O ' ' C' ' 703' ' ' PRO . . . 39.4 -165.39 0.0 OUTLIER 'General case' 0 N--CA 1.491 1.579 0 CA-C-O 121.744 0.783 . . . . 0.0 110.544 179.076 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' C' C ' 705' ' ' B27 . . . . . 0.521 ' SG ' ' ND1' ' A' ' 120' ' ' HIS . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 700' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 018 nuclear build full ' A' A ' 59' ' ' MET . . . . . . . . . . . . . 8.9 mmt . . . . . 0 N--CA 1.49 1.529 0 N-CA-C 109.406 -0.59 . . . . 0.0 109.406 . . . . . . . . . 0 0 . 1 . 018 nuclear build full ' A' A ' 60' ' ' GLN . . . . . 0.558 ' CD ' ' H ' ' A' ' 61' ' ' ALA . 0.0 OUTLIER -61.34 160.19 11.18 Favored 'General case' 0 N--CA 1.493 1.693 0 O-C-N 121.367 -0.833 . . . . 0.0 109.644 179.92 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 61' ' ' ALA . . . . . 0.558 ' H ' ' CD ' ' A' ' 60' ' ' GLN . . . -65.18 169.61 5.41 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.057 -1.027 . . . . 0.0 109.143 179.522 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 62' ' ' LYS . . . . . . . . . . . . . 64.9 tttt -147.24 86.1 6.59 Favored Pre-proline 0 C--N 1.303 -1.417 0 O-C-N 121.184 -0.947 . . . . 0.0 109.535 -179.677 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 63' ' ' PRO . . . . . 0.629 ' O ' HD13 ' A' ' 110' ' ' LEU . 5.3 Cg_exo -71.95 130.1 16.23 Favored 'Trans proline' 0 C--N 1.307 -1.626 0 C-N-CA 122.483 2.122 . . . . 0.0 112.269 -179.891 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 64' ' ' GLN . . . . . 0.518 ' N ' ' OE1' ' A' ' 64' ' ' GLN . 0.0 OUTLIER -150.34 101.75 3.0 Favored 'General case' 0 N--CA 1.494 1.732 0 O-C-N 121.205 -0.935 . . . . 0.0 109.618 -179.891 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 65' ' ' ILE . . . . . 0.471 ' C ' ' O ' ' A' ' 64' ' ' GLN . 2.8 mp -39.79 100.83 0.22 Allowed Pre-proline 0 N--CA 1.491 1.603 0 N-CA-C 108.557 -0.905 . . . . 0.0 108.557 179.523 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 66' ' ' PRO . . . . . 0.423 ' N ' ' O ' ' A' ' 64' ' ' GLN . 71.8 Cg_endo -83.87 -155.32 0.06 OUTLIER 'Trans proline' 0 C--N 1.317 -1.118 0 C-N-CA 122.286 1.991 . . . . 0.0 112.679 -178.311 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 67' ' ' LYS . . . . . 0.404 ' O ' ' N ' ' A' ' 69' ' ' LYS . 8.5 ptmt -83.93 -4.94 59.08 Favored 'General case' 0 C--N 1.304 -1.371 0 O-C-N 121.391 -0.818 . . . . 0.0 109.388 -179.825 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 68' ' ' ASP . . . . . 0.588 ' C ' ' N ' ' A' ' 70' ' ' SER . 0.1 OUTLIER -73.82 51.47 0.38 Allowed 'General case' 0 N--CA 1.491 1.58 0 CA-C-O 122.566 1.174 . . . . 0.0 108.326 179.52 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 69' ' ' LYS . . . . . 0.598 ' O ' ' NH1' ' A' ' 99' ' ' ARG . 12.0 mtmm -49.49 -16.11 0.19 Allowed 'General case' 0 N--CA 1.497 1.888 0 C-N-CA 116.949 -1.9 . . . . 0.0 107.152 178.857 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 70' ' ' SER . . . . . 0.588 ' N ' ' C ' ' A' ' 68' ' ' ASP . 1.2 t -83.94 -7.16 59.49 Favored 'General case' 0 C--N 1.293 -1.89 0 CA-C-N 113.995 -1.457 . . . . 0.0 110.22 179.976 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 71' ' ' LYS . . . . . 0.413 ' CD ' ' HB2' ' A' ' 68' ' ' ASP . 1.0 OUTLIER -96.84 141.41 30.07 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.126 -0.984 . . . . 0.0 110.826 179.825 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 72' ' ' VAL . . . . . 0.825 HG12 ' CE1' ' A' ' 88' ' ' TYR . 2.3 m -65.01 139.62 21.1 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.522 0 N-CA-C 103.988 -2.597 . . . . 0.0 103.988 174.361 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 73' ' ' ALA . . . . . 0.511 ' N ' ' O ' ' A' ' 87' ' ' VAL . . . -81.21 -14.18 57.8 Favored 'General case' 0 C--N 1.292 -1.917 0 C-N-CA 117.11 -1.836 . . . . 0.0 106.203 179.799 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . 169.07 -152.04 19.12 Favored Glycine 0 N--CA 1.481 1.677 0 N-CA-C 109.873 -1.291 . . . . 0.0 109.873 178.868 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 75' ' ' TYR . . . . . 0.468 ' CD2' ' O ' ' A' ' 85' ' ' GLU . 2.3 m-85 -142.59 173.25 11.7 Favored 'General case' 0 C--N 1.298 -1.639 0 CA-C-O 122.085 0.945 . . . . 0.0 110.545 -178.118 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 76' ' ' ILE . . . . . . . . . . . . . 1.6 tp -147.9 141.88 19.3 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.682 0 C-N-CA 119.93 -0.708 . . . . 0.0 109.142 -176.954 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 77' ' ' GLU . . . . . 0.563 ' N ' ' OE1' ' A' ' 77' ' ' GLU . 0.0 OUTLIER -149.96 163.07 39.08 Favored 'General case' 0 C--N 1.304 -1.39 0 O-C-N 121.014 -1.054 . . . . 0.0 109.244 178.913 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 78' ' ' ILE . . . . . 0.694 ' HB ' ' HB3' ' A' ' 81' ' ' ALA . 7.9 mt -144.35 100.57 4.82 Favored Pre-proline 0 C--N 1.302 -1.496 0 O-C-N 121.338 -0.851 . . . . 0.0 109.022 179.991 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 79' ' ' PRO . . . . . . . . . . . . . 81.9 Cg_exo -48.25 -50.55 11.84 Favored 'Trans proline' 0 N--CA 1.493 1.469 0 C-N-CA 122.794 2.329 . . . . 0.0 113.632 -179.453 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -65.94 -18.93 65.67 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 120.889 -1.132 . . . . 0.0 111.098 178.906 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 81' ' ' ALA . . . . . 0.813 ' HB2' ' HB2' ' A' ' 136' ' ' ALA . . . -105.32 -16.93 14.62 Favored 'General case' 0 N--CA 1.494 1.734 0 O-C-N 121.069 -1.019 . . . . 0.0 108.81 179.521 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 82' ' ' ASP . . . . . 0.495 ' N ' ' O ' ' A' ' 78' ' ' ILE . 9.1 t0 65.81 50.47 1.54 Allowed 'General case' 0 N--CA 1.493 1.704 0 O-C-N 121.372 -0.83 . . . . 0.0 111.368 178.157 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 83' ' ' ILE . . . . . . . . . . . . . 45.2 mt -130.66 153.94 39.86 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.92 0 O-C-N 121.14 -0.975 . . . . 0.0 109.668 -179.273 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 84' ' ' LYS . . . . . . . . . . . . . 30.8 ttmt -158.01 110.25 2.33 Favored 'General case' 0 N--CA 1.497 1.88 0 N-CA-C 108.184 -1.043 . . . . 0.0 108.184 179.991 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 85' ' ' GLU . . . . . 0.497 ' OE1' ' O ' ' A' ' 129' ' ' GLN . 0.0 OUTLIER -141.33 167.2 17.92 Favored Pre-proline 0 N--CA 1.499 1.976 0 O-C-N 121.281 -0.887 . . . . 0.0 110.871 -178.45 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 86' ' ' PRO . . . . . 0.485 ' O ' HG22 ' A' ' 101' ' ' VAL . 55.8 Cg_endo -74.75 161.92 38.53 Favored 'Trans proline' 0 N--CA 1.497 1.722 0 C-N-CA 123.263 2.642 . . . . 0.0 113.108 -179.869 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 87' ' ' VAL . . . . . 0.511 ' O ' ' N ' ' A' ' 73' ' ' ALA . 55.7 t -123.32 99.79 7.09 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.844 0 O-C-N 121.686 -0.634 . . . . 0.0 109.337 179.582 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 88' ' ' TYR . . . . . 0.825 ' CE1' HG12 ' A' ' 72' ' ' VAL . 15.3 m-85 -89.99 155.1 47.56 Favored Pre-proline 0 N--CA 1.496 1.849 0 O-C-N 120.835 -1.166 . . . . 0.0 109.423 179.861 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 89' ' ' PRO . . . . . . . . . . . . . 11.8 Cg_endo -64.39 146.66 90.12 Favored 'Trans proline' 0 N--CA 1.496 1.642 0 C-N-CA 122.529 2.152 . . . . 0.0 113.952 -179.343 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . -59.04 167.59 7.06 Favored Glycine 0 N--CA 1.495 2.609 0 N-CA-C 110.382 -1.087 . . . . 0.0 110.382 179.663 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 91' ' ' PRO . . . . . 0.428 ' C ' ' H ' ' A' ' 93' ' ' THR . 90.2 Cg_endo -93.48 168.68 20.81 Favored 'Cis proline' 0 C--N 1.314 -1.237 0 C-N-CA 123.592 -1.42 . . . . 0.0 111.762 0.569 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 92' ' ' ALA . . . . . 0.543 ' HB1' HD21 ' A' ' 97' ' ' LEU . . . -72.03 33.04 0.06 Allowed 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.032 -1.042 . . . . 0.0 110.713 -179.9 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 93' ' ' THR . . . . . 0.428 ' H ' ' C ' ' A' ' 91' ' ' PRO . 3.3 p -71.18 150.39 94.54 Favored Pre-proline 0 N--CA 1.488 1.472 0 O-C-N 120.668 -1.27 . . . . 0.0 108.157 -179.865 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 94' ' ' PRO . . . . . 0.421 ' C ' ' O ' ' A' ' 93' ' ' THR . 87.3 Cg_exo -30.35 -56.26 0.19 Allowed 'Trans proline' 0 C--N 1.308 -1.6 0 C-N-CA 123.007 2.471 . . . . 0.0 112.672 -179.011 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 98.6 mt-10 -51.06 -46.32 61.67 Favored 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.12 -0.988 . . . . 0.0 109.825 -179.76 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 96' ' ' GLN . . . . . 0.422 ' OE1' ' CZ ' ' A' ' 99' ' ' ARG . 1.1 mp0 -71.92 -36.95 70.1 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.387 -0.821 . . . . 0.0 110.712 -179.375 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 97' ' ' LEU . . . . . 0.543 HD21 ' HB1' ' A' ' 92' ' ' ALA . 89.0 mt -68.4 -5.94 21.85 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 120.833 -1.167 . . . . 0.0 109.248 -179.682 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 98' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER -78.24 -27.05 47.53 Favored 'General case' 0 N--CA 1.492 1.673 0 O-C-N 121.319 -0.863 . . . . 0.0 109.893 179.42 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 99' ' ' ARG . . . . . 0.598 ' NH1' ' O ' ' A' ' 69' ' ' LYS . 63.8 mtt180 -91.07 -43.5 9.88 Favored 'General case' 0 N--CA 1.488 1.47 0 O-C-N 121.531 -0.731 . . . . 0.0 109.956 -178.524 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . 169.81 -171.7 43.43 Favored Glycine 0 N--CA 1.49 2.28 0 N-CA-C 109.898 -1.281 . . . . 0.0 109.898 -179.992 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 101' ' ' VAL . . . . . 0.742 HG23 ' O ' ' A' ' 101' ' ' VAL . 13.0 m -57.48 106.63 0.18 Allowed 'Isoleucine or valine' 0 N--CA 1.494 1.758 0 O-C-N 121.401 -1.058 . . . . 0.0 109.152 -179.915 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -92.52 163.31 13.86 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 120.87 -1.144 . . . . 0.0 111.184 -179.176 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 103' ' ' PHE . . . . . 0.484 ' CZ ' ' CG1' ' A' ' 87' ' ' VAL . 25.0 m-85 -70.46 141.85 52.0 Favored 'General case' 0 N--CA 1.489 1.501 0 N-CA-C 108.145 -1.057 . . . . 0.0 108.145 178.334 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 104' ' ' ALA . . . . . . . . . . . . . . . -58.73 -15.86 14.0 Favored 'General case' 0 C--N 1.3 -1.548 0 O-C-N 121.474 -0.766 . . . . 0.0 111.104 -178.828 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -139.07 144.24 38.68 Favored 'General case' 0 N--CA 1.492 1.65 0 O-C-N 120.906 -1.121 . . . . 0.0 110.082 -179.304 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 106' ' ' GLU . . . . . . . . . . . . . 6.3 tt0 -58.1 -55.43 35.04 Favored 'General case' 0 C--N 1.299 -1.618 0 O-C-N 121.892 -0.505 . . . . 0.0 110.599 -179.363 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 107' ' ' ASN . . . . . . . . . . . . . 6.1 m-20 -77.85 35.15 0.2 Allowed 'General case' 0 N--CA 1.487 1.395 0 O-C-N 120.622 -1.299 . . . . 0.0 112.223 -176.152 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 108' ' ' GLU . . . . . . . . . . . . . 21.7 tp10 -57.81 139.82 53.15 Favored 'General case' 0 N--CA 1.488 1.457 0 N-CA-C 107.605 -1.257 . . . . 0.0 107.605 179.635 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 109' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -93.08 146.53 23.57 Favored 'General case' 0 C--N 1.302 -1.486 0 O-C-N 120.97 -1.081 . . . . 0.0 110.776 -178.08 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 110' ' ' LEU . . . . . 0.828 HD23 ' H ' ' A' ' 110' ' ' LEU . 0.3 OUTLIER -62.66 -24.5 67.65 Favored 'General case' 0 C--N 1.303 -1.424 0 N-CA-C 107.281 -1.377 . . . . 0.0 107.281 178.641 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 111' ' ' ASP . . . . . . . . . . . . . 4.0 m-20 -133.03 48.95 2.35 Favored 'General case' 0 N--CA 1.485 1.298 0 N-CA-C 109.396 -0.594 . . . . 0.0 109.396 179.663 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 112' ' ' ASP . . . . . . . . . . . . . 1.7 t0 -69.33 159.47 33.06 Favored 'General case' 0 N--CA 1.494 1.731 0 O-C-N 121.127 -0.983 . . . . 0.0 111.333 -179.608 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 113' ' ' GLN . . . . . 0.547 ' N ' ' CD ' ' A' ' 113' ' ' GLN . 0.0 OUTLIER -64.63 -17.98 64.52 Favored 'General case' 0 N--CA 1.491 1.607 0 N-CA-C 107.361 -1.348 . . . . 0.0 107.361 177.668 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 114' ' ' ASN . . . . . 0.532 ' ND2' ' OE1' ' A' ' 178' ' ' GLN . 59.9 t-20 -153.55 111.81 3.62 Favored 'General case' 0 C--N 1.298 -1.662 0 N-CA-C 107.803 -1.184 . . . . 0.0 107.803 177.631 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 115' ' ' ILE . . . . . 0.505 HG22 ' O ' ' A' ' 115' ' ' ILE . 2.8 mt -93.6 102.8 14.01 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.557 0 O-C-N 120.988 -1.07 . . . . 0.0 108.128 -179.935 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 116' ' ' SER . . . . . . . . . . . . . 72.3 m -81.76 141.31 33.64 Favored 'General case' 0 N--CA 1.488 1.453 0 CA-C-O 122.088 0.947 . . . . 0.0 112.114 -177.001 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 117' ' ' ILE . . . . . . . . . . . . . 28.2 mt -138.05 140.85 39.78 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.474 0 N-CA-C 107.357 -1.349 . . . . 0.0 107.357 178.609 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 118' ' ' ALA . . . . . . . . . . . . . . . -141.98 155.58 45.45 Favored 'General case' 0 N--CA 1.489 1.492 0 C-N-CA 118.63 -1.228 . . . . 0.0 111.043 -178.967 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 119' ' ' GLY . . . . . . . . . . . . . . . -166.8 152.55 21.55 Favored Glycine 0 N--CA 1.483 1.813 0 N-CA-C 109.967 -1.253 . . . . 0.0 109.967 179.769 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 120' ' ' HIS . . . . . 0.575 ' CD2' ' SG ' ' C' ' 705' ' ' B27 . 26.4 m170 -71.73 142.1 49.78 Favored 'General case' 0 N--CA 1.493 1.71 0 O-C-N 121.604 -0.939 . . . . 0.0 110.592 179.864 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 121' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -99.06 153.36 18.94 Favored 'General case' 0 N--CA 1.496 1.835 0 N-CA-C 107.896 -1.15 . . . . 0.0 107.896 178.419 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 122' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -116.85 140.69 49.15 Favored 'General case' 0 N--CA 1.496 1.869 0 O-C-N 121.139 -0.976 . . . . 0.0 110.603 -179.676 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 123' ' ' ILE . . . . . 0.505 HG23 ' N ' ' A' ' 124' ' ' ASP . 15.7 tt -90.28 -33.13 5.76 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.641 0 CA-C-O 121.876 0.846 . . . . 0.0 109.083 179.619 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 124' ' ' ASP . . . . . 0.505 ' N ' HG23 ' A' ' 123' ' ' ILE . 80.0 m-20 -89.78 3.08 53.95 Favored 'General case' 0 N--CA 1.497 1.888 0 CA-C-N 116.069 -0.514 . . . . 0.0 111.772 -178.706 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 125' ' ' ARG . . . . . 0.665 HH11 ' CG ' ' A' ' 125' ' ' ARG . 1.7 mtt-85 -151.3 120.7 3.53 Favored Pre-proline 0 N--CA 1.499 1.995 0 O-C-N 120.383 -1.448 . . . . 0.0 110.114 -179.193 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 126' ' ' PRO . . . . . . . . . . . . . 88.9 Cg_endo -81.48 -18.99 7.95 Favored 'Trans proline' 0 N--CA 1.489 1.257 0 C-N-CA 122.279 1.986 . . . . 0.0 112.396 179.199 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 127' ' ' ASN . . . . . 0.514 ' O ' ' O ' ' A' ' 128' ' ' TYR . 56.9 m-20 -92.65 4.35 53.84 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.274 -0.891 . . . . 0.0 110.109 -179.759 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 128' ' ' TYR . . . . . 0.514 ' O ' ' O ' ' A' ' 127' ' ' ASN . 9.1 t80 -58.7 -147.25 0.0 OUTLIER 'General case' 0 N--CA 1.488 1.447 0 O-C-N 121.283 -0.886 . . . . 0.0 109.337 179.995 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 129' ' ' GLN . . . . . 0.497 ' O ' ' OE1' ' A' ' 85' ' ' GLU . 12.7 mt-30 -64.96 -91.23 0.01 OUTLIER 'General case' 0 N--CA 1.493 1.724 0 O-C-N 120.833 -1.167 . . . . 0.0 110.284 -178.941 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 130' ' ' PHE . . . . . 0.711 ' CE2' HG11 ' A' ' 101' ' ' VAL . 44.2 m-85 -114.28 48.0 1.15 Allowed 'General case' 0 N--CA 1.496 1.835 0 O-C-N 121.159 -0.963 . . . . 0.0 109.355 179.851 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 131' ' ' THR . . . . . 0.526 ' O ' ' CD ' ' A' ' 134' ' ' LYS . 56.9 m -77.83 -26.54 49.51 Favored 'General case' 0 C--N 1.3 -1.558 0 O-C-N 121.213 -0.93 . . . . 0.0 109.563 -179.998 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 132' ' ' ASN . . . . . . . . . . . . . 28.8 t-20 -90.23 13.36 15.46 Favored 'General case' 0 N--CA 1.5 2.042 0 C-N-CA 119.759 -0.776 . . . . 0.0 111.932 -178.855 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 133' ' ' LEU . . . . . 0.993 HD13 ' HB3' ' A' ' 136' ' ' ALA . 0.2 OUTLIER -67.97 -29.81 68.94 Favored 'General case' 0 N--CA 1.495 1.779 0 O-C-N 120.399 -1.438 . . . . 0.0 109.594 -179.749 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 134' ' ' LYS . . . . . 0.746 ' H ' ' CD ' ' A' ' 134' ' ' LYS . 0.0 OUTLIER -44.09 -29.96 0.69 Allowed 'General case' 0 N--CA 1.496 1.862 0 O-C-N 121.43 -0.794 . . . . 0.0 110.455 -179.432 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 135' ' ' ALA . . . . . . . . . . . . . . . -84.76 -21.39 30.03 Favored 'General case' 0 N--CA 1.488 1.466 0 O-C-N 121.045 -1.034 . . . . 0.0 109.937 -179.621 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 136' ' ' ALA . . . . . 0.993 ' HB3' HD13 ' A' ' 133' ' ' LEU . . . -81.74 137.69 35.31 Favored 'General case' 0 C--N 1.301 -1.526 0 CA-C-O 122.039 0.924 . . . . 0.0 111.957 -178.336 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 137' ' ' LYS . . . . . 0.512 ' O ' ' OG ' ' A' ' 140' ' ' SER . 3.9 tttt -156.59 -166.0 2.02 Favored 'General case' 0 C--N 1.299 -1.604 0 C-N-CA 118.824 -1.15 . . . . 0.0 110.857 -179.349 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 138' ' ' LYS . . . . . 0.622 ' O ' ' N ' ' A' ' 140' ' ' SER . 29.0 mttt -46.61 -178.36 0.0 OUTLIER 'General case' 0 C--N 1.3 -1.549 0 CA-C-O 121.873 0.844 . . . . 0.0 110.107 -179.916 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 139' ' ' GLY . . . . . . . . . . . . . . . 44.95 8.41 0.01 OUTLIER Glycine 0 N--CA 1.489 2.198 0 N-CA-C 110.641 -0.984 . . . . 0.0 110.641 179.56 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 140' ' ' SER . . . . . 0.622 ' N ' ' O ' ' A' ' 138' ' ' LYS . 45.8 m -94.55 128.49 41.2 Favored 'General case' 0 N--CA 1.489 1.503 0 O-C-N 120.723 -1.457 . . . . 0.0 109.247 179.47 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 141' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -81.66 127.54 33.01 Favored 'General case' 0 C--N 1.3 -1.545 0 O-C-N 121.288 -0.883 . . . . 0.0 108.792 179.809 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 142' ' ' VAL . . . . . 0.481 HG22 HG23 ' A' ' 78' ' ' ILE . 12.8 t -113.72 135.13 54.33 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.553 0 N-CA-C 108.788 -0.819 . . . . 0.0 108.788 -179.529 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 143' ' ' TYR . . . . . 0.539 ' CE1' ' CG ' ' A' ' 152' ' ' LYS . 9.5 m-85 -111.36 136.13 50.93 Favored 'General case' 0 N--CA 1.493 1.7 0 O-C-N 121.012 -1.055 . . . . 0.0 110.316 -178.886 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 144' ' ' PHE . . . . . 0.528 ' O ' HG23 ' A' ' 150' ' ' THR . 44.6 t80 -113.37 160.1 18.75 Favored 'General case' 0 N--CA 1.493 1.696 0 CA-C-O 122.072 0.939 . . . . 0.0 110.806 -178.263 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 145' ' ' LYS . . . . . 0.463 ' N ' ' CG ' ' A' ' 144' ' ' PHE . 36.7 tttm -148.13 125.23 11.41 Favored 'General case' 0 C--N 1.301 -1.525 0 C-N-CA 119.25 -0.98 . . . . 0.0 110.761 -178.546 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 146' ' ' VAL . . . . . . . . . . . . . 11.8 p -145.82 138.94 20.95 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.63 0 N-CA-C 106.827 -1.545 . . . . 0.0 106.827 178.625 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 147' ' ' GLY . . . . . . . . . . . . . . . 58.67 -141.23 46.7 Favored Glycine 0 N--CA 1.486 1.985 0 N-CA-C 108.359 -1.896 . . . . 0.0 108.359 -179.273 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 148' ' ' ASN . . . . . 0.552 ' C ' HD22 ' A' ' 148' ' ' ASN . 0.4 OUTLIER -101.79 24.75 9.44 Favored 'General case' 0 C--N 1.296 -1.741 0 N-CA-C 107.821 -1.177 . . . . 0.0 107.821 178.821 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 149' ' ' GLU . . . . . . . . . . . . . 2.0 tm-20 -116.52 159.24 22.37 Favored 'General case' 0 N--CA 1.49 1.54 0 CA-C-O 121.796 0.808 . . . . 0.0 110.727 -179.086 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 150' ' ' THR . . . . . 0.528 HG23 ' O ' ' A' ' 144' ' ' PHE . 11.1 m -140.15 109.44 6.17 Favored 'General case' 0 N--CA 1.492 1.666 0 N-CA-C 109.029 -0.73 . . . . 0.0 109.029 179.212 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 151' ' ' ARG . . . . . . . . . . . . . 9.8 mtt180 -89.16 -161.01 0.72 Allowed 'General case' 0 N--CA 1.489 1.495 0 CA-C-O 121.546 0.688 . . . . 0.0 110.433 -178.586 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 152' ' ' LYS . . . . . 0.539 ' CG ' ' CE1' ' A' ' 143' ' ' TYR . 9.3 mtmt -148.26 148.78 30.85 Favored 'General case' 0 N--CA 1.486 1.359 0 O-C-N 121.394 -0.816 . . . . 0.0 110.326 -179.187 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 153' ' ' TYR . . . . . 0.449 ' HB3' ' HB1' ' A' ' 202' ' ' ALA . 52.8 m-85 -146.31 158.66 43.91 Favored 'General case' 0 C--N 1.303 -1.433 0 N-CA-C 108.111 -1.07 . . . . 0.0 108.111 179.277 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 154' ' ' LYS . . . . . . . . . . . . . 15.1 ttmm -137.1 121.5 18.21 Favored 'General case' 0 N--CA 1.495 1.824 0 O-C-N 121.186 -0.946 . . . . 0.0 108.538 179.053 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 155' ' ' MET . . . . . 0.467 ' HB3' HD11 ' A' ' 158' ' ' ILE . 5.7 mtt -47.96 107.79 0.14 Allowed 'General case' 0 N--CA 1.493 1.685 0 O-C-N 120.913 -1.117 . . . . 0.0 111.193 -178.588 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 156' ' ' THR . . . . . 0.679 ' OG1' HG23 ' A' ' 203' ' ' THR . 0.3 OUTLIER -108.02 -25.51 11.12 Favored 'General case' 0 C--N 1.293 -1.872 0 CA-C-N 115.3 -0.864 . . . . 0.0 109.635 -179.342 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 157' ' ' SER . . . . . 0.702 ' C ' HD12 ' A' ' 158' ' ' ILE . 60.7 m -149.87 146.3 27.03 Favored 'General case' 0 C--N 1.299 -1.626 0 C-N-CA 118.61 -1.236 . . . . 0.0 110.455 -179.048 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 158' ' ' ILE . . . . . 0.702 HD12 ' C ' ' A' ' 157' ' ' SER . 3.8 mp -151.48 141.73 15.71 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.445 0 CA-C-O 121.925 0.869 . . . . 0.0 109.988 -179.274 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 159' ' ' ARG . . . . . 0.496 HH21 HG13 ' A' ' 161' ' ' VAL . 3.0 ttp180 -155.09 -171.98 4.02 Favored 'General case' 0 C--N 1.292 -1.897 0 C-N-CA 119.67 -0.812 . . . . 0.0 110.394 -179.601 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 160' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -145.67 161.17 40.48 Favored 'General case' 0 C--N 1.301 -1.539 0 N-CA-C 108.0 -1.111 . . . . 0.0 108.0 -179.725 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 161' ' ' VAL . . . . . 0.496 HG13 HH21 ' A' ' 159' ' ' ARG . 0.0 OUTLIER -154.4 155.62 5.89 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.645 0 O-C-N 120.755 -1.216 . . . . 0.0 110.835 -179.091 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 162' ' ' LYS . . . . . 0.489 ' O ' ' O ' ' A' ' 161' ' ' VAL . 0.2 OUTLIER -51.47 179.47 0.04 OUTLIER Pre-proline 0 C--N 1.305 -1.33 0 N-CA-C 107.153 -1.425 . . . . 0.0 107.153 178.064 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 163' ' ' PRO . . . . . 0.453 ' C ' HD11 ' C' ' 702' ' ' LEU . 29.5 Cg_endo -87.69 45.79 1.2 Allowed 'Trans proline' 0 C--N 1.307 -1.631 0 C-N-CA 122.103 1.869 . . . . 0.0 111.748 -179.548 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 164' ' ' THR . . . . . . . . . . . . . 7.5 m -153.28 -16.41 0.15 Allowed 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.268 -0.895 . . . . 0.0 110.671 -179.626 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 165' ' ' ASP . . . . . 0.489 ' O ' ' N ' ' A' ' 167' ' ' GLY . 0.4 OUTLIER -72.36 58.94 0.41 Allowed 'General case' 0 N--CA 1.493 1.699 0 O-C-N 120.791 -1.193 . . . . 0.0 110.397 -179.063 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 166' ' ' VAL . . . . . 0.59 ' O ' ' N ' ' A' ' 168' ' ' VAL . 1.0 OUTLIER -40.64 -27.22 0.09 OUTLIER 'Isoleucine or valine' 0 N--CA 1.489 1.515 0 O-C-N 121.297 -0.877 . . . . 0.0 109.129 -178.797 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 167' ' ' GLY . . . . . 0.489 ' N ' ' O ' ' A' ' 165' ' ' ASP . . . -46.48 -4.64 0.01 OUTLIER Glycine 0 N--CA 1.496 2.658 0 O-C-N 120.799 -1.188 . . . . 0.0 112.006 -179.768 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 168' ' ' VAL . . . . . 0.59 ' N ' ' O ' ' A' ' 166' ' ' VAL . 0.2 OUTLIER -51.76 -36.33 18.82 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.894 0 O-C-N 120.131 -1.805 . . . . 0.0 108.69 179.866 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 169' ' ' LEU . . . . . 0.536 ' O ' ' C ' ' A' ' 170' ' ' ASP . 5.3 mt -52.69 -6.17 0.05 OUTLIER 'General case' 0 N--CA 1.492 1.653 0 N-CA-C 108.7 -0.852 . . . . 0.0 108.7 -177.469 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 170' ' ' ASP . . . . . 0.569 ' H ' ' C ' ' A' ' 168' ' ' VAL . 47.6 t0 18.22 58.87 0.01 OUTLIER 'General case' 0 N--CA 1.496 1.868 0 N-CA-C 112.419 0.525 . . . . 0.0 112.419 176.999 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 171' ' ' GLU . . . . . . . . . . . . . 11.4 pt-20 -94.87 62.13 2.62 Favored 'General case' 0 N--CA 1.499 2.017 0 O-C-N 120.34 -1.475 . . . . 0.0 109.896 179.924 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 172' ' ' GLN . . . . . . . . . . . . . 4.1 mt-30 -114.88 -63.63 1.43 Allowed 'General case' 0 N--CA 1.496 1.837 0 O-C-N 121.563 -0.71 . . . . 0.0 110.525 -178.711 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 173' ' ' LYS . . . . . 0.52 ' HD2' HE21 ' A' ' 178' ' ' GLN . 0.0 OUTLIER -60.18 127.58 32.54 Favored 'General case' 0 N--CA 1.496 1.831 0 O-C-N 121.216 -0.928 . . . . 0.0 109.751 -179.704 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 174' ' ' GLY . . . . . 0.49 ' O ' ' C ' ' A' ' 175' ' ' LYS . . . -117.1 -41.72 0.68 Allowed Glycine 0 N--CA 1.484 1.873 0 N-CA-C 108.824 -1.71 . . . . 0.0 108.824 179.682 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 175' ' ' LYS . . . . . 0.49 ' C ' ' O ' ' A' ' 174' ' ' GLY . 13.1 mptt -41.05 -59.78 1.38 Allowed 'General case' 0 N--CA 1.495 1.791 0 N-CA-C 107.804 -1.184 . . . . 0.0 107.804 179.573 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 176' ' ' ASP . . . . . 0.598 ' O ' ' O ' ' A' ' 177' ' ' LYS . 4.3 m-20 -103.22 83.04 2.14 Favored 'General case' 0 C--N 1.295 -1.791 0 N-CA-C 107.294 -1.373 . . . . 0.0 107.294 177.461 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 177' ' ' LYS . . . . . 0.598 ' O ' ' O ' ' A' ' 176' ' ' ASP . 2.6 mttt -43.59 -177.99 0.0 OUTLIER 'General case' 0 N--CA 1.494 1.73 0 O-C-N 121.425 -0.797 . . . . 0.0 109.464 -179.144 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 178' ' ' GLN . . . . . 0.532 ' OE1' ' ND2' ' A' ' 114' ' ' ASN . 0.0 OUTLIER -160.44 170.86 20.12 Favored 'General case' 0 C--N 1.302 -1.487 0 O-C-N 120.418 -1.426 . . . . 0.0 110.977 179.03 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 179' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -122.86 91.99 3.61 Favored 'General case' 0 C--N 1.302 -1.484 0 N-CA-C 107.446 -1.316 . . . . 0.0 107.446 178.493 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 180' ' ' THR . . . . . 0.444 ' OG1' ' ND2' ' A' ' 114' ' ' ASN . 1.3 m -71.74 118.32 14.44 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.172 -0.955 . . . . 0.0 110.457 -178.388 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 181' ' ' LEU . . . . . 0.506 HD11 ' CE2' ' A' ' 130' ' ' PHE . 41.1 tp -97.4 154.04 17.72 Favored 'General case' 0 C--N 1.3 -1.568 0 N-CA-C 107.458 -1.312 . . . . 0.0 107.458 177.57 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 182' ' ' ILE . . . . . 0.572 HG23 HG22 ' A' ' 199' ' ' ILE . 11.0 mt -145.77 121.31 3.33 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.554 0 O-C-N 120.613 -1.304 . . . . 0.0 110.489 179.496 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 183' ' ' THR . . . . . 0.569 ' O ' HG23 ' A' ' 183' ' ' THR . 5.2 t -134.44 116.8 15.57 Favored 'General case' 0 C--N 1.293 -1.865 0 N-CA-C 107.427 -1.323 . . . . 0.0 107.427 178.627 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 184' ' ' CYS . . . . . . . . . . . . . 5.1 p -78.57 157.15 28.85 Favored 'General case' 0 C--N 1.282 -2.337 0 C-N-CA 118.933 -1.107 . . . . 0.0 110.964 -177.687 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 185' ' ' ASP . . . . . . . . . . . . . 12.3 t0 -164.15 -157.47 0.39 Allowed 'General case' 0 N--CA 1.492 1.658 0 O-C-N 121.514 -0.742 . . . . 0.0 109.376 -179.613 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 186' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER 54.93 52.45 11.9 Favored 'General case' 0 N--CA 1.495 1.807 0 O-C-N 121.002 -1.061 . . . . 0.0 109.567 -179.7 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 187' ' ' TYR . . . . . 0.599 ' CE1' ' O ' ' A' ' 188' ' ' ASN . 63.4 t80 -67.69 134.36 50.96 Favored 'General case' 0 N--CA 1.493 1.675 0 O-C-N 121.122 -0.986 . . . . 0.0 110.582 -179.857 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 188' ' ' ASN . . . . . 0.599 ' O ' ' CE1' ' A' ' 187' ' ' TYR . 0.7 OUTLIER -101.52 145.66 28.71 Favored 'General case' 0 C--N 1.296 -1.749 0 N-CA-C 108.214 -1.032 . . . . 0.0 108.214 178.119 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 189' ' ' GLU . . . . . . . . . . . . . 2.0 tt0 -109.49 -14.31 14.42 Favored 'General case' 0 C--N 1.294 -1.81 0 N-CA-C 108.719 -0.845 . . . . 0.0 108.719 -179.557 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 190' ' ' LYS . . . . . . . . . . . . . 7.7 mttm -82.62 -54.47 5.14 Favored 'General case' 0 C--N 1.302 -1.489 0 N-CA-C 108.879 -0.785 . . . . 0.0 108.879 179.096 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 191' ' ' THR . . . . . 0.572 ' OG1' HG12 ' A' ' 193' ' ' VAL . 1.0 OUTLIER -88.48 -5.36 58.29 Favored 'General case' 0 C--N 1.301 -1.503 0 O-C-N 121.391 -0.818 . . . . 0.0 109.645 -179.756 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 192' ' ' GLY . . . . . . . . . . . . . . . 64.93 35.21 91.63 Favored Glycine 0 N--CA 1.496 2.697 0 O-C-N 120.992 -1.068 . . . . 0.0 111.928 177.988 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 193' ' ' VAL . . . . . 0.572 HG12 ' OG1' ' A' ' 191' ' ' THR . 3.4 p -149.27 167.87 2.98 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.681 0 O-C-N 120.692 -1.475 . . . . 0.0 110.383 179.178 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 194' ' ' TRP . . . . . 0.53 ' N ' ' CD1' ' A' ' 194' ' ' TRP . 10.1 m95 -84.83 120.86 26.92 Favored 'General case' 0 N--CA 1.493 1.704 0 N-CA-C 108.813 -0.81 . . . . 0.0 108.813 -179.933 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 195' ' ' GLU . . . . . 0.507 ' CD ' ' ND2' ' A' ' 188' ' ' ASN . 6.8 mt-10 -79.35 -61.64 1.94 Allowed 'General case' 0 N--CA 1.493 1.689 0 O-C-N 121.424 -0.798 . . . . 0.0 111.241 -178.29 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 196' ' ' LYS . . . . . . . . . . . . . 0.9 OUTLIER -101.64 151.14 22.37 Favored 'General case' 0 N--CA 1.494 1.73 0 O-C-N 120.906 -1.121 . . . . 0.0 110.262 -179.216 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 197' ' ' ARG . . . . . 0.883 ' HE ' HD13 ' C' ' 702' ' ' LEU . 1.4 mtt-85 -120.5 153.59 36.45 Favored 'General case' 0 N--CA 1.489 1.497 0 N-CA-C 108.432 -0.951 . . . . 0.0 108.432 178.34 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 198' ' ' LYS . . . . . . . . . . . . . 1.1 mptp? -114.97 123.14 48.33 Favored 'General case' 0 C--N 1.3 -1.585 0 O-C-N 121.645 -0.659 . . . . 0.0 110.581 -177.882 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 199' ' ' ILE . . . . . 0.63 ' C ' HD12 ' A' ' 199' ' ' ILE . 0.5 OUTLIER -136.79 118.49 19.11 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.757 0 CA-C-O 122.748 1.261 . . . . 0.0 110.655 179.693 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 200' ' ' PHE . . . . . 0.556 ' CD1' ' N ' ' A' ' 200' ' ' PHE . 0.2 OUTLIER -100.15 134.64 42.77 Favored 'General case' 0 N--CA 1.5 2.054 0 CA-C-N 115.604 -0.725 . . . . 0.0 110.481 -178.161 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 201' ' ' VAL . . . . . . . . . . . . . 52.9 t -103.48 141.34 19.45 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.992 0 O-C-N 120.721 -1.237 . . . . 0.0 108.554 177.922 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 202' ' ' ALA . . . . . 0.449 ' HB1' ' HB3' ' A' ' 153' ' ' TYR . . . -125.15 136.66 53.82 Favored 'General case' 0 N--CA 1.495 1.794 0 O-C-N 121.157 -0.964 . . . . 0.0 108.795 179.56 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 203' ' ' THR . . . . . 0.679 HG23 ' OG1' ' A' ' 156' ' ' THR . 1.2 p -88.98 134.66 33.9 Favored 'General case' 0 N--CA 1.49 1.529 0 CA-C-O 122.126 0.965 . . . . 0.0 111.383 -178.552 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 204' ' ' GLU . . . . . 0.418 ' HA ' ' CD2' ' A' ' 153' ' ' TYR . 2.6 tm-20 -62.53 135.07 57.23 Favored 'General case' 0 C--N 1.301 -1.541 0 C-N-CA 118.919 -1.113 . . . . 0.0 108.96 179.25 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 205' ' ' VAL . . . . . 0.54 ' O ' ' C ' ' A' ' 206' ' ' LYS . 71.5 t -123.9 -45.39 1.73 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.642 0 O-C-N 121.397 -0.814 . . . . 0.0 109.908 -178.91 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 206' ' ' LYS . . . . . 0.54 ' C ' ' O ' ' A' ' 205' ' ' VAL . 2.3 ttpt . . . . . 0 N--CA 1.496 1.838 0 CA-C-O 118.044 -0.979 . . . . 0.0 110.679 -179.655 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' C' C ' 701' ' ' PHQ . . . . . 0.487 ' O2 ' HG12 ' A' ' 166' ' ' VAL . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 018 nuclear build full ' C' C ' 702' ' ' LEU . . . . . 0.883 HD13 ' HE ' ' A' ' 197' ' ' ARG . 0.0 OUTLIER . . . . . 0 N--CA 1.491 1.584 0 N-CA-C 108.412 -0.959 . . . . 0.0 108.412 . . . . . . . . . 2 2 . 1 . 018 nuclear build full ' C' C ' 703' ' ' PRO . . . . . 0.492 ' O ' ' O ' ' C' ' 704' ' ' ALA . 97.2 Cg_endo -77.88 -162.48 0.17 Allowed 'Trans proline' 0 N--CA 1.494 1.55 0 C-N-CA 122.521 2.148 . . . . 0.0 113.081 -179.509 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' C' C ' 704' ' ' ALA . . . . . 0.493 ' C ' ' SG ' ' C' ' 705' ' ' B27 . . . 41.41 98.84 0.0 OUTLIER 'General case' 0 N--CA 1.49 1.553 0 CA-C-O 121.443 0.64 . . . . 0.0 110.273 179.457 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' C' C ' 705' ' ' B27 . . . . . 0.575 ' SG ' ' CD2' ' A' ' 120' ' ' HIS . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 700' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 019 nuclear build full ' A' A ' 59' ' ' MET . . . . . . . . . . . . . 5.0 mmt . . . . . 0 N--CA 1.49 1.549 0 N-CA-C 109.44 -0.578 . . . . 0.0 109.44 . . . . . . . . . 0 0 . 1 . 019 nuclear build full ' A' A ' 60' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -59.74 -161.91 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.673 0 O-C-N 121.079 -1.013 . . . . 0.0 109.198 179.804 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . -64.35 -168.02 0.03 OUTLIER 'General case' 0 N--CA 1.488 1.445 0 O-C-N 121.245 -0.91 . . . . 0.0 109.276 179.83 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 62' ' ' LYS . . . . . . . . . . . . . 6.1 pttm -138.5 90.08 13.26 Favored Pre-proline 0 N--CA 1.487 1.391 0 O-C-N 121.207 -0.933 . . . . 0.0 109.403 -179.276 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 63' ' ' PRO . . . . . 0.581 ' O ' ' CD1' ' A' ' 110' ' ' LEU . 29.3 Cg_endo -86.51 131.28 3.42 Favored 'Trans proline' 0 C--N 1.309 -1.541 0 C-N-CA 122.965 2.443 . . . . 0.0 110.156 179.414 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 64' ' ' GLN . . . . . 0.425 ' O ' ' C ' ' A' ' 65' ' ' ILE . 0.9 OUTLIER -162.47 115.62 1.71 Allowed 'General case' 0 C--N 1.297 -1.686 0 O-C-N 121.165 -0.96 . . . . 0.0 109.976 -179.836 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 65' ' ' ILE . . . . . 0.425 ' C ' ' O ' ' A' ' 64' ' ' GLN . 2.7 mp -42.78 102.41 0.27 Allowed Pre-proline 0 N--CA 1.489 1.511 0 O-C-N 121.518 -0.739 . . . . 0.0 109.262 179.536 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 66' ' ' PRO . . . . . . . . . . . . . 72.7 Cg_endo -89.13 -154.21 0.05 OUTLIER 'Trans proline' 0 N--CA 1.492 1.414 0 C-N-CA 122.697 2.265 . . . . 0.0 113.004 -179.011 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 67' ' ' LYS . . . . . 0.481 ' CG ' ' O ' ' A' ' 67' ' ' LYS . 7.8 ttmm -81.06 -7.45 59.56 Favored 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.239 -0.913 . . . . 0.0 108.766 179.666 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 68' ' ' ASP . . . . . 0.584 ' C ' ' N ' ' A' ' 70' ' ' SER . 0.5 OUTLIER -75.1 52.89 0.59 Allowed 'General case' 0 C--N 1.304 -1.393 0 CA-C-O 122.524 1.154 . . . . 0.0 108.594 179.608 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 69' ' ' LYS . . . . . 0.437 ' C ' ' O ' ' A' ' 68' ' ' ASP . 14.9 ptpt -49.7 -15.07 0.15 Allowed 'General case' 0 N--CA 1.501 2.088 0 C-N-CA 117.26 -1.776 . . . . 0.0 106.469 177.961 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 70' ' ' SER . . . . . 0.584 ' N ' ' C ' ' A' ' 68' ' ' ASP . 3.7 m -85.92 -4.68 59.22 Favored 'General case' 0 N--CA 1.494 1.77 0 CA-C-N 113.516 -1.675 . . . . 0.0 110.739 179.571 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 71' ' ' LYS . . . . . . . . . . . . . 7.9 ptmt -97.73 142.53 29.39 Favored 'General case' 0 N--CA 1.497 1.877 0 O-C-N 120.913 -1.117 . . . . 0.0 111.985 -179.181 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 72' ' ' VAL . . . . . 0.579 ' CG2' ' O ' ' A' ' 74' ' ' GLY . 0.3 OUTLIER -67.52 135.0 29.34 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.507 0 N-CA-C 105.186 -2.153 . . . . 0.0 105.186 174.777 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 73' ' ' ALA . . . . . 0.535 ' N ' ' O ' ' A' ' 87' ' ' VAL . . . -80.93 -16.58 53.14 Favored 'General case' 0 C--N 1.298 -1.635 0 O-C-N 119.988 -1.695 . . . . 0.0 107.219 -179.556 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 74' ' ' GLY . . . . . 0.579 ' O ' ' CG2' ' A' ' 72' ' ' VAL . . . 167.04 -148.9 13.85 Favored Glycine 0 N--CA 1.486 1.98 0 C-N-CA 119.078 -1.534 . . . . 0.0 110.253 178.774 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 75' ' ' TYR . . . . . 0.558 ' HA ' HG23 ' A' ' 87' ' ' VAL . 13.4 m-85 -144.91 174.79 10.71 Favored 'General case' 0 C--N 1.293 -1.885 0 O-C-N 121.153 -1.204 . . . . 0.0 109.921 -178.342 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 76' ' ' ILE . . . . . . . . . . . . . 0.4 OUTLIER -148.48 147.83 16.56 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.777 0 N-CA-C 108.124 -1.065 . . . . 0.0 108.124 -178.64 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 3.9 mt-10 -149.37 159.82 43.95 Favored 'General case' 0 C--N 1.302 -1.471 0 O-C-N 120.789 -1.194 . . . . 0.0 110.548 -179.353 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 78' ' ' ILE . . . . . 0.562 HG22 ' H ' ' A' ' 81' ' ' ALA . 83.3 mt -145.58 120.15 5.56 Favored Pre-proline 0 N--CA 1.488 1.442 0 N-CA-C 107.233 -1.395 . . . . 0.0 107.233 179.722 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 79' ' ' PRO . . . . . . . . . . . . . 68.9 Cg_endo -76.36 -39.66 0.76 Allowed 'Trans proline' 0 N--CA 1.493 1.468 0 C-N-CA 122.024 1.816 . . . . 0.0 113.613 -178.543 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 4.7 m-20 -65.72 -20.23 66.2 Favored 'General case' 0 N--CA 1.494 1.76 0 O-C-N 121.062 -1.024 . . . . 0.0 110.025 178.344 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 81' ' ' ALA . . . . . 0.575 ' O ' ' ND2' ' A' ' 132' ' ' ASN . . . -108.31 -18.63 13.71 Favored 'General case' 0 C--N 1.301 -1.535 0 N-CA-C 107.857 -1.164 . . . . 0.0 107.857 179.497 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 82' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER 67.41 54.72 0.68 Allowed 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.74 -0.6 . . . . 0.0 110.942 178.921 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 83' ' ' ILE . . . . . 0.409 ' CG1' HD21 ' A' ' 132' ' ' ASN . 61.2 mt -126.66 151.77 33.66 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.924 0 O-C-N 120.935 -1.103 . . . . 0.0 110.68 -179.02 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 84' ' ' LYS . . . . . . . . . . . . . 1.6 pttm -159.19 106.46 1.77 Allowed 'General case' 0 N--CA 1.489 1.512 0 N-CA-C 107.734 -1.21 . . . . 0.0 107.734 179.105 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 85' ' ' GLU . . . . . 0.435 ' OE2' ' O ' ' A' ' 129' ' ' GLN . 0.4 OUTLIER -141.6 174.16 4.09 Favored Pre-proline 0 N--CA 1.493 1.71 0 O-C-N 121.064 -1.023 . . . . 0.0 110.779 -178.344 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 86' ' ' PRO . . . . . . . . . . . . . 73.2 Cg_endo -83.96 157.75 13.55 Favored 'Trans proline' 0 N--CA 1.492 1.433 0 C-N-CA 123.147 2.565 . . . . 0.0 114.082 -178.869 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 87' ' ' VAL . . . . . 0.558 HG23 ' HA ' ' A' ' 75' ' ' TYR . 57.3 t -114.6 103.24 15.03 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.89 0 O-C-N 121.73 -0.606 . . . . 0.0 109.706 -179.816 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 88' ' ' TYR . . . . . 0.412 ' CD2' ' HD2' ' A' ' 99' ' ' ARG . 19.5 m-85 -94.83 153.71 39.97 Favored Pre-proline 0 N--CA 1.502 2.139 0 O-C-N 120.827 -1.17 . . . . 0.0 110.31 -179.916 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 89' ' ' PRO . . . . . 0.425 ' HA ' ' CD2' ' A' ' 103' ' ' PHE . 8.3 Cg_endo -58.4 145.38 94.24 Favored 'Trans proline' 0 N--CA 1.494 1.537 0 C-N-CA 122.908 2.405 . . . . 0.0 113.452 -179.514 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . -59.84 168.91 7.55 Favored Glycine 0 N--CA 1.492 2.384 0 N-CA-C 109.208 -1.557 . . . . 0.0 109.208 179.211 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 91' ' ' PRO . . . . . 0.444 ' C ' ' H ' ' A' ' 93' ' ' THR . 72.1 Cg_endo -93.24 170.45 19.98 Favored 'Cis proline' 0 C--N 1.306 -1.669 0 C-N-CA 123.765 -1.348 . . . . 0.0 111.903 -0.237 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 92' ' ' ALA . . . . . 0.47 ' HB3' ' HB2' ' C' ' 703' ' ' PRO . . . -72.44 32.15 0.06 Allowed 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.134 -0.979 . . . . 0.0 110.433 -179.892 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 93' ' ' THR . . . . . 0.444 ' H ' ' C ' ' A' ' 91' ' ' PRO . 1.1 p -73.51 149.9 88.86 Favored Pre-proline 0 C--N 1.302 -1.486 0 O-C-N 120.847 -1.158 . . . . 0.0 108.427 179.723 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 94' ' ' PRO . . . . . 0.412 ' C ' ' O ' ' A' ' 93' ' ' THR . 95.4 Cg_exo -35.54 -45.05 0.71 Allowed 'Trans proline' 0 C--N 1.304 -1.772 0 C-N-CA 122.438 2.092 . . . . 0.0 111.746 -179.615 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 95' ' ' GLU . . . . . 0.628 ' O ' ' ND2' ' A' ' 98' ' ' ASN . 7.1 mt-10 -49.97 -55.13 15.78 Favored 'General case' 0 N--CA 1.489 1.477 0 O-C-N 121.18 -0.95 . . . . 0.0 109.393 179.341 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 96' ' ' GLN . . . . . 0.563 ' C ' ' H ' ' A' ' 98' ' ' ASN . 2.7 mp0 -73.03 -47.77 42.06 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.162 -0.961 . . . . 0.0 110.719 -179.658 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 97' ' ' LEU . . . . . 0.448 HD23 ' HA ' ' A' ' 97' ' ' LEU . 42.2 mt -52.55 -5.34 0.04 OUTLIER 'General case' 0 N--CA 1.493 1.691 0 O-C-N 120.971 -1.08 . . . . 0.0 109.095 -179.046 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 98' ' ' ASN . . . . . 0.75 HD21 ' NE ' ' A' ' 99' ' ' ARG . 0.5 OUTLIER -73.23 -26.35 61.09 Favored 'General case' 0 N--CA 1.494 1.747 0 O-C-N 121.351 -0.843 . . . . 0.0 109.087 179.466 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 99' ' ' ARG . . . . . 0.75 ' NE ' HD21 ' A' ' 98' ' ' ASN . 0.1 OUTLIER -99.03 -50.2 4.25 Favored 'General case' 0 C--N 1.3 -1.544 0 C-N-CA 119.7 -0.8 . . . . 0.0 110.064 -179.016 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . 180.0 -169.17 39.83 Favored Glycine 0 N--CA 1.495 2.578 0 C-N-CA 118.858 -1.639 . . . . 0.0 111.224 179.497 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 101' ' ' VAL . . . . . 0.73 HG23 ' O ' ' A' ' 101' ' ' VAL . 18.5 m -55.01 106.16 0.11 Allowed 'Isoleucine or valine' 0 N--CA 1.496 1.84 0 O-C-N 121.883 -0.775 . . . . 0.0 109.289 -179.851 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -92.56 164.17 13.53 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.373 -0.829 . . . . 0.0 111.577 -178.713 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 103' ' ' PHE . . . . . 0.427 ' CE1' ' CG1' ' A' ' 87' ' ' VAL . 23.9 m-85 -68.2 126.58 29.99 Favored 'General case' 0 N--CA 1.485 1.278 0 N-CA-C 106.763 -1.569 . . . . 0.0 106.763 177.309 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 104' ' ' ALA . . . . . 0.453 ' HB1' ' CG ' ' C' ' 703' ' ' PRO . . . -50.37 -11.26 0.07 Allowed 'General case' 0 C--N 1.293 -1.856 0 O-C-N 121.513 -0.742 . . . . 0.0 111.593 -178.267 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 105' ' ' GLU . . . . . 0.495 ' OE2' ' OE1' ' A' ' 108' ' ' GLU . 0.4 OUTLIER -140.57 145.89 37.34 Favored 'General case' 0 N--CA 1.495 1.795 0 O-C-N 120.751 -1.218 . . . . 0.0 110.565 179.988 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 106' ' ' GLU . . . . . . . . . . . . . 25.0 tt0 -58.84 -63.22 1.37 Allowed 'General case' 0 C--N 1.305 -1.356 0 O-C-N 121.733 -0.604 . . . . 0.0 110.019 -179.993 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 107' ' ' ASN . . . . . . . . . . . . . 15.9 m-80 -76.94 33.2 0.14 Allowed 'General case' 0 N--CA 1.487 1.413 0 O-C-N 120.381 -1.449 . . . . 0.0 112.683 -176.103 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 108' ' ' GLU . . . . . 0.495 ' OE1' ' OE2' ' A' ' 105' ' ' GLU . 35.0 tp10 -60.16 146.9 41.65 Favored 'General case' 0 N--CA 1.493 1.698 0 O-C-N 120.483 -1.386 . . . . 0.0 107.801 179.448 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 109' ' ' SER . . . . . 0.401 ' C ' ' N ' ' A' ' 111' ' ' ASP . 0.1 OUTLIER -101.2 128.59 47.24 Favored 'General case' 0 N--CA 1.489 1.501 0 O-C-N 120.824 -1.172 . . . . 0.0 110.912 -178.285 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 110' ' ' LEU . . . . . 0.626 HD23 ' N ' ' A' ' 110' ' ' LEU . 1.2 pt? -59.0 -10.02 2.27 Favored 'General case' 0 C--N 1.303 -1.433 0 N-CA-C 108.45 -0.945 . . . . 0.0 108.45 179.48 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 111' ' ' ASP . . . . . 0.401 ' N ' ' C ' ' A' ' 109' ' ' SER . 44.8 m-20 -131.74 29.62 4.45 Favored 'General case' 0 N--CA 1.491 1.587 0 N-CA-C 108.598 -0.89 . . . . 0.0 108.598 179.32 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 112' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -65.37 149.48 49.92 Favored 'General case' 0 N--CA 1.493 1.686 0 O-C-N 121.273 -0.892 . . . . 0.0 110.479 -179.232 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 113' ' ' GLN . . . . . . . . . . . . . 2.3 mp0 -66.87 -11.41 55.72 Favored 'General case' 0 C--N 1.303 -1.442 0 N-CA-C 107.709 -1.219 . . . . 0.0 107.709 177.773 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 114' ' ' ASN . . . . . 0.49 HD21 ' HB3' ' A' ' 171' ' ' GLU . 0.3 OUTLIER -149.47 102.59 3.2 Favored 'General case' 0 C--N 1.305 -1.347 0 N-CA-C 107.683 -1.229 . . . . 0.0 107.683 177.838 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 115' ' ' ILE . . . . . 0.461 ' O ' HG22 ' A' ' 115' ' ' ILE . 3.8 mt -97.74 111.26 27.13 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.528 0 O-C-N 120.961 -1.087 . . . . 0.0 109.437 -179.19 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 116' ' ' SER . . . . . . . . . . . . . 50.5 m -96.97 140.68 31.14 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.24 -0.913 . . . . 0.0 111.707 -178.087 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 117' ' ' ILE . . . . . . . . . . . . . 11.9 mt -130.25 152.49 37.51 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.414 0 N-CA-C 107.284 -1.376 . . . . 0.0 107.284 178.305 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 118' ' ' ALA . . . . . 0.663 ' HB1' ' HB2' ' C' ' 704' ' ' ALA . . . -142.87 157.54 44.49 Favored 'General case' 0 N--CA 1.493 1.684 0 O-C-N 120.707 -1.246 . . . . 0.0 111.087 -179.836 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 119' ' ' GLY . . . . . . . . . . . . . . . -162.45 145.09 10.28 Favored Glycine 0 N--CA 1.487 2.056 0 N-CA-C 110.085 -1.206 . . . . 0.0 110.085 179.964 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 120' ' ' HIS . . . . . 0.436 ' ND1' ' SG ' ' C' ' 705' ' ' B27 . 1.6 m-70 -71.19 157.98 37.21 Favored 'General case' 0 N--CA 1.493 1.701 0 O-C-N 121.716 -0.873 . . . . 0.0 110.062 179.461 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 121' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -110.98 145.88 37.65 Favored 'General case' 0 N--CA 1.495 1.808 0 O-C-N 121.321 -0.862 . . . . 0.0 108.86 178.916 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 122' ' ' PHE . . . . . 0.489 ' O ' HG21 ' A' ' 131' ' ' THR . 0.3 OUTLIER -109.23 125.32 52.13 Favored 'General case' 0 N--CA 1.494 1.734 0 O-C-N 121.058 -1.026 . . . . 0.0 109.277 179.333 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 123' ' ' ILE . . . . . 0.559 HG23 ' N ' ' A' ' 124' ' ' ASP . 6.9 tp -74.43 -37.04 43.84 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.785 0 CA-C-O 121.876 0.846 . . . . 0.0 109.195 179.833 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 124' ' ' ASP . . . . . 0.559 ' N ' HG23 ' A' ' 123' ' ' ILE . 80.8 m-20 -92.88 15.13 15.49 Favored 'General case' 0 C--N 1.297 -1.715 0 O-C-N 121.897 -0.502 . . . . 0.0 111.281 -179.043 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 125' ' ' ARG . . . . . . . . . . . . . 7.3 ttt180 -153.95 115.17 2.58 Favored Pre-proline 0 N--CA 1.494 1.737 0 O-C-N 120.445 -1.409 . . . . 0.0 110.789 -178.555 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 126' ' ' PRO . . . . . . . . . . . . . 74.0 Cg_endo -83.76 -23.75 3.1 Favored 'Trans proline' 0 N--CA 1.487 1.123 0 C-N-CA 122.11 1.873 . . . . 0.0 112.083 178.81 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 127' ' ' ASN . . . . . 0.48 ' ND2' ' O ' ' A' ' 127' ' ' ASN . 2.3 p-10 -88.82 28.89 1.09 Allowed 'General case' 0 N--CA 1.492 1.654 0 O-C-N 120.898 -1.126 . . . . 0.0 110.051 -179.558 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 128' ' ' TYR . . . . . . . . . . . . . 9.9 t80 -87.71 -148.58 0.15 Allowed 'General case' 0 N--CA 1.49 1.564 0 O-C-N 120.94 -1.1 . . . . 0.0 109.554 179.906 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 129' ' ' GLN . . . . . 0.435 ' O ' ' OE2' ' A' ' 85' ' ' GLU . 80.4 mt-30 -66.95 -69.59 0.3 Allowed 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.29 -0.881 . . . . 0.0 110.802 -178.742 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 130' ' ' PHE . . . . . . . . . . . . . 55.8 m-85 -130.47 31.34 4.59 Favored 'General case' 0 N--CA 1.499 1.99 0 O-C-N 121.056 -1.027 . . . . 0.0 110.841 -179.126 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 131' ' ' THR . . . . . 0.489 HG21 ' O ' ' A' ' 122' ' ' PHE . 52.4 m -70.77 -32.99 70.3 Favored 'General case' 0 C--N 1.301 -1.522 0 O-C-N 120.344 -1.473 . . . . 0.0 108.205 179.451 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 132' ' ' ASN . . . . . 0.575 ' ND2' ' O ' ' A' ' 81' ' ' ALA . 2.0 p-10 -91.21 15.24 12.27 Favored 'General case' 0 N--CA 1.498 1.97 0 C-N-CA 119.915 -0.714 . . . . 0.0 111.179 -179.565 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 133' ' ' LEU . . . . . 0.599 ' O ' ' N ' ' A' ' 135' ' ' ALA . 0.2 OUTLIER -77.06 -44.17 31.69 Favored 'General case' 0 C--N 1.301 -1.535 0 O-C-N 120.651 -1.281 . . . . 0.0 109.185 -179.801 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 134' ' ' LYS . . . . . 0.71 ' CE ' ' H ' ' A' ' 134' ' ' LYS . 0.0 OUTLIER -46.97 -6.94 0.01 OUTLIER 'General case' 0 C--N 1.299 -1.606 0 O-C-N 121.661 -0.65 . . . . 0.0 110.428 -179.42 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 135' ' ' ALA . . . . . 0.599 ' N ' ' O ' ' A' ' 133' ' ' LEU . . . -84.0 -40.32 18.58 Favored 'General case' 0 N--CA 1.488 1.462 0 O-C-N 120.912 -1.118 . . . . 0.0 108.97 178.962 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 136' ' ' ALA . . . . . 0.555 ' HB2' ' HB2' ' A' ' 81' ' ' ALA . . . -79.77 162.3 25.21 Favored 'General case' 0 N--CA 1.487 1.402 0 CA-C-O 122.21 1.005 . . . . 0.0 111.357 -178.752 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 137' ' ' LYS . . . . . 0.513 ' O ' ' O ' ' A' ' 138' ' ' LYS . 17.4 pttt -153.04 -164.02 1.83 Allowed 'General case' 0 C--N 1.3 -1.584 0 C-N-CA 118.721 -1.192 . . . . 0.0 111.097 -177.918 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 138' ' ' LYS . . . . . 0.602 ' O ' ' N ' ' A' ' 140' ' ' SER . 1.4 mmmp? -45.92 -179.9 0.0 OUTLIER 'General case' 0 C--N 1.303 -1.445 0 CA-C-O 122.1 0.953 . . . . 0.0 110.356 -179.564 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 139' ' ' GLY . . . . . . . . . . . . . . . 46.14 7.81 0.02 OUTLIER Glycine 0 N--CA 1.49 2.283 0 N-CA-C 110.547 -1.021 . . . . 0.0 110.547 179.735 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 140' ' ' SER . . . . . 0.602 ' N ' ' O ' ' A' ' 138' ' ' LYS . 13.1 t -83.04 143.78 30.37 Favored 'General case' 0 N--CA 1.493 1.679 0 O-C-N 120.849 -1.383 . . . . 0.0 108.922 179.108 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 141' ' ' MET . . . . . . . . . . . . . 0.1 OUTLIER -88.68 133.91 34.06 Favored 'General case' 0 C--N 1.3 -1.552 0 O-C-N 121.091 -1.006 . . . . 0.0 109.316 179.787 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 142' ' ' VAL . . . . . 0.429 HG22 HG12 ' A' ' 78' ' ' ILE . 21.4 t -121.81 126.19 74.28 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.631 0 N-CA-C 108.781 -0.822 . . . . 0.0 108.781 179.934 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 143' ' ' TYR . . . . . . . . . . . . . 61.1 m-85 -104.2 134.28 47.71 Favored 'General case' 0 N--CA 1.496 1.857 0 O-C-N 121.26 -0.9 . . . . 0.0 110.975 -178.915 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 144' ' ' PHE . . . . . . . . . . . . . 53.0 t80 -112.0 154.3 25.53 Favored 'General case' 0 N--CA 1.492 1.666 0 CA-C-O 121.773 0.797 . . . . 0.0 110.101 -179.393 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 145' ' ' LYS . . . . . 0.429 ' CG ' ' OG1' ' A' ' 150' ' ' THR . 1.8 mttm -149.07 125.64 11.02 Favored 'General case' 0 N--CA 1.494 1.759 0 C-N-CA 118.866 -1.134 . . . . 0.0 111.707 -177.764 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 146' ' ' VAL . . . . . . . . . . . . . 0.2 OUTLIER -144.81 139.9 23.19 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.559 0 N-CA-C 107.028 -1.471 . . . . 0.0 107.028 178.149 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 147' ' ' GLY . . . . . . . . . . . . . . . 53.89 -138.07 38.95 Favored Glycine 0 N--CA 1.489 2.201 0 N-CA-C 107.878 -2.089 . . . . 0.0 107.878 -178.692 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 148' ' ' ASN . . . . . 0.591 ' C ' HD22 ' A' ' 148' ' ' ASN . 0.4 OUTLIER -101.63 26.65 7.12 Favored 'General case' 0 N--CA 1.489 1.498 0 O-C-N 121.052 -1.263 . . . . 0.0 107.832 178.491 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 149' ' ' GLU . . . . . . . . . . . . . 2.1 tm-20 -112.05 151.97 28.74 Favored 'General case' 0 N--CA 1.486 1.335 0 CA-C-O 121.872 0.844 . . . . 0.0 110.921 -178.805 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 150' ' ' THR . . . . . 0.429 ' OG1' ' CG ' ' A' ' 145' ' ' LYS . 2.9 m -141.02 104.89 4.75 Favored 'General case' 0 N--CA 1.495 1.818 0 CA-C-O 121.559 0.695 . . . . 0.0 109.216 179.828 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 151' ' ' ARG . . . . . . . . . . . . . 73.9 mtt180 -87.57 -164.9 1.17 Allowed 'General case' 0 N--CA 1.487 1.403 0 O-C-N 121.355 -0.841 . . . . 0.0 109.297 -179.52 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 152' ' ' LYS . . . . . 0.528 ' O ' ' N ' ' A' ' 205' ' ' VAL . 7.3 mtmt -147.34 144.24 28.61 Favored 'General case' 0 C--N 1.301 -1.535 0 O-C-N 121.433 -0.792 . . . . 0.0 109.329 -179.671 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 153' ' ' TYR . . . . . 0.536 ' CD2' ' HA ' ' A' ' 204' ' ' GLU . 26.9 m-85 -140.44 169.41 17.72 Favored 'General case' 0 N--CA 1.489 1.51 0 N-CA-C 108.344 -0.984 . . . . 0.0 108.344 179.948 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 154' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -143.38 120.91 11.74 Favored 'General case' 0 C--N 1.299 -1.623 0 O-C-N 121.329 -0.857 . . . . 0.0 108.986 179.175 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 155' ' ' MET . . . . . . . . . . . . . 27.0 mtp -46.61 110.09 0.25 Allowed 'General case' 0 N--CA 1.496 1.855 0 O-C-N 120.576 -1.327 . . . . 0.0 110.954 -179.112 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 156' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -104.24 -30.26 10.28 Favored 'General case' 0 C--N 1.294 -1.846 0 C-N-CA 119.817 -0.753 . . . . 0.0 111.034 -178.286 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 157' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -154.53 157.52 38.45 Favored 'General case' 0 N--CA 1.495 1.801 0 C-N-CA 118.179 -1.408 . . . . 0.0 111.757 -178.136 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 158' ' ' ILE . . . . . 0.423 HG12 ' N ' ' A' ' 159' ' ' ARG . 0.0 OUTLIER -155.26 146.23 12.99 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.562 0 CA-C-O 121.785 0.802 . . . . 0.0 110.748 -178.995 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 159' ' ' ARG . . . . . 0.65 ' CG ' HH11 ' A' ' 159' ' ' ARG . 0.0 OUTLIER -158.13 159.16 35.91 Favored 'General case' 0 C--N 1.303 -1.429 0 CA-C-O 121.757 0.789 . . . . 0.0 110.967 -179.824 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 160' ' ' ASP . . . . . 0.469 ' C ' HG22 ' A' ' 161' ' ' VAL . 0.3 OUTLIER -117.37 163.92 15.63 Favored 'General case' 0 N--CA 1.488 1.43 0 N-CA-C 108.326 -0.99 . . . . 0.0 108.326 178.829 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 161' ' ' VAL . . . . . 0.487 ' O ' ' O ' ' A' ' 162' ' ' LYS . 0.1 OUTLIER -162.11 156.2 2.64 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.816 0 O-C-N 121.158 -0.964 . . . . 0.0 109.828 -179.425 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 162' ' ' LYS . . . . . 0.584 ' H ' ' CD ' ' A' ' 162' ' ' LYS . 0.0 OUTLIER -44.96 171.68 0.05 OUTLIER Pre-proline 0 N--CA 1.494 1.738 0 O-C-N 121.378 -0.826 . . . . 0.0 109.63 179.723 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 163' ' ' PRO . . . . . . . . . . . . . 73.7 Cg_endo -81.87 36.38 0.62 Allowed 'Trans proline' 0 N--CA 1.493 1.451 0 C-N-CA 122.791 2.328 . . . . 0.0 113.141 -179.521 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 164' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -152.69 -4.8 0.22 Allowed 'General case' 0 N--CA 1.492 1.663 0 O-C-N 120.907 -1.121 . . . . 0.0 110.35 -179.981 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 165' ' ' ASP . . . . . 0.475 ' O ' ' N ' ' A' ' 167' ' ' GLY . 8.8 t0 -74.8 62.6 1.1 Allowed 'General case' 0 N--CA 1.492 1.631 0 O-C-N 120.925 -1.109 . . . . 0.0 110.641 -179.35 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 166' ' ' VAL . . . . . 0.648 ' O ' ' N ' ' A' ' 168' ' ' VAL . 0.9 OUTLIER -39.43 -29.03 0.09 OUTLIER 'Isoleucine or valine' 0 N--CA 1.497 1.89 0 O-C-N 121.284 -0.885 . . . . 0.0 109.563 -178.45 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 167' ' ' GLY . . . . . 0.475 ' N ' ' O ' ' A' ' 165' ' ' ASP . . . -43.07 -13.92 0.01 OUTLIER Glycine 0 N--CA 1.496 2.636 0 N-CA-C 109.515 -1.434 . . . . 0.0 109.515 179.622 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 168' ' ' VAL . . . . . 0.648 ' N ' ' O ' ' A' ' 166' ' ' VAL . 1.3 t -48.26 -44.41 12.73 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.454 0 O-C-N 121.448 -1.031 . . . . 0.0 108.43 178.925 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 169' ' ' LEU . . . . . 0.571 ' O ' ' C ' ' A' ' 170' ' ' ASP . 47.1 mt -49.92 -9.7 0.04 OUTLIER 'General case' 0 N--CA 1.492 1.66 0 N-CA-C 109.001 -0.741 . . . . 0.0 109.001 -178.092 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 170' ' ' ASP . . . . . 0.617 ' CG ' ' HG1' ' A' ' 180' ' ' THR . 17.7 p-10 19.46 86.51 0.01 OUTLIER 'General case' 0 N--CA 1.494 1.739 0 CA-C-O 121.051 0.453 . . . . 0.0 110.981 178.578 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 171' ' ' GLU . . . . . 0.49 ' HB3' HD21 ' A' ' 114' ' ' ASN . 6.7 pt-20 -121.29 61.38 0.91 Allowed 'General case' 0 N--CA 1.494 1.725 0 O-C-N 121.175 -0.953 . . . . 0.0 109.938 -179.228 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 172' ' ' GLN . . . . . . . . . . . . . 3.0 pt20 -135.03 -44.93 0.72 Allowed 'General case' 0 N--CA 1.492 1.668 0 O-C-N 121.527 -0.733 . . . . 0.0 109.942 -178.975 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 173' ' ' LYS . . . . . . . . . . . . . 21.5 mttp -62.54 128.93 38.29 Favored 'General case' 0 N--CA 1.489 1.498 0 O-C-N 120.899 -1.126 . . . . 0.0 108.106 178.949 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 174' ' ' GLY . . . . . 0.552 ' O ' ' C ' ' A' ' 175' ' ' LYS . . . -137.63 -40.37 0.11 Allowed Glycine 0 C--N 1.293 -1.807 0 N-CA-C 109.071 -1.612 . . . . 0.0 109.071 -179.722 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 175' ' ' LYS . . . . . 0.552 ' C ' ' O ' ' A' ' 174' ' ' GLY . 4.4 mptp? -30.87 -65.28 0.12 Allowed 'General case' 0 N--CA 1.499 2.011 0 N-CA-C 108.9 -0.778 . . . . 0.0 108.9 -179.751 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 176' ' ' ASP . . . . . 0.696 ' O ' ' O ' ' A' ' 177' ' ' LYS . 58.2 m-20 -101.39 78.7 1.9 Allowed 'General case' 0 C--N 1.296 -1.728 0 N-CA-C 107.79 -1.189 . . . . 0.0 107.79 177.843 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 177' ' ' LYS . . . . . 0.696 ' O ' ' O ' ' A' ' 176' ' ' ASP . 0.7 OUTLIER -20.54 158.02 0.0 OUTLIER 'General case' 0 N--CA 1.507 2.39 0 CA-C-O 122.218 1.009 . . . . 0.0 112.249 -179.075 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 178' ' ' GLN . . . . . . . . . . . . . 0.4 OUTLIER -157.03 164.22 38.2 Favored 'General case' 0 C--N 1.303 -1.414 0 C-N-CA 117.052 -1.859 . . . . 0.0 112.026 179.804 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 179' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -122.23 107.39 12.08 Favored 'General case' 0 C--N 1.303 -1.42 0 N-CA-C 107.345 -1.354 . . . . 0.0 107.345 179.083 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 180' ' ' THR . . . . . 0.617 ' HG1' ' CG ' ' A' ' 170' ' ' ASP . 1.0 OUTLIER -78.66 120.32 23.16 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 120.87 -1.144 . . . . 0.0 110.278 -178.427 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 181' ' ' LEU . . . . . . . . . . . . . 10.2 tp -100.16 105.78 17.42 Favored 'General case' 0 N--CA 1.492 1.671 0 O-C-N 121.536 -0.728 . . . . 0.0 109.099 178.883 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 182' ' ' ILE . . . . . . . . . . . . . 56.3 mt -95.63 125.86 48.29 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.419 0 O-C-N 121.064 -1.022 . . . . 0.0 110.046 179.875 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 183' ' ' THR . . . . . 0.434 HG21 ' CE2' ' A' ' 200' ' ' PHE . 0.0 OUTLIER -135.75 111.74 9.57 Favored 'General case' 0 C--N 1.294 -1.843 0 N-CA-C 107.367 -1.346 . . . . 0.0 107.367 178.493 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 184' ' ' CYS . . . . . . . . . . . . . 0.8 OUTLIER -79.6 156.14 27.81 Favored 'General case' 0 C--N 1.292 -1.909 0 C-N-CA 118.783 -1.167 . . . . 0.0 110.851 -177.947 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 185' ' ' ASP . . . . . 0.481 ' OD1' ' N ' ' A' ' 186' ' ' ASP . 10.3 t0 -167.24 -154.07 0.16 Allowed 'General case' 0 N--CA 1.495 1.789 0 O-C-N 121.365 -0.834 . . . . 0.0 109.821 -179.656 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 186' ' ' ASP . . . . . 0.481 ' N ' ' OD1' ' A' ' 185' ' ' ASP . 0.9 OUTLIER 52.8 52.63 13.58 Favored 'General case' 0 N--CA 1.496 1.862 0 O-C-N 121.294 -0.879 . . . . 0.0 109.504 -179.858 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 187' ' ' TYR . . . . . 0.577 ' CE1' ' O ' ' A' ' 188' ' ' ASN . 56.9 t80 -68.68 129.25 39.39 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.291 -0.881 . . . . 0.0 110.958 -179.677 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 188' ' ' ASN . . . . . 1.044 HD22 ' N ' ' A' ' 191' ' ' THR . 0.0 OUTLIER -101.09 151.39 21.87 Favored 'General case' 0 C--N 1.293 -1.86 0 N-CA-C 107.07 -1.456 . . . . 0.0 107.07 177.073 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 189' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -112.82 -7.15 13.79 Favored 'General case' 0 C--N 1.294 -1.816 0 N-CA-C 108.179 -1.045 . . . . 0.0 108.179 -179.526 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 190' ' ' LYS . . . . . 0.844 ' H ' ' ND2' ' A' ' 188' ' ' ASN . 0.6 OUTLIER -82.91 -56.16 3.98 Favored 'General case' 0 N--CA 1.489 1.482 0 C-N-CA 120.062 -0.655 . . . . 0.0 109.424 179.144 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 191' ' ' THR . . . . . 1.044 ' N ' HD22 ' A' ' 188' ' ' ASN . 4.9 p -88.12 -2.86 58.86 Favored 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.305 -0.872 . . . . 0.0 109.453 -179.779 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 192' ' ' GLY . . . . . . . . . . . . . . . 62.86 33.18 86.3 Favored Glycine 0 N--CA 1.493 2.483 0 O-C-N 121.345 -0.847 . . . . 0.0 111.657 178.349 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 193' ' ' VAL . . . . . 0.545 HG12 ' OG1' ' A' ' 191' ' ' THR . 4.0 p -147.81 167.05 4.97 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.689 0 O-C-N 120.686 -1.479 . . . . 0.0 109.959 178.873 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 194' ' ' TRP . . . . . 0.571 ' CD1' ' OG1' ' C' ' 705' ' ' B27 . 17.0 m95 -82.04 120.86 25.81 Favored 'General case' 0 C--N 1.295 -1.764 0 N-CA-C 108.495 -0.928 . . . . 0.0 108.495 179.854 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 195' ' ' GLU . . . . . . . . . . . . . 1.3 mt-10 -83.84 -60.97 1.95 Allowed 'General case' 0 C--N 1.301 -1.513 0 O-C-N 121.471 -0.768 . . . . 0.0 110.864 -178.086 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 196' ' ' LYS . . . . . . . . . . . . . 12.8 tttt -86.39 158.42 19.63 Favored 'General case' 0 C--N 1.301 -1.527 0 O-C-N 120.888 -1.132 . . . . 0.0 110.566 -179.007 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 197' ' ' ARG . . . . . 0.404 ' HE ' ' HB2' ' C' ' 702' ' ' LEU . 0.0 OUTLIER -126.29 135.73 51.89 Favored 'General case' 0 N--CA 1.489 1.482 0 N-CA-C 108.512 -0.922 . . . . 0.0 108.512 179.116 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 198' ' ' LYS . . . . . . . . . . . . . 14.3 mttt -115.39 120.93 41.23 Favored 'General case' 0 N--CA 1.494 1.727 0 O-C-N 121.553 -0.717 . . . . 0.0 110.422 -179.197 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 199' ' ' ILE . . . . . 0.462 ' C ' HD12 ' A' ' 199' ' ' ILE . 0.9 OUTLIER -141.51 118.81 8.06 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.646 0 CA-C-O 122.494 1.14 . . . . 0.0 110.043 179.478 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 200' ' ' PHE . . . . . 0.619 ' CD1' ' N ' ' A' ' 200' ' ' PHE . 0.3 OUTLIER -104.24 135.74 45.15 Favored 'General case' 0 N--CA 1.496 1.855 0 O-C-N 121.295 -0.878 . . . . 0.0 109.586 -178.441 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 201' ' ' VAL . . . . . 0.444 HG12 ' N ' ' A' ' 202' ' ' ALA . 85.2 t -104.36 154.57 6.1 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.611 0 O-C-N 120.979 -1.076 . . . . 0.0 109.07 178.585 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 202' ' ' ALA . . . . . 0.444 ' N ' HG12 ' A' ' 201' ' ' VAL . . . -136.49 142.37 43.52 Favored 'General case' 0 C--N 1.302 -1.472 0 O-C-N 121.153 -0.967 . . . . 0.0 109.055 179.991 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 203' ' ' THR . . . . . 0.507 ' O ' HG23 ' A' ' 205' ' ' VAL . 0.6 OUTLIER -88.59 129.66 35.44 Favored 'General case' 0 N--CA 1.488 1.465 0 CA-C-O 122.281 1.039 . . . . 0.0 111.26 -178.455 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 204' ' ' GLU . . . . . 0.536 ' HA ' ' CD2' ' A' ' 153' ' ' TYR . 12.0 tt0 -49.59 134.74 19.42 Favored 'General case' 0 C--N 1.298 -1.643 0 C-N-CA 119.098 -1.041 . . . . 0.0 108.626 178.38 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 205' ' ' VAL . . . . . 0.539 HG12 ' N ' ' A' ' 206' ' ' LYS . 39.0 t -125.86 161.13 31.62 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.304 0 CA-C-O 122.263 1.03 . . . . 0.0 110.431 -177.765 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 206' ' ' LYS . . . . . 0.539 ' N ' HG12 ' A' ' 205' ' ' VAL . 13.1 mtmt . . . . . 0 C--N 1.293 -1.864 0 CA-C-O 117.931 -1.033 . . . . 0.0 108.983 179.754 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' C' C ' 701' ' ' PHQ . . . . . 0.487 ' O2 ' HG12 ' A' ' 166' ' ' VAL . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 019 nuclear build full ' C' C ' 702' ' ' LEU . . . . . 0.858 ' N ' HD12 ' C' ' 702' ' ' LEU . 0.0 OUTLIER . . . . . 0 N--CA 1.488 1.453 0 N-CA-C 108.735 -0.839 . . . . 0.0 108.735 . . . . . . . . . 2 2 . 1 . 019 nuclear build full ' C' C ' 703' ' ' PRO . . . . . 0.47 ' HB2' ' HB3' ' A' ' 92' ' ' ALA . 9.4 Cg_endo -64.97 -173.0 0.23 Allowed 'Trans proline' 0 N--CA 1.491 1.341 0 C-N-CA 121.619 1.546 . . . . 0.0 112.099 -179.666 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' C' C ' 704' ' ' ALA . . . . . 0.663 ' HB2' ' HB1' ' A' ' 118' ' ' ALA . . . 56.99 97.51 0.02 OUTLIER 'General case' 0 N--CA 1.487 1.415 0 O-C-N 121.334 -0.854 . . . . 0.0 109.396 -179.558 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' C' C ' 705' ' ' B27 . . . . . 0.571 ' OG1' ' CD1' ' A' ' 194' ' ' TRP . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 700' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 020 nuclear build full ' A' A ' 59' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.491 1.575 0 N-CA-C 109.391 -0.596 . . . . 0.0 109.391 . . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 60' ' ' GLN . . . . . . . . . . . . . 0.4 OUTLIER -60.33 -176.54 0.05 Allowed 'General case' 0 N--CA 1.491 1.615 0 N-CA-C 108.794 -0.817 . . . . 0.0 108.794 179.665 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . -65.05 154.19 38.54 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 120.878 -1.139 . . . . 0.0 109.467 179.981 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 62' ' ' LYS . . . . . . . . . . . . . 5.4 tmtm? -141.46 74.64 23.56 Favored Pre-proline 0 N--CA 1.491 1.618 0 C-N-CA 119.397 -0.921 . . . . 0.0 109.896 179.932 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 63' ' ' PRO . . . . . . . . . . . . . 45.2 Cg_endo -91.71 156.74 3.49 Favored 'Trans proline' 0 C--N 1.307 -1.62 0 C-N-CA 123.378 2.718 . . . . 0.0 112.224 179.712 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 64' ' ' GLN . . . . . 0.591 ' N ' ' CD ' ' A' ' 64' ' ' GLN . 0.0 OUTLIER -153.98 117.49 4.63 Favored 'General case' 0 N--CA 1.498 1.932 0 O-C-N 121.531 -0.73 . . . . 0.0 109.163 179.517 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 65' ' ' ILE . . . . . 0.44 ' C ' ' O ' ' A' ' 64' ' ' GLN . 3.2 mp -45.28 105.75 0.49 Allowed Pre-proline 0 N--CA 1.493 1.682 0 O-C-N 121.027 -1.045 . . . . 0.0 108.758 179.395 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 66' ' ' PRO . . . . . . . . . . . . . 84.5 Cg_endo -86.46 -158.08 0.08 OUTLIER 'Trans proline' 0 N--CA 1.488 1.148 0 C-N-CA 122.048 1.832 . . . . 0.0 112.51 -179.536 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 67' ' ' LYS . . . . . 0.435 ' O ' ' N ' ' A' ' 69' ' ' LYS . 0.0 OUTLIER -82.82 -4.56 58.18 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.396 -0.815 . . . . 0.0 109.584 -179.756 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 68' ' ' ASP . . . . . 0.62 ' C ' ' N ' ' A' ' 70' ' ' SER . 0.3 OUTLIER -74.05 51.1 0.39 Allowed 'General case' 0 N--CA 1.487 1.411 0 CA-C-O 122.913 1.34 . . . . 0.0 107.919 179.28 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 69' ' ' LYS . . . . . 0.435 ' N ' ' O ' ' A' ' 67' ' ' LYS . 0.1 OUTLIER -49.54 -13.13 0.07 Allowed 'General case' 0 C--N 1.29 -1.99 0 C-N-CA 116.889 -1.924 . . . . 0.0 106.976 178.792 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 70' ' ' SER . . . . . 0.62 ' N ' ' C ' ' A' ' 68' ' ' ASP . 3.6 p -84.25 -8.99 58.87 Favored 'General case' 0 N--CA 1.498 1.96 0 CA-C-N 113.631 -1.622 . . . . 0.0 110.056 178.444 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 71' ' ' LYS . . . . . . . . . . . . . 2.6 ptmm? -96.89 140.57 31.24 Favored 'General case' 0 N--CA 1.494 1.737 0 O-C-N 120.905 -1.122 . . . . 0.0 111.003 -179.739 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 72' ' ' VAL . . . . . 0.674 HG12 ' CE1' ' A' ' 88' ' ' TYR . 1.1 m -63.23 139.78 20.71 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.387 0 N-CA-C 104.331 -2.47 . . . . 0.0 104.331 175.288 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 73' ' ' ALA . . . . . 0.512 ' N ' ' O ' ' A' ' 87' ' ' VAL . . . -82.15 -16.99 47.93 Favored 'General case' 0 C--N 1.287 -2.14 0 C-N-CA 117.405 -1.718 . . . . 0.0 106.806 -179.948 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . 177.7 -158.54 23.8 Favored Glycine 0 C--N 1.298 -1.54 0 N-CA-C 109.383 -1.487 . . . . 0.0 109.383 179.408 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 75' ' ' TYR . . . . . 0.499 ' HA ' HG23 ' A' ' 87' ' ' VAL . 0.7 OUTLIER -143.47 165.48 27.44 Favored 'General case' 0 C--N 1.296 -1.729 0 O-C-N 121.716 -0.873 . . . . 0.0 110.55 -176.722 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 76' ' ' ILE . . . . . . . . . . . . . 4.4 tt -148.66 146.68 17.42 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.453 0 C-N-CA 119.069 -1.052 . . . . 0.0 110.659 -177.866 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -150.13 167.84 25.66 Favored 'General case' 0 N--CA 1.489 1.482 0 O-C-N 121.181 -0.949 . . . . 0.0 109.195 179.119 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 78' ' ' ILE . . . . . 0.472 ' HB ' ' HB3' ' A' ' 81' ' ' ALA . 16.9 mt -149.67 98.18 3.43 Favored Pre-proline 0 C--N 1.303 -1.442 0 N-CA-C 108.543 -0.91 . . . . 0.0 108.543 179.474 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 79' ' ' PRO . . . . . . . . . . . . . 54.1 Cg_exo -48.83 -46.57 24.22 Favored 'Trans proline' 0 C--N 1.31 -1.481 0 C-N-CA 122.517 2.145 . . . . 0.0 113.76 -178.95 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -66.02 -19.83 65.99 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 120.892 -1.13 . . . . 0.0 111.244 179.339 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 81' ' ' ALA . . . . . 0.711 ' HB2' ' HB2' ' A' ' 136' ' ' ALA . . . -105.42 -19.34 13.82 Favored 'General case' 0 N--CA 1.495 1.806 0 O-C-N 121.052 -1.03 . . . . 0.0 108.861 179.633 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 82' ' ' ASP . . . . . 0.452 ' CB ' ' O ' ' A' ' 81' ' ' ALA . 5.6 t70 71.42 48.01 0.35 Allowed 'General case' 0 N--CA 1.494 1.736 0 O-C-N 120.988 -1.07 . . . . 0.0 110.328 179.33 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 83' ' ' ILE . . . . . 0.508 HD11 ' OD1' ' A' ' 132' ' ' ASN . 82.5 mt -127.42 152.57 35.63 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.696 0 O-C-N 121.265 -0.897 . . . . 0.0 110.021 -179.006 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 84' ' ' LYS . . . . . . . . . . . . . 33.2 tttt -159.46 107.32 1.76 Allowed 'General case' 0 N--CA 1.491 1.617 0 N-CA-C 107.944 -1.132 . . . . 0.0 107.944 179.427 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 85' ' ' GLU . . . . . 0.413 ' C ' ' CD2' ' A' ' 75' ' ' TYR . 0.3 OUTLIER -144.05 164.85 27.03 Favored Pre-proline 0 N--CA 1.491 1.604 0 O-C-N 121.281 -0.887 . . . . 0.0 110.488 -178.741 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 86' ' ' PRO . . . . . 0.409 ' O ' HG22 ' A' ' 101' ' ' VAL . 55.8 Cg_endo -72.46 170.38 19.47 Favored 'Trans proline' 0 N--CA 1.495 1.578 0 C-N-CA 123.635 2.89 . . . . 0.0 113.633 -179.494 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 87' ' ' VAL . . . . . 0.512 ' O ' ' N ' ' A' ' 73' ' ' ALA . 54.1 t -127.26 98.07 4.41 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.822 0 N-CA-C 109.047 -0.723 . . . . 0.0 109.047 179.828 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 88' ' ' TYR . . . . . 0.674 ' CE1' HG12 ' A' ' 72' ' ' VAL . 21.1 m-85 -88.17 154.05 51.74 Favored Pre-proline 0 N--CA 1.505 2.284 0 O-C-N 120.659 -1.276 . . . . 0.0 110.42 -179.443 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 89' ' ' PRO . . . . . 0.422 ' HA ' ' CD2' ' A' ' 103' ' ' PHE . 9.7 Cg_endo -61.54 145.09 98.12 Favored 'Trans proline' 0 C--N 1.311 -1.429 0 C-N-CA 122.5 2.133 . . . . 0.0 113.76 -179.677 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . -56.58 166.05 4.69 Favored Glycine 0 N--CA 1.491 2.342 0 N-CA-C 109.575 -1.41 . . . . 0.0 109.575 179.255 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 91' ' ' PRO . . . . . 0.439 ' C ' ' H ' ' A' ' 93' ' ' THR . 44.8 Cg_endo -94.29 168.22 19.08 Favored 'Cis proline' 0 C--N 1.312 -1.38 0 C-N-CA 123.864 -1.307 . . . . 0.0 111.949 0.167 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 92' ' ' ALA . . . . . 0.727 ' HB1' HD21 ' A' ' 97' ' ' LEU . . . -71.91 31.26 0.05 Allowed 'General case' 0 C--N 1.302 -1.463 0 O-C-N 121.281 -0.887 . . . . 0.0 110.396 179.952 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 93' ' ' THR . . . . . 0.439 ' H ' ' C ' ' A' ' 91' ' ' PRO . 1.0 OUTLIER -74.71 151.24 86.85 Favored Pre-proline 0 N--CA 1.491 1.605 0 O-C-N 120.501 -1.374 . . . . 0.0 108.43 179.846 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 94' ' ' PRO . . . . . 0.414 ' C ' ' O ' ' A' ' 93' ' ' THR . 86.5 Cg_exo -29.91 -54.42 0.19 Allowed 'Trans proline' 0 C--N 1.308 -1.565 0 C-N-CA 123.228 2.619 . . . . 0.0 113.207 -178.861 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 95' ' ' GLU . . . . . 0.413 ' HB2' HE22 ' A' ' 96' ' ' GLN . 83.6 mt-10 -47.24 -49.31 23.58 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 120.796 -1.19 . . . . 0.0 109.706 -179.528 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 96' ' ' GLN . . . . . 0.481 ' O ' ' N ' ' A' ' 98' ' ' ASN . 3.3 mp0 -71.72 -53.13 14.47 Favored 'General case' 0 C--N 1.303 -1.446 0 O-C-N 121.337 -0.852 . . . . 0.0 110.376 -179.658 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 97' ' ' LEU . . . . . 0.727 HD21 ' HB1' ' A' ' 92' ' ' ALA . 83.8 mt -50.53 -9.0 0.04 OUTLIER 'General case' 0 N--CA 1.493 1.724 0 O-C-N 121.149 -0.969 . . . . 0.0 110.299 -178.498 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 98' ' ' ASN . . . . . 0.628 HD21 ' NE ' ' A' ' 99' ' ' ARG . 0.2 OUTLIER -72.55 -27.69 62.38 Favored 'General case' 0 N--CA 1.488 1.45 0 O-C-N 121.029 -1.044 . . . . 0.0 108.863 179.534 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 99' ' ' ARG . . . . . 0.628 ' NE ' HD21 ' A' ' 98' ' ' ASN . 6.1 mtt180 -94.27 -60.17 1.79 Allowed 'General case' 0 N--CA 1.491 1.577 0 C-N-CA 119.973 -0.691 . . . . 0.0 110.529 -179.651 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . -171.66 -166.58 30.61 Favored Glycine 0 N--CA 1.499 2.835 0 C-N-CA 119.424 -1.369 . . . . 0.0 111.003 -179.501 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 101' ' ' VAL . . . . . 0.748 HG23 ' O ' ' A' ' 101' ' ' VAL . 16.3 m -57.47 106.46 0.18 Allowed 'Isoleucine or valine' 0 N--CA 1.498 1.928 0 O-C-N 121.554 -0.968 . . . . 0.0 109.455 -179.783 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -93.8 159.71 15.07 Favored 'General case' 0 N--CA 1.493 1.696 0 O-C-N 121.244 -0.91 . . . . 0.0 111.633 -179.068 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 103' ' ' PHE . . . . . 0.422 ' CD2' ' HA ' ' A' ' 89' ' ' PRO . 23.5 m-85 -63.18 130.93 46.71 Favored 'General case' 0 N--CA 1.49 1.531 0 N-CA-C 107.881 -1.155 . . . . 0.0 107.881 178.235 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 104' ' ' ALA . . . . . . . . . . . . . . . -50.95 -18.34 0.75 Allowed 'General case' 0 C--N 1.299 -1.619 0 O-C-N 121.58 -0.7 . . . . 0.0 111.42 -178.532 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -136.91 146.66 45.74 Favored 'General case' 0 N--CA 1.495 1.808 0 O-C-N 120.799 -1.188 . . . . 0.0 111.011 -179.447 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 106' ' ' GLU . . . . . . . . . . . . . 1.7 tt0 -55.26 -62.33 1.74 Allowed 'General case' 0 C--N 1.305 -1.351 0 CA-C-N 116.061 -0.518 . . . . 0.0 110.316 -179.903 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 107' ' ' ASN . . . . . 0.435 ' N ' ' OD1' ' A' ' 107' ' ' ASN . 1.9 m-20 -78.81 33.48 0.21 Allowed 'General case' 0 N--CA 1.491 1.607 0 O-C-N 120.609 -1.307 . . . . 0.0 113.184 -175.638 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 108' ' ' GLU . . . . . . . . . . . . . 29.0 tp10 -58.25 143.32 44.85 Favored 'General case' 0 N--CA 1.495 1.813 0 O-C-N 120.468 -1.395 . . . . 0.0 107.963 179.945 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 109' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -94.95 140.45 29.92 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 120.961 -1.087 . . . . 0.0 110.987 -178.013 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 110' ' ' LEU . . . . . 0.484 HD11 HG21 ' A' ' 146' ' ' VAL . 0.7 OUTLIER -63.7 -16.78 61.94 Favored 'General case' 0 C--N 1.302 -1.469 0 N-CA-C 108.754 -0.832 . . . . 0.0 108.754 179.207 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 111' ' ' ASP . . . . . . . . . . . . . 13.0 m-20 -133.1 36.83 3.43 Favored 'General case' 0 N--CA 1.488 1.475 0 O-C-N 121.677 -0.639 . . . . 0.0 109.762 -179.439 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 112' ' ' ASP . . . . . . . . . . . . . 1.7 t0 -65.93 150.07 49.22 Favored 'General case' 0 N--CA 1.494 1.76 0 O-C-N 121.033 -1.042 . . . . 0.0 110.706 -179.58 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 113' ' ' GLN . . . . . . . . . . . . . 2.4 mp0 -68.11 -13.12 61.97 Favored 'General case' 0 N--CA 1.491 1.598 0 N-CA-C 107.849 -1.167 . . . . 0.0 107.849 177.84 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 114' ' ' ASN . . . . . . . . . . . . . 2.7 t30 -149.38 103.0 3.25 Favored 'General case' 0 C--N 1.302 -1.477 0 N-CA-C 107.818 -1.178 . . . . 0.0 107.818 177.913 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 115' ' ' ILE . . . . . 0.492 ' O ' HG22 ' A' ' 115' ' ' ILE . 3.0 mt -97.34 110.47 25.26 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.479 0 O-C-N 121.156 -0.965 . . . . 0.0 109.837 -179.135 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 116' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -96.38 145.23 25.81 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.075 -1.015 . . . . 0.0 111.265 -178.392 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 117' ' ' ILE . . . . . . . . . . . . . 1.4 mt -139.65 156.55 26.21 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.768 0 N-CA-C 107.887 -1.153 . . . . 0.0 107.887 178.951 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 118' ' ' ALA . . . . . . . . . . . . . . . -142.06 160.38 40.34 Favored 'General case' 0 N--CA 1.491 1.601 0 C-N-CA 118.775 -1.17 . . . . 0.0 111.812 -179.07 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 119' ' ' GLY . . . . . . . . . . . . . . . -164.66 145.49 10.34 Favored Glycine 0 N--CA 1.481 1.688 0 N-CA-C 109.636 -1.386 . . . . 0.0 109.636 179.667 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 120' ' ' HIS . . . . . 0.449 ' CD2' HD13 ' A' ' 97' ' ' LEU . 10.5 m-70 -71.03 166.22 21.82 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.665 -0.903 . . . . 0.0 109.897 179.119 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 121' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -123.69 149.28 45.68 Favored 'General case' 0 N--CA 1.496 1.858 0 N-CA-C 107.637 -1.245 . . . . 0.0 107.637 178.53 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 122' ' ' PHE . . . . . 0.442 ' H ' ' HG1' ' A' ' 131' ' ' THR . 0.4 OUTLIER -114.88 138.02 51.28 Favored 'General case' 0 N--CA 1.492 1.666 0 O-C-N 121.178 -0.951 . . . . 0.0 109.99 -179.227 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 123' ' ' ILE . . . . . 0.487 HG23 ' N ' ' A' ' 124' ' ' ASP . 17.8 tt -89.39 -31.56 5.41 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.677 0 CA-C-O 121.98 0.895 . . . . 0.0 109.432 -179.782 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 124' ' ' ASP . . . . . 0.487 ' N ' HG23 ' A' ' 123' ' ' ILE . 0.2 OUTLIER -85.48 -3.67 58.93 Favored 'General case' 0 C--N 1.292 -1.908 0 C-N-CA 120.05 -0.66 . . . . 0.0 112.218 -177.71 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 125' ' ' ARG . . . . . 0.411 ' HG3' ' CD1' ' A' ' 122' ' ' PHE . 0.0 OUTLIER -157.15 130.97 4.8 Favored Pre-proline 0 N--CA 1.499 1.986 0 O-C-N 120.249 -1.532 . . . . 0.0 110.668 179.443 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 126' ' ' PRO . . . . . . . . . . . . . 88.7 Cg_endo -83.18 -13.23 9.02 Favored 'Trans proline' 0 N--CA 1.497 1.709 0 C-N-CA 122.676 2.251 . . . . 0.0 113.218 178.94 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 127' ' ' ASN . . . . . . . . . . . . . 1.4 t30 -89.32 24.79 2.1 Favored 'General case' 0 N--CA 1.494 1.735 0 O-C-N 121.041 -1.037 . . . . 0.0 110.05 -178.924 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 128' ' ' TYR . . . . . . . . . . . . . 9.6 t80 -83.15 -148.75 0.09 Allowed 'General case' 0 C--N 1.299 -1.621 0 O-C-N 121.237 -0.914 . . . . 0.0 109.322 -179.892 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 129' ' ' GLN . . . . . . . . . . . . . 6.9 mt-30 -65.75 -88.51 0.01 OUTLIER 'General case' 0 C--N 1.299 -1.63 0 O-C-N 121.345 -0.847 . . . . 0.0 110.172 -179.319 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 130' ' ' PHE . . . . . 0.576 ' CE2' HG11 ' A' ' 101' ' ' VAL . 35.8 m-85 -111.91 32.27 5.6 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.353 -0.842 . . . . 0.0 109.977 -179.249 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 131' ' ' THR . . . . . 0.442 ' HG1' ' H ' ' A' ' 122' ' ' PHE . 89.8 m -71.23 -33.94 70.32 Favored 'General case' 0 N--CA 1.497 1.878 0 O-C-N 121.385 -0.822 . . . . 0.0 109.441 179.514 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 132' ' ' ASN . . . . . 0.606 ' ND2' ' O ' ' A' ' 81' ' ' ALA . 0.1 OUTLIER -84.69 5.82 26.67 Favored 'General case' 0 N--CA 1.498 1.962 0 CA-C-O 121.945 0.879 . . . . 0.0 109.364 -179.624 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 133' ' ' LEU . . . . . 0.592 ' O ' ' N ' ' A' ' 135' ' ' ALA . 0.2 OUTLIER -72.34 -45.25 60.72 Favored 'General case' 0 C--N 1.297 -1.684 0 O-C-N 121.157 -0.964 . . . . 0.0 109.738 179.69 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 134' ' ' LYS . . . . . 0.624 ' CE ' ' H ' ' A' ' 134' ' ' LYS . 0.0 OUTLIER -47.39 -10.39 0.02 OUTLIER 'General case' 0 C--N 1.3 -1.585 0 O-C-N 121.14 -0.975 . . . . 0.0 109.546 -179.634 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 135' ' ' ALA . . . . . 0.592 ' N ' ' O ' ' A' ' 133' ' ' LEU . . . -84.65 -39.72 18.28 Favored 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.081 -1.012 . . . . 0.0 109.165 179.225 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 136' ' ' ALA . . . . . 0.711 ' HB2' ' HB2' ' A' ' 81' ' ' ALA . . . -78.19 159.58 28.47 Favored 'General case' 0 N--CA 1.489 1.49 0 CA-C-O 122.08 0.943 . . . . 0.0 111.586 -178.472 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 137' ' ' LYS . . . . . 0.559 ' O ' ' O ' ' A' ' 138' ' ' LYS . 7.9 tttt -154.25 -162.76 1.47 Allowed 'General case' 0 N--CA 1.492 1.662 0 C-N-CA 118.801 -1.159 . . . . 0.0 110.467 -178.515 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 138' ' ' LYS . . . . . 0.606 ' O ' ' N ' ' A' ' 140' ' ' SER . 23.0 mttt -44.25 -179.26 0.0 OUTLIER 'General case' 0 C--N 1.302 -1.468 0 CA-C-O 122.334 1.064 . . . . 0.0 110.667 -179.282 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 139' ' ' GLY . . . . . . . . . . . . . . . 46.41 8.25 0.02 OUTLIER Glycine 0 N--CA 1.492 2.408 0 N-CA-C 110.018 -1.233 . . . . 0.0 110.018 -179.676 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 140' ' ' SER . . . . . 0.606 ' N ' ' O ' ' A' ' 138' ' ' LYS . 9.9 m -81.2 144.11 31.85 Favored 'General case' 0 N--CA 1.493 1.705 0 O-C-N 120.864 -1.374 . . . . 0.0 109.224 179.235 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 141' ' ' MET . . . . . . . . . . . . . 2.1 tpt -96.39 125.95 41.25 Favored 'General case' 0 C--N 1.301 -1.535 0 O-C-N 121.127 -0.983 . . . . 0.0 109.403 -179.921 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 142' ' ' VAL . . . . . . . . . . . . . 2.4 t -113.77 128.77 70.52 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.838 0 O-C-N 121.269 -0.894 . . . . 0.0 109.554 -179.438 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 143' ' ' TYR . . . . . 0.409 ' CZ ' ' CD ' ' A' ' 152' ' ' LYS . 3.0 m-85 -107.48 134.39 50.58 Favored 'General case' 0 N--CA 1.497 1.91 0 O-C-N 121.172 -0.955 . . . . 0.0 111.158 -178.838 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 144' ' ' PHE . . . . . . . . . . . . . 24.7 t80 -118.86 99.89 7.04 Favored 'General case' 0 N--CA 1.494 1.726 0 N-CA-C 109.221 -0.659 . . . . 0.0 109.221 179.965 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 145' ' ' LYS . . . . . . . . . . . . . 8.2 mtpm? -98.56 122.47 41.8 Favored 'General case' 0 N--CA 1.488 1.426 0 O-C-N 121.231 -0.918 . . . . 0.0 110.196 -179.353 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 146' ' ' VAL . . . . . 0.498 HG23 ' O ' ' A' ' 73' ' ' ALA . 1.0 OUTLIER -143.51 122.82 8.25 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.499 0 O-C-N 120.885 -1.134 . . . . 0.0 109.058 179.005 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 147' ' ' GLY . . . . . . . . . . . . . . . 67.23 -132.91 30.7 Favored Glycine 0 N--CA 1.484 1.869 0 N-CA-C 108.186 -1.966 . . . . 0.0 108.186 -179.387 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 148' ' ' ASN . . . . . 0.514 ' CG ' ' O ' ' A' ' 148' ' ' ASN . 0.1 OUTLIER -101.28 11.36 39.44 Favored 'General case' 0 C--N 1.296 -1.727 0 N-CA-C 107.918 -1.141 . . . . 0.0 107.918 178.789 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 149' ' ' GLU . . . . . . . . . . . . . 2.4 tt0 -108.13 143.03 37.45 Favored 'General case' 0 N--CA 1.489 1.484 0 O-C-N 121.311 -0.868 . . . . 0.0 111.35 -178.841 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 150' ' ' THR . . . . . 0.405 ' O ' HG22 ' A' ' 150' ' ' THR . 3.7 m -131.03 100.64 5.3 Favored 'General case' 0 N--CA 1.495 1.822 0 CA-C-O 121.413 0.625 . . . . 0.0 109.724 179.923 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 151' ' ' ARG . . . . . 0.58 HH12 ' CD ' ' A' ' 204' ' ' GLU . 0.1 OUTLIER -86.63 -169.99 2.88 Favored 'General case' 0 C--N 1.305 -1.347 0 N-CA-C 108.382 -0.969 . . . . 0.0 108.382 179.466 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 152' ' ' LYS . . . . . 0.42 ' C ' ' CD1' ' A' ' 153' ' ' TYR . 24.8 mtmm -153.22 151.29 29.9 Favored 'General case' 0 C--N 1.3 -1.57 0 O-C-N 121.327 -0.858 . . . . 0.0 109.7 -179.857 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 153' ' ' TYR . . . . . 0.508 ' CD2' ' HA ' ' A' ' 204' ' ' GLU . 6.2 m-85 -142.79 168.81 18.85 Favored 'General case' 0 N--CA 1.493 1.706 0 N-CA-C 107.856 -1.164 . . . . 0.0 107.856 178.759 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 154' ' ' LYS . . . . . . . . . . . . . 20.5 ttpt -142.9 119.38 10.98 Favored 'General case' 0 N--CA 1.493 1.678 0 O-C-N 121.51 -0.744 . . . . 0.0 109.186 178.884 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 155' ' ' MET . . . . . . . . . . . . . 29.2 mtp -47.28 105.62 0.07 Allowed 'General case' 0 N--CA 1.494 1.747 0 O-C-N 120.819 -1.176 . . . . 0.0 112.321 -178.983 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 156' ' ' THR . . . . . . . . . . . . . 1.3 m -105.39 -21.29 13.26 Favored 'General case' 0 N--CA 1.494 1.755 0 CA-C-N 115.445 -0.798 . . . . 0.0 110.168 -179.548 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 157' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -148.38 147.02 28.75 Favored 'General case' 0 N--CA 1.494 1.753 0 C-N-CA 118.336 -1.345 . . . . 0.0 110.814 -178.689 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 158' ' ' ILE . . . . . . . . . . . . . 1.1 mt -148.49 138.24 16.22 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.547 0 CA-C-O 121.577 0.703 . . . . 0.0 109.953 -178.463 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 159' ' ' ARG . . . . . . . . . . . . . 5.7 ttm180 -156.45 -161.96 1.19 Allowed 'General case' 0 N--CA 1.497 1.893 0 O-C-N 121.325 -0.859 . . . . 0.0 110.594 -179.565 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 160' ' ' ASP . . . . . . . . . . . . . 67.4 m-20 -149.09 156.17 41.81 Favored 'General case' 0 N--CA 1.498 1.956 0 N-CA-C 108.954 -0.758 . . . . 0.0 108.954 -179.909 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 161' ' ' VAL . . . . . 0.454 ' O ' ' O ' ' A' ' 162' ' ' LYS . 0.1 OUTLIER -149.15 148.08 16.04 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.807 0 O-C-N 120.699 -1.251 . . . . 0.0 110.359 179.851 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 162' ' ' LYS . . . . . 0.578 ' H ' ' CD ' ' A' ' 162' ' ' LYS . 0.0 OUTLIER -44.33 169.07 0.07 OUTLIER Pre-proline 0 N--CA 1.494 1.756 0 O-C-N 121.409 -0.807 . . . . 0.0 110.191 179.997 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 163' ' ' PRO . . . . . 0.418 ' C ' HD21 ' C' ' 702' ' ' LEU . 58.0 Cg_endo -78.98 23.7 0.62 Allowed 'Trans proline' 0 C--N 1.31 -1.476 0 C-N-CA 122.917 2.411 . . . . 0.0 112.572 -179.169 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 164' ' ' THR . . . . . 0.704 ' HA ' HD11 ' C' ' 702' ' ' LEU . 0.2 OUTLIER -151.22 1.69 0.41 Allowed 'General case' 0 C--N 1.299 -1.592 0 O-C-N 121.322 -0.861 . . . . 0.0 109.864 -179.488 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 165' ' ' ASP . . . . . 0.481 ' O ' ' C ' ' A' ' 166' ' ' VAL . 8.3 t70 -77.35 66.44 3.11 Favored 'General case' 0 N--CA 1.493 1.687 0 O-C-N 121.15 -0.969 . . . . 0.0 110.334 -179.877 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 166' ' ' VAL . . . . . 0.639 ' O ' ' N ' ' A' ' 168' ' ' VAL . 0.9 OUTLIER -38.0 -32.54 0.11 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.576 0 O-C-N 121.158 -0.963 . . . . 0.0 109.375 -178.638 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 167' ' ' GLY . . . . . 0.466 ' N ' ' O ' ' A' ' 165' ' ' ASP . . . -43.16 -15.71 0.03 OUTLIER Glycine 0 N--CA 1.491 2.325 0 N-CA-C 108.848 -1.701 . . . . 0.0 108.848 179.428 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 168' ' ' VAL . . . . . 0.639 ' N ' ' O ' ' A' ' 166' ' ' VAL . 3.5 t -49.98 -44.28 21.39 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.735 0 N-CA-C 108.168 -1.049 . . . . 0.0 108.168 178.412 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 169' ' ' LEU . . . . . 0.54 ' O ' ' C ' ' A' ' 170' ' ' ASP . 8.9 mt -50.2 -9.38 0.04 OUTLIER 'General case' 0 C--N 1.299 -1.628 0 N-CA-C 108.425 -0.954 . . . . 0.0 108.425 -177.396 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 170' ' ' ASP . . . . . 0.553 ' H ' ' C ' ' A' ' 168' ' ' VAL . 10.6 p30 18.46 80.87 0.01 OUTLIER 'General case' 0 N--CA 1.5 2.05 0 CA-C-N 116.582 -0.281 . . . . 0.0 111.699 177.793 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 171' ' ' GLU . . . . . . . . . . . . . 3.7 pt-20 -117.33 65.09 0.73 Allowed 'General case' 0 N--CA 1.493 1.692 0 O-C-N 121.152 -0.967 . . . . 0.0 110.069 179.833 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 172' ' ' GLN . . . . . . . . . . . . . 12.2 mt-30 -134.44 -45.91 0.76 Allowed 'General case' 0 N--CA 1.492 1.663 0 O-C-N 121.41 -0.806 . . . . 0.0 110.253 -178.598 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 173' ' ' LYS . . . . . . . . . . . . . 17.9 mttp -62.64 135.15 57.24 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 120.769 -1.207 . . . . 0.0 108.615 179.049 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 174' ' ' GLY . . . . . 0.52 ' O ' ' C ' ' A' ' 175' ' ' LYS . . . -141.21 -40.64 0.08 OUTLIER Glycine 0 C--N 1.295 -1.707 0 N-CA-C 108.138 -1.985 . . . . 0.0 108.138 179.899 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 175' ' ' LYS . . . . . 0.52 ' C ' ' O ' ' A' ' 174' ' ' GLY . 13.0 mptt -31.84 -64.08 0.17 Allowed 'General case' 0 N--CA 1.501 2.075 0 N-CA-C 108.653 -0.869 . . . . 0.0 108.653 179.196 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 176' ' ' ASP . . . . . 0.726 ' O ' ' O ' ' A' ' 177' ' ' LYS . 2.6 m-20 -101.93 73.28 1.39 Allowed 'General case' 0 C--N 1.297 -1.706 0 N-CA-C 107.255 -1.387 . . . . 0.0 107.255 177.627 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 177' ' ' LYS . . . . . 0.726 ' O ' ' O ' ' A' ' 176' ' ' ASP . 28.2 mttt -20.62 157.79 0.0 OUTLIER 'General case' 0 N--CA 1.504 2.233 0 CA-C-O 122.132 0.968 . . . . 0.0 111.851 -178.907 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 178' ' ' GLN . . . . . . . . . . . . . 3.3 pt20 -156.07 170.89 21.14 Favored 'General case' 0 N--CA 1.488 1.467 0 C-N-CA 117.096 -1.842 . . . . 0.0 112.084 -178.727 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 179' ' ' LEU . . . . . 0.41 ' HB2' ' CE2' ' A' ' 153' ' ' TYR . 0.7 OUTLIER -126.55 97.78 5.15 Favored 'General case' 0 C--N 1.303 -1.433 0 N-CA-C 107.237 -1.394 . . . . 0.0 107.237 178.366 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 180' ' ' THR . . . . . . . . . . . . . 1.1 m -71.23 121.06 17.71 Favored 'General case' 0 C--N 1.302 -1.464 0 C-N-CA 118.726 -1.19 . . . . 0.0 110.004 -178.615 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 181' ' ' LEU . . . . . 0.526 HD11 ' CE2' ' A' ' 130' ' ' PHE . 66.8 tp -94.55 152.25 18.69 Favored 'General case' 0 C--N 1.298 -1.654 0 N-CA-C 107.589 -1.263 . . . . 0.0 107.589 177.632 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 182' ' ' ILE . . . . . 0.404 HG21 ' HG2' ' C' ' 703' ' ' PRO . 36.5 mt -142.12 109.22 1.99 Allowed 'Isoleucine or valine' 0 C--N 1.301 -1.53 0 C-N-CA 119.083 -1.047 . . . . 0.0 109.242 178.941 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 183' ' ' THR . . . . . . . . . . . . . 1.2 t -129.21 109.36 11.08 Favored 'General case' 0 C--N 1.294 -1.836 0 N-CA-C 107.751 -1.203 . . . . 0.0 107.751 179.635 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 184' ' ' CYS . . . . . . . . . . . . . 4.0 p -81.06 157.96 25.24 Favored 'General case' 0 C--N 1.293 -1.879 0 C-N-CA 119.182 -1.007 . . . . 0.0 111.349 -177.609 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 185' ' ' ASP . . . . . 0.534 ' CG ' ' H ' ' A' ' 186' ' ' ASP . 43.9 t0 -164.3 -158.4 0.42 Allowed 'General case' 0 N--CA 1.489 1.509 0 N-CA-C 108.88 -0.785 . . . . 0.0 108.88 -179.536 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 186' ' ' ASP . . . . . 0.534 ' H ' ' CG ' ' A' ' 185' ' ' ASP . 1.3 m-20 56.91 49.35 14.2 Favored 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.161 -0.962 . . . . 0.0 109.675 179.561 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 187' ' ' TYR . . . . . 0.58 ' CE1' ' O ' ' A' ' 188' ' ' ASN . 33.9 t80 -65.43 128.69 36.91 Favored 'General case' 0 C--N 1.297 -1.674 0 O-C-N 121.075 -1.016 . . . . 0.0 109.772 -179.945 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 188' ' ' ASN . . . . . 0.948 ' ND2' ' H ' ' A' ' 190' ' ' LYS . 0.0 OUTLIER -97.85 150.55 21.17 Favored 'General case' 0 C--N 1.294 -1.838 0 N-CA-C 107.886 -1.153 . . . . 0.0 107.886 178.591 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 189' ' ' GLU . . . . . . . . . . . . . 1.7 tt0 -112.58 -5.95 13.97 Favored 'General case' 0 C--N 1.294 -1.831 0 N-CA-C 108.674 -0.862 . . . . 0.0 108.674 -178.683 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 190' ' ' LYS . . . . . 0.948 ' H ' ' ND2' ' A' ' 188' ' ' ASN . 10.2 mmtm -84.06 -57.45 3.18 Favored 'General case' 0 C--N 1.299 -1.618 0 N-CA-C 108.939 -0.763 . . . . 0.0 108.939 179.401 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 191' ' ' THR . . . . . 0.92 ' N ' HD22 ' A' ' 188' ' ' ASN . 1.5 p -89.25 0.14 57.0 Favored 'General case' 0 N--CA 1.494 1.77 0 O-C-N 121.443 -0.785 . . . . 0.0 109.706 179.647 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 192' ' ' GLY . . . . . . . . . . . . . . . 60.34 37.2 92.73 Favored Glycine 0 N--CA 1.498 2.783 0 N-CA-C 110.634 -0.986 . . . . 0.0 110.634 179.318 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 193' ' ' VAL . . . . . 0.609 HG12 ' N ' ' A' ' 194' ' ' TRP . 73.9 t -148.64 163.84 4.99 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.629 0 O-C-N 120.996 -1.297 . . . . 0.0 110.298 179.879 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 194' ' ' TRP . . . . . 0.609 ' N ' HG12 ' A' ' 193' ' ' VAL . 5.5 m95 -82.44 121.36 26.64 Favored 'General case' 0 N--CA 1.489 1.518 0 N-CA-C 108.373 -0.973 . . . . 0.0 108.373 179.257 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 195' ' ' GLU . . . . . . . . . . . . . 2.5 mt-10 -86.16 -57.39 3.04 Favored 'General case' 0 C--N 1.3 -1.566 0 O-C-N 121.15 -0.969 . . . . 0.0 110.463 -178.597 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 196' ' ' LYS . . . . . . . . . . . . . 2.6 mttp -92.33 143.65 26.18 Favored 'General case' 0 N--CA 1.489 1.494 0 O-C-N 120.911 -1.118 . . . . 0.0 110.205 -179.302 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 197' ' ' ARG . . . . . 0.653 ' CG ' HH11 ' A' ' 197' ' ' ARG . 0.2 OUTLIER -122.14 144.42 48.95 Favored 'General case' 0 N--CA 1.488 1.447 0 N-CA-C 108.784 -0.821 . . . . 0.0 108.784 179.108 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 198' ' ' LYS . . . . . . . . . . . . . 13.4 mptt -115.78 119.42 35.96 Favored 'General case' 0 C--N 1.299 -1.606 0 C-N-CA 120.349 -0.54 . . . . 0.0 110.087 -178.91 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 199' ' ' ILE . . . . . 0.456 ' C ' HD12 ' A' ' 199' ' ' ILE . 1.0 OUTLIER -136.33 118.15 19.94 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.566 0 CA-C-O 122.716 1.246 . . . . 0.0 109.018 178.968 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 200' ' ' PHE . . . . . 0.535 ' CD1' ' N ' ' A' ' 200' ' ' PHE . 1.0 OUTLIER -102.84 138.37 39.82 Favored 'General case' 0 N--CA 1.492 1.671 0 CA-C-N 115.6 -0.727 . . . . 0.0 111.257 -176.918 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 201' ' ' VAL . . . . . . . . . . . . . 47.0 t -105.94 143.22 17.31 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.37 0 O-C-N 121.523 -0.736 . . . . 0.0 109.396 177.799 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 202' ' ' ALA . . . . . . . . . . . . . . . -130.37 137.57 49.96 Favored 'General case' 0 C--N 1.301 -1.502 0 N-CA-C 107.978 -1.119 . . . . 0.0 107.978 179.662 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 203' ' ' THR . . . . . 0.679 ' O ' HG23 ' A' ' 205' ' ' VAL . 0.2 OUTLIER -89.89 132.82 35.09 Favored 'General case' 0 C--N 1.303 -1.422 0 CA-C-O 122.576 1.179 . . . . 0.0 111.549 -178.796 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 204' ' ' GLU . . . . . 0.58 ' CD ' HH12 ' A' ' 151' ' ' ARG . 3.9 tt0 -49.45 135.01 18.5 Favored 'General case' 0 C--N 1.293 -1.888 0 C-N-CA 118.459 -1.296 . . . . 0.0 108.796 178.575 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 205' ' ' VAL . . . . . 0.679 HG23 ' O ' ' A' ' 203' ' ' THR . 70.8 t -129.79 162.41 37.5 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.547 0 CA-C-O 122.082 0.944 . . . . 0.0 110.284 -177.739 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 206' ' ' LYS . . . . . 0.55 ' N ' HG12 ' A' ' 205' ' ' VAL . 4.6 ptmt . . . . . 0 C--N 1.298 -1.651 0 CA-C-O 118.145 -0.931 . . . . 0.0 109.42 -179.661 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' C' C ' 701' ' ' PHQ . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 020 nuclear build full ' C' C ' 702' ' ' LEU . . . . . 0.884 ' N ' HD12 ' C' ' 702' ' ' LEU . 0.0 OUTLIER . . . . . 0 N--CA 1.485 1.32 0 N-CA-C 108.304 -0.998 . . . . 0.0 108.304 . . . . . . . . . 2 2 . 1 . 020 nuclear build full ' C' C ' 703' ' ' PRO . . . . . 0.603 ' O ' ' NH2' ' A' ' 197' ' ' ARG . 88.7 Cg_endo -81.1 172.76 12.56 Favored 'Trans proline' 0 C--N 1.303 -1.848 0 C-N-CA 122.632 2.221 . . . . 0.0 112.406 -179.688 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' C' C ' 704' ' ' ALA . . . . . 0.478 ' C ' ' O ' ' C' ' 703' ' ' PRO . . . 36.02 -156.04 0.0 OUTLIER 'General case' 0 N--CA 1.492 1.643 0 CA-C-O 121.536 0.684 . . . . 0.0 110.422 178.802 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' C' C ' 705' ' ' B27 . . . . . 0.586 ' OG1' ' CD1' ' A' ' 194' ' ' TRP . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 700' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 001 nuclear nobuild core ' A' A ' 63' ' ' PRO . . . . . 0.458 ' O ' HD22 ' A' ' 110' ' ' LEU . 6.7 Cg_exo . . . . . 0 N--CA 1.486 1.054 0 CA-C-O 121.228 0.428 . . . . 0.0 111.288 . . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 64' ' ' GLN . . . . . 0.617 HE21 ' C ' ' A' ' 64' ' ' GLN . 0.0 OUTLIER -155.75 126.9 7.09 Favored 'General case' 0 C--N 1.3 -1.56 0 O-C-N 121.117 -0.99 . . . . 0.0 109.347 179.316 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 65' ' ' ILE . . . . . 0.582 HD12 ' H ' ' A' ' 65' ' ' ILE . 2.1 mp -46.27 106.37 0.56 Allowed Pre-proline 0 N--CA 1.489 1.495 0 N-CA-C 107.519 -1.289 . . . . 0.0 107.519 178.935 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 66' ' ' PRO . . . . . . . . . . . . . 89.0 Cg_endo -83.42 -162.84 0.18 Allowed 'Trans proline' 0 C--N 1.315 -1.185 0 C-N-CA 122.462 2.108 . . . . 0.0 112.834 -178.111 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 67' ' ' LYS . . . . . . . . . . . . . 24.8 tttm -87.65 -7.56 57.29 Favored 'General case' 0 N--CA 1.487 1.423 0 O-C-N 121.414 -0.803 . . . . 0.0 109.421 179.965 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 68' ' ' ASP . . . . . 0.654 ' O ' ' N ' ' A' ' 70' ' ' SER . 0.7 OUTLIER -76.23 63.38 1.88 Allowed 'General case' 0 N--CA 1.488 1.461 0 CA-C-O 122.936 1.35 . . . . 0.0 108.822 179.561 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 69' ' ' LYS . . . . . 0.462 ' C ' ' O ' ' A' ' 68' ' ' ASP . 8.2 ptpt -45.45 -14.57 0.02 OUTLIER 'General case' 0 N--CA 1.512 2.67 0 C-N-CA 116.881 -1.928 . . . . 0.0 107.321 178.086 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 70' ' ' SER . . . . . 0.654 ' N ' ' O ' ' A' ' 68' ' ' ASP . 0.6 OUTLIER -86.83 -7.29 58.37 Favored 'General case' 0 N--CA 1.498 1.969 0 CA-C-N 113.856 -1.52 . . . . 0.0 111.661 179.793 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 71' ' ' LYS . . . . . 0.47 ' N ' ' O ' ' A' ' 68' ' ' ASP . 0.0 OUTLIER -97.05 142.47 28.95 Favored 'General case' 0 N--CA 1.505 2.323 0 O-C-N 120.435 -1.416 . . . . 0.0 112.552 -178.838 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 72' ' ' VAL . . . . . 0.844 HG12 ' CE1' ' A' ' 88' ' ' TYR . 2.6 m -68.0 130.55 33.27 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.418 0 N-CA-C 105.375 -2.083 . . . . 0.0 105.375 174.965 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 73' ' ' ALA . . . . . 0.607 ' N ' ' O ' ' A' ' 87' ' ' VAL . . . -79.02 -13.99 59.45 Favored 'General case' 0 C--N 1.293 -1.855 0 O-C-N 119.999 -1.688 . . . . 0.0 107.398 -179.596 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . 173.5 -157.72 26.5 Favored Glycine 0 N--CA 1.479 1.524 0 N-CA-C 109.48 -1.448 . . . . 0.0 109.48 179.771 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 75' ' ' TYR . . . . . 0.606 ' HA ' HG23 ' A' ' 87' ' ' VAL . 69.1 m-85 -142.06 169.72 17.06 Favored 'General case' 0 C--N 1.295 -1.787 0 CA-C-O 121.961 0.886 . . . . 0.0 110.456 -177.591 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 76' ' ' ILE . . . . . . . . . . . . . 0.8 OUTLIER -147.27 142.28 20.03 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.72 0 C-N-CA 119.234 -0.986 . . . . 0.0 109.634 -177.362 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -151.52 162.31 41.19 Favored 'General case' 0 N--CA 1.487 1.409 0 O-C-N 121.193 -0.942 . . . . 0.0 109.759 -179.934 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 78' ' ' ILE . . . . . 0.544 ' HB ' ' HB3' ' A' ' 81' ' ' ALA . 9.5 mt -145.65 123.76 6.4 Favored Pre-proline 0 C--N 1.303 -1.434 0 N-CA-C 107.821 -1.178 . . . . 0.0 107.821 179.338 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 79' ' ' PRO . . . . . . . . . . . . . 41.5 Cg_endo -71.94 -43.69 1.15 Allowed 'Trans proline' 0 C--N 1.314 -1.255 0 C-N-CA 121.867 1.712 . . . . 0.0 112.949 -178.798 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 1.3 m-20 -66.61 -21.4 66.13 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 120.959 -1.088 . . . . 0.0 110.861 178.339 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 81' ' ' ALA . . . . . 0.847 ' HB2' ' HB2' ' A' ' 136' ' ' ALA . . . -105.04 -15.89 14.97 Favored 'General case' 0 N--CA 1.496 1.838 0 O-C-N 121.139 -0.975 . . . . 0.0 109.095 179.672 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 82' ' ' ASP . . . . . . . . . . . . . 20.8 t0 62.84 52.2 2.77 Favored 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.472 -0.768 . . . . 0.0 110.847 179.292 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 83' ' ' ILE . . . . . . . . . . . . . 70.2 mt -127.27 152.85 35.79 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.735 0 O-C-N 121.229 -0.919 . . . . 0.0 109.677 -179.239 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 84' ' ' LYS . . . . . . . . . . . . . 34.6 tttp -158.21 106.49 1.98 Allowed 'General case' 0 N--CA 1.491 1.61 0 N-CA-C 107.778 -1.193 . . . . 0.0 107.778 -179.95 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 85' ' ' GLU . . . . . 0.508 ' OE2' ' O ' ' A' ' 128' ' ' TYR . 0.0 OUTLIER -141.31 165.54 28.2 Favored Pre-proline 0 N--CA 1.495 1.791 0 O-C-N 121.14 -0.975 . . . . 0.0 110.779 -178.366 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 86' ' ' PRO . . . . . . . . . . . . . 56.0 Cg_endo -73.57 168.13 25.55 Favored 'Trans proline' 0 N--CA 1.497 1.681 0 C-N-CA 123.335 2.69 . . . . 0.0 113.796 -179.595 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 87' ' ' VAL . . . . . 0.607 ' O ' ' N ' ' A' ' 73' ' ' ALA . 54.8 t -126.35 104.19 12.55 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.841 0 N-CA-C 109.368 -0.605 . . . . 0.0 109.368 179.917 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 88' ' ' TYR . . . . . 0.844 ' CE1' HG12 ' A' ' 72' ' ' VAL . 11.9 m-85 -94.92 156.76 37.66 Favored Pre-proline 0 N--CA 1.504 2.26 0 O-C-N 120.766 -1.209 . . . . 0.0 109.801 179.98 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 89' ' ' PRO . . . . . . . . . . . . . 13.4 Cg_endo -62.84 145.16 94.59 Favored 'Trans proline' 0 N--CA 1.498 1.778 0 C-N-CA 122.637 2.225 . . . . 0.0 113.273 179.591 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . -60.46 169.17 8.4 Favored Glycine 0 N--CA 1.494 2.527 0 N-CA-C 109.383 -1.487 . . . . 0.0 109.383 179.318 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 91' ' ' PRO . . . . . 0.469 ' C ' ' H ' ' A' ' 93' ' ' THR . 57.3 Cg_endo -93.5 169.15 20.47 Favored 'Cis proline' 0 C--N 1.307 -1.622 0 C-N-CA 123.966 -1.264 . . . . 0.0 111.989 0.194 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 92' ' ' ALA . . . . . 0.7 ' HB1' HD21 ' A' ' 97' ' ' LEU . . . -71.83 32.26 0.05 Allowed 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.214 -0.929 . . . . 0.0 109.988 179.957 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 93' ' ' THR . . . . . 0.469 ' H ' ' C ' ' A' ' 91' ' ' PRO . 5.4 p -72.22 150.48 92.11 Favored Pre-proline 0 C--N 1.303 -1.431 0 O-C-N 120.481 -1.387 . . . . 0.0 108.025 179.761 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 94' ' ' PRO . . . . . . . . . . . . . 74.1 Cg_exo -32.96 -52.8 0.41 Allowed 'Trans proline' 0 C--N 1.306 -1.7 0 C-N-CA 122.893 2.396 . . . . 0.0 112.965 -178.549 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 95' ' ' GLU . . . . . 0.436 ' O ' ' ND2' ' A' ' 98' ' ' ASN . 14.3 mt-10 -49.89 -47.84 51.85 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.079 -1.013 . . . . 0.0 110.061 -179.74 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 96' ' ' GLN . . . . . 0.579 ' O ' ' N ' ' A' ' 98' ' ' ASN . 1.5 mp0 -72.57 -53.99 10.4 Favored 'General case' 0 N--CA 1.489 1.487 0 O-C-N 120.98 -1.075 . . . . 0.0 110.187 -179.68 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 97' ' ' LEU . . . . . 0.7 HD21 ' HB1' ' A' ' 92' ' ' ALA . 94.0 mt -49.31 -6.56 0.02 OUTLIER 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.145 -0.972 . . . . 0.0 109.684 -179.26 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 98' ' ' ASN . . . . . 0.746 HD21 ' NE ' ' A' ' 99' ' ' ARG . 0.2 OUTLIER -73.88 -20.39 60.43 Favored 'General case' 0 N--CA 1.488 1.447 0 O-C-N 121.252 -0.905 . . . . 0.0 109.2 179.903 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 99' ' ' ARG . . . . . 0.746 ' NE ' HD21 ' A' ' 98' ' ' ASN . 3.0 mtt180 -103.06 -58.16 1.92 Allowed 'General case' 0 N--CA 1.489 1.492 0 O-C-N 121.379 -0.825 . . . . 0.0 110.182 -179.357 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . -173.82 -172.43 39.15 Favored Glycine 0 N--CA 1.492 2.4 0 C-N-CA 119.373 -1.394 . . . . 0.0 110.505 -179.752 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 101' ' ' VAL . . . . . 0.695 ' O ' HG23 ' A' ' 101' ' ' VAL . 34.0 m -51.49 103.75 0.05 OUTLIER 'Isoleucine or valine' 0 N--CA 1.493 1.701 0 O-C-N 121.575 -0.956 . . . . 0.0 110.017 -179.817 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -91.55 160.75 15.26 Favored 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.193 -0.942 . . . . 0.0 110.158 179.927 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 103' ' ' PHE . . . . . 0.563 ' O ' ' N ' ' A' ' 105' ' ' GLU . 23.1 m-85 -63.74 121.2 13.4 Favored 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.009 -1.057 . . . . 0.0 108.357 178.769 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 104' ' ' ALA . . . . . 0.615 ' HB3' ' HB2' ' A' ' 116' ' ' SER . . . -45.23 -12.45 0.02 OUTLIER 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.464 -0.772 . . . . 0.0 110.516 -179.063 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 105' ' ' GLU . . . . . 0.563 ' N ' ' O ' ' A' ' 103' ' ' PHE . 0.1 OUTLIER -136.6 142.7 43.34 Favored 'General case' 0 N--CA 1.494 1.753 0 O-C-N 120.852 -1.155 . . . . 0.0 110.23 179.958 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 106' ' ' GLU . . . . . 0.467 ' OE1' ' ND2' ' A' ' 107' ' ' ASN . 24.3 tt0 -58.79 -63.41 1.3 Allowed 'General case' 0 N--CA 1.488 1.439 0 CA-C-N 116.173 -0.467 . . . . 0.0 111.438 -178.904 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 107' ' ' ASN . . . . . 0.467 ' ND2' ' OE1' ' A' ' 106' ' ' GLU . 1.7 m120 -79.05 35.45 0.26 Allowed 'General case' 0 N--CA 1.49 1.572 0 O-C-N 120.653 -1.279 . . . . 0.0 113.138 -175.694 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 108' ' ' GLU . . . . . . . . . . . . . 1.5 tp10 -58.92 150.47 24.25 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 120.554 -1.341 . . . . 0.0 107.924 179.858 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 109' ' ' SER . . . . . . . . . . . . . 1.5 t -102.73 146.19 28.59 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.006 -1.059 . . . . 0.0 110.975 -178.192 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 110' ' ' LEU . . . . . 0.491 HD11 HG21 ' A' ' 146' ' ' VAL . 4.4 tp -62.4 -20.83 64.86 Favored 'General case' 0 N--CA 1.488 1.46 0 N-CA-C 107.79 -1.189 . . . . 0.0 107.79 178.827 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 111' ' ' ASP . . . . . 0.523 ' CG ' HH22 ' A' ' 151' ' ' ARG . 0.9 OUTLIER -131.46 43.23 3.1 Favored 'General case' 0 C--N 1.302 -1.497 0 N-CA-C 108.573 -0.899 . . . . 0.0 108.573 179.58 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 112' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -70.21 154.12 42.29 Favored 'General case' 0 C--N 1.302 -1.47 0 O-C-N 121.173 -0.954 . . . . 0.0 111.095 -179.812 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 113' ' ' GLN . . . . . 0.533 ' N ' ' CD ' ' A' ' 113' ' ' GLN . 0.0 OUTLIER -67.65 -18.27 64.89 Favored 'General case' 0 C--N 1.3 -1.585 0 N-CA-C 108.255 -1.017 . . . . 0.0 108.255 177.626 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 114' ' ' ASN . . . . . 0.57 ' OD1' ' NE2' ' A' ' 178' ' ' GLN . 11.2 t30 -150.84 105.7 3.3 Favored 'General case' 0 C--N 1.298 -1.654 0 N-CA-C 108.438 -0.949 . . . . 0.0 108.438 178.852 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 115' ' ' ILE . . . . . 0.532 HG22 ' O ' ' A' ' 115' ' ' ILE . 3.8 mt -95.13 105.34 16.86 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.446 0 O-C-N 120.876 -1.14 . . . . 0.0 108.284 179.806 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 116' ' ' SER . . . . . 0.615 ' HB2' ' HB3' ' A' ' 104' ' ' ALA . 11.5 m -91.72 153.85 19.37 Favored 'General case' 0 N--CA 1.488 1.454 0 O-C-N 121.286 -0.883 . . . . 0.0 111.23 -178.262 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 117' ' ' ILE . . . . . 0.411 HD13 HG21 ' A' ' 117' ' ' ILE . 2.3 mt -148.74 148.18 16.13 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.43 0 N-CA-C 108.124 -1.065 . . . . 0.0 108.124 179.286 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 118' ' ' ALA . . . . . 1.019 ' HB1' ' HB2' ' C' ' 704' ' ' ALA . . . -142.26 160.37 40.38 Favored 'General case' 0 N--CA 1.492 1.634 0 C-N-CA 118.934 -1.106 . . . . 0.0 111.597 -178.919 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 119' ' ' GLY . . . . . . . . . . . . . . . -171.53 149.77 12.56 Favored Glycine 0 N--CA 1.489 2.205 0 N-CA-C 110.214 -1.155 . . . . 0.0 110.214 -179.947 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 120' ' ' HIS . . . . . . . . . . . . . 14.1 m170 -70.18 168.12 16.38 Favored 'General case' 0 N--CA 1.494 1.74 0 O-C-N 121.728 -0.866 . . . . 0.0 110.128 179.517 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 121' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -115.78 160.34 20.25 Favored 'General case' 0 N--CA 1.496 1.843 0 O-C-N 121.362 -0.836 . . . . 0.0 109.425 179.455 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 122' ' ' PHE . . . . . 0.413 ' O ' HG21 ' A' ' 131' ' ' THR . 0.2 OUTLIER -133.48 123.49 25.34 Favored 'General case' 0 N--CA 1.497 1.92 0 O-C-N 121.238 -0.914 . . . . 0.0 109.612 -179.409 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 123' ' ' ILE . . . . . 0.608 HG23 ' N ' ' A' ' 124' ' ' ASP . 0.6 OUTLIER -66.0 -42.56 91.94 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.667 0 CA-C-O 121.71 0.767 . . . . 0.0 109.01 179.76 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 124' ' ' ASP . . . . . 0.608 ' N ' HG23 ' A' ' 123' ' ' ILE . 5.8 t70 -92.76 24.84 3.38 Favored 'General case' 0 N--CA 1.496 1.867 0 O-C-N 121.616 -0.678 . . . . 0.0 111.956 -177.917 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 125' ' ' ARG . . . . . 0.622 HH11 ' CG ' ' A' ' 125' ' ' ARG . 0.0 OUTLIER -157.92 103.57 1.76 Allowed Pre-proline 0 N--CA 1.492 1.647 0 O-C-N 120.347 -1.47 . . . . 0.0 110.406 -179.432 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 126' ' ' PRO . . . . . . . . . . . . . 60.1 Cg_endo -79.13 -17.0 12.08 Favored 'Trans proline' 0 C--N 1.315 -1.206 0 C-N-CA 122.078 1.852 . . . . 0.0 111.822 179.728 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 127' ' ' ASN . . . . . . . . . . . . . 14.0 m120 -90.89 10.79 24.92 Favored 'General case' 0 N--CA 1.488 1.448 0 O-C-N 121.309 -0.869 . . . . 0.0 109.515 179.75 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 128' ' ' TYR . . . . . 0.508 ' O ' ' OE2' ' A' ' 85' ' ' GLU . 2.7 t80 -68.17 -153.07 0.02 OUTLIER 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.154 -0.966 . . . . 0.0 109.531 -179.924 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 129' ' ' GLN . . . . . 0.548 ' OE1' ' N ' ' A' ' 129' ' ' GLN . 1.1 mp0 -68.13 -67.15 0.48 Allowed 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.451 -0.781 . . . . 0.0 109.85 -179.705 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 130' ' ' PHE . . . . . 0.498 ' O ' ' CE ' ' A' ' 134' ' ' LYS . 57.1 m-85 -135.61 52.6 2.0 Favored 'General case' 0 N--CA 1.493 1.686 0 O-C-N 121.038 -1.039 . . . . 0.0 110.35 179.981 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 131' ' ' THR . . . . . 0.413 HG21 ' O ' ' A' ' 122' ' ' PHE . 23.4 m -86.43 -41.07 14.73 Favored 'General case' 0 C--N 1.301 -1.523 0 O-C-N 121.075 -1.016 . . . . 0.0 108.764 179.33 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 132' ' ' ASN . . . . . 0.497 ' ND2' ' O ' ' A' ' 81' ' ' ALA . 4.0 t30 -83.47 6.2 21.11 Favored 'General case' 0 N--CA 1.496 1.851 0 O-C-N 121.561 -0.712 . . . . 0.0 111.347 -178.492 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 133' ' ' LEU . . . . . 0.568 HD13 ' HB3' ' A' ' 136' ' ' ALA . 0.1 OUTLIER -69.93 -43.46 71.59 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 120.821 -1.174 . . . . 0.0 109.871 -179.557 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 134' ' ' LYS . . . . . 0.521 ' CD ' ' H ' ' A' ' 134' ' ' LYS . 0.0 OUTLIER -45.37 -17.78 0.03 OUTLIER 'General case' 0 N--CA 1.497 1.921 0 O-C-N 121.172 -0.955 . . . . 0.0 110.154 -179.442 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 135' ' ' ALA . . . . . 0.493 ' N ' ' O ' ' A' ' 133' ' ' LEU . . . -84.66 -32.5 23.59 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 120.949 -1.095 . . . . 0.0 109.38 179.89 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 136' ' ' ALA . . . . . 0.847 ' HB2' ' HB2' ' A' ' 81' ' ' ALA . . . -80.52 153.23 28.24 Favored 'General case' 0 C--N 1.302 -1.466 0 CA-C-O 122.028 0.918 . . . . 0.0 111.386 -178.808 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 137' ' ' LYS . . . . . 0.551 ' O ' ' O ' ' A' ' 138' ' ' LYS . 51.5 mttp -153.38 -165.57 2.19 Favored 'General case' 0 N--CA 1.49 1.531 0 C-N-CA 118.461 -1.295 . . . . 0.0 110.611 -178.543 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 138' ' ' LYS . . . . . 0.585 ' O ' ' N ' ' A' ' 140' ' ' SER . 0.0 OUTLIER -42.74 177.77 0.0 OUTLIER 'General case' 0 C--N 1.302 -1.462 0 CA-C-O 122.232 1.015 . . . . 0.0 110.961 -178.941 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 139' ' ' GLY . . . . . . . . . . . . . . . 46.75 8.63 0.02 OUTLIER Glycine 0 N--CA 1.489 2.191 0 N-CA-C 110.123 -1.191 . . . . 0.0 110.123 -179.943 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 140' ' ' SER . . . . . 0.585 ' N ' ' O ' ' A' ' 138' ' ' LYS . 11.7 m -80.75 122.42 27.13 Favored 'General case' 0 N--CA 1.492 1.663 0 O-C-N 120.817 -1.402 . . . . 0.0 109.544 179.616 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 141' ' ' MET . . . . . . . . . . . . . 6.5 tpt -77.66 121.89 24.6 Favored 'General case' 0 C--N 1.301 -1.515 0 N-CA-C 108.461 -0.94 . . . . 0.0 108.461 179.252 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 142' ' ' VAL . . . . . . . . . . . . . 2.8 t -112.61 135.9 50.57 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.721 0 O-C-N 121.124 -0.985 . . . . 0.0 109.688 -178.918 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 143' ' ' TYR . . . . . . . . . . . . . 67.8 m-85 -115.14 138.37 50.98 Favored 'General case' 0 N--CA 1.495 1.801 0 O-C-N 121.271 -0.893 . . . . 0.0 110.827 -179.453 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 144' ' ' PHE . . . . . 0.409 ' CD1' ' C ' ' A' ' 144' ' ' PHE . 1.4 t80 -122.26 108.45 13.28 Favored 'General case' 0 N--CA 1.494 1.733 0 O-C-N 121.692 -0.63 . . . . 0.0 109.558 -179.315 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 145' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -97.08 132.43 42.88 Favored 'General case' 0 N--CA 1.494 1.76 0 O-C-N 121.227 -0.921 . . . . 0.0 111.073 -178.791 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 146' ' ' VAL . . . . . 0.518 HG23 ' O ' ' A' ' 73' ' ' ALA . 4.2 p -143.95 143.75 23.53 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.739 0 N-CA-C 107.854 -1.165 . . . . 0.0 107.854 178.632 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 147' ' ' GLY . . . . . 0.453 ' C ' ' O ' ' A' ' 146' ' ' VAL . . . 42.37 -128.28 4.68 Favored Glycine 0 N--CA 1.491 2.308 0 N-CA-C 108.894 -1.682 . . . . 0.0 108.894 -179.597 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 148' ' ' ASN . . . . . 0.552 HD22 ' C ' ' A' ' 148' ' ' ASN . 0.4 OUTLIER -103.34 18.02 22.74 Favored 'General case' 0 C--N 1.299 -1.594 0 O-C-N 121.49 -1.006 . . . . 0.0 108.348 178.976 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 149' ' ' GLU . . . . . . . . . . . . . 7.6 tt0 -113.84 144.49 42.92 Favored 'General case' 0 N--CA 1.49 1.54 0 CA-C-O 121.917 0.865 . . . . 0.0 111.604 -178.184 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 150' ' ' THR . . . . . . . . . . . . . 52.8 m -125.64 105.08 8.75 Favored 'General case' 0 C--N 1.302 -1.48 0 CA-C-O 121.574 0.702 . . . . 0.0 109.889 179.493 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 151' ' ' ARG . . . . . 0.523 HH22 ' CG ' ' A' ' 111' ' ' ASP . 73.8 mtt180 -86.44 -173.59 4.6 Favored 'General case' 0 N--CA 1.486 1.373 0 N-CA-C 108.709 -0.848 . . . . 0.0 108.709 179.863 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 152' ' ' LYS . . . . . . . . . . . . . 6.8 mtmp? -152.49 148.07 26.98 Favored 'General case' 0 C--N 1.301 -1.52 0 C-N-CA 119.145 -1.022 . . . . 0.0 110.589 -179.489 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 153' ' ' TYR . . . . . 0.412 ' CD2' ' HA ' ' A' ' 204' ' ' GLU . 47.0 m-85 -144.45 161.55 38.76 Favored 'General case' 0 N--CA 1.489 1.49 0 N-CA-C 108.424 -0.954 . . . . 0.0 108.424 178.739 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 154' ' ' LYS . . . . . . . . . . . . . 17.8 ttmt -137.24 119.7 15.9 Favored 'General case' 0 C--N 1.299 -1.611 0 O-C-N 121.273 -0.892 . . . . 0.0 108.801 179.251 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 155' ' ' MET . . . . . . . . . . . . . 27.1 mtp -45.94 109.04 0.15 Allowed 'General case' 0 N--CA 1.494 1.741 0 CA-C-O 122.443 1.116 . . . . 0.0 111.671 -178.484 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 156' ' ' THR . . . . . 0.691 ' OG1' HG23 ' A' ' 203' ' ' THR . 0.2 OUTLIER -103.3 -28.28 11.96 Favored 'General case' 0 C--N 1.296 -1.735 0 CA-C-N 115.168 -0.923 . . . . 0.0 110.22 -178.572 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 157' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -146.95 154.69 41.57 Favored 'General case' 0 N--CA 1.496 1.84 0 C-N-CA 118.337 -1.345 . . . . 0.0 110.569 -179.048 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 158' ' ' ILE . . . . . 0.405 HG12 ' CD1' ' A' ' 200' ' ' PHE . 1.6 mt -148.27 137.31 15.62 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.652 0 CA-C-O 121.322 0.582 . . . . 0.0 109.982 -177.927 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 159' ' ' ARG . . . . . . . . . . . . . 2.2 mtt180 -156.14 -177.62 6.72 Favored 'General case' 0 N--CA 1.494 1.742 0 O-C-N 121.298 -0.877 . . . . 0.0 110.931 -179.521 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 160' ' ' ASP . . . . . 0.494 ' C ' HG22 ' A' ' 161' ' ' VAL . 9.3 m-20 -146.8 165.01 30.98 Favored 'General case' 0 N--CA 1.493 1.692 0 N-CA-C 108.48 -0.933 . . . . 0.0 108.48 179.825 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 161' ' ' VAL . . . . . 0.494 HG22 ' C ' ' A' ' 160' ' ' ASP . 0.0 OUTLIER -162.0 158.78 1.84 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.701 0 O-C-N 120.822 -1.174 . . . . 0.0 111.033 -179.874 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 162' ' ' LYS . . . . . 0.461 ' O ' ' O ' ' A' ' 161' ' ' VAL . 0.0 OUTLIER -44.05 171.23 0.04 OUTLIER Pre-proline 0 N--CA 1.493 1.693 0 O-C-N 121.767 -0.583 . . . . 0.0 110.289 179.326 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 163' ' ' PRO . . . . . 0.483 ' C ' HD11 ' C' ' 702' ' ' LEU . 71.3 Cg_endo -77.89 32.24 0.44 Allowed 'Trans proline' 0 N--CA 1.495 1.591 0 C-N-CA 122.926 2.417 . . . . 0.0 113.669 -179.839 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 164' ' ' THR . . . . . 0.517 ' N ' HD11 ' C' ' 702' ' ' LEU . 0.0 OUTLIER -152.26 -2.84 0.26 Allowed 'General case' 0 N--CA 1.495 1.796 0 O-C-N 120.839 -1.163 . . . . 0.0 111.125 179.686 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 165' ' ' ASP . . . . . 0.42 ' O ' ' C ' ' A' ' 166' ' ' VAL . 1.4 t70 -73.31 61.1 0.63 Allowed 'General case' 0 N--CA 1.491 1.582 0 O-C-N 120.748 -1.22 . . . . 0.0 110.132 -179.245 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 166' ' ' VAL . . . . . 0.582 ' O ' ' N ' ' A' ' 168' ' ' VAL . 2.2 t -45.75 -31.66 1.18 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.604 0 O-C-N 121.048 -1.032 . . . . 0.0 109.614 -178.998 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 167' ' ' GLY . . . . . . . . . . . . . . . -44.8 -10.99 0.01 OUTLIER Glycine 0 N--CA 1.494 2.523 0 O-C-N 120.756 -1.215 . . . . 0.0 111.116 -179.583 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 168' ' ' VAL . . . . . 0.582 ' N ' ' O ' ' A' ' 166' ' ' VAL . 5.8 m -53.8 -29.96 18.53 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.634 0 O-C-N 120.552 -1.557 . . . . 0.0 108.774 179.814 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 169' ' ' LEU . . . . . 0.543 ' O ' ' C ' ' A' ' 170' ' ' ASP . 11.7 mt -49.83 -13.59 0.1 Allowed 'General case' 0 N--CA 1.491 1.62 0 N-CA-C 107.33 -1.359 . . . . 0.0 107.33 -178.994 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 170' ' ' ASP . . . . . 0.556 ' N ' ' C ' ' A' ' 168' ' ' VAL . 40.3 t0 19.46 90.97 0.01 OUTLIER 'General case' 0 N--CA 1.5 2.053 0 CA-C-N 116.355 -0.384 . . . . 0.0 111.587 177.322 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 171' ' ' GLU . . . . . . . . . . . . . 7.8 pt-20 -128.7 72.91 1.47 Allowed 'General case' 0 N--CA 1.496 1.873 0 O-C-N 120.952 -1.092 . . . . 0.0 111.099 -179.615 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 172' ' ' GLN . . . . . . . . . . . . . 6.6 mp0 -128.73 -52.12 1.24 Allowed 'General case' 0 N--CA 1.498 1.965 0 O-C-N 121.335 -0.853 . . . . 0.0 111.519 -178.559 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 173' ' ' LYS . . . . . . . . . . . . . 56.9 mttt -58.51 130.6 47.58 Favored 'General case' 0 N--CA 1.498 1.961 0 O-C-N 120.841 -1.162 . . . . 0.0 109.655 -179.34 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 174' ' ' GLY . . . . . 0.53 ' O ' ' C ' ' A' ' 175' ' ' LYS . . . -122.48 -43.76 0.37 Allowed Glycine 0 N--CA 1.48 1.607 0 N-CA-C 108.657 -1.777 . . . . 0.0 108.657 179.761 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 175' ' ' LYS . . . . . 0.53 ' C ' ' O ' ' A' ' 174' ' ' GLY . 13.6 mptt -37.98 -62.9 0.52 Allowed 'General case' 0 N--CA 1.495 1.776 0 N-CA-C 107.319 -1.363 . . . . 0.0 107.319 179.309 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 176' ' ' ASP . . . . . 0.599 ' O ' ' O ' ' A' ' 177' ' ' LYS . 1.1 m-20 -104.34 91.2 3.81 Favored 'General case' 0 C--N 1.293 -1.885 0 N-CA-C 106.942 -1.503 . . . . 0.0 106.942 176.725 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 177' ' ' LYS . . . . . 0.599 ' O ' ' O ' ' A' ' 176' ' ' ASP . 9.7 mttp -45.07 -176.01 0.0 OUTLIER 'General case' 0 N--CA 1.494 1.764 0 O-C-N 121.344 -0.848 . . . . 0.0 109.683 -179.093 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 178' ' ' GLN . . . . . 0.57 ' NE2' ' OD1' ' A' ' 114' ' ' ASN . 18.6 pt20 -161.0 176.45 11.37 Favored 'General case' 0 N--CA 1.487 1.399 0 C-N-CA 118.043 -1.463 . . . . 0.0 111.399 179.581 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 179' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -130.61 96.27 4.07 Favored 'General case' 0 C--N 1.302 -1.493 0 N-CA-C 107.525 -1.287 . . . . 0.0 107.525 178.187 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 180' ' ' THR . . . . . 0.404 ' O ' HG22 ' A' ' 180' ' ' THR . 1.2 m -71.09 114.17 8.87 Favored 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.069 -1.019 . . . . 0.0 109.485 -178.979 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 181' ' ' LEU . . . . . 0.729 HD13 ' N ' ' A' ' 182' ' ' ILE . 0.3 OUTLIER -90.14 141.15 28.97 Favored 'General case' 0 C--N 1.3 -1.554 0 N-CA-C 108.234 -1.024 . . . . 0.0 108.234 178.453 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 182' ' ' ILE . . . . . 0.729 ' N ' HD13 ' A' ' 181' ' ' LEU . 73.4 mt -135.07 118.72 24.91 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.594 0 N-CA-C 107.638 -1.245 . . . . 0.0 107.638 178.903 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 183' ' ' THR . . . . . 0.482 HG23 ' O ' ' A' ' 183' ' ' THR . 3.8 t -138.62 112.09 8.17 Favored 'General case' 0 C--N 1.289 -2.038 0 N-CA-C 107.894 -1.15 . . . . 0.0 107.894 179.902 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 184' ' ' CYS . . . . . . . . . . . . . 1.9 p -78.58 157.1 28.85 Favored 'General case' 0 C--N 1.292 -1.911 0 C-N-CA 119.326 -0.95 . . . . 0.0 110.911 -177.867 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 185' ' ' ASP . . . . . . . . . . . . . 20.7 t0 -165.68 -152.86 0.16 Allowed 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.456 -0.778 . . . . 0.0 109.518 -179.735 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 186' ' ' ASP . . . . . . . . . . . . . 13.0 m-20 47.69 56.48 7.07 Favored 'General case' 0 N--CA 1.496 1.829 0 O-C-N 121.139 -0.975 . . . . 0.0 109.071 -179.707 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 187' ' ' TYR . . . . . 0.623 ' CE1' ' O ' ' A' ' 188' ' ' ASN . 32.9 t80 -67.91 136.08 53.45 Favored 'General case' 0 N--CA 1.49 1.56 0 CA-C-O 121.799 0.809 . . . . 0.0 111.013 -179.221 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 188' ' ' ASN . . . . . 0.623 ' O ' ' CE1' ' A' ' 187' ' ' TYR . 1.1 t-20 -99.43 147.53 25.17 Favored 'General case' 0 C--N 1.297 -1.705 0 N-CA-C 108.128 -1.064 . . . . 0.0 108.128 178.503 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 189' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -112.52 -13.59 13.32 Favored 'General case' 0 C--N 1.293 -1.878 0 N-CA-C 108.114 -1.069 . . . . 0.0 108.114 -179.718 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 190' ' ' LYS . . . . . . . . . . . . . 88.3 mttt -84.32 -51.26 7.12 Favored 'General case' 0 N--CA 1.488 1.474 0 N-CA-C 108.853 -0.795 . . . . 0.0 108.853 178.791 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 191' ' ' THR . . . . . 0.473 ' OG1' HG12 ' A' ' 193' ' ' VAL . 9.4 p -89.61 -10.82 44.56 Favored 'General case' 0 N--CA 1.489 1.488 0 O-C-N 121.546 -0.721 . . . . 0.0 109.075 179.79 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 192' ' ' GLY . . . . . . . . . . . . . . . 68.69 30.76 72.81 Favored Glycine 0 N--CA 1.492 2.399 0 O-C-N 121.316 -0.865 . . . . 0.0 110.945 178.733 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 193' ' ' VAL . . . . . 0.514 HG22 ' H ' ' A' ' 194' ' ' TRP . 2.2 p -145.9 169.29 6.54 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.621 0 O-C-N 120.791 -1.417 . . . . 0.0 110.201 179.397 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 194' ' ' TRP . . . . . 0.541 ' CD1' ' N ' ' A' ' 194' ' ' TRP . 9.4 m95 -86.47 121.37 28.93 Favored 'General case' 0 C--N 1.294 -1.821 0 N-CA-C 109.104 -0.702 . . . . 0.0 109.104 -179.717 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 195' ' ' GLU . . . . . 0.492 ' CD ' ' ND2' ' A' ' 188' ' ' ASN . 1.3 mt-10 -85.04 -61.17 1.84 Allowed 'General case' 0 N--CA 1.497 1.888 0 O-C-N 121.275 -0.891 . . . . 0.0 111.703 -178.216 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 196' ' ' LYS . . . . . . . . . . . . . 1.8 mtpm? -84.61 151.27 24.62 Favored 'General case' 0 N--CA 1.494 1.74 0 O-C-N 120.814 -1.179 . . . . 0.0 110.488 -178.475 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 197' ' ' ARG . . . . . 0.544 ' NH1' ' O ' ' C' ' 704' ' ' ALA . 24.1 mmt180 -120.37 137.42 54.3 Favored 'General case' 0 N--CA 1.492 1.637 0 N-CA-C 108.942 -0.762 . . . . 0.0 108.942 179.497 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 198' ' ' LYS . . . . . . . . . . . . . 5.0 mptp? -115.1 120.01 38.37 Favored 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.467 -0.771 . . . . 0.0 110.304 -179.007 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 199' ' ' ILE . . . . . 0.423 ' O ' HG13 ' A' ' 199' ' ' ILE . 1.1 pp -141.42 121.01 11.35 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.803 0 CA-C-O 122.618 1.199 . . . . 0.0 110.826 179.201 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 200' ' ' PHE . . . . . 0.526 ' CD1' ' N ' ' A' ' 200' ' ' PHE . 0.7 OUTLIER -105.04 141.42 36.65 Favored 'General case' 0 N--CA 1.494 1.773 0 O-C-N 121.131 -0.981 . . . . 0.0 111.177 -178.133 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 201' ' ' VAL . . . . . . . . . . . . . 96.8 t -102.57 149.02 7.22 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.651 0 N-CA-C 107.726 -1.213 . . . . 0.0 107.726 176.722 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 202' ' ' ALA . . . . . . . . . . . . . . . -132.27 139.89 48.42 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.002 -1.061 . . . . 0.0 109.116 -179.513 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 203' ' ' THR . . . . . 0.691 HG23 ' OG1' ' A' ' 156' ' ' THR . 16.8 p -89.86 131.19 35.92 Favored 'General case' 0 N--CA 1.487 1.416 0 CA-C-O 122.556 1.169 . . . . 0.0 111.944 -178.316 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 204' ' ' GLU . . . . . 0.412 ' HA ' ' CD2' ' A' ' 153' ' ' TYR . 1.0 OUTLIER -61.96 135.43 57.55 Favored 'General case' 0 C--N 1.299 -1.598 0 CA-C-N 114.818 -1.083 . . . . 0.0 108.957 179.016 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 205' ' ' VAL . . . . . 0.504 ' O ' ' C ' ' A' ' 206' ' ' LYS . 37.6 t -122.67 -44.47 1.88 Allowed 'Isoleucine or valine' 0 N--CA 1.494 1.76 0 O-C-N 121.382 -0.824 . . . . 0.0 109.71 -179.703 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 206' ' ' LYS . . . . . 0.504 ' C ' ' O ' ' A' ' 205' ' ' VAL . 0.0 OUTLIER . . . . . 0 N--CA 1.494 1.767 0 CA-C-O 118.093 -0.956 . . . . 0.0 110.456 -179.636 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' C' C ' 702' ' ' LEU . . . . . 0.657 ' N ' HD12 ' C' ' 702' ' ' LEU . 0.0 OUTLIER . . . . . 0 N--CA 1.493 1.703 0 N-CA-C 110.009 -0.367 . . . . 0.0 110.009 . . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' C' C ' 703' ' ' PRO . . . . . 0.545 ' HB3' ' HB3' ' A' ' 92' ' ' ALA . 31.3 Cg_exo -51.34 -160.79 0.0 OUTLIER 'Trans proline' 0 N--CA 1.493 1.476 0 C-N-CA 121.945 1.764 . . . . 0.0 111.718 179.057 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' C' C ' 704' ' ' ALA . . . . . 1.019 ' HB2' ' HB1' ' A' ' 118' ' ' ALA . . . . . . . . 0 N--CA 1.489 1.481 0 O-C-N 120.981 -1.075 . . . . 0.0 109.055 179.898 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 63' ' ' PRO . . . . . . . . . . . . . 10.6 Cg_endo . . . . . 0 N--CA 1.481 0.781 0 CA-C-O 121.167 0.403 . . . . 0.0 111.473 . . . . . . . . . 0 0 . 1 . 002 nuclear nobuild core ' A' A ' 64' ' ' GLN . . . . . 0.682 ' NE2' ' N ' ' A' ' 64' ' ' GLN . 0.0 OUTLIER -153.71 119.93 5.44 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.163 -0.961 . . . . 0.0 109.433 179.732 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 65' ' ' ILE . . . . . 0.463 ' C ' ' O ' ' A' ' 64' ' ' GLN . 0.0 OUTLIER -42.18 103.78 0.32 Allowed Pre-proline 0 N--CA 1.495 1.782 0 N-CA-C 108.405 -0.961 . . . . 0.0 108.405 179.203 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 66' ' ' PRO . . . . . . . . . . . . . 88.3 Cg_endo -87.36 -159.99 0.1 OUTLIER 'Trans proline' 0 C--N 1.315 -1.191 0 C-N-CA 122.272 1.982 . . . . 0.0 112.421 -179.436 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 67' ' ' LYS . . . . . . . . . . . . . 13.5 pttt -79.67 -4.99 54.18 Favored 'General case' 0 C--N 1.302 -1.5 0 N-CA-C 108.739 -0.837 . . . . 0.0 108.739 179.765 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 68' ' ' ASP . . . . . 0.662 ' C ' ' N ' ' A' ' 70' ' ' SER . 1.0 OUTLIER -76.79 48.62 0.58 Allowed 'General case' 0 C--N 1.304 -1.396 0 CA-C-O 121.958 0.885 . . . . 0.0 109.393 179.705 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 69' ' ' LYS . . . . . 0.456 ' C ' ' O ' ' A' ' 68' ' ' ASP . 1.6 ptpt -49.3 -13.25 0.07 Allowed 'General case' 0 N--CA 1.508 2.442 0 C-N-CA 116.684 -2.006 . . . . 0.0 106.283 177.599 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 70' ' ' SER . . . . . 0.662 ' N ' ' C ' ' A' ' 68' ' ' ASP . 0.4 OUTLIER -83.43 -9.66 58.88 Favored 'General case' 0 N--CA 1.496 1.83 0 CA-C-N 113.164 -1.835 . . . . 0.0 110.162 179.221 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 71' ' ' LYS . . . . . 0.442 ' N ' ' O ' ' A' ' 68' ' ' ASP . 0.0 OUTLIER -97.36 142.98 28.57 Favored 'General case' 0 N--CA 1.496 1.838 0 O-C-N 120.991 -1.068 . . . . 0.0 110.753 179.601 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 72' ' ' VAL . . . . . 0.549 HG12 ' CZ ' ' A' ' 88' ' ' TYR . 0.8 OUTLIER -66.16 141.94 17.4 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.527 0 N-CA-C 105.131 -2.174 . . . . 0.0 105.131 174.702 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 73' ' ' ALA . . . . . 0.517 ' N ' ' O ' ' A' ' 87' ' ' VAL . . . -82.8 -15.9 49.88 Favored 'General case' 0 C--N 1.295 -1.762 0 O-C-N 119.928 -1.732 . . . . 0.0 106.704 179.75 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 74' ' ' GLY . . . . . 0.415 ' N ' HG23 ' A' ' 72' ' ' VAL . . . 175.4 -157.83 24.73 Favored Glycine 0 N--CA 1.479 1.546 0 N-CA-C 109.318 -1.513 . . . . 0.0 109.318 179.584 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 75' ' ' TYR . . . . . 0.605 ' HA ' HG23 ' A' ' 87' ' ' VAL . 0.6 OUTLIER -143.15 168.35 19.96 Favored 'General case' 0 C--N 1.295 -1.778 0 O-C-N 121.682 -0.893 . . . . 0.0 110.463 -177.234 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 76' ' ' ILE . . . . . . . . . . . . . 2.4 tt -148.75 145.91 17.84 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.601 0 C-N-CA 119.225 -0.99 . . . . 0.0 110.075 -178.04 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -150.65 166.43 30.36 Favored 'General case' 0 N--CA 1.489 1.49 0 O-C-N 121.059 -1.026 . . . . 0.0 109.289 179.371 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 78' ' ' ILE . . . . . 0.664 ' HB ' ' HB3' ' A' ' 81' ' ' ALA . 13.5 mt -147.75 94.98 4.3 Favored Pre-proline 0 C--N 1.302 -1.474 0 N-CA-C 108.6 -0.889 . . . . 0.0 108.6 -179.57 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 79' ' ' PRO . . . . . . . . . . . . . 75.0 Cg_exo -47.55 -47.56 17.69 Favored 'Trans proline' 0 N--CA 1.494 1.506 0 C-N-CA 122.811 2.34 . . . . 0.0 113.811 -178.645 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -65.86 -18.63 65.46 Favored 'General case' 0 N--CA 1.493 1.718 0 O-C-N 120.868 -1.145 . . . . 0.0 110.439 178.474 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 81' ' ' ALA . . . . . 0.743 ' HB2' ' HB2' ' A' ' 136' ' ' ALA . . . -105.01 -14.05 15.55 Favored 'General case' 0 N--CA 1.493 1.679 0 O-C-N 121.238 -0.914 . . . . 0.0 109.035 179.904 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 82' ' ' ASP . . . . . 0.4 ' N ' ' O ' ' A' ' 78' ' ' ILE . 0.3 OUTLIER 64.27 48.34 2.89 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.334 -0.853 . . . . 0.0 110.503 179.246 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 83' ' ' ILE . . . . . 0.487 HD11 ' HB3' ' A' ' 132' ' ' ASN . 64.2 mt -131.1 152.08 36.92 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.796 0 O-C-N 121.127 -0.983 . . . . 0.0 110.647 -178.583 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 84' ' ' LYS . . . . . . . . . . . . . 30.2 tttp -158.83 111.85 2.3 Favored 'General case' 0 N--CA 1.492 1.635 0 N-CA-C 108.315 -0.994 . . . . 0.0 108.315 179.282 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 85' ' ' GLU . . . . . 0.445 ' O ' ' CD2' ' A' ' 75' ' ' TYR . 0.4 OUTLIER -143.16 162.79 41.22 Favored Pre-proline 0 N--CA 1.494 1.729 0 O-C-N 121.279 -0.888 . . . . 0.0 110.225 -179.211 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 86' ' ' PRO . . . . . 0.416 ' N ' ' CE2' ' A' ' 75' ' ' TYR . 57.1 Cg_endo -70.92 167.65 25.33 Favored 'Trans proline' 0 N--CA 1.497 1.698 0 C-N-CA 123.346 2.697 . . . . 0.0 113.506 -179.141 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 87' ' ' VAL . . . . . 0.605 HG23 ' HA ' ' A' ' 75' ' ' TYR . 62.0 t -124.67 99.66 6.47 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.66 0 N-CA-C 108.972 -0.751 . . . . 0.0 108.972 179.717 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 88' ' ' TYR . . . . . 0.549 ' CZ ' HG12 ' A' ' 72' ' ' VAL . 33.0 m-85 -92.87 152.94 42.01 Favored Pre-proline 0 N--CA 1.502 2.164 0 O-C-N 120.832 -1.167 . . . . 0.0 110.029 -179.617 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 89' ' ' PRO . . . . . 0.432 ' O ' ' NE2' ' A' ' 96' ' ' GLN . 6.1 Cg_endo -57.19 144.47 90.47 Favored 'Trans proline' 0 C--N 1.312 -1.392 0 C-N-CA 122.531 2.154 . . . . 0.0 113.606 -179.901 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . -57.22 167.6 4.64 Favored Glycine 0 N--CA 1.49 2.268 0 N-CA-C 109.242 -1.543 . . . . 0.0 109.242 179.038 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 91' ' ' PRO . . . . . 0.423 ' C ' ' H ' ' A' ' 93' ' ' THR . 18.9 Cg_endo -93.44 170.4 19.62 Favored 'Cis proline' 0 C--N 1.307 -1.626 0 C-N-CA 123.968 -1.263 . . . . 0.0 112.054 -0.176 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 92' ' ' ALA . . . . . . . . . . . . . . . -72.78 30.57 0.06 Allowed 'General case' 0 N--CA 1.489 1.504 0 O-C-N 121.216 -0.928 . . . . 0.0 110.635 -179.868 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 93' ' ' THR . . . . . 0.423 ' H ' ' C ' ' A' ' 91' ' ' PRO . 1.0 OUTLIER -75.44 152.84 85.73 Favored Pre-proline 0 N--CA 1.49 1.572 0 O-C-N 120.743 -1.223 . . . . 0.0 109.095 -179.741 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 94' ' ' PRO . . . . . 0.412 ' C ' ' O ' ' A' ' 93' ' ' THR . 53.3 Cg_exo -32.82 -52.6 0.39 Allowed 'Trans proline' 0 C--N 1.309 -1.517 0 C-N-CA 122.933 2.422 . . . . 0.0 112.214 -179.292 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 95' ' ' GLU . . . . . 0.586 ' O ' ' ND2' ' A' ' 98' ' ' ASN . 13.0 mt-10 -45.9 -53.11 10.38 Favored 'General case' 0 N--CA 1.489 1.49 0 O-C-N 121.249 -0.907 . . . . 0.0 109.452 179.942 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 96' ' ' GLN . . . . . 0.556 ' O ' ' N ' ' A' ' 98' ' ' ASN . 29.6 mm100 -71.41 -51.66 22.8 Favored 'General case' 0 C--N 1.305 -1.368 0 O-C-N 120.955 -1.091 . . . . 0.0 109.747 179.956 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 97' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -49.52 -7.82 0.03 OUTLIER 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.209 -0.932 . . . . 0.0 109.675 -179.424 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 98' ' ' ASN . . . . . 0.722 HD21 ' CZ ' ' A' ' 99' ' ' ARG . 0.4 OUTLIER -73.05 -24.37 60.69 Favored 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.167 -0.958 . . . . 0.0 109.615 -179.931 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 99' ' ' ARG . . . . . 0.722 ' CZ ' HD21 ' A' ' 98' ' ' ASN . 0.6 OUTLIER -103.56 -59.42 1.72 Allowed 'General case' 0 N--CA 1.489 1.504 0 O-C-N 121.544 -0.722 . . . . 0.0 110.363 -178.936 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . -164.73 -171.53 31.09 Favored Glycine 0 N--CA 1.494 2.545 0 C-N-CA 119.21 -1.471 . . . . 0.0 110.608 -179.674 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 101' ' ' VAL . . . . . 0.687 ' O ' HG23 ' A' ' 101' ' ' VAL . 18.9 m -59.94 108.3 0.38 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.667 0 O-C-N 121.411 -1.053 . . . . 0.0 108.955 179.854 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -93.03 165.28 12.93 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.446 -0.784 . . . . 0.0 111.015 -179.133 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 103' ' ' PHE . . . . . 0.505 ' CE1' ' CG1' ' A' ' 87' ' ' VAL . 24.5 m-85 -66.17 160.5 24.0 Favored 'General case' 0 N--CA 1.486 1.368 0 N-CA-C 107.954 -1.128 . . . . 0.0 107.954 178.031 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 104' ' ' ALA . . . . . . . . . . . . . . . -72.5 -22.58 61.03 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.087 -1.008 . . . . 0.0 111.707 -177.913 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 1.2 pm0 -138.95 150.12 45.53 Favored 'General case' 0 N--CA 1.497 1.876 0 O-C-N 120.696 -1.253 . . . . 0.0 110.644 -179.296 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 106' ' ' GLU . . . . . . . . . . . . . 66.2 tt0 -52.7 -59.52 4.38 Favored 'General case' 0 C--N 1.303 -1.415 0 O-C-N 121.777 -0.577 . . . . 0.0 110.491 -179.928 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 107' ' ' ASN . . . . . 0.584 ' H ' ' ND2' ' A' ' 107' ' ' ASN . 0.2 OUTLIER -77.05 32.84 0.14 Allowed 'General case' 0 N--CA 1.488 1.461 0 O-C-N 120.614 -1.304 . . . . 0.0 112.583 -175.706 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 108' ' ' GLU . . . . . . . . . . . . . 2.8 tp10 -60.2 144.29 50.43 Favored 'General case' 0 N--CA 1.488 1.473 0 N-CA-C 107.029 -1.471 . . . . 0.0 107.029 179.742 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 109' ' ' SER . . . . . 0.524 ' C ' ' H ' ' A' ' 111' ' ' ASP . 0.2 OUTLIER -97.76 122.82 41.31 Favored 'General case' 0 N--CA 1.487 1.416 0 O-C-N 120.83 -1.169 . . . . 0.0 110.858 -177.776 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 110' ' ' LEU . . . . . . . . . . . . . 2.1 pp -59.81 -3.26 0.49 Allowed 'General case' 0 C--N 1.301 -1.521 0 N-CA-C 108.04 -1.096 . . . . 0.0 108.04 179.235 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 111' ' ' ASP . . . . . 0.524 ' H ' ' C ' ' A' ' 109' ' ' SER . 75.7 m-20 -132.83 18.63 4.19 Favored 'General case' 0 N--CA 1.489 1.498 0 O-C-N 121.735 -0.603 . . . . 0.0 109.716 179.668 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 112' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -65.07 135.84 56.04 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 120.887 -1.133 . . . . 0.0 109.684 -179.76 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 113' ' ' GLN . . . . . 0.525 ' NE2' ' O ' ' A' ' 173' ' ' LYS . 0.0 OUTLIER -64.44 -4.64 4.13 Favored 'General case' 0 C--N 1.303 -1.439 0 O-C-N 121.24 -0.913 . . . . 0.0 108.766 179.238 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 114' ' ' ASN . . . . . 0.592 HD22 ' C ' ' A' ' 114' ' ' ASN . 0.2 OUTLIER -144.78 92.49 2.29 Favored 'General case' 0 C--N 1.303 -1.436 0 N-CA-C 107.13 -1.433 . . . . 0.0 107.13 177.967 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 115' ' ' ILE . . . . . 0.445 HD11 ' O ' ' A' ' 109' ' ' SER . 2.1 mt -101.88 117.22 46.87 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.457 0 O-C-N 121.592 -0.693 . . . . 0.0 110.959 -178.304 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 116' ' ' SER . . . . . . . . . . . . . 97.0 p -99.04 146.82 25.67 Favored 'General case' 0 N--CA 1.495 1.807 0 O-C-N 121.244 -0.91 . . . . 0.0 111.544 -178.928 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 117' ' ' ILE . . . . . . . . . . . . . 2.7 mp -135.16 148.55 28.79 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.842 0 N-CA-C 107.521 -1.289 . . . . 0.0 107.521 178.891 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 118' ' ' ALA . . . . . . . . . . . . . . . -144.97 160.73 40.88 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 120.531 -1.356 . . . . 0.0 111.849 -179.251 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 119' ' ' GLY . . . . . . . . . . . . . . . -169.88 156.72 27.76 Favored Glycine 0 N--CA 1.485 1.909 0 N-CA-C 109.456 -1.457 . . . . 0.0 109.456 179.424 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 120' ' ' HIS . . . . . . . . . . . . . 20.0 m-70 -71.36 162.59 29.19 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.51 -0.994 . . . . 0.0 109.849 179.676 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 121' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -117.49 160.02 21.89 Favored 'General case' 0 N--CA 1.492 1.669 0 N-CA-C 107.962 -1.125 . . . . 0.0 107.962 178.586 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 122' ' ' PHE . . . . . 0.41 ' O ' HG21 ' A' ' 131' ' ' THR . 0.2 OUTLIER -127.28 133.35 50.17 Favored 'General case' 0 N--CA 1.495 1.805 0 O-C-N 121.144 -0.972 . . . . 0.0 110.273 -178.821 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 123' ' ' ILE . . . . . . . . . . . . . 15.9 tt -90.76 -27.1 5.04 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.624 0 CA-C-O 121.827 0.822 . . . . 0.0 110.097 -179.317 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 124' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -87.4 -2.29 58.52 Favored 'General case' 0 C--N 1.291 -1.938 0 C-N-CA 120.128 -0.629 . . . . 0.0 111.318 -178.663 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 125' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -154.2 124.08 3.29 Favored Pre-proline 0 N--CA 1.494 1.774 0 O-C-N 120.625 -1.297 . . . . 0.0 109.683 -179.702 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 126' ' ' PRO . . . . . . . . . . . . . 86.8 Cg_endo -81.14 -16.67 9.66 Favored 'Trans proline' 0 N--CA 1.494 1.518 0 C-N-CA 122.46 2.106 . . . . 0.0 112.992 179.994 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 127' ' ' ASN . . . . . 0.616 HD22 ' C ' ' A' ' 127' ' ' ASN . 0.1 OUTLIER -90.19 22.37 3.33 Favored 'General case' 0 N--CA 1.493 1.702 0 O-C-N 121.071 -1.018 . . . . 0.0 110.308 -179.342 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 128' ' ' TYR . . . . . . . . . . . . . 13.0 t80 -75.3 -150.52 0.03 OUTLIER 'General case' 0 N--CA 1.492 1.673 0 O-C-N 121.004 -1.06 . . . . 0.0 109.751 -179.73 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 129' ' ' GLN . . . . . . . . . . . . . 27.7 mt-30 -68.1 -89.1 0.01 OUTLIER 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.252 -0.905 . . . . 0.0 109.616 -179.636 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 130' ' ' PHE . . . . . 0.684 ' CE2' HG11 ' A' ' 101' ' ' VAL . 27.7 m-85 -108.14 35.13 3.26 Favored 'General case' 0 N--CA 1.493 1.684 0 O-C-N 121.421 -0.799 . . . . 0.0 110.003 -179.533 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 131' ' ' THR . . . . . 0.41 HG21 ' O ' ' A' ' 122' ' ' PHE . 55.0 m -75.37 -33.31 61.04 Favored 'General case' 0 N--CA 1.488 1.464 0 O-C-N 121.037 -1.039 . . . . 0.0 108.982 179.562 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 132' ' ' ASN . . . . . 0.531 ' ND2' ' O ' ' A' ' 81' ' ' ALA . 4.6 t30 -81.01 3.98 21.21 Favored 'General case' 0 N--CA 1.494 1.741 0 O-C-N 121.32 -0.863 . . . . 0.0 110.512 -179.014 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 133' ' ' LEU . . . . . 0.601 HD13 ' O ' ' A' ' 133' ' ' LEU . 0.4 OUTLIER -68.85 -48.96 62.17 Favored 'General case' 0 N--CA 1.488 1.456 0 O-C-N 120.982 -1.074 . . . . 0.0 109.318 -179.943 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 134' ' ' LYS . . . . . 0.664 ' H ' ' CE ' ' A' ' 134' ' ' LYS . 0.0 OUTLIER -43.0 -18.21 0.01 OUTLIER 'General case' 0 N--CA 1.488 1.452 0 O-C-N 121.363 -0.835 . . . . 0.0 109.121 179.869 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 135' ' ' ALA . . . . . 0.593 ' N ' ' O ' ' A' ' 133' ' ' LEU . . . -83.43 -39.02 21.14 Favored 'General case' 0 N--CA 1.488 1.435 0 O-C-N 121.219 -0.926 . . . . 0.0 109.266 179.012 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 136' ' ' ALA . . . . . 0.743 ' HB2' ' HB2' ' A' ' 81' ' ' ALA . . . -80.46 157.45 26.2 Favored 'General case' 0 N--CA 1.49 1.542 0 CA-C-O 121.996 0.903 . . . . 0.0 111.299 -178.965 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 137' ' ' LYS . . . . . 0.536 ' O ' ' O ' ' A' ' 138' ' ' LYS . 1.0 OUTLIER -154.19 -162.36 1.4 Allowed 'General case' 0 N--CA 1.49 1.575 0 C-N-CA 118.5 -1.28 . . . . 0.0 110.961 -178.161 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 138' ' ' LYS . . . . . 0.574 ' O ' ' N ' ' A' ' 140' ' ' SER . 9.4 mttp -43.17 178.27 0.0 OUTLIER 'General case' 0 N--CA 1.487 1.397 0 CA-C-O 122.438 1.113 . . . . 0.0 111.083 -179.03 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 139' ' ' GLY . . . . . . . . . . . . . . . 46.95 7.72 0.02 OUTLIER Glycine 0 N--CA 1.491 2.302 0 N-CA-C 110.668 -0.973 . . . . 0.0 110.668 179.858 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 140' ' ' SER . . . . . 0.574 ' N ' ' O ' ' A' ' 138' ' ' LYS . 58.4 m -86.87 127.14 35.04 Favored 'General case' 0 N--CA 1.496 1.87 0 O-C-N 120.811 -1.406 . . . . 0.0 109.599 179.349 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 141' ' ' MET . . . . . 0.591 ' SD ' ' N ' ' A' ' 142' ' ' VAL . 6.2 tpp -77.61 129.16 35.26 Favored 'General case' 0 N--CA 1.492 1.65 0 O-C-N 120.975 -1.078 . . . . 0.0 109.33 179.688 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 142' ' ' VAL . . . . . 0.591 ' N ' ' SD ' ' A' ' 141' ' ' MET . 1.4 t -112.09 133.27 58.34 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.617 0 N-CA-C 108.546 -0.909 . . . . 0.0 108.546 -179.982 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 143' ' ' TYR . . . . . . . . . . . . . 5.4 m-85 -108.22 134.36 51.17 Favored 'General case' 0 N--CA 1.497 1.897 0 O-C-N 120.719 -1.238 . . . . 0.0 112.31 -177.835 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 144' ' ' PHE . . . . . . . . . . . . . 36.9 t80 -119.92 99.92 6.92 Favored 'General case' 0 N--CA 1.494 1.726 0 N-CA-C 109.511 -0.551 . . . . 0.0 109.511 179.718 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 145' ' ' LYS . . . . . . . . . . . . . 1.0 OUTLIER -96.02 134.3 39.2 Favored 'General case' 0 N--CA 1.493 1.701 0 O-C-N 121.193 -0.942 . . . . 0.0 110.677 -179.348 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 146' ' ' VAL . . . . . 0.479 ' O ' ' C ' ' A' ' 147' ' ' GLY . 0.0 OUTLIER -144.03 141.14 24.97 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.789 0 N-CA-C 107.443 -1.317 . . . . 0.0 107.443 178.861 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 147' ' ' GLY . . . . . 0.479 ' C ' ' O ' ' A' ' 146' ' ' VAL . . . 38.42 -117.67 0.64 Allowed Glycine 0 N--CA 1.493 2.44 0 N-CA-C 109.67 -1.372 . . . . 0.0 109.67 179.78 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 148' ' ' ASN . . . . . 0.501 ' C ' ' ND2' ' A' ' 148' ' ' ASN . 0.4 OUTLIER -108.74 13.45 25.03 Favored 'General case' 0 C--N 1.303 -1.447 0 O-C-N 121.576 -0.955 . . . . 0.0 108.643 179.166 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 149' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -107.0 142.21 36.98 Favored 'General case' 0 N--CA 1.488 1.464 0 CA-C-O 121.934 0.873 . . . . 0.0 111.329 -178.863 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 150' ' ' THR . . . . . . . . . . . . . 97.3 m -134.64 99.06 4.22 Favored 'General case' 0 C--N 1.3 -1.583 0 CA-C-O 121.581 0.705 . . . . 0.0 109.841 -179.428 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 151' ' ' ARG . . . . . . . . . . . . . 86.6 mtt180 -88.24 -171.26 3.29 Favored 'General case' 0 N--CA 1.487 1.411 0 N-CA-C 108.872 -0.788 . . . . 0.0 108.872 179.973 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 152' ' ' LYS . . . . . 0.512 ' C ' ' CD1' ' A' ' 153' ' ' TYR . 34.8 mttp -151.38 150.85 30.95 Favored 'General case' 0 C--N 1.302 -1.471 0 O-C-N 121.201 -0.937 . . . . 0.0 110.139 179.703 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 153' ' ' TYR . . . . . 0.512 ' CD1' ' C ' ' A' ' 152' ' ' LYS . 22.0 m-85 -145.71 158.07 43.89 Favored 'General case' 0 C--N 1.299 -1.618 0 N-CA-C 107.516 -1.29 . . . . 0.0 107.516 178.183 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 154' ' ' LYS . . . . . . . . . . . . . 13.2 ttpp -130.55 125.43 34.21 Favored 'General case' 0 C--N 1.297 -1.71 0 N-CA-C 108.44 -0.948 . . . . 0.0 108.44 -179.996 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 155' ' ' MET . . . . . . . . . . . . . 74.5 mtp -45.87 107.33 0.1 Allowed 'General case' 0 N--CA 1.489 1.517 0 O-C-N 120.697 -1.252 . . . . 0.0 110.797 -178.954 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 156' ' ' THR . . . . . . . . . . . . . 0.4 OUTLIER -104.47 -27.16 12.08 Favored 'General case' 0 C--N 1.292 -1.933 0 CA-C-N 115.292 -0.867 . . . . 0.0 110.284 -178.385 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 157' ' ' SER . . . . . . . . . . . . . 10.0 t -150.63 150.52 31.26 Favored 'General case' 0 N--CA 1.493 1.702 0 C-N-CA 118.418 -1.313 . . . . 0.0 110.927 -178.812 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 158' ' ' ILE . . . . . 0.696 HD12 ' N ' ' A' ' 159' ' ' ARG . 0.1 OUTLIER -152.91 140.13 13.21 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.389 0 CA-C-O 121.75 0.786 . . . . 0.0 109.563 -178.476 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 159' ' ' ARG . . . . . 0.696 ' N ' HD12 ' A' ' 158' ' ' ILE . 26.8 mtm180 -154.73 165.2 37.33 Favored 'General case' 0 C--N 1.294 -1.822 0 CA-C-O 121.672 0.749 . . . . 0.0 109.882 -179.441 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 160' ' ' ASP . . . . . 0.49 ' O ' HG13 ' A' ' 161' ' ' VAL . 8.0 m-20 -116.18 155.03 28.99 Favored 'General case' 0 C--N 1.298 -1.645 0 N-CA-C 108.069 -1.085 . . . . 0.0 108.069 179.253 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 161' ' ' VAL . . . . . 0.49 HG13 ' O ' ' A' ' 160' ' ' ASP . 13.1 m -155.01 150.69 11.4 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.7 0 O-C-N 120.893 -1.129 . . . . 0.0 110.527 -178.995 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 162' ' ' LYS . . . . . 0.409 ' O ' ' O ' ' A' ' 161' ' ' VAL . 0.0 OUTLIER -47.36 170.38 0.09 OUTLIER Pre-proline 0 N--CA 1.49 1.571 0 O-C-N 121.295 -0.878 . . . . 0.0 109.495 179.677 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 163' ' ' PRO . . . . . . . . . . . . . 57.4 Cg_endo -78.0 37.32 0.62 Allowed 'Trans proline' 0 C--N 1.309 -1.525 0 C-N-CA 122.738 2.292 . . . . 0.0 112.769 -179.706 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 164' ' ' THR . . . . . . . . . . . . . 17.4 m -152.19 -7.98 0.21 Allowed 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.081 -1.012 . . . . 0.0 110.859 -179.88 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 165' ' ' ASP . . . . . 0.456 ' O ' ' C ' ' A' ' 166' ' ' VAL . 6.9 t70 -72.84 61.41 0.55 Allowed 'General case' 0 N--CA 1.492 1.653 0 O-C-N 120.627 -1.296 . . . . 0.0 110.193 -179.412 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 166' ' ' VAL . . . . . 0.67 ' O ' ' N ' ' A' ' 168' ' ' VAL . 0.7 OUTLIER -39.77 -30.0 0.13 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.637 0 O-C-N 121.411 -0.806 . . . . 0.0 109.789 -178.546 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 167' ' ' GLY . . . . . 0.443 ' N ' ' O ' ' A' ' 165' ' ' ASP . . . -42.55 -9.04 0.01 OUTLIER Glycine 0 N--CA 1.5 2.925 0 O-C-N 121.292 -0.88 . . . . 0.0 111.221 -179.497 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 168' ' ' VAL . . . . . 0.67 ' N ' ' O ' ' A' ' 166' ' ' VAL . 19.6 t -48.35 -40.72 10.47 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.62 0 O-C-N 120.89 -1.359 . . . . 0.0 108.729 179.263 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 169' ' ' LEU . . . . . 0.544 ' O ' ' N ' ' A' ' 171' ' ' GLU . 5.4 mt -47.54 -9.4 0.02 OUTLIER 'General case' 0 N--CA 1.496 1.86 0 N-CA-C 108.715 -0.846 . . . . 0.0 108.715 -178.207 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 170' ' ' ASP . . . . . 0.599 ' N ' ' O ' ' A' ' 168' ' ' VAL . 7.0 t0 35.6 27.86 0.01 OUTLIER 'General case' 0 N--CA 1.493 1.72 0 O-C-N 121.508 -0.745 . . . . 0.0 111.5 178.22 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 171' ' ' GLU . . . . . 0.544 ' N ' ' O ' ' A' ' 169' ' ' LEU . 3.8 pt-20 -69.34 94.56 0.72 Allowed 'General case' 0 C--N 1.301 -1.541 0 N-CA-C 107.157 -1.423 . . . . 0.0 107.157 178.034 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 172' ' ' GLN . . . . . . . . . . . . . 2.4 mt-30 -155.14 -74.06 0.11 Allowed 'General case' 0 N--CA 1.493 1.716 0 O-C-N 121.447 -0.783 . . . . 0.0 109.977 -178.645 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 173' ' ' LYS . . . . . 0.525 ' O ' ' NE2' ' A' ' 113' ' ' GLN . 2.3 mptt -59.65 137.84 57.91 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.335 -0.853 . . . . 0.0 109.119 179.841 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 174' ' ' GLY . . . . . 0.504 ' O ' ' C ' ' A' ' 175' ' ' LYS . . . -123.42 -43.61 0.35 Allowed Glycine 0 C--N 1.299 -1.505 0 N-CA-C 107.771 -2.132 . . . . 0.0 107.771 179.172 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 175' ' ' LYS . . . . . 0.504 ' C ' ' O ' ' A' ' 174' ' ' GLY . 0.1 OUTLIER -36.89 -76.9 0.02 OUTLIER 'General case' 0 N--CA 1.498 1.946 0 N-CA-C 108.943 -0.762 . . . . 0.0 108.943 179.729 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 176' ' ' ASP . . . . . 0.582 ' O ' ' O ' ' A' ' 177' ' ' LYS . 1.2 m-20 -91.38 86.62 6.15 Favored 'General case' 0 C--N 1.297 -1.708 0 N-CA-C 107.087 -1.449 . . . . 0.0 107.087 178.059 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 177' ' ' LYS . . . . . 0.582 ' O ' ' O ' ' A' ' 176' ' ' ASP . 0.9 OUTLIER -40.5 178.01 0.0 OUTLIER 'General case' 0 N--CA 1.493 1.713 0 CA-C-O 121.603 0.716 . . . . 0.0 110.907 -178.919 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 178' ' ' GLN . . . . . 0.492 ' NE2' ' CG ' ' A' ' 114' ' ' ASN . 1.0 OUTLIER -160.91 173.49 15.23 Favored 'General case' 0 C--N 1.307 -1.263 0 C-N-CA 118.637 -1.225 . . . . 0.0 110.692 -179.726 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 179' ' ' LEU . . . . . . . . . . . . . 2.2 tp -128.02 100.2 5.79 Favored 'General case' 0 C--N 1.3 -1.57 0 N-CA-C 106.896 -1.52 . . . . 0.0 106.896 178.127 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 180' ' ' THR . . . . . . . . . . . . . 1.4 m -75.18 118.95 18.67 Favored 'General case' 0 C--N 1.303 -1.417 0 C-N-CA 119.071 -1.052 . . . . 0.0 110.287 -178.101 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 181' ' ' LEU . . . . . . . . . . . . . 57.8 tp -94.76 146.95 23.82 Favored 'General case' 0 C--N 1.298 -1.647 0 N-CA-C 108.08 -1.081 . . . . 0.0 108.08 178.171 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 182' ' ' ILE . . . . . . . . . . . . . 54.9 mt -140.9 125.43 17.88 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.529 0 O-C-N 120.958 -1.089 . . . . 0.0 109.684 179.552 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 183' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -143.84 112.29 6.44 Favored 'General case' 0 C--N 1.295 -1.802 0 N-CA-C 107.047 -1.464 . . . . 0.0 107.047 178.722 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 184' ' ' CYS . . . . . 0.477 ' CB ' HH11 ' A' ' 197' ' ' ARG . 0.6 OUTLIER -78.48 163.06 25.91 Favored 'General case' 0 N--CA 1.498 1.964 0 C-N-CA 118.786 -1.166 . . . . 0.0 110.954 -177.114 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 185' ' ' ASP . . . . . . . . . . . . . 12.3 t0 -165.87 -153.92 0.19 Allowed 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.45 -0.781 . . . . 0.0 109.817 -179.712 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 186' ' ' ASP . . . . . 0.444 ' HB3' ' H ' ' A' ' 196' ' ' LYS . 0.4 OUTLIER 49.98 53.92 11.98 Favored 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.254 -0.904 . . . . 0.0 108.983 -179.67 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 187' ' ' TYR . . . . . 0.603 ' CE1' ' O ' ' A' ' 188' ' ' ASN . 34.2 t80 -65.93 135.17 54.39 Favored 'General case' 0 C--N 1.301 -1.521 0 O-C-N 121.205 -0.935 . . . . 0.0 110.222 -179.419 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 188' ' ' ASN . . . . . 0.603 ' O ' ' CE1' ' A' ' 187' ' ' TYR . 0.6 OUTLIER -100.93 147.68 25.87 Favored 'General case' 0 C--N 1.296 -1.737 0 N-CA-C 107.954 -1.128 . . . . 0.0 107.954 178.578 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 189' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -112.54 -13.65 13.31 Favored 'General case' 0 C--N 1.295 -1.772 0 N-CA-C 108.268 -1.012 . . . . 0.0 108.268 -179.872 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 190' ' ' LYS . . . . . . . . . . . . . 15.0 mtmt -83.46 -52.34 6.59 Favored 'General case' 0 C--N 1.303 -1.426 0 N-CA-C 108.814 -0.81 . . . . 0.0 108.814 179.118 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 191' ' ' THR . . . . . . . . . . . . . 2.6 p -90.56 -9.63 46.43 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.461 -0.775 . . . . 0.0 109.075 179.58 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 192' ' ' GLY . . . . . . . . . . . . . . . 63.68 39.94 98.04 Favored Glycine 0 N--CA 1.493 2.484 0 N-CA-C 110.836 -0.905 . . . . 0.0 110.836 178.941 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 193' ' ' VAL . . . . . 0.495 HG12 ' N ' ' A' ' 194' ' ' TRP . 57.8 t -145.98 159.32 11.75 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.563 0 O-C-N 121.01 -1.288 . . . . 0.0 109.34 179.346 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 194' ' ' TRP . . . . . 0.495 ' N ' HG12 ' A' ' 193' ' ' VAL . 19.9 m95 -85.31 120.48 26.84 Favored 'General case' 0 C--N 1.3 -1.584 0 N-CA-C 107.644 -1.243 . . . . 0.0 107.644 178.667 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 195' ' ' GLU . . . . . 0.514 ' CD ' ' ND2' ' A' ' 188' ' ' ASN . 1.1 mt-10 -89.27 -60.6 1.91 Allowed 'General case' 0 N--CA 1.493 1.713 0 O-C-N 121.138 -0.976 . . . . 0.0 111.749 -177.453 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 196' ' ' LYS . . . . . 0.444 ' H ' ' HB3' ' A' ' 186' ' ' ASP . 0.0 OUTLIER -78.98 144.34 34.85 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 120.823 -1.173 . . . . 0.0 110.405 -178.558 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 197' ' ' ARG . . . . . 0.56 ' NH2' ' O ' ' C' ' 703' ' ' PRO . 0.7 OUTLIER -120.77 137.15 54.66 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.632 -0.668 . . . . 0.0 109.206 179.714 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 198' ' ' LYS . . . . . . . . . . . . . 3.2 mtmm -114.97 122.06 45.09 Favored 'General case' 0 N--CA 1.489 1.491 0 O-C-N 121.722 -0.611 . . . . 0.0 110.323 -178.943 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 199' ' ' ILE . . . . . 0.648 ' C ' HD12 ' A' ' 199' ' ' ILE . 0.6 OUTLIER -141.85 118.32 6.85 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.7 0 O-C-N 120.957 -1.09 . . . . 0.0 110.416 179.937 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 200' ' ' PHE . . . . . 0.53 ' CD1' ' N ' ' A' ' 200' ' ' PHE . 6.5 m-85 -99.84 137.96 37.58 Favored 'General case' 0 N--CA 1.499 1.975 0 O-C-N 121.294 -0.879 . . . . 0.0 110.134 -179.371 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 201' ' ' VAL . . . . . . . . . . . . . 33.0 t -105.7 148.28 10.33 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.589 0 N-CA-C 107.981 -1.118 . . . . 0.0 107.981 177.744 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 202' ' ' ALA . . . . . . . . . . . . . . . -133.35 139.43 46.82 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.03 -1.044 . . . . 0.0 109.088 -179.608 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 203' ' ' THR . . . . . 0.403 ' O ' HG23 ' A' ' 205' ' ' VAL . 1.9 p -90.2 134.26 34.39 Favored 'General case' 0 N--CA 1.487 1.383 0 CA-C-O 122.565 1.174 . . . . 0.0 111.197 -178.827 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 204' ' ' GLU . . . . . 0.43 ' HA ' ' CD2' ' A' ' 153' ' ' TYR . 6.8 tt0 -56.0 134.88 52.69 Favored 'General case' 0 C--N 1.296 -1.76 0 C-N-CA 118.761 -1.176 . . . . 0.0 109.621 179.818 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 205' ' ' VAL . . . . . 0.531 ' O ' ' C ' ' A' ' 206' ' ' LYS . 61.0 t -128.35 -42.4 0.85 Allowed 'Isoleucine or valine' 0 N--CA 1.494 1.766 0 O-C-N 121.304 -0.873 . . . . 0.0 110.24 -178.788 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 206' ' ' LYS . . . . . 0.531 ' C ' ' O ' ' A' ' 205' ' ' VAL . 1.2 pptp? . . . . . 0 N--CA 1.501 2.093 0 CA-C-O 118.157 -0.925 . . . . 0.0 110.596 -179.505 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' C' C ' 702' ' ' LEU . . . . . 0.821 ' N ' HD12 ' C' ' 702' ' ' LEU . 0.0 OUTLIER . . . . . 0 N--CA 1.493 1.702 0 N-CA-C 108.676 -0.861 . . . . 0.0 108.676 . . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' C' C ' 703' ' ' PRO . . . . . 0.56 ' O ' ' NH2' ' A' ' 197' ' ' ARG . 42.8 Cg_endo -69.59 -179.19 2.66 Favored 'Trans proline' 0 N--CA 1.496 1.64 0 C-N-CA 122.868 2.379 . . . . 0.0 113.276 -178.935 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' C' C ' 704' ' ' ALA . . . . . 0.484 ' O ' ' O ' ' C' ' 703' ' ' PRO . . . . . . . . 0 N--CA 1.486 1.336 0 O-C-N 121.557 -0.714 . . . . 0.0 109.295 179.934 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 63' ' ' PRO . . . . . . . . . . . . . 3.7 Cg_endo . . . . . 0 N--CA 1.483 0.89 0 CA-C-O 121.096 0.374 . . . . 0.0 111.436 . . . . . . . . . 0 0 . 1 . 003 nuclear nobuild core ' A' A ' 64' ' ' GLN . . . . . 0.712 ' NE2' ' N ' ' A' ' 64' ' ' GLN . 0.0 OUTLIER -153.0 102.59 2.67 Favored 'General case' 0 N--CA 1.493 1.685 0 O-C-N 121.129 -0.982 . . . . 0.0 109.513 -179.63 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 65' ' ' ILE . . . . . 0.486 ' C ' ' O ' ' A' ' 64' ' ' GLN . 3.0 mp -37.83 99.3 0.18 Allowed Pre-proline 0 N--CA 1.494 1.747 0 N-CA-C 108.677 -0.86 . . . . 0.0 108.677 179.715 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 66' ' ' PRO . . . . . 0.463 ' N ' ' O ' ' A' ' 64' ' ' GLN . 57.8 Cg_endo -85.27 -162.55 0.16 Allowed 'Trans proline' 0 C--N 1.315 -1.203 0 C-N-CA 122.264 1.976 . . . . 0.0 112.505 -178.592 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 67' ' ' LYS . . . . . 0.515 ' C ' ' H ' ' A' ' 69' ' ' LYS . 6.6 ptpt -72.98 -5.73 40.69 Favored 'General case' 0 C--N 1.303 -1.415 0 O-C-N 121.393 -0.817 . . . . 0.0 108.829 179.737 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 68' ' ' ASP . . . . . 0.594 ' O ' ' N ' ' A' ' 70' ' ' SER . 1.0 OUTLIER -74.97 46.53 0.31 Allowed 'General case' 0 N--CA 1.486 1.374 0 CA-C-O 122.85 1.309 . . . . 0.0 107.735 178.876 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 69' ' ' LYS . . . . . 0.515 ' H ' ' C ' ' A' ' 67' ' ' LYS . 13.3 ptpt -48.63 -14.41 0.06 Allowed 'General case' 0 N--CA 1.501 2.123 0 C-N-CA 117.23 -1.788 . . . . 0.0 106.728 178.191 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 70' ' ' SER . . . . . 0.594 ' N ' ' O ' ' A' ' 68' ' ' ASP . 0.3 OUTLIER -85.25 -6.3 59.27 Favored 'General case' 0 N--CA 1.496 1.86 0 CA-C-N 113.53 -1.668 . . . . 0.0 110.764 179.284 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 71' ' ' LYS . . . . . 0.433 ' N ' ' O ' ' A' ' 68' ' ' ASP . 0.0 OUTLIER -97.53 140.96 31.17 Favored 'General case' 0 N--CA 1.497 1.886 0 O-C-N 120.876 -1.14 . . . . 0.0 111.478 -179.598 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 72' ' ' VAL . . . . . 0.574 HG23 ' H ' ' A' ' 87' ' ' VAL . 0.2 OUTLIER -65.45 136.57 26.48 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.414 0 N-CA-C 105.334 -2.099 . . . . 0.0 105.334 175.36 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 73' ' ' ALA . . . . . 0.535 ' N ' ' O ' ' A' ' 87' ' ' VAL . . . -83.53 -17.16 42.8 Favored 'General case' 0 C--N 1.296 -1.717 0 O-C-N 120.179 -1.576 . . . . 0.0 108.245 -179.017 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 74' ' ' GLY . . . . . 0.553 ' O ' ' CG2' ' A' ' 72' ' ' VAL . . . 172.44 -157.71 27.5 Favored Glycine 0 C--N 1.294 -1.776 0 N-CA-C 109.5 -1.44 . . . . 0.0 109.5 -179.554 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 75' ' ' TYR . . . . . 0.57 ' HA ' HG23 ' A' ' 87' ' ' VAL . 4.6 m-85 -141.47 170.37 15.86 Favored 'General case' 0 C--N 1.293 -1.866 0 O-C-N 121.363 -1.08 . . . . 0.0 110.362 -177.303 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 76' ' ' ILE . . . . . . . . . . . . . 3.0 tp -144.92 140.02 22.99 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.717 0 C-N-CA 119.359 -0.937 . . . . 0.0 109.446 -177.414 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 77' ' ' GLU . . . . . 0.572 ' N ' ' CD ' ' A' ' 77' ' ' GLU . 0.7 OUTLIER -146.71 159.43 43.48 Favored 'General case' 0 C--N 1.304 -1.388 0 O-C-N 121.015 -1.053 . . . . 0.0 109.148 -179.293 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 78' ' ' ILE . . . . . 0.505 ' HB ' ' HB3' ' A' ' 81' ' ' ALA . 12.2 mt -147.7 94.34 4.41 Favored Pre-proline 0 N--CA 1.489 1.498 0 N-CA-C 108.622 -0.881 . . . . 0.0 108.622 -179.963 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 79' ' ' PRO . . . . . . . . . . . . . 75.0 Cg_exo -46.83 -45.83 19.65 Favored 'Trans proline' 0 N--CA 1.493 1.488 0 C-N-CA 122.937 2.425 . . . . 0.0 114.212 -178.685 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -64.78 -19.83 66.03 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 120.644 -1.285 . . . . 0.0 110.507 178.704 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 81' ' ' ALA . . . . . 0.81 ' HB2' ' HB2' ' A' ' 136' ' ' ALA . . . -104.99 -16.73 14.73 Favored 'General case' 0 N--CA 1.493 1.707 0 N-CA-C 108.448 -0.945 . . . . 0.0 108.448 179.223 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 82' ' ' ASP . . . . . . . . . . . . . 7.8 t0 67.21 50.36 1.0 Allowed 'General case' 0 N--CA 1.488 1.437 0 O-C-N 121.364 -0.835 . . . . 0.0 109.951 179.736 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 83' ' ' ILE . . . . . 0.59 HD11 ' OD1' ' A' ' 132' ' ' ASN . 78.4 mt -127.82 152.78 36.32 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.671 0 O-C-N 121.395 -0.815 . . . . 0.0 110.009 -178.914 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 84' ' ' LYS . . . . . . . . . . . . . 1.8 tttt -159.06 108.71 1.94 Allowed 'General case' 0 N--CA 1.49 1.561 0 N-CA-C 107.099 -1.445 . . . . 0.0 107.099 179.036 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 85' ' ' GLU . . . . . 0.503 ' OE1' ' O ' ' A' ' 128' ' ' TYR . 0.0 OUTLIER -141.92 169.56 10.88 Favored Pre-proline 0 N--CA 1.494 1.733 0 O-C-N 121.236 -0.915 . . . . 0.0 110.972 -177.842 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 86' ' ' PRO . . . . . . . . . . . . . 73.4 Cg_endo -79.34 166.45 22.38 Favored 'Trans proline' 0 N--CA 1.492 1.385 0 C-N-CA 123.22 2.613 . . . . 0.0 113.43 -179.631 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 87' ' ' VAL . . . . . 0.574 ' H ' HG23 ' A' ' 72' ' ' VAL . 60.3 t -126.07 102.08 9.31 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.614 0 N-CA-C 109.056 -0.72 . . . . 0.0 109.056 179.705 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 88' ' ' TYR . . . . . 0.486 ' CB ' HE22 ' A' ' 96' ' ' GLN . 22.7 m-85 -96.33 153.82 38.86 Favored Pre-proline 0 N--CA 1.501 2.088 0 O-C-N 120.952 -1.092 . . . . 0.0 110.336 -179.34 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 89' ' ' PRO . . . . . . . . . . . . . 1.2 Cg_endo -55.72 143.82 78.57 Favored 'Trans proline' 0 C--N 1.309 -1.543 0 C-N-CA 122.715 2.277 . . . . 0.0 113.958 -179.891 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . -57.76 169.35 4.4 Favored Glycine 0 N--CA 1.493 2.44 0 N-CA-C 108.888 -1.685 . . . . 0.0 108.888 178.743 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 91' ' ' PRO . . . . . . . . . . . . . 56.3 Cg_endo -94.75 169.38 17.55 Favored 'Cis proline' 0 C--N 1.308 -1.558 0 C-N-CA 124.183 -1.174 . . . . 0.0 112.079 0.141 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 92' ' ' ALA . . . . . 0.637 ' HB3' ' HB3' ' C' ' 703' ' ' PRO . . . -72.99 32.07 0.07 Allowed 'General case' 0 N--CA 1.493 1.718 0 O-C-N 120.948 -1.095 . . . . 0.0 110.927 -179.724 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 93' ' ' THR . . . . . . . . . . . . . 11.1 p -73.15 150.4 89.9 Favored Pre-proline 0 C--N 1.302 -1.47 0 O-C-N 120.278 -1.514 . . . . 0.0 108.228 179.695 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 94' ' ' PRO . . . . . . . . . . . . . 91.1 Cg_exo -34.39 -46.41 0.51 Allowed 'Trans proline' 0 C--N 1.309 -1.527 0 C-N-CA 122.78 2.32 . . . . 0.0 112.44 -179.074 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 95' ' ' GLU . . . . . 0.59 ' O ' ' ND2' ' A' ' 98' ' ' ASN . 6.8 mt-10 -53.69 -51.94 61.61 Favored 'General case' 0 N--CA 1.488 1.465 0 O-C-N 121.111 -0.993 . . . . 0.0 109.702 179.9 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 96' ' ' GLN . . . . . 0.551 ' C ' ' H ' ' A' ' 98' ' ' ASN . 0.0 OUTLIER -71.92 -45.94 59.37 Favored 'General case' 0 C--N 1.303 -1.418 0 O-C-N 121.205 -0.935 . . . . 0.0 109.822 -179.848 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 97' ' ' LEU . . . . . 0.509 ' CD1' ' O ' ' A' ' 92' ' ' ALA . 88.9 mt -55.17 -4.91 0.09 Allowed 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.18 -0.95 . . . . 0.0 108.935 179.902 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 98' ' ' ASN . . . . . 0.59 ' ND2' ' O ' ' A' ' 95' ' ' GLU . 0.0 OUTLIER -71.88 -26.01 62.16 Favored 'General case' 0 N--CA 1.489 1.505 0 O-C-N 121.511 -0.743 . . . . 0.0 109.295 179.708 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 99' ' ' ARG . . . . . 0.681 ' CG ' HH11 ' A' ' 99' ' ' ARG . 0.2 OUTLIER -99.9 -59.06 1.78 Allowed 'General case' 0 N--CA 1.488 1.426 0 C-N-CA 119.71 -0.796 . . . . 0.0 110.483 -178.919 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . -170.84 -169.43 33.87 Favored Glycine 0 N--CA 1.49 2.277 0 C-N-CA 119.013 -1.565 . . . . 0.0 110.518 -179.789 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 101' ' ' VAL . . . . . 0.711 ' O ' HG23 ' A' ' 101' ' ' VAL . 27.0 m -53.95 106.25 0.1 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.525 0 O-C-N 121.662 -0.905 . . . . 0.0 109.561 -179.906 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -92.91 158.08 16.02 Favored 'General case' 0 N--CA 1.495 1.787 0 O-C-N 121.249 -0.907 . . . . 0.0 110.582 -179.88 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 103' ' ' PHE . . . . . 0.562 ' O ' ' N ' ' A' ' 105' ' ' GLU . 23.6 m-85 -61.06 121.76 13.27 Favored 'General case' 0 N--CA 1.491 1.612 0 N-CA-C 108.083 -1.081 . . . . 0.0 108.083 178.58 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 104' ' ' ALA . . . . . 0.43 ' HB1' ' HG2' ' C' ' 703' ' ' PRO . . . -40.03 -19.99 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.567 -0.708 . . . . 0.0 111.445 -178.434 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 105' ' ' GLU . . . . . 0.64 ' OE1' HD13 ' A' ' 169' ' ' LEU . 0.2 OUTLIER -139.33 151.2 46.2 Favored 'General case' 0 N--CA 1.494 1.767 0 O-C-N 120.688 -1.257 . . . . 0.0 110.707 -179.563 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 106' ' ' GLU . . . . . . . . . . . . . 30.3 tt0 -57.95 -64.19 0.99 Allowed 'General case' 0 C--N 1.303 -1.442 0 CA-C-N 116.146 -0.479 . . . . 0.0 111.3 -178.94 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 107' ' ' ASN . . . . . 0.462 ' C ' ' ND2' ' A' ' 107' ' ' ASN . 0.0 OUTLIER -77.47 33.0 0.16 Allowed 'General case' 0 N--CA 1.491 1.587 0 O-C-N 120.541 -1.349 . . . . 0.0 113.187 -175.214 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 108' ' ' GLU . . . . . . . . . . . . . 33.2 tp10 -59.55 148.61 32.7 Favored 'General case' 0 C--N 1.301 -1.53 0 N-CA-C 107.474 -1.306 . . . . 0.0 107.474 179.899 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 109' ' ' SER . . . . . 0.479 ' C ' ' H ' ' A' ' 111' ' ' ASP . 0.1 OUTLIER -100.59 124.67 46.48 Favored 'General case' 0 N--CA 1.487 1.409 0 O-C-N 120.9 -1.125 . . . . 0.0 110.486 -178.432 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 110' ' ' LEU . . . . . 0.451 HD12 ' OD1' ' A' ' 111' ' ' ASP . 1.5 pp -60.01 -4.61 0.79 Allowed 'General case' 0 C--N 1.301 -1.536 0 N-CA-C 108.467 -0.938 . . . . 0.0 108.467 179.721 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 111' ' ' ASP . . . . . 0.479 ' H ' ' C ' ' A' ' 109' ' ' SER . 11.8 m-20 -131.93 20.77 4.55 Favored 'General case' 0 C--N 1.303 -1.416 0 N-CA-C 108.825 -0.805 . . . . 0.0 108.825 179.57 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 112' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -66.3 140.02 58.09 Favored 'General case' 0 N--CA 1.489 1.505 0 O-C-N 121.349 -0.844 . . . . 0.0 110.198 -179.937 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 113' ' ' GLN . . . . . 0.477 ' NE2' ' CA ' ' A' ' 113' ' ' GLN . 0.8 OUTLIER -65.11 -6.68 9.61 Favored 'General case' 0 C--N 1.302 -1.488 0 N-CA-C 107.892 -1.151 . . . . 0.0 107.892 178.278 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 114' ' ' ASN . . . . . 0.417 ' CG ' ' O ' ' A' ' 114' ' ' ASN . 11.1 p-10 -146.02 95.01 2.56 Favored 'General case' 0 C--N 1.3 -1.545 0 N-CA-C 107.95 -1.13 . . . . 0.0 107.95 179.144 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 115' ' ' ILE . . . . . 0.479 ' O ' HG22 ' A' ' 115' ' ' ILE . 2.6 mt -98.24 111.67 28.5 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.536 0 O-C-N 121.493 -0.754 . . . . 0.0 109.487 -179.366 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 116' ' ' SER . . . . . . . . . . . . . 66.3 m -97.1 151.19 20.02 Favored 'General case' 0 N--CA 1.489 1.517 0 CA-C-O 121.77 0.795 . . . . 0.0 111.066 -178.804 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 117' ' ' ILE . . . . . . . . . . . . . 1.9 mt -146.59 155.85 11.69 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.588 0 N-CA-C 108.184 -1.043 . . . . 0.0 108.184 179.328 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 118' ' ' ALA . . . . . 0.748 ' HB1' ' HB2' ' C' ' 704' ' ' ALA . . . -146.04 163.41 35.32 Favored 'General case' 0 N--CA 1.493 1.683 0 O-C-N 120.569 -1.332 . . . . 0.0 111.88 -179.049 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 119' ' ' GLY . . . . . . . . . . . . . . . -169.9 148.57 11.95 Favored Glycine 0 N--CA 1.49 2.295 0 N-CA-C 110.403 -1.079 . . . . 0.0 110.403 -179.889 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 120' ' ' HIS . . . . . . . . . . . . . 34.2 m170 -69.33 167.71 15.87 Favored 'General case' 0 N--CA 1.495 1.799 0 O-C-N 121.768 -0.842 . . . . 0.0 110.498 179.783 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 121' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -122.9 155.11 37.35 Favored 'General case' 0 N--CA 1.493 1.715 0 N-CA-C 108.165 -1.05 . . . . 0.0 108.165 178.677 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 122' ' ' PHE . . . . . 0.7 ' O ' HG21 ' A' ' 131' ' ' THR . 0.4 OUTLIER -144.15 123.38 12.97 Favored 'General case' 0 N--CA 1.496 1.835 0 O-C-N 120.849 -1.157 . . . . 0.0 109.756 -179.487 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 123' ' ' ILE . . . . . 0.573 HG23 ' N ' ' A' ' 124' ' ' ASP . 11.1 tt -55.76 -40.75 62.7 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.462 0 CA-C-O 121.628 0.728 . . . . 0.0 109.065 179.963 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 124' ' ' ASP . . . . . 0.573 ' N ' HG23 ' A' ' 123' ' ' ILE . 31.3 t70 -88.75 23.4 2.32 Favored 'General case' 0 N--CA 1.493 1.714 0 O-C-N 121.653 -0.654 . . . . 0.0 111.731 -177.703 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 125' ' ' ARG . . . . . . . . . . . . . 54.1 mtt180 -153.62 98.59 2.66 Favored Pre-proline 0 N--CA 1.493 1.679 0 O-C-N 120.866 -1.146 . . . . 0.0 109.183 179.618 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 126' ' ' PRO . . . . . . . . . . . . . 69.7 Cg_endo -82.3 -28.57 1.85 Allowed 'Trans proline' 0 C--N 1.313 -1.321 0 C-N-CA 122.401 2.068 . . . . 0.0 111.939 179.734 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 127' ' ' ASN . . . . . 0.482 ' O ' ' O ' ' A' ' 128' ' ' TYR . 2.1 m120 -89.86 6.43 41.87 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.372 -0.83 . . . . 0.0 109.186 179.79 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 128' ' ' TYR . . . . . 0.503 ' O ' ' OE1' ' A' ' 85' ' ' GLU . 2.4 t80 -59.47 -148.53 0.0 OUTLIER 'General case' 0 N--CA 1.489 1.486 0 O-C-N 121.318 -0.864 . . . . 0.0 109.465 179.901 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 129' ' ' GLN . . . . . 0.489 ' O ' ' OE1' ' A' ' 85' ' ' GLU . 8.7 mt-30 -65.21 -72.45 0.15 Allowed 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.386 -0.821 . . . . 0.0 110.067 -179.321 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 130' ' ' PHE . . . . . 0.567 ' CE2' HG11 ' A' ' 101' ' ' VAL . 53.5 m-85 -135.78 42.0 2.67 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.012 -1.055 . . . . 0.0 109.993 -179.693 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 131' ' ' THR . . . . . 0.7 HG21 ' O ' ' A' ' 122' ' ' PHE . 38.9 m -77.19 -35.82 55.46 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.129 -0.982 . . . . 0.0 109.531 179.94 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 132' ' ' ASN . . . . . 0.604 ' ND2' ' O ' ' A' ' 81' ' ' ALA . 0.1 OUTLIER -84.15 4.71 29.21 Favored 'General case' 0 N--CA 1.498 1.925 0 O-C-N 121.44 -0.788 . . . . 0.0 110.456 -179.277 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 133' ' ' LEU . . . . . 0.569 ' O ' ' N ' ' A' ' 135' ' ' ALA . 0.2 OUTLIER -68.19 -45.52 73.2 Favored 'General case' 0 C--N 1.296 -1.76 0 O-C-N 120.961 -1.087 . . . . 0.0 110.578 -179.636 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 134' ' ' LYS . . . . . 0.52 ' CD ' ' H ' ' A' ' 134' ' ' LYS . 0.0 OUTLIER -43.17 -17.85 0.01 OUTLIER 'General case' 0 N--CA 1.496 1.865 0 O-C-N 120.955 -1.09 . . . . 0.0 110.191 -179.331 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 135' ' ' ALA . . . . . 0.569 ' N ' ' O ' ' A' ' 133' ' ' LEU . . . -83.24 -38.28 22.42 Favored 'General case' 0 N--CA 1.488 1.471 0 O-C-N 120.925 -1.109 . . . . 0.0 110.147 -179.566 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 136' ' ' ALA . . . . . 0.81 ' HB2' ' HB2' ' A' ' 81' ' ' ALA . . . -80.0 157.89 26.69 Favored 'General case' 0 C--N 1.302 -1.476 0 CA-C-O 122.283 1.04 . . . . 0.0 111.82 -178.412 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 137' ' ' LYS . . . . . 0.528 ' O ' ' O ' ' A' ' 138' ' ' LYS . 2.4 tttt -154.49 -162.71 1.45 Allowed 'General case' 0 N--CA 1.491 1.617 0 C-N-CA 119.083 -1.047 . . . . 0.0 110.579 -178.61 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 138' ' ' LYS . . . . . 0.601 ' O ' ' N ' ' A' ' 140' ' ' SER . 16.6 pttm -44.65 -179.19 0.0 OUTLIER 'General case' 0 C--N 1.302 -1.482 0 CA-C-O 122.228 1.013 . . . . 0.0 111.039 -179.13 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 139' ' ' GLY . . . . . . . . . . . . . . . 45.42 7.89 0.01 OUTLIER Glycine 0 N--CA 1.491 2.304 0 N-CA-C 110.646 -0.982 . . . . 0.0 110.646 179.978 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 140' ' ' SER . . . . . 0.601 ' N ' ' O ' ' A' ' 138' ' ' LYS . 58.7 m -85.99 124.39 32.38 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 120.71 -1.465 . . . . 0.0 109.244 179.459 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 141' ' ' MET . . . . . . . . . . . . . 1.1 tpt -72.88 136.08 45.23 Favored 'General case' 0 N--CA 1.489 1.506 0 O-C-N 121.133 -0.979 . . . . 0.0 109.16 179.93 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 142' ' ' VAL . . . . . . . . . . . . . 3.5 t -121.42 129.1 75.9 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.627 0 N-CA-C 108.865 -0.791 . . . . 0.0 108.865 -179.835 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 143' ' ' TYR . . . . . . . . . . . . . 16.6 m-85 -113.14 136.6 52.54 Favored 'General case' 0 N--CA 1.498 1.951 0 O-C-N 121.172 -0.955 . . . . 0.0 111.063 -178.667 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 144' ' ' PHE . . . . . 0.565 ' CE2' HG11 ' A' ' 146' ' ' VAL . 10.7 t80 -122.52 104.98 9.73 Favored 'General case' 0 N--CA 1.492 1.667 0 CA-C-O 121.5 0.667 . . . . 0.0 110.245 -178.989 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 145' ' ' LYS . . . . . . . . . . . . . 4.6 mttm -97.7 123.41 41.61 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.426 -0.796 . . . . 0.0 109.719 -179.965 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 146' ' ' VAL . . . . . 0.565 HG11 ' CE2' ' A' ' 144' ' ' PHE . 0.5 OUTLIER -143.78 122.62 7.42 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.582 0 O-C-N 121.196 -0.94 . . . . 0.0 108.648 179.402 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 147' ' ' GLY . . . . . . . . . . . . . . . 70.47 -131.01 21.6 Favored Glycine 0 N--CA 1.488 2.163 0 N-CA-C 108.525 -1.83 . . . . 0.0 108.525 -179.103 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 148' ' ' ASN . . . . . 0.525 HD22 ' C ' ' A' ' 148' ' ' ASN . 0.4 OUTLIER -106.51 11.72 30.35 Favored 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.407 -1.055 . . . . 0.0 108.665 179.101 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 149' ' ' GLU . . . . . . . . . . . . . 4.8 tt0 -114.2 149.42 35.8 Favored 'General case' 0 N--CA 1.491 1.594 0 CA-C-O 121.844 0.831 . . . . 0.0 111.043 -179.003 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 150' ' ' THR . . . . . . . . . . . . . 20.1 m -129.89 105.55 8.07 Favored 'General case' 0 N--CA 1.492 1.656 0 CA-C-O 121.341 0.591 . . . . 0.0 109.762 -179.986 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 151' ' ' ARG . . . . . . . . . . . . . 4.9 mtp180 -87.82 -175.29 5.08 Favored 'General case' 0 N--CA 1.487 1.403 0 N-CA-C 108.293 -1.003 . . . . 0.0 108.293 179.701 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 152' ' ' LYS . . . . . . . . . . . . . 26.3 mtmt -149.31 146.45 27.55 Favored 'General case' 0 C--N 1.301 -1.502 0 O-C-N 120.914 -1.116 . . . . 0.0 110.619 -179.454 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 153' ' ' TYR . . . . . 0.491 ' CD2' ' HA ' ' A' ' 204' ' ' GLU . 4.1 m-85 -138.6 170.25 16.35 Favored 'General case' 0 N--CA 1.488 1.443 0 N-CA-C 107.471 -1.307 . . . . 0.0 107.471 178.794 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 154' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -144.52 122.7 12.19 Favored 'General case' 0 C--N 1.296 -1.726 0 N-CA-C 108.087 -1.079 . . . . 0.0 108.087 178.581 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 155' ' ' MET . . . . . . . . . . . . . 3.7 mtt -46.75 105.88 0.07 Allowed 'General case' 0 N--CA 1.49 1.54 0 O-C-N 120.594 -1.316 . . . . 0.0 111.702 -178.445 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 156' ' ' THR . . . . . 0.724 ' OG1' HG23 ' A' ' 203' ' ' THR . 0.1 OUTLIER -106.28 -25.55 11.9 Favored 'General case' 0 C--N 1.292 -1.918 0 CA-C-N 115.183 -0.917 . . . . 0.0 110.074 -179.137 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 157' ' ' SER . . . . . 0.416 ' O ' ' N ' ' A' ' 201' ' ' VAL . 0.1 OUTLIER -153.72 152.72 31.1 Favored 'General case' 0 N--CA 1.495 1.81 0 C-N-CA 118.24 -1.384 . . . . 0.0 111.592 -178.766 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 158' ' ' ILE . . . . . 0.454 HG13 ' CD2' ' A' ' 200' ' ' PHE . 0.0 OUTLIER -156.17 146.52 12.04 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.527 0 CA-C-O 121.758 0.79 . . . . 0.0 110.376 -179.885 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 159' ' ' ARG . . . . . 0.471 ' CG ' HH11 ' A' ' 159' ' ' ARG . 0.0 OUTLIER -150.85 -175.59 5.19 Favored 'General case' 0 C--N 1.3 -1.574 0 CA-C-O 121.833 0.825 . . . . 0.0 110.821 -179.629 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 160' ' ' ASP . . . . . 0.648 ' O ' HG13 ' A' ' 161' ' ' VAL . 1.9 m-20 -143.2 157.34 44.59 Favored 'General case' 0 N--CA 1.49 1.566 0 N-CA-C 108.018 -1.105 . . . . 0.0 108.018 -179.851 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 161' ' ' VAL . . . . . 0.648 HG13 ' O ' ' A' ' 160' ' ' ASP . 2.3 m -160.08 157.38 2.89 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.833 0 C-N-CA 118.624 -1.231 . . . . 0.0 110.902 -179.256 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 162' ' ' LYS . . . . . 0.449 ' O ' ' O ' ' A' ' 161' ' ' VAL . 0.0 OUTLIER -44.02 169.04 0.06 OUTLIER Pre-proline 0 N--CA 1.493 1.685 0 O-C-N 121.559 -0.713 . . . . 0.0 109.833 -179.996 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 163' ' ' PRO . . . . . 0.463 ' C ' HD11 ' C' ' 702' ' ' LEU . 57.0 Cg_endo -77.2 34.74 0.46 Allowed 'Trans proline' 0 C--N 1.309 -1.521 0 C-N-CA 122.622 2.215 . . . . 0.0 112.402 179.725 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 164' ' ' THR . . . . . 0.478 ' N ' HD11 ' C' ' 702' ' ' LEU . 0.0 OUTLIER -150.76 -6.98 0.28 Allowed 'General case' 0 N--CA 1.495 1.778 0 O-C-N 121.1 -1.0 . . . . 0.0 110.904 -179.567 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 165' ' ' ASP . . . . . 0.422 ' O ' ' C ' ' A' ' 166' ' ' VAL . 13.7 t70 -72.53 61.16 0.49 Allowed 'General case' 0 C--N 1.3 -1.56 0 O-C-N 120.881 -1.137 . . . . 0.0 109.127 -179.831 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 166' ' ' VAL . . . . . 0.643 ' O ' ' N ' ' A' ' 168' ' ' VAL . 0.8 OUTLIER -44.0 -29.47 0.52 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.523 0 O-C-N 121.113 -0.992 . . . . 0.0 109.387 -178.567 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 167' ' ' GLY . . . . . . . . . . . . . . . -45.19 -6.43 0.01 OUTLIER Glycine 0 N--CA 1.498 2.788 0 O-C-N 121.197 -0.94 . . . . 0.0 110.763 179.905 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 168' ' ' VAL . . . . . 0.643 ' N ' ' O ' ' A' ' 166' ' ' VAL . 2.8 t -48.24 -34.56 4.99 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.417 0 O-C-N 120.88 -1.365 . . . . 0.0 108.381 179.188 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 169' ' ' LEU . . . . . 0.64 HD13 ' OE1' ' A' ' 105' ' ' GLU . 1.4 mt -47.23 -11.01 0.02 OUTLIER 'General case' 0 N--CA 1.494 1.767 0 N-CA-C 108.239 -1.022 . . . . 0.0 108.239 -178.313 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 170' ' ' ASP . . . . . 0.603 ' N ' ' O ' ' A' ' 168' ' ' VAL . 6.1 t70 38.49 64.65 0.71 Allowed 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.596 -0.69 . . . . 0.0 111.535 177.615 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 171' ' ' GLU . . . . . 0.426 ' H ' ' HG2' ' A' ' 171' ' ' GLU . 1.7 pt-20 -101.09 92.81 5.17 Favored 'General case' 0 C--N 1.299 -1.601 0 N-CA-C 106.965 -1.494 . . . . 0.0 106.965 177.715 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 172' ' ' GLN . . . . . . . . . . . . . 1.1 mt-30 -156.01 -79.16 0.09 Allowed 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.651 -0.656 . . . . 0.0 110.266 -178.361 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 173' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -59.49 128.41 36.91 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.15 -0.969 . . . . 0.0 109.195 -179.549 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 174' ' ' GLY . . . . . 0.526 ' O ' ' C ' ' A' ' 175' ' ' LYS . . . -119.36 -40.92 0.6 Allowed Glycine 0 N--CA 1.48 1.584 0 N-CA-C 108.117 -1.993 . . . . 0.0 108.117 179.321 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 175' ' ' LYS . . . . . 0.526 ' C ' ' O ' ' A' ' 174' ' ' GLY . 2.9 mmtt -35.79 -61.88 0.45 Allowed 'General case' 0 N--CA 1.496 1.829 0 N-CA-C 108.728 -0.841 . . . . 0.0 108.728 -179.877 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 176' ' ' ASP . . . . . 0.604 ' O ' ' O ' ' A' ' 177' ' ' LYS . 0.3 OUTLIER -103.48 88.87 3.2 Favored 'General case' 0 C--N 1.297 -1.676 0 N-CA-C 107.801 -1.185 . . . . 0.0 107.801 177.946 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 177' ' ' LYS . . . . . 0.604 ' O ' ' O ' ' A' ' 176' ' ' ASP . 6.0 mtmp? -39.29 177.82 0.0 OUTLIER 'General case' 0 N--CA 1.494 1.748 0 CA-C-O 121.805 0.812 . . . . 0.0 111.023 -179.09 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 178' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -161.69 171.81 17.29 Favored 'General case' 0 C--N 1.305 -1.331 0 O-C-N 120.837 -1.164 . . . . 0.0 110.508 179.186 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 179' ' ' LEU . . . . . . . . . . . . . 1.3 tp -126.74 95.33 4.3 Favored 'General case' 0 C--N 1.302 -1.485 0 N-CA-C 106.491 -1.67 . . . . 0.0 106.491 177.513 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 180' ' ' THR . . . . . . . . . . . . . 1.2 m -70.12 119.11 13.83 Favored 'General case' 0 C--N 1.304 -1.384 0 C-N-CA 119.134 -1.026 . . . . 0.0 109.41 -178.349 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 181' ' ' LEU . . . . . 0.467 HD21 ' HG ' ' A' ' 133' ' ' LEU . 36.8 tp -96.82 146.01 25.32 Favored 'General case' 0 C--N 1.294 -1.806 0 N-CA-C 108.028 -1.101 . . . . 0.0 108.028 178.706 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 182' ' ' ILE . . . . . . . . . . . . . 25.3 mt -139.34 119.77 14.58 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.484 0 O-C-N 120.956 -1.09 . . . . 0.0 109.718 179.088 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 183' ' ' THR . . . . . 0.592 HG23 ' O ' ' A' ' 183' ' ' THR . 10.3 t -135.76 115.45 12.9 Favored 'General case' 0 C--N 1.291 -1.977 0 N-CA-C 107.447 -1.316 . . . . 0.0 107.447 178.508 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 184' ' ' CYS . . . . . . . . . . . . . 5.1 p -78.15 157.38 29.44 Favored 'General case' 0 C--N 1.287 -2.12 0 C-N-CA 118.93 -1.108 . . . . 0.0 110.655 -177.867 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 185' ' ' ASP . . . . . 0.522 ' CG ' ' H ' ' A' ' 186' ' ' ASP . 37.3 t0 -165.7 -158.09 0.34 Allowed 'General case' 0 N--CA 1.492 1.654 0 N-CA-C 108.944 -0.761 . . . . 0.0 108.944 -179.5 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 186' ' ' ASP . . . . . 0.522 ' H ' ' CG ' ' A' ' 185' ' ' ASP . 1.3 m-20 52.93 53.83 11.44 Favored 'General case' 0 N--CA 1.494 1.73 0 O-C-N 120.902 -1.124 . . . . 0.0 109.444 179.979 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 187' ' ' TYR . . . . . 0.617 ' CE1' ' O ' ' A' ' 188' ' ' ASN . 61.2 t80 -67.9 135.03 51.82 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.171 -0.956 . . . . 0.0 110.719 -179.397 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 188' ' ' ASN . . . . . 0.617 ' O ' ' CE1' ' A' ' 187' ' ' TYR . 1.1 t-20 -101.68 146.16 28.11 Favored 'General case' 0 C--N 1.295 -1.792 0 N-CA-C 108.119 -1.067 . . . . 0.0 108.119 178.441 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 189' ' ' GLU . . . . . . . . . . . . . 1.8 tt0 -110.13 -13.39 14.37 Favored 'General case' 0 C--N 1.293 -1.875 0 N-CA-C 108.151 -1.055 . . . . 0.0 108.151 -179.782 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 190' ' ' LYS . . . . . . . . . . . . . 6.4 mttt -84.27 -55.68 4.05 Favored 'General case' 0 C--N 1.301 -1.522 0 N-CA-C 108.827 -0.805 . . . . 0.0 108.827 178.759 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 191' ' ' THR . . . . . 0.583 ' OG1' HG12 ' A' ' 193' ' ' VAL . 6.2 p -87.48 2.55 50.27 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.444 -0.785 . . . . 0.0 109.89 -179.644 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 192' ' ' GLY . . . . . . . . . . . . . . . 56.27 33.07 60.98 Favored Glycine 0 N--CA 1.495 2.62 0 O-C-N 121.172 -0.955 . . . . 0.0 111.79 178.615 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 193' ' ' VAL . . . . . 0.583 HG12 ' OG1' ' A' ' 191' ' ' THR . 4.1 p -149.25 167.94 2.97 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.75 0 O-C-N 120.677 -1.484 . . . . 0.0 110.583 179.009 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 194' ' ' TRP . . . . . 0.524 ' H ' HG22 ' A' ' 193' ' ' VAL . 9.4 m95 -83.98 120.23 25.87 Favored 'General case' 0 C--N 1.296 -1.724 0 N-CA-C 108.558 -0.904 . . . . 0.0 108.558 179.963 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 195' ' ' GLU . . . . . 0.444 ' CD ' ' ND2' ' A' ' 188' ' ' ASN . 3.7 mt-10 -76.23 -60.82 2.17 Favored 'General case' 0 N--CA 1.495 1.784 0 O-C-N 121.395 -0.816 . . . . 0.0 111.356 -178.323 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 196' ' ' LYS . . . . . . . . . . . . . 8.6 tttt -93.18 153.71 18.47 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 120.935 -1.103 . . . . 0.0 110.817 -178.494 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 197' ' ' ARG . . . . . 0.647 ' CG ' HH11 ' A' ' 197' ' ' ARG . 0.0 OUTLIER -119.66 140.13 51.12 Favored 'General case' 0 N--CA 1.49 1.525 0 N-CA-C 107.995 -1.113 . . . . 0.0 107.995 178.845 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 198' ' ' LYS . . . . . . . . . . . . . 2.4 mttm -114.16 122.02 45.54 Favored 'General case' 0 N--CA 1.493 1.719 0 O-C-N 121.899 -0.501 . . . . 0.0 110.904 -177.982 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 199' ' ' ILE . . . . . 0.694 ' C ' HD12 ' A' ' 199' ' ' ILE . 0.5 OUTLIER -142.58 120.02 7.02 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.546 0 CA-C-O 122.393 1.092 . . . . 0.0 110.515 179.925 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 200' ' ' PHE . . . . . 0.509 ' CD1' ' N ' ' A' ' 200' ' ' PHE . 3.5 m-85 -98.42 135.45 39.98 Favored 'General case' 0 N--CA 1.499 2.001 0 O-C-N 121.34 -0.85 . . . . 0.0 109.512 -178.982 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 201' ' ' VAL . . . . . 0.416 ' N ' ' O ' ' A' ' 157' ' ' SER . 72.3 t -100.08 130.75 48.76 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.633 0 O-C-N 120.885 -1.134 . . . . 0.0 108.318 177.671 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 202' ' ' ALA . . . . . . . . . . . . . . . -114.48 131.47 56.61 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.37 -0.831 . . . . 0.0 108.771 179.443 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 203' ' ' THR . . . . . 0.724 HG23 ' OG1' ' A' ' 156' ' ' THR . 6.7 p -88.59 130.35 35.28 Favored 'General case' 0 N--CA 1.487 1.399 0 CA-C-O 122.137 0.97 . . . . 0.0 110.768 -179.039 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 204' ' ' GLU . . . . . 0.491 ' HA ' ' CD2' ' A' ' 153' ' ' TYR . 0.8 OUTLIER -51.5 134.28 29.21 Favored 'General case' 0 C--N 1.298 -1.64 0 C-N-CA 119.091 -1.044 . . . . 0.0 109.034 179.305 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 205' ' ' VAL . . . . . 0.721 HG23 ' O ' ' A' ' 203' ' ' THR . 93.3 t -132.22 167.03 27.41 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.358 0 CA-C-O 122.081 0.943 . . . . 0.0 110.144 -178.132 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 206' ' ' LYS . . . . . 0.603 ' N ' HG12 ' A' ' 205' ' ' VAL . 0.0 OUTLIER . . . . . 0 C--N 1.295 -1.787 0 CA-C-O 117.933 -1.032 . . . . 0.0 109.509 -179.72 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' C' C ' 702' ' ' LEU . . . . . 0.784 ' N ' HD12 ' C' ' 702' ' ' LEU . 0.0 OUTLIER . . . . . 0 N--CA 1.494 1.741 0 N-CA-C 109.235 -0.654 . . . . 0.0 109.235 . . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' C' C ' 703' ' ' PRO . . . . . 0.637 ' HB3' ' HB3' ' A' ' 92' ' ' ALA . 50.7 Cg_exo -48.6 -164.59 0.0 OUTLIER 'Trans proline' 0 N--CA 1.494 1.504 0 C-N-CA 122.437 2.091 . . . . 0.0 113.216 -179.426 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' C' C ' 704' ' ' ALA . . . . . 0.748 ' HB2' ' HB1' ' A' ' 118' ' ' ALA . . . . . . . . 0 N--CA 1.489 1.511 0 O-C-N 121.679 -0.638 . . . . 0.0 109.983 -179.924 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 63' ' ' PRO . . . . . 0.47 ' O ' ' CD1' ' A' ' 110' ' ' LEU . 18.2 Cg_endo . . . . . 0 N--CA 1.482 0.828 0 CA-C-O 121.003 0.335 . . . . 0.0 111.231 . . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 64' ' ' GLN . . . . . 0.623 ' O ' ' NE2' ' A' ' 64' ' ' GLN . 0.0 OUTLIER -155.53 139.25 16.11 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.175 -0.953 . . . . 0.0 109.658 -179.967 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 65' ' ' ILE . . . . . . . . . . . . . 4.7 mm -48.05 107.7 0.79 Allowed Pre-proline 0 N--CA 1.491 1.592 0 O-C-N 121.009 -1.057 . . . . 0.0 108.183 179.345 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 66' ' ' PRO . . . . . . . . . . . . . 93.6 Cg_endo -85.75 -170.16 0.68 Allowed 'Trans proline' 0 C--N 1.315 -1.218 0 C-N-CA 122.15 1.9 . . . . 0.0 112.614 -179.015 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 67' ' ' LYS . . . . . . . . . . . . . 38.7 tttt -90.27 -8.86 49.89 Favored 'General case' 0 N--CA 1.488 1.459 0 O-C-N 121.436 -0.79 . . . . 0.0 109.178 179.567 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 68' ' ' ASP . . . . . 0.664 ' O ' ' N ' ' A' ' 70' ' ' SER . 0.4 OUTLIER -75.86 63.86 1.74 Allowed 'General case' 0 N--CA 1.488 1.431 0 CA-C-O 122.848 1.309 . . . . 0.0 109.033 179.813 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 69' ' ' LYS . . . . . 0.478 ' C ' ' O ' ' A' ' 68' ' ' ASP . 23.8 mtmt -45.76 -13.99 0.02 OUTLIER 'General case' 0 N--CA 1.512 2.653 0 C-N-CA 116.686 -2.005 . . . . 0.0 107.157 177.757 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 70' ' ' SER . . . . . 0.664 ' N ' ' O ' ' A' ' 68' ' ' ASP . 0.1 OUTLIER -86.04 -9.02 57.49 Favored 'General case' 0 N--CA 1.497 1.899 0 CA-C-N 113.701 -1.59 . . . . 0.0 111.656 179.395 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 71' ' ' LYS . . . . . 0.464 ' N ' ' O ' ' A' ' 68' ' ' ASP . 0.0 OUTLIER -95.88 142.18 28.44 Favored 'General case' 0 N--CA 1.505 2.303 0 O-C-N 120.468 -1.395 . . . . 0.0 112.971 -178.704 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 72' ' ' VAL . . . . . 0.633 HG12 ' CZ ' ' A' ' 88' ' ' TYR . 1.3 m -68.67 133.42 31.81 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.368 0 N-CA-C 105.305 -2.109 . . . . 0.0 105.305 174.711 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 73' ' ' ALA . . . . . 0.7 ' O ' HG23 ' A' ' 146' ' ' VAL . . . -80.87 -13.77 58.63 Favored 'General case' 0 C--N 1.297 -1.714 0 O-C-N 119.905 -1.747 . . . . 0.0 107.183 -179.813 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . 172.99 -156.71 25.24 Favored Glycine 0 N--CA 1.483 1.77 0 N-CA-C 109.299 -1.52 . . . . 0.0 109.299 179.648 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 75' ' ' TYR . . . . . 0.547 ' HA ' HG23 ' A' ' 87' ' ' VAL . 88.1 m-85 -141.54 169.99 16.56 Favored 'General case' 0 C--N 1.298 -1.668 0 O-C-N 121.58 -0.953 . . . . 0.0 111.044 -177.241 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 76' ' ' ILE . . . . . . . . . . . . . 3.9 tp -146.5 141.39 20.88 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.577 0 C-N-CA 119.461 -0.895 . . . . 0.0 109.455 -177.377 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -153.09 165.02 36.92 Favored 'General case' 0 C--N 1.304 -1.41 0 O-C-N 121.13 -0.981 . . . . 0.0 109.934 179.852 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 78' ' ' ILE . . . . . 0.639 ' HB ' ' HB3' ' A' ' 81' ' ' ALA . 5.0 mt -147.39 119.92 4.75 Favored Pre-proline 0 C--N 1.303 -1.455 0 N-CA-C 107.87 -1.159 . . . . 0.0 107.87 179.165 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 79' ' ' PRO . . . . . . . . . . . . . 31.1 Cg_endo -70.46 -42.36 2.74 Favored 'Trans proline' 0 C--N 1.315 -1.218 0 C-N-CA 121.658 1.572 . . . . 0.0 112.992 -178.755 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -66.43 -19.8 65.89 Favored 'General case' 0 N--CA 1.489 1.491 0 O-C-N 120.881 -1.137 . . . . 0.0 110.202 177.977 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 81' ' ' ALA . . . . . 0.931 ' HB2' ' HB2' ' A' ' 136' ' ' ALA . . . -106.61 -18.78 13.86 Favored 'General case' 0 N--CA 1.494 1.755 0 O-C-N 121.303 -0.873 . . . . 0.0 109.04 179.913 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 82' ' ' ASP . . . . . . . . . . . . . 2.3 t70 66.01 52.09 1.25 Allowed 'General case' 0 N--CA 1.494 1.732 0 O-C-N 121.43 -0.794 . . . . 0.0 111.493 178.781 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 83' ' ' ILE . . . . . . . . . . . . . 31.4 mt -131.46 153.08 38.3 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.862 0 O-C-N 120.977 -1.077 . . . . 0.0 109.636 -179.322 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 84' ' ' LYS . . . . . . . . . . . . . 23.1 tttt -158.11 110.48 2.33 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.244 -0.91 . . . . 0.0 108.628 179.57 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -141.46 165.75 26.6 Favored Pre-proline 0 N--CA 1.492 1.67 0 O-C-N 121.246 -0.909 . . . . 0.0 109.817 -179.256 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 86' ' ' PRO . . . . . . . . . . . . . 61.2 Cg_endo -76.29 168.61 23.58 Favored 'Trans proline' 0 C--N 1.309 -1.5 0 C-N-CA 122.939 2.426 . . . . 0.0 113.312 -179.53 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 87' ' ' VAL . . . . . 0.547 HG23 ' HA ' ' A' ' 75' ' ' TYR . 49.6 t -124.43 98.84 5.64 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.63 0 N-CA-C 109.27 -0.641 . . . . 0.0 109.27 -179.884 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 88' ' ' TYR . . . . . 0.633 ' CZ ' HG12 ' A' ' 72' ' ' VAL . 35.0 m-85 -90.42 153.55 46.22 Favored Pre-proline 0 N--CA 1.503 2.209 0 O-C-N 120.954 -1.091 . . . . 0.0 109.944 -179.606 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 89' ' ' PRO . . . . . 0.539 ' O ' ' NE2' ' A' ' 96' ' ' GLN . 10.2 Cg_endo -58.7 146.11 93.36 Favored 'Trans proline' 0 N--CA 1.493 1.469 0 C-N-CA 122.492 2.128 . . . . 0.0 113.135 179.82 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . -58.11 169.59 4.7 Favored Glycine 0 N--CA 1.492 2.398 0 N-CA-C 109.326 -1.51 . . . . 0.0 109.326 179.493 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 91' ' ' PRO . . . . . 0.4 ' C ' ' H ' ' A' ' 93' ' ' THR . 57.3 Cg_endo -95.23 169.21 16.63 Favored 'Cis proline' 0 C--N 1.31 -1.485 0 C-N-CA 124.298 -1.126 . . . . 0.0 112.065 0.103 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 92' ' ' ALA . . . . . 0.676 ' HB3' ' HB2' ' C' ' 703' ' ' PRO . . . -71.99 30.07 0.05 Allowed 'General case' 0 N--CA 1.493 1.691 0 O-C-N 121.241 -0.912 . . . . 0.0 111.274 -179.421 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 93' ' ' THR . . . . . 0.4 ' H ' ' C ' ' A' ' 91' ' ' PRO . 1.0 OUTLIER -75.85 151.29 84.35 Favored Pre-proline 0 N--CA 1.492 1.64 0 O-C-N 120.651 -1.281 . . . . 0.0 108.788 179.865 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 94' ' ' PRO . . . . . 0.4 ' C ' ' O ' ' A' ' 93' ' ' THR . 82.9 Cg_exo -35.52 -42.24 0.45 Allowed 'Trans proline' 0 C--N 1.308 -1.573 0 C-N-CA 122.511 2.14 . . . . 0.0 112.067 -179.566 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 5.8 mt-10 -49.95 -56.44 10.62 Favored 'General case' 0 C--N 1.304 -1.41 0 O-C-N 121.292 -0.88 . . . . 0.0 109.112 179.512 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 96' ' ' GLN . . . . . 0.596 ' O ' ' N ' ' A' ' 98' ' ' ASN . 13.0 mm100 -74.49 -47.86 30.64 Favored 'General case' 0 N--CA 1.487 1.424 0 O-C-N 121.323 -0.861 . . . . 0.0 109.995 179.69 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 97' ' ' LEU . . . . . 0.595 HD23 ' O ' ' A' ' 92' ' ' ALA . 0.4 OUTLIER -45.3 -11.89 0.02 OUTLIER 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.221 -0.925 . . . . 0.0 109.989 -178.949 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 98' ' ' ASN . . . . . 0.724 HD21 ' NH1' ' A' ' 99' ' ' ARG . 0.0 OUTLIER -73.88 -31.44 63.15 Favored 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.176 -0.953 . . . . 0.0 108.854 179.204 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 99' ' ' ARG . . . . . 0.724 ' NH1' HD21 ' A' ' 98' ' ' ASN . 1.1 mtt-85 -85.03 -58.2 2.79 Favored 'General case' 0 C--N 1.302 -1.47 0 O-C-N 121.865 -0.522 . . . . 0.0 109.89 -179.14 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . -179.65 -160.34 25.09 Favored Glycine 0 N--CA 1.493 2.442 0 C-N-CA 119.645 -1.264 . . . . 0.0 110.046 -179.944 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 101' ' ' VAL . . . . . 0.736 ' O ' HG23 ' A' ' 101' ' ' VAL . 17.8 m -61.66 107.82 0.46 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.594 0 O-C-N 121.403 -1.057 . . . . 0.0 109.522 -179.813 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -92.91 161.57 14.43 Favored 'General case' 0 N--CA 1.493 1.681 0 O-C-N 121.322 -0.861 . . . . 0.0 110.498 -179.84 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 103' ' ' PHE . . . . . 0.601 ' O ' ' N ' ' A' ' 105' ' ' GLU . 25.3 m-85 -64.13 123.32 18.77 Favored 'General case' 0 N--CA 1.488 1.447 0 N-CA-C 108.151 -1.055 . . . . 0.0 108.151 178.655 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 104' ' ' ALA . . . . . 0.702 ' HB1' ' HG3' ' C' ' 703' ' ' PRO . . . -40.39 -18.63 0.01 OUTLIER 'General case' 0 C--N 1.298 -1.636 0 O-C-N 121.602 -0.686 . . . . 0.0 110.774 -178.939 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 105' ' ' GLU . . . . . 0.601 ' N ' ' O ' ' A' ' 103' ' ' PHE . 0.4 OUTLIER -140.0 147.88 41.06 Favored 'General case' 0 N--CA 1.495 1.808 0 O-C-N 120.698 -1.251 . . . . 0.0 110.315 179.915 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 106' ' ' GLU . . . . . . . . . . . . . 4.3 tt0 -57.86 -63.37 1.27 Allowed 'General case' 0 N--CA 1.487 1.425 0 O-C-N 121.965 -0.459 . . . . 0.0 111.203 -179.058 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 107' ' ' ASN . . . . . . . . . . . . . 5.1 m120 -78.68 33.82 0.21 Allowed 'General case' 0 N--CA 1.49 1.544 0 O-C-N 120.477 -1.39 . . . . 0.0 113.465 -175.231 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 108' ' ' GLU . . . . . . . . . . . . . 30.6 tp10 -60.02 150.14 30.1 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 120.426 -1.421 . . . . 0.0 108.175 -179.614 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 109' ' ' SER . . . . . 0.489 ' C ' ' H ' ' A' ' 111' ' ' ASP . 0.1 OUTLIER -101.35 126.26 48.09 Favored 'General case' 0 N--CA 1.489 1.5 0 O-C-N 121.002 -1.061 . . . . 0.0 110.585 -178.613 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 110' ' ' LEU . . . . . 0.534 HD23 ' N ' ' A' ' 110' ' ' LEU . 1.0 OUTLIER -60.22 -2.33 0.44 Allowed 'General case' 0 C--N 1.298 -1.664 0 N-CA-C 108.891 -0.781 . . . . 0.0 108.891 -179.964 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 111' ' ' ASP . . . . . 0.489 ' H ' ' C ' ' A' ' 109' ' ' SER . 53.1 m-20 -133.26 20.47 4.02 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.386 -0.822 . . . . 0.0 109.607 179.831 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 112' ' ' ASP . . . . . 0.41 ' N ' ' OG ' ' A' ' 109' ' ' SER . 0.4 OUTLIER -68.05 140.14 56.29 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.002 -1.061 . . . . 0.0 110.661 -179.674 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 113' ' ' GLN . . . . . 0.531 ' N ' ' CD ' ' A' ' 113' ' ' GLN . 2.1 mm100 -64.92 -7.06 9.94 Favored 'General case' 0 C--N 1.303 -1.445 0 N-CA-C 107.521 -1.289 . . . . 0.0 107.521 177.876 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 114' ' ' ASN . . . . . 0.677 ' ND2' HE21 ' A' ' 178' ' ' GLN . 4.9 t-20 -144.68 92.17 2.26 Favored 'General case' 0 C--N 1.304 -1.403 0 N-CA-C 108.206 -1.035 . . . . 0.0 108.206 -179.954 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 115' ' ' ILE . . . . . 0.448 ' O ' HG22 ' A' ' 115' ' ' ILE . 2.8 mt -99.11 113.71 34.83 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.536 0 O-C-N 121.531 -0.731 . . . . 0.0 109.328 -179.438 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 116' ' ' SER . . . . . 0.572 ' OG ' ' HB3' ' A' ' 104' ' ' ALA . 69.3 p -98.02 146.61 25.34 Favored 'General case' 0 N--CA 1.488 1.471 0 CA-C-O 122.093 0.949 . . . . 0.0 111.387 -178.299 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 117' ' ' ILE . . . . . . . . . . . . . 2.7 mt -138.21 154.64 28.24 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.511 0 N-CA-C 107.477 -1.305 . . . . 0.0 107.477 178.996 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 118' ' ' ALA . . . . . . . . . . . . . . . -143.44 159.75 41.82 Favored 'General case' 0 N--CA 1.492 1.66 0 O-C-N 120.836 -1.165 . . . . 0.0 111.336 -179.233 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 119' ' ' GLY . . . . . . . . . . . . . . . -167.66 145.56 9.85 Favored Glycine 0 N--CA 1.489 2.183 0 N-CA-C 110.423 -1.071 . . . . 0.0 110.423 179.624 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 120' ' ' HIS . . . . . . . . . . . . . 3.1 m-70 -70.36 164.64 24.1 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.613 -0.933 . . . . 0.0 109.417 179.236 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 121' ' ' THR . . . . . 0.423 HG21 ' OD2' ' A' ' 185' ' ' ASP . 0.7 OUTLIER -118.06 155.28 30.62 Favored 'General case' 0 N--CA 1.494 1.733 0 O-C-N 121.318 -0.864 . . . . 0.0 108.855 179.422 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 122' ' ' PHE . . . . . 0.401 ' CD1' ' HB2' ' A' ' 125' ' ' ARG . 0.2 OUTLIER -112.36 128.07 56.19 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.308 -0.87 . . . . 0.0 109.637 179.761 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 123' ' ' ILE . . . . . 0.567 HG23 ' N ' ' A' ' 124' ' ' ASP . 16.3 tt -77.26 -38.52 27.21 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.809 0 N-CA-C 108.167 -1.049 . . . . 0.0 108.167 179.076 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 124' ' ' ASP . . . . . 0.567 ' N ' HG23 ' A' ' 123' ' ' ILE . 4.8 t70 -100.29 24.32 8.94 Favored 'General case' 0 N--CA 1.494 1.771 0 CA-C-N 115.771 -0.649 . . . . 0.0 110.82 -179.73 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 125' ' ' ARG . . . . . 0.401 ' HB2' ' CD1' ' A' ' 122' ' ' PHE . 5.1 ttt180 -157.64 99.77 1.87 Allowed Pre-proline 0 N--CA 1.492 1.671 0 O-C-N 120.664 -1.272 . . . . 0.0 110.541 -179.032 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 126' ' ' PRO . . . . . . . . . . . . . 41.3 Cg_endo -78.88 -18.91 11.33 Favored 'Trans proline' 0 C--N 1.314 -1.243 0 C-N-CA 122.175 1.917 . . . . 0.0 112.465 179.517 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 127' ' ' ASN . . . . . . . . . . . . . 14.8 m120 -90.65 26.69 1.95 Allowed 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.23 -0.919 . . . . 0.0 109.241 179.636 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 128' ' ' TYR . . . . . . . . . . . . . 13.1 t80 -87.04 -149.01 0.15 Allowed 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.306 -0.872 . . . . 0.0 109.774 -179.622 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 129' ' ' GLN . . . . . . . . . . . . . 63.3 mt-30 -67.95 -89.43 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.288 -0.882 . . . . 0.0 110.344 -179.323 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 130' ' ' PHE . . . . . 0.704 ' CE2' HG11 ' A' ' 101' ' ' VAL . 41.0 m-85 -110.15 40.07 2.02 Favored 'General case' 0 N--CA 1.494 1.752 0 O-C-N 121.287 -0.883 . . . . 0.0 110.338 -179.22 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 131' ' ' THR . . . . . . . . . . . . . 85.6 m -79.78 -32.95 40.9 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.088 -1.008 . . . . 0.0 109.128 179.38 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 132' ' ' ASN . . . . . 0.435 ' ND2' ' O ' ' A' ' 81' ' ' ALA . 4.6 t30 -84.33 7.54 19.04 Favored 'General case' 0 N--CA 1.495 1.784 0 O-C-N 121.608 -0.682 . . . . 0.0 110.335 -179.588 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 133' ' ' LEU . . . . . 0.6 ' O ' ' N ' ' A' ' 135' ' ' ALA . 0.2 OUTLIER -70.26 -46.37 64.53 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.186 -0.946 . . . . 0.0 110.686 -179.146 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 134' ' ' LYS . . . . . 0.597 ' CD ' ' H ' ' A' ' 134' ' ' LYS . 0.1 OUTLIER -42.53 -17.54 0.01 OUTLIER 'General case' 0 N--CA 1.493 1.692 0 O-C-N 121.024 -1.048 . . . . 0.0 109.983 -179.012 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 135' ' ' ALA . . . . . 0.6 ' N ' ' O ' ' A' ' 133' ' ' LEU . . . -85.12 -33.89 22.28 Favored 'General case' 0 N--CA 1.489 1.482 0 O-C-N 121.183 -0.948 . . . . 0.0 109.64 179.773 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 136' ' ' ALA . . . . . 0.931 ' HB2' ' HB2' ' A' ' 81' ' ' ALA . . . -80.43 153.21 28.39 Favored 'General case' 0 N--CA 1.489 1.504 0 CA-C-O 122.095 0.95 . . . . 0.0 111.769 -178.546 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 137' ' ' LYS . . . . . 0.511 ' O ' ' O ' ' A' ' 138' ' ' LYS . 2.8 ttmm -157.42 -163.47 1.37 Allowed 'General case' 0 N--CA 1.491 1.624 0 C-N-CA 119.109 -1.037 . . . . 0.0 110.431 -179.25 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 138' ' ' LYS . . . . . 0.604 ' O ' ' N ' ' A' ' 140' ' ' SER . 10.3 tttt -46.23 -178.39 0.0 OUTLIER 'General case' 0 C--N 1.306 -1.3 0 CA-C-O 121.864 0.84 . . . . 0.0 110.265 -179.818 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 139' ' ' GLY . . . . . . . . . . . . . . . 45.7 8.2 0.02 OUTLIER Glycine 0 N--CA 1.492 2.431 0 N-CA-C 110.713 -0.955 . . . . 0.0 110.713 179.574 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 140' ' ' SER . . . . . 0.604 ' N ' ' O ' ' A' ' 138' ' ' LYS . 37.9 m -96.5 133.74 40.57 Favored 'General case' 0 N--CA 1.493 1.679 0 O-C-N 120.814 -1.404 . . . . 0.0 109.125 179.195 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 141' ' ' MET . . . . . 0.409 ' HG2' ' CE2' ' A' ' 143' ' ' TYR . 0.0 OUTLIER -82.52 144.62 30.27 Favored 'General case' 0 N--CA 1.489 1.488 0 O-C-N 121.148 -0.97 . . . . 0.0 109.871 -179.816 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 142' ' ' VAL . . . . . . . . . . . . . 5.8 t -129.21 132.85 66.61 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.705 0 O-C-N 121.284 -0.885 . . . . 0.0 108.771 179.902 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 143' ' ' TYR . . . . . 0.409 ' CE2' ' HG2' ' A' ' 141' ' ' MET . 32.3 m-85 -114.66 137.68 51.61 Favored 'General case' 0 N--CA 1.501 2.098 0 O-C-N 121.116 -0.99 . . . . 0.0 111.421 -178.455 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 144' ' ' PHE . . . . . . . . . . . . . 26.9 t80 -122.36 107.1 11.69 Favored 'General case' 0 N--CA 1.495 1.817 0 CA-C-O 121.323 0.583 . . . . 0.0 110.442 -179.178 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 145' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -96.63 128.83 43.95 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.384 -0.823 . . . . 0.0 110.582 -179.752 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 146' ' ' VAL . . . . . 0.7 HG23 ' O ' ' A' ' 73' ' ' ALA . 3.7 p -143.38 142.8 25.15 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.777 0 N-CA-C 107.522 -1.288 . . . . 0.0 107.522 178.752 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 147' ' ' GLY . . . . . 0.41 ' C ' ' O ' ' A' ' 146' ' ' VAL . . . 46.97 -134.28 11.71 Favored Glycine 0 N--CA 1.489 2.224 0 N-CA-C 108.887 -1.685 . . . . 0.0 108.887 -179.754 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 148' ' ' ASN . . . . . 0.596 HD22 ' C ' ' A' ' 148' ' ' ASN . 0.4 OUTLIER -102.33 17.31 23.8 Favored 'General case' 0 C--N 1.301 -1.533 0 O-C-N 121.284 -1.127 . . . . 0.0 108.451 179.208 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 149' ' ' GLU . . . . . . . . . . . . . 8.7 tt0 -114.56 147.42 39.48 Favored 'General case' 0 N--CA 1.487 1.402 0 CA-C-O 121.919 0.866 . . . . 0.0 111.024 -178.605 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 150' ' ' THR . . . . . . . . . . . . . 88.3 m -129.42 105.97 8.47 Favored 'General case' 0 N--CA 1.491 1.596 0 CA-C-O 121.421 0.629 . . . . 0.0 109.718 179.891 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 151' ' ' ARG . . . . . . . . . . . . . 34.2 mtt180 -87.04 -174.54 4.96 Favored 'General case' 0 C--N 1.306 -1.299 0 N-CA-C 107.987 -1.116 . . . . 0.0 107.987 179.52 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 152' ' ' LYS . . . . . 0.433 ' CE ' ' OXT' ' A' ' 206' ' ' LYS . 18.6 mtmm -148.22 146.33 28.63 Favored 'General case' 0 C--N 1.3 -1.571 0 O-C-N 121.007 -1.058 . . . . 0.0 110.135 -179.799 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 153' ' ' TYR . . . . . 0.507 ' CD2' ' HA ' ' A' ' 204' ' ' GLU . 9.1 m-85 -139.02 166.56 24.17 Favored 'General case' 0 C--N 1.3 -1.546 0 N-CA-C 107.523 -1.288 . . . . 0.0 107.523 179.13 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 154' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -142.96 121.86 12.74 Favored 'General case' 0 C--N 1.296 -1.722 0 O-C-N 121.184 -0.948 . . . . 0.0 108.442 178.748 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 155' ' ' MET . . . . . . . . . . . . . 23.1 mmm -46.99 104.89 0.06 Allowed 'General case' 0 N--CA 1.49 1.526 0 O-C-N 120.758 -1.214 . . . . 0.0 111.445 -178.584 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 156' ' ' THR . . . . . . . . . . . . . 1.4 m -107.88 -23.95 11.84 Favored 'General case' 0 C--N 1.293 -1.885 0 CA-C-N 115.288 -0.869 . . . . 0.0 109.921 -179.291 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 157' ' ' SER . . . . . 0.485 ' O ' ' N ' ' A' ' 201' ' ' VAL . 2.0 m -153.94 150.56 28.45 Favored 'General case' 0 N--CA 1.492 1.669 0 C-N-CA 118.217 -1.393 . . . . 0.0 111.426 -178.362 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 158' ' ' ILE . . . . . 0.453 HG13 ' CD2' ' A' ' 200' ' ' PHE . 0.0 OUTLIER -154.95 146.45 13.29 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.44 0 CA-C-O 121.796 0.807 . . . . 0.0 110.333 -179.491 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 159' ' ' ARG . . . . . 0.434 ' N ' HG12 ' A' ' 158' ' ' ILE . 37.5 mtm180 -149.3 177.18 9.89 Favored 'General case' 0 C--N 1.298 -1.656 0 CA-C-O 121.557 0.694 . . . . 0.0 109.812 -179.732 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 160' ' ' ASP . . . . . 0.571 ' C ' HG22 ' A' ' 161' ' ' VAL . 1.0 OUTLIER -144.81 161.22 39.81 Favored 'General case' 0 C--N 1.3 -1.567 0 N-CA-C 108.859 -0.793 . . . . 0.0 108.859 -179.463 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 161' ' ' VAL . . . . . 0.571 HG22 ' C ' ' A' ' 160' ' ' ASP . 0.1 OUTLIER -169.47 166.6 0.34 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.612 0 O-C-N 121.294 -0.879 . . . . 0.0 109.768 179.673 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 162' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -55.29 177.36 0.13 Allowed Pre-proline 0 N--CA 1.489 1.482 0 O-C-N 121.528 -0.732 . . . . 0.0 109.189 179.669 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 163' ' ' PRO . . . . . 0.739 ' C ' HD11 ' C' ' 702' ' ' LEU . 9.8 Cg_endo -84.07 42.8 1.26 Allowed 'Trans proline' 0 C--N 1.315 -1.185 0 C-N-CA 122.466 2.111 . . . . 0.0 112.21 -179.87 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 164' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -151.92 -14.0 0.19 Allowed 'General case' 0 N--CA 1.492 1.674 0 O-C-N 121.103 -0.998 . . . . 0.0 110.443 -179.859 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 165' ' ' ASP . . . . . 0.436 ' O ' ' C ' ' A' ' 166' ' ' VAL . 9.5 t70 -73.03 61.63 0.59 Allowed 'General case' 0 N--CA 1.49 1.527 0 O-C-N 120.955 -1.091 . . . . 0.0 109.544 -179.817 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 166' ' ' VAL . . . . . 0.608 ' O ' ' N ' ' A' ' 168' ' ' VAL . 0.9 OUTLIER -39.6 -32.04 0.17 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.55 0 O-C-N 121.659 -0.65 . . . . 0.0 109.431 -178.416 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 167' ' ' GLY . . . . . 0.425 ' N ' ' O ' ' A' ' 165' ' ' ASP . . . -43.03 -14.96 0.02 OUTLIER Glycine 0 N--CA 1.492 2.375 0 N-CA-C 110.325 -1.11 . . . . 0.0 110.325 179.898 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 168' ' ' VAL . . . . . 0.616 ' C ' ' H ' ' A' ' 170' ' ' ASP . 4.8 m -52.72 -37.06 24.04 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.452 0 O-C-N 120.751 -1.441 . . . . 0.0 108.528 179.692 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 169' ' ' LEU . . . . . 0.508 ' O ' ' N ' ' A' ' 171' ' ' GLU . 16.1 mt -51.75 -5.39 0.03 OUTLIER 'General case' 0 N--CA 1.494 1.756 0 N-CA-C 108.088 -1.078 . . . . 0.0 108.088 -179.431 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 170' ' ' ASP . . . . . 0.616 ' H ' ' C ' ' A' ' 168' ' ' VAL . 22.4 t0 35.52 29.49 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.639 -0.663 . . . . 0.0 111.586 178.047 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 171' ' ' GLU . . . . . 0.508 ' N ' ' O ' ' A' ' 169' ' ' LEU . 11.6 pt-20 -68.31 94.5 0.54 Allowed 'General case' 0 N--CA 1.489 1.5 0 O-C-N 120.609 -1.307 . . . . 0.0 108.26 178.935 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 172' ' ' GLN . . . . . 0.427 ' HG3' ' H ' ' A' ' 173' ' ' LYS . 6.0 pt20 -175.98 -56.9 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.535 0 N-CA-C 108.885 -0.783 . . . . 0.0 108.885 179.969 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 173' ' ' LYS . . . . . 0.427 ' H ' ' HG3' ' A' ' 172' ' ' GLN . 44.5 mtpt -64.13 130.24 43.17 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.021 -1.049 . . . . 0.0 108.64 178.462 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 174' ' ' GLY . . . . . 0.571 ' O ' ' C ' ' A' ' 175' ' ' LYS . . . -134.91 -38.72 0.19 Allowed Glycine 0 N--CA 1.48 1.621 0 N-CA-C 108.621 -1.792 . . . . 0.0 108.621 179.581 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 175' ' ' LYS . . . . . 0.571 ' C ' ' O ' ' A' ' 174' ' ' GLY . 4.3 mmtp -27.02 -64.7 0.08 Allowed 'General case' 0 N--CA 1.503 2.199 0 CA-C-O 121.644 0.735 . . . . 0.0 109.033 179.853 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 176' ' ' ASP . . . . . 0.669 ' O ' ' O ' ' A' ' 177' ' ' LYS . 0.0 OUTLIER -102.6 79.26 1.79 Allowed 'General case' 0 C--N 1.298 -1.669 0 N-CA-C 107.163 -1.421 . . . . 0.0 107.163 177.442 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 177' ' ' LYS . . . . . 0.669 ' O ' ' O ' ' A' ' 176' ' ' ASP . 65.7 mttt -26.56 161.34 0.0 OUTLIER 'General case' 0 N--CA 1.503 2.212 0 CA-C-O 121.821 0.82 . . . . 0.0 111.17 -178.676 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 178' ' ' GLN . . . . . 0.677 HE21 ' ND2' ' A' ' 114' ' ' ASN . 3.3 pp0? -159.94 174.0 15.05 Favored 'General case' 0 C--N 1.302 -1.458 0 C-N-CA 117.265 -1.774 . . . . 0.0 112.029 -179.357 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 179' ' ' LEU . . . . . 0.469 ' N ' ' OE1' ' A' ' 178' ' ' GLN . 0.9 OUTLIER -126.01 99.05 5.75 Favored 'General case' 0 C--N 1.303 -1.446 0 N-CA-C 107.242 -1.392 . . . . 0.0 107.242 178.47 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 180' ' ' THR . . . . . 0.487 HG23 HD13 ' A' ' 199' ' ' ILE . 2.7 m -70.82 122.0 19.09 Favored 'General case' 0 N--CA 1.488 1.447 0 O-C-N 120.953 -1.092 . . . . 0.0 109.939 -178.642 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 181' ' ' LEU . . . . . . . . . . . . . 51.1 tp -96.84 145.78 25.54 Favored 'General case' 0 C--N 1.298 -1.67 0 N-CA-C 108.387 -0.968 . . . . 0.0 108.387 178.725 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 182' ' ' ILE . . . . . 0.486 HG22 ' O ' ' A' ' 182' ' ' ILE . 6.3 mt -138.31 110.58 6.39 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.458 0 O-C-N 120.994 -1.066 . . . . 0.0 108.982 178.987 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 183' ' ' THR . . . . . 0.445 HG23 ' O ' ' A' ' 183' ' ' THR . 1.9 t -129.11 113.47 15.14 Favored 'General case' 0 C--N 1.291 -1.938 0 N-CA-C 106.767 -1.568 . . . . 0.0 106.767 178.546 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 184' ' ' CYS . . . . . . . . . . . . . 28.2 p -78.38 164.52 24.74 Favored 'General case' 0 N--CA 1.497 1.916 0 C-N-CA 119.028 -1.069 . . . . 0.0 111.103 -177.359 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 185' ' ' ASP . . . . . 0.423 ' OD2' HG21 ' A' ' 121' ' ' THR . 6.4 t70 -165.72 -151.4 0.14 Allowed 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.584 -0.698 . . . . 0.0 109.347 -179.642 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 186' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER 48.15 56.63 7.08 Favored 'General case' 0 N--CA 1.493 1.724 0 O-C-N 121.175 -0.953 . . . . 0.0 109.03 -179.598 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 187' ' ' TYR . . . . . 0.6 ' CE1' ' O ' ' A' ' 188' ' ' ASN . 44.7 t80 -67.38 133.77 50.22 Favored 'General case' 0 C--N 1.302 -1.485 0 O-C-N 121.418 -0.801 . . . . 0.0 110.411 -179.417 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 188' ' ' ASN . . . . . 0.6 ' O ' ' CE1' ' A' ' 187' ' ' TYR . 0.6 OUTLIER -100.74 147.21 26.29 Favored 'General case' 0 C--N 1.296 -1.749 0 N-CA-C 107.79 -1.189 . . . . 0.0 107.79 178.302 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 189' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -112.3 -11.04 13.76 Favored 'General case' 0 C--N 1.295 -1.797 0 N-CA-C 108.373 -0.973 . . . . 0.0 108.373 -179.635 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 190' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -84.23 -52.47 6.22 Favored 'General case' 0 C--N 1.303 -1.447 0 N-CA-C 108.851 -0.796 . . . . 0.0 108.851 178.838 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 191' ' ' THR . . . . . 0.591 ' OG1' HG12 ' A' ' 193' ' ' VAL . 1.1 p -89.44 -12.63 39.64 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.475 -0.766 . . . . 0.0 109.2 179.663 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 192' ' ' GLY . . . . . . . . . . . . . . . 71.84 33.43 63.02 Favored Glycine 0 N--CA 1.493 2.495 0 O-C-N 121.291 -0.881 . . . . 0.0 111.303 178.706 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 193' ' ' VAL . . . . . 0.591 HG12 ' OG1' ' A' ' 191' ' ' THR . 3.3 p -147.71 170.85 3.2 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.67 0 O-C-N 120.778 -1.425 . . . . 0.0 110.035 179.216 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 194' ' ' TRP . . . . . 0.556 ' H ' HG22 ' A' ' 193' ' ' VAL . 2.5 m95 -84.97 121.63 28.05 Favored 'General case' 0 N--CA 1.494 1.726 0 N-CA-C 109.439 -0.578 . . . . 0.0 109.439 -179.809 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 195' ' ' GLU . . . . . 0.531 ' CD ' ' ND2' ' A' ' 188' ' ' ASN . 2.4 mt-10 -80.05 -60.38 2.36 Favored 'General case' 0 N--CA 1.496 1.87 0 O-C-N 121.348 -0.845 . . . . 0.0 111.037 -178.975 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 196' ' ' LYS . . . . . . . . . . . . . 10.6 tttt -93.44 157.34 16.27 Favored 'General case' 0 N--CA 1.493 1.688 0 O-C-N 120.977 -1.077 . . . . 0.0 110.695 -178.544 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 197' ' ' ARG . . . . . 0.636 ' CG ' HH11 ' A' ' 197' ' ' ARG . 0.1 OUTLIER -126.18 142.2 51.62 Favored 'General case' 0 N--CA 1.489 1.485 0 O-C-N 121.653 -0.654 . . . . 0.0 109.351 179.415 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 198' ' ' LYS . . . . . . . . . . . . . 38.5 mttt -115.56 121.73 43.53 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.794 -0.566 . . . . 0.0 110.101 -179.17 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 199' ' ' ILE . . . . . 0.667 ' C ' HD12 ' A' ' 199' ' ' ILE . 0.5 OUTLIER -138.09 118.65 16.19 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.811 0 CA-C-O 122.526 1.155 . . . . 0.0 110.076 179.834 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 200' ' ' PHE . . . . . 0.586 ' CZ ' HD12 ' A' ' 133' ' ' LEU . 7.0 m-85 -99.73 135.35 41.28 Favored 'General case' 0 N--CA 1.499 1.992 0 O-C-N 121.499 -0.751 . . . . 0.0 109.894 -178.358 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 201' ' ' VAL . . . . . 0.485 ' N ' ' O ' ' A' ' 157' ' ' SER . 59.9 t -101.03 131.86 47.88 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.714 0 O-C-N 120.984 -1.073 . . . . 0.0 108.826 177.684 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 202' ' ' ALA . . . . . . . . . . . . . . . -115.9 131.38 56.95 Favored 'General case' 0 N--CA 1.491 1.624 0 N-CA-C 108.525 -0.917 . . . . 0.0 108.525 179.43 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 203' ' ' THR . . . . . 0.683 ' O ' HG23 ' A' ' 205' ' ' VAL . 5.4 t -87.88 132.09 34.33 Favored 'General case' 0 N--CA 1.488 1.468 0 CA-C-O 122.327 1.061 . . . . 0.0 110.709 -179.332 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 204' ' ' GLU . . . . . 0.507 ' HA ' ' CD2' ' A' ' 153' ' ' TYR . 13.7 tm-20 -52.99 135.42 36.85 Favored 'General case' 0 C--N 1.296 -1.752 0 C-N-CA 118.619 -1.233 . . . . 0.0 108.909 179.205 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 205' ' ' VAL . . . . . 0.683 HG23 ' O ' ' A' ' 203' ' ' THR . 84.1 t -131.99 167.97 25.14 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.345 0 CA-C-O 121.993 0.902 . . . . 0.0 110.141 -178.056 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 206' ' ' LYS . . . . . 0.61 ' N ' HG12 ' A' ' 205' ' ' VAL . 25.5 mttt . . . . . 0 C--N 1.297 -1.675 0 CA-C-O 117.978 -1.011 . . . . 0.0 109.555 179.937 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' C' C ' 702' ' ' LEU . . . . . 0.739 HD11 ' C ' ' A' ' 163' ' ' PRO . 0.0 OUTLIER . . . . . 0 N--CA 1.49 1.561 0 N-CA-C 108.775 -0.824 . . . . 0.0 108.775 . . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' C' C ' 703' ' ' PRO . . . . . 0.702 ' HG3' ' HB1' ' A' ' 104' ' ' ALA . 55.5 Cg_endo -72.58 174.76 11.16 Favored 'Trans proline' 0 N--CA 1.495 1.597 0 C-N-CA 122.48 2.12 . . . . 0.0 112.418 -179.497 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' C' C ' 704' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.487 1.388 0 O-C-N 121.234 -0.916 . . . . 0.0 109.49 179.897 . . . . . . . . 0 0 . 1 . 005 nuclear nobuild core ' A' A ' 63' ' ' PRO . . . . . . . . . . . . . 53.7 Cg_endo . . . . . 0 N--CA 1.482 0.797 0 N-CA-C 110.929 -0.45 . . . . 0.0 110.929 . . . . . . . . . 0 0 . 1 . 005 nuclear nobuild core ' A' A ' 64' ' ' GLN . . . . . 0.699 HE21 ' C ' ' A' ' 64' ' ' GLN . 0.0 OUTLIER -153.38 111.93 3.68 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 120.986 -1.071 . . . . 0.0 110.19 -179.84 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 65' ' ' ILE . . . . . 0.482 HD12 ' H ' ' A' ' 65' ' ' ILE . 3.1 mp -43.45 103.76 0.34 Allowed Pre-proline 0 N--CA 1.491 1.596 0 N-CA-C 108.148 -1.056 . . . . 0.0 108.148 178.722 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 66' ' ' PRO . . . . . . . . . . . . . 97.9 Cg_endo -85.98 -155.05 0.05 OUTLIER 'Trans proline' 0 N--CA 1.49 1.282 0 C-N-CA 122.407 2.072 . . . . 0.0 113.002 -178.218 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 67' ' ' LYS . . . . . 0.434 ' O ' ' CG ' ' A' ' 67' ' ' LYS . 15.1 tttt -82.16 -6.01 58.88 Favored 'General case' 0 N--CA 1.487 1.395 0 O-C-N 121.311 -0.868 . . . . 0.0 109.037 179.936 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 68' ' ' ASP . . . . . 0.64 ' C ' ' N ' ' A' ' 70' ' ' SER . 0.4 OUTLIER -75.12 51.15 0.51 Allowed 'General case' 0 N--CA 1.487 1.384 0 CA-C-O 122.645 1.212 . . . . 0.0 108.308 179.411 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 69' ' ' LYS . . . . . 0.452 ' C ' ' O ' ' A' ' 68' ' ' ASP . 1.9 ptpp? -49.19 -14.32 0.08 Allowed 'General case' 0 N--CA 1.501 2.121 0 C-N-CA 116.769 -1.972 . . . . 0.0 106.61 178.151 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 70' ' ' SER . . . . . 0.64 ' N ' ' C ' ' A' ' 68' ' ' ASP . 38.4 t -85.27 -7.2 59.13 Favored 'General case' 0 N--CA 1.495 1.824 0 CA-C-N 113.786 -1.552 . . . . 0.0 110.534 179.354 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 71' ' ' LYS . . . . . 0.416 ' CD ' ' HB2' ' A' ' 68' ' ' ASP . 0.9 OUTLIER -98.04 140.82 31.8 Favored 'General case' 0 N--CA 1.496 1.841 0 O-C-N 120.85 -1.156 . . . . 0.0 111.333 -179.745 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 72' ' ' VAL . . . . . 0.621 HG12 ' CE1' ' A' ' 88' ' ' TYR . 1.0 OUTLIER -66.03 142.4 16.84 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.455 0 N-CA-C 105.319 -2.104 . . . . 0.0 105.319 174.989 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 73' ' ' ALA . . . . . 0.439 ' N ' ' O ' ' A' ' 87' ' ' VAL . . . -83.0 -15.31 51.68 Favored 'General case' 0 C--N 1.293 -1.854 0 N-CA-C 106.078 -1.823 . . . . 0.0 106.078 178.935 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 74' ' ' GLY . . . . . 0.483 ' C ' ' CD1' ' A' ' 75' ' ' TYR . . . 167.56 -150.6 17.2 Favored Glycine 0 N--CA 1.482 1.706 0 N-CA-C 109.38 -1.488 . . . . 0.0 109.38 179.172 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 75' ' ' TYR . . . . . 0.483 ' CD1' ' C ' ' A' ' 74' ' ' GLY . 25.7 m-85 -144.09 175.97 9.66 Favored 'General case' 0 C--N 1.296 -1.74 0 O-C-N 121.597 -0.943 . . . . 0.0 109.782 -178.839 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 76' ' ' ILE . . . . . . . . . . . . . 2.0 tt -150.37 147.65 15.81 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.797 0 N-CA-C 108.923 -0.769 . . . . 0.0 108.923 -178.261 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 4.6 mt-10 -148.67 162.03 40.55 Favored 'General case' 0 C--N 1.301 -1.541 0 O-C-N 121.044 -1.035 . . . . 0.0 109.322 179.845 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 78' ' ' ILE . . . . . 0.468 ' HB ' ' HB3' ' A' ' 81' ' ' ALA . 36.4 mt -144.24 93.27 5.98 Favored Pre-proline 0 N--CA 1.489 1.51 0 N-CA-C 108.385 -0.968 . . . . 0.0 108.385 -179.733 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 79' ' ' PRO . . . . . . . . . . . . . 74.0 Cg_exo -47.31 -46.84 18.81 Favored 'Trans proline' 0 N--CA 1.494 1.511 0 C-N-CA 122.855 2.37 . . . . 0.0 114.094 -178.598 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 53.8 t0 -65.3 -19.07 65.79 Favored 'General case' 0 N--CA 1.493 1.695 0 O-C-N 120.716 -1.24 . . . . 0.0 110.839 178.921 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 81' ' ' ALA . . . . . 0.91 ' HB2' ' HB2' ' A' ' 136' ' ' ALA . . . -106.9 -17.87 14.08 Favored 'General case' 0 N--CA 1.494 1.745 0 O-C-N 121.114 -0.991 . . . . 0.0 108.792 179.527 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 82' ' ' ASP . . . . . 0.428 ' N ' ' O ' ' A' ' 78' ' ' ILE . 0.8 OUTLIER 69.3 50.69 0.54 Allowed 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.472 -0.768 . . . . 0.0 110.688 178.947 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 83' ' ' ILE . . . . . . . . . . . . . 64.1 mt -128.07 152.38 36.11 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.876 0 O-C-N 121.144 -0.972 . . . . 0.0 110.118 -179.247 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 84' ' ' LYS . . . . . . . . . . . . . 8.0 pttm -159.05 109.27 1.99 Allowed 'General case' 0 N--CA 1.49 1.561 0 N-CA-C 107.893 -1.151 . . . . 0.0 107.893 179.309 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 85' ' ' GLU . . . . . 0.436 ' OE2' ' O ' ' A' ' 129' ' ' GLN . 0.2 OUTLIER -140.48 170.99 8.4 Favored Pre-proline 0 N--CA 1.496 1.873 0 O-C-N 121.334 -0.854 . . . . 0.0 110.412 -178.684 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 86' ' ' PRO . . . . . . . . . . . . . 72.2 Cg_endo -81.72 159.66 18.99 Favored 'Trans proline' 0 N--CA 1.492 1.436 0 C-N-CA 123.08 2.52 . . . . 0.0 113.494 -179.594 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 87' ' ' VAL . . . . . 0.439 ' O ' ' N ' ' A' ' 73' ' ' ALA . 72.5 t -115.45 100.61 10.88 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.69 0 O-C-N 121.659 -0.651 . . . . 0.0 109.808 -179.842 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 88' ' ' TYR . . . . . 0.621 ' CE1' HG12 ' A' ' 72' ' ' VAL . 20.2 m-85 -92.42 154.14 42.74 Favored Pre-proline 0 N--CA 1.498 1.95 0 O-C-N 120.879 -1.138 . . . . 0.0 109.483 179.717 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 89' ' ' PRO . . . . . 0.425 ' HA ' ' CD2' ' A' ' 103' ' ' PHE . 9.7 Cg_endo -61.98 146.15 96.43 Favored 'Trans proline' 0 C--N 1.307 -1.65 0 C-N-CA 122.373 2.049 . . . . 0.0 113.504 -179.907 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . -55.15 165.97 3.15 Favored Glycine 0 N--CA 1.494 2.509 0 N-CA-C 108.826 -1.709 . . . . 0.0 108.826 179.008 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 91' ' ' PRO . . . . . 0.447 ' C ' ' H ' ' A' ' 93' ' ' THR . 65.6 Cg_endo -94.83 168.07 17.8 Favored 'Cis proline' 0 C--N 1.307 -1.627 0 C-N-CA 124.08 -1.216 . . . . 0.0 112.205 0.269 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 92' ' ' ALA . . . . . 0.599 ' O ' HD13 ' A' ' 97' ' ' LEU . . . -70.71 28.25 0.04 OUTLIER 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.411 -0.806 . . . . 0.0 110.793 -179.626 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 93' ' ' THR . . . . . 0.447 ' H ' ' C ' ' A' ' 91' ' ' PRO . 1.7 p -73.56 152.66 89.65 Favored Pre-proline 0 N--CA 1.491 1.596 0 O-C-N 120.716 -1.24 . . . . 0.0 109.246 -179.743 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 94' ' ' PRO . . . . . . . . . . . . . 88.9 Cg_exo -36.19 -42.07 0.59 Allowed 'Trans proline' 0 C--N 1.31 -1.497 0 C-N-CA 122.821 2.347 . . . . 0.0 112.335 -179.283 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 95' ' ' GLU . . . . . 0.637 ' CD ' ' H ' ' A' ' 95' ' ' GLU . 0.1 OUTLIER -53.18 -53.98 42.61 Favored 'General case' 0 C--N 1.301 -1.507 0 O-C-N 121.254 -0.904 . . . . 0.0 109.302 179.756 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 96' ' ' GLN . . . . . 0.592 ' O ' ' N ' ' A' ' 98' ' ' ASN . 29.7 mm100 -73.64 -51.87 15.3 Favored 'General case' 0 N--CA 1.487 1.389 0 O-C-N 121.155 -0.966 . . . . 0.0 109.77 179.593 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 97' ' ' LEU . . . . . 0.599 HD13 ' O ' ' A' ' 92' ' ' ALA . 1.4 mp -46.25 -11.06 0.02 OUTLIER 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.416 -0.802 . . . . 0.0 109.741 -179.336 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 98' ' ' ASN . . . . . 0.681 HD21 ' HE ' ' A' ' 99' ' ' ARG . 0.0 OUTLIER -75.28 -23.42 57.4 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.197 -0.939 . . . . 0.0 110.005 -179.815 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 99' ' ' ARG . . . . . 0.681 ' HE ' HD21 ' A' ' 98' ' ' ASN . 7.7 mtt180 -103.19 -54.01 2.7 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.435 -0.79 . . . . 0.0 110.28 -178.88 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . -169.98 179.15 42.46 Favored Glycine 0 N--CA 1.492 2.41 0 C-N-CA 119.273 -1.442 . . . . 0.0 110.298 -179.834 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 101' ' ' VAL . . . . . 0.806 HG11 ' CE2' ' A' ' 130' ' ' PHE . 31.7 m -53.06 111.75 0.29 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.601 0 O-C-N 121.556 -0.967 . . . . 0.0 109.222 179.787 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -92.29 168.0 11.63 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.315 -0.866 . . . . 0.0 111.288 -179.155 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 103' ' ' PHE . . . . . 0.602 ' O ' ' N ' ' A' ' 105' ' ' GLU . 25.0 m-85 -69.64 120.79 15.95 Favored 'General case' 0 N--CA 1.488 1.439 0 N-CA-C 108.031 -1.1 . . . . 0.0 108.031 178.263 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 104' ' ' ALA . . . . . 0.572 ' HB1' ' HG3' ' C' ' 703' ' ' PRO . . . -41.09 -16.2 0.01 OUTLIER 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.686 -0.634 . . . . 0.0 111.066 -178.515 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 105' ' ' GLU . . . . . 0.602 ' N ' ' O ' ' A' ' 103' ' ' PHE . 0.4 OUTLIER -139.3 147.58 41.82 Favored 'General case' 0 N--CA 1.494 1.729 0 O-C-N 120.861 -1.149 . . . . 0.0 110.56 179.852 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 106' ' ' GLU . . . . . . . . . . . . . 16.2 tt0 -58.09 -63.9 1.1 Allowed 'General case' 0 C--N 1.302 -1.487 0 CA-C-N 116.113 -0.494 . . . . 0.0 110.863 -179.178 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 107' ' ' ASN . . . . . . . . . . . . . 11.1 m120 -78.02 33.29 0.18 Allowed 'General case' 0 N--CA 1.491 1.621 0 O-C-N 120.501 -1.374 . . . . 0.0 113.342 -175.318 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 108' ' ' GLU . . . . . 0.48 ' OE1' ' OE2' ' A' ' 105' ' ' GLU . 26.9 tp10 -59.73 150.5 27.69 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 120.426 -1.421 . . . . 0.0 107.856 179.681 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 109' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -101.19 144.21 30.34 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 120.986 -1.072 . . . . 0.0 111.099 -178.169 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 110' ' ' LEU . . . . . 0.55 ' H ' HD23 ' A' ' 110' ' ' LEU . 0.4 OUTLIER -62.63 -22.86 66.74 Favored 'General case' 0 C--N 1.303 -1.433 0 N-CA-C 108.684 -0.858 . . . . 0.0 108.684 179.214 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 111' ' ' ASP . . . . . . . . . . . . . 64.0 m-20 -132.04 40.36 3.35 Favored 'General case' 0 N--CA 1.487 1.376 0 O-C-N 121.642 -0.662 . . . . 0.0 109.426 -179.687 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 112' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -68.53 152.42 45.41 Favored 'General case' 0 C--N 1.299 -1.591 0 O-C-N 121.266 -0.896 . . . . 0.0 110.439 179.906 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 113' ' ' GLN . . . . . 0.449 ' HA ' ' NE2' ' A' ' 113' ' ' GLN . 1.0 OUTLIER -66.21 -13.78 60.86 Favored 'General case' 0 C--N 1.301 -1.525 0 N-CA-C 108.104 -1.073 . . . . 0.0 108.104 178.153 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 114' ' ' ASN . . . . . 0.492 ' OD1' ' O ' ' A' ' 169' ' ' LEU . 1.3 t-20 -151.58 102.27 2.86 Favored 'General case' 0 N--CA 1.489 1.515 0 N-CA-C 108.171 -1.048 . . . . 0.0 108.171 179.126 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 115' ' ' ILE . . . . . 0.45 ' O ' HG22 ' A' ' 115' ' ' ILE . 3.1 mt -98.75 112.67 31.45 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.511 0 O-C-N 121.199 -0.938 . . . . 0.0 109.435 -179.772 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 116' ' ' SER . . . . . . . . . . . . . 44.1 m -98.56 143.91 28.45 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.316 -0.865 . . . . 0.0 111.338 -178.569 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 117' ' ' ILE . . . . . . . . . . . . . 1.6 mt -135.87 155.94 36.62 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.625 0 N-CA-C 108.111 -1.07 . . . . 0.0 108.111 178.764 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 118' ' ' ALA . . . . . 0.691 ' HB1' ' HB2' ' C' ' 704' ' ' ALA . . . -142.03 159.83 41.45 Favored 'General case' 0 N--CA 1.493 1.687 0 O-C-N 120.838 -1.163 . . . . 0.0 111.609 -178.967 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 119' ' ' GLY . . . . . . . . . . . . . . . -167.46 146.51 10.75 Favored Glycine 0 N--CA 1.49 2.235 0 C-N-CA 120.206 -0.997 . . . . 0.0 110.774 179.594 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 120' ' ' HIS . . . . . . . . . . . . . 27.7 m170 -70.96 167.7 18.56 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.638 -0.919 . . . . 0.0 109.251 178.964 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 121' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -122.62 157.26 32.57 Favored 'General case' 0 N--CA 1.495 1.788 0 N-CA-C 108.552 -0.907 . . . . 0.0 108.552 179.105 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 122' ' ' PHE . . . . . 0.568 ' O ' HG21 ' A' ' 131' ' ' THR . 0.2 OUTLIER -122.03 124.25 43.53 Favored 'General case' 0 N--CA 1.495 1.798 0 O-C-N 121.205 -0.935 . . . . 0.0 109.923 -179.754 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 123' ' ' ILE . . . . . 0.513 HG23 ' N ' ' A' ' 124' ' ' ASP . 11.4 tt -72.96 -35.18 48.15 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.713 0 CA-C-O 121.69 0.757 . . . . 0.0 109.718 -179.923 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 124' ' ' ASP . . . . . 0.513 ' N ' HG23 ' A' ' 123' ' ' ILE . 52.0 m-20 -90.6 8.29 34.91 Favored 'General case' 0 C--N 1.294 -1.814 0 C-N-CA 120.154 -0.618 . . . . 0.0 111.501 -178.928 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 125' ' ' ARG . . . . . . . . . . . . . 6.4 mtp180 -152.6 113.52 2.79 Favored Pre-proline 0 N--CA 1.495 1.823 0 O-C-N 120.474 -1.391 . . . . 0.0 110.531 -179.64 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 126' ' ' PRO . . . . . . . . . . . . . 78.8 Cg_endo -82.61 -16.9 7.65 Favored 'Trans proline' 0 N--CA 1.488 1.199 0 C-N-CA 122.436 2.091 . . . . 0.0 112.303 178.965 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 127' ' ' ASN . . . . . . . . . . . . . 83.8 m-20 -89.76 6.83 39.87 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.098 -1.001 . . . . 0.0 109.675 -179.885 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 128' ' ' TYR . . . . . . . . . . . . . 7.0 t80 -62.36 -148.86 0.0 OUTLIER 'General case' 0 N--CA 1.489 1.477 0 O-C-N 121.258 -0.901 . . . . 0.0 109.686 -179.975 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 129' ' ' GLN . . . . . 0.436 ' O ' ' OE2' ' A' ' 85' ' ' GLU . 17.6 mt-30 -67.88 -88.47 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.303 -0.873 . . . . 0.0 110.355 -179.149 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 130' ' ' PHE . . . . . 0.806 ' CE2' HG11 ' A' ' 101' ' ' VAL . 30.4 m-85 -110.88 37.26 2.85 Favored 'General case' 0 N--CA 1.494 1.77 0 O-C-N 121.326 -0.859 . . . . 0.0 110.303 -179.054 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 131' ' ' THR . . . . . 0.568 HG21 ' O ' ' A' ' 122' ' ' PHE . 37.0 m -77.08 -31.69 56.2 Favored 'General case' 0 N--CA 1.489 1.486 0 O-C-N 121.045 -1.034 . . . . 0.0 109.464 179.701 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 132' ' ' ASN . . . . . 0.51 ' ND2' ' O ' ' A' ' 81' ' ' ALA . 3.9 t30 -83.78 7.01 19.18 Favored 'General case' 0 N--CA 1.498 1.968 0 O-C-N 121.387 -0.821 . . . . 0.0 111.033 -179.223 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 133' ' ' LEU . . . . . 0.609 HD13 ' O ' ' A' ' 133' ' ' LEU . 0.2 OUTLIER -70.21 -45.25 66.97 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 120.971 -1.081 . . . . 0.0 110.218 -179.274 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 134' ' ' LYS . . . . . 0.551 ' CD ' ' H ' ' A' ' 134' ' ' LYS . 0.2 OUTLIER -41.49 -18.98 0.01 OUTLIER 'General case' 0 N--CA 1.496 1.83 0 O-C-N 121.053 -1.029 . . . . 0.0 110.227 -179.212 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 135' ' ' ALA . . . . . 0.597 ' N ' ' O ' ' A' ' 133' ' ' LEU . . . -85.21 -31.49 23.15 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.082 -1.011 . . . . 0.0 110.038 179.854 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 136' ' ' ALA . . . . . 0.91 ' HB2' ' HB2' ' A' ' 81' ' ' ALA . . . -80.46 152.56 28.7 Favored 'General case' 0 N--CA 1.491 1.613 0 CA-C-O 122.055 0.931 . . . . 0.0 111.758 -178.437 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 137' ' ' LYS . . . . . 0.496 ' O ' ' O ' ' A' ' 138' ' ' LYS . 24.4 mtmt -151.63 -166.03 2.4 Favored 'General case' 0 N--CA 1.493 1.695 0 C-N-CA 118.597 -1.241 . . . . 0.0 111.004 -178.247 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 138' ' ' LYS . . . . . 0.598 ' O ' ' N ' ' A' ' 140' ' ' SER . 1.1 ptpt -45.21 178.71 0.0 OUTLIER 'General case' 0 C--N 1.305 -1.359 0 CA-C-O 122.127 0.965 . . . . 0.0 110.73 -179.074 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 139' ' ' GLY . . . . . . . . . . . . . . . 46.22 8.1 0.02 OUTLIER Glycine 0 N--CA 1.489 2.199 0 N-CA-C 110.407 -1.077 . . . . 0.0 110.407 179.98 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 140' ' ' SER . . . . . 0.598 ' N ' ' O ' ' A' ' 138' ' ' LYS . 13.3 t -80.55 146.21 31.4 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 120.845 -1.385 . . . . 0.0 109.514 179.366 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 141' ' ' MET . . . . . . . . . . . . . 4.6 tpt -93.46 121.16 34.57 Favored 'General case' 0 C--N 1.3 -1.561 0 O-C-N 121.343 -0.848 . . . . 0.0 108.849 179.409 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 142' ' ' VAL . . . . . . . . . . . . . 12.8 t -112.13 130.03 66.55 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.626 0 O-C-N 121.34 -0.85 . . . . 0.0 109.016 -179.396 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 143' ' ' TYR . . . . . . . . . . . . . 3.5 m-85 -109.16 135.55 50.1 Favored 'General case' 0 N--CA 1.499 1.976 0 O-C-N 121.141 -0.974 . . . . 0.0 111.859 -178.252 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 144' ' ' PHE . . . . . . . . . . . . . 57.8 t80 -120.61 102.06 8.17 Favored 'General case' 0 N--CA 1.494 1.744 0 CA-C-O 121.302 0.572 . . . . 0.0 110.272 -179.407 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 145' ' ' LYS . . . . . . . . . . . . . 23.1 tttt -93.8 122.4 36.23 Favored 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.331 -0.856 . . . . 0.0 109.602 179.799 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 146' ' ' VAL . . . . . 0.598 ' O ' HG13 ' A' ' 146' ' ' VAL . 7.1 p -142.39 118.47 5.91 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.671 0 O-C-N 121.185 -0.947 . . . . 0.0 109.18 179.752 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 147' ' ' GLY . . . . . . . . . . . . . . . 75.61 -135.8 18.85 Favored Glycine 0 N--CA 1.488 2.132 0 N-CA-C 108.386 -1.885 . . . . 0.0 108.386 -179.094 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 148' ' ' ASN . . . . . 0.585 HD22 ' C ' ' A' ' 148' ' ' ASN . 0.3 OUTLIER -103.47 14.27 31.7 Favored 'General case' 0 C--N 1.298 -1.659 0 N-CA-C 107.907 -1.146 . . . . 0.0 107.907 178.813 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 149' ' ' GLU . . . . . . . . . . . . . 47.9 tt0 -116.26 153.23 32.27 Favored 'General case' 0 N--CA 1.486 1.361 0 CA-C-O 121.987 0.898 . . . . 0.0 110.639 -179.466 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 150' ' ' THR . . . . . . . . . . . . . 86.5 m -130.44 107.29 9.12 Favored 'General case' 0 N--CA 1.494 1.747 0 CA-C-O 121.336 0.589 . . . . 0.0 109.938 -179.701 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 151' ' ' ARG . . . . . 0.459 ' CG ' HH11 ' A' ' 151' ' ' ARG . 0.4 OUTLIER -87.28 -171.03 3.29 Favored 'General case' 0 N--CA 1.487 1.38 0 N-CA-C 108.641 -0.874 . . . . 0.0 108.641 179.826 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 152' ' ' LYS . . . . . 0.497 ' O ' ' N ' ' A' ' 205' ' ' VAL . 20.4 mtpt -148.21 149.04 31.22 Favored 'General case' 0 C--N 1.299 -1.605 0 O-C-N 121.153 -0.967 . . . . 0.0 109.841 -179.694 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 153' ' ' TYR . . . . . 0.513 ' CD2' ' HA ' ' A' ' 204' ' ' GLU . 23.2 m-85 -139.98 164.57 29.65 Favored 'General case' 0 C--N 1.302 -1.481 0 N-CA-C 108.107 -1.072 . . . . 0.0 108.107 179.86 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 154' ' ' LYS . . . . . . . . . . . . . 26.2 ttpt -142.44 119.27 11.19 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.143 -0.973 . . . . 0.0 109.006 179.517 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 155' ' ' MET . . . . . . . . . . . . . 19.5 mmt -46.01 105.96 0.07 Allowed 'General case' 0 N--CA 1.494 1.737 0 O-C-N 120.846 -1.159 . . . . 0.0 112.198 -178.63 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 156' ' ' THR . . . . . . . . . . . . . 4.4 m -108.6 -22.47 12.25 Favored 'General case' 0 C--N 1.297 -1.71 0 C-N-CA 119.897 -0.721 . . . . 0.0 109.666 179.709 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 157' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -144.56 141.02 29.17 Favored 'General case' 0 N--CA 1.492 1.642 0 C-N-CA 118.781 -1.167 . . . . 0.0 109.835 -178.742 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 158' ' ' ILE . . . . . . . . . . . . . 37.2 mt -148.02 134.25 12.42 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.372 0 CA-C-O 121.602 0.715 . . . . 0.0 109.82 -178.147 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 159' ' ' ARG . . . . . . . . . . . . . 3.9 ptm180 -154.63 -175.68 5.53 Favored 'General case' 0 C--N 1.297 -1.711 0 C-N-CA 119.486 -0.886 . . . . 0.0 110.536 -179.763 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 160' ' ' ASP . . . . . 0.584 ' C ' HG22 ' A' ' 161' ' ' VAL . 5.3 m-20 -146.48 165.1 30.42 Favored 'General case' 0 N--CA 1.488 1.452 0 N-CA-C 108.336 -0.987 . . . . 0.0 108.336 179.979 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 161' ' ' VAL . . . . . 0.584 HG22 ' C ' ' A' ' 160' ' ' ASP . 0.1 OUTLIER -170.1 163.28 0.45 Allowed 'Isoleucine or valine' 0 N--CA 1.494 1.768 0 O-C-N 120.909 -1.12 . . . . 0.0 110.281 179.842 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 162' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -49.47 171.23 0.12 Allowed Pre-proline 0 N--CA 1.488 1.473 0 O-C-N 121.599 -0.688 . . . . 0.0 109.39 179.271 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 163' ' ' PRO . . . . . 0.666 ' C ' HD11 ' C' ' 702' ' ' LEU . 60.5 Cg_endo -79.21 38.65 0.74 Allowed 'Trans proline' 0 C--N 1.307 -1.618 0 C-N-CA 122.615 2.21 . . . . 0.0 112.49 -179.909 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 164' ' ' THR . . . . . 0.465 ' O ' HG22 ' A' ' 164' ' ' THR . 86.0 m -151.88 -8.82 0.21 Allowed 'General case' 0 N--CA 1.494 1.762 0 O-C-N 121.126 -0.984 . . . . 0.0 110.925 -179.732 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 165' ' ' ASP . . . . . 0.437 ' O ' ' C ' ' A' ' 166' ' ' VAL . 17.8 t70 -72.85 61.86 0.57 Allowed 'General case' 0 N--CA 1.494 1.755 0 O-C-N 120.764 -1.21 . . . . 0.0 110.235 -179.351 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 166' ' ' VAL . . . . . 0.61 ' O ' ' N ' ' A' ' 168' ' ' VAL . 1.5 m -39.91 -33.06 0.23 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.65 0 O-C-N 121.408 -0.808 . . . . 0.0 109.692 -178.587 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 167' ' ' GLY . . . . . 0.404 ' C ' ' O ' ' A' ' 166' ' ' VAL . . . -43.07 -13.84 0.01 OUTLIER Glycine 0 N--CA 1.495 2.579 0 O-C-N 120.918 -1.114 . . . . 0.0 110.823 -179.802 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 168' ' ' VAL . . . . . 0.641 ' C ' ' H ' ' A' ' 170' ' ' ASP . 4.8 m -53.34 -36.27 26.25 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.583 0 O-C-N 120.768 -1.43 . . . . 0.0 108.726 179.709 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 169' ' ' LEU . . . . . 0.544 ' O ' ' N ' ' A' ' 171' ' ' GLU . 34.4 mt -51.08 -4.6 0.02 OUTLIER 'General case' 0 N--CA 1.494 1.772 0 N-CA-C 108.117 -1.068 . . . . 0.0 108.117 -179.602 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 170' ' ' ASP . . . . . 0.641 ' H ' ' C ' ' A' ' 168' ' ' VAL . 4.1 m-20 33.41 28.92 0.0 OUTLIER 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.685 -0.634 . . . . 0.0 112.228 177.185 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 171' ' ' GLU . . . . . 0.544 ' N ' ' O ' ' A' ' 169' ' ' LEU . 11.2 pt-20 -67.31 94.46 0.38 Allowed 'General case' 0 N--CA 1.491 1.589 0 O-C-N 120.598 -1.314 . . . . 0.0 107.703 178.376 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 172' ' ' GLN . . . . . . . . . . . . . 0.7 OUTLIER -159.04 -72.75 0.08 Allowed 'General case' 0 N--CA 1.493 1.716 0 O-C-N 121.637 -0.665 . . . . 0.0 109.538 -179.449 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 173' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -62.15 127.07 29.62 Favored 'General case' 0 N--CA 1.492 1.668 0 O-C-N 121.265 -0.897 . . . . 0.0 109.195 179.627 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 174' ' ' GLY . . . . . 0.564 ' O ' ' C ' ' A' ' 175' ' ' LYS . . . -118.24 -39.06 0.76 Allowed Glycine 0 N--CA 1.482 1.733 0 N-CA-C 108.623 -1.791 . . . . 0.0 108.623 179.368 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 175' ' ' LYS . . . . . 0.564 ' C ' ' O ' ' A' ' 174' ' ' GLY . 0.0 OUTLIER -32.54 -62.97 0.22 Allowed 'General case' 0 N--CA 1.498 1.952 0 N-CA-C 108.492 -0.929 . . . . 0.0 108.492 179.822 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 176' ' ' ASP . . . . . 0.66 ' O ' ' O ' ' A' ' 177' ' ' LYS . 5.5 m-20 -103.09 87.01 2.8 Favored 'General case' 0 C--N 1.297 -1.712 0 N-CA-C 106.759 -1.571 . . . . 0.0 106.759 176.914 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 177' ' ' LYS . . . . . 0.66 ' O ' ' O ' ' A' ' 176' ' ' ASP . 12.9 mttt -37.28 176.04 0.0 OUTLIER 'General case' 0 N--CA 1.498 1.942 0 CA-C-O 121.762 0.791 . . . . 0.0 110.541 -178.703 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 178' ' ' GLN . . . . . 0.462 HE22 ' CB ' ' A' ' 170' ' ' ASP . 17.0 pt20 -159.59 171.07 20.3 Favored 'General case' 0 C--N 1.302 -1.459 0 C-N-CA 118.075 -1.45 . . . . 0.0 111.582 -179.867 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 179' ' ' LEU . . . . . . . . . . . . . 1.2 tp -127.02 95.17 4.23 Favored 'General case' 0 C--N 1.303 -1.443 0 N-CA-C 107.412 -1.329 . . . . 0.0 107.412 178.127 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 180' ' ' THR . . . . . . . . . . . . . 1.3 m -71.7 121.26 18.54 Favored 'General case' 0 N--CA 1.489 1.502 0 C-N-CA 119.217 -0.993 . . . . 0.0 110.213 -178.571 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 181' ' ' LEU . . . . . 0.419 HD11 ' CE2' ' A' ' 130' ' ' PHE . 49.7 tp -96.24 147.72 23.48 Favored 'General case' 0 C--N 1.297 -1.693 0 N-CA-C 108.342 -0.984 . . . . 0.0 108.342 178.308 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 182' ' ' ILE . . . . . 0.46 ' O ' HG22 ' A' ' 182' ' ' ILE . 2.0 mt -138.73 115.09 10.19 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.578 0 N-CA-C 108.245 -1.02 . . . . 0.0 108.245 178.732 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 183' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -137.02 112.56 9.35 Favored 'General case' 0 C--N 1.293 -1.889 0 N-CA-C 107.265 -1.383 . . . . 0.0 107.265 179.364 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 184' ' ' CYS . . . . . 0.491 ' HB3' HH12 ' A' ' 197' ' ' ARG . 0.8 OUTLIER -78.69 163.71 25.2 Favored 'General case' 0 C--N 1.292 -1.918 0 C-N-CA 119.514 -0.874 . . . . 0.0 111.653 -177.14 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 185' ' ' ASP . . . . . . . . . . . . . 18.9 t0 -166.36 -159.4 0.37 Allowed 'General case' 0 N--CA 1.489 1.509 0 N-CA-C 109.205 -0.665 . . . . 0.0 109.205 -179.944 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 186' ' ' ASP . . . . . . . . . . . . . 1.3 m-20 53.84 59.62 4.17 Favored 'General case' 0 N--CA 1.493 1.724 0 O-C-N 121.121 -0.987 . . . . 0.0 109.546 179.933 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 187' ' ' TYR . . . . . 0.608 ' CE1' ' O ' ' A' ' 188' ' ' ASN . 57.0 t80 -67.67 137.77 55.81 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.319 -0.863 . . . . 0.0 110.398 -179.708 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 188' ' ' ASN . . . . . 0.608 ' O ' ' CE1' ' A' ' 187' ' ' TYR . 0.8 OUTLIER -104.41 145.02 30.86 Favored 'General case' 0 C--N 1.298 -1.672 0 N-CA-C 108.255 -1.017 . . . . 0.0 108.255 178.617 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 189' ' ' GLU . . . . . . . . . . . . . 1.4 tt0 -110.57 -13.17 14.27 Favored 'General case' 0 C--N 1.296 -1.744 0 N-CA-C 108.818 -0.808 . . . . 0.0 108.818 -179.36 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 190' ' ' LYS . . . . . . . . . . . . . 29.1 mttt -82.8 -53.66 5.72 Favored 'General case' 0 C--N 1.302 -1.496 0 N-CA-C 108.714 -0.847 . . . . 0.0 108.714 178.873 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 191' ' ' THR . . . . . . . . . . . . . 1.1 p -90.09 -10.76 43.53 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.517 -0.739 . . . . 0.0 109.194 179.714 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 192' ' ' GLY . . . . . . . . . . . . . . . 65.77 40.75 95.83 Favored Glycine 0 N--CA 1.495 2.59 0 N-CA-C 110.637 -0.985 . . . . 0.0 110.637 178.914 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 193' ' ' VAL . . . . . 0.541 HG12 ' N ' ' A' ' 194' ' ' TRP . 64.8 t -147.63 161.61 7.55 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.641 0 O-C-N 121.023 -1.281 . . . . 0.0 109.565 179.487 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 194' ' ' TRP . . . . . 0.541 ' N ' HG12 ' A' ' 193' ' ' VAL . 19.4 m95 -83.71 118.42 23.87 Favored 'General case' 0 C--N 1.301 -1.537 0 N-CA-C 107.901 -1.148 . . . . 0.0 107.901 179.082 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 195' ' ' GLU . . . . . 0.551 ' CD ' ' ND2' ' A' ' 188' ' ' ASN . 2.3 mt-10 -85.17 -60.86 1.91 Allowed 'General case' 0 N--CA 1.492 1.665 0 O-C-N 121.241 -0.912 . . . . 0.0 111.112 -177.941 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 196' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER -78.63 149.18 32.96 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 120.935 -1.103 . . . . 0.0 109.731 -179.315 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 197' ' ' ARG . . . . . 0.669 ' NE ' HD13 ' C' ' 702' ' ' LEU . 0.0 OUTLIER -128.06 136.92 51.88 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.492 -0.755 . . . . 0.0 109.129 179.84 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 198' ' ' LYS . . . . . . . . . . . . . 2.3 mtmm -115.03 121.87 44.45 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.756 -0.59 . . . . 0.0 110.676 -178.623 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 199' ' ' ILE . . . . . 0.563 ' C ' HD12 ' A' ' 199' ' ' ILE . 0.9 OUTLIER -139.57 117.89 11.79 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.586 0 CA-C-O 122.477 1.132 . . . . 0.0 109.842 179.419 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 200' ' ' PHE . . . . . 0.551 ' CZ ' HD12 ' A' ' 133' ' ' LEU . 5.0 m-85 -98.88 136.11 39.35 Favored 'General case' 0 N--CA 1.498 1.948 0 O-C-N 121.322 -0.861 . . . . 0.0 110.262 -177.914 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 201' ' ' VAL . . . . . . . . . . . . . 24.2 t -105.12 141.33 20.72 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.76 0 O-C-N 121.032 -1.043 . . . . 0.0 108.777 178.13 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 202' ' ' ALA . . . . . . . . . . . . . . . -131.17 137.44 48.99 Favored 'General case' 0 C--N 1.3 -1.545 0 N-CA-C 108.429 -0.952 . . . . 0.0 108.429 179.874 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 203' ' ' THR . . . . . 0.615 ' O ' HG23 ' A' ' 205' ' ' VAL . 2.5 t -88.41 136.06 33.17 Favored 'General case' 0 N--CA 1.489 1.515 0 CA-C-O 122.116 0.96 . . . . 0.0 110.568 -179.177 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 204' ' ' GLU . . . . . 0.513 ' HA ' ' CD2' ' A' ' 153' ' ' TYR . 0.8 OUTLIER -53.66 136.22 39.56 Favored 'General case' 0 C--N 1.295 -1.799 0 C-N-CA 118.133 -1.427 . . . . 0.0 108.706 179.014 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 205' ' ' VAL . . . . . 0.615 HG23 ' O ' ' A' ' 203' ' ' THR . 77.7 t -129.99 166.41 27.66 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.34 0 CA-C-O 121.97 0.89 . . . . 0.0 110.063 -177.893 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 206' ' ' LYS . . . . . 0.611 ' N ' HG12 ' A' ' 205' ' ' VAL . 9.1 ptmt . . . . . 0 C--N 1.296 -1.752 0 CA-C-O 118.034 -0.984 . . . . 0.0 109.429 -179.836 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' C' C ' 702' ' ' LEU . . . . . 0.669 HD13 ' NE ' ' A' ' 197' ' ' ARG . 0.1 OUTLIER . . . . . 0 N--CA 1.49 1.56 0 N-CA-C 108.757 -0.831 . . . . 0.0 108.757 . . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' C' C ' 703' ' ' PRO . . . . . 0.577 ' HB2' ' HB3' ' A' ' 92' ' ' ALA . 29.4 Cg_endo -66.39 -162.92 0.06 OUTLIER 'Trans proline' 0 N--CA 1.495 1.581 0 C-N-CA 122.59 2.194 . . . . 0.0 112.783 -179.224 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' C' C ' 704' ' ' ALA . . . . . 0.691 ' HB2' ' HB1' ' A' ' 118' ' ' ALA . . . . . . . . 0 N--CA 1.488 1.456 0 O-C-N 121.476 -0.765 . . . . 0.0 109.356 -179.865 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 63' ' ' PRO . . . . . . . . . . . . . 9.9 Cg_endo . . . . . 0 N--CA 1.481 0.792 0 CA-C-O 121.21 0.421 . . . . 0.0 111.15 . . . . . . . . . 0 0 . 1 . 006 nuclear nobuild core ' A' A ' 64' ' ' GLN . . . . . 0.702 HE21 ' C ' ' A' ' 64' ' ' GLN . 0.0 OUTLIER -154.85 118.58 4.58 Favored 'General case' 0 N--CA 1.494 1.728 0 O-C-N 121.231 -0.918 . . . . 0.0 109.553 179.857 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 65' ' ' ILE . . . . . 0.501 HD12 ' H ' ' A' ' 65' ' ' ILE . 3.1 mp -46.58 106.4 0.57 Allowed Pre-proline 0 C--N 1.3 -1.548 0 O-C-N 121.316 -0.865 . . . . 0.0 108.773 179.197 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 66' ' ' PRO . . . . . . . . . . . . . 67.5 Cg_endo -86.51 -157.68 0.08 OUTLIER 'Trans proline' 0 C--N 1.314 -1.285 0 C-N-CA 122.487 2.125 . . . . 0.0 112.401 -179.224 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 67' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -82.88 -4.87 58.65 Favored 'General case' 0 C--N 1.302 -1.473 0 N-CA-C 108.838 -0.801 . . . . 0.0 108.838 179.528 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 68' ' ' ASP . . . . . 0.635 ' C ' ' N ' ' A' ' 70' ' ' SER . 0.3 OUTLIER -74.82 52.45 0.53 Allowed 'General case' 0 N--CA 1.488 1.425 0 CA-C-O 122.726 1.251 . . . . 0.0 108.444 179.492 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 69' ' ' LYS . . . . . 0.445 ' C ' ' O ' ' A' ' 68' ' ' ASP . 21.0 mtmt -49.48 -13.94 0.09 Allowed 'General case' 0 N--CA 1.502 2.173 0 C-N-CA 116.798 -1.961 . . . . 0.0 106.551 177.94 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 70' ' ' SER . . . . . 0.635 ' N ' ' C ' ' A' ' 68' ' ' ASP . 0.1 OUTLIER -85.48 -6.56 59.18 Favored 'General case' 0 N--CA 1.493 1.68 0 CA-C-N 113.508 -1.678 . . . . 0.0 110.601 179.285 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 71' ' ' LYS . . . . . . . . . . . . . 2.0 ptmm? -101.2 144.62 29.84 Favored 'General case' 0 N--CA 1.498 1.942 0 O-C-N 120.863 -1.148 . . . . 0.0 111.888 -179.395 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 72' ' ' VAL . . . . . 0.602 ' CG2' ' O ' ' A' ' 74' ' ' GLY . 0.7 OUTLIER -67.26 132.95 32.16 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.364 0 N-CA-C 105.49 -2.041 . . . . 0.0 105.49 174.363 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -83.77 -13.78 53.07 Favored 'General case' 0 C--N 1.297 -1.71 0 O-C-N 120.026 -1.671 . . . . 0.0 108.618 -179.183 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 74' ' ' GLY . . . . . 0.602 ' O ' ' CG2' ' A' ' 72' ' ' VAL . . . 173.29 -159.63 29.83 Favored Glycine 0 N--CA 1.487 2.086 0 N-CA-C 109.459 -1.456 . . . . 0.0 109.459 -179.805 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 75' ' ' TYR . . . . . . . . . . . . . 81.1 m-85 -140.12 169.9 16.83 Favored 'General case' 0 C--N 1.297 -1.689 0 O-C-N 121.02 -1.282 . . . . 0.0 111.354 -178.334 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 76' ' ' ILE . . . . . . . . . . . . . 1.3 tp -145.9 138.72 20.63 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.605 0 C-N-CA 119.376 -0.93 . . . . 0.0 109.235 -176.165 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -149.46 162.53 39.94 Favored 'General case' 0 C--N 1.302 -1.474 0 O-C-N 120.899 -1.126 . . . . 0.0 109.804 -179.606 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 78' ' ' ILE . . . . . 0.637 ' HB ' ' HB3' ' A' ' 81' ' ' ALA . 4.5 mt -147.74 99.54 3.79 Favored Pre-proline 0 N--CA 1.488 1.455 0 N-CA-C 108.421 -0.955 . . . . 0.0 108.421 179.879 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 79' ' ' PRO . . . . . . . . . . . . . 52.6 Cg_exo -49.81 -45.76 30.64 Favored 'Trans proline' 0 N--CA 1.493 1.483 0 C-N-CA 122.57 2.18 . . . . 0.0 113.464 -178.826 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 7.9 m-20 -66.04 -19.65 65.92 Favored 'General case' 0 N--CA 1.492 1.656 0 O-C-N 120.944 -1.098 . . . . 0.0 110.924 178.81 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 81' ' ' ALA . . . . . 0.772 ' HB2' ' HB2' ' A' ' 136' ' ' ALA . . . -105.01 -16.55 14.78 Favored 'General case' 0 N--CA 1.494 1.754 0 O-C-N 121.093 -1.005 . . . . 0.0 108.46 179.329 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 82' ' ' ASP . . . . . 0.419 ' N ' ' O ' ' A' ' 78' ' ' ILE . 0.6 OUTLIER 66.22 50.58 1.35 Allowed 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.385 -0.822 . . . . 0.0 110.434 179.191 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 83' ' ' ILE . . . . . 0.528 HD11 ' OD1' ' A' ' 132' ' ' ASN . 62.0 mt -129.42 151.97 36.59 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.788 0 O-C-N 121.09 -1.006 . . . . 0.0 110.481 -178.848 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 84' ' ' LYS . . . . . 0.491 ' N ' ' OE2' ' A' ' 85' ' ' GLU . 9.2 tttm -159.15 109.59 1.99 Allowed 'General case' 0 N--CA 1.487 1.38 0 N-CA-C 108.08 -1.081 . . . . 0.0 108.08 179.777 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 85' ' ' GLU . . . . . 0.491 ' OE2' ' N ' ' A' ' 84' ' ' LYS . 0.7 OUTLIER -144.05 171.85 6.26 Favored Pre-proline 0 N--CA 1.495 1.811 0 C-N-CA 119.858 -0.737 . . . . 0.0 109.874 -179.491 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 86' ' ' PRO . . . . . . . . . . . . . 68.7 Cg_endo -91.0 148.95 3.82 Favored 'Trans proline' 0 N--CA 1.488 1.19 0 C-N-CA 123.126 2.551 . . . . 0.0 112.963 -179.751 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 87' ' ' VAL . . . . . 0.428 ' CG2' ' C ' ' A' ' 74' ' ' GLY . 0.0 OUTLIER -104.91 106.03 19.72 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.576 0 N-CA-C 108.619 -0.882 . . . . 0.0 108.619 178.669 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 88' ' ' TYR . . . . . 0.405 ' CE1' ' HB3' ' A' ' 99' ' ' ARG . 13.7 m-85 -87.55 135.0 34.73 Favored Pre-proline 0 N--CA 1.492 1.648 0 O-C-N 120.95 -1.094 . . . . 0.0 110.37 -178.964 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 89' ' ' PRO . . . . . . . . . . . . . 20.2 Cg_exo -34.34 138.15 0.1 OUTLIER 'Trans proline' 0 N--CA 1.49 1.291 0 C-N-CA 123.253 2.635 . . . . 0.0 113.714 179.982 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . -58.87 167.26 7.04 Favored Glycine 0 N--CA 1.491 2.331 0 N-CA-C 109.546 -1.422 . . . . 0.0 109.546 179.679 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 91' ' ' PRO . . . . . 0.482 ' C ' ' H ' ' A' ' 93' ' ' THR . 57.5 Cg_endo -92.46 170.39 21.96 Favored 'Cis proline' 0 C--N 1.307 -1.625 0 C-N-CA 123.659 -1.392 . . . . 0.0 111.94 0.654 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 92' ' ' ALA . . . . . 0.639 ' O ' HD23 ' A' ' 97' ' ' LEU . . . -70.32 29.38 0.04 OUTLIER 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.253 -0.904 . . . . 0.0 110.54 -179.327 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 93' ' ' THR . . . . . 0.482 ' H ' ' C ' ' A' ' 91' ' ' PRO . 0.8 OUTLIER -72.8 154.55 91.13 Favored Pre-proline 0 N--CA 1.492 1.644 0 O-C-N 120.764 -1.21 . . . . 0.0 109.131 -179.678 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 94' ' ' PRO . . . . . 0.451 ' O ' ' C ' ' A' ' 95' ' ' GLU . 80.5 Cg_exo -30.82 -61.79 0.13 Allowed 'Trans proline' 0 C--N 1.308 -1.574 0 C-N-CA 123.058 2.505 . . . . 0.0 112.567 -179.144 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 95' ' ' GLU . . . . . 0.451 ' C ' ' O ' ' A' ' 94' ' ' PRO . 0.3 OUTLIER -41.67 -48.23 4.09 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.288 -0.882 . . . . 0.0 109.258 179.882 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 96' ' ' GLN . . . . . 0.704 HE21 ' NH1' ' A' ' 99' ' ' ARG . 0.4 OUTLIER -73.6 -59.54 2.67 Favored 'General case' 0 N--CA 1.487 1.391 0 O-C-N 121.221 -0.924 . . . . 0.0 109.934 179.591 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 97' ' ' LEU . . . . . 0.639 HD23 ' O ' ' A' ' 92' ' ' ALA . 0.5 OUTLIER -45.07 -13.37 0.02 OUTLIER 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.319 -0.863 . . . . 0.0 109.413 -179.393 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 98' ' ' ASN . . . . . 0.606 ' N ' ' O ' ' A' ' 96' ' ' GLN . 0.0 OUTLIER -73.58 -26.19 60.7 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.329 -0.857 . . . . 0.0 109.841 -179.995 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 99' ' ' ARG . . . . . 0.704 ' NH1' HE21 ' A' ' 96' ' ' GLN . 1.7 mpt_? -95.33 -45.58 7.08 Favored 'General case' 0 N--CA 1.488 1.454 0 O-C-N 121.396 -0.815 . . . . 0.0 110.048 -178.959 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . 169.99 -174.13 44.12 Favored Glycine 0 N--CA 1.494 2.537 0 C-N-CA 119.517 -1.325 . . . . 0.0 110.238 179.737 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 101' ' ' VAL . . . . . 0.737 ' O ' HG23 ' A' ' 101' ' ' VAL . 19.5 m -50.17 106.34 0.06 OUTLIER 'Isoleucine or valine' 0 N--CA 1.493 1.711 0 O-C-N 121.401 -1.058 . . . . 0.0 109.218 179.765 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -92.88 169.68 10.26 Favored 'General case' 0 N--CA 1.494 1.729 0 O-C-N 121.213 -0.93 . . . . 0.0 110.885 -179.306 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 103' ' ' PHE . . . . . 0.553 ' O ' ' N ' ' A' ' 105' ' ' GLU . 23.1 m-85 -69.52 120.83 15.9 Favored 'General case' 0 N--CA 1.487 1.404 0 N-CA-C 107.957 -1.127 . . . . 0.0 107.957 178.192 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 104' ' ' ALA . . . . . 0.597 ' HB1' ' HG3' ' C' ' 703' ' ' PRO . . . -46.85 -9.78 0.02 OUTLIER 'General case' 0 C--N 1.301 -1.529 0 O-C-N 121.335 -0.853 . . . . 0.0 110.852 -178.882 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 105' ' ' GLU . . . . . 0.553 ' N ' ' O ' ' A' ' 103' ' ' PHE . 0.1 OUTLIER -140.28 143.8 36.09 Favored 'General case' 0 N--CA 1.496 1.862 0 O-C-N 120.811 -1.181 . . . . 0.0 110.648 -179.786 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 106' ' ' GLU . . . . . . . . . . . . . 27.6 tt0 -59.42 -64.03 1.09 Allowed 'General case' 0 N--CA 1.489 1.502 0 CA-C-N 116.216 -0.447 . . . . 0.0 111.625 -178.892 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 107' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER -78.66 35.56 0.24 Allowed 'General case' 0 N--CA 1.491 1.604 0 O-C-N 120.661 -1.274 . . . . 0.0 112.672 -175.723 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 108' ' ' GLU . . . . . . . . . . . . . 2.0 tp10 -56.67 149.59 17.48 Favored 'General case' 0 N--CA 1.489 1.513 0 O-C-N 120.323 -1.486 . . . . 0.0 107.741 179.779 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 109' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -100.95 145.0 29.21 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 120.9 -1.125 . . . . 0.0 110.818 -178.261 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 110' ' ' LEU . . . . . 0.495 HD13 ' O ' ' A' ' 110' ' ' LEU . 0.2 OUTLIER -61.03 -24.62 66.32 Favored 'General case' 0 C--N 1.306 -1.317 0 N-CA-C 108.199 -1.037 . . . . 0.0 108.199 179.213 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 111' ' ' ASP . . . . . 0.436 ' OD1' ' C ' ' A' ' 110' ' ' LEU . 2.7 m-20 -132.37 45.1 2.8 Favored 'General case' 0 C--N 1.302 -1.463 0 N-CA-C 109.208 -0.664 . . . . 0.0 109.208 179.63 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 112' ' ' ASP . . . . . . . . . . . . . 1.3 t0 -68.06 155.32 39.8 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.346 -0.846 . . . . 0.0 111.094 -179.638 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 113' ' ' GLN . . . . . 0.623 HE22 ' N ' ' A' ' 172' ' ' GLN . 0.0 OUTLIER -67.06 -17.15 64.77 Favored 'General case' 0 N--CA 1.488 1.456 0 N-CA-C 108.137 -1.06 . . . . 0.0 108.137 177.613 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 114' ' ' ASN . . . . . 0.55 ' OD1' ' NE2' ' A' ' 178' ' ' GLN . 2.3 t30 -151.48 105.35 3.16 Favored 'General case' 0 C--N 1.295 -1.79 0 N-CA-C 107.654 -1.239 . . . . 0.0 107.654 179.528 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 115' ' ' ILE . . . . . 0.538 HG22 ' O ' ' A' ' 115' ' ' ILE . 3.1 mt -93.6 104.44 15.75 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.711 0 O-C-N 120.675 -1.265 . . . . 0.0 107.916 179.95 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 116' ' ' SER . . . . . 0.438 ' OG ' ' ND2' ' A' ' 114' ' ' ASN . 18.5 m -87.3 147.32 25.56 Favored 'General case' 0 C--N 1.304 -1.382 0 CA-C-O 121.861 0.838 . . . . 0.0 110.988 -177.962 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 117' ' ' ILE . . . . . . . . . . . . . 2.5 mt -142.05 151.3 18.64 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.438 0 N-CA-C 107.897 -1.149 . . . . 0.0 107.897 179.449 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 118' ' ' ALA . . . . . 0.401 ' HB1' ' HB2' ' C' ' 704' ' ' ALA . . . -142.81 157.15 44.9 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 120.964 -1.085 . . . . 0.0 111.025 -179.026 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 119' ' ' GLY . . . . . . . . . . . . . . . -163.96 145.01 9.94 Favored Glycine 0 N--CA 1.486 1.997 0 N-CA-C 109.889 -1.285 . . . . 0.0 109.889 179.49 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 120' ' ' HIS . . . . . . . . . . . . . 26.5 m170 -70.49 168.49 16.1 Favored 'General case' 0 N--CA 1.493 1.681 0 O-C-N 121.574 -0.957 . . . . 0.0 109.64 179.357 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 121' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -120.67 149.2 42.86 Favored 'General case' 0 N--CA 1.494 1.735 0 O-C-N 121.234 -0.916 . . . . 0.0 108.728 179.035 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 122' ' ' PHE . . . . . . . . . . . . . 0.5 OUTLIER -112.37 140.13 47.35 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.199 -0.938 . . . . 0.0 109.359 179.805 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 123' ' ' ILE . . . . . 0.577 HG23 ' N ' ' A' ' 124' ' ' ASP . 16.0 tt -88.57 -37.88 10.85 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.793 0 N-CA-C 108.509 -0.923 . . . . 0.0 108.509 179.631 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 124' ' ' ASP . . . . . 0.577 ' N ' HG23 ' A' ' 123' ' ' ILE . 4.9 p-10 -94.37 19.07 10.04 Favored 'General case' 0 C--N 1.296 -1.735 0 C-N-CA 120.121 -0.632 . . . . 0.0 110.633 -179.548 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 125' ' ' ARG . . . . . 0.664 HH11 ' CG ' ' A' ' 125' ' ' ARG . 0.0 OUTLIER -156.35 108.42 2.05 Favored Pre-proline 0 N--CA 1.49 1.55 0 O-C-N 120.628 -1.295 . . . . 0.0 110.348 -179.049 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 126' ' ' PRO . . . . . . . . . . . . . 90.1 Cg_endo -82.55 -22.19 4.75 Favored 'Trans proline' 0 C--N 1.316 -1.181 0 C-N-CA 122.222 1.948 . . . . 0.0 111.953 179.522 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 127' ' ' ASN . . . . . 0.421 ' OD1' ' NH1' ' A' ' 125' ' ' ARG . 1.1 p30 -89.17 29.04 1.11 Allowed 'General case' 0 N--CA 1.489 1.502 0 O-C-N 121.188 -0.945 . . . . 0.0 109.331 179.97 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 128' ' ' TYR . . . . . . . . . . . . . 9.7 t80 -86.12 -149.18 0.13 Allowed 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.269 -0.894 . . . . 0.0 109.922 -179.64 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 129' ' ' GLN . . . . . . . . . . . . . 32.4 mt-30 -67.72 -69.31 0.32 Allowed 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.371 -0.831 . . . . 0.0 110.746 -178.838 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 130' ' ' PHE . . . . . 0.512 ' CE2' HG11 ' A' ' 101' ' ' VAL . 50.0 m-85 -129.83 28.66 5.08 Favored 'General case' 0 N--CA 1.496 1.841 0 O-C-N 121.14 -0.975 . . . . 0.0 110.613 -179.405 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 131' ' ' THR . . . . . . . . . . . . . 94.6 m -67.8 -34.5 76.89 Favored 'General case' 0 N--CA 1.493 1.717 0 O-C-N 120.79 -1.194 . . . . 0.0 108.968 179.37 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 132' ' ' ASN . . . . . 0.602 ' ND2' ' O ' ' A' ' 81' ' ' ALA . 2.4 p-10 -91.11 13.59 16.48 Favored 'General case' 0 N--CA 1.494 1.752 0 C-N-CA 119.608 -0.837 . . . . 0.0 111.285 -179.665 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 133' ' ' LEU . . . . . 0.619 HD13 ' O ' ' A' ' 133' ' ' LEU . 0.2 OUTLIER -71.82 -42.74 66.65 Favored 'General case' 0 N--CA 1.492 1.668 0 O-C-N 120.571 -1.331 . . . . 0.0 110.266 -179.038 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 134' ' ' LYS . . . . . 0.627 ' CD ' ' H ' ' A' ' 134' ' ' LYS . 0.0 OUTLIER -44.44 -12.77 0.02 OUTLIER 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.165 -0.959 . . . . 0.0 110.402 -179.263 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 135' ' ' ALA . . . . . 0.595 ' N ' ' O ' ' A' ' 133' ' ' LEU . . . -82.77 -37.98 23.82 Favored 'General case' 0 N--CA 1.489 1.513 0 O-C-N 120.761 -1.212 . . . . 0.0 109.855 -179.829 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 136' ' ' ALA . . . . . 0.772 ' HB2' ' HB2' ' A' ' 81' ' ' ALA . . . -78.55 153.38 31.28 Favored 'General case' 0 C--N 1.302 -1.496 0 O-C-N 121.352 -0.843 . . . . 0.0 111.111 -178.741 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 137' ' ' LYS . . . . . 0.519 ' O ' ' O ' ' A' ' 138' ' ' LYS . 0.4 OUTLIER -151.38 -163.69 1.82 Allowed 'General case' 0 N--CA 1.492 1.661 0 C-N-CA 118.479 -1.288 . . . . 0.0 110.744 -178.07 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 138' ' ' LYS . . . . . 0.585 ' O ' ' N ' ' A' ' 140' ' ' SER . 0.2 OUTLIER -46.3 -179.29 0.0 OUTLIER 'General case' 0 C--N 1.304 -1.4 0 CA-C-O 122.145 0.974 . . . . 0.0 110.508 -179.043 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 139' ' ' GLY . . . . . . . . . . . . . . . 46.87 7.77 0.02 OUTLIER Glycine 0 N--CA 1.49 2.284 0 N-CA-C 110.354 -1.098 . . . . 0.0 110.354 -179.848 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 140' ' ' SER . . . . . 0.585 ' N ' ' O ' ' A' ' 138' ' ' LYS . 39.2 m -84.56 130.53 34.73 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 120.926 -1.338 . . . . 0.0 109.517 179.412 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 141' ' ' MET . . . . . 0.639 ' SD ' ' N ' ' A' ' 142' ' ' VAL . 8.7 tpp -83.9 127.25 33.71 Favored 'General case' 0 N--CA 1.488 1.446 0 O-C-N 121.074 -1.016 . . . . 0.0 108.978 179.523 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 142' ' ' VAL . . . . . 0.639 ' N ' ' SD ' ' A' ' 141' ' ' MET . 2.4 t -111.25 133.38 57.0 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.512 0 N-CA-C 108.586 -0.894 . . . . 0.0 108.586 -179.744 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 143' ' ' TYR . . . . . . . . . . . . . 8.1 m-85 -111.05 135.29 51.79 Favored 'General case' 0 N--CA 1.495 1.802 0 O-C-N 120.822 -1.174 . . . . 0.0 111.124 -178.511 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 144' ' ' PHE . . . . . . . . . . . . . 10.3 t80 -120.17 104.57 10.19 Favored 'General case' 0 N--CA 1.493 1.7 0 C-N-CA 120.081 -0.648 . . . . 0.0 110.139 -179.748 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 145' ' ' LYS . . . . . . . . . . . . . 14.3 ttmm -99.64 128.12 45.74 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.135 -0.978 . . . . 0.0 110.556 -179.487 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 146' ' ' VAL . . . . . 0.462 HG21 HD11 ' A' ' 110' ' ' LEU . 0.6 OUTLIER -142.7 146.15 22.36 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.568 0 N-CA-C 107.438 -1.319 . . . . 0.0 107.438 178.695 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 147' ' ' GLY . . . . . 0.432 ' C ' ' O ' ' A' ' 146' ' ' VAL . . . 45.8 -131.82 9.93 Favored Glycine 0 N--CA 1.487 2.046 0 N-CA-C 108.465 -1.854 . . . . 0.0 108.465 -179.222 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 148' ' ' ASN . . . . . 0.536 HD22 ' C ' ' A' ' 148' ' ' ASN . 0.4 OUTLIER -104.2 18.07 22.83 Favored 'General case' 0 C--N 1.301 -1.532 0 O-C-N 121.307 -1.113 . . . . 0.0 108.602 179.077 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 149' ' ' GLU . . . . . . . . . . . . . 14.4 tt0 -112.22 147.03 37.08 Favored 'General case' 0 N--CA 1.49 1.557 0 CA-C-O 121.817 0.818 . . . . 0.0 111.328 -178.263 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 150' ' ' THR . . . . . 0.479 HG22 ' O ' ' A' ' 150' ' ' THR . 1.4 m -131.79 103.97 6.63 Favored 'General case' 0 N--CA 1.491 1.586 0 CA-C-O 121.579 0.704 . . . . 0.0 109.832 179.796 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 151' ' ' ARG . . . . . 0.477 ' NH2' ' OH ' ' A' ' 153' ' ' TYR . 21.4 mtm180 -88.2 -170.97 3.18 Favored 'General case' 0 N--CA 1.488 1.439 0 N-CA-C 109.134 -0.691 . . . . 0.0 109.134 -179.877 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 152' ' ' LYS . . . . . 0.405 ' C ' ' CD1' ' A' ' 153' ' ' TYR . 40.4 mtmt -150.86 149.26 29.47 Favored 'General case' 0 N--CA 1.489 1.496 0 O-C-N 120.968 -1.083 . . . . 0.0 110.258 -179.574 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 153' ' ' TYR . . . . . 0.578 ' O ' ' SD ' ' A' ' 141' ' ' MET . 15.9 m-85 -141.18 165.77 26.62 Favored 'General case' 0 N--CA 1.489 1.518 0 N-CA-C 107.715 -1.217 . . . . 0.0 107.715 179.224 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 154' ' ' LYS . . . . . 0.454 ' HB2' HG21 ' A' ' 205' ' ' VAL . 5.3 ttmm -141.32 115.85 9.56 Favored 'General case' 0 C--N 1.297 -1.699 0 O-C-N 120.959 -1.088 . . . . 0.0 108.628 179.29 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 155' ' ' MET . . . . . . . . . . . . . 4.6 mtt -43.65 106.16 0.06 Allowed 'General case' 0 N--CA 1.492 1.649 0 O-C-N 120.741 -1.224 . . . . 0.0 111.548 -178.662 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 156' ' ' THR . . . . . 0.748 ' OG1' HG23 ' A' ' 203' ' ' THR . 0.6 OUTLIER -109.08 -23.18 11.79 Favored 'General case' 0 C--N 1.292 -1.896 0 CA-C-N 115.267 -0.879 . . . . 0.0 109.894 -179.514 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 157' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -153.14 151.45 30.16 Favored 'General case' 0 C--N 1.297 -1.713 0 C-N-CA 118.493 -1.283 . . . . 0.0 111.431 -178.598 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 158' ' ' ILE . . . . . 0.884 HD12 ' CD2' ' A' ' 200' ' ' PHE . 0.2 OUTLIER -152.43 145.13 15.6 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.295 0 CA-C-O 121.708 0.766 . . . . 0.0 110.132 -179.148 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 159' ' ' ARG . . . . . . . . . . . . . 66.2 ttt180 -152.69 149.22 28.18 Favored 'General case' 0 C--N 1.299 -1.614 0 CA-C-O 121.882 0.848 . . . . 0.0 111.089 -178.866 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 160' ' ' ASP . . . . . 0.592 ' C ' HG22 ' A' ' 161' ' ' VAL . 5.9 m-20 -119.1 161.51 20.18 Favored 'General case' 0 N--CA 1.49 1.528 0 N-CA-C 108.567 -0.901 . . . . 0.0 108.567 179.349 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 161' ' ' VAL . . . . . 0.592 HG22 ' C ' ' A' ' 160' ' ' ASP . 0.1 OUTLIER -173.13 164.55 0.26 Allowed 'Isoleucine or valine' 0 N--CA 1.501 2.096 0 O-C-N 121.097 -1.002 . . . . 0.0 109.82 179.463 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 162' ' ' LYS . . . . . 0.515 ' O ' ' O ' ' A' ' 161' ' ' VAL . 0.1 OUTLIER -42.83 168.1 0.06 OUTLIER Pre-proline 0 N--CA 1.491 1.603 0 O-C-N 121.152 -0.968 . . . . 0.0 109.062 179.121 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 163' ' ' PRO . . . . . 0.754 ' O ' HD11 ' C' ' 702' ' ' LEU . 57.4 Cg_endo -74.86 -20.41 17.24 Favored 'Trans proline' 0 C--N 1.306 -1.708 0 C-N-CA 122.697 2.264 . . . . 0.0 112.899 -179.294 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 164' ' ' THR . . . . . 0.416 ' O ' HG13 ' A' ' 166' ' ' VAL . 1.1 p -90.87 -3.1 57.61 Favored 'General case' 0 C--N 1.297 -1.688 0 O-C-N 120.48 -1.387 . . . . 0.0 109.995 -179.644 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 165' ' ' ASP . . . . . . . . . . . . . 11.4 t70 -71.89 58.47 0.34 Allowed 'General case' 0 N--CA 1.491 1.622 0 O-C-N 120.856 -1.153 . . . . 0.0 109.709 -179.543 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 166' ' ' VAL . . . . . 0.551 ' O ' ' N ' ' A' ' 168' ' ' VAL . 1.5 m -44.25 -32.34 0.77 Allowed 'Isoleucine or valine' 0 C--N 1.297 -1.707 0 O-C-N 121.692 -0.63 . . . . 0.0 109.784 -178.339 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 167' ' ' GLY . . . . . . . . . . . . . . . -43.52 -15.4 0.03 OUTLIER Glycine 0 N--CA 1.496 2.688 0 O-C-N 120.83 -1.169 . . . . 0.0 111.356 -179.517 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 168' ' ' VAL . . . . . 0.551 ' N ' ' O ' ' A' ' 166' ' ' VAL . 2.8 m -54.24 -31.52 22.24 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.605 0 O-C-N 120.581 -1.54 . . . . 0.0 109.082 -179.839 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 169' ' ' LEU . . . . . 0.549 ' O ' ' C ' ' A' ' 170' ' ' ASP . 15.8 mt -48.32 -14.93 0.06 Allowed 'General case' 0 N--CA 1.492 1.64 0 N-CA-C 107.748 -1.204 . . . . 0.0 107.748 -178.713 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 170' ' ' ASP . . . . . 0.549 ' C ' ' O ' ' A' ' 169' ' ' LEU . 9.0 m-20 20.62 91.05 0.01 OUTLIER 'General case' 0 N--CA 1.499 2.002 0 CA-C-N 116.583 -0.28 . . . . 0.0 111.701 177.769 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 171' ' ' GLU . . . . . . . . . . . . . 5.9 pt-20 -137.49 77.21 1.62 Allowed 'General case' 0 N--CA 1.495 1.777 0 O-C-N 120.863 -1.148 . . . . 0.0 110.536 179.782 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 172' ' ' GLN . . . . . 0.623 ' N ' HE22 ' A' ' 113' ' ' GLN . 1.9 pt20 -136.87 -42.32 0.59 Allowed 'General case' 0 N--CA 1.495 1.824 0 O-C-N 121.209 -0.932 . . . . 0.0 110.76 -178.988 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 173' ' ' LYS . . . . . . . . . . . . . 5.8 mttp -63.23 129.29 39.65 Favored 'General case' 0 N--CA 1.497 1.892 0 O-C-N 120.688 -1.258 . . . . 0.0 108.854 179.522 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 174' ' ' GLY . . . . . 0.544 ' O ' ' C ' ' A' ' 175' ' ' LYS . . . -118.78 -41.07 0.62 Allowed Glycine 0 N--CA 1.484 1.896 0 N-CA-C 108.605 -1.798 . . . . 0.0 108.605 179.478 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 175' ' ' LYS . . . . . 0.544 ' C ' ' O ' ' A' ' 174' ' ' GLY . 17.9 mmtp -40.8 -61.85 0.89 Allowed 'General case' 0 N--CA 1.491 1.577 0 N-CA-C 106.503 -1.666 . . . . 0.0 106.503 178.48 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 176' ' ' ASP . . . . . 0.583 ' O ' ' O ' ' A' ' 177' ' ' LYS . 7.0 m-20 -105.07 85.64 2.31 Favored 'General case' 0 C--N 1.296 -1.734 0 N-CA-C 107.332 -1.359 . . . . 0.0 107.332 176.405 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 177' ' ' LYS . . . . . 0.583 ' O ' ' O ' ' A' ' 176' ' ' ASP . 0.0 OUTLIER -46.98 -174.41 0.0 OUTLIER 'General case' 0 N--CA 1.501 2.09 0 O-C-N 121.311 -0.868 . . . . 0.0 109.291 -179.233 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 178' ' ' GLN . . . . . 0.55 ' NE2' ' OD1' ' A' ' 114' ' ' ASN . 20.8 pt20 -162.01 175.13 12.12 Favored 'General case' 0 N--CA 1.488 1.456 0 O-C-N 120.328 -1.483 . . . . 0.0 111.374 -179.884 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 179' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -129.8 93.75 3.58 Favored 'General case' 0 N--CA 1.487 1.403 0 N-CA-C 107.197 -1.408 . . . . 0.0 107.197 177.627 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 180' ' ' THR . . . . . 0.5 HG23 HD13 ' A' ' 199' ' ' ILE . 1.8 m -71.28 118.45 14.09 Favored 'General case' 0 N--CA 1.493 1.704 0 O-C-N 121.11 -0.994 . . . . 0.0 110.424 -178.335 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 181' ' ' LEU . . . . . . . . . . . . . 42.4 tp -94.11 150.5 20.27 Favored 'General case' 0 C--N 1.298 -1.648 0 N-CA-C 107.817 -1.179 . . . . 0.0 107.817 177.81 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 182' ' ' ILE . . . . . 0.422 ' O ' HG22 ' A' ' 182' ' ' ILE . 5.3 mt -141.54 112.89 3.55 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.553 0 O-C-N 121.011 -1.055 . . . . 0.0 108.695 178.717 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 183' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -130.58 111.38 12.18 Favored 'General case' 0 C--N 1.291 -1.953 0 N-CA-C 107.078 -1.453 . . . . 0.0 107.078 178.95 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 184' ' ' CYS . . . . . . . . . . . . . 1.8 p -78.82 159.36 27.88 Favored 'General case' 0 C--N 1.29 -1.98 0 C-N-CA 118.843 -1.143 . . . . 0.0 111.46 -177.345 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 185' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -165.73 -154.88 0.21 Allowed 'General case' 0 N--CA 1.49 1.566 0 N-CA-C 109.102 -0.703 . . . . 0.0 109.102 -179.699 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 186' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER 50.61 52.14 15.47 Favored 'General case' 0 N--CA 1.493 1.695 0 O-C-N 121.124 -0.985 . . . . 0.0 109.12 -179.848 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 187' ' ' TYR . . . . . 0.618 ' CE2' ' O ' ' A' ' 188' ' ' ASN . 54.4 t80 -67.37 136.59 55.01 Favored 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.342 -0.849 . . . . 0.0 110.777 -179.144 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 188' ' ' ASN . . . . . 0.618 ' O ' ' CE2' ' A' ' 187' ' ' TYR . 0.7 OUTLIER -101.56 146.8 27.19 Favored 'General case' 0 C--N 1.298 -1.641 0 N-CA-C 107.777 -1.194 . . . . 0.0 107.777 178.314 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 189' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -113.53 -10.16 13.2 Favored 'General case' 0 C--N 1.297 -1.697 0 N-CA-C 108.496 -0.928 . . . . 0.0 108.496 -179.624 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 190' ' ' LYS . . . . . . . . . . . . . 13.1 mttp -84.03 -53.48 5.52 Favored 'General case' 0 N--CA 1.488 1.459 0 N-CA-C 108.649 -0.871 . . . . 0.0 108.649 178.705 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 191' ' ' THR . . . . . . . . . . . . . 1.1 p -91.26 -8.3 48.75 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.588 -0.695 . . . . 0.0 109.129 179.714 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 192' ' ' GLY . . . . . . . . . . . . . . . 62.58 40.98 99.82 Favored Glycine 0 N--CA 1.492 2.425 0 N-CA-C 110.433 -1.067 . . . . 0.0 110.433 179.219 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 193' ' ' VAL . . . . . 0.489 HG12 ' N ' ' A' ' 194' ' ' TRP . 67.2 t -145.96 157.95 12.1 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.625 0 O-C-N 121.044 -1.268 . . . . 0.0 109.801 179.56 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 194' ' ' TRP . . . . . 0.489 ' N ' HG12 ' A' ' 193' ' ' VAL . 23.0 m95 -83.83 120.79 26.48 Favored 'General case' 0 C--N 1.301 -1.543 0 N-CA-C 108.509 -0.923 . . . . 0.0 108.509 179.627 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 195' ' ' GLU . . . . . . . . . . . . . 2.1 mt-10 -89.73 -60.65 1.88 Allowed 'General case' 0 N--CA 1.495 1.816 0 C-N-CA 119.55 -0.86 . . . . 0.0 111.148 -178.194 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 196' ' ' LYS . . . . . . . . . . . . . 5.1 tttm -80.49 143.23 33.49 Favored 'General case' 0 C--N 1.3 -1.545 0 O-C-N 120.815 -1.178 . . . . 0.0 110.165 -178.901 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 197' ' ' ARG . . . . . 0.565 ' NH1' ' O ' ' C' ' 704' ' ' ALA . 13.5 tpp180 -120.05 138.33 53.59 Favored 'General case' 0 N--CA 1.491 1.617 0 N-CA-C 108.552 -0.907 . . . . 0.0 108.552 179.084 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 198' ' ' LYS . . . . . . . . . . . . . 22.7 mttt -116.97 118.6 32.87 Favored 'General case' 0 C--N 1.302 -1.489 0 O-C-N 121.903 -0.498 . . . . 0.0 109.966 -179.464 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 199' ' ' ILE . . . . . 0.5 HD13 HG23 ' A' ' 180' ' ' THR . 0.6 OUTLIER -139.16 120.32 15.7 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.58 0 CA-C-O 122.505 1.145 . . . . 0.0 109.339 179.532 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 200' ' ' PHE . . . . . 0.884 ' CD2' HD12 ' A' ' 158' ' ' ILE . 3.3 m-85 -99.43 136.71 38.97 Favored 'General case' 0 N--CA 1.496 1.852 0 O-C-N 121.124 -0.985 . . . . 0.0 109.799 -178.074 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 201' ' ' VAL . . . . . . . . . . . . . 97.7 t -101.58 137.16 30.25 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.555 0 N-CA-C 108.004 -1.11 . . . . 0.0 108.004 177.652 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 202' ' ' ALA . . . . . 0.417 ' HB1' ' HB3' ' A' ' 153' ' ' TYR . . . -121.56 134.91 55.03 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.376 -0.828 . . . . 0.0 108.821 179.831 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 203' ' ' THR . . . . . 0.748 HG23 ' OG1' ' A' ' 156' ' ' THR . 2.1 p -88.1 130.36 35.04 Favored 'General case' 0 C--N 1.306 -1.288 0 CA-C-O 122.198 0.999 . . . . 0.0 110.652 -178.782 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 204' ' ' GLU . . . . . 0.507 ' HA ' ' CD2' ' A' ' 153' ' ' TYR . 0.2 OUTLIER -50.9 134.62 25.46 Favored 'General case' 0 C--N 1.298 -1.67 0 C-N-CA 118.688 -1.205 . . . . 0.0 108.673 178.933 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 205' ' ' VAL . . . . . 0.646 HG23 ' O ' ' A' ' 203' ' ' THR . 54.6 t -129.7 164.29 32.74 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.376 0 CA-C-O 121.93 0.872 . . . . 0.0 110.228 -177.741 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 206' ' ' LYS . . . . . 0.57 ' N ' HG12 ' A' ' 205' ' ' VAL . 0.5 OUTLIER . . . . . 0 C--N 1.297 -1.706 0 CA-C-O 118.006 -0.997 . . . . 0.0 109.559 -179.804 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' C' C ' 702' ' ' LEU . . . . . 0.754 HD11 ' O ' ' A' ' 163' ' ' PRO . 0.3 OUTLIER . . . . . 0 N--CA 1.493 1.714 0 N-CA-C 109.441 -0.577 . . . . 0.0 109.441 . . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' C' C ' 703' ' ' PRO . . . . . 0.597 ' HG3' ' HB1' ' A' ' 104' ' ' ALA . 40.5 Cg_endo -70.96 -179.29 3.33 Favored 'Trans proline' 0 C--N 1.31 -1.496 0 C-N-CA 122.796 2.331 . . . . 0.0 112.97 -179.691 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' C' C ' 704' ' ' ALA . . . . . 0.565 ' O ' ' NH1' ' A' ' 197' ' ' ARG . . . . . . . . 0 N--CA 1.49 1.567 0 CA-C-O 121.561 0.696 . . . . 0.0 110.168 179.809 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 63' ' ' PRO . . . . . 0.453 ' O ' HD22 ' A' ' 110' ' ' LEU . 5.6 Cg_exo . . . . . 0 N--CA 1.489 1.218 0 CA-C-O 121.065 0.36 . . . . 0.0 111.283 . . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 64' ' ' GLN . . . . . 0.631 ' O ' ' NE2' ' A' ' 64' ' ' GLN . 0.0 OUTLIER -155.26 127.44 7.7 Favored 'General case' 0 N--CA 1.494 1.77 0 O-C-N 121.054 -1.029 . . . . 0.0 110.315 179.81 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 65' ' ' ILE . . . . . 0.564 HD12 ' H ' ' A' ' 65' ' ' ILE . 2.1 mp -45.76 105.94 0.51 Allowed Pre-proline 0 N--CA 1.491 1.598 0 N-CA-C 107.857 -1.164 . . . . 0.0 107.857 178.471 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 66' ' ' PRO . . . . . . . . . . . . . 60.2 Cg_endo -81.94 -162.71 0.19 Allowed 'Trans proline' 0 N--CA 1.49 1.272 0 C-N-CA 122.105 1.87 . . . . 0.0 112.639 -178.785 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 67' ' ' LYS . . . . . . . . . . . . . 53.8 tttt -90.46 -8.04 51.5 Favored 'General case' 0 N--CA 1.487 1.405 0 O-C-N 121.223 -0.923 . . . . 0.0 109.727 -179.722 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 68' ' ' ASP . . . . . 0.646 ' O ' ' N ' ' A' ' 70' ' ' SER . 0.2 OUTLIER -75.86 66.14 2.07 Favored 'General case' 0 N--CA 1.487 1.421 0 CA-C-O 123.003 1.383 . . . . 0.0 108.896 179.839 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 69' ' ' LYS . . . . . 0.468 ' C ' ' O ' ' A' ' 68' ' ' ASP . 0.8 OUTLIER -45.77 -14.71 0.02 OUTLIER 'General case' 0 N--CA 1.511 2.579 0 C-N-CA 117.129 -1.828 . . . . 0.0 107.368 178.06 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 70' ' ' SER . . . . . 0.646 ' N ' ' O ' ' A' ' 68' ' ' ASP . 0.1 OUTLIER -87.58 -5.0 58.95 Favored 'General case' 0 N--CA 1.498 1.93 0 CA-C-N 113.615 -1.63 . . . . 0.0 111.9 179.893 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 71' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -100.56 142.65 31.74 Favored 'General case' 0 N--CA 1.503 2.221 0 O-C-N 120.251 -1.531 . . . . 0.0 112.615 -178.991 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 72' ' ' VAL . . . . . 0.587 ' CG2' ' O ' ' A' ' 74' ' ' GLY . 0.7 OUTLIER -67.72 127.13 28.85 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.336 0 N-CA-C 105.196 -2.149 . . . . 0.0 105.196 174.786 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 73' ' ' ALA . . . . . 0.569 ' N ' ' O ' ' A' ' 87' ' ' VAL . . . -80.33 -12.4 59.6 Favored 'General case' 0 C--N 1.297 -1.712 0 O-C-N 120.195 -1.566 . . . . 0.0 109.126 -178.309 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 74' ' ' GLY . . . . . 0.587 ' O ' ' CG2' ' A' ' 72' ' ' VAL . . . 173.53 -161.12 31.72 Favored Glycine 0 N--CA 1.488 2.13 0 N-CA-C 109.614 -1.394 . . . . 0.0 109.614 -179.849 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 75' ' ' TYR . . . . . . . . . . . . . 76.1 m-85 -142.27 170.16 16.23 Favored 'General case' 0 C--N 1.296 -1.747 0 O-C-N 121.076 -1.249 . . . . 0.0 110.767 -178.136 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 76' ' ' ILE . . . . . 0.468 ' CG2' ' OE1' ' A' ' 85' ' ' GLU . 0.4 OUTLIER -148.97 144.26 18.38 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.57 0 C-N-CA 119.422 -0.911 . . . . 0.0 108.994 -177.464 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -152.04 160.35 43.47 Favored 'General case' 0 N--CA 1.492 1.648 0 O-C-N 120.893 -1.129 . . . . 0.0 109.504 -179.855 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 78' ' ' ILE . . . . . 0.495 ' CG1' HG22 ' A' ' 142' ' ' VAL . 3.0 mp -143.16 99.08 5.47 Favored Pre-proline 0 N--CA 1.493 1.695 0 N-CA-C 107.929 -1.137 . . . . 0.0 107.929 179.303 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 79' ' ' PRO . . . . . . . . . . . . . 47.4 Cg_exo -51.06 -44.62 41.29 Favored 'Trans proline' 0 N--CA 1.492 1.425 0 C-N-CA 122.557 2.171 . . . . 0.0 113.808 -178.81 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -65.62 -18.05 65.04 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 120.691 -1.256 . . . . 0.0 110.752 178.741 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 81' ' ' ALA . . . . . 0.804 ' HB2' ' HB2' ' A' ' 136' ' ' ALA . . . -106.41 -19.04 13.81 Favored 'General case' 0 N--CA 1.494 1.774 0 O-C-N 121.136 -0.978 . . . . 0.0 108.886 179.746 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 82' ' ' ASP . . . . . 0.426 ' CB ' ' O ' ' A' ' 81' ' ' ALA . 11.6 t0 70.44 49.02 0.44 Allowed 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.475 -0.765 . . . . 0.0 110.767 179.106 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 83' ' ' ILE . . . . . 0.546 HD11 ' HB3' ' A' ' 132' ' ' ASN . 36.2 mt -131.1 152.74 38.01 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.822 0 O-C-N 121.145 -0.972 . . . . 0.0 110.275 -179.047 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 84' ' ' LYS . . . . . . . . . . . . . 9.3 ptmm? -157.7 110.22 2.4 Favored 'General case' 0 N--CA 1.489 1.491 0 N-CA-C 108.244 -1.021 . . . . 0.0 108.244 179.471 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 85' ' ' GLU . . . . . 0.47 ' N ' ' CD ' ' A' ' 85' ' ' GLU . 0.4 OUTLIER -138.32 167.74 18.68 Favored Pre-proline 0 N--CA 1.498 1.949 0 O-C-N 121.113 -0.992 . . . . 0.0 109.805 -178.973 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 86' ' ' PRO . . . . . . . . . . . . . 97.3 Cg_endo -82.99 158.89 15.64 Favored 'Trans proline' 0 N--CA 1.494 1.54 0 C-N-CA 122.944 2.429 . . . . 0.0 113.568 -179.184 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 87' ' ' VAL . . . . . 0.569 ' O ' ' N ' ' A' ' 73' ' ' ALA . 78.6 t -112.04 106.36 20.61 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.698 0 N-CA-C 109.319 -0.622 . . . . 0.0 109.319 180.0 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 88' ' ' TYR . . . . . 0.404 ' CZ ' ' HB3' ' A' ' 99' ' ' ARG . 10.5 m-85 -97.45 153.94 38.18 Favored Pre-proline 0 N--CA 1.5 2.057 0 O-C-N 120.766 -1.209 . . . . 0.0 109.607 179.582 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 89' ' ' PRO . . . . . . . . . . . . . 11.4 Cg_endo -58.78 141.94 98.35 Favored 'Trans proline' 0 N--CA 1.497 1.705 0 C-N-CA 122.954 2.436 . . . . 0.0 113.424 -179.923 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . -59.17 169.19 6.23 Favored Glycine 0 N--CA 1.496 2.667 0 N-CA-C 109.259 -1.537 . . . . 0.0 109.259 179.209 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 91' ' ' PRO . . . . . 0.469 ' C ' ' H ' ' A' ' 93' ' ' THR . 94.3 Cg_endo -93.09 168.92 21.57 Favored 'Cis proline' 0 C--N 1.31 -1.489 0 C-N-CA 123.861 -1.308 . . . . 0.0 111.994 0.239 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 92' ' ' ALA . . . . . 0.645 ' O ' HD23 ' A' ' 97' ' ' LEU . . . -70.86 29.76 0.04 OUTLIER 'General case' 0 N--CA 1.492 1.662 0 O-C-N 121.166 -0.959 . . . . 0.0 110.6 -179.489 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 93' ' ' THR . . . . . 0.469 ' H ' ' C ' ' A' ' 91' ' ' PRO . 6.5 p -72.42 150.79 91.74 Favored Pre-proline 0 C--N 1.302 -1.485 0 O-C-N 120.688 -1.257 . . . . 0.0 108.4 179.836 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 94' ' ' PRO . . . . . 0.427 ' C ' ' O ' ' A' ' 93' ' ' THR . 70.2 Cg_exo -30.46 -57.15 0.19 Allowed 'Trans proline' 0 C--N 1.309 -1.506 0 C-N-CA 122.973 2.448 . . . . 0.0 112.743 -179.144 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 16.3 mt-10 -44.56 -49.31 10.16 Favored 'General case' 0 C--N 1.302 -1.466 0 O-C-N 121.175 -0.953 . . . . 0.0 109.863 -179.931 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 96' ' ' GLN . . . . . 0.566 ' O ' ' N ' ' A' ' 98' ' ' ASN . 1.4 mp0 -73.15 -54.15 9.19 Favored 'General case' 0 N--CA 1.488 1.47 0 O-C-N 121.081 -1.012 . . . . 0.0 109.912 179.782 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 97' ' ' LEU . . . . . 0.645 HD23 ' O ' ' A' ' 92' ' ' ALA . 0.7 OUTLIER -44.11 -14.42 0.02 OUTLIER 'General case' 0 N--CA 1.494 1.732 0 O-C-N 121.453 -0.779 . . . . 0.0 110.29 -179.216 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 98' ' ' ASN . . . . . 0.689 ' ND2' ' NE ' ' A' ' 99' ' ' ARG . 0.0 OUTLIER -71.53 -33.53 69.26 Favored 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.052 -1.03 . . . . 0.0 108.599 179.327 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 99' ' ' ARG . . . . . 0.689 ' NE ' ' ND2' ' A' ' 98' ' ' ASN . 16.4 mmt180 -79.64 -58.39 3.21 Favored 'General case' 0 C--N 1.303 -1.442 0 O-C-N 121.688 -0.633 . . . . 0.0 109.565 -179.725 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . 174.08 -156.17 23.03 Favored Glycine 0 N--CA 1.492 2.422 0 N-CA-C 109.989 -1.245 . . . . 0.0 109.989 179.967 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 101' ' ' VAL . . . . . 0.639 ' O ' HG23 ' A' ' 101' ' ' VAL . 27.3 m -59.44 103.18 0.14 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.674 0 O-C-N 121.256 -1.144 . . . . 0.0 109.754 -179.908 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -91.63 166.19 12.94 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.032 -1.043 . . . . 0.0 109.953 -179.992 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 103' ' ' PHE . . . . . 0.597 ' O ' ' N ' ' A' ' 105' ' ' GLU . 26.0 m-85 -70.22 120.86 16.54 Favored 'General case' 0 N--CA 1.486 1.352 0 N-CA-C 107.969 -1.123 . . . . 0.0 107.969 178.639 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 104' ' ' ALA . . . . . 0.576 ' HB1' ' HG3' ' C' ' 703' ' ' PRO . . . -42.94 -14.54 0.01 OUTLIER 'General case' 0 C--N 1.3 -1.546 0 O-C-N 121.488 -0.757 . . . . 0.0 110.696 -178.729 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 105' ' ' GLU . . . . . 0.597 ' N ' ' O ' ' A' ' 103' ' ' PHE . 0.1 OUTLIER -138.85 146.61 41.44 Favored 'General case' 0 N--CA 1.496 1.86 0 O-C-N 120.828 -1.17 . . . . 0.0 110.762 -179.797 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 106' ' ' GLU . . . . . 0.412 ' HG2' ' H ' ' A' ' 107' ' ' ASN . 0.0 OUTLIER -59.59 -61.72 2.41 Favored 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.929 -0.482 . . . . 0.0 111.523 -179.178 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 107' ' ' ASN . . . . . 0.412 ' H ' ' HG2' ' A' ' 106' ' ' GLU . 17.1 m120 -77.65 34.35 0.18 Allowed 'General case' 0 N--CA 1.493 1.707 0 O-C-N 120.428 -1.42 . . . . 0.0 112.862 -175.553 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 108' ' ' GLU . . . . . . . . . . . . . 14.6 tp10 -57.43 146.73 28.49 Favored 'General case' 0 C--N 1.301 -1.508 0 O-C-N 120.698 -1.252 . . . . 0.0 107.937 179.622 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 109' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -102.26 146.72 27.6 Favored 'General case' 0 N--CA 1.488 1.453 0 O-C-N 121.124 -0.985 . . . . 0.0 111.133 -178.198 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 110' ' ' LEU . . . . . 0.453 HD22 ' O ' ' A' ' 63' ' ' PRO . 3.0 tp -62.81 -18.87 63.43 Favored 'General case' 0 C--N 1.303 -1.421 0 N-CA-C 108.028 -1.101 . . . . 0.0 108.028 178.783 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 111' ' ' ASP . . . . . 0.439 ' OD1' ' C ' ' A' ' 110' ' ' LEU . 4.0 m-20 -132.69 42.45 3.08 Favored 'General case' 0 N--CA 1.487 1.383 0 O-C-N 121.637 -0.664 . . . . 0.0 109.84 -179.849 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 112' ' ' ASP . . . . . . . . . . . . . 4.5 t0 -68.15 157.45 35.32 Favored 'General case' 0 N--CA 1.492 1.668 0 O-C-N 120.858 -1.151 . . . . 0.0 111.386 -179.725 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 113' ' ' GLN . . . . . 0.543 ' N ' ' CD ' ' A' ' 113' ' ' GLN . 0.0 OUTLIER -66.58 -16.07 63.9 Favored 'General case' 0 N--CA 1.494 1.742 0 N-CA-C 108.229 -1.026 . . . . 0.0 108.229 177.934 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 114' ' ' ASN . . . . . 0.64 ' ND2' HE21 ' A' ' 178' ' ' GLN . 34.6 t-20 -153.0 113.81 4.11 Favored 'General case' 0 C--N 1.295 -1.781 0 N-CA-C 107.58 -1.266 . . . . 0.0 107.58 177.141 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 115' ' ' ILE . . . . . 0.555 HG22 ' O ' ' A' ' 115' ' ' ILE . 3.8 mt -91.41 98.95 8.96 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.69 0 N-CA-C 107.232 -1.396 . . . . 0.0 107.232 179.588 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 116' ' ' SER . . . . . 0.43 ' OG ' ' HB3' ' A' ' 104' ' ' ALA . 87.6 p -86.44 149.03 25.28 Favored 'General case' 0 N--CA 1.488 1.437 0 CA-C-O 121.864 0.84 . . . . 0.0 111.22 -177.528 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 117' ' ' ILE . . . . . . . . . . . . . 1.7 mt -149.71 149.54 14.56 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.483 0 N-CA-C 107.813 -1.18 . . . . 0.0 107.813 179.112 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 118' ' ' ALA . . . . . . . . . . . . . . . -136.26 159.35 42.02 Favored 'General case' 0 N--CA 1.493 1.686 0 C-N-CA 119.277 -0.969 . . . . 0.0 110.903 -179.018 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 119' ' ' GLY . . . . . 0.516 ' HA2' HD11 ' A' ' 97' ' ' LEU . . . -172.01 146.76 9.54 Favored Glycine 0 N--CA 1.489 2.179 0 N-CA-C 110.482 -1.047 . . . . 0.0 110.482 179.94 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 120' ' ' HIS . . . . . . . . . . . . . 27.7 m170 -71.89 168.0 18.85 Favored 'General case' 0 N--CA 1.494 1.758 0 O-C-N 121.531 -0.981 . . . . 0.0 110.157 179.291 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 121' ' ' THR . . . . . 0.457 ' OG1' ' NZ ' ' A' ' 134' ' ' LYS . 0.7 OUTLIER -118.5 160.06 22.41 Favored 'General case' 0 N--CA 1.498 1.958 0 N-CA-C 108.357 -0.979 . . . . 0.0 108.357 178.818 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 122' ' ' PHE . . . . . . . . . . . . . 2.7 m-85 -143.59 123.35 13.39 Favored 'General case' 0 N--CA 1.498 1.951 0 O-C-N 120.838 -1.164 . . . . 0.0 109.812 -179.766 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 123' ' ' ILE . . . . . 0.563 HG23 ' N ' ' A' ' 124' ' ' ASP . 14.3 tt -59.18 -40.24 80.59 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.478 0 CA-C-O 121.545 0.688 . . . . 0.0 109.516 179.89 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 124' ' ' ASP . . . . . 0.563 ' N ' HG23 ' A' ' 123' ' ' ILE . 1.7 m-20 -88.92 22.62 2.64 Favored 'General case' 0 N--CA 1.497 1.912 0 O-C-N 121.492 -0.755 . . . . 0.0 111.942 -177.42 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 125' ' ' ARG . . . . . . . . . . . . . 37.9 mtp180 -154.47 99.75 2.45 Favored Pre-proline 0 N--CA 1.493 1.703 0 O-C-N 120.366 -1.459 . . . . 0.0 110.112 -179.862 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 126' ' ' PRO . . . . . . . . . . . . . 56.1 Cg_endo -80.02 -27.94 3.47 Favored 'Trans proline' 0 C--N 1.313 -1.328 0 C-N-CA 121.98 1.787 . . . . 0.0 111.635 179.266 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 127' ' ' ASN . . . . . . . . . . . . . 2.9 m120 -89.09 11.77 17.54 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.047 -1.033 . . . . 0.0 109.227 179.64 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 128' ' ' TYR . . . . . . . . . . . . . 5.1 t80 -65.58 -149.47 0.01 OUTLIER 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.388 -0.82 . . . . 0.0 109.425 179.908 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 129' ' ' GLN . . . . . 0.433 HE22 ' CD1' ' A' ' 97' ' ' LEU . 69.5 mt-30 -68.05 -70.95 0.23 Allowed 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.315 -0.866 . . . . 0.0 109.857 -179.787 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 130' ' ' PHE . . . . . 0.701 ' CE1' HD11 ' A' ' 181' ' ' LEU . 47.6 m-85 -134.88 52.62 2.03 Favored 'General case' 0 N--CA 1.493 1.71 0 O-C-N 121.104 -0.998 . . . . 0.0 110.303 -179.857 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 131' ' ' THR . . . . . . . . . . . . . 23.1 m -87.33 -39.69 15.12 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 120.903 -1.123 . . . . 0.0 109.396 179.681 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 132' ' ' ASN . . . . . 0.585 ' ND2' ' O ' ' A' ' 81' ' ' ALA . 1.8 t30 -82.86 6.32 18.79 Favored 'General case' 0 N--CA 1.498 1.938 0 O-C-N 121.505 -0.747 . . . . 0.0 111.701 -178.306 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 133' ' ' LEU . . . . . 0.503 ' O ' ' N ' ' A' ' 135' ' ' ALA . 0.2 OUTLIER -71.17 -45.54 63.28 Favored 'General case' 0 C--N 1.299 -1.616 0 O-C-N 120.739 -1.226 . . . . 0.0 109.999 -179.368 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 134' ' ' LYS . . . . . 0.652 ' CD ' ' H ' ' A' ' 134' ' ' LYS . 0.0 OUTLIER -46.12 -16.96 0.03 OUTLIER 'General case' 0 N--CA 1.494 1.749 0 O-C-N 120.988 -1.07 . . . . 0.0 109.727 -179.802 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 135' ' ' ALA . . . . . 0.503 ' N ' ' O ' ' A' ' 133' ' ' LEU . . . -84.08 -37.53 21.93 Favored 'General case' 0 N--CA 1.487 1.403 0 O-C-N 121.111 -0.993 . . . . 0.0 109.077 179.471 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 136' ' ' ALA . . . . . 0.804 ' HB2' ' HB2' ' A' ' 81' ' ' ALA . . . -79.76 157.96 26.99 Favored 'General case' 0 C--N 1.303 -1.454 0 CA-C-O 121.976 0.894 . . . . 0.0 110.984 -179.132 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 137' ' ' LYS . . . . . 0.542 ' O ' ' O ' ' A' ' 138' ' ' LYS . 2.4 mttm -150.84 -163.52 1.79 Allowed 'General case' 0 C--N 1.299 -1.628 0 C-N-CA 118.106 -1.438 . . . . 0.0 110.965 -177.902 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 138' ' ' LYS . . . . . 0.585 ' O ' ' N ' ' A' ' 140' ' ' SER . 28.8 mttp -41.18 174.17 0.0 OUTLIER 'General case' 0 C--N 1.301 -1.523 0 CA-C-O 122.589 1.185 . . . . 0.0 111.171 -178.557 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 139' ' ' GLY . . . . . . . . . . . . . . . 47.13 8.25 0.03 OUTLIER Glycine 0 N--CA 1.488 2.148 0 N-CA-C 110.162 -1.175 . . . . 0.0 110.162 -179.971 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 140' ' ' SER . . . . . 0.585 ' N ' ' O ' ' A' ' 138' ' ' LYS . 5.2 m -75.87 112.98 12.83 Favored 'General case' 0 N--CA 1.493 1.723 0 O-C-N 120.867 -1.372 . . . . 0.0 108.982 179.385 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 141' ' ' MET . . . . . 0.659 ' SD ' ' N ' ' A' ' 142' ' ' VAL . 3.0 tpp -68.26 128.02 35.06 Favored 'General case' 0 C--N 1.301 -1.503 0 O-C-N 121.036 -1.04 . . . . 0.0 109.178 179.854 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 142' ' ' VAL . . . . . 0.659 ' N ' ' SD ' ' A' ' 141' ' ' MET . 1.6 t -113.87 133.29 60.33 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.522 0 N-CA-C 108.456 -0.942 . . . . 0.0 108.456 -179.736 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 143' ' ' TYR . . . . . . . . . . . . . 13.4 m-85 -112.31 135.83 52.51 Favored 'General case' 0 N--CA 1.495 1.798 0 O-C-N 120.869 -1.145 . . . . 0.0 110.703 -178.899 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 144' ' ' PHE . . . . . 0.561 ' CZ ' ' CG1' ' A' ' 146' ' ' VAL . 4.2 t80 -120.96 105.88 11.08 Favored 'General case' 0 N--CA 1.493 1.707 0 C-N-CA 120.143 -0.623 . . . . 0.0 109.985 -179.467 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 145' ' ' LYS . . . . . . . . . . . . . 13.9 mtpp -102.3 122.76 44.86 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.23 -0.919 . . . . 0.0 109.819 -179.863 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 146' ' ' VAL . . . . . 0.561 ' CG1' ' CZ ' ' A' ' 144' ' ' PHE . 0.9 OUTLIER -142.65 125.4 13.74 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.629 0 N-CA-C 108.335 -0.987 . . . . 0.0 108.335 178.874 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 147' ' ' GLY . . . . . . . . . . . . . . . 60.47 -125.6 39.0 Favored Glycine 0 N--CA 1.489 2.225 0 N-CA-C 109.054 -1.618 . . . . 0.0 109.054 -179.426 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 148' ' ' ASN . . . . . 0.592 ' C ' ' ND2' ' A' ' 148' ' ' ASN . 0.0 OUTLIER -104.77 5.97 33.68 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.245 -1.15 . . . . 0.0 108.979 179.623 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 149' ' ' GLU . . . . . . . . . . . . . 1.3 tt0 -105.82 141.65 36.89 Favored 'General case' 0 N--CA 1.488 1.461 0 O-C-N 121.295 -0.878 . . . . 0.0 111.797 -178.32 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 150' ' ' THR . . . . . . . . . . . . . 3.5 m -131.93 98.47 4.46 Favored 'General case' 0 N--CA 1.493 1.709 0 CA-C-O 121.482 0.658 . . . . 0.0 109.271 -179.862 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 151' ' ' ARG . . . . . 0.427 HH12 ' HA ' ' A' ' 111' ' ' ASP . 92.6 mtt180 -85.7 -169.36 2.61 Favored 'General case' 0 N--CA 1.488 1.425 0 O-C-N 121.255 -0.903 . . . . 0.0 108.894 -179.711 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 152' ' ' LYS . . . . . 0.476 ' O ' ' N ' ' A' ' 205' ' ' VAL . 1.9 mtmp? -152.02 149.87 29.35 Favored 'General case' 0 C--N 1.301 -1.537 0 O-C-N 121.261 -0.899 . . . . 0.0 109.982 -179.309 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 153' ' ' TYR . . . . . 0.499 ' CD2' ' HA ' ' A' ' 204' ' ' GLU . 5.7 m-85 -143.86 168.51 19.78 Favored 'General case' 0 C--N 1.303 -1.417 0 N-CA-C 107.939 -1.134 . . . . 0.0 107.939 178.494 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 154' ' ' LYS . . . . . . . . . . . . . 1.4 ttpt -143.36 119.82 10.99 Favored 'General case' 0 C--N 1.295 -1.772 0 N-CA-C 108.403 -0.962 . . . . 0.0 108.403 178.689 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 155' ' ' MET . . . . . . . . . . . . . 46.5 mtp -46.3 107.68 0.11 Allowed 'General case' 0 N--CA 1.495 1.784 0 O-C-N 120.637 -1.289 . . . . 0.0 111.564 -178.602 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 156' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -106.4 -25.44 11.89 Favored 'General case' 0 C--N 1.294 -1.844 0 CA-C-N 115.249 -0.887 . . . . 0.0 110.633 -178.739 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 157' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -153.94 153.72 32.52 Favored 'General case' 0 N--CA 1.495 1.813 0 C-N-CA 118.559 -1.256 . . . . 0.0 111.431 -178.512 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 158' ' ' ILE . . . . . 0.633 HD12 ' CD1' ' A' ' 200' ' ' PHE . 0.2 OUTLIER -153.79 146.83 14.15 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.372 0 CA-C-O 122.067 0.937 . . . . 0.0 110.91 -179.76 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 159' ' ' ARG . . . . . . . . . . . . . 12.9 ttm180 -153.66 153.44 32.3 Favored 'General case' 0 C--N 1.296 -1.718 0 CA-C-O 121.642 0.734 . . . . 0.0 109.681 -179.894 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 160' ' ' ASP . . . . . 0.773 ' O ' HG13 ' A' ' 161' ' ' VAL . 0.3 OUTLIER -116.18 160.55 20.23 Favored 'General case' 0 C--N 1.301 -1.513 0 N-CA-C 107.895 -1.15 . . . . 0.0 107.895 179.428 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 161' ' ' VAL . . . . . 0.773 HG13 ' O ' ' A' ' 160' ' ' ASP . 1.6 m -165.35 159.34 1.14 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.7 0 O-C-N 120.881 -1.137 . . . . 0.0 110.54 -179.271 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 162' ' ' LYS . . . . . 0.497 ' O ' ' O ' ' A' ' 161' ' ' VAL . 0.0 OUTLIER -43.96 171.5 0.04 OUTLIER Pre-proline 0 N--CA 1.49 1.538 0 O-C-N 121.789 -0.569 . . . . 0.0 109.558 179.568 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 163' ' ' PRO . . . . . 0.503 ' C ' HD11 ' C' ' 702' ' ' LEU . 74.0 Cg_endo -81.47 37.32 0.67 Allowed 'Trans proline' 0 C--N 1.311 -1.431 0 C-N-CA 122.557 2.171 . . . . 0.0 112.107 179.891 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 164' ' ' THR . . . . . 0.607 ' N ' HD11 ' C' ' 702' ' ' LEU . 86.7 m -152.12 -5.65 0.23 Allowed 'General case' 0 N--CA 1.494 1.76 0 O-C-N 121.216 -0.927 . . . . 0.0 110.736 -179.446 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 165' ' ' ASP . . . . . . . . . . . . . 31.0 t70 -72.86 62.72 0.61 Allowed 'General case' 0 N--CA 1.496 1.834 0 O-C-N 120.796 -1.19 . . . . 0.0 110.169 -179.435 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 166' ' ' VAL . . . . . 0.608 ' O ' ' N ' ' A' ' 168' ' ' VAL . 2.8 t -45.68 -34.01 1.58 Allowed 'Isoleucine or valine' 0 N--CA 1.494 1.763 0 O-C-N 121.099 -1.001 . . . . 0.0 110.247 -178.534 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 167' ' ' GLY . . . . . 0.402 ' C ' ' O ' ' A' ' 166' ' ' VAL . . . -43.46 -12.81 0.01 OUTLIER Glycine 0 N--CA 1.496 2.672 0 O-C-N 120.785 -1.197 . . . . 0.0 110.994 -179.495 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 168' ' ' VAL . . . . . 0.608 ' N ' ' O ' ' A' ' 166' ' ' VAL . 5.3 m -53.97 -30.94 20.36 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.51 0 O-C-N 120.588 -1.537 . . . . 0.0 109.005 179.802 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 169' ' ' LEU . . . . . 0.545 ' O ' ' ND2' ' A' ' 114' ' ' ASN . 13.1 mt -49.04 -11.51 0.04 OUTLIER 'General case' 0 N--CA 1.489 1.519 0 N-CA-C 107.974 -1.121 . . . . 0.0 107.974 -178.535 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 170' ' ' ASP . . . . . 0.614 ' O ' ' ND2' ' A' ' 114' ' ' ASN . 2.2 m-20 19.88 77.21 0.01 OUTLIER 'General case' 0 N--CA 1.5 2.03 0 N-CA-C 112.21 0.448 . . . . 0.0 112.21 177.517 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 171' ' ' GLU . . . . . 0.572 ' N ' ' OE1' ' A' ' 172' ' ' GLN . 9.9 pt-20 -116.51 66.44 0.71 Allowed 'General case' 0 N--CA 1.498 1.957 0 O-C-N 120.922 -1.111 . . . . 0.0 109.499 179.495 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 172' ' ' GLN . . . . . 0.572 ' OE1' ' N ' ' A' ' 171' ' ' GLU . 2.5 mp0 -121.35 -57.28 1.85 Allowed 'General case' 0 N--CA 1.496 1.846 0 O-C-N 121.532 -0.73 . . . . 0.0 110.7 -178.697 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 173' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -58.92 127.0 30.0 Favored 'General case' 0 N--CA 1.494 1.739 0 O-C-N 121.017 -1.052 . . . . 0.0 109.301 -179.687 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 174' ' ' GLY . . . . . 0.498 ' O ' ' C ' ' A' ' 175' ' ' LYS . . . -118.55 -43.0 0.56 Allowed Glycine 0 N--CA 1.482 1.742 0 N-CA-C 108.625 -1.79 . . . . 0.0 108.625 179.835 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 175' ' ' LYS . . . . . 0.498 ' C ' ' O ' ' A' ' 174' ' ' GLY . 0.0 OUTLIER -40.42 -60.03 1.19 Allowed 'General case' 0 N--CA 1.494 1.742 0 N-CA-C 107.324 -1.361 . . . . 0.0 107.324 179.538 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 176' ' ' ASP . . . . . 0.601 ' O ' ' O ' ' A' ' 177' ' ' LYS . 11.4 m-20 -103.72 90.31 3.61 Favored 'General case' 0 C--N 1.292 -1.912 0 N-CA-C 106.792 -1.558 . . . . 0.0 106.792 176.896 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 177' ' ' LYS . . . . . 0.601 ' O ' ' O ' ' A' ' 176' ' ' ASP . 8.3 mtmt -45.28 -176.31 0.0 OUTLIER 'General case' 0 N--CA 1.492 1.641 0 N-CA-C 109.009 -0.737 . . . . 0.0 109.009 -179.161 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 178' ' ' GLN . . . . . 0.64 HE21 ' ND2' ' A' ' 114' ' ' ASN . 16.5 pt20 -161.77 175.84 11.53 Favored 'General case' 0 C--N 1.3 -1.557 0 O-C-N 120.37 -1.456 . . . . 0.0 110.511 179.322 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 179' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -132.51 98.96 4.5 Favored 'General case' 0 C--N 1.301 -1.503 0 N-CA-C 107.604 -1.258 . . . . 0.0 107.604 178.228 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 180' ' ' THR . . . . . 0.571 ' CB ' HD21 ' A' ' 114' ' ' ASN . 1.3 m -77.26 117.42 18.76 Favored 'General case' 0 N--CA 1.489 1.486 0 O-C-N 121.217 -0.927 . . . . 0.0 110.127 -178.628 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 181' ' ' LEU . . . . . 0.763 HD22 ' CE2' ' A' ' 200' ' ' PHE . 9.4 tt -92.76 147.05 23.18 Favored 'General case' 0 C--N 1.302 -1.463 0 N-CA-C 107.851 -1.166 . . . . 0.0 107.851 177.826 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 182' ' ' ILE . . . . . 0.614 ' N ' HD23 ' A' ' 181' ' ' LEU . 6.4 mt -138.39 109.05 5.0 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.643 0 N-CA-C 108.262 -1.014 . . . . 0.0 108.262 179.088 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 183' ' ' THR . . . . . 0.541 HG23 ' O ' ' A' ' 183' ' ' THR . 7.1 t -132.1 115.65 16.02 Favored 'General case' 0 C--N 1.29 -2.007 0 N-CA-C 107.921 -1.14 . . . . 0.0 107.921 179.509 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 184' ' ' CYS . . . . . . . . . . . . . 1.1 p -78.54 160.46 27.62 Favored 'General case' 0 C--N 1.288 -2.076 0 C-N-CA 119.441 -0.904 . . . . 0.0 110.996 -178.021 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 185' ' ' ASP . . . . . 0.53 ' CG ' ' N ' ' A' ' 186' ' ' ASP . 0.1 OUTLIER -166.93 -163.58 0.56 Allowed 'General case' 0 N--CA 1.49 1.53 0 N-CA-C 109.109 -0.7 . . . . 0.0 109.109 179.816 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 186' ' ' ASP . . . . . 0.53 ' N ' ' CG ' ' A' ' 185' ' ' ASP . 0.6 OUTLIER 55.95 54.3 8.2 Favored 'General case' 0 N--CA 1.496 1.828 0 O-C-N 121.126 -0.984 . . . . 0.0 109.476 -179.965 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 187' ' ' TYR . . . . . 0.596 ' CE1' ' O ' ' A' ' 188' ' ' ASN . 43.0 t80 -67.54 130.73 43.95 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.166 -0.959 . . . . 0.0 110.126 -179.829 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 188' ' ' ASN . . . . . 0.84 HD22 ' H ' ' A' ' 193' ' ' VAL . 0.0 OUTLIER -99.94 150.54 22.3 Favored 'General case' 0 C--N 1.292 -1.907 0 N-CA-C 107.318 -1.364 . . . . 0.0 107.318 177.825 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 189' ' ' GLU . . . . . 0.706 ' CD ' ' H ' ' A' ' 189' ' ' GLU . 0.0 OUTLIER -112.18 -8.09 14.01 Favored 'General case' 0 C--N 1.289 -2.034 0 N-CA-C 107.968 -1.123 . . . . 0.0 107.968 -179.476 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 190' ' ' LYS . . . . . 0.577 ' N ' ' OD1' ' A' ' 188' ' ' ASN . 2.7 mtpm? -82.89 -56.91 3.54 Favored 'General case' 0 C--N 1.299 -1.618 0 C-N-CA 119.894 -0.722 . . . . 0.0 109.381 179.51 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 191' ' ' THR . . . . . 0.598 ' C ' HD21 ' A' ' 188' ' ' ASN . 4.7 p -88.44 6.5 37.29 Favored 'General case' 0 N--CA 1.493 1.682 0 O-C-N 121.399 -0.813 . . . . 0.0 110.04 -179.675 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 192' ' ' GLY . . . . . 0.703 ' N ' HD21 ' A' ' 188' ' ' ASN . . . 53.92 35.82 54.38 Favored Glycine 0 N--CA 1.495 2.568 0 N-CA-C 110.664 -0.974 . . . . 0.0 110.664 179.129 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 193' ' ' VAL . . . . . 0.84 ' H ' HD22 ' A' ' 188' ' ' ASN . 58.8 t -149.5 163.58 4.08 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.588 0 O-C-N 120.95 -1.324 . . . . 0.0 109.962 179.708 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 194' ' ' TRP . . . . . 0.582 ' N ' HG12 ' A' ' 193' ' ' VAL . 16.1 m95 -84.97 121.17 27.38 Favored 'General case' 0 N--CA 1.49 1.534 0 N-CA-C 108.085 -1.08 . . . . 0.0 108.085 179.137 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 195' ' ' GLU . . . . . . . . . . . . . 2.6 mt-10 -79.69 -61.23 2.06 Favored 'General case' 0 N--CA 1.497 1.878 0 O-C-N 121.295 -0.878 . . . . 0.0 111.767 -177.667 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 196' ' ' LYS . . . . . . . . . . . . . 8.5 mmtm -93.29 145.38 24.49 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 120.777 -1.202 . . . . 0.0 110.296 -178.608 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 197' ' ' ARG . . . . . 0.599 ' CG ' HH11 ' A' ' 197' ' ' ARG . 0.0 OUTLIER -119.61 146.85 45.16 Favored 'General case' 0 N--CA 1.492 1.625 0 N-CA-C 108.711 -0.848 . . . . 0.0 108.711 179.806 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 198' ' ' LYS . . . . . 0.505 ' HZ1' ' CG ' ' A' ' 185' ' ' ASP . 0.5 OUTLIER -116.81 121.07 40.47 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.582 -0.699 . . . . 0.0 111.197 -178.212 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 199' ' ' ILE . . . . . 0.49 ' C ' HD12 ' A' ' 199' ' ' ILE . 0.8 OUTLIER -139.52 118.21 12.27 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.573 0 CA-C-O 122.515 1.15 . . . . 0.0 109.56 178.796 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 200' ' ' PHE . . . . . 0.763 ' CE2' HD22 ' A' ' 181' ' ' LEU . 0.3 OUTLIER -103.6 140.78 37.09 Favored 'General case' 0 N--CA 1.497 1.88 0 O-C-N 121.127 -0.983 . . . . 0.0 110.455 -178.074 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 201' ' ' VAL . . . . . . . . . . . . . 96.1 t -103.47 146.83 10.6 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.482 0 N-CA-C 108.255 -1.017 . . . . 0.0 108.255 177.352 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 202' ' ' ALA . . . . . . . . . . . . . . . -131.89 138.74 48.53 Favored 'General case' 0 C--N 1.3 -1.579 0 N-CA-C 108.34 -0.985 . . . . 0.0 108.34 -179.88 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 203' ' ' THR . . . . . 0.533 ' O ' HG23 ' A' ' 205' ' ' VAL . 3.2 p -89.1 130.77 35.49 Favored 'General case' 0 C--N 1.306 -1.315 0 CA-C-O 122.267 1.032 . . . . 0.0 111.213 -178.141 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 204' ' ' GLU . . . . . 0.499 ' HA ' ' CD2' ' A' ' 153' ' ' TYR . 0.2 OUTLIER -51.01 134.48 26.15 Favored 'General case' 0 C--N 1.297 -1.691 0 C-N-CA 119.076 -1.05 . . . . 0.0 109.043 179.346 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 205' ' ' VAL . . . . . 0.556 HG12 ' N ' ' A' ' 206' ' ' LYS . 53.3 t -125.03 164.06 24.55 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.369 0 CA-C-O 121.941 0.877 . . . . 0.0 110.433 -177.79 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 206' ' ' LYS . . . . . 0.556 ' N ' HG12 ' A' ' 205' ' ' VAL . 0.1 OUTLIER . . . . . 0 C--N 1.297 -1.693 0 CA-C-O 117.976 -1.011 . . . . 0.0 109.651 179.91 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' C' C ' 702' ' ' LEU . . . . . 0.607 HD11 ' N ' ' A' ' 164' ' ' THR . 0.0 OUTLIER . . . . . 0 N--CA 1.492 1.656 0 N-CA-C 108.941 -0.763 . . . . 0.0 108.941 . . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' C' C ' 703' ' ' PRO . . . . . 0.576 ' HG3' ' HB1' ' A' ' 104' ' ' ALA . 11.9 Cg_endo -61.7 -174.81 0.14 Allowed 'Trans proline' 0 N--CA 1.494 1.549 0 C-N-CA 122.609 2.206 . . . . 0.0 112.861 -179.083 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' C' C ' 704' ' ' ALA . . . . . 0.561 ' C ' ' NH2' ' A' ' 197' ' ' ARG . . . . . . . . 0 N--CA 1.49 1.539 0 O-C-N 121.395 -0.816 . . . . 0.0 109.364 -179.662 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 63' ' ' PRO . . . . . . . . . . . . . 72.9 Cg_endo . . . . . 0 C--O 1.215 -0.633 0 N-CA-C 110.684 -0.544 . . . . 0.0 110.684 . . . . . . . . . 0 0 . 1 . 008 nuclear nobuild core ' A' A ' 64' ' ' GLN . . . . . 0.601 ' O ' ' NE2' ' A' ' 64' ' ' GLN . 0.0 OUTLIER -159.83 137.72 10.03 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 120.97 -1.081 . . . . 0.0 109.841 179.115 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 65' ' ' ILE . . . . . 0.46 HG23 ' HB3' ' A' ' 89' ' ' PRO . 3.2 mp -47.95 108.0 0.83 Allowed Pre-proline 0 N--CA 1.489 1.488 0 O-C-N 121.172 -0.955 . . . . 0.0 108.701 179.136 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 66' ' ' PRO . . . . . 0.4 ' HG3' ' NZ ' ' A' ' 71' ' ' LYS . 61.4 Cg_endo -81.52 -158.74 0.1 OUTLIER 'Trans proline' 0 C--N 1.314 -1.246 0 C-N-CA 122.026 1.818 . . . . 0.0 112.445 -179.432 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 67' ' ' LYS . . . . . . . . . . . . . 3.4 pttm -90.18 -13.24 35.99 Favored 'General case' 0 N--CA 1.488 1.457 0 O-C-N 121.323 -0.861 . . . . 0.0 109.366 -179.975 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 68' ' ' ASP . . . . . 0.653 ' C ' ' N ' ' A' ' 70' ' ' SER . 0.5 OUTLIER -76.76 64.27 2.31 Favored 'General case' 0 N--CA 1.488 1.456 0 CA-C-O 122.656 1.217 . . . . 0.0 109.548 -179.885 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 69' ' ' LYS . . . . . 0.457 ' C ' ' O ' ' A' ' 68' ' ' ASP . 12.1 ptpt -47.48 -13.01 0.03 OUTLIER 'General case' 0 N--CA 1.512 2.655 0 C-N-CA 117.039 -1.864 . . . . 0.0 106.66 177.03 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 70' ' ' SER . . . . . 0.653 ' N ' ' C ' ' A' ' 68' ' ' ASP . 1.3 p -85.22 -7.06 59.21 Favored 'General case' 0 N--CA 1.497 1.883 0 CA-C-N 113.259 -1.791 . . . . 0.0 111.151 179.337 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 71' ' ' LYS . . . . . 0.519 ' N ' ' O ' ' A' ' 68' ' ' ASP . 0.0 OUTLIER -98.76 145.66 26.7 Favored 'General case' 0 N--CA 1.501 2.107 0 O-C-N 120.671 -1.268 . . . . 0.0 112.329 -179.141 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 72' ' ' VAL . . . . . 0.716 HG12 ' CE1' ' A' ' 88' ' ' TYR . 3.0 m -68.02 130.06 32.97 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.384 0 N-CA-C 105.227 -2.138 . . . . 0.0 105.227 175.235 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 73' ' ' ALA . . . . . 0.57 ' N ' ' O ' ' A' ' 87' ' ' VAL . . . -78.92 -15.17 58.67 Favored 'General case' 0 C--N 1.293 -1.858 0 O-C-N 120.16 -1.588 . . . . 0.0 107.623 -179.404 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 74' ' ' GLY . . . . . 0.418 ' O ' ' N ' ' A' ' 87' ' ' VAL . . . 176.04 -159.74 27.3 Favored Glycine 0 N--CA 1.48 1.592 0 N-CA-C 109.712 -1.355 . . . . 0.0 109.712 179.73 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 75' ' ' TYR . . . . . 0.624 ' HA ' HG23 ' A' ' 87' ' ' VAL . 0.6 OUTLIER -142.97 166.86 23.49 Favored 'General case' 0 C--N 1.295 -1.772 0 O-C-N 121.713 -0.875 . . . . 0.0 110.834 -177.221 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 76' ' ' ILE . . . . . . . . . . . . . 1.5 tt -149.86 146.98 16.58 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.517 0 C-N-CA 119.2 -1.0 . . . . 0.0 109.833 -178.528 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -150.96 164.78 35.55 Favored 'General case' 0 N--CA 1.489 1.495 0 N-CA-C 108.689 -0.856 . . . . 0.0 108.689 179.594 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 78' ' ' ILE . . . . . 0.607 ' HB ' ' HB3' ' A' ' 81' ' ' ALA . 14.9 mt -146.89 95.87 4.42 Favored Pre-proline 0 C--N 1.3 -1.562 0 N-CA-C 108.392 -0.966 . . . . 0.0 108.392 179.997 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 79' ' ' PRO . . . . . . . . . . . . . 73.5 Cg_exo -46.93 -46.45 18.59 Favored 'Trans proline' 0 N--CA 1.493 1.447 0 C-N-CA 122.865 2.377 . . . . 0.0 113.897 -178.503 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 4.0 t0 -65.38 -20.04 66.21 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 120.749 -1.219 . . . . 0.0 110.423 178.622 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 81' ' ' ALA . . . . . 0.817 ' HB2' ' HB2' ' A' ' 136' ' ' ALA . . . -104.35 -12.58 16.51 Favored 'General case' 0 N--CA 1.493 1.676 0 O-C-N 121.308 -0.87 . . . . 0.0 109.227 179.739 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 82' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER 62.4 48.82 4.43 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.332 -0.855 . . . . 0.0 110.154 179.574 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 83' ' ' ILE . . . . . . . . . . . . . 69.9 mt -129.08 151.84 36.35 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.801 0 O-C-N 121.142 -0.974 . . . . 0.0 110.408 -178.862 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 84' ' ' LYS . . . . . 0.458 ' O ' ' CD ' ' A' ' 85' ' ' GLU . 27.7 tttt -158.86 108.74 1.99 Allowed 'General case' 0 N--CA 1.49 1.545 0 N-CA-C 108.192 -1.04 . . . . 0.0 108.192 179.778 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 85' ' ' GLU . . . . . 0.595 ' O ' ' CD2' ' A' ' 75' ' ' TYR . 7.4 mm-40 -139.64 176.41 2.59 Favored Pre-proline 0 N--CA 1.496 1.859 0 O-C-N 121.457 -0.777 . . . . 0.0 109.899 -178.998 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 86' ' ' PRO . . . . . 0.419 ' O ' HG22 ' A' ' 101' ' ' VAL . 12.3 Cg_endo -85.86 169.68 8.98 Favored 'Trans proline' 0 N--CA 1.491 1.342 0 C-N-CA 123.15 2.566 . . . . 0.0 113.55 -178.75 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 87' ' ' VAL . . . . . 0.624 HG23 ' HA ' ' A' ' 75' ' ' TYR . 45.8 t -124.35 99.38 6.25 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.85 0 O-C-N 121.616 -0.677 . . . . 0.0 109.42 179.497 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 88' ' ' TYR . . . . . 0.716 ' CE1' HG12 ' A' ' 72' ' ' VAL . 26.1 m-85 -90.08 155.52 47.08 Favored Pre-proline 0 N--CA 1.506 2.345 0 O-C-N 120.861 -1.149 . . . . 0.0 109.716 -179.806 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 89' ' ' PRO . . . . . 0.578 ' O ' ' NE2' ' A' ' 96' ' ' GLN . 18.3 Cg_endo -65.62 145.46 81.81 Favored 'Trans proline' 0 N--CA 1.494 1.522 0 C-N-CA 122.486 2.124 . . . . 0.0 113.946 -179.587 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . -53.1 166.5 1.41 Allowed Glycine 0 N--CA 1.49 2.261 0 N-CA-C 109.369 -1.492 . . . . 0.0 109.369 179.167 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 91' ' ' PRO . . . . . 0.432 ' C ' ' H ' ' A' ' 93' ' ' THR . 57.8 Cg_endo -93.72 167.47 20.81 Favored 'Cis proline' 0 C--N 1.308 -1.589 0 C-N-CA 123.756 -1.352 . . . . 0.0 111.583 0.14 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 92' ' ' ALA . . . . . 0.473 ' O ' HD23 ' A' ' 97' ' ' LEU . . . -73.32 31.07 0.07 Allowed 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.104 -0.997 . . . . 0.0 110.495 -179.781 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 93' ' ' THR . . . . . 0.432 ' H ' ' C ' ' A' ' 91' ' ' PRO . 1.4 p -73.16 153.01 90.57 Favored Pre-proline 0 N--CA 1.49 1.534 0 O-C-N 120.725 -1.234 . . . . 0.0 109.288 -179.65 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 94' ' ' PRO . . . . . . . . . . . . . 89.8 Cg_exo -33.22 -56.83 0.35 Allowed 'Trans proline' 0 C--N 1.311 -1.431 0 C-N-CA 122.982 2.454 . . . . 0.0 112.299 -179.686 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 41.1 mt-10 -46.5 -48.33 19.24 Favored 'General case' 0 N--CA 1.488 1.444 0 O-C-N 121.171 -0.955 . . . . 0.0 108.874 179.813 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 96' ' ' GLN . . . . . 0.578 ' NE2' ' O ' ' A' ' 89' ' ' PRO . 3.4 mm-40 -72.29 -54.95 8.04 Favored 'General case' 0 C--N 1.305 -1.333 0 O-C-N 121.192 -0.942 . . . . 0.0 109.712 179.767 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 97' ' ' LEU . . . . . 0.703 HD11 ' HA2' ' A' ' 119' ' ' GLY . 0.5 OUTLIER -48.33 -8.01 0.02 OUTLIER 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.254 -0.904 . . . . 0.0 109.926 -179.593 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 98' ' ' ASN . . . . . 0.798 HD21 ' HE ' ' A' ' 99' ' ' ARG . 0.1 OUTLIER -74.41 -24.45 59.11 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.163 -0.961 . . . . 0.0 109.162 179.672 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 99' ' ' ARG . . . . . 0.798 ' HE ' HD21 ' A' ' 98' ' ' ASN . 4.2 mtt180 -95.2 -53.65 3.71 Favored 'General case' 0 C--N 1.3 -1.561 0 O-C-N 121.659 -0.651 . . . . 0.0 110.294 -178.813 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . 177.52 -159.7 25.9 Favored Glycine 0 N--CA 1.492 2.402 0 C-N-CA 119.366 -1.397 . . . . 0.0 110.167 179.807 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 101' ' ' VAL . . . . . 0.785 ' O ' HG23 ' A' ' 101' ' ' VAL . 25.0 m -62.03 100.07 0.15 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.629 0 O-C-N 121.523 -0.986 . . . . 0.0 109.296 -179.911 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 102' ' ' SER . . . . . 0.458 ' OG ' ' OE1' ' A' ' 96' ' ' GLN . 1.6 m -93.35 159.9 15.06 Favored 'General case' 0 C--N 1.298 -1.644 0 O-C-N 121.2 -0.938 . . . . 0.0 110.156 -179.963 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 103' ' ' PHE . . . . . . . . . . . . . 21.2 m-85 -59.63 160.72 6.88 Favored 'General case' 0 N--CA 1.49 1.57 0 N-CA-C 107.869 -1.16 . . . . 0.0 107.869 178.671 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 104' ' ' ALA . . . . . . . . . . . . . . . -72.33 -28.16 62.88 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.211 -0.93 . . . . 0.0 111.814 -177.932 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -135.25 150.45 50.06 Favored 'General case' 0 N--CA 1.495 1.819 0 O-C-N 120.822 -1.174 . . . . 0.0 111.023 -178.518 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 106' ' ' GLU . . . . . . . . . . . . . 1.3 pt-20 -54.15 -63.33 1.18 Allowed 'General case' 0 N--CA 1.487 1.402 0 CA-C-N 115.999 -0.546 . . . . 0.0 111.293 -179.256 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 107' ' ' ASN . . . . . . . . . . . . . 15.8 m120 -75.84 32.46 0.11 Allowed 'General case' 0 N--CA 1.49 1.543 0 O-C-N 120.175 -1.578 . . . . 0.0 112.621 -175.398 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 108' ' ' GLU . . . . . . . . . . . . . 44.6 tp10 -60.48 148.55 37.26 Favored 'General case' 0 C--N 1.299 -1.597 0 C-N-CA 118.865 -1.134 . . . . 0.0 108.008 -179.684 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 109' ' ' SER . . . . . 0.536 ' C ' ' H ' ' A' ' 111' ' ' ASP . 1.3 t -96.57 121.62 38.59 Favored 'General case' 0 C--N 1.302 -1.49 0 O-C-N 121.039 -1.038 . . . . 0.0 109.683 -178.77 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 110' ' ' LEU . . . . . . . . . . . . . 12.7 tp -59.19 -1.57 0.2 Allowed 'General case' 0 C--N 1.302 -1.479 0 N-CA-C 108.54 -0.911 . . . . 0.0 108.54 -179.912 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 111' ' ' ASP . . . . . 0.536 ' H ' ' C ' ' A' ' 109' ' ' SER . 8.7 m-20 -131.77 20.58 4.62 Favored 'General case' 0 N--CA 1.487 1.406 0 N-CA-C 108.927 -0.768 . . . . 0.0 108.927 179.36 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 112' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -65.47 133.82 52.1 Favored 'General case' 0 N--CA 1.49 1.525 0 O-C-N 121.348 -0.845 . . . . 0.0 109.944 -179.958 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 113' ' ' GLN . . . . . 0.594 ' NE2' ' O ' ' A' ' 173' ' ' LYS . 0.0 OUTLIER -65.46 -4.33 5.62 Favored 'General case' 0 C--N 1.303 -1.436 0 O-C-N 121.058 -1.026 . . . . 0.0 108.869 179.032 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 114' ' ' ASN . . . . . 0.685 ' ND2' ' NE2' ' A' ' 178' ' ' GLN . 18.4 t-20 -143.38 91.19 2.24 Favored 'General case' 0 C--N 1.301 -1.517 0 N-CA-C 107.559 -1.274 . . . . 0.0 107.559 178.409 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 115' ' ' ILE . . . . . 0.439 ' O ' HG22 ' A' ' 115' ' ' ILE . 3.3 mt -100.69 115.14 41.61 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.466 0 O-C-N 121.627 -0.671 . . . . 0.0 109.913 -178.913 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 116' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -101.82 145.53 29.05 Favored 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.345 -0.847 . . . . 0.0 110.93 -179.149 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 117' ' ' ILE . . . . . . . . . . . . . 1.2 mt -135.15 157.38 40.37 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.461 0 N-CA-C 108.101 -1.074 . . . . 0.0 108.101 179.521 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 118' ' ' ALA . . . . . . . . . . . . . . . -142.62 161.82 37.08 Favored 'General case' 0 N--CA 1.492 1.658 0 O-C-N 120.822 -1.174 . . . . 0.0 111.177 -179.611 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 119' ' ' GLY . . . . . 0.703 ' HA2' HD11 ' A' ' 97' ' ' LEU . . . -170.29 143.54 7.87 Favored Glycine 0 N--CA 1.49 2.249 0 C-N-CA 120.191 -1.004 . . . . 0.0 110.755 179.801 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 120' ' ' HIS . . . . . . . . . . . . . 29.9 m170 -71.16 167.86 18.44 Favored 'General case' 0 N--CA 1.493 1.693 0 O-C-N 121.674 -0.898 . . . . 0.0 109.514 179.024 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 121' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -118.29 159.57 23.14 Favored 'General case' 0 N--CA 1.496 1.863 0 O-C-N 121.211 -0.931 . . . . 0.0 108.84 179.449 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 122' ' ' PHE . . . . . . . . . . . . . 0.5 OUTLIER -143.68 127.97 17.77 Favored 'General case' 0 N--CA 1.497 1.918 0 O-C-N 120.935 -1.103 . . . . 0.0 109.705 -179.623 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 123' ' ' ILE . . . . . 0.511 HG23 ' N ' ' A' ' 124' ' ' ASP . 4.4 tt -64.66 -40.11 87.92 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.55 0 N-CA-C 108.982 -0.748 . . . . 0.0 108.982 179.858 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 124' ' ' ASP . . . . . 0.511 ' N ' HG23 ' A' ' 123' ' ' ILE . 70.3 m-20 -89.11 26.08 1.69 Allowed 'General case' 0 N--CA 1.496 1.829 0 O-C-N 121.563 -0.711 . . . . 0.0 112.253 -177.358 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 125' ' ' ARG . . . . . 0.684 HH11 ' CG ' ' A' ' 125' ' ' ARG . 1.8 mtt-85 -154.29 100.77 2.45 Favored Pre-proline 0 N--CA 1.496 1.826 0 O-C-N 120.754 -1.216 . . . . 0.0 109.692 179.781 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 126' ' ' PRO . . . . . . . . . . . . . 73.1 Cg_endo -80.69 -28.08 2.9 Favored 'Trans proline' 0 C--N 1.315 -1.195 0 C-N-CA 122.107 1.871 . . . . 0.0 112.546 -179.934 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 127' ' ' ASN . . . . . 0.427 ' O ' ' O ' ' A' ' 128' ' ' TYR . 1.6 m120 -91.61 7.5 41.19 Favored 'General case' 0 N--CA 1.489 1.478 0 O-C-N 121.089 -1.007 . . . . 0.0 109.715 -179.864 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 128' ' ' TYR . . . . . 0.687 ' CE2' ' NE2' ' A' ' 129' ' ' GLN . 4.6 t80 -60.48 -151.25 0.0 OUTLIER 'General case' 0 C--N 1.301 -1.529 0 O-C-N 121.258 -0.901 . . . . 0.0 109.84 -179.733 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 129' ' ' GLN . . . . . 0.687 ' NE2' ' CE2' ' A' ' 128' ' ' TYR . 2.6 mp0 -67.78 -71.57 0.2 Allowed 'General case' 0 N--CA 1.489 1.478 0 O-C-N 121.341 -0.849 . . . . 0.0 110.051 -179.482 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 130' ' ' PHE . . . . . 0.503 ' CE2' HG11 ' A' ' 101' ' ' VAL . 55.4 m-85 -135.44 50.82 2.1 Favored 'General case' 0 N--CA 1.492 1.673 0 O-C-N 121.193 -0.942 . . . . 0.0 110.473 -179.371 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 131' ' ' THR . . . . . . . . . . . . . 2.9 m -82.13 -38.77 24.26 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.031 -1.043 . . . . 0.0 108.81 179.067 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 132' ' ' ASN . . . . . . . . . . . . . 4.8 t30 -84.34 6.42 23.12 Favored 'General case' 0 N--CA 1.494 1.731 0 C-N-CA 120.083 -0.647 . . . . 0.0 111.121 -178.91 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 133' ' ' LEU . . . . . 0.598 ' O ' ' N ' ' A' ' 135' ' ' ALA . 0.2 OUTLIER -68.5 -47.75 66.18 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 120.906 -1.121 . . . . 0.0 110.69 -179.04 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 134' ' ' LYS . . . . . 0.625 ' CD ' ' H ' ' A' ' 134' ' ' LYS . 0.1 OUTLIER -42.15 -18.48 0.01 OUTLIER 'General case' 0 N--CA 1.494 1.747 0 O-C-N 121.098 -1.001 . . . . 0.0 109.949 -179.025 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 135' ' ' ALA . . . . . 0.598 ' N ' ' O ' ' A' ' 133' ' ' LEU . . . -83.87 -31.82 25.53 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.063 -1.023 . . . . 0.0 109.94 -179.946 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 136' ' ' ALA . . . . . 0.817 ' HB2' ' HB2' ' A' ' 81' ' ' ALA . . . -80.78 153.99 27.45 Favored 'General case' 0 N--CA 1.489 1.518 0 CA-C-O 122.163 0.982 . . . . 0.0 112.142 -178.366 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 137' ' ' LYS . . . . . 0.524 ' O ' ' O ' ' A' ' 138' ' ' LYS . 4.8 tttt -150.92 -166.93 2.67 Favored 'General case' 0 N--CA 1.493 1.717 0 C-N-CA 118.926 -1.11 . . . . 0.0 110.879 -178.197 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 138' ' ' LYS . . . . . 0.592 ' O ' ' N ' ' A' ' 140' ' ' SER . 36.3 mttm -44.45 178.72 0.0 OUTLIER 'General case' 0 N--CA 1.487 1.378 0 CA-C-O 122.221 1.01 . . . . 0.0 110.971 -178.755 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 139' ' ' GLY . . . . . . . . . . . . . . . 46.6 7.59 0.02 OUTLIER Glycine 0 N--CA 1.491 2.351 0 N-CA-C 110.545 -1.022 . . . . 0.0 110.545 -179.959 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 140' ' ' SER . . . . . 0.592 ' N ' ' O ' ' A' ' 138' ' ' LYS . 48.7 m -84.77 121.57 27.88 Favored 'General case' 0 N--CA 1.495 1.785 0 O-C-N 120.809 -1.406 . . . . 0.0 109.215 179.244 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 141' ' ' MET . . . . . 0.646 ' SD ' ' N ' ' A' ' 142' ' ' VAL . 10.8 tpp -72.47 131.76 42.98 Favored 'General case' 0 N--CA 1.488 1.462 0 O-C-N 121.125 -0.984 . . . . 0.0 109.223 179.898 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 142' ' ' VAL . . . . . 0.646 ' N ' ' SD ' ' A' ' 141' ' ' MET . 3.2 t -116.02 133.13 63.46 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.702 0 N-CA-C 108.794 -0.817 . . . . 0.0 108.794 -179.593 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 143' ' ' TYR . . . . . . . . . . . . . 17.9 m-85 -109.23 135.28 50.59 Favored 'General case' 0 N--CA 1.497 1.92 0 O-C-N 120.89 -1.132 . . . . 0.0 111.531 -178.434 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 144' ' ' PHE . . . . . . . . . . . . . 49.1 t80 -120.25 101.86 8.1 Favored 'General case' 0 N--CA 1.495 1.793 0 C-N-CA 120.359 -0.536 . . . . 0.0 109.566 -179.432 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 145' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -96.65 132.1 42.64 Favored 'General case' 0 N--CA 1.493 1.708 0 O-C-N 121.205 -0.935 . . . . 0.0 110.878 -178.822 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 146' ' ' VAL . . . . . 0.414 ' O ' ' C ' ' A' ' 147' ' ' GLY . 0.1 OUTLIER -142.96 143.78 24.79 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.738 0 N-CA-C 107.764 -1.199 . . . . 0.0 107.764 178.655 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 147' ' ' GLY . . . . . 0.414 ' C ' ' O ' ' A' ' 146' ' ' VAL . . . 44.37 -130.77 7.25 Favored Glycine 0 N--CA 1.489 2.221 0 O-C-N 120.28 -1.512 . . . . 0.0 109.324 -179.958 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 148' ' ' ASN . . . . . 0.575 HD22 ' C ' ' A' ' 148' ' ' ASN . 0.4 OUTLIER -102.86 18.49 21.4 Favored 'General case' 0 C--N 1.3 -1.572 0 O-C-N 121.374 -1.074 . . . . 0.0 108.588 179.537 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 149' ' ' GLU . . . . . . . . . . . . . 8.4 tt0 -114.38 147.94 38.41 Favored 'General case' 0 N--CA 1.489 1.523 0 CA-C-O 121.862 0.839 . . . . 0.0 111.249 -178.538 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 150' ' ' THR . . . . . 0.487 HG22 ' O ' ' A' ' 150' ' ' THR . 1.2 m -129.24 105.68 8.31 Favored 'General case' 0 N--CA 1.492 1.646 0 CA-C-O 121.585 0.707 . . . . 0.0 109.675 179.941 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 151' ' ' ARG . . . . . . . . . . . . . 10.8 mtp180 -87.34 -171.6 3.55 Favored 'General case' 0 N--CA 1.487 1.401 0 N-CA-C 108.624 -0.88 . . . . 0.0 108.624 -179.967 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 152' ' ' LYS . . . . . . . . . . . . . 1.1 ttmt -150.41 147.36 27.46 Favored 'General case' 0 C--N 1.303 -1.442 0 O-C-N 120.918 -1.114 . . . . 0.0 110.787 -179.299 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 153' ' ' TYR . . . . . 0.562 ' O ' ' SD ' ' A' ' 141' ' ' MET . 22.2 m-85 -142.2 165.6 26.98 Favored 'General case' 0 N--CA 1.49 1.574 0 N-CA-C 108.024 -1.102 . . . . 0.0 108.024 179.24 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 154' ' ' LYS . . . . . . . . . . . . . 30.9 ttpt -142.91 121.02 12.15 Favored 'General case' 0 N--CA 1.493 1.684 0 O-C-N 121.061 -1.025 . . . . 0.0 108.666 178.854 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 155' ' ' MET . . . . . . . . . . . . . 4.1 mtt -47.1 105.9 0.08 Allowed 'General case' 0 N--CA 1.493 1.687 0 O-C-N 120.889 -1.132 . . . . 0.0 112.017 -178.419 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 156' ' ' THR . . . . . 0.657 ' OG1' HG23 ' A' ' 203' ' ' THR . 0.0 OUTLIER -107.46 -23.38 12.21 Favored 'General case' 0 C--N 1.293 -1.886 0 CA-C-N 115.16 -0.927 . . . . 0.0 110.112 -179.572 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 157' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -153.16 150.43 29.06 Favored 'General case' 0 C--N 1.296 -1.728 0 C-N-CA 118.388 -1.325 . . . . 0.0 111.363 -178.797 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 158' ' ' ILE . . . . . 0.432 HG13 ' CD2' ' A' ' 200' ' ' PHE . 0.0 OUTLIER -154.18 145.12 14.08 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.357 0 CA-C-O 121.872 0.844 . . . . 0.0 110.055 -179.276 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 159' ' ' ARG . . . . . 0.424 ' N ' HG12 ' A' ' 158' ' ' ILE . 0.1 OUTLIER -151.38 156.6 41.04 Favored 'General case' 0 C--N 1.3 -1.568 0 CA-C-O 121.52 0.676 . . . . 0.0 109.747 -179.792 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 160' ' ' ASP . . . . . 0.5 ' C ' HG22 ' A' ' 161' ' ' VAL . 2.2 m-20 -117.62 157.08 27.04 Favored 'General case' 0 N--CA 1.49 1.563 0 N-CA-C 108.781 -0.822 . . . . 0.0 108.781 -179.909 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 161' ' ' VAL . . . . . 0.5 HG22 ' C ' ' A' ' 160' ' ' ASP . 0.1 OUTLIER -163.43 160.24 1.29 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.654 0 O-C-N 121.072 -1.017 . . . . 0.0 110.49 -179.912 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 162' ' ' LYS . . . . . . . . . . . . . 14.1 ptmt -52.13 177.88 0.06 OUTLIER Pre-proline 0 N--CA 1.49 1.562 0 N-CA-C 108.694 -0.854 . . . . 0.0 108.694 179.043 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 163' ' ' PRO . . . . . 0.721 ' C ' HD11 ' C' ' 702' ' ' LEU . 37.3 Cg_endo -86.63 43.39 1.03 Allowed 'Trans proline' 0 C--N 1.316 -1.18 0 C-N-CA 122.238 1.959 . . . . 0.0 112.502 -179.344 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 164' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -151.93 -11.21 0.2 Allowed 'General case' 0 N--CA 1.494 1.741 0 O-C-N 121.262 -0.899 . . . . 0.0 110.372 -179.972 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 165' ' ' ASP . . . . . 0.449 ' O ' ' C ' ' A' ' 166' ' ' VAL . 1.2 t70 -73.21 61.93 0.65 Allowed 'General case' 0 N--CA 1.49 1.558 0 O-C-N 120.867 -1.146 . . . . 0.0 110.258 -179.301 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 166' ' ' VAL . . . . . 0.623 ' O ' ' N ' ' A' ' 168' ' ' VAL . 0.9 OUTLIER -41.89 -31.42 0.35 Allowed 'Isoleucine or valine' 0 N--CA 1.494 1.73 0 O-C-N 121.399 -0.813 . . . . 0.0 109.023 -178.329 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 167' ' ' GLY . . . . . . . . . . . . . . . -42.65 -13.38 0.01 OUTLIER Glycine 0 N--CA 1.494 2.546 0 O-C-N 121.06 -1.025 . . . . 0.0 110.742 179.892 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 168' ' ' VAL . . . . . 0.623 ' N ' ' O ' ' A' ' 166' ' ' VAL . 6.1 m -53.46 -35.64 25.67 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.468 0 O-C-N 120.708 -1.466 . . . . 0.0 108.738 179.62 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 169' ' ' LEU . . . . . 0.522 ' O ' ' N ' ' A' ' 171' ' ' GLU . 27.8 mt -51.86 -7.19 0.05 OUTLIER 'General case' 0 N--CA 1.495 1.805 0 N-CA-C 108.004 -1.11 . . . . 0.0 108.004 -179.272 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 170' ' ' ASP . . . . . 0.604 ' CG ' HE22 ' A' ' 178' ' ' GLN . 34.4 t0 35.16 28.58 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.525 0 O-C-N 121.764 -0.585 . . . . 0.0 111.87 177.687 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 171' ' ' GLU . . . . . 0.522 ' N ' ' O ' ' A' ' 169' ' ' LEU . 12.7 pt-20 -62.3 94.26 0.06 Allowed 'General case' 0 N--CA 1.494 1.767 0 O-C-N 120.382 -1.449 . . . . 0.0 107.45 178.105 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 172' ' ' GLN . . . . . . . . . . . . . 2.2 mt-30 -152.66 -78.16 0.11 Allowed 'General case' 0 N--CA 1.497 1.877 0 O-C-N 121.434 -0.791 . . . . 0.0 110.548 -178.595 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 173' ' ' LYS . . . . . 0.594 ' O ' ' NE2' ' A' ' 113' ' ' GLN . 1.0 OUTLIER -55.95 136.52 51.77 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.43 -0.794 . . . . 0.0 109.386 -179.432 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 174' ' ' GLY . . . . . 0.477 ' O ' ' C ' ' A' ' 175' ' ' LYS . . . -120.03 -45.78 0.4 Allowed Glycine 0 N--CA 1.479 1.527 0 N-CA-C 107.441 -2.263 . . . . 0.0 107.441 179.239 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 175' ' ' LYS . . . . . 0.477 ' C ' ' O ' ' A' ' 174' ' ' GLY . 0.4 OUTLIER -38.13 -75.44 0.03 OUTLIER 'General case' 0 N--CA 1.493 1.724 0 N-CA-C 108.272 -1.011 . . . . 0.0 108.272 179.562 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 176' ' ' ASP . . . . . 0.547 ' O ' ' O ' ' A' ' 177' ' ' LYS . 66.7 m-20 -89.97 94.7 9.9 Favored 'General case' 0 C--N 1.296 -1.754 0 N-CA-C 106.967 -1.494 . . . . 0.0 106.967 177.943 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 177' ' ' LYS . . . . . 0.547 ' O ' ' O ' ' A' ' 176' ' ' ASP . 19.6 mttp -44.19 -178.4 0.0 OUTLIER 'General case' 0 N--CA 1.493 1.687 0 CA-C-O 121.487 0.66 . . . . 0.0 110.795 -178.311 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 178' ' ' GLN . . . . . 0.685 ' NE2' ' ND2' ' A' ' 114' ' ' ASN . 20.3 pt20 -161.06 161.38 31.29 Favored 'General case' 0 N--CA 1.487 1.386 0 C-N-CA 118.557 -1.257 . . . . 0.0 111.089 179.86 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 179' ' ' LEU . . . . . . . . . . . . . 1.2 tp -123.6 94.34 4.21 Favored 'General case' 0 C--N 1.303 -1.445 0 N-CA-C 106.944 -1.502 . . . . 0.0 106.944 177.398 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 180' ' ' THR . . . . . . . . . . . . . 3.3 m -71.64 120.32 17.06 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.111 -0.993 . . . . 0.0 110.427 -178.097 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 181' ' ' LEU . . . . . 0.466 HD21 ' HG ' ' A' ' 133' ' ' LEU . 34.4 tp -95.98 142.6 28.01 Favored 'General case' 0 C--N 1.302 -1.498 0 N-CA-C 108.153 -1.054 . . . . 0.0 108.153 178.338 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 182' ' ' ILE . . . . . 0.487 HG22 ' O ' ' A' ' 182' ' ' ILE . 3.9 mt -136.39 109.69 8.83 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.612 0 O-C-N 121.02 -1.05 . . . . 0.0 108.689 178.9 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 183' ' ' THR . . . . . 0.548 HG23 ' O ' ' A' ' 183' ' ' THR . 4.4 t -129.76 113.06 14.25 Favored 'General case' 0 C--N 1.293 -1.881 0 N-CA-C 107.337 -1.357 . . . . 0.0 107.337 179.327 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 184' ' ' CYS . . . . . . . . . . . . . 0.8 OUTLIER -79.23 164.03 24.49 Favored 'General case' 0 C--N 1.289 -2.026 0 C-N-CA 118.994 -1.082 . . . . 0.0 111.145 -177.691 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 185' ' ' ASP . . . . . . . . . . . . . 9.9 t0 -165.2 -154.33 0.21 Allowed 'General case' 0 N--CA 1.493 1.687 0 N-CA-C 108.892 -0.781 . . . . 0.0 108.892 -179.829 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 186' ' ' ASP . . . . . . . . . . . . . 1.5 m-20 49.43 59.28 4.6 Favored 'General case' 0 N--CA 1.495 1.802 0 O-C-N 120.95 -1.094 . . . . 0.0 108.971 -179.666 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 187' ' ' TYR . . . . . 0.607 ' CE2' ' O ' ' A' ' 188' ' ' ASN . 68.2 t80 -67.4 138.76 56.94 Favored 'General case' 0 N--CA 1.491 1.579 0 CA-C-O 121.85 0.833 . . . . 0.0 110.871 -179.184 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 188' ' ' ASN . . . . . 0.607 ' O ' ' CE2' ' A' ' 187' ' ' TYR . 0.7 OUTLIER -104.32 143.72 32.59 Favored 'General case' 0 C--N 1.299 -1.589 0 N-CA-C 108.305 -0.998 . . . . 0.0 108.305 178.391 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 189' ' ' GLU . . . . . . . . . . . . . 2.5 tt0 -108.22 -17.05 14.11 Favored 'General case' 0 C--N 1.293 -1.891 0 N-CA-C 108.879 -0.786 . . . . 0.0 108.879 -179.284 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 190' ' ' LYS . . . . . . . . . . . . . 24.4 mmtm -82.77 -51.64 7.49 Favored 'General case' 0 C--N 1.301 -1.541 0 C-N-CA 119.792 -0.763 . . . . 0.0 108.96 179.154 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 191' ' ' THR . . . . . . . . . . . . . 4.1 p -89.83 -10.91 43.64 Favored 'General case' 0 N--CA 1.489 1.477 0 O-C-N 121.442 -0.786 . . . . 0.0 109.802 -179.608 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 192' ' ' GLY . . . . . . . . . . . . . . . 63.73 39.32 97.36 Favored Glycine 0 N--CA 1.494 2.537 0 O-C-N 120.945 -1.097 . . . . 0.0 110.375 179.25 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 193' ' ' VAL . . . . . 0.591 HG12 ' N ' ' A' ' 194' ' ' TRP . 55.4 t -147.99 163.45 6.19 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.571 0 O-C-N 121.114 -1.227 . . . . 0.0 109.679 179.959 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 194' ' ' TRP . . . . . 0.591 ' N ' HG12 ' A' ' 193' ' ' VAL . 10.0 m95 -82.29 118.81 23.41 Favored 'General case' 0 C--N 1.301 -1.524 0 N-CA-C 108.356 -0.979 . . . . 0.0 108.356 179.613 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 195' ' ' GLU . . . . . 0.545 ' CD ' ' ND2' ' A' ' 188' ' ' ASN . 2.8 mt-10 -79.2 -60.82 2.22 Favored 'General case' 0 N--CA 1.493 1.692 0 O-C-N 121.32 -0.863 . . . . 0.0 110.946 -178.528 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 196' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -95.29 152.82 18.04 Favored 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.197 -0.939 . . . . 0.0 110.121 -178.789 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 197' ' ' ARG . . . . . 0.672 ' HE ' HD22 ' C' ' 702' ' ' LEU . 0.1 OUTLIER -122.94 143.18 50.07 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.668 -0.645 . . . . 0.0 109.723 179.86 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 198' ' ' LYS . . . . . . . . . . . . . 4.2 mptp? -113.77 120.72 41.75 Favored 'General case' 0 C--N 1.302 -1.487 0 O-C-N 121.7 -0.625 . . . . 0.0 109.56 -179.68 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 199' ' ' ILE . . . . . 0.662 ' C ' HD12 ' A' ' 199' ' ' ILE . 0.5 OUTLIER -139.66 118.41 12.13 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.677 0 CA-C-O 122.502 1.144 . . . . 0.0 109.829 179.926 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 200' ' ' PHE . . . . . 0.527 ' CD1' ' N ' ' A' ' 200' ' ' PHE . 6.6 m-85 -100.57 138.5 37.54 Favored 'General case' 0 N--CA 1.494 1.728 0 O-C-N 121.353 -0.842 . . . . 0.0 109.912 -178.626 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 201' ' ' VAL . . . . . . . . . . . . . 44.6 t -101.61 136.34 33.97 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.543 0 N-CA-C 107.795 -1.187 . . . . 0.0 107.795 177.662 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 202' ' ' ALA . . . . . . . . . . . . . . . -121.16 134.59 55.23 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.238 -0.914 . . . . 0.0 109.171 -179.939 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 203' ' ' THR . . . . . 0.657 HG23 ' OG1' ' A' ' 156' ' ' THR . 13.7 p -88.76 133.34 34.27 Favored 'General case' 0 C--N 1.306 -1.316 0 CA-C-O 122.158 0.98 . . . . 0.0 110.99 -178.72 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 204' ' ' GLU . . . . . 0.523 ' HA ' ' CD2' ' A' ' 153' ' ' TYR . 3.1 tt0 -51.72 133.84 30.87 Favored 'General case' 0 C--N 1.297 -1.686 0 C-N-CA 118.811 -1.155 . . . . 0.0 109.38 179.394 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 205' ' ' VAL . . . . . 0.545 HG23 ' O ' ' A' ' 203' ' ' THR . 44.3 t -127.53 161.66 34.64 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.295 0 CA-C-O 122.044 0.926 . . . . 0.0 110.242 -177.59 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 206' ' ' LYS . . . . . 0.497 ' N ' HG12 ' A' ' 205' ' ' VAL . 70.7 mttt . . . . . 0 C--N 1.296 -1.731 0 CA-C-O 118.047 -0.978 . . . . 0.0 109.294 179.85 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' C' C ' 702' ' ' LEU . . . . . 0.721 HD11 ' C ' ' A' ' 163' ' ' PRO . 0.0 OUTLIER . . . . . 0 N--CA 1.492 1.661 0 N-CA-C 109.227 -0.657 . . . . 0.0 109.227 . . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' C' C ' 703' ' ' PRO . . . . . 0.551 ' O ' ' NH2' ' A' ' 197' ' ' ARG . 16.3 Cg_endo -57.99 162.98 10.29 Favored 'Trans proline' 0 N--CA 1.499 1.845 0 C-N-CA 123.633 2.888 . . . . 0.0 113.55 -178.934 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' C' C ' 704' ' ' ALA . . . . . 0.47 ' C ' ' O ' ' C' ' 703' ' ' PRO . . . . . . . . 0 N--CA 1.491 1.622 0 CA-C-O 121.39 0.614 . . . . 0.0 110.277 179.274 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 63' ' ' PRO . . . . . 0.602 ' HG2' HD23 ' A' ' 110' ' ' LEU . 52.1 Cg_endo . . . . . 0 N--CA 1.481 0.762 0 CA-C-O 121.005 0.336 . . . . 0.0 111.467 . . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 64' ' ' GLN . . . . . 0.638 ' NE2' ' N ' ' A' ' 64' ' ' GLN . 0.0 OUTLIER -156.36 127.73 7.1 Favored 'General case' 0 N--CA 1.495 1.793 0 O-C-N 120.955 -1.091 . . . . 0.0 109.62 179.366 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 65' ' ' ILE . . . . . 0.639 HD13 ' H ' ' A' ' 65' ' ' ILE . 0.0 OUTLIER -50.79 110.03 1.58 Allowed Pre-proline 0 N--CA 1.49 1.552 0 O-C-N 121.085 -1.009 . . . . 0.0 109.195 178.929 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 66' ' ' PRO . . . . . . . . . . . . . 89.0 Cg_endo -85.64 -154.47 0.05 OUTLIER 'Trans proline' 0 C--N 1.312 -1.392 0 C-N-CA 121.954 1.769 . . . . 0.0 111.712 179.607 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 67' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -83.71 -4.69 58.83 Favored 'General case' 0 N--CA 1.488 1.46 0 O-C-N 121.189 -0.944 . . . . 0.0 109.185 179.553 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 68' ' ' ASP . . . . . 0.634 ' C ' ' N ' ' A' ' 70' ' ' SER . 4.6 t0 -76.14 52.1 0.71 Allowed 'General case' 0 N--CA 1.49 1.574 0 CA-C-O 122.221 1.01 . . . . 0.0 110.099 -179.689 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 69' ' ' LYS . . . . . 0.413 ' C ' ' O ' ' A' ' 68' ' ' ASP . 0.0 OUTLIER -49.38 -13.45 0.08 Allowed 'General case' 0 N--CA 1.507 2.375 0 C-N-CA 116.723 -1.991 . . . . 0.0 106.749 177.593 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 70' ' ' SER . . . . . 0.634 ' N ' ' C ' ' A' ' 68' ' ' ASP . 0.0 OUTLIER -83.31 -8.22 59.47 Favored 'General case' 0 N--CA 1.497 1.896 0 CA-C-N 113.331 -1.759 . . . . 0.0 110.381 179.557 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 71' ' ' LYS . . . . . . . . . . . . . 8.3 ptmt -101.88 142.88 32.49 Favored 'General case' 0 N--CA 1.495 1.793 0 O-C-N 121.021 -1.049 . . . . 0.0 110.643 179.875 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 72' ' ' VAL . . . . . 0.719 HG12 ' CE1' ' A' ' 88' ' ' TYR . 0.9 OUTLIER -64.92 142.63 16.68 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.434 0 N-CA-C 105.309 -2.108 . . . . 0.0 105.309 175.291 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 73' ' ' ALA . . . . . 0.498 ' N ' ' O ' ' A' ' 87' ' ' VAL . . . -83.16 -14.0 54.39 Favored 'General case' 0 C--N 1.296 -1.757 0 O-C-N 120.101 -1.624 . . . . 0.0 107.134 179.944 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 74' ' ' GLY . . . . . 0.409 ' N ' HG23 ' A' ' 72' ' ' VAL . . . 173.83 -157.11 25.1 Favored Glycine 0 C--N 1.296 -1.677 0 N-CA-C 108.595 -1.802 . . . . 0.0 108.595 179.472 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 75' ' ' TYR . . . . . 0.55 ' CE1' ' N ' ' A' ' 86' ' ' PRO . 0.3 OUTLIER -142.96 171.09 14.52 Favored 'General case' 0 C--N 1.292 -1.909 0 O-C-N 121.441 -1.034 . . . . 0.0 110.335 -177.624 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 76' ' ' ILE . . . . . . . . . . . . . 0.5 OUTLIER -148.12 143.72 19.19 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.601 0 C-N-CA 119.048 -1.061 . . . . 0.0 109.77 -177.29 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 2.2 mt-10 -151.53 163.35 39.23 Favored 'General case' 0 C--N 1.304 -1.41 0 O-C-N 121.136 -0.977 . . . . 0.0 109.254 179.573 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 78' ' ' ILE . . . . . 0.493 ' HB ' ' HB3' ' A' ' 81' ' ' ALA . 14.6 mt -144.77 126.51 7.95 Favored Pre-proline 0 N--CA 1.492 1.656 0 N-CA-C 108.538 -0.912 . . . . 0.0 108.538 179.886 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 79' ' ' PRO . . . . . . . . . . . . . 36.0 Cg_endo -71.52 -48.73 0.39 Allowed 'Trans proline' 0 N--CA 1.491 1.362 0 C-N-CA 122.011 1.807 . . . . 0.0 113.501 -179.064 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 50.5 t0 -66.48 -21.24 66.18 Favored 'General case' 0 N--CA 1.493 1.705 0 O-C-N 120.976 -1.077 . . . . 0.0 111.306 178.806 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 81' ' ' ALA . . . . . 0.87 ' HB2' ' HB2' ' A' ' 136' ' ' ALA . . . -104.55 -16.44 15.04 Favored 'General case' 0 N--CA 1.493 1.685 0 O-C-N 120.833 -1.167 . . . . 0.0 108.991 179.657 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 82' ' ' ASP . . . . . . . . . . . . . 8.5 t0 61.17 53.57 3.54 Favored 'General case' 0 N--CA 1.494 1.735 0 O-C-N 121.284 -0.885 . . . . 0.0 111.462 178.518 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 83' ' ' ILE . . . . . . . . . . . . . 50.8 mt -128.96 154.45 39.98 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.794 0 O-C-N 121.027 -1.045 . . . . 0.0 109.43 -179.798 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 84' ' ' LYS . . . . . . . . . . . . . 2.1 pttt -157.81 107.72 2.14 Favored 'General case' 0 N--CA 1.487 1.422 0 N-CA-C 107.959 -1.126 . . . . 0.0 107.959 -179.786 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 85' ' ' GLU . . . . . 0.498 ' C ' ' CE1' ' A' ' 75' ' ' TYR . 0.1 OUTLIER -141.17 160.32 58.13 Favored Pre-proline 0 N--CA 1.493 1.682 0 O-C-N 121.336 -0.852 . . . . 0.0 110.126 -179.065 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 86' ' ' PRO . . . . . 0.55 ' N ' ' CE1' ' A' ' 75' ' ' TYR . 36.7 Cg_endo -68.18 168.85 18.08 Favored 'Trans proline' 0 C--N 1.307 -1.611 0 C-N-CA 123.095 2.53 . . . . 0.0 113.081 -179.061 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 87' ' ' VAL . . . . . 0.502 HG23 ' HA ' ' A' ' 75' ' ' TYR . 94.1 t -127.46 99.31 5.2 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.627 0 N-CA-C 109.106 -0.701 . . . . 0.0 109.106 179.69 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 88' ' ' TYR . . . . . 0.719 ' CE1' HG12 ' A' ' 72' ' ' VAL . 20.9 m-85 -92.34 154.18 42.86 Favored Pre-proline 0 N--CA 1.503 2.204 0 O-C-N 120.873 -1.142 . . . . 0.0 109.79 -179.734 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 89' ' ' PRO . . . . . . . . . . . . . 7.3 Cg_endo -59.02 144.6 99.3 Favored 'Trans proline' 0 C--N 1.309 -1.518 0 C-N-CA 122.476 2.117 . . . . 0.0 113.551 -179.663 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . -59.14 169.1 6.23 Favored Glycine 0 N--CA 1.494 2.541 0 N-CA-C 108.899 -1.681 . . . . 0.0 108.899 178.902 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 91' ' ' PRO . . . . . 0.435 ' C ' ' H ' ' A' ' 93' ' ' THR . 59.8 Cg_endo -93.56 168.02 20.96 Favored 'Cis proline' 0 C--N 1.31 -1.452 0 C-N-CA 124.046 -1.231 . . . . 0.0 111.916 0.619 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 92' ' ' ALA . . . . . 0.473 ' HB1' HD21 ' A' ' 97' ' ' LEU . . . -71.99 32.05 0.06 Allowed 'General case' 0 N--CA 1.493 1.706 0 O-C-N 121.159 -0.963 . . . . 0.0 110.716 -179.664 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 93' ' ' THR . . . . . 0.435 ' H ' ' C ' ' A' ' 91' ' ' PRO . 0.8 OUTLIER -73.46 155.1 89.76 Favored Pre-proline 0 N--CA 1.489 1.523 0 O-C-N 120.692 -1.255 . . . . 0.0 108.751 -179.956 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 94' ' ' PRO . . . . . 0.401 ' C ' ' O ' ' A' ' 93' ' ' THR . 85.2 Cg_exo -34.55 -55.78 0.5 Allowed 'Trans proline' 0 C--N 1.306 -1.668 0 C-N-CA 122.818 2.346 . . . . 0.0 112.387 -179.506 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 95' ' ' GLU . . . . . 0.479 ' OE2' ' OE1' ' A' ' 96' ' ' GLN . 0.1 OUTLIER -47.36 -48.74 25.55 Favored 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.083 -1.011 . . . . 0.0 109.67 -179.812 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 96' ' ' GLN . . . . . 0.594 ' O ' ' N ' ' A' ' 98' ' ' ASN . 5.9 mp0 -71.94 -56.1 6.28 Favored 'General case' 0 N--CA 1.489 1.476 0 O-C-N 121.04 -1.038 . . . . 0.0 110.572 -179.563 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 97' ' ' LEU . . . . . 0.473 HD21 ' HB1' ' A' ' 92' ' ' ALA . 93.6 mt -48.09 -7.0 0.02 OUTLIER 'General case' 0 N--CA 1.494 1.74 0 O-C-N 121.193 -0.942 . . . . 0.0 110.005 -178.939 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 98' ' ' ASN . . . . . 0.716 HD21 ' NE ' ' A' ' 99' ' ' ARG . 0.2 OUTLIER -73.4 -26.35 60.95 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.201 -0.937 . . . . 0.0 109.042 179.274 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 99' ' ' ARG . . . . . 0.716 ' NE ' HD21 ' A' ' 98' ' ' ASN . 4.3 mtt180 -95.08 -51.15 4.77 Favored 'General case' 0 N--CA 1.488 1.442 0 C-N-CA 119.842 -0.743 . . . . 0.0 109.783 -179.218 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . 176.44 -165.29 35.55 Favored Glycine 0 N--CA 1.491 2.325 0 C-N-CA 119.462 -1.351 . . . . 0.0 110.232 179.776 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 101' ' ' VAL . . . . . 0.723 ' O ' HG23 ' A' ' 101' ' ' VAL . 21.0 m -58.47 105.76 0.19 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.632 0 O-C-N 121.498 -1.001 . . . . 0.0 109.554 -179.676 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -92.68 166.65 12.36 Favored 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.476 -0.765 . . . . 0.0 110.775 -179.519 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 103' ' ' PHE . . . . . 0.479 ' CE1' ' CG1' ' A' ' 87' ' ' VAL . 25.5 m-85 -72.25 131.15 42.34 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 120.987 -1.071 . . . . 0.0 108.176 178.458 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 104' ' ' ALA . . . . . 0.476 ' HB1' ' HG2' ' C' ' 703' ' ' PRO . . . -51.93 -7.21 0.05 OUTLIER 'General case' 0 C--N 1.295 -1.786 0 O-C-N 121.416 -0.802 . . . . 0.0 111.873 -178.596 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -141.22 139.54 33.81 Favored 'General case' 0 N--CA 1.499 2.023 0 O-C-N 120.444 -1.41 . . . . 0.0 111.469 -179.682 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 106' ' ' GLU . . . . . . . . . . . . . 1.9 pt-20 -54.3 -62.0 1.94 Allowed 'General case' 0 N--CA 1.488 1.472 0 O-C-N 121.855 -0.528 . . . . 0.0 109.947 179.51 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 107' ' ' ASN . . . . . . . . . . . . . 8.1 m120 -76.83 35.32 0.16 Allowed 'General case' 0 N--CA 1.489 1.483 0 O-C-N 120.545 -1.347 . . . . 0.0 111.607 -176.833 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 108' ' ' GLU . . . . . . . . . . . . . 35.1 tp10 -57.19 144.37 35.44 Favored 'General case' 0 C--N 1.303 -1.428 0 O-C-N 120.813 -1.179 . . . . 0.0 107.83 -179.802 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 109' ' ' SER . . . . . 0.557 ' C ' ' H ' ' A' ' 111' ' ' ASP . 1.2 m -101.24 124.85 47.59 Favored 'General case' 0 C--N 1.303 -1.438 0 O-C-N 121.058 -1.026 . . . . 0.0 110.648 -178.455 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 110' ' ' LEU . . . . . 0.602 HD23 ' HG2' ' A' ' 63' ' ' PRO . 3.5 tp -58.99 -3.45 0.35 Allowed 'General case' 0 C--N 1.3 -1.548 0 N-CA-C 107.693 -1.225 . . . . 0.0 107.693 179.066 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 111' ' ' ASP . . . . . 0.557 ' H ' ' C ' ' A' ' 109' ' ' SER . 1.6 m-20 -132.17 21.66 4.46 Favored 'General case' 0 N--CA 1.486 1.363 0 N-CA-C 109.128 -0.693 . . . . 0.0 109.128 179.696 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 112' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -64.96 138.34 58.3 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 120.985 -1.072 . . . . 0.0 109.543 179.839 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 113' ' ' GLN . . . . . 0.566 HE21 ' C ' ' A' ' 113' ' ' GLN . 0.0 OUTLIER -66.29 -5.86 11.98 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 120.94 -1.1 . . . . 0.0 108.696 179.201 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 114' ' ' ASN . . . . . 0.608 ' OD1' ' NE2' ' A' ' 178' ' ' GLN . 4.1 t30 -145.54 97.34 2.97 Favored 'General case' 0 C--N 1.297 -1.7 0 N-CA-C 107.305 -1.369 . . . . 0.0 107.305 178.16 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 115' ' ' ILE . . . . . 0.509 HG22 ' O ' ' A' ' 115' ' ' ILE . 1.8 mt -95.64 107.09 19.12 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.599 0 O-C-N 121.13 -0.981 . . . . 0.0 108.694 -179.522 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 116' ' ' SER . . . . . . . . . . . . . 7.5 p -90.22 154.71 19.53 Favored 'General case' 0 C--N 1.305 -1.355 0 CA-C-O 121.728 0.775 . . . . 0.0 110.814 -178.458 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 117' ' ' ILE . . . . . 0.419 HD13 HG21 ' A' ' 117' ' ' ILE . 3.2 mt -144.35 153.68 15.18 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.412 0 N-CA-C 108.337 -0.986 . . . . 0.0 108.337 179.135 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 118' ' ' ALA . . . . . 0.417 ' HB3' ' HB2' ' A' ' 92' ' ' ALA . . . -140.34 153.9 46.57 Favored 'General case' 0 N--CA 1.49 1.562 0 C-N-CA 119.217 -0.993 . . . . 0.0 110.481 -179.586 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 119' ' ' GLY . . . . . . . . . . . . . . . -166.57 148.17 13.07 Favored Glycine 0 N--CA 1.487 2.074 0 C-N-CA 119.912 -1.137 . . . . 0.0 110.715 -179.988 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 120' ' ' HIS . . . . . . . . . . . . . 3.2 m-70 -72.47 161.74 30.41 Favored 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.919 -0.754 . . . . 0.0 110.006 179.337 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 121' ' ' THR . . . . . . . . . . . . . 1.1 t -116.22 158.29 23.55 Favored 'General case' 0 N--CA 1.496 1.85 0 O-C-N 121.338 -0.851 . . . . 0.0 109.079 178.958 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 122' ' ' PHE . . . . . . . . . . . . . 0.3 OUTLIER -124.67 127.03 46.68 Favored 'General case' 0 N--CA 1.498 1.946 0 O-C-N 121.296 -0.877 . . . . 0.0 109.852 -179.637 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 123' ' ' ILE . . . . . 0.534 HG23 ' N ' ' A' ' 124' ' ' ASP . 16.3 tt -74.73 -36.74 41.08 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.665 0 CA-C-O 121.922 0.868 . . . . 0.0 109.141 179.712 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 124' ' ' ASP . . . . . 0.534 ' N ' HG23 ' A' ' 123' ' ' ILE . 2.0 p30 -95.54 22.49 7.01 Favored 'General case' 0 C--N 1.296 -1.756 0 O-C-N 121.827 -0.546 . . . . 0.0 111.042 -179.224 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 125' ' ' ARG . . . . . . . . . . . . . 9.4 ttt180 -157.06 107.42 1.91 Allowed Pre-proline 0 N--CA 1.492 1.674 0 O-C-N 120.518 -1.364 . . . . 0.0 110.441 -179.08 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 126' ' ' PRO . . . . . . . . . . . . . 56.9 Cg_endo -79.79 -23.27 7.01 Favored 'Trans proline' 0 C--N 1.315 -1.193 0 C-N-CA 122.056 1.837 . . . . 0.0 112.454 179.416 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 127' ' ' ASN . . . . . . . . . . . . . 28.4 m120 -91.5 29.64 1.45 Allowed 'General case' 0 N--CA 1.493 1.681 0 O-C-N 121.186 -0.946 . . . . 0.0 109.573 179.902 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 128' ' ' TYR . . . . . 0.687 ' CZ ' ' NE2' ' A' ' 129' ' ' GLN . 14.8 t80 -81.32 -151.04 0.08 Allowed 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.254 -0.904 . . . . 0.0 109.843 -179.669 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 129' ' ' GLN . . . . . 0.687 ' NE2' ' CZ ' ' A' ' 128' ' ' TYR . 1.7 mp0 -68.3 -71.85 0.2 Allowed 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.265 -0.897 . . . . 0.0 109.906 -179.507 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 130' ' ' PHE . . . . . 0.55 ' CE2' HG11 ' A' ' 101' ' ' VAL . 50.5 m-85 -125.88 25.94 6.72 Favored 'General case' 0 N--CA 1.497 1.884 0 O-C-N 121.21 -0.931 . . . . 0.0 110.278 -179.927 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 131' ' ' THR . . . . . . . . . . . . . 36.7 m -63.78 -34.85 78.81 Favored 'General case' 0 N--CA 1.493 1.693 0 O-C-N 120.844 -1.16 . . . . 0.0 109.754 -179.964 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 132' ' ' ASN . . . . . 0.6 ' ND2' ' O ' ' A' ' 81' ' ' ALA . 12.5 t30 -85.24 9.57 14.83 Favored 'General case' 0 N--CA 1.497 1.883 0 C-N-CA 119.913 -0.715 . . . . 0.0 111.788 -178.234 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 133' ' ' LEU . . . . . 0.606 ' O ' ' N ' ' A' ' 135' ' ' ALA . 0.1 OUTLIER -71.94 -44.56 63.4 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 120.565 -1.334 . . . . 0.0 110.328 -179.442 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 134' ' ' LYS . . . . . 0.62 ' CD ' ' H ' ' A' ' 134' ' ' LYS . 0.0 OUTLIER -42.58 -16.36 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.663 0 O-C-N 121.192 -0.942 . . . . 0.0 110.089 -179.132 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 135' ' ' ALA . . . . . 0.606 ' N ' ' O ' ' A' ' 133' ' ' LEU . . . -85.23 -37.06 20.52 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.02 -1.05 . . . . 0.0 109.738 179.708 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 136' ' ' ALA . . . . . 0.87 ' HB2' ' HB2' ' A' ' 81' ' ' ALA . . . -78.43 153.54 31.42 Favored 'General case' 0 N--CA 1.489 1.519 0 CA-C-O 121.977 0.894 . . . . 0.0 111.317 -178.6 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 137' ' ' LYS . . . . . 0.508 ' O ' ' OG ' ' A' ' 140' ' ' SER . 0.6 OUTLIER -156.15 -163.36 1.46 Allowed 'General case' 0 N--CA 1.494 1.744 0 C-N-CA 118.559 -1.257 . . . . 0.0 111.224 -178.387 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 138' ' ' LYS . . . . . 0.604 ' O ' ' N ' ' A' ' 140' ' ' SER . 24.9 pttt -45.95 179.74 0.0 OUTLIER 'General case' 0 C--N 1.305 -1.364 0 CA-C-O 121.95 0.881 . . . . 0.0 110.296 -179.395 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 139' ' ' GLY . . . . . . . . . . . . . . . 45.58 8.07 0.01 OUTLIER Glycine 0 N--CA 1.491 2.336 0 N-CA-C 110.817 -0.913 . . . . 0.0 110.817 179.705 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 140' ' ' SER . . . . . 0.604 ' N ' ' O ' ' A' ' 138' ' ' LYS . 46.9 m -94.07 136.85 33.91 Favored 'General case' 0 N--CA 1.494 1.734 0 O-C-N 120.823 -1.398 . . . . 0.0 109.333 179.225 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 141' ' ' MET . . . . . 0.407 ' HG2' ' CE1' ' A' ' 143' ' ' TYR . 0.4 OUTLIER -85.04 147.6 26.58 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.155 -0.965 . . . . 0.0 109.55 -179.96 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 142' ' ' VAL . . . . . . . . . . . . . 2.1 t -132.15 134.93 59.05 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.661 0 N-CA-C 108.368 -0.975 . . . . 0.0 108.368 -179.759 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 143' ' ' TYR . . . . . 0.407 ' CE1' ' HG2' ' A' ' 141' ' ' MET . 37.0 m-85 -114.03 137.53 51.59 Favored 'General case' 0 N--CA 1.499 2.008 0 O-C-N 120.792 -1.192 . . . . 0.0 111.391 -178.842 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 144' ' ' PHE . . . . . . . . . . . . . 5.1 t80 -123.15 107.02 11.28 Favored 'General case' 0 N--CA 1.494 1.77 0 CA-C-O 121.476 0.655 . . . . 0.0 109.833 -179.215 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 145' ' ' LYS . . . . . . . . . . . . . 14.7 tttt -95.55 132.83 40.25 Favored 'General case' 0 N--CA 1.495 1.799 0 O-C-N 121.417 -0.802 . . . . 0.0 111.43 -178.725 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 146' ' ' VAL . . . . . 0.458 ' O ' ' C ' ' A' ' 147' ' ' GLY . 0.0 OUTLIER -143.26 141.1 26.48 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.813 0 N-CA-C 107.629 -1.249 . . . . 0.0 107.629 178.589 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 147' ' ' GLY . . . . . 0.458 ' C ' ' O ' ' A' ' 146' ' ' VAL . . . 40.02 -126.3 2.54 Favored Glycine 0 N--CA 1.494 2.533 0 N-CA-C 109.776 -1.33 . . . . 0.0 109.776 179.778 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 148' ' ' ASN . . . . . 0.513 ' C ' ' ND2' ' A' ' 148' ' ' ASN . 0.4 OUTLIER -101.65 14.94 30.46 Favored 'General case' 0 C--N 1.302 -1.476 0 O-C-N 121.426 -1.043 . . . . 0.0 108.339 179.209 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 149' ' ' GLU . . . . . . . . . . . . . 3.2 tt0 -109.92 142.39 41.33 Favored 'General case' 0 N--CA 1.485 1.324 0 CA-C-O 121.946 0.879 . . . . 0.0 111.515 -178.43 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 150' ' ' THR . . . . . . . . . . . . . 54.3 m -129.48 101.83 6.12 Favored 'General case' 0 C--N 1.3 -1.58 0 CA-C-O 121.658 0.742 . . . . 0.0 109.713 179.81 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 151' ' ' ARG . . . . . . . . . . . . . 2.5 mtp180 -87.33 179.3 6.63 Favored 'General case' 0 C--N 1.306 -1.322 0 N-CA-C 108.601 -0.889 . . . . 0.0 108.601 179.951 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 152' ' ' LYS . . . . . 0.408 ' C ' ' CD1' ' A' ' 153' ' ' TYR . 24.6 mtmm -147.53 148.16 30.89 Favored 'General case' 0 C--N 1.302 -1.495 0 O-C-N 121.089 -1.007 . . . . 0.0 109.838 -179.671 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 153' ' ' TYR . . . . . 0.408 ' CD1' ' C ' ' A' ' 152' ' ' LYS . 20.6 m-85 -141.64 167.5 21.99 Favored 'General case' 0 N--CA 1.492 1.629 0 N-CA-C 108.491 -0.929 . . . . 0.0 108.491 179.258 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 154' ' ' LYS . . . . . 0.461 ' HZ3' HG21 ' A' ' 205' ' ' VAL . 4.4 ttpm? -137.7 122.41 18.68 Favored 'General case' 0 C--N 1.296 -1.731 0 N-CA-C 108.698 -0.853 . . . . 0.0 108.698 179.155 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 155' ' ' MET . . . . . . . . . . . . . 38.4 mmm -48.98 107.38 0.13 Allowed 'General case' 0 N--CA 1.491 1.604 0 O-C-N 120.785 -1.197 . . . . 0.0 110.904 -178.891 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 156' ' ' THR . . . . . 0.609 ' OG1' HG23 ' A' ' 203' ' ' THR . 0.0 OUTLIER -109.49 -22.18 12.12 Favored 'General case' 0 C--N 1.296 -1.748 0 C-N-CA 119.832 -0.747 . . . . 0.0 110.597 -178.959 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 157' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -151.67 146.98 26.19 Favored 'General case' 0 C--N 1.294 -1.838 0 C-N-CA 118.702 -1.199 . . . . 0.0 110.966 -178.411 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 158' ' ' ILE . . . . . 0.841 HD12 ' N ' ' A' ' 159' ' ' ARG . 0.1 OUTLIER -155.51 142.57 11.66 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.334 0 CA-C-O 121.778 0.799 . . . . 0.0 110.013 -178.834 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 159' ' ' ARG . . . . . 0.841 ' N ' HD12 ' A' ' 158' ' ' ILE . 23.1 ttm180 -155.99 160.3 39.94 Favored 'General case' 0 C--N 1.297 -1.679 0 CA-C-O 121.79 0.805 . . . . 0.0 110.44 -179.618 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 160' ' ' ASP . . . . . 0.547 ' O ' HG13 ' A' ' 161' ' ' VAL . 35.7 m-20 -116.02 161.44 18.87 Favored 'General case' 0 N--CA 1.49 1.564 0 N-CA-C 108.203 -1.036 . . . . 0.0 108.203 179.185 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 161' ' ' VAL . . . . . 0.577 HG21 ' CG1' ' A' ' 168' ' ' VAL . 3.3 m -156.79 155.01 5.57 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.63 0 O-C-N 121.117 -0.99 . . . . 0.0 110.722 -178.569 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 162' ' ' LYS . . . . . 0.438 ' O ' ' O ' ' A' ' 161' ' ' VAL . 0.0 OUTLIER -45.02 169.9 0.06 OUTLIER Pre-proline 0 N--CA 1.492 1.652 0 O-C-N 121.594 -0.691 . . . . 0.0 109.795 179.527 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 163' ' ' PRO . . . . . 0.467 ' C ' HD11 ' C' ' 702' ' ' LEU . 65.1 Cg_endo -78.54 34.59 0.51 Allowed 'Trans proline' 0 N--CA 1.493 1.466 0 C-N-CA 123.052 2.501 . . . . 0.0 113.026 -179.975 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 164' ' ' THR . . . . . 0.441 ' N ' HD11 ' C' ' 702' ' ' LEU . 0.3 OUTLIER -153.26 -3.86 0.2 Allowed 'General case' 0 N--CA 1.496 1.873 0 O-C-N 121.022 -1.049 . . . . 0.0 110.925 -179.824 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 165' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -77.2 64.44 2.62 Favored 'General case' 0 N--CA 1.496 1.857 0 O-C-N 120.861 -1.149 . . . . 0.0 110.899 -179.078 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 166' ' ' VAL . . . . . 0.593 ' O ' ' N ' ' A' ' 168' ' ' VAL . 1.4 m -46.44 -30.26 1.22 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.702 0 O-C-N 121.13 -0.981 . . . . 0.0 110.563 -178.244 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 167' ' ' GLY . . . . . . . . . . . . . . . -45.22 -9.1 0.01 OUTLIER Glycine 0 N--CA 1.498 2.796 0 O-C-N 120.694 -1.254 . . . . 0.0 111.313 -179.353 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 168' ' ' VAL . . . . . 0.593 ' N ' ' O ' ' A' ' 166' ' ' VAL . 4.2 m -53.88 -31.67 21.02 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.657 0 O-C-N 120.615 -1.521 . . . . 0.0 109.114 -179.988 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 169' ' ' LEU . . . . . 0.552 ' O ' ' C ' ' A' ' 170' ' ' ASP . 10.9 mt -45.57 -17.79 0.03 OUTLIER 'General case' 0 N--CA 1.493 1.677 0 N-CA-C 108.19 -1.041 . . . . 0.0 108.19 -178.41 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 170' ' ' ASP . . . . . 0.552 ' C ' ' O ' ' A' ' 169' ' ' LEU . 2.5 m-20 21.44 90.51 0.01 OUTLIER 'General case' 0 N--CA 1.501 2.086 0 CA-C-O 120.81 0.338 . . . . 0.0 111.797 178.151 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 171' ' ' GLU . . . . . 0.408 ' HB3' ' ND2' ' A' ' 114' ' ' ASN . 10.1 pt-20 -140.27 78.06 1.64 Allowed 'General case' 0 N--CA 1.494 1.754 0 O-C-N 120.845 -1.16 . . . . 0.0 109.808 179.512 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 172' ' ' GLN . . . . . . . . . . . . . 2.6 mp0 -136.49 -41.43 0.63 Allowed 'General case' 0 N--CA 1.495 1.793 0 O-C-N 121.453 -0.779 . . . . 0.0 110.607 -178.749 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 173' ' ' LYS . . . . . . . . . . . . . 49.7 mttp -58.24 140.41 53.2 Favored 'General case' 0 N--CA 1.493 1.686 0 O-C-N 120.74 -1.225 . . . . 0.0 108.514 179.676 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 174' ' ' GLY . . . . . 0.478 ' O ' ' C ' ' A' ' 175' ' ' LYS . . . -127.29 -46.6 0.2 Allowed Glycine 0 C--N 1.298 -1.534 0 N-CA-C 107.619 -2.192 . . . . 0.0 107.619 179.704 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 175' ' ' LYS . . . . . 0.478 ' C ' ' O ' ' A' ' 174' ' ' GLY . 27.9 mmtt -42.77 -61.42 1.26 Allowed 'General case' 0 N--CA 1.489 1.523 0 N-CA-C 108.023 -1.103 . . . . 0.0 108.023 178.611 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 176' ' ' ASP . . . . . 0.525 ' O ' ' O ' ' A' ' 177' ' ' LYS . 3.6 p30 -104.53 95.23 5.78 Favored 'General case' 0 C--N 1.299 -1.63 0 N-CA-C 108.059 -1.089 . . . . 0.0 108.059 178.086 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 177' ' ' LYS . . . . . 0.525 ' O ' ' O ' ' A' ' 176' ' ' ASP . 0.5 OUTLIER -48.39 -176.37 0.0 OUTLIER 'General case' 0 N--CA 1.494 1.734 0 O-C-N 121.119 -0.988 . . . . 0.0 109.432 -179.694 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 178' ' ' GLN . . . . . 0.608 ' NE2' ' OD1' ' A' ' 114' ' ' ASN . 20.9 pt20 -162.06 174.47 12.96 Favored 'General case' 0 C--N 1.308 -1.227 0 C-N-CA 118.605 -1.238 . . . . 0.0 110.663 179.214 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 179' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -134.62 100.36 4.61 Favored 'General case' 0 C--N 1.301 -1.518 0 N-CA-C 107.756 -1.201 . . . . 0.0 107.756 178.046 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 180' ' ' THR . . . . . 0.423 ' O ' HG22 ' A' ' 180' ' ' THR . 1.0 OUTLIER -79.99 116.62 20.23 Favored 'General case' 0 N--CA 1.493 1.707 0 O-C-N 121.095 -1.003 . . . . 0.0 110.186 -178.794 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 181' ' ' LEU . . . . . . . . . . . . . 8.8 tp -99.43 106.13 18.15 Favored 'General case' 0 C--N 1.3 -1.583 0 O-C-N 121.453 -0.779 . . . . 0.0 109.496 179.146 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 182' ' ' ILE . . . . . 0.4 ' O ' ' HA ' ' A' ' 118' ' ' ALA . 48.2 mt -93.74 127.83 45.52 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.541 0 O-C-N 120.895 -1.128 . . . . 0.0 108.76 178.909 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 183' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -144.55 111.28 5.73 Favored 'General case' 0 C--N 1.291 -1.948 0 N-CA-C 107.409 -1.33 . . . . 0.0 107.409 179.569 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 184' ' ' CYS . . . . . . . . . . . . . 15.9 p -79.62 161.0 26.16 Favored 'General case' 0 C--N 1.291 -1.975 0 C-N-CA 118.988 -1.085 . . . . 0.0 111.782 -177.334 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 185' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -166.67 -161.71 0.47 Allowed 'General case' 0 N--CA 1.494 1.775 0 O-C-N 121.665 -0.647 . . . . 0.0 109.338 179.759 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 186' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER 55.15 57.03 5.86 Favored 'General case' 0 N--CA 1.496 1.857 0 O-C-N 121.144 -0.973 . . . . 0.0 109.368 -179.838 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 187' ' ' TYR . . . . . 0.619 ' CE1' ' O ' ' A' ' 188' ' ' ASN . 65.7 t80 -67.78 137.23 55.24 Favored 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.342 -0.849 . . . . 0.0 110.703 -179.514 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 188' ' ' ASN . . . . . 0.619 ' O ' ' CE1' ' A' ' 187' ' ' TYR . 1.2 t-20 -101.98 145.66 28.96 Favored 'General case' 0 C--N 1.297 -1.697 0 N-CA-C 108.39 -0.967 . . . . 0.0 108.39 178.376 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 189' ' ' GLU . . . . . . . . . . . . . 1.9 tt0 -110.08 -14.74 14.17 Favored 'General case' 0 C--N 1.294 -1.823 0 N-CA-C 108.984 -0.747 . . . . 0.0 108.984 -179.217 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 190' ' ' LYS . . . . . . . . . . . . . 4.6 mttm -83.53 -52.36 6.54 Favored 'General case' 0 C--N 1.301 -1.506 0 C-N-CA 119.82 -0.752 . . . . 0.0 109.099 179.423 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 191' ' ' THR . . . . . 0.541 ' OG1' HG12 ' A' ' 193' ' ' VAL . 2.1 p -89.16 -9.25 51.62 Favored 'General case' 0 N--CA 1.489 1.525 0 O-C-N 121.52 -0.738 . . . . 0.0 109.235 179.799 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 192' ' ' GLY . . . . . . . . . . . . . . . 68.4 33.31 77.07 Favored Glycine 0 N--CA 1.493 2.496 0 O-C-N 121.298 -0.876 . . . . 0.0 111.119 178.606 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 193' ' ' VAL . . . . . 0.541 HG12 ' OG1' ' A' ' 191' ' ' THR . 2.4 p -147.54 169.63 3.96 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.582 0 O-C-N 120.806 -1.408 . . . . 0.0 109.891 179.169 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 194' ' ' TRP . . . . . 0.521 ' H ' HG22 ' A' ' 193' ' ' VAL . 10.7 m95 -85.74 121.55 28.56 Favored 'General case' 0 C--N 1.294 -1.836 0 O-C-N 121.648 -0.657 . . . . 0.0 109.271 -179.908 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 195' ' ' GLU . . . . . 0.512 ' CD ' ' ND2' ' A' ' 188' ' ' ASN . 7.5 mt-10 -77.31 -60.14 2.49 Favored 'General case' 0 N--CA 1.496 1.862 0 O-C-N 121.385 -0.822 . . . . 0.0 111.575 -178.521 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 196' ' ' LYS . . . . . . . . . . . . . 6.3 mtmt -92.1 158.16 16.35 Favored 'General case' 0 N--CA 1.493 1.72 0 O-C-N 120.86 -1.15 . . . . 0.0 111.397 -177.946 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 197' ' ' ARG . . . . . . . . . . . . . 25.3 mmt180 -124.14 139.17 54.19 Favored 'General case' 0 N--CA 1.488 1.466 0 N-CA-C 108.674 -0.862 . . . . 0.0 108.674 179.001 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 198' ' ' LYS . . . . . . . . . . . . . 14.9 mttt -119.8 120.63 37.07 Favored 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.544 -0.723 . . . . 0.0 110.13 -179.017 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 199' ' ' ILE . . . . . 0.566 ' C ' HD12 ' A' ' 199' ' ' ILE . 0.8 OUTLIER -139.81 119.83 13.54 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.66 0 O-C-N 121.192 -0.943 . . . . 0.0 109.562 179.43 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 200' ' ' PHE . . . . . 0.537 ' CD1' ' N ' ' A' ' 200' ' ' PHE . 8.7 m-85 -99.91 139.05 36.15 Favored 'General case' 0 N--CA 1.499 2.012 0 O-C-N 121.468 -0.77 . . . . 0.0 110.76 -178.534 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 201' ' ' VAL . . . . . 0.445 HG13 ' NE2' ' A' ' 178' ' ' GLN . 24.3 t -104.12 149.07 8.11 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.553 0 N-CA-C 107.39 -1.337 . . . . 0.0 107.39 176.489 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 202' ' ' ALA . . . . . . . . . . . . . . . -132.47 139.6 48.04 Favored 'General case' 0 C--N 1.3 -1.585 0 O-C-N 121.047 -1.033 . . . . 0.0 108.249 -179.864 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 203' ' ' THR . . . . . 0.609 HG23 ' OG1' ' A' ' 156' ' ' THR . 13.7 p -90.85 132.15 36.07 Favored 'General case' 0 C--N 1.305 -1.343 0 CA-C-O 122.647 1.213 . . . . 0.0 111.608 -178.242 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 204' ' ' GLU . . . . . 0.403 ' HA ' ' CD2' ' A' ' 153' ' ' TYR . 1.2 tm-20 -60.79 136.24 58.01 Favored 'General case' 0 C--N 1.297 -1.711 0 C-N-CA 118.334 -1.347 . . . . 0.0 108.798 179.159 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 205' ' ' VAL . . . . . 0.473 ' O ' ' C ' ' A' ' 206' ' ' LYS . 36.6 t -130.85 -35.82 0.59 Allowed 'Isoleucine or valine' 0 N--CA 1.495 1.795 0 O-C-N 121.298 -0.877 . . . . 0.0 110.189 -179.437 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 206' ' ' LYS . . . . . 0.473 ' C ' ' O ' ' A' ' 205' ' ' VAL . 0.0 OUTLIER . . . . . 0 N--CA 1.495 1.777 0 CA-C-O 117.945 -1.026 . . . . 0.0 110.259 -179.584 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' C' C ' 702' ' ' LEU . . . . . 0.632 ' N ' HD12 ' C' ' 702' ' ' LEU . 0.0 OUTLIER . . . . . 0 N--CA 1.491 1.614 0 N-CA-C 109.074 -0.713 . . . . 0.0 109.074 . . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' C' C ' 703' ' ' PRO . . . . . 0.476 ' HG2' ' HB1' ' A' ' 104' ' ' ALA . 31.9 Cg_exo -43.31 175.79 0.0 OUTLIER 'Trans proline' 0 N--CA 1.49 1.313 0 C-N-CA 122.593 2.195 . . . . 0.0 112.981 -179.097 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' C' C ' 704' ' ' ALA . . . . . 0.403 ' C ' ' O ' ' C' ' 703' ' ' PRO . . . . . . . . 0 N--CA 1.489 1.519 0 O-C-N 121.502 -0.749 . . . . 0.0 109.769 179.477 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 63' ' ' PRO . . . . . 0.843 ' O ' HD13 ' A' ' 110' ' ' LEU . 6.2 Cg_exo . . . . . 0 N--CA 1.487 1.094 0 CA-C-O 121.383 0.493 . . . . 0.0 111.455 . . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 64' ' ' GLN . . . . . 0.617 ' O ' ' NE2' ' A' ' 64' ' ' GLN . 0.0 OUTLIER -158.97 137.07 10.53 Favored 'General case' 0 C--N 1.299 -1.598 0 O-C-N 121.169 -0.957 . . . . 0.0 109.43 179.684 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 65' ' ' ILE . . . . . 0.75 ' N ' HD13 ' A' ' 65' ' ' ILE . 0.2 OUTLIER -50.79 110.42 1.73 Allowed Pre-proline 0 N--CA 1.489 1.501 0 O-C-N 120.829 -1.169 . . . . 0.0 108.624 179.253 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 66' ' ' PRO . . . . . . . . . . . . . 87.1 Cg_endo -82.52 -162.77 0.19 Allowed 'Trans proline' 0 C--N 1.314 -1.251 0 C-N-CA 121.998 1.798 . . . . 0.0 111.797 -179.784 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 67' ' ' LYS . . . . . . . . . . . . . 36.4 tttp -90.11 -10.28 45.23 Favored 'General case' 0 C--N 1.302 -1.481 0 O-C-N 121.176 -0.953 . . . . 0.0 109.081 179.534 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 68' ' ' ASP . . . . . 0.644 ' C ' ' H ' ' A' ' 70' ' ' SER . 0.2 OUTLIER -76.61 64.02 2.18 Favored 'General case' 0 N--CA 1.489 1.505 0 CA-C-O 122.763 1.268 . . . . 0.0 108.71 179.194 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 69' ' ' LYS . . . . . 0.459 ' C ' ' O ' ' A' ' 68' ' ' ASP . 6.3 ptpp? -46.99 -14.16 0.03 OUTLIER 'General case' 0 N--CA 1.508 2.472 0 C-N-CA 117.259 -1.776 . . . . 0.0 106.701 177.534 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 70' ' ' SER . . . . . 0.644 ' H ' ' C ' ' A' ' 68' ' ' ASP . 3.4 p -85.93 -6.36 59.08 Favored 'General case' 0 N--CA 1.496 1.839 0 CA-C-N 113.414 -1.721 . . . . 0.0 111.496 179.564 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 71' ' ' LYS . . . . . 0.496 ' N ' ' O ' ' A' ' 68' ' ' ASP . 0.0 OUTLIER -95.35 142.6 27.55 Favored 'General case' 0 N--CA 1.501 2.079 0 O-C-N 120.579 -1.325 . . . . 0.0 112.225 -179.288 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 72' ' ' VAL . . . . . 0.691 HG12 ' CZ ' ' A' ' 88' ' ' TYR . 3.1 m -66.46 134.44 29.95 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.5 0 N-CA-C 104.318 -2.475 . . . . 0.0 104.318 174.65 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 73' ' ' ALA . . . . . 0.517 ' N ' ' O ' ' A' ' 87' ' ' VAL . . . -81.47 -15.65 54.37 Favored 'General case' 0 C--N 1.291 -1.967 0 O-C-N 119.849 -1.782 . . . . 0.0 106.859 179.985 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . 172.16 -155.78 24.23 Favored Glycine 0 C--N 1.298 -1.533 0 N-CA-C 109.817 -1.313 . . . . 0.0 109.817 179.512 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 75' ' ' TYR . . . . . 0.527 ' HA ' HG23 ' A' ' 87' ' ' VAL . 73.0 m-85 -142.56 169.99 16.54 Favored 'General case' 0 C--N 1.297 -1.684 0 CA-C-O 122.06 0.933 . . . . 0.0 110.848 -177.459 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 76' ' ' ILE . . . . . . . . . . . . . 1.0 OUTLIER -150.15 146.9 16.46 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.814 0 C-N-CA 119.58 -0.848 . . . . 0.0 109.179 -178.382 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -151.15 164.8 35.68 Favored 'General case' 0 C--N 1.302 -1.494 0 O-C-N 120.919 -1.113 . . . . 0.0 109.262 -179.734 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 78' ' ' ILE . . . . . 0.512 ' HB ' ' HB3' ' A' ' 81' ' ' ALA . 10.0 mt -147.91 92.97 4.57 Favored Pre-proline 0 N--CA 1.488 1.425 0 N-CA-C 108.516 -0.92 . . . . 0.0 108.516 179.998 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 79' ' ' PRO . . . . . . . . . . . . . 72.3 Cg_exo -46.77 -43.54 23.41 Favored 'Trans proline' 0 N--CA 1.494 1.536 0 C-N-CA 122.852 2.368 . . . . 0.0 113.954 -178.972 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 37.9 t70 -65.54 -20.62 66.41 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 120.665 -1.272 . . . . 0.0 110.343 178.582 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 81' ' ' ALA . . . . . 0.788 ' HB2' ' HB2' ' A' ' 136' ' ' ALA . . . -106.33 -15.05 14.93 Favored 'General case' 0 C--N 1.302 -1.471 0 O-C-N 121.354 -0.841 . . . . 0.0 108.762 179.664 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 82' ' ' ASP . . . . . . . . . . . . . 2.5 t70 66.38 49.51 1.41 Allowed 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.163 -0.961 . . . . 0.0 110.227 179.506 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 83' ' ' ILE . . . . . 0.685 HD11 ' OD1' ' A' ' 132' ' ' ASN . 62.7 mt -128.57 151.38 35.28 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.786 0 O-C-N 121.259 -0.901 . . . . 0.0 110.333 -178.988 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 84' ' ' LYS . . . . . . . . . . . . . 17.4 tttt -159.53 106.42 1.7 Allowed 'General case' 0 N--CA 1.493 1.69 0 N-CA-C 108.416 -0.957 . . . . 0.0 108.416 178.964 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 85' ' ' GLU . . . . . 0.54 ' N ' ' OE2' ' A' ' 85' ' ' GLU . 0.0 OUTLIER -140.07 165.77 28.37 Favored Pre-proline 0 N--CA 1.491 1.621 0 O-C-N 121.393 -0.817 . . . . 0.0 109.858 -179.008 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 86' ' ' PRO . . . . . . . . . . . . . 56.9 Cg_endo -74.27 166.53 29.3 Favored 'Trans proline' 0 N--CA 1.496 1.621 0 C-N-CA 123.116 2.544 . . . . 0.0 113.779 -178.548 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 87' ' ' VAL . . . . . 0.527 HG23 ' HA ' ' A' ' 75' ' ' TYR . 61.3 t -122.9 100.07 7.6 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.539 0 N-CA-C 109.093 -0.706 . . . . 0.0 109.093 179.715 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 88' ' ' TYR . . . . . 0.691 ' CZ ' HG12 ' A' ' 72' ' ' VAL . 42.1 m-85 -91.87 154.76 43.7 Favored Pre-proline 0 N--CA 1.505 2.298 0 O-C-N 120.944 -1.098 . . . . 0.0 110.086 -179.359 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 89' ' ' PRO . . . . . . . . . . . . . 7.0 Cg_endo -56.84 145.78 81.98 Favored 'Trans proline' 0 N--CA 1.494 1.537 0 C-N-CA 122.467 2.111 . . . . 0.0 113.119 179.157 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . -63.57 169.52 19.56 Favored Glycine 0 N--CA 1.492 2.415 0 N-CA-C 109.159 -1.576 . . . . 0.0 109.159 179.188 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 91' ' ' PRO . . . . . . . . . . . . . 73.0 Cg_endo -93.4 170.25 19.82 Favored 'Cis proline' 0 C--N 1.309 -1.519 0 C-N-CA 123.939 -1.275 . . . . 0.0 112.424 0.101 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 92' ' ' ALA . . . . . 0.437 ' HB3' ' HB3' ' C' ' 703' ' ' PRO . . . -73.09 33.68 0.07 Allowed 'General case' 0 N--CA 1.494 1.767 0 O-C-N 121.323 -0.861 . . . . 0.0 111.261 -179.399 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 93' ' ' THR . . . . . 0.414 ' O ' ' C ' ' A' ' 94' ' ' PRO . 1.0 OUTLIER -73.54 152.5 89.66 Favored Pre-proline 0 C--N 1.3 -1.547 0 O-C-N 120.48 -1.387 . . . . 0.0 108.146 179.729 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 94' ' ' PRO . . . . . 0.414 ' C ' ' O ' ' A' ' 93' ' ' THR . 94.6 Cg_exo -33.29 -57.06 0.35 Allowed 'Trans proline' 0 C--N 1.306 -1.702 0 C-N-CA 122.749 2.299 . . . . 0.0 112.621 -178.463 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 88.0 mt-10 -46.57 -50.29 17.55 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.256 -0.902 . . . . 0.0 110.094 -179.896 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 96' ' ' GLN . . . . . 0.498 ' N ' ' CD ' ' A' ' 96' ' ' GLN . 10.9 mp0 -71.48 -45.41 62.61 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 120.992 -1.067 . . . . 0.0 110.534 -179.231 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 97' ' ' LEU . . . . . 0.422 HD23 ' HA ' ' A' ' 97' ' ' LEU . 61.5 mt -57.64 -7.29 0.63 Allowed 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.095 -1.003 . . . . 0.0 110.473 -178.585 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 98' ' ' ASN . . . . . 0.654 HD22 ' NH1' ' A' ' 99' ' ' ARG . 0.1 OUTLIER -77.66 -29.09 51.41 Favored 'General case' 0 N--CA 1.494 1.759 0 O-C-N 120.946 -1.097 . . . . 0.0 109.44 179.208 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 99' ' ' ARG . . . . . 0.667 ' CG ' HH11 ' A' ' 99' ' ' ARG . 1.1 mtt-85 -90.17 -44.63 9.64 Favored 'General case' 0 N--CA 1.489 1.495 0 O-C-N 121.667 -0.646 . . . . 0.0 110.322 -178.36 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . 173.71 175.83 41.71 Favored Glycine 0 N--CA 1.491 2.335 0 C-N-CA 119.342 -1.409 . . . . 0.0 110.343 179.938 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 101' ' ' VAL . . . . . 0.692 ' O ' HG23 ' A' ' 101' ' ' VAL . 33.5 m -50.05 109.0 0.1 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.543 0 O-C-N 121.564 -0.962 . . . . 0.0 109.029 179.814 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -92.58 159.29 15.55 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.159 -0.963 . . . . 0.0 110.683 -179.321 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 103' ' ' PHE . . . . . 0.58 ' O ' ' N ' ' A' ' 105' ' ' GLU . 26.7 m-85 -61.1 123.79 18.67 Favored 'General case' 0 N--CA 1.491 1.58 0 N-CA-C 107.982 -1.118 . . . . 0.0 107.982 178.662 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 104' ' ' ALA . . . . . 0.562 ' HB1' ' HG2' ' C' ' 703' ' ' PRO . . . -47.04 -9.75 0.02 OUTLIER 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.061 -1.024 . . . . 0.0 110.249 -179.073 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 105' ' ' GLU . . . . . 0.58 ' N ' ' O ' ' A' ' 103' ' ' PHE . 0.4 OUTLIER -137.89 142.84 40.66 Favored 'General case' 0 N--CA 1.496 1.839 0 O-C-N 120.803 -1.186 . . . . 0.0 110.266 179.643 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 106' ' ' GLU . . . . . . . . . . . . . 33.6 tt0 -58.24 -63.33 1.3 Allowed 'General case' 0 C--N 1.301 -1.516 0 O-C-N 121.951 -0.468 . . . . 0.0 110.661 -179.458 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 107' ' ' ASN . . . . . . . . . . . . . 7.6 m120 -78.67 34.98 0.23 Allowed 'General case' 0 N--CA 1.488 1.449 0 O-C-N 120.874 -1.141 . . . . 0.0 112.969 -175.924 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 108' ' ' GLU . . . . . . . . . . . . . 1.7 tp10 -60.55 148.28 38.57 Favored 'General case' 0 N--CA 1.489 1.486 0 O-C-N 120.685 -1.259 . . . . 0.0 108.327 179.766 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 109' ' ' SER . . . . . . . . . . . . . 2.8 t -98.02 146.91 25.05 Favored 'General case' 0 N--CA 1.489 1.482 0 O-C-N 121.115 -0.991 . . . . 0.0 110.664 -178.675 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 110' ' ' LEU . . . . . 0.843 HD13 ' O ' ' A' ' 63' ' ' PRO . 0.6 OUTLIER -63.42 -22.6 66.98 Favored 'General case' 0 C--N 1.301 -1.543 0 N-CA-C 107.974 -1.121 . . . . 0.0 107.974 179.136 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 111' ' ' ASP . . . . . 0.579 ' CG ' HH22 ' A' ' 151' ' ' ARG . 48.5 m-20 -132.81 44.01 2.91 Favored 'General case' 0 N--CA 1.487 1.412 0 O-C-N 121.589 -0.694 . . . . 0.0 110.21 -179.779 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 112' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -67.96 150.16 48.85 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 120.99 -1.069 . . . . 0.0 110.069 179.557 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 113' ' ' GLN . . . . . 0.437 ' HA ' ' NE2' ' A' ' 113' ' ' GLN . 0.9 OUTLIER -65.93 -13.92 60.61 Favored 'General case' 0 N--CA 1.488 1.475 0 N-CA-C 108.008 -1.108 . . . . 0.0 108.008 178.426 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 114' ' ' ASN . . . . . 0.437 ' HA ' HE21 ' A' ' 178' ' ' GLN . 1.8 t30 -147.87 99.26 3.06 Favored 'General case' 0 C--N 1.301 -1.523 0 N-CA-C 107.206 -1.405 . . . . 0.0 107.206 178.193 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 115' ' ' ILE . . . . . 0.474 ' O ' HG22 ' A' ' 115' ' ' ILE . 2.9 mt -98.13 111.41 27.79 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.627 0 O-C-N 120.969 -1.082 . . . . 0.0 109.637 -179.013 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 116' ' ' SER . . . . . . . . . . . . . 87.5 p -101.87 151.42 22.11 Favored 'General case' 0 N--CA 1.491 1.604 0 CA-C-O 122.055 0.931 . . . . 0.0 111.86 -178.329 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 117' ' ' ILE . . . . . . . . . . . . . 2.1 mt -139.66 159.78 27.54 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.599 0 N-CA-C 108.496 -0.927 . . . . 0.0 108.496 179.504 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 118' ' ' ALA . . . . . 0.867 ' HB1' ' HB2' ' C' ' 704' ' ' ALA . . . -143.3 155.72 44.53 Favored 'General case' 0 N--CA 1.489 1.518 0 C-N-CA 118.758 -1.177 . . . . 0.0 111.326 -179.391 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 119' ' ' GLY . . . . . . . . . . . . . . . -166.32 146.07 10.61 Favored Glycine 0 N--CA 1.485 1.966 0 N-CA-C 110.358 -1.097 . . . . 0.0 110.358 -179.854 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 120' ' ' HIS . . . . . . . . . . . . . 35.1 m170 -71.63 167.28 20.14 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.93 -0.747 . . . . 0.0 109.721 179.202 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 121' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -116.33 147.31 41.7 Favored 'General case' 0 N--CA 1.495 1.779 0 N-CA-C 108.158 -1.053 . . . . 0.0 108.158 178.533 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 122' ' ' PHE . . . . . 0.642 ' O ' HG21 ' A' ' 131' ' ' THR . 0.3 OUTLIER -110.61 123.56 50.21 Favored 'General case' 0 N--CA 1.497 1.924 0 O-C-N 120.908 -1.12 . . . . 0.0 109.955 -179.874 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 123' ' ' ILE . . . . . 0.615 HG23 ' N ' ' A' ' 124' ' ' ASP . 11.8 tt -69.17 -42.96 81.85 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.824 0 O-C-N 121.367 -0.833 . . . . 0.0 109.4 179.427 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 124' ' ' ASP . . . . . 0.615 ' N ' HG23 ' A' ' 123' ' ' ILE . 61.1 t0 -93.24 23.81 4.21 Favored 'General case' 0 N--CA 1.494 1.747 0 O-C-N 121.421 -0.799 . . . . 0.0 111.136 -179.16 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 125' ' ' ARG . . . . . . . . . . . . . 3.3 ttt180 -157.9 107.35 1.76 Allowed Pre-proline 0 N--CA 1.492 1.667 0 O-C-N 120.616 -1.303 . . . . 0.0 110.253 -179.523 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 126' ' ' PRO . . . . . . . . . . . . . 71.9 Cg_endo -83.05 -20.24 5.29 Favored 'Trans proline' 0 C--N 1.314 -1.289 0 C-N-CA 122.368 2.046 . . . . 0.0 112.325 179.482 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 127' ' ' ASN . . . . . . . . . . . . . 4.9 m120 -91.12 23.93 3.06 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.276 -0.89 . . . . 0.0 109.668 179.94 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 128' ' ' TYR . . . . . . . . . . . . . 10.0 t80 -81.09 -149.4 0.07 Allowed 'General case' 0 C--N 1.301 -1.516 0 O-C-N 121.162 -0.961 . . . . 0.0 109.589 -179.692 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 129' ' ' GLN . . . . . . . . . . . . . 69.2 mt-30 -67.12 -69.61 0.3 Allowed 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.246 -0.909 . . . . 0.0 110.684 -178.941 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 130' ' ' PHE . . . . . 0.492 ' CE2' HG11 ' A' ' 101' ' ' VAL . 52.8 m-85 -129.23 36.72 4.13 Favored 'General case' 0 N--CA 1.496 1.827 0 O-C-N 121.249 -0.907 . . . . 0.0 110.524 -179.214 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 131' ' ' THR . . . . . 0.642 HG21 ' O ' ' A' ' 122' ' ' PHE . 33.8 m -80.86 -33.72 34.27 Favored 'General case' 0 N--CA 1.493 1.687 0 O-C-N 120.815 -1.178 . . . . 0.0 108.965 179.461 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 132' ' ' ASN . . . . . 0.685 ' OD1' HD11 ' A' ' 83' ' ' ILE . 0.1 OUTLIER -84.62 5.89 26.12 Favored 'General case' 0 N--CA 1.495 1.8 0 CA-C-O 121.876 0.846 . . . . 0.0 109.986 -179.246 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 133' ' ' LEU . . . . . 0.599 ' O ' ' N ' ' A' ' 135' ' ' ALA . 0.2 OUTLIER -68.5 -46.76 68.77 Favored 'General case' 0 C--N 1.299 -1.595 0 O-C-N 121.159 -0.963 . . . . 0.0 110.529 -179.748 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 134' ' ' LYS . . . . . 0.543 ' CD ' ' H ' ' A' ' 134' ' ' LYS . 0.1 OUTLIER -41.68 -18.18 0.01 OUTLIER 'General case' 0 N--CA 1.496 1.826 0 O-C-N 121.07 -1.019 . . . . 0.0 110.328 -179.133 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 135' ' ' ALA . . . . . 0.599 ' N ' ' O ' ' A' ' 133' ' ' LEU . . . -82.87 -39.48 21.54 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 120.951 -1.093 . . . . 0.0 109.855 -179.773 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 136' ' ' ALA . . . . . 0.788 ' HB2' ' HB2' ' A' ' 81' ' ' ALA . . . -78.9 156.63 28.52 Favored 'General case' 0 C--N 1.299 -1.59 0 CA-C-O 122.179 0.99 . . . . 0.0 111.698 -178.506 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 137' ' ' LYS . . . . . 0.513 ' O ' ' O ' ' A' ' 138' ' ' LYS . 1.2 ttmt -156.01 -163.21 1.43 Allowed 'General case' 0 N--CA 1.49 1.543 0 C-N-CA 118.832 -1.147 . . . . 0.0 110.455 -178.92 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 138' ' ' LYS . . . . . 0.596 ' O ' ' N ' ' A' ' 140' ' ' SER . 0.1 OUTLIER -46.44 -178.29 0.0 OUTLIER 'General case' 0 C--N 1.302 -1.479 0 CA-C-O 122.043 0.925 . . . . 0.0 110.36 -179.332 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 139' ' ' GLY . . . . . . . . . . . . . . . 45.84 8.1 0.02 OUTLIER Glycine 0 N--CA 1.492 2.411 0 N-CA-C 110.707 -0.957 . . . . 0.0 110.707 179.956 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 140' ' ' SER . . . . . 0.596 ' N ' ' O ' ' A' ' 138' ' ' LYS . 66.1 m -90.54 136.86 32.79 Favored 'General case' 0 N--CA 1.493 1.7 0 O-C-N 120.768 -1.43 . . . . 0.0 109.606 179.412 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 141' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -78.21 142.16 38.11 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.092 -1.005 . . . . 0.0 109.154 179.729 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 142' ' ' VAL . . . . . . . . . . . . . 21.2 t -131.14 127.82 61.2 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.711 0 O-C-N 121.366 -0.834 . . . . 0.0 109.148 -179.845 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 143' ' ' TYR . . . . . . . . . . . . . 6.4 m-85 -105.51 134.22 48.99 Favored 'General case' 0 N--CA 1.498 1.971 0 O-C-N 121.313 -0.867 . . . . 0.0 112.223 -177.913 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 144' ' ' PHE . . . . . . . . . . . . . 57.4 t80 -119.7 98.09 5.95 Favored 'General case' 0 N--CA 1.494 1.741 0 CA-C-O 121.403 0.62 . . . . 0.0 109.406 179.409 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 145' ' ' LYS . . . . . . . . . . . . . 11.8 mttt -93.49 128.44 39.6 Favored 'General case' 0 N--CA 1.492 1.668 0 O-C-N 121.361 -0.837 . . . . 0.0 110.632 -179.217 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 146' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -142.11 137.87 30.23 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.778 0 N-CA-C 107.619 -1.252 . . . . 0.0 107.619 179.098 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 147' ' ' GLY . . . . . . . . . . . . . . . 48.45 -134.06 19.93 Favored Glycine 0 N--CA 1.49 2.241 0 N-CA-C 108.854 -1.698 . . . . 0.0 108.854 -179.493 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 148' ' ' ASN . . . . . 0.578 HD22 ' C ' ' A' ' 148' ' ' ASN . 0.4 OUTLIER -101.17 18.52 19.66 Favored 'General case' 0 C--N 1.301 -1.516 0 O-C-N 121.229 -1.159 . . . . 0.0 107.941 178.959 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 149' ' ' GLU . . . . . . . . . . . . . 26.2 tt0 -112.59 147.46 36.61 Favored 'General case' 0 N--CA 1.484 1.266 0 CA-C-O 121.97 0.89 . . . . 0.0 111.255 -178.957 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 150' ' ' THR . . . . . 0.468 HG22 ' O ' ' A' ' 150' ' ' THR . 1.7 m -129.42 103.64 7.02 Favored 'General case' 0 N--CA 1.489 1.509 0 CA-C-O 121.477 0.656 . . . . 0.0 110.052 -179.966 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 151' ' ' ARG . . . . . 0.579 HH22 ' CG ' ' A' ' 111' ' ' ASP . 94.5 mtt180 -93.05 128.75 39.06 Favored 'General case' 0 N--CA 1.487 1.403 0 N-CA-C 107.938 -1.134 . . . . 0.0 107.938 179.008 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 152' ' ' LYS . . . . . 0.432 ' O ' ' N ' ' A' ' 205' ' ' VAL . 14.4 mtmt -91.68 156.01 17.9 Favored 'General case' 0 C--N 1.297 -1.697 0 C-N-CA 119.183 -1.007 . . . . 0.0 110.021 -179.115 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 153' ' ' TYR . . . . . 0.516 ' CD2' ' HA ' ' A' ' 204' ' ' GLU . 30.7 m-85 -143.51 167.1 23.02 Favored 'General case' 0 N--CA 1.49 1.536 0 N-CA-C 107.428 -1.323 . . . . 0.0 107.428 178.953 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 154' ' ' LYS . . . . . . . . . . . . . 17.8 ttpt -143.16 123.0 13.44 Favored 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.071 -1.018 . . . . 0.0 108.286 178.592 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 155' ' ' MET . . . . . . . . . . . . . 3.6 mtt -47.07 109.49 0.21 Allowed 'General case' 0 N--CA 1.492 1.674 0 O-C-N 120.856 -1.153 . . . . 0.0 111.207 -178.595 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 156' ' ' THR . . . . . 0.458 ' OG1' ' N ' ' A' ' 203' ' ' THR . 0.2 OUTLIER -103.89 -29.78 10.75 Favored 'General case' 0 C--N 1.29 -1.99 0 CA-C-N 115.269 -0.878 . . . . 0.0 110.102 -178.915 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 157' ' ' SER . . . . . 0.409 ' O ' ' N ' ' A' ' 201' ' ' VAL . 0.1 OUTLIER -155.71 157.58 36.83 Favored 'General case' 0 N--CA 1.492 1.641 0 C-N-CA 118.438 -1.305 . . . . 0.0 111.556 -178.816 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 158' ' ' ILE . . . . . 0.465 HG13 ' CD2' ' A' ' 200' ' ' PHE . 0.0 OUTLIER -156.77 148.23 11.14 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.393 0 CA-C-O 121.823 0.82 . . . . 0.0 110.285 179.823 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 159' ' ' ARG . . . . . 0.454 ' O ' ' OD1' ' A' ' 160' ' ' ASP . 6.1 ttm180 -153.59 -173.24 4.5 Favored 'General case' 0 C--N 1.299 -1.622 0 CA-C-O 121.737 0.779 . . . . 0.0 110.502 -179.559 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 160' ' ' ASP . . . . . 0.454 ' OD1' ' O ' ' A' ' 159' ' ' ARG . 2.5 m-20 -145.0 158.78 43.71 Favored 'General case' 0 C--N 1.301 -1.535 0 N-CA-C 108.378 -0.971 . . . . 0.0 108.378 -179.817 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 161' ' ' VAL . . . . . 0.451 HG21 HG22 ' A' ' 168' ' ' VAL . 0.1 OUTLIER -155.57 157.27 4.19 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.99 0 O-C-N 120.994 -1.066 . . . . 0.0 110.686 179.706 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 162' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -46.22 169.19 0.09 OUTLIER Pre-proline 0 N--CA 1.496 1.827 0 O-C-N 121.419 -0.801 . . . . 0.0 110.372 -179.776 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 163' ' ' PRO . . . . . . . . . . . . . 73.8 Cg_endo -78.97 28.57 0.49 Allowed 'Trans proline' 0 N--CA 1.493 1.466 0 C-N-CA 123.025 2.483 . . . . 0.0 113.575 -179.778 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 164' ' ' THR . . . . . 0.585 ' O ' HG22 ' A' ' 164' ' ' THR . 67.3 m -150.87 -2.66 0.34 Allowed 'General case' 0 N--CA 1.496 1.842 0 O-C-N 120.962 -1.086 . . . . 0.0 110.012 179.792 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 165' ' ' ASP . . . . . 0.927 ' O ' HG23 ' A' ' 168' ' ' VAL . 2.2 t70 -76.3 64.98 2.15 Favored 'General case' 0 N--CA 1.488 1.471 0 O-C-N 121.203 -0.936 . . . . 0.0 110.112 -179.957 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 166' ' ' VAL . . . . . 0.605 ' O ' ' N ' ' A' ' 168' ' ' VAL . 1.0 OUTLIER -44.4 -32.05 0.78 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.531 0 O-C-N 120.943 -1.098 . . . . 0.0 108.805 -179.099 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 167' ' ' GLY . . . . . 0.446 ' C ' ' O ' ' A' ' 166' ' ' VAL . . . -42.67 -16.76 0.03 OUTLIER Glycine 0 N--CA 1.491 2.316 0 N-CA-C 109.795 -1.322 . . . . 0.0 109.795 179.535 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 168' ' ' VAL . . . . . 0.927 HG23 ' O ' ' A' ' 165' ' ' ASP . 47.6 t -50.27 -32.6 9.44 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.434 0 O-C-N 121.014 -1.286 . . . . 0.0 108.455 179.728 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 169' ' ' LEU . . . . . 0.518 ' O ' ' C ' ' A' ' 170' ' ' ASP . 98.8 mt -46.91 -14.48 0.03 OUTLIER 'General case' 0 N--CA 1.49 1.566 0 N-CA-C 108.075 -1.083 . . . . 0.0 108.075 -178.816 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 170' ' ' ASP . . . . . 0.567 ' N ' ' O ' ' A' ' 168' ' ' VAL . 9.2 p30 19.94 91.0 0.01 OUTLIER 'General case' 0 N--CA 1.499 2.012 0 N-CA-C 112.651 0.611 . . . . 0.0 112.651 177.669 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 171' ' ' GLU . . . . . . . . . . . . . 16.5 pt-20 -127.02 69.14 1.27 Allowed 'General case' 0 N--CA 1.495 1.809 0 O-C-N 121.099 -1.001 . . . . 0.0 109.493 178.488 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 172' ' ' GLN . . . . . . . . . . . . . 1.6 mp0 -133.69 -47.41 0.81 Allowed 'General case' 0 N--CA 1.495 1.79 0 O-C-N 121.329 -0.857 . . . . 0.0 110.723 -178.387 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 173' ' ' LYS . . . . . . . . . . . . . 9.0 mttp -63.4 125.56 24.58 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 120.835 -1.165 . . . . 0.0 108.992 179.861 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 174' ' ' GLY . . . . . 0.564 ' O ' ' C ' ' A' ' 175' ' ' LYS . . . -133.2 -39.13 0.21 Allowed Glycine 0 C--N 1.298 -1.541 0 N-CA-C 108.543 -1.823 . . . . 0.0 108.543 179.888 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 175' ' ' LYS . . . . . 0.564 ' C ' ' O ' ' A' ' 174' ' ' GLY . 3.8 mptt -32.33 -63.36 0.2 Allowed 'General case' 0 N--CA 1.499 2.015 0 N-CA-C 108.14 -1.059 . . . . 0.0 108.14 179.576 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 176' ' ' ASP . . . . . 0.665 ' O ' ' O ' ' A' ' 177' ' ' LYS . 1.0 OUTLIER -103.01 77.37 1.55 Allowed 'General case' 0 C--N 1.296 -1.72 0 N-CA-C 106.418 -1.697 . . . . 0.0 106.418 176.413 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 177' ' ' LYS . . . . . 0.665 ' O ' ' O ' ' A' ' 176' ' ' ASP . 10.1 mttt -26.74 163.55 0.0 OUTLIER 'General case' 0 N--CA 1.505 2.313 0 CA-C-O 122.091 0.948 . . . . 0.0 112.047 -178.111 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 178' ' ' GLN . . . . . 0.526 ' OE1' HG13 ' A' ' 201' ' ' VAL . 0.8 OUTLIER -158.45 168.33 27.23 Favored 'General case' 0 N--CA 1.489 1.499 0 C-N-CA 117.832 -1.547 . . . . 0.0 111.96 -179.792 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 179' ' ' LEU . . . . . 0.408 ' HB2' ' CE2' ' A' ' 153' ' ' TYR . 0.6 OUTLIER -124.65 101.9 7.34 Favored 'General case' 0 C--N 1.302 -1.47 0 N-CA-C 107.074 -1.454 . . . . 0.0 107.074 178.453 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 180' ' ' THR . . . . . . . . . . . . . 2.1 m -76.12 122.38 24.2 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.202 -0.936 . . . . 0.0 110.595 -177.973 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 181' ' ' LEU . . . . . . . . . . . . . 9.8 tp -98.8 111.79 24.07 Favored 'General case' 0 N--CA 1.493 1.706 0 O-C-N 121.272 -0.893 . . . . 0.0 109.23 178.774 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 182' ' ' ILE . . . . . 0.563 HG23 HG22 ' A' ' 199' ' ' ILE . 37.1 mt -100.1 122.99 52.66 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.489 0 O-C-N 120.972 -1.08 . . . . 0.0 109.148 178.357 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 183' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -138.9 107.12 5.76 Favored 'General case' 0 C--N 1.296 -1.743 0 N-CA-C 107.882 -1.155 . . . . 0.0 107.882 179.045 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 184' ' ' CYS . . . . . . . . . . . . . 1.9 p -80.88 157.27 25.7 Favored 'General case' 0 N--CA 1.497 1.915 0 C-N-CA 119.275 -0.97 . . . . 0.0 111.597 -177.48 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 185' ' ' ASP . . . . . 0.586 ' OD1' ' N ' ' A' ' 186' ' ' ASP . 20.0 t0 -167.27 177.16 6.27 Favored 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.635 -0.666 . . . . 0.0 109.393 -179.769 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 186' ' ' ASP . . . . . 0.586 ' N ' ' OD1' ' A' ' 185' ' ' ASP . 0.4 OUTLIER 81.05 54.6 0.02 OUTLIER 'General case' 0 N--CA 1.497 1.884 0 O-C-N 121.336 -0.853 . . . . 0.0 109.598 -179.779 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 187' ' ' TYR . . . . . 0.595 ' CE1' ' O ' ' A' ' 188' ' ' ASN . 37.2 t80 -66.07 132.54 48.76 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.124 -0.985 . . . . 0.0 110.204 -179.941 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 188' ' ' ASN . . . . . 0.834 ' ND2' ' H ' ' A' ' 193' ' ' VAL . 0.5 OUTLIER -99.93 149.72 23.14 Favored 'General case' 0 C--N 1.298 -1.632 0 N-CA-C 107.441 -1.318 . . . . 0.0 107.441 178.115 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 189' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -112.11 -2.84 14.88 Favored 'General case' 0 C--N 1.291 -1.938 0 N-CA-C 108.647 -0.872 . . . . 0.0 108.647 -179.179 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 190' ' ' LYS . . . . . . . . . . . . . 32.9 mttt -83.73 -59.8 2.32 Favored 'General case' 0 N--CA 1.488 1.439 0 N-CA-C 108.48 -0.933 . . . . 0.0 108.48 178.581 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 191' ' ' THR . . . . . 0.592 ' OG1' ' ND2' ' A' ' 188' ' ' ASN . 1.3 p -88.25 -12.18 44.42 Favored 'General case' 0 N--CA 1.493 1.687 0 O-C-N 121.338 -0.851 . . . . 0.0 108.954 179.094 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 192' ' ' GLY . . . . . 0.418 ' N ' ' OD1' ' A' ' 188' ' ' ASN . . . 73.29 41.54 45.74 Favored Glycine 0 N--CA 1.493 2.496 0 N-CA-C 110.588 -1.005 . . . . 0.0 110.588 178.902 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 193' ' ' VAL . . . . . 0.834 ' H ' ' ND2' ' A' ' 188' ' ' ASN . 95.9 t -149.14 163.52 4.4 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.612 0 O-C-N 121.043 -1.269 . . . . 0.0 110.542 179.817 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 194' ' ' TRP . . . . . 0.606 ' N ' HG12 ' A' ' 193' ' ' VAL . 73.4 m95 -83.07 121.55 27.18 Favored 'General case' 0 N--CA 1.49 1.553 0 N-CA-C 108.572 -0.899 . . . . 0.0 108.572 179.358 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 195' ' ' GLU . . . . . . . . . . . . . 2.3 mt-10 -89.65 -61.05 1.78 Allowed 'General case' 0 N--CA 1.495 1.796 0 O-C-N 121.401 -0.812 . . . . 0.0 112.089 -177.523 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 196' ' ' LYS . . . . . . . . . . . . . 12.5 tttt -75.88 148.36 38.36 Favored 'General case' 0 N--CA 1.494 1.736 0 O-C-N 121.142 -0.974 . . . . 0.0 111.068 -177.876 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 197' ' ' ARG . . . . . 0.567 ' CD ' HD22 ' C' ' 702' ' ' LEU . 21.8 mmt180 -124.45 128.56 49.2 Favored 'General case' 0 N--CA 1.494 1.74 0 N-CA-C 108.274 -1.009 . . . . 0.0 108.274 178.361 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 198' ' ' LYS . . . . . . . . . . . . . 11.1 mmtp -116.13 118.42 32.79 Favored 'General case' 0 C--N 1.3 -1.587 0 O-C-N 121.59 -0.694 . . . . 0.0 110.27 -178.916 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 199' ' ' ILE . . . . . 0.693 HG21 HG11 ' A' ' 168' ' ' VAL . 0.8 OUTLIER -136.95 121.39 24.05 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.768 0 CA-C-O 122.6 1.19 . . . . 0.0 110.877 179.474 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 200' ' ' PHE . . . . . 0.515 ' CD1' ' N ' ' A' ' 200' ' ' PHE . 3.1 m-85 -99.3 135.6 40.48 Favored 'General case' 0 N--CA 1.502 2.171 0 O-C-N 120.941 -1.099 . . . . 0.0 109.979 -178.293 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 201' ' ' VAL . . . . . 0.526 HG13 ' OE1' ' A' ' 178' ' ' GLN . 84.4 t -105.33 146.29 12.53 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.849 0 O-C-N 120.94 -1.1 . . . . 0.0 108.968 177.315 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 202' ' ' ALA . . . . . 0.402 ' HA ' ' H ' ' A' ' 156' ' ' THR . . . -134.32 141.46 46.93 Favored 'General case' 0 N--CA 1.493 1.677 0 O-C-N 121.031 -1.043 . . . . 0.0 109.628 -179.749 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 203' ' ' THR . . . . . 0.458 ' N ' ' OG1' ' A' ' 156' ' ' THR . 0.8 OUTLIER -88.93 130.64 35.4 Favored 'General case' 0 N--CA 1.488 1.426 0 CA-C-O 122.457 1.122 . . . . 0.0 111.27 -178.769 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 204' ' ' GLU . . . . . 0.516 ' HA ' ' CD2' ' A' ' 153' ' ' TYR . 1.3 tm-20 -49.39 134.52 18.78 Favored 'General case' 0 C--N 1.297 -1.713 0 C-N-CA 119.223 -0.991 . . . . 0.0 109.28 179.124 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 205' ' ' VAL . . . . . 0.516 ' CG1' ' N ' ' A' ' 206' ' ' LYS . 28.4 t -122.26 162.32 22.05 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.436 0 CA-C-O 122.055 0.931 . . . . 0.0 110.357 -178.02 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 206' ' ' LYS . . . . . 0.516 ' N ' ' CG1' ' A' ' 205' ' ' VAL . 1.3 ptpp? . . . . . 0 C--N 1.294 -1.838 0 CA-C-O 117.906 -1.045 . . . . 0.0 109.37 179.717 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' C' C ' 702' ' ' LEU . . . . . 0.911 ' N ' HD12 ' C' ' 702' ' ' LEU . 0.0 OUTLIER . . . . . 0 N--CA 1.494 1.744 0 N-CA-C 110.231 -0.285 . . . . 0.0 110.231 . . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' C' C ' 703' ' ' PRO . . . . . 0.562 ' HG2' ' HB1' ' A' ' 104' ' ' ALA . 51.0 Cg_exo -50.87 -157.23 0.0 OUTLIER 'Trans proline' 0 N--CA 1.496 1.646 0 C-N-CA 122.096 1.864 . . . . 0.0 112.6 179.864 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' C' C ' 704' ' ' ALA . . . . . 0.867 ' HB2' ' HB1' ' A' ' 118' ' ' ALA . . . . . . . . 0 N--CA 1.493 1.692 0 O-C-N 121.125 -0.984 . . . . 0.0 110.212 179.845 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 63' ' ' PRO . . . . . . . . . . . . . 18.9 Cg_endo . . . . . 0 N--CA 1.482 0.795 0 CA-C-O 121.234 0.431 . . . . 0.0 111.513 . . . . . . . . . 0 0 . 1 . 011 nuclear nobuild core ' A' A ' 64' ' ' GLN . . . . . 0.579 ' N ' ' CD ' ' A' ' 64' ' ' GLN . 0.0 OUTLIER -154.29 133.91 12.84 Favored 'General case' 0 N--CA 1.493 1.701 0 O-C-N 120.996 -1.065 . . . . 0.0 109.452 179.733 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 65' ' ' ILE . . . . . 0.532 ' CD1' HD13 ' A' ' 110' ' ' LEU . 0.0 OUTLIER -45.95 108.35 0.8 Allowed Pre-proline 0 N--CA 1.489 1.494 0 N-CA-C 107.812 -1.181 . . . . 0.0 107.812 179.155 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 66' ' ' PRO . . . . . . . . . . . . . 60.1 Cg_endo -78.1 -162.68 0.18 Allowed 'Trans proline' 0 C--N 1.311 -1.419 0 C-N-CA 121.618 1.545 . . . . 0.0 112.148 -179.024 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 67' ' ' LYS . . . . . . . . . . . . . 15.8 tttp -89.81 -13.92 35.55 Favored 'General case' 0 C--N 1.301 -1.543 0 O-C-N 121.287 -0.883 . . . . 0.0 109.289 -179.874 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 68' ' ' ASP . . . . . 0.659 ' C ' ' H ' ' A' ' 70' ' ' SER . 0.6 OUTLIER -77.07 64.87 2.6 Favored 'General case' 0 N--CA 1.487 1.395 0 CA-C-O 122.654 1.216 . . . . 0.0 109.762 -179.868 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 69' ' ' LYS . . . . . 0.447 ' C ' ' O ' ' A' ' 68' ' ' ASP . 16.6 ptpt -48.2 -12.16 0.04 OUTLIER 'General case' 0 N--CA 1.516 2.827 0 C-N-CA 116.921 -1.912 . . . . 0.0 106.332 176.567 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 70' ' ' SER . . . . . 0.659 ' H ' ' C ' ' A' ' 68' ' ' ASP . 1.9 m -84.83 -6.38 59.35 Favored 'General case' 0 C--N 1.297 -1.688 0 CA-C-N 113.094 -1.866 . . . . 0.0 110.764 179.117 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 71' ' ' LYS . . . . . 0.546 ' N ' ' O ' ' A' ' 68' ' ' ASP . 0.3 OUTLIER -100.42 144.33 29.55 Favored 'General case' 0 N--CA 1.5 2.068 0 O-C-N 120.649 -1.282 . . . . 0.0 111.759 -179.661 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 72' ' ' VAL . . . . . 0.525 HG12 ' CE1' ' A' ' 88' ' ' TYR . 0.7 OUTLIER -66.4 134.08 30.38 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.369 0 N-CA-C 105.085 -2.191 . . . . 0.0 105.085 175.638 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 73' ' ' ALA . . . . . 0.549 ' N ' ' O ' ' A' ' 87' ' ' VAL . . . -80.5 -13.96 58.66 Favored 'General case' 0 C--N 1.295 -1.776 0 O-C-N 119.587 -1.946 . . . . 0.0 107.161 -179.525 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 74' ' ' GLY . . . . . 0.417 ' N ' HG23 ' A' ' 72' ' ' VAL . . . 177.16 -159.63 26.06 Favored Glycine 0 N--CA 1.482 1.725 0 N-CA-C 109.835 -1.306 . . . . 0.0 109.835 179.07 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 75' ' ' TYR . . . . . 0.529 ' HA ' HG23 ' A' ' 87' ' ' VAL . 0.6 OUTLIER -143.83 165.96 26.25 Favored 'General case' 0 C--N 1.295 -1.768 0 C-N-CA 119.468 -0.893 . . . . 0.0 110.75 -177.283 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 76' ' ' ILE . . . . . . . . . . . . . 1.2 tt -148.38 147.4 17.0 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.534 0 C-N-CA 119.346 -0.942 . . . . 0.0 110.072 -178.189 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -150.76 162.48 40.65 Favored 'General case' 0 N--CA 1.486 1.373 0 O-C-N 121.276 -0.89 . . . . 0.0 109.042 179.934 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 78' ' ' ILE . . . . . 0.415 HD12 HD21 ' A' ' 133' ' ' LEU . 38.6 mt -147.62 97.08 4.04 Favored Pre-proline 0 N--CA 1.488 1.445 0 O-C-N 121.238 -0.913 . . . . 0.0 108.817 -179.444 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 79' ' ' PRO . . . . . . . . . . . . . 51.0 Cg_exo -49.15 -45.13 30.84 Favored 'Trans proline' 0 N--CA 1.493 1.485 0 C-N-CA 122.795 2.33 . . . . 0.0 114.423 -178.59 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 80' ' ' ASP . . . . . 0.482 ' O ' ' OD1' ' A' ' 80' ' ' ASP . 47.7 t0 -66.09 -20.26 66.11 Favored 'General case' 0 N--CA 1.496 1.843 0 O-C-N 120.48 -1.387 . . . . 0.0 111.024 179.073 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 81' ' ' ALA . . . . . 0.756 ' HB2' ' HB2' ' A' ' 136' ' ' ALA . . . -107.09 -10.49 15.88 Favored 'General case' 0 N--CA 1.491 1.582 0 N-CA-C 108.528 -0.916 . . . . 0.0 108.528 179.639 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 82' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER 61.42 50.88 4.41 Favored 'General case' 0 N--CA 1.493 1.697 0 O-C-N 121.541 -0.724 . . . . 0.0 110.719 179.481 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 83' ' ' ILE . . . . . . . . . . . . . 46.6 mt -128.83 152.2 36.67 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.815 0 O-C-N 121.062 -1.024 . . . . 0.0 110.229 -178.975 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 84' ' ' LYS . . . . . . . . . . . . . 27.2 tttp -157.88 108.47 2.19 Favored 'General case' 0 N--CA 1.49 1.566 0 N-CA-C 107.662 -1.236 . . . . 0.0 107.662 179.762 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 85' ' ' GLU . . . . . 0.512 ' OE2' ' O ' ' A' ' 129' ' ' GLN . 0.0 OUTLIER -141.6 163.35 41.61 Favored Pre-proline 0 N--CA 1.494 1.771 0 O-C-N 121.283 -0.886 . . . . 0.0 110.88 -178.361 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 86' ' ' PRO . . . . . 0.41 ' N ' ' CE2' ' A' ' 75' ' ' TYR . 40.9 Cg_endo -72.15 165.36 32.84 Favored 'Trans proline' 0 N--CA 1.495 1.609 0 C-N-CA 123.259 2.639 . . . . 0.0 113.031 -179.882 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 87' ' ' VAL . . . . . 0.549 ' O ' ' N ' ' A' ' 73' ' ' ALA . 66.0 t -124.36 98.96 5.76 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.695 0 N-CA-C 108.903 -0.777 . . . . 0.0 108.903 179.54 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 88' ' ' TYR . . . . . 0.525 ' CE1' HG12 ' A' ' 72' ' ' VAL . 15.9 m-85 -91.45 155.58 44.02 Favored Pre-proline 0 N--CA 1.501 2.12 0 O-C-N 120.964 -1.085 . . . . 0.0 110.224 -179.212 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 89' ' ' PRO . . . . . 0.411 ' HA ' ' CD2' ' A' ' 103' ' ' PHE . 9.6 Cg_endo -61.75 145.25 97.45 Favored 'Trans proline' 0 C--N 1.311 -1.443 0 C-N-CA 122.639 2.226 . . . . 0.0 113.408 179.683 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . -58.82 168.23 6.34 Favored Glycine 0 N--CA 1.494 2.504 0 N-CA-C 109.408 -1.477 . . . . 0.0 109.408 179.305 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 91' ' ' PRO . . . . . 0.426 ' C ' ' H ' ' A' ' 93' ' ' THR . 97.5 Cg_endo -94.13 169.53 18.82 Favored 'Cis proline' 0 C--N 1.307 -1.654 0 C-N-CA 123.873 -1.303 . . . . 0.0 112.021 -0.257 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 92' ' ' ALA . . . . . 0.631 ' HB1' HD21 ' A' ' 97' ' ' LEU . . . -72.16 31.47 0.06 Allowed 'General case' 0 N--CA 1.489 1.49 0 O-C-N 121.217 -0.927 . . . . 0.0 110.756 -179.786 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 93' ' ' THR . . . . . 0.435 ' O ' ' C ' ' A' ' 94' ' ' PRO . 6.0 p -72.41 151.42 91.88 Favored Pre-proline 0 N--CA 1.492 1.643 0 O-C-N 120.543 -1.348 . . . . 0.0 108.075 179.865 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 94' ' ' PRO . . . . . 0.435 ' C ' ' O ' ' A' ' 93' ' ' THR . 88.7 Cg_exo -31.68 -57.91 0.23 Allowed 'Trans proline' 0 C--N 1.306 -1.692 0 C-N-CA 122.702 2.268 . . . . 0.0 112.636 -178.656 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 95' ' ' GLU . . . . . 0.506 ' O ' ' ND2' ' A' ' 98' ' ' ASN . 29.0 mt-10 -43.87 -49.09 8.39 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.11 -0.994 . . . . 0.0 109.715 179.929 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 96' ' ' GLN . . . . . 0.586 ' O ' ' N ' ' A' ' 98' ' ' ASN . 39.2 mm-40 -71.63 -56.98 4.81 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.195 -0.941 . . . . 0.0 110.981 -179.058 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 97' ' ' LEU . . . . . 0.631 HD21 ' HB1' ' A' ' 92' ' ' ALA . 91.7 mt -48.95 -5.99 0.02 OUTLIER 'General case' 0 N--CA 1.495 1.783 0 O-C-N 120.989 -1.069 . . . . 0.0 109.878 -179.156 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 98' ' ' ASN . . . . . 0.836 HD21 ' NE ' ' A' ' 99' ' ' ARG . 0.1 OUTLIER -73.2 -28.63 62.3 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.213 -0.929 . . . . 0.0 108.904 179.466 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 99' ' ' ARG . . . . . 0.836 ' NE ' HD21 ' A' ' 98' ' ' ASN . 0.0 OUTLIER -92.34 -54.57 3.75 Favored 'General case' 0 N--CA 1.487 1.406 0 O-C-N 121.692 -0.63 . . . . 0.0 109.552 -179.659 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . -179.89 -160.63 25.71 Favored Glycine 0 N--CA 1.491 2.353 0 C-N-CA 119.554 -1.308 . . . . 0.0 110.188 -179.917 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 101' ' ' VAL . . . . . 0.718 ' O ' HG23 ' A' ' 101' ' ' VAL . 20.5 m -61.48 104.93 0.29 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.659 0 O-C-N 121.474 -1.015 . . . . 0.0 109.92 -179.507 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -92.73 157.16 16.59 Favored 'General case' 0 N--CA 1.493 1.715 0 O-C-N 121.495 -0.753 . . . . 0.0 110.67 -179.503 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 103' ' ' PHE . . . . . 0.411 ' CD2' ' HA ' ' A' ' 89' ' ' PRO . 22.1 m-85 -59.69 130.36 46.43 Favored 'General case' 0 N--CA 1.49 1.568 0 N-CA-C 107.468 -1.308 . . . . 0.0 107.468 178.276 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 104' ' ' ALA . . . . . . . . . . . . . . . -50.95 -16.45 0.43 Allowed 'General case' 0 C--N 1.301 -1.542 0 O-C-N 121.378 -0.826 . . . . 0.0 111.467 -178.337 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 105' ' ' GLU . . . . . 0.452 ' CD ' HD13 ' A' ' 169' ' ' LEU . 0.5 OUTLIER -139.49 147.61 41.53 Favored 'General case' 0 N--CA 1.494 1.766 0 O-C-N 120.722 -1.236 . . . . 0.0 110.577 -179.862 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 106' ' ' GLU . . . . . 0.559 ' OE2' ' ND2' ' A' ' 107' ' ' ASN . 3.3 tt0 -54.71 -64.44 0.83 Allowed 'General case' 0 C--N 1.301 -1.527 0 CA-C-N 115.857 -0.611 . . . . 0.0 111.151 -178.986 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 107' ' ' ASN . . . . . 0.559 ' ND2' ' OE2' ' A' ' 106' ' ' GLU . 2.5 m120 -78.28 33.37 0.19 Allowed 'General case' 0 N--CA 1.49 1.566 0 O-C-N 120.522 -1.361 . . . . 0.0 113.059 -175.325 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 108' ' ' GLU . . . . . . . . . . . . . 27.8 tp10 -59.39 148.41 32.66 Favored 'General case' 0 C--N 1.299 -1.597 0 N-CA-C 107.191 -1.411 . . . . 0.0 107.191 179.886 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 109' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -99.64 129.82 45.81 Favored 'General case' 0 C--N 1.301 -1.504 0 O-C-N 120.987 -1.071 . . . . 0.0 110.443 -178.019 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 110' ' ' LEU . . . . . 0.532 HD13 ' CD1' ' A' ' 65' ' ' ILE . 3.2 tp -59.03 -11.98 4.16 Favored 'General case' 0 C--N 1.301 -1.505 0 N-CA-C 108.02 -1.104 . . . . 0.0 108.02 179.63 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 111' ' ' ASP . . . . . . . . . . . . . 57.7 m-20 -132.57 30.03 4.15 Favored 'General case' 0 N--CA 1.491 1.615 0 N-CA-C 109.0 -0.741 . . . . 0.0 109.0 179.044 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 112' ' ' ASP . . . . . . . . . . . . . 6.2 t0 -67.27 149.1 50.86 Favored 'General case' 0 N--CA 1.493 1.704 0 O-C-N 121.105 -0.997 . . . . 0.0 111.19 -179.056 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 113' ' ' GLN . . . . . 0.743 HE22 ' NZ ' ' A' ' 177' ' ' LYS . 0.4 OUTLIER -66.36 -12.83 59.03 Favored 'General case' 0 N--CA 1.49 1.564 0 N-CA-C 108.319 -0.993 . . . . 0.0 108.319 178.285 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 114' ' ' ASN . . . . . 0.618 HD22 ' C ' ' A' ' 114' ' ' ASN . 0.2 OUTLIER -149.92 99.98 2.89 Favored 'General case' 0 N--CA 1.491 1.601 0 N-CA-C 108.204 -1.035 . . . . 0.0 108.204 179.351 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 115' ' ' ILE . . . . . 0.484 ' O ' HG22 ' A' ' 115' ' ' ILE . 3.9 mt -98.79 111.94 29.67 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.621 0 O-C-N 121.111 -0.993 . . . . 0.0 109.497 -179.367 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 116' ' ' SER . . . . . . . . . . . . . 48.9 m -97.84 153.58 18.21 Favored 'General case' 0 N--CA 1.492 1.675 0 O-C-N 121.026 -1.046 . . . . 0.0 110.94 -179.142 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 117' ' ' ILE . . . . . 0.402 HG21 HD13 ' A' ' 117' ' ' ILE . 1.5 mt -144.79 159.94 14.24 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.617 0 N-CA-C 108.629 -0.878 . . . . 0.0 108.629 179.586 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 118' ' ' ALA . . . . . 0.752 ' HB1' ' HB2' ' C' ' 704' ' ' ALA . . . -144.53 160.25 41.44 Favored 'General case' 0 N--CA 1.491 1.606 0 C-N-CA 118.639 -1.224 . . . . 0.0 112.17 -179.441 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 119' ' ' GLY . . . . . . . . . . . . . . . -172.16 146.24 9.16 Favored Glycine 0 N--CA 1.49 2.239 0 N-CA-C 110.622 -0.991 . . . . 0.0 110.622 179.909 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 120' ' ' HIS . . . . . . . . . . . . . 11.5 m170 -71.29 167.63 19.06 Favored 'General case' 0 N--CA 1.496 1.856 0 O-C-N 121.744 -0.857 . . . . 0.0 110.45 179.483 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 121' ' ' THR . . . . . 0.504 ' OG1' ' NZ ' ' A' ' 134' ' ' LYS . 0.7 OUTLIER -119.02 162.29 18.8 Favored 'General case' 0 N--CA 1.5 2.048 0 O-C-N 121.188 -0.945 . . . . 0.0 108.874 179.301 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 122' ' ' PHE . . . . . 0.648 ' O ' HG21 ' A' ' 131' ' ' THR . 0.3 OUTLIER -133.25 122.37 23.82 Favored 'General case' 0 N--CA 1.499 1.982 0 O-C-N 120.868 -1.145 . . . . 0.0 110.291 -179.281 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 123' ' ' ILE . . . . . 0.563 HG23 ' N ' ' A' ' 124' ' ' ASP . 18.1 tt -65.5 -40.75 89.15 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.582 0 CA-C-O 121.58 0.705 . . . . 0.0 109.217 179.588 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 124' ' ' ASP . . . . . 0.563 ' N ' HG23 ' A' ' 123' ' ' ILE . 1.2 t70 -96.69 25.75 4.97 Favored 'General case' 0 N--CA 1.497 1.914 0 C-N-CA 120.154 -0.619 . . . . 0.0 111.452 -178.473 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 125' ' ' ARG . . . . . 0.655 HH11 ' CG ' ' A' ' 125' ' ' ARG . 0.0 OUTLIER -158.67 106.15 1.62 Allowed Pre-proline 0 N--CA 1.493 1.712 0 O-C-N 120.553 -1.342 . . . . 0.0 110.126 -179.209 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 126' ' ' PRO . . . . . . . . . . . . . 74.3 Cg_endo -81.91 -23.61 4.52 Favored 'Trans proline' 0 N--CA 1.489 1.217 0 C-N-CA 122.293 1.995 . . . . 0.0 112.325 179.834 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 127' ' ' ASN . . . . . . . . . . . . . 1.3 m-20 -90.34 28.91 1.35 Allowed 'General case' 0 N--CA 1.489 1.495 0 O-C-N 121.295 -0.878 . . . . 0.0 109.815 -179.685 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 128' ' ' TYR . . . . . . . . . . . . . 7.6 t80 -83.9 -149.27 0.1 Allowed 'General case' 0 N--CA 1.494 1.735 0 O-C-N 121.303 -0.873 . . . . 0.0 109.15 179.61 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 129' ' ' GLN . . . . . 0.512 ' O ' ' OE2' ' A' ' 85' ' ' GLU . 51.3 mt-30 -67.77 -73.05 0.15 Allowed 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.102 -0.999 . . . . 0.0 109.875 -179.698 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 130' ' ' PHE . . . . . 0.736 ' CE1' HD11 ' A' ' 181' ' ' LEU . 38.7 m-85 -129.63 45.92 2.73 Favored 'General case' 0 N--CA 1.497 1.918 0 O-C-N 121.013 -1.054 . . . . 0.0 110.119 -179.845 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 131' ' ' THR . . . . . 0.648 HG21 ' O ' ' A' ' 122' ' ' PHE . 25.0 m -82.58 -37.64 24.79 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 120.991 -1.068 . . . . 0.0 110.222 -179.919 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 132' ' ' ASN . . . . . 0.577 ' ND2' ' O ' ' A' ' 81' ' ' ALA . 7.6 t30 -83.39 7.84 15.49 Favored 'General case' 0 N--CA 1.491 1.618 0 C-N-CA 119.389 -0.924 . . . . 0.0 111.145 -178.574 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 133' ' ' LEU . . . . . 0.545 ' O ' ' N ' ' A' ' 135' ' ' ALA . 0.1 OUTLIER -70.29 -46.21 64.76 Favored 'General case' 0 C--N 1.301 -1.523 0 O-C-N 120.793 -1.192 . . . . 0.0 109.237 179.936 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 134' ' ' LYS . . . . . 0.599 ' CD ' ' H ' ' A' ' 134' ' ' LYS . 0.0 OUTLIER -43.75 -18.16 0.02 OUTLIER 'General case' 0 N--CA 1.494 1.747 0 O-C-N 121.368 -0.832 . . . . 0.0 109.861 -179.74 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 135' ' ' ALA . . . . . 0.545 ' N ' ' O ' ' A' ' 133' ' ' LEU . . . -83.8 -37.14 22.93 Favored 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.048 -1.032 . . . . 0.0 109.433 179.943 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 136' ' ' ALA . . . . . 0.756 ' HB2' ' HB2' ' A' ' 81' ' ' ALA . . . -79.62 157.05 27.39 Favored 'General case' 0 C--N 1.301 -1.541 0 CA-C-O 122.298 1.047 . . . . 0.0 111.517 -178.502 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 137' ' ' LYS . . . . . 0.562 ' O ' ' O ' ' A' ' 138' ' ' LYS . 0.1 OUTLIER -152.04 -163.26 1.69 Allowed 'General case' 0 C--N 1.304 -1.404 0 C-N-CA 119.017 -1.073 . . . . 0.0 110.03 -178.016 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 138' ' ' LYS . . . . . 0.582 ' O ' ' N ' ' A' ' 140' ' ' SER . 51.2 mttm -41.0 177.67 0.0 OUTLIER 'General case' 0 C--N 1.304 -1.381 0 CA-C-O 122.583 1.182 . . . . 0.0 111.716 -179.093 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 139' ' ' GLY . . . . . . . . . . . . . . . 46.32 8.3 0.02 OUTLIER Glycine 0 N--CA 1.492 2.386 0 N-CA-C 110.353 -1.099 . . . . 0.0 110.353 -179.918 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 140' ' ' SER . . . . . 0.582 ' N ' ' O ' ' A' ' 138' ' ' LYS . 6.3 m -79.0 121.52 25.04 Favored 'General case' 0 N--CA 1.493 1.719 0 O-C-N 120.887 -1.36 . . . . 0.0 109.693 179.258 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 141' ' ' MET . . . . . 0.687 ' SD ' ' N ' ' A' ' 142' ' ' VAL . 5.1 tpp -77.99 125.15 28.92 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.192 -0.943 . . . . 0.0 108.971 179.529 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 142' ' ' VAL . . . . . 0.687 ' N ' ' SD ' ' A' ' 141' ' ' MET . 2.5 t -110.48 131.51 61.38 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.446 0 N-CA-C 108.585 -0.894 . . . . 0.0 108.585 -179.594 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 143' ' ' TYR . . . . . . . . . . . . . 9.8 m-85 -109.98 135.54 50.66 Favored 'General case' 0 N--CA 1.497 1.922 0 O-C-N 121.036 -1.04 . . . . 0.0 111.111 -178.321 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 144' ' ' PHE . . . . . . . . . . . . . 46.7 t80 -121.03 102.48 8.36 Favored 'General case' 0 N--CA 1.49 1.534 0 CA-C-O 121.262 0.553 . . . . 0.0 109.829 -178.957 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 145' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -100.93 121.81 42.4 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.202 -0.936 . . . . 0.0 110.117 -179.966 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 146' ' ' VAL . . . . . 0.537 HG23 ' O ' ' A' ' 73' ' ' ALA . 1.0 OUTLIER -142.53 124.49 12.86 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.581 0 O-C-N 121.126 -0.984 . . . . 0.0 108.424 179.091 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 147' ' ' GLY . . . . . . . . . . . . . . . 66.9 -132.1 31.26 Favored Glycine 0 N--CA 1.49 2.239 0 N-CA-C 108.103 -1.999 . . . . 0.0 108.103 -178.735 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 148' ' ' ASN . . . . . 0.606 ' C ' ' ND2' ' A' ' 148' ' ' ASN . 0.0 OUTLIER -102.43 10.31 39.09 Favored 'General case' 0 C--N 1.301 -1.526 0 O-C-N 121.266 -1.138 . . . . 0.0 108.209 178.955 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 149' ' ' GLU . . . . . 0.402 ' OE1' ' N ' ' A' ' 150' ' ' THR . 1.4 tm-20 -107.91 144.44 35.16 Favored 'General case' 0 N--CA 1.489 1.524 0 CA-C-O 121.941 0.877 . . . . 0.0 111.706 -178.666 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 150' ' ' THR . . . . . 0.402 ' N ' ' OE1' ' A' ' 149' ' ' GLU . 44.2 m -133.8 100.51 4.78 Favored 'General case' 0 N--CA 1.491 1.603 0 CA-C-O 121.517 0.675 . . . . 0.0 109.563 -179.749 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 151' ' ' ARG . . . . . . . . . . . . . 17.4 mtt180 -87.06 -174.16 4.78 Favored 'General case' 0 N--CA 1.488 1.445 0 N-CA-C 108.435 -0.95 . . . . 0.0 108.435 179.994 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 152' ' ' LYS . . . . . 0.477 ' O ' ' N ' ' A' ' 205' ' ' VAL . 35.6 mtmt -148.59 142.95 26.25 Favored 'General case' 0 N--CA 1.488 1.469 0 O-C-N 121.068 -1.02 . . . . 0.0 110.273 -179.335 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 153' ' ' TYR . . . . . 0.57 ' O ' ' SD ' ' A' ' 141' ' ' MET . 2.8 m-85 -136.18 167.77 20.66 Favored 'General case' 0 N--CA 1.492 1.642 0 N-CA-C 107.582 -1.266 . . . . 0.0 107.582 179.029 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 154' ' ' LYS . . . . . . . . . . . . . 1.5 ttpm? -142.26 122.93 14.23 Favored 'General case' 0 N--CA 1.493 1.704 0 O-C-N 121.127 -0.983 . . . . 0.0 108.393 178.387 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 155' ' ' MET . . . . . . . . . . . . . 67.2 mtp -45.57 105.94 0.07 Allowed 'General case' 0 N--CA 1.491 1.608 0 O-C-N 120.586 -1.321 . . . . 0.0 111.351 -178.67 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 156' ' ' THR . . . . . 0.554 ' OG1' HG23 ' A' ' 203' ' ' THR . 0.1 OUTLIER -106.41 -24.87 12.12 Favored 'General case' 0 C--N 1.293 -1.888 0 CA-C-N 115.401 -0.818 . . . . 0.0 110.073 -179.077 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 157' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -151.45 151.5 31.76 Favored 'General case' 0 N--CA 1.494 1.765 0 C-N-CA 118.405 -1.318 . . . . 0.0 111.206 -178.299 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 158' ' ' ILE . . . . . 0.433 HD12 ' CD1' ' A' ' 200' ' ' PHE . 0.1 OUTLIER -154.16 144.4 13.98 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.189 0 CA-C-O 122.039 0.923 . . . . 0.0 110.448 -179.538 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 159' ' ' ARG . . . . . . . . . . . . . 31.4 ttp180 -153.98 155.91 36.45 Favored 'General case' 0 C--N 1.297 -1.685 0 CA-C-O 121.934 0.873 . . . . 0.0 110.76 -179.036 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 160' ' ' ASP . . . . . 0.446 ' C ' HG22 ' A' ' 161' ' ' VAL . 26.5 m-20 -118.65 160.66 21.42 Favored 'General case' 0 N--CA 1.492 1.666 0 N-CA-C 108.957 -0.757 . . . . 0.0 108.957 179.325 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 161' ' ' VAL . . . . . 0.451 ' O ' ' O ' ' A' ' 162' ' ' LYS . 0.0 OUTLIER -164.54 161.65 0.94 Allowed 'Isoleucine or valine' 0 N--CA 1.496 1.826 0 O-C-N 121.003 -1.061 . . . . 0.0 110.213 179.508 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 162' ' ' LYS . . . . . 0.758 ' CD ' ' H ' ' A' ' 162' ' ' LYS . 0.0 OUTLIER -45.99 173.04 0.04 OUTLIER Pre-proline 0 N--CA 1.493 1.723 0 O-C-N 121.591 -0.693 . . . . 0.0 109.815 179.456 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 163' ' ' PRO . . . . . 0.659 ' CA ' HH21 ' A' ' 197' ' ' ARG . 63.1 Cg_endo -81.34 35.06 0.57 Allowed 'Trans proline' 0 C--N 1.313 -1.34 0 C-N-CA 122.532 2.155 . . . . 0.0 112.54 179.815 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 164' ' ' THR . . . . . 0.423 ' N ' HD11 ' C' ' 702' ' ' LEU . 0.2 OUTLIER -150.76 -2.66 0.35 Allowed 'General case' 0 N--CA 1.495 1.814 0 O-C-N 121.053 -1.03 . . . . 0.0 110.821 179.961 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 165' ' ' ASP . . . . . 0.432 ' O ' ' C ' ' A' ' 166' ' ' VAL . 9.7 t70 -75.8 62.66 1.56 Allowed 'General case' 0 N--CA 1.495 1.785 0 O-C-N 120.675 -1.266 . . . . 0.0 110.675 -179.58 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 166' ' ' VAL . . . . . 0.621 ' O ' ' N ' ' A' ' 168' ' ' VAL . 2.6 t -42.99 -31.48 0.49 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.659 0 O-C-N 121.236 -0.915 . . . . 0.0 109.096 -178.853 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 167' ' ' GLY . . . . . . . . . . . . . . . -44.08 -9.81 0.01 OUTLIER Glycine 0 N--CA 1.495 2.632 0 O-C-N 121.126 -0.983 . . . . 0.0 111.055 -179.788 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 168' ' ' VAL . . . . . 0.629 ' C ' ' H ' ' A' ' 170' ' ' ASP . 7.4 m -55.47 -32.18 29.38 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.51 0 O-C-N 120.615 -1.521 . . . . 0.0 108.759 179.543 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 169' ' ' LEU . . . . . 0.564 ' O ' ' N ' ' A' ' 171' ' ' GLU . 9.5 mt -52.53 -4.65 0.03 OUTLIER 'General case' 0 N--CA 1.498 1.969 0 N-CA-C 107.957 -1.127 . . . . 0.0 107.957 -179.328 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 170' ' ' ASP . . . . . 0.629 ' H ' ' C ' ' A' ' 168' ' ' VAL . 0.6 OUTLIER 34.12 28.21 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.762 -0.586 . . . . 0.0 111.713 177.838 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 171' ' ' GLU . . . . . 0.564 ' N ' ' O ' ' A' ' 169' ' ' LEU . 11.8 pt-20 -63.91 93.17 0.08 Allowed 'General case' 0 C--N 1.298 -1.647 0 N-CA-C 107.645 -1.242 . . . . 0.0 107.645 178.528 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 172' ' ' GLN . . . . . . . . . . . . . 1.0 OUTLIER -160.84 -71.75 0.06 Allowed 'General case' 0 N--CA 1.491 1.588 0 CA-C-O 121.263 0.554 . . . . 0.0 109.511 -179.371 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 173' ' ' LYS . . . . . 0.63 ' NZ ' HE21 ' A' ' 178' ' ' GLN . 8.9 pttm -62.09 126.6 27.91 Favored 'General case' 0 N--CA 1.488 1.446 0 O-C-N 121.143 -0.973 . . . . 0.0 108.908 179.631 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 174' ' ' GLY . . . . . 0.568 ' O ' ' C ' ' A' ' 175' ' ' LYS . . . -121.18 -39.81 0.57 Allowed Glycine 0 C--N 1.298 -1.565 0 N-CA-C 108.283 -1.927 . . . . 0.0 108.283 179.721 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 175' ' ' LYS . . . . . 0.568 ' C ' ' O ' ' A' ' 174' ' ' GLY . 0.8 OUTLIER -31.59 -62.22 0.2 Allowed 'General case' 0 N--CA 1.498 1.929 0 N-CA-C 108.124 -1.065 . . . . 0.0 108.124 179.783 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 176' ' ' ASP . . . . . 0.631 ' O ' ' O ' ' A' ' 177' ' ' LYS . 69.6 m-20 -104.09 85.72 2.44 Favored 'General case' 0 C--N 1.294 -1.815 0 N-CA-C 107.487 -1.301 . . . . 0.0 107.487 177.092 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 177' ' ' LYS . . . . . 0.743 ' NZ ' HE22 ' A' ' 113' ' ' GLN . 35.8 mttt -37.23 174.08 0.0 OUTLIER 'General case' 0 N--CA 1.497 1.904 0 CA-C-O 121.696 0.76 . . . . 0.0 110.588 -179.113 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 178' ' ' GLN . . . . . 0.63 HE21 ' NZ ' ' A' ' 173' ' ' LYS . 0.6 OUTLIER -161.51 175.42 12.15 Favored 'General case' 0 N--CA 1.489 1.479 0 C-N-CA 118.371 -1.332 . . . . 0.0 111.105 -179.864 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 179' ' ' LEU . . . . . 0.422 ' N ' ' OE1' ' A' ' 178' ' ' GLN . 1.3 tp -128.44 98.0 4.9 Favored 'General case' 0 C--N 1.302 -1.485 0 N-CA-C 107.274 -1.38 . . . . 0.0 107.274 178.103 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 180' ' ' THR . . . . . 0.481 ' N ' ' OE1' ' A' ' 178' ' ' GLN . 1.1 m -71.66 120.74 17.67 Favored 'General case' 0 N--CA 1.486 1.371 0 O-C-N 121.1 -1.0 . . . . 0.0 110.157 -178.341 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 181' ' ' LEU . . . . . 0.854 HD23 ' N ' ' A' ' 182' ' ' ILE . 6.6 tt -95.69 146.71 24.29 Favored 'General case' 0 C--N 1.299 -1.593 0 N-CA-C 107.915 -1.143 . . . . 0.0 107.915 178.01 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 182' ' ' ILE . . . . . 0.854 ' N ' HD23 ' A' ' 181' ' ' LEU . 19.8 mt -141.16 117.47 7.17 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.781 0 O-C-N 121.059 -1.026 . . . . 0.0 108.817 179.081 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 183' ' ' THR . . . . . 0.516 HG23 ' O ' ' A' ' 183' ' ' THR . 14.3 t -138.07 119.01 14.27 Favored 'General case' 0 C--N 1.29 -1.978 0 N-CA-C 108.002 -1.11 . . . . 0.0 108.002 179.229 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 184' ' ' CYS . . . . . . . . . . . . . 0.8 OUTLIER -79.85 162.5 25.01 Favored 'General case' 0 C--N 1.285 -2.236 0 C-N-CA 119.466 -0.894 . . . . 0.0 111.397 -177.842 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 185' ' ' ASP . . . . . 0.417 ' OD1' ' N ' ' A' ' 186' ' ' ASP . 4.4 t0 -165.51 -152.48 0.16 Allowed 'General case' 0 N--CA 1.492 1.644 0 N-CA-C 108.938 -0.764 . . . . 0.0 108.938 179.745 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 186' ' ' ASP . . . . . 0.417 ' N ' ' OD1' ' A' ' 185' ' ' ASP . 0.5 OUTLIER 47.78 59.34 4.25 Favored 'General case' 0 N--CA 1.495 1.777 0 O-C-N 121.136 -0.977 . . . . 0.0 109.072 -179.678 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 187' ' ' TYR . . . . . 0.591 ' CE1' ' O ' ' A' ' 188' ' ' ASN . 43.4 t80 -68.37 134.58 50.46 Favored 'General case' 0 N--CA 1.489 1.485 0 CA-C-O 121.821 0.819 . . . . 0.0 110.612 -179.585 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 188' ' ' ASN . . . . . 0.591 ' O ' ' CE1' ' A' ' 187' ' ' TYR . 0.8 OUTLIER -99.6 146.02 26.9 Favored 'General case' 0 C--N 1.294 -1.838 0 N-CA-C 107.916 -1.142 . . . . 0.0 107.916 178.224 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 189' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -111.55 -18.32 12.85 Favored 'General case' 0 C--N 1.296 -1.734 0 N-CA-C 108.1 -1.074 . . . . 0.0 108.1 -179.812 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 190' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER -83.68 -49.77 8.82 Favored 'General case' 0 C--N 1.302 -1.472 0 N-CA-C 108.267 -1.012 . . . . 0.0 108.267 178.457 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 191' ' ' THR . . . . . . . . . . . . . 44.4 p -87.41 -6.52 58.41 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.487 -0.758 . . . . 0.0 109.514 -179.971 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 192' ' ' GLY . . . . . . . . . . . . . . . 56.53 36.3 70.18 Favored Glycine 0 N--CA 1.493 2.463 0 O-C-N 121.081 -1.012 . . . . 0.0 110.648 179.025 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 193' ' ' VAL . . . . . . . . . . . . . 3.3 m -147.23 161.85 8.15 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.545 0 O-C-N 121.025 -1.279 . . . . 0.0 109.339 179.709 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 194' ' ' TRP . . . . . 0.472 ' CD1' ' N ' ' A' ' 194' ' ' TRP . 22.7 m95 -84.15 118.88 24.4 Favored 'General case' 0 N--CA 1.489 1.495 0 N-CA-C 107.604 -1.258 . . . . 0.0 107.604 178.654 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 195' ' ' GLU . . . . . 0.522 ' CD ' ' ND2' ' A' ' 188' ' ' ASN . 3.5 mt-10 -82.74 -62.09 1.7 Allowed 'General case' 0 N--CA 1.495 1.809 0 O-C-N 121.14 -0.975 . . . . 0.0 112.319 -177.103 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 196' ' ' LYS . . . . . . . . . . . . . 8.0 tptp -86.63 156.46 20.01 Favored 'General case' 0 N--CA 1.494 1.754 0 O-C-N 120.753 -1.217 . . . . 0.0 110.856 -178.141 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 197' ' ' ARG . . . . . 0.659 HH21 ' CA ' ' A' ' 163' ' ' PRO . 6.4 tpp180 -124.98 139.94 53.36 Favored 'General case' 0 N--CA 1.489 1.489 0 N-CA-C 109.133 -0.691 . . . . 0.0 109.133 179.389 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 198' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -112.46 121.8 45.87 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.626 -0.671 . . . . 0.0 109.863 -179.053 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 199' ' ' ILE . . . . . 0.66 HG22 HG23 ' A' ' 182' ' ' ILE . 0.9 OUTLIER -141.51 119.44 8.88 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.665 0 CA-C-O 122.615 1.198 . . . . 0.0 110.996 179.857 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 200' ' ' PHE . . . . . 0.564 ' CE2' HD22 ' A' ' 181' ' ' LEU . 0.2 OUTLIER -104.7 138.71 40.59 Favored 'General case' 0 N--CA 1.494 1.759 0 O-C-N 121.526 -0.734 . . . . 0.0 110.438 -178.305 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 201' ' ' VAL . . . . . . . . . . . . . 58.0 t -101.93 143.52 14.59 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.729 0 O-C-N 120.971 -1.081 . . . . 0.0 108.447 178.314 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 202' ' ' ALA . . . . . . . . . . . . . . . -124.95 135.23 52.63 Favored 'General case' 0 N--CA 1.489 1.477 0 N-CA-C 108.49 -0.93 . . . . 0.0 108.49 179.687 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 203' ' ' THR . . . . . 0.736 ' O ' HG23 ' A' ' 205' ' ' VAL . 1.3 p -89.17 128.4 35.8 Favored 'General case' 0 C--N 1.303 -1.427 0 CA-C-O 122.23 1.014 . . . . 0.0 111.225 -178.61 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 204' ' ' GLU . . . . . 0.484 ' HA ' ' CD2' ' A' ' 153' ' ' TYR . 5.5 tt0 -51.18 134.43 27.22 Favored 'General case' 0 C--N 1.297 -1.684 0 C-N-CA 118.949 -1.101 . . . . 0.0 108.369 178.728 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 205' ' ' VAL . . . . . 0.736 HG23 ' O ' ' A' ' 203' ' ' THR . 95.6 t -131.12 166.81 27.68 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.34 0 CA-C-O 121.934 0.873 . . . . 0.0 110.023 -177.859 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 206' ' ' LYS . . . . . 0.595 ' N ' HG12 ' A' ' 205' ' ' VAL . 2.0 pttp . . . . . 0 C--N 1.298 -1.658 0 CA-C-O 117.925 -1.036 . . . . 0.0 109.455 -179.672 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' C' C ' 702' ' ' LEU . . . . . 0.805 ' N ' HD12 ' C' ' 702' ' ' LEU . 0.0 OUTLIER . . . . . 0 N--CA 1.492 1.67 0 N-CA-C 109.762 -0.458 . . . . 0.0 109.762 . . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' C' C ' 703' ' ' PRO . . . . . 0.546 ' HB3' ' HB3' ' A' ' 92' ' ' ALA . 52.7 Cg_exo -48.01 -173.39 0.0 OUTLIER 'Trans proline' 0 N--CA 1.489 1.262 0 C-N-CA 121.957 1.771 . . . . 0.0 111.652 178.948 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' C' C ' 704' ' ' ALA . . . . . 0.752 ' HB2' ' HB1' ' A' ' 118' ' ' ALA . . . . . . . . 0 N--CA 1.492 1.662 0 O-C-N 121.501 -0.749 . . . . 0.0 109.806 179.673 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 63' ' ' PRO . . . . . 0.788 ' O ' HD13 ' A' ' 110' ' ' LEU . 16.3 Cg_exo . . . . . 0 N--CA 1.49 1.285 0 CA-C-O 121.254 0.439 . . . . 0.0 111.85 . . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 64' ' ' GLN . . . . . 0.622 HE21 ' C ' ' A' ' 64' ' ' GLN . 0.0 OUTLIER -152.75 103.92 2.82 Favored 'General case' 0 N--CA 1.489 1.476 0 O-C-N 121.372 -0.83 . . . . 0.0 109.408 -179.7 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 65' ' ' ILE . . . . . 0.58 HD12 ' H ' ' A' ' 65' ' ' ILE . 3.5 mp -40.14 102.27 0.26 Allowed Pre-proline 0 N--CA 1.488 1.45 0 N-CA-C 108.43 -0.952 . . . . 0.0 108.43 179.233 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 66' ' ' PRO . . . . . 0.411 ' N ' ' O ' ' A' ' 64' ' ' GLN . 97.9 Cg_endo -84.55 -155.61 0.06 OUTLIER 'Trans proline' 0 N--CA 1.489 1.206 0 C-N-CA 122.751 2.3 . . . . 0.0 112.968 -178.124 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 67' ' ' LYS . . . . . 0.44 ' C ' ' H ' ' A' ' 69' ' ' LYS . 6.5 ptpt -82.81 -5.03 58.76 Favored 'General case' 0 C--N 1.305 -1.362 0 N-CA-C 108.877 -0.786 . . . . 0.0 108.877 179.698 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 68' ' ' ASP . . . . . 0.631 ' C ' ' N ' ' A' ' 70' ' ' SER . 0.3 OUTLIER -75.39 50.18 0.51 Allowed 'General case' 0 N--CA 1.491 1.579 0 CA-C-O 123.005 1.383 . . . . 0.0 108.189 179.013 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 69' ' ' LYS . . . . . 0.455 ' C ' ' O ' ' A' ' 68' ' ' ASP . 1.9 mtpt -48.07 -15.17 0.06 Allowed 'General case' 0 N--CA 1.506 2.359 0 C-N-CA 116.758 -1.977 . . . . 0.0 107.149 178.425 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 70' ' ' SER . . . . . 0.631 ' N ' ' C ' ' A' ' 68' ' ' ASP . 0.2 OUTLIER -86.81 -5.22 59.17 Favored 'General case' 0 C--N 1.293 -1.856 0 CA-C-N 113.701 -1.591 . . . . 0.0 110.613 179.758 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 71' ' ' LYS . . . . . 0.446 ' N ' ' O ' ' A' ' 68' ' ' ASP . 2.4 ptmm? -97.28 138.36 34.87 Favored 'General case' 0 N--CA 1.494 1.736 0 O-C-N 120.899 -1.126 . . . . 0.0 112.007 -179.305 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 72' ' ' VAL . . . . . 0.593 ' CG2' ' O ' ' A' ' 74' ' ' GLY . 0.7 OUTLIER -67.01 132.25 32.38 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.444 0 N-CA-C 104.977 -2.231 . . . . 0.0 104.977 174.554 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 73' ' ' ALA . . . . . 0.452 ' N ' ' O ' ' A' ' 87' ' ' VAL . . . -82.04 -12.87 58.05 Favored 'General case' 0 C--N 1.299 -1.617 0 O-C-N 120.121 -1.612 . . . . 0.0 108.681 -178.671 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 74' ' ' GLY . . . . . 0.593 ' O ' ' CG2' ' A' ' 72' ' ' VAL . . . 170.35 -156.4 26.86 Favored Glycine 0 N--CA 1.483 1.784 0 N-CA-C 109.642 -1.383 . . . . 0.0 109.642 179.974 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 75' ' ' TYR . . . . . 0.55 ' CD1' ' C ' ' A' ' 74' ' ' GLY . 10.8 m-85 -143.71 173.81 11.34 Favored 'General case' 0 C--N 1.293 -1.889 0 O-C-N 121.276 -1.132 . . . . 0.0 109.702 -178.811 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 76' ' ' ILE . . . . . . . . . . . . . 1.4 tt -147.25 144.97 19.52 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.79 0 N-CA-C 108.72 -0.844 . . . . 0.0 108.72 -178.067 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -150.48 157.19 42.74 Favored 'General case' 0 C--N 1.301 -1.536 0 O-C-N 121.043 -1.035 . . . . 0.0 109.849 -179.513 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 78' ' ' ILE . . . . . 0.451 HG23 ' O ' ' A' ' 141' ' ' MET . 22.4 mt -142.6 121.28 7.51 Favored Pre-proline 0 C--N 1.301 -1.526 0 N-CA-C 107.291 -1.374 . . . . 0.0 107.291 179.718 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 79' ' ' PRO . . . . . . . . . . . . . 55.6 Cg_endo -73.33 -42.85 0.81 Allowed 'Trans proline' 0 N--CA 1.49 1.321 0 C-N-CA 121.893 1.729 . . . . 0.0 113.569 -177.89 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 19.6 t70 -65.98 -19.4 65.85 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 120.766 -1.209 . . . . 0.0 110.274 178.06 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 81' ' ' ALA . . . . . 0.95 ' HB2' ' HB2' ' A' ' 136' ' ' ALA . . . -105.6 -20.99 13.3 Favored 'General case' 0 N--CA 1.495 1.804 0 O-C-N 121.165 -0.959 . . . . 0.0 108.79 179.502 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 82' ' ' ASP . . . . . 0.423 ' OD2' ' C ' ' A' ' 81' ' ' ALA . 0.4 OUTLIER 68.65 51.56 0.61 Allowed 'General case' 0 C--N 1.303 -1.441 0 O-C-N 121.336 -0.853 . . . . 0.0 111.127 178.816 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 83' ' ' ILE . . . . . 0.6 HD11 ' OD1' ' A' ' 132' ' ' ASN . 57.6 mt -127.15 152.27 34.98 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.864 0 O-C-N 121.163 -0.96 . . . . 0.0 109.481 -179.777 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 84' ' ' LYS . . . . . . . . . . . . . 0.8 OUTLIER -159.26 108.36 1.87 Allowed 'General case' 0 C--N 1.303 -1.435 0 N-CA-C 107.892 -1.151 . . . . 0.0 107.892 179.727 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 85' ' ' GLU . . . . . 0.493 ' OE1' ' O ' ' A' ' 128' ' ' TYR . 0.0 OUTLIER -142.82 170.53 8.58 Favored Pre-proline 0 N--CA 1.497 1.921 0 O-C-N 121.362 -0.836 . . . . 0.0 111.105 -177.597 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 86' ' ' PRO . . . . . . . . . . . . . 90.4 Cg_endo -79.8 161.53 24.34 Favored 'Trans proline' 0 N--CA 1.493 1.474 0 C-N-CA 123.25 2.634 . . . . 0.0 113.247 179.752 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 87' ' ' VAL . . . . . 0.57 ' H ' HG23 ' A' ' 72' ' ' VAL . 92.8 t -118.14 101.97 12.57 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.485 0 N-CA-C 108.99 -0.744 . . . . 0.0 108.99 179.91 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 88' ' ' TYR . . . . . 0.402 ' CE1' ' HB3' ' A' ' 99' ' ' ARG . 17.5 m-85 -93.35 153.93 41.44 Favored Pre-proline 0 N--CA 1.504 2.236 0 O-C-N 120.865 -1.147 . . . . 0.0 110.664 -179.015 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 89' ' ' PRO . . . . . . . . . . . . . 11.2 Cg_endo -62.44 143.0 92.66 Favored 'Trans proline' 0 C--N 1.312 -1.346 0 C-N-CA 122.571 2.181 . . . . 0.0 113.863 -179.067 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 90' ' ' GLY . . . . . 0.412 ' O ' ' NZ ' ' A' ' 69' ' ' LYS . . . -58.33 168.24 5.71 Favored Glycine 0 N--CA 1.487 2.034 0 N-CA-C 110.167 -1.173 . . . . 0.0 110.167 179.611 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 91' ' ' PRO . . . . . 0.465 ' C ' ' H ' ' A' ' 93' ' ' THR . 38.2 Cg_endo -93.11 169.46 21.09 Favored 'Cis proline' 0 C--N 1.307 -1.606 0 C-N-CA 123.713 -1.37 . . . . 0.0 111.497 0.132 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 92' ' ' ALA . . . . . 0.605 ' HB3' ' CB ' ' C' ' 703' ' ' PRO . . . -72.81 33.3 0.07 Allowed 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.02 -1.05 . . . . 0.0 110.237 -179.691 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 93' ' ' THR . . . . . 0.465 ' H ' ' C ' ' A' ' 91' ' ' PRO . 1.6 p -72.21 152.74 92.47 Favored Pre-proline 0 C--N 1.3 -1.559 0 O-C-N 120.86 -1.15 . . . . 0.0 108.008 179.776 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 94' ' ' PRO . . . . . 0.428 ' C ' ' O ' ' A' ' 93' ' ' THR . 92.2 Cg_exo -32.79 -58.73 0.26 Allowed 'Trans proline' 0 C--N 1.305 -1.747 0 C-N-CA 122.575 2.184 . . . . 0.0 112.347 -179.253 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 21.0 mt-10 -44.2 -49.06 9.3 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.249 -0.907 . . . . 0.0 109.971 179.862 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 96' ' ' GLN . . . . . 0.628 ' NE2' HH12 ' A' ' 99' ' ' ARG . 3.8 mp0 -72.33 -55.87 6.41 Favored 'General case' 0 N--CA 1.489 1.491 0 O-C-N 121.203 -0.935 . . . . 0.0 111.014 -178.973 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 97' ' ' LEU . . . . . 0.417 ' CD1' ' O ' ' A' ' 92' ' ' ALA . 80.9 mt -49.21 -6.59 0.02 OUTLIER 'General case' 0 N--CA 1.496 1.845 0 O-C-N 121.067 -1.021 . . . . 0.0 110.279 -178.867 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 98' ' ' ASN . . . . . 0.773 HD21 ' NE ' ' A' ' 99' ' ' ARG . 0.2 OUTLIER -72.77 -25.16 61.07 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.337 -0.852 . . . . 0.0 108.928 179.679 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 99' ' ' ARG . . . . . 0.773 ' NE ' HD21 ' A' ' 98' ' ' ASN . 3.5 mtt180 -92.06 -51.97 4.93 Favored 'General case' 0 C--N 1.302 -1.467 0 O-C-N 121.682 -0.636 . . . . 0.0 110.497 -179.035 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . 172.23 -166.58 39.41 Favored Glycine 0 N--CA 1.493 2.486 0 N-CA-C 109.741 -1.343 . . . . 0.0 109.741 -179.687 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 101' ' ' VAL . . . . . 0.623 ' O ' HG23 ' A' ' 101' ' ' VAL . 34.7 m -54.69 100.41 0.04 OUTLIER 'Isoleucine or valine' 0 N--CA 1.493 1.724 0 O-C-N 121.146 -1.209 . . . . 0.0 109.802 -179.659 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 1.9 m -92.07 171.73 8.91 Favored 'General case' 0 N--CA 1.497 1.875 0 O-C-N 121.417 -0.802 . . . . 0.0 110.324 -179.789 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 103' ' ' PHE . . . . . 0.499 ' CE1' ' CG1' ' A' ' 87' ' ' VAL . 23.6 m-85 -75.08 145.68 42.09 Favored 'General case' 0 N--CA 1.493 1.697 0 N-CA-C 108.069 -1.086 . . . . 0.0 108.069 178.263 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 104' ' ' ALA . . . . . . . . . . . . . . . -66.71 -13.42 61.29 Favored 'General case' 0 N--CA 1.492 1.671 0 O-C-N 121.243 -0.911 . . . . 0.0 111.571 -178.105 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 105' ' ' GLU . . . . . 0.452 ' OE2' ' OE1' ' A' ' 108' ' ' GLU . 0.3 OUTLIER -138.6 144.32 39.72 Favored 'General case' 0 N--CA 1.496 1.838 0 O-C-N 120.762 -1.211 . . . . 0.0 110.592 -179.211 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 106' ' ' GLU . . . . . 0.505 ' CG ' ' N ' ' A' ' 107' ' ' ASN . 6.0 pt-20 -57.12 -59.6 4.85 Favored 'General case' 0 C--N 1.304 -1.402 0 O-C-N 121.732 -0.605 . . . . 0.0 110.224 -179.806 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 107' ' ' ASN . . . . . 0.743 HD22 ' N ' ' A' ' 107' ' ' ASN . 0.0 OUTLIER -78.27 33.96 0.2 Allowed 'General case' 0 N--CA 1.488 1.442 0 O-C-N 120.542 -1.349 . . . . 0.0 112.895 -176.114 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 108' ' ' GLU . . . . . 0.452 ' OE1' ' OE2' ' A' ' 105' ' ' GLU . 32.9 tp10 -60.09 147.45 39.37 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 120.824 -1.173 . . . . 0.0 108.141 -179.568 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 109' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -95.25 147.53 23.38 Favored 'General case' 0 N--CA 1.489 1.497 0 O-C-N 120.797 -1.189 . . . . 0.0 111.03 -178.093 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 110' ' ' LEU . . . . . 0.899 ' H ' HD23 ' A' ' 110' ' ' LEU . 0.2 OUTLIER -63.67 -24.61 67.85 Favored 'General case' 0 C--N 1.305 -1.337 0 N-CA-C 107.536 -1.283 . . . . 0.0 107.536 178.548 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 111' ' ' ASP . . . . . 0.491 ' CG ' HH22 ' A' ' 151' ' ' ARG . 55.3 m-20 -132.93 49.19 2.34 Favored 'General case' 0 N--CA 1.487 1.391 0 N-CA-C 109.183 -0.673 . . . . 0.0 109.183 179.513 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 112' ' ' ASP . . . . . . . . . . . . . 1.9 t0 -69.07 159.97 31.9 Favored 'General case' 0 N--CA 1.493 1.72 0 O-C-N 121.257 -0.902 . . . . 0.0 111.287 -179.745 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 113' ' ' GLN . . . . . 0.536 ' N ' ' CD ' ' A' ' 113' ' ' GLN . 0.0 OUTLIER -65.21 -18.52 65.38 Favored 'General case' 0 N--CA 1.491 1.614 0 N-CA-C 107.263 -1.384 . . . . 0.0 107.263 177.675 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 114' ' ' ASN . . . . . 0.608 ' ND2' ' O ' ' A' ' 169' ' ' LEU . 8.5 p-10 -153.11 111.85 3.73 Favored 'General case' 0 C--N 1.299 -1.588 0 N-CA-C 108.026 -1.102 . . . . 0.0 108.026 177.505 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 115' ' ' ILE . . . . . 0.485 HG22 ' O ' ' A' ' 115' ' ' ILE . 2.5 mt -96.82 105.68 17.44 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.692 0 N-CA-C 107.604 -1.258 . . . . 0.0 107.604 179.507 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 116' ' ' SER . . . . . . . . . . . . . 4.8 m -86.23 151.6 23.49 Favored 'General case' 0 C--N 1.303 -1.422 0 CA-C-O 122.088 0.947 . . . . 0.0 111.421 -177.739 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 117' ' ' ILE . . . . . . . . . . . . . 1.6 mt -147.19 142.26 20.11 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.532 0 N-CA-C 106.998 -1.482 . . . . 0.0 106.998 178.542 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 118' ' ' ALA . . . . . 0.54 ' HB1' ' HB2' ' C' ' 704' ' ' ALA . . . -137.89 158.37 44.48 Favored 'General case' 0 N--CA 1.493 1.722 0 O-C-N 120.985 -1.072 . . . . 0.0 110.698 -178.284 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 119' ' ' GLY . . . . . . . . . . . . . . . -169.93 145.86 9.54 Favored Glycine 0 N--CA 1.48 1.603 0 N-CA-C 110.055 -1.218 . . . . 0.0 110.055 179.342 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 120' ' ' HIS . . . . . . . . . . . . . 30.0 m170 -70.25 167.48 17.87 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.671 -0.899 . . . . 0.0 109.766 179.589 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 121' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -115.21 157.36 23.79 Favored 'General case' 0 N--CA 1.492 1.644 0 N-CA-C 108.49 -0.93 . . . . 0.0 108.49 179.038 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 122' ' ' PHE . . . . . 0.716 ' O ' HG21 ' A' ' 131' ' ' THR . 2.4 m-85 -141.07 122.95 15.39 Favored 'General case' 0 N--CA 1.494 1.769 0 O-C-N 121.152 -0.967 . . . . 0.0 108.873 -179.889 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 123' ' ' ILE . . . . . 0.555 HG23 ' N ' ' A' ' 124' ' ' ASP . 19.6 tt -60.32 -40.99 85.55 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.548 0 CA-C-O 121.62 0.724 . . . . 0.0 109.52 -179.608 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 124' ' ' ASP . . . . . 0.555 ' N ' HG23 ' A' ' 123' ' ' ILE . 6.0 p-10 -88.96 21.62 3.04 Favored 'General case' 0 C--N 1.295 -1.787 0 O-C-N 121.698 -0.626 . . . . 0.0 111.774 -177.548 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 125' ' ' ARG . . . . . . . . . . . . . 91.6 mtt180 -152.69 101.56 2.71 Favored Pre-proline 0 N--CA 1.492 1.663 0 O-C-N 120.708 -1.245 . . . . 0.0 109.561 179.778 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 126' ' ' PRO . . . . . . . . . . . . . 55.6 Cg_endo -79.32 -30.07 2.77 Favored 'Trans proline' 0 N--CA 1.488 1.177 0 C-N-CA 122.459 2.106 . . . . 0.0 112.903 -179.781 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 127' ' ' ASN . . . . . 0.49 ' O ' ' O ' ' A' ' 128' ' ' TYR . 1.2 m120 -90.07 8.65 31.58 Favored 'General case' 0 N--CA 1.493 1.696 0 O-C-N 121.047 -1.033 . . . . 0.0 109.199 179.594 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 128' ' ' TYR . . . . . 0.493 ' O ' ' OE1' ' A' ' 85' ' ' GLU . 2.1 t80 -59.43 -148.67 0.0 OUTLIER 'General case' 0 C--N 1.302 -1.464 0 O-C-N 121.459 -0.776 . . . . 0.0 109.444 -179.82 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 129' ' ' GLN . . . . . . . . . . . . . 26.7 mt-30 -64.42 -75.6 0.08 Allowed 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.24 -0.913 . . . . 0.0 110.14 -179.252 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 130' ' ' PHE . . . . . 0.523 ' O ' ' CE ' ' A' ' 134' ' ' LYS . 49.4 m-85 -133.87 48.28 2.37 Favored 'General case' 0 N--CA 1.492 1.67 0 O-C-N 121.402 -0.811 . . . . 0.0 109.71 -179.848 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 131' ' ' THR . . . . . 0.716 HG21 ' O ' ' A' ' 122' ' ' PHE . 23.7 m -83.02 -38.84 22.05 Favored 'General case' 0 C--N 1.298 -1.659 0 O-C-N 121.03 -1.044 . . . . 0.0 109.228 179.864 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 132' ' ' ASN . . . . . 0.6 ' OD1' HD11 ' A' ' 83' ' ' ILE . 0.2 OUTLIER -83.61 4.19 29.4 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.475 -0.766 . . . . 0.0 110.781 -179.079 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 133' ' ' LEU . . . . . 0.544 ' O ' ' N ' ' A' ' 135' ' ' ALA . 0.1 OUTLIER -66.49 -45.5 79.43 Favored 'General case' 0 N--CA 1.497 1.909 0 O-C-N 120.591 -1.318 . . . . 0.0 110.164 179.874 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 134' ' ' LYS . . . . . 0.541 ' CD ' ' H ' ' A' ' 134' ' ' LYS . 0.0 OUTLIER -43.07 -17.6 0.01 OUTLIER 'General case' 0 N--CA 1.499 1.995 0 O-C-N 121.142 -0.974 . . . . 0.0 110.814 -178.861 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 135' ' ' ALA . . . . . 0.544 ' N ' ' O ' ' A' ' 133' ' ' LEU . . . -84.09 -31.85 25.08 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 120.976 -1.078 . . . . 0.0 109.725 -179.931 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 136' ' ' ALA . . . . . 0.95 ' HB2' ' HB2' ' A' ' 81' ' ' ALA . . . -79.6 151.53 30.56 Favored 'General case' 0 C--N 1.3 -1.545 0 CA-C-O 121.874 0.845 . . . . 0.0 111.623 -178.413 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 137' ' ' LYS . . . . . 0.576 ' O ' ' O ' ' A' ' 138' ' ' LYS . 0.0 OUTLIER -153.11 -168.91 3.17 Favored 'General case' 0 N--CA 1.495 1.796 0 C-N-CA 118.474 -1.29 . . . . 0.0 111.313 -177.964 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 138' ' ' LYS . . . . . 0.576 ' O ' ' O ' ' A' ' 137' ' ' LYS . 50.1 mttm -38.55 172.37 0.0 OUTLIER 'General case' 0 N--CA 1.487 1.415 0 CA-C-O 122.488 1.137 . . . . 0.0 110.971 -178.986 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 139' ' ' GLY . . . . . . . . . . . . . . . 49.13 9.12 0.1 Allowed Glycine 0 N--CA 1.488 2.143 0 N-CA-C 109.8 -1.32 . . . . 0.0 109.8 -179.977 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 140' ' ' SER . . . . . 0.519 ' N ' ' O ' ' A' ' 138' ' ' LYS . 4.3 m -80.56 132.26 35.63 Favored 'General case' 0 N--CA 1.496 1.86 0 O-C-N 120.975 -1.309 . . . . 0.0 109.778 179.677 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 141' ' ' MET . . . . . 0.451 ' O ' HG23 ' A' ' 78' ' ' ILE . 0.1 OUTLIER -83.68 128.81 34.81 Favored 'General case' 0 N--CA 1.49 1.567 0 N-CA-C 108.515 -0.921 . . . . 0.0 108.515 179.195 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 142' ' ' VAL . . . . . . . . . . . . . 2.6 t -117.96 131.68 69.99 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.857 0 O-C-N 121.414 -0.804 . . . . 0.0 109.061 -179.185 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 143' ' ' TYR . . . . . . . . . . . . . 3.1 m-85 -110.58 135.58 51.01 Favored 'General case' 0 N--CA 1.496 1.866 0 O-C-N 120.851 -1.156 . . . . 0.0 111.444 -178.443 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 144' ' ' PHE . . . . . . . . . . . . . 52.6 t80 -122.15 103.11 8.56 Favored 'General case' 0 N--CA 1.493 1.718 0 CA-C-O 121.495 0.664 . . . . 0.0 109.844 -179.428 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 145' ' ' LYS . . . . . . . . . . . . . 46.1 mttt -96.94 128.59 44.05 Favored 'General case' 0 N--CA 1.494 1.764 0 O-C-N 121.458 -0.776 . . . . 0.0 110.992 -179.291 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 146' ' ' VAL . . . . . 0.443 ' O ' ' C ' ' A' ' 147' ' ' GLY . 2.0 p -141.46 142.12 29.4 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.668 0 N-CA-C 107.519 -1.289 . . . . 0.0 107.519 178.52 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 147' ' ' GLY . . . . . 0.443 ' C ' ' O ' ' A' ' 146' ' ' VAL . . . 43.59 -129.38 6.17 Favored Glycine 0 N--CA 1.49 2.276 0 N-CA-C 109.313 -1.515 . . . . 0.0 109.313 -179.827 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 148' ' ' ASN . . . . . 0.463 HD22 ' C ' ' A' ' 148' ' ' ASN . 0.5 OUTLIER -102.29 15.15 30.0 Favored 'General case' 0 N--CA 1.488 1.469 0 O-C-N 121.278 -1.131 . . . . 0.0 108.336 179.15 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 149' ' ' GLU . . . . . . . . . . . . . 2.3 mm-40 -109.07 143.91 37.79 Favored 'General case' 0 N--CA 1.49 1.531 0 CA-C-O 121.771 0.796 . . . . 0.0 111.576 -178.546 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 150' ' ' THR . . . . . . . . . . . . . 3.4 m -130.02 101.16 5.71 Favored 'General case' 0 N--CA 1.495 1.779 0 CA-C-O 121.46 0.647 . . . . 0.0 109.77 179.915 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 151' ' ' ARG . . . . . 0.491 HH22 ' CG ' ' A' ' 111' ' ' ASP . 16.5 mtt180 -86.13 -171.67 3.68 Favored 'General case' 0 N--CA 1.487 1.404 0 O-C-N 121.243 -0.91 . . . . 0.0 108.983 -179.671 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 152' ' ' LYS . . . . . 0.465 ' O ' ' N ' ' A' ' 205' ' ' VAL . 36.3 mtmt -151.38 148.35 28.02 Favored 'General case' 0 C--N 1.301 -1.532 0 O-C-N 121.111 -0.993 . . . . 0.0 110.423 -178.895 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 153' ' ' TYR . . . . . 0.503 ' CD2' ' HA ' ' A' ' 204' ' ' GLU . 11.1 m-85 -141.76 168.68 19.18 Favored 'General case' 0 C--N 1.302 -1.493 0 N-CA-C 108.157 -1.053 . . . . 0.0 108.157 179.189 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 154' ' ' LYS . . . . . . . . . . . . . 29.1 ttpt -143.17 119.0 10.54 Favored 'General case' 0 C--N 1.297 -1.714 0 N-CA-C 108.038 -1.097 . . . . 0.0 108.038 178.703 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 155' ' ' MET . . . . . . . . . . . . . 18.0 mtp -47.13 108.69 0.16 Allowed 'General case' 0 N--CA 1.492 1.662 0 O-C-N 120.536 -1.353 . . . . 0.0 111.528 -178.381 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 156' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -105.16 -25.15 12.6 Favored 'General case' 0 C--N 1.294 -1.822 0 CA-C-N 115.351 -0.841 . . . . 0.0 110.714 -178.638 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 157' ' ' SER . . . . . . . . . . . . . 49.8 m -145.84 147.44 31.82 Favored 'General case' 0 C--N 1.296 -1.748 0 C-N-CA 118.511 -1.276 . . . . 0.0 110.15 -178.769 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 158' ' ' ILE . . . . . . . . . . . . . 2.3 mt -146.96 136.54 16.67 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.611 0 CA-C-O 121.538 0.685 . . . . 0.0 110.111 -177.781 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 159' ' ' ARG . . . . . 0.684 ' CG ' HH11 ' A' ' 159' ' ' ARG . 0.0 OUTLIER -155.63 -172.83 4.29 Favored 'General case' 0 N--CA 1.491 1.604 0 C-N-CA 119.505 -0.878 . . . . 0.0 110.459 179.733 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 160' ' ' ASP . . . . . 0.514 ' C ' HG22 ' A' ' 161' ' ' VAL . 10.7 m-20 -149.54 165.47 32.11 Favored 'General case' 0 N--CA 1.489 1.507 0 N-CA-C 108.324 -0.991 . . . . 0.0 108.324 179.554 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 161' ' ' VAL . . . . . 0.514 HG22 ' C ' ' A' ' 160' ' ' ASP . 0.1 OUTLIER -166.07 161.44 0.81 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.685 0 O-C-N 121.088 -1.008 . . . . 0.0 109.877 179.829 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 162' ' ' LYS . . . . . 0.484 ' O ' ' O ' ' A' ' 161' ' ' VAL . 0.0 OUTLIER -44.62 170.99 0.05 OUTLIER Pre-proline 0 N--CA 1.489 1.503 0 O-C-N 121.366 -0.834 . . . . 0.0 109.653 179.73 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 163' ' ' PRO . . . . . 0.485 ' C ' HD11 ' C' ' 702' ' ' LEU . 62.1 Cg_endo -80.74 36.16 0.61 Allowed 'Trans proline' 0 C--N 1.31 -1.483 0 C-N-CA 122.672 2.248 . . . . 0.0 113.061 -179.851 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 164' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -151.88 -2.88 0.28 Allowed 'General case' 0 N--CA 1.497 1.896 0 O-C-N 121.047 -1.033 . . . . 0.0 110.214 179.987 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 165' ' ' ASP . . . . . . . . . . . . . 7.2 t70 -74.83 62.98 1.13 Allowed 'General case' 0 N--CA 1.488 1.45 0 O-C-N 120.899 -1.126 . . . . 0.0 109.386 -179.988 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 166' ' ' VAL . . . . . 0.589 ' O ' ' N ' ' A' ' 168' ' ' VAL . 1.8 m -49.68 -33.82 8.37 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.503 0 O-C-N 121.659 -0.65 . . . . 0.0 109.776 -178.392 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 167' ' ' GLY . . . . . 0.405 ' C ' ' O ' ' A' ' 166' ' ' VAL . . . -43.89 -13.35 0.02 OUTLIER Glycine 0 N--CA 1.496 2.65 0 O-C-N 120.865 -1.147 . . . . 0.0 110.725 -179.766 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 168' ' ' VAL . . . . . 0.589 ' N ' ' O ' ' A' ' 166' ' ' VAL . 3.5 m -53.48 -26.77 13.54 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.563 0 O-C-N 120.712 -1.463 . . . . 0.0 108.741 179.688 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 169' ' ' LEU . . . . . 0.608 ' O ' ' ND2' ' A' ' 114' ' ' ASN . 1.2 mm? -44.43 -24.67 0.19 Allowed 'General case' 0 C--N 1.299 -1.61 0 N-CA-C 107.808 -1.182 . . . . 0.0 107.808 -178.658 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 170' ' ' ASP . . . . . 0.474 ' N ' ' C ' ' A' ' 168' ' ' VAL . 14.9 t0 37.29 90.51 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.715 -0.616 . . . . 0.0 110.804 177.944 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 171' ' ' GLU . . . . . . . . . . . . . 14.9 pt-20 -130.13 60.09 1.62 Allowed 'General case' 0 N--CA 1.497 1.922 0 O-C-N 120.904 -1.123 . . . . 0.0 109.735 179.515 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 172' ' ' GLN . . . . . . . . . . . . . 10.7 mt-30 -123.06 -56.87 1.73 Allowed 'General case' 0 N--CA 1.497 1.899 0 O-C-N 121.438 -0.789 . . . . 0.0 110.958 -178.969 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 173' ' ' LYS . . . . . 0.467 ' H ' ' HD2' ' A' ' 173' ' ' LYS . 2.3 mptp? -57.62 123.2 14.79 Favored 'General case' 0 N--CA 1.493 1.696 0 O-C-N 120.817 -1.177 . . . . 0.0 108.909 -179.67 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 174' ' ' GLY . . . . . 0.485 ' O ' ' C ' ' A' ' 175' ' ' LYS . . . -117.29 -43.59 0.59 Allowed Glycine 0 N--CA 1.478 1.483 0 N-CA-C 108.166 -1.974 . . . . 0.0 108.166 179.589 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 175' ' ' LYS . . . . . 0.485 ' C ' ' O ' ' A' ' 174' ' ' GLY . 11.9 mptt -43.52 -58.53 2.57 Favored 'General case' 0 N--CA 1.49 1.545 0 N-CA-C 107.107 -1.442 . . . . 0.0 107.107 179.565 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 176' ' ' ASP . . . . . 0.617 ' O ' ' O ' ' A' ' 177' ' ' LYS . 3.4 m-20 -103.8 85.66 2.47 Favored 'General case' 0 C--N 1.293 -1.866 0 N-CA-C 106.835 -1.543 . . . . 0.0 106.835 176.672 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 177' ' ' LYS . . . . . 0.617 ' O ' ' O ' ' A' ' 176' ' ' ASP . 35.6 mttt -44.23 -175.92 0.0 OUTLIER 'General case' 0 N--CA 1.493 1.691 0 O-C-N 121.632 -0.667 . . . . 0.0 109.663 -179.159 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 178' ' ' GLN . . . . . . . . . . . . . 16.6 pt20 -160.7 173.68 15.07 Favored 'General case' 0 C--N 1.303 -1.439 0 O-C-N 120.307 -1.496 . . . . 0.0 110.949 179.524 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 179' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -129.35 97.74 4.66 Favored 'General case' 0 C--N 1.303 -1.453 0 N-CA-C 107.225 -1.398 . . . . 0.0 107.225 178.459 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 180' ' ' THR . . . . . 0.467 ' O ' HG22 ' A' ' 180' ' ' THR . 1.1 m -73.56 115.69 13.25 Favored 'General case' 0 N--CA 1.493 1.72 0 O-C-N 121.162 -0.961 . . . . 0.0 110.662 -178.372 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 181' ' ' LEU . . . . . 0.688 HD13 ' H ' ' A' ' 182' ' ' ILE . 0.2 OUTLIER -89.55 144.48 25.99 Favored 'General case' 0 C--N 1.301 -1.535 0 N-CA-C 108.11 -1.07 . . . . 0.0 108.11 177.47 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 182' ' ' ILE . . . . . 0.688 ' H ' HD13 ' A' ' 181' ' ' LEU . 4.7 mt -137.91 113.03 9.85 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.643 0 N-CA-C 107.822 -1.177 . . . . 0.0 107.822 179.102 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 183' ' ' THR . . . . . 0.479 HG23 ' O ' ' A' ' 183' ' ' THR . 5.8 t -134.34 119.44 18.65 Favored 'General case' 0 C--N 1.293 -1.88 0 N-CA-C 108.141 -1.059 . . . . 0.0 108.141 179.708 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 184' ' ' CYS . . . . . . . . . . . . . 1.0 OUTLIER -80.21 156.37 26.94 Favored 'General case' 0 C--N 1.289 -2.065 0 C-N-CA 119.514 -0.874 . . . . 0.0 111.183 -178.366 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 185' ' ' ASP . . . . . 0.549 ' O ' ' CB ' ' A' ' 186' ' ' ASP . 0.2 OUTLIER -166.68 170.55 12.44 Favored 'General case' 0 N--CA 1.493 1.698 0 O-C-N 121.538 -0.726 . . . . 0.0 109.058 179.831 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 186' ' ' ASP . . . . . 0.549 ' CB ' ' O ' ' A' ' 185' ' ' ASP . 1.0 OUTLIER 79.28 52.42 0.03 OUTLIER 'General case' 0 N--CA 1.492 1.668 0 O-C-N 121.23 -0.919 . . . . 0.0 109.704 179.863 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 187' ' ' TYR . . . . . 0.581 ' CE1' ' O ' ' A' ' 188' ' ' ASN . 36.9 t80 -65.9 131.42 46.23 Favored 'General case' 0 C--N 1.302 -1.497 0 O-C-N 120.92 -1.113 . . . . 0.0 109.623 179.946 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 188' ' ' ASN . . . . . 0.834 HD21 ' N ' ' A' ' 192' ' ' GLY . 0.0 OUTLIER -100.13 148.71 24.28 Favored 'General case' 0 C--N 1.291 -1.936 0 N-CA-C 107.589 -1.263 . . . . 0.0 107.589 178.68 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 189' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -109.9 -9.57 14.78 Favored 'General case' 0 C--N 1.294 -1.819 0 N-CA-C 108.495 -0.928 . . . . 0.0 108.495 -179.505 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 190' ' ' LYS . . . . . . . . . . . . . 6.4 mmtt -84.49 -56.23 3.73 Favored 'General case' 0 N--CA 1.488 1.432 0 C-N-CA 119.841 -0.744 . . . . 0.0 109.182 178.774 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 191' ' ' THR . . . . . 0.686 ' N ' HD21 ' A' ' 188' ' ' ASN . 7.1 p -86.44 7.93 23.86 Favored 'General case' 0 N--CA 1.493 1.678 0 O-C-N 121.559 -0.713 . . . . 0.0 110.688 -178.823 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 192' ' ' GLY . . . . . 0.834 ' N ' HD21 ' A' ' 188' ' ' ASN . . . 51.69 30.47 28.07 Favored Glycine 0 N--CA 1.494 2.544 0 O-C-N 121.098 -1.001 . . . . 0.0 111.733 178.82 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 193' ' ' VAL . . . . . 0.578 ' H ' HD22 ' A' ' 188' ' ' ASN . 0.4 OUTLIER -149.59 170.58 1.98 Allowed 'Isoleucine or valine' 0 N--CA 1.495 1.798 0 O-C-N 120.463 -1.61 . . . . 0.0 109.909 179.129 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 194' ' ' TRP . . . . . 0.437 ' CD1' ' N ' ' A' ' 194' ' ' TRP . 44.1 m95 -84.93 122.07 28.66 Favored 'General case' 0 C--N 1.295 -1.795 0 CA-C-O 121.577 0.704 . . . . 0.0 109.994 -179.427 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 195' ' ' GLU . . . . . 0.402 ' HG3' ' H ' ' A' ' 195' ' ' GLU . 2.0 mt-10 -77.81 -60.96 2.16 Favored 'General case' 0 N--CA 1.496 1.871 0 O-C-N 121.546 -0.721 . . . . 0.0 111.902 -178.326 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 196' ' ' LYS . . . . . . . . . . . . . 5.3 tttm -92.44 150.11 20.99 Favored 'General case' 0 N--CA 1.495 1.797 0 O-C-N 121.003 -1.061 . . . . 0.0 111.761 -177.481 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 197' ' ' ARG . . . . . 0.699 ' HE ' HD13 ' C' ' 702' ' ' LEU . 0.0 OUTLIER -120.7 139.03 53.64 Favored 'General case' 0 N--CA 1.493 1.676 0 N-CA-C 108.319 -0.993 . . . . 0.0 108.319 178.353 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 198' ' ' LYS . . . . . . . . . . . . . 7.9 mttt -116.72 120.46 38.68 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.447 -0.783 . . . . 0.0 110.406 -178.624 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 199' ' ' ILE . . . . . 0.441 ' O ' HG13 ' A' ' 199' ' ' ILE . 0.9 OUTLIER -140.78 121.06 13.09 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.733 0 CA-C-O 122.787 1.279 . . . . 0.0 110.724 179.77 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 200' ' ' PHE . . . . . . . . . . . . . 2.0 m-85 -105.33 141.44 36.83 Favored 'General case' 0 N--CA 1.496 1.841 0 O-C-N 121.218 -0.926 . . . . 0.0 111.012 -177.502 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 201' ' ' VAL . . . . . . . . . . . . . 61.3 t -104.63 148.39 9.32 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.539 0 N-CA-C 108.394 -0.965 . . . . 0.0 108.394 177.247 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 202' ' ' ALA . . . . . . . . . . . . . . . -133.05 139.84 47.39 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.037 -1.039 . . . . 0.0 109.022 -179.899 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 203' ' ' THR . . . . . 0.628 ' O ' HG23 ' A' ' 205' ' ' VAL . 1.5 p -90.14 129.19 36.45 Favored 'General case' 0 N--CA 1.489 1.509 0 CA-C-O 122.431 1.11 . . . . 0.0 111.753 -178.525 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 204' ' ' GLU . . . . . 0.503 ' HA ' ' CD2' ' A' ' 153' ' ' TYR . 3.6 tm-20 -50.53 135.36 22.81 Favored 'General case' 0 C--N 1.298 -1.656 0 C-N-CA 118.369 -1.333 . . . . 0.0 109.361 178.951 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 205' ' ' VAL . . . . . 0.628 HG23 ' O ' ' A' ' 203' ' ' THR . 72.1 t -129.57 164.82 31.15 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.359 0 CA-C-O 122.083 0.944 . . . . 0.0 110.273 -177.907 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 206' ' ' LYS . . . . . 0.599 ' N ' HG12 ' A' ' 205' ' ' VAL . 0.0 OUTLIER . . . . . 0 C--N 1.295 -1.776 0 CA-C-O 118.025 -0.988 . . . . 0.0 109.482 179.84 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' C' C ' 702' ' ' LEU . . . . . 0.798 ' N ' HD12 ' C' ' 702' ' ' LEU . 0.0 OUTLIER . . . . . 0 N--CA 1.488 1.436 0 N-CA-C 109.08 -0.711 . . . . 0.0 109.08 . . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' C' C ' 703' ' ' PRO . . . . . 0.605 ' CB ' ' HB3' ' A' ' 92' ' ' ALA . 16.2 Cg_exo -51.54 -160.81 0.0 OUTLIER 'Trans proline' 0 N--CA 1.49 1.319 0 C-N-CA 121.805 1.67 . . . . 0.0 112.242 179.911 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' C' C ' 704' ' ' ALA . . . . . 0.54 ' HB2' ' HB1' ' A' ' 118' ' ' ALA . . . . . . . . 0 N--CA 1.493 1.681 0 O-C-N 121.383 -0.823 . . . . 0.0 109.544 179.936 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 63' ' ' PRO . . . . . . . . . . . . . 58.0 Cg_endo . . . . . 0 C--O 1.213 -0.759 0 CA-C-O 120.958 0.316 . . . . 0.0 111.577 . . . . . . . . . 0 0 . 1 . 013 nuclear nobuild core ' A' A ' 64' ' ' GLN . . . . . 0.525 HE21 ' C ' ' A' ' 64' ' ' GLN . 0.0 OUTLIER -156.0 113.01 3.19 Favored 'General case' 0 C--N 1.302 -1.475 0 O-C-N 121.049 -1.032 . . . . 0.0 109.925 179.544 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 65' ' ' ILE . . . . . 0.459 ' C ' ' O ' ' A' ' 64' ' ' GLN . 0.1 OUTLIER -41.35 99.65 0.21 Allowed Pre-proline 0 N--CA 1.498 1.939 0 N-CA-C 108.174 -1.047 . . . . 0.0 108.174 179.386 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 66' ' ' PRO . . . . . 0.456 ' N ' ' O ' ' A' ' 64' ' ' GLN . 66.5 Cg_endo -89.76 -160.69 0.1 OUTLIER 'Trans proline' 0 C--N 1.317 -1.108 0 C-N-CA 122.222 1.948 . . . . 0.0 112.778 -178.76 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 67' ' ' LYS . . . . . 0.479 ' C ' ' H ' ' A' ' 69' ' ' LYS . 0.0 OUTLIER -71.91 -4.94 31.1 Favored 'General case' 0 N--CA 1.488 1.426 0 O-C-N 121.414 -0.804 . . . . 0.0 109.08 179.926 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 68' ' ' ASP . . . . . 0.586 ' C ' ' N ' ' A' ' 70' ' ' SER . 64.6 m-20 -76.21 42.86 0.28 Allowed 'General case' 0 N--CA 1.49 1.561 0 CA-C-O 122.45 1.119 . . . . 0.0 108.459 179.223 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 69' ' ' LYS . . . . . 0.479 ' H ' ' C ' ' A' ' 67' ' ' LYS . 0.5 OUTLIER -50.11 -16.26 0.29 Allowed 'General case' 0 N--CA 1.496 1.854 0 N-CA-C 105.984 -1.858 . . . . 0.0 105.984 178.102 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 70' ' ' SER . . . . . 0.586 ' N ' ' C ' ' A' ' 68' ' ' ASP . 3.0 p -86.66 50.84 2.08 Favored 'General case' 0 C--N 1.298 -1.643 0 CA-C-N 113.94 -1.482 . . . . 0.0 108.742 178.644 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 71' ' ' LYS . . . . . . . . . . . . . 6.5 ptmt -162.63 143.19 9.79 Favored 'General case' 0 C--N 1.296 -1.731 0 C-N-CA 118.224 -1.391 . . . . 0.0 111.235 -179.657 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 72' ' ' VAL . . . . . 0.582 HG12 ' CE1' ' A' ' 88' ' ' TYR . 0.8 OUTLIER -64.28 136.14 26.9 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.577 0 N-CA-C 105.644 -1.984 . . . . 0.0 105.644 175.434 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -81.66 -13.85 57.38 Favored 'General case' 0 C--N 1.292 -1.897 0 N-CA-C 105.661 -1.977 . . . . 0.0 105.661 179.371 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . 174.01 -156.88 24.49 Favored Glycine 0 N--CA 1.478 1.448 0 N-CA-C 109.251 -1.54 . . . . 0.0 109.251 179.388 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 75' ' ' TYR . . . . . . . . . . . . . 94.4 m-85 -141.32 170.62 15.37 Favored 'General case' 0 C--N 1.296 -1.754 0 CA-C-O 121.875 0.845 . . . . 0.0 109.766 -178.144 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 76' ' ' ILE . . . . . . . . . . . . . 0.7 OUTLIER -147.66 143.74 19.58 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.646 0 C-N-CA 119.366 -0.934 . . . . 0.0 109.258 -178.095 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 77' ' ' GLU . . . . . 0.518 ' N ' ' CD ' ' A' ' 77' ' ' GLU . 2.6 mp0 -146.76 162.66 38.08 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 120.929 -1.107 . . . . 0.0 109.967 -179.837 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 78' ' ' ILE . . . . . 0.661 ' HB ' ' HB3' ' A' ' 81' ' ' ALA . 4.1 mt -148.16 90.3 5.04 Favored Pre-proline 0 N--CA 1.489 1.48 0 N-CA-C 108.311 -0.996 . . . . 0.0 108.311 179.839 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 79' ' ' PRO . . . . . . . . . . . . . 73.5 Cg_exo -45.29 -44.49 16.06 Favored 'Trans proline' 0 C--N 1.31 -1.457 0 C-N-CA 122.597 2.198 . . . . 0.0 113.63 -178.583 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 4.4 m-20 -67.14 -19.29 65.58 Favored 'General case' 0 N--CA 1.492 1.652 0 O-C-N 120.869 -1.145 . . . . 0.0 110.789 178.418 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 81' ' ' ALA . . . . . 0.882 ' HB2' ' HB2' ' A' ' 136' ' ' ALA . . . -106.63 -15.01 14.88 Favored 'General case' 0 N--CA 1.493 1.717 0 O-C-N 121.137 -0.977 . . . . 0.0 109.176 179.976 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 82' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER 68.3 46.72 1.05 Allowed 'General case' 0 N--CA 1.488 1.459 0 O-C-N 121.375 -0.828 . . . . 0.0 110.338 179.22 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 83' ' ' ILE . . . . . 0.456 ' CG1' ' OD1' ' A' ' 132' ' ' ASN . 60.9 mt -120.98 148.36 24.29 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.797 0 O-C-N 121.296 -0.877 . . . . 0.0 110.357 -178.928 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 84' ' ' LYS . . . . . 0.402 ' O ' ' CD ' ' A' ' 85' ' ' GLU . 0.0 OUTLIER -160.44 102.63 1.38 Allowed 'General case' 0 C--N 1.305 -1.367 0 N-CA-C 107.322 -1.362 . . . . 0.0 107.322 179.731 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 85' ' ' GLU . . . . . 0.441 ' CB ' ' CD ' ' A' ' 86' ' ' PRO . 1.3 mm-40 -141.49 178.25 1.61 Allowed Pre-proline 0 N--CA 1.497 1.914 0 O-C-N 121.301 -0.874 . . . . 0.0 110.247 -178.831 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 86' ' ' PRO . . . . . 0.441 ' CD ' ' CB ' ' A' ' 85' ' ' GLU . 69.2 Cg_endo -91.2 158.02 3.81 Favored 'Trans proline' 0 N--CA 1.487 1.112 0 C-N-CA 123.314 2.676 . . . . 0.0 113.661 -178.565 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 87' ' ' VAL . . . . . 0.555 ' CG1' ' CZ ' ' A' ' 103' ' ' PHE . 35.5 t -111.07 100.04 9.93 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.498 0 N-CA-C 109.191 -0.67 . . . . 0.0 109.191 -179.85 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 88' ' ' TYR . . . . . 0.582 ' CE1' HG12 ' A' ' 72' ' ' VAL . 8.1 m-85 -91.71 170.31 9.69 Favored Pre-proline 0 N--CA 1.507 2.4 0 O-C-N 120.535 -1.353 . . . . 0.0 110.135 -179.102 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 89' ' ' PRO . . . . . . . . . . . . . 3.0 Cg_exo -71.35 141.71 39.54 Favored 'Trans proline' 0 N--CA 1.5 1.883 0 C-N-CA 122.505 2.137 . . . . 0.0 114.241 -178.394 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . -62.16 167.18 17.9 Favored Glycine 0 N--CA 1.492 2.394 0 N-CA-C 108.8 -1.72 . . . . 0.0 108.8 178.38 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 91' ' ' PRO . . . . . 0.41 ' C ' ' H ' ' A' ' 93' ' ' THR . 45.1 Cg_endo -91.67 172.69 21.43 Favored 'Cis proline' 0 C--N 1.307 -1.648 0 C-N-CA 123.55 -1.437 . . . . 0.0 112.001 0.651 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 92' ' ' ALA . . . . . 0.556 ' HB3' ' HB2' ' C' ' 703' ' ' PRO . . . -73.2 33.34 0.07 Allowed 'General case' 0 N--CA 1.493 1.706 0 O-C-N 121.352 -0.843 . . . . 0.0 110.677 -179.418 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 93' ' ' THR . . . . . 0.439 ' O ' ' C ' ' A' ' 94' ' ' PRO . 0.8 OUTLIER -71.8 149.56 92.85 Favored Pre-proline 0 C--N 1.301 -1.519 0 O-C-N 120.59 -1.319 . . . . 0.0 108.45 179.773 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 94' ' ' PRO . . . . . 0.439 ' C ' ' O ' ' A' ' 93' ' ' THR . 80.7 Cg_exo -31.78 -53.18 0.31 Allowed 'Trans proline' 0 C--N 1.308 -1.563 0 C-N-CA 122.723 2.282 . . . . 0.0 112.203 -179.183 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 95' ' ' GLU . . . . . 0.493 ' O ' ' ND2' ' A' ' 98' ' ' ASN . 7.1 tp10 -47.65 -52.64 17.37 Favored 'General case' 0 C--N 1.299 -1.601 0 O-C-N 121.397 -0.814 . . . . 0.0 109.259 179.487 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 96' ' ' GLN . . . . . 0.517 ' C ' ' H ' ' A' ' 98' ' ' ASN . 12.2 mp0 -70.14 -54.66 11.98 Favored 'General case' 0 N--CA 1.489 1.504 0 O-C-N 121.382 -0.824 . . . . 0.0 110.918 -179.349 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 97' ' ' LEU . . . . . 0.523 ' CD1' ' O ' ' A' ' 92' ' ' ALA . 81.5 mt -50.84 -6.28 0.03 OUTLIER 'General case' 0 N--CA 1.494 1.764 0 O-C-N 121.002 -1.061 . . . . 0.0 110.341 -178.671 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 98' ' ' ASN . . . . . 0.517 ' H ' ' C ' ' A' ' 96' ' ' GLN . 0.2 OUTLIER -75.3 -32.61 61.04 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.169 -0.957 . . . . 0.0 109.392 179.24 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 99' ' ' ARG . . . . . 0.44 ' HD2' ' CE2' ' A' ' 88' ' ' TYR . 9.3 mtt180 -85.53 -44.93 12.25 Favored 'General case' 0 N--CA 1.488 1.469 0 O-C-N 121.478 -0.764 . . . . 0.0 109.727 -179.321 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . 169.87 -170.6 42.91 Favored Glycine 0 N--CA 1.495 2.624 0 C-N-CA 119.698 -1.239 . . . . 0.0 110.141 179.653 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 101' ' ' VAL . . . . . 0.589 ' O ' HG23 ' A' ' 101' ' ' VAL . 26.8 m -55.0 106.74 0.12 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.572 0 O-C-N 121.093 -1.239 . . . . 0.0 109.17 -179.981 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -92.88 164.55 13.28 Favored 'General case' 0 N--CA 1.494 1.737 0 O-C-N 121.433 -0.792 . . . . 0.0 110.664 -179.282 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 103' ' ' PHE . . . . . 0.555 ' CZ ' ' CG1' ' A' ' 87' ' ' VAL . 28.5 m-85 -68.04 123.12 19.76 Favored 'General case' 0 N--CA 1.488 1.452 0 N-CA-C 108.549 -0.908 . . . . 0.0 108.549 178.413 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 104' ' ' ALA . . . . . 0.586 ' HB1' ' HG3' ' C' ' 703' ' ' PRO . . . -50.58 -7.33 0.03 OUTLIER 'General case' 0 C--N 1.3 -1.571 0 O-C-N 121.453 -0.779 . . . . 0.0 110.634 -179.42 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 105' ' ' GLU . . . . . 0.486 ' N ' ' O ' ' A' ' 103' ' ' PHE . 0.0 OUTLIER -139.83 144.22 37.2 Favored 'General case' 0 N--CA 1.495 1.814 0 O-C-N 120.915 -1.116 . . . . 0.0 110.433 -179.246 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 106' ' ' GLU . . . . . . . . . . . . . 28.2 tt0 -59.91 -64.35 0.98 Allowed 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.784 -0.572 . . . . 0.0 111.245 -178.959 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 107' ' ' ASN . . . . . . . . . . . . . 2.1 m-80 -78.5 35.51 0.23 Allowed 'General case' 0 N--CA 1.49 1.541 0 O-C-N 120.813 -1.179 . . . . 0.0 112.378 -175.981 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 108' ' ' GLU . . . . . 0.429 ' OE2' ' OE2' ' A' ' 105' ' ' GLU . 1.6 tp10 -59.0 149.24 27.97 Favored 'General case' 0 C--N 1.303 -1.415 0 O-C-N 120.703 -1.248 . . . . 0.0 107.725 -179.912 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 109' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -103.98 137.51 41.84 Favored 'General case' 0 C--N 1.304 -1.372 0 O-C-N 121.069 -1.019 . . . . 0.0 110.616 -178.236 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 110' ' ' LEU . . . . . . . . . . . . . 2.2 pp -60.74 -17.79 50.7 Favored 'General case' 0 C--N 1.298 -1.636 0 N-CA-C 108.225 -1.028 . . . . 0.0 108.225 179.138 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 111' ' ' ASP . . . . . . . . . . . . . 41.3 m-20 -132.13 37.77 3.55 Favored 'General case' 0 N--CA 1.489 1.492 0 N-CA-C 108.836 -0.801 . . . . 0.0 108.836 179.237 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 112' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -68.84 156.57 38.16 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.24 -0.913 . . . . 0.0 110.804 -179.786 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 113' ' ' GLN . . . . . 0.617 HE22 ' N ' ' A' ' 172' ' ' GLN . 0.0 OUTLIER -66.75 -15.96 63.91 Favored 'General case' 0 N--CA 1.487 1.402 0 N-CA-C 107.964 -1.125 . . . . 0.0 107.964 177.612 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 114' ' ' ASN . . . . . 0.607 ' OD1' ' NE2' ' A' ' 178' ' ' GLN . 3.0 t30 -151.4 106.11 3.26 Favored 'General case' 0 C--N 1.299 -1.61 0 N-CA-C 108.158 -1.053 . . . . 0.0 108.158 179.655 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 115' ' ' ILE . . . . . 0.511 HG22 ' O ' ' A' ' 115' ' ' ILE . 2.7 mt -94.92 105.25 16.74 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.604 0 N-CA-C 107.66 -1.237 . . . . 0.0 107.66 179.655 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 116' ' ' SER . . . . . 0.423 ' OG ' ' ND2' ' A' ' 114' ' ' ASN . 36.6 m -89.57 147.42 23.95 Favored 'General case' 0 N--CA 1.487 1.39 0 CA-C-O 121.905 0.859 . . . . 0.0 111.303 -177.596 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 117' ' ' ILE . . . . . . . . . . . . . 1.7 mt -144.48 150.92 16.1 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.394 0 N-CA-C 108.092 -1.077 . . . . 0.0 108.092 179.194 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 118' ' ' ALA . . . . . 0.942 ' HB1' ' HB2' ' C' ' 704' ' ' ALA . . . -141.41 160.58 39.83 Favored 'General case' 0 N--CA 1.493 1.703 0 O-C-N 120.921 -1.112 . . . . 0.0 111.209 -178.886 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 119' ' ' GLY . . . . . . . . . . . . . . . -168.36 149.01 13.25 Favored Glycine 0 N--CA 1.489 2.221 0 C-N-CA 119.962 -1.113 . . . . 0.0 111.092 -179.98 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 120' ' ' HIS . . . . . . . . . . . . . 12.7 m170 -71.35 168.93 16.36 Favored 'General case' 0 N--CA 1.495 1.781 0 O-C-N 122.13 -0.629 . . . . 0.0 110.232 179.202 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 121' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -123.7 155.62 37.48 Favored 'General case' 0 N--CA 1.495 1.819 0 N-CA-C 108.864 -0.791 . . . . 0.0 108.864 179.233 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 122' ' ' PHE . . . . . . . . . . . . . 0.7 OUTLIER -143.92 123.17 12.99 Favored 'General case' 0 N--CA 1.501 2.091 0 O-C-N 120.913 -1.117 . . . . 0.0 110.228 179.606 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 123' ' ' ILE . . . . . 0.538 HG23 ' N ' ' A' ' 124' ' ' ASP . 17.1 tt -57.83 -40.61 76.9 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.43 0 CA-C-O 121.582 0.705 . . . . 0.0 109.291 179.606 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 124' ' ' ASP . . . . . 0.538 ' N ' HG23 ' A' ' 123' ' ' ILE . 0.4 OUTLIER -87.19 23.43 1.82 Allowed 'General case' 0 N--CA 1.497 1.898 0 O-C-N 121.648 -0.658 . . . . 0.0 111.461 -177.477 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 125' ' ' ARG . . . . . . . . . . . . . 82.9 mtt180 -153.18 99.83 2.68 Favored Pre-proline 0 N--CA 1.493 1.696 0 O-C-N 120.761 -1.212 . . . . 0.0 109.665 -179.582 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 126' ' ' PRO . . . . . . . . . . . . . 34.0 Cg_endo -77.41 -33.65 2.38 Favored 'Trans proline' 0 N--CA 1.489 1.255 0 C-N-CA 122.263 1.976 . . . . 0.0 112.782 -179.744 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 127' ' ' ASN . . . . . 0.485 ' O ' ' O ' ' A' ' 128' ' ' TYR . 5.1 p30 -90.64 11.14 23.01 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.198 -0.939 . . . . 0.0 109.602 179.911 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 128' ' ' TYR . . . . . 0.485 ' O ' ' O ' ' A' ' 127' ' ' ASN . 2.8 t80 -59.53 -149.67 0.0 OUTLIER 'General case' 0 N--CA 1.489 1.478 0 O-C-N 121.091 -1.006 . . . . 0.0 109.516 179.978 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 129' ' ' GLN . . . . . . . . . . . . . 37.1 mt-30 -66.95 -70.37 0.25 Allowed 'General case' 0 N--CA 1.487 1.413 0 O-C-N 121.337 -0.852 . . . . 0.0 109.605 -179.779 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 130' ' ' PHE . . . . . 0.505 ' CZ ' HG11 ' A' ' 101' ' ' VAL . 50.6 m-85 -136.22 42.29 2.57 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.167 -0.958 . . . . 0.0 110.771 -179.39 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 131' ' ' THR . . . . . . . . . . . . . 8.5 m -74.68 -40.16 61.56 Favored 'General case' 0 N--CA 1.495 1.792 0 O-C-N 120.875 -1.141 . . . . 0.0 109.034 179.241 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 132' ' ' ASN . . . . . 0.558 ' ND2' ' O ' ' A' ' 81' ' ' ALA . 0.2 OUTLIER -89.18 11.59 18.27 Favored 'General case' 0 N--CA 1.492 1.673 0 C-N-CA 119.465 -0.894 . . . . 0.0 111.625 -178.678 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 133' ' ' LEU . . . . . 0.546 ' O ' ' N ' ' A' ' 135' ' ' ALA . 0.2 OUTLIER -68.02 -46.9 69.94 Favored 'General case' 0 N--CA 1.492 1.663 0 O-C-N 120.536 -1.353 . . . . 0.0 109.988 -179.16 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 134' ' ' LYS . . . . . 0.651 ' CD ' ' H ' ' A' ' 134' ' ' LYS . 0.0 OUTLIER -46.0 -14.11 0.02 OUTLIER 'General case' 0 N--CA 1.495 1.805 0 O-C-N 121.05 -1.031 . . . . 0.0 110.03 -179.514 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 135' ' ' ALA . . . . . 0.546 ' N ' ' O ' ' A' ' 133' ' ' LEU . . . -82.41 -35.89 27.23 Favored 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.108 -0.995 . . . . 0.0 109.123 179.669 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 136' ' ' ALA . . . . . 0.882 ' HB2' ' HB2' ' A' ' 81' ' ' ALA . . . -78.88 152.1 31.42 Favored 'General case' 0 C--N 1.302 -1.469 0 CA-C-O 121.858 0.837 . . . . 0.0 110.667 -179.35 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 137' ' ' LYS . . . . . 0.555 ' O ' ' O ' ' A' ' 138' ' ' LYS . 28.0 mtmm -153.06 -168.54 3.06 Favored 'General case' 0 N--CA 1.492 1.631 0 C-N-CA 118.351 -1.34 . . . . 0.0 110.939 -178.332 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 138' ' ' LYS . . . . . 0.555 ' O ' ' O ' ' A' ' 137' ' ' LYS . 0.0 OUTLIER -29.78 159.78 0.0 OUTLIER 'General case' 0 N--CA 1.489 1.509 0 CA-C-O 122.992 1.377 . . . . 0.0 112.681 -178.028 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 139' ' ' GLY . . . . . . . . . . . . . . . 51.9 8.81 0.44 Allowed Glycine 0 N--CA 1.489 2.199 0 N-CA-C 109.824 -1.311 . . . . 0.0 109.824 179.612 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 140' ' ' SER . . . . . 0.471 ' H ' ' C ' ' A' ' 138' ' ' LYS . 1.5 m -68.04 115.19 7.26 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.17 -1.194 . . . . 0.0 108.979 179.493 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 141' ' ' MET . . . . . . . . . . . . . 3.2 tpt -66.94 120.42 13.58 Favored 'General case' 0 C--N 1.301 -1.506 0 O-C-N 121.186 -0.946 . . . . 0.0 109.621 -179.866 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 142' ' ' VAL . . . . . . . . . . . . . 5.1 t -110.56 127.98 67.2 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.651 0 N-CA-C 108.192 -1.04 . . . . 0.0 108.192 179.835 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 143' ' ' TYR . . . . . . . . . . . . . 26.3 m-85 -107.79 135.06 49.84 Favored 'General case' 0 N--CA 1.498 1.963 0 O-C-N 121.022 -1.049 . . . . 0.0 111.348 -178.442 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 144' ' ' PHE . . . . . . . . . . . . . 58.5 t80 -119.19 101.16 7.8 Favored 'General case' 0 N--CA 1.486 1.355 0 N-CA-C 109.214 -0.661 . . . . 0.0 109.214 179.323 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 145' ' ' LYS . . . . . . . . . . . . . 35.8 mttt -95.47 129.33 42.67 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.127 -0.983 . . . . 0.0 109.62 -179.74 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 146' ' ' VAL . . . . . 0.428 ' O ' ' C ' ' A' ' 147' ' ' GLY . 3.3 p -141.67 141.43 29.85 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.636 0 N-CA-C 107.957 -1.127 . . . . 0.0 107.957 179.369 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 147' ' ' GLY . . . . . 0.428 ' C ' ' O ' ' A' ' 146' ' ' VAL . . . 44.43 -128.75 7.14 Favored Glycine 0 N--CA 1.487 2.05 0 N-CA-C 108.885 -1.686 . . . . 0.0 108.885 -179.59 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 148' ' ' ASN . . . . . 0.537 HD22 ' C ' ' A' ' 148' ' ' ASN . 0.4 OUTLIER -103.66 16.39 26.53 Favored 'General case' 0 C--N 1.298 -1.649 0 O-C-N 121.424 -1.045 . . . . 0.0 108.298 179.094 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 149' ' ' GLU . . . . . . . . . . . . . 13.9 tt0 -111.75 145.31 39.58 Favored 'General case' 0 N--CA 1.489 1.477 0 CA-C-O 121.896 0.855 . . . . 0.0 111.273 -178.471 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 150' ' ' THR . . . . . 0.429 ' O ' HG22 ' A' ' 150' ' ' THR . 2.1 m -127.4 102.69 7.0 Favored 'General case' 0 N--CA 1.491 1.613 0 CA-C-O 121.433 0.635 . . . . 0.0 109.757 -179.737 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 151' ' ' ARG . . . . . . . . . . . . . 50.9 mtt180 -86.22 -175.69 5.62 Favored 'General case' 0 N--CA 1.487 1.386 0 N-CA-C 108.541 -0.911 . . . . 0.0 108.541 -179.878 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 152' ' ' LYS . . . . . . . . . . . . . 1.7 mtmp? -145.0 149.36 35.0 Favored 'General case' 0 C--N 1.303 -1.45 0 C-N-CA 119.216 -0.993 . . . . 0.0 110.048 -179.457 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 153' ' ' TYR . . . . . 0.504 ' CD2' ' HA ' ' A' ' 204' ' ' GLU . 31.2 m-85 -143.71 166.29 25.28 Favored 'General case' 0 C--N 1.303 -1.454 0 N-CA-C 107.822 -1.177 . . . . 0.0 107.822 178.719 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 154' ' ' LYS . . . . . 0.587 ' HB2' HG21 ' A' ' 205' ' ' VAL . 5.9 ttmm -143.99 119.81 10.57 Favored 'General case' 0 C--N 1.296 -1.723 0 N-CA-C 108.125 -1.065 . . . . 0.0 108.125 179.074 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 155' ' ' MET . . . . . . . . . . . . . 14.1 mtp -48.45 107.71 0.14 Allowed 'General case' 0 N--CA 1.493 1.678 0 O-C-N 120.522 -1.361 . . . . 0.0 111.543 -178.623 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 156' ' ' THR . . . . . 0.515 ' OG1' HG23 ' A' ' 203' ' ' THR . 0.0 OUTLIER -107.45 -22.36 12.58 Favored 'General case' 0 C--N 1.296 -1.736 0 CA-C-N 115.34 -0.845 . . . . 0.0 110.758 -178.646 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 157' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -151.21 150.43 30.6 Favored 'General case' 0 N--CA 1.494 1.762 0 C-N-CA 118.395 -1.322 . . . . 0.0 111.284 -178.71 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 158' ' ' ILE . . . . . 0.994 HD12 ' N ' ' A' ' 159' ' ' ARG . 0.1 OUTLIER -154.53 142.46 12.96 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.3 0 CA-C-O 121.923 0.868 . . . . 0.0 110.3 -178.743 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 159' ' ' ARG . . . . . 0.994 ' N ' HD12 ' A' ' 158' ' ' ILE . 27.2 ptt180 -155.21 155.02 33.13 Favored 'General case' 0 C--N 1.296 -1.722 0 CA-C-O 121.663 0.744 . . . . 0.0 109.929 -179.902 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 160' ' ' ASP . . . . . 0.416 ' C ' HG22 ' A' ' 161' ' ' VAL . 0.2 OUTLIER -115.06 162.28 17.22 Favored 'General case' 0 N--CA 1.492 1.633 0 N-CA-C 108.165 -1.05 . . . . 0.0 108.165 179.218 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 161' ' ' VAL . . . . . 0.416 HG22 ' C ' ' A' ' 160' ' ' ASP . 0.0 OUTLIER -158.34 160.15 2.11 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.609 0 O-C-N 121.169 -0.957 . . . . 0.0 110.394 -179.539 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 162' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -52.45 176.91 0.07 OUTLIER Pre-proline 0 N--CA 1.488 1.456 0 O-C-N 121.477 -0.764 . . . . 0.0 109.053 179.663 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 163' ' ' PRO . . . . . 0.457 ' C ' HD11 ' C' ' 702' ' ' LEU . 2.4 Cg_endo -78.67 37.31 0.64 Allowed 'Trans proline' 0 N--CA 1.491 1.333 0 C-N-CA 122.478 2.119 . . . . 0.0 113.086 -179.531 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 164' ' ' THR . . . . . 0.423 ' N ' HD11 ' C' ' 702' ' ' LEU . 0.2 OUTLIER -152.65 -6.69 0.2 Allowed 'General case' 0 N--CA 1.495 1.821 0 O-C-N 120.464 -1.397 . . . . 0.0 111.792 -179.4 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 165' ' ' ASP . . . . . . . . . . . . . 6.0 t70 -74.7 62.29 1.05 Allowed 'General case' 0 N--CA 1.493 1.677 0 O-C-N 120.676 -1.265 . . . . 0.0 110.041 -179.581 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 166' ' ' VAL . . . . . 0.613 ' O ' ' N ' ' A' ' 168' ' ' VAL . 1.5 m -47.82 -31.44 2.68 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.594 0 O-C-N 121.144 -0.972 . . . . 0.0 109.968 -178.55 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 167' ' ' GLY . . . . . . . . . . . . . . . -44.26 -10.01 0.01 OUTLIER Glycine 0 N--CA 1.496 2.65 0 O-C-N 120.811 -1.18 . . . . 0.0 111.094 -179.545 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 168' ' ' VAL . . . . . 0.613 ' N ' ' O ' ' A' ' 166' ' ' VAL . 5.5 m -53.51 -29.35 16.82 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.614 0 O-C-N 120.62 -1.518 . . . . 0.0 108.976 179.785 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 169' ' ' LEU . . . . . 0.533 ' O ' ' C ' ' A' ' 170' ' ' ASP . 11.1 mt -49.47 -13.79 0.09 Allowed 'General case' 0 N--CA 1.49 1.564 0 N-CA-C 107.31 -1.367 . . . . 0.0 107.31 -179.14 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 170' ' ' ASP . . . . . 0.551 ' N ' ' C ' ' A' ' 168' ' ' VAL . 3.2 t70 21.84 91.77 0.01 OUTLIER 'General case' 0 N--CA 1.502 2.139 0 CA-C-N 116.281 -0.418 . . . . 0.0 111.649 177.261 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 171' ' ' GLU . . . . . 0.425 ' C ' ' OE1' ' A' ' 113' ' ' GLN . 3.3 pt-20 -136.93 74.41 1.49 Allowed 'General case' 0 N--CA 1.493 1.699 0 O-C-N 120.913 -1.117 . . . . 0.0 110.863 -179.814 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 172' ' ' GLN . . . . . 0.617 ' N ' HE22 ' A' ' 113' ' ' GLN . 1.1 pt20 -132.01 -47.95 0.94 Allowed 'General case' 0 N--CA 1.499 2.021 0 O-C-N 121.284 -0.885 . . . . 0.0 111.661 -178.451 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 173' ' ' LYS . . . . . 0.515 ' NZ ' ' O ' ' A' ' 176' ' ' ASP . 8.4 ptmm? -64.31 129.13 38.73 Favored 'General case' 0 N--CA 1.499 1.989 0 O-C-N 120.576 -1.327 . . . . 0.0 109.324 -179.968 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 174' ' ' GLY . . . . . 0.527 ' O ' ' C ' ' A' ' 175' ' ' LYS . . . -115.37 -40.0 0.9 Allowed Glycine 0 N--CA 1.484 1.89 0 N-CA-C 108.676 -1.769 . . . . 0.0 108.676 179.591 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 175' ' ' LYS . . . . . 0.527 ' C ' ' O ' ' A' ' 174' ' ' GLY . 0.2 OUTLIER -41.44 -62.08 0.93 Allowed 'General case' 0 N--CA 1.491 1.597 0 N-CA-C 107.022 -1.473 . . . . 0.0 107.022 178.864 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 176' ' ' ASP . . . . . 0.567 ' O ' ' O ' ' A' ' 177' ' ' LYS . 81.8 m-20 -104.4 85.36 2.34 Favored 'General case' 0 C--N 1.298 -1.635 0 N-CA-C 107.691 -1.226 . . . . 0.0 107.691 176.781 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 177' ' ' LYS . . . . . 0.567 ' O ' ' O ' ' A' ' 176' ' ' ASP . 2.1 mptp? -47.55 -175.16 0.0 OUTLIER 'General case' 0 N--CA 1.5 2.044 0 O-C-N 121.28 -0.888 . . . . 0.0 108.93 -179.755 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 178' ' ' GLN . . . . . 0.607 ' NE2' ' OD1' ' A' ' 114' ' ' ASN . 0.0 OUTLIER -162.75 178.63 8.31 Favored 'General case' 0 C--N 1.305 -1.355 0 O-C-N 120.264 -1.523 . . . . 0.0 110.936 179.836 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 179' ' ' LEU . . . . . 0.453 HD23 ' C ' ' A' ' 179' ' ' LEU . 4.6 tt -128.55 97.55 4.74 Favored 'General case' 0 C--N 1.302 -1.474 0 N-CA-C 107.54 -1.281 . . . . 0.0 107.54 178.436 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 180' ' ' THR . . . . . 0.441 ' O ' HG22 ' A' ' 180' ' ' THR . 1.2 m -71.29 115.18 10.15 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 120.996 -1.065 . . . . 0.0 109.967 -178.719 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 181' ' ' LEU . . . . . 0.475 HD21 ' HG ' ' A' ' 133' ' ' LEU . 48.5 tp -93.16 142.45 27.28 Favored 'General case' 0 C--N 1.295 -1.794 0 N-CA-C 108.368 -0.975 . . . . 0.0 108.368 178.328 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 182' ' ' ILE . . . . . . . . . . . . . 47.0 mt -136.11 120.58 25.93 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.533 0 N-CA-C 108.197 -1.038 . . . . 0.0 108.197 178.925 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 183' ' ' THR . . . . . 0.487 HG23 ' O ' ' A' ' 183' ' ' THR . 2.2 t -140.72 111.84 7.18 Favored 'General case' 0 C--N 1.291 -1.943 0 N-CA-C 107.718 -1.215 . . . . 0.0 107.718 179.117 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 184' ' ' CYS . . . . . . . . . . . . . 1.2 p -78.81 159.55 27.8 Favored 'General case' 0 C--N 1.292 -1.907 0 C-N-CA 118.856 -1.138 . . . . 0.0 110.665 -178.09 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 185' ' ' ASP . . . . . 0.438 ' HB3' ' HZ1' ' A' ' 198' ' ' LYS . 0.4 OUTLIER -164.57 -155.66 0.28 Allowed 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.629 -0.669 . . . . 0.0 109.413 -179.488 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 186' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER 52.32 60.67 3.65 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.128 -0.982 . . . . 0.0 108.597 -179.469 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 187' ' ' TYR . . . . . 0.593 ' CE1' ' O ' ' A' ' 188' ' ' ASN . 35.5 t80 -68.34 134.02 49.64 Favored 'General case' 0 N--CA 1.488 1.459 0 CA-C-O 121.812 0.815 . . . . 0.0 111.142 -178.977 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 188' ' ' ASN . . . . . 0.593 ' O ' ' CE1' ' A' ' 187' ' ' TYR . 0.9 OUTLIER -98.67 145.64 26.67 Favored 'General case' 0 C--N 1.296 -1.721 0 N-CA-C 108.218 -1.03 . . . . 0.0 108.218 178.395 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 189' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -112.01 -19.91 12.16 Favored 'General case' 0 C--N 1.296 -1.749 0 N-CA-C 107.904 -1.147 . . . . 0.0 107.904 -179.86 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 190' ' ' LYS . . . . . . . . . . . . . 33.5 mttt -82.63 -50.06 9.16 Favored 'General case' 0 C--N 1.3 -1.551 0 N-CA-C 108.235 -1.024 . . . . 0.0 108.235 178.62 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 191' ' ' THR . . . . . . . . . . . . . 71.4 p -87.97 -8.97 54.93 Favored 'General case' 0 C--N 1.303 -1.428 0 N-CA-C 109.105 -0.702 . . . . 0.0 109.105 -179.97 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 192' ' ' GLY . . . . . . . . . . . . . . . 57.56 38.73 88.91 Favored Glycine 0 N--CA 1.493 2.466 0 N-CA-C 110.745 -0.942 . . . . 0.0 110.745 178.872 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 193' ' ' VAL . . . . . . . . . . . . . 3.2 m -148.05 162.1 6.63 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.58 0 O-C-N 120.989 -1.3 . . . . 0.0 108.872 179.35 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 194' ' ' TRP . . . . . . . . . . . . . 47.6 m95 -83.58 120.47 26.0 Favored 'General case' 0 N--CA 1.489 1.518 0 N-CA-C 107.802 -1.184 . . . . 0.0 107.802 178.901 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 195' ' ' GLU . . . . . . . . . . . . . 2.0 mt-10 -86.8 -61.05 1.82 Allowed 'General case' 0 N--CA 1.496 1.858 0 O-C-N 121.132 -0.98 . . . . 0.0 112.083 -177.318 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 196' ' ' LYS . . . . . . . . . . . . . 11.1 tttm -76.84 150.51 36.08 Favored 'General case' 0 N--CA 1.493 1.723 0 O-C-N 120.973 -1.079 . . . . 0.0 111.304 -177.663 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 197' ' ' ARG . . . . . 0.431 ' NH1' ' O ' ' C' ' 704' ' ' ALA . 16.9 mmt180 -122.01 129.83 52.78 Favored 'General case' 0 N--CA 1.491 1.584 0 N-CA-C 108.839 -0.8 . . . . 0.0 108.839 179.481 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 198' ' ' LYS . . . . . 0.438 ' HZ1' ' HB3' ' A' ' 185' ' ' ASP . 9.6 mtmt -113.72 120.25 40.18 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.482 -0.761 . . . . 0.0 109.969 -179.399 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 199' ' ' ILE . . . . . 0.508 ' C ' HD12 ' A' ' 199' ' ' ILE . 0.8 OUTLIER -140.04 118.42 11.14 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.723 0 CA-C-O 122.405 1.097 . . . . 0.0 109.929 179.269 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 200' ' ' PHE . . . . . 0.524 ' CD1' ' N ' ' A' ' 200' ' ' PHE . 4.7 m-85 -100.09 139.68 35.41 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.181 -0.949 . . . . 0.0 109.512 -179.082 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 201' ' ' VAL . . . . . 0.453 HG13 ' NE2' ' A' ' 178' ' ' GLN . 40.7 t -102.33 145.79 11.42 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.645 0 N-CA-C 107.31 -1.367 . . . . 0.0 107.31 177.395 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 202' ' ' ALA . . . . . . . . . . . . . . . -129.25 137.42 51.07 Favored 'General case' 0 C--N 1.301 -1.503 0 O-C-N 120.949 -1.095 . . . . 0.0 109.146 -179.4 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 203' ' ' THR . . . . . 0.559 ' O ' HG23 ' A' ' 205' ' ' VAL . 2.5 p -88.83 129.99 35.47 Favored 'General case' 0 C--N 1.305 -1.352 0 CA-C-O 122.393 1.092 . . . . 0.0 110.705 -178.791 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 204' ' ' GLU . . . . . 0.504 ' HA ' ' CD2' ' A' ' 153' ' ' TYR . 3.9 tm-20 -50.84 133.82 26.06 Favored 'General case' 0 C--N 1.296 -1.734 0 C-N-CA 119.184 -1.007 . . . . 0.0 109.659 179.739 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 205' ' ' VAL . . . . . 0.597 HG12 ' N ' ' A' ' 206' ' ' LYS . 73.8 t -126.94 164.52 27.35 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.452 0 CA-C-O 122.109 0.957 . . . . 0.0 110.066 -178.14 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 206' ' ' LYS . . . . . 0.597 ' N ' HG12 ' A' ' 205' ' ' VAL . 0.9 OUTLIER . . . . . 0 C--N 1.295 -1.765 0 CA-C-O 117.931 -1.033 . . . . 0.0 109.468 179.929 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' C' C ' 702' ' ' LEU . . . . . 0.772 ' N ' HD12 ' C' ' 702' ' ' LEU . 0.0 OUTLIER . . . . . 0 N--CA 1.492 1.632 0 N-CA-C 108.998 -0.741 . . . . 0.0 108.998 . . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' C' C ' 703' ' ' PRO . . . . . 0.586 ' HG3' ' HB1' ' A' ' 104' ' ' ALA . 28.8 Cg_endo -68.95 -162.03 0.08 OUTLIER 'Trans proline' 0 N--CA 1.491 1.347 0 C-N-CA 122.271 1.981 . . . . 0.0 112.272 179.779 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' C' C ' 704' ' ' ALA . . . . . 0.942 ' HB2' ' HB1' ' A' ' 118' ' ' ALA . . . . . . . . 0 N--CA 1.489 1.491 0 O-C-N 121.306 -0.871 . . . . 0.0 108.993 -179.928 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 63' ' ' PRO . . . . . 0.644 ' O ' HD13 ' A' ' 110' ' ' LEU . 21.3 Cg_endo . . . . . 0 C--O 1.212 -0.794 0 CA-C-O 121.412 0.505 . . . . 0.0 111.586 . . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 64' ' ' GLN . . . . . 0.895 ' H ' HE21 ' A' ' 64' ' ' GLN . 0.0 OUTLIER -158.14 113.4 2.67 Favored 'General case' 0 N--CA 1.488 1.453 0 O-C-N 121.249 -0.907 . . . . 0.0 109.528 -179.773 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 65' ' ' ILE . . . . . 0.722 HD13 ' H ' ' A' ' 65' ' ' ILE . 0.0 OUTLIER -42.0 103.29 0.3 Allowed Pre-proline 0 N--CA 1.49 1.571 0 N-CA-C 108.757 -0.831 . . . . 0.0 108.757 179.471 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 66' ' ' PRO . . . . . . . . . . . . . 94.3 Cg_endo -87.6 -155.82 0.06 OUTLIER 'Trans proline' 0 C--N 1.313 -1.338 0 C-N-CA 122.372 2.048 . . . . 0.0 112.259 -179.18 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 67' ' ' LYS . . . . . . . . . . . . . 23.1 pttm -79.42 -7.86 58.7 Favored 'General case' 0 C--N 1.302 -1.474 0 O-C-N 121.308 -0.87 . . . . 0.0 108.847 179.673 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 68' ' ' ASP . . . . . 0.579 ' O ' ' N ' ' A' ' 70' ' ' SER . 1.9 t0 -76.7 48.3 0.55 Allowed 'General case' 0 N--CA 1.487 1.423 0 CA-C-O 122.342 1.068 . . . . 0.0 108.931 179.385 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 69' ' ' LYS . . . . . 0.444 ' C ' ' O ' ' A' ' 68' ' ' ASP . 0.0 OUTLIER -49.27 -14.69 0.1 Allowed 'General case' 0 N--CA 1.503 2.217 0 C-N-CA 117.094 -1.842 . . . . 0.0 106.554 178.257 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 70' ' ' SER . . . . . 0.579 ' N ' ' O ' ' A' ' 68' ' ' ASP . 1.1 p -82.28 -8.91 59.64 Favored 'General case' 0 N--CA 1.495 1.804 0 CA-C-N 113.942 -1.481 . . . . 0.0 110.035 179.552 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 71' ' ' LYS . . . . . 0.416 ' CD ' ' HB3' ' A' ' 68' ' ' ASP . 0.0 OUTLIER -99.19 144.17 28.62 Favored 'General case' 0 N--CA 1.494 1.73 0 O-C-N 121.034 -1.041 . . . . 0.0 110.312 179.294 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 72' ' ' VAL . . . . . 0.517 HG12 ' CZ ' ' A' ' 88' ' ' TYR . 1.0 OUTLIER -65.26 141.48 18.13 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.575 0 N-CA-C 104.868 -2.271 . . . . 0.0 104.868 174.542 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -80.82 -14.9 57.64 Favored 'General case' 0 C--N 1.294 -1.825 0 O-C-N 119.864 -1.772 . . . . 0.0 106.411 179.66 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . 175.46 -156.58 22.36 Favored Glycine 0 N--CA 1.481 1.645 0 N-CA-C 109.16 -1.576 . . . . 0.0 109.16 179.274 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 75' ' ' TYR . . . . . 0.572 ' CD2' ' O ' ' A' ' 85' ' ' GLU . 0.5 OUTLIER -141.7 167.98 20.86 Favored 'General case' 0 C--N 1.292 -1.893 0 O-C-N 121.664 -0.903 . . . . 0.0 110.655 -176.991 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 76' ' ' ILE . . . . . . . . . . . . . 0.6 OUTLIER -144.75 140.32 23.44 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.597 0 C-N-CA 119.087 -1.045 . . . . 0.0 109.781 -177.432 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -148.57 161.46 41.63 Favored 'General case' 0 C--N 1.303 -1.456 0 O-C-N 121.287 -0.883 . . . . 0.0 109.158 -179.571 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 78' ' ' ILE . . . . . 0.654 ' HB ' ' HB3' ' A' ' 81' ' ' ALA . 6.6 mt -146.89 94.42 4.64 Favored Pre-proline 0 C--N 1.3 -1.553 0 N-CA-C 108.53 -0.915 . . . . 0.0 108.53 -179.75 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 79' ' ' PRO . . . . . . . . . . . . . 74.4 Cg_exo -47.32 -47.42 17.47 Favored 'Trans proline' 0 N--CA 1.493 1.449 0 C-N-CA 122.805 2.337 . . . . 0.0 113.765 -178.745 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -65.24 -18.17 65.1 Favored 'General case' 0 N--CA 1.492 1.65 0 O-C-N 120.765 -1.209 . . . . 0.0 110.565 178.667 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 81' ' ' ALA . . . . . 0.893 ' HB2' ' HB2' ' A' ' 136' ' ' ALA . . . -105.69 -16.74 14.6 Favored 'General case' 0 N--CA 1.493 1.718 0 O-C-N 121.24 -0.912 . . . . 0.0 108.918 179.653 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 82' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER 69.39 47.79 0.67 Allowed 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.432 -0.793 . . . . 0.0 110.53 178.87 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 83' ' ' ILE . . . . . . . . . . . . . 67.2 mt -127.1 149.58 32.31 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.81 0 O-C-N 121.065 -1.022 . . . . 0.0 110.732 -178.87 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 84' ' ' LYS . . . . . . . . . . . . . 6.7 ttpm? -157.38 107.86 2.25 Favored 'General case' 0 N--CA 1.491 1.595 0 N-CA-C 107.544 -1.28 . . . . 0.0 107.544 179.516 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 85' ' ' GLU . . . . . 0.572 ' O ' ' CD2' ' A' ' 75' ' ' TYR . 0.4 OUTLIER -145.31 174.37 3.51 Favored Pre-proline 0 N--CA 1.492 1.65 0 O-C-N 121.503 -0.748 . . . . 0.0 110.409 -178.8 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 86' ' ' PRO . . . . . . . . . . . . . 60.3 Cg_endo -82.41 168.85 14.43 Favored 'Trans proline' 0 C--N 1.313 -1.305 0 C-N-CA 122.809 2.339 . . . . 0.0 113.841 -179.347 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 87' ' ' VAL . . . . . 0.531 ' CG1' ' CZ ' ' A' ' 103' ' ' PHE . 3.2 t -128.93 105.84 13.42 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.607 0 N-CA-C 108.448 -0.945 . . . . 0.0 108.448 179.91 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 88' ' ' TYR . . . . . 0.517 ' CZ ' HG12 ' A' ' 72' ' ' VAL . 34.6 m-85 -99.22 152.76 37.91 Favored Pre-proline 0 N--CA 1.499 2.006 0 O-C-N 120.769 -1.207 . . . . 0.0 110.129 -179.018 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 89' ' ' PRO . . . . . . . . . . . . . 2.7 Cg_exo -50.35 144.42 23.97 Favored 'Trans proline' 0 C--N 1.312 -1.351 0 C-N-CA 122.707 2.271 . . . . 0.0 113.487 179.871 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . -61.41 169.57 10.5 Favored Glycine 0 N--CA 1.493 2.47 0 N-CA-C 108.807 -1.717 . . . . 0.0 108.807 178.894 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 91' ' ' PRO . . . . . 0.487 ' C ' ' H ' ' A' ' 93' ' ' THR . 63.9 Cg_endo -95.7 172.86 13.58 Favored 'Cis proline' 0 C--N 1.311 -1.407 0 C-N-CA 124.227 -1.156 . . . . 0.0 112.226 0.133 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 92' ' ' ALA . . . . . 0.553 ' O ' HD13 ' A' ' 97' ' ' LEU . . . -70.48 29.03 0.04 OUTLIER 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.229 -0.919 . . . . 0.0 110.378 -179.794 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 93' ' ' THR . . . . . 0.487 ' H ' ' C ' ' A' ' 91' ' ' PRO . 1.8 p -75.19 152.14 86.05 Favored Pre-proline 0 N--CA 1.489 1.524 0 O-C-N 120.626 -1.296 . . . . 0.0 108.833 -179.958 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 94' ' ' PRO . . . . . . . . . . . . . 86.4 Cg_exo -35.03 -42.34 0.35 Allowed 'Trans proline' 0 C--N 1.309 -1.546 0 C-N-CA 122.821 2.348 . . . . 0.0 112.398 -179.362 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 95' ' ' GLU . . . . . 0.485 ' O ' ' OD1' ' A' ' 98' ' ' ASN . 53.2 mt-10 -52.84 -55.18 25.01 Favored 'General case' 0 C--N 1.304 -1.407 0 O-C-N 121.094 -1.004 . . . . 0.0 109.12 179.636 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 96' ' ' GLN . . . . . 0.569 ' O ' ' N ' ' A' ' 98' ' ' ASN . 28.6 mm100 -72.29 -50.99 22.87 Favored 'General case' 0 N--CA 1.488 1.458 0 O-C-N 121.124 -0.985 . . . . 0.0 110.151 179.965 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 97' ' ' LEU . . . . . 0.553 HD13 ' O ' ' A' ' 92' ' ' ALA . 2.5 mp -48.39 -9.12 0.02 OUTLIER 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.038 -1.039 . . . . 0.0 109.784 -179.306 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 98' ' ' ASN . . . . . 0.737 HD21 ' CZ ' ' A' ' 99' ' ' ARG . 14.4 p-10 -72.38 -30.35 64.6 Favored 'General case' 0 N--CA 1.492 1.625 0 CA-C-O 121.873 0.844 . . . . 0.0 109.48 179.624 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 99' ' ' ARG . . . . . 0.737 ' CZ ' HD21 ' A' ' 98' ' ' ASN . 1.2 mtt-85 -98.66 -47.1 5.47 Favored 'General case' 0 C--N 1.299 -1.591 0 C-N-CA 119.829 -0.749 . . . . 0.0 110.106 -178.479 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . 176.28 -176.58 47.78 Favored Glycine 0 N--CA 1.493 2.485 0 C-N-CA 119.096 -1.526 . . . . 0.0 110.916 179.857 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 101' ' ' VAL . . . . . 0.739 ' CG2' HG22 ' A' ' 117' ' ' ILE . 0.2 OUTLIER -50.46 111.7 0.2 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.597 0 O-C-N 121.697 -0.884 . . . . 0.0 109.892 -179.859 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -93.94 169.7 10.09 Favored 'General case' 0 N--CA 1.496 1.84 0 O-C-N 121.273 -0.892 . . . . 0.0 110.741 -179.888 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 103' ' ' PHE . . . . . 0.603 ' O ' ' N ' ' A' ' 105' ' ' GLU . 27.5 m-85 -71.06 121.02 17.48 Favored 'General case' 0 N--CA 1.485 1.314 0 N-CA-C 107.68 -1.23 . . . . 0.0 107.68 177.609 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 104' ' ' ALA . . . . . 0.806 ' HB3' ' OG ' ' A' ' 116' ' ' SER . . . -41.95 -15.65 0.01 OUTLIER 'General case' 0 C--N 1.299 -1.597 0 O-C-N 121.497 -0.752 . . . . 0.0 110.682 -178.821 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 105' ' ' GLU . . . . . 0.603 ' N ' ' O ' ' A' ' 103' ' ' PHE . 0.1 OUTLIER -136.22 145.45 45.67 Favored 'General case' 0 N--CA 1.496 1.86 0 O-C-N 120.811 -1.18 . . . . 0.0 110.243 179.638 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 106' ' ' GLU . . . . . . . . . . . . . 2.0 tt0 -60.02 -63.43 1.3 Allowed 'General case' 0 N--CA 1.489 1.482 0 O-C-N 121.835 -0.54 . . . . 0.0 111.416 -178.904 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 107' ' ' ASN . . . . . 0.798 ' H ' ' ND2' ' A' ' 107' ' ' ASN . 0.2 OUTLIER -78.11 35.09 0.21 Allowed 'General case' 0 N--CA 1.491 1.609 0 O-C-N 120.649 -1.282 . . . . 0.0 112.76 -175.608 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 108' ' ' GLU . . . . . . . . . . . . . 1.7 tp10 -58.24 148.94 25.51 Favored 'General case' 0 N--CA 1.488 1.451 0 N-CA-C 107.591 -1.263 . . . . 0.0 107.591 179.891 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 109' ' ' SER . . . . . 0.483 ' O ' HD11 ' A' ' 115' ' ' ILE . 0.2 OUTLIER -101.6 146.3 27.88 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.139 -0.975 . . . . 0.0 110.709 -178.305 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 110' ' ' LEU . . . . . 0.683 ' H ' HD23 ' A' ' 110' ' ' LEU . 0.3 OUTLIER -62.1 -24.15 66.95 Favored 'General case' 0 C--N 1.302 -1.477 0 N-CA-C 108.035 -1.098 . . . . 0.0 108.035 179.14 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 111' ' ' ASP . . . . . 0.405 ' CG ' HH12 ' A' ' 151' ' ' ARG . 13.0 m-20 -132.7 43.34 2.99 Favored 'General case' 0 N--CA 1.488 1.448 0 O-C-N 121.688 -0.633 . . . . 0.0 109.762 179.97 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 112' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -69.12 156.04 39.35 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.15 -0.969 . . . . 0.0 110.806 -179.852 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 113' ' ' GLN . . . . . 0.457 ' N ' ' CD ' ' A' ' 113' ' ' GLN . 0.8 OUTLIER -67.14 -18.16 65.17 Favored 'General case' 0 N--CA 1.491 1.622 0 N-CA-C 108.15 -1.055 . . . . 0.0 108.15 178.097 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 114' ' ' ASN . . . . . 0.605 HD22 ' CD ' ' A' ' 178' ' ' GLN . 1.9 t-20 -150.37 103.84 3.18 Favored 'General case' 0 C--N 1.299 -1.626 0 N-CA-C 107.871 -1.159 . . . . 0.0 107.871 178.533 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 115' ' ' ILE . . . . . 0.489 ' O ' HG22 ' A' ' 115' ' ' ILE . 2.9 mt -97.77 109.2 23.09 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.66 0 O-C-N 120.885 -1.134 . . . . 0.0 108.696 -179.955 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 116' ' ' SER . . . . . 0.806 ' OG ' ' HB3' ' A' ' 104' ' ' ALA . 80.8 p -88.0 152.24 22.18 Favored 'General case' 0 N--CA 1.49 1.538 0 CA-C-O 121.863 0.839 . . . . 0.0 110.842 -178.445 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 117' ' ' ILE . . . . . 0.739 HG22 ' CG2' ' A' ' 101' ' ' VAL . 1.5 mt -146.95 122.29 2.63 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.413 0 N-CA-C 107.876 -1.157 . . . . 0.0 107.876 -179.725 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 118' ' ' ALA . . . . . . . . . . . . . . . -118.58 159.72 23.07 Favored 'General case' 0 N--CA 1.496 1.846 0 C-N-CA 119.516 -0.874 . . . . 0.0 112.074 -177.933 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 119' ' ' GLY . . . . . . . . . . . . . . . -170.7 148.11 11.13 Favored Glycine 0 N--CA 1.49 2.255 0 CA-C-O 122.163 0.868 . . . . 0.0 110.936 179.929 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 120' ' ' HIS . . . . . 0.565 ' N ' ' OE1' ' A' ' 129' ' ' GLN . 6.4 m170 -71.19 168.47 17.17 Favored 'General case' 0 N--CA 1.496 1.831 0 O-C-N 121.889 -0.771 . . . . 0.0 109.909 179.084 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 121' ' ' THR . . . . . 0.503 HG22 ' CZ3' ' A' ' 194' ' ' TRP . 0.7 OUTLIER -122.64 158.07 30.81 Favored 'General case' 0 N--CA 1.496 1.844 0 N-CA-C 108.48 -0.933 . . . . 0.0 108.48 178.786 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 122' ' ' PHE . . . . . 0.438 ' O ' HG21 ' A' ' 131' ' ' THR . 1.1 m-85 -144.16 123.61 13.15 Favored 'General case' 0 N--CA 1.498 1.974 0 O-C-N 120.819 -1.175 . . . . 0.0 110.006 -179.926 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 123' ' ' ILE . . . . . 0.585 HG23 ' N ' ' A' ' 124' ' ' ASP . 14.4 tt -58.51 -40.92 80.34 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.541 0 CA-C-O 121.619 0.723 . . . . 0.0 109.46 179.714 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 124' ' ' ASP . . . . . 0.585 ' N ' HG23 ' A' ' 123' ' ' ILE . 13.1 t70 -90.14 26.21 1.95 Allowed 'General case' 0 N--CA 1.497 1.888 0 O-C-N 121.573 -0.704 . . . . 0.0 112.166 -177.215 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 125' ' ' ARG . . . . . 0.67 HH11 ' CG ' ' A' ' 125' ' ' ARG . 2.2 mtt-85 -155.59 99.69 2.25 Favored Pre-proline 0 N--CA 1.493 1.679 0 O-C-N 120.451 -1.406 . . . . 0.0 109.718 179.989 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 126' ' ' PRO . . . . . . . . . . . . . 53.9 Cg_endo -78.54 -25.15 6.93 Favored 'Trans proline' 0 C--N 1.314 -1.277 0 C-N-CA 122.067 1.845 . . . . 0.0 112.172 179.893 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 127' ' ' ASN . . . . . 0.447 ' O ' ' O ' ' A' ' 128' ' ' TYR . 3.0 t30 -91.77 5.17 50.88 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.264 -0.897 . . . . 0.0 109.43 179.743 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 128' ' ' TYR . . . . . 0.465 ' O ' ' OE2' ' A' ' 85' ' ' GLU . 9.7 t80 -59.22 -150.25 0.0 OUTLIER 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.296 -0.878 . . . . 0.0 109.88 -179.765 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 129' ' ' GLN . . . . . 0.565 ' OE1' ' N ' ' A' ' 120' ' ' HIS . 10.3 mt-30 -68.04 -70.26 0.27 Allowed 'General case' 0 C--N 1.303 -1.422 0 O-C-N 121.549 -0.72 . . . . 0.0 109.483 179.968 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 130' ' ' PHE . . . . . 0.641 ' CE1' HD21 ' A' ' 181' ' ' LEU . 55.6 m-85 -136.59 51.88 1.98 Allowed 'General case' 0 N--CA 1.489 1.501 0 O-C-N 121.29 -0.881 . . . . 0.0 110.289 -179.536 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 131' ' ' THR . . . . . 0.537 ' O ' ' CD ' ' A' ' 134' ' ' LYS . 54.0 m -81.78 -40.06 23.18 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 120.936 -1.102 . . . . 0.0 109.275 179.844 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 132' ' ' ASN . . . . . 0.575 ' ND2' ' O ' ' A' ' 81' ' ' ALA . 32.1 t30 -91.88 13.56 18.11 Favored 'General case' 0 N--CA 1.496 1.854 0 C-N-CA 119.61 -0.836 . . . . 0.0 111.783 -178.781 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 133' ' ' LEU . . . . . 0.598 HD13 ' O ' ' A' ' 133' ' ' LEU . 0.2 OUTLIER -68.15 -33.51 74.61 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 120.49 -1.381 . . . . 0.0 109.402 -179.696 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 134' ' ' LYS . . . . . 0.697 ' CD ' ' H ' ' A' ' 134' ' ' LYS . 0.0 OUTLIER -44.66 -25.41 0.28 Allowed 'General case' 0 N--CA 1.494 1.734 0 O-C-N 121.35 -0.844 . . . . 0.0 110.625 -179.977 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 135' ' ' ALA . . . . . . . . . . . . . . . -82.31 -29.83 30.87 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.087 -1.008 . . . . 0.0 110.651 -178.623 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 136' ' ' ALA . . . . . 0.893 ' HB2' ' HB2' ' A' ' 81' ' ' ALA . . . -79.91 145.24 32.77 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.034 -1.041 . . . . 0.0 111.496 -178.639 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 137' ' ' LYS . . . . . 0.565 ' CG ' ' H ' ' A' ' 138' ' ' LYS . 0.5 OUTLIER -153.18 -167.69 2.8 Favored 'General case' 0 N--CA 1.496 1.828 0 C-N-CA 118.676 -1.209 . . . . 0.0 110.698 -177.994 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 138' ' ' LYS . . . . . 0.596 ' O ' ' N ' ' A' ' 140' ' ' SER . 22.1 mtmt -44.09 178.77 0.0 OUTLIER 'General case' 0 N--CA 1.487 1.407 0 CA-C-O 122.335 1.064 . . . . 0.0 110.709 -179.197 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 139' ' ' GLY . . . . . . . . . . . . . . . 46.1 7.88 0.02 OUTLIER Glycine 0 N--CA 1.487 2.057 0 N-CA-C 110.526 -1.03 . . . . 0.0 110.526 179.593 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 140' ' ' SER . . . . . 0.596 ' N ' ' O ' ' A' ' 138' ' ' LYS . 38.2 t -92.57 135.63 33.91 Favored 'General case' 0 N--CA 1.494 1.748 0 O-C-N 120.706 -1.467 . . . . 0.0 109.293 179.318 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 141' ' ' MET . . . . . 0.673 ' SD ' ' N ' ' A' ' 142' ' ' VAL . 9.7 tpp -87.94 132.7 34.13 Favored 'General case' 0 C--N 1.299 -1.608 0 O-C-N 121.246 -0.908 . . . . 0.0 109.621 179.94 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 142' ' ' VAL . . . . . 0.673 ' N ' ' SD ' ' A' ' 141' ' ' MET . 2.3 t -115.51 136.51 52.08 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.457 0 N-CA-C 108.068 -1.086 . . . . 0.0 108.068 179.875 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 143' ' ' TYR . . . . . . . . . . . . . 10.0 m-85 -115.73 137.64 51.89 Favored 'General case' 0 N--CA 1.499 2.016 0 O-C-N 121.021 -1.049 . . . . 0.0 111.758 -178.1 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 144' ' ' PHE . . . . . . . . . . . . . 12.6 t80 -122.16 107.93 12.73 Favored 'General case' 0 N--CA 1.492 1.665 0 CA-C-O 121.322 0.582 . . . . 0.0 109.5 -179.951 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 145' ' ' LYS . . . . . 0.453 ' O ' ' N ' ' A' ' 75' ' ' TYR . 1.6 tttp -95.46 131.78 41.24 Favored 'General case' 0 N--CA 1.493 1.684 0 O-C-N 121.333 -0.854 . . . . 0.0 110.371 -179.291 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 146' ' ' VAL . . . . . 0.45 ' O ' ' C ' ' A' ' 147' ' ' GLY . 0.7 OUTLIER -144.54 141.23 23.94 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.644 0 N-CA-C 107.9 -1.148 . . . . 0.0 107.9 178.667 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 147' ' ' GLY . . . . . 0.45 ' C ' ' O ' ' A' ' 146' ' ' VAL . . . 42.56 -127.57 4.77 Favored Glycine 0 N--CA 1.49 2.28 0 N-CA-C 109.394 -1.482 . . . . 0.0 109.394 -179.821 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 148' ' ' ASN . . . . . 0.524 HD22 ' C ' ' A' ' 148' ' ' ASN . 0.4 OUTLIER -103.01 14.62 31.51 Favored 'General case' 0 C--N 1.3 -1.566 0 O-C-N 121.418 -1.048 . . . . 0.0 108.47 179.365 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 149' ' ' GLU . . . . . . . . . . . . . 3.6 tt0 -110.85 143.77 40.92 Favored 'General case' 0 N--CA 1.488 1.442 0 CA-C-O 122.031 0.919 . . . . 0.0 111.26 -178.589 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 150' ' ' THR . . . . . . . . . . . . . 6.4 m -127.22 102.18 6.82 Favored 'General case' 0 N--CA 1.49 1.544 0 CA-C-O 121.395 0.617 . . . . 0.0 109.452 179.896 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 151' ' ' ARG . . . . . 0.405 HH12 ' CG ' ' A' ' 111' ' ' ASP . 22.1 mtt180 -87.6 -178.33 6.08 Favored 'General case' 0 C--N 1.305 -1.368 0 N-CA-C 108.459 -0.941 . . . . 0.0 108.459 179.789 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 152' ' ' LYS . . . . . 0.447 ' C ' ' CD1' ' A' ' 153' ' ' TYR . 22.6 mtmt -148.8 152.51 36.66 Favored 'General case' 0 C--N 1.3 -1.57 0 C-N-CA 119.303 -0.959 . . . . 0.0 110.024 -179.677 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 153' ' ' TYR . . . . . 0.557 ' O ' ' SD ' ' A' ' 141' ' ' MET . 42.1 m-85 -144.23 157.19 44.42 Favored 'General case' 0 C--N 1.3 -1.565 0 N-CA-C 107.987 -1.116 . . . . 0.0 107.987 179.137 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 154' ' ' LYS . . . . . . . . . . . . . 26.1 ttpt -132.1 118.33 19.48 Favored 'General case' 0 C--N 1.297 -1.684 0 N-CA-C 108.514 -0.921 . . . . 0.0 108.514 179.529 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 155' ' ' MET . . . . . . . . . . . . . 15.0 mtp -45.33 105.64 0.06 Allowed 'General case' 0 N--CA 1.489 1.496 0 CA-C-O 122.284 1.04 . . . . 0.0 111.632 -178.494 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 156' ' ' THR . . . . . 0.528 ' OG1' HG23 ' A' ' 203' ' ' THR . 0.2 OUTLIER -105.7 -25.25 12.31 Favored 'General case' 0 C--N 1.295 -1.786 0 CA-C-N 115.37 -0.832 . . . . 0.0 110.538 -178.803 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 157' ' ' SER . . . . . 0.484 ' O ' ' N ' ' A' ' 201' ' ' VAL . 0.0 OUTLIER -152.93 155.73 37.56 Favored 'General case' 0 N--CA 1.496 1.835 0 C-N-CA 118.456 -1.298 . . . . 0.0 110.914 -178.684 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 158' ' ' ILE . . . . . 0.42 HG12 ' N ' ' A' ' 159' ' ' ARG . 0.0 OUTLIER -154.52 146.7 13.61 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.561 0 CA-C-O 121.812 0.815 . . . . 0.0 110.857 -178.998 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 159' ' ' ARG . . . . . 0.508 ' O ' ' OD1' ' A' ' 160' ' ' ASP . 1.6 tpt180 -148.83 167.84 24.58 Favored 'General case' 0 N--CA 1.491 1.589 0 CA-C-O 121.448 0.642 . . . . 0.0 109.755 -179.659 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 160' ' ' ASP . . . . . 0.508 ' OD1' ' O ' ' A' ' 159' ' ' ARG . 6.5 m-20 -140.5 163.29 33.22 Favored 'General case' 0 N--CA 1.493 1.71 0 O-C-N 121.488 -0.757 . . . . 0.0 108.976 -179.388 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 161' ' ' VAL . . . . . 0.713 HG22 ' N ' ' A' ' 162' ' ' LYS . 11.8 p -165.49 169.05 0.36 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.708 0 O-C-N 120.906 -1.121 . . . . 0.0 111.277 179.894 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 162' ' ' LYS . . . . . 0.713 ' N ' HG22 ' A' ' 161' ' ' VAL . 0.0 OUTLIER -60.82 174.0 0.59 Allowed Pre-proline 0 N--CA 1.492 1.643 0 N-CA-C 109.099 -0.704 . . . . 0.0 109.099 178.771 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 163' ' ' PRO . . . . . . . . . . . . . 59.2 Cg_endo -82.2 42.92 1.4 Allowed 'Trans proline' 0 C--N 1.311 -1.416 0 C-N-CA 122.444 2.096 . . . . 0.0 112.855 -179.324 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 164' ' ' THR . . . . . 0.412 ' N ' HD21 ' C' ' 702' ' ' LEU . 24.0 m -151.74 -11.58 0.2 Allowed 'General case' 0 N--CA 1.494 1.748 0 O-C-N 120.93 -1.106 . . . . 0.0 111.081 179.788 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 165' ' ' ASP . . . . . 0.699 ' CB ' HG21 ' A' ' 161' ' ' VAL . 37.0 t70 -78.82 67.77 4.62 Favored 'General case' 0 N--CA 1.492 1.67 0 O-C-N 120.771 -1.206 . . . . 0.0 110.684 -179.549 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 166' ' ' VAL . . . . . 0.652 ' O ' ' N ' ' A' ' 168' ' ' VAL . 0.9 OUTLIER -47.54 -35.07 3.93 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.479 0 O-C-N 120.828 -1.17 . . . . 0.0 109.44 -179.097 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 167' ' ' GLY . . . . . 0.439 ' C ' ' O ' ' A' ' 166' ' ' VAL . . . -42.37 -13.65 0.01 OUTLIER Glycine 0 N--CA 1.496 2.651 0 C-N-CA 119.937 -1.125 . . . . 0.0 110.389 179.958 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 168' ' ' VAL . . . . . 0.652 ' N ' ' O ' ' A' ' 166' ' ' VAL . 9.3 p -53.79 -28.23 16.4 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.408 0 O-C-N 120.782 -1.422 . . . . 0.0 109.108 179.849 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 169' ' ' LEU . . . . . 0.615 HD23 ' N ' ' A' ' 169' ' ' LEU . 1.4 mt -45.87 -19.66 0.07 Allowed 'General case' 0 N--CA 1.496 1.857 0 N-CA-C 107.068 -1.456 . . . . 0.0 107.068 -178.298 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 170' ' ' ASP . . . . . 0.581 ' O ' ' ND2' ' A' ' 114' ' ' ASN . 19.4 t0 27.32 91.09 0.01 OUTLIER 'General case' 0 N--CA 1.497 1.892 0 CA-C-N 116.392 -0.367 . . . . 0.0 111.486 177.399 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 171' ' ' GLU . . . . . 0.402 ' HA ' ' CB ' ' A' ' 114' ' ' ASN . 4.8 pt-20 -136.83 73.98 1.47 Allowed 'General case' 0 N--CA 1.493 1.71 0 O-C-N 120.967 -1.083 . . . . 0.0 110.252 179.663 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 172' ' ' GLN . . . . . . . . . . . . . 16.8 mm-40 -130.94 -48.41 1.02 Allowed 'General case' 0 N--CA 1.495 1.783 0 O-C-N 121.558 -0.714 . . . . 0.0 110.564 -178.745 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 173' ' ' LYS . . . . . 0.403 ' H ' ' HG3' ' A' ' 173' ' ' LYS . 7.2 mttp -58.8 133.94 56.43 Favored 'General case' 0 N--CA 1.492 1.669 0 O-C-N 120.926 -1.109 . . . . 0.0 108.988 -179.869 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 174' ' ' GLY . . . . . 0.571 ' O ' ' C ' ' A' ' 175' ' ' LYS . . . -130.45 -43.57 0.19 Allowed Glycine 0 C--N 1.299 -1.486 0 N-CA-C 108.363 -1.895 . . . . 0.0 108.363 179.567 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 175' ' ' LYS . . . . . 0.571 ' C ' ' O ' ' A' ' 174' ' ' GLY . 32.6 mmtt -33.78 -63.34 0.27 Allowed 'General case' 0 N--CA 1.496 1.831 0 N-CA-C 107.843 -1.169 . . . . 0.0 107.843 179.658 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 176' ' ' ASP . . . . . 0.618 ' O ' ' O ' ' A' ' 177' ' ' LYS . 15.8 m-20 -104.54 86.27 2.48 Favored 'General case' 0 C--N 1.294 -1.805 0 N-CA-C 107.406 -1.331 . . . . 0.0 107.406 176.854 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 177' ' ' LYS . . . . . 0.618 ' O ' ' O ' ' A' ' 176' ' ' ASP . 29.3 mtmt -39.25 176.65 0.0 OUTLIER 'General case' 0 N--CA 1.501 2.081 0 O-C-N 121.507 -0.746 . . . . 0.0 110.431 -179.053 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 178' ' ' GLN . . . . . 0.605 ' CD ' HD22 ' A' ' 114' ' ' ASN . 0.0 OUTLIER -161.88 176.35 10.93 Favored 'General case' 0 N--CA 1.488 1.434 0 O-C-N 120.431 -1.418 . . . . 0.0 111.365 -179.999 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 179' ' ' LEU . . . . . 0.408 ' HB2' ' CD2' ' A' ' 153' ' ' TYR . 1.0 OUTLIER -130.28 98.03 4.6 Favored 'General case' 0 N--CA 1.487 1.424 0 N-CA-C 107.105 -1.443 . . . . 0.0 107.105 178.191 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 180' ' ' THR . . . . . . . . . . . . . 1.1 m -71.42 119.89 16.22 Favored 'General case' 0 C--N 1.303 -1.448 0 O-C-N 121.06 -1.025 . . . . 0.0 110.193 -178.381 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 181' ' ' LEU . . . . . 0.856 HD13 ' N ' ' A' ' 182' ' ' ILE . 1.1 tm? -89.85 140.55 29.49 Favored 'General case' 0 C--N 1.303 -1.436 0 N-CA-C 106.91 -1.515 . . . . 0.0 106.91 177.456 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 182' ' ' ILE . . . . . 0.856 ' N ' HD13 ' A' ' 181' ' ' LEU . 5.3 mt -136.54 117.42 18.13 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.753 0 O-C-N 120.92 -1.112 . . . . 0.0 108.008 178.709 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 183' ' ' THR . . . . . . . . . . . . . 1.4 t -144.7 114.72 7.4 Favored 'General case' 0 C--N 1.287 -2.11 0 N-CA-C 107.84 -1.17 . . . . 0.0 107.84 -179.538 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 184' ' ' CYS . . . . . . . . . . . . . 0.7 OUTLIER -79.41 163.73 24.57 Favored 'General case' 0 C--N 1.288 -2.076 0 C-N-CA 118.762 -1.175 . . . . 0.0 110.649 -178.092 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 185' ' ' ASP . . . . . 0.438 ' OD1' ' N ' ' A' ' 186' ' ' ASP . 4.8 t70 -165.18 -154.42 0.22 Allowed 'General case' 0 N--CA 1.492 1.658 0 N-CA-C 109.232 -0.655 . . . . 0.0 109.232 -179.672 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 186' ' ' ASP . . . . . 0.438 ' N ' ' OD1' ' A' ' 185' ' ' ASP . 1.1 m-20 51.04 60.91 3.54 Favored 'General case' 0 N--CA 1.494 1.743 0 O-C-N 121.081 -1.012 . . . . 0.0 108.409 -179.246 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 187' ' ' TYR . . . . . 0.595 ' CE1' ' O ' ' A' ' 188' ' ' ASN . 50.7 t80 -67.78 134.37 50.86 Favored 'General case' 0 N--CA 1.49 1.544 0 CA-C-O 122.052 0.929 . . . . 0.0 111.591 -178.679 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 188' ' ' ASN . . . . . 0.595 ' O ' ' CE1' ' A' ' 187' ' ' TYR . 0.8 OUTLIER -100.78 146.15 27.63 Favored 'General case' 0 C--N 1.297 -1.7 0 N-CA-C 107.929 -1.137 . . . . 0.0 107.929 177.923 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 189' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -112.69 -14.78 13.1 Favored 'General case' 0 C--N 1.297 -1.706 0 N-CA-C 108.604 -0.887 . . . . 0.0 108.604 -179.712 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 190' ' ' LYS . . . . . . . . . . . . . 12.8 mttm -83.58 -49.87 8.79 Favored 'General case' 0 C--N 1.301 -1.505 0 N-CA-C 108.595 -0.891 . . . . 0.0 108.595 178.729 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 191' ' ' THR . . . . . 0.545 ' OG1' HG12 ' A' ' 193' ' ' VAL . 6.5 p -88.86 -11.99 43.12 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.432 -0.792 . . . . 0.0 108.916 179.454 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 192' ' ' GLY . . . . . . . . . . . . . . . 67.89 34.6 82.8 Favored Glycine 0 N--CA 1.493 2.438 0 O-C-N 121.309 -0.869 . . . . 0.0 111.059 178.561 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 193' ' ' VAL . . . . . 0.545 HG12 ' OG1' ' A' ' 191' ' ' THR . 3.5 p -148.12 167.96 4.15 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.543 0 O-C-N 120.789 -1.418 . . . . 0.0 110.216 179.382 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 194' ' ' TRP . . . . . 0.518 ' H ' HG22 ' A' ' 193' ' ' VAL . 36.7 m95 -84.89 120.85 26.94 Favored 'General case' 0 C--N 1.296 -1.74 0 N-CA-C 109.058 -0.719 . . . . 0.0 109.058 179.991 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 195' ' ' GLU . . . . . 0.546 ' CD ' ' ND2' ' A' ' 188' ' ' ASN . 3.8 mt-10 -84.99 -61.05 1.87 Allowed 'General case' 0 N--CA 1.496 1.865 0 O-C-N 121.268 -0.895 . . . . 0.0 111.089 -178.657 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 196' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -83.98 154.32 23.38 Favored 'General case' 0 N--CA 1.491 1.575 0 O-C-N 120.903 -1.123 . . . . 0.0 110.05 -178.917 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 197' ' ' ARG . . . . . 0.647 ' CG ' HH11 ' A' ' 197' ' ' ARG . 0.0 OUTLIER -126.89 140.17 52.53 Favored 'General case' 0 N--CA 1.489 1.482 0 N-CA-C 109.019 -0.734 . . . . 0.0 109.019 179.583 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 198' ' ' LYS . . . . . . . . . . . . . 23.4 mttt -114.58 121.17 42.61 Favored 'General case' 0 C--N 1.302 -1.478 0 O-C-N 121.793 -0.567 . . . . 0.0 110.2 -178.929 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 199' ' ' ILE . . . . . 0.539 HG21 HG21 ' A' ' 168' ' ' VAL . 0.8 OUTLIER -139.22 118.21 13.07 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.576 0 CA-C-O 122.809 1.29 . . . . 0.0 110.16 179.553 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 200' ' ' PHE . . . . . 0.501 ' CD1' ' N ' ' A' ' 200' ' ' PHE . 5.7 m-85 -101.0 137.03 39.91 Favored 'General case' 0 N--CA 1.495 1.814 0 O-C-N 120.707 -1.245 . . . . 0.0 110.276 -178.265 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 201' ' ' VAL . . . . . 0.484 ' N ' ' O ' ' A' ' 157' ' ' SER . 70.2 t -102.2 140.5 20.53 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.545 0 N-CA-C 108.09 -1.078 . . . . 0.0 108.09 177.465 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 202' ' ' ALA . . . . . . . . . . . . . . . -130.11 138.08 50.5 Favored 'General case' 0 C--N 1.301 -1.517 0 O-C-N 121.194 -0.941 . . . . 0.0 108.998 -179.66 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 203' ' ' THR . . . . . 0.528 HG23 ' OG1' ' A' ' 156' ' ' THR . 1.9 p -88.94 136.34 33.06 Favored 'General case' 0 C--N 1.306 -1.3 0 CA-C-O 122.474 1.13 . . . . 0.0 111.213 -178.276 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 204' ' ' GLU . . . . . 0.45 ' HA ' ' CD2' ' A' ' 153' ' ' TYR . 2.5 tt0 -60.22 134.06 56.69 Favored 'General case' 0 C--N 1.297 -1.686 0 CA-C-N 115.039 -0.982 . . . . 0.0 110.642 -179.915 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 205' ' ' VAL . . . . . 0.446 ' O ' ' OXT' ' A' ' 206' ' ' LYS . 42.2 t -121.11 -13.69 8.06 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.55 0 N-CA-C 107.997 -1.112 . . . . 0.0 107.997 179.247 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 206' ' ' LYS . . . . . 0.446 ' OXT' ' O ' ' A' ' 205' ' ' VAL . 0.1 OUTLIER . . . . . 0 N--CA 1.489 1.499 0 CA-C-O 118.029 -0.986 . . . . 0.0 109.674 -179.671 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' C' C ' 702' ' ' LEU . . . . . 0.871 ' N ' HD12 ' C' ' 702' ' ' LEU . 0.0 OUTLIER . . . . . 0 N--CA 1.491 1.599 0 N-CA-C 109.016 -0.735 . . . . 0.0 109.016 . . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' C' C ' 703' ' ' PRO . . . . . 0.65 ' HG2' ' HB1' ' A' ' 104' ' ' ALA . 52.6 Cg_exo -46.41 -176.71 0.0 OUTLIER 'Trans proline' 0 N--CA 1.49 1.287 0 C-N-CA 122.023 1.816 . . . . 0.0 112.239 -179.379 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' C' C ' 704' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.488 1.443 0 O-C-N 121.37 -0.831 . . . . 0.0 109.231 -179.905 . . . . . . . . 0 0 . 1 . 015 nuclear nobuild core ' A' A ' 63' ' ' PRO . . . . . . . . . . . . . 95.0 Cg_endo . . . . . 0 N--CA 1.482 0.843 0 CA-C-O 121.173 0.405 . . . . 0.0 111.975 . . . . . . . . . 0 0 . 1 . 015 nuclear nobuild core ' A' A ' 64' ' ' GLN . . . . . 0.673 HE21 ' C ' ' A' ' 64' ' ' GLN . 0.0 OUTLIER -153.49 120.16 5.62 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.158 -0.964 . . . . 0.0 109.424 179.537 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 65' ' ' ILE . . . . . 0.495 HD12 ' H ' ' A' ' 65' ' ' ILE . 2.9 mp -45.32 106.41 0.54 Allowed Pre-proline 0 N--CA 1.489 1.51 0 N-CA-C 107.874 -1.158 . . . . 0.0 107.874 179.079 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 66' ' ' PRO . . . . . . . . . . . . . 61.3 Cg_endo -77.64 -162.82 0.18 Allowed 'Trans proline' 0 N--CA 1.49 1.285 0 C-N-CA 122.113 1.875 . . . . 0.0 113.171 -178.075 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 67' ' ' LYS . . . . . . . . . . . . . 7.0 ttpt -84.75 -7.86 59.05 Favored 'General case' 0 N--CA 1.488 1.447 0 O-C-N 121.603 -0.686 . . . . 0.0 109.388 -179.74 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 68' ' ' ASP . . . . . 0.645 ' C ' ' N ' ' A' ' 70' ' ' SER . 1.0 OUTLIER -76.9 62.75 2.14 Favored 'General case' 0 N--CA 1.489 1.478 0 CA-C-O 122.756 1.265 . . . . 0.0 109.259 179.801 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 69' ' ' LYS . . . . . 0.463 ' C ' ' O ' ' A' ' 68' ' ' ASP . 0.9 OUTLIER -47.61 -13.36 0.04 OUTLIER 'General case' 0 N--CA 1.511 2.584 0 C-N-CA 116.926 -1.91 . . . . 0.0 106.79 177.397 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 70' ' ' SER . . . . . 0.645 ' N ' ' C ' ' A' ' 68' ' ' ASP . 0.0 OUTLIER -87.58 -3.14 58.99 Favored 'General case' 0 N--CA 1.498 1.944 0 CA-C-N 113.592 -1.64 . . . . 0.0 111.805 179.448 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 71' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -99.18 141.79 31.5 Favored 'General case' 0 N--CA 1.504 2.273 0 O-C-N 120.472 -1.393 . . . . 0.0 112.606 -178.941 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 72' ' ' VAL . . . . . 0.537 HG23 ' H ' ' A' ' 87' ' ' VAL . 0.2 OUTLIER -66.37 127.67 28.1 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.38 0 N-CA-C 104.551 -2.389 . . . . 0.0 104.551 174.397 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 73' ' ' ALA . . . . . 0.578 ' N ' ' O ' ' A' ' 87' ' ' VAL . . . -80.08 -13.71 59.08 Favored 'General case' 0 C--N 1.295 -1.783 0 O-C-N 120.165 -1.585 . . . . 0.0 108.381 -178.536 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 74' ' ' GLY . . . . . 0.53 ' O ' ' CG2' ' A' ' 72' ' ' VAL . . . 171.55 -155.42 24.11 Favored Glycine 0 N--CA 1.484 1.851 0 C-N-CA 118.759 -1.686 . . . . 0.0 110.819 179.23 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 75' ' ' TYR . . . . . 0.495 ' CA ' HG23 ' A' ' 87' ' ' VAL . 6.2 m-85 -144.29 169.22 18.32 Favored 'General case' 0 C--N 1.298 -1.647 0 O-C-N 121.639 -0.918 . . . . 0.0 110.79 -177.333 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 76' ' ' ILE . . . . . . . . . . . . . 0.8 OUTLIER -149.85 147.67 16.05 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.59 0 C-N-CA 119.902 -0.719 . . . . 0.0 109.414 -178.136 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -149.25 164.76 33.9 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 120.971 -1.081 . . . . 0.0 109.731 179.558 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 78' ' ' ILE . . . . . 0.604 ' HB ' ' HB3' ' A' ' 81' ' ' ALA . 32.6 mt -146.1 94.76 4.88 Favored Pre-proline 0 N--CA 1.489 1.517 0 N-CA-C 108.482 -0.933 . . . . 0.0 108.482 -179.808 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 79' ' ' PRO . . . . . . . . . . . . . 51.2 Cg_exo -49.02 -46.37 25.57 Favored 'Trans proline' 0 C--N 1.31 -1.451 0 C-N-CA 122.604 2.203 . . . . 0.0 113.622 -178.764 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 80' ' ' ASP . . . . . 0.553 ' OD1' ' N ' ' A' ' 80' ' ' ASP . 0.0 OUTLIER -65.41 -19.79 66.1 Favored 'General case' 0 N--CA 1.493 1.716 0 O-C-N 120.821 -1.174 . . . . 0.0 110.445 178.551 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 81' ' ' ALA . . . . . 0.857 ' HB2' ' HB2' ' A' ' 136' ' ' ALA . . . -106.33 -16.95 14.43 Favored 'General case' 0 N--CA 1.491 1.624 0 N-CA-C 108.361 -0.978 . . . . 0.0 108.361 179.33 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 82' ' ' ASP . . . . . 0.522 ' N ' ' O ' ' A' ' 78' ' ' ILE . 3.4 t70 66.52 51.61 1.12 Allowed 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.367 -0.833 . . . . 0.0 110.761 179.07 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 83' ' ' ILE . . . . . 0.658 HD11 ' OD1' ' A' ' 132' ' ' ASN . 89.5 mt -129.31 153.9 39.35 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.843 0 O-C-N 121.185 -0.947 . . . . 0.0 110.052 -179.282 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 84' ' ' LYS . . . . . 0.426 ' N ' HG22 ' A' ' 83' ' ' ILE . 22.9 tttt -158.13 109.0 2.17 Favored 'General case' 0 N--CA 1.491 1.613 0 N-CA-C 107.646 -1.242 . . . . 0.0 107.646 179.372 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 85' ' ' GLU . . . . . 0.504 ' OE1' ' O ' ' A' ' 128' ' ' TYR . 0.0 OUTLIER -141.43 165.17 30.4 Favored Pre-proline 0 N--CA 1.495 1.808 0 O-C-N 121.044 -1.035 . . . . 0.0 110.798 -178.118 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 86' ' ' PRO . . . . . . . . . . . . . 59.3 Cg_endo -74.52 161.58 39.64 Favored 'Trans proline' 0 N--CA 1.495 1.603 0 C-N-CA 123.404 2.736 . . . . 0.0 113.549 -179.362 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 87' ' ' VAL . . . . . 0.578 ' O ' ' N ' ' A' ' 73' ' ' ALA . 58.6 t -120.05 99.97 8.55 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.683 0 N-CA-C 109.294 -0.632 . . . . 0.0 109.294 179.588 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 88' ' ' TYR . . . . . 0.43 ' CD2' ' CD ' ' A' ' 99' ' ' ARG . 19.5 m-85 -92.09 154.9 43.32 Favored Pre-proline 0 N--CA 1.504 2.232 0 O-C-N 120.777 -1.202 . . . . 0.0 110.276 -179.479 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 89' ' ' PRO . . . . . . . . . . . . . 11.4 Cg_endo -60.2 143.65 99.52 Favored 'Trans proline' 0 N--CA 1.495 1.559 0 C-N-CA 122.741 2.294 . . . . 0.0 113.517 -179.902 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . -59.85 168.55 7.88 Favored Glycine 0 N--CA 1.496 2.654 0 N-CA-C 109.444 -1.462 . . . . 0.0 109.444 179.271 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 91' ' ' PRO . . . . . 0.438 ' C ' ' H ' ' A' ' 93' ' ' THR . 55.6 Cg_endo -93.32 169.78 20.36 Favored 'Cis proline' 0 C--N 1.309 -1.53 0 C-N-CA 123.941 -1.274 . . . . 0.0 111.941 0.168 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 92' ' ' ALA . . . . . 0.663 ' HB1' HD21 ' A' ' 97' ' ' LEU . . . -72.28 32.52 0.06 Allowed 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.081 -1.012 . . . . 0.0 110.398 -179.903 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 93' ' ' THR . . . . . 0.5 ' OG1' ' OE1' ' A' ' 96' ' ' GLN . 3.1 p -74.81 150.67 86.39 Favored Pre-proline 0 C--N 1.3 -1.548 0 O-C-N 120.485 -1.384 . . . . 0.0 108.487 179.993 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 94' ' ' PRO . . . . . 0.403 ' C ' ' O ' ' A' ' 93' ' ' THR . 82.0 Cg_exo -30.69 -52.32 0.23 Allowed 'Trans proline' 0 C--N 1.308 -1.569 0 C-N-CA 123.18 2.587 . . . . 0.0 113.022 -179.034 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 4.9 mm-40 -49.55 -49.3 46.81 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.09 -1.006 . . . . 0.0 109.688 -179.833 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 96' ' ' GLN . . . . . 0.57 ' O ' ' N ' ' A' ' 98' ' ' ASN . 12.5 mp0 -73.53 -54.35 8.42 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 120.96 -1.088 . . . . 0.0 110.452 -179.644 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 97' ' ' LEU . . . . . 0.663 HD21 ' HB1' ' A' ' 92' ' ' ALA . 95.8 mt -47.2 -9.32 0.02 OUTLIER 'General case' 0 N--CA 1.495 1.818 0 O-C-N 121.185 -0.947 . . . . 0.0 110.279 -178.793 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 98' ' ' ASN . . . . . 0.57 ' N ' ' O ' ' A' ' 96' ' ' GLN . 0.0 OUTLIER -74.86 -26.04 59.4 Favored 'General case' 0 N--CA 1.493 1.686 0 O-C-N 121.115 -0.991 . . . . 0.0 109.126 179.727 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 99' ' ' ARG . . . . . 0.581 ' CG ' HH11 ' A' ' 99' ' ' ARG . 0.3 OUTLIER -91.1 -56.11 3.28 Favored 'General case' 0 C--N 1.301 -1.527 0 O-C-N 121.796 -0.565 . . . . 0.0 109.642 -179.484 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . -179.46 -165.36 33.47 Favored Glycine 0 N--CA 1.49 2.283 0 N-CA-C 109.949 -1.26 . . . . 0.0 109.949 179.89 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 101' ' ' VAL . . . . . 0.551 ' O ' HG23 ' A' ' 101' ' ' VAL . 28.9 m -59.23 105.95 0.22 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.64 0 O-C-N 121.325 -1.103 . . . . 0.0 109.696 -179.731 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -91.63 169.04 11.06 Favored 'General case' 0 N--CA 1.495 1.777 0 O-C-N 121.224 -0.922 . . . . 0.0 110.864 -179.308 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 103' ' ' PHE . . . . . 0.559 ' O ' ' N ' ' A' ' 105' ' ' GLU . 26.0 m-85 -72.74 122.43 21.49 Favored 'General case' 0 N--CA 1.493 1.721 0 N-CA-C 108.123 -1.065 . . . . 0.0 108.123 178.469 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 104' ' ' ALA . . . . . 0.404 ' C ' ' O ' ' A' ' 103' ' ' PHE . . . -39.67 -20.51 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.526 -0.734 . . . . 0.0 111.716 -178.388 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 105' ' ' GLU . . . . . 0.559 ' N ' ' O ' ' A' ' 103' ' ' PHE . 13.4 pt-20 -139.51 148.71 43.01 Favored 'General case' 0 N--CA 1.498 1.943 0 O-C-N 120.673 -1.267 . . . . 0.0 110.696 -179.479 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 106' ' ' GLU . . . . . . . . . . . . . 8.8 tt0 -56.79 -62.5 1.7 Allowed 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.91 -0.494 . . . . 0.0 111.76 -178.575 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 107' ' ' ASN . . . . . 0.617 HD22 ' N ' ' A' ' 107' ' ' ASN . 1.0 OUTLIER -76.62 33.5 0.14 Allowed 'General case' 0 N--CA 1.492 1.65 0 O-C-N 120.533 -1.354 . . . . 0.0 112.782 -175.247 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 108' ' ' GLU . . . . . 0.499 ' OE1' ' OE2' ' A' ' 105' ' ' GLU . 38.3 tp10 -60.24 146.67 42.88 Favored 'General case' 0 N--CA 1.488 1.466 0 O-C-N 120.776 -1.202 . . . . 0.0 107.906 179.821 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 109' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -97.8 144.31 27.52 Favored 'General case' 0 N--CA 1.488 1.468 0 O-C-N 120.923 -1.111 . . . . 0.0 110.806 -178.243 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 110' ' ' LEU . . . . . 0.558 ' H ' HD23 ' A' ' 110' ' ' LEU . 0.4 OUTLIER -61.99 -21.05 64.53 Favored 'General case' 0 C--N 1.302 -1.46 0 N-CA-C 107.734 -1.21 . . . . 0.0 107.734 179.037 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 111' ' ' ASP . . . . . . . . . . . . . 75.5 m-20 -132.62 44.79 2.83 Favored 'General case' 0 N--CA 1.488 1.451 0 CA-C-O 121.388 0.613 . . . . 0.0 109.363 179.63 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 112' ' ' ASP . . . . . . . . . . . . . 1.1 t0 -68.64 157.38 36.3 Favored 'General case' 0 N--CA 1.493 1.685 0 O-C-N 121.195 -0.941 . . . . 0.0 111.232 -179.7 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 113' ' ' GLN . . . . . 0.541 ' N ' ' CD ' ' A' ' 113' ' ' GLN . 0.0 OUTLIER -65.92 -15.7 63.2 Favored 'General case' 0 N--CA 1.492 1.653 0 N-CA-C 107.387 -1.338 . . . . 0.0 107.387 177.495 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 114' ' ' ASN . . . . . 0.496 ' CG ' ' O ' ' A' ' 114' ' ' ASN . 11.8 p-10 -150.31 108.29 3.72 Favored 'General case' 0 C--N 1.298 -1.655 0 N-CA-C 107.72 -1.215 . . . . 0.0 107.72 178.054 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 115' ' ' ILE . . . . . 0.535 HG22 ' O ' ' A' ' 115' ' ' ILE . 2.9 mt -94.38 102.48 13.66 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.63 0 N-CA-C 107.437 -1.32 . . . . 0.0 107.437 179.61 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 116' ' ' SER . . . . . . . . . . . . . 9.0 p -88.87 150.46 22.87 Favored 'General case' 0 C--N 1.303 -1.419 0 CA-C-O 121.997 0.903 . . . . 0.0 111.483 -177.476 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 117' ' ' ILE . . . . . . . . . . . . . 1.4 mt -147.68 145.82 18.6 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.458 0 N-CA-C 107.34 -1.355 . . . . 0.0 107.34 178.762 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 118' ' ' ALA . . . . . 0.615 ' HB1' ' HB2' ' C' ' 704' ' ' ALA . . . -141.96 159.39 42.32 Favored 'General case' 0 N--CA 1.494 1.726 0 O-C-N 120.789 -1.194 . . . . 0.0 111.348 -178.434 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 119' ' ' GLY . . . . . . . . . . . . . . . -171.02 153.24 20.3 Favored Glycine 0 N--CA 1.487 2.096 0 N-CA-C 110.097 -1.201 . . . . 0.0 110.097 179.873 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 120' ' ' HIS . . . . . . . . . . . . . 12.0 m170 -71.19 167.97 18.25 Favored 'General case' 0 N--CA 1.493 1.713 0 O-C-N 121.724 -0.868 . . . . 0.0 109.944 179.378 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 121' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -117.37 158.3 24.66 Favored 'General case' 0 N--CA 1.496 1.831 0 N-CA-C 108.094 -1.076 . . . . 0.0 108.094 178.76 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 122' ' ' PHE . . . . . . . . . . . . . 3.8 m-85 -141.91 123.21 14.79 Favored 'General case' 0 N--CA 1.497 1.911 0 O-C-N 120.867 -1.145 . . . . 0.0 109.805 -179.39 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 123' ' ' ILE . . . . . 0.598 HG23 ' N ' ' A' ' 124' ' ' ASP . 14.0 tt -60.38 -41.41 87.22 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.567 0 CA-C-O 121.6 0.714 . . . . 0.0 109.285 179.622 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 124' ' ' ASP . . . . . 0.598 ' N ' HG23 ' A' ' 123' ' ' ILE . 0.3 OUTLIER -87.16 22.23 2.14 Favored 'General case' 0 N--CA 1.495 1.808 0 O-C-N 121.693 -0.629 . . . . 0.0 111.955 -177.13 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 125' ' ' ARG . . . . . . . . . . . . . 46.9 mtp180 -155.29 97.12 2.42 Favored Pre-proline 0 N--CA 1.492 1.673 0 O-C-N 120.546 -1.347 . . . . 0.0 109.757 179.763 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 126' ' ' PRO . . . . . . . . . . . . . 2.9 Cg_endo -73.66 -25.76 14.48 Favored 'Trans proline' 0 C--N 1.314 -1.239 0 C-N-CA 122.113 1.876 . . . . 0.0 111.662 178.634 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 127' ' ' ASN . . . . . 0.473 ' O ' ' O ' ' A' ' 128' ' ' TYR . 0.9 OUTLIER -91.2 5.73 47.92 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.429 -0.794 . . . . 0.0 109.736 -179.843 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 128' ' ' TYR . . . . . 0.504 ' O ' ' OE1' ' A' ' 85' ' ' GLU . 4.5 t80 -59.1 -149.27 0.0 OUTLIER 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.192 -0.943 . . . . 0.0 109.936 -179.751 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 129' ' ' GLN . . . . . 0.487 ' O ' ' OE1' ' A' ' 85' ' ' GLU . 63.4 mt-30 -66.79 -72.08 0.18 Allowed 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.439 -0.788 . . . . 0.0 109.614 -179.686 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 130' ' ' PHE . . . . . 0.504 ' O ' ' CE ' ' A' ' 134' ' ' LYS . 52.6 m-85 -133.78 47.8 2.41 Favored 'General case' 0 N--CA 1.492 1.658 0 O-C-N 121.279 -0.888 . . . . 0.0 110.059 -179.741 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 131' ' ' THR . . . . . . . . . . . . . 23.5 m -81.72 -40.82 22.16 Favored 'General case' 0 N--CA 1.489 1.481 0 O-C-N 121.052 -1.03 . . . . 0.0 109.281 179.783 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 132' ' ' ASN . . . . . 0.658 ' OD1' HD11 ' A' ' 83' ' ' ILE . 0.2 OUTLIER -83.09 2.7 33.92 Favored 'General case' 0 N--CA 1.495 1.785 0 O-C-N 121.364 -0.835 . . . . 0.0 111.377 -178.283 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 133' ' ' LEU . . . . . 0.568 HD13 ' O ' ' A' ' 133' ' ' LEU . 0.2 OUTLIER -65.6 -46.07 80.75 Favored 'General case' 0 N--CA 1.493 1.681 0 O-C-N 120.549 -1.344 . . . . 0.0 110.359 -179.568 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 134' ' ' LYS . . . . . 0.57 ' CD ' ' H ' ' A' ' 134' ' ' LYS . 0.0 OUTLIER -42.41 -18.15 0.01 OUTLIER 'General case' 0 N--CA 1.494 1.739 0 O-C-N 121.071 -1.018 . . . . 0.0 110.755 -179.185 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 135' ' ' ALA . . . . . 0.563 ' N ' ' O ' ' A' ' 133' ' ' LEU . . . -83.48 -35.39 24.94 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 120.837 -1.164 . . . . 0.0 110.251 -179.506 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 136' ' ' ALA . . . . . 0.857 ' HB2' ' HB2' ' A' ' 81' ' ' ALA . . . -79.98 155.76 27.51 Favored 'General case' 0 N--CA 1.489 1.51 0 CA-C-O 122.209 1.004 . . . . 0.0 111.889 -178.479 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 137' ' ' LYS . . . . . 0.505 ' O ' ' O ' ' A' ' 138' ' ' LYS . 0.1 OUTLIER -154.32 -165.91 2.21 Favored 'General case' 0 N--CA 1.493 1.725 0 C-N-CA 118.734 -1.186 . . . . 0.0 110.915 -178.44 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 138' ' ' LYS . . . . . 0.579 ' O ' ' N ' ' A' ' 140' ' ' SER . 17.4 mttp -45.44 179.23 0.0 OUTLIER 'General case' 0 C--N 1.305 -1.365 0 CA-C-O 121.987 0.898 . . . . 0.0 110.509 -179.222 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 139' ' ' GLY . . . . . . . . . . . . . . . 47.0 7.77 0.02 OUTLIER Glycine 0 N--CA 1.491 2.304 0 N-CA-C 110.253 -1.139 . . . . 0.0 110.253 -179.849 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 140' ' ' SER . . . . . 0.579 ' N ' ' O ' ' A' ' 138' ' ' LYS . 40.4 t -89.42 141.3 28.68 Favored 'General case' 0 N--CA 1.493 1.699 0 O-C-N 120.858 -1.378 . . . . 0.0 109.591 179.239 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 141' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -90.88 127.73 36.49 Favored 'General case' 0 C--N 1.301 -1.539 0 O-C-N 121.413 -0.805 . . . . 0.0 109.487 179.732 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 142' ' ' VAL . . . . . . . . . . . . . 3.2 t -114.48 133.6 60.07 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.674 0 O-C-N 121.364 -0.835 . . . . 0.0 108.814 179.928 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 143' ' ' TYR . . . . . 0.413 ' CE1' ' CG ' ' A' ' 152' ' ' LYS . 8.5 m-85 -107.9 135.39 49.36 Favored 'General case' 0 N--CA 1.496 1.851 0 O-C-N 121.177 -0.952 . . . . 0.0 111.521 -178.603 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 144' ' ' PHE . . . . . . . . . . . . . 66.8 t80 -115.36 157.21 24.2 Favored 'General case' 0 N--CA 1.493 1.698 0 CA-C-O 121.807 0.813 . . . . 0.0 110.82 -179.185 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 145' ' ' LYS . . . . . 0.418 ' HB3' ' H ' ' A' ' 75' ' ' TYR . 55.0 tttt -152.42 130.59 11.94 Favored 'General case' 0 N--CA 1.492 1.642 0 C-N-CA 118.887 -1.125 . . . . 0.0 111.962 -179.309 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 146' ' ' VAL . . . . . . . . . . . . . 1.9 p -145.04 139.95 22.71 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.485 0 N-CA-C 106.24 -1.763 . . . . 0.0 106.24 177.431 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 147' ' ' GLY . . . . . . . . . . . . . . . 53.88 -134.67 43.61 Favored Glycine 0 N--CA 1.488 2.157 0 N-CA-C 108.726 -1.749 . . . . 0.0 108.726 -179.079 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 148' ' ' ASN . . . . . 0.591 HD22 ' C ' ' A' ' 148' ' ' ASN . 0.4 OUTLIER -103.17 22.67 13.65 Favored 'General case' 0 C--N 1.302 -1.496 0 O-C-N 121.234 -1.156 . . . . 0.0 108.71 179.354 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 149' ' ' GLU . . . . . . . . . . . . . 18.4 tt0 -112.44 152.79 28.29 Favored 'General case' 0 N--CA 1.486 1.362 0 CA-C-O 121.752 0.786 . . . . 0.0 111.095 -179.023 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 150' ' ' THR . . . . . 0.437 ' O ' HG22 ' A' ' 150' ' ' THR . 1.3 m -141.78 105.13 4.65 Favored 'General case' 0 N--CA 1.493 1.698 0 CA-C-O 121.666 0.746 . . . . 0.0 109.436 179.996 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 151' ' ' ARG . . . . . 0.46 HH22 ' CD1' ' A' ' 115' ' ' ILE . 2.9 mpp_? -88.69 -161.55 0.76 Allowed 'General case' 0 N--CA 1.488 1.453 0 O-C-N 121.659 -0.651 . . . . 0.0 109.706 -179.149 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 152' ' ' LYS . . . . . 0.429 ' O ' ' N ' ' A' ' 205' ' ' VAL . 15.0 mtmm -149.73 146.06 27.01 Favored 'General case' 0 C--N 1.304 -1.381 0 O-C-N 121.211 -0.93 . . . . 0.0 110.139 -178.814 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 153' ' ' TYR . . . . . 0.513 ' CD2' ' HA ' ' A' ' 204' ' ' GLU . 15.0 m-85 -141.06 166.88 23.57 Favored 'General case' 0 N--CA 1.49 1.559 0 N-CA-C 107.922 -1.14 . . . . 0.0 107.922 179.193 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 154' ' ' LYS . . . . . 0.484 ' HB2' HG21 ' A' ' 205' ' ' VAL . 12.7 ttmt -142.8 120.43 11.8 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.236 -0.915 . . . . 0.0 108.576 178.865 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 155' ' ' MET . . . . . 0.409 ' H ' ' HG2' ' A' ' 155' ' ' MET . 44.4 mmm -47.83 107.26 0.11 Allowed 'General case' 0 N--CA 1.493 1.688 0 O-C-N 120.611 -1.306 . . . . 0.0 111.315 -178.626 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 156' ' ' THR . . . . . 0.488 ' OG1' HG23 ' A' ' 203' ' ' THR . 0.2 OUTLIER -105.18 -24.44 12.74 Favored 'General case' 0 C--N 1.294 -1.843 0 CA-C-N 115.259 -0.882 . . . . 0.0 110.836 -178.655 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 157' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -146.8 150.5 35.43 Favored 'General case' 0 C--N 1.296 -1.757 0 C-N-CA 118.51 -1.276 . . . . 0.0 110.367 -178.784 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 158' ' ' ILE . . . . . . . . . . . . . 1.9 mt -147.35 137.59 17.13 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.382 0 CA-C-O 121.324 0.583 . . . . 0.0 109.537 -178.459 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 159' ' ' ARG . . . . . 0.488 ' O ' ' OD1' ' A' ' 160' ' ' ASP . 44.7 mtp180 -155.59 -167.71 2.59 Favored 'General case' 0 N--CA 1.492 1.647 0 CA-C-O 121.907 0.86 . . . . 0.0 110.956 -178.799 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 160' ' ' ASP . . . . . 0.488 ' OD1' ' O ' ' A' ' 159' ' ' ARG . 63.8 m-20 -146.71 153.04 39.8 Favored 'General case' 0 N--CA 1.489 1.48 0 N-CA-C 108.183 -1.043 . . . . 0.0 108.183 179.512 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 161' ' ' VAL . . . . . 0.425 ' O ' ' O ' ' A' ' 162' ' ' LYS . 0.1 OUTLIER -143.11 146.54 21.48 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.627 0 O-C-N 120.899 -1.125 . . . . 0.0 109.884 179.939 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 162' ' ' LYS . . . . . 0.697 ' CD ' ' H ' ' A' ' 162' ' ' LYS . 0.0 OUTLIER -45.44 167.13 0.12 Allowed Pre-proline 0 N--CA 1.49 1.526 0 O-C-N 121.285 -0.884 . . . . 0.0 109.391 -179.787 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 163' ' ' PRO . . . . . . . . . . . . . 57.9 Cg_endo -76.54 30.4 0.4 Allowed 'Trans proline' 0 C--N 1.308 -1.574 0 C-N-CA 122.838 2.359 . . . . 0.0 113.387 -179.488 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 164' ' ' THR . . . . . 0.623 ' HA ' HD11 ' C' ' 702' ' ' LEU . 0.2 OUTLIER -152.29 -0.58 0.3 Allowed 'General case' 0 N--CA 1.495 1.817 0 O-C-N 120.921 -1.112 . . . . 0.0 110.306 179.612 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 165' ' ' ASP . . . . . 0.414 ' O ' ' C ' ' A' ' 166' ' ' VAL . 7.4 t70 -76.85 64.4 2.38 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.12 -0.987 . . . . 0.0 110.16 -179.866 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 166' ' ' VAL . . . . . 0.616 ' O ' ' N ' ' A' ' 168' ' ' VAL . 1.3 m -47.1 -31.4 1.79 Allowed 'Isoleucine or valine' 0 N--CA 1.487 1.405 0 O-C-N 120.642 -1.286 . . . . 0.0 108.941 -178.837 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 167' ' ' GLY . . . . . . . . . . . . . . . -46.86 -9.49 0.03 OUTLIER Glycine 0 N--CA 1.495 2.571 0 N-CA-C 109.458 -1.457 . . . . 0.0 109.458 179.35 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 168' ' ' VAL . . . . . 0.708 HG21 HG21 ' A' ' 199' ' ' ILE . 9.8 p -49.43 -31.54 5.58 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.481 0 N-CA-C 107.775 -1.194 . . . . 0.0 107.775 179.22 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 169' ' ' LEU . . . . . 0.509 ' O ' ' C ' ' A' ' 170' ' ' ASP . 1.7 mm? -45.21 -19.38 0.04 OUTLIER 'General case' 0 C--N 1.293 -1.852 0 N-CA-C 107.694 -1.225 . . . . 0.0 107.694 -178.25 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 170' ' ' ASP . . . . . 0.531 ' N ' ' O ' ' A' ' 168' ' ' VAL . 8.3 t0 27.88 91.38 0.01 OUTLIER 'General case' 0 N--CA 1.501 2.121 0 CA-C-N 116.459 -0.337 . . . . 0.0 111.399 177.268 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 171' ' ' GLU . . . . . 0.433 ' CB ' ' OD1' ' A' ' 114' ' ' ASN . 17.1 pt-20 -130.85 67.27 1.51 Allowed 'General case' 0 N--CA 1.499 1.984 0 O-C-N 121.016 -1.053 . . . . 0.0 110.435 -179.989 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 172' ' ' GLN . . . . . . . . . . . . . 2.1 mt-30 -127.96 -52.6 1.32 Allowed 'General case' 0 N--CA 1.498 1.942 0 O-C-N 121.26 -0.9 . . . . 0.0 110.745 -178.979 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 173' ' ' LYS . . . . . . . . . . . . . 15.4 mttt -58.82 124.93 21.46 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 120.886 -1.134 . . . . 0.0 108.453 179.9 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 174' ' ' GLY . . . . . 0.538 ' O ' ' C ' ' A' ' 175' ' ' LYS . . . -124.74 -43.63 0.3 Allowed Glycine 0 N--CA 1.48 1.602 0 N-CA-C 108.337 -1.905 . . . . 0.0 108.337 -179.838 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 175' ' ' LYS . . . . . 0.538 ' C ' ' O ' ' A' ' 174' ' ' GLY . 2.2 mptm? -37.9 -61.85 0.61 Allowed 'General case' 0 N--CA 1.492 1.655 0 N-CA-C 107.243 -1.392 . . . . 0.0 107.243 179.308 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 176' ' ' ASP . . . . . 0.624 ' O ' ' O ' ' A' ' 177' ' ' LYS . 8.7 m-20 -104.32 85.9 2.44 Favored 'General case' 0 C--N 1.295 -1.787 0 N-CA-C 106.7 -1.592 . . . . 0.0 106.7 176.512 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 177' ' ' LYS . . . . . 0.624 ' O ' ' O ' ' A' ' 176' ' ' ASP . 12.5 mttt -40.97 179.8 0.0 OUTLIER 'General case' 0 N--CA 1.496 1.85 0 O-C-N 121.489 -0.757 . . . . 0.0 110.235 -178.726 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 178' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -161.21 170.08 20.97 Favored 'General case' 0 N--CA 1.487 1.398 0 O-C-N 120.339 -1.476 . . . . 0.0 111.138 179.911 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 179' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -123.49 99.09 6.14 Favored 'General case' 0 C--N 1.304 -1.389 0 N-CA-C 107.406 -1.331 . . . . 0.0 107.406 178.297 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 180' ' ' THR . . . . . 0.462 HG22 ' O ' ' A' ' 180' ' ' THR . 1.1 m -70.56 114.08 8.31 Favored 'General case' 0 N--CA 1.487 1.418 0 O-C-N 121.18 -0.95 . . . . 0.0 109.857 -178.774 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 181' ' ' LEU . . . . . 0.725 HD13 ' N ' ' A' ' 182' ' ' ILE . 0.3 OUTLIER -88.9 142.58 27.53 Favored 'General case' 0 C--N 1.303 -1.456 0 N-CA-C 107.339 -1.356 . . . . 0.0 107.339 177.677 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 182' ' ' ILE . . . . . 0.725 ' N ' HD13 ' A' ' 181' ' ' LEU . 81.6 mt -137.87 115.72 12.96 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.76 0 N-CA-C 107.824 -1.176 . . . . 0.0 107.824 179.259 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 183' ' ' THR . . . . . 0.464 HG23 ' O ' ' A' ' 183' ' ' THR . 3.7 t -139.54 113.49 8.73 Favored 'General case' 0 C--N 1.289 -2.063 0 N-CA-C 108.155 -1.054 . . . . 0.0 108.155 -179.623 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 184' ' ' CYS . . . . . . . . . . . . . 0.8 OUTLIER -78.84 159.75 27.67 Favored 'General case' 0 C--N 1.291 -1.938 0 C-N-CA 119.101 -1.04 . . . . 0.0 111.095 -178.078 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 185' ' ' ASP . . . . . . . . . . . . . 1.2 t70 -165.93 -155.81 0.24 Allowed 'General case' 0 N--CA 1.493 1.683 0 N-CA-C 109.046 -0.724 . . . . 0.0 109.046 -179.613 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 186' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER 54.2 55.22 8.47 Favored 'General case' 0 N--CA 1.496 1.826 0 O-C-N 121.047 -1.033 . . . . 0.0 109.335 179.898 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 187' ' ' TYR . . . . . 0.611 ' CE2' ' O ' ' A' ' 188' ' ' ASN . 71.2 t80 -67.61 132.2 47.07 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 120.975 -1.078 . . . . 0.0 111.402 -179.151 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 188' ' ' ASN . . . . . 0.831 HD21 ' N ' ' A' ' 192' ' ' GLY . 0.0 OUTLIER -100.54 149.36 23.8 Favored 'General case' 0 C--N 1.296 -1.736 0 N-CA-C 107.292 -1.373 . . . . 0.0 107.292 177.364 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 189' ' ' GLU . . . . . . . . . . . . . 1.8 tt0 -111.65 -10.56 14.09 Favored 'General case' 0 C--N 1.293 -1.871 0 N-CA-C 108.833 -0.802 . . . . 0.0 108.833 -179.122 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 190' ' ' LYS . . . . . . . . . . . . . 13.9 mttm -85.88 -50.89 6.76 Favored 'General case' 0 C--N 1.301 -1.5 0 CA-C-O 121.583 0.706 . . . . 0.0 109.447 179.537 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 191' ' ' THR . . . . . 0.705 ' N ' HD21 ' A' ' 188' ' ' ASN . 72.6 p -89.15 -1.09 57.94 Favored 'General case' 0 N--CA 1.493 1.713 0 O-C-N 121.584 -0.698 . . . . 0.0 110.781 -178.879 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 192' ' ' GLY . . . . . 0.831 ' N ' HD21 ' A' ' 188' ' ' ASN . . . 56.38 36.08 68.39 Favored Glycine 0 N--CA 1.492 2.388 0 O-C-N 120.865 -1.147 . . . . 0.0 110.327 179.622 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 193' ' ' VAL . . . . . 0.524 ' H ' HD22 ' A' ' 188' ' ' ASN . 3.1 m -148.63 163.77 5.04 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.738 0 O-C-N 120.885 -1.362 . . . . 0.0 109.449 179.519 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 194' ' ' TRP . . . . . 0.495 ' CD1' ' N ' ' A' ' 194' ' ' TRP . 24.2 m95 -84.46 121.16 27.18 Favored 'General case' 0 C--N 1.303 -1.42 0 N-CA-C 107.97 -1.122 . . . . 0.0 107.97 178.845 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 195' ' ' GLU . . . . . . . . . . . . . 1.7 mt-10 -76.7 -61.27 2.02 Favored 'General case' 0 N--CA 1.496 1.832 0 O-C-N 121.225 -0.922 . . . . 0.0 112.905 -176.831 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 196' ' ' LYS . . . . . . . . . . . . . 2.0 tptm -93.02 159.49 15.28 Favored 'General case' 0 N--CA 1.495 1.809 0 O-C-N 120.762 -1.211 . . . . 0.0 111.51 -177.201 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 197' ' ' ARG . . . . . 0.423 ' NH1' ' HB2' ' A' ' 194' ' ' TRP . 0.0 OUTLIER -121.75 135.83 54.94 Favored 'General case' 0 N--CA 1.493 1.676 0 N-CA-C 109.179 -0.675 . . . . 0.0 109.179 179.577 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 198' ' ' LYS . . . . . . . . . . . . . 49.3 mttt -117.4 120.38 37.97 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.495 -0.753 . . . . 0.0 110.104 -179.243 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 199' ' ' ILE . . . . . 0.708 HG21 HG21 ' A' ' 168' ' ' VAL . 1.0 OUTLIER -137.8 122.26 22.97 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.677 0 CA-C-O 122.667 1.222 . . . . 0.0 110.623 179.554 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 200' ' ' PHE . . . . . 0.471 ' CD1' ' N ' ' A' ' 200' ' ' PHE . 1.6 m-85 -103.5 138.83 39.66 Favored 'General case' 0 C--N 1.297 -1.689 0 O-C-N 120.91 -1.119 . . . . 0.0 110.334 -178.22 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 201' ' ' VAL . . . . . . . . . . . . . 59.7 t -102.36 147.04 9.48 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.494 0 N-CA-C 107.678 -1.23 . . . . 0.0 107.678 177.615 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 202' ' ' ALA . . . . . . . . . . . . . . . -130.53 138.63 50.3 Favored 'General case' 0 C--N 1.3 -1.567 0 O-C-N 121.138 -0.976 . . . . 0.0 108.388 -179.874 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 203' ' ' THR . . . . . 0.714 ' O ' HG23 ' A' ' 205' ' ' VAL . 6.5 p -89.0 127.78 35.68 Favored 'General case' 0 C--N 1.305 -1.365 0 CA-C-O 122.226 1.012 . . . . 0.0 111.41 -178.167 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 204' ' ' GLU . . . . . 0.513 ' HA ' ' CD2' ' A' ' 153' ' ' TYR . 1.1 tm-20 -50.37 134.9 22.79 Favored 'General case' 0 C--N 1.299 -1.595 0 C-N-CA 118.957 -1.097 . . . . 0.0 108.607 178.766 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 205' ' ' VAL . . . . . 0.714 HG23 ' O ' ' A' ' 203' ' ' THR . 69.8 t -130.54 163.96 34.82 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.338 0 CA-C-O 122.116 0.96 . . . . 0.0 110.606 -177.333 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 206' ' ' LYS . . . . . 0.578 ' N ' HG12 ' A' ' 205' ' ' VAL . 0.1 OUTLIER . . . . . 0 C--N 1.299 -1.627 0 CA-C-O 118.032 -0.985 . . . . 0.0 109.366 179.876 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' C' C ' 702' ' ' LEU . . . . . 0.899 ' N ' HD12 ' C' ' 702' ' ' LEU . 0.0 OUTLIER . . . . . 0 N--CA 1.501 2.08 0 N-CA-C 109.991 -0.374 . . . . 0.0 109.991 . . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' C' C ' 703' ' ' PRO . . . . . 0.623 ' CB ' ' HB3' ' A' ' 92' ' ' ALA . 27.7 Cg_exo -55.6 -166.77 0.02 OUTLIER 'Trans proline' 0 N--CA 1.493 1.498 0 C-N-CA 122.195 1.93 . . . . 0.0 112.606 -179.463 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' C' C ' 704' ' ' ALA . . . . . 0.615 ' HB2' ' HB1' ' A' ' 118' ' ' ALA . . . . . . . . 0 N--CA 1.49 1.563 0 O-C-N 121.493 -0.754 . . . . 0.0 109.207 -179.817 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 63' ' ' PRO . . . . . . . . . . . . . 9.8 Cg_exo . . . . . 0 N--CA 1.491 1.37 0 CA-C-O 121.349 0.479 . . . . 0.0 111.65 . . . . . . . . . 0 0 . 1 . 016 nuclear nobuild core ' A' A ' 64' ' ' GLN . . . . . 0.677 ' NE2' ' N ' ' A' ' 64' ' ' GLN . 0.0 OUTLIER -156.41 117.75 3.83 Favored 'General case' 0 N--CA 1.494 1.739 0 O-C-N 121.276 -0.89 . . . . 0.0 109.071 179.816 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 65' ' ' ILE . . . . . 0.492 ' CD1' ' H ' ' A' ' 65' ' ' ILE . 0.0 OUTLIER -42.72 103.97 0.34 Allowed Pre-proline 0 N--CA 1.497 1.923 0 O-C-N 121.119 -0.988 . . . . 0.0 108.743 179.626 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 66' ' ' PRO . . . . . . . . . . . . . 61.3 Cg_endo -90.15 -154.86 0.05 OUTLIER 'Trans proline' 0 C--N 1.313 -1.339 0 C-N-CA 122.194 1.929 . . . . 0.0 112.043 -179.742 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 67' ' ' LYS . . . . . 0.409 ' C ' ' H ' ' A' ' 69' ' ' LYS . 22.0 tttt -85.32 -4.76 59.26 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.119 -0.988 . . . . 0.0 108.771 179.597 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 68' ' ' ASP . . . . . 0.616 ' C ' ' N ' ' A' ' 70' ' ' SER . 1.1 t0 -75.03 49.58 0.44 Allowed 'General case' 0 N--CA 1.488 1.452 0 CA-C-O 122.533 1.159 . . . . 0.0 108.997 179.87 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 69' ' ' LYS . . . . . 0.418 ' C ' ' O ' ' A' ' 68' ' ' ASP . 4.1 mtmp? -48.7 -14.77 0.07 Allowed 'General case' 0 N--CA 1.503 2.211 0 C-N-CA 117.218 -1.793 . . . . 0.0 106.664 177.99 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 70' ' ' SER . . . . . 0.616 ' N ' ' C ' ' A' ' 68' ' ' ASP . 0.0 OUTLIER -86.15 -4.46 59.17 Favored 'General case' 0 N--CA 1.494 1.766 0 CA-C-N 113.702 -1.59 . . . . 0.0 110.916 179.714 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 71' ' ' LYS . . . . . 0.402 ' CD ' ' HB3' ' A' ' 68' ' ' ASP . 5.4 ptmt -99.54 140.5 33.63 Favored 'General case' 0 N--CA 1.493 1.72 0 O-C-N 120.896 -1.127 . . . . 0.0 110.957 179.698 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 72' ' ' VAL . . . . . 0.6 ' CG2' ' O ' ' A' ' 74' ' ' GLY . 0.6 OUTLIER -64.82 136.57 26.42 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.476 0 N-CA-C 104.883 -2.265 . . . . 0.0 104.883 174.725 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 73' ' ' ALA . . . . . 0.651 ' O ' HG23 ' A' ' 146' ' ' VAL . . . -84.68 -14.72 47.62 Favored 'General case' 0 C--N 1.296 -1.745 0 O-C-N 120.211 -1.556 . . . . 0.0 108.386 -179.163 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 74' ' ' GLY . . . . . 0.6 ' O ' ' CG2' ' A' ' 72' ' ' VAL . . . 172.7 -158.51 28.65 Favored Glycine 0 N--CA 1.485 1.93 0 N-CA-C 109.432 -1.467 . . . . 0.0 109.432 -179.692 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 75' ' ' TYR . . . . . 0.59 ' CD2' ' O ' ' A' ' 85' ' ' GLU . 2.0 m-85 -142.81 170.32 15.92 Favored 'General case' 0 C--N 1.299 -1.63 0 O-C-N 121.013 -1.286 . . . . 0.0 111.544 -177.16 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 76' ' ' ILE . . . . . . . . . . . . . 3.0 tp -146.92 143.94 20.16 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.453 0 C-N-CA 119.906 -0.718 . . . . 0.0 109.734 -177.528 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -151.29 159.99 44.04 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 120.999 -1.063 . . . . 0.0 109.129 179.572 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 78' ' ' ILE . . . . . 0.488 ' HB ' ' HB3' ' A' ' 81' ' ' ALA . 19.0 mt -146.83 103.27 3.89 Favored Pre-proline 0 N--CA 1.491 1.604 0 O-C-N 121.296 -0.877 . . . . 0.0 109.067 -179.703 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 79' ' ' PRO . . . . . . . . . . . . . 46.6 Cg_exo -51.16 -44.02 45.11 Favored 'Trans proline' 0 N--CA 1.494 1.538 0 C-N-CA 122.566 2.177 . . . . 0.0 113.949 -179.149 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 1.1 m-20 -67.28 -22.71 65.64 Favored 'General case' 0 N--CA 1.493 1.676 0 O-C-N 120.69 -1.256 . . . . 0.0 110.991 178.975 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 81' ' ' ALA . . . . . 0.77 ' HB2' ' HB2' ' A' ' 136' ' ' ALA . . . -104.03 -10.85 17.75 Favored 'General case' 0 N--CA 1.493 1.716 0 O-C-N 121.135 -0.978 . . . . 0.0 109.106 179.588 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 82' ' ' ASP . . . . . . . . . . . . . 1.1 t70 59.05 50.24 8.46 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.336 -0.853 . . . . 0.0 110.439 179.322 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 83' ' ' ILE . . . . . . . . . . . . . 70.3 mt -125.97 152.61 33.32 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.854 0 O-C-N 121.298 -0.876 . . . . 0.0 110.285 -179.061 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 84' ' ' LYS . . . . . 0.408 ' C ' ' CD ' ' A' ' 85' ' ' GLU . 0.2 OUTLIER -160.69 105.07 1.4 Allowed 'General case' 0 N--CA 1.492 1.667 0 O-C-N 121.166 -0.959 . . . . 0.0 108.762 179.469 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 85' ' ' GLU . . . . . 0.59 ' O ' ' CD2' ' A' ' 75' ' ' TYR . 1.2 mm-40 -139.72 179.2 1.34 Allowed Pre-proline 0 N--CA 1.499 1.979 0 O-C-N 121.13 -0.981 . . . . 0.0 109.674 -179.373 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 86' ' ' PRO . . . . . 0.47 ' CD ' ' CB ' ' A' ' 85' ' ' GLU . 35.5 Cg_endo -86.15 167.33 9.38 Favored 'Trans proline' 0 C--N 1.314 -1.24 0 C-N-CA 122.707 2.272 . . . . 0.0 113.34 -178.691 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 87' ' ' VAL . . . . . 0.563 ' H ' HG23 ' A' ' 72' ' ' VAL . 57.5 t -124.43 104.76 14.3 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.469 0 N-CA-C 108.042 -1.096 . . . . 0.0 108.042 178.901 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 88' ' ' TYR . . . . . 0.409 ' CD2' ' HG2' ' A' ' 99' ' ' ARG . 29.5 m-85 -97.83 154.73 37.72 Favored Pre-proline 0 N--CA 1.496 1.831 0 O-C-N 121.047 -1.033 . . . . 0.0 110.202 -178.731 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 89' ' ' PRO . . . . . . . . . . . . . 8.9 Cg_endo -56.33 144.32 82.93 Favored 'Trans proline' 0 N--CA 1.496 1.62 0 C-N-CA 122.961 2.44 . . . . 0.0 113.949 -179.972 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . -59.87 170.25 6.71 Favored Glycine 0 N--CA 1.489 2.208 0 N-CA-C 109.01 -1.636 . . . . 0.0 109.01 178.553 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 91' ' ' PRO . . . . . 0.429 ' C ' ' H ' ' A' ' 93' ' ' THR . 54.6 Cg_endo -93.94 167.4 20.28 Favored 'Cis proline' 0 C--N 1.307 -1.645 0 C-N-CA 124.016 -1.243 . . . . 0.0 111.275 -0.04 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 92' ' ' ALA . . . . . 0.659 ' HB1' HD21 ' A' ' 97' ' ' LEU . . . -72.11 32.61 0.06 Allowed 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.125 -0.985 . . . . 0.0 110.532 -179.612 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 93' ' ' THR . . . . . 0.429 ' H ' ' C ' ' A' ' 91' ' ' PRO . 2.0 p -73.3 149.78 89.26 Favored Pre-proline 0 N--CA 1.489 1.52 0 O-C-N 120.566 -1.333 . . . . 0.0 108.653 -179.817 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 94' ' ' PRO . . . . . . . . . . . . . 91.8 Cg_exo -30.53 -50.43 0.22 Allowed 'Trans proline' 0 C--N 1.31 -1.454 0 C-N-CA 123.372 2.715 . . . . 0.0 112.944 -179.125 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 95' ' ' GLU . . . . . 0.434 ' O ' ' NH2' ' A' ' 99' ' ' ARG . 10.6 mt-10 -53.8 -47.65 70.62 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.201 -0.937 . . . . 0.0 109.702 -179.973 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 96' ' ' GLN . . . . . 0.452 ' C ' ' H ' ' A' ' 98' ' ' ASN . 3.3 mp0 -72.08 -49.21 38.3 Favored 'General case' 0 C--N 1.302 -1.478 0 O-C-N 121.263 -0.898 . . . . 0.0 110.416 -179.453 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 97' ' ' LEU . . . . . 0.659 HD21 ' HB1' ' A' ' 92' ' ' ALA . 96.2 mt -52.8 -8.25 0.09 Allowed 'General case' 0 N--CA 1.493 1.695 0 O-C-N 121.055 -1.028 . . . . 0.0 110.06 -178.936 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 98' ' ' ASN . . . . . 0.628 ' ND2' ' CZ ' ' A' ' 99' ' ' ARG . 0.0 OUTLIER -75.68 -37.73 59.3 Favored 'General case' 0 N--CA 1.488 1.432 0 N-CA-C 107.91 -1.145 . . . . 0.0 107.91 178.269 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 99' ' ' ARG . . . . . 0.628 ' CZ ' ' ND2' ' A' ' 98' ' ' ASN . 1.0 OUTLIER -72.41 -51.28 21.06 Favored 'General case' 0 C--N 1.304 -1.378 0 CA-C-N 115.893 -0.594 . . . . 0.0 109.646 179.677 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . 169.6 -158.43 30.7 Favored Glycine 0 N--CA 1.497 2.762 0 N-CA-C 109.565 -1.414 . . . . 0.0 109.565 -179.834 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 101' ' ' VAL . . . . . 0.763 ' O ' HG23 ' A' ' 101' ' ' VAL . 16.2 m -66.2 104.26 0.57 Allowed 'Isoleucine or valine' 0 N--CA 1.496 1.848 0 O-C-N 120.924 -1.339 . . . . 0.0 108.987 179.697 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -92.4 167.71 11.79 Favored 'General case' 0 N--CA 1.495 1.813 0 O-C-N 121.218 -0.926 . . . . 0.0 111.6 -178.719 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 103' ' ' PHE . . . . . 0.425 ' CE1' ' CG1' ' A' ' 87' ' ' VAL . 24.3 m-85 -70.97 143.88 50.69 Favored 'General case' 0 N--CA 1.489 1.505 0 N-CA-C 107.876 -1.157 . . . . 0.0 107.876 178.238 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 104' ' ' ALA . . . . . . . . . . . . . . . -61.94 -13.47 25.43 Favored 'General case' 0 C--N 1.297 -1.68 0 O-C-N 121.179 -0.951 . . . . 0.0 111.376 -178.71 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -138.29 143.27 39.92 Favored 'General case' 0 N--CA 1.498 1.964 0 O-C-N 120.618 -1.301 . . . . 0.0 110.998 -179.49 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 106' ' ' GLU . . . . . . . . . . . . . 6.1 pt-20 -57.09 -58.92 6.06 Favored 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.935 -0.478 . . . . 0.0 111.134 -179.432 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 107' ' ' ASN . . . . . 0.466 HD22 ' N ' ' A' ' 107' ' ' ASN . 1.1 m-80 -77.99 35.22 0.2 Allowed 'General case' 0 N--CA 1.489 1.478 0 O-C-N 120.361 -1.462 . . . . 0.0 112.107 -176.24 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 108' ' ' GLU . . . . . . . . . . . . . 40.6 tp10 -59.28 145.46 43.02 Favored 'General case' 0 C--N 1.304 -1.374 0 O-C-N 120.742 -1.224 . . . . 0.0 107.834 -179.96 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 109' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -96.86 144.22 27.01 Favored 'General case' 0 C--N 1.301 -1.542 0 O-C-N 121.119 -0.988 . . . . 0.0 110.67 -178.324 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 110' ' ' LEU . . . . . 0.513 HD11 HG21 ' A' ' 146' ' ' VAL . 5.6 tp -60.9 -21.52 63.43 Favored 'General case' 0 C--N 1.302 -1.465 0 N-CA-C 107.971 -1.122 . . . . 0.0 107.971 179.165 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 111' ' ' ASP . . . . . . . . . . . . . 82.5 m-20 -132.19 43.77 2.98 Favored 'General case' 0 C--N 1.302 -1.482 0 C-N-CA 120.269 -0.572 . . . . 0.0 109.861 -179.616 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 112' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -67.09 148.79 51.42 Favored 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.153 -0.967 . . . . 0.0 110.059 179.63 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 113' ' ' GLN . . . . . 0.432 ' HA ' ' NE2' ' A' ' 113' ' ' GLN . 1.0 OUTLIER -68.12 -12.4 60.83 Favored 'General case' 0 C--N 1.302 -1.482 0 O-C-N 121.256 -0.902 . . . . 0.0 109.199 179.029 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 114' ' ' ASN . . . . . 0.674 ' ND2' ' NE2' ' A' ' 178' ' ' GLN . 8.0 t-20 -149.97 101.79 3.06 Favored 'General case' 0 C--N 1.301 -1.517 0 N-CA-C 107.167 -1.42 . . . . 0.0 107.167 177.378 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 115' ' ' ILE . . . . . 0.432 ' O ' HG22 ' A' ' 115' ' ' ILE . 4.0 mt -97.83 110.55 25.74 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.45 0 O-C-N 121.047 -1.033 . . . . 0.0 108.848 -179.253 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 116' ' ' SER . . . . . . . . . . . . . 28.9 m -98.93 138.26 36.31 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.154 -0.966 . . . . 0.0 111.122 -178.485 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 117' ' ' ILE . . . . . 0.459 ' CD1' HD21 ' A' ' 179' ' ' LEU . 14.4 mt -123.42 151.52 28.01 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.424 0 N-CA-C 107.229 -1.397 . . . . 0.0 107.229 178.83 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 118' ' ' ALA . . . . . 0.405 ' HA ' ' O ' ' A' ' 182' ' ' ILE . . . -140.93 154.67 46.2 Favored 'General case' 0 N--CA 1.487 1.409 0 O-C-N 120.95 -1.094 . . . . 0.0 110.609 -179.171 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 119' ' ' GLY . . . . . . . . . . . . . . . -166.57 151.73 20.14 Favored Glycine 0 N--CA 1.484 1.849 0 N-CA-C 110.201 -1.16 . . . . 0.0 110.201 179.984 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 120' ' ' HIS . . . . . . . . . . . . . 10.9 m170 -71.71 165.51 23.87 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.918 -0.754 . . . . 0.0 110.465 179.642 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 121' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -121.03 148.32 44.3 Favored 'General case' 0 N--CA 1.495 1.823 0 N-CA-C 107.75 -1.204 . . . . 0.0 107.75 178.293 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 122' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -107.41 138.33 43.81 Favored 'General case' 0 N--CA 1.495 1.782 0 O-C-N 120.882 -1.136 . . . . 0.0 110.192 -179.663 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 123' ' ' ILE . . . . . 0.536 HG23 ' N ' ' A' ' 124' ' ' ASP . 15.0 tt -90.26 -36.54 8.5 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.771 0 N-CA-C 108.152 -1.055 . . . . 0.0 108.152 178.277 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 124' ' ' ASP . . . . . 0.536 ' N ' HG23 ' A' ' 123' ' ' ILE . 18.3 t0 -96.6 17.18 16.9 Favored 'General case' 0 N--CA 1.496 1.843 0 CA-C-N 115.777 -0.647 . . . . 0.0 111.13 -179.638 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 125' ' ' ARG . . . . . . . . . . . . . 7.7 ttt180 -156.72 107.35 1.97 Allowed Pre-proline 0 N--CA 1.499 1.993 0 O-C-N 120.516 -1.365 . . . . 0.0 110.152 -178.856 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 126' ' ' PRO . . . . . . . . . . . . . 66.0 Cg_endo -81.04 -17.02 9.6 Favored 'Trans proline' 0 C--N 1.314 -1.247 0 C-N-CA 121.886 1.724 . . . . 0.0 112.703 179.885 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 127' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -90.95 31.24 1.1 Allowed 'General case' 0 N--CA 1.494 1.742 0 O-C-N 121.152 -0.968 . . . . 0.0 109.946 -179.933 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 128' ' ' TYR . . . . . . . . . . . . . 8.8 t80 -89.41 -153.16 0.26 Allowed 'General case' 0 N--CA 1.492 1.668 0 O-C-N 120.956 -1.09 . . . . 0.0 110.675 -179.193 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 129' ' ' GLN . . . . . . . . . . . . . 39.8 mt-30 -66.77 -72.71 0.15 Allowed 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.32 -0.863 . . . . 0.0 110.919 -178.308 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 130' ' ' PHE . . . . . 0.573 ' CE2' HG11 ' A' ' 101' ' ' VAL . 49.2 m-85 -121.6 28.98 7.4 Favored 'General case' 0 N--CA 1.497 1.876 0 O-C-N 121.289 -0.882 . . . . 0.0 110.126 -179.447 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 131' ' ' THR . . . . . . . . . . . . . 99.0 m -72.55 -30.92 64.86 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 120.781 -1.199 . . . . 0.0 109.146 179.933 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 132' ' ' ASN . . . . . . . . . . . . . 4.6 t30 -85.0 7.99 19.39 Favored 'General case' 0 N--CA 1.496 1.86 0 C-N-CA 119.513 -0.875 . . . . 0.0 109.923 -179.869 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 133' ' ' LEU . . . . . 0.583 ' O ' ' N ' ' A' ' 135' ' ' ALA . 0.2 OUTLIER -70.81 -49.64 44.2 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.353 -0.842 . . . . 0.0 109.827 179.897 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 134' ' ' LYS . . . . . 0.599 ' CD ' ' H ' ' A' ' 134' ' ' LYS . 0.0 OUTLIER -44.39 -16.14 0.02 OUTLIER 'General case' 0 N--CA 1.495 1.804 0 O-C-N 120.995 -1.066 . . . . 0.0 109.386 -179.311 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 135' ' ' ALA . . . . . 0.583 ' N ' ' O ' ' A' ' 133' ' ' LEU . . . -83.15 -35.87 25.2 Favored 'General case' 0 N--CA 1.494 1.773 0 O-C-N 121.264 -0.898 . . . . 0.0 109.824 179.78 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 136' ' ' ALA . . . . . 0.77 ' HB2' ' HB2' ' A' ' 81' ' ' ALA . . . -80.43 158.71 25.87 Favored 'General case' 0 N--CA 1.491 1.621 0 CA-C-O 121.778 0.799 . . . . 0.0 111.446 -178.735 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 137' ' ' LYS . . . . . 0.55 ' O ' ' O ' ' A' ' 138' ' ' LYS . 17.1 mtmt -149.64 -168.08 3.01 Favored 'General case' 0 N--CA 1.493 1.7 0 C-N-CA 118.935 -1.106 . . . . 0.0 110.619 -177.888 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 138' ' ' LYS . . . . . 0.581 ' O ' ' N ' ' A' ' 140' ' ' SER . 21.7 mtmm -40.48 176.06 0.0 OUTLIER 'General case' 0 C--N 1.304 -1.407 0 CA-C-O 122.608 1.194 . . . . 0.0 111.502 -178.618 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 139' ' ' GLY . . . . . . . . . . . . . . . 47.83 7.81 0.04 OUTLIER Glycine 0 N--CA 1.487 2.072 0 N-CA-C 109.825 -1.31 . . . . 0.0 109.825 -179.649 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 140' ' ' SER . . . . . 0.581 ' N ' ' O ' ' A' ' 138' ' ' LYS . 2.3 p -75.32 116.67 16.3 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 120.96 -1.318 . . . . 0.0 109.156 179.207 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 141' ' ' MET . . . . . . . . . . . . . 3.3 tpt -70.6 139.3 51.38 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.215 -0.928 . . . . 0.0 109.393 -179.956 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 142' ' ' VAL . . . . . . . . . . . . . 5.0 t -125.35 128.25 72.53 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.719 0 O-C-N 121.491 -0.755 . . . . 0.0 108.998 -179.789 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 143' ' ' TYR . . . . . . . . . . . . . 64.4 m-85 -107.41 135.04 49.57 Favored 'General case' 0 N--CA 1.5 2.056 0 O-C-N 121.236 -0.915 . . . . 0.0 110.69 -179.295 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 144' ' ' PHE . . . . . . . . . . . . . 62.9 t80 -118.78 101.65 8.24 Favored 'General case' 0 N--CA 1.5 2.066 0 O-C-N 121.474 -0.766 . . . . 0.0 110.406 -179.405 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 145' ' ' LYS . . . . . 0.405 ' O ' ' N ' ' A' ' 75' ' ' TYR . 36.5 tttt -96.51 129.98 43.78 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.03 -1.044 . . . . 0.0 110.543 -179.554 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 146' ' ' VAL . . . . . 0.651 HG23 ' O ' ' A' ' 73' ' ' ALA . 2.6 p -146.16 141.84 21.37 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.574 0 N-CA-C 107.238 -1.393 . . . . 0.0 107.238 178.376 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 147' ' ' GLY . . . . . 0.42 ' C ' ' O ' ' A' ' 146' ' ' VAL . . . 47.85 -133.72 16.87 Favored Glycine 0 N--CA 1.487 2.077 0 N-CA-C 108.857 -1.697 . . . . 0.0 108.857 -179.391 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 148' ' ' ASN . . . . . 0.507 ' C ' ' ND2' ' A' ' 148' ' ' ASN . 0.5 OUTLIER -102.91 17.85 23.0 Favored 'General case' 0 C--N 1.302 -1.495 0 O-C-N 121.314 -1.109 . . . . 0.0 108.418 179.314 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 149' ' ' GLU . . . . . 0.525 ' CD ' ' N ' ' A' ' 150' ' ' THR . 11.5 tp10 -113.03 145.31 41.09 Favored 'General case' 0 N--CA 1.486 1.368 0 CA-C-O 121.714 0.768 . . . . 0.0 110.658 -178.447 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 150' ' ' THR . . . . . 0.525 ' N ' ' CD ' ' A' ' 149' ' ' GLU . 86.0 m -129.72 104.79 7.62 Favored 'General case' 0 N--CA 1.492 1.647 0 CA-C-O 121.487 0.66 . . . . 0.0 109.526 179.815 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 151' ' ' ARG . . . . . . . . . . . . . 84.3 mtt180 -85.92 -168.97 2.43 Favored 'General case' 0 N--CA 1.486 1.363 0 N-CA-C 108.646 -0.872 . . . . 0.0 108.646 -179.759 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 152' ' ' LYS . . . . . 0.589 ' N ' ' OXT' ' A' ' 206' ' ' LYS . 21.7 mtpt -149.9 148.47 29.16 Favored 'General case' 0 C--N 1.3 -1.563 0 O-C-N 120.999 -1.063 . . . . 0.0 110.317 -178.855 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 153' ' ' TYR . . . . . 0.446 ' CD1' ' C ' ' A' ' 152' ' ' LYS . 51.7 m-85 -146.94 151.48 37.08 Favored 'General case' 0 C--N 1.302 -1.475 0 N-CA-C 108.401 -0.963 . . . . 0.0 108.401 178.718 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 154' ' ' LYS . . . . . . . . . . . . . 10.8 ttmt -133.05 117.05 17.11 Favored 'General case' 0 C--N 1.298 -1.648 0 N-CA-C 108.711 -0.848 . . . . 0.0 108.711 179.291 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 155' ' ' MET . . . . . 0.557 ' SD ' ' OG ' ' A' ' 140' ' ' SER . 6.5 mtt -41.66 107.71 0.08 Allowed 'General case' 0 N--CA 1.489 1.483 0 CA-C-O 122.75 1.262 . . . . 0.0 111.858 -178.126 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 156' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -106.07 -26.19 11.73 Favored 'General case' 0 C--N 1.293 -1.865 0 CA-C-N 114.537 -1.211 . . . . 0.0 110.03 -178.842 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 157' ' ' SER . . . . . 0.488 ' O ' ' N ' ' A' ' 201' ' ' VAL . 19.8 t -154.27 150.77 28.37 Favored 'General case' 0 N--CA 1.494 1.748 0 C-N-CA 118.713 -1.195 . . . . 0.0 111.394 -178.678 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 158' ' ' ILE . . . . . 0.444 HG13 ' CD2' ' A' ' 200' ' ' PHE . 0.0 OUTLIER -155.25 146.9 12.98 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.486 0 CA-C-O 121.767 0.794 . . . . 0.0 110.252 -179.884 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 159' ' ' ARG . . . . . 0.599 ' CG ' HH11 ' A' ' 159' ' ' ARG . 0.0 OUTLIER -151.32 -167.46 2.81 Favored 'General case' 0 N--CA 1.491 1.603 0 CA-C-O 121.785 0.802 . . . . 0.0 110.551 -179.147 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 160' ' ' ASP . . . . . . . . . . . . . 5.5 m-20 -145.11 152.91 40.8 Favored 'General case' 0 N--CA 1.491 1.599 0 N-CA-C 108.585 -0.894 . . . . 0.0 108.585 -179.429 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 161' ' ' VAL . . . . . 0.653 HG21 HG22 ' A' ' 168' ' ' VAL . 0.1 OUTLIER -153.04 150.83 12.38 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.873 0 O-C-N 120.713 -1.242 . . . . 0.0 111.21 -178.834 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 162' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -49.07 171.3 0.11 Allowed Pre-proline 0 N--CA 1.496 1.866 0 O-C-N 121.652 -0.655 . . . . 0.0 109.961 179.418 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 163' ' ' PRO . . . . . . . . . . . . . 74.2 Cg_endo -81.07 29.37 0.53 Allowed 'Trans proline' 0 N--CA 1.492 1.428 0 C-N-CA 122.792 2.328 . . . . 0.0 113.008 179.83 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 164' ' ' THR . . . . . 0.506 ' O ' HG22 ' A' ' 164' ' ' THR . 55.3 m -151.16 -6.01 0.27 Allowed 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.005 -1.059 . . . . 0.0 110.356 -179.949 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 165' ' ' ASP . . . . . 0.86 ' O ' HG23 ' A' ' 168' ' ' VAL . 12.0 t0 -75.8 63.62 1.68 Allowed 'General case' 0 N--CA 1.487 1.411 0 O-C-N 120.994 -1.066 . . . . 0.0 109.292 179.549 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 166' ' ' VAL . . . . . 0.538 ' O ' ' N ' ' A' ' 168' ' ' VAL . 1.0 OUTLIER -39.54 -31.96 0.17 Allowed 'Isoleucine or valine' 0 N--CA 1.488 1.433 0 O-C-N 121.473 -0.767 . . . . 0.0 109.152 -178.647 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 167' ' ' GLY . . . . . 0.442 ' N ' ' O ' ' A' ' 165' ' ' ASP . . . -45.52 -13.52 0.05 OUTLIER Glycine 0 N--CA 1.494 2.545 0 N-CA-C 110.541 -1.024 . . . . 0.0 110.541 179.929 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 168' ' ' VAL . . . . . 0.86 HG23 ' O ' ' A' ' 165' ' ' ASP . 16.7 t -52.74 -35.39 21.28 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.607 0 O-C-N 120.818 -1.401 . . . . 0.0 108.115 179.531 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 169' ' ' LEU . . . . . 0.54 ' O ' ' C ' ' A' ' 170' ' ' ASP . 84.3 mt -46.23 -14.05 0.02 OUTLIER 'General case' 0 C--N 1.3 -1.569 0 N-CA-C 108.26 -1.015 . . . . 0.0 108.26 -178.268 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 170' ' ' ASP . . . . . 0.6 ' O ' ' ND2' ' A' ' 114' ' ' ASN . 39.1 t0 19.78 54.36 0.01 OUTLIER 'General case' 0 N--CA 1.501 2.079 0 N-CA-C 111.874 0.324 . . . . 0.0 111.874 177.699 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 171' ' ' GLU . . . . . 0.435 ' N ' ' O ' ' A' ' 169' ' ' LEU . 4.9 pt-20 -100.87 75.6 1.71 Allowed 'General case' 0 N--CA 1.497 1.878 0 O-C-N 120.777 -1.202 . . . . 0.0 110.554 -179.597 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 172' ' ' GLN . . . . . . . . . . . . . 4.3 pt20 -139.69 -39.25 0.46 Allowed 'General case' 0 N--CA 1.492 1.665 0 O-C-N 121.568 -0.708 . . . . 0.0 109.266 -179.843 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 173' ' ' LYS . . . . . . . . . . . . . 9.2 mtpp -63.82 131.05 46.6 Favored 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.06 -1.025 . . . . 0.0 108.743 178.818 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 174' ' ' GLY . . . . . 0.559 ' O ' ' C ' ' A' ' 175' ' ' LYS . . . -137.5 -38.94 0.13 Allowed Glycine 0 C--N 1.294 -1.761 0 N-CA-C 108.514 -1.834 . . . . 0.0 108.514 179.763 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 175' ' ' LYS . . . . . 0.559 ' C ' ' O ' ' A' ' 174' ' ' GLY . 3.4 tptp -33.41 -62.97 0.26 Allowed 'General case' 0 N--CA 1.493 1.717 0 N-CA-C 108.529 -0.915 . . . . 0.0 108.529 179.676 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 176' ' ' ASP . . . . . 0.715 ' O ' ' O ' ' A' ' 177' ' ' LYS . 0.9 OUTLIER -103.6 76.1 1.37 Allowed 'General case' 0 C--N 1.297 -1.697 0 N-CA-C 107.796 -1.187 . . . . 0.0 107.796 177.775 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 177' ' ' LYS . . . . . 0.715 ' O ' ' O ' ' A' ' 176' ' ' ASP . 17.6 mtmt -19.16 158.63 0.0 OUTLIER 'General case' 0 N--CA 1.508 2.458 0 CA-C-O 122.145 0.974 . . . . 0.0 112.719 -178.985 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 178' ' ' GLN . . . . . 0.674 ' NE2' ' ND2' ' A' ' 114' ' ' ASN . 18.0 pt20 -156.08 159.23 38.91 Favored 'General case' 0 N--CA 1.491 1.593 0 C-N-CA 117.061 -1.856 . . . . 0.0 112.483 179.863 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 179' ' ' LEU . . . . . 0.459 HD21 ' CD1' ' A' ' 117' ' ' ILE . 0.8 OUTLIER -121.58 102.88 8.51 Favored 'General case' 0 N--CA 1.486 1.349 0 N-CA-C 107.072 -1.455 . . . . 0.0 107.072 178.418 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 180' ' ' THR . . . . . 0.45 ' OG1' HG22 ' A' ' 201' ' ' VAL . 1.0 OUTLIER -79.92 123.9 28.2 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.148 -0.97 . . . . 0.0 110.438 -178.454 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 181' ' ' LEU . . . . . . . . . . . . . 7.5 tp -99.8 110.9 23.25 Favored 'General case' 0 N--CA 1.492 1.661 0 N-CA-C 108.711 -0.848 . . . . 0.0 108.711 178.386 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 182' ' ' ILE . . . . . 0.405 ' O ' ' HA ' ' A' ' 118' ' ' ALA . 18.1 mt -98.94 120.23 47.98 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.549 0 O-C-N 120.85 -1.156 . . . . 0.0 109.768 179.432 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 183' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -135.44 109.06 7.97 Favored 'General case' 0 C--N 1.296 -1.718 0 N-CA-C 107.279 -1.378 . . . . 0.0 107.279 178.548 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 184' ' ' CYS . . . . . 0.408 ' HB3' HH12 ' A' ' 197' ' ' ARG . 0.7 OUTLIER -79.83 156.68 27.28 Favored 'General case' 0 N--CA 1.498 1.933 0 C-N-CA 118.935 -1.106 . . . . 0.0 111.341 -177.306 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 185' ' ' ASP . . . . . 0.613 ' CG ' ' H ' ' A' ' 186' ' ' ASP . 28.9 t0 -166.53 -161.92 0.49 Allowed 'General case' 0 N--CA 1.489 1.523 0 N-CA-C 108.659 -0.867 . . . . 0.0 108.659 -179.943 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 186' ' ' ASP . . . . . 0.613 ' H ' ' CG ' ' A' ' 185' ' ' ASP . 0.6 OUTLIER 58.49 49.12 11.08 Favored 'General case' 0 N--CA 1.497 1.916 0 O-C-N 121.026 -1.046 . . . . 0.0 109.457 -179.656 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 187' ' ' TYR . . . . . 0.587 ' CE1' ' O ' ' A' ' 188' ' ' ASN . 30.1 t80 -67.16 133.09 49.11 Favored 'General case' 0 C--N 1.3 -1.562 0 CA-C-O 121.843 0.83 . . . . 0.0 110.469 -179.858 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 188' ' ' ASN . . . . . 0.86 ' ND2' ' H ' ' A' ' 193' ' ' VAL . 0.1 OUTLIER -102.56 150.66 23.18 Favored 'General case' 0 C--N 1.292 -1.894 0 N-CA-C 107.572 -1.27 . . . . 0.0 107.572 178.033 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 189' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -113.24 -3.08 13.92 Favored 'General case' 0 C--N 1.292 -1.934 0 N-CA-C 108.178 -1.045 . . . . 0.0 108.178 -179.61 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 190' ' ' LYS . . . . . 0.566 ' N ' ' OD1' ' A' ' 188' ' ' ASN . 2.6 mtpm? -83.66 -60.21 2.19 Favored 'General case' 0 N--CA 1.489 1.49 0 N-CA-C 108.714 -0.847 . . . . 0.0 108.714 178.558 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 191' ' ' THR . . . . . 0.623 ' OG1' ' ND2' ' A' ' 188' ' ' ASN . 1.1 p -89.34 4.15 49.86 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.41 -0.806 . . . . 0.0 109.245 179.896 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 192' ' ' GLY . . . . . . . . . . . . . . . 56.73 38.01 80.27 Favored Glycine 0 N--CA 1.494 2.53 0 N-CA-C 110.05 -1.22 . . . . 0.0 110.05 179.4 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 193' ' ' VAL . . . . . 0.86 ' H ' ' ND2' ' A' ' 188' ' ' ASN . 46.0 t -148.35 161.02 6.5 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.493 0 O-C-N 121.162 -1.199 . . . . 0.0 110.042 -179.975 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 194' ' ' TRP . . . . . 0.537 ' N ' HG12 ' A' ' 193' ' ' VAL . 11.1 m95 -83.4 120.62 26.11 Favored 'General case' 0 C--N 1.298 -1.656 0 N-CA-C 108.564 -0.902 . . . . 0.0 108.564 179.55 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 195' ' ' GLU . . . . . . . . . . . . . 1.4 mt-10 -79.53 -60.09 2.5 Favored 'General case' 0 N--CA 1.493 1.709 0 O-C-N 121.309 -0.869 . . . . 0.0 111.013 -178.888 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 196' ' ' LYS . . . . . . . . . . . . . 19.0 mttp -95.04 146.37 24.32 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.285 -0.884 . . . . 0.0 110.31 -178.759 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 197' ' ' ARG . . . . . 0.657 ' CG ' HH11 ' A' ' 197' ' ' ARG . 0.0 OUTLIER -118.81 145.42 45.65 Favored 'General case' 0 N--CA 1.492 1.635 0 N-CA-C 108.564 -0.902 . . . . 0.0 108.564 179.035 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 198' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER -116.95 120.75 39.4 Favored 'General case' 0 N--CA 1.492 1.666 0 O-C-N 121.672 -0.643 . . . . 0.0 110.358 -178.704 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 199' ' ' ILE . . . . . 0.514 HG21 HG11 ' A' ' 168' ' ' VAL . 0.8 OUTLIER -141.67 121.46 11.17 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.527 0 CA-C-O 122.672 1.225 . . . . 0.0 110.551 179.554 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 200' ' ' PHE . . . . . 0.53 ' CD1' ' N ' ' A' ' 200' ' ' PHE . 3.3 m-85 -99.52 134.64 42.1 Favored 'General case' 0 N--CA 1.497 1.915 0 O-C-N 121.163 -0.961 . . . . 0.0 110.125 -177.653 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 201' ' ' VAL . . . . . 0.488 ' N ' ' O ' ' A' ' 157' ' ' SER . 3.4 t -103.95 145.38 12.9 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.456 0 N-CA-C 107.646 -1.242 . . . . 0.0 107.646 176.805 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 202' ' ' ALA . . . . . . . . . . . . . . . -135.01 142.31 46.39 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.042 -1.036 . . . . 0.0 109.465 -179.753 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 203' ' ' THR . . . . . . . . . . . . . 2.2 p -90.11 127.55 36.11 Favored 'General case' 0 C--N 1.306 -1.322 0 CA-C-O 122.694 1.235 . . . . 0.0 111.693 -178.353 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 204' ' ' GLU . . . . . . . . . . . . . 2.7 tm-20 -53.99 135.84 42.21 Favored 'General case' 0 C--N 1.291 -1.976 0 CA-C-N 114.364 -1.289 . . . . 0.0 108.286 178.594 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 205' ' ' VAL . . . . . . . . . . . . . 62.6 t -121.55 -50.14 3.02 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.898 0 O-C-N 121.177 -0.952 . . . . 0.0 109.436 -179.13 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 206' ' ' LYS . . . . . 0.589 ' OXT' ' N ' ' A' ' 152' ' ' LYS . 4.4 mmtp . . . . . 0 C--N 1.302 -1.469 0 CA-C-O 118.114 -0.946 . . . . 0.0 109.667 179.151 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' C' C ' 702' ' ' LEU . . . . . 0.827 ' N ' HD12 ' C' ' 702' ' ' LEU . 0.0 OUTLIER . . . . . 0 N--CA 1.491 1.598 0 N-CA-C 108.316 -0.994 . . . . 0.0 108.316 . . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' C' C ' 703' ' ' PRO . . . . . 0.586 ' O ' ' NH2' ' A' ' 197' ' ' ARG . 64.8 Cg_endo -80.85 164.11 20.5 Favored 'Trans proline' 0 C--N 1.308 -1.584 0 C-N-CA 122.381 2.054 . . . . 0.0 113.119 -179.123 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' C' C ' 704' ' ' ALA . . . . . 0.462 ' O ' ' O ' ' C' ' 703' ' ' PRO . . . . . . . . 0 N--CA 1.488 1.462 0 O-C-N 121.345 -0.847 . . . . 0.0 110.033 179.441 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 63' ' ' PRO . . . . . . . . . . . . . 75.7 Cg_endo . . . . . 0 N--CA 1.487 1.098 0 CA-C-O 121.054 0.356 . . . . 0.0 111.488 . . . . . . . . . 0 0 . 1 . 017 nuclear nobuild core ' A' A ' 64' ' ' GLN . . . . . 0.635 HE21 ' C ' ' A' ' 64' ' ' GLN . 0.0 OUTLIER -156.31 117.53 3.83 Favored 'General case' 0 N--CA 1.496 1.87 0 O-C-N 121.118 -0.989 . . . . 0.0 109.39 179.664 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 65' ' ' ILE . . . . . 0.45 HD12 ' H ' ' A' ' 65' ' ' ILE . 3.2 mp -43.86 104.39 0.37 Allowed Pre-proline 0 N--CA 1.494 1.767 0 O-C-N 120.972 -1.08 . . . . 0.0 109.119 179.48 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 66' ' ' PRO . . . . . . . . . . . . . 83.8 Cg_endo -87.34 -158.81 0.09 OUTLIER 'Trans proline' 0 C--N 1.315 -1.23 0 C-N-CA 122.287 1.991 . . . . 0.0 112.651 -179.476 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 67' ' ' LYS . . . . . 0.467 ' CG ' ' O ' ' A' ' 67' ' ' LYS . 19.5 tttm -77.86 -6.87 55.65 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.306 -0.871 . . . . 0.0 108.7 179.516 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 68' ' ' ASP . . . . . 0.589 ' O ' ' N ' ' A' ' 70' ' ' SER . 3.6 t0 -76.5 48.04 0.52 Allowed 'General case' 0 N--CA 1.489 1.488 0 CA-C-O 122.237 1.018 . . . . 0.0 109.05 179.477 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 69' ' ' LYS . . . . . 0.456 ' C ' ' O ' ' A' ' 68' ' ' ASP . 9.5 ptpt -49.11 -14.57 0.08 Allowed 'General case' 0 N--CA 1.503 2.186 0 C-N-CA 116.845 -1.942 . . . . 0.0 106.863 178.234 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 70' ' ' SER . . . . . 0.589 ' N ' ' O ' ' A' ' 68' ' ' ASP . 1.8 t -82.85 -8.49 59.57 Favored 'General case' 0 N--CA 1.494 1.764 0 CA-C-N 113.629 -1.623 . . . . 0.0 110.15 179.958 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 71' ' ' LYS . . . . . 0.408 ' CD ' ' HB3' ' A' ' 68' ' ' ASP . 0.0 OUTLIER -97.54 145.93 25.76 Favored 'General case' 0 N--CA 1.492 1.665 0 O-C-N 120.981 -1.074 . . . . 0.0 109.929 179.109 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 72' ' ' VAL . . . . . 0.703 HG12 ' CE1' ' A' ' 88' ' ' TYR . 1.1 m -65.24 140.06 20.33 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.58 0 N-CA-C 105.046 -2.205 . . . . 0.0 105.046 174.853 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 73' ' ' ALA . . . . . 0.636 ' O ' HG23 ' A' ' 146' ' ' VAL . . . -80.64 -18.61 47.54 Favored 'General case' 0 C--N 1.291 -1.935 0 O-C-N 120.022 -1.674 . . . . 0.0 106.645 179.764 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 74' ' ' GLY . . . . . 0.453 ' O ' ' N ' ' A' ' 87' ' ' VAL . . . 176.16 -159.05 26.08 Favored Glycine 0 N--CA 1.483 1.796 0 N-CA-C 109.721 -1.352 . . . . 0.0 109.721 179.323 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 75' ' ' TYR . . . . . 0.551 ' HA ' HG23 ' A' ' 87' ' ' VAL . 92.1 m-85 -140.77 166.66 24.16 Favored 'General case' 0 C--N 1.299 -1.619 0 O-C-N 121.62 -0.929 . . . . 0.0 110.63 -177.268 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 76' ' ' ILE . . . . . . . . . . . . . 1.7 tt -147.71 143.39 19.64 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.551 0 C-N-CA 118.98 -1.088 . . . . 0.0 109.959 -178.189 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 77' ' ' GLU . . . . . 0.56 ' N ' ' CD ' ' A' ' 77' ' ' GLU . 2.3 mp0 -147.31 164.35 33.52 Favored 'General case' 0 N--CA 1.487 1.424 0 O-C-N 121.116 -0.99 . . . . 0.0 108.823 -179.831 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 78' ' ' ILE . . . . . 0.608 ' HB ' ' HB3' ' A' ' 81' ' ' ALA . 5.1 mt -147.5 93.39 4.62 Favored Pre-proline 0 N--CA 1.49 1.552 0 N-CA-C 108.181 -1.044 . . . . 0.0 108.181 179.674 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 79' ' ' PRO . . . . . . . . . . . . . 80.7 Cg_exo -46.87 -48.49 14.18 Favored 'Trans proline' 0 N--CA 1.494 1.527 0 C-N-CA 122.995 2.464 . . . . 0.0 114.098 -178.428 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -64.8 -18.98 65.58 Favored 'General case' 0 N--CA 1.494 1.73 0 O-C-N 120.868 -1.145 . . . . 0.0 110.749 178.968 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 81' ' ' ALA . . . . . 0.786 ' HB2' ' HB2' ' A' ' 136' ' ' ALA . . . -105.5 -17.49 14.4 Favored 'General case' 0 N--CA 1.492 1.663 0 O-C-N 121.176 -0.953 . . . . 0.0 108.488 179.207 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 82' ' ' ASP . . . . . 0.438 ' N ' ' O ' ' A' ' 78' ' ' ILE . 0.7 OUTLIER 67.93 51.12 0.78 Allowed 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.528 -0.732 . . . . 0.0 110.453 179.022 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 83' ' ' ILE . . . . . . . . . . . . . 70.8 mt -128.75 151.57 35.72 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.756 0 O-C-N 121.343 -0.848 . . . . 0.0 110.074 -178.768 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 84' ' ' LYS . . . . . 0.45 ' CG ' ' O ' ' A' ' 84' ' ' LYS . 7.7 pttt -158.37 107.86 2.03 Favored 'General case' 0 N--CA 1.494 1.757 0 N-CA-C 108.345 -0.984 . . . . 0.0 108.345 -179.923 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -142.34 166.12 23.1 Favored Pre-proline 0 N--CA 1.496 1.833 0 O-C-N 121.234 -0.916 . . . . 0.0 110.759 -179.064 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 86' ' ' PRO . . . . . . . . . . . . . 73.8 Cg_endo -77.35 166.35 26.25 Favored 'Trans proline' 0 N--CA 1.498 1.761 0 C-N-CA 123.333 2.689 . . . . 0.0 113.652 -179.225 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 87' ' ' VAL . . . . . 0.551 HG23 ' HA ' ' A' ' 75' ' ' TYR . 39.9 t -122.83 100.95 8.82 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.651 0 O-C-N 121.735 -0.603 . . . . 0.0 109.422 179.953 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 88' ' ' TYR . . . . . 0.703 ' CE1' HG12 ' A' ' 72' ' ' VAL . 7.5 m-85 -89.73 173.61 5.69 Favored Pre-proline 0 N--CA 1.499 2.005 0 O-C-N 120.946 -1.096 . . . . 0.0 109.468 -179.684 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 89' ' ' PRO . . . . . 0.434 ' HA ' ' CD2' ' A' ' 103' ' ' PHE . 9.4 Cg_endo -83.84 145.61 11.44 Favored 'Trans proline' 0 N--CA 1.484 0.96 0 C-N-CA 122.064 1.843 . . . . 0.0 113.898 -177.982 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . -55.97 164.41 4.8 Favored Glycine 0 N--CA 1.487 2.069 0 N-CA-C 109.081 -1.608 . . . . 0.0 109.081 179.133 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 91' ' ' PRO . . . . . 0.453 ' C ' ' H ' ' A' ' 93' ' ' THR . 58.0 Cg_endo -91.5 167.27 27.37 Favored 'Cis proline' 0 C--N 1.305 -1.747 0 C-N-CA 123.408 -1.497 . . . . 0.0 112.401 0.69 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 92' ' ' ALA . . . . . 0.551 ' HB3' ' HB2' ' C' ' 703' ' ' PRO . . . -73.21 30.52 0.07 Allowed 'General case' 0 C--N 1.303 -1.449 0 C-N-CA 119.887 -0.725 . . . . 0.0 110.091 -179.944 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 93' ' ' THR . . . . . 0.453 ' H ' ' C ' ' A' ' 91' ' ' PRO . 6.5 p -71.5 150.6 93.82 Favored Pre-proline 0 N--CA 1.489 1.493 0 O-C-N 121.034 -1.041 . . . . 0.0 108.847 -179.289 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 94' ' ' PRO . . . . . . . . . . . . . 77.8 Cg_exo -33.35 -49.03 0.45 Allowed 'Trans proline' 0 C--N 1.308 -1.562 0 C-N-CA 122.898 2.398 . . . . 0.0 112.385 -178.9 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 95' ' ' GLU . . . . . 0.596 ' O ' ' ND2' ' A' ' 98' ' ' ASN . 5.4 mp0 -49.83 -51.36 40.5 Favored 'General case' 0 C--N 1.3 -1.551 0 O-C-N 121.317 -0.865 . . . . 0.0 109.773 -179.838 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 96' ' ' GLN . . . . . 0.566 ' O ' ' N ' ' A' ' 98' ' ' ASN . 3.3 mp0 -72.32 -50.76 24.45 Favored 'General case' 0 N--CA 1.489 1.493 0 O-C-N 120.99 -1.069 . . . . 0.0 109.954 179.908 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 97' ' ' LEU . . . . . 0.627 ' CD2' ' CE1' ' A' ' 120' ' ' HIS . 1.3 mp -48.5 -8.75 0.02 OUTLIER 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.135 -0.978 . . . . 0.0 109.737 -179.786 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 98' ' ' ASN . . . . . 0.596 ' ND2' ' O ' ' A' ' 95' ' ' GLU . 0.4 OUTLIER -72.66 -28.01 62.46 Favored 'General case' 0 N--CA 1.489 1.479 0 O-C-N 121.379 -0.826 . . . . 0.0 109.346 179.868 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 99' ' ' ARG . . . . . 0.646 ' CG ' HH11 ' A' ' 99' ' ' ARG . 0.2 OUTLIER -96.17 -57.61 2.29 Favored 'General case' 0 N--CA 1.488 1.428 0 C-N-CA 119.79 -0.764 . . . . 0.0 110.186 -179.526 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . -170.2 -162.8 23.15 Favored Glycine 0 N--CA 1.493 2.468 0 C-N-CA 119.383 -1.389 . . . . 0.0 110.531 -179.934 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 101' ' ' VAL . . . . . 0.75 HG11 ' CZ ' ' A' ' 130' ' ' PHE . 13.7 m -64.58 106.27 0.57 Allowed 'Isoleucine or valine' 0 N--CA 1.496 1.845 0 O-C-N 121.698 -0.883 . . . . 0.0 109.351 -179.61 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -92.57 161.44 14.59 Favored 'General case' 0 N--CA 1.494 1.731 0 O-C-N 121.23 -0.919 . . . . 0.0 110.679 -179.55 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 103' ' ' PHE . . . . . 0.434 ' CD2' ' HA ' ' A' ' 89' ' ' PRO . 23.8 m-85 -63.6 150.42 44.14 Favored 'General case' 0 N--CA 1.489 1.48 0 N-CA-C 107.724 -1.213 . . . . 0.0 107.724 178.11 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 104' ' ' ALA . . . . . . . . . . . . . . . -69.71 -13.08 62.11 Favored 'General case' 0 N--CA 1.492 1.652 0 O-C-N 120.998 -1.064 . . . . 0.0 111.309 -178.504 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -136.3 142.01 43.87 Favored 'General case' 0 N--CA 1.498 1.97 0 O-C-N 120.841 -1.162 . . . . 0.0 110.803 -179.307 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 106' ' ' GLU . . . . . . . . . . . . . 2.3 tm-20 -51.89 -61.64 2.13 Favored 'General case' 0 N--CA 1.489 1.495 0 O-C-N 121.883 -0.511 . . . . 0.0 110.675 -179.556 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 107' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER -76.63 34.49 0.14 Allowed 'General case' 0 N--CA 1.489 1.52 0 O-C-N 120.698 -1.251 . . . . 0.0 112.251 -175.832 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 108' ' ' GLU . . . . . 0.488 ' OE2' HD13 ' A' ' 115' ' ' ILE . 29.6 tp10 -55.22 146.74 18.12 Favored 'General case' 0 C--N 1.303 -1.422 0 O-C-N 120.585 -1.322 . . . . 0.0 107.624 179.681 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 109' ' ' SER . . . . . 0.752 ' O ' HD11 ' A' ' 115' ' ' ILE . 0.3 OUTLIER -103.59 143.49 32.68 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 120.941 -1.099 . . . . 0.0 110.901 -178.038 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 110' ' ' LEU . . . . . 0.645 HD11 HG21 ' A' ' 146' ' ' VAL . 0.2 OUTLIER -64.47 -16.47 62.53 Favored 'General case' 0 C--N 1.303 -1.447 0 N-CA-C 108.884 -0.784 . . . . 0.0 108.884 179.217 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 111' ' ' ASP . . . . . . . . . . . . . 74.0 m-20 -132.97 35.99 3.51 Favored 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.248 -0.907 . . . . 0.0 110.298 -179.539 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 112' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -66.52 153.36 43.15 Favored 'General case' 0 N--CA 1.493 1.7 0 O-C-N 120.825 -1.172 . . . . 0.0 111.203 -179.673 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 113' ' ' GLN . . . . . 0.561 ' NE2' ' O ' ' A' ' 173' ' ' LYS . 0.0 OUTLIER -67.77 -13.78 62.41 Favored 'General case' 0 N--CA 1.494 1.755 0 CA-C-O 121.949 0.88 . . . . 0.0 109.537 178.677 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 114' ' ' ASN . . . . . 0.615 ' ND2' ' O ' ' A' ' 114' ' ' ASN . 0.3 OUTLIER -150.33 106.71 3.48 Favored 'General case' 0 C--N 1.298 -1.669 0 N-CA-C 107.205 -1.405 . . . . 0.0 107.205 179.477 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 115' ' ' ILE . . . . . 0.752 HD11 ' O ' ' A' ' 109' ' ' SER . 1.5 mm -94.23 104.52 15.86 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.737 0 O-C-N 120.534 -1.354 . . . . 0.0 108.823 -179.459 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 116' ' ' SER . . . . . . . . . . . . . 42.8 m -82.55 153.12 25.68 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.291 -0.881 . . . . 0.0 110.986 -178.182 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 117' ' ' ILE . . . . . 0.453 HG22 ' HB ' ' A' ' 101' ' ' VAL . 7.9 mt -151.13 147.12 15.8 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.437 0 N-CA-C 108.207 -1.034 . . . . 0.0 108.207 179.736 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 118' ' ' ALA . . . . . . . . . . . . . . . -144.89 160.97 40.45 Favored 'General case' 0 N--CA 1.491 1.582 0 C-N-CA 118.742 -1.183 . . . . 0.0 111.435 -179.948 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 119' ' ' GLY . . . . . . . . . . . . . . . -167.95 151.0 17.71 Favored Glycine 0 N--CA 1.485 1.939 0 N-CA-C 109.65 -1.38 . . . . 0.0 109.65 179.718 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 120' ' ' HIS . . . . . 0.627 ' CE1' ' CD2' ' A' ' 97' ' ' LEU . 3.9 m-70 -70.91 167.73 18.41 Favored 'General case' 0 N--CA 1.493 1.699 0 O-C-N 121.639 -0.918 . . . . 0.0 109.972 179.689 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 121' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -121.39 157.95 29.37 Favored 'General case' 0 N--CA 1.496 1.842 0 N-CA-C 108.363 -0.977 . . . . 0.0 108.363 178.954 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 122' ' ' PHE . . . . . 0.73 ' O ' HG21 ' A' ' 131' ' ' THR . 0.1 OUTLIER -140.66 121.97 14.92 Favored 'General case' 0 N--CA 1.498 1.934 0 O-C-N 120.927 -1.108 . . . . 0.0 110.31 -179.234 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 123' ' ' ILE . . . . . 0.502 HG23 ' N ' ' A' ' 124' ' ' ASP . 8.6 tt -59.44 -38.54 75.61 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.485 0 O-C-N 121.556 -0.715 . . . . 0.0 110.096 -179.884 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 124' ' ' ASP . . . . . 0.502 ' N ' HG23 ' A' ' 123' ' ' ILE . 0.1 OUTLIER -90.97 18.29 6.85 Favored 'General case' 0 N--CA 1.496 1.858 0 C-N-CA 119.659 -0.816 . . . . 0.0 111.988 -177.718 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 125' ' ' ARG . . . . . 0.443 HH11 ' CG ' ' A' ' 125' ' ' ARG . 0.3 OUTLIER -152.08 99.31 2.9 Favored Pre-proline 0 N--CA 1.493 1.706 0 O-C-N 120.521 -1.362 . . . . 0.0 109.719 -179.821 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 126' ' ' PRO . . . . . . . . . . . . . 58.4 Cg_endo -77.55 -19.03 13.31 Favored 'Trans proline' 0 N--CA 1.489 1.236 0 C-N-CA 122.061 1.841 . . . . 0.0 112.143 179.697 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 127' ' ' ASN . . . . . 0.489 ' O ' ' O ' ' A' ' 128' ' ' TYR . 0.7 OUTLIER -91.29 2.59 56.27 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.301 -0.874 . . . . 0.0 109.948 -179.811 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 128' ' ' TYR . . . . . 0.679 ' CE2' ' NE2' ' A' ' 129' ' ' GLN . 2.5 t80 -57.82 -148.83 0.0 OUTLIER 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.182 -0.949 . . . . 0.0 110.025 -179.657 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 129' ' ' GLN . . . . . 0.679 ' NE2' ' CE2' ' A' ' 128' ' ' TYR . 0.5 OUTLIER -65.39 -71.24 0.19 Allowed 'General case' 0 N--CA 1.493 1.703 0 O-C-N 121.316 -0.865 . . . . 0.0 109.871 -179.387 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 130' ' ' PHE . . . . . 0.75 ' CZ ' HG11 ' A' ' 101' ' ' VAL . 28.8 m-85 -135.16 39.78 2.91 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.288 -0.883 . . . . 0.0 109.808 -179.633 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 131' ' ' THR . . . . . 0.73 HG21 ' O ' ' A' ' 122' ' ' PHE . 60.5 m -74.94 -32.88 61.86 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.246 -0.909 . . . . 0.0 109.354 179.858 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 132' ' ' ASN . . . . . 0.552 ' ND2' ' O ' ' A' ' 81' ' ' ALA . 22.1 t30 -92.83 14.12 18.32 Favored 'General case' 0 N--CA 1.498 1.972 0 C-N-CA 119.698 -0.801 . . . . 0.0 111.63 -178.889 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 133' ' ' LEU . . . . . 0.774 HD13 ' HB3' ' A' ' 136' ' ' ALA . 0.2 OUTLIER -68.5 -26.98 65.73 Favored 'General case' 0 N--CA 1.496 1.875 0 O-C-N 120.582 -1.324 . . . . 0.0 109.429 -179.92 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 134' ' ' LYS . . . . . 0.68 ' CD ' ' H ' ' A' ' 134' ' ' LYS . 0.0 OUTLIER -46.14 -28.71 1.29 Allowed 'General case' 0 N--CA 1.495 1.817 0 O-C-N 121.401 -0.812 . . . . 0.0 110.937 -179.176 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 135' ' ' ALA . . . . . . . . . . . . . . . -83.37 -22.61 32.74 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 120.758 -1.214 . . . . 0.0 109.954 -179.189 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 136' ' ' ALA . . . . . 0.786 ' HB2' ' HB2' ' A' ' 81' ' ' ALA . . . -79.79 138.02 37.14 Favored 'General case' 0 C--N 1.3 -1.559 0 O-C-N 121.29 -0.881 . . . . 0.0 111.405 -178.897 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 137' ' ' LYS . . . . . 0.554 ' O ' ' O ' ' A' ' 138' ' ' LYS . 6.3 mttt -151.46 -170.26 3.6 Favored 'General case' 0 N--CA 1.494 1.77 0 C-N-CA 118.639 -1.225 . . . . 0.0 111.221 -178.231 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 138' ' ' LYS . . . . . 0.554 ' O ' ' O ' ' A' ' 137' ' ' LYS . 15.4 tttt -32.55 163.96 0.0 OUTLIER 'General case' 0 N--CA 1.492 1.653 0 CA-C-O 122.902 1.334 . . . . 0.0 112.342 -178.204 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 139' ' ' GLY . . . . . . . . . . . . . . . 49.68 8.73 0.14 Allowed Glycine 0 N--CA 1.491 2.317 0 N-CA-C 110.146 -1.182 . . . . 0.0 110.146 179.78 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 140' ' ' SER . . . . . 0.491 ' N ' ' O ' ' A' ' 138' ' ' LYS . 2.0 m -69.33 130.01 41.39 Favored 'General case' 0 N--CA 1.495 1.812 0 O-C-N 120.803 -1.41 . . . . 0.0 109.194 179.539 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 141' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -83.78 123.17 29.6 Favored 'General case' 0 N--CA 1.489 1.498 0 O-C-N 121.224 -0.923 . . . . 0.0 109.214 179.743 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 142' ' ' VAL . . . . . . . . . . . . . 2.4 t -112.99 132.12 62.7 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.576 0 N-CA-C 108.069 -1.086 . . . . 0.0 108.069 179.75 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 143' ' ' TYR . . . . . . . . . . . . . 5.3 m-85 -108.65 134.24 51.65 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.025 -1.047 . . . . 0.0 110.897 -178.42 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 144' ' ' PHE . . . . . . . . . . . . . 44.8 t80 -120.13 102.62 8.64 Favored 'General case' 0 N--CA 1.489 1.524 0 N-CA-C 109.056 -0.72 . . . . 0.0 109.056 179.633 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 145' ' ' LYS . . . . . . . . . . . . . 25.2 tttm -100.21 129.99 46.29 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.319 -0.863 . . . . 0.0 110.868 -179.008 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 146' ' ' VAL . . . . . 0.645 HG21 HD11 ' A' ' 110' ' ' LEU . 6.8 p -142.43 146.51 22.2 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.566 0 N-CA-C 107.805 -1.183 . . . . 0.0 107.805 178.415 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 147' ' ' GLY . . . . . 0.441 ' C ' ' O ' ' A' ' 146' ' ' VAL . . . 42.61 -124.08 3.84 Favored Glycine 0 N--CA 1.491 2.355 0 N-CA-C 109.336 -1.506 . . . . 0.0 109.336 -179.795 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 148' ' ' ASN . . . . . 0.513 ' C ' ' ND2' ' A' ' 148' ' ' ASN . 0.4 OUTLIER -108.36 15.62 23.84 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.483 -1.01 . . . . 0.0 109.041 179.393 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 149' ' ' GLU . . . . . . . . . . . . . 8.7 tt0 -112.28 144.02 42.4 Favored 'General case' 0 N--CA 1.489 1.479 0 O-C-N 121.388 -0.82 . . . . 0.0 111.444 -178.288 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 150' ' ' THR . . . . . . . . . . . . . 29.9 m -127.25 104.12 7.78 Favored 'General case' 0 N--CA 1.49 1.541 0 CA-C-O 121.373 0.606 . . . . 0.0 109.6 179.561 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 151' ' ' ARG . . . . . . . . . . . . . 15.4 mtp180 -88.17 -173.1 4.08 Favored 'General case' 0 C--N 1.301 -1.513 0 N-CA-C 107.748 -1.204 . . . . 0.0 107.748 179.357 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 152' ' ' LYS . . . . . 0.491 ' O ' ' N ' ' A' ' 205' ' ' VAL . 15.4 mtmm -149.15 150.74 33.17 Favored 'General case' 0 C--N 1.298 -1.67 0 O-C-N 120.811 -1.181 . . . . 0.0 109.728 -179.678 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 153' ' ' TYR . . . . . 0.527 ' CD2' ' HA ' ' A' ' 204' ' ' GLU . 27.6 m-85 -142.97 164.47 29.99 Favored 'General case' 0 C--N 1.297 -1.697 0 N-CA-C 107.695 -1.224 . . . . 0.0 107.695 178.69 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 154' ' ' LYS . . . . . 0.525 ' HB2' HG21 ' A' ' 205' ' ' VAL . 26.2 ttpp -140.31 118.01 11.64 Favored 'General case' 0 C--N 1.296 -1.745 0 N-CA-C 108.308 -0.997 . . . . 0.0 108.308 179.499 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 155' ' ' MET . . . . . . . . . . . . . 36.8 mtp -44.95 109.09 0.14 Allowed 'General case' 0 N--CA 1.497 1.895 0 O-C-N 120.507 -1.371 . . . . 0.0 111.344 -178.307 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 156' ' ' THR . . . . . 0.677 ' OG1' HG23 ' A' ' 203' ' ' THR . 0.2 OUTLIER -107.59 -26.79 10.72 Favored 'General case' 0 C--N 1.298 -1.645 0 CA-C-N 115.452 -0.794 . . . . 0.0 110.893 -178.858 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 157' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -154.03 153.33 31.75 Favored 'General case' 0 N--CA 1.5 2.044 0 C-N-CA 118.171 -1.411 . . . . 0.0 111.903 -178.334 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 158' ' ' ILE . . . . . 0.867 HD12 ' CD1' ' A' ' 200' ' ' PHE . 0.2 OUTLIER -154.49 146.91 13.61 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.425 0 CA-C-O 122.068 0.937 . . . . 0.0 111.383 -178.946 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 159' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -153.35 158.48 41.6 Favored 'General case' 0 C--N 1.299 -1.612 0 CA-C-O 121.707 0.765 . . . . 0.0 109.86 179.834 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 160' ' ' ASP . . . . . 0.478 ' O ' HG13 ' A' ' 161' ' ' VAL . 7.9 m-20 -116.52 156.46 26.87 Favored 'General case' 0 N--CA 1.491 1.597 0 N-CA-C 108.081 -1.081 . . . . 0.0 108.081 179.254 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 161' ' ' VAL . . . . . 0.486 ' O ' ' O ' ' A' ' 162' ' ' LYS . 14.8 m -155.35 154.25 6.93 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.921 0 O-C-N 120.841 -1.162 . . . . 0.0 111.357 -178.507 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 162' ' ' LYS . . . . . 0.486 ' O ' ' O ' ' A' ' 161' ' ' VAL . 0.0 OUTLIER -43.25 170.46 0.04 OUTLIER Pre-proline 0 N--CA 1.495 1.799 0 O-C-N 121.555 -0.716 . . . . 0.0 109.986 179.651 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 163' ' ' PRO . . . . . . . . . . . . . 65.2 Cg_endo -79.56 30.9 0.47 Allowed 'Trans proline' 0 N--CA 1.492 1.408 0 C-N-CA 122.904 2.403 . . . . 0.0 113.071 179.82 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 164' ' ' THR . . . . . 0.586 ' HA ' HD11 ' C' ' 702' ' ' LEU . 0.2 OUTLIER -151.02 0.31 0.39 Allowed 'General case' 0 N--CA 1.495 1.789 0 O-C-N 121.064 -1.022 . . . . 0.0 110.11 -179.968 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 165' ' ' ASP . . . . . 0.438 ' O ' ' C ' ' A' ' 166' ' ' VAL . 13.0 t70 -75.46 63.9 1.53 Allowed 'General case' 0 N--CA 1.489 1.491 0 O-C-N 121.251 -0.906 . . . . 0.0 110.362 -179.749 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 166' ' ' VAL . . . . . 0.685 ' O ' ' N ' ' A' ' 168' ' ' VAL . 1.0 OUTLIER -39.73 -31.12 0.15 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.517 0 O-C-N 121.14 -0.975 . . . . 0.0 109.79 -178.668 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 167' ' ' GLY . . . . . 0.428 ' N ' ' O ' ' A' ' 165' ' ' ASP . . . -41.48 -12.01 0.01 OUTLIER Glycine 0 N--CA 1.496 2.652 0 N-CA-C 110.288 -1.125 . . . . 0.0 110.288 -179.94 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 168' ' ' VAL . . . . . 0.685 ' N ' ' O ' ' A' ' 166' ' ' VAL . 3.5 t -49.03 -42.52 14.56 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.432 0 O-C-N 121.121 -1.223 . . . . 0.0 108.841 179.235 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 169' ' ' LEU . . . . . 0.551 ' O ' ' C ' ' A' ' 170' ' ' ASP . 10.8 mt -46.84 -14.71 0.03 OUTLIER 'General case' 0 N--CA 1.491 1.601 0 N-CA-C 108.444 -0.947 . . . . 0.0 108.444 -178.274 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 170' ' ' ASP . . . . . 0.555 ' N ' ' O ' ' A' ' 168' ' ' VAL . 32.7 p30 17.78 91.26 0.01 OUTLIER 'General case' 0 N--CA 1.505 2.319 0 N-CA-C 111.927 0.343 . . . . 0.0 111.927 177.206 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 171' ' ' GLU . . . . . 0.701 ' H ' HE21 ' A' ' 172' ' ' GLN . 3.0 pt-20 -141.48 78.79 1.65 Allowed 'General case' 0 N--CA 1.494 1.733 0 O-C-N 120.732 -1.23 . . . . 0.0 110.272 179.965 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 172' ' ' GLN . . . . . 0.701 HE21 ' H ' ' A' ' 171' ' ' GLU . 32.3 mm-40 -130.13 -47.51 1.11 Allowed 'General case' 0 N--CA 1.499 2.002 0 O-C-N 121.282 -0.886 . . . . 0.0 110.967 -178.788 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 173' ' ' LYS . . . . . 0.561 ' O ' ' NE2' ' A' ' 113' ' ' GLN . 0.0 OUTLIER -60.48 137.85 58.1 Favored 'General case' 0 N--CA 1.498 1.967 0 O-C-N 120.894 -1.129 . . . . 0.0 109.064 -179.894 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 174' ' ' GLY . . . . . 0.533 ' O ' ' C ' ' A' ' 175' ' ' LYS . . . -122.93 -44.09 0.34 Allowed Glycine 0 N--CA 1.481 1.648 0 N-CA-C 108.093 -2.003 . . . . 0.0 108.093 179.547 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 175' ' ' LYS . . . . . 0.533 ' C ' ' O ' ' A' ' 174' ' ' GLY . 3.0 mmtt -40.48 -63.87 0.58 Allowed 'General case' 0 N--CA 1.491 1.59 0 N-CA-C 107.072 -1.455 . . . . 0.0 107.072 178.725 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 176' ' ' ASP . . . . . 0.589 ' O ' ' O ' ' A' ' 177' ' ' LYS . 1.2 p-10 -104.7 88.18 2.86 Favored 'General case' 0 C--N 1.299 -1.614 0 N-CA-C 108.207 -1.035 . . . . 0.0 108.207 177.428 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 177' ' ' LYS . . . . . 0.589 ' O ' ' O ' ' A' ' 176' ' ' ASP . 23.6 mttm -47.32 -174.19 0.0 OUTLIER 'General case' 0 N--CA 1.499 1.978 0 N-CA-C 108.793 -0.817 . . . . 0.0 108.793 179.936 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 178' ' ' GLN . . . . . 0.55 HE22 ' HG1' ' A' ' 180' ' ' THR . 0.0 OUTLIER -162.59 167.28 23.53 Favored 'General case' 0 C--N 1.303 -1.419 0 O-C-N 120.267 -1.521 . . . . 0.0 110.862 179.626 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 179' ' ' LEU . . . . . 0.419 ' HB2' ' CD2' ' A' ' 153' ' ' TYR . 0.9 OUTLIER -119.03 98.03 5.98 Favored 'General case' 0 C--N 1.304 -1.408 0 N-CA-C 107.028 -1.471 . . . . 0.0 107.028 177.976 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 180' ' ' THR . . . . . 0.55 ' HG1' HE22 ' A' ' 178' ' ' GLN . 1.3 m -76.98 116.13 17.38 Favored 'General case' 0 C--N 1.302 -1.488 0 O-C-N 121.411 -0.806 . . . . 0.0 110.205 -178.449 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 181' ' ' LEU . . . . . 0.525 HD23 ' CD2' ' A' ' 200' ' ' PHE . 54.4 tp -93.78 152.08 19.17 Favored 'General case' 0 C--N 1.301 -1.537 0 N-CA-C 107.774 -1.195 . . . . 0.0 107.774 177.715 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 182' ' ' ILE . . . . . . . . . . . . . 85.4 mt -141.07 117.88 7.81 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.713 0 O-C-N 121.009 -1.057 . . . . 0.0 108.687 179.247 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 183' ' ' THR . . . . . 0.604 HG23 ' O ' ' A' ' 183' ' ' THR . 10.1 t -131.12 111.44 11.98 Favored 'General case' 0 C--N 1.292 -1.908 0 N-CA-C 108.039 -1.097 . . . . 0.0 108.039 179.485 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 184' ' ' CYS . . . . . . . . . . . . . 0.8 OUTLIER -78.46 153.06 31.76 Favored 'General case' 0 C--N 1.289 -2.044 0 C-N-CA 118.882 -1.127 . . . . 0.0 110.583 -177.977 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 185' ' ' ASP . . . . . . . . . . . . . 2.5 t0 -166.1 -159.13 0.37 Allowed 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.616 -0.677 . . . . 0.0 109.504 -179.447 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 186' ' ' ASP . . . . . . . . . . . . . 1.2 m-20 55.79 52.78 10.28 Favored 'General case' 0 N--CA 1.493 1.717 0 O-C-N 121.233 -0.917 . . . . 0.0 109.453 179.977 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 187' ' ' TYR . . . . . 0.628 ' CE2' ' O ' ' A' ' 188' ' ' ASN . 64.5 t80 -67.96 134.18 50.32 Favored 'General case' 0 C--N 1.3 -1.551 0 O-C-N 121.063 -1.023 . . . . 0.0 110.949 -179.508 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 188' ' ' ASN . . . . . 0.628 ' O ' ' CE2' ' A' ' 187' ' ' TYR . 0.7 OUTLIER -101.46 146.46 27.59 Favored 'General case' 0 C--N 1.295 -1.766 0 N-CA-C 108.091 -1.077 . . . . 0.0 108.091 178.201 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 189' ' ' GLU . . . . . . . . . . . . . 3.1 tt0 -109.65 -12.17 14.68 Favored 'General case' 0 C--N 1.292 -1.923 0 N-CA-C 108.458 -0.942 . . . . 0.0 108.458 -179.793 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 190' ' ' LYS . . . . . . . . . . . . . 11.7 mtpt -85.75 -55.03 4.17 Favored 'General case' 0 C--N 1.302 -1.469 0 N-CA-C 109.079 -0.712 . . . . 0.0 109.079 178.908 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 191' ' ' THR . . . . . . . . . . . . . 1.2 p -89.55 1.59 55.74 Favored 'General case' 0 N--CA 1.494 1.729 0 O-C-N 121.236 -0.915 . . . . 0.0 110.073 -179.754 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 192' ' ' GLY . . . . . . . . . . . . . . . 52.78 40.89 57.27 Favored Glycine 0 N--CA 1.496 2.644 0 O-C-N 120.97 -1.081 . . . . 0.0 110.969 179.169 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 193' ' ' VAL . . . . . 0.537 HG12 ' N ' ' A' ' 194' ' ' TRP . 52.9 t -149.65 160.5 5.01 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.653 0 O-C-N 120.858 -1.377 . . . . 0.0 109.356 178.999 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 194' ' ' TRP . . . . . 0.537 ' N ' HG12 ' A' ' 193' ' ' VAL . 12.7 m95 -82.94 118.98 23.86 Favored 'General case' 0 N--CA 1.491 1.586 0 N-CA-C 107.989 -1.115 . . . . 0.0 107.989 179.308 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 195' ' ' GLU . . . . . . . . . . . . . 2.1 mt-10 -75.88 -60.46 2.31 Favored 'General case' 0 N--CA 1.494 1.769 0 O-C-N 121.336 -0.853 . . . . 0.0 111.538 -177.745 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 196' ' ' LYS . . . . . . . . . . . . . 16.8 mmtp -92.01 153.18 19.6 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 120.901 -1.124 . . . . 0.0 111.262 -178.047 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 197' ' ' ARG . . . . . 0.47 ' NE ' HD22 ' C' ' 702' ' ' LEU . 21.5 mmm180 -119.17 138.97 52.58 Favored 'General case' 0 N--CA 1.488 1.471 0 N-CA-C 107.825 -1.176 . . . . 0.0 107.825 178.659 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 198' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -116.77 116.68 27.95 Favored 'General case' 0 C--N 1.301 -1.519 0 O-C-N 121.61 -0.681 . . . . 0.0 110.192 -178.715 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 199' ' ' ILE . . . . . 0.632 ' C ' HD12 ' A' ' 199' ' ' ILE . 0.6 OUTLIER -141.18 122.26 13.4 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.685 0 CA-C-O 122.338 1.066 . . . . 0.0 109.842 179.456 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 200' ' ' PHE . . . . . 0.867 ' CD1' HD12 ' A' ' 158' ' ' ILE . 0.2 OUTLIER -106.33 142.1 36.56 Favored 'General case' 0 N--CA 1.494 1.769 0 O-C-N 121.438 -0.789 . . . . 0.0 110.318 -178.55 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 201' ' ' VAL . . . . . . . . . . . . . 47.6 t -104.45 150.11 7.66 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.532 0 N-CA-C 108.476 -0.935 . . . . 0.0 108.476 178.555 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 202' ' ' ALA . . . . . . . . . . . . . . . -131.37 139.38 49.47 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.246 -0.909 . . . . 0.0 109.035 -179.802 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 203' ' ' THR . . . . . 0.677 HG23 ' OG1' ' A' ' 156' ' ' THR . 25.1 p -88.86 127.46 35.63 Favored 'General case' 0 C--N 1.303 -1.452 0 CA-C-O 122.354 1.073 . . . . 0.0 110.917 -178.57 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 204' ' ' GLU . . . . . 0.527 ' HA ' ' CD2' ' A' ' 153' ' ' TYR . 1.7 tt0 -48.75 134.35 16.34 Favored 'General case' 0 C--N 1.297 -1.713 0 C-N-CA 118.873 -1.131 . . . . 0.0 109.248 179.83 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 205' ' ' VAL . . . . . 0.603 HG23 ' O ' ' A' ' 203' ' ' THR . 72.7 t -126.54 163.6 28.44 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.361 0 CA-C-O 122.141 0.972 . . . . 0.0 110.039 -177.674 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 206' ' ' LYS . . . . . 0.558 ' N ' HG12 ' A' ' 205' ' ' VAL . 0.2 OUTLIER . . . . . 0 C--N 1.291 -1.949 0 CA-C-O 118.024 -0.989 . . . . 0.0 109.45 -179.981 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' C' C ' 702' ' ' LEU . . . . . 0.852 ' N ' HD12 ' C' ' 702' ' ' LEU . 0.0 OUTLIER . . . . . 0 N--CA 1.489 1.511 0 N-CA-C 109.303 -0.628 . . . . 0.0 109.303 . . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' C' C ' 703' ' ' PRO . . . . . 0.551 ' HB2' ' HB3' ' A' ' 92' ' ' ALA . 96.9 Cg_endo -79.79 -174.44 2.27 Favored 'Trans proline' 0 N--CA 1.495 1.612 0 C-N-CA 122.94 2.427 . . . . 0.0 113.524 -179.418 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' C' C ' 704' ' ' ALA . . . . . 0.495 ' O ' ' O ' ' C' ' 703' ' ' PRO . . . . . . . . 0 N--CA 1.491 1.579 0 CA-C-O 121.744 0.783 . . . . 0.0 110.544 179.076 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 63' ' ' PRO . . . . . 0.629 ' O ' HD13 ' A' ' 110' ' ' LEU . 5.3 Cg_exo . . . . . 0 N--CA 1.487 1.146 0 CA-C-O 121.416 0.507 . . . . 0.0 112.269 . . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 64' ' ' GLN . . . . . 0.755 ' N ' HE21 ' A' ' 64' ' ' GLN . 0.0 OUTLIER -150.34 101.75 3.0 Favored 'General case' 0 N--CA 1.494 1.732 0 O-C-N 121.205 -0.935 . . . . 0.0 109.618 -179.891 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 65' ' ' ILE . . . . . 0.471 ' C ' ' O ' ' A' ' 64' ' ' GLN . 2.8 mp -39.79 100.83 0.22 Allowed Pre-proline 0 N--CA 1.491 1.603 0 N-CA-C 108.557 -0.905 . . . . 0.0 108.557 179.523 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 66' ' ' PRO . . . . . 0.423 ' N ' ' O ' ' A' ' 64' ' ' GLN . 71.8 Cg_endo -83.87 -155.32 0.06 OUTLIER 'Trans proline' 0 C--N 1.317 -1.118 0 C-N-CA 122.286 1.991 . . . . 0.0 112.679 -178.311 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 67' ' ' LYS . . . . . 0.404 ' O ' ' N ' ' A' ' 69' ' ' LYS . 8.5 ptmt -83.93 -4.94 59.08 Favored 'General case' 0 C--N 1.304 -1.371 0 O-C-N 121.391 -0.818 . . . . 0.0 109.388 -179.825 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 68' ' ' ASP . . . . . 0.588 ' C ' ' N ' ' A' ' 70' ' ' SER . 0.1 OUTLIER -73.82 51.47 0.38 Allowed 'General case' 0 N--CA 1.491 1.58 0 CA-C-O 122.566 1.174 . . . . 0.0 108.326 179.52 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 69' ' ' LYS . . . . . 0.598 ' O ' ' NH1' ' A' ' 99' ' ' ARG . 12.0 mtmm -49.49 -16.11 0.19 Allowed 'General case' 0 N--CA 1.497 1.888 0 C-N-CA 116.949 -1.9 . . . . 0.0 107.152 178.857 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 70' ' ' SER . . . . . 0.588 ' N ' ' C ' ' A' ' 68' ' ' ASP . 1.2 t -83.94 -7.16 59.49 Favored 'General case' 0 C--N 1.293 -1.89 0 CA-C-N 113.995 -1.457 . . . . 0.0 110.22 179.976 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 71' ' ' LYS . . . . . 0.413 ' CD ' ' HB2' ' A' ' 68' ' ' ASP . 1.0 OUTLIER -96.84 141.41 30.07 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.126 -0.984 . . . . 0.0 110.826 179.825 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 72' ' ' VAL . . . . . 0.825 HG12 ' CE1' ' A' ' 88' ' ' TYR . 2.3 m -65.01 139.62 21.1 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.522 0 N-CA-C 103.988 -2.597 . . . . 0.0 103.988 174.361 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 73' ' ' ALA . . . . . 0.511 ' N ' ' O ' ' A' ' 87' ' ' VAL . . . -81.21 -14.18 57.8 Favored 'General case' 0 C--N 1.292 -1.917 0 C-N-CA 117.11 -1.836 . . . . 0.0 106.203 179.799 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . 169.07 -152.04 19.12 Favored Glycine 0 N--CA 1.481 1.677 0 N-CA-C 109.873 -1.291 . . . . 0.0 109.873 178.868 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 75' ' ' TYR . . . . . 0.468 ' CD2' ' O ' ' A' ' 85' ' ' GLU . 2.3 m-85 -142.59 173.25 11.7 Favored 'General case' 0 C--N 1.298 -1.639 0 CA-C-O 122.085 0.945 . . . . 0.0 110.545 -178.118 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 76' ' ' ILE . . . . . . . . . . . . . 1.6 tp -147.9 141.88 19.3 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.682 0 C-N-CA 119.93 -0.708 . . . . 0.0 109.142 -176.954 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 77' ' ' GLU . . . . . 0.563 ' N ' ' OE1' ' A' ' 77' ' ' GLU . 0.0 OUTLIER -149.96 163.07 39.08 Favored 'General case' 0 C--N 1.304 -1.39 0 O-C-N 121.014 -1.054 . . . . 0.0 109.244 178.913 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 78' ' ' ILE . . . . . 0.694 ' HB ' ' HB3' ' A' ' 81' ' ' ALA . 7.9 mt -144.35 100.57 4.82 Favored Pre-proline 0 C--N 1.302 -1.496 0 O-C-N 121.338 -0.851 . . . . 0.0 109.022 179.991 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 79' ' ' PRO . . . . . . . . . . . . . 81.9 Cg_exo -48.25 -50.55 11.84 Favored 'Trans proline' 0 N--CA 1.493 1.469 0 C-N-CA 122.794 2.329 . . . . 0.0 113.632 -179.453 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -65.94 -18.93 65.67 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 120.889 -1.132 . . . . 0.0 111.098 178.906 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 81' ' ' ALA . . . . . 0.813 ' HB2' ' HB2' ' A' ' 136' ' ' ALA . . . -105.32 -16.93 14.62 Favored 'General case' 0 N--CA 1.494 1.734 0 O-C-N 121.069 -1.019 . . . . 0.0 108.81 179.521 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 82' ' ' ASP . . . . . 0.495 ' N ' ' O ' ' A' ' 78' ' ' ILE . 9.1 t0 65.81 50.47 1.54 Allowed 'General case' 0 N--CA 1.493 1.704 0 O-C-N 121.372 -0.83 . . . . 0.0 111.368 178.157 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 83' ' ' ILE . . . . . . . . . . . . . 45.2 mt -130.66 153.94 39.86 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.92 0 O-C-N 121.14 -0.975 . . . . 0.0 109.668 -179.273 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 84' ' ' LYS . . . . . . . . . . . . . 30.8 ttmt -158.01 110.25 2.33 Favored 'General case' 0 N--CA 1.497 1.88 0 N-CA-C 108.184 -1.043 . . . . 0.0 108.184 179.991 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 85' ' ' GLU . . . . . 0.497 ' OE1' ' O ' ' A' ' 129' ' ' GLN . 0.0 OUTLIER -141.33 167.2 17.92 Favored Pre-proline 0 N--CA 1.499 1.976 0 O-C-N 121.281 -0.887 . . . . 0.0 110.871 -178.45 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 86' ' ' PRO . . . . . 0.485 ' O ' HG22 ' A' ' 101' ' ' VAL . 55.8 Cg_endo -74.75 161.92 38.53 Favored 'Trans proline' 0 N--CA 1.497 1.722 0 C-N-CA 123.263 2.642 . . . . 0.0 113.108 -179.869 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 87' ' ' VAL . . . . . 0.511 ' O ' ' N ' ' A' ' 73' ' ' ALA . 55.7 t -123.32 99.79 7.09 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.844 0 O-C-N 121.686 -0.634 . . . . 0.0 109.337 179.582 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 88' ' ' TYR . . . . . 0.825 ' CE1' HG12 ' A' ' 72' ' ' VAL . 15.3 m-85 -89.99 155.1 47.56 Favored Pre-proline 0 N--CA 1.496 1.849 0 O-C-N 120.835 -1.166 . . . . 0.0 109.423 179.861 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 89' ' ' PRO . . . . . . . . . . . . . 11.8 Cg_endo -64.39 146.66 90.12 Favored 'Trans proline' 0 N--CA 1.496 1.642 0 C-N-CA 122.529 2.152 . . . . 0.0 113.952 -179.343 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . -59.04 167.59 7.06 Favored Glycine 0 N--CA 1.495 2.609 0 N-CA-C 110.382 -1.087 . . . . 0.0 110.382 179.663 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 91' ' ' PRO . . . . . 0.428 ' C ' ' H ' ' A' ' 93' ' ' THR . 90.2 Cg_endo -93.48 168.68 20.81 Favored 'Cis proline' 0 C--N 1.314 -1.237 0 C-N-CA 123.592 -1.42 . . . . 0.0 111.762 0.569 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 92' ' ' ALA . . . . . 0.543 ' HB1' HD21 ' A' ' 97' ' ' LEU . . . -72.03 33.04 0.06 Allowed 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.032 -1.042 . . . . 0.0 110.713 -179.9 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 93' ' ' THR . . . . . 0.428 ' H ' ' C ' ' A' ' 91' ' ' PRO . 3.3 p -71.18 150.39 94.54 Favored Pre-proline 0 N--CA 1.488 1.472 0 O-C-N 120.668 -1.27 . . . . 0.0 108.157 -179.865 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 94' ' ' PRO . . . . . 0.421 ' C ' ' O ' ' A' ' 93' ' ' THR . 87.3 Cg_exo -30.35 -56.26 0.19 Allowed 'Trans proline' 0 C--N 1.308 -1.6 0 C-N-CA 123.007 2.471 . . . . 0.0 112.672 -179.011 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 98.6 mt-10 -51.06 -46.32 61.67 Favored 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.12 -0.988 . . . . 0.0 109.825 -179.76 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 96' ' ' GLN . . . . . 0.422 ' OE1' ' CZ ' ' A' ' 99' ' ' ARG . 1.1 mp0 -71.92 -36.95 70.1 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.387 -0.821 . . . . 0.0 110.712 -179.375 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 97' ' ' LEU . . . . . 0.543 HD21 ' HB1' ' A' ' 92' ' ' ALA . 89.0 mt -68.4 -5.94 21.85 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 120.833 -1.167 . . . . 0.0 109.248 -179.682 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 98' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER -78.24 -27.05 47.53 Favored 'General case' 0 N--CA 1.492 1.673 0 O-C-N 121.319 -0.863 . . . . 0.0 109.893 179.42 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 99' ' ' ARG . . . . . 0.598 ' NH1' ' O ' ' A' ' 69' ' ' LYS . 63.8 mtt180 -91.07 -43.5 9.88 Favored 'General case' 0 N--CA 1.488 1.47 0 O-C-N 121.531 -0.731 . . . . 0.0 109.956 -178.524 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . 169.81 -171.7 43.43 Favored Glycine 0 N--CA 1.49 2.28 0 N-CA-C 109.898 -1.281 . . . . 0.0 109.898 -179.992 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 101' ' ' VAL . . . . . 0.742 ' O ' HG23 ' A' ' 101' ' ' VAL . 13.0 m -57.48 106.63 0.18 Allowed 'Isoleucine or valine' 0 N--CA 1.494 1.758 0 O-C-N 121.401 -1.058 . . . . 0.0 109.152 -179.915 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -92.52 163.31 13.86 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 120.87 -1.144 . . . . 0.0 111.184 -179.176 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 103' ' ' PHE . . . . . 0.484 ' CZ ' ' CG1' ' A' ' 87' ' ' VAL . 25.0 m-85 -70.46 141.85 52.0 Favored 'General case' 0 N--CA 1.489 1.501 0 N-CA-C 108.145 -1.057 . . . . 0.0 108.145 178.334 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 104' ' ' ALA . . . . . . . . . . . . . . . -58.73 -15.86 14.0 Favored 'General case' 0 C--N 1.3 -1.548 0 O-C-N 121.474 -0.766 . . . . 0.0 111.104 -178.828 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -139.07 144.24 38.68 Favored 'General case' 0 N--CA 1.492 1.65 0 O-C-N 120.906 -1.121 . . . . 0.0 110.082 -179.304 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 106' ' ' GLU . . . . . . . . . . . . . 6.3 tt0 -58.1 -55.43 35.04 Favored 'General case' 0 C--N 1.299 -1.618 0 O-C-N 121.892 -0.505 . . . . 0.0 110.599 -179.363 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 107' ' ' ASN . . . . . 0.498 ' N ' ' ND2' ' A' ' 107' ' ' ASN . 1.8 m120 -77.85 35.15 0.2 Allowed 'General case' 0 N--CA 1.487 1.395 0 O-C-N 120.622 -1.299 . . . . 0.0 112.223 -176.152 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 108' ' ' GLU . . . . . . . . . . . . . 21.7 tp10 -57.81 139.82 53.15 Favored 'General case' 0 N--CA 1.488 1.457 0 N-CA-C 107.605 -1.257 . . . . 0.0 107.605 179.635 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 109' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -93.08 146.53 23.57 Favored 'General case' 0 C--N 1.302 -1.486 0 O-C-N 120.97 -1.081 . . . . 0.0 110.776 -178.08 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 110' ' ' LEU . . . . . 0.828 ' H ' HD23 ' A' ' 110' ' ' LEU . 0.3 OUTLIER -62.66 -24.5 67.65 Favored 'General case' 0 C--N 1.303 -1.424 0 N-CA-C 107.281 -1.377 . . . . 0.0 107.281 178.641 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 111' ' ' ASP . . . . . . . . . . . . . 4.0 m-20 -133.03 48.95 2.35 Favored 'General case' 0 N--CA 1.485 1.298 0 N-CA-C 109.396 -0.594 . . . . 0.0 109.396 179.663 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 112' ' ' ASP . . . . . . . . . . . . . 1.7 t0 -69.33 159.47 33.06 Favored 'General case' 0 N--CA 1.494 1.731 0 O-C-N 121.127 -0.983 . . . . 0.0 111.333 -179.608 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 113' ' ' GLN . . . . . 0.547 ' N ' ' CD ' ' A' ' 113' ' ' GLN . 0.0 OUTLIER -64.63 -17.98 64.52 Favored 'General case' 0 N--CA 1.491 1.607 0 N-CA-C 107.361 -1.348 . . . . 0.0 107.361 177.668 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 114' ' ' ASN . . . . . 0.682 ' ND2' ' NE2' ' A' ' 178' ' ' GLN . 59.9 t-20 -153.55 111.81 3.62 Favored 'General case' 0 C--N 1.298 -1.662 0 N-CA-C 107.803 -1.184 . . . . 0.0 107.803 177.631 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 115' ' ' ILE . . . . . 0.505 HG22 ' O ' ' A' ' 115' ' ' ILE . 2.8 mt -93.6 102.8 14.01 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.557 0 O-C-N 120.988 -1.07 . . . . 0.0 108.128 -179.935 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 116' ' ' SER . . . . . . . . . . . . . 72.3 m -81.76 141.31 33.64 Favored 'General case' 0 N--CA 1.488 1.453 0 CA-C-O 122.088 0.947 . . . . 0.0 112.114 -177.001 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 117' ' ' ILE . . . . . . . . . . . . . 28.2 mt -138.05 140.85 39.78 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.474 0 N-CA-C 107.357 -1.349 . . . . 0.0 107.357 178.609 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 118' ' ' ALA . . . . . . . . . . . . . . . -141.98 155.58 45.45 Favored 'General case' 0 N--CA 1.489 1.492 0 C-N-CA 118.63 -1.228 . . . . 0.0 111.043 -178.967 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 119' ' ' GLY . . . . . . . . . . . . . . . -166.8 152.55 21.55 Favored Glycine 0 N--CA 1.483 1.813 0 N-CA-C 109.967 -1.253 . . . . 0.0 109.967 179.769 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 120' ' ' HIS . . . . . . . . . . . . . 26.4 m170 -71.73 142.1 49.78 Favored 'General case' 0 N--CA 1.493 1.71 0 O-C-N 121.604 -0.939 . . . . 0.0 110.592 179.864 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 121' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -99.06 153.36 18.94 Favored 'General case' 0 N--CA 1.496 1.835 0 N-CA-C 107.896 -1.15 . . . . 0.0 107.896 178.419 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 122' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -116.85 140.69 49.15 Favored 'General case' 0 N--CA 1.496 1.869 0 O-C-N 121.139 -0.976 . . . . 0.0 110.603 -179.676 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 123' ' ' ILE . . . . . 0.505 HG23 ' N ' ' A' ' 124' ' ' ASP . 15.7 tt -90.28 -33.13 5.76 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.641 0 CA-C-O 121.876 0.846 . . . . 0.0 109.083 179.619 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 124' ' ' ASP . . . . . 0.505 ' N ' HG23 ' A' ' 123' ' ' ILE . 80.0 m-20 -89.78 3.08 53.95 Favored 'General case' 0 N--CA 1.497 1.888 0 CA-C-N 116.069 -0.514 . . . . 0.0 111.772 -178.706 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 125' ' ' ARG . . . . . 0.665 HH11 ' CG ' ' A' ' 125' ' ' ARG . 1.7 mtt-85 -151.3 120.7 3.53 Favored Pre-proline 0 N--CA 1.499 1.995 0 O-C-N 120.383 -1.448 . . . . 0.0 110.114 -179.193 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 126' ' ' PRO . . . . . . . . . . . . . 88.9 Cg_endo -81.48 -18.99 7.95 Favored 'Trans proline' 0 N--CA 1.489 1.257 0 C-N-CA 122.279 1.986 . . . . 0.0 112.396 179.199 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 127' ' ' ASN . . . . . 0.514 ' O ' ' O ' ' A' ' 128' ' ' TYR . 3.9 m120 -92.65 4.35 53.84 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.274 -0.891 . . . . 0.0 110.109 -179.759 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 128' ' ' TYR . . . . . 0.514 ' O ' ' O ' ' A' ' 127' ' ' ASN . 9.1 t80 -58.7 -147.25 0.0 OUTLIER 'General case' 0 N--CA 1.488 1.447 0 O-C-N 121.283 -0.886 . . . . 0.0 109.337 179.995 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 129' ' ' GLN . . . . . 0.497 ' O ' ' OE1' ' A' ' 85' ' ' GLU . 12.7 mt-30 -64.96 -91.23 0.01 OUTLIER 'General case' 0 N--CA 1.493 1.724 0 O-C-N 120.833 -1.167 . . . . 0.0 110.284 -178.941 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 130' ' ' PHE . . . . . 0.711 ' CE2' HG11 ' A' ' 101' ' ' VAL . 44.2 m-85 -114.28 48.0 1.15 Allowed 'General case' 0 N--CA 1.496 1.835 0 O-C-N 121.159 -0.963 . . . . 0.0 109.355 179.851 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 131' ' ' THR . . . . . 0.526 ' O ' ' CD ' ' A' ' 134' ' ' LYS . 56.9 m -77.83 -26.54 49.51 Favored 'General case' 0 C--N 1.3 -1.558 0 O-C-N 121.213 -0.93 . . . . 0.0 109.563 -179.998 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 132' ' ' ASN . . . . . 0.543 ' ND2' ' O ' ' A' ' 81' ' ' ALA . 12.4 t30 -90.23 13.36 15.46 Favored 'General case' 0 N--CA 1.5 2.042 0 C-N-CA 119.759 -0.776 . . . . 0.0 111.932 -178.855 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 133' ' ' LEU . . . . . 0.993 HD13 ' HB3' ' A' ' 136' ' ' ALA . 0.2 OUTLIER -67.97 -29.81 68.94 Favored 'General case' 0 N--CA 1.495 1.779 0 O-C-N 120.399 -1.438 . . . . 0.0 109.594 -179.749 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 134' ' ' LYS . . . . . 0.746 ' CD ' ' H ' ' A' ' 134' ' ' LYS . 0.0 OUTLIER -44.09 -29.96 0.69 Allowed 'General case' 0 N--CA 1.496 1.862 0 O-C-N 121.43 -0.794 . . . . 0.0 110.455 -179.432 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 135' ' ' ALA . . . . . . . . . . . . . . . -84.76 -21.39 30.03 Favored 'General case' 0 N--CA 1.488 1.466 0 O-C-N 121.045 -1.034 . . . . 0.0 109.937 -179.621 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 136' ' ' ALA . . . . . 0.993 ' HB3' HD13 ' A' ' 133' ' ' LEU . . . -81.74 137.69 35.31 Favored 'General case' 0 C--N 1.301 -1.526 0 CA-C-O 122.039 0.924 . . . . 0.0 111.957 -178.336 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 137' ' ' LYS . . . . . 0.512 ' O ' ' OG ' ' A' ' 140' ' ' SER . 3.9 tttt -156.59 -166.0 2.02 Favored 'General case' 0 C--N 1.299 -1.604 0 C-N-CA 118.824 -1.15 . . . . 0.0 110.857 -179.349 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 138' ' ' LYS . . . . . 0.622 ' O ' ' N ' ' A' ' 140' ' ' SER . 29.0 mttt -46.61 -178.36 0.0 OUTLIER 'General case' 0 C--N 1.3 -1.549 0 CA-C-O 121.873 0.844 . . . . 0.0 110.107 -179.916 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 139' ' ' GLY . . . . . . . . . . . . . . . 44.95 8.41 0.01 OUTLIER Glycine 0 N--CA 1.489 2.198 0 N-CA-C 110.641 -0.984 . . . . 0.0 110.641 179.56 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 140' ' ' SER . . . . . 0.622 ' N ' ' O ' ' A' ' 138' ' ' LYS . 45.8 m -94.55 128.49 41.2 Favored 'General case' 0 N--CA 1.489 1.503 0 O-C-N 120.723 -1.457 . . . . 0.0 109.247 179.47 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 141' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -81.66 127.54 33.01 Favored 'General case' 0 C--N 1.3 -1.545 0 O-C-N 121.288 -0.883 . . . . 0.0 108.792 179.809 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 142' ' ' VAL . . . . . 0.481 HG22 HG23 ' A' ' 78' ' ' ILE . 12.8 t -113.72 135.13 54.33 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.553 0 N-CA-C 108.788 -0.819 . . . . 0.0 108.788 -179.529 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 143' ' ' TYR . . . . . 0.539 ' CE1' ' CG ' ' A' ' 152' ' ' LYS . 9.5 m-85 -111.36 136.13 50.93 Favored 'General case' 0 N--CA 1.493 1.7 0 O-C-N 121.012 -1.055 . . . . 0.0 110.316 -178.886 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 144' ' ' PHE . . . . . 0.528 ' O ' HG23 ' A' ' 150' ' ' THR . 44.6 t80 -113.37 160.1 18.75 Favored 'General case' 0 N--CA 1.493 1.696 0 CA-C-O 122.072 0.939 . . . . 0.0 110.806 -178.263 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 145' ' ' LYS . . . . . 0.463 ' N ' ' CG ' ' A' ' 144' ' ' PHE . 36.7 tttm -148.13 125.23 11.41 Favored 'General case' 0 C--N 1.301 -1.525 0 C-N-CA 119.25 -0.98 . . . . 0.0 110.761 -178.546 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 146' ' ' VAL . . . . . . . . . . . . . 11.8 p -145.82 138.94 20.95 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.63 0 N-CA-C 106.827 -1.545 . . . . 0.0 106.827 178.625 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 147' ' ' GLY . . . . . . . . . . . . . . . 58.67 -141.23 46.7 Favored Glycine 0 N--CA 1.486 1.985 0 N-CA-C 108.359 -1.896 . . . . 0.0 108.359 -179.273 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 148' ' ' ASN . . . . . 0.552 HD22 ' C ' ' A' ' 148' ' ' ASN . 0.4 OUTLIER -101.79 24.75 9.44 Favored 'General case' 0 C--N 1.296 -1.741 0 N-CA-C 107.821 -1.177 . . . . 0.0 107.821 178.821 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 149' ' ' GLU . . . . . . . . . . . . . 2.0 tm-20 -116.52 159.24 22.37 Favored 'General case' 0 N--CA 1.49 1.54 0 CA-C-O 121.796 0.808 . . . . 0.0 110.727 -179.086 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 150' ' ' THR . . . . . 0.528 HG23 ' O ' ' A' ' 144' ' ' PHE . 11.1 m -140.15 109.44 6.17 Favored 'General case' 0 N--CA 1.492 1.666 0 N-CA-C 109.029 -0.73 . . . . 0.0 109.029 179.212 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 151' ' ' ARG . . . . . . . . . . . . . 9.8 mtt180 -89.16 -161.01 0.72 Allowed 'General case' 0 N--CA 1.489 1.495 0 CA-C-O 121.546 0.688 . . . . 0.0 110.433 -178.586 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 152' ' ' LYS . . . . . 0.539 ' CG ' ' CE1' ' A' ' 143' ' ' TYR . 9.3 mtmt -148.26 148.78 30.85 Favored 'General case' 0 N--CA 1.486 1.359 0 O-C-N 121.394 -0.816 . . . . 0.0 110.326 -179.187 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 153' ' ' TYR . . . . . 0.449 ' HB3' ' HB1' ' A' ' 202' ' ' ALA . 52.8 m-85 -146.31 158.66 43.91 Favored 'General case' 0 C--N 1.303 -1.433 0 N-CA-C 108.111 -1.07 . . . . 0.0 108.111 179.277 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 154' ' ' LYS . . . . . . . . . . . . . 15.1 ttmm -137.1 121.5 18.21 Favored 'General case' 0 N--CA 1.495 1.824 0 O-C-N 121.186 -0.946 . . . . 0.0 108.538 179.053 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 155' ' ' MET . . . . . 0.467 ' HB3' HD11 ' A' ' 158' ' ' ILE . 5.7 mtt -47.96 107.79 0.14 Allowed 'General case' 0 N--CA 1.493 1.685 0 O-C-N 120.913 -1.117 . . . . 0.0 111.193 -178.588 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 156' ' ' THR . . . . . 0.679 ' OG1' HG23 ' A' ' 203' ' ' THR . 0.3 OUTLIER -108.02 -25.51 11.12 Favored 'General case' 0 C--N 1.293 -1.872 0 CA-C-N 115.3 -0.864 . . . . 0.0 109.635 -179.342 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 157' ' ' SER . . . . . 0.702 ' C ' HD12 ' A' ' 158' ' ' ILE . 60.7 m -149.87 146.3 27.03 Favored 'General case' 0 C--N 1.299 -1.626 0 C-N-CA 118.61 -1.236 . . . . 0.0 110.455 -179.048 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 158' ' ' ILE . . . . . 0.702 HD12 ' C ' ' A' ' 157' ' ' SER . 3.8 mp -151.48 141.73 15.71 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.445 0 CA-C-O 121.925 0.869 . . . . 0.0 109.988 -179.274 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 159' ' ' ARG . . . . . 0.496 HH21 HG13 ' A' ' 161' ' ' VAL . 3.0 ttp180 -155.09 -171.98 4.02 Favored 'General case' 0 C--N 1.292 -1.897 0 C-N-CA 119.67 -0.812 . . . . 0.0 110.394 -179.601 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 160' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -145.67 161.17 40.48 Favored 'General case' 0 C--N 1.301 -1.539 0 N-CA-C 108.0 -1.111 . . . . 0.0 108.0 -179.725 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 161' ' ' VAL . . . . . 0.496 HG13 HH21 ' A' ' 159' ' ' ARG . 0.0 OUTLIER -154.4 155.62 5.89 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.645 0 O-C-N 120.755 -1.216 . . . . 0.0 110.835 -179.091 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 162' ' ' LYS . . . . . 0.489 ' O ' ' O ' ' A' ' 161' ' ' VAL . 0.2 OUTLIER -51.47 179.47 0.04 OUTLIER Pre-proline 0 C--N 1.305 -1.33 0 N-CA-C 107.153 -1.425 . . . . 0.0 107.153 178.064 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 163' ' ' PRO . . . . . 0.453 ' C ' HD11 ' C' ' 702' ' ' LEU . 29.5 Cg_endo -87.69 45.79 1.2 Allowed 'Trans proline' 0 C--N 1.307 -1.631 0 C-N-CA 122.103 1.869 . . . . 0.0 111.748 -179.548 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 164' ' ' THR . . . . . . . . . . . . . 7.5 m -153.28 -16.41 0.15 Allowed 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.268 -0.895 . . . . 0.0 110.671 -179.626 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 165' ' ' ASP . . . . . 0.489 ' O ' ' N ' ' A' ' 167' ' ' GLY . 0.4 OUTLIER -72.36 58.94 0.41 Allowed 'General case' 0 N--CA 1.493 1.699 0 O-C-N 120.791 -1.193 . . . . 0.0 110.397 -179.063 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 166' ' ' VAL . . . . . 0.59 ' O ' ' N ' ' A' ' 168' ' ' VAL . 1.0 OUTLIER -40.64 -27.22 0.09 OUTLIER 'Isoleucine or valine' 0 N--CA 1.489 1.515 0 O-C-N 121.297 -0.877 . . . . 0.0 109.129 -178.797 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 167' ' ' GLY . . . . . 0.489 ' N ' ' O ' ' A' ' 165' ' ' ASP . . . -46.48 -4.64 0.01 OUTLIER Glycine 0 N--CA 1.496 2.658 0 O-C-N 120.799 -1.188 . . . . 0.0 112.006 -179.768 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 168' ' ' VAL . . . . . 0.59 ' N ' ' O ' ' A' ' 166' ' ' VAL . 0.2 OUTLIER -51.76 -36.33 18.82 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.894 0 O-C-N 120.131 -1.805 . . . . 0.0 108.69 179.866 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 169' ' ' LEU . . . . . 0.536 ' O ' ' C ' ' A' ' 170' ' ' ASP . 5.3 mt -52.69 -6.17 0.05 OUTLIER 'General case' 0 N--CA 1.492 1.653 0 N-CA-C 108.7 -0.852 . . . . 0.0 108.7 -177.469 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 170' ' ' ASP . . . . . 0.569 ' H ' ' C ' ' A' ' 168' ' ' VAL . 47.6 t0 18.22 58.87 0.01 OUTLIER 'General case' 0 N--CA 1.496 1.868 0 N-CA-C 112.419 0.525 . . . . 0.0 112.419 176.999 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 171' ' ' GLU . . . . . . . . . . . . . 11.4 pt-20 -94.87 62.13 2.62 Favored 'General case' 0 N--CA 1.499 2.017 0 O-C-N 120.34 -1.475 . . . . 0.0 109.896 179.924 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 172' ' ' GLN . . . . . . . . . . . . . 0.6 OUTLIER -114.88 -63.63 1.43 Allowed 'General case' 0 N--CA 1.496 1.837 0 O-C-N 121.563 -0.71 . . . . 0.0 110.525 -178.711 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 173' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -60.18 127.58 32.54 Favored 'General case' 0 N--CA 1.496 1.831 0 O-C-N 121.216 -0.928 . . . . 0.0 109.751 -179.704 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 174' ' ' GLY . . . . . 0.49 ' O ' ' C ' ' A' ' 175' ' ' LYS . . . -117.1 -41.72 0.68 Allowed Glycine 0 N--CA 1.484 1.873 0 N-CA-C 108.824 -1.71 . . . . 0.0 108.824 179.682 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 175' ' ' LYS . . . . . 0.49 ' C ' ' O ' ' A' ' 174' ' ' GLY . 13.1 mptt -41.05 -59.78 1.38 Allowed 'General case' 0 N--CA 1.495 1.791 0 N-CA-C 107.804 -1.184 . . . . 0.0 107.804 179.573 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 176' ' ' ASP . . . . . 0.598 ' O ' ' O ' ' A' ' 177' ' ' LYS . 4.3 m-20 -103.22 83.04 2.14 Favored 'General case' 0 C--N 1.295 -1.791 0 N-CA-C 107.294 -1.373 . . . . 0.0 107.294 177.461 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 177' ' ' LYS . . . . . 0.598 ' O ' ' O ' ' A' ' 176' ' ' ASP . 2.6 mttt -43.59 -177.99 0.0 OUTLIER 'General case' 0 N--CA 1.494 1.73 0 O-C-N 121.425 -0.797 . . . . 0.0 109.464 -179.144 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 178' ' ' GLN . . . . . 0.682 ' NE2' ' ND2' ' A' ' 114' ' ' ASN . 0.0 OUTLIER -160.44 170.86 20.12 Favored 'General case' 0 C--N 1.302 -1.487 0 O-C-N 120.418 -1.426 . . . . 0.0 110.977 179.03 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 179' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -122.86 91.99 3.61 Favored 'General case' 0 C--N 1.302 -1.484 0 N-CA-C 107.446 -1.316 . . . . 0.0 107.446 178.493 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 180' ' ' THR . . . . . 0.444 ' OG1' ' ND2' ' A' ' 114' ' ' ASN . 1.3 m -71.74 118.32 14.44 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.172 -0.955 . . . . 0.0 110.457 -178.388 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 181' ' ' LEU . . . . . 0.506 HD11 ' CE2' ' A' ' 130' ' ' PHE . 41.1 tp -97.4 154.04 17.72 Favored 'General case' 0 C--N 1.3 -1.568 0 N-CA-C 107.458 -1.312 . . . . 0.0 107.458 177.57 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 182' ' ' ILE . . . . . 0.572 HG23 HG22 ' A' ' 199' ' ' ILE . 11.0 mt -145.77 121.31 3.33 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.554 0 O-C-N 120.613 -1.304 . . . . 0.0 110.489 179.496 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 183' ' ' THR . . . . . 0.569 HG23 ' O ' ' A' ' 183' ' ' THR . 5.2 t -134.44 116.8 15.57 Favored 'General case' 0 C--N 1.293 -1.865 0 N-CA-C 107.427 -1.323 . . . . 0.0 107.427 178.627 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 184' ' ' CYS . . . . . . . . . . . . . 5.1 p -78.57 157.15 28.85 Favored 'General case' 0 C--N 1.282 -2.337 0 C-N-CA 118.933 -1.107 . . . . 0.0 110.964 -177.687 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 185' ' ' ASP . . . . . . . . . . . . . 12.3 t0 -164.15 -157.47 0.39 Allowed 'General case' 0 N--CA 1.492 1.658 0 O-C-N 121.514 -0.742 . . . . 0.0 109.376 -179.613 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 186' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER 54.93 52.45 11.9 Favored 'General case' 0 N--CA 1.495 1.807 0 O-C-N 121.002 -1.061 . . . . 0.0 109.567 -179.7 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 187' ' ' TYR . . . . . 0.599 ' CE1' ' O ' ' A' ' 188' ' ' ASN . 63.4 t80 -67.69 134.36 50.96 Favored 'General case' 0 N--CA 1.493 1.675 0 O-C-N 121.122 -0.986 . . . . 0.0 110.582 -179.857 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 188' ' ' ASN . . . . . 0.599 ' O ' ' CE1' ' A' ' 187' ' ' TYR . 0.7 OUTLIER -101.52 145.66 28.71 Favored 'General case' 0 C--N 1.296 -1.749 0 N-CA-C 108.214 -1.032 . . . . 0.0 108.214 178.119 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 189' ' ' GLU . . . . . . . . . . . . . 2.0 tt0 -109.49 -14.31 14.42 Favored 'General case' 0 C--N 1.294 -1.81 0 N-CA-C 108.719 -0.845 . . . . 0.0 108.719 -179.557 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 190' ' ' LYS . . . . . . . . . . . . . 7.7 mttm -82.62 -54.47 5.14 Favored 'General case' 0 C--N 1.302 -1.489 0 N-CA-C 108.879 -0.785 . . . . 0.0 108.879 179.096 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 191' ' ' THR . . . . . 0.572 ' OG1' HG12 ' A' ' 193' ' ' VAL . 1.0 OUTLIER -88.48 -5.36 58.29 Favored 'General case' 0 C--N 1.301 -1.503 0 O-C-N 121.391 -0.818 . . . . 0.0 109.645 -179.756 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 192' ' ' GLY . . . . . . . . . . . . . . . 64.93 35.21 91.63 Favored Glycine 0 N--CA 1.496 2.697 0 O-C-N 120.992 -1.068 . . . . 0.0 111.928 177.988 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 193' ' ' VAL . . . . . 0.572 HG12 ' OG1' ' A' ' 191' ' ' THR . 3.4 p -149.27 167.87 2.98 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.681 0 O-C-N 120.692 -1.475 . . . . 0.0 110.383 179.178 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 194' ' ' TRP . . . . . 0.53 ' CD1' ' N ' ' A' ' 194' ' ' TRP . 10.1 m95 -84.83 120.86 26.92 Favored 'General case' 0 N--CA 1.493 1.704 0 N-CA-C 108.813 -0.81 . . . . 0.0 108.813 -179.933 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 195' ' ' GLU . . . . . 0.507 ' CD ' ' ND2' ' A' ' 188' ' ' ASN . 6.8 mt-10 -79.35 -61.64 1.94 Allowed 'General case' 0 N--CA 1.493 1.689 0 O-C-N 121.424 -0.798 . . . . 0.0 111.241 -178.29 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 196' ' ' LYS . . . . . . . . . . . . . 0.9 OUTLIER -101.64 151.14 22.37 Favored 'General case' 0 N--CA 1.494 1.73 0 O-C-N 120.906 -1.121 . . . . 0.0 110.262 -179.216 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 197' ' ' ARG . . . . . 0.883 ' HE ' HD13 ' C' ' 702' ' ' LEU . 1.4 mtt-85 -120.5 153.59 36.45 Favored 'General case' 0 N--CA 1.489 1.497 0 N-CA-C 108.432 -0.951 . . . . 0.0 108.432 178.34 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 198' ' ' LYS . . . . . . . . . . . . . 1.1 mptp? -114.97 123.14 48.33 Favored 'General case' 0 C--N 1.3 -1.585 0 O-C-N 121.645 -0.659 . . . . 0.0 110.581 -177.882 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 199' ' ' ILE . . . . . 0.63 ' C ' HD12 ' A' ' 199' ' ' ILE . 0.5 OUTLIER -136.79 118.49 19.11 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.757 0 CA-C-O 122.748 1.261 . . . . 0.0 110.655 179.693 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 200' ' ' PHE . . . . . 0.556 ' CD1' ' N ' ' A' ' 200' ' ' PHE . 0.2 OUTLIER -100.15 134.64 42.77 Favored 'General case' 0 N--CA 1.5 2.054 0 CA-C-N 115.604 -0.725 . . . . 0.0 110.481 -178.161 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 201' ' ' VAL . . . . . . . . . . . . . 52.9 t -103.48 141.34 19.45 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.992 0 O-C-N 120.721 -1.237 . . . . 0.0 108.554 177.922 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 202' ' ' ALA . . . . . 0.449 ' HB1' ' HB3' ' A' ' 153' ' ' TYR . . . -125.15 136.66 53.82 Favored 'General case' 0 N--CA 1.495 1.794 0 O-C-N 121.157 -0.964 . . . . 0.0 108.795 179.56 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 203' ' ' THR . . . . . 0.679 HG23 ' OG1' ' A' ' 156' ' ' THR . 1.2 p -88.98 134.66 33.9 Favored 'General case' 0 N--CA 1.49 1.529 0 CA-C-O 122.126 0.965 . . . . 0.0 111.383 -178.552 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 204' ' ' GLU . . . . . 0.418 ' HA ' ' CD2' ' A' ' 153' ' ' TYR . 2.6 tm-20 -62.53 135.07 57.23 Favored 'General case' 0 C--N 1.301 -1.541 0 C-N-CA 118.919 -1.113 . . . . 0.0 108.96 179.25 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 205' ' ' VAL . . . . . 0.54 ' O ' ' C ' ' A' ' 206' ' ' LYS . 71.5 t -123.9 -45.39 1.73 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.642 0 O-C-N 121.397 -0.814 . . . . 0.0 109.908 -178.91 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 206' ' ' LYS . . . . . 0.54 ' C ' ' O ' ' A' ' 205' ' ' VAL . 2.3 ttpt . . . . . 0 N--CA 1.496 1.838 0 CA-C-O 118.044 -0.979 . . . . 0.0 110.679 -179.655 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' C' C ' 702' ' ' LEU . . . . . 0.883 HD13 ' HE ' ' A' ' 197' ' ' ARG . 0.0 OUTLIER . . . . . 0 N--CA 1.491 1.584 0 N-CA-C 108.412 -0.959 . . . . 0.0 108.412 . . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' C' C ' 703' ' ' PRO . . . . . 0.492 ' O ' ' O ' ' C' ' 704' ' ' ALA . 97.2 Cg_endo -77.88 -162.48 0.17 Allowed 'Trans proline' 0 N--CA 1.494 1.55 0 C-N-CA 122.521 2.148 . . . . 0.0 113.081 -179.509 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' C' C ' 704' ' ' ALA . . . . . 0.492 ' O ' ' O ' ' C' ' 703' ' ' PRO . . . . . . . . 0 N--CA 1.49 1.553 0 CA-C-O 121.443 0.64 . . . . 0.0 110.273 179.457 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 63' ' ' PRO . . . . . 0.581 ' O ' ' CD1' ' A' ' 110' ' ' LEU . 29.3 Cg_endo . . . . . 0 C--O 1.21 -0.894 0 N-CA-C 110.156 -0.748 . . . . 0.0 110.156 . . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 64' ' ' GLN . . . . . 0.425 ' O ' ' C ' ' A' ' 65' ' ' ILE . 0.0 OUTLIER -162.47 115.62 1.71 Allowed 'General case' 0 C--N 1.297 -1.686 0 O-C-N 121.165 -0.96 . . . . 0.0 109.976 -179.836 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 65' ' ' ILE . . . . . 0.425 ' C ' ' O ' ' A' ' 64' ' ' GLN . 2.7 mp -42.78 102.41 0.27 Allowed Pre-proline 0 N--CA 1.489 1.511 0 O-C-N 121.518 -0.739 . . . . 0.0 109.262 179.536 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 66' ' ' PRO . . . . . . . . . . . . . 72.7 Cg_endo -89.13 -154.21 0.05 OUTLIER 'Trans proline' 0 N--CA 1.492 1.414 0 C-N-CA 122.697 2.265 . . . . 0.0 113.004 -179.011 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 67' ' ' LYS . . . . . 0.481 ' CG ' ' O ' ' A' ' 67' ' ' LYS . 7.8 ttmm -81.06 -7.45 59.56 Favored 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.239 -0.913 . . . . 0.0 108.766 179.666 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 68' ' ' ASP . . . . . 0.584 ' C ' ' N ' ' A' ' 70' ' ' SER . 0.5 OUTLIER -75.1 52.89 0.59 Allowed 'General case' 0 C--N 1.304 -1.393 0 CA-C-O 122.524 1.154 . . . . 0.0 108.594 179.608 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 69' ' ' LYS . . . . . 0.437 ' C ' ' O ' ' A' ' 68' ' ' ASP . 14.9 ptpt -49.7 -15.07 0.15 Allowed 'General case' 0 N--CA 1.501 2.088 0 C-N-CA 117.26 -1.776 . . . . 0.0 106.469 177.961 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 70' ' ' SER . . . . . 0.584 ' N ' ' C ' ' A' ' 68' ' ' ASP . 3.7 m -85.92 -4.68 59.22 Favored 'General case' 0 N--CA 1.494 1.77 0 CA-C-N 113.516 -1.675 . . . . 0.0 110.739 179.571 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 71' ' ' LYS . . . . . . . . . . . . . 7.9 ptmt -97.73 142.53 29.39 Favored 'General case' 0 N--CA 1.497 1.877 0 O-C-N 120.913 -1.117 . . . . 0.0 111.985 -179.181 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 72' ' ' VAL . . . . . 0.579 ' CG2' ' O ' ' A' ' 74' ' ' GLY . 0.3 OUTLIER -67.52 135.0 29.34 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.507 0 N-CA-C 105.186 -2.153 . . . . 0.0 105.186 174.777 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 73' ' ' ALA . . . . . 0.535 ' N ' ' O ' ' A' ' 87' ' ' VAL . . . -80.93 -16.58 53.14 Favored 'General case' 0 C--N 1.298 -1.635 0 O-C-N 119.988 -1.695 . . . . 0.0 107.219 -179.556 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 74' ' ' GLY . . . . . 0.579 ' O ' ' CG2' ' A' ' 72' ' ' VAL . . . 167.04 -148.9 13.85 Favored Glycine 0 N--CA 1.486 1.98 0 C-N-CA 119.078 -1.534 . . . . 0.0 110.253 178.774 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 75' ' ' TYR . . . . . 0.558 ' HA ' HG23 ' A' ' 87' ' ' VAL . 13.4 m-85 -144.91 174.79 10.71 Favored 'General case' 0 C--N 1.293 -1.885 0 O-C-N 121.153 -1.204 . . . . 0.0 109.921 -178.342 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 76' ' ' ILE . . . . . . . . . . . . . 0.4 OUTLIER -148.48 147.83 16.56 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.777 0 N-CA-C 108.124 -1.065 . . . . 0.0 108.124 -178.64 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 3.9 mt-10 -149.37 159.82 43.95 Favored 'General case' 0 C--N 1.302 -1.471 0 O-C-N 120.789 -1.194 . . . . 0.0 110.548 -179.353 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 78' ' ' ILE . . . . . 0.562 HG22 ' H ' ' A' ' 81' ' ' ALA . 83.3 mt -145.58 120.15 5.56 Favored Pre-proline 0 N--CA 1.488 1.442 0 N-CA-C 107.233 -1.395 . . . . 0.0 107.233 179.722 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 79' ' ' PRO . . . . . . . . . . . . . 68.9 Cg_endo -76.36 -39.66 0.76 Allowed 'Trans proline' 0 N--CA 1.493 1.468 0 C-N-CA 122.024 1.816 . . . . 0.0 113.613 -178.543 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 4.7 m-20 -65.72 -20.23 66.2 Favored 'General case' 0 N--CA 1.494 1.76 0 O-C-N 121.062 -1.024 . . . . 0.0 110.025 178.344 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 81' ' ' ALA . . . . . 0.575 ' O ' ' ND2' ' A' ' 132' ' ' ASN . . . -108.31 -18.63 13.71 Favored 'General case' 0 C--N 1.301 -1.535 0 N-CA-C 107.857 -1.164 . . . . 0.0 107.857 179.497 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 82' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER 67.41 54.72 0.68 Allowed 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.74 -0.6 . . . . 0.0 110.942 178.921 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 83' ' ' ILE . . . . . 0.409 ' CG1' HD21 ' A' ' 132' ' ' ASN . 61.2 mt -126.66 151.77 33.66 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.924 0 O-C-N 120.935 -1.103 . . . . 0.0 110.68 -179.02 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 84' ' ' LYS . . . . . . . . . . . . . 1.6 pttm -159.19 106.46 1.77 Allowed 'General case' 0 N--CA 1.489 1.512 0 N-CA-C 107.734 -1.21 . . . . 0.0 107.734 179.105 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 85' ' ' GLU . . . . . 0.435 ' OE2' ' O ' ' A' ' 129' ' ' GLN . 0.4 OUTLIER -141.6 174.16 4.09 Favored Pre-proline 0 N--CA 1.493 1.71 0 O-C-N 121.064 -1.023 . . . . 0.0 110.779 -178.344 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 86' ' ' PRO . . . . . . . . . . . . . 73.2 Cg_endo -83.96 157.75 13.55 Favored 'Trans proline' 0 N--CA 1.492 1.433 0 C-N-CA 123.147 2.565 . . . . 0.0 114.082 -178.869 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 87' ' ' VAL . . . . . 0.558 HG23 ' HA ' ' A' ' 75' ' ' TYR . 57.3 t -114.6 103.24 15.03 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.89 0 O-C-N 121.73 -0.606 . . . . 0.0 109.706 -179.816 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 88' ' ' TYR . . . . . 0.412 ' CD2' ' HD2' ' A' ' 99' ' ' ARG . 19.5 m-85 -94.83 153.71 39.97 Favored Pre-proline 0 N--CA 1.502 2.139 0 O-C-N 120.827 -1.17 . . . . 0.0 110.31 -179.916 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 89' ' ' PRO . . . . . 0.425 ' HA ' ' CD2' ' A' ' 103' ' ' PHE . 8.3 Cg_endo -58.4 145.38 94.24 Favored 'Trans proline' 0 N--CA 1.494 1.537 0 C-N-CA 122.908 2.405 . . . . 0.0 113.452 -179.514 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . -59.84 168.91 7.55 Favored Glycine 0 N--CA 1.492 2.384 0 N-CA-C 109.208 -1.557 . . . . 0.0 109.208 179.211 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 91' ' ' PRO . . . . . 0.444 ' C ' ' H ' ' A' ' 93' ' ' THR . 72.1 Cg_endo -93.24 170.45 19.98 Favored 'Cis proline' 0 C--N 1.306 -1.669 0 C-N-CA 123.765 -1.348 . . . . 0.0 111.903 -0.237 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 92' ' ' ALA . . . . . 0.47 ' HB3' ' HB2' ' C' ' 703' ' ' PRO . . . -72.44 32.15 0.06 Allowed 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.134 -0.979 . . . . 0.0 110.433 -179.892 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 93' ' ' THR . . . . . 0.444 ' H ' ' C ' ' A' ' 91' ' ' PRO . 1.1 p -73.51 149.9 88.86 Favored Pre-proline 0 C--N 1.302 -1.486 0 O-C-N 120.847 -1.158 . . . . 0.0 108.427 179.723 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 94' ' ' PRO . . . . . 0.412 ' C ' ' O ' ' A' ' 93' ' ' THR . 95.4 Cg_exo -35.54 -45.05 0.71 Allowed 'Trans proline' 0 C--N 1.304 -1.772 0 C-N-CA 122.438 2.092 . . . . 0.0 111.746 -179.615 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 95' ' ' GLU . . . . . 0.628 ' O ' ' ND2' ' A' ' 98' ' ' ASN . 7.1 mt-10 -49.97 -55.13 15.78 Favored 'General case' 0 N--CA 1.489 1.477 0 O-C-N 121.18 -0.95 . . . . 0.0 109.393 179.341 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 96' ' ' GLN . . . . . 0.563 ' C ' ' H ' ' A' ' 98' ' ' ASN . 2.7 mp0 -73.03 -47.77 42.06 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.162 -0.961 . . . . 0.0 110.719 -179.658 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 97' ' ' LEU . . . . . 0.448 HD23 ' HA ' ' A' ' 97' ' ' LEU . 42.2 mt -52.55 -5.34 0.04 OUTLIER 'General case' 0 N--CA 1.493 1.691 0 O-C-N 120.971 -1.08 . . . . 0.0 109.095 -179.046 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 98' ' ' ASN . . . . . 0.75 HD21 ' NE ' ' A' ' 99' ' ' ARG . 0.5 OUTLIER -73.23 -26.35 61.09 Favored 'General case' 0 N--CA 1.494 1.747 0 O-C-N 121.351 -0.843 . . . . 0.0 109.087 179.466 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 99' ' ' ARG . . . . . 0.75 ' NE ' HD21 ' A' ' 98' ' ' ASN . 0.1 OUTLIER -99.03 -50.2 4.25 Favored 'General case' 0 C--N 1.3 -1.544 0 C-N-CA 119.7 -0.8 . . . . 0.0 110.064 -179.016 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . 180.0 -169.17 39.83 Favored Glycine 0 N--CA 1.495 2.578 0 C-N-CA 118.858 -1.639 . . . . 0.0 111.224 179.497 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 101' ' ' VAL . . . . . 0.73 ' O ' HG23 ' A' ' 101' ' ' VAL . 18.5 m -55.01 106.16 0.11 Allowed 'Isoleucine or valine' 0 N--CA 1.496 1.84 0 O-C-N 121.883 -0.775 . . . . 0.0 109.289 -179.851 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -92.56 164.17 13.53 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.373 -0.829 . . . . 0.0 111.577 -178.713 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 103' ' ' PHE . . . . . 0.427 ' CE1' ' CG1' ' A' ' 87' ' ' VAL . 23.9 m-85 -68.2 126.58 29.99 Favored 'General case' 0 N--CA 1.485 1.278 0 N-CA-C 106.763 -1.569 . . . . 0.0 106.763 177.309 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 104' ' ' ALA . . . . . 0.453 ' HB1' ' CG ' ' C' ' 703' ' ' PRO . . . -50.37 -11.26 0.07 Allowed 'General case' 0 C--N 1.293 -1.856 0 O-C-N 121.513 -0.742 . . . . 0.0 111.593 -178.267 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 105' ' ' GLU . . . . . 0.495 ' OE2' ' OE1' ' A' ' 108' ' ' GLU . 0.4 OUTLIER -140.57 145.89 37.34 Favored 'General case' 0 N--CA 1.495 1.795 0 O-C-N 120.751 -1.218 . . . . 0.0 110.565 179.988 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 106' ' ' GLU . . . . . . . . . . . . . 25.0 tt0 -58.84 -63.22 1.37 Allowed 'General case' 0 C--N 1.305 -1.356 0 O-C-N 121.733 -0.604 . . . . 0.0 110.019 -179.993 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 107' ' ' ASN . . . . . . . . . . . . . 15.9 m-80 -76.94 33.2 0.14 Allowed 'General case' 0 N--CA 1.487 1.413 0 O-C-N 120.381 -1.449 . . . . 0.0 112.683 -176.103 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 108' ' ' GLU . . . . . 0.495 ' OE1' ' OE2' ' A' ' 105' ' ' GLU . 35.0 tp10 -60.16 146.9 41.65 Favored 'General case' 0 N--CA 1.493 1.698 0 O-C-N 120.483 -1.386 . . . . 0.0 107.801 179.448 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 109' ' ' SER . . . . . 0.401 ' C ' ' N ' ' A' ' 111' ' ' ASP . 0.1 OUTLIER -101.2 128.59 47.24 Favored 'General case' 0 N--CA 1.489 1.501 0 O-C-N 120.824 -1.172 . . . . 0.0 110.912 -178.285 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 110' ' ' LEU . . . . . 0.626 HD23 ' N ' ' A' ' 110' ' ' LEU . 1.2 pt? -59.0 -10.02 2.27 Favored 'General case' 0 C--N 1.303 -1.433 0 N-CA-C 108.45 -0.945 . . . . 0.0 108.45 179.48 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 111' ' ' ASP . . . . . 0.401 ' N ' ' C ' ' A' ' 109' ' ' SER . 44.8 m-20 -131.74 29.62 4.45 Favored 'General case' 0 N--CA 1.491 1.587 0 N-CA-C 108.598 -0.89 . . . . 0.0 108.598 179.32 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 112' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -65.37 149.48 49.92 Favored 'General case' 0 N--CA 1.493 1.686 0 O-C-N 121.273 -0.892 . . . . 0.0 110.479 -179.232 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 113' ' ' GLN . . . . . 0.44 ' HA ' ' NE2' ' A' ' 113' ' ' GLN . 0.8 OUTLIER -66.87 -11.41 55.72 Favored 'General case' 0 C--N 1.303 -1.442 0 N-CA-C 107.709 -1.219 . . . . 0.0 107.709 177.773 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 114' ' ' ASN . . . . . 0.455 HD22 ' NE2' ' A' ' 178' ' ' GLN . 0.1 OUTLIER -149.47 102.59 3.2 Favored 'General case' 0 C--N 1.305 -1.347 0 N-CA-C 107.683 -1.229 . . . . 0.0 107.683 177.838 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 115' ' ' ILE . . . . . 0.461 ' O ' HG22 ' A' ' 115' ' ' ILE . 3.8 mt -97.74 111.26 27.13 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.528 0 O-C-N 120.961 -1.087 . . . . 0.0 109.437 -179.19 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 116' ' ' SER . . . . . . . . . . . . . 50.5 m -96.97 140.68 31.14 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.24 -0.913 . . . . 0.0 111.707 -178.087 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 117' ' ' ILE . . . . . . . . . . . . . 11.9 mt -130.25 152.49 37.51 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.414 0 N-CA-C 107.284 -1.376 . . . . 0.0 107.284 178.305 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 118' ' ' ALA . . . . . 0.663 ' HB1' ' HB2' ' C' ' 704' ' ' ALA . . . -142.87 157.54 44.49 Favored 'General case' 0 N--CA 1.493 1.684 0 O-C-N 120.707 -1.246 . . . . 0.0 111.087 -179.836 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 119' ' ' GLY . . . . . . . . . . . . . . . -162.45 145.09 10.28 Favored Glycine 0 N--CA 1.487 2.056 0 N-CA-C 110.085 -1.206 . . . . 0.0 110.085 179.964 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 120' ' ' HIS . . . . . . . . . . . . . 29.4 m170 -71.19 157.98 37.21 Favored 'General case' 0 N--CA 1.493 1.701 0 O-C-N 121.716 -0.873 . . . . 0.0 110.062 179.461 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 121' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -110.98 145.88 37.65 Favored 'General case' 0 N--CA 1.495 1.808 0 O-C-N 121.321 -0.862 . . . . 0.0 108.86 178.916 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 122' ' ' PHE . . . . . 0.489 ' O ' HG21 ' A' ' 131' ' ' THR . 0.3 OUTLIER -109.23 125.32 52.13 Favored 'General case' 0 N--CA 1.494 1.734 0 O-C-N 121.058 -1.026 . . . . 0.0 109.277 179.333 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 123' ' ' ILE . . . . . 0.559 HG23 ' N ' ' A' ' 124' ' ' ASP . 6.9 tp -74.43 -37.04 43.84 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.785 0 CA-C-O 121.876 0.846 . . . . 0.0 109.195 179.833 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 124' ' ' ASP . . . . . 0.559 ' N ' HG23 ' A' ' 123' ' ' ILE . 80.8 m-20 -92.88 15.13 15.49 Favored 'General case' 0 C--N 1.297 -1.715 0 O-C-N 121.897 -0.502 . . . . 0.0 111.281 -179.043 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 125' ' ' ARG . . . . . . . . . . . . . 7.3 ttt180 -153.95 115.17 2.58 Favored Pre-proline 0 N--CA 1.494 1.737 0 O-C-N 120.445 -1.409 . . . . 0.0 110.789 -178.555 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 126' ' ' PRO . . . . . . . . . . . . . 74.0 Cg_endo -83.76 -23.75 3.1 Favored 'Trans proline' 0 N--CA 1.487 1.123 0 C-N-CA 122.11 1.873 . . . . 0.0 112.083 178.81 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 127' ' ' ASN . . . . . 0.48 ' ND2' ' O ' ' A' ' 127' ' ' ASN . 2.3 p-10 -88.82 28.89 1.09 Allowed 'General case' 0 N--CA 1.492 1.654 0 O-C-N 120.898 -1.126 . . . . 0.0 110.051 -179.558 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 128' ' ' TYR . . . . . . . . . . . . . 9.9 t80 -87.71 -148.58 0.15 Allowed 'General case' 0 N--CA 1.49 1.564 0 O-C-N 120.94 -1.1 . . . . 0.0 109.554 179.906 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 129' ' ' GLN . . . . . 0.435 ' O ' ' OE2' ' A' ' 85' ' ' GLU . 80.4 mt-30 -66.95 -69.59 0.3 Allowed 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.29 -0.881 . . . . 0.0 110.802 -178.742 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 130' ' ' PHE . . . . . . . . . . . . . 55.8 m-85 -130.47 31.34 4.59 Favored 'General case' 0 N--CA 1.499 1.99 0 O-C-N 121.056 -1.027 . . . . 0.0 110.841 -179.126 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 131' ' ' THR . . . . . 0.489 HG21 ' O ' ' A' ' 122' ' ' PHE . 52.4 m -70.77 -32.99 70.3 Favored 'General case' 0 C--N 1.301 -1.522 0 O-C-N 120.344 -1.473 . . . . 0.0 108.205 179.451 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 132' ' ' ASN . . . . . 0.575 ' ND2' ' O ' ' A' ' 81' ' ' ALA . 2.0 p-10 -91.21 15.24 12.27 Favored 'General case' 0 N--CA 1.498 1.97 0 C-N-CA 119.915 -0.714 . . . . 0.0 111.179 -179.565 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 133' ' ' LEU . . . . . 0.599 ' O ' ' N ' ' A' ' 135' ' ' ALA . 0.2 OUTLIER -77.06 -44.17 31.69 Favored 'General case' 0 C--N 1.301 -1.535 0 O-C-N 120.651 -1.281 . . . . 0.0 109.185 -179.801 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 134' ' ' LYS . . . . . 0.71 ' H ' ' CE ' ' A' ' 134' ' ' LYS . 0.0 OUTLIER -46.97 -6.94 0.01 OUTLIER 'General case' 0 C--N 1.299 -1.606 0 O-C-N 121.661 -0.65 . . . . 0.0 110.428 -179.42 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 135' ' ' ALA . . . . . 0.599 ' N ' ' O ' ' A' ' 133' ' ' LEU . . . -84.0 -40.32 18.58 Favored 'General case' 0 N--CA 1.488 1.462 0 O-C-N 120.912 -1.118 . . . . 0.0 108.97 178.962 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 136' ' ' ALA . . . . . 0.555 ' HB2' ' HB2' ' A' ' 81' ' ' ALA . . . -79.77 162.3 25.21 Favored 'General case' 0 N--CA 1.487 1.402 0 CA-C-O 122.21 1.005 . . . . 0.0 111.357 -178.752 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 137' ' ' LYS . . . . . 0.513 ' O ' ' O ' ' A' ' 138' ' ' LYS . 17.4 pttt -153.04 -164.02 1.83 Allowed 'General case' 0 C--N 1.3 -1.584 0 C-N-CA 118.721 -1.192 . . . . 0.0 111.097 -177.918 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 138' ' ' LYS . . . . . 0.602 ' O ' ' N ' ' A' ' 140' ' ' SER . 1.4 mmmp? -45.92 -179.9 0.0 OUTLIER 'General case' 0 C--N 1.303 -1.445 0 CA-C-O 122.1 0.953 . . . . 0.0 110.356 -179.564 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 139' ' ' GLY . . . . . . . . . . . . . . . 46.14 7.81 0.02 OUTLIER Glycine 0 N--CA 1.49 2.283 0 N-CA-C 110.547 -1.021 . . . . 0.0 110.547 179.735 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 140' ' ' SER . . . . . 0.602 ' N ' ' O ' ' A' ' 138' ' ' LYS . 13.1 t -83.04 143.78 30.37 Favored 'General case' 0 N--CA 1.493 1.679 0 O-C-N 120.849 -1.383 . . . . 0.0 108.922 179.108 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 141' ' ' MET . . . . . . . . . . . . . 0.1 OUTLIER -88.68 133.91 34.06 Favored 'General case' 0 C--N 1.3 -1.552 0 O-C-N 121.091 -1.006 . . . . 0.0 109.316 179.787 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 142' ' ' VAL . . . . . 0.429 HG22 HG12 ' A' ' 78' ' ' ILE . 21.4 t -121.81 126.19 74.28 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.631 0 N-CA-C 108.781 -0.822 . . . . 0.0 108.781 179.934 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 143' ' ' TYR . . . . . . . . . . . . . 61.1 m-85 -104.2 134.28 47.71 Favored 'General case' 0 N--CA 1.496 1.857 0 O-C-N 121.26 -0.9 . . . . 0.0 110.975 -178.915 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 144' ' ' PHE . . . . . . . . . . . . . 53.0 t80 -112.0 154.3 25.53 Favored 'General case' 0 N--CA 1.492 1.666 0 CA-C-O 121.773 0.797 . . . . 0.0 110.101 -179.393 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 145' ' ' LYS . . . . . 0.429 ' CG ' ' OG1' ' A' ' 150' ' ' THR . 1.8 mttm -149.07 125.64 11.02 Favored 'General case' 0 N--CA 1.494 1.759 0 C-N-CA 118.866 -1.134 . . . . 0.0 111.707 -177.764 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 146' ' ' VAL . . . . . . . . . . . . . 0.2 OUTLIER -144.81 139.9 23.19 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.559 0 N-CA-C 107.028 -1.471 . . . . 0.0 107.028 178.149 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 147' ' ' GLY . . . . . . . . . . . . . . . 53.89 -138.07 38.95 Favored Glycine 0 N--CA 1.489 2.201 0 N-CA-C 107.878 -2.089 . . . . 0.0 107.878 -178.692 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 148' ' ' ASN . . . . . 0.591 HD22 ' C ' ' A' ' 148' ' ' ASN . 0.4 OUTLIER -101.63 26.65 7.12 Favored 'General case' 0 N--CA 1.489 1.498 0 O-C-N 121.052 -1.263 . . . . 0.0 107.832 178.491 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 149' ' ' GLU . . . . . . . . . . . . . 2.1 tm-20 -112.05 151.97 28.74 Favored 'General case' 0 N--CA 1.486 1.335 0 CA-C-O 121.872 0.844 . . . . 0.0 110.921 -178.805 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 150' ' ' THR . . . . . 0.429 ' OG1' ' CG ' ' A' ' 145' ' ' LYS . 2.9 m -141.02 104.89 4.75 Favored 'General case' 0 N--CA 1.495 1.818 0 CA-C-O 121.559 0.695 . . . . 0.0 109.216 179.828 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 151' ' ' ARG . . . . . . . . . . . . . 73.9 mtt180 -87.57 -164.9 1.17 Allowed 'General case' 0 N--CA 1.487 1.403 0 O-C-N 121.355 -0.841 . . . . 0.0 109.297 -179.52 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 152' ' ' LYS . . . . . 0.528 ' O ' ' N ' ' A' ' 205' ' ' VAL . 7.3 mtmt -147.34 144.24 28.61 Favored 'General case' 0 C--N 1.301 -1.535 0 O-C-N 121.433 -0.792 . . . . 0.0 109.329 -179.671 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 153' ' ' TYR . . . . . 0.536 ' CD2' ' HA ' ' A' ' 204' ' ' GLU . 26.9 m-85 -140.44 169.41 17.72 Favored 'General case' 0 N--CA 1.489 1.51 0 N-CA-C 108.344 -0.984 . . . . 0.0 108.344 179.948 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 154' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -143.38 120.91 11.74 Favored 'General case' 0 C--N 1.299 -1.623 0 O-C-N 121.329 -0.857 . . . . 0.0 108.986 179.175 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 155' ' ' MET . . . . . . . . . . . . . 27.0 mtp -46.61 110.09 0.25 Allowed 'General case' 0 N--CA 1.496 1.855 0 O-C-N 120.576 -1.327 . . . . 0.0 110.954 -179.112 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 156' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -104.24 -30.26 10.28 Favored 'General case' 0 C--N 1.294 -1.846 0 C-N-CA 119.817 -0.753 . . . . 0.0 111.034 -178.286 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 157' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -154.53 157.52 38.45 Favored 'General case' 0 N--CA 1.495 1.801 0 C-N-CA 118.179 -1.408 . . . . 0.0 111.757 -178.136 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 158' ' ' ILE . . . . . 0.423 HG12 ' N ' ' A' ' 159' ' ' ARG . 0.0 OUTLIER -155.26 146.23 12.99 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.562 0 CA-C-O 121.785 0.802 . . . . 0.0 110.748 -178.995 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 159' ' ' ARG . . . . . 0.65 ' CG ' HH11 ' A' ' 159' ' ' ARG . 0.0 OUTLIER -158.13 159.16 35.91 Favored 'General case' 0 C--N 1.303 -1.429 0 CA-C-O 121.757 0.789 . . . . 0.0 110.967 -179.824 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 160' ' ' ASP . . . . . 0.469 ' C ' HG22 ' A' ' 161' ' ' VAL . 0.3 OUTLIER -117.37 163.92 15.63 Favored 'General case' 0 N--CA 1.488 1.43 0 N-CA-C 108.326 -0.99 . . . . 0.0 108.326 178.829 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 161' ' ' VAL . . . . . 0.487 ' O ' ' O ' ' A' ' 162' ' ' LYS . 0.1 OUTLIER -162.11 156.2 2.64 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.816 0 O-C-N 121.158 -0.964 . . . . 0.0 109.828 -179.425 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 162' ' ' LYS . . . . . 0.584 ' CD ' ' H ' ' A' ' 162' ' ' LYS . 0.0 OUTLIER -44.96 171.68 0.05 OUTLIER Pre-proline 0 N--CA 1.494 1.738 0 O-C-N 121.378 -0.826 . . . . 0.0 109.63 179.723 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 163' ' ' PRO . . . . . . . . . . . . . 73.7 Cg_endo -81.87 36.38 0.62 Allowed 'Trans proline' 0 N--CA 1.493 1.451 0 C-N-CA 122.791 2.328 . . . . 0.0 113.141 -179.521 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 164' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -152.69 -4.8 0.22 Allowed 'General case' 0 N--CA 1.492 1.663 0 O-C-N 120.907 -1.121 . . . . 0.0 110.35 -179.981 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 165' ' ' ASP . . . . . 0.475 ' O ' ' N ' ' A' ' 167' ' ' GLY . 8.8 t0 -74.8 62.6 1.1 Allowed 'General case' 0 N--CA 1.492 1.631 0 O-C-N 120.925 -1.109 . . . . 0.0 110.641 -179.35 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 166' ' ' VAL . . . . . 0.648 ' O ' ' N ' ' A' ' 168' ' ' VAL . 0.9 OUTLIER -39.43 -29.03 0.09 OUTLIER 'Isoleucine or valine' 0 N--CA 1.497 1.89 0 O-C-N 121.284 -0.885 . . . . 0.0 109.563 -178.45 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 167' ' ' GLY . . . . . 0.475 ' N ' ' O ' ' A' ' 165' ' ' ASP . . . -43.07 -13.92 0.01 OUTLIER Glycine 0 N--CA 1.496 2.636 0 N-CA-C 109.515 -1.434 . . . . 0.0 109.515 179.622 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 168' ' ' VAL . . . . . 0.648 ' N ' ' O ' ' A' ' 166' ' ' VAL . 1.3 t -48.26 -44.41 12.73 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.454 0 O-C-N 121.448 -1.031 . . . . 0.0 108.43 178.925 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 169' ' ' LEU . . . . . 0.571 ' O ' ' C ' ' A' ' 170' ' ' ASP . 47.1 mt -49.92 -9.7 0.04 OUTLIER 'General case' 0 N--CA 1.492 1.66 0 N-CA-C 109.001 -0.741 . . . . 0.0 109.001 -178.092 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 170' ' ' ASP . . . . . 0.617 ' CG ' ' HG1' ' A' ' 180' ' ' THR . 17.7 p-10 19.46 86.51 0.01 OUTLIER 'General case' 0 N--CA 1.494 1.739 0 CA-C-O 121.051 0.453 . . . . 0.0 110.981 178.578 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 171' ' ' GLU . . . . . . . . . . . . . 6.7 pt-20 -121.29 61.38 0.91 Allowed 'General case' 0 N--CA 1.494 1.725 0 O-C-N 121.175 -0.953 . . . . 0.0 109.938 -179.228 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 172' ' ' GLN . . . . . . . . . . . . . 3.0 pt20 -135.03 -44.93 0.72 Allowed 'General case' 0 N--CA 1.492 1.668 0 O-C-N 121.527 -0.733 . . . . 0.0 109.942 -178.975 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 173' ' ' LYS . . . . . . . . . . . . . 21.5 mttp -62.54 128.93 38.29 Favored 'General case' 0 N--CA 1.489 1.498 0 O-C-N 120.899 -1.126 . . . . 0.0 108.106 178.949 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 174' ' ' GLY . . . . . 0.552 ' O ' ' C ' ' A' ' 175' ' ' LYS . . . -137.63 -40.37 0.11 Allowed Glycine 0 C--N 1.293 -1.807 0 N-CA-C 109.071 -1.612 . . . . 0.0 109.071 -179.722 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 175' ' ' LYS . . . . . 0.552 ' C ' ' O ' ' A' ' 174' ' ' GLY . 4.4 mptp? -30.87 -65.28 0.12 Allowed 'General case' 0 N--CA 1.499 2.011 0 N-CA-C 108.9 -0.778 . . . . 0.0 108.9 -179.751 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 176' ' ' ASP . . . . . 0.696 ' O ' ' O ' ' A' ' 177' ' ' LYS . 58.2 m-20 -101.39 78.7 1.9 Allowed 'General case' 0 C--N 1.296 -1.728 0 N-CA-C 107.79 -1.189 . . . . 0.0 107.79 177.843 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 177' ' ' LYS . . . . . 0.696 ' O ' ' O ' ' A' ' 176' ' ' ASP . 0.7 OUTLIER -20.54 158.02 0.0 OUTLIER 'General case' 0 N--CA 1.507 2.39 0 CA-C-O 122.218 1.009 . . . . 0.0 112.249 -179.075 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 178' ' ' GLN . . . . . 0.455 ' NE2' HD22 ' A' ' 114' ' ' ASN . 0.4 OUTLIER -157.03 164.22 38.2 Favored 'General case' 0 C--N 1.303 -1.414 0 C-N-CA 117.052 -1.859 . . . . 0.0 112.026 179.804 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 179' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -122.23 107.39 12.08 Favored 'General case' 0 C--N 1.303 -1.42 0 N-CA-C 107.345 -1.354 . . . . 0.0 107.345 179.083 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 180' ' ' THR . . . . . 0.617 ' HG1' ' CG ' ' A' ' 170' ' ' ASP . 1.0 OUTLIER -78.66 120.32 23.16 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 120.87 -1.144 . . . . 0.0 110.278 -178.427 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 181' ' ' LEU . . . . . . . . . . . . . 10.2 tp -100.16 105.78 17.42 Favored 'General case' 0 N--CA 1.492 1.671 0 O-C-N 121.536 -0.728 . . . . 0.0 109.099 178.883 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 182' ' ' ILE . . . . . . . . . . . . . 56.3 mt -95.63 125.86 48.29 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.419 0 O-C-N 121.064 -1.022 . . . . 0.0 110.046 179.875 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 183' ' ' THR . . . . . 0.434 HG21 ' CE2' ' A' ' 200' ' ' PHE . 0.0 OUTLIER -135.75 111.74 9.57 Favored 'General case' 0 C--N 1.294 -1.843 0 N-CA-C 107.367 -1.346 . . . . 0.0 107.367 178.493 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 184' ' ' CYS . . . . . . . . . . . . . 0.8 OUTLIER -79.6 156.14 27.81 Favored 'General case' 0 C--N 1.292 -1.909 0 C-N-CA 118.783 -1.167 . . . . 0.0 110.851 -177.947 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 185' ' ' ASP . . . . . 0.481 ' OD1' ' N ' ' A' ' 186' ' ' ASP . 10.3 t0 -167.24 -154.07 0.16 Allowed 'General case' 0 N--CA 1.495 1.789 0 O-C-N 121.365 -0.834 . . . . 0.0 109.821 -179.656 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 186' ' ' ASP . . . . . 0.481 ' N ' ' OD1' ' A' ' 185' ' ' ASP . 0.9 OUTLIER 52.8 52.63 13.58 Favored 'General case' 0 N--CA 1.496 1.862 0 O-C-N 121.294 -0.879 . . . . 0.0 109.504 -179.858 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 187' ' ' TYR . . . . . 0.577 ' CE1' ' O ' ' A' ' 188' ' ' ASN . 56.9 t80 -68.68 129.25 39.39 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.291 -0.881 . . . . 0.0 110.958 -179.677 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 188' ' ' ASN . . . . . 0.817 HD21 ' N ' ' A' ' 192' ' ' GLY . 0.0 OUTLIER -101.09 151.39 21.87 Favored 'General case' 0 C--N 1.293 -1.86 0 N-CA-C 107.07 -1.456 . . . . 0.0 107.07 177.073 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 189' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -112.82 -7.15 13.79 Favored 'General case' 0 C--N 1.294 -1.816 0 N-CA-C 108.179 -1.045 . . . . 0.0 108.179 -179.526 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 190' ' ' LYS . . . . . 0.585 ' N ' ' OD1' ' A' ' 188' ' ' ASN . 0.6 OUTLIER -82.91 -56.16 3.98 Favored 'General case' 0 N--CA 1.489 1.482 0 C-N-CA 120.062 -0.655 . . . . 0.0 109.424 179.144 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 191' ' ' THR . . . . . 0.56 ' C ' HD21 ' A' ' 188' ' ' ASN . 4.9 p -88.12 -2.86 58.86 Favored 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.305 -0.872 . . . . 0.0 109.453 -179.779 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 192' ' ' GLY . . . . . 0.817 ' N ' HD21 ' A' ' 188' ' ' ASN . . . 62.86 33.18 86.3 Favored Glycine 0 N--CA 1.493 2.483 0 O-C-N 121.345 -0.847 . . . . 0.0 111.657 178.349 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 193' ' ' VAL . . . . . 0.791 ' H ' HD22 ' A' ' 188' ' ' ASN . 4.0 p -147.81 167.05 4.97 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.689 0 O-C-N 120.686 -1.479 . . . . 0.0 109.959 178.873 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 194' ' ' TRP . . . . . 0.491 ' H ' HG22 ' A' ' 193' ' ' VAL . 17.0 m95 -82.04 120.86 25.81 Favored 'General case' 0 C--N 1.295 -1.764 0 N-CA-C 108.495 -0.928 . . . . 0.0 108.495 179.854 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 195' ' ' GLU . . . . . . . . . . . . . 1.3 mt-10 -83.84 -60.97 1.95 Allowed 'General case' 0 C--N 1.301 -1.513 0 O-C-N 121.471 -0.768 . . . . 0.0 110.864 -178.086 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 196' ' ' LYS . . . . . . . . . . . . . 12.8 tttt -86.39 158.42 19.63 Favored 'General case' 0 C--N 1.301 -1.527 0 O-C-N 120.888 -1.132 . . . . 0.0 110.566 -179.007 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 197' ' ' ARG . . . . . 0.404 ' HE ' ' HB2' ' C' ' 702' ' ' LEU . 0.0 OUTLIER -126.29 135.73 51.89 Favored 'General case' 0 N--CA 1.489 1.482 0 N-CA-C 108.512 -0.922 . . . . 0.0 108.512 179.116 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 198' ' ' LYS . . . . . . . . . . . . . 14.3 mttt -115.39 120.93 41.23 Favored 'General case' 0 N--CA 1.494 1.727 0 O-C-N 121.553 -0.717 . . . . 0.0 110.422 -179.197 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 199' ' ' ILE . . . . . 0.462 ' C ' HD12 ' A' ' 199' ' ' ILE . 0.9 OUTLIER -141.51 118.81 8.06 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.646 0 CA-C-O 122.494 1.14 . . . . 0.0 110.043 179.478 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 200' ' ' PHE . . . . . 0.619 ' CD1' ' N ' ' A' ' 200' ' ' PHE . 0.3 OUTLIER -104.24 135.74 45.15 Favored 'General case' 0 N--CA 1.496 1.855 0 O-C-N 121.295 -0.878 . . . . 0.0 109.586 -178.441 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 201' ' ' VAL . . . . . 0.444 HG12 ' N ' ' A' ' 202' ' ' ALA . 85.2 t -104.36 154.57 6.1 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.611 0 O-C-N 120.979 -1.076 . . . . 0.0 109.07 178.585 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 202' ' ' ALA . . . . . 0.444 ' N ' HG12 ' A' ' 201' ' ' VAL . . . -136.49 142.37 43.52 Favored 'General case' 0 C--N 1.302 -1.472 0 O-C-N 121.153 -0.967 . . . . 0.0 109.055 179.991 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 203' ' ' THR . . . . . 0.507 ' O ' HG23 ' A' ' 205' ' ' VAL . 0.6 OUTLIER -88.59 129.66 35.44 Favored 'General case' 0 N--CA 1.488 1.465 0 CA-C-O 122.281 1.039 . . . . 0.0 111.26 -178.455 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 204' ' ' GLU . . . . . 0.536 ' HA ' ' CD2' ' A' ' 153' ' ' TYR . 12.0 tt0 -49.59 134.74 19.42 Favored 'General case' 0 C--N 1.298 -1.643 0 C-N-CA 119.098 -1.041 . . . . 0.0 108.626 178.38 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 205' ' ' VAL . . . . . 0.539 HG12 ' N ' ' A' ' 206' ' ' LYS . 39.0 t -125.86 161.13 31.62 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.304 0 CA-C-O 122.263 1.03 . . . . 0.0 110.431 -177.765 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 206' ' ' LYS . . . . . 0.539 ' N ' HG12 ' A' ' 205' ' ' VAL . 13.1 mtmt . . . . . 0 C--N 1.293 -1.864 0 CA-C-O 117.931 -1.033 . . . . 0.0 108.983 179.754 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' C' C ' 702' ' ' LEU . . . . . 0.858 ' N ' HD12 ' C' ' 702' ' ' LEU . 0.0 OUTLIER . . . . . 0 N--CA 1.488 1.453 0 N-CA-C 108.735 -0.839 . . . . 0.0 108.735 . . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' C' C ' 703' ' ' PRO . . . . . 0.47 ' HB2' ' HB3' ' A' ' 92' ' ' ALA . 9.4 Cg_endo -64.97 -173.0 0.23 Allowed 'Trans proline' 0 N--CA 1.491 1.341 0 C-N-CA 121.619 1.546 . . . . 0.0 112.099 -179.666 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' C' C ' 704' ' ' ALA . . . . . 0.663 ' HB2' ' HB1' ' A' ' 118' ' ' ALA . . . . . . . . 0 N--CA 1.487 1.415 0 O-C-N 121.334 -0.854 . . . . 0.0 109.396 -179.558 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 63' ' ' PRO . . . . . . . . . . . . . 45.2 Cg_endo . . . . . 0 C--O 1.217 -0.57 0 CA-C-O 121.339 0.474 . . . . 0.0 112.224 . . . . . . . . . 0 0 . 1 . 020 nuclear nobuild core ' A' A ' 64' ' ' GLN . . . . . 0.672 ' NE2' ' N ' ' A' ' 64' ' ' GLN . 0.0 OUTLIER -153.98 117.49 4.63 Favored 'General case' 0 N--CA 1.498 1.932 0 O-C-N 121.531 -0.73 . . . . 0.0 109.163 179.517 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 65' ' ' ILE . . . . . 0.44 ' C ' ' O ' ' A' ' 64' ' ' GLN . 3.2 mp -45.28 105.75 0.49 Allowed Pre-proline 0 N--CA 1.493 1.682 0 O-C-N 121.027 -1.045 . . . . 0.0 108.758 179.395 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 66' ' ' PRO . . . . . . . . . . . . . 84.5 Cg_endo -86.46 -158.08 0.08 OUTLIER 'Trans proline' 0 N--CA 1.488 1.148 0 C-N-CA 122.048 1.832 . . . . 0.0 112.51 -179.536 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 67' ' ' LYS . . . . . 0.435 ' O ' ' N ' ' A' ' 69' ' ' LYS . 0.0 OUTLIER -82.82 -4.56 58.18 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.396 -0.815 . . . . 0.0 109.584 -179.756 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 68' ' ' ASP . . . . . 0.62 ' C ' ' N ' ' A' ' 70' ' ' SER . 0.3 OUTLIER -74.05 51.1 0.39 Allowed 'General case' 0 N--CA 1.487 1.411 0 CA-C-O 122.913 1.34 . . . . 0.0 107.919 179.28 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 69' ' ' LYS . . . . . 0.435 ' N ' ' O ' ' A' ' 67' ' ' LYS . 0.1 OUTLIER -49.54 -13.13 0.07 Allowed 'General case' 0 C--N 1.29 -1.99 0 C-N-CA 116.889 -1.924 . . . . 0.0 106.976 178.792 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 70' ' ' SER . . . . . 0.62 ' N ' ' C ' ' A' ' 68' ' ' ASP . 3.6 p -84.25 -8.99 58.87 Favored 'General case' 0 N--CA 1.498 1.96 0 CA-C-N 113.631 -1.622 . . . . 0.0 110.056 178.444 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 71' ' ' LYS . . . . . . . . . . . . . 2.6 ptmm? -96.89 140.57 31.24 Favored 'General case' 0 N--CA 1.494 1.737 0 O-C-N 120.905 -1.122 . . . . 0.0 111.003 -179.739 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 72' ' ' VAL . . . . . 0.674 HG12 ' CE1' ' A' ' 88' ' ' TYR . 1.1 m -63.23 139.78 20.71 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.387 0 N-CA-C 104.331 -2.47 . . . . 0.0 104.331 175.288 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 73' ' ' ALA . . . . . 0.512 ' N ' ' O ' ' A' ' 87' ' ' VAL . . . -82.15 -16.99 47.93 Favored 'General case' 0 C--N 1.287 -2.14 0 C-N-CA 117.405 -1.718 . . . . 0.0 106.806 -179.948 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . 177.7 -158.54 23.8 Favored Glycine 0 C--N 1.298 -1.54 0 N-CA-C 109.383 -1.487 . . . . 0.0 109.383 179.408 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 75' ' ' TYR . . . . . 0.499 ' HA ' HG23 ' A' ' 87' ' ' VAL . 0.7 OUTLIER -143.47 165.48 27.44 Favored 'General case' 0 C--N 1.296 -1.729 0 O-C-N 121.716 -0.873 . . . . 0.0 110.55 -176.722 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 76' ' ' ILE . . . . . . . . . . . . . 4.4 tt -148.66 146.68 17.42 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.453 0 C-N-CA 119.069 -1.052 . . . . 0.0 110.659 -177.866 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -150.13 167.84 25.66 Favored 'General case' 0 N--CA 1.489 1.482 0 O-C-N 121.181 -0.949 . . . . 0.0 109.195 179.119 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 78' ' ' ILE . . . . . 0.472 ' HB ' ' HB3' ' A' ' 81' ' ' ALA . 16.9 mt -149.67 98.18 3.43 Favored Pre-proline 0 C--N 1.303 -1.442 0 N-CA-C 108.543 -0.91 . . . . 0.0 108.543 179.474 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 79' ' ' PRO . . . . . . . . . . . . . 54.1 Cg_exo -48.83 -46.57 24.22 Favored 'Trans proline' 0 C--N 1.31 -1.481 0 C-N-CA 122.517 2.145 . . . . 0.0 113.76 -178.95 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -66.02 -19.83 65.99 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 120.892 -1.13 . . . . 0.0 111.244 179.339 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 81' ' ' ALA . . . . . 0.711 ' HB2' ' HB2' ' A' ' 136' ' ' ALA . . . -105.42 -19.34 13.82 Favored 'General case' 0 N--CA 1.495 1.806 0 O-C-N 121.052 -1.03 . . . . 0.0 108.861 179.633 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 82' ' ' ASP . . . . . 0.452 ' CB ' ' O ' ' A' ' 81' ' ' ALA . 5.6 t70 71.42 48.01 0.35 Allowed 'General case' 0 N--CA 1.494 1.736 0 O-C-N 120.988 -1.07 . . . . 0.0 110.328 179.33 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 83' ' ' ILE . . . . . 0.508 HD11 ' OD1' ' A' ' 132' ' ' ASN . 82.5 mt -127.42 152.57 35.63 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.696 0 O-C-N 121.265 -0.897 . . . . 0.0 110.021 -179.006 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 84' ' ' LYS . . . . . . . . . . . . . 33.2 tttt -159.46 107.32 1.76 Allowed 'General case' 0 N--CA 1.491 1.617 0 N-CA-C 107.944 -1.132 . . . . 0.0 107.944 179.427 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 85' ' ' GLU . . . . . 0.413 ' C ' ' CD2' ' A' ' 75' ' ' TYR . 0.3 OUTLIER -144.05 164.85 27.03 Favored Pre-proline 0 N--CA 1.491 1.604 0 O-C-N 121.281 -0.887 . . . . 0.0 110.488 -178.741 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 86' ' ' PRO . . . . . 0.409 ' O ' HG22 ' A' ' 101' ' ' VAL . 55.8 Cg_endo -72.46 170.38 19.47 Favored 'Trans proline' 0 N--CA 1.495 1.578 0 C-N-CA 123.635 2.89 . . . . 0.0 113.633 -179.494 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 87' ' ' VAL . . . . . 0.512 ' O ' ' N ' ' A' ' 73' ' ' ALA . 54.1 t -127.26 98.07 4.41 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.822 0 N-CA-C 109.047 -0.723 . . . . 0.0 109.047 179.828 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 88' ' ' TYR . . . . . 0.674 ' CE1' HG12 ' A' ' 72' ' ' VAL . 21.1 m-85 -88.17 154.05 51.74 Favored Pre-proline 0 N--CA 1.505 2.284 0 O-C-N 120.659 -1.276 . . . . 0.0 110.42 -179.443 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 89' ' ' PRO . . . . . 0.422 ' HA ' ' CD2' ' A' ' 103' ' ' PHE . 9.7 Cg_endo -61.54 145.09 98.12 Favored 'Trans proline' 0 C--N 1.311 -1.429 0 C-N-CA 122.5 2.133 . . . . 0.0 113.76 -179.677 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . -56.58 166.05 4.69 Favored Glycine 0 N--CA 1.491 2.342 0 N-CA-C 109.575 -1.41 . . . . 0.0 109.575 179.255 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 91' ' ' PRO . . . . . 0.439 ' C ' ' H ' ' A' ' 93' ' ' THR . 44.8 Cg_endo -94.29 168.22 19.08 Favored 'Cis proline' 0 C--N 1.312 -1.38 0 C-N-CA 123.864 -1.307 . . . . 0.0 111.949 0.167 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 92' ' ' ALA . . . . . 0.727 ' HB1' HD21 ' A' ' 97' ' ' LEU . . . -71.91 31.26 0.05 Allowed 'General case' 0 C--N 1.302 -1.463 0 O-C-N 121.281 -0.887 . . . . 0.0 110.396 179.952 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 93' ' ' THR . . . . . 0.439 ' H ' ' C ' ' A' ' 91' ' ' PRO . 1.0 OUTLIER -74.71 151.24 86.85 Favored Pre-proline 0 N--CA 1.491 1.605 0 O-C-N 120.501 -1.374 . . . . 0.0 108.43 179.846 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 94' ' ' PRO . . . . . 0.414 ' C ' ' O ' ' A' ' 93' ' ' THR . 86.5 Cg_exo -29.91 -54.42 0.19 Allowed 'Trans proline' 0 C--N 1.308 -1.565 0 C-N-CA 123.228 2.619 . . . . 0.0 113.207 -178.861 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 83.6 mt-10 -47.24 -49.31 23.58 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 120.796 -1.19 . . . . 0.0 109.706 -179.528 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 96' ' ' GLN . . . . . 0.694 HE21 HH12 ' A' ' 99' ' ' ARG . 6.1 mp0 -71.72 -53.13 14.47 Favored 'General case' 0 C--N 1.303 -1.446 0 O-C-N 121.337 -0.852 . . . . 0.0 110.376 -179.658 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 97' ' ' LEU . . . . . 0.727 HD21 ' HB1' ' A' ' 92' ' ' ALA . 83.8 mt -50.53 -9.0 0.04 OUTLIER 'General case' 0 N--CA 1.493 1.724 0 O-C-N 121.149 -0.969 . . . . 0.0 110.299 -178.498 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 98' ' ' ASN . . . . . 0.628 HD21 ' NE ' ' A' ' 99' ' ' ARG . 0.2 OUTLIER -72.55 -27.69 62.38 Favored 'General case' 0 N--CA 1.488 1.45 0 O-C-N 121.029 -1.044 . . . . 0.0 108.863 179.534 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 99' ' ' ARG . . . . . 0.694 HH12 HE21 ' A' ' 96' ' ' GLN . 6.1 mtt180 -94.27 -60.17 1.79 Allowed 'General case' 0 N--CA 1.491 1.577 0 C-N-CA 119.973 -0.691 . . . . 0.0 110.529 -179.651 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . -171.66 -166.58 30.61 Favored Glycine 0 N--CA 1.499 2.835 0 C-N-CA 119.424 -1.369 . . . . 0.0 111.003 -179.501 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 101' ' ' VAL . . . . . 0.748 ' O ' HG23 ' A' ' 101' ' ' VAL . 16.3 m -57.47 106.46 0.18 Allowed 'Isoleucine or valine' 0 N--CA 1.498 1.928 0 O-C-N 121.554 -0.968 . . . . 0.0 109.455 -179.783 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -93.8 159.71 15.07 Favored 'General case' 0 N--CA 1.493 1.696 0 O-C-N 121.244 -0.91 . . . . 0.0 111.633 -179.068 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 103' ' ' PHE . . . . . 0.422 ' CD2' ' HA ' ' A' ' 89' ' ' PRO . 23.5 m-85 -63.18 130.93 46.71 Favored 'General case' 0 N--CA 1.49 1.531 0 N-CA-C 107.881 -1.155 . . . . 0.0 107.881 178.235 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 104' ' ' ALA . . . . . . . . . . . . . . . -50.95 -18.34 0.75 Allowed 'General case' 0 C--N 1.299 -1.619 0 O-C-N 121.58 -0.7 . . . . 0.0 111.42 -178.532 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -136.91 146.66 45.74 Favored 'General case' 0 N--CA 1.495 1.808 0 O-C-N 120.799 -1.188 . . . . 0.0 111.011 -179.447 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 106' ' ' GLU . . . . . . . . . . . . . 1.7 tt0 -55.26 -62.33 1.74 Allowed 'General case' 0 C--N 1.305 -1.351 0 CA-C-N 116.061 -0.518 . . . . 0.0 110.316 -179.903 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 107' ' ' ASN . . . . . 0.661 HD22 ' N ' ' A' ' 107' ' ' ASN . 0.7 OUTLIER -78.81 33.48 0.21 Allowed 'General case' 0 N--CA 1.491 1.607 0 O-C-N 120.609 -1.307 . . . . 0.0 113.184 -175.638 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 108' ' ' GLU . . . . . . . . . . . . . 29.0 tp10 -58.25 143.32 44.85 Favored 'General case' 0 N--CA 1.495 1.813 0 O-C-N 120.468 -1.395 . . . . 0.0 107.963 179.945 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 109' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -94.95 140.45 29.92 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 120.961 -1.087 . . . . 0.0 110.987 -178.013 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 110' ' ' LEU . . . . . 0.484 HD11 HG21 ' A' ' 146' ' ' VAL . 0.7 OUTLIER -63.7 -16.78 61.94 Favored 'General case' 0 C--N 1.302 -1.469 0 N-CA-C 108.754 -0.832 . . . . 0.0 108.754 179.207 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 111' ' ' ASP . . . . . . . . . . . . . 13.0 m-20 -133.1 36.83 3.43 Favored 'General case' 0 N--CA 1.488 1.475 0 O-C-N 121.677 -0.639 . . . . 0.0 109.762 -179.439 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 112' ' ' ASP . . . . . . . . . . . . . 1.7 t0 -65.93 150.07 49.22 Favored 'General case' 0 N--CA 1.494 1.76 0 O-C-N 121.033 -1.042 . . . . 0.0 110.706 -179.58 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 113' ' ' GLN . . . . . 0.477 ' HA ' ' NE2' ' A' ' 113' ' ' GLN . 0.8 OUTLIER -68.11 -13.12 61.97 Favored 'General case' 0 N--CA 1.491 1.598 0 N-CA-C 107.849 -1.167 . . . . 0.0 107.849 177.84 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 114' ' ' ASN . . . . . . . . . . . . . 2.7 t30 -149.38 103.0 3.25 Favored 'General case' 0 C--N 1.302 -1.477 0 N-CA-C 107.818 -1.178 . . . . 0.0 107.818 177.913 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 115' ' ' ILE . . . . . 0.492 ' O ' HG22 ' A' ' 115' ' ' ILE . 3.0 mt -97.34 110.47 25.26 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.479 0 O-C-N 121.156 -0.965 . . . . 0.0 109.837 -179.135 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 116' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -96.38 145.23 25.81 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.075 -1.015 . . . . 0.0 111.265 -178.392 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 117' ' ' ILE . . . . . . . . . . . . . 1.4 mt -139.65 156.55 26.21 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.768 0 N-CA-C 107.887 -1.153 . . . . 0.0 107.887 178.951 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 118' ' ' ALA . . . . . . . . . . . . . . . -142.06 160.38 40.34 Favored 'General case' 0 N--CA 1.491 1.601 0 C-N-CA 118.775 -1.17 . . . . 0.0 111.812 -179.07 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 119' ' ' GLY . . . . . . . . . . . . . . . -164.66 145.49 10.34 Favored Glycine 0 N--CA 1.481 1.688 0 N-CA-C 109.636 -1.386 . . . . 0.0 109.636 179.667 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 120' ' ' HIS . . . . . 0.449 ' CD2' HD13 ' A' ' 97' ' ' LEU . 10.5 m-70 -71.03 166.22 21.82 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.665 -0.903 . . . . 0.0 109.897 179.119 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 121' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -123.69 149.28 45.68 Favored 'General case' 0 N--CA 1.496 1.858 0 N-CA-C 107.637 -1.245 . . . . 0.0 107.637 178.53 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 122' ' ' PHE . . . . . 0.442 ' H ' ' HG1' ' A' ' 131' ' ' THR . 0.4 OUTLIER -114.88 138.02 51.28 Favored 'General case' 0 N--CA 1.492 1.666 0 O-C-N 121.178 -0.951 . . . . 0.0 109.99 -179.227 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 123' ' ' ILE . . . . . 0.487 HG23 ' N ' ' A' ' 124' ' ' ASP . 17.8 tt -89.39 -31.56 5.41 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.677 0 CA-C-O 121.98 0.895 . . . . 0.0 109.432 -179.782 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 124' ' ' ASP . . . . . 0.487 ' N ' HG23 ' A' ' 123' ' ' ILE . 0.2 OUTLIER -85.48 -3.67 58.93 Favored 'General case' 0 C--N 1.292 -1.908 0 C-N-CA 120.05 -0.66 . . . . 0.0 112.218 -177.71 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 125' ' ' ARG . . . . . 0.411 ' HG3' ' CD1' ' A' ' 122' ' ' PHE . 0.0 OUTLIER -157.15 130.97 4.8 Favored Pre-proline 0 N--CA 1.499 1.986 0 O-C-N 120.249 -1.532 . . . . 0.0 110.668 179.443 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 126' ' ' PRO . . . . . . . . . . . . . 88.7 Cg_endo -83.18 -13.23 9.02 Favored 'Trans proline' 0 N--CA 1.497 1.709 0 C-N-CA 122.676 2.251 . . . . 0.0 113.218 178.94 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 127' ' ' ASN . . . . . . . . . . . . . 1.4 t30 -89.32 24.79 2.1 Favored 'General case' 0 N--CA 1.494 1.735 0 O-C-N 121.041 -1.037 . . . . 0.0 110.05 -178.924 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 128' ' ' TYR . . . . . . . . . . . . . 9.6 t80 -83.15 -148.75 0.09 Allowed 'General case' 0 C--N 1.299 -1.621 0 O-C-N 121.237 -0.914 . . . . 0.0 109.322 -179.892 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 129' ' ' GLN . . . . . . . . . . . . . 6.4 mt-30 -65.75 -88.51 0.01 OUTLIER 'General case' 0 C--N 1.299 -1.63 0 O-C-N 121.345 -0.847 . . . . 0.0 110.172 -179.319 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 130' ' ' PHE . . . . . 0.576 ' CE2' HG11 ' A' ' 101' ' ' VAL . 35.8 m-85 -111.91 32.27 5.6 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.353 -0.842 . . . . 0.0 109.977 -179.249 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 131' ' ' THR . . . . . 0.442 ' HG1' ' H ' ' A' ' 122' ' ' PHE . 89.8 m -71.23 -33.94 70.32 Favored 'General case' 0 N--CA 1.497 1.878 0 O-C-N 121.385 -0.822 . . . . 0.0 109.441 179.514 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 132' ' ' ASN . . . . . 0.606 ' ND2' ' O ' ' A' ' 81' ' ' ALA . 0.1 OUTLIER -84.69 5.82 26.67 Favored 'General case' 0 N--CA 1.498 1.962 0 CA-C-O 121.945 0.879 . . . . 0.0 109.364 -179.624 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 133' ' ' LEU . . . . . 0.592 ' O ' ' N ' ' A' ' 135' ' ' ALA . 0.2 OUTLIER -72.34 -45.25 60.72 Favored 'General case' 0 C--N 1.297 -1.684 0 O-C-N 121.157 -0.964 . . . . 0.0 109.738 179.69 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 134' ' ' LYS . . . . . 0.624 ' H ' ' CE ' ' A' ' 134' ' ' LYS . 0.0 OUTLIER -47.39 -10.39 0.02 OUTLIER 'General case' 0 C--N 1.3 -1.585 0 O-C-N 121.14 -0.975 . . . . 0.0 109.546 -179.634 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 135' ' ' ALA . . . . . 0.592 ' N ' ' O ' ' A' ' 133' ' ' LEU . . . -84.65 -39.72 18.28 Favored 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.081 -1.012 . . . . 0.0 109.165 179.225 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 136' ' ' ALA . . . . . 0.711 ' HB2' ' HB2' ' A' ' 81' ' ' ALA . . . -78.19 159.58 28.47 Favored 'General case' 0 N--CA 1.489 1.49 0 CA-C-O 122.08 0.943 . . . . 0.0 111.586 -178.472 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 137' ' ' LYS . . . . . 0.559 ' O ' ' O ' ' A' ' 138' ' ' LYS . 7.9 tttt -154.25 -162.76 1.47 Allowed 'General case' 0 N--CA 1.492 1.662 0 C-N-CA 118.801 -1.159 . . . . 0.0 110.467 -178.515 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 138' ' ' LYS . . . . . 0.606 ' O ' ' N ' ' A' ' 140' ' ' SER . 23.0 mttt -44.25 -179.26 0.0 OUTLIER 'General case' 0 C--N 1.302 -1.468 0 CA-C-O 122.334 1.064 . . . . 0.0 110.667 -179.282 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 139' ' ' GLY . . . . . . . . . . . . . . . 46.41 8.25 0.02 OUTLIER Glycine 0 N--CA 1.492 2.408 0 N-CA-C 110.018 -1.233 . . . . 0.0 110.018 -179.676 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 140' ' ' SER . . . . . 0.606 ' N ' ' O ' ' A' ' 138' ' ' LYS . 9.9 m -81.2 144.11 31.85 Favored 'General case' 0 N--CA 1.493 1.705 0 O-C-N 120.864 -1.374 . . . . 0.0 109.224 179.235 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 141' ' ' MET . . . . . . . . . . . . . 2.1 tpt -96.39 125.95 41.25 Favored 'General case' 0 C--N 1.301 -1.535 0 O-C-N 121.127 -0.983 . . . . 0.0 109.403 -179.921 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 142' ' ' VAL . . . . . . . . . . . . . 2.4 t -113.77 128.77 70.52 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.838 0 O-C-N 121.269 -0.894 . . . . 0.0 109.554 -179.438 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 143' ' ' TYR . . . . . 0.409 ' CZ ' ' CD ' ' A' ' 152' ' ' LYS . 3.0 m-85 -107.48 134.39 50.58 Favored 'General case' 0 N--CA 1.497 1.91 0 O-C-N 121.172 -0.955 . . . . 0.0 111.158 -178.838 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 144' ' ' PHE . . . . . . . . . . . . . 24.7 t80 -118.86 99.89 7.04 Favored 'General case' 0 N--CA 1.494 1.726 0 N-CA-C 109.221 -0.659 . . . . 0.0 109.221 179.965 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 145' ' ' LYS . . . . . . . . . . . . . 8.2 mtpm? -98.56 122.47 41.8 Favored 'General case' 0 N--CA 1.488 1.426 0 O-C-N 121.231 -0.918 . . . . 0.0 110.196 -179.353 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 146' ' ' VAL . . . . . 0.498 HG23 ' O ' ' A' ' 73' ' ' ALA . 1.0 OUTLIER -143.51 122.82 8.25 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.499 0 O-C-N 120.885 -1.134 . . . . 0.0 109.058 179.005 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 147' ' ' GLY . . . . . . . . . . . . . . . 67.23 -132.91 30.7 Favored Glycine 0 N--CA 1.484 1.869 0 N-CA-C 108.186 -1.966 . . . . 0.0 108.186 -179.387 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 148' ' ' ASN . . . . . 0.611 ' C ' ' ND2' ' A' ' 148' ' ' ASN . 0.0 OUTLIER -101.28 11.36 39.44 Favored 'General case' 0 C--N 1.296 -1.727 0 N-CA-C 107.918 -1.141 . . . . 0.0 107.918 178.789 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 149' ' ' GLU . . . . . . . . . . . . . 2.4 tt0 -108.13 143.03 37.45 Favored 'General case' 0 N--CA 1.489 1.484 0 O-C-N 121.311 -0.868 . . . . 0.0 111.35 -178.841 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 150' ' ' THR . . . . . 0.405 ' O ' HG22 ' A' ' 150' ' ' THR . 3.7 m -131.03 100.64 5.3 Favored 'General case' 0 N--CA 1.495 1.822 0 CA-C-O 121.413 0.625 . . . . 0.0 109.724 179.923 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 151' ' ' ARG . . . . . 0.58 HH12 ' CD ' ' A' ' 204' ' ' GLU . 0.1 OUTLIER -86.63 -169.99 2.88 Favored 'General case' 0 C--N 1.305 -1.347 0 N-CA-C 108.382 -0.969 . . . . 0.0 108.382 179.466 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 152' ' ' LYS . . . . . 0.42 ' C ' ' CD1' ' A' ' 153' ' ' TYR . 24.8 mtmm -153.22 151.29 29.9 Favored 'General case' 0 C--N 1.3 -1.57 0 O-C-N 121.327 -0.858 . . . . 0.0 109.7 -179.857 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 153' ' ' TYR . . . . . 0.508 ' CD2' ' HA ' ' A' ' 204' ' ' GLU . 6.2 m-85 -142.79 168.81 18.85 Favored 'General case' 0 N--CA 1.493 1.706 0 N-CA-C 107.856 -1.164 . . . . 0.0 107.856 178.759 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 154' ' ' LYS . . . . . . . . . . . . . 20.5 ttpt -142.9 119.38 10.98 Favored 'General case' 0 N--CA 1.493 1.678 0 O-C-N 121.51 -0.744 . . . . 0.0 109.186 178.884 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 155' ' ' MET . . . . . . . . . . . . . 29.2 mtp -47.28 105.62 0.07 Allowed 'General case' 0 N--CA 1.494 1.747 0 O-C-N 120.819 -1.176 . . . . 0.0 112.321 -178.983 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 156' ' ' THR . . . . . . . . . . . . . 1.3 m -105.39 -21.29 13.26 Favored 'General case' 0 N--CA 1.494 1.755 0 CA-C-N 115.445 -0.798 . . . . 0.0 110.168 -179.548 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 157' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -148.38 147.02 28.75 Favored 'General case' 0 N--CA 1.494 1.753 0 C-N-CA 118.336 -1.345 . . . . 0.0 110.814 -178.689 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 158' ' ' ILE . . . . . . . . . . . . . 1.1 mt -148.49 138.24 16.22 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.547 0 CA-C-O 121.577 0.703 . . . . 0.0 109.953 -178.463 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 159' ' ' ARG . . . . . . . . . . . . . 5.7 ttm180 -156.45 -161.96 1.19 Allowed 'General case' 0 N--CA 1.497 1.893 0 O-C-N 121.325 -0.859 . . . . 0.0 110.594 -179.565 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 160' ' ' ASP . . . . . . . . . . . . . 67.4 m-20 -149.09 156.17 41.81 Favored 'General case' 0 N--CA 1.498 1.956 0 N-CA-C 108.954 -0.758 . . . . 0.0 108.954 -179.909 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 161' ' ' VAL . . . . . 0.454 ' O ' ' O ' ' A' ' 162' ' ' LYS . 0.1 OUTLIER -149.15 148.08 16.04 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.807 0 O-C-N 120.699 -1.251 . . . . 0.0 110.359 179.851 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 162' ' ' LYS . . . . . 0.578 ' CD ' ' H ' ' A' ' 162' ' ' LYS . 0.0 OUTLIER -44.33 169.07 0.07 OUTLIER Pre-proline 0 N--CA 1.494 1.756 0 O-C-N 121.409 -0.807 . . . . 0.0 110.191 179.997 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 163' ' ' PRO . . . . . 0.418 ' C ' HD21 ' C' ' 702' ' ' LEU . 58.0 Cg_endo -78.98 23.7 0.62 Allowed 'Trans proline' 0 C--N 1.31 -1.476 0 C-N-CA 122.917 2.411 . . . . 0.0 112.572 -179.169 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 164' ' ' THR . . . . . 0.704 ' HA ' HD11 ' C' ' 702' ' ' LEU . 0.2 OUTLIER -151.22 1.69 0.41 Allowed 'General case' 0 C--N 1.299 -1.592 0 O-C-N 121.322 -0.861 . . . . 0.0 109.864 -179.488 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 165' ' ' ASP . . . . . 0.481 ' O ' ' C ' ' A' ' 166' ' ' VAL . 8.3 t70 -77.35 66.44 3.11 Favored 'General case' 0 N--CA 1.493 1.687 0 O-C-N 121.15 -0.969 . . . . 0.0 110.334 -179.877 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 166' ' ' VAL . . . . . 0.639 ' O ' ' N ' ' A' ' 168' ' ' VAL . 0.9 OUTLIER -38.0 -32.54 0.11 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.576 0 O-C-N 121.158 -0.963 . . . . 0.0 109.375 -178.638 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 167' ' ' GLY . . . . . 0.466 ' N ' ' O ' ' A' ' 165' ' ' ASP . . . -43.16 -15.71 0.03 OUTLIER Glycine 0 N--CA 1.491 2.325 0 N-CA-C 108.848 -1.701 . . . . 0.0 108.848 179.428 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 168' ' ' VAL . . . . . 0.639 ' N ' ' O ' ' A' ' 166' ' ' VAL . 3.5 t -49.98 -44.28 21.39 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.735 0 N-CA-C 108.168 -1.049 . . . . 0.0 108.168 178.412 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 169' ' ' LEU . . . . . 0.54 ' O ' ' C ' ' A' ' 170' ' ' ASP . 8.9 mt -50.2 -9.38 0.04 OUTLIER 'General case' 0 C--N 1.299 -1.628 0 N-CA-C 108.425 -0.954 . . . . 0.0 108.425 -177.396 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 170' ' ' ASP . . . . . 0.553 ' H ' ' C ' ' A' ' 168' ' ' VAL . 10.6 p30 18.46 80.87 0.01 OUTLIER 'General case' 0 N--CA 1.5 2.05 0 CA-C-N 116.582 -0.281 . . . . 0.0 111.699 177.793 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 171' ' ' GLU . . . . . . . . . . . . . 3.7 pt-20 -117.33 65.09 0.73 Allowed 'General case' 0 N--CA 1.493 1.692 0 O-C-N 121.152 -0.967 . . . . 0.0 110.069 179.833 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 172' ' ' GLN . . . . . . . . . . . . . 12.2 mt-30 -134.44 -45.91 0.76 Allowed 'General case' 0 N--CA 1.492 1.663 0 O-C-N 121.41 -0.806 . . . . 0.0 110.253 -178.598 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 173' ' ' LYS . . . . . . . . . . . . . 17.9 mttp -62.64 135.15 57.24 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 120.769 -1.207 . . . . 0.0 108.615 179.049 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 174' ' ' GLY . . . . . 0.52 ' O ' ' C ' ' A' ' 175' ' ' LYS . . . -141.21 -40.64 0.08 OUTLIER Glycine 0 C--N 1.295 -1.707 0 N-CA-C 108.138 -1.985 . . . . 0.0 108.138 179.899 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 175' ' ' LYS . . . . . 0.52 ' C ' ' O ' ' A' ' 174' ' ' GLY . 13.0 mptt -31.84 -64.08 0.17 Allowed 'General case' 0 N--CA 1.501 2.075 0 N-CA-C 108.653 -0.869 . . . . 0.0 108.653 179.196 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 176' ' ' ASP . . . . . 0.726 ' O ' ' O ' ' A' ' 177' ' ' LYS . 2.6 m-20 -101.93 73.28 1.39 Allowed 'General case' 0 C--N 1.297 -1.706 0 N-CA-C 107.255 -1.387 . . . . 0.0 107.255 177.627 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 177' ' ' LYS . . . . . 0.726 ' O ' ' O ' ' A' ' 176' ' ' ASP . 28.2 mttt -20.62 157.79 0.0 OUTLIER 'General case' 0 N--CA 1.504 2.233 0 CA-C-O 122.132 0.968 . . . . 0.0 111.851 -178.907 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 178' ' ' GLN . . . . . . . . . . . . . 3.3 pt20 -156.07 170.89 21.14 Favored 'General case' 0 N--CA 1.488 1.467 0 C-N-CA 117.096 -1.842 . . . . 0.0 112.084 -178.727 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 179' ' ' LEU . . . . . 0.41 ' HB2' ' CE2' ' A' ' 153' ' ' TYR . 0.7 OUTLIER -126.55 97.78 5.15 Favored 'General case' 0 C--N 1.303 -1.433 0 N-CA-C 107.237 -1.394 . . . . 0.0 107.237 178.366 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 180' ' ' THR . . . . . . . . . . . . . 1.1 m -71.23 121.06 17.71 Favored 'General case' 0 C--N 1.302 -1.464 0 C-N-CA 118.726 -1.19 . . . . 0.0 110.004 -178.615 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 181' ' ' LEU . . . . . 0.526 HD11 ' CE2' ' A' ' 130' ' ' PHE . 66.8 tp -94.55 152.25 18.69 Favored 'General case' 0 C--N 1.298 -1.654 0 N-CA-C 107.589 -1.263 . . . . 0.0 107.589 177.632 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 182' ' ' ILE . . . . . 0.404 HG21 ' HG2' ' C' ' 703' ' ' PRO . 36.5 mt -142.12 109.22 1.99 Allowed 'Isoleucine or valine' 0 C--N 1.301 -1.53 0 C-N-CA 119.083 -1.047 . . . . 0.0 109.242 178.941 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 183' ' ' THR . . . . . . . . . . . . . 1.2 t -129.21 109.36 11.08 Favored 'General case' 0 C--N 1.294 -1.836 0 N-CA-C 107.751 -1.203 . . . . 0.0 107.751 179.635 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 184' ' ' CYS . . . . . . . . . . . . . 4.0 p -81.06 157.96 25.24 Favored 'General case' 0 C--N 1.293 -1.879 0 C-N-CA 119.182 -1.007 . . . . 0.0 111.349 -177.609 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 185' ' ' ASP . . . . . 0.534 ' CG ' ' H ' ' A' ' 186' ' ' ASP . 43.9 t0 -164.3 -158.4 0.42 Allowed 'General case' 0 N--CA 1.489 1.509 0 N-CA-C 108.88 -0.785 . . . . 0.0 108.88 -179.536 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 186' ' ' ASP . . . . . 0.534 ' H ' ' CG ' ' A' ' 185' ' ' ASP . 1.3 m-20 56.91 49.35 14.2 Favored 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.161 -0.962 . . . . 0.0 109.675 179.561 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 187' ' ' TYR . . . . . 0.58 ' CE1' ' O ' ' A' ' 188' ' ' ASN . 33.9 t80 -65.43 128.69 36.91 Favored 'General case' 0 C--N 1.297 -1.674 0 O-C-N 121.075 -1.016 . . . . 0.0 109.772 -179.945 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 188' ' ' ASN . . . . . 0.821 HD22 ' H ' ' A' ' 193' ' ' VAL . 0.0 OUTLIER -97.85 150.55 21.17 Favored 'General case' 0 C--N 1.294 -1.838 0 N-CA-C 107.886 -1.153 . . . . 0.0 107.886 178.591 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 189' ' ' GLU . . . . . . . . . . . . . 1.7 tt0 -112.58 -5.95 13.97 Favored 'General case' 0 C--N 1.294 -1.831 0 N-CA-C 108.674 -0.862 . . . . 0.0 108.674 -178.683 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 190' ' ' LYS . . . . . 0.613 ' N ' ' OD1' ' A' ' 188' ' ' ASN . 10.2 mmtm -84.06 -57.45 3.18 Favored 'General case' 0 C--N 1.299 -1.618 0 N-CA-C 108.939 -0.763 . . . . 0.0 108.939 179.401 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 191' ' ' THR . . . . . 0.572 ' OG1' ' ND2' ' A' ' 188' ' ' ASN . 1.5 p -89.25 0.14 57.0 Favored 'General case' 0 N--CA 1.494 1.77 0 O-C-N 121.443 -0.785 . . . . 0.0 109.706 179.647 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 192' ' ' GLY . . . . . 0.66 ' N ' HD21 ' A' ' 188' ' ' ASN . . . 60.34 37.2 92.73 Favored Glycine 0 N--CA 1.498 2.783 0 N-CA-C 110.634 -0.986 . . . . 0.0 110.634 179.318 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 193' ' ' VAL . . . . . 0.821 ' H ' HD22 ' A' ' 188' ' ' ASN . 73.9 t -148.64 163.84 4.99 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.629 0 O-C-N 120.996 -1.297 . . . . 0.0 110.298 179.879 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 194' ' ' TRP . . . . . 0.609 ' N ' HG12 ' A' ' 193' ' ' VAL . 5.5 m95 -82.44 121.36 26.64 Favored 'General case' 0 N--CA 1.489 1.518 0 N-CA-C 108.373 -0.973 . . . . 0.0 108.373 179.257 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 195' ' ' GLU . . . . . . . . . . . . . 2.5 mt-10 -86.16 -57.39 3.04 Favored 'General case' 0 C--N 1.3 -1.566 0 O-C-N 121.15 -0.969 . . . . 0.0 110.463 -178.597 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 196' ' ' LYS . . . . . . . . . . . . . 2.6 mttp -92.33 143.65 26.18 Favored 'General case' 0 N--CA 1.489 1.494 0 O-C-N 120.911 -1.118 . . . . 0.0 110.205 -179.302 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 197' ' ' ARG . . . . . 0.653 ' CG ' HH11 ' A' ' 197' ' ' ARG . 0.2 OUTLIER -122.14 144.42 48.95 Favored 'General case' 0 N--CA 1.488 1.447 0 N-CA-C 108.784 -0.821 . . . . 0.0 108.784 179.108 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 198' ' ' LYS . . . . . . . . . . . . . 13.4 mptt -115.78 119.42 35.96 Favored 'General case' 0 C--N 1.299 -1.606 0 C-N-CA 120.349 -0.54 . . . . 0.0 110.087 -178.91 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 199' ' ' ILE . . . . . 0.456 ' C ' HD12 ' A' ' 199' ' ' ILE . 1.0 OUTLIER -136.33 118.15 19.94 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.566 0 CA-C-O 122.716 1.246 . . . . 0.0 109.018 178.968 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 200' ' ' PHE . . . . . 0.535 ' CD1' ' N ' ' A' ' 200' ' ' PHE . 1.0 OUTLIER -102.84 138.37 39.82 Favored 'General case' 0 N--CA 1.492 1.671 0 CA-C-N 115.6 -0.727 . . . . 0.0 111.257 -176.918 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 201' ' ' VAL . . . . . . . . . . . . . 47.0 t -105.94 143.22 17.31 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.37 0 O-C-N 121.523 -0.736 . . . . 0.0 109.396 177.799 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 202' ' ' ALA . . . . . . . . . . . . . . . -130.37 137.57 49.96 Favored 'General case' 0 C--N 1.301 -1.502 0 N-CA-C 107.978 -1.119 . . . . 0.0 107.978 179.662 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 203' ' ' THR . . . . . 0.679 ' O ' HG23 ' A' ' 205' ' ' VAL . 0.2 OUTLIER -89.89 132.82 35.09 Favored 'General case' 0 C--N 1.303 -1.422 0 CA-C-O 122.576 1.179 . . . . 0.0 111.549 -178.796 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 204' ' ' GLU . . . . . 0.58 ' CD ' HH12 ' A' ' 151' ' ' ARG . 3.9 tt0 -49.45 135.01 18.5 Favored 'General case' 0 C--N 1.293 -1.888 0 C-N-CA 118.459 -1.296 . . . . 0.0 108.796 178.575 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 205' ' ' VAL . . . . . 0.679 HG23 ' O ' ' A' ' 203' ' ' THR . 70.8 t -129.79 162.41 37.5 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.547 0 CA-C-O 122.082 0.944 . . . . 0.0 110.284 -177.739 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 206' ' ' LYS . . . . . 0.55 ' N ' HG12 ' A' ' 205' ' ' VAL . 4.6 ptmt . . . . . 0 C--N 1.298 -1.651 0 CA-C-O 118.145 -0.931 . . . . 0.0 109.42 -179.661 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' C' C ' 702' ' ' LEU . . . . . 0.884 ' N ' HD12 ' C' ' 702' ' ' LEU . 0.0 OUTLIER . . . . . 0 N--CA 1.485 1.32 0 N-CA-C 108.304 -0.998 . . . . 0.0 108.304 . . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' C' C ' 703' ' ' PRO . . . . . 0.603 ' O ' ' NH2' ' A' ' 197' ' ' ARG . 88.7 Cg_endo -81.1 172.76 12.56 Favored 'Trans proline' 0 C--N 1.303 -1.848 0 C-N-CA 122.632 2.221 . . . . 0.0 112.406 -179.688 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' C' C ' 704' ' ' ALA . . . . . 0.478 ' C ' ' O ' ' C' ' 703' ' ' PRO . . . . . . . . 0 N--CA 1.492 1.643 0 CA-C-O 121.536 0.684 . . . . 0.0 110.422 178.802 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 59' ' ' MET . . . . . . . . . . . . . 11.1 mtp . . . . . 0 N--CA 1.491 1.592 0 CA-C-O 121.212 0.529 . . . . 0.0 109.628 . . . . . . . . . 0 0 . 1 . 001 nuclear nobuild full ' A' A ' 60' ' ' GLN . . . . . . . . . . . . . 9.6 mm100 -60.03 173.39 0.63 Allowed 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.252 -0.905 . . . . 0.0 109.471 -179.773 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 61' ' ' ALA . . . . . 0.411 ' HB2' ' OD1' ' A' ' 148' ' ' ASN . . . -64.09 156.88 26.91 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.23 -0.919 . . . . 0.0 109.424 -179.988 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 62' ' ' LYS . . . . . 0.494 ' O ' ' OE1' ' A' ' 64' ' ' GLN . 0.0 OUTLIER -147.61 71.18 11.63 Favored Pre-proline 0 N--CA 1.488 1.446 0 O-C-N 121.293 -0.879 . . . . 0.0 109.022 -179.9 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 63' ' ' PRO . . . . . 0.458 ' O ' HD22 ' A' ' 110' ' ' LEU . 6.7 Cg_exo -68.37 139.44 45.46 Favored 'Trans proline' 0 C--N 1.302 -1.876 0 C-N-CA 122.725 2.283 . . . . 0.0 111.288 -179.868 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 64' ' ' GLN . . . . . 0.617 HE21 ' C ' ' A' ' 64' ' ' GLN . 0.0 OUTLIER -155.75 126.9 7.09 Favored 'General case' 0 C--N 1.3 -1.56 0 O-C-N 121.117 -0.99 . . . . 0.0 109.347 179.316 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 65' ' ' ILE . . . . . 0.582 HD12 ' H ' ' A' ' 65' ' ' ILE . 2.1 mp -46.27 106.37 0.56 Allowed Pre-proline 0 N--CA 1.489 1.495 0 N-CA-C 107.519 -1.289 . . . . 0.0 107.519 178.935 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 66' ' ' PRO . . . . . . . . . . . . . 89.0 Cg_endo -83.42 -162.84 0.18 Allowed 'Trans proline' 0 C--N 1.315 -1.185 0 C-N-CA 122.462 2.108 . . . . 0.0 112.834 -178.111 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 67' ' ' LYS . . . . . . . . . . . . . 24.8 tttm -87.65 -7.56 57.29 Favored 'General case' 0 N--CA 1.487 1.423 0 O-C-N 121.414 -0.803 . . . . 0.0 109.421 179.965 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 68' ' ' ASP . . . . . 0.654 ' O ' ' N ' ' A' ' 70' ' ' SER . 0.7 OUTLIER -76.23 63.38 1.88 Allowed 'General case' 0 N--CA 1.488 1.461 0 CA-C-O 122.936 1.35 . . . . 0.0 108.822 179.561 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 69' ' ' LYS . . . . . 0.462 ' C ' ' O ' ' A' ' 68' ' ' ASP . 8.2 ptpt -45.45 -14.57 0.02 OUTLIER 'General case' 0 N--CA 1.512 2.67 0 C-N-CA 116.881 -1.928 . . . . 0.0 107.321 178.086 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 70' ' ' SER . . . . . 0.654 ' N ' ' O ' ' A' ' 68' ' ' ASP . 0.6 OUTLIER -86.83 -7.29 58.37 Favored 'General case' 0 N--CA 1.498 1.969 0 CA-C-N 113.856 -1.52 . . . . 0.0 111.661 179.793 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 71' ' ' LYS . . . . . 0.47 ' N ' ' O ' ' A' ' 68' ' ' ASP . 0.0 OUTLIER -97.05 142.47 28.95 Favored 'General case' 0 N--CA 1.505 2.323 0 O-C-N 120.435 -1.416 . . . . 0.0 112.552 -178.838 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 72' ' ' VAL . . . . . 0.844 HG12 ' CE1' ' A' ' 88' ' ' TYR . 2.6 m -68.0 130.55 33.27 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.418 0 N-CA-C 105.375 -2.083 . . . . 0.0 105.375 174.965 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 73' ' ' ALA . . . . . 0.607 ' N ' ' O ' ' A' ' 87' ' ' VAL . . . -79.02 -13.99 59.45 Favored 'General case' 0 C--N 1.293 -1.855 0 O-C-N 119.999 -1.688 . . . . 0.0 107.398 -179.596 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . 173.5 -157.72 26.5 Favored Glycine 0 N--CA 1.479 1.524 0 N-CA-C 109.48 -1.448 . . . . 0.0 109.48 179.771 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 75' ' ' TYR . . . . . 0.606 ' HA ' HG23 ' A' ' 87' ' ' VAL . 69.1 m-85 -142.06 169.72 17.06 Favored 'General case' 0 C--N 1.295 -1.787 0 CA-C-O 121.961 0.886 . . . . 0.0 110.456 -177.591 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 76' ' ' ILE . . . . . . . . . . . . . 0.8 OUTLIER -147.27 142.28 20.03 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.72 0 C-N-CA 119.234 -0.986 . . . . 0.0 109.634 -177.362 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -151.52 162.31 41.19 Favored 'General case' 0 N--CA 1.487 1.409 0 O-C-N 121.193 -0.942 . . . . 0.0 109.759 -179.934 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 78' ' ' ILE . . . . . 0.544 ' HB ' ' HB3' ' A' ' 81' ' ' ALA . 9.5 mt -145.65 123.76 6.4 Favored Pre-proline 0 C--N 1.303 -1.434 0 N-CA-C 107.821 -1.178 . . . . 0.0 107.821 179.338 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 79' ' ' PRO . . . . . . . . . . . . . 41.5 Cg_endo -71.94 -43.69 1.15 Allowed 'Trans proline' 0 C--N 1.314 -1.255 0 C-N-CA 121.867 1.712 . . . . 0.0 112.949 -178.798 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 1.3 m-20 -66.61 -21.4 66.13 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 120.959 -1.088 . . . . 0.0 110.861 178.339 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 81' ' ' ALA . . . . . 0.847 ' HB2' ' HB2' ' A' ' 136' ' ' ALA . . . -105.04 -15.89 14.97 Favored 'General case' 0 N--CA 1.496 1.838 0 O-C-N 121.139 -0.975 . . . . 0.0 109.095 179.672 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 82' ' ' ASP . . . . . . . . . . . . . 20.8 t0 62.84 52.2 2.77 Favored 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.472 -0.768 . . . . 0.0 110.847 179.292 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 83' ' ' ILE . . . . . . . . . . . . . 70.2 mt -127.27 152.85 35.79 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.735 0 O-C-N 121.229 -0.919 . . . . 0.0 109.677 -179.239 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 84' ' ' LYS . . . . . . . . . . . . . 34.6 tttp -158.21 106.49 1.98 Allowed 'General case' 0 N--CA 1.491 1.61 0 N-CA-C 107.778 -1.193 . . . . 0.0 107.778 -179.95 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 85' ' ' GLU . . . . . 0.508 ' OE2' ' O ' ' A' ' 128' ' ' TYR . 0.0 OUTLIER -141.31 165.54 28.2 Favored Pre-proline 0 N--CA 1.495 1.791 0 O-C-N 121.14 -0.975 . . . . 0.0 110.779 -178.366 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 86' ' ' PRO . . . . . . . . . . . . . 56.0 Cg_endo -73.57 168.13 25.55 Favored 'Trans proline' 0 N--CA 1.497 1.681 0 C-N-CA 123.335 2.69 . . . . 0.0 113.796 -179.595 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 87' ' ' VAL . . . . . 0.607 ' O ' ' N ' ' A' ' 73' ' ' ALA . 54.8 t -126.35 104.19 12.55 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.841 0 N-CA-C 109.368 -0.605 . . . . 0.0 109.368 179.917 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 88' ' ' TYR . . . . . 0.844 ' CE1' HG12 ' A' ' 72' ' ' VAL . 11.9 m-85 -94.92 156.76 37.66 Favored Pre-proline 0 N--CA 1.504 2.26 0 O-C-N 120.766 -1.209 . . . . 0.0 109.801 179.98 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 89' ' ' PRO . . . . . . . . . . . . . 13.4 Cg_endo -62.84 145.16 94.59 Favored 'Trans proline' 0 N--CA 1.498 1.778 0 C-N-CA 122.637 2.225 . . . . 0.0 113.273 179.591 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . -60.46 169.17 8.4 Favored Glycine 0 N--CA 1.494 2.527 0 N-CA-C 109.383 -1.487 . . . . 0.0 109.383 179.318 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 91' ' ' PRO . . . . . 0.469 ' C ' ' H ' ' A' ' 93' ' ' THR . 57.3 Cg_endo -93.5 169.15 20.47 Favored 'Cis proline' 0 C--N 1.307 -1.622 0 C-N-CA 123.966 -1.264 . . . . 0.0 111.989 0.194 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 92' ' ' ALA . . . . . 0.7 ' HB1' HD21 ' A' ' 97' ' ' LEU . . . -71.83 32.26 0.05 Allowed 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.214 -0.929 . . . . 0.0 109.988 179.957 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 93' ' ' THR . . . . . 0.469 ' H ' ' C ' ' A' ' 91' ' ' PRO . 5.4 p -72.22 150.48 92.11 Favored Pre-proline 0 C--N 1.303 -1.431 0 O-C-N 120.481 -1.387 . . . . 0.0 108.025 179.761 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 94' ' ' PRO . . . . . . . . . . . . . 74.1 Cg_exo -32.96 -52.8 0.41 Allowed 'Trans proline' 0 C--N 1.306 -1.7 0 C-N-CA 122.893 2.396 . . . . 0.0 112.965 -178.549 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 95' ' ' GLU . . . . . 0.436 ' O ' ' ND2' ' A' ' 98' ' ' ASN . 14.3 mt-10 -49.89 -47.84 51.85 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.079 -1.013 . . . . 0.0 110.061 -179.74 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 96' ' ' GLN . . . . . 0.579 ' O ' ' N ' ' A' ' 98' ' ' ASN . 1.5 mp0 -72.57 -53.99 10.4 Favored 'General case' 0 N--CA 1.489 1.487 0 O-C-N 120.98 -1.075 . . . . 0.0 110.187 -179.68 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 97' ' ' LEU . . . . . 0.7 HD21 ' HB1' ' A' ' 92' ' ' ALA . 94.0 mt -49.31 -6.56 0.02 OUTLIER 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.145 -0.972 . . . . 0.0 109.684 -179.26 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 98' ' ' ASN . . . . . 0.746 HD21 ' NE ' ' A' ' 99' ' ' ARG . 0.2 OUTLIER -73.88 -20.39 60.43 Favored 'General case' 0 N--CA 1.488 1.447 0 O-C-N 121.252 -0.905 . . . . 0.0 109.2 179.903 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 99' ' ' ARG . . . . . 0.746 ' NE ' HD21 ' A' ' 98' ' ' ASN . 3.0 mtt180 -103.06 -58.16 1.92 Allowed 'General case' 0 N--CA 1.489 1.492 0 O-C-N 121.379 -0.825 . . . . 0.0 110.182 -179.357 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . -173.82 -172.43 39.15 Favored Glycine 0 N--CA 1.492 2.4 0 C-N-CA 119.373 -1.394 . . . . 0.0 110.505 -179.752 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 101' ' ' VAL . . . . . 0.695 ' O ' HG23 ' A' ' 101' ' ' VAL . 34.0 m -51.49 103.75 0.05 OUTLIER 'Isoleucine or valine' 0 N--CA 1.493 1.701 0 O-C-N 121.575 -0.956 . . . . 0.0 110.017 -179.817 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -91.55 160.75 15.26 Favored 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.193 -0.942 . . . . 0.0 110.158 179.927 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 103' ' ' PHE . . . . . 0.563 ' O ' ' N ' ' A' ' 105' ' ' GLU . 23.1 m-85 -63.74 121.2 13.4 Favored 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.009 -1.057 . . . . 0.0 108.357 178.769 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 104' ' ' ALA . . . . . 0.615 ' HB3' ' HB2' ' A' ' 116' ' ' SER . . . -45.23 -12.45 0.02 OUTLIER 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.464 -0.772 . . . . 0.0 110.516 -179.063 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 105' ' ' GLU . . . . . 0.563 ' N ' ' O ' ' A' ' 103' ' ' PHE . 0.1 OUTLIER -136.6 142.7 43.34 Favored 'General case' 0 N--CA 1.494 1.753 0 O-C-N 120.852 -1.155 . . . . 0.0 110.23 179.958 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 106' ' ' GLU . . . . . 0.467 ' OE1' ' ND2' ' A' ' 107' ' ' ASN . 24.3 tt0 -58.79 -63.41 1.3 Allowed 'General case' 0 N--CA 1.488 1.439 0 CA-C-N 116.173 -0.467 . . . . 0.0 111.438 -178.904 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 107' ' ' ASN . . . . . 0.467 ' ND2' ' OE1' ' A' ' 106' ' ' GLU . 1.7 m120 -79.05 35.45 0.26 Allowed 'General case' 0 N--CA 1.49 1.572 0 O-C-N 120.653 -1.279 . . . . 0.0 113.138 -175.694 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 108' ' ' GLU . . . . . . . . . . . . . 1.5 tp10 -58.92 150.47 24.25 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 120.554 -1.341 . . . . 0.0 107.924 179.858 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 109' ' ' SER . . . . . . . . . . . . . 1.5 t -102.73 146.19 28.59 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.006 -1.059 . . . . 0.0 110.975 -178.192 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 110' ' ' LEU . . . . . 0.491 HD11 HG21 ' A' ' 146' ' ' VAL . 4.4 tp -62.4 -20.83 64.86 Favored 'General case' 0 N--CA 1.488 1.46 0 N-CA-C 107.79 -1.189 . . . . 0.0 107.79 178.827 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 111' ' ' ASP . . . . . 0.523 ' CG ' HH22 ' A' ' 151' ' ' ARG . 0.9 OUTLIER -131.46 43.23 3.1 Favored 'General case' 0 C--N 1.302 -1.497 0 N-CA-C 108.573 -0.899 . . . . 0.0 108.573 179.58 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 112' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -70.21 154.12 42.29 Favored 'General case' 0 C--N 1.302 -1.47 0 O-C-N 121.173 -0.954 . . . . 0.0 111.095 -179.812 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 113' ' ' GLN . . . . . 0.533 ' N ' ' CD ' ' A' ' 113' ' ' GLN . 0.0 OUTLIER -67.65 -18.27 64.89 Favored 'General case' 0 C--N 1.3 -1.585 0 N-CA-C 108.255 -1.017 . . . . 0.0 108.255 177.626 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 114' ' ' ASN . . . . . 0.57 ' OD1' ' NE2' ' A' ' 178' ' ' GLN . 11.2 t30 -150.84 105.7 3.3 Favored 'General case' 0 C--N 1.298 -1.654 0 N-CA-C 108.438 -0.949 . . . . 0.0 108.438 178.852 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 115' ' ' ILE . . . . . 0.532 HG22 ' O ' ' A' ' 115' ' ' ILE . 3.8 mt -95.13 105.34 16.86 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.446 0 O-C-N 120.876 -1.14 . . . . 0.0 108.284 179.806 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 116' ' ' SER . . . . . 0.615 ' HB2' ' HB3' ' A' ' 104' ' ' ALA . 11.5 m -91.72 153.85 19.37 Favored 'General case' 0 N--CA 1.488 1.454 0 O-C-N 121.286 -0.883 . . . . 0.0 111.23 -178.262 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 117' ' ' ILE . . . . . 0.411 HD13 HG21 ' A' ' 117' ' ' ILE . 2.3 mt -148.74 148.18 16.13 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.43 0 N-CA-C 108.124 -1.065 . . . . 0.0 108.124 179.286 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 118' ' ' ALA . . . . . 1.019 ' HB1' ' HB2' ' C' ' 704' ' ' ALA . . . -142.26 160.37 40.38 Favored 'General case' 0 N--CA 1.492 1.634 0 C-N-CA 118.934 -1.106 . . . . 0.0 111.597 -178.919 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 119' ' ' GLY . . . . . . . . . . . . . . . -171.53 149.77 12.56 Favored Glycine 0 N--CA 1.489 2.205 0 N-CA-C 110.214 -1.155 . . . . 0.0 110.214 -179.947 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 120' ' ' HIS . . . . . . . . . . . . . 14.1 m170 -70.18 168.12 16.38 Favored 'General case' 0 N--CA 1.494 1.74 0 O-C-N 121.728 -0.866 . . . . 0.0 110.128 179.517 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 121' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -115.78 160.34 20.25 Favored 'General case' 0 N--CA 1.496 1.843 0 O-C-N 121.362 -0.836 . . . . 0.0 109.425 179.455 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 122' ' ' PHE . . . . . 0.413 ' O ' HG21 ' A' ' 131' ' ' THR . 0.2 OUTLIER -133.48 123.49 25.34 Favored 'General case' 0 N--CA 1.497 1.92 0 O-C-N 121.238 -0.914 . . . . 0.0 109.612 -179.409 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 123' ' ' ILE . . . . . 0.608 HG23 ' N ' ' A' ' 124' ' ' ASP . 0.6 OUTLIER -66.0 -42.56 91.94 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.667 0 CA-C-O 121.71 0.767 . . . . 0.0 109.01 179.76 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 124' ' ' ASP . . . . . 0.608 ' N ' HG23 ' A' ' 123' ' ' ILE . 5.8 t70 -92.76 24.84 3.38 Favored 'General case' 0 N--CA 1.496 1.867 0 O-C-N 121.616 -0.678 . . . . 0.0 111.956 -177.917 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 125' ' ' ARG . . . . . 0.622 HH11 ' CG ' ' A' ' 125' ' ' ARG . 0.0 OUTLIER -157.92 103.57 1.76 Allowed Pre-proline 0 N--CA 1.492 1.647 0 O-C-N 120.347 -1.47 . . . . 0.0 110.406 -179.432 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 126' ' ' PRO . . . . . . . . . . . . . 60.1 Cg_endo -79.13 -17.0 12.08 Favored 'Trans proline' 0 C--N 1.315 -1.206 0 C-N-CA 122.078 1.852 . . . . 0.0 111.822 179.728 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 127' ' ' ASN . . . . . . . . . . . . . 14.0 m120 -90.89 10.79 24.92 Favored 'General case' 0 N--CA 1.488 1.448 0 O-C-N 121.309 -0.869 . . . . 0.0 109.515 179.75 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 128' ' ' TYR . . . . . 0.508 ' O ' ' OE2' ' A' ' 85' ' ' GLU . 2.7 t80 -68.17 -153.07 0.02 OUTLIER 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.154 -0.966 . . . . 0.0 109.531 -179.924 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 129' ' ' GLN . . . . . 0.548 ' OE1' ' N ' ' A' ' 129' ' ' GLN . 1.1 mp0 -68.13 -67.15 0.48 Allowed 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.451 -0.781 . . . . 0.0 109.85 -179.705 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 130' ' ' PHE . . . . . 0.498 ' O ' ' CE ' ' A' ' 134' ' ' LYS . 57.1 m-85 -135.61 52.6 2.0 Favored 'General case' 0 N--CA 1.493 1.686 0 O-C-N 121.038 -1.039 . . . . 0.0 110.35 179.981 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 131' ' ' THR . . . . . 0.413 HG21 ' O ' ' A' ' 122' ' ' PHE . 23.4 m -86.43 -41.07 14.73 Favored 'General case' 0 C--N 1.301 -1.523 0 O-C-N 121.075 -1.016 . . . . 0.0 108.764 179.33 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 132' ' ' ASN . . . . . 0.497 ' ND2' ' O ' ' A' ' 81' ' ' ALA . 4.0 t30 -83.47 6.2 21.11 Favored 'General case' 0 N--CA 1.496 1.851 0 O-C-N 121.561 -0.712 . . . . 0.0 111.347 -178.492 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 133' ' ' LEU . . . . . 0.568 HD13 ' HB3' ' A' ' 136' ' ' ALA . 0.1 OUTLIER -69.93 -43.46 71.59 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 120.821 -1.174 . . . . 0.0 109.871 -179.557 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 134' ' ' LYS . . . . . 0.521 ' CD ' ' H ' ' A' ' 134' ' ' LYS . 0.0 OUTLIER -45.37 -17.78 0.03 OUTLIER 'General case' 0 N--CA 1.497 1.921 0 O-C-N 121.172 -0.955 . . . . 0.0 110.154 -179.442 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 135' ' ' ALA . . . . . 0.493 ' N ' ' O ' ' A' ' 133' ' ' LEU . . . -84.66 -32.5 23.59 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 120.949 -1.095 . . . . 0.0 109.38 179.89 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 136' ' ' ALA . . . . . 0.847 ' HB2' ' HB2' ' A' ' 81' ' ' ALA . . . -80.52 153.23 28.24 Favored 'General case' 0 C--N 1.302 -1.466 0 CA-C-O 122.028 0.918 . . . . 0.0 111.386 -178.808 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 137' ' ' LYS . . . . . 0.551 ' O ' ' O ' ' A' ' 138' ' ' LYS . 51.5 mttp -153.38 -165.57 2.19 Favored 'General case' 0 N--CA 1.49 1.531 0 C-N-CA 118.461 -1.295 . . . . 0.0 110.611 -178.543 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 138' ' ' LYS . . . . . 0.585 ' O ' ' N ' ' A' ' 140' ' ' SER . 0.0 OUTLIER -42.74 177.77 0.0 OUTLIER 'General case' 0 C--N 1.302 -1.462 0 CA-C-O 122.232 1.015 . . . . 0.0 110.961 -178.941 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 139' ' ' GLY . . . . . . . . . . . . . . . 46.75 8.63 0.02 OUTLIER Glycine 0 N--CA 1.489 2.191 0 N-CA-C 110.123 -1.191 . . . . 0.0 110.123 -179.943 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 140' ' ' SER . . . . . 0.585 ' N ' ' O ' ' A' ' 138' ' ' LYS . 11.7 m -80.75 122.42 27.13 Favored 'General case' 0 N--CA 1.492 1.663 0 O-C-N 120.817 -1.402 . . . . 0.0 109.544 179.616 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 141' ' ' MET . . . . . . . . . . . . . 6.5 tpt -77.66 121.89 24.6 Favored 'General case' 0 C--N 1.301 -1.515 0 N-CA-C 108.461 -0.94 . . . . 0.0 108.461 179.252 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 142' ' ' VAL . . . . . . . . . . . . . 2.8 t -112.61 135.9 50.57 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.721 0 O-C-N 121.124 -0.985 . . . . 0.0 109.688 -178.918 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 143' ' ' TYR . . . . . . . . . . . . . 67.8 m-85 -115.14 138.37 50.98 Favored 'General case' 0 N--CA 1.495 1.801 0 O-C-N 121.271 -0.893 . . . . 0.0 110.827 -179.453 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 144' ' ' PHE . . . . . 0.409 ' CD1' ' C ' ' A' ' 144' ' ' PHE . 1.4 t80 -122.26 108.45 13.28 Favored 'General case' 0 N--CA 1.494 1.733 0 O-C-N 121.692 -0.63 . . . . 0.0 109.558 -179.315 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 145' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -97.08 132.43 42.88 Favored 'General case' 0 N--CA 1.494 1.76 0 O-C-N 121.227 -0.921 . . . . 0.0 111.073 -178.791 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 146' ' ' VAL . . . . . 0.518 HG23 ' O ' ' A' ' 73' ' ' ALA . 4.2 p -143.95 143.75 23.53 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.739 0 N-CA-C 107.854 -1.165 . . . . 0.0 107.854 178.632 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 147' ' ' GLY . . . . . 0.453 ' C ' ' O ' ' A' ' 146' ' ' VAL . . . 42.37 -128.28 4.68 Favored Glycine 0 N--CA 1.491 2.308 0 N-CA-C 108.894 -1.682 . . . . 0.0 108.894 -179.597 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 148' ' ' ASN . . . . . 0.552 HD22 ' C ' ' A' ' 148' ' ' ASN . 0.4 OUTLIER -103.34 18.02 22.74 Favored 'General case' 0 C--N 1.299 -1.594 0 O-C-N 121.49 -1.006 . . . . 0.0 108.348 178.976 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 149' ' ' GLU . . . . . . . . . . . . . 7.6 tt0 -113.84 144.49 42.92 Favored 'General case' 0 N--CA 1.49 1.54 0 CA-C-O 121.917 0.865 . . . . 0.0 111.604 -178.184 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 150' ' ' THR . . . . . . . . . . . . . 52.8 m -125.64 105.08 8.75 Favored 'General case' 0 C--N 1.302 -1.48 0 CA-C-O 121.574 0.702 . . . . 0.0 109.889 179.493 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 151' ' ' ARG . . . . . 0.523 HH22 ' CG ' ' A' ' 111' ' ' ASP . 73.8 mtt180 -86.44 -173.59 4.6 Favored 'General case' 0 N--CA 1.486 1.373 0 N-CA-C 108.709 -0.848 . . . . 0.0 108.709 179.863 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 152' ' ' LYS . . . . . . . . . . . . . 6.8 mtmp? -152.49 148.07 26.98 Favored 'General case' 0 C--N 1.301 -1.52 0 C-N-CA 119.145 -1.022 . . . . 0.0 110.589 -179.489 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 153' ' ' TYR . . . . . 0.412 ' CD2' ' HA ' ' A' ' 204' ' ' GLU . 47.0 m-85 -144.45 161.55 38.76 Favored 'General case' 0 N--CA 1.489 1.49 0 N-CA-C 108.424 -0.954 . . . . 0.0 108.424 178.739 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 154' ' ' LYS . . . . . . . . . . . . . 17.8 ttmt -137.24 119.7 15.9 Favored 'General case' 0 C--N 1.299 -1.611 0 O-C-N 121.273 -0.892 . . . . 0.0 108.801 179.251 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 155' ' ' MET . . . . . . . . . . . . . 27.1 mtp -45.94 109.04 0.15 Allowed 'General case' 0 N--CA 1.494 1.741 0 CA-C-O 122.443 1.116 . . . . 0.0 111.671 -178.484 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 156' ' ' THR . . . . . 0.691 ' OG1' HG23 ' A' ' 203' ' ' THR . 0.2 OUTLIER -103.3 -28.28 11.96 Favored 'General case' 0 C--N 1.296 -1.735 0 CA-C-N 115.168 -0.923 . . . . 0.0 110.22 -178.572 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 157' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -146.95 154.69 41.57 Favored 'General case' 0 N--CA 1.496 1.84 0 C-N-CA 118.337 -1.345 . . . . 0.0 110.569 -179.048 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 158' ' ' ILE . . . . . 0.405 HG12 ' CD1' ' A' ' 200' ' ' PHE . 1.6 mt -148.27 137.31 15.62 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.652 0 CA-C-O 121.322 0.582 . . . . 0.0 109.982 -177.927 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 159' ' ' ARG . . . . . . . . . . . . . 2.2 mtt180 -156.14 -177.62 6.72 Favored 'General case' 0 N--CA 1.494 1.742 0 O-C-N 121.298 -0.877 . . . . 0.0 110.931 -179.521 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 160' ' ' ASP . . . . . 0.494 ' C ' HG22 ' A' ' 161' ' ' VAL . 9.3 m-20 -146.8 165.01 30.98 Favored 'General case' 0 N--CA 1.493 1.692 0 N-CA-C 108.48 -0.933 . . . . 0.0 108.48 179.825 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 161' ' ' VAL . . . . . 0.494 HG22 ' C ' ' A' ' 160' ' ' ASP . 0.0 OUTLIER -162.0 158.78 1.84 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.701 0 O-C-N 120.822 -1.174 . . . . 0.0 111.033 -179.874 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 162' ' ' LYS . . . . . 0.461 ' O ' ' O ' ' A' ' 161' ' ' VAL . 0.0 OUTLIER -44.05 171.23 0.04 OUTLIER Pre-proline 0 N--CA 1.493 1.693 0 O-C-N 121.767 -0.583 . . . . 0.0 110.289 179.326 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 163' ' ' PRO . . . . . 0.483 ' C ' HD11 ' C' ' 702' ' ' LEU . 71.3 Cg_endo -77.89 32.24 0.44 Allowed 'Trans proline' 0 N--CA 1.495 1.591 0 C-N-CA 122.926 2.417 . . . . 0.0 113.669 -179.839 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 164' ' ' THR . . . . . 0.517 ' N ' HD11 ' C' ' 702' ' ' LEU . 0.0 OUTLIER -152.26 -2.84 0.26 Allowed 'General case' 0 N--CA 1.495 1.796 0 O-C-N 120.839 -1.163 . . . . 0.0 111.125 179.686 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 165' ' ' ASP . . . . . 0.42 ' O ' ' C ' ' A' ' 166' ' ' VAL . 1.4 t70 -73.31 61.1 0.63 Allowed 'General case' 0 N--CA 1.491 1.582 0 O-C-N 120.748 -1.22 . . . . 0.0 110.132 -179.245 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 166' ' ' VAL . . . . . 0.596 HG22 ' O2 ' ' C' ' 701' ' ' PHQ . 2.2 t -45.75 -31.66 1.18 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.604 0 O-C-N 121.048 -1.032 . . . . 0.0 109.614 -178.998 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 167' ' ' GLY . . . . . . . . . . . . . . . -44.8 -10.99 0.01 OUTLIER Glycine 0 N--CA 1.494 2.523 0 O-C-N 120.756 -1.215 . . . . 0.0 111.116 -179.583 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 168' ' ' VAL . . . . . 0.582 ' N ' ' O ' ' A' ' 166' ' ' VAL . 5.8 m -53.8 -29.96 18.53 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.634 0 O-C-N 120.552 -1.557 . . . . 0.0 108.774 179.814 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 169' ' ' LEU . . . . . 0.543 ' O ' ' C ' ' A' ' 170' ' ' ASP . 11.7 mt -49.83 -13.59 0.1 Allowed 'General case' 0 N--CA 1.491 1.62 0 N-CA-C 107.33 -1.359 . . . . 0.0 107.33 -178.994 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 170' ' ' ASP . . . . . 0.556 ' N ' ' C ' ' A' ' 168' ' ' VAL . 40.3 t0 19.46 90.97 0.01 OUTLIER 'General case' 0 N--CA 1.5 2.053 0 CA-C-N 116.355 -0.384 . . . . 0.0 111.587 177.322 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 171' ' ' GLU . . . . . . . . . . . . . 7.8 pt-20 -128.7 72.91 1.47 Allowed 'General case' 0 N--CA 1.496 1.873 0 O-C-N 120.952 -1.092 . . . . 0.0 111.099 -179.615 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 172' ' ' GLN . . . . . . . . . . . . . 6.6 mp0 -128.73 -52.12 1.24 Allowed 'General case' 0 N--CA 1.498 1.965 0 O-C-N 121.335 -0.853 . . . . 0.0 111.519 -178.559 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 173' ' ' LYS . . . . . . . . . . . . . 56.9 mttt -58.51 130.6 47.58 Favored 'General case' 0 N--CA 1.498 1.961 0 O-C-N 120.841 -1.162 . . . . 0.0 109.655 -179.34 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 174' ' ' GLY . . . . . 0.53 ' O ' ' C ' ' A' ' 175' ' ' LYS . . . -122.48 -43.76 0.37 Allowed Glycine 0 N--CA 1.48 1.607 0 N-CA-C 108.657 -1.777 . . . . 0.0 108.657 179.761 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 175' ' ' LYS . . . . . 0.53 ' C ' ' O ' ' A' ' 174' ' ' GLY . 13.6 mptt -37.98 -62.9 0.52 Allowed 'General case' 0 N--CA 1.495 1.776 0 N-CA-C 107.319 -1.363 . . . . 0.0 107.319 179.309 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 176' ' ' ASP . . . . . 0.599 ' O ' ' O ' ' A' ' 177' ' ' LYS . 1.1 m-20 -104.34 91.2 3.81 Favored 'General case' 0 C--N 1.293 -1.885 0 N-CA-C 106.942 -1.503 . . . . 0.0 106.942 176.725 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 177' ' ' LYS . . . . . 0.599 ' O ' ' O ' ' A' ' 176' ' ' ASP . 9.7 mttp -45.07 -176.01 0.0 OUTLIER 'General case' 0 N--CA 1.494 1.764 0 O-C-N 121.344 -0.848 . . . . 0.0 109.683 -179.093 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 178' ' ' GLN . . . . . 0.57 ' NE2' ' OD1' ' A' ' 114' ' ' ASN . 18.6 pt20 -161.0 176.45 11.37 Favored 'General case' 0 N--CA 1.487 1.399 0 C-N-CA 118.043 -1.463 . . . . 0.0 111.399 179.581 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 179' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -130.61 96.27 4.07 Favored 'General case' 0 C--N 1.302 -1.493 0 N-CA-C 107.525 -1.287 . . . . 0.0 107.525 178.187 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 180' ' ' THR . . . . . 0.404 ' O ' HG22 ' A' ' 180' ' ' THR . 1.2 m -71.09 114.17 8.87 Favored 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.069 -1.019 . . . . 0.0 109.485 -178.979 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 181' ' ' LEU . . . . . 0.729 HD13 ' N ' ' A' ' 182' ' ' ILE . 0.3 OUTLIER -90.14 141.15 28.97 Favored 'General case' 0 C--N 1.3 -1.554 0 N-CA-C 108.234 -1.024 . . . . 0.0 108.234 178.453 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 182' ' ' ILE . . . . . 0.729 ' N ' HD13 ' A' ' 181' ' ' LEU . 73.4 mt -135.07 118.72 24.91 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.594 0 N-CA-C 107.638 -1.245 . . . . 0.0 107.638 178.903 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 183' ' ' THR . . . . . 0.482 HG23 ' O ' ' A' ' 183' ' ' THR . 3.8 t -138.62 112.09 8.17 Favored 'General case' 0 C--N 1.289 -2.038 0 N-CA-C 107.894 -1.15 . . . . 0.0 107.894 179.902 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 184' ' ' CYS . . . . . . . . . . . . . 1.9 p -78.58 157.1 28.85 Favored 'General case' 0 C--N 1.292 -1.911 0 C-N-CA 119.326 -0.95 . . . . 0.0 110.911 -177.867 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 185' ' ' ASP . . . . . . . . . . . . . 20.7 t0 -165.68 -152.86 0.16 Allowed 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.456 -0.778 . . . . 0.0 109.518 -179.735 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 186' ' ' ASP . . . . . . . . . . . . . 13.0 m-20 47.69 56.48 7.07 Favored 'General case' 0 N--CA 1.496 1.829 0 O-C-N 121.139 -0.975 . . . . 0.0 109.071 -179.707 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 187' ' ' TYR . . . . . 0.623 ' CE1' ' O ' ' A' ' 188' ' ' ASN . 32.9 t80 -67.91 136.08 53.45 Favored 'General case' 0 N--CA 1.49 1.56 0 CA-C-O 121.799 0.809 . . . . 0.0 111.013 -179.221 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 188' ' ' ASN . . . . . 0.623 ' O ' ' CE1' ' A' ' 187' ' ' TYR . 1.1 t-20 -99.43 147.53 25.17 Favored 'General case' 0 C--N 1.297 -1.705 0 N-CA-C 108.128 -1.064 . . . . 0.0 108.128 178.503 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 189' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -112.52 -13.59 13.32 Favored 'General case' 0 C--N 1.293 -1.878 0 N-CA-C 108.114 -1.069 . . . . 0.0 108.114 -179.718 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 190' ' ' LYS . . . . . . . . . . . . . 88.3 mttt -84.32 -51.26 7.12 Favored 'General case' 0 N--CA 1.488 1.474 0 N-CA-C 108.853 -0.795 . . . . 0.0 108.853 178.791 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 191' ' ' THR . . . . . 0.473 ' OG1' HG12 ' A' ' 193' ' ' VAL . 9.4 p -89.61 -10.82 44.56 Favored 'General case' 0 N--CA 1.489 1.488 0 O-C-N 121.546 -0.721 . . . . 0.0 109.075 179.79 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 192' ' ' GLY . . . . . . . . . . . . . . . 68.69 30.76 72.81 Favored Glycine 0 N--CA 1.492 2.399 0 O-C-N 121.316 -0.865 . . . . 0.0 110.945 178.733 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 193' ' ' VAL . . . . . 0.514 HG22 ' H ' ' A' ' 194' ' ' TRP . 2.2 p -145.9 169.29 6.54 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.621 0 O-C-N 120.791 -1.417 . . . . 0.0 110.201 179.397 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 194' ' ' TRP . . . . . 0.541 ' CD1' ' N ' ' A' ' 194' ' ' TRP . 9.4 m95 -86.47 121.37 28.93 Favored 'General case' 0 C--N 1.294 -1.821 0 N-CA-C 109.104 -0.702 . . . . 0.0 109.104 -179.717 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 195' ' ' GLU . . . . . 0.492 ' CD ' ' ND2' ' A' ' 188' ' ' ASN . 1.3 mt-10 -85.04 -61.17 1.84 Allowed 'General case' 0 N--CA 1.497 1.888 0 O-C-N 121.275 -0.891 . . . . 0.0 111.703 -178.216 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 196' ' ' LYS . . . . . . . . . . . . . 1.8 mtpm? -84.61 151.27 24.62 Favored 'General case' 0 N--CA 1.494 1.74 0 O-C-N 120.814 -1.179 . . . . 0.0 110.488 -178.475 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 197' ' ' ARG . . . . . 0.544 ' NH1' ' O ' ' C' ' 704' ' ' ALA . 24.1 mmt180 -120.37 137.42 54.3 Favored 'General case' 0 N--CA 1.492 1.637 0 N-CA-C 108.942 -0.762 . . . . 0.0 108.942 179.497 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 198' ' ' LYS . . . . . . . . . . . . . 5.0 mptp? -115.1 120.01 38.37 Favored 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.467 -0.771 . . . . 0.0 110.304 -179.007 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 199' ' ' ILE . . . . . 0.423 ' O ' HG13 ' A' ' 199' ' ' ILE . 1.1 pp -141.42 121.01 11.35 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.803 0 CA-C-O 122.618 1.199 . . . . 0.0 110.826 179.201 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 200' ' ' PHE . . . . . 0.526 ' CD1' ' N ' ' A' ' 200' ' ' PHE . 0.7 OUTLIER -105.04 141.42 36.65 Favored 'General case' 0 N--CA 1.494 1.773 0 O-C-N 121.131 -0.981 . . . . 0.0 111.177 -178.133 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 201' ' ' VAL . . . . . . . . . . . . . 96.8 t -102.57 149.02 7.22 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.651 0 N-CA-C 107.726 -1.213 . . . . 0.0 107.726 176.722 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 202' ' ' ALA . . . . . . . . . . . . . . . -132.27 139.89 48.42 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.002 -1.061 . . . . 0.0 109.116 -179.513 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 203' ' ' THR . . . . . 0.691 HG23 ' OG1' ' A' ' 156' ' ' THR . 16.8 p -89.86 131.19 35.92 Favored 'General case' 0 N--CA 1.487 1.416 0 CA-C-O 122.556 1.169 . . . . 0.0 111.944 -178.316 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 204' ' ' GLU . . . . . 0.412 ' HA ' ' CD2' ' A' ' 153' ' ' TYR . 1.0 OUTLIER -61.96 135.43 57.55 Favored 'General case' 0 C--N 1.299 -1.598 0 CA-C-N 114.818 -1.083 . . . . 0.0 108.957 179.016 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 205' ' ' VAL . . . . . 0.504 ' O ' ' C ' ' A' ' 206' ' ' LYS . 37.6 t -122.67 -44.47 1.88 Allowed 'Isoleucine or valine' 0 N--CA 1.494 1.76 0 O-C-N 121.382 -0.824 . . . . 0.0 109.71 -179.703 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 206' ' ' LYS . . . . . 0.504 ' C ' ' O ' ' A' ' 205' ' ' VAL . 0.0 OUTLIER . . . . . 0 N--CA 1.494 1.767 0 CA-C-O 118.093 -0.956 . . . . 0.0 110.456 -179.636 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' C' C ' 701' ' ' PHQ . . . . . 0.596 ' O2 ' HG22 ' A' ' 166' ' ' VAL . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' C' C ' 702' ' ' LEU . . . . . 0.657 ' N ' HD12 ' C' ' 702' ' ' LEU . 0.0 OUTLIER . . . . . 0 N--CA 1.493 1.703 0 N-CA-C 110.009 -0.367 . . . . 0.0 110.009 . . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' C' C ' 703' ' ' PRO . . . . . 0.545 ' HB3' ' HB3' ' A' ' 92' ' ' ALA . 31.3 Cg_exo -51.34 -160.79 0.0 OUTLIER 'Trans proline' 0 N--CA 1.493 1.476 0 C-N-CA 121.945 1.764 . . . . 0.0 111.718 179.057 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' C' C ' 704' ' ' ALA . . . . . 1.019 ' HB2' ' HB1' ' A' ' 118' ' ' ALA . . . 51.03 98.39 0.01 OUTLIER 'General case' 0 N--CA 1.489 1.481 0 O-C-N 120.981 -1.075 . . . . 0.0 109.055 179.898 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' C' C ' 705' ' ' B27 . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 001 nuclear nobuild full ' A' A ' 700' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 002 nuclear nobuild full ' A' A ' 59' ' ' MET . . . . . . . . . . . . . 5.8 ptp . . . . . 0 N--CA 1.492 1.674 0 N-CA-C 109.468 -0.568 . . . . 0.0 109.468 . . . . . . . . . 0 0 . 1 . 002 nuclear nobuild full ' A' A ' 60' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -60.17 175.05 0.45 Allowed 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.296 -0.878 . . . . 0.0 109.556 -179.95 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . -65.2 147.34 53.63 Favored 'General case' 0 C--N 1.303 -1.419 0 O-C-N 121.47 -0.769 . . . . 0.0 109.756 179.986 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 62' ' ' LYS . . . . . . . . . . . . . 55.1 mttt -141.6 70.69 25.76 Favored Pre-proline 0 C--N 1.303 -1.453 0 O-C-N 121.363 -0.836 . . . . 0.0 109.103 179.437 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 63' ' ' PRO . . . . . . . . . . . . . 10.6 Cg_endo -87.4 157.46 8.03 Favored 'Trans proline' 0 C--N 1.31 -1.458 0 C-N-CA 123.51 2.807 . . . . 0.0 111.473 179.999 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 64' ' ' GLN . . . . . 0.682 ' NE2' ' N ' ' A' ' 64' ' ' GLN . 0.0 OUTLIER -153.71 119.93 5.44 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.163 -0.961 . . . . 0.0 109.433 179.732 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 65' ' ' ILE . . . . . 0.463 ' C ' ' O ' ' A' ' 64' ' ' GLN . 0.0 OUTLIER -42.18 103.78 0.32 Allowed Pre-proline 0 N--CA 1.495 1.782 0 N-CA-C 108.405 -0.961 . . . . 0.0 108.405 179.203 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 66' ' ' PRO . . . . . . . . . . . . . 88.3 Cg_endo -87.36 -159.99 0.1 OUTLIER 'Trans proline' 0 C--N 1.315 -1.191 0 C-N-CA 122.272 1.982 . . . . 0.0 112.421 -179.436 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 67' ' ' LYS . . . . . . . . . . . . . 13.5 pttt -79.67 -4.99 54.18 Favored 'General case' 0 C--N 1.302 -1.5 0 N-CA-C 108.739 -0.837 . . . . 0.0 108.739 179.765 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 68' ' ' ASP . . . . . 0.662 ' C ' ' N ' ' A' ' 70' ' ' SER . 1.0 OUTLIER -76.79 48.62 0.58 Allowed 'General case' 0 C--N 1.304 -1.396 0 CA-C-O 121.958 0.885 . . . . 0.0 109.393 179.705 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 69' ' ' LYS . . . . . 0.456 ' C ' ' O ' ' A' ' 68' ' ' ASP . 1.6 ptpt -49.3 -13.25 0.07 Allowed 'General case' 0 N--CA 1.508 2.442 0 C-N-CA 116.684 -2.006 . . . . 0.0 106.283 177.599 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 70' ' ' SER . . . . . 0.662 ' N ' ' C ' ' A' ' 68' ' ' ASP . 0.4 OUTLIER -83.43 -9.66 58.88 Favored 'General case' 0 N--CA 1.496 1.83 0 CA-C-N 113.164 -1.835 . . . . 0.0 110.162 179.221 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 71' ' ' LYS . . . . . 0.442 ' N ' ' O ' ' A' ' 68' ' ' ASP . 0.0 OUTLIER -97.36 142.98 28.57 Favored 'General case' 0 N--CA 1.496 1.838 0 O-C-N 120.991 -1.068 . . . . 0.0 110.753 179.601 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 72' ' ' VAL . . . . . 0.549 HG12 ' CZ ' ' A' ' 88' ' ' TYR . 0.8 OUTLIER -66.16 141.94 17.4 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.527 0 N-CA-C 105.131 -2.174 . . . . 0.0 105.131 174.702 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 73' ' ' ALA . . . . . 0.517 ' N ' ' O ' ' A' ' 87' ' ' VAL . . . -82.8 -15.9 49.88 Favored 'General case' 0 C--N 1.295 -1.762 0 O-C-N 119.928 -1.732 . . . . 0.0 106.704 179.75 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 74' ' ' GLY . . . . . 0.415 ' N ' HG23 ' A' ' 72' ' ' VAL . . . 175.4 -157.83 24.73 Favored Glycine 0 N--CA 1.479 1.546 0 N-CA-C 109.318 -1.513 . . . . 0.0 109.318 179.584 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 75' ' ' TYR . . . . . 0.605 ' HA ' HG23 ' A' ' 87' ' ' VAL . 0.6 OUTLIER -143.15 168.35 19.96 Favored 'General case' 0 C--N 1.295 -1.778 0 O-C-N 121.682 -0.893 . . . . 0.0 110.463 -177.234 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 76' ' ' ILE . . . . . . . . . . . . . 2.4 tt -148.75 145.91 17.84 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.601 0 C-N-CA 119.225 -0.99 . . . . 0.0 110.075 -178.04 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -150.65 166.43 30.36 Favored 'General case' 0 N--CA 1.489 1.49 0 O-C-N 121.059 -1.026 . . . . 0.0 109.289 179.371 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 78' ' ' ILE . . . . . 0.664 ' HB ' ' HB3' ' A' ' 81' ' ' ALA . 13.5 mt -147.75 94.98 4.3 Favored Pre-proline 0 C--N 1.302 -1.474 0 N-CA-C 108.6 -0.889 . . . . 0.0 108.6 -179.57 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 79' ' ' PRO . . . . . . . . . . . . . 75.0 Cg_exo -47.55 -47.56 17.69 Favored 'Trans proline' 0 N--CA 1.494 1.506 0 C-N-CA 122.811 2.34 . . . . 0.0 113.811 -178.645 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -65.86 -18.63 65.46 Favored 'General case' 0 N--CA 1.493 1.718 0 O-C-N 120.868 -1.145 . . . . 0.0 110.439 178.474 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 81' ' ' ALA . . . . . 0.743 ' HB2' ' HB2' ' A' ' 136' ' ' ALA . . . -105.01 -14.05 15.55 Favored 'General case' 0 N--CA 1.493 1.679 0 O-C-N 121.238 -0.914 . . . . 0.0 109.035 179.904 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 82' ' ' ASP . . . . . 0.4 ' N ' ' O ' ' A' ' 78' ' ' ILE . 0.3 OUTLIER 64.27 48.34 2.89 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.334 -0.853 . . . . 0.0 110.503 179.246 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 83' ' ' ILE . . . . . 0.487 HD11 ' HB3' ' A' ' 132' ' ' ASN . 64.2 mt -131.1 152.08 36.92 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.796 0 O-C-N 121.127 -0.983 . . . . 0.0 110.647 -178.583 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 84' ' ' LYS . . . . . . . . . . . . . 30.2 tttp -158.83 111.85 2.3 Favored 'General case' 0 N--CA 1.492 1.635 0 N-CA-C 108.315 -0.994 . . . . 0.0 108.315 179.282 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 85' ' ' GLU . . . . . 0.445 ' O ' ' CD2' ' A' ' 75' ' ' TYR . 0.4 OUTLIER -143.16 162.79 41.22 Favored Pre-proline 0 N--CA 1.494 1.729 0 O-C-N 121.279 -0.888 . . . . 0.0 110.225 -179.211 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 86' ' ' PRO . . . . . 0.416 ' N ' ' CE2' ' A' ' 75' ' ' TYR . 57.1 Cg_endo -70.92 167.65 25.33 Favored 'Trans proline' 0 N--CA 1.497 1.698 0 C-N-CA 123.346 2.697 . . . . 0.0 113.506 -179.141 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 87' ' ' VAL . . . . . 0.605 HG23 ' HA ' ' A' ' 75' ' ' TYR . 62.0 t -124.67 99.66 6.47 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.66 0 N-CA-C 108.972 -0.751 . . . . 0.0 108.972 179.717 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 88' ' ' TYR . . . . . 0.549 ' CZ ' HG12 ' A' ' 72' ' ' VAL . 33.0 m-85 -92.87 152.94 42.01 Favored Pre-proline 0 N--CA 1.502 2.164 0 O-C-N 120.832 -1.167 . . . . 0.0 110.029 -179.617 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 89' ' ' PRO . . . . . 0.432 ' O ' ' NE2' ' A' ' 96' ' ' GLN . 6.1 Cg_endo -57.19 144.47 90.47 Favored 'Trans proline' 0 C--N 1.312 -1.392 0 C-N-CA 122.531 2.154 . . . . 0.0 113.606 -179.901 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . -57.22 167.6 4.64 Favored Glycine 0 N--CA 1.49 2.268 0 N-CA-C 109.242 -1.543 . . . . 0.0 109.242 179.038 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 91' ' ' PRO . . . . . 0.423 ' C ' ' H ' ' A' ' 93' ' ' THR . 18.9 Cg_endo -93.44 170.4 19.62 Favored 'Cis proline' 0 C--N 1.307 -1.626 0 C-N-CA 123.968 -1.263 . . . . 0.0 112.054 -0.176 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 92' ' ' ALA . . . . . . . . . . . . . . . -72.78 30.57 0.06 Allowed 'General case' 0 N--CA 1.489 1.504 0 O-C-N 121.216 -0.928 . . . . 0.0 110.635 -179.868 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 93' ' ' THR . . . . . 0.423 ' H ' ' C ' ' A' ' 91' ' ' PRO . 1.0 OUTLIER -75.44 152.84 85.73 Favored Pre-proline 0 N--CA 1.49 1.572 0 O-C-N 120.743 -1.223 . . . . 0.0 109.095 -179.741 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 94' ' ' PRO . . . . . 0.412 ' C ' ' O ' ' A' ' 93' ' ' THR . 53.3 Cg_exo -32.82 -52.6 0.39 Allowed 'Trans proline' 0 C--N 1.309 -1.517 0 C-N-CA 122.933 2.422 . . . . 0.0 112.214 -179.292 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 95' ' ' GLU . . . . . 0.586 ' O ' ' ND2' ' A' ' 98' ' ' ASN . 13.0 mt-10 -45.9 -53.11 10.38 Favored 'General case' 0 N--CA 1.489 1.49 0 O-C-N 121.249 -0.907 . . . . 0.0 109.452 179.942 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 96' ' ' GLN . . . . . 0.556 ' O ' ' N ' ' A' ' 98' ' ' ASN . 29.6 mm100 -71.41 -51.66 22.8 Favored 'General case' 0 C--N 1.305 -1.368 0 O-C-N 120.955 -1.091 . . . . 0.0 109.747 179.956 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 97' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -49.52 -7.82 0.03 OUTLIER 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.209 -0.932 . . . . 0.0 109.675 -179.424 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 98' ' ' ASN . . . . . 0.722 HD21 ' CZ ' ' A' ' 99' ' ' ARG . 0.4 OUTLIER -73.05 -24.37 60.69 Favored 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.167 -0.958 . . . . 0.0 109.615 -179.931 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 99' ' ' ARG . . . . . 0.722 ' CZ ' HD21 ' A' ' 98' ' ' ASN . 0.6 OUTLIER -103.56 -59.42 1.72 Allowed 'General case' 0 N--CA 1.489 1.504 0 O-C-N 121.544 -0.722 . . . . 0.0 110.363 -178.936 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . -164.73 -171.53 31.09 Favored Glycine 0 N--CA 1.494 2.545 0 C-N-CA 119.21 -1.471 . . . . 0.0 110.608 -179.674 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 101' ' ' VAL . . . . . 0.687 ' O ' HG23 ' A' ' 101' ' ' VAL . 18.9 m -59.94 108.3 0.38 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.667 0 O-C-N 121.411 -1.053 . . . . 0.0 108.955 179.854 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -93.03 165.28 12.93 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.446 -0.784 . . . . 0.0 111.015 -179.133 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 103' ' ' PHE . . . . . 0.505 ' CE1' ' CG1' ' A' ' 87' ' ' VAL . 24.5 m-85 -66.17 160.5 24.0 Favored 'General case' 0 N--CA 1.486 1.368 0 N-CA-C 107.954 -1.128 . . . . 0.0 107.954 178.031 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 104' ' ' ALA . . . . . . . . . . . . . . . -72.5 -22.58 61.03 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.087 -1.008 . . . . 0.0 111.707 -177.913 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 1.2 pm0 -138.95 150.12 45.53 Favored 'General case' 0 N--CA 1.497 1.876 0 O-C-N 120.696 -1.253 . . . . 0.0 110.644 -179.296 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 106' ' ' GLU . . . . . . . . . . . . . 66.2 tt0 -52.7 -59.52 4.38 Favored 'General case' 0 C--N 1.303 -1.415 0 O-C-N 121.777 -0.577 . . . . 0.0 110.491 -179.928 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 107' ' ' ASN . . . . . 0.584 ' H ' ' ND2' ' A' ' 107' ' ' ASN . 0.2 OUTLIER -77.05 32.84 0.14 Allowed 'General case' 0 N--CA 1.488 1.461 0 O-C-N 120.614 -1.304 . . . . 0.0 112.583 -175.706 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 108' ' ' GLU . . . . . . . . . . . . . 2.8 tp10 -60.2 144.29 50.43 Favored 'General case' 0 N--CA 1.488 1.473 0 N-CA-C 107.029 -1.471 . . . . 0.0 107.029 179.742 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 109' ' ' SER . . . . . 0.524 ' C ' ' H ' ' A' ' 111' ' ' ASP . 0.2 OUTLIER -97.76 122.82 41.31 Favored 'General case' 0 N--CA 1.487 1.416 0 O-C-N 120.83 -1.169 . . . . 0.0 110.858 -177.776 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 110' ' ' LEU . . . . . . . . . . . . . 2.1 pp -59.81 -3.26 0.49 Allowed 'General case' 0 C--N 1.301 -1.521 0 N-CA-C 108.04 -1.096 . . . . 0.0 108.04 179.235 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 111' ' ' ASP . . . . . 0.524 ' H ' ' C ' ' A' ' 109' ' ' SER . 75.7 m-20 -132.83 18.63 4.19 Favored 'General case' 0 N--CA 1.489 1.498 0 O-C-N 121.735 -0.603 . . . . 0.0 109.716 179.668 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 112' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -65.07 135.84 56.04 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 120.887 -1.133 . . . . 0.0 109.684 -179.76 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 113' ' ' GLN . . . . . 0.525 ' NE2' ' O ' ' A' ' 173' ' ' LYS . 0.0 OUTLIER -64.44 -4.64 4.13 Favored 'General case' 0 C--N 1.303 -1.439 0 O-C-N 121.24 -0.913 . . . . 0.0 108.766 179.238 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 114' ' ' ASN . . . . . 0.592 HD22 ' C ' ' A' ' 114' ' ' ASN . 0.2 OUTLIER -144.78 92.49 2.29 Favored 'General case' 0 C--N 1.303 -1.436 0 N-CA-C 107.13 -1.433 . . . . 0.0 107.13 177.967 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 115' ' ' ILE . . . . . 0.445 HD11 ' O ' ' A' ' 109' ' ' SER . 2.1 mt -101.88 117.22 46.87 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.457 0 O-C-N 121.592 -0.693 . . . . 0.0 110.959 -178.304 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 116' ' ' SER . . . . . . . . . . . . . 97.0 p -99.04 146.82 25.67 Favored 'General case' 0 N--CA 1.495 1.807 0 O-C-N 121.244 -0.91 . . . . 0.0 111.544 -178.928 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 117' ' ' ILE . . . . . . . . . . . . . 2.7 mp -135.16 148.55 28.79 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.842 0 N-CA-C 107.521 -1.289 . . . . 0.0 107.521 178.891 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 118' ' ' ALA . . . . . . . . . . . . . . . -144.97 160.73 40.88 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 120.531 -1.356 . . . . 0.0 111.849 -179.251 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 119' ' ' GLY . . . . . . . . . . . . . . . -169.88 156.72 27.76 Favored Glycine 0 N--CA 1.485 1.909 0 N-CA-C 109.456 -1.457 . . . . 0.0 109.456 179.424 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 120' ' ' HIS . . . . . . . . . . . . . 20.0 m-70 -71.36 162.59 29.19 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.51 -0.994 . . . . 0.0 109.849 179.676 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 121' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -117.49 160.02 21.89 Favored 'General case' 0 N--CA 1.492 1.669 0 N-CA-C 107.962 -1.125 . . . . 0.0 107.962 178.586 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 122' ' ' PHE . . . . . 0.41 ' O ' HG21 ' A' ' 131' ' ' THR . 0.2 OUTLIER -127.28 133.35 50.17 Favored 'General case' 0 N--CA 1.495 1.805 0 O-C-N 121.144 -0.972 . . . . 0.0 110.273 -178.821 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 123' ' ' ILE . . . . . . . . . . . . . 15.9 tt -90.76 -27.1 5.04 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.624 0 CA-C-O 121.827 0.822 . . . . 0.0 110.097 -179.317 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 124' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -87.4 -2.29 58.52 Favored 'General case' 0 C--N 1.291 -1.938 0 C-N-CA 120.128 -0.629 . . . . 0.0 111.318 -178.663 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 125' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -154.2 124.08 3.29 Favored Pre-proline 0 N--CA 1.494 1.774 0 O-C-N 120.625 -1.297 . . . . 0.0 109.683 -179.702 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 126' ' ' PRO . . . . . . . . . . . . . 86.8 Cg_endo -81.14 -16.67 9.66 Favored 'Trans proline' 0 N--CA 1.494 1.518 0 C-N-CA 122.46 2.106 . . . . 0.0 112.992 179.994 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 127' ' ' ASN . . . . . 0.616 HD22 ' C ' ' A' ' 127' ' ' ASN . 0.1 OUTLIER -90.19 22.37 3.33 Favored 'General case' 0 N--CA 1.493 1.702 0 O-C-N 121.071 -1.018 . . . . 0.0 110.308 -179.342 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 128' ' ' TYR . . . . . . . . . . . . . 13.0 t80 -75.3 -150.52 0.03 OUTLIER 'General case' 0 N--CA 1.492 1.673 0 O-C-N 121.004 -1.06 . . . . 0.0 109.751 -179.73 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 129' ' ' GLN . . . . . . . . . . . . . 27.7 mt-30 -68.1 -89.1 0.01 OUTLIER 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.252 -0.905 . . . . 0.0 109.616 -179.636 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 130' ' ' PHE . . . . . 0.684 ' CE2' HG11 ' A' ' 101' ' ' VAL . 27.7 m-85 -108.14 35.13 3.26 Favored 'General case' 0 N--CA 1.493 1.684 0 O-C-N 121.421 -0.799 . . . . 0.0 110.003 -179.533 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 131' ' ' THR . . . . . 0.41 HG21 ' O ' ' A' ' 122' ' ' PHE . 55.0 m -75.37 -33.31 61.04 Favored 'General case' 0 N--CA 1.488 1.464 0 O-C-N 121.037 -1.039 . . . . 0.0 108.982 179.562 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 132' ' ' ASN . . . . . 0.531 ' ND2' ' O ' ' A' ' 81' ' ' ALA . 4.6 t30 -81.01 3.98 21.21 Favored 'General case' 0 N--CA 1.494 1.741 0 O-C-N 121.32 -0.863 . . . . 0.0 110.512 -179.014 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 133' ' ' LEU . . . . . 0.601 HD13 ' O ' ' A' ' 133' ' ' LEU . 0.4 OUTLIER -68.85 -48.96 62.17 Favored 'General case' 0 N--CA 1.488 1.456 0 O-C-N 120.982 -1.074 . . . . 0.0 109.318 -179.943 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 134' ' ' LYS . . . . . 0.664 ' H ' ' CE ' ' A' ' 134' ' ' LYS . 0.0 OUTLIER -43.0 -18.21 0.01 OUTLIER 'General case' 0 N--CA 1.488 1.452 0 O-C-N 121.363 -0.835 . . . . 0.0 109.121 179.869 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 135' ' ' ALA . . . . . 0.593 ' N ' ' O ' ' A' ' 133' ' ' LEU . . . -83.43 -39.02 21.14 Favored 'General case' 0 N--CA 1.488 1.435 0 O-C-N 121.219 -0.926 . . . . 0.0 109.266 179.012 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 136' ' ' ALA . . . . . 0.743 ' HB2' ' HB2' ' A' ' 81' ' ' ALA . . . -80.46 157.45 26.2 Favored 'General case' 0 N--CA 1.49 1.542 0 CA-C-O 121.996 0.903 . . . . 0.0 111.299 -178.965 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 137' ' ' LYS . . . . . 0.536 ' O ' ' O ' ' A' ' 138' ' ' LYS . 1.0 OUTLIER -154.19 -162.36 1.4 Allowed 'General case' 0 N--CA 1.49 1.575 0 C-N-CA 118.5 -1.28 . . . . 0.0 110.961 -178.161 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 138' ' ' LYS . . . . . 0.574 ' O ' ' N ' ' A' ' 140' ' ' SER . 9.4 mttp -43.17 178.27 0.0 OUTLIER 'General case' 0 N--CA 1.487 1.397 0 CA-C-O 122.438 1.113 . . . . 0.0 111.083 -179.03 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 139' ' ' GLY . . . . . . . . . . . . . . . 46.95 7.72 0.02 OUTLIER Glycine 0 N--CA 1.491 2.302 0 N-CA-C 110.668 -0.973 . . . . 0.0 110.668 179.858 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 140' ' ' SER . . . . . 0.574 ' N ' ' O ' ' A' ' 138' ' ' LYS . 58.4 m -86.87 127.14 35.04 Favored 'General case' 0 N--CA 1.496 1.87 0 O-C-N 120.811 -1.406 . . . . 0.0 109.599 179.349 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 141' ' ' MET . . . . . 0.591 ' SD ' ' N ' ' A' ' 142' ' ' VAL . 6.2 tpp -77.61 129.16 35.26 Favored 'General case' 0 N--CA 1.492 1.65 0 O-C-N 120.975 -1.078 . . . . 0.0 109.33 179.688 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 142' ' ' VAL . . . . . 0.591 ' N ' ' SD ' ' A' ' 141' ' ' MET . 1.4 t -112.09 133.27 58.34 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.617 0 N-CA-C 108.546 -0.909 . . . . 0.0 108.546 -179.982 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 143' ' ' TYR . . . . . . . . . . . . . 5.4 m-85 -108.22 134.36 51.17 Favored 'General case' 0 N--CA 1.497 1.897 0 O-C-N 120.719 -1.238 . . . . 0.0 112.31 -177.835 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 144' ' ' PHE . . . . . . . . . . . . . 36.9 t80 -119.92 99.92 6.92 Favored 'General case' 0 N--CA 1.494 1.726 0 N-CA-C 109.511 -0.551 . . . . 0.0 109.511 179.718 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 145' ' ' LYS . . . . . . . . . . . . . 1.0 OUTLIER -96.02 134.3 39.2 Favored 'General case' 0 N--CA 1.493 1.701 0 O-C-N 121.193 -0.942 . . . . 0.0 110.677 -179.348 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 146' ' ' VAL . . . . . 0.479 ' O ' ' C ' ' A' ' 147' ' ' GLY . 0.0 OUTLIER -144.03 141.14 24.97 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.789 0 N-CA-C 107.443 -1.317 . . . . 0.0 107.443 178.861 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 147' ' ' GLY . . . . . 0.479 ' C ' ' O ' ' A' ' 146' ' ' VAL . . . 38.42 -117.67 0.64 Allowed Glycine 0 N--CA 1.493 2.44 0 N-CA-C 109.67 -1.372 . . . . 0.0 109.67 179.78 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 148' ' ' ASN . . . . . 0.501 ' C ' ' ND2' ' A' ' 148' ' ' ASN . 0.4 OUTLIER -108.74 13.45 25.03 Favored 'General case' 0 C--N 1.303 -1.447 0 O-C-N 121.576 -0.955 . . . . 0.0 108.643 179.166 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 149' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -107.0 142.21 36.98 Favored 'General case' 0 N--CA 1.488 1.464 0 CA-C-O 121.934 0.873 . . . . 0.0 111.329 -178.863 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 150' ' ' THR . . . . . . . . . . . . . 97.3 m -134.64 99.06 4.22 Favored 'General case' 0 C--N 1.3 -1.583 0 CA-C-O 121.581 0.705 . . . . 0.0 109.841 -179.428 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 151' ' ' ARG . . . . . . . . . . . . . 86.6 mtt180 -88.24 -171.26 3.29 Favored 'General case' 0 N--CA 1.487 1.411 0 N-CA-C 108.872 -0.788 . . . . 0.0 108.872 179.973 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 152' ' ' LYS . . . . . 0.512 ' C ' ' CD1' ' A' ' 153' ' ' TYR . 34.8 mttp -151.38 150.85 30.95 Favored 'General case' 0 C--N 1.302 -1.471 0 O-C-N 121.201 -0.937 . . . . 0.0 110.139 179.703 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 153' ' ' TYR . . . . . 0.512 ' CD1' ' C ' ' A' ' 152' ' ' LYS . 22.0 m-85 -145.71 158.07 43.89 Favored 'General case' 0 C--N 1.299 -1.618 0 N-CA-C 107.516 -1.29 . . . . 0.0 107.516 178.183 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 154' ' ' LYS . . . . . . . . . . . . . 13.2 ttpp -130.55 125.43 34.21 Favored 'General case' 0 C--N 1.297 -1.71 0 N-CA-C 108.44 -0.948 . . . . 0.0 108.44 -179.996 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 155' ' ' MET . . . . . . . . . . . . . 74.5 mtp -45.87 107.33 0.1 Allowed 'General case' 0 N--CA 1.489 1.517 0 O-C-N 120.697 -1.252 . . . . 0.0 110.797 -178.954 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 156' ' ' THR . . . . . . . . . . . . . 0.4 OUTLIER -104.47 -27.16 12.08 Favored 'General case' 0 C--N 1.292 -1.933 0 CA-C-N 115.292 -0.867 . . . . 0.0 110.284 -178.385 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 157' ' ' SER . . . . . . . . . . . . . 10.0 t -150.63 150.52 31.26 Favored 'General case' 0 N--CA 1.493 1.702 0 C-N-CA 118.418 -1.313 . . . . 0.0 110.927 -178.812 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 158' ' ' ILE . . . . . 0.696 HD12 ' N ' ' A' ' 159' ' ' ARG . 0.1 OUTLIER -152.91 140.13 13.21 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.389 0 CA-C-O 121.75 0.786 . . . . 0.0 109.563 -178.476 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 159' ' ' ARG . . . . . 0.696 ' N ' HD12 ' A' ' 158' ' ' ILE . 26.8 mtm180 -154.73 165.2 37.33 Favored 'General case' 0 C--N 1.294 -1.822 0 CA-C-O 121.672 0.749 . . . . 0.0 109.882 -179.441 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 160' ' ' ASP . . . . . 0.49 ' O ' HG13 ' A' ' 161' ' ' VAL . 8.0 m-20 -116.18 155.03 28.99 Favored 'General case' 0 C--N 1.298 -1.645 0 N-CA-C 108.069 -1.085 . . . . 0.0 108.069 179.253 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 161' ' ' VAL . . . . . 0.49 HG13 ' O ' ' A' ' 160' ' ' ASP . 13.1 m -155.01 150.69 11.4 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.7 0 O-C-N 120.893 -1.129 . . . . 0.0 110.527 -178.995 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 162' ' ' LYS . . . . . 0.409 ' O ' ' O ' ' A' ' 161' ' ' VAL . 0.0 OUTLIER -47.36 170.38 0.09 OUTLIER Pre-proline 0 N--CA 1.49 1.571 0 O-C-N 121.295 -0.878 . . . . 0.0 109.495 179.677 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 163' ' ' PRO . . . . . . . . . . . . . 57.4 Cg_endo -78.0 37.32 0.62 Allowed 'Trans proline' 0 C--N 1.309 -1.525 0 C-N-CA 122.738 2.292 . . . . 0.0 112.769 -179.706 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 164' ' ' THR . . . . . . . . . . . . . 17.4 m -152.19 -7.98 0.21 Allowed 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.081 -1.012 . . . . 0.0 110.859 -179.88 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 165' ' ' ASP . . . . . 0.456 ' O ' ' C ' ' A' ' 166' ' ' VAL . 6.9 t70 -72.84 61.41 0.55 Allowed 'General case' 0 N--CA 1.492 1.653 0 O-C-N 120.627 -1.296 . . . . 0.0 110.193 -179.412 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 166' ' ' VAL . . . . . 0.67 ' O ' ' N ' ' A' ' 168' ' ' VAL . 0.7 OUTLIER -39.77 -30.0 0.13 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.637 0 O-C-N 121.411 -0.806 . . . . 0.0 109.789 -178.546 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 167' ' ' GLY . . . . . 0.443 ' N ' ' O ' ' A' ' 165' ' ' ASP . . . -42.55 -9.04 0.01 OUTLIER Glycine 0 N--CA 1.5 2.925 0 O-C-N 121.292 -0.88 . . . . 0.0 111.221 -179.497 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 168' ' ' VAL . . . . . 0.67 ' N ' ' O ' ' A' ' 166' ' ' VAL . 19.6 t -48.35 -40.72 10.47 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.62 0 O-C-N 120.89 -1.359 . . . . 0.0 108.729 179.263 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 169' ' ' LEU . . . . . 0.544 ' O ' ' N ' ' A' ' 171' ' ' GLU . 5.4 mt -47.54 -9.4 0.02 OUTLIER 'General case' 0 N--CA 1.496 1.86 0 N-CA-C 108.715 -0.846 . . . . 0.0 108.715 -178.207 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 170' ' ' ASP . . . . . 0.599 ' N ' ' O ' ' A' ' 168' ' ' VAL . 7.0 t0 35.6 27.86 0.01 OUTLIER 'General case' 0 N--CA 1.493 1.72 0 O-C-N 121.508 -0.745 . . . . 0.0 111.5 178.22 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 171' ' ' GLU . . . . . 0.544 ' N ' ' O ' ' A' ' 169' ' ' LEU . 3.8 pt-20 -69.34 94.56 0.72 Allowed 'General case' 0 C--N 1.301 -1.541 0 N-CA-C 107.157 -1.423 . . . . 0.0 107.157 178.034 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 172' ' ' GLN . . . . . . . . . . . . . 2.4 mt-30 -155.14 -74.06 0.11 Allowed 'General case' 0 N--CA 1.493 1.716 0 O-C-N 121.447 -0.783 . . . . 0.0 109.977 -178.645 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 173' ' ' LYS . . . . . 0.525 ' O ' ' NE2' ' A' ' 113' ' ' GLN . 2.3 mptt -59.65 137.84 57.91 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.335 -0.853 . . . . 0.0 109.119 179.841 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 174' ' ' GLY . . . . . 0.504 ' O ' ' C ' ' A' ' 175' ' ' LYS . . . -123.42 -43.61 0.35 Allowed Glycine 0 C--N 1.299 -1.505 0 N-CA-C 107.771 -2.132 . . . . 0.0 107.771 179.172 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 175' ' ' LYS . . . . . 0.504 ' C ' ' O ' ' A' ' 174' ' ' GLY . 0.1 OUTLIER -36.89 -76.9 0.02 OUTLIER 'General case' 0 N--CA 1.498 1.946 0 N-CA-C 108.943 -0.762 . . . . 0.0 108.943 179.729 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 176' ' ' ASP . . . . . 0.582 ' O ' ' O ' ' A' ' 177' ' ' LYS . 1.2 m-20 -91.38 86.62 6.15 Favored 'General case' 0 C--N 1.297 -1.708 0 N-CA-C 107.087 -1.449 . . . . 0.0 107.087 178.059 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 177' ' ' LYS . . . . . 0.582 ' O ' ' O ' ' A' ' 176' ' ' ASP . 0.9 OUTLIER -40.5 178.01 0.0 OUTLIER 'General case' 0 N--CA 1.493 1.713 0 CA-C-O 121.603 0.716 . . . . 0.0 110.907 -178.919 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 178' ' ' GLN . . . . . 0.492 ' NE2' ' CG ' ' A' ' 114' ' ' ASN . 1.0 OUTLIER -160.91 173.49 15.23 Favored 'General case' 0 C--N 1.307 -1.263 0 C-N-CA 118.637 -1.225 . . . . 0.0 110.692 -179.726 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 179' ' ' LEU . . . . . . . . . . . . . 2.2 tp -128.02 100.2 5.79 Favored 'General case' 0 C--N 1.3 -1.57 0 N-CA-C 106.896 -1.52 . . . . 0.0 106.896 178.127 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 180' ' ' THR . . . . . . . . . . . . . 1.4 m -75.18 118.95 18.67 Favored 'General case' 0 C--N 1.303 -1.417 0 C-N-CA 119.071 -1.052 . . . . 0.0 110.287 -178.101 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 181' ' ' LEU . . . . . . . . . . . . . 57.8 tp -94.76 146.95 23.82 Favored 'General case' 0 C--N 1.298 -1.647 0 N-CA-C 108.08 -1.081 . . . . 0.0 108.08 178.171 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 182' ' ' ILE . . . . . . . . . . . . . 54.9 mt -140.9 125.43 17.88 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.529 0 O-C-N 120.958 -1.089 . . . . 0.0 109.684 179.552 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 183' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -143.84 112.29 6.44 Favored 'General case' 0 C--N 1.295 -1.802 0 N-CA-C 107.047 -1.464 . . . . 0.0 107.047 178.722 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 184' ' ' CYS . . . . . 0.477 ' CB ' HH11 ' A' ' 197' ' ' ARG . 0.6 OUTLIER -78.48 163.06 25.91 Favored 'General case' 0 N--CA 1.498 1.964 0 C-N-CA 118.786 -1.166 . . . . 0.0 110.954 -177.114 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 185' ' ' ASP . . . . . . . . . . . . . 12.3 t0 -165.87 -153.92 0.19 Allowed 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.45 -0.781 . . . . 0.0 109.817 -179.712 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 186' ' ' ASP . . . . . 0.444 ' HB3' ' H ' ' A' ' 196' ' ' LYS . 0.4 OUTLIER 49.98 53.92 11.98 Favored 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.254 -0.904 . . . . 0.0 108.983 -179.67 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 187' ' ' TYR . . . . . 0.603 ' CE1' ' O ' ' A' ' 188' ' ' ASN . 34.2 t80 -65.93 135.17 54.39 Favored 'General case' 0 C--N 1.301 -1.521 0 O-C-N 121.205 -0.935 . . . . 0.0 110.222 -179.419 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 188' ' ' ASN . . . . . 0.603 ' O ' ' CE1' ' A' ' 187' ' ' TYR . 0.6 OUTLIER -100.93 147.68 25.87 Favored 'General case' 0 C--N 1.296 -1.737 0 N-CA-C 107.954 -1.128 . . . . 0.0 107.954 178.578 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 189' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -112.54 -13.65 13.31 Favored 'General case' 0 C--N 1.295 -1.772 0 N-CA-C 108.268 -1.012 . . . . 0.0 108.268 -179.872 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 190' ' ' LYS . . . . . . . . . . . . . 15.0 mtmt -83.46 -52.34 6.59 Favored 'General case' 0 C--N 1.303 -1.426 0 N-CA-C 108.814 -0.81 . . . . 0.0 108.814 179.118 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 191' ' ' THR . . . . . . . . . . . . . 2.6 p -90.56 -9.63 46.43 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.461 -0.775 . . . . 0.0 109.075 179.58 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 192' ' ' GLY . . . . . . . . . . . . . . . 63.68 39.94 98.04 Favored Glycine 0 N--CA 1.493 2.484 0 N-CA-C 110.836 -0.905 . . . . 0.0 110.836 178.941 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 193' ' ' VAL . . . . . 0.495 HG12 ' N ' ' A' ' 194' ' ' TRP . 57.8 t -145.98 159.32 11.75 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.563 0 O-C-N 121.01 -1.288 . . . . 0.0 109.34 179.346 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 194' ' ' TRP . . . . . 0.495 ' N ' HG12 ' A' ' 193' ' ' VAL . 19.9 m95 -85.31 120.48 26.84 Favored 'General case' 0 C--N 1.3 -1.584 0 N-CA-C 107.644 -1.243 . . . . 0.0 107.644 178.667 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 195' ' ' GLU . . . . . 0.514 ' CD ' ' ND2' ' A' ' 188' ' ' ASN . 1.1 mt-10 -89.27 -60.6 1.91 Allowed 'General case' 0 N--CA 1.493 1.713 0 O-C-N 121.138 -0.976 . . . . 0.0 111.749 -177.453 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 196' ' ' LYS . . . . . 0.444 ' H ' ' HB3' ' A' ' 186' ' ' ASP . 0.0 OUTLIER -78.98 144.34 34.85 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 120.823 -1.173 . . . . 0.0 110.405 -178.558 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 197' ' ' ARG . . . . . 0.56 ' NH2' ' O ' ' C' ' 703' ' ' PRO . 0.7 OUTLIER -120.77 137.15 54.66 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.632 -0.668 . . . . 0.0 109.206 179.714 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 198' ' ' LYS . . . . . . . . . . . . . 3.2 mtmm -114.97 122.06 45.09 Favored 'General case' 0 N--CA 1.489 1.491 0 O-C-N 121.722 -0.611 . . . . 0.0 110.323 -178.943 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 199' ' ' ILE . . . . . 0.648 ' C ' HD12 ' A' ' 199' ' ' ILE . 0.6 OUTLIER -141.85 118.32 6.85 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.7 0 O-C-N 120.957 -1.09 . . . . 0.0 110.416 179.937 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 200' ' ' PHE . . . . . 0.53 ' CD1' ' N ' ' A' ' 200' ' ' PHE . 6.5 m-85 -99.84 137.96 37.58 Favored 'General case' 0 N--CA 1.499 1.975 0 O-C-N 121.294 -0.879 . . . . 0.0 110.134 -179.371 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 201' ' ' VAL . . . . . . . . . . . . . 33.0 t -105.7 148.28 10.33 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.589 0 N-CA-C 107.981 -1.118 . . . . 0.0 107.981 177.744 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 202' ' ' ALA . . . . . . . . . . . . . . . -133.35 139.43 46.82 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.03 -1.044 . . . . 0.0 109.088 -179.608 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 203' ' ' THR . . . . . 0.403 ' O ' HG23 ' A' ' 205' ' ' VAL . 1.9 p -90.2 134.26 34.39 Favored 'General case' 0 N--CA 1.487 1.383 0 CA-C-O 122.565 1.174 . . . . 0.0 111.197 -178.827 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 204' ' ' GLU . . . . . 0.43 ' HA ' ' CD2' ' A' ' 153' ' ' TYR . 6.8 tt0 -56.0 134.88 52.69 Favored 'General case' 0 C--N 1.296 -1.76 0 C-N-CA 118.761 -1.176 . . . . 0.0 109.621 179.818 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 205' ' ' VAL . . . . . 0.531 ' O ' ' C ' ' A' ' 206' ' ' LYS . 61.0 t -128.35 -42.4 0.85 Allowed 'Isoleucine or valine' 0 N--CA 1.494 1.766 0 O-C-N 121.304 -0.873 . . . . 0.0 110.24 -178.788 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 206' ' ' LYS . . . . . 0.531 ' C ' ' O ' ' A' ' 205' ' ' VAL . 1.2 pptp? . . . . . 0 N--CA 1.501 2.093 0 CA-C-O 118.157 -0.925 . . . . 0.0 110.596 -179.505 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' C' C ' 701' ' ' PHQ . . . . . 0.409 ' O2 ' HG12 ' A' ' 166' ' ' VAL . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' C' C ' 702' ' ' LEU . . . . . 0.821 ' N ' HD12 ' C' ' 702' ' ' LEU . 0.0 OUTLIER . . . . . 0 N--CA 1.493 1.702 0 N-CA-C 108.676 -0.861 . . . . 0.0 108.676 . . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' C' C ' 703' ' ' PRO . . . . . 0.56 ' O ' ' NH2' ' A' ' 197' ' ' ARG . 42.8 Cg_endo -69.59 -179.19 2.66 Favored 'Trans proline' 0 N--CA 1.496 1.64 0 C-N-CA 122.868 2.379 . . . . 0.0 113.276 -178.935 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' C' C ' 704' ' ' ALA . . . . . 0.484 ' O ' ' O ' ' C' ' 703' ' ' PRO . . . 45.05 -171.3 0.01 OUTLIER 'General case' 0 N--CA 1.486 1.336 0 O-C-N 121.557 -0.714 . . . . 0.0 109.295 179.934 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' C' C ' 705' ' ' B27 . . . . . 0.41 ' HX ' ' CG ' ' A' ' 194' ' ' TRP . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 700' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 003 nuclear nobuild full ' A' A ' 59' ' ' MET . . . . . . . . . . . . . 9.4 ttt . . . . . 0 N--CA 1.491 1.596 0 CA-C-O 121.32 0.581 . . . . 0.0 109.455 . . . . . . . . . 0 0 . 1 . 003 nuclear nobuild full ' A' A ' 60' ' ' GLN . . . . . . . . . . . . . 2.7 mp0 -61.01 -177.41 0.08 Allowed 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.232 -0.918 . . . . 0.0 110.005 -179.769 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . -64.29 177.39 0.85 Allowed 'General case' 0 N--CA 1.494 1.743 0 O-C-N 121.365 -0.834 . . . . 0.0 109.917 -179.889 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 62' ' ' LYS . . . . . . . . . . . . . 14.3 mtpt -145.42 78.19 12.23 Favored Pre-proline 0 N--CA 1.492 1.636 0 C-N-CA 119.343 -0.943 . . . . 0.0 110.397 -179.438 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 63' ' ' PRO . . . . . . . . . . . . . 3.7 Cg_endo -82.21 147.58 14.6 Favored 'Trans proline' 0 C--N 1.304 -1.809 0 C-N-CA 123.234 2.623 . . . . 0.0 111.436 178.97 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 64' ' ' GLN . . . . . 0.712 ' NE2' ' N ' ' A' ' 64' ' ' GLN . 0.0 OUTLIER -153.0 102.59 2.67 Favored 'General case' 0 N--CA 1.493 1.685 0 O-C-N 121.129 -0.982 . . . . 0.0 109.513 -179.63 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 65' ' ' ILE . . . . . 0.486 ' C ' ' O ' ' A' ' 64' ' ' GLN . 3.0 mp -37.83 99.3 0.18 Allowed Pre-proline 0 N--CA 1.494 1.747 0 N-CA-C 108.677 -0.86 . . . . 0.0 108.677 179.715 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 66' ' ' PRO . . . . . 0.463 ' N ' ' O ' ' A' ' 64' ' ' GLN . 57.8 Cg_endo -85.27 -162.55 0.16 Allowed 'Trans proline' 0 C--N 1.315 -1.203 0 C-N-CA 122.264 1.976 . . . . 0.0 112.505 -178.592 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 67' ' ' LYS . . . . . 0.515 ' C ' ' H ' ' A' ' 69' ' ' LYS . 6.6 ptpt -72.98 -5.73 40.69 Favored 'General case' 0 C--N 1.303 -1.415 0 O-C-N 121.393 -0.817 . . . . 0.0 108.829 179.737 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 68' ' ' ASP . . . . . 0.594 ' O ' ' N ' ' A' ' 70' ' ' SER . 1.0 OUTLIER -74.97 46.53 0.31 Allowed 'General case' 0 N--CA 1.486 1.374 0 CA-C-O 122.85 1.309 . . . . 0.0 107.735 178.876 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 69' ' ' LYS . . . . . 0.515 ' H ' ' C ' ' A' ' 67' ' ' LYS . 13.3 ptpt -48.63 -14.41 0.06 Allowed 'General case' 0 N--CA 1.501 2.123 0 C-N-CA 117.23 -1.788 . . . . 0.0 106.728 178.191 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 70' ' ' SER . . . . . 0.594 ' N ' ' O ' ' A' ' 68' ' ' ASP . 0.3 OUTLIER -85.25 -6.3 59.27 Favored 'General case' 0 N--CA 1.496 1.86 0 CA-C-N 113.53 -1.668 . . . . 0.0 110.764 179.284 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 71' ' ' LYS . . . . . 0.433 ' N ' ' O ' ' A' ' 68' ' ' ASP . 0.0 OUTLIER -97.53 140.96 31.17 Favored 'General case' 0 N--CA 1.497 1.886 0 O-C-N 120.876 -1.14 . . . . 0.0 111.478 -179.598 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 72' ' ' VAL . . . . . 0.574 HG23 ' H ' ' A' ' 87' ' ' VAL . 0.2 OUTLIER -65.45 136.57 26.48 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.414 0 N-CA-C 105.334 -2.099 . . . . 0.0 105.334 175.36 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 73' ' ' ALA . . . . . 0.535 ' N ' ' O ' ' A' ' 87' ' ' VAL . . . -83.53 -17.16 42.8 Favored 'General case' 0 C--N 1.296 -1.717 0 O-C-N 120.179 -1.576 . . . . 0.0 108.245 -179.017 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 74' ' ' GLY . . . . . 0.553 ' O ' ' CG2' ' A' ' 72' ' ' VAL . . . 172.44 -157.71 27.5 Favored Glycine 0 C--N 1.294 -1.776 0 N-CA-C 109.5 -1.44 . . . . 0.0 109.5 -179.554 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 75' ' ' TYR . . . . . 0.57 ' HA ' HG23 ' A' ' 87' ' ' VAL . 4.6 m-85 -141.47 170.37 15.86 Favored 'General case' 0 C--N 1.293 -1.866 0 O-C-N 121.363 -1.08 . . . . 0.0 110.362 -177.303 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 76' ' ' ILE . . . . . . . . . . . . . 3.0 tp -144.92 140.02 22.99 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.717 0 C-N-CA 119.359 -0.937 . . . . 0.0 109.446 -177.414 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 77' ' ' GLU . . . . . 0.572 ' N ' ' CD ' ' A' ' 77' ' ' GLU . 0.7 OUTLIER -146.71 159.43 43.48 Favored 'General case' 0 C--N 1.304 -1.388 0 O-C-N 121.015 -1.053 . . . . 0.0 109.148 -179.293 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 78' ' ' ILE . . . . . 0.505 ' HB ' ' HB3' ' A' ' 81' ' ' ALA . 12.2 mt -147.7 94.34 4.41 Favored Pre-proline 0 N--CA 1.489 1.498 0 N-CA-C 108.622 -0.881 . . . . 0.0 108.622 -179.963 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 79' ' ' PRO . . . . . . . . . . . . . 75.0 Cg_exo -46.83 -45.83 19.65 Favored 'Trans proline' 0 N--CA 1.493 1.488 0 C-N-CA 122.937 2.425 . . . . 0.0 114.212 -178.685 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -64.78 -19.83 66.03 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 120.644 -1.285 . . . . 0.0 110.507 178.704 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 81' ' ' ALA . . . . . 0.81 ' HB2' ' HB2' ' A' ' 136' ' ' ALA . . . -104.99 -16.73 14.73 Favored 'General case' 0 N--CA 1.493 1.707 0 N-CA-C 108.448 -0.945 . . . . 0.0 108.448 179.223 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 82' ' ' ASP . . . . . . . . . . . . . 7.8 t0 67.21 50.36 1.0 Allowed 'General case' 0 N--CA 1.488 1.437 0 O-C-N 121.364 -0.835 . . . . 0.0 109.951 179.736 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 83' ' ' ILE . . . . . 0.59 HD11 ' OD1' ' A' ' 132' ' ' ASN . 78.4 mt -127.82 152.78 36.32 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.671 0 O-C-N 121.395 -0.815 . . . . 0.0 110.009 -178.914 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 84' ' ' LYS . . . . . . . . . . . . . 1.8 tttt -159.06 108.71 1.94 Allowed 'General case' 0 N--CA 1.49 1.561 0 N-CA-C 107.099 -1.445 . . . . 0.0 107.099 179.036 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 85' ' ' GLU . . . . . 0.503 ' OE1' ' O ' ' A' ' 128' ' ' TYR . 0.0 OUTLIER -141.92 169.56 10.88 Favored Pre-proline 0 N--CA 1.494 1.733 0 O-C-N 121.236 -0.915 . . . . 0.0 110.972 -177.842 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 86' ' ' PRO . . . . . . . . . . . . . 73.4 Cg_endo -79.34 166.45 22.38 Favored 'Trans proline' 0 N--CA 1.492 1.385 0 C-N-CA 123.22 2.613 . . . . 0.0 113.43 -179.631 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 87' ' ' VAL . . . . . 0.574 ' H ' HG23 ' A' ' 72' ' ' VAL . 60.3 t -126.07 102.08 9.31 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.614 0 N-CA-C 109.056 -0.72 . . . . 0.0 109.056 179.705 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 88' ' ' TYR . . . . . 0.486 ' CB ' HE22 ' A' ' 96' ' ' GLN . 22.7 m-85 -96.33 153.82 38.86 Favored Pre-proline 0 N--CA 1.501 2.088 0 O-C-N 120.952 -1.092 . . . . 0.0 110.336 -179.34 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 89' ' ' PRO . . . . . . . . . . . . . 1.2 Cg_endo -55.72 143.82 78.57 Favored 'Trans proline' 0 C--N 1.309 -1.543 0 C-N-CA 122.715 2.277 . . . . 0.0 113.958 -179.891 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . -57.76 169.35 4.4 Favored Glycine 0 N--CA 1.493 2.44 0 N-CA-C 108.888 -1.685 . . . . 0.0 108.888 178.743 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 91' ' ' PRO . . . . . . . . . . . . . 56.3 Cg_endo -94.75 169.38 17.55 Favored 'Cis proline' 0 C--N 1.308 -1.558 0 C-N-CA 124.183 -1.174 . . . . 0.0 112.079 0.141 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 92' ' ' ALA . . . . . 0.637 ' HB3' ' HB3' ' C' ' 703' ' ' PRO . . . -72.99 32.07 0.07 Allowed 'General case' 0 N--CA 1.493 1.718 0 O-C-N 120.948 -1.095 . . . . 0.0 110.927 -179.724 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 93' ' ' THR . . . . . . . . . . . . . 11.1 p -73.15 150.4 89.9 Favored Pre-proline 0 C--N 1.302 -1.47 0 O-C-N 120.278 -1.514 . . . . 0.0 108.228 179.695 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 94' ' ' PRO . . . . . . . . . . . . . 91.1 Cg_exo -34.39 -46.41 0.51 Allowed 'Trans proline' 0 C--N 1.309 -1.527 0 C-N-CA 122.78 2.32 . . . . 0.0 112.44 -179.074 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 95' ' ' GLU . . . . . 0.59 ' O ' ' ND2' ' A' ' 98' ' ' ASN . 6.8 mt-10 -53.69 -51.94 61.61 Favored 'General case' 0 N--CA 1.488 1.465 0 O-C-N 121.111 -0.993 . . . . 0.0 109.702 179.9 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 96' ' ' GLN . . . . . 0.551 ' C ' ' H ' ' A' ' 98' ' ' ASN . 0.0 OUTLIER -71.92 -45.94 59.37 Favored 'General case' 0 C--N 1.303 -1.418 0 O-C-N 121.205 -0.935 . . . . 0.0 109.822 -179.848 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 97' ' ' LEU . . . . . 0.509 ' CD1' ' O ' ' A' ' 92' ' ' ALA . 88.9 mt -55.17 -4.91 0.09 Allowed 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.18 -0.95 . . . . 0.0 108.935 179.902 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 98' ' ' ASN . . . . . 0.59 ' ND2' ' O ' ' A' ' 95' ' ' GLU . 0.0 OUTLIER -71.88 -26.01 62.16 Favored 'General case' 0 N--CA 1.489 1.505 0 O-C-N 121.511 -0.743 . . . . 0.0 109.295 179.708 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 99' ' ' ARG . . . . . 0.681 ' CG ' HH11 ' A' ' 99' ' ' ARG . 0.2 OUTLIER -99.9 -59.06 1.78 Allowed 'General case' 0 N--CA 1.488 1.426 0 C-N-CA 119.71 -0.796 . . . . 0.0 110.483 -178.919 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . -170.84 -169.43 33.87 Favored Glycine 0 N--CA 1.49 2.277 0 C-N-CA 119.013 -1.565 . . . . 0.0 110.518 -179.789 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 101' ' ' VAL . . . . . 0.711 ' O ' HG23 ' A' ' 101' ' ' VAL . 27.0 m -53.95 106.25 0.1 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.525 0 O-C-N 121.662 -0.905 . . . . 0.0 109.561 -179.906 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -92.91 158.08 16.02 Favored 'General case' 0 N--CA 1.495 1.787 0 O-C-N 121.249 -0.907 . . . . 0.0 110.582 -179.88 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 103' ' ' PHE . . . . . 0.562 ' O ' ' N ' ' A' ' 105' ' ' GLU . 23.6 m-85 -61.06 121.76 13.27 Favored 'General case' 0 N--CA 1.491 1.612 0 N-CA-C 108.083 -1.081 . . . . 0.0 108.083 178.58 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 104' ' ' ALA . . . . . 0.43 ' HB1' ' HG2' ' C' ' 703' ' ' PRO . . . -40.03 -19.99 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.567 -0.708 . . . . 0.0 111.445 -178.434 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 105' ' ' GLU . . . . . 0.64 ' OE1' HD13 ' A' ' 169' ' ' LEU . 0.2 OUTLIER -139.33 151.2 46.2 Favored 'General case' 0 N--CA 1.494 1.767 0 O-C-N 120.688 -1.257 . . . . 0.0 110.707 -179.563 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 106' ' ' GLU . . . . . . . . . . . . . 30.3 tt0 -57.95 -64.19 0.99 Allowed 'General case' 0 C--N 1.303 -1.442 0 CA-C-N 116.146 -0.479 . . . . 0.0 111.3 -178.94 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 107' ' ' ASN . . . . . 0.462 ' C ' ' ND2' ' A' ' 107' ' ' ASN . 0.0 OUTLIER -77.47 33.0 0.16 Allowed 'General case' 0 N--CA 1.491 1.587 0 O-C-N 120.541 -1.349 . . . . 0.0 113.187 -175.214 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 108' ' ' GLU . . . . . . . . . . . . . 33.2 tp10 -59.55 148.61 32.7 Favored 'General case' 0 C--N 1.301 -1.53 0 N-CA-C 107.474 -1.306 . . . . 0.0 107.474 179.899 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 109' ' ' SER . . . . . 0.479 ' C ' ' H ' ' A' ' 111' ' ' ASP . 0.1 OUTLIER -100.59 124.67 46.48 Favored 'General case' 0 N--CA 1.487 1.409 0 O-C-N 120.9 -1.125 . . . . 0.0 110.486 -178.432 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 110' ' ' LEU . . . . . 0.451 HD12 ' OD1' ' A' ' 111' ' ' ASP . 1.5 pp -60.01 -4.61 0.79 Allowed 'General case' 0 C--N 1.301 -1.536 0 N-CA-C 108.467 -0.938 . . . . 0.0 108.467 179.721 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 111' ' ' ASP . . . . . 0.479 ' H ' ' C ' ' A' ' 109' ' ' SER . 11.8 m-20 -131.93 20.77 4.55 Favored 'General case' 0 C--N 1.303 -1.416 0 N-CA-C 108.825 -0.805 . . . . 0.0 108.825 179.57 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 112' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -66.3 140.02 58.09 Favored 'General case' 0 N--CA 1.489 1.505 0 O-C-N 121.349 -0.844 . . . . 0.0 110.198 -179.937 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 113' ' ' GLN . . . . . 0.477 ' NE2' ' CA ' ' A' ' 113' ' ' GLN . 0.8 OUTLIER -65.11 -6.68 9.61 Favored 'General case' 0 C--N 1.302 -1.488 0 N-CA-C 107.892 -1.151 . . . . 0.0 107.892 178.278 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 114' ' ' ASN . . . . . 0.417 ' CG ' ' O ' ' A' ' 114' ' ' ASN . 11.1 p-10 -146.02 95.01 2.56 Favored 'General case' 0 C--N 1.3 -1.545 0 N-CA-C 107.95 -1.13 . . . . 0.0 107.95 179.144 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 115' ' ' ILE . . . . . 0.479 ' O ' HG22 ' A' ' 115' ' ' ILE . 2.6 mt -98.24 111.67 28.5 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.536 0 O-C-N 121.493 -0.754 . . . . 0.0 109.487 -179.366 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 116' ' ' SER . . . . . . . . . . . . . 66.3 m -97.1 151.19 20.02 Favored 'General case' 0 N--CA 1.489 1.517 0 CA-C-O 121.77 0.795 . . . . 0.0 111.066 -178.804 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 117' ' ' ILE . . . . . . . . . . . . . 1.9 mt -146.59 155.85 11.69 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.588 0 N-CA-C 108.184 -1.043 . . . . 0.0 108.184 179.328 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 118' ' ' ALA . . . . . 0.748 ' HB1' ' HB2' ' C' ' 704' ' ' ALA . . . -146.04 163.41 35.32 Favored 'General case' 0 N--CA 1.493 1.683 0 O-C-N 120.569 -1.332 . . . . 0.0 111.88 -179.049 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 119' ' ' GLY . . . . . . . . . . . . . . . -169.9 148.57 11.95 Favored Glycine 0 N--CA 1.49 2.295 0 N-CA-C 110.403 -1.079 . . . . 0.0 110.403 -179.889 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 120' ' ' HIS . . . . . . . . . . . . . 34.2 m170 -69.33 167.71 15.87 Favored 'General case' 0 N--CA 1.495 1.799 0 O-C-N 121.768 -0.842 . . . . 0.0 110.498 179.783 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 121' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -122.9 155.11 37.35 Favored 'General case' 0 N--CA 1.493 1.715 0 N-CA-C 108.165 -1.05 . . . . 0.0 108.165 178.677 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 122' ' ' PHE . . . . . 0.7 ' O ' HG21 ' A' ' 131' ' ' THR . 0.4 OUTLIER -144.15 123.38 12.97 Favored 'General case' 0 N--CA 1.496 1.835 0 O-C-N 120.849 -1.157 . . . . 0.0 109.756 -179.487 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 123' ' ' ILE . . . . . 0.573 HG23 ' N ' ' A' ' 124' ' ' ASP . 11.1 tt -55.76 -40.75 62.7 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.462 0 CA-C-O 121.628 0.728 . . . . 0.0 109.065 179.963 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 124' ' ' ASP . . . . . 0.573 ' N ' HG23 ' A' ' 123' ' ' ILE . 31.3 t70 -88.75 23.4 2.32 Favored 'General case' 0 N--CA 1.493 1.714 0 O-C-N 121.653 -0.654 . . . . 0.0 111.731 -177.703 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 125' ' ' ARG . . . . . . . . . . . . . 54.1 mtt180 -153.62 98.59 2.66 Favored Pre-proline 0 N--CA 1.493 1.679 0 O-C-N 120.866 -1.146 . . . . 0.0 109.183 179.618 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 126' ' ' PRO . . . . . . . . . . . . . 69.7 Cg_endo -82.3 -28.57 1.85 Allowed 'Trans proline' 0 C--N 1.313 -1.321 0 C-N-CA 122.401 2.068 . . . . 0.0 111.939 179.734 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 127' ' ' ASN . . . . . 0.482 ' O ' ' O ' ' A' ' 128' ' ' TYR . 2.1 m120 -89.86 6.43 41.87 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.372 -0.83 . . . . 0.0 109.186 179.79 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 128' ' ' TYR . . . . . 0.503 ' O ' ' OE1' ' A' ' 85' ' ' GLU . 2.4 t80 -59.47 -148.53 0.0 OUTLIER 'General case' 0 N--CA 1.489 1.486 0 O-C-N 121.318 -0.864 . . . . 0.0 109.465 179.901 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 129' ' ' GLN . . . . . 0.489 ' O ' ' OE1' ' A' ' 85' ' ' GLU . 8.7 mt-30 -65.21 -72.45 0.15 Allowed 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.386 -0.821 . . . . 0.0 110.067 -179.321 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 130' ' ' PHE . . . . . 0.567 ' CE2' HG11 ' A' ' 101' ' ' VAL . 53.5 m-85 -135.78 42.0 2.67 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.012 -1.055 . . . . 0.0 109.993 -179.693 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 131' ' ' THR . . . . . 0.7 HG21 ' O ' ' A' ' 122' ' ' PHE . 38.9 m -77.19 -35.82 55.46 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.129 -0.982 . . . . 0.0 109.531 179.94 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 132' ' ' ASN . . . . . 0.604 ' ND2' ' O ' ' A' ' 81' ' ' ALA . 0.1 OUTLIER -84.15 4.71 29.21 Favored 'General case' 0 N--CA 1.498 1.925 0 O-C-N 121.44 -0.788 . . . . 0.0 110.456 -179.277 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 133' ' ' LEU . . . . . 0.569 ' O ' ' N ' ' A' ' 135' ' ' ALA . 0.2 OUTLIER -68.19 -45.52 73.2 Favored 'General case' 0 C--N 1.296 -1.76 0 O-C-N 120.961 -1.087 . . . . 0.0 110.578 -179.636 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 134' ' ' LYS . . . . . 0.52 ' CD ' ' H ' ' A' ' 134' ' ' LYS . 0.0 OUTLIER -43.17 -17.85 0.01 OUTLIER 'General case' 0 N--CA 1.496 1.865 0 O-C-N 120.955 -1.09 . . . . 0.0 110.191 -179.331 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 135' ' ' ALA . . . . . 0.569 ' N ' ' O ' ' A' ' 133' ' ' LEU . . . -83.24 -38.28 22.42 Favored 'General case' 0 N--CA 1.488 1.471 0 O-C-N 120.925 -1.109 . . . . 0.0 110.147 -179.566 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 136' ' ' ALA . . . . . 0.81 ' HB2' ' HB2' ' A' ' 81' ' ' ALA . . . -80.0 157.89 26.69 Favored 'General case' 0 C--N 1.302 -1.476 0 CA-C-O 122.283 1.04 . . . . 0.0 111.82 -178.412 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 137' ' ' LYS . . . . . 0.528 ' O ' ' O ' ' A' ' 138' ' ' LYS . 2.4 tttt -154.49 -162.71 1.45 Allowed 'General case' 0 N--CA 1.491 1.617 0 C-N-CA 119.083 -1.047 . . . . 0.0 110.579 -178.61 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 138' ' ' LYS . . . . . 0.601 ' O ' ' N ' ' A' ' 140' ' ' SER . 16.6 pttm -44.65 -179.19 0.0 OUTLIER 'General case' 0 C--N 1.302 -1.482 0 CA-C-O 122.228 1.013 . . . . 0.0 111.039 -179.13 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 139' ' ' GLY . . . . . . . . . . . . . . . 45.42 7.89 0.01 OUTLIER Glycine 0 N--CA 1.491 2.304 0 N-CA-C 110.646 -0.982 . . . . 0.0 110.646 179.978 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 140' ' ' SER . . . . . 0.601 ' N ' ' O ' ' A' ' 138' ' ' LYS . 58.7 m -85.99 124.39 32.38 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 120.71 -1.465 . . . . 0.0 109.244 179.459 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 141' ' ' MET . . . . . . . . . . . . . 1.1 tpt -72.88 136.08 45.23 Favored 'General case' 0 N--CA 1.489 1.506 0 O-C-N 121.133 -0.979 . . . . 0.0 109.16 179.93 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 142' ' ' VAL . . . . . . . . . . . . . 3.5 t -121.42 129.1 75.9 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.627 0 N-CA-C 108.865 -0.791 . . . . 0.0 108.865 -179.835 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 143' ' ' TYR . . . . . . . . . . . . . 16.6 m-85 -113.14 136.6 52.54 Favored 'General case' 0 N--CA 1.498 1.951 0 O-C-N 121.172 -0.955 . . . . 0.0 111.063 -178.667 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 144' ' ' PHE . . . . . 0.565 ' CE2' HG11 ' A' ' 146' ' ' VAL . 10.7 t80 -122.52 104.98 9.73 Favored 'General case' 0 N--CA 1.492 1.667 0 CA-C-O 121.5 0.667 . . . . 0.0 110.245 -178.989 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 145' ' ' LYS . . . . . . . . . . . . . 4.6 mttm -97.7 123.41 41.61 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.426 -0.796 . . . . 0.0 109.719 -179.965 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 146' ' ' VAL . . . . . 0.565 HG11 ' CE2' ' A' ' 144' ' ' PHE . 0.5 OUTLIER -143.78 122.62 7.42 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.582 0 O-C-N 121.196 -0.94 . . . . 0.0 108.648 179.402 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 147' ' ' GLY . . . . . . . . . . . . . . . 70.47 -131.01 21.6 Favored Glycine 0 N--CA 1.488 2.163 0 N-CA-C 108.525 -1.83 . . . . 0.0 108.525 -179.103 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 148' ' ' ASN . . . . . 0.525 HD22 ' C ' ' A' ' 148' ' ' ASN . 0.4 OUTLIER -106.51 11.72 30.35 Favored 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.407 -1.055 . . . . 0.0 108.665 179.101 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 149' ' ' GLU . . . . . . . . . . . . . 4.8 tt0 -114.2 149.42 35.8 Favored 'General case' 0 N--CA 1.491 1.594 0 CA-C-O 121.844 0.831 . . . . 0.0 111.043 -179.003 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 150' ' ' THR . . . . . . . . . . . . . 20.1 m -129.89 105.55 8.07 Favored 'General case' 0 N--CA 1.492 1.656 0 CA-C-O 121.341 0.591 . . . . 0.0 109.762 -179.986 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 151' ' ' ARG . . . . . . . . . . . . . 4.9 mtp180 -87.82 -175.29 5.08 Favored 'General case' 0 N--CA 1.487 1.403 0 N-CA-C 108.293 -1.003 . . . . 0.0 108.293 179.701 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 152' ' ' LYS . . . . . . . . . . . . . 26.3 mtmt -149.31 146.45 27.55 Favored 'General case' 0 C--N 1.301 -1.502 0 O-C-N 120.914 -1.116 . . . . 0.0 110.619 -179.454 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 153' ' ' TYR . . . . . 0.491 ' CD2' ' HA ' ' A' ' 204' ' ' GLU . 4.1 m-85 -138.6 170.25 16.35 Favored 'General case' 0 N--CA 1.488 1.443 0 N-CA-C 107.471 -1.307 . . . . 0.0 107.471 178.794 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 154' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -144.52 122.7 12.19 Favored 'General case' 0 C--N 1.296 -1.726 0 N-CA-C 108.087 -1.079 . . . . 0.0 108.087 178.581 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 155' ' ' MET . . . . . . . . . . . . . 3.7 mtt -46.75 105.88 0.07 Allowed 'General case' 0 N--CA 1.49 1.54 0 O-C-N 120.594 -1.316 . . . . 0.0 111.702 -178.445 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 156' ' ' THR . . . . . 0.724 ' OG1' HG23 ' A' ' 203' ' ' THR . 0.1 OUTLIER -106.28 -25.55 11.9 Favored 'General case' 0 C--N 1.292 -1.918 0 CA-C-N 115.183 -0.917 . . . . 0.0 110.074 -179.137 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 157' ' ' SER . . . . . 0.416 ' O ' ' N ' ' A' ' 201' ' ' VAL . 0.1 OUTLIER -153.72 152.72 31.1 Favored 'General case' 0 N--CA 1.495 1.81 0 C-N-CA 118.24 -1.384 . . . . 0.0 111.592 -178.766 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 158' ' ' ILE . . . . . 0.454 HG13 ' CD2' ' A' ' 200' ' ' PHE . 0.0 OUTLIER -156.17 146.52 12.04 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.527 0 CA-C-O 121.758 0.79 . . . . 0.0 110.376 -179.885 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 159' ' ' ARG . . . . . 0.471 ' CG ' HH11 ' A' ' 159' ' ' ARG . 0.0 OUTLIER -150.85 -175.59 5.19 Favored 'General case' 0 C--N 1.3 -1.574 0 CA-C-O 121.833 0.825 . . . . 0.0 110.821 -179.629 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 160' ' ' ASP . . . . . 0.648 ' O ' HG13 ' A' ' 161' ' ' VAL . 1.9 m-20 -143.2 157.34 44.59 Favored 'General case' 0 N--CA 1.49 1.566 0 N-CA-C 108.018 -1.105 . . . . 0.0 108.018 -179.851 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 161' ' ' VAL . . . . . 0.648 HG13 ' O ' ' A' ' 160' ' ' ASP . 2.3 m -160.08 157.38 2.89 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.833 0 C-N-CA 118.624 -1.231 . . . . 0.0 110.902 -179.256 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 162' ' ' LYS . . . . . 0.449 ' O ' ' O ' ' A' ' 161' ' ' VAL . 0.0 OUTLIER -44.02 169.04 0.06 OUTLIER Pre-proline 0 N--CA 1.493 1.685 0 O-C-N 121.559 -0.713 . . . . 0.0 109.833 -179.996 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 163' ' ' PRO . . . . . 0.463 ' C ' HD11 ' C' ' 702' ' ' LEU . 57.0 Cg_endo -77.2 34.74 0.46 Allowed 'Trans proline' 0 C--N 1.309 -1.521 0 C-N-CA 122.622 2.215 . . . . 0.0 112.402 179.725 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 164' ' ' THR . . . . . 0.478 ' N ' HD11 ' C' ' 702' ' ' LEU . 0.0 OUTLIER -150.76 -6.98 0.28 Allowed 'General case' 0 N--CA 1.495 1.778 0 O-C-N 121.1 -1.0 . . . . 0.0 110.904 -179.567 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 165' ' ' ASP . . . . . 0.422 ' O ' ' C ' ' A' ' 166' ' ' VAL . 13.7 t70 -72.53 61.16 0.49 Allowed 'General case' 0 C--N 1.3 -1.56 0 O-C-N 120.881 -1.137 . . . . 0.0 109.127 -179.831 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 166' ' ' VAL . . . . . 0.643 ' O ' ' N ' ' A' ' 168' ' ' VAL . 0.8 OUTLIER -44.0 -29.47 0.52 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.523 0 O-C-N 121.113 -0.992 . . . . 0.0 109.387 -178.567 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 167' ' ' GLY . . . . . . . . . . . . . . . -45.19 -6.43 0.01 OUTLIER Glycine 0 N--CA 1.498 2.788 0 O-C-N 121.197 -0.94 . . . . 0.0 110.763 179.905 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 168' ' ' VAL . . . . . 0.643 ' N ' ' O ' ' A' ' 166' ' ' VAL . 2.8 t -48.24 -34.56 4.99 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.417 0 O-C-N 120.88 -1.365 . . . . 0.0 108.381 179.188 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 169' ' ' LEU . . . . . 0.64 HD13 ' OE1' ' A' ' 105' ' ' GLU . 1.4 mt -47.23 -11.01 0.02 OUTLIER 'General case' 0 N--CA 1.494 1.767 0 N-CA-C 108.239 -1.022 . . . . 0.0 108.239 -178.313 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 170' ' ' ASP . . . . . 0.603 ' N ' ' O ' ' A' ' 168' ' ' VAL . 6.1 t70 38.49 64.65 0.71 Allowed 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.596 -0.69 . . . . 0.0 111.535 177.615 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 171' ' ' GLU . . . . . 0.426 ' H ' ' HG2' ' A' ' 171' ' ' GLU . 1.7 pt-20 -101.09 92.81 5.17 Favored 'General case' 0 C--N 1.299 -1.601 0 N-CA-C 106.965 -1.494 . . . . 0.0 106.965 177.715 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 172' ' ' GLN . . . . . . . . . . . . . 1.1 mt-30 -156.01 -79.16 0.09 Allowed 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.651 -0.656 . . . . 0.0 110.266 -178.361 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 173' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -59.49 128.41 36.91 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.15 -0.969 . . . . 0.0 109.195 -179.549 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 174' ' ' GLY . . . . . 0.526 ' O ' ' C ' ' A' ' 175' ' ' LYS . . . -119.36 -40.92 0.6 Allowed Glycine 0 N--CA 1.48 1.584 0 N-CA-C 108.117 -1.993 . . . . 0.0 108.117 179.321 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 175' ' ' LYS . . . . . 0.526 ' C ' ' O ' ' A' ' 174' ' ' GLY . 2.9 mmtt -35.79 -61.88 0.45 Allowed 'General case' 0 N--CA 1.496 1.829 0 N-CA-C 108.728 -0.841 . . . . 0.0 108.728 -179.877 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 176' ' ' ASP . . . . . 0.604 ' O ' ' O ' ' A' ' 177' ' ' LYS . 0.3 OUTLIER -103.48 88.87 3.2 Favored 'General case' 0 C--N 1.297 -1.676 0 N-CA-C 107.801 -1.185 . . . . 0.0 107.801 177.946 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 177' ' ' LYS . . . . . 0.604 ' O ' ' O ' ' A' ' 176' ' ' ASP . 6.0 mtmp? -39.29 177.82 0.0 OUTLIER 'General case' 0 N--CA 1.494 1.748 0 CA-C-O 121.805 0.812 . . . . 0.0 111.023 -179.09 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 178' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -161.69 171.81 17.29 Favored 'General case' 0 C--N 1.305 -1.331 0 O-C-N 120.837 -1.164 . . . . 0.0 110.508 179.186 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 179' ' ' LEU . . . . . . . . . . . . . 1.3 tp -126.74 95.33 4.3 Favored 'General case' 0 C--N 1.302 -1.485 0 N-CA-C 106.491 -1.67 . . . . 0.0 106.491 177.513 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 180' ' ' THR . . . . . . . . . . . . . 1.2 m -70.12 119.11 13.83 Favored 'General case' 0 C--N 1.304 -1.384 0 C-N-CA 119.134 -1.026 . . . . 0.0 109.41 -178.349 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 181' ' ' LEU . . . . . 0.467 HD21 ' HG ' ' A' ' 133' ' ' LEU . 36.8 tp -96.82 146.01 25.32 Favored 'General case' 0 C--N 1.294 -1.806 0 N-CA-C 108.028 -1.101 . . . . 0.0 108.028 178.706 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 182' ' ' ILE . . . . . . . . . . . . . 25.3 mt -139.34 119.77 14.58 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.484 0 O-C-N 120.956 -1.09 . . . . 0.0 109.718 179.088 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 183' ' ' THR . . . . . 0.592 HG23 ' O ' ' A' ' 183' ' ' THR . 10.3 t -135.76 115.45 12.9 Favored 'General case' 0 C--N 1.291 -1.977 0 N-CA-C 107.447 -1.316 . . . . 0.0 107.447 178.508 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 184' ' ' CYS . . . . . . . . . . . . . 5.1 p -78.15 157.38 29.44 Favored 'General case' 0 C--N 1.287 -2.12 0 C-N-CA 118.93 -1.108 . . . . 0.0 110.655 -177.867 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 185' ' ' ASP . . . . . 0.522 ' CG ' ' H ' ' A' ' 186' ' ' ASP . 37.3 t0 -165.7 -158.09 0.34 Allowed 'General case' 0 N--CA 1.492 1.654 0 N-CA-C 108.944 -0.761 . . . . 0.0 108.944 -179.5 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 186' ' ' ASP . . . . . 0.522 ' H ' ' CG ' ' A' ' 185' ' ' ASP . 1.3 m-20 52.93 53.83 11.44 Favored 'General case' 0 N--CA 1.494 1.73 0 O-C-N 120.902 -1.124 . . . . 0.0 109.444 179.979 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 187' ' ' TYR . . . . . 0.617 ' CE1' ' O ' ' A' ' 188' ' ' ASN . 61.2 t80 -67.9 135.03 51.82 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.171 -0.956 . . . . 0.0 110.719 -179.397 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 188' ' ' ASN . . . . . 0.617 ' O ' ' CE1' ' A' ' 187' ' ' TYR . 1.1 t-20 -101.68 146.16 28.11 Favored 'General case' 0 C--N 1.295 -1.792 0 N-CA-C 108.119 -1.067 . . . . 0.0 108.119 178.441 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 189' ' ' GLU . . . . . . . . . . . . . 1.8 tt0 -110.13 -13.39 14.37 Favored 'General case' 0 C--N 1.293 -1.875 0 N-CA-C 108.151 -1.055 . . . . 0.0 108.151 -179.782 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 190' ' ' LYS . . . . . . . . . . . . . 6.4 mttt -84.27 -55.68 4.05 Favored 'General case' 0 C--N 1.301 -1.522 0 N-CA-C 108.827 -0.805 . . . . 0.0 108.827 178.759 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 191' ' ' THR . . . . . 0.583 ' OG1' HG12 ' A' ' 193' ' ' VAL . 6.2 p -87.48 2.55 50.27 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.444 -0.785 . . . . 0.0 109.89 -179.644 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 192' ' ' GLY . . . . . . . . . . . . . . . 56.27 33.07 60.98 Favored Glycine 0 N--CA 1.495 2.62 0 O-C-N 121.172 -0.955 . . . . 0.0 111.79 178.615 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 193' ' ' VAL . . . . . 0.583 HG12 ' OG1' ' A' ' 191' ' ' THR . 4.1 p -149.25 167.94 2.97 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.75 0 O-C-N 120.677 -1.484 . . . . 0.0 110.583 179.009 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 194' ' ' TRP . . . . . 0.524 ' H ' HG22 ' A' ' 193' ' ' VAL . 9.4 m95 -83.98 120.23 25.87 Favored 'General case' 0 C--N 1.296 -1.724 0 N-CA-C 108.558 -0.904 . . . . 0.0 108.558 179.963 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 195' ' ' GLU . . . . . 0.444 ' CD ' ' ND2' ' A' ' 188' ' ' ASN . 3.7 mt-10 -76.23 -60.82 2.17 Favored 'General case' 0 N--CA 1.495 1.784 0 O-C-N 121.395 -0.816 . . . . 0.0 111.356 -178.323 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 196' ' ' LYS . . . . . . . . . . . . . 8.6 tttt -93.18 153.71 18.47 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 120.935 -1.103 . . . . 0.0 110.817 -178.494 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 197' ' ' ARG . . . . . 0.647 ' CG ' HH11 ' A' ' 197' ' ' ARG . 0.0 OUTLIER -119.66 140.13 51.12 Favored 'General case' 0 N--CA 1.49 1.525 0 N-CA-C 107.995 -1.113 . . . . 0.0 107.995 178.845 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 198' ' ' LYS . . . . . . . . . . . . . 2.4 mttm -114.16 122.02 45.54 Favored 'General case' 0 N--CA 1.493 1.719 0 O-C-N 121.899 -0.501 . . . . 0.0 110.904 -177.982 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 199' ' ' ILE . . . . . 0.694 ' C ' HD12 ' A' ' 199' ' ' ILE . 0.5 OUTLIER -142.58 120.02 7.02 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.546 0 CA-C-O 122.393 1.092 . . . . 0.0 110.515 179.925 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 200' ' ' PHE . . . . . 0.509 ' CD1' ' N ' ' A' ' 200' ' ' PHE . 3.5 m-85 -98.42 135.45 39.98 Favored 'General case' 0 N--CA 1.499 2.001 0 O-C-N 121.34 -0.85 . . . . 0.0 109.512 -178.982 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 201' ' ' VAL . . . . . 0.416 ' N ' ' O ' ' A' ' 157' ' ' SER . 72.3 t -100.08 130.75 48.76 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.633 0 O-C-N 120.885 -1.134 . . . . 0.0 108.318 177.671 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 202' ' ' ALA . . . . . . . . . . . . . . . -114.48 131.47 56.61 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.37 -0.831 . . . . 0.0 108.771 179.443 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 203' ' ' THR . . . . . 0.724 HG23 ' OG1' ' A' ' 156' ' ' THR . 6.7 p -88.59 130.35 35.28 Favored 'General case' 0 N--CA 1.487 1.399 0 CA-C-O 122.137 0.97 . . . . 0.0 110.768 -179.039 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 204' ' ' GLU . . . . . 0.491 ' HA ' ' CD2' ' A' ' 153' ' ' TYR . 0.8 OUTLIER -51.5 134.28 29.21 Favored 'General case' 0 C--N 1.298 -1.64 0 C-N-CA 119.091 -1.044 . . . . 0.0 109.034 179.305 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 205' ' ' VAL . . . . . 0.721 HG23 ' O ' ' A' ' 203' ' ' THR . 93.3 t -132.22 167.03 27.41 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.358 0 CA-C-O 122.081 0.943 . . . . 0.0 110.144 -178.132 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 206' ' ' LYS . . . . . 0.603 ' N ' HG12 ' A' ' 205' ' ' VAL . 0.0 OUTLIER . . . . . 0 C--N 1.295 -1.787 0 CA-C-O 117.933 -1.032 . . . . 0.0 109.509 -179.72 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' C' C ' 701' ' ' PHQ . . . . . 0.613 ' O2 ' HG12 ' A' ' 166' ' ' VAL . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' C' C ' 702' ' ' LEU . . . . . 0.784 ' N ' HD12 ' C' ' 702' ' ' LEU . 0.0 OUTLIER . . . . . 0 N--CA 1.494 1.741 0 N-CA-C 109.235 -0.654 . . . . 0.0 109.235 . . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' C' C ' 703' ' ' PRO . . . . . 0.637 ' HB3' ' HB3' ' A' ' 92' ' ' ALA . 50.7 Cg_exo -48.6 -164.59 0.0 OUTLIER 'Trans proline' 0 N--CA 1.494 1.504 0 C-N-CA 122.437 2.091 . . . . 0.0 113.216 -179.426 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' C' C ' 704' ' ' ALA . . . . . 0.748 ' HB2' ' HB1' ' A' ' 118' ' ' ALA . . . 48.05 99.62 0.01 OUTLIER 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.679 -0.638 . . . . 0.0 109.983 -179.924 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' C' C ' 705' ' ' B27 . . . . . 0.502 ' SG ' ' C ' ' C' ' 704' ' ' ALA . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 700' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 004 nuclear nobuild full ' A' A ' 59' ' ' MET . . . . . . . . . . . . . 2.2 mtt . . . . . 0 N--CA 1.491 1.581 0 N-CA-C 109.4 -0.592 . . . . 0.0 109.4 . . . . . . . . . 0 0 . 1 . 004 nuclear nobuild full ' A' A ' 60' ' ' GLN . . . . . . . . . . . . . 7.5 tp-100 -60.62 113.07 2.26 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.295 -0.878 . . . . 0.0 109.588 -179.91 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . -64.0 -169.8 0.03 OUTLIER 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.192 -0.942 . . . . 0.0 109.238 179.804 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 62' ' ' LYS . . . . . . . . . . . . . 27.2 mttp -147.41 83.75 7.54 Favored Pre-proline 0 N--CA 1.489 1.516 0 O-C-N 121.252 -0.905 . . . . 0.0 109.567 -179.682 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 63' ' ' PRO . . . . . 0.47 ' O ' ' CD1' ' A' ' 110' ' ' LEU . 18.2 Cg_endo -81.46 141.2 12.42 Favored 'Trans proline' 0 C--N 1.306 -1.672 0 C-N-CA 122.792 2.328 . . . . 0.0 111.231 179.584 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 64' ' ' GLN . . . . . 0.623 ' O ' ' NE2' ' A' ' 64' ' ' GLN . 0.0 OUTLIER -155.53 139.25 16.11 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.175 -0.953 . . . . 0.0 109.658 -179.967 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 65' ' ' ILE . . . . . . . . . . . . . 4.7 mm -48.05 107.7 0.79 Allowed Pre-proline 0 N--CA 1.491 1.592 0 O-C-N 121.009 -1.057 . . . . 0.0 108.183 179.345 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 66' ' ' PRO . . . . . . . . . . . . . 93.6 Cg_endo -85.75 -170.16 0.68 Allowed 'Trans proline' 0 C--N 1.315 -1.218 0 C-N-CA 122.15 1.9 . . . . 0.0 112.614 -179.015 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 67' ' ' LYS . . . . . . . . . . . . . 38.7 tttt -90.27 -8.86 49.89 Favored 'General case' 0 N--CA 1.488 1.459 0 O-C-N 121.436 -0.79 . . . . 0.0 109.178 179.567 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 68' ' ' ASP . . . . . 0.664 ' O ' ' N ' ' A' ' 70' ' ' SER . 0.4 OUTLIER -75.86 63.86 1.74 Allowed 'General case' 0 N--CA 1.488 1.431 0 CA-C-O 122.848 1.309 . . . . 0.0 109.033 179.813 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 69' ' ' LYS . . . . . 0.478 ' C ' ' O ' ' A' ' 68' ' ' ASP . 23.8 mtmt -45.76 -13.99 0.02 OUTLIER 'General case' 0 N--CA 1.512 2.653 0 C-N-CA 116.686 -2.005 . . . . 0.0 107.157 177.757 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 70' ' ' SER . . . . . 0.664 ' N ' ' O ' ' A' ' 68' ' ' ASP . 0.1 OUTLIER -86.04 -9.02 57.49 Favored 'General case' 0 N--CA 1.497 1.899 0 CA-C-N 113.701 -1.59 . . . . 0.0 111.656 179.395 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 71' ' ' LYS . . . . . 0.464 ' N ' ' O ' ' A' ' 68' ' ' ASP . 0.0 OUTLIER -95.88 142.18 28.44 Favored 'General case' 0 N--CA 1.505 2.303 0 O-C-N 120.468 -1.395 . . . . 0.0 112.971 -178.704 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 72' ' ' VAL . . . . . 0.633 HG12 ' CZ ' ' A' ' 88' ' ' TYR . 1.3 m -68.67 133.42 31.81 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.368 0 N-CA-C 105.305 -2.109 . . . . 0.0 105.305 174.711 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 73' ' ' ALA . . . . . 0.7 ' O ' HG23 ' A' ' 146' ' ' VAL . . . -80.87 -13.77 58.63 Favored 'General case' 0 C--N 1.297 -1.714 0 O-C-N 119.905 -1.747 . . . . 0.0 107.183 -179.813 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . 172.99 -156.71 25.24 Favored Glycine 0 N--CA 1.483 1.77 0 N-CA-C 109.299 -1.52 . . . . 0.0 109.299 179.648 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 75' ' ' TYR . . . . . 0.547 ' HA ' HG23 ' A' ' 87' ' ' VAL . 88.1 m-85 -141.54 169.99 16.56 Favored 'General case' 0 C--N 1.298 -1.668 0 O-C-N 121.58 -0.953 . . . . 0.0 111.044 -177.241 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 76' ' ' ILE . . . . . . . . . . . . . 3.9 tp -146.5 141.39 20.88 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.577 0 C-N-CA 119.461 -0.895 . . . . 0.0 109.455 -177.377 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -153.09 165.02 36.92 Favored 'General case' 0 C--N 1.304 -1.41 0 O-C-N 121.13 -0.981 . . . . 0.0 109.934 179.852 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 78' ' ' ILE . . . . . 0.639 ' HB ' ' HB3' ' A' ' 81' ' ' ALA . 5.0 mt -147.39 119.92 4.75 Favored Pre-proline 0 C--N 1.303 -1.455 0 N-CA-C 107.87 -1.159 . . . . 0.0 107.87 179.165 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 79' ' ' PRO . . . . . . . . . . . . . 31.1 Cg_endo -70.46 -42.36 2.74 Favored 'Trans proline' 0 C--N 1.315 -1.218 0 C-N-CA 121.658 1.572 . . . . 0.0 112.992 -178.755 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -66.43 -19.8 65.89 Favored 'General case' 0 N--CA 1.489 1.491 0 O-C-N 120.881 -1.137 . . . . 0.0 110.202 177.977 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 81' ' ' ALA . . . . . 0.931 ' HB2' ' HB2' ' A' ' 136' ' ' ALA . . . -106.61 -18.78 13.86 Favored 'General case' 0 N--CA 1.494 1.755 0 O-C-N 121.303 -0.873 . . . . 0.0 109.04 179.913 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 82' ' ' ASP . . . . . . . . . . . . . 2.3 t70 66.01 52.09 1.25 Allowed 'General case' 0 N--CA 1.494 1.732 0 O-C-N 121.43 -0.794 . . . . 0.0 111.493 178.781 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 83' ' ' ILE . . . . . . . . . . . . . 31.4 mt -131.46 153.08 38.3 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.862 0 O-C-N 120.977 -1.077 . . . . 0.0 109.636 -179.322 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 84' ' ' LYS . . . . . . . . . . . . . 23.1 tttt -158.11 110.48 2.33 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.244 -0.91 . . . . 0.0 108.628 179.57 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -141.46 165.75 26.6 Favored Pre-proline 0 N--CA 1.492 1.67 0 O-C-N 121.246 -0.909 . . . . 0.0 109.817 -179.256 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 86' ' ' PRO . . . . . . . . . . . . . 61.2 Cg_endo -76.29 168.61 23.58 Favored 'Trans proline' 0 C--N 1.309 -1.5 0 C-N-CA 122.939 2.426 . . . . 0.0 113.312 -179.53 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 87' ' ' VAL . . . . . 0.547 HG23 ' HA ' ' A' ' 75' ' ' TYR . 49.6 t -124.43 98.84 5.64 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.63 0 N-CA-C 109.27 -0.641 . . . . 0.0 109.27 -179.884 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 88' ' ' TYR . . . . . 0.633 ' CZ ' HG12 ' A' ' 72' ' ' VAL . 35.0 m-85 -90.42 153.55 46.22 Favored Pre-proline 0 N--CA 1.503 2.209 0 O-C-N 120.954 -1.091 . . . . 0.0 109.944 -179.606 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 89' ' ' PRO . . . . . 0.539 ' O ' ' NE2' ' A' ' 96' ' ' GLN . 10.2 Cg_endo -58.7 146.11 93.36 Favored 'Trans proline' 0 N--CA 1.493 1.469 0 C-N-CA 122.492 2.128 . . . . 0.0 113.135 179.82 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . -58.11 169.59 4.7 Favored Glycine 0 N--CA 1.492 2.398 0 N-CA-C 109.326 -1.51 . . . . 0.0 109.326 179.493 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 91' ' ' PRO . . . . . 0.4 ' C ' ' H ' ' A' ' 93' ' ' THR . 57.3 Cg_endo -95.23 169.21 16.63 Favored 'Cis proline' 0 C--N 1.31 -1.485 0 C-N-CA 124.298 -1.126 . . . . 0.0 112.065 0.103 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 92' ' ' ALA . . . . . 0.676 ' HB3' ' HB2' ' C' ' 703' ' ' PRO . . . -71.99 30.07 0.05 Allowed 'General case' 0 N--CA 1.493 1.691 0 O-C-N 121.241 -0.912 . . . . 0.0 111.274 -179.421 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 93' ' ' THR . . . . . 0.4 ' H ' ' C ' ' A' ' 91' ' ' PRO . 1.0 OUTLIER -75.85 151.29 84.35 Favored Pre-proline 0 N--CA 1.492 1.64 0 O-C-N 120.651 -1.281 . . . . 0.0 108.788 179.865 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 94' ' ' PRO . . . . . 0.4 ' C ' ' O ' ' A' ' 93' ' ' THR . 82.9 Cg_exo -35.52 -42.24 0.45 Allowed 'Trans proline' 0 C--N 1.308 -1.573 0 C-N-CA 122.511 2.14 . . . . 0.0 112.067 -179.566 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 5.8 mt-10 -49.95 -56.44 10.62 Favored 'General case' 0 C--N 1.304 -1.41 0 O-C-N 121.292 -0.88 . . . . 0.0 109.112 179.512 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 96' ' ' GLN . . . . . 0.596 ' O ' ' N ' ' A' ' 98' ' ' ASN . 13.0 mm100 -74.49 -47.86 30.64 Favored 'General case' 0 N--CA 1.487 1.424 0 O-C-N 121.323 -0.861 . . . . 0.0 109.995 179.69 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 97' ' ' LEU . . . . . 0.595 HD23 ' O ' ' A' ' 92' ' ' ALA . 0.4 OUTLIER -45.3 -11.89 0.02 OUTLIER 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.221 -0.925 . . . . 0.0 109.989 -178.949 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 98' ' ' ASN . . . . . 0.724 HD21 ' NH1' ' A' ' 99' ' ' ARG . 0.0 OUTLIER -73.88 -31.44 63.15 Favored 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.176 -0.953 . . . . 0.0 108.854 179.204 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 99' ' ' ARG . . . . . 0.724 ' NH1' HD21 ' A' ' 98' ' ' ASN . 1.1 mtt-85 -85.03 -58.2 2.79 Favored 'General case' 0 C--N 1.302 -1.47 0 O-C-N 121.865 -0.522 . . . . 0.0 109.89 -179.14 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . -179.65 -160.34 25.09 Favored Glycine 0 N--CA 1.493 2.442 0 C-N-CA 119.645 -1.264 . . . . 0.0 110.046 -179.944 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 101' ' ' VAL . . . . . 0.736 ' O ' HG23 ' A' ' 101' ' ' VAL . 17.8 m -61.66 107.82 0.46 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.594 0 O-C-N 121.403 -1.057 . . . . 0.0 109.522 -179.813 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -92.91 161.57 14.43 Favored 'General case' 0 N--CA 1.493 1.681 0 O-C-N 121.322 -0.861 . . . . 0.0 110.498 -179.84 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 103' ' ' PHE . . . . . 0.601 ' O ' ' N ' ' A' ' 105' ' ' GLU . 25.3 m-85 -64.13 123.32 18.77 Favored 'General case' 0 N--CA 1.488 1.447 0 N-CA-C 108.151 -1.055 . . . . 0.0 108.151 178.655 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 104' ' ' ALA . . . . . 0.702 ' HB1' ' HG3' ' C' ' 703' ' ' PRO . . . -40.39 -18.63 0.01 OUTLIER 'General case' 0 C--N 1.298 -1.636 0 O-C-N 121.602 -0.686 . . . . 0.0 110.774 -178.939 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 105' ' ' GLU . . . . . 0.601 ' N ' ' O ' ' A' ' 103' ' ' PHE . 0.4 OUTLIER -140.0 147.88 41.06 Favored 'General case' 0 N--CA 1.495 1.808 0 O-C-N 120.698 -1.251 . . . . 0.0 110.315 179.915 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 106' ' ' GLU . . . . . . . . . . . . . 4.3 tt0 -57.86 -63.37 1.27 Allowed 'General case' 0 N--CA 1.487 1.425 0 O-C-N 121.965 -0.459 . . . . 0.0 111.203 -179.058 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 107' ' ' ASN . . . . . . . . . . . . . 5.1 m120 -78.68 33.82 0.21 Allowed 'General case' 0 N--CA 1.49 1.544 0 O-C-N 120.477 -1.39 . . . . 0.0 113.465 -175.231 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 108' ' ' GLU . . . . . . . . . . . . . 30.6 tp10 -60.02 150.14 30.1 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 120.426 -1.421 . . . . 0.0 108.175 -179.614 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 109' ' ' SER . . . . . 0.489 ' C ' ' H ' ' A' ' 111' ' ' ASP . 0.1 OUTLIER -101.35 126.26 48.09 Favored 'General case' 0 N--CA 1.489 1.5 0 O-C-N 121.002 -1.061 . . . . 0.0 110.585 -178.613 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 110' ' ' LEU . . . . . 0.534 HD23 ' N ' ' A' ' 110' ' ' LEU . 1.0 OUTLIER -60.22 -2.33 0.44 Allowed 'General case' 0 C--N 1.298 -1.664 0 N-CA-C 108.891 -0.781 . . . . 0.0 108.891 -179.964 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 111' ' ' ASP . . . . . 0.489 ' H ' ' C ' ' A' ' 109' ' ' SER . 53.1 m-20 -133.26 20.47 4.02 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.386 -0.822 . . . . 0.0 109.607 179.831 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 112' ' ' ASP . . . . . 0.41 ' N ' ' OG ' ' A' ' 109' ' ' SER . 0.4 OUTLIER -68.05 140.14 56.29 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.002 -1.061 . . . . 0.0 110.661 -179.674 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 113' ' ' GLN . . . . . 0.531 ' N ' ' CD ' ' A' ' 113' ' ' GLN . 2.1 mm100 -64.92 -7.06 9.94 Favored 'General case' 0 C--N 1.303 -1.445 0 N-CA-C 107.521 -1.289 . . . . 0.0 107.521 177.876 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 114' ' ' ASN . . . . . 0.677 ' ND2' HE21 ' A' ' 178' ' ' GLN . 4.9 t-20 -144.68 92.17 2.26 Favored 'General case' 0 C--N 1.304 -1.403 0 N-CA-C 108.206 -1.035 . . . . 0.0 108.206 -179.954 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 115' ' ' ILE . . . . . 0.448 ' O ' HG22 ' A' ' 115' ' ' ILE . 2.8 mt -99.11 113.71 34.83 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.536 0 O-C-N 121.531 -0.731 . . . . 0.0 109.328 -179.438 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 116' ' ' SER . . . . . 0.572 ' OG ' ' HB3' ' A' ' 104' ' ' ALA . 69.3 p -98.02 146.61 25.34 Favored 'General case' 0 N--CA 1.488 1.471 0 CA-C-O 122.093 0.949 . . . . 0.0 111.387 -178.299 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 117' ' ' ILE . . . . . . . . . . . . . 2.7 mt -138.21 154.64 28.24 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.511 0 N-CA-C 107.477 -1.305 . . . . 0.0 107.477 178.996 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 118' ' ' ALA . . . . . . . . . . . . . . . -143.44 159.75 41.82 Favored 'General case' 0 N--CA 1.492 1.66 0 O-C-N 120.836 -1.165 . . . . 0.0 111.336 -179.233 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 119' ' ' GLY . . . . . . . . . . . . . . . -167.66 145.56 9.85 Favored Glycine 0 N--CA 1.489 2.183 0 N-CA-C 110.423 -1.071 . . . . 0.0 110.423 179.624 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 120' ' ' HIS . . . . . 0.403 ' ND1' ' SG ' ' C' ' 705' ' ' B27 . 3.1 m-70 -70.36 164.64 24.1 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.613 -0.933 . . . . 0.0 109.417 179.236 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 121' ' ' THR . . . . . 0.423 HG21 ' OD2' ' A' ' 185' ' ' ASP . 0.7 OUTLIER -118.06 155.28 30.62 Favored 'General case' 0 N--CA 1.494 1.733 0 O-C-N 121.318 -0.864 . . . . 0.0 108.855 179.422 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 122' ' ' PHE . . . . . 0.401 ' CD1' ' HB2' ' A' ' 125' ' ' ARG . 0.2 OUTLIER -112.36 128.07 56.19 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.308 -0.87 . . . . 0.0 109.637 179.761 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 123' ' ' ILE . . . . . 0.567 HG23 ' N ' ' A' ' 124' ' ' ASP . 16.3 tt -77.26 -38.52 27.21 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.809 0 N-CA-C 108.167 -1.049 . . . . 0.0 108.167 179.076 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 124' ' ' ASP . . . . . 0.567 ' N ' HG23 ' A' ' 123' ' ' ILE . 4.8 t70 -100.29 24.32 8.94 Favored 'General case' 0 N--CA 1.494 1.771 0 CA-C-N 115.771 -0.649 . . . . 0.0 110.82 -179.73 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 125' ' ' ARG . . . . . 0.401 ' HB2' ' CD1' ' A' ' 122' ' ' PHE . 5.1 ttt180 -157.64 99.77 1.87 Allowed Pre-proline 0 N--CA 1.492 1.671 0 O-C-N 120.664 -1.272 . . . . 0.0 110.541 -179.032 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 126' ' ' PRO . . . . . . . . . . . . . 41.3 Cg_endo -78.88 -18.91 11.33 Favored 'Trans proline' 0 C--N 1.314 -1.243 0 C-N-CA 122.175 1.917 . . . . 0.0 112.465 179.517 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 127' ' ' ASN . . . . . . . . . . . . . 14.8 m120 -90.65 26.69 1.95 Allowed 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.23 -0.919 . . . . 0.0 109.241 179.636 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 128' ' ' TYR . . . . . . . . . . . . . 13.1 t80 -87.04 -149.01 0.15 Allowed 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.306 -0.872 . . . . 0.0 109.774 -179.622 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 129' ' ' GLN . . . . . . . . . . . . . 63.3 mt-30 -67.95 -89.43 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.288 -0.882 . . . . 0.0 110.344 -179.323 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 130' ' ' PHE . . . . . 0.704 ' CE2' HG11 ' A' ' 101' ' ' VAL . 41.0 m-85 -110.15 40.07 2.02 Favored 'General case' 0 N--CA 1.494 1.752 0 O-C-N 121.287 -0.883 . . . . 0.0 110.338 -179.22 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 131' ' ' THR . . . . . . . . . . . . . 85.6 m -79.78 -32.95 40.9 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.088 -1.008 . . . . 0.0 109.128 179.38 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 132' ' ' ASN . . . . . 0.435 ' ND2' ' O ' ' A' ' 81' ' ' ALA . 4.6 t30 -84.33 7.54 19.04 Favored 'General case' 0 N--CA 1.495 1.784 0 O-C-N 121.608 -0.682 . . . . 0.0 110.335 -179.588 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 133' ' ' LEU . . . . . 0.6 ' O ' ' N ' ' A' ' 135' ' ' ALA . 0.2 OUTLIER -70.26 -46.37 64.53 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.186 -0.946 . . . . 0.0 110.686 -179.146 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 134' ' ' LYS . . . . . 0.597 ' CD ' ' H ' ' A' ' 134' ' ' LYS . 0.1 OUTLIER -42.53 -17.54 0.01 OUTLIER 'General case' 0 N--CA 1.493 1.692 0 O-C-N 121.024 -1.048 . . . . 0.0 109.983 -179.012 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 135' ' ' ALA . . . . . 0.6 ' N ' ' O ' ' A' ' 133' ' ' LEU . . . -85.12 -33.89 22.28 Favored 'General case' 0 N--CA 1.489 1.482 0 O-C-N 121.183 -0.948 . . . . 0.0 109.64 179.773 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 136' ' ' ALA . . . . . 0.931 ' HB2' ' HB2' ' A' ' 81' ' ' ALA . . . -80.43 153.21 28.39 Favored 'General case' 0 N--CA 1.489 1.504 0 CA-C-O 122.095 0.95 . . . . 0.0 111.769 -178.546 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 137' ' ' LYS . . . . . 0.511 ' O ' ' O ' ' A' ' 138' ' ' LYS . 2.8 ttmm -157.42 -163.47 1.37 Allowed 'General case' 0 N--CA 1.491 1.624 0 C-N-CA 119.109 -1.037 . . . . 0.0 110.431 -179.25 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 138' ' ' LYS . . . . . 0.604 ' O ' ' N ' ' A' ' 140' ' ' SER . 10.3 tttt -46.23 -178.39 0.0 OUTLIER 'General case' 0 C--N 1.306 -1.3 0 CA-C-O 121.864 0.84 . . . . 0.0 110.265 -179.818 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 139' ' ' GLY . . . . . . . . . . . . . . . 45.7 8.2 0.02 OUTLIER Glycine 0 N--CA 1.492 2.431 0 N-CA-C 110.713 -0.955 . . . . 0.0 110.713 179.574 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 140' ' ' SER . . . . . 0.604 ' N ' ' O ' ' A' ' 138' ' ' LYS . 37.9 m -96.5 133.74 40.57 Favored 'General case' 0 N--CA 1.493 1.679 0 O-C-N 120.814 -1.404 . . . . 0.0 109.125 179.195 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 141' ' ' MET . . . . . 0.409 ' HG2' ' CE2' ' A' ' 143' ' ' TYR . 0.0 OUTLIER -82.52 144.62 30.27 Favored 'General case' 0 N--CA 1.489 1.488 0 O-C-N 121.148 -0.97 . . . . 0.0 109.871 -179.816 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 142' ' ' VAL . . . . . . . . . . . . . 5.8 t -129.21 132.85 66.61 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.705 0 O-C-N 121.284 -0.885 . . . . 0.0 108.771 179.902 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 143' ' ' TYR . . . . . 0.409 ' CE2' ' HG2' ' A' ' 141' ' ' MET . 32.3 m-85 -114.66 137.68 51.61 Favored 'General case' 0 N--CA 1.501 2.098 0 O-C-N 121.116 -0.99 . . . . 0.0 111.421 -178.455 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 144' ' ' PHE . . . . . . . . . . . . . 26.9 t80 -122.36 107.1 11.69 Favored 'General case' 0 N--CA 1.495 1.817 0 CA-C-O 121.323 0.583 . . . . 0.0 110.442 -179.178 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 145' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -96.63 128.83 43.95 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.384 -0.823 . . . . 0.0 110.582 -179.752 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 146' ' ' VAL . . . . . 0.7 HG23 ' O ' ' A' ' 73' ' ' ALA . 3.7 p -143.38 142.8 25.15 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.777 0 N-CA-C 107.522 -1.288 . . . . 0.0 107.522 178.752 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 147' ' ' GLY . . . . . 0.41 ' C ' ' O ' ' A' ' 146' ' ' VAL . . . 46.97 -134.28 11.71 Favored Glycine 0 N--CA 1.489 2.224 0 N-CA-C 108.887 -1.685 . . . . 0.0 108.887 -179.754 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 148' ' ' ASN . . . . . 0.596 HD22 ' C ' ' A' ' 148' ' ' ASN . 0.4 OUTLIER -102.33 17.31 23.8 Favored 'General case' 0 C--N 1.301 -1.533 0 O-C-N 121.284 -1.127 . . . . 0.0 108.451 179.208 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 149' ' ' GLU . . . . . . . . . . . . . 8.7 tt0 -114.56 147.42 39.48 Favored 'General case' 0 N--CA 1.487 1.402 0 CA-C-O 121.919 0.866 . . . . 0.0 111.024 -178.605 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 150' ' ' THR . . . . . . . . . . . . . 88.3 m -129.42 105.97 8.47 Favored 'General case' 0 N--CA 1.491 1.596 0 CA-C-O 121.421 0.629 . . . . 0.0 109.718 179.891 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 151' ' ' ARG . . . . . . . . . . . . . 34.2 mtt180 -87.04 -174.54 4.96 Favored 'General case' 0 C--N 1.306 -1.299 0 N-CA-C 107.987 -1.116 . . . . 0.0 107.987 179.52 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 152' ' ' LYS . . . . . 0.433 ' CE ' ' OXT' ' A' ' 206' ' ' LYS . 18.6 mtmm -148.22 146.33 28.63 Favored 'General case' 0 C--N 1.3 -1.571 0 O-C-N 121.007 -1.058 . . . . 0.0 110.135 -179.799 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 153' ' ' TYR . . . . . 0.507 ' CD2' ' HA ' ' A' ' 204' ' ' GLU . 9.1 m-85 -139.02 166.56 24.17 Favored 'General case' 0 C--N 1.3 -1.546 0 N-CA-C 107.523 -1.288 . . . . 0.0 107.523 179.13 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 154' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -142.96 121.86 12.74 Favored 'General case' 0 C--N 1.296 -1.722 0 O-C-N 121.184 -0.948 . . . . 0.0 108.442 178.748 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 155' ' ' MET . . . . . . . . . . . . . 23.1 mmm -46.99 104.89 0.06 Allowed 'General case' 0 N--CA 1.49 1.526 0 O-C-N 120.758 -1.214 . . . . 0.0 111.445 -178.584 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 156' ' ' THR . . . . . . . . . . . . . 1.4 m -107.88 -23.95 11.84 Favored 'General case' 0 C--N 1.293 -1.885 0 CA-C-N 115.288 -0.869 . . . . 0.0 109.921 -179.291 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 157' ' ' SER . . . . . 0.485 ' O ' ' N ' ' A' ' 201' ' ' VAL . 2.0 m -153.94 150.56 28.45 Favored 'General case' 0 N--CA 1.492 1.669 0 C-N-CA 118.217 -1.393 . . . . 0.0 111.426 -178.362 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 158' ' ' ILE . . . . . 0.453 HG13 ' CD2' ' A' ' 200' ' ' PHE . 0.0 OUTLIER -154.95 146.45 13.29 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.44 0 CA-C-O 121.796 0.807 . . . . 0.0 110.333 -179.491 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 159' ' ' ARG . . . . . 0.434 ' N ' HG12 ' A' ' 158' ' ' ILE . 37.5 mtm180 -149.3 177.18 9.89 Favored 'General case' 0 C--N 1.298 -1.656 0 CA-C-O 121.557 0.694 . . . . 0.0 109.812 -179.732 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 160' ' ' ASP . . . . . 0.571 ' C ' HG22 ' A' ' 161' ' ' VAL . 1.0 OUTLIER -144.81 161.22 39.81 Favored 'General case' 0 C--N 1.3 -1.567 0 N-CA-C 108.859 -0.793 . . . . 0.0 108.859 -179.463 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 161' ' ' VAL . . . . . 0.571 HG22 ' C ' ' A' ' 160' ' ' ASP . 0.1 OUTLIER -169.47 166.6 0.34 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.612 0 O-C-N 121.294 -0.879 . . . . 0.0 109.768 179.673 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 162' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -55.29 177.36 0.13 Allowed Pre-proline 0 N--CA 1.489 1.482 0 O-C-N 121.528 -0.732 . . . . 0.0 109.189 179.669 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 163' ' ' PRO . . . . . 0.739 ' C ' HD11 ' C' ' 702' ' ' LEU . 9.8 Cg_endo -84.07 42.8 1.26 Allowed 'Trans proline' 0 C--N 1.315 -1.185 0 C-N-CA 122.466 2.111 . . . . 0.0 112.21 -179.87 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 164' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -151.92 -14.0 0.19 Allowed 'General case' 0 N--CA 1.492 1.674 0 O-C-N 121.103 -0.998 . . . . 0.0 110.443 -179.859 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 165' ' ' ASP . . . . . 0.436 ' O ' ' C ' ' A' ' 166' ' ' VAL . 9.5 t70 -73.03 61.63 0.59 Allowed 'General case' 0 N--CA 1.49 1.527 0 O-C-N 120.955 -1.091 . . . . 0.0 109.544 -179.817 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 166' ' ' VAL . . . . . 0.608 ' O ' ' N ' ' A' ' 168' ' ' VAL . 0.9 OUTLIER -39.6 -32.04 0.17 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.55 0 O-C-N 121.659 -0.65 . . . . 0.0 109.431 -178.416 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 167' ' ' GLY . . . . . 0.425 ' N ' ' O ' ' A' ' 165' ' ' ASP . . . -43.03 -14.96 0.02 OUTLIER Glycine 0 N--CA 1.492 2.375 0 N-CA-C 110.325 -1.11 . . . . 0.0 110.325 179.898 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 168' ' ' VAL . . . . . 0.616 ' C ' ' H ' ' A' ' 170' ' ' ASP . 4.8 m -52.72 -37.06 24.04 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.452 0 O-C-N 120.751 -1.441 . . . . 0.0 108.528 179.692 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 169' ' ' LEU . . . . . 0.508 ' O ' ' N ' ' A' ' 171' ' ' GLU . 16.1 mt -51.75 -5.39 0.03 OUTLIER 'General case' 0 N--CA 1.494 1.756 0 N-CA-C 108.088 -1.078 . . . . 0.0 108.088 -179.431 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 170' ' ' ASP . . . . . 0.616 ' H ' ' C ' ' A' ' 168' ' ' VAL . 22.4 t0 35.52 29.49 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.639 -0.663 . . . . 0.0 111.586 178.047 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 171' ' ' GLU . . . . . 0.508 ' N ' ' O ' ' A' ' 169' ' ' LEU . 11.6 pt-20 -68.31 94.5 0.54 Allowed 'General case' 0 N--CA 1.489 1.5 0 O-C-N 120.609 -1.307 . . . . 0.0 108.26 178.935 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 172' ' ' GLN . . . . . 0.427 ' HG3' ' H ' ' A' ' 173' ' ' LYS . 6.0 pt20 -175.98 -56.9 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.535 0 N-CA-C 108.885 -0.783 . . . . 0.0 108.885 179.969 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 173' ' ' LYS . . . . . 0.427 ' H ' ' HG3' ' A' ' 172' ' ' GLN . 44.5 mtpt -64.13 130.24 43.17 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.021 -1.049 . . . . 0.0 108.64 178.462 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 174' ' ' GLY . . . . . 0.571 ' O ' ' C ' ' A' ' 175' ' ' LYS . . . -134.91 -38.72 0.19 Allowed Glycine 0 N--CA 1.48 1.621 0 N-CA-C 108.621 -1.792 . . . . 0.0 108.621 179.581 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 175' ' ' LYS . . . . . 0.571 ' C ' ' O ' ' A' ' 174' ' ' GLY . 4.3 mmtp -27.02 -64.7 0.08 Allowed 'General case' 0 N--CA 1.503 2.199 0 CA-C-O 121.644 0.735 . . . . 0.0 109.033 179.853 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 176' ' ' ASP . . . . . 0.669 ' O ' ' O ' ' A' ' 177' ' ' LYS . 0.0 OUTLIER -102.6 79.26 1.79 Allowed 'General case' 0 C--N 1.298 -1.669 0 N-CA-C 107.163 -1.421 . . . . 0.0 107.163 177.442 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 177' ' ' LYS . . . . . 0.669 ' O ' ' O ' ' A' ' 176' ' ' ASP . 65.7 mttt -26.56 161.34 0.0 OUTLIER 'General case' 0 N--CA 1.503 2.212 0 CA-C-O 121.821 0.82 . . . . 0.0 111.17 -178.676 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 178' ' ' GLN . . . . . 0.677 HE21 ' ND2' ' A' ' 114' ' ' ASN . 3.3 pp0? -159.94 174.0 15.05 Favored 'General case' 0 C--N 1.302 -1.458 0 C-N-CA 117.265 -1.774 . . . . 0.0 112.029 -179.357 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 179' ' ' LEU . . . . . 0.469 ' N ' ' OE1' ' A' ' 178' ' ' GLN . 0.9 OUTLIER -126.01 99.05 5.75 Favored 'General case' 0 C--N 1.303 -1.446 0 N-CA-C 107.242 -1.392 . . . . 0.0 107.242 178.47 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 180' ' ' THR . . . . . 0.487 HG23 HD13 ' A' ' 199' ' ' ILE . 2.7 m -70.82 122.0 19.09 Favored 'General case' 0 N--CA 1.488 1.447 0 O-C-N 120.953 -1.092 . . . . 0.0 109.939 -178.642 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 181' ' ' LEU . . . . . . . . . . . . . 51.1 tp -96.84 145.78 25.54 Favored 'General case' 0 C--N 1.298 -1.67 0 N-CA-C 108.387 -0.968 . . . . 0.0 108.387 178.725 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 182' ' ' ILE . . . . . 0.486 HG22 ' O ' ' A' ' 182' ' ' ILE . 6.3 mt -138.31 110.58 6.39 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.458 0 O-C-N 120.994 -1.066 . . . . 0.0 108.982 178.987 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 183' ' ' THR . . . . . 0.445 HG23 ' O ' ' A' ' 183' ' ' THR . 1.9 t -129.11 113.47 15.14 Favored 'General case' 0 C--N 1.291 -1.938 0 N-CA-C 106.767 -1.568 . . . . 0.0 106.767 178.546 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 184' ' ' CYS . . . . . . . . . . . . . 28.2 p -78.38 164.52 24.74 Favored 'General case' 0 N--CA 1.497 1.916 0 C-N-CA 119.028 -1.069 . . . . 0.0 111.103 -177.359 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 185' ' ' ASP . . . . . 0.423 ' OD2' HG21 ' A' ' 121' ' ' THR . 6.4 t70 -165.72 -151.4 0.14 Allowed 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.584 -0.698 . . . . 0.0 109.347 -179.642 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 186' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER 48.15 56.63 7.08 Favored 'General case' 0 N--CA 1.493 1.724 0 O-C-N 121.175 -0.953 . . . . 0.0 109.03 -179.598 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 187' ' ' TYR . . . . . 0.6 ' CE1' ' O ' ' A' ' 188' ' ' ASN . 44.7 t80 -67.38 133.77 50.22 Favored 'General case' 0 C--N 1.302 -1.485 0 O-C-N 121.418 -0.801 . . . . 0.0 110.411 -179.417 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 188' ' ' ASN . . . . . 0.6 ' O ' ' CE1' ' A' ' 187' ' ' TYR . 0.6 OUTLIER -100.74 147.21 26.29 Favored 'General case' 0 C--N 1.296 -1.749 0 N-CA-C 107.79 -1.189 . . . . 0.0 107.79 178.302 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 189' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -112.3 -11.04 13.76 Favored 'General case' 0 C--N 1.295 -1.797 0 N-CA-C 108.373 -0.973 . . . . 0.0 108.373 -179.635 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 190' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -84.23 -52.47 6.22 Favored 'General case' 0 C--N 1.303 -1.447 0 N-CA-C 108.851 -0.796 . . . . 0.0 108.851 178.838 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 191' ' ' THR . . . . . 0.591 ' OG1' HG12 ' A' ' 193' ' ' VAL . 1.1 p -89.44 -12.63 39.64 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.475 -0.766 . . . . 0.0 109.2 179.663 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 192' ' ' GLY . . . . . . . . . . . . . . . 71.84 33.43 63.02 Favored Glycine 0 N--CA 1.493 2.495 0 O-C-N 121.291 -0.881 . . . . 0.0 111.303 178.706 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 193' ' ' VAL . . . . . 0.591 HG12 ' OG1' ' A' ' 191' ' ' THR . 3.3 p -147.71 170.85 3.2 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.67 0 O-C-N 120.778 -1.425 . . . . 0.0 110.035 179.216 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 194' ' ' TRP . . . . . 0.556 ' H ' HG22 ' A' ' 193' ' ' VAL . 2.5 m95 -84.97 121.63 28.05 Favored 'General case' 0 N--CA 1.494 1.726 0 N-CA-C 109.439 -0.578 . . . . 0.0 109.439 -179.809 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 195' ' ' GLU . . . . . 0.531 ' CD ' ' ND2' ' A' ' 188' ' ' ASN . 2.4 mt-10 -80.05 -60.38 2.36 Favored 'General case' 0 N--CA 1.496 1.87 0 O-C-N 121.348 -0.845 . . . . 0.0 111.037 -178.975 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 196' ' ' LYS . . . . . . . . . . . . . 10.6 tttt -93.44 157.34 16.27 Favored 'General case' 0 N--CA 1.493 1.688 0 O-C-N 120.977 -1.077 . . . . 0.0 110.695 -178.544 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 197' ' ' ARG . . . . . 0.636 ' CG ' HH11 ' A' ' 197' ' ' ARG . 0.1 OUTLIER -126.18 142.2 51.62 Favored 'General case' 0 N--CA 1.489 1.485 0 O-C-N 121.653 -0.654 . . . . 0.0 109.351 179.415 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 198' ' ' LYS . . . . . . . . . . . . . 38.5 mttt -115.56 121.73 43.53 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.794 -0.566 . . . . 0.0 110.101 -179.17 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 199' ' ' ILE . . . . . 0.667 ' C ' HD12 ' A' ' 199' ' ' ILE . 0.5 OUTLIER -138.09 118.65 16.19 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.811 0 CA-C-O 122.526 1.155 . . . . 0.0 110.076 179.834 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 200' ' ' PHE . . . . . 0.586 ' CZ ' HD12 ' A' ' 133' ' ' LEU . 7.0 m-85 -99.73 135.35 41.28 Favored 'General case' 0 N--CA 1.499 1.992 0 O-C-N 121.499 -0.751 . . . . 0.0 109.894 -178.358 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 201' ' ' VAL . . . . . 0.485 ' N ' ' O ' ' A' ' 157' ' ' SER . 59.9 t -101.03 131.86 47.88 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.714 0 O-C-N 120.984 -1.073 . . . . 0.0 108.826 177.684 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 202' ' ' ALA . . . . . . . . . . . . . . . -115.9 131.38 56.95 Favored 'General case' 0 N--CA 1.491 1.624 0 N-CA-C 108.525 -0.917 . . . . 0.0 108.525 179.43 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 203' ' ' THR . . . . . 0.683 ' O ' HG23 ' A' ' 205' ' ' VAL . 5.4 t -87.88 132.09 34.33 Favored 'General case' 0 N--CA 1.488 1.468 0 CA-C-O 122.327 1.061 . . . . 0.0 110.709 -179.332 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 204' ' ' GLU . . . . . 0.507 ' HA ' ' CD2' ' A' ' 153' ' ' TYR . 13.7 tm-20 -52.99 135.42 36.85 Favored 'General case' 0 C--N 1.296 -1.752 0 C-N-CA 118.619 -1.233 . . . . 0.0 108.909 179.205 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 205' ' ' VAL . . . . . 0.683 HG23 ' O ' ' A' ' 203' ' ' THR . 84.1 t -131.99 167.97 25.14 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.345 0 CA-C-O 121.993 0.902 . . . . 0.0 110.141 -178.056 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 206' ' ' LYS . . . . . 0.61 ' N ' HG12 ' A' ' 205' ' ' VAL . 25.5 mttt . . . . . 0 C--N 1.297 -1.675 0 CA-C-O 117.978 -1.011 . . . . 0.0 109.555 179.937 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' C' C ' 701' ' ' PHQ . . . . . 0.504 ' C1 ' HG12 ' A' ' 166' ' ' VAL . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' C' C ' 702' ' ' LEU . . . . . 0.739 HD11 ' C ' ' A' ' 163' ' ' PRO . 0.0 OUTLIER . . . . . 0 N--CA 1.49 1.561 0 N-CA-C 108.775 -0.824 . . . . 0.0 108.775 . . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' C' C ' 703' ' ' PRO . . . . . 0.702 ' HG3' ' HB1' ' A' ' 104' ' ' ALA . 55.5 Cg_endo -72.58 174.76 11.16 Favored 'Trans proline' 0 N--CA 1.495 1.597 0 C-N-CA 122.48 2.12 . . . . 0.0 112.418 -179.497 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' C' C ' 704' ' ' ALA . . . . . . . . . . . . . . . 54.77 -173.81 0.04 OUTLIER 'General case' 0 N--CA 1.487 1.388 0 O-C-N 121.234 -0.916 . . . . 0.0 109.49 179.897 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' C' C ' 705' ' ' B27 . . . . . 0.486 ' OG1' ' CD1' ' A' ' 194' ' ' TRP . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 700' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 005 nuclear nobuild full ' A' A ' 59' ' ' MET . . . . . . . . . . . . . 0.3 OUTLIER . . . . . 0 N--CA 1.49 1.534 0 N-CA-C 109.474 -0.565 . . . . 0.0 109.474 . . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 60' ' ' GLN . . . . . 0.615 ' CD ' ' H ' ' A' ' 60' ' ' GLN . 1.4 mp0 -59.65 -179.73 0.1 Allowed 'General case' 0 N--CA 1.489 1.49 0 O-C-N 121.174 -0.954 . . . . 0.0 109.109 179.862 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . -63.49 157.11 24.34 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.099 -1.001 . . . . 0.0 109.262 -179.908 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 62' ' ' LYS . . . . . . . . . . . . . 40.0 mtpt -142.26 71.9 22.14 Favored Pre-proline 0 N--CA 1.489 1.491 0 O-C-N 121.152 -0.967 . . . . 0.0 109.693 -179.64 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 63' ' ' PRO . . . . . . . . . . . . . 53.7 Cg_endo -84.92 153.61 11.31 Favored 'Trans proline' 0 C--N 1.305 -1.737 0 C-N-CA 123.247 2.631 . . . . 0.0 110.929 179.271 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 64' ' ' GLN . . . . . 0.699 HE21 ' C ' ' A' ' 64' ' ' GLN . 0.0 OUTLIER -153.38 111.93 3.68 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 120.986 -1.071 . . . . 0.0 110.19 -179.84 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 65' ' ' ILE . . . . . 0.482 HD12 ' H ' ' A' ' 65' ' ' ILE . 3.1 mp -43.45 103.76 0.34 Allowed Pre-proline 0 N--CA 1.491 1.596 0 N-CA-C 108.148 -1.056 . . . . 0.0 108.148 178.722 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 66' ' ' PRO . . . . . . . . . . . . . 97.9 Cg_endo -85.98 -155.05 0.05 OUTLIER 'Trans proline' 0 N--CA 1.49 1.282 0 C-N-CA 122.407 2.072 . . . . 0.0 113.002 -178.218 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 67' ' ' LYS . . . . . 0.434 ' O ' ' CG ' ' A' ' 67' ' ' LYS . 15.1 tttt -82.16 -6.01 58.88 Favored 'General case' 0 N--CA 1.487 1.395 0 O-C-N 121.311 -0.868 . . . . 0.0 109.037 179.936 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 68' ' ' ASP . . . . . 0.64 ' C ' ' N ' ' A' ' 70' ' ' SER . 0.4 OUTLIER -75.12 51.15 0.51 Allowed 'General case' 0 N--CA 1.487 1.384 0 CA-C-O 122.645 1.212 . . . . 0.0 108.308 179.411 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 69' ' ' LYS . . . . . 0.452 ' C ' ' O ' ' A' ' 68' ' ' ASP . 1.9 ptpp? -49.19 -14.32 0.08 Allowed 'General case' 0 N--CA 1.501 2.121 0 C-N-CA 116.769 -1.972 . . . . 0.0 106.61 178.151 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 70' ' ' SER . . . . . 0.64 ' N ' ' C ' ' A' ' 68' ' ' ASP . 38.4 t -85.27 -7.2 59.13 Favored 'General case' 0 N--CA 1.495 1.824 0 CA-C-N 113.786 -1.552 . . . . 0.0 110.534 179.354 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 71' ' ' LYS . . . . . 0.416 ' CD ' ' HB2' ' A' ' 68' ' ' ASP . 0.9 OUTLIER -98.04 140.82 31.8 Favored 'General case' 0 N--CA 1.496 1.841 0 O-C-N 120.85 -1.156 . . . . 0.0 111.333 -179.745 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 72' ' ' VAL . . . . . 0.621 HG12 ' CE1' ' A' ' 88' ' ' TYR . 1.0 OUTLIER -66.03 142.4 16.84 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.455 0 N-CA-C 105.319 -2.104 . . . . 0.0 105.319 174.989 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 73' ' ' ALA . . . . . 0.439 ' N ' ' O ' ' A' ' 87' ' ' VAL . . . -83.0 -15.31 51.68 Favored 'General case' 0 C--N 1.293 -1.854 0 N-CA-C 106.078 -1.823 . . . . 0.0 106.078 178.935 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 74' ' ' GLY . . . . . 0.483 ' C ' ' CD1' ' A' ' 75' ' ' TYR . . . 167.56 -150.6 17.2 Favored Glycine 0 N--CA 1.482 1.706 0 N-CA-C 109.38 -1.488 . . . . 0.0 109.38 179.172 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 75' ' ' TYR . . . . . 0.483 ' CD1' ' C ' ' A' ' 74' ' ' GLY . 25.7 m-85 -144.09 175.97 9.66 Favored 'General case' 0 C--N 1.296 -1.74 0 O-C-N 121.597 -0.943 . . . . 0.0 109.782 -178.839 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 76' ' ' ILE . . . . . . . . . . . . . 2.0 tt -150.37 147.65 15.81 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.797 0 N-CA-C 108.923 -0.769 . . . . 0.0 108.923 -178.261 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 4.6 mt-10 -148.67 162.03 40.55 Favored 'General case' 0 C--N 1.301 -1.541 0 O-C-N 121.044 -1.035 . . . . 0.0 109.322 179.845 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 78' ' ' ILE . . . . . 0.468 ' HB ' ' HB3' ' A' ' 81' ' ' ALA . 36.4 mt -144.24 93.27 5.98 Favored Pre-proline 0 N--CA 1.489 1.51 0 N-CA-C 108.385 -0.968 . . . . 0.0 108.385 -179.733 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 79' ' ' PRO . . . . . . . . . . . . . 74.0 Cg_exo -47.31 -46.84 18.81 Favored 'Trans proline' 0 N--CA 1.494 1.511 0 C-N-CA 122.855 2.37 . . . . 0.0 114.094 -178.598 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 53.8 t0 -65.3 -19.07 65.79 Favored 'General case' 0 N--CA 1.493 1.695 0 O-C-N 120.716 -1.24 . . . . 0.0 110.839 178.921 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 81' ' ' ALA . . . . . 0.91 ' HB2' ' HB2' ' A' ' 136' ' ' ALA . . . -106.9 -17.87 14.08 Favored 'General case' 0 N--CA 1.494 1.745 0 O-C-N 121.114 -0.991 . . . . 0.0 108.792 179.527 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 82' ' ' ASP . . . . . 0.428 ' N ' ' O ' ' A' ' 78' ' ' ILE . 0.8 OUTLIER 69.3 50.69 0.54 Allowed 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.472 -0.768 . . . . 0.0 110.688 178.947 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 83' ' ' ILE . . . . . . . . . . . . . 64.1 mt -128.07 152.38 36.11 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.876 0 O-C-N 121.144 -0.972 . . . . 0.0 110.118 -179.247 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 84' ' ' LYS . . . . . . . . . . . . . 8.0 pttm -159.05 109.27 1.99 Allowed 'General case' 0 N--CA 1.49 1.561 0 N-CA-C 107.893 -1.151 . . . . 0.0 107.893 179.309 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 85' ' ' GLU . . . . . 0.436 ' OE2' ' O ' ' A' ' 129' ' ' GLN . 0.2 OUTLIER -140.48 170.99 8.4 Favored Pre-proline 0 N--CA 1.496 1.873 0 O-C-N 121.334 -0.854 . . . . 0.0 110.412 -178.684 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 86' ' ' PRO . . . . . . . . . . . . . 72.2 Cg_endo -81.72 159.66 18.99 Favored 'Trans proline' 0 N--CA 1.492 1.436 0 C-N-CA 123.08 2.52 . . . . 0.0 113.494 -179.594 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 87' ' ' VAL . . . . . 0.439 ' O ' ' N ' ' A' ' 73' ' ' ALA . 72.5 t -115.45 100.61 10.88 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.69 0 O-C-N 121.659 -0.651 . . . . 0.0 109.808 -179.842 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 88' ' ' TYR . . . . . 0.621 ' CE1' HG12 ' A' ' 72' ' ' VAL . 20.2 m-85 -92.42 154.14 42.74 Favored Pre-proline 0 N--CA 1.498 1.95 0 O-C-N 120.879 -1.138 . . . . 0.0 109.483 179.717 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 89' ' ' PRO . . . . . 0.425 ' HA ' ' CD2' ' A' ' 103' ' ' PHE . 9.7 Cg_endo -61.98 146.15 96.43 Favored 'Trans proline' 0 C--N 1.307 -1.65 0 C-N-CA 122.373 2.049 . . . . 0.0 113.504 -179.907 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . -55.15 165.97 3.15 Favored Glycine 0 N--CA 1.494 2.509 0 N-CA-C 108.826 -1.709 . . . . 0.0 108.826 179.008 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 91' ' ' PRO . . . . . 0.447 ' C ' ' H ' ' A' ' 93' ' ' THR . 65.6 Cg_endo -94.83 168.07 17.8 Favored 'Cis proline' 0 C--N 1.307 -1.627 0 C-N-CA 124.08 -1.216 . . . . 0.0 112.205 0.269 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 92' ' ' ALA . . . . . 0.599 ' O ' HD13 ' A' ' 97' ' ' LEU . . . -70.71 28.25 0.04 OUTLIER 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.411 -0.806 . . . . 0.0 110.793 -179.626 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 93' ' ' THR . . . . . 0.447 ' H ' ' C ' ' A' ' 91' ' ' PRO . 1.7 p -73.56 152.66 89.65 Favored Pre-proline 0 N--CA 1.491 1.596 0 O-C-N 120.716 -1.24 . . . . 0.0 109.246 -179.743 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 94' ' ' PRO . . . . . . . . . . . . . 88.9 Cg_exo -36.19 -42.07 0.59 Allowed 'Trans proline' 0 C--N 1.31 -1.497 0 C-N-CA 122.821 2.347 . . . . 0.0 112.335 -179.283 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 95' ' ' GLU . . . . . 0.637 ' CD ' ' H ' ' A' ' 95' ' ' GLU . 0.1 OUTLIER -53.18 -53.98 42.61 Favored 'General case' 0 C--N 1.301 -1.507 0 O-C-N 121.254 -0.904 . . . . 0.0 109.302 179.756 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 96' ' ' GLN . . . . . 0.592 ' O ' ' N ' ' A' ' 98' ' ' ASN . 29.7 mm100 -73.64 -51.87 15.3 Favored 'General case' 0 N--CA 1.487 1.389 0 O-C-N 121.155 -0.966 . . . . 0.0 109.77 179.593 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 97' ' ' LEU . . . . . 0.599 HD13 ' O ' ' A' ' 92' ' ' ALA . 1.4 mp -46.25 -11.06 0.02 OUTLIER 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.416 -0.802 . . . . 0.0 109.741 -179.336 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 98' ' ' ASN . . . . . 0.681 HD21 ' HE ' ' A' ' 99' ' ' ARG . 0.0 OUTLIER -75.28 -23.42 57.4 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.197 -0.939 . . . . 0.0 110.005 -179.815 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 99' ' ' ARG . . . . . 0.681 ' HE ' HD21 ' A' ' 98' ' ' ASN . 7.7 mtt180 -103.19 -54.01 2.7 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.435 -0.79 . . . . 0.0 110.28 -178.88 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . -169.98 179.15 42.46 Favored Glycine 0 N--CA 1.492 2.41 0 C-N-CA 119.273 -1.442 . . . . 0.0 110.298 -179.834 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 101' ' ' VAL . . . . . 0.806 HG11 ' CE2' ' A' ' 130' ' ' PHE . 31.7 m -53.06 111.75 0.29 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.601 0 O-C-N 121.556 -0.967 . . . . 0.0 109.222 179.787 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -92.29 168.0 11.63 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.315 -0.866 . . . . 0.0 111.288 -179.155 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 103' ' ' PHE . . . . . 0.602 ' O ' ' N ' ' A' ' 105' ' ' GLU . 25.0 m-85 -69.64 120.79 15.95 Favored 'General case' 0 N--CA 1.488 1.439 0 N-CA-C 108.031 -1.1 . . . . 0.0 108.031 178.263 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 104' ' ' ALA . . . . . 0.572 ' HB1' ' HG3' ' C' ' 703' ' ' PRO . . . -41.09 -16.2 0.01 OUTLIER 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.686 -0.634 . . . . 0.0 111.066 -178.515 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 105' ' ' GLU . . . . . 0.602 ' N ' ' O ' ' A' ' 103' ' ' PHE . 0.4 OUTLIER -139.3 147.58 41.82 Favored 'General case' 0 N--CA 1.494 1.729 0 O-C-N 120.861 -1.149 . . . . 0.0 110.56 179.852 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 106' ' ' GLU . . . . . . . . . . . . . 16.2 tt0 -58.09 -63.9 1.1 Allowed 'General case' 0 C--N 1.302 -1.487 0 CA-C-N 116.113 -0.494 . . . . 0.0 110.863 -179.178 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 107' ' ' ASN . . . . . . . . . . . . . 11.1 m120 -78.02 33.29 0.18 Allowed 'General case' 0 N--CA 1.491 1.621 0 O-C-N 120.501 -1.374 . . . . 0.0 113.342 -175.318 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 108' ' ' GLU . . . . . 0.48 ' OE1' ' OE2' ' A' ' 105' ' ' GLU . 26.9 tp10 -59.73 150.5 27.69 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 120.426 -1.421 . . . . 0.0 107.856 179.681 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 109' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -101.19 144.21 30.34 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 120.986 -1.072 . . . . 0.0 111.099 -178.169 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 110' ' ' LEU . . . . . 0.55 ' H ' HD23 ' A' ' 110' ' ' LEU . 0.4 OUTLIER -62.63 -22.86 66.74 Favored 'General case' 0 C--N 1.303 -1.433 0 N-CA-C 108.684 -0.858 . . . . 0.0 108.684 179.214 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 111' ' ' ASP . . . . . . . . . . . . . 64.0 m-20 -132.04 40.36 3.35 Favored 'General case' 0 N--CA 1.487 1.376 0 O-C-N 121.642 -0.662 . . . . 0.0 109.426 -179.687 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 112' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -68.53 152.42 45.41 Favored 'General case' 0 C--N 1.299 -1.591 0 O-C-N 121.266 -0.896 . . . . 0.0 110.439 179.906 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 113' ' ' GLN . . . . . 0.449 ' HA ' ' NE2' ' A' ' 113' ' ' GLN . 1.0 OUTLIER -66.21 -13.78 60.86 Favored 'General case' 0 C--N 1.301 -1.525 0 N-CA-C 108.104 -1.073 . . . . 0.0 108.104 178.153 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 114' ' ' ASN . . . . . 0.492 ' OD1' ' O ' ' A' ' 169' ' ' LEU . 1.3 t-20 -151.58 102.27 2.86 Favored 'General case' 0 N--CA 1.489 1.515 0 N-CA-C 108.171 -1.048 . . . . 0.0 108.171 179.126 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 115' ' ' ILE . . . . . 0.45 ' O ' HG22 ' A' ' 115' ' ' ILE . 3.1 mt -98.75 112.67 31.45 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.511 0 O-C-N 121.199 -0.938 . . . . 0.0 109.435 -179.772 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 116' ' ' SER . . . . . . . . . . . . . 44.1 m -98.56 143.91 28.45 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.316 -0.865 . . . . 0.0 111.338 -178.569 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 117' ' ' ILE . . . . . . . . . . . . . 1.6 mt -135.87 155.94 36.62 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.625 0 N-CA-C 108.111 -1.07 . . . . 0.0 108.111 178.764 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 118' ' ' ALA . . . . . 0.691 ' HB1' ' HB2' ' C' ' 704' ' ' ALA . . . -142.03 159.83 41.45 Favored 'General case' 0 N--CA 1.493 1.687 0 O-C-N 120.838 -1.163 . . . . 0.0 111.609 -178.967 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 119' ' ' GLY . . . . . . . . . . . . . . . -167.46 146.51 10.75 Favored Glycine 0 N--CA 1.49 2.235 0 C-N-CA 120.206 -0.997 . . . . 0.0 110.774 179.594 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 120' ' ' HIS . . . . . 0.551 ' CD2' ' SG ' ' C' ' 705' ' ' B27 . 27.7 m170 -70.96 167.7 18.56 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.638 -0.919 . . . . 0.0 109.251 178.964 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 121' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -122.62 157.26 32.57 Favored 'General case' 0 N--CA 1.495 1.788 0 N-CA-C 108.552 -0.907 . . . . 0.0 108.552 179.105 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 122' ' ' PHE . . . . . 0.568 ' O ' HG21 ' A' ' 131' ' ' THR . 0.2 OUTLIER -122.03 124.25 43.53 Favored 'General case' 0 N--CA 1.495 1.798 0 O-C-N 121.205 -0.935 . . . . 0.0 109.923 -179.754 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 123' ' ' ILE . . . . . 0.513 HG23 ' N ' ' A' ' 124' ' ' ASP . 11.4 tt -72.96 -35.18 48.15 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.713 0 CA-C-O 121.69 0.757 . . . . 0.0 109.718 -179.923 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 124' ' ' ASP . . . . . 0.513 ' N ' HG23 ' A' ' 123' ' ' ILE . 52.0 m-20 -90.6 8.29 34.91 Favored 'General case' 0 C--N 1.294 -1.814 0 C-N-CA 120.154 -0.618 . . . . 0.0 111.501 -178.928 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 125' ' ' ARG . . . . . . . . . . . . . 6.4 mtp180 -152.6 113.52 2.79 Favored Pre-proline 0 N--CA 1.495 1.823 0 O-C-N 120.474 -1.391 . . . . 0.0 110.531 -179.64 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 126' ' ' PRO . . . . . . . . . . . . . 78.8 Cg_endo -82.61 -16.9 7.65 Favored 'Trans proline' 0 N--CA 1.488 1.199 0 C-N-CA 122.436 2.091 . . . . 0.0 112.303 178.965 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 127' ' ' ASN . . . . . . . . . . . . . 83.8 m-20 -89.76 6.83 39.87 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.098 -1.001 . . . . 0.0 109.675 -179.885 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 128' ' ' TYR . . . . . . . . . . . . . 7.0 t80 -62.36 -148.86 0.0 OUTLIER 'General case' 0 N--CA 1.489 1.477 0 O-C-N 121.258 -0.901 . . . . 0.0 109.686 -179.975 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 129' ' ' GLN . . . . . 0.436 ' O ' ' OE2' ' A' ' 85' ' ' GLU . 17.6 mt-30 -67.88 -88.47 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.303 -0.873 . . . . 0.0 110.355 -179.149 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 130' ' ' PHE . . . . . 0.806 ' CE2' HG11 ' A' ' 101' ' ' VAL . 30.4 m-85 -110.88 37.26 2.85 Favored 'General case' 0 N--CA 1.494 1.77 0 O-C-N 121.326 -0.859 . . . . 0.0 110.303 -179.054 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 131' ' ' THR . . . . . 0.568 HG21 ' O ' ' A' ' 122' ' ' PHE . 37.0 m -77.08 -31.69 56.2 Favored 'General case' 0 N--CA 1.489 1.486 0 O-C-N 121.045 -1.034 . . . . 0.0 109.464 179.701 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 132' ' ' ASN . . . . . 0.51 ' ND2' ' O ' ' A' ' 81' ' ' ALA . 3.9 t30 -83.78 7.01 19.18 Favored 'General case' 0 N--CA 1.498 1.968 0 O-C-N 121.387 -0.821 . . . . 0.0 111.033 -179.223 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 133' ' ' LEU . . . . . 0.609 HD13 ' O ' ' A' ' 133' ' ' LEU . 0.2 OUTLIER -70.21 -45.25 66.97 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 120.971 -1.081 . . . . 0.0 110.218 -179.274 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 134' ' ' LYS . . . . . 0.551 ' CD ' ' H ' ' A' ' 134' ' ' LYS . 0.2 OUTLIER -41.49 -18.98 0.01 OUTLIER 'General case' 0 N--CA 1.496 1.83 0 O-C-N 121.053 -1.029 . . . . 0.0 110.227 -179.212 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 135' ' ' ALA . . . . . 0.597 ' N ' ' O ' ' A' ' 133' ' ' LEU . . . -85.21 -31.49 23.15 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.082 -1.011 . . . . 0.0 110.038 179.854 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 136' ' ' ALA . . . . . 0.91 ' HB2' ' HB2' ' A' ' 81' ' ' ALA . . . -80.46 152.56 28.7 Favored 'General case' 0 N--CA 1.491 1.613 0 CA-C-O 122.055 0.931 . . . . 0.0 111.758 -178.437 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 137' ' ' LYS . . . . . 0.496 ' O ' ' O ' ' A' ' 138' ' ' LYS . 24.4 mtmt -151.63 -166.03 2.4 Favored 'General case' 0 N--CA 1.493 1.695 0 C-N-CA 118.597 -1.241 . . . . 0.0 111.004 -178.247 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 138' ' ' LYS . . . . . 0.598 ' O ' ' N ' ' A' ' 140' ' ' SER . 1.1 ptpt -45.21 178.71 0.0 OUTLIER 'General case' 0 C--N 1.305 -1.359 0 CA-C-O 122.127 0.965 . . . . 0.0 110.73 -179.074 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 139' ' ' GLY . . . . . . . . . . . . . . . 46.22 8.1 0.02 OUTLIER Glycine 0 N--CA 1.489 2.199 0 N-CA-C 110.407 -1.077 . . . . 0.0 110.407 179.98 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 140' ' ' SER . . . . . 0.598 ' N ' ' O ' ' A' ' 138' ' ' LYS . 13.3 t -80.55 146.21 31.4 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 120.845 -1.385 . . . . 0.0 109.514 179.366 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 141' ' ' MET . . . . . . . . . . . . . 4.6 tpt -93.46 121.16 34.57 Favored 'General case' 0 C--N 1.3 -1.561 0 O-C-N 121.343 -0.848 . . . . 0.0 108.849 179.409 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 142' ' ' VAL . . . . . . . . . . . . . 12.8 t -112.13 130.03 66.55 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.626 0 O-C-N 121.34 -0.85 . . . . 0.0 109.016 -179.396 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 143' ' ' TYR . . . . . . . . . . . . . 3.5 m-85 -109.16 135.55 50.1 Favored 'General case' 0 N--CA 1.499 1.976 0 O-C-N 121.141 -0.974 . . . . 0.0 111.859 -178.252 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 144' ' ' PHE . . . . . . . . . . . . . 57.8 t80 -120.61 102.06 8.17 Favored 'General case' 0 N--CA 1.494 1.744 0 CA-C-O 121.302 0.572 . . . . 0.0 110.272 -179.407 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 145' ' ' LYS . . . . . . . . . . . . . 23.1 tttt -93.8 122.4 36.23 Favored 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.331 -0.856 . . . . 0.0 109.602 179.799 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 146' ' ' VAL . . . . . 0.598 ' O ' HG13 ' A' ' 146' ' ' VAL . 7.1 p -142.39 118.47 5.91 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.671 0 O-C-N 121.185 -0.947 . . . . 0.0 109.18 179.752 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 147' ' ' GLY . . . . . . . . . . . . . . . 75.61 -135.8 18.85 Favored Glycine 0 N--CA 1.488 2.132 0 N-CA-C 108.386 -1.885 . . . . 0.0 108.386 -179.094 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 148' ' ' ASN . . . . . 0.585 HD22 ' C ' ' A' ' 148' ' ' ASN . 0.3 OUTLIER -103.47 14.27 31.7 Favored 'General case' 0 C--N 1.298 -1.659 0 N-CA-C 107.907 -1.146 . . . . 0.0 107.907 178.813 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 149' ' ' GLU . . . . . . . . . . . . . 47.9 tt0 -116.26 153.23 32.27 Favored 'General case' 0 N--CA 1.486 1.361 0 CA-C-O 121.987 0.898 . . . . 0.0 110.639 -179.466 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 150' ' ' THR . . . . . . . . . . . . . 86.5 m -130.44 107.29 9.12 Favored 'General case' 0 N--CA 1.494 1.747 0 CA-C-O 121.336 0.589 . . . . 0.0 109.938 -179.701 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 151' ' ' ARG . . . . . 0.459 ' CG ' HH11 ' A' ' 151' ' ' ARG . 0.4 OUTLIER -87.28 -171.03 3.29 Favored 'General case' 0 N--CA 1.487 1.38 0 N-CA-C 108.641 -0.874 . . . . 0.0 108.641 179.826 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 152' ' ' LYS . . . . . 0.497 ' O ' ' N ' ' A' ' 205' ' ' VAL . 20.4 mtpt -148.21 149.04 31.22 Favored 'General case' 0 C--N 1.299 -1.605 0 O-C-N 121.153 -0.967 . . . . 0.0 109.841 -179.694 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 153' ' ' TYR . . . . . 0.513 ' CD2' ' HA ' ' A' ' 204' ' ' GLU . 23.2 m-85 -139.98 164.57 29.65 Favored 'General case' 0 C--N 1.302 -1.481 0 N-CA-C 108.107 -1.072 . . . . 0.0 108.107 179.86 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 154' ' ' LYS . . . . . . . . . . . . . 26.2 ttpt -142.44 119.27 11.19 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.143 -0.973 . . . . 0.0 109.006 179.517 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 155' ' ' MET . . . . . . . . . . . . . 19.5 mmt -46.01 105.96 0.07 Allowed 'General case' 0 N--CA 1.494 1.737 0 O-C-N 120.846 -1.159 . . . . 0.0 112.198 -178.63 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 156' ' ' THR . . . . . . . . . . . . . 4.4 m -108.6 -22.47 12.25 Favored 'General case' 0 C--N 1.297 -1.71 0 C-N-CA 119.897 -0.721 . . . . 0.0 109.666 179.709 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 157' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -144.56 141.02 29.17 Favored 'General case' 0 N--CA 1.492 1.642 0 C-N-CA 118.781 -1.167 . . . . 0.0 109.835 -178.742 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 158' ' ' ILE . . . . . . . . . . . . . 37.2 mt -148.02 134.25 12.42 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.372 0 CA-C-O 121.602 0.715 . . . . 0.0 109.82 -178.147 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 159' ' ' ARG . . . . . . . . . . . . . 3.9 ptm180 -154.63 -175.68 5.53 Favored 'General case' 0 C--N 1.297 -1.711 0 C-N-CA 119.486 -0.886 . . . . 0.0 110.536 -179.763 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 160' ' ' ASP . . . . . 0.584 ' C ' HG22 ' A' ' 161' ' ' VAL . 5.3 m-20 -146.48 165.1 30.42 Favored 'General case' 0 N--CA 1.488 1.452 0 N-CA-C 108.336 -0.987 . . . . 0.0 108.336 179.979 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 161' ' ' VAL . . . . . 0.584 HG22 ' C ' ' A' ' 160' ' ' ASP . 0.1 OUTLIER -170.1 163.28 0.45 Allowed 'Isoleucine or valine' 0 N--CA 1.494 1.768 0 O-C-N 120.909 -1.12 . . . . 0.0 110.281 179.842 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 162' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -49.47 171.23 0.12 Allowed Pre-proline 0 N--CA 1.488 1.473 0 O-C-N 121.599 -0.688 . . . . 0.0 109.39 179.271 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 163' ' ' PRO . . . . . 0.666 ' C ' HD11 ' C' ' 702' ' ' LEU . 60.5 Cg_endo -79.21 38.65 0.74 Allowed 'Trans proline' 0 C--N 1.307 -1.618 0 C-N-CA 122.615 2.21 . . . . 0.0 112.49 -179.909 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 164' ' ' THR . . . . . 0.465 ' O ' HG22 ' A' ' 164' ' ' THR . 86.0 m -151.88 -8.82 0.21 Allowed 'General case' 0 N--CA 1.494 1.762 0 O-C-N 121.126 -0.984 . . . . 0.0 110.925 -179.732 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 165' ' ' ASP . . . . . 0.437 ' O ' ' C ' ' A' ' 166' ' ' VAL . 17.8 t70 -72.85 61.86 0.57 Allowed 'General case' 0 N--CA 1.494 1.755 0 O-C-N 120.764 -1.21 . . . . 0.0 110.235 -179.351 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 166' ' ' VAL . . . . . 0.61 ' O ' ' N ' ' A' ' 168' ' ' VAL . 1.5 m -39.91 -33.06 0.23 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.65 0 O-C-N 121.408 -0.808 . . . . 0.0 109.692 -178.587 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 167' ' ' GLY . . . . . 0.404 ' C ' ' O ' ' A' ' 166' ' ' VAL . . . -43.07 -13.84 0.01 OUTLIER Glycine 0 N--CA 1.495 2.579 0 O-C-N 120.918 -1.114 . . . . 0.0 110.823 -179.802 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 168' ' ' VAL . . . . . 0.641 ' C ' ' H ' ' A' ' 170' ' ' ASP . 4.8 m -53.34 -36.27 26.25 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.583 0 O-C-N 120.768 -1.43 . . . . 0.0 108.726 179.709 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 169' ' ' LEU . . . . . 0.544 ' O ' ' N ' ' A' ' 171' ' ' GLU . 34.4 mt -51.08 -4.6 0.02 OUTLIER 'General case' 0 N--CA 1.494 1.772 0 N-CA-C 108.117 -1.068 . . . . 0.0 108.117 -179.602 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 170' ' ' ASP . . . . . 0.641 ' H ' ' C ' ' A' ' 168' ' ' VAL . 4.1 m-20 33.41 28.92 0.0 OUTLIER 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.685 -0.634 . . . . 0.0 112.228 177.185 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 171' ' ' GLU . . . . . 0.544 ' N ' ' O ' ' A' ' 169' ' ' LEU . 11.2 pt-20 -67.31 94.46 0.38 Allowed 'General case' 0 N--CA 1.491 1.589 0 O-C-N 120.598 -1.314 . . . . 0.0 107.703 178.376 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 172' ' ' GLN . . . . . . . . . . . . . 0.7 OUTLIER -159.04 -72.75 0.08 Allowed 'General case' 0 N--CA 1.493 1.716 0 O-C-N 121.637 -0.665 . . . . 0.0 109.538 -179.449 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 173' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -62.15 127.07 29.62 Favored 'General case' 0 N--CA 1.492 1.668 0 O-C-N 121.265 -0.897 . . . . 0.0 109.195 179.627 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 174' ' ' GLY . . . . . 0.564 ' O ' ' C ' ' A' ' 175' ' ' LYS . . . -118.24 -39.06 0.76 Allowed Glycine 0 N--CA 1.482 1.733 0 N-CA-C 108.623 -1.791 . . . . 0.0 108.623 179.368 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 175' ' ' LYS . . . . . 0.564 ' C ' ' O ' ' A' ' 174' ' ' GLY . 0.0 OUTLIER -32.54 -62.97 0.22 Allowed 'General case' 0 N--CA 1.498 1.952 0 N-CA-C 108.492 -0.929 . . . . 0.0 108.492 179.822 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 176' ' ' ASP . . . . . 0.66 ' O ' ' O ' ' A' ' 177' ' ' LYS . 5.5 m-20 -103.09 87.01 2.8 Favored 'General case' 0 C--N 1.297 -1.712 0 N-CA-C 106.759 -1.571 . . . . 0.0 106.759 176.914 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 177' ' ' LYS . . . . . 0.66 ' O ' ' O ' ' A' ' 176' ' ' ASP . 12.9 mttt -37.28 176.04 0.0 OUTLIER 'General case' 0 N--CA 1.498 1.942 0 CA-C-O 121.762 0.791 . . . . 0.0 110.541 -178.703 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 178' ' ' GLN . . . . . 0.462 HE22 ' CB ' ' A' ' 170' ' ' ASP . 17.0 pt20 -159.59 171.07 20.3 Favored 'General case' 0 C--N 1.302 -1.459 0 C-N-CA 118.075 -1.45 . . . . 0.0 111.582 -179.867 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 179' ' ' LEU . . . . . . . . . . . . . 1.2 tp -127.02 95.17 4.23 Favored 'General case' 0 C--N 1.303 -1.443 0 N-CA-C 107.412 -1.329 . . . . 0.0 107.412 178.127 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 180' ' ' THR . . . . . . . . . . . . . 1.3 m -71.7 121.26 18.54 Favored 'General case' 0 N--CA 1.489 1.502 0 C-N-CA 119.217 -0.993 . . . . 0.0 110.213 -178.571 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 181' ' ' LEU . . . . . 0.419 HD11 ' CE2' ' A' ' 130' ' ' PHE . 49.7 tp -96.24 147.72 23.48 Favored 'General case' 0 C--N 1.297 -1.693 0 N-CA-C 108.342 -0.984 . . . . 0.0 108.342 178.308 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 182' ' ' ILE . . . . . 0.46 ' O ' HG22 ' A' ' 182' ' ' ILE . 2.0 mt -138.73 115.09 10.19 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.578 0 N-CA-C 108.245 -1.02 . . . . 0.0 108.245 178.732 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 183' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -137.02 112.56 9.35 Favored 'General case' 0 C--N 1.293 -1.889 0 N-CA-C 107.265 -1.383 . . . . 0.0 107.265 179.364 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 184' ' ' CYS . . . . . 0.491 ' HB3' HH12 ' A' ' 197' ' ' ARG . 0.8 OUTLIER -78.69 163.71 25.2 Favored 'General case' 0 C--N 1.292 -1.918 0 C-N-CA 119.514 -0.874 . . . . 0.0 111.653 -177.14 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 185' ' ' ASP . . . . . . . . . . . . . 18.9 t0 -166.36 -159.4 0.37 Allowed 'General case' 0 N--CA 1.489 1.509 0 N-CA-C 109.205 -0.665 . . . . 0.0 109.205 -179.944 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 186' ' ' ASP . . . . . . . . . . . . . 1.3 m-20 53.84 59.62 4.17 Favored 'General case' 0 N--CA 1.493 1.724 0 O-C-N 121.121 -0.987 . . . . 0.0 109.546 179.933 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 187' ' ' TYR . . . . . 0.608 ' CE1' ' O ' ' A' ' 188' ' ' ASN . 57.0 t80 -67.67 137.77 55.81 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.319 -0.863 . . . . 0.0 110.398 -179.708 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 188' ' ' ASN . . . . . 0.608 ' O ' ' CE1' ' A' ' 187' ' ' TYR . 0.8 OUTLIER -104.41 145.02 30.86 Favored 'General case' 0 C--N 1.298 -1.672 0 N-CA-C 108.255 -1.017 . . . . 0.0 108.255 178.617 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 189' ' ' GLU . . . . . . . . . . . . . 1.4 tt0 -110.57 -13.17 14.27 Favored 'General case' 0 C--N 1.296 -1.744 0 N-CA-C 108.818 -0.808 . . . . 0.0 108.818 -179.36 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 190' ' ' LYS . . . . . . . . . . . . . 29.1 mttt -82.8 -53.66 5.72 Favored 'General case' 0 C--N 1.302 -1.496 0 N-CA-C 108.714 -0.847 . . . . 0.0 108.714 178.873 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 191' ' ' THR . . . . . . . . . . . . . 1.1 p -90.09 -10.76 43.53 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.517 -0.739 . . . . 0.0 109.194 179.714 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 192' ' ' GLY . . . . . . . . . . . . . . . 65.77 40.75 95.83 Favored Glycine 0 N--CA 1.495 2.59 0 N-CA-C 110.637 -0.985 . . . . 0.0 110.637 178.914 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 193' ' ' VAL . . . . . 0.541 HG12 ' N ' ' A' ' 194' ' ' TRP . 64.8 t -147.63 161.61 7.55 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.641 0 O-C-N 121.023 -1.281 . . . . 0.0 109.565 179.487 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 194' ' ' TRP . . . . . 0.541 ' N ' HG12 ' A' ' 193' ' ' VAL . 19.4 m95 -83.71 118.42 23.87 Favored 'General case' 0 C--N 1.301 -1.537 0 N-CA-C 107.901 -1.148 . . . . 0.0 107.901 179.082 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 195' ' ' GLU . . . . . 0.551 ' CD ' ' ND2' ' A' ' 188' ' ' ASN . 2.3 mt-10 -85.17 -60.86 1.91 Allowed 'General case' 0 N--CA 1.492 1.665 0 O-C-N 121.241 -0.912 . . . . 0.0 111.112 -177.941 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 196' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER -78.63 149.18 32.96 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 120.935 -1.103 . . . . 0.0 109.731 -179.315 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 197' ' ' ARG . . . . . 0.669 ' NE ' HD13 ' C' ' 702' ' ' LEU . 0.0 OUTLIER -128.06 136.92 51.88 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.492 -0.755 . . . . 0.0 109.129 179.84 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 198' ' ' LYS . . . . . . . . . . . . . 2.3 mtmm -115.03 121.87 44.45 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.756 -0.59 . . . . 0.0 110.676 -178.623 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 199' ' ' ILE . . . . . 0.563 ' C ' HD12 ' A' ' 199' ' ' ILE . 0.9 OUTLIER -139.57 117.89 11.79 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.586 0 CA-C-O 122.477 1.132 . . . . 0.0 109.842 179.419 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 200' ' ' PHE . . . . . 0.551 ' CZ ' HD12 ' A' ' 133' ' ' LEU . 5.0 m-85 -98.88 136.11 39.35 Favored 'General case' 0 N--CA 1.498 1.948 0 O-C-N 121.322 -0.861 . . . . 0.0 110.262 -177.914 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 201' ' ' VAL . . . . . . . . . . . . . 24.2 t -105.12 141.33 20.72 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.76 0 O-C-N 121.032 -1.043 . . . . 0.0 108.777 178.13 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 202' ' ' ALA . . . . . . . . . . . . . . . -131.17 137.44 48.99 Favored 'General case' 0 C--N 1.3 -1.545 0 N-CA-C 108.429 -0.952 . . . . 0.0 108.429 179.874 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 203' ' ' THR . . . . . 0.615 ' O ' HG23 ' A' ' 205' ' ' VAL . 2.5 t -88.41 136.06 33.17 Favored 'General case' 0 N--CA 1.489 1.515 0 CA-C-O 122.116 0.96 . . . . 0.0 110.568 -179.177 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 204' ' ' GLU . . . . . 0.513 ' HA ' ' CD2' ' A' ' 153' ' ' TYR . 0.8 OUTLIER -53.66 136.22 39.56 Favored 'General case' 0 C--N 1.295 -1.799 0 C-N-CA 118.133 -1.427 . . . . 0.0 108.706 179.014 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 205' ' ' VAL . . . . . 0.615 HG23 ' O ' ' A' ' 203' ' ' THR . 77.7 t -129.99 166.41 27.66 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.34 0 CA-C-O 121.97 0.89 . . . . 0.0 110.063 -177.893 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 206' ' ' LYS . . . . . 0.611 ' N ' HG12 ' A' ' 205' ' ' VAL . 9.1 ptmt . . . . . 0 C--N 1.296 -1.752 0 CA-C-O 118.034 -0.984 . . . . 0.0 109.429 -179.836 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' C' C ' 701' ' ' PHQ . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 005 nuclear nobuild full ' C' C ' 702' ' ' LEU . . . . . 0.669 HD13 ' NE ' ' A' ' 197' ' ' ARG . 0.1 OUTLIER . . . . . 0 N--CA 1.49 1.56 0 N-CA-C 108.757 -0.831 . . . . 0.0 108.757 . . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' C' C ' 703' ' ' PRO . . . . . 0.577 ' HB2' ' HB3' ' A' ' 92' ' ' ALA . 29.4 Cg_endo -66.39 -162.92 0.06 OUTLIER 'Trans proline' 0 N--CA 1.495 1.581 0 C-N-CA 122.59 2.194 . . . . 0.0 112.783 -179.224 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' C' C ' 704' ' ' ALA . . . . . 0.691 ' HB2' ' HB1' ' A' ' 118' ' ' ALA . . . 60.25 161.04 0.05 OUTLIER 'General case' 0 N--CA 1.488 1.456 0 O-C-N 121.476 -0.765 . . . . 0.0 109.356 -179.865 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' C' C ' 705' ' ' B27 . . . . . 0.551 ' SG ' ' CD2' ' A' ' 120' ' ' HIS . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 700' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 006 nuclear nobuild full ' A' A ' 59' ' ' MET . . . . . 0.547 ' N ' ' SD ' ' A' ' 59' ' ' MET . 1.9 mpt? . . . . . 0 N--CA 1.49 1.558 0 N-CA-C 109.444 -0.576 . . . . 0.0 109.444 . . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 60' ' ' GLN . . . . . . . . . . . . . 1.9 tp60 -60.37 148.34 37.5 Favored 'General case' 0 N--CA 1.488 1.452 0 O-C-N 121.227 -0.92 . . . . 0.0 109.265 -179.978 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 61' ' ' ALA . . . . . 0.468 ' HB2' ' OD1' ' A' ' 148' ' ' ASN . . . -64.15 179.06 0.59 Allowed 'General case' 0 N--CA 1.488 1.457 0 O-C-N 121.238 -0.913 . . . . 0.0 109.679 -179.907 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 62' ' ' LYS . . . . . . . . . . . . . 2.7 pttm -150.64 83.14 5.92 Favored Pre-proline 0 N--CA 1.489 1.522 0 O-C-N 121.339 -0.851 . . . . 0.0 109.757 -179.843 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 63' ' ' PRO . . . . . . . . . . . . . 9.9 Cg_endo -80.0 144.18 16.71 Favored 'Trans proline' 0 C--N 1.304 -1.802 0 C-N-CA 122.556 2.171 . . . . 0.0 111.15 179.501 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 64' ' ' GLN . . . . . 0.702 HE21 ' C ' ' A' ' 64' ' ' GLN . 0.0 OUTLIER -154.85 118.58 4.58 Favored 'General case' 0 N--CA 1.494 1.728 0 O-C-N 121.231 -0.918 . . . . 0.0 109.553 179.857 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 65' ' ' ILE . . . . . 0.501 HD12 ' H ' ' A' ' 65' ' ' ILE . 3.1 mp -46.58 106.4 0.57 Allowed Pre-proline 0 C--N 1.3 -1.548 0 O-C-N 121.316 -0.865 . . . . 0.0 108.773 179.197 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 66' ' ' PRO . . . . . . . . . . . . . 67.5 Cg_endo -86.51 -157.68 0.08 OUTLIER 'Trans proline' 0 C--N 1.314 -1.285 0 C-N-CA 122.487 2.125 . . . . 0.0 112.401 -179.224 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 67' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -82.88 -4.87 58.65 Favored 'General case' 0 C--N 1.302 -1.473 0 N-CA-C 108.838 -0.801 . . . . 0.0 108.838 179.528 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 68' ' ' ASP . . . . . 0.635 ' C ' ' N ' ' A' ' 70' ' ' SER . 0.3 OUTLIER -74.82 52.45 0.53 Allowed 'General case' 0 N--CA 1.488 1.425 0 CA-C-O 122.726 1.251 . . . . 0.0 108.444 179.492 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 69' ' ' LYS . . . . . 0.445 ' C ' ' O ' ' A' ' 68' ' ' ASP . 21.0 mtmt -49.48 -13.94 0.09 Allowed 'General case' 0 N--CA 1.502 2.173 0 C-N-CA 116.798 -1.961 . . . . 0.0 106.551 177.94 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 70' ' ' SER . . . . . 0.635 ' N ' ' C ' ' A' ' 68' ' ' ASP . 0.1 OUTLIER -85.48 -6.56 59.18 Favored 'General case' 0 N--CA 1.493 1.68 0 CA-C-N 113.508 -1.678 . . . . 0.0 110.601 179.285 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 71' ' ' LYS . . . . . . . . . . . . . 2.0 ptmm? -101.2 144.62 29.84 Favored 'General case' 0 N--CA 1.498 1.942 0 O-C-N 120.863 -1.148 . . . . 0.0 111.888 -179.395 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 72' ' ' VAL . . . . . 0.602 ' CG2' ' O ' ' A' ' 74' ' ' GLY . 0.7 OUTLIER -67.26 132.95 32.16 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.364 0 N-CA-C 105.49 -2.041 . . . . 0.0 105.49 174.363 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -83.77 -13.78 53.07 Favored 'General case' 0 C--N 1.297 -1.71 0 O-C-N 120.026 -1.671 . . . . 0.0 108.618 -179.183 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 74' ' ' GLY . . . . . 0.602 ' O ' ' CG2' ' A' ' 72' ' ' VAL . . . 173.29 -159.63 29.83 Favored Glycine 0 N--CA 1.487 2.086 0 N-CA-C 109.459 -1.456 . . . . 0.0 109.459 -179.805 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 75' ' ' TYR . . . . . . . . . . . . . 81.1 m-85 -140.12 169.9 16.83 Favored 'General case' 0 C--N 1.297 -1.689 0 O-C-N 121.02 -1.282 . . . . 0.0 111.354 -178.334 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 76' ' ' ILE . . . . . . . . . . . . . 1.3 tp -145.9 138.72 20.63 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.605 0 C-N-CA 119.376 -0.93 . . . . 0.0 109.235 -176.165 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -149.46 162.53 39.94 Favored 'General case' 0 C--N 1.302 -1.474 0 O-C-N 120.899 -1.126 . . . . 0.0 109.804 -179.606 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 78' ' ' ILE . . . . . 0.637 ' HB ' ' HB3' ' A' ' 81' ' ' ALA . 4.5 mt -147.74 99.54 3.79 Favored Pre-proline 0 N--CA 1.488 1.455 0 N-CA-C 108.421 -0.955 . . . . 0.0 108.421 179.879 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 79' ' ' PRO . . . . . . . . . . . . . 52.6 Cg_exo -49.81 -45.76 30.64 Favored 'Trans proline' 0 N--CA 1.493 1.483 0 C-N-CA 122.57 2.18 . . . . 0.0 113.464 -178.826 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 7.9 m-20 -66.04 -19.65 65.92 Favored 'General case' 0 N--CA 1.492 1.656 0 O-C-N 120.944 -1.098 . . . . 0.0 110.924 178.81 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 81' ' ' ALA . . . . . 0.772 ' HB2' ' HB2' ' A' ' 136' ' ' ALA . . . -105.01 -16.55 14.78 Favored 'General case' 0 N--CA 1.494 1.754 0 O-C-N 121.093 -1.005 . . . . 0.0 108.46 179.329 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 82' ' ' ASP . . . . . 0.419 ' N ' ' O ' ' A' ' 78' ' ' ILE . 0.6 OUTLIER 66.22 50.58 1.35 Allowed 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.385 -0.822 . . . . 0.0 110.434 179.191 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 83' ' ' ILE . . . . . 0.528 HD11 ' OD1' ' A' ' 132' ' ' ASN . 62.0 mt -129.42 151.97 36.59 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.788 0 O-C-N 121.09 -1.006 . . . . 0.0 110.481 -178.848 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 84' ' ' LYS . . . . . 0.491 ' N ' ' OE2' ' A' ' 85' ' ' GLU . 9.2 tttm -159.15 109.59 1.99 Allowed 'General case' 0 N--CA 1.487 1.38 0 N-CA-C 108.08 -1.081 . . . . 0.0 108.08 179.777 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 85' ' ' GLU . . . . . 0.491 ' OE2' ' N ' ' A' ' 84' ' ' LYS . 0.7 OUTLIER -144.05 171.85 6.26 Favored Pre-proline 0 N--CA 1.495 1.811 0 C-N-CA 119.858 -0.737 . . . . 0.0 109.874 -179.491 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 86' ' ' PRO . . . . . . . . . . . . . 68.7 Cg_endo -91.0 148.95 3.82 Favored 'Trans proline' 0 N--CA 1.488 1.19 0 C-N-CA 123.126 2.551 . . . . 0.0 112.963 -179.751 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 87' ' ' VAL . . . . . 0.428 ' CG2' ' C ' ' A' ' 74' ' ' GLY . 0.0 OUTLIER -104.91 106.03 19.72 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.576 0 N-CA-C 108.619 -0.882 . . . . 0.0 108.619 178.669 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 88' ' ' TYR . . . . . 0.405 ' CE1' ' HB3' ' A' ' 99' ' ' ARG . 13.7 m-85 -87.55 135.0 34.73 Favored Pre-proline 0 N--CA 1.492 1.648 0 O-C-N 120.95 -1.094 . . . . 0.0 110.37 -178.964 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 89' ' ' PRO . . . . . . . . . . . . . 20.2 Cg_exo -34.34 138.15 0.1 OUTLIER 'Trans proline' 0 N--CA 1.49 1.291 0 C-N-CA 123.253 2.635 . . . . 0.0 113.714 179.982 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . -58.87 167.26 7.04 Favored Glycine 0 N--CA 1.491 2.331 0 N-CA-C 109.546 -1.422 . . . . 0.0 109.546 179.679 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 91' ' ' PRO . . . . . 0.482 ' C ' ' H ' ' A' ' 93' ' ' THR . 57.5 Cg_endo -92.46 170.39 21.96 Favored 'Cis proline' 0 C--N 1.307 -1.625 0 C-N-CA 123.659 -1.392 . . . . 0.0 111.94 0.654 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 92' ' ' ALA . . . . . 0.639 ' O ' HD23 ' A' ' 97' ' ' LEU . . . -70.32 29.38 0.04 OUTLIER 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.253 -0.904 . . . . 0.0 110.54 -179.327 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 93' ' ' THR . . . . . 0.482 ' H ' ' C ' ' A' ' 91' ' ' PRO . 0.8 OUTLIER -72.8 154.55 91.13 Favored Pre-proline 0 N--CA 1.492 1.644 0 O-C-N 120.764 -1.21 . . . . 0.0 109.131 -179.678 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 94' ' ' PRO . . . . . 0.451 ' O ' ' C ' ' A' ' 95' ' ' GLU . 80.5 Cg_exo -30.82 -61.79 0.13 Allowed 'Trans proline' 0 C--N 1.308 -1.574 0 C-N-CA 123.058 2.505 . . . . 0.0 112.567 -179.144 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 95' ' ' GLU . . . . . 0.451 ' C ' ' O ' ' A' ' 94' ' ' PRO . 0.3 OUTLIER -41.67 -48.23 4.09 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.288 -0.882 . . . . 0.0 109.258 179.882 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 96' ' ' GLN . . . . . 0.704 HE21 ' NH1' ' A' ' 99' ' ' ARG . 0.4 OUTLIER -73.6 -59.54 2.67 Favored 'General case' 0 N--CA 1.487 1.391 0 O-C-N 121.221 -0.924 . . . . 0.0 109.934 179.591 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 97' ' ' LEU . . . . . 0.639 HD23 ' O ' ' A' ' 92' ' ' ALA . 0.5 OUTLIER -45.07 -13.37 0.02 OUTLIER 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.319 -0.863 . . . . 0.0 109.413 -179.393 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 98' ' ' ASN . . . . . 0.606 ' N ' ' O ' ' A' ' 96' ' ' GLN . 0.0 OUTLIER -73.58 -26.19 60.7 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.329 -0.857 . . . . 0.0 109.841 -179.995 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 99' ' ' ARG . . . . . 0.704 ' NH1' HE21 ' A' ' 96' ' ' GLN . 1.7 mpt_? -95.33 -45.58 7.08 Favored 'General case' 0 N--CA 1.488 1.454 0 O-C-N 121.396 -0.815 . . . . 0.0 110.048 -178.959 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . 169.99 -174.13 44.12 Favored Glycine 0 N--CA 1.494 2.537 0 C-N-CA 119.517 -1.325 . . . . 0.0 110.238 179.737 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 101' ' ' VAL . . . . . 0.737 ' O ' HG23 ' A' ' 101' ' ' VAL . 19.5 m -50.17 106.34 0.06 OUTLIER 'Isoleucine or valine' 0 N--CA 1.493 1.711 0 O-C-N 121.401 -1.058 . . . . 0.0 109.218 179.765 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -92.88 169.68 10.26 Favored 'General case' 0 N--CA 1.494 1.729 0 O-C-N 121.213 -0.93 . . . . 0.0 110.885 -179.306 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 103' ' ' PHE . . . . . 0.553 ' O ' ' N ' ' A' ' 105' ' ' GLU . 23.1 m-85 -69.52 120.83 15.9 Favored 'General case' 0 N--CA 1.487 1.404 0 N-CA-C 107.957 -1.127 . . . . 0.0 107.957 178.192 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 104' ' ' ALA . . . . . 0.597 ' HB1' ' HG3' ' C' ' 703' ' ' PRO . . . -46.85 -9.78 0.02 OUTLIER 'General case' 0 C--N 1.301 -1.529 0 O-C-N 121.335 -0.853 . . . . 0.0 110.852 -178.882 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 105' ' ' GLU . . . . . 0.553 ' N ' ' O ' ' A' ' 103' ' ' PHE . 0.1 OUTLIER -140.28 143.8 36.09 Favored 'General case' 0 N--CA 1.496 1.862 0 O-C-N 120.811 -1.181 . . . . 0.0 110.648 -179.786 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 106' ' ' GLU . . . . . . . . . . . . . 27.6 tt0 -59.42 -64.03 1.09 Allowed 'General case' 0 N--CA 1.489 1.502 0 CA-C-N 116.216 -0.447 . . . . 0.0 111.625 -178.892 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 107' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER -78.66 35.56 0.24 Allowed 'General case' 0 N--CA 1.491 1.604 0 O-C-N 120.661 -1.274 . . . . 0.0 112.672 -175.723 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 108' ' ' GLU . . . . . . . . . . . . . 2.0 tp10 -56.67 149.59 17.48 Favored 'General case' 0 N--CA 1.489 1.513 0 O-C-N 120.323 -1.486 . . . . 0.0 107.741 179.779 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 109' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -100.95 145.0 29.21 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 120.9 -1.125 . . . . 0.0 110.818 -178.261 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 110' ' ' LEU . . . . . 0.495 HD13 ' O ' ' A' ' 110' ' ' LEU . 0.2 OUTLIER -61.03 -24.62 66.32 Favored 'General case' 0 C--N 1.306 -1.317 0 N-CA-C 108.199 -1.037 . . . . 0.0 108.199 179.213 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 111' ' ' ASP . . . . . 0.436 ' OD1' ' C ' ' A' ' 110' ' ' LEU . 2.7 m-20 -132.37 45.1 2.8 Favored 'General case' 0 C--N 1.302 -1.463 0 N-CA-C 109.208 -0.664 . . . . 0.0 109.208 179.63 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 112' ' ' ASP . . . . . . . . . . . . . 1.3 t0 -68.06 155.32 39.8 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.346 -0.846 . . . . 0.0 111.094 -179.638 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 113' ' ' GLN . . . . . 0.623 HE22 ' N ' ' A' ' 172' ' ' GLN . 0.0 OUTLIER -67.06 -17.15 64.77 Favored 'General case' 0 N--CA 1.488 1.456 0 N-CA-C 108.137 -1.06 . . . . 0.0 108.137 177.613 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 114' ' ' ASN . . . . . 0.55 ' OD1' ' NE2' ' A' ' 178' ' ' GLN . 2.3 t30 -151.48 105.35 3.16 Favored 'General case' 0 C--N 1.295 -1.79 0 N-CA-C 107.654 -1.239 . . . . 0.0 107.654 179.528 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 115' ' ' ILE . . . . . 0.538 HG22 ' O ' ' A' ' 115' ' ' ILE . 3.1 mt -93.6 104.44 15.75 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.711 0 O-C-N 120.675 -1.265 . . . . 0.0 107.916 179.95 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 116' ' ' SER . . . . . 0.438 ' OG ' ' ND2' ' A' ' 114' ' ' ASN . 18.5 m -87.3 147.32 25.56 Favored 'General case' 0 C--N 1.304 -1.382 0 CA-C-O 121.861 0.838 . . . . 0.0 110.988 -177.962 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 117' ' ' ILE . . . . . . . . . . . . . 2.5 mt -142.05 151.3 18.64 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.438 0 N-CA-C 107.897 -1.149 . . . . 0.0 107.897 179.449 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 118' ' ' ALA . . . . . 0.401 ' HB1' ' HB2' ' C' ' 704' ' ' ALA . . . -142.81 157.15 44.9 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 120.964 -1.085 . . . . 0.0 111.025 -179.026 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 119' ' ' GLY . . . . . . . . . . . . . . . -163.96 145.01 9.94 Favored Glycine 0 N--CA 1.486 1.997 0 N-CA-C 109.889 -1.285 . . . . 0.0 109.889 179.49 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 120' ' ' HIS . . . . . . . . . . . . . 26.5 m170 -70.49 168.49 16.1 Favored 'General case' 0 N--CA 1.493 1.681 0 O-C-N 121.574 -0.957 . . . . 0.0 109.64 179.357 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 121' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -120.67 149.2 42.86 Favored 'General case' 0 N--CA 1.494 1.735 0 O-C-N 121.234 -0.916 . . . . 0.0 108.728 179.035 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 122' ' ' PHE . . . . . . . . . . . . . 0.5 OUTLIER -112.37 140.13 47.35 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.199 -0.938 . . . . 0.0 109.359 179.805 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 123' ' ' ILE . . . . . 0.577 HG23 ' N ' ' A' ' 124' ' ' ASP . 16.0 tt -88.57 -37.88 10.85 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.793 0 N-CA-C 108.509 -0.923 . . . . 0.0 108.509 179.631 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 124' ' ' ASP . . . . . 0.577 ' N ' HG23 ' A' ' 123' ' ' ILE . 4.9 p-10 -94.37 19.07 10.04 Favored 'General case' 0 C--N 1.296 -1.735 0 C-N-CA 120.121 -0.632 . . . . 0.0 110.633 -179.548 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 125' ' ' ARG . . . . . 0.664 HH11 ' CG ' ' A' ' 125' ' ' ARG . 0.0 OUTLIER -156.35 108.42 2.05 Favored Pre-proline 0 N--CA 1.49 1.55 0 O-C-N 120.628 -1.295 . . . . 0.0 110.348 -179.049 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 126' ' ' PRO . . . . . . . . . . . . . 90.1 Cg_endo -82.55 -22.19 4.75 Favored 'Trans proline' 0 C--N 1.316 -1.181 0 C-N-CA 122.222 1.948 . . . . 0.0 111.953 179.522 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 127' ' ' ASN . . . . . 0.421 ' OD1' ' NH1' ' A' ' 125' ' ' ARG . 1.1 p30 -89.17 29.04 1.11 Allowed 'General case' 0 N--CA 1.489 1.502 0 O-C-N 121.188 -0.945 . . . . 0.0 109.331 179.97 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 128' ' ' TYR . . . . . . . . . . . . . 9.7 t80 -86.12 -149.18 0.13 Allowed 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.269 -0.894 . . . . 0.0 109.922 -179.64 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 129' ' ' GLN . . . . . . . . . . . . . 32.4 mt-30 -67.72 -69.31 0.32 Allowed 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.371 -0.831 . . . . 0.0 110.746 -178.838 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 130' ' ' PHE . . . . . 0.512 ' CE2' HG11 ' A' ' 101' ' ' VAL . 50.0 m-85 -129.83 28.66 5.08 Favored 'General case' 0 N--CA 1.496 1.841 0 O-C-N 121.14 -0.975 . . . . 0.0 110.613 -179.405 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 131' ' ' THR . . . . . . . . . . . . . 94.6 m -67.8 -34.5 76.89 Favored 'General case' 0 N--CA 1.493 1.717 0 O-C-N 120.79 -1.194 . . . . 0.0 108.968 179.37 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 132' ' ' ASN . . . . . 0.602 ' ND2' ' O ' ' A' ' 81' ' ' ALA . 2.4 p-10 -91.11 13.59 16.48 Favored 'General case' 0 N--CA 1.494 1.752 0 C-N-CA 119.608 -0.837 . . . . 0.0 111.285 -179.665 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 133' ' ' LEU . . . . . 0.619 HD13 ' O ' ' A' ' 133' ' ' LEU . 0.2 OUTLIER -71.82 -42.74 66.65 Favored 'General case' 0 N--CA 1.492 1.668 0 O-C-N 120.571 -1.331 . . . . 0.0 110.266 -179.038 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 134' ' ' LYS . . . . . 0.627 ' CD ' ' H ' ' A' ' 134' ' ' LYS . 0.0 OUTLIER -44.44 -12.77 0.02 OUTLIER 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.165 -0.959 . . . . 0.0 110.402 -179.263 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 135' ' ' ALA . . . . . 0.595 ' N ' ' O ' ' A' ' 133' ' ' LEU . . . -82.77 -37.98 23.82 Favored 'General case' 0 N--CA 1.489 1.513 0 O-C-N 120.761 -1.212 . . . . 0.0 109.855 -179.829 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 136' ' ' ALA . . . . . 0.772 ' HB2' ' HB2' ' A' ' 81' ' ' ALA . . . -78.55 153.38 31.28 Favored 'General case' 0 C--N 1.302 -1.496 0 O-C-N 121.352 -0.843 . . . . 0.0 111.111 -178.741 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 137' ' ' LYS . . . . . 0.519 ' O ' ' O ' ' A' ' 138' ' ' LYS . 0.4 OUTLIER -151.38 -163.69 1.82 Allowed 'General case' 0 N--CA 1.492 1.661 0 C-N-CA 118.479 -1.288 . . . . 0.0 110.744 -178.07 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 138' ' ' LYS . . . . . 0.585 ' O ' ' N ' ' A' ' 140' ' ' SER . 0.2 OUTLIER -46.3 -179.29 0.0 OUTLIER 'General case' 0 C--N 1.304 -1.4 0 CA-C-O 122.145 0.974 . . . . 0.0 110.508 -179.043 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 139' ' ' GLY . . . . . . . . . . . . . . . 46.87 7.77 0.02 OUTLIER Glycine 0 N--CA 1.49 2.284 0 N-CA-C 110.354 -1.098 . . . . 0.0 110.354 -179.848 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 140' ' ' SER . . . . . 0.585 ' N ' ' O ' ' A' ' 138' ' ' LYS . 39.2 m -84.56 130.53 34.73 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 120.926 -1.338 . . . . 0.0 109.517 179.412 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 141' ' ' MET . . . . . 0.639 ' SD ' ' N ' ' A' ' 142' ' ' VAL . 8.7 tpp -83.9 127.25 33.71 Favored 'General case' 0 N--CA 1.488 1.446 0 O-C-N 121.074 -1.016 . . . . 0.0 108.978 179.523 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 142' ' ' VAL . . . . . 0.639 ' N ' ' SD ' ' A' ' 141' ' ' MET . 2.4 t -111.25 133.38 57.0 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.512 0 N-CA-C 108.586 -0.894 . . . . 0.0 108.586 -179.744 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 143' ' ' TYR . . . . . . . . . . . . . 8.1 m-85 -111.05 135.29 51.79 Favored 'General case' 0 N--CA 1.495 1.802 0 O-C-N 120.822 -1.174 . . . . 0.0 111.124 -178.511 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 144' ' ' PHE . . . . . . . . . . . . . 10.3 t80 -120.17 104.57 10.19 Favored 'General case' 0 N--CA 1.493 1.7 0 C-N-CA 120.081 -0.648 . . . . 0.0 110.139 -179.748 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 145' ' ' LYS . . . . . . . . . . . . . 14.3 ttmm -99.64 128.12 45.74 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.135 -0.978 . . . . 0.0 110.556 -179.487 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 146' ' ' VAL . . . . . 0.462 HG21 HD11 ' A' ' 110' ' ' LEU . 0.6 OUTLIER -142.7 146.15 22.36 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.568 0 N-CA-C 107.438 -1.319 . . . . 0.0 107.438 178.695 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 147' ' ' GLY . . . . . 0.432 ' C ' ' O ' ' A' ' 146' ' ' VAL . . . 45.8 -131.82 9.93 Favored Glycine 0 N--CA 1.487 2.046 0 N-CA-C 108.465 -1.854 . . . . 0.0 108.465 -179.222 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 148' ' ' ASN . . . . . 0.536 HD22 ' C ' ' A' ' 148' ' ' ASN . 0.4 OUTLIER -104.2 18.07 22.83 Favored 'General case' 0 C--N 1.301 -1.532 0 O-C-N 121.307 -1.113 . . . . 0.0 108.602 179.077 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 149' ' ' GLU . . . . . . . . . . . . . 14.4 tt0 -112.22 147.03 37.08 Favored 'General case' 0 N--CA 1.49 1.557 0 CA-C-O 121.817 0.818 . . . . 0.0 111.328 -178.263 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 150' ' ' THR . . . . . 0.479 HG22 ' O ' ' A' ' 150' ' ' THR . 1.4 m -131.79 103.97 6.63 Favored 'General case' 0 N--CA 1.491 1.586 0 CA-C-O 121.579 0.704 . . . . 0.0 109.832 179.796 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 151' ' ' ARG . . . . . 0.477 ' NH2' ' OH ' ' A' ' 153' ' ' TYR . 21.4 mtm180 -88.2 -170.97 3.18 Favored 'General case' 0 N--CA 1.488 1.439 0 N-CA-C 109.134 -0.691 . . . . 0.0 109.134 -179.877 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 152' ' ' LYS . . . . . 0.405 ' C ' ' CD1' ' A' ' 153' ' ' TYR . 40.4 mtmt -150.86 149.26 29.47 Favored 'General case' 0 N--CA 1.489 1.496 0 O-C-N 120.968 -1.083 . . . . 0.0 110.258 -179.574 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 153' ' ' TYR . . . . . 0.578 ' O ' ' SD ' ' A' ' 141' ' ' MET . 15.9 m-85 -141.18 165.77 26.62 Favored 'General case' 0 N--CA 1.489 1.518 0 N-CA-C 107.715 -1.217 . . . . 0.0 107.715 179.224 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 154' ' ' LYS . . . . . 0.454 ' HB2' HG21 ' A' ' 205' ' ' VAL . 5.3 ttmm -141.32 115.85 9.56 Favored 'General case' 0 C--N 1.297 -1.699 0 O-C-N 120.959 -1.088 . . . . 0.0 108.628 179.29 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 155' ' ' MET . . . . . . . . . . . . . 4.6 mtt -43.65 106.16 0.06 Allowed 'General case' 0 N--CA 1.492 1.649 0 O-C-N 120.741 -1.224 . . . . 0.0 111.548 -178.662 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 156' ' ' THR . . . . . 0.748 ' OG1' HG23 ' A' ' 203' ' ' THR . 0.6 OUTLIER -109.08 -23.18 11.79 Favored 'General case' 0 C--N 1.292 -1.896 0 CA-C-N 115.267 -0.879 . . . . 0.0 109.894 -179.514 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 157' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -153.14 151.45 30.16 Favored 'General case' 0 C--N 1.297 -1.713 0 C-N-CA 118.493 -1.283 . . . . 0.0 111.431 -178.598 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 158' ' ' ILE . . . . . 0.884 HD12 ' CD2' ' A' ' 200' ' ' PHE . 0.2 OUTLIER -152.43 145.13 15.6 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.295 0 CA-C-O 121.708 0.766 . . . . 0.0 110.132 -179.148 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 159' ' ' ARG . . . . . . . . . . . . . 66.2 ttt180 -152.69 149.22 28.18 Favored 'General case' 0 C--N 1.299 -1.614 0 CA-C-O 121.882 0.848 . . . . 0.0 111.089 -178.866 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 160' ' ' ASP . . . . . 0.592 ' C ' HG22 ' A' ' 161' ' ' VAL . 5.9 m-20 -119.1 161.51 20.18 Favored 'General case' 0 N--CA 1.49 1.528 0 N-CA-C 108.567 -0.901 . . . . 0.0 108.567 179.349 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 161' ' ' VAL . . . . . 0.592 HG22 ' C ' ' A' ' 160' ' ' ASP . 0.1 OUTLIER -173.13 164.55 0.26 Allowed 'Isoleucine or valine' 0 N--CA 1.501 2.096 0 O-C-N 121.097 -1.002 . . . . 0.0 109.82 179.463 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 162' ' ' LYS . . . . . 0.515 ' O ' ' O ' ' A' ' 161' ' ' VAL . 0.1 OUTLIER -42.83 168.1 0.06 OUTLIER Pre-proline 0 N--CA 1.491 1.603 0 O-C-N 121.152 -0.968 . . . . 0.0 109.062 179.121 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 163' ' ' PRO . . . . . 0.754 ' O ' HD11 ' C' ' 702' ' ' LEU . 57.4 Cg_endo -74.86 -20.41 17.24 Favored 'Trans proline' 0 C--N 1.306 -1.708 0 C-N-CA 122.697 2.264 . . . . 0.0 112.899 -179.294 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 164' ' ' THR . . . . . 0.416 ' O ' HG13 ' A' ' 166' ' ' VAL . 1.1 p -90.87 -3.1 57.61 Favored 'General case' 0 C--N 1.297 -1.688 0 O-C-N 120.48 -1.387 . . . . 0.0 109.995 -179.644 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 165' ' ' ASP . . . . . . . . . . . . . 11.4 t70 -71.89 58.47 0.34 Allowed 'General case' 0 N--CA 1.491 1.622 0 O-C-N 120.856 -1.153 . . . . 0.0 109.709 -179.543 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 166' ' ' VAL . . . . . 0.551 ' O ' ' N ' ' A' ' 168' ' ' VAL . 1.5 m -44.25 -32.34 0.77 Allowed 'Isoleucine or valine' 0 C--N 1.297 -1.707 0 O-C-N 121.692 -0.63 . . . . 0.0 109.784 -178.339 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 167' ' ' GLY . . . . . . . . . . . . . . . -43.52 -15.4 0.03 OUTLIER Glycine 0 N--CA 1.496 2.688 0 O-C-N 120.83 -1.169 . . . . 0.0 111.356 -179.517 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 168' ' ' VAL . . . . . 0.551 ' N ' ' O ' ' A' ' 166' ' ' VAL . 2.8 m -54.24 -31.52 22.24 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.605 0 O-C-N 120.581 -1.54 . . . . 0.0 109.082 -179.839 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 169' ' ' LEU . . . . . 0.549 ' O ' ' C ' ' A' ' 170' ' ' ASP . 15.8 mt -48.32 -14.93 0.06 Allowed 'General case' 0 N--CA 1.492 1.64 0 N-CA-C 107.748 -1.204 . . . . 0.0 107.748 -178.713 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 170' ' ' ASP . . . . . 0.549 ' C ' ' O ' ' A' ' 169' ' ' LEU . 9.0 m-20 20.62 91.05 0.01 OUTLIER 'General case' 0 N--CA 1.499 2.002 0 CA-C-N 116.583 -0.28 . . . . 0.0 111.701 177.769 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 171' ' ' GLU . . . . . . . . . . . . . 5.9 pt-20 -137.49 77.21 1.62 Allowed 'General case' 0 N--CA 1.495 1.777 0 O-C-N 120.863 -1.148 . . . . 0.0 110.536 179.782 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 172' ' ' GLN . . . . . 0.623 ' N ' HE22 ' A' ' 113' ' ' GLN . 1.9 pt20 -136.87 -42.32 0.59 Allowed 'General case' 0 N--CA 1.495 1.824 0 O-C-N 121.209 -0.932 . . . . 0.0 110.76 -178.988 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 173' ' ' LYS . . . . . . . . . . . . . 5.8 mttp -63.23 129.29 39.65 Favored 'General case' 0 N--CA 1.497 1.892 0 O-C-N 120.688 -1.258 . . . . 0.0 108.854 179.522 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 174' ' ' GLY . . . . . 0.544 ' O ' ' C ' ' A' ' 175' ' ' LYS . . . -118.78 -41.07 0.62 Allowed Glycine 0 N--CA 1.484 1.896 0 N-CA-C 108.605 -1.798 . . . . 0.0 108.605 179.478 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 175' ' ' LYS . . . . . 0.544 ' C ' ' O ' ' A' ' 174' ' ' GLY . 17.9 mmtp -40.8 -61.85 0.89 Allowed 'General case' 0 N--CA 1.491 1.577 0 N-CA-C 106.503 -1.666 . . . . 0.0 106.503 178.48 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 176' ' ' ASP . . . . . 0.583 ' O ' ' O ' ' A' ' 177' ' ' LYS . 7.0 m-20 -105.07 85.64 2.31 Favored 'General case' 0 C--N 1.296 -1.734 0 N-CA-C 107.332 -1.359 . . . . 0.0 107.332 176.405 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 177' ' ' LYS . . . . . 0.583 ' O ' ' O ' ' A' ' 176' ' ' ASP . 0.0 OUTLIER -46.98 -174.41 0.0 OUTLIER 'General case' 0 N--CA 1.501 2.09 0 O-C-N 121.311 -0.868 . . . . 0.0 109.291 -179.233 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 178' ' ' GLN . . . . . 0.55 ' NE2' ' OD1' ' A' ' 114' ' ' ASN . 20.8 pt20 -162.01 175.13 12.12 Favored 'General case' 0 N--CA 1.488 1.456 0 O-C-N 120.328 -1.483 . . . . 0.0 111.374 -179.884 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 179' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -129.8 93.75 3.58 Favored 'General case' 0 N--CA 1.487 1.403 0 N-CA-C 107.197 -1.408 . . . . 0.0 107.197 177.627 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 180' ' ' THR . . . . . 0.5 HG23 HD13 ' A' ' 199' ' ' ILE . 1.8 m -71.28 118.45 14.09 Favored 'General case' 0 N--CA 1.493 1.704 0 O-C-N 121.11 -0.994 . . . . 0.0 110.424 -178.335 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 181' ' ' LEU . . . . . . . . . . . . . 42.4 tp -94.11 150.5 20.27 Favored 'General case' 0 C--N 1.298 -1.648 0 N-CA-C 107.817 -1.179 . . . . 0.0 107.817 177.81 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 182' ' ' ILE . . . . . 0.422 ' O ' HG22 ' A' ' 182' ' ' ILE . 5.3 mt -141.54 112.89 3.55 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.553 0 O-C-N 121.011 -1.055 . . . . 0.0 108.695 178.717 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 183' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -130.58 111.38 12.18 Favored 'General case' 0 C--N 1.291 -1.953 0 N-CA-C 107.078 -1.453 . . . . 0.0 107.078 178.95 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 184' ' ' CYS . . . . . . . . . . . . . 1.8 p -78.82 159.36 27.88 Favored 'General case' 0 C--N 1.29 -1.98 0 C-N-CA 118.843 -1.143 . . . . 0.0 111.46 -177.345 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 185' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -165.73 -154.88 0.21 Allowed 'General case' 0 N--CA 1.49 1.566 0 N-CA-C 109.102 -0.703 . . . . 0.0 109.102 -179.699 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 186' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER 50.61 52.14 15.47 Favored 'General case' 0 N--CA 1.493 1.695 0 O-C-N 121.124 -0.985 . . . . 0.0 109.12 -179.848 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 187' ' ' TYR . . . . . 0.618 ' CE2' ' O ' ' A' ' 188' ' ' ASN . 54.4 t80 -67.37 136.59 55.01 Favored 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.342 -0.849 . . . . 0.0 110.777 -179.144 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 188' ' ' ASN . . . . . 0.618 ' O ' ' CE2' ' A' ' 187' ' ' TYR . 0.7 OUTLIER -101.56 146.8 27.19 Favored 'General case' 0 C--N 1.298 -1.641 0 N-CA-C 107.777 -1.194 . . . . 0.0 107.777 178.314 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 189' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -113.53 -10.16 13.2 Favored 'General case' 0 C--N 1.297 -1.697 0 N-CA-C 108.496 -0.928 . . . . 0.0 108.496 -179.624 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 190' ' ' LYS . . . . . . . . . . . . . 13.1 mttp -84.03 -53.48 5.52 Favored 'General case' 0 N--CA 1.488 1.459 0 N-CA-C 108.649 -0.871 . . . . 0.0 108.649 178.705 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 191' ' ' THR . . . . . . . . . . . . . 1.1 p -91.26 -8.3 48.75 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.588 -0.695 . . . . 0.0 109.129 179.714 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 192' ' ' GLY . . . . . . . . . . . . . . . 62.58 40.98 99.82 Favored Glycine 0 N--CA 1.492 2.425 0 N-CA-C 110.433 -1.067 . . . . 0.0 110.433 179.219 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 193' ' ' VAL . . . . . 0.489 HG12 ' N ' ' A' ' 194' ' ' TRP . 67.2 t -145.96 157.95 12.1 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.625 0 O-C-N 121.044 -1.268 . . . . 0.0 109.801 179.56 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 194' ' ' TRP . . . . . 0.489 ' N ' HG12 ' A' ' 193' ' ' VAL . 23.0 m95 -83.83 120.79 26.48 Favored 'General case' 0 C--N 1.301 -1.543 0 N-CA-C 108.509 -0.923 . . . . 0.0 108.509 179.627 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 195' ' ' GLU . . . . . . . . . . . . . 2.1 mt-10 -89.73 -60.65 1.88 Allowed 'General case' 0 N--CA 1.495 1.816 0 C-N-CA 119.55 -0.86 . . . . 0.0 111.148 -178.194 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 196' ' ' LYS . . . . . . . . . . . . . 5.1 tttm -80.49 143.23 33.49 Favored 'General case' 0 C--N 1.3 -1.545 0 O-C-N 120.815 -1.178 . . . . 0.0 110.165 -178.901 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 197' ' ' ARG . . . . . 0.565 ' NH1' ' O ' ' C' ' 704' ' ' ALA . 13.5 tpp180 -120.05 138.33 53.59 Favored 'General case' 0 N--CA 1.491 1.617 0 N-CA-C 108.552 -0.907 . . . . 0.0 108.552 179.084 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 198' ' ' LYS . . . . . . . . . . . . . 22.7 mttt -116.97 118.6 32.87 Favored 'General case' 0 C--N 1.302 -1.489 0 O-C-N 121.903 -0.498 . . . . 0.0 109.966 -179.464 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 199' ' ' ILE . . . . . 0.5 HD13 HG23 ' A' ' 180' ' ' THR . 0.6 OUTLIER -139.16 120.32 15.7 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.58 0 CA-C-O 122.505 1.145 . . . . 0.0 109.339 179.532 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 200' ' ' PHE . . . . . 0.884 ' CD2' HD12 ' A' ' 158' ' ' ILE . 3.3 m-85 -99.43 136.71 38.97 Favored 'General case' 0 N--CA 1.496 1.852 0 O-C-N 121.124 -0.985 . . . . 0.0 109.799 -178.074 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 201' ' ' VAL . . . . . . . . . . . . . 97.7 t -101.58 137.16 30.25 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.555 0 N-CA-C 108.004 -1.11 . . . . 0.0 108.004 177.652 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 202' ' ' ALA . . . . . 0.417 ' HB1' ' HB3' ' A' ' 153' ' ' TYR . . . -121.56 134.91 55.03 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.376 -0.828 . . . . 0.0 108.821 179.831 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 203' ' ' THR . . . . . 0.748 HG23 ' OG1' ' A' ' 156' ' ' THR . 2.1 p -88.1 130.36 35.04 Favored 'General case' 0 C--N 1.306 -1.288 0 CA-C-O 122.198 0.999 . . . . 0.0 110.652 -178.782 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 204' ' ' GLU . . . . . 0.507 ' HA ' ' CD2' ' A' ' 153' ' ' TYR . 0.2 OUTLIER -50.9 134.62 25.46 Favored 'General case' 0 C--N 1.298 -1.67 0 C-N-CA 118.688 -1.205 . . . . 0.0 108.673 178.933 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 205' ' ' VAL . . . . . 0.646 HG23 ' O ' ' A' ' 203' ' ' THR . 54.6 t -129.7 164.29 32.74 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.376 0 CA-C-O 121.93 0.872 . . . . 0.0 110.228 -177.741 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 206' ' ' LYS . . . . . 0.57 ' N ' HG12 ' A' ' 205' ' ' VAL . 0.5 OUTLIER . . . . . 0 C--N 1.297 -1.706 0 CA-C-O 118.006 -0.997 . . . . 0.0 109.559 -179.804 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' C' C ' 701' ' ' PHQ . . . . . 0.48 ' C1 ' HG12 ' A' ' 166' ' ' VAL . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' C' C ' 702' ' ' LEU . . . . . 0.754 HD11 ' O ' ' A' ' 163' ' ' PRO . 0.3 OUTLIER . . . . . 0 N--CA 1.493 1.714 0 N-CA-C 109.441 -0.577 . . . . 0.0 109.441 . . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' C' C ' 703' ' ' PRO . . . . . 0.597 ' HG3' ' HB1' ' A' ' 104' ' ' ALA . 40.5 Cg_endo -70.96 -179.29 3.33 Favored 'Trans proline' 0 C--N 1.31 -1.496 0 C-N-CA 122.796 2.331 . . . . 0.0 112.97 -179.691 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' C' C ' 704' ' ' ALA . . . . . 0.565 ' O ' ' NH1' ' A' ' 197' ' ' ARG . . . 56.44 122.02 0.0 OUTLIER 'General case' 0 N--CA 1.49 1.567 0 CA-C-O 121.561 0.696 . . . . 0.0 110.168 179.809 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' C' C ' 705' ' ' B27 . . . . . 0.413 ' HX ' ' NE1' ' A' ' 194' ' ' TRP . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 700' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 007 nuclear nobuild full ' A' A ' 59' ' ' MET . . . . . . . . . . . . . 1.3 mpt? . . . . . 0 N--CA 1.49 1.561 0 N-CA-C 109.256 -0.646 . . . . 0.0 109.256 . . . . . . . . . 0 0 . 1 . 007 nuclear nobuild full ' A' A ' 60' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -60.74 153.45 24.21 Favored 'General case' 0 N--CA 1.489 1.496 0 O-C-N 121.376 -0.827 . . . . 0.0 109.861 -179.704 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . -65.3 -172.11 0.09 Allowed 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.376 -0.827 . . . . 0.0 109.801 -179.991 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 62' ' ' LYS . . . . . 0.483 ' O ' ' OE1' ' A' ' 64' ' ' GLN . 24.4 ttpt -147.5 79.06 9.77 Favored Pre-proline 0 N--CA 1.49 1.528 0 O-C-N 121.398 -0.814 . . . . 0.0 109.557 179.764 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 63' ' ' PRO . . . . . 0.453 ' O ' HD22 ' A' ' 110' ' ' LEU . 5.6 Cg_exo -71.53 137.45 30.49 Favored 'Trans proline' 0 C--N 1.306 -1.707 0 C-N-CA 122.915 2.41 . . . . 0.0 111.283 179.585 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 64' ' ' GLN . . . . . 0.631 ' O ' ' NE2' ' A' ' 64' ' ' GLN . 0.0 OUTLIER -155.26 127.44 7.7 Favored 'General case' 0 N--CA 1.494 1.77 0 O-C-N 121.054 -1.029 . . . . 0.0 110.315 179.81 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 65' ' ' ILE . . . . . 0.564 HD12 ' H ' ' A' ' 65' ' ' ILE . 2.1 mp -45.76 105.94 0.51 Allowed Pre-proline 0 N--CA 1.491 1.598 0 N-CA-C 107.857 -1.164 . . . . 0.0 107.857 178.471 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 66' ' ' PRO . . . . . . . . . . . . . 60.2 Cg_endo -81.94 -162.71 0.19 Allowed 'Trans proline' 0 N--CA 1.49 1.272 0 C-N-CA 122.105 1.87 . . . . 0.0 112.639 -178.785 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 67' ' ' LYS . . . . . . . . . . . . . 53.8 tttt -90.46 -8.04 51.5 Favored 'General case' 0 N--CA 1.487 1.405 0 O-C-N 121.223 -0.923 . . . . 0.0 109.727 -179.722 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 68' ' ' ASP . . . . . 0.646 ' O ' ' N ' ' A' ' 70' ' ' SER . 0.2 OUTLIER -75.86 66.14 2.07 Favored 'General case' 0 N--CA 1.487 1.421 0 CA-C-O 123.003 1.383 . . . . 0.0 108.896 179.839 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 69' ' ' LYS . . . . . 0.468 ' C ' ' O ' ' A' ' 68' ' ' ASP . 0.8 OUTLIER -45.77 -14.71 0.02 OUTLIER 'General case' 0 N--CA 1.511 2.579 0 C-N-CA 117.129 -1.828 . . . . 0.0 107.368 178.06 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 70' ' ' SER . . . . . 0.646 ' N ' ' O ' ' A' ' 68' ' ' ASP . 0.1 OUTLIER -87.58 -5.0 58.95 Favored 'General case' 0 N--CA 1.498 1.93 0 CA-C-N 113.615 -1.63 . . . . 0.0 111.9 179.893 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 71' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -100.56 142.65 31.74 Favored 'General case' 0 N--CA 1.503 2.221 0 O-C-N 120.251 -1.531 . . . . 0.0 112.615 -178.991 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 72' ' ' VAL . . . . . 0.587 ' CG2' ' O ' ' A' ' 74' ' ' GLY . 0.7 OUTLIER -67.72 127.13 28.85 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.336 0 N-CA-C 105.196 -2.149 . . . . 0.0 105.196 174.786 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 73' ' ' ALA . . . . . 0.569 ' N ' ' O ' ' A' ' 87' ' ' VAL . . . -80.33 -12.4 59.6 Favored 'General case' 0 C--N 1.297 -1.712 0 O-C-N 120.195 -1.566 . . . . 0.0 109.126 -178.309 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 74' ' ' GLY . . . . . 0.587 ' O ' ' CG2' ' A' ' 72' ' ' VAL . . . 173.53 -161.12 31.72 Favored Glycine 0 N--CA 1.488 2.13 0 N-CA-C 109.614 -1.394 . . . . 0.0 109.614 -179.849 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 75' ' ' TYR . . . . . . . . . . . . . 76.1 m-85 -142.27 170.16 16.23 Favored 'General case' 0 C--N 1.296 -1.747 0 O-C-N 121.076 -1.249 . . . . 0.0 110.767 -178.136 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 76' ' ' ILE . . . . . 0.468 ' CG2' ' OE1' ' A' ' 85' ' ' GLU . 0.4 OUTLIER -148.97 144.26 18.38 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.57 0 C-N-CA 119.422 -0.911 . . . . 0.0 108.994 -177.464 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -152.04 160.35 43.47 Favored 'General case' 0 N--CA 1.492 1.648 0 O-C-N 120.893 -1.129 . . . . 0.0 109.504 -179.855 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 78' ' ' ILE . . . . . 0.495 ' CG1' HG22 ' A' ' 142' ' ' VAL . 3.0 mp -143.16 99.08 5.47 Favored Pre-proline 0 N--CA 1.493 1.695 0 N-CA-C 107.929 -1.137 . . . . 0.0 107.929 179.303 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 79' ' ' PRO . . . . . . . . . . . . . 47.4 Cg_exo -51.06 -44.62 41.29 Favored 'Trans proline' 0 N--CA 1.492 1.425 0 C-N-CA 122.557 2.171 . . . . 0.0 113.808 -178.81 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -65.62 -18.05 65.04 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 120.691 -1.256 . . . . 0.0 110.752 178.741 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 81' ' ' ALA . . . . . 0.804 ' HB2' ' HB2' ' A' ' 136' ' ' ALA . . . -106.41 -19.04 13.81 Favored 'General case' 0 N--CA 1.494 1.774 0 O-C-N 121.136 -0.978 . . . . 0.0 108.886 179.746 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 82' ' ' ASP . . . . . 0.426 ' CB ' ' O ' ' A' ' 81' ' ' ALA . 11.6 t0 70.44 49.02 0.44 Allowed 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.475 -0.765 . . . . 0.0 110.767 179.106 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 83' ' ' ILE . . . . . 0.546 HD11 ' HB3' ' A' ' 132' ' ' ASN . 36.2 mt -131.1 152.74 38.01 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.822 0 O-C-N 121.145 -0.972 . . . . 0.0 110.275 -179.047 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 84' ' ' LYS . . . . . . . . . . . . . 9.3 ptmm? -157.7 110.22 2.4 Favored 'General case' 0 N--CA 1.489 1.491 0 N-CA-C 108.244 -1.021 . . . . 0.0 108.244 179.471 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 85' ' ' GLU . . . . . 0.47 ' N ' ' CD ' ' A' ' 85' ' ' GLU . 0.4 OUTLIER -138.32 167.74 18.68 Favored Pre-proline 0 N--CA 1.498 1.949 0 O-C-N 121.113 -0.992 . . . . 0.0 109.805 -178.973 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 86' ' ' PRO . . . . . . . . . . . . . 97.3 Cg_endo -82.99 158.89 15.64 Favored 'Trans proline' 0 N--CA 1.494 1.54 0 C-N-CA 122.944 2.429 . . . . 0.0 113.568 -179.184 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 87' ' ' VAL . . . . . 0.569 ' O ' ' N ' ' A' ' 73' ' ' ALA . 78.6 t -112.04 106.36 20.61 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.698 0 N-CA-C 109.319 -0.622 . . . . 0.0 109.319 180.0 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 88' ' ' TYR . . . . . 0.404 ' CZ ' ' HB3' ' A' ' 99' ' ' ARG . 10.5 m-85 -97.45 153.94 38.18 Favored Pre-proline 0 N--CA 1.5 2.057 0 O-C-N 120.766 -1.209 . . . . 0.0 109.607 179.582 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 89' ' ' PRO . . . . . . . . . . . . . 11.4 Cg_endo -58.78 141.94 98.35 Favored 'Trans proline' 0 N--CA 1.497 1.705 0 C-N-CA 122.954 2.436 . . . . 0.0 113.424 -179.923 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . -59.17 169.19 6.23 Favored Glycine 0 N--CA 1.496 2.667 0 N-CA-C 109.259 -1.537 . . . . 0.0 109.259 179.209 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 91' ' ' PRO . . . . . 0.469 ' C ' ' H ' ' A' ' 93' ' ' THR . 94.3 Cg_endo -93.09 168.92 21.57 Favored 'Cis proline' 0 C--N 1.31 -1.489 0 C-N-CA 123.861 -1.308 . . . . 0.0 111.994 0.239 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 92' ' ' ALA . . . . . 0.645 ' O ' HD23 ' A' ' 97' ' ' LEU . . . -70.86 29.76 0.04 OUTLIER 'General case' 0 N--CA 1.492 1.662 0 O-C-N 121.166 -0.959 . . . . 0.0 110.6 -179.489 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 93' ' ' THR . . . . . 0.469 ' H ' ' C ' ' A' ' 91' ' ' PRO . 6.5 p -72.42 150.79 91.74 Favored Pre-proline 0 C--N 1.302 -1.485 0 O-C-N 120.688 -1.257 . . . . 0.0 108.4 179.836 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 94' ' ' PRO . . . . . 0.427 ' C ' ' O ' ' A' ' 93' ' ' THR . 70.2 Cg_exo -30.46 -57.15 0.19 Allowed 'Trans proline' 0 C--N 1.309 -1.506 0 C-N-CA 122.973 2.448 . . . . 0.0 112.743 -179.144 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 16.3 mt-10 -44.56 -49.31 10.16 Favored 'General case' 0 C--N 1.302 -1.466 0 O-C-N 121.175 -0.953 . . . . 0.0 109.863 -179.931 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 96' ' ' GLN . . . . . 0.566 ' O ' ' N ' ' A' ' 98' ' ' ASN . 1.4 mp0 -73.15 -54.15 9.19 Favored 'General case' 0 N--CA 1.488 1.47 0 O-C-N 121.081 -1.012 . . . . 0.0 109.912 179.782 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 97' ' ' LEU . . . . . 0.645 HD23 ' O ' ' A' ' 92' ' ' ALA . 0.7 OUTLIER -44.11 -14.42 0.02 OUTLIER 'General case' 0 N--CA 1.494 1.732 0 O-C-N 121.453 -0.779 . . . . 0.0 110.29 -179.216 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 98' ' ' ASN . . . . . 0.689 ' ND2' ' NE ' ' A' ' 99' ' ' ARG . 0.0 OUTLIER -71.53 -33.53 69.26 Favored 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.052 -1.03 . . . . 0.0 108.599 179.327 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 99' ' ' ARG . . . . . 0.689 ' NE ' ' ND2' ' A' ' 98' ' ' ASN . 16.4 mmt180 -79.64 -58.39 3.21 Favored 'General case' 0 C--N 1.303 -1.442 0 O-C-N 121.688 -0.633 . . . . 0.0 109.565 -179.725 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . 174.08 -156.17 23.03 Favored Glycine 0 N--CA 1.492 2.422 0 N-CA-C 109.989 -1.245 . . . . 0.0 109.989 179.967 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 101' ' ' VAL . . . . . 0.639 ' O ' HG23 ' A' ' 101' ' ' VAL . 27.3 m -59.44 103.18 0.14 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.674 0 O-C-N 121.256 -1.144 . . . . 0.0 109.754 -179.908 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -91.63 166.19 12.94 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.032 -1.043 . . . . 0.0 109.953 -179.992 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 103' ' ' PHE . . . . . 0.597 ' O ' ' N ' ' A' ' 105' ' ' GLU . 26.0 m-85 -70.22 120.86 16.54 Favored 'General case' 0 N--CA 1.486 1.352 0 N-CA-C 107.969 -1.123 . . . . 0.0 107.969 178.639 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 104' ' ' ALA . . . . . 0.576 ' HB1' ' HG3' ' C' ' 703' ' ' PRO . . . -42.94 -14.54 0.01 OUTLIER 'General case' 0 C--N 1.3 -1.546 0 O-C-N 121.488 -0.757 . . . . 0.0 110.696 -178.729 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 105' ' ' GLU . . . . . 0.597 ' N ' ' O ' ' A' ' 103' ' ' PHE . 0.1 OUTLIER -138.85 146.61 41.44 Favored 'General case' 0 N--CA 1.496 1.86 0 O-C-N 120.828 -1.17 . . . . 0.0 110.762 -179.797 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 106' ' ' GLU . . . . . 0.412 ' HG2' ' H ' ' A' ' 107' ' ' ASN . 0.0 OUTLIER -59.59 -61.72 2.41 Favored 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.929 -0.482 . . . . 0.0 111.523 -179.178 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 107' ' ' ASN . . . . . 0.412 ' H ' ' HG2' ' A' ' 106' ' ' GLU . 17.1 m120 -77.65 34.35 0.18 Allowed 'General case' 0 N--CA 1.493 1.707 0 O-C-N 120.428 -1.42 . . . . 0.0 112.862 -175.553 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 108' ' ' GLU . . . . . . . . . . . . . 14.6 tp10 -57.43 146.73 28.49 Favored 'General case' 0 C--N 1.301 -1.508 0 O-C-N 120.698 -1.252 . . . . 0.0 107.937 179.622 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 109' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -102.26 146.72 27.6 Favored 'General case' 0 N--CA 1.488 1.453 0 O-C-N 121.124 -0.985 . . . . 0.0 111.133 -178.198 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 110' ' ' LEU . . . . . 0.453 HD22 ' O ' ' A' ' 63' ' ' PRO . 3.0 tp -62.81 -18.87 63.43 Favored 'General case' 0 C--N 1.303 -1.421 0 N-CA-C 108.028 -1.101 . . . . 0.0 108.028 178.783 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 111' ' ' ASP . . . . . 0.439 ' OD1' ' C ' ' A' ' 110' ' ' LEU . 4.0 m-20 -132.69 42.45 3.08 Favored 'General case' 0 N--CA 1.487 1.383 0 O-C-N 121.637 -0.664 . . . . 0.0 109.84 -179.849 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 112' ' ' ASP . . . . . . . . . . . . . 4.5 t0 -68.15 157.45 35.32 Favored 'General case' 0 N--CA 1.492 1.668 0 O-C-N 120.858 -1.151 . . . . 0.0 111.386 -179.725 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 113' ' ' GLN . . . . . 0.543 ' N ' ' CD ' ' A' ' 113' ' ' GLN . 0.0 OUTLIER -66.58 -16.07 63.9 Favored 'General case' 0 N--CA 1.494 1.742 0 N-CA-C 108.229 -1.026 . . . . 0.0 108.229 177.934 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 114' ' ' ASN . . . . . 0.64 ' ND2' HE21 ' A' ' 178' ' ' GLN . 34.6 t-20 -153.0 113.81 4.11 Favored 'General case' 0 C--N 1.295 -1.781 0 N-CA-C 107.58 -1.266 . . . . 0.0 107.58 177.141 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 115' ' ' ILE . . . . . 0.555 HG22 ' O ' ' A' ' 115' ' ' ILE . 3.8 mt -91.41 98.95 8.96 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.69 0 N-CA-C 107.232 -1.396 . . . . 0.0 107.232 179.588 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 116' ' ' SER . . . . . 0.43 ' OG ' ' HB3' ' A' ' 104' ' ' ALA . 87.6 p -86.44 149.03 25.28 Favored 'General case' 0 N--CA 1.488 1.437 0 CA-C-O 121.864 0.84 . . . . 0.0 111.22 -177.528 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 117' ' ' ILE . . . . . . . . . . . . . 1.7 mt -149.71 149.54 14.56 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.483 0 N-CA-C 107.813 -1.18 . . . . 0.0 107.813 179.112 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 118' ' ' ALA . . . . . . . . . . . . . . . -136.26 159.35 42.02 Favored 'General case' 0 N--CA 1.493 1.686 0 C-N-CA 119.277 -0.969 . . . . 0.0 110.903 -179.018 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 119' ' ' GLY . . . . . 0.516 ' HA2' HD11 ' A' ' 97' ' ' LEU . . . -172.01 146.76 9.54 Favored Glycine 0 N--CA 1.489 2.179 0 N-CA-C 110.482 -1.047 . . . . 0.0 110.482 179.94 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 120' ' ' HIS . . . . . 0.527 ' CD2' ' SG ' ' C' ' 705' ' ' B27 . 27.7 m170 -71.89 168.0 18.85 Favored 'General case' 0 N--CA 1.494 1.758 0 O-C-N 121.531 -0.981 . . . . 0.0 110.157 179.291 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 121' ' ' THR . . . . . 0.457 ' OG1' ' NZ ' ' A' ' 134' ' ' LYS . 0.7 OUTLIER -118.5 160.06 22.41 Favored 'General case' 0 N--CA 1.498 1.958 0 N-CA-C 108.357 -0.979 . . . . 0.0 108.357 178.818 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 122' ' ' PHE . . . . . . . . . . . . . 2.7 m-85 -143.59 123.35 13.39 Favored 'General case' 0 N--CA 1.498 1.951 0 O-C-N 120.838 -1.164 . . . . 0.0 109.812 -179.766 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 123' ' ' ILE . . . . . 0.563 HG23 ' N ' ' A' ' 124' ' ' ASP . 14.3 tt -59.18 -40.24 80.59 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.478 0 CA-C-O 121.545 0.688 . . . . 0.0 109.516 179.89 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 124' ' ' ASP . . . . . 0.563 ' N ' HG23 ' A' ' 123' ' ' ILE . 1.7 m-20 -88.92 22.62 2.64 Favored 'General case' 0 N--CA 1.497 1.912 0 O-C-N 121.492 -0.755 . . . . 0.0 111.942 -177.42 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 125' ' ' ARG . . . . . . . . . . . . . 37.9 mtp180 -154.47 99.75 2.45 Favored Pre-proline 0 N--CA 1.493 1.703 0 O-C-N 120.366 -1.459 . . . . 0.0 110.112 -179.862 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 126' ' ' PRO . . . . . . . . . . . . . 56.1 Cg_endo -80.02 -27.94 3.47 Favored 'Trans proline' 0 C--N 1.313 -1.328 0 C-N-CA 121.98 1.787 . . . . 0.0 111.635 179.266 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 127' ' ' ASN . . . . . . . . . . . . . 2.9 m120 -89.09 11.77 17.54 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.047 -1.033 . . . . 0.0 109.227 179.64 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 128' ' ' TYR . . . . . . . . . . . . . 5.1 t80 -65.58 -149.47 0.01 OUTLIER 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.388 -0.82 . . . . 0.0 109.425 179.908 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 129' ' ' GLN . . . . . 0.433 HE22 ' CD1' ' A' ' 97' ' ' LEU . 69.5 mt-30 -68.05 -70.95 0.23 Allowed 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.315 -0.866 . . . . 0.0 109.857 -179.787 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 130' ' ' PHE . . . . . 0.701 ' CE1' HD11 ' A' ' 181' ' ' LEU . 47.6 m-85 -134.88 52.62 2.03 Favored 'General case' 0 N--CA 1.493 1.71 0 O-C-N 121.104 -0.998 . . . . 0.0 110.303 -179.857 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 131' ' ' THR . . . . . . . . . . . . . 23.1 m -87.33 -39.69 15.12 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 120.903 -1.123 . . . . 0.0 109.396 179.681 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 132' ' ' ASN . . . . . 0.585 ' ND2' ' O ' ' A' ' 81' ' ' ALA . 1.8 t30 -82.86 6.32 18.79 Favored 'General case' 0 N--CA 1.498 1.938 0 O-C-N 121.505 -0.747 . . . . 0.0 111.701 -178.306 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 133' ' ' LEU . . . . . 0.503 ' O ' ' N ' ' A' ' 135' ' ' ALA . 0.2 OUTLIER -71.17 -45.54 63.28 Favored 'General case' 0 C--N 1.299 -1.616 0 O-C-N 120.739 -1.226 . . . . 0.0 109.999 -179.368 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 134' ' ' LYS . . . . . 0.652 ' CD ' ' H ' ' A' ' 134' ' ' LYS . 0.0 OUTLIER -46.12 -16.96 0.03 OUTLIER 'General case' 0 N--CA 1.494 1.749 0 O-C-N 120.988 -1.07 . . . . 0.0 109.727 -179.802 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 135' ' ' ALA . . . . . 0.503 ' N ' ' O ' ' A' ' 133' ' ' LEU . . . -84.08 -37.53 21.93 Favored 'General case' 0 N--CA 1.487 1.403 0 O-C-N 121.111 -0.993 . . . . 0.0 109.077 179.471 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 136' ' ' ALA . . . . . 0.804 ' HB2' ' HB2' ' A' ' 81' ' ' ALA . . . -79.76 157.96 26.99 Favored 'General case' 0 C--N 1.303 -1.454 0 CA-C-O 121.976 0.894 . . . . 0.0 110.984 -179.132 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 137' ' ' LYS . . . . . 0.542 ' O ' ' O ' ' A' ' 138' ' ' LYS . 2.4 mttm -150.84 -163.52 1.79 Allowed 'General case' 0 C--N 1.299 -1.628 0 C-N-CA 118.106 -1.438 . . . . 0.0 110.965 -177.902 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 138' ' ' LYS . . . . . 0.585 ' O ' ' N ' ' A' ' 140' ' ' SER . 28.8 mttp -41.18 174.17 0.0 OUTLIER 'General case' 0 C--N 1.301 -1.523 0 CA-C-O 122.589 1.185 . . . . 0.0 111.171 -178.557 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 139' ' ' GLY . . . . . . . . . . . . . . . 47.13 8.25 0.03 OUTLIER Glycine 0 N--CA 1.488 2.148 0 N-CA-C 110.162 -1.175 . . . . 0.0 110.162 -179.971 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 140' ' ' SER . . . . . 0.585 ' N ' ' O ' ' A' ' 138' ' ' LYS . 5.2 m -75.87 112.98 12.83 Favored 'General case' 0 N--CA 1.493 1.723 0 O-C-N 120.867 -1.372 . . . . 0.0 108.982 179.385 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 141' ' ' MET . . . . . 0.659 ' SD ' ' N ' ' A' ' 142' ' ' VAL . 3.0 tpp -68.26 128.02 35.06 Favored 'General case' 0 C--N 1.301 -1.503 0 O-C-N 121.036 -1.04 . . . . 0.0 109.178 179.854 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 142' ' ' VAL . . . . . 0.659 ' N ' ' SD ' ' A' ' 141' ' ' MET . 1.6 t -113.87 133.29 60.33 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.522 0 N-CA-C 108.456 -0.942 . . . . 0.0 108.456 -179.736 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 143' ' ' TYR . . . . . . . . . . . . . 13.4 m-85 -112.31 135.83 52.51 Favored 'General case' 0 N--CA 1.495 1.798 0 O-C-N 120.869 -1.145 . . . . 0.0 110.703 -178.899 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 144' ' ' PHE . . . . . 0.561 ' CZ ' ' CG1' ' A' ' 146' ' ' VAL . 4.2 t80 -120.96 105.88 11.08 Favored 'General case' 0 N--CA 1.493 1.707 0 C-N-CA 120.143 -0.623 . . . . 0.0 109.985 -179.467 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 145' ' ' LYS . . . . . . . . . . . . . 13.9 mtpp -102.3 122.76 44.86 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.23 -0.919 . . . . 0.0 109.819 -179.863 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 146' ' ' VAL . . . . . 0.561 ' CG1' ' CZ ' ' A' ' 144' ' ' PHE . 0.9 OUTLIER -142.65 125.4 13.74 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.629 0 N-CA-C 108.335 -0.987 . . . . 0.0 108.335 178.874 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 147' ' ' GLY . . . . . . . . . . . . . . . 60.47 -125.6 39.0 Favored Glycine 0 N--CA 1.489 2.225 0 N-CA-C 109.054 -1.618 . . . . 0.0 109.054 -179.426 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 148' ' ' ASN . . . . . 0.592 ' C ' ' ND2' ' A' ' 148' ' ' ASN . 0.0 OUTLIER -104.77 5.97 33.68 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.245 -1.15 . . . . 0.0 108.979 179.623 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 149' ' ' GLU . . . . . . . . . . . . . 1.3 tt0 -105.82 141.65 36.89 Favored 'General case' 0 N--CA 1.488 1.461 0 O-C-N 121.295 -0.878 . . . . 0.0 111.797 -178.32 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 150' ' ' THR . . . . . . . . . . . . . 3.5 m -131.93 98.47 4.46 Favored 'General case' 0 N--CA 1.493 1.709 0 CA-C-O 121.482 0.658 . . . . 0.0 109.271 -179.862 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 151' ' ' ARG . . . . . 0.427 HH12 ' HA ' ' A' ' 111' ' ' ASP . 92.6 mtt180 -85.7 -169.36 2.61 Favored 'General case' 0 N--CA 1.488 1.425 0 O-C-N 121.255 -0.903 . . . . 0.0 108.894 -179.711 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 152' ' ' LYS . . . . . 0.476 ' O ' ' N ' ' A' ' 205' ' ' VAL . 1.9 mtmp? -152.02 149.87 29.35 Favored 'General case' 0 C--N 1.301 -1.537 0 O-C-N 121.261 -0.899 . . . . 0.0 109.982 -179.309 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 153' ' ' TYR . . . . . 0.499 ' CD2' ' HA ' ' A' ' 204' ' ' GLU . 5.7 m-85 -143.86 168.51 19.78 Favored 'General case' 0 C--N 1.303 -1.417 0 N-CA-C 107.939 -1.134 . . . . 0.0 107.939 178.494 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 154' ' ' LYS . . . . . . . . . . . . . 1.4 ttpt -143.36 119.82 10.99 Favored 'General case' 0 C--N 1.295 -1.772 0 N-CA-C 108.403 -0.962 . . . . 0.0 108.403 178.689 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 155' ' ' MET . . . . . . . . . . . . . 46.5 mtp -46.3 107.68 0.11 Allowed 'General case' 0 N--CA 1.495 1.784 0 O-C-N 120.637 -1.289 . . . . 0.0 111.564 -178.602 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 156' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -106.4 -25.44 11.89 Favored 'General case' 0 C--N 1.294 -1.844 0 CA-C-N 115.249 -0.887 . . . . 0.0 110.633 -178.739 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 157' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -153.94 153.72 32.52 Favored 'General case' 0 N--CA 1.495 1.813 0 C-N-CA 118.559 -1.256 . . . . 0.0 111.431 -178.512 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 158' ' ' ILE . . . . . 0.633 HD12 ' CD1' ' A' ' 200' ' ' PHE . 0.2 OUTLIER -153.79 146.83 14.15 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.372 0 CA-C-O 122.067 0.937 . . . . 0.0 110.91 -179.76 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 159' ' ' ARG . . . . . . . . . . . . . 12.9 ttm180 -153.66 153.44 32.3 Favored 'General case' 0 C--N 1.296 -1.718 0 CA-C-O 121.642 0.734 . . . . 0.0 109.681 -179.894 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 160' ' ' ASP . . . . . 0.773 ' O ' HG13 ' A' ' 161' ' ' VAL . 0.3 OUTLIER -116.18 160.55 20.23 Favored 'General case' 0 C--N 1.301 -1.513 0 N-CA-C 107.895 -1.15 . . . . 0.0 107.895 179.428 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 161' ' ' VAL . . . . . 0.773 HG13 ' O ' ' A' ' 160' ' ' ASP . 1.6 m -165.35 159.34 1.14 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.7 0 O-C-N 120.881 -1.137 . . . . 0.0 110.54 -179.271 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 162' ' ' LYS . . . . . 0.497 ' O ' ' O ' ' A' ' 161' ' ' VAL . 0.0 OUTLIER -43.96 171.5 0.04 OUTLIER Pre-proline 0 N--CA 1.49 1.538 0 O-C-N 121.789 -0.569 . . . . 0.0 109.558 179.568 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 163' ' ' PRO . . . . . 0.503 ' C ' HD11 ' C' ' 702' ' ' LEU . 74.0 Cg_endo -81.47 37.32 0.67 Allowed 'Trans proline' 0 C--N 1.311 -1.431 0 C-N-CA 122.557 2.171 . . . . 0.0 112.107 179.891 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 164' ' ' THR . . . . . 0.607 ' N ' HD11 ' C' ' 702' ' ' LEU . 86.7 m -152.12 -5.65 0.23 Allowed 'General case' 0 N--CA 1.494 1.76 0 O-C-N 121.216 -0.927 . . . . 0.0 110.736 -179.446 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 165' ' ' ASP . . . . . . . . . . . . . 31.0 t70 -72.86 62.72 0.61 Allowed 'General case' 0 N--CA 1.496 1.834 0 O-C-N 120.796 -1.19 . . . . 0.0 110.169 -179.435 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 166' ' ' VAL . . . . . 0.668 HG22 ' C1 ' ' C' ' 701' ' ' PHQ . 2.8 t -45.68 -34.01 1.58 Allowed 'Isoleucine or valine' 0 N--CA 1.494 1.763 0 O-C-N 121.099 -1.001 . . . . 0.0 110.247 -178.534 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 167' ' ' GLY . . . . . 0.402 ' C ' ' O ' ' A' ' 166' ' ' VAL . . . -43.46 -12.81 0.01 OUTLIER Glycine 0 N--CA 1.496 2.672 0 O-C-N 120.785 -1.197 . . . . 0.0 110.994 -179.495 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 168' ' ' VAL . . . . . 0.608 ' N ' ' O ' ' A' ' 166' ' ' VAL . 5.3 m -53.97 -30.94 20.36 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.51 0 O-C-N 120.588 -1.537 . . . . 0.0 109.005 179.802 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 169' ' ' LEU . . . . . 0.545 ' O ' ' ND2' ' A' ' 114' ' ' ASN . 13.1 mt -49.04 -11.51 0.04 OUTLIER 'General case' 0 N--CA 1.489 1.519 0 N-CA-C 107.974 -1.121 . . . . 0.0 107.974 -178.535 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 170' ' ' ASP . . . . . 0.614 ' O ' ' ND2' ' A' ' 114' ' ' ASN . 2.2 m-20 19.88 77.21 0.01 OUTLIER 'General case' 0 N--CA 1.5 2.03 0 N-CA-C 112.21 0.448 . . . . 0.0 112.21 177.517 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 171' ' ' GLU . . . . . 0.572 ' N ' ' OE1' ' A' ' 172' ' ' GLN . 9.9 pt-20 -116.51 66.44 0.71 Allowed 'General case' 0 N--CA 1.498 1.957 0 O-C-N 120.922 -1.111 . . . . 0.0 109.499 179.495 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 172' ' ' GLN . . . . . 0.572 ' OE1' ' N ' ' A' ' 171' ' ' GLU . 2.5 mp0 -121.35 -57.28 1.85 Allowed 'General case' 0 N--CA 1.496 1.846 0 O-C-N 121.532 -0.73 . . . . 0.0 110.7 -178.697 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 173' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -58.92 127.0 30.0 Favored 'General case' 0 N--CA 1.494 1.739 0 O-C-N 121.017 -1.052 . . . . 0.0 109.301 -179.687 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 174' ' ' GLY . . . . . 0.498 ' O ' ' C ' ' A' ' 175' ' ' LYS . . . -118.55 -43.0 0.56 Allowed Glycine 0 N--CA 1.482 1.742 0 N-CA-C 108.625 -1.79 . . . . 0.0 108.625 179.835 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 175' ' ' LYS . . . . . 0.498 ' C ' ' O ' ' A' ' 174' ' ' GLY . 0.0 OUTLIER -40.42 -60.03 1.19 Allowed 'General case' 0 N--CA 1.494 1.742 0 N-CA-C 107.324 -1.361 . . . . 0.0 107.324 179.538 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 176' ' ' ASP . . . . . 0.601 ' O ' ' O ' ' A' ' 177' ' ' LYS . 11.4 m-20 -103.72 90.31 3.61 Favored 'General case' 0 C--N 1.292 -1.912 0 N-CA-C 106.792 -1.558 . . . . 0.0 106.792 176.896 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 177' ' ' LYS . . . . . 0.601 ' O ' ' O ' ' A' ' 176' ' ' ASP . 8.3 mtmt -45.28 -176.31 0.0 OUTLIER 'General case' 0 N--CA 1.492 1.641 0 N-CA-C 109.009 -0.737 . . . . 0.0 109.009 -179.161 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 178' ' ' GLN . . . . . 0.64 HE21 ' ND2' ' A' ' 114' ' ' ASN . 16.5 pt20 -161.77 175.84 11.53 Favored 'General case' 0 C--N 1.3 -1.557 0 O-C-N 120.37 -1.456 . . . . 0.0 110.511 179.322 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 179' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -132.51 98.96 4.5 Favored 'General case' 0 C--N 1.301 -1.503 0 N-CA-C 107.604 -1.258 . . . . 0.0 107.604 178.228 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 180' ' ' THR . . . . . 0.571 ' CB ' HD21 ' A' ' 114' ' ' ASN . 1.3 m -77.26 117.42 18.76 Favored 'General case' 0 N--CA 1.489 1.486 0 O-C-N 121.217 -0.927 . . . . 0.0 110.127 -178.628 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 181' ' ' LEU . . . . . 0.763 HD22 ' CE2' ' A' ' 200' ' ' PHE . 9.4 tt -92.76 147.05 23.18 Favored 'General case' 0 C--N 1.302 -1.463 0 N-CA-C 107.851 -1.166 . . . . 0.0 107.851 177.826 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 182' ' ' ILE . . . . . 0.614 ' N ' HD23 ' A' ' 181' ' ' LEU . 6.4 mt -138.39 109.05 5.0 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.643 0 N-CA-C 108.262 -1.014 . . . . 0.0 108.262 179.088 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 183' ' ' THR . . . . . 0.541 HG23 ' O ' ' A' ' 183' ' ' THR . 7.1 t -132.1 115.65 16.02 Favored 'General case' 0 C--N 1.29 -2.007 0 N-CA-C 107.921 -1.14 . . . . 0.0 107.921 179.509 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 184' ' ' CYS . . . . . . . . . . . . . 1.1 p -78.54 160.46 27.62 Favored 'General case' 0 C--N 1.288 -2.076 0 C-N-CA 119.441 -0.904 . . . . 0.0 110.996 -178.021 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 185' ' ' ASP . . . . . 0.53 ' CG ' ' N ' ' A' ' 186' ' ' ASP . 0.1 OUTLIER -166.93 -163.58 0.56 Allowed 'General case' 0 N--CA 1.49 1.53 0 N-CA-C 109.109 -0.7 . . . . 0.0 109.109 179.816 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 186' ' ' ASP . . . . . 0.53 ' N ' ' CG ' ' A' ' 185' ' ' ASP . 0.6 OUTLIER 55.95 54.3 8.2 Favored 'General case' 0 N--CA 1.496 1.828 0 O-C-N 121.126 -0.984 . . . . 0.0 109.476 -179.965 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 187' ' ' TYR . . . . . 0.596 ' CE1' ' O ' ' A' ' 188' ' ' ASN . 43.0 t80 -67.54 130.73 43.95 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.166 -0.959 . . . . 0.0 110.126 -179.829 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 188' ' ' ASN . . . . . 0.84 HD22 ' H ' ' A' ' 193' ' ' VAL . 0.0 OUTLIER -99.94 150.54 22.3 Favored 'General case' 0 C--N 1.292 -1.907 0 N-CA-C 107.318 -1.364 . . . . 0.0 107.318 177.825 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 189' ' ' GLU . . . . . 0.706 ' CD ' ' H ' ' A' ' 189' ' ' GLU . 0.0 OUTLIER -112.18 -8.09 14.01 Favored 'General case' 0 C--N 1.289 -2.034 0 N-CA-C 107.968 -1.123 . . . . 0.0 107.968 -179.476 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 190' ' ' LYS . . . . . 0.577 ' N ' ' OD1' ' A' ' 188' ' ' ASN . 2.7 mtpm? -82.89 -56.91 3.54 Favored 'General case' 0 C--N 1.299 -1.618 0 C-N-CA 119.894 -0.722 . . . . 0.0 109.381 179.51 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 191' ' ' THR . . . . . 0.598 ' C ' HD21 ' A' ' 188' ' ' ASN . 4.7 p -88.44 6.5 37.29 Favored 'General case' 0 N--CA 1.493 1.682 0 O-C-N 121.399 -0.813 . . . . 0.0 110.04 -179.675 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 192' ' ' GLY . . . . . 0.703 ' N ' HD21 ' A' ' 188' ' ' ASN . . . 53.92 35.82 54.38 Favored Glycine 0 N--CA 1.495 2.568 0 N-CA-C 110.664 -0.974 . . . . 0.0 110.664 179.129 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 193' ' ' VAL . . . . . 0.84 ' H ' HD22 ' A' ' 188' ' ' ASN . 58.8 t -149.5 163.58 4.08 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.588 0 O-C-N 120.95 -1.324 . . . . 0.0 109.962 179.708 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 194' ' ' TRP . . . . . 0.582 ' N ' HG12 ' A' ' 193' ' ' VAL . 16.1 m95 -84.97 121.17 27.38 Favored 'General case' 0 N--CA 1.49 1.534 0 N-CA-C 108.085 -1.08 . . . . 0.0 108.085 179.137 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 195' ' ' GLU . . . . . . . . . . . . . 2.6 mt-10 -79.69 -61.23 2.06 Favored 'General case' 0 N--CA 1.497 1.878 0 O-C-N 121.295 -0.878 . . . . 0.0 111.767 -177.667 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 196' ' ' LYS . . . . . . . . . . . . . 8.5 mmtm -93.29 145.38 24.49 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 120.777 -1.202 . . . . 0.0 110.296 -178.608 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 197' ' ' ARG . . . . . 0.599 ' CG ' HH11 ' A' ' 197' ' ' ARG . 0.0 OUTLIER -119.61 146.85 45.16 Favored 'General case' 0 N--CA 1.492 1.625 0 N-CA-C 108.711 -0.848 . . . . 0.0 108.711 179.806 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 198' ' ' LYS . . . . . 0.505 ' HZ1' ' CG ' ' A' ' 185' ' ' ASP . 0.5 OUTLIER -116.81 121.07 40.47 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.582 -0.699 . . . . 0.0 111.197 -178.212 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 199' ' ' ILE . . . . . 0.49 ' C ' HD12 ' A' ' 199' ' ' ILE . 0.8 OUTLIER -139.52 118.21 12.27 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.573 0 CA-C-O 122.515 1.15 . . . . 0.0 109.56 178.796 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 200' ' ' PHE . . . . . 0.763 ' CE2' HD22 ' A' ' 181' ' ' LEU . 0.3 OUTLIER -103.6 140.78 37.09 Favored 'General case' 0 N--CA 1.497 1.88 0 O-C-N 121.127 -0.983 . . . . 0.0 110.455 -178.074 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 201' ' ' VAL . . . . . . . . . . . . . 96.1 t -103.47 146.83 10.6 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.482 0 N-CA-C 108.255 -1.017 . . . . 0.0 108.255 177.352 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 202' ' ' ALA . . . . . . . . . . . . . . . -131.89 138.74 48.53 Favored 'General case' 0 C--N 1.3 -1.579 0 N-CA-C 108.34 -0.985 . . . . 0.0 108.34 -179.88 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 203' ' ' THR . . . . . 0.533 ' O ' HG23 ' A' ' 205' ' ' VAL . 3.2 p -89.1 130.77 35.49 Favored 'General case' 0 C--N 1.306 -1.315 0 CA-C-O 122.267 1.032 . . . . 0.0 111.213 -178.141 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 204' ' ' GLU . . . . . 0.499 ' HA ' ' CD2' ' A' ' 153' ' ' TYR . 0.2 OUTLIER -51.01 134.48 26.15 Favored 'General case' 0 C--N 1.297 -1.691 0 C-N-CA 119.076 -1.05 . . . . 0.0 109.043 179.346 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 205' ' ' VAL . . . . . 0.556 HG12 ' N ' ' A' ' 206' ' ' LYS . 53.3 t -125.03 164.06 24.55 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.369 0 CA-C-O 121.941 0.877 . . . . 0.0 110.433 -177.79 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 206' ' ' LYS . . . . . 0.556 ' N ' HG12 ' A' ' 205' ' ' VAL . 0.1 OUTLIER . . . . . 0 C--N 1.297 -1.693 0 CA-C-O 117.976 -1.011 . . . . 0.0 109.651 179.91 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' C' C ' 701' ' ' PHQ . . . . . 0.668 ' C1 ' HG22 ' A' ' 166' ' ' VAL . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' C' C ' 702' ' ' LEU . . . . . 0.607 HD11 ' N ' ' A' ' 164' ' ' THR . 0.0 OUTLIER . . . . . 0 N--CA 1.492 1.656 0 N-CA-C 108.941 -0.763 . . . . 0.0 108.941 . . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' C' C ' 703' ' ' PRO . . . . . 0.576 ' HG3' ' HB1' ' A' ' 104' ' ' ALA . 11.9 Cg_endo -61.7 -174.81 0.14 Allowed 'Trans proline' 0 N--CA 1.494 1.549 0 C-N-CA 122.609 2.206 . . . . 0.0 112.861 -179.083 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' C' C ' 704' ' ' ALA . . . . . 0.561 ' C ' ' NH2' ' A' ' 197' ' ' ARG . . . 54.23 175.3 0.02 OUTLIER 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.395 -0.816 . . . . 0.0 109.364 -179.662 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' C' C ' 705' ' ' B27 . . . . . 0.527 ' SG ' ' CD2' ' A' ' 120' ' ' HIS . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 700' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 008 nuclear nobuild full ' A' A ' 59' ' ' MET . . . . . . . . . . . . . 1.5 mpt? . . . . . 0 N--CA 1.491 1.58 0 CA-C-O 121.385 0.612 . . . . 0.0 109.501 . . . . . . . . . 0 0 . 1 . 008 nuclear nobuild full ' A' A ' 60' ' ' GLN . . . . . . . . . . . . . 1.1 tt0 -60.95 149.9 35.05 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.393 -0.817 . . . . 0.0 109.929 -179.856 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . -65.04 157.6 27.96 Favored 'General case' 0 N--CA 1.489 1.5 0 O-C-N 121.245 -0.91 . . . . 0.0 109.117 179.533 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 62' ' ' LYS . . . . . . . . . . . . . 3.5 tptm -139.0 75.19 35.67 Favored Pre-proline 0 N--CA 1.491 1.583 0 C-N-CA 119.533 -0.867 . . . . 0.0 109.651 -179.696 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 63' ' ' PRO . . . . . . . . . . . . . 72.9 Cg_endo -93.0 151.63 2.63 Favored 'Trans proline' 0 C--N 1.301 -1.921 0 C-N-CA 124.011 3.141 . . . . 0.0 110.684 179.386 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 64' ' ' GLN . . . . . 0.601 ' O ' ' NE2' ' A' ' 64' ' ' GLN . 0.0 OUTLIER -159.83 137.72 10.03 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 120.97 -1.081 . . . . 0.0 109.841 179.115 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 65' ' ' ILE . . . . . 0.46 HG23 ' HB3' ' A' ' 89' ' ' PRO . 3.2 mp -47.95 108.0 0.83 Allowed Pre-proline 0 N--CA 1.489 1.488 0 O-C-N 121.172 -0.955 . . . . 0.0 108.701 179.136 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 66' ' ' PRO . . . . . 0.4 ' HG3' ' NZ ' ' A' ' 71' ' ' LYS . 61.4 Cg_endo -81.52 -158.74 0.1 OUTLIER 'Trans proline' 0 C--N 1.314 -1.246 0 C-N-CA 122.026 1.818 . . . . 0.0 112.445 -179.432 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 67' ' ' LYS . . . . . . . . . . . . . 3.4 pttm -90.18 -13.24 35.99 Favored 'General case' 0 N--CA 1.488 1.457 0 O-C-N 121.323 -0.861 . . . . 0.0 109.366 -179.975 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 68' ' ' ASP . . . . . 0.653 ' C ' ' N ' ' A' ' 70' ' ' SER . 0.5 OUTLIER -76.76 64.27 2.31 Favored 'General case' 0 N--CA 1.488 1.456 0 CA-C-O 122.656 1.217 . . . . 0.0 109.548 -179.885 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 69' ' ' LYS . . . . . 0.457 ' C ' ' O ' ' A' ' 68' ' ' ASP . 12.1 ptpt -47.48 -13.01 0.03 OUTLIER 'General case' 0 N--CA 1.512 2.655 0 C-N-CA 117.039 -1.864 . . . . 0.0 106.66 177.03 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 70' ' ' SER . . . . . 0.653 ' N ' ' C ' ' A' ' 68' ' ' ASP . 1.3 p -85.22 -7.06 59.21 Favored 'General case' 0 N--CA 1.497 1.883 0 CA-C-N 113.259 -1.791 . . . . 0.0 111.151 179.337 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 71' ' ' LYS . . . . . 0.519 ' N ' ' O ' ' A' ' 68' ' ' ASP . 0.0 OUTLIER -98.76 145.66 26.7 Favored 'General case' 0 N--CA 1.501 2.107 0 O-C-N 120.671 -1.268 . . . . 0.0 112.329 -179.141 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 72' ' ' VAL . . . . . 0.716 HG12 ' CE1' ' A' ' 88' ' ' TYR . 3.0 m -68.02 130.06 32.97 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.384 0 N-CA-C 105.227 -2.138 . . . . 0.0 105.227 175.235 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 73' ' ' ALA . . . . . 0.57 ' N ' ' O ' ' A' ' 87' ' ' VAL . . . -78.92 -15.17 58.67 Favored 'General case' 0 C--N 1.293 -1.858 0 O-C-N 120.16 -1.588 . . . . 0.0 107.623 -179.404 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 74' ' ' GLY . . . . . 0.418 ' O ' ' N ' ' A' ' 87' ' ' VAL . . . 176.04 -159.74 27.3 Favored Glycine 0 N--CA 1.48 1.592 0 N-CA-C 109.712 -1.355 . . . . 0.0 109.712 179.73 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 75' ' ' TYR . . . . . 0.624 ' HA ' HG23 ' A' ' 87' ' ' VAL . 0.6 OUTLIER -142.97 166.86 23.49 Favored 'General case' 0 C--N 1.295 -1.772 0 O-C-N 121.713 -0.875 . . . . 0.0 110.834 -177.221 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 76' ' ' ILE . . . . . . . . . . . . . 1.5 tt -149.86 146.98 16.58 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.517 0 C-N-CA 119.2 -1.0 . . . . 0.0 109.833 -178.528 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -150.96 164.78 35.55 Favored 'General case' 0 N--CA 1.489 1.495 0 N-CA-C 108.689 -0.856 . . . . 0.0 108.689 179.594 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 78' ' ' ILE . . . . . 0.607 ' HB ' ' HB3' ' A' ' 81' ' ' ALA . 14.9 mt -146.89 95.87 4.42 Favored Pre-proline 0 C--N 1.3 -1.562 0 N-CA-C 108.392 -0.966 . . . . 0.0 108.392 179.997 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 79' ' ' PRO . . . . . . . . . . . . . 73.5 Cg_exo -46.93 -46.45 18.59 Favored 'Trans proline' 0 N--CA 1.493 1.447 0 C-N-CA 122.865 2.377 . . . . 0.0 113.897 -178.503 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 4.0 t0 -65.38 -20.04 66.21 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 120.749 -1.219 . . . . 0.0 110.423 178.622 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 81' ' ' ALA . . . . . 0.817 ' HB2' ' HB2' ' A' ' 136' ' ' ALA . . . -104.35 -12.58 16.51 Favored 'General case' 0 N--CA 1.493 1.676 0 O-C-N 121.308 -0.87 . . . . 0.0 109.227 179.739 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 82' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER 62.4 48.82 4.43 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.332 -0.855 . . . . 0.0 110.154 179.574 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 83' ' ' ILE . . . . . . . . . . . . . 69.9 mt -129.08 151.84 36.35 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.801 0 O-C-N 121.142 -0.974 . . . . 0.0 110.408 -178.862 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 84' ' ' LYS . . . . . 0.458 ' O ' ' CD ' ' A' ' 85' ' ' GLU . 27.7 tttt -158.86 108.74 1.99 Allowed 'General case' 0 N--CA 1.49 1.545 0 N-CA-C 108.192 -1.04 . . . . 0.0 108.192 179.778 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 85' ' ' GLU . . . . . 0.595 ' O ' ' CD2' ' A' ' 75' ' ' TYR . 7.4 mm-40 -139.64 176.41 2.59 Favored Pre-proline 0 N--CA 1.496 1.859 0 O-C-N 121.457 -0.777 . . . . 0.0 109.899 -178.998 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 86' ' ' PRO . . . . . 0.419 ' O ' HG22 ' A' ' 101' ' ' VAL . 12.3 Cg_endo -85.86 169.68 8.98 Favored 'Trans proline' 0 N--CA 1.491 1.342 0 C-N-CA 123.15 2.566 . . . . 0.0 113.55 -178.75 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 87' ' ' VAL . . . . . 0.624 HG23 ' HA ' ' A' ' 75' ' ' TYR . 45.8 t -124.35 99.38 6.25 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.85 0 O-C-N 121.616 -0.677 . . . . 0.0 109.42 179.497 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 88' ' ' TYR . . . . . 0.716 ' CE1' HG12 ' A' ' 72' ' ' VAL . 26.1 m-85 -90.08 155.52 47.08 Favored Pre-proline 0 N--CA 1.506 2.345 0 O-C-N 120.861 -1.149 . . . . 0.0 109.716 -179.806 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 89' ' ' PRO . . . . . 0.578 ' O ' ' NE2' ' A' ' 96' ' ' GLN . 18.3 Cg_endo -65.62 145.46 81.81 Favored 'Trans proline' 0 N--CA 1.494 1.522 0 C-N-CA 122.486 2.124 . . . . 0.0 113.946 -179.587 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . -53.1 166.5 1.41 Allowed Glycine 0 N--CA 1.49 2.261 0 N-CA-C 109.369 -1.492 . . . . 0.0 109.369 179.167 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 91' ' ' PRO . . . . . 0.432 ' C ' ' H ' ' A' ' 93' ' ' THR . 57.8 Cg_endo -93.72 167.47 20.81 Favored 'Cis proline' 0 C--N 1.308 -1.589 0 C-N-CA 123.756 -1.352 . . . . 0.0 111.583 0.14 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 92' ' ' ALA . . . . . 0.473 ' O ' HD23 ' A' ' 97' ' ' LEU . . . -73.32 31.07 0.07 Allowed 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.104 -0.997 . . . . 0.0 110.495 -179.781 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 93' ' ' THR . . . . . 0.432 ' H ' ' C ' ' A' ' 91' ' ' PRO . 1.4 p -73.16 153.01 90.57 Favored Pre-proline 0 N--CA 1.49 1.534 0 O-C-N 120.725 -1.234 . . . . 0.0 109.288 -179.65 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 94' ' ' PRO . . . . . . . . . . . . . 89.8 Cg_exo -33.22 -56.83 0.35 Allowed 'Trans proline' 0 C--N 1.311 -1.431 0 C-N-CA 122.982 2.454 . . . . 0.0 112.299 -179.686 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 41.1 mt-10 -46.5 -48.33 19.24 Favored 'General case' 0 N--CA 1.488 1.444 0 O-C-N 121.171 -0.955 . . . . 0.0 108.874 179.813 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 96' ' ' GLN . . . . . 0.578 ' NE2' ' O ' ' A' ' 89' ' ' PRO . 3.4 mm-40 -72.29 -54.95 8.04 Favored 'General case' 0 C--N 1.305 -1.333 0 O-C-N 121.192 -0.942 . . . . 0.0 109.712 179.767 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 97' ' ' LEU . . . . . 0.703 HD11 ' HA2' ' A' ' 119' ' ' GLY . 0.5 OUTLIER -48.33 -8.01 0.02 OUTLIER 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.254 -0.904 . . . . 0.0 109.926 -179.593 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 98' ' ' ASN . . . . . 0.798 HD21 ' HE ' ' A' ' 99' ' ' ARG . 0.1 OUTLIER -74.41 -24.45 59.11 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.163 -0.961 . . . . 0.0 109.162 179.672 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 99' ' ' ARG . . . . . 0.798 ' HE ' HD21 ' A' ' 98' ' ' ASN . 4.2 mtt180 -95.2 -53.65 3.71 Favored 'General case' 0 C--N 1.3 -1.561 0 O-C-N 121.659 -0.651 . . . . 0.0 110.294 -178.813 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . 177.52 -159.7 25.9 Favored Glycine 0 N--CA 1.492 2.402 0 C-N-CA 119.366 -1.397 . . . . 0.0 110.167 179.807 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 101' ' ' VAL . . . . . 0.785 ' O ' HG23 ' A' ' 101' ' ' VAL . 25.0 m -62.03 100.07 0.15 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.629 0 O-C-N 121.523 -0.986 . . . . 0.0 109.296 -179.911 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 102' ' ' SER . . . . . 0.458 ' OG ' ' OE1' ' A' ' 96' ' ' GLN . 1.6 m -93.35 159.9 15.06 Favored 'General case' 0 C--N 1.298 -1.644 0 O-C-N 121.2 -0.938 . . . . 0.0 110.156 -179.963 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 103' ' ' PHE . . . . . . . . . . . . . 21.2 m-85 -59.63 160.72 6.88 Favored 'General case' 0 N--CA 1.49 1.57 0 N-CA-C 107.869 -1.16 . . . . 0.0 107.869 178.671 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 104' ' ' ALA . . . . . . . . . . . . . . . -72.33 -28.16 62.88 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.211 -0.93 . . . . 0.0 111.814 -177.932 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -135.25 150.45 50.06 Favored 'General case' 0 N--CA 1.495 1.819 0 O-C-N 120.822 -1.174 . . . . 0.0 111.023 -178.518 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 106' ' ' GLU . . . . . . . . . . . . . 1.3 pt-20 -54.15 -63.33 1.18 Allowed 'General case' 0 N--CA 1.487 1.402 0 CA-C-N 115.999 -0.546 . . . . 0.0 111.293 -179.256 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 107' ' ' ASN . . . . . . . . . . . . . 15.8 m120 -75.84 32.46 0.11 Allowed 'General case' 0 N--CA 1.49 1.543 0 O-C-N 120.175 -1.578 . . . . 0.0 112.621 -175.398 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 108' ' ' GLU . . . . . . . . . . . . . 44.6 tp10 -60.48 148.55 37.26 Favored 'General case' 0 C--N 1.299 -1.597 0 C-N-CA 118.865 -1.134 . . . . 0.0 108.008 -179.684 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 109' ' ' SER . . . . . 0.536 ' C ' ' H ' ' A' ' 111' ' ' ASP . 1.3 t -96.57 121.62 38.59 Favored 'General case' 0 C--N 1.302 -1.49 0 O-C-N 121.039 -1.038 . . . . 0.0 109.683 -178.77 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 110' ' ' LEU . . . . . . . . . . . . . 12.7 tp -59.19 -1.57 0.2 Allowed 'General case' 0 C--N 1.302 -1.479 0 N-CA-C 108.54 -0.911 . . . . 0.0 108.54 -179.912 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 111' ' ' ASP . . . . . 0.536 ' H ' ' C ' ' A' ' 109' ' ' SER . 8.7 m-20 -131.77 20.58 4.62 Favored 'General case' 0 N--CA 1.487 1.406 0 N-CA-C 108.927 -0.768 . . . . 0.0 108.927 179.36 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 112' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -65.47 133.82 52.1 Favored 'General case' 0 N--CA 1.49 1.525 0 O-C-N 121.348 -0.845 . . . . 0.0 109.944 -179.958 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 113' ' ' GLN . . . . . 0.594 ' NE2' ' O ' ' A' ' 173' ' ' LYS . 0.0 OUTLIER -65.46 -4.33 5.62 Favored 'General case' 0 C--N 1.303 -1.436 0 O-C-N 121.058 -1.026 . . . . 0.0 108.869 179.032 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 114' ' ' ASN . . . . . 0.685 ' ND2' ' NE2' ' A' ' 178' ' ' GLN . 18.4 t-20 -143.38 91.19 2.24 Favored 'General case' 0 C--N 1.301 -1.517 0 N-CA-C 107.559 -1.274 . . . . 0.0 107.559 178.409 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 115' ' ' ILE . . . . . 0.439 ' O ' HG22 ' A' ' 115' ' ' ILE . 3.3 mt -100.69 115.14 41.61 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.466 0 O-C-N 121.627 -0.671 . . . . 0.0 109.913 -178.913 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 116' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -101.82 145.53 29.05 Favored 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.345 -0.847 . . . . 0.0 110.93 -179.149 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 117' ' ' ILE . . . . . . . . . . . . . 1.2 mt -135.15 157.38 40.37 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.461 0 N-CA-C 108.101 -1.074 . . . . 0.0 108.101 179.521 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 118' ' ' ALA . . . . . . . . . . . . . . . -142.62 161.82 37.08 Favored 'General case' 0 N--CA 1.492 1.658 0 O-C-N 120.822 -1.174 . . . . 0.0 111.177 -179.611 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 119' ' ' GLY . . . . . 0.703 ' HA2' HD11 ' A' ' 97' ' ' LEU . . . -170.29 143.54 7.87 Favored Glycine 0 N--CA 1.49 2.249 0 C-N-CA 120.191 -1.004 . . . . 0.0 110.755 179.801 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 120' ' ' HIS . . . . . . . . . . . . . 29.9 m170 -71.16 167.86 18.44 Favored 'General case' 0 N--CA 1.493 1.693 0 O-C-N 121.674 -0.898 . . . . 0.0 109.514 179.024 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 121' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -118.29 159.57 23.14 Favored 'General case' 0 N--CA 1.496 1.863 0 O-C-N 121.211 -0.931 . . . . 0.0 108.84 179.449 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 122' ' ' PHE . . . . . . . . . . . . . 0.5 OUTLIER -143.68 127.97 17.77 Favored 'General case' 0 N--CA 1.497 1.918 0 O-C-N 120.935 -1.103 . . . . 0.0 109.705 -179.623 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 123' ' ' ILE . . . . . 0.511 HG23 ' N ' ' A' ' 124' ' ' ASP . 4.4 tt -64.66 -40.11 87.92 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.55 0 N-CA-C 108.982 -0.748 . . . . 0.0 108.982 179.858 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 124' ' ' ASP . . . . . 0.511 ' N ' HG23 ' A' ' 123' ' ' ILE . 70.3 m-20 -89.11 26.08 1.69 Allowed 'General case' 0 N--CA 1.496 1.829 0 O-C-N 121.563 -0.711 . . . . 0.0 112.253 -177.358 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 125' ' ' ARG . . . . . 0.684 HH11 ' CG ' ' A' ' 125' ' ' ARG . 1.8 mtt-85 -154.29 100.77 2.45 Favored Pre-proline 0 N--CA 1.496 1.826 0 O-C-N 120.754 -1.216 . . . . 0.0 109.692 179.781 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 126' ' ' PRO . . . . . . . . . . . . . 73.1 Cg_endo -80.69 -28.08 2.9 Favored 'Trans proline' 0 C--N 1.315 -1.195 0 C-N-CA 122.107 1.871 . . . . 0.0 112.546 -179.934 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 127' ' ' ASN . . . . . 0.427 ' O ' ' O ' ' A' ' 128' ' ' TYR . 1.6 m120 -91.61 7.5 41.19 Favored 'General case' 0 N--CA 1.489 1.478 0 O-C-N 121.089 -1.007 . . . . 0.0 109.715 -179.864 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 128' ' ' TYR . . . . . 0.687 ' CE2' ' NE2' ' A' ' 129' ' ' GLN . 4.6 t80 -60.48 -151.25 0.0 OUTLIER 'General case' 0 C--N 1.301 -1.529 0 O-C-N 121.258 -0.901 . . . . 0.0 109.84 -179.733 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 129' ' ' GLN . . . . . 0.687 ' NE2' ' CE2' ' A' ' 128' ' ' TYR . 2.6 mp0 -67.78 -71.57 0.2 Allowed 'General case' 0 N--CA 1.489 1.478 0 O-C-N 121.341 -0.849 . . . . 0.0 110.051 -179.482 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 130' ' ' PHE . . . . . 0.503 ' CE2' HG11 ' A' ' 101' ' ' VAL . 55.4 m-85 -135.44 50.82 2.1 Favored 'General case' 0 N--CA 1.492 1.673 0 O-C-N 121.193 -0.942 . . . . 0.0 110.473 -179.371 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 131' ' ' THR . . . . . . . . . . . . . 2.9 m -82.13 -38.77 24.26 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.031 -1.043 . . . . 0.0 108.81 179.067 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 132' ' ' ASN . . . . . . . . . . . . . 4.8 t30 -84.34 6.42 23.12 Favored 'General case' 0 N--CA 1.494 1.731 0 C-N-CA 120.083 -0.647 . . . . 0.0 111.121 -178.91 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 133' ' ' LEU . . . . . 0.598 ' O ' ' N ' ' A' ' 135' ' ' ALA . 0.2 OUTLIER -68.5 -47.75 66.18 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 120.906 -1.121 . . . . 0.0 110.69 -179.04 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 134' ' ' LYS . . . . . 0.625 ' CD ' ' H ' ' A' ' 134' ' ' LYS . 0.1 OUTLIER -42.15 -18.48 0.01 OUTLIER 'General case' 0 N--CA 1.494 1.747 0 O-C-N 121.098 -1.001 . . . . 0.0 109.949 -179.025 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 135' ' ' ALA . . . . . 0.598 ' N ' ' O ' ' A' ' 133' ' ' LEU . . . -83.87 -31.82 25.53 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.063 -1.023 . . . . 0.0 109.94 -179.946 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 136' ' ' ALA . . . . . 0.817 ' HB2' ' HB2' ' A' ' 81' ' ' ALA . . . -80.78 153.99 27.45 Favored 'General case' 0 N--CA 1.489 1.518 0 CA-C-O 122.163 0.982 . . . . 0.0 112.142 -178.366 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 137' ' ' LYS . . . . . 0.524 ' O ' ' O ' ' A' ' 138' ' ' LYS . 4.8 tttt -150.92 -166.93 2.67 Favored 'General case' 0 N--CA 1.493 1.717 0 C-N-CA 118.926 -1.11 . . . . 0.0 110.879 -178.197 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 138' ' ' LYS . . . . . 0.592 ' O ' ' N ' ' A' ' 140' ' ' SER . 36.3 mttm -44.45 178.72 0.0 OUTLIER 'General case' 0 N--CA 1.487 1.378 0 CA-C-O 122.221 1.01 . . . . 0.0 110.971 -178.755 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 139' ' ' GLY . . . . . . . . . . . . . . . 46.6 7.59 0.02 OUTLIER Glycine 0 N--CA 1.491 2.351 0 N-CA-C 110.545 -1.022 . . . . 0.0 110.545 -179.959 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 140' ' ' SER . . . . . 0.592 ' N ' ' O ' ' A' ' 138' ' ' LYS . 48.7 m -84.77 121.57 27.88 Favored 'General case' 0 N--CA 1.495 1.785 0 O-C-N 120.809 -1.406 . . . . 0.0 109.215 179.244 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 141' ' ' MET . . . . . 0.646 ' SD ' ' N ' ' A' ' 142' ' ' VAL . 10.8 tpp -72.47 131.76 42.98 Favored 'General case' 0 N--CA 1.488 1.462 0 O-C-N 121.125 -0.984 . . . . 0.0 109.223 179.898 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 142' ' ' VAL . . . . . 0.646 ' N ' ' SD ' ' A' ' 141' ' ' MET . 3.2 t -116.02 133.13 63.46 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.702 0 N-CA-C 108.794 -0.817 . . . . 0.0 108.794 -179.593 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 143' ' ' TYR . . . . . . . . . . . . . 17.9 m-85 -109.23 135.28 50.59 Favored 'General case' 0 N--CA 1.497 1.92 0 O-C-N 120.89 -1.132 . . . . 0.0 111.531 -178.434 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 144' ' ' PHE . . . . . . . . . . . . . 49.1 t80 -120.25 101.86 8.1 Favored 'General case' 0 N--CA 1.495 1.793 0 C-N-CA 120.359 -0.536 . . . . 0.0 109.566 -179.432 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 145' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -96.65 132.1 42.64 Favored 'General case' 0 N--CA 1.493 1.708 0 O-C-N 121.205 -0.935 . . . . 0.0 110.878 -178.822 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 146' ' ' VAL . . . . . 0.414 ' O ' ' C ' ' A' ' 147' ' ' GLY . 0.1 OUTLIER -142.96 143.78 24.79 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.738 0 N-CA-C 107.764 -1.199 . . . . 0.0 107.764 178.655 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 147' ' ' GLY . . . . . 0.414 ' C ' ' O ' ' A' ' 146' ' ' VAL . . . 44.37 -130.77 7.25 Favored Glycine 0 N--CA 1.489 2.221 0 O-C-N 120.28 -1.512 . . . . 0.0 109.324 -179.958 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 148' ' ' ASN . . . . . 0.575 HD22 ' C ' ' A' ' 148' ' ' ASN . 0.4 OUTLIER -102.86 18.49 21.4 Favored 'General case' 0 C--N 1.3 -1.572 0 O-C-N 121.374 -1.074 . . . . 0.0 108.588 179.537 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 149' ' ' GLU . . . . . . . . . . . . . 8.4 tt0 -114.38 147.94 38.41 Favored 'General case' 0 N--CA 1.489 1.523 0 CA-C-O 121.862 0.839 . . . . 0.0 111.249 -178.538 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 150' ' ' THR . . . . . 0.487 HG22 ' O ' ' A' ' 150' ' ' THR . 1.2 m -129.24 105.68 8.31 Favored 'General case' 0 N--CA 1.492 1.646 0 CA-C-O 121.585 0.707 . . . . 0.0 109.675 179.941 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 151' ' ' ARG . . . . . . . . . . . . . 10.8 mtp180 -87.34 -171.6 3.55 Favored 'General case' 0 N--CA 1.487 1.401 0 N-CA-C 108.624 -0.88 . . . . 0.0 108.624 -179.967 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 152' ' ' LYS . . . . . . . . . . . . . 1.1 ttmt -150.41 147.36 27.46 Favored 'General case' 0 C--N 1.303 -1.442 0 O-C-N 120.918 -1.114 . . . . 0.0 110.787 -179.299 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 153' ' ' TYR . . . . . 0.562 ' O ' ' SD ' ' A' ' 141' ' ' MET . 22.2 m-85 -142.2 165.6 26.98 Favored 'General case' 0 N--CA 1.49 1.574 0 N-CA-C 108.024 -1.102 . . . . 0.0 108.024 179.24 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 154' ' ' LYS . . . . . . . . . . . . . 30.9 ttpt -142.91 121.02 12.15 Favored 'General case' 0 N--CA 1.493 1.684 0 O-C-N 121.061 -1.025 . . . . 0.0 108.666 178.854 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 155' ' ' MET . . . . . . . . . . . . . 4.1 mtt -47.1 105.9 0.08 Allowed 'General case' 0 N--CA 1.493 1.687 0 O-C-N 120.889 -1.132 . . . . 0.0 112.017 -178.419 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 156' ' ' THR . . . . . 0.657 ' OG1' HG23 ' A' ' 203' ' ' THR . 0.0 OUTLIER -107.46 -23.38 12.21 Favored 'General case' 0 C--N 1.293 -1.886 0 CA-C-N 115.16 -0.927 . . . . 0.0 110.112 -179.572 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 157' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -153.16 150.43 29.06 Favored 'General case' 0 C--N 1.296 -1.728 0 C-N-CA 118.388 -1.325 . . . . 0.0 111.363 -178.797 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 158' ' ' ILE . . . . . 0.432 HG13 ' CD2' ' A' ' 200' ' ' PHE . 0.0 OUTLIER -154.18 145.12 14.08 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.357 0 CA-C-O 121.872 0.844 . . . . 0.0 110.055 -179.276 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 159' ' ' ARG . . . . . 0.424 ' N ' HG12 ' A' ' 158' ' ' ILE . 0.1 OUTLIER -151.38 156.6 41.04 Favored 'General case' 0 C--N 1.3 -1.568 0 CA-C-O 121.52 0.676 . . . . 0.0 109.747 -179.792 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 160' ' ' ASP . . . . . 0.5 ' C ' HG22 ' A' ' 161' ' ' VAL . 2.2 m-20 -117.62 157.08 27.04 Favored 'General case' 0 N--CA 1.49 1.563 0 N-CA-C 108.781 -0.822 . . . . 0.0 108.781 -179.909 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 161' ' ' VAL . . . . . 0.5 HG22 ' C ' ' A' ' 160' ' ' ASP . 0.1 OUTLIER -163.43 160.24 1.29 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.654 0 O-C-N 121.072 -1.017 . . . . 0.0 110.49 -179.912 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 162' ' ' LYS . . . . . . . . . . . . . 14.1 ptmt -52.13 177.88 0.06 OUTLIER Pre-proline 0 N--CA 1.49 1.562 0 N-CA-C 108.694 -0.854 . . . . 0.0 108.694 179.043 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 163' ' ' PRO . . . . . 0.721 ' C ' HD11 ' C' ' 702' ' ' LEU . 37.3 Cg_endo -86.63 43.39 1.03 Allowed 'Trans proline' 0 C--N 1.316 -1.18 0 C-N-CA 122.238 1.959 . . . . 0.0 112.502 -179.344 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 164' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -151.93 -11.21 0.2 Allowed 'General case' 0 N--CA 1.494 1.741 0 O-C-N 121.262 -0.899 . . . . 0.0 110.372 -179.972 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 165' ' ' ASP . . . . . 0.449 ' O ' ' C ' ' A' ' 166' ' ' VAL . 1.2 t70 -73.21 61.93 0.65 Allowed 'General case' 0 N--CA 1.49 1.558 0 O-C-N 120.867 -1.146 . . . . 0.0 110.258 -179.301 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 166' ' ' VAL . . . . . 0.623 ' O ' ' N ' ' A' ' 168' ' ' VAL . 0.9 OUTLIER -41.89 -31.42 0.35 Allowed 'Isoleucine or valine' 0 N--CA 1.494 1.73 0 O-C-N 121.399 -0.813 . . . . 0.0 109.023 -178.329 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 167' ' ' GLY . . . . . . . . . . . . . . . -42.65 -13.38 0.01 OUTLIER Glycine 0 N--CA 1.494 2.546 0 O-C-N 121.06 -1.025 . . . . 0.0 110.742 179.892 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 168' ' ' VAL . . . . . 0.623 ' N ' ' O ' ' A' ' 166' ' ' VAL . 6.1 m -53.46 -35.64 25.67 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.468 0 O-C-N 120.708 -1.466 . . . . 0.0 108.738 179.62 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 169' ' ' LEU . . . . . 0.522 ' O ' ' N ' ' A' ' 171' ' ' GLU . 27.8 mt -51.86 -7.19 0.05 OUTLIER 'General case' 0 N--CA 1.495 1.805 0 N-CA-C 108.004 -1.11 . . . . 0.0 108.004 -179.272 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 170' ' ' ASP . . . . . 0.604 ' CG ' HE22 ' A' ' 178' ' ' GLN . 34.4 t0 35.16 28.58 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.525 0 O-C-N 121.764 -0.585 . . . . 0.0 111.87 177.687 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 171' ' ' GLU . . . . . 0.522 ' N ' ' O ' ' A' ' 169' ' ' LEU . 12.7 pt-20 -62.3 94.26 0.06 Allowed 'General case' 0 N--CA 1.494 1.767 0 O-C-N 120.382 -1.449 . . . . 0.0 107.45 178.105 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 172' ' ' GLN . . . . . . . . . . . . . 2.2 mt-30 -152.66 -78.16 0.11 Allowed 'General case' 0 N--CA 1.497 1.877 0 O-C-N 121.434 -0.791 . . . . 0.0 110.548 -178.595 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 173' ' ' LYS . . . . . 0.594 ' O ' ' NE2' ' A' ' 113' ' ' GLN . 1.0 OUTLIER -55.95 136.52 51.77 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.43 -0.794 . . . . 0.0 109.386 -179.432 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 174' ' ' GLY . . . . . 0.477 ' O ' ' C ' ' A' ' 175' ' ' LYS . . . -120.03 -45.78 0.4 Allowed Glycine 0 N--CA 1.479 1.527 0 N-CA-C 107.441 -2.263 . . . . 0.0 107.441 179.239 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 175' ' ' LYS . . . . . 0.477 ' C ' ' O ' ' A' ' 174' ' ' GLY . 0.4 OUTLIER -38.13 -75.44 0.03 OUTLIER 'General case' 0 N--CA 1.493 1.724 0 N-CA-C 108.272 -1.011 . . . . 0.0 108.272 179.562 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 176' ' ' ASP . . . . . 0.547 ' O ' ' O ' ' A' ' 177' ' ' LYS . 66.7 m-20 -89.97 94.7 9.9 Favored 'General case' 0 C--N 1.296 -1.754 0 N-CA-C 106.967 -1.494 . . . . 0.0 106.967 177.943 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 177' ' ' LYS . . . . . 0.547 ' O ' ' O ' ' A' ' 176' ' ' ASP . 19.6 mttp -44.19 -178.4 0.0 OUTLIER 'General case' 0 N--CA 1.493 1.687 0 CA-C-O 121.487 0.66 . . . . 0.0 110.795 -178.311 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 178' ' ' GLN . . . . . 0.685 ' NE2' ' ND2' ' A' ' 114' ' ' ASN . 20.3 pt20 -161.06 161.38 31.29 Favored 'General case' 0 N--CA 1.487 1.386 0 C-N-CA 118.557 -1.257 . . . . 0.0 111.089 179.86 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 179' ' ' LEU . . . . . . . . . . . . . 1.2 tp -123.6 94.34 4.21 Favored 'General case' 0 C--N 1.303 -1.445 0 N-CA-C 106.944 -1.502 . . . . 0.0 106.944 177.398 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 180' ' ' THR . . . . . . . . . . . . . 3.3 m -71.64 120.32 17.06 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.111 -0.993 . . . . 0.0 110.427 -178.097 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 181' ' ' LEU . . . . . 0.466 HD21 ' HG ' ' A' ' 133' ' ' LEU . 34.4 tp -95.98 142.6 28.01 Favored 'General case' 0 C--N 1.302 -1.498 0 N-CA-C 108.153 -1.054 . . . . 0.0 108.153 178.338 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 182' ' ' ILE . . . . . 0.487 HG22 ' O ' ' A' ' 182' ' ' ILE . 3.9 mt -136.39 109.69 8.83 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.612 0 O-C-N 121.02 -1.05 . . . . 0.0 108.689 178.9 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 183' ' ' THR . . . . . 0.548 HG23 ' O ' ' A' ' 183' ' ' THR . 4.4 t -129.76 113.06 14.25 Favored 'General case' 0 C--N 1.293 -1.881 0 N-CA-C 107.337 -1.357 . . . . 0.0 107.337 179.327 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 184' ' ' CYS . . . . . . . . . . . . . 0.8 OUTLIER -79.23 164.03 24.49 Favored 'General case' 0 C--N 1.289 -2.026 0 C-N-CA 118.994 -1.082 . . . . 0.0 111.145 -177.691 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 185' ' ' ASP . . . . . . . . . . . . . 9.9 t0 -165.2 -154.33 0.21 Allowed 'General case' 0 N--CA 1.493 1.687 0 N-CA-C 108.892 -0.781 . . . . 0.0 108.892 -179.829 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 186' ' ' ASP . . . . . . . . . . . . . 1.5 m-20 49.43 59.28 4.6 Favored 'General case' 0 N--CA 1.495 1.802 0 O-C-N 120.95 -1.094 . . . . 0.0 108.971 -179.666 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 187' ' ' TYR . . . . . 0.607 ' CE2' ' O ' ' A' ' 188' ' ' ASN . 68.2 t80 -67.4 138.76 56.94 Favored 'General case' 0 N--CA 1.491 1.579 0 CA-C-O 121.85 0.833 . . . . 0.0 110.871 -179.184 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 188' ' ' ASN . . . . . 0.607 ' O ' ' CE2' ' A' ' 187' ' ' TYR . 0.7 OUTLIER -104.32 143.72 32.59 Favored 'General case' 0 C--N 1.299 -1.589 0 N-CA-C 108.305 -0.998 . . . . 0.0 108.305 178.391 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 189' ' ' GLU . . . . . . . . . . . . . 2.5 tt0 -108.22 -17.05 14.11 Favored 'General case' 0 C--N 1.293 -1.891 0 N-CA-C 108.879 -0.786 . . . . 0.0 108.879 -179.284 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 190' ' ' LYS . . . . . . . . . . . . . 24.4 mmtm -82.77 -51.64 7.49 Favored 'General case' 0 C--N 1.301 -1.541 0 C-N-CA 119.792 -0.763 . . . . 0.0 108.96 179.154 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 191' ' ' THR . . . . . . . . . . . . . 4.1 p -89.83 -10.91 43.64 Favored 'General case' 0 N--CA 1.489 1.477 0 O-C-N 121.442 -0.786 . . . . 0.0 109.802 -179.608 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 192' ' ' GLY . . . . . . . . . . . . . . . 63.73 39.32 97.36 Favored Glycine 0 N--CA 1.494 2.537 0 O-C-N 120.945 -1.097 . . . . 0.0 110.375 179.25 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 193' ' ' VAL . . . . . 0.591 HG12 ' N ' ' A' ' 194' ' ' TRP . 55.4 t -147.99 163.45 6.19 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.571 0 O-C-N 121.114 -1.227 . . . . 0.0 109.679 179.959 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 194' ' ' TRP . . . . . 0.591 ' N ' HG12 ' A' ' 193' ' ' VAL . 10.0 m95 -82.29 118.81 23.41 Favored 'General case' 0 C--N 1.301 -1.524 0 N-CA-C 108.356 -0.979 . . . . 0.0 108.356 179.613 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 195' ' ' GLU . . . . . 0.545 ' CD ' ' ND2' ' A' ' 188' ' ' ASN . 2.8 mt-10 -79.2 -60.82 2.22 Favored 'General case' 0 N--CA 1.493 1.692 0 O-C-N 121.32 -0.863 . . . . 0.0 110.946 -178.528 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 196' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -95.29 152.82 18.04 Favored 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.197 -0.939 . . . . 0.0 110.121 -178.789 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 197' ' ' ARG . . . . . 0.672 ' HE ' HD22 ' C' ' 702' ' ' LEU . 0.1 OUTLIER -122.94 143.18 50.07 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.668 -0.645 . . . . 0.0 109.723 179.86 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 198' ' ' LYS . . . . . . . . . . . . . 4.2 mptp? -113.77 120.72 41.75 Favored 'General case' 0 C--N 1.302 -1.487 0 O-C-N 121.7 -0.625 . . . . 0.0 109.56 -179.68 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 199' ' ' ILE . . . . . 0.662 ' C ' HD12 ' A' ' 199' ' ' ILE . 0.5 OUTLIER -139.66 118.41 12.13 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.677 0 CA-C-O 122.502 1.144 . . . . 0.0 109.829 179.926 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 200' ' ' PHE . . . . . 0.527 ' CD1' ' N ' ' A' ' 200' ' ' PHE . 6.6 m-85 -100.57 138.5 37.54 Favored 'General case' 0 N--CA 1.494 1.728 0 O-C-N 121.353 -0.842 . . . . 0.0 109.912 -178.626 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 201' ' ' VAL . . . . . . . . . . . . . 44.6 t -101.61 136.34 33.97 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.543 0 N-CA-C 107.795 -1.187 . . . . 0.0 107.795 177.662 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 202' ' ' ALA . . . . . . . . . . . . . . . -121.16 134.59 55.23 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.238 -0.914 . . . . 0.0 109.171 -179.939 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 203' ' ' THR . . . . . 0.657 HG23 ' OG1' ' A' ' 156' ' ' THR . 13.7 p -88.76 133.34 34.27 Favored 'General case' 0 C--N 1.306 -1.316 0 CA-C-O 122.158 0.98 . . . . 0.0 110.99 -178.72 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 204' ' ' GLU . . . . . 0.523 ' HA ' ' CD2' ' A' ' 153' ' ' TYR . 3.1 tt0 -51.72 133.84 30.87 Favored 'General case' 0 C--N 1.297 -1.686 0 C-N-CA 118.811 -1.155 . . . . 0.0 109.38 179.394 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 205' ' ' VAL . . . . . 0.545 HG23 ' O ' ' A' ' 203' ' ' THR . 44.3 t -127.53 161.66 34.64 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.295 0 CA-C-O 122.044 0.926 . . . . 0.0 110.242 -177.59 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 206' ' ' LYS . . . . . 0.497 ' N ' HG12 ' A' ' 205' ' ' VAL . 70.7 mttt . . . . . 0 C--N 1.296 -1.731 0 CA-C-O 118.047 -0.978 . . . . 0.0 109.294 179.85 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' C' C ' 701' ' ' PHQ . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 008 nuclear nobuild full ' C' C ' 702' ' ' LEU . . . . . 0.721 HD11 ' C ' ' A' ' 163' ' ' PRO . 0.0 OUTLIER . . . . . 0 N--CA 1.492 1.661 0 N-CA-C 109.227 -0.657 . . . . 0.0 109.227 . . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' C' C ' 703' ' ' PRO . . . . . 0.551 ' O ' ' NH2' ' A' ' 197' ' ' ARG . 16.3 Cg_endo -57.99 162.98 10.29 Favored 'Trans proline' 0 N--CA 1.499 1.845 0 C-N-CA 123.633 2.888 . . . . 0.0 113.55 -178.934 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' C' C ' 704' ' ' ALA . . . . . 0.47 ' C ' ' O ' ' C' ' 703' ' ' PRO . . . 34.97 -151.38 0.0 OUTLIER 'General case' 0 N--CA 1.491 1.622 0 CA-C-O 121.39 0.614 . . . . 0.0 110.277 179.274 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' C' C ' 705' ' ' B27 . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 008 nuclear nobuild full ' A' A ' 700' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 009 nuclear nobuild full ' A' A ' 59' ' ' MET . . . . . . . . . . . . . 1.1 ttp . . . . . 0 N--CA 1.49 1.555 0 CA-C-O 121.31 0.576 . . . . 0.0 109.491 . . . . . . . . . 0 0 . 1 . 009 nuclear nobuild full ' A' A ' 60' ' ' GLN . . . . . . . . . . . . . 1.5 tt0 -60.89 145.24 50.9 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.298 -0.876 . . . . 0.0 109.702 -179.936 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 61' ' ' ALA . . . . . 0.558 ' HB2' HD21 ' A' ' 148' ' ' ASN . . . -64.71 172.24 2.87 Favored 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.156 -0.965 . . . . 0.0 109.479 179.908 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 62' ' ' LYS . . . . . . . . . . . . . 6.8 tttt -143.77 72.12 17.11 Favored Pre-proline 0 N--CA 1.489 1.478 0 O-C-N 121.156 -0.965 . . . . 0.0 109.59 179.848 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 63' ' ' PRO . . . . . 0.602 ' HG2' HD23 ' A' ' 110' ' ' LEU . 52.1 Cg_endo -88.4 156.54 6.64 Favored 'Trans proline' 0 C--N 1.305 -1.763 0 C-N-CA 123.6 2.867 . . . . 0.0 111.467 179.536 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 64' ' ' GLN . . . . . 0.638 ' NE2' ' N ' ' A' ' 64' ' ' GLN . 0.0 OUTLIER -156.36 127.73 7.1 Favored 'General case' 0 N--CA 1.495 1.793 0 O-C-N 120.955 -1.091 . . . . 0.0 109.62 179.366 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 65' ' ' ILE . . . . . 0.639 HD13 ' H ' ' A' ' 65' ' ' ILE . 0.0 OUTLIER -50.79 110.03 1.58 Allowed Pre-proline 0 N--CA 1.49 1.552 0 O-C-N 121.085 -1.009 . . . . 0.0 109.195 178.929 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 66' ' ' PRO . . . . . . . . . . . . . 89.0 Cg_endo -85.64 -154.47 0.05 OUTLIER 'Trans proline' 0 C--N 1.312 -1.392 0 C-N-CA 121.954 1.769 . . . . 0.0 111.712 179.607 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 67' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -83.71 -4.69 58.83 Favored 'General case' 0 N--CA 1.488 1.46 0 O-C-N 121.189 -0.944 . . . . 0.0 109.185 179.553 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 68' ' ' ASP . . . . . 0.634 ' C ' ' N ' ' A' ' 70' ' ' SER . 4.6 t0 -76.14 52.1 0.71 Allowed 'General case' 0 N--CA 1.49 1.574 0 CA-C-O 122.221 1.01 . . . . 0.0 110.099 -179.689 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 69' ' ' LYS . . . . . 0.413 ' C ' ' O ' ' A' ' 68' ' ' ASP . 0.0 OUTLIER -49.38 -13.45 0.08 Allowed 'General case' 0 N--CA 1.507 2.375 0 C-N-CA 116.723 -1.991 . . . . 0.0 106.749 177.593 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 70' ' ' SER . . . . . 0.634 ' N ' ' C ' ' A' ' 68' ' ' ASP . 0.0 OUTLIER -83.31 -8.22 59.47 Favored 'General case' 0 N--CA 1.497 1.896 0 CA-C-N 113.331 -1.759 . . . . 0.0 110.381 179.557 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 71' ' ' LYS . . . . . . . . . . . . . 8.3 ptmt -101.88 142.88 32.49 Favored 'General case' 0 N--CA 1.495 1.793 0 O-C-N 121.021 -1.049 . . . . 0.0 110.643 179.875 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 72' ' ' VAL . . . . . 0.719 HG12 ' CE1' ' A' ' 88' ' ' TYR . 0.9 OUTLIER -64.92 142.63 16.68 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.434 0 N-CA-C 105.309 -2.108 . . . . 0.0 105.309 175.291 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 73' ' ' ALA . . . . . 0.498 ' N ' ' O ' ' A' ' 87' ' ' VAL . . . -83.16 -14.0 54.39 Favored 'General case' 0 C--N 1.296 -1.757 0 O-C-N 120.101 -1.624 . . . . 0.0 107.134 179.944 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 74' ' ' GLY . . . . . 0.409 ' N ' HG23 ' A' ' 72' ' ' VAL . . . 173.83 -157.11 25.1 Favored Glycine 0 C--N 1.296 -1.677 0 N-CA-C 108.595 -1.802 . . . . 0.0 108.595 179.472 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 75' ' ' TYR . . . . . 0.55 ' CE1' ' N ' ' A' ' 86' ' ' PRO . 0.3 OUTLIER -142.96 171.09 14.52 Favored 'General case' 0 C--N 1.292 -1.909 0 O-C-N 121.441 -1.034 . . . . 0.0 110.335 -177.624 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 76' ' ' ILE . . . . . . . . . . . . . 0.5 OUTLIER -148.12 143.72 19.19 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.601 0 C-N-CA 119.048 -1.061 . . . . 0.0 109.77 -177.29 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 2.2 mt-10 -151.53 163.35 39.23 Favored 'General case' 0 C--N 1.304 -1.41 0 O-C-N 121.136 -0.977 . . . . 0.0 109.254 179.573 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 78' ' ' ILE . . . . . 0.493 ' HB ' ' HB3' ' A' ' 81' ' ' ALA . 14.6 mt -144.77 126.51 7.95 Favored Pre-proline 0 N--CA 1.492 1.656 0 N-CA-C 108.538 -0.912 . . . . 0.0 108.538 179.886 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 79' ' ' PRO . . . . . . . . . . . . . 36.0 Cg_endo -71.52 -48.73 0.39 Allowed 'Trans proline' 0 N--CA 1.491 1.362 0 C-N-CA 122.011 1.807 . . . . 0.0 113.501 -179.064 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 50.5 t0 -66.48 -21.24 66.18 Favored 'General case' 0 N--CA 1.493 1.705 0 O-C-N 120.976 -1.077 . . . . 0.0 111.306 178.806 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 81' ' ' ALA . . . . . 0.87 ' HB2' ' HB2' ' A' ' 136' ' ' ALA . . . -104.55 -16.44 15.04 Favored 'General case' 0 N--CA 1.493 1.685 0 O-C-N 120.833 -1.167 . . . . 0.0 108.991 179.657 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 82' ' ' ASP . . . . . . . . . . . . . 8.5 t0 61.17 53.57 3.54 Favored 'General case' 0 N--CA 1.494 1.735 0 O-C-N 121.284 -0.885 . . . . 0.0 111.462 178.518 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 83' ' ' ILE . . . . . . . . . . . . . 50.8 mt -128.96 154.45 39.98 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.794 0 O-C-N 121.027 -1.045 . . . . 0.0 109.43 -179.798 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 84' ' ' LYS . . . . . . . . . . . . . 2.1 pttt -157.81 107.72 2.14 Favored 'General case' 0 N--CA 1.487 1.422 0 N-CA-C 107.959 -1.126 . . . . 0.0 107.959 -179.786 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 85' ' ' GLU . . . . . 0.498 ' C ' ' CE1' ' A' ' 75' ' ' TYR . 0.1 OUTLIER -141.17 160.32 58.13 Favored Pre-proline 0 N--CA 1.493 1.682 0 O-C-N 121.336 -0.852 . . . . 0.0 110.126 -179.065 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 86' ' ' PRO . . . . . 0.55 ' N ' ' CE1' ' A' ' 75' ' ' TYR . 36.7 Cg_endo -68.18 168.85 18.08 Favored 'Trans proline' 0 C--N 1.307 -1.611 0 C-N-CA 123.095 2.53 . . . . 0.0 113.081 -179.061 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 87' ' ' VAL . . . . . 0.502 HG23 ' HA ' ' A' ' 75' ' ' TYR . 94.1 t -127.46 99.31 5.2 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.627 0 N-CA-C 109.106 -0.701 . . . . 0.0 109.106 179.69 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 88' ' ' TYR . . . . . 0.719 ' CE1' HG12 ' A' ' 72' ' ' VAL . 20.9 m-85 -92.34 154.18 42.86 Favored Pre-proline 0 N--CA 1.503 2.204 0 O-C-N 120.873 -1.142 . . . . 0.0 109.79 -179.734 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 89' ' ' PRO . . . . . . . . . . . . . 7.3 Cg_endo -59.02 144.6 99.3 Favored 'Trans proline' 0 C--N 1.309 -1.518 0 C-N-CA 122.476 2.117 . . . . 0.0 113.551 -179.663 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . -59.14 169.1 6.23 Favored Glycine 0 N--CA 1.494 2.541 0 N-CA-C 108.899 -1.681 . . . . 0.0 108.899 178.902 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 91' ' ' PRO . . . . . 0.435 ' C ' ' H ' ' A' ' 93' ' ' THR . 59.8 Cg_endo -93.56 168.02 20.96 Favored 'Cis proline' 0 C--N 1.31 -1.452 0 C-N-CA 124.046 -1.231 . . . . 0.0 111.916 0.619 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 92' ' ' ALA . . . . . 0.473 ' HB1' HD21 ' A' ' 97' ' ' LEU . . . -71.99 32.05 0.06 Allowed 'General case' 0 N--CA 1.493 1.706 0 O-C-N 121.159 -0.963 . . . . 0.0 110.716 -179.664 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 93' ' ' THR . . . . . 0.435 ' H ' ' C ' ' A' ' 91' ' ' PRO . 0.8 OUTLIER -73.46 155.1 89.76 Favored Pre-proline 0 N--CA 1.489 1.523 0 O-C-N 120.692 -1.255 . . . . 0.0 108.751 -179.956 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 94' ' ' PRO . . . . . 0.401 ' C ' ' O ' ' A' ' 93' ' ' THR . 85.2 Cg_exo -34.55 -55.78 0.5 Allowed 'Trans proline' 0 C--N 1.306 -1.668 0 C-N-CA 122.818 2.346 . . . . 0.0 112.387 -179.506 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 95' ' ' GLU . . . . . 0.479 ' OE2' ' OE1' ' A' ' 96' ' ' GLN . 0.1 OUTLIER -47.36 -48.74 25.55 Favored 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.083 -1.011 . . . . 0.0 109.67 -179.812 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 96' ' ' GLN . . . . . 0.594 ' O ' ' N ' ' A' ' 98' ' ' ASN . 5.9 mp0 -71.94 -56.1 6.28 Favored 'General case' 0 N--CA 1.489 1.476 0 O-C-N 121.04 -1.038 . . . . 0.0 110.572 -179.563 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 97' ' ' LEU . . . . . 0.473 HD21 ' HB1' ' A' ' 92' ' ' ALA . 93.6 mt -48.09 -7.0 0.02 OUTLIER 'General case' 0 N--CA 1.494 1.74 0 O-C-N 121.193 -0.942 . . . . 0.0 110.005 -178.939 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 98' ' ' ASN . . . . . 0.716 HD21 ' NE ' ' A' ' 99' ' ' ARG . 0.2 OUTLIER -73.4 -26.35 60.95 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.201 -0.937 . . . . 0.0 109.042 179.274 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 99' ' ' ARG . . . . . 0.716 ' NE ' HD21 ' A' ' 98' ' ' ASN . 4.3 mtt180 -95.08 -51.15 4.77 Favored 'General case' 0 N--CA 1.488 1.442 0 C-N-CA 119.842 -0.743 . . . . 0.0 109.783 -179.218 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . 176.44 -165.29 35.55 Favored Glycine 0 N--CA 1.491 2.325 0 C-N-CA 119.462 -1.351 . . . . 0.0 110.232 179.776 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 101' ' ' VAL . . . . . 0.723 ' O ' HG23 ' A' ' 101' ' ' VAL . 21.0 m -58.47 105.76 0.19 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.632 0 O-C-N 121.498 -1.001 . . . . 0.0 109.554 -179.676 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -92.68 166.65 12.36 Favored 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.476 -0.765 . . . . 0.0 110.775 -179.519 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 103' ' ' PHE . . . . . 0.479 ' CE1' ' CG1' ' A' ' 87' ' ' VAL . 25.5 m-85 -72.25 131.15 42.34 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 120.987 -1.071 . . . . 0.0 108.176 178.458 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 104' ' ' ALA . . . . . 0.476 ' HB1' ' HG2' ' C' ' 703' ' ' PRO . . . -51.93 -7.21 0.05 OUTLIER 'General case' 0 C--N 1.295 -1.786 0 O-C-N 121.416 -0.802 . . . . 0.0 111.873 -178.596 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -141.22 139.54 33.81 Favored 'General case' 0 N--CA 1.499 2.023 0 O-C-N 120.444 -1.41 . . . . 0.0 111.469 -179.682 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 106' ' ' GLU . . . . . . . . . . . . . 1.9 pt-20 -54.3 -62.0 1.94 Allowed 'General case' 0 N--CA 1.488 1.472 0 O-C-N 121.855 -0.528 . . . . 0.0 109.947 179.51 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 107' ' ' ASN . . . . . . . . . . . . . 8.1 m120 -76.83 35.32 0.16 Allowed 'General case' 0 N--CA 1.489 1.483 0 O-C-N 120.545 -1.347 . . . . 0.0 111.607 -176.833 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 108' ' ' GLU . . . . . . . . . . . . . 35.1 tp10 -57.19 144.37 35.44 Favored 'General case' 0 C--N 1.303 -1.428 0 O-C-N 120.813 -1.179 . . . . 0.0 107.83 -179.802 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 109' ' ' SER . . . . . 0.557 ' C ' ' H ' ' A' ' 111' ' ' ASP . 1.2 m -101.24 124.85 47.59 Favored 'General case' 0 C--N 1.303 -1.438 0 O-C-N 121.058 -1.026 . . . . 0.0 110.648 -178.455 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 110' ' ' LEU . . . . . 0.602 HD23 ' HG2' ' A' ' 63' ' ' PRO . 3.5 tp -58.99 -3.45 0.35 Allowed 'General case' 0 C--N 1.3 -1.548 0 N-CA-C 107.693 -1.225 . . . . 0.0 107.693 179.066 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 111' ' ' ASP . . . . . 0.557 ' H ' ' C ' ' A' ' 109' ' ' SER . 1.6 m-20 -132.17 21.66 4.46 Favored 'General case' 0 N--CA 1.486 1.363 0 N-CA-C 109.128 -0.693 . . . . 0.0 109.128 179.696 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 112' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -64.96 138.34 58.3 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 120.985 -1.072 . . . . 0.0 109.543 179.839 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 113' ' ' GLN . . . . . 0.566 HE21 ' C ' ' A' ' 113' ' ' GLN . 0.0 OUTLIER -66.29 -5.86 11.98 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 120.94 -1.1 . . . . 0.0 108.696 179.201 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 114' ' ' ASN . . . . . 0.608 ' OD1' ' NE2' ' A' ' 178' ' ' GLN . 4.1 t30 -145.54 97.34 2.97 Favored 'General case' 0 C--N 1.297 -1.7 0 N-CA-C 107.305 -1.369 . . . . 0.0 107.305 178.16 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 115' ' ' ILE . . . . . 0.509 HG22 ' O ' ' A' ' 115' ' ' ILE . 1.8 mt -95.64 107.09 19.12 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.599 0 O-C-N 121.13 -0.981 . . . . 0.0 108.694 -179.522 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 116' ' ' SER . . . . . . . . . . . . . 7.5 p -90.22 154.71 19.53 Favored 'General case' 0 C--N 1.305 -1.355 0 CA-C-O 121.728 0.775 . . . . 0.0 110.814 -178.458 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 117' ' ' ILE . . . . . 0.419 HD13 HG21 ' A' ' 117' ' ' ILE . 3.2 mt -144.35 153.68 15.18 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.412 0 N-CA-C 108.337 -0.986 . . . . 0.0 108.337 179.135 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 118' ' ' ALA . . . . . 0.417 ' HB3' ' HB2' ' A' ' 92' ' ' ALA . . . -140.34 153.9 46.57 Favored 'General case' 0 N--CA 1.49 1.562 0 C-N-CA 119.217 -0.993 . . . . 0.0 110.481 -179.586 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 119' ' ' GLY . . . . . . . . . . . . . . . -166.57 148.17 13.07 Favored Glycine 0 N--CA 1.487 2.074 0 C-N-CA 119.912 -1.137 . . . . 0.0 110.715 -179.988 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 120' ' ' HIS . . . . . 0.501 ' ND1' ' SG ' ' C' ' 705' ' ' B27 . 3.2 m-70 -72.47 161.74 30.41 Favored 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.919 -0.754 . . . . 0.0 110.006 179.337 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 121' ' ' THR . . . . . . . . . . . . . 1.1 t -116.22 158.29 23.55 Favored 'General case' 0 N--CA 1.496 1.85 0 O-C-N 121.338 -0.851 . . . . 0.0 109.079 178.958 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 122' ' ' PHE . . . . . . . . . . . . . 0.3 OUTLIER -124.67 127.03 46.68 Favored 'General case' 0 N--CA 1.498 1.946 0 O-C-N 121.296 -0.877 . . . . 0.0 109.852 -179.637 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 123' ' ' ILE . . . . . 0.534 HG23 ' N ' ' A' ' 124' ' ' ASP . 16.3 tt -74.73 -36.74 41.08 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.665 0 CA-C-O 121.922 0.868 . . . . 0.0 109.141 179.712 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 124' ' ' ASP . . . . . 0.534 ' N ' HG23 ' A' ' 123' ' ' ILE . 2.0 p30 -95.54 22.49 7.01 Favored 'General case' 0 C--N 1.296 -1.756 0 O-C-N 121.827 -0.546 . . . . 0.0 111.042 -179.224 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 125' ' ' ARG . . . . . . . . . . . . . 9.4 ttt180 -157.06 107.42 1.91 Allowed Pre-proline 0 N--CA 1.492 1.674 0 O-C-N 120.518 -1.364 . . . . 0.0 110.441 -179.08 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 126' ' ' PRO . . . . . . . . . . . . . 56.9 Cg_endo -79.79 -23.27 7.01 Favored 'Trans proline' 0 C--N 1.315 -1.193 0 C-N-CA 122.056 1.837 . . . . 0.0 112.454 179.416 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 127' ' ' ASN . . . . . . . . . . . . . 28.4 m120 -91.5 29.64 1.45 Allowed 'General case' 0 N--CA 1.493 1.681 0 O-C-N 121.186 -0.946 . . . . 0.0 109.573 179.902 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 128' ' ' TYR . . . . . 0.687 ' CZ ' ' NE2' ' A' ' 129' ' ' GLN . 14.8 t80 -81.32 -151.04 0.08 Allowed 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.254 -0.904 . . . . 0.0 109.843 -179.669 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 129' ' ' GLN . . . . . 0.687 ' NE2' ' CZ ' ' A' ' 128' ' ' TYR . 1.7 mp0 -68.3 -71.85 0.2 Allowed 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.265 -0.897 . . . . 0.0 109.906 -179.507 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 130' ' ' PHE . . . . . 0.55 ' CE2' HG11 ' A' ' 101' ' ' VAL . 50.5 m-85 -125.88 25.94 6.72 Favored 'General case' 0 N--CA 1.497 1.884 0 O-C-N 121.21 -0.931 . . . . 0.0 110.278 -179.927 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 131' ' ' THR . . . . . . . . . . . . . 36.7 m -63.78 -34.85 78.81 Favored 'General case' 0 N--CA 1.493 1.693 0 O-C-N 120.844 -1.16 . . . . 0.0 109.754 -179.964 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 132' ' ' ASN . . . . . 0.6 ' ND2' ' O ' ' A' ' 81' ' ' ALA . 12.5 t30 -85.24 9.57 14.83 Favored 'General case' 0 N--CA 1.497 1.883 0 C-N-CA 119.913 -0.715 . . . . 0.0 111.788 -178.234 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 133' ' ' LEU . . . . . 0.606 ' O ' ' N ' ' A' ' 135' ' ' ALA . 0.1 OUTLIER -71.94 -44.56 63.4 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 120.565 -1.334 . . . . 0.0 110.328 -179.442 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 134' ' ' LYS . . . . . 0.62 ' CD ' ' H ' ' A' ' 134' ' ' LYS . 0.0 OUTLIER -42.58 -16.36 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.663 0 O-C-N 121.192 -0.942 . . . . 0.0 110.089 -179.132 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 135' ' ' ALA . . . . . 0.606 ' N ' ' O ' ' A' ' 133' ' ' LEU . . . -85.23 -37.06 20.52 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.02 -1.05 . . . . 0.0 109.738 179.708 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 136' ' ' ALA . . . . . 0.87 ' HB2' ' HB2' ' A' ' 81' ' ' ALA . . . -78.43 153.54 31.42 Favored 'General case' 0 N--CA 1.489 1.519 0 CA-C-O 121.977 0.894 . . . . 0.0 111.317 -178.6 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 137' ' ' LYS . . . . . 0.508 ' O ' ' OG ' ' A' ' 140' ' ' SER . 0.6 OUTLIER -156.15 -163.36 1.46 Allowed 'General case' 0 N--CA 1.494 1.744 0 C-N-CA 118.559 -1.257 . . . . 0.0 111.224 -178.387 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 138' ' ' LYS . . . . . 0.604 ' O ' ' N ' ' A' ' 140' ' ' SER . 24.9 pttt -45.95 179.74 0.0 OUTLIER 'General case' 0 C--N 1.305 -1.364 0 CA-C-O 121.95 0.881 . . . . 0.0 110.296 -179.395 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 139' ' ' GLY . . . . . . . . . . . . . . . 45.58 8.07 0.01 OUTLIER Glycine 0 N--CA 1.491 2.336 0 N-CA-C 110.817 -0.913 . . . . 0.0 110.817 179.705 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 140' ' ' SER . . . . . 0.604 ' N ' ' O ' ' A' ' 138' ' ' LYS . 46.9 m -94.07 136.85 33.91 Favored 'General case' 0 N--CA 1.494 1.734 0 O-C-N 120.823 -1.398 . . . . 0.0 109.333 179.225 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 141' ' ' MET . . . . . 0.407 ' HG2' ' CE1' ' A' ' 143' ' ' TYR . 0.4 OUTLIER -85.04 147.6 26.58 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.155 -0.965 . . . . 0.0 109.55 -179.96 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 142' ' ' VAL . . . . . . . . . . . . . 2.1 t -132.15 134.93 59.05 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.661 0 N-CA-C 108.368 -0.975 . . . . 0.0 108.368 -179.759 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 143' ' ' TYR . . . . . 0.407 ' CE1' ' HG2' ' A' ' 141' ' ' MET . 37.0 m-85 -114.03 137.53 51.59 Favored 'General case' 0 N--CA 1.499 2.008 0 O-C-N 120.792 -1.192 . . . . 0.0 111.391 -178.842 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 144' ' ' PHE . . . . . . . . . . . . . 5.1 t80 -123.15 107.02 11.28 Favored 'General case' 0 N--CA 1.494 1.77 0 CA-C-O 121.476 0.655 . . . . 0.0 109.833 -179.215 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 145' ' ' LYS . . . . . . . . . . . . . 14.7 tttt -95.55 132.83 40.25 Favored 'General case' 0 N--CA 1.495 1.799 0 O-C-N 121.417 -0.802 . . . . 0.0 111.43 -178.725 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 146' ' ' VAL . . . . . 0.458 ' O ' ' C ' ' A' ' 147' ' ' GLY . 0.0 OUTLIER -143.26 141.1 26.48 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.813 0 N-CA-C 107.629 -1.249 . . . . 0.0 107.629 178.589 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 147' ' ' GLY . . . . . 0.458 ' C ' ' O ' ' A' ' 146' ' ' VAL . . . 40.02 -126.3 2.54 Favored Glycine 0 N--CA 1.494 2.533 0 N-CA-C 109.776 -1.33 . . . . 0.0 109.776 179.778 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 148' ' ' ASN . . . . . 0.558 HD21 ' HB2' ' A' ' 61' ' ' ALA . 0.4 OUTLIER -101.65 14.94 30.46 Favored 'General case' 0 C--N 1.302 -1.476 0 O-C-N 121.426 -1.043 . . . . 0.0 108.339 179.209 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 149' ' ' GLU . . . . . . . . . . . . . 3.2 tt0 -109.92 142.39 41.33 Favored 'General case' 0 N--CA 1.485 1.324 0 CA-C-O 121.946 0.879 . . . . 0.0 111.515 -178.43 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 150' ' ' THR . . . . . . . . . . . . . 54.3 m -129.48 101.83 6.12 Favored 'General case' 0 C--N 1.3 -1.58 0 CA-C-O 121.658 0.742 . . . . 0.0 109.713 179.81 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 151' ' ' ARG . . . . . . . . . . . . . 2.5 mtp180 -87.33 179.3 6.63 Favored 'General case' 0 C--N 1.306 -1.322 0 N-CA-C 108.601 -0.889 . . . . 0.0 108.601 179.951 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 152' ' ' LYS . . . . . 0.408 ' C ' ' CD1' ' A' ' 153' ' ' TYR . 24.6 mtmm -147.53 148.16 30.89 Favored 'General case' 0 C--N 1.302 -1.495 0 O-C-N 121.089 -1.007 . . . . 0.0 109.838 -179.671 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 153' ' ' TYR . . . . . 0.408 ' CD1' ' C ' ' A' ' 152' ' ' LYS . 20.6 m-85 -141.64 167.5 21.99 Favored 'General case' 0 N--CA 1.492 1.629 0 N-CA-C 108.491 -0.929 . . . . 0.0 108.491 179.258 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 154' ' ' LYS . . . . . 0.461 ' HZ3' HG21 ' A' ' 205' ' ' VAL . 4.4 ttpm? -137.7 122.41 18.68 Favored 'General case' 0 C--N 1.296 -1.731 0 N-CA-C 108.698 -0.853 . . . . 0.0 108.698 179.155 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 155' ' ' MET . . . . . . . . . . . . . 38.4 mmm -48.98 107.38 0.13 Allowed 'General case' 0 N--CA 1.491 1.604 0 O-C-N 120.785 -1.197 . . . . 0.0 110.904 -178.891 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 156' ' ' THR . . . . . 0.609 ' OG1' HG23 ' A' ' 203' ' ' THR . 0.0 OUTLIER -109.49 -22.18 12.12 Favored 'General case' 0 C--N 1.296 -1.748 0 C-N-CA 119.832 -0.747 . . . . 0.0 110.597 -178.959 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 157' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -151.67 146.98 26.19 Favored 'General case' 0 C--N 1.294 -1.838 0 C-N-CA 118.702 -1.199 . . . . 0.0 110.966 -178.411 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 158' ' ' ILE . . . . . 0.841 HD12 ' N ' ' A' ' 159' ' ' ARG . 0.1 OUTLIER -155.51 142.57 11.66 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.334 0 CA-C-O 121.778 0.799 . . . . 0.0 110.013 -178.834 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 159' ' ' ARG . . . . . 0.841 ' N ' HD12 ' A' ' 158' ' ' ILE . 23.1 ttm180 -155.99 160.3 39.94 Favored 'General case' 0 C--N 1.297 -1.679 0 CA-C-O 121.79 0.805 . . . . 0.0 110.44 -179.618 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 160' ' ' ASP . . . . . 0.547 ' O ' HG13 ' A' ' 161' ' ' VAL . 35.7 m-20 -116.02 161.44 18.87 Favored 'General case' 0 N--CA 1.49 1.564 0 N-CA-C 108.203 -1.036 . . . . 0.0 108.203 179.185 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 161' ' ' VAL . . . . . 0.577 HG21 ' CG1' ' A' ' 168' ' ' VAL . 3.3 m -156.79 155.01 5.57 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.63 0 O-C-N 121.117 -0.99 . . . . 0.0 110.722 -178.569 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 162' ' ' LYS . . . . . 0.438 ' O ' ' O ' ' A' ' 161' ' ' VAL . 0.0 OUTLIER -45.02 169.9 0.06 OUTLIER Pre-proline 0 N--CA 1.492 1.652 0 O-C-N 121.594 -0.691 . . . . 0.0 109.795 179.527 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 163' ' ' PRO . . . . . 0.467 ' C ' HD11 ' C' ' 702' ' ' LEU . 65.1 Cg_endo -78.54 34.59 0.51 Allowed 'Trans proline' 0 N--CA 1.493 1.466 0 C-N-CA 123.052 2.501 . . . . 0.0 113.026 -179.975 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 164' ' ' THR . . . . . 0.441 ' N ' HD11 ' C' ' 702' ' ' LEU . 0.3 OUTLIER -153.26 -3.86 0.2 Allowed 'General case' 0 N--CA 1.496 1.873 0 O-C-N 121.022 -1.049 . . . . 0.0 110.925 -179.824 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 165' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -77.2 64.44 2.62 Favored 'General case' 0 N--CA 1.496 1.857 0 O-C-N 120.861 -1.149 . . . . 0.0 110.899 -179.078 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 166' ' ' VAL . . . . . 0.593 ' O ' ' N ' ' A' ' 168' ' ' VAL . 1.4 m -46.44 -30.26 1.22 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.702 0 O-C-N 121.13 -0.981 . . . . 0.0 110.563 -178.244 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 167' ' ' GLY . . . . . . . . . . . . . . . -45.22 -9.1 0.01 OUTLIER Glycine 0 N--CA 1.498 2.796 0 O-C-N 120.694 -1.254 . . . . 0.0 111.313 -179.353 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 168' ' ' VAL . . . . . 0.593 ' N ' ' O ' ' A' ' 166' ' ' VAL . 4.2 m -53.88 -31.67 21.02 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.657 0 O-C-N 120.615 -1.521 . . . . 0.0 109.114 -179.988 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 169' ' ' LEU . . . . . 0.552 ' O ' ' C ' ' A' ' 170' ' ' ASP . 10.9 mt -45.57 -17.79 0.03 OUTLIER 'General case' 0 N--CA 1.493 1.677 0 N-CA-C 108.19 -1.041 . . . . 0.0 108.19 -178.41 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 170' ' ' ASP . . . . . 0.552 ' C ' ' O ' ' A' ' 169' ' ' LEU . 2.5 m-20 21.44 90.51 0.01 OUTLIER 'General case' 0 N--CA 1.501 2.086 0 CA-C-O 120.81 0.338 . . . . 0.0 111.797 178.151 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 171' ' ' GLU . . . . . 0.408 ' HB3' ' ND2' ' A' ' 114' ' ' ASN . 10.1 pt-20 -140.27 78.06 1.64 Allowed 'General case' 0 N--CA 1.494 1.754 0 O-C-N 120.845 -1.16 . . . . 0.0 109.808 179.512 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 172' ' ' GLN . . . . . . . . . . . . . 2.6 mp0 -136.49 -41.43 0.63 Allowed 'General case' 0 N--CA 1.495 1.793 0 O-C-N 121.453 -0.779 . . . . 0.0 110.607 -178.749 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 173' ' ' LYS . . . . . . . . . . . . . 49.7 mttp -58.24 140.41 53.2 Favored 'General case' 0 N--CA 1.493 1.686 0 O-C-N 120.74 -1.225 . . . . 0.0 108.514 179.676 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 174' ' ' GLY . . . . . 0.478 ' O ' ' C ' ' A' ' 175' ' ' LYS . . . -127.29 -46.6 0.2 Allowed Glycine 0 C--N 1.298 -1.534 0 N-CA-C 107.619 -2.192 . . . . 0.0 107.619 179.704 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 175' ' ' LYS . . . . . 0.478 ' C ' ' O ' ' A' ' 174' ' ' GLY . 27.9 mmtt -42.77 -61.42 1.26 Allowed 'General case' 0 N--CA 1.489 1.523 0 N-CA-C 108.023 -1.103 . . . . 0.0 108.023 178.611 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 176' ' ' ASP . . . . . 0.525 ' O ' ' O ' ' A' ' 177' ' ' LYS . 3.6 p30 -104.53 95.23 5.78 Favored 'General case' 0 C--N 1.299 -1.63 0 N-CA-C 108.059 -1.089 . . . . 0.0 108.059 178.086 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 177' ' ' LYS . . . . . 0.525 ' O ' ' O ' ' A' ' 176' ' ' ASP . 0.5 OUTLIER -48.39 -176.37 0.0 OUTLIER 'General case' 0 N--CA 1.494 1.734 0 O-C-N 121.119 -0.988 . . . . 0.0 109.432 -179.694 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 178' ' ' GLN . . . . . 0.608 ' NE2' ' OD1' ' A' ' 114' ' ' ASN . 20.9 pt20 -162.06 174.47 12.96 Favored 'General case' 0 C--N 1.308 -1.227 0 C-N-CA 118.605 -1.238 . . . . 0.0 110.663 179.214 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 179' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -134.62 100.36 4.61 Favored 'General case' 0 C--N 1.301 -1.518 0 N-CA-C 107.756 -1.201 . . . . 0.0 107.756 178.046 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 180' ' ' THR . . . . . 0.423 ' O ' HG22 ' A' ' 180' ' ' THR . 1.0 OUTLIER -79.99 116.62 20.23 Favored 'General case' 0 N--CA 1.493 1.707 0 O-C-N 121.095 -1.003 . . . . 0.0 110.186 -178.794 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 181' ' ' LEU . . . . . . . . . . . . . 8.8 tp -99.43 106.13 18.15 Favored 'General case' 0 C--N 1.3 -1.583 0 O-C-N 121.453 -0.779 . . . . 0.0 109.496 179.146 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 182' ' ' ILE . . . . . 0.4 ' O ' ' HA ' ' A' ' 118' ' ' ALA . 48.2 mt -93.74 127.83 45.52 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.541 0 O-C-N 120.895 -1.128 . . . . 0.0 108.76 178.909 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 183' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -144.55 111.28 5.73 Favored 'General case' 0 C--N 1.291 -1.948 0 N-CA-C 107.409 -1.33 . . . . 0.0 107.409 179.569 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 184' ' ' CYS . . . . . . . . . . . . . 15.9 p -79.62 161.0 26.16 Favored 'General case' 0 C--N 1.291 -1.975 0 C-N-CA 118.988 -1.085 . . . . 0.0 111.782 -177.334 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 185' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -166.67 -161.71 0.47 Allowed 'General case' 0 N--CA 1.494 1.775 0 O-C-N 121.665 -0.647 . . . . 0.0 109.338 179.759 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 186' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER 55.15 57.03 5.86 Favored 'General case' 0 N--CA 1.496 1.857 0 O-C-N 121.144 -0.973 . . . . 0.0 109.368 -179.838 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 187' ' ' TYR . . . . . 0.619 ' CE1' ' O ' ' A' ' 188' ' ' ASN . 65.7 t80 -67.78 137.23 55.24 Favored 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.342 -0.849 . . . . 0.0 110.703 -179.514 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 188' ' ' ASN . . . . . 0.619 ' O ' ' CE1' ' A' ' 187' ' ' TYR . 1.2 t-20 -101.98 145.66 28.96 Favored 'General case' 0 C--N 1.297 -1.697 0 N-CA-C 108.39 -0.967 . . . . 0.0 108.39 178.376 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 189' ' ' GLU . . . . . . . . . . . . . 1.9 tt0 -110.08 -14.74 14.17 Favored 'General case' 0 C--N 1.294 -1.823 0 N-CA-C 108.984 -0.747 . . . . 0.0 108.984 -179.217 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 190' ' ' LYS . . . . . . . . . . . . . 4.6 mttm -83.53 -52.36 6.54 Favored 'General case' 0 C--N 1.301 -1.506 0 C-N-CA 119.82 -0.752 . . . . 0.0 109.099 179.423 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 191' ' ' THR . . . . . 0.541 ' OG1' HG12 ' A' ' 193' ' ' VAL . 2.1 p -89.16 -9.25 51.62 Favored 'General case' 0 N--CA 1.489 1.525 0 O-C-N 121.52 -0.738 . . . . 0.0 109.235 179.799 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 192' ' ' GLY . . . . . . . . . . . . . . . 68.4 33.31 77.07 Favored Glycine 0 N--CA 1.493 2.496 0 O-C-N 121.298 -0.876 . . . . 0.0 111.119 178.606 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 193' ' ' VAL . . . . . 0.541 HG12 ' OG1' ' A' ' 191' ' ' THR . 2.4 p -147.54 169.63 3.96 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.582 0 O-C-N 120.806 -1.408 . . . . 0.0 109.891 179.169 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 194' ' ' TRP . . . . . 0.594 ' CD1' HG2B ' C' ' 705' ' ' B27 . 10.7 m95 -85.74 121.55 28.56 Favored 'General case' 0 C--N 1.294 -1.836 0 O-C-N 121.648 -0.657 . . . . 0.0 109.271 -179.908 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 195' ' ' GLU . . . . . 0.512 ' CD ' ' ND2' ' A' ' 188' ' ' ASN . 7.5 mt-10 -77.31 -60.14 2.49 Favored 'General case' 0 N--CA 1.496 1.862 0 O-C-N 121.385 -0.822 . . . . 0.0 111.575 -178.521 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 196' ' ' LYS . . . . . . . . . . . . . 6.3 mtmt -92.1 158.16 16.35 Favored 'General case' 0 N--CA 1.493 1.72 0 O-C-N 120.86 -1.15 . . . . 0.0 111.397 -177.946 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 197' ' ' ARG . . . . . . . . . . . . . 25.3 mmt180 -124.14 139.17 54.19 Favored 'General case' 0 N--CA 1.488 1.466 0 N-CA-C 108.674 -0.862 . . . . 0.0 108.674 179.001 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 198' ' ' LYS . . . . . . . . . . . . . 14.9 mttt -119.8 120.63 37.07 Favored 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.544 -0.723 . . . . 0.0 110.13 -179.017 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 199' ' ' ILE . . . . . 0.566 ' C ' HD12 ' A' ' 199' ' ' ILE . 0.8 OUTLIER -139.81 119.83 13.54 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.66 0 O-C-N 121.192 -0.943 . . . . 0.0 109.562 179.43 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 200' ' ' PHE . . . . . 0.537 ' CD1' ' N ' ' A' ' 200' ' ' PHE . 8.7 m-85 -99.91 139.05 36.15 Favored 'General case' 0 N--CA 1.499 2.012 0 O-C-N 121.468 -0.77 . . . . 0.0 110.76 -178.534 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 201' ' ' VAL . . . . . 0.445 HG13 ' NE2' ' A' ' 178' ' ' GLN . 24.3 t -104.12 149.07 8.11 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.553 0 N-CA-C 107.39 -1.337 . . . . 0.0 107.39 176.489 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 202' ' ' ALA . . . . . . . . . . . . . . . -132.47 139.6 48.04 Favored 'General case' 0 C--N 1.3 -1.585 0 O-C-N 121.047 -1.033 . . . . 0.0 108.249 -179.864 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 203' ' ' THR . . . . . 0.609 HG23 ' OG1' ' A' ' 156' ' ' THR . 13.7 p -90.85 132.15 36.07 Favored 'General case' 0 C--N 1.305 -1.343 0 CA-C-O 122.647 1.213 . . . . 0.0 111.608 -178.242 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 204' ' ' GLU . . . . . 0.403 ' HA ' ' CD2' ' A' ' 153' ' ' TYR . 1.2 tm-20 -60.79 136.24 58.01 Favored 'General case' 0 C--N 1.297 -1.711 0 C-N-CA 118.334 -1.347 . . . . 0.0 108.798 179.159 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 205' ' ' VAL . . . . . 0.473 ' O ' ' C ' ' A' ' 206' ' ' LYS . 36.6 t -130.85 -35.82 0.59 Allowed 'Isoleucine or valine' 0 N--CA 1.495 1.795 0 O-C-N 121.298 -0.877 . . . . 0.0 110.189 -179.437 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 206' ' ' LYS . . . . . 0.473 ' C ' ' O ' ' A' ' 205' ' ' VAL . 0.0 OUTLIER . . . . . 0 N--CA 1.495 1.777 0 CA-C-O 117.945 -1.026 . . . . 0.0 110.259 -179.584 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' C' C ' 701' ' ' PHQ . . . . . 0.583 ' C1 ' HG12 ' A' ' 166' ' ' VAL . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' C' C ' 702' ' ' LEU . . . . . 0.632 ' N ' HD12 ' C' ' 702' ' ' LEU . 0.0 OUTLIER . . . . . 0 N--CA 1.491 1.614 0 N-CA-C 109.074 -0.713 . . . . 0.0 109.074 . . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' C' C ' 703' ' ' PRO . . . . . 0.476 ' HG2' ' HB1' ' A' ' 104' ' ' ALA . 31.9 Cg_exo -43.31 175.79 0.0 OUTLIER 'Trans proline' 0 N--CA 1.49 1.313 0 C-N-CA 122.593 2.195 . . . . 0.0 112.981 -179.097 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' C' C ' 704' ' ' ALA . . . . . 0.403 ' C ' ' O ' ' C' ' 703' ' ' PRO . . . 43.19 -158.29 0.02 OUTLIER 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.502 -0.749 . . . . 0.0 109.769 179.477 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' C' C ' 705' ' ' B27 . . . . . 0.594 HG2B ' CD1' ' A' ' 194' ' ' TRP . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 700' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 010 nuclear nobuild full ' A' A ' 59' ' ' MET . . . . . . . . . . . . . 28.4 mtt . . . . . 0 N--CA 1.49 1.559 0 N-CA-C 109.664 -0.495 . . . . 0.0 109.664 . . . . . . . . . 0 0 . 1 . 010 nuclear nobuild full ' A' A ' 60' ' ' GLN . . . . . . . . . . . . . 74.9 mt-30 -61.31 -97.99 0.0 OUTLIER 'General case' 0 N--CA 1.492 1.669 0 O-C-N 121.083 -1.011 . . . . 0.0 109.549 -179.993 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . -64.91 -163.7 0.02 OUTLIER 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.076 -1.015 . . . . 0.0 109.17 179.734 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 62' ' ' LYS . . . . . . . . . . . . . 15.8 tttm -146.93 79.21 10.16 Favored Pre-proline 0 N--CA 1.491 1.601 0 O-C-N 121.222 -0.924 . . . . 0.0 109.454 179.993 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 63' ' ' PRO . . . . . 0.843 ' O ' HD13 ' A' ' 110' ' ' LEU . 6.2 Cg_exo -74.54 138.6 24.49 Favored 'Trans proline' 0 C--N 1.302 -1.869 0 C-N-CA 123.004 2.469 . . . . 0.0 111.455 179.781 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 64' ' ' GLN . . . . . 0.617 ' O ' ' NE2' ' A' ' 64' ' ' GLN . 0.0 OUTLIER -158.97 137.07 10.53 Favored 'General case' 0 C--N 1.299 -1.598 0 O-C-N 121.169 -0.957 . . . . 0.0 109.43 179.684 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 65' ' ' ILE . . . . . 0.75 ' N ' HD13 ' A' ' 65' ' ' ILE . 0.2 OUTLIER -50.79 110.42 1.73 Allowed Pre-proline 0 N--CA 1.489 1.501 0 O-C-N 120.829 -1.169 . . . . 0.0 108.624 179.253 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 66' ' ' PRO . . . . . . . . . . . . . 87.1 Cg_endo -82.52 -162.77 0.19 Allowed 'Trans proline' 0 C--N 1.314 -1.251 0 C-N-CA 121.998 1.798 . . . . 0.0 111.797 -179.784 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 67' ' ' LYS . . . . . . . . . . . . . 36.4 tttp -90.11 -10.28 45.23 Favored 'General case' 0 C--N 1.302 -1.481 0 O-C-N 121.176 -0.953 . . . . 0.0 109.081 179.534 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 68' ' ' ASP . . . . . 0.644 ' C ' ' H ' ' A' ' 70' ' ' SER . 0.2 OUTLIER -76.61 64.02 2.18 Favored 'General case' 0 N--CA 1.489 1.505 0 CA-C-O 122.763 1.268 . . . . 0.0 108.71 179.194 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 69' ' ' LYS . . . . . 0.459 ' C ' ' O ' ' A' ' 68' ' ' ASP . 6.3 ptpp? -46.99 -14.16 0.03 OUTLIER 'General case' 0 N--CA 1.508 2.472 0 C-N-CA 117.259 -1.776 . . . . 0.0 106.701 177.534 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 70' ' ' SER . . . . . 0.644 ' H ' ' C ' ' A' ' 68' ' ' ASP . 3.4 p -85.93 -6.36 59.08 Favored 'General case' 0 N--CA 1.496 1.839 0 CA-C-N 113.414 -1.721 . . . . 0.0 111.496 179.564 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 71' ' ' LYS . . . . . 0.496 ' N ' ' O ' ' A' ' 68' ' ' ASP . 0.0 OUTLIER -95.35 142.6 27.55 Favored 'General case' 0 N--CA 1.501 2.079 0 O-C-N 120.579 -1.325 . . . . 0.0 112.225 -179.288 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 72' ' ' VAL . . . . . 0.691 HG12 ' CZ ' ' A' ' 88' ' ' TYR . 3.1 m -66.46 134.44 29.95 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.5 0 N-CA-C 104.318 -2.475 . . . . 0.0 104.318 174.65 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 73' ' ' ALA . . . . . 0.517 ' N ' ' O ' ' A' ' 87' ' ' VAL . . . -81.47 -15.65 54.37 Favored 'General case' 0 C--N 1.291 -1.967 0 O-C-N 119.849 -1.782 . . . . 0.0 106.859 179.985 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . 172.16 -155.78 24.23 Favored Glycine 0 C--N 1.298 -1.533 0 N-CA-C 109.817 -1.313 . . . . 0.0 109.817 179.512 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 75' ' ' TYR . . . . . 0.527 ' HA ' HG23 ' A' ' 87' ' ' VAL . 73.0 m-85 -142.56 169.99 16.54 Favored 'General case' 0 C--N 1.297 -1.684 0 CA-C-O 122.06 0.933 . . . . 0.0 110.848 -177.459 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 76' ' ' ILE . . . . . . . . . . . . . 1.0 OUTLIER -150.15 146.9 16.46 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.814 0 C-N-CA 119.58 -0.848 . . . . 0.0 109.179 -178.382 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -151.15 164.8 35.68 Favored 'General case' 0 C--N 1.302 -1.494 0 O-C-N 120.919 -1.113 . . . . 0.0 109.262 -179.734 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 78' ' ' ILE . . . . . 0.512 ' HB ' ' HB3' ' A' ' 81' ' ' ALA . 10.0 mt -147.91 92.97 4.57 Favored Pre-proline 0 N--CA 1.488 1.425 0 N-CA-C 108.516 -0.92 . . . . 0.0 108.516 179.998 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 79' ' ' PRO . . . . . . . . . . . . . 72.3 Cg_exo -46.77 -43.54 23.41 Favored 'Trans proline' 0 N--CA 1.494 1.536 0 C-N-CA 122.852 2.368 . . . . 0.0 113.954 -178.972 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 37.9 t70 -65.54 -20.62 66.41 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 120.665 -1.272 . . . . 0.0 110.343 178.582 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 81' ' ' ALA . . . . . 0.788 ' HB2' ' HB2' ' A' ' 136' ' ' ALA . . . -106.33 -15.05 14.93 Favored 'General case' 0 C--N 1.302 -1.471 0 O-C-N 121.354 -0.841 . . . . 0.0 108.762 179.664 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 82' ' ' ASP . . . . . . . . . . . . . 2.5 t70 66.38 49.51 1.41 Allowed 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.163 -0.961 . . . . 0.0 110.227 179.506 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 83' ' ' ILE . . . . . 0.685 HD11 ' OD1' ' A' ' 132' ' ' ASN . 62.7 mt -128.57 151.38 35.28 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.786 0 O-C-N 121.259 -0.901 . . . . 0.0 110.333 -178.988 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 84' ' ' LYS . . . . . . . . . . . . . 17.4 tttt -159.53 106.42 1.7 Allowed 'General case' 0 N--CA 1.493 1.69 0 N-CA-C 108.416 -0.957 . . . . 0.0 108.416 178.964 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 85' ' ' GLU . . . . . 0.54 ' N ' ' OE2' ' A' ' 85' ' ' GLU . 0.0 OUTLIER -140.07 165.77 28.37 Favored Pre-proline 0 N--CA 1.491 1.621 0 O-C-N 121.393 -0.817 . . . . 0.0 109.858 -179.008 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 86' ' ' PRO . . . . . . . . . . . . . 56.9 Cg_endo -74.27 166.53 29.3 Favored 'Trans proline' 0 N--CA 1.496 1.621 0 C-N-CA 123.116 2.544 . . . . 0.0 113.779 -178.548 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 87' ' ' VAL . . . . . 0.527 HG23 ' HA ' ' A' ' 75' ' ' TYR . 61.3 t -122.9 100.07 7.6 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.539 0 N-CA-C 109.093 -0.706 . . . . 0.0 109.093 179.715 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 88' ' ' TYR . . . . . 0.691 ' CZ ' HG12 ' A' ' 72' ' ' VAL . 42.1 m-85 -91.87 154.76 43.7 Favored Pre-proline 0 N--CA 1.505 2.298 0 O-C-N 120.944 -1.098 . . . . 0.0 110.086 -179.359 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 89' ' ' PRO . . . . . . . . . . . . . 7.0 Cg_endo -56.84 145.78 81.98 Favored 'Trans proline' 0 N--CA 1.494 1.537 0 C-N-CA 122.467 2.111 . . . . 0.0 113.119 179.157 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . -63.57 169.52 19.56 Favored Glycine 0 N--CA 1.492 2.415 0 N-CA-C 109.159 -1.576 . . . . 0.0 109.159 179.188 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 91' ' ' PRO . . . . . . . . . . . . . 73.0 Cg_endo -93.4 170.25 19.82 Favored 'Cis proline' 0 C--N 1.309 -1.519 0 C-N-CA 123.939 -1.275 . . . . 0.0 112.424 0.101 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 92' ' ' ALA . . . . . 0.437 ' HB3' ' HB3' ' C' ' 703' ' ' PRO . . . -73.09 33.68 0.07 Allowed 'General case' 0 N--CA 1.494 1.767 0 O-C-N 121.323 -0.861 . . . . 0.0 111.261 -179.399 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 93' ' ' THR . . . . . 0.414 ' O ' ' C ' ' A' ' 94' ' ' PRO . 1.0 OUTLIER -73.54 152.5 89.66 Favored Pre-proline 0 C--N 1.3 -1.547 0 O-C-N 120.48 -1.387 . . . . 0.0 108.146 179.729 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 94' ' ' PRO . . . . . 0.414 ' C ' ' O ' ' A' ' 93' ' ' THR . 94.6 Cg_exo -33.29 -57.06 0.35 Allowed 'Trans proline' 0 C--N 1.306 -1.702 0 C-N-CA 122.749 2.299 . . . . 0.0 112.621 -178.463 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 88.0 mt-10 -46.57 -50.29 17.55 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.256 -0.902 . . . . 0.0 110.094 -179.896 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 96' ' ' GLN . . . . . 0.498 ' N ' ' CD ' ' A' ' 96' ' ' GLN . 10.9 mp0 -71.48 -45.41 62.61 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 120.992 -1.067 . . . . 0.0 110.534 -179.231 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 97' ' ' LEU . . . . . 0.422 HD23 ' HA ' ' A' ' 97' ' ' LEU . 61.5 mt -57.64 -7.29 0.63 Allowed 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.095 -1.003 . . . . 0.0 110.473 -178.585 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 98' ' ' ASN . . . . . 0.654 HD22 ' NH1' ' A' ' 99' ' ' ARG . 0.1 OUTLIER -77.66 -29.09 51.41 Favored 'General case' 0 N--CA 1.494 1.759 0 O-C-N 120.946 -1.097 . . . . 0.0 109.44 179.208 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 99' ' ' ARG . . . . . 0.667 ' CG ' HH11 ' A' ' 99' ' ' ARG . 1.1 mtt-85 -90.17 -44.63 9.64 Favored 'General case' 0 N--CA 1.489 1.495 0 O-C-N 121.667 -0.646 . . . . 0.0 110.322 -178.36 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . 173.71 175.83 41.71 Favored Glycine 0 N--CA 1.491 2.335 0 C-N-CA 119.342 -1.409 . . . . 0.0 110.343 179.938 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 101' ' ' VAL . . . . . 0.692 ' O ' HG23 ' A' ' 101' ' ' VAL . 33.5 m -50.05 109.0 0.1 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.543 0 O-C-N 121.564 -0.962 . . . . 0.0 109.029 179.814 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -92.58 159.29 15.55 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.159 -0.963 . . . . 0.0 110.683 -179.321 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 103' ' ' PHE . . . . . 0.58 ' O ' ' N ' ' A' ' 105' ' ' GLU . 26.7 m-85 -61.1 123.79 18.67 Favored 'General case' 0 N--CA 1.491 1.58 0 N-CA-C 107.982 -1.118 . . . . 0.0 107.982 178.662 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 104' ' ' ALA . . . . . 0.562 ' HB1' ' HG2' ' C' ' 703' ' ' PRO . . . -47.04 -9.75 0.02 OUTLIER 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.061 -1.024 . . . . 0.0 110.249 -179.073 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 105' ' ' GLU . . . . . 0.58 ' N ' ' O ' ' A' ' 103' ' ' PHE . 0.4 OUTLIER -137.89 142.84 40.66 Favored 'General case' 0 N--CA 1.496 1.839 0 O-C-N 120.803 -1.186 . . . . 0.0 110.266 179.643 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 106' ' ' GLU . . . . . . . . . . . . . 33.6 tt0 -58.24 -63.33 1.3 Allowed 'General case' 0 C--N 1.301 -1.516 0 O-C-N 121.951 -0.468 . . . . 0.0 110.661 -179.458 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 107' ' ' ASN . . . . . . . . . . . . . 7.6 m120 -78.67 34.98 0.23 Allowed 'General case' 0 N--CA 1.488 1.449 0 O-C-N 120.874 -1.141 . . . . 0.0 112.969 -175.924 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 108' ' ' GLU . . . . . . . . . . . . . 1.7 tp10 -60.55 148.28 38.57 Favored 'General case' 0 N--CA 1.489 1.486 0 O-C-N 120.685 -1.259 . . . . 0.0 108.327 179.766 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 109' ' ' SER . . . . . . . . . . . . . 2.8 t -98.02 146.91 25.05 Favored 'General case' 0 N--CA 1.489 1.482 0 O-C-N 121.115 -0.991 . . . . 0.0 110.664 -178.675 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 110' ' ' LEU . . . . . 0.843 HD13 ' O ' ' A' ' 63' ' ' PRO . 0.6 OUTLIER -63.42 -22.6 66.98 Favored 'General case' 0 C--N 1.301 -1.543 0 N-CA-C 107.974 -1.121 . . . . 0.0 107.974 179.136 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 111' ' ' ASP . . . . . 0.579 ' CG ' HH22 ' A' ' 151' ' ' ARG . 48.5 m-20 -132.81 44.01 2.91 Favored 'General case' 0 N--CA 1.487 1.412 0 O-C-N 121.589 -0.694 . . . . 0.0 110.21 -179.779 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 112' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -67.96 150.16 48.85 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 120.99 -1.069 . . . . 0.0 110.069 179.557 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 113' ' ' GLN . . . . . 0.437 ' HA ' ' NE2' ' A' ' 113' ' ' GLN . 0.9 OUTLIER -65.93 -13.92 60.61 Favored 'General case' 0 N--CA 1.488 1.475 0 N-CA-C 108.008 -1.108 . . . . 0.0 108.008 178.426 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 114' ' ' ASN . . . . . 0.437 ' HA ' HE21 ' A' ' 178' ' ' GLN . 1.8 t30 -147.87 99.26 3.06 Favored 'General case' 0 C--N 1.301 -1.523 0 N-CA-C 107.206 -1.405 . . . . 0.0 107.206 178.193 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 115' ' ' ILE . . . . . 0.474 ' O ' HG22 ' A' ' 115' ' ' ILE . 2.9 mt -98.13 111.41 27.79 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.627 0 O-C-N 120.969 -1.082 . . . . 0.0 109.637 -179.013 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 116' ' ' SER . . . . . . . . . . . . . 87.5 p -101.87 151.42 22.11 Favored 'General case' 0 N--CA 1.491 1.604 0 CA-C-O 122.055 0.931 . . . . 0.0 111.86 -178.329 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 117' ' ' ILE . . . . . . . . . . . . . 2.1 mt -139.66 159.78 27.54 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.599 0 N-CA-C 108.496 -0.927 . . . . 0.0 108.496 179.504 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 118' ' ' ALA . . . . . 0.867 ' HB1' ' HB2' ' C' ' 704' ' ' ALA . . . -143.3 155.72 44.53 Favored 'General case' 0 N--CA 1.489 1.518 0 C-N-CA 118.758 -1.177 . . . . 0.0 111.326 -179.391 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 119' ' ' GLY . . . . . . . . . . . . . . . -166.32 146.07 10.61 Favored Glycine 0 N--CA 1.485 1.966 0 N-CA-C 110.358 -1.097 . . . . 0.0 110.358 -179.854 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 120' ' ' HIS . . . . . 0.633 ' NE2' ' N ' ' C' ' 705' ' ' B27 . 35.1 m170 -71.63 167.28 20.14 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.93 -0.747 . . . . 0.0 109.721 179.202 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 121' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -116.33 147.31 41.7 Favored 'General case' 0 N--CA 1.495 1.779 0 N-CA-C 108.158 -1.053 . . . . 0.0 108.158 178.533 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 122' ' ' PHE . . . . . 0.642 ' O ' HG21 ' A' ' 131' ' ' THR . 0.3 OUTLIER -110.61 123.56 50.21 Favored 'General case' 0 N--CA 1.497 1.924 0 O-C-N 120.908 -1.12 . . . . 0.0 109.955 -179.874 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 123' ' ' ILE . . . . . 0.615 HG23 ' N ' ' A' ' 124' ' ' ASP . 11.8 tt -69.17 -42.96 81.85 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.824 0 O-C-N 121.367 -0.833 . . . . 0.0 109.4 179.427 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 124' ' ' ASP . . . . . 0.615 ' N ' HG23 ' A' ' 123' ' ' ILE . 61.1 t0 -93.24 23.81 4.21 Favored 'General case' 0 N--CA 1.494 1.747 0 O-C-N 121.421 -0.799 . . . . 0.0 111.136 -179.16 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 125' ' ' ARG . . . . . . . . . . . . . 3.3 ttt180 -157.9 107.35 1.76 Allowed Pre-proline 0 N--CA 1.492 1.667 0 O-C-N 120.616 -1.303 . . . . 0.0 110.253 -179.523 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 126' ' ' PRO . . . . . . . . . . . . . 71.9 Cg_endo -83.05 -20.24 5.29 Favored 'Trans proline' 0 C--N 1.314 -1.289 0 C-N-CA 122.368 2.046 . . . . 0.0 112.325 179.482 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 127' ' ' ASN . . . . . . . . . . . . . 4.9 m120 -91.12 23.93 3.06 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.276 -0.89 . . . . 0.0 109.668 179.94 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 128' ' ' TYR . . . . . . . . . . . . . 10.0 t80 -81.09 -149.4 0.07 Allowed 'General case' 0 C--N 1.301 -1.516 0 O-C-N 121.162 -0.961 . . . . 0.0 109.589 -179.692 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 129' ' ' GLN . . . . . . . . . . . . . 69.2 mt-30 -67.12 -69.61 0.3 Allowed 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.246 -0.909 . . . . 0.0 110.684 -178.941 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 130' ' ' PHE . . . . . 0.492 ' CE2' HG11 ' A' ' 101' ' ' VAL . 52.8 m-85 -129.23 36.72 4.13 Favored 'General case' 0 N--CA 1.496 1.827 0 O-C-N 121.249 -0.907 . . . . 0.0 110.524 -179.214 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 131' ' ' THR . . . . . 0.642 HG21 ' O ' ' A' ' 122' ' ' PHE . 33.8 m -80.86 -33.72 34.27 Favored 'General case' 0 N--CA 1.493 1.687 0 O-C-N 120.815 -1.178 . . . . 0.0 108.965 179.461 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 132' ' ' ASN . . . . . 0.685 ' OD1' HD11 ' A' ' 83' ' ' ILE . 0.1 OUTLIER -84.62 5.89 26.12 Favored 'General case' 0 N--CA 1.495 1.8 0 CA-C-O 121.876 0.846 . . . . 0.0 109.986 -179.246 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 133' ' ' LEU . . . . . 0.599 ' O ' ' N ' ' A' ' 135' ' ' ALA . 0.2 OUTLIER -68.5 -46.76 68.77 Favored 'General case' 0 C--N 1.299 -1.595 0 O-C-N 121.159 -0.963 . . . . 0.0 110.529 -179.748 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 134' ' ' LYS . . . . . 0.543 ' CD ' ' H ' ' A' ' 134' ' ' LYS . 0.1 OUTLIER -41.68 -18.18 0.01 OUTLIER 'General case' 0 N--CA 1.496 1.826 0 O-C-N 121.07 -1.019 . . . . 0.0 110.328 -179.133 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 135' ' ' ALA . . . . . 0.599 ' N ' ' O ' ' A' ' 133' ' ' LEU . . . -82.87 -39.48 21.54 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 120.951 -1.093 . . . . 0.0 109.855 -179.773 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 136' ' ' ALA . . . . . 0.788 ' HB2' ' HB2' ' A' ' 81' ' ' ALA . . . -78.9 156.63 28.52 Favored 'General case' 0 C--N 1.299 -1.59 0 CA-C-O 122.179 0.99 . . . . 0.0 111.698 -178.506 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 137' ' ' LYS . . . . . 0.513 ' O ' ' O ' ' A' ' 138' ' ' LYS . 1.2 ttmt -156.01 -163.21 1.43 Allowed 'General case' 0 N--CA 1.49 1.543 0 C-N-CA 118.832 -1.147 . . . . 0.0 110.455 -178.92 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 138' ' ' LYS . . . . . 0.596 ' O ' ' N ' ' A' ' 140' ' ' SER . 0.1 OUTLIER -46.44 -178.29 0.0 OUTLIER 'General case' 0 C--N 1.302 -1.479 0 CA-C-O 122.043 0.925 . . . . 0.0 110.36 -179.332 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 139' ' ' GLY . . . . . . . . . . . . . . . 45.84 8.1 0.02 OUTLIER Glycine 0 N--CA 1.492 2.411 0 N-CA-C 110.707 -0.957 . . . . 0.0 110.707 179.956 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 140' ' ' SER . . . . . 0.596 ' N ' ' O ' ' A' ' 138' ' ' LYS . 66.1 m -90.54 136.86 32.79 Favored 'General case' 0 N--CA 1.493 1.7 0 O-C-N 120.768 -1.43 . . . . 0.0 109.606 179.412 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 141' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -78.21 142.16 38.11 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.092 -1.005 . . . . 0.0 109.154 179.729 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 142' ' ' VAL . . . . . . . . . . . . . 21.2 t -131.14 127.82 61.2 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.711 0 O-C-N 121.366 -0.834 . . . . 0.0 109.148 -179.845 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 143' ' ' TYR . . . . . . . . . . . . . 6.4 m-85 -105.51 134.22 48.99 Favored 'General case' 0 N--CA 1.498 1.971 0 O-C-N 121.313 -0.867 . . . . 0.0 112.223 -177.913 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 144' ' ' PHE . . . . . . . . . . . . . 57.4 t80 -119.7 98.09 5.95 Favored 'General case' 0 N--CA 1.494 1.741 0 CA-C-O 121.403 0.62 . . . . 0.0 109.406 179.409 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 145' ' ' LYS . . . . . . . . . . . . . 11.8 mttt -93.49 128.44 39.6 Favored 'General case' 0 N--CA 1.492 1.668 0 O-C-N 121.361 -0.837 . . . . 0.0 110.632 -179.217 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 146' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -142.11 137.87 30.23 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.778 0 N-CA-C 107.619 -1.252 . . . . 0.0 107.619 179.098 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 147' ' ' GLY . . . . . . . . . . . . . . . 48.45 -134.06 19.93 Favored Glycine 0 N--CA 1.49 2.241 0 N-CA-C 108.854 -1.698 . . . . 0.0 108.854 -179.493 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 148' ' ' ASN . . . . . 0.578 HD22 ' C ' ' A' ' 148' ' ' ASN . 0.4 OUTLIER -101.17 18.52 19.66 Favored 'General case' 0 C--N 1.301 -1.516 0 O-C-N 121.229 -1.159 . . . . 0.0 107.941 178.959 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 149' ' ' GLU . . . . . . . . . . . . . 26.2 tt0 -112.59 147.46 36.61 Favored 'General case' 0 N--CA 1.484 1.266 0 CA-C-O 121.97 0.89 . . . . 0.0 111.255 -178.957 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 150' ' ' THR . . . . . 0.468 HG22 ' O ' ' A' ' 150' ' ' THR . 1.7 m -129.42 103.64 7.02 Favored 'General case' 0 N--CA 1.489 1.509 0 CA-C-O 121.477 0.656 . . . . 0.0 110.052 -179.966 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 151' ' ' ARG . . . . . 0.579 HH22 ' CG ' ' A' ' 111' ' ' ASP . 94.5 mtt180 -93.05 128.75 39.06 Favored 'General case' 0 N--CA 1.487 1.403 0 N-CA-C 107.938 -1.134 . . . . 0.0 107.938 179.008 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 152' ' ' LYS . . . . . 0.432 ' O ' ' N ' ' A' ' 205' ' ' VAL . 14.4 mtmt -91.68 156.01 17.9 Favored 'General case' 0 C--N 1.297 -1.697 0 C-N-CA 119.183 -1.007 . . . . 0.0 110.021 -179.115 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 153' ' ' TYR . . . . . 0.516 ' CD2' ' HA ' ' A' ' 204' ' ' GLU . 30.7 m-85 -143.51 167.1 23.02 Favored 'General case' 0 N--CA 1.49 1.536 0 N-CA-C 107.428 -1.323 . . . . 0.0 107.428 178.953 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 154' ' ' LYS . . . . . . . . . . . . . 17.8 ttpt -143.16 123.0 13.44 Favored 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.071 -1.018 . . . . 0.0 108.286 178.592 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 155' ' ' MET . . . . . . . . . . . . . 3.6 mtt -47.07 109.49 0.21 Allowed 'General case' 0 N--CA 1.492 1.674 0 O-C-N 120.856 -1.153 . . . . 0.0 111.207 -178.595 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 156' ' ' THR . . . . . 0.458 ' OG1' ' N ' ' A' ' 203' ' ' THR . 0.2 OUTLIER -103.89 -29.78 10.75 Favored 'General case' 0 C--N 1.29 -1.99 0 CA-C-N 115.269 -0.878 . . . . 0.0 110.102 -178.915 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 157' ' ' SER . . . . . 0.409 ' O ' ' N ' ' A' ' 201' ' ' VAL . 0.1 OUTLIER -155.71 157.58 36.83 Favored 'General case' 0 N--CA 1.492 1.641 0 C-N-CA 118.438 -1.305 . . . . 0.0 111.556 -178.816 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 158' ' ' ILE . . . . . 0.465 HG13 ' CD2' ' A' ' 200' ' ' PHE . 0.0 OUTLIER -156.77 148.23 11.14 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.393 0 CA-C-O 121.823 0.82 . . . . 0.0 110.285 179.823 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 159' ' ' ARG . . . . . 0.454 ' O ' ' OD1' ' A' ' 160' ' ' ASP . 6.1 ttm180 -153.59 -173.24 4.5 Favored 'General case' 0 C--N 1.299 -1.622 0 CA-C-O 121.737 0.779 . . . . 0.0 110.502 -179.559 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 160' ' ' ASP . . . . . 0.454 ' OD1' ' O ' ' A' ' 159' ' ' ARG . 2.5 m-20 -145.0 158.78 43.71 Favored 'General case' 0 C--N 1.301 -1.535 0 N-CA-C 108.378 -0.971 . . . . 0.0 108.378 -179.817 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 161' ' ' VAL . . . . . 0.451 HG21 HG22 ' A' ' 168' ' ' VAL . 0.1 OUTLIER -155.57 157.27 4.19 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.99 0 O-C-N 120.994 -1.066 . . . . 0.0 110.686 179.706 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 162' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -46.22 169.19 0.09 OUTLIER Pre-proline 0 N--CA 1.496 1.827 0 O-C-N 121.419 -0.801 . . . . 0.0 110.372 -179.776 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 163' ' ' PRO . . . . . . . . . . . . . 73.8 Cg_endo -78.97 28.57 0.49 Allowed 'Trans proline' 0 N--CA 1.493 1.466 0 C-N-CA 123.025 2.483 . . . . 0.0 113.575 -179.778 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 164' ' ' THR . . . . . 0.585 ' O ' HG22 ' A' ' 164' ' ' THR . 67.3 m -150.87 -2.66 0.34 Allowed 'General case' 0 N--CA 1.496 1.842 0 O-C-N 120.962 -1.086 . . . . 0.0 110.012 179.792 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 165' ' ' ASP . . . . . 0.927 ' O ' HG23 ' A' ' 168' ' ' VAL . 2.2 t70 -76.3 64.98 2.15 Favored 'General case' 0 N--CA 1.488 1.471 0 O-C-N 121.203 -0.936 . . . . 0.0 110.112 -179.957 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 166' ' ' VAL . . . . . 0.605 ' O ' ' N ' ' A' ' 168' ' ' VAL . 1.0 OUTLIER -44.4 -32.05 0.78 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.531 0 O-C-N 120.943 -1.098 . . . . 0.0 108.805 -179.099 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 167' ' ' GLY . . . . . 0.446 ' C ' ' O ' ' A' ' 166' ' ' VAL . . . -42.67 -16.76 0.03 OUTLIER Glycine 0 N--CA 1.491 2.316 0 N-CA-C 109.795 -1.322 . . . . 0.0 109.795 179.535 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 168' ' ' VAL . . . . . 0.927 HG23 ' O ' ' A' ' 165' ' ' ASP . 47.6 t -50.27 -32.6 9.44 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.434 0 O-C-N 121.014 -1.286 . . . . 0.0 108.455 179.728 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 169' ' ' LEU . . . . . 0.518 ' O ' ' C ' ' A' ' 170' ' ' ASP . 98.8 mt -46.91 -14.48 0.03 OUTLIER 'General case' 0 N--CA 1.49 1.566 0 N-CA-C 108.075 -1.083 . . . . 0.0 108.075 -178.816 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 170' ' ' ASP . . . . . 0.567 ' N ' ' O ' ' A' ' 168' ' ' VAL . 9.2 p30 19.94 91.0 0.01 OUTLIER 'General case' 0 N--CA 1.499 2.012 0 N-CA-C 112.651 0.611 . . . . 0.0 112.651 177.669 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 171' ' ' GLU . . . . . . . . . . . . . 16.5 pt-20 -127.02 69.14 1.27 Allowed 'General case' 0 N--CA 1.495 1.809 0 O-C-N 121.099 -1.001 . . . . 0.0 109.493 178.488 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 172' ' ' GLN . . . . . . . . . . . . . 1.6 mp0 -133.69 -47.41 0.81 Allowed 'General case' 0 N--CA 1.495 1.79 0 O-C-N 121.329 -0.857 . . . . 0.0 110.723 -178.387 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 173' ' ' LYS . . . . . . . . . . . . . 9.0 mttp -63.4 125.56 24.58 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 120.835 -1.165 . . . . 0.0 108.992 179.861 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 174' ' ' GLY . . . . . 0.564 ' O ' ' C ' ' A' ' 175' ' ' LYS . . . -133.2 -39.13 0.21 Allowed Glycine 0 C--N 1.298 -1.541 0 N-CA-C 108.543 -1.823 . . . . 0.0 108.543 179.888 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 175' ' ' LYS . . . . . 0.564 ' C ' ' O ' ' A' ' 174' ' ' GLY . 3.8 mptt -32.33 -63.36 0.2 Allowed 'General case' 0 N--CA 1.499 2.015 0 N-CA-C 108.14 -1.059 . . . . 0.0 108.14 179.576 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 176' ' ' ASP . . . . . 0.665 ' O ' ' O ' ' A' ' 177' ' ' LYS . 1.0 OUTLIER -103.01 77.37 1.55 Allowed 'General case' 0 C--N 1.296 -1.72 0 N-CA-C 106.418 -1.697 . . . . 0.0 106.418 176.413 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 177' ' ' LYS . . . . . 0.665 ' O ' ' O ' ' A' ' 176' ' ' ASP . 10.1 mttt -26.74 163.55 0.0 OUTLIER 'General case' 0 N--CA 1.505 2.313 0 CA-C-O 122.091 0.948 . . . . 0.0 112.047 -178.111 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 178' ' ' GLN . . . . . 0.526 ' OE1' HG13 ' A' ' 201' ' ' VAL . 0.8 OUTLIER -158.45 168.33 27.23 Favored 'General case' 0 N--CA 1.489 1.499 0 C-N-CA 117.832 -1.547 . . . . 0.0 111.96 -179.792 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 179' ' ' LEU . . . . . 0.408 ' HB2' ' CE2' ' A' ' 153' ' ' TYR . 0.6 OUTLIER -124.65 101.9 7.34 Favored 'General case' 0 C--N 1.302 -1.47 0 N-CA-C 107.074 -1.454 . . . . 0.0 107.074 178.453 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 180' ' ' THR . . . . . . . . . . . . . 2.1 m -76.12 122.38 24.2 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.202 -0.936 . . . . 0.0 110.595 -177.973 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 181' ' ' LEU . . . . . . . . . . . . . 9.8 tp -98.8 111.79 24.07 Favored 'General case' 0 N--CA 1.493 1.706 0 O-C-N 121.272 -0.893 . . . . 0.0 109.23 178.774 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 182' ' ' ILE . . . . . 0.563 HG23 HG22 ' A' ' 199' ' ' ILE . 37.1 mt -100.1 122.99 52.66 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.489 0 O-C-N 120.972 -1.08 . . . . 0.0 109.148 178.357 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 183' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -138.9 107.12 5.76 Favored 'General case' 0 C--N 1.296 -1.743 0 N-CA-C 107.882 -1.155 . . . . 0.0 107.882 179.045 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 184' ' ' CYS . . . . . . . . . . . . . 1.9 p -80.88 157.27 25.7 Favored 'General case' 0 N--CA 1.497 1.915 0 C-N-CA 119.275 -0.97 . . . . 0.0 111.597 -177.48 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 185' ' ' ASP . . . . . 0.586 ' OD1' ' N ' ' A' ' 186' ' ' ASP . 20.0 t0 -167.27 177.16 6.27 Favored 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.635 -0.666 . . . . 0.0 109.393 -179.769 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 186' ' ' ASP . . . . . 0.586 ' N ' ' OD1' ' A' ' 185' ' ' ASP . 0.4 OUTLIER 81.05 54.6 0.02 OUTLIER 'General case' 0 N--CA 1.497 1.884 0 O-C-N 121.336 -0.853 . . . . 0.0 109.598 -179.779 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 187' ' ' TYR . . . . . 0.595 ' CE1' ' O ' ' A' ' 188' ' ' ASN . 37.2 t80 -66.07 132.54 48.76 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.124 -0.985 . . . . 0.0 110.204 -179.941 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 188' ' ' ASN . . . . . 0.834 ' ND2' ' H ' ' A' ' 193' ' ' VAL . 0.5 OUTLIER -99.93 149.72 23.14 Favored 'General case' 0 C--N 1.298 -1.632 0 N-CA-C 107.441 -1.318 . . . . 0.0 107.441 178.115 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 189' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -112.11 -2.84 14.88 Favored 'General case' 0 C--N 1.291 -1.938 0 N-CA-C 108.647 -0.872 . . . . 0.0 108.647 -179.179 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 190' ' ' LYS . . . . . . . . . . . . . 32.9 mttt -83.73 -59.8 2.32 Favored 'General case' 0 N--CA 1.488 1.439 0 N-CA-C 108.48 -0.933 . . . . 0.0 108.48 178.581 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 191' ' ' THR . . . . . 0.592 ' OG1' ' ND2' ' A' ' 188' ' ' ASN . 1.3 p -88.25 -12.18 44.42 Favored 'General case' 0 N--CA 1.493 1.687 0 O-C-N 121.338 -0.851 . . . . 0.0 108.954 179.094 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 192' ' ' GLY . . . . . 0.418 ' N ' ' OD1' ' A' ' 188' ' ' ASN . . . 73.29 41.54 45.74 Favored Glycine 0 N--CA 1.493 2.496 0 N-CA-C 110.588 -1.005 . . . . 0.0 110.588 178.902 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 193' ' ' VAL . . . . . 0.834 ' H ' ' ND2' ' A' ' 188' ' ' ASN . 95.9 t -149.14 163.52 4.4 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.612 0 O-C-N 121.043 -1.269 . . . . 0.0 110.542 179.817 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 194' ' ' TRP . . . . . 0.675 ' CG ' ' SG ' ' C' ' 705' ' ' B27 . 73.4 m95 -83.07 121.55 27.18 Favored 'General case' 0 N--CA 1.49 1.553 0 N-CA-C 108.572 -0.899 . . . . 0.0 108.572 179.358 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 195' ' ' GLU . . . . . . . . . . . . . 2.3 mt-10 -89.65 -61.05 1.78 Allowed 'General case' 0 N--CA 1.495 1.796 0 O-C-N 121.401 -0.812 . . . . 0.0 112.089 -177.523 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 196' ' ' LYS . . . . . . . . . . . . . 12.5 tttt -75.88 148.36 38.36 Favored 'General case' 0 N--CA 1.494 1.736 0 O-C-N 121.142 -0.974 . . . . 0.0 111.068 -177.876 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 197' ' ' ARG . . . . . 0.567 ' CD ' HD22 ' C' ' 702' ' ' LEU . 21.8 mmt180 -124.45 128.56 49.2 Favored 'General case' 0 N--CA 1.494 1.74 0 N-CA-C 108.274 -1.009 . . . . 0.0 108.274 178.361 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 198' ' ' LYS . . . . . . . . . . . . . 11.1 mmtp -116.13 118.42 32.79 Favored 'General case' 0 C--N 1.3 -1.587 0 O-C-N 121.59 -0.694 . . . . 0.0 110.27 -178.916 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 199' ' ' ILE . . . . . 0.693 HG21 HG11 ' A' ' 168' ' ' VAL . 0.8 OUTLIER -136.95 121.39 24.05 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.768 0 CA-C-O 122.6 1.19 . . . . 0.0 110.877 179.474 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 200' ' ' PHE . . . . . 0.515 ' CD1' ' N ' ' A' ' 200' ' ' PHE . 3.1 m-85 -99.3 135.6 40.48 Favored 'General case' 0 N--CA 1.502 2.171 0 O-C-N 120.941 -1.099 . . . . 0.0 109.979 -178.293 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 201' ' ' VAL . . . . . 0.526 HG13 ' OE1' ' A' ' 178' ' ' GLN . 84.4 t -105.33 146.29 12.53 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.849 0 O-C-N 120.94 -1.1 . . . . 0.0 108.968 177.315 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 202' ' ' ALA . . . . . 0.402 ' HA ' ' H ' ' A' ' 156' ' ' THR . . . -134.32 141.46 46.93 Favored 'General case' 0 N--CA 1.493 1.677 0 O-C-N 121.031 -1.043 . . . . 0.0 109.628 -179.749 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 203' ' ' THR . . . . . 0.458 ' N ' ' OG1' ' A' ' 156' ' ' THR . 0.8 OUTLIER -88.93 130.64 35.4 Favored 'General case' 0 N--CA 1.488 1.426 0 CA-C-O 122.457 1.122 . . . . 0.0 111.27 -178.769 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 204' ' ' GLU . . . . . 0.516 ' HA ' ' CD2' ' A' ' 153' ' ' TYR . 1.3 tm-20 -49.39 134.52 18.78 Favored 'General case' 0 C--N 1.297 -1.713 0 C-N-CA 119.223 -0.991 . . . . 0.0 109.28 179.124 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 205' ' ' VAL . . . . . 0.516 ' CG1' ' N ' ' A' ' 206' ' ' LYS . 28.4 t -122.26 162.32 22.05 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.436 0 CA-C-O 122.055 0.931 . . . . 0.0 110.357 -178.02 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 206' ' ' LYS . . . . . 0.516 ' N ' ' CG1' ' A' ' 205' ' ' VAL . 1.3 ptpp? . . . . . 0 C--N 1.294 -1.838 0 CA-C-O 117.906 -1.045 . . . . 0.0 109.37 179.717 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' C' C ' 701' ' ' PHQ . . . . . 0.539 ' O2 ' HG12 ' A' ' 166' ' ' VAL . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' C' C ' 702' ' ' LEU . . . . . 0.911 ' N ' HD12 ' C' ' 702' ' ' LEU . 0.0 OUTLIER . . . . . 0 N--CA 1.494 1.744 0 N-CA-C 110.231 -0.285 . . . . 0.0 110.231 . . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' C' C ' 703' ' ' PRO . . . . . 0.562 ' HG2' ' HB1' ' A' ' 104' ' ' ALA . 51.0 Cg_exo -50.87 -157.23 0.0 OUTLIER 'Trans proline' 0 N--CA 1.496 1.646 0 C-N-CA 122.096 1.864 . . . . 0.0 112.6 179.864 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' C' C ' 704' ' ' ALA . . . . . 0.867 ' HB2' ' HB1' ' A' ' 118' ' ' ALA . . . 51.25 106.75 0.01 OUTLIER 'General case' 0 N--CA 1.493 1.692 0 O-C-N 121.125 -0.984 . . . . 0.0 110.212 179.845 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' C' C ' 705' ' ' B27 . . . . . 0.675 ' SG ' ' CG ' ' A' ' 194' ' ' TRP . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 700' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 011 nuclear nobuild full ' A' A ' 59' ' ' MET . . . . . . . . . . . . . 1.7 mpt? . . . . . 0 N--CA 1.491 1.596 0 N-CA-C 109.591 -0.522 . . . . 0.0 109.591 . . . . . . . . . 0 0 . 1 . 011 nuclear nobuild full ' A' A ' 60' ' ' GLN . . . . . . . . . . . . . 2.4 mt-30 -59.57 -86.47 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.092 -1.005 . . . . 0.0 109.439 -179.879 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . -65.23 169.6 5.5 Favored 'General case' 0 N--CA 1.493 1.714 0 O-C-N 121.308 -0.87 . . . . 0.0 110.194 -179.779 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 62' ' ' LYS . . . . . . . . . . . . . 61.4 tttm -142.17 72.61 22.31 Favored Pre-proline 0 N--CA 1.491 1.614 0 O-C-N 121.285 -0.884 . . . . 0.0 109.716 -179.614 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 63' ' ' PRO . . . . . . . . . . . . . 18.9 Cg_endo -89.32 156.37 5.52 Favored 'Trans proline' 0 C--N 1.307 -1.61 0 C-N-CA 123.576 2.85 . . . . 0.0 111.513 179.64 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 64' ' ' GLN . . . . . 0.579 ' N ' ' CD ' ' A' ' 64' ' ' GLN . 0.0 OUTLIER -154.29 133.91 12.84 Favored 'General case' 0 N--CA 1.493 1.701 0 O-C-N 120.996 -1.065 . . . . 0.0 109.452 179.733 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 65' ' ' ILE . . . . . 0.532 ' CD1' HD13 ' A' ' 110' ' ' LEU . 0.0 OUTLIER -45.95 108.35 0.8 Allowed Pre-proline 0 N--CA 1.489 1.494 0 N-CA-C 107.812 -1.181 . . . . 0.0 107.812 179.155 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 66' ' ' PRO . . . . . . . . . . . . . 60.1 Cg_endo -78.1 -162.68 0.18 Allowed 'Trans proline' 0 C--N 1.311 -1.419 0 C-N-CA 121.618 1.545 . . . . 0.0 112.148 -179.024 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 67' ' ' LYS . . . . . . . . . . . . . 15.8 tttp -89.81 -13.92 35.55 Favored 'General case' 0 C--N 1.301 -1.543 0 O-C-N 121.287 -0.883 . . . . 0.0 109.289 -179.874 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 68' ' ' ASP . . . . . 0.659 ' C ' ' H ' ' A' ' 70' ' ' SER . 0.6 OUTLIER -77.07 64.87 2.6 Favored 'General case' 0 N--CA 1.487 1.395 0 CA-C-O 122.654 1.216 . . . . 0.0 109.762 -179.868 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 69' ' ' LYS . . . . . 0.447 ' C ' ' O ' ' A' ' 68' ' ' ASP . 16.6 ptpt -48.2 -12.16 0.04 OUTLIER 'General case' 0 N--CA 1.516 2.827 0 C-N-CA 116.921 -1.912 . . . . 0.0 106.332 176.567 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 70' ' ' SER . . . . . 0.659 ' H ' ' C ' ' A' ' 68' ' ' ASP . 1.9 m -84.83 -6.38 59.35 Favored 'General case' 0 C--N 1.297 -1.688 0 CA-C-N 113.094 -1.866 . . . . 0.0 110.764 179.117 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 71' ' ' LYS . . . . . 0.546 ' N ' ' O ' ' A' ' 68' ' ' ASP . 0.3 OUTLIER -100.42 144.33 29.55 Favored 'General case' 0 N--CA 1.5 2.068 0 O-C-N 120.649 -1.282 . . . . 0.0 111.759 -179.661 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 72' ' ' VAL . . . . . 0.525 HG12 ' CE1' ' A' ' 88' ' ' TYR . 0.7 OUTLIER -66.4 134.08 30.38 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.369 0 N-CA-C 105.085 -2.191 . . . . 0.0 105.085 175.638 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 73' ' ' ALA . . . . . 0.549 ' N ' ' O ' ' A' ' 87' ' ' VAL . . . -80.5 -13.96 58.66 Favored 'General case' 0 C--N 1.295 -1.776 0 O-C-N 119.587 -1.946 . . . . 0.0 107.161 -179.525 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 74' ' ' GLY . . . . . 0.417 ' N ' HG23 ' A' ' 72' ' ' VAL . . . 177.16 -159.63 26.06 Favored Glycine 0 N--CA 1.482 1.725 0 N-CA-C 109.835 -1.306 . . . . 0.0 109.835 179.07 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 75' ' ' TYR . . . . . 0.529 ' HA ' HG23 ' A' ' 87' ' ' VAL . 0.6 OUTLIER -143.83 165.96 26.25 Favored 'General case' 0 C--N 1.295 -1.768 0 C-N-CA 119.468 -0.893 . . . . 0.0 110.75 -177.283 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 76' ' ' ILE . . . . . . . . . . . . . 1.2 tt -148.38 147.4 17.0 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.534 0 C-N-CA 119.346 -0.942 . . . . 0.0 110.072 -178.189 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -150.76 162.48 40.65 Favored 'General case' 0 N--CA 1.486 1.373 0 O-C-N 121.276 -0.89 . . . . 0.0 109.042 179.934 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 78' ' ' ILE . . . . . 0.415 HD12 HD21 ' A' ' 133' ' ' LEU . 38.6 mt -147.62 97.08 4.04 Favored Pre-proline 0 N--CA 1.488 1.445 0 O-C-N 121.238 -0.913 . . . . 0.0 108.817 -179.444 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 79' ' ' PRO . . . . . . . . . . . . . 51.0 Cg_exo -49.15 -45.13 30.84 Favored 'Trans proline' 0 N--CA 1.493 1.485 0 C-N-CA 122.795 2.33 . . . . 0.0 114.423 -178.59 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 80' ' ' ASP . . . . . 0.482 ' O ' ' OD1' ' A' ' 80' ' ' ASP . 47.7 t0 -66.09 -20.26 66.11 Favored 'General case' 0 N--CA 1.496 1.843 0 O-C-N 120.48 -1.387 . . . . 0.0 111.024 179.073 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 81' ' ' ALA . . . . . 0.756 ' HB2' ' HB2' ' A' ' 136' ' ' ALA . . . -107.09 -10.49 15.88 Favored 'General case' 0 N--CA 1.491 1.582 0 N-CA-C 108.528 -0.916 . . . . 0.0 108.528 179.639 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 82' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER 61.42 50.88 4.41 Favored 'General case' 0 N--CA 1.493 1.697 0 O-C-N 121.541 -0.724 . . . . 0.0 110.719 179.481 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 83' ' ' ILE . . . . . . . . . . . . . 46.6 mt -128.83 152.2 36.67 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.815 0 O-C-N 121.062 -1.024 . . . . 0.0 110.229 -178.975 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 84' ' ' LYS . . . . . . . . . . . . . 27.2 tttp -157.88 108.47 2.19 Favored 'General case' 0 N--CA 1.49 1.566 0 N-CA-C 107.662 -1.236 . . . . 0.0 107.662 179.762 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 85' ' ' GLU . . . . . 0.512 ' OE2' ' O ' ' A' ' 129' ' ' GLN . 0.0 OUTLIER -141.6 163.35 41.61 Favored Pre-proline 0 N--CA 1.494 1.771 0 O-C-N 121.283 -0.886 . . . . 0.0 110.88 -178.361 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 86' ' ' PRO . . . . . 0.41 ' N ' ' CE2' ' A' ' 75' ' ' TYR . 40.9 Cg_endo -72.15 165.36 32.84 Favored 'Trans proline' 0 N--CA 1.495 1.609 0 C-N-CA 123.259 2.639 . . . . 0.0 113.031 -179.882 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 87' ' ' VAL . . . . . 0.549 ' O ' ' N ' ' A' ' 73' ' ' ALA . 66.0 t -124.36 98.96 5.76 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.695 0 N-CA-C 108.903 -0.777 . . . . 0.0 108.903 179.54 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 88' ' ' TYR . . . . . 0.525 ' CE1' HG12 ' A' ' 72' ' ' VAL . 15.9 m-85 -91.45 155.58 44.02 Favored Pre-proline 0 N--CA 1.501 2.12 0 O-C-N 120.964 -1.085 . . . . 0.0 110.224 -179.212 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 89' ' ' PRO . . . . . 0.411 ' HA ' ' CD2' ' A' ' 103' ' ' PHE . 9.6 Cg_endo -61.75 145.25 97.45 Favored 'Trans proline' 0 C--N 1.311 -1.443 0 C-N-CA 122.639 2.226 . . . . 0.0 113.408 179.683 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . -58.82 168.23 6.34 Favored Glycine 0 N--CA 1.494 2.504 0 N-CA-C 109.408 -1.477 . . . . 0.0 109.408 179.305 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 91' ' ' PRO . . . . . 0.426 ' C ' ' H ' ' A' ' 93' ' ' THR . 97.5 Cg_endo -94.13 169.53 18.82 Favored 'Cis proline' 0 C--N 1.307 -1.654 0 C-N-CA 123.873 -1.303 . . . . 0.0 112.021 -0.257 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 92' ' ' ALA . . . . . 0.631 ' HB1' HD21 ' A' ' 97' ' ' LEU . . . -72.16 31.47 0.06 Allowed 'General case' 0 N--CA 1.489 1.49 0 O-C-N 121.217 -0.927 . . . . 0.0 110.756 -179.786 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 93' ' ' THR . . . . . 0.435 ' O ' ' C ' ' A' ' 94' ' ' PRO . 6.0 p -72.41 151.42 91.88 Favored Pre-proline 0 N--CA 1.492 1.643 0 O-C-N 120.543 -1.348 . . . . 0.0 108.075 179.865 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 94' ' ' PRO . . . . . 0.435 ' C ' ' O ' ' A' ' 93' ' ' THR . 88.7 Cg_exo -31.68 -57.91 0.23 Allowed 'Trans proline' 0 C--N 1.306 -1.692 0 C-N-CA 122.702 2.268 . . . . 0.0 112.636 -178.656 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 95' ' ' GLU . . . . . 0.506 ' O ' ' ND2' ' A' ' 98' ' ' ASN . 29.0 mt-10 -43.87 -49.09 8.39 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.11 -0.994 . . . . 0.0 109.715 179.929 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 96' ' ' GLN . . . . . 0.586 ' O ' ' N ' ' A' ' 98' ' ' ASN . 39.2 mm-40 -71.63 -56.98 4.81 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.195 -0.941 . . . . 0.0 110.981 -179.058 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 97' ' ' LEU . . . . . 0.631 HD21 ' HB1' ' A' ' 92' ' ' ALA . 91.7 mt -48.95 -5.99 0.02 OUTLIER 'General case' 0 N--CA 1.495 1.783 0 O-C-N 120.989 -1.069 . . . . 0.0 109.878 -179.156 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 98' ' ' ASN . . . . . 0.836 HD21 ' NE ' ' A' ' 99' ' ' ARG . 0.1 OUTLIER -73.2 -28.63 62.3 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.213 -0.929 . . . . 0.0 108.904 179.466 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 99' ' ' ARG . . . . . 0.836 ' NE ' HD21 ' A' ' 98' ' ' ASN . 0.0 OUTLIER -92.34 -54.57 3.75 Favored 'General case' 0 N--CA 1.487 1.406 0 O-C-N 121.692 -0.63 . . . . 0.0 109.552 -179.659 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . -179.89 -160.63 25.71 Favored Glycine 0 N--CA 1.491 2.353 0 C-N-CA 119.554 -1.308 . . . . 0.0 110.188 -179.917 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 101' ' ' VAL . . . . . 0.718 ' O ' HG23 ' A' ' 101' ' ' VAL . 20.5 m -61.48 104.93 0.29 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.659 0 O-C-N 121.474 -1.015 . . . . 0.0 109.92 -179.507 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -92.73 157.16 16.59 Favored 'General case' 0 N--CA 1.493 1.715 0 O-C-N 121.495 -0.753 . . . . 0.0 110.67 -179.503 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 103' ' ' PHE . . . . . 0.411 ' CD2' ' HA ' ' A' ' 89' ' ' PRO . 22.1 m-85 -59.69 130.36 46.43 Favored 'General case' 0 N--CA 1.49 1.568 0 N-CA-C 107.468 -1.308 . . . . 0.0 107.468 178.276 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 104' ' ' ALA . . . . . . . . . . . . . . . -50.95 -16.45 0.43 Allowed 'General case' 0 C--N 1.301 -1.542 0 O-C-N 121.378 -0.826 . . . . 0.0 111.467 -178.337 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 105' ' ' GLU . . . . . 0.452 ' CD ' HD13 ' A' ' 169' ' ' LEU . 0.5 OUTLIER -139.49 147.61 41.53 Favored 'General case' 0 N--CA 1.494 1.766 0 O-C-N 120.722 -1.236 . . . . 0.0 110.577 -179.862 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 106' ' ' GLU . . . . . 0.559 ' OE2' ' ND2' ' A' ' 107' ' ' ASN . 3.3 tt0 -54.71 -64.44 0.83 Allowed 'General case' 0 C--N 1.301 -1.527 0 CA-C-N 115.857 -0.611 . . . . 0.0 111.151 -178.986 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 107' ' ' ASN . . . . . 0.559 ' ND2' ' OE2' ' A' ' 106' ' ' GLU . 2.5 m120 -78.28 33.37 0.19 Allowed 'General case' 0 N--CA 1.49 1.566 0 O-C-N 120.522 -1.361 . . . . 0.0 113.059 -175.325 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 108' ' ' GLU . . . . . . . . . . . . . 27.8 tp10 -59.39 148.41 32.66 Favored 'General case' 0 C--N 1.299 -1.597 0 N-CA-C 107.191 -1.411 . . . . 0.0 107.191 179.886 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 109' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -99.64 129.82 45.81 Favored 'General case' 0 C--N 1.301 -1.504 0 O-C-N 120.987 -1.071 . . . . 0.0 110.443 -178.019 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 110' ' ' LEU . . . . . 0.532 HD13 ' CD1' ' A' ' 65' ' ' ILE . 3.2 tp -59.03 -11.98 4.16 Favored 'General case' 0 C--N 1.301 -1.505 0 N-CA-C 108.02 -1.104 . . . . 0.0 108.02 179.63 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 111' ' ' ASP . . . . . . . . . . . . . 57.7 m-20 -132.57 30.03 4.15 Favored 'General case' 0 N--CA 1.491 1.615 0 N-CA-C 109.0 -0.741 . . . . 0.0 109.0 179.044 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 112' ' ' ASP . . . . . . . . . . . . . 6.2 t0 -67.27 149.1 50.86 Favored 'General case' 0 N--CA 1.493 1.704 0 O-C-N 121.105 -0.997 . . . . 0.0 111.19 -179.056 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 113' ' ' GLN . . . . . 0.743 HE22 ' NZ ' ' A' ' 177' ' ' LYS . 0.4 OUTLIER -66.36 -12.83 59.03 Favored 'General case' 0 N--CA 1.49 1.564 0 N-CA-C 108.319 -0.993 . . . . 0.0 108.319 178.285 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 114' ' ' ASN . . . . . 0.618 HD22 ' C ' ' A' ' 114' ' ' ASN . 0.2 OUTLIER -149.92 99.98 2.89 Favored 'General case' 0 N--CA 1.491 1.601 0 N-CA-C 108.204 -1.035 . . . . 0.0 108.204 179.351 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 115' ' ' ILE . . . . . 0.484 ' O ' HG22 ' A' ' 115' ' ' ILE . 3.9 mt -98.79 111.94 29.67 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.621 0 O-C-N 121.111 -0.993 . . . . 0.0 109.497 -179.367 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 116' ' ' SER . . . . . . . . . . . . . 48.9 m -97.84 153.58 18.21 Favored 'General case' 0 N--CA 1.492 1.675 0 O-C-N 121.026 -1.046 . . . . 0.0 110.94 -179.142 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 117' ' ' ILE . . . . . 0.402 HG21 HD13 ' A' ' 117' ' ' ILE . 1.5 mt -144.79 159.94 14.24 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.617 0 N-CA-C 108.629 -0.878 . . . . 0.0 108.629 179.586 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 118' ' ' ALA . . . . . 0.752 ' HB1' ' HB2' ' C' ' 704' ' ' ALA . . . -144.53 160.25 41.44 Favored 'General case' 0 N--CA 1.491 1.606 0 C-N-CA 118.639 -1.224 . . . . 0.0 112.17 -179.441 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 119' ' ' GLY . . . . . . . . . . . . . . . -172.16 146.24 9.16 Favored Glycine 0 N--CA 1.49 2.239 0 N-CA-C 110.622 -0.991 . . . . 0.0 110.622 179.909 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 120' ' ' HIS . . . . . 0.694 ' CE1' HOG1 ' C' ' 705' ' ' B27 . 11.5 m170 -71.29 167.63 19.06 Favored 'General case' 0 N--CA 1.496 1.856 0 O-C-N 121.744 -0.857 . . . . 0.0 110.45 179.483 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 121' ' ' THR . . . . . 0.504 ' OG1' ' NZ ' ' A' ' 134' ' ' LYS . 0.7 OUTLIER -119.02 162.29 18.8 Favored 'General case' 0 N--CA 1.5 2.048 0 O-C-N 121.188 -0.945 . . . . 0.0 108.874 179.301 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 122' ' ' PHE . . . . . 0.648 ' O ' HG21 ' A' ' 131' ' ' THR . 0.3 OUTLIER -133.25 122.37 23.82 Favored 'General case' 0 N--CA 1.499 1.982 0 O-C-N 120.868 -1.145 . . . . 0.0 110.291 -179.281 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 123' ' ' ILE . . . . . 0.563 HG23 ' N ' ' A' ' 124' ' ' ASP . 18.1 tt -65.5 -40.75 89.15 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.582 0 CA-C-O 121.58 0.705 . . . . 0.0 109.217 179.588 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 124' ' ' ASP . . . . . 0.563 ' N ' HG23 ' A' ' 123' ' ' ILE . 1.2 t70 -96.69 25.75 4.97 Favored 'General case' 0 N--CA 1.497 1.914 0 C-N-CA 120.154 -0.619 . . . . 0.0 111.452 -178.473 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 125' ' ' ARG . . . . . 0.655 HH11 ' CG ' ' A' ' 125' ' ' ARG . 0.0 OUTLIER -158.67 106.15 1.62 Allowed Pre-proline 0 N--CA 1.493 1.712 0 O-C-N 120.553 -1.342 . . . . 0.0 110.126 -179.209 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 126' ' ' PRO . . . . . . . . . . . . . 74.3 Cg_endo -81.91 -23.61 4.52 Favored 'Trans proline' 0 N--CA 1.489 1.217 0 C-N-CA 122.293 1.995 . . . . 0.0 112.325 179.834 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 127' ' ' ASN . . . . . . . . . . . . . 1.3 m-20 -90.34 28.91 1.35 Allowed 'General case' 0 N--CA 1.489 1.495 0 O-C-N 121.295 -0.878 . . . . 0.0 109.815 -179.685 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 128' ' ' TYR . . . . . . . . . . . . . 7.6 t80 -83.9 -149.27 0.1 Allowed 'General case' 0 N--CA 1.494 1.735 0 O-C-N 121.303 -0.873 . . . . 0.0 109.15 179.61 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 129' ' ' GLN . . . . . 0.512 ' O ' ' OE2' ' A' ' 85' ' ' GLU . 51.3 mt-30 -67.77 -73.05 0.15 Allowed 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.102 -0.999 . . . . 0.0 109.875 -179.698 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 130' ' ' PHE . . . . . 0.736 ' CE1' HD11 ' A' ' 181' ' ' LEU . 38.7 m-85 -129.63 45.92 2.73 Favored 'General case' 0 N--CA 1.497 1.918 0 O-C-N 121.013 -1.054 . . . . 0.0 110.119 -179.845 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 131' ' ' THR . . . . . 0.648 HG21 ' O ' ' A' ' 122' ' ' PHE . 25.0 m -82.58 -37.64 24.79 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 120.991 -1.068 . . . . 0.0 110.222 -179.919 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 132' ' ' ASN . . . . . 0.577 ' ND2' ' O ' ' A' ' 81' ' ' ALA . 7.6 t30 -83.39 7.84 15.49 Favored 'General case' 0 N--CA 1.491 1.618 0 C-N-CA 119.389 -0.924 . . . . 0.0 111.145 -178.574 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 133' ' ' LEU . . . . . 0.545 ' O ' ' N ' ' A' ' 135' ' ' ALA . 0.1 OUTLIER -70.29 -46.21 64.76 Favored 'General case' 0 C--N 1.301 -1.523 0 O-C-N 120.793 -1.192 . . . . 0.0 109.237 179.936 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 134' ' ' LYS . . . . . 0.599 ' CD ' ' H ' ' A' ' 134' ' ' LYS . 0.0 OUTLIER -43.75 -18.16 0.02 OUTLIER 'General case' 0 N--CA 1.494 1.747 0 O-C-N 121.368 -0.832 . . . . 0.0 109.861 -179.74 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 135' ' ' ALA . . . . . 0.545 ' N ' ' O ' ' A' ' 133' ' ' LEU . . . -83.8 -37.14 22.93 Favored 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.048 -1.032 . . . . 0.0 109.433 179.943 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 136' ' ' ALA . . . . . 0.756 ' HB2' ' HB2' ' A' ' 81' ' ' ALA . . . -79.62 157.05 27.39 Favored 'General case' 0 C--N 1.301 -1.541 0 CA-C-O 122.298 1.047 . . . . 0.0 111.517 -178.502 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 137' ' ' LYS . . . . . 0.562 ' O ' ' O ' ' A' ' 138' ' ' LYS . 0.1 OUTLIER -152.04 -163.26 1.69 Allowed 'General case' 0 C--N 1.304 -1.404 0 C-N-CA 119.017 -1.073 . . . . 0.0 110.03 -178.016 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 138' ' ' LYS . . . . . 0.582 ' O ' ' N ' ' A' ' 140' ' ' SER . 51.2 mttm -41.0 177.67 0.0 OUTLIER 'General case' 0 C--N 1.304 -1.381 0 CA-C-O 122.583 1.182 . . . . 0.0 111.716 -179.093 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 139' ' ' GLY . . . . . . . . . . . . . . . 46.32 8.3 0.02 OUTLIER Glycine 0 N--CA 1.492 2.386 0 N-CA-C 110.353 -1.099 . . . . 0.0 110.353 -179.918 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 140' ' ' SER . . . . . 0.582 ' N ' ' O ' ' A' ' 138' ' ' LYS . 6.3 m -79.0 121.52 25.04 Favored 'General case' 0 N--CA 1.493 1.719 0 O-C-N 120.887 -1.36 . . . . 0.0 109.693 179.258 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 141' ' ' MET . . . . . 0.687 ' SD ' ' N ' ' A' ' 142' ' ' VAL . 5.1 tpp -77.99 125.15 28.92 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.192 -0.943 . . . . 0.0 108.971 179.529 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 142' ' ' VAL . . . . . 0.687 ' N ' ' SD ' ' A' ' 141' ' ' MET . 2.5 t -110.48 131.51 61.38 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.446 0 N-CA-C 108.585 -0.894 . . . . 0.0 108.585 -179.594 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 143' ' ' TYR . . . . . . . . . . . . . 9.8 m-85 -109.98 135.54 50.66 Favored 'General case' 0 N--CA 1.497 1.922 0 O-C-N 121.036 -1.04 . . . . 0.0 111.111 -178.321 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 144' ' ' PHE . . . . . . . . . . . . . 46.7 t80 -121.03 102.48 8.36 Favored 'General case' 0 N--CA 1.49 1.534 0 CA-C-O 121.262 0.553 . . . . 0.0 109.829 -178.957 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 145' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -100.93 121.81 42.4 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.202 -0.936 . . . . 0.0 110.117 -179.966 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 146' ' ' VAL . . . . . 0.537 HG23 ' O ' ' A' ' 73' ' ' ALA . 1.0 OUTLIER -142.53 124.49 12.86 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.581 0 O-C-N 121.126 -0.984 . . . . 0.0 108.424 179.091 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 147' ' ' GLY . . . . . . . . . . . . . . . 66.9 -132.1 31.26 Favored Glycine 0 N--CA 1.49 2.239 0 N-CA-C 108.103 -1.999 . . . . 0.0 108.103 -178.735 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 148' ' ' ASN . . . . . 0.606 ' C ' ' ND2' ' A' ' 148' ' ' ASN . 0.0 OUTLIER -102.43 10.31 39.09 Favored 'General case' 0 C--N 1.301 -1.526 0 O-C-N 121.266 -1.138 . . . . 0.0 108.209 178.955 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 149' ' ' GLU . . . . . 0.402 ' OE1' ' N ' ' A' ' 150' ' ' THR . 1.4 tm-20 -107.91 144.44 35.16 Favored 'General case' 0 N--CA 1.489 1.524 0 CA-C-O 121.941 0.877 . . . . 0.0 111.706 -178.666 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 150' ' ' THR . . . . . 0.402 ' N ' ' OE1' ' A' ' 149' ' ' GLU . 44.2 m -133.8 100.51 4.78 Favored 'General case' 0 N--CA 1.491 1.603 0 CA-C-O 121.517 0.675 . . . . 0.0 109.563 -179.749 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 151' ' ' ARG . . . . . . . . . . . . . 17.4 mtt180 -87.06 -174.16 4.78 Favored 'General case' 0 N--CA 1.488 1.445 0 N-CA-C 108.435 -0.95 . . . . 0.0 108.435 179.994 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 152' ' ' LYS . . . . . 0.477 ' O ' ' N ' ' A' ' 205' ' ' VAL . 35.6 mtmt -148.59 142.95 26.25 Favored 'General case' 0 N--CA 1.488 1.469 0 O-C-N 121.068 -1.02 . . . . 0.0 110.273 -179.335 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 153' ' ' TYR . . . . . 0.57 ' O ' ' SD ' ' A' ' 141' ' ' MET . 2.8 m-85 -136.18 167.77 20.66 Favored 'General case' 0 N--CA 1.492 1.642 0 N-CA-C 107.582 -1.266 . . . . 0.0 107.582 179.029 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 154' ' ' LYS . . . . . . . . . . . . . 1.5 ttpm? -142.26 122.93 14.23 Favored 'General case' 0 N--CA 1.493 1.704 0 O-C-N 121.127 -0.983 . . . . 0.0 108.393 178.387 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 155' ' ' MET . . . . . . . . . . . . . 67.2 mtp -45.57 105.94 0.07 Allowed 'General case' 0 N--CA 1.491 1.608 0 O-C-N 120.586 -1.321 . . . . 0.0 111.351 -178.67 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 156' ' ' THR . . . . . 0.554 ' OG1' HG23 ' A' ' 203' ' ' THR . 0.1 OUTLIER -106.41 -24.87 12.12 Favored 'General case' 0 C--N 1.293 -1.888 0 CA-C-N 115.401 -0.818 . . . . 0.0 110.073 -179.077 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 157' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -151.45 151.5 31.76 Favored 'General case' 0 N--CA 1.494 1.765 0 C-N-CA 118.405 -1.318 . . . . 0.0 111.206 -178.299 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 158' ' ' ILE . . . . . 0.433 HD12 ' CD1' ' A' ' 200' ' ' PHE . 0.1 OUTLIER -154.16 144.4 13.98 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.189 0 CA-C-O 122.039 0.923 . . . . 0.0 110.448 -179.538 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 159' ' ' ARG . . . . . . . . . . . . . 31.4 ttp180 -153.98 155.91 36.45 Favored 'General case' 0 C--N 1.297 -1.685 0 CA-C-O 121.934 0.873 . . . . 0.0 110.76 -179.036 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 160' ' ' ASP . . . . . 0.446 ' C ' HG22 ' A' ' 161' ' ' VAL . 26.5 m-20 -118.65 160.66 21.42 Favored 'General case' 0 N--CA 1.492 1.666 0 N-CA-C 108.957 -0.757 . . . . 0.0 108.957 179.325 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 161' ' ' VAL . . . . . 0.451 ' O ' ' O ' ' A' ' 162' ' ' LYS . 0.0 OUTLIER -164.54 161.65 0.94 Allowed 'Isoleucine or valine' 0 N--CA 1.496 1.826 0 O-C-N 121.003 -1.061 . . . . 0.0 110.213 179.508 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 162' ' ' LYS . . . . . 0.758 ' CD ' ' H ' ' A' ' 162' ' ' LYS . 0.0 OUTLIER -45.99 173.04 0.04 OUTLIER Pre-proline 0 N--CA 1.493 1.723 0 O-C-N 121.591 -0.693 . . . . 0.0 109.815 179.456 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 163' ' ' PRO . . . . . 0.659 ' CA ' HH21 ' A' ' 197' ' ' ARG . 63.1 Cg_endo -81.34 35.06 0.57 Allowed 'Trans proline' 0 C--N 1.313 -1.34 0 C-N-CA 122.532 2.155 . . . . 0.0 112.54 179.815 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 164' ' ' THR . . . . . 0.423 ' N ' HD11 ' C' ' 702' ' ' LEU . 0.2 OUTLIER -150.76 -2.66 0.35 Allowed 'General case' 0 N--CA 1.495 1.814 0 O-C-N 121.053 -1.03 . . . . 0.0 110.821 179.961 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 165' ' ' ASP . . . . . 0.432 ' O ' ' C ' ' A' ' 166' ' ' VAL . 9.7 t70 -75.8 62.66 1.56 Allowed 'General case' 0 N--CA 1.495 1.785 0 O-C-N 120.675 -1.266 . . . . 0.0 110.675 -179.58 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 166' ' ' VAL . . . . . 0.621 ' O ' ' N ' ' A' ' 168' ' ' VAL . 2.6 t -42.99 -31.48 0.49 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.659 0 O-C-N 121.236 -0.915 . . . . 0.0 109.096 -178.853 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 167' ' ' GLY . . . . . . . . . . . . . . . -44.08 -9.81 0.01 OUTLIER Glycine 0 N--CA 1.495 2.632 0 O-C-N 121.126 -0.983 . . . . 0.0 111.055 -179.788 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 168' ' ' VAL . . . . . 0.629 ' C ' ' H ' ' A' ' 170' ' ' ASP . 7.4 m -55.47 -32.18 29.38 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.51 0 O-C-N 120.615 -1.521 . . . . 0.0 108.759 179.543 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 169' ' ' LEU . . . . . 0.564 ' O ' ' N ' ' A' ' 171' ' ' GLU . 9.5 mt -52.53 -4.65 0.03 OUTLIER 'General case' 0 N--CA 1.498 1.969 0 N-CA-C 107.957 -1.127 . . . . 0.0 107.957 -179.328 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 170' ' ' ASP . . . . . 0.629 ' H ' ' C ' ' A' ' 168' ' ' VAL . 0.6 OUTLIER 34.12 28.21 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.762 -0.586 . . . . 0.0 111.713 177.838 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 171' ' ' GLU . . . . . 0.564 ' N ' ' O ' ' A' ' 169' ' ' LEU . 11.8 pt-20 -63.91 93.17 0.08 Allowed 'General case' 0 C--N 1.298 -1.647 0 N-CA-C 107.645 -1.242 . . . . 0.0 107.645 178.528 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 172' ' ' GLN . . . . . . . . . . . . . 1.0 OUTLIER -160.84 -71.75 0.06 Allowed 'General case' 0 N--CA 1.491 1.588 0 CA-C-O 121.263 0.554 . . . . 0.0 109.511 -179.371 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 173' ' ' LYS . . . . . 0.63 ' NZ ' HE21 ' A' ' 178' ' ' GLN . 8.9 pttm -62.09 126.6 27.91 Favored 'General case' 0 N--CA 1.488 1.446 0 O-C-N 121.143 -0.973 . . . . 0.0 108.908 179.631 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 174' ' ' GLY . . . . . 0.568 ' O ' ' C ' ' A' ' 175' ' ' LYS . . . -121.18 -39.81 0.57 Allowed Glycine 0 C--N 1.298 -1.565 0 N-CA-C 108.283 -1.927 . . . . 0.0 108.283 179.721 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 175' ' ' LYS . . . . . 0.568 ' C ' ' O ' ' A' ' 174' ' ' GLY . 0.8 OUTLIER -31.59 -62.22 0.2 Allowed 'General case' 0 N--CA 1.498 1.929 0 N-CA-C 108.124 -1.065 . . . . 0.0 108.124 179.783 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 176' ' ' ASP . . . . . 0.631 ' O ' ' O ' ' A' ' 177' ' ' LYS . 69.6 m-20 -104.09 85.72 2.44 Favored 'General case' 0 C--N 1.294 -1.815 0 N-CA-C 107.487 -1.301 . . . . 0.0 107.487 177.092 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 177' ' ' LYS . . . . . 0.743 ' NZ ' HE22 ' A' ' 113' ' ' GLN . 35.8 mttt -37.23 174.08 0.0 OUTLIER 'General case' 0 N--CA 1.497 1.904 0 CA-C-O 121.696 0.76 . . . . 0.0 110.588 -179.113 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 178' ' ' GLN . . . . . 0.63 HE21 ' NZ ' ' A' ' 173' ' ' LYS . 0.6 OUTLIER -161.51 175.42 12.15 Favored 'General case' 0 N--CA 1.489 1.479 0 C-N-CA 118.371 -1.332 . . . . 0.0 111.105 -179.864 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 179' ' ' LEU . . . . . 0.422 ' N ' ' OE1' ' A' ' 178' ' ' GLN . 1.3 tp -128.44 98.0 4.9 Favored 'General case' 0 C--N 1.302 -1.485 0 N-CA-C 107.274 -1.38 . . . . 0.0 107.274 178.103 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 180' ' ' THR . . . . . 0.481 ' N ' ' OE1' ' A' ' 178' ' ' GLN . 1.1 m -71.66 120.74 17.67 Favored 'General case' 0 N--CA 1.486 1.371 0 O-C-N 121.1 -1.0 . . . . 0.0 110.157 -178.341 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 181' ' ' LEU . . . . . 0.854 HD23 ' N ' ' A' ' 182' ' ' ILE . 6.6 tt -95.69 146.71 24.29 Favored 'General case' 0 C--N 1.299 -1.593 0 N-CA-C 107.915 -1.143 . . . . 0.0 107.915 178.01 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 182' ' ' ILE . . . . . 0.854 ' N ' HD23 ' A' ' 181' ' ' LEU . 19.8 mt -141.16 117.47 7.17 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.781 0 O-C-N 121.059 -1.026 . . . . 0.0 108.817 179.081 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 183' ' ' THR . . . . . 0.516 HG23 ' O ' ' A' ' 183' ' ' THR . 14.3 t -138.07 119.01 14.27 Favored 'General case' 0 C--N 1.29 -1.978 0 N-CA-C 108.002 -1.11 . . . . 0.0 108.002 179.229 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 184' ' ' CYS . . . . . . . . . . . . . 0.8 OUTLIER -79.85 162.5 25.01 Favored 'General case' 0 C--N 1.285 -2.236 0 C-N-CA 119.466 -0.894 . . . . 0.0 111.397 -177.842 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 185' ' ' ASP . . . . . 0.417 ' OD1' ' N ' ' A' ' 186' ' ' ASP . 4.4 t0 -165.51 -152.48 0.16 Allowed 'General case' 0 N--CA 1.492 1.644 0 N-CA-C 108.938 -0.764 . . . . 0.0 108.938 179.745 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 186' ' ' ASP . . . . . 0.417 ' N ' ' OD1' ' A' ' 185' ' ' ASP . 0.5 OUTLIER 47.78 59.34 4.25 Favored 'General case' 0 N--CA 1.495 1.777 0 O-C-N 121.136 -0.977 . . . . 0.0 109.072 -179.678 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 187' ' ' TYR . . . . . 0.591 ' CE1' ' O ' ' A' ' 188' ' ' ASN . 43.4 t80 -68.37 134.58 50.46 Favored 'General case' 0 N--CA 1.489 1.485 0 CA-C-O 121.821 0.819 . . . . 0.0 110.612 -179.585 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 188' ' ' ASN . . . . . 0.591 ' O ' ' CE1' ' A' ' 187' ' ' TYR . 0.8 OUTLIER -99.6 146.02 26.9 Favored 'General case' 0 C--N 1.294 -1.838 0 N-CA-C 107.916 -1.142 . . . . 0.0 107.916 178.224 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 189' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -111.55 -18.32 12.85 Favored 'General case' 0 C--N 1.296 -1.734 0 N-CA-C 108.1 -1.074 . . . . 0.0 108.1 -179.812 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 190' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER -83.68 -49.77 8.82 Favored 'General case' 0 C--N 1.302 -1.472 0 N-CA-C 108.267 -1.012 . . . . 0.0 108.267 178.457 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 191' ' ' THR . . . . . . . . . . . . . 44.4 p -87.41 -6.52 58.41 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.487 -0.758 . . . . 0.0 109.514 -179.971 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 192' ' ' GLY . . . . . . . . . . . . . . . 56.53 36.3 70.18 Favored Glycine 0 N--CA 1.493 2.463 0 O-C-N 121.081 -1.012 . . . . 0.0 110.648 179.025 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 193' ' ' VAL . . . . . . . . . . . . . 3.3 m -147.23 161.85 8.15 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.545 0 O-C-N 121.025 -1.279 . . . . 0.0 109.339 179.709 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 194' ' ' TRP . . . . . 0.472 ' CD1' ' N ' ' A' ' 194' ' ' TRP . 22.7 m95 -84.15 118.88 24.4 Favored 'General case' 0 N--CA 1.489 1.495 0 N-CA-C 107.604 -1.258 . . . . 0.0 107.604 178.654 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 195' ' ' GLU . . . . . 0.522 ' CD ' ' ND2' ' A' ' 188' ' ' ASN . 3.5 mt-10 -82.74 -62.09 1.7 Allowed 'General case' 0 N--CA 1.495 1.809 0 O-C-N 121.14 -0.975 . . . . 0.0 112.319 -177.103 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 196' ' ' LYS . . . . . . . . . . . . . 8.0 tptp -86.63 156.46 20.01 Favored 'General case' 0 N--CA 1.494 1.754 0 O-C-N 120.753 -1.217 . . . . 0.0 110.856 -178.141 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 197' ' ' ARG . . . . . 0.659 HH21 ' CA ' ' A' ' 163' ' ' PRO . 6.4 tpp180 -124.98 139.94 53.36 Favored 'General case' 0 N--CA 1.489 1.489 0 N-CA-C 109.133 -0.691 . . . . 0.0 109.133 179.389 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 198' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -112.46 121.8 45.87 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.626 -0.671 . . . . 0.0 109.863 -179.053 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 199' ' ' ILE . . . . . 0.66 HG22 HG23 ' A' ' 182' ' ' ILE . 0.9 OUTLIER -141.51 119.44 8.88 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.665 0 CA-C-O 122.615 1.198 . . . . 0.0 110.996 179.857 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 200' ' ' PHE . . . . . 0.564 ' CE2' HD22 ' A' ' 181' ' ' LEU . 0.2 OUTLIER -104.7 138.71 40.59 Favored 'General case' 0 N--CA 1.494 1.759 0 O-C-N 121.526 -0.734 . . . . 0.0 110.438 -178.305 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 201' ' ' VAL . . . . . . . . . . . . . 58.0 t -101.93 143.52 14.59 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.729 0 O-C-N 120.971 -1.081 . . . . 0.0 108.447 178.314 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 202' ' ' ALA . . . . . . . . . . . . . . . -124.95 135.23 52.63 Favored 'General case' 0 N--CA 1.489 1.477 0 N-CA-C 108.49 -0.93 . . . . 0.0 108.49 179.687 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 203' ' ' THR . . . . . 0.736 ' O ' HG23 ' A' ' 205' ' ' VAL . 1.3 p -89.17 128.4 35.8 Favored 'General case' 0 C--N 1.303 -1.427 0 CA-C-O 122.23 1.014 . . . . 0.0 111.225 -178.61 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 204' ' ' GLU . . . . . 0.484 ' HA ' ' CD2' ' A' ' 153' ' ' TYR . 5.5 tt0 -51.18 134.43 27.22 Favored 'General case' 0 C--N 1.297 -1.684 0 C-N-CA 118.949 -1.101 . . . . 0.0 108.369 178.728 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 205' ' ' VAL . . . . . 0.736 HG23 ' O ' ' A' ' 203' ' ' THR . 95.6 t -131.12 166.81 27.68 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.34 0 CA-C-O 121.934 0.873 . . . . 0.0 110.023 -177.859 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 206' ' ' LYS . . . . . 0.595 ' N ' HG12 ' A' ' 205' ' ' VAL . 2.0 pttp . . . . . 0 C--N 1.298 -1.658 0 CA-C-O 117.925 -1.036 . . . . 0.0 109.455 -179.672 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' C' C ' 701' ' ' PHQ . . . . . 0.471 ' C1 ' HG22 ' A' ' 166' ' ' VAL . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' C' C ' 702' ' ' LEU . . . . . 0.805 ' N ' HD12 ' C' ' 702' ' ' LEU . 0.0 OUTLIER . . . . . 0 N--CA 1.492 1.67 0 N-CA-C 109.762 -0.458 . . . . 0.0 109.762 . . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' C' C ' 703' ' ' PRO . . . . . 0.546 ' HB3' ' HB3' ' A' ' 92' ' ' ALA . 52.7 Cg_exo -48.01 -173.39 0.0 OUTLIER 'Trans proline' 0 N--CA 1.489 1.262 0 C-N-CA 121.957 1.771 . . . . 0.0 111.652 178.948 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' C' C ' 704' ' ' ALA . . . . . 0.752 ' HB2' ' HB1' ' A' ' 118' ' ' ALA . . . 56.76 123.12 0.0 OUTLIER 'General case' 0 N--CA 1.492 1.662 0 O-C-N 121.501 -0.749 . . . . 0.0 109.806 179.673 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' C' C ' 705' ' ' B27 . . . . . 0.694 HOG1 ' CE1' ' A' ' 120' ' ' HIS . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 700' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 012 nuclear nobuild full ' A' A ' 59' ' ' MET . . . . . . . . . . . . . 2.4 mpt? . . . . . 0 N--CA 1.488 1.444 0 CA-C-O 121.519 0.676 . . . . 0.0 109.553 . . . . . . . . . 0 0 . 1 . 012 nuclear nobuild full ' A' A ' 60' ' ' GLN . . . . . . . . . . . . . 27.2 mt-30 -60.71 164.53 4.59 Favored 'General case' 0 C--N 1.299 -1.621 0 N-CA-C 108.576 -0.898 . . . . 0.0 108.576 179.205 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 61' ' ' ALA . . . . . 0.444 ' HB2' ' OD1' ' A' ' 148' ' ' ASN . . . -65.08 -174.42 0.15 Allowed 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.228 -0.92 . . . . 0.0 109.936 -179.673 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 62' ' ' LYS . . . . . 0.499 ' O ' ' OE1' ' A' ' 64' ' ' GLN . 28.2 tttm -148.12 80.36 8.69 Favored Pre-proline 0 N--CA 1.493 1.696 0 O-C-N 121.47 -0.769 . . . . 0.0 109.249 179.448 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 63' ' ' PRO . . . . . 0.788 ' O ' HD13 ' A' ' 110' ' ' LEU . 16.3 Cg_exo -66.94 134.41 34.37 Favored 'Trans proline' 0 C--N 1.305 -1.753 0 C-N-CA 122.741 2.294 . . . . 0.0 111.85 -179.863 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 64' ' ' GLN . . . . . 0.622 HE21 ' C ' ' A' ' 64' ' ' GLN . 0.0 OUTLIER -152.75 103.92 2.82 Favored 'General case' 0 N--CA 1.489 1.476 0 O-C-N 121.372 -0.83 . . . . 0.0 109.408 -179.7 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 65' ' ' ILE . . . . . 0.58 HD12 ' H ' ' A' ' 65' ' ' ILE . 3.5 mp -40.14 102.27 0.26 Allowed Pre-proline 0 N--CA 1.488 1.45 0 N-CA-C 108.43 -0.952 . . . . 0.0 108.43 179.233 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 66' ' ' PRO . . . . . 0.411 ' N ' ' O ' ' A' ' 64' ' ' GLN . 97.9 Cg_endo -84.55 -155.61 0.06 OUTLIER 'Trans proline' 0 N--CA 1.489 1.206 0 C-N-CA 122.751 2.3 . . . . 0.0 112.968 -178.124 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 67' ' ' LYS . . . . . 0.44 ' C ' ' H ' ' A' ' 69' ' ' LYS . 6.5 ptpt -82.81 -5.03 58.76 Favored 'General case' 0 C--N 1.305 -1.362 0 N-CA-C 108.877 -0.786 . . . . 0.0 108.877 179.698 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 68' ' ' ASP . . . . . 0.631 ' C ' ' N ' ' A' ' 70' ' ' SER . 0.3 OUTLIER -75.39 50.18 0.51 Allowed 'General case' 0 N--CA 1.491 1.579 0 CA-C-O 123.005 1.383 . . . . 0.0 108.189 179.013 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 69' ' ' LYS . . . . . 0.455 ' C ' ' O ' ' A' ' 68' ' ' ASP . 1.9 mtpt -48.07 -15.17 0.06 Allowed 'General case' 0 N--CA 1.506 2.359 0 C-N-CA 116.758 -1.977 . . . . 0.0 107.149 178.425 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 70' ' ' SER . . . . . 0.631 ' N ' ' C ' ' A' ' 68' ' ' ASP . 0.2 OUTLIER -86.81 -5.22 59.17 Favored 'General case' 0 C--N 1.293 -1.856 0 CA-C-N 113.701 -1.591 . . . . 0.0 110.613 179.758 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 71' ' ' LYS . . . . . 0.446 ' N ' ' O ' ' A' ' 68' ' ' ASP . 2.4 ptmm? -97.28 138.36 34.87 Favored 'General case' 0 N--CA 1.494 1.736 0 O-C-N 120.899 -1.126 . . . . 0.0 112.007 -179.305 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 72' ' ' VAL . . . . . 0.593 ' CG2' ' O ' ' A' ' 74' ' ' GLY . 0.7 OUTLIER -67.01 132.25 32.38 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.444 0 N-CA-C 104.977 -2.231 . . . . 0.0 104.977 174.554 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 73' ' ' ALA . . . . . 0.452 ' N ' ' O ' ' A' ' 87' ' ' VAL . . . -82.04 -12.87 58.05 Favored 'General case' 0 C--N 1.299 -1.617 0 O-C-N 120.121 -1.612 . . . . 0.0 108.681 -178.671 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 74' ' ' GLY . . . . . 0.593 ' O ' ' CG2' ' A' ' 72' ' ' VAL . . . 170.35 -156.4 26.86 Favored Glycine 0 N--CA 1.483 1.784 0 N-CA-C 109.642 -1.383 . . . . 0.0 109.642 179.974 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 75' ' ' TYR . . . . . 0.55 ' CD1' ' C ' ' A' ' 74' ' ' GLY . 10.8 m-85 -143.71 173.81 11.34 Favored 'General case' 0 C--N 1.293 -1.889 0 O-C-N 121.276 -1.132 . . . . 0.0 109.702 -178.811 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 76' ' ' ILE . . . . . . . . . . . . . 1.4 tt -147.25 144.97 19.52 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.79 0 N-CA-C 108.72 -0.844 . . . . 0.0 108.72 -178.067 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -150.48 157.19 42.74 Favored 'General case' 0 C--N 1.301 -1.536 0 O-C-N 121.043 -1.035 . . . . 0.0 109.849 -179.513 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 78' ' ' ILE . . . . . 0.451 HG23 ' O ' ' A' ' 141' ' ' MET . 22.4 mt -142.6 121.28 7.51 Favored Pre-proline 0 C--N 1.301 -1.526 0 N-CA-C 107.291 -1.374 . . . . 0.0 107.291 179.718 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 79' ' ' PRO . . . . . . . . . . . . . 55.6 Cg_endo -73.33 -42.85 0.81 Allowed 'Trans proline' 0 N--CA 1.49 1.321 0 C-N-CA 121.893 1.729 . . . . 0.0 113.569 -177.89 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 19.6 t70 -65.98 -19.4 65.85 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 120.766 -1.209 . . . . 0.0 110.274 178.06 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 81' ' ' ALA . . . . . 0.95 ' HB2' ' HB2' ' A' ' 136' ' ' ALA . . . -105.6 -20.99 13.3 Favored 'General case' 0 N--CA 1.495 1.804 0 O-C-N 121.165 -0.959 . . . . 0.0 108.79 179.502 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 82' ' ' ASP . . . . . 0.423 ' OD2' ' C ' ' A' ' 81' ' ' ALA . 0.4 OUTLIER 68.65 51.56 0.61 Allowed 'General case' 0 C--N 1.303 -1.441 0 O-C-N 121.336 -0.853 . . . . 0.0 111.127 178.816 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 83' ' ' ILE . . . . . 0.6 HD11 ' OD1' ' A' ' 132' ' ' ASN . 57.6 mt -127.15 152.27 34.98 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.864 0 O-C-N 121.163 -0.96 . . . . 0.0 109.481 -179.777 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 84' ' ' LYS . . . . . . . . . . . . . 0.8 OUTLIER -159.26 108.36 1.87 Allowed 'General case' 0 C--N 1.303 -1.435 0 N-CA-C 107.892 -1.151 . . . . 0.0 107.892 179.727 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 85' ' ' GLU . . . . . 0.493 ' OE1' ' O ' ' A' ' 128' ' ' TYR . 0.0 OUTLIER -142.82 170.53 8.58 Favored Pre-proline 0 N--CA 1.497 1.921 0 O-C-N 121.362 -0.836 . . . . 0.0 111.105 -177.597 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 86' ' ' PRO . . . . . . . . . . . . . 90.4 Cg_endo -79.8 161.53 24.34 Favored 'Trans proline' 0 N--CA 1.493 1.474 0 C-N-CA 123.25 2.634 . . . . 0.0 113.247 179.752 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 87' ' ' VAL . . . . . 0.57 ' H ' HG23 ' A' ' 72' ' ' VAL . 92.8 t -118.14 101.97 12.57 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.485 0 N-CA-C 108.99 -0.744 . . . . 0.0 108.99 179.91 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 88' ' ' TYR . . . . . 0.402 ' CE1' ' HB3' ' A' ' 99' ' ' ARG . 17.5 m-85 -93.35 153.93 41.44 Favored Pre-proline 0 N--CA 1.504 2.236 0 O-C-N 120.865 -1.147 . . . . 0.0 110.664 -179.015 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 89' ' ' PRO . . . . . . . . . . . . . 11.2 Cg_endo -62.44 143.0 92.66 Favored 'Trans proline' 0 C--N 1.312 -1.346 0 C-N-CA 122.571 2.181 . . . . 0.0 113.863 -179.067 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 90' ' ' GLY . . . . . 0.412 ' O ' ' NZ ' ' A' ' 69' ' ' LYS . . . -58.33 168.24 5.71 Favored Glycine 0 N--CA 1.487 2.034 0 N-CA-C 110.167 -1.173 . . . . 0.0 110.167 179.611 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 91' ' ' PRO . . . . . 0.465 ' C ' ' H ' ' A' ' 93' ' ' THR . 38.2 Cg_endo -93.11 169.46 21.09 Favored 'Cis proline' 0 C--N 1.307 -1.606 0 C-N-CA 123.713 -1.37 . . . . 0.0 111.497 0.132 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 92' ' ' ALA . . . . . 0.605 ' HB3' ' CB ' ' C' ' 703' ' ' PRO . . . -72.81 33.3 0.07 Allowed 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.02 -1.05 . . . . 0.0 110.237 -179.691 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 93' ' ' THR . . . . . 0.465 ' H ' ' C ' ' A' ' 91' ' ' PRO . 1.6 p -72.21 152.74 92.47 Favored Pre-proline 0 C--N 1.3 -1.559 0 O-C-N 120.86 -1.15 . . . . 0.0 108.008 179.776 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 94' ' ' PRO . . . . . 0.428 ' C ' ' O ' ' A' ' 93' ' ' THR . 92.2 Cg_exo -32.79 -58.73 0.26 Allowed 'Trans proline' 0 C--N 1.305 -1.747 0 C-N-CA 122.575 2.184 . . . . 0.0 112.347 -179.253 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 21.0 mt-10 -44.2 -49.06 9.3 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.249 -0.907 . . . . 0.0 109.971 179.862 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 96' ' ' GLN . . . . . 0.628 ' NE2' HH12 ' A' ' 99' ' ' ARG . 3.8 mp0 -72.33 -55.87 6.41 Favored 'General case' 0 N--CA 1.489 1.491 0 O-C-N 121.203 -0.935 . . . . 0.0 111.014 -178.973 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 97' ' ' LEU . . . . . 0.417 ' CD1' ' O ' ' A' ' 92' ' ' ALA . 80.9 mt -49.21 -6.59 0.02 OUTLIER 'General case' 0 N--CA 1.496 1.845 0 O-C-N 121.067 -1.021 . . . . 0.0 110.279 -178.867 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 98' ' ' ASN . . . . . 0.773 HD21 ' NE ' ' A' ' 99' ' ' ARG . 0.2 OUTLIER -72.77 -25.16 61.07 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.337 -0.852 . . . . 0.0 108.928 179.679 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 99' ' ' ARG . . . . . 0.773 ' NE ' HD21 ' A' ' 98' ' ' ASN . 3.5 mtt180 -92.06 -51.97 4.93 Favored 'General case' 0 C--N 1.302 -1.467 0 O-C-N 121.682 -0.636 . . . . 0.0 110.497 -179.035 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . 172.23 -166.58 39.41 Favored Glycine 0 N--CA 1.493 2.486 0 N-CA-C 109.741 -1.343 . . . . 0.0 109.741 -179.687 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 101' ' ' VAL . . . . . 0.623 ' O ' HG23 ' A' ' 101' ' ' VAL . 34.7 m -54.69 100.41 0.04 OUTLIER 'Isoleucine or valine' 0 N--CA 1.493 1.724 0 O-C-N 121.146 -1.209 . . . . 0.0 109.802 -179.659 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 1.9 m -92.07 171.73 8.91 Favored 'General case' 0 N--CA 1.497 1.875 0 O-C-N 121.417 -0.802 . . . . 0.0 110.324 -179.789 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 103' ' ' PHE . . . . . 0.499 ' CE1' ' CG1' ' A' ' 87' ' ' VAL . 23.6 m-85 -75.08 145.68 42.09 Favored 'General case' 0 N--CA 1.493 1.697 0 N-CA-C 108.069 -1.086 . . . . 0.0 108.069 178.263 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 104' ' ' ALA . . . . . . . . . . . . . . . -66.71 -13.42 61.29 Favored 'General case' 0 N--CA 1.492 1.671 0 O-C-N 121.243 -0.911 . . . . 0.0 111.571 -178.105 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 105' ' ' GLU . . . . . 0.452 ' OE2' ' OE1' ' A' ' 108' ' ' GLU . 0.3 OUTLIER -138.6 144.32 39.72 Favored 'General case' 0 N--CA 1.496 1.838 0 O-C-N 120.762 -1.211 . . . . 0.0 110.592 -179.211 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 106' ' ' GLU . . . . . 0.505 ' CG ' ' N ' ' A' ' 107' ' ' ASN . 6.0 pt-20 -57.12 -59.6 4.85 Favored 'General case' 0 C--N 1.304 -1.402 0 O-C-N 121.732 -0.605 . . . . 0.0 110.224 -179.806 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 107' ' ' ASN . . . . . 0.743 HD22 ' N ' ' A' ' 107' ' ' ASN . 0.0 OUTLIER -78.27 33.96 0.2 Allowed 'General case' 0 N--CA 1.488 1.442 0 O-C-N 120.542 -1.349 . . . . 0.0 112.895 -176.114 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 108' ' ' GLU . . . . . 0.452 ' OE1' ' OE2' ' A' ' 105' ' ' GLU . 32.9 tp10 -60.09 147.45 39.37 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 120.824 -1.173 . . . . 0.0 108.141 -179.568 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 109' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -95.25 147.53 23.38 Favored 'General case' 0 N--CA 1.489 1.497 0 O-C-N 120.797 -1.189 . . . . 0.0 111.03 -178.093 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 110' ' ' LEU . . . . . 0.899 ' H ' HD23 ' A' ' 110' ' ' LEU . 0.2 OUTLIER -63.67 -24.61 67.85 Favored 'General case' 0 C--N 1.305 -1.337 0 N-CA-C 107.536 -1.283 . . . . 0.0 107.536 178.548 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 111' ' ' ASP . . . . . 0.491 ' CG ' HH22 ' A' ' 151' ' ' ARG . 55.3 m-20 -132.93 49.19 2.34 Favored 'General case' 0 N--CA 1.487 1.391 0 N-CA-C 109.183 -0.673 . . . . 0.0 109.183 179.513 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 112' ' ' ASP . . . . . . . . . . . . . 1.9 t0 -69.07 159.97 31.9 Favored 'General case' 0 N--CA 1.493 1.72 0 O-C-N 121.257 -0.902 . . . . 0.0 111.287 -179.745 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 113' ' ' GLN . . . . . 0.536 ' N ' ' CD ' ' A' ' 113' ' ' GLN . 0.0 OUTLIER -65.21 -18.52 65.38 Favored 'General case' 0 N--CA 1.491 1.614 0 N-CA-C 107.263 -1.384 . . . . 0.0 107.263 177.675 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 114' ' ' ASN . . . . . 0.608 ' ND2' ' O ' ' A' ' 169' ' ' LEU . 8.5 p-10 -153.11 111.85 3.73 Favored 'General case' 0 C--N 1.299 -1.588 0 N-CA-C 108.026 -1.102 . . . . 0.0 108.026 177.505 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 115' ' ' ILE . . . . . 0.485 HG22 ' O ' ' A' ' 115' ' ' ILE . 2.5 mt -96.82 105.68 17.44 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.692 0 N-CA-C 107.604 -1.258 . . . . 0.0 107.604 179.507 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 116' ' ' SER . . . . . . . . . . . . . 4.8 m -86.23 151.6 23.49 Favored 'General case' 0 C--N 1.303 -1.422 0 CA-C-O 122.088 0.947 . . . . 0.0 111.421 -177.739 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 117' ' ' ILE . . . . . . . . . . . . . 1.6 mt -147.19 142.26 20.11 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.532 0 N-CA-C 106.998 -1.482 . . . . 0.0 106.998 178.542 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 118' ' ' ALA . . . . . 0.54 ' HB1' ' HB2' ' C' ' 704' ' ' ALA . . . -137.89 158.37 44.48 Favored 'General case' 0 N--CA 1.493 1.722 0 O-C-N 120.985 -1.072 . . . . 0.0 110.698 -178.284 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 119' ' ' GLY . . . . . . . . . . . . . . . -169.93 145.86 9.54 Favored Glycine 0 N--CA 1.48 1.603 0 N-CA-C 110.055 -1.218 . . . . 0.0 110.055 179.342 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 120' ' ' HIS . . . . . 0.65 ' CD2' ' SG ' ' C' ' 705' ' ' B27 . 30.0 m170 -70.25 167.48 17.87 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.671 -0.899 . . . . 0.0 109.766 179.589 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 121' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -115.21 157.36 23.79 Favored 'General case' 0 N--CA 1.492 1.644 0 N-CA-C 108.49 -0.93 . . . . 0.0 108.49 179.038 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 122' ' ' PHE . . . . . 0.716 ' O ' HG21 ' A' ' 131' ' ' THR . 2.4 m-85 -141.07 122.95 15.39 Favored 'General case' 0 N--CA 1.494 1.769 0 O-C-N 121.152 -0.967 . . . . 0.0 108.873 -179.889 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 123' ' ' ILE . . . . . 0.555 HG23 ' N ' ' A' ' 124' ' ' ASP . 19.6 tt -60.32 -40.99 85.55 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.548 0 CA-C-O 121.62 0.724 . . . . 0.0 109.52 -179.608 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 124' ' ' ASP . . . . . 0.555 ' N ' HG23 ' A' ' 123' ' ' ILE . 6.0 p-10 -88.96 21.62 3.04 Favored 'General case' 0 C--N 1.295 -1.787 0 O-C-N 121.698 -0.626 . . . . 0.0 111.774 -177.548 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 125' ' ' ARG . . . . . . . . . . . . . 91.6 mtt180 -152.69 101.56 2.71 Favored Pre-proline 0 N--CA 1.492 1.663 0 O-C-N 120.708 -1.245 . . . . 0.0 109.561 179.778 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 126' ' ' PRO . . . . . . . . . . . . . 55.6 Cg_endo -79.32 -30.07 2.77 Favored 'Trans proline' 0 N--CA 1.488 1.177 0 C-N-CA 122.459 2.106 . . . . 0.0 112.903 -179.781 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 127' ' ' ASN . . . . . 0.49 ' O ' ' O ' ' A' ' 128' ' ' TYR . 1.2 m120 -90.07 8.65 31.58 Favored 'General case' 0 N--CA 1.493 1.696 0 O-C-N 121.047 -1.033 . . . . 0.0 109.199 179.594 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 128' ' ' TYR . . . . . 0.493 ' O ' ' OE1' ' A' ' 85' ' ' GLU . 2.1 t80 -59.43 -148.67 0.0 OUTLIER 'General case' 0 C--N 1.302 -1.464 0 O-C-N 121.459 -0.776 . . . . 0.0 109.444 -179.82 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 129' ' ' GLN . . . . . . . . . . . . . 26.7 mt-30 -64.42 -75.6 0.08 Allowed 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.24 -0.913 . . . . 0.0 110.14 -179.252 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 130' ' ' PHE . . . . . 0.523 ' O ' ' CE ' ' A' ' 134' ' ' LYS . 49.4 m-85 -133.87 48.28 2.37 Favored 'General case' 0 N--CA 1.492 1.67 0 O-C-N 121.402 -0.811 . . . . 0.0 109.71 -179.848 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 131' ' ' THR . . . . . 0.716 HG21 ' O ' ' A' ' 122' ' ' PHE . 23.7 m -83.02 -38.84 22.05 Favored 'General case' 0 C--N 1.298 -1.659 0 O-C-N 121.03 -1.044 . . . . 0.0 109.228 179.864 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 132' ' ' ASN . . . . . 0.6 ' OD1' HD11 ' A' ' 83' ' ' ILE . 0.2 OUTLIER -83.61 4.19 29.4 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.475 -0.766 . . . . 0.0 110.781 -179.079 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 133' ' ' LEU . . . . . 0.544 ' O ' ' N ' ' A' ' 135' ' ' ALA . 0.1 OUTLIER -66.49 -45.5 79.43 Favored 'General case' 0 N--CA 1.497 1.909 0 O-C-N 120.591 -1.318 . . . . 0.0 110.164 179.874 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 134' ' ' LYS . . . . . 0.541 ' CD ' ' H ' ' A' ' 134' ' ' LYS . 0.0 OUTLIER -43.07 -17.6 0.01 OUTLIER 'General case' 0 N--CA 1.499 1.995 0 O-C-N 121.142 -0.974 . . . . 0.0 110.814 -178.861 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 135' ' ' ALA . . . . . 0.544 ' N ' ' O ' ' A' ' 133' ' ' LEU . . . -84.09 -31.85 25.08 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 120.976 -1.078 . . . . 0.0 109.725 -179.931 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 136' ' ' ALA . . . . . 0.95 ' HB2' ' HB2' ' A' ' 81' ' ' ALA . . . -79.6 151.53 30.56 Favored 'General case' 0 C--N 1.3 -1.545 0 CA-C-O 121.874 0.845 . . . . 0.0 111.623 -178.413 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 137' ' ' LYS . . . . . 0.576 ' O ' ' O ' ' A' ' 138' ' ' LYS . 0.0 OUTLIER -153.11 -168.91 3.17 Favored 'General case' 0 N--CA 1.495 1.796 0 C-N-CA 118.474 -1.29 . . . . 0.0 111.313 -177.964 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 138' ' ' LYS . . . . . 0.576 ' O ' ' O ' ' A' ' 137' ' ' LYS . 50.1 mttm -38.55 172.37 0.0 OUTLIER 'General case' 0 N--CA 1.487 1.415 0 CA-C-O 122.488 1.137 . . . . 0.0 110.971 -178.986 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 139' ' ' GLY . . . . . . . . . . . . . . . 49.13 9.12 0.1 Allowed Glycine 0 N--CA 1.488 2.143 0 N-CA-C 109.8 -1.32 . . . . 0.0 109.8 -179.977 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 140' ' ' SER . . . . . 0.519 ' N ' ' O ' ' A' ' 138' ' ' LYS . 4.3 m -80.56 132.26 35.63 Favored 'General case' 0 N--CA 1.496 1.86 0 O-C-N 120.975 -1.309 . . . . 0.0 109.778 179.677 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 141' ' ' MET . . . . . 0.451 ' O ' HG23 ' A' ' 78' ' ' ILE . 0.1 OUTLIER -83.68 128.81 34.81 Favored 'General case' 0 N--CA 1.49 1.567 0 N-CA-C 108.515 -0.921 . . . . 0.0 108.515 179.195 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 142' ' ' VAL . . . . . . . . . . . . . 2.6 t -117.96 131.68 69.99 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.857 0 O-C-N 121.414 -0.804 . . . . 0.0 109.061 -179.185 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 143' ' ' TYR . . . . . . . . . . . . . 3.1 m-85 -110.58 135.58 51.01 Favored 'General case' 0 N--CA 1.496 1.866 0 O-C-N 120.851 -1.156 . . . . 0.0 111.444 -178.443 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 144' ' ' PHE . . . . . . . . . . . . . 52.6 t80 -122.15 103.11 8.56 Favored 'General case' 0 N--CA 1.493 1.718 0 CA-C-O 121.495 0.664 . . . . 0.0 109.844 -179.428 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 145' ' ' LYS . . . . . . . . . . . . . 46.1 mttt -96.94 128.59 44.05 Favored 'General case' 0 N--CA 1.494 1.764 0 O-C-N 121.458 -0.776 . . . . 0.0 110.992 -179.291 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 146' ' ' VAL . . . . . 0.443 ' O ' ' C ' ' A' ' 147' ' ' GLY . 2.0 p -141.46 142.12 29.4 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.668 0 N-CA-C 107.519 -1.289 . . . . 0.0 107.519 178.52 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 147' ' ' GLY . . . . . 0.443 ' C ' ' O ' ' A' ' 146' ' ' VAL . . . 43.59 -129.38 6.17 Favored Glycine 0 N--CA 1.49 2.276 0 N-CA-C 109.313 -1.515 . . . . 0.0 109.313 -179.827 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 148' ' ' ASN . . . . . 0.463 HD22 ' C ' ' A' ' 148' ' ' ASN . 0.5 OUTLIER -102.29 15.15 30.0 Favored 'General case' 0 N--CA 1.488 1.469 0 O-C-N 121.278 -1.131 . . . . 0.0 108.336 179.15 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 149' ' ' GLU . . . . . . . . . . . . . 2.3 mm-40 -109.07 143.91 37.79 Favored 'General case' 0 N--CA 1.49 1.531 0 CA-C-O 121.771 0.796 . . . . 0.0 111.576 -178.546 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 150' ' ' THR . . . . . . . . . . . . . 3.4 m -130.02 101.16 5.71 Favored 'General case' 0 N--CA 1.495 1.779 0 CA-C-O 121.46 0.647 . . . . 0.0 109.77 179.915 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 151' ' ' ARG . . . . . 0.491 HH22 ' CG ' ' A' ' 111' ' ' ASP . 16.5 mtt180 -86.13 -171.67 3.68 Favored 'General case' 0 N--CA 1.487 1.404 0 O-C-N 121.243 -0.91 . . . . 0.0 108.983 -179.671 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 152' ' ' LYS . . . . . 0.465 ' O ' ' N ' ' A' ' 205' ' ' VAL . 36.3 mtmt -151.38 148.35 28.02 Favored 'General case' 0 C--N 1.301 -1.532 0 O-C-N 121.111 -0.993 . . . . 0.0 110.423 -178.895 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 153' ' ' TYR . . . . . 0.503 ' CD2' ' HA ' ' A' ' 204' ' ' GLU . 11.1 m-85 -141.76 168.68 19.18 Favored 'General case' 0 C--N 1.302 -1.493 0 N-CA-C 108.157 -1.053 . . . . 0.0 108.157 179.189 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 154' ' ' LYS . . . . . . . . . . . . . 29.1 ttpt -143.17 119.0 10.54 Favored 'General case' 0 C--N 1.297 -1.714 0 N-CA-C 108.038 -1.097 . . . . 0.0 108.038 178.703 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 155' ' ' MET . . . . . . . . . . . . . 18.0 mtp -47.13 108.69 0.16 Allowed 'General case' 0 N--CA 1.492 1.662 0 O-C-N 120.536 -1.353 . . . . 0.0 111.528 -178.381 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 156' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -105.16 -25.15 12.6 Favored 'General case' 0 C--N 1.294 -1.822 0 CA-C-N 115.351 -0.841 . . . . 0.0 110.714 -178.638 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 157' ' ' SER . . . . . . . . . . . . . 49.8 m -145.84 147.44 31.82 Favored 'General case' 0 C--N 1.296 -1.748 0 C-N-CA 118.511 -1.276 . . . . 0.0 110.15 -178.769 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 158' ' ' ILE . . . . . . . . . . . . . 2.3 mt -146.96 136.54 16.67 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.611 0 CA-C-O 121.538 0.685 . . . . 0.0 110.111 -177.781 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 159' ' ' ARG . . . . . 0.684 ' CG ' HH11 ' A' ' 159' ' ' ARG . 0.0 OUTLIER -155.63 -172.83 4.29 Favored 'General case' 0 N--CA 1.491 1.604 0 C-N-CA 119.505 -0.878 . . . . 0.0 110.459 179.733 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 160' ' ' ASP . . . . . 0.514 ' C ' HG22 ' A' ' 161' ' ' VAL . 10.7 m-20 -149.54 165.47 32.11 Favored 'General case' 0 N--CA 1.489 1.507 0 N-CA-C 108.324 -0.991 . . . . 0.0 108.324 179.554 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 161' ' ' VAL . . . . . 0.514 HG22 ' C ' ' A' ' 160' ' ' ASP . 0.1 OUTLIER -166.07 161.44 0.81 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.685 0 O-C-N 121.088 -1.008 . . . . 0.0 109.877 179.829 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 162' ' ' LYS . . . . . 0.484 ' O ' ' O ' ' A' ' 161' ' ' VAL . 0.0 OUTLIER -44.62 170.99 0.05 OUTLIER Pre-proline 0 N--CA 1.489 1.503 0 O-C-N 121.366 -0.834 . . . . 0.0 109.653 179.73 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 163' ' ' PRO . . . . . 0.485 ' C ' HD11 ' C' ' 702' ' ' LEU . 62.1 Cg_endo -80.74 36.16 0.61 Allowed 'Trans proline' 0 C--N 1.31 -1.483 0 C-N-CA 122.672 2.248 . . . . 0.0 113.061 -179.851 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 164' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -151.88 -2.88 0.28 Allowed 'General case' 0 N--CA 1.497 1.896 0 O-C-N 121.047 -1.033 . . . . 0.0 110.214 179.987 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 165' ' ' ASP . . . . . . . . . . . . . 7.2 t70 -74.83 62.98 1.13 Allowed 'General case' 0 N--CA 1.488 1.45 0 O-C-N 120.899 -1.126 . . . . 0.0 109.386 -179.988 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 166' ' ' VAL . . . . . 0.589 ' O ' ' N ' ' A' ' 168' ' ' VAL . 1.8 m -49.68 -33.82 8.37 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.503 0 O-C-N 121.659 -0.65 . . . . 0.0 109.776 -178.392 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 167' ' ' GLY . . . . . 0.405 ' C ' ' O ' ' A' ' 166' ' ' VAL . . . -43.89 -13.35 0.02 OUTLIER Glycine 0 N--CA 1.496 2.65 0 O-C-N 120.865 -1.147 . . . . 0.0 110.725 -179.766 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 168' ' ' VAL . . . . . 0.589 ' N ' ' O ' ' A' ' 166' ' ' VAL . 3.5 m -53.48 -26.77 13.54 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.563 0 O-C-N 120.712 -1.463 . . . . 0.0 108.741 179.688 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 169' ' ' LEU . . . . . 0.608 ' O ' ' ND2' ' A' ' 114' ' ' ASN . 1.2 mm? -44.43 -24.67 0.19 Allowed 'General case' 0 C--N 1.299 -1.61 0 N-CA-C 107.808 -1.182 . . . . 0.0 107.808 -178.658 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 170' ' ' ASP . . . . . 0.474 ' N ' ' C ' ' A' ' 168' ' ' VAL . 14.9 t0 37.29 90.51 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.715 -0.616 . . . . 0.0 110.804 177.944 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 171' ' ' GLU . . . . . . . . . . . . . 14.9 pt-20 -130.13 60.09 1.62 Allowed 'General case' 0 N--CA 1.497 1.922 0 O-C-N 120.904 -1.123 . . . . 0.0 109.735 179.515 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 172' ' ' GLN . . . . . . . . . . . . . 10.7 mt-30 -123.06 -56.87 1.73 Allowed 'General case' 0 N--CA 1.497 1.899 0 O-C-N 121.438 -0.789 . . . . 0.0 110.958 -178.969 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 173' ' ' LYS . . . . . 0.467 ' H ' ' HD2' ' A' ' 173' ' ' LYS . 2.3 mptp? -57.62 123.2 14.79 Favored 'General case' 0 N--CA 1.493 1.696 0 O-C-N 120.817 -1.177 . . . . 0.0 108.909 -179.67 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 174' ' ' GLY . . . . . 0.485 ' O ' ' C ' ' A' ' 175' ' ' LYS . . . -117.29 -43.59 0.59 Allowed Glycine 0 N--CA 1.478 1.483 0 N-CA-C 108.166 -1.974 . . . . 0.0 108.166 179.589 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 175' ' ' LYS . . . . . 0.485 ' C ' ' O ' ' A' ' 174' ' ' GLY . 11.9 mptt -43.52 -58.53 2.57 Favored 'General case' 0 N--CA 1.49 1.545 0 N-CA-C 107.107 -1.442 . . . . 0.0 107.107 179.565 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 176' ' ' ASP . . . . . 0.617 ' O ' ' O ' ' A' ' 177' ' ' LYS . 3.4 m-20 -103.8 85.66 2.47 Favored 'General case' 0 C--N 1.293 -1.866 0 N-CA-C 106.835 -1.543 . . . . 0.0 106.835 176.672 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 177' ' ' LYS . . . . . 0.617 ' O ' ' O ' ' A' ' 176' ' ' ASP . 35.6 mttt -44.23 -175.92 0.0 OUTLIER 'General case' 0 N--CA 1.493 1.691 0 O-C-N 121.632 -0.667 . . . . 0.0 109.663 -179.159 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 178' ' ' GLN . . . . . . . . . . . . . 16.6 pt20 -160.7 173.68 15.07 Favored 'General case' 0 C--N 1.303 -1.439 0 O-C-N 120.307 -1.496 . . . . 0.0 110.949 179.524 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 179' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -129.35 97.74 4.66 Favored 'General case' 0 C--N 1.303 -1.453 0 N-CA-C 107.225 -1.398 . . . . 0.0 107.225 178.459 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 180' ' ' THR . . . . . 0.467 ' O ' HG22 ' A' ' 180' ' ' THR . 1.1 m -73.56 115.69 13.25 Favored 'General case' 0 N--CA 1.493 1.72 0 O-C-N 121.162 -0.961 . . . . 0.0 110.662 -178.372 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 181' ' ' LEU . . . . . 0.688 HD13 ' H ' ' A' ' 182' ' ' ILE . 0.2 OUTLIER -89.55 144.48 25.99 Favored 'General case' 0 C--N 1.301 -1.535 0 N-CA-C 108.11 -1.07 . . . . 0.0 108.11 177.47 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 182' ' ' ILE . . . . . 0.688 ' H ' HD13 ' A' ' 181' ' ' LEU . 4.7 mt -137.91 113.03 9.85 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.643 0 N-CA-C 107.822 -1.177 . . . . 0.0 107.822 179.102 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 183' ' ' THR . . . . . 0.479 HG23 ' O ' ' A' ' 183' ' ' THR . 5.8 t -134.34 119.44 18.65 Favored 'General case' 0 C--N 1.293 -1.88 0 N-CA-C 108.141 -1.059 . . . . 0.0 108.141 179.708 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 184' ' ' CYS . . . . . . . . . . . . . 1.0 OUTLIER -80.21 156.37 26.94 Favored 'General case' 0 C--N 1.289 -2.065 0 C-N-CA 119.514 -0.874 . . . . 0.0 111.183 -178.366 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 185' ' ' ASP . . . . . 0.549 ' O ' ' CB ' ' A' ' 186' ' ' ASP . 0.2 OUTLIER -166.68 170.55 12.44 Favored 'General case' 0 N--CA 1.493 1.698 0 O-C-N 121.538 -0.726 . . . . 0.0 109.058 179.831 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 186' ' ' ASP . . . . . 0.549 ' CB ' ' O ' ' A' ' 185' ' ' ASP . 1.0 OUTLIER 79.28 52.42 0.03 OUTLIER 'General case' 0 N--CA 1.492 1.668 0 O-C-N 121.23 -0.919 . . . . 0.0 109.704 179.863 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 187' ' ' TYR . . . . . 0.581 ' CE1' ' O ' ' A' ' 188' ' ' ASN . 36.9 t80 -65.9 131.42 46.23 Favored 'General case' 0 C--N 1.302 -1.497 0 O-C-N 120.92 -1.113 . . . . 0.0 109.623 179.946 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 188' ' ' ASN . . . . . 0.834 HD21 ' N ' ' A' ' 192' ' ' GLY . 0.0 OUTLIER -100.13 148.71 24.28 Favored 'General case' 0 C--N 1.291 -1.936 0 N-CA-C 107.589 -1.263 . . . . 0.0 107.589 178.68 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 189' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -109.9 -9.57 14.78 Favored 'General case' 0 C--N 1.294 -1.819 0 N-CA-C 108.495 -0.928 . . . . 0.0 108.495 -179.505 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 190' ' ' LYS . . . . . . . . . . . . . 6.4 mmtt -84.49 -56.23 3.73 Favored 'General case' 0 N--CA 1.488 1.432 0 C-N-CA 119.841 -0.744 . . . . 0.0 109.182 178.774 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 191' ' ' THR . . . . . 0.686 ' N ' HD21 ' A' ' 188' ' ' ASN . 7.1 p -86.44 7.93 23.86 Favored 'General case' 0 N--CA 1.493 1.678 0 O-C-N 121.559 -0.713 . . . . 0.0 110.688 -178.823 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 192' ' ' GLY . . . . . 0.834 ' N ' HD21 ' A' ' 188' ' ' ASN . . . 51.69 30.47 28.07 Favored Glycine 0 N--CA 1.494 2.544 0 O-C-N 121.098 -1.001 . . . . 0.0 111.733 178.82 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 193' ' ' VAL . . . . . 0.578 ' H ' HD22 ' A' ' 188' ' ' ASN . 0.4 OUTLIER -149.59 170.58 1.98 Allowed 'Isoleucine or valine' 0 N--CA 1.495 1.798 0 O-C-N 120.463 -1.61 . . . . 0.0 109.909 179.129 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 194' ' ' TRP . . . . . 0.479 ' CD1' HG2B ' C' ' 705' ' ' B27 . 44.1 m95 -84.93 122.07 28.66 Favored 'General case' 0 C--N 1.295 -1.795 0 CA-C-O 121.577 0.704 . . . . 0.0 109.994 -179.427 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 195' ' ' GLU . . . . . 0.402 ' HG3' ' H ' ' A' ' 195' ' ' GLU . 2.0 mt-10 -77.81 -60.96 2.16 Favored 'General case' 0 N--CA 1.496 1.871 0 O-C-N 121.546 -0.721 . . . . 0.0 111.902 -178.326 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 196' ' ' LYS . . . . . . . . . . . . . 5.3 tttm -92.44 150.11 20.99 Favored 'General case' 0 N--CA 1.495 1.797 0 O-C-N 121.003 -1.061 . . . . 0.0 111.761 -177.481 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 197' ' ' ARG . . . . . 0.699 ' HE ' HD13 ' C' ' 702' ' ' LEU . 0.0 OUTLIER -120.7 139.03 53.64 Favored 'General case' 0 N--CA 1.493 1.676 0 N-CA-C 108.319 -0.993 . . . . 0.0 108.319 178.353 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 198' ' ' LYS . . . . . . . . . . . . . 7.9 mttt -116.72 120.46 38.68 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.447 -0.783 . . . . 0.0 110.406 -178.624 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 199' ' ' ILE . . . . . 0.441 ' O ' HG13 ' A' ' 199' ' ' ILE . 0.9 OUTLIER -140.78 121.06 13.09 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.733 0 CA-C-O 122.787 1.279 . . . . 0.0 110.724 179.77 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 200' ' ' PHE . . . . . . . . . . . . . 2.0 m-85 -105.33 141.44 36.83 Favored 'General case' 0 N--CA 1.496 1.841 0 O-C-N 121.218 -0.926 . . . . 0.0 111.012 -177.502 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 201' ' ' VAL . . . . . . . . . . . . . 61.3 t -104.63 148.39 9.32 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.539 0 N-CA-C 108.394 -0.965 . . . . 0.0 108.394 177.247 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 202' ' ' ALA . . . . . . . . . . . . . . . -133.05 139.84 47.39 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.037 -1.039 . . . . 0.0 109.022 -179.899 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 203' ' ' THR . . . . . 0.628 ' O ' HG23 ' A' ' 205' ' ' VAL . 1.5 p -90.14 129.19 36.45 Favored 'General case' 0 N--CA 1.489 1.509 0 CA-C-O 122.431 1.11 . . . . 0.0 111.753 -178.525 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 204' ' ' GLU . . . . . 0.503 ' HA ' ' CD2' ' A' ' 153' ' ' TYR . 3.6 tm-20 -50.53 135.36 22.81 Favored 'General case' 0 C--N 1.298 -1.656 0 C-N-CA 118.369 -1.333 . . . . 0.0 109.361 178.951 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 205' ' ' VAL . . . . . 0.628 HG23 ' O ' ' A' ' 203' ' ' THR . 72.1 t -129.57 164.82 31.15 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.359 0 CA-C-O 122.083 0.944 . . . . 0.0 110.273 -177.907 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 206' ' ' LYS . . . . . 0.599 ' N ' HG12 ' A' ' 205' ' ' VAL . 0.0 OUTLIER . . . . . 0 C--N 1.295 -1.776 0 CA-C-O 118.025 -0.988 . . . . 0.0 109.482 179.84 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' C' C ' 701' ' ' PHQ . . . . . 0.55 ' C1 ' HG12 ' A' ' 166' ' ' VAL . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' C' C ' 702' ' ' LEU . . . . . 0.798 ' N ' HD12 ' C' ' 702' ' ' LEU . 0.0 OUTLIER . . . . . 0 N--CA 1.488 1.436 0 N-CA-C 109.08 -0.711 . . . . 0.0 109.08 . . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' C' C ' 703' ' ' PRO . . . . . 0.605 ' CB ' ' HB3' ' A' ' 92' ' ' ALA . 16.2 Cg_exo -51.54 -160.81 0.0 OUTLIER 'Trans proline' 0 N--CA 1.49 1.319 0 C-N-CA 121.805 1.67 . . . . 0.0 112.242 179.911 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' C' C ' 704' ' ' ALA . . . . . 0.54 ' HB2' ' HB1' ' A' ' 118' ' ' ALA . . . 53.46 175.11 0.02 OUTLIER 'General case' 0 N--CA 1.493 1.681 0 O-C-N 121.383 -0.823 . . . . 0.0 109.544 179.936 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' C' C ' 705' ' ' B27 . . . . . 0.65 ' SG ' ' CD2' ' A' ' 120' ' ' HIS . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 700' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 013 nuclear nobuild full ' A' A ' 59' ' ' MET . . . . . . . . . . . . . 39.9 mtt . . . . . 0 N--CA 1.491 1.588 0 CA-C-O 121.245 0.545 . . . . 0.0 109.776 . . . . . . . . . 0 0 . 1 . 013 nuclear nobuild full ' A' A ' 60' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -59.95 -109.13 0.0 OUTLIER 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.253 -0.904 . . . . 0.0 109.779 -179.699 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . -63.11 159.85 16.53 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.205 -0.935 . . . . 0.0 109.212 -179.89 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 62' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -142.15 71.47 22.8 Favored Pre-proline 0 N--CA 1.49 1.568 0 O-C-N 121.262 -0.899 . . . . 0.0 109.178 -179.377 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 63' ' ' PRO . . . . . . . . . . . . . 58.0 Cg_endo -91.86 160.25 3.38 Favored 'Trans proline' 0 C--N 1.304 -1.795 0 C-N-CA 123.794 2.996 . . . . 0.0 111.577 -179.883 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 64' ' ' GLN . . . . . 0.525 HE21 ' C ' ' A' ' 64' ' ' GLN . 0.0 OUTLIER -156.0 113.01 3.19 Favored 'General case' 0 C--N 1.302 -1.475 0 O-C-N 121.049 -1.032 . . . . 0.0 109.925 179.544 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 65' ' ' ILE . . . . . 0.459 ' C ' ' O ' ' A' ' 64' ' ' GLN . 0.1 OUTLIER -41.35 99.65 0.21 Allowed Pre-proline 0 N--CA 1.498 1.939 0 N-CA-C 108.174 -1.047 . . . . 0.0 108.174 179.386 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 66' ' ' PRO . . . . . 0.456 ' N ' ' O ' ' A' ' 64' ' ' GLN . 66.5 Cg_endo -89.76 -160.69 0.1 OUTLIER 'Trans proline' 0 C--N 1.317 -1.108 0 C-N-CA 122.222 1.948 . . . . 0.0 112.778 -178.76 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 67' ' ' LYS . . . . . 0.479 ' C ' ' H ' ' A' ' 69' ' ' LYS . 0.0 OUTLIER -71.91 -4.94 31.1 Favored 'General case' 0 N--CA 1.488 1.426 0 O-C-N 121.414 -0.804 . . . . 0.0 109.08 179.926 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 68' ' ' ASP . . . . . 0.586 ' C ' ' N ' ' A' ' 70' ' ' SER . 64.6 m-20 -76.21 42.86 0.28 Allowed 'General case' 0 N--CA 1.49 1.561 0 CA-C-O 122.45 1.119 . . . . 0.0 108.459 179.223 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 69' ' ' LYS . . . . . 0.479 ' H ' ' C ' ' A' ' 67' ' ' LYS . 0.5 OUTLIER -50.11 -16.26 0.29 Allowed 'General case' 0 N--CA 1.496 1.854 0 N-CA-C 105.984 -1.858 . . . . 0.0 105.984 178.102 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 70' ' ' SER . . . . . 0.586 ' N ' ' C ' ' A' ' 68' ' ' ASP . 3.0 p -86.66 50.84 2.08 Favored 'General case' 0 C--N 1.298 -1.643 0 CA-C-N 113.94 -1.482 . . . . 0.0 108.742 178.644 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 71' ' ' LYS . . . . . . . . . . . . . 6.5 ptmt -162.63 143.19 9.79 Favored 'General case' 0 C--N 1.296 -1.731 0 C-N-CA 118.224 -1.391 . . . . 0.0 111.235 -179.657 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 72' ' ' VAL . . . . . 0.582 HG12 ' CE1' ' A' ' 88' ' ' TYR . 0.8 OUTLIER -64.28 136.14 26.9 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.577 0 N-CA-C 105.644 -1.984 . . . . 0.0 105.644 175.434 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -81.66 -13.85 57.38 Favored 'General case' 0 C--N 1.292 -1.897 0 N-CA-C 105.661 -1.977 . . . . 0.0 105.661 179.371 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . 174.01 -156.88 24.49 Favored Glycine 0 N--CA 1.478 1.448 0 N-CA-C 109.251 -1.54 . . . . 0.0 109.251 179.388 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 75' ' ' TYR . . . . . . . . . . . . . 94.4 m-85 -141.32 170.62 15.37 Favored 'General case' 0 C--N 1.296 -1.754 0 CA-C-O 121.875 0.845 . . . . 0.0 109.766 -178.144 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 76' ' ' ILE . . . . . . . . . . . . . 0.7 OUTLIER -147.66 143.74 19.58 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.646 0 C-N-CA 119.366 -0.934 . . . . 0.0 109.258 -178.095 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 77' ' ' GLU . . . . . 0.518 ' N ' ' CD ' ' A' ' 77' ' ' GLU . 2.6 mp0 -146.76 162.66 38.08 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 120.929 -1.107 . . . . 0.0 109.967 -179.837 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 78' ' ' ILE . . . . . 0.661 ' HB ' ' HB3' ' A' ' 81' ' ' ALA . 4.1 mt -148.16 90.3 5.04 Favored Pre-proline 0 N--CA 1.489 1.48 0 N-CA-C 108.311 -0.996 . . . . 0.0 108.311 179.839 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 79' ' ' PRO . . . . . . . . . . . . . 73.5 Cg_exo -45.29 -44.49 16.06 Favored 'Trans proline' 0 C--N 1.31 -1.457 0 C-N-CA 122.597 2.198 . . . . 0.0 113.63 -178.583 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 4.4 m-20 -67.14 -19.29 65.58 Favored 'General case' 0 N--CA 1.492 1.652 0 O-C-N 120.869 -1.145 . . . . 0.0 110.789 178.418 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 81' ' ' ALA . . . . . 0.882 ' HB2' ' HB2' ' A' ' 136' ' ' ALA . . . -106.63 -15.01 14.88 Favored 'General case' 0 N--CA 1.493 1.717 0 O-C-N 121.137 -0.977 . . . . 0.0 109.176 179.976 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 82' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER 68.3 46.72 1.05 Allowed 'General case' 0 N--CA 1.488 1.459 0 O-C-N 121.375 -0.828 . . . . 0.0 110.338 179.22 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 83' ' ' ILE . . . . . 0.456 ' CG1' ' OD1' ' A' ' 132' ' ' ASN . 60.9 mt -120.98 148.36 24.29 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.797 0 O-C-N 121.296 -0.877 . . . . 0.0 110.357 -178.928 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 84' ' ' LYS . . . . . 0.402 ' O ' ' CD ' ' A' ' 85' ' ' GLU . 0.0 OUTLIER -160.44 102.63 1.38 Allowed 'General case' 0 C--N 1.305 -1.367 0 N-CA-C 107.322 -1.362 . . . . 0.0 107.322 179.731 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 85' ' ' GLU . . . . . 0.441 ' CB ' ' CD ' ' A' ' 86' ' ' PRO . 1.3 mm-40 -141.49 178.25 1.61 Allowed Pre-proline 0 N--CA 1.497 1.914 0 O-C-N 121.301 -0.874 . . . . 0.0 110.247 -178.831 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 86' ' ' PRO . . . . . 0.441 ' CD ' ' CB ' ' A' ' 85' ' ' GLU . 69.2 Cg_endo -91.2 158.02 3.81 Favored 'Trans proline' 0 N--CA 1.487 1.112 0 C-N-CA 123.314 2.676 . . . . 0.0 113.661 -178.565 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 87' ' ' VAL . . . . . 0.555 ' CG1' ' CZ ' ' A' ' 103' ' ' PHE . 35.5 t -111.07 100.04 9.93 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.498 0 N-CA-C 109.191 -0.67 . . . . 0.0 109.191 -179.85 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 88' ' ' TYR . . . . . 0.582 ' CE1' HG12 ' A' ' 72' ' ' VAL . 8.1 m-85 -91.71 170.31 9.69 Favored Pre-proline 0 N--CA 1.507 2.4 0 O-C-N 120.535 -1.353 . . . . 0.0 110.135 -179.102 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 89' ' ' PRO . . . . . . . . . . . . . 3.0 Cg_exo -71.35 141.71 39.54 Favored 'Trans proline' 0 N--CA 1.5 1.883 0 C-N-CA 122.505 2.137 . . . . 0.0 114.241 -178.394 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . -62.16 167.18 17.9 Favored Glycine 0 N--CA 1.492 2.394 0 N-CA-C 108.8 -1.72 . . . . 0.0 108.8 178.38 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 91' ' ' PRO . . . . . 0.41 ' C ' ' H ' ' A' ' 93' ' ' THR . 45.1 Cg_endo -91.67 172.69 21.43 Favored 'Cis proline' 0 C--N 1.307 -1.648 0 C-N-CA 123.55 -1.437 . . . . 0.0 112.001 0.651 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 92' ' ' ALA . . . . . 0.556 ' HB3' ' HB2' ' C' ' 703' ' ' PRO . . . -73.2 33.34 0.07 Allowed 'General case' 0 N--CA 1.493 1.706 0 O-C-N 121.352 -0.843 . . . . 0.0 110.677 -179.418 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 93' ' ' THR . . . . . 0.439 ' O ' ' C ' ' A' ' 94' ' ' PRO . 0.8 OUTLIER -71.8 149.56 92.85 Favored Pre-proline 0 C--N 1.301 -1.519 0 O-C-N 120.59 -1.319 . . . . 0.0 108.45 179.773 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 94' ' ' PRO . . . . . 0.439 ' C ' ' O ' ' A' ' 93' ' ' THR . 80.7 Cg_exo -31.78 -53.18 0.31 Allowed 'Trans proline' 0 C--N 1.308 -1.563 0 C-N-CA 122.723 2.282 . . . . 0.0 112.203 -179.183 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 95' ' ' GLU . . . . . 0.493 ' O ' ' ND2' ' A' ' 98' ' ' ASN . 7.1 tp10 -47.65 -52.64 17.37 Favored 'General case' 0 C--N 1.299 -1.601 0 O-C-N 121.397 -0.814 . . . . 0.0 109.259 179.487 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 96' ' ' GLN . . . . . 0.517 ' C ' ' H ' ' A' ' 98' ' ' ASN . 12.2 mp0 -70.14 -54.66 11.98 Favored 'General case' 0 N--CA 1.489 1.504 0 O-C-N 121.382 -0.824 . . . . 0.0 110.918 -179.349 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 97' ' ' LEU . . . . . 0.523 ' CD1' ' O ' ' A' ' 92' ' ' ALA . 81.5 mt -50.84 -6.28 0.03 OUTLIER 'General case' 0 N--CA 1.494 1.764 0 O-C-N 121.002 -1.061 . . . . 0.0 110.341 -178.671 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 98' ' ' ASN . . . . . 0.517 ' H ' ' C ' ' A' ' 96' ' ' GLN . 0.2 OUTLIER -75.3 -32.61 61.04 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.169 -0.957 . . . . 0.0 109.392 179.24 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 99' ' ' ARG . . . . . 0.44 ' HD2' ' CE2' ' A' ' 88' ' ' TYR . 9.3 mtt180 -85.53 -44.93 12.25 Favored 'General case' 0 N--CA 1.488 1.469 0 O-C-N 121.478 -0.764 . . . . 0.0 109.727 -179.321 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . 169.87 -170.6 42.91 Favored Glycine 0 N--CA 1.495 2.624 0 C-N-CA 119.698 -1.239 . . . . 0.0 110.141 179.653 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 101' ' ' VAL . . . . . 0.589 ' O ' HG23 ' A' ' 101' ' ' VAL . 26.8 m -55.0 106.74 0.12 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.572 0 O-C-N 121.093 -1.239 . . . . 0.0 109.17 -179.981 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -92.88 164.55 13.28 Favored 'General case' 0 N--CA 1.494 1.737 0 O-C-N 121.433 -0.792 . . . . 0.0 110.664 -179.282 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 103' ' ' PHE . . . . . 0.555 ' CZ ' ' CG1' ' A' ' 87' ' ' VAL . 28.5 m-85 -68.04 123.12 19.76 Favored 'General case' 0 N--CA 1.488 1.452 0 N-CA-C 108.549 -0.908 . . . . 0.0 108.549 178.413 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 104' ' ' ALA . . . . . 0.586 ' HB1' ' HG3' ' C' ' 703' ' ' PRO . . . -50.58 -7.33 0.03 OUTLIER 'General case' 0 C--N 1.3 -1.571 0 O-C-N 121.453 -0.779 . . . . 0.0 110.634 -179.42 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 105' ' ' GLU . . . . . 0.486 ' N ' ' O ' ' A' ' 103' ' ' PHE . 0.0 OUTLIER -139.83 144.22 37.2 Favored 'General case' 0 N--CA 1.495 1.814 0 O-C-N 120.915 -1.116 . . . . 0.0 110.433 -179.246 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 106' ' ' GLU . . . . . . . . . . . . . 28.2 tt0 -59.91 -64.35 0.98 Allowed 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.784 -0.572 . . . . 0.0 111.245 -178.959 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 107' ' ' ASN . . . . . . . . . . . . . 2.1 m-80 -78.5 35.51 0.23 Allowed 'General case' 0 N--CA 1.49 1.541 0 O-C-N 120.813 -1.179 . . . . 0.0 112.378 -175.981 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 108' ' ' GLU . . . . . 0.429 ' OE2' ' OE2' ' A' ' 105' ' ' GLU . 1.6 tp10 -59.0 149.24 27.97 Favored 'General case' 0 C--N 1.303 -1.415 0 O-C-N 120.703 -1.248 . . . . 0.0 107.725 -179.912 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 109' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -103.98 137.51 41.84 Favored 'General case' 0 C--N 1.304 -1.372 0 O-C-N 121.069 -1.019 . . . . 0.0 110.616 -178.236 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 110' ' ' LEU . . . . . . . . . . . . . 2.2 pp -60.74 -17.79 50.7 Favored 'General case' 0 C--N 1.298 -1.636 0 N-CA-C 108.225 -1.028 . . . . 0.0 108.225 179.138 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 111' ' ' ASP . . . . . . . . . . . . . 41.3 m-20 -132.13 37.77 3.55 Favored 'General case' 0 N--CA 1.489 1.492 0 N-CA-C 108.836 -0.801 . . . . 0.0 108.836 179.237 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 112' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -68.84 156.57 38.16 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.24 -0.913 . . . . 0.0 110.804 -179.786 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 113' ' ' GLN . . . . . 0.617 HE22 ' N ' ' A' ' 172' ' ' GLN . 0.0 OUTLIER -66.75 -15.96 63.91 Favored 'General case' 0 N--CA 1.487 1.402 0 N-CA-C 107.964 -1.125 . . . . 0.0 107.964 177.612 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 114' ' ' ASN . . . . . 0.607 ' OD1' ' NE2' ' A' ' 178' ' ' GLN . 3.0 t30 -151.4 106.11 3.26 Favored 'General case' 0 C--N 1.299 -1.61 0 N-CA-C 108.158 -1.053 . . . . 0.0 108.158 179.655 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 115' ' ' ILE . . . . . 0.511 HG22 ' O ' ' A' ' 115' ' ' ILE . 2.7 mt -94.92 105.25 16.74 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.604 0 N-CA-C 107.66 -1.237 . . . . 0.0 107.66 179.655 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 116' ' ' SER . . . . . 0.423 ' OG ' ' ND2' ' A' ' 114' ' ' ASN . 36.6 m -89.57 147.42 23.95 Favored 'General case' 0 N--CA 1.487 1.39 0 CA-C-O 121.905 0.859 . . . . 0.0 111.303 -177.596 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 117' ' ' ILE . . . . . . . . . . . . . 1.7 mt -144.48 150.92 16.1 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.394 0 N-CA-C 108.092 -1.077 . . . . 0.0 108.092 179.194 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 118' ' ' ALA . . . . . 0.942 ' HB1' ' HB2' ' C' ' 704' ' ' ALA . . . -141.41 160.58 39.83 Favored 'General case' 0 N--CA 1.493 1.703 0 O-C-N 120.921 -1.112 . . . . 0.0 111.209 -178.886 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 119' ' ' GLY . . . . . . . . . . . . . . . -168.36 149.01 13.25 Favored Glycine 0 N--CA 1.489 2.221 0 C-N-CA 119.962 -1.113 . . . . 0.0 111.092 -179.98 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 120' ' ' HIS . . . . . . . . . . . . . 12.7 m170 -71.35 168.93 16.36 Favored 'General case' 0 N--CA 1.495 1.781 0 O-C-N 122.13 -0.629 . . . . 0.0 110.232 179.202 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 121' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -123.7 155.62 37.48 Favored 'General case' 0 N--CA 1.495 1.819 0 N-CA-C 108.864 -0.791 . . . . 0.0 108.864 179.233 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 122' ' ' PHE . . . . . . . . . . . . . 0.7 OUTLIER -143.92 123.17 12.99 Favored 'General case' 0 N--CA 1.501 2.091 0 O-C-N 120.913 -1.117 . . . . 0.0 110.228 179.606 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 123' ' ' ILE . . . . . 0.538 HG23 ' N ' ' A' ' 124' ' ' ASP . 17.1 tt -57.83 -40.61 76.9 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.43 0 CA-C-O 121.582 0.705 . . . . 0.0 109.291 179.606 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 124' ' ' ASP . . . . . 0.538 ' N ' HG23 ' A' ' 123' ' ' ILE . 0.4 OUTLIER -87.19 23.43 1.82 Allowed 'General case' 0 N--CA 1.497 1.898 0 O-C-N 121.648 -0.658 . . . . 0.0 111.461 -177.477 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 125' ' ' ARG . . . . . . . . . . . . . 82.9 mtt180 -153.18 99.83 2.68 Favored Pre-proline 0 N--CA 1.493 1.696 0 O-C-N 120.761 -1.212 . . . . 0.0 109.665 -179.582 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 126' ' ' PRO . . . . . . . . . . . . . 34.0 Cg_endo -77.41 -33.65 2.38 Favored 'Trans proline' 0 N--CA 1.489 1.255 0 C-N-CA 122.263 1.976 . . . . 0.0 112.782 -179.744 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 127' ' ' ASN . . . . . 0.485 ' O ' ' O ' ' A' ' 128' ' ' TYR . 5.1 p30 -90.64 11.14 23.01 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.198 -0.939 . . . . 0.0 109.602 179.911 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 128' ' ' TYR . . . . . 0.485 ' O ' ' O ' ' A' ' 127' ' ' ASN . 2.8 t80 -59.53 -149.67 0.0 OUTLIER 'General case' 0 N--CA 1.489 1.478 0 O-C-N 121.091 -1.006 . . . . 0.0 109.516 179.978 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 129' ' ' GLN . . . . . . . . . . . . . 37.1 mt-30 -66.95 -70.37 0.25 Allowed 'General case' 0 N--CA 1.487 1.413 0 O-C-N 121.337 -0.852 . . . . 0.0 109.605 -179.779 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 130' ' ' PHE . . . . . 0.505 ' CZ ' HG11 ' A' ' 101' ' ' VAL . 50.6 m-85 -136.22 42.29 2.57 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.167 -0.958 . . . . 0.0 110.771 -179.39 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 131' ' ' THR . . . . . . . . . . . . . 8.5 m -74.68 -40.16 61.56 Favored 'General case' 0 N--CA 1.495 1.792 0 O-C-N 120.875 -1.141 . . . . 0.0 109.034 179.241 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 132' ' ' ASN . . . . . 0.558 ' ND2' ' O ' ' A' ' 81' ' ' ALA . 0.2 OUTLIER -89.18 11.59 18.27 Favored 'General case' 0 N--CA 1.492 1.673 0 C-N-CA 119.465 -0.894 . . . . 0.0 111.625 -178.678 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 133' ' ' LEU . . . . . 0.546 ' O ' ' N ' ' A' ' 135' ' ' ALA . 0.2 OUTLIER -68.02 -46.9 69.94 Favored 'General case' 0 N--CA 1.492 1.663 0 O-C-N 120.536 -1.353 . . . . 0.0 109.988 -179.16 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 134' ' ' LYS . . . . . 0.651 ' CD ' ' H ' ' A' ' 134' ' ' LYS . 0.0 OUTLIER -46.0 -14.11 0.02 OUTLIER 'General case' 0 N--CA 1.495 1.805 0 O-C-N 121.05 -1.031 . . . . 0.0 110.03 -179.514 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 135' ' ' ALA . . . . . 0.546 ' N ' ' O ' ' A' ' 133' ' ' LEU . . . -82.41 -35.89 27.23 Favored 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.108 -0.995 . . . . 0.0 109.123 179.669 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 136' ' ' ALA . . . . . 0.882 ' HB2' ' HB2' ' A' ' 81' ' ' ALA . . . -78.88 152.1 31.42 Favored 'General case' 0 C--N 1.302 -1.469 0 CA-C-O 121.858 0.837 . . . . 0.0 110.667 -179.35 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 137' ' ' LYS . . . . . 0.555 ' O ' ' O ' ' A' ' 138' ' ' LYS . 28.0 mtmm -153.06 -168.54 3.06 Favored 'General case' 0 N--CA 1.492 1.631 0 C-N-CA 118.351 -1.34 . . . . 0.0 110.939 -178.332 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 138' ' ' LYS . . . . . 0.555 ' O ' ' O ' ' A' ' 137' ' ' LYS . 0.0 OUTLIER -29.78 159.78 0.0 OUTLIER 'General case' 0 N--CA 1.489 1.509 0 CA-C-O 122.992 1.377 . . . . 0.0 112.681 -178.028 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 139' ' ' GLY . . . . . . . . . . . . . . . 51.9 8.81 0.44 Allowed Glycine 0 N--CA 1.489 2.199 0 N-CA-C 109.824 -1.311 . . . . 0.0 109.824 179.612 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 140' ' ' SER . . . . . 0.471 ' H ' ' C ' ' A' ' 138' ' ' LYS . 1.5 m -68.04 115.19 7.26 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.17 -1.194 . . . . 0.0 108.979 179.493 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 141' ' ' MET . . . . . . . . . . . . . 3.2 tpt -66.94 120.42 13.58 Favored 'General case' 0 C--N 1.301 -1.506 0 O-C-N 121.186 -0.946 . . . . 0.0 109.621 -179.866 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 142' ' ' VAL . . . . . . . . . . . . . 5.1 t -110.56 127.98 67.2 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.651 0 N-CA-C 108.192 -1.04 . . . . 0.0 108.192 179.835 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 143' ' ' TYR . . . . . . . . . . . . . 26.3 m-85 -107.79 135.06 49.84 Favored 'General case' 0 N--CA 1.498 1.963 0 O-C-N 121.022 -1.049 . . . . 0.0 111.348 -178.442 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 144' ' ' PHE . . . . . . . . . . . . . 58.5 t80 -119.19 101.16 7.8 Favored 'General case' 0 N--CA 1.486 1.355 0 N-CA-C 109.214 -0.661 . . . . 0.0 109.214 179.323 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 145' ' ' LYS . . . . . . . . . . . . . 35.8 mttt -95.47 129.33 42.67 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.127 -0.983 . . . . 0.0 109.62 -179.74 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 146' ' ' VAL . . . . . 0.428 ' O ' ' C ' ' A' ' 147' ' ' GLY . 3.3 p -141.67 141.43 29.85 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.636 0 N-CA-C 107.957 -1.127 . . . . 0.0 107.957 179.369 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 147' ' ' GLY . . . . . 0.428 ' C ' ' O ' ' A' ' 146' ' ' VAL . . . 44.43 -128.75 7.14 Favored Glycine 0 N--CA 1.487 2.05 0 N-CA-C 108.885 -1.686 . . . . 0.0 108.885 -179.59 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 148' ' ' ASN . . . . . 0.537 HD22 ' C ' ' A' ' 148' ' ' ASN . 0.4 OUTLIER -103.66 16.39 26.53 Favored 'General case' 0 C--N 1.298 -1.649 0 O-C-N 121.424 -1.045 . . . . 0.0 108.298 179.094 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 149' ' ' GLU . . . . . . . . . . . . . 13.9 tt0 -111.75 145.31 39.58 Favored 'General case' 0 N--CA 1.489 1.477 0 CA-C-O 121.896 0.855 . . . . 0.0 111.273 -178.471 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 150' ' ' THR . . . . . 0.429 ' O ' HG22 ' A' ' 150' ' ' THR . 2.1 m -127.4 102.69 7.0 Favored 'General case' 0 N--CA 1.491 1.613 0 CA-C-O 121.433 0.635 . . . . 0.0 109.757 -179.737 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 151' ' ' ARG . . . . . . . . . . . . . 50.9 mtt180 -86.22 -175.69 5.62 Favored 'General case' 0 N--CA 1.487 1.386 0 N-CA-C 108.541 -0.911 . . . . 0.0 108.541 -179.878 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 152' ' ' LYS . . . . . . . . . . . . . 1.7 mtmp? -145.0 149.36 35.0 Favored 'General case' 0 C--N 1.303 -1.45 0 C-N-CA 119.216 -0.993 . . . . 0.0 110.048 -179.457 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 153' ' ' TYR . . . . . 0.504 ' CD2' ' HA ' ' A' ' 204' ' ' GLU . 31.2 m-85 -143.71 166.29 25.28 Favored 'General case' 0 C--N 1.303 -1.454 0 N-CA-C 107.822 -1.177 . . . . 0.0 107.822 178.719 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 154' ' ' LYS . . . . . 0.587 ' HB2' HG21 ' A' ' 205' ' ' VAL . 5.9 ttmm -143.99 119.81 10.57 Favored 'General case' 0 C--N 1.296 -1.723 0 N-CA-C 108.125 -1.065 . . . . 0.0 108.125 179.074 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 155' ' ' MET . . . . . . . . . . . . . 14.1 mtp -48.45 107.71 0.14 Allowed 'General case' 0 N--CA 1.493 1.678 0 O-C-N 120.522 -1.361 . . . . 0.0 111.543 -178.623 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 156' ' ' THR . . . . . 0.515 ' OG1' HG23 ' A' ' 203' ' ' THR . 0.0 OUTLIER -107.45 -22.36 12.58 Favored 'General case' 0 C--N 1.296 -1.736 0 CA-C-N 115.34 -0.845 . . . . 0.0 110.758 -178.646 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 157' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -151.21 150.43 30.6 Favored 'General case' 0 N--CA 1.494 1.762 0 C-N-CA 118.395 -1.322 . . . . 0.0 111.284 -178.71 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 158' ' ' ILE . . . . . 0.994 HD12 ' N ' ' A' ' 159' ' ' ARG . 0.1 OUTLIER -154.53 142.46 12.96 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.3 0 CA-C-O 121.923 0.868 . . . . 0.0 110.3 -178.743 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 159' ' ' ARG . . . . . 0.994 ' N ' HD12 ' A' ' 158' ' ' ILE . 27.2 ptt180 -155.21 155.02 33.13 Favored 'General case' 0 C--N 1.296 -1.722 0 CA-C-O 121.663 0.744 . . . . 0.0 109.929 -179.902 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 160' ' ' ASP . . . . . 0.416 ' C ' HG22 ' A' ' 161' ' ' VAL . 0.2 OUTLIER -115.06 162.28 17.22 Favored 'General case' 0 N--CA 1.492 1.633 0 N-CA-C 108.165 -1.05 . . . . 0.0 108.165 179.218 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 161' ' ' VAL . . . . . 0.416 HG22 ' C ' ' A' ' 160' ' ' ASP . 0.0 OUTLIER -158.34 160.15 2.11 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.609 0 O-C-N 121.169 -0.957 . . . . 0.0 110.394 -179.539 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 162' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -52.45 176.91 0.07 OUTLIER Pre-proline 0 N--CA 1.488 1.456 0 O-C-N 121.477 -0.764 . . . . 0.0 109.053 179.663 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 163' ' ' PRO . . . . . 0.457 ' C ' HD11 ' C' ' 702' ' ' LEU . 2.4 Cg_endo -78.67 37.31 0.64 Allowed 'Trans proline' 0 N--CA 1.491 1.333 0 C-N-CA 122.478 2.119 . . . . 0.0 113.086 -179.531 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 164' ' ' THR . . . . . 0.423 ' N ' HD11 ' C' ' 702' ' ' LEU . 0.2 OUTLIER -152.65 -6.69 0.2 Allowed 'General case' 0 N--CA 1.495 1.821 0 O-C-N 120.464 -1.397 . . . . 0.0 111.792 -179.4 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 165' ' ' ASP . . . . . . . . . . . . . 6.0 t70 -74.7 62.29 1.05 Allowed 'General case' 0 N--CA 1.493 1.677 0 O-C-N 120.676 -1.265 . . . . 0.0 110.041 -179.581 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 166' ' ' VAL . . . . . 0.613 ' O ' ' N ' ' A' ' 168' ' ' VAL . 1.5 m -47.82 -31.44 2.68 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.594 0 O-C-N 121.144 -0.972 . . . . 0.0 109.968 -178.55 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 167' ' ' GLY . . . . . . . . . . . . . . . -44.26 -10.01 0.01 OUTLIER Glycine 0 N--CA 1.496 2.65 0 O-C-N 120.811 -1.18 . . . . 0.0 111.094 -179.545 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 168' ' ' VAL . . . . . 0.613 ' N ' ' O ' ' A' ' 166' ' ' VAL . 5.5 m -53.51 -29.35 16.82 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.614 0 O-C-N 120.62 -1.518 . . . . 0.0 108.976 179.785 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 169' ' ' LEU . . . . . 0.533 ' O ' ' C ' ' A' ' 170' ' ' ASP . 11.1 mt -49.47 -13.79 0.09 Allowed 'General case' 0 N--CA 1.49 1.564 0 N-CA-C 107.31 -1.367 . . . . 0.0 107.31 -179.14 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 170' ' ' ASP . . . . . 0.551 ' N ' ' C ' ' A' ' 168' ' ' VAL . 3.2 t70 21.84 91.77 0.01 OUTLIER 'General case' 0 N--CA 1.502 2.139 0 CA-C-N 116.281 -0.418 . . . . 0.0 111.649 177.261 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 171' ' ' GLU . . . . . 0.425 ' C ' ' OE1' ' A' ' 113' ' ' GLN . 3.3 pt-20 -136.93 74.41 1.49 Allowed 'General case' 0 N--CA 1.493 1.699 0 O-C-N 120.913 -1.117 . . . . 0.0 110.863 -179.814 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 172' ' ' GLN . . . . . 0.617 ' N ' HE22 ' A' ' 113' ' ' GLN . 1.1 pt20 -132.01 -47.95 0.94 Allowed 'General case' 0 N--CA 1.499 2.021 0 O-C-N 121.284 -0.885 . . . . 0.0 111.661 -178.451 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 173' ' ' LYS . . . . . 0.515 ' NZ ' ' O ' ' A' ' 176' ' ' ASP . 8.4 ptmm? -64.31 129.13 38.73 Favored 'General case' 0 N--CA 1.499 1.989 0 O-C-N 120.576 -1.327 . . . . 0.0 109.324 -179.968 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 174' ' ' GLY . . . . . 0.527 ' O ' ' C ' ' A' ' 175' ' ' LYS . . . -115.37 -40.0 0.9 Allowed Glycine 0 N--CA 1.484 1.89 0 N-CA-C 108.676 -1.769 . . . . 0.0 108.676 179.591 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 175' ' ' LYS . . . . . 0.527 ' C ' ' O ' ' A' ' 174' ' ' GLY . 0.2 OUTLIER -41.44 -62.08 0.93 Allowed 'General case' 0 N--CA 1.491 1.597 0 N-CA-C 107.022 -1.473 . . . . 0.0 107.022 178.864 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 176' ' ' ASP . . . . . 0.567 ' O ' ' O ' ' A' ' 177' ' ' LYS . 81.8 m-20 -104.4 85.36 2.34 Favored 'General case' 0 C--N 1.298 -1.635 0 N-CA-C 107.691 -1.226 . . . . 0.0 107.691 176.781 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 177' ' ' LYS . . . . . 0.567 ' O ' ' O ' ' A' ' 176' ' ' ASP . 2.1 mptp? -47.55 -175.16 0.0 OUTLIER 'General case' 0 N--CA 1.5 2.044 0 O-C-N 121.28 -0.888 . . . . 0.0 108.93 -179.755 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 178' ' ' GLN . . . . . 0.607 ' NE2' ' OD1' ' A' ' 114' ' ' ASN . 0.0 OUTLIER -162.75 178.63 8.31 Favored 'General case' 0 C--N 1.305 -1.355 0 O-C-N 120.264 -1.523 . . . . 0.0 110.936 179.836 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 179' ' ' LEU . . . . . 0.453 HD23 ' C ' ' A' ' 179' ' ' LEU . 4.6 tt -128.55 97.55 4.74 Favored 'General case' 0 C--N 1.302 -1.474 0 N-CA-C 107.54 -1.281 . . . . 0.0 107.54 178.436 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 180' ' ' THR . . . . . 0.441 ' O ' HG22 ' A' ' 180' ' ' THR . 1.2 m -71.29 115.18 10.15 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 120.996 -1.065 . . . . 0.0 109.967 -178.719 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 181' ' ' LEU . . . . . 0.475 HD21 ' HG ' ' A' ' 133' ' ' LEU . 48.5 tp -93.16 142.45 27.28 Favored 'General case' 0 C--N 1.295 -1.794 0 N-CA-C 108.368 -0.975 . . . . 0.0 108.368 178.328 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 182' ' ' ILE . . . . . . . . . . . . . 47.0 mt -136.11 120.58 25.93 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.533 0 N-CA-C 108.197 -1.038 . . . . 0.0 108.197 178.925 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 183' ' ' THR . . . . . 0.487 HG23 ' O ' ' A' ' 183' ' ' THR . 2.2 t -140.72 111.84 7.18 Favored 'General case' 0 C--N 1.291 -1.943 0 N-CA-C 107.718 -1.215 . . . . 0.0 107.718 179.117 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 184' ' ' CYS . . . . . . . . . . . . . 1.2 p -78.81 159.55 27.8 Favored 'General case' 0 C--N 1.292 -1.907 0 C-N-CA 118.856 -1.138 . . . . 0.0 110.665 -178.09 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 185' ' ' ASP . . . . . 0.438 ' HB3' ' HZ1' ' A' ' 198' ' ' LYS . 0.4 OUTLIER -164.57 -155.66 0.28 Allowed 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.629 -0.669 . . . . 0.0 109.413 -179.488 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 186' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER 52.32 60.67 3.65 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.128 -0.982 . . . . 0.0 108.597 -179.469 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 187' ' ' TYR . . . . . 0.593 ' CE1' ' O ' ' A' ' 188' ' ' ASN . 35.5 t80 -68.34 134.02 49.64 Favored 'General case' 0 N--CA 1.488 1.459 0 CA-C-O 121.812 0.815 . . . . 0.0 111.142 -178.977 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 188' ' ' ASN . . . . . 0.593 ' O ' ' CE1' ' A' ' 187' ' ' TYR . 0.9 OUTLIER -98.67 145.64 26.67 Favored 'General case' 0 C--N 1.296 -1.721 0 N-CA-C 108.218 -1.03 . . . . 0.0 108.218 178.395 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 189' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -112.01 -19.91 12.16 Favored 'General case' 0 C--N 1.296 -1.749 0 N-CA-C 107.904 -1.147 . . . . 0.0 107.904 -179.86 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 190' ' ' LYS . . . . . . . . . . . . . 33.5 mttt -82.63 -50.06 9.16 Favored 'General case' 0 C--N 1.3 -1.551 0 N-CA-C 108.235 -1.024 . . . . 0.0 108.235 178.62 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 191' ' ' THR . . . . . . . . . . . . . 71.4 p -87.97 -8.97 54.93 Favored 'General case' 0 C--N 1.303 -1.428 0 N-CA-C 109.105 -0.702 . . . . 0.0 109.105 -179.97 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 192' ' ' GLY . . . . . . . . . . . . . . . 57.56 38.73 88.91 Favored Glycine 0 N--CA 1.493 2.466 0 N-CA-C 110.745 -0.942 . . . . 0.0 110.745 178.872 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 193' ' ' VAL . . . . . . . . . . . . . 3.2 m -148.05 162.1 6.63 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.58 0 O-C-N 120.989 -1.3 . . . . 0.0 108.872 179.35 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 194' ' ' TRP . . . . . 0.497 ' CD1' HG2B ' C' ' 705' ' ' B27 . 47.6 m95 -83.58 120.47 26.0 Favored 'General case' 0 N--CA 1.489 1.518 0 N-CA-C 107.802 -1.184 . . . . 0.0 107.802 178.901 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 195' ' ' GLU . . . . . . . . . . . . . 2.0 mt-10 -86.8 -61.05 1.82 Allowed 'General case' 0 N--CA 1.496 1.858 0 O-C-N 121.132 -0.98 . . . . 0.0 112.083 -177.318 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 196' ' ' LYS . . . . . . . . . . . . . 11.1 tttm -76.84 150.51 36.08 Favored 'General case' 0 N--CA 1.493 1.723 0 O-C-N 120.973 -1.079 . . . . 0.0 111.304 -177.663 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 197' ' ' ARG . . . . . 0.431 ' NH1' ' O ' ' C' ' 704' ' ' ALA . 16.9 mmt180 -122.01 129.83 52.78 Favored 'General case' 0 N--CA 1.491 1.584 0 N-CA-C 108.839 -0.8 . . . . 0.0 108.839 179.481 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 198' ' ' LYS . . . . . 0.438 ' HZ1' ' HB3' ' A' ' 185' ' ' ASP . 9.6 mtmt -113.72 120.25 40.18 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.482 -0.761 . . . . 0.0 109.969 -179.399 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 199' ' ' ILE . . . . . 0.508 ' C ' HD12 ' A' ' 199' ' ' ILE . 0.8 OUTLIER -140.04 118.42 11.14 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.723 0 CA-C-O 122.405 1.097 . . . . 0.0 109.929 179.269 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 200' ' ' PHE . . . . . 0.524 ' CD1' ' N ' ' A' ' 200' ' ' PHE . 4.7 m-85 -100.09 139.68 35.41 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.181 -0.949 . . . . 0.0 109.512 -179.082 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 201' ' ' VAL . . . . . 0.453 HG13 ' NE2' ' A' ' 178' ' ' GLN . 40.7 t -102.33 145.79 11.42 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.645 0 N-CA-C 107.31 -1.367 . . . . 0.0 107.31 177.395 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 202' ' ' ALA . . . . . . . . . . . . . . . -129.25 137.42 51.07 Favored 'General case' 0 C--N 1.301 -1.503 0 O-C-N 120.949 -1.095 . . . . 0.0 109.146 -179.4 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 203' ' ' THR . . . . . 0.559 ' O ' HG23 ' A' ' 205' ' ' VAL . 2.5 p -88.83 129.99 35.47 Favored 'General case' 0 C--N 1.305 -1.352 0 CA-C-O 122.393 1.092 . . . . 0.0 110.705 -178.791 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 204' ' ' GLU . . . . . 0.504 ' HA ' ' CD2' ' A' ' 153' ' ' TYR . 3.9 tm-20 -50.84 133.82 26.06 Favored 'General case' 0 C--N 1.296 -1.734 0 C-N-CA 119.184 -1.007 . . . . 0.0 109.659 179.739 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 205' ' ' VAL . . . . . 0.597 HG12 ' N ' ' A' ' 206' ' ' LYS . 73.8 t -126.94 164.52 27.35 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.452 0 CA-C-O 122.109 0.957 . . . . 0.0 110.066 -178.14 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 206' ' ' LYS . . . . . 0.597 ' N ' HG12 ' A' ' 205' ' ' VAL . 0.9 OUTLIER . . . . . 0 C--N 1.295 -1.765 0 CA-C-O 117.931 -1.033 . . . . 0.0 109.468 179.929 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' C' C ' 701' ' ' PHQ . . . . . 0.517 ' C1 ' HG12 ' A' ' 166' ' ' VAL . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' C' C ' 702' ' ' LEU . . . . . 0.772 ' N ' HD12 ' C' ' 702' ' ' LEU . 0.0 OUTLIER . . . . . 0 N--CA 1.492 1.632 0 N-CA-C 108.998 -0.741 . . . . 0.0 108.998 . . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' C' C ' 703' ' ' PRO . . . . . 0.586 ' HG3' ' HB1' ' A' ' 104' ' ' ALA . 28.8 Cg_endo -68.95 -162.03 0.08 OUTLIER 'Trans proline' 0 N--CA 1.491 1.347 0 C-N-CA 122.271 1.981 . . . . 0.0 112.272 179.779 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' C' C ' 704' ' ' ALA . . . . . 0.942 ' HB2' ' HB1' ' A' ' 118' ' ' ALA . . . 48.38 97.48 0.01 OUTLIER 'General case' 0 N--CA 1.489 1.491 0 O-C-N 121.306 -0.871 . . . . 0.0 108.993 -179.928 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' C' C ' 705' ' ' B27 . . . . . 0.54 ' SG ' ' C ' ' C' ' 704' ' ' ALA . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 700' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 014 nuclear nobuild full ' A' A ' 59' ' ' MET . . . . . . . . . . . . . 11.4 mtt . . . . . 0 N--CA 1.489 1.522 0 N-CA-C 109.456 -0.572 . . . . 0.0 109.456 . . . . . . . . . 0 0 . 1 . 014 nuclear nobuild full ' A' A ' 60' ' ' GLN . . . . . . . . . . . . . 13.3 mt-30 -60.54 179.08 0.17 Allowed 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.38 -0.825 . . . . 0.0 109.437 -179.992 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 61' ' ' ALA . . . . . 0.449 ' HB2' ' OD1' ' A' ' 148' ' ' ASN . . . -64.1 -164.26 0.02 OUTLIER 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.27 -0.894 . . . . 0.0 109.508 -179.921 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 62' ' ' LYS . . . . . . . . . . . . . 24.8 tttt -147.88 89.63 5.27 Favored Pre-proline 0 N--CA 1.491 1.596 0 O-C-N 121.347 -0.846 . . . . 0.0 109.653 -179.645 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 63' ' ' PRO . . . . . 0.644 ' O ' HD13 ' A' ' 110' ' ' LEU . 21.3 Cg_endo -83.57 138.86 8.66 Favored 'Trans proline' 0 C--N 1.31 -1.474 0 C-N-CA 122.598 2.199 . . . . 0.0 111.586 179.722 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 64' ' ' GLN . . . . . 0.895 ' H ' HE21 ' A' ' 64' ' ' GLN . 0.0 OUTLIER -158.14 113.4 2.67 Favored 'General case' 0 N--CA 1.488 1.453 0 O-C-N 121.249 -0.907 . . . . 0.0 109.528 -179.773 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 65' ' ' ILE . . . . . 0.722 HD13 ' H ' ' A' ' 65' ' ' ILE . 0.0 OUTLIER -42.0 103.29 0.3 Allowed Pre-proline 0 N--CA 1.49 1.571 0 N-CA-C 108.757 -0.831 . . . . 0.0 108.757 179.471 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 66' ' ' PRO . . . . . . . . . . . . . 94.3 Cg_endo -87.6 -155.82 0.06 OUTLIER 'Trans proline' 0 C--N 1.313 -1.338 0 C-N-CA 122.372 2.048 . . . . 0.0 112.259 -179.18 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 67' ' ' LYS . . . . . . . . . . . . . 23.1 pttm -79.42 -7.86 58.7 Favored 'General case' 0 C--N 1.302 -1.474 0 O-C-N 121.308 -0.87 . . . . 0.0 108.847 179.673 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 68' ' ' ASP . . . . . 0.579 ' O ' ' N ' ' A' ' 70' ' ' SER . 1.9 t0 -76.7 48.3 0.55 Allowed 'General case' 0 N--CA 1.487 1.423 0 CA-C-O 122.342 1.068 . . . . 0.0 108.931 179.385 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 69' ' ' LYS . . . . . 0.444 ' C ' ' O ' ' A' ' 68' ' ' ASP . 0.0 OUTLIER -49.27 -14.69 0.1 Allowed 'General case' 0 N--CA 1.503 2.217 0 C-N-CA 117.094 -1.842 . . . . 0.0 106.554 178.257 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 70' ' ' SER . . . . . 0.579 ' N ' ' O ' ' A' ' 68' ' ' ASP . 1.1 p -82.28 -8.91 59.64 Favored 'General case' 0 N--CA 1.495 1.804 0 CA-C-N 113.942 -1.481 . . . . 0.0 110.035 179.552 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 71' ' ' LYS . . . . . 0.416 ' CD ' ' HB3' ' A' ' 68' ' ' ASP . 0.0 OUTLIER -99.19 144.17 28.62 Favored 'General case' 0 N--CA 1.494 1.73 0 O-C-N 121.034 -1.041 . . . . 0.0 110.312 179.294 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 72' ' ' VAL . . . . . 0.517 HG12 ' CZ ' ' A' ' 88' ' ' TYR . 1.0 OUTLIER -65.26 141.48 18.13 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.575 0 N-CA-C 104.868 -2.271 . . . . 0.0 104.868 174.542 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -80.82 -14.9 57.64 Favored 'General case' 0 C--N 1.294 -1.825 0 O-C-N 119.864 -1.772 . . . . 0.0 106.411 179.66 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . 175.46 -156.58 22.36 Favored Glycine 0 N--CA 1.481 1.645 0 N-CA-C 109.16 -1.576 . . . . 0.0 109.16 179.274 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 75' ' ' TYR . . . . . 0.572 ' CD2' ' O ' ' A' ' 85' ' ' GLU . 0.5 OUTLIER -141.7 167.98 20.86 Favored 'General case' 0 C--N 1.292 -1.893 0 O-C-N 121.664 -0.903 . . . . 0.0 110.655 -176.991 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 76' ' ' ILE . . . . . . . . . . . . . 0.6 OUTLIER -144.75 140.32 23.44 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.597 0 C-N-CA 119.087 -1.045 . . . . 0.0 109.781 -177.432 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -148.57 161.46 41.63 Favored 'General case' 0 C--N 1.303 -1.456 0 O-C-N 121.287 -0.883 . . . . 0.0 109.158 -179.571 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 78' ' ' ILE . . . . . 0.654 ' HB ' ' HB3' ' A' ' 81' ' ' ALA . 6.6 mt -146.89 94.42 4.64 Favored Pre-proline 0 C--N 1.3 -1.553 0 N-CA-C 108.53 -0.915 . . . . 0.0 108.53 -179.75 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 79' ' ' PRO . . . . . . . . . . . . . 74.4 Cg_exo -47.32 -47.42 17.47 Favored 'Trans proline' 0 N--CA 1.493 1.449 0 C-N-CA 122.805 2.337 . . . . 0.0 113.765 -178.745 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -65.24 -18.17 65.1 Favored 'General case' 0 N--CA 1.492 1.65 0 O-C-N 120.765 -1.209 . . . . 0.0 110.565 178.667 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 81' ' ' ALA . . . . . 0.893 ' HB2' ' HB2' ' A' ' 136' ' ' ALA . . . -105.69 -16.74 14.6 Favored 'General case' 0 N--CA 1.493 1.718 0 O-C-N 121.24 -0.912 . . . . 0.0 108.918 179.653 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 82' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER 69.39 47.79 0.67 Allowed 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.432 -0.793 . . . . 0.0 110.53 178.87 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 83' ' ' ILE . . . . . . . . . . . . . 67.2 mt -127.1 149.58 32.31 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.81 0 O-C-N 121.065 -1.022 . . . . 0.0 110.732 -178.87 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 84' ' ' LYS . . . . . . . . . . . . . 6.7 ttpm? -157.38 107.86 2.25 Favored 'General case' 0 N--CA 1.491 1.595 0 N-CA-C 107.544 -1.28 . . . . 0.0 107.544 179.516 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 85' ' ' GLU . . . . . 0.572 ' O ' ' CD2' ' A' ' 75' ' ' TYR . 0.4 OUTLIER -145.31 174.37 3.51 Favored Pre-proline 0 N--CA 1.492 1.65 0 O-C-N 121.503 -0.748 . . . . 0.0 110.409 -178.8 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 86' ' ' PRO . . . . . . . . . . . . . 60.3 Cg_endo -82.41 168.85 14.43 Favored 'Trans proline' 0 C--N 1.313 -1.305 0 C-N-CA 122.809 2.339 . . . . 0.0 113.841 -179.347 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 87' ' ' VAL . . . . . 0.531 ' CG1' ' CZ ' ' A' ' 103' ' ' PHE . 3.2 t -128.93 105.84 13.42 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.607 0 N-CA-C 108.448 -0.945 . . . . 0.0 108.448 179.91 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 88' ' ' TYR . . . . . 0.517 ' CZ ' HG12 ' A' ' 72' ' ' VAL . 34.6 m-85 -99.22 152.76 37.91 Favored Pre-proline 0 N--CA 1.499 2.006 0 O-C-N 120.769 -1.207 . . . . 0.0 110.129 -179.018 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 89' ' ' PRO . . . . . . . . . . . . . 2.7 Cg_exo -50.35 144.42 23.97 Favored 'Trans proline' 0 C--N 1.312 -1.351 0 C-N-CA 122.707 2.271 . . . . 0.0 113.487 179.871 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . -61.41 169.57 10.5 Favored Glycine 0 N--CA 1.493 2.47 0 N-CA-C 108.807 -1.717 . . . . 0.0 108.807 178.894 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 91' ' ' PRO . . . . . 0.487 ' C ' ' H ' ' A' ' 93' ' ' THR . 63.9 Cg_endo -95.7 172.86 13.58 Favored 'Cis proline' 0 C--N 1.311 -1.407 0 C-N-CA 124.227 -1.156 . . . . 0.0 112.226 0.133 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 92' ' ' ALA . . . . . 0.553 ' O ' HD13 ' A' ' 97' ' ' LEU . . . -70.48 29.03 0.04 OUTLIER 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.229 -0.919 . . . . 0.0 110.378 -179.794 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 93' ' ' THR . . . . . 0.487 ' H ' ' C ' ' A' ' 91' ' ' PRO . 1.8 p -75.19 152.14 86.05 Favored Pre-proline 0 N--CA 1.489 1.524 0 O-C-N 120.626 -1.296 . . . . 0.0 108.833 -179.958 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 94' ' ' PRO . . . . . . . . . . . . . 86.4 Cg_exo -35.03 -42.34 0.35 Allowed 'Trans proline' 0 C--N 1.309 -1.546 0 C-N-CA 122.821 2.348 . . . . 0.0 112.398 -179.362 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 95' ' ' GLU . . . . . 0.485 ' O ' ' OD1' ' A' ' 98' ' ' ASN . 53.2 mt-10 -52.84 -55.18 25.01 Favored 'General case' 0 C--N 1.304 -1.407 0 O-C-N 121.094 -1.004 . . . . 0.0 109.12 179.636 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 96' ' ' GLN . . . . . 0.569 ' O ' ' N ' ' A' ' 98' ' ' ASN . 28.6 mm100 -72.29 -50.99 22.87 Favored 'General case' 0 N--CA 1.488 1.458 0 O-C-N 121.124 -0.985 . . . . 0.0 110.151 179.965 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 97' ' ' LEU . . . . . 0.553 HD13 ' O ' ' A' ' 92' ' ' ALA . 2.5 mp -48.39 -9.12 0.02 OUTLIER 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.038 -1.039 . . . . 0.0 109.784 -179.306 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 98' ' ' ASN . . . . . 0.737 HD21 ' CZ ' ' A' ' 99' ' ' ARG . 14.4 p-10 -72.38 -30.35 64.6 Favored 'General case' 0 N--CA 1.492 1.625 0 CA-C-O 121.873 0.844 . . . . 0.0 109.48 179.624 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 99' ' ' ARG . . . . . 0.737 ' CZ ' HD21 ' A' ' 98' ' ' ASN . 1.2 mtt-85 -98.66 -47.1 5.47 Favored 'General case' 0 C--N 1.299 -1.591 0 C-N-CA 119.829 -0.749 . . . . 0.0 110.106 -178.479 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . 176.28 -176.58 47.78 Favored Glycine 0 N--CA 1.493 2.485 0 C-N-CA 119.096 -1.526 . . . . 0.0 110.916 179.857 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 101' ' ' VAL . . . . . 0.739 ' CG2' HG22 ' A' ' 117' ' ' ILE . 0.2 OUTLIER -50.46 111.7 0.2 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.597 0 O-C-N 121.697 -0.884 . . . . 0.0 109.892 -179.859 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -93.94 169.7 10.09 Favored 'General case' 0 N--CA 1.496 1.84 0 O-C-N 121.273 -0.892 . . . . 0.0 110.741 -179.888 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 103' ' ' PHE . . . . . 0.603 ' O ' ' N ' ' A' ' 105' ' ' GLU . 27.5 m-85 -71.06 121.02 17.48 Favored 'General case' 0 N--CA 1.485 1.314 0 N-CA-C 107.68 -1.23 . . . . 0.0 107.68 177.609 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 104' ' ' ALA . . . . . 0.806 ' HB3' ' OG ' ' A' ' 116' ' ' SER . . . -41.95 -15.65 0.01 OUTLIER 'General case' 0 C--N 1.299 -1.597 0 O-C-N 121.497 -0.752 . . . . 0.0 110.682 -178.821 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 105' ' ' GLU . . . . . 0.603 ' N ' ' O ' ' A' ' 103' ' ' PHE . 0.1 OUTLIER -136.22 145.45 45.67 Favored 'General case' 0 N--CA 1.496 1.86 0 O-C-N 120.811 -1.18 . . . . 0.0 110.243 179.638 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 106' ' ' GLU . . . . . . . . . . . . . 2.0 tt0 -60.02 -63.43 1.3 Allowed 'General case' 0 N--CA 1.489 1.482 0 O-C-N 121.835 -0.54 . . . . 0.0 111.416 -178.904 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 107' ' ' ASN . . . . . 0.798 ' H ' ' ND2' ' A' ' 107' ' ' ASN . 0.2 OUTLIER -78.11 35.09 0.21 Allowed 'General case' 0 N--CA 1.491 1.609 0 O-C-N 120.649 -1.282 . . . . 0.0 112.76 -175.608 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 108' ' ' GLU . . . . . . . . . . . . . 1.7 tp10 -58.24 148.94 25.51 Favored 'General case' 0 N--CA 1.488 1.451 0 N-CA-C 107.591 -1.263 . . . . 0.0 107.591 179.891 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 109' ' ' SER . . . . . 0.483 ' O ' HD11 ' A' ' 115' ' ' ILE . 0.2 OUTLIER -101.6 146.3 27.88 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.139 -0.975 . . . . 0.0 110.709 -178.305 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 110' ' ' LEU . . . . . 0.683 ' H ' HD23 ' A' ' 110' ' ' LEU . 0.3 OUTLIER -62.1 -24.15 66.95 Favored 'General case' 0 C--N 1.302 -1.477 0 N-CA-C 108.035 -1.098 . . . . 0.0 108.035 179.14 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 111' ' ' ASP . . . . . 0.405 ' CG ' HH12 ' A' ' 151' ' ' ARG . 13.0 m-20 -132.7 43.34 2.99 Favored 'General case' 0 N--CA 1.488 1.448 0 O-C-N 121.688 -0.633 . . . . 0.0 109.762 179.97 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 112' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -69.12 156.04 39.35 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.15 -0.969 . . . . 0.0 110.806 -179.852 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 113' ' ' GLN . . . . . 0.457 ' N ' ' CD ' ' A' ' 113' ' ' GLN . 0.8 OUTLIER -67.14 -18.16 65.17 Favored 'General case' 0 N--CA 1.491 1.622 0 N-CA-C 108.15 -1.055 . . . . 0.0 108.15 178.097 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 114' ' ' ASN . . . . . 0.605 HD22 ' CD ' ' A' ' 178' ' ' GLN . 1.9 t-20 -150.37 103.84 3.18 Favored 'General case' 0 C--N 1.299 -1.626 0 N-CA-C 107.871 -1.159 . . . . 0.0 107.871 178.533 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 115' ' ' ILE . . . . . 0.489 ' O ' HG22 ' A' ' 115' ' ' ILE . 2.9 mt -97.77 109.2 23.09 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.66 0 O-C-N 120.885 -1.134 . . . . 0.0 108.696 -179.955 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 116' ' ' SER . . . . . 0.806 ' OG ' ' HB3' ' A' ' 104' ' ' ALA . 80.8 p -88.0 152.24 22.18 Favored 'General case' 0 N--CA 1.49 1.538 0 CA-C-O 121.863 0.839 . . . . 0.0 110.842 -178.445 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 117' ' ' ILE . . . . . 0.739 HG22 ' CG2' ' A' ' 101' ' ' VAL . 1.5 mt -146.95 122.29 2.63 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.413 0 N-CA-C 107.876 -1.157 . . . . 0.0 107.876 -179.725 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 118' ' ' ALA . . . . . . . . . . . . . . . -118.58 159.72 23.07 Favored 'General case' 0 N--CA 1.496 1.846 0 C-N-CA 119.516 -0.874 . . . . 0.0 112.074 -177.933 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 119' ' ' GLY . . . . . . . . . . . . . . . -170.7 148.11 11.13 Favored Glycine 0 N--CA 1.49 2.255 0 CA-C-O 122.163 0.868 . . . . 0.0 110.936 179.929 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 120' ' ' HIS . . . . . 0.565 ' N ' ' OE1' ' A' ' 129' ' ' GLN . 6.4 m170 -71.19 168.47 17.17 Favored 'General case' 0 N--CA 1.496 1.831 0 O-C-N 121.889 -0.771 . . . . 0.0 109.909 179.084 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 121' ' ' THR . . . . . 0.503 HG22 ' CZ3' ' A' ' 194' ' ' TRP . 0.7 OUTLIER -122.64 158.07 30.81 Favored 'General case' 0 N--CA 1.496 1.844 0 N-CA-C 108.48 -0.933 . . . . 0.0 108.48 178.786 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 122' ' ' PHE . . . . . 0.438 ' O ' HG21 ' A' ' 131' ' ' THR . 1.1 m-85 -144.16 123.61 13.15 Favored 'General case' 0 N--CA 1.498 1.974 0 O-C-N 120.819 -1.175 . . . . 0.0 110.006 -179.926 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 123' ' ' ILE . . . . . 0.585 HG23 ' N ' ' A' ' 124' ' ' ASP . 14.4 tt -58.51 -40.92 80.34 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.541 0 CA-C-O 121.619 0.723 . . . . 0.0 109.46 179.714 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 124' ' ' ASP . . . . . 0.585 ' N ' HG23 ' A' ' 123' ' ' ILE . 13.1 t70 -90.14 26.21 1.95 Allowed 'General case' 0 N--CA 1.497 1.888 0 O-C-N 121.573 -0.704 . . . . 0.0 112.166 -177.215 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 125' ' ' ARG . . . . . 0.67 HH11 ' CG ' ' A' ' 125' ' ' ARG . 2.2 mtt-85 -155.59 99.69 2.25 Favored Pre-proline 0 N--CA 1.493 1.679 0 O-C-N 120.451 -1.406 . . . . 0.0 109.718 179.989 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 126' ' ' PRO . . . . . . . . . . . . . 53.9 Cg_endo -78.54 -25.15 6.93 Favored 'Trans proline' 0 C--N 1.314 -1.277 0 C-N-CA 122.067 1.845 . . . . 0.0 112.172 179.893 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 127' ' ' ASN . . . . . 0.447 ' O ' ' O ' ' A' ' 128' ' ' TYR . 3.0 t30 -91.77 5.17 50.88 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.264 -0.897 . . . . 0.0 109.43 179.743 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 128' ' ' TYR . . . . . 0.465 ' O ' ' OE2' ' A' ' 85' ' ' GLU . 9.7 t80 -59.22 -150.25 0.0 OUTLIER 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.296 -0.878 . . . . 0.0 109.88 -179.765 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 129' ' ' GLN . . . . . 0.565 ' OE1' ' N ' ' A' ' 120' ' ' HIS . 10.3 mt-30 -68.04 -70.26 0.27 Allowed 'General case' 0 C--N 1.303 -1.422 0 O-C-N 121.549 -0.72 . . . . 0.0 109.483 179.968 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 130' ' ' PHE . . . . . 0.641 ' CE1' HD21 ' A' ' 181' ' ' LEU . 55.6 m-85 -136.59 51.88 1.98 Allowed 'General case' 0 N--CA 1.489 1.501 0 O-C-N 121.29 -0.881 . . . . 0.0 110.289 -179.536 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 131' ' ' THR . . . . . 0.537 ' O ' ' CD ' ' A' ' 134' ' ' LYS . 54.0 m -81.78 -40.06 23.18 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 120.936 -1.102 . . . . 0.0 109.275 179.844 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 132' ' ' ASN . . . . . 0.575 ' ND2' ' O ' ' A' ' 81' ' ' ALA . 32.1 t30 -91.88 13.56 18.11 Favored 'General case' 0 N--CA 1.496 1.854 0 C-N-CA 119.61 -0.836 . . . . 0.0 111.783 -178.781 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 133' ' ' LEU . . . . . 0.598 HD13 ' O ' ' A' ' 133' ' ' LEU . 0.2 OUTLIER -68.15 -33.51 74.61 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 120.49 -1.381 . . . . 0.0 109.402 -179.696 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 134' ' ' LYS . . . . . 0.697 ' CD ' ' H ' ' A' ' 134' ' ' LYS . 0.0 OUTLIER -44.66 -25.41 0.28 Allowed 'General case' 0 N--CA 1.494 1.734 0 O-C-N 121.35 -0.844 . . . . 0.0 110.625 -179.977 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 135' ' ' ALA . . . . . . . . . . . . . . . -82.31 -29.83 30.87 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.087 -1.008 . . . . 0.0 110.651 -178.623 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 136' ' ' ALA . . . . . 0.893 ' HB2' ' HB2' ' A' ' 81' ' ' ALA . . . -79.91 145.24 32.77 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.034 -1.041 . . . . 0.0 111.496 -178.639 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 137' ' ' LYS . . . . . 0.565 ' CG ' ' H ' ' A' ' 138' ' ' LYS . 0.5 OUTLIER -153.18 -167.69 2.8 Favored 'General case' 0 N--CA 1.496 1.828 0 C-N-CA 118.676 -1.209 . . . . 0.0 110.698 -177.994 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 138' ' ' LYS . . . . . 0.596 ' O ' ' N ' ' A' ' 140' ' ' SER . 22.1 mtmt -44.09 178.77 0.0 OUTLIER 'General case' 0 N--CA 1.487 1.407 0 CA-C-O 122.335 1.064 . . . . 0.0 110.709 -179.197 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 139' ' ' GLY . . . . . . . . . . . . . . . 46.1 7.88 0.02 OUTLIER Glycine 0 N--CA 1.487 2.057 0 N-CA-C 110.526 -1.03 . . . . 0.0 110.526 179.593 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 140' ' ' SER . . . . . 0.596 ' N ' ' O ' ' A' ' 138' ' ' LYS . 38.2 t -92.57 135.63 33.91 Favored 'General case' 0 N--CA 1.494 1.748 0 O-C-N 120.706 -1.467 . . . . 0.0 109.293 179.318 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 141' ' ' MET . . . . . 0.673 ' SD ' ' N ' ' A' ' 142' ' ' VAL . 9.7 tpp -87.94 132.7 34.13 Favored 'General case' 0 C--N 1.299 -1.608 0 O-C-N 121.246 -0.908 . . . . 0.0 109.621 179.94 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 142' ' ' VAL . . . . . 0.673 ' N ' ' SD ' ' A' ' 141' ' ' MET . 2.3 t -115.51 136.51 52.08 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.457 0 N-CA-C 108.068 -1.086 . . . . 0.0 108.068 179.875 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 143' ' ' TYR . . . . . . . . . . . . . 10.0 m-85 -115.73 137.64 51.89 Favored 'General case' 0 N--CA 1.499 2.016 0 O-C-N 121.021 -1.049 . . . . 0.0 111.758 -178.1 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 144' ' ' PHE . . . . . . . . . . . . . 12.6 t80 -122.16 107.93 12.73 Favored 'General case' 0 N--CA 1.492 1.665 0 CA-C-O 121.322 0.582 . . . . 0.0 109.5 -179.951 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 145' ' ' LYS . . . . . 0.453 ' O ' ' N ' ' A' ' 75' ' ' TYR . 1.6 tttp -95.46 131.78 41.24 Favored 'General case' 0 N--CA 1.493 1.684 0 O-C-N 121.333 -0.854 . . . . 0.0 110.371 -179.291 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 146' ' ' VAL . . . . . 0.45 ' O ' ' C ' ' A' ' 147' ' ' GLY . 0.7 OUTLIER -144.54 141.23 23.94 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.644 0 N-CA-C 107.9 -1.148 . . . . 0.0 107.9 178.667 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 147' ' ' GLY . . . . . 0.45 ' C ' ' O ' ' A' ' 146' ' ' VAL . . . 42.56 -127.57 4.77 Favored Glycine 0 N--CA 1.49 2.28 0 N-CA-C 109.394 -1.482 . . . . 0.0 109.394 -179.821 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 148' ' ' ASN . . . . . 0.524 HD22 ' C ' ' A' ' 148' ' ' ASN . 0.4 OUTLIER -103.01 14.62 31.51 Favored 'General case' 0 C--N 1.3 -1.566 0 O-C-N 121.418 -1.048 . . . . 0.0 108.47 179.365 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 149' ' ' GLU . . . . . . . . . . . . . 3.6 tt0 -110.85 143.77 40.92 Favored 'General case' 0 N--CA 1.488 1.442 0 CA-C-O 122.031 0.919 . . . . 0.0 111.26 -178.589 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 150' ' ' THR . . . . . . . . . . . . . 6.4 m -127.22 102.18 6.82 Favored 'General case' 0 N--CA 1.49 1.544 0 CA-C-O 121.395 0.617 . . . . 0.0 109.452 179.896 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 151' ' ' ARG . . . . . 0.405 HH12 ' CG ' ' A' ' 111' ' ' ASP . 22.1 mtt180 -87.6 -178.33 6.08 Favored 'General case' 0 C--N 1.305 -1.368 0 N-CA-C 108.459 -0.941 . . . . 0.0 108.459 179.789 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 152' ' ' LYS . . . . . 0.447 ' C ' ' CD1' ' A' ' 153' ' ' TYR . 22.6 mtmt -148.8 152.51 36.66 Favored 'General case' 0 C--N 1.3 -1.57 0 C-N-CA 119.303 -0.959 . . . . 0.0 110.024 -179.677 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 153' ' ' TYR . . . . . 0.557 ' O ' ' SD ' ' A' ' 141' ' ' MET . 42.1 m-85 -144.23 157.19 44.42 Favored 'General case' 0 C--N 1.3 -1.565 0 N-CA-C 107.987 -1.116 . . . . 0.0 107.987 179.137 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 154' ' ' LYS . . . . . . . . . . . . . 26.1 ttpt -132.1 118.33 19.48 Favored 'General case' 0 C--N 1.297 -1.684 0 N-CA-C 108.514 -0.921 . . . . 0.0 108.514 179.529 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 155' ' ' MET . . . . . . . . . . . . . 15.0 mtp -45.33 105.64 0.06 Allowed 'General case' 0 N--CA 1.489 1.496 0 CA-C-O 122.284 1.04 . . . . 0.0 111.632 -178.494 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 156' ' ' THR . . . . . 0.528 ' OG1' HG23 ' A' ' 203' ' ' THR . 0.2 OUTLIER -105.7 -25.25 12.31 Favored 'General case' 0 C--N 1.295 -1.786 0 CA-C-N 115.37 -0.832 . . . . 0.0 110.538 -178.803 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 157' ' ' SER . . . . . 0.484 ' O ' ' N ' ' A' ' 201' ' ' VAL . 0.0 OUTLIER -152.93 155.73 37.56 Favored 'General case' 0 N--CA 1.496 1.835 0 C-N-CA 118.456 -1.298 . . . . 0.0 110.914 -178.684 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 158' ' ' ILE . . . . . 0.42 HG12 ' N ' ' A' ' 159' ' ' ARG . 0.0 OUTLIER -154.52 146.7 13.61 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.561 0 CA-C-O 121.812 0.815 . . . . 0.0 110.857 -178.998 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 159' ' ' ARG . . . . . 0.508 ' O ' ' OD1' ' A' ' 160' ' ' ASP . 1.6 tpt180 -148.83 167.84 24.58 Favored 'General case' 0 N--CA 1.491 1.589 0 CA-C-O 121.448 0.642 . . . . 0.0 109.755 -179.659 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 160' ' ' ASP . . . . . 0.508 ' OD1' ' O ' ' A' ' 159' ' ' ARG . 6.5 m-20 -140.5 163.29 33.22 Favored 'General case' 0 N--CA 1.493 1.71 0 O-C-N 121.488 -0.757 . . . . 0.0 108.976 -179.388 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 161' ' ' VAL . . . . . 0.713 HG22 ' N ' ' A' ' 162' ' ' LYS . 11.8 p -165.49 169.05 0.36 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.708 0 O-C-N 120.906 -1.121 . . . . 0.0 111.277 179.894 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 162' ' ' LYS . . . . . 0.713 ' N ' HG22 ' A' ' 161' ' ' VAL . 0.0 OUTLIER -60.82 174.0 0.59 Allowed Pre-proline 0 N--CA 1.492 1.643 0 N-CA-C 109.099 -0.704 . . . . 0.0 109.099 178.771 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 163' ' ' PRO . . . . . . . . . . . . . 59.2 Cg_endo -82.2 42.92 1.4 Allowed 'Trans proline' 0 C--N 1.311 -1.416 0 C-N-CA 122.444 2.096 . . . . 0.0 112.855 -179.324 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 164' ' ' THR . . . . . 0.412 ' N ' HD21 ' C' ' 702' ' ' LEU . 24.0 m -151.74 -11.58 0.2 Allowed 'General case' 0 N--CA 1.494 1.748 0 O-C-N 120.93 -1.106 . . . . 0.0 111.081 179.788 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 165' ' ' ASP . . . . . 0.699 ' CB ' HG21 ' A' ' 161' ' ' VAL . 37.0 t70 -78.82 67.77 4.62 Favored 'General case' 0 N--CA 1.492 1.67 0 O-C-N 120.771 -1.206 . . . . 0.0 110.684 -179.549 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 166' ' ' VAL . . . . . 0.652 ' O ' ' N ' ' A' ' 168' ' ' VAL . 0.9 OUTLIER -47.54 -35.07 3.93 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.479 0 O-C-N 120.828 -1.17 . . . . 0.0 109.44 -179.097 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 167' ' ' GLY . . . . . 0.439 ' C ' ' O ' ' A' ' 166' ' ' VAL . . . -42.37 -13.65 0.01 OUTLIER Glycine 0 N--CA 1.496 2.651 0 C-N-CA 119.937 -1.125 . . . . 0.0 110.389 179.958 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 168' ' ' VAL . . . . . 0.652 ' N ' ' O ' ' A' ' 166' ' ' VAL . 9.3 p -53.79 -28.23 16.4 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.408 0 O-C-N 120.782 -1.422 . . . . 0.0 109.108 179.849 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 169' ' ' LEU . . . . . 0.615 HD23 ' N ' ' A' ' 169' ' ' LEU . 1.4 mt -45.87 -19.66 0.07 Allowed 'General case' 0 N--CA 1.496 1.857 0 N-CA-C 107.068 -1.456 . . . . 0.0 107.068 -178.298 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 170' ' ' ASP . . . . . 0.581 ' O ' ' ND2' ' A' ' 114' ' ' ASN . 19.4 t0 27.32 91.09 0.01 OUTLIER 'General case' 0 N--CA 1.497 1.892 0 CA-C-N 116.392 -0.367 . . . . 0.0 111.486 177.399 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 171' ' ' GLU . . . . . 0.402 ' HA ' ' CB ' ' A' ' 114' ' ' ASN . 4.8 pt-20 -136.83 73.98 1.47 Allowed 'General case' 0 N--CA 1.493 1.71 0 O-C-N 120.967 -1.083 . . . . 0.0 110.252 179.663 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 172' ' ' GLN . . . . . . . . . . . . . 16.8 mm-40 -130.94 -48.41 1.02 Allowed 'General case' 0 N--CA 1.495 1.783 0 O-C-N 121.558 -0.714 . . . . 0.0 110.564 -178.745 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 173' ' ' LYS . . . . . 0.403 ' H ' ' HG3' ' A' ' 173' ' ' LYS . 7.2 mttp -58.8 133.94 56.43 Favored 'General case' 0 N--CA 1.492 1.669 0 O-C-N 120.926 -1.109 . . . . 0.0 108.988 -179.869 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 174' ' ' GLY . . . . . 0.571 ' O ' ' C ' ' A' ' 175' ' ' LYS . . . -130.45 -43.57 0.19 Allowed Glycine 0 C--N 1.299 -1.486 0 N-CA-C 108.363 -1.895 . . . . 0.0 108.363 179.567 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 175' ' ' LYS . . . . . 0.571 ' C ' ' O ' ' A' ' 174' ' ' GLY . 32.6 mmtt -33.78 -63.34 0.27 Allowed 'General case' 0 N--CA 1.496 1.831 0 N-CA-C 107.843 -1.169 . . . . 0.0 107.843 179.658 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 176' ' ' ASP . . . . . 0.618 ' O ' ' O ' ' A' ' 177' ' ' LYS . 15.8 m-20 -104.54 86.27 2.48 Favored 'General case' 0 C--N 1.294 -1.805 0 N-CA-C 107.406 -1.331 . . . . 0.0 107.406 176.854 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 177' ' ' LYS . . . . . 0.618 ' O ' ' O ' ' A' ' 176' ' ' ASP . 29.3 mtmt -39.25 176.65 0.0 OUTLIER 'General case' 0 N--CA 1.501 2.081 0 O-C-N 121.507 -0.746 . . . . 0.0 110.431 -179.053 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 178' ' ' GLN . . . . . 0.605 ' CD ' HD22 ' A' ' 114' ' ' ASN . 0.0 OUTLIER -161.88 176.35 10.93 Favored 'General case' 0 N--CA 1.488 1.434 0 O-C-N 120.431 -1.418 . . . . 0.0 111.365 -179.999 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 179' ' ' LEU . . . . . 0.408 ' HB2' ' CD2' ' A' ' 153' ' ' TYR . 1.0 OUTLIER -130.28 98.03 4.6 Favored 'General case' 0 N--CA 1.487 1.424 0 N-CA-C 107.105 -1.443 . . . . 0.0 107.105 178.191 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 180' ' ' THR . . . . . . . . . . . . . 1.1 m -71.42 119.89 16.22 Favored 'General case' 0 C--N 1.303 -1.448 0 O-C-N 121.06 -1.025 . . . . 0.0 110.193 -178.381 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 181' ' ' LEU . . . . . 0.856 HD13 ' N ' ' A' ' 182' ' ' ILE . 1.1 tm? -89.85 140.55 29.49 Favored 'General case' 0 C--N 1.303 -1.436 0 N-CA-C 106.91 -1.515 . . . . 0.0 106.91 177.456 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 182' ' ' ILE . . . . . 0.856 ' N ' HD13 ' A' ' 181' ' ' LEU . 5.3 mt -136.54 117.42 18.13 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.753 0 O-C-N 120.92 -1.112 . . . . 0.0 108.008 178.709 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 183' ' ' THR . . . . . . . . . . . . . 1.4 t -144.7 114.72 7.4 Favored 'General case' 0 C--N 1.287 -2.11 0 N-CA-C 107.84 -1.17 . . . . 0.0 107.84 -179.538 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 184' ' ' CYS . . . . . . . . . . . . . 0.7 OUTLIER -79.41 163.73 24.57 Favored 'General case' 0 C--N 1.288 -2.076 0 C-N-CA 118.762 -1.175 . . . . 0.0 110.649 -178.092 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 185' ' ' ASP . . . . . 0.438 ' OD1' ' N ' ' A' ' 186' ' ' ASP . 4.8 t70 -165.18 -154.42 0.22 Allowed 'General case' 0 N--CA 1.492 1.658 0 N-CA-C 109.232 -0.655 . . . . 0.0 109.232 -179.672 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 186' ' ' ASP . . . . . 0.438 ' N ' ' OD1' ' A' ' 185' ' ' ASP . 1.1 m-20 51.04 60.91 3.54 Favored 'General case' 0 N--CA 1.494 1.743 0 O-C-N 121.081 -1.012 . . . . 0.0 108.409 -179.246 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 187' ' ' TYR . . . . . 0.595 ' CE1' ' O ' ' A' ' 188' ' ' ASN . 50.7 t80 -67.78 134.37 50.86 Favored 'General case' 0 N--CA 1.49 1.544 0 CA-C-O 122.052 0.929 . . . . 0.0 111.591 -178.679 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 188' ' ' ASN . . . . . 0.595 ' O ' ' CE1' ' A' ' 187' ' ' TYR . 0.8 OUTLIER -100.78 146.15 27.63 Favored 'General case' 0 C--N 1.297 -1.7 0 N-CA-C 107.929 -1.137 . . . . 0.0 107.929 177.923 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 189' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -112.69 -14.78 13.1 Favored 'General case' 0 C--N 1.297 -1.706 0 N-CA-C 108.604 -0.887 . . . . 0.0 108.604 -179.712 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 190' ' ' LYS . . . . . . . . . . . . . 12.8 mttm -83.58 -49.87 8.79 Favored 'General case' 0 C--N 1.301 -1.505 0 N-CA-C 108.595 -0.891 . . . . 0.0 108.595 178.729 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 191' ' ' THR . . . . . 0.545 ' OG1' HG12 ' A' ' 193' ' ' VAL . 6.5 p -88.86 -11.99 43.12 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.432 -0.792 . . . . 0.0 108.916 179.454 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 192' ' ' GLY . . . . . . . . . . . . . . . 67.89 34.6 82.8 Favored Glycine 0 N--CA 1.493 2.438 0 O-C-N 121.309 -0.869 . . . . 0.0 111.059 178.561 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 193' ' ' VAL . . . . . 0.545 HG12 ' OG1' ' A' ' 191' ' ' THR . 3.5 p -148.12 167.96 4.15 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.543 0 O-C-N 120.789 -1.418 . . . . 0.0 110.216 179.382 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 194' ' ' TRP . . . . . 0.518 ' H ' HG22 ' A' ' 193' ' ' VAL . 36.7 m95 -84.89 120.85 26.94 Favored 'General case' 0 C--N 1.296 -1.74 0 N-CA-C 109.058 -0.719 . . . . 0.0 109.058 179.991 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 195' ' ' GLU . . . . . 0.546 ' CD ' ' ND2' ' A' ' 188' ' ' ASN . 3.8 mt-10 -84.99 -61.05 1.87 Allowed 'General case' 0 N--CA 1.496 1.865 0 O-C-N 121.268 -0.895 . . . . 0.0 111.089 -178.657 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 196' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -83.98 154.32 23.38 Favored 'General case' 0 N--CA 1.491 1.575 0 O-C-N 120.903 -1.123 . . . . 0.0 110.05 -178.917 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 197' ' ' ARG . . . . . 0.647 ' CG ' HH11 ' A' ' 197' ' ' ARG . 0.0 OUTLIER -126.89 140.17 52.53 Favored 'General case' 0 N--CA 1.489 1.482 0 N-CA-C 109.019 -0.734 . . . . 0.0 109.019 179.583 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 198' ' ' LYS . . . . . . . . . . . . . 23.4 mttt -114.58 121.17 42.61 Favored 'General case' 0 C--N 1.302 -1.478 0 O-C-N 121.793 -0.567 . . . . 0.0 110.2 -178.929 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 199' ' ' ILE . . . . . 0.539 HG21 HG21 ' A' ' 168' ' ' VAL . 0.8 OUTLIER -139.22 118.21 13.07 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.576 0 CA-C-O 122.809 1.29 . . . . 0.0 110.16 179.553 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 200' ' ' PHE . . . . . 0.501 ' CD1' ' N ' ' A' ' 200' ' ' PHE . 5.7 m-85 -101.0 137.03 39.91 Favored 'General case' 0 N--CA 1.495 1.814 0 O-C-N 120.707 -1.245 . . . . 0.0 110.276 -178.265 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 201' ' ' VAL . . . . . 0.484 ' N ' ' O ' ' A' ' 157' ' ' SER . 70.2 t -102.2 140.5 20.53 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.545 0 N-CA-C 108.09 -1.078 . . . . 0.0 108.09 177.465 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 202' ' ' ALA . . . . . . . . . . . . . . . -130.11 138.08 50.5 Favored 'General case' 0 C--N 1.301 -1.517 0 O-C-N 121.194 -0.941 . . . . 0.0 108.998 -179.66 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 203' ' ' THR . . . . . 0.528 HG23 ' OG1' ' A' ' 156' ' ' THR . 1.9 p -88.94 136.34 33.06 Favored 'General case' 0 C--N 1.306 -1.3 0 CA-C-O 122.474 1.13 . . . . 0.0 111.213 -178.276 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 204' ' ' GLU . . . . . 0.45 ' HA ' ' CD2' ' A' ' 153' ' ' TYR . 2.5 tt0 -60.22 134.06 56.69 Favored 'General case' 0 C--N 1.297 -1.686 0 CA-C-N 115.039 -0.982 . . . . 0.0 110.642 -179.915 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 205' ' ' VAL . . . . . 0.446 ' O ' ' OXT' ' A' ' 206' ' ' LYS . 42.2 t -121.11 -13.69 8.06 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.55 0 N-CA-C 107.997 -1.112 . . . . 0.0 107.997 179.247 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 206' ' ' LYS . . . . . 0.446 ' OXT' ' O ' ' A' ' 205' ' ' VAL . 0.1 OUTLIER . . . . . 0 N--CA 1.489 1.499 0 CA-C-O 118.029 -0.986 . . . . 0.0 109.674 -179.671 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' C' C ' 701' ' ' PHQ . . . . . 0.419 ' O2 ' HG12 ' A' ' 166' ' ' VAL . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' C' C ' 702' ' ' LEU . . . . . 0.871 ' N ' HD12 ' C' ' 702' ' ' LEU . 0.0 OUTLIER . . . . . 0 N--CA 1.491 1.599 0 N-CA-C 109.016 -0.735 . . . . 0.0 109.016 . . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' C' C ' 703' ' ' PRO . . . . . 0.65 ' HG2' ' HB1' ' A' ' 104' ' ' ALA . 52.6 Cg_exo -46.41 -176.71 0.0 OUTLIER 'Trans proline' 0 N--CA 1.49 1.287 0 C-N-CA 122.023 1.816 . . . . 0.0 112.239 -179.379 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' C' C ' 704' ' ' ALA . . . . . . . . . . . . . . . 49.87 -164.06 0.04 OUTLIER 'General case' 0 N--CA 1.488 1.443 0 O-C-N 121.37 -0.831 . . . . 0.0 109.231 -179.905 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' C' C ' 705' ' ' B27 . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 014 nuclear nobuild full ' A' A ' 700' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 015 nuclear nobuild full ' A' A ' 59' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.491 1.578 0 N-CA-C 109.432 -0.581 . . . . 0.0 109.432 . . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 60' ' ' GLN . . . . . . . . . . . . . 14.6 mm100 -60.48 -159.36 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.315 -0.866 . . . . 0.0 109.569 -179.916 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . -64.48 152.04 42.76 Favored 'General case' 0 N--CA 1.488 1.473 0 O-C-N 121.29 -0.881 . . . . 0.0 109.381 179.914 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 62' ' ' LYS . . . . . . . . . . . . . 5.4 tptt -138.66 72.04 43.05 Favored Pre-proline 0 N--CA 1.49 1.549 0 O-C-N 121.314 -0.866 . . . . 0.0 109.248 -179.72 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 63' ' ' PRO . . . . . . . . . . . . . 95.0 Cg_endo -88.95 153.81 5.87 Favored 'Trans proline' 0 C--N 1.306 -1.692 0 C-N-CA 123.703 2.936 . . . . 0.0 111.975 -179.89 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 64' ' ' GLN . . . . . 0.673 HE21 ' C ' ' A' ' 64' ' ' GLN . 0.0 OUTLIER -153.49 120.16 5.62 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.158 -0.964 . . . . 0.0 109.424 179.537 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 65' ' ' ILE . . . . . 0.495 HD12 ' H ' ' A' ' 65' ' ' ILE . 2.9 mp -45.32 106.41 0.54 Allowed Pre-proline 0 N--CA 1.489 1.51 0 N-CA-C 107.874 -1.158 . . . . 0.0 107.874 179.079 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 66' ' ' PRO . . . . . . . . . . . . . 61.3 Cg_endo -77.64 -162.82 0.18 Allowed 'Trans proline' 0 N--CA 1.49 1.285 0 C-N-CA 122.113 1.875 . . . . 0.0 113.171 -178.075 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 67' ' ' LYS . . . . . . . . . . . . . 7.0 ttpt -84.75 -7.86 59.05 Favored 'General case' 0 N--CA 1.488 1.447 0 O-C-N 121.603 -0.686 . . . . 0.0 109.388 -179.74 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 68' ' ' ASP . . . . . 0.645 ' C ' ' N ' ' A' ' 70' ' ' SER . 1.0 OUTLIER -76.9 62.75 2.14 Favored 'General case' 0 N--CA 1.489 1.478 0 CA-C-O 122.756 1.265 . . . . 0.0 109.259 179.801 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 69' ' ' LYS . . . . . 0.463 ' C ' ' O ' ' A' ' 68' ' ' ASP . 0.9 OUTLIER -47.61 -13.36 0.04 OUTLIER 'General case' 0 N--CA 1.511 2.584 0 C-N-CA 116.926 -1.91 . . . . 0.0 106.79 177.397 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 70' ' ' SER . . . . . 0.645 ' N ' ' C ' ' A' ' 68' ' ' ASP . 0.0 OUTLIER -87.58 -3.14 58.99 Favored 'General case' 0 N--CA 1.498 1.944 0 CA-C-N 113.592 -1.64 . . . . 0.0 111.805 179.448 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 71' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -99.18 141.79 31.5 Favored 'General case' 0 N--CA 1.504 2.273 0 O-C-N 120.472 -1.393 . . . . 0.0 112.606 -178.941 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 72' ' ' VAL . . . . . 0.537 HG23 ' H ' ' A' ' 87' ' ' VAL . 0.2 OUTLIER -66.37 127.67 28.1 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.38 0 N-CA-C 104.551 -2.389 . . . . 0.0 104.551 174.397 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 73' ' ' ALA . . . . . 0.578 ' N ' ' O ' ' A' ' 87' ' ' VAL . . . -80.08 -13.71 59.08 Favored 'General case' 0 C--N 1.295 -1.783 0 O-C-N 120.165 -1.585 . . . . 0.0 108.381 -178.536 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 74' ' ' GLY . . . . . 0.53 ' O ' ' CG2' ' A' ' 72' ' ' VAL . . . 171.55 -155.42 24.11 Favored Glycine 0 N--CA 1.484 1.851 0 C-N-CA 118.759 -1.686 . . . . 0.0 110.819 179.23 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 75' ' ' TYR . . . . . 0.495 ' CA ' HG23 ' A' ' 87' ' ' VAL . 6.2 m-85 -144.29 169.22 18.32 Favored 'General case' 0 C--N 1.298 -1.647 0 O-C-N 121.639 -0.918 . . . . 0.0 110.79 -177.333 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 76' ' ' ILE . . . . . . . . . . . . . 0.8 OUTLIER -149.85 147.67 16.05 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.59 0 C-N-CA 119.902 -0.719 . . . . 0.0 109.414 -178.136 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -149.25 164.76 33.9 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 120.971 -1.081 . . . . 0.0 109.731 179.558 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 78' ' ' ILE . . . . . 0.604 ' HB ' ' HB3' ' A' ' 81' ' ' ALA . 32.6 mt -146.1 94.76 4.88 Favored Pre-proline 0 N--CA 1.489 1.517 0 N-CA-C 108.482 -0.933 . . . . 0.0 108.482 -179.808 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 79' ' ' PRO . . . . . . . . . . . . . 51.2 Cg_exo -49.02 -46.37 25.57 Favored 'Trans proline' 0 C--N 1.31 -1.451 0 C-N-CA 122.604 2.203 . . . . 0.0 113.622 -178.764 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 80' ' ' ASP . . . . . 0.553 ' OD1' ' N ' ' A' ' 80' ' ' ASP . 0.0 OUTLIER -65.41 -19.79 66.1 Favored 'General case' 0 N--CA 1.493 1.716 0 O-C-N 120.821 -1.174 . . . . 0.0 110.445 178.551 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 81' ' ' ALA . . . . . 0.857 ' HB2' ' HB2' ' A' ' 136' ' ' ALA . . . -106.33 -16.95 14.43 Favored 'General case' 0 N--CA 1.491 1.624 0 N-CA-C 108.361 -0.978 . . . . 0.0 108.361 179.33 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 82' ' ' ASP . . . . . 0.522 ' N ' ' O ' ' A' ' 78' ' ' ILE . 3.4 t70 66.52 51.61 1.12 Allowed 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.367 -0.833 . . . . 0.0 110.761 179.07 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 83' ' ' ILE . . . . . 0.658 HD11 ' OD1' ' A' ' 132' ' ' ASN . 89.5 mt -129.31 153.9 39.35 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.843 0 O-C-N 121.185 -0.947 . . . . 0.0 110.052 -179.282 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 84' ' ' LYS . . . . . 0.426 ' N ' HG22 ' A' ' 83' ' ' ILE . 22.9 tttt -158.13 109.0 2.17 Favored 'General case' 0 N--CA 1.491 1.613 0 N-CA-C 107.646 -1.242 . . . . 0.0 107.646 179.372 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 85' ' ' GLU . . . . . 0.504 ' OE1' ' O ' ' A' ' 128' ' ' TYR . 0.0 OUTLIER -141.43 165.17 30.4 Favored Pre-proline 0 N--CA 1.495 1.808 0 O-C-N 121.044 -1.035 . . . . 0.0 110.798 -178.118 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 86' ' ' PRO . . . . . . . . . . . . . 59.3 Cg_endo -74.52 161.58 39.64 Favored 'Trans proline' 0 N--CA 1.495 1.603 0 C-N-CA 123.404 2.736 . . . . 0.0 113.549 -179.362 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 87' ' ' VAL . . . . . 0.578 ' O ' ' N ' ' A' ' 73' ' ' ALA . 58.6 t -120.05 99.97 8.55 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.683 0 N-CA-C 109.294 -0.632 . . . . 0.0 109.294 179.588 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 88' ' ' TYR . . . . . 0.43 ' CD2' ' CD ' ' A' ' 99' ' ' ARG . 19.5 m-85 -92.09 154.9 43.32 Favored Pre-proline 0 N--CA 1.504 2.232 0 O-C-N 120.777 -1.202 . . . . 0.0 110.276 -179.479 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 89' ' ' PRO . . . . . . . . . . . . . 11.4 Cg_endo -60.2 143.65 99.52 Favored 'Trans proline' 0 N--CA 1.495 1.559 0 C-N-CA 122.741 2.294 . . . . 0.0 113.517 -179.902 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . -59.85 168.55 7.88 Favored Glycine 0 N--CA 1.496 2.654 0 N-CA-C 109.444 -1.462 . . . . 0.0 109.444 179.271 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 91' ' ' PRO . . . . . 0.438 ' C ' ' H ' ' A' ' 93' ' ' THR . 55.6 Cg_endo -93.32 169.78 20.36 Favored 'Cis proline' 0 C--N 1.309 -1.53 0 C-N-CA 123.941 -1.274 . . . . 0.0 111.941 0.168 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 92' ' ' ALA . . . . . 0.663 ' HB1' HD21 ' A' ' 97' ' ' LEU . . . -72.28 32.52 0.06 Allowed 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.081 -1.012 . . . . 0.0 110.398 -179.903 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 93' ' ' THR . . . . . 0.5 ' OG1' ' OE1' ' A' ' 96' ' ' GLN . 3.1 p -74.81 150.67 86.39 Favored Pre-proline 0 C--N 1.3 -1.548 0 O-C-N 120.485 -1.384 . . . . 0.0 108.487 179.993 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 94' ' ' PRO . . . . . 0.403 ' C ' ' O ' ' A' ' 93' ' ' THR . 82.0 Cg_exo -30.69 -52.32 0.23 Allowed 'Trans proline' 0 C--N 1.308 -1.569 0 C-N-CA 123.18 2.587 . . . . 0.0 113.022 -179.034 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 4.9 mm-40 -49.55 -49.3 46.81 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.09 -1.006 . . . . 0.0 109.688 -179.833 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 96' ' ' GLN . . . . . 0.57 ' O ' ' N ' ' A' ' 98' ' ' ASN . 12.5 mp0 -73.53 -54.35 8.42 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 120.96 -1.088 . . . . 0.0 110.452 -179.644 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 97' ' ' LEU . . . . . 0.663 HD21 ' HB1' ' A' ' 92' ' ' ALA . 95.8 mt -47.2 -9.32 0.02 OUTLIER 'General case' 0 N--CA 1.495 1.818 0 O-C-N 121.185 -0.947 . . . . 0.0 110.279 -178.793 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 98' ' ' ASN . . . . . 0.57 ' N ' ' O ' ' A' ' 96' ' ' GLN . 0.0 OUTLIER -74.86 -26.04 59.4 Favored 'General case' 0 N--CA 1.493 1.686 0 O-C-N 121.115 -0.991 . . . . 0.0 109.126 179.727 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 99' ' ' ARG . . . . . 0.581 ' CG ' HH11 ' A' ' 99' ' ' ARG . 0.3 OUTLIER -91.1 -56.11 3.28 Favored 'General case' 0 C--N 1.301 -1.527 0 O-C-N 121.796 -0.565 . . . . 0.0 109.642 -179.484 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . -179.46 -165.36 33.47 Favored Glycine 0 N--CA 1.49 2.283 0 N-CA-C 109.949 -1.26 . . . . 0.0 109.949 179.89 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 101' ' ' VAL . . . . . 0.551 ' O ' HG23 ' A' ' 101' ' ' VAL . 28.9 m -59.23 105.95 0.22 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.64 0 O-C-N 121.325 -1.103 . . . . 0.0 109.696 -179.731 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -91.63 169.04 11.06 Favored 'General case' 0 N--CA 1.495 1.777 0 O-C-N 121.224 -0.922 . . . . 0.0 110.864 -179.308 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 103' ' ' PHE . . . . . 0.559 ' O ' ' N ' ' A' ' 105' ' ' GLU . 26.0 m-85 -72.74 122.43 21.49 Favored 'General case' 0 N--CA 1.493 1.721 0 N-CA-C 108.123 -1.065 . . . . 0.0 108.123 178.469 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 104' ' ' ALA . . . . . 0.404 ' C ' ' O ' ' A' ' 103' ' ' PHE . . . -39.67 -20.51 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.526 -0.734 . . . . 0.0 111.716 -178.388 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 105' ' ' GLU . . . . . 0.559 ' N ' ' O ' ' A' ' 103' ' ' PHE . 13.4 pt-20 -139.51 148.71 43.01 Favored 'General case' 0 N--CA 1.498 1.943 0 O-C-N 120.673 -1.267 . . . . 0.0 110.696 -179.479 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 106' ' ' GLU . . . . . . . . . . . . . 8.8 tt0 -56.79 -62.5 1.7 Allowed 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.91 -0.494 . . . . 0.0 111.76 -178.575 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 107' ' ' ASN . . . . . 0.617 HD22 ' N ' ' A' ' 107' ' ' ASN . 1.0 OUTLIER -76.62 33.5 0.14 Allowed 'General case' 0 N--CA 1.492 1.65 0 O-C-N 120.533 -1.354 . . . . 0.0 112.782 -175.247 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 108' ' ' GLU . . . . . 0.499 ' OE1' ' OE2' ' A' ' 105' ' ' GLU . 38.3 tp10 -60.24 146.67 42.88 Favored 'General case' 0 N--CA 1.488 1.466 0 O-C-N 120.776 -1.202 . . . . 0.0 107.906 179.821 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 109' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -97.8 144.31 27.52 Favored 'General case' 0 N--CA 1.488 1.468 0 O-C-N 120.923 -1.111 . . . . 0.0 110.806 -178.243 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 110' ' ' LEU . . . . . 0.558 ' H ' HD23 ' A' ' 110' ' ' LEU . 0.4 OUTLIER -61.99 -21.05 64.53 Favored 'General case' 0 C--N 1.302 -1.46 0 N-CA-C 107.734 -1.21 . . . . 0.0 107.734 179.037 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 111' ' ' ASP . . . . . . . . . . . . . 75.5 m-20 -132.62 44.79 2.83 Favored 'General case' 0 N--CA 1.488 1.451 0 CA-C-O 121.388 0.613 . . . . 0.0 109.363 179.63 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 112' ' ' ASP . . . . . . . . . . . . . 1.1 t0 -68.64 157.38 36.3 Favored 'General case' 0 N--CA 1.493 1.685 0 O-C-N 121.195 -0.941 . . . . 0.0 111.232 -179.7 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 113' ' ' GLN . . . . . 0.541 ' N ' ' CD ' ' A' ' 113' ' ' GLN . 0.0 OUTLIER -65.92 -15.7 63.2 Favored 'General case' 0 N--CA 1.492 1.653 0 N-CA-C 107.387 -1.338 . . . . 0.0 107.387 177.495 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 114' ' ' ASN . . . . . 0.496 ' CG ' ' O ' ' A' ' 114' ' ' ASN . 11.8 p-10 -150.31 108.29 3.72 Favored 'General case' 0 C--N 1.298 -1.655 0 N-CA-C 107.72 -1.215 . . . . 0.0 107.72 178.054 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 115' ' ' ILE . . . . . 0.535 HG22 ' O ' ' A' ' 115' ' ' ILE . 2.9 mt -94.38 102.48 13.66 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.63 0 N-CA-C 107.437 -1.32 . . . . 0.0 107.437 179.61 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 116' ' ' SER . . . . . . . . . . . . . 9.0 p -88.87 150.46 22.87 Favored 'General case' 0 C--N 1.303 -1.419 0 CA-C-O 121.997 0.903 . . . . 0.0 111.483 -177.476 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 117' ' ' ILE . . . . . . . . . . . . . 1.4 mt -147.68 145.82 18.6 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.458 0 N-CA-C 107.34 -1.355 . . . . 0.0 107.34 178.762 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 118' ' ' ALA . . . . . 0.615 ' HB1' ' HB2' ' C' ' 704' ' ' ALA . . . -141.96 159.39 42.32 Favored 'General case' 0 N--CA 1.494 1.726 0 O-C-N 120.789 -1.194 . . . . 0.0 111.348 -178.434 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 119' ' ' GLY . . . . . . . . . . . . . . . -171.02 153.24 20.3 Favored Glycine 0 N--CA 1.487 2.096 0 N-CA-C 110.097 -1.201 . . . . 0.0 110.097 179.873 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 120' ' ' HIS . . . . . . . . . . . . . 12.0 m170 -71.19 167.97 18.25 Favored 'General case' 0 N--CA 1.493 1.713 0 O-C-N 121.724 -0.868 . . . . 0.0 109.944 179.378 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 121' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -117.37 158.3 24.66 Favored 'General case' 0 N--CA 1.496 1.831 0 N-CA-C 108.094 -1.076 . . . . 0.0 108.094 178.76 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 122' ' ' PHE . . . . . . . . . . . . . 3.8 m-85 -141.91 123.21 14.79 Favored 'General case' 0 N--CA 1.497 1.911 0 O-C-N 120.867 -1.145 . . . . 0.0 109.805 -179.39 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 123' ' ' ILE . . . . . 0.598 HG23 ' N ' ' A' ' 124' ' ' ASP . 14.0 tt -60.38 -41.41 87.22 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.567 0 CA-C-O 121.6 0.714 . . . . 0.0 109.285 179.622 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 124' ' ' ASP . . . . . 0.598 ' N ' HG23 ' A' ' 123' ' ' ILE . 0.3 OUTLIER -87.16 22.23 2.14 Favored 'General case' 0 N--CA 1.495 1.808 0 O-C-N 121.693 -0.629 . . . . 0.0 111.955 -177.13 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 125' ' ' ARG . . . . . . . . . . . . . 46.9 mtp180 -155.29 97.12 2.42 Favored Pre-proline 0 N--CA 1.492 1.673 0 O-C-N 120.546 -1.347 . . . . 0.0 109.757 179.763 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 126' ' ' PRO . . . . . . . . . . . . . 2.9 Cg_endo -73.66 -25.76 14.48 Favored 'Trans proline' 0 C--N 1.314 -1.239 0 C-N-CA 122.113 1.876 . . . . 0.0 111.662 178.634 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 127' ' ' ASN . . . . . 0.473 ' O ' ' O ' ' A' ' 128' ' ' TYR . 0.9 OUTLIER -91.2 5.73 47.92 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.429 -0.794 . . . . 0.0 109.736 -179.843 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 128' ' ' TYR . . . . . 0.504 ' O ' ' OE1' ' A' ' 85' ' ' GLU . 4.5 t80 -59.1 -149.27 0.0 OUTLIER 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.192 -0.943 . . . . 0.0 109.936 -179.751 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 129' ' ' GLN . . . . . 0.487 ' O ' ' OE1' ' A' ' 85' ' ' GLU . 63.4 mt-30 -66.79 -72.08 0.18 Allowed 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.439 -0.788 . . . . 0.0 109.614 -179.686 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 130' ' ' PHE . . . . . 0.504 ' O ' ' CE ' ' A' ' 134' ' ' LYS . 52.6 m-85 -133.78 47.8 2.41 Favored 'General case' 0 N--CA 1.492 1.658 0 O-C-N 121.279 -0.888 . . . . 0.0 110.059 -179.741 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 131' ' ' THR . . . . . . . . . . . . . 23.5 m -81.72 -40.82 22.16 Favored 'General case' 0 N--CA 1.489 1.481 0 O-C-N 121.052 -1.03 . . . . 0.0 109.281 179.783 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 132' ' ' ASN . . . . . 0.658 ' OD1' HD11 ' A' ' 83' ' ' ILE . 0.2 OUTLIER -83.09 2.7 33.92 Favored 'General case' 0 N--CA 1.495 1.785 0 O-C-N 121.364 -0.835 . . . . 0.0 111.377 -178.283 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 133' ' ' LEU . . . . . 0.568 HD13 ' O ' ' A' ' 133' ' ' LEU . 0.2 OUTLIER -65.6 -46.07 80.75 Favored 'General case' 0 N--CA 1.493 1.681 0 O-C-N 120.549 -1.344 . . . . 0.0 110.359 -179.568 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 134' ' ' LYS . . . . . 0.57 ' CD ' ' H ' ' A' ' 134' ' ' LYS . 0.0 OUTLIER -42.41 -18.15 0.01 OUTLIER 'General case' 0 N--CA 1.494 1.739 0 O-C-N 121.071 -1.018 . . . . 0.0 110.755 -179.185 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 135' ' ' ALA . . . . . 0.563 ' N ' ' O ' ' A' ' 133' ' ' LEU . . . -83.48 -35.39 24.94 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 120.837 -1.164 . . . . 0.0 110.251 -179.506 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 136' ' ' ALA . . . . . 0.857 ' HB2' ' HB2' ' A' ' 81' ' ' ALA . . . -79.98 155.76 27.51 Favored 'General case' 0 N--CA 1.489 1.51 0 CA-C-O 122.209 1.004 . . . . 0.0 111.889 -178.479 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 137' ' ' LYS . . . . . 0.505 ' O ' ' O ' ' A' ' 138' ' ' LYS . 0.1 OUTLIER -154.32 -165.91 2.21 Favored 'General case' 0 N--CA 1.493 1.725 0 C-N-CA 118.734 -1.186 . . . . 0.0 110.915 -178.44 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 138' ' ' LYS . . . . . 0.579 ' O ' ' N ' ' A' ' 140' ' ' SER . 17.4 mttp -45.44 179.23 0.0 OUTLIER 'General case' 0 C--N 1.305 -1.365 0 CA-C-O 121.987 0.898 . . . . 0.0 110.509 -179.222 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 139' ' ' GLY . . . . . . . . . . . . . . . 47.0 7.77 0.02 OUTLIER Glycine 0 N--CA 1.491 2.304 0 N-CA-C 110.253 -1.139 . . . . 0.0 110.253 -179.849 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 140' ' ' SER . . . . . 0.579 ' N ' ' O ' ' A' ' 138' ' ' LYS . 40.4 t -89.42 141.3 28.68 Favored 'General case' 0 N--CA 1.493 1.699 0 O-C-N 120.858 -1.378 . . . . 0.0 109.591 179.239 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 141' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -90.88 127.73 36.49 Favored 'General case' 0 C--N 1.301 -1.539 0 O-C-N 121.413 -0.805 . . . . 0.0 109.487 179.732 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 142' ' ' VAL . . . . . . . . . . . . . 3.2 t -114.48 133.6 60.07 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.674 0 O-C-N 121.364 -0.835 . . . . 0.0 108.814 179.928 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 143' ' ' TYR . . . . . 0.413 ' CE1' ' CG ' ' A' ' 152' ' ' LYS . 8.5 m-85 -107.9 135.39 49.36 Favored 'General case' 0 N--CA 1.496 1.851 0 O-C-N 121.177 -0.952 . . . . 0.0 111.521 -178.603 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 144' ' ' PHE . . . . . . . . . . . . . 66.8 t80 -115.36 157.21 24.2 Favored 'General case' 0 N--CA 1.493 1.698 0 CA-C-O 121.807 0.813 . . . . 0.0 110.82 -179.185 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 145' ' ' LYS . . . . . 0.418 ' HB3' ' H ' ' A' ' 75' ' ' TYR . 55.0 tttt -152.42 130.59 11.94 Favored 'General case' 0 N--CA 1.492 1.642 0 C-N-CA 118.887 -1.125 . . . . 0.0 111.962 -179.309 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 146' ' ' VAL . . . . . . . . . . . . . 1.9 p -145.04 139.95 22.71 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.485 0 N-CA-C 106.24 -1.763 . . . . 0.0 106.24 177.431 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 147' ' ' GLY . . . . . . . . . . . . . . . 53.88 -134.67 43.61 Favored Glycine 0 N--CA 1.488 2.157 0 N-CA-C 108.726 -1.749 . . . . 0.0 108.726 -179.079 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 148' ' ' ASN . . . . . 0.591 HD22 ' C ' ' A' ' 148' ' ' ASN . 0.4 OUTLIER -103.17 22.67 13.65 Favored 'General case' 0 C--N 1.302 -1.496 0 O-C-N 121.234 -1.156 . . . . 0.0 108.71 179.354 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 149' ' ' GLU . . . . . . . . . . . . . 18.4 tt0 -112.44 152.79 28.29 Favored 'General case' 0 N--CA 1.486 1.362 0 CA-C-O 121.752 0.786 . . . . 0.0 111.095 -179.023 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 150' ' ' THR . . . . . 0.437 ' O ' HG22 ' A' ' 150' ' ' THR . 1.3 m -141.78 105.13 4.65 Favored 'General case' 0 N--CA 1.493 1.698 0 CA-C-O 121.666 0.746 . . . . 0.0 109.436 179.996 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 151' ' ' ARG . . . . . 0.46 HH22 ' CD1' ' A' ' 115' ' ' ILE . 2.9 mpp_? -88.69 -161.55 0.76 Allowed 'General case' 0 N--CA 1.488 1.453 0 O-C-N 121.659 -0.651 . . . . 0.0 109.706 -179.149 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 152' ' ' LYS . . . . . 0.429 ' O ' ' N ' ' A' ' 205' ' ' VAL . 15.0 mtmm -149.73 146.06 27.01 Favored 'General case' 0 C--N 1.304 -1.381 0 O-C-N 121.211 -0.93 . . . . 0.0 110.139 -178.814 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 153' ' ' TYR . . . . . 0.513 ' CD2' ' HA ' ' A' ' 204' ' ' GLU . 15.0 m-85 -141.06 166.88 23.57 Favored 'General case' 0 N--CA 1.49 1.559 0 N-CA-C 107.922 -1.14 . . . . 0.0 107.922 179.193 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 154' ' ' LYS . . . . . 0.484 ' HB2' HG21 ' A' ' 205' ' ' VAL . 12.7 ttmt -142.8 120.43 11.8 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.236 -0.915 . . . . 0.0 108.576 178.865 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 155' ' ' MET . . . . . 0.409 ' H ' ' HG2' ' A' ' 155' ' ' MET . 44.4 mmm -47.83 107.26 0.11 Allowed 'General case' 0 N--CA 1.493 1.688 0 O-C-N 120.611 -1.306 . . . . 0.0 111.315 -178.626 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 156' ' ' THR . . . . . 0.488 ' OG1' HG23 ' A' ' 203' ' ' THR . 0.2 OUTLIER -105.18 -24.44 12.74 Favored 'General case' 0 C--N 1.294 -1.843 0 CA-C-N 115.259 -0.882 . . . . 0.0 110.836 -178.655 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 157' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -146.8 150.5 35.43 Favored 'General case' 0 C--N 1.296 -1.757 0 C-N-CA 118.51 -1.276 . . . . 0.0 110.367 -178.784 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 158' ' ' ILE . . . . . . . . . . . . . 1.9 mt -147.35 137.59 17.13 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.382 0 CA-C-O 121.324 0.583 . . . . 0.0 109.537 -178.459 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 159' ' ' ARG . . . . . 0.488 ' O ' ' OD1' ' A' ' 160' ' ' ASP . 44.7 mtp180 -155.59 -167.71 2.59 Favored 'General case' 0 N--CA 1.492 1.647 0 CA-C-O 121.907 0.86 . . . . 0.0 110.956 -178.799 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 160' ' ' ASP . . . . . 0.488 ' OD1' ' O ' ' A' ' 159' ' ' ARG . 63.8 m-20 -146.71 153.04 39.8 Favored 'General case' 0 N--CA 1.489 1.48 0 N-CA-C 108.183 -1.043 . . . . 0.0 108.183 179.512 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 161' ' ' VAL . . . . . 0.425 ' O ' ' O ' ' A' ' 162' ' ' LYS . 0.1 OUTLIER -143.11 146.54 21.48 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.627 0 O-C-N 120.899 -1.125 . . . . 0.0 109.884 179.939 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 162' ' ' LYS . . . . . 0.697 ' CD ' ' H ' ' A' ' 162' ' ' LYS . 0.0 OUTLIER -45.44 167.13 0.12 Allowed Pre-proline 0 N--CA 1.49 1.526 0 O-C-N 121.285 -0.884 . . . . 0.0 109.391 -179.787 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 163' ' ' PRO . . . . . . . . . . . . . 57.9 Cg_endo -76.54 30.4 0.4 Allowed 'Trans proline' 0 C--N 1.308 -1.574 0 C-N-CA 122.838 2.359 . . . . 0.0 113.387 -179.488 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 164' ' ' THR . . . . . 0.623 ' HA ' HD11 ' C' ' 702' ' ' LEU . 0.2 OUTLIER -152.29 -0.58 0.3 Allowed 'General case' 0 N--CA 1.495 1.817 0 O-C-N 120.921 -1.112 . . . . 0.0 110.306 179.612 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 165' ' ' ASP . . . . . 0.414 ' O ' ' C ' ' A' ' 166' ' ' VAL . 7.4 t70 -76.85 64.4 2.38 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.12 -0.987 . . . . 0.0 110.16 -179.866 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 166' ' ' VAL . . . . . 0.616 ' O ' ' N ' ' A' ' 168' ' ' VAL . 1.3 m -47.1 -31.4 1.79 Allowed 'Isoleucine or valine' 0 N--CA 1.487 1.405 0 O-C-N 120.642 -1.286 . . . . 0.0 108.941 -178.837 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 167' ' ' GLY . . . . . . . . . . . . . . . -46.86 -9.49 0.03 OUTLIER Glycine 0 N--CA 1.495 2.571 0 N-CA-C 109.458 -1.457 . . . . 0.0 109.458 179.35 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 168' ' ' VAL . . . . . 0.708 HG21 HG21 ' A' ' 199' ' ' ILE . 9.8 p -49.43 -31.54 5.58 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.481 0 N-CA-C 107.775 -1.194 . . . . 0.0 107.775 179.22 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 169' ' ' LEU . . . . . 0.509 ' O ' ' C ' ' A' ' 170' ' ' ASP . 1.7 mm? -45.21 -19.38 0.04 OUTLIER 'General case' 0 C--N 1.293 -1.852 0 N-CA-C 107.694 -1.225 . . . . 0.0 107.694 -178.25 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 170' ' ' ASP . . . . . 0.531 ' N ' ' O ' ' A' ' 168' ' ' VAL . 8.3 t0 27.88 91.38 0.01 OUTLIER 'General case' 0 N--CA 1.501 2.121 0 CA-C-N 116.459 -0.337 . . . . 0.0 111.399 177.268 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 171' ' ' GLU . . . . . 0.433 ' CB ' ' OD1' ' A' ' 114' ' ' ASN . 17.1 pt-20 -130.85 67.27 1.51 Allowed 'General case' 0 N--CA 1.499 1.984 0 O-C-N 121.016 -1.053 . . . . 0.0 110.435 -179.989 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 172' ' ' GLN . . . . . . . . . . . . . 2.1 mt-30 -127.96 -52.6 1.32 Allowed 'General case' 0 N--CA 1.498 1.942 0 O-C-N 121.26 -0.9 . . . . 0.0 110.745 -178.979 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 173' ' ' LYS . . . . . . . . . . . . . 15.4 mttt -58.82 124.93 21.46 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 120.886 -1.134 . . . . 0.0 108.453 179.9 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 174' ' ' GLY . . . . . 0.538 ' O ' ' C ' ' A' ' 175' ' ' LYS . . . -124.74 -43.63 0.3 Allowed Glycine 0 N--CA 1.48 1.602 0 N-CA-C 108.337 -1.905 . . . . 0.0 108.337 -179.838 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 175' ' ' LYS . . . . . 0.538 ' C ' ' O ' ' A' ' 174' ' ' GLY . 2.2 mptm? -37.9 -61.85 0.61 Allowed 'General case' 0 N--CA 1.492 1.655 0 N-CA-C 107.243 -1.392 . . . . 0.0 107.243 179.308 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 176' ' ' ASP . . . . . 0.624 ' O ' ' O ' ' A' ' 177' ' ' LYS . 8.7 m-20 -104.32 85.9 2.44 Favored 'General case' 0 C--N 1.295 -1.787 0 N-CA-C 106.7 -1.592 . . . . 0.0 106.7 176.512 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 177' ' ' LYS . . . . . 0.624 ' O ' ' O ' ' A' ' 176' ' ' ASP . 12.5 mttt -40.97 179.8 0.0 OUTLIER 'General case' 0 N--CA 1.496 1.85 0 O-C-N 121.489 -0.757 . . . . 0.0 110.235 -178.726 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 178' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -161.21 170.08 20.97 Favored 'General case' 0 N--CA 1.487 1.398 0 O-C-N 120.339 -1.476 . . . . 0.0 111.138 179.911 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 179' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -123.49 99.09 6.14 Favored 'General case' 0 C--N 1.304 -1.389 0 N-CA-C 107.406 -1.331 . . . . 0.0 107.406 178.297 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 180' ' ' THR . . . . . 0.462 HG22 ' O ' ' A' ' 180' ' ' THR . 1.1 m -70.56 114.08 8.31 Favored 'General case' 0 N--CA 1.487 1.418 0 O-C-N 121.18 -0.95 . . . . 0.0 109.857 -178.774 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 181' ' ' LEU . . . . . 0.725 HD13 ' N ' ' A' ' 182' ' ' ILE . 0.3 OUTLIER -88.9 142.58 27.53 Favored 'General case' 0 C--N 1.303 -1.456 0 N-CA-C 107.339 -1.356 . . . . 0.0 107.339 177.677 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 182' ' ' ILE . . . . . 0.725 ' N ' HD13 ' A' ' 181' ' ' LEU . 81.6 mt -137.87 115.72 12.96 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.76 0 N-CA-C 107.824 -1.176 . . . . 0.0 107.824 179.259 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 183' ' ' THR . . . . . 0.464 HG23 ' O ' ' A' ' 183' ' ' THR . 3.7 t -139.54 113.49 8.73 Favored 'General case' 0 C--N 1.289 -2.063 0 N-CA-C 108.155 -1.054 . . . . 0.0 108.155 -179.623 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 184' ' ' CYS . . . . . . . . . . . . . 0.8 OUTLIER -78.84 159.75 27.67 Favored 'General case' 0 C--N 1.291 -1.938 0 C-N-CA 119.101 -1.04 . . . . 0.0 111.095 -178.078 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 185' ' ' ASP . . . . . . . . . . . . . 1.2 t70 -165.93 -155.81 0.24 Allowed 'General case' 0 N--CA 1.493 1.683 0 N-CA-C 109.046 -0.724 . . . . 0.0 109.046 -179.613 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 186' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER 54.2 55.22 8.47 Favored 'General case' 0 N--CA 1.496 1.826 0 O-C-N 121.047 -1.033 . . . . 0.0 109.335 179.898 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 187' ' ' TYR . . . . . 0.611 ' CE2' ' O ' ' A' ' 188' ' ' ASN . 71.2 t80 -67.61 132.2 47.07 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 120.975 -1.078 . . . . 0.0 111.402 -179.151 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 188' ' ' ASN . . . . . 0.831 HD21 ' N ' ' A' ' 192' ' ' GLY . 0.0 OUTLIER -100.54 149.36 23.8 Favored 'General case' 0 C--N 1.296 -1.736 0 N-CA-C 107.292 -1.373 . . . . 0.0 107.292 177.364 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 189' ' ' GLU . . . . . . . . . . . . . 1.8 tt0 -111.65 -10.56 14.09 Favored 'General case' 0 C--N 1.293 -1.871 0 N-CA-C 108.833 -0.802 . . . . 0.0 108.833 -179.122 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 190' ' ' LYS . . . . . . . . . . . . . 13.9 mttm -85.88 -50.89 6.76 Favored 'General case' 0 C--N 1.301 -1.5 0 CA-C-O 121.583 0.706 . . . . 0.0 109.447 179.537 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 191' ' ' THR . . . . . 0.705 ' N ' HD21 ' A' ' 188' ' ' ASN . 72.6 p -89.15 -1.09 57.94 Favored 'General case' 0 N--CA 1.493 1.713 0 O-C-N 121.584 -0.698 . . . . 0.0 110.781 -178.879 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 192' ' ' GLY . . . . . 0.831 ' N ' HD21 ' A' ' 188' ' ' ASN . . . 56.38 36.08 68.39 Favored Glycine 0 N--CA 1.492 2.388 0 O-C-N 120.865 -1.147 . . . . 0.0 110.327 179.622 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 193' ' ' VAL . . . . . 0.524 ' H ' HD22 ' A' ' 188' ' ' ASN . 3.1 m -148.63 163.77 5.04 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.738 0 O-C-N 120.885 -1.362 . . . . 0.0 109.449 179.519 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 194' ' ' TRP . . . . . 0.495 ' CD1' ' N ' ' A' ' 194' ' ' TRP . 24.2 m95 -84.46 121.16 27.18 Favored 'General case' 0 C--N 1.303 -1.42 0 N-CA-C 107.97 -1.122 . . . . 0.0 107.97 178.845 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 195' ' ' GLU . . . . . . . . . . . . . 1.7 mt-10 -76.7 -61.27 2.02 Favored 'General case' 0 N--CA 1.496 1.832 0 O-C-N 121.225 -0.922 . . . . 0.0 112.905 -176.831 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 196' ' ' LYS . . . . . . . . . . . . . 2.0 tptm -93.02 159.49 15.28 Favored 'General case' 0 N--CA 1.495 1.809 0 O-C-N 120.762 -1.211 . . . . 0.0 111.51 -177.201 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 197' ' ' ARG . . . . . 0.423 ' NH1' ' HB2' ' A' ' 194' ' ' TRP . 0.0 OUTLIER -121.75 135.83 54.94 Favored 'General case' 0 N--CA 1.493 1.676 0 N-CA-C 109.179 -0.675 . . . . 0.0 109.179 179.577 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 198' ' ' LYS . . . . . . . . . . . . . 49.3 mttt -117.4 120.38 37.97 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.495 -0.753 . . . . 0.0 110.104 -179.243 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 199' ' ' ILE . . . . . 0.708 HG21 HG21 ' A' ' 168' ' ' VAL . 1.0 OUTLIER -137.8 122.26 22.97 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.677 0 CA-C-O 122.667 1.222 . . . . 0.0 110.623 179.554 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 200' ' ' PHE . . . . . 0.471 ' CD1' ' N ' ' A' ' 200' ' ' PHE . 1.6 m-85 -103.5 138.83 39.66 Favored 'General case' 0 C--N 1.297 -1.689 0 O-C-N 120.91 -1.119 . . . . 0.0 110.334 -178.22 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 201' ' ' VAL . . . . . . . . . . . . . 59.7 t -102.36 147.04 9.48 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.494 0 N-CA-C 107.678 -1.23 . . . . 0.0 107.678 177.615 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 202' ' ' ALA . . . . . . . . . . . . . . . -130.53 138.63 50.3 Favored 'General case' 0 C--N 1.3 -1.567 0 O-C-N 121.138 -0.976 . . . . 0.0 108.388 -179.874 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 203' ' ' THR . . . . . 0.714 ' O ' HG23 ' A' ' 205' ' ' VAL . 6.5 p -89.0 127.78 35.68 Favored 'General case' 0 C--N 1.305 -1.365 0 CA-C-O 122.226 1.012 . . . . 0.0 111.41 -178.167 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 204' ' ' GLU . . . . . 0.513 ' HA ' ' CD2' ' A' ' 153' ' ' TYR . 1.1 tm-20 -50.37 134.9 22.79 Favored 'General case' 0 C--N 1.299 -1.595 0 C-N-CA 118.957 -1.097 . . . . 0.0 108.607 178.766 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 205' ' ' VAL . . . . . 0.714 HG23 ' O ' ' A' ' 203' ' ' THR . 69.8 t -130.54 163.96 34.82 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.338 0 CA-C-O 122.116 0.96 . . . . 0.0 110.606 -177.333 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 206' ' ' LYS . . . . . 0.578 ' N ' HG12 ' A' ' 205' ' ' VAL . 0.1 OUTLIER . . . . . 0 C--N 1.299 -1.627 0 CA-C-O 118.032 -0.985 . . . . 0.0 109.366 179.876 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' C' C ' 701' ' ' PHQ . . . . . 0.428 ' O2 ' HG12 ' A' ' 166' ' ' VAL . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' C' C ' 702' ' ' LEU . . . . . 0.899 ' N ' HD12 ' C' ' 702' ' ' LEU . 0.0 OUTLIER . . . . . 0 N--CA 1.501 2.08 0 N-CA-C 109.991 -0.374 . . . . 0.0 109.991 . . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' C' C ' 703' ' ' PRO . . . . . 0.623 ' CB ' ' HB3' ' A' ' 92' ' ' ALA . 27.7 Cg_exo -55.6 -166.77 0.02 OUTLIER 'Trans proline' 0 N--CA 1.493 1.498 0 C-N-CA 122.195 1.93 . . . . 0.0 112.606 -179.463 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' C' C ' 704' ' ' ALA . . . . . 0.615 ' HB2' ' HB1' ' A' ' 118' ' ' ALA . . . 48.48 99.45 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.493 -0.754 . . . . 0.0 109.207 -179.817 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' C' C ' 705' ' ' B27 . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 015 nuclear nobuild full ' A' A ' 700' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 016 nuclear nobuild full ' A' A ' 59' ' ' MET . . . . . . . . . . . . . 9.4 mmt . . . . . 0 N--CA 1.492 1.634 0 CA-C-O 121.383 0.611 . . . . 0.0 109.414 . . . . . . . . . 0 0 . 1 . 016 nuclear nobuild full ' A' A ' 60' ' ' GLN . . . . . . . . . . . . . 1.2 pt20 -60.91 170.56 1.49 Allowed 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.58 -0.7 . . . . 0.0 110.111 -179.406 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 61' ' ' ALA . . . . . 0.574 ' HB2' ' OD1' ' A' ' 148' ' ' ASN . . . -63.86 -178.17 0.3 Allowed 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.301 -0.874 . . . . 0.0 109.883 -179.607 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 62' ' ' LYS . . . . . 0.488 ' O ' ' OE1' ' A' ' 64' ' ' GLN . 19.2 tttp -149.69 74.26 9.53 Favored Pre-proline 0 N--CA 1.491 1.586 0 O-C-N 121.208 -0.933 . . . . 0.0 110.126 -179.525 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 63' ' ' PRO . . . . . . . . . . . . . 9.8 Cg_exo -70.52 141.07 41.26 Favored 'Trans proline' 0 C--N 1.305 -1.754 0 C-N-CA 122.879 2.386 . . . . 0.0 111.65 179.753 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 64' ' ' GLN . . . . . 0.677 ' NE2' ' N ' ' A' ' 64' ' ' GLN . 0.0 OUTLIER -156.41 117.75 3.83 Favored 'General case' 0 N--CA 1.494 1.739 0 O-C-N 121.276 -0.89 . . . . 0.0 109.071 179.816 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 65' ' ' ILE . . . . . 0.492 ' CD1' ' H ' ' A' ' 65' ' ' ILE . 0.0 OUTLIER -42.72 103.97 0.34 Allowed Pre-proline 0 N--CA 1.497 1.923 0 O-C-N 121.119 -0.988 . . . . 0.0 108.743 179.626 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 66' ' ' PRO . . . . . . . . . . . . . 61.3 Cg_endo -90.15 -154.86 0.05 OUTLIER 'Trans proline' 0 C--N 1.313 -1.339 0 C-N-CA 122.194 1.929 . . . . 0.0 112.043 -179.742 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 67' ' ' LYS . . . . . 0.409 ' C ' ' H ' ' A' ' 69' ' ' LYS . 22.0 tttt -85.32 -4.76 59.26 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.119 -0.988 . . . . 0.0 108.771 179.597 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 68' ' ' ASP . . . . . 0.616 ' C ' ' N ' ' A' ' 70' ' ' SER . 1.1 t0 -75.03 49.58 0.44 Allowed 'General case' 0 N--CA 1.488 1.452 0 CA-C-O 122.533 1.159 . . . . 0.0 108.997 179.87 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 69' ' ' LYS . . . . . 0.418 ' C ' ' O ' ' A' ' 68' ' ' ASP . 4.1 mtmp? -48.7 -14.77 0.07 Allowed 'General case' 0 N--CA 1.503 2.211 0 C-N-CA 117.218 -1.793 . . . . 0.0 106.664 177.99 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 70' ' ' SER . . . . . 0.616 ' N ' ' C ' ' A' ' 68' ' ' ASP . 0.0 OUTLIER -86.15 -4.46 59.17 Favored 'General case' 0 N--CA 1.494 1.766 0 CA-C-N 113.702 -1.59 . . . . 0.0 110.916 179.714 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 71' ' ' LYS . . . . . 0.402 ' CD ' ' HB3' ' A' ' 68' ' ' ASP . 5.4 ptmt -99.54 140.5 33.63 Favored 'General case' 0 N--CA 1.493 1.72 0 O-C-N 120.896 -1.127 . . . . 0.0 110.957 179.698 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 72' ' ' VAL . . . . . 0.6 ' CG2' ' O ' ' A' ' 74' ' ' GLY . 0.6 OUTLIER -64.82 136.57 26.42 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.476 0 N-CA-C 104.883 -2.265 . . . . 0.0 104.883 174.725 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 73' ' ' ALA . . . . . 0.651 ' O ' HG23 ' A' ' 146' ' ' VAL . . . -84.68 -14.72 47.62 Favored 'General case' 0 C--N 1.296 -1.745 0 O-C-N 120.211 -1.556 . . . . 0.0 108.386 -179.163 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 74' ' ' GLY . . . . . 0.6 ' O ' ' CG2' ' A' ' 72' ' ' VAL . . . 172.7 -158.51 28.65 Favored Glycine 0 N--CA 1.485 1.93 0 N-CA-C 109.432 -1.467 . . . . 0.0 109.432 -179.692 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 75' ' ' TYR . . . . . 0.59 ' CD2' ' O ' ' A' ' 85' ' ' GLU . 2.0 m-85 -142.81 170.32 15.92 Favored 'General case' 0 C--N 1.299 -1.63 0 O-C-N 121.013 -1.286 . . . . 0.0 111.544 -177.16 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 76' ' ' ILE . . . . . . . . . . . . . 3.0 tp -146.92 143.94 20.16 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.453 0 C-N-CA 119.906 -0.718 . . . . 0.0 109.734 -177.528 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -151.29 159.99 44.04 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 120.999 -1.063 . . . . 0.0 109.129 179.572 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 78' ' ' ILE . . . . . 0.488 ' HB ' ' HB3' ' A' ' 81' ' ' ALA . 19.0 mt -146.83 103.27 3.89 Favored Pre-proline 0 N--CA 1.491 1.604 0 O-C-N 121.296 -0.877 . . . . 0.0 109.067 -179.703 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 79' ' ' PRO . . . . . . . . . . . . . 46.6 Cg_exo -51.16 -44.02 45.11 Favored 'Trans proline' 0 N--CA 1.494 1.538 0 C-N-CA 122.566 2.177 . . . . 0.0 113.949 -179.149 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 1.1 m-20 -67.28 -22.71 65.64 Favored 'General case' 0 N--CA 1.493 1.676 0 O-C-N 120.69 -1.256 . . . . 0.0 110.991 178.975 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 81' ' ' ALA . . . . . 0.77 ' HB2' ' HB2' ' A' ' 136' ' ' ALA . . . -104.03 -10.85 17.75 Favored 'General case' 0 N--CA 1.493 1.716 0 O-C-N 121.135 -0.978 . . . . 0.0 109.106 179.588 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 82' ' ' ASP . . . . . . . . . . . . . 1.1 t70 59.05 50.24 8.46 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.336 -0.853 . . . . 0.0 110.439 179.322 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 83' ' ' ILE . . . . . . . . . . . . . 70.3 mt -125.97 152.61 33.32 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.854 0 O-C-N 121.298 -0.876 . . . . 0.0 110.285 -179.061 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 84' ' ' LYS . . . . . 0.408 ' C ' ' CD ' ' A' ' 85' ' ' GLU . 0.2 OUTLIER -160.69 105.07 1.4 Allowed 'General case' 0 N--CA 1.492 1.667 0 O-C-N 121.166 -0.959 . . . . 0.0 108.762 179.469 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 85' ' ' GLU . . . . . 0.59 ' O ' ' CD2' ' A' ' 75' ' ' TYR . 1.2 mm-40 -139.72 179.2 1.34 Allowed Pre-proline 0 N--CA 1.499 1.979 0 O-C-N 121.13 -0.981 . . . . 0.0 109.674 -179.373 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 86' ' ' PRO . . . . . 0.47 ' CD ' ' CB ' ' A' ' 85' ' ' GLU . 35.5 Cg_endo -86.15 167.33 9.38 Favored 'Trans proline' 0 C--N 1.314 -1.24 0 C-N-CA 122.707 2.272 . . . . 0.0 113.34 -178.691 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 87' ' ' VAL . . . . . 0.563 ' H ' HG23 ' A' ' 72' ' ' VAL . 57.5 t -124.43 104.76 14.3 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.469 0 N-CA-C 108.042 -1.096 . . . . 0.0 108.042 178.901 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 88' ' ' TYR . . . . . 0.409 ' CD2' ' HG2' ' A' ' 99' ' ' ARG . 29.5 m-85 -97.83 154.73 37.72 Favored Pre-proline 0 N--CA 1.496 1.831 0 O-C-N 121.047 -1.033 . . . . 0.0 110.202 -178.731 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 89' ' ' PRO . . . . . . . . . . . . . 8.9 Cg_endo -56.33 144.32 82.93 Favored 'Trans proline' 0 N--CA 1.496 1.62 0 C-N-CA 122.961 2.44 . . . . 0.0 113.949 -179.972 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . -59.87 170.25 6.71 Favored Glycine 0 N--CA 1.489 2.208 0 N-CA-C 109.01 -1.636 . . . . 0.0 109.01 178.553 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 91' ' ' PRO . . . . . 0.429 ' C ' ' H ' ' A' ' 93' ' ' THR . 54.6 Cg_endo -93.94 167.4 20.28 Favored 'Cis proline' 0 C--N 1.307 -1.645 0 C-N-CA 124.016 -1.243 . . . . 0.0 111.275 -0.04 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 92' ' ' ALA . . . . . 0.659 ' HB1' HD21 ' A' ' 97' ' ' LEU . . . -72.11 32.61 0.06 Allowed 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.125 -0.985 . . . . 0.0 110.532 -179.612 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 93' ' ' THR . . . . . 0.429 ' H ' ' C ' ' A' ' 91' ' ' PRO . 2.0 p -73.3 149.78 89.26 Favored Pre-proline 0 N--CA 1.489 1.52 0 O-C-N 120.566 -1.333 . . . . 0.0 108.653 -179.817 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 94' ' ' PRO . . . . . . . . . . . . . 91.8 Cg_exo -30.53 -50.43 0.22 Allowed 'Trans proline' 0 C--N 1.31 -1.454 0 C-N-CA 123.372 2.715 . . . . 0.0 112.944 -179.125 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 95' ' ' GLU . . . . . 0.434 ' O ' ' NH2' ' A' ' 99' ' ' ARG . 10.6 mt-10 -53.8 -47.65 70.62 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.201 -0.937 . . . . 0.0 109.702 -179.973 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 96' ' ' GLN . . . . . 0.452 ' C ' ' H ' ' A' ' 98' ' ' ASN . 3.3 mp0 -72.08 -49.21 38.3 Favored 'General case' 0 C--N 1.302 -1.478 0 O-C-N 121.263 -0.898 . . . . 0.0 110.416 -179.453 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 97' ' ' LEU . . . . . 0.659 HD21 ' HB1' ' A' ' 92' ' ' ALA . 96.2 mt -52.8 -8.25 0.09 Allowed 'General case' 0 N--CA 1.493 1.695 0 O-C-N 121.055 -1.028 . . . . 0.0 110.06 -178.936 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 98' ' ' ASN . . . . . 0.628 ' ND2' ' CZ ' ' A' ' 99' ' ' ARG . 0.0 OUTLIER -75.68 -37.73 59.3 Favored 'General case' 0 N--CA 1.488 1.432 0 N-CA-C 107.91 -1.145 . . . . 0.0 107.91 178.269 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 99' ' ' ARG . . . . . 0.628 ' CZ ' ' ND2' ' A' ' 98' ' ' ASN . 1.0 OUTLIER -72.41 -51.28 21.06 Favored 'General case' 0 C--N 1.304 -1.378 0 CA-C-N 115.893 -0.594 . . . . 0.0 109.646 179.677 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . 169.6 -158.43 30.7 Favored Glycine 0 N--CA 1.497 2.762 0 N-CA-C 109.565 -1.414 . . . . 0.0 109.565 -179.834 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 101' ' ' VAL . . . . . 0.763 ' O ' HG23 ' A' ' 101' ' ' VAL . 16.2 m -66.2 104.26 0.57 Allowed 'Isoleucine or valine' 0 N--CA 1.496 1.848 0 O-C-N 120.924 -1.339 . . . . 0.0 108.987 179.697 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -92.4 167.71 11.79 Favored 'General case' 0 N--CA 1.495 1.813 0 O-C-N 121.218 -0.926 . . . . 0.0 111.6 -178.719 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 103' ' ' PHE . . . . . 0.425 ' CE1' ' CG1' ' A' ' 87' ' ' VAL . 24.3 m-85 -70.97 143.88 50.69 Favored 'General case' 0 N--CA 1.489 1.505 0 N-CA-C 107.876 -1.157 . . . . 0.0 107.876 178.238 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 104' ' ' ALA . . . . . . . . . . . . . . . -61.94 -13.47 25.43 Favored 'General case' 0 C--N 1.297 -1.68 0 O-C-N 121.179 -0.951 . . . . 0.0 111.376 -178.71 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -138.29 143.27 39.92 Favored 'General case' 0 N--CA 1.498 1.964 0 O-C-N 120.618 -1.301 . . . . 0.0 110.998 -179.49 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 106' ' ' GLU . . . . . . . . . . . . . 6.1 pt-20 -57.09 -58.92 6.06 Favored 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.935 -0.478 . . . . 0.0 111.134 -179.432 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 107' ' ' ASN . . . . . 0.466 HD22 ' N ' ' A' ' 107' ' ' ASN . 1.1 m-80 -77.99 35.22 0.2 Allowed 'General case' 0 N--CA 1.489 1.478 0 O-C-N 120.361 -1.462 . . . . 0.0 112.107 -176.24 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 108' ' ' GLU . . . . . . . . . . . . . 40.6 tp10 -59.28 145.46 43.02 Favored 'General case' 0 C--N 1.304 -1.374 0 O-C-N 120.742 -1.224 . . . . 0.0 107.834 -179.96 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 109' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -96.86 144.22 27.01 Favored 'General case' 0 C--N 1.301 -1.542 0 O-C-N 121.119 -0.988 . . . . 0.0 110.67 -178.324 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 110' ' ' LEU . . . . . 0.513 HD11 HG21 ' A' ' 146' ' ' VAL . 5.6 tp -60.9 -21.52 63.43 Favored 'General case' 0 C--N 1.302 -1.465 0 N-CA-C 107.971 -1.122 . . . . 0.0 107.971 179.165 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 111' ' ' ASP . . . . . . . . . . . . . 82.5 m-20 -132.19 43.77 2.98 Favored 'General case' 0 C--N 1.302 -1.482 0 C-N-CA 120.269 -0.572 . . . . 0.0 109.861 -179.616 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 112' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -67.09 148.79 51.42 Favored 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.153 -0.967 . . . . 0.0 110.059 179.63 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 113' ' ' GLN . . . . . 0.432 ' HA ' ' NE2' ' A' ' 113' ' ' GLN . 1.0 OUTLIER -68.12 -12.4 60.83 Favored 'General case' 0 C--N 1.302 -1.482 0 O-C-N 121.256 -0.902 . . . . 0.0 109.199 179.029 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 114' ' ' ASN . . . . . 0.674 ' ND2' ' NE2' ' A' ' 178' ' ' GLN . 8.0 t-20 -149.97 101.79 3.06 Favored 'General case' 0 C--N 1.301 -1.517 0 N-CA-C 107.167 -1.42 . . . . 0.0 107.167 177.378 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 115' ' ' ILE . . . . . 0.432 ' O ' HG22 ' A' ' 115' ' ' ILE . 4.0 mt -97.83 110.55 25.74 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.45 0 O-C-N 121.047 -1.033 . . . . 0.0 108.848 -179.253 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 116' ' ' SER . . . . . . . . . . . . . 28.9 m -98.93 138.26 36.31 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.154 -0.966 . . . . 0.0 111.122 -178.485 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 117' ' ' ILE . . . . . 0.459 ' CD1' HD21 ' A' ' 179' ' ' LEU . 14.4 mt -123.42 151.52 28.01 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.424 0 N-CA-C 107.229 -1.397 . . . . 0.0 107.229 178.83 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 118' ' ' ALA . . . . . 0.405 ' HA ' ' O ' ' A' ' 182' ' ' ILE . . . -140.93 154.67 46.2 Favored 'General case' 0 N--CA 1.487 1.409 0 O-C-N 120.95 -1.094 . . . . 0.0 110.609 -179.171 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 119' ' ' GLY . . . . . . . . . . . . . . . -166.57 151.73 20.14 Favored Glycine 0 N--CA 1.484 1.849 0 N-CA-C 110.201 -1.16 . . . . 0.0 110.201 179.984 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 120' ' ' HIS . . . . . . . . . . . . . 10.9 m170 -71.71 165.51 23.87 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.918 -0.754 . . . . 0.0 110.465 179.642 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 121' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -121.03 148.32 44.3 Favored 'General case' 0 N--CA 1.495 1.823 0 N-CA-C 107.75 -1.204 . . . . 0.0 107.75 178.293 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 122' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -107.41 138.33 43.81 Favored 'General case' 0 N--CA 1.495 1.782 0 O-C-N 120.882 -1.136 . . . . 0.0 110.192 -179.663 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 123' ' ' ILE . . . . . 0.536 HG23 ' N ' ' A' ' 124' ' ' ASP . 15.0 tt -90.26 -36.54 8.5 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.771 0 N-CA-C 108.152 -1.055 . . . . 0.0 108.152 178.277 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 124' ' ' ASP . . . . . 0.536 ' N ' HG23 ' A' ' 123' ' ' ILE . 18.3 t0 -96.6 17.18 16.9 Favored 'General case' 0 N--CA 1.496 1.843 0 CA-C-N 115.777 -0.647 . . . . 0.0 111.13 -179.638 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 125' ' ' ARG . . . . . . . . . . . . . 7.7 ttt180 -156.72 107.35 1.97 Allowed Pre-proline 0 N--CA 1.499 1.993 0 O-C-N 120.516 -1.365 . . . . 0.0 110.152 -178.856 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 126' ' ' PRO . . . . . . . . . . . . . 66.0 Cg_endo -81.04 -17.02 9.6 Favored 'Trans proline' 0 C--N 1.314 -1.247 0 C-N-CA 121.886 1.724 . . . . 0.0 112.703 179.885 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 127' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -90.95 31.24 1.1 Allowed 'General case' 0 N--CA 1.494 1.742 0 O-C-N 121.152 -0.968 . . . . 0.0 109.946 -179.933 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 128' ' ' TYR . . . . . . . . . . . . . 8.8 t80 -89.41 -153.16 0.26 Allowed 'General case' 0 N--CA 1.492 1.668 0 O-C-N 120.956 -1.09 . . . . 0.0 110.675 -179.193 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 129' ' ' GLN . . . . . . . . . . . . . 39.8 mt-30 -66.77 -72.71 0.15 Allowed 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.32 -0.863 . . . . 0.0 110.919 -178.308 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 130' ' ' PHE . . . . . 0.573 ' CE2' HG11 ' A' ' 101' ' ' VAL . 49.2 m-85 -121.6 28.98 7.4 Favored 'General case' 0 N--CA 1.497 1.876 0 O-C-N 121.289 -0.882 . . . . 0.0 110.126 -179.447 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 131' ' ' THR . . . . . . . . . . . . . 99.0 m -72.55 -30.92 64.86 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 120.781 -1.199 . . . . 0.0 109.146 179.933 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 132' ' ' ASN . . . . . . . . . . . . . 4.6 t30 -85.0 7.99 19.39 Favored 'General case' 0 N--CA 1.496 1.86 0 C-N-CA 119.513 -0.875 . . . . 0.0 109.923 -179.869 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 133' ' ' LEU . . . . . 0.583 ' O ' ' N ' ' A' ' 135' ' ' ALA . 0.2 OUTLIER -70.81 -49.64 44.2 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.353 -0.842 . . . . 0.0 109.827 179.897 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 134' ' ' LYS . . . . . 0.599 ' CD ' ' H ' ' A' ' 134' ' ' LYS . 0.0 OUTLIER -44.39 -16.14 0.02 OUTLIER 'General case' 0 N--CA 1.495 1.804 0 O-C-N 120.995 -1.066 . . . . 0.0 109.386 -179.311 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 135' ' ' ALA . . . . . 0.583 ' N ' ' O ' ' A' ' 133' ' ' LEU . . . -83.15 -35.87 25.2 Favored 'General case' 0 N--CA 1.494 1.773 0 O-C-N 121.264 -0.898 . . . . 0.0 109.824 179.78 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 136' ' ' ALA . . . . . 0.77 ' HB2' ' HB2' ' A' ' 81' ' ' ALA . . . -80.43 158.71 25.87 Favored 'General case' 0 N--CA 1.491 1.621 0 CA-C-O 121.778 0.799 . . . . 0.0 111.446 -178.735 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 137' ' ' LYS . . . . . 0.55 ' O ' ' O ' ' A' ' 138' ' ' LYS . 17.1 mtmt -149.64 -168.08 3.01 Favored 'General case' 0 N--CA 1.493 1.7 0 C-N-CA 118.935 -1.106 . . . . 0.0 110.619 -177.888 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 138' ' ' LYS . . . . . 0.581 ' O ' ' N ' ' A' ' 140' ' ' SER . 21.7 mtmm -40.48 176.06 0.0 OUTLIER 'General case' 0 C--N 1.304 -1.407 0 CA-C-O 122.608 1.194 . . . . 0.0 111.502 -178.618 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 139' ' ' GLY . . . . . . . . . . . . . . . 47.83 7.81 0.04 OUTLIER Glycine 0 N--CA 1.487 2.072 0 N-CA-C 109.825 -1.31 . . . . 0.0 109.825 -179.649 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 140' ' ' SER . . . . . 0.581 ' N ' ' O ' ' A' ' 138' ' ' LYS . 2.3 p -75.32 116.67 16.3 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 120.96 -1.318 . . . . 0.0 109.156 179.207 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 141' ' ' MET . . . . . . . . . . . . . 3.3 tpt -70.6 139.3 51.38 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.215 -0.928 . . . . 0.0 109.393 -179.956 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 142' ' ' VAL . . . . . . . . . . . . . 5.0 t -125.35 128.25 72.53 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.719 0 O-C-N 121.491 -0.755 . . . . 0.0 108.998 -179.789 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 143' ' ' TYR . . . . . . . . . . . . . 64.4 m-85 -107.41 135.04 49.57 Favored 'General case' 0 N--CA 1.5 2.056 0 O-C-N 121.236 -0.915 . . . . 0.0 110.69 -179.295 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 144' ' ' PHE . . . . . . . . . . . . . 62.9 t80 -118.78 101.65 8.24 Favored 'General case' 0 N--CA 1.5 2.066 0 O-C-N 121.474 -0.766 . . . . 0.0 110.406 -179.405 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 145' ' ' LYS . . . . . 0.405 ' O ' ' N ' ' A' ' 75' ' ' TYR . 36.5 tttt -96.51 129.98 43.78 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.03 -1.044 . . . . 0.0 110.543 -179.554 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 146' ' ' VAL . . . . . 0.651 HG23 ' O ' ' A' ' 73' ' ' ALA . 2.6 p -146.16 141.84 21.37 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.574 0 N-CA-C 107.238 -1.393 . . . . 0.0 107.238 178.376 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 147' ' ' GLY . . . . . 0.42 ' C ' ' O ' ' A' ' 146' ' ' VAL . . . 47.85 -133.72 16.87 Favored Glycine 0 N--CA 1.487 2.077 0 N-CA-C 108.857 -1.697 . . . . 0.0 108.857 -179.391 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 148' ' ' ASN . . . . . 0.574 ' OD1' ' HB2' ' A' ' 61' ' ' ALA . 0.5 OUTLIER -102.91 17.85 23.0 Favored 'General case' 0 C--N 1.302 -1.495 0 O-C-N 121.314 -1.109 . . . . 0.0 108.418 179.314 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 149' ' ' GLU . . . . . 0.525 ' CD ' ' N ' ' A' ' 150' ' ' THR . 11.5 tp10 -113.03 145.31 41.09 Favored 'General case' 0 N--CA 1.486 1.368 0 CA-C-O 121.714 0.768 . . . . 0.0 110.658 -178.447 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 150' ' ' THR . . . . . 0.525 ' N ' ' CD ' ' A' ' 149' ' ' GLU . 86.0 m -129.72 104.79 7.62 Favored 'General case' 0 N--CA 1.492 1.647 0 CA-C-O 121.487 0.66 . . . . 0.0 109.526 179.815 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 151' ' ' ARG . . . . . . . . . . . . . 84.3 mtt180 -85.92 -168.97 2.43 Favored 'General case' 0 N--CA 1.486 1.363 0 N-CA-C 108.646 -0.872 . . . . 0.0 108.646 -179.759 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 152' ' ' LYS . . . . . 0.589 ' N ' ' OXT' ' A' ' 206' ' ' LYS . 21.7 mtpt -149.9 148.47 29.16 Favored 'General case' 0 C--N 1.3 -1.563 0 O-C-N 120.999 -1.063 . . . . 0.0 110.317 -178.855 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 153' ' ' TYR . . . . . 0.446 ' CD1' ' C ' ' A' ' 152' ' ' LYS . 51.7 m-85 -146.94 151.48 37.08 Favored 'General case' 0 C--N 1.302 -1.475 0 N-CA-C 108.401 -0.963 . . . . 0.0 108.401 178.718 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 154' ' ' LYS . . . . . . . . . . . . . 10.8 ttmt -133.05 117.05 17.11 Favored 'General case' 0 C--N 1.298 -1.648 0 N-CA-C 108.711 -0.848 . . . . 0.0 108.711 179.291 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 155' ' ' MET . . . . . 0.557 ' SD ' ' OG ' ' A' ' 140' ' ' SER . 6.5 mtt -41.66 107.71 0.08 Allowed 'General case' 0 N--CA 1.489 1.483 0 CA-C-O 122.75 1.262 . . . . 0.0 111.858 -178.126 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 156' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -106.07 -26.19 11.73 Favored 'General case' 0 C--N 1.293 -1.865 0 CA-C-N 114.537 -1.211 . . . . 0.0 110.03 -178.842 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 157' ' ' SER . . . . . 0.488 ' O ' ' N ' ' A' ' 201' ' ' VAL . 19.8 t -154.27 150.77 28.37 Favored 'General case' 0 N--CA 1.494 1.748 0 C-N-CA 118.713 -1.195 . . . . 0.0 111.394 -178.678 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 158' ' ' ILE . . . . . 0.444 HG13 ' CD2' ' A' ' 200' ' ' PHE . 0.0 OUTLIER -155.25 146.9 12.98 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.486 0 CA-C-O 121.767 0.794 . . . . 0.0 110.252 -179.884 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 159' ' ' ARG . . . . . 0.599 ' CG ' HH11 ' A' ' 159' ' ' ARG . 0.0 OUTLIER -151.32 -167.46 2.81 Favored 'General case' 0 N--CA 1.491 1.603 0 CA-C-O 121.785 0.802 . . . . 0.0 110.551 -179.147 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 160' ' ' ASP . . . . . . . . . . . . . 5.5 m-20 -145.11 152.91 40.8 Favored 'General case' 0 N--CA 1.491 1.599 0 N-CA-C 108.585 -0.894 . . . . 0.0 108.585 -179.429 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 161' ' ' VAL . . . . . 0.653 HG21 HG22 ' A' ' 168' ' ' VAL . 0.1 OUTLIER -153.04 150.83 12.38 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.873 0 O-C-N 120.713 -1.242 . . . . 0.0 111.21 -178.834 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 162' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -49.07 171.3 0.11 Allowed Pre-proline 0 N--CA 1.496 1.866 0 O-C-N 121.652 -0.655 . . . . 0.0 109.961 179.418 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 163' ' ' PRO . . . . . . . . . . . . . 74.2 Cg_endo -81.07 29.37 0.53 Allowed 'Trans proline' 0 N--CA 1.492 1.428 0 C-N-CA 122.792 2.328 . . . . 0.0 113.008 179.83 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 164' ' ' THR . . . . . 0.506 ' O ' HG22 ' A' ' 164' ' ' THR . 55.3 m -151.16 -6.01 0.27 Allowed 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.005 -1.059 . . . . 0.0 110.356 -179.949 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 165' ' ' ASP . . . . . 0.86 ' O ' HG23 ' A' ' 168' ' ' VAL . 12.0 t0 -75.8 63.62 1.68 Allowed 'General case' 0 N--CA 1.487 1.411 0 O-C-N 120.994 -1.066 . . . . 0.0 109.292 179.549 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 166' ' ' VAL . . . . . 0.538 ' O ' ' N ' ' A' ' 168' ' ' VAL . 1.0 OUTLIER -39.54 -31.96 0.17 Allowed 'Isoleucine or valine' 0 N--CA 1.488 1.433 0 O-C-N 121.473 -0.767 . . . . 0.0 109.152 -178.647 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 167' ' ' GLY . . . . . 0.442 ' N ' ' O ' ' A' ' 165' ' ' ASP . . . -45.52 -13.52 0.05 OUTLIER Glycine 0 N--CA 1.494 2.545 0 N-CA-C 110.541 -1.024 . . . . 0.0 110.541 179.929 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 168' ' ' VAL . . . . . 0.86 HG23 ' O ' ' A' ' 165' ' ' ASP . 16.7 t -52.74 -35.39 21.28 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.607 0 O-C-N 120.818 -1.401 . . . . 0.0 108.115 179.531 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 169' ' ' LEU . . . . . 0.54 ' O ' ' C ' ' A' ' 170' ' ' ASP . 84.3 mt -46.23 -14.05 0.02 OUTLIER 'General case' 0 C--N 1.3 -1.569 0 N-CA-C 108.26 -1.015 . . . . 0.0 108.26 -178.268 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 170' ' ' ASP . . . . . 0.6 ' O ' ' ND2' ' A' ' 114' ' ' ASN . 39.1 t0 19.78 54.36 0.01 OUTLIER 'General case' 0 N--CA 1.501 2.079 0 N-CA-C 111.874 0.324 . . . . 0.0 111.874 177.699 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 171' ' ' GLU . . . . . 0.435 ' N ' ' O ' ' A' ' 169' ' ' LEU . 4.9 pt-20 -100.87 75.6 1.71 Allowed 'General case' 0 N--CA 1.497 1.878 0 O-C-N 120.777 -1.202 . . . . 0.0 110.554 -179.597 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 172' ' ' GLN . . . . . . . . . . . . . 4.3 pt20 -139.69 -39.25 0.46 Allowed 'General case' 0 N--CA 1.492 1.665 0 O-C-N 121.568 -0.708 . . . . 0.0 109.266 -179.843 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 173' ' ' LYS . . . . . . . . . . . . . 9.2 mtpp -63.82 131.05 46.6 Favored 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.06 -1.025 . . . . 0.0 108.743 178.818 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 174' ' ' GLY . . . . . 0.559 ' O ' ' C ' ' A' ' 175' ' ' LYS . . . -137.5 -38.94 0.13 Allowed Glycine 0 C--N 1.294 -1.761 0 N-CA-C 108.514 -1.834 . . . . 0.0 108.514 179.763 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 175' ' ' LYS . . . . . 0.559 ' C ' ' O ' ' A' ' 174' ' ' GLY . 3.4 tptp -33.41 -62.97 0.26 Allowed 'General case' 0 N--CA 1.493 1.717 0 N-CA-C 108.529 -0.915 . . . . 0.0 108.529 179.676 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 176' ' ' ASP . . . . . 0.715 ' O ' ' O ' ' A' ' 177' ' ' LYS . 0.9 OUTLIER -103.6 76.1 1.37 Allowed 'General case' 0 C--N 1.297 -1.697 0 N-CA-C 107.796 -1.187 . . . . 0.0 107.796 177.775 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 177' ' ' LYS . . . . . 0.715 ' O ' ' O ' ' A' ' 176' ' ' ASP . 17.6 mtmt -19.16 158.63 0.0 OUTLIER 'General case' 0 N--CA 1.508 2.458 0 CA-C-O 122.145 0.974 . . . . 0.0 112.719 -178.985 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 178' ' ' GLN . . . . . 0.674 ' NE2' ' ND2' ' A' ' 114' ' ' ASN . 18.0 pt20 -156.08 159.23 38.91 Favored 'General case' 0 N--CA 1.491 1.593 0 C-N-CA 117.061 -1.856 . . . . 0.0 112.483 179.863 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 179' ' ' LEU . . . . . 0.459 HD21 ' CD1' ' A' ' 117' ' ' ILE . 0.8 OUTLIER -121.58 102.88 8.51 Favored 'General case' 0 N--CA 1.486 1.349 0 N-CA-C 107.072 -1.455 . . . . 0.0 107.072 178.418 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 180' ' ' THR . . . . . 0.45 ' OG1' HG22 ' A' ' 201' ' ' VAL . 1.0 OUTLIER -79.92 123.9 28.2 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.148 -0.97 . . . . 0.0 110.438 -178.454 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 181' ' ' LEU . . . . . . . . . . . . . 7.5 tp -99.8 110.9 23.25 Favored 'General case' 0 N--CA 1.492 1.661 0 N-CA-C 108.711 -0.848 . . . . 0.0 108.711 178.386 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 182' ' ' ILE . . . . . 0.405 ' O ' ' HA ' ' A' ' 118' ' ' ALA . 18.1 mt -98.94 120.23 47.98 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.549 0 O-C-N 120.85 -1.156 . . . . 0.0 109.768 179.432 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 183' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -135.44 109.06 7.97 Favored 'General case' 0 C--N 1.296 -1.718 0 N-CA-C 107.279 -1.378 . . . . 0.0 107.279 178.548 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 184' ' ' CYS . . . . . 0.408 ' HB3' HH12 ' A' ' 197' ' ' ARG . 0.7 OUTLIER -79.83 156.68 27.28 Favored 'General case' 0 N--CA 1.498 1.933 0 C-N-CA 118.935 -1.106 . . . . 0.0 111.341 -177.306 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 185' ' ' ASP . . . . . 0.613 ' CG ' ' H ' ' A' ' 186' ' ' ASP . 28.9 t0 -166.53 -161.92 0.49 Allowed 'General case' 0 N--CA 1.489 1.523 0 N-CA-C 108.659 -0.867 . . . . 0.0 108.659 -179.943 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 186' ' ' ASP . . . . . 0.613 ' H ' ' CG ' ' A' ' 185' ' ' ASP . 0.6 OUTLIER 58.49 49.12 11.08 Favored 'General case' 0 N--CA 1.497 1.916 0 O-C-N 121.026 -1.046 . . . . 0.0 109.457 -179.656 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 187' ' ' TYR . . . . . 0.587 ' CE1' ' O ' ' A' ' 188' ' ' ASN . 30.1 t80 -67.16 133.09 49.11 Favored 'General case' 0 C--N 1.3 -1.562 0 CA-C-O 121.843 0.83 . . . . 0.0 110.469 -179.858 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 188' ' ' ASN . . . . . 0.86 ' ND2' ' H ' ' A' ' 193' ' ' VAL . 0.1 OUTLIER -102.56 150.66 23.18 Favored 'General case' 0 C--N 1.292 -1.894 0 N-CA-C 107.572 -1.27 . . . . 0.0 107.572 178.033 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 189' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -113.24 -3.08 13.92 Favored 'General case' 0 C--N 1.292 -1.934 0 N-CA-C 108.178 -1.045 . . . . 0.0 108.178 -179.61 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 190' ' ' LYS . . . . . 0.566 ' N ' ' OD1' ' A' ' 188' ' ' ASN . 2.6 mtpm? -83.66 -60.21 2.19 Favored 'General case' 0 N--CA 1.489 1.49 0 N-CA-C 108.714 -0.847 . . . . 0.0 108.714 178.558 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 191' ' ' THR . . . . . 0.623 ' OG1' ' ND2' ' A' ' 188' ' ' ASN . 1.1 p -89.34 4.15 49.86 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.41 -0.806 . . . . 0.0 109.245 179.896 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 192' ' ' GLY . . . . . . . . . . . . . . . 56.73 38.01 80.27 Favored Glycine 0 N--CA 1.494 2.53 0 N-CA-C 110.05 -1.22 . . . . 0.0 110.05 179.4 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 193' ' ' VAL . . . . . 0.86 ' H ' ' ND2' ' A' ' 188' ' ' ASN . 46.0 t -148.35 161.02 6.5 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.493 0 O-C-N 121.162 -1.199 . . . . 0.0 110.042 -179.975 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 194' ' ' TRP . . . . . 0.563 ' NE1' ' OG1' ' C' ' 705' ' ' B27 . 11.1 m95 -83.4 120.62 26.11 Favored 'General case' 0 C--N 1.298 -1.656 0 N-CA-C 108.564 -0.902 . . . . 0.0 108.564 179.55 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 195' ' ' GLU . . . . . . . . . . . . . 1.4 mt-10 -79.53 -60.09 2.5 Favored 'General case' 0 N--CA 1.493 1.709 0 O-C-N 121.309 -0.869 . . . . 0.0 111.013 -178.888 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 196' ' ' LYS . . . . . . . . . . . . . 19.0 mttp -95.04 146.37 24.32 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.285 -0.884 . . . . 0.0 110.31 -178.759 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 197' ' ' ARG . . . . . 0.657 ' CG ' HH11 ' A' ' 197' ' ' ARG . 0.0 OUTLIER -118.81 145.42 45.65 Favored 'General case' 0 N--CA 1.492 1.635 0 N-CA-C 108.564 -0.902 . . . . 0.0 108.564 179.035 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 198' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER -116.95 120.75 39.4 Favored 'General case' 0 N--CA 1.492 1.666 0 O-C-N 121.672 -0.643 . . . . 0.0 110.358 -178.704 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 199' ' ' ILE . . . . . 0.514 HG21 HG11 ' A' ' 168' ' ' VAL . 0.8 OUTLIER -141.67 121.46 11.17 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.527 0 CA-C-O 122.672 1.225 . . . . 0.0 110.551 179.554 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 200' ' ' PHE . . . . . 0.53 ' CD1' ' N ' ' A' ' 200' ' ' PHE . 3.3 m-85 -99.52 134.64 42.1 Favored 'General case' 0 N--CA 1.497 1.915 0 O-C-N 121.163 -0.961 . . . . 0.0 110.125 -177.653 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 201' ' ' VAL . . . . . 0.488 ' N ' ' O ' ' A' ' 157' ' ' SER . 3.4 t -103.95 145.38 12.9 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.456 0 N-CA-C 107.646 -1.242 . . . . 0.0 107.646 176.805 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 202' ' ' ALA . . . . . . . . . . . . . . . -135.01 142.31 46.39 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.042 -1.036 . . . . 0.0 109.465 -179.753 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 203' ' ' THR . . . . . . . . . . . . . 2.2 p -90.11 127.55 36.11 Favored 'General case' 0 C--N 1.306 -1.322 0 CA-C-O 122.694 1.235 . . . . 0.0 111.693 -178.353 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 204' ' ' GLU . . . . . . . . . . . . . 2.7 tm-20 -53.99 135.84 42.21 Favored 'General case' 0 C--N 1.291 -1.976 0 CA-C-N 114.364 -1.289 . . . . 0.0 108.286 178.594 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 205' ' ' VAL . . . . . . . . . . . . . 62.6 t -121.55 -50.14 3.02 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.898 0 O-C-N 121.177 -0.952 . . . . 0.0 109.436 -179.13 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 206' ' ' LYS . . . . . 0.589 ' OXT' ' N ' ' A' ' 152' ' ' LYS . 4.4 mmtp . . . . . 0 C--N 1.302 -1.469 0 CA-C-O 118.114 -0.946 . . . . 0.0 109.667 179.151 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' C' C ' 701' ' ' PHQ . . . . . 0.46 ' O2 ' HG12 ' A' ' 166' ' ' VAL . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' C' C ' 702' ' ' LEU . . . . . 0.827 ' N ' HD12 ' C' ' 702' ' ' LEU . 0.0 OUTLIER . . . . . 0 N--CA 1.491 1.598 0 N-CA-C 108.316 -0.994 . . . . 0.0 108.316 . . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' C' C ' 703' ' ' PRO . . . . . 0.586 ' O ' ' NH2' ' A' ' 197' ' ' ARG . 64.8 Cg_endo -80.85 164.11 20.5 Favored 'Trans proline' 0 C--N 1.308 -1.584 0 C-N-CA 122.381 2.054 . . . . 0.0 113.119 -179.123 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' C' C ' 704' ' ' ALA . . . . . 0.462 ' O ' ' O ' ' C' ' 703' ' ' PRO . . . 51.9 173.73 0.01 OUTLIER 'General case' 0 N--CA 1.488 1.462 0 O-C-N 121.345 -0.847 . . . . 0.0 110.033 179.441 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' C' C ' 705' ' ' B27 . . . . . 0.563 ' OG1' ' NE1' ' A' ' 194' ' ' TRP . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 700' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 017 nuclear nobuild full ' A' A ' 59' ' ' MET . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 N--CA 1.491 1.597 0 N-CA-C 109.335 -0.617 . . . . 0.0 109.335 . . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 60' ' ' GLN . . . . . . . . . . . . . 1.8 mp0 -60.32 -170.23 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.044 -1.035 . . . . 0.0 109.922 -179.846 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . -62.2 154.07 28.51 Favored 'General case' 0 N--CA 1.488 1.443 0 O-C-N 121.351 -0.843 . . . . 0.0 109.265 179.87 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 62' ' ' LYS . . . . . . . . . . . . . 10.3 tttm -139.9 69.22 36.24 Favored Pre-proline 0 N--CA 1.491 1.583 0 C-N-CA 119.578 -0.849 . . . . 0.0 109.548 -179.547 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 63' ' ' PRO . . . . . . . . . . . . . 75.7 Cg_endo -81.23 148.63 16.81 Favored 'Trans proline' 0 C--N 1.303 -1.824 0 C-N-CA 123.455 2.77 . . . . 0.0 111.488 179.571 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 64' ' ' GLN . . . . . 0.635 HE21 ' C ' ' A' ' 64' ' ' GLN . 0.0 OUTLIER -156.31 117.53 3.83 Favored 'General case' 0 N--CA 1.496 1.87 0 O-C-N 121.118 -0.989 . . . . 0.0 109.39 179.664 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 65' ' ' ILE . . . . . 0.45 HD12 ' H ' ' A' ' 65' ' ' ILE . 3.2 mp -43.86 104.39 0.37 Allowed Pre-proline 0 N--CA 1.494 1.767 0 O-C-N 120.972 -1.08 . . . . 0.0 109.119 179.48 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 66' ' ' PRO . . . . . . . . . . . . . 83.8 Cg_endo -87.34 -158.81 0.09 OUTLIER 'Trans proline' 0 C--N 1.315 -1.23 0 C-N-CA 122.287 1.991 . . . . 0.0 112.651 -179.476 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 67' ' ' LYS . . . . . 0.467 ' CG ' ' O ' ' A' ' 67' ' ' LYS . 19.5 tttm -77.86 -6.87 55.65 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.306 -0.871 . . . . 0.0 108.7 179.516 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 68' ' ' ASP . . . . . 0.589 ' O ' ' N ' ' A' ' 70' ' ' SER . 3.6 t0 -76.5 48.04 0.52 Allowed 'General case' 0 N--CA 1.489 1.488 0 CA-C-O 122.237 1.018 . . . . 0.0 109.05 179.477 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 69' ' ' LYS . . . . . 0.456 ' C ' ' O ' ' A' ' 68' ' ' ASP . 9.5 ptpt -49.11 -14.57 0.08 Allowed 'General case' 0 N--CA 1.503 2.186 0 C-N-CA 116.845 -1.942 . . . . 0.0 106.863 178.234 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 70' ' ' SER . . . . . 0.589 ' N ' ' O ' ' A' ' 68' ' ' ASP . 1.8 t -82.85 -8.49 59.57 Favored 'General case' 0 N--CA 1.494 1.764 0 CA-C-N 113.629 -1.623 . . . . 0.0 110.15 179.958 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 71' ' ' LYS . . . . . 0.408 ' CD ' ' HB3' ' A' ' 68' ' ' ASP . 0.0 OUTLIER -97.54 145.93 25.76 Favored 'General case' 0 N--CA 1.492 1.665 0 O-C-N 120.981 -1.074 . . . . 0.0 109.929 179.109 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 72' ' ' VAL . . . . . 0.703 HG12 ' CE1' ' A' ' 88' ' ' TYR . 1.1 m -65.24 140.06 20.33 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.58 0 N-CA-C 105.046 -2.205 . . . . 0.0 105.046 174.853 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 73' ' ' ALA . . . . . 0.636 ' O ' HG23 ' A' ' 146' ' ' VAL . . . -80.64 -18.61 47.54 Favored 'General case' 0 C--N 1.291 -1.935 0 O-C-N 120.022 -1.674 . . . . 0.0 106.645 179.764 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 74' ' ' GLY . . . . . 0.453 ' O ' ' N ' ' A' ' 87' ' ' VAL . . . 176.16 -159.05 26.08 Favored Glycine 0 N--CA 1.483 1.796 0 N-CA-C 109.721 -1.352 . . . . 0.0 109.721 179.323 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 75' ' ' TYR . . . . . 0.551 ' HA ' HG23 ' A' ' 87' ' ' VAL . 92.1 m-85 -140.77 166.66 24.16 Favored 'General case' 0 C--N 1.299 -1.619 0 O-C-N 121.62 -0.929 . . . . 0.0 110.63 -177.268 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 76' ' ' ILE . . . . . . . . . . . . . 1.7 tt -147.71 143.39 19.64 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.551 0 C-N-CA 118.98 -1.088 . . . . 0.0 109.959 -178.189 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 77' ' ' GLU . . . . . 0.56 ' N ' ' CD ' ' A' ' 77' ' ' GLU . 2.3 mp0 -147.31 164.35 33.52 Favored 'General case' 0 N--CA 1.487 1.424 0 O-C-N 121.116 -0.99 . . . . 0.0 108.823 -179.831 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 78' ' ' ILE . . . . . 0.608 ' HB ' ' HB3' ' A' ' 81' ' ' ALA . 5.1 mt -147.5 93.39 4.62 Favored Pre-proline 0 N--CA 1.49 1.552 0 N-CA-C 108.181 -1.044 . . . . 0.0 108.181 179.674 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 79' ' ' PRO . . . . . . . . . . . . . 80.7 Cg_exo -46.87 -48.49 14.18 Favored 'Trans proline' 0 N--CA 1.494 1.527 0 C-N-CA 122.995 2.464 . . . . 0.0 114.098 -178.428 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -64.8 -18.98 65.58 Favored 'General case' 0 N--CA 1.494 1.73 0 O-C-N 120.868 -1.145 . . . . 0.0 110.749 178.968 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 81' ' ' ALA . . . . . 0.786 ' HB2' ' HB2' ' A' ' 136' ' ' ALA . . . -105.5 -17.49 14.4 Favored 'General case' 0 N--CA 1.492 1.663 0 O-C-N 121.176 -0.953 . . . . 0.0 108.488 179.207 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 82' ' ' ASP . . . . . 0.438 ' N ' ' O ' ' A' ' 78' ' ' ILE . 0.7 OUTLIER 67.93 51.12 0.78 Allowed 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.528 -0.732 . . . . 0.0 110.453 179.022 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 83' ' ' ILE . . . . . . . . . . . . . 70.8 mt -128.75 151.57 35.72 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.756 0 O-C-N 121.343 -0.848 . . . . 0.0 110.074 -178.768 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 84' ' ' LYS . . . . . 0.45 ' CG ' ' O ' ' A' ' 84' ' ' LYS . 7.7 pttt -158.37 107.86 2.03 Favored 'General case' 0 N--CA 1.494 1.757 0 N-CA-C 108.345 -0.984 . . . . 0.0 108.345 -179.923 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -142.34 166.12 23.1 Favored Pre-proline 0 N--CA 1.496 1.833 0 O-C-N 121.234 -0.916 . . . . 0.0 110.759 -179.064 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 86' ' ' PRO . . . . . . . . . . . . . 73.8 Cg_endo -77.35 166.35 26.25 Favored 'Trans proline' 0 N--CA 1.498 1.761 0 C-N-CA 123.333 2.689 . . . . 0.0 113.652 -179.225 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 87' ' ' VAL . . . . . 0.551 HG23 ' HA ' ' A' ' 75' ' ' TYR . 39.9 t -122.83 100.95 8.82 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.651 0 O-C-N 121.735 -0.603 . . . . 0.0 109.422 179.953 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 88' ' ' TYR . . . . . 0.703 ' CE1' HG12 ' A' ' 72' ' ' VAL . 7.5 m-85 -89.73 173.61 5.69 Favored Pre-proline 0 N--CA 1.499 2.005 0 O-C-N 120.946 -1.096 . . . . 0.0 109.468 -179.684 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 89' ' ' PRO . . . . . 0.434 ' HA ' ' CD2' ' A' ' 103' ' ' PHE . 9.4 Cg_endo -83.84 145.61 11.44 Favored 'Trans proline' 0 N--CA 1.484 0.96 0 C-N-CA 122.064 1.843 . . . . 0.0 113.898 -177.982 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . -55.97 164.41 4.8 Favored Glycine 0 N--CA 1.487 2.069 0 N-CA-C 109.081 -1.608 . . . . 0.0 109.081 179.133 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 91' ' ' PRO . . . . . 0.453 ' C ' ' H ' ' A' ' 93' ' ' THR . 58.0 Cg_endo -91.5 167.27 27.37 Favored 'Cis proline' 0 C--N 1.305 -1.747 0 C-N-CA 123.408 -1.497 . . . . 0.0 112.401 0.69 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 92' ' ' ALA . . . . . 0.551 ' HB3' ' HB2' ' C' ' 703' ' ' PRO . . . -73.21 30.52 0.07 Allowed 'General case' 0 C--N 1.303 -1.449 0 C-N-CA 119.887 -0.725 . . . . 0.0 110.091 -179.944 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 93' ' ' THR . . . . . 0.453 ' H ' ' C ' ' A' ' 91' ' ' PRO . 6.5 p -71.5 150.6 93.82 Favored Pre-proline 0 N--CA 1.489 1.493 0 O-C-N 121.034 -1.041 . . . . 0.0 108.847 -179.289 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 94' ' ' PRO . . . . . . . . . . . . . 77.8 Cg_exo -33.35 -49.03 0.45 Allowed 'Trans proline' 0 C--N 1.308 -1.562 0 C-N-CA 122.898 2.398 . . . . 0.0 112.385 -178.9 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 95' ' ' GLU . . . . . 0.596 ' O ' ' ND2' ' A' ' 98' ' ' ASN . 5.4 mp0 -49.83 -51.36 40.5 Favored 'General case' 0 C--N 1.3 -1.551 0 O-C-N 121.317 -0.865 . . . . 0.0 109.773 -179.838 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 96' ' ' GLN . . . . . 0.566 ' O ' ' N ' ' A' ' 98' ' ' ASN . 3.3 mp0 -72.32 -50.76 24.45 Favored 'General case' 0 N--CA 1.489 1.493 0 O-C-N 120.99 -1.069 . . . . 0.0 109.954 179.908 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 97' ' ' LEU . . . . . 0.627 ' CD2' ' CE1' ' A' ' 120' ' ' HIS . 1.3 mp -48.5 -8.75 0.02 OUTLIER 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.135 -0.978 . . . . 0.0 109.737 -179.786 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 98' ' ' ASN . . . . . 0.596 ' ND2' ' O ' ' A' ' 95' ' ' GLU . 0.4 OUTLIER -72.66 -28.01 62.46 Favored 'General case' 0 N--CA 1.489 1.479 0 O-C-N 121.379 -0.826 . . . . 0.0 109.346 179.868 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 99' ' ' ARG . . . . . 0.646 ' CG ' HH11 ' A' ' 99' ' ' ARG . 0.2 OUTLIER -96.17 -57.61 2.29 Favored 'General case' 0 N--CA 1.488 1.428 0 C-N-CA 119.79 -0.764 . . . . 0.0 110.186 -179.526 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . -170.2 -162.8 23.15 Favored Glycine 0 N--CA 1.493 2.468 0 C-N-CA 119.383 -1.389 . . . . 0.0 110.531 -179.934 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 101' ' ' VAL . . . . . 0.75 HG11 ' CZ ' ' A' ' 130' ' ' PHE . 13.7 m -64.58 106.27 0.57 Allowed 'Isoleucine or valine' 0 N--CA 1.496 1.845 0 O-C-N 121.698 -0.883 . . . . 0.0 109.351 -179.61 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -92.57 161.44 14.59 Favored 'General case' 0 N--CA 1.494 1.731 0 O-C-N 121.23 -0.919 . . . . 0.0 110.679 -179.55 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 103' ' ' PHE . . . . . 0.434 ' CD2' ' HA ' ' A' ' 89' ' ' PRO . 23.8 m-85 -63.6 150.42 44.14 Favored 'General case' 0 N--CA 1.489 1.48 0 N-CA-C 107.724 -1.213 . . . . 0.0 107.724 178.11 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 104' ' ' ALA . . . . . . . . . . . . . . . -69.71 -13.08 62.11 Favored 'General case' 0 N--CA 1.492 1.652 0 O-C-N 120.998 -1.064 . . . . 0.0 111.309 -178.504 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -136.3 142.01 43.87 Favored 'General case' 0 N--CA 1.498 1.97 0 O-C-N 120.841 -1.162 . . . . 0.0 110.803 -179.307 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 106' ' ' GLU . . . . . . . . . . . . . 2.3 tm-20 -51.89 -61.64 2.13 Favored 'General case' 0 N--CA 1.489 1.495 0 O-C-N 121.883 -0.511 . . . . 0.0 110.675 -179.556 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 107' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER -76.63 34.49 0.14 Allowed 'General case' 0 N--CA 1.489 1.52 0 O-C-N 120.698 -1.251 . . . . 0.0 112.251 -175.832 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 108' ' ' GLU . . . . . 0.488 ' OE2' HD13 ' A' ' 115' ' ' ILE . 29.6 tp10 -55.22 146.74 18.12 Favored 'General case' 0 C--N 1.303 -1.422 0 O-C-N 120.585 -1.322 . . . . 0.0 107.624 179.681 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 109' ' ' SER . . . . . 0.752 ' O ' HD11 ' A' ' 115' ' ' ILE . 0.3 OUTLIER -103.59 143.49 32.68 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 120.941 -1.099 . . . . 0.0 110.901 -178.038 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 110' ' ' LEU . . . . . 0.645 HD11 HG21 ' A' ' 146' ' ' VAL . 0.2 OUTLIER -64.47 -16.47 62.53 Favored 'General case' 0 C--N 1.303 -1.447 0 N-CA-C 108.884 -0.784 . . . . 0.0 108.884 179.217 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 111' ' ' ASP . . . . . . . . . . . . . 74.0 m-20 -132.97 35.99 3.51 Favored 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.248 -0.907 . . . . 0.0 110.298 -179.539 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 112' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -66.52 153.36 43.15 Favored 'General case' 0 N--CA 1.493 1.7 0 O-C-N 120.825 -1.172 . . . . 0.0 111.203 -179.673 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 113' ' ' GLN . . . . . 0.561 ' NE2' ' O ' ' A' ' 173' ' ' LYS . 0.0 OUTLIER -67.77 -13.78 62.41 Favored 'General case' 0 N--CA 1.494 1.755 0 CA-C-O 121.949 0.88 . . . . 0.0 109.537 178.677 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 114' ' ' ASN . . . . . 0.615 ' ND2' ' O ' ' A' ' 114' ' ' ASN . 0.3 OUTLIER -150.33 106.71 3.48 Favored 'General case' 0 C--N 1.298 -1.669 0 N-CA-C 107.205 -1.405 . . . . 0.0 107.205 179.477 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 115' ' ' ILE . . . . . 0.752 HD11 ' O ' ' A' ' 109' ' ' SER . 1.5 mm -94.23 104.52 15.86 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.737 0 O-C-N 120.534 -1.354 . . . . 0.0 108.823 -179.459 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 116' ' ' SER . . . . . . . . . . . . . 42.8 m -82.55 153.12 25.68 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.291 -0.881 . . . . 0.0 110.986 -178.182 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 117' ' ' ILE . . . . . 0.453 HG22 ' HB ' ' A' ' 101' ' ' VAL . 7.9 mt -151.13 147.12 15.8 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.437 0 N-CA-C 108.207 -1.034 . . . . 0.0 108.207 179.736 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 118' ' ' ALA . . . . . . . . . . . . . . . -144.89 160.97 40.45 Favored 'General case' 0 N--CA 1.491 1.582 0 C-N-CA 118.742 -1.183 . . . . 0.0 111.435 -179.948 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 119' ' ' GLY . . . . . . . . . . . . . . . -167.95 151.0 17.71 Favored Glycine 0 N--CA 1.485 1.939 0 N-CA-C 109.65 -1.38 . . . . 0.0 109.65 179.718 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 120' ' ' HIS . . . . . 0.627 ' CE1' ' CD2' ' A' ' 97' ' ' LEU . 3.9 m-70 -70.91 167.73 18.41 Favored 'General case' 0 N--CA 1.493 1.699 0 O-C-N 121.639 -0.918 . . . . 0.0 109.972 179.689 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 121' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -121.39 157.95 29.37 Favored 'General case' 0 N--CA 1.496 1.842 0 N-CA-C 108.363 -0.977 . . . . 0.0 108.363 178.954 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 122' ' ' PHE . . . . . 0.73 ' O ' HG21 ' A' ' 131' ' ' THR . 0.1 OUTLIER -140.66 121.97 14.92 Favored 'General case' 0 N--CA 1.498 1.934 0 O-C-N 120.927 -1.108 . . . . 0.0 110.31 -179.234 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 123' ' ' ILE . . . . . 0.502 HG23 ' N ' ' A' ' 124' ' ' ASP . 8.6 tt -59.44 -38.54 75.61 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.485 0 O-C-N 121.556 -0.715 . . . . 0.0 110.096 -179.884 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 124' ' ' ASP . . . . . 0.502 ' N ' HG23 ' A' ' 123' ' ' ILE . 0.1 OUTLIER -90.97 18.29 6.85 Favored 'General case' 0 N--CA 1.496 1.858 0 C-N-CA 119.659 -0.816 . . . . 0.0 111.988 -177.718 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 125' ' ' ARG . . . . . 0.443 HH11 ' CG ' ' A' ' 125' ' ' ARG . 0.3 OUTLIER -152.08 99.31 2.9 Favored Pre-proline 0 N--CA 1.493 1.706 0 O-C-N 120.521 -1.362 . . . . 0.0 109.719 -179.821 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 126' ' ' PRO . . . . . . . . . . . . . 58.4 Cg_endo -77.55 -19.03 13.31 Favored 'Trans proline' 0 N--CA 1.489 1.236 0 C-N-CA 122.061 1.841 . . . . 0.0 112.143 179.697 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 127' ' ' ASN . . . . . 0.489 ' O ' ' O ' ' A' ' 128' ' ' TYR . 0.7 OUTLIER -91.29 2.59 56.27 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.301 -0.874 . . . . 0.0 109.948 -179.811 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 128' ' ' TYR . . . . . 0.679 ' CE2' ' NE2' ' A' ' 129' ' ' GLN . 2.5 t80 -57.82 -148.83 0.0 OUTLIER 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.182 -0.949 . . . . 0.0 110.025 -179.657 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 129' ' ' GLN . . . . . 0.679 ' NE2' ' CE2' ' A' ' 128' ' ' TYR . 0.5 OUTLIER -65.39 -71.24 0.19 Allowed 'General case' 0 N--CA 1.493 1.703 0 O-C-N 121.316 -0.865 . . . . 0.0 109.871 -179.387 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 130' ' ' PHE . . . . . 0.75 ' CZ ' HG11 ' A' ' 101' ' ' VAL . 28.8 m-85 -135.16 39.78 2.91 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.288 -0.883 . . . . 0.0 109.808 -179.633 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 131' ' ' THR . . . . . 0.73 HG21 ' O ' ' A' ' 122' ' ' PHE . 60.5 m -74.94 -32.88 61.86 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.246 -0.909 . . . . 0.0 109.354 179.858 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 132' ' ' ASN . . . . . 0.552 ' ND2' ' O ' ' A' ' 81' ' ' ALA . 22.1 t30 -92.83 14.12 18.32 Favored 'General case' 0 N--CA 1.498 1.972 0 C-N-CA 119.698 -0.801 . . . . 0.0 111.63 -178.889 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 133' ' ' LEU . . . . . 0.774 HD13 ' HB3' ' A' ' 136' ' ' ALA . 0.2 OUTLIER -68.5 -26.98 65.73 Favored 'General case' 0 N--CA 1.496 1.875 0 O-C-N 120.582 -1.324 . . . . 0.0 109.429 -179.92 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 134' ' ' LYS . . . . . 0.68 ' CD ' ' H ' ' A' ' 134' ' ' LYS . 0.0 OUTLIER -46.14 -28.71 1.29 Allowed 'General case' 0 N--CA 1.495 1.817 0 O-C-N 121.401 -0.812 . . . . 0.0 110.937 -179.176 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 135' ' ' ALA . . . . . . . . . . . . . . . -83.37 -22.61 32.74 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 120.758 -1.214 . . . . 0.0 109.954 -179.189 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 136' ' ' ALA . . . . . 0.786 ' HB2' ' HB2' ' A' ' 81' ' ' ALA . . . -79.79 138.02 37.14 Favored 'General case' 0 C--N 1.3 -1.559 0 O-C-N 121.29 -0.881 . . . . 0.0 111.405 -178.897 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 137' ' ' LYS . . . . . 0.554 ' O ' ' O ' ' A' ' 138' ' ' LYS . 6.3 mttt -151.46 -170.26 3.6 Favored 'General case' 0 N--CA 1.494 1.77 0 C-N-CA 118.639 -1.225 . . . . 0.0 111.221 -178.231 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 138' ' ' LYS . . . . . 0.554 ' O ' ' O ' ' A' ' 137' ' ' LYS . 15.4 tttt -32.55 163.96 0.0 OUTLIER 'General case' 0 N--CA 1.492 1.653 0 CA-C-O 122.902 1.334 . . . . 0.0 112.342 -178.204 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 139' ' ' GLY . . . . . . . . . . . . . . . 49.68 8.73 0.14 Allowed Glycine 0 N--CA 1.491 2.317 0 N-CA-C 110.146 -1.182 . . . . 0.0 110.146 179.78 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 140' ' ' SER . . . . . 0.491 ' N ' ' O ' ' A' ' 138' ' ' LYS . 2.0 m -69.33 130.01 41.39 Favored 'General case' 0 N--CA 1.495 1.812 0 O-C-N 120.803 -1.41 . . . . 0.0 109.194 179.539 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 141' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -83.78 123.17 29.6 Favored 'General case' 0 N--CA 1.489 1.498 0 O-C-N 121.224 -0.923 . . . . 0.0 109.214 179.743 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 142' ' ' VAL . . . . . . . . . . . . . 2.4 t -112.99 132.12 62.7 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.576 0 N-CA-C 108.069 -1.086 . . . . 0.0 108.069 179.75 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 143' ' ' TYR . . . . . . . . . . . . . 5.3 m-85 -108.65 134.24 51.65 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.025 -1.047 . . . . 0.0 110.897 -178.42 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 144' ' ' PHE . . . . . . . . . . . . . 44.8 t80 -120.13 102.62 8.64 Favored 'General case' 0 N--CA 1.489 1.524 0 N-CA-C 109.056 -0.72 . . . . 0.0 109.056 179.633 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 145' ' ' LYS . . . . . . . . . . . . . 25.2 tttm -100.21 129.99 46.29 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.319 -0.863 . . . . 0.0 110.868 -179.008 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 146' ' ' VAL . . . . . 0.645 HG21 HD11 ' A' ' 110' ' ' LEU . 6.8 p -142.43 146.51 22.2 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.566 0 N-CA-C 107.805 -1.183 . . . . 0.0 107.805 178.415 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 147' ' ' GLY . . . . . 0.441 ' C ' ' O ' ' A' ' 146' ' ' VAL . . . 42.61 -124.08 3.84 Favored Glycine 0 N--CA 1.491 2.355 0 N-CA-C 109.336 -1.506 . . . . 0.0 109.336 -179.795 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 148' ' ' ASN . . . . . 0.513 ' C ' ' ND2' ' A' ' 148' ' ' ASN . 0.4 OUTLIER -108.36 15.62 23.84 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.483 -1.01 . . . . 0.0 109.041 179.393 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 149' ' ' GLU . . . . . . . . . . . . . 8.7 tt0 -112.28 144.02 42.4 Favored 'General case' 0 N--CA 1.489 1.479 0 O-C-N 121.388 -0.82 . . . . 0.0 111.444 -178.288 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 150' ' ' THR . . . . . . . . . . . . . 29.9 m -127.25 104.12 7.78 Favored 'General case' 0 N--CA 1.49 1.541 0 CA-C-O 121.373 0.606 . . . . 0.0 109.6 179.561 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 151' ' ' ARG . . . . . . . . . . . . . 15.4 mtp180 -88.17 -173.1 4.08 Favored 'General case' 0 C--N 1.301 -1.513 0 N-CA-C 107.748 -1.204 . . . . 0.0 107.748 179.357 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 152' ' ' LYS . . . . . 0.491 ' O ' ' N ' ' A' ' 205' ' ' VAL . 15.4 mtmm -149.15 150.74 33.17 Favored 'General case' 0 C--N 1.298 -1.67 0 O-C-N 120.811 -1.181 . . . . 0.0 109.728 -179.678 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 153' ' ' TYR . . . . . 0.527 ' CD2' ' HA ' ' A' ' 204' ' ' GLU . 27.6 m-85 -142.97 164.47 29.99 Favored 'General case' 0 C--N 1.297 -1.697 0 N-CA-C 107.695 -1.224 . . . . 0.0 107.695 178.69 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 154' ' ' LYS . . . . . 0.525 ' HB2' HG21 ' A' ' 205' ' ' VAL . 26.2 ttpp -140.31 118.01 11.64 Favored 'General case' 0 C--N 1.296 -1.745 0 N-CA-C 108.308 -0.997 . . . . 0.0 108.308 179.499 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 155' ' ' MET . . . . . . . . . . . . . 36.8 mtp -44.95 109.09 0.14 Allowed 'General case' 0 N--CA 1.497 1.895 0 O-C-N 120.507 -1.371 . . . . 0.0 111.344 -178.307 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 156' ' ' THR . . . . . 0.677 ' OG1' HG23 ' A' ' 203' ' ' THR . 0.2 OUTLIER -107.59 -26.79 10.72 Favored 'General case' 0 C--N 1.298 -1.645 0 CA-C-N 115.452 -0.794 . . . . 0.0 110.893 -178.858 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 157' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -154.03 153.33 31.75 Favored 'General case' 0 N--CA 1.5 2.044 0 C-N-CA 118.171 -1.411 . . . . 0.0 111.903 -178.334 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 158' ' ' ILE . . . . . 0.867 HD12 ' CD1' ' A' ' 200' ' ' PHE . 0.2 OUTLIER -154.49 146.91 13.61 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.425 0 CA-C-O 122.068 0.937 . . . . 0.0 111.383 -178.946 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 159' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -153.35 158.48 41.6 Favored 'General case' 0 C--N 1.299 -1.612 0 CA-C-O 121.707 0.765 . . . . 0.0 109.86 179.834 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 160' ' ' ASP . . . . . 0.478 ' O ' HG13 ' A' ' 161' ' ' VAL . 7.9 m-20 -116.52 156.46 26.87 Favored 'General case' 0 N--CA 1.491 1.597 0 N-CA-C 108.081 -1.081 . . . . 0.0 108.081 179.254 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 161' ' ' VAL . . . . . 0.486 ' O ' ' O ' ' A' ' 162' ' ' LYS . 14.8 m -155.35 154.25 6.93 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.921 0 O-C-N 120.841 -1.162 . . . . 0.0 111.357 -178.507 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 162' ' ' LYS . . . . . 0.486 ' O ' ' O ' ' A' ' 161' ' ' VAL . 0.0 OUTLIER -43.25 170.46 0.04 OUTLIER Pre-proline 0 N--CA 1.495 1.799 0 O-C-N 121.555 -0.716 . . . . 0.0 109.986 179.651 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 163' ' ' PRO . . . . . . . . . . . . . 65.2 Cg_endo -79.56 30.9 0.47 Allowed 'Trans proline' 0 N--CA 1.492 1.408 0 C-N-CA 122.904 2.403 . . . . 0.0 113.071 179.82 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 164' ' ' THR . . . . . 0.586 ' HA ' HD11 ' C' ' 702' ' ' LEU . 0.2 OUTLIER -151.02 0.31 0.39 Allowed 'General case' 0 N--CA 1.495 1.789 0 O-C-N 121.064 -1.022 . . . . 0.0 110.11 -179.968 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 165' ' ' ASP . . . . . 0.438 ' O ' ' C ' ' A' ' 166' ' ' VAL . 13.0 t70 -75.46 63.9 1.53 Allowed 'General case' 0 N--CA 1.489 1.491 0 O-C-N 121.251 -0.906 . . . . 0.0 110.362 -179.749 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 166' ' ' VAL . . . . . 0.685 ' O ' ' N ' ' A' ' 168' ' ' VAL . 1.0 OUTLIER -39.73 -31.12 0.15 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.517 0 O-C-N 121.14 -0.975 . . . . 0.0 109.79 -178.668 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 167' ' ' GLY . . . . . 0.428 ' N ' ' O ' ' A' ' 165' ' ' ASP . . . -41.48 -12.01 0.01 OUTLIER Glycine 0 N--CA 1.496 2.652 0 N-CA-C 110.288 -1.125 . . . . 0.0 110.288 -179.94 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 168' ' ' VAL . . . . . 0.685 ' N ' ' O ' ' A' ' 166' ' ' VAL . 3.5 t -49.03 -42.52 14.56 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.432 0 O-C-N 121.121 -1.223 . . . . 0.0 108.841 179.235 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 169' ' ' LEU . . . . . 0.551 ' O ' ' C ' ' A' ' 170' ' ' ASP . 10.8 mt -46.84 -14.71 0.03 OUTLIER 'General case' 0 N--CA 1.491 1.601 0 N-CA-C 108.444 -0.947 . . . . 0.0 108.444 -178.274 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 170' ' ' ASP . . . . . 0.555 ' N ' ' O ' ' A' ' 168' ' ' VAL . 32.7 p30 17.78 91.26 0.01 OUTLIER 'General case' 0 N--CA 1.505 2.319 0 N-CA-C 111.927 0.343 . . . . 0.0 111.927 177.206 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 171' ' ' GLU . . . . . 0.701 ' H ' HE21 ' A' ' 172' ' ' GLN . 3.0 pt-20 -141.48 78.79 1.65 Allowed 'General case' 0 N--CA 1.494 1.733 0 O-C-N 120.732 -1.23 . . . . 0.0 110.272 179.965 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 172' ' ' GLN . . . . . 0.701 HE21 ' H ' ' A' ' 171' ' ' GLU . 32.3 mm-40 -130.13 -47.51 1.11 Allowed 'General case' 0 N--CA 1.499 2.002 0 O-C-N 121.282 -0.886 . . . . 0.0 110.967 -178.788 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 173' ' ' LYS . . . . . 0.561 ' O ' ' NE2' ' A' ' 113' ' ' GLN . 0.0 OUTLIER -60.48 137.85 58.1 Favored 'General case' 0 N--CA 1.498 1.967 0 O-C-N 120.894 -1.129 . . . . 0.0 109.064 -179.894 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 174' ' ' GLY . . . . . 0.533 ' O ' ' C ' ' A' ' 175' ' ' LYS . . . -122.93 -44.09 0.34 Allowed Glycine 0 N--CA 1.481 1.648 0 N-CA-C 108.093 -2.003 . . . . 0.0 108.093 179.547 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 175' ' ' LYS . . . . . 0.533 ' C ' ' O ' ' A' ' 174' ' ' GLY . 3.0 mmtt -40.48 -63.87 0.58 Allowed 'General case' 0 N--CA 1.491 1.59 0 N-CA-C 107.072 -1.455 . . . . 0.0 107.072 178.725 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 176' ' ' ASP . . . . . 0.589 ' O ' ' O ' ' A' ' 177' ' ' LYS . 1.2 p-10 -104.7 88.18 2.86 Favored 'General case' 0 C--N 1.299 -1.614 0 N-CA-C 108.207 -1.035 . . . . 0.0 108.207 177.428 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 177' ' ' LYS . . . . . 0.589 ' O ' ' O ' ' A' ' 176' ' ' ASP . 23.6 mttm -47.32 -174.19 0.0 OUTLIER 'General case' 0 N--CA 1.499 1.978 0 N-CA-C 108.793 -0.817 . . . . 0.0 108.793 179.936 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 178' ' ' GLN . . . . . 0.55 HE22 ' HG1' ' A' ' 180' ' ' THR . 0.0 OUTLIER -162.59 167.28 23.53 Favored 'General case' 0 C--N 1.303 -1.419 0 O-C-N 120.267 -1.521 . . . . 0.0 110.862 179.626 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 179' ' ' LEU . . . . . 0.419 ' HB2' ' CD2' ' A' ' 153' ' ' TYR . 0.9 OUTLIER -119.03 98.03 5.98 Favored 'General case' 0 C--N 1.304 -1.408 0 N-CA-C 107.028 -1.471 . . . . 0.0 107.028 177.976 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 180' ' ' THR . . . . . 0.55 ' HG1' HE22 ' A' ' 178' ' ' GLN . 1.3 m -76.98 116.13 17.38 Favored 'General case' 0 C--N 1.302 -1.488 0 O-C-N 121.411 -0.806 . . . . 0.0 110.205 -178.449 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 181' ' ' LEU . . . . . 0.525 HD23 ' CD2' ' A' ' 200' ' ' PHE . 54.4 tp -93.78 152.08 19.17 Favored 'General case' 0 C--N 1.301 -1.537 0 N-CA-C 107.774 -1.195 . . . . 0.0 107.774 177.715 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 182' ' ' ILE . . . . . . . . . . . . . 85.4 mt -141.07 117.88 7.81 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.713 0 O-C-N 121.009 -1.057 . . . . 0.0 108.687 179.247 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 183' ' ' THR . . . . . 0.604 HG23 ' O ' ' A' ' 183' ' ' THR . 10.1 t -131.12 111.44 11.98 Favored 'General case' 0 C--N 1.292 -1.908 0 N-CA-C 108.039 -1.097 . . . . 0.0 108.039 179.485 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 184' ' ' CYS . . . . . . . . . . . . . 0.8 OUTLIER -78.46 153.06 31.76 Favored 'General case' 0 C--N 1.289 -2.044 0 C-N-CA 118.882 -1.127 . . . . 0.0 110.583 -177.977 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 185' ' ' ASP . . . . . . . . . . . . . 2.5 t0 -166.1 -159.13 0.37 Allowed 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.616 -0.677 . . . . 0.0 109.504 -179.447 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 186' ' ' ASP . . . . . . . . . . . . . 1.2 m-20 55.79 52.78 10.28 Favored 'General case' 0 N--CA 1.493 1.717 0 O-C-N 121.233 -0.917 . . . . 0.0 109.453 179.977 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 187' ' ' TYR . . . . . 0.628 ' CE2' ' O ' ' A' ' 188' ' ' ASN . 64.5 t80 -67.96 134.18 50.32 Favored 'General case' 0 C--N 1.3 -1.551 0 O-C-N 121.063 -1.023 . . . . 0.0 110.949 -179.508 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 188' ' ' ASN . . . . . 0.628 ' O ' ' CE2' ' A' ' 187' ' ' TYR . 0.7 OUTLIER -101.46 146.46 27.59 Favored 'General case' 0 C--N 1.295 -1.766 0 N-CA-C 108.091 -1.077 . . . . 0.0 108.091 178.201 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 189' ' ' GLU . . . . . . . . . . . . . 3.1 tt0 -109.65 -12.17 14.68 Favored 'General case' 0 C--N 1.292 -1.923 0 N-CA-C 108.458 -0.942 . . . . 0.0 108.458 -179.793 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 190' ' ' LYS . . . . . . . . . . . . . 11.7 mtpt -85.75 -55.03 4.17 Favored 'General case' 0 C--N 1.302 -1.469 0 N-CA-C 109.079 -0.712 . . . . 0.0 109.079 178.908 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 191' ' ' THR . . . . . . . . . . . . . 1.2 p -89.55 1.59 55.74 Favored 'General case' 0 N--CA 1.494 1.729 0 O-C-N 121.236 -0.915 . . . . 0.0 110.073 -179.754 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 192' ' ' GLY . . . . . . . . . . . . . . . 52.78 40.89 57.27 Favored Glycine 0 N--CA 1.496 2.644 0 O-C-N 120.97 -1.081 . . . . 0.0 110.969 179.169 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 193' ' ' VAL . . . . . 0.537 HG12 ' N ' ' A' ' 194' ' ' TRP . 52.9 t -149.65 160.5 5.01 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.653 0 O-C-N 120.858 -1.377 . . . . 0.0 109.356 178.999 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 194' ' ' TRP . . . . . 0.537 ' N ' HG12 ' A' ' 193' ' ' VAL . 12.7 m95 -82.94 118.98 23.86 Favored 'General case' 0 N--CA 1.491 1.586 0 N-CA-C 107.989 -1.115 . . . . 0.0 107.989 179.308 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 195' ' ' GLU . . . . . . . . . . . . . 2.1 mt-10 -75.88 -60.46 2.31 Favored 'General case' 0 N--CA 1.494 1.769 0 O-C-N 121.336 -0.853 . . . . 0.0 111.538 -177.745 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 196' ' ' LYS . . . . . . . . . . . . . 16.8 mmtp -92.01 153.18 19.6 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 120.901 -1.124 . . . . 0.0 111.262 -178.047 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 197' ' ' ARG . . . . . 0.47 ' NE ' HD22 ' C' ' 702' ' ' LEU . 21.5 mmm180 -119.17 138.97 52.58 Favored 'General case' 0 N--CA 1.488 1.471 0 N-CA-C 107.825 -1.176 . . . . 0.0 107.825 178.659 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 198' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -116.77 116.68 27.95 Favored 'General case' 0 C--N 1.301 -1.519 0 O-C-N 121.61 -0.681 . . . . 0.0 110.192 -178.715 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 199' ' ' ILE . . . . . 0.632 ' C ' HD12 ' A' ' 199' ' ' ILE . 0.6 OUTLIER -141.18 122.26 13.4 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.685 0 CA-C-O 122.338 1.066 . . . . 0.0 109.842 179.456 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 200' ' ' PHE . . . . . 0.867 ' CD1' HD12 ' A' ' 158' ' ' ILE . 0.2 OUTLIER -106.33 142.1 36.56 Favored 'General case' 0 N--CA 1.494 1.769 0 O-C-N 121.438 -0.789 . . . . 0.0 110.318 -178.55 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 201' ' ' VAL . . . . . . . . . . . . . 47.6 t -104.45 150.11 7.66 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.532 0 N-CA-C 108.476 -0.935 . . . . 0.0 108.476 178.555 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 202' ' ' ALA . . . . . . . . . . . . . . . -131.37 139.38 49.47 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.246 -0.909 . . . . 0.0 109.035 -179.802 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 203' ' ' THR . . . . . 0.677 HG23 ' OG1' ' A' ' 156' ' ' THR . 25.1 p -88.86 127.46 35.63 Favored 'General case' 0 C--N 1.303 -1.452 0 CA-C-O 122.354 1.073 . . . . 0.0 110.917 -178.57 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 204' ' ' GLU . . . . . 0.527 ' HA ' ' CD2' ' A' ' 153' ' ' TYR . 1.7 tt0 -48.75 134.35 16.34 Favored 'General case' 0 C--N 1.297 -1.713 0 C-N-CA 118.873 -1.131 . . . . 0.0 109.248 179.83 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 205' ' ' VAL . . . . . 0.603 HG23 ' O ' ' A' ' 203' ' ' THR . 72.7 t -126.54 163.6 28.44 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.361 0 CA-C-O 122.141 0.972 . . . . 0.0 110.039 -177.674 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 206' ' ' LYS . . . . . 0.558 ' N ' HG12 ' A' ' 205' ' ' VAL . 0.2 OUTLIER . . . . . 0 C--N 1.291 -1.949 0 CA-C-O 118.024 -0.989 . . . . 0.0 109.45 -179.981 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' C' C ' 701' ' ' PHQ . . . . . 0.568 ' O2 ' HG12 ' A' ' 166' ' ' VAL . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' C' C ' 702' ' ' LEU . . . . . 0.852 ' N ' HD12 ' C' ' 702' ' ' LEU . 0.0 OUTLIER . . . . . 0 N--CA 1.489 1.511 0 N-CA-C 109.303 -0.628 . . . . 0.0 109.303 . . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' C' C ' 703' ' ' PRO . . . . . 0.551 ' HB2' ' HB3' ' A' ' 92' ' ' ALA . 96.9 Cg_endo -79.79 -174.44 2.27 Favored 'Trans proline' 0 N--CA 1.495 1.612 0 C-N-CA 122.94 2.427 . . . . 0.0 113.524 -179.418 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' C' C ' 704' ' ' ALA . . . . . 0.495 ' O ' ' O ' ' C' ' 703' ' ' PRO . . . 39.4 -165.39 0.0 OUTLIER 'General case' 0 N--CA 1.491 1.579 0 CA-C-O 121.744 0.783 . . . . 0.0 110.544 179.076 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' C' C ' 705' ' ' B27 . . . . . 0.521 ' SG ' ' ND1' ' A' ' 120' ' ' HIS . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 700' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 018 nuclear nobuild full ' A' A ' 59' ' ' MET . . . . . . . . . . . . . 8.9 mmt . . . . . 0 N--CA 1.49 1.529 0 N-CA-C 109.406 -0.59 . . . . 0.0 109.406 . . . . . . . . . 0 0 . 1 . 018 nuclear nobuild full ' A' A ' 60' ' ' GLN . . . . . 0.731 ' NE2' ' H ' ' A' ' 61' ' ' ALA . 0.1 OUTLIER -61.34 160.19 11.18 Favored 'General case' 0 N--CA 1.493 1.693 0 O-C-N 121.367 -0.833 . . . . 0.0 109.644 179.92 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 61' ' ' ALA . . . . . 0.731 ' H ' ' NE2' ' A' ' 60' ' ' GLN . . . -65.18 169.61 5.41 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.057 -1.027 . . . . 0.0 109.143 179.522 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 62' ' ' LYS . . . . . . . . . . . . . 64.9 tttt -147.24 86.1 6.59 Favored Pre-proline 0 C--N 1.303 -1.417 0 O-C-N 121.184 -0.947 . . . . 0.0 109.535 -179.677 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 63' ' ' PRO . . . . . 0.629 ' O ' HD13 ' A' ' 110' ' ' LEU . 5.3 Cg_exo -71.95 130.1 16.23 Favored 'Trans proline' 0 C--N 1.307 -1.626 0 C-N-CA 122.483 2.122 . . . . 0.0 112.269 -179.891 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 64' ' ' GLN . . . . . 0.755 ' N ' HE21 ' A' ' 64' ' ' GLN . 0.0 OUTLIER -150.34 101.75 3.0 Favored 'General case' 0 N--CA 1.494 1.732 0 O-C-N 121.205 -0.935 . . . . 0.0 109.618 -179.891 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 65' ' ' ILE . . . . . 0.471 ' C ' ' O ' ' A' ' 64' ' ' GLN . 2.8 mp -39.79 100.83 0.22 Allowed Pre-proline 0 N--CA 1.491 1.603 0 N-CA-C 108.557 -0.905 . . . . 0.0 108.557 179.523 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 66' ' ' PRO . . . . . 0.423 ' N ' ' O ' ' A' ' 64' ' ' GLN . 71.8 Cg_endo -83.87 -155.32 0.06 OUTLIER 'Trans proline' 0 C--N 1.317 -1.118 0 C-N-CA 122.286 1.991 . . . . 0.0 112.679 -178.311 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 67' ' ' LYS . . . . . 0.404 ' O ' ' N ' ' A' ' 69' ' ' LYS . 8.5 ptmt -83.93 -4.94 59.08 Favored 'General case' 0 C--N 1.304 -1.371 0 O-C-N 121.391 -0.818 . . . . 0.0 109.388 -179.825 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 68' ' ' ASP . . . . . 0.588 ' C ' ' N ' ' A' ' 70' ' ' SER . 0.1 OUTLIER -73.82 51.47 0.38 Allowed 'General case' 0 N--CA 1.491 1.58 0 CA-C-O 122.566 1.174 . . . . 0.0 108.326 179.52 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 69' ' ' LYS . . . . . 0.598 ' O ' ' NH1' ' A' ' 99' ' ' ARG . 12.0 mtmm -49.49 -16.11 0.19 Allowed 'General case' 0 N--CA 1.497 1.888 0 C-N-CA 116.949 -1.9 . . . . 0.0 107.152 178.857 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 70' ' ' SER . . . . . 0.588 ' N ' ' C ' ' A' ' 68' ' ' ASP . 1.2 t -83.94 -7.16 59.49 Favored 'General case' 0 C--N 1.293 -1.89 0 CA-C-N 113.995 -1.457 . . . . 0.0 110.22 179.976 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 71' ' ' LYS . . . . . 0.413 ' CD ' ' HB2' ' A' ' 68' ' ' ASP . 1.0 OUTLIER -96.84 141.41 30.07 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.126 -0.984 . . . . 0.0 110.826 179.825 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 72' ' ' VAL . . . . . 0.825 HG12 ' CE1' ' A' ' 88' ' ' TYR . 2.3 m -65.01 139.62 21.1 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.522 0 N-CA-C 103.988 -2.597 . . . . 0.0 103.988 174.361 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 73' ' ' ALA . . . . . 0.511 ' N ' ' O ' ' A' ' 87' ' ' VAL . . . -81.21 -14.18 57.8 Favored 'General case' 0 C--N 1.292 -1.917 0 C-N-CA 117.11 -1.836 . . . . 0.0 106.203 179.799 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . 169.07 -152.04 19.12 Favored Glycine 0 N--CA 1.481 1.677 0 N-CA-C 109.873 -1.291 . . . . 0.0 109.873 178.868 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 75' ' ' TYR . . . . . 0.468 ' CD2' ' O ' ' A' ' 85' ' ' GLU . 2.3 m-85 -142.59 173.25 11.7 Favored 'General case' 0 C--N 1.298 -1.639 0 CA-C-O 122.085 0.945 . . . . 0.0 110.545 -178.118 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 76' ' ' ILE . . . . . . . . . . . . . 1.6 tp -147.9 141.88 19.3 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.682 0 C-N-CA 119.93 -0.708 . . . . 0.0 109.142 -176.954 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 77' ' ' GLU . . . . . 0.563 ' N ' ' OE1' ' A' ' 77' ' ' GLU . 0.0 OUTLIER -149.96 163.07 39.08 Favored 'General case' 0 C--N 1.304 -1.39 0 O-C-N 121.014 -1.054 . . . . 0.0 109.244 178.913 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 78' ' ' ILE . . . . . 0.694 ' HB ' ' HB3' ' A' ' 81' ' ' ALA . 7.9 mt -144.35 100.57 4.82 Favored Pre-proline 0 C--N 1.302 -1.496 0 O-C-N 121.338 -0.851 . . . . 0.0 109.022 179.991 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 79' ' ' PRO . . . . . . . . . . . . . 81.9 Cg_exo -48.25 -50.55 11.84 Favored 'Trans proline' 0 N--CA 1.493 1.469 0 C-N-CA 122.794 2.329 . . . . 0.0 113.632 -179.453 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -65.94 -18.93 65.67 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 120.889 -1.132 . . . . 0.0 111.098 178.906 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 81' ' ' ALA . . . . . 0.813 ' HB2' ' HB2' ' A' ' 136' ' ' ALA . . . -105.32 -16.93 14.62 Favored 'General case' 0 N--CA 1.494 1.734 0 O-C-N 121.069 -1.019 . . . . 0.0 108.81 179.521 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 82' ' ' ASP . . . . . 0.495 ' N ' ' O ' ' A' ' 78' ' ' ILE . 9.1 t0 65.81 50.47 1.54 Allowed 'General case' 0 N--CA 1.493 1.704 0 O-C-N 121.372 -0.83 . . . . 0.0 111.368 178.157 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 83' ' ' ILE . . . . . . . . . . . . . 45.2 mt -130.66 153.94 39.86 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.92 0 O-C-N 121.14 -0.975 . . . . 0.0 109.668 -179.273 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 84' ' ' LYS . . . . . . . . . . . . . 30.8 ttmt -158.01 110.25 2.33 Favored 'General case' 0 N--CA 1.497 1.88 0 N-CA-C 108.184 -1.043 . . . . 0.0 108.184 179.991 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 85' ' ' GLU . . . . . 0.497 ' OE1' ' O ' ' A' ' 129' ' ' GLN . 0.0 OUTLIER -141.33 167.2 17.92 Favored Pre-proline 0 N--CA 1.499 1.976 0 O-C-N 121.281 -0.887 . . . . 0.0 110.871 -178.45 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 86' ' ' PRO . . . . . 0.485 ' O ' HG22 ' A' ' 101' ' ' VAL . 55.8 Cg_endo -74.75 161.92 38.53 Favored 'Trans proline' 0 N--CA 1.497 1.722 0 C-N-CA 123.263 2.642 . . . . 0.0 113.108 -179.869 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 87' ' ' VAL . . . . . 0.511 ' O ' ' N ' ' A' ' 73' ' ' ALA . 55.7 t -123.32 99.79 7.09 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.844 0 O-C-N 121.686 -0.634 . . . . 0.0 109.337 179.582 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 88' ' ' TYR . . . . . 0.825 ' CE1' HG12 ' A' ' 72' ' ' VAL . 15.3 m-85 -89.99 155.1 47.56 Favored Pre-proline 0 N--CA 1.496 1.849 0 O-C-N 120.835 -1.166 . . . . 0.0 109.423 179.861 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 89' ' ' PRO . . . . . . . . . . . . . 11.8 Cg_endo -64.39 146.66 90.12 Favored 'Trans proline' 0 N--CA 1.496 1.642 0 C-N-CA 122.529 2.152 . . . . 0.0 113.952 -179.343 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . -59.04 167.59 7.06 Favored Glycine 0 N--CA 1.495 2.609 0 N-CA-C 110.382 -1.087 . . . . 0.0 110.382 179.663 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 91' ' ' PRO . . . . . 0.428 ' C ' ' H ' ' A' ' 93' ' ' THR . 90.2 Cg_endo -93.48 168.68 20.81 Favored 'Cis proline' 0 C--N 1.314 -1.237 0 C-N-CA 123.592 -1.42 . . . . 0.0 111.762 0.569 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 92' ' ' ALA . . . . . 0.543 ' HB1' HD21 ' A' ' 97' ' ' LEU . . . -72.03 33.04 0.06 Allowed 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.032 -1.042 . . . . 0.0 110.713 -179.9 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 93' ' ' THR . . . . . 0.428 ' H ' ' C ' ' A' ' 91' ' ' PRO . 3.3 p -71.18 150.39 94.54 Favored Pre-proline 0 N--CA 1.488 1.472 0 O-C-N 120.668 -1.27 . . . . 0.0 108.157 -179.865 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 94' ' ' PRO . . . . . 0.421 ' C ' ' O ' ' A' ' 93' ' ' THR . 87.3 Cg_exo -30.35 -56.26 0.19 Allowed 'Trans proline' 0 C--N 1.308 -1.6 0 C-N-CA 123.007 2.471 . . . . 0.0 112.672 -179.011 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 98.6 mt-10 -51.06 -46.32 61.67 Favored 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.12 -0.988 . . . . 0.0 109.825 -179.76 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 96' ' ' GLN . . . . . 0.422 ' OE1' ' CZ ' ' A' ' 99' ' ' ARG . 1.1 mp0 -71.92 -36.95 70.1 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.387 -0.821 . . . . 0.0 110.712 -179.375 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 97' ' ' LEU . . . . . 0.543 HD21 ' HB1' ' A' ' 92' ' ' ALA . 89.0 mt -68.4 -5.94 21.85 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 120.833 -1.167 . . . . 0.0 109.248 -179.682 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 98' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER -78.24 -27.05 47.53 Favored 'General case' 0 N--CA 1.492 1.673 0 O-C-N 121.319 -0.863 . . . . 0.0 109.893 179.42 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 99' ' ' ARG . . . . . 0.598 ' NH1' ' O ' ' A' ' 69' ' ' LYS . 63.8 mtt180 -91.07 -43.5 9.88 Favored 'General case' 0 N--CA 1.488 1.47 0 O-C-N 121.531 -0.731 . . . . 0.0 109.956 -178.524 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . 169.81 -171.7 43.43 Favored Glycine 0 N--CA 1.49 2.28 0 N-CA-C 109.898 -1.281 . . . . 0.0 109.898 -179.992 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 101' ' ' VAL . . . . . 0.742 ' O ' HG23 ' A' ' 101' ' ' VAL . 13.0 m -57.48 106.63 0.18 Allowed 'Isoleucine or valine' 0 N--CA 1.494 1.758 0 O-C-N 121.401 -1.058 . . . . 0.0 109.152 -179.915 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -92.52 163.31 13.86 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 120.87 -1.144 . . . . 0.0 111.184 -179.176 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 103' ' ' PHE . . . . . 0.484 ' CZ ' ' CG1' ' A' ' 87' ' ' VAL . 25.0 m-85 -70.46 141.85 52.0 Favored 'General case' 0 N--CA 1.489 1.501 0 N-CA-C 108.145 -1.057 . . . . 0.0 108.145 178.334 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 104' ' ' ALA . . . . . . . . . . . . . . . -58.73 -15.86 14.0 Favored 'General case' 0 C--N 1.3 -1.548 0 O-C-N 121.474 -0.766 . . . . 0.0 111.104 -178.828 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -139.07 144.24 38.68 Favored 'General case' 0 N--CA 1.492 1.65 0 O-C-N 120.906 -1.121 . . . . 0.0 110.082 -179.304 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 106' ' ' GLU . . . . . . . . . . . . . 6.3 tt0 -58.1 -55.43 35.04 Favored 'General case' 0 C--N 1.299 -1.618 0 O-C-N 121.892 -0.505 . . . . 0.0 110.599 -179.363 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 107' ' ' ASN . . . . . 0.498 ' N ' ' ND2' ' A' ' 107' ' ' ASN . 1.8 m120 -77.85 35.15 0.2 Allowed 'General case' 0 N--CA 1.487 1.395 0 O-C-N 120.622 -1.299 . . . . 0.0 112.223 -176.152 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 108' ' ' GLU . . . . . . . . . . . . . 21.7 tp10 -57.81 139.82 53.15 Favored 'General case' 0 N--CA 1.488 1.457 0 N-CA-C 107.605 -1.257 . . . . 0.0 107.605 179.635 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 109' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -93.08 146.53 23.57 Favored 'General case' 0 C--N 1.302 -1.486 0 O-C-N 120.97 -1.081 . . . . 0.0 110.776 -178.08 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 110' ' ' LEU . . . . . 0.828 ' H ' HD23 ' A' ' 110' ' ' LEU . 0.3 OUTLIER -62.66 -24.5 67.65 Favored 'General case' 0 C--N 1.303 -1.424 0 N-CA-C 107.281 -1.377 . . . . 0.0 107.281 178.641 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 111' ' ' ASP . . . . . . . . . . . . . 4.0 m-20 -133.03 48.95 2.35 Favored 'General case' 0 N--CA 1.485 1.298 0 N-CA-C 109.396 -0.594 . . . . 0.0 109.396 179.663 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 112' ' ' ASP . . . . . . . . . . . . . 1.7 t0 -69.33 159.47 33.06 Favored 'General case' 0 N--CA 1.494 1.731 0 O-C-N 121.127 -0.983 . . . . 0.0 111.333 -179.608 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 113' ' ' GLN . . . . . 0.547 ' N ' ' CD ' ' A' ' 113' ' ' GLN . 0.0 OUTLIER -64.63 -17.98 64.52 Favored 'General case' 0 N--CA 1.491 1.607 0 N-CA-C 107.361 -1.348 . . . . 0.0 107.361 177.668 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 114' ' ' ASN . . . . . 0.682 ' ND2' ' NE2' ' A' ' 178' ' ' GLN . 59.9 t-20 -153.55 111.81 3.62 Favored 'General case' 0 C--N 1.298 -1.662 0 N-CA-C 107.803 -1.184 . . . . 0.0 107.803 177.631 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 115' ' ' ILE . . . . . 0.505 HG22 ' O ' ' A' ' 115' ' ' ILE . 2.8 mt -93.6 102.8 14.01 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.557 0 O-C-N 120.988 -1.07 . . . . 0.0 108.128 -179.935 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 116' ' ' SER . . . . . . . . . . . . . 72.3 m -81.76 141.31 33.64 Favored 'General case' 0 N--CA 1.488 1.453 0 CA-C-O 122.088 0.947 . . . . 0.0 112.114 -177.001 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 117' ' ' ILE . . . . . . . . . . . . . 28.2 mt -138.05 140.85 39.78 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.474 0 N-CA-C 107.357 -1.349 . . . . 0.0 107.357 178.609 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 118' ' ' ALA . . . . . . . . . . . . . . . -141.98 155.58 45.45 Favored 'General case' 0 N--CA 1.489 1.492 0 C-N-CA 118.63 -1.228 . . . . 0.0 111.043 -178.967 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 119' ' ' GLY . . . . . . . . . . . . . . . -166.8 152.55 21.55 Favored Glycine 0 N--CA 1.483 1.813 0 N-CA-C 109.967 -1.253 . . . . 0.0 109.967 179.769 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 120' ' ' HIS . . . . . 0.575 ' CD2' ' SG ' ' C' ' 705' ' ' B27 . 26.4 m170 -71.73 142.1 49.78 Favored 'General case' 0 N--CA 1.493 1.71 0 O-C-N 121.604 -0.939 . . . . 0.0 110.592 179.864 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 121' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -99.06 153.36 18.94 Favored 'General case' 0 N--CA 1.496 1.835 0 N-CA-C 107.896 -1.15 . . . . 0.0 107.896 178.419 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 122' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -116.85 140.69 49.15 Favored 'General case' 0 N--CA 1.496 1.869 0 O-C-N 121.139 -0.976 . . . . 0.0 110.603 -179.676 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 123' ' ' ILE . . . . . 0.505 HG23 ' N ' ' A' ' 124' ' ' ASP . 15.7 tt -90.28 -33.13 5.76 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.641 0 CA-C-O 121.876 0.846 . . . . 0.0 109.083 179.619 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 124' ' ' ASP . . . . . 0.505 ' N ' HG23 ' A' ' 123' ' ' ILE . 80.0 m-20 -89.78 3.08 53.95 Favored 'General case' 0 N--CA 1.497 1.888 0 CA-C-N 116.069 -0.514 . . . . 0.0 111.772 -178.706 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 125' ' ' ARG . . . . . 0.665 HH11 ' CG ' ' A' ' 125' ' ' ARG . 1.7 mtt-85 -151.3 120.7 3.53 Favored Pre-proline 0 N--CA 1.499 1.995 0 O-C-N 120.383 -1.448 . . . . 0.0 110.114 -179.193 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 126' ' ' PRO . . . . . . . . . . . . . 88.9 Cg_endo -81.48 -18.99 7.95 Favored 'Trans proline' 0 N--CA 1.489 1.257 0 C-N-CA 122.279 1.986 . . . . 0.0 112.396 179.199 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 127' ' ' ASN . . . . . 0.514 ' O ' ' O ' ' A' ' 128' ' ' TYR . 3.9 m120 -92.65 4.35 53.84 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.274 -0.891 . . . . 0.0 110.109 -179.759 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 128' ' ' TYR . . . . . 0.514 ' O ' ' O ' ' A' ' 127' ' ' ASN . 9.1 t80 -58.7 -147.25 0.0 OUTLIER 'General case' 0 N--CA 1.488 1.447 0 O-C-N 121.283 -0.886 . . . . 0.0 109.337 179.995 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 129' ' ' GLN . . . . . 0.497 ' O ' ' OE1' ' A' ' 85' ' ' GLU . 12.7 mt-30 -64.96 -91.23 0.01 OUTLIER 'General case' 0 N--CA 1.493 1.724 0 O-C-N 120.833 -1.167 . . . . 0.0 110.284 -178.941 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 130' ' ' PHE . . . . . 0.711 ' CE2' HG11 ' A' ' 101' ' ' VAL . 44.2 m-85 -114.28 48.0 1.15 Allowed 'General case' 0 N--CA 1.496 1.835 0 O-C-N 121.159 -0.963 . . . . 0.0 109.355 179.851 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 131' ' ' THR . . . . . 0.526 ' O ' ' CD ' ' A' ' 134' ' ' LYS . 56.9 m -77.83 -26.54 49.51 Favored 'General case' 0 C--N 1.3 -1.558 0 O-C-N 121.213 -0.93 . . . . 0.0 109.563 -179.998 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 132' ' ' ASN . . . . . 0.543 ' ND2' ' O ' ' A' ' 81' ' ' ALA . 12.4 t30 -90.23 13.36 15.46 Favored 'General case' 0 N--CA 1.5 2.042 0 C-N-CA 119.759 -0.776 . . . . 0.0 111.932 -178.855 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 133' ' ' LEU . . . . . 0.993 HD13 ' HB3' ' A' ' 136' ' ' ALA . 0.2 OUTLIER -67.97 -29.81 68.94 Favored 'General case' 0 N--CA 1.495 1.779 0 O-C-N 120.399 -1.438 . . . . 0.0 109.594 -179.749 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 134' ' ' LYS . . . . . 0.746 ' CD ' ' H ' ' A' ' 134' ' ' LYS . 0.0 OUTLIER -44.09 -29.96 0.69 Allowed 'General case' 0 N--CA 1.496 1.862 0 O-C-N 121.43 -0.794 . . . . 0.0 110.455 -179.432 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 135' ' ' ALA . . . . . . . . . . . . . . . -84.76 -21.39 30.03 Favored 'General case' 0 N--CA 1.488 1.466 0 O-C-N 121.045 -1.034 . . . . 0.0 109.937 -179.621 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 136' ' ' ALA . . . . . 0.993 ' HB3' HD13 ' A' ' 133' ' ' LEU . . . -81.74 137.69 35.31 Favored 'General case' 0 C--N 1.301 -1.526 0 CA-C-O 122.039 0.924 . . . . 0.0 111.957 -178.336 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 137' ' ' LYS . . . . . 0.512 ' O ' ' OG ' ' A' ' 140' ' ' SER . 3.9 tttt -156.59 -166.0 2.02 Favored 'General case' 0 C--N 1.299 -1.604 0 C-N-CA 118.824 -1.15 . . . . 0.0 110.857 -179.349 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 138' ' ' LYS . . . . . 0.622 ' O ' ' N ' ' A' ' 140' ' ' SER . 29.0 mttt -46.61 -178.36 0.0 OUTLIER 'General case' 0 C--N 1.3 -1.549 0 CA-C-O 121.873 0.844 . . . . 0.0 110.107 -179.916 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 139' ' ' GLY . . . . . . . . . . . . . . . 44.95 8.41 0.01 OUTLIER Glycine 0 N--CA 1.489 2.198 0 N-CA-C 110.641 -0.984 . . . . 0.0 110.641 179.56 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 140' ' ' SER . . . . . 0.622 ' N ' ' O ' ' A' ' 138' ' ' LYS . 45.8 m -94.55 128.49 41.2 Favored 'General case' 0 N--CA 1.489 1.503 0 O-C-N 120.723 -1.457 . . . . 0.0 109.247 179.47 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 141' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -81.66 127.54 33.01 Favored 'General case' 0 C--N 1.3 -1.545 0 O-C-N 121.288 -0.883 . . . . 0.0 108.792 179.809 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 142' ' ' VAL . . . . . 0.481 HG22 HG23 ' A' ' 78' ' ' ILE . 12.8 t -113.72 135.13 54.33 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.553 0 N-CA-C 108.788 -0.819 . . . . 0.0 108.788 -179.529 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 143' ' ' TYR . . . . . 0.539 ' CE1' ' CG ' ' A' ' 152' ' ' LYS . 9.5 m-85 -111.36 136.13 50.93 Favored 'General case' 0 N--CA 1.493 1.7 0 O-C-N 121.012 -1.055 . . . . 0.0 110.316 -178.886 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 144' ' ' PHE . . . . . 0.528 ' O ' HG23 ' A' ' 150' ' ' THR . 44.6 t80 -113.37 160.1 18.75 Favored 'General case' 0 N--CA 1.493 1.696 0 CA-C-O 122.072 0.939 . . . . 0.0 110.806 -178.263 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 145' ' ' LYS . . . . . 0.463 ' N ' ' CG ' ' A' ' 144' ' ' PHE . 36.7 tttm -148.13 125.23 11.41 Favored 'General case' 0 C--N 1.301 -1.525 0 C-N-CA 119.25 -0.98 . . . . 0.0 110.761 -178.546 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 146' ' ' VAL . . . . . . . . . . . . . 11.8 p -145.82 138.94 20.95 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.63 0 N-CA-C 106.827 -1.545 . . . . 0.0 106.827 178.625 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 147' ' ' GLY . . . . . . . . . . . . . . . 58.67 -141.23 46.7 Favored Glycine 0 N--CA 1.486 1.985 0 N-CA-C 108.359 -1.896 . . . . 0.0 108.359 -179.273 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 148' ' ' ASN . . . . . 0.552 HD22 ' C ' ' A' ' 148' ' ' ASN . 0.4 OUTLIER -101.79 24.75 9.44 Favored 'General case' 0 C--N 1.296 -1.741 0 N-CA-C 107.821 -1.177 . . . . 0.0 107.821 178.821 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 149' ' ' GLU . . . . . . . . . . . . . 2.0 tm-20 -116.52 159.24 22.37 Favored 'General case' 0 N--CA 1.49 1.54 0 CA-C-O 121.796 0.808 . . . . 0.0 110.727 -179.086 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 150' ' ' THR . . . . . 0.528 HG23 ' O ' ' A' ' 144' ' ' PHE . 11.1 m -140.15 109.44 6.17 Favored 'General case' 0 N--CA 1.492 1.666 0 N-CA-C 109.029 -0.73 . . . . 0.0 109.029 179.212 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 151' ' ' ARG . . . . . . . . . . . . . 9.8 mtt180 -89.16 -161.01 0.72 Allowed 'General case' 0 N--CA 1.489 1.495 0 CA-C-O 121.546 0.688 . . . . 0.0 110.433 -178.586 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 152' ' ' LYS . . . . . 0.539 ' CG ' ' CE1' ' A' ' 143' ' ' TYR . 9.3 mtmt -148.26 148.78 30.85 Favored 'General case' 0 N--CA 1.486 1.359 0 O-C-N 121.394 -0.816 . . . . 0.0 110.326 -179.187 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 153' ' ' TYR . . . . . 0.449 ' HB3' ' HB1' ' A' ' 202' ' ' ALA . 52.8 m-85 -146.31 158.66 43.91 Favored 'General case' 0 C--N 1.303 -1.433 0 N-CA-C 108.111 -1.07 . . . . 0.0 108.111 179.277 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 154' ' ' LYS . . . . . . . . . . . . . 15.1 ttmm -137.1 121.5 18.21 Favored 'General case' 0 N--CA 1.495 1.824 0 O-C-N 121.186 -0.946 . . . . 0.0 108.538 179.053 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 155' ' ' MET . . . . . 0.467 ' HB3' HD11 ' A' ' 158' ' ' ILE . 5.7 mtt -47.96 107.79 0.14 Allowed 'General case' 0 N--CA 1.493 1.685 0 O-C-N 120.913 -1.117 . . . . 0.0 111.193 -178.588 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 156' ' ' THR . . . . . 0.679 ' OG1' HG23 ' A' ' 203' ' ' THR . 0.3 OUTLIER -108.02 -25.51 11.12 Favored 'General case' 0 C--N 1.293 -1.872 0 CA-C-N 115.3 -0.864 . . . . 0.0 109.635 -179.342 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 157' ' ' SER . . . . . 0.702 ' C ' HD12 ' A' ' 158' ' ' ILE . 60.7 m -149.87 146.3 27.03 Favored 'General case' 0 C--N 1.299 -1.626 0 C-N-CA 118.61 -1.236 . . . . 0.0 110.455 -179.048 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 158' ' ' ILE . . . . . 0.702 HD12 ' C ' ' A' ' 157' ' ' SER . 3.8 mp -151.48 141.73 15.71 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.445 0 CA-C-O 121.925 0.869 . . . . 0.0 109.988 -179.274 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 159' ' ' ARG . . . . . 0.496 HH21 HG13 ' A' ' 161' ' ' VAL . 3.0 ttp180 -155.09 -171.98 4.02 Favored 'General case' 0 C--N 1.292 -1.897 0 C-N-CA 119.67 -0.812 . . . . 0.0 110.394 -179.601 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 160' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -145.67 161.17 40.48 Favored 'General case' 0 C--N 1.301 -1.539 0 N-CA-C 108.0 -1.111 . . . . 0.0 108.0 -179.725 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 161' ' ' VAL . . . . . 0.496 HG13 HH21 ' A' ' 159' ' ' ARG . 0.0 OUTLIER -154.4 155.62 5.89 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.645 0 O-C-N 120.755 -1.216 . . . . 0.0 110.835 -179.091 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 162' ' ' LYS . . . . . 0.489 ' O ' ' O ' ' A' ' 161' ' ' VAL . 0.2 OUTLIER -51.47 179.47 0.04 OUTLIER Pre-proline 0 C--N 1.305 -1.33 0 N-CA-C 107.153 -1.425 . . . . 0.0 107.153 178.064 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 163' ' ' PRO . . . . . 0.453 ' C ' HD11 ' C' ' 702' ' ' LEU . 29.5 Cg_endo -87.69 45.79 1.2 Allowed 'Trans proline' 0 C--N 1.307 -1.631 0 C-N-CA 122.103 1.869 . . . . 0.0 111.748 -179.548 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 164' ' ' THR . . . . . . . . . . . . . 7.5 m -153.28 -16.41 0.15 Allowed 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.268 -0.895 . . . . 0.0 110.671 -179.626 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 165' ' ' ASP . . . . . 0.489 ' O ' ' N ' ' A' ' 167' ' ' GLY . 0.4 OUTLIER -72.36 58.94 0.41 Allowed 'General case' 0 N--CA 1.493 1.699 0 O-C-N 120.791 -1.193 . . . . 0.0 110.397 -179.063 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 166' ' ' VAL . . . . . 0.59 ' O ' ' N ' ' A' ' 168' ' ' VAL . 1.0 OUTLIER -40.64 -27.22 0.09 OUTLIER 'Isoleucine or valine' 0 N--CA 1.489 1.515 0 O-C-N 121.297 -0.877 . . . . 0.0 109.129 -178.797 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 167' ' ' GLY . . . . . 0.489 ' N ' ' O ' ' A' ' 165' ' ' ASP . . . -46.48 -4.64 0.01 OUTLIER Glycine 0 N--CA 1.496 2.658 0 O-C-N 120.799 -1.188 . . . . 0.0 112.006 -179.768 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 168' ' ' VAL . . . . . 0.59 ' N ' ' O ' ' A' ' 166' ' ' VAL . 0.2 OUTLIER -51.76 -36.33 18.82 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.894 0 O-C-N 120.131 -1.805 . . . . 0.0 108.69 179.866 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 169' ' ' LEU . . . . . 0.536 ' O ' ' C ' ' A' ' 170' ' ' ASP . 5.3 mt -52.69 -6.17 0.05 OUTLIER 'General case' 0 N--CA 1.492 1.653 0 N-CA-C 108.7 -0.852 . . . . 0.0 108.7 -177.469 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 170' ' ' ASP . . . . . 0.569 ' H ' ' C ' ' A' ' 168' ' ' VAL . 47.6 t0 18.22 58.87 0.01 OUTLIER 'General case' 0 N--CA 1.496 1.868 0 N-CA-C 112.419 0.525 . . . . 0.0 112.419 176.999 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 171' ' ' GLU . . . . . . . . . . . . . 11.4 pt-20 -94.87 62.13 2.62 Favored 'General case' 0 N--CA 1.499 2.017 0 O-C-N 120.34 -1.475 . . . . 0.0 109.896 179.924 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 172' ' ' GLN . . . . . . . . . . . . . 0.6 OUTLIER -114.88 -63.63 1.43 Allowed 'General case' 0 N--CA 1.496 1.837 0 O-C-N 121.563 -0.71 . . . . 0.0 110.525 -178.711 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 173' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -60.18 127.58 32.54 Favored 'General case' 0 N--CA 1.496 1.831 0 O-C-N 121.216 -0.928 . . . . 0.0 109.751 -179.704 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 174' ' ' GLY . . . . . 0.49 ' O ' ' C ' ' A' ' 175' ' ' LYS . . . -117.1 -41.72 0.68 Allowed Glycine 0 N--CA 1.484 1.873 0 N-CA-C 108.824 -1.71 . . . . 0.0 108.824 179.682 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 175' ' ' LYS . . . . . 0.49 ' C ' ' O ' ' A' ' 174' ' ' GLY . 13.1 mptt -41.05 -59.78 1.38 Allowed 'General case' 0 N--CA 1.495 1.791 0 N-CA-C 107.804 -1.184 . . . . 0.0 107.804 179.573 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 176' ' ' ASP . . . . . 0.598 ' O ' ' O ' ' A' ' 177' ' ' LYS . 4.3 m-20 -103.22 83.04 2.14 Favored 'General case' 0 C--N 1.295 -1.791 0 N-CA-C 107.294 -1.373 . . . . 0.0 107.294 177.461 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 177' ' ' LYS . . . . . 0.598 ' O ' ' O ' ' A' ' 176' ' ' ASP . 2.6 mttt -43.59 -177.99 0.0 OUTLIER 'General case' 0 N--CA 1.494 1.73 0 O-C-N 121.425 -0.797 . . . . 0.0 109.464 -179.144 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 178' ' ' GLN . . . . . 0.682 ' NE2' ' ND2' ' A' ' 114' ' ' ASN . 0.0 OUTLIER -160.44 170.86 20.12 Favored 'General case' 0 C--N 1.302 -1.487 0 O-C-N 120.418 -1.426 . . . . 0.0 110.977 179.03 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 179' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -122.86 91.99 3.61 Favored 'General case' 0 C--N 1.302 -1.484 0 N-CA-C 107.446 -1.316 . . . . 0.0 107.446 178.493 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 180' ' ' THR . . . . . 0.444 ' OG1' ' ND2' ' A' ' 114' ' ' ASN . 1.3 m -71.74 118.32 14.44 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.172 -0.955 . . . . 0.0 110.457 -178.388 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 181' ' ' LEU . . . . . 0.506 HD11 ' CE2' ' A' ' 130' ' ' PHE . 41.1 tp -97.4 154.04 17.72 Favored 'General case' 0 C--N 1.3 -1.568 0 N-CA-C 107.458 -1.312 . . . . 0.0 107.458 177.57 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 182' ' ' ILE . . . . . 0.572 HG23 HG22 ' A' ' 199' ' ' ILE . 11.0 mt -145.77 121.31 3.33 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.554 0 O-C-N 120.613 -1.304 . . . . 0.0 110.489 179.496 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 183' ' ' THR . . . . . 0.569 HG23 ' O ' ' A' ' 183' ' ' THR . 5.2 t -134.44 116.8 15.57 Favored 'General case' 0 C--N 1.293 -1.865 0 N-CA-C 107.427 -1.323 . . . . 0.0 107.427 178.627 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 184' ' ' CYS . . . . . . . . . . . . . 5.1 p -78.57 157.15 28.85 Favored 'General case' 0 C--N 1.282 -2.337 0 C-N-CA 118.933 -1.107 . . . . 0.0 110.964 -177.687 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 185' ' ' ASP . . . . . . . . . . . . . 12.3 t0 -164.15 -157.47 0.39 Allowed 'General case' 0 N--CA 1.492 1.658 0 O-C-N 121.514 -0.742 . . . . 0.0 109.376 -179.613 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 186' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER 54.93 52.45 11.9 Favored 'General case' 0 N--CA 1.495 1.807 0 O-C-N 121.002 -1.061 . . . . 0.0 109.567 -179.7 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 187' ' ' TYR . . . . . 0.599 ' CE1' ' O ' ' A' ' 188' ' ' ASN . 63.4 t80 -67.69 134.36 50.96 Favored 'General case' 0 N--CA 1.493 1.675 0 O-C-N 121.122 -0.986 . . . . 0.0 110.582 -179.857 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 188' ' ' ASN . . . . . 0.599 ' O ' ' CE1' ' A' ' 187' ' ' TYR . 0.7 OUTLIER -101.52 145.66 28.71 Favored 'General case' 0 C--N 1.296 -1.749 0 N-CA-C 108.214 -1.032 . . . . 0.0 108.214 178.119 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 189' ' ' GLU . . . . . . . . . . . . . 2.0 tt0 -109.49 -14.31 14.42 Favored 'General case' 0 C--N 1.294 -1.81 0 N-CA-C 108.719 -0.845 . . . . 0.0 108.719 -179.557 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 190' ' ' LYS . . . . . . . . . . . . . 7.7 mttm -82.62 -54.47 5.14 Favored 'General case' 0 C--N 1.302 -1.489 0 N-CA-C 108.879 -0.785 . . . . 0.0 108.879 179.096 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 191' ' ' THR . . . . . 0.572 ' OG1' HG12 ' A' ' 193' ' ' VAL . 1.0 OUTLIER -88.48 -5.36 58.29 Favored 'General case' 0 C--N 1.301 -1.503 0 O-C-N 121.391 -0.818 . . . . 0.0 109.645 -179.756 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 192' ' ' GLY . . . . . . . . . . . . . . . 64.93 35.21 91.63 Favored Glycine 0 N--CA 1.496 2.697 0 O-C-N 120.992 -1.068 . . . . 0.0 111.928 177.988 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 193' ' ' VAL . . . . . 0.572 HG12 ' OG1' ' A' ' 191' ' ' THR . 3.4 p -149.27 167.87 2.98 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.681 0 O-C-N 120.692 -1.475 . . . . 0.0 110.383 179.178 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 194' ' ' TRP . . . . . 0.53 ' CD1' ' N ' ' A' ' 194' ' ' TRP . 10.1 m95 -84.83 120.86 26.92 Favored 'General case' 0 N--CA 1.493 1.704 0 N-CA-C 108.813 -0.81 . . . . 0.0 108.813 -179.933 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 195' ' ' GLU . . . . . 0.507 ' CD ' ' ND2' ' A' ' 188' ' ' ASN . 6.8 mt-10 -79.35 -61.64 1.94 Allowed 'General case' 0 N--CA 1.493 1.689 0 O-C-N 121.424 -0.798 . . . . 0.0 111.241 -178.29 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 196' ' ' LYS . . . . . . . . . . . . . 0.9 OUTLIER -101.64 151.14 22.37 Favored 'General case' 0 N--CA 1.494 1.73 0 O-C-N 120.906 -1.121 . . . . 0.0 110.262 -179.216 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 197' ' ' ARG . . . . . 0.883 ' HE ' HD13 ' C' ' 702' ' ' LEU . 1.4 mtt-85 -120.5 153.59 36.45 Favored 'General case' 0 N--CA 1.489 1.497 0 N-CA-C 108.432 -0.951 . . . . 0.0 108.432 178.34 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 198' ' ' LYS . . . . . . . . . . . . . 1.1 mptp? -114.97 123.14 48.33 Favored 'General case' 0 C--N 1.3 -1.585 0 O-C-N 121.645 -0.659 . . . . 0.0 110.581 -177.882 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 199' ' ' ILE . . . . . 0.63 ' C ' HD12 ' A' ' 199' ' ' ILE . 0.5 OUTLIER -136.79 118.49 19.11 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.757 0 CA-C-O 122.748 1.261 . . . . 0.0 110.655 179.693 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 200' ' ' PHE . . . . . 0.556 ' CD1' ' N ' ' A' ' 200' ' ' PHE . 0.2 OUTLIER -100.15 134.64 42.77 Favored 'General case' 0 N--CA 1.5 2.054 0 CA-C-N 115.604 -0.725 . . . . 0.0 110.481 -178.161 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 201' ' ' VAL . . . . . . . . . . . . . 52.9 t -103.48 141.34 19.45 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.992 0 O-C-N 120.721 -1.237 . . . . 0.0 108.554 177.922 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 202' ' ' ALA . . . . . 0.449 ' HB1' ' HB3' ' A' ' 153' ' ' TYR . . . -125.15 136.66 53.82 Favored 'General case' 0 N--CA 1.495 1.794 0 O-C-N 121.157 -0.964 . . . . 0.0 108.795 179.56 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 203' ' ' THR . . . . . 0.679 HG23 ' OG1' ' A' ' 156' ' ' THR . 1.2 p -88.98 134.66 33.9 Favored 'General case' 0 N--CA 1.49 1.529 0 CA-C-O 122.126 0.965 . . . . 0.0 111.383 -178.552 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 204' ' ' GLU . . . . . 0.418 ' HA ' ' CD2' ' A' ' 153' ' ' TYR . 2.6 tm-20 -62.53 135.07 57.23 Favored 'General case' 0 C--N 1.301 -1.541 0 C-N-CA 118.919 -1.113 . . . . 0.0 108.96 179.25 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 205' ' ' VAL . . . . . 0.54 ' O ' ' C ' ' A' ' 206' ' ' LYS . 71.5 t -123.9 -45.39 1.73 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.642 0 O-C-N 121.397 -0.814 . . . . 0.0 109.908 -178.91 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 206' ' ' LYS . . . . . 0.54 ' C ' ' O ' ' A' ' 205' ' ' VAL . 2.3 ttpt . . . . . 0 N--CA 1.496 1.838 0 CA-C-O 118.044 -0.979 . . . . 0.0 110.679 -179.655 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' C' C ' 701' ' ' PHQ . . . . . 0.487 ' O2 ' HG12 ' A' ' 166' ' ' VAL . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' C' C ' 702' ' ' LEU . . . . . 0.883 HD13 ' HE ' ' A' ' 197' ' ' ARG . 0.0 OUTLIER . . . . . 0 N--CA 1.491 1.584 0 N-CA-C 108.412 -0.959 . . . . 0.0 108.412 . . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' C' C ' 703' ' ' PRO . . . . . 0.492 ' O ' ' O ' ' C' ' 704' ' ' ALA . 97.2 Cg_endo -77.88 -162.48 0.17 Allowed 'Trans proline' 0 N--CA 1.494 1.55 0 C-N-CA 122.521 2.148 . . . . 0.0 113.081 -179.509 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' C' C ' 704' ' ' ALA . . . . . 0.493 ' C ' ' SG ' ' C' ' 705' ' ' B27 . . . 41.41 98.84 0.0 OUTLIER 'General case' 0 N--CA 1.49 1.553 0 CA-C-O 121.443 0.64 . . . . 0.0 110.273 179.457 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' C' C ' 705' ' ' B27 . . . . . 0.575 ' SG ' ' CD2' ' A' ' 120' ' ' HIS . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 700' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 019 nuclear nobuild full ' A' A ' 59' ' ' MET . . . . . . . . . . . . . 5.0 mmt . . . . . 0 N--CA 1.49 1.549 0 N-CA-C 109.44 -0.578 . . . . 0.0 109.44 . . . . . . . . . 0 0 . 1 . 019 nuclear nobuild full ' A' A ' 60' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -59.74 -161.91 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.673 0 O-C-N 121.079 -1.013 . . . . 0.0 109.198 179.804 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . -64.35 -168.02 0.03 OUTLIER 'General case' 0 N--CA 1.488 1.445 0 O-C-N 121.245 -0.91 . . . . 0.0 109.276 179.83 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 62' ' ' LYS . . . . . . . . . . . . . 6.1 pttm -138.5 90.08 13.26 Favored Pre-proline 0 N--CA 1.487 1.391 0 O-C-N 121.207 -0.933 . . . . 0.0 109.403 -179.276 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 63' ' ' PRO . . . . . 0.581 ' O ' ' CD1' ' A' ' 110' ' ' LEU . 29.3 Cg_endo -86.51 131.28 3.42 Favored 'Trans proline' 0 C--N 1.309 -1.541 0 C-N-CA 122.965 2.443 . . . . 0.0 110.156 179.414 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 64' ' ' GLN . . . . . 0.425 ' O ' ' C ' ' A' ' 65' ' ' ILE . 0.0 OUTLIER -162.47 115.62 1.71 Allowed 'General case' 0 C--N 1.297 -1.686 0 O-C-N 121.165 -0.96 . . . . 0.0 109.976 -179.836 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 65' ' ' ILE . . . . . 0.425 ' C ' ' O ' ' A' ' 64' ' ' GLN . 2.7 mp -42.78 102.41 0.27 Allowed Pre-proline 0 N--CA 1.489 1.511 0 O-C-N 121.518 -0.739 . . . . 0.0 109.262 179.536 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 66' ' ' PRO . . . . . . . . . . . . . 72.7 Cg_endo -89.13 -154.21 0.05 OUTLIER 'Trans proline' 0 N--CA 1.492 1.414 0 C-N-CA 122.697 2.265 . . . . 0.0 113.004 -179.011 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 67' ' ' LYS . . . . . 0.481 ' CG ' ' O ' ' A' ' 67' ' ' LYS . 7.8 ttmm -81.06 -7.45 59.56 Favored 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.239 -0.913 . . . . 0.0 108.766 179.666 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 68' ' ' ASP . . . . . 0.584 ' C ' ' N ' ' A' ' 70' ' ' SER . 0.5 OUTLIER -75.1 52.89 0.59 Allowed 'General case' 0 C--N 1.304 -1.393 0 CA-C-O 122.524 1.154 . . . . 0.0 108.594 179.608 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 69' ' ' LYS . . . . . 0.437 ' C ' ' O ' ' A' ' 68' ' ' ASP . 14.9 ptpt -49.7 -15.07 0.15 Allowed 'General case' 0 N--CA 1.501 2.088 0 C-N-CA 117.26 -1.776 . . . . 0.0 106.469 177.961 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 70' ' ' SER . . . . . 0.584 ' N ' ' C ' ' A' ' 68' ' ' ASP . 3.7 m -85.92 -4.68 59.22 Favored 'General case' 0 N--CA 1.494 1.77 0 CA-C-N 113.516 -1.675 . . . . 0.0 110.739 179.571 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 71' ' ' LYS . . . . . . . . . . . . . 7.9 ptmt -97.73 142.53 29.39 Favored 'General case' 0 N--CA 1.497 1.877 0 O-C-N 120.913 -1.117 . . . . 0.0 111.985 -179.181 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 72' ' ' VAL . . . . . 0.579 ' CG2' ' O ' ' A' ' 74' ' ' GLY . 0.3 OUTLIER -67.52 135.0 29.34 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.507 0 N-CA-C 105.186 -2.153 . . . . 0.0 105.186 174.777 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 73' ' ' ALA . . . . . 0.535 ' N ' ' O ' ' A' ' 87' ' ' VAL . . . -80.93 -16.58 53.14 Favored 'General case' 0 C--N 1.298 -1.635 0 O-C-N 119.988 -1.695 . . . . 0.0 107.219 -179.556 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 74' ' ' GLY . . . . . 0.579 ' O ' ' CG2' ' A' ' 72' ' ' VAL . . . 167.04 -148.9 13.85 Favored Glycine 0 N--CA 1.486 1.98 0 C-N-CA 119.078 -1.534 . . . . 0.0 110.253 178.774 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 75' ' ' TYR . . . . . 0.558 ' HA ' HG23 ' A' ' 87' ' ' VAL . 13.4 m-85 -144.91 174.79 10.71 Favored 'General case' 0 C--N 1.293 -1.885 0 O-C-N 121.153 -1.204 . . . . 0.0 109.921 -178.342 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 76' ' ' ILE . . . . . . . . . . . . . 0.4 OUTLIER -148.48 147.83 16.56 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.777 0 N-CA-C 108.124 -1.065 . . . . 0.0 108.124 -178.64 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 3.9 mt-10 -149.37 159.82 43.95 Favored 'General case' 0 C--N 1.302 -1.471 0 O-C-N 120.789 -1.194 . . . . 0.0 110.548 -179.353 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 78' ' ' ILE . . . . . 0.562 HG22 ' H ' ' A' ' 81' ' ' ALA . 83.3 mt -145.58 120.15 5.56 Favored Pre-proline 0 N--CA 1.488 1.442 0 N-CA-C 107.233 -1.395 . . . . 0.0 107.233 179.722 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 79' ' ' PRO . . . . . . . . . . . . . 68.9 Cg_endo -76.36 -39.66 0.76 Allowed 'Trans proline' 0 N--CA 1.493 1.468 0 C-N-CA 122.024 1.816 . . . . 0.0 113.613 -178.543 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 4.7 m-20 -65.72 -20.23 66.2 Favored 'General case' 0 N--CA 1.494 1.76 0 O-C-N 121.062 -1.024 . . . . 0.0 110.025 178.344 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 81' ' ' ALA . . . . . 0.575 ' O ' ' ND2' ' A' ' 132' ' ' ASN . . . -108.31 -18.63 13.71 Favored 'General case' 0 C--N 1.301 -1.535 0 N-CA-C 107.857 -1.164 . . . . 0.0 107.857 179.497 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 82' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER 67.41 54.72 0.68 Allowed 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.74 -0.6 . . . . 0.0 110.942 178.921 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 83' ' ' ILE . . . . . 0.409 ' CG1' HD21 ' A' ' 132' ' ' ASN . 61.2 mt -126.66 151.77 33.66 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.924 0 O-C-N 120.935 -1.103 . . . . 0.0 110.68 -179.02 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 84' ' ' LYS . . . . . . . . . . . . . 1.6 pttm -159.19 106.46 1.77 Allowed 'General case' 0 N--CA 1.489 1.512 0 N-CA-C 107.734 -1.21 . . . . 0.0 107.734 179.105 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 85' ' ' GLU . . . . . 0.435 ' OE2' ' O ' ' A' ' 129' ' ' GLN . 0.4 OUTLIER -141.6 174.16 4.09 Favored Pre-proline 0 N--CA 1.493 1.71 0 O-C-N 121.064 -1.023 . . . . 0.0 110.779 -178.344 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 86' ' ' PRO . . . . . . . . . . . . . 73.2 Cg_endo -83.96 157.75 13.55 Favored 'Trans proline' 0 N--CA 1.492 1.433 0 C-N-CA 123.147 2.565 . . . . 0.0 114.082 -178.869 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 87' ' ' VAL . . . . . 0.558 HG23 ' HA ' ' A' ' 75' ' ' TYR . 57.3 t -114.6 103.24 15.03 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.89 0 O-C-N 121.73 -0.606 . . . . 0.0 109.706 -179.816 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 88' ' ' TYR . . . . . 0.412 ' CD2' ' HD2' ' A' ' 99' ' ' ARG . 19.5 m-85 -94.83 153.71 39.97 Favored Pre-proline 0 N--CA 1.502 2.139 0 O-C-N 120.827 -1.17 . . . . 0.0 110.31 -179.916 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 89' ' ' PRO . . . . . 0.425 ' HA ' ' CD2' ' A' ' 103' ' ' PHE . 8.3 Cg_endo -58.4 145.38 94.24 Favored 'Trans proline' 0 N--CA 1.494 1.537 0 C-N-CA 122.908 2.405 . . . . 0.0 113.452 -179.514 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . -59.84 168.91 7.55 Favored Glycine 0 N--CA 1.492 2.384 0 N-CA-C 109.208 -1.557 . . . . 0.0 109.208 179.211 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 91' ' ' PRO . . . . . 0.444 ' C ' ' H ' ' A' ' 93' ' ' THR . 72.1 Cg_endo -93.24 170.45 19.98 Favored 'Cis proline' 0 C--N 1.306 -1.669 0 C-N-CA 123.765 -1.348 . . . . 0.0 111.903 -0.237 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 92' ' ' ALA . . . . . 0.47 ' HB3' ' HB2' ' C' ' 703' ' ' PRO . . . -72.44 32.15 0.06 Allowed 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.134 -0.979 . . . . 0.0 110.433 -179.892 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 93' ' ' THR . . . . . 0.444 ' H ' ' C ' ' A' ' 91' ' ' PRO . 1.1 p -73.51 149.9 88.86 Favored Pre-proline 0 C--N 1.302 -1.486 0 O-C-N 120.847 -1.158 . . . . 0.0 108.427 179.723 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 94' ' ' PRO . . . . . 0.412 ' C ' ' O ' ' A' ' 93' ' ' THR . 95.4 Cg_exo -35.54 -45.05 0.71 Allowed 'Trans proline' 0 C--N 1.304 -1.772 0 C-N-CA 122.438 2.092 . . . . 0.0 111.746 -179.615 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 95' ' ' GLU . . . . . 0.628 ' O ' ' ND2' ' A' ' 98' ' ' ASN . 7.1 mt-10 -49.97 -55.13 15.78 Favored 'General case' 0 N--CA 1.489 1.477 0 O-C-N 121.18 -0.95 . . . . 0.0 109.393 179.341 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 96' ' ' GLN . . . . . 0.563 ' C ' ' H ' ' A' ' 98' ' ' ASN . 2.7 mp0 -73.03 -47.77 42.06 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.162 -0.961 . . . . 0.0 110.719 -179.658 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 97' ' ' LEU . . . . . 0.448 HD23 ' HA ' ' A' ' 97' ' ' LEU . 42.2 mt -52.55 -5.34 0.04 OUTLIER 'General case' 0 N--CA 1.493 1.691 0 O-C-N 120.971 -1.08 . . . . 0.0 109.095 -179.046 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 98' ' ' ASN . . . . . 0.75 HD21 ' NE ' ' A' ' 99' ' ' ARG . 0.5 OUTLIER -73.23 -26.35 61.09 Favored 'General case' 0 N--CA 1.494 1.747 0 O-C-N 121.351 -0.843 . . . . 0.0 109.087 179.466 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 99' ' ' ARG . . . . . 0.75 ' NE ' HD21 ' A' ' 98' ' ' ASN . 0.1 OUTLIER -99.03 -50.2 4.25 Favored 'General case' 0 C--N 1.3 -1.544 0 C-N-CA 119.7 -0.8 . . . . 0.0 110.064 -179.016 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . 180.0 -169.17 39.83 Favored Glycine 0 N--CA 1.495 2.578 0 C-N-CA 118.858 -1.639 . . . . 0.0 111.224 179.497 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 101' ' ' VAL . . . . . 0.73 ' O ' HG23 ' A' ' 101' ' ' VAL . 18.5 m -55.01 106.16 0.11 Allowed 'Isoleucine or valine' 0 N--CA 1.496 1.84 0 O-C-N 121.883 -0.775 . . . . 0.0 109.289 -179.851 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -92.56 164.17 13.53 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.373 -0.829 . . . . 0.0 111.577 -178.713 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 103' ' ' PHE . . . . . 0.427 ' CE1' ' CG1' ' A' ' 87' ' ' VAL . 23.9 m-85 -68.2 126.58 29.99 Favored 'General case' 0 N--CA 1.485 1.278 0 N-CA-C 106.763 -1.569 . . . . 0.0 106.763 177.309 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 104' ' ' ALA . . . . . 0.453 ' HB1' ' CG ' ' C' ' 703' ' ' PRO . . . -50.37 -11.26 0.07 Allowed 'General case' 0 C--N 1.293 -1.856 0 O-C-N 121.513 -0.742 . . . . 0.0 111.593 -178.267 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 105' ' ' GLU . . . . . 0.495 ' OE2' ' OE1' ' A' ' 108' ' ' GLU . 0.4 OUTLIER -140.57 145.89 37.34 Favored 'General case' 0 N--CA 1.495 1.795 0 O-C-N 120.751 -1.218 . . . . 0.0 110.565 179.988 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 106' ' ' GLU . . . . . . . . . . . . . 25.0 tt0 -58.84 -63.22 1.37 Allowed 'General case' 0 C--N 1.305 -1.356 0 O-C-N 121.733 -0.604 . . . . 0.0 110.019 -179.993 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 107' ' ' ASN . . . . . . . . . . . . . 15.9 m-80 -76.94 33.2 0.14 Allowed 'General case' 0 N--CA 1.487 1.413 0 O-C-N 120.381 -1.449 . . . . 0.0 112.683 -176.103 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 108' ' ' GLU . . . . . 0.495 ' OE1' ' OE2' ' A' ' 105' ' ' GLU . 35.0 tp10 -60.16 146.9 41.65 Favored 'General case' 0 N--CA 1.493 1.698 0 O-C-N 120.483 -1.386 . . . . 0.0 107.801 179.448 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 109' ' ' SER . . . . . 0.401 ' C ' ' N ' ' A' ' 111' ' ' ASP . 0.1 OUTLIER -101.2 128.59 47.24 Favored 'General case' 0 N--CA 1.489 1.501 0 O-C-N 120.824 -1.172 . . . . 0.0 110.912 -178.285 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 110' ' ' LEU . . . . . 0.626 HD23 ' N ' ' A' ' 110' ' ' LEU . 1.2 pt? -59.0 -10.02 2.27 Favored 'General case' 0 C--N 1.303 -1.433 0 N-CA-C 108.45 -0.945 . . . . 0.0 108.45 179.48 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 111' ' ' ASP . . . . . 0.401 ' N ' ' C ' ' A' ' 109' ' ' SER . 44.8 m-20 -131.74 29.62 4.45 Favored 'General case' 0 N--CA 1.491 1.587 0 N-CA-C 108.598 -0.89 . . . . 0.0 108.598 179.32 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 112' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -65.37 149.48 49.92 Favored 'General case' 0 N--CA 1.493 1.686 0 O-C-N 121.273 -0.892 . . . . 0.0 110.479 -179.232 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 113' ' ' GLN . . . . . 0.44 ' HA ' ' NE2' ' A' ' 113' ' ' GLN . 0.8 OUTLIER -66.87 -11.41 55.72 Favored 'General case' 0 C--N 1.303 -1.442 0 N-CA-C 107.709 -1.219 . . . . 0.0 107.709 177.773 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 114' ' ' ASN . . . . . 0.455 HD22 ' NE2' ' A' ' 178' ' ' GLN . 0.1 OUTLIER -149.47 102.59 3.2 Favored 'General case' 0 C--N 1.305 -1.347 0 N-CA-C 107.683 -1.229 . . . . 0.0 107.683 177.838 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 115' ' ' ILE . . . . . 0.461 ' O ' HG22 ' A' ' 115' ' ' ILE . 3.8 mt -97.74 111.26 27.13 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.528 0 O-C-N 120.961 -1.087 . . . . 0.0 109.437 -179.19 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 116' ' ' SER . . . . . . . . . . . . . 50.5 m -96.97 140.68 31.14 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.24 -0.913 . . . . 0.0 111.707 -178.087 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 117' ' ' ILE . . . . . . . . . . . . . 11.9 mt -130.25 152.49 37.51 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.414 0 N-CA-C 107.284 -1.376 . . . . 0.0 107.284 178.305 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 118' ' ' ALA . . . . . 0.663 ' HB1' ' HB2' ' C' ' 704' ' ' ALA . . . -142.87 157.54 44.49 Favored 'General case' 0 N--CA 1.493 1.684 0 O-C-N 120.707 -1.246 . . . . 0.0 111.087 -179.836 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 119' ' ' GLY . . . . . . . . . . . . . . . -162.45 145.09 10.28 Favored Glycine 0 N--CA 1.487 2.056 0 N-CA-C 110.085 -1.206 . . . . 0.0 110.085 179.964 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 120' ' ' HIS . . . . . 0.632 ' CD2' ' SG ' ' C' ' 705' ' ' B27 . 29.4 m170 -71.19 157.98 37.21 Favored 'General case' 0 N--CA 1.493 1.701 0 O-C-N 121.716 -0.873 . . . . 0.0 110.062 179.461 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 121' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -110.98 145.88 37.65 Favored 'General case' 0 N--CA 1.495 1.808 0 O-C-N 121.321 -0.862 . . . . 0.0 108.86 178.916 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 122' ' ' PHE . . . . . 0.489 ' O ' HG21 ' A' ' 131' ' ' THR . 0.3 OUTLIER -109.23 125.32 52.13 Favored 'General case' 0 N--CA 1.494 1.734 0 O-C-N 121.058 -1.026 . . . . 0.0 109.277 179.333 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 123' ' ' ILE . . . . . 0.559 HG23 ' N ' ' A' ' 124' ' ' ASP . 6.9 tp -74.43 -37.04 43.84 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.785 0 CA-C-O 121.876 0.846 . . . . 0.0 109.195 179.833 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 124' ' ' ASP . . . . . 0.559 ' N ' HG23 ' A' ' 123' ' ' ILE . 80.8 m-20 -92.88 15.13 15.49 Favored 'General case' 0 C--N 1.297 -1.715 0 O-C-N 121.897 -0.502 . . . . 0.0 111.281 -179.043 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 125' ' ' ARG . . . . . . . . . . . . . 7.3 ttt180 -153.95 115.17 2.58 Favored Pre-proline 0 N--CA 1.494 1.737 0 O-C-N 120.445 -1.409 . . . . 0.0 110.789 -178.555 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 126' ' ' PRO . . . . . . . . . . . . . 74.0 Cg_endo -83.76 -23.75 3.1 Favored 'Trans proline' 0 N--CA 1.487 1.123 0 C-N-CA 122.11 1.873 . . . . 0.0 112.083 178.81 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 127' ' ' ASN . . . . . 0.48 ' ND2' ' O ' ' A' ' 127' ' ' ASN . 2.3 p-10 -88.82 28.89 1.09 Allowed 'General case' 0 N--CA 1.492 1.654 0 O-C-N 120.898 -1.126 . . . . 0.0 110.051 -179.558 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 128' ' ' TYR . . . . . . . . . . . . . 9.9 t80 -87.71 -148.58 0.15 Allowed 'General case' 0 N--CA 1.49 1.564 0 O-C-N 120.94 -1.1 . . . . 0.0 109.554 179.906 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 129' ' ' GLN . . . . . 0.435 ' O ' ' OE2' ' A' ' 85' ' ' GLU . 80.4 mt-30 -66.95 -69.59 0.3 Allowed 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.29 -0.881 . . . . 0.0 110.802 -178.742 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 130' ' ' PHE . . . . . . . . . . . . . 55.8 m-85 -130.47 31.34 4.59 Favored 'General case' 0 N--CA 1.499 1.99 0 O-C-N 121.056 -1.027 . . . . 0.0 110.841 -179.126 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 131' ' ' THR . . . . . 0.489 HG21 ' O ' ' A' ' 122' ' ' PHE . 52.4 m -70.77 -32.99 70.3 Favored 'General case' 0 C--N 1.301 -1.522 0 O-C-N 120.344 -1.473 . . . . 0.0 108.205 179.451 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 132' ' ' ASN . . . . . 0.575 ' ND2' ' O ' ' A' ' 81' ' ' ALA . 2.0 p-10 -91.21 15.24 12.27 Favored 'General case' 0 N--CA 1.498 1.97 0 C-N-CA 119.915 -0.714 . . . . 0.0 111.179 -179.565 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 133' ' ' LEU . . . . . 0.599 ' O ' ' N ' ' A' ' 135' ' ' ALA . 0.2 OUTLIER -77.06 -44.17 31.69 Favored 'General case' 0 C--N 1.301 -1.535 0 O-C-N 120.651 -1.281 . . . . 0.0 109.185 -179.801 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 134' ' ' LYS . . . . . 0.71 ' H ' ' CE ' ' A' ' 134' ' ' LYS . 0.0 OUTLIER -46.97 -6.94 0.01 OUTLIER 'General case' 0 C--N 1.299 -1.606 0 O-C-N 121.661 -0.65 . . . . 0.0 110.428 -179.42 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 135' ' ' ALA . . . . . 0.599 ' N ' ' O ' ' A' ' 133' ' ' LEU . . . -84.0 -40.32 18.58 Favored 'General case' 0 N--CA 1.488 1.462 0 O-C-N 120.912 -1.118 . . . . 0.0 108.97 178.962 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 136' ' ' ALA . . . . . 0.555 ' HB2' ' HB2' ' A' ' 81' ' ' ALA . . . -79.77 162.3 25.21 Favored 'General case' 0 N--CA 1.487 1.402 0 CA-C-O 122.21 1.005 . . . . 0.0 111.357 -178.752 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 137' ' ' LYS . . . . . 0.513 ' O ' ' O ' ' A' ' 138' ' ' LYS . 17.4 pttt -153.04 -164.02 1.83 Allowed 'General case' 0 C--N 1.3 -1.584 0 C-N-CA 118.721 -1.192 . . . . 0.0 111.097 -177.918 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 138' ' ' LYS . . . . . 0.602 ' O ' ' N ' ' A' ' 140' ' ' SER . 1.4 mmmp? -45.92 -179.9 0.0 OUTLIER 'General case' 0 C--N 1.303 -1.445 0 CA-C-O 122.1 0.953 . . . . 0.0 110.356 -179.564 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 139' ' ' GLY . . . . . . . . . . . . . . . 46.14 7.81 0.02 OUTLIER Glycine 0 N--CA 1.49 2.283 0 N-CA-C 110.547 -1.021 . . . . 0.0 110.547 179.735 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 140' ' ' SER . . . . . 0.602 ' N ' ' O ' ' A' ' 138' ' ' LYS . 13.1 t -83.04 143.78 30.37 Favored 'General case' 0 N--CA 1.493 1.679 0 O-C-N 120.849 -1.383 . . . . 0.0 108.922 179.108 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 141' ' ' MET . . . . . . . . . . . . . 0.1 OUTLIER -88.68 133.91 34.06 Favored 'General case' 0 C--N 1.3 -1.552 0 O-C-N 121.091 -1.006 . . . . 0.0 109.316 179.787 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 142' ' ' VAL . . . . . 0.429 HG22 HG12 ' A' ' 78' ' ' ILE . 21.4 t -121.81 126.19 74.28 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.631 0 N-CA-C 108.781 -0.822 . . . . 0.0 108.781 179.934 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 143' ' ' TYR . . . . . . . . . . . . . 61.1 m-85 -104.2 134.28 47.71 Favored 'General case' 0 N--CA 1.496 1.857 0 O-C-N 121.26 -0.9 . . . . 0.0 110.975 -178.915 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 144' ' ' PHE . . . . . . . . . . . . . 53.0 t80 -112.0 154.3 25.53 Favored 'General case' 0 N--CA 1.492 1.666 0 CA-C-O 121.773 0.797 . . . . 0.0 110.101 -179.393 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 145' ' ' LYS . . . . . 0.429 ' CG ' ' OG1' ' A' ' 150' ' ' THR . 1.8 mttm -149.07 125.64 11.02 Favored 'General case' 0 N--CA 1.494 1.759 0 C-N-CA 118.866 -1.134 . . . . 0.0 111.707 -177.764 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 146' ' ' VAL . . . . . . . . . . . . . 0.2 OUTLIER -144.81 139.9 23.19 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.559 0 N-CA-C 107.028 -1.471 . . . . 0.0 107.028 178.149 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 147' ' ' GLY . . . . . . . . . . . . . . . 53.89 -138.07 38.95 Favored Glycine 0 N--CA 1.489 2.201 0 N-CA-C 107.878 -2.089 . . . . 0.0 107.878 -178.692 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 148' ' ' ASN . . . . . 0.591 HD22 ' C ' ' A' ' 148' ' ' ASN . 0.4 OUTLIER -101.63 26.65 7.12 Favored 'General case' 0 N--CA 1.489 1.498 0 O-C-N 121.052 -1.263 . . . . 0.0 107.832 178.491 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 149' ' ' GLU . . . . . . . . . . . . . 2.1 tm-20 -112.05 151.97 28.74 Favored 'General case' 0 N--CA 1.486 1.335 0 CA-C-O 121.872 0.844 . . . . 0.0 110.921 -178.805 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 150' ' ' THR . . . . . 0.429 ' OG1' ' CG ' ' A' ' 145' ' ' LYS . 2.9 m -141.02 104.89 4.75 Favored 'General case' 0 N--CA 1.495 1.818 0 CA-C-O 121.559 0.695 . . . . 0.0 109.216 179.828 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 151' ' ' ARG . . . . . . . . . . . . . 73.9 mtt180 -87.57 -164.9 1.17 Allowed 'General case' 0 N--CA 1.487 1.403 0 O-C-N 121.355 -0.841 . . . . 0.0 109.297 -179.52 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 152' ' ' LYS . . . . . 0.528 ' O ' ' N ' ' A' ' 205' ' ' VAL . 7.3 mtmt -147.34 144.24 28.61 Favored 'General case' 0 C--N 1.301 -1.535 0 O-C-N 121.433 -0.792 . . . . 0.0 109.329 -179.671 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 153' ' ' TYR . . . . . 0.536 ' CD2' ' HA ' ' A' ' 204' ' ' GLU . 26.9 m-85 -140.44 169.41 17.72 Favored 'General case' 0 N--CA 1.489 1.51 0 N-CA-C 108.344 -0.984 . . . . 0.0 108.344 179.948 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 154' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -143.38 120.91 11.74 Favored 'General case' 0 C--N 1.299 -1.623 0 O-C-N 121.329 -0.857 . . . . 0.0 108.986 179.175 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 155' ' ' MET . . . . . . . . . . . . . 27.0 mtp -46.61 110.09 0.25 Allowed 'General case' 0 N--CA 1.496 1.855 0 O-C-N 120.576 -1.327 . . . . 0.0 110.954 -179.112 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 156' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -104.24 -30.26 10.28 Favored 'General case' 0 C--N 1.294 -1.846 0 C-N-CA 119.817 -0.753 . . . . 0.0 111.034 -178.286 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 157' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -154.53 157.52 38.45 Favored 'General case' 0 N--CA 1.495 1.801 0 C-N-CA 118.179 -1.408 . . . . 0.0 111.757 -178.136 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 158' ' ' ILE . . . . . 0.423 HG12 ' N ' ' A' ' 159' ' ' ARG . 0.0 OUTLIER -155.26 146.23 12.99 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.562 0 CA-C-O 121.785 0.802 . . . . 0.0 110.748 -178.995 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 159' ' ' ARG . . . . . 0.65 ' CG ' HH11 ' A' ' 159' ' ' ARG . 0.0 OUTLIER -158.13 159.16 35.91 Favored 'General case' 0 C--N 1.303 -1.429 0 CA-C-O 121.757 0.789 . . . . 0.0 110.967 -179.824 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 160' ' ' ASP . . . . . 0.469 ' C ' HG22 ' A' ' 161' ' ' VAL . 0.3 OUTLIER -117.37 163.92 15.63 Favored 'General case' 0 N--CA 1.488 1.43 0 N-CA-C 108.326 -0.99 . . . . 0.0 108.326 178.829 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 161' ' ' VAL . . . . . 0.487 ' O ' ' O ' ' A' ' 162' ' ' LYS . 0.1 OUTLIER -162.11 156.2 2.64 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.816 0 O-C-N 121.158 -0.964 . . . . 0.0 109.828 -179.425 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 162' ' ' LYS . . . . . 0.584 ' CD ' ' H ' ' A' ' 162' ' ' LYS . 0.0 OUTLIER -44.96 171.68 0.05 OUTLIER Pre-proline 0 N--CA 1.494 1.738 0 O-C-N 121.378 -0.826 . . . . 0.0 109.63 179.723 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 163' ' ' PRO . . . . . . . . . . . . . 73.7 Cg_endo -81.87 36.38 0.62 Allowed 'Trans proline' 0 N--CA 1.493 1.451 0 C-N-CA 122.791 2.328 . . . . 0.0 113.141 -179.521 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 164' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -152.69 -4.8 0.22 Allowed 'General case' 0 N--CA 1.492 1.663 0 O-C-N 120.907 -1.121 . . . . 0.0 110.35 -179.981 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 165' ' ' ASP . . . . . 0.475 ' O ' ' N ' ' A' ' 167' ' ' GLY . 8.8 t0 -74.8 62.6 1.1 Allowed 'General case' 0 N--CA 1.492 1.631 0 O-C-N 120.925 -1.109 . . . . 0.0 110.641 -179.35 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 166' ' ' VAL . . . . . 0.648 ' O ' ' N ' ' A' ' 168' ' ' VAL . 0.9 OUTLIER -39.43 -29.03 0.09 OUTLIER 'Isoleucine or valine' 0 N--CA 1.497 1.89 0 O-C-N 121.284 -0.885 . . . . 0.0 109.563 -178.45 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 167' ' ' GLY . . . . . 0.475 ' N ' ' O ' ' A' ' 165' ' ' ASP . . . -43.07 -13.92 0.01 OUTLIER Glycine 0 N--CA 1.496 2.636 0 N-CA-C 109.515 -1.434 . . . . 0.0 109.515 179.622 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 168' ' ' VAL . . . . . 0.648 ' N ' ' O ' ' A' ' 166' ' ' VAL . 1.3 t -48.26 -44.41 12.73 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.454 0 O-C-N 121.448 -1.031 . . . . 0.0 108.43 178.925 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 169' ' ' LEU . . . . . 0.571 ' O ' ' C ' ' A' ' 170' ' ' ASP . 47.1 mt -49.92 -9.7 0.04 OUTLIER 'General case' 0 N--CA 1.492 1.66 0 N-CA-C 109.001 -0.741 . . . . 0.0 109.001 -178.092 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 170' ' ' ASP . . . . . 0.617 ' CG ' ' HG1' ' A' ' 180' ' ' THR . 17.7 p-10 19.46 86.51 0.01 OUTLIER 'General case' 0 N--CA 1.494 1.739 0 CA-C-O 121.051 0.453 . . . . 0.0 110.981 178.578 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 171' ' ' GLU . . . . . . . . . . . . . 6.7 pt-20 -121.29 61.38 0.91 Allowed 'General case' 0 N--CA 1.494 1.725 0 O-C-N 121.175 -0.953 . . . . 0.0 109.938 -179.228 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 172' ' ' GLN . . . . . . . . . . . . . 3.0 pt20 -135.03 -44.93 0.72 Allowed 'General case' 0 N--CA 1.492 1.668 0 O-C-N 121.527 -0.733 . . . . 0.0 109.942 -178.975 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 173' ' ' LYS . . . . . . . . . . . . . 21.5 mttp -62.54 128.93 38.29 Favored 'General case' 0 N--CA 1.489 1.498 0 O-C-N 120.899 -1.126 . . . . 0.0 108.106 178.949 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 174' ' ' GLY . . . . . 0.552 ' O ' ' C ' ' A' ' 175' ' ' LYS . . . -137.63 -40.37 0.11 Allowed Glycine 0 C--N 1.293 -1.807 0 N-CA-C 109.071 -1.612 . . . . 0.0 109.071 -179.722 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 175' ' ' LYS . . . . . 0.552 ' C ' ' O ' ' A' ' 174' ' ' GLY . 4.4 mptp? -30.87 -65.28 0.12 Allowed 'General case' 0 N--CA 1.499 2.011 0 N-CA-C 108.9 -0.778 . . . . 0.0 108.9 -179.751 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 176' ' ' ASP . . . . . 0.696 ' O ' ' O ' ' A' ' 177' ' ' LYS . 58.2 m-20 -101.39 78.7 1.9 Allowed 'General case' 0 C--N 1.296 -1.728 0 N-CA-C 107.79 -1.189 . . . . 0.0 107.79 177.843 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 177' ' ' LYS . . . . . 0.696 ' O ' ' O ' ' A' ' 176' ' ' ASP . 0.7 OUTLIER -20.54 158.02 0.0 OUTLIER 'General case' 0 N--CA 1.507 2.39 0 CA-C-O 122.218 1.009 . . . . 0.0 112.249 -179.075 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 178' ' ' GLN . . . . . 0.455 ' NE2' HD22 ' A' ' 114' ' ' ASN . 0.4 OUTLIER -157.03 164.22 38.2 Favored 'General case' 0 C--N 1.303 -1.414 0 C-N-CA 117.052 -1.859 . . . . 0.0 112.026 179.804 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 179' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -122.23 107.39 12.08 Favored 'General case' 0 C--N 1.303 -1.42 0 N-CA-C 107.345 -1.354 . . . . 0.0 107.345 179.083 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 180' ' ' THR . . . . . 0.617 ' HG1' ' CG ' ' A' ' 170' ' ' ASP . 1.0 OUTLIER -78.66 120.32 23.16 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 120.87 -1.144 . . . . 0.0 110.278 -178.427 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 181' ' ' LEU . . . . . . . . . . . . . 10.2 tp -100.16 105.78 17.42 Favored 'General case' 0 N--CA 1.492 1.671 0 O-C-N 121.536 -0.728 . . . . 0.0 109.099 178.883 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 182' ' ' ILE . . . . . . . . . . . . . 56.3 mt -95.63 125.86 48.29 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.419 0 O-C-N 121.064 -1.022 . . . . 0.0 110.046 179.875 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 183' ' ' THR . . . . . 0.434 HG21 ' CE2' ' A' ' 200' ' ' PHE . 0.0 OUTLIER -135.75 111.74 9.57 Favored 'General case' 0 C--N 1.294 -1.843 0 N-CA-C 107.367 -1.346 . . . . 0.0 107.367 178.493 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 184' ' ' CYS . . . . . . . . . . . . . 0.8 OUTLIER -79.6 156.14 27.81 Favored 'General case' 0 C--N 1.292 -1.909 0 C-N-CA 118.783 -1.167 . . . . 0.0 110.851 -177.947 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 185' ' ' ASP . . . . . 0.481 ' OD1' ' N ' ' A' ' 186' ' ' ASP . 10.3 t0 -167.24 -154.07 0.16 Allowed 'General case' 0 N--CA 1.495 1.789 0 O-C-N 121.365 -0.834 . . . . 0.0 109.821 -179.656 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 186' ' ' ASP . . . . . 0.481 ' N ' ' OD1' ' A' ' 185' ' ' ASP . 0.9 OUTLIER 52.8 52.63 13.58 Favored 'General case' 0 N--CA 1.496 1.862 0 O-C-N 121.294 -0.879 . . . . 0.0 109.504 -179.858 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 187' ' ' TYR . . . . . 0.577 ' CE1' ' O ' ' A' ' 188' ' ' ASN . 56.9 t80 -68.68 129.25 39.39 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.291 -0.881 . . . . 0.0 110.958 -179.677 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 188' ' ' ASN . . . . . 0.817 HD21 ' N ' ' A' ' 192' ' ' GLY . 0.0 OUTLIER -101.09 151.39 21.87 Favored 'General case' 0 C--N 1.293 -1.86 0 N-CA-C 107.07 -1.456 . . . . 0.0 107.07 177.073 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 189' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -112.82 -7.15 13.79 Favored 'General case' 0 C--N 1.294 -1.816 0 N-CA-C 108.179 -1.045 . . . . 0.0 108.179 -179.526 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 190' ' ' LYS . . . . . 0.585 ' N ' ' OD1' ' A' ' 188' ' ' ASN . 0.6 OUTLIER -82.91 -56.16 3.98 Favored 'General case' 0 N--CA 1.489 1.482 0 C-N-CA 120.062 -0.655 . . . . 0.0 109.424 179.144 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 191' ' ' THR . . . . . 0.56 ' C ' HD21 ' A' ' 188' ' ' ASN . 4.9 p -88.12 -2.86 58.86 Favored 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.305 -0.872 . . . . 0.0 109.453 -179.779 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 192' ' ' GLY . . . . . 0.817 ' N ' HD21 ' A' ' 188' ' ' ASN . . . 62.86 33.18 86.3 Favored Glycine 0 N--CA 1.493 2.483 0 O-C-N 121.345 -0.847 . . . . 0.0 111.657 178.349 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 193' ' ' VAL . . . . . 0.791 ' H ' HD22 ' A' ' 188' ' ' ASN . 4.0 p -147.81 167.05 4.97 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.689 0 O-C-N 120.686 -1.479 . . . . 0.0 109.959 178.873 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 194' ' ' TRP . . . . . 0.571 ' CD1' ' OG1' ' C' ' 705' ' ' B27 . 17.0 m95 -82.04 120.86 25.81 Favored 'General case' 0 C--N 1.295 -1.764 0 N-CA-C 108.495 -0.928 . . . . 0.0 108.495 179.854 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 195' ' ' GLU . . . . . . . . . . . . . 1.3 mt-10 -83.84 -60.97 1.95 Allowed 'General case' 0 C--N 1.301 -1.513 0 O-C-N 121.471 -0.768 . . . . 0.0 110.864 -178.086 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 196' ' ' LYS . . . . . . . . . . . . . 12.8 tttt -86.39 158.42 19.63 Favored 'General case' 0 C--N 1.301 -1.527 0 O-C-N 120.888 -1.132 . . . . 0.0 110.566 -179.007 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 197' ' ' ARG . . . . . 0.404 ' HE ' ' HB2' ' C' ' 702' ' ' LEU . 0.0 OUTLIER -126.29 135.73 51.89 Favored 'General case' 0 N--CA 1.489 1.482 0 N-CA-C 108.512 -0.922 . . . . 0.0 108.512 179.116 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 198' ' ' LYS . . . . . . . . . . . . . 14.3 mttt -115.39 120.93 41.23 Favored 'General case' 0 N--CA 1.494 1.727 0 O-C-N 121.553 -0.717 . . . . 0.0 110.422 -179.197 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 199' ' ' ILE . . . . . 0.462 ' C ' HD12 ' A' ' 199' ' ' ILE . 0.9 OUTLIER -141.51 118.81 8.06 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.646 0 CA-C-O 122.494 1.14 . . . . 0.0 110.043 179.478 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 200' ' ' PHE . . . . . 0.619 ' CD1' ' N ' ' A' ' 200' ' ' PHE . 0.3 OUTLIER -104.24 135.74 45.15 Favored 'General case' 0 N--CA 1.496 1.855 0 O-C-N 121.295 -0.878 . . . . 0.0 109.586 -178.441 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 201' ' ' VAL . . . . . 0.444 HG12 ' N ' ' A' ' 202' ' ' ALA . 85.2 t -104.36 154.57 6.1 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.611 0 O-C-N 120.979 -1.076 . . . . 0.0 109.07 178.585 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 202' ' ' ALA . . . . . 0.444 ' N ' HG12 ' A' ' 201' ' ' VAL . . . -136.49 142.37 43.52 Favored 'General case' 0 C--N 1.302 -1.472 0 O-C-N 121.153 -0.967 . . . . 0.0 109.055 179.991 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 203' ' ' THR . . . . . 0.507 ' O ' HG23 ' A' ' 205' ' ' VAL . 0.6 OUTLIER -88.59 129.66 35.44 Favored 'General case' 0 N--CA 1.488 1.465 0 CA-C-O 122.281 1.039 . . . . 0.0 111.26 -178.455 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 204' ' ' GLU . . . . . 0.536 ' HA ' ' CD2' ' A' ' 153' ' ' TYR . 12.0 tt0 -49.59 134.74 19.42 Favored 'General case' 0 C--N 1.298 -1.643 0 C-N-CA 119.098 -1.041 . . . . 0.0 108.626 178.38 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 205' ' ' VAL . . . . . 0.539 HG12 ' N ' ' A' ' 206' ' ' LYS . 39.0 t -125.86 161.13 31.62 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.304 0 CA-C-O 122.263 1.03 . . . . 0.0 110.431 -177.765 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 206' ' ' LYS . . . . . 0.539 ' N ' HG12 ' A' ' 205' ' ' VAL . 13.1 mtmt . . . . . 0 C--N 1.293 -1.864 0 CA-C-O 117.931 -1.033 . . . . 0.0 108.983 179.754 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' C' C ' 701' ' ' PHQ . . . . . 0.487 ' O2 ' HG12 ' A' ' 166' ' ' VAL . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' C' C ' 702' ' ' LEU . . . . . 0.858 ' N ' HD12 ' C' ' 702' ' ' LEU . 0.0 OUTLIER . . . . . 0 N--CA 1.488 1.453 0 N-CA-C 108.735 -0.839 . . . . 0.0 108.735 . . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' C' C ' 703' ' ' PRO . . . . . 0.47 ' HB2' ' HB3' ' A' ' 92' ' ' ALA . 9.4 Cg_endo -64.97 -173.0 0.23 Allowed 'Trans proline' 0 N--CA 1.491 1.341 0 C-N-CA 121.619 1.546 . . . . 0.0 112.099 -179.666 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' C' C ' 704' ' ' ALA . . . . . 0.663 ' HB2' ' HB1' ' A' ' 118' ' ' ALA . . . 56.99 97.51 0.02 OUTLIER 'General case' 0 N--CA 1.487 1.415 0 O-C-N 121.334 -0.854 . . . . 0.0 109.396 -179.558 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' C' C ' 705' ' ' B27 . . . . . 0.632 ' SG ' ' CD2' ' A' ' 120' ' ' HIS . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 700' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 020 nuclear nobuild full ' A' A ' 59' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.491 1.575 0 N-CA-C 109.391 -0.596 . . . . 0.0 109.391 . . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 60' ' ' GLN . . . . . . . . . . . . . 0.4 OUTLIER -60.33 -176.54 0.05 Allowed 'General case' 0 N--CA 1.491 1.615 0 N-CA-C 108.794 -0.817 . . . . 0.0 108.794 179.665 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . -65.05 154.19 38.54 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 120.878 -1.139 . . . . 0.0 109.467 179.981 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 62' ' ' LYS . . . . . . . . . . . . . 5.4 tmtm? -141.46 74.64 23.56 Favored Pre-proline 0 N--CA 1.491 1.618 0 C-N-CA 119.397 -0.921 . . . . 0.0 109.896 179.932 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 63' ' ' PRO . . . . . . . . . . . . . 45.2 Cg_endo -91.71 156.74 3.49 Favored 'Trans proline' 0 C--N 1.307 -1.62 0 C-N-CA 123.378 2.718 . . . . 0.0 112.224 179.712 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 64' ' ' GLN . . . . . 0.672 ' NE2' ' N ' ' A' ' 64' ' ' GLN . 0.0 OUTLIER -153.98 117.49 4.63 Favored 'General case' 0 N--CA 1.498 1.932 0 O-C-N 121.531 -0.73 . . . . 0.0 109.163 179.517 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 65' ' ' ILE . . . . . 0.44 ' C ' ' O ' ' A' ' 64' ' ' GLN . 3.2 mp -45.28 105.75 0.49 Allowed Pre-proline 0 N--CA 1.493 1.682 0 O-C-N 121.027 -1.045 . . . . 0.0 108.758 179.395 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 66' ' ' PRO . . . . . . . . . . . . . 84.5 Cg_endo -86.46 -158.08 0.08 OUTLIER 'Trans proline' 0 N--CA 1.488 1.148 0 C-N-CA 122.048 1.832 . . . . 0.0 112.51 -179.536 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 67' ' ' LYS . . . . . 0.435 ' O ' ' N ' ' A' ' 69' ' ' LYS . 0.0 OUTLIER -82.82 -4.56 58.18 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.396 -0.815 . . . . 0.0 109.584 -179.756 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 68' ' ' ASP . . . . . 0.62 ' C ' ' N ' ' A' ' 70' ' ' SER . 0.3 OUTLIER -74.05 51.1 0.39 Allowed 'General case' 0 N--CA 1.487 1.411 0 CA-C-O 122.913 1.34 . . . . 0.0 107.919 179.28 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 69' ' ' LYS . . . . . 0.435 ' N ' ' O ' ' A' ' 67' ' ' LYS . 0.1 OUTLIER -49.54 -13.13 0.07 Allowed 'General case' 0 C--N 1.29 -1.99 0 C-N-CA 116.889 -1.924 . . . . 0.0 106.976 178.792 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 70' ' ' SER . . . . . 0.62 ' N ' ' C ' ' A' ' 68' ' ' ASP . 3.6 p -84.25 -8.99 58.87 Favored 'General case' 0 N--CA 1.498 1.96 0 CA-C-N 113.631 -1.622 . . . . 0.0 110.056 178.444 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 71' ' ' LYS . . . . . . . . . . . . . 2.6 ptmm? -96.89 140.57 31.24 Favored 'General case' 0 N--CA 1.494 1.737 0 O-C-N 120.905 -1.122 . . . . 0.0 111.003 -179.739 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 72' ' ' VAL . . . . . 0.674 HG12 ' CE1' ' A' ' 88' ' ' TYR . 1.1 m -63.23 139.78 20.71 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.387 0 N-CA-C 104.331 -2.47 . . . . 0.0 104.331 175.288 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 73' ' ' ALA . . . . . 0.512 ' N ' ' O ' ' A' ' 87' ' ' VAL . . . -82.15 -16.99 47.93 Favored 'General case' 0 C--N 1.287 -2.14 0 C-N-CA 117.405 -1.718 . . . . 0.0 106.806 -179.948 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . 177.7 -158.54 23.8 Favored Glycine 0 C--N 1.298 -1.54 0 N-CA-C 109.383 -1.487 . . . . 0.0 109.383 179.408 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 75' ' ' TYR . . . . . 0.499 ' HA ' HG23 ' A' ' 87' ' ' VAL . 0.7 OUTLIER -143.47 165.48 27.44 Favored 'General case' 0 C--N 1.296 -1.729 0 O-C-N 121.716 -0.873 . . . . 0.0 110.55 -176.722 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 76' ' ' ILE . . . . . . . . . . . . . 4.4 tt -148.66 146.68 17.42 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.453 0 C-N-CA 119.069 -1.052 . . . . 0.0 110.659 -177.866 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -150.13 167.84 25.66 Favored 'General case' 0 N--CA 1.489 1.482 0 O-C-N 121.181 -0.949 . . . . 0.0 109.195 179.119 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 78' ' ' ILE . . . . . 0.472 ' HB ' ' HB3' ' A' ' 81' ' ' ALA . 16.9 mt -149.67 98.18 3.43 Favored Pre-proline 0 C--N 1.303 -1.442 0 N-CA-C 108.543 -0.91 . . . . 0.0 108.543 179.474 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 79' ' ' PRO . . . . . . . . . . . . . 54.1 Cg_exo -48.83 -46.57 24.22 Favored 'Trans proline' 0 C--N 1.31 -1.481 0 C-N-CA 122.517 2.145 . . . . 0.0 113.76 -178.95 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -66.02 -19.83 65.99 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 120.892 -1.13 . . . . 0.0 111.244 179.339 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 81' ' ' ALA . . . . . 0.711 ' HB2' ' HB2' ' A' ' 136' ' ' ALA . . . -105.42 -19.34 13.82 Favored 'General case' 0 N--CA 1.495 1.806 0 O-C-N 121.052 -1.03 . . . . 0.0 108.861 179.633 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 82' ' ' ASP . . . . . 0.452 ' CB ' ' O ' ' A' ' 81' ' ' ALA . 5.6 t70 71.42 48.01 0.35 Allowed 'General case' 0 N--CA 1.494 1.736 0 O-C-N 120.988 -1.07 . . . . 0.0 110.328 179.33 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 83' ' ' ILE . . . . . 0.508 HD11 ' OD1' ' A' ' 132' ' ' ASN . 82.5 mt -127.42 152.57 35.63 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.696 0 O-C-N 121.265 -0.897 . . . . 0.0 110.021 -179.006 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 84' ' ' LYS . . . . . . . . . . . . . 33.2 tttt -159.46 107.32 1.76 Allowed 'General case' 0 N--CA 1.491 1.617 0 N-CA-C 107.944 -1.132 . . . . 0.0 107.944 179.427 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 85' ' ' GLU . . . . . 0.413 ' C ' ' CD2' ' A' ' 75' ' ' TYR . 0.3 OUTLIER -144.05 164.85 27.03 Favored Pre-proline 0 N--CA 1.491 1.604 0 O-C-N 121.281 -0.887 . . . . 0.0 110.488 -178.741 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 86' ' ' PRO . . . . . 0.409 ' O ' HG22 ' A' ' 101' ' ' VAL . 55.8 Cg_endo -72.46 170.38 19.47 Favored 'Trans proline' 0 N--CA 1.495 1.578 0 C-N-CA 123.635 2.89 . . . . 0.0 113.633 -179.494 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 87' ' ' VAL . . . . . 0.512 ' O ' ' N ' ' A' ' 73' ' ' ALA . 54.1 t -127.26 98.07 4.41 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.822 0 N-CA-C 109.047 -0.723 . . . . 0.0 109.047 179.828 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 88' ' ' TYR . . . . . 0.674 ' CE1' HG12 ' A' ' 72' ' ' VAL . 21.1 m-85 -88.17 154.05 51.74 Favored Pre-proline 0 N--CA 1.505 2.284 0 O-C-N 120.659 -1.276 . . . . 0.0 110.42 -179.443 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 89' ' ' PRO . . . . . 0.422 ' HA ' ' CD2' ' A' ' 103' ' ' PHE . 9.7 Cg_endo -61.54 145.09 98.12 Favored 'Trans proline' 0 C--N 1.311 -1.429 0 C-N-CA 122.5 2.133 . . . . 0.0 113.76 -179.677 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . -56.58 166.05 4.69 Favored Glycine 0 N--CA 1.491 2.342 0 N-CA-C 109.575 -1.41 . . . . 0.0 109.575 179.255 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 91' ' ' PRO . . . . . 0.439 ' C ' ' H ' ' A' ' 93' ' ' THR . 44.8 Cg_endo -94.29 168.22 19.08 Favored 'Cis proline' 0 C--N 1.312 -1.38 0 C-N-CA 123.864 -1.307 . . . . 0.0 111.949 0.167 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 92' ' ' ALA . . . . . 0.727 ' HB1' HD21 ' A' ' 97' ' ' LEU . . . -71.91 31.26 0.05 Allowed 'General case' 0 C--N 1.302 -1.463 0 O-C-N 121.281 -0.887 . . . . 0.0 110.396 179.952 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 93' ' ' THR . . . . . 0.439 ' H ' ' C ' ' A' ' 91' ' ' PRO . 1.0 OUTLIER -74.71 151.24 86.85 Favored Pre-proline 0 N--CA 1.491 1.605 0 O-C-N 120.501 -1.374 . . . . 0.0 108.43 179.846 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 94' ' ' PRO . . . . . 0.414 ' C ' ' O ' ' A' ' 93' ' ' THR . 86.5 Cg_exo -29.91 -54.42 0.19 Allowed 'Trans proline' 0 C--N 1.308 -1.565 0 C-N-CA 123.228 2.619 . . . . 0.0 113.207 -178.861 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 83.6 mt-10 -47.24 -49.31 23.58 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 120.796 -1.19 . . . . 0.0 109.706 -179.528 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 96' ' ' GLN . . . . . 0.694 HE21 HH12 ' A' ' 99' ' ' ARG . 6.1 mp0 -71.72 -53.13 14.47 Favored 'General case' 0 C--N 1.303 -1.446 0 O-C-N 121.337 -0.852 . . . . 0.0 110.376 -179.658 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 97' ' ' LEU . . . . . 0.727 HD21 ' HB1' ' A' ' 92' ' ' ALA . 83.8 mt -50.53 -9.0 0.04 OUTLIER 'General case' 0 N--CA 1.493 1.724 0 O-C-N 121.149 -0.969 . . . . 0.0 110.299 -178.498 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 98' ' ' ASN . . . . . 0.628 HD21 ' NE ' ' A' ' 99' ' ' ARG . 0.2 OUTLIER -72.55 -27.69 62.38 Favored 'General case' 0 N--CA 1.488 1.45 0 O-C-N 121.029 -1.044 . . . . 0.0 108.863 179.534 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 99' ' ' ARG . . . . . 0.694 HH12 HE21 ' A' ' 96' ' ' GLN . 6.1 mtt180 -94.27 -60.17 1.79 Allowed 'General case' 0 N--CA 1.491 1.577 0 C-N-CA 119.973 -0.691 . . . . 0.0 110.529 -179.651 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . -171.66 -166.58 30.61 Favored Glycine 0 N--CA 1.499 2.835 0 C-N-CA 119.424 -1.369 . . . . 0.0 111.003 -179.501 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 101' ' ' VAL . . . . . 0.748 ' O ' HG23 ' A' ' 101' ' ' VAL . 16.3 m -57.47 106.46 0.18 Allowed 'Isoleucine or valine' 0 N--CA 1.498 1.928 0 O-C-N 121.554 -0.968 . . . . 0.0 109.455 -179.783 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -93.8 159.71 15.07 Favored 'General case' 0 N--CA 1.493 1.696 0 O-C-N 121.244 -0.91 . . . . 0.0 111.633 -179.068 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 103' ' ' PHE . . . . . 0.422 ' CD2' ' HA ' ' A' ' 89' ' ' PRO . 23.5 m-85 -63.18 130.93 46.71 Favored 'General case' 0 N--CA 1.49 1.531 0 N-CA-C 107.881 -1.155 . . . . 0.0 107.881 178.235 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 104' ' ' ALA . . . . . . . . . . . . . . . -50.95 -18.34 0.75 Allowed 'General case' 0 C--N 1.299 -1.619 0 O-C-N 121.58 -0.7 . . . . 0.0 111.42 -178.532 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -136.91 146.66 45.74 Favored 'General case' 0 N--CA 1.495 1.808 0 O-C-N 120.799 -1.188 . . . . 0.0 111.011 -179.447 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 106' ' ' GLU . . . . . . . . . . . . . 1.7 tt0 -55.26 -62.33 1.74 Allowed 'General case' 0 C--N 1.305 -1.351 0 CA-C-N 116.061 -0.518 . . . . 0.0 110.316 -179.903 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 107' ' ' ASN . . . . . 0.661 HD22 ' N ' ' A' ' 107' ' ' ASN . 0.7 OUTLIER -78.81 33.48 0.21 Allowed 'General case' 0 N--CA 1.491 1.607 0 O-C-N 120.609 -1.307 . . . . 0.0 113.184 -175.638 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 108' ' ' GLU . . . . . . . . . . . . . 29.0 tp10 -58.25 143.32 44.85 Favored 'General case' 0 N--CA 1.495 1.813 0 O-C-N 120.468 -1.395 . . . . 0.0 107.963 179.945 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 109' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -94.95 140.45 29.92 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 120.961 -1.087 . . . . 0.0 110.987 -178.013 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 110' ' ' LEU . . . . . 0.484 HD11 HG21 ' A' ' 146' ' ' VAL . 0.7 OUTLIER -63.7 -16.78 61.94 Favored 'General case' 0 C--N 1.302 -1.469 0 N-CA-C 108.754 -0.832 . . . . 0.0 108.754 179.207 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 111' ' ' ASP . . . . . . . . . . . . . 13.0 m-20 -133.1 36.83 3.43 Favored 'General case' 0 N--CA 1.488 1.475 0 O-C-N 121.677 -0.639 . . . . 0.0 109.762 -179.439 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 112' ' ' ASP . . . . . . . . . . . . . 1.7 t0 -65.93 150.07 49.22 Favored 'General case' 0 N--CA 1.494 1.76 0 O-C-N 121.033 -1.042 . . . . 0.0 110.706 -179.58 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 113' ' ' GLN . . . . . 0.477 ' HA ' ' NE2' ' A' ' 113' ' ' GLN . 0.8 OUTLIER -68.11 -13.12 61.97 Favored 'General case' 0 N--CA 1.491 1.598 0 N-CA-C 107.849 -1.167 . . . . 0.0 107.849 177.84 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 114' ' ' ASN . . . . . . . . . . . . . 2.7 t30 -149.38 103.0 3.25 Favored 'General case' 0 C--N 1.302 -1.477 0 N-CA-C 107.818 -1.178 . . . . 0.0 107.818 177.913 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 115' ' ' ILE . . . . . 0.492 ' O ' HG22 ' A' ' 115' ' ' ILE . 3.0 mt -97.34 110.47 25.26 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.479 0 O-C-N 121.156 -0.965 . . . . 0.0 109.837 -179.135 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 116' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -96.38 145.23 25.81 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.075 -1.015 . . . . 0.0 111.265 -178.392 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 117' ' ' ILE . . . . . . . . . . . . . 1.4 mt -139.65 156.55 26.21 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.768 0 N-CA-C 107.887 -1.153 . . . . 0.0 107.887 178.951 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 118' ' ' ALA . . . . . . . . . . . . . . . -142.06 160.38 40.34 Favored 'General case' 0 N--CA 1.491 1.601 0 C-N-CA 118.775 -1.17 . . . . 0.0 111.812 -179.07 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 119' ' ' GLY . . . . . . . . . . . . . . . -164.66 145.49 10.34 Favored Glycine 0 N--CA 1.481 1.688 0 N-CA-C 109.636 -1.386 . . . . 0.0 109.636 179.667 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 120' ' ' HIS . . . . . 0.449 ' CD2' HD13 ' A' ' 97' ' ' LEU . 10.5 m-70 -71.03 166.22 21.82 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.665 -0.903 . . . . 0.0 109.897 179.119 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 121' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -123.69 149.28 45.68 Favored 'General case' 0 N--CA 1.496 1.858 0 N-CA-C 107.637 -1.245 . . . . 0.0 107.637 178.53 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 122' ' ' PHE . . . . . 0.442 ' H ' ' HG1' ' A' ' 131' ' ' THR . 0.4 OUTLIER -114.88 138.02 51.28 Favored 'General case' 0 N--CA 1.492 1.666 0 O-C-N 121.178 -0.951 . . . . 0.0 109.99 -179.227 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 123' ' ' ILE . . . . . 0.487 HG23 ' N ' ' A' ' 124' ' ' ASP . 17.8 tt -89.39 -31.56 5.41 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.677 0 CA-C-O 121.98 0.895 . . . . 0.0 109.432 -179.782 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 124' ' ' ASP . . . . . 0.487 ' N ' HG23 ' A' ' 123' ' ' ILE . 0.2 OUTLIER -85.48 -3.67 58.93 Favored 'General case' 0 C--N 1.292 -1.908 0 C-N-CA 120.05 -0.66 . . . . 0.0 112.218 -177.71 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 125' ' ' ARG . . . . . 0.411 ' HG3' ' CD1' ' A' ' 122' ' ' PHE . 0.0 OUTLIER -157.15 130.97 4.8 Favored Pre-proline 0 N--CA 1.499 1.986 0 O-C-N 120.249 -1.532 . . . . 0.0 110.668 179.443 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 126' ' ' PRO . . . . . . . . . . . . . 88.7 Cg_endo -83.18 -13.23 9.02 Favored 'Trans proline' 0 N--CA 1.497 1.709 0 C-N-CA 122.676 2.251 . . . . 0.0 113.218 178.94 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 127' ' ' ASN . . . . . . . . . . . . . 1.4 t30 -89.32 24.79 2.1 Favored 'General case' 0 N--CA 1.494 1.735 0 O-C-N 121.041 -1.037 . . . . 0.0 110.05 -178.924 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 128' ' ' TYR . . . . . . . . . . . . . 9.6 t80 -83.15 -148.75 0.09 Allowed 'General case' 0 C--N 1.299 -1.621 0 O-C-N 121.237 -0.914 . . . . 0.0 109.322 -179.892 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 129' ' ' GLN . . . . . . . . . . . . . 6.4 mt-30 -65.75 -88.51 0.01 OUTLIER 'General case' 0 C--N 1.299 -1.63 0 O-C-N 121.345 -0.847 . . . . 0.0 110.172 -179.319 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 130' ' ' PHE . . . . . 0.576 ' CE2' HG11 ' A' ' 101' ' ' VAL . 35.8 m-85 -111.91 32.27 5.6 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.353 -0.842 . . . . 0.0 109.977 -179.249 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 131' ' ' THR . . . . . 0.442 ' HG1' ' H ' ' A' ' 122' ' ' PHE . 89.8 m -71.23 -33.94 70.32 Favored 'General case' 0 N--CA 1.497 1.878 0 O-C-N 121.385 -0.822 . . . . 0.0 109.441 179.514 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 132' ' ' ASN . . . . . 0.606 ' ND2' ' O ' ' A' ' 81' ' ' ALA . 0.1 OUTLIER -84.69 5.82 26.67 Favored 'General case' 0 N--CA 1.498 1.962 0 CA-C-O 121.945 0.879 . . . . 0.0 109.364 -179.624 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 133' ' ' LEU . . . . . 0.592 ' O ' ' N ' ' A' ' 135' ' ' ALA . 0.2 OUTLIER -72.34 -45.25 60.72 Favored 'General case' 0 C--N 1.297 -1.684 0 O-C-N 121.157 -0.964 . . . . 0.0 109.738 179.69 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 134' ' ' LYS . . . . . 0.624 ' H ' ' CE ' ' A' ' 134' ' ' LYS . 0.0 OUTLIER -47.39 -10.39 0.02 OUTLIER 'General case' 0 C--N 1.3 -1.585 0 O-C-N 121.14 -0.975 . . . . 0.0 109.546 -179.634 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 135' ' ' ALA . . . . . 0.592 ' N ' ' O ' ' A' ' 133' ' ' LEU . . . -84.65 -39.72 18.28 Favored 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.081 -1.012 . . . . 0.0 109.165 179.225 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 136' ' ' ALA . . . . . 0.711 ' HB2' ' HB2' ' A' ' 81' ' ' ALA . . . -78.19 159.58 28.47 Favored 'General case' 0 N--CA 1.489 1.49 0 CA-C-O 122.08 0.943 . . . . 0.0 111.586 -178.472 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 137' ' ' LYS . . . . . 0.559 ' O ' ' O ' ' A' ' 138' ' ' LYS . 7.9 tttt -154.25 -162.76 1.47 Allowed 'General case' 0 N--CA 1.492 1.662 0 C-N-CA 118.801 -1.159 . . . . 0.0 110.467 -178.515 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 138' ' ' LYS . . . . . 0.606 ' O ' ' N ' ' A' ' 140' ' ' SER . 23.0 mttt -44.25 -179.26 0.0 OUTLIER 'General case' 0 C--N 1.302 -1.468 0 CA-C-O 122.334 1.064 . . . . 0.0 110.667 -179.282 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 139' ' ' GLY . . . . . . . . . . . . . . . 46.41 8.25 0.02 OUTLIER Glycine 0 N--CA 1.492 2.408 0 N-CA-C 110.018 -1.233 . . . . 0.0 110.018 -179.676 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 140' ' ' SER . . . . . 0.606 ' N ' ' O ' ' A' ' 138' ' ' LYS . 9.9 m -81.2 144.11 31.85 Favored 'General case' 0 N--CA 1.493 1.705 0 O-C-N 120.864 -1.374 . . . . 0.0 109.224 179.235 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 141' ' ' MET . . . . . . . . . . . . . 2.1 tpt -96.39 125.95 41.25 Favored 'General case' 0 C--N 1.301 -1.535 0 O-C-N 121.127 -0.983 . . . . 0.0 109.403 -179.921 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 142' ' ' VAL . . . . . . . . . . . . . 2.4 t -113.77 128.77 70.52 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.838 0 O-C-N 121.269 -0.894 . . . . 0.0 109.554 -179.438 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 143' ' ' TYR . . . . . 0.409 ' CZ ' ' CD ' ' A' ' 152' ' ' LYS . 3.0 m-85 -107.48 134.39 50.58 Favored 'General case' 0 N--CA 1.497 1.91 0 O-C-N 121.172 -0.955 . . . . 0.0 111.158 -178.838 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 144' ' ' PHE . . . . . . . . . . . . . 24.7 t80 -118.86 99.89 7.04 Favored 'General case' 0 N--CA 1.494 1.726 0 N-CA-C 109.221 -0.659 . . . . 0.0 109.221 179.965 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 145' ' ' LYS . . . . . . . . . . . . . 8.2 mtpm? -98.56 122.47 41.8 Favored 'General case' 0 N--CA 1.488 1.426 0 O-C-N 121.231 -0.918 . . . . 0.0 110.196 -179.353 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 146' ' ' VAL . . . . . 0.498 HG23 ' O ' ' A' ' 73' ' ' ALA . 1.0 OUTLIER -143.51 122.82 8.25 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.499 0 O-C-N 120.885 -1.134 . . . . 0.0 109.058 179.005 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 147' ' ' GLY . . . . . . . . . . . . . . . 67.23 -132.91 30.7 Favored Glycine 0 N--CA 1.484 1.869 0 N-CA-C 108.186 -1.966 . . . . 0.0 108.186 -179.387 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 148' ' ' ASN . . . . . 0.611 ' C ' ' ND2' ' A' ' 148' ' ' ASN . 0.0 OUTLIER -101.28 11.36 39.44 Favored 'General case' 0 C--N 1.296 -1.727 0 N-CA-C 107.918 -1.141 . . . . 0.0 107.918 178.789 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 149' ' ' GLU . . . . . . . . . . . . . 2.4 tt0 -108.13 143.03 37.45 Favored 'General case' 0 N--CA 1.489 1.484 0 O-C-N 121.311 -0.868 . . . . 0.0 111.35 -178.841 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 150' ' ' THR . . . . . 0.405 ' O ' HG22 ' A' ' 150' ' ' THR . 3.7 m -131.03 100.64 5.3 Favored 'General case' 0 N--CA 1.495 1.822 0 CA-C-O 121.413 0.625 . . . . 0.0 109.724 179.923 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 151' ' ' ARG . . . . . 0.58 HH12 ' CD ' ' A' ' 204' ' ' GLU . 0.1 OUTLIER -86.63 -169.99 2.88 Favored 'General case' 0 C--N 1.305 -1.347 0 N-CA-C 108.382 -0.969 . . . . 0.0 108.382 179.466 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 152' ' ' LYS . . . . . 0.42 ' C ' ' CD1' ' A' ' 153' ' ' TYR . 24.8 mtmm -153.22 151.29 29.9 Favored 'General case' 0 C--N 1.3 -1.57 0 O-C-N 121.327 -0.858 . . . . 0.0 109.7 -179.857 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 153' ' ' TYR . . . . . 0.508 ' CD2' ' HA ' ' A' ' 204' ' ' GLU . 6.2 m-85 -142.79 168.81 18.85 Favored 'General case' 0 N--CA 1.493 1.706 0 N-CA-C 107.856 -1.164 . . . . 0.0 107.856 178.759 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 154' ' ' LYS . . . . . . . . . . . . . 20.5 ttpt -142.9 119.38 10.98 Favored 'General case' 0 N--CA 1.493 1.678 0 O-C-N 121.51 -0.744 . . . . 0.0 109.186 178.884 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 155' ' ' MET . . . . . . . . . . . . . 29.2 mtp -47.28 105.62 0.07 Allowed 'General case' 0 N--CA 1.494 1.747 0 O-C-N 120.819 -1.176 . . . . 0.0 112.321 -178.983 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 156' ' ' THR . . . . . . . . . . . . . 1.3 m -105.39 -21.29 13.26 Favored 'General case' 0 N--CA 1.494 1.755 0 CA-C-N 115.445 -0.798 . . . . 0.0 110.168 -179.548 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 157' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -148.38 147.02 28.75 Favored 'General case' 0 N--CA 1.494 1.753 0 C-N-CA 118.336 -1.345 . . . . 0.0 110.814 -178.689 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 158' ' ' ILE . . . . . . . . . . . . . 1.1 mt -148.49 138.24 16.22 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.547 0 CA-C-O 121.577 0.703 . . . . 0.0 109.953 -178.463 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 159' ' ' ARG . . . . . . . . . . . . . 5.7 ttm180 -156.45 -161.96 1.19 Allowed 'General case' 0 N--CA 1.497 1.893 0 O-C-N 121.325 -0.859 . . . . 0.0 110.594 -179.565 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 160' ' ' ASP . . . . . . . . . . . . . 67.4 m-20 -149.09 156.17 41.81 Favored 'General case' 0 N--CA 1.498 1.956 0 N-CA-C 108.954 -0.758 . . . . 0.0 108.954 -179.909 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 161' ' ' VAL . . . . . 0.454 ' O ' ' O ' ' A' ' 162' ' ' LYS . 0.1 OUTLIER -149.15 148.08 16.04 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.807 0 O-C-N 120.699 -1.251 . . . . 0.0 110.359 179.851 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 162' ' ' LYS . . . . . 0.578 ' CD ' ' H ' ' A' ' 162' ' ' LYS . 0.0 OUTLIER -44.33 169.07 0.07 OUTLIER Pre-proline 0 N--CA 1.494 1.756 0 O-C-N 121.409 -0.807 . . . . 0.0 110.191 179.997 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 163' ' ' PRO . . . . . 0.418 ' C ' HD21 ' C' ' 702' ' ' LEU . 58.0 Cg_endo -78.98 23.7 0.62 Allowed 'Trans proline' 0 C--N 1.31 -1.476 0 C-N-CA 122.917 2.411 . . . . 0.0 112.572 -179.169 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 164' ' ' THR . . . . . 0.704 ' HA ' HD11 ' C' ' 702' ' ' LEU . 0.2 OUTLIER -151.22 1.69 0.41 Allowed 'General case' 0 C--N 1.299 -1.592 0 O-C-N 121.322 -0.861 . . . . 0.0 109.864 -179.488 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 165' ' ' ASP . . . . . 0.481 ' O ' ' C ' ' A' ' 166' ' ' VAL . 8.3 t70 -77.35 66.44 3.11 Favored 'General case' 0 N--CA 1.493 1.687 0 O-C-N 121.15 -0.969 . . . . 0.0 110.334 -179.877 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 166' ' ' VAL . . . . . 0.639 ' O ' ' N ' ' A' ' 168' ' ' VAL . 0.9 OUTLIER -38.0 -32.54 0.11 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.576 0 O-C-N 121.158 -0.963 . . . . 0.0 109.375 -178.638 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 167' ' ' GLY . . . . . 0.466 ' N ' ' O ' ' A' ' 165' ' ' ASP . . . -43.16 -15.71 0.03 OUTLIER Glycine 0 N--CA 1.491 2.325 0 N-CA-C 108.848 -1.701 . . . . 0.0 108.848 179.428 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 168' ' ' VAL . . . . . 0.639 ' N ' ' O ' ' A' ' 166' ' ' VAL . 3.5 t -49.98 -44.28 21.39 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.735 0 N-CA-C 108.168 -1.049 . . . . 0.0 108.168 178.412 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 169' ' ' LEU . . . . . 0.54 ' O ' ' C ' ' A' ' 170' ' ' ASP . 8.9 mt -50.2 -9.38 0.04 OUTLIER 'General case' 0 C--N 1.299 -1.628 0 N-CA-C 108.425 -0.954 . . . . 0.0 108.425 -177.396 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 170' ' ' ASP . . . . . 0.553 ' H ' ' C ' ' A' ' 168' ' ' VAL . 10.6 p30 18.46 80.87 0.01 OUTLIER 'General case' 0 N--CA 1.5 2.05 0 CA-C-N 116.582 -0.281 . . . . 0.0 111.699 177.793 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 171' ' ' GLU . . . . . . . . . . . . . 3.7 pt-20 -117.33 65.09 0.73 Allowed 'General case' 0 N--CA 1.493 1.692 0 O-C-N 121.152 -0.967 . . . . 0.0 110.069 179.833 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 172' ' ' GLN . . . . . . . . . . . . . 12.2 mt-30 -134.44 -45.91 0.76 Allowed 'General case' 0 N--CA 1.492 1.663 0 O-C-N 121.41 -0.806 . . . . 0.0 110.253 -178.598 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 173' ' ' LYS . . . . . . . . . . . . . 17.9 mttp -62.64 135.15 57.24 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 120.769 -1.207 . . . . 0.0 108.615 179.049 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 174' ' ' GLY . . . . . 0.52 ' O ' ' C ' ' A' ' 175' ' ' LYS . . . -141.21 -40.64 0.08 OUTLIER Glycine 0 C--N 1.295 -1.707 0 N-CA-C 108.138 -1.985 . . . . 0.0 108.138 179.899 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 175' ' ' LYS . . . . . 0.52 ' C ' ' O ' ' A' ' 174' ' ' GLY . 13.0 mptt -31.84 -64.08 0.17 Allowed 'General case' 0 N--CA 1.501 2.075 0 N-CA-C 108.653 -0.869 . . . . 0.0 108.653 179.196 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 176' ' ' ASP . . . . . 0.726 ' O ' ' O ' ' A' ' 177' ' ' LYS . 2.6 m-20 -101.93 73.28 1.39 Allowed 'General case' 0 C--N 1.297 -1.706 0 N-CA-C 107.255 -1.387 . . . . 0.0 107.255 177.627 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 177' ' ' LYS . . . . . 0.726 ' O ' ' O ' ' A' ' 176' ' ' ASP . 28.2 mttt -20.62 157.79 0.0 OUTLIER 'General case' 0 N--CA 1.504 2.233 0 CA-C-O 122.132 0.968 . . . . 0.0 111.851 -178.907 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 178' ' ' GLN . . . . . . . . . . . . . 3.3 pt20 -156.07 170.89 21.14 Favored 'General case' 0 N--CA 1.488 1.467 0 C-N-CA 117.096 -1.842 . . . . 0.0 112.084 -178.727 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 179' ' ' LEU . . . . . 0.41 ' HB2' ' CE2' ' A' ' 153' ' ' TYR . 0.7 OUTLIER -126.55 97.78 5.15 Favored 'General case' 0 C--N 1.303 -1.433 0 N-CA-C 107.237 -1.394 . . . . 0.0 107.237 178.366 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 180' ' ' THR . . . . . . . . . . . . . 1.1 m -71.23 121.06 17.71 Favored 'General case' 0 C--N 1.302 -1.464 0 C-N-CA 118.726 -1.19 . . . . 0.0 110.004 -178.615 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 181' ' ' LEU . . . . . 0.526 HD11 ' CE2' ' A' ' 130' ' ' PHE . 66.8 tp -94.55 152.25 18.69 Favored 'General case' 0 C--N 1.298 -1.654 0 N-CA-C 107.589 -1.263 . . . . 0.0 107.589 177.632 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 182' ' ' ILE . . . . . 0.404 HG21 ' HG2' ' C' ' 703' ' ' PRO . 36.5 mt -142.12 109.22 1.99 Allowed 'Isoleucine or valine' 0 C--N 1.301 -1.53 0 C-N-CA 119.083 -1.047 . . . . 0.0 109.242 178.941 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 183' ' ' THR . . . . . . . . . . . . . 1.2 t -129.21 109.36 11.08 Favored 'General case' 0 C--N 1.294 -1.836 0 N-CA-C 107.751 -1.203 . . . . 0.0 107.751 179.635 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 184' ' ' CYS . . . . . . . . . . . . . 4.0 p -81.06 157.96 25.24 Favored 'General case' 0 C--N 1.293 -1.879 0 C-N-CA 119.182 -1.007 . . . . 0.0 111.349 -177.609 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 185' ' ' ASP . . . . . 0.534 ' CG ' ' H ' ' A' ' 186' ' ' ASP . 43.9 t0 -164.3 -158.4 0.42 Allowed 'General case' 0 N--CA 1.489 1.509 0 N-CA-C 108.88 -0.785 . . . . 0.0 108.88 -179.536 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 186' ' ' ASP . . . . . 0.534 ' H ' ' CG ' ' A' ' 185' ' ' ASP . 1.3 m-20 56.91 49.35 14.2 Favored 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.161 -0.962 . . . . 0.0 109.675 179.561 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 187' ' ' TYR . . . . . 0.58 ' CE1' ' O ' ' A' ' 188' ' ' ASN . 33.9 t80 -65.43 128.69 36.91 Favored 'General case' 0 C--N 1.297 -1.674 0 O-C-N 121.075 -1.016 . . . . 0.0 109.772 -179.945 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 188' ' ' ASN . . . . . 0.821 HD22 ' H ' ' A' ' 193' ' ' VAL . 0.0 OUTLIER -97.85 150.55 21.17 Favored 'General case' 0 C--N 1.294 -1.838 0 N-CA-C 107.886 -1.153 . . . . 0.0 107.886 178.591 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 189' ' ' GLU . . . . . . . . . . . . . 1.7 tt0 -112.58 -5.95 13.97 Favored 'General case' 0 C--N 1.294 -1.831 0 N-CA-C 108.674 -0.862 . . . . 0.0 108.674 -178.683 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 190' ' ' LYS . . . . . 0.613 ' N ' ' OD1' ' A' ' 188' ' ' ASN . 10.2 mmtm -84.06 -57.45 3.18 Favored 'General case' 0 C--N 1.299 -1.618 0 N-CA-C 108.939 -0.763 . . . . 0.0 108.939 179.401 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 191' ' ' THR . . . . . 0.572 ' OG1' ' ND2' ' A' ' 188' ' ' ASN . 1.5 p -89.25 0.14 57.0 Favored 'General case' 0 N--CA 1.494 1.77 0 O-C-N 121.443 -0.785 . . . . 0.0 109.706 179.647 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 192' ' ' GLY . . . . . 0.66 ' N ' HD21 ' A' ' 188' ' ' ASN . . . 60.34 37.2 92.73 Favored Glycine 0 N--CA 1.498 2.783 0 N-CA-C 110.634 -0.986 . . . . 0.0 110.634 179.318 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 193' ' ' VAL . . . . . 0.821 ' H ' HD22 ' A' ' 188' ' ' ASN . 73.9 t -148.64 163.84 4.99 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.629 0 O-C-N 120.996 -1.297 . . . . 0.0 110.298 179.879 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 194' ' ' TRP . . . . . 0.609 ' N ' HG12 ' A' ' 193' ' ' VAL . 5.5 m95 -82.44 121.36 26.64 Favored 'General case' 0 N--CA 1.489 1.518 0 N-CA-C 108.373 -0.973 . . . . 0.0 108.373 179.257 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 195' ' ' GLU . . . . . . . . . . . . . 2.5 mt-10 -86.16 -57.39 3.04 Favored 'General case' 0 C--N 1.3 -1.566 0 O-C-N 121.15 -0.969 . . . . 0.0 110.463 -178.597 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 196' ' ' LYS . . . . . . . . . . . . . 2.6 mttp -92.33 143.65 26.18 Favored 'General case' 0 N--CA 1.489 1.494 0 O-C-N 120.911 -1.118 . . . . 0.0 110.205 -179.302 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 197' ' ' ARG . . . . . 0.653 ' CG ' HH11 ' A' ' 197' ' ' ARG . 0.2 OUTLIER -122.14 144.42 48.95 Favored 'General case' 0 N--CA 1.488 1.447 0 N-CA-C 108.784 -0.821 . . . . 0.0 108.784 179.108 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 198' ' ' LYS . . . . . . . . . . . . . 13.4 mptt -115.78 119.42 35.96 Favored 'General case' 0 C--N 1.299 -1.606 0 C-N-CA 120.349 -0.54 . . . . 0.0 110.087 -178.91 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 199' ' ' ILE . . . . . 0.456 ' C ' HD12 ' A' ' 199' ' ' ILE . 1.0 OUTLIER -136.33 118.15 19.94 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.566 0 CA-C-O 122.716 1.246 . . . . 0.0 109.018 178.968 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 200' ' ' PHE . . . . . 0.535 ' CD1' ' N ' ' A' ' 200' ' ' PHE . 1.0 OUTLIER -102.84 138.37 39.82 Favored 'General case' 0 N--CA 1.492 1.671 0 CA-C-N 115.6 -0.727 . . . . 0.0 111.257 -176.918 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 201' ' ' VAL . . . . . . . . . . . . . 47.0 t -105.94 143.22 17.31 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.37 0 O-C-N 121.523 -0.736 . . . . 0.0 109.396 177.799 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 202' ' ' ALA . . . . . . . . . . . . . . . -130.37 137.57 49.96 Favored 'General case' 0 C--N 1.301 -1.502 0 N-CA-C 107.978 -1.119 . . . . 0.0 107.978 179.662 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 203' ' ' THR . . . . . 0.679 ' O ' HG23 ' A' ' 205' ' ' VAL . 0.2 OUTLIER -89.89 132.82 35.09 Favored 'General case' 0 C--N 1.303 -1.422 0 CA-C-O 122.576 1.179 . . . . 0.0 111.549 -178.796 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 204' ' ' GLU . . . . . 0.58 ' CD ' HH12 ' A' ' 151' ' ' ARG . 3.9 tt0 -49.45 135.01 18.5 Favored 'General case' 0 C--N 1.293 -1.888 0 C-N-CA 118.459 -1.296 . . . . 0.0 108.796 178.575 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 205' ' ' VAL . . . . . 0.679 HG23 ' O ' ' A' ' 203' ' ' THR . 70.8 t -129.79 162.41 37.5 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.547 0 CA-C-O 122.082 0.944 . . . . 0.0 110.284 -177.739 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 206' ' ' LYS . . . . . 0.55 ' N ' HG12 ' A' ' 205' ' ' VAL . 4.6 ptmt . . . . . 0 C--N 1.298 -1.651 0 CA-C-O 118.145 -0.931 . . . . 0.0 109.42 -179.661 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' C' C ' 701' ' ' PHQ . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 020 nuclear nobuild full ' C' C ' 702' ' ' LEU . . . . . 0.884 ' N ' HD12 ' C' ' 702' ' ' LEU . 0.0 OUTLIER . . . . . 0 N--CA 1.485 1.32 0 N-CA-C 108.304 -0.998 . . . . 0.0 108.304 . . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' C' C ' 703' ' ' PRO . . . . . 0.603 ' O ' ' NH2' ' A' ' 197' ' ' ARG . 88.7 Cg_endo -81.1 172.76 12.56 Favored 'Trans proline' 0 C--N 1.303 -1.848 0 C-N-CA 122.632 2.221 . . . . 0.0 112.406 -179.688 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' C' C ' 704' ' ' ALA . . . . . 0.478 ' C ' ' O ' ' C' ' 703' ' ' PRO . . . 36.02 -156.04 0.0 OUTLIER 'General case' 0 N--CA 1.492 1.643 0 CA-C-O 121.536 0.684 . . . . 0.0 110.422 178.802 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' C' C ' 705' ' ' B27 . . . . . 0.586 ' OG1' ' CD1' ' A' ' 194' ' ' TRP . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 700' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 stop_ save_